PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Lee, DY; Wauquier, F; Eid, AA; Roman, LJ; Ghosh-Choudhury, G; Khazim, K; Block, K; Gorin, Y				Lee, Doug-Yoon; Wauquier, Fabien; Eid, Assaad A.; Roman, Linda J.; Ghosh-Choudhury, Goutam; Khazim, Khaled; Block, Karen; Gorin, Yves			Nox4 NADPH Oxidase Mediates Peroxynitrite-dependent Uncoupling of Endothelial Nitric-oxide Synthase and Fibronectin Expression in Response to Angiotensin II ROLE OF MITOCHONDRIAL REACTIVE OXYGEN SPECIES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Angiotensin II; Extracellular Matrix Proteins; Kidney; Nitric-oxide Synthase; Nox; Oxidative Stress	RAT MESANGIAL CELLS; EXPERIMENTAL DIABETIC-NEPHROPATHY; NAD(P)H OXIDASE; MOLECULAR-MECHANISMS; GLOMERULAR INJURY; RECEPTOR BLOCKADE; VASCULAR-DISEASE; REDOX CONTROL; UP-REGULATION; SUPEROXIDE	Activation of glomerular mesangial cells (MCs) by angiotensin II (Ang II) leads to extracellular matrix accumulation. Here, we demonstrate that, in MCs, Ang II induces endothelial nitric-oxide synthase (eNOS) uncoupling with enhanced generation of reactive oxygen species (ROS) and decreased production of NO. Ang II promotes a rapid increase in 3-nitrotyrosine formation, and uric acid attenuates Ang II-induced decrease in NO bioavailability, demonstrating that peroxynitrite mediates the effects of Ang II on eNOS dysfunction. Ang II rapidly up-regulates Nox4 protein. Inhibition of Nox4 abolishes the increase in ROS and peroxynitrite generation as well as eNOS uncoupling triggered by Ang II, indicating that Nox4 is upstream of eNOS. This pathway contributes to Ang II-mediated fibronectin accumulation in MCs. Ang II also elicits an increase in mitochondrial abundance of Nox4 protein, and the oxidase contributes to ROS production in mitochondria. Overexpression of mitochondrial manganese superoxide dismutase prevents the stimulatory effects of Ang II on mitochondrial ROS production, loss of NO availability, and MC fibronectin accumulation, whereas manganese superoxide dismutase depletion increases mitochondrial ROS, NO deficiency, and fibronectin synthesis basally and in cells exposed to Ang II. This work provides the first evidence that uncoupled eNOS is responsible for Ang II-induced MC fibronectin accumulation and identifies Nox4 and mitochondrial ROS as mediators of eNOS dysfunction. These data shed light on molecular processes underlying the oxidative signaling cascade engaged by Ang II and identify potential targets for intervention to prevent renal fibrosis.	[Lee, Doug-Yoon; Wauquier, Fabien; Eid, Assaad A.; Ghosh-Choudhury, Goutam; Khazim, Khaled; Block, Karen; Gorin, Yves] Univ Texas Hlth Sci Ctr San Antonio, Dept Med, San Antonio, TX 78229 USA; [Roman, Linda J.] Univ Texas Hlth Sci Ctr San Antonio, Dept Biochem, San Antonio, TX 78229 USA; [Ghosh-Choudhury, Goutam] Vet Adm Res & Geriatr Res Educ & Clin Ctr, San Antonio, TX 78229 USA; [Ghosh-Choudhury, Goutam; Block, Karen] South Texas Vet Hlth Care Syst, Audie Leon Murphy Mem Hosp Div, San Antonio, TX 78229 USA	University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio; Geriatric Research Education & Clinical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); Audie L. Murphy Memorial Veterans Hospital	Gorin, Y (corresponding author), Univ Texas Hlth Sci Ctr San Antonio, Div Nephrol MC 7882, Dept Med, 7703 Floyd Curl Dr, San Antonio, TX 78229 USA.	gorin@uthscsa.edu			National Institutes of Health [RO1 DK 079996, RO1 CA 131272, RO1 DK 50190]; Juvenile Diabetes Research Foundation Multiproject Grant; Juvenile Diabetes Research Foundation Advanced Research Fellowship Grant; Veterans Administration Merit Awards; Veterans Administration Senior Research Career Scientist Award; NATIONAL CANCER INSTITUTE [R01CA131272] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK079996, R01DK050190] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Juvenile Diabetes Research Foundation Multiproject Grant(Juvenile Diabetes Research Foundation); Juvenile Diabetes Research Foundation Advanced Research Fellowship Grant(Juvenile Diabetes Research Foundation); Veterans Administration Merit Awards; Veterans Administration Senior Research Career Scientist Award; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants RO1 DK 079996 (to Y. G.), RO1 CA 131272 (to K. B.), and RO1 DK 50190 (to G. G. C.). This work was also supported in part by a Juvenile Diabetes Research Foundation Multiproject Grant (to Y. G. and K. B.), a Juvenile Diabetes Research Foundation Advanced Research Fellowship Grant (to A. A. E.), and Veterans Administration Merit Awards (to K. B. and G. G. C.).; Recipient of Veterans Administration Senior Research Career Scientist Award.	Abboud HE, 2012, EXP CELL RES, V318, P979, DOI 10.1016/j.yexcr.2012.02.025; Alp NJ, 2004, ARTERIOSCL THROM VAS, V24, P413, DOI 10.1161/01.ATV.0000110785.96039.f6; Awad AS, 2004, J HYPERTENS, V22, P1571, DOI 10.1097/01.hjh.0000133718.86451.6a; Barnes JL, 2011, KIDNEY INT, V79, P944, DOI 10.1038/ki.2010.516; Bedard K, 2007, PHYSIOL REV, V87, P245, DOI 10.1152/physrev.00044.2005; Block K, 2008, J BIOL CHEM, V283, P24061, DOI 10.1074/jbc.M803964200; Block K, 2006, ANTIOXID REDOX SIGN, V8, P1497, DOI 10.1089/ars.2006.8.1497; Block K, 2009, P NATL ACAD SCI USA, V106, P14385, DOI 10.1073/pnas.0906805106; Brandes RP, 2011, ARTERIOSCL THROM VAS, V31, P1255, DOI 10.1161/ATVBAHA.111.226894; Chatziantoniou C, 2005, AM J PHYSIOL-RENAL, V289, pF227, DOI 10.1152/ajprenal.00453.2004; Craige SM, 2011, CIRCULATION, V124, P731, DOI 10.1161/CIRCULATIONAHA.111.030775; Cucoranu I, 2005, CIRC RES, V97, P900, DOI 10.1161/01.RES.0000187457.24338.3D; Dai DF, 2012, CIRC RES, V110, P1109, DOI 10.1161/CIRCRESAHA.111.246140; Dai DF, 2011, CIRC RES, V108, P837, DOI 10.1161/CIRCRESAHA.110.232306; Denicola A, 1996, ARCH BIOCHEM BIOPHYS, V328, P208, DOI 10.1006/abbi.1996.0162; Dikalov S, 2011, FREE RADICAL BIO MED, V51, P1289, DOI 10.1016/j.freeradbiomed.2011.06.033; Dikalov SI, 2008, FREE RADICAL BIO MED, V45, P1340, DOI 10.1016/j.freeradbiomed.2008.08.013; Dikalov SI, 2013, ANTIOXID REDOX SIGN, V19, P1085, DOI 10.1089/ars.2012.4604; Dikalova AE, 2010, AM J PHYSIOL-HEART C, V299, pH673, DOI 10.1152/ajpheart.00242.2010; Dikalova AE, 2010, CIRC RES, V107, P106, DOI 10.1161/CIRCRESAHA.109.214601; Doughan AK, 2008, CIRC RES, V102, P488, DOI 10.1161/CIRCRESAHA.107.162800; Eid AA, 2010, J BIOL CHEM, V285, P37503, DOI 10.1074/jbc.M110.136796; Faria AM, 2012, DIABETES, V61, P1838, DOI 10.2337/db11-1241; Feliers D, 2005, KIDNEY INT, V68, P1648, DOI 10.1111/j.1523-1755.2005.00575.x; Fernandes DC, 2007, AM J PHYSIOL-CELL PH, V292, pC413, DOI 10.1152/ajpcell.00188.2006; Fogo AB, 1999, EXP NEPHROL, V7, P147; Forstermann U, 2006, CIRCULATION, V113, P1708, DOI 10.1161/CIRCULATIONAHA.105.602532; Gao SJ, 2004, J BIOL CHEM, V279, P15968, DOI 10.1074/jbc.M308504200; Garrido AM, 2009, MOL CELL ENDOCRINOL, V302, P148, DOI 10.1016/j.mce.2008.11.003; Giacco F, 2010, CIRC RES, V107, P1058, DOI 10.1161/CIRCRESAHA.110.223545; Gomez-Guerrero Carmen, 2005, Current Drug Targets - Inflammation and Allergy, V4, P341, DOI 10.2174/1568010054022169; Gorin Y, 2005, J BIOL CHEM, V280, P39616, DOI 10.1074/jbc.M502412200; Gorin Y, 2003, AM J PHYSIOL-RENAL, V285, pF219, DOI 10.1152/ajprenal.00414.2002; Gorin Y, 2013, FREE RADICAL BIO MED, V61, P130, DOI 10.1016/j.freeradbiomed.2013.03.014; Gorin Y, 2013, CLIN SCI, V125, P361, DOI 10.1042/CS20130065; GUSKOVA RA, 1984, BIOCHIM BIOPHYS ACTA, V778, P579, DOI 10.1016/0005-2736(84)90409-7; Kagami S, 2012, CLIN EXP NEPHROL, V16, P214, DOI 10.1007/s10157-011-0568-0; Kanetsuna Y, 2007, AM J PATHOL, V170, P1473, DOI 10.2353/ajpath.2007.060481; Kashyap SR, 2005, J CLIN ENDOCR METAB, V90, P1100, DOI 10.1210/jc.2004-0745; Kietadisorn R, 2012, AM J PHYSIOL-ENDOC M, V302, pE481, DOI 10.1152/ajpendo.00540.2011; Kim S, 2000, PHARMACOL REV, V52, P11; Kim S, 2012, PLOS ONE; LAFAYETTE RA, 1992, J CLIN INVEST, V90, P766, DOI 10.1172/JCI115949; Landmesser U, 2003, J CLIN INVEST, V111, P1201, DOI 10.1172/JCI200314172; Lassegue B, 2012, CIRC RES, V110, P1364, DOI 10.1161/CIRCRESAHA.111.243972; Li YZ, 2010, BIOCHEM BIOPH RES CO, V397, P5, DOI 10.1016/j.bbrc.2010.04.084; Lustgarten MS, 2012, BIOCHEM BIOPH RES CO, V422, P515, DOI 10.1016/j.bbrc.2012.05.055; Lyle AN, 2009, CIRC RES, V105, P249, DOI 10.1161/CIRCRESAHA.109.193722; Martinez-Ruiz A, 2011, FREE RADICAL BIO MED, V51, P17, DOI 10.1016/j.freeradbiomed.2011.04.010; Martyn KD, 2006, CELL SIGNAL, V18, P69, DOI 10.1016/j.cellsig.2005.03.023; Miyata K, 2005, J AM SOC NEPHROL, V16, P2906, DOI 10.1681/ASN.2005040390; Mount PF, 2006, ACTA PHYSIOL, V187, P433, DOI 10.1111/j.1748-1716.2006.01582.x; Nakagawa T, 2007, J AM SOC NEPHROL, V18, P539, DOI 10.1681/ASN.2006050459; New DD, 2012, AM J PHYSIOL-CELL PH, V302, pC122, DOI 10.1152/ajpcell.00141.2011; Nistala R, 2008, ANTIOXID REDOX SIGN, V10, P2047, DOI 10.1089/ars.2008.2034; Pleskova M, 2005, FASEB J, V19, P139, DOI 10.1096/fj.05-3791fje; RADEKE HH, 1991, J BIOL CHEM, V266, P21025; Radi R, 2002, FREE RADICAL BIO MED, V33, P1451, DOI 10.1016/S0891-5849(02)01111-5; Rafikov R, 2013, J BIOL CHEM, V288, P6212, DOI 10.1074/jbc.M112.423269; Rincon-Choles H, 2002, KIDNEY INT, V62, pS8, DOI 10.1046/j.1523-1755.62.s82.3.x; ROMAN LJ, 1995, P NATL ACAD SCI USA, V92, P8428, DOI 10.1073/pnas.92.18.8428; Ruiz-Ortega M, 2006, NEPHROL DIAL TRANSPL, V21, P16, DOI 10.1093/ndt/gfi265; Satoh M, 2005, AM J PHYSIOL-RENAL, V288, pF1144, DOI 10.1152/ajprenal.00221.2004; Satoh M, 2008, NEPHROL DIAL TRANSPL, V23, P3806, DOI 10.1093/ndt/gfn357; Schroder K, 2012, CIRC RES, V110, P1217, DOI 10.1161/CIRCRESAHA.112.267054; Shah A, 2013, J BIOL CHEM, V288, P6835, DOI 10.1074/jbc.M112.419101; Spencer NY, 2011, J BIOL CHEM, V286, P8977, DOI 10.1074/jbc.M110.193821; Takac I, 2011, J BIOL CHEM, V286, P13304, DOI 10.1074/jbc.M110.192138; Thomas SR, 2008, ANTIOXID REDOX SIGN, V10, P1713, DOI 10.1089/ars.2008.2027; Wang SX, 2002, J BIOL CHEM, V277, P9880, DOI 10.1074/jbc.M108360200; Xia Y, 2007, ANTIOXID REDOX SIGN, V9, P1773, DOI 10.1089/ars.2007.1733; Xu J, 2006, ARTERIOSCL THROM VAS, V26, P2688, DOI 10.1161/01.ATV.0000249394.94588.82; Youn JY, 2012, DIABETOLOGIA, V55, P2069, DOI 10.1007/s00125-012-2557-6; Zhang MA, 2011, ARTERIOSCL THROM VAS, V31, P125, DOI 10.1161/ATVBAHA.110.207712; Zhang M, 2013, ANTIOXID REDOX SIGN, V18, P1024, DOI 10.1089/ars.2012.4550; Zhang WK, 2007, AM J PHYSIOL-RENAL, V292, pF1054, DOI 10.1152/ajprenal.00286.2006; Zhao HJ, 2006, J AM SOC NEPHROL, V17, P2664, DOI 10.1681/ASN.2006070798; Zou MH, 2002, J CLIN INVEST, V109, P817, DOI 10.1172/JCI200214442	78	98	104	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 4	2013	288	40					28668	28686		10.1074/jbc.M113.470971	http://dx.doi.org/10.1074/jbc.M113.470971			19	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	298BL	23940049	Green Published, hybrid			2022-12-25	WOS:000330298800022
J	Zucconi, BE; Wilson, GM				Zucconi, Beth E.; Wilson, Gerald M.			Assembly of Functional Ribonucleoprotein Complexes by AU-rich Element RNA-binding Protein 1 (AUF1) Requires Base-dependent and -independent RNA Contacts	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TARGET MESSENGER-RNAS; RESONANCE ENERGY-TRANSFER; NUCLEIC ACID INTERACTIONS; HIGH-AFFINITY BINDING; GENE-EXPRESSION; POSTTRANSCRIPTIONAL CONTROL; FLUORESCENCE ANISOTROPY; THERMODYNAMIC ANALYSIS; CONFORMATIONAL-CHANGES; DNA-BINDING	AU-rich element RNA-binding protein 1 (AUF1) regulates the stability and/or translational efficiency of diverse mRNA targets, including many encoding products controlling the cell cycle, apoptosis, and inflammation by associating with AU-rich elements residing in their 3' -untranslated regions. Previous biochemical studies showed that optimal AUF1 binding requires 33-34 nucleotides with a strong preference for U-rich RNA despite observations that few AUF1-associated cellular mRNAs contain such extended U-rich domains. Using the smallest AUF1 isoform (p37(AUF1)) as a model, we employed fluorescence anisotropy-based approaches to define thermodynamic parameters describing AUF1 ribonucleoprotein (RNP) complex formation across a panel of RNA substrates. These data demonstrated that 15 nucleotides of AU-rich sequence were sufficient to nucleate high affinity p37(AUF1) RNP complexes within a larger RNA context. In particular, p37(AUF1) binding to short AU-rich RNA targets was significantly stabilized by interactions with a 3' -purine residue and largely base-independent but non-ionic contacts 5' of the AU-rich site. RNP stabilization by the upstream RNA domain was associated with an enhanced negative change in heat capacity consistent with conformational changes in protein and/or RNA components, and fluorescence resonance energy transfer-based assays demonstrated that these contacts were required for p37(AUF1) to remodel local RNA structure. Finally, reporter mRNAs containing minimal high affinity p37(AUF1) target sequences associated with AUF1 and were destabilized in a p37(AUF1) -dependent manner in cells. These findings provide a mechanistic explanation for the diverse population of AUF1 target mRNAs but also suggest how AUF1 binding could regulate protein and/or microRNA binding events at adjacent sites.	[Wilson, Gerald M.] Univ Maryland, Sch Med, Dept Biochem & Mol Biol, Baltimore, MD 21201 USA; Univ Maryland, Sch Med, Marlene & Stewart Greenebaum Canc Ctr, Baltimore, MD 21201 USA	University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore	Wilson, GM (corresponding author), Univ Maryland, Sch Med, Dept Biochem & Mol Biol, 108 N Greene St, Baltimore, MD 21201 USA.	gwilson@som.umaryland.edu	Wilson, Gerald/AAF-3874-2019	Wilson, Gerald/0000-0002-1273-7507	National Institutes of Health [R01 CA102428, T32 GM066706]; American Heart Association [11PRE6900008]; NATIONAL CANCER INSTITUTE [R01CA102428] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM066706] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 CA102428 (NCI; to G.M.W.).; Supported by American Heart Association Grant 11PRE6900008 and National Institutes of Health Grant T32 GM066706.	Arao Y, 2000, ARCH BIOCHEM BIOPHYS, V380, P228, DOI 10.1006/abbi.2000.1938; Bakheet T, 2006, NUCLEIC ACIDS RES, V34, pD111, DOI 10.1093/nar/gkj052; Ballin JD, 2010, BIOCHEMISTRY-US, V49, P2018, DOI 10.1021/bi902027z; Barraud P, 2013, J BIOMOL NMR, V55, P119, DOI 10.1007/s10858-012-9696-4; Barreau C, 2005, NUCLEIC ACIDS RES, V33, P7138, DOI 10.1093/nar/gki1012; Baumann C, 1996, J BIOL CHEM, V271, P12269, DOI 10.1074/jbc.271.21.12269; Brewer BY, 2004, J BIOL CHEM, V279, P27870, DOI 10.1074/jbc.M402551200; Chen TM, 2010, NUCLEIC ACIDS RES, V38, P8061, DOI 10.1093/nar/gkq717; DEHASETH PL, 1977, BIOCHEMISTRY-US, V16, P4783, DOI 10.1021/bi00641a004; DeMaria CT, 1996, J BIOL CHEM, V271, P12179, DOI 10.1074/jbc.271.21.12179; Ding JZ, 1999, GENE DEV, V13, P1102, DOI 10.1101/gad.13.9.1102; DRAPER DE, 1995, ANNU REV BIOCHEM, V64, P593, DOI 10.1146/annurev.bi.64.070195.003113; Enokizono Y, 2005, J BIOL CHEM, V280, P18862, DOI 10.1074/jbc.M411822200; Fialcowitz EJ, 2005, J BIOL CHEM, V280, P22406, DOI 10.1074/jbc.M500618200; Fialcowitz-White EJ, 2007, J BIOL CHEM, V282, P20948, DOI 10.1074/jbc.M701751200; Fisher BM, 1998, BIOCHEMISTRY-US, V37, P12121, DOI 10.1021/bi980743l; FRIED MG, 1993, EUR J BIOCHEM, V218, P469, DOI 10.1111/j.1432-1033.1993.tb18398.x; Garneau NL, 2007, NAT REV MOL CELL BIO, V8, P113, DOI 10.1038/nrm2104; GORLACH M, 1994, EXP CELL RES, V211, P400, DOI 10.1006/excr.1994.1104; HA JH, 1989, J MOL BIOL, V209, P801, DOI 10.1016/0022-2836(89)90608-6; Halees AS, 2008, NUCLEIC ACIDS RES, V36, pD137, DOI 10.1093/nar/gkm959; Hall KB, 1995, METHOD ENZYMOL, V259, P261; He C, 2006, EMBO J, V25, P3823, DOI 10.1038/sj.emboj.7601264; Heyduk T, 1996, METHOD ENZYMOL, V274, P492; Katsamba PS, 2001, J BIOL CHEM, V276, P21476, DOI 10.1074/jbc.M101624200; Khabar KSA, 2010, CELL MOL LIFE SCI, V67, P2937, DOI 10.1007/s00018-010-0383-x; Kim HS, 2011, NUCLEIC ACIDS RES, V39, P1117, DOI 10.1093/nar/gkq837; Kishor A, 2013, MOL CELL BIOL, V33, P71, DOI 10.1128/MCB.01275-12; Lakowicz J.R, 1999, PRINCIPLES FLUORESCE, P368; Lal A, 2004, EMBO J, V23, P3092, DOI 10.1038/sj.emboj.7600305; Lamichhane R, 2010, P NATL ACAD SCI USA, V107, P4105, DOI 10.1073/pnas.0907072107; Laroia G, 1999, SCIENCE, V284, P499, DOI 10.1126/science.284.5413.499; Lin SK, 2000, MOL CELL BIOL, V20, P7903, DOI 10.1128/MCB.20.21.7903-7913.2000; LOHMAN TM, 1980, BIOCHEMISTRY-US, V19, P3522, DOI 10.1021/bi00556a017; LOHMAN TM, 1992, METHOD ENZYMOL, V212, P400; LOHMAN TM, 1986, CRIT REV BIOCHEM MOL, V19, P191, DOI 10.3109/10409238609084656; Lu JY, 2006, RNA, V12, P883, DOI 10.1261/rna.2308106; Lund N, 2012, NUCLEIC ACIDS RES, V40, P3663, DOI 10.1093/nar/gkr1238; Lundblad JR, 1996, MOL ENDOCRINOL, V10, P607, DOI 10.1210/me.10.6.607; MARTIN KJ, 1987, J MOL BIOL, V195, P741, DOI 10.1016/0022-2836(87)90193-8; Matsui H, 2007, MOL CELL, V25, P99, DOI 10.1016/j.molcel.2006.12.007; Mazan-Mamczarz K, 2009, NUCLEIC ACIDS RES, V37, P204, DOI 10.1093/nar/gkn929; Mili S, 2001, MOL CELL BIOL, V21, P7307, DOI 10.1128/MCB.21.21.7307-7319.2001; Norman DG, 2000, BIOCHEMISTRY-US, V39, P6317, DOI 10.1021/bi992944a; Raghavan A, 2001, J BIOL CHEM, V276, P47958, DOI 10.1074/jbc.M109511200; Raineri I, 2004, NUCLEIC ACIDS RES, V32, P1279, DOI 10.1093/nar/gkh282; RECORD MT, 1978, Q REV BIOPHYS, V11, P103, DOI 10.1017/S003358350000202X; RECORD MT, 1976, BIOPOLYMERS, V15, P893, DOI 10.1002/bip.1976.360150507; RECORD MT, 1976, J MOL BIOL, V107, P145, DOI 10.1016/S0022-2836(76)80023-X; Sarkar B, 2003, MOL CELL BIOL, V23, P6685, DOI 10.1128/MCB.23.18.6685-6693.2003; Sarkar S, 2008, J INTERF CYTOK RES, V28, P679, DOI 10.1089/jir.2008.0028; Schoenberg DR, 2012, NAT REV GENET, V13, P246, DOI 10.1038/nrg3160; Sinsimer KS, 2008, MOL CELL BIOL, V28, P5223, DOI 10.1128/MCB.00431-08; SPOLAR RS, 1994, SCIENCE, V263, P777, DOI 10.1126/science.8303294; Stickle DF, 2007, BIOPHYS CHEM, V126, P106, DOI 10.1016/j.bpc.2006.05.016; Wagner BJ, 1998, GENOMICS, V48, P195, DOI 10.1006/geno.1997.5142; Wang H, 2013, ACTA CRYSTALLOGR D, V69, P373, DOI 10.1107/S0907444912047828; WEBER G, 1952, BIOCHEM J, V51, P145, DOI 10.1042/bj0510145; White EJF, 2013, BBA-GENE REGUL MECH, V1829, P680, DOI 10.1016/j.bbagrm.2012.12.002; Wilson GM, 1999, J BIOL CHEM, V274, P33374, DOI 10.1074/jbc.274.47.33374; Wilson GM, 2001, J BIOL CHEM, V276, P38400, DOI 10.1074/jbc.M106509200; Wilson GM, 2005, REV FLUORESCENCE, V2, P223; Wilson GM, 2003, J BIOL CHEM, V278, P33029, DOI 10.1074/jbc.M305772200; Wilson GM, 2003, J BIOL CHEM, V278, P33039, DOI 10.1074/jbc.M305775200; Wilson GM, 1999, METHODS, V17, P74, DOI 10.1006/meth.1998.0709; Wilson GM, 2001, J BIOL CHEM, V276, P8695, DOI 10.1074/jbc.M009848200; Winzen R, 2007, MOL CELL BIOL, V27, P8388, DOI 10.1128/MCB.01493-07; Wu XY, 2013, NUCLEIC ACIDS RES, V41, P2644, DOI 10.1093/nar/gks1453; Wu XY, 2012, GENE, V500, P10, DOI 10.1016/j.gene.2012.03.021; Ysla RM, 2008, METHOD ENZYMOL, V449, P47, DOI 10.1016/S0076-6879(08)02403-8; ZHANG W, 1993, MOL CELL BIOL, V13, P7652, DOI 10.1128/MCB.13.12.7652; Zucconi BE, 2010, J BIOL CHEM, V285, P39127, DOI 10.1074/jbc.M110.180182	72	12	12	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 27	2013	288	39					28034	28048		10.1074/jbc.M113.489559	http://dx.doi.org/10.1074/jbc.M113.489559			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302OB	23940053	Green Published, hybrid			2022-12-25	WOS:000330612800029
J	Callewaert, C; Kerckhof, FM; Granitsiotis, MS; Van Gele, M; Van de Wiele, T; Boon, N				Callewaert, Chris; Kerckhof, Frederiek-Maarten; Granitsiotis, Michael S.; Van Gele, Mireille; Van de Wiele, Tom; Boon, Nico			Characterization of Staphylococcus and Corynebacterium Clusters in the Human Axillary Region	PLOS ONE			English	Article							HUMAN SKIN; MOLECULAR ANALYSIS; DIVERSITY; COMMUNITIES; MICROBIOTA; SURFACE; HEALTH	The skin microbial community is regarded as essential for human health and well-being, but likewise plays an important role in the formation of body odor in, for instance, the axillae. Few molecular-based research was done on the axillary microbiome. This study typified the axillary microbiome of a group of 53 healthy subjects. A profound view was obtained of the interpersonal, intrapersonal and temporal diversity of the human axillary microbiota. Denaturing gradient gel electrophoresis (DGGE) and next generation sequencing on 16S rRNA gene region were combined and used as extent to each other. Two important clusters were characterized, where Staphylococcus and Corynebacterium species were the abundant species. Females predominantly clustered within the Staphylococcus cluster (87%, n = 17), whereas males clustered more in the Corynebacterium cluster (39%, n = 36). The axillary microbiota was unique to each individual. Left-right asymmetry occurred in about half of the human population. For the first time, an elaborate study was performed on the dynamics of the axillary microbiome. A relatively stable axillary microbiome was noticed, although a few subjects evolved towards another stable community. The deodorant usage had a proportional linear influence on the species diversity of the axillary microbiome.	[Callewaert, Chris; Kerckhof, Frederiek-Maarten; Van de Wiele, Tom; Boon, Nico] Univ Ghent, Lab Microbial Ecol & Technol, B-9000 Ghent, Belgium; [Granitsiotis, Michael S.] Helmholtz Ctr Munich, German Res Ctr Environm Hlth GmbH, Res Unit Environm Genom, Neuherberg, Germany; [Van Gele, Mireille] Ghent Univ Hosp, Dept Dermatol, Ghent, Belgium	Ghent University; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Ghent University; Ghent University Hospital	Boon, N (corresponding author), Univ Ghent, Lab Microbial Ecol & Technol, B-9000 Ghent, Belgium.	Nico.Boon@UGent.be	Callewaert, Chris/X-6236-2018; Kerckhof, Frederiek-Maarten/E-5059-2011; Van de Wiele, Tom/C-8638-2011; Boon, Nico/B-4083-2011	Callewaert, Chris/0000-0001-7697-9188; Kerckhof, Frederiek-Maarten/0000-0002-4472-6810; Van de Wiele, Tom/0000-0001-6854-5689; Boon, Nico/0000-0002-7734-3103; Granitsiotis, Michael S./0000-0002-8634-6103	geconcerteerde onderzoeksactie (GOA) of Ghent University [BOF09/GOA/005]	geconcerteerde onderzoeksactie (GOA) of Ghent University	This work was supported through the assistantship of Chris Callewaert by the Flemish Government. Frederiek-Maarten Kerckhof was funded through the geconcerteerde onderzoeksactie (GOA) of Ghent University (BOF09/GOA/005). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Caporaso JG, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-5-r50; Costello EK, 2009, SCIENCE, V326, P1694, DOI 10.1126/science.1177486; Dowd SE, 2008, BMC MICROBIOL, V8, DOI [10.1186/1471-2180-8-125, 10.1186/1471-2180-8-43]; Egert M, 2011, FEMS MICROBIOL ECOL, V77, P146, DOI 10.1111/j.1574-6941.2011.01097.x; EVANS CA, 1976, J CLIN MICROBIOL, V3, P576; Fierer N, 2008, P NATL ACAD SCI USA, V105, P17994, DOI 10.1073/pnas.0807920105; Fredricks DN, 2001, J INVEST DERM SYMP P, V6, P167, DOI 10.1046/j.0022-202x.2001.00039.x; Gao Z, 2007, P NATL ACAD SCI USA, V104, P2927, DOI 10.1073/pnas.0607077104; Giacomoni PU, 2009, J DERMATOL SCI, V55, P144, DOI 10.1016/j.jdermsci.2009.06.001; Grice EA, 2008, GENOME RES, V18, P1043, DOI 10.1101/gr.075549.107; Grice EA, 2011, NAT REV MICROBIOL, V9, P244, DOI 10.1038/nrmicro2537; Grice EA, 2009, SCIENCE, V324, P1190, DOI 10.1126/science.1171700; Hulcr J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047712; JACKMAN PJH, 1983, CLIN EXP DERMATOL, V8, P259, DOI 10.1111/j.1365-2230.1983.tb01778.x; LEYDEN JJ, 1981, J INVEST DERMATOL, V77, P413, DOI 10.1111/1523-1747.ep12494624; MARPLES MJ, 1969, SCI AM, V220, P108, DOI 10.1038/scientificamerican0169-108; MUYZER G, 1993, APPL ENVIRON MICROB, V59, P695, DOI 10.1128/AEM.59.3.695-700.1993; NICOLAIDES N, 1974, SCIENCE, V186, P19, DOI 10.1126/science.186.4158.19; NOBLE W. C., 1981, MICROBIOLOGY HUMAN S; Novick RP, 2008, ANNU REV GENET, V42, P541, DOI 10.1146/annurev.genet.42.110807.091640; Possemiers S, 2010, INT J FOOD MICROBIOL, V141, P97, DOI 10.1016/j.ijfoodmicro.2010.03.008; Read S, 2011, APPL MICROBIOL BIOT, V90, P861, DOI 10.1007/s00253-011-3223-5; ROBINSON S, 1954, PHYSIOL REV, V34, P202, DOI 10.1152/physrev.1954.34.2.202; Rodriguez-Lazaro D, 2004, APPL ENVIRON MICROB, V70, P6299, DOI 10.1128/AEM.70.10.6299-6301.2004; Roh SW, 2010, ISME J, V4, P1, DOI 10.1038/ismej.2009.83; Rosenthal M, 2011, INFECT GENET EVOL, V11, P839, DOI 10.1016/j.meegid.2011.03.022; SATO K, 1987, AM J PHYSIOL, V252, pR166, DOI 10.1152/ajpregu.1987.252.1.R166; Staudinger T, 2011, J APPL MICROBIOL, V110, P1381, DOI 10.1111/j.1365-2672.2011.04991.x; Suau A, 1999, APPL ENVIRON MICROB, V65, P4799; Turnbaugh PJ, 2007, NATURE, V449, P804, DOI 10.1038/nature06244; Weinert N, 2009, APPL ENVIRON MICROB, V75, P3859, DOI 10.1128/AEM.00414-09; Zeeuwen PLJM, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-11-r101	32	51	58	2	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2013	8	8							e70538	10.1371/journal.pone.0070538	http://dx.doi.org/10.1371/journal.pone.0070538			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	200UV	23950955	Green Submitted, gold, Green Published			2022-12-25	WOS:000323097300024
J	Verschuren, JJW; Trompet, S; Sampietro, ML; Heijmans, BT; Koch, W; Kastrati, A; Houwing-Duistermaat, JJ; Slagboom, PE; Quax, PHA; Jukema, JW				Verschuren, Jeffrey J. W.; Trompet, Stella; Sampietro, M. Lourdes; Heijmans, Bastiaan T.; Koch, Werner; Kastrati, Adnan; Houwing-Duistermaat, Jeanine J.; Slagboom, P. Eline; Quax, Paul H. A.; Jukema, J. Wouter			Pathway Analysis Using Genome-Wide Association Study Data for Coronary Restenosis - A Potential Role for the PARVB Gene	PLOS ONE			English	Article							BIOLOGICAL PATHWAYS; ENRICHMENT ANALYSIS; BETA-PARVIN; INTERVENTION; POLYMORPHISM; DISEASES; RISK; SET; SCHIZOPHRENIA; HERITABILITY	Background: Coronary restenosis after percutaneous coronary intervention (PCI) still remains a significant limitation of the procedure. The causative mechanisms of restenosis have not yet been fully identified. The goal of the current study was to perform gene-set analysis of biological pathways related to inflammation, proliferation, vascular function and transcriptional regulation on coronary restenosis to identify novel genes and pathways related to this condition. Methods: The GENetic DEterminants of Restenosis (GENDER) databank contains genotypic data of 556,099SNPs of 295 cases with restenosis and 571 matched controls. Fifty-four pathways, related to known restenosis-related processes, were selected. Gene-set analysis was performed using PLINK, GRASS and ALIGATOR software. Pathways with a p<0.01 were fine-mapped and significantly associated SNPs were analyzed in an independent replication cohort. Results: Six pathways (cell-extracellular matrix (ECM) interactions pathway, IL2 signaling pathway, IL6 signaling pathway, platelet derived growth factor pathway, vitamin D receptor pathway and the mitochondria pathway) were significantly associated in one or two of the software packages. Two SNPs in the cell-ECM interactions pathway were replicated in an independent restenosis cohort. No replication was obtained for the other pathways. Conclusion: With these results we demonstrate a potential role of the cell-ECM interactions pathway in the development of coronary restenosis. These findings contribute to the increasing knowledge of the genetic etiology of restenosis formation and could serve as a hypothesis-generating effort for further functional studies.	[Verschuren, Jeffrey J. W.; Trompet, Stella; Jukema, J. Wouter] Leiden Univ, Dept Cardiol, Med Ctr, Leiden, Netherlands; [Trompet, Stella] Leiden Univ, Dept Gerontol & Geriatr, Med Ctr, Leiden, Netherlands; [Sampietro, M. Lourdes] Leiden Univ, Dept Human Genet, Med Ctr, NL-2300 RA Leiden, Netherlands; [Heijmans, Bastiaan T.; Slagboom, P. Eline] Leiden Univ, Med Ctr, Leiden, Netherlands; [Koch, Werner; Kastrati, Adnan] Tech Univ Munich, Deutsch Herzzentrum Munchen, D-80290 Munich, Germany; [Houwing-Duistermaat, Jeanine J.] Leiden Univ, Dept Med Stat & Bioinformat, Med Ctr, Leiden, Netherlands; [Heijmans, Bastiaan T.; Slagboom, P. Eline; Jukema, J. Wouter] Leiden Univ, Netherlands Consortium Hlth Ageing, Med Ctr, Leiden, Netherlands; [Quax, Paul H. A.] Leiden Univ, Dept Vasc Surg, Med Ctr, Leiden, Netherlands; [Jukema, J. Wouter] Durrer Ctr Cardiogenet Res, Amsterdam, Netherlands; [Sampietro, M. Lourdes; Jukema, J. Wouter] Interuniv Cardiol Inst Netherlands ICIN, Utrecht, Netherlands	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; German Heart Centre Munich; Technical University of Munich; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Jukema, JW (corresponding author), Leiden Univ, Dept Cardiol, Med Ctr, Leiden, Netherlands.	j.w.jukema@lumc.nl	Quax, Paul/W-8520-2019; Jukema, J. Wouter/ABD-6503-2021; , Kastrati/Y-2389-2019; Slagboom, P. Eline/R-4790-2016; Quax, Paul/ABD-5294-2020; Houwing-Duistermaat, Jeanne/V-9048-2018	Jukema, J. Wouter/0000-0002-3246-8359; Slagboom, P. Eline/0000-0002-2875-4723; Quax, Paul/0000-0002-6853-5760; Houwing-Duistermaat, Jeanine/0000-0002-4505-7137	Interuniversity Cardiology Institute of the Netherlands (ICIN); European Community [HEALTH-F2-2009-223004]; Center for Medical Systems Biology (CMSB); Netherlands Consortium for Healthy Ageing (NCHA); Netherlands Heart Foundation [2001D032]	Interuniversity Cardiology Institute of the Netherlands (ICIN); European Community(European Commission); Center for Medical Systems Biology (CMSB); Netherlands Consortium for Healthy Ageing (NCHA); Netherlands Heart Foundation(Netherlands Heart Foundation)	This work was funded by grants from the Interuniversity Cardiology Institute of the Netherlands (ICIN) http://www.icin.nl/, the European Community Framework FP7 Programme under grant agreement [no HEALTH-F2-2009-223004], the Center for Medical Systems Biology (CMSB) [http://www.cmsb.nl], a center of excellence approved by the Netherlands Genomics Initiative/Netherlands Organisation for Scientific Research (NWO), and the Netherlands Consortium for Healthy Ageing (NCHA) [http://www.healthy-ageing.nl]. JWJ is an established clinical investigator of the Netherlands Heart Foundation (2001D032) [http://www.hartstichting.nl/]. The funders had no role in study design, data collection and analysis, decision to publish or the preparation of the manuscript.	Agema WRP, 2004, EUR HEART J, V25, P1163, DOI 10.1016/j.ehj.2004.05.006; Ballard D, 2010, BMC MED GENOMICS, V3, DOI 10.1186/1755-8794-3-25; Chen LS, 2010, AM J HUM GENET, V86, P860, DOI 10.1016/j.ajhg.2010.04.014; Croft D, 2011, NUCLEIC ACIDS RES, V39, pD691, DOI 10.1093/nar/gkq1018; D'Eustachio P, 2011, METHODS MOL BIOL, V694, P49, DOI 10.1007/978-1-60761-977-2_4; Deelen J, 2013, AGE, V35, P235, DOI 10.1007/s11357-011-9340-3; Fridley BL, 2011, EUR J HUM GENET, V19, P837, DOI 10.1038/ejhg.2011.57; Gabriel Stacey, 2009, Curr Protoc Hum Genet, VChapter 2, DOI 10.1002/0471142905.hg0212s60; Gui Hongsheng, 2011, BMC Res Notes, V4, P386, DOI 10.1186/1756-0500-4-386; Hindorff LA, 2009, P NATL ACAD SCI USA, V106, P9362, DOI 10.1073/pnas.0903103106; Holmans P, 2009, AM J HUM GENET, V85, P13, DOI 10.1016/j.ajhg.2009.05.011; Hoppmann P, 2009, JACC-CARDIOVASC INTE, V2, P1149, DOI 10.1016/j.jcin.2009.08.021; Javerzat S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007856; Jia PL, 2011, BMC SYST BIOL, V5, DOI 10.1186/1752-0509-5-S3-S12; Jia PL, 2012, J MED GENET, V49, P96, DOI 10.1136/jmedgenet-2011-100397; Jukema JW, 2012, NAT REV CARDIOL, V9, P53, DOI 10.1038/nrcardio.2011.132; Kanehisa M, 2012, NUCLEIC ACIDS RES, V40, pD109, DOI 10.1093/nar/gkr988; Kendler KS, 2011, ALCOHOL CLIN EXP RES, V35, P963, DOI 10.1111/j.1530-0277.2010.01427.x; Kimura M, 2010, J CELL SCI, V123, P747, DOI 10.1242/jcs.052498; Koch W, 2000, CIRCULATION, V102, P197, DOI 10.1161/01.CIR.102.2.197; Manolio TA, 2009, NATURE, V461, P747, DOI 10.1038/nature08494; McClellan J, 2010, CELL, V141, P210, DOI 10.1016/j.cell.2010.03.032; Monraats PS, 2007, GENES IMMUN, V8, P44, DOI 10.1038/sj.gene.6364343; Monraats PS, 2005, CIRCULATION, V112, P2417, DOI 10.1161/CIRCULATIONAHA.105.536268; Oguri M, 2007, ATHEROSCLEROSIS, V194, pE172, DOI 10.1016/j.atherosclerosis.2006.12.019; Pastinen T, 2004, PHYSIOL GENOMICS, V16, P184, DOI 10.1152/physiolgenomics.00163.2003; Pons D, 2009, DIS MARKERS, V26, P75, DOI [10.1155/2009/520653, 10.3233/DMA-2009-0609]; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Rosenberger G, 2003, HUM MOL GENET, V12, P155, DOI 10.1093/hmg/ddg019; Sampietro ML, 2009, NETH HEART J, V17, P262, DOI 10.1007/BF03086261; Sampietro ML, 2011, HUM MOL GENET, V20, P4748, DOI 10.1093/hmg/ddr389; Shimada MK, 2009, NUCLEIC ACIDS RES, V37, pD810, DOI 10.1093/nar/gkn798; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Sun YV, 2012, HUM GENET, V131, P1677, DOI 10.1007/s00439-012-1198-7; Torkamani A, 2008, GENOMICS, V92, P265, DOI 10.1016/j.ygeno.2008.07.011; van Tiel CM, 2009, CIRCULATION, V120, P669, DOI 10.1161/CIRCULATIONAHA.108.842179; Verschuren JJW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042401; Wang K, 2010, NAT REV GENET, V11, P843, DOI 10.1038/nrg2884; Wei P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046887; Yamaji S, 2001, J CELL BIOL, V153, P1251, DOI 10.1083/jcb.153.6.1251; Zaitlen N, 2012, HUM GENET, V131, P1655, DOI 10.1007/s00439-012-1199-6	41	11	12	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 9	2013	8	8							e70676	10.1371/journal.pone.0070676	http://dx.doi.org/10.1371/journal.pone.0070676			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	245OM	23950981	gold, Green Submitted, Green Published			2022-12-25	WOS:000326473200015
J	Audet, CM; McGowan, CC; Wallston, KA; Kipp, AM				Audet, Carolyn M.; McGowan, Catherine C.; Wallston, Kenneth A.; Kipp, Aaron M.			Relationship between HIV Stigma and Self-Isolation among People Living with HIV in Tennessee	PLOS ONE			English	Article							AIDS-RELATED STIGMA; QUALITY-OF-LIFE; HIV/AIDS STIGMA; INFECTED WOMEN; UNITED-STATES; CAPE-TOWN; BARRIERS; INTERVENTIONS; ADHERENCE; CARE	Introduction: HIV stigma is a contributing factor to poor patient outcomes. Although HIV stigma has been documented, its impact on patient well-being in the southern US is not well understood. Methods: Thirty-two adults participated in cognitive interviews after completing the Berger HIV or the Van Rie stigma scale. Participant responses were probed to ensure the scales accurately measured stigma and to assess the impact stigma had on behavior. Results: Three main themes emerged regarding HIV stigma: (1) negative attitudes, fear of contagion, and misperceptions about transmission; (2) acts of discrimination by families, friends, health care providers, and within the workplace; and (3) participants' use of self-isolation as a coping mechanism. Overwhelming reluctance to disclose a person's HIV status made identifying enacted stigma with a quantitative scale difficult. Discussion: Fear of discrimination resulted in participants isolating themselves from friends or experiences to avoid disclosure. Participant unwillingness to disclose their HIV status to friends and family could lead to an underestimation of enacted HIV stigma in quantitative scales.	[Audet, Carolyn M.] Vanderbilt Univ, Inst Global Hlth, Nashville, TN 37235 USA; [Audet, Carolyn M.] Vanderbilt Univ, Sch Med, Dept Prevent Med, Nashville, TN 37235 USA; [McGowan, Catherine C.] Vanderbilt Univ, Sch Med, Dept Med, Div Infect Dis, Nashville, TN 37235 USA; [Wallston, Kenneth A.] Vanderbilt Univ, Sch Nursing, Nashville, TN 37235 USA; [Kipp, Aaron M.] Vanderbilt Univ, Inst Med & Publ Hlth, Vanderbilt Epidemiol Ctr, Nashville, TN 37235 USA	Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University	Audet, CM (corresponding author), Vanderbilt Univ, Inst Global Hlth, 221 Kirkland Hall, Nashville, TN 37235 USA.	carolyn.m.audet@vanderbilt.edu			Vanderbilt Institute for Clinical and Translational Research from NCATS/NIH [UL1TR000011]; Vanderbilt Clinical and Translational Science Award from NCRR/NIH [UL1 RR024975]; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024975] Funding Source: NIH RePORTER	Vanderbilt Institute for Clinical and Translational Research from NCATS/NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); Vanderbilt Clinical and Translational Science Award from NCRR/NIH; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	Support for this study was provided in part by the Vanderbilt Institute for Clinical and Translational Research grant (UL1TR000011 from NCATS/NIH) and the Vanderbilt Clinical and Translational Science Award grant (UL1 RR024975 from NCRR/NIH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abadia-Barrero CE, 2006, SOC SCI MED, V62, P1219, DOI 10.1016/j.socscimed.2005.07.006; Agee BS, 2006, AIDS CARE, V18, pS51, DOI 10.1080/09540120600839355; Anglewicz P, 2011, AIDS CARE, V23, P998, DOI 10.1080/09540121.2010.542130; Baunach DM, 2013, SOCIOL SPECTRUM, V33, P175, DOI 10.1080/02732173.2013.732878; Berger BE, 2001, RES NURS HEALTH, V24, P518, DOI 10.1002/nur.10011; Brown L, 2003, AIDS EDUC PREV, V15, P49, DOI 10.1521/aeap.15.1.49.23844; Bunn JY, 2007, AIDS EDUC PREV, V19, P198, DOI 10.1521/aeap.2007.19.3.198; Castro A, 2005, AM J PUBLIC HEALTH, V95, P53, DOI 10.2105/AJPH.2003.028563; Centers for Disease Control and Prevention, 2011, HIV SURV REP 2009; Centers for Disease Control and Prevention, 2011, HIV SURV REP; Coleman JD, 2012, AIDS PATIENT CARE ST, V26, P116, DOI 10.1089/apc.2011.0163; Courtenay-Quirk C, 2006, AIDS EDUC PREV, V18, P56, DOI 10.1521/aeap.2006.18.1.56; Dinos S, 2004, BRIT J PSYCHIAT, V184, P176, DOI 10.1192/bjp.184.2.176; Earnshaw VA, 2009, AIDS BEHAV, V13, P1160, DOI 10.1007/s10461-009-9593-3; Fair C, 2012, AIDS PATIENT CARE ST, V26, P746, DOI 10.1089/apc.2012.0290; Fortenberry JD, 2002, AM J PUBLIC HEALTH, V92, P378, DOI 10.2105/AJPH.92.3.378; Goffman E., 1963, BEHAV PUBLIC PLACES; Hanna DB, 2012, AIDS, V26, P95, DOI 10.1097/QAD.0b013e32834dcf87; Herek GM, 2002, AM J PUBLIC HEALTH, V92, P371, DOI 10.2105/AJPH.92.3.371; Holzemer WL, 2009, J ASSOC NURSE AIDS C, V20, P161, DOI 10.1016/j.jana.2009.02.002; Kalichman SC, 2003, SEX TRANSM INFECT, V79, P442, DOI 10.1136/sti.79.6.442; Kalichman SC, 2009, AIDS CARE, V21, P87, DOI 10.1080/09540120802032627; Kempf MC, 2010, AIDS PATIENT CARE ST, V24, P515, DOI 10.1089/apc.2010.0065; Lichtenstein B, 2004, GENDER SOC, V18, P369, DOI 10.1177/0891243204264809; Lichtenstein B, 2002, AIDS PATIENT CARE ST, V16, P27, DOI 10.1089/108729102753429370; Lichtenstein B, 2005, FACT SHEET STIGMA BA; Lindley LL, 2010, PUBLIC HEALTH REP, V125, P12, DOI 10.1177/00333549101250S103; Malterud K, 2001, LANCET, V358, P483, DOI 10.1016/S0140-6736(01)05627-6; Mbonu NC, 2009, J TROP MED-US, V2009, DOI 10.1155/2009/145891; Meiberg Annemarie E, 2008, East Afr J Public Health, V5, P49; Mills EJ, 2006, PLOS MED, V3, P2039, DOI 10.1371/journal.pmed.0030438; Moneyham L, 2010, J ASSOC NURSE AIDS C, V21, P467, DOI 10.1016/j.jana.2010.03.003; Mugavero Michael J, 2008, Top HIV Med, V16, P156; Nachega Jean B, 2012, J Int Assoc Physicians AIDS Care (Chic), V11, P172, DOI 10.1177/1545109712436723; Nyblade Laura C, 2006, Psychol Health Med, V11, P335, DOI 10.1080/13548500600595178; Park WB, 2008, INT J STD AIDS, V19, P125, DOI 10.1258/ijsa.2007.007101; Pescosolido BA, 2008, SOC SCI MED, V67, P431, DOI 10.1016/j.socscimed.2008.03.018; Phillips Kenneth D, 2011, Issues Ment Health Nurs, V32, P374, DOI 10.3109/01612840.2011.568273; Pope C, 2000, BMJ-BRIT MED J, V320, P114, DOI 10.1136/bmj.320.7227.114; Rafferty J, 2005, LEPROSY REV, V76, P119; Rajabiun S, 2007, AIDS PATIENT CARE ST, V21, pS20, DOI 10.1089/apc.2007.9990; Rao D, 2007, AIDS CARE, V19, P28, DOI 10.1080/09540120600652303; Rintamaki LS, 2006, AIDS PATIENT CARE ST, V20, P359, DOI 10.1089/apc.2006.20.359; Sayles JN, 2009, J GEN INTERN MED, V24, P1101, DOI 10.1007/s11606-009-1068-8; Sears B, 2011, HIV DISCIMINATION DE; Simbayi LC, 2007, SOC SCI MED, V64, P1823, DOI 10.1016/j.socscimed.2007.01.006; Sowell RL, 1997, AIDS CARE, V9, P501, DOI 10.1080/713613191; Van Rie A, 2008, TROP MED INT HEALTH, V13, P21, DOI 10.1111/j.1365-3156.2007.01971.x; Ware NC, 2006, AIDS CARE, V18, P904, DOI 10.1080/09540120500330554	49	17	20	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2013	8	8							e69564	10.1371/journal.pone.0069564	http://dx.doi.org/10.1371/journal.pone.0069564			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	201ER	23950897	Green Submitted, Green Published, gold			2022-12-25	WOS:000323124000007
J	El Ayadi, A; Raifman, S; Jega, F; Butrick, E; Ojo, Y; Geller, S; Miller, S				El Ayadi, Alison; Raifman, Sarah; Jega, Farouk; Butrick, Elizabeth; Ojo, Yemisi; Geller, Stacie; Miller, Suellen			Comorbidities and Lack of Blood Transfusion May Negatively Affect Maternal Outcomes of Women with Obstetric Hemorrhage Treated with NASG	PLOS ONE			English	Article							ANTI-SHOCK GARMENT; POSTPARTUM HEMORRHAGE; PREGNANT-WOMEN; HIV-INFECTION; DELIVERY; ANEMIA; EGYPT	The Non-Pneumatic Anti-Shock Garment (NASG) is a first-aid device to reduce mortality from severe obstetric hemorrhage, the leading cause of maternal mortality globally. We sought to evaluate patient characteristics associated with mortality among a cohort of women treated with the NASG in Nigeria. Data on 1,149 women were collected from 50 facilities participating in the Pathfinder International Continuum of Care: Addressing Postpartum Hemorrhage project in Nigeria from 2007-2012. Characteristics were compared using the appropriate distributional tests, and we estimated multivariable logistic regression models to control for treatment received. There were 201 deaths (17.5%). Women who died were significantly more likely to have any co-morbidity (AOR 3.63, 95% CI: 2.41-5.48), ruptured uterus (AOR 2.79, 95% CI: 1.48-5.28), macerated stillbirth (AOR 2.96, 95% CI 1.60-5.48) and to have had 6 or more previous births, (AOR 1.53, 95% CI 1.11-2.12), after adjusting for treatment received. These results suggest certain maternal conditions, particularly the presence of another life-threatening co-morbidity or macerated stillbirth, conferred a higher risk of mortality from PPH. This underscores the need for multi-system assessment and a comprehensive approach to the treatment of women with pregnancy complications.	[El Ayadi, Alison; Butrick, Elizabeth; Miller, Suellen] Univ Calif San Francisco, Dept Obstet Gynecol & Reprod Sci, San Francisco, CA 94143 USA; [Raifman, Sarah] Harvard Univ, Sch Publ Hlth, Dept Global Hlth & Populat, Boston, MA 02115 USA; [Jega, Farouk; Ojo, Yemisi] Pathfinder Int, Abuja, Nigeria; [Geller, Stacie] Univ Illinois, Coll Med, Dept Obstet & Gynecol, Chicago, IL 60612 USA	University of California System; University of California San Francisco; Harvard University; Harvard T.H. Chan School of Public Health; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	El Ayadi, A (corresponding author), Univ Calif San Francisco, Dept Obstet Gynecol & Reprod Sci, San Francisco, CA 94143 USA.	elayadia@globalhealth.ucsf.edu			MacArthur Foundation	MacArthur Foundation	The authors would like to thank the MacArthur Foundation for funding the CCAPPH project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agomo CO, 2009, KOREAN J PARASITOL, V47, P179, DOI 10.3347/kjp.2009.47.2.179; [Anonymous], 2009, WHO GUID MAN POSTP H; [Anonymous], 2010, MEAN ARTERIAL PRESSU; Begley CM, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007412.pub3; Brabin BJ, 2001, J NUTR, V131, p604S, DOI 10.1093/jn/131.2.604S; Brock JH, 1999, IRON INFECT; Cunningham FG, 2010, OBSTET HEMORRHAGE; DeLee J., 1901, AM J OBSTET GYNECOL, V44; Derman RJ, 2006, LANCET, V368, P1248, DOI 10.1016/S0140-6736(06)69522-6; Fawole B, 2010, WHO RECOMMENDATIONS; FLEMING AF, 1989, T ROY SOC TROP MED H, V83, P441, DOI 10.1016/0035-9203(89)90241-1; Habek D, 2008, FETAL DIAGN THER, V24, P42, DOI 10.1159/000132405; Ismail S, 2012, APHA 140 ANN M EXP S; Karoshi M, 2009, CLIN OBSTET GYNECOL, V52, P285, DOI 10.1097/GRF.0b013e3181a4f737; Kavle JA, 2008, J HEALTH POPUL NUTR, V26, P232; Khan KS, 2006, LANCET, V367, P1066, DOI 10.1016/S0140-6736(06)68397-9; Lalonde A, 2006, INT J GYNECOL OBSTET, V94, P243, DOI 10.1016/j.ijgo.2006.04.016; Le Coeur S, 2005, AIDS, V19, P69, DOI 10.1097/00002030-200501030-00008; Maine D, 1999, AM J PUBLIC HEALTH, V89, P480, DOI 10.2105/AJPH.89.4.480; Miller S, 2006, INT J GYNECOL OBSTET, V94, pS154, DOI 10.1016/S0020-7292(06)60022-2; Miller S, 2010, BMC PREGNANCY CHILDB, V10, DOI 10.1186/1471-2393-10-64; Miller S, 2009, INT J GYNECOL OBSTET, V107, P121, DOI 10.1016/j.ijgo.2009.06.005; Mourad-Youssif M, 2010, REPROD HEALTH, V7, DOI 10.1186/1742-4755-7-24; National Agency for the Control of AIDS, 2011, FACTSH 2011 UPD HIV; Ojengbede O, 2011, AFRICAN J MIDWIFERY, V5, P135; Ojengbede OA, 2011, GYNECOLOGIC OBSTET I; Pathfinder International, 2010, CLIN COMM ACT ADDR P; Pathfinder International, 2012, NIG CLIN COMM ACT AD; Qazi Qudsia, 2012, Maedica (Bucur), V7, P49; Ransom EI, 2002, MAKING MOTHERHOOD SA; Sagay AS, 2005, INT J GYNECOL OBSTET, V90, P61, DOI 10.1016/j.ijgo.2005.03.030; Sewankambo NK, 2000, AIDS, V14, P2391, DOI 10.1097/00002030-200010200-00021; Turan Janet, 2011, J Womens Health (Larchmt), V20, P91, DOI 10.1089/jwh.2010.2081; van Dillen J, 2010, CURR OPIN INFECT DIS, V23, P249, DOI 10.1097/QCO.0b013e328339257c; World Health Organization (WHO), 2012, TRENDS MAT MORT 1990; World Health Organization WHO, 2012, RECOMMENDATIONS PREV	36	4	4	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2013	8	8							e70446	10.1371/journal.pone.0070446	http://dx.doi.org/10.1371/journal.pone.0070446			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	201ER	23950937	Green Published, Green Submitted, gold			2022-12-25	WOS:000323124000015
J	Tokiwa, T; Hashimoto, T; Yabe, T; Komatsu, N; Akao, N; Ohta, N				Tokiwa, Toshihiro; Hashimoto, Takuma; Yabe, Tatsuo; Komatsu, Noriyuki; Akao, Nobuaki; Ohta, Nobuo			First Report of Angiostrongylus cantonensis (Nematoda: Angiostrongylidae) Infections in Invasive Rodents from Five Islands of the Ogasawara Archipelago, Japan	PLOS ONE			English	Article							RATTUS-NORVEGICUS; METASTRONGYLIDAE; CHEN; LUNGWORM; RECORD; GENE	Background: Angiostrongylus cantonensis (Chen, 1935) is a parasite of murid rodents and causative agent of human neuro-angiostrongyliasis. In 2011, the Ogasawara Islands in the western North Pacific were assigned a World Natural Heritage site status. The occurrence of A. cantonensis is well documented in the Chichijima, Hahajima, and Anijima Islands. However, the occurrence of A. cantonensis in the other islands of the Ogasawara Islands has not been reported. Methodology/Principal Findings: Between March 2010 and July 2011, 57 Rattus norvegicus and 79 R. rattus were collected from 9 islands (the Hahajima group: Anejima, Imoutojima, Meijima, Mukohjima, and Hirajima; Chichijima group: Minamijima; Mukojima group: Nakoudojima and Yomejima; and Iwojima group: Iwojima). Adult nematodes were found in the pulmonary artery of 46 R. norvegicus collected in the 5 islands of the Hahajima group (Anejima, Meijima, Imoutojima, Hrajima, and Mukohjima Islands). These nematodes were identified by molecular analysis as A. cantonensis. Comparison of the mitochondrial DNA sequences confirmed that all the samples from the Ogasawara Islands shared only a single lineage of A. cantonensis, which has been previously detected in the Okinawa, Hawaii, and Brazil. Conclusions/Significance: We describe new endemic foci of rat angiostrongyliasis in the Hahajima group (Anejima, Meijima, Imoutojima, Hirajima, and Mukohjima Islands) of the Ogasawara Islands. These findings indicate that the endemic foci of A. cantonensis are widely distributed in the Ogasawara Islands. Although human cases have not yet been reported in the Ogasawara Islands, the widespread detection of A. cantonensis could be of importance from the perspective of public health.	[Tokiwa, Toshihiro; Akao, Nobuaki; Ohta, Nobuo] Tokyo Med & Dent Univ, Grad Sch, Sect Environm Parasitol, Tokyo, Japan; [Hashimoto, Takuma] Japan Wildlife Res Ctr, Tokyo, Japan; [Komatsu, Noriyuki] Civil Int Corp, Div Res & Dev, Tokyo, Japan	Tokyo Medical & Dental University (TMDU)	Ohta, N (corresponding author), Tokyo Med & Dent Univ, Grad Sch, Sect Environm Parasitol, Tokyo, Japan.	matata.vip@tmd.ac.jp	Tokiwaa, Toshihiro/B-4664-2015	Tokiwaa, Toshihiro/0000-0003-1943-5146	Ministry of Health, Labor and Welfare of Japan [H20-Sinkou-ippan-015]; Japan Society for the Promotion of Sciences [25460513]	Ministry of Health, Labor and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Japan Society for the Promotion of Sciences(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This study was supported by Grant-in Aid from the Ministry of Health, Labor and Welfare of Japan (H20-Sinkou-ippan-015), and Grant-in Aid from Japan Society for the Promotion of Sciences (#25460513). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AGUIAR PH, 1981, AM J TROP MED HYG, V30, P963, DOI 10.4269/ajtmh.1981.30.963; ANDERSEN E, 1986, AM J TROP MED HYG, V35, P319, DOI 10.4269/ajtmh.1986.35.319; Archer CE, 2001, S AFR MED J, V101, P174; Blaxter ML, 1998, NATURE, V392, P71, DOI 10.1038/32160; Caldeira RL, 2007, MEM I OSWALDO CRUZ, V102, P887, DOI 10.1590/S0074-02762007000700018; Chiba S, 2011, P NATL ACAD SCI USA, V108, P9496, DOI 10.1073/pnas.1100085108; Chikweto A, 2009, VET PARASITOL, V162, P160, DOI 10.1016/j.vetpar.2009.02.020; Eamsobhana P, 2010, ACTA TROP, V116, P152, DOI 10.1016/j.actatropica.2010.07.005; Fontanilla IKC, 2008, ACTA TROP, V105, P181, DOI 10.1016/j.actatropica.2007.10.007; Foronda P, 2010, ACTA TROP, V114, P123, DOI 10.1016/j.actatropica.2010.02.004; Hashimoto T., 2009, EARTH ENV, V14, P93; HORI E, 1974, Japanese Journal of Parasitology, V23, P138; HORI E, 1973, Japanese Journal of Parasitology, V22, P347; Kanazawa T, 1984, J CHIBA MED SOC, V60, P377; Kanoh T, 1975, ANN REP TOKYO METR R, VPH26, P42; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; Katoh K, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-212; KLIKS MM, 1982, AM J TROP MED HYG, V31, P1114, DOI 10.4269/ajtmh.1982.31.1114; Lv S, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000368; Mead AR., 1961, GIANT AFRICAN SNAIL; Monte TCC, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-248; Murata I., 1985, Annual Report of the Tokyo Metropolitan Research Laboratory of Public Health, V36, P23; Pipitgool V, 1997, Southeast Asian J Trop Med Public Health, V28 Suppl 1, P190; PIPPIN WARREN F., 1966, J MED ENTOMOL, V2, P384, DOI 10.1093/jmedent/2.4.384; Prociv P, 2000, INT J PARASITOL, V30, P1295, DOI 10.1016/S0020-7519(00)00133-8; Raccurt CP, 2003, TROP MED INT HEALTH, V8, P423, DOI 10.1046/j.1365-3156.2003.01035.x; Russell JC, 2005, NATURE, V437, P1107, DOI 10.1038/4371107a; Sasa M, 1969, INVESTIGATION REPORT, P1; Suzuki J., 2004, ANN REP TOKYO METR I, V55, P295; Tokiwa T, 2012, PARASITOL INT, V61, P431, DOI 10.1016/j.parint.2012.02.005; Tokiwa T, 2011, PARASITOL INT, V60, P324, DOI 10.1016/j.parint.2011.03.003; Tomiyama K, 1988, ANN REP OGASAWARA ST, V11, P2; UCHIKAWA R, 1984, J HELMINTHOL, V58, P231, DOI 10.1017/S0022149X00027024; Uchikawa R, 1986, KISEICHUGAKU ZASSHI, V36, P94; VARGAS M, 1992, TROP MED PARASITOL, V43, P253; Wang QP, 2012, EUR J CLIN MICROBIOL, V31, P389, DOI 10.1007/s10096-011-1328-5; Wang QP, 2008, LANCET INFECT DIS, V8, P621, DOI 10.1016/S1473-3099(08)70229-9; Yabe T., 2006, ANN REPORT OGASAWARA, V29, P19; Yabe T, 1982, MAMM STUDY, V9, P14; Yabe T, 2008, ANN REP OGASAWARA ST, V31, P49	40	11	11	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2013	8	8							e70729	10.1371/journal.pone.0070729	http://dx.doi.org/10.1371/journal.pone.0070729			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	200ZE	23950989	Green Published, gold, Green Submitted			2022-12-25	WOS:000323109700047
J	Woolley-Meza, O; Grady, D; Thiemann, C; Bagrow, JP; Brockmann, D				Woolley-Meza, Olivia; Grady, Daniel; Thiemann, Christian; Bagrow, James P.; Brockmann, Dirk			Eyjafjallajokull and 9/11: The Impact of Large-Scale Disasters on Worldwide Mobility	PLOS ONE			English	Article							TRANSPORTATION NETWORK; COMPLEX NETWORKS; CENTRALITY; INTERNET	Large-scale disasters that interfere with globalized socio-technical infrastructure, such as mobility and transportation networks, trigger high socio-economic costs. Although the origin of such events is often geographically confined, their impact reverberates through entire networks in ways that are poorly understood, difficult to assess, and even more difficult to predict. We investigate how the eruption of volcano Eyjafjallajokull, the September 11th terrorist attacks, and geographical disruptions in general interfere with worldwide mobility. To do this we track changes in effective distance in the worldwide air transportation network from the perspective of individual airports. We find that universal features exist across these events: airport susceptibilities to regional disruptions follow similar, strongly heterogeneous distributions that lack a scale. On the other hand, airports are more uniformly susceptible to attacks that target the most important hubs in the network, exhibiting a well-defined scale. The statistical behavior of susceptibility can be characterized by a single scaling exponent. Using scaling arguments that capture the interplay between individual airport characteristics and the structural properties of routes we can recover the exponent for all types of disruption. We find that the same mechanisms responsible for efficient passenger flow may also keep the system in a vulnerable state. Our approach can be applied to understand the impact of large, correlated disruptions in financial systems, ecosystems and other systems with a complex interaction structure between heterogeneous components.	[Woolley-Meza, Olivia; Grady, Daniel; Thiemann, Christian; Bagrow, James P.; Brockmann, Dirk] Northwestern Univ, Evanston, IL 60208 USA; [Woolley-Meza, Olivia; Grady, Daniel; Bagrow, James P.; Brockmann, Dirk] Northwestern Univ, Northwestern Inst Complex Syst, Evanston, IL USA; [Thiemann, Christian] Max Planck Inst Dynam & Self Org, Gottingen, Germany; [Brockmann, Dirk] Robert Koch Inst, Berlin, Germany	Northwestern University; Northwestern University; Max Planck Society; Robert Koch Institute	Woolley-Meza, O (corresponding author), Northwestern Univ, Evanston, IL 60208 USA.	o-woolley@northwestern.edu	Grady, Daniel/E-9789-2015; Bagrow, James/E-1701-2016	Grady, Daniel/0000-0002-2446-2096; Bagrow, James/0000-0002-4614-0792	Volkswagen Foundation	Volkswagen Foundation(Volkswagen)	This work was supported by a Volkswagen Foundation grant (http://www.volkswagenstiftung.de/nc/en.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert R, 2000, NATURE, V406, P378, DOI 10.1038/35019019; [Anonymous], [No title captured]; Bagrow JP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017680; Barrat A, 2005, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2005/05/P05003; Barrat A, 2004, P NATL ACAD SCI USA, V101, P3747, DOI 10.1073/pnas.0400087101; Barthelemy Marc, 2011, Physics Reports, V499, P1, DOI 10.1016/j.physrep.2010.11.002; Barthelemy M, 2004, EUR PHYS J B, V38, P163, DOI 10.1140/epjb/e2004-00111-4; Beale N, 2011, P NATL ACAD SCI USA, V108, P12647, DOI 10.1073/pnas.1105882108; Boccaletti S, 2006, PHYS REP, V424, P175, DOI 10.1016/j.physrep.2005.10.009; Boguna M, 2009, NAT PHYS, V5, P74, DOI 10.1038/NPHYS1130; Buldyrev SV, 2010, NATURE, V464, P1025, DOI 10.1038/nature08932; Callaway DS, 2000, PHYS REV LETT, V85, P5468, DOI 10.1103/PhysRevLett.85.5468; Cohen R, 2001, PHYS REV LETT, V86, P3682, DOI 10.1103/PhysRevLett.86.3682; Cohen R, 2000, PHYS REV LETT, V85, P4626, DOI 10.1103/PhysRevLett.85.4626; Colizza V, 2006, P NATL ACAD SCI USA, V103, P2015, DOI 10.1073/pnas.0510525103; Colizza V, 2007, PLOS MED, V4, P95, DOI 10.1371/journal.pmed.0040013; Dall'Asta L, 2006, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2006/P04006; Epstein JM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000401; FREEMAN LC, 1980, QUAL QUANT, V14, P585; Grady D, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1847; Guimera R, 2004, EUR PHYS J B, V38, P381, DOI 10.1140/epjb/e2004-00131-0; Guimera R, 2005, P NATL ACAD SCI USA, V102, P7794, DOI 10.1073/pnas.0407994102; Holme Petter, 2002, Phys Rev E Stat Nonlin Soft Matter Phys, V65, P066109; Hufnagel L, 2004, P NATL ACAD SCI USA, V101, P15124, DOI 10.1073/pnas.0308344101; May RM, 2008, NATURE, V451, P893, DOI 10.1038/451893a; Newman MEJ, 2005, CONTEMP PHYS, V46, P323, DOI 10.1080/00107510500052444; Newman MEJ, 2004, PHYS REV E, V69, DOI [10.1103/PhysRevE.69.026113, 10.1103/PhysRevE.70.056131]; Ravasz E, 2003, PHYS REV E, V67, DOI 10.1103/PhysRevE.67.026112; Schneider CM, 2011, P NATL ACAD SCI USA, V108, P3838, DOI 10.1073/pnas.1009440108; Serrano MA, 2009, P NATL ACAD SCI USA, V106, P6483, DOI 10.1073/pnas.0808904106; Strogatz SH, 2001, NATURE, V410, P268, DOI 10.1038/35065725; Vespignani A, 2009, SCIENCE, V325, P425, DOI 10.1126/science.1171990; Woolley-Meza O, 2011, EUR PHYS J B, V84, P589, DOI 10.1140/epjb/e2011-20208-9	33	19	19	2	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2013	8	8							e69829	10.1371/journal.pone.0069829	http://dx.doi.org/10.1371/journal.pone.0069829			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	200ZE	23950904	Green Published, gold, Green Submitted			2022-12-25	WOS:000323109700020
J	Cheng, BH; Chu, TMG; Chang, CS; Kang, HY; Huang, KE				Cheng, Bi-Hua; Chu, Tien-Min G.; Chang, Chawnshang; Kang, Hong-Yo; Huang, Ko-En			Testosterone Delivered with a Scaffold Is as Effective as Bone Morphologic Protein-2 in Promoting the Repair of Critical-Size Segmental Defect of Femoral Bone in Mice	PLOS ONE			English	Article							GROWTH-FACTOR-BETA; LACKING ANDROGEN RECEPTOR; HUMAN OSTEOBLASTIC CELLS; MORPHOGENETIC PROTEIN-2; HYPOGONADAL MEN; MINERAL DENSITY; SEX STEROIDS; IN-VIVO; FRACTURE MODEL; DIFFERENTIATION	Loss of large bone segments due to fracture resulting from trauma or tumor removal is a common clinical problem. The goal of this study was to evaluate the use of scaffolds containing testosterone, bone morphogenetic protein-2 (BMP-2), or a combination of both for treatment of critical-size segmental bone defects in mice. A 2.5-mm wide osteotomy was created on the left femur of wildtype and androgen receptor knockout (ARKO) mice. Testosterone, BMP-2, or both were delivered locally using a scaffold that bridged the fracture. Results of X-ray imaging showed that in both wildtype and ARKO mice, BMP-2 treatment induced callus formation within 14 days after initiation of the treatment. Testosterone treatment also induced callus formation within 14 days in wildtype but not in ARKO mice. Micro-computed tomography and histological examinations revealed that testosterone treatment caused similar degrees of callus formation as BMP-2 treatment in wildtype mice, but had no such effect in ARKO mice, suggesting that the androgen receptor is required for testosterone to initiate fracture healing. These results demonstrate that testosterone is as effective as BMP-2 in promoting the healing of critical-size segmental defects and that combination therapy with testosterone and BMP-2 is superior to single therapy. Results of this study may provide a foundation to develop a cost effective and efficient therapeutic modality for treatment of bone fractures with segmental defects.	[Cheng, Bi-Hua] Chiayi Chang Gung Mem Hosp, Dept Obstet & Gynecol, Chiayi, Taiwan; [Cheng, Bi-Hua; Huang, Ko-En] Chang Gung Univ, Coll Med, Kaohsiung Chang Gung Mem Hosp, Dept Obstet & Gynecol, Kaohsiung, Taiwan; [Cheng, Bi-Hua; Kang, Hong-Yo] Chang Gung Univ, Coll Med, Grad Inst Clin Med Sci, Tao Yuan, Taiwan; [Cheng, Bi-Hua; Kang, Hong-Yo; Huang, Ko-En] Chang Gung Univ, Coll Med, Kaohsiung Chang Gung Mem Hosp, Ctr Menopause & Reprod Med Res, Kaohsiung, Taiwan; [Chu, Tien-Min G.] Indiana Univ, Sch Dent, Dept Restorat Dent, Indianapolis, IN USA; [Chang, Chawnshang] Univ Rochester, Med Ctr, Dept Pathol, George Whipple Lab Canc Res, Rochester, NY 14642 USA; [Chang, Chawnshang] Univ Rochester, Med Ctr, Dept Urol, Rochester, NY 14642 USA; [Chang, Chawnshang] Univ Rochester, Med Ctr, Dept Radiat Oncol, Rochester, NY 14642 USA; [Chang, Chawnshang] Univ Rochester, Med Ctr, Wilmot Canc Ctr, Rochester, NY 14642 USA	Chang Gung Memorial Hospital; Chang Gung Memorial Hospital; Chang Gung University; Chang Gung University; Chang Gung Memorial Hospital; Chang Gung University; Indiana University System; Indiana University-Purdue University Indianapolis; University of Rochester; University of Rochester; University of Rochester; University of Rochester	Kang, HY (corresponding author), Chang Gung Univ, Coll Med, Grad Inst Clin Med Sci, Tao Yuan, Taiwan.	hkang3@mail.cgu.edu.tw; khuang@adm.cgmh.org.tw	Kang, Hong-Yo/W-9031-2019; Chu, Tien-Min Gabriel/W-1009-2019	Kang, Hong-Yo/0000-0003-0626-5037; Chang, Chawnshang/0000-0001-8510-3516; Chu, Tien-Min Gabriel/0000-0002-7190-837X	Chang Gung Memorial Hospital [CMRPG891191-3, CMRPG891171-3, CMRPD830501]; National Science Council of Taiwan [NMRPG890051 (NSC99-2314-B-182A-042-), NMRPG 8A0101 (NSC100-2314-B-182A-019)]; IUPUI International Development Award	Chang Gung Memorial Hospital(Chang Gung Memorial Hospital); National Science Council of Taiwan(Ministry of Science and Technology, Taiwan); IUPUI International Development Award	This study was supported in part by the following grants: CMRPG891191-3, CMRPG891171-3, and CMRPD830501 from the Chang Gung Memorial Hospital to Bi-Hua Cheng, H. Y. Kang, and K. E. Huang, respectively; NMRPG890051 (NSC99-2314-B-182A-042-), NMRPG 8A0101 (NSC100-2314-B-182A-019) from the National Science Council of Taiwan to K. E. Huang; and IUPUI International Development Award to T. M. Chu. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adah F, 2006, BIOMED SCI INSTRUM, V42, P126; AHRENS M, 1993, DNA CELL BIOL, V12, P871, DOI 10.1089/dna.1993.12.871; Angle SR, 2012, J MUSCULOSKEL NEURON, V12, P28; Benghuzzi H, 2004, TECH PAPERS ISA, V449, P99; BENZ DJ, 1991, ENDOCRINOLOGY, V128, P2723, DOI 10.1210/endo-128-6-2723; BODINE PVN, 1995, J STEROID BIOCHEM, V52, P149, DOI 10.1016/0960-0760(94)00165-I; Bouxsein ML, 2001, J BONE JOINT SURG AM, V83A, P1219, DOI 10.2106/00004623-200108000-00012; Canalis E, 1997, BONE, V21, P215, DOI 10.1016/S8756-3282(97)00150-6; Chu TMG, 2007, BIOMATERIALS, V28, P459, DOI 10.1016/j.biomaterials.2006.09.004; Compston JE, 2001, PHYSIOL REV, V81, P419, DOI 10.1152/physrev.2001.81.1.419; De Luca F, 2001, ENDOCRINOLOGY, V142, P430, DOI 10.1210/en.142.1.430; Derynck R, 1998, CELL, V95, P737, DOI 10.1016/S0092-8674(00)81696-7; Diab T, 2012, J MECH BEHAV BIOMED, V11, P123, DOI 10.1016/j.jmbbm.2011.11.007; Epstein Nancy E, 2011, Surg Neurol Int, V2, P10, DOI 10.4103/2152-7806.76147; Feldman HA, 2002, J CLIN ENDOCR METAB, V87, P589, DOI 10.1210/jc.87.2.589; Floerkemeier T, 2012, ORTHOP REV, V4, P59, DOI 10.4081/or.2012.e13; FREIREICH EMIL J., 1966, CANCER CHEMOTHERAP REP, V50, P219; Garrison KR, 2007, HEALTH TECHNOL ASSES, V11, P1; Gill RK, 1998, ENDOCRINOLOGY, V139, P546, DOI 10.1210/en.139.2.546; Gooren LJG, 2008, J SEX MED, V5, P765, DOI 10.1111/j.1743-6109.2007.00646.x; Gordon E, 1997, Biomed Sci Instrum, V33, P131; Govender S, 2002, J BONE JOINT SURG AM, V84A, P2123, DOI 10.2106/00004623-200212000-00001; Gu Y, 2011, J BIOMED MATER RES A, V97A, P177, DOI 10.1002/jbm.a.33018; Guo CY, 1997, J CLIN ENDOCR METAB, V82, P658, DOI 10.1210/jc.82.2.658; Kang Hong-Yo, 2003, Chang Gung Med J, V26, P388; Kang HY, 2008, MOL CELL BIOL, V28, P7354, DOI 10.1128/MCB.00582-08; Kang HY, 2004, J BONE MINER RES, V19, P1181, DOI 10.1359/JBMR.040306; Katznelson L, 1996, J CLIN ENDOCR METAB, V81, P4358, DOI 10.1210/jc.81.12.4358; Kawano H, 2003, P NATL ACAD SCI USA, V100, P9416, DOI 10.1073/pnas.1533500100; Kousteni S, 2002, SCIENCE, V298, P843, DOI 10.1126/science.1074935; Kousteni S, 2001, CELL, V104, P719, DOI 10.1016/S0092-8674(01)00268-9; Kretzschmar M, 1998, CURR OPIN GENET DEV, V8, P103, DOI 10.1016/S0959-437X(98)80069-5; Lai CF, 2002, J BIOL CHEM, V277, P15514, DOI 10.1074/jbc.M200794200; Leifke E, 1998, EUR J ENDOCRINOL, V138, P51, DOI 10.1530/eje.0.1380051; Lin SC, 1997, J CLIN INVEST, V100, P1980, DOI 10.1172/JCI119729; LIU F, 1995, MOL CELL BIOL, V15, P3479; Maus U, 2008, Z ORTHOP UNFALLCHIR, V146, P59, DOI 10.1055/s-2007-989436; Miller MA, 2011, INT ORTHOP, V35, P599, DOI 10.1007/s00264-010-1013-9; Nohe A, 2002, J BIOL CHEM, V277, P5330, DOI 10.1074/jbc.M102750200; Ohura K, 1999, J BIOMED MATER RES, V44, P168, DOI 10.1002/(SICI)1097-4636(199902)44:2<168::AID-JBM7>3.0.CO;2-4; OZKAYNAK E, 1992, J BIOL CHEM, V267, P25220; Peter SJ, 1998, J BIOMED MATER RES, V41, P1; Rajaram S, 1997, ENDOCR REV, V18, P801, DOI 10.1210/er.18.6.801; REN SG, 1989, ACTA ENDOCRINOL-COP, V121, P401, DOI 10.1530/acta.0.1210401; Ridha H, 2011, J RECONSTR MICROSURG, V27, P383, DOI 10.1055/s-0031-1281520; Russell PK, 2012, J MOL ENDOCRINOL, V49, P1, DOI 10.1530/JME-12-0014; Schenk RK., 1984, METHODS CALCIFIED TI, P1; Shahlaie K, 2008, SPINE, V33, P2361, DOI 10.1097/BRS.0b013e318183971d; Snyder PJ, 2000, J CLIN ENDOCR METAB, V85, P2670, DOI 10.1210/jc.85.8.2670; Stambough JL, 2010, SPINE, V35, P124, DOI 10.1097/BRS.0b013e3181c46c3a; Stewart RL, 2010, J ORTHOP TRAUMA, V24, P587, DOI 10.1097/BOT.0b013e3181ed1349; Stewart RL, 2008, 24 ANN M OTA DENV CO; Tsai MY, 2006, P NATL ACAD SCI USA, V103, P18975, DOI 10.1073/pnas.0608565103; Valcourt U, 2002, J BIOL CHEM, V277, P33545, DOI 10.1074/jbc.M202086200; Vanderschueren D, 2004, ENDOCR REV, V25, P389, DOI 10.1210/er.2003-0003; Venken K, 2006, J BONE MINER RES, V21, P576, DOI 10.1359/JBMR.060103; Verdelis K, 2011, BONE, V49, P580, DOI 10.1016/j.bone.2011.05.013; Wang C, 1996, J CLIN ENDOCR METAB, V81, P3654, DOI 10.1210/jc.81.10.3654; Wang C, 2001, CLIN ENDOCRINOL, V54, P739, DOI 10.1046/j.1365-2265.2001.01271.x; WANG EA, 1993, GROWTH FACTORS, V9, P57, DOI 10.3109/08977199308991582; Welch RD, 1998, J BONE MINER RES, V13, P1483, DOI 10.1359/jbmr.1998.13.9.1483; Wiren KM, 2008, BONE, V43, P440, DOI 10.1016/j.bone.2008.04.026; Wiren KM, 2010, BONE, V46, P710, DOI 10.1016/j.bone.2009.10.039; Wong DA, 2008, SPINE J, V8, P1011, DOI 10.1016/j.spinee.2007.06.014; Xiong JH, 2012, J BONE MINER RES, V27, P499, DOI 10.1002/jbmr.1547; Yamashita H, 1996, BONE, V19, P569, DOI 10.1016/S8756-3282(96)00259-1; Yaremchuk KL, 2010, LARYNGOSCOPE, V120, P1954, DOI 10.1002/lary.21096; Yeh SY, 2002, P NATL ACAD SCI USA, V99, P13498, DOI 10.1073/pnas.212474399; Zafirau W, 1996, Biomed Sci Instrum, V32, P63; Zimmer G, 2013, J BIOMED MAT RES A	70	18	22	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2013	8	8							e70234	10.1371/journal.pone.0070234	http://dx.doi.org/10.1371/journal.pone.0070234			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	218XC	23940550	gold, Green Submitted, Green Published			2022-12-25	WOS:000324465000044
J	Chowdhury, S; Guha, R; Trivedi, R; Kompella, UB; Konar, A; Hazra, S				Chowdhury, Sushovan; Guha, Rajdeep; Trivedi, Ruchit; Kompella, Uday B.; Konar, Aditya; Hazra, Sarbani			Pirfenidone Nanoparticles Improve Corneal Wound Healing and Prevent Scarring Following Alkali Burn	PLOS ONE			English	Article							CELL-PROLIFERATION; ORGANIZATION; KERATOCYTES; AGENT	Purpose: To evaluate the effects of pirfenidone nanoparticles on corneal re-epithelialization and scarring, major clinical challenges after alkali burn. Methods: Effect of pirfenidone on collagen I and alpha-smooth muscle actin (alpha-SMA) synthesis by TGF beta induced primary corneal fibroblast cells was evaluated by immunoblotting and immunocytochemistry. Pirfenidone loaded poly (lactide-co-glycolide) (PLGA) nanoparticles were prepared, characterized and their cellular entry was examined in primary corneal fibroblast cells by fluorescence microscopy. Alkali burn was induced in one eye of Sprague Dawley rats followed by daily topical treatment with free pirfenidone, pirfenidone nanoparticles or vehicle. Corneal re-epithelialization was assessed daily by flourescein dye test; absence of stained area indicated complete re-epithelialization and the time for complete re-epithelialization was determined. Corneal haze was assessed daily for 7 days under slit lamp microscope and graded using a standard method. After 7 days, collagen I deposition in the superficial layer of cornea was examined by immunohistochemistry. Results: Pirfenidone prevented (P<0.05) increase in TGF beta induced collagen I and alpha-SMA synthesis by corneal fibroblasts in a dose dependent manner. Pirfenidone could be loaded successfully within PLGA nanoparticles, which entered the corneal fibroblasts within 5 minutes. Pirfenidone nanoparticles but not free pirfenidone significantly (P<0.05) reduced collagen I level, corneal haze and the time for corneal re-epithelialization following alkali burn. Conclusion: Pirfenidone decreases collagen synthesis and prevents myofibroblast formation. Pirfenidone nanoparticles improve corneal wound healing and prevent fibrosis. Pirfenidone nanoparticles are of potential value in treating corneal chemical burns and other corneal fibrotic diseases.	[Chowdhury, Sushovan; Guha, Rajdeep; Konar, Aditya] CSIR Indian Inst Chem Biol, Dept Lab Anim Facil, Kolkata, India; [Trivedi, Ruchit; Kompella, Uday B.] Univ Colorado, Dept Pharmaceut Sci, Aurora, CO USA; [Hazra, Sarbani] West Bengal Univ Anim & Fishery Sci, Deptartment Vet Surg & Radiol, Kolkata, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Indian Institute of Chemical Biology (IICB); University of Colorado System; University of Colorado Anschutz Medical Campus; West Bengal University of Animal & Fishery Sciences	Hazra, S (corresponding author), West Bengal Univ Anim & Fishery Sci, Deptartment Vet Surg & Radiol, Kolkata, India.	shazrakon@yahoo.co.in	Trivedi, Ruchit/N-6920-2014		Department of Biotechnology (New Delhi, India); NIH [EY018940]; NATIONAL EYE INSTITUTE [R01EY018940] Funding Source: NIH RePORTER	Department of Biotechnology (New Delhi, India)(Department of Biotechnology (DBT) India); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	Financial support was provided by the Department of Biotechnology (New Delhi, India) and in part by the NIH grant EY018940 (UBK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Azuma A, 2005, AM J RESP CRIT CARE, V171, P1040, DOI 10.1164/rccm.200404-571OC; Choi K, 2012, MOL VIS, V18, P1010; Di Sario A, 2002, J HEPATOL, V37, P584, DOI 10.1016/S0168-8278(02)00245-3; FANTES FE, 1990, ARCH OPHTHALMOL-CHIC, V108, P665, DOI 10.1001/archopht.1990.01070070051034; Guha R, 2013, NANOMEDICINE-UK, V8, P1415, DOI [10.2217/NNM.12.175, 10.2217/nnm.12.175]; Haber M, 2003, VET OPHTHALMOL, V6, P211, DOI 10.1046/j.1463-5224.2003.00296.x; Hassell JR, 2010, EXP EYE RES, V91, P326, DOI 10.1016/j.exer.2010.06.021; Hewitson TD, 2001, J NEPHROL, V14, P453; Hisatomi K, 2012, BMC PULM MED, V12, DOI 10.1186/1471-2466-12-24; Iyer SN, 1999, J PHARMACOL EXP THER, V291, P367; Jester JV, 1999, J CELL SCI, V112, P613; JESTER JV, 1994, INVEST OPHTH VIS SCI, V35, P730; Kim H, 2010, INVEST OPHTH VIS SCI, V51, P3061, DOI 10.1167/iovs.09-4257; Lee BS, 1998, J CLIN ENDOCR METAB, V83, P219, DOI 10.1210/jc.83.1.219; McGwin G, 2005, ARCH OPHTHALMOL-CHIC, V123, P970, DOI 10.1001/archopht.123.7.970; MULLER LJ, 1995, INVEST OPHTH VIS SCI, V36, P2557; Raghu G, 1999, AM J RESP CRIT CARE, V159, P1061, DOI 10.1164/ajrccm.159.4.9805017; Saika Shizuya, 2004, Cornea, V23, pS25, DOI 10.1097/01.ico.0000136668.41000.73; Seoane J, 2006, CARCINOGENESIS, V27, P2148, DOI 10.1093/carcin/bgl068; Shi Q, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028134; Sun GY, 2011, MOL VIS, V17, P2191; Trivedi R, 2012, NANOTECHNOLOGY, V23, DOI 10.1088/0957-4484/23/50/505101; Wagoner MD, 1997, SURV OPHTHALMOL, V41, P275, DOI 10.1016/S0039-6257(96)00007-0; Whitcher JP, 2001, B WORLD HEALTH ORGAN, V79, P214; Yang H, 2012, ACS NANO, V6, P7595, DOI 10.1021/nn301873v; Zhong H, 2011, INVEST OPHTH VIS SCI, V52, P3136, DOI 10.1167/iovs.10-6240; Zieske JD, 2001, EXP EYE RES, V72, P33, DOI 10.1006/exer.2000.0926; Zieske JD, 2001, INVEST OPHTH VIS SCI, V42, P1465	28	35	36	3	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2013	8	8							e70528	10.1371/journal.pone.0070528	http://dx.doi.org/10.1371/journal.pone.0070528			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	218XC	23940587	Green Submitted, Green Published, gold			2022-12-25	WOS:000324465000081
J	Chtourou, H; Aloui, A; Hammouda, O; Chaouachi, A; Chamari, K; Souissi, N				Chtourou, Hamdi; Aloui, Asma; Hammouda, Omar; Chaouachi, Anis; Chamari, Karim; Souissi, Nizar			Effect of Static and Dynamic Stretching on the Diurnal Variations of Jump Performance in Soccer Players	PLOS ONE			English	Article							TIME-OF-DAY; PROPRIOCEPTIVE NEUROMUSCULAR FACILITATION; TERM EXERCISE PERFORMANCES; WARM-UP; WINGATE TEST; STRENGTH; MUSCLE; FORCE; POWER; MECHANISMS	Purpose: The present study addressed the lack of data on the effect of different types of stretching on diurnal variations in vertical jump height -i.e., squat-jump (SJ) and countermovement-jump (CMJ). We hypothesized that dynamic stretching could affect the diurnal variations of jump height by producing a greater increase in short-term maximal performance in the morning than the evening through increasing core temperature at this time-of-day. Methods: Twenty male soccer players (age, 18.6 +/- 1.3 yrs; height, 174.6 +/- 3.8 cm; body-mass, 71.1 +/- 8.6 kg; mean +/- SD) completed the SJ and CMJ tests either after static stretching, dynamic stretching or no-stretching protocols at two times of day, 07: 00 h and 17: 00 h, with a minimum of 48 hours between testing sessions. One minute after warming-up for 5 minutes by light jogging and performing one of the three stretching protocols (i.e., static stretching, dynamic stretching or no-stretching) for 8 minutes, each subject completed the SJ and CMJ tests. Jumping heights were recorded and analyzed using a two-way analysis of variance with repeated measures (3 [stretching] x2 [time-of-day]). Results: The SJ and CMJ heights were significantly higher at 17: 00 than 07: 00 h (p<0.01) after the no-stretching protocol. These daily variations disappeared (i.e., the diurnal gain decreased from 4.2 +/- 2.81% (p<0.01) to 1.81 +/- 4.39% (not-significant) for SJ and from 3.99 +/- 3.43% (p<0.01) to 1.51 +/- 3.83% (not-significant) for CMJ) after dynamic stretching due to greater increases in SJ and CMJ heights in the morning than the evening (8.4 +/- 6.36% vs. 4.4 +/- 2.64%, p<0.05 for SJ and 10.61 +/- 5.49% vs. 6.03 +/- 3.14%, p<0.05 for CMJ). However, no significant effect of static stretching on the diurnal variations of SJ and CMJ heights was observed. Conclusion: Dynamic stretching affects the typical diurnal variations of SJ and CMJ and helps to counteract the lower morning values in vertical jump height.	[Chtourou, Hamdi; Aloui, Asma; Hammouda, Omar; Chaouachi, Anis; Chamari, Karim; Souissi, Nizar] Natl Ctr Med & Sci Sport CNMSS, Res Lab Sport Performance Optimizat, Tunis, Tunisia; [Chtourou, Hamdi] Sfax Univ, High Inst Sport & Phys Educ, Res Unit EM2S, Sfax, Tunisia; [Chamari, Karim] Qatar Orthoped & Sports Med Hosp, Res & Educ Ctr, Aspetar, Doha, Qatar; [Souissi, Nizar] Manouba Univ, High Inst Sport & Phys Educ, Manouba, Tunisia	Centre National de la Medecine Sciences des Sports; Universite de Sfax; Aspetar Orthopaedic & Sports Medicine Hospital; Universite de la Manouba	Chtourou, H (corresponding author), Natl Ctr Med & Sci Sport CNMSS, Res Lab Sport Performance Optimizat, Tunis, Tunisia.	h_chtourou@yahoo.fr	Chtourou, Hamdi/GVU-1967-2022; Aloui, Asma/J-1300-2019; Nizar, Souissi/AAF-4490-2019; CHAMARI, Karim/AAJ-7938-2021	Chtourou, Hamdi/0000-0002-5482-9151; Aloui, Asma/0000-0001-5054-1540; Nizar, Souissi/0000-0003-1227-8221; CHAMARI, Karim/0000-0001-9178-7678; HAMMOUDA, Omar/0000-0002-5002-687X	Ministry of Higher Education and Scientific Research, Tunisia	Ministry of Higher Education and Scientific Research, Tunisia	The authors wish to thank Prof. Jim Waterhouse who checked the English of the manuscript. This study was supported by the Ministry of Higher Education and Scientific Research, Tunisia. We are grateful to all the players who participated so willingly in the study.	Aloui A, 2013, INT J SPORT PHYSIOL, V8, P254, DOI 10.1123/ijspp.8.3.254; Behm DG, 2011, EUR J APPL PHYSIOL, V111, P2633, DOI 10.1007/s00421-011-1879-2; Behm DG, 2006, J SPORT SCI MED, V5, P33; Bishop D, 2003, SPORTS MED, V33, P439, DOI 10.2165/00007256-200333060-00005; Bougard C, 2009, CHRONOBIOL INT, V26, P307, DOI 10.1080/07420520902774532; Bradley PS, 2007, J STRENGTH COND RES, V21, P223, DOI 10.1519/00124278-200702000-00040; Chamari K, 2004, BRIT J SPORT MED, V38, P191, DOI 10.1136/bjsm.2002.004374; Christensen BK, 2008, J STRENGTH COND RES, V22, P1826, DOI 10.1519/JSC.0b013e31817ae316; Chtourou H, 2012, INT J SPORTS MED, V33, P142, DOI 10.1055/s-0031-1286251; Chtourou H, 2012, INT J SPORTS MED, V33, P43, DOI 10.1055/s-0031-1284398; Chtourou H., 2013, J NOV PHYSIOTHER, V3, P160, DOI [10.4172/2165-7025.1000160, DOI 10.4172/2165-7025.1000160]; Chtourou H, 2012, SCI SPORT, V27, P85, DOI [10.1016/j.scispo.2012.02.006, DOI 10.1016/J.SCISPO.2012.02.006]; Chtourou H, 2013, BIOL RHYTHM RES, V44, P797, DOI 10.1080/09291016.2012.756269; Chtourou Hamdi, 2012, Asian J Sports Med, V3, P139; Chtourou H, 2012, J STRENGTH COND RES, V26, P1984, DOI 10.1519/JSC.0b013e31825770a7; Chtourou H, 2012, J STRENGTH COND RES, V26, P697, DOI 10.1519/JSC.0b013e3182281c87; Chtourou Hamdi, 2011, Asian J Sports Med, V2, P177; Chtourou H, 2012, J STRENGTH COND RES, V26, P217, DOI 10.1519/JSC.0b013e31821d5e8d; Chtourou H, 2011, CHRONOBIOL INT, V28, P706, DOI 10.3109/07420528.2011.596295; Cornwell A, 2001, J HUM MOVEMENT STUD, V40, P307; Dalrymple KJ, 2010, J STRENGTH COND RES, V24, P149, DOI 10.1519/JSC.0b013e3181b29614; Fletcher IM, 2010, APPL PHYSIOL NUTR ME, V35, P27, DOI 10.1139/H09-125; Fowles JR, 2000, J APPL PHYSIOL, V89, P1179, DOI 10.1152/jappl.2000.89.3.1179; Gauthier A, 1996, CHRONOBIOL INT, V13, P135, DOI 10.3109/07420529609037077; Hammouda O, 2011, CHRONOBIOL INT, V28, P958, DOI 10.3109/07420528.2011.613683; Hamouda O, 2012, BIOL RHYTHM RES, V43, P177, DOI 10.1080/09291016.2011.560050; Holt BW, 2008, J STRENGTH COND RES, V22, P226, DOI 10.1519/JSC.0b013e31815f9d6a; HORNE J A, 1976, International Journal of Chronobiology, V4, P97; Hough PA, 2009, J STRENGTH COND RES, V23, P507, DOI 10.1519/JSC.0b013e31818cc65d; Jaggers JR, 2008, J STRENGTH COND RES, V22, P1844, DOI 10.1519/JSC.0b013e3181854a3d; Marek SM, 2005, J ATHL TRAINING, V40, P94; Gonzalez-Rave JM, 2009, J STRENGTH COND RES, V23, P472, DOI 10.1519/JSC.0b013e318198f912; Martin A, 1999, MUSCLE NERVE, V22, P1380, DOI 10.1002/(SICI)1097-4598(199910)22:10<1380::AID-MUS7>3.3.CO;2-L; McNeal JR, 2003, PEDIATR EXERC SCI, V15, P139, DOI 10.1123/pes.15.2.139; Nelson AG, 2001, J STRENGTH COND RES, V15, P241; Nicolas A, 2005, CHRONOBIOL INT, V22, P997, DOI 10.1080/07420520500397892; Pearce AJ, 2009, EUR J APPL PHYSIOL, V105, P175, DOI 10.1007/s00421-008-0887-3; Robbins JW, 2008, J STRENGTH COND RES, V22, P781, DOI 10.1519/JSC.0b013e31816a59a9; Samuel MN, 2008, J STRENGTH COND RES, V22, P1422, DOI 10.1519/JSC.0b013e318181a314; Souissi H, 2012, J SPORT SCI MED, V11, P380; Souissi H, 2012, PEDIATR EXERC SCI, V24, P84, DOI 10.1123/pes.24.1.84; Souissi H, 2010, PEDIATR EXERC SCI, V22, P613, DOI 10.1123/pes.22.4.613; Souissi M, 2013, BIOL RHYTHM RES, V44, P245, DOI 10.1080/09291016.2012.667981; Souissi M, 2012, BIOL RHYTHM RES, V43, P323, DOI 10.1080/09291016.2011.589159; Souissi N, 2004, INT J SPORTS MED, V25, P14; Souissi N, 2010, CHRONOBIOL INT, V27, P640, DOI 10.3109/07420528.2010.483157; Torres EM, 2008, J STRENGTH COND RES, V22, P1279, DOI 10.1519/JSC.0b013e31816eb501; Turki-Belkhiria L, 2014, EUR J SPORT SCI, V14, P19, DOI 10.1080/17461391.2012.726651; Unick J, 2005, J STRENGTH COND RES, V19, P206; Wallmann HW, 2005, J STRENGTH COND RES, V19, P684; Waterhouse J, 2005, CHRONOBIOL INT, V22, P207, DOI 10.1081/CBI-200053477; Yamaguchi T, 2005, J STRENGTH COND RES, V19, P677; Young WB, 2003, J SPORT MED PHYS FIT, V43, P21; Young WB, 2002, STRENGTH COND J, V24, P33, DOI 10.1519/1533-4295(2002)024<0033:SSSBUD>2.0.CO;2; Zarrouk N, 2012, INT J SPORTS MED, V33, P975, DOI 10.1055/s-0032-1312626; Zarrouk N, 2012, SCI SPORT, V27, P101, DOI 10.1016/j.scispo.2011.07.002	56	28	29	0	60	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2013	8	8							e70534	10.1371/journal.pone.0070534	http://dx.doi.org/10.1371/journal.pone.0070534			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	218XC	23940589	Green Submitted, Green Published, gold			2022-12-25	WOS:000324465000083
J	Deng, L; Shangguan, ZP; Sweeney, S				Deng, Lei; Shangguan, Zhou-Ping; Sweeney, Sandra			Changes in Soil Carbon and Nitrogen following Land Abandonment of Farmland on the Loess Plateau, China	PLOS ONE			English	Article							ORGANIC-CARBON; GREEN PROGRAM; RESTORATION; SUCCESSION; FOREST; SEQUESTRATION; FRACTIONS; NUTRIENTS; STOCKS; AREA	The revegetation of abandoned farmland significantly influences soil organic C (SOC) and total N (TN). However, the dynamics of both soil OC and N storage following the abandonment of farmland are not well understood. To learn more about soil C and N storages dynamics 30 years after the conversion of farmland to grassland, we measured SOC and TN content in paired grassland and farmland sites in the Zhifanggou watershed on the Loess Plateau, China. The grassland sites were established on farmland abandoned for 1, 7, 13, 20, and 30 years. Top soil OC and TN were higher in older grassland, especially in the 0-5 cm soil depths; deeper soil OC and TN was lower in younger grasslands (<20 yr), and higher in older grasslands (30 yr). Soil OC and N storage (0-100 cm) was significantly lower in the younger grasslands (<20 yr), had increased in the older grasslands (30 yr), and at 30 years SOC had increased to pre-abandonment levels. For a thirty year period following abandonment the soil C/N value remained at 10. Our results indicate that soil C and TN were significantly and positively correlated, indicating that studies on the storage of soil OC and TN needs to focus on deeper soil and not be restricted to the uppermost (0-30 cm) soil levels.	[Deng, Lei; Shangguan, Zhou-Ping] Northwest A&F Univ, State Key Lab Soil Eros & Dryland Farming Loess P, Yangling, Shaanxi, Peoples R China; [Sweeney, Sandra] Univ Bosphorus, Inst Environm Sci, Istanbul, Turkey	Northwest A&F University - China; Bogazici University	Shangguan, ZP (corresponding author), Northwest A&F Univ, State Key Lab Soil Eros & Dryland Farming Loess P, Yangling, Shaanxi, Peoples R China.	shangguan@ms.iswc.ac.cn	deng, lei/M-1340-2014		Chinese Academy of Sciences [XDA05060403]; Ministry of Education	Chinese Academy of Sciences(Chinese Academy of Sciences); Ministry of Education	The study was funded by the Strategic Priority Research Program of the Chinese Academy of Sciences (XDA05060403) and the Scholarship Award for Excellent Doctoral Student granted by Ministry of Education. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arora VK, 2010, GLOBAL CHANGE BIOL, V16, P3327, DOI 10.1111/j.1365-2486.2010.02202.x; Bhojvaid PP, 1998, FOREST ECOL MANAG, V106, P181, DOI 10.1016/S0378-1127(97)00310-1; BORMANN BT, 1990, J ECOL, V78, P561, DOI 10.2307/2260884; Bremner JM., 1965, METHODS SOIL ANAL, V9, P1149; Brown J, 2010, RANGELAND ECOL MANAG, V63, P147, DOI 10.2111/08-089.1; Chen FS, 2010, APPL SOIL ECOL, V44, P42, DOI 10.1016/j.apsoil.2009.09.003; De Deyn GB, 2008, ECOL LETT, V11, P516, DOI 10.1111/j.1461-0248.2008.01164.x; Deng L, 2012, INT J SEDIMENT RES, V27, P120, DOI 10.1016/S1001-6279(12)60021-3; Deng L, 2011, J FOOD AGRIC ENVIRON, V9, P826; Eaton J, 2008, CLIMATIC CHANGE, V91, P317, DOI 10.1007/s10584-008-9412-2; Fang W, 1997, FOREST ECOL MANAG, V99, P185, DOI 10.1016/S0378-1127(97)00204-1; Ficetola GF, 2010, GLOBAL CHANGE BIOL, V16, P528, DOI 10.1111/j.1365-2486.2009.01957.x; Foster D, 2003, BIOSCIENCE, V53, P77, DOI 10.1641/0006-3568(2003)053[0077:TIOLUL]2.0.CO;2; Fu BJ, 2000, CATENA, V39, P69, DOI 10.1016/S0341-8162(99)00084-3; Fu XL, 2010, GEODERMA, V155, P31, DOI 10.1016/j.geoderma.2009.11.020; Guo LB, 2002, GLOBAL CHANGE BIOL, V8, P345, DOI 10.1046/j.1354-1013.2002.00486.x; He NP, 2009, GEODERMA, V150, P302, DOI 10.1016/j.geoderma.2009.02.004; Jia GM, 2005, FOREST ECOL MANAG, V217, P117, DOI 10.1016/j.foreco.2005.05.055; Jia XX, 2012, CATENA, V95, P160, DOI 10.1016/j.catena.2012.02.018; Jobbagy EG, 2000, ECOL APPL, V10, P423, DOI 10.1890/1051-0761(2000)010[0423:TVDOSO]2.0.CO;2; Johnson EA, 2008, ECOL LETT, V11, P419, DOI 10.1111/j.1461-0248.2008.01173.x; KALEMBASA SJ, 1973, J SCI FOOD AGR, V24, P1085, DOI 10.1002/jsfa.2740240910; Kalnay E, 2003, NATURE, V423, P528, DOI 10.1038/nature01675; Langley JA, 2003, ECOLOGY, V84, P2302, DOI 10.1890/02-0282; Li DJ, 2012, NEW PHYTOL, V195, P172, DOI 10.1111/j.1469-8137.2012.04150.x; Li MM, 2013, CATENA, V101, P11, DOI 10.1016/j.catena.2012.09.012; Li XR, 2007, PLANT SOIL, V300, P221, DOI 10.1007/s11104-007-9407-1; Li YuQiang, 2006, Acta Prataculturae Sinica, V15, P25; Liu X, 2010, PEDOSPHERE, V20, P146, DOI 10.1016/S1002-0160(10)60002-1; Luo Y, 2004, BIOSCIENCE, V54, P731, DOI 10.1641/0006-3568(2004)054[0731:PNLOER]2.0.CO;2; Luo YQ, 2006, ECOLOGY, V87, P3, DOI 10.1890/05-0923; Piao SL, 2009, NATURE, V458, P1009, DOI 10.1038/nature07944; Prietzel J, 2012, FOREST ECOL MANAG, V269, P134, DOI 10.1016/j.foreco.2011.12.034; Qiu SJ, 2010, SOIL TILL RES, V107, P80, DOI 10.1016/j.still.2010.02.006; Russell AE, 2005, SOIL SCI SOC AM J, V69, P413, DOI 10.2136/sssaj2005.0413; Rytter RM, 2012, CATENA, V95, P153, DOI 10.1016/j.catena.2012.02.015; She DL, 2009, PESQUI AGROPECU BRAS, V44, P189, DOI 10.1590/S0100-204X2009000200011; Shepherd TG, 2001, AUST J SOIL RES, V39, P465, DOI 10.1071/SR00018; Singh K, 2012, CATENA, V96, P57, DOI 10.1016/j.catena.2012.04.007; Singh K, 2012, ECOL ENG, V43, P70, DOI 10.1016/j.ecoleng.2012.02.029; Six J, 2006, SOIL SCI SOC AM J, V70, P555, DOI 10.2136/sssaj2004.0347; Sparling GP, 2004, AGR ECOSYST ENVIRON, V104, P523, DOI 10.1016/j.agee.2004.01.021; Udawatta RP, 2008, APPL SOIL ECOL, V39, P153, DOI 10.1016/j.apsoil.2007.12.002; Wang B, 2011, ENVIRON EARTH SCI, V62, P915, DOI 10.1007/s12665-010-0577-4; Wei XR, 2010, PLANT SOIL, V331, P165, DOI 10.1007/s11104-009-0243-3; Wu GL, 2010, PLANT SOIL, V332, P331, DOI 10.1007/s11104-010-0299-0; Wu TY, 2004, SOIL TILL RES, V77, P59, DOI 10.1016/j.still.2003.10.002; Zeng ZX, 2008, J SUSTAIN AGR, V32, P335, DOI 10.1080/10440040802171341; Zhao WZ, 2005, CATENA, V59, P173, DOI 10.1016/j.catena.2004.06.004	49	66	77	10	115	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2013	8	8							e71923	10.1371/journal.pone.0071923	http://dx.doi.org/10.1371/journal.pone.0071923			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	218XC	23940793	gold, Green Published, Green Submitted			2022-12-25	WOS:000324465000232
J	Kamphans, T; Sabri, P; Zhu, N; Heinrich, V; Mundlos, S; Robinson, PN; Parkhomchuk, D; Krawitz, PM				Kamphans, Tom; Sabri, Peggy; Zhu, Na; Heinrich, Verena; Mundlos, Stefan; Robinson, Peter N.; Parkhomchuk, Dmitri; Krawitz, Peter M.			Filtering for Compound Heterozygous Sequence Variants in Non-Consanguineous Pedigrees	PLOS ONE			English	Article							ANNOTATION; DISCOVERY; MUTATIONS; FRAMEWORK; PLATFORM; DISEASES; GENES; TOOLS	The identification of disease-causing mutations in next-generation sequencing (NGS) data requires efficient filtering techniques. In patients with rare recessive diseases, compound heterozygosity of pathogenic mutations is the most likely inheritance model if the parents are non-consanguineous. We developed a web-based compound heterozygous filter that is suited for data from NGS projects and that is easy to use for non-bioinformaticians. We analyzed the power of compound heterozygous mutation filtering by deriving background distributions for healthy individuals from different ethnicities and studied the effectiveness in trios as well as more complex pedigree structures. While usually more then 30 genes harbor potential compound heterozygotes in single exomes, this number can be markedly reduced with every additional member of the pedigree that is included in the analysis. In a real data set with exomes of four family members, two sisters affected by Mabry syndrome and their healthy parents, the disease-causing gene PIGO, which harbors the pathogenic compound heterozygous variants, could be readily identified. Compound heterozygous filtering is an efficient means to reduce the number of candidate mutations in studies aiming at identifying recessive disease genes in non-consanguineous families. A web-server is provided to make this filtering strategy available at www.gene-talk.de.	[Kamphans, Tom] Smart Algos, Berlin, Germany; [Sabri, Peggy; Zhu, Na; Heinrich, Verena; Mundlos, Stefan; Robinson, Peter N.; Parkhomchuk, Dmitri; Krawitz, Peter M.] Charite, Inst Med Genet & Human Genet, D-13353 Berlin, Germany; [Mundlos, Stefan; Krawitz, Peter M.] Max Planck Inst Mol Genet, D-14195 Berlin, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Max Planck Society	Krawitz, PM (corresponding author), Charite, Inst Med Genet & Human Genet, D-13353 Berlin, Germany.	peter.krawitz@gmail.com	Mundlos, Stefan/ABH-9585-2020; Krawitz, Peter M/F-3142-2012; Zhu, Na/L-3444-2019; Heinrich, Verena/B-4128-2014	Krawitz, Peter M/0000-0002-3194-8625; Robinson, Peter/0000-0002-0736-9199; Mundlos, Stefan/0000-0002-9788-3166; Zhu, Na/0000-0001-6460-3087	Deutsche Forschungsgemeinschaft [DFG KR 3985/1-1]; Bundesministerium fur Wirtschaft und Technologie (BMWT) [03EGSBB082]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [UC2HL103010, UC2HL102924, RC2HL103010, UC2HL102926, RC2HL102925, RC2HL102926, UC2HL102925, UC2HL102923, RC2HL102923, RC2HL102924] Funding Source: NIH RePORTER	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Bundesministerium fur Wirtschaft und Technologie (BMWT); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by a grant from the Deutsche Forschungsgemeinschaft grant to P.M.K. (DFG KR 3985/1-1). GeneTalk is supported by a grant from the Bundesministerium fur Wirtschaft und Technologie (BMWT; 03EGSBB082). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Bornigen D, 2012, BIOINFORMATICS, V28, P3081, DOI 10.1093/bioinformatics/bts581; (ESP) NGESP, 2013, EX VAR SERV; Haider S, 2009, NUCLEIC ACIDS RES, V37, pW23, DOI 10.1093/nar/gkp265; Kamphans T, 2012, BIOINFORMATICS, V28, P2515, DOI 10.1093/bioinformatics/bts462; Karro JE, 2007, NUCLEIC ACIDS RES, V35, pD55, DOI 10.1093/nar/gkl851; Krawitz PM, 2012, AM J HUM GENET, V91, P146, DOI 10.1016/j.ajhg.2012.05.004; Li H, 2011, BIOINFORMATICS, V27, P2987, DOI 10.1093/bioinformatics/btr509; Li MX, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gkr1257; Moreau Y, 2012, NAT REV GENET, V13, P523, DOI 10.1038/nrg3253; Neale BM, 2012, NATURE, V485, P242, DOI 10.1038/nature11011; Pei BK, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-9-r51; Roach JC, 2010, SCIENCE, V328, P636, DOI 10.1126/science.1186802; Roedelsperger C, 2011, BIOINFORMATICS, V27, P829, DOI 10.1093/bioinformatics/btr022; Sifrim A, 2012, GENOME MED, V4, DOI 10.1186/gm374; Tennessen JA, 2012, SCIENCE, V337, P64, DOI 10.1126/science.1219240; Tiffin N, 2009, GENOME MED, V1, DOI 10.1186/gm77; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603	18	28	28	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2013	8	8							e70151	10.1371/journal.pone.0070151	http://dx.doi.org/10.1371/journal.pone.0070151			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	218XC	23940540	Green Published, gold, Green Submitted			2022-12-25	WOS:000324465000034
J	Keuper, K; Zwitserlood, P; Rehbein, MA; Eden, AS; Laeger, I; Junghofer, M; Zwanzger, P; Dobel, C				Keuper, Kati; Zwitserlood, Pienie; Rehbein, Maimu A.; Eden, Annuschka S.; Laeger, Inga; Junghoefer, Markus; Zwanzger, Peter; Dobel, Christian			Early Prefrontal Brain Responses to the Hedonic Quality of Emotional Words - A Simultaneous EEG and MEG Study	PLOS ONE			English	Article							EVENT-RELATED POTENTIALS; ANTERIOR CINGULATE CORTEX; HUMAN ORBITOFRONTAL CORTEX; TIME-COURSE; ERP ANALYSIS; CEREBRAL HEMISPHERES; MOTIVATED ATTENTION; REGRESSION-ANALYSIS; NEGATIVE STIMULI; VISUAL-CORTEX	The hedonic meaning of words affects word recognition, as shown by behavioral, functional imaging, and event-related potential (ERP) studies. However, the spatiotemporal dynamics and cognitive functions behind are elusive, partly due to methodological limitations of previous studies. Here, we account for these difficulties by computing combined electromagnetoencephalographic (EEG/MEG) source localization techniques. Participants covertly read emotionally high-arousing positive and negative nouns, while EEG and MEG were recorded simultaneously. Combined EEG/MEG current-density reconstructions for the P1 (80-120 ms), P2 (150-190 ms) and EPN component (200-300 ms) were computed using realistic individual head models, with a cortical constraint. Relative to negative words, the P1 to positive words predominantly involved language-related structures (left middle temporal and inferior frontal regions), and posterior structures related to directed attention (occipital and parietal regions). Effects shifted to the right hemisphere in the P2 component. By contrast, negative words received more activation in the P1 time-range only, recruiting prefrontal regions, including the anterior cingulate cortex (ACC). Effects in the EPN were not statistically significant. These findings show that different neuronal networks are active when positive versus negative words are processed. We account for these effects in terms of an "emotional tagging" of word forms during language acquisition. These tags then give rise to different processing strategies, including enhanced lexical processing of positive words and a very fast language-independent alert response to negative words. The valence-specific recruitment of different networks might underlie fast adaptive responses to both approach-and withdrawal-related stimuli, be they acquired or biological.	[Keuper, Kati; Rehbein, Maimu A.; Eden, Annuschka S.; Junghoefer, Markus; Dobel, Christian] Univ Munster, Inst Biomagnetism & Biosignalanal, D-48149 Munster, Germany; [Keuper, Kati; Zwitserlood, Pienie] Univ Munster, Inst Psychol, D-48149 Munster, Germany; [Keuper, Kati; Zwitserlood, Pienie; Rehbein, Maimu A.; Junghoefer, Markus; Dobel, Christian] Univ Munster, Otto Creutzfeldt Ctr Cognit & Behav Neurosci, D-48149 Munster, Germany; [Laeger, Inga; Zwanzger, Peter] Univ Hosp Munster, Dept Psychiat, Munster, Germany	University of Munster; University of Munster; University of Munster; University of Munster	Keuper, K (corresponding author), Univ Munster, Inst Biomagnetism & Biosignalanal, D-48149 Munster, Germany.	k.keuper@uni-muenster.de	Junghoefer, Markus/AAA-2892-2021	Roesmann (Keuper), Kati/0000-0001-6940-3551; Junghoefer, Markus/0000-0002-8532-2986	IZKF [Do3/021/10]	IZKF	Funding came from contract grant sponsor: IZKF (awarded to C. D. and P. Zwanger); Contract grant number: Do3/021/10. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbassi E, 2011, COGN AFFECT BEHAV NE, V11, P372, DOI 10.3758/s13415-011-0034-1; Algom D, 2004, J EXP PSYCHOL GEN, V133, P323, DOI 10.1037/0096-3445.133.3.323; Baayen R. H, 1995, CELEX LEXICAL DATABA; Bayer M, 2012, PSYCHOPHYSIOLOGY, V49, P959, DOI 10.1111/j.1469-8986.2012.01381.x; Bayer M, 2011, PSYCHOPHYSIOLOGY, V48, P1553, DOI 10.1111/j.1469-8986.2011.01219.x; Bradley MA, 2003, BEHAV NEUROSCI, V117, P369, DOI 10.1037/0735-7044.117.2.369; BRADLEY MM, 1994, J BEHAV THER EXP PSY, V25, P49, DOI 10.1016/0005-7916(94)90063-9; Brockelmann AK, 2013, EUR J NEUROSCI, V37, P303, DOI 10.1111/ejn.12043; Brockelmann AK, 2011, J NEUROSCI, V31, P7801, DOI 10.1523/JNEUROSCI.6236-10.2011; Bruchmann M, 2010, NEUROIMAGE, V49, P1800, DOI 10.1016/j.neuroimage.2009.09.032; Bush G, 2000, TRENDS COGN SCI, V4, P215, DOI 10.1016/S1364-6613(00)01483-2; CABALLERO JAR, 1992, EUR J PERSONALITY, V6, P215, DOI 10.1002/per.2410060304; Canli T, 1998, NEUROREPORT, V9, P3233, DOI 10.1097/00001756-199810050-00019; Carretie L, 2004, HUM BRAIN MAPP, V22, P290, DOI 10.1002/hbm.20037; Cato MA, 2004, J COGNITIVE NEUROSCI, V16, P167, DOI 10.1162/089892904322984481; Citron F. M., 2012, EVIDENCE SUSSEX AFFE, V1, P1; Citron FMM, 2012, BRAIN LANG, V122, P211, DOI 10.1016/j.bandl.2011.12.007; COHEN D, 1983, ELECTROEN CLIN NEURO, V56, P38, DOI 10.1016/0013-4694(83)90005-6; Cox RW, 1996, COMPUT BIOMED RES, V29, P162, DOI 10.1006/cbmr.1996.0014; Crawford LE, 2002, PSYCHOL SCI, V13, P449, DOI 10.1111/1467-9280.00479; DAVIDSON RJ, 1992, BRAIN COGNITION, V20, P125, DOI 10.1016/0278-2626(92)90065-T; DAVIDSON RJ, 1992, PSYCHOL SCI, V3, P39, DOI 10.1111/j.1467-9280.1992.tb00254.x; Dijksterhuis A, 2003, PSYCHOL SCI, V14, P14, DOI 10.1111/1467-9280.t01-1-01412; Dolcos F, 2004, NEUROIMAGE, V23, P64, DOI 10.1016/j.neuroimage.2004.05.015; EKMAN P, 1992, COGNITION EMOTION, V6, P169, DOI 10.1080/02699939208411068; Estes Z, 2008, COGNITION, V108, P557, DOI 10.1016/j.cognition.2008.03.003; Flaisch T, 2011, SOC COGN AFFECT NEUR, V6, P109, DOI 10.1093/scan/nsq022; Friederici AD, 2000, CEREB CORTEX, V10, P698, DOI 10.1093/cercor/10.7.698; Fuchs M, 1999, J CLIN NEUROPHYSIOL, V16, P267, DOI 10.1097/00004691-199905000-00006; Fuchs M, 2002, CLIN NEUROPHYSIOL, V113, P702, DOI 10.1016/S1388-2457(02)00030-5; GEDDES LA, 1967, MED BIOL ENG, V5, P271, DOI 10.1007/BF02474537; Gianotti LRR, 2008, BRAIN TOPOGR, V20, P143, DOI 10.1007/s10548-007-0041-2; Goldenholz DM, 2009, HUM BRAIN MAPP, V30, P1077, DOI 10.1002/hbm.20571; HAMALAINEN MS, 1994, MED BIOL ENG COMPUT, V32, P35, DOI 10.1007/BF02512476; Harmon-Jones E, 2010, BIOL PSYCHOL, V84, P451, DOI 10.1016/j.biopsycho.2009.08.010; Hauk O, 2006, NEUROIMAGE, V30, P1383, DOI 10.1016/j.neuroimage.2005.11.048; Hauk O, 2012, NEUROIMAGE, V60, P1462, DOI 10.1016/j.neuroimage.2012.01.061; Hauk O, 2009, BIOL PSYCHOL, V80, P64, DOI 10.1016/j.biopsycho.2008.04.015; Herbert C, 2008, PSYCHOPHYSIOLOGY, V45, P487, DOI 10.1111/j.1469-8986.2007.00638.x; Herbert C, 2006, PSYCHOPHYSIOLOGY, V43, P197, DOI 10.1111/j.1469-8986.2006.00385.x; Herrington JD, 2005, EMOTION, V5, P200, DOI 10.1037/1528-3542.5.2.200; Hinojosa JA, 2010, PSYCHOPHYSIOLOGY, V47, P748, DOI 10.1111/j.1469-8986.2010.00982.x; Hofmann MJ, 2009, COGN AFFECT BEHAV NE, V9, P389, DOI 10.3758/9.4.389; Ille N, 2002, J CLIN NEUROPHYSIOL, V19, P113, DOI 10.1097/00004691-200203000-00002; Indefrey P, 2004, COGNITIVE NEUROSCIENCES III, THIRD EDITION, P759; Isenberg N, 1999, P NATL ACAD SCI USA, V96, P10456, DOI 10.1073/pnas.96.18.10456; Junghofer M, 2006, PROG BRAIN RES, V156, P123, DOI 10.1016/S0079-6123(06)56007-8; Junghofer M, 2001, PSYCHOPHYSIOLOGY, V38, P175, DOI 10.1017/S0048577201000762; Kanske P, 2007, BRAIN RES, V1148, P138, DOI 10.1016/j.brainres.2007.02.044; Keil A, 2002, PSYCHOPHYSIOLOGY, V39, P641, DOI 10.1017/S0048577202394162; Kensinger EA, 2004, P NATL ACAD SCI USA, V101, P3310, DOI 10.1073/pnas.0306408101; Kensinger EA, 2006, COGN AFFECT BEHAV NE, V6, P110, DOI 10.3758/CABN.6.2.110; Keuper K, 2012, HUM BRAIN MAPP; Kissler J, 2007, PSYCHOL SCI, V18, P475, DOI 10.1111/j.1467-9280.2007.01924.x; Kissler J, 2006, PROG BRAIN RES, V156, P147, DOI 10.1016/S0079-6123(06)56008-X; Kissler J, 2009, BIOL PSYCHOL, V80, P75, DOI 10.1016/j.biopsycho.2008.03.004; Koivisto M, 1997, NEUROPSYCHOLOGIA, V35, P497, DOI 10.1016/S0028-3932(96)00100-5; Koivisto M, 1998, NEUROPSYCHOLOGIA, V36, P661, DOI 10.1016/S0028-3932(97)00147-4; Kringelbach ML, 2005, NAT REV NEUROSCI, V6, P691, DOI 10.1038/nrn1747; Kringelbach ML, 2004, PROG NEUROBIOL, V72, P341, DOI 10.1016/j.pneurobio.2004.03.006; Kuchinke L, 2005, NEUROIMAGE, V28, P1022, DOI 10.1016/j.neuroimage.2005.06.050; Laeger I, 2012, BEHAV BRAIN RES, V233, P508, DOI 10.1016/j.bbr.2012.05.036; Lang PJ, 1997, ATTENTION ORIENTING; Lau EF, 2008, NAT REV NEUROSCI, V9, P920, DOI 10.1038/nrn2532; LeDoux JE, 2000, ANNU REV NEUROSCI, V23, P155, DOI 10.1146/annurev.neuro.23.1.155; Lewis PA, 2007, CEREB CORTEX, V17, P742, DOI 10.1093/cercor/bhk024; Maddock RJ, 2003, HUM BRAIN MAPP, V18, P30, DOI 10.1002/hbm.10075; Molins A, 2008, NEUROIMAGE, V42, P1069, DOI 10.1016/j.neuroimage.2008.05.064; Ohman A, 2001, J EXP PSYCHOL GEN, V130, P466, DOI 10.1037/0096-3445.130.3.466; Ohman A., 2000, HDB PSYCHOPHYSIOLOGY, P533; Olofsson JK, 2008, BIOL PSYCHOL, V77, P247, DOI 10.1016/j.biopsycho.2007.11.006; Ortigue S, 2004, NEUROIMAGE, V21, P1242, DOI 10.1016/j.neuroimage.2003.11.007; Osgood C.E., 1957, MEASUREMENT MEANING; Palazova M, 2011, NEUROPSYCHOLOGIA, V49, P2766, DOI 10.1016/j.neuropsychologia.2011.06.005; Paus T, 2001, NAT REV NEUROSCI, V2, P417, DOI 10.1038/35077500; Peoples LL, 2002, SCIENCE, V296, P1623, DOI 10.1126/science.1072997; Poeppel D, 2004, COGNITION, V92, P1, DOI 10.1016/j.cognition.2003.11.001; POSNER MI, 1990, ANNU REV NEUROSCI, V13, P25, DOI 10.1146/annurev.ne.13.030190.000325; Price CJ, 2000, J ANAT, V197, P335, DOI 10.1046/j.1469-7580.2000.19730335.x; Pulvermuller F, 2009, BRAIN LANG, V110, P81, DOI 10.1016/j.bandl.2008.12.001; Rehbein M, 2011, 2 INT S SFB TRR 58 F; RUSSELL JA, 1979, J PERS SOC PSYCHOL, V37, P345, DOI 10.1037/0022-3514.37.3.345; Schacht A, 2009, BRAIN COGNITION, V69, P538, DOI 10.1016/j.bandc.2008.11.005; Schacht A, 2009, COGN AFFECT BEHAV NE, V9, P28, DOI 10.3758/CABN.9.1.28; Scherer K. R., 2001, APPRAISAL PROCESSES, DOI DOI 10.1016/S0166-4115(08)62387-0; Schneider F, 1995, PSYCHIAT RES-NEUROIM, V61, P265, DOI 10.1016/0925-4927(95)02678-Q; Schonwald LI, 2013, HUM BRAIN MAPP; Schupp HT, 2004, EMOTION, V4, P189, DOI 10.1037/1528-3542.4.2.189; Schupp HT, 2004, COGNITION EMOTION, V18, P593, DOI 10.1080/02699930341000239; Schupp HT, 2004, PSYCHOPHYSIOLOGY, V41, P441, DOI 10.1111/j.1469-8986.2004.00174.x; Schupp HT, 2003, NEUROREPORT, V14, P1107, DOI 10.1097/00001756-200306110-00002; Scott GG, 2009, BIOL PSYCHOL, V80, P95, DOI 10.1016/j.biopsycho.2008.03.010; Sereno SC, 2003, TRENDS COGN SCI, V7, P489, DOI 10.1016/j.tics.2003.09.010; Sereno SC, 1998, NEUROREPORT, V9, P2195, DOI 10.1097/00001756-199807130-00009; Sharon D, 2007, NEUROIMAGE, V36, P1225, DOI 10.1016/j.neuroimage.2007.03.066; Shima K, 1998, SCIENCE, V282, P1335, DOI 10.1126/science.282.5392.1335; Skrandies W, 1998, COGNITIVE BRAIN RES, V6, P173, DOI 10.1016/S0926-6410(97)00033-5; Small DM, 2001, BRAIN, V124, P1720, DOI 10.1093/brain/124.9.1720; Song XW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025031; Steinberg C, 2013, BIOL PSYCHOL, V92, P526, DOI 10.1016/j.biopsycho.2012.02.009; Straube T, 2011, BEHAV BRAIN RES, V222, P66, DOI 10.1016/j.bbr.2011.03.037; STRAUSS E, 1983, NEUROPSYCHOLOGIA, V21, P99, DOI 10.1016/0028-3932(83)90104-5; Tabert MH, 2001, NEUROPSYCHOLOGIA, V39, P556, DOI 10.1016/S0028-3932(00)00157-3; Teasdale JD, 1999, AM J PSYCHIAT, V156, P209; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; Vuilleumier P, 2005, TRENDS COGN SCI, V9, P585, DOI 10.1016/j.tics.2005.10.011	106	28	29	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2013	8	8							e70788	10.1371/journal.pone.0070788	http://dx.doi.org/10.1371/journal.pone.0070788			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	218XC	23940642	Green Submitted, Green Published, gold			2022-12-25	WOS:000324465000134
J	Minten, MA; Bilby, TR; Bruno, RGS; Allen, CC; Madsen, CA; Wang, ZP; Sawyer, JE; Tibary, A; Neibergs, HL; Geary, TW; Bauersachs, S; Spencer, TE				Minten, Megan A.; Bilby, Todd R.; Bruno, Ralph G. S.; Allen, Carolyn C.; Madsen, Crystal A.; Wang, Zeping; Sawyer, Jason E.; Tibary, Ahmed; Neibergs, Holly L.; Geary, Thomas W.; Bauersachs, Stefan; Spencer, Thomas E.			Effects of Fertility on Gene Expression and Function of the Bovine Endometrium	PLOS ONE			English	Article							FACTOR-BINDING PROTEIN-1; ESTROUS-CYCLE; CONCEPTUS ELONGATION; EARLY-PREGNANCY; UTERINE RECEPTIVITY; EMBRYO-TRANSFER; DAIRY-CATTLE; OVINE UTERUS; ARTIFICIAL-INSEMINATION; EXTRACELLULAR-MATRIX	Infertility and subfertility are important and pervasive reproductive problems in both domestic animals and humans. The majority of embryonic loss occurs during the first three weeks of pregnancy in cattle and women due, in part, to inadequate endometrial receptivity for support of embryo implantation. To identify heifers of contrasting fertility, serial rounds of artificial insemination (AI) were conducted in 201 synchronized crossbred beef heifers. The heifers were then fertility classified based on number of pregnancies detected on day 35 in four AI opportunities. Heifers, classified as having high fertility, subfertility or infertility, were selected for further study. The fertility-classified heifers were superovulated and flushed, and the recovered embryos were graded and then transferred to synchronized recipients. Quantity of embryos recovered per flush, embryo quality, and subsequent recipient pregnancy rates did not differ by fertility classification. Two in vivo-produced bovine embryos (stage 4 or 5, grade 1 or 2) were then transferred into each heifer on day 7 post-estrus. Pregnancy rates were greater in high fertility than lower fertility heifers when heifers were used as embryo recipients. The reproductive tracts of the classified heifers were obtained on day 14 of the estrous cycle. No obvious morphological differences in reproductive tract structures and histology of the uterus were observed in the heifers. Microarray analysis revealed differences in the endometrial transcriptome based on fertility classification. A genome-wide association study, based on SNP genotyping, detected 7 moderate associations with fertility across 6 different chromosomes. Collectively, these studies support the idea that innate differences in uterine function underlie fertility and early pregnancy loss in ruminants. Cattle with defined early pregnancy success or loss is useful to elucidate the complex biological and genetic mechanisms governing endometrial receptivity and uterine competency for pregnancy.	[Minten, Megan A.; Allen, Carolyn C.; Wang, Zeping; Neibergs, Holly L.; Spencer, Thomas E.] Washington State Univ, Dept Anim Sci, Pullman, WA 99164 USA; [Bilby, Todd R.] Texas AgriLife Res & Extens, Stephenville, TX USA; [Bruno, Ralph G. S.] West Texas A&M Univ, Amarillo, TX USA; [Bruno, Ralph G. S.] Texas AgriLife Res & Extens, Amarillo, TX USA; [Madsen, Crystal A.; Geary, Thomas W.] USDA ARS, Miles City, MT USA; [Sawyer, Jason E.] Texas A&M Univ, Dept Anim Sci, College Stn, TX 77843 USA; [Tibary, Ahmed] Washington State Univ, Coll Vet Med, Dept Vet Clin Sci, Pullman, WA 99164 USA; [Tibary, Ahmed] Washington State Univ, Ctr Reprod Biol, Pullman, WA 99164 USA; [Bauersachs, Stefan] Univ Munich, Gene Ctr, Lab Funct Genome Anal LAFUGA, Munich, Germany	Washington State University; United States Department of Agriculture (USDA); Texas A&M University System; Texas A&M University College Station; Washington State University; Washington State University; University of Munich	Spencer, TE (corresponding author), Washington State Univ, Dept Anim Sci, Pullman, WA 99164 USA.	thomas.spencer@wsu.edu	Sawyer, Jason/Q-4971-2019; Spencer, Thomas/AAD-6434-2020; Sawyer, Jason/A-9951-2016	Spencer, Thomas/0000-0003-2815-766X; Sawyer, Jason/0000-0003-2669-0567; Bauersachs, Stefan/0000-0003-2450-1216	National Institutes of Health [1 R01 HD072898]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD072898] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This project was supported in part by grant no. 1 R01 HD072898 from the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	[Anonymous], 1952, MARSHALLS PHYSL REPR; Armant DR, 2005, DEV BIOL, V280, P260, DOI 10.1016/j.ydbio.2005.02.009; Arnold GJ, 2011, REPROD FERT DEVELOP, V23, P81, DOI 10.1071/RD10223; Bauersachs S, 2008, EXP CLIN ENDOCR DIAB, V116, P371, DOI 10.1055/s-2008-1076714; Bauersachs S, 2005, J MOL ENDOCRINOL, V34, P889, DOI 10.1677/jme.1.01799; Bauersachs S, 2006, REPRODUCTION, V132, P319, DOI 10.1530/rep.1.00996; Bauersachs S, 2012, BIOL REPROD, V86, DOI 10.1095/biolreprod.111.094771; Bazer FW, 1996, AM J REPROD IMMUNOL, V35, P297; BAZER FW, 1983, J ANIM SCI, V57, P425; BAZER FW, 1979, J ANIM SCI, V49, P1522; BAZER FW, 1975, J ANIM SCI, V41, P1376, DOI 10.2527/jas1975.4151376x; BELLOWS RA, 1991, THERIOGENOLOGY, V35, P1069, DOI 10.1016/0093-691X(91)90355-H; Beltman ME, 2009, THERIOGENOLOGY, V72, P986, DOI 10.1016/j.theriogenology.2009.06.018; Berg DK, 2010, THERIOGENOLOGY, V73, P250, DOI 10.1016/j.theriogenology.2009.09.005; Berry DP, 2012, ANIMAL, V6, P1206, DOI 10.1017/S1751731112000067; BETTERIDGE KJ, 1988, THERIOGENOLOGY, V29, P155, DOI 10.1016/0093-691X(88)90038-6; Bridges GA, 2008, THERIOGENOLOGY, V69, P843, DOI 10.1016/j.theriogenology.2007.12.011; Burghardt RC, 2002, CELLS TISSUES ORGANS, V172, P202, DOI 10.1159/000066969; Carmon KS, 2008, MOL CANCER RES, V6, P1017, DOI 10.1158/1541-7786.MCR-08-0039; Cerri RLA, 2012, J DAIRY SCI, V95, P5657, DOI 10.3168/jds.2011-5114; COOKE NE, 1989, ENDOCR REV, V10, P294, DOI 10.1210/edrv-10-3-294; Daikoku T, 2004, MOL ENDOCRINOL, V18, P1238, DOI 10.1210/me.2003-0403; De Vries A, 2006, J DAIRY SCI, V89, P3876, DOI 10.3168/jds.S0022-0302(06)72430-4; Denicol AC, 2013, SCI REP-UK, V3, DOI 10.1038/srep01266; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Dey SK, 2004, ENDOCR REV, V25, P341, DOI 10.1210/er.2003-0020; Diskin MG, 2008, REPROD DOMEST ANIM, V43, P260, DOI 10.1111/j.1439-0531.2008.01171.x; Diskin MG, 2006, ANIM REPROD SCI, V96, P297, DOI 10.1016/j.anireprosci.2006.08.008; DISKIN MG, 1980, J REPROD FERTIL, V59, P463, DOI 10.1530/jrf.0.0590463; Dorniak P, 2013, J ANIM SCI, V91, P1627, DOI 10.2527/jas.2012-5845; FARIN CE, 1989, MOL ENDOCRINOL, V3, P1099, DOI 10.1210/mend-3-7-1099; Finch PW, 1997, P NATL ACAD SCI USA, V94, P6770, DOI 10.1073/pnas.94.13.6770; Forde N, 2011, BIOL REPROD, V85, P144, DOI 10.1095/biolreprod.110.090019; Forde N, 2011, BIOL REPROD, V84, P266, DOI 10.1095/biolreprod.110.085910; Forde N, 2010, PHYSIOL GENOMICS, V41, P53, DOI 10.1152/physiolgenomics.00162.2009; Forde N, 2009, BIOL REPROD, V81, P784, DOI 10.1095/biolreprod.108.074336; Forde N, 2012, BIOL REPROD, V87, DOI 10.1095/biolreprod.112.103424; Forde N, 2012, J REPROD DEVELOP, V58, P189, DOI 10.1262/jrd.2011-021; Gardner DK, 2003, PLACENTA, V24, pS5, DOI 10.1016/S0143-4004(03)00136-X; GEISERT RD, 1991, J REPROD FERTIL, V92, P475, DOI 10.1530/jrf.0.0920475; Gleeson LM, 2001, J CLIN ENDOCR METAB, V86, P2484, DOI 10.1210/jc.86.6.2484; Gray CA, 2002, REPRODUCTION, V124, P289, DOI 10.1530/rep.0.1240289; Gray CA, 2001, BIOL REPROD, V64, P1608, DOI 10.1095/biolreprod64.6.1608; Gray CA, 2001, BIOL REPROD, V65, P1311, DOI 10.1095/biolreprod65.5.1311; GUILLOMOT M, 1981, PLACENTA, V2, P169, DOI 10.1016/S0143-4004(81)80021-5; Hannan NJ, 2010, J PROTEOME RES, V9, P6256, DOI 10.1021/pr1004828; Hansen PJ, 2004, REPROD FERT DEVELOP, V16, P1, DOI 10.1071/RD03073; Hayashi K, 2007, ENDOCRINOLOGY, V148, P3496, DOI 10.1210/en.2007-0283; Horcajadas JA, 2007, HUM REPROD UPDATE, V13, P77, DOI 10.1093/humupd/dml046; Huber W, 2002, BIOINFORMATICS, V18, pS96; IRVING JA, 1995, EXP CELL RES, V217, P419, DOI 10.1006/excr.1995.1105; Irwin JC, 1998, GROWTH HORM IGF RES, V8, P21, DOI 10.1016/S1096-6374(98)80318-3; Irwin JC, 1999, HUM REPROD, V14, P90, DOI 10.1093/humrep/14.suppl_2.90; Johnson GA, 1999, BIOL REPROD, V61, P892, DOI 10.1095/biolreprod61.4.892; Johnson GA, 2001, BIOL REPROD, V65, P820, DOI 10.1095/biolreprod65.3.820; Kao LC, 2002, ENDOCRINOLOGY, V143, P2119, DOI 10.1210/en.143.6.2119; Kobayashi A, 2003, NAT REV GENET, V4, P969, DOI 10.1038/nrg1225; Ledgard AM, 2012, REPROD FERT DEVELOP, V24, P962, DOI 10.1071/RD11225; Ledgard AM, 2011, REPROD FERT DEVELOP, V23, P737, DOI 10.1071/RD10183; Lessey BA, 1998, HUM REPROD, V13, P247, DOI 10.1093/humrep/13.suppl_3.247; Liu YA, 2010, HUM REPROD, V25, P479, DOI 10.1093/humrep/dep429; Llanos S, 2006, CELL CYCLE, V5, P1880, DOI 10.4161/cc.5.16.3140; Lonergan P, 2007, Soc Reprod Fertil Suppl, V64, P315; Looney CR, 2006, THERIOGENOLOGY, V65, P201, DOI 10.1016/j.theriogenology.2005.09.023; Luk J, 2012, HUM REPROD, V27, P3015, DOI 10.1093/humrep/des248; MacIntyre DM, 2002, BIOL REPROD, V66, P1430, DOI 10.1095/biolreprod66.5.1430; McMillan WH, 1998, THERIOGENOLOGY, V50, P1053, DOI 10.1016/S0093-691X(98)00207-6; McMillan WH, 1999, ANIM REPROD SCI, V57, P127, DOI 10.1016/S0378-4320(99)00063-9; Mitko K, 2008, REPRODUCTION, V135, P225, DOI 10.1530/REP-07-0415; Mohamed OA, 2005, P NATL ACAD SCI USA, V102, P8579, DOI 10.1073/pnas.0500612102; Moore K, 2006, J DAIRY SCI, V89, P1254, DOI 10.3168/jds.S0022-0302(06)72194-4; Nusse R, 2001, NATURE, V411, P254, DOI 10.1038/35077199; Nyegaard M, 2010, BIOL REPROD, V82, P1129, DOI 10.1095/biolreprod.109.079517; ODENSVIK K, 1993, J VET MED A, V40, P561, DOI 10.1111/j.1439-0442.1993.tb00667.x; Peng S, 2008, REPRODUCTION, V135, P367, DOI 10.1530/REP-07-0191; Peterson AJ, 2003, THERIOGENOLOGY, V59, P687, DOI 10.1016/S0093-691X(02)01248-7; Pimentel ECG, 2011, ANIM GENET, V42, P251, DOI 10.1111/j.1365-2052.2010.02148.x; Polakis P, 2000, GENE DEV, V14, P1837; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Racowsky C, 2002, THERIO, V2, P700; Rattner A, 1997, P NATL ACAD SCI USA, V94, P2859, DOI 10.1073/pnas.94.7.2859; Revel A, 2011, HUM REPROD, V26, P2830, DOI 10.1093/humrep/der255; Robert C, 2011, MOL REPROD DEV, V78, P651, DOI 10.1002/mrd.21364; Robinson RS, 1999, J ENDOCRINOL, V160, P21, DOI 10.1677/joe.0.1600021; Robinson RS, 2000, J ENDOCRINOL, V165, P231, DOI 10.1677/joe.0.1650231; ROCHE JF, 1981, VET REC, V109, P401, DOI 10.1136/vr.109.18.401; Santos JEP, 2004, ANIM REPROD SCI, V82-3, P513, DOI 10.1016/j.anireprosci.2004.04.015; Satterfield MC, 2006, BIOL REPROD, V75, P289, DOI 10.1095/biolreprod.106.052944; Satterfield MC, 2010, BIOL REPROD, V82, P224, DOI 10.1095/biolreprod.109.076729; Satterfield MC, 2009, PHYSIOL GENOMICS, V39, P85, DOI 10.1152/physiolgenomics.00001.2009; Simmons RM, 2009, ENDOCRINOLOGY, V150, P4295, DOI 10.1210/en.2009-0060; Sonderegger S, 2010, PLACENTA, V31, P839, DOI 10.1016/j.placenta.2010.07.011; Song G, 2008, BIOL REPROD, V79, P376, DOI 10.1095/biolreprod.108.068403; Spencer TE, 2008, REPRODUCTION, V135, P165, DOI 10.1530/REP-07-0327; SREENAN JM, 1987, THERIOGENOLOGY, V27, P99, DOI 10.1016/0093-691X(87)90073-2; Sterchi EE, 2008, MOL ASPECTS MED, V29, P309, DOI 10.1016/j.mam.2008.08.002; Thatcher WW, 2001, THERIOGENOLOGY, V56, P1435, DOI 10.1016/S0093-691X(01)00645-8; Tulac S, 2006, J CLIN ENDOCR METAB, V91, P1453, DOI 10.1210/jc.2005-0769; Ulbrich SE, 2013, METHODS, V59, P108, DOI 10.1016/j.ymeth.2012.10.013; Veerkamp RF, 2007, THERIOGENOLOGY, V68, pS266, DOI 10.1016/j.theriogenology.2007.04.034; Wathes DC, 1998, J DAIRY SCI, V81, P1778, DOI 10.3168/jds.S0022-0302(98)75747-9; Weigel KA, 2006, ANIM REPROD SCI, V96, P323, DOI 10.1016/j.anireprosci.2006.08.010; Zanella R, 2011, ANIM GENET, V42, P28, DOI 10.1111/j.1365-2052.2010.02076.x; Zhang JX, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-S13-S1	104	49	50	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2013	8	8							e69444	10.1371/journal.pone.0069444	http://dx.doi.org/10.1371/journal.pone.0069444			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	218XC	23940519	Green Published, Green Submitted, gold			2022-12-25	WOS:000324465000014
J	Ojha, RP; Tota, JE; Offutt-Powell, TN; Klosky, JL; Minniear, TD; Jackson, BE; Gurney, JG				Ojha, Rohit P.; Tota, Joseph E.; Offutt-Powell, Tabatha N.; Klosky, James L.; Minniear, Timothy D.; Jackson, Bradford E.; Gurney, James G.			Human Papillomavirus-Associated Subsequent Malignancies among Long-Term Survivors of Pediatric and Young Adult Cancers	PLOS ONE			English	Article							CHILDHOOD-CANCER; PRIMARY NEOPLASMS; 5-YEAR SURVIVORS; POLYMORPHISMS; RISK; INFECTIONS; LEUKEMIA; CHILDREN; SMOKING; TUMORS	Long-term survivors of pediatric and young adult (PAYA) cancers have a high incidence of subsequent neoplasms, but few risk factors other than cancer treatment have been identified. We aimed to describe the burden of human papillomavirus (HPV)-associated malignancies among survivors of PAYA cancers to assess whether HPV infections might be a reasonable area of future etiologic research on subsequent malignancies in this population. We used longitudinal data from 9 population-based registries of the Surveillance, Epidemiology, and End Results program collected between 1973 and 2010 to assemble a cohort of individuals who were diagnosed with any cancer between the ages of 0 and 29 years and survived at least 5 years post-diagnosis. We estimated sex-specific standardized incidence ratios (SIRs) with corresponding 95% confidence limits (CL) of HPV-associated subsequent malignancies (cervical, vaginal, vulvar, penile, anal, tongue, tonsillar, and oropharyngeal). Our study population comprised 64,547 long-term survivors of PAYA cancers diagnosed between 1973 and 2010. Compared with females in the general US population, female PAYA cancer survivors had a 40% relative excess of HPV-associated malignancies overall (SIR = 1.4, 95% CL: 1.2, 1.8). Compared with males in the general US population, male PAYA cancer survivors had a 150% relative excess of HPV-associated malignancies overall (SIR = 2.5, 95% CL: 1.9, 3.4). Our findings suggest an excess of HPV-associated malignancies among PAYA cancer survivors compared with the general US population. We hypothesize that a portion of subsequent malignancies among PAYA cancer survivors may be directly attributable to HPV infection. This hypothesis warrants exploration in future studies.	[Ojha, Rohit P.; Gurney, James G.] St Jude Childrens Res Hosp, Dept Epidemiol & Canc Control, Memphis, TN 38105 USA; [Tota, Joseph E.] McGill Univ, Dept Epidemiol Biostat & Occupat Hlth, Montreal, PQ, Canada; [Offutt-Powell, Tabatha N.] Delaware Hlth & Social Serv, Div Publ Hlth, Off Infect Dis Epidemiol, Dover, DE USA; [Klosky, James L.] St Jude Childrens Res Hosp, Dept Psychol, Memphis, TN 38105 USA; [Minniear, Timothy D.] St Jude Childrens Res Hosp, Dept Infect Dis, Memphis, TN 38105 USA; [Jackson, Bradford E.] Univ Alabama Birmingham, Dept Prevent Med, Birmingham, AL USA; [Gurney, James G.] Univ Memphis, Sch Publ Hlth, Dept Epidemiol Biostat & Environm Hlth, Memphis, TN 38152 USA	St Jude Children's Research Hospital; McGill University; St Jude Children's Research Hospital; St Jude Children's Research Hospital; University of Alabama System; University of Alabama Birmingham; University of Memphis	Ojha, RP (corresponding author), St Jude Childrens Res Hosp, Dept Epidemiol & Canc Control, 332 N Lauderdale St, Memphis, TN 38105 USA.	rohit.ojha@stjude.org	Ojha, Rohit/CZV-3380-2022; Ojha, Rohit/AAI-9434-2020	Ojha, Rohit/0000-0003-0595-8990	American Lebanese Syrian Associated Charities (ALSAC)	American Lebanese Syrian Associated Charities (ALSAC)(American Lebanese Syrian Associated Charities (ALSAC))	This work was supported by the American Lebanese Syrian Associated Charities (ALSAC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arbyn M, 2012, INT J CANCER, V131, P1969, DOI 10.1002/ijc.27650; Blanco JG, 2002, PHARMACOGENETICS, V12, P605, DOI 10.1097/00008571-200211000-00004; Bleyer A, 2006, NIH PUB; Curtis R, 2006, NEW MALIGNANCIES CAN; de Martel C, 2012, LANCET ONCOL, V13, DOI 10.1016/S1470-2045(12)70137-7; Emmons K, 2002, J CLIN ONCOL, V20, P1608, DOI 10.1200/JCO.20.6.1608; Erculj N, 2012, J CANCER RES CLIN, V138, P1919, DOI 10.1007/s00432-012-1265-4; Felix CA, 1996, BLOOD, V87, P4376, DOI 10.1182/blood.V87.10.4376.bloodjournal87104376; Friedman DL, 2010, JNCI-J NATL CANCER I, V102, P1083, DOI 10.1093/jnci/djq238; Henderson TO, 2007, JNCI-J NATL CANCER I, V99, P300, DOI 10.1093/jnci/djk052; Howlander N, 2012, SEER CANC STAT REV 1; Huang SF, 2012, ORAL DIS, V18, P809, DOI 10.1111/j.1601-0825.2012.01950.x; Inskip PD, 2007, INT J CANCER, V121, P2233, DOI 10.1002/ijc.22827; International Agency for Research on Cancer (IARC), 2007, IARC MON EV CARC RIS; Jain KS, 2013, CANCER; Jazbec J, 2005, LEUKEMIA LYMPHOMA, V46, P893, DOI 10.1080/10428190500086428; Jazbec J, 2003, LEUKEMIA, V17, P2540, DOI 10.1038/sj.leu.2403164; Jemal A, 2013, J NATL CANC I; Kenney LB, 2004, ANN INTERN MED, V141, P590, DOI 10.7326/0003-4819-141-8-200410190-00006; Klosky JL, 2012, J PEDIATR PSYCHOL, V37, P634, DOI 10.1093/jpepsy/jss046; Kovalchik SA, 2012, J NATL CANCER I, V104, P1517, DOI 10.1093/jnci/djs360; Lau B, 2009, AM J EPIDEMIOL, V170, P244, DOI 10.1093/aje/kwp107; Mertens AC, 2004, CANCER-AM CANCER SOC, V101, P1463, DOI 10.1002/cncr.20520; Mertens AC, 2007, PEDIATR BLOOD CANCER, V48, P723, DOI 10.1002/pbc.21114; Murphy D, 2012, CONTRACEPTION; Nottage K, 2011, BLOOD, V117, P6315, DOI 10.1182/blood-2011-02-335158; Oeffinger KC, 2004, ANN FAM MED, V2, P61, DOI 10.1370/afm.26; Park Henry S, 2012, Curr Probl Cancer, V36, P183, DOI 10.1016/j.currproblcancer.2012.03.007; Park Henry S, 2012, Curr Probl Cancer, V36, P216, DOI 10.1016/j.currproblcancer.2012.03.011; Reulen RC, 2011, JAMA-J AM MED ASSOC, V305, P2311, DOI 10.1001/jama.2011.747; Robison LL, 2011, HEMATOL-AM SOC HEMAT, P238, DOI 10.1182/asheducation-2011.1.238; Rothman KJ., 2008, MODERN EPIDEMIOLOGY, V3rd ed; Sinha P, 2012, AM J OTOLARYNG, V33, P130, DOI 10.1016/j.amjoto.2011.02.001; Stanulla M, 1999, LANCET, V354, P1126, DOI 10.1016/S0140-6736(05)76923-3; Taylor AJ, 2010, J CLIN ONCOL, V28, P5287, DOI 10.1200/JCO.2009.27.0090; Taylor AJ, 2009, INT J CANCER, V125, P2400, DOI 10.1002/ijc.24581; Tohma Y, 1998, J NEUROPATH EXP NEUR, V57, P684, DOI 10.1097/00005072-199807000-00005; Walboomers JMM, 1999, J PATHOL, V189, P12, DOI 10.1002/(SICI)1096-9896(199909)189:1&lt;12::AID-PATH431&gt;3.0.CO;2-F; Woo MH, 2000, LEUKEMIA, V14, P232, DOI 10.1038/sj.leu.2401660; Wu Xiaocheng, 2012, Morbidity and Mortality Weekly Report, V61, P258; Yeazel MW, 2004, CANCER-AM CANCER SOC, V100, P631, DOI 10.1002/cncr.20008; Yonemoto T, 2004, AM J CLIN ONCOL-CANC, V27, P220, DOI 10.1097/01.COC.0000054534.43117.76	42	39	39	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2013	8	8							e70349	10.1371/journal.pone.0070349	http://dx.doi.org/10.1371/journal.pone.0070349			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	218XC	23940566	Green Submitted, Green Published, gold			2022-12-25	WOS:000324465000060
J	Rendon-Ramirez, A; Shukla, M; Oda, M; Chakraborty, S; Minda, R; Dandekar, AM; Asgeirsson, B; Goni, FM; Rao, BJ				Rendon-Ramirez, Adela; Shukla, Manish; Oda, Masataka; Chakraborty, Sandeep; Minda, Renu; Dandekar, Abhaya M.; Asgeirsson, Bjarni; Goni, Felix M.; Rao, Basuthkar J.			A Computational Module Assembled from Different Protease Family Motifs Identifies PI PLC from Bacillus cereus as a Putative Prolyl Peptidase with a Serine Protease Scaffold	PLOS ONE			English	Article							PERFRINGENS ALPHA-TOXIN; PHOSPHOLIPASE-C; MEMBRANE-VESICLES; SPHINGOMYELINASE ACTIVITIES; BACTERIAL PHOSPHOLIPASES; PSEUDOMONAS-AERUGINOSA; ALKALINE-PHOSPHATASE; CONVERGENT EVOLUTION; CYSTEINE PROTEASES; CRYSTAL-STRUCTURE	Proteolytic enzymes have evolved several mechanisms to cleave peptide bonds. These distinct types have been systematically categorized in the MEROPS database. While a BLAST search on these proteases identifies homologous proteins, sequence alignment methods often fail to identify relationships arising from convergent evolution, exon shuffling, and modular reuse of catalytic units. We have previously established a computational method to detect functions in proteins based on the spatial and electrostatic properties of the catalytic residues (CLASP). CLASP identified a promiscuous serine protease scaffold in alkaline phosphatases (AP) and a scaffold recognizing a beta-lactam (imipenem) in a cold-active Vibrio AP. Subsequently, we defined a methodology to quantify promiscuous activities in a wide range of proteins. Here, we assemble a module which encapsulates the multifarious motifs used by protease families listed in the MEROPS database. Since APs and proteases are an integral component of outer membrane vesicles (OMV), we sought to query other OMV proteins, like phospholipase C (PLC), using this search module. Our analysis indicated that phosphoinositide-specific PLC from Bacillus cereus is a serine protease. This was validated by protease assays, mass spectrometry and by inhibition of the native phospholipase activity of PI-PLC by the well-known serine protease inhibitor AEBSF (IC50 = 0.018 mM). Edman degradation analysis linked the specificity of the protease activity to a proline in the amino terminal, suggesting that the PI-PLC is a prolyl peptidase. Thus, we propose a computational method of extending protein families based on the spatial and electrostatic congruence of active site residues.	[Rendon-Ramirez, Adela; Goni, Felix M.] Univ Basque Country, Unidad Biofis, Consejo Super Invest Cient, Euskal Herriko Unibertsitatea, E-48080 Bilbao, Spain; [Rendon-Ramirez, Adela; Goni, Felix M.] Univ Basque Country, Dept Bioquim, E-48080 Bilbao, Spain; [Shukla, Manish; Chakraborty, Sandeep; Minda, Renu; Rao, Basuthkar J.] Tata Inst Fundamental Res, Dept Biol Sci, Bombay 400005, Maharashtra, India; [Oda, Masataka] Tokushima Bunri Univ, Fac Pharmaceut Sci, Dept Microbiol, Tokushima 770, Japan; [Dandekar, Abhaya M.] Univ Calif Davis, Dept Plant Sci, Davis, CA 95616 USA; [Asgeirsson, Bjarni] Univ Iceland, Inst Sci, Dept Biochem, IS-107 Reykjavik, Iceland	Consejo Superior de Investigaciones Cientificas (CSIC); University of Basque Country; CSIC - UPV EHU - Instituto Biofisika; University of Basque Country; Tata Institute of Fundamental Research (TIFR); Tokushima Bunri University; University of California System; University of California Davis; University of Iceland	Chakraborty, S (corresponding author), Tata Inst Fundamental Res, Dept Biol Sci, Homi Bhabha Rd, Bombay 400005, Maharashtra, India.	sanchak@gmail.com	Oda, Masataka/ABG-6047-2020; Goni, Felix M/M-5425-2015; Ásgeirsson, Bjarni/E-3747-2015; Minda, Renu/M-5476-2016	Goni, Felix M/0000-0001-6270-9216; Ásgeirsson, Bjarni/0000-0002-4275-2732; Dandekar, Abhaya/0000-0001-7925-4086; Minda, Renu/0000-0002-2359-9146	Tata Institute of Fundamental Research (Department of Atomic Energy); Ministry of Education, Culture, Sports, Science and Technology, Japan [21790431]; Spanish Ministerio de Ciencia e Innovacion [BFU 2007/62062]; University of the Basque Country [IT 461-07]; Icelandic National Research Council; University of Iceland	Tata Institute of Fundamental Research (Department of Atomic Energy); Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Spanish Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); University of the Basque Country; Icelandic National Research Council; University of Iceland	BJR would like to thank the Tata Institute of Fundamental Research (Department of Atomic Energy) for financial support. MO was supported in part by a Grant-in-aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology, Japan; (grant No. 21790431). FMG thanks the Spanish Ministerio de Ciencia e Innovacion for grant No. BFU 2007/62062, and the University of the Basque Country for grant No. IT 461-07. BA extends gratitude to the Icelandic National Research Council and the University of Iceland Research Found for supporting the project financially. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahyayauch H, 2005, BIOCHEMISTRY-US, V44, P11592, DOI 10.1021/bi050715k; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Amano A, 2010, MICROBES INFECT, V12, P791, DOI 10.1016/j.micinf.2010.05.008; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Bomberger JM, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000382; Boulware KT, 2006, P NATL ACAD SCI USA, V103, P7583, DOI 10.1073/pnas.0511108103; CAMILLI A, 1991, J EXP MED, V173, P751, DOI 10.1084/jem.173.3.751; Chakraborty S., 2013, INTRINSICALLY DISORD, V1; Chakraborty S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059352; Chakraborty Sandeep, 2013, Methods Mol Biol, V978, P205, DOI 10.1007/978-1-62703-293-3_15; Chakraborty S, 2012, FEBS LETT, V586, P3710, DOI 10.1016/j.febslet.2012.08.030; Chakraborty S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040408; Chakraborty S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039577; Chakraborty S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032011; Chakraborty S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028470; Cheng K, 2010, BIOINF BIOM ENG ICBB, P1, DOI [10.1109/ICBBE.2010.5517430, DOI 10.1109/ICBBE.2010.5517430]; Chou KC, 2006, BIOCHEM BIOPH RES CO, V339, P1015, DOI 10.1016/j.bbrc.2005.10.196; Dolinsky TJ, 2004, NUCLEIC ACIDS RES, V32, pW665, DOI 10.1093/nar/gkh381; DOOLITTLE RF, 1994, TRENDS BIOCHEM SCI, V19, P15, DOI 10.1016/0968-0004(94)90167-8; Ekici OD, 2008, PROTEIN SCI, V17, P2023, DOI 10.1110/ps.035436.108; Ellis TN, 2010, MICROBIOL MOL BIOL R, V74, P81, DOI 10.1128/MMBR.00031-09; Furuta N, 2009, INFECT IMMUN, V77, P4761, DOI 10.1128/IAI.00841-09; Gherardini PF, 2007, J MOL BIOL, V372, P817, DOI 10.1016/j.jmb.2007.06.017; Goni FM, 2012, PROG LIPID RES, V51, P238, DOI 10.1016/j.plipres.2012.03.002; Gosalia DN, 2005, MOL CELL PROTEOMICS, V4, P626, DOI 10.1074/mcp.M500004-MCP200; Griffith OH, 1999, BBA-MOL CELL BIOL L, V1441, P237, DOI 10.1016/S1388-1981(99)00153-5; Guillouard I, 1997, MOL MICROBIOL, V26, P867, DOI 10.1046/j.1365-2958.1997.6161993.x; HEINZ DW, 1995, EMBO J, V14, P3855, DOI 10.1002/j.1460-2075.1995.tb00057.x; Helland R, 2009, BBA-PROTEINS PROTEOM, V1794, P297, DOI 10.1016/j.bbapap.2008.09.020; Holm L, 2008, BIOINFORMATICS, V24, P2780, DOI 10.1093/bioinformatics/btn507; Ingmer H, 2009, RES MICROBIOL, V160, P704, DOI 10.1016/j.resmic.2009.08.017; Jackson MW, 2004, MOL MICROBIOL, V54, P1364, DOI 10.1111/j.1365-2958.2004.04353.x; Jeffery CJ, 2009, MOL BIOSYST, V5, P345, DOI 10.1039/b900658n; KADURUGAMUWA JL, 1995, J BACTERIOL, V177, P3998, DOI 10.1128/jb.177.14.3998-4008.1995; Katan M, 1998, BBA-MOL CELL BIOL L, V1436, P5, DOI 10.1016/S0005-2760(98)00125-8; Koblinski JE, 2000, CLIN CHIM ACTA, V291, P113, DOI 10.1016/S0009-8981(99)00224-7; Korkmaz B, 2008, BIOCHIMIE, V90, P227, DOI 10.1016/j.biochi.2007.10.009; KRAUT J, 1977, ANNU REV BIOCHEM, V46, P331, DOI 10.1146/annurev.bi.46.070177.001555; Krojer T, 2008, NATURE, V453, P885, DOI 10.1038/nature07004; Kruger E, 2000, J BACTERIOL, V182, P3259, DOI 10.1128/JB.182.11.3259-3265.2000; Kunkel M, 2007, CRIT REV IMMUNOL, V27, P233, DOI 10.1615/CritRevImmunol.v27.i3.40; Li ZS, 1998, J BACTERIOL, V180, P5478, DOI 10.1128/JB.180.20.5478-5483.1998; LOBKOVSKY E, 1993, P NATL ACAD SCI USA, V90, P11257, DOI 10.1073/pnas.90.23.11257; Lodola A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032397; Lone AM, 2010, AAPS J, V12, P483, DOI 10.1208/s12248-010-9208-y; Lopez-Otin C, 2008, J BIOL CHEM, V283, P30433, DOI 10.1074/jbc.R800035200; Lutgens SPM, 2007, FASEB J, V21, P3029, DOI 10.1096/fj.06-7924com; MCDONEL JL, 1980, PHARMACOL THERAPEUT, V10, P617, DOI 10.1016/0163-7258(80)90031-5; Nagahama M, 2002, MICROBIOL IMMUNOL, V46, P647, DOI 10.1111/j.1348-0421.2002.tb02748.x; Naylor CE, 1998, NAT STRUCT BIOL, V5, P738, DOI 10.1038/1447; O'Brien PJ, 1999, CHEM BIOL, V6, pR91, DOI 10.1016/S1074-5521(99)80033-7; Page MJ, 2008, J BIOL CHEM, V283, P30010, DOI 10.1074/jbc.M804650200; Pomerantsev AP, 2003, INFECT IMMUN, V71, P6591, DOI 10.1128/IAI.71.11.6591-6606.2003; Quesada V, 2009, NUCLEIC ACIDS RES, V37, pD239, DOI 10.1093/nar/gkn570; RAWLINGS ND, 1993, BIOCHEM J, V290, P205, DOI 10.1042/bj2900205; Rawlings ND, 2008, BIOCHIMIE, V90, P243, DOI 10.1016/j.biochi.2007.09.014; Rawlings ND, 2014, NUCLEIC ACIDS RES, V42, pD503, DOI [10.1093/nar/gkt953, 10.1093/nar/gkr987]; Rawlings ND, 2011, J BIOL CHEM, V286, P38321, DOI 10.1074/jbc.M111.260026; Rosenblum G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011043; Rosenblum JS, 2003, CURR OPIN CHEM BIOL, V7, P496, DOI 10.1016/S1367-5931(03)00084-X; Rout AK, 2010, BIOMOL NMR ASSIGN, V4, P171, DOI 10.1007/s12104-010-9239-4; Russell RB, 1998, J MOL BIOL, V279, P1211, DOI 10.1006/jmbi.1998.1844; Sakurai J, 2004, J BIOCHEM, V136, P569, DOI 10.1093/jb/mvh161; Schroder HK, 1998, ACTA CRYSTALLOGR D, V54, P780, DOI 10.1107/S0907444997018611; Shen HB, 2009, ANAL BIOCHEM, V385, P153, DOI 10.1016/j.ab.2008.10.020; Shindo T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029317; Shukla M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051913; Song JN, 2011, J BIOINF COMPUT BIOL, V9, P149, DOI 10.1142/S0219720011005288; Songer JG, 1997, TRENDS MICROBIOL, V5, P156, DOI 10.1016/S0966-842X(97)01005-6; Tajima N, 2010, J MOL BIOL, V402, P645, DOI 10.1016/j.jmb.2010.06.068; Takaya A, 2008, J BACTERIOL, V190, P4181, DOI 10.1128/JB.01873-07; Titball RV, 1999, ANAEROBE, V5, P51, DOI 10.1006/anae.1999.0191; TITBALL RW, 1991, INFECT IMMUN, V59, P1872, DOI 10.1128/IAI.59.5.1872-1874.1991; TITBALL RW, 1993, MICROBIOL REV, V57, P347, DOI 10.1128/MMBR.57.2.347-366.1993; Tomoyasu T, 2002, J BACTERIOL, V184, P645, DOI 10.1128/JB.184.3.645-653.2002; van Loo B, 2010, P NATL ACAD SCI USA, V107, P2740, DOI 10.1073/pnas.0903951107; Venekei I, 1996, FEBS LETT, V379, P143, DOI 10.1016/0014-5793(95)01484-5; Villar AV, 2000, BIOCHEMISTRY-US, V39, P14012, DOI 10.1021/bi992515c; WALSH KA, 1964, P NATL ACAD SCI USA, V52, P884, DOI 10.1073/pnas.52.4.884; Zhao HM, 1999, PROTEIN ENG, V12, P47, DOI 10.1093/protein/12.1.47	80	3	3	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2013	8	8							e70923	10.1371/journal.pone.0070923	http://dx.doi.org/10.1371/journal.pone.0070923			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	218XC	23940667	Green Submitted, Green Published, gold			2022-12-25	WOS:000324465000156
J	Silliman, BR; McCoy, MW; Trussell, GC; Crain, CM; Ewanchuk, PJ; Bertness, MD				Silliman, Brian R.; McCoy, Michael W.; Trussell, Geoffrey C.; Crain, Caitlin M.; Ewanchuk, Patrick J.; Bertness, Mark D.			Non-Linear Interactions between Consumers and Flow Determine the Probability of Plant Community Dominance on Maine Rocky Shores	PLOS ONE			English	Article							INTER-TIDAL COMMUNITY; SALT-MARSH; PREDATION INTENSITY; NATURAL COMMUNITIES; SPECIES-DIVERSITY; NEUTRAL THEORY; WAVE ACTION; SEA OTTERS; FOOD WEB; STATES	Although consumers can strongly influence community recovery from disturbance, few studies have explored the effects of consumer identity and density and how they may vary across abiotic gradients. On rocky shores in Maine, recent experiments suggest that recovery of plant- or animal- dominated community states is governed by rates of water movement and consumer pressure. To further elucidate the mechanisms of consumer control, we examined the species-specific and density-dependent effects of rocky shore consumers (crabs and snails) on community recovery under both high (mussel dominated) and low flow (plant dominated) conditions. By partitioning the direct impacts of predators (crabs) and grazers (snails) on community recovery across a flow gradient, we found that grazers, but not predators, are likely the primary agent of consumer control and that their impact is highly non-linear. Manipulating snail densities revealed that herbivorous and bull-dozing snails (Littorina littorea) alone can control recovery of high and low flow communities. After similar to 1.5 years of recovery, snail density explained a significant amount of the variation in macroalgal coverage at low flow sites and also mussel recovery at high flow sites. These density-dependent grazer effects were were both non-linear and flow-dependent, with low abundance thresholds needed to suppress plant community recovery, and much higher levels needed to control mussel bed development. Our study suggests that consumer density and identity are key in regulating both plant and animal community recovery and that physical conditions can determine the functional forms of these consumer effects.	[Silliman, Brian R.; McCoy, Michael W.] Univ Florida, Dept Biol, Gainesville, FL 32610 USA; [McCoy, Michael W.] E Carolina Univ, Dept Biol, Greenville, NC USA; [Trussell, Geoffrey C.] Northeastern Univ, Ctr Marine Sci, Nahant, MA 01908 USA; [Crain, Caitlin M.; Ewanchuk, Patrick J.; Bertness, Mark D.] Brown Univ, Dept Ecol & Evolutionary Biol, Providence, RI 02912 USA	State University System of Florida; University of Florida; University of North Carolina; East Carolina University; Northeastern University; Brown University	Silliman, BR (corresponding author), Univ Florida, Dept Biol, Gainesville, FL 32610 USA.	brs@ufl.edu	Trussell, Geoffrey/AAQ-9165-2020	McCoy, Michael/0000-0002-7993-6236; Silliman, Brian/0000-0001-6360-650X	NSF-BIO OCE grant	NSF-BIO OCE grant	Funding for this project was provided by a NSF-BIO OCE grant to M. D. Bertness. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso D, 2006, TRENDS ECOL EVOL, V21, P451, DOI 10.1016/j.tree.2006.03.019; Bertness MD, 2002, ECOLOGY, V83, P3434, DOI 10.1890/0012-9658(2002)083[3434:DASCSE]2.0.CO;2; BERTNESS MD, 1984, ECOLOGY, V65, P370, DOI 10.2307/1941400; Bertness MD, 2004, ECOLOGY, V85, P1321, DOI 10.1890/02-0636; Bertness MD, 1999, ECOLOGY, V80, P2711, DOI 10.1890/0012-9658(1999)080[2711:TTRCOP]2.0.CO;2; BERTNESS MD, 1993, AM NAT, V142, P718, DOI 10.1086/285567; BERTNESS MD, 1987, ECOL MONOGR, V57, P129, DOI 10.2307/1942621; Borer ET, 2005, ECOLOGY, V86, P528, DOI 10.1890/03-0816; BROOKS JL, 1965, SCIENCE, V150, P28, DOI 10.1126/science.150.3692.28; Bustamante RH, 1996, J BIOGEOGR, V23, P339, DOI 10.1046/j.1365-2699.1996.00026.x; CALLAWAY RM, 1994, ECOLOGY, V75, P681, DOI 10.2307/1941726; CARR MH, 1995, MAR ECOL PROG SER, V124, P31, DOI 10.3354/meps124031; Chase JM, 2003, OECOLOGIA, V136, P489, DOI 10.1007/s00442-003-1311-7; Chase JM, 2009, ECOL LETT, V12, P1210, DOI 10.1111/j.1461-0248.2009.01362.x; Chave J, 2004, ECOL LETT, V7, P241, DOI 10.1111/j.1461-0248.2003.00566.x; Clements F.E., 1916, PLANT SUCCESSION ANA; CONNELL JH, 1977, AM NAT, V111, P1119, DOI 10.1086/283241; CONNELL JH, 1985, J EXP MAR BIOL ECOL, V93, P11, DOI 10.1016/0022-0981(85)90146-7; Connell JH, 1997, ECOL MONOGR, V67, P461, DOI 10.1890/0012-9615(1997)067[0461:AYSOCA]2.0.CO;2; DRAKE JA, 1990, J THEOR BIOL, V147, P213, DOI 10.1016/S0022-5193(05)80053-0; Eckman JE, 2008, LIMNOLOGY, V28, P241; Estes JA, 1998, SCIENCE, V282, P473, DOI 10.1126/science.282.5388.473; ESTES JA, 1974, SCIENCE, V185, P1058, DOI 10.1126/science.185.4156.1058; Gleason HA, 1926, J TORREY BOT CLUB, V53, P7; HAY ME, 1984, ECOLOGY, V65, P446, DOI 10.2307/1941407; HECK KL, 1995, J EXP MAR BIOL ECOL, V189, P205, DOI 10.1016/0022-0981(95)00012-G; Holling C.S., 1973, Annual Rev Ecol Syst, V4, P1, DOI 10.1146/annurev.es.04.110173.000245; Jenkins SR, 2005, MAR ECOL PROG SER, V287, P77, DOI 10.3354/meps287077; Jenkins SR, 1999, J EXP MAR BIOL ECOL, V233, P41, DOI 10.1016/S0022-0981(98)00128-2; Jonsson PR, 2006, ECOLOGY, V87, P1169, DOI 10.1890/0012-9658(2006)87[1169:IBWAAG]2.0.CO;2; Leonard GH, 1999, OECOLOGIA, V118, P492, DOI 10.1007/s004420050752; Leonard GH, 1998, ECOLOGY, V79, P1395; LEWONTIN RC, 1969, BROOKHAVEN SYM BIOL, P13; LUBCHENCO J, 1978, AM NAT, V112, P23, DOI 10.1086/283250; LUBCHENCO J, 1978, ECOL MONOGR, V48, P67, DOI 10.2307/2937360; LUBCHENCO J, 1983, ECOLOGY, V64, P1116, DOI 10.2307/1937822; Maron JL, 2006, P R SOC B, V273, P2575, DOI 10.1098/rspb.2006.3587; McQuaid CD, 1996, OCEANOGR MAR BIOL, V34, P263; MENGE BA, 1976, ECOL MONOGR, V46, P355, DOI 10.2307/1942563; MENGE BA, 1978, OECOLOGIA, V34, P17, DOI 10.1007/BF00346238; MENGE BA, 1978, OECOLOGIA, V34, P1, DOI 10.1007/BF00346237; MENGE BA, 1986, OECOLOGIA, V71, P75, DOI 10.1007/BF00377324; PAINE RT, 1966, AM NAT, V100, P65, DOI 10.1086/282400; PETRAITIS PS, 1983, ECOLOGY, V64, P522, DOI 10.2307/1939972; Petraitis PS, 1999, ECOLOGY, V80, P429, DOI 10.1890/0012-9658(1999)080[0429:TIOSIT]2.0.CO;2; Petraitis PS, 2002, MAR ECOL PROG SER, V236, P179, DOI 10.3354/meps236179; Petraitis PS, 1999, OIKOS, V84, P239, DOI 10.2307/3546718; Polis G.A., 1996, FOOD WEBS INTEGRATIO; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Roughgarden J, 1987, ORG COMMUNITIES PAST, P459; Scheffer M, 2001, NATURE, V413, P591, DOI 10.1038/35098000; Shurin JB, 2002, ECOL LETT, V5, P785, DOI 10.1046/j.1461-0248.2002.00381.x; Silliman BR, 2002, P NATL ACAD SCI USA, V99, P10500, DOI 10.1073/pnas.162366599; Silliman BR, 2001, ECOLOGY, V82, P2830, DOI 10.1890/0012-9658(2001)082[2830:TDCOSA]2.0.CO;2; Skaug H., 2011, GLMMADMB GEN LINEAR; SUTHERLAND JP, 1974, AM NAT, V108, P859, DOI 10.1086/282961; UNDERWOOD AJ, 1989, TRENDS ECOL EVOL, V4, P16, DOI 10.1016/0169-5347(89)90008-6; Vonesh JR, 2009, OIKOS, V118, P1219, DOI 10.1111/j.1600-0706.2009.17369.x	59	6	6	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2013	8	8							e67625	10.1371/journal.pone.0067625	http://dx.doi.org/10.1371/journal.pone.0067625			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	218XC	23940510	Green Published, Green Submitted, gold			2022-12-25	WOS:000324465000004
J	Wideman, JG; Lackey, SWK; Srayko, MA; Norton, KA; Nargang, FE				Wideman, Jeremy G.; Lackey, Sebastian W. K.; Srayko, Martin A.; Norton, Kacie A.; Nargang, Frank E.			Analysis of Mutations in Neurospora crassa ERMES Components Reveals Specific Functions Related to beta-Barrel Protein Assembly and Maintenance of Mitochondrial Morphology	PLOS ONE			English	Article							OUTER-MEMBRANE PROTEIN; BLUE NATIVE ELECTROPHORESIS; ORGANELLE CONTACT SITES; ENDOPLASMIC-RETICULUM; SACCHAROMYCES-CEREVISIAE; PREPROTEIN TRANSLOCASE; MTDNA NUCLEOIDS; BUDDING YEAST; GENETIC-BASIS; COMPLEX	The endoplasmic reticulum mitochondria encounter structure (ERMES) tethers the ER to mitochondria and contains four structural components: Mmm1, Mdm12, Mdm10, and Mmm2 (Mdm34). The Gem1 protein may play a role in regulating ERMES function. Saccharomyces cerevisiae and Neurospora crassa strains lacking any of Mmm1, Mdm12, or Mdm10 are known to show a variety of phenotypic defects including altered mitochondrial morphology and defects in the assembly of b-barrel proteins into the mitochondrial outer membrane. Here we examine ERMES complex components in N. crassa and show that Mmm1 is an ER membrane protein containing a Cys residue near its N-terminus that is conserved in the class Sordariomycetes. The residue occurs in the ER-lumen domain of the protein and is involved in the formation of disulphide bonds that give rise to Mmm1 dimers. Dimer formation is required for efficient assembly of Tom40 into the TOM complex. However, no effects are seen on porin assembly or mitochondrial morphology. This demonstrates a specificity of function and suggests a direct role for Mmm1 in Tom40 assembly. Mutation of a highly conserved region in the cytosolic domain of Mmm1 results in moderate defects in Tom40 and porin assembly, as well as a slight morphological phenotype. Previous reports have not examined the role of Mmm2 with respect to mitochondrial protein import and assembly. Here we show that absence of Mmm2 affects assembly of b-barrel proteins and that lack of any ERMES structural component results in defects in Tom22 assembly. Loss of N. crassa Gem1 has no effect on the assembly of these proteins but does affect mitochondrial morphology.	[Wideman, Jeremy G.; Lackey, Sebastian W. K.; Srayko, Martin A.; Norton, Kacie A.; Nargang, Frank E.] Univ Alberta, Dept Biol Sci, Edmonton, AB, Canada	University of Alberta	Nargang, FE (corresponding author), Univ Alberta, Dept Biol Sci, Edmonton, AB, Canada.	frank.nargang@ualberta.ca	Srayko, Martin/A-3755-2014; Norton, Kacie/AAO-8174-2021	Wideman, Jeremy/0000-0002-4426-9533; Srayko, Martin/0000-0003-0196-0364; Norton, Kacie/0000-0002-0198-2726	Canadian Institutes of Health Research (CIHR) [MOP-84284]	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR))	Supported by the Canadian Institutes of Health Research (CIHR) grant: MOP-84284 to FEN. URL: http://www.cihr-irsc.gc.ca/e/193.html. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Addison R, 1998, FUNGAL GENET BIOL, V24, P345, DOI 10.1006/fgbi.1998.1066; Alkhaja AK, 2012, MOL BIOL CELL, V23, P247, DOI 10.1091/mbc.E11-09-0774; Becker T, 2011, J MOL BIOL, V405, P113, DOI 10.1016/j.jmb.2010.11.002; Berger KH, 1997, J CELL BIOL, V136, P545, DOI 10.1083/jcb.136.3.545; Boldogh I, 1998, J CELL BIOL, V141, P1371, DOI 10.1083/jcb.141.6.1371; Boldogh IR, 2003, MOL BIOL CELL, V14, P4618, DOI 10.1091/mbc.E03-04-0225; BORKOVICH KA, 1987, J BACTERIOL, V169, P5510, DOI 10.1128/jb.169.12.5510-5517.1987; BURGESS SM, 1994, J CELL BIOL, V126, P1375, DOI 10.1083/jcb.126.6.1375; Colot HV, 2006, P NATL ACAD SCI USA, V103, P10352, DOI 10.1073/pnas.0601456103; Davis R.H., 1970, 789 METHODS ENZYMOLO, VVolume 17, P79, DOI DOI 10.1016/0076-6879(71)17168-6; de Brito OM, 2008, NATURE, V456, P605, DOI 10.1038/nature07534; Dimmer KS, 2002, MOL BIOL CELL, V13, P847, DOI 10.1091/mbc.01-12-0588; Elbaz Y, 2011, TRENDS BIOCHEM SCI, V36, P616, DOI 10.1016/j.tibs.2011.08.004; Fransson A, 2003, J BIOL CHEM, V278, P6495, DOI 10.1074/jbc.M208609200; Frederick RL, 2008, GENETICS, V178, P825, DOI 10.1534/genetics.107.083055; Frederick RL, 2004, J CELL BIOL, V167, P87, DOI 10.1083/jcb.200405100; GOOD AG, 1989, PLANT PHYSIOL, V90, P1305, DOI 10.1104/pp.90.4.1305; Grimm S, 2012, BBA-MOL CELL RES, V1823, P327, DOI 10.1016/j.bbamcr.2011.11.018; Hanekamp T, 2002, GENETICS, V162, P1147; HARKNESS TAA, 1994, J CELL BIOL, V124, P637, DOI 10.1083/jcb.124.5.637; Harner M, 2011, EMBO J, V30, P4356, DOI 10.1038/emboj.2011.379; Hayashi T, 2009, TRENDS CELL BIOL, V19, P81, DOI 10.1016/j.tcb.2008.12.002; Hobbs AEA, 2001, J CELL BIOL, V152, P401, DOI 10.1083/jcb.152.2.401; Hoppins S, 2011, J CELL BIOL, V195, P323, DOI 10.1083/jcb.201107053; Hoppins SC, 2007, GENETICS, V177, P137, DOI 10.1534/genetics.107.075051; JametVierny C, 1997, MOL CELL BIOL, V17, P6359, DOI 10.1128/MCB.17.11.6359; Klein A, 2012, J CELL BIOL, V199, P599, DOI 10.1083/jcb.201207161; Koch KV, 2003, CELL MOTIL CYTOSKEL, V55, P114, DOI 10.1002/cm.10117; Korner C, 2012, MOL BIOL CELL, V23, P2143, DOI 10.1091/mbc.E11-10-0831; Kondo-Okamoto N, 2003, J BIOL CHEM, V278, P48997, DOI 10.1074/jbc.M308436200; Kopec KO, 2010, BIOINFORMATICS, V26, P1927, DOI 10.1093/bioinformatics/btq326; Kornmann B., 2013, CURR OPIN CELL BIOL; Kornmann B, 2011, P NATL ACAD SCI USA, V108, P14151, DOI 10.1073/pnas.1111314108; Kornmann B, 2009, SCIENCE, V325, P477, DOI 10.1126/science.1175088; Lackey SWK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025650; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lambowitz A M, 1979, Methods Enzymol, V59, P421; Marathe S, 1998, J BIOL CHEM, V273, P29776, DOI 10.1074/jbc.273.45.29776; Mayer A, 1995, METHOD ENZYMOL, V260, P252, DOI 10.1016/0076-6879(95)60143-0; Meeusen S, 2003, J CELL BIOL, V163, P503, DOI 10.1083/jcb.200304040; Meisinger C, 2004, DEV CELL, V7, P61, DOI 10.1016/j.devcel.2004.06.003; Meisinger C, 2007, EMBO J, V26, P2229, DOI 10.1038/sj.emboj.7601673; Michel AH, 2012, BIOCHEM SOC T, V40, P445, DOI 10.1042/BST20110758; Model K, 2001, NAT STRUCT BIOL, V8, P361, DOI 10.1038/86253; Nargang FE, 2007, MITOCHONDRIA PRACTIC; Nguyen TT, 2012, TRAFFIC, V13, P880, DOI 10.1111/j.1600-0854.2012.01352.x; Osman C, 2009, J CELL BIOL, V184, P583, DOI 10.1083/jcb.200810189; Pall ML, 1993, FUNGAL GENET NEWSL, V40, P59, DOI DOI 10.4148/1941-4765.1413; Prokisch H, 2000, MOL BIOL CELL, V11, P2961, DOI 10.1091/mbc.11.9.2961; Rapaport D, 1999, J CELL BIOL, V146, P321, DOI 10.1083/jcb.146.2.321; Raturi A, 2013, BBA-MOL CELL RES, V1833, P213, DOI 10.1016/j.bbamcr.2012.04.013; SCHAGGER H, 1994, ANAL BIOCHEM, V217, P220, DOI 10.1006/abio.1994.1112; SCHAGGER H, 1991, ANAL BIOCHEM, V199, P223, DOI 10.1016/0003-2697(91)90094-A; Schmitt S, 2006, PROTEOMICS, V6, P72, DOI 10.1002/pmic.200402084; Seiler S, 2003, MOL BIOL CELL, V14, P4352, DOI 10.1091/mbc.E02-07-0433; SOGO LF, 1994, J CELL BIOL, V126, P1361, DOI 10.1083/jcb.126.6.1361; Stojanovski D, 2007, J CELL BIOL, V179, P881, DOI 10.1083/jcb.200706043; Stroud DA, 2011, J MOL BIOL, V413, P743, DOI 10.1016/j.jmb.2011.09.012; Szabadkai G, 2006, J CELL BIOL, V175, P901, DOI 10.1083/jcb.200608073; Taylor RD, 2003, J BIOL CHEM, V278, P765, DOI 10.1074/jbc.M208083200; Thornton N, 2010, J MOL BIOL, V396, P540, DOI 10.1016/j.jmb.2009.12.026; Toulmay A, 2012, J CELL SCI, V125, P49, DOI 10.1242/jcs.085118; Vaden DL, 2005, ANAL BIOCHEM, V338, P162, DOI 10.1016/j.ab.2004.11.020; van der Laan M, 2012, TRENDS CELL BIOL, V22, P185, DOI 10.1016/j.tcb.2012.01.004; van Wilpe S, 1999, NATURE, V401, P485, DOI 10.1038/46802; von der Malsburg K, 2011, DEV CELL, V21, P694, DOI 10.1016/j.devcel.2011.08.026; Wideman JG, 2010, MOL BIOL CELL, V21, P1725, DOI 10.1091/mbc.E09-10-0844; Yamano K, 2010, EMBO REP, V11, P187, DOI 10.1038/embor.2009.283; Youngman MJ, 2004, J CELL BIOL, V164, P677, DOI 10.1083/jcb.200308012; Zerbes RM, 2012, J MOL BIOL, V422, P183, DOI 10.1016/j.jmb.2012.05.004	70	18	19	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2013	8	8							e71837	10.1371/journal.pone.0071837	http://dx.doi.org/10.1371/journal.pone.0071837			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	218XC	23940790	Green Submitted, Green Published, gold			2022-12-25	WOS:000324465000229
J	Corton, M; Nishiguchi, KM; Avila-Fernandez, A; Nikopoulos, K; Riveiro-Alvarez, R; Tatu, SD; Ayuso, C; Rivolta, C				Corton, Marta; Nishiguchi, Koji M.; Avila-Fernandez, Almudena; Nikopoulos, Konstantinos; Riveiro-Alvarez, Rosa; Tatu, Sorina D.; Ayuso, Carmen; Rivolta, Carlo			Exome Sequencing of Index Patients with Retinal Dystrophies as a Tool for Molecular Diagnosis	PLOS ONE			English	Article							LEBER CONGENITAL AMAUROSIS; RECESSIVE RETINITIS-PIGMENTOSA; GENOTYPING MICROARRAY; SPANISH FAMILIES; MODIFIER ALLELES; USHER-SYNDROME; MUTATIONS; IDENTIFICATION; RP1; GENE	Background: Retinal dystrophies (RD) are a group of hereditary diseases that lead to debilitating visual impairment and are usually transmitted as a Mendelian trait. Pathogenic mutations can occur in any of the 100 or more disease genes identified so far, making molecular diagnosis a rather laborious process. In this work we explored the use of whole exome sequencing (WES) as a tool for identification of RD mutations, with the aim of assessing its applicability in a diagnostic context. Methodology/Principal Findings: We ascertained 12 Spanish families with seemingly recessive RD. All of the index patients underwent mutational pre-screening by chip-based sequence hybridization and resulted to be negative for known RD mutations. With the exception of one pedigree, to simulate a standard diagnostic scenario we processed by WES only the DNA from the index patient of each family, followed by in silico data analysis. We successfully identified causative mutations in patients from 10 different families, which were later verified by Sanger sequencing and co-segregation analyses. Specifically, we detected pathogenic DNA variants (similar to 50% novel mutations) in the genes RP1, USH2A, CNGB3, NMNAT1, CHM, and ABCA4, responsible for retinitis pigmentosa, Usher syndrome, achromatopsia, Leber congenital amaurosis, choroideremia, or recessive Stargardt/cone-rod dystrophy cases. Conclusions/Significance: Despite the absence of genetic information from other family members that could help excluding nonpathogenic DNA variants, we could detect causative mutations in a variety of genes known to represent a wide spectrum of clinical phenotypes in 83% of the patients analyzed. Considering the constant drop in costs for human exome sequencing and the relative simplicity of the analyses made, this technique could represent a valuable tool for molecular diagnostics or genetic research, even in cases for which no genotypes from family members are available.	[Nishiguchi, Koji M.; Nikopoulos, Konstantinos; Rivolta, Carlo] Univ Lausanne, Dept Med Genet, Lausanne, Switzerland; [Corton, Marta; Avila-Fernandez, Almudena; Riveiro-Alvarez, Rosa; Tatu, Sorina D.; Ayuso, Carmen] CIBERER, IIS Fdn Jimenez Diaz, Dept Genet, Madrid, Spain	University of Lausanne; CIBER - Centro de Investigacion Biomedica en Red; CIBERER; Fundacion Jimenez Diaz	Rivolta, C (corresponding author), Univ Lausanne, Dept Med Genet, Lausanne, Switzerland.	carlo.rivolta@unil.ch		Nikopoulos, Konstantinos/0000-0002-1856-2752; Corton, Marta/0000-0003-0087-1626; Ayuso, Carmen/0000-0002-9242-7065; Rivolta, Carlo/0000-0002-0733-9950	Swiss National Science Foundation [320030-121929, 310030_138346]; Gebert Ruf Foundation, Switzerland (Rare Diseases - New Technologies grant); Centre for Biomedical Network Research on Rare Diseases (CIBERER); FIS (Fondo de Investigaciones Sanitarias) from the Spanish Ministry of Health (ISCIII) [PS09/00459]; Spanish National Organization of the Blind (ONCE); Fighting Blindness Spanish Foundation (FUNDALUCE); CIBERER; Fundacion Conchita Rabago de Jimenez Diaz; FIS [PI09/90047]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Gebert Ruf Foundation, Switzerland (Rare Diseases - New Technologies grant); Centre for Biomedical Network Research on Rare Diseases (CIBERER); FIS (Fondo de Investigaciones Sanitarias) from the Spanish Ministry of Health (ISCIII); Spanish National Organization of the Blind (ONCE); Fighting Blindness Spanish Foundation (FUNDALUCE); CIBERER; Fundacion Conchita Rabago de Jimenez Diaz; FIS(Instituto de Salud Carlos III)	The authors would like to acknowledge the Swiss National Science Foundation (grants 320030-121929 and 310030_138346), the Gebert Ruf Foundation, Switzerland (Rare Diseases - New Technologies grant), the Centre for Biomedical Network Research on Rare Diseases (CIBERER), the FIS (Fondo de Investigaciones Sanitarias, grant PS09/00459) from the Spanish Ministry of Health (ISCIII), the Spanish National Organization of the Blind (ONCE) and the Fighting Blindness Spanish Foundation (FUNDALUCE) grants. MC is supported by CIBERER, SDT by Fundacion Conchita Rabago de Jimenez Diaz, AAV by CIBERER and FIS PI09/90047. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguirre-Lamban Jana, 2008, Hum Genet, V123, P546; Al-Rashed M, 2012, BRIT J OPHTHALMOL, V96, P1018, DOI 10.1136/bjophthalmol-2011-301134; Allikmets R, 1997, NAT GENET, V15, P236, DOI 10.1038/ng0397-236; Avila-Fernandez A, 2012, OPHTHALMOLOGY, V119, P2616, DOI 10.1016/j.ophtha.2012.06.033; Avila-Fernandez A, 2010, MOL VIS, V16, P2550; AYUSO C, 1995, CLIN GENET, V48, P120; Ayuso C, 2010, GENOME MED, V2, DOI 10.1186/gm155; BERSON EL, 1993, INVEST OPHTH VIS SCI, V34, P1659; Blanco-Kelly F, 2012, MOL VIS, V18, P1478; Bowne SJ, 2011, INVEST OPHTH VIS SCI, V52, P494, DOI 10.1167/iovs.10-6180; Chen LJ, 2010, INVEST OPHTH VIS SCI, V51, P2236, DOI 10.1167/iovs.09-4437; Chiang PW, 2012, NAT GENET, V44, P972, DOI 10.1038/ng.2370; Clark GR, 2010, OPHTHALMOLOGY, V117, P2169, DOI 10.1016/j.ophtha.2010.02.029; Coppieters F, 2012, GENET MED, V14, P576, DOI 10.1038/gim.2011.51; Coppieters F, 2010, HUM MUTAT, V31, pE1709, DOI 10.1002/humu.21336; Cremers FPM, 2007, J MED GENET, V44, P153, DOI 10.1136/jmg.2006.044784; De Laey J J, 1991, Bull Soc Belge Ophtalmol, V241, P41; den Hollander AI, 2007, INVEST OPHTH VIS SCI, V48, P5690, DOI 10.1167/iovs.07-0610; Henderson RH, 2007, INVEST OPHTH VIS SCI, V48, P5684, DOI 10.1167/iovs.07-0207; Khaliq S, 2005, J MED GENET, V42, P436, DOI 10.1136/jmg.2004.024281; Koenekoop RK, 2007, CLIN EXP OPHTHALMOL, V35, P473, DOI 10.1111/j.1442-9071.2007.01534.x; Licastro D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043799; Liu Q, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043251; Maia-Lopes S, 2009, MOL VIS, V15, P584; MARMOR MF, 1983, OPHTHALMOLOGY, V90, P126; MOORE AT, 1992, J MED GENET, V29, P289, DOI 10.1136/jmg.29.5.289; Neveling K, 2012, HUM MUTAT, V33, P963, DOI 10.1002/humu.22045; Ng SB, 2009, NATURE, V461, P272, DOI 10.1038/nature08250; Nishiguchi KM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041902; Pomares E, 2007, HUM MUTAT, V28, P511, DOI 10.1002/humu.20479; Riazuddin SA, 2005, INVEST OPHTH VIS SCI, V46, P2264, DOI 10.1167/iovs.04-1280; Rivolta C, 2000, AM J HUM GENET, V66, P1975, DOI 10.1086/302926; Shi Y, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002084; Siemiatkowska AM, 2012, MOL VIS, V18, P2411; Simonelli F, 2007, INVEST OPHTH VIS SCI, V48, P4284, DOI 10.1167/iovs.07-0068; Simpson DA, 2011, J MED GENET, V48, P145, DOI 10.1136/jmg.2010.083568; Singh HP, 2009, INVEST OPHTH VIS SCI, V50, P4065, DOI 10.1167/iovs.09-3479; Staden R, 2000, Methods Mol Biol, V132, P115; Sundin OH, 2000, NAT GENET, V25, P289, DOI 10.1038/77162; Tonisson N, 2000, MICROARRAY BIOCHIP TECHNOLOGY, P247; Traboulsi E., 1998, GENETIC DIS EYE; Vallespin E, 2007, INVEST OPHTH VIS SCI, V48, P5653, DOI 10.1167/iovs.07-0007; Wang X, 2011, HUM MUTAT, V32, P1450, DOI 10.1002/humu.21587; Weston MD, 2000, AM J HUM GENET, V66, P1199, DOI 10.1086/302855; Yzer S, 2006, INVEST OPHTH VIS SCI, V47, P1167, DOI 10.1167/iovs.05-0848; Zernant J, 2005, INVEST OPHTH VIS SCI, V46, P3052, DOI 10.1167/iovs.05-0111; Zuchner S, 2011, AM J HUM GENET, V88, P201, DOI 10.1016/j.ajhg.2011.01.001	47	62	64	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2013	8	6							e65574	10.1371/journal.pone.0065574	http://dx.doi.org/10.1371/journal.pone.0065574			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163UV	23940504	Green Submitted, Green Published, Green Accepted, gold			2022-12-25	WOS:000320363300025
J	James, LR; Le, C; Doherty, H; Kim, HS; Maeda, N				James, Leighton R.; Le, Catherine; Doherty, Heather; Kim, Hyung-Suk; Maeda, Nobuyo			Connective Tissue Growth Factor (CTGF) Expression Modulates Response to High Glucose	PLOS ONE			English	Article							MOUSE EMBRYO FIBROBLASTS; DIABETIC-NEPHROPATHY; FACTOR-BETA; CAPILLARY-ELECTROPHORESIS; PANCREATIC LIPASE; MESANGIAL CELLS; DOWN-REGULATION; RENAL-DISEASE; CCN PROTEINS; FIBROSIS	Connective tissue growth factor (CTGF) is an important mediator of fibrosis; emerging evidence link changes in plasma and urinary CTGF levels to diabetic kidney disease. To further ascertain the role of CTGF in responses to high glucose, we assessed the consequence of 4 months of streptozotocin-induced diabetes in wild type (+/+) and CTGF heterozygous (+/-) mice. Subsequently, we studied the influence of glucose on gene expression and protein in mice embryonic fibroblasts (MEF) cells derived from wildtype and heterozygous mice. At study initiation, plasma glucose, creatinine, triglyceride and cholesterol levels were similar between non-diabetic CTGF+/+ and CTGF+/- mice. In the diabetic state, plasma glucose levels were increased in CTGF+/+ and CTGF+/- mice (28.2 3.3 mmol/L vs 27.0 3.1 mmol/L), plasma triglyceride levels were lower in CTGF+/- mice than in CTGF+/+ (0.7 0.2 mmol/L vs 0.5 0.1 mmol/L, p<0.05), but cholesterol was essentially unchanged in both groups. Plasma creatinine was higher in diabetic CTGF+/+ group (11.7 +/- 1.2 vs 7.9 +/- 0.6 mu mol/L p<0.01), while urinary albumin excretion and mesangial expansion were reduced in diabetic CTGF+/- animals. Cortices from diabetic mice (both CTGF +/+ and CTGF +/-) manifested higher expression of CTGF and thrombospondin 1 (TSP1). Expression of nephrin was reduced in CTGF +/+ animals; this reduction was attenuated in CTGF+/- group. In cultured MEF from CTGF+/+ mice, glucose (25 mM) increased expression of pro-collagens 1, IV and XVIII as well as fibronectin and thrombospondin 1 (TSP1). In contrast, activation of these genes by high glucose was attenuated in CTGF+/- MEF. We conclude that induction of Ctgf mediates expression of extracellular matrix proteins in diabetic kidney. Thus, genetic variability in CTGF expression directly modulates the severity of diabetic nephropathy.	[James, Leighton R.] Univ Florida, Dept Med, Jacksonville, FL 32209 USA; [James, Leighton R.; Le, Catherine] Univ Texas SW Med Ctr Dallas, Dept Med, Dallas, TX 75390 USA; [Doherty, Heather; Kim, Hyung-Suk; Maeda, Nobuyo] Univ N Carolina, Dept Pathol & Lab Med, Chapel Hill, NC USA	State University System of Florida; University of Florida; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of North Carolina; University of North Carolina Chapel Hill	James, LR (corresponding author), Univ Florida, Dept Med, Jacksonville, FL 32209 USA.	Leighton.James@jax.ufl.edu	James, Leighton/AAJ-1455-2021	James, Leighton/0000-0002-7613-705X	American Heart Association; NIDDK O'Brien Center [P30DK079328]; NIH [HL77145, HL87946]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL077145, R01HL042630, U01HL087946] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK079328] Funding Source: NIH RePORTER	American Heart Association(American Heart Association); NIDDK O'Brien Center; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by grants from the American Heart Association to LRJ; NIDDK O'Brien Center Research Grant (P30DK079328) and NIH grants HL77145 and HL87946 to NM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen S, 2005, KIDNEY INT, V67, P2325, DOI 10.1111/j.1523-1755.2005.00337.x; BARCELLI U, 1981, J CLIN INVEST, V67, P20, DOI 10.1172/JCI110013; Barnes JL, 2011, KIDNEY INT, V79, P944, DOI 10.1038/ki.2010.516; Bernardi S, 2011, NEPHROL DIAL TRANSPL, V26, P832, DOI 10.1093/ndt/gfq524; BLACKBERG L, 1981, J CLIN INVEST, V67, P1748, DOI 10.1172/JCI110213; Bonniaud P, 2004, AM J RESP CELL MOL, V31, P510, DOI 10.1165/rcmb.2004-0158OC; Brigstock D, 2005, J Clin Pathol, V58, P463, DOI 10.1136/jcp.2005.025759; Brigstock DR, 2003, J ENDOCRINOL, V178, P169, DOI 10.1677/joe.0.1780169; Brosius FC, 2009, J AM SOC NEPHROL, V20, P2503, DOI 10.1681/ASN.2009070721; Caron KM, 2002, HYPERTENSION, V40, P384; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; Clark EA, 2001, J PHARMACEUT BIOMED, V25, P795, DOI 10.1016/S0731-7085(01)00340-5; Cozzolino M, 2010, BLOOD PURIFICAT, V30, P272, DOI 10.1159/000320706; Dendooven A, 2011, J NEGAT RESULTS BIOM, V10, DOI 10.1186/1477-5751-10-4; Dessein A, 2009, J EXP MED, V206, P2321, DOI 10.1084/jem.20090383; Duncan MR, 1999, FASEB J, V13, P1774, DOI 10.1096/fasebj.13.13.1774; Falke LL, 2012, MATRIX BIOL, V31, P421, DOI 10.1016/j.matbio.2012.06.002; Fonseca C, 2007, NEW ENGL J MED, V357, P1210, DOI 10.1056/NEJMoa067655; Gomez-Garre D, 2006, KIDNEY INT, V69, P1237, DOI 10.1038/sj.ki.5000034; Gourh P, 2008, NEW ENGL J MED, V358, P308; Granel B, 2010, J RHEUMATOL, V37, P351, DOI 10.3899/jrheum.090290; Guha M, 2007, FASEB J, V21, P3355, DOI 10.1096/fj.06-6713com; Guney MA, 2011, P NATL ACAD SCI USA, V108, P15242, DOI 10.1073/pnas.1100072108; Gurley SB, 2010, AM J PHYSIOL-RENAL, V298, pF788, DOI 10.1152/ajprenal.90515.2008; Hamano Y, 2010, J AM SOC NEPHROL, V21, P1445, DOI 10.1681/ASN.2009050492; Ivkovic S, 2003, DEVELOPMENT, V130, P2779, DOI 10.1242/dev.00505; Jacobson A, 2012, FIBROGENESIS TISSUE, V5, DOI 10.1186/1755-1536-5-S1-S8; JAMES L, 1995, CLIN BIOCHEM, V28, P451, DOI 10.1016/0009-9120(95)00026-6; James LR, 2001, AM J PHYSIOL-RENAL, V281, pF151, DOI 10.1152/ajprenal.2001.281.1.F151; Kawaguchi Y, 2009, ANN RHEUM DIS, V68, P1921, DOI 10.1136/ard.2008.100586; Kim HS, 2002, P NATL ACAD SCI USA, V99, P4602, DOI 10.1073/pnas.072083799; Kinnunen AI, 2011, J BIOL CHEM, V286, P7755, DOI 10.1074/jbc.M110.166132; Kovalenko E, 2009, J VIRAL HEPATITIS, V16, P612, DOI 10.1111/j.1365-2893.2009.01110.x; Kreisberg RA, 1998, AM J CARDIOL, V82, p67U, DOI 10.1016/S0002-9149(98)00848-0; Kunjathoor VV, 1996, J CLIN INVEST, V97, P1767, DOI 10.1172/JCI118604; Lam S, 2003, DIABETES, V52, P2975, DOI 10.2337/diabetes.52.12.2975; Liu XJ, 2007, BMC CELL BIOL, V8, DOI 10.1186/1471-2121-8-1; MACCARTHY EP, 1985, J CLIN INVEST, V76, P426, DOI 10.1172/JCI111989; Maeshima Y, 2001, J BIOL CHEM, V276, P15240, DOI 10.1074/jbc.M007764200; Nguyen TQ, 2006, DIABETES CARE, V29, P83, DOI 10.2337/diacare.29.1.83; Nguyen TQ, 2008, J AM SOC NEPHROL; OReilly MS, 1997, CELL, V88, P277, DOI 10.1016/S0092-8674(00)81848-6; Patel SK, 2012, CARDIOVASC DIABETOL, V11, DOI 10.1186/1475-2840-11-42; Perbal B, 2001, J CLIN PATHOL-MOL PA, V54, P103, DOI 10.1136/mp.54.2.103; Perbal B, 2004, LANCET, V363, P62, DOI 10.1016/S0140-6736(03)15172-0; Poczatek MH, 2000, AM J PATHOL, V157, P1353, DOI 10.1016/S0002-9440(10)64649-4; Rachfal AW, 2005, VITAM HORM, V70, P69, DOI 10.1016/S0083-6729(05)70003-0; REITSMA JB, 1994, METABOLISM, V43, P293, DOI 10.1016/0026-0495(94)90095-7; Roestenberg P, 2005, AM J PHYSL RENAL PHY; Rueda B, 2009, ANN RHEUM DIS, V68, P1618, DOI 10.1136/ard.2008.100180; Seppinen L, 2011, MATRIX BIOL, V30, P83, DOI 10.1016/j.matbio.2010.11.001; Shastry S, 2004, J CELL BIOCHEM, V93, P207, DOI 10.1002/jcb.20137; Sonnylal S, 2010, ARTHRITIS RHEUM-US, V62, P1523, DOI 10.1002/art.27382; Thomson SE, 2008, J DIABETES COMPLICAT, V22, P284, DOI 10.1016/j.jdiacomp.2007.07.001; Tolstonog GV, 2005, DNA CELL BIOL, V24, P680, DOI 10.1089/dna.2005.24.680; Tolstonog GV, 2001, DNA CELL BIOL, V20, P509, DOI 10.1089/104454901317094945; Turk T, 2009, J HISTOCHEM CYTOCHEM, V57, P623, DOI 10.1369/jhc.2009.953224; Wahab NA, 2005, DIABETOLOGIA, V48, P2650, DOI 10.1007/s00125-005-0006-5; Wang B, 2010, J MED GENET, V47, P391, DOI 10.1136/jmg.2009.073098; Wang SN, 2001, KIDNEY INT, V60, P96, DOI 10.1046/j.1523-1755.2001.00776.x; Wang SX, 2004, J BIOL CHEM, V279, P34311, DOI 10.1074/jbc.M401629200; Yi XW, 2011, J DIABETES COMPLICAT, V25, P193, DOI 10.1016/j.jdiacomp.2010.07.004; Zeisberg EM, 2008, J AM SOC NEPHROL, V19, P2282, DOI 10.1681/ASN.2008050513; Zinellu A, 2005, ANAL BIOCHEM, V342, P186, DOI 10.1016/j.ab.2005.01.045	64	18	19	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2013	8	8							e70441	10.1371/journal.pone.0070441	http://dx.doi.org/10.1371/journal.pone.0070441			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	200UV	23950936	Green Submitted, Green Published, gold			2022-12-25	WOS:000323097300018
J	Urbanus, AT; van Keep, M; Matser, AA; Rozenbaum, MH; Weegink, CJ; van den Hoek, A; Prins, M; Postma, MJ				Urbanus, Anouk T. c; van Keep, Marjolijn; Matser, Amy A.; Rozenbaum, Mark H.; Weegink, Christine J.; van den Hoek, Anneke; Prins, Maria; Postma, Maarten J.			Is Adding HCV Screening to the Antenatal National Screening Program in Amsterdam, The Netherlands, Cost-Effective?	PLOS ONE			English	Article							HEPATITIS-C VIRUS; INITIAL TREATMENT; INFECTION; RIBAVIRIN; INTERFERON-ALPHA-2B	Introduction: Hepatitis C virus (HCV) infection can lead to severe liver disease. Pregnant women are already routinely screened for several infectious diseases, but not yet for HCV infection. Here we examine whether adding HCV screening to routine screening is cost-effective. Methods: To estimate the cost-effectiveness of implementing HCV screening of all pregnant women and HCV screening of first-generation non-Western pregnant women as compared to no screening, we developed a Markov model. For the parameters of the model, we used prevalence data from pregnant women retrospectively tested for HCV in Amsterdam, the Netherlands, and from literature sources. In addition, we estimated the effect of possible treatment improvement in the future. Results: The incremental costs per woman screened was (sic)41 and 0.0008 life-years were gained. The incremental cost-effectiveness ratio (ICER) was (sic)52,473 which is above the cost-effectiveness threshold of (sic)50,000. For screening first-generation non-Western migrants, the ICER was (sic)47,113. Best-case analysis for both scenarios showed ICERs of respectively (sic)19,505 and (sic)17,533. We estimated that if costs per treatment were to decline to (sic)3,750 (a reduction in price of (sic)31,000), screening all pregnant women would be cost-effective. Conclusions: Currently, adding HCV screening to the already existing screening program for pregnant women is not cost-effective for women in general. However, adding HCV screening for first-generation non-Western women shows a modest cost-effective outcome. Yet, best case analysis shows potentials for an ICER below (sic)20,000 per life-year gained. Treatment options will improve further in the coming years, enhancing cost-effectiveness even more.	[Urbanus, Anouk T. c; Matser, Amy A.; van den Hoek, Anneke; Prins, Maria] Publ Hlth Serv, Amsterdam, Netherlands; [van Keep, Marjolijn; van den Hoek, Anneke; Prins, Maria] Univ Amsterdam, Acad Med Ctr, Ctr Infect & Immunol Amsterdam CINIMA, NL-1105 AZ Amsterdam, Netherlands; [van Keep, Marjolijn; Rozenbaum, Mark H.; Postma, Maarten J.] Univ Groningen, Dept Pharm, Unit PharmacoEpidemiol & PharmacoEcon PE2, Groningen, Netherlands; [Matser, Amy A.] Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Hlth Care, Utrecht, Netherlands; [Weegink, Christine J.] Univ Amsterdam, Acad Med Ctr, Dept Gastroenterol Hepatol, AMC Liver Centre, NL-1105 AZ Amsterdam, Netherlands	Public Health Service Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; University of Groningen; Utrecht University; Utrecht University Medical Center; University of Amsterdam; Academic Medical Center Amsterdam	Urbanus, AT (corresponding author), Publ Hlth Serv, Amsterdam, Netherlands.	aurbanus@ggd.amsterdam.nl		Matser, Amy/0000-0003-4291-1905; Postma, Maarten/0000-0002-6306-3653	ZonMw [7115 0001]	ZonMw(Netherlands Organization for Health Research and Development)	This study was funded by grant 7115 0001 from ZonMw. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alter MJ, 2002, HEPATOLOGY, V36, pS93, DOI 10.1053/jhep.2002.36389; Briggs A, 2008, DECISION MODELLING H; Cooper C, 2012, CLIN INFECT DIS, V55, P418, DOI 10.1093/cid/cis375; Deuffic-Burban S, 2004, J HEPATOL, V40, P319, DOI 10.1016/j.jhep.2003.10.018; Helsper CW, 2012, NETH J MED, V70, P145; Helsper CW, 2011, EPIDEMIOL INFECT, P1; Indolfi G, 2009, J MED VIROL, V81, P836, DOI 10.1002/jmv.21437; Jacobson IM, 2011, NEW ENGL J MED, V364, P2405, DOI 10.1056/NEJMoa1012912; Lindenburg CEA, 2011, EUR J GASTROEN HEPAT, V23, P23, DOI 10.1097/MEG.0b013e328340c451; Micallef JM, 2006, J VIRAL HEPATITIS, V13, P34, DOI 10.1111/j.1365-2893.2005.00651.x; Miners A, 2012, EC EVALUATION FINDIN; Op DE, 2011, BMC INFECT DIS, V11, P185; Plunkett BA, 2005, AM J OBSTET GYNECOL, V192, P1153, DOI 10.1016/j.ajog.2004.10.600; Poordad F, 2011, NEW ENGL J MED, V364, P1195, DOI 10.1056/NEJMoa1010494; Rozenbaum MH, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c2509; Shepard CW, 2005, LANCET INFECT DIS, V5, P558, DOI 10.1016/S1473-3099(05)70216-4; Shepherd J, 2007, HEALTH TECHNOL ASSES, V11, P1; Siebert U, 2003, GUT, V52, P425, DOI 10.1136/gut.52.3.425; Singer ME, 2001, AM J MED, V111, P614, DOI 10.1016/S0002-9343(01)00951-2; Sroczynski G, 2010, J VIRAL HEPATITIS, V17, P34, DOI 10.1111/j.1365-2893.2009.01147.x; Sroczynski G, 2009, EUR J PUBLIC HEALTH, V19, P245, DOI 10.1093/eurpub/ckp001; Statistics Netherlands, 2012, MORT RAT; Urbanus AT, 2011, J HEPATOL; Urbanus AT, 2011, J HEPATOLOG IN PRESS, DOI 10 1016/j jhep 2011 02 028; van der Bij A K, 2003, Ned Tijdschr Geneeskd, V147, P1232; Vriend HJ, 2012, EPIDEMIOL INFECT, P1; Wong JB, 2000, AM J GASTROENTEROL, V95, P1524; Wong Vincent Wai-Sun, 2012, Gastroenterology, V143, P264, DOI 10.1053/j.gastro.2012.05.025; Zuure FR, 2011, AM J PREV MED, V40, P345, DOI 10.1016/j.amepre.2010.11.019	29	21	21	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2013	8	8							e70319	10.1371/journal.pone.0070319	http://dx.doi.org/10.1371/journal.pone.0070319			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	200UV	23950920	Green Published, gold, Green Submitted			2022-12-25	WOS:000323097300014
J	Godinho, MJ; Teh, L; Pollett, MA; Goodman, D; Hodgetts, SI; Sweetman, I; Walters, M; Verhaagen, J; Plant, GW; Harvey, AR				Godinho, Maria Joao; Teh, Lip; Pollett, Margaret A.; Goodman, Douglas; Hodgetts, Stuart I.; Sweetman, Iain; Walters, Mark; Verhaagen, Joost; Plant, Giles W.; Harvey, Alan R.			Immunohistochemical, Ultrastructural and Functional Analysis of Axonal Regeneration through Peripheral Nerve Grafts Containing Schwann Cells Expressing BDNF, CNTF or NT3	PLOS ONE			English	Article							CILIARY NEUROTROPHIC FACTOR; VENTRAL ROOT AVULSION; CATWALK GAIT ANALYSIS; SCIATIC-NERVE; SENSORY NEURONS; GENE-THERAPY; MOTOR-NEURONS; GROWTH-FACTOR; RAT; MYELINATION	We used morphological, immunohistochemical and functional assessments to determine the impact of genetically-modified peripheral nerve (PN) grafts on axonal regeneration after injury. Grafts were assembled from acellular nerve sheaths repopulated ex vivo with Schwann cells (SCs) modified to express brain-derived neurotrophic factor (BDNF), a secretable form of ciliary neurotrophic factor (CNTF), or neurotrophin-3 (NT3). Grafts were used to repair unilateral 1 cm defects in rat peroneal nerves and 10 weeks later outcomes were compared to normal nerves and various controls: autografts, acellular grafts and grafts with unmodified SCs. The number of regenerated beta III-Tubulin positive axons was similar in all grafts with the exception of CNTF, which contained the fewest immunostained axons. There were significantly lower fiber counts in acellular, untransduced SC and NT3 groups using a PanNF antibody, suggesting a paucity of large caliber axons. In addition, NT3 grafts contained the greatest number of sensory fibres, identified with either IB4 or CGRP markers. Examination of semi- and ultra-thin sections revealed heterogeneous graft morphologies, particularly in BDNF and NT3 grafts in which the fascicular organization was pronounced. Unmyelinated axons were loosely organized in numerous Remak bundles in NT3 grafts, while the BDNF graft group displayed the lowest ratio of umyelinated to myelinated axons. Gait analysis revealed that stance width was increased in rats with CNTF and NT3 grafts, and step length involving the injured left hindlimb was significantly greater in NT3 grafted rats, suggesting enhanced sensory sensitivity in these animals. In summary, the selective expression of BDNF, CNTF or NT3 by genetically modified SCs had differential effects on PN graft morphology, the number and type of regenerating axons, myelination, and locomotor function.	[Godinho, Maria Joao; Pollett, Margaret A.; Hodgetts, Stuart I.; Sweetman, Iain; Plant, Giles W.; Harvey, Alan R.] Univ Western Australia, Sch Anat Physiol & Human Biol, Crawley, WA, Australia; [Teh, Lip; Walters, Mark] Princess Margaret Hosp Children, Craniomaxillofacial Unit, Perth, WA, Australia; [Goodman, Douglas] Murdoch Univ, Sch Vet & Biomed Sci, Murdoch, WA 6150, Australia; [Verhaagen, Joost] Netherlands Inst Neurosci, Amsterdam, Netherlands	University of Western Australia; University of Western Australia; Murdoch University; Royal Netherlands Academy of Arts & Sciences; Netherlands Institute for Neuroscience (NIN-KNAW)	Harvey, AR (corresponding author), Univ Western Australia, Sch Anat Physiol & Human Biol, Crawley, WA, Australia.	alan.harvey@uwa.edu.au	Verhaagen, Joost/G-4773-2012	Hodgetts, Stuart/0000-0002-3318-0410; , Alan/0000-0002-2590-831X	Princess Margaret Hospital for Children, Subiaco, Australia; University of Western Australia; Australian Federation of University Women (Western Australia); NHMRC; WA Neurotrauma Research Program	Princess Margaret Hospital for Children, Subiaco, Australia; University of Western Australia; Australian Federation of University Women (Western Australia); NHMRC(National Health and Medical Research Council (NHMRC) of Australia); WA Neurotrauma Research Program	The work and MJG were partially supported in the early stages by funds from the Princess Margaret Hospital for Children, Subiaco, Australia. MJG was supported by an Australian Postgraduate Award from The University of Western Australia and by a Mary and Elsie Stevens Bursary from the Australian Federation of University Women (Western Australia). Aspects of this work were supported by grants from the NHMRC and WA Neurotrauma Research Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anand P, 2004, PROG BRAIN RES, V146, P477; AUGUSTINVOSS HG, 1990, VET PATHOL, V27, P103, DOI 10.1177/030098589002700205; Beggs S, 2012, PAIN, V153, P2133, DOI 10.1016/j.pain.2012.07.012; Bozkurt A, 2008, J NEUROSCI METH, V173, P91, DOI 10.1016/j.jneumeth.2008.05.020; Cellerino A, 1997, MOL CELL NEUROSCI, V9, P397, DOI 10.1006/mcne.1997.0641; Cen LP, 2007, INVEST OPHTH VIS SCI, V48, P4257, DOI 10.1167/iovs.06-0791; Chan JR, 2001, P NATL ACAD SCI USA, V98, P14661, DOI 10.1073/pnas.251543398; Chomiak T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007754; CHRISTIE KN, 1989, J HISTOCHEM CYTOCHEM, V37, P1303, DOI 10.1177/37.8.2754256; Cosgaya JM, 2002, SCIENCE, V298, P1245, DOI 10.1126/science.1076595; Costa LM, 2009, INT REV NEUROBIOL, V87, P127, DOI 10.1016/S0074-7742(09)87007-4; Cui Q, 2003, J NEUROTRAUM, V20, P17, DOI 10.1089/08977150360517155; Dahlin LB, 2008, CURR ORTHOPAED, V22, P9, DOI 10.1016/j.cuor.2008.01.002; Dahlin LB, 2004, OPER TECHN ORTHOP, V14, P138; Decosterd I, 2000, PAIN, V87, P149, DOI 10.1016/S0304-3959(00)00276-1; DEMEDINACELI L, 1982, EXP NEUROL, V77, P634, DOI 10.1016/0014-4886(82)90234-5; Deumens R, 2007, J NEUROSCI METH, V164, P120, DOI 10.1016/j.jneumeth.2007.04.009; Eggers R, 2010, EXP NEUROL, V223, P207, DOI 10.1016/j.expneurol.2009.07.021; Eggers R, 2008, MOL CELL NEUROSCI, V39, P105, DOI 10.1016/j.mcn.2008.05.018; Ernst C, 2006, J NEUROSCI METH, V150, P138, DOI 10.1016/j.jneumeth.2005.06.018; Evans PJ, 1998, MUSCLE NERVE, V21, P1507, DOI 10.1002/(SICI)1097-4598(199811)21:11<1507::AID-MUS21>3.0.CO;2-W; Frostick SP, 1998, MICROSURG, V18, P397, DOI 10.1002/(SICI)1098-2752(1998)18:7<397::AID-MICR2>3.0.CO;2-F; Gavazzi I, 1999, EUR J NEUROSCI, V11, P3405, DOI 10.1046/j.1460-9568.1999.00756.x; Gomez-Sanchez JA, 2009, J NEUROSCI, V29, P11304, DOI 10.1523/JNEUROSCI.1753-09.2009; Gordon T, 2009, NEUROSURG FOCUS, V26, P1; Gordon T, 2011, J NEUROSCI, V31, P5325, DOI 10.1523/JNEUROSCI.6156-10.2011; Griffin JW, 2008, GLIA, V56, P1518, DOI 10.1002/glia.20778; Gulati AK, 1995, BRAIN RES, V705, P118, DOI 10.1016/0006-8993(95)01144-7; GULATI AK, 1990, J NEUROSURG, V72, P114, DOI 10.3171/jns.1990.72.1.0114; Hamers FPT, 2006, J NEUROTRAUM, V23, P537, DOI 10.1089/neu.2006.23.537; Hamers FPT, 2001, J NEUROTRAUM, V18, P187, DOI 10.1089/08977150150502613; Hess DM, 2007, J COMP NEUROL, V501, P465, DOI 10.1002/cne.21163; Hoke A, 2010, EXP NEUROL, V223, P1, DOI 10.1016/j.expneurol.2009.12.001; Hoffman PN, 2010, EXP NEUROL, V223, P11, DOI 10.1016/j.expneurol.2009.09.006; HOFFMAN PN, 1987, P NATL ACAD SCI USA, V84, P3472, DOI 10.1073/pnas.84.10.3472; Hoke A, 2006, J NEUROSCI, V26, P9646, DOI 10.1523/JNEUROSCI.1620-06.2006; Hoyng SA, 2011, J HAND SURG-EUR VOL, V36E, P735, DOI 10.1177/1753193411420348; Hu XH, 2010, EXP NEUROL, V223, P153, DOI 10.1016/j.expneurol.2009.08.025; Hu Y, 2005, MOL THER, V11, P906, DOI 10.1016/j.ymthe.2005.01.016; Hu Y, 2007, EXP NEUROL, V207, P314, DOI 10.1016/j.expneurol.2007.07.001; Ip NY, 1996, ANNU REV NEUROSCI, V19, P491; Jiang X, 2010, EXP NEUROL, V223, P86, DOI 10.1016/j.expneurol.2009.09.009; JU G, 1987, CELL TISSUE RES, V247, P417; Kobayashi H, 2000, NEUROPEPTIDES, V34, P338, DOI 10.1054/npep.2000.0829; Koopmans GC, 2005, J NEUROTRAUM, V22, P214, DOI 10.1089/neu.2005.22.214; Lang EM, 2008, J NEUROTRAUM, V25, P384, DOI 10.1089/neu.2007.0396; Leclere PG, 2007, J NEUROSCI, V27, P1190, DOI 10.1523/JNEUROSCI.5089-06.2007; Li Q, 2005, MICROSURG, V26, P116; Lundborg G, 2000, J HAND SURG-AM, V25A, P391, DOI 10.1053/jhsu.2000.4165; Madduri S, 2010, J PERIPHER NERV SYST, V15, P93, DOI 10.1111/j.1529-8027.2010.00257.x; Mason MRJ, 2011, CURR GENE THER, V11, P75; Meier C, 1999, J NEUROSCI, V19, P3847; MEYER M, 1992, J CELL BIOL, V119, P45, DOI 10.1083/jcb.119.1.45; MIDHA R, 1993, J NEUROSURG, V78, P90, DOI 10.3171/jns.1993.78.1.0090; Midha R, 2001, J NEUROSURG, V94, P102, DOI 10.3171/jns.2001.94.1.0102; MORRISSEY TK, 1991, J NEUROSCI, V11, P2433; MOSKOWITZ PF, 1995, J NEUROSCI, V15, P1545; Munson JB, 1997, J NEUROSCI, V17, P470, DOI 10.1523/JNEUROSCI.17-01-00470.1997; Murinson BB, 2004, J NEUROPATH EXP NEUR, V63, P246, DOI 10.1093/jnen/63.3.246; Nave KA, 2005, NAT NEUROSCI, V8, P1420, DOI 10.1038/nn1105-1420; NEW HV, 1986, NATURE, V323, P809, DOI 10.1038/323809a0; Ng BK, 2007, J NEUROSCI, V27, P7597, DOI 10.1523/JNEUROSCI.0563-07.2007; Nieuwenhuis S, 2011, NAT NEUROSCI, V14, P1105, DOI 10.1038/nn.2886; OBLINGER MM, 1988, J NEUROSCI, V8, P1747; Pallant J., 2020, SPSS SURVIVAL MANUAL; Plant GW, 2002, J NEUROSCI, V22, P6083; RABINOVSKY ED, 1992, J NEUROSCI RES, V31, P188, DOI 10.1002/jnr.490310124; Ray WZ, 2010, EXP NEUROL, V223, P77, DOI 10.1016/j.expneurol.2009.03.031; Ro LS, 1999, PAIN, V79, P265, DOI 10.1016/S0304-3959(98)00164-X; SANTOS PM, 1995, J NEUROSCI METH, V61, P79, DOI 10.1016/0165-0270(95)00026-Q; Santosa KB, 2013, MUSCLE NERVE, V47, P213, DOI 10.1002/mus.23490; Schmidt CE, 2003, ANNU REV BIOMED ENG, V5, P293, DOI 10.1146/annurev.bioeng.5.011303.120731; SENDTNER M, 1990, NATURE, V345, P440, DOI 10.1038/345440a0; Stankoff B, 2002, J NEUROSCI, V22, P9221; Stucky CL, 1999, J NEUROSCI, V19, P6497; Symons NA, 2001, EUR J NEUROSCI, V14, P522, DOI 10.1046/j.0953-816x.2001.01681.x; Tannemaat MR, 2007, NEUROSURGERY, V61, P1286, DOI 10.1227/01.neu.0000306108.78044.a2; Tannemaat MR, 2008, EUR J NEUROSCI, V28, P1467, DOI 10.1111/j.1460-9568.2008.06452.x; Tebar LA, 2008, P NATL ACAD SCI USA, V105, P11400, DOI 10.1073/pnas.0711978105; Terenghi G, 1999, J ANAT, V194, P1, DOI 10.1046/j.1469-7580.1999.19410001.x; TETZLAFF W, 1988, J NEUROSCI, V8, P3181; Tucker BA, 2005, BRAIN RES PROTOC, V16, P50, DOI 10.1016/j.brainresprot.2005.10.004; Varejao ASP, 2003, EXP NEUROL, V183, P695, DOI 10.1016/S0014-4886(03)00208-5; Verge VMK, 1996, PHILOS T R SOC B, V351, P423, DOI 10.1098/rstb.1996.0038; VOYVODIC JT, 1989, NATURE, V342, P430, DOI 10.1038/342430a0; Vulchanova L, 2001, NEUROSCIENCE, V108, P143, DOI 10.1016/S0306-4522(01)00377-3; Wiberg Mikael, 2003, Surg Technol Int, V11, P303; Xiao JH, 2009, J NEUROSCI, V29, P4016, DOI 10.1523/JNEUROSCI.3811-08.2009; Yamauchi J, 2003, P NATL ACAD SCI USA, V100, P14421, DOI 10.1073/pnas.2336152100; Yu HL, 2009, MICROSURG, V29, P330, DOI 10.1002/micr.20635; Zhang JY, 2000, EUR J NEUROSCI, V12, P4171, DOI 10.1046/j.1460-9568.2000.01312.x; Zheng LF, 2008, BRAIN RES, V1187, P20, DOI 10.1016/j.brainres.2007.10.044	92	50	52	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 9	2013	8	8							e69987	10.1371/journal.pone.0069987	http://dx.doi.org/10.1371/journal.pone.0069987			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	245OM	23950907	gold, Green Submitted, Green Published			2022-12-25	WOS:000326473200008
J	Seo, KW; Lee, SJ; Kim, YH; Bae, JU; Park, SY; Bae, SS; Kim, CD				Seo, Kyo Won; Lee, Seung Jin; Kim, Yun Hak; Bae, Jin Ung; Park, So Youn; Bae, Sun Sik; Kim, Chi Dae			Mechanical Stretch Increases MMP-2 Production in Vascular Smooth Muscle Cells via Activation of PDGFR-beta/Akt Signaling Pathway	PLOS ONE			English	Article							MATRIX METALLOPROTEINASES; MOLECULAR-BASIS; GROWTH; EXPRESSION; PROLIFERATION; AKT; RECEPTOR; PHOSPHORYLATION; DIFFERENTIATION	Increased blood pressure, leading to mechanical stress on vascular smooth muscle cells (VSMC), is a known risk factor for vascular remodeling via increased activity of matrix metalloproteinase (MMP) within the vascular wall. This study aimed to identify cell surface mechanoreceptors and intracellular signaling pathways that influence VSMC to produce MMP in response to mechanical stretch (MS). When VSMC was stimulated with MS (0-10% strain, 60 cycles/min), both production and gelatinolytic activity of MMP-2, but not MMP-9, were increased in a force-dependent manner. MS-enhanced MMP-2 expression and activity were inhibited by molecular inhibition of Akt using Akt siRNA as well as by PI3K/Akt inhibitors, LY293002 and AI, but not by MAPK inhibitors such as PD98059, SP600125 and SB203580. MS also increased Akt phosphorylation in VSMC, which was attenuated by AG1295, a PDGF receptor (PDGFR) inhibitor, but not by inhibitors for other receptor tyrosine kinase including EGF, IGF, and FGF receptors. Although MS activated PDGFR-alpha as well as PDGFR-beta in VSMC, MS-induced Akt phosphorylation was inhibited by molecular deletion of PDGFR-beta using siRNA, but not by inhibition of PDGFR-alpha. Collectively, our data indicate that MS induces MMP-2 production in VSMC via activation of Akt pathway, that is mediated by activation of PDGFR-beta signaling pathways.	[Kim, Chi Dae] Pusan Natl Univ, Dept Pharmacol, Sch Med, Yangsan, Gyeongnam, South Korea; Pusan Natl Univ, Med Res Ctr Ischem Tissue Regenerat, Yangsan, Gyeongnam, South Korea	Pusan National University; Pusan National University Hospital; Pusan National University	Kim, CD (corresponding author), Pusan Natl Univ, Dept Pharmacol, Sch Med, Yangsan, Gyeongnam, South Korea.	chidkim@pusan.ac.kr		Kim, Yun Hak/0000-0002-9796-8266	National Research Foundation of Korea (NRF); Korea government (MSIP) [2005-0049416]	National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Korea government (MSIP)	This work was supported by the National Research Foundation of Korea (NRF) grant funded by the Korea government (MSIP) (2005-0049416). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akbal Cem, 2006, J Pediatr Urol, V2, P402, DOI 10.1016/j.jpurol.2005.08.004; Anwar MA, 2012, J VASC RES, V49, P463, DOI 10.1159/000339151; Boudreault F, 2010, AM J RESP CELL MOL, V43, P64, DOI 10.1165/rcmb.2009-0092OC; Caird J, 2006, EUR J NEUROL, V13, P1098, DOI 10.1111/j.1468-1331.2006.01469.x; Cheng JZ, 2007, ARTERIOSCL THROM VAS, V27, P1744, DOI 10.1161/ATVBAHA.107.147371; Chung AWY, 2005, J VASC SURG, V42, P747, DOI 10.1016/j.jvs.2005.05.037; French WJ, 2008, MOL CELL BIOL, V28, P5646, DOI 10.1128/MCB.00441-08; Galis ZS, 2002, CIRC RES, V90, P251, DOI 10.1161/res.90.3.251; Gharibi B, 2012, J CELL MOL MED, V16, P2789, DOI 10.1111/j.1582-4934.2012.01602.x; Godin D, 2000, CIRCULATION, V102, P2861; Grote K, 2003, CIRC RES, V92, pE80, DOI 10.1161/01.RES.0000077044.60138.7C; Haga JH, 2007, J BIOMECH, V40, P947, DOI 10.1016/j.jbiomech.2006.04.011; Kappert K, 2006, ARTERIOSCL THROM VAS, V26, P2644, DOI 10.1161/01.ATV.0000246777.30819.85; Kippenberger S, 2005, J BIOL CHEM, V280, P3060, DOI 10.1074/jbc.M409590200; Kouri FM, 2006, CIRC RES, V99, P348, DOI 10.1161/01.RES.0000239429.72678.e1; Lee SJ, 2008, FREE RADICAL BIO MED, V45, P1487, DOI 10.1016/j.freeradbiomed.2008.08.022; Li CH, 2000, CELL SIGNAL, V12, P435, DOI 10.1016/S0898-6568(00)00096-6; Li L, 2011, J CELL BIOCHEM, V112, P289, DOI 10.1002/jcb.22924; Lin CC, 2012, J CELL PHYSIOL, V227, P1628, DOI 10.1002/jcp.22880; Liu G, 2011, EXP CELL RES, V317, P2420, DOI 10.1016/j.yexcr.2011.07.016; MURPHY G, 1994, ANN NY ACAD SCI, V732, P31, DOI 10.1111/j.1749-6632.1994.tb24722.x; Newby AC, 2005, PHYSIOL REV, V85, P1, DOI 10.1152/physrev.00048.2003; Owens Gary K, 2007, Novartis Found Symp, V283, P174; Papachristou DJ, 2009, ARCH ORAL BIOL, V54, P1035, DOI 10.1016/j.archoralbio.2009.08.010; Pascarella L, 2008, EUR J VASC ENDOVASC, V35, P102, DOI 10.1016/j.ejvs.2007.08.011; Raines EW, 2004, CYTOKINE GROWTH F R, V15, P237, DOI 10.1016/j.cytogfr.2004.03.004; Ramachandran A, 2010, AM J PATHOL, V177, P119, DOI 10.2353/ajpath.2010.090772; Risinger GM, 2006, J BIOL CHEM, V281, P25915, DOI 10.1074/jbc.M513513200; Salabei JK, 2013, BIOCHEM J, V451, P375, DOI 10.1042/BJ20121344; Saygili E, 2009, BASIC RES CARDIOL, V104, P435, DOI 10.1007/s00395-008-0772-6; Sedding DG, 2005, CIRC RES, V96, P635, DOI 10.1161/01.RES.0000160610.61306.0f; Seo KW, 2010, ATHEROSCLEROSIS, V208, P56, DOI 10.1016/j.atherosclerosis.2009.06.012; Shimizu N, 2008, J APPL PHYSIOL, V104, P766, DOI 10.1152/japplphysiol.00870.2007; Shyu KG, 2009, CLIN SCI, V116, P377, DOI 10.1042/CS20080163; SUNDARESAN M, 1995, SCIENCE, V270, P296, DOI 10.1126/science.270.5234.296; Sweeney NV, 2004, BIOCHEM BIOPH RES CO, V320, P325, DOI 10.1016/j.bbrc.2004.05.174; Ungvari Z, 2006, ANTIOXID REDOX SIGN, V8, P1121, DOI 10.1089/ars.2006.8.1121; WILSON E, 1993, J CELL BIOL, V123, P741, DOI 10.1083/jcb.123.3.741; Xiong W, 2010, CURR EYE RES, V35, P389, DOI 10.3109/02713680903584686; Zemskov EA, 2012, J CELL PHYSIOL, V227, P2089, DOI 10.1002/jcp.22938; Zhang BF, 2007, CELL SIGNAL, V19, P1690, DOI 10.1016/j.cellsig.2007.03.005	41	37	40	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2013	8	8							e70437	10.1371/journal.pone.0070437	http://dx.doi.org/10.1371/journal.pone.0070437			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	200ZE	23950935	Green Submitted, Green Published, gold			2022-12-25	WOS:000323109700035
J	Lou, JL; Wang, Y; Yao, CJ; Jin, LZ; Wang, XZ; Xiao, Y; Wu, NX; Song, P; Song, Y; Tan, YF; Gao, M; Liu, KC; Zhang, X				Lou, Jianlin; Wang, Yu; Yao, Chunji; Jin, Lingzhi; Wang, Xiuzhi; Xiao, Yun; Wu, Nanxiang; Song, Peng; Song, Yang; Tan, Yufeng; Gao, Ming; Liu, Kecheng; Zhang, Xing			Role of DNA Methylation in Cell Cycle Arrest Induced by Cr (VI) in Two Cell Lines	PLOS ONE			English	Article							SOLUBLE HEXAVALENT CHROMIUM; S-PHASE CHECKPOINT; LUNG-CANCER; HISTONE METHYLATION; GROWTH ARREST; EXPRESSION; WORKERS; GENE; PATHWAY; HYPOMETHYLATION	Hexavalent chromium [Cr(IV)], a well-known industrial waste product and an environmental pollutant, is recognized as a human carcinogen. But its mechanisms of carcinogenicity remain unclear, and recent studies suggest that DNA methylation may play an important role in the carcinogenesis of Cr(IV). The aim of our study was to investigate the effects of Cr(IV) on cell cycle progress, global DNA methylation, and DNA methylation of p16 gene. A human B lymphoblastoid cell line and a human lung cell line A549 were exposed to 5-15 mu M potassium dichromate or 1.25-5 mu g/cm(2) lead chromate for 2-24 hours. Cell cycle was arrested at G(1) phase by both compounds in 24 hours exposure group, but global hypomethylation occurred earlier than cell cycle arrest, and the hypomethylation status maintained for more than 20 hours. The mRNA expression of p16 was significantly up-regulated by Cr(IV), especially by potassium dichromate, and the mRNA expression of cyclin-dependent kinases (CDK4 and CDK6) was significantly down-regulated. But protein expression analysis showed very little change of p16 gene. Both qualitative and quantitative results showed that DNA methylation status of p16 remained unchanged. Collectively, our data suggested that global hypomethylation was possibly responsible for Cr(IV) - induced G(1) phase arrest, but DNA methylation might not be related to up-regulation of p16 gene by Cr(IV).	[Lou, Jianlin; Wang, Yu; Yao, Chunji; Jin, Lingzhi; Wang, Xiuzhi; Xiao, Yun; Wu, Nanxiang; Song, Peng; Song, Yang; Tan, Yufeng; Gao, Ming; Liu, Kecheng; Zhang, Xing] Zhejiang Acad Med Sci, Inst Hyg, Hangzhou, Zhejiang, Peoples R China	Zhejiang Academy of Medical Sciences	Lou, JL (corresponding author), Zhejiang Acad Med Sci, Inst Hyg, Hangzhou, Zhejiang, Peoples R China.	jianlinlou@163.com; xingtyou@mail.hz.zj.cn			National Natural Science Foundation of China [81001242]; Zhejiang Provincial Natural Science Foundation of China [Y2100687]; Key Medical Discipline Construction Plan of Zhejiang Province, China [11-ZC02]; Young Core Researcher program from Health Bureau of Zhejiang Province, China [2011RCA001]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Zhejiang Provincial Natural Science Foundation of China(Natural Science Foundation of Zhejiang Province); Key Medical Discipline Construction Plan of Zhejiang Province, China; Young Core Researcher program from Health Bureau of Zhejiang Province, China	This research work was supported by National Natural Science Foundation of China (Grant No. 81001242), Zhejiang Provincial Natural Science Foundation of China (Grant No. Y2100687), Key Medical Discipline Construction Plan of Zhejiang Province, China (Grant No. 11-ZC02), and the Young Core Researcher program from Health Bureau of Zhejiang Province, China (Grant No. 2011RCA001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali AHK, 2011, MOL CARCINOGEN, V50, P89, DOI 10.1002/mc.20697; Burhans WC, 2009, FREE RADICAL BIO MED, V47, P1282, DOI 10.1016/j.freeradbiomed.2009.05.026; Chen TL, 2012, COMP BIOCHEM PHYS C, V155, P143, DOI 10.1016/j.cbpc.2011.03.011; Chiu A, 2010, J ENVIRON SCI HEAL C, V28, P188, DOI 10.1080/10590501.2010.504980; Choo Kong-Bung, 2011, Malays J Pathol, V33, P61; Duthie SJ, 2011, P NUTR SOC, V70, P47, DOI 10.1017/S0029665110003952; Gibb HJ, 2000, AM J IND MED, V38, P115, DOI 10.1002/1097-0274(200008)38:2<115::AID-AJIM1>3.0.CO;2-Y; Hatziapostolou M, 2011, CELL MOL LIFE SCI, V68, P1681, DOI 10.1007/s00018-010-0624-z; Hayashi Y, 2004, TOXICOL APPL PHARM, V197, P96, DOI 10.1016/j.taap.2004.02.011; Holmes AL, 2008, INDIAN J MED RES, V128, P353; Klein CB, 2002, ENVIRON HEALTH PERSP, V110, P739, DOI 10.1289/ehp.02110s5739; Kondo K, 2006, LUNG CANCER, V53, P295, DOI 10.1016/j.lungcan.2006.05.022; Kondo Y, 2003, MOL CELL BIOL, V23, P206, DOI 10.1128/MCB.23.1.206-215.2003; Labra M, 2004, CHEMOSPHERE, V54, P1049, DOI 10.1016/j.chemosphere.2003.10.024; Martinez-Zamudio R, 2011, EPIGENETICS-US, V6, P820, DOI 10.4161/epi.6.7.16250; Panayiotidis MI, 2006, IN VIVO, V20, P861; Permenter MG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027730; Raynal NJM, 2012, CANCER RES, V72, P1170, DOI 10.1158/0008-5472.CAN-11-3248; Reynolds M, 2012, MUTAGENESIS, V27, P437, DOI 10.1093/mutage/ger095; Rusiecki JA, 2008, ENVIRON HEALTH PERSP, V116, P1547, DOI 10.1289/ehp.11338; Schnekenburger M, 2007, MOL CELL BIOL, V27, P7089, DOI 10.1128/MCB.00838-07; Semczuk A, 2004, CANCER LETT, V203, P1, DOI 10.1016/j.canlet.2003.09.012; Shackelford RE, 2000, FREE RADICAL BIO MED, V28, P1387, DOI 10.1016/S0891-5849(00)00224-0; Shen XP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044822; Stanley JA, 2011, REPROD TOXICOL, V32, P112, DOI 10.1016/j.reprotox.2011.05.007; Sugawara H, 2011, EPIGENETICS-US, V6, P509, DOI 10.4161/epi.6.4.14876; Sun H, 2009, TOXICOL APPL PHARM, V237, P258, DOI 10.1016/j.taap.2009.04.008; Takahashi Y, 2005, MOL CARCINOGEN, V42, P150, DOI 10.1002/mc.20073; Wakeman TP, 2006, MUTAT RES-GEN TOX EN, V610, P14, DOI 10.1016/j.mrgentox.2006.06.007; Wakeman TP, 2004, MUTAT RES-FUND MOL M, V554, P241, DOI 10.1016/j.mrfmmm.2004.05.006; Wang TC, 2012, J HAZARD MATER, V213, P440, DOI 10.1016/j.jhazmat.2012.02.024; Wise SS, 2006, MUTAT RES-GEN TOX EN, V610, P2, DOI 10.1016/j.mrgentox.2006.06.005; Witkiewicz AK, 2011, CELL CYCLE, V10, P2497, DOI 10.4161/cc.10.15.16776; Wolffe AP, 1999, SCIENCE, V286, P481, DOI 10.1126/science.286.5439.481; Zhang Z, 2001, MOL CELL BIOCHEM, V222, P77, DOI 10.1023/A:1017963307358	35	29	30	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2013	8	8							e71031	10.1371/journal.pone.0071031	http://dx.doi.org/10.1371/journal.pone.0071031			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	217ZG	23940686	Green Published, Green Submitted, gold			2022-12-25	WOS:000324401500057
J	Baroja-Mazo, A; Barbera-Cremades, M; Pelegrin, P				Baroja-Mazo, Alberto; Barbera-Cremades, Maria; Pelegrin, Pablo			P2X7 Receptor Activation Impairs Exogenous MHC Class I Oligopeptides Presentation in Antigen Presenting Cells	PLOS ONE			English	Article							P2X(7) RECEPTOR; EXTRACELLULAR ATP; DENDRITIC CELLS; CROSS-PRESENTATION; HEAVY-CHAINS; T-CELLS; INFLAMMATION; MOLECULES; RELEASE; EXPRESSION	Major histocompatibility complex class I (MHC I) on antigen presenting cells (APCs) is a potent molecule to activate CD8(+) T cells and initiate immunity. P2X7 receptors (P2X7Rs) are present on the plasma membrane of APCs to sense the extracellular danger signal adenosine-5'-triphosphate (ATP). P2X7R activates the inflammasome and the release of IL-1 beta in macrophages and other immune cells to initiate the inflammatory response. Here we show that P2X7R stimulation by ATP in APCs decreased the amount of MHC I at the plasma membrane. Specific antagonism or genetic ablation of P2X7R inhibited the effects of ATP on levels of cellular MHC I. Furthermore, P2X7R stimulation was able to inhibit activation of CD8(+) T cells via specific MHC I-oligopeptide complexes. Our study suggests that P2X7R activation on APCs is a novel inhibitor of adaptive CD8(+) T cell immunity.	[Baroja-Mazo, Alberto; Barbera-Cremades, Maria; Pelegrin, Pablo] Hosp Univ Virgen de la Arrixaca, Fdn Formac Invest Sanitaria Reg Murcia FFIS, Ctr Invest Biomed Red Area Temat Enfermedades Hep, Unidad Inflamac & Cirugia Expt,IMIB, Murcia, Spain	CIBER - Centro de Investigacion Biomedica en Red; CIBEREHD; Hospital Clinico Universitario Virgen de la Arrixaca	Pelegrin, P (corresponding author), Hosp Univ Virgen de la Arrixaca, Fdn Formac Invest Sanitaria Reg Murcia FFIS, Ctr Invest Biomed Red Area Temat Enfermedades Hep, Unidad Inflamac & Cirugia Expt,IMIB, Murcia, Spain.	pablo.pelegrin@ffis.es	Pelegrin, Pablo/M-2007-2014; Baroja-Mazo, Alberto/E-6270-2016	Pelegrin, Pablo/0000-0002-9688-1804; Baroja-Mazo, Alberto/0000-0001-5212-5006	Instituto Salud Carlos III-Fondo Europeo de Desarrollo Regional [EMER07/049, PI09/0120]; Fundacion Seneca [11922/PI/09]	Instituto Salud Carlos III-Fondo Europeo de Desarrollo Regional; Fundacion Seneca(Fundacion Seneca)	This work was supported by grants from Plan Nacional I+D+I 2008-2011-Instituto Salud Carlos III-Fondo Europeo de Desarrollo Regional (EMER07/049 and PI09/0120) and Fundacion Seneca (11922/PI/09), managed by Fundacion Formacion Investigacion Sanitaria Region de Murcia (FFIS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS DO, 1984, ANNU REV IMMUNOL, V2, P283, DOI 10.1146/annurev.immunol.2.1.283; Adinolfi E, 2012, CANCER RES, V72, P2957, DOI 10.1158/0008-5472.CAN-11-1947; Aleyas AG, 2012, EUR J IMMUNOL, V42, P2655, DOI 10.1002/eji.201142052; Arulkumaran N, 2011, EXPERT OPIN INV DRUG, V20, P897, DOI 10.1517/13543784.2011.578068; Barbera-Cremades M, 2012, FASEB J, V26, P2951, DOI 10.1096/fj.12-205765; Biswas SK, 2010, NAT IMMUNOL, V11, P889, DOI 10.1038/ni.1937; Chessell IP, 2005, PAIN, V114, P386, DOI 10.1016/j.pain.2005.01.002; Compeer EB, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00037; DEMARIA S, 1994, J BIOL CHEM, V269, P6689; Ferrari D, 2006, J IMMUNOL, V176, P3877, DOI 10.4049/jimmunol.176.7.3877; Fransen MF, 2010, J IMMUNOL, V185, P3167, DOI 10.4049/jimmunol.0904046; Gerlini G, 2004, AM J PATHOL, V165, P1853, DOI 10.1016/S0002-9440(10)63238-5; Gromme M, 1999, P NATL ACAD SCI USA, V96, P10326, DOI 10.1073/pnas.96.18.10326; Gu BJ, 2006, BLOOD, V107, P4946, DOI 10.1182/blood-2005-07-2994; Hanley PJ, 2012, J BIOL CHEM, V287, P10650, DOI 10.1074/jbc.M111.332676; HENDERSON RA, 1992, SCIENCE, V255, P1264, DOI 10.1126/science.1546329; Hsu C, 2010, J CELL BIOL, V189, P223, DOI 10.1083/jcb.200911018; Hughes EA, 1997, P NATL ACAD SCI USA, V94, P1896, DOI 10.1073/pnas.94.5.1896; Idzko M, 2007, NAT MED, V13, P913, DOI 10.1038/nm1617; Jelassi B, 2011, ONCOGENE, V30, P2108, DOI 10.1038/onc.2010.593; Kaczmarek M, 2007, FOLIA HISTOCHEM CYTO, V45, P205; Keating C, 2011, J IMMUNOL, V187, P1467, DOI 10.4049/jimmunol.1100423; King BF, 2007, BRIT J PHARMACOL, V151, P565, DOI 10.1038/sj.bjp.0707266; Kurts C, 1996, J EXP MED, V184, P923, DOI 10.1084/jem.184.3.923; Li YH, 2008, CANCER RES, V68, P6889, DOI 10.1158/0008-5472.CAN-08-0161; Lopez-Castejon G, 2011, CELL MOL LIFE SCI, V68, P3095, DOI 10.1007/s00018-010-0609-y; Lopez-Castejon G, 2010, J IMMUNOL, V185, P2611, DOI 10.4049/jimmunol.1000436; MacKenzie A, 2001, IMMUNITY, V15, P825, DOI 10.1016/S1074-7613(01)00229-1; Mantovani A, 2010, CURR OPIN IMMUNOL, V22, P231, DOI 10.1016/j.coi.2010.01.009; Maroof A, 2009, J IMMUNOL, V183, P7095, DOI 10.4049/jimmunol.0901330; Marques-da-Silva C, 2011, PLOS ONE, V6; Mellman I, 2001, CELL, V106, P255, DOI 10.1016/S0092-8674(01)00449-4; Moore SF, 2009, J IMMUNOL, V183, P3302, DOI 10.4049/jimmunol.0900394; Neefjes J, 2011, NAT REV IMMUNOL, V11, P823, DOI 10.1038/nri3084; North RA, 2002, PHYSIOL REV, V82, P1013, DOI 10.1152/physrev.00015.2002; Pang BX, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001245; Pelegrin P, 2009, EMBO J, V28, P2114, DOI 10.1038/emboj.2009.163; Pellegatti P, 2005, MOL BIOL CELL, V16, P3659, DOI 10.1091/mbc.E05-03-0222; Pellegatti P, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002599; Petersen TR, 2010, CRIT REV IMMUNOL, V30, P345, DOI 10.1615/CritRevImmunol.v30.i4.30; Polyak S, 1997, J IMMUNOL, V159, P2177; Qu Y, 2009, J IMMUNOL, V182, P5052, DOI 10.4049/jimmunol.0802968; Rabinovich GA, 2007, ANNU REV IMMUNOL, V25, P267, DOI 10.1146/annurev.immunol.25.022106.141609; Riteau N, 2010, AM J RESP CRIT CARE, V182, P774, DOI 10.1164/rccm.201003-0359OC; Roger S, 2011, EXPERT OPIN INV DRUG, V20, P875, DOI 10.1517/13543784.2011.583918; Santos SG, 2004, J BIOL CHEM, V279, P53062, DOI 10.1074/jbc.M408794200; Savina A, 2003, J BIOL CHEM, V278, P20083, DOI 10.1074/jbc.M301642200; Simmons DP, 2010, J IMMUNOL, V185, P2405, DOI 10.4049/jimmunol.0904005; Smed-Sorensen A, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002572; Solle M, 2001, J BIOL CHEM, V276, P125, DOI 10.1074/jbc.M006781200; Trombetta ES, 2003, SCIENCE, V299, P1400, DOI 10.1126/science.1080106; Weber FC, 2010, J EXP MED, V207, P2609, DOI 10.1084/jem.20092489; Wilhelm K, 2010, NAT MED, V16, P1434, DOI 10.1038/nm.2242; Win SJ, 2011, IMMUNOL CELL BIOL, V89, P681, DOI 10.1038/icb.2010.161	54	7	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2013	8	8							e70577	10.1371/journal.pone.0070577	http://dx.doi.org/10.1371/journal.pone.0070577			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	218XC	23940597	Green Published, gold, Green Submitted			2022-12-25	WOS:000324465000091
J	Li, R; Wang, MX; Jin, L; He, YG				Li, Ran; Wang, Minxian; Jin, Li; He, Yungang			A Monte Carlo Permutation Test for Random Mating Using Genome Sequences	PLOS ONE			English	Article							HARDY-WEINBERG EQUILIBRIUM; MULTILOCUS GENOTYPE DATA; POPULATION-STRUCTURE; WIDE ASSOCIATION; MULTIPLE ALLELES; STRATIFICATION; INFERENCE; LOCI; TRAITS; MODEL	Testing for random mating of a population is important in population genetics, because deviations from randomness of mating may indicate inbreeding, population stratification, natural selection, or sampling bias. However, current methods use only observed numbers of genotypes and alleles, and do not take advantage of the fact that the advent of sequencing technology provides an opportunity to investigate this topic in unprecedented detail. To address this opportunity, a novel statistical test for random mating is required in population genomics studies for which large sequencing datasets are generally available. Here, we propose a Monte-Carlo-based-permutation test (MCP) as an approach to detect random mating. Computer simulations used to evaluate the performance of the permutation test indicate that its type I error is well controlled and that its statistical power is greater than that of the commonly used chi-square test (CHI). Our simulation study shows the power of our test is greater for datasets characterized by lower levels of migration between subpopulations. In addition, test power increases with increasing recombination rate, sample size, and divergence time of subpopulations. For populations exhibiting limited migration and having average levels of population divergence, the statistical power approaches 1 for sequences longer than 1Mbp and for samples of 400 individuals or more. Taken together, our results suggest that our permutation test is a valuable tool to detect random mating of populations, especially in population genomics studies.	[Li, Ran; Wang, Minxian; Jin, Li; He, Yungang] Chinese Acad Sci, Chinese Acad Sci & Max Planck Soc CAS MPG Partner, Shanghai Inst Biol Sci, Shanghai, Peoples R China; [Li, Ran; Wang, Minxian; Jin, Li; He, Yungang] Chinese Acad Sci, Chinese Acad Sci & Max Planck Soc CAS MPG Partner, Key Lab Computat Biol, Shanghai, Peoples R China; [Jin, Li] Fudan Univ, State Key Lab Genet Engn, Shanghai 200433, Peoples R China; [Jin, Li] Fudan Univ, Minist Educ, Key Lab Contemporary Anthropol, Sch Life Sci, Shanghai 200433, Peoples R China; [Jin, Li] Fudan Univ, Inst Biomed Sci, Shanghai 200433, Peoples R China	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Max Planck Society; Chinese Academy of Sciences; Max Planck Society; Fudan University; Fudan University; Fudan University	Jin, L (corresponding author), Chinese Acad Sci, Chinese Acad Sci & Max Planck Soc CAS MPG Partner, Shanghai Inst Biol Sci, Shanghai, Peoples R China.	lijin.fudan@gmail.com; yunganghe@picb.ac.cn	Wang, Minxian/GQH-5416-2022; Jin, Li/M-5063-2019; Jin, Li/C-1468-2009	Jin, Li/0000-0002-4546-2415; He, Yungang/0000-0002-2931-2871	National Natural Science Foundation of China [81100997, 31171279, 30890034, 30625016]; Shanghai Leading Academic Discipline Project [B111]; Center for Evolutionary Biology at Fudan University; SA-SIBS scholarship program; Youth Innovation Promotion Association of Chinese Academy of Science	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Leading Academic Discipline Project(Shanghai Leading Academic Discipline Project); Center for Evolutionary Biology at Fudan University; SA-SIBS scholarship program; Youth Innovation Promotion Association of Chinese Academy of Science	This work was supported by grants from the National Natural Science Foundation of China (81100997 and 31171279 to YH; 30890034 and 30625016 to LJ). LJ was also supported by the Shanghai Leading Academic Discipline Project (B111) and the Center for Evolutionary Biology at Fudan University. YH gratefully acknowledges the supports of SA-SIBS scholarship program and the Youth Innovation Promotion Association of Chinese Academy of Science. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AGRESTI A, 1979, PSYCHOMETRIKA, V44, P75, DOI 10.1007/BF02293786; Aoki S, 2003, BIOMETRICAL J, V45, P471, DOI 10.1002/bimj.200390026; Bubb KL, 2006, GENETICS, V173, P2165, DOI 10.1534/genetics.106.055715; CHAKRABORTY R, 1994, HUM HERED, V44, P1, DOI 10.1159/000154181; CHAKRABORTY R, 1988, P NATL ACAD SCI USA, V85, P9119, DOI 10.1073/pnas.85.23.9119; Coop G, 2008, SCIENCE, V319, P1395, DOI 10.1126/science.1151851; ELSTON RC, 1977, BIOMETRICS, V33, P536, DOI 10.2307/2529370; EMIGH TH, 1980, BIOMETRICS, V36, P627, DOI 10.2307/2556115; Falush D, 2003, GENETICS, V164, P1567; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Freedman ML, 2004, NAT GENET, V36, P388, DOI 10.1038/ng1333; Gao H, 2007, GENETICS, V176, P1635, DOI 10.1534/genetics.107.072371; Guo JZ, 2012, BMC GENET, V13, DOI 10.1186/1471-2156-13-82; GUO SW, 1992, BIOMETRICS, V48, P361, DOI 10.2307/2532296; HALDANE JBS, 1954, J GENET, V52, P631, DOI 10.1007/BF02985085; Handley LJL, 2007, TRENDS GENET, V23, P432, DOI 10.1016/j.tig.2007.07.002; HERNANDEZ JL, 1989, BIOMETRICS, V45, P53, DOI 10.2307/2532034; Hirschhorn JN, 2011, ANNU REV MED, V62, P11, DOI 10.1146/annurev.med.091708.162036; Hubisz MJ, 2009, MOL ECOL RESOUR, V9, P1322, DOI 10.1111/j.1755-0998.2009.02591.x; Hudson RR, 2002, BIOINFORMATICS, V18, P337, DOI 10.1093/bioinformatics/18.2.337; Huelsenbeck JP, 2007, GENETICS, V175, P1787, DOI 10.1534/genetics.106.061317; JIN K, 1995, BIOMETRICS, V51, P1064, DOI 10.2307/2533005; Kaeuffer R, 2007, HEREDITY, V99, P374, DOI 10.1038/sj.hdy.6801010; Kang SH, 2008, COMMUN STAT-SIMUL C, V37, P14, DOI 10.1080/03610910701420065; Kong A, 2010, NATURE, V467, P1099, DOI 10.1038/nature09525; Korte A, 2012, NAT GENET, V44, P1066, DOI 10.1038/ng.2376; Kuhn D, 2005, PSYCHOL SCI, V16, P866, DOI 10.1111/j.1467-9280.2005.01628.x; Kummerfeld SK, 2005, TRENDS GENET, V21, P25, DOI 10.1016/j.tig.2004.11.007; LANDER ES, 1994, SCIENCE, V265, P2037, DOI 10.1126/science.8091226; LEVENE H, 1949, ANN MATH STAT, V20, P91, DOI 10.1214/aoms/1177730093; LI CC, 1955, AM NAT, V89, P281, DOI 10.1086/281893; LOUIS EJ, 1987, BIOMETRICS, V43, P805, DOI 10.2307/2531534; Maiste PJ, 2004, COMPUT STAT DATA AN, V46, P605, DOI 10.1016/j.csda.2003.08.002; MANTEL N, 1974, ANN HUM GENET, V37, P445, DOI 10.1111/j.1469-1809.1974.tb01849.x; McVean GAT, 2004, SCIENCE, V304, P581, DOI 10.1126/science.1092500; Pemberton TJ, 2012, AM J HUM GENET, V91, P275, DOI 10.1016/j.ajhg.2012.06.014; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Price AL, 2010, NAT REV GENET, V11, P459, DOI 10.1038/nrg2813; Pritchard JK, 1999, AM J HUM GENET, V65, P220, DOI 10.1086/302449; Pritchard JK, 2000, GENETICS, V155, P945; Raymond M, 1995, EVOLUTION, V49, P1280, DOI 10.1111/j.1558-5646.1995.tb04456.x; Rohlfs RV, 2008, GENETICS, V180, P1609, DOI 10.1534/genetics.108.088005; SMITH CAB, 1970, ANN HUM GENET, V33, P377, DOI 10.1111/j.1469-1809.1970.tb01664.x; WEIR BS, 1992, P NATL ACAD SCI USA, V89, P11654, DOI 10.1073/pnas.89.24.11654; Wigginton JE, 2005, AM J HUM GENET, V76, P887, DOI 10.1086/429864	45	1	3	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2013	8	8							e71496	10.1371/journal.pone.0071496	http://dx.doi.org/10.1371/journal.pone.0071496			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	218XC	23940765	Green Published, gold, Green Submitted			2022-12-25	WOS:000324465000214
J	Lindsey, JD; Duong-Polk, KX; Dai, Y; Nguyen, DH; Leung, CK; Weinreb, RN				Lindsey, James D.; Duong-Polk, Karen X.; Dai, Yi; Nguyen, Duy H.; Leung, Christopher K.; Weinreb, Robert N.			Protection by an Oral Disubstituted Hydroxylamine Derivative against Loss of Retinal Ganglion Cell Differentiation following Optic Nerve Crush	PLOS ONE			English	Article							FLUORESCENT PROTEIN EXPRESSION; OXIDATIVE STRESS; INJURY; DAMAGE; BRAIN; NEUROPROTECTION; GLAUCOMA; TEMPOL; MICE; RAT	Thy-1 is a cell surface protein that is expressed during the differentiation of retinal ganglion cells (RGCs). Optic nerve injury induces progressive loss in the number of RGCs expressing Thy-1. The rate of this loss is fastest during the first week after optic nerve injury and slower in subsequent weeks. This study was undertaken to determine whether oral treatment with a water-soluble N-hydroxy-2,2,6,6-tetramethylpiperidine derivative (OT-440) protects against loss of Thy-1 promoter activation following optic nerve crush and whether this effect targets the earlier quick phase or the later slow phase. The retina of mice expressing cyan fluorescent protein under control of the Thy-1 promoter (Thy1-CFP mice) was imaged using a blue-light confocal scanning laser ophthalmoscope (bCSLO). These mice then received oral OT-440 prepared in cream cheese or dissolved in water, or plain vehicle, for two weeks and were imaged again prior to unilateral optic nerve crush. Treatments and weekly imaging continued for four more weeks. Fluorescent neurons were counted in the same defined retinal areas imaged at each time point in a masked fashion. When the counts at each time point were directly compared, the numbers of fluorescent cells at each time point were greater in the animals that received OT-440 in cream cheese by 8%, 27%, 52% and 60% than in corresponding control animals at 1, 2, 3 and 4 weeks after optic nerve crush. Similar results were obtained when the vehicle was water. Rate analysis indicated the protective effect of OT-440 was greatest during the first two weeks and was maintained in the second two weeks after crush for both the cream cheese vehicle study and water vehicle study. Because most of the fluorescent cells detected by bCSLO are RGCs, these findings suggest that oral OT-440 can either protect against or delay early degenerative responses occurring in RGCs following optic nerve injury.	[Lindsey, James D.; Duong-Polk, Karen X.; Nguyen, Duy H.; Weinreb, Robert N.] Univ Calif San Diego, Hamilton Glaucoma Ctr, La Jolla, CA 92093 USA; [Lindsey, James D.; Duong-Polk, Karen X.; Nguyen, Duy H.; Weinreb, Robert N.] Univ Calif San Diego, Dept Ophthalmol, La Jolla, CA 92093 USA; [Dai, Yi] Fudan Univ, Dept Ophthalmol, Shanghai 200433, Peoples R China; [Leung, Christopher K.] Chinese Univ Hong Kong, Dept Ophthalmol & Visual Sci, Hong Kong, Hong Kong, Peoples R China	University of California System; University of California San Diego; University of California System; University of California San Diego; Fudan University; Chinese University of Hong Kong	Lindsey, JD (corresponding author), Univ Calif San Diego, Hamilton Glaucoma Ctr, La Jolla, CA 92093 USA.	jdlindsey@ucsd.edu	Leung, Chris/N-8015-2019; Dai, Yi/AAX-2979-2021; Nguyen, Duy/HDO-8098-2022	Leung, Chris/0000-0003-4862-777X; 	Othera Pharmaceuticals; National Institutes of Health [RO1 EY019692]; NATIONAL EYE INSTITUTE [R01EY019692] Funding Source: NIH RePORTER	Othera Pharmaceuticals; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	Funding to support this investigation was provided by Othera Pharmaceuticals (http://www.othera.com). Additional support was provided by National Institutes of Health grant RO1 EY019692. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AGRAWAL HC, 1968, J NEUROCHEM, V15, P917, DOI 10.1111/j.1471-4159.1968.tb11633.x; Arsham H, ANAL COVARIANCE COMP; Bessero AC, 2010, CURR OPIN NEUROL, V23, P10, DOI 10.1097/WCO.0b013e3283344461; BLINDERMAN E, 1966, ANAT RECORD, V154, P753, DOI 10.1002/ar.1091540406; Bodeutsch N, 1999, J NEUROBIOL, V38, P116, DOI 10.1002/(SICI)1097-4695(199901)38:1<116::AID-NEU9>3.0.CO;2-F; Calkins DJ, 2012, PROG RETIN EYE RES, V31, P702, DOI 10.1016/j.preteyeres.2012.07.001; Chatterjee PK, 2000, KIDNEY INT, V58, P658, DOI 10.1046/j.1523-1755.2000.00212.x; Chindasub P, 2013, INVEST OPHTH VIS SCI, V54, P96, DOI 10.1167/iovs.12-10850; Dibas A, 2010, MOL VIS, V16, P330; Hall ED, 2010, NEUROTHERAPEUTICS, V7, P51, DOI 10.1016/j.nurt.2009.10.021; Kirsch M, 2010, GLIA, V58, P768, DOI 10.1002/glia.20961; Leung CKS, 2008, J NEUROSCI METH, V168, P475, DOI 10.1016/j.jneumeth.2007.10.018; Leung CKS, 2008, INVEST OPHTH VIS SCI, V49, P4898, DOI 10.1167/iovs.07-1447; Levkovitch-Verbin H, 2000, INVEST OPHTH VIS SCI, V41, P4169; Lieven CJ, 2006, INVEST OPHTH VIS SCI, V47, P1477, DOI 10.1167/iovs.05-0921; Liu CJL, 1996, INVEST OPHTH VIS SCI, V37, P1469; Liu Q, 2007, INVEST OPHTH VIS SCI, V48, P4580, DOI 10.1167/iovs.07-0170; Liu S, 2012, INVEST OPHTH VIS SCI, V53, P6254, DOI 10.1167/iovs.12-9450; MITCHELL JB, 1990, BIOCHEMISTRY-US, V29, P2802, DOI 10.1021/bi00463a024; Patil G, 2008, U.S. Patent, Patent No. [2008/0280890A1, 20080280890]; Raymond ID, 2008, MOL VIS, V14, P1559; Raymond ID, 2009, VISUAL NEUROSCI, V26, P453, DOI 10.1017/S095252380999023X; Sampugna J, 1975, J NEUROBIOL, V16, P259; Schlamp CL, 2001, MOL VIS, V7, P192; Schnichels S, 2011, J NEUROSCI RES, V89, P490, DOI 10.1002/jnr.22584; SCHWAB C, 1990, NEUROCHEM RES, V15, P1127, DOI 10.1007/BF01101715; Tanito M, 2007, INVEST OPHTH VIS SCI, V48, P1900, DOI 10.1167/iovs.06-1057; Thaler S, 2010, EXP EYE RES, V90, P254, DOI 10.1016/j.exer.2009.10.013; Wang X, 2010, NEUROSCI LETT, V468, P110, DOI 10.1016/j.neulet.2009.10.077; Weinreb RN, 2004, LANCET, V363, P1711, DOI 10.1016/S0140-6736(04)16257-0; Wilcox CS, 2010, PHARMACOL THERAPEUT, V126, P119, DOI 10.1016/j.pharmthera.2010.01.003	31	11	11	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2013	8	8							e65966	10.1371/journal.pone.0065966	http://dx.doi.org/10.1371/journal.pone.0065966			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	218XC	23940507	gold, Green Published			2022-12-25	WOS:000324465000001
J	Loureiro, C; Pereira, JL; Pedrosa, MA; Goncalves, F; Castro, BB				Loureiro, Claudia; Pereira, Joana L.; Arminda Pedrosa, M.; Goncalves, Fernando; Castro, Bruno B.			Competitive Outcome of Daphnia-Simocephalus Experimental Microcosms: Salinity versus Priority Effects	PLOS ONE			English	Article							FRESH-WATER ZOOPLANKTON; LIFE-HISTORY; INTERSPECIFIC COMPETITION; ESTABLISHMENT SUCCESS; RELATIVE IMPORTANCE; CHRONIC RESPONSES; POPULATIONS; COMMUNITIES; INCREASES; GRADIENT	Competition is a major driving force in freshwaters, especially given the cyclic nature and dynamics of pelagic food webs. Competition is especially important in the initial species assortment during colonization and re-colonization events, which depends strongly on the environmental context. Subtle changes, such as saline intrusion, may disrupt competitive relationships and, thus, influence community composition. Bearing this in mind, our objective was to assess whether low salinity levels (using NaCl as a proxy) alter the competitive outcome (measured as the rate of population biomass increase) of Daphnia-Simocephalus experimental microcosms, taking into account interactions with priority effects (sequential species arrival order). With this approach, we aimed to experimentally demonstrate a putative mechanism of differential species sorting in brackish environments or in freshwaters facing secondary salinization. Experiments considered three salinity levels, regarding NaCl added (0.00, 0.75 and 1.50 g L-1), crossed with three competition scenarios (no priority, priority of Daphnia over Simocephalus, and vice-versa). At lower NaCl concentrations (0.00 and 0.75 g L-1), Daphnia was a significantly superior competitor, irrespective of the species inoculation order, suggesting negligible priority effects. However, the strong decrease in Daphnia population growth at 1.50 g L-1 alleviated the competitive pressure on Simocephalus, causing an inversion of the competitive outcome in favour of Simocephalus. The intensity of this inversion depended on the competition scenario. This salinity-mediated disruption of the competitive outcome demonstrates that subtle environmental changes produce indirect effects in key ecological mechanisms, thus altering community composition, which may lead to serious implications in terms of ecosystem functioning (e. g. lake regime shifts due to reduced grazing) and biodiversity.	[Loureiro, Claudia; Pereira, Joana L.; Goncalves, Fernando; Castro, Bruno B.] Univ Aveiro, Dept Biol, P-3800 Aveiro, Portugal; [Loureiro, Claudia; Pereira, Joana L.; Goncalves, Fernando; Castro, Bruno B.] Univ Aveiro, CESAM, P-3800 Aveiro, Portugal; [Arminda Pedrosa, M.] Univ Coimbra, Dept Quim, Fac Ciencias & Tecnol, Unidade I&D Quim Fis Mol FC 70 94, Coimbra, Portugal	Universidade de Aveiro; Universidade de Aveiro; Universidade de Coimbra	Castro, BB (corresponding author), Univ Aveiro, Dept Biol, P-3800 Aveiro, Portugal.	brunocastro@ua.pt	Castro, Bruno Branco/B-7552-2008; Gonçalves, Fernando J. M./B-8000-2008; Pereira, Joana Luísa/A-5003-2009	Castro, Bruno Branco/0000-0002-7130-6061; Gonçalves, Fernando J. M./0000-0002-9326-187X; Pereira, Joana Luísa/0000-0001-7573-6184; Loureiro, Claudia/0000-0002-0007-9551; Pedrosa/0000-0002-0146-067X	FCT - Fundacao para a Ciencia e a Tecnologia (Portugal) [SFRH/BD/36333/2007, SFRH/BPD/44733/2008]; Human Potential Operational Programme; European Social Fund (European Union); CESAM; FEDER through COMPETE-Programa Operacional Factores de Competitividade [PTDC/AAC-AMB/104532/2008]; FCT; Fundação para a Ciência e a Tecnologia [PTDC/AAC-AMB/104532/2008] Funding Source: FCT	FCT - Fundacao para a Ciencia e a Tecnologia (Portugal)(Portuguese Foundation for Science and Technology); Human Potential Operational Programme; European Social Fund (European Union); CESAM; FEDER through COMPETE-Programa Operacional Factores de Competitividade; FCT(Portuguese Foundation for Science and TechnologyEuropean Commission); Fundação para a Ciência e a Tecnologia	This work was supported by FCT - Fundacao para a Ciencia e a Tecnologia (Portugal) in the form of a PhD grant to Claudia Loureiro (SFRH/BD/36333/2007) and a post-doctoral grant to Joana L. Pereira (SFRH/BPD/44733/2008). Bruno B. Castro is hired under the programme Ciencia2008 (FCT, Portugal), co-funded by the Human Potential Operational Programme (National Strategic Reference Framework 2007-2013) and European Social Fund (European Union). This work was also partly funded by CESAM, via internal funding (kick-off projects for young researchers) granted to Bruno B. Castro. This work is also part of the project Saltfree (PTDC/AAC-AMB/104532/2008), which is funded by FEDER through COMPETE-Programa Operacional Factores de Competitividade, by national funding from FCT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamczuk M, 2010, ANN LIMNOL-INT J LIM, V46, P241, DOI 10.1051/limn/2010022; Alonso M., 1996, FAUNA IBERICA CRUSTA; Antunes SC, 2004, ENVIRON POLLUT, V127, P367, DOI 10.1016/j.envpol.2003.08.015; Antunes SC, 2003, ACTA OECOL, V24, pS325, DOI 10.1016/S1146-609X(03)00026-2; ASTM, 1980, E72980 ASTM; Balayla DJ, 2004, ARCH HYDROBIOL, V161, P199, DOI 10.1127/0003-9136/2004/0161-0199; Beklioglu M, 2007, HYDROBIOLOGIA, V584, P317, DOI 10.1007/s10750-007-0577-x; BENGTSSON J, 1986, J ANIM ECOL, V55, P641, DOI 10.2307/4745; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; BOTTRELL HH, 1976, NORW J ZOOL, V24, P419; Brucet S, 2010, LIMNOL OCEANOGR, V55, P1697, DOI 10.4319/lo.2010.55.4.1697; Brucet S, 2009, ECOGRAPHY, V32, P692, DOI 10.1111/j.1600-0587.2009.05823.x; Caceres CE, 1998, OECOLOGIA, V115, P233, DOI 10.1007/s004420050512; Chen ZH, 2004, J HYDROL, V290, P43, DOI 10.1016/j.jhydrol.2003.11.029; Crump BC, 2004, APPL ENVIRON MICROB, V70, P1494, DOI 10.1128/AEM.70.3.1494-1505.2004; De Meester L, 2002, ACTA OECOL, V23, P121, DOI 10.1016/S1146-609X(02)01145-1; De Meester L, 2007, OECOLOGIA, V153, P431, DOI 10.1007/s00442-007-0721-3; Distel CA, 2011, ECOTOXICOLOGY, V20, P875, DOI 10.1007/s10646-011-0651-z; Emery NC, 2001, ECOLOGY, V82, P2471, DOI 10.1890/0012-9658(2001)082[2471:CASMPZ]2.0.CO;2; EPA, 2002, METH MEAS AC TOX EFF; GLIWICZ ZM, 1990, NATURE, V343, P638, DOI 10.1038/343638a0; Goncalves AMM, 2007, ANN LIMNOL-INT J LIM, V43, P13, DOI 10.1051/limn/2007022; Hairston NG, 1996, LIMNOL OCEANOGR, V41, P1087, DOI 10.4319/lo.1996.41.5.1087; Hall CJ, 2002, FRESHWATER BIOL, V47, P451, DOI 10.1046/j.1365-2427.2002.00815.x; Hessen DO, 1996, POLAR BIOL, V16, P573; HUTCHINSON GE, 1961, AM NAT, V95, P137, DOI 10.1086/282171; IPCC, 2008, CLIM CHANG WAT TECHN; Jeppesen E, 2007, ECOSYSTEMS, V10, P47, DOI 10.1007/s10021-006-9007-6; Kreutzer C, 1999, ECOLOGY, V80, P2348, DOI 10.2307/176915; Loeuille N, 2008, AM NAT, V171, P788, DOI 10.1086/587745; Louette G, 2006, LIMNOL OCEANOGR, V51, P1021, DOI 10.4319/lo.2006.51.2.1021; Louette G, 2007, OIKOS, V116, P419, DOI 10.1111/j.2006.0030-1299.15381.x; Loureiro C, 2013, HYDROBIOLOGIA, V702, P73, DOI 10.1007/s10750-012-1308-5; Loureiro C, 2012, ANN LIMNOL-INT J LIM, V48, P95, DOI 10.1051/limn/2012002; Loureiro C, 2011, ECOTOXICOLOGY, V20, P139, DOI 10.1007/s10646-010-0565-1; McCauley E., 1984, IBP HDB, P228; Mergeay J, 2011, ECOLOGY, V92, P2267, DOI 10.1890/10-1645.1; Nandini S, 2007, AQUAT ECOL, V41, P547, DOI 10.1007/s10452-007-9116-0; Nielsen DL, 2008, MAR FRESHWATER RES, V59, P549, DOI 10.1071/MF07166; Nielsen DL, 2009, CLIMATIC CHANGE, V95, P523, DOI 10.1007/s10584-009-9564-8; Pike N, 2011, METHODS ECOL EVOL, V2, P278, DOI 10.1111/j.2041-210X.2010.00061.x; Piscart C, 2005, HYDROBIOLOGIA, V551, P227, DOI 10.1007/s10750-005-4463-0; Quinn GP, 2003, EXPT DESIGN DATA ANA; Santangelo JM, 2008, MAR FRESHWATER RES, V59, P808, DOI 10.1071/MF08026; Sarma SSS, 2006, AQUAT ECOL, V40, P349, DOI 10.1007/s10452-006-9039-1; Schallenberg M, 2003, MAR ECOL PROG SER, V251, P181, DOI 10.3354/meps251181; Semenchenko VP, 2007, HYDROBIOLOGIA, V579, P219, DOI 10.1007/s10750-006-0411-x; SOMMER U, 1986, ARCH HYDROBIOL, V106, P433; Stampfli NC, 2011, AQUAT TOXICOL, V104, P116, DOI 10.1016/j.aquatox.2011.04.004; Tautz D, 2011, BMC BIOL, V9, DOI 10.1186/1741-7007-9-8; van Gremberghe I, 2009, ENVIRON MICROBIOL, V11, P2564, DOI 10.1111/j.1462-2920.2009.01981.x; Watkins J, 2011, CORNELL BIOL FIELD S; WILSON SD, 1986, ECOLOGY, V67, P1236, DOI 10.2307/1938679; Wittebolle L, 2009, NATURE, V458, P623, DOI 10.1038/nature07840	54	26	26	1	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2013	8	8							e70572	10.1371/journal.pone.0070572	http://dx.doi.org/10.1371/journal.pone.0070572			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	218XC	23940594	gold, Green Published, Green Submitted			2022-12-25	WOS:000324465000088
J	Mallik, S; Kundu, S				Mallik, Saurav; Kundu, Sudip			A Comparison of Structural and Evolutionary Attributes of Escherichia coli and Thermus thermophilus Small Ribosomal Subunits: Signatures of Thermal Adaptation	PLOS ONE			English	Article							AMINO-ACID-COMPOSITION; ANGSTROM RESOLUTION; PROTEIN SEQUENCES; CRYSTAL-STRUCTURE; ATOMIC-STRUCTURE; RNA; DISORDER; TEMPERATURE; PACKING; PROKARYOTES	Here we compare the structural and evolutionary attributes of Thermus thermophilus and Escherichia coli small ribosomal subunits (SSU). Our results indicate that with few exceptions, thermophilic 16S ribosomal RNA (16S rRNA) is densely packed compared to that of mesophilic at most of the analogous spatial regions. In addition, we have located species-specific cavity clusters (SSCCs) in both species. E. coli SSCCs are numerous and larger compared to T. thermophilus SSCCs, which again indicates densely packed thermophilic 16S rRNA. Thermophilic ribosomal proteins (r-proteins) have longer disordered regions than their mesophilic homologs and they experience larger disorder-to-order transitions during SSU-assembly. This is reflected in the predicted higher conformational changes of thermophilic r-proteins compared to their mesophilic homologs during SSU-assembly. This high conformational change of thermophilic r-proteins may help them to associate with the 16S ribosomal RNA with high complementary interfaces, larger interface areas, and denser molecular contacts, compared to those of mesophilic. Thus, thermophilic protein-rRNA interfaces are tightly associated with 16S rRNA than their mesophilic homologs. Densely packed 16S rRNA interior and tight protein-rRNA binding of T. thermophilus (compared to those of E. coli) are likely the signatures of its thermal adaptation. We have found a linear correlation between the free energy of protein-RNA interface formation, interface size, and square of conformational changes, which is followed in both prokaryotic and eukaryotic SSU. Disorder is associated with high protein-RNA interface polarity. We have found an evolutionary tendency to maintain high polarity (thereby disorder) at protein-rRNA interfaces, than that at rest of the protein structures. However, some proteins exhibit exceptions to this general trend.	[Mallik, Saurav; Kundu, Sudip] Univ Calcutta, Dept Biophys Mol Biol & Bioinformat, Kolkata, India	University of Calcutta	Kundu, S (corresponding author), Univ Calcutta, Dept Biophys Mol Biol & Bioinformat, Kolkata, India.	skbmbg@caluniv.ac.in	Mallik, Saurav/AAF-1447-2020	Mallik, Saurav/0000-0002-9390-0715				Ban N, 2000, SCIENCE, V289, P905, DOI 10.1126/science.289.5481.905; Bellay J, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-2-r14; Brodersen DE, 2002, J MOL BIOL, V316, P725, DOI 10.1006/jmbi.2001.5359; Burra PV, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012069; Chen K, 2012, J PHYS CHEM B, V116, P6819, DOI 10.1021/jp212614b; CONNOLLY ML, 1986, INT J PEPT PROT RES, V28, P360; Friedman R, 2004, GENETICS, V167, P1507, DOI 10.1534/genetics.104.026344; Galtier N, 1997, J MOL EVOL, V44, P632, DOI 10.1007/PL00006186; Gunasekaran K, 2003, TRENDS BIOCHEM SCI, V28, P81, DOI 10.1016/S0968-0004(03)00003-3; HELD WA, 1974, J BIOL CHEM, V249, P3103; Hickey DA, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-117; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; JANIN J, 1988, J MOL BIOL, V204, P155, DOI 10.1016/0022-2836(88)90606-7; Jeffares DC, 1998, J MOL EVOL, V46, P18, DOI 10.1007/PL00006280; Karshikoff A, 1998, PROTEIN ENG, V11, P867, DOI 10.1093/protein/11.10.867; Klein DJ, 2004, J MOL BIOL, V340, P141, DOI 10.1016/j.jmb.2004.03.076; Korostelev A, 2006, CELL, V126, P1065, DOI 10.1016/j.cell.2006.08.032; Krissinel E, 2005, LECT NOTES COMPUT SC, V3695, P163; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Lee C, 2000, P NATL ACAD SCI USA, V97, P7727, DOI 10.1073/pnas.97.14.7727; Linding R, 2003, NUCLEIC ACIDS RES, V31, P3701, DOI 10.1093/nar/gkg519; Linding R, 2003, STRUCTURE, V11, P1453, DOI 10.1016/j.str.2003.10.002; Lo Conte L, 1999, J MOL BIOL, V285, P2177; Marsh JA, 2011, STRUCTURE, V19, P859, DOI 10.1016/j.str.2011.03.010; McDonald JH, 2010, GENOME BIOL EVOL, V2, P267, DOI 10.1093/gbe/evq017; Mulder AM, 2010, SCIENCE, V330, P673, DOI 10.1126/science.1193220; NIERHAUS KH, 1991, BIOCHIMIE, V73, P739, DOI 10.1016/0300-9084(91)90054-5; Noller HF, 2002, BIOCHEM SOC T, V30, P1159, DOI 10.1042/BST0301159; NOMURA M, 1969, COLD SPRING HARB SYM, V34, P49, DOI 10.1101/SQB.1969.034.01.009; Pack SP, 2005, INT J BIOL MACROMOL, V35, P169, DOI 10.1016/j.ijbiomac.2005.01.007; Razvi A, 2006, PROTEIN SCI, V15, P1569, DOI 10.1110/ps.062130306; Scandurra R, 1998, BIOCHIMIE, V80, P933, DOI 10.1016/S0300-9084(00)88890-2; Schluenzen F, 2000, CELL, V102, P615, DOI 10.1016/S0092-8674(00)00084-2; Schuwirth BS, 2005, SCIENCE, V310, P827, DOI 10.1126/science.1117230; Singer GAC, 2000, MOL BIOL EVOL, V17, P1581, DOI 10.1093/oxfordjournals.molbev.a026257; Singer GAC, 2003, GENE, V317, P39, DOI 10.1016/S0378-1119(03)00660-7; Sonavane S, 2009, NUCLEIC ACIDS RES, V37, P4613, DOI 10.1093/nar/gkp488; Sonavane S, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000188; STERN S, 1989, SCIENCE, V244, P783, DOI 10.1126/science.2658053; Szilagyi A, 2008, BIOPHYS J, V95, P1612, DOI 10.1529/biophysj.108.131151; VENYAMINOV SY, 1982, EUR J BIOCHEM, V126, P299; Vishwanath P, 2004, MOL PHYLOGENET EVOL, V33, P615, DOI 10.1016/j.ympev.2004.07.003; Vuzman D, 2010, P NATL ACAD SCI USA, V107, P21004, DOI 10.1073/pnas.1011775107; Wimberly BT, 2000, NATURE, V407, P327, DOI 10.1038/35030006; WOESE CR, 1980, NUCLEIC ACIDS RES, V8, P2275, DOI 10.1093/nar/8.10.2275	46	11	11	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2013	8	8							e69898	10.1371/journal.pone.0069898	http://dx.doi.org/10.1371/journal.pone.0069898			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	218XC	23940533	Green Published, gold, Green Submitted			2022-12-25	WOS:000324465000027
J	Monteiro, FA; Peretolchina, T; Lazoski, C; Harris, K; Dotson, EM; Abad-Franch, F; Tamayo, E; Pennington, PM; Monroy, C; Cordon-Rosales, C; Salazar-Schettino, PM; Gomez-Palacio, A; Grijalva, MJ; Beard, CB; Marcet, PL				Monteiro, Fernando A.; Peretolchina, Tatiana; Lazoski, Cristiano; Harris, Kecia; Dotson, Ellen M.; Abad-Franch, Fernando; Tamayo, Elsa; Pennington, Pamela M.; Monroy, Carlota; Cordon-Rosales, Celia; Maria Salazar-Schettino, Paz; Gomez-Palacio, Andres; Grijalva, Mario J.; Beard, Charles B.; Marcet, Paula L.			Phylogeographic Pattern and Extensive Mitochondrial DNA Divergence Disclose a Species Complex within the Chagas Disease Vector Triatoma dimidiata	PLOS ONE			English	Article							PHYLOGENETIC-RELATIONSHIPS; EVOLUTIONARY RATES; MAXIMUM-LIKELIHOOD; GENETIC-VARIATION; REDUVIIDAE; HEMIPTERA; POPULATIONS; GUATEMALA; LATREILLE; ECUADOR	Background: Triatoma dimidiata is among the main vectors of Chagas disease in Latin America. However, and despite important advances, there is no consensus about the taxonomic status of phenotypically divergent T. dimidiata populations, which in most recent papers are regarded as subspecies. Methodology and Findings: A total of 126 cyt b sequences (621 bp long) were produced for specimens from across the species range. Forty-seven selected specimens representing the main cyt b clades observed (after a preliminary phylogenetic analysis) were also sequenced for an ND4 fragment (554 bp long) and concatenated with their respective cyt b sequences to produce a combined data set totalling 1175 bp/individual. Bayesian and Maximum-Likelihood phylogenetic analyses of both data sets (cyt b, and cyt b+ND4) disclosed four strongly divergent (all pairwise Kimura 2-parameter distances >0.08), monophyletic groups: Group I occurs from Southern Mexico through Central America into Colombia, with Ecuadorian specimens resembling Nicaraguan material; Group II includes samples from Western-Southwestern Mexico; Group III comprises specimens from the Yucatan peninsula; and Group IV consists of sylvatic samples from Belize. The closely-related, yet formally recognized species T. hegneri from the island of Cozumel falls within the divergence range of the T. dimidiata populations studied. Conclusions: We propose that Groups I-IV, as well as T. hegneri, should be regarded as separate species. In the Peten of Guatemala, representatives of Groups I, II, and III occur in sympatry; the absence of haplotypes with intermediate genetic distances, as shown by multimodal mismatch distribution plots, clearly indicates that reproductive barriers actively promote within-group cohesion. Some sylvatic specimens from Belize belong to a different species - likely the basal lineage of the T. dimidiata complex, originated similar to 8.25 Mya. The evidence presented here strongly supports the proposition that T. dimidiata is a complex of five cryptic species (Groups I-IV plus T. hegneri) that play different roles as vectors of Chagas disease in the region.	[Monteiro, Fernando A.] Fiocruz MS, Lab Epidemiol & Sistema Mol, Inst Oswaldo Cruz, BR-21045900 Rio De Janeiro, Brazil; [Peretolchina, Tatiana] Russian Acad Sci, Inst Limnol, Lab Mol Systemat, Siberian Branch, Irkutsk 664003, Russia; [Lazoski, Cristiano] Univ Fed Rio de Janeiro, Inst Biol, Rio De Janeiro, Brazil; [Harris, Kecia; Dotson, Ellen M.; Marcet, Paula L.] Ctr Dis Control & Prevent, Div Parasit Dis & Malaria, Entomol Branch, Atlanta, GA USA; [Abad-Franch, Fernando] Fiocruz Amazonia, Inst Leonidas & Maria Deane, Manaus, Amazonas, Brazil; [Tamayo, Elsa] Univ Guadalajara, Area Entomol Med, Ctr Univ Sur, Ciudad Guzman, Mexico; [Pennington, Pamela M.] Univ Valle Guatemala, Ctr Hlth Studies, Guatemala City, Guatemala; [Monroy, Carlota] Univ San Carlos, Fac Ciencias Quim & Farm, Lab Appl Entomol & Parasitol, Ciudad De Guatemala, Guatemala; [Maria Salazar-Schettino, Paz] Univ Nacl Autonoma Mexico, Lab Biol Parasitos, Dept Microbiol & Parasitol, Ciudad De Mexico, Mexico; [Gomez-Palacio, Andres] Univ Antioquia, Inst Biol, Grp Biol & Control Enfermedades Infecc, Medellin, Colombia; [Grijalva, Mario J.] Ohio Univ, Trop Dis Inst, Dept Biomed Sci, Heritage Coll Osteopath Med, Athens, OH 45701 USA; [Beard, Charles B.] Ctr Dis Control & Prevent, Div Vector Borne Infect Dis, Ft Collins, CO USA	Fundacao Oswaldo Cruz; Irkutsk Science Centre of the Russian Academy of Sciences; Russian Academy of Sciences; Limnological Institute SB RAS; Universidade Federal do Rio de Janeiro; Centers for Disease Control & Prevention - USA; Fundacao Oswaldo Cruz; Universidad de Guadalajara; Universidad del Valle de Guatemala; Universidad de San Carlos de Guatemala; Universidad Nacional Autonoma de Mexico; Universidad de Antioquia; University System of Ohio; Ohio University; Centers for Disease Control & Prevention - USA	Monteiro, FA (corresponding author), Fiocruz MS, Lab Epidemiol & Sistema Mol, Inst Oswaldo Cruz, BR-21045900 Rio De Janeiro, Brazil.	fermonte@globo.com	Abad-Franch, Fernando/L-4741-2013; Peretolchina, Tatiana/AAQ-1563-2020; Tamayo-Legorreta, Elsa María/ABW-2021-2022; Grijalva, Mario J/U-8356-2018; Abad-Franch, Fernando/AAG-2432-2020; Lazoski, Cristiano/H-6192-2013; Abad-Franch, Fernando/AAB-6729-2021; marcet, Paula L/B-1758-2012; Salazar-Schettino, Paz Maria/GRY-2001-2022; Lazoski, Cristiano/U-5549-2019	Grijalva, Mario J/0000-0003-1964-1425; Abad-Franch, Fernando/0000-0002-7715-0328; Salazar-Schettino, Paz Maria/0000-0001-8490-5293; Gomez-Palacio, Andres/0000-0002-1069-9199; Lazoski, Cristiano/0000-0002-6322-4672; Marcet, Paula L/0000-0002-0676-3020	CODI-Universidad de Antioquia [CPT-0812]; COLCIENCIAS [111545921460]; Brazilian National Research Council, CNPq; Direct For Biological Sciences [1216193] Funding Source: National Science Foundation	CODI-Universidad de Antioquia; COLCIENCIAS(Departamento Administrativo de Ciencia, Tecnologia e Innovacion Colciencias); Brazilian National Research Council, CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	AGP received support from CODI-Universidad de Antioquia (project CPT-0812), and COLCIENCIAS (project #111545921460). This work received support from the Brazilian National Research Council, CNPq. The findings and conclusions in this manuscript are those of the authors and do not necessarily represent the views of the Centers for Disease Control and Prevention. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abad-Franch F, 2001, MEM I OSWALDO CRUZ, V96, P611, DOI 10.1590/S0074-02762001000500004; Acevedo F, 2000, MEM I OSWALDO CRUZ, V95, P867, DOI 10.1590/S0074-02762000000600022; Akaike H., 1973, 2 INT S INF THEOR, P267, DOI DOI 10.1007/978-1-4612-1694-0_15; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Bevan RB, 2005, SYST BIOL, V54, P900, DOI 10.1080/10635150500354829; Bustamante DM, 2004, J MED ENTOMOL, V41, P296, DOI 10.1603/0022-2585-41.3.296; Calderon CI, 2004, J MED ENTOMOL, V41, P882, DOI 10.1603/0022-2585-41.5.882; Calderon-Fernandez GM, 2011, J MED ENTOMOL, V48, P262, DOI 10.1603/ME10141; Catala S, 2005, J MED ENTOMOL, V42, P719, DOI 10.1603/0022-2585(2005)042[0719:APOTDP]2.0.CO;2; Costa J, 2007, MEM I OSWALDO CRUZ, V102, P87, DOI 10.1590/S0074-02762007000100015; Costa Jane, 2006, Zootaxa, V1385, P47; Devitt TJ, 2006, MOL ECOL, V15, P4387, DOI 10.1111/j.1365-294X.2006.03015.x; Dias JCP, 2007, MEM I OSWALDO CRUZ, V102, P11, DOI 10.1590/S0074-02762007005000092; Bargues MD, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000233; Dorn PL, 2007, INFECT GENET EVOL, V7, P343, DOI 10.1016/j.meegid.2006.10.001; Dorn PL, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000393; Dotson EM, 2001, INSECT MOL BIOL, V10, P205, DOI 10.1046/j.1365-2583.2001.00258.x; Drummond AJ, 2007, ROUGH GUIDE BEAST 1; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Dumonteil E, 2002, AM J TROP MED HYG, V67, P176, DOI 10.4269/ajtmh.2002.67.176; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Fernandez GC, 2005, J MED ENTOMOL, V42, P780, DOI 10.1603/0022-2585(2005)042[0780:CHVATD]2.0.CO;2; Gonzalez C, 2011, BMC EVOL BIOL, V11; Grijalva MJ, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-20; Grijalva MJ, 2010, MEM I OSWALDO CRUZ, V105, P677, DOI 10.1590/S0074-02762010000500013; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; HASEGAWA M, 1985, J MOL EVOL, V22, P160, DOI 10.1007/BF02101694; Herrera-Aguilar M, 2009, INFECT GENET EVOL, V9, P1345, DOI 10.1016/j.meegid.2009.09.009; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Lee Julian C., 1996; LENT H, 1979, Bulletin of the American Museum of Natural History, V163, P123; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Marcilla A, 2001, MOL PHYLOGENET EVOL, V18, P136, DOI 10.1006/mpev.2000.0864; Monroy Carlota, 1998, Medical Entomology and Zoology, V49, P195; Monroy MC, 2003, J MED ENTOMOL, V40, P800, DOI 10.1603/0022-2585-40.6.800; Monteiro FA, 2004, MOL PHYLOGENET EVOL, V32, P46, DOI 10.1016/j.ympev.2003.12.011; Monteiro FA, 2003, MOL ECOL, V12, P997, DOI 10.1046/j.1365-294X.2003.01802.x; Panzera F, 2006, TROP MED INT HEALTH, V11, P1092, DOI 10.1111/j.1365-3156.2006.01656.x; Peakall R, 2006, MOL ECOL NOTES, V6, P288, DOI 10.1111/j.1471-8286.2005.01155.x; Peterson AT, 1999, SCIENCE, V285, P1265, DOI 10.1126/science.285.5431.1265; Pfeiler E, 2006, MOL PHYLOGENET EVOL, V41, P209, DOI 10.1016/j.ympev.2006.07.001; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Rambaut A., 2007, TRACER V1 4; TAJIMA F, 1989, GENETICS, V123, P585; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Telleria J, 2010, AM TRYPANOSOMIASIS C, P848; Usinger RL, 1944, PUB HLTH B, P82; USINGER ROBERT L., 1941, PAN PACIFIC ENT, V17, P49; WHO, 2002, WHO TECHN REP SER, V905, P40; World Health Organization, 2006, REP SCI WORK GROUP C, P7; World Health Organization (WHO), 2020, CHAG DIS AM TRYP; ZELEDON R, 1981, ANNU REV ENTOMOL, V26, P101, DOI 10.1146/annurev.en.26.010181.000533; Zeledon R, 1981, TRIATOMA DIMIDIATA L	54	57	58	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2013	8	8							e70974	10.1371/journal.pone.0070974	http://dx.doi.org/10.1371/journal.pone.0070974			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	218XC	23940678	Green Published, gold, Green Submitted			2022-12-25	WOS:000324465000166
J	Muturi, EJ; Orindi, BO; Kim, CH				Muturi, Ephantus J.; Orindi, Benedict O.; Kim, Chang-Hyun			Effect of Leaf Type and Pesticide Exposure on Abundance of Bacterial Taxa in Mosquito Larval Habitats	PLOS ONE			English	Article							MICROBIAL COMMUNITY; SEDIMENT MICROBES; VECTOR CONTROL; DETRITUS TYPE; SOILS; DIVERSITY; DYNAMICS; COMBINATION; COMPETITION; GLYPHOSATE	Lentic freshwater systems including those inhabited by aquatic stages of mosquitoes derive most of their carbon inputs from terrestrial organic matter mainly leaf litter. The leaf litter is colonized by microbial communities that provide the resource base for mosquito larvae. While the microbial biomass associated with different leaf species in container aquatic habitats is well documented, the taxonomic composition of these microbes and their response to common environmental stressors is poorly understood. We used indoor aquatic microcosms to determine the abundances of major taxonomic groups of bacteria in leaf litters from seven plant species and their responses to low concentrations of four pesticides with different modes of action on the target organisms; permethrin, malathion, atrazine and glyphosate. We tested the hypotheses that leaf species support different quantities of major taxonomic groups of bacteria and that exposure to pesticides at environmentally relevant concentrations alters bacterial abundance and community structure in mosquito larval habitats. We found support for both hypotheses suggesting that leaf litter identity and chemical contamination may alter the quality and quantity of mosquito food base (microbial communities) in larval habitats. The effect of pesticides on microbial communities varied significantly among leaf types, suggesting that the impact of pesticides on natural microbial communities may be highly complex and difficult to predict. Collectively, these findings demonstrate the potential for detritus composition within mosquito larval habitats and exposure to pesticides to influence the quality of mosquito larval habitats.	[Muturi, Ephantus J.; Kim, Chang-Hyun] Univ Illinois, Illinois Nat Hist Survey, Urbana, IL 61801 USA; [Orindi, Benedict O.] Int Ctr Insect Physiol & Ecol, Biostat Unit, Nairobi, Kenya	Illinois Natural History Survey; University of Illinois System; University of Illinois Urbana-Champaign; International Centre of Insect Physiology & Ecology (ICIPE)	Muturi, EJ (corresponding author), Univ Illinois, Illinois Nat Hist Survey, Urbana, IL 61801 USA.	ephajumu@yahoo.com		Orindi, Benedict/0000-0002-4601-7890	Used Tire Fund from State of Illinois; Emergency Public Health Fund from State of Illinois; USDA National Institute of Food and Agriculture [875-334]	Used Tire Fund from State of Illinois; Emergency Public Health Fund from State of Illinois; USDA National Institute of Food and Agriculture(United States Department of Agriculture (USDA))	This study was supported by the Used Tire Fund and Emergency Public Health Fund from the State of Illinois and USDA National Institute of Food and Agriculture, Hatch project number 875-334. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Araujo ASF, 2003, CHEMOSPHERE, V52, P799, DOI 10.1016/S0045-6535(03)00266-2; BALTHAZOR TM, 1986, APPL ENVIRON MICROB, V51, P432, DOI 10.1128/AEM.51.2.432-434.1986; Chen SK, 2001, SOIL BIOL BIOCHEM, V33, P1971, DOI 10.1016/S0038-0717(01)00131-6; Ding YP, 2010, ENVIRON TOXICOL CHEM, V29, P149, DOI 10.1002/etc.13; El Fantroussi S, 1999, APPL ENVIRON MICROB, V65, P982; Fierer N, 2005, APPL ENVIRON MICROB, V71, P4117, DOI 10.1128/AEM.71.7.4117-4120.2005; FISH D, 1982, ECOLOGY, V63, P283, DOI 10.2307/1938943; Gilliom R. J., 2007, 1291 US GEOL SURV; Gilliom Robert J, 2007, Environ Sci Technol, V41, P3408, DOI 10.1021/es072531u; Girvan MS, 2004, APPL ENVIRON MICROB, V70, P2692, DOI 10.1128/AEM.70.5.2692-2701.2004; Hill CA, 2005, NAT REV MICROBIOL, V3, P262, DOI 10.1038/nrmicro1101; Johnsen K, 2001, BIOL FERT SOILS, V33, P443, DOI 10.1007/s003740100351; Kaufman MG, 2008, MICROB ECOL, V55, P673, DOI 10.1007/s00248-007-9310-6; Kaufman MG, 2006, J MED ENTOMOL, V43, P669, DOI 10.1603/0022-2585(2006)43[669:IOABTG]2.0.CO;2; Kitching R.L., 2000, FOOD WEBS CONTAINER, DOI [10.1017/CBO9780511542107, DOI 10.1017/CBO9780511542107]; Klappenbach JA, 2001, NUCLEIC ACIDS RES, V29, P181, DOI 10.1093/nar/29.1.181; Kotouckova L, 2004, INT J SYST EVOL MICR, V54, P773, DOI 10.1099/ijs.0.02923-0; Kumari A.R., 2012, J PHARM, V2, P37; Lee S, 2004, ENVIRON TOXICOL CHEM, V23, P1, DOI 10.1897/03-114; Leys NM, 2005, MICROB ECOL, V49, P443, DOI 10.1007/s00248-004-0011-0; Lupwayi NZ, 2009, AGR ECOSYST ENVIRON, V130, P109, DOI 10.1016/j.agee.2008.12.002; Martin-Laurent F, 2001, APPL ENVIRON MICROB, V67, P2354, DOI 10.1128/AEM.67.5.2354-2359.2001; MELENDEZ AL, 1993, ARCH ENVIRON CON TOX, V25, P95, DOI 10.1007/BF00230718; MERRITT RW, 1992, ANNU REV ENTOMOL, V37, P349, DOI 10.1146/annurev.en.37.010192.002025; Muller AK, 2001, FEMS MICROBIOL LETT, V204, P49, DOI 10.1016/S0378-1097(01)00376-7; Murrell EG, 2008, J MED ENTOMOL, V45, P375, DOI 10.1603/0022-2585(2008)45[375:DTATOO]2.0.CO;2; Muturi EJ, 2013, CHEMOSPHERE, DOI DOI 10.1016/J.CHEM0SPHERE.-2013.01.055; Muturi EJ, 2012, ENVIRON ENTOMOL, V41, P1062, DOI 10.1603/EN11301; Paivio J., 1999, EFFECTS MODERN PESTI; Paul D, 2006, FEMS MICROBIOL ECOL, V57, P116, DOI 10.1111/j.1574-6941.2006.00103.x; Ponnusamy L, 2008, P NATL ACAD SCI USA, V105, P9262, DOI 10.1073/pnas.0802505105; Ponnusamy L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024409; Ponnusamy L, 2010, J CHEM ECOL, V36, P709, DOI 10.1007/s10886-010-9806-2; Rasmussen LD, 2001, FEMS MICROBIOL ECOL, V36, P1, DOI 10.1111/j.1574-6941.2001.tb00820.x; Reiskind MH, 2012, B ENTOMOL RES, V102, P424, DOI 10.1017/S0007485311000861; Reiskind MH, 2009, ECOL ENTOMOL, V34, P447, DOI 10.1111/j.1365-2311.2008.01067.x; Townson H, 2005, B WORLD HEALTH ORGAN, V83, P942; WALKER ED, 1991, ECOLOGY, V72, P1529, DOI 10.2307/1940953; Widenfalk A, 2004, ENVIRON TOXICOL CHEM, V23, P1920, DOI 10.1897/03-345; Widenfalk A, 2008, ECOTOX ENVIRON SAFE, V71, P490, DOI 10.1016/j.ecoenv.2007.10.028; Widenfalk A, 2008, ENVIRON POLLUT, V152, P576, DOI 10.1016/j.envpol.2007.07.003	41	19	19	1	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2013	8	8							e71812	10.1371/journal.pone.0071812	http://dx.doi.org/10.1371/journal.pone.0071812			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	218XC	23940789	Green Published, Green Submitted, gold			2022-12-25	WOS:000324465000228
J	Nagaprashantha, LD; Talamantes, T; Singhal, J; Guo, J; Vatsyayan, R; Rauniyar, N; Awasthi, S; Singhal, SS; Prokai, L				Nagaprashantha, Lokesh Dalasanur; Talamantes, Tatjana; Singhal, Jyotsana; Guo, Jia; Vatsyayan, Rit; Rauniyar, Navin; Awasthi, Sanjay; Singhal, Sharad S.; Prokai, Laszlo			Proteomic Analysis of Signaling Network Regulation in Renal Cell Carcinomas with Differential Hypoxia-Inducible Factor-2 alpha Expression	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; STATISTICAL-MODEL; KIDNEY CANCER; MOUSE-BRAIN; IDENTIFICATION; PROTEINS; DATABASE; SORAFENIB	Background: The loss of von Hippel-Lindau (VHL) protein function leads to highly vascular renal tumors characterized by an aggressive course of disease and refractoriness to chemotherapy and radiotherapy. Loss of VHL in renal tumors also differs from tumors of other organs in that the oncogenic cascade is mediated by an increase in the levels of hypoxia-inducible factor-2 alpha (HIF2 alpha) instead of hypoxia-inducible factor-1 alpha (HIF1 alpha). Methods and Principal Findings: We used renal carcinoma cell lines that recapitulate the differences between mutant VHL and wild-type VHL genotypes. Utilizing a method relying on extracted peptide intensities as a label-free approach for quantitation by liquid chromatography-mass spectrometry, our proteomics study revealed regulation of key proteins important for cancer cell survival, proliferation and stress-resistance, and implicated differential regulation of signaling networks in VHL-mutant renal cell carcinoma. We also observed upregulation of cellular energy pathway enzymes and the stress-responsive mitochondrial 60-kDa heat shock protein. Finding reliance on glutaminolysis in VHL-mutant renal cell carcinoma was of particular significance, given the generally predominant dependence of tumors on glycolysis. The data have been deposited to the ProteomeXchange with identifier PXD000335. Conclusions and Significance: Pathway analyses provided corroborative evidence for differential regulation of molecular and cellular functions influencing cancer energetics, metabolism and cell proliferation in renal cell carcinoma with distinct VHL genotype. Collectively, the differentially regulated proteome characterized by this study can potentially guide translational research specifically aimed at effective clinical interventions for advanced VHL-mutant, HIF2 alpha-over-expressing tumors.	[Nagaprashantha, Lokesh Dalasanur; Talamantes, Tatjana; Singhal, Jyotsana; Guo, Jia; Vatsyayan, Rit; Rauniyar, Navin; Awasthi, Sanjay; Singhal, Sharad S.; Prokai, Laszlo] Univ N Texas, Hlth Sci Ctr, Dept Mol Biol & Immunol, Ft Worth, TX 76107 USA	University of North Texas System; University of North Texas Health Science Center	Prokai, L (corresponding author), Univ N Texas, Hlth Sci Ctr, Dept Mol Biol & Immunol, Ft Worth, TX 76107 USA.	Laszlo.Prokai@unthsc.edu	Rauniyar, Navin/A-3318-2016; Awasthi, Sanjay/R-4904-2019	Prokai, Laszlo/0000-0002-4559-3458	National Institutes of Health [CA077495]; Cancer Research Foundation of North Texas; Institute for Cancer Research of the University North Texas Health Science Center at Fort Worth; Joe & Jessie Crump Fund for Medical Education; Robert A. Welch Foundation [BK-0031]; NATIONAL CANCER INSTITUTE [R01CA077495] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cancer Research Foundation of North Texas; Institute for Cancer Research of the University North Texas Health Science Center at Fort Worth; Joe & Jessie Crump Fund for Medical Education; Robert A. Welch Foundation(The Welch Foundation); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported in part by the National Institutes of Health (to S. A.; grant number CA077495), by the Cancer Research Foundation of North Texas, the Institute for Cancer Research of the University North Texas Health Science Center at Fort Worth, the Joe & Jessie Crump Fund for Medical Education (to S. S. S.), and by the Robert A. Welch Foundation endowment BK-0031 (to L. P.). The opinions, findings, and conclusions or recommendations expressed in this material are those of the authors and do not necessarily reflect the views of the funding organizations. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arjumand W, 2012, TUMOR BIOL, V33, P9, DOI 10.1007/s13277-011-0257-3; Arlt VM, 2011, INT J CANCER, V128, P21, DOI 10.1002/ijc.25324; Chiou JF, 2009, CANCER BIOL THER, V8, P1904, DOI 10.4161/cbt.8.20.9436; Choi JW, 2004, CANCER RES, V64, P35, DOI 10.1158/0008-5472.CAN-03-0145; Ciocca DR, 2005, CELL STRESS CHAPERON, V10, P86, DOI 10.1379/CSC-99r.1; DeBerardinis RJ, 2008, CELL METAB, V7, P11, DOI 10.1016/j.cmet.2007.10.002; Hu CJ, 2003, MOL CELL BIOL, V23, P9361, DOI 10.1128/MCB.23.24.9361-9374.2003; Kaelin WG, 2008, NAT REV CANCER, V8, P865, DOI 10.1038/nrc2502; Keith B, 2012, NAT REV CANCER, V12, P9, DOI 10.1038/nrc3183; Keller A, 2002, ANAL CHEM, V74, P5383, DOI 10.1021/ac025747h; Kondo K, 2003, PLOS BIOL, V1, P439, DOI 10.1371/journal.pbio.0000083; Kroemer G, 2008, CANCER CELL, V13, P472, DOI 10.1016/j.ccr.2008.05.005; Lai YL, 2011, J PROTEOME RES, V10, P5175, DOI 10.1021/pr200642c; Lai YL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016975; Maxwell PH, 1999, NATURE, V399, P271, DOI 10.1038/20459; McDonald WH, 2002, DIS MARKERS, V18, P99, DOI 10.1155/2002/505397; Mnatsakanyan N, 2011, J BIOL CHEM, V286, P29788, DOI 10.1074/jbc.M111.254730; Nagaprashantha LD, 2010, J CLIN ONCOL, V28; Nesvizhskii AI, 2003, ANAL CHEM, V75, P4646, DOI 10.1021/ac0341261; Perroud B, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-64; Pfaffenroth EC, 2008, EXPERT OPIN BIOL TH, V8, P779, DOI [10.1517/14712598.8.6.779, 10.1517/14712598.8.6.779 ]; Prokai L, 2009, J PROTEOME RES, V8, P3862, DOI 10.1021/pr900083v; Schumacker PT, 2006, CANCER CELL, V10, P175, DOI 10.1016/j.ccr.2006.08.015; Shinojima T, 2007, CARCINOGENESIS, V28, P529, DOI 10.1093/carcin/bgl143; Siemeister G, 1996, CANCER RES, V56, P2299; Singh MP, 2009, TOXICOL APPL PHARM, V235, P226, DOI 10.1016/j.taap.2008.12.002; Singhal SS, 2010, INT J CANCER, V126, P1327, DOI 10.1002/ijc.24767; Soussi T, 2011, ADV CANCER RES, V110, P107, DOI 10.1016/B978-0-12-386469-7.00005-0; Stevens SM, 2008, J PROTEOME RES, V7, P1046, DOI 10.1021/pr7006279; Tennant DA, 2010, NAT REV CANCER, V10, P267, DOI 10.1038/nrc2817; Togashi A, 2005, CANCER RES, V65, P4817, DOI 10.1158/0008-5472.CAN-05-0120; Unwin RD, 2003, PROTEOMICS, V3, P1620, DOI 10.1002/pmic.200300464; Vizcaino JA, 2013, NUCLEIC ACIDS RES, V41, pD1063, DOI 10.1093/nar/gks1262; Wang Mu, 2008, Briefings in Functional Genomics & Proteomics, V7, P329, DOI 10.1093/bfgp/eln031; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309; Washburn MP, 2002, ANAL CHEM, V74, P1650, DOI 10.1021/ac015704l; Wilm M, 2009, PROTEOMICS, V9, P4590, DOI 10.1002/pmic.200900299; Wu CC, 2003, NAT BIOTECHNOL, V21, P532, DOI 10.1038/nbt819	38	8	8	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2013	8	8							e71654	10.1371/journal.pone.0071654	http://dx.doi.org/10.1371/journal.pone.0071654			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	218XC	23940778	Green Published, Green Submitted, gold			2022-12-25	WOS:000324465000221
J	Opio, A; Muyonga, M; Mulumba, N				Opio, Alex; Muyonga, Michael; Mulumba, Noordin			HIV Infection in Fishing Communities of Lake Victoria Basin of Uganda - A Cross-Sectional Sero-Behavioral Survey	PLOS ONE			English	Article								Background: Uganda's first AIDS case was reported in a fishing village. Thereafter, due to varying risk factors, the epidemic spread heterogeneously to all regions, with some populations more affected. Given the recent rising trends in HIV infection in Uganda, it is crucial to know the risk factors in different populations. The aim of this study was to determine the prevalence and risk factors of HIV infection among fishing communities. Methodology: A cross-sectional survey of 46 fishing communities was conducted in 2010. Following written consent, 911 randomly selected respondents age 15-59 years were interviewed and gave blood for HIV testing. HIV testing was conducted in the field and central laboratory according to national algorithm. Survey protocol was approved by the Science and Ethics Committee of Uganda Virus Research Institute, and cleared by Uganda National Council for Science and Technology. Data was captured by EPIINFO and statistical analysis done in SPSS. Findings: Overall HIV prevalence was 22%; there was no difference by sex (chi(2) test, p>0.05). Association with HIV infection was determined by chi(2) test, p<0.5. Never married respondents had lower HIV prevalence (6.2%) than the ever married (24.1%). HIV prevalence was lower in younger respondents, age 15-24 years (10.8%) than in age group 25 years and above (26.1%). Muslims had lower HIV prevalence (14.4%) than Christians (25.2%). HIV prevalence was higher among respondents reporting 3 or more lifetime sexual partners (25.3%) than in those reporting less numbers (10.8%). HIV prevalence was higher among uncircumcised men (27%) than in circumcised men (11%). Multivariate analysis identified 4 risk factors for HIV infection; age, religion, ever condom use and number of lifetime sexual partners. Conclusions: HIV prevalence in the surveyed communities was three times higher than of general population. This underscores the need for tailor made HIV combination prevention interventions targeting fishing communities.	[Opio, Alex; Muyonga, Michael; Mulumba, Noordin] Minist Hlth, Dept Natl Dis Control, Kampala, Uganda		Opio, A (corresponding author), Minist Hlth, Dept Natl Dis Control, Kampala, Uganda.	opioalex@infocom.co.ug			Lake Victoria Basin Commission, Arusha	Lake Victoria Basin Commission, Arusha	This study was funded by the Lake Victoria Basin Commission, Arusha. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akumu J, 2006, PREVALENCE IMPACTS H; Hladik W, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038143; Kissling E, 2005, AIDS, V19, P1939, DOI 10.1097/01.aids.0000191925.54679.94; Leslie Kish, 1965, SURVEY SAMPLING; Ministry of Health (MOH) [Uganda] and ICF Macro, 2001, UG AIDS IND SURV; Ministry of Health Uganda, 2010, SAF MAL CIRC POL; MOH, 2006, UG HIV AIDS SER SURV; Nunan F, 2007, REGIONAL SYNTHESIS S; Odongkara K, 2006, PREVALENCE HIV AIDS; Opio A, 2011, HIV SEROBEHAV SURVEY; Seeley JA, 2005, AIDS CARE, V17, P688, DOI 10.1080/09540120412331336698; SERWADDA D, 1985, LANCET, V2, P849, DOI 10.1016/S0140-6736(85)90122-9; Uganda AIDS Commission, 2007, NAT HIV AIDS STRAT P	13	56	58	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2013	8	8							e70770	10.1371/journal.pone.0070770	http://dx.doi.org/10.1371/journal.pone.0070770			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	218XC	23940638	Green Published, Green Submitted, gold			2022-12-25	WOS:000324465000130
J	Poukchanski, A; Fritz, HM; Tonkin, ML; Treeck, M; Boulanger, MJ; Boothroyd, JC				Poukchanski, Anna; Fritz, Heather M.; Tonkin, Michelle L.; Treeck, Moritz; Boulanger, Martin J.; Boothroyd, John C.			Toxoplasma gondii Sporozoites Invade Host Cells Using Two Novel Paralogues of RON2 and AMA1	PLOS ONE			English	Article							APICAL MEMBRANE ANTIGEN-1; MOVING JUNCTION; TRANSEPITHELIAL MIGRATION; PARASITOPHOROUS VACUOLE; SURFACE-ANTIGEN; INVASION; EXPRESSION; ERYTHROCYTE; PARASITES; MOTILITY	Toxoplasma gondii is an obligate intracellular parasite of the phylum Apicomplexa. The interaction of two well-studied proteins, Apical Membrane Antigen 1 (AMA1) and Rhoptry Neck protein 2 (RON2), has been shown to be critical for invasion by the asexual tachyzoite stage. Recently, two paralogues of these proteins, dubbed sporoAMA1 and sporoRON2 (or RON2L2), respectively, have been identified but not further characterized in proteomic and transcriptomic analyses of Toxoplasma sporozoites. Here, we show that sporoAMA1 and sporoRON2 localize to the apical region of sporozoites and that, in vitro, they interact specifically and exclusively, with no detectable interaction of sporoAMA1 with generic RON2 or sporoRON2 with generic AMA1. Structural studies of the interacting domains of sporoRON2 and sporoAMA1 indicate a novel pairing that is similar in overall form but distinct in detail from the previously described interaction of the generic pairing. Most notably, binding of sporoRON2 domain 3 to domains I/II of sporoAMA1 results in major alterations in the latter protein at the site of binding and allosterically in the membrane-proximal domain III of sporoAMA1 suggesting a possible role in signaling. Lastly, pretreatment of sporozoites with domain 3 of sporoRON2 substantially impedes their invasion into host cells while having no effect on tachyzoites, and vice versa for domain 3 of generic RON2 (which inhibits tachyzoite but not sporozoite invasion). These data indicate that sporozoites and tachyzoites each use a distinct pair of paralogous AMA1 and RON2 proteins for invasion into host cells, possibly due to the very different environment in which they each must function.	[Poukchanski, Anna; Treeck, Moritz; Boothroyd, John C.] Stanford Univ, Dept Microbiol & Immunol, Sch Med, Stanford, CA 94305 USA; [Fritz, Heather M.] Univ Calif Davis, Sch Vet Med, Dept Pathol Microbiol & Immunol, Davis, CA 95616 USA; [Tonkin, Michelle L.; Boulanger, Martin J.] Univ Victoria, Dept Biochem & Microbiol, Victoria, BC, Canada	Stanford University; University of California System; University of California Davis; University of Victoria	Boothroyd, JC (corresponding author), Stanford Univ, Dept Microbiol & Immunol, Sch Med, Stanford, CA 94305 USA.	john.boothroyd@stanford.edu	Treeck, Moritz/O-6662-2017; Treeck, Moritz/X-8007-2019; Treeck, Moritz/Q-9078-2019	Treeck, Moritz/0000-0002-9727-6657; Treeck, Moritz/0000-0002-9727-6657; Boothroyd, John C./0000-0001-9719-745X	National Institutes of Health (NIH) [RO1AI21423, RO1AI41014, K01OD010917]; CIHR [MOP82915]; Stanford Graduate Fellowship (SGF); Masters of Medicine Program; Natural Sciences and Engineering Research Council of Canada NSERC) Alexander Graham Bell Canada Graduate Scholarship (CGS-D3); Ventura Neale Trust Endowed PEO Scholar Award; American Heart Association; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI021423, R01AI041014] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [K01OD010917] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CIHR(Canadian Institutes of Health Research (CIHR)); Stanford Graduate Fellowship (SGF)(Stanford University); Masters of Medicine Program; Natural Sciences and Engineering Research Council of Canada NSERC) Alexander Graham Bell Canada Graduate Scholarship (CGS-D3); Ventura Neale Trust Endowed PEO Scholar Award; American Heart Association(American Heart Association); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by National Institutes of Health (NIH) grants RO1AI21423 and RO1AI41014 to JCB, and K01OD010917 to HMF and CIHR grant MOP82915 to MJB. AP is supported by a Stanford Graduate Fellowship (SGF) and the Masters of Medicine Program. MLT is supported by a Natural Sciences and Engineering Research Council of Canada (NSERC) Alexander Graham Bell Canada Graduate Scholarship (CGS-D3), and a Ventura Neale Trust Endowed PEO Scholar Award. MT is supported by a fellowship from the American Heart Association. MJB is a Michael Smith Foundation for Health Research (MSFHR) scholar and a Canada Research Chair. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AIKAWA M, 1978, J CELL BIOL, V77, P72, DOI 10.1083/jcb.77.1.72; Alexander DL, 2006, EUKARYOT CELL, V5, P1169, DOI 10.1128/EC.00040-06; Alexander DL, 2005, PLOS PATHOG, V1, P137, DOI 10.1371/journal.ppat.0010017; Bai T, 2005, P NATL ACAD SCI USA, V102, P12736, DOI 10.1073/pnas.0501808102; Barragan A, 2005, CELL MICROBIOL, V7, P561, DOI 10.1111/j.1462-5822.2005.00486.x; Barragan A, 2002, J EXP MED, V195, P1625, DOI 10.1084/jem.20020258; Battye TGG, 2011, ACTA CRYSTALLOGR D, V67, P271, DOI 10.1107/S0907444910048675; Besteiro S, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000309; Bradley PJ, 2005, J BIOL CHEM, V280, P34245, DOI 10.1074/jbc.M504158200; Brydges SD, 2000, MOL BIOCHEM PARASIT, V111, P51, DOI 10.1016/S0166-6851(00)00296-6; BURG JL, 1988, J IMMUNOL, V141, P3584; Camilleri M, 2012, NEUROGASTROENT MOTIL, V24, P503, DOI 10.1111/j.1365-2982.2012.01921.x; Collins CR, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000273; Crawford J, 2010, J BIOL CHEM, V285, P15644, DOI 10.1074/jbc.M109.092619; Dobrowolski JM, 1996, CELL, V84, P933, DOI 10.1016/S0092-8674(00)81071-5; Donahue CG, 2000, MOL BIOCHEM PARASIT, V111, P15, DOI 10.1016/S0166-6851(00)00289-9; Donald RGK, 1996, J BIOL CHEM, V271, P14010, DOI 10.1074/jbc.271.24.14010; Dubey JP, 1997, J PARASITOL, V83, P870, DOI 10.2307/3284282; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Fauquenoy S, 2008, MOL CELL PROTEOMICS, V7, P891, DOI 10.1074/mcp.M700391-MCP200; Fritz HM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029998; Fritz HM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029955; Garrison E, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1003049; Hansson GC, 2012, CURR OPIN MICROBIOL, V15, P57, DOI 10.1016/j.mib.2011.11.002; Hehl A, 1997, MOL BIOCHEM PARASIT, V89, P271, DOI 10.1016/S0166-6851(97)00126-6; Hehl AB, 2000, INFECT IMMUN, V68, P7078, DOI 10.1128/IAI.68.12.7078-7086.2000; Hoff EF, 2001, EXP PARASITOL, V97, P77, DOI 10.1006/expr.2000.4585; Keeley A, 2004, TRENDS CELL BIOL, V14, P528, DOI 10.1016/j.tcb.2004.08.002; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Lamarque M, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001276; Lebrun M, 2005, CELL MICROBIOL, V7, P1823, DOI 10.1111/j.1462-5822.2005.00646.x; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; MICHEL R, 1980, INT J PARASITOL, V10, P309, DOI 10.1016/0020-7519(80)90012-0; Mital J, 2005, MOL BIOL CELL, V16, P4341, DOI 10.1091/mbc.E05-04-0281; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Pizarro JC, 2005, SCIENCE, V308, P408, DOI 10.1126/science.1107449; Richard D, 2010, J BIOL CHEM, V285, P14815, DOI 10.1074/jbc.M109.080770; Schwarzenbacher R, 2004, ACTA CRYSTALLOGR D, V60, P1229, DOI 10.1107/S0907444904010145; SOLDATI D, 1993, SCIENCE, V260, P349, DOI 10.1126/science.8469986; Speer CA, 1995, MOL BIOCHEM PARASIT, V75, P75, DOI 10.1016/0166-6851(95)02515-4; Srinivasan P, 2011, P NATL ACAD SCI USA, V108, P13275, DOI 10.1073/pnas.1110303108; Straub KW, 2009, CELL MICROBIOL, V11, P590, DOI 10.1111/j.1462-5822.2008.01276.x; SussToby E, 1996, P NATL ACAD SCI USA, V93, P8413, DOI 10.1073/pnas.93.16.8413; Tilley M, 1997, INFECT IMMUN, V65, P4598, DOI 10.1128/IAI.65.11.4598-4605.1997; Tonkin ML, 2013, PROTEIN SCI, V22, P114, DOI 10.1002/pro.2193; Tonkin ML, 2011, SCIENCE, V333, P463, DOI 10.1126/science.1204988; Treeck M, 2009, TRENDS PARASITOL, V25, P494, DOI 10.1016/j.pt.2009.07.008; Treeck M, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000322; Tyler JS, 2011, TRENDS PARASITOL, V27, P410, DOI 10.1016/j.pt.2011.04.002; Tyler JS, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001282; Vulliez-Le Normand B, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002755; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749	53	38	41	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2013	8	8							e70637	10.1371/journal.pone.0070637	http://dx.doi.org/10.1371/journal.pone.0070637			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	218XC	23940612	Green Published, gold, Green Submitted			2022-12-25	WOS:000324465000106
J	Cao, ZH; Zhang, SZ; Wang, RK; Zhang, RF; Hao, YJ				Cao, Zhong-Hui; Zhang, Shi-Zhong; Wang, Rong-Kai; Zhang, Rui-Fen; Hao, Yu-Jin			Genome Wide Analysis of the Apple MYB Transcription Factor Family Allows the Identification of MdoMYB121 Gene Confering Abiotic Stress Tolerance in Plants	PLOS ONE			English	Article							CELL-MEMBRANE STABILITY; OVER-EXPRESSION; GLUCOSINOLATE BIOSYNTHESIS; ARABIDOPSIS-THALIANA; SALT; DROUGHT; DUPLICATION; OVEREXPRESSION; ANTHOCYANIN; EVOLUTION	The MYB proteins comprise one of the largest families of transcription factors (TFs) in plants. Although several MYB genes have been characterized to play roles in secondary metabolism, the MYB family has not yet been identified in apple. In this study, 229 apple MYB genes were identified through a genome-wide analysis and divided into 45 subgroups. A computational analysis was conducted using the apple genomic database to yield a complete overview of the MYB family, including the intron-exon organizations, the sequence features of the MYB DNA-binding domains, the carboxy-terminal motifs, and the chromosomal locations. Subsequently, the expression of 18 MYB genes, including 12 were chosen from stress-related subgroups, while another 6 ones from other subgroups, in response to various abiotic stresses was examined. It was found that several of these MYB genes, particularly MdoMYB121, were induced by multiple stresses. The MdoMYB121 was then further functionally characterized. Its predicted protein was found to be localized in the nucleus. A transgenic analysis indicated that the overexpression of the MdoMYB121 gene remarkably enhanced the tolerance to high salinity, drought, and cold stresses in transgenic tomato and apple plants. Our results indicate that the MYB genes are highly conserved in plant species and that MdoMYB121 can be used as a target gene in genetic engineering approaches to improve the tolerance of plants to multiple abiotic stresses.	[Cao, Zhong-Hui; Zhang, Shi-Zhong; Wang, Rong-Kai; Zhang, Rui-Fen; Hao, Yu-Jin] Shandong Agr Univ, State Key Lab Crop Biol, Tai An, Shandong, Peoples R China; [Cao, Zhong-Hui; Zhang, Shi-Zhong; Wang, Rong-Kai; Zhang, Rui-Fen; Hao, Yu-Jin] Shandong Agr Univ, MOA Key Lab Hort Crop Biol & Germplasm Innovat, Tai An, Shandong, Peoples R China; [Cao, Zhong-Hui; Zhang, Shi-Zhong; Wang, Rong-Kai; Zhang, Rui-Fen; Hao, Yu-Jin] Shandong Agr Univ, Coll Hort Sci & Engn, Tai An, Shandong, Peoples R China	Shandong Agricultural University; Shandong Agricultural University; Shandong Agricultural University	Hao, YJ (corresponding author), Shandong Agr Univ, State Key Lab Crop Biol, Tai An, Shandong, Peoples R China.	haoyujin@sdau.edu.cn	Zhang, Rui/GXN-3801-2022		National High Technology Research and Development Program of China [2011AA100204]; Natural Science Foundation of China [30971969]; 948 project from Ministry of Agriculture of China [2011-G21]; Program for Changjiang Scholars and Innovative Research Team in University [IRT1155]	National High Technology Research and Development Program of China(National High Technology Research and Development Program of China); Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); 948 project from Ministry of Agriculture of China; Program for Changjiang Scholars and Innovative Research Team in University(Program for Changjiang Scholars & Innovative Research Team in University (PCSIRT))	This work was supported by National High Technology Research and Development Program of China (2011AA100204), Natural Science Foundation of China (30971969), 948 project from Ministry of Agriculture of China (2011-G21) and Program for Changjiang Scholars and Innovative Research Team in University (IRT1155). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe H, 2003, PLANT CELL, V15, P63, DOI 10.1105/tpc.006130; Allan AC, 2008, TRENDS PLANT SCI, V13, P99, DOI 10.1016/j.tplants.2007.11.012; Ashraf M, 2007, ENVIRON EXP BOT, V59, P206, DOI 10.1016/j.envexpbot.2005.12.006; Bailey T L, 1994, Proc Int Conf Intell Syst Mol Biol, V2, P28; Bajji M, 2002, PLANT GROWTH REGUL, V36, P61, DOI 10.1023/A:1014732714549; Bates LS, 1973, RAPID DETERMINATION, V39, P207; Baumann K, 2007, DEVELOPMENT, V134, P1691, DOI 10.1242/dev.02836; Bowers JE, 2003, NATURE, V422, P433, DOI 10.1038/nature01521; Cannon Steven B., 2004, BMC Plant Biology, V4, P10, DOI 10.1186/1471-2229-4-10; Chen YH, 2006, PLANT MOL BIOL, V60, P107, DOI 10.1007/s11103-005-2910-y; Chinnusamy V, 2005, CROP SCI, V45, P437, DOI 10.2135/cropsci2005.0437; Cominelli E, 2005, CURR BIOL, V15, P1196, DOI 10.1016/j.cub.2005.05.048; Cominelli E, 2008, PLANT J, V53, P53, DOI 10.1111/j.1365-313X.2007.03310.x; Molinari HBC, 2007, PHYSIOL PLANTARUM, V130, P218, DOI 10.1111/j.1399-3054.2007.00909.x; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Dai XY, 2007, PLANT PHYSIOL, V143, P1739, DOI 10.1104/pp.106.094532; Dias AP, 2003, PLANT PHYSIOL, V131, P610, DOI 10.1104/pp.012047; Du H, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-106; Du H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037463; Dubos C, 2010, TRENDS PLANT SCI, V15, P573, DOI 10.1016/j.tplants.2010.06.005; Fukuda KI, 2007, BIOCHEM BIOPH RES CO, V361, P670, DOI 10.1016/j.bbrc.2007.07.088; Galbiati M, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-142; Gao JJ, 2011, MOL BIOL REP, V38, P205, DOI 10.1007/s11033-010-0096-0; Gigolashvili T, 2008, NEW PHYTOL, V177, P627, DOI 10.1111/j.1469-8137.2007.02295.x; Gigolashvili T, 2007, PLANT J, V51, P247, DOI 10.1111/j.1365-313X.2007.03133.x; Grubb CD, 2006, TRENDS PLANT SCI, V11, P89, DOI 10.1016/j.tplants.2005.12.006; Gunes A, 2007, J PLANT PHYSIOL, V164, P728, DOI 10.1016/j.jplph.2005.12.009; Guo An-Yuan, 2007, Yichuan, V29, P1023, DOI 10.1360/yc-007-1023; Halkier BA, 2006, ANNU REV PLANT BIOL, V57, P303, DOI 10.1146/annurev.arplant.57.032905.105228; Hodges DM, 1999, PLANTA, V207, P604, DOI 10.1007/s004250050524; Horie T, 2009, TRENDS PLANT SCI, V14, P660, DOI 10.1016/j.tplants.2009.08.009; Jiang CH, 2004, GENE, V326, P13, DOI 10.1016/j.gene.2003.09.049; Jiang CZ, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-7-r46; Jin HL, 1999, PLANT MOL BIOL, V41, P577, DOI 10.1023/A:1006319732410; Jung C, 2008, PLANT PHYSIOL, V146, P623, DOI 10.1104/pp.107.110981; Kent WJ, 2003, P NATL ACAD SCI USA, V100, P11484, DOI 10.1073/pnas.1932072100; Kotoda N, 2010, PLANT CELL PHYSIOL, V51, P561, DOI 10.1093/pcp/pcq021; Kranz HD, 1998, PLANT J, V16, P263, DOI 10.1046/j.1365-313x.1998.00278.x; Lai LB, 2005, PLANT CELL, V17, P2754, DOI 10.1105/tpc.105.034116; Li JG, 2006, BIOCHEM BIOPH RES CO, V341, P1155, DOI 10.1016/j.bbrc.2006.01.077; Li Q, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047576; Li WM, 2010, BIOL PLANTARUM, V54, P639, DOI 10.1007/s10535-010-0114-z; Liang YK, 2005, CURR BIOL, V15, P1201, DOI 10.1016/j.cub.2005.06.041; Lippold F, 2009, PLANT PHYSIOL, V149, P1761, DOI 10.1104/pp.108.134874; Liu JP, 2000, P NATL ACAD SCI USA, V97, P3730, DOI 10.1073/pnas.060034197; Martin C, 1997, TRENDS GENET, V13, P67, DOI 10.1016/S0168-9525(96)10049-4; Matus JT, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-83; OGATA K, 1994, CELL, V79, P639, DOI 10.1016/0092-8674(94)90549-5; PREMACHANDRA GS, 1991, J EXP BOT, V42, P167, DOI 10.1093/jxb/42.2.167; Qin YX, 2012, MOL BIOL REP, V39, P7183, DOI 10.1007/s11033-012-1550-y; Schaberg PG, 2011, FOREST ECOL MANAG, V262, P2142, DOI 10.1016/j.foreco.2011.08.004; Seo PJ, 2010, NEW PHYTOL, V186, P471, DOI 10.1111/j.1469-8137.2010.03183.x; Seo PJ, 2009, PLANT PHYSIOL, V151, P275, DOI 10.1104/pp.109.144220; Shi HZ, 2003, NAT BIOTECHNOL, V21, P81, DOI 10.1038/nbt766; Teng S, 2005, PLANT PHYSIOL, V139, P1840, DOI 10.1104/pp.105.066688; Vannini C, 2004, PLANT J, V37, P115, DOI 10.1046/j.1365-313X.2003.01938.x; Velasco R, 2010, NAT GENET, V42, P833, DOI 10.1038/ng.654; Volkov V, 2006, PLANT J, V48, P342, DOI 10.1111/j.1365-313X.2006.02876.x; Wilkins O, 2009, PLANT PHYSIOL, V149, P981, DOI 10.1104/pp.108.132795; Xie ZD, 2010, PLANT J, V64, P731, DOI 10.1111/j.1365-313X.2010.04364.x; Zhang HX, 2001, NAT BIOTECHNOL, V19, P765, DOI 10.1038/90824; Zhang SZ, 2013, PLANT GROWTH REGUL, V70, P199, DOI 10.1007/s10725-013-9787-6; Zhu JH, 2005, P NATL ACAD SCI USA, V102, P9966, DOI 10.1073/pnas.0503960102	63	119	142	14	132	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2013	8	7							e69955	10.1371/journal.pone.0069955	http://dx.doi.org/10.1371/journal.pone.0069955			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	197GU	23950843	Green Published, Green Submitted, gold			2022-12-25	WOS:000322838900119
J	Cabodevilla, AG; Sanchez-Caballero, L; Nintou, E; Boiadjieva, VG; Picatoste, F; Gubern, A; Claro, E				Cabodevilla, Ainara G.; Sanchez-Caballero, Laura; Nintou, Eleni; Boiadjieva, Violeta G.; Picatoste, Fernando; Gubern, Albert; Claro, Enrique			Cell Survival during Complete Nutrient Deprivation Depends on Lipid Droplet-fueled beta-Oxidation of Fatty Acids	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROUP-IVA PHOSPHOLIPASE-A(2); NUCLEAR-MAGNETIC-RESONANCE; VISIBLE LIPIDS; INSULIN-RESISTANCE; PERILIPIN 5; INTRACELLULAR LIPIDS; MUSCLE MITOCHONDRIA; C6 CELLS; IN-VIVO; METABOLISM	Cells exposed to stress of different origins synthesize triacylglycerols and generate lipid droplets (LD), but the physiological relevance of this response is uncertain. Using complete nutrient deprivation of cells in culture as a simple model of stress, we have addressed whether LD biogenesis has a protective role in cells committed to die. Complete nutrient deprivation induced the biogenesis of LD in human LN18 glioblastoma and HeLa cells and also in CHO and rat primary astrocytes. In all cell types, death was associated with LD depletion and was accelerated by blocking LD biogenesis after pharmacological inhibition of Group IVA phospholipase A(2) (cPLA(2)alpha) or down-regulation of ceramide kinase. Nutrient deprivation also induced beta-oxidation of fatty acids that was sensitive to cPLA(2)alpha inhibition, and cell survival in these conditions became strictly dependent on fatty acid catabolism. These results show that, during nutrient deprivation, cell viability is sustained by beta-oxidation of fatty acids that requires biogenesis and mobilization of LD.	[Cabodevilla, Ainara G.; Sanchez-Caballero, Laura; Nintou, Eleni; Boiadjieva, Violeta G.; Picatoste, Fernando; Claro, Enrique] Univ Autonoma Barcelona, Inst Neurosci, E-08193 Cerdanyola Del Valles, Spain; [Cabodevilla, Ainara G.; Sanchez-Caballero, Laura; Nintou, Eleni; Boiadjieva, Violeta G.; Picatoste, Fernando; Claro, Enrique] Univ Autonoma Barcelona, Dept Bioquim & Biol Mol, E-08193 Cerdanyola Del Valles, Spain; [Gubern, Albert] Univ Pompeu Fabra, Cell Signaling Res Grp, Dept Ciencies Expt & Salut, E-08003 Barcelona, Spain	Autonomous University of Barcelona; Autonomous University of Barcelona; Pompeu Fabra University	Claro, E (corresponding author), Univ Autonoma Barcelona, Inst Neurosci, Edifici M2,Campus UAB, E-08193 Cerdanyola Del Valles, Spain.	enrique.claro@uab.es	Gubern, Albert/C-9902-2011; Claro, Enrique/D-5612-2009	Gubern, Albert/0000-0001-6458-1498; Claro, Enrique/0000-0002-7592-7906; Gonzalez Cabodevilla, Ainara/0000-0002-4026-7637	Spanish Ministry of Economy [BFU2009-07823, BFU2012-34987]	Spanish Ministry of Economy(Spanish Government)	This work was supported in part by Spanish Ministry of Economy Grants BFU2009-07823 and BFU2012-34987).	Barba I, 1999, CANCER RES, V59, P1861; Barba I, 2001, NMR BIOMED, V14, P33, DOI 10.1002/nbm.688; Barcelo-Torns M, 2011, FEBS LETT, V585, P2300, DOI 10.1016/j.febslet.2011.05.062; Bell M, 2008, DIABETES, V57, P2037, DOI 10.2337/db07-1383; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Boren J, 2012, CELL DEATH DIFFER, V19, P1561, DOI 10.1038/cdd.2012.34; Bosma M, 2012, HISTOCHEM CELL BIOL, V137, P205, DOI 10.1007/s00418-011-0888-x; Bozza PT, 2011, PROSTAG LEUKOTR ESS, V85, P205, DOI 10.1016/j.plefa.2011.04.020; Carman GM, 2012, J BIOL CHEM, V287, P2272, DOI 10.1074/jbc.R111.323931; Carracedo A, 2013, NAT REV CANCER, V13, P227, DOI 10.1038/nrc3483; Coen PM, 2012, TRENDS ENDOCRIN MET, V23, P391, DOI 10.1016/j.tem.2012.05.009; Delikatny EJ, 2011, NMR BIOMED, V24, P592, DOI 10.1002/nbm.1661; Djouadi F, 2003, MOL GENET METAB, V78, P112, DOI 10.1016/S1096-7192(03)00017-9; Du L, 2009, J BIOL CHEM, V284, P2383, DOI 10.1074/jbc.M804396200; Farese RV, 2009, CELL, V139, P855, DOI 10.1016/j.cell.2009.11.005; FREITAS I, 1990, ANTICANCER RES, V10, P613; Freitas I, 1996, ANTICANCER RES, V16, P1491; Friedman EJ, 2011, J BIOL CHEM, V286, P30107, DOI 10.1074/jbc.M111.227256; Fujimoto T, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a004838; Goodman JM, 2008, J BIOL CHEM, V283, P28005, DOI 10.1074/jbc.R800042200; Goodman JM, 2009, J LIPID RES, V50, P2148, DOI 10.1194/jlr.R001446; Goodpaster BH, 2001, J CLIN ENDOCR METAB, V86, P5755, DOI 10.1210/jc.86.12.5755; Greenberg AS, 2011, TRENDS ENDOCRIN MET, V22, P195, DOI 10.1016/j.tem.2011.04.002; Greenberg AS, 2011, J CLIN INVEST, V121, P2102, DOI 10.1172/JCI46069; Gubern A, 2008, J BIOL CHEM, V283, P27369, DOI 10.1074/jbc.M800696200; Gubern A, 2009, J BIOL CHEM, V284, P32359, DOI 10.1074/jbc.M109.061515; Gubern A, 2009, J BIOL CHEM, V284, P5697, DOI 10.1074/jbc.M806173200; Guijas C, 2012, J LIPID RES, V53, P2343, DOI 10.1194/jlr.M028423; Hakumaki JM, 1999, NAT MED, V5, P1323, DOI 10.1038/15279; Hakumaki JM, 2003, TRENDS PHARMACOL SCI, V24, P146, DOI 10.1016/S0165-6147(03)00032-4; Hakumaki JM, 2000, TRENDS BIOCHEM SCI, V25, P357, DOI 10.1016/S0968-0004(00)01614-5; Hapala I, 2011, BIOL CELL, V103, P271, DOI 10.1042/BC20100144; Herker E, 2011, TRENDS ENDOCRIN MET, V22, P241, DOI 10.1016/j.tem.2011.03.004; Hirosumi J, 2002, NATURE, V420, P333, DOI 10.1038/nature01137; Ii H, 2008, PROSTAG OTH LIPID M, V86, P12, DOI 10.1016/j.prostaglandins.2007.12.002; Ii H, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008089; Iorio E, 2003, BBA-MOL CELL BIOL L, V1634, P1, DOI 10.1016/j.bbalip.2003.07.001; Kaushik S, 2011, CELL METAB, V14, P173, DOI 10.1016/j.cmet.2011.06.008; Khatchadourian A, 2009, MOL PHARMACEUT, V6, P1125, DOI 10.1021/mp900098p; Koopman R, 2001, HISTOCHEM CELL BIOL, V116, P63; Le Lay S, 2009, PROG LIPID RES, V48, P191, DOI 10.1016/j.plipres.2009.03.001; Lei P, 2013, BASIC RES CARDIOL, V108, DOI 10.1007/s00395-012-0323-z; Li LO, 2010, BBA-MOL CELL BIOL L, V1801, P246, DOI 10.1016/j.bbalip.2009.09.024; Menzel N, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002829; Murakami M, 2011, PROG LIPID RES, V50, P152, DOI 10.1016/j.plipres.2010.12.001; Murphy DJ, 2012, PROTOPLASMA, V249, P541, DOI 10.1007/s00709-011-0329-7; Murphy DJ, 1999, TRENDS BIOCHEM SCI, V24, P109, DOI 10.1016/S0968-0004(98)01349-8; Ouimet M, 2011, CELL METAB, V13, P655, DOI 10.1016/j.cmet.2011.03.023; Quintero M, 2007, BBA-MOL CELL BIOL L, V1771, P31, DOI 10.1016/j.bbalip.2006.10.003; Saka HA, 2012, ANNU REV CELL DEV BI, V28, P411, DOI 10.1146/annurev-cellbio-092910-153958; Schmitz JE, 2005, MAGN RESON MED, V54, P43, DOI 10.1002/mrm.20529; Singh R, 2009, NATURE, V458, P1131, DOI 10.1038/nature07976; Wang H, 2011, J LIPID RES, V52, P2159, DOI 10.1194/jlr.M017939; Wang H, 2011, TRENDS ENDOCRIN MET, V22, P197, DOI 10.1016/j.tem.2011.03.008; Zechner R, 2012, CELL METAB, V15, P279, DOI 10.1016/j.cmet.2011.12.018; Zoula S, 2003, BRIT J CANCER, V88, P1439, DOI 10.1038/sj.bjc.6600837	56	94	94	0	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 27	2013	288	39					27777	27788		10.1074/jbc.M113.466656	http://dx.doi.org/10.1074/jbc.M113.466656			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302OB	23940052	Green Published, hybrid			2022-12-25	WOS:000330612800007
J	Teixeira, FR; Manfiolli, AO; Soares, CS; Baqui, MMA; Koide, T; Gomes, MD				Teixeira, Felipe R.; Manfiolli, Adriana O.; Soares, Claudia S.; Baqui, Munira M. A.; Koide, Tie; Gomes, Marcelo D.			The F-box Protein FBXO25 Promotes the Proteasome-dependent Degradation of ELK-1 Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SERUM RESPONSE FACTOR; UBIQUITIN LIGASE; CYCLIN D1; IDENTIFICATION; EXPRESSION; FAMILY; PHOSPHORYLATION; PROLIFERATION; ACTIVATION; INDUCTION	FBXO25 is one of the 69 known human F-box proteins that serve as specificity factors for a family of ubiquitin ligases composed of SKP1, Rbx1, Cullin1, and F-box protein (SCF1) that are involved in targeting proteins for degradation across the ubiquitin proteasome system. However, the substrates of most SCF E3 ligases remain unknown. Here, we applied an in chip ubiquitination screen using a human protein microarray to uncover putative substrates for the FBXO25 protein. Among several novel putative targets identified, the c-fos protooncogene regulator ELK-1 was characterized as the first endogenous substrate for SCF1(FBXO25) E3 ligase. FBXO25 interacted with and mediated the ubiquitination and proteasomal degradation of ELK-1 in HEK293T cells. In addition, FBXO25 overexpression suppressed induction of two ELK-1 target genes, c-fos and egr-1, in response to phorbol 12-myristate 13-acetate. Together, our findings show that FBXO25 mediates ELK-1 degradation through the ubiquitin proteasome system and thereby plays a role in regulating the activation of ELK-1 pathway in response to mitogens.	[Teixeira, Felipe R.; Manfiolli, Adriana O.; Soares, Claudia S.; Koide, Tie; Gomes, Marcelo D.] Univ Sao Paulo, Fac Med Ribeirao Preto, Dept Biochem & Immunol, BR-14049900 Ribeirao Preto, SP, Brazil; [Baqui, Munira M. A.] Univ Sao Paulo, Fac Med Ribeirao Preto, Dept Cell Biol, BR-14049900 Ribeirao Preto, SP, Brazil	Universidade de Sao Paulo; Universidade de Sao Paulo	Gomes, MD (corresponding author), Av Bandeirantes 3900, BR-14049900 Sao Paulo, Brazil.	mdamario@fmrp.usp.br	Teixeira, Felipe R/D-6235-2012; Baqui, Munira M. A/H-5243-2013; Koide, Tie/D-4406-2014; Teixeira, Felipe/ABB-4687-2020; Gomes, Marcelo/AAC-6041-2021	Teixeira, Felipe R/0000-0003-0251-2686; Baqui, Munira M. A/0000-0002-7945-2899; Koide, Tie/0000-0003-4760-2423; Teixeira, Felipe/0000-0003-0251-2686; 	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [201013045-4]; CNPq [GENOPROT 42/2009]; Fundacao de Apoio ao Ensino, Pequisa e Assistencia (FAEPA); University of Sao Paulo through the Nucleo de Apoio a Pesquisa na Interface Proteolise Sinalizacao Celular (NAPPS)	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao de Apoio ao Ensino, Pequisa e Assistencia (FAEPA); University of Sao Paulo through the Nucleo de Apoio a Pesquisa na Interface Proteolise Sinalizacao Celular (NAPPS)	This work was supported by Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) Grant 201013045-4, CNPq Grant GENOPROT 42/2009, Fundacao de Apoio ao Ensino, Pequisa e Assistencia (FAEPA), and the University of Sao Paulo through the Nucleo de Apoio a Pesquisa na Interface Proteolise Sinalizacao Celular (NAPPS).	Andrews PS, 2010, ASSAY DRUG DEV TECHN, V8, P471, DOI 10.1089/adt.2009.0264; Cardozo T, 2004, NAT REV MOL CELL BIO, V5, P739, DOI 10.1038/nrm1471; Carrano AC, 1999, NAT CELL BIOL, V1, P193, DOI 10.1038/12013; Cenciarelli C, 1999, CURR BIOL, V9, P1177, DOI 10.1016/S0960-9822(00)80020-2; CIECHANOVER A, 1994, CELL, V79, P13, DOI 10.1016/0092-8674(94)90396-4; Cleveland BM, 2010, COMP BIOCHEM PHYS B, V157, P248, DOI 10.1016/j.cbpb.2010.06.010; DALTON S, 1992, CELL, V68, P597, DOI 10.1016/0092-8674(92)90194-H; Evans EL, 2011, NUCLEIC ACIDS RES, V39, P6390, DOI 10.1093/nar/gkr266; GILLE H, 1992, NATURE, V358, P414, DOI 10.1038/358414a0; Gomes MD, 2001, P NATL ACAD SCI USA, V98, P14440, DOI 10.1073/pnas.251541198; HERSHKO A, 1992, ANNU REV BIOCHEM, V61, P761, DOI 10.1146/annurev.bi.61.070192.003553; HIPSKIND RA, 1991, NATURE, V354, P531, DOI 10.1038/354531a0; JANKNECHT R, 1993, EMBO J, V12, P5097, DOI 10.1002/j.1460-2075.1993.tb06204.x; Jin JP, 2005, METHOD ENZYMOL, V399, P287, DOI 10.1016/S0076-6879(05)99020-4; Kamura T, 2004, NAT CELL BIOL, V6, P1229, DOI 10.1038/ncb1194; Kanie T, 2012, MOL CELL BIOL, V32, P590, DOI 10.1128/MCB.06570-11; Laman H, 2005, EMBO J, V24, P3104, DOI 10.1038/sj.emboj.7600775; Lin DI, 2006, MOL CELL, V24, P355, DOI 10.1016/j.molcel.2006.09.007; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lomonosov M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021165; Lu JY, 2008, MOL CELL PROTEOMICS, V7, P35, DOI 10.1074/mcp.M700353-MCP200; Manfiolli AO, 2008, MOL BIOL CELL, V19, P1848, DOI 10.1091/mbc.E07-08-0815; Maragno ALGC, 2006, BBA-GEN SUBJECTS, V1760, P966, DOI 10.1016/j.bbagen.2006.03.020; MARAIS R, 1993, CELL, V73, P381, DOI 10.1016/0092-8674(93)90237-K; Merbl Y, 2009, P NATL ACAD SCI USA, V106, P2543, DOI 10.1073/pnas.0812892106; Meziane E, 2011, J CELL SCI, V124, P2175, DOI 10.1242/jcs.080465; Persaud A, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.85; Petroski MD, 2005, NAT REV MOL CELL BIO, V6, P9, DOI 10.1038/nrm1547; Phizicky E, 2003, NATURE, V422, P208, DOI 10.1038/nature01512; Sambrook J., 1989, MOL CLONING LAB MANU, V2; Shao NS, 1998, ONCOGENE, V17, P527, DOI 10.1038/sj.onc.1201931; Skaar JR, 2009, CELL, V137, P1358, DOI 10.1016/j.cell.2009.05.040; Teixeira FR, 2010, PROTEOMICS, V10, P2746, DOI 10.1002/pmic.200900419; Townsend KJ, 1999, J BIOL CHEM, V274, P1801, DOI 10.1074/jbc.274.3.1801; Uht RM, 2007, ONCOGENE, V26, P2885, DOI 10.1038/sj.onc.1210090; Vanhoutte P, 2001, J BIOL CHEM, V276, P5189, DOI 10.1074/jbc.M006678200; Vinas-Castells R, 2010, J BIOL CHEM, V285, P3794, DOI 10.1074/jbc.M109.065995; Wagner SA, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M111.013284; Winston JT, 1999, CURR BIOL, V9, P1180, DOI 10.1016/S0960-9822(00)80021-4; Zhang JX, 2003, P NATL ACAD SCI USA, V100, P14127, DOI 10.1073/pnas.2233012100; Zhu H, 2001, SCIENCE, V293, P2101, DOI 10.1126/science.1062191	41	11	11	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 27	2013	288	39					28152	28162		10.1074/jbc.M113.504308	http://dx.doi.org/10.1074/jbc.M113.504308			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302OB	23940030	Green Published, hybrid			2022-12-25	WOS:000330612800039
J	Ding, T; Zhou, Y; Sun, K; Jiang, WZ; Li, WL; Liu, XL; Tian, CY; Li, ZH; Ying, GG; Fu, L; Gu, F; Li, WD; Ma, YJ				Ding, Ting; Zhou, Ying; Sun, Kai; Jiang, Weizhong; Li, Wenliang; Liu, Xiaoli; Tian, Chunying; Li, Zhihui; Ying, Guoguang; Fu, Li; Gu, Feng; Li, Weidong; Ma, Yongjie			Knockdown a Water Channel Protein, Aquaporin-4, Induced Glioblastoma Cell Apoptosis	PLOS ONE			English	Article							CENTRAL-NERVOUS-SYSTEM; CYTOCHROME-C RELEASE; GLIOMA-CELLS; MIGRATION; EXPRESSION; INVASION; SUPPRESSES; ASTROCYTES; MECHANISMS	Glioblastomas are the most aggressive forms of primary brain tumors due to their tendency to invade surrounding healthy brain tissues, rendering them largely incurable. The water channel protein, Aquaporin-4 (AQP4) is a key molecule for maintaining water and ion homeostasis in the central nervous system and has recently been reported with cell survival except for its well-known function in brain edema. An increased AQP4 expression has been demonstrated in glioblastoma multiforme (GBM), suggesting it is also involved in malignant brain tumors. In this study, we show that siRNA-mediated down regulation of AQP4 induced glioblastoma cell apoptosis in vitro and in vivo. We further show that several apoptotic key proteins, Cytochrome C, Bcl-2 and Bad are involved in AQP4 signaling pathways. Our results indicate that AQP4 may serve as an anti-apoptosis target for therapy of glioblastoma.	[Ding, Ting; Li, Wenliang; Liu, Xiaoli; Tian, Chunying; Li, Zhihui; Ying, Guoguang; Fu, Li; Gu, Feng; Ma, Yongjie] Tianjin Med Univ Canc Inst & Hosp, Key Lab Breast Canc Prevent & Therapy, Minist Educ, Key Lab Canc Prevent & Therapy Tianjin, Tianjin, Peoples R China; [Zhou, Ying; Li, Weidong] Shanghai Jiao Tong Univ, Key Lab Genet Dev & Neuropsychiat Disorders, Bio X Inst, Shanghai 200030, Peoples R China; [Sun, Kai] Shanghai Jiao Tong Univ, Sch Med, Renji Hosp, Dept Urol, Shanghai 200030, Peoples R China; [Jiang, Weizhong] Fudan Univ, Dept Neurosurg, Peoples Hosp Shanghai 5, Shanghai 200433, Peoples R China	Tianjin Medical University; Shanghai Jiao Tong University; Shanghai Jiao Tong University; Fudan University	Li, WD (corresponding author), Shanghai Jiao Tong Univ, Key Lab Genet Dev & Neuropsychiat Disorders, Bio X Inst, Shanghai 200030, Peoples R China.	liwd@sjtu.edu.cn; yongjiemagu@aliyun.com	Liu, Xiaoli/HGE-7614-2022; Zhou, Qinghua/A-4184-2008	Li, Weidong/0000-0001-5384-4838	China 973 project [2009CB521705, 2010CB529405, 2010CB529604]; National Scientific Foundation of China [81072158, 81272358, 81271511]; Key Program of the National Scientific Foundation of China [30930038]; Program for Professor of Special Appointment (Eastern Scholar) at Shanghai Institutions of Higher Learning; Shanghai Municipal Education Commission; Shanghai Education Development Foundation [10SG14]; Pujiang Program of Shanghai [11PJ1405100]	China 973 project(National Basic Research Program of China); National Scientific Foundation of China(National Natural Science Foundation of China (NSFC)); Key Program of the National Scientific Foundation of China; Program for Professor of Special Appointment (Eastern Scholar) at Shanghai Institutions of Higher Learning; Shanghai Municipal Education Commission(Shanghai Municipal Education Commission (SHMEC)); Shanghai Education Development Foundation; Pujiang Program of Shanghai(Shanghai Pujiang Program)	This study was supported by the China 973 project (2009CB521705, 2010CB529405, 2010CB529604), the National Scientific Foundation of China (81072158, 81272358, 81271511), the Key Program of the National Scientific Foundation of China (30930038), the Program for Professor of Special Appointment (Eastern Scholar) at Shanghai Institutions of Higher Learning, "Shu Guang'' project supported by Shanghai Municipal Education Commission and Shanghai Education Development Foundation (10SG14) and the Pujiang Program of Shanghai (11PJ1405100). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AGRE P, 1993, AM J PHYSIOL, V265, pF461, DOI 10.1152/ajprenal.1993.265.3.F461; Belizario JE, 2007, BRAZ J MED BIOL RES, V40, P1011, DOI 10.1590/S0100-879X2006005000109; Chen MJ, 2008, CURR NEUROPHARMACOL, V6, P102, DOI 10.2174/157015908784533879; Datta SR, 2000, MOL CELL, V6, P41, DOI 10.1016/S1097-2765(00)00006-X; Demuth T, 2004, J NEURO-ONCOL, V70, P217, DOI 10.1007/s11060-004-2751-6; Ding T, 2011, INT J ONCOL, V38, P1521, DOI 10.3892/ijo.2011.983; Gogvadze V, 2004, BIOCHEM J, V378, P213, DOI 10.1042/BJ20031193; Gu F, 2003, J NEUROSCI RES, V72, P709, DOI 10.1002/jnr.10603; Hughes FM, 1997, J BIOL CHEM, V272, P30567, DOI 10.1074/jbc.272.48.30567; Jablonski EM, 2004, AM J PHYSIOL-CELL PH, V286, pC975, DOI 10.1152/ajpcell.00180.2003; Jeyaseelan K, 2006, EXPERT OPIN THER TAR, V10, P889, DOI 10.1517/14728222.10.6.889; Kong H, 2008, J CELL SCI, V121, P4029, DOI 10.1242/jcs.035758; Lee WK, 2006, AM J PHYSIOL-CELL PH, V291, pC195, DOI 10.1152/ajpcell.00641.2005; Maeno E, 2000, P NATL ACAD SCI USA, V97, P9487, DOI 10.1073/pnas.140216197; Nakahama K, 1999, GLIA, V25, P240, DOI 10.1002/(SICI)1098-1136(19990201)25:3<240::AID-GLIA4>3.3.CO;2-3; Perez G, 2000, DANCE MAG, V74, P63; Pham PH, 2012, VIRUS RES; Piccotti L, 2002, J BIOL CHEM, V277, P12075, DOI 10.1074/jbc.M200029200; Senger D, 2003, CANCER J, V9, P214, DOI 10.1097/00130404-200305000-00009; Venero JL, 2001, PROG NEUROBIOL, V63, P321, DOI 10.1016/S0301-0082(00)00035-6; Wang HB, 2010, J EXP CLIN CANC RES, V29, DOI 10.1186/1756-9966-29-123; Zhang BB, 2009, INT J CANCER, V125, P585, DOI 10.1002/ijc.24314	22	23	27	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2013	8	8							e66751	10.1371/journal.pone.0066751	http://dx.doi.org/10.1371/journal.pone.0066751			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	200UV	23950863	Green Published, gold, Green Submitted			2022-12-25	WOS:000323097300003
J	Motwani, M; Li, DQ; Horvath, A; Kumar, R				Motwani, Mona; Li, Da-Qiang; Horvath, Anelia; Kumar, Rakesh			Identification of Novel Gene Targets and Functions of p21-Activated Kinase 1 during DNA Damage by Gene Expression Profiling	PLOS ONE			English	Article							EPSILON-SARCOGLYCAN; PROTEIN; KINASE; CELLS; PAK1; ACTIVATION; CARCINOMA; RSK4; PHOSPHORYLATION; METASTASIS	P21-activated kinase 1 (PAK1), a serine/threonine protein kinase, modulates many cellular processes by phosphorylating its downstream substrates. In addition to its role in the cytoplasm, PAK1 also affects gene transcription due to its nuclear localization and association with chromatin. It is now recognized that PAK1 kinase activity and its nuclear translocation are rapidly stimulated by ionizing radiation (IR), and that PAK1 activation is a component of the DNA damage response. Owing to the role of PAK1 in the cell survival, its association with the chromatin, and now, stimulation by ionizing radiation, we hypothesize that PAK1 may be contributing to modulation of genes with roles in cellular processes that might be important in the DNA damage response. The purpose of this study was to identify new PAK1 targets in response to ionizing radiation with putative role in the DNA damage response. We examined the effect of IR on the gene expression patterns in the murine embryonic fibroblasts with or without Pak1 using microarray technology. Differentially expressed transcripts were identified using Gene Spring GX 10.0.2. Pathway, network, functional analyses and gene family classification were carried out using Kyoto Encyclopedia of Genes and Genomes (KEGG), Ingenuity Pathway, Gene Ontology and PANTHER respectively. Selective targets of PAK1 were validated by RT-qPCR. For the first time, we provide a genome-wide analysis of PAK1 and identify its targets with potential roles in the DNA damage response. Gene Ontology analysis identified genes in the IR-stimulated cells that were involved in cell cycle arrest and cell death. Pathway analysis revealed p53 pathway being most influenced by IR responsive, PAK1 targets. Gene family of transcription factors was over represented and gene networks involved in DNA replication, repair and cellular signaling were identified. In brief, this study identifies novel PAK1 dependent IR responsive genes which reveal new aspects of PAK1 biology.	[Motwani, Mona; Horvath, Anelia; Kumar, Rakesh] George Washington Univ, McCormick Genom & Prote Ctr, Washington, DC 20052 USA; [Li, Da-Qiang; Kumar, Rakesh] George Washington Univ, Sch Med & Hlth Sci, Dept Biochem & Mol Med, Washington, DC 20052 USA	George Washington University; George Washington University	Kumar, R (corresponding author), George Washington Univ, McCormick Genom & Prote Ctr, Washington, DC 20052 USA.	bcmrxk@gwu.edu	Kumar, Rakesh/ABD-1065-2020; Motwani, Mona/AAV-8162-2020	Kumar, Rakesh/0000-0001-7664-0803; Motwani, Mona/0000-0003-0912-5478	McCormick Genomic and Proteomics Center; NIH [CA90970]; NATIONAL CANCER INSTITUTE [R01CA090970] Funding Source: NIH RePORTER	McCormick Genomic and Proteomics Center; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was supported in part by McCormick Genomic and Proteomics Center and in part by NIH grant CA90970. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anjum R, 2008, NAT REV MOL CELL BIO, V9, P747, DOI 10.1038/nrm2509; Balasenthil S, 2004, J BIOL CHEM, V279, P1422, DOI 10.1074/jbc.M309937200; Barrett T, 2006, METHOD ENZYMOL, V411, P352, DOI 10.1016/S0076-6879(06)11019-8; Bauer K, 2000, BLOOD, V96, P4236; Bokoch GM, 1998, J BIOL CHEM, V273, P8137, DOI 10.1074/jbc.273.14.8137; Bokoch GM, 2003, ANNU REV BIOCHEM, V72, P743, DOI 10.1146/annurev.biochem.72.121801.161742; Dong H, 2009, BMC MED GENOMICS, V2, DOI 10.1186/1755-8794-2-5; Dummler BA, 2005, J BIOL CHEM, V280, P13304, DOI 10.1074/jbc.M408194200; Edwards DC, 1999, NAT CELL BIOL, V1, P253, DOI 10.1038/12963; Eswaran J, 2012, CLIN CANCER RES, V18, P3743, DOI 10.1158/1078-0432.CCR-11-1952; Ettinger AJ, 1997, J BIOL CHEM, V272, P32534, DOI 10.1074/jbc.272.51.32534; Frost JA, 2000, J BIOL CHEM, V275, P19693, DOI 10.1074/jbc.M909860199; Grabowski M, 2003, EUR J HUM GENET, V11, P138, DOI 10.1038/sj.ejhg.5200938; Hackanson B, 2008, CANCER RES, V68, P3142, DOI 10.1158/0008-5472.CAN-08-0483; HARPER JW, 1993, CELL, V75, P805; Hong Su-Hyung, 2005, Cancer Res Treat, V37, P71, DOI 10.4143/crt.2005.37.1.71; Jin HO, 2009, FEBS LETT, V583, P123, DOI 10.1016/j.febslet.2008.11.035; Kawase T, 2009, CELL, V136, P535, DOI 10.1016/j.cell.2008.12.002; Kumar R, 2006, NAT REV CANCER, V6, P459, DOI 10.1038/nrc1892; Leis O, 2012, ONCOGENE, V31, P1354, DOI 10.1038/onc.2011.338; Li DQ, 2012, CELL REP, V2, P1657, DOI 10.1016/j.celrep.2012.11.018; Li DQ, 2010, J BIOL CHEM, V285, P10044, DOI 10.1074/jbc.M109.079095; Li DQ, 2009, J BIOL CHEM, V284, P34545, DOI 10.1074/jbc.M109.056499; Li DQ, 2009, P NATL ACAD SCI USA, V106, P17493, DOI 10.1073/pnas.0908027106; Li F, 2002, EMBO REP, V3, P767, DOI 10.1093/embo-reports/kvf157; Lleonart ME, 2006, ONCOL REP, V16, P603; MANSER E, 1994, NATURE, V367, P40, DOI 10.1038/367040a0; Molli PR, 2009, ONCOGENE, V28, P2545, DOI 10.1038/onc.2009.119; Molli PR, 2010, J CELL BIOL, V190, P101, DOI 10.1083/jcb.200908050; Monte M, 2003, J BIOL CHEM, V278, P30356, DOI 10.1074/jbc.M302902200; Nikolova DN, 2008, ONCOL REP, V20, P105; Olbryt M, 2006, GENE EXPRESSION, V13, P191, DOI 10.3727/000000006783991818; SANDERS MC, 1992, P NATL ACAD SCI USA, V89, P4678, DOI 10.1073/pnas.89.10.4678; Schurmann A, 2000, MOL CELL BIOL, V20, P453, DOI 10.1128/MCB.20.2.453-461.2000; Sells MA, 1997, CURR BIOL, V7, P202, DOI 10.1016/S0960-9822(97)70091-5; Shrestha Y, 2012, ONCOGENE, V31, P3397, DOI 10.1038/onc.2011.515; Singh RR, 2005, J BIOL CHEM, V280, P18130, DOI 10.1074/jbc.M412607200; Tamborini E, 2001, INT J CANCER, V92, P790, DOI 10.1002/ijc.1271; Tanikawa C, 2010, MOL CANCER RES, V8, P855, DOI 10.1158/1541-7786.MCR-09-0484; Tatenhorst L, 2004, J NEUROPATH EXP NEUR, V63, P210, DOI 10.1093/jnen/63.3.210; Thakur A, 2008, CLIN CANCER RES, V14, P4427, DOI 10.1158/1078-0432.CCR-08-0458; Thakur A, 2007, MOL CANCER RES, V5, P171, DOI 10.1158/1541-7786.MCR-06-0071; Tsakiridis T, 1996, J BIOL CHEM, V271, P19664, DOI 10.1074/jbc.271.33.19664; Vadlamudi RK, 2005, ONCOGENE, V24, P4591, DOI 10.1038/sj.onc.1208672; Vadlamudi RK, 2004, CANCER CELL, V5, P575, DOI 10.1016/j.ccr.2004.05.022; Vadlamudi RK, 2004, EMBO REP, V5, P154, DOI 10.1038/sj.embor.7400079; Vadlamudi RK, 2002, NAT CELL BIOL, V4, P681, DOI 10.1038/ncb838; Wang WS, 2004, ONCOGENE, V23, P6666, DOI 10.1038/sj.onc.1207888; Xiang R, 2011, BRIT J CANCER, V104, P1410, DOI 10.1038/bjc.2011.94; Xie Y, 2009, CANCER RES, V69, P5743, DOI 10.1158/0008-5472.CAN-08-3564; Yang SP, 2005, MOL CELL BIOCHEM, V272, P97, DOI 10.1007/s11010-005-7642-4; Ye Diana Zi, 2012, Cell Logist, V2, P105; Yntema HG, 1999, GENOMICS, V62, P332, DOI 10.1006/geno.1999.6004; Zhao CY, 2009, ENDOCRINE, V36, P224, DOI 10.1007/s12020-009-9233-8	54	21	21	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2013	8	8							e66585	10.1371/journal.pone.0066585	http://dx.doi.org/10.1371/journal.pone.0066585			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	200UV	23950862	Green Published, gold, Green Submitted			2022-12-25	WOS:000323097300002
J	Takanashi, K; Quyen, DT; Le Hoa, NT; Khan, NC; Yasuoka, J; Jimba, M				Takanashi, Kumiko; Dao To Quyen; Nguyen Thi Le Hoa; Nguyen Cong Khan; Yasuoka, Junko; Jimba, Masamine			Long-Term Impact of Community-Based Information, Education and Communication Activities on Food Hygiene and Food Safety Behaviors in Vietnam: A Longitudinal Study	PLOS ONE			English	Article							DIARRHEA; INTERVENTION; SANITATION; PROMOTION; CHILDREN; WATER; COUNTRIES; CHANNELS; HANOI; WOMEN	Background: Ingestion of contaminated water or food is a major contributor to childhood diarrhea in developing countries. In Vietnam, the use of community-based information, education and communication (IEC) activities could be a sustainable strategy to improve food hygiene and food safety behaviors. This study thus examined the long-term impact of community-based IEC activities on food hygiene and food safety behaviors. Methods: In this longitudinal study, we interviewed caregivers of children aged between six months and four years in suburban Hanoi. Baseline data were collected in January 2006 (n = 125). After conducting IEC interventions, we collected a 1st set of evaluation data in January 2007 (n = 132). To examine the long-term impact of the interventions, we then collected a 2nd set of evaluation data in January 2008 (n = 185). Changes in childhood diarrhea prevalence, IEC coverage, and food hygiene and food safety behaviors were assessed over a two-year period using bivariate and logistic regression analyses. Effective IEC channels were determined through multiple linear regression analysis. Results: Childhood diarrhea was significantly reduced from 21.6% at baseline to 7.6% at the 1st post-intervention evaluation (P = 0.002), and to 5.9% at the 2nd evaluation. Among 17 food hygiene and food safety behaviors measured, a total of 11 behaviors were improved or maintained by the 2nd evaluation. Handwashing after toilet use was significantly improved at both evaluation points. Overall, 3 food safety behaviors and 7 food hygiene behaviors were found to have significantly improved at the 1st and at the 2nd evaluations, respectively. Flip chart communication administered by community groups was identified to be the most effective IEC channel for effecting behavior change (P = 0.018). Conclusions: Flip chart communication administered by community groups is effective for improving multiple food hygiene and food safety behaviors in sustainable ways, and should be included in water and health promotion programs.	[Takanashi, Kumiko; Yasuoka, Junko; Jimba, Masamine] Univ Tokyo, Grad Sch Med, Dept Community & Global Hlth, Tokyo, Japan; [Takanashi, Kumiko] Int Life Sci Inst Japan, Ctr Hlth Promot, Tokyo, Japan; [Dao To Quyen; Nguyen Thi Le Hoa] Natl Inst Nutr, Dept Food Sci & Safety, Hanoi, Vietnam; [Nguyen Cong Khan] Minist Hlth, Dept Sci & Training Management, Hanoi, Vietnam	University of Tokyo	Jimba, M (corresponding author), Univ Tokyo, Grad Sch Med, Dept Community & Global Hlth, Tokyo, Japan.	mjimba@m.u-tokyo.ac.jp	Jimba, Masamine/AAF-5630-2020; Yasuoka, Junko/GVT-8950-2022		Japan International Cooperation Agency	Japan International Cooperation Agency	This study was funded by the Grassroots Partner Project Fund from Japan International Cooperation Agency (http://www.jica.go.jp/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AHMED NU, 1993, SOC SCI MED, V37, P159, DOI 10.1016/0277-9536(93)90452-A; Bajracharya D, 2003, INT J ENVIRON HEAL R, V13, pS141, DOI 10.1080/0960312031000102903; Cairncross S, 2005, SOC SCI MED, V61, P2212, DOI 10.1016/j.socscimed.2005.04.019; Center for Rural Water Supply and Sanitation Ministry of Agriculture and Rural Development, 2003, GUID INF ED COMM RUR; Chase C, 2012, HANDWASHING BEHAV CH; CURTIS V, 1993, B WORLD HEALTH ORGAN, V71, P23; Curtis V, 2003, LANCET INFECT DIS, V3, P275, DOI 10.1016/S1473-3099(03)00606-6; Curtis V, 2001, B WORLD HEALTH ORGAN, V79, P518; Curtis V, 2000, TROP MED INT HEALTH, V5, P22, DOI 10.1046/j.1365-3156.2000.00512.x; Curtis V, 2011, LANCET INFECT DIS, V11, P312, DOI 10.1016/S1473-3099(10)70224-3; Ejemot-Nwadiaro RI, 2012, HAND WASHING PREVENT, P1; FEACHEM RG, 1984, B WORLD HEALTH ORGAN, V62, P467; Fewtrell L, 2005, LANCET INFECT DIS, V5, P42, DOI 10.1016/S1473-3099(04)01253-8; Food and Nutrition Technical Assistance, 1999, WAT SAN IND MEAS GUI; Hornik R., 2002, PUBLIC HLTH COMMUNIC; Hunter PR, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-219; Joint FAO/WHO Codex Alimentarius Commission, 2003, FOOD HYG BAS TEXTS, P1; Lanata CF, 2003, INT J ENVIRON HEAL R, V13, pS175, DOI 10.1080/0960312031000102921; Laverack G., 2003, HLTH ED, V103, P363, DOI DOI 10.1108/09654280310502852; LOEVINSOHN BP, 1990, INT J EPIDEMIOL, V19, P788, DOI 10.1093/ije/19.4.788; Ministry of Health Center for Preventive Medicine of Nam Dinh Province, 2003, KAP PRES REP ASS KNO, P1; Nguyen TVH, 2008, WATER SCI TECHNOL, V58, P2403, DOI 10.2166/wst.2008.435; Nguyen TV, 2006, INT J INFECT DIS, V10, P298, DOI 10.1016/j.ijid.2005.05.009; Pinfold JV, 1996, T ROY SOC TROP MED H, V90, P366, DOI 10.1016/S0035-9203(96)90507-6; Pinfold JV, 1999, HEALTH EDUC RES, V14, P629, DOI 10.1093/her/14.5.629; Scott BE, 2008, HEALTH EDUC RES, V23, P392, DOI 10.1093/her/cym056; Sheth Mini, 2004, Indian Journal of Pediatrics, V71, P879, DOI 10.1007/BF02830824; Takanashi K, 2009, J HEALTH POPUL NUTR, V27, P602; Toure O, 2011, FOOD CONTROL, V22, P1565, DOI 10.1016/j.foodcont.2011.03.012; [UNICEF WHO], 2009, DIARRH WHY CHILDR ST; UNICEF Vietnam, 2002, EFF INF ED COMM VIET; van den Berg LM, 2003, ENVIRON URBAN, V15, P35, DOI 10.1177/095624780301500122; [Vietnam Ministry of Health UNICEF], 2011, SUMM REP STUD CORRE; Vietnam Ministry of Health, 2005, 142005QDBYT VIET MIN; Waterkeyn J, 2005, SOC SCI MED, V61, P1958, DOI 10.1016/j.socscimed.2005.04.012; WHO, 2006, 5 KEYS SAF FOOD MAN; WILSON JM, 1993, T ROY SOC TROP MED H, V87, P615, DOI 10.1016/0035-9203(93)90260-W; World Health Organization, 1996, BAS PRINC PREP SAF F; World Health Organization, 2001, INF ED COMM LESS PER	39	15	16	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2013	8	8							e70654	10.1371/journal.pone.0070654	http://dx.doi.org/10.1371/journal.pone.0070654			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	200UV	23950978	Green Submitted, Green Published, gold			2022-12-25	WOS:000323097300038
J	Banstola, A; Banstola, A				Banstola, Amrit; Banstola, Ashik			The Epidemiology of Hospitalization for Pneumonia in Children under Five in the Rural Western Region of Nepal: A Descriptive Study	PLOS ONE			English	Article							CHILDHOOD PNEUMONIA; TAIWAN	Pneumonia is one of the major public health problems in children under five years of age. The aim of this study was to analyze the time, place, and characteristics of the distribution of pneumonia in hospitalized children under five years of age at the Dhaulagiri Zonal Hospital (DZH) in Nepal. A descriptive cross-sectional study was carried out at DZH from July 16, 2008 to August 17, 2011 for hospitalized children under five years of age and diagnosed with pneumonia. The main bacterial cause of pneumonia was Streptococcus pneumoniae and the main viral cause was Respiratory Syntical Virus (RSV). The majority of children admitted for treatment of pneumonia were males (60%), from upper class ethnic groups, and common among those aged 29 days to one year (49.1% of overall pneumonia cases). Data from this study show that pneumonia episodes in DZH occurred throughout the year with a sharp increase in the occurrence at the end of August to September. More cases were recorded during the rainy seasons and winter months in all three study years. The cases were from households most concentrated in Baglung municipality where the hospital is located. Pneumonia was found in higher proportions among hospitalized male children, those aged 29 days to one year, and in upper ethnic groups, during the rainy seasons and in winter months, and among local populations near the hospital in the rural western region of Nepal. Strengthening community-based case management, prevention strategies, and health care delivery system would help reduce pneumonia cases and the overall burden associated with it.	[Banstola, Amrit] Pokhara Univ, Sch Hlth & Allied Sci, Dept Publ Hlth, Kaski, Nepal; [Banstola, Ashik] Valley Coll Sci & Technol, Dept Pharm, Kathmandu, Nepal		Banstola, A (corresponding author), Pokhara Univ, Sch Hlth & Allied Sci, Dept Publ Hlth, Kaski, Nepal.	amritbanstola@outlook.com	Banstola, Amrit/T-4242-2019	Banstola, Amrit/0000-0003-3185-9638; Banstola, Ashik/0000-0002-2842-5567				Akbar MS, 1992, J CHILD HLTH, V16, P5; [Anonymous], 2009, GLOB ACT PLAN PREV C; Department of Health Services, 2012, 206768 MIN HLTH POP; Ghimire M, 2012, INDIAN J MED RES, V135, P459; Madhi SA, 2008, B WORLD HEALTH ORGAN, V86, P365, DOI 10.2471/BLT.07.044503; Mathisen M, 2009, BMC MED, V7, DOI 10.1186/1741-7015-7-35; Michelow IC, 2004, PEDIATRICS, V113, P701, DOI 10.1542/peds.113.4.701; Rudan I, 2008, B WORLD HEALTH ORGAN, V86, P408, DOI 10.2471/BLT.07.048769; Tsai HP, 2001, J CLIN MICROBIOL, V39, P111, DOI 10.1128/JCM.39.1.111-118.2001; Wahed MA, 2008, ORION MED J, V29, P519; Wardlaw TM, 2006, PNEUMONIA FORGOTTEN; World Health Organization, 2012, PNEUM; World Health Organization, 2011, PNEUM KEY FACTS; Wu PS, 2009, PEDIATR PULM, V44, P162, DOI 10.1002/ppul.20969	14	15	16	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2013	8	8							e71311	10.1371/journal.pone.0071311	http://dx.doi.org/10.1371/journal.pone.0071311			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	200ZE	23940739	Green Submitted, Green Published, gold			2022-12-25	WOS:000323109700093
J	Li, J; Wang, LJ; Ip, M; Sun, MJ; Sun, J; Huang, GY; Wang, CQ; Deng, L; Zheng, YJ; Fu, Z; Li, CC; Shang, YX; Zhao, CA; Yu, SJ; Yao, KH; Yang, YH; Shen, XZ				Li, Juan; Wang, Lijuan; Ip, Margaret; Sun, Mingjiao; Sun, Jing; Huang, Guoying; Wang, Chuanqing; Deng, Li; Zheng, Yuejie; Fu, Zhou; Li, Changcong; Shang, Yunxiao; Zhao, Changan; Yu, Sangjie; Yao, Kaihu; Yang, Yonghong; Shen, Xuzhuang			Molecular and Clinical Characteristics of Clonal Complex 59 Methicillin-Resistant Staphylococcus aureus Infections in Mainland China	PLOS ONE			English	Article							PANTON-VALENTINE LEUKOCIDIN; FIELD GEL-ELECTROPHORESIS; BLOOD-STREAM INFECTIONS; NECROTIZING FASCIITIS; VIRULENCE GENES; NORTHERN TAIWAN; UNITED-STATES; RISK-FACTORS; COMMUNITY; STRAINS	Detailed molecular analyses of Clonal Complex 59 (CC59) methicillin-resistant Staphylococcus aureus (MRSA) isolates from children in seven major cities across Mainland China were examined. A total of 110 CC59 isolates from invasive and non-invasive diseases were analyzed by multilocus sequence typing (MLST), Staphylococcus cassette chromosome mec (SCCmec) typing, staphylococcal protein A (spa) typing and pulsed-field gel electrophoresis (PFGE). Antibiotics susceptibilities, carriage of plasmids and 42 virulence genes and the expression of virulence factors were examined. ST59 (101/110, 91.8%) was the predominant sequence type (ST), while single locus variants (SLVs) belonging to ST338 (8/110, 7.3%) and ST375 (1/110, 0.9%) were obtained. Three SCCmec types were found, namely type III (2.7%), type IV (74.5%) and type V (22.7%). Seven spa types including t437, which accounted for 87.3%, were determined. Thirteen PFGE types were obtained. PFGE types A and B were the major types totally accounting for 81.8%. The dominant clone was ST59-t437-IVa (65.5%), followed by ST59-t437-V (14.5%). The positive rate of luks-PV and lukF-PV PVL encoding (pvl) gene was 55.5%. Plasmids were detected in 83.6% (92/110) of the strains. The plasmid size ranging from 23.4 kb to 50 kb was most prevalent which accounted for 83.7% (77/92). A significantly lower expression of hla was found in ST59-t437-IVa compared with ST59-t437-V. Among the 110 cases, 61.8% of the patients were less than 1 year old. A total of 90 cases (81.8%) were community-associated (CA) infections whereas 20 cases (18.2%) were hospital-associated (HA) infections. Out of the 110 patients, 36.4% (40/110) were diagnosed with invasive infectious diseases in which ST59-t437-IVa accounted for 67.5% (27/40). In brief, ST59-t437-IVa was proved as the dominant clone in CC59 MRSA strains. The carriage rate of pvl gene was high. CC59 MRSA could result in CA and HA infections. The majortiy of MRSA infection children were in young age.	[Li, Juan; Wang, Lijuan; Sun, Mingjiao; Sun, Jing; Yu, Sangjie; Yao, Kaihu; Yang, Yonghong; Shen, Xuzhuang] Capital Med Univ, Beijing Childrens Hosp, Beijing Pediat Res Inst, Key Lab Major Dis Children,Minist Educ, Beijing, Peoples R China; [Li, Juan; Wang, Lijuan; Sun, Mingjiao; Sun, Jing; Yu, Sangjie; Yao, Kaihu; Yang, Yonghong; Shen, Xuzhuang] Capital Med Univ, Beijing Childrens Hosp, Beijing Pediat Res Inst, Natl Key Discipline Pediat,Minist Educ, Beijing, Peoples R China; [Ip, Margaret] Chinese Univ Hong Kong, Prince Wales Hosp, Dept Microbiol, Shatin, Hong Kong, Peoples R China; [Huang, Guoying; Wang, Chuanqing] Fudan Univ, Pediat Hosp, Shanghai 200433, Peoples R China; [Deng, Li] Guangzhou Childrens Hosp, Guangzhou, Guangdong, Peoples R China; [Zheng, Yuejie] Shenzhen Childrens Hosp, Shenzhen, Peoples R China; [Fu, Zhou] Chongqing Childrens Hosp, Chongqing, Peoples R China; [Li, Changcong] Wenzhou Med Coll, Affiliated Hosp, Wenzhou, Peoples R China; [Shang, Yunxiao] Shenyang Shengjing Hosp, Shenyang, Peoples R China; [Zhao, Changan] Guangzhou Maternal & Child Hlth Hosp, Guangzhou, Peoples R China	Capital Medical University; Capital Medical University; Chinese University of Hong Kong; Prince of Wales Hospital; Fudan University; Wenzhou Medical University	Shen, XZ (corresponding author), Capital Med Univ, Beijing Childrens Hosp, Beijing Pediat Res Inst, Key Lab Major Dis Children,Minist Educ, Beijing, Peoples R China.	xuzhuangshen@163.com	Sun, Jing/AAS-1582-2020; Ip, Margaret/K-1096-2013; SUN, JIN/GPX-9641-2022	Sun, Jing/0000-0002-0097-2438; Ip, Margaret/0000-0003-1291-6537; 	National Natural Science Foundation of China; Research Grants Council of Hong Kong Joint Research Scheme [81061160509]; National Natural Science Foundation of China [81171648]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Research Grants Council of Hong Kong Joint Research Scheme(Hong Kong Research Grants Council); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	The current study was supported by the National Natural Science Foundation of China and the Research Grants Council of Hong Kong Joint Research Scheme (no. 81061160509) and the National Natural Science Foundation of China (no. 81171648). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baba T, 2002, LANCET, V359, P1819, DOI 10.1016/S0140-6736(02)08713-5; BANNERMAN TL, 1995, J CLIN MICROBIOL, V33, P551, DOI 10.1128/JCM.33.3.551-555.1995; BARTON BM, 1995, ANAL BIOCHEM, V226, P235, DOI 10.1006/abio.1995.1220; Brauner J, 2012, EUR J CLIN MICROBIOL; Campbell SJ, 2008, J CLIN MICROBIOL, V46, P678, DOI 10.1128/JCM.01822-07; Changchien CH, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-297; Chen FJ, 2005, EMERG INFECT DIS, V11, P1761, DOI 10.3201/eid1111.050367; COIA JE, 1988, J MED MICROBIOL, V27, P271, DOI 10.1099/00222615-27-4-271; Coombs GW, 2010, ANTIMICROB AGENTS CH, V54, P1914, DOI 10.1128/AAC.01287-09; CRISTINO JAGM, 1989, J HOSP INFECT, V13, P133, DOI 10.1016/0195-6701(89)90019-4; DeLeo FR, 2010, LANCET, V375, P1557, DOI 10.1016/S0140-6736(09)61999-1; Deleo FR, 2009, J CLIN INVEST, V119, P2464, DOI 10.1172/JCI38226; Diep BA, 2006, J INFECT DIS, V193, P1495, DOI 10.1086/503777; Enright MC, 2000, J CLIN MICROBIOL, V38, P1008, DOI 10.1128/JCM.38.3.1008-1015.2000; Ferreira DD, 2012, AM J RESP CRIT CARE, V186, P202, DOI 10.1164/ajrccm.186.2.202; Fridkin SK, 2005, NEW ENGL J MED, V352, P1436, DOI 10.1056/NEJMoa043252; Geng WJJ, 2010, PEDIATR PULM, V45, P387, DOI 10.1002/ppul.21202; Geng WJ, 2010, FEMS IMMUNOL MED MIC, V58, P356, DOI [10.1111/j.1574-695X.2009.00648.x, 10.1111/j.1574-695X.2010.00648.x]; Gonzalez BE, 2006, PEDIATRICS, V117, P1673, DOI 10.1542/peds.2005-2009; Gonzalez BE, 2005, PEDIATRICS, V115, P642, DOI 10.1542/peds.2004-2300; Grundmann H, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000215; Holtfreter S, 2004, INFECT IMMUN, V72, P4061, DOI 10.1128/IAI.72.7.4061-4071.2004; Huang YC, 2008, CLIN MICROBIOL INFEC, V14, P1167, DOI 10.1111/j.1469-0691.2008.02115.x; Huang YH, 2007, CLIN MICROBIOL INFEC, V13, P717, DOI 10.1111/j.1469-0691.2007.01718.x; Huang YC, 2006, J CLIN MICROBIOL, V44, P2268, DOI 10.1128/JCM.00776-06; Ip M, 2003, J CLIN MICROBIOL, V41, P4980, DOI 10.1128/JCM.41.11.4980-4985.2003; Jarraud S, 2002, INFECT IMMUN, V70, P631, DOI 10.1128/IAI.70.2.631-641.2002; Klevens RM, 2007, JAMA-J AM MED ASSOC, V298, P1763, DOI 10.1001/jama.298.15.1763; Koreen L, 2004, J CLIN MICROBIOL, V42, P792, DOI 10.1128/JCM.42.2.792-799.2004; Kuntova L, 2012, ARCH MICROBIOL, V194, P607, DOI 10.1007/s00203-012-0797-y; Laupland KB, 2008, J INFECT DIS, V198, P336, DOI 10.1086/589717; Lee SC, 2013, DIAGN MICROBIOL INFE; Li M, 2010, J INFECT DIS, V202, P1866, DOI 10.1086/657419; Li M, 2009, P NATL ACAD SCI USA, V106, P5883, DOI 10.1073/pnas.0900743106; Lina G, 2003, APPL ENVIRON MICROB, V69, P18, DOI 10.1128/AEM.69.1.18-23.2003; Lindsay Jodi A., 2006, Functional & Integrative Genomics, V6, P186, DOI 10.1007/s10142-005-0019-7; Liu C, 2011, CLIN INFECT DIS, V52, P285, DOI 10.1093/cid/cir034; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Milheirico C, 2007, ANTIMICROB AGENTS CH, V51, P3374, DOI 10.1128/AAC.00275-07; Monecke S, 2008, CLIN MICROBIOL INFEC, V14, P534, DOI 10.1111/j.1469-0691.2008.01986.x; Monecke S, 2007, CLIN MICROBIOL INFEC, V13, P236, DOI 10.1111/j.1469-0691.2006.01635.x; Otto M, 2012, CELL MICROBIOL, V14, P1513, DOI 10.1111/j.1462-5822.2012.01832.x; Pan ES, 2005, J INFECT DIS, V192, P811, DOI 10.1086/432072; Park SH, 2009, INFECT CONT HOSP EP, V30, P146, DOI 10.1086/593953; Rolo J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034768; Schuenck RP, 2012, FEMS IMMUNOL MED MIC, V65, P501, DOI 10.1111/j.1574-695X.2012.00958.x; Seltz LB, 2011, PEDIATRICS, V127, pE566, DOI 10.1542/peds.2010-2117; Shukla SK, 2010, J CLIN MICROBIOL, V48, P3582, DOI 10.1128/JCM.00657-10; Simor AE, 2010, INFECT CONT HOSP EP, V31, P348, DOI 10.1086/651313; Song JH, 2011, J ANTIMICROB CHEMOTH, V66, P1061, DOI 10.1093/jac/dkr024; Stefani S, 2012, INT J ANTIMICROB AG, V39, P273, DOI 10.1016/j.ijantimicag.2011.09.030; Tenover FC, 2006, J CLIN MICROBIOL, V44, P108, DOI 10.1128/JCM.44.1.108-118.2006; Thomas R, 2011, RESPIROLOGY, V16, P926, DOI 10.1111/j.1440-1843.2011.01965.x; Vandenesch F, 2003, EMERG INFECT DIS, V9, P978; Varshney AK, 2009, APPL ENVIRON MICROB, V75, P6839, DOI 10.1128/AEM.00272-09; Wang JT, 2010, J INFECTION, V61, P449, DOI 10.1016/j.jinf.2010.09.029; Wang LJ, 2012, J MED MICROBIOL, V61, P1240, DOI 10.1099/jmm.0.042663-0; Wang WY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030394; Wu DJ, 2011, J MED MICROBIOL, V60, P35, DOI 10.1099/jmm.0.023465-0; Wu DJ, 2010, DIAGN MICR INFEC DIS, V67, P1, DOI 10.1016/j.diagmicrobio.2009.12.006	60	33	47	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2013	8	8							e70602	10.1371/journal.pone.0070602	http://dx.doi.org/10.1371/journal.pone.0070602			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	200ZE	23950969	Green Published, Green Submitted, gold			2022-12-25	WOS:000323109700044
J	Barriere, DA; Mallet, C; Blomgren, A; Simonsen, C; Daulhac, L; Libert, F; Chapuy, E; Etienne, M; Hogestatt, ED; Zygmunt, PM; Eschalier, A				Barriere, David A.; Mallet, Christophe; Blomgren, Anders; Simonsen, Charlotte; Daulhac, Laurence; Libert, Frederic; Chapuy, Eric; Etienne, Monique; Hogestatt, Edward D.; Zygmunt, Peter M.; Eschalier, Alain			Fatty Acid Amide Hydrolase-Dependent Generation of Antinociceptive Drug Metabolites Acting on TRPV1 in the Brain	PLOS ONE			English	Article							ANANDAMIDE TRANSPORTER; VANILLOID RECEPTORS; PARA-AMINOPHENOL; P-AMINOPHENOL; MICE LACKING; IN-VITRO; ACETAMINOPHEN; RATS; CAPSAICIN; INHIBITOR	The discovery that paracetamol is metabolized to the potent TRPV1 activator N-(4-hydroxyphenyl)-5Z, 8Z, 11Z, 14Z-eicosatetraenamide (AM404) and that this metabolite contributes to paracetamol's antinociceptive effect in rodents via activation of TRPV1 in the central nervous system (CNS) has provided a potential strategy for developing novel analgesics. Here we validated this strategy by examining the metabolism and antinociceptive activity of the de-acetylated paracetamol metabolite 4-aminophenol and 4-hydroxy-3-methoxybenzylamine (HMBA), both of which may undergo a fatty acid amide hydrolase (FAAH)-dependent biotransformation to potent TRPV1 activators in the brain. Systemic administration of 4-aminophenol and HMBA led to a dose-dependent formation of AM404 plus N-(4-hydroxyphenyl)-9Z-octadecenamide (HPODA) and arvanil plus olvanil in the mouse brain, respectively. The order of potency of these lipid metabolites as TRPV1 activators was arvanil = olvanil >> AM404. HPODA. Both 4-aminophenol and HMBA displayed antinociceptive activity in various rodent pain tests. The formation of AM404, arvanil and olvanil, but not HPODA, and the antinociceptive effects of 4-aminophenol and HMBA were substantially reduced or disappeared in FAAH null mice. The activity of 4-aminophenol in the mouse formalin, von Frey and tail immersion tests was also lost in TRPV1 null mice. Intracerebroventricular injection of the TRPV1 blocker capsazepine eliminated the antinociceptive effects of 4-aminophenol and HMBA in the mouse formalin test. In the rat, pharmacological inhibition of FAAH, TRPV1, cannabinoid CB1 receptors and spinal 5-HT3 or 5-HT1A receptors, and chemical deletion of bulbospinal serotonergic pathways prevented the antinociceptive action of 4-aminophenol. Thus, the pharmacological profile of 4-aminophenol was identical to that previously reported for paracetamol, supporting our suggestion that this drug metabolite contributes to paracetamol's analgesic activity via activation of bulbospinal pathways. Our findings demonstrate that it is possible to construct novel antinociceptive drugs based on fatty acid conjugation as a metabolic pathway for the generation of TRPV1 modulators in the CNS.	[Barriere, David A.; Mallet, Christophe; Daulhac, Laurence; Libert, Frederic; Chapuy, Eric; Etienne, Monique; Eschalier, Alain] Univ Auvergne, Clermont Univ, Lab Pharmacol, Fac Med Pharm, Clermont Ferrand, France; [Barriere, David A.; Mallet, Christophe; Daulhac, Laurence; Libert, Frederic; Chapuy, Eric; Etienne, Monique; Eschalier, Alain] INSERM, Neurodol U1107, Clermont Ferrand, France; [Blomgren, Anders; Simonsen, Charlotte; Hogestatt, Edward D.; Zygmunt, Peter M.] Lund Univ, Dept Clin Chem & Pharmacol, Lund, Sweden; [Eschalier, Alain] Hop G Montpied, CHU Clermont Ferrand, Serv Pharmacol, Clermont Ferrand, France	Universite Clermont Auvergne (UCA); Institut National de la Sante et de la Recherche Medicale (Inserm); Lund University; CHU Clermont Ferrand	Hogestatt, ED (corresponding author), Lund Univ, Dept Clin Chem & Pharmacol, Lund, Sweden.	edward.hogestatt@med.lu.se; alain.eschalier@udamail.fr	ESCHALIER, Alain/L-9957-2015; Barrière, David André/ABC-3925-2021; Mallet, Christophe/K-2918-2015	Barrière, David André/0000-0003-4355-3329; Zygmunt, Peter/0000-0002-5102-8199; Mallet, Christophe/0000-0002-0873-6763; Libert, Frederic/0000-0001-7090-4724	Association Nationale de la Recherche Technique; Bristol-Myers-Squibb; University of Auvergne; Inserm; Swedish Medical Research Council [2010-3347]; Medical Faculty of Lund	Association Nationale de la Recherche Technique; Bristol-Myers-Squibb(Bristol-Myers Squibb); University of Auvergne; Inserm(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Swedish Medical Research Council(Swedish Medical Research Council (SMRC)); Medical Faculty of Lund	This work was supported by the "Association Nationale de la Recherche Technique", Bristol-Myers-Squibb (grants to CM and DAB), the University of Auvergne, Inserm, the Swedish Medical Research Council (2010-3347) and the Medical Faculty of Lund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson DA, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1559; Appendino G, 2005, J PHARMACOL EXP THER, V312, P561, DOI 10.1124/jpet.104.074864; Beltramo M, 1997, SCIENCE, V277, P1094, DOI 10.1126/science.277.5329.1094; Bonnefont J, 2005, PAIN, V114, P482, DOI 10.1016/j.pain.2005.01.019; Caterina MJ, 2000, SCIENCE, V288, P306, DOI 10.1126/science.288.5464.306; Correll CC, 2004, NEUROSCI LETT, V370, P55, DOI 10.1016/j.neulet.2004.07.058; Courade JP, 2001, EUR J PHARMACOL, V432, P1, DOI 10.1016/S0014-2999(01)01464-9; Cravatt BF, 2001, P NATL ACAD SCI USA, V98, P9371, DOI 10.1073/pnas.161191698; De Petrocellis L, 2000, FEBS LETT, V483, P52, DOI 10.1016/S0014-5793(00)02082-2; Di Marzo V, 2000, EUR J PHARMACOL, V406, P363, DOI 10.1016/S0014-2999(00)00687-7; Di Marzo V, 1998, FEBS LETT, V436, P449, DOI 10.1016/S0014-5793(98)01175-2; Fegley D, 2004, P NATL ACAD SCI USA, V101, P8756, DOI 10.1073/pnas.0400997101; GARTLAND KPR, 1989, ARCH TOXICOL, V63, P97, DOI 10.1007/BF00316430; Glaser ST, 2009, NEUROSCIENCE, V163, P594, DOI 10.1016/j.neuroscience.2009.06.043; Glaser ST, 2003, P NATL ACAD SCI USA, V100, P4269, DOI 10.1073/pnas.0730816100; GREEN CR, 1969, BRIT MED J, V1, P162, DOI 10.1136/bmj.1.5637.162; Hinz B, 2008, FASEB J, V22, P383, DOI 10.1096/fj.07-8506com; Hogestatt ED, 2005, J BIOL CHEM, V280, P31405, DOI 10.1074/jbc.M501489200; IGARASHI T, 1989, Drug Metabolism and Drug Interactions, V7, P191; Jarrahian A, 2000, J NEUROCHEM, V74, P2597, DOI 10.1046/j.1471-4159.2000.0742597.x; Kawahara H, 2011, BRIT J PHARMACOL, V163, P1214, DOI 10.1111/j.1476-5381.2010.01157.x; Keay KA, 2001, NEUROSCI BIOBEHAV R, V25, P669, DOI 10.1016/S0149-7634(01)00049-5; KLOS C, 1992, TOXICOL APPL PHARM, V115, P98, DOI 10.1016/0041-008X(92)90372-Y; Lever IJ, 2009, J NEUROSCI, V29, P3766, DOI 10.1523/JNEUROSCI.4071-08.2009; Li DP, 2004, J NEUROPHYSIOL, V92, P1807, DOI 10.1152/jn.00171.2004; Li W, 2003, TOXICOL IN VITRO, V17, P107, DOI 10.1016/S0887-2333(02)00128-5; Liao HT, 2011, BRIT J PHARMACOL, V163, P330, DOI 10.1111/j.1476-5381.2011.01214.x; Maione S, 2006, J PHARMACOL EXP THER, V316, P969, DOI 10.1124/jpet.105.093286; Mallet C, 2008, PAIN, V139, P190, DOI 10.1016/j.pain.2008.03.030; Mallet C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012748; Marinelli S, 2002, J PHYSIOL-LONDON, V543, P531, DOI 10.1113/jphysiol.2002.022863; McPartland JM, 2004, BRAIN RES REV, V45, P18, DOI 10.1016/j.brainresrev.2003.11.005; Melck D, 1999, BIOCHEM BIOPH RES CO, V262, P275, DOI 10.1006/bbrc.1999.1105; MESTRE C, 1994, J PHARMACOL TOX MET, V32, P197, DOI 10.1016/1056-8719(94)90087-6; NEWTON JF, 1983, TOXICOL APPL PHARM, V69, P307, DOI 10.1016/0041-008X(83)90312-5; Ossipov MH, 2010, J CLIN INVEST, V120, P3779, DOI 10.1172/JCI43766; Palazzo E, 2010, MOL PAIN, V6, DOI 10.1186/1744-8069-6-66; Pickering G, 2006, CLIN PHARMACOL THER, V79, P371, DOI 10.1016/j.clpt.2005.12.307; REYNOLDS DV, 1969, SCIENCE, V164, P444, DOI 10.1126/science.164.3878.444; Rogosch T, 2012, BIOORGAN MED CHEM, V20, P101, DOI 10.1016/j.bmc.2011.11.028; Ross RA, 2001, BRIT J PHARMACOL, V132, P631, DOI 10.1038/sj.bjp.0703850; Seal RP, 2009, NATURE, V462, P651, DOI 10.1038/nature08505; Shao R, 1996, FUND APPL TOXICOL, V31, P268, DOI 10.1006/faat.1996.0099; Sinning C, 2008, CHEMMEDCHEM, V3, P1956, DOI 10.1002/cmdc.200800271; Song H, 2001, J BIOCHEM MOL TOXIC, V15, P34, DOI 10.1002/1099-0461(2001)15:1<34::AID-JBT4>3.0.CO;2-U; Toms L, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004602.pub2; Xing JH, 2007, J NEUROPHYSIOL, V97, P503, DOI 10.1152/jn.01023.2006; ZIMMERMANN M, 1983, PAIN, V16, P109, DOI 10.1016/0304-3959(83)90201-4; Zygmunt PM, 2000, EUR J PHARMACOL, V396, P39, DOI 10.1016/S0014-2999(00)00207-7	49	43	44	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2013	8	8							e70690	10.1371/journal.pone.0070690	http://dx.doi.org/10.1371/journal.pone.0070690			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	218XC	23940628	Green Published, Green Submitted, gold			2022-12-25	WOS:000324465000122
J	Dolley-Sonneville, PJ; Romeo, LE; Melkoumian, ZK				Dolley-Sonneville, Paula J.; Romeo, Lori E.; Melkoumian, Zara K.			Synthetic Surface for Expansion of Human Mesenchymal Stem Cells in Xeno-Free, Chemically Defined Culture Conditions	PLOS ONE			English	Article							HUMAN-BONE-MARROW; STROMAL CELLS; DIFFERENTIATION CAPACITY; INTERNATIONAL-SOCIETY; PROGENITOR CELLS; ADIPOSE-TISSUE; MSC	Human mesenchymal stem cells (hMSCs) possess three properties of great interest for the development of cell therapies and tissue engineering: multilineage differentiation, immunomodulation, and production of trophic factors. Efficient ex vivo expansion of hMSCs is a challenging requirement for large scale production of clinical grade cells. Low-cost, robust, scalable culture methods using chemically defined materials need to be developed to address this need. This study describes the use of a xeno-free synthetic peptide acrylate surface, the Corning (R) Synthemax (R) Surface, for culture of hMSCs in serum-free, defined medium. Cell performance on the Corning Synthemax Surface was compared to cells cultured on biological extracellular matrix (ECM) coatings in xeno-free defined medium and in traditional conditions on tissue culture treated (TCT) plastic in fetal bovine serum (FBS) supplemented medium. Our results show successful maintenance of hMSCs on Corning Synthemax Surface for eight passages, with cell expansion rate comparable to cells cultured on ECM and significantly higher than for cells in TCT/FBS condition. Importantly, on the Corning Synthemax Surface, cells maintained elongated, spindle-like morphology, typical hMSC marker profile and in vitro multilineage differentiation potential. We believe the Corning Synthemax Surface, in combination with defined media, provides a complete synthetic, xeno-free, cell culture system for scalable production of hMSCs.	[Dolley-Sonneville, Paula J.; Romeo, Lori E.; Melkoumian, Zara K.] Corning Inc, Corning Life Sci Dev, Corning, NY 14831 USA	Corning Inc; State University of New York (SUNY) System; SUNY Community College	Dolley-Sonneville, PJ (corresponding author), Corning Inc, Corning Life Sci Dev, Corning, NY 14831 USA.	dolleypj@corning.com			Corning Incorporated	Corning Incorporated	This work was supported by Corning Incorporated. The funder played a role in the study design, data collection and analysis, decision to publish, and preparation of the manuscript.	Ankrum J, 2010, TRENDS MOL MED, V16, P203, DOI 10.1016/j.molmed.2010.02.005; [Anonymous], OSTEOGENIC STEM CELL; Asakura A, 2001, DIFFERENTIATION, V68, P245, DOI 10.1046/j.1432-0436.2001.680412.x; Bianco P, 2001, STEM CELLS, V19, P180, DOI 10.1634/stemcells.19-3-180; Bourin P, 2008, TRANSFUS MED HEMOTH, V35, P160, DOI 10.1159/000124734; Boxall SA, 2012, STEM CELLS INT, V2012, DOI 10.1155/2012/975871; Buhring HJ, 2009, ANN NY ACAD SCI, V1176, P124, DOI 10.1111/j.1749-6632.2009.04564.x; Bunnell BA, 2008, METHODS, V45, P115, DOI 10.1016/j.ymeth.2008.03.006; Caplan A, 2009, J PATHOL, V217, P318, DOI 10.1002/path.2469; Caplan AI, 2006, J CELL BIOCHEM, V98, P1076, DOI 10.1002/jcb.20886; Caplan AI, 2011, PRINCIPLES OF REGENERATIVE MEDICINE, 2ND EDITION, P253, DOI 10.1016/B978-0-12-381422-7.10014-8; CASTROMALASPINA H, 1980, BLOOD, V56, P289; Chamberlain G, 2007, STEM CELLS, V25, P2739, DOI 10.1634/stemcells.2007-0197; Chase LG, 2012, STEM CELL TRANSL MED, V1, P750, DOI 10.5966/sctm.2012-0072; Chase LG, 2010, STEM CELL RES THER, V1, DOI 10.1186/scrt8; Colter DC, 2000, P NATL ACAD SCI USA, V97, P3213, DOI 10.1073/pnas.070034097; Curran JM, 2011, BIOMATERIALS, V32, P4753, DOI 10.1016/j.biomaterials.2011.03.045; Curran JM, 2006, BIOMATERIALS, V27, P4783, DOI 10.1016/j.biomaterials.2006.05.001; Meirelles LDS, 2006, J CELL SCI, V119, P2204, DOI 10.1242/jcs.02932; Danmark S, 2012, BIOMED MATER, V7, DOI 10.1088/1748-6041/7/3/035011; De Bari C, 2001, ARTHRITIS RHEUM-US, V44, P1928, DOI 10.1002/1529-0131(200108)44:8<1928::AID-ART331>3.0.CO;2-P; Dominici M, 2006, CYTOTHERAPY, V8, P315, DOI 10.1080/14653240600855905; Dos Santos F, 2011, TISSUE ENG, V17, P1; English K, 2010, CELL STEM CELL, V7, P431, DOI 10.1016/j.stem.2010.09.009; Erices A, 2000, BRIT J HAEMATOL, V109, P235, DOI 10.1046/j.1365-2141.2000.01986.x; Fauza D, 2004, BEST PRACT RES CL OB, V18, P877, DOI 10.1016/j.bpobgyn.2004.07.001; Fehrer C, 2007, AGING CELL, V6, P745, DOI 10.1111/j.1474-9726.2007.00336.x; Freidenstein MF, 1999, SCIENCE, V284, P143; FRIEDENS.AJ, 1966, J EMBRYOL EXP MORPH, V16, P381; FRIEDENSTEIN AJ, 1970, CELL TISSUE KINET, V3, P393, DOI 10.1111/j.1365-2184.1970.tb00347.x; FRIEDENSTEIN AJ, 1968, TRANSPLANTATION, V6, P230, DOI 10.1097/00007890-196803000-00009; Goldring K, 2002, J PATHOL, V197, P457, DOI 10.1002/path.1157; Halfon S, 2011, STEM CELLS DEV, V20, P53, DOI 10.1089/scd.2010.0040; Ho JE, 2007, J BIOMED MATER RES A, V83A, P1200, DOI 10.1002/jbm.a.31355; Horwitz EM, 2007, BIOL BLOOD MARROW TR, V13, P53, DOI 10.1016/j.bbmt.2006.10.016; Horwitz EM, 2005, CYTOTHERAPY, V7, P393, DOI 10.1080/14653240500319234; Jin S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050880; LeBlanc K, 2008, LANCET, V371, P1579, DOI 10.1016/S0140-6736(08)60690-X; Lee RH, 2004, CELL PHYSIOL BIOCHEM, V14, P311, DOI 10.1159/000080341; Lindroos B, 2009, CYTOTHERAPY, V11, P958, DOI 10.3109/14653240903233081; MacMillan ML, 2009, BONE MARROW TRANSPL, V43, P447, DOI 10.1038/bmt.2008.348; Mauney JR, 2004, BIOMATERIALS, V25, P3233, DOI 10.1016/j.biomaterials.2003.10.005; Melkoumian Z, 2010, NAT BIOTECHNOL, V28, P606, DOI 10.1038/nbt.1629; Mitchell JB, 2006, STEM CELLS, V24, P376, DOI 10.1634/stemcells.2005-0234; Orbay H, 2012, STEM CELLS INT, V2012, DOI 10.1155/2012/461718; OWEN M, 1988, CIBA F SYMP, V136, P42, DOI 10.1002/9780470513637.ch4; Petersen BE, 1999, SCIENCE, V284, P1168, DOI 10.1126/science.284.5417.1168; Philippe B, 2010, STEM CELLS INT, V2010, DOI 10.4061/2010/503593; Phillips JE, 2010, ACTA BIOMATER, V6, P12, DOI 10.1016/j.actbio.2009.07.023; Puissant N, 2005, BRIT J HAEMATOL, V129, P118, DOI 10.1111/j.1365-2141.2005.05409.x; Qian LC, 2004, BIOMATERIALS, V25, P1331, DOI 10.1016/j.biomaterials.2003.08.013; Rowley J., 2012, BIOPROCESS INT, V10, P16; Saha K, 2007, CURR OPIN CHEM BIOL, V11, P381, DOI 10.1016/j.cbpa.2007.05.030; Salasznyk RM, 2004, J BIOMED BIOTECHNOL, P24, DOI 10.1155/S1110724304306017; SALE GE, 1983, EXP HEMATOL, V11, P961; Salem HK, 2010, STEM CELLS, V28, P585, DOI 10.1002/stem.269; Salingcarnboriboon R, 2003, EXP CELL RES, V287, P289, DOI 10.1016/S0014-4827(03)00107-1; Santiago LY, 2006, BIOMATERIALS, V27, P2962, DOI 10.1016/j.biomaterials.2006.01.011; Seo BM, 2004, LANCET, V364, P149, DOI 10.1016/S0140-6736(04)16627-0; Solchaga LA, 2005, J CELL PHYSIOL, V203, P398, DOI 10.1002/jcp.20238; Stewart K, 2003, CELL TISSUE RES, V313, P281, DOI 10.1007/s00441-003-0762-9; Toma JG, 2001, NAT CELL BIOL, V3, P778, DOI 10.1038/ncb0901-778; Varma MJO, 2007, STEM CELLS DEV, V16, P91, DOI 10.1089/scd.2006.0026; Wagner W, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002213; Wagner W, 2007, STEM CELL REV, V3, P239, DOI 10.1007/s12015-007-9001-1; Zomorodian E, 2012, STEM CELLS INT, V2012, DOI 10.1155/2012/980353; Zuk PA, 2002, MOL BIOL CELL, V13, P4279, DOI 10.1091/mbc.E02-02-0105	67	25	26	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2013	8	8							e70263	10.1371/journal.pone.0070263	http://dx.doi.org/10.1371/journal.pone.0070263			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	218XC	23940553	Green Published, Green Submitted, gold			2022-12-25	WOS:000324465000047
J	Jha, B; Mishra, A; Jha, A; Joshi, M				Jha, Bhavanath; Mishra, Avinash; Jha, Anupama; Joshi, Mukul			Developing Transgenic Jatropha Using the SbNHX1 Gene from an Extreme Halophyte for Cultivation in Saline Wasteland	PLOS ONE			English	Article							VACUOLAR NA+/H+ ANTIPORTER; ENHANCED SALT TOLERANCE; TIME QUANTITATIVE PCR; CURCAS L.; ARABIDOPSIS-THALIANA; BIODIESEL PRODUCTION; COPY NUMBER; SEED OIL; PLANTS; OVEREXPRESSION	Jatropha is an important second-generation biofuel plant. Salinity is a major factor adversely impacting the growth and yield of several plants including Jatropha. SbNHX1 is a vacuolar Na+/H+ antiporter gene that compartmentalises excess Na+ ions into the vacuole and maintains ion homeostasis. We have previously cloned and characterised the SbNHX1 gene from an extreme halophyte, Salicornia brachiata. Transgenic plants of Jatropha curcas with the SbNHX1 gene were developed using microprojectile bombardment mediated transformation. Integration of the transgene was confirmed by PCR and Rt-PCR and the copy number was determined by real time qPCR. The present study of engineering salt tolerance in Jatropha is the first report to date. Salt tolerance of the transgenic lines JL2, JL8 and JL19 was confirmed by leaf senescence assay, chlorophyll estimation, plant growth, ion content, electrolyte leakage and malondialdehyde (MDA) content analysis. Transgenic lines showed better salt tolerance than WT up to 200 mM NaCl. Imparting salt tolerance to Jatropha using the SbNHX1 gene may open up the possibility of cultivating it in marginal salty land, releasing arable land presently under Jatropha cultivation for agriculture purposes. Apart from this, transgenic Jatropha can be cultivated with brackish water, opening up the possibility of sustainable cultivation of this biofuel plant in salty coastal areas.	[Jha, Bhavanath; Mishra, Avinash; Jha, Anupama; Joshi, Mukul] Cent Salt & Marine Chem Res Inst, CSIR, Discipline Marine Biotechnol & Ecol, Bhavnagar 364002, Gujarat, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Central Salt & Marine Chemical Research Institute (CSMCRI)	Jha, B (corresponding author), Cent Salt & Marine Chem Res Inst, CSIR, Discipline Marine Biotechnol & Ecol, Bhavnagar 364002, Gujarat, India.	bjha@csmcri.org	Mishra, Avinash/C-3210-2009; Mishra, Avinash/AAG-2961-2019	Mishra, Avinash/0000-0003-0342-010X; Mishra, Avinash/0000-0003-0342-010X; Joshi, Mukul/0000-0002-9789-2003	CSIR, New Delhi [CSC0102: TapCoal]	CSIR, New Delhi(Council of Scientific & Industrial Research (CSIR) - India)	The financial assistance received from CSIR (www.csir.res.in), New Delhi (CSC0102: TapCoal) is duly acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achten WMJ, 2010, J ARID ENVIRON, V74, P164, DOI 10.1016/j.jaridenv.2009.08.010; Altpeter F, 2005, MOL BREEDING, V15, P305, DOI 10.1007/s11032-004-8001-y; Apse MP, 1999, SCIENCE, V285, P1256, DOI 10.1126/science.285.5431.1256; ARNON DI, 1949, PLANT PHYSIOL, V24, P1, DOI 10.1104/pp.24.1.1; Barragan V, 2012, PLANT CELL, V24, P1127, DOI 10.1105/tpc.111.095273; Bassil E, 2012, J EXP BOT, V63, P5727, DOI 10.1093/jxb/ers250; Bassil E, 2011, PLANT CELL, V23, P3482, DOI 10.1105/tpc.111.089581; Berchmans HJ, 2008, BIORESOURCE TECHNOL, V99, P1716, DOI 10.1016/j.biortech.2007.03.051; Bhaskaran S, 2011, J EXP BOT, V62, P5561, DOI 10.1093/jxb/err237; Bhatnagar-Mathur P, 2008, PLANT CELL REP, V27, P411, DOI 10.1007/s00299-007-0474-9; Blumwald E, 2000, CURR OPIN CELL BIOL, V12, P431, DOI 10.1016/S0955-0674(00)00112-5; Casu RE, 2012, PLANT CELL REP, V31, P167, DOI 10.1007/s00299-011-1150-7; Chen LH, 2008, TRANSGENIC RES, V17, P121, DOI 10.1007/s11248-007-9085-z; Chhetri AB, 2008, INT J MOL SCI, V9, P169, DOI 10.3390/ijms9020169; Diaz-Lopez L, 2012, PLANT PHYSIOL BIOCH, V54, P34, DOI 10.1016/j.plaphy.2012.02.005; Divakara BN, 2010, APPL ENERG, V87, P732, DOI 10.1016/j.apenergy.2009.07.013; Dyer JC, 2012, J ARID ENVIRON, V79, P107, DOI 10.1016/j.jaridenv.2011.12.004; Fairless D, 2007, NATURE, V449, P652, DOI 10.1038/449652a; Fan L, 1997, PLANT CELL, V9, P2183, DOI 10.1105/tpc.9.12.2183; FAO, 2005, GLOB NETW INT SOIL M; Flowers TJ, 2004, J EXP BOT, V55, P307, DOI 10.1093/jxb/erh003; Fujimaki H, 2010, INT AGROPHYS, V24, P121; Hodges DM, 1999, PLANTA, V207, P604, DOI 10.1007/s004250050524; Ilham Z, 2010, BIORESOURCE TECHNOL, V101, P2735, DOI 10.1016/j.biortech.2009.10.053; JEFFERSON RA, 1987, EMBO J, V6, P3901; Jha A, 2011, MOL BIOL REP, V38, P1965, DOI 10.1007/s11033-010-0318-5; Jha B, 2011, MOL BIOL REP, V38, P4823, DOI 10.1007/s11033-010-0625-x; Jiang XY, 2010, PLANT SIGNAL BEHAV, V5, P792, DOI 10.4161/psb.5.7.11767; Joshi M, 2011, IND CROP PROD, V33, P67, DOI 10.1016/j.indcrop.2010.09.002; Li J, 2008, TREE PHYSIOL, V28, P921, DOI 10.1093/treephys/28.6.921; Liu L, 2012, MOL BIOL REP, V39, P7193, DOI 10.1007/s11033-012-1551-x; Lutts S, 1996, ANN BOT-LONDON, V78, P389, DOI 10.1006/anbo.1996.0134; Ministry of New & Renewable Energy, 2009, NAT POL BIOF; Niu G, 2012, INT J AGRON, V2012, DOI 10.1155/2012/632026; Pandey VC, 2012, RENEW SUST ENERG REV, V16, P2870, DOI 10.1016/j.rser.2012.02.004; Qu J, 2012, BIOTECHNOL BIOFUELS, V5, DOI 10.1186/1754-6834-5-10; Rajagopal D, 2007, MOL BREEDING, V19, P137, DOI 10.1007/s11032-006-9052-z; Ravindranath NH, 2011, ENERG POLICY, V39, P5737, DOI 10.1016/j.enpol.2010.07.044; Shepherd CT, 2009, METHODS MOL BIOL, V526, P129, DOI 10.1007/978-1-59745-494-0_11; Shi HZ, 2000, P NATL ACAD SCI USA, V97, P6896, DOI 10.1073/pnas.120170197; Shi HZ, 2003, NAT BIOTECHNOL, V21, P81, DOI 10.1038/nbt766; Silva EN, 2010, J ARID ENVIRON, V74, P1130, DOI 10.1016/j.jaridenv.2010.05.036; Sunil N, 2009, GENET RESOUR CROP EV, V56, P115, DOI 10.1007/s10722-008-9350-x; Tsuchimoto S, 2012, PLANT BIOTECHNOL-NAR, V29, P137, DOI 10.5511/plantbiotechnology.12.0406d; Tzfira T, 2006, CURR OPIN BIOTECH, V17, P147, DOI 10.1016/j.copbio.2006.01.009; Xue ZY, 2004, PLANT SCI, V167, P849, DOI 10.1016/j.plantsci.2004.05.034; Zhang HX, 2001, NAT BIOTECHNOL, V19, P765, DOI 10.1038/90824; Zhang HX, 2001, P NATL ACAD SCI USA, V98, P12832, DOI 10.1073/pnas.231476498; Zhao JS, 2007, J PLANT PHYSIOL, V164, P1377, DOI 10.1016/j.jplph.2007.04.001	49	64	68	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2013	8	8							e71136	10.1371/journal.pone.0071136	http://dx.doi.org/10.1371/journal.pone.0071136			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	218XC	23940703	Green Submitted, Green Published, gold			2022-12-25	WOS:000324465000182
J	Li, YX; Cheng, KC; Asakawa, A; Kato, I; Sato, Y; Amitani, H; Kawamura, N; Cheng, JT; Inui, A				Li, Ying-Xiao; Cheng, Kai-Chun; Asakawa, Akihiro; Kato, Ikuo; Sato, Yuki; Amitani, Haruka; Kawamura, Namiko; Cheng, Juei-Tang; Inui, Akio			Role of Musclin in the Pathogenesis of Hypertension in Rat	PLOS ONE			English	Article							ATRIAL-NATRIURETIC-PEPTIDE; CLEARANCE RECEPTOR; SKELETAL-MUSCLE; FUNCTIONAL EXPRESSION; SECRETORY FACTOR; BLOOD-PRESSURE; C-RECEPTOR; ACTIVATION; PHENOTYPE; OSTEOCRIN	Musclin is a novel skeletal muscle-derived secretory factor found in the signal sequence trap of mouse skeletal muscle cDNAs. Musclin possesses a region homologous to the natriuretic peptide family. Thus, musclin is found to bind with the natriuretic peptide clearance receptors. However, the role of musclin in vascular regulation remains unclear. In this study, we aim to investigate the direct effect of musclin on vascular tone and to analyze its role in hypertension using the spontaneously hypertensive rats (SHR). In aortic strips isolated from SHR, musclin induced contractions in a dose-dependent manner. We found that the musclin-induced vasoconstriction was more marked in SHR than in normal rats (WKY). Moreover, this contraction was reduced by blockade of natriuretic peptide receptor C using the ab14355 antibody. Therefore, mediation of the natriuretic peptide receptor in musclin-induced vasoconstriction can be considered. In addition, similar to the natriuretic peptide receptor, expression of the musclin gene in blood vessels was higher in SHR than in WKY. Injection of musclin markedly increased the blood pressure in rats that can be inhibited by anti-musclin antibodies. Musclin-induced vasoconstriction was more pronounced in SHR than in WKY as in its expression. Taken together, these results suggest that musclin is involved in blood pressure regulation. The higher expression of musclin in hypertension indicates that musclin could be used as a new target for the treatment of hypertension in the future.	[Li, Ying-Xiao; Cheng, Kai-Chun; Asakawa, Akihiro; Amitani, Haruka; Kawamura, Namiko; Inui, Akio] Kagoshima Univ, Dept Psychosomat Internal Med, Grad Sch Med & Dent Sci, Kagoshima 890, Japan; [Kato, Ikuo; Sato, Yuki] Hokuriku Univ, Fac Pharmaceut Sci, Dept Bioorgan Chem, Kanazawa, Ishikawa 92011, Japan; [Cheng, Juei-Tang] Chi Mei Med Ctr, Dept Med Res, Tainan, Taiwan	Kagoshima University; Hokuriku University; Chi Mei Hospital	Inui, A (corresponding author), Kagoshima Univ, Dept Psychosomat Internal Med, Grad Sch Med & Dent Sci, Kagoshima 890, Japan.	inui@m.kufm.kagoshima-u.ac.jp		Kai Chun, Cheng/0000-0003-4983-4666	Japan society for the promotion of science	Japan society for the promotion of science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by the Young Researcher Overseas Visits Program for Vitalizing Brain Circulation by the Japan society for the promotion of science. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AnandSrivastava MB, 1996, MOL CELL BIOCHEM, V157, P163; AnandSrivastava MB, 1997, J HYPERTENS, V15, P815, DOI 10.1097/00004872-199715080-00004; ANDRESEN MC, 1980, CIRC RES, V47, P829, DOI 10.1161/01.RES.47.6.829; Banzet S, 2007, BIOCHEM BIOPH RES CO, V353, P713, DOI 10.1016/j.bbrc.2006.12.074; Bord S, 2005, J HISTOCHEM CYTOCHEM, V53, P1181, DOI 10.1369/jhc.4C6561.2005; Chen ZC, 2011, PHARMACOLOGY, V87, P257, DOI 10.1159/000326084; Christoffersen TEH, 2006, AM J PHYSIOL-HEART C, V290, pH1635, DOI 10.1152/ajpheart.00612.2005; Costa MA, 2010, AM J PHYSIOL-HEART C, V298, pH778, DOI 10.1152/ajpheart.00488.2009; Costa MA, 2006, REGUL PEPTIDES, V135, P63, DOI 10.1016/j.regpep.2006.04.002; FULLER F, 1988, J BIOL CHEM, V263, P9395; Hammoud Y, 2013, BIOCHIMIE, V95, P568, DOI 10.1016/j.biochi.2012.08.003; HIRATA Y, 1991, HYPERTENSION, V17, P1025, DOI 10.1161/01.HYP.17.6.1025; Kita S, 2009, J ENDOCRINOL, V201, P287, DOI 10.1677/JOE-08-0551; Lee PY, 2007, CLIN EXP PHARMACOL P, V34, P979, DOI 10.1111/j.1440-1681.2007.04668.x; Liu Y, 2008, J INT MED RES, V36, P496, DOI 10.1177/147323000803600314; MAACK T, 1987, SCIENCE, V238, P675, DOI 10.1126/science.2823385; Matsukawa N, 1999, P NATL ACAD SCI USA, V96, P7403, DOI 10.1073/pnas.96.13.7403; Nagase M, 1997, J HYPERTENS, V15, P1235, DOI 10.1097/00004872-199715110-00007; Nishizawa H, 2004, J BIOL CHEM, V279, P19391, DOI 10.1074/jbc.C400066200; PORTER JG, 1990, BIOCHEM BIOPH RES CO, V171, P796, DOI 10.1016/0006-291X(90)91216-F; Potter LR, 2006, ENDOCR REV, V27, P47, DOI 10.1210/er.2005-0014; Rose RA, 2008, J PHYSIOL-LONDON, V586, P353, DOI 10.1113/jphysiol.2007.144253; Rubattu S, 2010, J MOL MED, V88, P889, DOI 10.1007/s00109-010-0641-2; Thibault G, 1996, LIFE SCI, V58, P2345, DOI 10.1016/0024-3205(96)00235-4; Thomas G, 2003, J BIOL CHEM, V278, P50563, DOI 10.1074/jbc.M307310200; Yasui A, 2007, BIOCHEM BIOPH RES CO, V364, P358, DOI 10.1016/j.bbrc.2007.10.013	26	7	8	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2013	8	8							e72004	10.1371/journal.pone.0072004	http://dx.doi.org/10.1371/journal.pone.0072004			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	218XC	23940802	Green Submitted, Green Published, gold			2022-12-25	WOS:000324465000240
J	Warntjes, JBM; Engstrom, M; Tisell, A; Lundberg, P				Warntjes, Jan B. M.; Engstrom, Maria; Tisell, Anders; Lundberg, Peter			Brain Characterization Using Normalized Quantitative Magnetic Resonance Imaging	PLOS ONE			English	Article							APPEARING WHITE-MATTER; VOXEL-BASED MORPHOMETRY; T2 RELAXATION-TIMES; HIGH-RESOLUTION T-1; MULTIPLE-SCLEROSIS; MRI MEASURES; EDEMA; T1; RELAXOMETRY; DIFFUSION	Objectives: To present a method for generating reference maps of typical brain characteristics of groups of subjects using a novel combination of rapid quantitative Magnetic Resonance Imaging (qMRI) and brain normalization. The reference maps can be used to detect significant tissue differences in patients, both locally and globally. Materials and Methods: A rapid qMRI method was used to obtain the longitudinal relaxation rate (R-1), the transverse relaxation rate (R-2) and the proton density (PD). These three tissue properties were measured in the brains of 32 healthy subjects and in one patient diagnosed with Multiple Sclerosis (MS). The maps were normalized to a standard brain template using a linear affine registration. The differences of the mean value ofR(1), R-2 and PD of 31 healthy subjects in comparison to the oldest healthy subject and in comparison to an MS patient were calculated. Larger anatomical structures were characterized using a standard atlas. The vector sum of the normalized differences was used to show significant tissue differences. Results: The coefficient of variation of the reference maps was high at the edges of the brain and the ventricles, moderate in the cortical grey matter and low in white matter and the deep grey matter structures. The elderly subject mainly showed significantly lower R-1 and R-2 and higher PD values along all sulci. The MS patient showed significantly lower R-1 and R-2 and higher PD values at the edges of the ventricular system as well as throughout the periventricular white matter, at the internal and external capsules and at each of the MS lesions. Conclusion: Brain normalization of rapid qMRI is a promising new method to generate reference maps of typical brain characteristics and to automatically detect deviating tissue properties in the brain.	[Warntjes, Jan B. M.; Engstrom, Maria; Tisell, Anders; Lundberg, Peter] Linkoping Univ, Ctr Med Image Sci & Visualizat, CMIV, Linkoping, Sweden; [Warntjes, Jan B. M.] Linkoping Univ, Cty Council Ostergotland, Dept Clin Physiol, Dept Med & Hlth Sci,UHL, Linkoping, Sweden; [Engstrom, Maria] Linkoping Univ, Dept Med & Hlth Sci, Linkoping, Sweden; [Tisell, Anders; Lundberg, Peter] Linkoping Univ, Dept Radiat Phys, Cty Council Ostergotland, Dept Med & Hlth Sci,UHL, Linkoping, Sweden	Linkoping University; City Council Ostergotland; Linkoping University; Linkoping University; City Council Ostergotland; Linkoping University	Warntjes, JBM (corresponding author), Linkoping Univ, Ctr Med Image Sci & Visualizat, CMIV, Linkoping, Sweden.	marcel.warntjes@cmiv.liu.se	Lundberg, Peter/AGD-9679-2022	Engstrom, Maria/0000-0002-2167-2450	National Research Council (VR/NT); University Hospital of Linkoping; County Council of Ostergotland	National Research Council (VR/NT)(Swedish Research Council); University Hospital of Linkoping; County Council of Ostergotland	The study was supported by grants from The National Research Council (VR/NT), the University Hospital of Linkoping and the County Council of Ostergotland. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alfano B, 2000, J MAGN RESON IMAGING, V12, P799, DOI 10.1002/1522-2586(200012)12:6<799::AID-JMRI2>3.0.CO;2-#; Aubert-Broche B, 2009, NEUROIMAGE, V47, P523, DOI 10.1016/j.neuroimage.2009.04.079; Barkhof F, 2002, CURR OPIN NEUROL, V15, P239, DOI 10.1097/00019052-200206000-00003; BOBMAN SA, 1985, AM J NEURORADIOL, V6, P265; Chard D, 2009, CURR OPIN NEUROL, V22, P214, DOI 10.1097/WCO.0b013e32832b4c62; Deichmann R, 2005, MAGNET RESON MED, V54, P20, DOI 10.1002/mrm.20552; Deoni SCL, 2005, MAGN RESON MED, V53, P237, DOI 10.1002/mrm.20314; Engstrom M, 2009, SLEEP, V32, P681, DOI 10.1093/sleep/32.5.681; Filippi M, 1999, MULT SCLER J, V5, P273; Filippi M, 2010, J MAGN RESON IMAGING, V31, P770, DOI 10.1002/jmri.22102; Friston KJ, 1995, HUM BRAIN MAPP, V3, P165, DOI 10.1002/hbm.460030303; Hasan KM, 2012, J MAGN RESON IMAGING, V35, P1300, DOI 10.1002/jmri.23539; Hasan KM, 2012, J NEUROL SCI, V313, P99, DOI 10.1016/j.jns.2011.09.015; Kumar R, 2012, J MAGN RESON IMAGING, V35, P300, DOI 10.1002/jmri.22831; LARSSON HBW, 1989, MAGNET RESON MED, V11, P337, DOI 10.1002/mrm.1910110308; Larsson MBO, 2012, GASTROENTEROLOGY, V142, P463, DOI 10.1053/j.gastro.2011.11.022; Li JP, 2012, NEUROSCI BIOBEHAV R, V36, P757, DOI 10.1016/j.neubiorev.2011.12.001; Loubinoux I, 1997, STROKE, V28, P419, DOI 10.1161/01.STR.28.2.419; Maldjian JA, 2003, NEUROIMAGE, V19, P1233, DOI 10.1016/S1053-8119(03)00169-1; Neeb H, 2006, NEUROIMAGE, V31, P1156, DOI 10.1016/j.neuroimage.2005.12.063; Neema M, 2007, J NEUROIMAGING, V17, p16S, DOI 10.1111/j.1552-6569.2007.00131.x; Neema M, 2009, NEUROIMAGE, V46, P633, DOI 10.1016/j.neuroimage.2009.03.001; Oh J, 2005, J MAGN RESON IMAGING, V21, P701, DOI 10.1002/jmri.20335; Pell GS, 2004, NEUROIMAGE, V21, P707, DOI 10.1016/j.neuroimage.2003.09.059; Riccitelli G, 2012, MULT SCLER J, V18, P1027, DOI 10.1177/1352458512439239; Riederer S J, 1986, Acta Radiol Suppl, V369, P466; Saito N, 2009, MAGN RESON IMAGING, V27, P895, DOI 10.1016/j.mri.2009.05.006; Sbarbati A, 2002, ANAT REC, V266, P118, DOI 10.1002/ar.10044; Selvaraj S, 2012, BIPOLAR DISORD, V14, P135, DOI 10.1111/j.1399-5618.2012.01000.x; Stevenson VL, 2000, J NEUROL SCI, V178, P81, DOI 10.1016/S0022-510X(00)00339-7; Tofts P, 2003, QUANTITATIVE MRI OF THE BRAIN: MEASURING CHANGES CAUSED BY DISEASE, pXV; van Ettinger-Veenstra HM, 2010, NEUROIMAGE, V49, P3481, DOI 10.1016/j.neuroimage.2009.10.041; Van Hecke W, 2010, J MAGN RESON IMAGING, V31, P1492, DOI 10.1002/jmri.22198; Verhaert D, 2011, JACC-CARDIOVASC IMAG, V4, P269, DOI 10.1016/j.jcmg.2010.09.023; Vrenken H, 2006, RADIOLOGY, V240, P811, DOI 10.1148/radiol.2403050569; Vymazal J, 1999, RADIOLOGY, V211, P489, DOI 10.1148/radiology.211.2.r99ma53489; Walimuni IS, 2011, NEUROIMAGE, V57, P1402, DOI 10.1016/j.neuroimage.2011.05.063; Warnties JBM, 2008, MAGN RESON MED, V60, P320, DOI 10.1002/mrm.21635; West J, 2012, EUR RADIOL, V22, P998, DOI 10.1007/s00330-011-2336-7	39	22	22	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2013	8	8							e70864	10.1371/journal.pone.0070864	http://dx.doi.org/10.1371/journal.pone.0070864			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	218XC	23940653	Green Submitted, Green Published, gold			2022-12-25	WOS:000324465000144
J	Xiao, YS; Gao, Q; Xu, XN; Li, YW; Ju, MJ; Cai, MY; Dai, CX; Hu, J; Qiu, SJ; Zhou, J; Fan, J				Xiao, Yong-Sheng; Gao, Qiang; Xu, Xiang-Nan; Li, Yi-Wei; Ju, Min-Jie; Cai, Ming-Yan; Dai, Chen-Xin; Hu, Jie; Qiu, Shuang-Jian; Zhou, Jian; Fan, Jia			Combination of Intratumoral Invariant Natural Killer T Cells and Interferon-Gamma Is Associated with Prognosis of Hepatocellular Carcinoma after Curative Resection	PLOS ONE			English	Article							NKT CELLS; PHASE-I; LIVER RESECTION; DENDRITIC CELLS; RECURRENCE; INNATE; TRANSPLANTATION; LYMPHOCYTES; SUPPRESSION; BIOLOGY	Purpose: To investigate the prognostic value of intratumoral invariant natural killer T (iNKT) cells and interferon-gamma (IFN-gamma) in hepatocellular carcinoma (HCC) after curative resection. Experimental Design: Expression of TRAV10, encoding the V alpha 24 domain of iNKT cells, and IFN-gamma mRNA were assessed by quantitative real-time polymerase chain reaction in tumor from 224 HCC patients undergoing curative resection. The prognostic value of these two and other clinicopathologic factors was evaluated. Results: Either intratumoral iNKT cells and IFN-gamma alone or their combination was an independent prognostic factor for OS (P = 0.001) and RFS (P = 0.001) by multivariate Cox proportional hazards analysis. Patients with concurrent low levels of iNKT cells and IFN-gamma had a hazard ratio (HR) of 2.784 for OS and 2.673 for RFS. The areas under the curve of iNKT cells, IFN-gamma and their combination were 0.618 vs 0.608 vs 0.654 for death and 0.591 vs 0.604 vs 0.633 for recurrence respectively by receiver operating characteristic curve analysis. The prognosis was the worst for HCC patients with concurrent low levels of iNKT cells and IFN-gamma, which might be related with more advanced pTNM stage and more vascular invasion. Conclusions: Combination of intratumoral iNKT cells and IFN-gamma is a promising independent predictor for recurrence and survival in HCC, which has a better power to predict HCC patients' outcome compared with intratumoral iNKT cells or IFN-gamma alone.	[Xiao, Yong-Sheng; Gao, Qiang; Xu, Xiang-Nan; Li, Yi-Wei; Ju, Min-Jie; Cai, Ming-Yan; Dai, Chen-Xin; Hu, Jie; Qiu, Shuang-Jian; Zhou, Jian; Fan, Jia] Fudan Univ, Liver Canc Inst, Zhongshan Hosp, Shanghai 200032, Peoples R China; [Xiao, Yong-Sheng; Gao, Qiang; Xu, Xiang-Nan; Li, Yi-Wei; Ju, Min-Jie; Cai, Ming-Yan; Dai, Chen-Xin; Hu, Jie; Qiu, Shuang-Jian; Zhou, Jian; Fan, Jia] Minist Educ, Key Lab Carcinogenesis & Canc Invas, Shanghai, Peoples R China	Fudan University	Fan, J (corresponding author), Fudan Univ, Liver Canc Inst, Zhongshan Hosp, Shanghai 200032, Peoples R China.	jiafan99@yahoo.com	Cai, Mingyan/ACQ-4127-2022; Fan, Jia/C-6689-2017	Zhou, Jian/0000-0002-7650-7540; Gao, Qiang/0000-0002-6695-9906	National Key Sci-Tech Special Project of China [2012ZX10002010-001/002, 2012ZX10002011-002, 2012ZX10002013-005, 2012ZX10002-016]; Major Program of the National Nature Science Foundation of China [81030038]; National Natural Science Foundation of China [81141087, 81071707]	National Key Sci-Tech Special Project of China; Major Program of the National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	Supported by grants from the National Key Sci-Tech Special Project of China (No. 2012ZX10002010-001/002, 2012ZX10002011-002, 2012ZX10002013-005 and 2012ZX10002-016), the Major Program of the National Nature Science Foundation of China (No. 81030038), and the National Natural Science Foundation of China (No. 81141087 and 81071707). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bendelac A, 2007, ANNU REV IMMUNOL, V25, P297, DOI 10.1146/annurev.immunol.25.022106.141711; Bricard G, 2009, J IMMUNOL, V182, P5140, DOI 10.4049/jimmunol.0711086; Brigl M, 2004, ANNU REV IMMUNOL, V22, P817, DOI 10.1146/annurev.immunol.22.012703.104608; Bruix J, 2011, HEPATOLOGY, V53, P1020, DOI 10.1002/hep.24199; Budhu A, 2006, J LEUKOCYTE BIOL, V80, P1197, DOI 10.1189/jlb.0506297; Budhu A, 2006, CANCER CELL, V10, P99, DOI 10.1016/j.ccr.2006.06.016; Butterfield LH, 2007, SWISS MED WKLY, V137, P83; Camp RL., 2004, CLIN CANCER RES, V10, P7252, DOI [DOI 10.1158/1078-0432.CCR-04-0713, 10.1158/1078-0432.CCR-04-0713]; Cariani E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032493; Chang DH, 2005, J EXP MED, V201, P1503, DOI 10.1084/jem.20042592; Exley MA, 2004, HEPATOLOGY, V40, P1033, DOI 10.1002/hep.20433; Fu JL, 2007, GASTROENTEROLOGY, V132, P2328, DOI 10.1053/j.gastro.2007.03.102; Gao B, 2008, HEPATOLOGY, V47, P729, DOI 10.1002/hep.22034; Gao Q, 2008, J CANCER RES CLIN, V134, P979, DOI 10.1007/s00432-008-0369-3; Gao Q, 2007, J CLIN ONCOL, V25, P2586, DOI 10.1200/JCO.2006.09.4565; Gao Q, 2009, CLIN CANCER RES, V15, P971, DOI 10.1158/1078-0432.CCR-08-1608; Giaccone G, 2002, CLIN CANCER RES, V8, P3702; Godfrey DI, 2004, NAT REV IMMUNOL, V4, P231, DOI 10.1038/nri1309; Hasegawa K, 2005, ANN SURG, V242, P252, DOI 10.1097/01.sla.0000171307.37401.db; Ishikawa A, 2005, CLIN CANCER RES, V11, P1910, DOI 10.1158/1078-0432.CCR-04-1453; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20115, 10.3322/caac.20107]; Ju MJ, 2009, AM J CLIN PATHOL, V131, P498, DOI 10.1309/AJCP86PPBNGOHNNL; Kronenberg M, 2005, ANNU REV IMMUNOL, V23, P877, DOI 10.1146/annurev.immunol.23.021704.115742; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Margalit M, 2005, INT J CANCER, V115, P443, DOI 10.1002/ijc.20889; Metelitsa LS, 2004, J EXP MED, V199, P1213, DOI 10.1084/jem.20031462; Miyagi T, 2003, INT J CANCER, V106, P81, DOI 10.1002/ijc.11163; Molling JW, 2007, J CLIN ONCOL, V25, P862, DOI 10.1200/JCO.2006.08.5787; Motohashi S, 2006, CLIN CANCER RES, V12, P6079, DOI 10.1158/1078-0432.CCR-06-0114; Nieda M, 2004, BLOOD, V103, P383, DOI 10.1182/blood-2003-04-1155; Notas G, 2009, CLIN IMMUNOL, V130, P16, DOI 10.1016/j.clim.2008.08.008; Poon RTP, 2007, ANN SURG, V245, P51, DOI 10.1097/01.sla.0000225255.01668.65; Portolani N, 2006, ANN SURG, V243, P229, DOI 10.1097/01.sla.0000197706.21803.a1; Racanelli V, 2006, HEPATOLOGY, V43, pS54, DOI 10.1002/hep.21060; Sasaki A, 2008, EJSO-EUR J SURG ONC, V34, P173, DOI 10.1016/j.ejso.2007.08.008; Schoenborn JR, 2007, ADV IMMUNOL, V96, P41, DOI 10.1016/S0065-2776(07)96002-2; Seino K, 2005, J EXP MED, V202, P1623, DOI 10.1084/jem.20051600; Shah SA, 2007, SURGERY, V141, P330, DOI 10.1016/j.surg.2006.06.028; Shibolet O, 2003, INT J CANCER, V106, P236, DOI 10.1002/ijc.11201; Sobin L, 2002, TNM CLASSIFICATION M, P81; Sun HC, 2007, J SURG ONCOL, V96, P37, DOI 10.1002/jso.20772; Tachibana T, 2005, CLIN CANCER RES, V11, P7322, DOI 10.1158/1078-0432.CCR-05-0877; Taniguchi M, 2003, ANNU REV IMMUNOL, V21, P483, DOI 10.1146/annurev.immunol.21.120601.141057; Terabe M, 2007, TRENDS IMMUNOL, V28, P491, DOI 10.1016/j.it.2007.05.008; Van Kaer L, 2007, CURR OPIN IMMUNOL, V19, P354, DOI 10.1016/j.coi.2007.03.001; Vijayanand P, 2007, NEW ENGL J MED, V356, P1410, DOI 10.1056/NEJMoa064691; Watarai H, 2008, NAT PROTOC, V3, P70, DOI 10.1038/nprot.2007.515; Zigmond E, 2008, J AUTOIMMUN, V31, P188, DOI 10.1016/j.jaut.2008.07.003	48	20	20	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2013	8	8							e70345	10.1371/journal.pone.0070345	http://dx.doi.org/10.1371/journal.pone.0070345			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	218XC	23940564	Green Published, Green Submitted, gold			2022-12-25	WOS:000324465000058
J	Samsonov, A; Zenser, N; Zhang, F; Zhang, HY; Fetter, J; Malkov, D				Samsonov, Andrey; Zenser, Nathan; Zhang, Fan; Zhang, Hongyi; Fetter, John; Malkov, Dmitry			Tagging of Genomic STAT3 and STAT1 with Fluorescent Proteins and Insertion of a Luciferase Reporter in the Cyclin D1 Gene Provides a Modified A549 Cell Line to Screen for Selective STAT3 Inhibitors	PLOS ONE			English	Article							SIGNAL TRANSDUCER; CANCER; ACTIVATION; EXPRESSION; INTERFERON; INFLAMMATION; THERAPY	Signal transducer and activator of transcription 3 (STAT3) is an oncogenic protein that is constitutively activated in numerous cancer cell lines and human cancers. Another STAT family member, STAT1, possesses cancer-inhibitory properties and can promote apoptosis in tumor cells upon activation. To better characterize these important cancer related genes, we tagged STAT3 and STAT1 loci with fluorescent protein (FP) sequences (RFP and GFP respectively) by targeted integration via zinc finger nuclease (ZFN) - mediated homologous recombination in A549 cells that express aberrantly activated STAT3. We inserted the FP transgenes at the N-terminus of the STAT3 locus and at the C-terminus of the STAT1 locus. The integration resulted in endogenous expression of fluorescent STAT3 and STAT1 chimeric fusion proteins. When stimulated with IL-6 or IFN-gamma, the cells showed robust nuclear translocation of RFP-STAT3 or STAT1-GFP, respectively. Pre-incubation of cells with a known specific STAT3 inhibitor showed that IFN-gamma-induced translocation of STAT1-GFP was not impaired. STAT3 activates multiple downstream targets such as genes involved in cell cycle progression - e.g. cyclin D1. To detect changes in expression of endogenous cyclin D1, we used ZFN technology to insert a secreted luciferase reporter behind the cyclin D1 promoter and separated the luciferase and cyclin D1 coding regions by a 2A sequence to induce a translational skip. The luciferase insertion was made in the RFP-STAT3/STAT1-GFP cell line to have all three reporters in a single cell line. Addition of a STAT3 inhibitor led to suppression of cyclin D1 promoter activity and cell growth arrest. The triple-modified cell line provides a simple and convenient method for high-content screening and pre-clinical testing of potential STAT3 inhibitors in live cells while ensuring that the STAT1 pathway is not affected. This approach of reporting endogenous gene activities using ZFN technology could be applied to other cancer targets.	[Samsonov, Andrey; Zenser, Nathan; Zhang, Fan; Zhang, Hongyi; Fetter, John; Malkov, Dmitry] Sigma Aldrich, Cell Based Assays Reporter Cell Lines, St Louis, MO USA	Merck KGaA; MilliporeSigma	Malkov, D (corresponding author), Sigma Aldrich, Cell Based Assays Reporter Cell Lines, St Louis, MO USA.	dmitry.malkov@sial.com			SIGMA-ALDRICH	SIGMA-ALDRICH	SIGMA-ALDRICH has funded this work and approved its publishing. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adach A, 2009, METHODS MOL BIOL, V512, P265, DOI 10.1007/978-1-60327-530-9_14; Aggarwal BB, 2006, ANN NY ACAD SCI, V1091, P151, DOI 10.1196/annals.1378.063; Battle TE, 2006, CANCER RES, V66, P3649, DOI 10.1158/0008-5472.CAN-05-3612; Bill MA, 2012, MOL CANCER, V9, P165; Bromberg JF, 1999, CELL, V98, P295, DOI 10.1016/S0092-8674(00)81959-5; Cheon H, 2011, J INTERF CYTOK RES, V31, P33, DOI 10.1089/jir.2010.0100; Cimica V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020188; Daly J, 2012, IMPROVED LIGHT-EMITTING MOLECULES, Patent No. [WO2012071631, 2012071631]; Debnath B, 2012, J MED CHEM; Donnelly MLL, 2001, J GEN VIROL, V82, P1013, DOI 10.1099/0022-1317-82-5-1013; Doyon JB, 2011, NAT CELL BIOL, V13, P331, DOI 10.1038/ncb2175; Doyon Y, 2010, NAT METHODS, V7, P459, DOI [10.1038/NMETH.1456, 10.1038/nmeth.1456]; Driscoll B, 1999, AM J PHYSIOL-LUNG C, V276, pL679, DOI 10.1152/ajplung.1999.276.4.L679; Elliott B, 1998, MOL CELL BIOL, V18, P93, DOI 10.1128/MCB.18.1.93; Funston GM, 2008, J GEN VIROL, V89, P389, DOI 10.1099/vir.0.83444-0; Gao L, 2011, BRIT J PHARMACOL, V162, P633, DOI 10.1111/j.1476-5381.2010.01071.x; Goldberg AD, 2010, CELL, V140, P678, DOI 10.1016/j.cell.2010.01.003; Hoey T, 1998, CURR OPIN GENET DEV, V8, P582, DOI 10.1016/S0959-437X(98)80015-4; Isaka T, 2003, J HISTOCHEM CYTOCHEM, V51, P1343, DOI 10.1177/002215540305101011; Jing N, 2005, ANTI-CANCER DRUG, V16, P601, DOI 10.1097/00001813-200507000-00002; Jing NJ, 2006, MOL CANCER THER, V5, P279, DOI 10.1158/1535-7163.MCT-05-0302; Johnston PA, 2011, MOL INTERV, V11, P18, DOI 10.1124/mi.11.1.4; Katze MG, 2002, NAT REV IMMUNOL, V2, P675, DOI 10.1038/nri888; Kulinski J, 2000, BIOTECHNIQUES, V29, P44, DOI 10.2144/00291bm07; Lim CP, 2006, MOL BIOSYST, V2, P536, DOI 10.1039/b606246f; Lu Hsu-Fung, 2007, Cancer Genomics & Proteomics, V4, P93; Miller JC, 2007, NAT BIOTECHNOL, V25, P778, DOI 10.1038/nbt1319; Moynahan ME, 2010, NAT REV MOL CELL BIO, V11, P196, DOI 10.1038/nrm2851; Porteus MH, 2006, MOL THER, V13, P438, DOI 10.1016/j.ymthe.2005.08.003; Sauter ER, 1999, CANCER RES, V59, P4876; Schust J, 2006, CHEM BIOL, V13, P1235, DOI 10.1016/j.chembiol.2006.09.018; Sharp ZD, 2006, J CELL SCI, V119, P4101, DOI 10.1242/jcs.03161; Siddiquee K, 2007, P NATL ACAD SCI USA, V104, P7391, DOI 10.1073/pnas.0609757104; Snapp EL, 2009, TRENDS CELL BIOL, V19, P649, DOI 10.1016/j.tcb.2009.08.002; Song LX, 2003, ONCOGENE, V22, P4150, DOI 10.1038/sj.onc.1206479; Thyrell L, 2007, EXP CELL RES, V313, P4015, DOI 10.1016/j.yexcr.2007.08.007; Wang J, 2012, INT J OPT, V2012, DOI 10.1155/2012/575429; Wesoly J, 2007, ACTA BIOCHIM POL, V54, P27, DOI 10.18388/abp.2007_3266; Xu XJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004783; Yin ZJ, 2011, J SURG RES, V171, P675, DOI 10.1016/j.jss.2010.03.053; Yu H, 2009, NAT REV CANCER, V9, P798, DOI 10.1038/nrc2734; Zhang XL, 2010, BIOCHEM PHARMACOL, V79, P1398, DOI 10.1016/j.bcp.2010.01.001; Zhao M, 2011, LUNG CANCER, V73, P366, DOI 10.1016/j.lungcan.2011.01.002; Zhao SH, 2011, RADIOL ONCOL, V45, P196, DOI 10.2478/v10019-011-0013-8	44	22	23	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2013	8	7							e68391	10.1371/journal.pone.0068391	http://dx.doi.org/10.1371/journal.pone.0068391			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182JD	23950841	Green Published, gold, Green Submitted			2022-12-25	WOS:000321736900084
J	Viswakarma, N; Jia, YZ; Bai, L; Gao, Q; Lin, BL; Zhang, XH; Misra, P; Rana, A; Jain, S; Gonzalez, FJ; Zhu, YJ; Thimmapaya, B; Reddy, JK				Viswakarma, Navin; Jia, Yuzhi; Bai, Liang; Gao, Qian; Lin, Bingliang; Zhang, Xiaohong; Misra, Parimal; Rana, Ajay; Jain, Sanjay; Gonzalez, Frank J.; Zhu, Yi-Jun; Thimmapaya, Bayar; Reddy, Janardan K.			The Med1 Subunit of the Mediator Complex Induces Liver Cell Proliferation and Is Phosphorylated by AMP Kinase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED PROTEIN-KINASE; RECEPTOR-BINDING PROTEIN; RNA-POLYMERASE-II; PEROXISOME-PROLIFERATOR; MOUSE-LIVER; TRANSCRIPTIONAL COACTIVATOR; (PPAR)-BINDING PROTEIN; HEPATIC STEATOSIS; TRAP220 COMPONENT; NUCLEAR RECEPTORS	Mediator, a large multisubunit protein complex, plays a pivotal role in gene transcription by linking gene-specific transcription factors with the preinitiation complex and RNA polymerase II. In the liver, the key subunit of the Mediator complex, Med1, interacts with several nuclear receptors and transcription factors to direct gene-specific transcription. Conditional knock-out of Med1 in the liver showed that hepatocytes lacking Med1 did not regenerate following either partial hepatectomy or treatment with certain nuclear receptor activators and failed to give rise to tumors when challenged with carcinogens. We now report that the adenovirally driven overexpression of Med1 in mouse liver stimulates hepatocyte DNA synthesis with enhanced expression of DNA replication, cell cycle control, and liver-specific genes, indicating that Med1 alone is necessary and sufficient for liver cell proliferation. Importantly, we demonstrate that AMP-activated protein kinase (AMPK), an important cellular energy sensor, interacts with, and directly phosphorylates, Med1 in vitro at serine 656, serine 756, and serine 796. AMPK also phosphorylates Med1 in vivo in mouse liver and in cultured primary hepatocytes and HEK293 and HeLa cells. In addition, we demonstrate that PPAR alpha activators increase AMPK-mediated Med1 phosphorylation in vivo. Inhibition of AMPK by compound C decreased hepatocyte proliferation induced by Med1 and also by the PPAR alpha activators fenofibrate and Wy-14,643. Co-treatment with compound C attenuated PPAR alpha activator-inducible fatty acid beta-oxidation in liver. Our results suggest that Med1 phosphorylation by its association with AMPK regulates liver cell proliferation and fatty acid oxidation, most likely as a downstream effector of PPAR alpha and AMPK.	[Viswakarma, Navin; Jia, Yuzhi; Bai, Liang; Gao, Qian; Lin, Bingliang; Zhang, Xiaohong; Zhu, Yi-Jun; Reddy, Janardan K.] Northwestern Univ, Feinberg Sch Med, Dept Pathol, Chicago, IL 60611 USA; [Misra, Parimal] Dr Reddys Inst Life Sci, Hyderabad 500046, Andhra Pradesh, India; [Rana, Ajay] Loyola Univ Chicago, Dept Mol Pharmacol & Therapeut, Maywood, IL 60153 USA; [Jain, Sanjay] Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA; [Gonzalez, Frank J.] NCI, Lab Metab, Ctr Canc Res, NIH, Bethesda, MD 20892 USA; [Thimmapaya, Bayar] Northwestern Univ, Feinberg Sch Med, Dept Microbiol & Immunol, Chicago, IL 60611 USA	Northwestern University; Feinberg School of Medicine; Loyola University Chicago; Washington University (WUSTL); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Northwestern University; Feinberg School of Medicine	Reddy, JK (corresponding author), 303 E Chicago Ave, Chicago, IL 60611 USA.	jkreddy@northwestern.edu	Rana, Ajay/ABE-3739-2020	Rana, Ajay/0000-0003-0951-2566; jain, sanjay/0000-0003-2804-127X	National Institutes of Health Cancer Center [NIH CA06600553]; NATIONAL CANCER INSTITUTE [P30CA060553, ZIABC005708] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK097249, R01DK083163, R56DK083163] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM055835] Funding Source: NIH RePORTER	National Institutes of Health Cancer Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Dr. Samuel G. Mackintosh (Department of Biochemistry and Molecular Biology, University of Arkansas for Medical Sciences, Little Rock) for his generous help with LC-MS/MS studies. We express our appreciation to Dr. Aurore Vluggens for her participation in the early phases of this work. We also thank Rahil Hasan, Sandeep Bharadwaj, and Izer Martinez for their participation in this work as summer students and Dr. Nadereh Zafri for helpful discussions on microarray studies. The genomic core facility used in this study was supported by National Institutes of Health Cancer Center Support Grant NIH CA06600553.	Apte U, 2008, HEPATOLOGY, V47, P288, DOI 10.1002/hep.21973; Bai LA, 2011, HEPATOLOGY, V53, P1164, DOI 10.1002/hep.24155; Belakavadi M, 2008, MOL CELL BIOL, V28, P3932, DOI 10.1128/MCB.02191-07; Boden G, 2001, DIABETES, V50, P810, DOI 10.2337/diabetes.50.4.810; BUCHER NLR, 1963, INT REV CYTOL, V15, P245, DOI 10.1016/S0074-7696(08)61119-5; Carling D, 2012, BIOCHEM J, V445, P11, DOI 10.1042/BJ20120546; Chen W, 2011, SEMIN CELL DEV BIOL, V22, P749, DOI 10.1016/j.semcdb.2011.07.026; Chen W, 2010, P NATL ACAD SCI USA, V107, P10196, DOI 10.1073/pnas.1005626107; Chen WL, 2012, BIOCHEM PHARMACOL, V84, P522, DOI 10.1016/j.bcp.2012.05.022; Chen Z, 2011, EMBO J, V30, P2405, DOI 10.1038/emboj.2011.154; Crawford SE, 2002, J BIOL CHEM, V277, P3585, DOI 10.1074/jbc.M107995200; Cui JJ, 2012, CANCER RES, V72, P5625, DOI 10.1158/0008-5472.CAN-12-1305; Frade R, 2000, CANCER RES, V60, P6585; Greer EL, 2007, J BIOL CHEM, V282, P30107, DOI 10.1074/jbc.M705325200; Gwinn DM, 2008, MOL CELL, V30, P214, DOI 10.1016/j.molcel.2008.03.003; Hardie DG, 2013, BMC BIOL, V11, DOI 10.1186/1741-7007-11-36; Hardie DG, 2012, NAT REV MOL CELL BIO, V13, P251, DOI 10.1038/nrm3311; Hardie DG, 2003, FEBS LETT, V546, P113, DOI 10.1016/S0014-5793(03)00560-X; Hasegawa N, 2012, MOL CELL BIOL, V32, P1483, DOI 10.1128/MCB.05245-11; Hayashi T, 1998, DIABETES, V47, P1369, DOI 10.2337/diabetes.47.8.1369; Huang JS, 2007, HEPATOLOGY, V46, P147, DOI 10.1002/hep.21632; Huang JS, 2011, MOL PATHOL LIB, V5, P133, DOI 10.1007/978-1-4419-7107-4_10; Inoki K, 2003, CELL, V115, P577, DOI 10.1016/S0092-8674(03)00929-2; Ito M, 2000, MOL CELL, V5, P683, DOI 10.1016/S1097-2765(00)80247-6; Jager S, 2007, P NATL ACAD SCI USA, V104, P12017, DOI 10.1073/pnas.0705070104; Jia YZ, 2009, GENE EXPRESSION, V14, P291, DOI 10.3727/105221609788681213; Jia YZ, 2005, P NATL ACAD SCI USA, V102, P12531, DOI 10.1073/pnas.0506000102; Jia YZ, 2004, J BIOL CHEM, V279, P24427, DOI 10.1074/jbc.M402391200; Jin F, 2013, MOL CANCER RES, V11, P736, DOI 10.1158/1541-7786.MCR-12-0618; Kim HJ, 2012, CANCER LETT, V321, P195, DOI 10.1016/j.canlet.2012.02.009; KIM YJ, 1994, CELL, V77, P599, DOI 10.1016/0092-8674(94)90221-6; Kornberg R, 2007, ANGEW CHEM INT EDIT, V46, P6957, DOI 10.1002/anie.200701832; Krebs P, 2011, P NATL ACAD SCI USA, V108, P19678, DOI 10.1073/pnas.1117835108; Krupczak-Hollis K, 2004, DEV BIOL, V276, P74, DOI 10.1016/j.ydbio.2004.08.022; Lamy PJ, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2824; Landles C, 2003, MOL ENDOCRINOL, V17, P2418, DOI 10.1210/me.2003-0097; Lee JHW, 2009, J HYDRO-ENVIRON RES, V3, P1, DOI 10.1016/j.jher.2009.05.002; Lee SK, 2012, CELL SIGNAL, V24, P2329, DOI 10.1016/j.cellsig.2012.07.022; LEE SST, 1995, MOL CELL BIOL, V15, P3012; Lee WH, 2010, PPAR RES, V2010, DOI 10.1155/2010/549101; Li Y, 2011, CELL METAB, V13, P376, DOI 10.1016/j.cmet.2011.03.009; Liangpunsakul S, 2009, ARCH BIOCHEM BIOPHYS, V485, P10, DOI 10.1016/j.abb.2009.02.006; Locker J, 2003, HEPATOLOGY, V38, P314, DOI 10.1053/jhep.2003.50299; Matsumoto K, 2007, J BIOL CHEM, V282, P17053, DOI 10.1074/jbc.M701956200; Matsumoto K, 2010, CARCINOGENESIS, V31, P318, DOI 10.1093/carcin/bgp306; Meng RS, 2011, ARCH BIOCHEM BIOPHYS, V511, P1, DOI 10.1016/j.abb.2011.04.010; Michalopoulos GK, 1997, SCIENCE, V276, P60, DOI 10.1126/science.276.5309.60; Misra P, 2002, J BIOL CHEM, V277, P48745, DOI 10.1074/jbc.M208829200; Murakami H, 2006, BIOCHEM BIOPH RES CO, V341, P973, DOI 10.1016/j.bbrc.2006.01.052; Pyper S.R., 2010, NUCL RECEPT SIGNAL, V8; Rachez C, 1999, NATURE, V398, P824, DOI 10.1038/19783; Rana A, 1996, J BIOL CHEM, V271, P19025, DOI 10.1074/jbc.271.32.19025; REDDY JK, 1979, CANCER RES, V39, P152; Reddy JK, 2001, ANNU REV NUTR, V21, P193, DOI 10.1146/annurev.nutr.21.1.193; Riehle KJ, 2011, J GASTROEN HEPATOL, V26, P203, DOI 10.1111/j.1440-1746.2010.06539.x; Ryu SJ, 1999, NATURE, V397, P446, DOI 10.1038/17141; Sanders Jennifer A., 2012, BMC Physiology, V12, P1, DOI 10.1186/1472-6793-12-1; Shaw RJ, 2012, SCIENCE, V336, P813, DOI 10.1126/science.1223140; Shaw RJ, 2005, SCIENCE, V310, P1642, DOI 10.1126/science.1120781; Solaz-Fuster MC, 2006, CELL SIGNAL, V18, P1702, DOI 10.1016/j.cellsig.2006.01.021; Taub R, 2004, NAT REV MOL CELL BIO, V5, P836, DOI 10.1038/nrm1489; Viswakarma N, 2010, PPAR RES, V2010, DOI 10.1155/2010/250126; Walsh C., 2006, POSTTRANSLATIONAL MO; White P, 2005, J BIOL CHEM, V280, P3715, DOI 10.1074/jbc.M410844200; Wolf J, 2010, FEBS J, V277, P3268, DOI 10.1111/j.1742-4658.2010.07739.x; Yu ST, 2001, J BIOL CHEM, V276, P42485, DOI 10.1074/jbc.M106480200; Yuan CX, 1998, P NATL ACAD SCI USA, V95, P7939, DOI 10.1073/pnas.95.14.7939; Zhang XT, 2005, MOL CELL, V19, P89, DOI 10.1016/j.molcel.2005.05.015; Zhou GC, 2001, J CLIN INVEST, V108, P1167, DOI 10.1172/JCI200113505; Zhu YJ, 2000, J BIOL CHEM, V275, P14779, DOI 10.1074/jbc.C000121200; Zhu YJ, 1997, J BIOL CHEM, V272, P25500, DOI 10.1074/jbc.272.41.25500; Zhu YJ, 1999, P NATL ACAD SCI USA, V96, P10848, DOI 10.1073/pnas.96.19.10848	72	17	18	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 27	2013	288	39					27898	27911		10.1074/jbc.M113.486696	http://dx.doi.org/10.1074/jbc.M113.486696			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302OB	23943624	hybrid, Green Published			2022-12-25	WOS:000330612800018
J	Nihira, T; Suzuki, E; Kitaoka, M; Nishimoto, M; Ohtsubo, K; Nakai, H				Nihira, Takanori; Suzuki, Erika; Kitaoka, Motomitsu; Nishimoto, Mamoru; Ohtsubo, Ken'ichi; Nakai, Hiroyuki			Discovery of beta-1,4-D-Mannosyl-N-acetyl-D-glucosamine Phosphorylase Involved in the Metabolism of N-Glycans	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EXTENSIVE DNA INVERSIONS; COMPLETE GENOME SEQUENCE; BACTEROIDES-THETAIOTAOMICRON; LAMINARIBIOSE PHOSPHORYLASE; BIOSE PHOSPHORYLASE; GUT; IDENTIFICATION; PREDICTION; MICROBIOTA; MECHANISM	A gene cluster involved in N-glycan metabolism was identified in the genome of Bacteroides thetaiotaomicron VPI-5482. This gene cluster encodes a major facilitator superfamily transporter, a starch utilization system-like transporter consisting of a TonB-dependent oligosaccharide transporter and an outer membrane lipoprotein, four glycoside hydrolases (alpha-mannosidase, beta-N-acetylhexosaminidase, exo-alpha-sialidase, and endo-beta-N-acetylglucosaminidase), and a phosphorylase (BT1033) with unknown function. It was demonstrated that BT1033 catalyzed the reversible phosphorolysis of beta-1,4-D-mannosyl-N-acetyl-D-glucosamine in a typical sequential Bi Bi mechanism. These results indicate that BT1033 plays a crucial role as a key enzyme in the N-glycan catabolism where beta-1,4-D-mannosyl-N-acetyl-D-glucosamine is liberated from N-glycans by sequential glycoside hydrolase-catalyzed reactions, transported into the cell, and intracellularly converted into alpha-D-mannose 1-phosphate and N-acetyl-D-glucosamine. In addition, intestinal anaerobic bacteria such as Bacteroides fragilis, Bacteroides helcogenes, Bacteroides salanitronis, Bacteroides vulgatus, Prevotella denticola, Prevotella dentalis, Prevotella melaninogenica, Parabacteroides distasonis, and Alistipes finegoldii were also suggested to possess the similar metabolic pathway for N-glycans. A notable feature of the new metabolic pathway for N-glycans is the more efficient use of ATP-stored energy, in comparison with the conventional pathway where beta-mannosidase and ATP-dependent hexokinase participate, because it is possible to directly phosphorylate the D-mannose residue of beta-1,4-D-mannosyl-N-acetyl-D-glucosamine to enter glycolysis. This is the first report of a metabolic pathway for N-glycans that includes a phosphorylase. We propose 4-O-beta-D-mannopyranosyl-N-acetyl-D-glucosamine:phosphate alpha-D-mannosyltransferase as the systematic name and beta-1,4-D-mannosyl-N-acetyl-D-glucosamine phosphorylase as the short name for BT1033.	[Nihira, Takanori; Suzuki, Erika; Ohtsubo, Ken'ichi; Nakai, Hiroyuki] Niigata Univ, Fac Agr, Niigata 9502181, Japan; [Kitaoka, Motomitsu; Nishimoto, Mamoru] Natl Agr & Food Res Org, Natl Food Res Inst, Tsukuba, Ibaraki 3058642, Japan	Niigata University; National Agriculture & Food Research Organization - Japan; National Food Research Institute - Japan	Nakai, H (corresponding author), Niigata Univ, Fac Agr, Nishi Ku, 8050 Ikarashi 2 No Cho, Niigata 9502181, Japan.	nakai@agr.niigata-u.ac.jp	Ohtsubo, Kenichi/AAW-1700-2020; Kitaoka, Motomitsu/R-1536-2019	Ohtsubo, Kenichi/0000-0001-9354-3087; Kitaoka, Motomitsu/0000-0002-0083-1838	MEXT Promotion of Environmental Improvement for Independence of Young Researchers Program under the Special Coordination Funds for Promoting Science and Technology; Sapporo Bioscience Foundation Research Grant	MEXT Promotion of Environmental Improvement for Independence of Young Researchers Program under the Special Coordination Funds for Promoting Science and Technology; Sapporo Bioscience Foundation Research Grant	This work was supported in part by the MEXT Promotion of Environmental Improvement for Independence of Young Researchers Program under the Special Coordination Funds for Promoting Science and Technology and Sapporo Bioscience Foundation Research Grant.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; [Anonymous], 2009, ESSENTIALS GLYCOBIOL; Bjursell MK, 2006, J BIOL CHEM, V281, P36269, DOI 10.1074/jbc.M606509200; Cerdeno-Tarraga AM, 2005, SCIENCE, V307, P1463, DOI 10.1126/science.1107008; Gardy JL, 2003, NUCLEIC ACIDS RES, V31, P3613, DOI 10.1093/nar/gkg602; Gronow S, 2011, STAND GENOMIC SCI, V4, P191, DOI 10.4056/sigs.1704212; HENRISSAT B, 1991, BIOCHEM J, V280, P309, DOI 10.1042/bj2800309; Hidaka M, 2004, STRUCTURE, V12, P937, DOI 10.1016/j.str.2004.03.027; Hidaka M, 2006, BIOCHEM J, V398, P37, DOI 10.1042/BJ20060274; Ito Y., 2001, GLYCOSCIENCE CHEM CH, V2, P1589; Kawahara R, 2012, J BIOL CHEM, V287, P42389, DOI 10.1074/jbc.M112.390336; Kitaoka M, 2005, APPL ENVIRON MICROB, V71, P3158, DOI 10.1128/AEM.71.6.3158-3162.2005; KITAOKA M, 1993, ARCH BIOCHEM BIOPHYS, V304, P508, DOI 10.1006/abbi.1993.1383; Kitaoka M, 2012, BIOSCI BIOTECH BIOCH, V76, P343, DOI 10.1271/bbb.110772; Koropatkin NM, 2012, NAT REV MICROBIOL, V10, P323, DOI 10.1038/nrmicro2746; Kuwahara T, 2004, P NATL ACAD SCI USA, V101, P14919, DOI 10.1073/pnas.0404172101; LOWRY OH, 1946, J BIOL CHEM, V162, P421; Martens EC, 2008, CELL HOST MICROBE, V4, P447, DOI 10.1016/j.chom.2008.09.007; Martens EC, 2009, J BIOL CHEM, V284, P24673, DOI 10.1074/jbc.R109.022848; Martens EC, 2009, J BIOL CHEM, V284, P18445, DOI 10.1074/jbc.M109.008094; Mohnen D, 2008, CURR OPIN PLANT BIOL, V11, P266, DOI 10.1016/j.pbi.2008.03.006; Nakai H, 2013, CURR OPIN CHEM BIOL, V17, P301, DOI 10.1016/j.cbpa.2013.01.006; Nakajima M, 2008, APPL MICROBIOL BIOT, V78, P465, DOI 10.1007/s00253-007-1319-8; Nakajima M, 2009, J BIOL CHEM, V284, P19220, DOI 10.1074/jbc.M109.007666; Nakayama-Imaohji H, 2012, J MED INVESTIG, V59, P79, DOI 10.2152/jmi.59.79; Nielsen H, 1997, PROTEIN ENG, V10, P1, DOI 10.1093/protein/10.1.1; Nihira T., 2013, J APPL GLYCOSCI, V60, P137; Nihira T, 2012, CARBOHYD RES, V361, P49, DOI 10.1016/j.carres.2012.08.006; Nihira T, 2012, CARBOHYD RES, V360, P25, DOI 10.1016/j.carres.2012.07.014; Nihira T, 2012, APPL MICROBIOL BIOT, V93, P1513, DOI 10.1007/s00253-011-3515-9; Nihira T, 2012, CARBOHYD RES, V350, P94, DOI 10.1016/j.carres.2011.12.019; Nishimoto M, 2007, BIOSCI BIOTECH BIOCH, V71, P2101, DOI 10.1271/bbb.70320; PACE CN, 1995, PROTEIN SCI, V4, P2411, DOI 10.1002/pro.5560041120; Pati A, 2011, STAND GENOMIC SCI, V4, P45, DOI 10.4056/sigs.1513795; Senoura T, 2011, BIOCHEM BIOPH RES CO, V408, P701, DOI 10.1016/j.bbrc.2011.04.095; Tap J, 2009, ENVIRON MICROBIOL, V11, P2574, DOI 10.1111/j.1462-2920.2009.01982.x; WHITE RJ, 1968, BIOCHEM J, V106, P847, DOI 10.1042/bj1060847; Xu J, 2003, P NATL ACAD SCI USA, V100, P10452, DOI 10.1073/pnas.1734063100; Xu J, 2007, PLOS BIOL, V5, P1574, DOI 10.1371/journal.pbio.0050156; Zocco MA, 2007, DIGEST LIVER DIS, V39, P707, DOI 10.1016/j.dld.2007.04.003	40	51	55	0	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 20	2013	288	38					27366	27374		10.1074/jbc.M113.469080	http://dx.doi.org/10.1074/jbc.M113.469080			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302IG	23943617	Green Published, hybrid			2022-12-25	WOS:000330597300032
J	Lin, JF; Sheih, YL; Chang, TC; Chang, NY; Chang, CW; Shen, CP; Lee, HJ				Lin, Jang-Foung; Sheih, Yung-Lin; Chang, Tsu-Chung; Chang, Ni-Yuan; Chang, Chiung-Wen; Shen, Chia-Pei; Lee, Hwei-Jen			The Interactions in the Carboxyl Terminus of Human 4-Hydroxyphenylpyruvate Dioxygenase Are Critical to Mediate the Conformation of the Final Helix and the Tail to Shield the Active Site for Catalysis	PLOS ONE			English	Article							P-HYDROXYPHENYLPYRUVATE DIOXYGENASE; 2-HIS-1-CARBOXYLATE FACIAL TRIAD; NONHEME IRON(II) ENZYMES; CRYSTAL-STRUCTURE; STREPTOMYCES-AVERMITILIS; (4-HYDROXYPHENYL)PYRUVATE DIOXYGENASE; HYDROXYMANDELATE SYNTHASE; PROLYL 4-HYDROXYLASE; STRUCTURAL BASIS; HERBICIDE	4-Hydroxylphenylpyruvate dioxygenase (4-HPPD) is an important enzyme for tyrosine catabolism, which catalyzes the conversion of 4-hydroxylphenylpyruvate (4-HPP) to homogentisate. In the present study, human 4-HPPD was cloned and expressed in E. coli. The kinetic parameters for 4-HPP conversion were: k(cat)=2.2 +/- 0.1 s(-1); and K-m=0.08 +/- 0.02 mM. Sequence alignments show that human 4-HPPD possesses an extended C-terminus compared to other 4-HPPD enzymes. Successive truncation of the disordered tail which follows the final alpha-helix resulted in no changes in the Km value for 4-HPP substrate but the k(cat) values were significantly reduced. The results suggest that this disordered C-terminal tail plays an important role in catalysis. For inspection the effect of terminal truncation on protein structure, mutant models were built. These models suggest that the different conformation of E254, R378 and Q375 in the final helix might be the cause of the activity loss. In the structure E254 interacts with R378, the end residue in the final helix; mutation of either one of these residues causes a ca. 95% reductions in k(cat) values. Q375 provides bifurcate interactions to fix the tail and the final helix in position. The model of the Q375N mutant shows that a solvent accessible channel opens to the putative substrate binding site, suggesting this is responsible for the complete loss of activity. These results highlight the critical role of Q375 in orientating the tail and ensuring the conformation of the terminal alpha-helix to maintain the integrity of the active site for catalysis.	[Lin, Jang-Foung; Sheih, Yung-Lin; Chang, Tsu-Chung; Chang, Ni-Yuan; Chang, Chiung-Wen; Shen, Chia-Pei; Lee, Hwei-Jen] Natl Def Med Ctr, Dept Biochem, Taipei 10764, Taiwan	National Defense Medical Center	Lee, HJ (corresponding author), Natl Def Med Ctr, Dept Biochem, Taipei 10764, Taiwan.	hjlee@mail.ndmctsgh.edu.tw			National Science Council [NSC 99-2311-B-016-001-MY3]; National Defense Medical Bureau [MAB101-49]	National Science Council(Ministry of Science and Technology, Taiwan); National Defense Medical Bureau	This study was supported financially by the National Science Council (NSC 99-2311-B-016-001-MY3) and National Defense Medical Bureau (MAB101-49). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brownlee JM, 2004, BIOCHEMISTRY-US, V43, P6370, DOI 10.1021/bi049317s; Brownlee J, 2008, BIOCHEMISTRY-US, V47, P2002, DOI 10.1021/bi701438r; Clifton IJ, 2006, J INORG BIOCHEM, V100, P644, DOI 10.1016/j.jinorgbio.2006.01.024; Crouch NP, 1996, BIOORG MED CHEM LETT, V5, P1255; DENOYA CD, 1994, J BACTERIOL, V176, P5312, DOI 10.1128/JB.176.17.5312-5319.1994; Dubus A, 2001, CELL MOL LIFE SCI, V58, P835, DOI 10.1007/PL00000904; Fritze IM, 2004, PLANT PHYSIOL, V134, P1388, DOI 10.1104/pp.103.034082; Garcia I, 1999, PLANT PHYSIOL, V119, P1507, DOI 10.1104/pp.119.4.1507; Garcia I, 2000, BIOCHEMISTRY-US, V39, P7501, DOI 10.1021/bi000135h; Goodwin T.W., 1983, INTRO PLANT BIOCH; Gunsior M, 2004, BIOCHEMISTRY-US, V43, P663, DOI 10.1021/bi035762w; HAN S, 1995, SCIENCE, V270, P976, DOI 10.1126/science.270.5238.976; Hausinger RP, 2004, CRIT REV BIOCHEM MOL, V39, P21, DOI 10.1080/10409230490440541; Hegg EL, 1997, EUR J BIOCHEM, V250, P625, DOI 10.1111/j.1432-1033.1997.t01-1-00625.x; Johnson-Winters K, 2005, BIOCHEMISTRY-US, V44, P7189, DOI 10.1021/bi047625k; Kita A, 1999, STRUCTURE, V7, P25, DOI 10.1016/S0969-2126(99)80006-9; Koehntop KD, 2005, J BIOL INORG CHEM, V10, P87, DOI 10.1007/s00775-005-0624-x; Lancaster DE, 2004, BIOCHEM J, V383, P429, DOI 10.1042/BJ20040735; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lee MH, 1996, FEBS LETT, V393, P269, DOI 10.1016/0014-5793(96)00902-7; LINDBLAD B, 1977, J BIOL CHEM, V252, P5073; MAJAMAA K, 1984, EUR J BIOCHEM, V138, P239, DOI 10.1111/j.1432-1033.1984.tb07907.x; McDonough MA, 2005, J BIOL CHEM, V280, P41101, DOI 10.1074/jbc.M507528200; Mitchell G, 2001, PEST MANAG SCI, V57, P120, DOI 10.1002/1526-4998(200102)57:2<120::AID-PS254>3.0.CO;2-E; Moran GR, 2005, ARCH BIOCHEM BIOPHYS, V433, P117, DOI 10.1016/j.abb.2004.08.015; MYLLYLA R, 1984, J BIOL CHEM, V259, P5403; Pilka ES, 2009, CRYSTAL STRUCTURE HU; Raspail C, 2011, J BIOL CHEM, V286, P26061, DOI 10.1074/jbc.M111.227595; RUETSCHI U, 1993, EUR J BIOCHEM, V213, P1081, DOI 10.1111/j.1432-1033.1993.tb17857.x; SABOURIN PJ, 1981, ARCH BIOCHEM BIOPHYS, V206, P132, DOI 10.1016/0003-9861(81)90074-6; SCHULZ A, 1993, FEBS LETT, V318, P162, DOI 10.1016/0014-5793(93)80013-K; Serre L, 1999, STRUCTURE, V7, P977, DOI 10.1016/S0969-2126(99)80124-5; Tomoeda K, 2000, MOL GENET METAB, V71, P506, DOI 10.1006/mgme.2000.3085; Valegard K, 2004, NAT STRUCT MOL BIOL, V11, P95, DOI 10.1038/nsmb712; Valegard K, 1998, NATURE, V394, P805, DOI 10.1038/29575; Yang C, 2004, BIOCHEMISTRY-US, V43, P10414, DOI 10.1021/bi049323o; You Z, 2007, J BIOL CHEM, V282, P36552, DOI 10.1074/jbc.M706358200	37	17	19	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 9	2013	8	8							e69733	10.1371/journal.pone.0069733	http://dx.doi.org/10.1371/journal.pone.0069733			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	245OM	23950902	Green Published, Green Submitted, gold			2022-12-25	WOS:000326473200006
J	Namjou, B; Kim-Howard, X; Sun, CL; Adler, A; Chung, SA; Kaufman, KM; Kelly, JA; Glenn, SB; Guthridge, JM; Scofield, RH; Kimberly, RP; Brown, EE; Alarcon, GS; Edberg, JC; Kim, JH; Choi, J; Ramsey-Goldman, R; Petri, MA; Reveille, JD; Vila, LM; Boackle, SA; Freedman, BI; Tsao, BP; Langefeld, CD; Vyse, TJ; Jacob, CO; Pons-Estel, B; Niewold, TB; Sivils, KLM; Merrill, JT; Anaya, JM; Gilkeson, GS; Gaffney, PM; Bae, SC; Alarcon-Riquelme, ME; Harley, JB; Criswell, LA; James, JA; Nath, SK				Namjou, Bahram; Kim-Howard, Xana; Sun, Celi; Adler, Adam; Chung, Sharon A.; Kaufman, Kenneth M.; Kelly, Jennifer A.; Glenn, Stuart B.; Guthridge, Joel M.; Scofield, Robert H.; Kimberly, Robert P.; Brown, Elizabeth E.; Alarcon, Graciela S.; Edberg, Jeffrey C.; Kim, Jae-Hoon; Choi, Jiyoung; Ramsey-Goldman, Rosalind; Petri, Michelle A.; Reveille, John D.; Vila, Luis M.; Boackle, Susan A.; Freedman, Barry I.; Tsao, Betty P.; Langefeld, Carl D.; Vyse, Timothy J.; Jacob, Chaim O.; Pons-Estel, Bernardo; Niewold, Timothy B.; Sivils, Kathy L. Moser; Merrill, Joan T.; Anaya, Juan-Manuel; Gilkeson, Gary S.; Gaffney, Patrick M.; Bae, Sang-Cheol; Alarcon-Riquelme, Marta E.; Harley, John B.; Criswell, Lindsey A.; James, Judith A.; Nath, Swapan K.		Argentine Collaborative Grp; BIOLUPUS GENLES Networks	PTPN22 Association in Systemic Lupus Erythematosus (SLE) with Respect to Individual Ancestry and Clinical Sub-Phenotypes	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; SINGLE-NUCLEOTIDE POLYMORPHISM; LYMPHOID TYROSINE PHOSPHATASE; OF-FUNCTION VARIANT; AUTOIMMUNE-DISEASE; RHEUMATOID-ARTHRITIS; R620W POLYMORPHISM; C1858T POLYMORPHISM; GENETIC ASSOCIATION; SUSCEPTIBILITY LOCI	Protein tyrosine phosphatase non-receptor type 22 (PTPN22) is a negative regulator of T-cell activation associated with several autoimmune diseases, including systemic lupus erythematosus (SLE). Missense rs2476601 is associated with SLE in individuals with European ancestry. Since the rs2476601 risk allele frequency differs dramatically across ethnicities, we assessed robustness of PTPN22 association with SLE and its clinical sub-phenotypes across four ethnically diverse populations. Ten SNPs were genotyped in 8220 SLE cases and 7369 controls from in European-Americans (EA), African-Americans (AA), Asians (AS), and Hispanics (HS). We performed imputation-based association followed by conditional analysis to identify independent associations. Significantly associated SNPs were tested for association with SLE clinical sub-phenotypes, including autoantibody profiles. Multiple testing was accounted for by using false discovery rate. We successfully imputed and tested allelic association for 107 SNPs within the PTPN22 region and detected evidence of ethnic-specific associations from EA and HS. In EA, the strongest association was at rs2476601 (P = 4.7 x 10(-9), OR = 1.40 (95% CI = 1.25-1.56)). Independent association with rs1217414 was also observed in EA, and both SNPs are correlated with increased European ancestry. For HS imputed intronic SNP, rs3765598, predicted to be a cis-eQTL, was associated (P = 0.007, OR = 0.79 and 95% CI = 0.67-0.94). No significant associations were observed in AA or AS. Case-only analysis using lupus-related clinical criteria revealed differences between EA SLE patients positive for moderate to high titers of IgG anti-cardiolipin (aCL IgG >20) versus negative aCL IgG at rs2476601 (P = 0.012, OR = 1.65). Association was reinforced when these cases were compared to controls (P = 2.7 x 10(-5), OR = 2.11). Our results validate that rs2476601 is the most significantly associated SNP in individuals with European ancestry. Additionally, rs1217414 and rs3765598 may be associated with SLE. Further studies are required to confirm the involvement of rs2476601 with aCL IgG.	[Namjou, Bahram; Kim-Howard, Xana; Sun, Celi; Adler, Adam; Kelly, Jennifer A.; Glenn, Stuart B.; Guthridge, Joel M.; Scofield, Robert H.; Sivils, Kathy L. Moser; Gaffney, Patrick M.; Alarcon-Riquelme, Marta E.; James, Judith A.; Nath, Swapan K.] Oklahoma Med Res Fdn, Arthrit & Clin Immunol Res Program, Oklahoma City, OK 73104 USA; [Namjou, Bahram; Kaufman, Kenneth M.; Harley, John B.] Cincinnati Childrens Hosp Med Ctr, Cincinnati, OH 45229 USA; [Chung, Sharon A.; Criswell, Lindsey A.] Univ Calif San Francisco, Rosalind Russell Med Res Ctr Arthrit, Dept Med, San Francisco, CA 94143 USA; [Kaufman, Kenneth M.; Harley, John B.] US Dept Vet Affairs, Med Ctr, Cincinnati, OH USA; [Scofield, Robert H.; James, Judith A.] Univ Oklahoma, Hlth Sci Ctr, Dept Med, Oklahoma City, OK USA; [Kimberly, Robert P.; Brown, Elizabeth E.; Alarcon, Graciela S.; Edberg, Jeffrey C.] Univ Alabama Birmingham, Dept Med, Birmingham, AL 35294 USA; [Kim, Jae-Hoon; Choi, Jiyoung; Bae, Sang-Cheol] Hanyang Univ, Hosp Rheumat Dis, Dept Rheumatol, Seoul 133791, South Korea; [Ramsey-Goldman, Rosalind] Northwestern Univ, Feinberg Sch Med, Div Rheumatol, Chicago, IL 60611 USA; [Petri, Michelle A.] Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD 21205 USA; [Reveille, John D.] Univ Texas Hlth Sci Ctr Houston, Dept Internal Med, Houston, TX 77030 USA; [Vila, Luis M.] Univ Puerto Rico Med Sci Campus, Dept Med, San Juan, PR USA; [Boackle, Susan A.] Univ Colorado, Sch Med, Div Rheumatol, Aurora, CO USA; [Freedman, Barry I.] Wake Forest Univ Hlth Sci, Ctr Publ Hlth Genom, Wake Forest, NC USA; [Freedman, Barry I.; Langefeld, Carl D.] Wake Forest Univ Hlth Sci, Dept Biostat Sci, Wake Forest, NC USA; [Tsao, Betty P.] Univ Calif Los Angeles, Div Rheumatol, Los Angeles, CA USA; [Vyse, Timothy J.] Kings Coll London, Div Genet & Mol Med, London, England; [Vyse, Timothy J.] Kings Coll London, Div Immunol, London, England; [Jacob, Chaim O.] Univ So Calif, Keck Sch Med, Dept Med, Los Angeles, CA 90033 USA; [Pons-Estel, Bernardo] Sanatorio Parque, Dept Med, Rosario, Santa Fe, Argentina; [Niewold, Timothy B.] Mayo Clin, Div Rheumatol, Rochester, MN USA; [Niewold, Timothy B.] Mayo Clin, Dept Immunol, Rochester, MN USA; [Merrill, Joan T.] Oklahoma Med Res Fdn, Oklahoma City, OK 73104 USA; [Anaya, Juan-Manuel] Univ Rosario, Ctr Autoimmune Dis Res, Bogota, Colombia; [Gilkeson, Gary S.] Med Univ S Carolina, Dept Med, Div Rheumatol, Charleston, SC 29425 USA; [Alarcon-Riquelme, Marta E.] Pfizer Univ Granada Junta Andalucia, Ctr Genom & Invest Oncol GENYO, Granada, Spain	Oklahoma Medical Research Foundation; Cincinnati Children's Hospital Medical Center; University of California System; University of California San Francisco; US Department of Veterans Affairs; Veterans Health Administration (VHA); Cincinnati VA Medical Center; University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Alabama System; University of Alabama Birmingham; Hanyang University; Northwestern University; Feinberg School of Medicine; Johns Hopkins University; University of Texas System; University of Texas Health Science Center Houston; University of Puerto Rico; University of Puerto Rico Medical Sciences Campus; University of Colorado System; University of Colorado Anschutz Medical Campus; Wake Forest University; Wake Forest University School of Medicine; Wake Forest University; Wake Forest University School of Medicine; University of California System; University of California Los Angeles; University of London; King's College London; University of London; King's College London; University of Southern California; Mayo Clinic; Mayo Clinic; Oklahoma Medical Research Foundation; Universidad del Rosario; Medical University of South Carolina; Pfizer; University of Granada	Nath, SK (corresponding author), Oklahoma Med Res Fdn, Arthrit & Clin Immunol Res Program, 825 NE 13th St, Oklahoma City, OK 73104 USA.	Swapan-nath@omrf.org	Alarcón-Riquelme, Marta E./ABF-8163-2020; Witte, Torsten/B-5783-2016; Centeno, Norberto Ortego/C-4793-2019; Scofield, Robert Hal/AEJ-8314-2022; Martin, Javier/B-8141-2008; D'Alfonso, Sandra/K-7295-2014; Bae, Sang-Cheol/P-2051-2015; Anaya, Juan-Manuel/J-1960-2016; Merrill, Joan/HDL-9141-2022; Niewold, Timothy/D-2669-2018	Alarcón-Riquelme, Marta E./0000-0002-7632-4154; Centeno, Norberto Ortego/0000-0003-2325-0937; Martin, Javier/0000-0002-2202-0622; D'Alfonso, Sandra/0000-0002-3983-9925; Anaya, Juan-Manuel/0000-0002-6444-1249; Kim, Jae-Hoon/0000-0002-4756-1281; Universidad del Rosario, Biblioteca/0000-0003-3491-9392; Kelly, Jennifer/0000-0002-3203-2467; Kimberly, Robert/0000-0002-5330-3086; Guthridge, Joel/0000-0002-9308-237X; Tsao, Betty/0000-0001-7938-5975; Vasconcelos, Carlos/0000-0002-8073-5028; Silva, Berta/0000-0001-6579-5068; Bae, Sang-Cheol/0000-0003-4658-1093; Frostegard, Johan/0000-0002-3569-3367; Gaffney, Patrick/0000-0002-1580-869X; Niewold, Timothy/0000-0003-3532-6660; Pons-Estel, Bernardo/0000-0003-2518-0266; Berbotto, Guillermo/0000-0003-0264-6182	US National Institutes of Health [AR060366, AR053483, AR43814, AR049084, AR002138, AR030692, AR053308, AR057172, AI094377, AI101934, AI082714, AI070304, AI078004, AI063274, GM103510, GM103456, RR025741, RR020143]; National Center for Advancing Translational Research of the National Institutes of Health [UL1TR00165, UL1TR000004, UL1RR024131]; Alliance for Lupus Research; Kirkland Scholar Award; Korea Healthcare Technology RD Project; Ministry for Health and Welfare, Republic of Korea [A120404]; European Union; European Science Foundation; NATIONAL CANCER INSTITUTE [P30CA046934] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000165, UL1TR000004, UL1TR000154, UL1TR000150] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025741, P20RR020143, UL1RR024131] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI101934, R56AI063274, U19AI082714, R21AI103399, R21AI070304, P01AI083194, R01AI063274, R21AI094377, K24AI078004] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR057172, R01AR043814, P60AR030692, R55AR043814, P30AR053483, P01AR049084, P60AR062755, P60AR053308, R01AR060366, K24AR002138] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103456, P30GM103510] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Center for Advancing Translational Research of the National Institutes of Health; Alliance for Lupus Research; Kirkland Scholar Award; Korea Healthcare Technology RD Project; Ministry for Health and Welfare, Republic of Korea(Ministry of Health & Welfare (MOHW), Republic of Korea); European Union(European Commission); European Science Foundation(European Science Foundation (ESF)European Commission); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by grants from the US National Institutes of Health (AR060366, AR053483, AR43814, AR049084, AR002138, AR030692, AR053308, AR057172, AI094377, AI101934, AI082714, AI063274, AI070304, AI078004, AI063274, AI083194, AI078004, GM103510, GM103456, RR025741, and RR020143); National Center for Advancing Translational Research of the National Institutes of Health (UL1TR00165, UL1TR000004, and UL1RR024131); the Alliance for Lupus Research, Kirkland Scholar Award, the Korea Healthcare Technology R&D Project, Ministry for Health and Welfare, Republic of Korea (A120404). Instituto de Salud Carlos III partly financed through FEDER funds from the European Union; the BIOLUPUS Research Network is supported by funding from the European Science Foundation. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arechiga AF, 2009, J IMMUNOL, V182, P3343, DOI 10.4049/jimmunol.0713370; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Begovich AB, 2004, AM J HUM GENET, V75, P330, DOI 10.1086/422827; Behrens TW, 2011, NAT GENET, V43, P821, DOI 10.1038/ng.914; Bottini N, 2004, NAT GENET, V36, P337, DOI 10.1038/ng1323; Brownlie RJ, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2003365; Burn GL, 2011, FEBS LETT; Cambier JC, 2013, J CLIN INVEST, V123, P1928, DOI 10.1172/JCI69289; Canton I, 2005, GENES IMMUN, V6, P584, DOI 10.1038/sj.gene.6364243; Cooper GS, 2002, LUPUS, V11, P161, DOI 10.1191/0961203302lu161oa; Criswell LA, 2005, AM J HUM GENET, V76, P561, DOI 10.1086/429096; Curtin Karen, 2007, BMC Proc, V1 Suppl 1, pS12; Dai XZ, 2013, J CLIN INVEST, V123, P2024, DOI 10.1172/JCI66963; Diaz-Gallo L, 2011, ANN RHEUM DIS, V70, P454, DOI 10.1136/ard.2010.130138; DRENKARD C, 1994, J RHEUMATOL, V21, P1067; Dultz G, 2009, HORM METAB RES, V41, P426, DOI 10.1055/s-0029-1214414; Fernandez M, 2007, ARTHRIT RHEUM-ARTHR, V57, P576, DOI 10.1002/art.22672; Gianchecchi E., 2012, AUTOIMMUN REV; Gomez LM, 2005, GENES IMMUN, V6, P628, DOI 10.1038/sj.gene.6364261; Gregersen PK, 2006, SEMIN IMMUNOL, V18, P214, DOI 10.1016/j.smim.2006.03.009; Han JW, 2009, NAT GENET, V41, P1234, DOI 10.1038/ng.472; Harley JB, 2008, NAT GENET, V40, P204, DOI 10.1038/ng.81; HARRIS EN, 1987, CLIN EXP IMMUNOL, V68, P215; Hindorff LA, 2009, P NATL ACAD SCI USA, V106, P9362, DOI 10.1073/pnas.0903103106; Hinks A, 2005, ARTHRITIS RHEUM-US, V52, P1694, DOI 10.1002/art.21049; Hochberg MC, 1997, ARTHRITIS RHEUM, V40, P1725, DOI 10.1002/art.1780400928; Jagiello P, 2005, ARTHRITIS RHEUM-US, V52, P4039, DOI 10.1002/art.21487; Kaufman KM, 2006, ARTHRITIS RHEUM-US, V54, P2533, DOI 10.1002/art.21963; Kim KW, 2012, ENVIRON GEOCHEM HLTH, V34, P1, DOI 10.1007/s10653-011-9402-6; Kyogoku C, 2004, AM J HUM GENET, V75, P504, DOI 10.1086/423790; Lea WW, 2011, LUPUS, V20, P51, DOI 10.1177/0961203310381774; Lee YH, 2007, RHEUMATOLOGY, V46, P49, DOI 10.1093/rheumatology/kel170; Lessard CJ, 2011, AM J HUM GENET, V88, P83, DOI 10.1016/j.ajhg.2010.11.014; Manjarrez-Orduno N, 2012, NAT GENET, V44, P1227, DOI 10.1038/ng.2439; McClain MT, 2004, ARTHRITIS RHEUM-US, V50, P1226, DOI 10.1002/art.20120; Menard L, 2011, J CLIN INVEST, V121, P3635, DOI 10.1172/JCI45790; Mori M, 2005, J HUM GENET, V50, P264, DOI 10.1007/s10038-005-0246-8; Orozco G, 2005, ARTHRITIS RHEUM-US, V52, P219, DOI 10.1002/art.20771; Orru V, 2009, HUM MOL GENET, V18, P569, DOI 10.1093/hmg/ddn363; PETRI M, 1991, AM J MED, V91, P345, DOI 10.1016/0002-9343(91)90151-M; Piotrowski P, 2008, CLIN EXP RHEUMATOL, V26, P1099; Ploski R, 2009, J REPROD IMMUNOL, V79, P196, DOI 10.1016/j.jri.2008.11.004; Pradhan V, 2010, J POSTGRAD MED, V56, P239, DOI 10.4103/0022-3859.68651; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Pritchard JK, 1999, AM J HUM GENET, V65, P220, DOI 10.1086/302449; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Purcell S, 2007, BIOINFORMATICS, V23, P255, DOI 10.1093/bioinformatics/btl580; Reddy MVPL, 2005, GENES IMMUN, V6, P658, DOI 10.1038/sj.gene.6364252; Reveille JD, 1998, ARTHRITIS RHEUM, V41, P1161, DOI 10.1002/1529-0131(199807)41:7<1161::AID-ART4>3.0.CO;2-K; Rodriguez-Rodriguez L, 2011, ARTHRITIS RHEUM-US, V63, P365, DOI 10.1002/art.30145; Sanchez E, 2011, ARTHRITIS RHEUM-US, V63, P3493, DOI 10.1002/art.30563; Siminovitch KA, 2004, NAT GENET, V36, P1248, DOI 10.1038/ng1204-1248; Skinningsrud B, 2008, EUR J HUM GENET, V16, P977, DOI 10.1038/ejhg.2008.33; Smith RL, 2008, BRIT J DERMATOL, V158, P962, DOI 10.1111/j.1365-2133.2008.08482.x; TAN EM, 1982, ARTHRITIS RHEUM, V25, P1271, DOI 10.1002/art.1780251101; Totaro MC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024292; Vandiedonck C, 2006, ANN NEUROL, V59, P404, DOI 10.1002/ana.20751; Vang T, 2005, NAT GENET, V37, P1317, DOI 10.1038/ng1673; Vang T, 2013, HUM IMMUNOL; Velaga MR, 2004, J CLIN ENDOCR METAB, V89, P5862, DOI 10.1210/jc.2004-1108; Yang Li, 2006, AM J HUM GENET S, VS79, P2290; Yoo Yun Joo, 2007, BMC Proc, V1 Suppl 1, pS33; Zeller T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010693; Zhang JY, 2011, NAT GENET, V43, P902, DOI 10.1038/ng.904	64	48	48	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2013	8	8							e69404	10.1371/journal.pone.0069404	http://dx.doi.org/10.1371/journal.pone.0069404			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	200ZE	23950893	Green Accepted, Green Published, gold			2022-12-25	WOS:000323109700017
J	Pell, CL; Williams, MJ; Dunne, EM; Porter, BD; Satzke, C				Pell, Casey L.; Williams, Melanie J.; Dunne, Eileen M.; Porter, Barbara D.; Satzke, Catherine			Silica Desiccant Packets for Storage and Transport of Streptococcus pneumoniae and Other Clinically Relevant Species	PLOS ONE			English	Article							CORYNEBACTERIUM-DIPHTHERIAE; MEDIA; GEL	Bacterial isolates are often transported between laboratories for research and diagnostic purposes. Silica desiccant packets (SDPs), which are inexpensive and do not require freezing, were evaluated for storage and recovery of bacterial isolates. Conditions such as inoculum size, swab type and temperature of storage were investigated using ten Streptococcus pneumoniae isolates. The optimized protocol was then tested using 49 additional S. pneumoniae isolates representing 40 serogroups. Overall, S. pneumoniae growth was considered satisfactory (> 100 colony forming units) for 98/109 (89.9%) and 20/20 (100%) swabs after 14 days at room temperature or 28 days at 4 degrees C, respectively. Storage in SDPs did not impact on the ability of S. pneumoniae isolates to be subsequently serotyped. When the survival of nine other clinically relevant bacterial species was tested, seven were viable after 28 days at room temperature, the exceptions being Neisseria gonorrhoeae and Haemophilus influenzae. SDPs are suitable for transport and short-term storage of bacterial species including S. pneumoniae.	[Pell, Casey L.; Williams, Melanie J.; Dunne, Eileen M.; Porter, Barbara D.; Satzke, Catherine] Royal Childrens Hosp, Murdoch Childrens Res Inst, Parkville, Vic 3052, Australia; [Satzke, Catherine] Univ Melbourne, Dept Microbiol & Immunol, Parkville, Vic 3052, Australia	Murdoch Children's Research Institute; Royal Children's Hospital Melbourne; University of Melbourne	Satzke, C (corresponding author), Royal Childrens Hosp, Murdoch Childrens Res Inst, Flemington Rd, Parkville, Vic 3052, Australia.	catherine.satzke@mcri.edu.au	Satzke, Catherine/D-6501-2013; Dunne, Eileen M/M-3203-2019	Satzke, Catherine/0000-0003-3164-8849; Dunne, Eileen M/0000-0001-5542-0780; Williams, Melanie/0000-0003-4802-1874	Bill and Melinda Gates Foundation [52099]; Victorian Government's Operational Infrastructure Support Program	Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); Victorian Government's Operational Infrastructure Support Program	This work was supported by The Bill and Melinda Gates Foundation as part of the PneuCarriage project (Grant 52099), and the Victorian Government's Operational Infrastructure Support Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Castillo D, 2011, LAB METHODS DIAGNOSI, P265; Charalambous BM, 2003, J CLIN MICROBIOL, V41, P5551, DOI 10.1128/JCM.41.12.5551-5556.2003; FACKLAM RR, 1978, J CLIN MICROBIOL, V7, P137; Gray BM, 2002, EUR J CLIN MICROBIOL, V21, P666, DOI 10.1007/s10096-002-0796-z; Joshi HH, 2008, J CLIN MICROBIOL, V46, P3175, DOI 10.1128/JCM.00906-08; KIMFARLEY RJ, 1987, J CLIN MICROBIOL, V25, P964, DOI 10.1128/JCM.25.5.964-965.1987; Mason CK, 2010, BRIT J BIOMED SCI, V67, P1; McDonald M, 2006, J CLIN MICROBIOL, V44, P547, DOI 10.1128/JCM.44.2.547-552.2006; O'Brien KL, 2009, LANCET, V374, P893, DOI 10.1016/S0140-6736(09)61204-6; O'Brien KL, 2001, J CLIN MICROBIOL, V39, P1021, DOI 10.1128/JCM.39.3.1021-1024.2001; Ortika Belinda D, 2013, BMC Res Notes, V6, P49, DOI 10.1186/1756-0500-6-49; Paul JR, 1927, J EXP MED, V46, P793, DOI 10.1084/jem.46.5.793; Popovic T, 1998, J CLIN MICROBIOL, V36, P1765, DOI 10.1128/JCM.36.6.1765-1766.1998; REDYS JJ, 1968, PUBLIC HEALTH REP, V83, P143, DOI 10.2307/4593249; Siberry G, 2001, B WORLD HEALTH ORGAN, V79, P43; Walsh RL, 2011, MBIO, V2, DOI 10.1128/mBio.00092-11; Wasas AD, 1998, J CLIN MICROBIOL, V36, P1139, DOI 10.1128/JCM.36.4.1139-1140.1998	17	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2013	8	8							e72353	10.1371/journal.pone.0072353	http://dx.doi.org/10.1371/journal.pone.0072353			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	200ZE	23940811	Green Published, gold			2022-12-25	WOS:000323109700136
J	Kim, MG; Kim, SH; Noh, H; Ko, YS; Lee, HY; Jo, SK; Cho, WY; Kim, HK				Kim, Myung-Gyu; Kim, Su Hee; Noh, Hyunjin; Ko, Yoon Sook; Lee, Hee Young; Jo, Sang-Kyung; Cho, Won Yong; Kim, Hyoung Kyu			CD11c(+) Cells Partially Mediate the Renoprotective Effect Induced by Bone Marrow-Derived Mesenchymal Stem Cells	PLOS ONE			English	Article							ACUTE KIDNEY INJURY; ISCHEMIA-REPERFUSION INJURY; REGULATORY T-CELLS; DENDRITIC CELLS; STROMAL CELLS; DIFFERENTIATION; MATURATION; DEPLETION; INHIBIT; PROTECT	Previous studies have shown that induction of immune tolerance by mesenchymal stem cells (MSCs) is partially mediated via monocytes or dendritic cells (DCs). The purpose of this study was to determine the role of CD11c(+) cells in MSC-induced effects on ischemia/reperfusion injury (IRI). IRI was induced in wildtype (WT) mice and CD11c(+)-depleted mice following pretreatment with or without MSCs. In the in-vitro experiments, the MSC-treated CD11c(+) cells acquired regulatory phenotype with increased intracellular IL-10 production. Although splenocytes cocultured with MSCs showed reduced T cell proliferation and expansion of CD4(+)FoxP3(+) regulatory T cells (Tregs), depletion of CD11c(+) cells was associated with partial loss of MSCs effect on T cells. In in-vivo experiment, MSCs' renoprotective effect was also associated with induction of more immature CD11c(+) cells and increased FoxP3 expression in I/R kidneys. However all these effects induced by the MSCs were partially abrogated when CD11c(+) cells were depleted in the CD11c(+)-DTR transgenic mice. In addition, the observation that adoptive transfer of WT CD11c(+) cells partially restored the beneficial effect of the MSCs, while transferring IL-10 deficient CD11c(+) cells did not, strongly suggest the important contribution of IL-10 producing CD11c(+) cells in attenuating kidney injury by MSCs. Our results suggest that the CD11c(+) cell-Tregs play critical role in mediating renoprotective effect of MSCs.	[Kim, Myung-Gyu; Ko, Yoon Sook; Lee, Hee Young; Jo, Sang-Kyung; Cho, Won Yong; Kim, Hyoung Kyu] Korea Univ, Dept Internal Med, Anam Hosp, Seoul, South Korea; [Kim, Su Hee] Gangneung Asan Hosp, Dept Internal Med, Kangnung, South Korea; [Noh, Hyunjin] Soonchunhyang Univ Hosp, Dept Internal Med, Seoul, South Korea	Korea University; Korea University Medicine (KU Medicine); Soonchunhyang University; Soonchunhyang University Hospital	Jo, SK (corresponding author), Korea Univ, Dept Internal Med, Anam Hosp, Seoul, South Korea.	sang-kyung@korea.ac.kr			Korea University [K1031961]	Korea University	This study was supported by a Korea University grant (project no. K1031961). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ascon DB, 2006, J IMMUNOL, V177, P3380, DOI 10.4049/jimmunol.177.5.3380; Banchereau J, 2000, ANNU REV IMMUNOL, V18, P767, DOI 10.1146/annurev.immunol.18.1.767; Beyth S, 2005, BLOOD, V105, P2214, DOI 10.1182/blood-2004-07-2921; Burne MJ, 2001, J CLIN INVEST, V108, P1283, DOI 10.1172/JCI200112080; Corcione A, 2006, BLOOD, V107, P367, DOI 10.1182/blood-2005-07-2657; Djouad F, 2007, STEM CELLS, V25, P2025, DOI 10.1634/stemcells.2006-0548; Dong X, 2007, KIDNEY INT, V71, P619, DOI 10.1038/sj.ki.5002132; Duffield JS, 2005, J CLIN INVEST, V115, P1743, DOI 10.1172/JCI22593; English K, 2008, IMMUNOL LETT, V115, P50, DOI 10.1016/j.imlet.2007.10.002; Fiorina P, 2009, J IMMUNOL, V183, P993, DOI 10.4049/jimmunol.0900803; Gandolfo MT, 2009, KIDNEY INT, V76, P717, DOI 10.1038/ki.2009.259; Glennie S, 2005, BLOOD, V105, P2821, DOI 10.1182/blood-2004-09-3696; Gonzalez-Rey E, 2009, GUT, V58, P929, DOI 10.1136/gut.2008.168534; Griffin MD, 2012, KIDNEY INT, V82, P835, DOI 10.1038/ki.2012.164; Huang YF, 2010, TRANSPLANTATION, V90, P1307, DOI 10.1097/TP.0b013e3181fdd9eb; Jiang XX, 2005, BLOOD, V105, P4120, DOI 10.1182/blood-2004-02-0586; Kim MG, 2010, NEPHROL DIAL TRANSPL, V25, P2908, DOI 10.1093/ndt/gfq183; Kinsey GR, 2009, J AM SOC NEPHROL, V20, P1744, DOI 10.1681/ASN.2008111160; Krampera M, 2003, BLOOD, V101, P3722, DOI 10.1182/blood-2002-07-2104; Kuo YR, 2009, TRANSPLANTATION, V87, P1769, DOI 10.1097/TP.0b013e3181a664f1; Kurts C, 2007, SEMIN IMMUNOPATHOL, V29, P317, DOI 10.1007/s00281-007-0096-x; Li L, 2010, SEMIN NEPHROL, V30, P268, DOI 10.1016/j.semnephrol.2010.03.005; Lu L, 2012, AM J NEPHROL, V35, P181, DOI 10.1159/000335582; Madec AM, 2009, DIABETOLOGIA, V52, P1391, DOI 10.1007/s00125-009-1374-z; Melief SM, 2013, HAEMATOLOGICA, V98, P888, DOI 10.3324/haematol.2012.078055; Patel SA, 2010, J IMMUNOL, V184, P5885, DOI 10.4049/jimmunol.0903143; Rasmusson I, 2007, SCAND J IMMUNOL, V65, P336, DOI 10.1111/j.1365-3083.2007.01905.x; Scholz J, 2008, J AM SOC NEPHROL, V19, P527, DOI 10.1681/ASN.2007060684; Tadagavadi RK, 2010, J AM SOC NEPHROL, V21, P53, DOI 10.1681/ASN.2009040407; Togel F, 2009, STEM CELLS DEV, V18, P475, DOI 10.1089/scd.2008.0092; Togel F, 2005, AM J PHYSIOL-RENAL, V289, pF31, DOI 10.1152/ajprenal.00007.2005; Togel F, 2007, AM J PHYSIOL-RENAL, V292, pF1626, DOI 10.1152/ajprenal.00339.2006; Town T, 2005, J NEUROINFLAMM, V2, DOI 10.1186/1742-2094-2-24; Zhang B, 2009, BLOOD, V113, P46, DOI 10.1182/blood-2008-04-154138; Zhang W, 2004, STEM CELLS DEV, V13, P263, DOI 10.1089/154732804323099190; Zheng D, 2012, KIDNEY INT, V81, P892, DOI 10.1038/ki.2011.471	36	10	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2013	8	8							e72544	10.1371/journal.pone.0072544	http://dx.doi.org/10.1371/journal.pone.0072544			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	217ZG	23940814	gold, Green Published, Green Submitted			2022-12-25	WOS:000324401500093
J	Gonzalez-Jamett, AM; Momboisse, F; Guerra, MJ; Ory, S; Baez-Matus, X; Barraza, N; Calco, V; Houy, S; Couve, E; Neely, A; Martinez, AD; Gasman, S; Cardenas, AM				Gonzalez-Jamett, Arlek M.; Momboisse, Fanny; Jose Guerra, Maria; Ory, Stephane; Baez-Matus, Ximena; Barraza, Natalia; Calco, Valerie; Houy, Sebastien; Couve, Eduardo; Neely, Alan; Martinez, Agustin D.; Gasman, Stephane; Cardenas, Ana M.			Dynamin-2 Regulates Fusion Pore Expansion and Quantal Release through a Mechanism that Involves Actin Dynamics in Neuroendocrine Chromaffin Cells	PLOS ONE			English	Article							PLASMA-MEMBRANE; EXOCYTOTIC EVENTS; VESICLE FORMATION; DEPENDENT FUSION; BAR PROTEINS; ENDOCYTOSIS; GTPASE; ACTIVATION; RECAPTURE; MODE	Over the past years, dynamin has been implicated in tuning the amount and nature of transmitter released during exocytosis. However, the mechanism involved remains poorly understood. Here, using bovine adrenal chromaffin cells, we investigated whether this mechanism rely on dynamin's ability to remodel actin cytoskeleton. According to this idea, inhibition of dynamin GTPase activity suppressed the calcium-dependent de novo cortical actin and altered the cortical actin network. Similarly, expression of a small interfering RNA directed against dynamin-2, an isoform highly expressed in chromaffin cells, changed the cortical actin network pattern. Disruption of dynamin-2 function, as well as the pharmacological inhibition of actin polymerization with cytochalasine-D, slowed down fusion pore expansion and increased the quantal size of individual exocytotic events. The effects of cytochalasine-D and dynamin-2 disruption were not additive indicating that dynamin-2 and F-actin regulate the late steps of exocytosis by a common mechanism. Together our data support a model in which dynamin-2 directs actin polymerization at the exocytosis site where both, in concert, adjust the hormone quantal release to efficiently respond to physiological demands.	[Gonzalez-Jamett, Arlek M.; Momboisse, Fanny; Jose Guerra, Maria; Baez-Matus, Ximena; Barraza, Natalia; Neely, Alan; Martinez, Agustin D.; Cardenas, Ana M.] Univ Valparaiso, Fac Ciencias, Ctr Interdisciplinario Neurociencia Valparaiso, Valparaiso, Chile; [Momboisse, Fanny; Ory, Stephane; Calco, Valerie; Houy, Sebastien; Gasman, Stephane] CNRS, Inst Neurosci Cellulaires & Integrat, UPR 3212, Strasbourg, France; [Momboisse, Fanny; Ory, Stephane; Calco, Valerie; Houy, Sebastien; Gasman, Stephane] Univ Strasbourg, Strasbourg, France; [Couve, Eduardo] Univ Valparaiso, Fac Ciencias, Dept Biol, Valparaiso, Chile	Universidad de Valparaiso; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Universidad de Valparaiso	Gasman, S (corresponding author), CNRS, Inst Neurosci Cellulaires & Integrat, UPR 3212, Strasbourg, France.	gasman@unistra.fr; ana.cardenas@uv.cl	Ory, Stéphane/G-9714-2019; Ory, Stéphane/E-9947-2010; Gasman, Stephane/D-5113-2017; stéphane, gasman/Q-1145-2019	Ory, Stéphane/0000-0003-4359-1157; Ory, Stéphane/0000-0003-4359-1157; Gasman, Stephane/0000-0001-8415-1276; stéphane, gasman/0000-0001-8415-1276; Baez-Matus, Ximena/0000-0002-4176-0239; Neely, Alan/0000-0002-6007-2159	cooperation program between France and Chile ECOS-SUD/Conicyt [C08B01]; FONDECYT [1110552]; CONICYT [AT24100005, 21080096]; ICM-ECONOMIA, Chile [P09-022-F];  [ANR-07-JCJC-088-01]	cooperation program between France and Chile ECOS-SUD/Conicyt; FONDECYT(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); CONICYT(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)); ICM-ECONOMIA, Chile; 	This work has been supported by the cooperation program between France and Chile ECOS-SUD/Conicyt (#C08B01) to SG and AMC, and by grants FONDECYT 1110552 (to AMC), ANR-07-JCJC-088-01 (to SG), CONICYT AT24100005 and 21080096 (to A G-J), and P09-022-F from ICM-ECONOMIA, Chile. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albillos A, 1997, NATURE, V389, P509, DOI 10.1038/39081; Ales E, 1999, NAT CELL BIOL, V1, P40, DOI 10.1038/9012; Amatore C, 2000, BIOCHIMIE, V82, P481, DOI 10.1016/S0300-9084(00)00213-3; Anantharam A, 2011, MOL BIOL CELL, V22, P1907, DOI 10.1091/mbc.E11-02-0101; Ardiles AO, 2006, J NEUROCHEM, V99, P29, DOI 10.1111/j.1471-4159.2006.04080.x; Artalejo CR, 2002, P NATL ACAD SCI USA, V99, P6358, DOI 10.1073/pnas.082658499; Berberian K, 2009, J NEUROSCI, V29, P863, DOI 10.1523/JNEUROSCI.2818-08.2009; Cao H, 1998, MOL BIOL CELL, V9, P2595, DOI 10.1091/mbc.9.9.2595; Ceridono M, 2011, TRAFFIC, V12, P72, DOI 10.1111/j.1600-0854.2010.01125.x; CHOW RH, 1992, NATURE, V356, P60, DOI 10.1038/356060a0; Colliver TL, 2000, J NEUROSCI, V20, P5276, DOI 10.1523/JNEUROSCI.20-14-05276.2000; Cook T, 1996, J NEUROCHEM, V67, P927; DAMKE H, 1994, J CELL BIOL, V127, P915, DOI 10.1083/jcb.127.4.915; de la Vega M, 2011, RETROVIROLOGY, V8, DOI 10.1186/1742-4690-8-99; Dharmalingam E, 2009, J NEUROSCI, V29, P13315, DOI 10.1523/JNEUROSCI.3973-09.2009; Doreian BW, 2008, J NEUROSCI, V28, P4470, DOI 10.1523/JNEUROSCI.0008-08.2008; Duan R, 2009, DEV BIOL, V325, P374, DOI 10.1016/j.ydbio.2008.10.035; Durieux AC, 2010, J MOL MED, V88, P339, DOI 10.1007/s00109-009-0587-4; Elhamdani A, 2001, NEURON, V31, P819, DOI 10.1016/S0896-6273(01)00418-4; Ferguson S, 2009, DEV CELL, V17, P811, DOI 10.1016/j.devcel.2009.11.005; Ferguson SM, 2012, NAT REV MOL CELL BIO, V13, P75, DOI 10.1038/nrm3266; Fulop T, 2005, J NEUROSCI, V25, P7324, DOI 10.1523/JNEUROSCI.2042-05.2005; Fulop T, 2008, ARCH BIOCHEM BIOPHYS, V477, P146, DOI 10.1016/j.abb.2008.04.039; Gasman S, 2004, MOL BIOL CELL, V15, P520, DOI 10.1091/mbc.E03-06-0402; Gomez TS, 2005, NAT IMMUNOL, V6, P261, DOI 10.1038/ni1168; Gong LW, 2003, J NEUROSCI, V23, P7917; Gonzalez-Jamett AM, 2010, J NEUROSCI, V30, P10683, DOI 10.1523/JNEUROSCI.5210-09.2010; Graham ME, 2002, P NATL ACAD SCI USA, V99, P7124, DOI 10.1073/pnas.102645099; Gu C, 2010, EMBO J, V29, P3593, DOI 10.1038/emboj.2010.249; Harper CB, 2013, TRENDS CELL BIOL, V23, P90, DOI 10.1016/j.tcb.2012.10.007; Harper CB, 2011, J BIOL CHEM, V286, P35966, DOI 10.1074/jbc.M111.283879; Hartig SM, 2009, J CELL SCI, V122, P2283, DOI 10.1242/jcs.041343; Holroyd P, 2002, P NATL ACAD SCI USA, V99, P16806, DOI 10.1073/pnas.222677399; Itoh T, 2005, DEV CELL, V9, P791, DOI 10.1016/j.devcel.2005.11.005; Kessels MM, 2006, J CELL SCI, V119, P1504, DOI 10.1242/jcs.02877; Koch D, 2011, EMBO J, V30, P4955, DOI 10.1038/emboj.2011.339; Koutsopoulos OS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027498; Lai WH, 2011, AIDS RES HUM RETROV, V27, P1013, DOI [10.1089/AID.2010.0259, 10.1089/aid.2010.0259]; Lee E, 2002, P NATL ACAD SCI USA, V99, P161, DOI 10.1073/pnas.012607799; Leikina E, 2013, J CELL BIOL, V200, P109, DOI 10.1083/jcb.201207012; Lin HC, 1997, J BIOL CHEM, V272, P25999, DOI 10.1074/jbc.272.41.25999; Lindau M, 2003, BBA-MOL CELL RES, V1641, P167, DOI 10.1016/S0167-4889(03)00085-5; Liu YW, 2011, TRAFFIC, V12, P1620, DOI 10.1111/j.1600-0854.2011.01250.x; Liu YW, 2011, P NATL ACAD SCI USA, V108, pE234, DOI 10.1073/pnas.1102710108; Malacombe M, 2006, BBA-MOL CELL RES, V1763, P1175, DOI 10.1016/j.bbamcr.2006.09.004; Merrifield CJ, 2002, NAT CELL BIOL, V4, P691, DOI 10.1038/ncb837; Miyauchi K, 2009, CELL, V137, P433, DOI 10.1016/j.cell.2009.02.046; Momboisse F, 2009, J CELL SCI, V122, P798, DOI 10.1242/jcs.038109; Montiel C, 2003, J NEUROSCI RES, V71, P353, DOI 10.1002/jnr.10499; Mooren OL, 2009, J BIOL CHEM, V284, P23995, DOI 10.1074/jbc.M109.024398; Neco P, 2008, J BIOL CHEM, V283, P10949, DOI 10.1074/jbc.M709058200; Nguyen TH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036913; Nowak SJ, 2009, J CELL SCI, V122, P3282, DOI 10.1242/jcs.047597; Orth JD, 2002, P NATL ACAD SCI USA, V99, P167, DOI 10.1073/pnas.012607899; Otsuka A, 2009, BIOCHEM BIOPH RES CO, V378, P478, DOI 10.1016/j.bbrc.2008.11.066; PARSONS TD, 1995, NEURON, V15, P1085, DOI 10.1016/0896-6273(95)90097-7; Perrais D, 2004, J PHYSIOL-LONDON, V560, P413, DOI 10.1113/jphysiol.2004.064410; Pickett JA, 2006, TRAFFIC, V7, P109, DOI 10.1111/j.1600-0854.2005.00372.x; Praefcke GJK, 2004, NAT REV MOL CELL BIO, V5, P133, DOI 10.1038/nrm1313; Raimondi A, 2011, NEURON, V70, P1100, DOI 10.1016/j.neuron.2011.04.031; Reid AT, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.392803; Riedl J, 2008, NAT METHODS, V5, P605, DOI 10.1038/nmeth.1220; Samasilp P, 2012, J NEUROSCI, V32, P10438, DOI 10.1523/JNEUROSCI.1299-12.2012; Shin N, 2008, J CELL SCI, V121, P1252, DOI 10.1242/jcs.016709; SPUNGIN B, 1995, J CELL SCI, V108, P2525; Taylor MJ, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001302; Tsuboi T, 2004, J BIOL CHEM, V279, P47115, DOI 10.1074/jbc.M408179200; Upadhyaya A, 2003, P NATL ACAD SCI USA, V100, P4521, DOI 10.1073/pnas.0837027100; VITALE N, 1993, J BIOL CHEM, V268, P14715; WARNOCK DE, 1995, EMBO J, V14, P1322, DOI 10.1002/j.1460-2075.1995.tb07118.x; Warnock DE, 1997, MOL BIOL CELL, V8, P2553, DOI 10.1091/mbc.8.12.2553; Wurth MA, 2010, VIROLOGY, V404, P117, DOI 10.1016/j.virol.2010.04.024; Yamada H, 2013, J NEUROSCI, V33, P4514, DOI 10.1523/JNEUROSCI.2762-12.2013; Yamada H, 2009, BIOCHEM BIOPH RES CO, V390, P1142, DOI 10.1016/j.bbrc.2009.10.105; Yang ZY, 2001, J BIOL CHEM, V276, P4251, DOI 10.1074/jbc.M006371200	75	47	48	2	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2013	8	8							e70638	10.1371/journal.pone.0070638	http://dx.doi.org/10.1371/journal.pone.0070638			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	218XC	23940613	Green Published, Green Submitted, gold			2022-12-25	WOS:000324465000107
J	Langelueddecke, C; Roussa, E; Fenton, RA; Thevenod, F				Langelueddecke, Christian; Roussa, Eleni; Fenton, Robert A.; Thevenod, Frank			Expression and Function of the Lipocalin-2 (24p3/NGAL) Receptor in Rodent and Human Intestinal Epithelia	PLOS ONE			English	Article							KIDNEY PROXIMAL TUBULE; CELL-LINE CACO-2; GELATINASE-ASSOCIATED LIPOCALIN; INTRINSIC-FACTOR-COBALAMIN; GUT MICROBIOTA; PROTEIN; TRANSFERRIN; TRANSCYTOSIS; ENDOCYTOSIS; INFECTION	The lipocalin 2//NGAL/24p3 receptor (NGAL-R/24p3-R) is expressed in rodent distal nephron where it mediates protein endocytosis. The mechanisms of apical endocytosis and transcytosis of proteins and peptides in the intestine are poorly understood. In the present study, the expression and localization of rodent 24p3-R (r24p3-R) and human NGAL-R (hNGAL-R) was investigated in intestinal segments by immunofluorescence and confocal laser scanning microscopy, immunohistochemistry and immunoblotting. r24p3-R/hNGAL-R was also studied in human Caco-2 BBE cells and CHO cells transiently transfected with r24p3-R by immunofluorescence microscopy, RT-PCR and immunoblotting of plasma membrane enriched vesicles (PM). To assay function, endocytosis/transcytosis of putative ligands phytochelatin (PC3), metallothionein (MT) and transferrin (Tf) was assayed by measuring internalization of fluorescence-labelled ligands in Caco-2 BBE cells grown on plastic or as monolayers on Transwell inserts. The binding affinity of Alexa 488-PC3 to colon-like Caco-2 BBE PM was quantified by microscale thermophoresis (MST). r24p3-R/hNGAL-R expression was detected apically in all intestinal segments but showed the highest expression in ileum and colon. Colon-like, but not duodenum-like, Caco-2 BBE cells expressed hNGAL-R on their surface. Colon-like Caco-2 BBE cells or r24p3-R transfected CHO cells internalized fluorescence-labelled PC3 or MT with half-maximal saturation at submicromolar concentrations. Uptake of PC3 and MT (0.7 mu M) by Caco-2 BBE cells was partially blocked by hNGAL (500 pM) and an EC50 of 18.6 +/- 12.2 nM was determined for binding of Alexa 488-PC3 to PM vesicles by MST. Transwell experiments showed rapid (0.5-2 h) apical uptake and basolateral delivery of fluorescent PC3/MT/Tf (0.7 mu M). Apical uptake of ligands was significantly blocked by 500 pM hNGAL. hNGAL-R dependent uptake was more prominent with MT but transcytosis efficiency was reduced compared to PC3 and Tf. Hence, r24p3-R/hNGAL-R may represent a high-affinity multi-ligand receptor for apical internalization and transcytosis of intact proteins/peptides by the lower intestine.	[Langelueddecke, Christian; Thevenod, Frank] Univ Witten Herdecke, Inst Physiol & Pathophysiol, ZBAF, Witten, Germany; [Roussa, Eleni] Univ Freiburg, D-79106 Freiburg, Germany; [Fenton, Robert A.] Aarhus Univ, Dept Biomed, Aarhus C, Denmark; [Fenton, Robert A.] Aarhus Univ, InterPrET Ctr, Aarhus C, Denmark	Witten Herdecke University; University of Freiburg; Aarhus University; Aarhus University	Thevenod, F (corresponding author), Univ Witten Herdecke, Inst Physiol & Pathophysiol, ZBAF, Witten, Germany.	frank.thevenod@uni-wh.de	Fenton, Robert/AFR-6983-2022; Fenton, Robert A/ABD-9824-2021	Fenton, Robert/0000-0003-1623-199X; 	Deutsche Forschungsgemeinschaft [DFG TH345/11-1, DFG RO2495/1-3]; Centre for Biomedical Training and Research (ZBAF) of the University of Witten/Herdecke; Danish Medical Research Council; Novo Nordisk Foundation; Lundbeck Foundation	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Centre for Biomedical Training and Research (ZBAF) of the University of Witten/Herdecke; Danish Medical Research Council(Danish Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Lundbeck Foundation(Lundbeckfonden)	This work was supported by the Deutsche Forschungsgemeinschaft (DFG TH345/11-1; DFG RO2495/1-3), by the Centre for Biomedical Training and Research (ZBAF) of the University of Witten/Herdecke, and by the Danish Medical Research Council, The Novo Nordisk Foundation and the Lundbeck Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abouhamed M, 2006, AM J PHYSIOL-RENAL, V290, pF1525, DOI 10.1152/ajprenal.00359.2005; Abouhamed M, 2007, AM J PHYSIOL-RENAL, V293, pF705, DOI 10.1152/ajprenal.00198.2007; Berger T, 2006, P NATL ACAD SCI USA, V103, P1834, DOI 10.1073/pnas.0510847103; Birn H, 1997, J BIOL CHEM, V272, P26497, DOI 10.1074/jbc.272.42.26497; Bomsel M, 2003, NAT REV MOL CELL BIO, V4, P57, DOI 10.1038/nrm1005; Bose S, 2007, J PHYSIOL-LONDON, V581, P457, DOI 10.1113/jphysiol.2007.129171; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brandes A, 2007, AM J PHYSIOL-REG I, V293, pR2400, DOI 10.1152/ajpregu.00208.2007; CHANTRET I, 1994, J CELL SCI, V107, P213; CHERIAN MG, 1979, ENVIRON HEALTH PERSP, V28, P127, DOI 10.2307/3428914; Christensen EI, 2002, NAT REV MOL CELL BIO, V3, P258, DOI 10.1038/nrm778; Christensen EI, 2009, PFLUG ARCH EUR J PHY, V458, P1039, DOI 10.1007/s00424-009-0685-8; CREWS HM, 1989, ANALYST, V114, P895, DOI 10.1039/an9891400895; Cui L, 2008, CLIN CANCER RES, V14, P7674, DOI 10.1158/1078-0432.CCR-08-0420; DAN N, 1994, J BIOL CHEM, V269, P18849; Davila AM, 2013, PHARMACOL RES, V68, P95, DOI 10.1016/j.phrs.2012.11.005; Devireddy LR, 2005, CELL, V123, P1293, DOI 10.1016/j.cell.2005.10.027; Devireddy LR, 2001, SCIENCE, V293, P829, DOI 10.1126/science.1061075; Duhr S, 2006, P NATL ACAD SCI USA, V103, P19678, DOI 10.1073/pnas.0603873103; Fenton RA, 2007, AM J PHYSIOL-RENAL, V293, pF748, DOI 10.1152/ajprenal.00316.2006; Flint HJ, 2012, NAT REV GASTRO HEPAT, V9, P577, DOI 10.1038/nrgastro.2012.156; Flint HJ, 2012, GUT MICROBES, V3, P289, DOI 10.4161/gmic.19897; Flo TH, 2004, NATURE, V432, P917, DOI 10.1038/nature03104; FUJITA Y, 1993, RES COMMUN CHEM PATH, V82, P357; GALASKE RG, 1979, KIDNEY INT, V16, P394, DOI 10.1038/ki.1979.142; Hvidberg V, 2005, FEBS LETT, V579, P773, DOI 10.1016/j.febslet.2004.12.031; Kozyraki R, 2001, P NATL ACAD SCI USA, V98, P12491, DOI 10.1073/pnas.211291398; Kozyraki R, 2013, BIOCHIMIE, V95, P1002, DOI 10.1016/j.biochi.2012.11.004; Langelueddecke C, 2012, J BIOL CHEM, V287, P159, DOI 10.1074/jbc.M111.308296; Lebreton C, 2012, GASTROENTEROLOGY, V143, P698, DOI 10.1053/j.gastro.2012.05.051; LEVINE JS, 1984, J CELL BIOL, V98, P1111, DOI 10.1083/jcb.98.3.1111; Lim CJ, 2007, J CONTROL RELEASE, V122, P393, DOI 10.1016/j.jconrel.2007.03.021; MADSEN KM, 1982, KIDNEY INT, V21, P354, DOI 10.1038/ki.1982.29; Martin-Latil S, 2012, BLOOD, V120, P572, DOI 10.1182/blood-2011-08-374637; Moeller HB, 2009, KIDNEY INT, V75, P295, DOI 10.1038/ki.2008.505; Mori K, 2005, J CLIN INVEST, V115, P610, DOI 10.1172/JCI200523056; MOSTOV KE, 1994, ANNU REV IMMUNOL, V12, P63, DOI 10.1146/annurev.immunol.12.1.63; Norouziyan F, 2008, AM J PHYSIOL-CELL PH, V294, pC7, DOI 10.1152/ajpcell.00372.2006; PINTO M, 1983, BIOL CELL, V47, P323; Rath T, 2013, J CLIN IMMUNOL, V33, pS9, DOI 10.1007/s10875-012-9768-y; Rautava S, 2012, NAT REV GASTRO HEPAT, V9, P565, DOI 10.1038/nrgastro.2012.144; ROUSSET M, 1985, J CELL PHYSIOL, V123, P377, DOI 10.1002/jcp.1041230313; SHAH D, 1994, J DRUG TARGET, V2, P93, DOI 10.3109/10611869409015897; TOJO A, 1992, AM J PHYSIOL, V263, pF601, DOI 10.1152/ajprenal.1992.263.4.F601; Ullrich R, 1998, PATHOBIOLOGY, V66, P145, DOI 10.1159/000028012; Wang RY, 2007, ELECTROPHORESIS, V28, P2942, DOI 10.1002/elps.200600835; WEINER ML, 1988, FOOD CHEM TOXICOL, V26, P867, DOI 10.1016/0278-6915(88)90028-2; Wienken CJ, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1093; Wolff NA, 2011, TOXICOL LETT, V203, P210, DOI 10.1016/j.toxlet.2011.03.014	49	18	18	2	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2013	8	8							e71586	10.1371/journal.pone.0071586	http://dx.doi.org/10.1371/journal.pone.0071586			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	218XC	23940770	Green Published, Green Submitted, gold			2022-12-25	WOS:000324465000217
J	Luo, YJ; Tan, GZ; Yu, M; Li, KW; Liu, YY; Guo, Q; Zeng, FQ; Wang, LC				Luo, Yi-jin; Tan, Guo-zhen; Yu, Min; Li, Kai-wen; Liu, Yue-yang; Guo, Qing; Zeng, Fan-qin; Wang, Liangchun			Correlation of Cutaneous Immunoreactants in Lesional Skin with the Serological Disorders and Disease Activity of Systemic Lupus Erythematosus	PLOS ONE			English	Article							BAND TEST; UNINVOLVED SKIN; IMMUNE DEPOSITS; IMMUNOGLOBULIN	Detection of immunoreactants including IgG, IgM, IgA, and C3 by direct immunofluorescence (DIF) from skin is useful for distinguishing lupus lesions from other skin disorders. Despite their diagnostic value, the type and number of cutaneous immunoreactants as they relate to serological disorders and disease severity has been poorly studied. We examined 36 patients with systemic lupus erythematosis (SLE) with positive DIF (DIF+) and 28 patients with negative DIF (DIF-) tests performed on lesional skin. Among DIF+ patients, the most frequent patterns of immunoreactants were IgM alone (36%) and the coexistence of IgM with C3 (28%). IgM was the highest detected individual immunoreactant (86%). As classified by number, 17 of 36 DIF+ patients had one immunoreactant (=1), while the remaining patients had two to four immunoreactants (>1). Compared with DIF- patients, DIF+ patients were more likely to have severe disease as indicated by lower serum C3 levels and a higher SLE disease activity index (SLEDAI). The coexistence of IgM with any other immunoreactants indicated a more severe disease than that present in the DIF- group, whereas the IgM-alone group was comparable with the DIF- group in both serum C3 levels and SLEDAI. These findings were also applicable in the comparison of patients with more than one (>1) immunoreactant and patients with no (DIF-) and one (=1) immunoreactant. Collectively, the presence of multiple immunoreactants in lesional skin implies a more severe disease activity of SLE, while a single immunoreactant may be equal to the absence of immunoreactants (DIF-) in terms of predicting disease activity.	[Luo, Yi-jin; Tan, Guo-zhen; Yu, Min; Li, Kai-wen; Guo, Qing; Zeng, Fan-qin; Wang, Liangchun] Sun Yat Sen Univ, Sun Yat Sen Mem Hosp, Dept Dermatol, Guangzhou 510275, Guangdong, Peoples R China; [Liu, Yue-yang] 7th Hosp Shenyang, Dept Dermatol, Shenyang, Peoples R China	Sun Yat Sen University	Wang, LC (corresponding author), Sun Yat Sen Univ, Sun Yat Sen Mem Hosp, Dept Dermatol, Guangzhou 510275, Guangdong, Peoples R China.	wliangch@mail.sysu.edu.cn	Wang, Liangchun/C-5995-2018	Wang, Liangchun/0000-0002-5169-2751	National Natural Science Foundation of China [81101196]; Scientific Research Foundation for the Returned Overseas Chinese Scholars, the Chinese Ministry of Education; Hundred Outstanding New Investigators of Sun Yat-sen University; New Century Outstanding Investigator Award, the Chinese Ministry of Education	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Scientific Research Foundation for the Returned Overseas Chinese Scholars, the Chinese Ministry of Education; Hundred Outstanding New Investigators of Sun Yat-sen University; New Century Outstanding Investigator Award, the Chinese Ministry of Education(Ministry of Education, China)	This study was supported by the National Natural Science Foundation of China (81101196) and the Scientific Research Foundation for the Returned Overseas Chinese Scholars, the Chinese Ministry of Education. LW is the recipient of Hundred Outstanding New Investigators of Sun Yat-sen University, and the New Century Outstanding Investigator Award, the Chinese Ministry of Education. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cardinali C, 1999, LUPUS, V8, P755, DOI 10.1191/096120399678840945; DAVIS BM, 1984, J INVEST DERMATOL, V83, P242, DOI 10.1111/1523-1747.ep12340246; GABRIELLI A, 1985, CLIN IMMUNOL IMMUNOP, V36, P266, DOI 10.1016/0090-1229(85)90047-9; GILLIAM JN, 1974, J CLIN INVEST, V53, P1434, DOI 10.1172/JCI107691; HALBERG P, 1982, ARCH DERMATOL, V118, P572, DOI 10.1001/archderm.118.8.572; HELM KF, 1993, J AM ACAD DERMATOL, V28, P687, DOI 10.1016/0190-9622(93)70093-9; Hochberg MC, 1997, ARTHRITIS RHEUM, V40, P1725, DOI 10.1002/art.1780400928; Isfer R S, 1996, Sao Paulo Med J, V114, P1141; JONSSON R, 1983, ACTA MED SCAND, V213, P269; Kontos AP, 2005, J CUTAN PATHOL, V32, P352, DOI 10.1111/j.0303-6987.2005.00337.x; Mehta V, 2010, INDIAN J DERMATOL VE, V76, P298, DOI 10.4103/0378-6323.62983; MORRIS RJ, 1979, ARTHRITIS RHEUM, V22, P864, DOI 10.1002/art.1780220809; Reich A, 2011, THER CLIN RISK MANAG, V7, P27, DOI 10.2147/TCRM.S10145; Rothfield N, 2006, CLIN DERMATOL, V24, P348, DOI 10.1016/j.clindermatol.2006.07.014; SMITH CD, 1984, ARTHRITIS RHEUM, V27, P382, DOI 10.1002/art.1780270404; Yu M, 2012, CLIN EXP RHEUMATOL, V30, P103; Zecevic RD, 2006, CLIN EXP DERMATOL, V31, P358, DOI 10.1111/j.1365-2230.2006.02113.x	17	8	9	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2013	8	8							e70983	10.1371/journal.pone.0070983	http://dx.doi.org/10.1371/journal.pone.0070983			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	218XC	23940681	gold, Green Published, Green Submitted			2022-12-25	WOS:000324465000168
J	Muir, JW; Kiel, DP; Hannan, M; Magaziner, J; Rubin, CT				Muir, Jesse W.; Kiel, Douglas P.; Hannan, Marian; Magaziner, Jay; Rubin, Clinton T.			Dynamic Parameters of Balance Which Correlate to Elderly Persons with a History of Falls	PLOS ONE			English	Article							POSTURAL SWAY; OLDER WOMEN; RISK; STABILITY; FRACTURE; STANCE; BONE	Poor balance in older persons contributes to a rise in fall risk and serious injury, yet no consensus has developed on which measures of postural sway can identify those at greatest risk of falling. Postural sway was measured in 161 elderly individuals (81.8y +/- 7.4), 24 of which had at least one self-reported fall in the prior six months, and compared to sway measured in 37 young adults (34.9y +/- 7.1). Center of pressure (COP) was measured during 4 minutes of quiet stance with eyes opened. In the elderly with fall history, all measures but one were worse than those taken from young adults (e. g., maximal COP velocity was 2.7x greater in fallers than young adults; p<0.05), while three measures of balance were significantly worse in fallers as compared to older persons with no recent fall history (COP Displacement, Short Term Diffusion Coefficient, and Critical Displacement). Variance of elderly subjects' COP measures from the young adult cohort were weighted to establish a balance score ("B-score") algorithm designed to distinguish subjects with a fall history from those more sure on their feet. Relative to a young adult B-score of zero, elderly "non-fallers" had a B-score of 0.334, compared to 0.645 for those with a fall history (p<0.001). A weighted amalgam of postural sway elements may identify individuals at greatest risk of falling, allowing interventions to target those with greatest need of attention.	[Muir, Jesse W.; Rubin, Clinton T.] SUNY Stony Brook, Dept Biomed Engn, Stony Brook, NY 11794 USA; [Kiel, Douglas P.; Hannan, Marian] Harvard Univ, Sch Med, Hebrew SeniorLife, Inst Aging Res, Boston, MA USA; [Magaziner, Jay] Univ Maryland, Sch Med, Baltimore, MD 21201 USA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; Harvard University; Harvard Medical School; Hebrew SeniorLife; University System of Maryland; University of Maryland Baltimore	Rubin, CT (corresponding author), SUNY Stony Brook, Dept Biomed Engn, Stony Brook, NY 11794 USA.	clinton.rubin@stonybrook.edu		Kiel, Douglas/0000-0001-8474-0310; Hannan, Marian/0000-0002-9586-6928	National Institute on Aging [AG025489]; National Aeronautic and Space Administration [NNJ04HI06G]; NATIONAL INSTITUTE ON AGING [R01AG025489, P30AG028747] Funding Source: NIH RePORTER	National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Aeronautic and Space Administration(National Aeronautics & Space Administration (NASA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by a grant from the National Institute on Aging, AG025489 (Musculoskeletal Health in the Elderly) and the National Aeronautic and Space Administration grant NNJ04HI06G (Disuse Osteoporosis in the Young Adult). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bloem BR, 2003, CURR OPIN NEUROL, V16, P15, DOI 10.1097/00019052-200302000-00003; Bloem BR, 2002, EXP BRAIN RES, V142, P91, DOI 10.1007/s00221-001-0926-3; BYUNG YJ, 1991, ARCH PHYS MED REHAB, V72, P642; Carmona R, 2004, BONE HLTH OSTEOPOROS; Carty CP, 2011, GAIT POSTURE, V33, P261, DOI 10.1016/j.gaitpost.2010.11.017; COLLINS JJ, 1993, EXP BRAIN RES, V95, P308, DOI 10.1007/BF00229788; EDGERTON VR, 1995, J APPL PHYSIOL, V78, P1733, DOI 10.1152/jappl.1995.78.5.1733; Ensrud KE, 2007, J GERONTOL A-BIOL, V62, P744, DOI 10.1093/gerona/62.7.744; FERNIE GR, 1982, AGE AGEING, V11, P11, DOI 10.1093/ageing/11.1.11; Golomer E, 1999, NEUROSCI LETT, V267, P189, DOI 10.1016/S0304-3940(99)00356-0; Horak FB, 2009, PHYS THER, V89, P484, DOI 10.2522/ptj.20080071; Kiel DP, 2010, CLIN TRIALS, V7, P354, DOI 10.1177/1740774510371014; Kwan MMS, 2011, J AM GERIATR SOC, V59, P536, DOI 10.1111/j.1532-5415.2010.03286.x; Liu-Ambrose TYL, 2005, J AM GERIATR SOC, V53, P1767, DOI 10.1111/j.1532-5415.2005.53525.x; Logan D, 2010, EXP BRAIN RES, V206, P337, DOI 10.1007/s00221-010-2414-0; MAKI BE, 1994, J GERONTOL, V49, pM72, DOI 10.1093/geronj/49.2.M72; Marks R, 2003, AGEING RES REV, V2, P57, DOI 10.1016/S1568-1637(02)00045-4; Melzer I, 2004, AGE AGEING, V33, P602, DOI 10.1093/ageing/afh218; Meyer PF, 2004, EXP BRAIN RES, V156, P505, DOI 10.1007/s00221-003-1804-y; Meyer PF, 2004, EXP BRAIN RES, V157, P526, DOI 10.1007/s00221-004-1868-3; Muir J, 2011, GAIT POSTURE, V33, P429, DOI 10.1016/j.gaitpost.2010.12.019; Pajala S, 2008, J GERONTOL A-BIOL, V63, P171, DOI 10.1093/gerona/63.2.171; Rousseau P, 1993, Arch Fam Med, V2, P169, DOI 10.1001/archfami.2.2.169; Rousseau P, 1993, ARCH FAM MED, V2, P166; SCHUMANN T, 1995, J BIOMECH, V28, P603, DOI 10.1016/0021-9290(94)00113-I; Services UDoHaH, 2004, BON HLTH OST REP SUR; SHUMWAYCOOK A, 1988, ARCH PHYS MED REHAB, V69, P395; van Helden S, 2008, J BONE JOINT SURG AM, V90A, P241, DOI 10.2106/JBJS.G.00150; Williams HG, 1997, ARCH PHYS MED REHAB, V78, P737, DOI 10.1016/S0003-9993(97)90082-4	29	49	50	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2013	8	8							e70566	10.1371/journal.pone.0070566	http://dx.doi.org/10.1371/journal.pone.0070566			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	218XC	23940592	Green Published, gold			2022-12-25	WOS:000324465000086
J	Paolinelli, R; Corada, M; Ferrarini, L; Devraj, K; Artus, C; Czupalla, CJ; Rudini, N; Maddaluno, L; Papa, E; Engelhardt, B; Couraud, PO; Liebner, S; Dejana, E				Paolinelli, Roberta; Corada, Monica; Ferrarini, Luca; Devraj, Kavi; Artus, Cedric; Czupalla, Cathrin J.; Rudini, Noemi; Maddaluno, Luigi; Papa, Eleanna; Engelhardt, Britta; Couraud, Pierre Olivier; Liebner, Stefan; Dejana, Elisabetta			Wnt Activation of Immortalized Brain Endothelial Cells as a Tool for Generating a Standardized Model of the Blood Brain Barrier In Vitro	PLOS ONE			English	Article							GLYCOGEN-SYNTHASE KINASE-3; TIGHT JUNCTION PROTEINS; GLUCOSE-TRANSPORTER; XENOPUS EMBRYOS; STEM-CELLS; HUMAN GENE; CATENIN; EXPRESSION; CADHERIN; INHIBITORS	Reproducing the characteristics and the functional responses of the blood-brain barrier (BBB) in vitro represents an important task for the research community, and would be a critical biotechnological breakthrough. Pharmaceutical and biotechnology industries provide strong demand for inexpensive and easy-to-handle in vitro BBB models to screen novel drug candidates. Recently, it was shown that canonical Wnt signaling is responsible for the induction of the BBB properties in the neonatal brain microvasculature in vivo. In the present study, following on from earlier observations, we have developed a novel model of the BBB in vitro that may be suitable for large scale screening assays. This model is based on immortalized endothelial cell lines derived from murine and human brain, with no need for co-culture with astrocytes. To maintain the BBB endothelial cell properties, the cell lines are cultured in the presence of Wnt3a or drugs that stabilize beta-catenin, or they are infected with a transcriptionally active form of beta-catenin. Upon these treatments, the cell lines maintain expression of BBB-specific markers, which results in elevated transendothelial electrical resistance and reduced cell permeability. Importantly, these properties are retained for several passages in culture, and they can be reproduced and maintained in different laboratories over time. We conclude that the brain-derived endothelial cell lines that we have investigated gain their specialized characteristics upon activation of the canonical Wnt pathway. This model may be thus suitable to test the BBB permeability to chemicals or large molecular weight proteins, transmigration of inflammatory cells, treatments with cytokines, and genetic manipulation.	[Paolinelli, Roberta; Corada, Monica; Ferrarini, Luca; Rudini, Noemi; Maddaluno, Luigi; Papa, Eleanna; Dejana, Elisabetta] IFOM FIRC Inst Mol Oncol Fdn, Milan, Italy; [Dejana, Elisabetta] Univ Milan, Dept Biosci, Milan, Italy; [Devraj, Kavi; Czupalla, Cathrin J.; Liebner, Stefan] Goethe Univ Frankfurt, Inst Neurol, Edinger Inst, D-60054 Frankfurt, Germany; [Artus, Cedric; Couraud, Pierre Olivier] Inst Cochin Genet Mol, INSERM, U1016, F-75014 Paris, France; [Artus, Cedric; Couraud, Pierre Olivier] CNRS, UMR8104, Paris, France; [Artus, Cedric; Couraud, Pierre Olivier] Univ Paris 05, Sorbonne Paris Cite, Paris, France; [Engelhardt, Britta] Univ Bern, Theodor Kocher Inst, Bern, Switzerland	IFOM - FIRC Institute of Molecular Oncology; University of Milan; Goethe University Frankfurt; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; University of Bern	Dejana, E (corresponding author), IFOM FIRC Inst Mol Oncol Fdn, Milan, Italy.	elisabetta.dejana@ifom.eu	Dejana, Elisabetta/A-6274-2016; Devraj, Kavi/I-4701-2019; Engelhardt, Britta/K-7267-2014	Devraj, Kavi/0000-0002-5005-3413; Engelhardt, Britta/0000-0003-3059-9846; Corada, Monica/0000-0001-8220-0871; DEJANA, ELISABETTA/0000-0002-0007-0426	Fondation Leducq Transatlantic Network of Excellence; Associazione Italiana per la Ricerca sul Cancro (AIRC); Special Program Molecular Clinical Oncology [561000]; European Community [202213, 223098, ANGIOSCAFF-NMP3-LA-2008-214402, ENDOSTEM-HEALTH-2009-241440, JUSTBRAIN-HEALTH-2009-241861]; European Research Council; CARIPLO Foundation	Fondation Leducq Transatlantic Network of Excellence(Leducq Foundation); Associazione Italiana per la Ricerca sul Cancro (AIRC)(Fondazione AIRC per la ricerca sul cancro); Special Program Molecular Clinical Oncology; European Community(European Commission); European Research Council(European Research Council (ERC)European Commission); CARIPLO Foundation(Fondazione Cariplo)	This study was supported by grants from: Fondation Leducq Transatlantic Network of Excellence, Associazione Italiana per la Ricerca sul Cancro (AIRC), and "Special Program Molecular Clinical Oncology 561000" to AGIMM (AIRC-Gruppo Italiano Malattie Mieloproliferative), the European Community (EUSTROKE-contract-202213, OPTISTEM-contract-223098, ANGIOSCAFF-NMP3-LA-2008-214402 Networks; ENDOSTEM-HEALTH-2009-241440; JUSTBRAIN-HEALTH-2009-241861; ITN Vessels), the European Research Council and CARIPLO Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott NJ, 2010, NEUROBIOL DIS, V37, P13, DOI 10.1016/j.nbd.2009.07.030; ALBRITTON LM, 1992, GENOMICS, V12, P430, DOI 10.1016/0888-7543(92)90431-Q; Balconi G, 2000, ARTERIOSCL THROM VAS, V20, P1443, DOI 10.1161/01.ATV.20.6.1443; Bao RY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048670; Begley DJ, 2004, PHARMACOL THERAPEUT, V104, P29, DOI 10.1016/j.pharmthera.2004.08.001; Benson K, 2013, FLUIDS BARRIERS CNS, V10, DOI 10.1186/2045-8118-10-5; Bernas MJ, 2010, NAT PROTOC, V5, P1265, DOI 10.1038/nprot.2010.76; BREVIARIO F, 1995, ARTERIOSCL THROM VAS, V15, P1229, DOI 10.1161/01.ATV.15.8.1229; Calabria AR, 2006, J NEUROCHEM, V97, P922, DOI 10.1111/j.1471-4159.2006.03793.x; Carson-Walter EB, 2005, CLIN CANCER RES, V11, P7643, DOI 10.1158/1078-0432.CCR-05-1099; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; Coghlan MP, 2000, CHEM BIOL, V7, P793, DOI 10.1016/S1074-5521(00)00025-9; Daneman R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013741; Daneman R, 2009, P NATL ACAD SCI USA, V106, P641, DOI 10.1073/pnas.0805165106; Deane R, 2009, CNS NEUROL DISORD-DR, V8, P16, DOI 10.2174/187152709787601867; DOMINGUEZ I, 1995, P NATL ACAD SCI USA, V92, P8498, DOI 10.1073/pnas.92.18.8498; Doyle LA, 1998, P NATL ACAD SCI USA, V95, P15665, DOI 10.1073/pnas.95.26.15665; Engelhardt B, 2003, CELL TISSUE RES, V314, P119, DOI 10.1007/s00441-003-0751-z; Gabathuler R, 2010, NEUROBIOL DIS, V37, P48, DOI 10.1016/j.nbd.2009.07.028; GARLANDA C, 1994, P NATL ACAD SCI USA, V91, P7291, DOI 10.1073/pnas.91.15.7291; Gerhard DS, 2004, GENOME RES, V14, P2121, DOI 10.1101/gr.2596504; Gumbleton M, 2001, J PHARM SCI-US, V90, P1681, DOI 10.1002/jps.1119; HE X, 1995, NATURE, V374, P617, DOI 10.1038/374617a0; Hermann DM, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002886; Kehr NS, 2013, ANGEW CHEM INT EDIT, V52, P1156, DOI 10.1002/anie.201206951; Kondoh M, 2008, DRUG DISCOV TODAY, V13, P180, DOI 10.1016/j.drudis.2007.11.005; Lampugnani MG, 2010, J CELL SCI, V123, P1073, DOI 10.1242/jcs.059329; Lampugnani MG, 2002, MOL BIOL CELL, V13, P1175, DOI 10.1091/mbc.01-07-0368; Lee K, 1998, CANCER RES, V58, P2741; Liebner S, 2000, EUR J CELL BIOL, V79, P707, DOI 10.1078/0171-9335-00101; Liebner S, 2008, J CELL BIOL, V183, P409, DOI 10.1083/jcb.200806024; Liebner S, 2011, INT J DEV BIOL, V55, P467, DOI 10.1387/ijdb.103224sl; Lippmann ES, 2012, NAT BIOTECHNOL, V30, P783, DOI 10.1038/nbt.2247; Lluis F, 2008, CELL STEM CELL, V3, P493, DOI 10.1016/j.stem.2008.08.017; Lyck R, 2009, J CEREBR BLOOD F MET, V29, P1491, DOI 10.1038/jcbfm.2009.72; Macdonald JA, 2010, J NEUROSCI RES, V88, P1457, DOI 10.1002/jnr.22316; Manel N, 2003, CELL, V115, P449, DOI 10.1016/S0092-8674(03)00881-X; Meijer L, 2003, CHEM BIOL, V10, P1255, DOI 10.1016/j.chembiol.2003.11.010; Morita K, 1999, P NATL ACAD SCI USA, V96, P511, DOI 10.1073/pnas.96.2.511; MYKLEBOST O, 1989, GENOMICS, V5, P65, DOI 10.1016/0888-7543(89)90087-6; Neuhaus W, 2008, NEUROSCI LETT, V446, P59, DOI 10.1016/j.neulet.2008.09.025; Pardridge WM, 2002, DRUG DISCOV TODAY, V7, P5, DOI 10.1016/S1359-6446(01)02082-7; Patel MM, 2009, CNS DRUGS, V23, P35, DOI 10.2165/0023210-200923010-00003; Phiel CJ, 2001, ANNU REV PHARMACOL, V41, P789, DOI 10.1146/annurev.pharmtox.41.1.789; PIERCE SB, 1995, DEVELOPMENT, V121, P755; Polychronopoulos P, 2004, J MED CHEM, V47, P935, DOI 10.1021/jm031016d; Rempe R, 2011, BIOCHEM BIOPH RES CO, V406, P64, DOI 10.1016/j.bbrc.2011.01.110; Ribeiro MMB, 2010, MINI-REV MED CHEM, V10, P263, DOI 10.2174/138955710791185082; Rohnelt RK, 1997, INT IMMUNOL, V9, P435, DOI 10.1093/intimm/9.3.435; Schinkel AH, 1999, ADV DRUG DELIVER REV, V36, P179, DOI 10.1016/S0169-409X(98)00085-4; Schrade A, 2012, FLUIDS BARRIERS CNS, V9, DOI 10.1186/2045-8118-9-6; SEULBERGER H, 1990, EMBO J, V9, P2151, DOI 10.1002/j.1460-2075.1990.tb07384.x; SIFLINGERBIRNBOIM A, 1987, J CELL PHYSIOL, V132, P111, DOI 10.1002/jcp.1041320115; Sirotkin H, 1997, GENOMICS, V42, P245, DOI 10.1006/geno.1997.4734; Spokoini R, 2010, MOL ENDOCRINOL, V24, P1136, DOI 10.1210/me.2009-0466; Stan RV, 2001, GENOMICS, V72, P304, DOI 10.1006/geno.2000.6489; Steiner O, 2011, J CEREBR BLOOD F MET, V31, P315, DOI 10.1038/jcbfm.2010.96; Stenman JM, 2008, SCIENCE, V322, P1247, DOI 10.1126/science.1164594; SUZUKI S, 1991, CELL REGUL, V2, P261, DOI 10.1091/mbc.2.4.261; Taddei A, 2008, NAT CELL BIOL, V10, P923, DOI 10.1038/ncb1752; TAKATA K, 1990, BIOCHEM BIOPH RES CO, V173, P67, DOI 10.1016/S0006-291X(05)81022-8; Toth Andrea, 2011, Recent Pat CNS Drug Discov, V6, P107; UEDA K, 1987, J BIOL CHEM, V262, P505; Umeki Nobuo, 2002, Drug Metab Pharmacokinet, V17, P367, DOI 10.2133/dmpk.17.367; UNGER CM, 1993, ADV EXP MED BIOL, V331, P211; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; VISSING H, 1994, GENOMICS, V24, P606, DOI 10.1006/geno.1994.1676; Vleminckx K, 1999, MECH DEVELOP, V81, P65, DOI 10.1016/S0925-4773(98)00225-1; WAGNER EF, 1994, SEMIN CANCER BIOL, V5, P137; Warren MS, 2009, PHARMACOL RES, V59, P404, DOI 10.1016/j.phrs.2009.02.007; Weksler BB, 2005, FASEB J, V19, P1872, DOI 10.1096/fj.04-3458fje; Wilhelm I, 2011, ACTA NEUROBIOL EXP, V71, P113; Willert K, 2003, NATURE, V423, P448, DOI 10.1038/nature01611; Zhang WD, 2003, FASEB J, V17, P2085, DOI 10.1096/fj.02-1131fje	74	65	68	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2013	8	8							e70233	10.1371/journal.pone.0070233	http://dx.doi.org/10.1371/journal.pone.0070233			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	218XC	23940549	Green Published, Green Submitted, gold			2022-12-25	WOS:000324465000043
J	Seehuus, SC; Taylor, S; Petersen, K; Aamodt, RM				Seehuus, Siri-Christine; Taylor, Simon; Petersen, Kjell; Aamodt, Randi M.			Somatic Maintenance Resources in the Honeybee Worker Fat Body Are Distributed to Withstand the Most Life-Threatening Challenges at Each Life Stage	PLOS ONE			English	Article							DNA-DAMAGE; PROTEIN; GENE; EVOLUTION; BEE	In a global transcriptome analysis of three natural and three manipulated honeybee worker phenotypes at different ages, we have investigated the distribution of investment in somatic maintenance of the fat body. Gene expression is modulated so that the bees are able to resist the most life-threatening challenges at the actual life stage. Different modes of maintenance and repair are regulated, apparently to meet the environmental challenges most detrimental to survival and reproductive potential for the hive. We observed a broad down-regulation of genomic and cellular maintenance in the short-lived foragers and nurse bees compared to the long-lived winter bees. Our results show that survival and reproduction of the entire hive is given priority over the individual bees, hence supporting the idea of the honeybee society as a superorganism. Our results also fit the disposable soma theory of aging.	[Seehuus, Siri-Christine; Aamodt, Randi M.] Norwegian Univ Life Sci, Dept Aquaculture & Anim Sci, As, Norway; [Seehuus, Siri-Christine] Queen Maud Univ Coll, Trondheim, Norway; [Taylor, Simon] Norwegian Univ Life Sci, Ctr Integrat Genet CIGENE, As, Norway; [Petersen, Kjell] Uni Res AS, Uni Comp, Computat Biol Unit, Bergen, Norway	Norwegian University of Life Sciences; Norwegian University of Life Sciences; University of Bergen	Seehuus, SC (corresponding author), Norwegian Univ Life Sci, Dept Aquaculture & Anim Sci, As, Norway.	scs@dmmh.no	Seehuus, Christine/GYV-3988-2022		Norwegian Research Council [186362/V40, 159951/V40]; National Program for Research in Functional Genomics (FUGE); FUGE 2 program, National Bioinformatics Platform, Norwegian Research Council; EU [FP6 03689]	Norwegian Research Council(Research Council of NorwayEuropean Commission); National Program for Research in Functional Genomics (FUGE); FUGE 2 program, National Bioinformatics Platform, Norwegian Research Council; EU(European Commission)	Siri-Christine Seehuus was funded by the Norwegian Research Council grant number 186362/V40. Simon Taylor was funded by the National Program for Research in Functional Genomics (FUGE) granted by the Norwegian Research Council. Kjell Petersen was funded by the FUGE 2 program, National Bioinformatics Platform, Norwegian Research Council. Randi Aamodt was funded by the Norwegian Research Council grant number 159951/V40 and the EU funded Network of Excellence LifeSpan (FP6 03689). None of the authors or funding institutions has any conflict of interest in the publishing of this paper. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aamodt RM, 2009, EXP GERONTOL, V44, P586, DOI 10.1016/j.exger.2009.06.004; Albert S, 2011, INSECT BIOCHEM MOLEC, V41, P968, DOI 10.1016/j.ibmb.2011.09.006; Amdam GV, 2006, ADV CANCER RES, V95, P31, DOI 10.1016/S0065-230X(06)95002-7; Amdam GV, 2003, BMC BIOTECHNOL, V3, DOI 10.1186/1472-6750-3-1; Arakane Y, 2010, CELL MOL LIFE SCI, V67, P201, DOI 10.1007/s00018-009-0161-9; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Breitling R, 2004, FEBS LETT, V573, P83, DOI 10.1016/j.febslet.2004.07.055; Brody T, 2000, J CELL BIOL, V150, pF83, DOI 10.1083/jcb.150.2.F83; Calderone NW, 1998, APIDOLOGIE, V29, P127, DOI 10.1051/apido:19980108; Carrard A, 2011, J AFFECT DISORDERS, V132, P450, DOI 10.1016/j.jad.2011.03.018; Claudianos C, 2006, INSECT MOL BIOL, V15, P615, DOI 10.1111/j.1365-2583.2006.00672.x; CRAILSHEIM K, 1991, J COMP PHYSIOL B, V161, P55, DOI 10.1007/BF00258746; Fluri P., 1989, Schweizerische Bienen-Zeitung, V112, P452; Freitas AA, 2011, MUTAT RES-REV MUTAT, V728, P12, DOI 10.1016/j.mrrev.2011.05.001; Garinis GA, 2008, NAT CELL BIOL, V10, P1241, DOI 10.1038/ncb1108-1241; HAUNERLAND NH, 1995, ANNU REV ENTOMOL, V40, P121, DOI 10.1146/annurev.en.40.010195.001005; Hodges F.E.D., 1950, BEE WORLD, V31, DOI [10.1080/0005772X.1950.11094617, DOI 10.1080/0005772X.1950.11094617, https://doi.org/10.1080/0005772X.1950.11094617]; Hoeijmakers JHJ, 2008, EJC SUPPL, V6, P63, DOI 10.1016/S1359-6349(08)71414-9; Hoeijmakers JHJ, 2009, NEW ENGL J MED, V361, P1914; Johnson O, 2009, NEUROSCIENCE, V158, P1292, DOI 10.1016/j.neuroscience.2008.10.055; Kaeberlein M, 2007, AGING CELL, V6, P731, DOI 10.1111/j.1474-9726.2007.00341.x; KIRKWOOD TBL, 1977, NATURE, V270, P301, DOI 10.1038/270301a0; Luo JN, 2012, CELL MOL LIFE SCI, V69, P471, DOI 10.1007/s00018-011-0789-0; Maurizio A., 1954, LANDWIRTSCH JB SCHWE, V68, P115, DOI DOI 10.1051/APIDO/2010012; Molina E, 2011, PSYCHIAT GENET, V21, P195, DOI 10.1097/YPG.0b013e3283457a48; Moncalvo VGR, 2009, BMC NEUROSCI, V10, DOI 10.1186/1471-2202-10-66; OMHOLT SW, 1987, J THEOR BIOL, V128, P219, DOI 10.1016/S0022-5193(87)80170-4; Omholt SW, 2004, SCI AGING KNOWL ENV, V2004, P28; Queller DC, 2002, SCIENCE, V296, P311, DOI 10.1126/science.1070671; ROBINSON GE, 1989, SCIENCE, V246, P109, DOI 10.1126/science.246.4926.109; Rutherford SL, 2003, NAT REV GENET, V4, P263, DOI 10.1038/nrg1041; Rutherford S, 2007, CRIT REV BIOCHEM MOL, V42, P355, DOI 10.1080/10409230701597782; Sawin ER, 2000, NEURON, V26, P619, DOI 10.1016/S0896-6273(00)81199-X; Stavrum R, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001973; Syntichaki P, 2006, EXP GERONTOL, V41, P1020, DOI 10.1016/j.exger.2006.05.014; WILSON DS, 1989, J THEOR BIOL, V136, P337, DOI 10.1016/S0022-5193(89)80169-9; Winston M.L., 1991, BIOL HONEY BEE	37	18	19	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2013	8	8							e69870	10.1371/journal.pone.0069870	http://dx.doi.org/10.1371/journal.pone.0069870			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	218XC	23940531	Green Submitted, Green Published, gold			2022-12-25	WOS:000324465000025
J	Vilches, S; Vergara, C; Nicolas, O; Sanclimens, G; Merino, S; Varon, S; Acosta, GA; Albericio, F; Royo, M; Del Rio, JA; Gavin, R				Vilches, Silvia; Vergara, Cristina; Nicolas, Oriol; Sanclimens, Gloria; Merino, Sandra; Varon, Sonia; Acosta, Gerardo A.; Albericio, Fernando; Royo, Miriam; Del Rio, Jose A.; Gavin, Rosalina			Neurotoxicity of Prion Peptides Mimicking the Central Domain of the Cellular Prion Protein	PLOS ONE			English	Article							AMYLOID-BETA-PEPTIDE; LONG-TERM POTENTIATION; SOLID-PHASE SYNTHESIS; IN-VITRO; PRP FRAGMENT; EXPRESSION; CELLS; PRP106-126; NEURONS; DISEASE	The physiological functions of PrPC remain enigmatic, but the central domain, comprising highly conserved regions of the protein may play an important role. Indeed, a large number of studies indicate that synthetic peptides containing residues 106-126 (CR) located in the central domain (CD, 95-133) of PrPC are neurotoxic. The central domain comprises two chemically distinct subdomains, the charge cluster (CC, 95-110) and a hydrophobic region (HR, 112-133). The aim of the present study was to establish the individual cytotoxicity of CC, HR and CD. Our results show that only the CD peptide is neurotoxic. Biochemical, Transmission Electron Microscopy and Atomic Force Microscopy experiments demonstrated that the CD peptide is able to activate caspase-3 and disrupt the cell membrane, leading to cell death.	[Vilches, Silvia; Vergara, Cristina; Nicolas, Oriol; Del Rio, Jose A.; Gavin, Rosalina] Inst Bioengn Catalonia IBEC, Barcelona, Spain; [Vilches, Silvia; Vergara, Cristina; Del Rio, Jose A.; Gavin, Rosalina] Ctr Invest Biomed Red Enfermedades Neurodegenerat, Barcelona, Spain; [Nicolas, Oriol; Del Rio, Jose A.; Gavin, Rosalina] Univ Barcelona, Fac Biol, Dept Cell Biol, Barcelona, Spain; [Sanclimens, Gloria; Varon, Sonia; Royo, Miriam] Sci Pk Barcelona, Combinatorial Chem Unit, Barcelona, Spain; [Merino, Sandra] Univ Barcelona, Fac Pharm, Dept Physicochem, Barcelona, Spain; [Acosta, Gerardo A.; Albericio, Fernando] Inst Res Biomed, Barcelona, Spain; [Acosta, Gerardo A.; Albericio, Fernando; Royo, Miriam] Networking Res Ctr Bioengn Biomat & Nanomed CIBER, Barcelona, Spain; [Albericio, Fernando] Univ Barcelona, Fac Chem, Dept Organ Chem, Barcelona, Spain	Barcelona Institute of Science & Technology; Institut de Bioenginyeria de Catalunya; University of Barcelona; CIBERNED; University of Barcelona; University of Barcelona; Barcelona Institute of Science & Technology; Institute for Research in Biomedicine - IRB Barcelona; CIBER - Centro de Investigacion Biomedica en Red; CIBERBBN; University of Barcelona	Del Rio, JA (corresponding author), Inst Bioengn Catalonia IBEC, Barcelona, Spain.	jadelrio@ibecbarcelona.eu; rgavin@ub.edu	Royo, Miriam/AAH-4918-2019; Gavín, Rosalina/D-4341-2014; Royo, Miriam/B-1665-2013; Albericio, Fernando/B-4383-2013; Del Rio Fernandez, Jose A/AAD-1121-2020; del rio, jose antonio/L-9232-2014	Royo, Miriam/0000-0001-5292-0819; Gavín, Rosalina/0000-0003-1982-2162; Royo, Miriam/0000-0001-5292-0819; Albericio, Fernando/0000-0002-8946-0462; del rio, jose antonio/0000-0002-5214-4909	FP7-PRIORITY; DEMTEST; MINECO [BFU2012-32617, CTQ2008-00177]; Generalitat de Catalunya [SGR2009-366]; Instituto Salud Carlos III; Fondo de Investigaciones Sanitarias [PI11-00075]; Spanish Ministry of Science and Innovation (MICINN); Fundacion Ramon Areces	FP7-PRIORITY; DEMTEST; MINECO(Spanish Government); Generalitat de Catalunya(Generalitat de Catalunya); Instituto Salud Carlos III(Instituto de Salud Carlos III); Fondo de Investigaciones Sanitarias(Instituto de Salud Carlos III); Spanish Ministry of Science and Innovation (MICINN)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Fundacion Ramon Areces	This research was supported by funding from FP7-PRIORITY and DEMTEST (Joint Programming of Neurodegenerative Diseases), MINECO (BFU2012-32617), Generalitat de Catalunya (SGR2009-366), the Instituto Salud Carlos III to JADR and Fondo de Investigaciones Sanitarias (PI11-00075) to RG and MINECO (CTQ2008-00177) to MR. CV and ON are supported by the Spanish Ministry of Science and Innovation (MICINN) and Fundacion Ramon Areces respectively. SV is a Juan de la Cierva post-doctoral fellow of the MICINN. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bahadi R, 2003, AM J PHYSIOL-CELL PH, V285, pC862, DOI 10.1152/ajpcell.00077.2003; Baumann F, 2007, EMBO J, V26, P538, DOI 10.1038/sj.emboj.7601510; Benvegnu S, 2011, PHYSIOL GENOMICS, V43, P711, DOI 10.1152/physiolgenomics.00205.2010; Bergstrom AL, 2005, J BIOL CHEM, V280, P23114, DOI 10.1074/jbc.M500210200; Biasini E, 2012, TRENDS NEUROSCI, V35, P92, DOI 10.1016/j.tins.2011.10.002; Bischofberger M, 2009, CURR OPIN CELL BIOL, V21, P589, DOI 10.1016/j.ceb.2009.04.003; Bribian A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033872; Brorsson AC, 2010, BIOPHYS J, V98, P1677, DOI 10.1016/j.bpj.2009.12.4320; Brown DR, 2002, J NEUROSCI RES, V67, P211, DOI 10.1002/jnr.10118; Brown DR, 1996, GLIA, V18, P59, DOI 10.1002/(SICI)1098-1136(199609)18:1<59::AID-GLIA6>3.0.CO;2-Z; BROWN DR, 1994, NEUROREPORT, V5, P2057, DOI 10.1097/00001756-199410270-00017; Brown DR, 2000, MOL CELL NEUROSCI, V15, P66, DOI 10.1006/mcne.1999.0796; Brown DR, 1999, FEBS LETT, V460, P559, DOI 10.1016/S0014-5793(99)01343-5; BUELER H, 1992, NATURE, V356, P577, DOI 10.1038/356577a0; Caetano FA, 2011, J NEUROCHEM, V117, P538, DOI 10.1111/j.1471-4159.2011.07225.x; Caughey B, 2003, ANNU REV NEUROSCI, V26, P267, DOI 10.1146/annurev.neuro.26.010302.081142; Chabry J, 2003, J NEUROSCI, V23, P462; Chesebro B, 2005, SCIENCE, V308, P1435, DOI 10.1126/science.1110837; Choi YP, 2011, BRAIN PATHOL, V21, P298, DOI 10.1111/j.1750-3639.2010.00446.x; Enguita M, 2005, MOL PHARMACOL, V67, P1237, DOI 10.1124/mol.104.007062; Fioriti L, 2005, MOL CELL NEUROSCI, V28, P165, DOI 10.1016/j.mcn.2004.09.006; Florio T, 2003, J NEUROCHEM, V85, P62, DOI 10.1046/j.1471-4159.2003.01664.x; FORLONI G, 1994, EUR J NEUROSCI, V6, P1415, DOI 10.1111/j.1460-9568.1994.tb01003.x; Forloni G, 1996, CURR OPIN NEUROL, V9, P492, DOI 10.1097/00019052-199612000-00017; FORLONI G, 1993, NATURE, V362, P543, DOI 10.1038/362543a0; Forloni G, 2000, FEBS LETT, V466, P205, DOI 10.1016/S0014-5793(99)01781-0; Furumoto S, 2007, CURR TOP MED CHEM, V7, P1773, DOI 10.2174/156802607782507402; Garcia-Martin F, 2006, J COMB CHEM, V8, P213, DOI 10.1021/cc0600019; Gavin R, 2005, FEBS LETT, V579, P4099, DOI 10.1016/j.febslet.2005.06.037; Glabe CG, 2008, J BIOL CHEM, V283, P29639, DOI 10.1074/jbc.R800016200; Goldsbury C, 2005, J MOL BIOL, V352, P282, DOI 10.1016/j.jmb.2005.07.029; Goldsbury CS, 2000, J STRUCT BIOL, V130, P217, DOI 10.1006/jsbi.2000.4259; Grillo-Bosch D, 2011, J PEPT SCI, V17, P32, DOI 10.1002/psc.1293; Groenning Minna, 2010, J Chem Biol, V3, P1, DOI 10.1007/s12154-009-0027-5; Haass C, 2007, NAT REV MOL CELL BIO, V8, P101, DOI 10.1038/nrm2101; Haik S, 2000, NEUROBIOL DIS, V7, P644, DOI 10.1006/nbdi.2000.0316; Harris DA, 2003, BRIT MED BULL, V66, P71, DOI 10.1093/bmb/66.1.71; HATTEN ME, 1984, J CELL BIOL, V98, P193, DOI 10.1083/jcb.98.1.193; Hegde RS, 1998, SCIENCE, V279, P827, DOI 10.1126/science.279.5352.827; Henriques ST, 2009, BIOCHEMISTRY-US, V48, P4198, DOI 10.1021/bi900009d; Kayed R, 2009, J BIOL CHEM, V284, P4230, DOI 10.1074/jbc.M808591200; Khalife M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023253; Kourie JI, 2000, AM J PHYSIOL-CELL PH, V278, pC1063, DOI 10.1152/ajpcell.2000.278.6.C1063; Kourie JI, 2000, J NEUROSCI RES, V62, P120, DOI 10.1002/1097-4547(20001001)62:1<120::AID-JNR13>3.0.CO;2-2; Kunz B, 1999, FEBS LETT, V458, P65, DOI 10.1016/S0014-5793(99)01123-0; Kupfer L, 2009, CURR MOL MED, V9, P826, DOI 10.2174/156652409789105543; Lansbury PT, 2006, NATURE, V443, P774, DOI 10.1038/nature05290; Lashuel HA, 2006, Q REV BIOPHYS, V39, P167, DOI 10.1017/S0033583506004422; Lawson VA, 2004, J BIOL CHEM, V279, P13689, DOI 10.1074/jbc.M303697200; Lawson VA, 2001, J BIOL CHEM, V276, P35265, DOI 10.1074/jbc.M103799200; Le YY, 2001, J IMMUNOL, V166, P1448, DOI 10.4049/jimmunol.166.3.1448; Linden R, 2008, PHYSIOL REV, V88, P673, DOI 10.1152/physrev.00007.2007; Martins VR, 2010, CURR ISSUES MOL BIOL, V12, P63; Merino S, 2005, BIOSENS BIOELECTRON, V20, P1843, DOI 10.1016/j.bios.2004.05.001; Minaki H, 2009, NEUROPATHOLOGY, V29, P536, DOI 10.1111/j.1440-1789.2009.01007.x; Mucke L, 1996, ANN NY ACAD SCI, V777, P82, DOI 10.1111/j.1749-6632.1996.tb34405.x; Nicolas O, 2009, BRAIN RES REV, V61, P170, DOI 10.1016/j.brainresrev.2009.06.002; Norstrom EM, 2005, J BIOL CHEM, V280, P27236, DOI 10.1074/jbc.M413441200; Pedersen JS, 2006, J MOL BIOL, V355, P501, DOI 10.1016/j.jmb.2005.09.100; Pietri M, 2006, J BIOL CHEM, V281, P28470, DOI 10.1074/jbc.M602774200; Pillot T, 1997, J MOL BIOL, V274, P381, DOI 10.1006/jmbi.1997.1382; Priola SA, 2009, PRION, V3, P134, DOI 10.4161/pri.3.3.9771; Prusiner SB, 1998, P NATL ACAD SCI USA, V95, P13363, DOI 10.1073/pnas.95.23.13363; Rangel A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007592; Sales N, 2002, EUR J NEUROSCI, V15, P1163, DOI 10.1046/j.1460-9568.2002.01953.x; Salmona M, 1997, NEUROBIOL DIS, V4, P47, DOI 10.1006/nbdi.1997.0133; Sauve S, 2012, J BIOL CHEM, V287, P1915, DOI 10.1074/jbc.M111.279364; Seira O, 2010, J NEUROCHEM, V113, P1644, DOI 10.1111/j.1471-4159.2010.06726.x; Simoneau S, 2007, PLOS PATHOG, V3, P1175, DOI 10.1371/journal.ppat.0030125; Steele AD, 2006, P NATL ACAD SCI USA, V103, P3416, DOI 10.1073/pnas.0511290103; Stella R, 2012, J PROTEOME RES, V11, P523, DOI 10.1021/pr200759m; Surewicz WK, 2011, TOP CURR CHEM, V305, P135, DOI 10.1007/128_2011_165; Taylor CJ, 2008, NEUROBIOL DIS, V31, P250, DOI 10.1016/j.nbd.2008.04.011; Thellung S, 2002, NEUROBIOL DIS, V9, P69, DOI 10.1006/nbdi.2001.0461; Walsh P, 2010, J AM CHEM SOC, V132, P7684, DOI 10.1021/ja100431q; Walsh P, 2009, STRUCTURE, V17, P417, DOI 10.1016/j.str.2008.12.018; Zagorski MG, 1999, METHOD ENZYMOL, V309, P189; Zhang Y, 2002, J CELL BIOL, V156, P519, DOI 10.1083/jcb.200110119; Zhong J, 2007, BBA-BIOMEMBRANES, V1768, P1420, DOI 10.1016/j.bbamem.2007.03.003; Zhong J, 2010, COLLOID SURFACE B, V77, P40, DOI 10.1016/j.colsurfb.2010.01.001	80	19	20	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2013	8	8							e70881	10.1371/journal.pone.0070881	http://dx.doi.org/10.1371/journal.pone.0070881			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	218XC	23940658	Green Published, Green Submitted, gold			2022-12-25	WOS:000324465000148
J	Zhao, J; Yao, PJ; Li, MY; Chen, Z; Shen, Y; Zhao, ZN; Zhou, ZM; Zhou, XT				Zhao, Jing; Yao, Peijun; Li, Meiyan; Chen, Zhi; Shen, Yang; Zhao, Zhennan; Zhou, Zimei; Zhou, Xingtao			The Morphology of Corneal Cap and Its Relation to Refractive Outcomes in Femtosecond Laser Small Incision Lenticule Extraction (SMILE) with Anterior Segment Optical Coherence Tomography Observation	PLOS ONE			English	Article							IN-SITU KERATOMILEUSIS; MYOPIC ASTIGMATISM; LASIK FLAP; THICKNESS; SURGERY; MICROKERATOME; PACHYMETRY; ACCURACY; OCT	Purpose: To investigate the morphology of corneal caps in femtosecond laser small incision lenticule extraction (SMILE) and its relation to the refractive outcomes. Methods: A prospective study of fifty-four corneal caps created with VisuMax femtosecond laser were examined using an Fourier-domain optical coherence tomography at 1 day, 1 week, 1 month and 6 months after SMILE. The cap thickness at nine points on each of the four meridians (0 degrees, 45 degrees, 90 degrees, 135 degrees) and the diameter were measured. Cap morphology, changes over time and its correlation with refractive outcomes were assessed. Results: The mean achieved central cap thickness were (108.74 +/- 5.06) mu m at 6 months and (107.3 +/- 64.81) mu m at 1 month postoperatively, significantly thinner than that at 1 day (110.81 +/- 7.95) mu m and 1 week (109.58 +/- 7.48) mu m (P<0.05). The mean diameter on 0 degrees meridian was (7.61 +/- 0.07) mm, significantly larger than that on 90 degrees meridian (7.57 +/- 0.06) mm (P=0.001). Cap morphology showed good regularity, except that the differences of points in two pairs were significant at 1 day postoperatively. The uniformity was consistent over time and the central cap thickness was thinner than those in the paracentral and peripheral areas. The refractive outcomes stabilized within 1 month. Uncorrected distance visual acuity (UDVA) was correlated to the central cap thickness at 1 day and 1 week (both r(s) = 0.33, p<0.05). The uniformity index was correlated with UDVA (r(s) = 0.34, p<0.05) and corrected distance visual acuity (r(s) = 0.32, p<0.05) at 1 week postoperatively. Conclusions: Corneal caps of SMILE are predictable with good reproducibility, regularity and uniformity. Cap morphology might have a mild effect on refractive outcomes in the early stage. Further study should focus on the impact on the visual quality.	[Zhao, Jing; Yao, Peijun; Li, Meiyan; Chen, Zhi; Shen, Yang; Zhao, Zhennan; Zhou, Xingtao] Fudan Univ, Dept Ophthalmol, Eye & ENT Hosp, Myopia Key Lab,Hlth Minist, Shanghai 200433, Peoples R China; [Zhou, Zimei] Albert Einstein Coll Med, Bronx Lebanon Hosp Ctr, Dept Ophthalmol, Bronx, NY 10467 USA	Fudan University; BronxCare Health System; Yeshiva University; Albert Einstein College of Medicine	Zhou, XT (corresponding author), Fudan Univ, Dept Ophthalmol, Eye & ENT Hosp, Myopia Key Lab,Hlth Minist, Shanghai 200433, Peoples R China.	doctzhouxingtao@163.com	zhou, xt/GWZ-9212-2022; Chen, Zhi/ABB-2353-2020; Shen, Yang/R-3539-2016	Shen, Yang/0000-0002-5859-0790	National Natural Science Foundation of China [11074052]; Key Project of Science and Technology of Shanghai [11JC1402000]; Outstanding Academic Leaders Program of Shanghai [12XD1401600]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Key Project of Science and Technology of Shanghai; Outstanding Academic Leaders Program of Shanghai	This work was supported in part by the National Natural Science Foundation of China (Grant No. 11074052), the Key Project of Science and Technology of Shanghai (Grant No. 11JC1402000) and the Outstanding Academic Leaders Program of Shanghai (Grant No. 12XD1401600). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Binder PS, 2006, J CATARACT REFR SURG, V32, P962, DOI 10.1016/j.jcrs.2006.02.043; Binder PS, 2004, J CATARACT REFR SURG, V30, P26, DOI 10.1016/S0886-3350(03)00578-9; Blum M, 2010, KLIN MONATSBL AUGENH, V227, P961, DOI 10.1055/s-0029-1245894; Blum M, 2010, GRAEF ARCH CLIN EXP, V248, P1019, DOI 10.1007/s00417-009-1293-1; Dawson DG, 2008, J REFRACT SURG, V24, P90, DOI 10.3928/1081597X-20080101-16; Heichel J, 2011, OPHTHALMIC RES, V46, P107, DOI 10.1159/000323814; Holzer MP, 2006, INVEST OPHTH VIS SCI, V47, P2828, DOI 10.1167/iovs.05-1123; Ju WK, 2011, J REFRACT SURG, V27, P106, DOI 10.3928/1081597X-20100428-04; Kermani O, 2010, J REFRACT SURG, V26, P57, DOI 10.3928/1081597X-20101215-09; Kezirian GM, 2004, J CATARACT REFR SURG, V30, P804, DOI 10.1016/j.jcrs.2003.10.026; Kim Chan Young, 2011, Korean J Ophthalmol, V25, P8, DOI 10.3341/kjo.2011.25.1.8; Kunert KS, 2011, GRAEF ARCH CLIN EXP, V249, P1417, DOI 10.1007/s00417-010-1578-4; Li Y, 2007, OPHTHALMOLOGY, V114, P1124, DOI 10.1016/j.ophtha.2006.09.031; Lubatschowski H, 2008, J REFRACT SURG, V24, P102, DOI 10.3928/1081597X-20080101-18; Murakami Y, 2011, J CATARACT REFR SURG, V37, P1879, DOI 10.1016/j.jcrs.2011.05.024; Prakash G, 2009, AM J OPHTHALMOL, V148, P282, DOI 10.1016/j.ajo.2009.03.012; Qazi MA, 2005, J CATARACT REFR SURG, V31, P48, DOI 10.1016/j.jcrs.2004.10.043; Riau AK, 2011, INVEST OPHTH VIS SCI, V52, P6213, DOI 10.1167/iovs.11-7439; Salaroli CHR, 2011, J CATARACT REFR SURG, V37, P649, DOI 10.1016/j.jcrs.2010.10.047; Sarunic MV, 2008, ARCH OPHTHALMOL-CHIC, V126, P537, DOI 10.1001/archopht.126.4.537; Sekundo W, 2008, J CATARACT REFR SURG, V34, P1513, DOI 10.1016/j.jcrs.2008.05.033; Sekundo W, 2011, BRIT J OPHTHALMOL, V95, P335, DOI 10.1136/bjo.2009.174284; Shah R, 2011, J CATARACT REFR SURG, V37, P1636, DOI 10.1016/j.jcrs.2011.03.056; Shah R, 2011, J CATARACT REFR SURG, V37, P127, DOI 10.1016/j.jcrs.2010.07.033; Stahl JE, 2007, J REFRACT SURG, V23, P555; Sutton G, 2008, J REFRACT SURG, V24, P802, DOI 10.3928/1081597X-20081001-06; Tay E, 2012, J CATARACT REFR SURG, V38, P1544, DOI 10.1016/j.jcrs.2012.05.030; Thomas J, 2006, J REFRACT SURG, V22, P671, DOI 10.3928/1081-597X-20060901-08; von Jagow B, 2009, J CATARACT REFR SURG, V35, P35, DOI 10.1016/j.jcrs.2008.09.013; Westphal V, 2002, OPT EXPRESS, V10, P397, DOI 10.1364/OE.10.000397; Yao P, 2011, J INT MED RES, V39, P748, DOI 10.1177/147323001103900306	31	36	38	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2013	8	8							e70208	10.1371/journal.pone.0070208	http://dx.doi.org/10.1371/journal.pone.0070208			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	218XC	23940547	Green Submitted, Green Published, gold			2022-12-25	WOS:000324465000041
J	Do, JL; Bonni, A; Tuszynski, MH				Do, Jiun L.; Bonni, Azad; Tuszynski, Mark H.			SnoN Facilitates Axonal Regeneration after Spinal Cord Injury	PLOS ONE			English	Article							ANAPHASE-PROMOTING COMPLEX; IN-VIVO; GROWTH; MORPHOGENESIS; NEURONS; PATHWAY; CELLS; GENE; SKI; DEGRADATION	Adult CNS neurons exhibit a reduced capacity for growth compared to developing neurons, due in part to downregulation of growth-associated genes as development is completed. We tested the hypothesis that SnoN, an embryonically regulated transcription factor that specifies growth of the axonal compartment, can enhance growth in injured adult neurons. In vitro, SnoN overexpression in dissociated adult DRG neuronal cultures significantly enhanced neurite outgrowth. Moreover, TGF-beta 1, a negative regulator of SnoN, inhibited neurite outgrowth, and SnoN over-expression overcame this inhibition. We then examined whether SnoN influenced axonal regeneration in vivo: indeed, expression of a mutant form of SnoN resistant to degradation significantly enhanced axonal regeneration following cervical spinal cord injury, despite peri-lesional upregulation of TGF-beta 1. Thus, a developmental mechanism that specifies extension of the axonal compartment also promotes axonal regeneration after adult CNS injury.	[Do, Jiun L.; Tuszynski, Mark H.] Univ Calif San Diego, Dept Neurosci, La Jolla, CA 92093 USA; [Bonni, Azad] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA; [Tuszynski, Mark H.] Vet Affairs Med Ctr, San Diego, CA 92161 USA	University of California System; University of California San Diego; Harvard University; Harvard Medical School; US Department of Veterans Affairs; Veterans Health Administration (VHA)	Tuszynski, MH (corresponding author), Univ Calif San Diego, Dept Neurosci, La Jolla, CA 92093 USA.	mtuszynski@ucsd.edu		Do, Jiun/0000-0003-4768-0624	Veterans Administration; NIH [NS42291]; Dr. Miriam and Sheldon G. Adelson Medical Research Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007198] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS042291, R01NS041021] Funding Source: NIH RePORTER	Veterans Administration(US Department of Veterans Affairs); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Dr. Miriam and Sheldon G. Adelson Medical Research Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	The work was supported by the Veterans Administration, NIH (NS42291), and the Dr. Miriam and Sheldon G. Adelson Medical Research Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alto LT, 2009, NAT NEUROSCI, V12, P1106, DOI 10.1038/nn.2365; Bonni S, 2001, NAT CELL BIOL, V3, P587, DOI 10.1038/35078562; Bonni S, 2012, FEBS LETT, V586, P1977, DOI 10.1016/j.febslet.2012.02.048; Bradbury EJ, 1999, EUR J NEUROSCI, V11, P3873, DOI 10.1046/j.1460-9568.1999.00809.x; Cai DM, 2002, NEURON, V35, P711, DOI 10.1016/S0896-6273(02)00826-7; Gaillard A, 2007, NAT NEUROSCI, V10, P1294, DOI 10.1038/nn1970; Gao Y, 2004, NEURON, V44, P609, DOI 10.1016/j.neuron.2004.10.030; Hofstetter CP, 2002, P NATL ACAD SCI USA, V99, P2199, DOI 10.1073/pnas.042678299; Hollis ER, 2010, MOL THER, V18, P1496, DOI 10.1038/mt.2010.97; Ikeuchi Y, 2009, J NEUROSCI, V29, P4312, DOI 10.1523/JNEUROSCI.0126-09.2009; Kadoya K, 2009, NEURON, V64, P165, DOI 10.1016/j.neuron.2009.09.016; Low K, 2010, GENE THER, V17, P577, DOI 10.1038/gt.2010.14; Lu P, 2004, J NEUROSCI, V24, P6402, DOI 10.1523/JNEUROSCI.1492-04.2004; Lu P, 2012, CELL, V150, P1264, DOI 10.1016/j.cell.2012.08.020; Moore DL, 2011, DEV NEUROBIOL, V71, P1186, DOI 10.1002/dneu.20934; Neumann S, 1999, NEURON, V23, P83, DOI 10.1016/S0896-6273(00)80755-2; NOMURA N, 1989, NUCLEIC ACIDS RES, V17, P5489, DOI 10.1093/nar/17.14.5489; Nomura T, 1999, GENE DEV, V13, P412, DOI 10.1101/gad.13.4.412; Park KK, 2008, SCIENCE, V322, P963, DOI 10.1126/science.1161566; Stegmuller J, 2008, J NEUROSCI, V28, P1961, DOI 10.1523/JNEUROSCI.3061-07.2008; Stegmuller J, 2006, NEURON, V50, P389, DOI 10.1016/j.neuron.2006.03.034; Stroschein SL, 2001, GENE DEV, V15, P2822; Stroschein SL, 1999, SCIENCE, V286, P771, DOI 10.1126/science.286.5440.771; Sun Y, 1999, P NATL ACAD SCI USA, V96, P12442, DOI 10.1073/pnas.96.22.12442; Taylor L, 2006, J NEUROSCI, V26, P9713, DOI 10.1523/JNEUROSCI.0734-06.2006; Tessier-Lavigne Marc, 2002, Harvey Lect, V98, P103; Wan Y, 2001, MOL CELL, V8, P1027, DOI 10.1016/S1097-2765(01)00382-3; Yu PP, 2011, EXP NEUROL, V231, P38, DOI 10.1016/j.expneurol.2011.05.013; Zou HY, 2009, J NEUROSCI, V29, P7116, DOI 10.1523/JNEUROSCI.5397-08.2009	29	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 2	2013	8	8							e71906	10.1371/journal.pone.0071906	http://dx.doi.org/10.1371/journal.pone.0071906			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219XU	23936531	Green Submitted, Green Published, gold			2022-12-25	WOS:000324545800070
J	Hollingsworth, TJ; Gross, AK				Hollingsworth, T. J.; Gross, Alecia K.			The Severe Autosomal Dominant Retinitis Pigmentosa Rhodopsin Mutant Ter349Glu Mislocalizes and Induces Rapid Rod Cell Death	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cilia; G Protein-coupled Receptors (GPCRs); Neurodegeneration; Neurodegenerative Diseases; Photoreceptors; Phototransduction; Retinal Degeneration; Rhodopsin; Vision; Ter349Glu	BIEDL-SYNDROME PROTEINS; KNOCKIN MOUSE MODEL; TERMINAL SEQUENCE; MUTATION; GENE; TRAFFICKING; MICE; COMPLEX; IDENTIFICATION; LOCALIZATION	Mutations in the rhodopsin gene cause approximately one-tenth of retinitis pigmentosa cases worldwide, and most result in endoplasmic reticulum retention and apoptosis. Other rhodopsin mutations cause receptor mislocalization, diminished/constitutive activity, or faulty protein-protein interactions. The purpose of this study was to test for mechanisms by which the autosomal dominant rhodopsin mutation Ter349Glu causes an early, rapid retinal degeneration in patients. The mutation adds an additional 51 amino acids to the C terminus of the protein. Folding and ligand interaction of Ter349Glu rhodopsin were tested by ultraviolet-visible (UV-visible) spectrophotometry. The ability of the mutant to initiate phototransduction was tested using a radioactive filter binding assay. Photoreceptor localization was assessed both in vitro and in vivo utilizing fluorescent immunochemistry on transfected cells, transgenic Xenopus laevis, and knock-in mice. Photoreceptor ultrastructure was observed by transmission electron microscopy. Spectrally, Ter349Glu rhodopsin behaves similarly to wild-type rhodopsin, absorbing maximally at 500 nm. The mutant protein also displays in vitro G protein activation similar to that of WT. In cultured cells, mislocalization was observed at high expression levels whereas ciliary localization occurred at low expression levels. Similarly, transgenic X. laevis expressing Ter349Glu rhodopsin exhibited partial mislocalization. Analysis of the Ter349Glu rhodopsin knock-in mouse showed a rapid, early onset degeneration in homozygotes with a loss of proper rod outer segment development and improper disc formation. Together, the data show that both mislocalization and rod outer segment morphogenesis are likely associated with the human phenotype.	Univ Alabama Birmingham, Dept Vis Sci, Birmingham, AL 35294 USA; Univ Alabama Birmingham, Sch Optometry, Birmingham, AL 35294 USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham	Gross, AK (corresponding author), Univ Alabama Birmingham, Sch Optometry, Dept Vis Sci, 1825 Univ Blvd,SHEL 970, Birmingham, AL 35294 USA.	agross@uab.edu	Hollingsworth, T.J./AAD-2814-2022; Gross, Alecia K./AAJ-1792-2021	Gross, Alecia K./0000-0003-1857-6633; Hollingsworth, T.J./0000-0002-2119-521X	National Institutes of Health from NEI [R01 EY019311]; Eye-Sight Foundation of Alabama; Karl Kirchgessner Foundation; Matilda E. Ziegler Foundation; NATIONAL EYE INSTITUTE [R01EY019311] Funding Source: NIH RePORTER	National Institutes of Health from NEI; Eye-Sight Foundation of Alabama; Karl Kirchgessner Foundation; Matilda E. Ziegler Foundation; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 EY019311 from NEI. This work was also supported by the Eye-Sight Foundation of Alabama, the Karl Kirchgessner Foundation, and The Matilda E. Ziegler Foundation.	Abd-El-Barr MM, 2007, VISION RES, V47, P3394, DOI 10.1016/j.visres.2007.09.016; ALMAGHTHEH M, 1993, HUM MUTAT, V2, P249, DOI 10.1002/humu.1380020403; Amaya E, 1999, METH MOL B, V97, P393, DOI 10.1385/1-59259-270-8:393; APFELSTEDTSYLLA E, 1993, BRIT J OPHTHALMOL, V77, P495, DOI 10.1136/bjo.77.8.495; BAEHR W, 1982, J BIOL CHEM, V257, P6452; Berbari NF, 2008, P NATL ACAD SCI USA, V105, P4242, DOI 10.1073/pnas.0711027105; Bessant D A, 1999, Hum Mutat, V13, P83, DOI 10.1002/(SICI)1098-1004(1999)13:1<83::AID-HUMU12>3.0.CO;2-5; Chan F, 2004, P NATL ACAD SCI USA, V101, P9109, DOI 10.1073/pnas.0403149101; Chiang AP, 2004, AM J HUM GENET, V75, P475, DOI 10.1086/423903; Chuang JZ, 1998, J CELL BIOL, V142, P1245, DOI 10.1083/jcb.142.5.1245; Concepcion F, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010904; Davis RE, 2007, P NATL ACAD SCI USA, V104, P19422, DOI 10.1073/pnas.0708571104; Deretic D, 1998, P NATL ACAD SCI USA, V95, P10620, DOI 10.1073/pnas.95.18.10620; Gross AK, 2006, VISION RES, V46, P4510, DOI 10.1016/j.visres.2006.07.012; Hagstrom SA, 1999, INVEST OPHTH VIS SCI, V40, P2795; Hagstrom SA, 1998, NAT GENET, V18, P174, DOI 10.1038/ng0298-174; Hashimoto T, 2007, GENE THER, V14, P584, DOI 10.1038/sj.gt.3302897; Hollingsworth TJ, 2012, INT REV CEL MOL BIO, V293, P1, DOI 10.1016/B978-0-12-394304-0.00006-3; Illing ME, 2002, J BIOL CHEM, V277, P34150, DOI 10.1074/jbc.M204955200; Jin H, 2010, CELL, V141, P1208, DOI 10.1016/j.cell.2010.05.015; Lakso M, 1996, P NATL ACAD SCI USA, V93, P5860, DOI 10.1073/pnas.93.12.5860; Lehtokari VL, 2008, EUR J HUM GENET, V16, P1055, DOI 10.1038/ejhg.2008.60; Lem J, 1999, P NATL ACAD SCI USA, V96, P736, DOI 10.1073/pnas.96.2.736; Leroux A, 2005, EUR J HAEMATOL, V74, P389, DOI 10.1111/j.1600-0609.2004.00388.x; Liang Y, 2004, J BIOL CHEM, V279, P48189, DOI 10.1074/jbc.M408362200; Mazelova J, 2009, EMBO J, V28, P183, DOI 10.1038/emboj.2008.267; Melia TJ, 1997, BIOPHYS J, V73, P3182, DOI 10.1016/S0006-3495(97)78344-9; Nachury MV, 2007, CELL, V129, P1201, DOI 10.1016/j.cell.2007.03.053; Nakao T., 2012, PLOS ONE, V7; Nishimura DY, 2004, P NATL ACAD SCI USA, V101, P16588, DOI 10.1073/pnas.0405496101; PETERS KR, 1983, J CELL BIOL, V96, P265, DOI 10.1083/jcb.96.1.265; PORTERACAILLIAU C, 1994, P NATL ACAD SCI USA, V91, P974, DOI 10.1073/pnas.91.3.974; Price BA, 2011, INVEST OPHTH VIS SCI, V52, P9728, DOI 10.1167/iovs.11-8654; Robinson PR, 2000, METHOD ENZYMOL, V315, P207; Sancho-Pelluz J, 2012, MOL MED, V18, P549, DOI 10.2119/molmed.2011.00475; Schluter MA, 2009, MOL BIOL CELL, V20, P4652, DOI 10.1091/mbc.E09-02-0137; Seo S, 2010, P NATL ACAD SCI USA, V107, P1488, DOI 10.1073/pnas.0910268107; SUNG CH, 1994, J NEUROSCI, V14, P5818; Swiderski RE, 2007, INVEST OPHTH VIS SCI, V48, P3329, DOI 10.1167/iovs.06-1477; Tam BM, 2009, J NEUROSCI, V29, P15145, DOI 10.1523/JNEUROSCI.4259-09.2009; Zeitz C, 2008, INVEST OPHTH VIS SCI, V49, P4105, DOI 10.1167/iovs.08-1717; Zirn B, 2005, AM J KIDNEY DIS, V45, P1100, DOI 10.1053/j.ajkd.2005.03.013	42	31	31	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 4	2013	288	40					29047	29055		10.1074/jbc.M113.495184	http://dx.doi.org/10.1074/jbc.M113.495184			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	298BL	23940033	Green Published, hybrid			2022-12-25	WOS:000330298800058
J	Kadiyala, V; Patrick, NM; Mathieu, W; Jaime-Frias, R; Pookhao, N; An, LL; Smith, CL				Kadiyala, Vineela; Patrick, Nina M.; Mathieu, Wana; Jaime-Frias, Rosa; Pookhao, Naruekamol; An, Lingling; Smith, Catharine L.			Class I Lysine Deacetylases Facilitate Glucocorticoid-induced Transcription	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Gene Transcription; Glucocorticoid Receptor; Histone Deacetylase; Histone Deacetylase Inhibitors; Transcription Coactivators	HISTONE DEACETYLASES; SODIUM-BUTYRATE; N-COR; RECEPTOR; ACETYLATION; INHIBITION; REGULATORS; RECRUITMENT; ACTIVATION; DIVERSITY	Nuclear receptors use lysine acetyltransferases and lysine deacetylases (KDACs) in regulating transcription through histone acetylation. Lysine acetyltransferases interact with steroid receptors upon binding of an agonist and are recruited to target genes. KDACs have been shown to interact with steroid receptors upon binding to an antagonist. We have shown previously that KDAC inhibitors (KDACis) potently repress the mouse mammary tumor virus promoter through transcriptional mechanisms and impair the ability of the glucocorticoid receptor (GR) to activate it, suggesting that KDACs can play a positive role in GR transactivation. In the current study, we extended this analysis to the entire GR transcriptome and found that the KDACi valproic acid impairs the ability of agonist-bound GR to activate about 50% of its target genes. This inhibition is largely due to impaired transcription rather than defective GR processing and was also observed using a structurally distinct KDACi. Depletion of KDAC1 expression mimicked the effects of KDACi in over half of the genes found to be impaired in GR transactivation. Simultaneous depletion of KDACs 1 and 2 caused full or partial impairment of several more GR target genes. Altogether we found that Class I KDAC activity facilitates GR-mediated activation at a sizable fraction of GR-activated target genes and that KDAC1 alone or in coordination with KDAC2 is required for efficient GR transactivation at many of these target genes. Finally, our work demonstrates that KDACi exposure has a significant impact on GR signaling and thus has ramifications for the clinical use of these drugs.	[Kadiyala, Vineela; Patrick, Nina M.; Mathieu, Wana; Jaime-Frias, Rosa; Smith, Catharine L.] Univ Arizona, Dept Pharmacol & Toxicol, Coll Pharm, Tucson, AZ 85721 USA; [Kadiyala, Vineela] Univ Arizona, Dept Chem & Biochem, Coll Agr & Life Sci, Tucson, AZ 85721 USA; [Pookhao, Naruekamol; An, Lingling] Univ Arizona, Dept Agr & Biosyst Engn, Coll Agr & Life Sci, Tucson, AZ 85721 USA	University of Arizona; University of Arizona; University of Arizona	Smith, CL (corresponding author), Univ Arizona, Dept Pharmacol & Toxicol, Coll Pharm, 1703 E Mabel St, Tucson, AZ 85721 USA.	csmith@pharmacy.arizona.edu			Southwest Environmental Health Science Center; National Institutes of Health [ES006694]; Arizona Cancer Center; Direct For Biological Sciences [1122088] Funding Source: National Science Foundation; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES006694] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T34GM008718] Funding Source: NIH RePORTER	Southwest Environmental Health Science Center; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Arizona Cancer Center; Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	For assistance with expression profiling, we thank the staff of the Genomics Shared Service, which is jointly supported by the Southwest Environmental Health Science Center (National Institutes of Health Grant ES006694) and the Arizona Cancer Center. We are also grateful to Dr. Dean Billheimer (University of Arizona) for providing guidance with the statistical analyses of the RT-qPCR results. Finally, we thank Drs. Gordon Hager and Sam John (National Cancer Institute) for providing us with the positions of GR binding sites in Hepa-1c1c7 cells as determined by ChIP-sequencing.	Bantscheff M, 2011, NAT BIOTECHNOL, V29, P255, DOI 10.1038/nbt.1759; BRESNICK EH, 1990, P NATL ACAD SCI USA, V87, P3977, DOI 10.1073/pnas.87.10.3977; Chen HW, 1999, CELL, V98, P675, DOI 10.1016/S0092-8674(00)80054-9; Chen JD, 1998, CRIT REV EUKAR GENE, V8, P169, DOI 10.1615/CritRevEukarGeneExpr.v8.i2.40; Chng KR, 2012, EMBO J, V31, P2810, DOI 10.1038/emboj.2012.112; Choudhary C, 2009, SCIENCE, V325, P834, DOI 10.1126/science.1175371; Chuang DM, 2009, TRENDS NEUROSCI, V32, P591, DOI 10.1016/j.tins.2009.06.002; Clayton AL, 2006, MOL CELL, V23, P289, DOI 10.1016/j.molcel.2006.06.017; Dinarello CA, 2011, MOL MED, V17, P333, DOI 10.2119/molmed.2011.00116; Haberland M, 2009, NAT REV GENET, V10, P32, DOI 10.1038/nrg2485; Houtkooper RH, 2012, NAT REV MOL CELL BIO, V13, P225, DOI 10.1038/nrm3293; Isojarvi JIT, 2005, CNS DRUGS, V19, P207, DOI 10.2165/00023210-200519030-00003; Isojarvi J, 2008, SEIZURE-EUR J EPILEP, V17, P111, DOI 10.1016/j.seizure.2007.11.007; Ito K, 2006, J EXP MED, V203, P7, DOI 10.1084/jem.20050466; Jackson TA, 1997, MOL ENDOCRINOL, V11, P693, DOI 10.1210/me.11.6.693; John S, 2009, ENDOCRINOLOGY, V150, P1766, DOI 10.1210/en.2008-0863; Khan N, 2008, BIOCHEM J, V409, P581, DOI 10.1042/BJ20070779; Kidder BL, 2012, NUCLEIC ACIDS RES, V40, P2925, DOI 10.1093/nar/gkr1151; Kim SC, 2006, MOL CELL, V23, P607, DOI 10.1016/j.molcel.2006.06.026; Kovacs JJ, 2005, MOL CELL, V18, P601, DOI 10.1016/j.molcel.2005.04.021; Lahm A, 2007, P NATL ACAD SCI USA, V104, P17335, DOI 10.1073/pnas.0706487104; Lavinsky RM, 1998, P NATL ACAD SCI USA, V95, P2920, DOI 10.1073/pnas.95.6.2920; Lee HA, 2013, CIRC RES, V112, P1004, DOI 10.1161/CIRCRESAHA.113.301071; Lee SC, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/416905; Luef G, 2009, EPILEPSY RES, V86, P42, DOI 10.1016/j.eplepsyres.2009.04.004; Luo Y, 2009, J BIOL CHEM, V284, P34901, DOI 10.1074/jbc.M109.038356; Mulholland NM, 2003, ONCOGENE, V22, P4807, DOI 10.1038/sj.onc.1206722; Murphy PJM, 2005, J BIOL CHEM, V280, P33792, DOI 10.1074/jbc.M506997200; Nader N, 2009, FASEB J, V23, P1572, DOI 10.1096/fj.08-117697; PLESKO MM, 1983, J BIOL CHEM, V258, P3738; Pylvanen V, 2006, EPILEPSY BEHAV, V8, P643, DOI 10.1016/j.yebeh.2006.02.008; Qiu Y, 2006, MOL CELL, V22, P669, DOI 10.1016/j.molcel.2006.04.019; Qiu Y, 2011, J BIOL CHEM, V286, P7641, DOI 10.1074/jbc.M110.185488; Ram O, 2011, CELL, V147, P1628, DOI 10.1016/j.cell.2011.09.057; Rascle A, 2003, MOL CELL BIOL, V23, P4162, DOI 10.1128/MCB.23.12.4162-4173.2003; Robyr D, 2000, MOL ENDOCRINOL, V14, P329, DOI 10.1210/me.14.3.329; Sheldon LA, 2001, J BIOL CHEM, V276, P32423, DOI 10.1074/jbc.C100315200; Spiegel S, 2012, ONCOGENE, V31, P537, DOI 10.1038/onc.2011.267; Terbach N, 2009, BIOCHEM SOC T, V37, P1126, DOI 10.1042/BST0371126; TICHONICKY L, 1981, EUR J BIOCHEM, V120, P427, DOI 10.1111/j.1432-1033.1981.tb05720.x; Wagner BL, 1998, MOL CELL BIOL, V18, P1369, DOI 10.1128/MCB.18.3.1369; Wang ZB, 2009, CELL, V138, P1019, DOI 10.1016/j.cell.2009.06.049; Welsbie DS, 2009, CANCER RES, V69, P958, DOI 10.1158/0008-5472.CAN-08-2216; Yang XJ, 2008, NAT REV MOL CELL BIO, V9, P206, DOI 10.1038/nrm2346; Zhang Y, 2008, MOL CELL BIOL, V28, P1688, DOI 10.1128/MCB.01154-06	45	17	18	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 4	2013	288	40					28900	28912		10.1074/jbc.M113.505115	http://dx.doi.org/10.1074/jbc.M113.505115			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	298BL	23946490	hybrid, Green Published			2022-12-25	WOS:000330298800042
J	Reiter, K; Mukhopadhyay, D; Zhang, H; Boucher, LE; Kumar, N; Bosch, J; Matunis, MJ				Reiter, Katherine; Mukhopadhyay, Debaditya; Zhang, Hong; Boucher, Lauren E.; Kumar, Nirbhay; Bosch, Juergen; Matunis, Michael J.			Identification of Biochemically Distinct Properties of the Small Ubiquitin-related Modifier (SUMO) Conjugation Pathway in Plasmodium falciparum	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POSTTRANSLATIONAL MODIFICATIONS; STRUCTURE VALIDATION; PROTEIN SUMOYLATION; BINDING; INSIGHTS; UBC9; LIFE; MECHANISMS; RESISTANCE; MODEL	Small ubiquitin-related modifiers (SUMOs) are post-translationally conjugated to other proteins and are thereby essential regulators of a wide range of cellular processes. Sumoylation, and enzymes of the sumoylation pathway, are conserved in the malaria causing parasite, Plasmodium falciparum. However, the specific functions of sumoylation in P. falciparum, and the degree of functional conservation between enzymes of the human and P. falciparum sumoylation pathways, have not been characterized. Here, we demonstrate that sumoylation levels peak during midstages of the intra-erythrocyte developmental cycle, concomitant with hemoglobin consumption and elevated oxidative stress. In vitro studies revealed that P. falciparum E1- and E2-conjugating enzymes interact effectively to recognize and modify RanGAP1, a model mammalian SUMO substrate. However, in heterologous reactions, P. falciparum E1 and E2 enzymes failed to interact with cognate human E2 and E1 partners, respectively, to modify RanGAP1. Structural analysis, binding studies, and functional assays revealed divergent amino acid residues within the E1-E2 binding interface that define organism-specific enzyme interactions. Our studies identify sumoylation as a potentially important regulator of oxidative stress response during the P. falciparum intra-erythrocyte developmental cycle, and define E1 and E2 interactions as a promising target for development of parasite-specific inhibitors of sumoylation and parasite replication.	[Reiter, Katherine; Mukhopadhyay, Debaditya; Zhang, Hong; Boucher, Lauren E.; Bosch, Juergen; Matunis, Michael J.] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Biochem & Mol Biol, Baltimore, MD 21205 USA; [Zhang, Hong] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Mol Microbiol & Immunol, Baltimore, MD 21205 USA; [Boucher, Lauren E.; Kumar, Nirbhay; Bosch, Juergen] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Johns Hopkins Malaria Res Inst, Baltimore, MD 21205 USA; [Kumar, Nirbhay] Tulane Univ, Dept Trop Med, New Orleans, LA 70112 USA	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Tulane University	Matunis, MJ (corresponding author), 615 N Wolfe St, Baltimore, MD 21205 USA.	mmatunis@jhsph.edu	Bosch, Jürgen/E-9370-2011	Bosch, Jürgen/0000-0002-2624-4105; Boucher, Lauren/0000-0003-3152-6155; Matunis, Michael/0000-0002-9350-6611	National Institutes of Health [GM060980]; Sommer Scholar's Program; Bloomberg Philanthropies and Johns Hopkins Malaria Research Institute; NATIONAL CANCER INSTITUTE [T32CA009110] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM060980] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Sommer Scholar's Program; Bloomberg Philanthropies and Johns Hopkins Malaria Research Institute; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM060980 (to M. J. M.), the Sommer Scholar's Program (to K. R.), and the Bloomberg Philanthropies and Johns Hopkins Malaria Research Institute (to J. B. and M. J. M.).	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Becker K, 2004, INT J PARASITOL, V34, P163, DOI 10.1016/j.ijpara.2003.09.011; Bencsath KP, 2002, J BIOL CHEM, V277, P47938, DOI 10.1074/jbc.M207442200; Bernier-Villamor V, 2002, CELL, V108, P345, DOI 10.1016/S0092-8674(02)00630-X; Bozdech Z, 2003, PLOS BIOL, V1, P85, DOI 10.1371/journal.pbio.0000005; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Chung DWD, 2009, MOL BIOCHEM PARASIT, V168, P123, DOI 10.1016/j.molbiopara.2009.08.001; Cubenas-Potts C, 2013, DEV CELL, V24, P1, DOI 10.1016/j.devcel.2012.11.020; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Evans PR, 2011, ACTA CRYSTALLOGR D, V67, P282, DOI 10.1107/S090744491003982X; Foth BJ, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-12-r177; Foth BJ, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.006411; Gallagher JR, 2011, TRAFFIC, V12, P1124, DOI 10.1111/j.1600-0854.2011.01232.x; Gareau JR, 2010, NAT REV MOL CELL BIO, V11, P861, DOI 10.1038/nrm3011; Geiss-Friedlander R, 2007, NAT REV MOL CELL BIO, V8, P947, DOI 10.1038/nrm2293; Golebiowski F, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000282; Issar N, 2008, CELL MICROBIOL, V10, P1999, DOI 10.1111/j.1462-5822.2008.01183.x; Jackson SP, 2013, MOL CELL, V49, P795, DOI 10.1016/j.molcel.2013.01.017; Johnson ES, 2004, ANNU REV BIOCHEM, V73, P355, DOI 10.1146/annurev.biochem.73.011303.074118; Jortzik E, 2012, INT J MED MICROBIOL, V302, P187, DOI 10.1016/j.ijmm.2012.07.007; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P133, DOI 10.1107/S0907444909047374; Karplus PA, 2012, SCIENCE, V336, P1030, DOI [10.1126/science.121823, 10.1126/science.1218231]; LAMBROS C, 1979, J PARASITOL, V65, P418, DOI 10.2307/3280287; Le Roch KG, 2004, GENOME RES, V14, P2308, DOI 10.1101/gr.2523904; Le Roch KG, 2003, SCIENCE, V301, P1503, DOI 10.1126/science.1087025; Lee Y, 2007, J CEREBR BLOOD F MET, V27, P950, DOI 10.1038/sj.jcbfm.9600395; Lois LM, 2005, EMBO J, V24, P439, DOI 10.1038/sj.emboj.7600552; Long F, 2008, ACTA CRYSTALLOGR D, V64, P125, DOI 10.1107/S0907444907050172; Lovell SC, 2003, PROTEINS, V50, P437, DOI 10.1002/prot.10286; Matunis MJ, 1996, J CELL BIOL, V135, P1457, DOI 10.1083/jcb.135.6.1457; Muller IB, 2010, FUTURE MICROBIOL, V5, P1857, DOI 10.2217/FMB.10.136; Murray CJL, 2012, LANCET, V379, P413, DOI 10.1016/S0140-6736(12)60034-8; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; O'Brien C, 2011, CURR OPIN INFECT DIS, V24, P570, DOI 10.1097/QCO.0b013e32834cd3ed; Ponder EL, 2011, CHEM BIOL, V18, P711, DOI 10.1016/j.chembiol.2011.04.010; Reverter D, 2005, NATURE, V435, P687, DOI 10.1038/nature03588; Richardson SM, 2006, GENOME RES, V16, P550, DOI 10.1101/gr.4431306; Rodriguez MS, 2001, J BIOL CHEM, V276, P12654, DOI 10.1074/jbc.M009476200; Roy A, 2011, JOVE-J VIS EXP, DOI 10.3791/3259; Sampson DA, 2001, J BIOL CHEM, V276, P21664, DOI 10.1074/jbc.M100006200; Szewczyk E, 2006, NAT PROTOC, V1, P3111, DOI 10.1038/nprot.2006.405; Tempe D, 2008, BIOCHEM SOC T, V36, P874, DOI 10.1042/BST0360874; Tilley L, 2011, INT J BIOCHEM CELL B, V43, P839, DOI 10.1016/j.biocel.2011.03.012; Trager W, 2005, J PARASITOL, V91, P484, DOI 10.1645/0022-3395(2005)091[0484:HMPICC]2.0.CO;2; Vagin AA, 2004, ACTA CRYSTALLOGR D, V60, P2184, DOI 10.1107/S0907444904023510; van Waardenburg RCAM, 2006, MOL CELL BIOL, V26, P4958, DOI 10.1128/MCB.00160-06; van Wijk SJL, 2010, FASEB J, V24, P981, DOI 10.1096/fj.09-136259; Wan J, 2012, CURR PROTEIN PEPT SC, V13, P467, DOI 10.2174/138920312802430563; Wang JH, 2007, MOL CELL, V27, P228, DOI 10.1016/j.molcel.2007.05.023; Wang J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015805; Zhang XD, 2008, MOL CELL, V29, P729, DOI 10.1016/j.molcel.2008.01.013; Zhu JM, 2008, J BIOL CHEM, V283, P29405, DOI 10.1074/jbc.M803632200	53	22	22	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 27	2013	288	39					27724	27736		10.1074/jbc.M113.498410	http://dx.doi.org/10.1074/jbc.M113.498410			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302OB	23943616	Green Published, hybrid			2022-12-25	WOS:000330612800003
J	Ochoa-Leyva, A; Montero-Moran, G; Saab-Rincon, G; Brieba, LG; Soberon, X				Ochoa-Leyva, Adrian; Montero-Moran, Gabriela; Saab-Rincon, Gloria; Brieba, Luis G.; Soberon, Xavier			Alternative Splice Variants in TIM Barrel Proteins from Human Genome Correlate with the Structural and Evolutionary Modularity of this Versatile Protein Fold	PLOS ONE			English	Article							PRE-MESSENGER-RNA; TRIOSEPHOSPHATE ISOMERASE; HUMAN TRANSCRIPTOME; CRYSTAL-STRUCTURE; PHOSPHORIBOSYLANTHRANILATE ISOMERASE; (BETA-ALPHA)(8)-BARREL ENZYME; FRAGMENT COMPLEMENTATION; (BETA/ALPHA)(8) BARREL; TRYPTOPHAN SYNTHASE; ALPHA-SUBUNIT	After the surprisingly low number of genes identified in the human genome, alternative splicing emerged as a major mechanism to generate protein diversity in higher eukaryotes. However, it is still not known if its prevalence along the genome evolution has contributed to the overall functional protein diversity or if it simply reflects splicing noise. The (beta alpha)(8) barrel or TIM barrel is one of the most frequent, versatile, and ancient fold encountered among enzymes. Here, we analyze the structural modifications present in TIM barrel proteins from the human genome product of alternative splicing events. We found that 87% of all splicing events involved deletions; most of these events resulted in protein fragments that corresponded to the (beta alpha)(2), (beta alpha)(4), (beta alpha)(5), (beta alpha)(6), and (beta alpha)(7) subdomains of TIM barrels. Because approximately 7% of all the splicing events involved internal beta-strand substitutions, we decided, based on the genomic data, to design beta-strand and alpha-helix substitutions in a well-studied TIM barrel enzyme. The biochemical characterization of one of the chimeric variants suggests that some of the splice variants in the human genome with beta-strand substitutions may be evolving novel functions via either the oligomeric state or substrate specificity. We provide results of how the splice variants represent subdomains that correlate with the independently folding and evolving structural units previously reported. This work is the first to observe a link between the structural features of the barrel and a recurrent genetic mechanism. Our results suggest that it is reasonable to expect that a sizeable fraction of splice variants found in the human genome represent structurally viable functional proteins. Our data provide additional support for the hypothesis of the origin of the TIM barrel fold through the assembly of smaller subdomains. We suggest a model of how nature explores new proteins through alternative splicing as a mechanism to diversify the proteins encoded in the human genome.	[Ochoa-Leyva, Adrian; Soberon, Xavier] Inst Nacl Med Genom INMEGEN, Mexico City, DF, Mexico; [Montero-Moran, Gabriela; Brieba, Luis G.] Inst Politecn Nacl, Ctr Invest & Estudios Avanzados, Lab Nacl Genom Biodiversidad, Guanajuato, Mexico; [Saab-Rincon, Gloria; Soberon, Xavier] Univ Nacl Autonoma Mexico, Inst Biotecnol, Dept Ingn Celular & Biocatalisis, Cuernavaca 62191, Morelos, Mexico	Instituto Nacional de Medicina Genomica; CINVESTAV - Centro de Investigacion y de Estudios Avanzados del Instituto Politecnico Nacional; Instituto Politecnico Nacional - Mexico; Universidad Nacional Autonoma de Mexico	Ochoa-Leyva, A (corresponding author), Univ Nacl Autonoma Mexico, Fac Quim, Unidad Genom Poblac Aplicada Salud, Inst Nacl Med Genom INMEGEN, Mexico City, DF, Mexico.	aochoa@inmegen.gob.mx; xsoberon@inmegen.gob.mx	Ochoa-Leyva, Adrián/E-5540-2013; Saab-RIncon, Gloria/AFO-4892-2022; Brieba, Luis/I-8447-2016	Ochoa-Leyva, Adrián/0000-0002-4701-2303; Saab-RIncon, Gloria/0000-0002-5251-1000; Brieba, Luis/0000-0002-6073-5207; Montero-Moran, Gabriela Margarita/0000-0003-3951-9726	National Institute of Genomic Medicine [08/2012/I, 07/2012/E]	National Institute of Genomic Medicine	This work was supported by National Institute of Genomic Medicine grants 08/2012/I and 07/2012/E. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afriat-Jurnou L, 2012, BIOCHEMISTRY-US, V51, P6047, DOI 10.1021/bi300694t; Akanuma S, 2005, J MOL BIOL, V353, P1161, DOI 10.1016/j.jmb.2005.08.070; Apweiler R, 2012, NUCLEIC ACIDS RES, V40, pD71, DOI 10.1093/nar/gkr981; Barbour AP, 2003, CANCER RES, V63, P887; BERNSTEIN FC, 1977, J MOL BIOL, V112, P535, DOI 10.1016/S0022-2836(77)80200-3; BERTOLAET BL, 1995, BIOCHEMISTRY-US, V34, P5736, DOI 10.1021/bi00017a005; Bharat TAM, 2008, P NATL ACAD SCI USA, V105, P9942, DOI 10.1073/pnas.0802202105; Birzele F, 2008, NUCLEIC ACIDS RES, V36, P550, DOI 10.1093/nar/gkm1054; Blencowe BJ, 2006, CELL, V126, P37, DOI 10.1016/j.cell.2006.06.023; Bogarad LD, 1999, P NATL ACAD SCI USA, V96, P2591, DOI 10.1073/pnas.96.6.2591; Boot RG, 1998, J BIOL CHEM, V273, P25680, DOI 10.1074/jbc.273.40.25680; Caetano-Anolles G, 2007, P NATL ACAD SCI USA, V104, P9358, DOI 10.1073/pnas.0701214104; Chen Lu, 2012, Int J Evol Biol, V2012, P596274, DOI 10.1155/2012/596274; Clark TA, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-4-r64; Eads JC, 1997, STRUCTURE, V5, P47, DOI 10.1016/S0969-2126(97)00165-2; EDER J, 1992, BIOCHEMISTRY-US, V31, P3617, DOI 10.1021/bi00129a010; Ge K, 1999, P NATL ACAD SCI USA, V96, P9689, DOI 10.1073/pnas.96.17.9689; Gilbert W, 1997, P NATL ACAD SCI USA, V94, P7698, DOI 10.1073/pnas.94.15.7698; GILBERT W, 1987, COLD SPRING HARB SYM, V52, P901, DOI 10.1101/SQB.1987.052.01.098; Grosso AR, 2008, NUCLEIC ACIDS RES, V36, P4823, DOI 10.1093/nar/gkn463; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Hatakeyama K, 2011, PROTEOMICS, V11, P2275, DOI 10.1002/pmic.201100016; Hocker B, 2004, P NATL ACAD SCI USA, V101, P16448, DOI 10.1073/pnas.0405832101; Hocker B, 2001, NAT STRUCT BIOL, V8, P32; Jezyk MR, 2006, NAT STRUCT MOL BIOL, V13, P1135, DOI 10.1038/nsmb1175; Lang D, 2000, SCIENCE, V289, P1546, DOI 10.1126/science.289.5484.1546; Lees J, 2010, NUCLEIC ACIDS RES, V38, pD296, DOI 10.1093/nar/gkp987; Liu MY, 2004, TRENDS GENET, V20, P399, DOI 10.1016/j.tig.2004.06.013; Lokeshwar VB, 2002, J BIOL CHEM, V277, P33654, DOI 10.1074/jbc.M203821200; Lopez AJ, 1998, ANNU REV GENET, V32, P279, DOI 10.1146/annurev.genet.32.1.279; MAINFROID V, 1993, PROTEIN ENG, V6, P893, DOI 10.1093/protein/6.8.893; MOORE SA, 1993, EMBO J, V12, P1767, DOI 10.1002/j.1460-2075.1993.tb05824.x; Ochoa-Leyva A, 2011, J MOL BIOL, V411, P143, DOI 10.1016/j.jmb.2011.05.027; Ochoa-Leyva A, 2009, J MOL BIOL, V387, P949, DOI 10.1016/j.jmb.2009.02.022; Pan Q, 2008, NAT GENET, V40, P1413, DOI 10.1038/ng.259; Patrick WM, 2005, FEBS J, V272, P3684, DOI 10.1111/j.1742-4658.2005.04794.x; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pieper U, 2011, NUCLEIC ACIDS RES, V39, pD465, DOI 10.1093/nar/gkq1091; Pitkanen LT, 2001, BIOCHEM BIOPH RES CO, V287, P1051, DOI 10.1006/bbrc.2001.5703; Privitera S, 1998, J BIOL CHEM, V273, P6319, DOI 10.1074/jbc.273.11.6319; Pucci L, 2007, FEBS J, V274, P827, DOI 10.1111/j.1742-4658.2007.05635.x; Puisac B, 2012, MOL BIOL REP, V39, P4777, DOI 10.1007/s11033-011-1270-8; Richter M, 2010, J MOL BIOL, V398, P763, DOI 10.1016/j.jmb.2010.03.057; ROUVINEN J, 1990, SCIENCE, V249, P380, DOI 10.1126/science.2377893; Saito A, 1999, GENE, V239, P325, DOI 10.1016/S0378-1119(99)00394-7; Salabei JK, 2011, CHEM-BIOL INTERACT, V191, P177, DOI 10.1016/j.cbi.2011.01.020; Schymkowitz J, 2005, NUCLEIC ACIDS RES, V33, pW382, DOI 10.1093/nar/gki387; Setiyaputra S, 2011, J MOL BIOL, V408, P291, DOI 10.1016/j.jmb.2011.02.048; Shukla A, 2004, PROTEINS, V55, P548, DOI 10.1002/prot.20066; Silverman JA, 2002, J MOL BIOL, V324, P1031, DOI 10.1016/S0022-2836(02)01100-2; Smith CWJ, 2000, TRENDS BIOCHEM SCI, V25, P381, DOI 10.1016/S0968-0004(00)01604-2; Soberon X, 2004, FEBS LETT, V560, P167, DOI 10.1016/S0014-5793(04)00098-5; Sterner R, 2005, CHEM REV, V105, P4038, DOI 10.1021/cr030191z; Stetefeld J, 2005, TRENDS BIOCHEM SCI, V30, P515, DOI 10.1016/j.tibs.2005.07.001; Sultan M, 2008, SCIENCE, V321, P956, DOI 10.1126/science.1160342; Toth-Petroczy A, 2013, MOL BIOL EVOL, V30, P761, DOI 10.1093/molbev/mst003; URFER R, 1992, PROTEIN SCI, V1, P31; Van Durme J, 2011, BIOINFORMATICS, V27, P1711, DOI 10.1093/bioinformatics/btr254; Wang ET, 2008, NATURE, V456, P470, DOI 10.1038/nature07509; Wang P, 2005, P NATL ACAD SCI USA, V102, P18920, DOI 10.1073/pnas.0506770102; Wang Y, 2009, BIOCHEMISTRY-US, V48, P4548, DOI 10.1021/bi9002887; Wierenga RK, 2001, FEBS LETT, V492, P193, DOI 10.1016/S0014-5793(01)02236-0; Wu MQ, 2005, DNA SEQUENCE, V16, P137, DOI 10.1080/10425170400020373; Xu Q, 2002, NUCLEIC ACIDS RES, V30, P3754, DOI 10.1093/nar/gkf492; Yeo G, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r74; Zitzewitz JA, 1999, BIOCHEMISTRY-US, V38, P10205, DOI 10.1021/bi9909041; Zitzewitz JA, 1999, PROTEIN SCI, V8, P1200, DOI 10.1110/ps.8.6.1200	67	7	7	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2013	8	8							e70582	10.1371/journal.pone.0070582	http://dx.doi.org/10.1371/journal.pone.0070582			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	200UV	23950966	Green Published, Green Submitted, gold			2022-12-25	WOS:000323097300031
J	Fang, Y; Yu, S; Ma, YY; Sun, P; Ma, DX; Ji, CY; Kong, BH				Fang, Yan; Yu, Shuang; Ma, Yuyan; Sun, Ping; Ma, Daoxin; Ji, Chunyan; Kong, Beihua			Association of Dll4/Notch and HIF-1a-VEGF Signaling in the Angiogenesis of Missed Abortion	PLOS ONE			English	Article							GROWTH-FACTOR; RECURRENT MISCARRIAGE; EMBRYONIC LETHALITY; TYROSINE KINASE; ORF VIRUS; EXPRESSION; VEGF; DLL4; RECEPTOR; HYPOXIA	Background: Dll4/Notch and HIF-1a-VEGF have been shown to play an important role during angiogenesis, but there are no data about their roles and association in missed abortion. In this study, we investigated the association of Dll4/Notch and HIF-1a-VEGF signaling in missed abortion. Methods: Women with missed abortion (n = 27) and healthy controls (n = 26) were included in the study. Real-time Reverse Transcription-PCR Analyses (RT-PCR) was used to analyze the mRNA levels of Dll4/Notch and HIF-1a-VEGF signaling molecules. The protein level for Dll4 was measured by immunohistochemistry. Results: Compared with induced abortion, the expression of VEGF was statistically reduced while the level of VEGFR1 and Notch1 was significantly up-regulated in missed abortion. Though other molecules (VEGFR2 and Dll4) were marginally higher in missed abortion, no statistical difference was observed. The expression of HIF-1a was significantly up-regulated, and close negatively correlated with VEGF in missed abortion. Both in induced abortion and missed abortion, Dll4 was positively correlated with Notch1. Conclusions: The early pregnancy is in a hypoxic environment, this may encourage the angiogenesis, but severe hypoxic may inhibit the angiogenesis. Aberrant Dll4/Notch and HIF-1a-VEGF signaling may have a role in missed abortion.	[Fang, Yan; Ma, Yuyan; Sun, Ping; Kong, Beihua] Shandong Univ, Dept Obstet & Gynecol, Qilu Hosp, Jinan 250100, Shandong, Peoples R China; [Yu, Shuang; Ma, Daoxin; Ji, Chunyan] Shandong Univ, Dept Hematol, Qilu Hosp, Jinan 250100, Shandong, Peoples R China	Shandong University; Shandong University	Ma, DX (corresponding author), Shandong Univ, Dept Hematol, Qilu Hosp, Jinan 250100, Shandong, Peoples R China.	daoxinma@sdu.edu.cn; kongbeihua@sdu.edu.cn			National Natural Science Foundation [30600680, 81070407, 81170515, 81100425]; Shandong Technological Development Project [2005BS03022, Q2008C07, BS2009SW014]; SRF for ROCS, SEM; IIFSDU [2009TS063]	National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Shandong Technological Development Project; SRF for ROCS, SEM(Scientific Research Foundation for the Returned Overseas Chinese Scholars); IIFSDU	This study was partially supported by research funding from the National Natural Science Foundation (30600680, 81070407, 81170515, 81100425), the Shandong Technological Development Project (2005BS03022, Q2008C07 and BS2009SW014), the SRF for ROCS, SEM and IIFSDU (2009TS063). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arjamaa O, 2009, AGEING RES REV, V8, P349, DOI 10.1016/j.arr.2009.06.002; Benedito R, 2005, GENE EXPR PATTERNS, V5, P750, DOI 10.1016/j.modgep.2005.04.004; Carmeliet P, 1996, NATURE, V380, P435, DOI 10.1038/380435a0; Claxton S, 2004, GENE EXPR PATTERNS, V5, P123, DOI 10.1016/j.modgep.2004.05.004; CLIFFORD K, 1994, HUM REPROD, V9, P1328, DOI 10.1093/oxfordjournals.humrep.a138703; Conrad KP, 1997, AM J REPROD IMMUNOL, V37, P240; Coultas L, 2005, NATURE, V438, P937, DOI 10.1038/nature04479; Dong X, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018481; Duarte A, 2004, GENE DEV, V18, P2474, DOI 10.1101/gad.1239004; Ferrara N, 1996, NATURE, V380, P439, DOI 10.1038/380439a0; Gale NW, 2004, P NATL ACAD SCI USA, V101, P15949, DOI 10.1073/pnas.0407290101; Griebel CP, 2005, AM FAM PHYSICIAN, V72, P1243; HATASAKA HH, 1994, CLIN OBSTET GYNECOL, V37, P625, DOI 10.1097/00003081-199409000-00016; Hayashi M, 2005, ENDOCRINOLOGY, V146, P4682, DOI 10.1210/en.2005-0416; Hellstrom M, 2007, NATURE, V445, P776, DOI 10.1038/nature05571; Jubb AM, 2009, BRIT J CANCER, V101, P1749, DOI 10.1038/sj.bjc.6605368; Karamysheva AF, 2008, BIOCHEMISTRY-MOSCOW+, V73, P751, DOI 10.1134/S0006297908070031; Krebs LT, 2000, GENE DEV, V14, P1343; Krebs LT, 2004, GENE DEV, V18, P2469, DOI 10.1101/gad.1239204; Lim KH, 1997, AM J PATHOL, V151, P1809; Lohela M, 2009, CURR OPIN CELL BIOL, V21, P154, DOI 10.1016/j.ceb.2008.12.012; Mailhos C, 2001, DIFFERENTIATION, V69, P135, DOI 10.1046/j.1432-0436.2001.690207.x; Meyer M, 1999, EMBO J, V18, P363, DOI 10.1093/emboj/18.2.363; MILLAUER B, 1993, CELL, V72, P835, DOI 10.1016/0092-8674(93)90573-9; MILLAUER B, 1994, NATURE, V367, P576, DOI 10.1038/367576a0; Rajakumar A, 2000, BIOL REPROD, V63, P559, DOI 10.1095/biolreprod63.2.559; Sawano A, 1996, CELL GROWTH DIFFER, V7, P213; Schaffer L, 2006, AM J PHYSIOL-REG I, V290, pR844, DOI 10.1152/ajpregu.00237.2005; Shutter JR, 2000, GENE DEV, V14, P1313; Siekmann AF, 2007, NATURE, V445, P781, DOI 10.1038/nature05577; Skinner HD, 2004, J BIOL CHEM, V279, P45643, DOI 10.1074/jbc.M404097200; Suchting S, 2007, P NATL ACAD SCI USA, V104, P3225, DOI 10.1073/pnas.0611177104; TERMAN BI, 1992, BIOCHEM BIOPH RES CO, V187, P1579, DOI 10.1016/0006-291X(92)90483-2; Vuorela P, 2000, MOL HUM REPROD, V6, P276, DOI 10.1093/molehr/6.3.276; Wise LM, 1999, P NATL ACAD SCI USA, V96, P3071, DOI 10.1073/pnas.96.6.3071; Yamanda S, 2009, BLOOD, V113, P3631, DOI 10.1182/blood-2008-07-170381; Zhang P, 2009, GRAEF ARCH CLIN EXP, V247, P633, DOI 10.1007/s00417-008-1031-0	37	43	51	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 9	2013	8	8							e70667	10.1371/journal.pone.0070667	http://dx.doi.org/10.1371/journal.pone.0070667			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	245OM	23950980	Green Published, Green Submitted, gold			2022-12-25	WOS:000326473200014
J	Lange, M; Neuzeret, F; Fabreges, B; Froc, C; Bedu, S; Bally-Cuif, L; Norton, WHJ				Lange, Merlin; Neuzeret, Frederic; Fabreges, Benoit; Froc, Cynthia; Bedu, Sebastien; Bally-Cuif, Laure; Norton, William H. J.			Inter-Individual and Inter-Strain Variations in Zebrafish Locomotor Ontogeny	PLOS ONE			English	Article							LARVAL ZEBRAFISH; DANIO-RERIO; ADULT ZEBRAFISH; MODEL SYSTEM; BEHAVIOR; SIZE; MOVEMENT; SCHIZOPHRENIA; INTERNEURONS; RECRUITMENT	Zebrafish exhibit remarkable alterations in behaviour and morphology as they develop from early larval stages to mature adults. In this study we compare the locomotion parameters of six common zebrafish strains from two different laboratories to determine the stability and repeatability of these behaviours. Our results demonstrate large variability in locomotion and fast swim events between strains and between laboratories across time. These data highlight the necessity for careful, strain-specific controls when analysing locomotor phenotypes and open up the possibility of standardising the quantification of zebrafish behaviour at multiple life stages.	[Lange, Merlin; Froc, Cynthia; Bedu, Sebastien; Bally-Cuif, Laure] CNRS, Insitut Neurobiol Albert Fessard, Gif Sur Yvette, Essonne, France; [Neuzeret, Frederic] ViewPoint Life Sci, Lissieu, Rhone, France; [Fabreges, Benoit] Univ Paris 11, Dept Math, F-91405 Orsay, Essonne, France; [Norton, William H. J.] Univ Leicester, Dept Biol, Leicester, Leics, England	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; Universite Paris Saclay; University of Leicester	Bally-Cuif, L (corresponding author), CNRS, Insitut Neurobiol Albert Fessard, Gif Sur Yvette, Essonne, France.	bally-cuif@inaf.cnrs-gif.fr; whjn1@le.ac.uk		Bally-Cuif, Laure/0000-0001-6611-6274; Norton, William/0000-0002-3244-0145; Bedu, Sebastien/0000-0002-5358-3014	EU [223262, 242048]; ANR [ANR-08-CEX-08-000-01, ANR-2012-BSV4-0004-01]; ENP; FRM [FRP "Equipe" DEQ20120323692]	EU(European Commission); ANR(French National Research Agency (ANR)); ENP; FRM(Fondation pour la Recherche Medicale)	Work in the L. B-C. laboratory was funded by the EU projects NeuroXsys (FP7/2007-2013 grant agreement no 223262) and ZF-Health (FP7/2010-2015 grant agreement no 242048), the ANR (grants ANR-08-CEX-08-000-01 and ANR-2012-BSV4-0004-01), the ENP, and the FRM (FRP "Equipe" DEQ20120323692). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ausborn J, 2012, P NATL ACAD SCI USA, V109, pE3631, DOI 10.1073/pnas.1216256110; Brown KH, 2012, P NATL ACAD SCI USA, V109, P529, DOI 10.1073/pnas.1112163109; Buss RR, 2002, J NEUROPHYSIOL, V87, P1244, DOI 10.1152/jn.00659.2001; Clobert J, 2000, FUNCT ECOL, V14, P675, DOI 10.1046/j.1365-2435.2000.00477.x; Crabbe JC, 1999, SCIENCE, V284, P1670, DOI 10.1126/science.284.5420.1670; de Esch C, 2012, NEUROTOXICOL TERATOL, V34, P425, DOI 10.1016/j.ntt.2012.03.002; Del Bene F, 2010, SCIENCE, V330, P669, DOI 10.1126/science.1192949; FERO K, 2010, ZEBRAFISH MODELS NEU; Flinn L, 2008, J NEUROCHEM, V106, P1991, DOI 10.1111/j.1471-4159.2008.05463.x; Gabriel JP, 2011, NAT NEUROSCI, V14, P93, DOI 10.1038/nn.2704; Gauthier J, 2010, P NATL ACAD SCI USA, V107, P7863, DOI 10.1073/pnas.0906232107; Green MH, 2011, J EXP BIOL, V214, P3111, DOI 10.1242/jeb.057497; Howe K, 2013, NATURE, V496, P498, DOI 10.1038/nature12111; Kokel D, 2010, NAT CHEM BIOL, V6, P231, DOI 10.1038/NCHEMBIO.307; Lange M, 2012, MOL PSYCHIATR, V17, P946, DOI 10.1038/mp.2012.29; Liu KS, 1999, NEURON, V23, P325, DOI 10.1016/S0896-6273(00)80783-7; McHenry MJ, 2005, J EXP BIOL, V208, P2289, DOI 10.1242/jeb.01642; McLean DL, 2011, CURR OPIN NEUROBIOL, V21, P110, DOI 10.1016/j.conb.2010.09.011; McLean DL, 2008, NAT NEUROSCI, V11, P1419, DOI 10.1038/nn.2225; Menelaou E, 2012, J NEUROSCI, V32, P10925, DOI 10.1523/JNEUROSCI.1809-12.2012; Morris JA, 2009, PROG BRAIN RES, V179, P97, DOI 10.1016/S0079-6123(09)17911-6; Muller UK, 2004, J EXP BIOL, V207, P853, DOI 10.1242/jeb.00821; Muller UK, 2000, J EXP BIOL, V203, P193; Muto Akira, 2011, Commun Integr Biol, V4, P566, DOI 10.4161/cib.4.5.15848; Naumann EA, 2010, NAT NEUROSCI, V13, P513, DOI 10.1038/nn.2518; Ninkovic J, 2006, METHODS, V39, P262, DOI 10.1016/j.ymeth.2005.12.007; Norton W, 2011, ZEBRAFISH NEUROBEHAV, V2; Norton W, 2010, BMC NEUROSCI, V11, DOI 10.1186/1471-2202-11-90; Norton WHJ, 2011, J NEUROSCI, V31, P13796, DOI 10.1523/JNEUROSCI.2892-11.2011; O'Malley DM, 2004, METHOD CELL BIOL, V76, P261; OMalley DM, 1996, NEURON, V17, P1145, DOI 10.1016/S0896-6273(00)80246-9; Padilla S, 2011, NEUROTOXICOL TERATOL, V33, P624, DOI 10.1016/j.ntt.2011.08.005; Parichy DM, 2009, DEV DYNAM, V238, P2975, DOI 10.1002/dvdy.22113; Plaut I, 2000, J EXP BIOL, V203, P813; Rauscent A, 2006, J PHYSIOLOGY-PARIS, V100, P317, DOI 10.1016/j.jphysparis.2007.05.009; Rihel J, 2010, SCIENCE, V327, P348, DOI 10.1126/science.1183090; Saint-Amant Louis, 2003, Methods in Cell Science, V25, P59, DOI 10.1023/B:MICS.0000006896.02938.49; Tinbergen N., 1963, Zeitschrift fuer Tierpsychologie, V20, P410; Uusi-Heikkila S, 2010, J FISH BIOL, V77, P552, DOI 10.1111/j.1095-8649.2010.02698.x; Wahlsten D, 2006, P NATL ACAD SCI USA, V103, P16364, DOI 10.1073/pnas.0605342103; Westerfield M., 2000, GUIDE LAB USE ZEBRAF; White RM, 2008, CELL STEM CELL, V2, P183, DOI 10.1016/j.stem.2007.11.002; Zellner D, 2011, NEUROTOXICOL TERATOL, V33, P674, DOI 10.1016/j.ntt.2011.06.007; Zon LI, 2005, NAT REV DRUG DISCOV, V4, P35, DOI 10.1038/nrd1606	44	39	39	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 9	2013	8	8							e70172	10.1371/journal.pone.0070172	http://dx.doi.org/10.1371/journal.pone.0070172			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	245OM	23950910	gold, Green Published, Green Submitted			2022-12-25	WOS:000326473200010
J	Matsuoka, Y; Nasuda, S; Ashida, Y; Nitta, M; Tsujimoto, H; Takumi, S; Kawahara, T				Matsuoka, Yoshihiro; Nasuda, Shuhei; Ashida, Yasuyo; Nitta, Miyuki; Tsujimoto, Hisashi; Takumi, Shigeo; Kawahara, Taihachi			Genetic Basis for Spontaneous Hybrid Genome Doubling during Allopolyploid Speciation of Common Wheat Shown by Natural Variation Analyses of the Paternal Species	PLOS ONE			English	Article							AEGILOPS-TAUSCHII COSS.; TETRAPLOID EMMER WHEATS; MICROSATELLITE MARKERS; POPULATION-STRUCTURE; CHROMOSOMAL LOCATION; SSR MARKERS; BREAD WHEAT; DURUM-WHEAT; F-1 HYBRID; HISTONE H3	The complex process of allopolyploid speciation includes various mechanisms ranging from species crosses and hybrid genome doubling to genome alterations and the establishment of new allopolyploids as persisting natural entities. Currently, little is known about the genetic mechanisms that underlie hybrid genome doubling, despite the fact that natural allopolyploid formation is highly dependent on this phenomenon. We examined the genetic basis for the spontaneous genome doubling of triploid F-1 hybrids between the direct ancestors of allohexaploid common wheat (Triticum aestivum L., AABBDD genome), namely Triticum turgidum L. (AABB genome) and Aegilops tauschii Coss. (DD genome). An Ae. tauschii intraspecific lineage that is closely related to the D genome of common wheat was identified by population-based analysis. Two representative accessions, one that produces a high-genome-doubling-frequency hybrid when crossed with a T. turgidum cultivar and the other that produces a low-genome-doubling-frequency hybrid with the same cultivar, were chosen from that lineage for further analyses. A series of investigations including fertility analysis, immunostaining, and quantitative trait locus (QTL) analysis showed that (1) production of functional unreduced gametes through nonreductional meiosis is an early step key to successful hybrid genome doubling, (2) first division restitution is one of the cytological mechanisms that cause meiotic nonreduction during the production of functional male unreduced gametes, and (3) six QTLs in the Ae. tauschii genome, most of which likely regulate nonreductional meiosis and its subsequent gamete production processes, are involved in hybrid genome doubling. Interlineage comparisons of Ae. tauschii's ability to cause hybrid genome doubling suggested an evolutionary model for the natural variation pattern of the trait in which non-deleterious mutations in six QTLs may have important roles. The findings of this study demonstrated that the genetic mechanisms for hybrid genome doubling could be studied based on the intrinsic natural variation that exists in the parental species.	[Matsuoka, Yoshihiro] Fukui Prefectural Univ, Yoshida, Fukui, Japan; [Nasuda, Shuhei; Ashida, Yasuyo; Nitta, Miyuki] Kyoto Univ, Grad Sch Agr, Lab Plant Genet, Sakyo Ku, Kyoto, Japan; [Tsujimoto, Hisashi] Tottori Univ, Arid Land Res Ctr, Lab Mol Breeding, Tottori 680, Japan; [Takumi, Shigeo] Kobe Univ, Grad Sch Agr Sci, Lab Plant Genet, Nada Ku, Kobe, Hyogo 657, Japan; [Kawahara, Taihachi] Kyoto Univ, Grad Sch Agr, Plant Germ Plasm Inst, Lab Crop Evolut, Muko, Kyoto, Japan	Fukui Prefectural University; Kyoto University; Tottori University; Kobe University; Kyoto University	Nasuda, S (corresponding author), Kyoto Univ, Grad Sch Agr, Lab Plant Genet, Sakyo Ku, Kyoto, Japan.	nasushu@kais.kyoto-u.ac.jp	Tsujimoto, Hisashi/A-5914-2016	Tsujimoto, Hisashi/0000-0003-0203-0759; Nasuda, Shuhei/0000-0002-9019-8692	Ministry of Education, Science, Sports, and Culture of Japan [18687001, 21770090, 22310144]; Ministry of Agriculture, Forestry, and Fishery of Japan [GD-2006]; Grants-in-Aid for Scientific Research [23255007] Funding Source: KAKEN	Ministry of Education, Science, Sports, and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Agriculture, Forestry, and Fishery of Japan; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by a Grant-in-Aid (Nos. 18687001, 21770090, and 22310144) and a National BioResource Project (NBRP) grant from the Ministry of Education, Science, Sports, and Culture of Japan, and a Green Technology Project grant (GD-2006) from the Ministry of Agriculture, Forestry, and Fishery of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beauregard M. S., 2008, P135, DOI 10.1007/978-1-4020-8770-7_5; BRETAGNOLLE F, 1995, NEW PHYTOL, V129, P1, DOI 10.1111/j.1469-8137.1995.tb03005.x; Bustamante CD, 2001, GENETICS, V159, P1779; Cai XW, 2010, CHROMOSOMA, V119, P275, DOI 10.1007/s00412-010-0256-y; Chu CG, 2008, MOL BREEDING, V22, P251, DOI 10.1007/s11032-008-9171-9; DOEBLEY J, 1991, GENETICS, V129, P285; Dou BD, 2009, GENET RES, V91, P337, DOI 10.1017/S0016672309990218; Doyle JJ, 2008, ANNU REV GENET, V42, P443, DOI 10.1146/annurev.genet.42.110807.091524; Dvorak J, 1998, THEOR APPL GENET, V97, P657, DOI 10.1007/s001220050942; Earl DA, 2012, CONSERV GENET RESOUR, V4, P359, DOI 10.1007/s12686-011-9548-7; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; FUKUDA K, 1992, JPN J BREED, V42, P255; FUKUDA K, 1992, JPN J BREED, V42, P747; GOSMAN N, 2011, 21 INT TRIT MAPP IN, P31; Guyomarc'h H, 2002, THEOR APPL GENET, V104, P1164, DOI 10.1007/s00122-001-0827-7; HARLAN JR, 1975, BOT REV, V41, P361, DOI 10.1007/BF02860830; Hauf S, 2004, CELL, V119, P317, DOI 10.1016/j.cell.2004.10.014; Houben A, 1999, PLANT J, V19, P1, DOI DOI 10.1046/J.1365-313X.1999.00488.X.PUBMED:10417721; Huang S, 2002, P NATL ACAD SCI USA, V99, P8133, DOI 10.1073/pnas.072223799; Jaccoud D, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.4.e25; Jakobsson M, 2007, BIOINFORMATICS, V23, P1801, DOI 10.1093/bioinformatics/btm233; JANSEN RC, 1993, GENETICS, V135, P205; Jauhar PP, 2000, CROP SCI, V40, P1742, DOI 10.2135/cropsci2000.4061742x; JOPPA LR, 1987, GENOME, V29, P578, DOI 10.1139/g87-096; Kao CH, 1999, GENETICS, V152, P1203; KIHARA H., 1949, Hereditas, P307; Kihara H., 1965, RESULTS KYOTO U SCI, P1; KIHARA H, 1944, AGR HORTIC, V19, P889, DOI DOI 10.1016/J.JGG.2011.07.002; Kihara H., 1946, KROMOSOMO, V1, P6; Kitajima TS, 2004, NATURE, V427, P510, DOI 10.1038/nature02312; Kosambi D. D., 1944, ANN EUGENICS, V12, P172; LANDER E S, 1987, Genomics, V1, P174, DOI 10.1016/0888-7543(87)90010-3; Li XX, 2009, NAT CELL BIOL, V11, P1103, DOI 10.1038/ncb1923; Lincoln SE, 1993, CONSTRUCTING GENETIC; Lopes JS, 2010, INFECT GENET EVOL, V10, P826, DOI 10.1016/j.meegid.2009.10.010; Lopes JS, 2009, BIOINFORMATICS, V25, P2747, DOI 10.1093/bioinformatics/btp487; Manzanero S, 2000, CHROMOSOMA, V109, P308, DOI 10.1007/s004120000087; Matsuoka Y, 2004, THEOR APPL GENET, V109, P1710, DOI 10.1007/s00122-004-1806-6; Matsuoka Y, 2007, THEOR APPL GENET, V115, P509, DOI 10.1007/s00122-007-0584-3; Matsuoka Y, 2011, PLANT CELL PHYSIOL, V52, P750, DOI 10.1093/pcp/pcr018; McFadden E.S., 1944, REC GENET SOC AM, V13, P26; Mello-Sampayo T., 1968, EWAC NEWSL, V2, P16; MELLOSAMPAYO T, 1971, NATURE-NEW BIOL, V230, P22, DOI 10.1038/newbio230022a0; Mizuno N, 2011, PLANT J, V68, P114, DOI 10.1111/j.1365-313X.2011.04667.x; Mizuno N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011326; Mizuno N, 2010, MOL ECOL, V19, P999, DOI 10.1111/j.1365-294X.2010.04537.x; NISHIKAWA KOZO, 1960, SEIKEN ZIHO, V11, P21; Nowak SJ, 2004, TRENDS GENET, V20, P214, DOI 10.1016/j.tig.2004.02.007; OKAMOTO M., 1957, Wheat Information Service, pp; Ossowski S, 2010, SCIENCE, V327, P92, DOI 10.1126/science.1180677; Pestsova E, 2000, GENOME, V43, P689, DOI 10.1139/gen-43-4-689; Pritchard JK, 2000, GENETICS, V155, P945; R Development Core Team, 2011, R LANG ENV STAT COMP; Ramsey J, 1998, ANNU REV ECOL SYST, V29, P467, DOI 10.1146/annurev.ecolsys.29.1.467; RILEY R, 1958, NATURE, V182, P713, DOI 10.1038/182713a0; Roder MS, 1998, GENOME, V41, P278, DOI 10.1139/gen-41-2-278; Roder MS, 1998, GENETICS, V149, P2007; SAGHAIMAROOF MA, 1984, P NATL ACAD SCI-BIOL, V81, P8014, DOI 10.1073/pnas.81.24.8014; SHANNON CE, 1948, BELL SYST TECH J, V27, P379, DOI DOI 10.1002/J.1538-7305.1948.TB01338.X; Sohail Q, 2012, BREEDING SCI, V62, P38, DOI 10.1270/jsbbs.62.38; Somers DJ, 2004, THEOR APPL GENET, V109, P1105, DOI 10.1007/s00122-004-1740-7; Song QJ, 2005, THEOR APPL GENET, V110, P550, DOI 10.1007/s00122-004-1871-x; Talbert LE, 1998, GENOME, V41, P402, DOI 10.1139/gen-41-3-402; UPADHYA M D, 1967, Biologisches Zentralblatt, V86, P239; Van Slageren M.W., 1994, ICARDA WAGENINGEN AG; Wang JR, 2013, NEW PHYTOL, V198, P925, DOI 10.1111/nph.12164; Wang S., 2007, WINDOWS QTL CARTOGRA; Wittenberg AHJ, 2005, MOL GENET GENOMICS, V274, P30, DOI 10.1007/s00438-005-1145-6; XU SJ, 1992, GENOME, V35, P379, DOI 10.1139/g92-057; XU SJ, 1995, GENOME, V38, P607, DOI 10.1139/g95-077; Xu SJ, 2000, PLANT BREEDING, V119, P233, DOI 10.1046/j.1439-0523.2000.00472.x; Yu JK, 2004, MOL GENET GENOMICS, V271, P742, DOI 10.1007/s00438-004-1027-3; ZENG ZB, 1993, P NATL ACAD SCI USA, V90, P10972, DOI 10.1073/pnas.90.23.10972; Zhang LQ, 2007, SEX PLANT REPROD, V20, P159, DOI 10.1007/s00497-007-0052-x; Zhang LQ, 2010, EUPHYTICA, V172, P285, DOI 10.1007/s10681-009-0081-7; Zohary D., 1996, ORIGINS SPREAD AGR P, P142	76	37	39	2	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2013	8	8							e68310	10.1371/journal.pone.0068310	http://dx.doi.org/10.1371/journal.pone.0068310			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	201ER	23950867	Green Submitted, Green Published, gold			2022-12-25	WOS:000323124000001
J	Cho, SJ; Jung, YS; Chen, XB				Cho, Seong-Jun; Jung, Yong-Sam; Chen, Xinbin			Poly (C)-Binding Protein 1 Regulates p63 Expression through mRNA Stability	PLOS ONE			English	Article							PROTECTS MOUSE OOCYTES; BINDING PROTEIN; P53 FAMILY; ENDORIBONUCLEASE ACTIVITY; TARGET GENES; RNPC1; APOPTOSIS; HUR; DIFFERENTIATION; INDUCTION	p63, a transcription factor and p53 family protein, plays a crucial role in tumor suppression and development of various epithelial tissues. While p63 expression is controlled mostly by post-translational modifications, recent studies indicate that transcriptional and posttranscriptional regulations are essential for proper p63 expression. Here, we investigated the regulation of p63 expression by poly (C)-binding protein 1 (PCBP1, also known as hnRNP-E1 and alpha CP1). We found that knockdown of PCBP1 decreases the level of p63 transcript and protein. We also found that PCBP1 regulates the stability of p63 mRNA via binding to p63 3'UTR. Additionally, we found that a CU-rich element (CUE) in p63 3'UTR is bound by and responsive to PCBP1. Together, we conclude that PCBP1 regulates p63 expression via mRNA stability.	[Cho, Seong-Jun; Jung, Yong-Sam; Chen, Xinbin] Univ Calif Davis, Sch Vet Med, Comparat Oncol Lab, Davis, CA 95616 USA	University of California System; University of California Davis	Chen, XB (corresponding author), Univ Calif Davis, Sch Vet Med, Comparat Oncol Lab, Davis, CA 95616 USA.	xbchen@ucdavis.edu	Cho, Seong-Jun/P-2491-2019		National Institutes of Health (NIH) [CA102188]; NATIONAL CANCER INSTITUTE [R01CA102188] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work is supported in part by National Institutes of Health (NIH) grants (CA102188). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Chaudhury A, 2010, RNA, V16, P1449, DOI 10.1261/rna.2254110; Chaudhury A, 2010, NAT CELL BIOL, V12, P286, DOI 10.1038/ncb2029; Cho SJ, 2010, NUCLEIC ACIDS RES, V38, P2256, DOI 10.1093/nar/gkp1229; Cho SJ, 2012, J BIOL CHEM, V287, P14535, DOI 10.1074/jbc.M111.326827; Dotsch V, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a004887; Dohn M, 2001, ONCOGENE, V20, P3193, DOI 10.1038/sj.onc.1204427; Flores ER, 2007, CELL CYCLE, V6, P300, DOI 10.4161/cc.6.3.3793; Flores ER, 2005, CANCER CELL, V7, P363, DOI 10.1016/j.ccr.2005.02.019; Gonfloni S, 2009, NAT MED, V15, P1179, DOI 10.1038/nm.2033; Gressner O, 2005, EMBO J, V24, P2458, DOI 10.1038/sj.emboj.7600708; Guo XC, 2009, NAT CELL BIOL, V11, P1451, DOI 10.1038/ncb1988; Harms K, 2004, CELL MOL LIFE SCI, V61, P822, DOI 10.1007/s00018-003-3304-4; Harms KL, 2006, CELL DEATH DIFFER, V13, P890, DOI 10.1038/sj.cdd.4401904; Ihrie RA, 2005, CELL, V120, P843, DOI 10.1016/j.cell.2005.01.008; Jung YS, 2013, J INVEST DERMATOL, V133, P1178, DOI 10.1038/jid.2012.466; Kerr JB, 2012, MOL CELL, V48, P343, DOI 10.1016/j.molcel.2012.08.017; Livera G, 2008, REPRODUCTION, V135, P3, DOI 10.1530/REP-07-0054; Mazan-Mamczarz K, 2003, P NATL ACAD SCI USA, V100, P8354, DOI 10.1073/pnas.1432104100; Mills AA, 1999, NATURE, V398, P708, DOI 10.1038/19531; Peritz T, 2006, NAT PROTOC, V1, P577, DOI 10.1038/nprot.2006.82; Romano RA, 2012, DEVELOPMENT, V139, P772, DOI 10.1242/dev.071191; Rossi M, 2006, P NATL ACAD SCI USA, V103, P12753, DOI 10.1073/pnas.0603449103; Shu LM, 2006, GENE DEV, V20, P2961, DOI 10.1101/gad.1463306; Suh EK, 2006, NATURE, V444, P624, DOI 10.1038/nature05337; Vanbokhoven H, 2011, J INVEST DERMATOL, V131, P1196, DOI 10.1038/jid.2011.84; Waggoner SA, 2009, J BIOL CHEM, V284, P9039, DOI 10.1074/jbc.M806986200; Wang ZR, 2000, MOL CELL BIOL, V20, P6334, DOI 10.1128/MCB.20.17.6334-6341.2000; Wang ZR, 2000, EMBO J, V19, P295, DOI 10.1093/emboj/19.2.295; Wu GJ, 2003, CANCER RES, V63, P2351; Yan WS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045336; Yan WS, 2009, J BIOL CHEM, V284, P12178, DOI 10.1074/jbc.M900994200; Yang AN, 1998, MOL CELL, V2, P305, DOI 10.1016/S1097-2765(00)80275-0; Yi R, 2008, NATURE, V452, P225, DOI 10.1038/nature06642; Zhang J, 2011, GENE DEV, V25, P1528, DOI 10.1101/gad.2069311; Zhang J, 2010, P NATL ACAD SCI USA, V107, P9614, DOI 10.1073/pnas.0912594107; Zhang Y, 2013, ONCOGENE; Zou TT, 2006, J BIOL CHEM, V281, P19387, DOI 10.1074/jbc.M602344200	37	36	38	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2013	8	8							e71724	10.1371/journal.pone.0071724	http://dx.doi.org/10.1371/journal.pone.0071724			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	200ZE	23940783	Green Submitted, gold, Green Published			2022-12-25	WOS:000323109700116
J	Dart, DA; Waxman, J; Aboagye, EO; Bevan, CL				Dart, D. Alwyn; Waxman, Jonathan; Aboagye, Eric O.; Bevan, Charlotte L.			Visualising Androgen Receptor Activity in Male and Female Mice	PLOS ONE			English	Article							VISCERAL ADIPOSE-TISSUE; LIGAND-BINDING DOMAIN; DNA-BINDING; TESTICULAR FEMINIZATION; RESPONSE ELEMENTS; MESSENGER-RNA; UP-REGULATION; B-CELLS; ESTROGEN; EXPRESSION	Androgens, required for normal development and fertility of males and females, have vital roles in the reproductive tract, brain, cardiovascular system, smooth muscle and bone. Androgens function via the androgen receptor (AR), a ligand-dependent transcription factor. To assay and localise AR activity in vivo we generated the transgenic "ARELuc" mouse, expressing a luciferase reporter gene under the control of activated endogenous AR. In vivo imaging of androgen-mediated luciferase activity revealed several strongly expressing tissues in the male mouse as expected and also in certain female tissues. In males the testes, prostate, seminal vesicles and bone marrow all showed high AR activity. In females, strong activity was seen in the ovaries, uterus, omentum tissue and mammary glands. In both sexes AR expression and activity was also found in salivary glands, the eye (and associated glands), adipose tissue, spleen and, notably, regions of the brain. Luciferase protein expression was found in the same cell layers as androgen receptor expression. Additionally, mouse AR expression and activity correlated well with AR expression in human tissues. The anti-androgen bicalutamide reduced luciferase signal in all tissues. Our model demonstrates that androgens can act in these tissues directly via AR, rather than exclusively via androgen aromatisation to estrogens and activation of the estrogen receptor. Additionally, it visually demonstrates the fundamental importance of AR signalling outside the normal role in the reproductive organs. This model represents an important tool for physiological and developmental analysis of androgen signalling, and for characterization of known and novel androgenic or antiandrogenic compounds.	[Dart, D. Alwyn; Waxman, Jonathan; Aboagye, Eric O.; Bevan, Charlotte L.] Univ London Imperial Coll Sci Technol & Med, Dept Surg & Canc, Imperial Ctr Translat & Expt Med, London, England	Imperial College London	Bevan, CL (corresponding author), Univ London Imperial Coll Sci Technol & Med, Dept Surg & Canc, Imperial Ctr Translat & Expt Med, London, England.	charlotte.bevan@imperial.ac.uk	Bevan, Charlotte L/K-2276-2012; Bevan, Charlotte/T-7769-2019	Bevan, Charlotte L/0000-0002-7533-0552; ABOAGYE, Eric/0000-0003-2276-6771	Medical Research Council of the UK [G0700915]; Genesis Research Trust [P39565]; Harris Family Trusts; Medical Research Council [G0700915] Funding Source: researchfish; MRC [G0700915] Funding Source: UKRI	Medical Research Council of the UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Genesis Research Trust; Harris Family Trusts; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was funded by the Medical Research Council of the UK (www.mrc.ac.uk), grant ref. G0700915, Genesis Research Trust (www.genesisresearchtrust.com), grant ref. P39565 and the Harris Family Trusts. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bachmann G, 2002, FERTIL STERIL, V77, P660, DOI 10.1016/S0015-0282(02)02969-2; BEATO M, 1989, J STEROID BIOCHEM, V32, P737, DOI 10.1016/0022-4731(89)90521-9; Benten WPM, 2002, STEROIDS, V67, P647, DOI 10.1016/S0039-128X(02)00013-2; Berman JR, 2003, FERTIL STERIL, V79, P925, DOI 10.1016/S0015-0282(02)04923-3; Braunstein GD, 2002, FERTIL STERIL, V77, pS94; Brinkmann AO, 2011, METHODS MOL BIOL, V776, P3, DOI 10.1007/978-1-61779-243-4_1; Butts Cherie L, 2007, Nucl Recept Signal, V5, pe007; CARMENA MJ, 1988, BIOCHIM BIOPHYS ACTA, V969, P86, DOI 10.1016/0167-4889(88)90091-2; CARRIERE RM, 1966, ANAT REC, V156, P423, DOI 10.1002/ar.1091560406; CHANG CS, 1995, CRIT REV EUKAR GENE, V5, P97, DOI 10.1615/CritRevEukarGeneExpr.v5.i2.10; CHAREST NJ, 1991, MOL ENDOCRINOL, V5, P573, DOI 10.1210/mend-5-4-573; Ciana P, 2001, MOL ENDOCRINOL, V15, P1104, DOI 10.1210/me.15.7.1104; Ciana P, 2003, NAT MED, V9, P82, DOI 10.1038/nm809; Dart DA, 2009, ENDOCR-RELAT CANCER, V16, P1157, DOI 10.1677/ERC-09-0028; Davis SR, 2001, TRENDS ENDOCRIN MET, V12, P33, DOI 10.1016/S1043-2760(00)00333-7; Demerath EW, 2007, INT J OBESITY, V31, P285, DOI 10.1038/sj.ijo.0803409; Demerath EW, 2007, OBESITY, V15, P2984, DOI 10.1038/oby.2007.356; Denayer S, 2010, MOL ENDOCRINOL, V24, P898, DOI 10.1210/me.2009-0310; DODD JG, 1983, J BIOL CHEM, V258, P731; Ellis TM, 2001, INT IMMUNOL, V13, P553, DOI 10.1093/intimm/13.4.553; Ellwood-Yen K, 2006, CANCER RES, V66, P10513, DOI 10.1158/0008-5472.CAN-06-1397; FELDMAN SR, 1992, J AM ACAD DERMATOL, V27, P615, DOI 10.1016/0190-9622(92)70231-4; Fernandez-Guasti A, 2000, J COMP NEUROL, V425, P422, DOI 10.1002/1096-9861(20000925)425:3<422::AID-CNE7>3.0.CO;2-H; Goldstein JM, 2001, CEREB CORTEX, V11, P490, DOI 10.1093/cercor/11.6.490; Gonzalez-Montelongo MC, 2010, STEROIDS, V75, P533, DOI 10.1016/j.steroids.2009.09.012; Grad JM, 1999, MOL ENDOCRINOL, V13, P1896, DOI 10.1210/me.13.11.1896; Grumbach MM, 1999, J CLIN ENDOCR METAB, V84, P4677, DOI 10.1210/jc.84.12.4677; HACKER A, 1995, DEVELOPMENT, V121, P1603; He B, 1999, J BIOL CHEM, V274, P37219, DOI 10.1074/jbc.274.52.37219; Helsen C, 2012, MOL CELL BIOL, V32, P3033, DOI 10.1128/MCB.00151-12; Hodgins MB, 1998, BRIT J OBSTET GYNAEC, V105, P216, DOI 10.1111/j.1471-0528.1998.tb10056.x; IMPERATOMCGINLEY J, 1993, J CLIN ENDOCR METAB, V76, P524, DOI 10.1210/jc.76.2.524; JANSSEN PJ, 1994, J HISTOCHEM CYTOCHEM, V42, P1169, DOI 10.1177/42.8.8027537; Jenster G, 1999, SEMIN ONCOL, V26, P407; KANTOR AB, 1993, ANNU REV IMMUNOL, V11, P501, DOI 10.1146/annurev.immunol.11.1.501; LODA M, 1994, MODERN PATHOL, V7, P388; Lyons SK, 2006, CANCER RES, V66, P4701, DOI 10.1158/0008-5472.CAN-05-3598; MacLean HE, 2010, J ENDOCRINOL, V206, P93, DOI 10.1677/JOE-10-0026; MENARD CS, 1993, BRAIN RES, V622, P226, DOI 10.1016/0006-8993(93)90823-6; MOSTOV KE, 1994, ANNU REV IMMUNOL, V12, P63, DOI 10.1146/annurev.immunol.12.1.63; Narayanan Ramesh, 2008, Nucl Recept Signal, V6, pe010, DOI 10.1621/nrs.06010; Ogawa S, 1999, P NATL ACAD SCI USA, V96, P12887, DOI 10.1073/pnas.96.22.12887; Pfaffl MW, 2003, J STEROID BIOCHEM, V84, P159, DOI 10.1016/S0960-0760(03)00025-6; Pihlajamaa P, 2011, ENDOCRINOLOGY, V152, P4395, DOI 10.1210/en.2011-0221; Platell C, 2000, WORLD J GASTROENTERO, V6, P169; Powell SM, 2004, ENDOCR-RELAT CANCER, V11, P117, DOI 10.1677/erc.0.0110117; RENNIE PS, 1993, MOL ENDOCRINOL, V7, P23, DOI 10.1210/me.7.1.23; Sato T, 2004, P NATL ACAD SCI USA, V101, P1673, DOI 10.1073/pnas.0305303101; SAUERWEIN H, 1995, DEUT TIERARZTL WOCH, V102, P164; Schauwaers K, 2007, P NATL ACAD SCI USA, V104, P4961, DOI 10.1073/pnas.0610814104; Schoenmakers E, 1999, BIOCHEM J, V341, P515, DOI 10.1042/0264-6021:3410515; Seethammagari MR, 2006, CANCER RES, V66, P6199, DOI 10.1158/0008-5472.CAN-05-3954; Sekido R, 2004, DEV BIOL, V274, P271, DOI 10.1016/j.ydbio.2004.07.011; Sekido R, 2010, INT J BIOCHEM CELL B, V42, P417, DOI 10.1016/j.biocel.2009.12.005; Sen A, 2010, MOL ENDOCRINOL, V24, P1393, DOI 10.1210/me.2010-0006; Shiina H, 2006, P NATL ACAD SCI USA, V103, P224, DOI 10.1073/pnas.0506736102; Tachibana M, 2000, INVEST OPHTH VIS SCI, V41, P64; TAKEDA H, 1990, J ENDOCRINOL, V126, P17, DOI 10.1677/joe.0.1260017; TUOHIMAA P, 1968, ACTA ENDOCRINOL-COP, V58, P696, DOI 10.1530/acta.0.0580696; Verrijdt G, 1999, MOL ENDOCRINOL, V13, P1558, DOI 10.1210/me.13.9.1558; VISELLI SM, 1995, IMMUNOLOGY, V84, P337; Wickham LA, 1998, ADV EXP MED BIOL, V438, P95; Wood RI, 1999, J NEUROBIOL, V39, P359, DOI 10.1002/(SICI)1097-4695(19990605)39:3<359::AID-NEU3>3.0.CO;2-W; Ye XC, 2005, P NATL ACAD SCI USA, V102, P9487, DOI 10.1073/pnas.0503577102; Zuloaga DG, 2008, HORM BEHAV, V53, P613, DOI 10.1016/j.yhbeh.2008.01.013	65	65	70	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2013	8	8							e71694	10.1371/journal.pone.0071694	http://dx.doi.org/10.1371/journal.pone.0071694			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	200ZE	23940781	Green Published, gold, Green Accepted, Green Submitted			2022-12-25	WOS:000323109700114
J	Pannek, K; Hatzigeorgiou, X; Colditz, PB; Rose, S				Pannek, Kerstin; Hatzigeorgiou, Xanthy; Colditz, Paul B.; Rose, Stephen			Assessment of Structural Connectivity in the Preterm Brain at Term Equivalent Age Using Diffusion MRI and T-2 Relaxometry: A Network-Based Analysis	PLOS ONE			English	Article							QUANTITATIVE FIBER TRACKING; WHITE-MATTER; CORPUS-CALLOSUM; GENDER-DIFFERENCES; INTERNAL CAPSULE; TENSOR; TRACTOGRAPHY; INFANTS; CHILDREN; BIRTH	Preterm birth is associated with a high prevalence of adverse neurodevelopmental outcome. Non- invasive techniques which can probe the neural correlates underpinning these deficits are required. This can be achieved by measuring the structural network of connections within the preterm infant's brain using diffusion MRI and tractography. We used diffusion MRI and T-2 relaxometry to identify connections with altered white matter properties in preterm infants compared to term infants. Diffusion and T-2 data were obtained from 9 term neonates and 18 preterm- born infants (born <32 weeks gestational age) at term equivalent age. Probabilistic tractography incorporating multiple fibre orientations was used in combination with the Johns Hopkins neonatal brain atlas to calculate the structural network of connections. Connections of altered diffusivity or T-2, as well as their relationship with gestational age at birth and postmenstrual age at the time of MRI, were identified using the network based statistic framework. A total of 433 connections were assessed. FA was significantly reduced in 17, and T-2 significantly increased in 18 connections in preterm infants, following correction for multiple comparisons. Cortical networks associated with affected connections mainly involved left frontal and temporal cortical areas: regions which are associated with working memory, verbal comprehension and higher cognitive function - deficits which are often observed later in children and adults born preterm. Gestational age at birth correlated with T-2, but not diffusion in several connections. We found no association between diffusion or T-2 and postmenstrual age at the time of MRI in preterm infants. This study demonstrates that alterations in the structural network of connections can be identified in preterm infants at term equivalent age, and that incorporation of non- diffusion measures such as T-2 in the connectome framework provides complementary information for the assessment of brain development.	[Pannek, Kerstin] Univ Queensland, Sch Med, Brisbane, Qld, Australia; [Pannek, Kerstin] Univ Queensland, Queensland Cerebral Palsy & Rehabil Res Ctr, Brisbane, Qld, Australia; [Hatzigeorgiou, Xanthy; Colditz, Paul B.] Univ Queensland, Perinatal Res Ctr, Brisbane, Qld, Australia; [Hatzigeorgiou, Xanthy] Univ Queensland, Brisbane, Qld, Australia; [Hatzigeorgiou, Xanthy] Royal Childrens Hosp, Childrens Nutr Res Ctr, Brisbane, Qld, Australia; [Colditz, Paul B.] Univ Queensland, Clin Res Ctr, Brisbane, Qld, Australia; [Rose, Stephen] CSIRO, Australian E Hlth Res Ctr, Brisbane, Qld, Australia	University of Queensland; University of Queensland; University of Queensland; University of Queensland; Royal Children's Hospital Brisbane; University of Queensland; Commonwealth Scientific & Industrial Research Organisation (CSIRO)	Rose, S (corresponding author), CSIRO, Australian E Hlth Res Ctr, Brisbane, Qld, Australia.	Stephen.Rose@csiro.au	Pannek, Kerstin/C-8059-2011; Rose, Stephen/C-8044-2009; Colditz, Paul B/F-6772-2010	Pannek, Kerstin/0000-0002-6512-7630; Colditz, Paul B/0000-0002-6408-8238; Rose, Stephen/0000-0003-1558-6297	PBC	PBC	This study was an investigator-driven study funded by PBC for a PhD project (XH). No external funding was received. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams E, 2010, J PEDIATR-US, V156, P882, DOI 10.1016/j.jpeds.2009.12.030; Anderson P, 2003, JAMA-J AM MED ASSOC, V289, P3264, DOI 10.1001/jama.289.24.3264; Avants BB, 2008, MED IMAGE ANAL, V12, P26, DOI 10.1016/j.media.2007.06.004; Ball G, 2012, CORTEX; Bassi L, 2008, BRAIN, V131, P573, DOI 10.1093/brain/awm327; Bassi L, 2011, PEDIATR RES, V69, P561, DOI 10.1203/PDR.0b013e3182182836; Behrens TEJ, 2007, NEUROIMAGE, V34, P144, DOI 10.1016/j.neuroimage.2006.09.018; Berman JI, 2009, AM J NEURORADIOL, V30, P120, DOI 10.3174/ajnr.A1304; Berman JI, 2005, NEUROIMAGE, V27, P862, DOI 10.1016/j.neuroimage.2005.05.018; Calamante F, 2010, NEUROIMAGE, V53, P1233, DOI 10.1016/j.neuroimage.2010.07.024; Counsell SJ, 2003, AM J NEURORADIOL, V24, P1654; de Bruine FT, 2011, EUR RADIOL, V21, P538, DOI 10.1007/s00330-010-1945-x; de Vries LS, 2011, SEMIN FETAL NEONAT M, V16, P279, DOI 10.1016/j.siny.2011.04.004; Ding XQ, 2008, AM J NEURORADIOL, V29, P1261, DOI 10.3174/ajnr.A1097; Ding XQ, 2004, INVEST RADIOL, V39, P740, DOI 10.1097/00004424-200412000-00005; Doyle LW, 2010, PEDIATRICS, V126, P342, DOI 10.1542/peds.2010-0710; Dubois J, 2008, HUM BRAIN MAPP, V29, P14, DOI 10.1002/hbm.20363; Fischl B, 2004, CEREB CORTEX, V14, P11, DOI 10.1093/cercor/bhg087; Frye RE, 2010, J INT NEUROPSYCH SOC, V16, P784, DOI 10.1017/S1355617710000585; Glass HC, 2010, AM J NEURORADIOL, V31, P1424, DOI 10.3174/ajnr.A2110; Groppo M., 2012, CORTEX, DOI 10.1016/j.cortex.2012.02.008; Hasegawa T, 2011, PEDIATR RES, V69, P249, DOI 10.1203/PDR.0b013e3182084e54; Huppi PS, 2006, SEMIN FETAL NEONAT M, V11, P489, DOI 10.1016/j.siny.2006.07.006; Jenkinson M, 2012, NEUROIMAGE, V62, P782, DOI 10.1016/j.neuroimage.2011.09.015; Jones DK, 1999, MAGNET RESON MED, V42, P515, DOI 10.1002/(SICI)1522-2594(199909)42:3<515::AID-MRM14>3.0.CO;2-Q; Jones DK, 2012, NEUROIMAGE; Kesler SR, 2008, J PEDIATR-US, V152, P513, DOI 10.1016/j.jpeds.2007.08.009; Leemans A, 2009, MAGN RESON MED, V61, P1336, DOI 10.1002/mrm.21890; Leppert IR, 2009, J MAGN RESON IMAGING, V29, P258, DOI 10.1002/jmri.21646; Liu Y, 2012, AM J NEURORADIOL, V33, P839, DOI 10.3174/ajnr.A2872; Liu Y, 2011, AM J NEURORADIOL, V32, P2011, DOI 10.3174/ajnr.A2690; Liu Y, 2010, NEUROIMAGE, V51, P783, DOI 10.1016/j.neuroimage.2010.02.066; Nagy Z, 2011, CEREB CORTEX, V21, P300, DOI 10.1093/cercor/bhq095; Nam H, 2011, NEUROIMAGE, V57, P968, DOI 10.1016/j.neuroimage.2011.05.018; Oishi K, 2011, NEUROIMAGE, V56, P8, DOI 10.1016/j.neuroimage.2011.01.051; Partridge SC, 2005, J MAGN RESON IMAGING, V22, P467, DOI 10.1002/jmri.20410; Rohde GK, 2004, MAGN RESON MED, V51, P103, DOI 10.1002/mrm.10677; Soria-Pastor S, 2009, PEDIATRICS, V124, pE1161, DOI 10.1542/peds.2009-0244; Thompson DK, 2012, NEUROIMAGE, V59, P3571, DOI 10.1016/j.neuroimage.2011.11.057; Thompson DK, 2011, NEUROIMAGE, V55, P479, DOI 10.1016/j.neuroimage.2010.12.025; van Kooij BJM, 2011, PEDIATR RES, V70, P626, DOI 10.1203/PDR.0b013e318232a963; van Pul C, 2012, AM J NEURORADIOL, V33, P678, DOI 10.3174/ajnr.A2859; Verstraete E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024239; Wang B, 2013, NEUROIMAGE, V65, P476, DOI 10.1016/j.neuroimage.2012.10.007; Zalesky A, 2012, BRAIN, V135, P2245, DOI 10.1093/brain/aws136; Zalesky A, 2011, BIOL PSYCHIAT, V69, P80, DOI 10.1016/j.biopsych.2010.08.022; Zalesky A, 2010, NEUROIMAGE, V53, P1197, DOI 10.1016/j.neuroimage.2010.06.041; Zubiaurre-Elorza L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042148; Zwicker JG, 2013, PEDIATR NEUROL, V48, P123, DOI 10.1016/j.pediatrneurol.2012.10.016	49	22	22	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2013	8	8							e68593	10.1371/journal.pone.0068593	http://dx.doi.org/10.1371/journal.pone.0068593			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	200ZE	23950872	Green Published, gold, Green Submitted			2022-12-25	WOS:000323109700006
J	Subramanian, N; Navaneethakrishnan, S; Biswas, J; Kanwar, RK; Kanwar, JR; Krishnakumar, S				Subramanian, Nithya; Navaneethakrishnan, Saranya; Biswas, Jyotirmay; Kanwar, Rupinder K.; Kanwar, Jagat R.; Krishnakumar, Subramanian			RNAi Mediated Tiam1 Gene Knockdown Inhibits Invasion of Retinoblastoma (Publication with Expression of Concern. See vol. 16, 2021)	PLOS ONE			English	Article; Publication with Expression of Concern							EXCHANGE FACTOR TIAM1; PLECKSTRIN HOMOLOGY DOMAIN; TUMOR-CELL INVASION; LYMPHOMA INVASION; EPITHELIAL-CELLS; PLASMA-MEMBRANE; RAC1; MAP1B; EXPRESSION; PROTEIN	T lymphoma invasion and metastasis protein (Tiam1) is up-regulated in variety of cancers and its expression level is related to metastatic potential of the type of cancer. Earlier, Tiam1 was shown to be overexpressed in retinoblastoma (RB) and we hypothesized that it was involved in invasiveness of RB. This was tested by silencing Tiam1 in RB cell lines (Y79 and Weri-Rb1) using siRNA pool, targeting different regions of Tiam1 mRNA. The cDNA microarray of Tiam1 silenced cells showed gene regulations altered by Tiam1 were predominantly on the actin cytoskeleton interacting proteins, apoptotic initiators and tumorogenic potential targets. The silenced phenotype resulted in decreased growth and increased apoptosis with non-invasive characteristics. Transfection of full length and N-terminal truncated construct (C1199) clearly revealed membrane localization of Tiam1 and not in the case of C580 construct. F-actin staining showed the interaction of Tiam1 with actin in the membrane edges that leads to ruffling, and also imparts varying invasive potential to the cell. The results obtained from our study show for the first time that Tiam1 modulates the cell invasion, mediated by actin cytoskeleton remodeling in RB.	[Subramanian, Nithya; Navaneethakrishnan, Saranya; Biswas, Jyotirmay; Krishnakumar, Subramanian] Vis Res Fdn, Larsen & Toubro Dept Ocular Pathol, Madras, Tamil Nadu, India; [Subramanian, Nithya; Kanwar, Rupinder K.; Kanwar, Jagat R.] Deakin Univ, Nanomed Lab Immunol & Mol Biomed Res N LIMBR, Sch Med SoM, Strateg Res Ctr,Fac Hlth, Geelong, Vic 3217, Australia	Deakin University	Kanwar, JR (corresponding author), Deakin Univ, Nanomed Lab Immunol & Mol Biomed Res N LIMBR, Sch Med SoM, Strateg Res Ctr,Fac Hlth, Geelong, Vic 3217, Australia.	jagat.kanwar@deakin.edu.au; drkrishnakumar_2000@yahoo.com		Khetan, Vikas/0000-0003-4396-9877	Indian Council for Medical Research [ICMR/5/13/77/2008-NCDIII]	Indian Council for Medical Research(Indian Council of Medical Research (ICMR))	This work was supported by the Indian Council for Medical Research, Grant No. ICMR/5/13/77/2008-NCDIII. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams HC, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2637; Adithi M, 2006, EXP EYE RES, V83, P1446, DOI 10.1016/j.exer.2006.08.003; Bourguignon LYW, 2000, J CELL BIOL, V150, P177, DOI 10.1083/jcb.150.1.177; Bourguignon LYW, 2000, J BIOL CHEM, V275, P1829, DOI 10.1074/jbc.275.3.1829; Buongiorno P, 2008, MOL CANCER, V7, DOI 10.1186/1476-4598-7-73; Cajanek L, 2013, MOL CELL BIOL, V33, P59, DOI 10.1128/MCB.00745-12; Ceccarelli DFJ, 2007, J BIOL CHEM, V282, P13864, DOI 10.1074/jbc.M700505200; Collard JG, 1996, CURR TOP MICROBIOL, V213, P253; Connolly BA, 2005, MOL CELL BIOL, V25, P4602, DOI 10.1128/MCB.25.11.4602-4614.2005; Crompton AM, 2000, J BIOL CHEM, V275, P25751, DOI 10.1074/jbc.M002050200; Cueille N, 2007, BRAIN RES BULL, V71, P610, DOI 10.1016/j.brainresbull.2006.12.003; Demarco RS, 2012, PLOS GENET, V8, P513, DOI 10.1371/journal.pgen.1002665; Engers R, 2000, INT J CANCER, V88, P369, DOI 10.1002/1097-0215(20001101)88:3<369::AID-IJC8>3.0.CO;2-K; Engers R, 2006, BRIT J CANCER, V95, P1081, DOI 10.1038/sj.bjc.6603385; Fard SS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009647; Fleming IN, 2004, BIOCHEM J, V382, P857, DOI 10.1042/BJ20040916; Goeckeler ZM, 2000, J BIOL CHEM, V275, P18366, DOI 10.1074/jbc.M001339200; Gonzalez-Billault C, 2005, CEREB CORTEX, V15, P1134, DOI 10.1093/cercor/bhh213; Gonzalez-Billault C, 2001, MOL BIOL CELL, V12, P2087, DOI 10.1091/mbc.12.7.2087; Gordon-Weeks PR, 2000, MICROSC RES TECHNIQ, V48, P63, DOI 10.1002/(SICI)1097-0029(20000115)48:2<63::AID-JEMT2>3.0.CO;2-1; HABETS GGM, 1994, CELL, V77, P537, DOI 10.1016/0092-8674(94)90216-X; HABETS GGM, 1995, ONCOGENE, V10, P1371; Hordijk PL, 1997, SCIENCE, V278, P1464, DOI 10.1126/science.278.5342.1464; Liu L, 2006, NEOPLASIA, V8, P917, DOI 10.1593/neo.06364; Liu L, 2005, WORLD J GASTROENTERO, V11, P705, DOI 10.3748/wjg.v11.i5.705; Malliri A, 2006, J BIOL CHEM, V281, P543, DOI 10.1074/jbc.M507582200; Malliri A, 2004, J BIOL CHEM, V279, P30092, DOI 10.1074/jbc.M401192200; Masuda M, 2010, J BIOL CHEM, V285, P15511, DOI 10.1074/jbc.M109.076653; Matsuo N, 2003, MOL CELL NEUROSCI, V24, P69, DOI 10.1016/S1044-7431(03)00122-2; Mertens AE, 2003, FEBS LETT, V546, P11, DOI 10.1016/S0014-5793(03)00435-6; MICHIELS F, 1995, NATURE, V375, P338, DOI 10.1038/375338a0; Michiels F, 1997, J CELL BIOL, V137, P387, DOI 10.1083/jcb.137.2.387; Montenegro-Venegas C, 2010, MOL BIOL CELL, V21, P3518, DOI 10.1091/mbc.E09-08-0709; Nakayama M, 2005, GENES CELLS, V10, P107, DOI 10.1111/j.1365-2443.2005.00823.x; Parsons BD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008471; Qi Y, 2009, ORL-J OTO-RHIN-LARYN, V71, P163, DOI 10.1159/000223440; Rossman KL, 2005, NAT REV MOL CELL BIO, V6, P167, DOI 10.1038/nrm1587; Sander EE, 1998, J CELL BIOL, V143, P1385, DOI 10.1083/jcb.143.5.1385; Sengupta S, 2013, PEDIATR BLOOD CANCER, V60, P336, DOI 10.1002/pbc.24357; Shin DH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007451; Stam JC, 1997, J BIOL CHEM, V272, P28447, DOI 10.1074/jbc.272.45.28447; Takei Y, 2000, J CELL BIOL, V150, P989, DOI 10.1083/jcb.150.5.989; Tanaka M, 2004, EMBO J, V23, P1075, DOI 10.1038/sj.emboj.7600128; Ten Klooster JP, 2006, BIOCHEM J, V397, P39, DOI 10.1042/BJ20051957; Terawaki S, 2010, EMBO J, V29, P236, DOI 10.1038/emboj.2009.323; Tolias KF, 2007, P NATL ACAD SCI USA, V104, P7265, DOI 10.1073/pnas.0702044104; Tortosa E, 2011, J BIOL CHEM, V286, P40638, DOI 10.1074/jbc.M111.271320; Tymanskyj SR, 2012, MOL CELL NEUROSCI, V49, P110, DOI 10.1016/j.mcn.2011.10.003; vanLeeuwen FN, 1995, ONCOGENE, V11, P2215; Veluthakal R, 2009, BIOCHEM PHARMACOL, V77, P101, DOI 10.1016/j.bcp.2008.09.021; Xu K, 2010, ONCOGENE, V29, P6533, DOI 10.1038/onc.2010.385; Yamauchi J, 2005, P NATL ACAD SCI USA, V102, P14889, DOI 10.1073/pnas.0507125102; Yang WY, 2010, JPN J CLIN ONCOL, V40, P1053, DOI 10.1093/jjco/hyq086; Zhao LA, 2011, J CANCER RES CLIN, V137, P393, DOI 10.1007/s00432-010-0895-7; Zhong DP, 2009, CANCER BIOL THER, V8, P689, DOI 10.4161/cbt.8.8.7833	55	23	24	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2013	8	8							e70422	10.1371/journal.pone.0070422	http://dx.doi.org/10.1371/journal.pone.0070422			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	200ZE	23950931	Green Published, Green Submitted, gold			2022-12-25	WOS:000323109700033
J	Basu, D; Tian, YX; Bhandari, J; Jiang, JR; Hui, P; Johnson, RL; Mishra, RK				Basu, Dipannita; Tian, Yuxin; Bhandari, Jayant; Jiang, Jian Ru; Hui, Patricia; Johnson, Rodney L.; Mishra, Ram K.			Effects of the Dopamine D2 Allosteric Modulator, PAOPA, on the Expression of GRK2, Arrestin-3, ERK1/2, and on Receptor Internalization	PLOS ONE			English	Article							L-LEUCYL-GLYCINAMIDE; CONFORMATIONALLY CONSTRAINED ANALOGS; THIAZOLIDINE LACTAM PEPTIDOMIMETICS; INDUCED ROTATIONAL BEHAVIOR; PROTEIN-COUPLED RECEPTORS; GENE-EXPRESSION; BETA-ARRESTINS; KINASES; PRO-LEU-GLY-NH2; BINDING	The activity of G protein-coupled receptors (GPCRs) is intricately regulated by a range of intracellular proteins, including G protein-coupled kinases (GRKs) and arrestins. Understanding the effects of ligands on these signaling pathways could provide insights into disease pathophysiologies and treatment. The dopamine D2 receptor is a GPCR strongly implicated in the pathophysiology of a range of neurological and neuropsychiatric disorders, particularly schizophrenia. Previous studies from our lab have shown the preclinical efficacy of a novel allosteric drug, 3(R)- [(2(S)-pyrrolidinylcarbonyl)amino]-2-oxo-1-pyrrolidineacetamide (PAOPA), in attenuating schizophrenia-like behavioural abnormalities in rodent models of the disease. As an allosteric modulator, PAOPA binds to a site on the D2 receptor, which is distinct from the endogenous ligand-binding site, in order to modulate the binding of the D2 receptor ligand, dopamine. The exact signaling pathways affected by this allosteric modulator are currently unknown. The objectives of this study were to decipher the in vivo effects, in rats, of chronic PAOPA administration on D2 receptor regulatory and downstream molecules, including GRK2, arrestin-3 and extracellular receptor kinase (ERK) 1/2. Additionally, an in vitro cellular model was also used to study PAOPA's effects on D2 receptor internalization. Results from western immunoblots showed that chronic PAOPA treatment increased the striatal expression of GRK2 by 41%, arrestin-3 by 34%, phospho-ERK1 by 51% and phospho-ERK2 by 36%. Results also showed that the addition of PAOPA to agonist treatment in cells increased D2 receptor internalization by 33%. This study provides the foundational evidence of putative signaling pathways, and changes in receptor localization, affected by treatment with PAOPA. It improves our understanding on the diverse mechanisms of action of allosteric modulators, while advancing PAOPA's development into a novel drug for the improved treatment of schizophrenia.	[Basu, Dipannita; Tian, Yuxin; Bhandari, Jayant; Jiang, Jian Ru; Hui, Patricia; Mishra, Ram K.] McMaster Univ, Dept Psychiat & Behav Neurosci, Hamilton, ON, Canada; [Johnson, Rodney L.] Univ Minnesota, Dept Med Chem, Minneapolis, MN 55455 USA	McMaster University; University of Minnesota System; University of Minnesota Twin Cities	Mishra, RK (corresponding author), McMaster Univ, Dept Psychiat & Behav Neurosci, Hamilton, ON, Canada.	mishrar@mcmaster.ca	Mishra, Ram K/B-3885-2009; Mishra, Ram/AAJ-1538-2020		Ontario Mental Health Foundation (OMHF); Canadian Institutues of Health Research (CIHR) [PPP114816]; National Institutes of Health (NIH) [NS 20036]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS020036] Funding Source: NIH RePORTER	Ontario Mental Health Foundation (OMHF); Canadian Institutues of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We are grateful for this work to be funded by the Ontario Mental Health Foundation (OMHF) - Type A Grant, the Canadian Institutues of Health Research (CIHR) PPP114816 and the National Institutes of Health (NIH) NS 20036. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed MR, 2008, J PHARMACOL EXP THER, V325, P276, DOI 10.1124/jpet.107.131987; Baures PW, 1999, BIOORG MED CHEM LETT, V9, P2349, DOI 10.1016/S0960-894X(99)00386-8; Beaulieu JM, 2005, CELL, V122, P261, DOI 10.1016/j.cell.2005.05.012; Beyaert MGR, 2013, EUR NEUROPSYCHOPHARM, V23, P253, DOI 10.1016/j.euroneuro.2012.04.010; Bhagwanth S, 2013, BEILSTEIN J ORG CHEM, V9, P204, DOI 10.3762/bjoc.9.24; Bhagwanth S, 2012, ACS CHEM NEUROSCI, V3, P274, DOI 10.1021/cn200096u; Bychkov ER, 2011, NEUROBIOL DIS, V44, P248, DOI 10.1016/j.nbd.2011.07.009; Cai GP, 2000, J NEUROSCI, V20, P1849; Castellano JM, 2007, PEPTIDES, V28, P2009, DOI 10.1016/j.peptides.2007.07.026; Chong VZ, 2002, J NEUROCHEM, V82, P1533, DOI 10.1046/j.1471-4159.2002.01104.x; Christopoulos A, 2002, NAT REV DRUG DISCOV, V1, P198, DOI 10.1038/nrd746; Christopoulos A, 2002, PHARMACOL REV, V54, P323, DOI 10.1124/pr.54.2.323; Conn PJ, 2009, NAT REV DRUG DISCOV, V8, P41, DOI 10.1038/nrd2760; DeWire SM, 2007, ANNU REV PHYSIOL, V69, P483, DOI 10.1146/annurev.physiol.69.022405.154749; Dolbeare K, 2003, J MED CHEM, V46, P727, DOI 10.1021/jm020441o; Dyck B, 2011, SCHIZOPHR RES, V125, P88, DOI 10.1016/j.schres.2010.09.025; Evans MC, 1999, J MED CHEM, V42, P1441, DOI 10.1021/jm980656r; Fisher A, 2006, J MED CHEM, V49, P307, DOI 10.1021/jm050644n; Freedman NJ, 1996, RECENT PROG HORM RES, V51, P319; Gainetdinov RR, 2004, ANNU REV NEUROSCI, V27, P107, DOI 10.1146/annurev.neuro.27.070203.144206; GENIN MJ, 1993, J MED CHEM, V36, P3481, DOI 10.1021/jm00074a032; Guo NN, 2010, NEUROPSYCHOPHARMACOL, V35, P806, DOI 10.1038/npp.2009.189; Harrison PJ, 2005, MOL PSYCHIATR, V10, P40, DOI 10.1038/sj.mp.4001558; Howes OD, 2009, SCHIZOPHRENIA BULL, V35, P549, DOI 10.1093/schbul/sbp006; Iaccarino G, 1998, CIRCULATION, V98, P1783, DOI 10.1161/01.CIR.98.17.1783; Ito K, 1999, EUR J BIOCHEM, V260, P112, DOI 10.1046/j.1432-1327.1999.00125.x; Iwata K, 1999, EUR J BIOCHEM, V263, P596, DOI 10.1046/j.1432-1327.1999.00549.x; Jaworski JN, 2001, EUR J PHARMACOL, V418, P201, DOI 10.1016/S0014-2999(01)00936-0; JOHNSON RL, 1990, J MED CHEM, V33, P1828, DOI 10.1021/jm00168a045; Keov P, 2011, NEUROPHARMACOLOGY, V60, P24, DOI 10.1016/j.neuropharm.2010.07.010; Khalil EM, 1999, J MED CHEM, V42, P2977, DOI 10.1021/jm990140n; Kim KM, 2001, J BIOL CHEM, V276, P37409, DOI 10.1074/jbc.M106728200; Konradi C, 2001, BIOL PSYCHIAT, V50, P729, DOI 10.1016/S0006-3223(01)01267-7; KORNHUBER J, 1995, J NEURAL TRANSM-GEN, V101, P95, DOI 10.1007/BF01271548; LEVEY AI, 1993, P NATL ACAD SCI USA, V90, P8861, DOI 10.1073/pnas.90.19.8861; Luo YQ, 1998, J NEUROCHEM, V71, P980; Mann A, 2010, EUR J PHARMACOL, V641, P96, DOI 10.1016/j.ejphar.2010.05.018; May LT, 2007, ANNU REV PHARMACOL, V47, P1, DOI 10.1146/annurev.pharmtox.47.120505.105159; Mishra RK, 1997, PEPTIDES, V18, P1209, DOI 10.1016/S0196-9781(97)00147-2; MISHRA RK, 1990, PROG NEURO-PSYCHOPH, V14, P821, DOI 10.1016/0278-5846(90)90054-K; Missale C, 1998, PHYSIOL REV, V78, P189, DOI 10.1152/physrev.1998.78.1.189; Namkung Y, 2009, J BIOL CHEM, V284, P15038, DOI 10.1074/jbc.M900388200; Pereira A, 2012, INT J NEUROPSYCHOPH, V15, P1149, DOI 10.1017/S1461145711001404; Pereira A, 2009, J MOL NEUROSCI, V39, P185, DOI 10.1007/s12031-009-9188-5; Pilowsky LS, 1997, LANCET, V350, P490, DOI 10.1016/S0140-6736(05)63079-6; Premont RT, 2007, ANNU REV PHYSIOL, V69, P511, DOI 10.1146/annurev.physiol.69.022405.154731; Raghavan B, 2009, J MED CHEM, V52, P2043, DOI 10.1021/jm801575w; Salim S, 2007, J PHARMACOL EXP THER, V321, P51, DOI 10.1124/jpet.106.116921; Shenoy SK, 2003, BIOCHEM J, V375, P503, DOI 10.1042/BJ20031076; Skinbjerg M, 2009, SYNAPSE, V63, P621, DOI 10.1002/syn.20636; SREENIVASAN U, 1993, J MED CHEM, V36, P256, DOI 10.1021/jm00054a010; SUBASINGHE NL, 1993, J MED CHEM, V36, P2356, DOI 10.1021/jm00068a013; Suhara T, 1999, INT J NEUROPSYCHOP, V2, P73, DOI 10.1017/S1461145799001431; Thibault D, 2011, J BIOL CHEM, V286, P9174, DOI 10.1074/jbc.M110.166454; Vallone D, 2000, NEUROSCI BIOBEHAV R, V24, P125, DOI 10.1016/S0149-7634(99)00063-9; Vartak AP, 2007, J MED CHEM, V50, P6725, DOI 10.1021/jm070895r; Verma V, 2005, J PHARMACOL EXP THER, V315, P1228, DOI 10.1124/jpet.105.091256; Welsh GI, 1998, J NEUROCHEM, V70, P2139; YU KL, 1988, J MED CHEM, V31, P1430, DOI 10.1021/jm00402a031; ZAHNISER NR, 1983, J PHARMACOL EXP THER, V227, P592	60	12	12	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2013	8	8							e70736	10.1371/journal.pone.0070736	http://dx.doi.org/10.1371/journal.pone.0070736			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	217ZG	23940634	Green Published, gold, Green Submitted			2022-12-25	WOS:000324401500049
J	Steinacher, R; Osman, F; Lorenz, A; Bryer, C; Whitby, MC				Steinacher, Roland; Osman, Fekret; Lorenz, Alexander; Bryer, Claire; Whitby, Matthew C.			Slx8 Removes Pli1-Dependent Protein-SUMO Conjugates Including SUMOylated Topoisomerase I to Promote Genome Stability	PLOS ONE			English	Article							THYMINE-DNA GLYCOSYLASE; REPLICATION FORKS; UBIQUITIN LIGASE; RECOMBINATION; REPAIR; COMPLEX; TERMINATION; PATHWAY; PCNA; REARRANGEMENTS	The SUMO-dependent ubiquitin ligase Slx8 plays key roles in promoting genome stability, including the processing of trapped Topoisomerase I (Top1) cleavage complexes and removal of toxic SUMO conjugates. We show that it is the latter function that constitutes Slx8's primary role in fission yeast. The SUMO conjugates in question are formed by the SUMO ligase Pli1, which is necessary for limiting spontaneous homologous recombination when Top1 is present. Surprisingly there is no requirement for Pli1 to limit recombination in the vicinity of a replication fork blocked at the programmed barrier RTS1. Notably, once committed to Pli1-mediated SUMOylation Slx8 becomes essential for genotoxin resistance, limiting both spontaneous and RTS1 induced recombination, and promoting normal chromosome segregation. We show that Slx8 removes Pli1-dependent Top1-SUMO conjugates and in doing so helps to constrain recombination at RTS1. Overall our data highlight how SUMOylation and SUMO-dependent ubiquitylation by the Pli1-Slx8 axis contribute in different ways to maintain genome stability.	[Steinacher, Roland; Osman, Fekret; Lorenz, Alexander; Bryer, Claire; Whitby, Matthew C.] Univ Oxford, Dept Biochem, Oxford OX1 3QU, England	University of Oxford	Whitby, MC (corresponding author), Univ Oxford, Dept Biochem, Oxford OX1 3QU, England.	matthew.whitby@bioch.ox.ac.uk	Lorenz, Alexander/B-4735-2008	Lorenz, Alexander/0000-0003-1925-3713; Whitby, Matthew/0000-0003-0951-3374; Bryer, Claire/0000-0002-7900-3460	Wellcome Trust [090767/Z/09/Z]; DFG	Wellcome Trust(Wellcome Trust); DFG(German Research Foundation (DFG))	This work was funded by grant 090767/Z/09/Z from the Wellcome Trust (http://www.wellcome.ac.uk/). Roland Steinacher was supported in part by a Research Fellowship from the DFG (http://www.dfg.de/en/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn JS, 2005, EMBO J, V24, P2011, DOI 10.1038/sj.emboj.7600670; Andrews EA, 2005, MOL CELL BIOL, V25, P185, DOI 10.1128/MCB.25.1.185-196.2005; Bahler J, 1998, YEAST, V14, P943, DOI 10.1002/(SICI)1097-0061(199807)14:10<943::AID-YEA292>3.0.CO;2-Y; Bergink S, 2009, NATURE, V458, P461, DOI 10.1038/nature07963; Berti M, 2013, NAT STRUCT MOL BIOL, V20, P347, DOI 10.1038/nsmb.2501; Branzei D, 2006, CELL, V127, P509, DOI 10.1016/j.cell.2006.08.050; Burgess RC, 2007, MOL CELL BIOL, V27, P6153, DOI 10.1128/MCB.00787-07; Cai QL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012636; Champoux JJ, 2001, ANNU REV BIOCHEM, V70, P369, DOI 10.1146/annurev.biochem.70.1.369; Chaudhuri AR, 2012, NAT STRUCT MOL BIOL, V19, P417, DOI 10.1038/nsmb.2258; Chen XL, 2007, GENETICS, V177, P17, DOI 10.1534/genetics.107.074708; Codlin S, 2003, EMBO J, V22, P3431, DOI 10.1093/emboj/cdg330; DARPA P, 1990, CANCER RES, V50, P6919; Desai SD, 1997, J BIOL CHEM, V272, P24159, DOI 10.1074/jbc.272.39.24159; Desai SD, 2001, CANCER RES, V61, P5926; Doe CL, 2004, NUCLEIC ACIDS RES, V32, P5570, DOI 10.1093/nar/gkh853; Galanty Y, 2012, GENE DEV, V26, P1179, DOI 10.1101/gad.188284.112; Geoffroy MC, 2009, NAT REV MOL CELL BIO, V10, P564, DOI 10.1038/nrm2707; Gill G, 2004, GENE DEV, V18, P2046, DOI 10.1101/gad.1214604; Golebiowski F, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000282; Hardeland U, 2002, EMBO J, V21, P1456, DOI 10.1093/emboj/21.6.1456; Heideker J, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001320; Horie K, 2002, ONCOGENE, V21, P7913, DOI 10.1038/sj.onc.1205917; Hunter T, 2009, ERNST SCHERING FOUND, V1, P1, DOI 10.1007/2789_2008_098; Ii T, 2007, CELL CYCLE, V6, P2800, DOI 10.4161/cc.6.22.4882; Inagawa T, 2009, P NATL ACAD SCI USA, V106, P7927, DOI 10.1073/pnas.0812323106; Jackson SP, 2013, MOL CELL, V49, P795, DOI 10.1016/j.molcel.2013.01.017; Jentsch S, 2010, SUBCELL BIOCHEM, V54, P184, DOI 10.1007/978-1-4419-6676-6_15; Kai M, 2007, NAT CELL BIOL, V9, P691, DOI 10.1038/ncb1600; Lambert S, 2005, CELL, V121, P689, DOI 10.1016/j.cell.2005.03.022; Lambert S, 2010, MOL CELL, V39, P346, DOI 10.1016/j.molcel.2010.07.015; Li TK, 2001, ANNU REV PHARMACOL, V41, P53, DOI 10.1146/annurev.pharmtox.41.1.53; Lin CP, 2008, J BIOL CHEM, V283, P21074, DOI 10.1074/jbc.M803493200; Lorenz A, 2009, MOL CELL BIOL, V29, P4742, DOI 10.1128/MCB.00471-09; Mao Y, 2000, P NATL ACAD SCI USA, V97, P4046, DOI 10.1073/pnas.080536597; Matsuo Y, 2006, BIOSCI BIOTECH BIOCH, V70, P1992, DOI 10.1271/bbb.60087; Mizuno K, 2013, NATURE, V493, P246, DOI 10.1038/nature11676; Mizuno K, 2009, GENE DEV, V23, P2876, DOI 10.1101/gad.1863009; MORENO S, 1991, METHOD ENZYMOL, V194, P795; Mullen JR, 2008, J BIOL CHEM, V283, P19912, DOI 10.1074/jbc.M802690200; Osman F, 2007, DNA REPAIR, V6, P1004, DOI 10.1016/j.dnarep.2007.02.019; Osman Fekret, 2009, V521, P535, DOI [10.1007/978-1-60327-817-5_31, 10.1007/978-1-60327-815-7_31]; Panse VG, 2004, J BIOL CHEM, V279, P41346, DOI 10.1074/jbc.M407950200; Papouli E, 2005, MOL CELL, V19, P123, DOI 10.1016/j.molcel.2005.06.001; Burkovics P, 2013, EMBO J, V32, P742, DOI 10.1038/emboj.2013.9; Pfander B, 2005, NATURE, V436, P428, DOI 10.1038/nature03665; Prudden J, 2007, EMBO J, V26, P4089, DOI 10.1038/sj.emboj.7601838; Prudden J, 2011, MOL CELL BIOL, V31, P2299, DOI 10.1128/MCB.05188-11; Regairaz M, 2011, J CELL BIOL, V195, P739, DOI 10.1083/jcb.201104003; Rosas-Acosta G, 2005, MOL CELL PROTEOMICS, V4, P56, DOI 10.1074/mcp.M400149-MCP200; Roseaulin L, 2008, EMBO J, V27, P1378, DOI 10.1038/emboj.2008.65; Schleker T, 2009, DNA REPAIR, V8, P1089, DOI 10.1016/j.dnarep.2009.04.010; SQUIRES S, 1993, CANCER RES, V53, P2012; Steinacher R, 2005, CURR BIOL, V15, P616, DOI 10.1016/j.cub.2005.02.054; Steinacher R, 2012, GENE DEV, V26, P594, DOI 10.1101/gad.184663.111; Sun H, 2007, EMBO J, V26, P4102, DOI 10.1038/sj.emboj.7601839; Sun W, 2008, MOL CELL, V32, P118, DOI 10.1016/j.molcel.2008.08.024; Tatham MH, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001484; Ulrich HD, 2005, CELL CYCLE, V4, P1699, DOI 10.4161/cc.4.12.2194; Ulrich HD, 2008, MOL CELL, V32, P301, DOI 10.1016/j.molcel.2008.10.010; Uzunova K, 2007, J BIOL CHEM, V282, P34167, DOI 10.1074/jbc.M706505200; Watts FZ, 2007, BIOCHEM SOC T, V35, P1379, DOI 10.1042/BST0351379; Wei F, 2007, J BIOL CHEM, V282, P21551, DOI 10.1074/jbc.M611041200; Xhemalce B, 2004, EMBO J, V23, P3844, DOI 10.1038/sj.emboj.7600394; Xhemalce B, 2007, P NATL ACAD SCI USA, V104, P893, DOI 10.1073/pnas.0605442104; Xie Y, 2007, J BIOL CHEM, V282, P34176, DOI 10.1074/jbc.M706025200	66	15	16	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2013	8	8							e71960	10.1371/journal.pone.0071960	http://dx.doi.org/10.1371/journal.pone.0071960			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	217ZG	23936535	Green Submitted, Green Published, gold			2022-12-25	WOS:000324401500085
J	Stoepler, TM; Castillo, JC; Lill, JT; Eleftherianos, I				Stoepler, Teresa M.; Castillo, Julio C.; Lill, John T.; Eleftherianos, Ioannis			Hemocyte Density Increases with Developmental Stage in an Immune-Challenged Forest Caterpillar	PLOS ONE			English	Article							PSEUDOPLUSIA-INCLUDENS; HONEY-BEE; HOST; LEPIDOPTERA; SYSTEM; HEMATOPOIESIS; ENCAPSULATION; EVOLUTION; PROTEINS; ONTOGENY	The cellular arm of the insect immune response is mediated by the activity of hemocytes. While hemocytes have been well-characterized morphologically and functionally in model insects, few studies have characterized the hemocytes of non-model insects. Further, the role of ontogeny in mediating immune response is not well understood in non-model invertebrate systems. The goals of the current study were to (1) determine the effects of caterpillar size (and age) on hemocyte density in naive caterpillars and caterpillars challenged with non-pathogenic bacteria, and (2) characterize the hemocyte activity and diversity of cell types present in two forest caterpillars: Euclea delphinii and Lithacodes fasciola (Limacodidae). We found that although early and late instar (small and large size, respectively) naive caterpillars had similar constitutive hemocyte densities in both species, late instar Lithacodes caterpillars injected with non-pathogenic E. coli produced more than a twofold greater density of hemocytes than those in early instars. We also found that both caterpillar species contained plasmatocytes, granulocytes and oenocytoids, all of which are found in other lepidopteran species, but lacked spherulocytes. Granulocytes and plasmatocytes were found to be strongly phagocytic in both species, but granulocytes exhibited a higher phagocytic activity than plasmatocytes. Our results strongly suggest that for at least one measure of immunological response, the production of hemocytes in response to infection, response magnitudes can increase over ontogeny. While the underlying raison d' etre for this improvement remains unclear, these findings may be useful in explaining natural patterns of stage-dependent parasitism and pathogen infection.	[Stoepler, Teresa M.; Castillo, Julio C.; Lill, John T.; Eleftherianos, Ioannis] George Washington Univ, Dept Biol Sci, Washington, DC 20052 USA	George Washington University	Eleftherianos, I (corresponding author), George Washington Univ, Dept Biol Sci, Washington, DC 20052 USA.	ioannise@gwu.edu	Castillo, Julio C./AAC-3869-2020	Castillo, Julio C./0000-0002-6921-810X; de la Puente, Teresa Michelle/0000-0002-6138-2079	Washington Biologists' Field Club grant; GWU Columbian College Facilitating Fund grant	Washington Biologists' Field Club grant; GWU Columbian College Facilitating Fund grant	This work was funded by a Washington Biologists' Field Club grant to TMS and a GWU Columbian College Facilitating Fund grant to IE. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asgari S, 2011, ANNU REV ENTOMOL, V56, P313, DOI 10.1146/annurev-ento-120709-144849; Beetz S, 2008, ARCH INSECT BIOCHEM, V67, P63, DOI 10.1002/arch.20221; Bradley JE, 2008, PARASITOLOGY, V135, P807, DOI 10.1017/S0031182008000322; BRODEUR J, 1995, PHYSIOL ENTOMOL, V20, P7, DOI 10.1111/j.1365-3032.1995.tb00794.x; Crozatier M, 2007, CELL MICROBIOL, V9, P1117, DOI 10.1111/j.1462-5822.2007.00930.x; Davis MM, 2012, J INNATE IMMUN, V4, P273, DOI 10.1159/000332947; Eleftherianos I, 2011, J INNATE IMMUN, V3, P28, DOI 10.1159/000321931; Ganesan S, 2011, CURR TOP MICROBIOL, V349, P25, DOI 10.1007/82_2010_107; Gardiner EMM, 2000, ARCH INSECT BIOCHEM, V43, P147, DOI 10.1002/(SICI)1520-6327(200004)43:4&lt;147::AID-ARCH1&gt;3.0.CO;2-J; Gates MW, 2012, P ENTOMOL SOC WASH, V114, P24, DOI 10.4289/0013-8797.114.1.24; GUPTA AP, 1967, ANN ENTOMOL SOC AM, V60, P557, DOI 10.1093/aesa/60.3.557; GUPTA AP, 1988, TISSUE CELL, V20, P629, DOI 10.1016/0040-8166(88)90064-X; Hillyer JF, 2010, ADV EXP MED BIOL, V708, P218; Jiang H, 2010, ADV EXP MED BIOL, V708, P181; Kacsoh BZ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034721; Kanost MR, 2004, IMMUNOLOGICAL REV, V198; Kirkpatrick BA, 1998, J INVERTEBR PATHOL, V72, P63, DOI 10.1006/jipa.1997.4752; Kraaijeveld AR, 2001, P ROY SOC B-BIOL SCI, V268, P259, DOI 10.1098/rspb.2000.1354; Laughton AM, 2011, J INSECT PHYSIOL, V57, P1023, DOI 10.1016/j.jinsphys.2011.04.020; Lill JT, 2006, ENVIRON ENTOMOL, V35, P797, DOI 10.1603/0046-225X-35.3.797; Loof TG, 2011, J INNATE IMMUN, V3, P34, DOI 10.1159/000321641; Marmaras VJ, 2009, CELL SIGNAL, V21, P186, DOI 10.1016/j.cellsig.2008.08.014; Murphy SM, 2011, J LEPID SOC, V65, P137; Nakahara Y, 2009, DEV COMP IMMUNOL, V33, P439, DOI 10.1016/j.dci.2008.09.005; Nakahara Y, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011816; PECH LL, 1995, J INSECT PHYSIOL, V41, P481, DOI 10.1016/0022-1910(94)00136-5; Poulin R, 2007, PARASITOLOGY, V134, P763, DOI 10.1017/S0031182006002150; Regier JC, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-280; Ribeiro C, 2006, J INSECT PHYSIOL, V52, P417, DOI 10.1016/j.jinsphys.2006.01.005; Royet J, 2011, CELL MOL LIFE SCI, V68, P3651, DOI 10.1007/s00018-011-0828-x; Ryu JH, 2010, DEV COMP IMMUNOL, V34, P369, DOI 10.1016/j.dci.2009.11.010; SAIT SM, 1994, J INVERTEBR PATHOL, V63, P107, DOI 10.1006/jipa.1994.1020; Sandland GJ, 2003, TRENDS PARASITOL, V19, P571, DOI 10.1016/j.pt.2003.10.006; Stireman JO, 2006, ANNU REV ENTOMOL, V51, P525, DOI 10.1146/annurev.ento.51.110104.151133; Stoepler TM, 2012, JOVE-J VIS EXP, DOI 10.3791/4173; Stoepler TM, 2011, ECOL ENTOMOL, V36, P724, DOI 10.1111/j.1365-2311.2011.01322.x; Stoepler TM, 2012, THESIS G WASHINGTON; Strand MR, 2008, INSECT IMMUNOLOGY, P25, DOI 10.1016/S0965-1748(02)00092-9; Strand MR, 2008, INSECT SCI, V15, P1, DOI 10.1111/j.1744-7917.2008.00183.x; STRAND MR, 1995, ANNU REV ENTOMOL, V40, P31, DOI 10.1146/annurev.en.40.010195.000335; Tate AT, 2012, OIKOS, V121, P1083, DOI 10.1111/j.1600-0706.2011.19725.x; Tsakas S, 2010, ISJ-INVERT SURVIV J, V7, P228; Vallet-Gely I, 2008, NAT REV MICROBIOL, V6, P302, DOI 10.1038/nrmicro1870; VINSON SB, 1990, ARCH INSECT BIOCHEM, V13, P3, DOI 10.1002/arch.940130103; Williams MJ, 2007, J IMMUNOL, V178, P4711, DOI 10.4049/jimmunol.178.8.4711; Wilson-Rich N, 2008, J INSECT PHYSIOL, V54, P1392, DOI 10.1016/j.jinsphys.2008.07.016; Wood W, 2007, NAT REV MOL CELL BIO, V8, P542, DOI 10.1038/nrm2202	47	26	27	1	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2013	8	8							e70978	10.1371/journal.pone.0070978	http://dx.doi.org/10.1371/journal.pone.0070978			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	217ZG	23940679	Green Submitted, Green Published, gold			2022-12-25	WOS:000324401500055
J	Vey, G				Vey, Gregory			Metagenomic Guilt by Association: An Operonic Perspective	PLOS ONE			English	Article							PROTEIN FUNCTION; ESCHERICHIA-COLI; BY-ASSOCIATION; GENOME; GENE; REVEALS; CONTEXT	Next-generation sequencing projects continue to drive a vast accumulation of metagenomic sequence data. Given the growth rate of this data, automated approaches to functional annotation are indispensable and a cornerstone heuristic of many computational protocols is the concept of guilt by association. The guilt by association paradigm has been heavily exploited by genomic context methods that offer functional predictions that are complementary to homology-based annotations, thereby offering a means to extend functional annotation. In particular, operon methods that exploit co-directional intergenic distances can provide homology-free functional annotation through the transfer of functions among co-operonic genes, under the assumption that guilt by association is indeed applicable. Although guilt by association is a well-accepted annotative device, its applicability to metagenomic functional annotation has not been definitively demonstrated. Here a large-scale assessment of metagenomic guilt by association is undertaken where functional associations are predicted on the basis of co-directional intergenic distances. Specifically, functional annotations are compared within pairs of adjacent co-directional genes, as well as operons of various lengths (i.e. number of member genes), in order to reveal new information about annotative cohesion versus operon length. The results suggests that co-directional gene pairs offer reduced confidence for metagenomic guilt by association due to difficulty in resolving the existence of functional associations when intergenic distance is the sole predictor of pairwise gene interactions. However, metagenomic operons, particularly those with substantial lengths, appear to be capable of providing a superior basis for metagenomic guilt by association due to increased annotative stability. The need for improved recognition of metagenomic operons is discussed, as well as the limitations of the present work.	Univ Waterloo, Dept Biol, Waterloo, ON N2L 3G1, Canada	University of Waterloo	Vey, G (corresponding author), Univ Waterloo, Dept Biol, Waterloo, ON N2L 3G1, Canada.	gvey@uwaterloo.ca		Vey, Gregory/0000-0003-1574-1373	NSERC	NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC))	GV is supported by an NSERC Strategic Grant to Trevor Charles. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aravind L, 2000, GENOME RES, V10, P1074, DOI 10.1101/gr.10.8.1074; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkp985, 10.1093/nar/gkr1065]; Bockhorst J, 2003, BIOINFORMATICS, V19, P1227, DOI 10.1093/bioinformatics/btg147; Brown PO, 1999, NAT GENET, V21, P33, DOI 10.1038/4462; Craven M, 2000, Proc Int Conf Intell Syst Mol Biol, V8, P116; Dandekar T, 1998, TRENDS BIOCHEM SCI, V23, P324, DOI 10.1016/S0968-0004(98)01274-2; Date Shailesh V., 2007, V408, P109, DOI 10.1007/978-1-59745-547-3_7; Doerks T, 2004, NUCLEIC ACIDS RES, V32, P6321, DOI 10.1093/nar/gkh973; Dougherty J., 1995, Machine Learning. Proceedings of the Twelfth International Conference on Machine Learning, P194; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Enright AJ, 1999, NATURE, V402, P86, DOI 10.1038/47056; FAYYAD UM, 1993, IJCAI-93, VOLS 1 AND 2, P1022; Gaasterland T, 1998, Microb Comp Genomics, V3, P199; Gama-Castro S, 2011, NUCLEIC ACIDS RES, V39, pD98, DOI 10.1093/nar/gkq1110; Gillis J, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002444; Gillis J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017258; Haft DH, 2013, NUCLEIC ACIDS RES, V41, pD387, DOI 10.1093/nar/gks1234; Harrington ED, 2007, P NATL ACAD SCI USA, V104, P13913, DOI 10.1073/pnas.0702636104; Huynen MA, 2000, ADV PROTEIN CHEM, V54, P345, DOI 10.1016/S0065-3233(00)54010-8; IBM Corp, 2011, IBM SPSS STAT WIND V; Kodama Y, 2012, NUCLEIC ACIDS RES, V40, pD54, DOI 10.1093/nar/gkr854; Leinonen R, 2011, NUCLEIC ACIDS RES, V39, pD19, DOI 10.1093/nar/gkq1019; Marcotte EM, 1999, SCIENCE, V285, P751, DOI 10.1126/science.285.5428.751; Markowitz VM, 2012, NUCLEIC ACIDS RES, V40, pD123, DOI 10.1093/nar/gkr975; Mason Christopher E, 2012, Genome Biol, V13, P314, DOI 10.1186/gb-2012-13-3-314; Moreno-Hagelsieb Gabriel, 2002, Bioinformatics, V18 Suppl 1, pS329; National Center for Biotechnology Information, 2012, FTP DIR BACT GEN; Oliver S, 2000, NATURE, V403, P601, DOI 10.1038/35001165; Pellegrini M, 1999, P NATL ACAD SCI USA, V96, P4285, DOI 10.1073/pnas.96.8.4285; Pignatelli M, 2008, BIOINFORMATICS, V24, P2124, DOI 10.1093/bioinformatics/btn355; Quackenbush J, 2001, NAT REV GENET, V2, P418, DOI 10.1038/35076576; RISSANEN J, 1978, AUTOMATICA, V14, P465, DOI 10.1016/0005-1098(78)90005-5; Rogozin IB, 2004, BRIEF BIOINFORM, V5, P131, DOI 10.1093/bib/5.2.131; Salgado H, 2000, P NATL ACAD SCI USA, V97, P6652, DOI 10.1073/pnas.110147297; Semple Jennifer I., 2002, Briefings in Functional Genomics & Proteomics, V1, P40, DOI 10.1093/bfgp/1.1.40; Smoot ME, 2011, BIOINFORMATICS, V27, P431, DOI 10.1093/bioinformatics/btq675; Suhre Karsten, 2007, V396, P31; Tamames J, 2001, GENOME BIOL, V2; Tatusov RL, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-41; Vey G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041283; Vey G, 2010, MOL BIOSYST, V6, P1247, DOI 10.1039/b919263h; Wolfe CJ, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-227	42	7	7	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2013	8	8							e71484	10.1371/journal.pone.0071484	http://dx.doi.org/10.1371/journal.pone.0071484			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	217ZG	23940763	Green Published, Green Submitted, gold			2022-12-25	WOS:000324401500073
J	Amil-Ruiz, F; Garrido-Gala, J; Blanco-Portales, R; Folta, KM; Munoz-Blanco, J; Caballero, JL				Amil-Ruiz, Francisco; Garrido-Gala, Jose; Blanco-Portales, Rosario; Folta, Kevin M.; Munoz-Blanco, Juan; Caballero, Jose L.			Identification and Validation of Reference Genes for Transcript Normalization in Strawberry (Fragaria x ananassa) Defense Responses	PLOS ONE			English	Article							REAL-TIME PCR; SUPERIOR REFERENCE GENES; RT-PCR; QUANTITATIVE-PCR; HOUSEKEEPING GENES; EXPRESSION ANALYSIS; SALICYLIC-ACID; RNA; COLLETOTRICHUM; ARABIDOPSIS	Strawberry (Fragaria spp) is an emerging model for the development of basic genomics and recombinant DNA studies among rosaceous crops. Functional genomic and molecular studies involve relative quantification of gene expression under experimental conditions of interest. Accuracy and reliability are dependent upon the choice of an optimal reference control transcript. There is no information available on validated endogenous reference genes for use in studies testing strawberry-pathogen interactions. Thirteen potential pre-selected strawberry reference genes were tested against different tissues, strawberry cultivars, biotic stresses, ripening and senescent conditions, and SA/JA treatments. Evaluation of reference candidate's suitability was analyzed by five different methodologies, and information was merged to identify best reference transcripts. A combination of all five methods was used for selective classification of reference genes. The resulting superior reference genes, FaRIB413, FaACTIN, FaEF1 alpha and FaGAPDH2 are strongly recommended as control genes for relative quantification of gene expression in strawberry. This report constitutes the first systematic study to identify and validate optimal reference genes for accurate normalization of gene expression in strawberry plant defense response studies.	[Amil-Ruiz, Francisco; Garrido-Gala, Jose; Blanco-Portales, Rosario; Munoz-Blanco, Juan; Caballero, Jose L.] Univ Cordoba, Dept Bioquim & Biol Mol, Cordoba, Andalucia, Spain; [Amil-Ruiz, Francisco; Garrido-Gala, Jose; Blanco-Portales, Rosario; Munoz-Blanco, Juan; Caballero, Jose L.] Univ Cordoba, Inst Andaluz Biotecnol, Cordoba, Andalucia, Spain; [Folta, Kevin M.] Univ Florida, Dept Hort Sci, Gainesville, FL USA; [Folta, Kevin M.] Univ Florida, Grad Program Plant Mol & Cellular Biol, Gainesville, FL USA	Universidad de Cordoba; Universidad de Cordoba; State University System of Florida; University of Florida; State University System of Florida; University of Florida	Caballero, JL (corresponding author), Univ Cordoba, Dept Bioquim & Biol Mol, Campus Univ Rabanales & Campus Excelencia Int Agr, Cordoba, Andalucia, Spain.	bb1carej@uco.es	Blanco-Portales, Rosario/K-8352-2017; Gala, José Garrido/N-9215-2019; Caballero, José L./L-2067-2014; Muñoz-Blanco, Juan/K-8357-2017	Blanco-Portales, Rosario/0000-0001-7540-6417; Gala, José Garrido/0000-0003-1357-3580; Caballero, José L./0000-0002-2678-4849; Muñoz-Blanco, Juan/0000-0003-3968-9493; Amil-Ruiz, Francisco/0000-0002-3470-0860	Junta de Andalucia [P07-AGR-02482, Grupo-BIO278]	Junta de Andalucia(Junta de Andalucia)	This work was supported by Junta de Andalucia (Proyecto de Excelencia P07-AGR-02482, and grants to Grupo-BIO278). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Accerbi M, 2010, METHODS MOL BIOL, V592, P31, DOI 10.1007/978-1-60327-005-2_3; Amil-Ruiz F, 2012, ACTA HORTIC, V929, P47; Amil-Ruiz F, 2011, PLANT CELL PHYSIOL, V52, P1873, DOI 10.1093/pcp/pcr136; Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; Benitez-Burraco A, 2003, J EXP BOT, V54, P633, DOI 10.1093/jxb/erg065; Brunner Amy M., 2004, BMC Plant Biology, V4, P14, DOI 10.1186/1471-2229-4-14; Bustin SA, 2005, J MOL ENDOCRINOL, V34, P597, DOI 10.1677/jme.1.01755; Bustin SA, 2002, J MOL ENDOCRINOL, V29, DOI 10.1677/jme.0.0290023; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Casado-Diaz A, 2006, PHYSIOL PLANTARUM, V128, P633, DOI 10.1111/j.1399-3054.2006.00798.x; Chen L, 2011, PLANTA, V234, P377, DOI 10.1007/s00425-011-1410-3; Cordoba EM, 2011, ANAL BIOCHEM, V409, P236, DOI 10.1016/j.ab.2010.10.031; Csukasi F, 2011, NEW PHYTOL, V191, P376, DOI 10.1111/j.1469-8137.2011.03700.x; Czechowski T, 2005, PLANT PHYSIOL, V139, P5, DOI 10.1104/pp.105.063743; Czechowski T, 2004, PLANT J, V38, P366, DOI 10.1111/j.1365-313X.2004.02051.x; de Oliveira LA, 2012, PLANT CELL PHYSIOL, V53, P405, DOI 10.1093/pcp/pcr187; Dekkers BJW, 2012, PLANT CELL PHYSIOL, V53, P28, DOI 10.1093/pcp/pcr113; Dheda K, 2004, BIOTECHNIQUES, V37, P112, DOI 10.2144/04371RR03; Die JV, 2010, PLANTA, V232, P145, DOI 10.1007/s00425-010-1158-1; Encinas-Villarejo S, 2009, J EXP BOT, V60, P3043, DOI 10.1093/jxb/erp152; Fan HPY, 2009, CLIN CHEM, V55, P774, DOI 10.1373/clinchem.2008.119107; Gachon C, 2004, J EXP BOT, V55, P1445, DOI 10.1093/jxb/erh181; Goidin D, 2001, ANAL BIOCHEM, V295, P17, DOI 10.1006/abio.2001.5171; Grellet-Bournonville CF, 2012, PLANT PHYSIOL BIOCH, V54, P10, DOI 10.1016/j.plaphy.2012.01.019; Guenin S, 2009, J EXP BOT, V60, P487, DOI 10.1093/jxb/ern305; Guidarelli M, 2011, PLANT PATHOL, V60, P685, DOI 10.1111/j.1365-3059.2010.02423.x; Gutierrez L, 2008, PLANT BIOTECHNOL J, V6, P609, DOI 10.1111/j.1467-7652.2008.00346.x; Hellemans J, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-r19; Hong SM, 2010, PLANT CELL PHYSIOL, V51, P1694, DOI 10.1093/pcp/pcq128; Hruz T, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-156; Khan AA, 2004, PLANT SCI, V166, P753, DOI 10.1016/j.plantsci.2003.11.015; Kim BR, 2003, BIOTECHNOL LETT, V25, P1869, DOI 10.1023/A:1026298032009; Lefever S, 2009, NUCLEIC ACIDS RES, V37, P2065, DOI 10.1093/nar/gkp056; Lin-Wang Kui, 2010, BMC Plant Biol, V10, P50, DOI 10.1186/1471-2229-10-50; Mafra V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031263; Mamani A, 2012, MOL PLANT MICROBE IN, V25, P1430, DOI 10.1094/MPMI-12-11-0306; MANNING K, 1991, ANAL BIOCHEM, V195, P45, DOI 10.1016/0003-2697(91)90292-2; Zamora MGM, 2012, FUNCT PLANT BIOL, V39, P412, DOI 10.1071/FP11275; Matta BP, 2011, DEV GENES EVOL, V221, P49, DOI 10.1007/s00427-011-0356-6; Mehta R, 2010, BMC MOL BIOL, V11, DOI 10.1186/1471-2199-11-39; Mezzetti B, 2009, GENETICS GEONOMICS R; Moyano-Canete E, 2013, PLANT CELL PHYSIOL, V54, P218, DOI 10.1093/pcp/pcs167; Obrero A, 2011, J AGR FOOD CHEM, V59, P5402, DOI 10.1021/jf200689r; Osorio S, 2008, PLANT J, V54, P43, DOI 10.1111/j.1365-313X.2007.03398.x; Pfaffl MW, 2004, BIOTECHNOL LETT, V26, P509, DOI 10.1023/B:BILE.0000019559.84305.47; Pihur V, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-62; Podevin N, 2012, MOL BREEDING, V30, P1237, DOI 10.1007/s11032-012-9711-1; Radonic A, 2004, BIOCHEM BIOPH RES CO, V313, P856, DOI 10.1016/j.bbrc.2003.11.177; Ramakers C, 2003, NEUROSCI LETT, V339, P62, DOI 10.1016/S0304-3940(02)01423-4; Ruijter JM, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp045; Shulaev V, 2011, NAT GENET, V43, P109, DOI 10.1038/ng.740; Silver N, 2006, BMC MOL BIOL, V7, DOI 10.1186/1471-2199-7-33; Udvardi MK, 2008, PLANT CELL, V20, P1736, DOI 10.1105/tpc.108.061143; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Wong ML, 2005, BIOTECHNIQUES, V39, P75, DOI 10.2144/05391RV01	55	69	73	0	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2013	8	8							e70603	10.1371/journal.pone.0070603	http://dx.doi.org/10.1371/journal.pone.0070603			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	218XC	23940602	Green Published, gold, Green Submitted			2022-12-25	WOS:000324465000096
J	Ang, LF; Por, LY; Yam, MF				Ang, Lee Fung; Por, Lip Yee; Yam, Mun Fei			Study on Different Molecular Weights of Chitosan as an Immobilization Matrix for a Glucose Biosensor	PLOS ONE			English	Article							HORSERADISH-PEROXIDASE; OXIDASE; ELECTRODE; SENSOR; FILMS; NANOPARTICLES	Two chitosan samples (medium molecular weight (MMCHI) and low molecular weight (LMCHI)) were investigated as an enzyme immobilization matrix for the fabrication of a glucose biosensor. Chitosan membranes prepared from acetic acid were flexible, transparent, smooth and quick-drying. The FTIR spectra showed the existence of intermolecular interactions between chitosan and glucose oxidase (GOD). Higher catalytic activities were observed on for GOD-MMCHI than GOD-LMCHI and for those crosslinked with glutaraldehyde than using the adsorption technique. Enzyme loading greater than 0.6 mg decreased the activity. Under optimum conditions (pH 6.0, 35 degrees C and applied potential of 0.6 V) response times of 85 s and 65 s were observed for medium molecular weight chitosan glucose biosensor (GOD-MMCHI/PT) and low molecular weight chitosan glucose biosensor (GOD-LMCHI/PT), respectively. The apparent Michaelis-Menten constant (K-M(app)) was found to be 12.737 mM for GOD-MMCHI/PT and 17.692 mM for GOD-LMCHI/PT. This indicated that GOD-MMCHI/PT had greater affinity for the enzyme. Moreover, GOD-MMCHI/PT showed higher sensitivity (52.3666 nA/mM glucose) when compared with GOD-LMCHI/PT (9.8579 nA/mM glucose) at S/N>3. Better repeatability and reproducibility were achieved with GOD-MMCHI/PT than GOD-LMCHI/PT regarding glucose measurement. GOD-MMCHI/PT was found to give the highest enzymatic activity among the electrodes under investigation. The extent of interference encountered by GOD-MMCHI/PT and GOD-LMCHI/PT was not significantly different. Although the Nafion coated biosensor significantly reduced the signal due to the interferents under study, it also significantly reduced the response to glucose. The performance of the biosensors in the determination of glucose in rat serum was evaluated. Comparatively better accuracy and recovery results were obtained for GOD-MMCHI/PT. Hence, GOD-MMCHI/PT showed a better performance when compared with GOD-LMCHI/PT. In conclusion, chitosan membranes shave the potential to be a suitable matrix for the development of glucose biosensors.	[Ang, Lee Fung; Yam, Mun Fei] Univ Sains Malaysia, Sch Pharmaceut Sci, Minden, Penang, Malaysia; [Por, Lip Yee] Univ Malaya, Fac Comp Sci & Informat Technol, Kuala Lumpur, Malaysia	Universiti Sains Malaysia; Universiti Malaya	Yam, MF (corresponding author), Univ Sains Malaysia, Sch Pharmaceut Sci, Minden, Penang, Malaysia.	yammunfei@yahoo.com	POR, LIP YEE/B-5309-2010	POR, LIP YEE/0000-0001-5865-1533	Malaysia Toray Science Foundation (MTSF) [304, PFARMASI 650295, T102]; High Impact Research Grant from the University of Malaya [UM.C/625/1/HIR/MOHE/FCSIT/15]; Fundamental Research Grant Scheme from the University of Malaya [FRGS/FP31-2012A]	Malaysia Toray Science Foundation (MTSF); High Impact Research Grant from the University of Malaya; Fundamental Research Grant Scheme from the University of Malaya	This project was supported by research grant from the Malaysia Toray Science Foundation (MTSF) (Grant No. 304, PFARMASI 650295, T102) and High Impact Research Grant (UM.C/625/1/HIR/MOHE/FCSIT/15), Fundamental Research Grant Scheme (FRGS/FP31-2012A) from the University of Malaya. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alsarra IA, 2002, BIOMATERIALS, V23, P3637, DOI 10.1016/S0142-9612(02)00096-0; Bergmeyer H, 1974, METHODS ENZYMATIC AN, P1205; Bhatia RB, 2000, CHEM MATER, V12, P2434, DOI 10.1021/cm000260f; Bindhu LV, 2003, J APPL POLYM SCI, V88, P1456, DOI 10.1002/app.11815; Chen C, 2006, BIOSENS BIOELECTRON, V22, P639, DOI 10.1016/j.bios.2006.01.023; CLARK LC, 1962, ANN NY ACAD SCI, V102, P29, DOI 10.1111/j.1749-6632.1962.tb13623.x; Dhanikula AB, 2004, AAPS J, V6; Freitag R, 1999, J CHROMATOGR B, V722, P279, DOI 10.1016/S0378-4347(98)00507-6; KARNES HT, 1991, PHARMACEUT RES, V8, P421, DOI 10.1023/A:1015882607690; KAUPPINEN JK, 1981, APPL SPECTROSC, V35, P271, DOI 10.1366/0003702814732634; Li J, 1997, SENSOR ACTUAT B-CHEM, V40, P135, DOI 10.1016/S0925-4005(97)80252-3; Lim SH, 2005, BIOSENS BIOELECTRON, V20, P2341, DOI 10.1016/j.bios.2004.08.005; Magalhaes JMCS, 1998, TALANTA, V47, P183, DOI 10.1016/S0039-9140(98)00066-6; Musale DA, 2000, SEP PURIF TECHNOL, V21, P27, DOI 10.1016/S1383-5866(00)00188-X; Onda M, 1999, J BIOSCI BIOENG, V87, P69, DOI 10.1016/S1389-1723(99)80010-3; Orphan DD, 2003, LIFE SCI, V72, P2273; Pan DW, 2004, ELECTROCHIM ACTA, V49, P795, DOI 10.1016/j.electacta.2003.09.033; Pekel N, 2003, J MOL CATAL B-ENZYM, V21, P273, DOI 10.1016/S1381-1177(02)00232-1; Scheller F., 1992, BIOSENSORS, V1 st ed; Segel IH, 1976, BIOCH CALCULATIONS; Shankaran DR, 2003, BIOSENS BIOELECTRON, V18, P721, DOI 10.1016/S0956-5663(03)00005-8; SHU FR, 1976, ANAL CHEM, V48, P1679, DOI 10.1021/ac50006a014; Singhal R, 2002, SENSOR ACTUAT B-CHEM, V86, P42, DOI 10.1016/S0925-4005(02)00145-4; Spagna G, 1998, PROCESS BIOCHEM, V33, P57, DOI 10.1016/S0032-9592(97)00067-8; Wang G, 2003, BIOSENS BIOELECTRON, V18, P335, DOI 10.1016/S0956-5663(02)00152-5; Wang L, 2003, SENSORS-BASEL, V3, P544; Wilkins E, 1996, MED ENG PHYS, V18, P273, DOI 10.1016/1350-4533(95)00046-1; Wu BY, 2007, BIOSENS BIOELECTRON, V22, P838, DOI 10.1016/j.bios.2006.03.009; Xu JJ, 2000, ANAL CHIM ACTA, V423, P101, DOI 10.1016/S0003-2670(00)01098-9; Xu JJ, 2001, FRESEN J ANAL CHEM, V369, P486, DOI 10.1007/s002160000690; Xu YM, 2003, INT J PHARMACEUT, V250, P215, DOI 10.1016/S0378-5173(02)00548-3; Yang MH, 2004, SENSOR ACTUAT B-CHEM, V101, P269, DOI 10.1016/j.snb.2004.01.003; Yang YM, 2004, ENZYME MICROB TECH, V34, P126, DOI 10.1016/j.enzmictec.2003.09.007; Zhao CZ, 1998, ANAL SCI, V14, P439, DOI 10.2116/analsci.14.439; Zhou GJ, 2002, SENSOR ACTUAT B-CHEM, V81, P334, DOI 10.1016/S0925-4005(01)00978-9; Zhu YF, 2005, J MATER RES, V20, P2682, DOI 10.1557/JMR.2005.0360	36	27	27	1	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2013	8	8							e70597	10.1371/journal.pone.0070597	http://dx.doi.org/10.1371/journal.pone.0070597			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	218XC	23940599	Green Published, Green Submitted, gold			2022-12-25	WOS:000324465000093
J	Chang, KY; Yang, JR				Chang, Kuan Y.; Yang, Je-Ruei			Analysis and Prediction of Highly Effective Antiviral Peptides Based on Random Forests	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; REVERSE-TRANSCRIPTASE; POTENT; PROTEIN; INHIBITOR; REPLICATION; INFECTIVITY; LIBRARIES; DESIGN; SERVER	The goal of this study was to examine and predict antiviral peptides. Although antiviral peptides hold great potential in antiviral drug discovery, little is done in antiviral peptide prediction. In this study, we demonstrate that a physicochemical model using random forests outperform in distinguishing antiviral peptides. On the experimental benchmark, our physicochemical model aided with aggregation and secondary structural features reaches 90% accuracy and 0.79 Matthew's correlation coefficient, which exceeds the previous models. The results suggest that aggregation could be an important feature for identifying antiviral peptides. In addition, our analysis reveals the characteristics of the antiviral peptides such as the importance of lysine and the abundance of alpha-helical secondary structures.	[Chang, Kuan Y.; Yang, Je-Ruei] Natl Taiwan Ocean Univ, Dept Comp Sci & Engn, Keelung, Taiwan	National Taiwan Ocean University	Chang, KY (corresponding author), Natl Taiwan Ocean Univ, Dept Comp Sci & Engn, Keelung, Taiwan.	kchang@ntou.edu.tw	Chang, Kuan Y./AAB-3639-2020	Chang, Kuan Y./0000-0002-2262-5218	National Taiwan Ocean University; Center for Excellence for the Oceans at National Taiwan Ocean University	National Taiwan Ocean University; Center for Excellence for the Oceans at National Taiwan Ocean University	The work was supported by National Taiwan Ocean University. Je-Ruei Yang was partially supported by Center for Excellence for the Oceans at National Taiwan Ocean University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akkarawongsa R, 2009, ANTIMICROB AGENTS CH, V53, P987, DOI 10.1128/AAC.00793-08; Azzarito V, 2013, NAT CHEM, V5, P161, DOI [10.1038/nchem.1568, 10.1038/NCHEM.1568]; BABA M, 1987, BIOCHEM BIOPH RES CO, V142, P128, DOI 10.1016/0006-291X(87)90460-8; Bai FW, 2007, J VIROL, V81, P2047, DOI 10.1128/JVI.01840-06; Breiman L, 2001, MACH LEARN, V45, P5, DOI 10.1023/A:1010933404324; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Calle M Luz, 2011, Brief Bioinform, V12, P86, DOI 10.1093/bib/bbq011; Caruana R, 2008, EMPIRICAL EVALUATION; Castel G, 2011, MOLECULES, V16, P3499, DOI 10.3390/molecules16053499; Conchillo-Sole O, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-65; De Clercq E, 2011, ANNU REV PHARMACOL, V51, P1, DOI 10.1146/annurev-pharmtox-010510-100228; DECLERCO E, 1980, BRIT MED J, V281, P1178, DOI 10.1136/bmj.281.6249.1178; Drummond JE, 2008, J IMMUNOL METHODS, V334, P11, DOI 10.1016/j.jim.2008.01.017; Dwyer JJ, 2007, P NATL ACAD SCI USA, V104, P12772, DOI 10.1073/pnas.0701478104; Field H.J., 2004, MICROBIOLOGY TODAY, V31, P58, DOI [DOI 10.1016/J.AGEE.2005.08.0.10, 10.1016/j.agee.2005.08.0.10]; Fjell CD, 2012, NAT REV DRUG DISCOV, V11, P37, DOI 10.1038/nrd3591; Gasteiger E, 2005, PROTEOMICS PROTOCOLS, P571, DOI [10.1385/1-59259-890-0:571, DOI 10.1385/1-59259-890-0:571]; Gleenberg IO, 2005, J BIOL CHEM, V280, P21987, DOI 10.1074/jbc.M414679200; Gleenberg IO, 2007, J MOL BIOL, V369, P1230, DOI 10.1016/j.jmb.2007.03.073; GURUPRASAD K, 1990, PROTEIN ENG, V4, P155, DOI 10.1093/protein/4.2.155; HAMAMOTO Y, 1987, ANTIMICROB AGENTS CH, V31, P907, DOI 10.1128/AAC.31.6.907; Hancock REW, 2000, TRENDS MICROBIOL, V8, P402, DOI 10.1016/S0966-842X(00)01823-0; Ho TK, 1998, IEEE T PATTERN ANAL, V20, P832, DOI 10.1109/34.709601; IKAI A, 1980, J BIOCHEM-TOKYO, V88, P1895; Jones JC, 2011, ANTIMICROB AGENTS CH, V55, P1810, DOI 10.1128/AAC.01428-10; Kawashima S, 2000, NUCLEIC ACIDS RES, V28, P374, DOI 10.1093/nar/28.1.374; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; Lata S, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-S1-S19; LEWIS W, 1995, NAT MED, V1, P417, DOI 10.1038/nm0595-417; LIN TS, 1987, BIOCHEM PHARMACOL, V36, P2713; Louis JM, 1998, BIOCHEMISTRY-US, V37, P2105, DOI 10.1021/bi972059x; MITSUYA H, 1985, P NATL ACAD SCI USA, V82, P7096, DOI 10.1073/pnas.82.20.7096; Pang Wei, 2009, Antivir Chem Chemother, V20, P1, DOI 10.3851/IMP1369; Peng HC, 2005, IEEE T PATTERN ANAL, V27, P1226, DOI 10.1109/TPAMI.2005.159; Portal-Nunez Sergio, 2003, Antiviral Chemistry & Chemotherapy, V14, P225; Qureshi A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054908; RAUSCH DM, 1990, ANN NY ACAD SCI, V616, P125; Real E, 2004, J VIROL, V78, P7410, DOI 10.1128/JVI.78.14.7410-7417.2004; Rider TH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022572; SCHAEFFER HJ, 1978, NATURE, V272, P583, DOI 10.1038/272583a0; Thakur N, 2012, NUCLEIC ACIDS RES, V40, pW199, DOI 10.1093/nar/gks450; Thomas S, 2010, NUCLEIC ACIDS RES, V38, pD774, DOI 10.1093/nar/gkp1021; Torrent M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016968; Wainberg MA, 2009, ANTIVIR RES, V81, P1, DOI 10.1016/j.antiviral.2008.09.003; Wang P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018476; WILD C, 1993, AIDS RES HUM RETROV, V9, P1051, DOI 10.1089/aid.1993.9.1051; Wunderlich K, 2011, ANTIMICROB AGENTS CH, V55, P696, DOI 10.1128/AAC.01419-10; YOUNG SD, 1995, ANTIMICROB AGENTS CH, V39, P2602, DOI 10.1128/AAC.39.12.2602; Zhang Y, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-40	49	89	91	4	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2013	8	8							e70166	10.1371/journal.pone.0070166	http://dx.doi.org/10.1371/journal.pone.0070166			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	218XC	23940542	gold, Green Submitted, Green Published			2022-12-25	WOS:000324465000036
J	Dong, JX; Xie, X; He, YS; Beier, RC; Sun, YM; Xu, ZL; Wu, WJ; Shen, YD; Xiao, ZL; Lai, LN; Wang, H; Yang, JY				Dong, Jie-Xian; Xie, Xi; He, Yong-Sheng; Beier, Ross C.; Sun, Yuan-Ming; Xu, Zhen-Lin; Wu, Wei-Jian; Shen, Yu-Dong; Xiao, Zhi-Li; Lai, Li-Na; Wang, Hong; Yang, Jin-Yi			Surface Display and Bioactivity of Bombyx mori Acetylcholinesterase on Pichia pastoris	PLOS ONE			English	Article							EXPRESSION; PURIFICATION; ORGANOPHOSPHATE; INHIBITION; SILKWORM; CLONING; CELLS; GENE	A Pichia pastoris (P. pastoris) cell surface display system of Bombyx mori acetylcholinesterase (BmAChE) was constructed and its bioactivity was studied. The modified Bombyx mori acetylcholinesterase gene (bmace) was fused with the anchor protein (AG alpha 1) from Saccharomyces cerevisiae and transformed into P. pastoris strain GS115. The recombinant strain harboring the fusion gene bmace-AG alpha 1 was induced to display BmAChE on the P. pastoris cell surface. Fluorescence microscopy and flow cytometry assays revealed that the BmAChE was successfully displayed on the cell surface of P. pastoris GS115. The enzyme activity of the displayed BmAChE was detected by the Ellman method at 787.7 U/g (wet cell weight). In addition, bioactivity of the displayed BmAChE was verified by inhibition tests conducted with eserine, and with carbamate and organophosphorus pesticides. The displayed BmAChE had an IC50 of 4.17 x 10(-8) M and was highly sensitive to eserine and five carbamate pesticides, as well as seven organophosphorus pesticides. Results suggest that the displayed BmAChE had good bioactivity.	[Dong, Jie-Xian; Xie, Xi; He, Yong-Sheng; Sun, Yuan-Ming; Xu, Zhen-Lin; Wu, Wei-Jian; Shen, Yu-Dong; Xiao, Zhi-Li; Lai, Li-Na; Wang, Hong; Yang, Jin-Yi] South China Agr Univ, Guangdong Prov Key Lab Food Qual & Safety, Guangzhou, Guangdong, Peoples R China; [He, Yong-Sheng] Shenzhen Acad Metrol & Qual Inspect, Shenzhen, Guangdong, Peoples R China; [Beier, Ross C.] ARS, USDA, Southern Plains Agr Res Ctr, Food & Feed Safety Res Unit, College Stn, TX USA	South China Agricultural University; United States Department of Agriculture (USDA)	Wang, H (corresponding author), South China Agr Univ, Guangdong Prov Key Lab Food Qual & Safety, Guangzhou, Guangdong, Peoples R China.	gzwhongd@163.com; yjy361@163.com	Yang, Jun/B-2262-2010; Xu, Zhen-Lin/E-9193-2012	Yang, Jun/0000-0001-8126-1728; 	National Natural Science Foundation of China [31201361, 31271866]; National Science & Technology Pillar Program of China [2012BAD31B0302]; Science and Technology Plan Projects in Guangdong Province [2012A020100002, 2010A032000001-4]; Doctoral Innovation Program of Hopson Zhujiang Education Fund [H2011001]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Science & Technology Pillar Program of China; Science and Technology Plan Projects in Guangdong Province; Doctoral Innovation Program of Hopson Zhujiang Education Fund	This research was granted by the National Natural Science Foundation of China (31201361, 31271866), the National Science & Technology Pillar Program of China (2012BAD31B0302), Science and Technology Plan Projects in Guangdong Province (2012A020100002, 2010A032000001-4) and the Doctoral Innovation Program of Hopson Zhujiang Education Fund (H2011001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alcocer MJC, 2000, J AGR FOOD CHEM, V48, P2228, DOI 10.1021/jf990691m; Askar KA, 2011, APPL BIOCHEM BIOTECH, V165, P336, DOI 10.1007/s12010-011-9254-7; BOCQUENE G, 1990, MAR ENVIRON RES, V30, P75, DOI 10.1016/0141-1136(90)90012-D; Boder ET, 2005, BIOTECHNOL BIOENG, V92, P485, DOI 10.1002/bit.20616; Cajka T, 2005, J SEP SCI, V28, P1048, DOI 10.1002/jssc.200500050; COPPAGE DL, 1971, B ENVIRON CONTAM TOX, V6, P304, DOI 10.1007/BF01539994; Cregg JM, 1998, METH MOL B, V103, P27; DURAND G, 1992, J CHROMATOGR, V607, P319, DOI 10.1016/0021-9673(92)87091-L; ELLMAN GL, 1961, BIOCHEM PHARMACOL, V7, P88, DOI 10.1016/0006-2952(61)90145-9; Forget J, 2002, COMP BIOCHEM PHYS C, V132, P85, DOI 10.1016/S1532-0456(02)00050-9; Fujita Y, 2002, APPL ENVIRON MICROB, V68, P5136, DOI 10.1128/AEM.68.10.5136-5141.2002; He YongSheng, 2012, Scientia Agricultura Sinica, V45, P2189; Jo JH, 2011, BIOTECHNOL LETT, V33, P1113, DOI 10.1007/s10529-011-0536-5; Keane S, 1999, INSECT BIOCHEM MOLEC, V29, P1097, DOI 10.1016/S0965-1748(99)00088-0; Khodi S, 2012, J MICROBIOL BIOTECHN, V22, P234, DOI 10.4014/jmb.1104.04011; Kulthong K., 2009, The Thai Journal of Pharmaceutical Sciences, V33, P91; Lang GJ, 2010, PESTIC BIOCHEM PHYS, V98, P175, DOI 10.1016/j.pestbp.2010.06.003; LEGAY C, 1993, J NEUROCHEM, V60, P337, DOI 10.1111/j.1471-4159.1993.tb05856.x; Lei Y, 2006, ANAL CHIM ACTA, V568, P200, DOI 10.1016/j.aca.2005.11.065; Li B, 2010, AFR J BIOTECHNOL, V9, P1771; Li F, 2002, ARCH INSECT BIOCHEM, V51, P37, DOI 10.1002/arch.10048; Liu WS, 2010, APPL MICROBIOL BIOT, V88, P885, DOI 10.1007/s00253-010-2782-1; Mezcua M, 2006, J CHROMATOGR A, V1109, P222, DOI 10.1016/j.chroma.2006.01.024; RADIC Z, 1992, BIOCHEMISTRY-US, V31, P9760, DOI 10.1021/bi00155a032; Sato R, 2009, PROTEIN EXPRES PURIF, V64, P205, DOI 10.1016/j.pep.2008.12.003; Shang JY, 2007, INSECT SCI, V14, P443, DOI 10.1111/j.1744-7917.2007.00172.x; Shim JH, 2007, J AGR FOOD CHEM, V55, P4735, DOI 10.1021/jf070217d; Su GD, 2010, BIOTECHNOL LETT, V32, P1131, DOI 10.1007/s10529-010-0270-4; Su GD, 2010, APPL MICROBIOL BIOT, V86, P1493, DOI 10.1007/s00253-009-2382-0; Tan FR, 2011, BIOPROC BIOSYST ENG, V34, P305, DOI 10.1007/s00449-010-0472-0; Tanaka T, 2012, APPL MICROBIOL BIOT, V95, P577, DOI 10.1007/s00253-012-4175-0; Uccelletti D, 2002, BIOCHEM BIOPH RES CO, V298, P559, DOI 10.1016/S0006-291X(02)02513-5; Van Dyk JS, 2011, CHEMOSPHERE, V82, P291, DOI 10.1016/j.chemosphere.2010.10.033; Wang G-Z, 2005, HEBEI J IND SCI TECH, V22, P228; Wu S, 2010, INSECT BIOCHEM MOLEC, V40, P415, DOI 10.1016/j.ibmb.2010.04.001; Xu SC, 2007, BIOMOL ENG, V24, P253, DOI 10.1016/j.bioeng.2006.12.002; Zhu KL, 2006, VACCINE, V24, P6046, DOI 10.1016/j.vaccine.2006.05.043	37	12	13	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2013	8	8							e70451	10.1371/journal.pone.0070451	http://dx.doi.org/10.1371/journal.pone.0070451			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	218XC	23940577	Green Submitted, gold, Green Published			2022-12-25	WOS:000324465000071
J	Friedel, RH; Friedel, CC; Bonfert, T; Shi, RJ; Rad, R; Soriano, P				Friedel, Roland H.; Friedel, Caroline C.; Bonfert, Thomas; Shi, Ruijin; Rad, Roland; Soriano, Philippe			Clonal Expansion Analysis of Transposon Insertions by High-Throughput Sequencing Identifies Candidate Cancer Genes in a PiggyBac Mutagenesis Screen	PLOS ONE			English	Article							SLEEPING-BEAUTY; MUTATIONS; REINTEGRATION; DISCOVERY; NETWORKS; GROWTH; MICE	Somatic transposon mutagenesis in mice is an efficient strategy to investigate the genetic mechanisms of tumorigenesis. The identification of tumor driving transposon insertions traditionally requires the generation of large tumor cohorts to obtain information about common insertion sites. Tumor driving insertions are also characterized by their clonal expansion in tumor tissue, a phenomenon that is facilitated by the slow and evolving transformation process of transposon mutagenesis. We describe here an improved approach for the detection of tumor driving insertions that assesses the clonal expansion of insertions by quantifying the relative proportion of sequence reads obtained in individual tumors. To this end, we have developed a protocol for insertion site sequencing that utilizes acoustic shearing of tumor DNA and Illumina sequencing. We analyzed various solid tumors generated by PiggyBac mutagenesis and for each tumor >10(6) reads corresponding to >10(4) insertion sites were obtained. In each tumor, 9 to 25 insertions stood out by their enriched sequence read frequencies when compared to frequencies obtained from tail DNA controls. These enriched insertions are potential clonally expanded tumor driving insertions, and thus identify candidate cancer genes. The candidate cancer genes of our study comprised many established cancer genes, but also novel candidate genes such as Mastermind-like1 (Mamld1) and Diacylglycerolkinase delta (Dgkd). We show that clonal expansion analysis by high-throughput sequencing is a robust approach for the identification of candidate cancer genes in insertional mutagenesis screens on the level of individual tumors.	[Friedel, Roland H.] Icahn Sch Med Mt, Dept Neurosurg, Dept Dev & Regenerat Biol, Dept Neurosci, New York, NY USA; [Friedel, Caroline C.; Bonfert, Thomas] Univ Munich, Inst Informat, D-80539 Munich, Germany; [Shi, Ruijin] Icahn Sch Med Mt, Dept Neurol, Dept Pathol, New York, NY USA; [Rad, Roland] Wellcome Trust Sanger Inst, Hinxton, England; [Soriano, Philippe] Icahn Sch Med Mt Sinai, Dept Oncol Sci, Dept Dev & Regenerat Biol, Tisch Canc Inst, New York, NY USA	Icahn School of Medicine at Mount Sinai; University of Munich; Icahn School of Medicine at Mount Sinai; Wellcome Trust Sanger Institute; Icahn School of Medicine at Mount Sinai	Friedel, RH (corresponding author), Icahn Sch Med Mt, Dept Neurosurg, Dept Dev & Regenerat Biol, Dept Neurosci, New York, NY USA.	roland.friedel@mssm.edu	Soriano, Philippe M/E-5797-2015; Friedel, Caroline/AAG-5017-2019	Soriano, Philippe M/0000-0002-0427-926X; Friedel, Caroline/0000-0003-3569-4877; Friedel, Roland/0000-0002-7513-3604	National Institute of Child Health and Human Development [HD24875]; Tisch Cancer Institute, Mount Sinai School of Medicine; DFG [FR2938/1-1]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD024875] Funding Source: NIH RePORTER	National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Tisch Cancer Institute, Mount Sinai School of Medicine; DFG(German Research Foundation (DFG)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported by grant HD24875 from the National Institute of Child Health and Human Development to P. S., by development funds from the Tisch Cancer Institute, Mount Sinai School of Medicine, to R. F. and P. S., and by DFG grant FR2938/1-1 to C. F. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brett BT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024668; Collier LS, 2005, NATURE, V436, P272, DOI 10.1038/nature03681; Copeland NG, 2010, NAT REV CANCER, V10, P696, DOI 10.1038/nrc2916; Ding S, 2005, CELL, V122, P473, DOI 10.1016/j.cell.2005.07.013; Dupuy AJ, 2005, NATURE, V436, P221, DOI 10.1038/nature03691; Fukami M, 2008, J BIOL CHEM, V283, P5525, DOI 10.1074/jbc.M703289200; Futreal PA, 2004, NAT REV CANCER, V4, P177, DOI 10.1038/nrc1299; Griner EM, 2007, NAT REV CANCER, V7, P281, DOI 10.1038/nrc2110; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Kool J, 2009, NAT REV CANCER, V9, P389, DOI 10.1038/nrc2647; Koudijs MJ, 2011, GENOME RES, V21, P2181, DOI 10.1101/gr.112763.110; Landrette SF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026650; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Levine AJ, 1997, CELL, V88, P323, DOI 10.1016/S0092-8674(00)81871-1; Li MA, 2013, MOL CELL BIOL, V33, P1317, DOI 10.1128/MCB.00670-12; Liang Q, 2009, GENESIS, V47, P404, DOI 10.1002/dvg.20508; Mann KM, 2012, P NATL ACAD SCI USA, V109, P5934, DOI 10.1073/pnas.1202490109; March HN, 2011, NAT GENET, V43, P1202, DOI 10.1038/ng.990; NICOLSON GL, 1988, CANCER METAST REV, V7, P143, DOI 10.1007/BF00046483; Panelos J, 2009, CANCER BIOL THER, V8, P1986, DOI 10.4161/cbt.8.21.9921; Quail MA, 2009, CURR PROTOC HUM GENE, P12; Rad R, 2010, SCIENCE, V330, P1104, DOI 10.1126/science.1193004; Rohrbeck A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007315; Serrano M, 1996, CELL, V85, P27, DOI 10.1016/S0092-8674(00)81079-X; Starr TK, 2009, SCIENCE, V323, P1747, DOI 10.1126/science.1163040; Uren AG, 2009, NAT PROTOC, V4, P789, DOI 10.1038/nprot.2009.64; VOGELSTEIN B, 1993, TRENDS GENET, V9, P138, DOI 10.1016/0168-9525(93)90209-Z; Wang W, 2008, P NATL ACAD SCI USA, V105, P9290, DOI 10.1073/pnas.0801017105	29	10	11	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2013	8	8							e72338	10.1371/journal.pone.0072338	http://dx.doi.org/10.1371/journal.pone.0072338			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	218XC	23940809	Green Published, gold, Green Submitted			2022-12-25	WOS:000324465000246
J	Jemison, LA; Pendleton, GW; Fritz, LW; Hastings, KK; Maniscalco, JM; Trites, AW; Gelatt, TS				Jemison, Lauri A.; Pendleton, Grey W.; Fritz, Lowell W.; Hastings, Kelly K.; Maniscalco, John M.; Trites, Andrew W.; Gelatt, Tom S.			Inter-Population Movements of Steller Sea Lions in Alaska with Implications for Population Separation	PLOS ONE			English	Article							CONTROL-REGION SEQUENCES; EUMETOPIAS-JUBATUS; FORAGING BEHAVIOR; ADULT FEMALE; DISPERSAL; ABUNDANCE; SURVIVAL; DECLINE; PHYLOGEOGRAPHY	Genetic studies and differing population trends support the separation of Steller sea lions (Eumetopias jubatus) into a western distinct population segment (WDPS) and an eastern DPS (EDPS) with the dividing line between populations at 144 degrees W. Despite little exchange for thousands of years, the gap between the breeding ranges narrowed during the past 15-30 years with the formation of new rookeries near the DPS boundary. We analyzed >22,000 sightings of 4,172 sea lions branded as pups in each DPS from 2000-2010 to estimate probabilities of a sea lion born in one DPS being seen within the range of the other DPS (either 'West' or 'East'). Males from both populations regularly traveled across the DPS boundary; probabilities were highest at ages 2-5 and for males born in Prince William Sound and southern Southeast Alaska. The probability of WDPS females being in the East at age 5 was 0.067 but 0 for EDPS females which rarely traveled to the West. Prince William Sound-born females had high probabilities of being in the East during breeding and non-breeding seasons. We present strong evidence that WDPS females have permanently emigrated to the East, reproducing at two 'mixing zone' rookeries. We documented breeding bulls that traveled >6,500 km round trip from their natal rookery in southern Alaska to the northern Bering Sea and central Aleutian Islands and back within one year. WDPS animals began moving East in the 1990s, following steep population declines in the central Gulf of Alaska. Results of our study, and others documenting high survival and rapid population growth in northern Southeast Alaska suggest that conditions in this mixing zone region have been optimal for sea lions. It is unclear whether eastward movement across the DPS boundary is due to less-optimal conditions in the West or a reflection of favorable conditions in the East.	[Jemison, Lauri A.; Pendleton, Grey W.; Hastings, Kelly K.] Alaska Dept Fish & Game, Div Wildlife Conservat, Douglas, AK USA; [Fritz, Lowell W.; Gelatt, Tom S.] NOAA, Natl Marine Fisheries Serv, Natl Marine Mammal Lab, Seattle, WA 98115 USA; [Maniscalco, John M.] Alaska SeaLife Ctr, Dept Sci, Seward, AK USA; [Trites, Andrew W.] Univ British Columbia, Fisheries Ctr, Marine Mammal Res Unit, Vancouver, BC V5Z 1M9, Canada	Alaska Department of Fish & Game; National Oceanic Atmospheric Admin (NOAA) - USA; University of British Columbia	Jemison, LA (corresponding author), Alaska Dept Fish & Game, Div Wildlife Conservat, Douglas, AK USA.	lauri.jemison@alaska.gov	Trites, Andrew/K-5648-2012	Trites, Andrew/0000-0003-0342-5322	National Oceanic and Atmospheric Administration (NOAA) Fisheries Alaska Region [NA11NMF4390200, NA08NMF4390544, NA04NMF4390170, NA17FX1079]; Outer Continental Shelf Oil and Gas Revenues, Coastal Impact Assistance Program, United States Fish and Wildlife Service, United States Department of the Interior; National Marine Fisheries Service; NOAA Fisheries; North Pacific Universities Marine Mammal Research Consortium through the North Pacific Marine Science Foundation	National Oceanic and Atmospheric Administration (NOAA) Fisheries Alaska Region; Outer Continental Shelf Oil and Gas Revenues, Coastal Impact Assistance Program, United States Fish and Wildlife Service, United States Department of the Interior; National Marine Fisheries Service; NOAA Fisheries(National Oceanic Atmospheric Admin (NOAA) - USA); North Pacific Universities Marine Mammal Research Consortium through the North Pacific Marine Science Foundation	Funding for this study was provided to the Alaska Department of Fish and Game by the National Oceanic and Atmospheric Administration (NOAA) Fisheries Alaska Region under several grants from 2001-2012 (including NA11NMF4390200, NA08NMF4390544, NA04NMF4390170, NA17FX1079) and by the Outer Continental Shelf Oil and Gas Revenues, Coastal Impact Assistance Program, United States Fish and Wildlife Service, United States Department of the Interior. Funding was provided by the National Marine Fisheries Service through several grants to the Alaska SeaLife Center and to the North Pacific Universities Marine Mammal Research Consortium through the North Pacific Marine Science Foundation. Funding was provided to the National Marine Mammal Laboratory, Alaska Fisheries Science Center, by NOAA Fisheries. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atkinson S, 2008, MAMMAL REV, V38, P1, DOI 10.1111/j.1365-2907.2008.00128.x; Baker AR, 2005, J MAMMAL, V86, P1075, DOI 10.1644/04-MAMM-A-113R1.1; Bickham JW, 1996, J MAMMAL, V77, P95, DOI 10.2307/1382712; Bickham JW, 1998, BIOSPHERE CONSERVATI, V1, P107; BIGG MA, 1988, CAN FIELD NAT, V102, P307; Boyd IL, 1998, CAN J FISH AQUAT SCI, V55, P845, DOI 10.1139/cjfas-55-4-845; BRAHAM HW, 1980, J WILDLIFE MANAGE, V44, P25, DOI 10.2307/3808347; Burdin AM, 2009, MAR MAMMAL SCI, V25, P888, DOI 10.1111/j.1748-7692.2009.00294.x; Burkanov V N., 2005, MAR FISH REV, V67, P1; Burnham KP, 2002, MULTIMODEL INFERENCE; Calkins D.G., 1998, BIOSPH CONSERV NAT W, V1, P33, DOI DOI 10.20798/BI0SPHEREC0NS.1.1_; Calkins DG, 1999, MAR MAMMAL SCI, V15, P462, DOI 10.1111/j.1748-7692.1999.tb00813.x; Calkins DG, 1982, POPULATION ASSESSMEN; Cooch E., 2010, PROGRAM MARK GENTLE, V9th; Fritz LW, 2013, AERIAL SHIP IN PRESS; Gelatt T. S., 2007, P 4 GLAC BAY SCI S G, P145; Harlin-Cognato A, 2006, J EVOLUTION BIOL, V19, P955, DOI 10.1111/j.1420-9101.2005.01052.x; Hastings KK, 2011, ECOSPHERE, V2, DOI 10.1890/ES11-00215.1; Hastings KK, 2009, J WILDLIFE MANAGE, V73, P1040, DOI 10.2193/2007-208; Himes Boor GK, 2012, MAR MAMMAL SCI, V28, pE375, DOI 10.1111/j.1748-7692.2011.00541.x; Hines, 2017, OCCUPANCY ESTIMATION; Hoffman JI, 2006, MOL ECOL, V15, P2821, DOI 10.1111/j.1365-294X.2006.02991.x; Holmes EE, 2007, ECOL APPL, V17, P2214, DOI 10.1890/07-0508.1; Holmes EE, 2003, CONSERV BIOL, V17, P1794, DOI 10.1111/j.1523-1739.2003.00191.x; Kenyon K. W., 1961, Journal of Mammalogy, V43, P223; Kirkwood R, 2006, CAN J ZOOL, V84, P1781, DOI 10.1139/Z06-164; Kucey L, 2005, THESIS U BRIT COLUMB; Laake J., 2010, PROGRAM MARK GENTLE; Loughlin Thomas R., 1997, Society for Marine Mammalogy Special Publication, V3, P159; LOUGHLIN TR, 1992, MAR MAMMAL SCI, V8, P220, DOI 10.1111/j.1748-7692.1992.tb00406.x; LOUGHLIN TR, 1987, CAN J ZOOL, V65, P2079, DOI 10.1139/z87-318; LOUGHLIN TR, 1984, J WILDLIFE MANAGE, V48, P729, DOI 10.2307/3801420; Maniscalco JM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010076; Marcotte M, 2006, THESIS U BRIT COLUMB; MATE B R, 1975, Rapports et Proces-Verbaux des Reunions Conseil International pour l'Exploration de la Mer, V169, P455; Mathews EA, 2011, MAR MAMMAL SCI, V27, P852, DOI 10.1111/j.1748-7692.2010.00455.x; Merrick RL, 1997, CAN J ZOOL, V75, P776, DOI 10.1139/z97-099; MERRICK RL, 1987, FISH B-NOAA, V85, P351; Merrick RL, 1996, NMFSAFSX68 NOAA, P1; O'Corry-Crowe G, 2005, 114 FISHERY B, V105(1); Pendleton GW, 2006, CAN J ZOOL, V84, P1163, DOI 10.1139/Z06-103; Phillips CD, 2011, J MAMMAL, V92, P1091, DOI 10.1644/10-MAMM-A-305.1; Phillips Caleb D., 2009, Occasional Papers Museum of Texas Tech University, V283, P1; Pitcher KW, 2007, FISH B-NOAA, V105, P102; Raum-Suryan KL, 2004, MAR MAMMAL SCI, V20, P823, DOI 10.1111/j.1748-7692.2004.tb01195.x; Raum-Suryan KL, 2002, MAR MAMMAL SCI, V18, P746, DOI 10.1111/j.1748-7692.2002.tb01071.x; Rehberg MJ, 2009, MAR MAMMAL SCI, V25, P588, DOI 10.1111/j.1748-7692.2008.00278.x; Robertson BC, 2006, BIOL CONSERV, V127, P227, DOI 10.1016/j.biocon.2005.08.011; Scordino J., 2006, THESIS OREGON STATE; Sigler MF, 2004, CAN J FISH AQUAT SCI, V61, P1475, DOI 10.1139/F04-086; Trites Andrew W., 1996, Aquatic Mammals, V22, P153; Trites AW, 2007, FISH OCEANOGR, V16, P46, DOI 10.1111/j.1365-2419.2006.00408.x; White GC, 1999, BIRD STUDY, V46, P120, DOI 10.1080/00063659909477239; Williams B. K., 2002, ANAL MANAGEMENT ANIM; Wilson K, 2012, MAR MAMMAL SCI, V28, pE58, DOI 10.1111/j.1748-7692.2011.00485.x; Womble JN, 2009, J BIOGEOGR, V36, P439, DOI 10.1111/j.1365-2699.2007.01873.x; YORK AE, 1994, MAR MAMMAL SCI, V10, P38, DOI 10.1111/j.1748-7692.1994.tb00388.x	57	20	20	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2013	8	8							e70167	10.1371/journal.pone.0070167	http://dx.doi.org/10.1371/journal.pone.0070167			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	218XC	23940543	gold, Green Published, Green Submitted			2022-12-25	WOS:000324465000037
J	Komegae, EN; Grund, LZ; Lopes-Ferreira, M; Lima, C				Komegae, Evilin Naname; Grund, Lidiane Zito; Lopes-Ferreira, Monica; Lima, Carla			TLR2, TLR4 and the MyD88 Signaling Are Crucial For the In Vivo Generation and the Longevity of Long-Lived Antibody-Secreting Cells	PLOS ONE			English	Article							TOLL-LIKE RECEPTORS; MEMORY B-CELLS; NATTERERI FISH VENOM; PLASMA-CELLS; THALASSOPHRYNE-NATTERERI; TRANSCRIPTION FACTOR; B-1 CELLS; KININOGENASE ACTIVITY; ACQUIRED-IMMUNITY; GENE-EXPRESSION	This study was undertaken to gain better insights into the role of TLRs and MyD88 in the development and differentiation of memory B cells, especially of ASC, during the Th2 polarized memory response induced by Natterins. Our in vivo findings demonstrated that the anaphylactic IgG1 production is dependent on TLR2 and MyD88 signaling, and that TLR4 acts as adjuvant accelerating the synthesis of high affinity-IgE. Also, TLR4 (MyD88-independent) modulated the migration of innate-like B cells (B1a and B2) out of the peritoneal cavity, and the emigration from the spleen of B1b and B2 cells. TLR4 (MyD88-independent) modulated the emigration from the spleen of Bmem as well as ASC B220(pos). TLR2 triggered to the egress from the peritoneum of Bmem (MyD88-dependent) and ASC B220(pos) (MyD88-independent). We showed that TLR4 regulates the degree of expansion of Bmem in the peritoneum (MyD88-dependent) and in BM (MyD88-independent) as well as of ASC B220(neg) in the spleen (MyD88-independent). TLR2 regulated the intensity of the expansion of Bmem (MyD88-independent) and ASC B220(pos) (MyD88-dependent) in BM. Finally, TLR4 signals sustained the longevity of ASC B220(pos) (MyD88-independent) and ASC B220(neg) into the peritoneum (MyD88-dependent) and TLR2 MyD88-dependent signaling supported the persistence of B2 cells in BM, Bmem in the spleen and ASC B220(neg) in peritoneum and BM. Terminally differentiated ASC B220(neg) required the cooperation of both signals through TLR2/TLR4 via MyD88 for longevity in peritoneum, whereas Bmem required only TLR2/MyD88 to stay in spleen, and ASC B220(pos) rested in peritoneum dependent on TLR4 signaling. Our data sustain that earlier events on memory B cells differentiation induced in secondary immune response against Natterins, after secondary lymph organs influx and egress, may be the key to determining peripheral localization of innate-like B cells and memory B cells as ASC B220(pos) and ASC B220(neg)	[Lima, Carla] Univ Sao Paulo, Butantan Inst, Special Lab Appl Toxinol, Immunoregulat Unit, Sao Paulo, Brazil; Univ Sao Paulo, Dept Immunol, Sao Paulo, Brazil	Instituto Butantan; Universidade de Sao Paulo; Universidade de Sao Paulo	Lima, C (corresponding author), Univ Sao Paulo, Butantan Inst, Special Lab Appl Toxinol, Immunoregulat Unit, Sao Paulo, Brazil.	carla.lima@butantan.gov.br	Lima, Carla/B-6750-2019; Grund, Lidiane/AAJ-1844-2021; Instituto Butantan, Center of Toxins Immune Response and Cell Signaling CeTICS/J-5731-2015; komegae, Evilin/H-4791-2015	Lima, Carla/0000-0002-8161-966X; Grund, Lidiane/0000-0001-6587-0283; Lopes-Ferreira, Monica/0000-0003-0244-7482				Akira S, 2001, NAT IMMUNOL, V2, P675, DOI 10.1038/90609; Allen CDC, 2004, NAT IMMUNOL, V5, P943, DOI 10.1038/ni1100; Allen CDC, 2007, IMMUNITY, V27, P190, DOI 10.1016/j.immuni.2007.07.009; Alugupalli KR, 2003, J IMMUNOL, V170, P3819, DOI 10.4049/jimmunol.170.7.3819; Barton GM, 2009, NAT REV IMMUNOL, V9, P535, DOI 10.1038/nri2587; Baumgarth N, 2000, CURR TOP MICROBIOL, V252, P163; Bernasconi NL, 2003, BLOOD, V101, P4500, DOI 10.1182/blood-2002-11-3569; Browne EP, 2012, IMMUNOLOGY, V136, P370, DOI 10.1111/j.1365-2567.2012.03587.x; Calame K, 2006, IMMUNOL REV, V211, P269, DOI 10.1111/j.0105-2896.2006.00377.x; Cinamon G, 2004, NAT IMMUNOL, V5, P713, DOI 10.1038/ni1083; Foster SL, 2007, NATURE, V447, P972, DOI 10.1038/nature05836; Foussat A, 2001, EUR J IMMUNOL, V31, P350, DOI 10.1002/1521-4141(200102)31:2<350::AID-IMMU350>3.0.CO;2-0; Genestier L, 2007, J IMMUNOL, V178, P7779, DOI 10.4049/jimmunol.178.12.7779; Girkontaite I, 2004, J EXP MED, V200, P1491, DOI 10.1084/jem.20041483; Grund LZ, 2006, TOXICON, V48, P499, DOI 10.1016/j.toxicon.2006.06.014; Grund LZ, 2012, CYTOKINE, V59, P335, DOI 10.1016/j.cyto.2012.04.045; Gururajan M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000863; Ha SA, 2006, J EXP MED, V203, P2541, DOI 10.1084/jem.20061041; Haas KM, 2005, IMMUNITY, V23, P7, DOI 10.1016/j.immuni.2005.04.011; Hargreaves DC, 2001, J EXP MED, V194, P45, DOI 10.1084/jem.194.1.45; Hirschfeld M, 2001, INFECT IMMUN, V69, P1477, DOI 10.1128/IAI.69.3.1477-1482.2001; Hoyer BF, 2008, ANN RHEUM DIS, V67, P87, DOI 10.1136/ard.2008.098418; Hwang IY, 2009, J EXP MED, V206, P2641, DOI 10.1084/jem.20091982; JONES BW, 2001, ANN RHEUM DIS     S3, V60, P6; Kawai T, 2011, IMMUNITY, V34, P637, DOI 10.1016/j.immuni.2011.05.006; Klein U, 2006, NAT IMMUNOL, V7, P773, DOI 10.1038/ni1357; Kubo T, 2009, J EXP MED, V206, P1971, DOI 10.1084/jem.20082392; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Leadbetter EA, 2002, NATURE, V416, P603, DOI 10.1038/416603a; Liew FY, 2005, NAT REV IMMUNOL, V5, P446, DOI 10.1038/nri1630; Lin KI, 2002, MOL CELL BIOL, V22, P4771, DOI 10.1128/MCB.22.13.4771-4780.2002; Liu Z, 2011, EUR J IMMUNOL, V41, P588, DOI 10.1002/eji.201041354; Lopes-Ferreira M, 2004, BIOCHEM PHARMACOL, V68, P2151, DOI 10.1016/j.bcp.2004.07.037; Magalhaes GS, 2006, BIOCHIMIE, V88, P693, DOI 10.1016/j.biochi.2005.12.008; Magalhaes GS, 2005, BIOCHIMIE, V87, P687, DOI 10.1016/j.biochi.2005.03.016; Manicassamy S, 2009, SEMIN IMMUNOL, V21, P185, DOI 10.1016/j.smim.2009.05.005; Manz RA, 2005, ANNU REV IMMUNOL, V23, P367, DOI 10.1146/annurev.immunol.23.021704.115723; McHeyzer-Williams LJ, 2000, J EXP MED, V191, P1149, DOI 10.1084/jem.191.7.1149; Medzhitov R, 2002, SCIENCE, V296, P298, DOI 10.1126/science.1068883; MOTA I, 1969, LIFE SCI PT 1 PHYSI, V8, P813, DOI 10.1016/0024-3205(69)90099-X; MURAKAMI M, 1994, J EXP MED, V180, P111, DOI 10.1084/jem.180.1.111; Niu HF, 1998, GENE DEV, V12, P1953, DOI 10.1101/gad.12.13.1953; O'Connor BP, 2002, J EXP MED, V195, P737, DOI 10.1084/jem.20011626; O'Neill LAJ, 2002, TRENDS IMMUNOL, V23, P296, DOI 10.1016/S1471-4906(02)02222-6; OVARY Z, 1958, J IMMUNOL, V81, P355; Pasare C, 2005, NATURE, V438, P364, DOI 10.1038/nature04267; Rawlings DJ, 2012, NAT REV IMMUNOL, V12, P282, DOI 10.1038/nri3190; Reimold AM, 2001, NATURE, V412, P300, DOI 10.1038/35085509; Richard K, 2008, J IMMUNOL, V181, P1746, DOI 10.4049/jimmunol.181.3.1746; SANDERSON RD, 1989, CELL REGUL, V1, P27, DOI 10.1091/mbc.1.1.27; Schilling D, 2002, J IMMUNOL, V169, P5874, DOI 10.4049/jimmunol.169.10.5874; Shaffer AL, 2004, IMMUNITY, V21, P81, DOI 10.1016/j.immuni.2004.06.010; Shaffer AL, 2002, IMMUNITY, V17, P51, DOI 10.1016/S1074-7613(02)00335-7; Shapiro-Shelef M, 2005, NAT REV IMMUNOL, V5, P230, DOI 10.1038/nri1572; Shapiro-Shelef M, 2003, IMMUNITY, V19, P607, DOI 10.1016/S1074-7613(03)00267-X; Shi GX, 2002, J IMMUNOL, V169, P2507, DOI 10.4049/jimmunol.169.5.2507; Shi M, 2008, NAT IMMUNOL, V9, P369, DOI 10.1038/ni1577; Sokol CL, 2008, NAT IMMUNOL, V9, P310, DOI 10.1038/ni1558; Talay O, 2012, NAT IMMUNOL, V13, P396, DOI 10.1038/ni.2256; Tangye SG, 1998, J EXP MED, V188, P1691, DOI 10.1084/jem.188.9.1691; Tangye SG, 2009, EUR J IMMUNOL, V39, P2065, DOI 10.1002/eji.200939531; Thomassen E, 1999, CYTOKINE, V11, P389, DOI 10.1006/cyto.1998.0452; Tumang JR, 2005, J IMMUNOL, V174, P3173, DOI 10.4049/jimmunol.174.6.3173; Wald D, 2003, NAT IMMUNOL, V4, P920, DOI 10.1038/ni968; Yoshida T, 2010, IMMUNOL REV, V237, P117, DOI 10.1111/j.1600-065X.2010.00938.x	65	15	15	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2013	8	8							e71185	10.1371/journal.pone.0071185	http://dx.doi.org/10.1371/journal.pone.0071185			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	218XC	23940714	gold, Green Published, Green Submitted			2022-12-25	WOS:000324465000189
J	Li, W; Chen, LN; He, WM; Li, WG; Qu, XL; Liang, BH; Gao, QP; Feng, CC; Jia, X; Lv, YN; Zhang, SY; Li, X				Li, Wan; Chen, Lina; He, Weiming; Li, Weiguo; Qu, Xiaoli; Liang, Binhua; Gao, Qianping; Feng, Chenchen; Jia, Xu; Lv, Yana; Zhang, Siya; Li, Xia			Prioritizing Disease Candidate Proteins in Cardiomyopathy-Specific Protein-Protein Interaction Networks Based on "Guilt by Association" Analysis	PLOS ONE			English	Article							INFLAMMATORY DILATED CARDIOMYOPATHY; GENE PRIORITIZATION; HYPERTROPHIC CARDIOMYOPATHY; ENDOTHELIAL-CELLS; IDENTIFICATION; EXPRESSION; MUTATIONS; KINASE; HEART; CLASSIFICATION	The cardiomyopathies are a group of heart muscle diseases which can be inherited (familial). Identifying potential disease-related proteins is important to understand mechanisms of cardiomyopathies. Experimental identification of cardiomyophthies is costly and labour-intensive. In contrast, bioinformatics approach has a competitive advantage over experimental method. Based on "guilt by association" analysis, we prioritized candidate proteins involving in human cardiomyopathies. We first built weighted human cardiomyopathy-specific protein-protein interaction networks for three subtypes of cardiomyopathies using the known disease proteins from Online Mendelian Inheritance in Man as seeds. We then developed a method in prioritizing disease candidate proteins to rank candidate proteins in the network based on "guilt by association'' analysis. It was found that most candidate proteins with high scores shared disease-related pathways with disease seed proteins. These top ranked candidate proteins were related with the corresponding disease subtypes, and were potential disease-related proteins. Cross-validation and comparison with other methods indicated that our approach could be used for the identification of potentially novel disease proteins, which may provide insights into cardiomyopathy-related mechanisms in a more comprehensive and integrated way.	[Li, Wan; Chen, Lina; Li, Weiguo; Qu, Xiaoli; Feng, Chenchen; Jia, Xu; Lv, Yana; Zhang, Siya; Li, Xia] Harbin Med Univ, Coll Bioinformat Sci & Technol, Harbin, Heilongjiang Pr, Peoples R China; [He, Weiming] Harbin Inst Technol, Inst Optoelect, Harbin 150006, Heilongjiang Pr, Peoples R China; [Liang, Binhua] Publ Hlth Agcy Canada, Natl Microbiol Lab, Winnipeg, MB, Canada; [Gao, Qianping] Harbin Med Univ, Affiliated Hosp 1, Dept Cardiol, Harbin, Heilongjiang Pr, Peoples R China	Harbin Medical University; Harbin Institute of Technology; Public Health Agency of Canada; Harbin Medical University	Chen, LN (corresponding author), Harbin Med Univ, Coll Bioinformat Sci & Technol, Harbin, Heilongjiang Pr, Peoples R China.	chenlina@ems.hrbmu.edu.cn; lixia@hrbmu.edu.cn	Liang, Binhua/ABN-9806-2022; li, xia/HHZ-7468-2022	Li, Wan/0000-0002-9797-0315; Chen, Lina/0000-0002-4576-6814	National Natural Science Foundation of China [61272388]; National Natural Science Foundation of Heilongjiang [F201237]; Heilongjiang Ministry of Education [12511271]; Student Innovation Funds of Heilongjiang Province [2010-016HMU, 2012-011HLJ]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Natural Science Foundation of Heilongjiang; Heilongjiang Ministry of Education; Student Innovation Funds of Heilongjiang Province	This work was supported by the National Natural Science Foundation of China (Grant NO. 61272388), the National Natural Science Foundation of Heilongjiang (Grant NO. F201237), the Science & Technology Research Project of the Heilongjiang Ministry of Education (Grant No. 12511271) and the Student Innovation Funds of Heilongjiang Province (Grant No. 2010-016HMU and 2012-011HLJ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aerts S, 2006, NAT BIOTECHNOL, V24, P537, DOI 10.1038/nbt1203; Alcalai R, 2008, J CARDIOVASC ELECTR, V19, P104, DOI 10.1111/j.1540-8167.2007.00965.x; Arad M, 2005, NEW ENGL J MED, V352, P362, DOI 10.1056/NEJMoa033349; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Badorff C, 1999, NAT MED, V5, P320, DOI 10.1038/6543; Bos JM, 2009, J AM COLL CARDIOL, V54, P201, DOI 10.1016/j.jacc.2009.02.075; Carll AP, 2011, TOXICOL PATHOL, V39, P925, DOI 10.1177/0192623311416373; Cernuda-Morollon E, 2006, CIRC RES, V98, P757, DOI 10.1161/01.RES.0000210579.35304.d3; Chen CY, 2008, ARTERIOSCL THROM VAS, V28, P906, DOI 10.1161/ATVBAHA.108.163667; Chen J, 2009, NUCLEIC ACIDS RES, V37, pW305, DOI 10.1093/nar/gkp427; Chen J, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-73; Chen JX, 2006, PROCEEDINGS OF THE 2006 IEEE INTERNATIONAL CONFERENCE ON VEHICULAR ELECTRONICS AND SAFETY, P367; Chu MS, 2011, CARDIOVASC RES, V92, P409, DOI 10.1093/cvr/cvr247; Chu X, 2000, GENE, V256, P271, DOI 10.1016/S0378-1119(00)00327-9; Clarke NF, 2009, NEUROMUSCULAR DISORD, V19, P348, DOI 10.1016/j.nmd.2009.03.003; Dellefave L, 2010, CURR OPIN CARDIOL, V25, P198, DOI 10.1097/HCO.0b013e328337ba52; Delmar M, 2012, CURR OPIN CARDIOL, V27, P236, DOI 10.1097/HCO.0b013e328352220e; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Elliott P, 2008, EUR HEART J, V29, P270, DOI 10.1093/eurheartj/ehm342; Erten S, 2011, BIODATA MIN, V4, DOI 10.1186/1756-0381-4-19; Ewing RM, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100134; Feldman I, 2008, P NATL ACAD SCI USA, V105, P4323, DOI 10.1073/pnas.0701722105; Frohlich H, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-166; Furney SJ, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn482; Gazzerro E, 2011, Handb Clin Neurol, V101, P135, DOI 10.1016/B978-0-08-045031-5.00010-4; Gefen A, 2010, HUM MUTAT, V31, P229, DOI 10.1002/humu.21171; Glazier AM, 2002, SCIENCE, V298, P2345, DOI 10.1126/science.1076641; Goh KI, 2007, P NATL ACAD SCI USA, V104, P8685, DOI 10.1073/pnas.0701361104; Hammer E, 2011, J PROTEOME RES, V10, P2161, DOI 10.1021/pr1008042; Han JDJ, 2004, NATURE, V430, P88, DOI 10.1038/nature02555; Haugaa K.H., 2009, F1000 MED REP, V1; Herman DS, 2012, NEW ENGL J MED, V366, P619, DOI 10.1056/NEJMoa1110186; Hotarkova S, 2004, PATHOL RES PRACT, V200, P59, DOI 10.1016/j.prp.2004.01.003; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Hughes SE, 2005, HEART, V91, P257, DOI 10.1136/hrt.2004.040337; Janssen PML, 2010, AM J PHYSIOL-HEART C, V299, pH1092, DOI 10.1152/ajpheart.00417.2010; Jin B, 2011, TISSUE ANTIGENS, V77, P107, DOI 10.1111/j.1399-0039.2010.01589.x; Jin B, 2012, MOL BIOL REP, V39, P221, DOI 10.1007/s11033-011-0729-y; Kang MY, 2010, CIRC RES, V107, P903, DOI 10.1161/CIRCRESAHA.110.220772; Kato H, 2008, BIOCHEM BIOPH RES CO, V366, P885, DOI 10.1016/j.bbrc.2007.11.175; Kohler S, 2008, AM J HUM GENET, V82, P949, DOI 10.1016/j.ajhg.2008.02.013; Krishnamurthy P, 2007, HYPERTENSION, V49, P865, DOI 10.1161/01.HYP.0000258703.36986.13; Lahtinen AM, 2011, HEART RHYTHM, V8, P1214, DOI 10.1016/j.hrthm.2011.03.015; Lee I, 2011, GENOME RES, V21, P1109, DOI 10.1101/gr.118992.110; Lee TI, 2002, SCIENCE, V298, P799, DOI 10.1126/science.1075090; Lefeber DJ, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002427; Li YJ, 2010, BIOINFORMATICS, V26, P1219, DOI 10.1093/bioinformatics/btq108; Lin AE, 2011, AM J MED GENET A, V155A, P486, DOI 10.1002/ajmg.a.33857; Linghu B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-9-r91; Mahon NG, 2005, ANN INTERN MED, V143, P108, DOI 10.7326/0003-4819-143-2-200507190-00009; Maisch B, 2005, HERZ, V30, P535, DOI 10.1007/s00059-005-2730-5; Marmolino D, 2011, BRAIN RES REV, V67, P311, DOI 10.1016/j.brainresrev.2011.04.001; Maron BJ, 2002, JAMA-J AM MED ASSOC, V287, P1308, DOI 10.1001/jama.287.10.1308; Masuelli L, 2003, CARDIOVASC RES, V60, P376, DOI 10.1016/j.cardiores.2003.08.005; McKusick VA, 2007, AM J HUM GENET, V80, P588, DOI 10.1086/514346; Mearini G, 2010, CARDIOVASC RES, V85, P357, DOI 10.1093/cvr/cvp348; Nakajima H, 2003, JPN HEART J, V44, P833, DOI 10.1536/jhj.44.833; Nitsch D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005526; Oliver S, 2000, NATURE, V403, P601, DOI 10.1038/35001165; OrtizLopez R, 1997, CIRCULATION, V95, P2434, DOI 10.1161/01.CIR.95.10.2434; Oti M, 2007, CLIN GENET, V71, P1, DOI 10.1111/j.1399-0004.2006.00708.x; Pankuweit S, 2004, HERZ, V29, P788, DOI 10.1007/s00059-004-2626-9; Pashmforoush M, 2004, CELL, V117, P373, DOI 10.1016/S0092-8674(04)00405-2; Paul M, 2009, HERZ, V34, P98, DOI 10.1007/s00059-009-3215-8; Pendas AM, 2002, NAT GENET, V31, P94, DOI 10.1038/ng871; Piro RM, 2012, FEBS J, V279, P678, DOI 10.1111/j.1742-4658.2012.08471.x; Ravasz E, 2002, SCIENCE, V297, P1551, DOI 10.1126/science.1073374; Ren J, 2007, J MOL CELL CARDIOL, V42, P367, DOI 10.1016/j.yjmcc.2006.11.002; Rosales XQ, 2011, J CARDIOVASC MAGN R, V13, DOI 10.1186/1532-429X-13-39; Seal RL, 2011, NUCLEIC ACIDS RES, V39, pD514, DOI 10.1093/nar/gkq892; Sen-Chowdhry Srijita, 2010, Heart Fail Clin, V6, P179, DOI 10.1016/j.hfc.2009.11.005; Snel B, 2000, NUCLEIC ACIDS RES, V28, P3442, DOI 10.1093/nar/28.18.3442; Teixeira PC, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001205; Teraguchi M, 2003, EUR J PEDIATR, V162, P264, DOI 10.1007/s00431-002-1118-2; Tranchevent LC, 2008, NUCLEIC ACIDS RES, V36, pW377, DOI 10.1093/nar/gkn325; Traverso M, 2008, LAB INVEST, V88, P275, DOI 10.1038/labinvest.3700713; Vanunu O, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000641; von Mering C, 2005, NUCLEIC ACIDS RES, V33, pD433, DOI 10.1093/nar/gki005; Wang L, 2009, BMC GENOMICS, V10, DOI [10.1186/1471-2164-10-220, 10.1186/1471-2164-10-S1-S1]; Warde-Farley D, 2010, NUCLEIC ACIDS RES, V38, pW214, DOI 10.1093/nar/gkq537; Wu XB, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.27; Zhao HP, 2010, ACTA PHARMACOL SIN, V31, P281, DOI 10.1038/aps.2010.6	82	7	7	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2013	8	8							e71191	10.1371/journal.pone.0071191	http://dx.doi.org/10.1371/journal.pone.0071191			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	218XC	23940716	Green Published, gold, Green Submitted			2022-12-25	WOS:000324465000191
J	Sattler, S; Forlini, C; Racine, E; Sauer, C				Sattler, Sebastian; Forlini, Cynthia; Racine, Eric; Sauer, Carsten			Impact of Contextual Factors and Substance Characteristics on Perspectives toward Cognitive Enhancement	PLOS ONE			English	Article							NONMEDICAL USE; COLLEGE-STUDENTS; PRESCRIPTION STIMULANTS; HEALTHY-INDIVIDUALS; VIGNETTE WORLD; DRUGS; METHYLPHENIDATE; NEUROENHANCEMENT; ETHICS; RISK	Enhancing cognitive performance with substances-especially prescription drugs-is a fiercely debated topic among scholars and in the media. The empirical basis for these discussions is limited, given that the actual nature of factors that influence the acceptability of and willingness to use cognitive enhancement substances remains unclear. In an online factorial survey, contextual and substance-specific characteristics of substances that improve academic performance were varied experimentally and presented to respondents. Students in four German universities rated their willingness to use and moral acceptance of different substances for cognitive enhancement. We found that the overall willingness to use performance enhancing substances is low. Most respondents considered the use of these substances as morally unacceptable. Situational influences such as peer pressure, policies concerning substance use, relative performance level of peers, but also characteristics of the substance, such as perceptions of substance safety, shape the willingness and acceptability of using a substance to enhance academic performance. Among the findings is evidence of a contagion effect meaning that the willingness was higher when the respondents have more CE drug users in their social network. We also found deterrence effects from strong side effects of using the substance, as well as from policy regulations and sanctions. Regulations might activate social norms against usage and sanctions can be seen as costly to users. Moreover, enhancement substances seem to be most tempting to low performers to catch up with others compared to high performers. By identifying contextual factors and substance characteristics influencing the willingness and acceptability of cognitive enhancers, policy approaches could consider these insights to better manage the use of such substances.	[Sattler, Sebastian] Univ Bielefeld, Fac Sociol, D-33615 Bielefeld, Germany; [Forlini, Cynthia; Racine, Eric] Inst Rech Clin Montreal, Unite Rech Neuroeth, Montreal, PQ H2W 1R7, Canada; [Forlini, Cynthia; Racine, Eric] McGill Univ, Montreal, PQ, Canada; [Racine, Eric] Univ Montreal, Montreal, PQ, Canada; [Sauer, Carsten] Univ Bielefeld, Collaborat Res Ctr 882, D-33615 Bielefeld, Germany	University of Bielefeld; Institut de Recherche Clinique de Montreal (IRCM); Universite de Montreal; McGill University; Universite de Montreal; University of Bielefeld	Sattler, S (corresponding author), Univ Bielefeld, Fac Sociol, D-33615 Bielefeld, Germany.	sebastian.sattler@uni-bielefeld.de	Sattler, Sebastian/Y-3590-2018; Forlini, Cynthia/K-2864-2013	Sattler, Sebastian/0000-0002-6491-0754; Forlini, Cynthia/0000-0003-3809-8229; Sauer, Carsten/0000-0002-8090-6886	Federal Ministry of Education and Research (FMER) [01PH08024]; Bielefeld Graduate School in History and Sociology (BGHS); Bielefeld University [3521.01]; Fonds de recherche du Quebec-Sante; Deutsche Forschungsgemeinschaft	Federal Ministry of Education and Research (FMER); Bielefeld Graduate School in History and Sociology (BGHS); Bielefeld University; Fonds de recherche du Quebec-Sante(Fonds de la Recherche en Sante du Quebec); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This research was funded by the Federal Ministry of Education and Research (FMER; grant number: 01PH08024, headed by Sebastian Sattler and Martin Diewald; http://www.bmbf.de/en/index.php). Carsten Sauer gratefully acknowledges a grant from the Bielefeld Graduate School in History and Sociology (BGHS; http://www.uni-bielefeld.de/(en)/bghs/) and Sebastian Sattler a Rectorate Fellowship of the Bielefeld University (grant number: 3521.01; http://www.uni-bielefeld.de/(en)/nachwuchs/finanzierung_und_foerderung/promovierende/rektoratsstipendien.html). Doctoral award from the Fonds de recherche du Quebec-Sante (CF; http://www.frsq.gouv.qc.ca/en/index.shtml). The authors acknowledge the support for the publication fee by the Deutsche Forschungsgemeinschaft and the Open Access Publication Funds of Bielefeld University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALEXANDER CS, 1978, PUBLIC OPIN QUART, V42, P93, DOI 10.1086/268432; ALVES WM, 1978, AM J SOCIOL, V84, P541, DOI 10.1086/226826; Arria AM, 2008, PREV SCI, V9, P191, DOI 10.1007/s11121-008-0095-8; Banjo OC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014322; BECK L, 1991, J RES PERS, V25, P285, DOI 10.1016/0092-6566(91)90021-H; Beck M, 2001, KOLNER Z SOZIOL SOZ, V53, P283, DOI 10.1007/s11577-001-0040-3; Bennett T, 1986, REASONING CRIMINAL R, P83; Bergstrom LS, 2008, SCAND J PUBLIC HEALT, V36, P532, DOI 10.1177/1403494807087558; Bostrom N, 2009, SCI ENG ETHICS, V15, P311, DOI 10.1007/s11948-009-9142-5; Castaldi S, 2012, J ADDICT MED, V6, P112, DOI 10.1097/ADM.0b013e3182479584; Chatterjee A, 2006, J MED ETHICS, V32, P110, DOI 10.1136/jme.2005.013599; Choong P., 2002, INT J MANAGEMENT, V19, P3; Commission de l'ethique de la science et la technologie, 2009, POS STAT PSYCH DRUGS; Dietz P, 2013, PHARMACOTHERAPY, V33, P44, DOI 10.1002/phar.1166; DUITSMAN DM, 1995, HEALTH VAL, V19, P44; Eaton ML, 2007, NAT BIOTECHNOL, V25, P393, DOI 10.1038/nbt0407-393; FAIA MA, 1980, AM J SOCIOL, V85, P951, DOI 10.1086/227096; Farah MJ, 2011, ADDICTION, V106, P1190, DOI 10.1111/j.1360-0443.2011.03394.x; Farah MJ, 2004, NAT REV NEUROSCI, V5, P421, DOI 10.1038/nrn1390; FINCH J, 1987, SOCIOLOGY, V21, P105, DOI 10.1177/0038038587021001008; Forlini C, 2009, NEUROETHICS-NETH, V2, P163, DOI 10.1007/s12152-009-9043-y; Forlini C, 2009, BMC MED ETHICS, V10, DOI 10.1186/1472-6939-10-9; Franke AG, 2011, PHARMACOPSYCHIATRY, V44, P331, DOI 10.1055/s-0031-1286347; Franke AG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040047; Franke AndreasG., 2012, AJOB PRIMARY RES, V3, P48, DOI [DOI 10.1080/21507716.2011.608411, 10.1080/21507716.2011.608411]; Glannon W, 2008, NEUROETHICS-NETH, V1, P45, DOI 10.1007/s12152-008-9005-9; Goritz AS, 2006, INT J INTERNET SCI, V1, P58; Greely H, 2008, NATURE, V456, P702, DOI 10.1038/456702a; Hall W, 2004, EMBO REP, V5, P1105, DOI 10.1038/sj.embor.7400303; Harris J., 2007, ENHANCING EVOLUTION; Herman-Stahl MA, 2006, J ADOLESCENT HEALTH, V39, P374, DOI 10.1016/j.jadohealth.2006.01.006; Hilbe J., 2011, NEGATIVE BINOMIAL RE; Hotze TD, 2011, AM J BIOETHICS, V11, P3, DOI 10.1080/15265161.2011.534957; Husain M, 2011, TRENDS COGN SCI, V15, P28, DOI 10.1016/j.tics.2010.11.002; Jasso G, 2006, SOCIOL METHOD RES, V34, P334, DOI 10.1177/0049124105283121; Kroneberg C, 2010, CRIMINOLOGY, V48, P259, DOI 10.1111/j.1745-9125.2010.00187.x; Landry Gregory L, 2003, Curr Sports Med Rep, V2, P1; Larriviere D, 2009, NEUROLOGY, V73, P1406, DOI 10.1212/WNL.0b013e3181beecfe; Lipman Arthur G, 2004, J Pain Palliat Care Pharmacother, V18, P1, DOI 10.1300/J354v18n03_01; Lizzio A, 2002, STUD HIGH EDUC, V27, P27, DOI 10.1080/03075070120099359; Long S., 2001, REGRESSION MODELS CA; Lucke JC, 2010, BIOSOCIETIES, V5, P482, DOI 10.1057/biosoc.2010.31; Lucke Jayne C., 2011, AJOB NEUROSCIENCE, V2, P38, DOI [10.1080/21507740.2011.611122, DOI 10.1080/21507740.2011.611122]; Lynch G, 2011, PHARMACOL BIOCHEM BE, V99, P116, DOI 10.1016/j.pbb.2010.12.024; Mache S, 2012, WIEN MED WOCHENSCHR, V162, P262, DOI [10.1007/s10354-012-0115-y, 10.1007/s10354-012-0144-6]; Maher B, 2008, NATURE, V452, P674, DOI 10.1038/452674a; McCabe SE, 2005, ADDICTION, V100, P96, DOI 10.1111/j.1360-0443.2005.00944.x; Middendorff E., 2012, HOCHSCHUL INF SYST E, P11; Muller CP, 2011, BEHAV BRAIN SCI, V34, P328, DOI 10.1017/S0140525X1100135X; Nehlig A, 2010, J ALZHEIMERS DIS, V20, pS85, DOI 10.3233/JAD-2010-091315; Normann C, 2008, EUR ARCH PSY CLIN N, V258, P110, DOI 10.1007/s00406-008-5022-2; Novak SP, 2007, SUBST ABUSE TREAT PR, V2, DOI 10.1186/1747-597X-2-32; Ong AD, 2000, J APPL SOC PSYCHOL, V30, P1691, DOI 10.1111/j.1559-1816.2000.tb02462.x; Outram SM, 2012, NEUROETHICS-NETH, V5, P173, DOI 10.1007/s12152-011-9131-7; Outram SM, 2011, PUBLIC HEALTH ETH-UK, V4, P93, DOI 10.1093/phe/phr006; Outram SM, 2010, J MED ETHICS, V36, P198, DOI 10.1136/jme.2009.034421; Partridge BJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028416; Porter S.R., 2004, NEW DIRECT INSTITUTI, V2004, P63, DOI [DOI 10.1002/IR.101, 10.1002/ir.101]; Rabiner DL, 2009, J ATTEN DISORD, V13, P259, DOI 10.1177/1087054708320399; Racine E, 2009, J MED ETHICS, V35, P469, DOI 10.1136/jme.2009.030460; Racine E, 2010, NEUROETHICS-NETH, V3, P1, DOI 10.1007/s12152-008-9023-7; Racine Eric, 2010, BASIC BIOETHICS; Repantis D, 2010, PHARMACOL RES, V62, P187, DOI 10.1016/j.phrs.2010.04.002; Repantis D, 2010, PHARMACOL RES, V61, P473, DOI 10.1016/j.phrs.2010.02.009; Reyna VF, 2006, PSYCHOL SCI, P1, DOI 10.1111/j.1529-1006.2006.00026.x; Rosenfield D, 2011, CAN MED ASSOC J, V183, P1345, DOI 10.1503/cmaj.111149; ROSSI PH, 1980, AM J SOCIOL, V85, P954, DOI 10.1086/227097; Sabini J, 2005, ETHICS BEHAV, V15, P81, DOI 10.1207/s15327019eb1501_6; Sahakian B, 2007, NATURE, V450, P1157, DOI 10.1038/4501157a; Sattler S, 2013, SUBST USE MISUSE, V48, P220, DOI 10.3109/10826084.2012.751426; Schermer M, 2008, J MED ETHICS, V34, P85, DOI 10.1136/jme.2006.019646; Schlattmann P., 2008, POIESIS PRAXIS, V6, P139, DOI DOI 10.1007/S10202-008-0060-4; Sepkowitz KA, 2013, JAMA-J AM MED ASSOC, V309, P243, DOI 10.1001/jama.2012.173526; STAFFORD JE, 1966, J MARKETING RES, V3, P410, DOI 10.2307/3149860; Sutherland E.H., 1966, PRINCIPLES CRIMINOLO, V5th ed.; Tinsley JA, 1998, MAYO CLIN PROC, V73, P977, DOI 10.4065/73.10.977; Tittle CR, 2010, SOC SCI RES, V39, P1029, DOI 10.1016/j.ssresearch.2010.08.007; Tourangeau R, 2007, PSYCHOL BULL, V133, P859, DOI 10.1037/0033-2909.133.5.859; Trigwell K., 2002, ART DES COMMUN HIGH, V1, P69, DOI [DOI 10.1386/ADCH.1.2.69, 10.1386/adch.1.2.69]; Turk M P, 1997, US News World Rep, V123, P79; Tye KM, 2010, NAT NEUROSCI, V13, P475, DOI 10.1038/nn.2506; Valente Thomas W, 2004, Subst Use Misuse, V39, P1685, DOI 10.1081/JA-200033210; Volkow ND, 2009, JAMA-J AM MED ASSOC, V301, P1148, DOI 10.1001/jama.2009.351; Wallander L, 2009, SOC SCI RES, V38, P505, DOI 10.1016/j.ssresearch.2009.03.004; Wason K. D., 2002, AUSTRALASIAN MARKETI, V10, P41, DOI DOI 10.1016/S1441-3582(02)70157-2; Weyandt LL, 2009, J ATTEN DISORD, V13, P284, DOI 10.1177/1087054709342212; Wilens TE, 2008, J AM ACAD CHILD PSY, V47, P21, DOI 10.1097/chi.0b013e31815a56f1	87	30	32	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2013	8	8							e71452	10.1371/journal.pone.0071452	http://dx.doi.org/10.1371/journal.pone.0071452			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	218XC	23940757	gold, Green Published, Green Submitted			2022-12-25	WOS:000324465000213
J	Siddiqui, MA; Alhadlaq, HA; Ahmad, J; Al-Khedhairy, AA; Musarrat, J; Ahamed, M				Siddiqui, Maqsood A.; Alhadlaq, Hisham A.; Ahmad, Javed; Al-Khedhairy, Abdulaziz A.; Musarrat, Javed; Ahamed, Maqusood			Copper Oxide Nanoparticles Induced Mitochondria Mediated Apoptosis in Human Hepatocarcinoma Cells	PLOS ONE			English	Article							DNA-DAMAGE RESPONSE; OXIDATIVE STRESS; SILVER NANOPARTICLES; SILICA NANOPARTICLES; CUO NANOPARTICLES; TOXICITY; CYTOTOXICITY; PROTEIN; METAL; P53	Copper oxide nanoparticles (CuO NPs) are heavily utilized in semiconductor devices, gas sensor, batteries, solar energy converter, microelectronics and heat transfer fluids. It has been reported that liver is one of the target organs for nanoparticles after they gain entry into the body through any of the possible routes. Recent studies have shown cytotoxic response of CuO NPs in liver cells. However, the underlying mechanism of apoptosis in liver cells due to CuO NPs exposure is largely lacking. We explored the possible mechanisms of apoptosis induced by CuO NPs in human hepatocellular carcinoma HepG2 cells. Prepared CuO NPs were spherical in shape with a smooth surface and had an average diameter of 22 nm. CuO NPs (concentration range 2-50 mu g/ml) were found to induce cytotoxicity in HepG2 cells in dose-dependent manner, which was likely to be mediated through reactive oxygen species generation and oxidative stress. Tumor suppressor gene p53 and apoptotic gene caspase-3 were up-regulated due to CuO NPs exposure. Decrease in mitochondrial membrane potential with a concomitant increase in the gene expression of bax/bcl2 ratio suggested that mitochondria mediated pathway involved in CuO NPs induced apoptosis. This study has provided valuable insights into the possible mechanism of apoptosis caused by CuO NPs at in vitro level. Underlying mechanism(s) of apoptosis due to CuO NPs exposure should be further invested at in vivo level.	[Siddiqui, Maqsood A.; Ahmad, Javed; Al-Khedhairy, Abdulaziz A.] King Saud Univ, Coll Sci, Dept Zool, Riyadh 11451, Saudi Arabia; [Alhadlaq, Hisham A.; Ahamed, Maqusood] King Saud Univ, King Abdullah Inst Nanotechnol, Riyadh, Saudi Arabia; [Alhadlaq, Hisham A.] King Saud Univ, Coll Sci, Dept Phys & Astron, Riyadh 11451, Saudi Arabia; [Musarrat, Javed] Aligarh Muslim Univ, Fac Agr Sci, Dept Agr Microbiol, Aligarh, Uttar Pradesh, India	King Saud University; King Saud University; King Saud University; Aligarh Muslim University	Ahamed, M (corresponding author), King Saud Univ, King Abdullah Inst Nanotechnol, Riyadh, Saudi Arabia.	maqusood@gmail.com	Siddiqui, Maqsood A./I-1644-2013; Alhadlaq, Hisham A/A-7840-2011; Ahamed, Maqusood/R-8619-2017; Al-Khedhairy, Abdulaziz A A/F-8327-2011; Alhadlaq, Hisham/AFQ-4913-2022; Musarrat, Javed/N-4094-2019; Musarrat, Javed/I-1942-2013	Siddiqui, Maqsood A./0000-0002-2010-3088; Alhadlaq, Hisham A/0000-0002-3073-7025; Ahamed, Maqusood/0000-0001-6025-1950; Al-Khedhairy, Abdulaziz A A/0000-0002-1210-6262; Alhadlaq, Hisham/0000-0002-3073-7025; AHMAD, JAVED/0000-0001-6011-5238; Musarrat, Javed/0000-0001-5981-3813	King Abdulaziz City for Science and Technology (KACST) under the National Plan for Science and Technology (NPST) [10-NAN1201-02]	King Abdulaziz City for Science and Technology (KACST) under the National Plan for Science and Technology (NPST)	This work was supported by King Abdulaziz City for Science and Technology (KACST) under the National Plan for Science and Technology (NPST) (Grant No.: 10-NAN1201-02). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahamed M, 2011, NANOMED-NANOTECHNOL, V7, P904, DOI 10.1016/j.nano.2011.04.011; Ahamed M, 2011, TOXICOLOGY, V283, P101, DOI 10.1016/j.tox.2011.02.010; Ahamed M, 2010, BIOCHEM BIOPH RES CO, V396, P578, DOI 10.1016/j.bbrc.2010.04.156; Ahamed M, 2008, TOXICOL APPL PHARM, V233, P404, DOI 10.1016/j.taap.2008.09.015; Ahmad J, 2012, TOXICOL APPL PHARM, V259, P160, DOI 10.1016/j.taap.2011.12.020; Akhtar MJ, 2012, INT J NANOMED, V7, P845, DOI 10.2147/IJN.S29129; AshaRani PV, 2009, ACS NANO, V3, P279, DOI 10.1021/nn800596w; Ashkenazi A, 2002, NAT REV CANCER, V2, P420, DOI 10.1038/nrc821; Bai JL, 2005, REGUL TOXICOL PHARM, V43, P272, DOI 10.1016/j.yrtph.2005.09.002; Bai W, 2010, J NANOPART RES, V12, P1645, DOI 10.1007/s11051-009-9740-9; Benz CC, 2008, NAT REV CANCER, V8, P875, DOI 10.1038/nrc2522; Borenfreund E., 1985, J TISSUE CULTURE MET, V9, P7, DOI DOI 10.1007/BF01666038; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Chougule M, 2011, LUNG CANCER, V71, P271, DOI 10.1016/j.lungcan.2010.06.002; Dastjerdi R, 2010, COLLOID SURFACE B, V79, P5, DOI 10.1016/j.colsurfb.2010.03.029; Delgado K, 2011, LETT APPL MICROBIOL, V53, P50, DOI 10.1111/j.1472-765X.2011.03069.x; ELLMAN GL, 1959, ARCH BIOCHEM BIOPHYS, V82, P70, DOI 10.1016/0003-9861(59)90090-6; Fahmy B, 2009, TOXICOL IN VITRO, V23, P1365, DOI 10.1016/j.tiv.2009.08.005; Fuentes-Prior P, 2004, BIOCHEM J, V384, P201, DOI 10.1042/BJ20041142; Gao C, 2009, J HISTOCHEM CYTOCHEM, V57, P1139, DOI 10.1369/jhc.2009.954446; Gomes T, 2012, AQUAT TOXICOL, V118, P72, DOI 10.1016/j.aquatox.2012.03.017; Gopinath P, 2010, COLLOID SURFACE B, V77, P240, DOI 10.1016/j.colsurfb.2010.01.033; Janicke RU, 1998, J BIOL CHEM, V273, P9357, DOI 10.1074/jbc.273.16.9357; Jiang LC, 2010, BIOSENS BIOELECTRON, V25, P1402, DOI 10.1016/j.bios.2009.10.038; Jomova K, 2011, TOXICOLOGY, V283, P65, DOI 10.1016/j.tox.2011.03.001; Kannan, 2000, Pathophysiology, V7, P153, DOI 10.1016/S0928-4680(00)00053-5; Li TY, 2012, CELL, V149, P1269, DOI 10.1016/j.cell.2012.04.026; Liu YG, 2001, CARCINOGENESIS, V22, P851, DOI 10.1093/carcin/22.6.851; Mortimer M, 2010, TOXICOLOGY, V269, P182, DOI 10.1016/j.tox.2009.07.007; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Murdock RC, 2008, TOXICOL SCI, V101, P239, DOI 10.1093/toxsci/kfm240; Nel A, 2006, SCIENCE, V311, P622, DOI 10.1126/science.1114397; Ng KW, 2011, BIOMATERIALS, V32, P8218, DOI 10.1016/j.biomaterials.2011.07.036; Nishimori H, 2009, EUR J PHARM BIOPHARM, V72, P496, DOI 10.1016/j.ejpb.2009.02.005; OHKAWA H, 1979, ANAL BIOCHEM, V95, P351, DOI 10.1016/0003-2697(79)90738-3; Ott M, 2007, APOPTOSIS, V12, P913, DOI 10.1007/s10495-007-0756-2; Patterson AL, 1939, PHYS REV, V56, P978, DOI 10.1103/PhysRev.56.978; Perreault F, 2012, SCI TOTAL ENVIRON, V441, P117, DOI 10.1016/j.scitotenv.2012.09.065; Piret JP, 2012, NANOSCALE, V4, P7168, DOI 10.1039/c2nr31785k; Pradhan A, 2012, CHEMOSPHERE, V89, P1142, DOI 10.1016/j.chemosphere.2012.06.001; Reed JC, 2006, CELL DEATH DIFFER, V13, P1378, DOI 10.1038/sj.cdd.4401975; Sharma V, 2012, APOPTOSIS, V17, P852, DOI 10.1007/s10495-012-0705-6; Sharma V, 2009, TOXICOL LETT, V185, P211, DOI 10.1016/j.toxlet.2009.01.008; Siddiqui MA, 2010, TOXICOL IN VITRO, V24, P1592, DOI 10.1016/j.tiv.2010.06.008; Siddiqui MA, 2012, FOOD CHEM TOXICOL, V50, P641, DOI 10.1016/j.fct.2012.01.017; Song MJ, 2010, TALANTA, V80, P1648, DOI 10.1016/j.talanta.2009.09.061; Sun J, 2011, CELL BIOL TOXICOL, V27, P333, DOI 10.1007/s10565-011-9191-9; Wang H, 1999, FREE RADICAL BIO MED, V27, P612, DOI 10.1016/S0891-5849(99)00107-0; Wang YG, 2011, SCI TOTAL ENVIRON, V409, P4753, DOI 10.1016/j.scitotenv.2011.07.039; Wise JP, 2010, AQUAT TOXICOL, V97, P34, DOI 10.1016/j.aquatox.2009.11.016; Xia T, 2008, ACS NANO, V2, P2121, DOI 10.1021/nn800511k; Xie GP, 2010, ARCH TOXICOL, V84, P183, DOI 10.1007/s00204-009-0488-x; Xu J, 2012, ARCH TOXICOL, DOI [10.1007/s00204-012-0925-0, DOI 10.1007/S00204-012-0925-0)]; Youle RJ, 2008, NAT REV MOL CELL BIO, V9, P47, DOI 10.1038/nrm2308; Yu KO, 2009, J NANOPART RES, V11, P15, DOI 10.1007/s11051-008-9417-9; Zhang Y, 2011, CHEM-BIOL INTERACT, V189, P186, DOI 10.1016/j.cbi.2010.12.011; Zhao J, 2011, J HAZARD MATER, V197, P304, DOI 10.1016/j.jhazmat.2011.09.094	57	222	228	8	74	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2013	8	8							e69534	10.1371/journal.pone.0069534	http://dx.doi.org/10.1371/journal.pone.0069534			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	218XC	23940521	gold, Green Published, Green Submitted			2022-12-25	WOS:000324465000016
J	Tang, ZH; Liu, JM; Zeng, FF; Li, ZT; Yu, XL; Zhou, LN				Tang, Zi-Hui; Liu, Juanmei; Zeng, Fangfang; Li, Zhongtao; Yu, Xiaoling; Zhou, Linuo			Comparison of Prediction Model for Cardiovascular Autonomic Dysfunction Using Artificial Neural Network and Logistic Regression Analysis	PLOS ONE			English	Article							POPULATION	Background: This study aimed to develop the artificial neural network (ANN) and multivariable logistic regression (LR) analyses for prediction modeling of cardiovascular autonomic (CA) dysfunction in the general population, and compare the prediction models using the two approaches. Methods and Materials: We analyzed a previous dataset based on a Chinese population sample consisting of 2,092 individuals aged 30-80 years. The prediction models were derived from an exploratory set using ANN and LR analysis, and were tested in the validation set. Performances of these prediction models were then compared. Results: Univariate analysis indicated that 14 risk factors showed statistically significant association with the prevalence of CA dysfunction (P<0.05). The mean area under the receiver-operating curve was 0.758 (95% CI 0.724-0.793) for LR and 0.762 (95% CI 0.732-0.793) for ANN analysis, but noninferiority result was found (P<0.001). The similar results were found in comparisons of sensitivity, specificity, and predictive values in the prediction models between the LR and ANN analyses. Conclusion: The prediction models for CA dysfunction were developed using ANN and LR. ANN and LR are two effective tools for developing prediction models based on our dataset.	[Tang, Zi-Hui; Zeng, Fangfang; Li, Zhongtao; Yu, Xiaoling; Zhou, Linuo] Fudan Univ, Huashan Hosp, Dept Endocrinol & Metab, Shanghai 200433, Peoples R China; [Liu, Juanmei] Youzhou Vocat & Technol Collage, Dept Comp Sci, Yongzhou, Hunan, Peoples R China	Fudan University	Zhou, LN (corresponding author), Fudan Univ, Huashan Hosp, Dept Endocrinol & Metab, Shanghai 200433, Peoples R China.	dr.zhoulinuo@gmail.com	Tang, Zihui/P-2222-2016		China National Grant on Science and Technology [30570740]	China National Grant on Science and Technology	This study was supported by the grant from China National Grant on Science and Technology (grant number: 30570740). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ayer T, 2010, RADIOGRAPHICS, V30, P13, DOI 10.1148/rg.301095057; BAXT WG, 1991, ANN INTERN MED, V115, P843, DOI 10.7326/0003-4819-115-11-843; Chen ZY, 2012, J INT MED RES, V40, P184, DOI 10.1177/147323001204000119; Ding W, 2011, ACTA CARDIOL, V66, P465, DOI 10.1080/AC.66.4.2126595; Garruti G, 2012, EXP DIABETES RES, DOI 10.1155/2012/615835; Grundy SM, 2004, CIRCULATION, V109, P551, DOI 10.1161/01.CIR.0000112379.88385.67; Harrison RF, 2005, ANN EMERG MED, V46, P431, DOI 10.1016/j.annemergmed.2004.09.012; Hazari MA, 2012, NEUROSCIENCES, V17, P173; Hedlund E, 1996, MOL PHARMACOL, V50, P342; HOSMER DW, 1989, APPL LOGISTIC REGRES; Iodice V, 2011, J NEUROL SCI, V310, P133, DOI 10.1016/j.jns.2011.07.014; Levy PS, 2000, STAT METHODS MED RES, V9, P41, DOI 10.1191/096228000666554731; McGinn TG, 2000, JAMA-J AM MED ASSOC, V284, P79, DOI 10.1001/jama.284.1.79; Min KB, 2008, INT HEART J, V49, P175, DOI 10.1536/ihj.49.175; Ottenbacher KJ, 2004, ANN EPIDEMIOL, V14, P551, DOI 10.1016/j.annepidem.2003.10.005; Spallone V, 2011, DIABETES METAB RES R; Terrin N, 2003, J CLIN EPIDEMIOL, V56, P721, DOI 10.1016/S0895-4356(03)00120-3; Tuerlinckx D, 2009, PEDIATR INFECT DIS J, V28, P394, DOI 10.1097/INF.0b013e318191f035; Warner B, 1996, AM STAT, V50, P284, DOI 10.2307/2684922; Ziegler D, 2006, EXP CLIN ENDOCR DIAB, V114, P153, DOI 10.1055/s-2006-924083	20	25	25	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2013	8	8							e70571	10.1371/journal.pone.0070571	http://dx.doi.org/10.1371/journal.pone.0070571			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	218XC	23940593	Green Submitted, Green Published, gold			2022-12-25	WOS:000324465000087
J	Virto, C; Zarate, CA; Lopez-Ferber, M; Murillo, R; Caballero, P; Williams, T				Virto, Cristina; Zarate, Carlos A.; Lopez-Ferber, Miguel; Murillo, Rosa; Caballero, Primitivo; Williams, Trevor			Gender-Mediated Differences in Vertical Transmission of a Nucleopolyhedrovirus	PLOS ONE			English	Article							MAMESTRA-BRASSICAE; TRICHOPLUSIA-NI; BACULOVIRUS; INSECTS; VIRUS; MOTH; LEPIDOPTERA; INFECTION; HOST; REPRODUCTION	With the development of sensitive molecular techniques for detection of low levels of asymptomatic pathogens, it becoming clear that vertical transmission is a common feature of some insect pathogenic viruses, and likely to be essential to virus survival when opportunities for horizontal transmission are unfavorable. Vertical transmission of Spodoptera exigua multiple nucleopolyhedrovirus (SeMNPV) is common in natural populations of S. exigua. To assess whether gender affected transgenerational virus transmission, four mating group treatments were performed using healthy and sublethally infected insects: i) healthy males (H male) xhealthy females (H female); ii) infected males (I male) xhealthy females (H female); iii) healthy males (H male) xinfected females (I female) and iv) infected males (I male) xinfected females (I female). Experimental adults and their offspring were analyzed by qPCR to determine the prevalence of infection. Both males and females were able to transmit the infection to the next generation, although female-mediated transmission resulted in a higher prevalence of infected offspring. Male-mediated venereal transmission was half as efficient as maternally-mediated transmission. Egg surface decontamination studies indicated that the main route of transmission is likely transovarial rather than transovum. Both male and female offspring were infected by their parents in similar proportions. Incorporating vertically-transmitted genotypes into virus-based insecticides could provide moderate levels of transgenerational pest control, thereby extending the periods between bioinsecticide applications.	[Virto, Cristina; Zarate, Carlos A.; Murillo, Rosa; Caballero, Primitivo] CSIC Gobierno Navarra, Inst Agrobiotecnol, Mutilva Baja, Navarra, Spain; [Lopez-Ferber, Miguel] Ecole Mines Ales, Ales, France; [Virto, Cristina; Murillo, Rosa; Caballero, Primitivo] Univ Publ Navarra, Dept Prod Agr, Pamplona, Navarra, Spain; [Williams, Trevor] Inst Ecol AC, Xalapa, Veracruz, Mexico	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC-GN-UPNA - Instituto de Agrobiotecnologia (IDAB); IMT - Institut Mines-Telecom; IMT Mines Ales; Universidad Publica de Navarra; Instituto de Ecologia - Mexico	Williams, T (corresponding author), Inst Ecol AC, Xalapa, Veracruz, Mexico.	trevor.inecol@gmail.com	Williams, Trevor/F-1447-2011; Williams, Trevor/ABG-3961-2020; Caballero, Primitivo/D-5063-2009; Williams, Trevor/J-4239-2013; Murillo, Rosa/G-5506-2010; Lopez-Ferber, Miguel/F-5465-2012	Williams, Trevor/0000-0003-3414-3440; Caballero, Primitivo/0000-0003-0065-9625; Williams, Trevor/0000-0003-3414-3440; Murillo, Rosa/0000-0001-9535-0000; Lopez-Ferber, Miguel/0000-0002-3850-1703	Spanish Ministry for Science and Technology [AGL2011-30352-C02-01]; Universidad Publica de Navarra	Spanish Ministry for Science and Technology(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Universidad Publica de Navarra	This work was supported by the Spanish Ministry for Science and Technology, project AGL2011-30352-C02-01. CV received a predoctoral fellowship from the Universidad Publica de Navarra. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barreau C, 1997, AM J TROP MED HYG, V57, P126, DOI 10.4269/ajtmh.1997.57.126; Belda JE, 1994, THESIS U ALMERIA ALM; Burand JP, 2011, J INVERTEBR PATHOL, V108, P217, DOI 10.1016/j.jip.2011.08.005; Burden JP, 2003, ECOL LETT, V6, P524, DOI 10.1046/j.1461-0248.2003.00459.x; Burden JP, 2002, MOL ECOL, V11, P547, DOI 10.1046/j.0962-1083.2001.01439.x; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Cabodevilla O, 2011, APPL ENVIRON MICROB, V77, P2954, DOI 10.1128/AEM.02762-10; Cabodevilla O, 2011, BIOL CONTROL, V56, P184, DOI 10.1016/j.biocontrol.2010.10.007; Cory JS, 2003, ANNU REV ECOL EVOL S, V34, P239, DOI 10.1146/annurev.ecolsys.34.011802.132402; de Miranda JR, 2008, J INVERTEBR PATHOL, V98, P184, DOI 10.1016/j.jip.2008.02.004; Eberle KE, 2012, INTEGRATED PEST MANAGEMENT, P281, DOI 10.1079/9781845938086.0281; Hatem AE, 2011, BIOL CONTROL, V59, P192, DOI 10.1016/j.biocontrol.2011.07.004; Elvira S, 2010, J ECON ENTOMOL, V103, P577, DOI 10.1603/EC09325; Ferber ML, 1997, J INVERTEBR PATHOL, V70, P143, DOI 10.1006/jipa.1997.4683; FLEURIET A, 1988, EVOL BIOL, V23, P1; Fuxa JR, 2002, J INVERTEBR PATHOL, V79, P44, DOI 10.1016/S0022-2011(02)00003-4; Fuxa JR, 1999, J INVERTEBR PATHOL, V74, P149, DOI 10.1006/jipa.1999.4869; GOULSON D, 1995, BIOL CONTROL, V5, P361, DOI 10.1006/bcon.1995.1042; Hamm JJ, 1996, ANN ENTOMOL SOC AM, V89, P266, DOI 10.1093/aesa/89.2.266; Hitchman RB, 2011, METHODS, V55, P52, DOI 10.1016/j.ymeth.2011.06.011; HUGHES DS, 1993, VIROLOGY, V194, P608, DOI 10.1006/viro.1993.1300; Hughes DS, 1997, J GEN VIROL, V78, P1801, DOI 10.1099/0022-1317-78-7-1801; Khurad AM, 2004, J INVERTEBR PATHOL, V87, P8, DOI 10.1016/j.jip.2004.05.008; Knell RJ, 2004, BIOL REV, V79, P557, DOI 10.1017/S1464793103006365; Kukan B, 1999, J INVERTEBR PATHOL, V74, P103, DOI 10.1006/jipa.1999.4873; Lasa R, 2007, BIOCONTROL SCI TECHN, V17, P221, DOI 10.1080/09583150701211335; Longdon B, 2012, P ROY SOC B-BIOL SCI, V279, P3889, DOI 10.1098/rspb.2012.1208; Longdon B, 2011, GENETICS, V188, P141, DOI 10.1534/genetics.111.127696; Murillo R, 2011, J GEN VIROL, V92, P1061, DOI 10.1099/vir.0.028027-0; Myers JH, 2000, ENVIRON ENTOMOL, V29, P1268, DOI 10.1603/0046-225X-29.6.1268; THOMASORILLARD M, 1990, ENDOCYT CELL RES, V7, P97; Vilaplana L, 2008, OECOLOGIA, V155, P237, DOI 10.1007/s00442-007-0914-9; Vilaplana L, 2010, EVOL ECOL, V24, P147, DOI 10.1007/s10682-009-9296-2; ZELAZNY B, 1976, J INVERTEBR PATHOL, V27, P221, DOI 10.1016/0022-2011(76)90149-X	34	14	16	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2013	8	8							e70932	10.1371/journal.pone.0070932	http://dx.doi.org/10.1371/journal.pone.0070932			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	218XC	23940671	Green Published, Green Submitted, gold			2022-12-25	WOS:000324465000160
J	Wallrodt, I; Jelsbak, L; Thorndahl, L; Thomsen, LE; Lemire, S; Olsen, JE				Wallrodt, Inke; Jelsbak, Lotte; Thorndahl, Lotte; Thomsen, Line E.; Lemire, Sebastien; Olsen, John E.			The Putative Thiosulfate Sulfurtransferases PspE and GlpE Contribute to Virulence of Salmonella Typhimurium in the Mouse Model of Systemic Disease	PLOS ONE			English	Article							ENTERICA-SV. TYPHIMURIUM; ESCHERICHIA-COLI K-12; SHOCK-PROTEIN RESPONSE; IRON-SULFUR CLUSTER; NITRIC-OXIDE; GENE-EXPRESSION; ENZYMIC-SYNTHESIS; STRESS TOLERANCE; HOST-CELLS; IN-VIVO	The phage-shock protein PspE and GlpE of the glycerol 3-phosphate regulon of Salmonella enterica serovar Typhimurium are predicted to belong to the class of thiosulfate sulfurtransferases, enzymes that traffic sulfur between molecules. In the present study we demonstrated that the two genes contribute to S. Typhimurium virulence, as a glpE and pspE double deletion strain showed significantly decreased virulence in a mouse model of systemic infection. However, challenge of cultured epithelial cells and macrophages did not reveal any virulence-associated phenotypes. We hypothesized that their contribution to virulence could be in sulfur metabolism or by contributing to resistance to nitric oxide, oxidative stress, or cyanide detoxification. In vitro studies demonstrated that glpE but not pspE was important for resistance to H2O2. Since the double mutant, which was the one affected in virulence, was not affected in this assay, we concluded that resistance to oxidative stress and the virulence phenotype was most likely not linked. The two genes did not contribute to nitric oxid stress, to synthesis of essential sulfur containing amino acids, nor to detoxification of cyanide. Currently, the precise mechanism by which they contribute to virulence remains elusive.	[Wallrodt, Inke; Jelsbak, Lotte; Thorndahl, Lotte; Thomsen, Line E.; Olsen, John E.] Univ Copenhagen, Fac Hlth & Med Sci, Dept Vet Dis Biol, Copenhagen, Denmark; [Lemire, Sebastien] Tech Univ Denmark, Dept Syst Biol, DK-2800 Lyngby, Denmark	University of Copenhagen; Technical University of Denmark	Olsen, JE (corresponding author), Univ Copenhagen, Fac Hlth & Med Sci, Dept Vet Dis Biol, Copenhagen, Denmark.	jeo@sund.ku.dk	Olsen, John Elmerdahl/N-9271-2019	Jelsbak, Lotte/0000-0002-6642-7424; Thomsen, Line Elnif/0000-0001-5460-9178; Olsen, John Elmerdahl/0000-0001-6225-6587	Danish Research Council for Technology and Production [274-07-0328]	Danish Research Council for Technology and Production	This work was funded by the Danish Research Council for Technology and Production through grant no. 274-07-0328. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMOWICZ M, 1991, J BACTERIOL, V173, P229, DOI 10.1128/jb.173.1.229-233.1991; Adams H, 2002, FEBS LETT, V518, P173, DOI 10.1016/S0014-5793(02)02695-9; Bang IS, 2006, J BIOL CHEM, V281, P28039, DOI 10.1074/jbc.M605174200; Beuzon CR, 2002, MICROBIOL-SGM, V148, P2705, DOI 10.1099/00221287-148-9-2705; Beuzon CR, 2001, MICROBES INFECT, V3, P1345, DOI 10.1016/S1286-4579(01)01496-4; BONOMI F, 1977, EUR J BIOCHEM, V72, P17, DOI 10.1111/j.1432-1033.1977.tb11219.x; BONOMI F, 1985, EUR J BIOCHEM, V148, P67, DOI 10.1111/j.1432-1033.1985.tb08808.x; Bordo D, 2002, EMBO REP, V3, P741, DOI 10.1093/embo-reports/kvf150; BRISSETTE JL, 1991, J MOL BIOL, V220, P35, DOI 10.1016/0022-2836(91)90379-K; CHANG ACY, 1978, J BACTERIOL, V134, P1141, DOI 10.1128/JB.134.3.1141-1156.1978; Cheng Hui, 2008, Open Microbiol J, V2, P18, DOI 10.2174/1874285800802010018; Cherayil BJ, 2001, MICROBES INFECT, V3, P771, DOI 10.1016/S1286-4579(01)01428-9; Chng SS, 2012, MOL MICROBIOL, V85, P996, DOI 10.1111/j.1365-2958.2012.08157.x; CHOI YL, 1991, BIOCHIM BIOPHYS ACTA, V1088, P31, DOI 10.1016/0167-4781(91)90149-G; Cipollone R, 2007, IUBMB LIFE, V59, P51, DOI 10.1080/15216540701206859; Cipollone R, 2007, APPL ENVIRON MICROB, V73, P390, DOI 10.1128/AEM.02143-06; Darwin AJ, 2005, MOL MICROBIOL, V57, P621, DOI 10.1111/j.1365-2958.2005.04694.x; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Djaman O, 2004, J BIOL CHEM, V279, P44590, DOI 10.1074/jbc.M406487200; DONADIO S, 1990, J BACTERIOL, V172, P350, DOI 10.1128/JB.172.1.350-360.1990; Edwards RR, 1988, APPL MICROBIOL, V4, P46; ENOMOTO M, 1974, VIROLOGY, V60, P503, DOI 10.1016/0042-6822(74)90344-4; Eriksson S, 2003, MOL MICROBIOL, V47, P103, DOI 10.1046/j.1365-2958.2003.03313.x; Eriksson S, 2000, CELL MICROBIOL, V2, P239, DOI 10.1046/j.1462-5822.2000.00051.x; Fang FC, 1997, J CLIN INVEST, V99, P2818, DOI 10.1172/JCI119473; Finlay BB, 2000, PHILOS T ROY SOC B, V355, P623, DOI 10.1098/rstb.2000.0603; FOSTER JW, 1995, ANNU REV MICROBIOL, V49, P145, DOI 10.1146/annurev.micro.49.1.145; Frees D, 2003, MOL MICROBIOL, V48, P1565, DOI 10.1046/j.1365-2958.2003.03524.x; GALAN JE, 1989, P NATL ACAD SCI USA, V86, P6383, DOI 10.1073/pnas.86.16.6383; Haraga A, 2008, NAT REV MICROBIOL, V6, P53, DOI 10.1038/nrmicro1788; Hautefort I, 2008, CELL MICROBIOL, V10, P958, DOI 10.1111/j.1462-5822.2007.01099.x; Henard CA, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00084; Holzer SU, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033220; Huvet M, 2011, MOL BIOL EVOL, V28, P1141, DOI 10.1093/molbev/msq301; Hyduke DR, 2007, P NATL ACAD SCI USA, V104, P8484, DOI 10.1073/pnas.0610888104; Ibarra JA, 2009, CELL MICROBIOL, V11, P1579, DOI 10.1111/j.1462-5822.2009.01368.x; Jelsbak L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036149; Joly N, 2010, FEMS MICROBIOL REV, V34, P797, DOI 10.1111/j.1574-6976.2010.00240.x; Karlinsey JE, 2010, MOL MICROBIOL, V78, P669, DOI 10.1111/j.1365-2958.2010.07357.x; Kundinger MM, 2008, J RAPID METH AUT MIC, V16, P273, DOI 10.1111/j.1745-4581.2008.00133.x; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lloyd LJ, 2004, J BIOL CHEM, V279, P55707, DOI 10.1074/jbc.M408994200; Model P, 1997, MOL MICROBIOL, V24, P255, DOI 10.1046/j.1365-2958.1997.3481712.x; PAGANI S, 1983, BIOCHIM BIOPHYS ACTA, V742, P278, DOI 10.1016/0167-4838(83)90312-6; PAGANI S, 1984, EUR J BIOCHEM, V142, P361, DOI 10.1111/j.1432-1033.1984.tb08295.x; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Portillo FGD, 2001, MICROBES INFECT, V3, P1305, DOI 10.1016/S1286-4579(01)01491-5; Ray WK, 2000, J BACTERIOL, V182, P2277, DOI 10.1128/JB.182.8.2277-2284.2000; Rychlik I, 2005, FEMS MICROBIOL REV, V29, P1021, DOI 10.1016/j.femsre.2005.03.005; Thomsen LE, 2003, FEMS MICROBIOL LETT, V228, P225, DOI 10.1016/S0378-1097(03)00762-6; Troxell B, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-236; Velayudhan J, 2007, MOL MICROBIOL, V63, P1495, DOI 10.1111/j.1365-2958.2007.05600.x; VENNESLAND B, 1982, FED PROC, V41, P2639; WALLIS TS, 1995, INFECT IMMUN, V63, P2755, DOI 10.1128/IAI.63.7.2755-2761.1995; WATSON PR, 1995, INFECT IMMUN, V63, P2743, DOI 10.1128/IAI.63.7.2743-2754.1995; Westley J, 1981, Methods Enzymol, V77, P285; Yang B, 1998, BBA-GENE STRUCT EXPR, V1396, P114, DOI 10.1016/S0167-4781(97)00179-6; Zeng G, 1996, J BACTERIOL, V178, P7080, DOI 10.1128/jb.178.24.7080-7089.1996	58	15	15	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2013	8	8							e70829	10.1371/journal.pone.0070829	http://dx.doi.org/10.1371/journal.pone.0070829			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	218XC	23940650	gold, Green Published, Green Submitted			2022-12-25	WOS:000324465000141
J	Iwata, J; Suzuki, A; Pelikan, RC; Ho, TV; Chai, Y				Iwata, Jun-ichi; Suzuki, Akiko; Pelikan, Richard C.; Thach-Vu Ho; Chai, Yang			Noncanonical Transforming Growth Factor beta (TGF beta) Signaling in Cranial Neural Crest Cells Causes Tongue Muscle Developmental Defects	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEPARAN-SULFATE PROTEOGLYCANS; BONE MORPHOGENETIC PROTEINS; CRANIOFACIAL MUSCLES; MUTANT MICE; DIFFERENTIATION; FATE; TENDONS; BMP7; PROLIFERATION; MACHINERY	Microglossia is a congenital birth defect in humans and adversely impacts quality of life. In vertebrates, tongue muscle derives from the cranial mesoderm, whereas tendons and connective tissues in the craniofacial region originate from cranial neural crest (CNC) cells. Loss of transforming growth factor beta (TGF beta) type II receptor in CNC cells in mice (Tgfbr2(fl/fl); Wnt1-Cre) causes microglossia due to a failure of cell-cell communication between cranial mesoderm and CNC cells during tongue development. However, it is still unclear how TGF beta signaling in CNC cells regulates the fate of mesoderm-derived myoblasts during tongue development. Here we show that activation of the cytoplasmic and nuclear tyrosine kinase 1 (ABL1) cascade in Tgfbr2(fl/fl); Wnt1-Cre mice results in a failure of CNC-derived cell differentiation followed by a disruption of TGF beta-mediated induction of growth factors and reduction of myogenic cell proliferation and differentiation activities. Among the affected growth factors, the addition of fibroblast growth factor 4 (FGF4) and neutralizing antibody for follistatin (FST; an antagonist of bone morphogenetic protein (BMP)) could most efficiently restore cell proliferation, differentiation, and organization of muscle cells in the tongue of Tgfbr2(fl/fl); Wnt1-Cre mice. Thus, our data indicate that CNC-derived fibroblasts regulate the fate of mesoderm-derived myoblasts through TGF beta-mediated regulation of FGF and BMP signaling during tongue development.	[Iwata, Jun-ichi; Suzuki, Akiko; Pelikan, Richard C.; Thach-Vu Ho; Chai, Yang] Univ So Calif, Ostrow Sch Dent, Ctr Craniofacial Mol Biol, Los Angeles, CA 90033 USA	University of Southern California	Chai, Y (corresponding author), Univ So Calif, Ostrow Sch Dent, Ctr Craniofacial Mol Biol, 2250 Alcazar St CSA 103, Los Angeles, CA 90033 USA.	ychai@usc.edu			National Institutes of Health through the NIDCR [DE14078, DE020065, DE012711]; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE014078, R37DE012711, U01DE020065] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE012711] Funding Source: NIH RePORTER	National Institutes of Health through the NIDCR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported, in whole or in part, by National Institutes of Health Grants DE14078, DE020065, and DE012711 (to Y.C.) through the NIDCR.	Bishop JR, 2007, NATURE, V446, P1030, DOI 10.1038/nature05817; Chai Y, 2000, DEVELOPMENT, V127, P1671; Chai Y, 2006, DEV DYNAM, V235, P2353, DOI 10.1002/dvdy.20833; Daniels CE, 2004, J CLIN INVEST, V114, P1308, DOI 10.1175/JCI200419603; Derynck R, 2003, NATURE, V425, P577, DOI 10.1038/nature02006; Dudley AT, 1997, DEV DYNAM, V208, P349; Edom-Vovard F, 2004, DEV DYNAM, V229, P449, DOI 10.1002/dvdy.10481; Eloy-Trinquet S, 2009, DEV DYNAM, V238, P1195, DOI 10.1002/dvdy.21946; Emmanouil-Nikoloussi E N, 1992, Bull Group Int Rech Sci Stomatol Odontol, V35, P5; Floss T, 1997, GENE DEV, V11, P2040, DOI 10.1101/gad.11.16.2040; Grenier J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004381; Hacker U, 2005, NAT REV MOL CELL BIO, V6, P530, DOI 10.1038/nrm1681; HAHN GV, 1992, GENOMICS, V14, P759, DOI 10.1016/S0888-7543(05)80181-8; HEBERT JM, 1994, CELL, V78, P1017, DOI 10.1016/0092-8674(94)90276-3; Hosokawa R, 2010, DEV BIOL, V341, P186, DOI 10.1016/j.ydbio.2010.02.030; Iwata J, 2006, J BIOL CHEM, V281, P4035, DOI 10.1074/jbc.M512283200; Iwata J, 2011, ORAL DIS, V17, P733, DOI 10.1111/j.1601-0825.2011.01806.x; Iwata J, 2012, J CLIN INVEST, V122, P873, DOI 10.1172/JCI61498; Iwata J, 2012, J BIOL CHEM, V287, P2353, DOI 10.1074/jbc.M111.280974; Iwata J, 2010, J BIOL CHEM, V285, P4975, DOI 10.1074/jbc.M109.035105; Jones PL, 2000, MATRIX BIOL, V19, P581, DOI 10.1016/S0945-053X(00)00106-2; Kim RY, 2001, DEV BIOL, V235, P449, DOI 10.1006/dbio.2001.0284; KINGSLEY DM, 1992, CELL, V71, P399, DOI 10.1016/0092-8674(92)90510-J; Massague J, 2000, GENE DEV, V14, P627; McLennan IS, 2002, INT J DEV BIOL, V46, P559; Moustakas A, 2005, J CELL SCI, V118, P3573, DOI 10.1242/jcs.02554; Noden DM, 2006, DEV DYNAM, V235, P1194, DOI 10.1002/dvdy.20697; OLSON EN, 1986, J CELL BIOL, V103, P1799, DOI 10.1083/jcb.103.5.1799; Parada C, 2012, J DENT RES, V91, P528, DOI 10.1177/0022034511434055; Pounds S, 2004, BIOINFORMATICS, V20, P1737, DOI 10.1093/bioinformatics/bth160; Sambasivan R, 2011, DEVELOPMENT, V138, P2401, DOI 10.1242/dev.040972; Schneider MD, 2003, CYTOKINE GROWTH F R, V14, P1, DOI 10.1016/S1359-6101(02)00053-9; Schweitzer R, 2001, DEVELOPMENT, V128, P3855; Schweitzer R, 2010, DEVELOPMENT, V137, P2807, DOI 10.1242/dev.047498; Shimokawa K, 2011, DEV CELL, V21, P257, DOI 10.1016/j.devcel.2011.06.027; Smyth G.K., 2004, STAT APPL GENET MOL, V3, DOI DOI 10.2202/1544-6115.1027; Solloway MJ, 1999, DEVELOPMENT, V126, P1753; Sou Y, 2008, MOL BIOL CELL, V19, P4762, DOI 10.1091/mbc.E08-03-0309; Tirosh-Finkel L, 2010, DEVELOPMENT, V137, P2989, DOI 10.1242/dev.051649; TRAINOR PA, 1994, DEVELOPMENT, V120, P2397; Tsuchida K, 2006, EXPERT OPIN BIOL TH, V6, P147, DOI 10.1517/14712598.6.2.147; van Wijk B, 2007, CARDIOVASC RES, V74, P244, DOI 10.1016/j.cardiores.2006.11.022; Wang SN, 2005, FASEB J, V19, P1, DOI 10.1096/fj.04-2370com; Wang Y., 2009, COLD SPRING HARB PRO; Xia XQ, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-306; Xu X, 2008, DEV CELL, V15, P322, DOI 10.1016/j.devcel.2008.06.004; Yan D, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a002493	47	29	30	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 11	2013	288	41					29760	29770		10.1074/jbc.M113.493551	http://dx.doi.org/10.1074/jbc.M113.493551			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302OT	23950180	Green Published, hybrid			2022-12-25	WOS:000330615300051
J	Adams, NBP; Reid, JD				Adams, Nathan B. P.; Reid, James D.			The Allosteric Role of the AAA(+) Domain of ChlD Protein from the Magnesium Chelatase of Synechocystis Species PCC 6803	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						ATPases; Biosynthesis; Enzyme Catalysis; Mutagenesis Site-specific; Porphyrin	PROTOPORPHYRIN IX CHELATASE; ATPASE ACTIVITY; RHODOBACTER-SPHAEROIDES; ESCHERICHIA-COLI; BARLEY MUTANTS; MG-CHELATASE; SUBUNIT; PCC6803; HYDROLYSIS; COMPLEX	Magnesium chelatase is an AAA(+) ATPase that catalyzes the first step in chlorophyll biosynthesis, the energetically unfavorable insertion of a magnesium ion into a porphyrin ring. This enzyme contains two AAA(+) domains, one active in the ChlI protein and one inactive in the ChlD protein. Using a series of mutants in the AAA(+) domain of ChlD, we show that this site is essential for magnesium chelation and allosterically regulates Mg2+ and MgATP(2-) binding.	[Adams, Nathan B. P.; Reid, James D.] Univ Sheffield, Dept Chem, Sheffield S3 7HF, S Yorkshire, England	University of Sheffield	Reid, JD (corresponding author), Univ Sheffield, Dept Chem, Sheffield S3 7HF, S Yorkshire, England.	j.reid@sheffield.ac.uk		Reid, James/0000-0003-4921-1047; Adams, Nathan/0000-0003-3080-3448	Biotechnology and Biological Sciences Research Council (BBSRC) of the United Kingdom	Biotechnology and Biological Sciences Research Council (BBSRC) of the United Kingdom(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by the Biotechnology and Biological Sciences Research Council (BBSRC) of the United Kingdom.	Adams NBP, 2012, BIOCHEMISTRY-US, V51, P2029, DOI 10.1021/bi300149z; Axelsson E, 2006, PLANT CELL, V18, P3606, DOI 10.1105/tpc.106.042374; Babst M, 1998, EMBO J, V17, P2982, DOI 10.1093/emboj/17.11.2982; Dalal S, 2004, MOL BIOL CELL, V15, P637, DOI 10.1091/mbc.E03-02-0097; Dawson R. M. C., 1991, DATA BIOCH RES, V3rd, P363; Elmlund H, 2008, J MOL BIOL, V375, P934, DOI 10.1016/j.jmb.2007.11.028; Falk JE, 1964, PORPHYRINS METALLOPO, P236; Fodje MN, 2001, J MOL BIOL, V311, P111, DOI 10.1006/jmbi.2001.4834; GIBSON LCD, 1995, P NATL ACAD SCI USA, V92, P1941, DOI 10.1073/pnas.92.6.1941; Grafe S, 1999, P NATL ACAD SCI USA, V96, P1941, DOI 10.1073/pnas.96.5.1941; Hanson PI, 2005, NAT REV MOL CELL BIO, V6, P519, DOI 10.1038/nrm1684; Hansson A, 2002, P NATL ACAD SCI USA, V99, P13944, DOI 10.1073/pnas.212504499; Jensen PE, 1999, BIOCHEM J, V339, P127, DOI 10.1042/0264-6021:3390127; Jensen PE, 1998, BIOCHEM J, V334, P335, DOI 10.1042/bj3340335; Jensen PE, 1996, J BIOL CHEM, V271, P16662, DOI 10.1074/jbc.271.28.16662; Karger GA, 2001, BIOCHEMISTRY-US, V40, P9291, DOI 10.1021/bi010562a; Lundqvist J, 2010, STRUCTURE, V18, P354, DOI 10.1016/j.str.2010.01.001; Ogura T, 2004, J STRUCT BIOL, V146, P106, DOI 10.1016/j.jsb.2003.11.008; Reid JD, 2003, BIOCHEMISTRY-US, V42, P6912, DOI 10.1021/bi034082q; Reid JD, 2004, J BIOL CHEM, V279, P26893, DOI 10.1074/jbc.M400958200; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; Wendler P, 2012, BBA-MOL CELL RES, V1823, P2, DOI 10.1016/j.bbamcr.2011.06.014; Willows RD, 1996, EUR J BIOCHEM, V235, P438, DOI 10.1111/j.1432-1033.1996.00438.x	23	13	15	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 4	2013	288	40					28727	28732		10.1074/jbc.M113.477943	http://dx.doi.org/10.1074/jbc.M113.477943			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	298BL	23940041	Green Published, Green Accepted, hybrid			2022-12-25	WOS:000330298800026
J	Juan-Jorda, MJ; Mosqueira, I; Freire, J; Dulvy, NK				Jose Juan-Jorda, Maria; Mosqueira, Iago; Freire, Juan; Dulvy, Nicholas K.			The Conservation and Management of Tunas and Their Relatives: Setting Life History Research Priorities	PLOS ONE			English	Article							MACKEREL SCOMBER-JAPONICUS; SOUTHERN BLUEFIN TUNA; EXTINCTION RISK; INTRASPECIFIC VARIATION; REPRODUCTIVE-BIOLOGY; THUNNUS-ORIENTALIS; AGE-DETERMINATION; GROWTH; STRATEGIES; FISHERIES	Scombrids (tunas, bonitos, Spanish mackerels and mackerels) support important fisheries in tropical, subtropical and temperate waters around the world, being one of the most economically- and socially-important marine species globally. Their sustainable exploitation, management and conservation depend on accurate life history information for the development of quantitative fisheries stock assessments, and in the fishery data-poor situations for the identification of vulnerable species. Here, we assemble life history traits (maximum size, growth, longevity, maturity, fecundity, spawning duration and spawning interval) for the 51 species of scombrids globally. We identify major biological gaps in knowledge and prioritize life history research needs in scombrids based on their biological gaps in knowledge, the importance of their fisheries and their current conservation status according to the International Union for Conservation of Nature Red List. We find that the growth and reproductive biology of tunas and mackerel species have been more extensively studied than for Spanish mackerels and bonitos, although there are notable exceptions in all groups. We also reveal that reproductive biology of species, particular fecundity, is the least studied biological aspect in scombrids. We identify two priority groups, including 32 species of scombrids, and several populations of principal market tunas, for which life history research should be prioritized following the species-specific life history gaps identified in this study in the coming decades. By highlighting the important gaps in biological knowledge and providing a priority setting for life history research in scombrid species this study provides guidance for management and conservation and serves as a guide for biologists and resource managers interested in the biology, ecology, and management of scombrid species.	[Jose Juan-Jorda, Maria] Univ A Coruna, Fac Ciencias, Grp Recursos Marinos & Pesquerias, La Coruna, Spain; [Jose Juan-Jorda, Maria; Dulvy, Nicholas K.] Simon Fraser Univ, Dept Biol Sci, Earth Ocean Res Grp, Burnaby, BC V5A 1S6, Canada; [Jose Juan-Jorda, Maria] AZTI Tecnalia, Pasaia, Spain; [Mosqueira, Iago] Commiss European Communities, Joint Res Ctr, IPSC Maritime Affairs Unit, FISHREG, I-21020 Ispra, VA, Italy; [Freire, Juan] Barrabes Next, Madrid, Spain	Universidade da Coruna; Simon Fraser University; AZTI; European Commission Joint Research Centre; EC JRC ISPRA Site	Juan-Jorda, MJ (corresponding author), Univ A Coruna, Fac Ciencias, Grp Recursos Marinos & Pesquerias, La Coruna, Spain.	m.juan.jor@sfu.ca	Juan-Jordá, Maria José/B-4542-2019; Dulvy, Nicholas/I-2895-2012	Juan-Jordá, Maria José/0000-0002-4586-2400; Dulvy, Nicholas/0000-0002-4295-9725; Mosqueira, Iago/0000-0002-3252-0591; Freire, Juan/0000-0003-4323-4918	EU Marie Curie Early Stage Research Training project METAOCEANS [MEST-CT-2005-019678]; La Xunta de Galicia, Spain; Caja Madrid Foundation, Spain; Natural Environment Research Council of Canada	EU Marie Curie Early Stage Research Training project METAOCEANS; La Xunta de Galicia, Spain(Xunta de Galicia); Caja Madrid Foundation, Spain; Natural Environment Research Council of Canada	Maria Jose Juan Jorda was supported in part by EU Marie Curie Early Stage Research Training project METAOCEANS, MEST-CT-2005-019678, a Maria Barbeito Scholarship from La Xunta de Galicia, Spain, and a graduate scholarship from Caja Madrid Foundation, Spain. Nicholas K Dulvy was supported by the Natural Environment Research Council of Canada. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beverton R. J. H., 1963, Rapport Conseil Exploration Mer, V154, P44; Beverton R.J.H., 1959, CIBA FDN C AGEING, V5, P142, DOI DOI 10.1002/9780470715253.CH10; Blanck A, 2007, J BIOGEOGR, V34, P862, DOI 10.1111/j.1365-2699.2006.01654.x; Cailliet Gregor M., 2008, P103; Campana SE, 2001, J FISH BIOL, V59, P197, DOI 10.1006/jfbi.2001.1668; Chen H, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-35; Chen KS, 2010, J FISH BIOL, V77, P119, DOI 10.1111/j.1095-8649.2010.02662.x; Chen KS, 2006, FISHERIES SCI, V72, P985, DOI 10.1111/j.1444-2906.2006.01247.x; Collette BB, 2011, SCIENCE, V333, P291, DOI 10.1126/science.1208730; Collette BB, 1983, FAO FISH SYNOPOSIS, V125, P137; Collette Bruce B., 2001, Fish Physiology, V19, P1; Di Natale A, 2009, STUDIES REV GEN FISH, V35, P132; Dulvy NK, 2004, FISH FISH, V5, P255, DOI 10.1111/j.1467-2679.2004.00158.x; FAO, 2009, STAT WORLD FISH AQ 2; Farley J.H., 2012, POPULATION BIOL ALBA; Gillett R, 2001, PACIFIC STUDIES SERI; Gregoire F, 1993, BIOL CHARACTERISTICS; Gunn JS, 2008, FISH RES, V92, P207, DOI 10.1016/j.fishres.2008.01.018; Horikawa H., 2001, BIOL EC CHAR VAL FIS, P65; Hunter J.R., 1985, NOAA Technical Report NMFS, V36, P67; ICES, 2012, WORKSH EGG STAG FEC; ICES, 2011, WORK GROUP MACK HORS, P109; IUCN, 2010, GUID US IUCN RED LIS; Jennings S, 1999, CONSERV BIOL, V13, P1466, DOI 10.1046/j.1523-1739.1999.98324.x; JENNINGS S, 1991, ICES J MAR SCI, V48, P117, DOI 10.1093/icesjms/48.1.117; Juan-Jorda MJ, 2013, REV FISH BIOL FISHER, V23, P135, DOI 10.1007/s11160-012-9284-4; Juan-Jorda MJ, 2011, P NATL ACAD SCI USA, V108, P20650, DOI 10.1073/pnas.1107743108; Kalish JM, 1996, MAR ECOL PROG SER, V143, P1, DOI 10.3354/meps143001; King JR, 2003, FISHERIES MANAG ECOL, V10, P249, DOI 10.1046/j.1365-2400.2003.00359.x; Kohno H, 1994, JAPANESE J ICHTHYOLO, V31, P268; Majkowski J., 2007, FAO FISH TECH PAP, V483, P1; McIlwain JL, 2005, FISH RES, V73, P283, DOI 10.1016/j.fishres.2004.10.020; Munro JL, 1983, ICLARM FISHBYTE, V1, P5; Murua H., 2003, Journal of Northwest Atlantic Fishery Science, V33, P23, DOI 10.2960/J.v33.a2; Musick JA, 1999, FISHERIES, V24, P6, DOI 10.1577/1548-8446(1999)024<0006:CTDERI>2.0.CO;2; Ni IH, 1999, ZOOL STUD, V38, P130; Obata Y, 2008, REV FISH SCI, V16, P235, DOI 10.1080/10641260701697041; Pardo S, 2012, CRITICAL REV ANAL EX; PAULY D, 1981, MEERESFORSCHUNG, V28, P251; Pauly D, 2010, EXCELLENCE ECOLOGY; Pauly D, 1979, BERICHTE DTSCH WISSE, V28, P251; Pauly D, 1991, ICLARM, V4, P3; R Development Core Team, 2012, R LANG ENV STAT COMP; Reynolds JD, 2005, P ROY SOC B-BIOL SCI, V272, P2337, DOI 10.1098/rspb.2005.3281; Rochet MJ, 1998, ICES J MAR SCI, V55, P371, DOI 10.1006/jmsc.1997.0324; SCHAEFER K M, 1987, Inter-American Tropical Tuna Commission Bulletin, V19, P169; Schaefer Kurt M., 2001, Fish Physiology, V19, P225; Schaefer Kurt M., 1998, Inter-American Tropical Tuna Commission Bulletin, V21, P205; Shimose T, 2009, FISH RES, V100, P134, DOI 10.1016/j.fishres.2009.06.016; Shiraishi T, 2008, FISHERIES SCI, V74, P947, DOI 10.1111/j.1444-2906.2008.01612.x; TAYLOR C. C., 1958, JOUR CONS PERM INTERNATL EXPLOR MER, V23, P366; Watanabe C, 2006, FISH RES, V78, P323, DOI 10.1016/j.fishres.2006.01.001; Wegner NC, 2010, J MORPHOL, V271, P36, DOI 10.1002/jmor.10777; Winemiller KO, 2005, CAN J FISH AQUAT SCI, V62, P872, DOI 10.1139/F05-040; Xianshi J, 2008, BIOL ASSESSMENT ECOL; Zeller D, 2005, MAR POLICY, V29, P69, DOI 10.1016/j.marpol.2004.02.003	56	26	27	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2013	8	8							e70405	10.1371/journal.pone.0070405	http://dx.doi.org/10.1371/journal.pone.0070405			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	201ER	23950930	Green Published, Green Submitted, gold			2022-12-25	WOS:000323124000014
J	Sun, KP; Luo, L; Kimball, RT; Wei, XW; Jin, LR; Jiang, TL; Li, GH; Feng, J				Sun, Keping; Luo, Li; Kimball, Rebecca T.; Wei, Xuewen; Jin, Longru; Jiang, Tinglei; Li, Guohong; Feng, Jiang			Geographic Variation in the Acoustic Traits of Greater Horseshoe Bats: Testing the Importance of Drift and Ecological Selection in Evolutionary Processes	PLOS ONE			English	Article							ECHOLOCATION CALL FREQUENCY; WHITE-CROWNED SPARROWS; RHINOLOPHUS-FERRUMEQUINUM; BODY-SIZE; BIRD SONG; CHIROPTERA; DIVERGENCE; SEX; AGE; COMMUNICATION	Patterns of intraspecific geographic variation of signaling systems provide insight into the microevolutionary processes driving phenotypic divergence. The acoustic calls of bats are sensitive to diverse evolutionary forces, but processes that shape call variation are largely unexplored. In China, Rhinolophus ferrumequinum displays a diverse call frequency and inhabits a heterogeneous landscape, presenting an excellent opportunity for this kind of research. We quantified geographic variation in resting frequency (RF) of echolocation calls, estimated genetic structure and phylogeny of R. ferrumequinum populations, and combined this with climatic factors to test three hypotheses to explain acoustic variation: genetic drift, cultural drift, and local adaptation. Our results demonstrated significant regional divergence in frequency and phylogeny among the bat populations in China's northeast (NE), central-east (CE) and southwest (SW) regions. The CE region had higher frequencies than the NE and SW regions. Drivers of RF divergence were estimated in the entire range and just the CE/NE region (since these two regions form a clade). In both cases, RF divergence was not correlated with mtDNA or nDNA genetic distance, but was significantly correlated with geographic distance and mean annual temperature, indicating cultural drift and ecological selection pressures are likely important in shaping RF divergence among different regions in China.	[Sun, Keping; Luo, Li; Wei, Xuewen; Jin, Longru; Jiang, Tinglei; Li, Guohong; Feng, Jiang] NE Normal Univ, Jilin Key Lab Anim Resource Conservat & Utilizat, Changchun, Peoples R China; [Sun, Keping; Feng, Jiang] NE Normal Univ, Key Lab Wetland Ecol & Vegetat Restorat Natl Envi, Changchun, Peoples R China; [Sun, Keping; Kimball, Rebecca T.] Univ Florida, Dept Biol, Gainesville, FL USA; [Li, Guohong] Guizhou Normal Univ, Sch Life Sci, Guiyang, Peoples R China	Northeast Normal University - China; Northeast Normal University - China; State University System of Florida; University of Florida; Guizhou Normal University	Feng, J (corresponding author), NE Normal Univ, Jilin Key Lab Anim Resource Conservat & Utilizat, Changchun, Peoples R China.	fengj@nenu.edu.cn	Jiang, Tinglei/GQQ-9485-2022; Kimball, Rebecca T/C-2290-2009; Kimball, Rebecca/Q-6862-2019	Kimball, Rebecca/0000-0001-5449-5481	National Natural Science Foundation of China [30900132, 31030011, 91131003, 31270414, 31100305]; Program of Introducing Talents to Universities [B07017]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program of Introducing Talents to Universities	This research was financed by the National Natural Science Foundation of China (Grant Nos. 30900132, 31030011, 91131003, 31270414 and 31100305), and Program of Introducing Talents to Universities (B07017). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2002, PAUP 4 0 PHYLOGENETI; Armstrong KN, 2007, J MAMMAL, V88, P94, DOI 10.1644/06-MAMM-A-115R1.1; Armstrong KN, 2011, J THEOR BIOL, V278, P44, DOI 10.1016/j.jtbi.2011.02.026; Boughman J, 2003, ACOUSTIC COMMUNICATI, P138; Campbell P, 2010, EVOLUTION, V64, P1955, DOI 10.1111/j.1558-5646.2010.00962.x; Chen SF, 2009, P ROY SOC B-BIOL SCI, V276, P3901, DOI 10.1098/rspb.2009.1185; Csorba G., 2003, HORSESHOE BATS WORLD; Dawson DA, 2004, MOL ECOL NOTES, V4, P96, DOI 10.1046/j.1471-8286.2003.00580.x; Deecke VB, 2000, ANIM BEHAV, V60, P629, DOI 10.1006/anbe.2000.1454; Delarue J, 2009, J ACOUST SOC AM, V125, P1774, DOI 10.1121/1.3068454; Dingle C, 2008, J EVOLUTION BIOL, V21, P1079, DOI 10.1111/j.1420-9101.2008.01536.x; EXCOFFIER L, 1994, GENETICS, V136, P343; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Fenton MB, 2003, MAMMAL REV, V33, P193, DOI 10.1046/j.1365-2907.2003.00019.x; Flanders J, 2011, J BIOGEOGR, V38, P439, DOI 10.1111/j.1365-2699.2010.02411.x; Flanders J, 2009, MOL ECOL, V18, P306, DOI 10.1111/j.1365-294X.2008.04021.x; Funk WC, 2009, J EVOLUTION BIOL, V22, P1839, DOI 10.1111/j.1420-9101.2009.01795.x; Gascuel O, 1997, MOL BIOL EVOL, V14, P685, DOI 10.1093/oxfordjournals.molbev.a025808; Gonzalez C, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-38; Grant BR, 1996, EVOLUTION, V50, P2471, DOI 10.1111/j.1558-5646.1996.tb03633.x; Guillen A, 2000, J EVOLUTION BIOL, V13, P70; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Hoffman EA, 2006, MOL ECOL, V15, P2627, DOI 10.1111/j.1365-294X.2006.02934.x; Hubisz MJ, 2009, MOL ECOL RESOUR, V9, P1322, DOI 10.1111/j.1755-0998.2009.02591.x; Irwin DE, 2008, J EVOLUTION BIOL, V21, P435, DOI 10.1111/j.1420-9101.2007.01499.x; Jiang TL, 2010, J ACOUST SOC AM, V128, P2204, DOI 10.1121/1.3478855; Jiang TL, 2010, ETHOLOGY, V116, P691, DOI 10.1111/j.1439-0310.2010.01785.x; JONES G, 1993, P ROY SOC B-BIOL SCI, V252, P125, DOI 10.1098/rspb.1993.0055; JONES G, 1992, MAMMALIA, V56, P189; Kemp MU, 2012, METHODS ECOL EVOL, V3, P65, DOI 10.1111/j.2041-210X.2011.00138.x; Kingston T, 2004, NATURE, V429, P654, DOI 10.1038/nature02487; Langella O., 2007, POPULATIONS 1 2 30 P; Lynch Alejandro, 1996, P181; Ma J, 2006, J COMP PHYSIOL A, V192, P535, DOI 10.1007/s00359-006-0094-9; MacDougall-Shackleton EA, 2001, EVOLUTION, V55, P2568, DOI 10.1111/j.0014-3820.2001.tb00769.x; MORTON ES, 1975, AM NAT, V109, P17, DOI 10.1086/282971; Nelson DA, 2004, ANIM BEHAV, V68, P395, DOI 10.1016/j.anbehav.2003.08.027; Nicholls JA, 2008, BEHAV ECOL SOCIOBIOL, V62, P831, DOI 10.1007/s00265-007-0509-9; Odendaal LJ, 2011, J COMP PHYSIOL A, V197, P435, DOI 10.1007/s00359-010-0601-x; Ohmer ME, 2009, BIOL J LINN SOC, V97, P298, DOI 10.1111/j.1095-8312.2009.01210.x; Pfennig DW, 2010, TRENDS ECOL EVOL, V25, P459, DOI 10.1016/j.tree.2010.05.006; Posada D, 2006, NUCLEIC ACIDS RES, V34, pW700, DOI 10.1093/nar/gkl042; Prohl H, 2006, EVOLUTION, V60, P1669; Puechmaille SJ, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1582; Rendell L, 2001, BEHAV BRAIN SCI, V24, P309, DOI 10.1017/S0140525X0100396X; Rom DM, 2013, BRIT J MATH STAT PSY, V66, P189, DOI 10.1111/j.2044-8317.2012.02042.x; Rosenberg MS, 2011, METHODS ECOL EVOL, V2, P229, DOI 10.1111/j.2041-210X.2010.00081.x; Rosenberg NA, 2004, MOL ECOL NOTES, V4, P137, DOI 10.1046/j.1471-8286.2003.00566.x; Russo D, 2001, MAMMALIA, V65, P429, DOI 10.1515/mamm.2001.65.4.429; Russo D, 2007, J BIOGEOGR, V34, P2129, DOI 10.1111/j.1365-2699.2007.01762.x; RYAN MJ, 1985, AM NAT, V126, P87, DOI 10.1086/284398; SCHULLER G, 1979, J COMP PHYSIOL, V132, P47, DOI 10.1007/BF00617731; Siemers BM, 2005, ACTA CHIROPTEROL, V7, P259, DOI 10.3161/1733-5329(2005)7[259:ISISAO]2.0.CO;2; Simmons LW, 2001, EVOLUTION, V55, P1386, DOI 10.1111/j.0014-3820.2001.tb00660.x; Slabbekoorn H, 2002, PHILOS T R SOC B, V357, P493, DOI 10.1098/rstb.2001.1056; Smith Andrew T., 2008, P1; Snell-Rood EC, 2012, J ACOUST SOC AM, V131, P1650, DOI 10.1121/1.3672695; Stoffberg S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031946; TAMURA K, 1993, MOL BIOL EVOL, V10, P512, DOI 10.1093/oxfordjournals.molbev.a040023; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Tyack PL, 2008, J COMP PSYCHOL, V122, P319, DOI 10.1037/a0013087; Van Oosterhout C, 2004, MOL ECOL NOTES, V4, P535, DOI 10.1111/j.1471-8286.2004.00684.x; Wang J, 2010, MAMMALIA, V74, P257, DOI 10.1515/MAMM.2010.034; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI [10.2307/2408641, 10.1111/j.1558-5646.1984.tb05657.x]; Wilczynski W, 1999, GEOGRAPHIC VARIATION IN BEHAVIOR, P234; WILKINSON GS, 1991, GENETICS, V128, P607; WORTHINGTON WILMER J. M., 1996, BAT RES NEWS, V37, P1; Yoshino H, 2006, ZOOL SCI, V23, P661, DOI 10.2108/zsj.23.661; Yoshino H, 2008, MOL ECOL, V17, P4978, DOI 10.1111/j.1365-294X.2008.03975.x; Zhao HH, 2003, J ZOOL, V259, P189, DOI 10.1017/S0952836902003199	71	30	32	3	79	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2013	8	8							e70368	10.1371/journal.pone.0070368	http://dx.doi.org/10.1371/journal.pone.0070368			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	201ER	23950926	Green Published, Green Submitted, gold			2022-12-25	WOS:000323124000013
J	Crettaz, B; Marziniak, M; Willeke, P; Young, P; Hellhammer, D; Stumpf, A; Burgmer, M				Crettaz, Benjamin; Marziniak, Martin; Willeke, Peter; Young, Peter; Hellhammer, Dirk; Stumpf, Astrid; Burgmer, Markus			Stress-Induced Allodynia - Evidence of Increased Pain Sensitivity in Healthy Humans and Patients with Chronic Pain after Experimentally Induced Psychosocial Stress	PLOS ONE			English	Article							ADVERSE CHILDHOOD EXPERIENCES; PITUITARY-ADRENAL AXIS; FIBROMYALGIA PATIENTS; INDUCED ANALGESIA; SENSORY NEURONS; PSYCHOLOGICAL STRESS; HYPERALGESIA; MUSCLE; MECHANISMS; RATS	Background: Experimental stress has been shown to have analgesic as well as allodynic effect in animals. Despite the obvious negative influence of stress in clinical pain conditions, stress-induced alteration of pain sensitivity has not been tested in humans so far. Therefore, we tested changes of pain sensitivity using an experimental stressor in ten female healthy subjects and 13 female patients with fibromyalgia. Methods: Multiple sensory aspects of pain were evaluated in all participants with the help of the quantitative sensory testing protocol before (60 min) and after (10 and 90 min) inducing psychological stress with a standardized psychosocial stress test ("Trier Social Stress Test''). Results: Both healthy subjects and patients with fibromyalgia showed stress-induced enhancement of pain sensitivity in response to thermal stimuli. However, only patients showed increased sensitivity in response to pressure pain. Conclusions: Our results provide evidence for stress-induced allodynia/hyperalgesia in humans for the first time and suggest differential underlying mechanisms determining response to stressors in healthy subjects and patients suffering from chronic pain. Possible mechanisms of the interplay of stress and mediating factors (e.g. cytokines, cortisol) on pain sensitivity are mentioned. Future studies should help understand better how stress impacts on chronic pain conditions.	[Crettaz, Benjamin; Stumpf, Astrid; Burgmer, Markus] Univ Hosp Munster, Dept Psychosomat & Psychotherapy, Munster, Germany; [Marziniak, Martin] Univ Hosp Munster, Dept Neurol, Munster, Germany; [Marziniak, Martin] Univ Hosp Munster, Dept Inflammatory Disorders Nervous Syst & Neuroo, Munster, Germany; [Willeke, Peter] Univ Hosp Munster, Dept Med D, Rheumatol Sect, Munster, Germany; [Young, Peter] Univ Hosp Munster, Dept Sleep Med & Neuromuscular Disorders, Munster, Germany; [Hellhammer, Dirk] Univ Trier, Dept Psychol, Trier, Germany	University of Munster; University of Munster; University of Munster; University of Munster; University of Munster; Universitat Trier	Burgmer, M (corresponding author), Univ Hosp Munster, Dept Psychosomat & Psychotherapy, Munster, Germany.	burgmem@mednet.uni-muenster.de			Deutsche Forschungsgemeinschaft; University of Muenster	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); University of Muenster	No external funding existed for the study. But we acknowledge financial publication support by Deutsche Forschungsgemeinschaft and Open Access Publication Fund of University of Muenster. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Psychiatric Association, 2003, DIAGN STAT MAN MENT; Anda R, 2010, HEADACHE, V50, P1473, DOI 10.1111/j.1526-4610.2010.01756.x; Anderberg UM, 2000, EUR PSYCHIAT, V15, P295, DOI 10.1016/S0924-9338(00)00397-7; Andress-Rothrock D, 2010, HEADACHE, V50, P1366, DOI 10.1111/j.1526-4610.2010.01753.x; Bardin L, 2009, BEHAV BRAIN RES, V205, P360, DOI 10.1016/j.bbr.2009.07.005; Basbaum AI, 2009, CELL, V139, P267, DOI 10.1016/j.cell.2009.09.028; Baum C, 2011, PERCEPT MOTOR SKILL, V112, P926, DOI 10.2466/02.09.22.PMS.112.3.926-946; Beck A.T., 1996, PSYCHOL ASSESS, V10, DOI [10.1037/t00742-000, DOI 10.1037/T00742-000]; Bernstein DP, 2003, CHILD ABUSE NEGLECT, V27, P169, DOI 10.1016/S0145-2134(02)00541-0; BODNAR RJ, 1980, NEUROSCI BIOBEHAV R, V4, P87, DOI 10.1016/0149-7634(80)90028-7; Brydon L, 2009, BRAIN BEHAV IMMUN, V23, P217, DOI 10.1016/j.bbi.2008.09.007; Burgmer M, 2012, EUR J PAIN, V16, P636, DOI 10.1002/j.1532-2149.2011.00058.x; Burgmer M, 2011, PSYCHOSOM MED, V73, P751, DOI 10.1097/PSY.0b013e318236588a; Burnes LA, 2008, AM J PHYSIOL-REG I, V294, pR1347, DOI 10.1152/ajpregu.00687.2007; Butler RK, 2009, PROG NEUROBIOL, V88, P184, DOI 10.1016/j.pneurobio.2009.04.003; Cao L, 2007, J NEUROIMMUNOL, V186, P63, DOI 10.1016/j.jneuroim.2007.03.003; Cunha TM, 2005, P NATL ACAD SCI USA, V102, P1755, DOI 10.1073/pnas.0409225102; DeLeo JA, 1996, J INTERF CYTOK RES, V16, P695, DOI 10.1089/jir.1996.16.695; Dina OA, 2008, NEUROSCIENCE, V152, P521, DOI 10.1016/j.neuroscience.2008.01.006; Dina OA, 2008, J PAIN, V9, P457, DOI 10.1016/j.jpain.2008.01.328; Dina OA, 2011, EUR J PAIN, V15, P796, DOI 10.1016/j.ejpain.2011.02.005; Donello JE, 2011, ANESTHESIOLOGY, V114, P1403, DOI 10.1097/ALN.0b013e31821c3878; Gameiro GH, 2006, PHYSIOL BEHAV, V87, P643, DOI 10.1016/j.physbeh.2005.12.007; Geenen R, 2006, ANN NY ACAD SCI, V1069, P77, DOI 10.1196/annals.1351.007; Geisser ME, 2003, PAIN, V102, P243, DOI 10.1016/S0304-3959(02)00417-7; Giesecke T, 2003, ARTHRITIS RHEUM, V48, P2916, DOI 10.1002/art.11272; Glombiewski JA, 2008, PSYCHOSOM MED, V70, P125, DOI 10.1097/PSY.0b013e31815c6db1; Green PG, 2011, PAIN, V152, P2549, DOI 10.1016/j.pain.2011.07.021; Hedenberg-Magnusson B, 2001, ACTA ODONTOL SCAND, V59, P348, DOI 10.1080/000163501317153185; Heinricher MM, 2009, BRAIN RES REV, V60, P214, DOI 10.1016/j.brainresrev.2008.12.009; HELMSTETTER FJ, 1994, BEHAV NEUROSCI, V108, P177, DOI 10.1037/0735-7044.108.1.177; Hurtig IM, 2001, CLIN J PAIN, V17, P316, DOI 10.1097/00002508-200112000-00005; Imbe H, 2006, FRONT BIOSCI-LANDMRK, V11, P2179, DOI 10.2741/1960; JORUM E, 1988, PAIN, V32, P341, DOI 10.1016/0304-3959(88)90046-2; Juif PE, 2012, PHYSIOL BEHAV, V105, P901, DOI 10.1016/j.physbeh.2011.11.008; Khasar SG, 2008, J NEUROSCI, V28, P5721, DOI 10.1523/JNEUROSCI.0256-08.2008; Khasar SG, 2009, J PAIN, V10, P1073, DOI 10.1016/j.jpain.2009.04.005; KIRSCHBAUM C, 1993, NEUROPSYCHOBIOLOGY, V28, P76, DOI 10.1159/000119004; Kuehl LK, 2010, PAIN, V149, P539, DOI 10.1016/j.pain.2010.03.026; Leistad RB, 2008, J HEADACHE PAIN, V9, P165, DOI 10.1007/s10194-008-0029-7; McBeth J, 1999, ARTHRITIS RHEUM, V42, P1397, DOI 10.1002/1529-0131(199907)42:7<1397::AID-ANR13>3.0.CO;2-7; McEwen BS, 1998, ANN NY ACAD SCI, V840, P33, DOI 10.1111/j.1749-6632.1998.tb09546.x; MCMAHON SB, 1995, NAT MED, V1, P774, DOI 10.1038/nm0895-774; Mense S, 2003, SCHMERZ, V17, P459, DOI 10.1007/s00482-003-0264-4; Michaux GPN, 2012, PAIN, V153, P420, DOI 10.1016/j.pain.2011.10.043; MIKKELSSON M, 1992, ARCH PHYS MED REHAB, V73, P814; Miller GE, 2002, HEALTH PSYCHOL, V21, P531, DOI 10.1037//0278-6133.21.6.531; Naylor MR, 2011, COMPR PSYCHIAT, V52, P731, DOI 10.1016/j.comppsych.2010.11.008; Nicol GD, 1997, J NEUROSCI, V17, P975; Nie HL, 2005, J PAIN, V6, P348, DOI 10.1016/j.jpain.2005.01.352; Petzke F, 2003, PAIN, V105, P403, DOI 10.1016/S0304-3959(03)00204-5; PRICE DD, 1977, PAIN, V3, P57, DOI 10.1016/0304-3959(77)90035-5; Riva R, 2010, INT J BEHAV MED, V17, P223, DOI 10.1007/s12529-010-9097-6; Rivat C, 2007, NEUROPSYCHOPHARMACOL, V32, P2217, DOI 10.1038/sj.npp.1301340; Rolke R, 2006, PAIN, V123, P231, DOI 10.1016/j.pain.2006.01.041; Rolke R, 2006, EUR J PAIN, V10, P77, DOI 10.1016/j.ejpain.2005.02.003; Sachs D, 2002, PAIN, V96, P89, DOI 10.1016/S0304-3959(01)00433-X; Sainz B, 2001, MED HYPOTHESES, V56, P348, DOI 10.1054/mehy.2000.1219; Schulz P, 1999, DIAGNOSTICA, V45, P8, DOI 10.1026//0012-1924.45.1.8; SELYE H, 1950, PSYCHOSOM MED, V12, P149, DOI 10.1097/00006842-195005000-00003; Spielberger C.D., 1983, MANUAL STATE TRAIT A; Staud R, 2009, PAIN, V145, P96, DOI 10.1016/j.pain.2009.05.020; Stein C, 2009, BRAIN RES REV, V60, P90, DOI 10.1016/j.brainresrev.2008.12.017; Steptoe A, 2007, BRAIN BEHAV IMMUN, V21, P901, DOI 10.1016/j.bbi.2007.03.011; Van Damme S, 2002, PAIN, V96, P319, DOI 10.1016/S0304-3959(01)00463-8; Van Houdenhove B, 2002, PSYCHOTHER PSYCHOSOM, V71, P207, DOI 10.1159/000063646	66	84	85	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2013	8	8							e69460	10.1371/journal.pone.0069460	http://dx.doi.org/10.1371/journal.pone.0069460			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	200ZE	23950894	Green Published, Green Submitted, gold			2022-12-25	WOS:000323109700018
J	Eaton, JW; Garnett, GP; Takavarasha, FR; Mason, PR; Robertson, L; Schumacher, CM; Nyamukapa, CA; Gregson, S				Eaton, Jeffrey W.; Garnett, Geoffrey P.; Takavarasha, Felicia R.; Mason, Peter R.; Robertson, Laura; Schumacher, Christina M.; Nyamukapa, Constance A.; Gregson, Simon			Increasing Adolescent HIV Prevalence in Eastern Zimbabwe - Evidence of Long-Term Survivors of Mother-to-Child Transmission?	PLOS ONE			English	Article							OLDER CHILDREN; PARENTAL DEATH; INCREASED RISK; YOUNG-PEOPLE; INFECTION; WOMEN; TIME; AIDS; SEX; SEROCONVERSION	Recent data from the Manicaland HIV/STD Prevention Project, a general-population open HIV cohort study, suggested that between 2004 and 2007 HIV prevalence amongst males aged 15-17 years in eastern Zimbabwe increased from 1.20% to 2.23%, and in females remained unchanged at 2.23% to 2.39%, while prevalence continued to decline in the rest of the adult population. We assess whether the more likely source of the increase in adolescent HIV prevalence is recent sexual HIV acquisition, or the aging of long-term survivors of perinatal HIV acquisition that occurred during the early growth of the epidemic. Using data collected between August 2006 and November 2008, we investigated associations between adolescent HIV and (1) maternal orphanhood and maternal HIV status, (2) reported sexual behaviour, and (3) reporting recurring sickness or chronic illness, suggesting infected adolescents might be in a late stage of HIV infection. HIV-infected adolescent males were more likely to be maternal orphans (RR = 2.97, p<0.001) and both HIV-infected adolescent males and females were more likely to be maternal orphans or have an HIV-infected mother (male RR = 1.83, p<0.001; female RR = 16.6, p<0.001). None of 22 HIV-infected adolescent males and only three of 23 HIV-infected females reported ever having had sex. HIV-infected adolescents were 60% more likely to report illness than HIV-infected young adults. Taken together, all three hypotheses suggest that recent increases in adolescent HIV prevalence in eastern Zimbabwe are more likely attributable to long-term survival of mother-to-child transmission rather than increases in risky sexual behaviour. HIV prevalence in adolescents and young adults cannot be used as a surrogate for recent HIV incidence, and health systems should prepare for increasing numbers of long-term infected adolescents.	[Eaton, Jeffrey W.; Garnett, Geoffrey P.; Robertson, Laura; Nyamukapa, Constance A.; Gregson, Simon] Univ London Imperial Coll Sci Technol & Med, Dept Infect Dis Epidemiol, London, England; [Garnett, Geoffrey P.] Bill & Melinda Gates Fdn, Seattle, WA USA; [Takavarasha, Felicia R.; Mason, Peter R.; Nyamukapa, Constance A.; Gregson, Simon] Biomed Res & Training Inst, Harare, Zimbabwe; [Schumacher, Christina M.] Johns Hopkins Univ, Sch Med, Dept Pediat, Baltimore, MD 21205 USA	Imperial College London; Bill & Melinda Gates Foundation; Biomedical Research Training Institute; Johns Hopkins University	Eaton, JW (corresponding author), Univ London Imperial Coll Sci Technol & Med, Dept Infect Dis Epidemiol, London, England.	jeffrey.eaton@imperial.ac.uk	Garnett, Geoffrey P/A-9312-2008	Eaton, Jeffrey/0000-0001-7728-728X; Nyamukapa, Constance/0000-0001-6779-4069; Gregson, Simon/0000-0003-2707-0714	Wellcome Trust [050517/z/97abc]; British Marshall Aid and Commemoration Commission; Bill and Melinda Gates Foundation; Medical Research Council [MR/K010174/1B] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); British Marshall Aid and Commemoration Commission; Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	The Manicaland HIV/STD Prevention Project is supported by a grant from the Wellcome Trust (grant 050517/z/97abc). JWE thanks the British Marshall Aid and Commemoration Commission for scholarship support and the Bill and Melinda Gates Foundation for support through a grant to the HIV Modelling Consortium. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2012, GLOB REP UNAIDS REP; Babiker A, 2000, LANCET, V355, P1131, DOI 10.1016/S0140-6736(00)02061-4; Birdthistle I, 2009, SOC SCI MED, V68, P1810, DOI 10.1016/j.socscimed.2009.02.035; Birdthistle IJ, 2008, AIDS, V22, P759, DOI 10.1097/QAD.0b013e3282f4cac7; Cowan FM, 2008, TROP MED INT HEALTH, V13, P1235, DOI 10.1111/j.1365-3156.2008.02137.x; Ferrand R, 2010, B WORLD HEALTH ORGAN, V88, P428, DOI 10.2471/BLT.09.066126; Ferrand RA, 2007, CLIN INFECT DIS, V44, P874, DOI 10.1086/511878; Ferrand RA, 2010, CLIN INFECT DIS, V51, P844, DOI 10.1086/656361; Ferrand RA, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000178; Ferrand RA, 2009, AIDS, V23, P2039, DOI 10.1097/QAD.0b013e32833016ce; Ghys P. D., 2010, Sexually Transmitted Infections, V86, pii72; Gray GE, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000227; Gray RH, 2005, LANCET, V366, P1182, DOI 10.1016/S0140-6736(05)67481-8; Gregson S, 2006, SCIENCE, V311, P664, DOI 10.1126/science.1121054; Gregson S, 2005, AIDS CARE, V17, P785, DOI 10.1080/09540120500258029; Gregson S, 2002, SEX TRANSM DIS, V29, P568, DOI 10.1097/00007435-200210000-00002; Gregson S, 2010, INT J EPIDEMIOL, V39, P1311, DOI 10.1093/ije/dyq055; GRUBMAN S, 1995, PEDIATRICS, V95, P657; Hue S, 2005, P NATL ACAD SCI USA, V102, P4425, DOI 10.1073/pnas.0407534102; Johnson LF, 2012, JAIDS-J ACQ IMM DEF, V59, P417, DOI 10.1097/QAI.0b013e3182432f27; Kang M, 2008, AIDS CARE, V20, P221, DOI 10.1080/09540120701534715; Leitner T, 1996, P NATL ACAD SCI USA, V93, P10864, DOI 10.1073/pnas.93.20.10864; Lopman BA, 2005, PLOS MED, V2, P142, DOI 10.1371/journal.pmed.0020037; Marsh KA, 2011, J INT AIDS SOC, V14, DOI 10.1186/1758-2652-14-27; Marston M, 2011, INT J EPIDEMIOL, V40, P385, DOI 10.1093/ije/dyq255; Minnis AM, 2009, AM J EPIDEMIOL, V170, P918, DOI 10.1093/aje/kwp219; Mugo NR, 2011, AIDS, V25, P1887, DOI 10.1097/QAD.0b013e32834a9338; Nyirenda M, 2010, VULNERABLE CHILD YOU, V5, P284, DOI 10.1080/17450128.2010.507804; O'Shea S, 1998, J MED VIROL, V54, P113, DOI 10.1002/(SICI)1096-9071(199802)54:2&lt;113::AID-JMV8&gt;3.0.CO;2-9; Operario D, 2007, JAIDS-J ACQ IMM DEF, V44, P93, DOI 10.1097/01.qai.0000243126.75153.3c; Pascoe SJS, 2010, AIDS CARE, V22, P206, DOI 10.1080/09540120903111528; Pettifor AE, 2007, AIDS, V21, P861, DOI 10.1097/QAD.0b013e3280f00fb3; Robertson L, 2008, SEX TRANSM INFECT, V84, pI57, DOI 10.1136/sti.2008.029926; Robertson L, 2010, AIDS CARE, V22, P927, DOI 10.1080/09540121003758622; Shisana O, 2009, S AFRICAN NATL HIV P; Stover J, 2010, SEX TRANSM INFECT, V86, pII16, DOI 10.1136/sti.2010.044222; Todd J, 2007, AIDS, V21, pS55, DOI 10.1097/01.aids.0000299411.75269.e8; Zaba B, 2000, AIDS, V14, P1633, DOI 10.1097/00002030-200007280-00020; *ZIMB MIN HLTH CHI, 2007, ZIMB NAT HIV AIDS ES	39	26	26	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2013	8	8							e70447	10.1371/journal.pone.0070447	http://dx.doi.org/10.1371/journal.pone.0070447			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	200ZE	23950938	Green Published, Green Submitted, gold			2022-12-25	WOS:000323109700036
J	Knight, A; Arnouk, H; Britt, W; Gillespie, GY; Cloud, GA; Harkins, L; Su, Y; Lowdell, MW; Lamb, LS				Knight, Andrea; Arnouk, Hilal; Britt, William; Gillespie, G. Yancey; Cloud, Gretchen A.; Harkins, Lualhati; Su, Yun; Lowdell, Mark W.; Lamb, Lawrence S.			CMV-Independent Lysis of Glioblastoma by Ex Vivo Expanded/Activated V delta 1+gamma delta T Cells	PLOS ONE			English	Article							HUMAN CYTOMEGALOVIRUS; INTRACELLULAR SEQUESTRATION; PERIPHERAL-BLOOD; IMMUNE-RESPONSES; NK CELLS; LYMPHOCYTES; RECEPTOR; RECOGNITION; EXPRESSION; EXPANSION	V delta 2(neg) gamma delta T cells, of which V delta 1+ gamma delta T cells are by far the largest subset, are important effectors against CMV infection. Malignant gliomas often contain CMV genetic material and proteins, and evidence exists that CMV infection may be associated with initiation and/or progression of glioblastoma multiforme (GBM). We sought to determine if V delta 1+ gamma delta T cells were cytotoxic to GBM and the extent to which their cytotoxicity was CMV dependent. We examined the cytotoxic effect of ex vivo expanded/activated V delta 1+ gamma delta T cells from healthy CMV seropositive and CMV seronegative donors on unmanipulated and CMV-infected established GBM cell lines and cell lines developed from short-term culture of primary tumors. Expanded/ activated V delta 1+ T cells killed CMV-negative U251, U87, and U373 GBM cell lines and two primary tumor explants regardless of the serologic status of the donor. Experimental CMV infection did not increase V delta 1+ T cell - mediated cytotoxicity and in some cases the cell lines were more resistant to lysis when infected with CMV. Flow cytometry analysis of CMV-infected cell lines revealed down-regulation of the NKG2D ligands ULBP-2, and ULBP-3 as well as MICA/B in CMV-infected cells. These studies show that ex vivo expanded/activated V delta 1+ gamma delta T cells readily recognize and kill established GBM cell lines and primary tumor-derived GBM cells regardless of whether CMV infection is present, however, CMV may enhance the resistance GBM cell lines to innate recognition possibly contributing to the poor immunogenicity of GBM.	[Knight, Andrea; Lowdell, Mark W.] UCL, Dept Haematol, London, England; [Arnouk, Hilal; Cloud, Gretchen A.; Harkins, Lualhati; Su, Yun; Lamb, Lawrence S.] Univ Alabama Birmingham, Sch Med, Dept Med, Birmingham, AL 35294 USA; [Britt, William; Lamb, Lawrence S.] Univ Alabama Birmingham, Sch Med, Dept Pediat, Birmingham, AL USA; [Gillespie, G. Yancey] Univ Alabama Birmingham, Sch Med, Dept Surg, Birmingham, AL 35294 USA	University of London; University College London; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham	Lamb, LS (corresponding author), Univ Alabama Birmingham, Sch Med, Dept Med, Birmingham, AL 35294 USA.	Lawrence.Lamb@ccc.uab.edu	Arnouk, MD, PhD, Hilal/U-4445-2019	Arnouk, MD, PhD, Hilal/0000-0002-8448-0798; Gillespie, George/0000-0001-6436-9542; Knight, Andrea/0000-0001-7291-7975; Lamb, Lawrence/0000-0001-7180-0994	National Institutes of Health [R21 NS 057031-S1]; NIH/NCI [P50 CA097247]; NATIONAL CANCER INSTITUTE [P50CA097247] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS065845] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH/NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This study was funded in part by the National Institutes of Health grant R21 NS 057031-S1 (LSL) and NIH/NCI P50 CA097247 (GYG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Argentati K, 2003, J INVEST DERMATOL, V120, P829, DOI 10.1046/j.1523-1747.2003.12141.x; Bady P, 2012, NEURO-ONCOLOGY, V14, P701, DOI 10.1093/neuonc/nos072; Bennett NJ, 2010, J IMMUNOL, V185, P1093, DOI 10.4049/jimmunol.1000789; Bryant NL, 2011, J NEURO-ONCOL, V101, P179, DOI 10.1007/s11060-010-0245-2; Bryant NL, 2009, NEURO-ONCOLOGY, V11, P357, DOI 10.1215/15228517-2008-111; Cavanaugh VJ, 2003, J VIROL, V77, P1703, DOI 10.1128/JVI.77.3.1703-1717.2003; Clark MJ, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000832; Cobbs CS, 2007, J NEURO-ONCOL, V85, P271, DOI 10.1007/s11060-007-9423-2; Dechanet J, 1999, J CLIN INVEST, V103, P1437, DOI 10.1172/JCI5409; Dechanet J, 1999, J INFECT DIS, V179, P1, DOI 10.1086/314568; DEPAOLI P, 1990, J INFECT DIS, V161, P1013, DOI 10.1093/infdis/161.5.1013; Dunn C, 2003, J EXP MED, V197, P1427, DOI 10.1084/jem.20022059; Ferrarini M, 1996, JNCI-J NATL CANCER I, V88, P436, DOI 10.1093/jnci/88.7.436; Godder KT, 2007, BONE MARROW TRANSPL, V39, P751, DOI 10.1038/sj.bmt.1705650; Groh V, 1999, P NATL ACAD SCI USA, V96, P6879, DOI 10.1073/pnas.96.12.6879; Groh V, 1998, SCIENCE, V279, P1737, DOI 10.1126/science.279.5357.1737; Halary F, 2005, J EXP MED, V201, P1567, DOI 10.1084/jem.20041851; Hayday A, 2003, NAT REV IMMUNOL, V3, P233, DOI 10.1038/nri1030; INGE TH, 1992, J IMMUNOL, V148, P3847; JACHIMCZAK P, 1993, J NEUROSURG, V78, P944, DOI 10.3171/jns.1993.78.6.0944; JANSSEN O, 1991, J IMMUNOL, V146, P35; KABELITZ D, 1991, IMMUNOL REV, V120, P71, DOI 10.1111/j.1600-065X.1991.tb00588.x; Karman J, 2004, IMMUNOL LETT, V92, P107, DOI 10.1016/j.imlet.2003.10.017; Karman J, 2004, J IMMUNOL, V173, P2353, DOI 10.4049/jimmunol.173.4.2353; Knight A, 2012, CYTOTHERAPY, V14, P1110, DOI 10.3109/14653249.2012.700766; Knight A, 2010, BLOOD, V116, P2164, DOI 10.1182/blood-2010-01-255166; Lamb LS, 2009, IMMUNOL RES, V45, P85, DOI 10.1007/s12026-009-8114-9; Lamb LS, 1999, CYTOTHERAPY, V1, P7, DOI 10.1080/0032472031000141295; Lamb LS, 2001, BONE MARROW TRANSPL, V27, P601, DOI 10.1038/sj.bmt.1702830; Lau SK, 2005, MODERN PATHOL, V18, P838, DOI 10.1038/modpathol.3800352; Leslie DS, 2002, J EXP MED, V196, P1575, DOI 10.1084/jem.20021515; Lopez RD, 2000, BLOOD, V96, P3827, DOI 10.1182/blood.V96.12.3827.h8003827_3827_3837; Luo MH, 2007, J VIROL, V81, P10424, DOI 10.1128/JVI.00866-07; MACCARIO R, 1993, J IMMUNOL, V150, P1437; Maeurer MJ, 1996, J EXP MED, V183, P1681, DOI 10.1084/jem.183.4.1681; Maeurer MJ, 1997, SCAND J IMMUNOL, V45, P182, DOI 10.1046/j.1365-3083.1997.d01-384.x; MEDAWAR PB, 1948, BRIT J EXP PATHOL, V29, P58; Meeh PF, 2006, CANCER IMMUNOL IMMUN, V55, P1072, DOI 10.1007/s00262-005-0094-6; Mitchell DA, 2008, NEURO-ONCOLOGY, V10, P10, DOI 10.1215/15228517-2007-035; Muntasell A, 2010, BLOOD, V115, P5170, DOI 10.1182/blood-2009-11-256479; Odeberg J, 2007, J NEUROSCI RES, V85, P583, DOI 10.1002/jnr.21144; Peng G, 2007, IMMUNITY, V27, P334, DOI 10.1016/j.immuni.2007.05.020; Pitard V, 2008, BLOOD, V112, P1317, DOI 10.1182/blood-2008-01-136713; Poggi A, 2004, CANCER RES, V64, P9172, DOI 10.1158/0008-5472.CAN-04-2417; PONTEN J, 1968, ACTA PATHOL MIC SC, V74, P465; Rolle A, 2003, J IMMUNOL, V171, P902, DOI 10.4049/jimmunol.171.2.902; Scheurer ME, 2008, ACTA NEUROPATHOL, V116, P79, DOI 10.1007/s00401-008-0359-1; Schilbach K, 2008, J IMMUNOTHER, V31, P896, DOI 10.1097/CJI.0b013e31818955ad; Schilbach KE, 2000, J IMMUNOTHER, V23, P536, DOI 10.1097/00002371-200009000-00004; SMYTH MJ, 1991, J IMMUNOL, V146, P3289; Spada FM, 2000, J EXP MED, V191, P937, DOI 10.1084/jem.191.6.937; Wu J, 2002, J IMMUNOL, V169, P1236, DOI 10.4049/jimmunol.169.3.1236	52	24	24	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2013	8	8							e68729	10.1371/journal.pone.0068729	http://dx.doi.org/10.1371/journal.pone.0068729			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	200ZE	23950874	Green Published, gold, Green Submitted			2022-12-25	WOS:000323109700008
J	Nordt, A; Klenke, R				Nordt, Anja; Klenke, Reinhard			Sleepless in Town - Drivers of the Temporal Shift in Dawn Song in Urban European Blackbirds	PLOS ONE			English	Article							TIT PARUS-MAJOR; LIGHT POLLUTION; SINGING ACTIVITY; DARK SIDE; NOISE; CHORUS; BIRDS; COMMUNICATION; URBANIZATION; COST	Organisms living in urban environments are exposed to different environmental conditions compared to their rural conspecifics. Especially anthropogenic noise and artificial night light are closely linked to urbanization and pose new challenges to urban species. Songbirds are particularly affected by these factors, because they rely on the spread of acoustic information and adjust their behaviour to the rhythm of night and day, e. g. time their dawn song according to changing light intensities. Our aim was to clarify the specific contributions of artificial night light and traffic noise on the timing of dawn song of urban European Blackbirds (Turdus merula). We investigated the onset of blackbird dawn song along a steep urban gradient ranging from an urban forest to the city centre of Leipzig, Germany. This gradient of anthropogenic noise and artificial night light was reflected in the timing of dawn song. In the city centre, blackbirds started their dawn song up to 5 hours earlier compared to those in semi-natural habitats. We found traffic noise to be the driving factor of the shift of dawn song into true night, although it was not completely separable from the effects of ambient night light. We additionally included meteorological conditions into the analysis and found an effect on the song onset. Cloudy and cold weather delayed the onset, but cloud cover was assumed to reflect night light emissions, thus, amplified sky luminance and increased the effect of artificial night light. Beside these temporal effects, we also found differences in the spatial autocorrelation of dawn song onset showing a much higher variability in noisy city areas than in rural parks and forests. These findings indicate that urban hazards such as ambient noise and light pollution show a manifold interference with naturally evolved cycles and have significant effects on the activity patterns of urban blackbirds.	[Nordt, Anja; Klenke, Reinhard] UFZ Helmholtz Ctr Environm Res, Dept Conservat Biol, Leipzig, Germany	Helmholtz Association; Helmholtz Center for Environmental Research (UFZ)	Nordt, A (corresponding author), UFZ Helmholtz Ctr Environm Res, Dept Conservat Biol, Leipzig, Germany.	anja.nordt@ufz.de	Russ, Anja/D-4797-2015; Klenke, Reinhard/J-4686-2013	Russ, Anja/0000-0002-6236-5828; Klenke, Reinhard/0000-0002-6860-8085	Federal Ministry of Education and Research (BMBF) [FKZ: 033L038E]; Helmholtz Impulse and Networking Fund through Helmholtz Interdisciplinary Graduate School for Environmental Research	Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); Helmholtz Impulse and Networking Fund through Helmholtz Interdisciplinary Graduate School for Environmental Research	The project was funded by the Federal Ministry of Education and Research (BMBF, http://www.bmbf.de/en/index.php, FKZ: 033L038E), additional financial support was provided by Helmholtz Impulse and Networking Fund through Helmholtz Interdisciplinary Graduate School for Environmental Research (http://www.higrade.ufz.de). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMLANER CJ, 1983, BEHAVIOUR, V87, P85, DOI 10.1163/156853983X00138; Astrom G, 1976, ZOON S, V2; BEIER P, 1995, J WILDLIFE MANAGE, V59, P228, DOI 10.2307/3808935; Bergen F, 1997, J ORNITHOL, V138, P451, DOI 10.1007/BF01651380; Berry BJL, 1990, EARTH TRANSFORMED HU, P103; Bivand R., 2017, SPDEP SPATIAL DEPEND; Bivand RS, 2008, USE R, P1; Brown Lester, 2001, ECOECONOMY BUILDING, P121; Brumm H, 2005, ADV STUD BEHAV, V35, P151, DOI 10.1016/S0065-3454(05)35004-2; Brumm H, 2004, J ANIM ECOL, V73, P434, DOI 10.1111/j.0021-8790.2004.00814.x; Brumm H, 2006, J COMP PHYSIOL A, V192, P1279, DOI 10.1007/s00359-006-0158-x; Burnham K.P., 2002, MODEL SELECTION MULT, DOI 10.1007/b97636; Catchpole C., 1995, BIRD SONG BIOL THEME; Coppack T, 2007, J ORNITHOL, V148, pS459, DOI 10.1007/s10336-007-0158-9; Crutzen PJ, 2002, NATURE, V415, P23, DOI 10.1038/415023a; CUTHILL IC, 1990, BEHAV ECOL SOCIOBIOL, V26, P209; Davidson AJ, 2003, CURR OPIN NEUROBIOL, V13, P765, DOI 10.1016/j.conb.2003.10.011; Dawson A, 2001, J BIOL RHYTHM, V16, P365, DOI 10.1177/074873001129002079; De Molenaar JG, 2005, ECOLOGICAL CONSEQUEN; DERRICKSON KC, 1988, CONDOR, V90, P592, DOI 10.2307/1368348; Dominoni D, 2013, P ROYAL SOC B, P280; Dray S, 2007, J STAT SOFTW, V22, P1, DOI 10.18637/jss.v022.i04; Duffett-Smith P., 2011, PRACTICAL ASTRONOMY, P238; EENS M, 1994, BELG J ZOOL, V124, P167; Evans Ogden LJ, 1996, FATAL LIGHT AWARE PR, V1, P3; Fernandez-Juricic Esteban, 2005, Urban Habitats, V3, P49; Foote JR, 2011, ANIM BEHAV, V81, P871, DOI 10.1016/j.anbehav.2011.01.028; Francis CD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027052; Francis CD, 2009, CURR BIOL, V19, P1415, DOI 10.1016/j.cub.2009.06.052; FRANK K D, 1988, Journal of the Lepidopterists' Society, V42, P63; Fuller RA, 2007, BIOLOGY LETT, V3, P368, DOI 10.1098/rsbl.2007.0134; Glutz von Blotzheim U. N., 1988, HDB VOGEL MITTELEURO; Grimm NB, 2008, SCIENCE, V319, P756, DOI 10.1126/science.1150195; Gwinner E., 1975, AVIAN BIOL, VV, P221; Harder B., 2002, SCI NEWS, V161, P248, DOI [10.2307/4013350, DOI 10.2307/4013350]; Hesler N, 2012, ACTA ETHOL, V15, P203, DOI 10.1007/s10211-012-0127-z; Hesler N, 2012, BEHAVIOUR, V149, P645, DOI 10.1163/156853912X649920; Holker F, 2010, ECOL SOC, V15; Holker F, 2010, TRENDS ECOL EVOL, V25, P681, DOI 10.1016/j.tree.2010.09.007; Hoffman K., 1959, Journal fuer Ornithologie, V109, P84; KACELNIK A, 1983, BEHAVIOUR, V83, P287, DOI 10.1163/156853983X00200; Kempenaers B, 2010, CURR BIOL, V20, P1735, DOI 10.1016/j.cub.2010.08.028; King B., 1966, British Birds, V59, P501; Kuechly HU, 2012, REMOTE SENS ENVIRON, V126, P39, DOI 10.1016/j.rse.2012.08.008; Kunc HP, 2005, ANIM BEHAV, V70, P1265, DOI 10.1016/j.anbehav.2005.02.010; Kyba CCM, 2012, MON NOT R ASTRON SOC, V425, P701, DOI 10.1111/j.1365-2966.2012.21559.x; Kyba CCM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017307; LEOPOLD ALDO, 1961, CONDOR, V63, P269, DOI 10.2307/1365621; Lewin-Koh N, 2013, MAPTOOLS TOOLS READI; Li BG, 2002, APPL ACOUST, V63, P1137, DOI 10.1016/S0003-682X(02)00024-5; Longcore T, 2004, FRONT ECOL ENVIRON, V2, P191, DOI 10.1890/1540-9295(2004)002[0191:ELP]2.0.CO;2; Longcore T, 2008, AUK, V125, P485, DOI 10.1525/auk.2008.06253; Luniak M., 1990, P187; Luniak M, 2004, SYNURBIZATION ADAPTA; MACE R, 1989, J ANIM ECOL, V58, P143, DOI 10.2307/4991; MACE R, 1987, NATURE, V330, P745, DOI 10.1038/330745a0; Marzluff John M., 2001, P19; Mendes S, 2011, LANDSCAPE URBAN PLAN, V99, P51, DOI 10.1016/j.landurbplan.2010.08.013; Miller MW, 2006, CONDOR, V108, P130, DOI 10.1650/0010-5422(2006)108[0130:AEOLPO]2.0.CO;2; MITCHELL K. D. G., 1967, BRIT BIRDS, V60, P373; Murphy MT, 2008, ANIM BEHAV, V75, P1075, DOI 10.1016/j.anbehav.2007.08.020; Navara KJ, 2007, J PINEAL RES, V43, P215, DOI 10.1111/j.1600-079X.2007.00473.x; Nemeth E, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2012.2798; Nemeth E, 2009, ANIM BEHAV, V78, P637, DOI 10.1016/j.anbehav.2009.06.016; Oberweger K, 2001, J EXP BIOL, V204, P3379; Otter K, 1997, BEHAV ECOL, V8, P167, DOI 10.1093/beheco/8.2.167; Partecke J, 2007, ECOLOGY, V88, P882, DOI 10.1890/06-1105; Partecke J, 2006, J ORNITHOL, V147, P549, DOI 10.1007/s10336-006-0078-0; Partecke J, 2006, ECOLOGY, V87, P1945, DOI 10.1890/0012-9658(2006)87[1945:SATCUA]2.0.CO;2; Partecke J, 2005, J AVIAN BIOL, V36, P295, DOI 10.1111/j.0908-8857.2005.03344.x; Paton D, 2012, LANDSCAPE URBAN PLAN, V104, P1, DOI 10.1016/j.landurbplan.2011.09.002; Patricelli GL, 2006, AUK, V123, P639, DOI 10.1642/0004-8038(2006)123[639:ACIUNC]2.0.CO;2; Pebesma E, 2005, R NEWS, V5, P9, DOI DOI 10.1007/978-1-4614-7618-4_2; Pebesma EJ, 2004, COMPUT GEOSCI-UK, V30, P683, DOI 10.1016/j.cageo.2004.03.012; Pinheiro J., 2019, NLME LINEAR NONLINEA; Poesel A, 2006, ANIM BEHAV, V72, P531, DOI 10.1016/j.anbehav.2005.10.022; Pohl H, 1999, PHYSIOL BEHAV, V67, P327, DOI 10.1016/S0031-9384(99)00070-0; Poot H, 2008, ECOL SOC, V13; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Ripmeester EAP, 2010, BEHAV ECOL SOCIOBIOL, V64, P409, DOI 10.1007/s00265-009-0857-8; Rowan W, 1938, P ZOOL SOC LOND A-GE, V108, P51; Rydell Jens, 2006, P43; Scheer G., 1952, Biologische Abhandlung, V3/4, P1; Schroeder J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039200; Slabbekoorn H, 2003, NATURE, V424, P267, DOI 10.1038/424267a; Slabbekoorn H, 2008, MOL ECOL, V17, P72, DOI 10.1111/j.1365-294X.2007.03487.x; Slabbekoorn H, 2006, CURR BIOL, V16, P2326, DOI 10.1016/j.cub.2006.10.008; Stephan B., 1999, AMSEL NEUE BREHM BUC; Stone EL, 2012, GLOBAL CHANGE BIOL, V18, P2458, DOI 10.1111/j.1365-2486.2012.02705.x; Suter SM, 2009, ANIM BEHAV, V77, P473, DOI 10.1016/j.anbehav.2008.11.002; Szymczak JT, 1996, PHYSIOL BEHAV, V60, P1115, DOI 10.1016/0031-9384(96)00231-4; Thapan K, 2001, J PHYSIOL-LONDON, V535, P261, DOI 10.1111/j.1469-7793.2001.t01-1-00261.x; Titulaer M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037377; UN, 2008, WORLD URB PROSP 2007; Valcu M, 2010, BEHAV ECOL, V21, P902, DOI 10.1093/beheco/arq107; VERHEIJEN F. J., 1958, ARCH NEERLAND ZOOL, V13, P1; Vitousek PM, 1997, SCIENCE, V277, P494, DOI 10.1126/science.277.5325.494; Ward S, 2003, ANIM BEHAV, V66, P893, DOI 10.1006/anbe.2003.2250; WELLING P, 1995, J AVIAN BIOL, V26, P241, DOI 10.2307/3677325; Wood SN, 2004, J AM STAT ASSOC, V99, P673, DOI 10.1198/016214504000000980; Wood WE, 2006, AUK, V123, P650, DOI 10.1642/0004-8038(2006)123[650:SSMMSV]2.0.CO;2; Zuur Alain F., 2009, P1	102	73	77	4	234	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2013	8	8							e71476	10.1371/journal.pone.0071476	http://dx.doi.org/10.1371/journal.pone.0071476			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	200ZE	23940759	gold, Green Published, Green Submitted			2022-12-25	WOS:000323109700102
J	Shearer, K; Fox, MP; Maskew, M; Berhanu, R; Long, L; Sanne, I				Shearer, Kate; Fox, Matthew P.; Maskew, Mhairi; Berhanu, Rebecca; Long, Lawrence; Sanne, Ian			The Impact of Choice of NNRTI on Short-Term Treatment Outcomes among HIV-Infected Patients Prescribed Tenofovir and Lamivudine in Johannesburg, South Africa	PLOS ONE			English	Article							EARLY VIROLOGICAL FAILURE; ANTIRETROVIRAL THERAPY; CONTAINING REGIMENS; DAILY NEVIRAPINE; EMTRICITABINE; COMBINATION; PREVALENCE; EFAVIRENZ; 1ST-LINE; EFFICACY	Introduction: Recent WHO guidelines for resource-limited settings recommend tenofovir in first-line antiretroviral therapy (ART) yet there are suggestions that patients receiving nevirapine with tenofovir have worse outcomes than those receiving efavirenz. We sought to compare outcomes among those taking nevirapine vs. efavirenz with tenofovir and lamivudine. Methods: We analyzed data on ART naive, non-pregnant patients, >= 18 years old without tuberculosis co-infection, initiating tenofovir with lamivudine and either nevirapine or efavirenz between April 1, 2010 and July 31, 2011 (when South Africa's public-sector use of tenofovir began) at Themba Lethu Clinic in South Africa. We measured virologic suppression (viral load <400 copies/ml), virologic failure (2 consecutive viral loads >1000 copies/ml), and attrition (death/loss to follow-up) all at 12 months after ART initiation. Modified Poisson regression with robust error estimation was used to estimate risk ratios (RR) and 95% confidence intervals (CI) for predictors of each outcome. Results: 2,254 patients were prescribed efavirenz, 131 nevirapine. Patients were followed a median (range) of 12.0 (0.1-12.0) person-months. 62.2% were female and median (IQR) age was 37.7 years (31.5-44.1). Patients prescribed efavirenz had similar initiating CD4 counts (median 132 for both regimens) but were somewhat more likely to be WHO Stage III or IV (39.6% vs. 33.6%) than those prescribed nevirapine. No difference in attrition was found (aRR: 0.83; 95% CI: 0.49-1.41). Among patients with >= 1 viral load within 1 year on ART, those prescribed nevirapine were as likely to reach virologic suppression (aRR: 0.97; 95% CI: 0.88-1.07) but more likely to experience virologic failure (aRR: 1.84; 95% CI: 1.02-3.31) than those prescribed efavirenz. Conclusions: Our results support the notion that, among patients prescribed tenofovir and lamivudine, virologic failure is more common among those taking nevirapine than among those taking efavirenz. Longer-term follow up and larger studies will be needed to confirm this finding.	[Shearer, Kate; Fox, Matthew P.; Maskew, Mhairi; Long, Lawrence; Sanne, Ian] Univ Witwatersrand, Hlth Econ & Epidemiol Res Off, Dept Internal Med, Sch Clin Med,Fac Hlth Sci, Johannesburg, South Africa; [Fox, Matthew P.] Boston Univ, Ctr Global Hlth & Dev, Boston, MA 02215 USA; [Fox, Matthew P.] Boston Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA USA; [Berhanu, Rebecca; Sanne, Ian] Right Care, Johannesburg, South Africa; [Sanne, Ian] Univ Witwatersrand, Fac Hlth Sci, Sch Clin Med, Clin HIV Res Unit,Dept Internal Med, Johannesburg, South Africa	University of Witwatersrand; Boston University; Boston University; University of Witwatersrand	Shearer, K (corresponding author), Univ Witwatersrand, Hlth Econ & Epidemiol Res Off, Dept Internal Med, Sch Clin Med,Fac Hlth Sci, Johannesburg, South Africa.	kshearer@heroza.org	Fox, Matthew/K-2004-2019; Sanne, Ian/ABH-2231-2020	MASKEW, MHAIRI/0000-0003-4238-0200; Fox, Matthew/0000-0001-9887-0634; Long, Lawrence/0000-0003-4986-4988; Berhanu, Rebecca/0000-0002-9692-8748	South Africa Mission of the US Agency for International Development (USAID) [674-A-00-09-00018-00, 674-A-00-02-00018]; National Institute of Allergy and Infectious Diseases (NIAID) [K01AI083097]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K01AI083097] Funding Source: NIH RePORTER	South Africa Mission of the US Agency for International Development (USAID)(United States Agency for International Development (USAID)); National Institute of Allergy and Infectious Diseases (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was funded through the South Africa Mission of the US Agency for International Development (USAID) under the terms of Cooperative Agreement 674-A-00-09-00018-00 to Boston University and Cooperative Agreement 674-A-00-02-00018 to Right to Care. Matthew Fox was also supported by Award Number K01AI083097 from the National Institute of Allergy and Infectious Diseases (NIAID). The opinions expressed herein are those of the authors and do not necessarily reflect the views of USAID, the National Institutes of Health, the United States Government, or the Themba Lethu Clinic. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boulle A, 2008, JAMA-J AM MED ASSOC, V300, P530, DOI 10.1001/jama.300.5.530; Clotet B, 2008, J ANTIMICROB CHEMOTH, V61, P13, DOI 10.1093/jac/dkm432; Darin K, 2010, 10 INT AIDS C VIENN; Ford N, 2010, AIDS, V24, P1461, DOI 10.1097/QAD.0b013e32833a2a14; Fox MP, 2013, INT J EPIDEMIOL, V42, P430, DOI 10.1093/ije/dys029; Fox MP, 2010, TROP MED INT HEALTH, V15, P405, DOI 10.1111/j.1365-3156.2010.02473.x; Geddes R, 2006, SAMJ S AFR MED J, V96, P722; Lapadula G, 2008, CLIN INFECT DIS, V46, P1127, DOI 10.1086/529394; Mutimura E, 2007, JAIDS-J ACQ IMM DEF, V46, P451, DOI 10.1097/QAI.0b013e318158c0a6; National Department of Health Republic of South Africa, 2010, CLIN GUID MAN HIV AI; National Department of Health Republic of South Africa, 2013, S AFR ANT TREATM GUI; Redfield RR, 2008, CLIN INFECT DIS, V47, P984, DOI 10.1086/591802; Renaud-Thery F, 2007, AIDS, V21, pS89, DOI 10.1097/01.aids.0000279711.54922.f0; Rey D, 2009, J ANTIMICROB CHEMOTH, V63, P380, DOI 10.1093/jac/dkn471; Robertson C, 2007, 11 EUR AIDS C MADR; Smith DE, 2011, INT J STD AIDS, V22, P228, DOI 10.1258/ijsa.2010.010258; Tang MW, 2012, CLIN INFECT DIS, V54, P862, DOI 10.1093/cid/cir1034; Towner W, 2004, 7 INT C DRUG THER HI; van Griensven J, 2007, T ROY SOC TROP MED H, V101, P793, DOI 10.1016/j.trstmh.2007.02.020; Weberschock T, 2009, EUR J MED RES, V14, P516, DOI 10.1186/2047-783X-14-12-516; WHO, 2010, ANT THER HIV INF AD; World Health Organization, 2010, UN ACC SCAL PRIOR HI; World Health Organization, 2006, ANT THER HIV INF AD; Zou GY, 2004, AM J EPIDEMIOL, V159, P702, DOI 10.1093/aje/kwh090	24	7	8	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2013	8	8							e71719	10.1371/journal.pone.0071719	http://dx.doi.org/10.1371/journal.pone.0071719			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	200ZE	23940782	Green Submitted, gold, Green Published			2022-12-25	WOS:000323109700115
J	Xu, M; Li, XX; Ritter, JK; Abais, JM; Zhang, Y; Li, PL				Xu, Ming; Li, Xiao-Xue; Ritter, Joseph K.; Abais, Justine M.; Zhang, Yang; Li, Pin-Lan			Contribution of NADPH Oxidase to Membrane CD38 Internalization and Activation in Coronary Arterial Myocytes	PLOS ONE			English	Article							CYCLIC ADP-RIBOSE; ADENINE-DINUCLEOTIDE PHOSPHATE; REDOX SIGNALING PLATFORMS; SMOOTH-MUSCLE-CELLS; ENDOTHELIAL DYSFUNCTION; AFFERENT ARTERIOLES; CA2+ MOBILIZATION; OXIDATIVE STRESS; FAMILY PROTEINS; KNOCKOUT MICE	The CD38-ADP-ribosylcyclase-mediated Ca2+ signaling pathway importantly contributes to the vasomotor response in different arteries. Although there is evidence indicating that the activation of CD38-ADP-ribosylcyclase is associated with CD38 internalization, the molecular mechanism mediating CD38 internalization and consequent activation in response to a variety of physiological and pathological stimuli remains poorly understood. Recent studies have shown that CD38 may sense redox signals and is thereby activated to produce cellular response and that the NADPH oxidase isoform, NOX1, is a major resource to produce superoxide (O-2(center dot-)) in coronary arterial myocytes (CAMs) in response to muscarinic receptor agonist, which uses CD38-ADP-ribosylcyclase signaling pathway to exert its action in these CAMs. These findings led us hypothesize that NOX1-derived O-2(center dot-) serves in an autocrine fashion to enhance CD38 internalization, leading to redox activation of CD38-ADP-ribosylcyclase activity in mouse CAMs. To test this hypothesis, confocal microscopy, flow cytometry and a membrane protein biotinylation assay were used in the present study. We first demonstrated that CD38 internalization induced by endothelin-1 (ET-1) was inhibited by silencing of NOX1 gene, but not NOX4 gene. Correspondingly, NOX1 gene silencing abolished ET-1-induced O-2(center dot-) production and increased CD38-ADP-ribosylcyclase activity in CAMs, while activation of NOX1 by overexpression of Rac1 or Vav2 or administration of exogenous O-2(center dot-) significantly increased CD38 internalization in CAMs. Lastly, ET-1 was found to markedly increase membrane raft clustering as shown by increased colocalization of cholera toxin-B with CD38 and NOX1. Taken together, these results provide direct evidence that Rac1-NOX1-dependent O-2(center dot-) production mediates CD38 internalization in CAMs, which may represent an important mechanism linking receptor activation with CD38 activity in these cells.	[Xu, Ming; Li, Xiao-Xue; Ritter, Joseph K.; Abais, Justine M.; Zhang, Yang; Li, Pin-Lan] Virginia Commonwealth Univ, Sch Med, Dept Pharmacol & Toxicol, Richmond, VA 23284 USA	Virginia Commonwealth University	Li, PL (corresponding author), Virginia Commonwealth Univ, Sch Med, Dept Pharmacol & Toxicol, Richmond, VA 23284 USA.	pli@vcu.edu			National Institute of Health [HL057244, HL075316, HL091464]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R29HL057244, R01HL091464, R01HL075316, R01HL057244] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by National Institute of Health (HL057244, HL075316, and HL091464). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aarhus R, 1995, J BIOL CHEM, V270, P30327, DOI 10.1074/jbc.270.51.30327; Ahmad M, 2010, AM J PHYSIOL-HEART C, V298, pH1879, DOI 10.1152/ajpheart.01228.2009; Cancela JM, 2001, ANNU REV PHYSIOL, V63, P99, DOI 10.1146/annurev.physiol.63.1.99; Cheng G, 2006, J BIOL CHEM, V281, P17718, DOI 10.1074/jbc.M512751200; Cherednichenko G, 2004, CIRC RES, V94, P478, DOI 10.1161/01.RES.0000115554.65513.7C; Chidambaram N, 1999, ARCH BIOCHEM BIOPHYS, V363, P267, DOI 10.1006/abbi.1999.1103; Choi DH, 2012, ANTIOXID REDOX SIGN, V16, P1033, DOI 10.1089/ars.2011.3960; DIEDERICH D, 1994, AM J PHYSIOL, V266, pH1153, DOI 10.1152/ajpheart.1994.266.3.H1153; DIEKMANN D, 1994, SCIENCE, V265, P531, DOI 10.1126/science.8036496; Fellner SK, 2005, AM J PHYSIOL-RENAL, V288, pF785, DOI 10.1152/ajprenal.00372.2004; Funaro A, 1998, J IMMUNOL, V160, P2238; Galione A, 2006, BIOCHEM SOC T, V34, P922, DOI 10.1042/BST0340922; Ge ZD, 2003, J VASC RES, V40, P28, DOI 10.1159/000068936; Gerasimenko JV, 2003, J CELL BIOL, V163, P271, DOI 10.1083/jcb.200306134; Han MK, 2002, J BIOL CHEM, V277, P5315, DOI 10.1074/jbc.M106439200; Higashida H, 2001, BIOL CHEM, V382, P23, DOI 10.1515/BC.2001.004; Hirotani S, 2004, J MOL CELL CARDIOL, V36, P799, DOI 10.1016/j.yjmcc.2004.03.002; Hornstein I, 2004, CELL SIGNAL, V16, P1, DOI 10.1016/S0898-6568(03)00110-4; JACKSON DG, 1990, J IMMUNOL, V144, P2811; Jia SJ, 2008, AM J PHYSIOL-HEART C, V295, pH1743, DOI 10.1152/ajpheart.00617.2008; Jin S, 2008, ARTERIOSCL THROM VAS, V28, P485, DOI 10.1161/ATVBAHA.107.159772; Kang MA, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2011.134; Kawahara T, 2005, AM J PHYSIOL-CELL PH, V288, pC450, DOI 10.1152/ajpcell.00319.2004; Kinnear NP, 2004, J BIOL CHEM, V279, P54319, DOI 10.1074/jbc.M406132200; Lassegue B, 2010, ARTERIOSCL THROM VAS, V30, P653, DOI 10.1161/ATVBAHA.108.181610; Lee HC, 2000, J MEMBRANE BIOL, V173, P1, DOI 10.1007/s002320001001; Li LX, 2003, CIRCULATION, V107, P1053, DOI 10.1161/01.CIR.0000051459.74466.46; Liang M, 1999, ARCH BIOCHEM BIOPHYS, V371, P317, DOI 10.1006/abbi.1999.1463; Miller FJ, 2010, ANTIOXID REDOX SIGN, V12, P583, DOI 10.1089/ars.2009.2857; MOHAZZABH KM, 1994, AM J PHYSIOL, V266, pH2568, DOI 10.1152/ajpheart.1994.266.6.H2568; Munoz P, 2003, J BIOL CHEM, V278, P50791, DOI 10.1074/jbc.M308034200; Perrotta C, 2010, J BIOL CHEM, V285, P40240, DOI 10.1074/jbc.M110.139287; Ridley AJ, 2001, TRENDS CELL BIOL, V11, P471, DOI 10.1016/S0962-8924(01)02153-5; Sarfstein R, 2004, J BIOL CHEM, V279, P16007, DOI 10.1074/jbc.M312394200; Teggatz EG, 2005, MICROVASC RES, V70, P65, DOI 10.1016/j.mvr.2005.06.004; Teng BY, 2006, AM J PHYSIOL-HEART C, V290, pH1713, DOI 10.1152/ajpheart.00826.2005; Thai TL, 2009, AM J PHYSIOL-RENAL, V297, pF510, DOI 10.1152/ajprenal.00116.2009; Thorin E, 2010, ADV PHARMACOL, V60, P1, DOI [10.1016/S1054-3589(10)60009-9, 10.1016/B978-0-12-385061-4.00001-5]; TOHGO A, 1994, J BIOL CHEM, V269, P28555; Trubiani O, 2004, INT J IMMUNOPATH PH, V17, P293, DOI 10.1177/039463200401700309; Tybulewicz VL, 2005, CURR OPIN IMMUNOL, V17, P267, DOI 10.1016/j.coi.2005.04.003; Utomo A, 2006, J IMMUNOL, V177, P6388, DOI 10.4049/jimmunol.177.9.6388; Varsano S, 1998, AM J RESP CELL MOL, V19, P522, DOI 10.1165/ajrcmb.19.3.3181; Xia M, 2011, CARDIOVASC RES, V89, P401, DOI 10.1093/cvr/cvq286; Xu M, 2012, FREE RADICAL BIO MED, V52, P357, DOI 10.1016/j.freeradbiomed.2011.10.485; Yi F, 2006, KIDNEY INT, V70, P88, DOI 10.1038/sj.ki.5001517; Yi F, 2004, KIDNEY INT, V66, P1977, DOI 10.1111/j.1523-1755.2004.00968.x; Yi F, 2009, HYPERTENSION, V53, P90, DOI 10.1161/HYPERTENSIONAHA.108.115675; Yu JZ, 2000, AM J PHYSIOL-HEART C, V279, pH873, DOI 10.1152/ajpheart.2000.279.3.H873; Zhang AY, 2006, HYPERTENSION, V47, P74, DOI 10.1161/01.HYP.0000196727.53300.62; Zhang AY, 2004, MICROVASC RES, V67, P159, DOI 10.1016/j.mvr.2003.11.001; Zhang F, 2006, AM J PHYSIOL-HEART C, V291, pH274, DOI 10.1152/ajpheart.01064.2005; Zilber MT, 2005, BLOOD, V106, P3074, DOI 10.1182/blood-2004-10-4094; Zocchi E, 1996, FEBS LETT, V396, P327, DOI 10.1016/0014-5793(96)01125-8	54	14	14	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2013	8	8							e71212	10.1371/journal.pone.0071212	http://dx.doi.org/10.1371/journal.pone.0071212			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	200ZE	23940720	Green Published, gold, Green Submitted			2022-12-25	WOS:000323109700087
J	Hung, SW; Mody, H; Marrache, S; Bhutia, YD; Davis, F; Cho, JH; Zastre, J; Dhar, S; Chu, CK; Govindarajan, R				Hung, Sau Wai; Mody, Hardik; Marrache, Sean; Bhutia, Yangzom D.; Davis, Franklin; Cho, Jong Hyun; Zastre, Jason; Dhar, Shanta; Chu, Chung K.; Govindarajan, Rajgopal			Pharmacological Reversal of Histone Methylation Presensitizes Pancreatic Cancer Cells to Nucleoside Drugs: In Vitro Optimization and Novel Nanoparticle Delivery Studies	PLOS ONE			English	Article							ZESTE HOMOLOG 2; INHIBITOR 3-DEAZANEPLANOCIN; EZH2 EXPRESSION; TUMOR-GROWTH; CARCINOMA; ENHANCER; BREAST; DZNEP; H3; TROXACITABINE	We evaluated the potential of an investigational histone methylation reversal agent, 3-deazaneplanocin A (DZNep), in improving the chemosensitivity of pancreatic cancer to nucleoside analogs (i.e., gemcitabine). DZNep brought delayed but selective cytotoxicity to pancreatic cancer cells without affecting normal human pancreatic ductal epithelial (HPDE) cells. Co-exposure of DZNep and gemcitabine induced cytotoxic additivity or synergism in both well-and poorly-differentiated pancreatic cell lines by increased apoptosis. In contrast, DZNep exerted antagonism with gemcitabine against HPDE cells with significant reduction in cytotoxicity compared with the gemcitabine-alone regimen. DZNep marginally depended on purine nucleoside transporters for its cytotoxicity, but the transport dependence was circumvented by acyl derivatization. Drug exposure studies revealed that a short priming with DZNep followed by gemcitabine treatment rather than co-treatment of both agents to produce a maximal chemosensitization response in both gemcitabine-sensitive and gemcitabine-resistant pancreatic cancer cells. DZNep rapidly and reversibly decreased trimethylation of histone H3 lysine 27 but increased trimethylation of lysine 9 in an EZH2- and JMJD1A/2C-dependent manner, respectively. However, DZNep potentiation of nucleoside analog chemosensitization was found to be temporally coupled to trimethylation changes in lysine 27 and not lysine 9. Polymeric nanoparticles engineered to chronologically release DZNep followed by gemcitabine produced pronounced chemosensitization and dose-lowering effects. Together, our results identify that an optimized DZNep exposure can presensitize pancreatic cancer cells to anticancer nucleoside analogs through the reversal of histone methylation, emphasizing the promising clinical utilities of epigenetic reversal agents in future pancreatic cancer combination therapies.	[Hung, Sau Wai; Mody, Hardik; Bhutia, Yangzom D.; Cho, Jong Hyun; Zastre, Jason; Chu, Chung K.; Govindarajan, Rajgopal] Univ Georgia, Dept Pharmaceut & Biomed Sci, Athens, GA 30602 USA; [Marrache, Sean; Dhar, Shanta] Univ Georgia, Dept Chem, Athens, GA 30602 USA; [Davis, Franklin] Univ Georgia, Dept Biol Sci, Athens, GA 30602 USA	University System of Georgia; University of Georgia; University System of Georgia; University of Georgia; University System of Georgia; University of Georgia	Govindarajan, R (corresponding author), Univ Georgia, Dept Pharmaceut & Biomed Sci, Athens, GA 30602 USA.	rgovinda@rx.uga.edu	Mody, Hardik/J-8054-2019	Dhar, Shanta/0000-0003-3042-5272	National Institutes of Health [P30GM092378]; National Cancer Institute [1R03CA161832-01]; Georgia Cancer Coalition; OVPR of The University of Georgia; NATIONAL CANCER INSTITUTE [R03CA161832] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P30GM092378] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Georgia Cancer Coalition; OVPR of The University of Georgia; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the National Institutes of Health [Grant P30GM092378] (S.D.), the National Cancer Institute [Grant 1R03CA161832-01] (R.G.), the Georgia Cancer Coalition (R.G.), and OVPR of The University of Georgia (S.D.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdel-Wahab O, 2010, CANCER CELL, V18, P105, DOI 10.1016/j.ccr.2010.07.006; Adema AD, 2007, NUCLEOS NUCLEOT NUCL, V26, P1073, DOI 10.1080/15257770701515591; Avan A, 2012, MOL CANCER THER, V11, P1735, DOI 10.1158/1535-7163.MCT-12-0037; Bao B, 2012, CANCER RES, V72, P335, DOI 10.1158/0008-5472.CAN-11-2182; Bayraktar S, 2010, WORLD J GASTROENTERO, V16, P673, DOI 10.3748/wjg.v16.i6.673; Bhutia YD, 2011, CANCER RES, V71, P1825, DOI 10.1158/0008-5472.CAN-10-2736; Chang C.J., 2011, BRIT J CANCER, V106, P243; Chase A, 2011, CLIN CANCER RES, V17, P2613, DOI 10.1158/1078-0432.CCR-10-2156; Chen YC, 2010, CANCER LETT, V297, P109, DOI 10.1016/j.canlet.2010.05.003; Cheng LL, 2012, CLIN CANCER RES, V18, P4201, DOI 10.1158/1078-0432.CCR-12-0036; CHOU TC, 1984, ADV ENZYME REGUL, V22, P27, DOI 10.1016/0065-2571(84)90007-4; Choudhury SR, 2011, CARCINOGENESIS, V32, P1525, DOI 10.1093/carcin/bgr171; COULOMBE RA, 1995, EUR J DRUG METAB PH, V20, P197, DOI 10.1007/BF03189670; Crea F, 2012, CANCER METAST REV, P1; Crea F, 2012, CRIT REV ONCOL HEMAT, V83, P184, DOI 10.1016/j.critrevonc.2011.10.007; Crea F, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-40; DEROOSE FD, 1995, J ORG CHEM, V60, P321, DOI 10.1021/jo00107a009; Fujii S, 2008, J BIOL CHEM, V283, P17324, DOI 10.1074/jbc.M800224200; Fujii S, 2012, BIOCHEM BIOPH RES CO, V417, P1074, DOI 10.1016/j.bbrc.2011.12.099; Fussbroich B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021651; GLAZER RI, 1986, BIOCHEM BIOPH RES CO, V135, P688, DOI 10.1016/0006-291X(86)90048-3; Govindarajan R, 2008, AM J PHYSIOL-GASTR L, V295, pG570, DOI 10.1152/ajpgi.00542.2007; Hayden A, 2011, BREAST CANCER RES TR, V127, P109, DOI 10.1007/s10549-010-0982-0; Hou JL, 2012, AM J TRANSL RES, V4, P247; Kang N, 2010, J BIOL CHEM, V285, P28343, DOI 10.1074/jbc.M110.109199; Mallen-St Clair J, 2012, GENE DEV, V26, P439, DOI 10.1101/gad.181800.111; Marrache S, 2012, P NATL ACAD SCI USA, V109, P16288, DOI 10.1073/pnas.1210096109; Ougolkov AV, 2008, CLIN CANCER RES, V14, P6790, DOI 10.1158/1078-0432.CCR-08-1013; Paproski RJ, 2008, MOL PHARMACOL, V74, P1372, DOI 10.1124/mol.108.048900; Plunkett W, 1995, SEMIN ONCOL, V22; Puppe J, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2354; Qazi AM, 2011, METHODS MOL BIOL, V755, P245, DOI 10.1007/978-1-61779-163-5_20; Radi M, 2007, J MED CHEM, V50, P2249, DOI 10.1021/jm0612923; Rogenhofer S, 2012, ANTICANCER RES, V32, P879; Shi L, 2011, P NATL ACAD SCI USA, V108, P7541, DOI 10.1073/pnas.1017374108; Simon JA, 2009, NAT REV MOL CELL BIO, V10, P697, DOI 10.1038/nrm2763; Stathis A, 2010, NAT REV CLIN ONCOL, V7, P163, DOI 10.1038/nrclinonc.2009.236; Suva ML, 2009, CANCER RES, V69, P9211, DOI 10.1158/0008-5472.CAN-09-1622; Tan J, 2007, GENE DEV, V21, P1050, DOI 10.1101/gad.1524107; Toll AD, 2010, HUM PATHOL, V41, P1205, DOI 10.1016/j.humpath.2010.03.004; Toth M, 2012, CANCER SCI, V103, P659, DOI 10.1111/j.1349-7006.2012.02215.x; Wei YK, 2008, MOL CARCINOGEN, V47, P701, DOI 10.1002/mc.20413; Wong A, 2009, DRUG METAB REV, V41, P77, DOI 10.1080/03602530902741828; Yang XJ, 2010, TRENDS PHARMACOL SCI, V31, P536, DOI 10.1016/j.tips.2010.08.001; Zhou JB, 2011, BLOOD, V118, P2830, DOI 10.1182/blood-2010-07-294827	45	14	15	2	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2013	8	8							e71196	10.1371/journal.pone.0071196	http://dx.doi.org/10.1371/journal.pone.0071196			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	217ZG	23940717	Green Submitted, gold, Green Published			2022-12-25	WOS:000324401500061
J	Searle, KM; Shields, T; Hamapumbu, H; Kobayashi, T; Mharakurwa, S; Thuma, PE; Smith, DL; Glass, G; Moss, WJ				Searle, Kelly M.; Shields, Timothy; Hamapumbu, Harry; Kobayashi, Tamaki; Mharakurwa, Sungano; Thuma, Philip E.; Smith, David L.; Glass, Gregory; Moss, William J.			Efficiency of Household Reactive Case Detection for Malaria in Rural Southern Zambia: Simulations Based on Cross-Sectional Surveys from Two Epidemiological Settings	PLOS ONE			English	Article							ACTIVE CASE DETECTION; PLASMODIUM-FALCIPARUM; TRANSMISSION; INFECTIONS; ELIMINATION; PROPORTION; PROVINCE; AREA	Background: Case detection and treatment are critical to malaria control and elimination as infected individuals who do not seek medical care can serve as persistent reservoirs for transmission. Methods: Household malaria surveys were conducted in two study areas within Southern Province, Zambia in 2007 and 2008. Cross-sectional surveys were conducted approximately five times throughout the year in each of the two study areas. During study visits, adults and caretakers of children were administered a questionnaire and a blood sample was obtained for a rapid diagnostic test (RDT) for malaria. These data were used to estimate the proportions of individuals with malaria potentially identified through passive case detection at health care facilities and those potentially identified through reactive case finding. Simulations were performed to extrapolate data from sampled to non-sampled households. Radii of increasing size surrounding households with an index case were examined to determine the proportion of households with an infected individual that would be identified through reactive case detection. Results: In the 2007 high transmission setting, with a parasite prevalence of 23%, screening neighboring households within 500 meters of an index case could have identified 89% of all households with an RDT positive resident and 90% of all RDT positive individuals. In the 2008 low transmission setting, with a parasite prevalence of 8%, screening neighboring households within 500 meters of a household with an index case could have identified 77% of all households with an RDT positive resident and 76% of all RDT positive individuals. Conclusions: Testing and treating individuals residing within a defined radius from an index case has the potential to be an effective strategy to identify and treat a large proportion of infected individuals who do not seek medical care, although the efficiency of this strategy is likely to decrease with declining parasite prevalence.	[Searle, Kelly M.; Kobayashi, Tamaki; Smith, David L.; Moss, William J.] Johns Hopkins Univ, Bloomberg Sch Publ, Dept Epidemiol, Baltimore, MD 21218 USA; [Shields, Timothy; Mharakurwa, Sungano; Glass, Gregory; Moss, William J.] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, W Harry Feinstone Dept Mol Microbiol & Immunol, Baltimore, MD USA; [Hamapumbu, Harry; Mharakurwa, Sungano; Thuma, Philip E.] Macha Res Trust, Choma, Zambia	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Moss, WJ (corresponding author), Johns Hopkins Univ, Bloomberg Sch Publ, Dept Epidemiol, Baltimore, MD 21218 USA.	wmoss@jhsph.edu	Smith, David L/L-8850-2013	Smith, David L/0000-0003-4367-3849; Searle, Kelly/0000-0003-1316-9342	Johns Hopkins Malaria Research Institute; Bloomberg Family Foundation; Division of Microbiology and Infectious Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI089680] Funding Source: NIH RePORTER	Johns Hopkins Malaria Research Institute; Bloomberg Family Foundation; Division of Microbiology and Infectious Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the Johns Hopkins Malaria Research Institute, the Bloomberg Family Foundation, and the Division of Microbiology and Infectious Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2009, MAL RAP DIAGN TEST P; Aregawi MW, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-46; Baltzell KA, 2013, AM J TROP MED HYG, V88, P289, DOI 10.4269/ajtmh.2012.12-0095; Barnes KI, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-S1-S8; Bejon P, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000304; Harris I, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-254; Kent RJ, 2007, AM J TROP MED HYG, V76, P267, DOI 10.4269/ajtmh.2007.76.267; LARKIN GL, 1991, AM J TROP MED HYG, V45, P587, DOI 10.4269/ajtmh.1991.45.587; Mabunda S, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-74; Macauley C, 2005, SOC SCI MED, V60, P563, DOI 10.1016/j.socscimed.2004.05.025; Moonen B, 2010, LANCET, V376, P1592, DOI 10.1016/S0140-6736(10)61269-X; Moss WJ, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-163; Okell LC, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2241; Otten M, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-14; Owusu-Agyei S, 2002, TROP MED INT HEALTH, V7, P421, DOI 10.1046/j.1365-3156.2002.00881.x; Raghunathan TE, 2001, SURV METHODOL, V27, P85; Stresman GH, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-265; Sutcliffe CG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031396; van Buuren S, 2007, STAT METHODS MED RES, V16, P219, DOI 10.1177/0962280206074463; White IR, 2011, STAT MED, V30, P377, DOI 10.1002/sim.4067; WHO, 2010, WORLD MALARIA REPORT 2010, P1	21	18	18	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2013	8	8							e70972	10.1371/journal.pone.0070972	http://dx.doi.org/10.1371/journal.pone.0070972			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	217ZG	23940677	Green Published, gold			2022-12-25	WOS:000324401500054
J	Stewart, M; Dunlap, T; Dourlain, E; Grant, B; McFail-Isom, L				Stewart, Mikaela; Dunlap, Tori; Dourlain, Elizabeth; Grant, Bryce; McFail-Isom, Lori			Cations Form Sequence Selective Motifs within DNA Grooves via a Combination of Cation-Pi and Ion-Dipole/Hydrogen Bond Interactions	PLOS ONE			English	Article							BINDING-SITE; LIGAND RECOGNITION; MONOVALENT CATIONS; AROMATIC RINGS; STAIR MOTIFS; B-DNA; PROTEINS; RNA; RECEPTOR; DEFORMATION	The fine conformational subtleties of DNA structure modulate many fundamental cellular processes including gene activation/repression, cellular division, and DNA repair. Most of these cellular processes rely on the conformational heterogeneity of specific DNA sequences. Factors including those structural characteristics inherent in the particular base sequence as well as those induced through interaction with solvent components combine to produce fine DNA structural variation including helical flexibility and conformation. Cation-pi interactions between solvent cations or their first hydration shell waters and the faces of DNA bases form sequence selectively and contribute to DNA structural heterogeneity. In this paper, we detect and characterize the binding patterns found in cation-pi interactions between solvent cations and DNA bases in a set of high resolution x-ray crystal structures. Specifically, we found that monovalent cations (Tl+) and the polarized first hydration shell waters of divalent cations (Mg2+, Ca2+) form cation-pi interactions with DNA bases stabilizing unstacked conformations. When these cation-pi interactions are combined with electrostatic interactions a pattern of specific binding motifs is formed within the grooves.	[Stewart, Mikaela; Dunlap, Tori; Dourlain, Elizabeth; Grant, Bryce; McFail-Isom, Lori] Univ Cent Arkansas, Dept Chem, Conway, AR USA	University of Central Arkansas	McFail-Isom, L (corresponding author), Univ Cent Arkansas, Dept Chem, Conway, AR USA.	lorii@uca.edu	Stewart, Mikaela/GXN-3417-2022	Stewart, Mikaela/0000-0002-0809-9469	National Science Foundation [420807]; University of Central Arkansas Department of Chemistry	National Science Foundation(National Science Foundation (NSF)); University of Central Arkansas Department of Chemistry	This work was supported by the National Science Foundation [grant number 420807, www.nsf.gov] and the University of Central Arkansas Department of Chemistry. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bashtovyy D, 2011, J LIPID RES, V52, P435, DOI 10.1194/jlr.R012658; Beene DL, 2002, BIOCHEMISTRY-US, V41, P10262, DOI 10.1021/bi020266d; BERMAN HM, 1992, BIOPHYS J, V63, P751, DOI 10.1016/S0006-3495(92)81649-1; Biot C, 2004, J AM CHEM SOC, V126, P6220, DOI 10.1021/ja049620g; BRUKNER I, 1994, J MOL BIOL, V236, P26, DOI 10.1006/jmbi.1994.1115; BURLEY SK, 1986, FEBS LETT, V203, P139, DOI 10.1016/0014-5793(86)80730-X; Dickerson RE, 1997, BIOPOLYMERS, V44, P361, DOI 10.1002/(SICI)1097-0282(1997)44:4<361::AID-BIP4>3.0.CO;2-X; DIEKMANN S, 1985, J MOL BIOL, V186, P1, DOI 10.1016/0022-2836(85)90251-7; Gromiha MM, 2004, INT J BIOL MACROMOL, V34, P203, DOI 10.1016/j.ijbiomac.2004.04.003; Heindl H, 2011, BIOCHEM SOC T, V39, P31, DOI 10.1042/BST0390031; Howerton SB, 2001, BIOCHEMISTRY-US, V40, P10023, DOI 10.1021/bi010391+; Hud NV, 1999, J MOL BIOL, V285, P233, DOI 10.1006/jmbi.1998.2327; Jackson MR, 2007, J PHYS CHEM B, V111, P8242, DOI 10.1021/jp0661995; Lamoureux JS, 2004, J MOL BIOL, V335, P399, DOI 10.1016/j.jmb.2003.10.071; LAUNDON CH, 1987, BIOCHEMISTRY-US, V26, P3759, DOI 10.1021/bi00387a003; Lummis SCR, 2005, CHEM BIOL, V12, P993, DOI 10.1016/j.chembiol.2005.06.012; Ma JC, 1997, CHEM REV, V97, P1303, DOI 10.1021/cr9603744; Magnuson EC, 2002, INT J QUANTUM CHEM, V88, P236, DOI 10.1002/qua.10114; Mahadevi AS, 2013, CHEM REV, V113, P2100, DOI 10.1021/cr300222d; McFail-Isom L, 1999, CURR OPIN STRUC BIOL, V9, P298, DOI 10.1016/S0959-440X(99)80040-2; McFail-Isom L, 1998, BIOCHEMISTRY-US, V37, P17105, DOI 10.1021/bi982201+; Olson WK, 1998, P NATL ACAD SCI USA, V95, P11163, DOI 10.1073/pnas.95.19.11163; Padgett CL, 2007, J NEUROSCI, V27, P886, DOI 10.1523/JNEUROSCI.4791-06.2007; Petrov AS, 2002, J PHYS CHEM B, V106, P3294, DOI 10.1021/jp013941m; Philip V, 2011, BIOCHEMISTRY-US, V50, P2939, DOI 10.1021/bi200066k; Rao JS, 2009, J PHYS CHEM B, V113, P7225, DOI 10.1021/jp900013e; Reddy AS, 2007, J PHYS CHEM B, V111, P11546, DOI 10.1021/jp075768l; Rooman M, 2002, J MOL BIOL, V319, P67, DOI 10.1016/S0022-2836(02)00263-2; Salonen LM, 2011, ANGEW CHEM INT EDIT, V50, P4808, DOI 10.1002/anie.201007560; Shui XQ, 1998, BIOCHEMISTRY-US, V37, P8341, DOI 10.1021/bi973073c; Shui XQ, 1998, BIOCHEMISTRY-US, V37, P16877, DOI 10.1021/bi982063o; Sponer J, 2001, BIOPOLYMERS, V61, P3, DOI 10.1002/1097-0282(2001)61:1<3::AID-BIP10048>3.0.CO;2-4; Steiner T, 2001, J MOL BIOL, V305, P535, DOI 10.1006/jmbi.2000.4301; SUSSMAN JL, 1978, J MOL BIOL, V123, P607, DOI 10.1016/0022-2836(78)90209-7; Wilkinson OJ, 2012, P NATL ACAD SCI USA, V109, P18755, DOI 10.1073/pnas.1209451109; Williams LD, 2000, ANNU REV BIOPH BIOM, V29, P497, DOI 10.1146/annurev.biophys.29.1.497; Wintjens R, 2000, J MOL BIOL, V302, P395, DOI 10.1006/jmbi.2000.4040; Woods KK, 2000, J AM CHEM SOC, V122, P1546, DOI 10.1021/ja9919579; Zacharias N, 2002, TRENDS PHARMACOL SCI, V23, P281, DOI 10.1016/S0165-6147(02)02027-8; Zhong WG, 1998, P NATL ACAD SCI USA, V95, P12088, DOI 10.1073/pnas.95.21.12088; Zou XQ, 2012, NUCLEIC ACIDS RES, V40, P2747, DOI 10.1093/nar/gkr1057	41	11	11	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2013	8	8							e71420	10.1371/journal.pone.0071420	http://dx.doi.org/10.1371/journal.pone.0071420			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	217ZG	23940752	Green Submitted, Green Published, gold			2022-12-25	WOS:000324401500070
J	Dasgupta, P; Qi, XL; Smith, EP; Keegan, AD				Dasgupta, Preeta; Qi, Xiulan; Smith, Elizabeth P.; Keegan, Achsah D.			Absence of the Common Gamma Chain (gamma(c)), a Critical Component of the Type I IL-4 Receptor, Increases the Severity of Allergic Lung Inflammation	PLOS ONE			English	Article							GENE-EXPRESSION; DENDRITIC CELLS; MICE LACKING; IFN-GAMMA; T-CELLS; AIRWAY; INTERLEUKIN-4; MECHANISMS; INDUCE; ROLES	The T(H)2 cytokines, IL-4 and IL-13, play critical roles in inducing allergic lung inflammation and drive the alternative activation of macrophages (AAM). Although both cytokines share receptor subunits, IL-4 and IL-13 have differential roles in asthma pathogenesis: IL-4 regulates T(H)2 cell differentiation, while IL-13 regulates airway hyperreactivity and mucus production. Aside from controlling T(H)2 differentiation, the unique contribution of IL-4 signaling via the Type I receptor in airway inflammation remains unclear. Therefore, we analyzed responses in mice deficient in gamma c(gamma(c)) to elucidate the role of the Type I IL-4 receptor. OVA primed CD4(+) OT-II T cells were adoptively transferred into RAG2(-/-) and gamma(-/-)(c) mice and allergic lung disease was induced. Both gamma(-/-)(c) and gamma(c)xRAG2(-/-) mice developed increased pulmonary inflammation and eosinophilia upon OVA challenge, compared to RAG2(-/-) mice. Characteristic AAM proteins FIZZ1 and YM1 were expressed in lung epithelial cells in both mouse strains, but greater numbers of FIZZ1+ or YM1+ airways were present in gamma(-/-)(c) mice. Absence of cc in macrophages, however, resulted in reduced YM1 expression. We observed higher T(H)2 cytokine levels in the BAL and an altered DC phenotype in the gamma(-/-)(c) recipient mice suggesting the potential for dysregulated T cell and dendritic cell (DC) activation in the gamma(c)-deficient environment. These results demonstrate that in absence of the Type I IL-4R, the Type II R can mediate allergic responses in the presence of T(H)2 effectors. However, the Type I R regulates AAM protein expression in macrophages.	[Dasgupta, Preeta; Keegan, Achsah D.] Univ Maryland, Sch Med, Dept Microbiol & Immunol, Ctr Vasc & Inflammatory Dis, Baltimore, MD 21201 USA; [Qi, Xiulan; Smith, Elizabeth P.] Univ Maryland, Sch Med, Ctr Vasc & Inflammatory Dis, Baltimore, MD 21201 USA	University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore	Keegan, AD (corresponding author), Univ Maryland, Sch Med, Dept Microbiol & Immunol, Ctr Vasc & Inflammatory Dis, Baltimore, MD 21201 USA.	akeegan@som.umaryland.edu			PHS [AI038985]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI038985, R01AI059775, R29AI038985] Funding Source: NIH RePORTER	PHS(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by PHS grant AI038985 (ADK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barlow JL, 2012, J ALLERGY CLIN IMMUN, V129, P191, DOI 10.1016/j.jaci.2011.09.041; Bream JH, 2003, BLOOD, V102, P207, DOI 10.1182/blood-2002-08-2602; CAO XQ, 1995, IMMUNITY, V2, P223, DOI 10.1016/1074-7613(95)90047-0; Chang NCA, 2001, J BIOL CHEM, V276, P17497, DOI 10.1074/jbc.M010417200; Dasgupta P, 2011, BMC IMMUNOL, V12, DOI 10.1186/1471-2172-12-60; Grunig G, 1998, SCIENCE, V282, P2261, DOI 10.1126/science.282.5397.2261; Heller NM, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.1164795; Heller NM, 2004, AM J RESP CELL MOL, V31, P573, DOI 10.1165/rcmb.2004-0195OC; Humbles AA, 2004, SCIENCE, V305, P1776, DOI 10.1126/science.1100283; Ito T, 2005, J EXP MED, V202, P1213, DOI 10.1084/jem.20051135; Kearley J, 2011, AM J RESP CRIT CARE, V183, P865, DOI 10.1164/rccm.200909-1462OC; Kelly-Welch AE, 2004, J IMMUNOL, V172, P4545, DOI 10.4049/jimmunol.172.7.4545; Kovanen PE, 2004, IMMUNOL REV, V202, P67, DOI 10.1111/j.0105-2896.2004.00203.x; Kuperman D, 1998, J EXP MED, V187, P939, DOI 10.1084/jem.187.6.939; Liang HE, 2012, NAT IMMUNOL, V13, P58, DOI 10.1038/ni.2182; Liu TJ, 2004, AM J PATHOL, V164, P1315, DOI 10.1016/S0002-9440(10)63218-X; Lutz MB, 2002, J IMMUNOL, V169, P3574, DOI 10.4049/jimmunol.169.7.3574; Matsuda H, 2002, AM J RESP CRIT CARE, V166, P1050, DOI 10.1164/rccm.2110066; McMillan S, 2002, J EXP MED, V195, P51, DOI 10.1084/jem.20011732; Morris SC, 2006, J IMMUNOL, V176, P5299, DOI 10.4049/jimmunol.176.9.5299; Munitz A, 2008, P NATL ACAD SCI USA, V105, P7240, DOI 10.1073/pnas.0802465105; Neill DR, 2011, TRENDS PARASITOL, V27, P214, DOI 10.1016/j.pt.2011.01.001; Nelms K, 1999, ANNU REV IMMUNOL, V17, P701, DOI 10.1146/annurev.immunol.17.1.701; Perkins C, 2006, J ALLERGY CLIN IMMUN, V118, P410, DOI 10.1016/j.jaci.2006.06.004; PESCHON JJ, 1994, J EXP MED, V180, P1955, DOI 10.1084/jem.180.5.1955; Price AE, 2010, P NATL ACAD SCI USA, V107, P11489, DOI 10.1073/pnas.1003988107; Ramalingam TR, 2008, NAT IMMUNOL, V9, P25, DOI 10.1038/ni1544; Rankin JA, 1996, P NATL ACAD SCI USA, V93, P7821, DOI 10.1073/pnas.93.15.7821; Rochman Y, 2009, NAT REV IMMUNOL, V9, P480, DOI 10.1038/nri2580; Wills-Karp M, 1998, SCIENCE, V282, P2258, DOI 10.1126/science.282.5397.2258; Wills-Karp M, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.1.51.pe55; Wynn TA, 2011, J EXP MED, V208, P1339, DOI 10.1084/jem.20110551; Zhou Z, 1999, J CLIN INVEST, V103, P779, DOI 10.1172/JCI5909	33	5	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2013	8	8							e71344	10.1371/journal.pone.0071344	http://dx.doi.org/10.1371/journal.pone.0071344			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	218XC	23940740	gold, Green Published, Green Submitted			2022-12-25	WOS:000324465000206
J	Fraenkel, M; Novack, V; Liel, Y; Koretz, M; Siris, E; Norton, L; Shafat, T; Shany, S; Geffen, DB				Fraenkel, Merav; Novack, Victor; Liel, Yair; Koretz, Michael; Siris, Ethel; Norton, Larry; Shafat, Tali; Shany, Shraga; Geffen, David B.			Association between Bone Mineral Density and Incidence of Breast Cancer	PLOS ONE			English	Article							OSTEOPOROSIS TRIAL MABOT; POSTMENOPAUSAL WOMEN; OLDER WOMEN; RISK; MASS; MAMMOGRAPHY; HEALTH	Introduction: Previous studies have suggested an inverse relationship between bone mineral density (BMD) and breast cancer incidence. The primary objective of this study was to assess whether BMD is associated with risk of subsequent breast cancer occurrence in the female population of southern Israel. Methods: The electronic medical charts of women who underwent BMD at the Soroka Medical Center (SMC) between February 2003 and March 2011 were screened for subsequent breast cancer diagnoses. Women were divided by tertiles of BMD at 3 skeletal sites: lumbar spine (LS, L1-4), total hip (TH) and femoral neck (FN). The incidence of breast cancer was calculated. Results: Of 15268 women who underwent BMD testing, 86 were subsequently diagnosed with breast cancer. Most women in the study were older than 50 years (94.2% and 92.7%, respectively; p = 0.597). Women who subsequently developed breast cancer had a higher mean body-mass index (BMI) (30.9 +/- 5.5 vs. 29.1 +/- 5.7 p = 0.004) and the mean BMD Z-score was significantly higher than in those without breast cancer for all 3 skeletal sites (LS: 0.36 +/- 1.58 vs. -0.12 +/- 1.42, p = 0.002; TH: 0.37 +/- 1.08 vs. 0.03 +/- 1.02, p = 0.002; FN: 0.04 +/- 0.99 vs. -0.18 +/- 0.94; p = 0.026). Women in the highest Z-score tertiles at the FN and TH had a higher chance of developing breast cancer compared to the lowest tertile; odds ratio of 2.15, 2.02, respectively (P = 0.004 and 0.01 respectively). No association was found between the BMD Z-score and the stage, histology, grade or survival from breast cancer. Conclusions: This study provides additional support for an inverse association between BMD and the risk of breast cancer.	[Fraenkel, Merav; Liel, Yair] Columbia Univ, Med Ctr, Endocrine Unit, New York, NY 10027 USA; [Novack, Victor; Shafat, Tali] Columbia Univ, Clin Res Ctr, Med Ctr, New York, NY USA; [Koretz, Michael] Columbia Univ, Breast Hlth Ctr, Med Ctr, New York, NY USA; [Siris, Ethel] Columbia Univ, Div Endocrinol, Med Ctr, New York, NY USA; [Norton, Larry] Mem Sloan Kettering Canc Ctr, Breast Ctr, New York, NY 10021 USA; [Shany, Shraga] Ben Gurion Univ Negev, Dept Clin Biochem, IL-84105 Beer Sheva, Israel; [Geffen, David B.] Soroka Univ, Dept Oncol, Med Ctr, Beer Sheva, Israel; [Geffen, David B.] Ben Gurion Univ Negev, Fac Hlth Sci, Beer Sheva, Israel	Columbia University; Columbia University; Columbia University; Columbia University; Memorial Sloan Kettering Cancer Center; Ben Gurion University; Ben Gurion University; Soroka Medical Center; Ben Gurion University	Fraenkel, M (corresponding author), Columbia Univ, Med Ctr, Endocrine Unit, New York, NY 10027 USA.	meravfra@gmail.com	Fraenkel, Mearv/A-5120-2016; shafat, tali/AAA-3566-2019	Fraenkel, Mearv/0000-0002-9039-5565; Norton, Larry/0000-0003-3701-9250	Cure Breast Cancer Foundation	Cure Breast Cancer Foundation	Funded by an unrestricted research grant, Cure Breast Cancer Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Buist DSM, 2001, CANCER CAUSE CONTROL, V12, P213, DOI 10.1023/A:1011231106772; Buist DSM, 2001, J CLIN EPIDEMIOL, V54, P417, DOI 10.1016/S0895-4356(00)00301-2; Burstein HJ, 2011, CANC PRINCIPLES PRAC, P1401; Cauley JA, 1996, JAMA-J AM MED ASSOC, V276, P1404, DOI 10.1001/jama.276.17.1404; Cauley JA, 2007, BREAST CANCER RES TR, V102, P181, DOI 10.1007/s10549-006-9326-5; Chen Z, 2008, CANCER-AM CANCER SOC, V113, P907, DOI 10.1002/cncr.23674; Ganry O, 2004, EUR J EPIDEMIOL, V19, P785, DOI 10.1023/B:EJEP.0000036567.60387.39; Grenier D, 2011, BREAST CANCER RES TR, V126, P679, DOI 10.1007/s10549-010-1138-y; Hadji P, 2007, MATURITAS, V56, P312, DOI 10.1016/j.maturitas.2006.09.005; Kalder M, 2011, CLIMACTERIC, V14, P352, DOI 10.3109/13697137.2011.557754; Kerlikowske K, 1999, JAMA-J AM MED ASSOC, V282, P2156, DOI 10.1001/jama.282.22.2156; Kritz-Silverstein D, 2006, OSTEOPOROSIS INT, V17, P1196, DOI 10.1007/s00198-006-0124-z; Nguyen TV, 2000, MATURITAS, V36, P27, DOI 10.1016/S0378-5122(00)00133-X; Reginster JY, 2005, CURR MED RES OPIN, V21, P579, DOI 10.1185/030079905X41435; Stewart A, 2005, OSTEOPOROSIS INT, V16, P1627, DOI 10.1007/s00198-005-1886-4; Tremollieres FA, 2008, OSTEOPOROSIS INT, V19, P1497, DOI 10.1007/s00198-008-0596-0; Tremollieres F, 2010, MATURITAS, V65, P348, DOI 10.1016/j.maturitas.2009.12.023; van der Klift M, 2003, BONE, V32, P211, DOI 10.1016/S8756-3282(02)00972-9; Zhang YQ, 1997, NEW ENGL J MED, V336, P611, DOI 10.1056/NEJM199702273360903	19	19	19	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2013	8	8							e70980	10.1371/journal.pone.0070980	http://dx.doi.org/10.1371/journal.pone.0070980			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	218XC	23940680	Green Published, gold, Green Submitted			2022-12-25	WOS:000324465000167
J	Ho, J; Ondos, J; Ning, H; Smith, S; Kreisl, T; Iwamoto, F; Sul, J; Kim, L; McNeil, K; Krauze, A; Shankavaram, U; Fine, HA; Camphausen, K				Ho, Jennifer; Ondos, John; Ning, Holly; Smith, Sharon; Kreisl, Teri; Iwamoto, Fabio; Sul, Joohee; Kim, Lyndon; McNeil, Kate; Krauze, Andra; Shankavaram, Uma; Fine, Howard A.; Camphausen, Kevin			Chemoirradiation for Glioblastoma Multiforme: The National Cancer Institute Experience	PLOS ONE			English	Article							NEWLY-DIAGNOSED GLIOBLASTOMA; RECURSIVE PARTITIONING ANALYSIS; RADIATION-THERAPY; PROGNOSTIC-SIGNIFICANCE; ADJUVANT TEMOZOLOMIDE; VOLUMETRIC-ANALYSIS; PHASE-II; SURVIVAL; RADIOTHERAPY; BEVACIZUMAB	Purpose: Standard treatment for glioblastoma (GBM) is surgery followed by radiation (RT) and temozolomide (TMZ). While there is variability in survival based on several established prognostic factors, the prognostic utility of other factors such as tumor size and location are not well established. Experimental Design: The charts of ninety two patients with GBM treated with RT at the National Cancer Institute (NCI) between 1998 and 2012 were retrospectively reviewed. Most patients received RT with concurrent and adjuvant TMZ. Topographic locations were classified using preoperative imaging. Gross tumor volumes were contoured using treatment planning systems utilizing both pre-operative and post-operative MR imaging. Results: At a median follow-up of 18.7 months, the median overall survival (OS) and progression-free survival (PFS) for all patients was 17.9 and 7.6 months. Patients with the smallest tumors had a median OS of 52.3 months compared to 16.3 months among patients with the largest tumors, P = 0.006. The patients who received bevacizumab after recurrence had a median OS of 23.3 months, compared to 16.3 months in patients who did not receive it, P = 0.0284. The median PFS and OS in patients with periventricular tumors was 5.7 and 17.5 months, versus 8.9 and 23.3 months in patients with non-periventricular tumors, P = 0.005. Conclusions: Survival in our cohort was comparable to the outcome of the defining EORTC-NCIC trial establishing the use of RT+TMZ. This study also identifies several potential prognostic factors that may be useful in stratifying patients.	[Ho, Jennifer; Smith, Sharon; Krauze, Andra; Shankavaram, Uma; Camphausen, Kevin] NCI, Radiat Oncol Branch, NIH, Bethesda, MD 20892 USA; [Kreisl, Teri; Iwamoto, Fabio; Sul, Joohee; McNeil, Kate; Fine, Howard A.] NCI, Neurooncol Branch, NIH, Bethesda, MD 20892 USA; [Ondos, John; Ning, Holly] Radiat Management Associates, Bethesda, MD USA; [Kim, Lyndon] Thomas Jefferson Univ, Jefferson Med Coll, Philadelphia, PA 19107 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Jefferson University	Camphausen, K (corresponding author), NCI, Radiat Oncol Branch, NIH, Bldg 10, Bethesda, MD 20892 USA.	camphauk@mail.nih.gov			National Cancer Institute, NIH	National Cancer Institute, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the intramural research program of the National Cancer Institute, NIH. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afra D, 2002, LANCET, V359, P1011; American Cancer Society, 2022, CANC FACTS FIGURES 2; Cao Y, 2006, CANCER RES, V66, P8912, DOI 10.1158/0008-5472.CAN-05-4328; Chaichana KL, 2008, J NEURO-ONCOL, V89, P219, DOI 10.1007/s11060-008-9609-2; Chen W, 2007, J CLIN ONCOL, V25, P4714, DOI 10.1200/JCO.2006.10.5825; Crawford FW, 2009, J NEURO-ONCOL, V91, P337, DOI 10.1007/s11060-008-9719-x; CURRAN WJ, 1993, J NATL CANCER I, V85, P704, DOI 10.1093/jnci/85.9.704; Ellingson BM, 2011, NEURO-ONCOLOGY, V13, P401, DOI 10.1093/neuonc/noq206; Ellingson BM, 2011, J NEURO-ONCOL, V102, P95, DOI 10.1007/s11060-010-0293-7; Grossman SA, 2010, CLIN CANCER RES, V16, P2443, DOI 10.1158/1078-0432.CCR-09-3106; Hammoud MA, 1996, J NEURO-ONCOL, V27, P65, DOI 10.1007/BF00146086; Iliadis G, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-3; Jalali R, 2007, BRIT J NEUROSURG, V21, P583, DOI 10.1080/02688690701604574; Jeon HJ, 2009, CLIN NEUROL NEUROSUR, V111, P679, DOI 10.1016/j.clineuro.2009.06.013; Keles GE, 2004, J NEUROSURG, V100, P41, DOI 10.3171/jns.2004.100.1.0041; Kowalczuk A, 1997, NEUROSURGERY, V41, P1028, DOI 10.1097/00006123-199711000-00004; Lacroix M, 2001, J NEUROSURG, V95, P190, DOI 10.3171/jns.2001.95.2.0190; Lai A, 2011, J CLIN ONCOL, V29, P142, DOI 10.1200/JCO.2010.30.2729; Li J, 2011, INT J RADIAT ONCOL, V81, P623, DOI 10.1016/j.ijrobp.2010.06.012; Lim DA, 2007, NEURO-ONCOLOGY, V9, P424, DOI 10.1215/15228517-2007-023; MACDONALD DR, 1990, J CLIN ONCOL, V8, P1277, DOI 10.1200/JCO.1990.8.7.1277; Milano MT, 2010, INT J RADIAT ONCOL, V78, P1147, DOI 10.1016/j.ijrobp.2009.09.018; Mirimanoff RO, 2006, J CLIN ONCOL, V24, P2563, DOI 10.1200/JCO.2005.04.5963; Oppitz U, 1999, RADIOTHER ONCOL, V53, P53, DOI 10.1016/S0167-8140(99)00117-6; Paravati AJ, 2011, J NEURO-ONCOL, V104, P339, DOI 10.1007/s11060-010-0499-8; Parsa AT, 2005, J NEUROSURG, V102, P622, DOI 10.3171/jns.2005.102.4.0622; Pope WB, 2009, RADIOLOGY, V252, P182, DOI 10.1148/radiol.2521081534; Ramakrishna R, 2010, SURG NEUROL INT, V1; Saraswathy S, 2009, J NEURO-ONCOL, V91, P69, DOI 10.1007/s11060-008-9685-3; Sawlani RN, 2010, RADIOLOGY, V255, P622, DOI 10.1148/radiol.10091341; Stall B, 2010, RADIAT ONCOL, V5, DOI 10.1186/1748-717X-5-5; Stupp R, 2005, NEW ENGL J MED, V352, P987, DOI 10.1056/NEJMoa043330; Tralins KS, 2002, J NUCL MED, V43, P1667; Tsien CI, 2012, CLIN CANCER RES, V18, P273, DOI 10.1158/1078-0432.CCR-11-2073; Wang Yun-yan, 2004, Chinese Medical Sciences Journal, V19, P105; Young GS, 2011, J NEURO-ONCOL, V104, P261, DOI 10.1007/s11060-010-0477-1	36	14	19	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2013	8	8							e70745	10.1371/journal.pone.0070745	http://dx.doi.org/10.1371/journal.pone.0070745			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	218XC	23940635	gold, Green Published, Green Submitted			2022-12-25	WOS:000324465000128
J	Povysheva, NV; Zaitsev, AV; Gonzalez-Burgos, G; Lewis, DA				Povysheva, Nadezhda V.; Zaitsev, Aleksey V.; Gonzalez-Burgos, Guillermo; Lewis, David A.			Electrophysiological Heterogeneity of Fast-Spiking Interneurons: Chandelier versus Basket Cells	PLOS ONE			English	Article							DORSOLATERAL PREFRONTAL CORTEX; LOCAL-CIRCUIT NEURONS; RAT FRONTAL-CORTEX; PYRAMIDAL NEURONS; MORPHOLOGICAL PROPERTIES; SYNAPTIC CONNECTIONS; CORTICAL-NEURONS; IN-VITRO; PARVALBUMIN; CHANNELS	In the prefrontal cortex, parvalbumin-positive inhibitory neurons play a prominent role in the neural circuitry that subserves working memory, and alterations in these neurons contribute to the pathophysiology of schizophrenia. Two morphologically distinct classes of parvalbumin neurons that target the perisomatic region of pyramidal neurons, chandelier cells (ChCs) and basket cells (BCs), are generally thought to have the same "fast-spiking" phenotype, which is characterized by a short action potential and high frequency firing without adaptation. However, findings from studies in different species suggest that certain electrophysiological membrane properties might differ between these two cell classes. In this study, we assessed the physiological heterogeneity of fast-spiking interneurons as a function of two factors: species (macaque monkey vs. rat) and morphology (chandelier vs. basket). We showed previously that electrophysiological membrane properties of BCs differ between these two species. Here, for the first time, we report differences in ChCs membrane properties between monkey and rat. We also found that a number of membrane properties differentiate ChCs from BCs. Some of these differences were species-independent (e. g., fast and medium afterhyperpolarization, firing frequency, and depolarizing sag), whereas the differences in the first spike latency between ChCs and BCs were species-specific. Our findings indicate that different combinations of electrophysiological membrane properties distinguish ChCs from BCs in rodents and primates. Such electrophysiological differences between ChCs and BCs likely contribute to their distinctive roles in cortical circuitry in each species.	[Povysheva, Nadezhda V.; Zaitsev, Aleksey V.; Gonzalez-Burgos, Guillermo; Lewis, David A.] Univ Pittsburgh, Dept Psychiat, Pittsburgh, PA 15260 USA; [Povysheva, Nadezhda V.; Lewis, David A.] Univ Pittsburgh, Dept Neurosci, Pittsburgh, PA USA; [Zaitsev, Aleksey V.] Russian Acad Sci, Inst Evolutionary Physiol & Biochem, St Petersburg 196140, Russia	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Russian Academy of Sciences; Sechenov Institute of Evolutionary Physiology & Biochemistry	Povysheva, NV (corresponding author), Univ Pittsburgh, Dept Psychiat, Pittsburgh, PA 15260 USA.	nvp1@pitt.edu	Lewis, David A/G-4053-2014; Zaitsev, Aleksey/A-5648-2008	Lewis, David A/0000-0002-3225-6778; Zaitsev, Aleksey/0000-0002-4503-0647; Gonzalez-Burgos, Guillermo/0000-0002-1650-8111	National Institute of Mental Health [MH043784, MH084053]; Alzheimer's Association [NIRG-10-174367]; Russian Foundation for Basic Research [11-04-00912]; Program for Basic Research of the Presidium of the Russian Academy of Sciences (Molecular and Cell Biology); Bristol-Myers Squibb; Pfizer; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH043784, R37MH043784, P50MH084053] Funding Source: NIH RePORTER	National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Alzheimer's Association(Alzheimer's Association); Russian Foundation for Basic Research(Russian Foundation for Basic Research (RFBR)); Program for Basic Research of the Presidium of the Russian Academy of Sciences (Molecular and Cell Biology); Bristol-Myers Squibb(Bristol-Myers Squibb); Pfizer(Pfizer); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by National Institute of Mental Health Grants MH043784 and MH084053 to DAL. NVP was partially supported by the Alzheimer's Association Grant NIRG-10-174367. AVZ was supported by Russian Foundation for Basic Research Grant 11-04-00912 and by the Program for Basic Research of the Presidium of the Russian Academy of Sciences (Molecular and Cell Biology). DAL currently receives investigator-initiated research support from Bristol-Myers Squibb and Pfizer and in 2010-2012 served as a consultant in the areas of target identification and validation and new compound development to Bristol-Myers Squibb and Concert. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aponte Y, 2006, J PHYSIOL-LONDON, V574, P229, DOI 10.1113/jphysiol.2005.104042; Ascoli GA, 2008, NAT REV NEUROSCI, V9, P557, DOI 10.1038/nrn2402; Bartos M, 2007, NAT REV NEUROSCI, V8, P45, DOI 10.1038/nrn2044; Breiman L, 1984, CLASSIFICATION REGRE, Vx; CONDE F, 1994, J COMP NEUROL, V341, P95, DOI 10.1002/cne.903410109; Constantinidis C, 2002, J NEUROPHYSIOL, V88, P3487, DOI 10.1152/jn.00188.2002; Descalzo VF, 2005, J NEUROPHYSIOL, V93, P1111, DOI 10.1152/jn.00658.2004; Douglas RJ, 2004, ANNU REV NEUROSCI, V27, P419, DOI 10.1146/annurev.neuro.27.070203.144152; Dugladze T, 2012, SCIENCE, V336, P1458, DOI 10.1126/science.1222017; Gabbott PLA, 1997, J COMP NEUROL, V377, P465, DOI 10.1002/(SICI)1096-9861(19970127)377:4<465::AID-CNE1>3.0.CO;2-0; Glazebrook PA, 2002, J PHYSIOL-LONDON, V541, P467, DOI 10.1113/jphysiol.2001.018333; Glickfeld LL, 2009, NAT NEUROSCI, V12, P21, DOI 10.1038/nn.2230; Gonzalez-Burgos G, 2005, J NEUROPHYSIOL, V93, P942, DOI 10.1152/jn.00787.2004; Guan D, 2006, J PHYSIOL-LONDON, V571, P371, DOI 10.1113/jphysiol.2005.097006; Inan M, 2013, J NEUROSCI, V33, P1907, DOI 10.1523/JNEUROSCI.4049-12.2013; Jung MW, 1998, CEREB CORTEX, V8, P437, DOI 10.1093/cercor/8.5.437; Kawaguchi Y, 1997, CEREB CORTEX, V7, P476, DOI 10.1093/cercor/7.6.476; KAWAGUCHI Y, 1995, J NEUROSCI, V15, P2638; KAWAGUCHI Y, 1993, J NEUROSCI, V13, P4908; Krimer LS, 2005, J NEUROPHYSIOL, V94, P3009, DOI 10.1152/jn.00156.2005; Krimer LS, 2001, J NEUROSCI, V21, P3788, DOI 10.1523/JNEUROSCI.21-11-03788.2001; Lewis DA, 2012, TRENDS NEUROSCI, V35, P57, DOI 10.1016/j.tins.2011.10.004; LUND JS, 1993, J COMP NEUROL, V328, P282, DOI 10.1002/cne.903280209; Massi L, 2012, J NEUROSCI, V32, P16496, DOI 10.1523/JNEUROSCI.3475-12.2012; MCCORMICK DA, 1985, J NEUROPHYSIOL, V54, P782, DOI 10.1152/jn.1985.54.4.782; Pape HC, 1996, ANNU REV PHYSIOL, V58, P299, DOI 10.1146/annurev.ph.58.030196.001503; Povysheva NV, 2008, J NEUROPHYSIOL, V100, P2348, DOI 10.1152/jn.90396.2008; Robinson RB, 2003, ANNU REV PHYSIOL, V65, P453, DOI 10.1146/annurev.physiol.65.092101.142734; Rudy B, 1999, ANN NY ACAD SCI, V868, P304, DOI 10.1111/j.1749-6632.1999.tb11295.x; Sah P, 2002, PROG NEUROBIOL, V66, P345, DOI 10.1016/S0301-0082(02)00004-7; Sanchez-Vives MV, 2000, J NEUROSCI, V20, P4286; Sauer JF, 2012, J NEUROSCI, V32, P4224, DOI 10.1523/JNEUROSCI.5702-11.2012; Seamans JK, 2008, NEUROTOX RES, V14, P249, DOI 10.1007/BF03033814; SIMONS DJ, 1978, J NEUROPHYSIOL, V41, P798, DOI 10.1152/jn.1978.41.3.798; Sohal VS, 2009, NATURE, V459, P698, DOI 10.1038/nature07991; Steriade M, 2001, J NEUROPHYSIOL, V85, P1969, DOI 10.1152/jn.2001.85.5.1969; Szabadics J, 2006, SCIENCE, V311, P233, DOI 10.1126/science.1121325; Taniguchi H, 2012, SCIENCE; Thomson AM, 1996, J PHYSIOL-LONDON, V496, P81, DOI 10.1113/jphysiol.1996.sp021667; WILSON FAW, 1994, P NATL ACAD SCI USA, V91, P4009, DOI 10.1073/pnas.91.9.4009; Woodruff A, 2009, FRONT NEURAL CIRCUIT, V3, DOI 10.3389/neuro.04.015.2009; Woodruff AR, 2011, J NEUROSCI, V31, P17872, DOI 10.1523/JNEUROSCI.3894-11.2011; Xu XM, 2009, J NEUROSCI, V29, P70, DOI 10.1523/JNEUROSCI.4104-08.2009; Yang CR, 1996, J NEUROSCI, V16, P1904; Zaitsev AV, 2009, CEREB CORTEX, V19, P1597, DOI 10.1093/cercor/bhn198; Zaitsev AV, 2005, CEREB CORTEX, V15, P1178, DOI 10.1093/cercor/bhh218	46	38	38	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2013	8	8							e70553	10.1371/journal.pone.0070553	http://dx.doi.org/10.1371/journal.pone.0070553			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	200UV	23950961	Green Published, gold, Green Accepted, Green Submitted			2022-12-25	WOS:000323097300028
J	Cong, WN; Wang, R; Cai, H; Daimon, CM; Scheibye-Knudsen, M; Bohr, VA; Turkin, R; Wood, WH; Becker, KG; Moaddel, R; Maudsley, S; Martin, B				Cong, Wei-na; Wang, Rui; Cai, Huan; Daimon, Caitlin M.; Scheibye-Knudsen, Morten; Bohr, Vilhelm A.; Turkin, Rebecca; Wood, William H., III; Becker, Kevin G.; Moaddel, Ruin; Maudsley, Stuart; Martin, Bronwen			Long-Term Artificial Sweetener Acesulfame Potassium Treatment Alters Neurometabolic Functions in C57BL/6J Mice	PLOS ONE			English	Article							BODY-SURFACE AREA; SYNAPTIC PLASTICITY; ALZHEIMERS-DISEASE; METABOLIC SYNDROME; CREATINE-KINASE; MAMMALIAN SWEET; SH-SY5Y CELLS; UP-REGULATION; P-ERK; TASTE	With the prevalence of obesity, artificial, non-nutritive sweeteners have been widely used as dietary supplements that provide sweet taste without excessive caloric load. In order to better understand the overall actions of artificial sweeteners, especially when they are chronically used, we investigated the peripheral and central nervous system effects of protracted exposure to a widely used artificial sweetener, acesulfame K (ACK). We found that extended ACK exposure (40 weeks) in normal C57BL/6J mice demonstrated a moderate and limited influence on metabolic homeostasis, including altering fasting insulin and leptin levels, pancreatic islet size and lipid levels, without affecting insulin sensitivity and bodyweight. Interestingly, impaired cognitive memory functions (evaluated by Morris Water Maze and Novel Objective Preference tests) were found in ACK-treated C57BL/6J mice, while no differences in motor function and anxiety levels were detected. The generation of an ACK-induced neurological phenotype was associated with metabolic dysregulation (glycolysis inhibition and functional ATP depletion) and neurosynaptic abnormalities (dysregulation of TrkB-mediated BDNF and Akt/Erk-mediated cell growth/survival pathway) in hippocampal neurons. Our data suggest that chronic use of ACK could affect cognitive functions, potentially via altering neuro-metabolic functions in male C57BL/6J mice.	[Cong, Wei-na; Wang, Rui; Cai, Huan; Daimon, Caitlin M.; Turkin, Rebecca; Martin, Bronwen] NIA, Metab Unit, Clin Invest Lab, Baltimore, MD 21224 USA; [Scheibye-Knudsen, Morten; Bohr, Vilhelm A.] NIA, Sect DNA Repair, Lab Mol Gerontol, Baltimore, MD 21224 USA; [Wood, William H., III; Becker, Kevin G.] NIA, Gene Express & Genom Unit, Genet Lab, Baltimore, MD 21224 USA; [Maudsley, Stuart] NIA, Receptor Pharmacol Unit, Neurosci Lab, Baltimore, MD 21224 USA; [Moaddel, Ruin] NIA, Bioanalyt Chem & Drug Discovery Sect, Clin Invest Lab, Baltimore, MD 21224 USA	National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA)	Martin, B (corresponding author), NIA, Metab Unit, Clin Invest Lab, Baltimore, MD 21224 USA.	martinbro@mail.nih.gov	Moaddel, Ruin/AAE-3378-2020; Cai, Huan/B-6578-2016; Bohr, Vilhelm/AAP-5931-2020; Maudsley, Stuart/Q-4782-2019; Wang, Rui/I-5643-2019; Maudsley, Stuart/AAV-9929-2021	Cai, Huan/0000-0001-7731-8891; Wang, Rui/0000-0001-7015-0272; Maudsley, Stuart/0000-0002-1868-184X; Becker, Kevin/0000-0002-6794-6656; Moaddel, Ruin/0000-0002-6812-0127; Scheibye-Knudsen, Morten/0000-0002-6637-1280; Martin, Bronwen/0000-0002-9185-6925	Intramural Research Program of the National Institute on Aging at the National Institutes of Health; NATIONAL INSTITUTE ON AGING [ZICAG000616, ZIAAG000291] Funding Source: NIH RePORTER	Intramural Research Program of the National Institute on Aging at the National Institutes of Health; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was carried out with the support of the Intramural Research Program of the National Institute on Aging at the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andreasson KI, 2001, J NEUROSCI, V21, P8198; Bandyopadhyay A, 2008, DRUG CHEM TOXICOL, V31, P447, DOI [10.1080/01480540802390270, 10.1080/01480540802390270 ]; Bolognani F, 2007, NEUROCHEM RES, V32, P2142, DOI 10.1007/s11064-007-9388-8; Borgesius NZ, 2011, J NEUROSCI, V31, P10141, DOI 10.1523/JNEUROSCI.5105-10.2011; Brown RJ, 2009, DIABETES CARE, V32, P2184, DOI 10.2337/dc09-1185; Cai H, 2012, CURR ALZHEIMER RES, V9, P5, DOI 10.2174/156720512799015064; Chadwick W, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021660; Chadwick W, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021638; Chadwick W, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014352; Chiba T, 2007, ANN NY ACAD SCI, V1119, P216, DOI 10.1196/annals.1404.013; CLAUSS K, 1976, Z LEBENSM UNTERS FOR, V162, P37, DOI 10.1007/BF01104359; Damak S, 2003, SCIENCE, V301, P850, DOI 10.1126/science.1087155; de Koning L, 2012, CIRCULATION, V125, P1735, DOI 10.1161/CIRCULATIONAHA.111.067017; Dhingra R, 2007, CIRCULATION, V116, P480, DOI 10.1161/CIRCULATIONAHA.107.689935; Donnelly D, 1999, BIOCHEM J, V339, P55, DOI 10.1042/0264-6021:3390055; Duffy VB, 2004, J AM DIET ASSOC, V104, P255, DOI 10.1016/j.jada.2003.12.001; Fehm HL, 2006, PROG BRAIN RES, V153, P129, DOI 10.1016/S0079-6123(06)53007-9; Fowler SP, 2008, OBESITY, V16, P1894, DOI 10.1038/oby.2008.284; FRIEDMAN DL, 1994, J COMP NEUROL, V343, P500, DOI 10.1002/cne.903430311; Grice HC, 2000, FOOD CHEM TOXICOL, V38, pS1, DOI 10.1016/S0278-6915(00)00023-5; Grotz VL, 2009, REGUL TOXICOL PHARM, V55, P1, DOI 10.1016/j.yrtph.2009.05.011; Hamdan FF, 2011, EUR J HUM GENET, V19, P607, DOI 10.1038/ejhg.2010.183; Herrmann AG, 2013, J CEREB BLOOD FLOW M; Huang G, 2007, CELL DEATH DIFFER, V14, P327, DOI 10.1038/sj.cdd.4402004; Hur J, 2010, BIOCHEM BIOPH RES CO, V391, P1526, DOI 10.1016/j.bbrc.2009.12.114; Ilieva H, 2003, J NEUROL SCI, V215, P57, DOI 10.1016/S0022-510X(03)00186-2; Inoue K, 2006, J NEUROCHEM, V96, P598, DOI 10.1111/j.1471-4159.2005.03560.x; Inoue M, 2001, CHEM SENSES, V26, P915, DOI 10.1093/chemse/26.7.915; Li F, 2003, BRAIN RES, V962, P21, DOI 10.1016/S0006-8993(02)03774-5; Li HS, 2001, PHYSIOL GENOMICS, V6, P91, DOI 10.1152/physiolgenomics.2001.6.2.91; Lloret A, 2011, J ALZHEIMERS DIS, V27, P701, DOI 10.3233/JAD-2011-110890; Lutsey PL, 2008, CIRCULATION, V117, P754, DOI 10.1161/CIRCULATIONAHA.107.716159; Mace OJ, 2007, J PHYSIOL-LONDON, V582, P379, DOI 10.1113/jphysiol.2007.130906; Magnuson BA, 2007, CRIT REV TOXICOL, V37, P629, DOI 10.1080/10408440701516184; Majda BT, 2001, MOL BRAIN RES, V93, P173, DOI 10.1016/S0169-328X(01)00203-0; Malaisse WJ, 1998, CELL SIGNAL, V10, P727, DOI 10.1016/S0898-6568(98)00017-5; Margolskee RF, 2007, P NATL ACAD SCI USA, V104, P15075, DOI 10.1073/pnas.0706678104; Martin B, 2008, HISTOL HISTOPATHOL, V23, P237, DOI 10.14670/HH-23.237; Martin B, 2007, ENDOCRINOLOGY, V148, P4318, DOI 10.1210/en.2007-0161; Martin B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036911; Martin B, 2010, DIABETES, V59, P1143, DOI 10.2337/db09-0807; Martin B, 2009, TRENDS ENDOCRIN MET, V20, P163, DOI 10.1016/j.tem.2009.01.006; Martin B, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004146; Martin B, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002750; Martin B, 2009, DIABETES, V58, P318, DOI 10.2337/db08-0799; Martins-de-Souza Daniel, 2012, BMC Res Notes, V5, P146, DOI 10.1186/1756-0500-5-146; Mateo I, 2009, ACTA NEUROL SCAND, V120, P130, DOI 10.1111/j.1600-0404.2008.01128.x; Mattes RD, 2009, AM J CLIN NUTR, V89, P1, DOI 10.3945/ajcn.2008.26792; Maudsley S, 2005, J PHARMACOL EXP THER, V314, P485, DOI 10.1124/jpet.105.083121; Maudsley S, 2012, MINI-REV MED CHEM, V12, P831, DOI 10.2174/138955712800959071; Maudsley S, 1998, BRIT J PHARMACOL, V124, P675, DOI 10.1038/sj.bjp.0701889; Maudsley S, 2007, CURR ALZHEIMER RES, V4, P3, DOI 10.2174/156720507779939850; Maudsley S, 2011, ENDOCRINOLOGY, V152, P3592, DOI 10.1210/en.2011-1615; Mukherjee A, 1997, FOOD CHEM TOXICOL, V35, P1177, DOI 10.1016/S0278-6915(97)85469-5; Murray J, 2003, J BIOL CHEM, V278, P37223, DOI 10.1074/jbc.M305694200; Nakagawa Y, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005106; Nelson G, 2001, CELL, V106, P381, DOI 10.1016/S0092-8674(01)00451-2; Pellerin L, 2003, J CEREBR BLOOD F MET, V23, P1282, DOI 10.1097/01.WCB.0000096064.12129.3D; Pepino MY, 2011, CURR OPIN CLIN NUTR, V14, P391, DOI 10.1097/MCO.0b013e3283468e7e; Potter WB, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008996; Reagan-Shaw S, 2008, FASEB J, V22, P659, DOI 10.1096/fj.07-9574LSF; Ren XY, 2009, FRONT INTEGR NEUROSC, V3, DOI 10.3389/neuro.07.012.2009; Riera CE, 2008, BIOCHEM BIOPH RES CO, V376, P653, DOI 10.1016/j.bbrc.2008.09.029; Riera CE, 2007, AM J PHYSIOL-REG I, V293, pR626, DOI 10.1152/ajpregu.00286.2007; Russo VC, 2012, NEUROCHEM RES, V37, P1768, DOI 10.1007/s11064-012-0789-y; Sato S, 2013, AM J PHYSIOL-GASTR L; Sawyer M, 2001, INVEST NEW DRUG, V19, P171, DOI 10.1023/A:1010639201787; Scheibye-Knudsen M, 2012, J EXP MED, V209, P855, DOI 10.1084/jem.20111721; Schneider L, 2011, FREE RADICAL BIO MED, V51, P2007, DOI 10.1016/j.freeradbiomed.2011.08.030; Scribner KB, 2008, AM J PHYSIOL-ENDOC M, V295, pE1126, DOI 10.1152/ajpendo.90487.2008; Shin SJ, 2004, PROTEOMICS, V4, P3359, DOI 10.1002/pmic.200400961; Shin YK, 2012, J GERONTOL A-BIOL, V67, P336, DOI 10.1093/gerona/glr192; Storch A, 2000, BRAIN RES, V855, P67, DOI 10.1016/S0006-8993(99)02272-6; Sung JY, 2008, P NATL ACAD SCI USA, V105, P3112, DOI 10.1073/pnas.0712180105; Swerdlow RH, 2013, BBA-GEN SUBJECTS, V1830, P2891, DOI 10.1016/j.bbagen.2013.01.002; Swithers SE, 2012, BEHAV BRAIN RES, V233, P1, DOI 10.1016/j.bbr.2012.04.024; Swithers SE, 2009, BEHAV NEUROSCI, V123, P772, DOI 10.1037/a0016139; van de Woestijne AP, 2011, OBES REV, V12, P829, DOI 10.1111/j.1467-789X.2011.00900.x; VanGuilder HD, 2011, NEUROBIOL DIS, V43, P201, DOI 10.1016/j.nbd.2011.03.012; Verbraecken J, 2006, METABOLISM, V55, P515, DOI 10.1016/j.metabol.2005.11.004; Vitale M, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/728178; Volz M, 1976, 01L42017776 WHO HOEC; Yamada K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008596; Yamamoto H, 2011, J BIOL CHEM, V286, P26158, DOI 10.1074/jbc.M111.256446; Yang Qing, 2010, Yale Journal of Biology and Medicine, V83, P101; Zeigerer A, 2008, EXP CELL RES, V314, P2249, DOI 10.1016/j.yexcr.2008.04.003; Zhang GH, 2011, CHEM SENSES, V36, P763, DOI 10.1093/chemse/bjr050; Zhao GQ, 2003, CELL, V115, P255, DOI 10.1016/S0092-8674(03)00844-4; Zheng Y, 2013, J GASTROINTEST SURG, V17, P153, DOI 10.1007/s11605-012-1998-z	89	35	36	2	65	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2013	8	8							e70257	10.1371/journal.pone.0070257	http://dx.doi.org/10.1371/journal.pone.0070257			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	200ZE	23950916	Green Submitted, Green Published, gold			2022-12-25	WOS:000323109700025
J	Ouyang, SD; Hung, HC; Kastin, AJ; Pan, WH				Ouyang, Suidong; Hung Hsuchou; Kastin, Abba J.; Pan, Weihong			TNF Stimulates Nuclear Export and Secretion of IL-15 by Acting on CRM1 and ARF6	PLOS ONE			English	Article							NF-KAPPA-B; INTRACELLULAR TRAFFICKING; CEREBRAL ENDOTHELIA; PLASMA-MEMBRANE; ALPHA-CHAIN; INTERLEUKIN-15; RECEPTOR; EXPRESSION; BINDING; IDENTIFICATION	Interleukin (IL)-15 is a ubiquitously expressed cytokine that in the basal state is mainly localized intracellularly, including the nucleus. Unexpectedly, tumor necrosis factor-alpha (TNF) time-dependently induced nuclear export of IL-15R alpha and IL15. This process was inhibited by leptomycine B (LMB), a specific inhibitor of nuclear export receptor chromosomal region maintenance 1 (CRM1). In the presence of TNF, LMB co-treatment led to accumulation of both IL-15R alpha and IL-15 in the nucleus of HeLa cells, suggesting that CRM1 facilitates nuclear export and that TNF enhances CRM1 activity. Once in the cytoplasm, IL-15 showed partial co-localization with late endosomes but very little with other organelles tested 4 h after TNF treatment. IL-15R alpha showed co-localization with both early and late endosomes, and to a lesser extent with endoplasmic reticulum and Golgi. This indicates different kinetics and possibly different trafficking routes of IL-15 from its specific receptor. The TNF-induced secretion of IL-15 was attenuated by pretreatment of cells by brefeldin A that inhibits ER-to-Golgi transport, or by use of domain negative ADP-ribosylation factor 6 (ARF6) that interferes with exocytotic sorting. We conclude that TNF abolishes nuclear localization of IL-15 and IL-15R alpha by acting on CRM1, and it facilitates exocytosis of IL-15 with the involvement of ARF6.	[Ouyang, Suidong; Hung Hsuchou; Kastin, Abba J.; Pan, Weihong] Pennington Biomed Res Ctr, Baton Rouge, LA USA	Louisiana State University System; Louisiana State University; Pennington Biomedical Research Center	Pan, WH (corresponding author), Pennington Biomed Res Ctr, Baton Rouge, LA USA.	panw@pbrc.edu			National Institutes of Health (NIH) [NS62291, DK54880, DK92245]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK054880, R56DK054880] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS062291] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	Funding support was provided by National Institutes of Health (NIH) (NS62291 to WP and DK54880 and DK92245 to AJK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aikawa Y, 2003, J CELL BIOL, V162, P647, DOI 10.1083/jcb.200212142; Askjaer P, 1998, J BIOL CHEM, V273, P33414, DOI 10.1074/jbc.273.50.33414; Bamford RN, 1996, P NATL ACAD SCI USA, V93, P2897, DOI 10.1073/pnas.93.7.2897; Barzegar C, 1998, ONCOGENE, V16, P2503, DOI 10.1038/sj.onc.1201775; Bolte S, 2006, J MICROSC-OXFORD, V224, P213, DOI 10.1111/j.1365-2818.2006.01706.x; Buck M, 2001, EMBO J, V20, P6712, DOI 10.1093/emboj/20.23.6712; Cordelieres FP, 2008, P 2 IMAGEJ US DEV C, P174; D'Souza-Schorey C, 1998, J CELL BIOL, V140, P603, DOI 10.1083/jcb.140.3.603; D'Souza-Schorey C, 2006, NAT REV MOL CELL BIO, V7, P347, DOI 10.1038/nrm1910; deJong JLO, 1996, J IMMUNOL, V156, P1339; Dubois S, 1999, J BIOL CHEM, V274, P26978, DOI 10.1074/jbc.274.38.26978; Duitman EH, 2008, MOL CELL BIOL, V28, P4851, DOI 10.1128/MCB.02178-07; Dyer N, 2007, DEVELOPMENT, V134, P4437, DOI 10.1242/dev.010983; Fornerod M, 1997, CELL, V90, P1051, DOI 10.1016/S0092-8674(00)80371-2; Gaggero A, 1999, EUR J IMMUNOL, V29, P1265, DOI 10.1002/(SICI)1521-4141(199904)29:04<1265::AID-IMMU1265>3.0.CO;2-V; GIRI JG, 1995, EMBO J, V14, P3654, DOI 10.1002/j.1460-2075.1995.tb00035.x; Kudo N, 1999, P NATL ACAD SCI USA, V96, P9112, DOI 10.1073/pnas.96.16.9112; Kudo N, 1998, EXP CELL RES, V242, P540, DOI 10.1006/excr.1998.4136; Kurys G, 2000, J BIOL CHEM, V275, P30653, DOI 10.1074/jbc.M002373200; Lorenzen I, 2006, J BIOL CHEM, V281, P6642, DOI 10.1074/jbc.M513118200; Meazza R, 1996, ONCOGENE, V12, P2187; Pan WH, 2010, CELL PHYSIOL BIOCHEM, V25, P623, DOI 10.1159/000315081; Pan WH, 2009, J NEUROCHEM, V111, P819, DOI 10.1111/j.1471-4159.2009.06371.x; Pereno R, 2000, ONCOGENE, V19, P5153, DOI 10.1038/sj.onc.1203873; PETERS PJ, 1995, J CELL BIOL, V128, P1003, DOI 10.1083/jcb.128.6.1003; Quinn LS, 2010, EXP GERONTOL, V45, P106, DOI 10.1016/j.exger.2009.10.012; Richards SA, 1997, SCIENCE, V276, P1842, DOI 10.1126/science.276.5320.1842; Schafer DA, 2000, TRAFFIC, V1, P892; Stade K, 1997, CELL, V90, P1041, DOI 10.1016/S0092-8674(00)80370-0; Stone KP, 2011, CELL PHYSIOL BIOCHEM, V28, P115, DOI 10.1159/000331720; Stone KP, 2011, J NEUROCHEM, V116, P544, DOI 10.1111/j.1471-4159.2010.07142.x; Tagaya Y, 1997, P NATL ACAD SCI USA, V94, P14444, DOI 10.1073/pnas.94.26.14444; Vischioni B, 2004, EXP CELL RES, V298, P535, DOI 10.1016/j.yexcr.2004.04.040; Wu XJ, 2010, J NEUROCHEM, V114, P122, DOI 10.1111/j.1471-4159.2010.06729.x	34	12	12	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2013	8	8							e69356	10.1371/journal.pone.0069356	http://dx.doi.org/10.1371/journal.pone.0069356			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	200ZE	23950892	Green Published, Green Submitted, gold			2022-12-25	WOS:000323109700016
J	Coch, C; Luck, C; Schwickart, A; Putschli, B; Renn, M; Holler, T; Barchet, W; Hartmann, G; Schlee, M				Coch, Christoph; Lueck, Christian; Schwickart, Anna; Putschli, Bastian; Renn, Marcel; Hoeller, Tobias; Barchet, Winfried; Hartmann, Gunther; Schlee, Martin			A Human In Vitro Whole Blood Assay to Predict the Systemic Cytokine Response to Therapeutic Oligonucleotides Including siRNA	PLOS ONE			English	Article							PLASMACYTOID DENDRITIC CELLS; INNATE IMMUNE-RESPONSE; RIG-I; CPG OLIGONUCLEOTIDES; NORMAL VOLUNTEERS; IFN-ALPHA; RNA; INDUCTION; RECOGNITION; ACTIVATION	Therapeutic oligonucleotides including siRNA and immunostimulatory ligands of Toll-like receptors (TLR) or RIG-I like helicases (RLH) are a promising novel class of drugs. They are in clinical development for a broad spectrum of applications, e. g. as adjuvants in vaccines and for the immunotherapy of cancer. Species-specific immune activation leading to cytokine release is characteristic for therapeutic oligonucleotides either as an unwanted side effect or intended pharmacology. Reliable in vitro tests designed for therapeutic oligonucleotides are therefore urgently needed in order to predict clinical efficacy and to prevent unexpected harmful effects in clinical development. To serve this purpose, we here established a human whole blood assay (WBA) that is fast and easy to perform. Its response to synthetic TLR ligands (R848: TLR7/8, LPS: TLR4) was on a comparable threshold to the more time consuming peripheral blood mononuclear cell (PBMC) based assay. By contrast, the type I IFN profile provoked by intravenous CpG-DNA (TLR9 ligand) in humans in vivo was more precisely replicated in the WBA than in stimulated PBMC. Since Heparin and EDTA, but not Hirudin, displaced oligonucleotides from their delivery agent, only Hirudin qualified as the anticoagulant to be used in the WBA. The Hirudin WBA exhibited a similar capacity as the PBMC assay to distinguish between TLR7-activating and modified non-stimulatory siRNA sequences. RNA-based immunoactivating TLR7/8-and RIG-I-ligands induced substantial amounts of IFN-alpha in the Hirudin-WBA dependent on delivery agent used. In conclusion, we present a human Hirudin WBA to determine therapeutic oligonucleotide-induced cytokine release during preclinical development that can readily be performed and offers a close reflection of human cytokine response in vivo.	[Coch, Christoph; Lueck, Christian; Schwickart, Anna; Putschli, Bastian; Renn, Marcel; Barchet, Winfried; Hartmann, Gunther; Schlee, Martin] Univ Bonn, Inst Clin Chem & Clin Pharmacol, Univ Hosp Bonn, Bonn, Germany; [Hoeller, Tobias] Univ Bonn, Inst Med Biometry Informat & Epidemiol, Univ Hosp Bonn, Bonn, Germany	University of Bonn; University of Bonn	Coch, C (corresponding author), Univ Bonn, Inst Clin Chem & Clin Pharmacol, Univ Hosp Bonn, Bonn, Germany.	ccoch@uni-bonn.de	Coch, Christoph/AAW-5336-2021; Schlee, Martin/AAL-1238-2021; Hartmann, Gunther/P-7492-2017	Hartmann, Gunther/0000-0003-1021-2018; Schlee, Martin/0000-0003-3671-7639; Barchet, Winfried/0000-0002-6745-6606; Renn, Marcel/0000-0002-0120-4035	Bundesministerium fur Bildung und Forschung Biofuture [0311896, Go-Bio, SFB 670 (TP-A20), SFB 704 (TP-A16), SFB832 (TP-A20), KFO177]; Cluster of Excellence ImmunoSensation, BONFOR; BONFOR	Bundesministerium fur Bildung und Forschung Biofuture(Federal Ministry of Education & Research (BMBF)); Cluster of Excellence ImmunoSensation, BONFOR; BONFOR	This study was supported by Grants of the Bundesministerium fur Bildung und Forschung Biofuture 0311896, Go-Bio, SFB 670 (TP-A20), SFB 704 (TP-A16), SFB832 (TP-A20) and KFO177, Cluster of Excellence ImmunoSensation, BONFOR to G. H., M. S., and C. C. and by BONFOR to C. L. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ablasser A, 2009, NAT IMMUNOL, V10, P1065, DOI 10.1038/ni.1779; Barchet W, 2008, CURR OPIN IMMUNOL, V20, P389, DOI 10.1016/j.coi.2008.07.007; Erikci E, 2011, BIOMATERIALS, V32, P1715, DOI 10.1016/j.biomaterials.2010.10.054; Gitlin L, 2006, P NATL ACAD SCI USA, V103, P8459, DOI 10.1073/pnas.0603082103; Hamm S, 2010, IMMUNOBIOLOGY, V215, P559, DOI 10.1016/j.imbio.2009.09.003; Hamzah J, 2009, J IMMUNOL, V183, P1091, DOI 10.4049/jimmunol.0900736; Hartmann G, 2003, EUR J IMMUNOL, V33, P1633, DOI 10.1002/eji.200323813; Hornung V, 2005, NAT MED, V11, P263, DOI 10.1038/nm1191; Hornung V, 2006, SCIENCE, V314, P994, DOI 10.1126/science.1132505; Huntjens DRH, 2005, RHEUMATOLOGY, V44, P846, DOI 10.1093/rheumatology/keh627; Ida JA, 2006, J IMMUNOL METHODS, V310, P86, DOI 10.1016/j.jim.2005.12.008; Ishii KJ, 2006, NAT IMMUNOL, V7, P40, DOI 10.1038/ni1282; Janke M, 2009, J ALLERGY CLIN IMMUN, V123, P1026, DOI 10.1016/j.jaci.2009.02.015; Judge AD, 2005, NAT BIOTECHNOL, V23, P457, DOI 10.1038/nbt1081; Kato H, 2006, NATURE, V441, P101, DOI 10.1038/nature04734; KRIEG AM, 1995, NATURE, V374, P546, DOI 10.1038/374546a0; Krieg AM, 2004, J IMMUNOTHER, V27, P460, DOI 10.1097/00002371-200411000-00006; Krieg AM, 2006, NAT REV DRUG DISCOV, V5, P471, DOI 10.1038/nrd2059; Langezaal I, 2001, TOXICOL IN VITRO, V15, P313, DOI 10.1016/S0887-2333(01)00028-5; Lankveld DPK, 2010, METHODS MOL BIOL, V598, P401, DOI 10.1007/978-1-60761-401-2_26; Laufer S, 2010, METHODS MOL BIOL, V644, P91, DOI 10.1007/978-1-59745-364-6_8; Ludwig Ralf J, 2009, Curr Drug Discov Technol, V6, P281; May L, 2009, CYTOKINE, V45, P184, DOI 10.1016/j.cyto.2008.12.010; Muller-Steinhardt M, 2009, IMMUNOBIOLOGY, V214, P17, DOI 10.1016/j.imbio.2008.04.002; Opal SM, 2002, CRIT CARE MED, V30, pS325, DOI 10.1097/00003246-200205001-00024; Rosas-Ballina M, 2009, MOL MED, V15, P195, DOI 10.2119/molmed.2009.00039; Schlee M, 2006, MOL THER, V14, P463, DOI 10.1016/j.ymthe.2006.06.001; Schlee M, 2009, IMMUNITY, V31, P25, DOI 10.1016/j.immuni.2009.05.008; Smorenburg SM, 2001, PHARMACOL REV, V53, P93; Stetson DB, 2006, IMMUNITY, V24, P93, DOI 10.1016/j.immuni.2005.12.003; Suntharalingam G, 2006, NEW ENGL J MED, V355, P1018, DOI 10.1056/NEJMoa063842; Thurm Cary W, 2005, Curr Protoc Immunol, VChapter 7, DOI 10.1002/0471142735.im0718bs66; Ushiyama S, 2008, EUR J PHARMACOL, V578, P76, DOI 10.1016/j.ejphar.2007.08.034; Vaishnaw Akshay K, 2010, Silence, V1, P14, DOI 10.1186/1758-907X-1-14; Vicari AP, 2007, ANTIVIR THER, V12, P741; Wang JE, 2000, EUR SURG RES, V32, P65, DOI 10.1159/000008743; Wouters IM, 2002, TOXICOL IND HEALTH, V18, P15, DOI 10.1191/0748233702th126oa; Zwiorek K, 2008, PHARM RES-DORDR, V25, P551, DOI 10.1007/s11095-007-9410-5	38	31	32	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2013	8	8							e71057	10.1371/journal.pone.0071057	http://dx.doi.org/10.1371/journal.pone.0071057			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	218XC	23940691	gold, Green Published, Green Submitted			2022-12-25	WOS:000324465000174
J	Lee, JH; Jeon, EJ; Kim, N; Nam, YS; Im, KI; Lim, JY; Kim, EJ; Cho, ML; Han, KT; Cho, SG				Lee, Jung Ho; Jeon, Eun-Joo; Kim, Nayoun; Nam, Young-Sun; Im, Keon-Il; Lim, Jung-Yeon; Kim, Eun-Jung; Cho, Mi-La; Han, Ki Taik; Cho, Seok-Goo			The Synergistic Immunoregulatory Effects of Culture-Expanded Mesenchymal Stromal Cells and CD4(+)25(+)Foxp3(+) Regulatory T Cells on Skin Allograft Rejection	PLOS ONE			English	Article							COMPOSITE-TISSUE ALLOTRANSPLANTATION; STEM-CELLS; TRANSPLANTATION TOLERANCE; HAND TRANSPLANTATION; RISK ACCEPTANCE; IN-VITRO; RESPONSES; THERAPY; INHIBIT; IMMUNOSUPPRESSION	Mesenchymal stromal cells (MSCs) are seen as an ideal source of cells to induce graft acceptance; however, some reports have shown that MSCs can be immunogenic rather than immunosuppressive. We speculate that the immunomodulatory effects of regulatory T cells (Tregs) can aid the maintenance of immunoregulatory functions of MSCs, and that a combinatorial approach to cell therapy can have synergistic immunomodulatory effects on allograft rejection. After preconditioning with Fludarabine, followed by total body irradiation and anti-asialo-GM-1(ASGM-1), tail skin grafts from C57BL/6 (H-2k(b)) mice were grafted onto the lateral thoracic wall of BALB/c (H-2k(d)) mice. Group A mice (control group, n = 9) did not receive any further treatment after preconditioning, whereas groups B and C (n = 9) received cell therapy with MSCs or Tregs, respectively, on days -1, +6 and +13 relative to the skin transplantation. Group D (n = 10) received cell therapy with MSCs and Tregs on days -1, +6 and +13. Cell suspensions were obtained from the spleens of five randomly chosen mice from each group on day +7, and the immunomodulatory effects of the cell therapy were evaluated by flow cytometry and real-time PCR. Our results show that allograft survival was significantly longer in group D compared to the control group (group A). Flow cytometric analysis and real-time PCR for splenocytes revealed that the Th2 subpopulation in group D increased significantly compared to the group B. Also, the expression of Foxp3 and STAT 5 increased significantly in group D compared to the conventional cell therapy groups (B and C). Taken together, these data suggest that a combined cell therapy approach with MSCs and Tregs has a synergistic effect on immunoregulatory function in vivo, and might provide a novel strategy for improving survival in allograft transplantation.	[Lee, Jung Ho; Jeon, Eun-Joo; Kim, Nayoun; Nam, Young-Sun; Im, Keon-Il; Lim, Jung-Yeon; Kim, Eun-Jung; Cho, Seok-Goo] Catholic Univ Korea, Lab Immune Regulat, Convergent Res Consortium Immunol Dis, Seoul St Marys Hosp,Coll Med, Seoul, South Korea; [Lee, Jung Ho; Han, Ki Taik] Catholic Univ Korea, Dept Plast & Reconstruct Surg, Coll Med, Seoul, South Korea; [Cho, Mi-La] Catholic Inst Med Sci, Rheumatism Res Ctr, Seoul, South Korea; [Cho, Seok-Goo] Catholic Univ Korea, Catholic Blood & Marrow Transplantat Ctr, Seoul St Marys Hosp, Coll Med, Seoul, South Korea	Catholic University of Korea; Seoul St. Mary's Hospital; Catholic University of Korea; Catholic University of Korea; Catholic University of Korea; Seoul St. Mary's Hospital	Cho, SG (corresponding author), Catholic Univ Korea, Lab Immune Regulat, Convergent Res Consortium Immunol Dis, Seoul St Marys Hosp,Coll Med, Seoul, South Korea.	chosg@catholic.ac.kr		Nam, Young-Sun/0000-0002-9327-5745; Kim, Nayoun/0000-0001-8317-2921; Cho, Seok-Goo/0000-0002-5429-4839	Ministry for Health & Welfare, Republic of Korea [A092258]	Ministry for Health & Welfare, Republic of Korea(Ministry of Health & Welfare (MOHW), Republic of Korea)	This study was supported by a grant from the Korean Health Technology R&D Project, Ministry for Health & Welfare, Republic of Korea. (A092258). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adeegbe D, 2010, BLOOD, V115, P1932, DOI 10.1182/blood-2009-08-238584; Aggarwal S, 2005, BLOOD, V105, P1815, DOI 10.1182/blood-2004-04-1559; Antov A, 2003, J IMMUNOL, V171, P3435, DOI 10.4049/jimmunol.171.7.3435; Bartholomew A, 2002, EXP HEMATOL, V30, P42, DOI 10.1016/S0301-472X(01)00769-X; Beyth S, 2005, BLOOD, V105, P2214, DOI 10.1182/blood-2004-07-2921; Brenner MJ, 2002, J BONE JOINT SURG AM, V84A, P1861, DOI 10.2106/00004623-200210000-00020; Brouha P, 2006, MICROSURG, V26, P144, DOI 10.1002/micr.20227; Corcione A, 2006, BLOOD, V107, P367, DOI 10.1182/blood-2005-07-2657; Devauchelle B, 2006, LANCET, V368, P203, DOI 10.1016/S0140-6736(06)68935-6; Di Nicola M, 2002, BLOOD, V99, P3838, DOI 10.1182/blood.V99.10.3838; Doi K, 1996, LANCET, V347, P970, DOI 10.1016/S0140-6736(96)91458-0; Dubernard JM, 2007, NEW ENGL J MED, V357, P2451, DOI 10.1056/NEJMoa072828; Dubernard JM, 1999, LANCET, V353, P1315, DOI 10.1016/S0140-6736(99)02062-0; Field EH, 1997, TRANSPLANTATION, V64, P1, DOI 10.1097/00007890-199707150-00002; Ge W, 2009, AM J TRANSPLANT, V9, P1760, DOI 10.1111/j.1600-6143.2009.02721.x; Golshayan D, 2009, INT IMMUNOPHARMACOL, V9, P683, DOI 10.1016/j.intimp.2008.12.006; Gorantla VS, 2010, TRANSPLANT REV-ORLAN, V24, P147, DOI 10.1016/j.trre.2010.04.002; Griffin MD, 2010, HUM GENE THER, V21, P1641, DOI 10.1089/hum.2010.156; Hettiaratchy S, 2004, BRIT J PLAST SURG, V57, P381, DOI 10.1016/j.bjps.2004.02.012; Horner BM, 2008, TRANSPL INT, V21, P101, DOI 10.1111/j.1432-2277.2007.00559.x; Hutchinson JA, 2008, TRANSPL INT, V21, P742, DOI 10.1111/j.1432-2277.2008.00692.x; Inoue S, 2006, TRANSPLANTATION, V81, P1589, DOI 10.1097/01.tp.0000209919.90630.7b; Jeon EJ, 2012, AUTOIMMUNITY, V45, P460, DOI 10.3109/08916934.2012.682666; Komatsu N, 2009, P NATL ACAD SCI USA, V106, P1903, DOI 10.1073/pnas.0811556106; Krampera M, 2003, BLOOD, V101, P3722, DOI 10.1182/blood-2002-07-2104; Lanzetta M, 2004, TRANSPL P, V36, P664, DOI 10.1016/j.transproceed.2004.03.006; Maccario R, 2005, HAEMATOLOGICA, V90, P516; Majzoub RK, 2006, J HAND SURG-AM, V31A, P295, DOI 10.1016/j.jhsa.2005.09.013; McCurry KR, 2006, TRANSPL INT, V19, P525, DOI 10.1111/j.1432-2277.2006.00306.x; Meisel R, 2004, BLOOD, V103, P4619, DOI 10.1182/blood-2003-11-3909; Nauta AJ, 2006, BLOOD, V108, P2114, DOI 10.1182/blood-2005-11-011650; Noel D, 2007, LEUKEMIA LYMPHOMA, V48, P1283, DOI 10.1080/10428190701361869; Onishi Y, 2008, P NATL ACAD SCI USA, V105, P10113, DOI 10.1073/pnas.0711106105; Petruzzo P, 2003, CLIN TRANSPLANT, V17, P455, DOI 10.1034/j.1399-0012.2003.00005.x; Plumas J, 2005, LEUKEMIA, V19, P1597, DOI 10.1038/sj.leu.2403871; Rasmusson I, 2006, EXP CELL RES, V312, P2169, DOI 10.1016/j.yexcr.2006.03.019; Ringden O, 2006, TRANSPLANTATION, V81, P1390, DOI 10.1097/01.tp.0000214462.63943.14; ROSE KG, 1979, LANCET, V1, P433; Sbano P, 2008, ARCH DERMATOL RES, V300, P115, DOI 10.1007/s00403-007-0827-9; Scandling JD, 2008, NEW ENGL J MED, V358, P362, DOI 10.1056/NEJMoa074191; Schliesser U, 2012, CURR OPIN ORGAN TRAN, V17, P34, DOI 10.1097/MOT.0b013e32834ee69f; Siemionow M, 2006, PLAST RECONSTR SURG, V118, P268, DOI 10.1097/01.prs.0000222222.18263.0f; Soleimani M, 2009, NAT PROTOC, V4, P102, DOI 10.1038/nprot.2008.221; Tay SS, 2009, CURR OPIN ORGAN TRAN, V14, P16, DOI 10.1097/MOT.0b013e32831ebdf5; Velasquez-Lopera MM, 2008, TRANSPL IMMUNOL, V19, P127, DOI 10.1016/j.trim.2008.02.003; Waaga AM, 2001, J CLIN INVEST, V107, P909, DOI 10.1172/JCI11427; Zappia E, 2005, BLOOD, V106, P1755, DOI 10.1182/blood-2005-04-1496	47	15	16	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2013	8	8							e70968	10.1371/journal.pone.0070968	http://dx.doi.org/10.1371/journal.pone.0070968			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	218XC	23940676	Green Published, gold, Green Submitted			2022-12-25	WOS:000324465000165
J	Molnar, I; Simkova, H; Leverington-Waite, M; Goram, R; Cseh, A; Vrana, J; Farkas, A; Dolezel, J; Molnar-Lang, M; Griffiths, S				Molnar, Istvan; Simkova, Hana; Leverington-Waite, Michelle; Goram, Richard; Cseh, Andras; Vrana, Jan; Farkas, Andras; Dolezel, Jaroslav; Molnar-Lang, Marta; Griffiths, Simon			Syntenic Relationships between the U and M Genomes of Aegilops, Wheat and the Model Species Brachypodium and Rice as Revealed by COS Markers	PLOS ONE			English	Article							TRITICUM-AESTIVUM; CHROMOSOMAL REARRANGEMENTS; GENETIC DIVERSITY; IDENTIFICATION; EVOLUTION; BIUNCIALIS; TOLERANCE; CEREALS; HYBRIDIZATION; MECHANISMS	Diploid Aegilops umbellulata and Ae. comosa and their natural allotetraploid hybrids Ae. biuncialis and Ae. geniculata are important wild gene sources for wheat. With the aim of assisting in alien gene transfer, this study provides gene-based conserved orthologous set (COS) markers for the U and M genome chromosomes. Out of the 140 markers tested on a series of wheat-Aegilops chromosome introgression lines and flow-sorted subgenomic chromosome fractions, 100 were assigned to Aegilops chromosomes and six and seven duplications were identified in the U and M genomes, respectively. The marker-specific EST sequences were BLAST-ed to Brachypodium and rice genomic sequences to investigate macrosyntenic relationships between the U and M genomes of Aegilops, wheat and the model species. Five syntenic regions of Brachypodium identified genome rearrangements differentiating the U genome from the M genome and from the D genome of wheat. All of them seem to have evolved at the diploid level and to have been modified differentially in the polyploid species Ae. biuncialis and Ae. geniculata. A certain level of wheat-Aegilops homology was detected for group 1, 2, 3 and 5 chromosomes, while a clearly rearranged structure was showed for the group 4, 6 and 7 Aegilops chromosomes relative to wheat. The conserved orthologous set markers assigned to Aegilops chromosomes promise to accelerate gene introgression by facilitating the identification of alien chromatin. The syntenic relationships between the Aegilops species, wheat and model species will facilitate the targeted development of new markers specific for U and M genomic regions and will contribute to the understanding of molecular processes related to allopolyploidization.	[Molnar, Istvan; Cseh, Andras; Farkas, Andras; Molnar-Lang, Marta] Hungarian Acad Sci, Inst Agr, Agr Res Ctr, Martonvasar, Hungary; [Simkova, Hana; Vrana, Jan; Dolezel, Jaroslav] Inst Expt Bot, Ctr Reg Hana Biotechnol & Agr Res, Olomouc, Czech Republic; [Leverington-Waite, Michelle; Goram, Richard; Griffiths, Simon] John Innes Ctr, Dept Crop Genet, Norwich, Norfolk, England	Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Centre for Agricultural Research; Czech Academy of Sciences; Institute of Experimental Botany of the Czech Academy of Sciences; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); John Innes Center	Molnar, I (corresponding author), Hungarian Acad Sci, Inst Agr, Agr Res Ctr, Martonvasar, Hungary.	molnar.istvan@agrar.mta.hu	Molnar, istvan/L-9779-2019; Vrana, Jan/F-7306-2014; Simkova, Hana/F-7734-2014; Dolezel, Jaroslav/B-7716-2008; Farkas, András/AAA-5663-2022; Cseh, Andras/AAP-3999-2021	Vrana, Jan/0000-0001-6171-8516; Simkova, Hana/0000-0003-4159-7619; Dolezel, Jaroslav/0000-0002-6263-0492; Cseh, Andras/0000-0002-8681-6654; Molnar, Istvan/0000-0002-7167-9319	Hungarian National Research Fund [PD83444]; Hungarian Academy of Sciences; Agrisafe Programme [EU-FP7-REGPOT-2007-1, 203288]; Czech Science Foundation [P501/12/G090]; Ministry of Education, Youth and Sports of the Czech Republic; European Regional Development Fund [ED0007/01/01]; United Kingdom Biotechnology and Biological Sciences Research Council;  [TAMOP-4.2.2.A-11-1-KONV-2012-0008]; BBSRC [BB/E023568/1, BBS/E/J/000CA393] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/E023568/1, BBS/E/J/000CA393] Funding Source: researchfish	Hungarian National Research Fund(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA)); Hungarian Academy of Sciences(Hungarian Academy of Sciences); Agrisafe Programme; Czech Science Foundation(Grant Agency of the Czech Republic); Ministry of Education, Youth and Sports of the Czech Republic(Ministry of Education, Youth & Sports - Czech Republic); European Regional Development Fund(European Commission); United Kingdom Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); ; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was funded by the Hungarian National Research Fund (PD83444), by TAMOP-4.2.2.A-11-1-KONV-2012-0008, by a Janos Bolyai Research Scholarship from the Hungarian Academy of Sciences (for MI and CSA), by the Agrisafe Programme (EU-FP7-REGPOT-2007-1, No. 203288), by the Czech Science Foundation (grant award P501/12/G090), by the Ministry of Education, Youth and Sports of the Czech Republic and the European Regional Development Fund (Operational Programme Research and Development for Innovations No. ED0007/01/01) and by the United Kingdom Biotechnology and Biological Sciences Research Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Badaeva ED, 2007, GENOME, V50, P907, DOI 10.1139/G07-072; Badaeva ED, 2004, PLANT SYST EVOL, V246, P45, DOI 10.1007/s00606-003-0072-4; Bartos J, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-155; Bennett MD, 2012, ANGIOSPERM DNA C VAL; Bennetzen JL, 2005, ANN BOT-LONDON, V95, P127, DOI 10.1093/aob/mci008; Bennetzen JL, 2003, CURR OPIN PLANT BIOL, V6, P128, DOI 10.1016/S1369-5266(03)00015-3; Berkman PJ, 2012, AM J BOT, V99, P365, DOI 10.3732/ajb.1100309; Brenchley R, 2012, NATURE, V491, P705, DOI 10.1038/nature11650; Burt C, 2011, THEOR APPL GENET, V123, P1387, DOI 10.1007/s00122-011-1674-9; Chantret N, 2005, PLANT CELL, V17, P1033, DOI 10.1105/tpc.104.029181; Colmer TD, 2006, J EXP BOT, V57, P1059, DOI 10.1093/jxb/erj124; Devos KM, 2000, PLANT CELL, V12, P637, DOI 10.1105/tpc.12.5.637; DEVOS KM, 1993, THEOR APPL GENET, V85, P673, DOI 10.1007/BF00225004; Devos KM, 1997, PLANT MOL BIOL, V35, P3, DOI 10.1023/A:1005820229043; Draper J, 2001, PLANT PHYSIOL, V127, P1539, DOI 10.1104/pp.010196; Dulai Sandor, 2005, Acta Biologica Szegediensis, V49, P215; FELDMAN M, 1965, EVOLUTION, V19, P162, DOI 10.2307/2406371; FELDMAN M, 1965, EVOLUTION, V19, P563, DOI 10.2307/2406254; Feuillet C, 2002, ANN BOT-LONDON, V89, P3, DOI 10.1093/aob/mcf008; Feuillet C, 2009, PLANT GENET GENOMICS, V7, P451, DOI 10.1007/978-0-387-77489-3_17; Foote Trade N., 2004, Functional & Integrative Genomics, V4, P26, DOI 10.1007/s10142-003-0101-y; Friebe B, 1996, EUPHYTICA, V91, P59, DOI 10.1007/BF00035277; Friebe BR, 1999, GENOME, V42, P374, DOI 10.1139/gen-42-3-374; Gale MD, 1998, P NATL ACAD SCI USA, V95, P1971, DOI 10.1073/pnas.95.5.1971; Hasterok R, 2006, GENETICS, V173, P349, DOI 10.1534/genetics.105.049726; Hernandez P, 2012, PLANT J, V69, P377, DOI 10.1111/j.1365-313X.2011.04808.x; Howard T, 2011, J EXP BOT, V62, P2217, DOI 10.1093/jxb/erq423; JIANG JM, 1994, EUPHYTICA, V73, P199, DOI 10.1007/BF00036700; KIMBER G, 1988, GENOME, V30, P218, DOI 10.1139/g88-037; Kozub NA, 2011, RUSS J GENET+, V47, P1078, DOI 10.1134/S1022795411090092; Lelley T, 2000, GENOME, V43, P661, DOI 10.1139/gen-43-4-661; Luo MC, 2009, P NATL ACAD SCI USA, V106, P15780, DOI 10.1073/pnas.0908195106; Matsumoto T, 2005, NATURE, V436, P793, DOI 10.1038/nature03895; Mayer KFX, 2011, PLANT CELL, V23, P1249, DOI 10.1105/tpc.110.082537; Molnar I, 2004, FUNCT PLANT BIOL, V31, P1149, DOI 10.1071/FP03143; Molnar I, 2010, BIOL PLANTARUM, V54, P259, DOI 10.1007/s10535-010-0045-8; Molnar I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027708; Molnar I, 2011, ANN BOT-LONDON, V107, P65, DOI 10.1093/aob/mcq215; Molnar I, 2009, GENOME, V52, P156, DOI [10.1139/G08-114, 10.1139/g08-114]; Murat F, 2010, GENOME RES, V20, P1545, DOI 10.1101/gr.109744.110; Nagy ED, 2006, GENOME, V49, P289, DOI 10.1139/G05-109; Parida SK, 2006, THEOR APPL GENET, V112, P808, DOI 10.1007/s00122-005-0182-1; Peil A, 1998, THEOR APPL GENET, V96, P138, DOI 10.1007/s001220050720; Pestsova E, 2000, THEOR APPL GENET, V101, P100, DOI 10.1007/s001220051456; Quraishi UM, 2009, FUNCT INTEGR GENOMIC, V9, P473, DOI 10.1007/s10142-009-0129-8; Rawat N, 2009, GENET RESOUR CROP EV, V56, P53, DOI 10.1007/s10722-008-9344-8; Rekika D, 1997, J PLANT PHYSIOL, V150, P734, DOI 10.1016/S0176-1617(97)80291-X; Salse J, 2008, PLANT CELL, V20, P11, DOI 10.1105/tpc.107.056309; Salse J, 2012, CURR OPIN PLANT BIOL, V15, P122, DOI 10.1016/j.pbi.2012.01.001; Schneider A, 2005, GENOME, V48, P1070, DOI 10.1139/G05-062; Schneider A, 2008, EUPHYTICA, V163, P1, DOI 10.1007/s10681-007-9624-y; Schneider A, 2010, EUPHYTICA, V175, P357, DOI 10.1007/s10681-010-0180-5; Shiferaw G. A., 2012, Acta Agronomica Hungarica, V60, P71, DOI 10.1556/AAgr.60.2012.1.8; Sim S, 2005, THEOR APPL GENET, V110, P1011, DOI 10.1007/s00122-004-1916-1; Simkova H, 2008, BMC GENOMICS, V9, DOI [10.1186/1471-2164-9-237, 10.1186/1471-2164-9-294]; Sorrells ME, 2003, GENOME RES, V13, P1818, DOI 10.1101/gr.1113003; Van Slageren MW, 1994, WILD WHEATS MONOGRAP; Vogel JP, 2010, NATURE, V463, P763, DOI 10.1038/nature08747; Waines J. G., 1993, Biodiversity and wheat improvement., P173; Wicker T, 2007, GENETICS, V177, P1207, DOI 10.1534/genetics.107.077354; Wicker T, 2011, PLANT CELL, V23, P1706, DOI 10.1105/tpc.111.086629; Wicker T, 2010, GENOME RES, V20, P1229, DOI 10.1101/gr.107284.110; Xu YB, 2005, PLANT MOL BIOL, V59, P7, DOI 10.1007/s11103-004-4681-2; Yang YC, 1996, THEOR APPL GENET, V92, P591, DOI 10.1007/BF00224563; Yu J, 2005, PLOS BIOL, V3, P266, DOI 10.1371/journal.pbio.0030038; ZAHARIEVA M, 2003, ANN WHEAT NEWSLETTER, V49, P75; Zhang H, 1998, THEOR APPL GENET, V96, P69, DOI 10.1007/s001220050710; ZOHARY D, 1962, EVOLUTION, V16, P44, DOI 10.2307/2406265	68	31	32	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2013	8	8							e70844	10.1371/journal.pone.0070844	http://dx.doi.org/10.1371/journal.pone.0070844			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	218XC	23940651	Green Submitted, Green Published, gold			2022-12-25	WOS:000324465000142
J	Pan, SJ; Cheng, XY; Chen, HA; Castro, PD; Ittmann, MM; Hutson, AW; Zapata, SK; Sifers, RN				Pan, Shujuan; Cheng, Xiaoyun; Chen, Hongan; Castro, Patricia D.; Ittmann, Michael M.; Hutson, Anne W.; Zapata, Susan K.; Sifers, Richard N.			ERManI Is a Target of miR-125b and Promotes Transformation Phenotypes in Hepatocellular Carcinoma (HCC)	PLOS ONE			English	Article							POLY(ADP-RIBOSE) POLYMERASE PARP; ER-ASSOCIATED DEGRADATION; RETICULUM MANNOSIDASE-I; HUMAN-DISEASE; PROSTATE-CANCER; QUALITY-CONTROL; MICRORNAS; IDENTIFICATION; ALPHA-1-ANTITRYPSIN; APOPTOSIS	The MAN1B1 gene product, designated ER alpha-1, 2-mannosidase (ERManI), is an enzyme localized in the Golgi complex of mammalian cells. By functioning as a "gate keeper" to prevent the inappropriate secretion of misfolded glycoproteins, it plays a critical role in maintaining protein homeostasis in the mammalian secretory pathway. In the present study, we identified that a conserved motif within the 3'UTR of ERManI is a target of miR-125b, a microRNA frequently down-regulated in numerous types of cancers, including hepatocellular carcinoma (HCC). As predicted, the expression of ERManI is significantly elevated in HCC, as measured by immunohistochemistry in a liver spectrum tissue microarray. Additional analyses using several hepatoma cell lines demonstrated that the elevated ERManI inversely correlates with a diminished intracellular concentration of miR-125b. Moreover, functional studies indicated that RNAi-mediated knock-down of endogenous ERManI was sufficient to inhibit proliferation, migration, and invasion of hepatoma cells. These phenotypical changes occurred in the absence of alterations in global glycoprotein secretion or ER-stress status. Together, these results revealed a novel post-transcriptional regulatory mechanism for ERManI and implied that this molecule contributes to the regulation of carcinogenesis in HCC independent of its function in glycoprotein quality control.	[Pan, Shujuan; Cheng, Xiaoyun; Chen, Hongan; Castro, Patricia D.; Ittmann, Michael M.; Zapata, Susan K.; Sifers, Richard N.] Baylor Coll Med, Dept Pathol & Immunol, Houston, TX 77030 USA; [Sifers, Richard N.] Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA; [Sifers, Richard N.] Baylor Coll Med, Dept Mol Physiol & Biophys, Houston, TX 77030 USA; [Hutson, Anne W.] Baylor Coll Med, Dept Pediat Gastroenterol Hepatol & Nutr, Houston, TX 77030 USA; [Cheng, Xiaoyun] Univ Texas MD Anderson Canc Ctr, Dept Lymphoma & Myeloma, Houston, TX 77030 USA; [Chen, Hongan] Baylor Coll Med, Baylor Coll Med Summer Med & Res Training Program, Houston, TX 77030 USA	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; University of Texas System; UTMD Anderson Cancer Center; Baylor College of Medicine	Sifers, RN (corresponding author), Baylor Coll Med, Dept Pathol & Immunol, Houston, TX 77030 USA.	rsifers@bcm.edu	Castro, Patricia/AAN-3032-2021; Sifers, Richard Norman/AGQ-7262-2022; Cheng, Xiaoyun/HDM-5535-2022	Castro, Patricia/0000-0001-5286-8037; Chen, Hongan/0000-0003-1379-1561; Cheng, Xiaoyun/0000-0002-0115-711X	National Institutes of Health [RO1 DK064232]; Alpha1-Foundation [R06-06]; Alpha-1 Foundation; National Institute of Diabetes and Digestive and Kidney Disease Center [P30 DK56338]; Burroughs Wellcome Fund - The Houston Laboratory and Population Science Training Program in Gene-Environment Interaction (BWF) [1008200]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK056338, R01DK064232] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Alpha1-Foundation; Alpha-1 Foundation; National Institute of Diabetes and Digestive and Kidney Disease Center; Burroughs Wellcome Fund - The Houston Laboratory and Population Science Training Program in Gene-Environment Interaction (BWF); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health grants RO1 DK064232 (to R.N. Sifers), grant #R06-06 from the Alpha1-Foundation (to R.N. Sifers), a postdoctoral research grant (to S. Pan) from the Alpha-1 Foundation, a Pilot/Feasibility Grant as part of the Grant P30 DK56338 from National Institute of Diabetes and Digestive and Kidney Disease Center, and a training fellowship from the Burroughs Wellcome Fund - The Houston Laboratory and Population Science Training Program in Gene-Environment Interaction (BWF Grant No. 1008200). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aebi M, 2010, TRENDS BIOCHEM SCI, V35, P74, DOI 10.1016/j.tibs.2009.10.001; ALEXANDER JJ, 1976, S AFR MED J, V50, P2124; Alvarez-Garcia I, 2005, DEVELOPMENT, V132, P4653, DOI 10.1242/dev.02073; Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Anelli T, 2008, EMBO J, V27, P315, DOI 10.1038/sj.emboj.7601974; Avezov E, 2008, MOL BIOL CELL, V19, P216, DOI 10.1091/mbc.E07-05-0505; Ayala GE, 2004, CANCER RES, V64, P6082, DOI 10.1158/0008-5472.CAN-04-0838; Baffa R, 2009, J PATHOL, V219, P214, DOI 10.1002/path.2586; Banez LL, 2010, J UROLOGY, V184, P149, DOI 10.1016/j.juro.2010.03.012; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Boulares AH, 1999, J BIOL CHEM, V274, P22932, DOI 10.1074/jbc.274.33.22932; Budhu A, 2008, HEPATOLOGY, V47, P897, DOI 10.1002/hep.22160; Comunale MA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012419; Corvalan AH, 2012, DIGEST DIS SCI, V57, P2737, DOI 10.1007/s10620-012-2384-0; De Santa F, 2013, CURR PHARM DESIGN, V19, P745, DOI 10.2174/138161213804581846; Diaz G, 2013, INT J CANCER, V133, P816, DOI 10.1002/ijc.28075; El-Serag HB, 2007, GASTROENTEROLOGY, V132, P2557, DOI 10.1053/j.gastro.2007.04.061; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Gutschner T, 2012, RNA BIOL, V9, P703, DOI 10.4161/rna.20481; He L, 2004, NAT REV GENET, V5, P522, DOI 10.1038/nrg1379; Hidvegi T, 2005, J BIOL CHEM, V280, P39002, DOI 10.1074/jbc.M508652200; Hosokawa N, 2001, EMBO REP, V2, P415, DOI 10.1093/embo-reports/kve084; Iorio MV, 2005, CANCER RES, V65, P7065, DOI 10.1158/0008-5472.CAN-05-1783; Jakob CA, 1998, J CELL BIOL, V142, P1223, DOI 10.1083/jcb.142.5.1223; Ji JF, 2012, METHODS MOL BIOL, V826, P163, DOI 10.1007/978-1-61779-468-1_14; Kim JK, 2013, HEPATOLOGY, V57, P1055, DOI 10.1002/hep.26101; Kumari SR, 1998, CANCER RES, V58, P5075; Laitala-Leinonen T, 2010, RECENT PAT DNA GENE, V4, P113, DOI [10.2174/187221510793205755, DOI 10.2174/187221510793205755.PUBMED:20550514]; Li WX, 2008, INT J CANCER, V123, P1616, DOI 10.1002/ijc.23693; Liang LH, 2010, HEPATOLOGY, V52, P1731, DOI 10.1002/hep.23904; Mo YY, 2012, CELL MOL LIFE SCI, V69, P3529, DOI 10.1007/s00018-012-1123-1; Mobasheri A, 2004, HISTOL HISTOPATHOL, V19, P325, DOI 10.14670/HH-19.325; Pan S, 2013, MOL BIOL CELL; Pan SJ, 2011, MOL BIOL CELL, V22, P2810, DOI 10.1091/mbc.E11-02-0118; Pan SJ, 2009, HEPATOLOGY, V50, P275, DOI 10.1002/hep.22974; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Ruddock LW, 2006, J CELL SCI, V119, P4373, DOI 10.1242/jcs.03225; SAITOH A, 1993, ARCH BIOCHEM BIOPHYS, V303, P281, DOI 10.1006/abbi.1993.1284; Scovassi AI, 1998, EUR J HISTOCHEM, V42, P251; Shiraha H, 2013, INT J ONCOL, V42, P1133, DOI 10.3892/ijo.2013.1829; Sifers RN, 2003, SCIENCE, V299, P1330, DOI 10.1126/science.1082718; Termine DJ, 2009, J CELL SCI, V122, P976, DOI 10.1242/jcs.037291; Topic A, 2012, HEPAT MON, V12, DOI 10.5812/hepatmon.7042; Ura S, 2009, HEPATOLOGY, V49, P1098, DOI 10.1002/hep.22749; Visone R, 2007, ONCOGENE, V26, P7590, DOI 10.1038/sj.onc.1210564; Wang JH, 2006, PROSTATE, V66, P847, DOI 10.1002/pros.20389; Wang JH, 2011, CANCER RES, V71, P1325, DOI 10.1158/0008-5472.CAN-10-2210; Wu WJ, 2000, NATURE, V405, P800, DOI 10.1038/35015585; Wu Y, 2003, P NATL ACAD SCI USA, V100, P8229, DOI 10.1073/pnas.1430537100; Wu Y, 2007, J BIOL CHEM, V282, P4841, DOI 10.1074/jbc.M607156200; Xiong J, 2012, CURR MOL MED, V12, P247, DOI 10.2174/156652412799218886; Yang Z, 2013, INT J MOL SCI, V14, P1105, DOI 10.3390/ijms14011105	52	11	11	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2013	8	8							e72829	10.1371/journal.pone.0072829	http://dx.doi.org/10.1371/journal.pone.0072829			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	218XC	23940818	gold, Green Published, Green Submitted			2022-12-25	WOS:000324465000248
J	Sachs, S; Kear, BP; Everhart, MJ				Sachs, Sven; Kear, Benjamin P.; Everhart, Michael J.			Revised Vertebral Count in the "Longest-Necked Vertebrate'' Elasmosaurus platyurus Cope 1868, and Clarification of the Cervical-Dorsal Transition in Plesiosauria	PLOS ONE			English	Article							REPTILIA SAUROPTERYGIA; INTERRELATIONSHIPS	Elasmosaurid plesiosaurians are renowned for their immensely long necks, and indeed, possessed the highest number of cervical vertebrae for any known vertebrate. Historically, the largest count has been attributed to the iconic Elasmosaurus platyurus from the Late Cretaceous of Kansas, but estimates for the total neck series in this taxon have varied between published reports. Accurately determining the number of vertebral centra vis-a-vis the maximum length of the neck in plesiosaurians has significant implications for phylogenetic character designations, as well as the inconsistent terminology applied to some osteological structures. With these issues in mind, we reassessed the holotype of E. platyurus as a model for standardizing the debated cervical-dorsal transition in plesiosaurians, and during this procedure, documented a "lost'' cervical centrum. Our revision also advocates retention of the term "pectorals'' to describe the usually three or more distinctive vertebrae close to the cranial margin of the forelimb girdle that bear a functional rib facet transected by the neurocentral suture, and thus conjointly formed by both the parapophysis on the centrum body and diapophysis from the neural arch (irrespective of rib length). This morphology is unambiguously distinguishable from standard cervicals, in which the functional rib facet is borne exclusively on the centrum, and dorsals in which the rib articulation is situated above the neurocentral suture and functionally borne only by the transverse process of the neural arch. Given these easily distinguishable definitions, the maximum number of neck vertebrae preserved in E. platyurus is 72; this is only three vertebrae shorter than the recently described Albertonectes, which together with E. platyurus constitute the "longest necked'' animals ever to have lived.	[Kear, Benjamin P.] Uppsala Univ, Dept Earth Sci, Uppsala, Sweden; [Everhart, Michael J.] Ft Hays State Univ, Sternberg Museum Nat Hist, Hays, KS 67601 USA	Uppsala University		Sachs.Pal@gmx.de			Swedish Research Council; Australian Research Council	Swedish Research Council(Swedish Research CouncilEuropean Commission); Australian Research Council(Australian Research Council)	BPK acknowledges funding from the Swedish Research Council and Australian Research Council. These grants supported the analyses of the paper. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ballou WH, 1890, NEW YORK HERALD, V19, P11; Bardet N, 1999, PALAEONTOLOGY, V42, P927, DOI 10.1111/1475-4983.00103; Benson RBJ, 2014, BIOL REV, V89, P1, DOI 10.1111/brv.12038; Benson RBJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031838; Benson RBJ, 2011, PALAEONTOLOGY, V54, P547, DOI 10.1111/j.1475-4983.2011.01044.x; Brown D.S., 1981, Bulletin of the British Museum (Natural History) Geology, V35, P253; Brown David Stanley, 1994, Revue de Paleobiologie Volume Special, V7, P9; Carpenter Kenneth, 1999, Paludicola, V2, P148; CARROLL RL, 1981, PHILOS T ROY SOC B, V293, P315, DOI 10.1098/rstb.1981.0079; Cheng YN, 2012, J VERTEBR PALEONTOL, V32, P1335, DOI 10.1080/02724634.2012.695983; Cope E.D., 1869, T AM PHIL SOC, V14, P1; Cope E. D., 1868, P ACAD NAT SCI PHILA, V20, P92; Cope ED, 1870, AM J SCI, V50, P140; Dalla Vecchia FM, 2006, RIV ITAL PALEONTOL S, V112, P207, DOI 10.13130/2039-4942/6337; Davidson JP, 2002, P ACAD NAT SCI PHILA, V152, P215, DOI 10.1635/0097-3157(2002)152[0215:HPOVBM]2.0.CO;2; Druckenmiller Patrick S., 2006, Paludicola, V5, P184; Druckenmiller PS, 2008, ZOOTAXA, P1; Everhart M.J., 2005, PALARCH, V4, P19; Everhart M. J., 2005, OCEANS KANSAS NATURA; Everhart Michael J., 2006, Paludicola, V5, P170; Hiller N, 2005, J VERTEBR PALEONTOL, V25, P588, DOI 10.1671/0272-4634(2005)025[0588:TNOMHH]2.0.CO;2; Hoffstetter R., 1969, P201; Kear BP, 2005, J VERTEBR PALEONTOL, V25, P792, DOI 10.1671/0272-4634(2005)025[0792:ANEPFT]2.0.CO;2; Ketchum HF, 2010, BIOL REV, V85, P361, DOI 10.1111/j.1469-185X.2009.00107.x; Knutsen EM, 2012, NORW J GEOL, V92, P187; Kubo T, 2012, J VERTEBR PALEONTOL, V32, P557, DOI 10.1080/02724634.2012.658124; Leidy J, 1870, AM J SCI, V49, P392; Leidy J., 1870, P ACAD NAT SCI PHILA, V22, P9; Lin K., 1998, FIELDIANA GEOLOGY, V39, P1, DOI 10.5962/bhl.title.5174; Liu J, 2011, J VERTEBR PALEONTOL, V31, P292, DOI 10.1080/02724634.2011.550363; Marsh OC, 1870, P ACAD NAT SCI PHILA, V22, P11; Nicholls E.L., 1991, Neues Jahrbuch fuer Geologie und Palaeontologie Abhandlungen, V182, P161; Noe L.F., 2007, PalArch Series Vertebrate Palaeontology, V2, P1; Noe LF, 2007, PALARCHS J VERTEBRAT, V4, P19; O'Gorman JP, 2013, ANTARCT SCI, V25, P71, DOI 10.1017/S0954102012000673; O'Keefe F. Robin, 2006, Paludicola, V5, P206; O'Keefe Frank Robin, 2001, Acta Zoologica Fennica, V213, P1; Rieppel O, 2000, HDB PALAOHERPETOLO A, V12A, P1; Romer A, 1956, OSTEOLOGY REPTILES; Sachs Sven, 2005, Paludicola, V5, P92; Sachs Sven, 2005, Memoirs of the Queensland Museum, V50, P425; Sander PM, 1997, J VERTEBR PALEONTOL, V17, P526, DOI 10.1080/02724634.1997.10010999; Sato T, 2002, THESIS U CALGARY CAL; Sato T, 2014, PALAEONTOLOGY, V57, P55, DOI 10.1111/pala.12048; Sato T, 2010, PALEONTOL RES, V14, P179, DOI 10.2517/1342-8144-14.3.179; Seeley HG, 1874, J GEOLOGICAL SOC LON, V30, P197; Spamer Earle E., 1995, Special Publication Academy of Natural Sciences Philadelphia, V16, P1; Storrs G.W., 1991, B PEABODY MUS NAT HI, V44, P1; Storrs Glenn W., 1999, University of Kansas Paleontological Contributions New Series, V10-11, P1; Storrs Glenn W., 1997, P145, DOI 10.1016/B978-012155210-7/50010-7; SUES HD, 1987, ZOOL J LINN SOC-LOND, V90, P109, DOI 10.1111/j.1096-3642.1987.tb01351.x; SWINTON W. E., 1947, PROC BRISTOL NAT SOC, V27, P343; TARLO L. B., 1960, B BRIT MUS NAT HIST, V4, P147; Vincent P, 2011, GONDWANA RES, V19, P1062, DOI 10.1016/j.gr.2010.10.005; WELLES S. P., 1949, FONDREN SCI SER, V1, P1; Welles S. P., 1962, Publications Dep Geol University California, V44, P1; Welles SP, 1943, U CALIFORNIA MEMOIRS, V13, P125; Welles SP, 1952, U CALIFORNIA PUBLICA, V29, P44; Williston SW, 1906, AM J SCI, V21, P221	59	37	38	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2013	8	8							e70877	10.1371/journal.pone.0070877	http://dx.doi.org/10.1371/journal.pone.0070877			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	218XC	23940656	Green Published, gold			2022-12-25	WOS:000324465000146
J	Yao, YS; Zhou, JH; Wang, LX; Gao, XN; Ning, QY; Jiang, MM; Wang, J; Wang, LL; Yu, L				Yao, Yushi; Zhou, Jihao; Wang, Lixin; Gao, Xiaoning; Ning, Qiaoyang; Jiang, Mengmeng; Wang, Jia; Wang, Lili; Yu, Li			Increased PRAME-Specific CTL Killing of Acute Myeloid Leukemia Cells by Either a Novel Histone Deacetylase Inhibitor Chidamide Alone or Combined Treatment with Decitabine	PLOS ONE			English	Article							CANCER-TESTIS ANTIGEN; PREFERENTIALLY EXPRESSED ANTIGEN; VERSUS-HOST-DISEASE; T-CELLS; GENE-EXPRESSION; TUMOR-ANTIGEN; IN-VIVO; CANCER/TESTIS ANTIGENS; MELANOMA PRAME; MEMORY	As one of the best known cancer testis antigens, PRAME is overexpressed exclusively in germ line tissues such as the testis as well as in a variety of solid and hematological malignant cells including acute myeloid leukemia. Therefore, PRAME has been recognized as a promising target for both active and adoptive anti-leukemia immunotherapy. However, in most patients with PRAME-expressing acute myeloid leukemia, PRAME antigen-specific CD8(+) CTL response are either undetectable or too weak to exert immune surveillance presumably due to the inadequate PRAME antigen expression and PRAME-specific antigen presentation by leukemia cells. In this study, we observed remarkably increased PRAME mRNA expression in human acute myeloid leukemia cell lines and primary acute myeloid leukemia cells after treatment with a novel subtype-selective histone deacetylase inhibitor chidamide in vitro. PRAME expression was further enhanced in acute myeloid leukemia cell lines after combined treatment with chidamide and DNA demethylating agent decitabine. Pretreatment of an HLA-A0201(+) acute myeloid leukemia cell line THP-1 with chidamide and/or decitabine increased sensitivity to purified CTLs that recognize PRAME(100-108) or PRAME(300-309) peptide presented by HLA-A0201. Chidamide-induced epigenetic upregulation of CD86 also contributed to increased cytotoxicity of PRAME antigen-specific CTLs. Our data thus provide a new line of evidence that epigenetic upregulation of cancer testis antigens by a subtype-selective HDAC inhibitor or in combination with hypomethylating agent increases CTL cytotoxicity and may represent a new opportunity in future design of treatment strategy targeting specifically PRAME-expressing acute myeloid leukemia.	[Yao, Yushi; Zhou, Jihao; Gao, Xiaoning; Ning, Qiaoyang; Jiang, Mengmeng; Wang, Jia; Wang, Lili; Yu, Li] Chinese Peoples Liberat Army Gen Hosp, Dept Hematol, Beijing, Peoples R China; [Yao, Yushi; Zhou, Jihao; Gao, Xiaoning; Ning, Qiaoyang; Jiang, Mengmeng; Wang, Jia; Wang, Lili; Yu, Li] Chinese Peoples Liberat Army Gen Hosp, BMT Ctr, Beijing, Peoples R China; [Wang, Lixin] Navy Gen Hosp, Dept Hematol, Beijing, Peoples R China	Chinese People's Liberation Army General Hospital; Chinese People's Liberation Army General Hospital; Sixth Medical Center of Chinese PLA General Hospital	Yu, L (corresponding author), Chinese Peoples Liberat Army Gen Hosp, Dept Hematol, Beijing, Peoples R China.	chunhuiliyu@yahoo.com	wang, lili/HDL-7210-2022	Yao, Yushi/0000-0003-1715-6805; Yu, Li/0000-0001-6872-2665	National Natural Science Foundation of China [81170518, 90919044, 30971297, 81000221]; Public Health Program of Beijing [Z111107067311070]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Public Health Program of Beijing	This study is funded by National Natural Science Foundation of China (No. 81170518, 90919044, 30971297, and 81000221, http://www.nsfc.gov.cn). The authors' current study has also been funded by the Public Health Program of Beijing (Z111107067311070). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal P, 2009, J IMMUNOL, V183, P1695, DOI 10.4049/jimmunol.0900592; Akers SN, 2010, FUTURE ONCOL, V6, P717, DOI [10.2217/fon.10.36, 10.2217/FON.10.36]; Atanackovic D, 2011, AM J HEMATOL, V86, P918, DOI 10.1002/ajh.22141; Carreno BM, 2002, ANNU REV IMMUNOL, V20, P29, DOI 10.1146/annurev.immunol.20.091101.091806; Carta S, 2006, BLOOD, V108, P1618, DOI 10.1182/blood-2006-03-014126; Choi J, 2010, BLOOD, V116, P129, DOI 10.1182/blood-2009-12-257253; Cruz CR, 2011, CLIN CANCER RES, V17, P7058, DOI 10.1158/1078-0432.CCR-11-1873; Doolan P, 2008, BREAST CANCER RES TR, V109, P359, DOI 10.1007/s10549-007-9643-3; Drummond DC, 2005, ANNU REV PHARMACOL, V45, P495, DOI 10.1146/annurev.pharmtox.45.120403.095825; Dubovsky JA, 2009, CLIN CANCER RES, V15, P3406, DOI 10.1158/1078-0432.CCR-08-2099; Epping MT, 2007, P NATL ACAD SCI USA, V104, P17777, DOI 10.1073/pnas.0702518104; Epping MT, 2005, CELL, V122, P835, DOI 10.1016/j.cell.2005.07.003; Fann M, 2006, BLOOD, V108, P3363, DOI 10.1182/blood-2006-02-005520; Fooksman DR, 2010, ANNU REV IMMUNOL, V28, P79, DOI 10.1146/annurev-immunol-030409-101308; Gong K, 2012, BIOCHEM J, V443, P735, DOI 10.1042/BJ20111685; Goodyear O, 2010, BLOOD, V116, P1908, DOI 10.1182/blood-2009-11-249474; Greiner J, 2006, BLOOD, V108, P4109, DOI 10.1182/blood-2006-01-023127; Griffioen M, 2006, CLIN CANCER RES, V12, P3130, DOI 10.1158/1078-0432.CCR-05-2578; Kessler JH, 2001, J EXP MED, V193, P73, DOI 10.1084/jem.193.1.73; Liu L, 2010, BIOCHEM BIOPH RES CO, V392, P190, DOI 10.1016/j.bbrc.2010.01.011; Maeda T, 2000, BLOOD, V96, P3847, DOI 10.1182/blood.V96.12.3847.h8003847_3847_3856; Natsume A, 2008, INT J CANCER, V122, P2542, DOI 10.1002/ijc.23407; Ning ZQ, 2012, CANCER CHEMOTH PHARM, V69, P901, DOI 10.1007/s00280-011-1766-x; Northrop JK, 2008, J IMMUNOL, V181, P865, DOI 10.4049/jimmunol.181.2.865; Oberthuer A, 2004, CLIN CANCER RES, V10, P4307, DOI 10.1158/1078-0432.CCR-03-0813; Ortmann CA, 2008, ANN HEMATOL, V87, P809, DOI 10.1007/s00277-008-0514-8; Pollack SM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032165; Qin T, 2007, CLIN CANCER RES, V13, P4225, DOI 10.1158/1078-0432.CCR-06-2762; Quintarelli C, 2008, BLOOD, V112, P1876, DOI 10.1182/blood-2008-04-150045; Reddy P, 2008, J CLIN INVEST, V118, P2562, DOI 10.1172/JCI34712; Rezvani K, 2009, BLOOD, V113, P2245, DOI 10.1182/blood-2008-03-144071; RIDDELL SR, 1990, J IMMUNOL METHODS, V128, P189, DOI 10.1016/0022-1759(90)90210-M; Rosborough BR, 2012, J LEUKOCYTE BIOL, V91, P701, DOI 10.1189/jlb.0311119; Rossi LE, 2012, J LEUKOCYTE BIOL, V91, P321, DOI 10.1189/jlb.0711339; Santamaria C, 2008, HAEMATOL-HEMATOL J, V93, P1797, DOI 10.3324/haematol.13214; Scanlan MJ, 2002, IMMUNOL REV, V188, P22, DOI 10.1034/j.1600-065X.2002.18803.x; Sharpe AH, 2002, NAT REV IMMUNOL, V2, P116, DOI 10.1038/nri727; Shen L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030815; Simpson AJG, 2005, NAT REV CANCER, V5, P615, DOI 10.1038/nrc1669; Skov S, 2005, CANCER RES, V65, P11136, DOI 10.1158/0008-5472.CAN-05-0599; Song W, 2011, LEUKEMIA, V25, P161, DOI 10.1038/leu.2010.244; Steinbach D, 2002, CANCER GENET CYTOGEN, V133, P118, DOI 10.1016/S0165-4608(01)00570-2; Szyf M, 2009, ANNU REV PHARMACOL, V49, P243, DOI 10.1146/annurev-pharmtox-061008-103102; Tajeddine N, 2008, LEUKEMIA LYMPHOMA, V49, P1123, DOI 10.1080/10428190802035933; van Baren N, 1998, BRIT J HAEMATOL, V102, P1376; Vo DD, 2009, CANCER RES, V69, P8693, DOI 10.1158/0008-5472.CAN-09-1456; WEBER J, 1994, CANCER RES, V54, P1766; Weiser TS, 2001, J IMMUNOTHER, V24, P151, DOI 10.1097/00002371-200103000-00010; Xia S, 2008, MOL IMMUNOL, V45, P2831, DOI 10.1016/j.molimm.2008.01.035; Yan MY, 2011, CANCER IMMUNOL IMMUN, V60, P1243, DOI 10.1007/s00262-011-1024-4	50	57	65	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2013	8	8							e70522	10.1371/journal.pone.0070522	http://dx.doi.org/10.1371/journal.pone.0070522			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	218XC	23940586	gold, Green Submitted, Green Published			2022-12-25	WOS:000324465000080
J	Offenbacher, AR; Polander, BC; Barry, BA				Offenbacher, Adam R.; Polander, Brandon C.; Barry, Bridgette A.			An Intrinsically Disordered Photosystem II Subunit, PsbO, Provides a Structural Template and a Sensor of the Hydrogen-bonding Network in Photosynthetic Water Oxidation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Intrinsically Disordered Proteins; Metalloproteins; Photosynthesis; Protein Dynamics; Protein-Protein Interactions; Conformational Landscape	MANGANESE-STABILIZING PROTEIN; OXYGEN-EVOLVING COMPLEX; RAY-ABSORPTION SPECTROSCOPY; ELECTRON-PARAMAGNETIC-RES; 33-KDA EXTRINSIC PROTEIN; SITE-DIRECTED MUTANTS; AMINO-ACID-SEQUENCES; ARABIDOPSIS-THALIANA; CONFORMATIONAL-CHANGES; INFRARED-SPECTROSCOPY	Photosystem II (PSII) is a membrane-bound enzyme that utilizes solar energy to catalyze the photooxidation of water. Molecular oxygen is evolved after four sequential light-driven oxidation reactions at the Mn4CaO5 oxygen-evolving complex, producing five sequentially oxidized states, S-n. PSII is composed of 17 membrane-spanning subunits and three extrinsic subunits, PsbP, PsbQ, and PsbO. PsbO is intrinsically disordered and plays a role in facilitation of the water oxidizing cycle. Native PsbO can be removed and substituted with recombinant PsbO, thereby restoring steady-state activity. In this report, we used reaction-induced Fourier transform infrared spectroscopy to obtain information concerning the role of PsbP, PsbQ, and PsbO during the S state cycle. Light-minus-dark difference spectra were acquired, monitoring structural changes associated with each accessible flash-induced S state transition in a highly purified plant PSII preparation (Triton X-100, octylthioglucoside). A comparison of S-2 minus S-1 spectra revealed that removal of PsbP and PsbQ had no significant effect on the data, whereas amide frequency and intensity changes were associated with PsbO removal. These data suggest that PsbO acts as an organizational template for the PSII reaction center. To identify any coupled conformational changes arising directly from PsbO, global C-13-PsbO isotope editing was employed. The reaction-induced Fourier transform infrared spectra of accessible S states provide evidence that PsbO spectral contributions are temperature (263 and 277 K) and S state dependent. These experiments show that PsbO undergoes catalytically relevant structural dynamics, which are coupled over long distance to hydrogen-bonding changes at the Mn4CaO5 cluster.	Georgia Inst Technol, Sch Chem & Biochem, Atlanta, GA 30332 USA; Georgia Inst Technol, Petit Inst Bioengn & Biosci, Atlanta, GA 30332 USA	University System of Georgia; Georgia Institute of Technology; University System of Georgia; Georgia Institute of Technology	Barry, BA (corresponding author), 901 Atlantic Dr NW, Atlanta, GA 30332 USA.	bridgette.barry@chemistry.gatech.edu		Offenbacher, Adam/0000-0001-6990-7178	National Science Foundation [MCB 08-42246]	National Science Foundation(National Science Foundation (NSF))	This work was supported by National Science Foundation Grant MCB 08-42246 (to B. A. B.)	Al-Khaldi SF, 2000, PLANT MOL BIOL, V43, P33, DOI 10.1023/A:1006419928712; Allahverdiyeva Y, 2009, BBA-BIOENERGETICS, V1787, P1230, DOI 10.1016/j.bbabio.2009.05.013; Baldwin AJ, 2009, NAT CHEM BIOL, V5, P808, DOI 10.1038/nchembio.238; BARRY BA, 1995, METHOD ENZYMOL, V258, P303; Barry BA, 2006, P NATL ACAD SCI USA, V103, P7288, DOI 10.1073/pnas.0600216103; Barry BA, 2011, J PHOTOCH PHOTOBIO B, V104, P60, DOI 10.1016/j.jphotobiol.2011.01.026; Barth A, 2007, BBA-BIOENERGETICS, V1767, P1073, DOI 10.1016/j.bbabio.2007.06.004; BERTHOLD DA, 1981, FEBS LETT, V134, P231, DOI 10.1016/0014-5793(81)80608-4; Betts SD, 1998, BIOCHEMISTRY-US, V37, P14230, DOI 10.1021/bi981305h; Betts SD, 1997, BIOCHEMISTRY-US, V36, P4047, DOI 10.1021/bi962413b; BETTS SD, 1994, PLANT MOL BIOL, V26, P117, DOI 10.1007/BF00039525; Betts SD, 1996, BIOCHEMISTRY-US, V35, P6302, DOI 10.1021/bi953066t; Boehr DD, 2006, SCIENCE, V313, P1638, DOI 10.1126/science.1130258; Bondar AN, 2012, BBA-BIOENERGETICS, V1817, P1177, DOI 10.1016/j.bbabio.2012.03.031; Bricker T. M., 2013, PHOTOSYNTH RES, DOI 10.1007/s11120-013-9820-7; Bricker TM, 2008, J BIOL CHEM, V283, P29022, DOI 10.1074/jbc.M805122200; Bricker TM, 2012, BBA-BIOENERGETICS, V1817, P121, DOI 10.1016/j.bbabio.2011.07.006; Bricker TM, 2011, J PHOTOCH PHOTOBIO B, V104, P165, DOI 10.1016/j.jphotobiol.2011.01.025; BRICKER TM, 1992, BIOCHEMISTRY-US, V31, P4623, DOI 10.1021/bi00134a012; Bricker TM, 1998, PHOTOSYNTH RES, V56, P157, DOI 10.1023/A:1006068615220; BURNAP RL, 1994, BIOCHEMISTRY-US, V33, P13712, DOI 10.1021/bi00250a023; BURNAP RL, 1992, BIOCHEMISTRY-US, V31, P7404, DOI 10.1021/bi00147a027; Campbell KA, 1998, BIOCHEMISTRY-US, V37, P5039, DOI 10.1021/bi9800552; Commet A, 2012, BIOCHEMISTRY-US, V51, P3808, DOI 10.1021/bi201678m; Dau H, 2012, CURR OPIN CHEM BIOL, V16, P3, DOI 10.1016/j.cbpa.2012.02.011; De Riso A, 2006, BIOPHYS J, V91, P1999, DOI 10.1529/biophysj.106.087171; Dwyer SA, 2012, J EXP BOT, V63, P4781, DOI 10.1093/jxb/ers156; EATONRYE JJ, 1989, BIOCHIM BIOPHYS ACTA, V977, P219, DOI 10.1016/S0005-2728(89)80075-1; Enami I, 1998, J BIOL CHEM, V273, P4629, DOI 10.1074/jbc.273.8.4629; Fink AL, 2005, CURR OPIN STRUC BIOL, V15, P35, DOI 10.1016/j.sbi.2005.01.002; FRANKEL LK, 1995, BIOCHEMISTRY-US, V34, P7492, DOI 10.1021/bi00022a024; Freier E, 2011, P NATL ACAD SCI USA, V108, P11435, DOI 10.1073/pnas.1104735108; GHANOTAKIS DF, 1985, FEBS LETT, V192, P1, DOI 10.1016/0014-5793(85)80030-2; Haumann M, 2005, BIOCHEMISTRY-US, V44, P1894, DOI 10.1021/bi048697e; Haumann M, 2002, FEBS LETT, V512, P116, DOI 10.1016/S0014-5793(02)02237-8; Henzler-Wildman K, 2007, NATURE, V450, P964, DOI 10.1038/nature06522; Hillier W, 2001, BIOCHEMISTRY-US, V40, P1503, DOI 10.1021/bi002436x; Hutchison RS, 1998, BIOCHEMISTRY-US, V37, P5643, DOI 10.1021/bi9724467; Hutchison RS, 1999, J BIOL CHEM, V274, P31987, DOI 10.1074/jbc.274.45.31987; Joliot P., 1975, BIOENERG PHOTOSYNTH, P388; Kapoor S, 2012, P NATL ACAD SCI USA, V109, P460, DOI 10.1073/pnas.1110553109; Kashino Y, 2002, BIOCHEMISTRY-US, V41, P8004, DOI 10.1021/bi026012+; Kotting C, 2005, CHEMPHYSCHEM, V6, P881, DOI 10.1002/cphc.200400504; Leuschner C, 1996, BIOCHEMISTRY-US, V35, P4551, DOI 10.1021/bi9522615; Liang WC, 2000, J AM CHEM SOC, V122, P3399, DOI 10.1021/ja992501u; Liu HJ, 2007, BIOCHEMISTRY-US, V46, P7607, DOI 10.1021/bi700107w; Lundin B, 2008, PHOTOSYNTH RES, V98, P405, DOI 10.1007/s11120-008-9325-y; Lundin B, 2007, BBA-BIOENERGETICS, V1767, P500, DOI 10.1016/j.bbabio.2006.10.009; Lundin B, 2007, PLANT J, V49, P528, DOI 10.1111/j.1365-313X.2006.02976.x; Lydakis-Simantiris N, 1999, BIOCHEMISTRY-US, V38, P404, DOI 10.1021/bi981847z; Lydakis-Simantiris N, 1999, BIOCHEMISTRY-US, V38, P15528, DOI 10.1021/bi991599m; Masterson LR, 2011, P NATL ACAD SCI USA, V108, P6969, DOI 10.1073/pnas.1102701108; MAYFIELD SP, 1987, P NATL ACAD SCI USA, V84, P749, DOI 10.1073/pnas.84.3.749; MILLER AF, 1987, PHOTOSYNTH RES, V12, P205, DOI 10.1007/BF00055121; MISHRA RK, 1994, PHOTOSYNTH RES, V42, P37, DOI 10.1007/BF00019056; Miura T, 1997, J BIOL CHEM, V272, P3788, DOI 10.1074/jbc.272.6.3788; MIYAO M, 1984, FEBS LETT, V168, P118, DOI 10.1016/0014-5793(84)80218-5; MIYAO M, 1984, FEBS LETT, V170, P350, DOI 10.1016/0014-5793(84)81342-3; MIYAO M, 1987, BIOCHIM BIOPHYS ACTA, V890, P151, DOI 10.1016/0005-2728(87)90016-8; Motoki A, 2002, J BIOL CHEM, V277, P14747, DOI 10.1074/jbc.M100766200; Murakami R, 2005, FEBS J, V272, P2165, DOI 10.1111/j.1742-4658.2005.04636.x; Murakami R, 2002, FEBS LETT, V523, P138, DOI 10.1016/S0014-5793(02)02963-0; Murray JW, 2007, J STRUCT BIOL, V159, P228, DOI 10.1016/j.jsb.2007.01.016; Nagel ZD, 2013, J BIOL CHEM, V288, P14087, DOI 10.1074/jbc.M113.453951; Nashine VC, 2010, CURR OPIN CHEM BIOL, V14, P644, DOI 10.1016/j.cbpa.2010.07.020; Nelson N, 2006, ANNU REV PLANT BIOL, V57, P521, DOI 10.1146/annurev.arplant.57.032905.105350; Noguchi T, 2001, BIOCHEMISTRY-US, V40, P1497, DOI 10.1021/bi0023807; NOREN GH, 1991, BIOCHEMISTRY-US, V30, P3943, DOI 10.1021/bi00230a020; ONO T, 1984, FEBS LETT, V168, P281, DOI 10.1016/0014-5793(84)80263-X; Ouelette AJA, 2002, PHOTOSYNTH RES, V72, P159, DOI 10.1023/A:1016132700844; PICCIONI R, 1982, METHODS CHLOROPLAST, P985; Polander BC, 2013, P NATL ACAD SCI USA, V110, P10634, DOI 10.1073/pnas.1306532110; Polander BC, 2013, J PHYS CHEM LETT, V4, P786, DOI 10.1021/jz400071k; Polander BC, 2012, P NATL ACAD SCI USA, V109, P6112, DOI 10.1073/pnas.1200093109; Popelka H, 2012, PHOTOSYNTH RES, V112, P117, DOI 10.1007/s11120-012-9745-6; Popelkova H, 2006, BIOCHEMISTRY-US, V45, P3107, DOI 10.1021/bi0523759; Popelkova H, 2003, PHOTOSYNTH RES, V77, P21, DOI 10.1023/A:1024970926655; Popelkova H, 2003, BIOCHEMISTRY-US, V42, P6193, DOI 10.1021/bi0207115; Popelkova H, 2002, BIOCHEMISTRY-US, V41, P2702, DOI 10.1021/bi0118761; Popelkova H, 2002, BIOCHEMISTRY-US, V41, P10038, DOI 10.1021/bi020228u; Popelkova H, 2008, BIOCHEMISTRY-US, V47, P12593, DOI 10.1021/bi801512s; Popelkova H, 2007, PHOTOSYNTH RES, V93, P111, DOI 10.1007/s11120-006-9121-5; Popelkova H, 2011, PHOTOSYNTH RES, V110, P111, DOI 10.1007/s11120-011-9703-8; Popelkova H, 2010, FEBS LETT, V584, P4009, DOI 10.1016/j.febslet.2010.08.011; Popelkova H, 2009, BIOCHEMISTRY-US, V48, P11920, DOI 10.1021/bi9016999; Popelkova L, 2011, J PHOTOCH PHOTOBIO B, V104, P179, DOI 10.1016/j.jphotobiol.2011.01.015; Qian M, 1997, BIOCHEMISTRY-US, V36, P15244, DOI 10.1021/bi9713198; Roose JL, 2011, BIOCHEMISTRY-US, V50, P5988, DOI 10.1021/bi2008068; Roose JL, 2010, BIOCHEMISTRY-US, V49, P6042, DOI 10.1021/bi100303f; Roose JL, 2010, BIOCHEMISTRY-US, V49, P36, DOI 10.1021/bi9017818; Sachs RK, 2003, J BIOL CHEM, V278, P44222, DOI 10.1074/jbc.M307148200; Seidler A, 1996, BBA-BIOENERGETICS, V1277, P35, DOI 10.1016/S0005-2728(96)00102-8; SEIDLER A, 1994, PROTEIN ENG, V7, P1277, DOI 10.1093/protein/7.10.1277; Shutova T, 2007, BBA-BIOENERGETICS, V1767, P434, DOI 10.1016/j.bbabio.2007.01.020; Speranskiy K, 2004, J CHEM PHYS, V121, P1516, DOI 10.1063/1.1752887; STYRING S, 1987, BIOCHIM BIOPHYS ACTA, V890, P32, DOI 10.1016/0005-2728(87)90065-X; SUREWICZ WK, 1993, BIOCHEMISTRY-US, V32, P389, DOI 10.1021/bi00053a001; Svensson B, 2004, BIOPHYS J, V86, P1807, DOI 10.1016/S0006-3495(04)74247-2; Thornton LE, 2004, PLANT CELL, V16, P2164, DOI 10.1105/tpc.104.023515; Tomita M, 2009, BIOCHEMISTRY-US, V48, P6318, DOI 10.1021/bi9006308; Tompa P, 2012, TRENDS BIOCHEM SCI, V37, P509, DOI 10.1016/j.tibs.2012.08.004; Umena Y, 2011, NATURE, V473, P55, DOI 10.1038/nature09913; Wyman AJ, 2008, BIOCHEMISTRY-US, V47, P6490, DOI 10.1021/bi800225m; Wyman AJ, 2005, PHOTOSYNTH RES, V85, P359, DOI 10.1007/s11120-005-7385-9; XU Q, 1992, J BIOL CHEM, V267, P25816; YAMAMOTO Y, 1987, ARCH BIOCHEM BIOPHYS, V255, P156, DOI 10.1016/0003-9861(87)90305-5; Yi XP, 2006, J BIOL CHEM, V281, P26260, DOI 10.1074/jbc.M603582200; Yi XP, 2008, PHOTOSYNTH RES, V98, P439, DOI 10.1007/s11120-008-9352-8; Yi XP, 2005, J BIOL CHEM, V280, P16170, DOI 10.1074/jbc.M501550200; Yocum CF, 2008, COORDIN CHEM REV, V252, P296, DOI 10.1016/j.ccr.2007.08.010; Zhang F, 2005, BIOCHEMISTRY-US, V44, P719, DOI 10.1021/bi0483559	111	22	23	0	40	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 4	2013	288	40					29056	29068		10.1074/jbc.M113.487561	http://dx.doi.org/10.1074/jbc.M113.487561			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	298BL	23940038	hybrid, Green Published			2022-12-25	WOS:000330298800059
J	Holdo, RM				Holdo, Ricardo M.			Revisiting the Two-Layer Hypothesis: Coexistence of Alternative Functional Rooting Strategies in Savannas	PLOS ONE			English	Article							WATER-CONTROLLED ECOSYSTEMS; TREE-GRASS COEXISTENCE; PIPE-MODEL-THEORY; SOIL-MOISTURE; HYDROLOGIC PROCESSES; SUBTROPICAL SAVANNA; AFRICAN SAVANNAS; EXISTING MODELS; SOUTHERN AFRICA; ACTIVE-ROLE	The two-layer hypothesis of tree-grass coexistence posits that trees and grasses differ in rooting depth, with grasses exploiting soil moisture in shallow layers while trees have exclusive access to deep water. The lack of clear differences in maximum rooting depth between these two functional groups, however, has caused this model to fall out of favor. The alternative model, the demographic bottleneck hypothesis, suggests that trees and grasses occupy overlapping rooting niches, and that stochastic events such as fires and droughts result in episodic tree mortality at various life stages, thus preventing trees from otherwise displacing grasses, at least in mesic savannas. Two potential problems with this view are: 1) we lack data on functional rooting profiles in trees and grasses, and these profiles are not necessarily reflected by differences in maximum or physical rooting depth, and 2) subtle, difficult-to-detect differences in rooting profiles between the two functional groups may be sufficient to result in coexistence in many situations. To tackle this question, I coupled a plant uptake model with a soil moisture dynamics model to explore the environmental conditions under which functional rooting profiles with equal rooting depth but different depth distributions (i.e., shapes) can coexist when competing for water. I show that, as long as rainfall inputs are stochastic, coexistence based on rooting differences is viable under a wide range of conditions, even when these differences are subtle. The results also indicate that coexistence mechanisms based on rooting niche differentiation are more viable under some climatic and edaphic conditions than others. This suggests that the two-layer model is both viable and stochastic in nature, and that a full understanding of tree-grass coexistence and dynamics may require incorporating fine-scale rooting differences between these functional groups and realistic stochastic climate drivers into future models.	Univ Missouri, Div Biol Sci, Columbia, MO 65211 USA	University of Missouri System; University of Missouri Columbia	Holdo, RM (corresponding author), Univ Missouri, Div Biol Sci, Columbia, MO 65211 USA.	holdor@missouri.edu			University of Missouri	University of Missouri	This work was funded by the University of Missouri. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1975, COMMUNITIES ECOSYSTE; BELSKY AJ, 1990, J BIOGEOGR, V17, P483, DOI 10.2307/2845380; Bond WJ, 2008, ANNU REV ECOL EVOL S, V39, P641, DOI 10.1146/annurev.ecolsys.39.110707.173411; BROWN JR, 1990, OIKOS, V57, P366, DOI 10.2307/3565966; CHESSON PL, 1985, THEOR POPUL BIOL, V28, P263, DOI 10.1016/0040-5809(85)90030-9; Dodd MB, 1998, OECOLOGIA, V117, P504, DOI 10.1007/s004420050686; EAGLESON PS, 1985, WATER RESOUR RES, V21, P1483, DOI 10.1029/WR021i010p01483; February EC, 2010, S AFR J BOT, V76, P517, DOI 10.1016/j.sajb.2010.04.001; Guswa AJ, 2002, WATER RESOUR RES, V38, DOI 10.1029/2001WR000528; HARDIN G, 1960, SCIENCE, V131, P1292, DOI 10.1126/science.131.3409.1292; Higgins SI, 2000, J ECOL, V88, P213, DOI 10.1046/j.1365-2745.2000.00435.x; Hipondoka MHT, 2003, J ARID ENVIRON, V54, P319, DOI 10.1006/jare.2002.1093; Hoffmann WA, 2012, ECOL LETT, V15, P759, DOI 10.1111/j.1461-0248.2012.01789.x; Holdo RM, 2008, J TROP ECOL, V24, P169, DOI 10.1017/S0266467408004835; Holdo RM, 2013, OIKOS, V122, P441, DOI 10.1111/j.1600-0706.2012.20735.x; Holdo RM, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000210; House JI, 2003, J BIOGEOGR, V30, P1763, DOI 10.1046/j.1365-2699.2003.00873.x; Infante JM, 2001, TREE PHYSIOL, V21, P409, DOI 10.1093/treephys/21.6.409; Jeltsch F, 2000, PLANT ECOL, V150, P161, DOI 10.1023/A:1026590806682; Jeltsch F, 1996, J ECOL, V84, P583, DOI 10.2307/2261480; Jung M, 2010, NATURE, V467, P951, DOI 10.1038/nature09396; Kulmatiski A, 2013, OECOLOGIA, V171, P25, DOI 10.1007/s00442-012-2390-0; Kulmatiski A, 2010, NEW PHYTOL, V188, P199, DOI 10.1111/j.1469-8137.2010.03338.x; Laio F, 2001, ADV WATER RESOUR, V24, P707, DOI 10.1016/S0309-1708(01)00005-7; Moorcroft PR, 2001, ECOL MONOGR, V71, P557, DOI 10.1890/0012-9615(2001)071[0557:AMFSVD]2.0.CO;2; Mordelet P, 1997, J VEG SCI, V8, P65, DOI 10.2307/3237243; Nippert JB, 2007, OECOLOGIA, V153, P261, DOI 10.1007/s00442-007-0745-8; Nippert JB, 2007, OIKOS, V116, P1017, DOI [10.1111/j.2007.0030-1299.15630.x, 10.1111/j.0030-1299.2007.15630.x]; Nippert JB, 2012, PLANT SOIL, V355, P385, DOI 10.1007/s11104-011-1112-4; NYGREN P, 1993, AGROFOREST SYST, V23, P63, DOI 10.1007/BF00704851; Ogle K, 2004, OECOLOGIA, V141, P282, DOI 10.1007/s00442-004-1507-5; Ogle K, 2004, ECOLOGY, V85, P1967, DOI 10.1890/03-0346; Pacala S, 2002, MG POP BIOL, V33, P169; Porporato A, 2002, ADV WATER RESOUR, V25, P1335, DOI 10.1016/S0309-1708(02)00058-1; Porporato A, 2003, J GEOPHYS RES-ATMOS, V108, DOI 10.1029/2002JD002448; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Rodriguez-Iturbe I, 1999, GEOPHYS RES LETT, V26, P247, DOI 10.1029/1998GL900296; Rodriguez-Iturbe I, 2001, ADV WATER RESOUR, V24, P695, DOI 10.1016/S0309-1708(01)00004-5; Rodriguez-Iturbe I, 1999, P ROY SOC A-MATH PHY, V455, P3789, DOI 10.1098/rspa.1999.0477; SALA OE, 1989, OECOLOGIA, V81, P501, DOI 10.1007/BF00378959; Sankaran M, 2004, ECOL LETT, V7, P480, DOI 10.1111/j.1461-0248.2004.00596.x; Sankaran M, 2005, NATURE, V438, P846, DOI 10.1038/nature04070; Scheiter S, 2007, AM NAT, V170, P587, DOI 10.1086/521317; Scholes R.J., 1993, AFRICAN SAVANNA SYNT; Scholes RJ, 1997, ANNU REV ECOL SYST, V28, P517, DOI 10.1146/annurev.ecolsys.28.1.517; Scholz FG, 2002, TREE PHYSIOL, V22, P603, DOI 10.1093/treephys/22.9.603; Sperry JS, 2002, FUNCT ECOL, V16, P367, DOI 10.1046/j.1365-2435.2002.00628.x; Staver AC, 2011, SCIENCE, V334, P230, DOI 10.1126/science.1210465; Tomlinson KW, 2012, J ECOL, V100, P1113, DOI 10.1111/j.1365-2745.2012.01975.x; VALENTINE HT, 1988, ANN BOT-LONDON, V62, P389, DOI 10.1093/oxfordjournals.aob.a087672; van Wijk MT, 2002, WATER RESOUR RES, V38, DOI 10.1029/2001WR000768; Verweij RJT, 2011, ENVIRON EXP BOT, V74, P229, DOI 10.1016/j.envexpbot.2011.06.004; Walker B. H., 1982, Ecology of tropical savannas, P556; WALKER BH, 1981, J ECOL, V69, P473, DOI 10.2307/2259679; Walter H., 1973, VEGETATION EARTH REL; Walter H., 1971, ECOLOGY TROPICAL SUB; Ward D, 2012, OECOLOGIA, P1; Weltzin JF, 1997, OECOLOGIA, V112, P156, DOI 10.1007/s004420050295; West GB, 1999, NATURE, V400, P664, DOI 10.1038/23251; Xiao X, 2011, VADOSE ZONE J, V10, P1016, DOI 10.2136/vzj2010.0070; Zucchini W, 2006, ENVIRONMETRICS, V17, P269, DOI 10.1002/env.748	61	51	52	1	59	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2013	8	8							e69625	10.1371/journal.pone.0069625	http://dx.doi.org/10.1371/journal.pone.0069625			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	200UV	23950900	Green Published, Green Submitted, gold			2022-12-25	WOS:000323097300010
J	White, WTJ; Zhong, BJ; Penny, D				White, W. Timothy J.; Zhong, Bojian; Penny, David			Beyond Reasonable Doubt: Evolution from DNA Sequences	PLOS ONE			English	Article							CHLOROPLAST GENOMES; PHYLOGENY; MODEL; GENES; TIME	We demonstrate quantitatively that, as predicted by evolutionary theory, sequences of homologous proteins from different species converge as we go further and further back in time. The converse, a non-evolutionary model can be expressed as probabilities, and the test works for chloroplast, nuclear and mitochondrial sequences, as well as for sequences that diverged at different time depths. Even on our conservative test, the probability that chance could produce the observed levels of ancestral convergence for just one of the eight datasets of 51 proteins is approximate to 1 x 10(-19) and combined over 8 datasets is approximate to 1 x 10(-132). By comparison, there are about 10(80) protons in the universe, hence the probability that the sequences could have been produced by a process involving unrelated ancestral sequences is about 10(50) lower than picking, among all protons, the same proton at random twice in a row. A non-evolutionary control model shows no convergence, and only a small number of parameters are required to account for the observations. It is time that that researchers insisted that doubters put up testable alternatives to evolution.	[White, W. Timothy J.; Zhong, Bojian; Penny, David] Massey Univ, Inst Fundamental Sci, Palmerston North, New Zealand	Massey University	Penny, D (corresponding author), Massey Univ, Inst Fundamental Sci, Palmerston North, New Zealand.	d.penny@massey.ac.nz	Zhong, Bojian/AAH-1236-2020	Zhong, Bojian/0000-0002-6496-7646	N Z Marsden Fund	N Z Marsden Fund(Royal Society of New ZealandMarsden Fund (NZ))	The work was supported (in part) by the N Z Marsden Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Adachi J, 2000, J MOL EVOL, V50, P348, DOI 10.1007/s002399910038; Adachi J., 1996, COMPUT SCI MONOGR, V28, P1; [Anonymous], 1932, STAT METHODS RES WOR; Clarke JT, 2011, NEW PHYTOL, V192, P266, DOI 10.1111/j.1469-8137.2011.03794.x; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Erwin DH, 2011, SCIENCE, V334, P1091, DOI 10.1126/science.1206375; Finnigan GC, 2012, NATURE, V481, P360, DOI 10.1038/nature10724; FITCH WM, 1970, SYST ZOOL, V19, P99, DOI 10.2307/2412448; Garwood R, 2012, NATURE, V485, P281, DOI 10.1038/485281a; GILBERT EN, 1968, SIAM J APPL MATH, V16, P1, DOI 10.1137/0116001; Hanson-Smith V, 2010, MOL BIOL EVOL, V27, P1988, DOI 10.1093/molbev/msq081; Harrison A, 2011, VIRUSES-BASEL, V3, P83, DOI 10.3390/v3020083; HENDERSON IM, 1989, J THEOR BIOL, V140, P289, DOI 10.1016/S0022-5193(89)80087-6; Herr AJ, 2011, CRIT REV BIOCHEM MOL, V46, P548, DOI 10.3109/10409238.2011.620941; Holmes E., 2009, EVOLUTION EMERGENCE; HWANG FK, 1992, NETWORKS, V22, P55, DOI 10.1002/net.3230220105; Leliaert F, 2011, BIOESSAYS, V33, P683, DOI 10.1002/bies.201100035; Martin W, 2002, P NATL ACAD SCI USA, V99, P12246, DOI 10.1073/pnas.182432999; Mossel E, 2004, MATH BIOSCI, V187, P189, DOI 10.1016/j.mbs.2003.10.004; Pacheco MA, 2011, MOL BIOL EVOL, V28, P1927, DOI 10.1093/molbev/msr014; PENNY D, 1995, MOL BIOL EVOL, V12, P863; Penny D, 2003, J THEOR BIOL, V223, P377, DOI 10.1016/S0022-5193(03)00099-7; PENNY D, 1982, NATURE, V297, P197, DOI 10.1038/297197a0; Penny D, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001096; Phillips MJ, 2010, SYST BIOL, V59, P90, DOI 10.1093/sysbio/syp079; Popper KR., 1981, CONJECTURES REFUTATI; Rapley C, 2012, NATURE, V488, P583, DOI 10.1038/488583a; Roberts L, 2012, SCIENCE, V337, P517, DOI 10.1126/science.337.6094.517; Soltis DE, 2011, AM J BOT, V98, P704, DOI 10.3732/ajb.1000404; Theobald DL, 2011, BIOL DIRECT, V6, DOI 10.1186/1745-6150-6-60; Theobald DL, 2010, NATURE, V465, P219, DOI 10.1038/nature09014; Wei T, 2012, P NATL ACAD SCI USA, V109, P12911, DOI 10.1073/pnas.1203282109; Whelan S, 2001, MOL BIOL EVOL, V18, P691, DOI 10.1093/oxfordjournals.molbev.a003851; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088; Zhong BJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005297	35	10	10	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2013	8	8							e69924	10.1371/journal.pone.0069924	http://dx.doi.org/10.1371/journal.pone.0069924			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	201ER	23950906	gold, Green Published, Green Submitted			2022-12-25	WOS:000323124000011
J	Jenkins, AB; Batterham, M; Samocha-Bonet, D; Tonks, K; Greenfield, JR; Campbell, LV				Jenkins, Arthur B.; Batterham, Marijka; Samocha-Bonet, Dorit; Tonks, Katherine; Greenfield, Jerry R.; Campbell, Lesley V.			Segregation of a Latent High Adiposity Phenotype in Families with a History of Type 2 Diabetes Mellitus Implicates Rare Obesity-Susceptibility Genetic Variants with Large Effects in Diabetes-Related Obesity	PLOS ONE			English	Article							BODY-MASS INDEX; MISSING HERITABILITY; LARGE-SAMPLE; FAT MASS; TWINS; RISK; OVERWEIGHT; EPIDEMIC; BMI	Background: We recently reported significantly greater weight gain in non-diabetic healthy subjects with a 1st degree family history (FH+) of type 2 diabetes mellitus (T2DM) than in a matched control group without such history (FH-) during voluntary overfeeding, implying co-inheritance of susceptibilities to T2DM and obesity. We have estimated the extent and mode of inheritance of susceptibility to increased adiposity in FH+. Methods: Normoglycaemic participants were categorised either FH+ (>= 1 1st degree relative with T2DM, 50F/30M, age 45 +/- 14 (SD) yr) or FH- (71F/51M, age 43 +/- 14 yr). Log-transformed anthropometric measurements (height, hip and waist circumferences) and lean, bone and fat mass (Dual Energy X-ray Absorptiometry) data were analysed by rotated Factor Analysis. The age- and gender-adjusted distributions of indices of adiposity in FH+ were assessed by fits to a bimodal model and by relative risk ratios (RR, FH+/FH-) and interpreted in a purely genetic model of FH effects. Results: The two orthogonal factors extracted, interpretable as Frame and Adiposity accounted for 80% of the variance in the input data. FH+ was associated with significantly higher Adiposity scores (p<0.01) without affecting Frame scores. Adiposity scores in FH+ conformed to a bimodal normal distribution, consistent with dominant expression of major susceptibility genes with 59% (95% CI 40%, 74%) of individuals under the higher mode. Calculated risk allele frequencies were 0.09 (0.02, 0.23) in FH-, 0.36 (0.22, 0.48) in FH+ and 0.62 (0.36, 0.88) in unobserved T2DM-affected family members. Conclusions: The segregation of Adiposity in T2DM-affected families is consistent with dominant expression of rare risk variants with major effects, which are expressed in over half of FH+ and which can account for most T2DM-associated obesity in our population. The calculated risk allele frequency in FH- suggests that rare genetic variants could also account for a substantial fraction of the prevalent obesity in this society.	[Jenkins, Arthur B.] Univ Wollongong, Sch Hlth Sci, Wollongong, NSW, Australia; [Jenkins, Arthur B.; Samocha-Bonet, Dorit; Tonks, Katherine; Greenfield, Jerry R.; Campbell, Lesley V.] Garvan Inst Med Res, Diabet & Obes Res Program, Sydney, NSW, Australia; [Batterham, Marijka] Univ Wollongong, Ctr Stat & Survey Methodol, Wollongong, NSW, Australia; [Tonks, Katherine; Greenfield, Jerry R.; Campbell, Lesley V.] St Vincents Hosp, Ctr Diabet, Sydney, NSW 2010, Australia; [Tonks, Katherine; Greenfield, Jerry R.; Campbell, Lesley V.] St Vincents Hosp, Dept Endocrinol, Sydney, NSW 2010, Australia	University of Wollongong; Garvan Institute of Medical Research; University of Wollongong; St Vincents Hospital Sydney; St Vincents Hospital Sydney	Jenkins, AB (corresponding author), Univ Wollongong, Sch Hlth Sci, Wollongong, NSW, Australia.	ajenkins@uow.edu.au	Jenkins, Alicia/N-2482-2015; Jenkins, Arthur B/D-4533-2012	Jenkins, Arthur B/0000-0003-1310-264X; Batterham, Marijka/0000-0002-9520-6508; Samocha-Bonet, Dorit/0000-0001-9422-7852	National Health and Medical Research Council of Australia	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia)	The studies were funded by grants and fellowships awarded by the National Health and Medical Research Council of Australia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbasi A, 2011, J INTERN MED, V270, P388, DOI 10.1111/j.1365-2796.2011.02347.x; Astrup A, 2000, Obes Rev, V1, P57, DOI 10.1046/j.1467-789x.2000.00013.x; Australian Bureau of Statistics, 2012, AUSTR HLTH SURV 1 RE; BAUMGARTNER RN, 1995, OBES RES, V3, P73, DOI 10.1002/j.1550-8528.1995.tb00124.x; Carey DG, 1996, DIABETES, V45, P633, DOI 10.2337/diabetes.45.5.633; CARMELLI D, 1994, AM J HUM GENET, V55, P566; COMUZZIE AG, 1995, GENET EPIDEMIOL, V12, P475, DOI 10.1002/gepi.1370120505; Condon J, 2008, TWIN RES HUM GENET, V11, P28, DOI 10.1375/twin.11.1.28; Conrad DF, 2010, NATURE, V464, P704, DOI 10.1038/nature08516; Creemers JWM, 2012, DIABETES, V61, P383, DOI 10.2337/db11-0305; Eckel RH, 2011, J CLIN ENDOCR METAB, V96, P1654, DOI 10.1210/jc.2011-0585; Hasstedt SJ, 2011, J HUM GENET, V56, P491, DOI 10.1038/jhg.2011.46; Hasstedt SJ, 1997, AM J HUM GENET, V61, P668, DOI 10.1086/515509; Hebebrand J, 2010, OBESITY FACTS, V3, P294, DOI 10.1159/000321537; Hemminki K, 2010, DIABETES CARE, V33, P293, DOI 10.2337/dc09-0947; Hill JO, 2009, AM J CLIN NUTR, V89, P477, DOI 10.3945/ajcn.2008.26566; Hirschhorn JN, 2011, ANNU REV MED, V62, P11, DOI 10.1146/annurev.med.091708.162036; Ho-Pham Lan T, 2011, Mayo Clin Proc, V86, P584, DOI 10.4065/mcp.2011.0097; Jenkins AB, 2004, J INHERIT METAB DIS, V27, P331, DOI 10.1023/B:BOLI.0000031097.31587.81; Jenkins AB, 2001, INT J OBESITY, V25, P1625, DOI 10.1038/sj.ijo.0801802; Jiao H, 2011, J CLIN ENDOCR METAB, V96, pE962, DOI 10.1210/jc.2010-2639; KAPRIO J, 1992, DIABETOLOGIA, V35, P1060, DOI 10.1007/BF02221682; Keinan A, 2012, SCIENCE, V336, P740, DOI 10.1126/science.1217283; Kriketos AD, 2004, DIABETES CARE, V27, P2033, DOI 10.2337/diacare.27.8.2033; Kriketos AD, 2003, DIABETIC MED, V20, P294, DOI 10.1046/j.1464-5491.2003.00938.x; Lecomte E, 1997, GENET EPIDEMIOL, V14, P51, DOI 10.1002/(SICI)1098-2272(1997)14:1<51::AID-GEPI4>3.0.CO;2-8; Lehtovirta M, 2010, DIABETOLOGIA, V53, P1314, DOI 10.1007/s00125-010-1746-4; Lindgren CM, 2008, NAT CLIN PRACT ENDOC, V4, P156, DOI 10.1038/ncpendmet0723; Maes HHM, 1997, BEHAV GENET, V27, P325, DOI 10.1023/A:1025635913927; Manolio TA, 2009, NATURE, V461, P747, DOI 10.1038/nature08494; Mayo O, 2008, TWIN RES HUM GENET, V11, P249, DOI 10.1375/twin.11.3.249; McCarthy MI, 2010, NEW ENGL J MED, V363, P2339, DOI 10.1056/NEJMra0906948; McClellan J, 2010, CELL, V141, P210, DOI 10.1016/j.cell.2010.03.032; Muller MJ, 2010, OBES REV, V11, P612, DOI 10.1111/j.1467-789X.2010.00734.x; Neale M. C., 2004, METHODOLOGY GENETIC; Nelson MR, 2012, SCIENCE, V337, P100, DOI 10.1126/science.1217876; O'Rahilly S, 2009, NATURE, V462, P307, DOI 10.1038/nature08532; Okorodudu DO, 2010, INT J OBESITY, V34, P791, DOI 10.1038/ijo.2010.5; Olds T, 2011, INT J PEDIATR OBES, V6, P342, DOI 10.3109/17477166.2011.605895; Pecioska S, 2010, PLOS ONE, V5, P8541; Poulsen P, 1999, DIABETOLOGIA, V42, P139, DOI 10.1007/s001250051131; Poulsen P, 2009, DIABETES, V58, P1350, DOI 10.2337/db08-1714; PRICE RA, 1989, HUM HERED, V39, P121; PRICE RA, 1994, HUM BIOL, V66, P251; PRICE RA, 1991, AM J EPIDEMIOL, V133, P501, DOI 10.1093/oxfordjournals.aje.a115917; R Core Team, 2021, R LANG ENV STAT COMP; Rice T, 1999, OBES RES, V7, P246, DOI 10.1002/j.1550-8528.1999.tb00403.x; Rokholm B, 2010, OBES REV, V11, P835, DOI 10.1111/j.1467-789X.2010.00810.x; Rokholm B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020816; Samaras K, 1997, J CLIN ENDOCR METAB, V82, P781, DOI 10.1210/jc.82.3.781; Samocha-Bonet D, 2010, DIABETOLOGIA, V53, P1700, DOI 10.1007/s00125-010-1768-y; Silventoinen K, 2003, AM J HUM BIOL, V15, P620, DOI 10.1002/ajhb.10183; Silventoinen K, 2010, INT J OBESITY, V34, P29, DOI 10.1038/ijo.2009.177; STUNKARD AJ, 1986, NEW ENGL J MED, V314, P193, DOI 10.1056/NEJM198601233140401; STUNKARD AJ, 1990, NEW ENGL J MED, V322, P1483, DOI 10.1056/NEJM199005243222102; Tayo BO, 2008, INT J OBESITY, V32, P1799, DOI 10.1038/ijo.2008.194; Tennessen JA, 2012, SCIENCE, V337, P64, DOI 10.1126/science.1219240; Tirosh A, 2011, NEW ENGL J MED, V364, P1315, DOI 10.1056/NEJMoa1006992; Tonks KT, 2013, DIABETOLOGIA; Wardle J, 2009, ANN BEHAV MED, V38, pS25, DOI 10.1007/s12160-009-9116-5; Zimmet P, 2001, NATURE, V414, P782, DOI 10.1038/414782a	61	10	10	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2013	8	8							e70435	10.1371/journal.pone.0070435	http://dx.doi.org/10.1371/journal.pone.0070435			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	200ZE	23950934	Green Published, Green Submitted, gold			2022-12-25	WOS:000323109700034
J	Yao, JX; Rotenberg, D; Afsharifar, A; Barandoc-Alviar, K; Whitfield, AE				Yao, Jianxiu; Rotenberg, Dorith; Afsharifar, Alireza; Barandoc-Alviar, Karen; Whitfield, Anna E.			Development of RNAi Methods for Peregrinus maidis, the Corn Planthopper	PLOS ONE			English	Article							V-ATPASE; HOMOPTERA DELPHACIDAE; INTERFERENCE; INSECT; REVEALS; VIRUS; MAIZE; GENE; EXPRESSION; LEAFHOPPER	The corn planthopper, Peregrinus maidis, is a major pest of agronomically-important crops. Peregrinus maidis has a large geographical distribution and transmits Maize mosaic rhabdovirus (MMV) and Maize stripe tenuivirus (MSpV). The objective of this study was to develop effective RNAi methods for P. maidis. Vacuolar-ATPase (V-ATPase) is an essential enzyme for hydrolysis of ATP and for transport of protons out of cells thereby maintaining membrane ion balance, and it has been demonstrated to be an efficacious target for RNAi in other insects. In this study, two genes encoding subunits of P. maidis V-ATPase (V-ATPase B and V-ATPase D) were chosen as RNAi target genes. The open reading frames of V-ATPase B and D were generated and used for constructing dsRNA fragments. Experiments were conducted using oral delivery and microinjection of V-ATPase B and V-ATPase D dsRNA to investigate the effectiveness of RNAi in P. maidis. Real-time quantitative reverse transcriptase-PCR (qRT-PCR) analysis indicated that microinjection of V-ATPase dsRNA led to a minimum reduction of 27-fold in the normalized abundance of V-ATPase transcripts two days post injection, while ingestion of dsRNA resulted in a twofold reduction after six days of feeding. While both methods of dsRNA delivery resulted in knockdown of target transcripts, the injection method was more rapid and effective. The reduction in V-ATPase transcript abundance resulted in observable phenotypes. Specifically, the development of nymphs injected with 200 ng of either V-ATPase B or D dsRNA was impaired, resulting in higher mortality and lower fecundity than control insects injected with GFP dsRNA. Microscopic examination of these insects revealed that female reproductive organs did not develop normally. The successful development of RNAi in P. maidis to target specific genes will enable the development of new insect control strategies and functional analysis of vital genes and genes associated with interactions between P. maidis and MMV.	[Yao, Jianxiu; Rotenberg, Dorith; Barandoc-Alviar, Karen; Whitfield, Anna E.] Kansas State Univ, Dept Plant Pathol, Manhattan, KS 66506 USA; [Afsharifar, Alireza] Shiraz Univ, Coll Agr, Plant Virol Res Ctr, Shiraz, Iran	Kansas State University; Shiraz University	Whitfield, AE (corresponding author), Kansas State Univ, Dept Plant Pathol, Throckmorton Hall, Manhattan, KS 66506 USA.	aewtospo@ksu.edu		Alviar, Karen/0000-0002-6759-0100; Rotenberg, Dorith/0000-0002-9018-8822	National Science Foundation [IOS-0953786]	National Science Foundation(National Science Foundation (NSF))	The project was supported by the National Science Foundation CAREER grant IOS-0953786 to AEW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allan AK, 2005, PHYSIOL GENOMICS, V22, P128, DOI 10.1152/physiolgenomics.00233.2004; Ammar ED, 2009, ANNU REV ENTOMOL, V54, P447, DOI 10.1146/annurev.ento.54.110807.090454; Ammar ED, 2008, VIRUS RES, V131, P77, DOI 10.1016/j.virusres.2007.08.010; Araujo RN, 2006, INSECT BIOCHEM MOLEC, V36, P683, DOI 10.1016/j.ibmb.2006.05.012; Autrey L. J. C., 1983, P INT MAIZ VIR DIS C, P167; Baum JA, 2007, NAT BIOTECHNOL, V25, P1322, DOI 10.1038/nbt1359; Bohrmann J, 1999, BIOL CELL, V91, P85, DOI 10.1016/S0248-4900(99)80033-1; Brown D, 1997, J EXP BIOL, V200, P257; Chakrabarty R, 2007, MOL PLANT MICROBE IN, V20, P740, DOI 10.1094/MPMI-20-7-0740; CHELLIAH S., 1965, INDIAN JENTOMOL, V27, P466; Chen J, 2010, INSECT MOL BIOL, V19, P777, DOI 10.1111/j.1365-2583.2010.01038.x; Chintapalli VR, 2007, NAT GENET, V39, P715, DOI 10.1038/ng2049; Davies SA, 1996, J BIOL CHEM, V271, P30677, DOI 10.1074/jbc.271.48.30677; DENNO RF, 1989, ECOL ENTOMOL, V14, P31, DOI 10.1111/j.1365-2311.1989.tb00751.x; Forgac M, 1998, FEBS LETT, V440, P258, DOI 10.1016/S0014-5793(98)01425-2; Hermle T, 2010, CURR BIOL, V20, P1269, DOI 10.1016/j.cub.2010.05.057; Huvenne H, 2010, J INSECT PHYSIOL, V56, P227, DOI 10.1016/j.jinsphys.2009.10.004; Jefferies KC, 2008, ARCH BIOCHEM BIOPHYS, V476, P33, DOI 10.1016/j.abb.2008.03.025; Laemmlen F, 2011, PEST NOTES, P74108; LASTRA JR, 1976, J GEN VIROL, V32, P139, DOI 10.1099/0022-1317-32-1-139; Li J, 2011, PEST MANAG SCI, V67, P852, DOI 10.1002/ps.2124; Li XK, 2011, NANOSCALE RES LETT, V6, P1, DOI 10.1186/1556-276X-6-625; Liu SH, 2010, INSECT BIOCHEM MOLEC, V40, P666, DOI 10.1016/j.ibmb.2010.06.007; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mao YB, 2007, NAT BIOTECHNOL, V25, P1307, DOI 10.1038/nbt1352; Martin D, 2006, J INSECT PHYSIOL, V52, P410, DOI 10.1016/j.jinsphys.2005.12.002; Mutti NS, 2006, J INSECT SCI, V6, DOI 10.1673/031.006.3801; NAULT LR, 1989, ANNU REV ENTOMOL, V34, P503, DOI 10.1146/annurev.en.34.010189.002443; Price DRG, 2008, TRENDS BIOTECHNOL, V26, P393, DOI 10.1016/j.tibtech.2008.04.004; Redinbaugh M. G., 2012, RHABDOVIRUSES MOL TA, P147; Singh BU, 2008, ARTHROPOD-PLANT INTE, V2, P163, DOI 10.1007/s11829-007-9026-z; Siomi H, 2009, NATURE, V457, P396, DOI 10.1038/nature07754; TSAI JH, 1990, J ENTOMOL SCI, V25, P106, DOI 10.18474/0749-8004-25.1.106; Tsai JH, 1996, FLA ENTOMOL, V79, P19, DOI 10.2307/3495750; Upadhyay SK, 2011, J BIOSCIENCES, V36, P153, DOI 10.1007/s12038-011-9009-1; Wang J, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-9-r69; Whitfield AE, 2011, INSECT MOL BIOL, V20, P225, DOI 10.1111/j.1365-2583.2010.01060.x; Whyard S, 2009, INSECT BIOCHEM MOLEC, V39, P824, DOI 10.1016/j.ibmb.2009.09.007; Wieczorek H, 2000, J EXP BIOL, V203, P127; Wieczorek H, 2009, J EXP BIOL, V212, P1611, DOI 10.1242/jeb.030007	40	44	48	1	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2013	8	8							e70243	10.1371/journal.pone.0070243	http://dx.doi.org/10.1371/journal.pone.0070243			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	200ZE	23950915	Green Published, Green Submitted, gold			2022-12-25	WOS:000323109700024
J	Azad, AKM; Lee, H				Azad, A. K. M.; Lee, Hyunju			Voting-Based Cancer Module Identification by Combining Topological and Data-Driven Properties	PLOS ONE			English	Article							PROTEIN INTERACTION NETWORKS; COPY NUMBER ABERRATIONS; EPIDERMAL-GROWTH-FACTOR; GENE-EXPRESSION; INTEGRATIVE ANALYSIS; FUNCTIONAL MODULES; GLIOBLASTOMA CELLS; CORE PATHWAYS; BREAST-CANCER; ACTIVATION	Recently, computational approaches integrating copy number aberrations (CNAs) and gene expression (GE) have been extensively studied to identify cancer-related genes and pathways. In this work, we integrate these two data sets with protein-protein interaction (PPI) information to find cancer-related functional modules. To integrate CNA and GE data, we first built a gene-gene relationship network from a set of seed genes by enumerating all types of pairwise correlations, e.g. GE-GE, CNA-GE, and CNA-CNA, over multiple patients. Next, we propose a voting-based cancer module identification algorithm by combining topological and data-driven properties (VToD algorithm) by using the gene-gene relationship network as a source of data-driven information, and the PPI data as topological information. We applied the VToD algorithm to 266 glioblastoma multiforme (GBM) and 96 ovarian carcinoma (OVC) samples that have both expression and copy number measurements, and identified 22 GBM modules and 23 OVC modules. Among 22 GBM modules, 15, 12, and 20 modules were significantly enriched with cancer-related KEGG, BioCarta pathways, and GO terms, respectively. Among 23 OVC modules, 19, 18, and 23 modules were significantly enriched with cancer-related KEGG, BioCarta pathways, and GO terms, respectively. Similarly, we also observed that 9 and 2 GBM modules and 15 and 18 OVC modules were enriched with cancer gene census (CGC) and specific cancer driver genes, respectively. Our proposed module-detection algorithm significantly outperformed other existing methods in terms of both functional and cancer gene set enrichments. Most of the cancer-related pathways from both cancer data sets found in our algorithm contained more than two types of gene-gene relationships, showing strong positive correlations between the number of different types of relationship and CGC enrichment q-values (0.64 for GBM and 0.49 for OVC). This study suggests that identified modules containing both expression changes and CNAs can explain cancer-related activities with greater insights.	[Azad, A. K. M.; Lee, Hyunju] Gwangju Inst Sci & Technol, Sch Informat & Commun, Kwangju, South Korea	Gwangju Institute of Science & Technology (GIST)	Lee, H (corresponding author), Gwangju Inst Sci & Technol, Sch Informat & Commun, Kwangju, South Korea.	hyunjulee@gist.ac.kr		Lee, Hyunju/0000-0003-2389-7183	National Research Foundation [2011-0029447]; Ministry of Education, Science and Technology	National Research Foundation; Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea)	This work (No. 2011-0029447) was supported by the Mid-career Researcher Program through a National Research Foundation grant funded by the Ministry of Education, Science and Technology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akavia UD, 2010, CELL, V143, P1005, DOI 10.1016/j.cell.2010.11.013; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Barahmand-Pour F, 1998, J BIOL CHEM, V273, P12567, DOI 10.1074/jbc.273.20.12567; Bast RC, 2009, NAT REV CANCER, V9, P415, DOI 10.1038/nrc2644; Bell D, 2011, NATURE, V474, P609, DOI 10.1038/nature10166; Benito M, 1996, INT J BIOCHEM CELL B, V28, P499, DOI 10.1016/1357-2725(95)00168-9; Beroukhim R, 2007, P NATL ACAD SCI USA, V104, P20007, DOI 10.1073/pnas.0710052104; Bouilly J, 2012, MOL CELL ENDOCRINOL, V356, P80, DOI 10.1016/j.mce.2011.05.004; Carrero P, 2000, MOL CELL BIOL, V20, P402, DOI 10.1128/MCB.20.1.402-415.2000; Cerami E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008918; Chen HZ, 2004, GYNECOL ONCOL, V94, P630, DOI 10.1016/j.ygyno.2004.05.056; Chin L, 2008, NATURE, V455, P1061, DOI 10.1038/nature07385; Choi JK, 2005, BIOINFORMATICS, V21, P4348, DOI 10.1093/bioinformatics/bti722; Chuang HY, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100180; Colomiere M, 2009, BRIT J CANCER, V100, P134, DOI 10.1038/sj.bjc.6604794; Cui QH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013180; Davies H, 2002, NATURE, V417, P949, DOI 10.1038/nature00766; Donovan LK, 2012, TRANSL ONCOL, V5, P141, DOI 10.1593/tlo.11337; Feuk L, 2006, NAT REV GENET, V7, P85, DOI 10.1038/nrg1767; Fujitani Y, 1997, ONCOGENE, V14, P751, DOI 10.1038/sj.onc.1200907; Futreal PA, 2004, NAT REV CANCER, V4, P177, DOI 10.1038/nrc1299; Girvan M, 2002, P NATL ACAD SCI USA, V99, P7821, DOI 10.1073/pnas.122653799; Gorringe KL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011408; Grandis JR, 1998, J CLIN INVEST, V102, P1385, DOI 10.1172/JCI3785; Guren TK, 1999, BIOCHEM BIOPH RES CO, V258, P565, DOI 10.1006/bbrc.1999.0684; Hahn WC, 2002, NAT REV CANCER, V2, P331, DOI 10.1038/nrc795; Hennighausen L, 2005, NAT REV MOL CELL BIO, V6, P715, DOI 10.1038/nrm1714; HENSON JW, 1994, ANN NEUROL, V36, P714, DOI 10.1002/ana.410360505; Horvath S, 2006, P NATL ACAD SCI USA, V103, P17402, DOI 10.1073/pnas.0608396103; Hur Y, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-146; Hwang W, 2006, ALGORITHM MOL BIOL, V1, DOI 10.1186/1748-7188-1-24; Inda MD, 2003, MOL CARCINOGEN, V36, P6, DOI 10.1002/mc.10085; Irminger-Finger I, 2001, MOL CELL, V8, P1255, DOI 10.1016/S1097-2765(01)00406-3; Jones RB, 2006, NATURE, V439, P168, DOI 10.1038/nature04177; Jornsten R, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.17; Kanehisa M, 2012, NUCLEIC ACIDS RES, V40, pD109, DOI 10.1093/nar/gkr988; Kanu OO, 2009, CLIN MED INSIGHTS-ON, V3, P39; Klijn C, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000631; Langfelder P, 2008, BIOINFORMATICS, V24, P719, DOI 10.1093/bioinformatics/btm563; Lee H, 2008, BIOINFORMATICS, V24, P889, DOI 10.1093/bioinformatics/btn034; Li DM, 1998, P NATL ACAD SCI USA, V95, P15406, DOI 10.1073/pnas.95.26.15406; Li M, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-109; Liu YH, 2010, J CLIN ONCOL, V28, P2467, DOI 10.1200/JCO.2009.26.6213; Masica DL, 2011, CANCER RES, V71, P4550, DOI 10.1158/0008-5472.CAN-11-0180; Mo WJ, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-340; Nakanishi A, 2007, BIOCHEM BIOPH RES CO, V355, P34, DOI 10.1016/j.bbrc.2007.01.100; Nepusz T, 2012, NAT METHODS, V9, P471, DOI [10.1038/nmeth.1938, 10.1038/NMETH.1938]; Parsons DW, 2008, SCIENCE, V321, P1807, DOI 10.1126/science.1164382; Prasad TSK, 2009, NUCLEIC ACIDS RES, V37, pD767, DOI 10.1093/nar/gkn892; Quiros S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027183; Ren ZY, 2002, J BIOL CHEM, V277, P38486, DOI 10.1074/jbc.M112438200; Rosenthal LA, 1997, CELL IMMUNOL, V181, P172, DOI 10.1006/cimm.1997.1208; Santarosa M, 2004, BBA-REV CANCER, V1654, P105, DOI 10.1016/j.bbcan.2004.01.001; Sarela AI, 1999, EUR J CANCER, V35, P1264, DOI 10.1016/S0959-8049(99)00104-5; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Sobottka SB, 2000, J NEURO-ONCOL, V49, P187, DOI 10.1023/A:1006442024874; Solvang HK, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-197; Stortelers C, 2002, BIOCHEMISTRY-US, V41, P8732, DOI 10.1021/bi025878c; Tallen G, 2009, ONCOL RES, V18, P95, DOI 10.3727/096504009789954645; Taylor BS, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003179; Thornton C, 2003, J BIOL CHEM, V278, P23823, DOI 10.1074/jbc.M302389200; Ulitsky I, 2007, BMC SYST BIOL, V1, DOI 10.1186/1752-0509-1-8; Vaske CJ, 2010, BIOINFORMATICS, V26, pi237, DOI 10.1093/bioinformatics/btq182; Vogelstein B, 2004, NAT MED, V10, P789, DOI 10.1038/nm1087; Wan PTC, 2004, CELL, V116, P855, DOI 10.1016/S0092-8674(04)00215-6; Watanabe A, 2011, P NATL ACAD SCI USA, V108, P12384, DOI 10.1073/pnas.0906930108; Witten DM, 2009, BIOSTATISTICS, V10, P515, DOI 10.1093/biostatistics/kxp008; Xu C, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-143; Yip AM, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-22	69	6	6	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2013	8	8							e70498	10.1371/journal.pone.0070498	http://dx.doi.org/10.1371/journal.pone.0070498			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	218XC	23940583	Green Published, gold, Green Submitted			2022-12-25	WOS:000324465000077
J	Han, H; Kampik, D; Grehn, F; Schlunck, G				Han, Hong; Kampik, Daniel; Grehn, Franz; Schlunck, Guenther			TGF-beta 2-Induced Invadosomes in Human Trabecular Meshwork Cells	PLOS ONE			English	Article							EXTRACELLULAR-MATRIX TURNOVER; ENDOTHELIAL-CELLS; AQUEOUS-HUMOR; PODOSOMES; INVADOPODIA; RHO; DOWNSTREAM; MODULATION; GLAUCOMA; INVASION	Primary open-angle glaucoma (POAG) is a leading cause of blindness due to chronic degeneration of retinal ganglion cells and their optic nerve axons. It is associated with disturbed regulation of intraocular pressure, elevated intraocular levels of TGF-beta 2, aberrant extracellular matrix (ECM) deposition and increased outflow resistance in the trabecular meshwork (TM). The mechanisms underlying these changes are not fully understood. Cell-matrix interactions have a decisive role in TM maintenance and it has been suggested that TGF-beta-induced inhibition of matrix metalloproteases may drive aberrant ECM deposition in POAG. Invadopodia and podosomes (invadosomes) are distinct sites of cell-matrix interaction and localized matrix-metalloprotease (MMP) activity. Here, we report on the effects of TGF-beta 2 on invadosomes in human trabecular meshwork cells. Human TM (HTM) cells were derived from donor tissue and pretreated with vehicle or TGF-beta 2 (2 ng/ml) for 3d. Invadosomes were studied in ECM degradation assays, protein expression and MMP-2 activity were assessed by western blot and zymography and ECM protein transcription was detected by RT-qPCR. HTM cells spontaneously formed podosomes and invadopodia as detected by colocalization of Gr beta 2 or Nck1 to sites of gelatinolysis. Pretreatment with TGF-beta 2 enhanced invadosomal proteolysis and zymographic MMP-2 activity as well as MMP-2, TIMP-2 and PAI-1 levels in HTM cell culture supernatants. Rho-kinase inhibition by H1152 blocked the effects of TGF-beta 2. Concomitant transcription of fibronectin and collagens-1, -4 and -6 was increased by TGF-beta 2 and fibrillar fibronectin deposits were observed in areas of invadosomal ECM remodelling. In contrast to a current hypothesis, our data indicate that TGF-beta 2 induces an active ECM remodelling process in TM cells, characterized by concurrent increases in localized ECM digestion and ECM expression, rather than a mere buildup of material due to a lack of degradation. Invadosomal cell adhesion and signaling may thus have a role in POAG pathophysiology.	[Han, Hong; Kampik, Daniel; Grehn, Franz; Schlunck, Guenther] Wurzburg Univ Hosp, Dept Ophthalmol, Wurzburg, Germany; [Kampik, Daniel] UCL, Inst Ophthalmol, London, England; [Schlunck, Guenther] Freiburg Univ Hosp, Dept Ophthalmol, Freiburg, Germany	University of Wurzburg; University of London; University College London; University of Freiburg	Schlunck, G (corresponding author), Wurzburg Univ Hosp, Dept Ophthalmol, Wurzburg, Germany.	guenther.schlunck@uniklinik-freiburg.de	Kampik, Daniel/AAE-9819-2020	Kampik, Daniel/0000-0002-8613-5875	Deutsche Forschungsgemeinschaft [DFG Schl563/3]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	Grant support by Deutsche Forschungsgemeinschaft (DFG Schl563/3) to GS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramoff MD, 2004, BIOPHOTONICS INT, V11, P36, DOI DOI 10.1117/1.3589100; Aga M, 2008, INVEST OPHTH VIS SCI, V49, P5353, DOI 10.1167/iovs.07-1666; Ayala I, 2008, J CELL SCI, V121, P369, DOI 10.1242/jcs.008037; Berdeaux RL, 2004, J CELL BIOL, V166, P317, DOI 10.1083/jcb.200312168; Bhowmick NA, 2001, MOL BIOL CELL, V12, P27, DOI 10.1091/mbc.12.1.27; Bravo-Cordero JJ, 2011, CURR BIOL, V21, P635, DOI 10.1016/j.cub.2011.03.039; Buccione R, 2004, NAT REV MOL CELL BIO, V5, P647, DOI 10.1038/nrm1436; Fleenor DL, 2006, INVEST OPHTH VIS SCI, V47, P226, DOI 10.1167/iovs.05-1060; Fuchshofer R, 2003, EXP EYE RES, V77, P757, DOI 10.1016/S0014-4835(03)00220-3; Fuchshofer R, 2009, EXP EYE RES, V88, P683, DOI 10.1016/j.exer.2009.01.005; Gottanka J, 1997, J GLAUCOMA, V6, P123; Gottanka J, 2004, INVEST OPHTH VIS SCI, V45, P153, DOI 10.1167/iovs.03-0796; Han H, 2011, INVEST OPHTH VIS SCI, V52, P2889, DOI 10.1167/iovs.10-6640; Honjo M, 2001, INVEST OPHTH VIS SCI, V42, P137; Ikenoya M, 2002, J NEUROCHEM, V81, P9, DOI 10.1046/j.1471-4159.2002.00801.x; Katsumi A, 2002, J CELL BIOL, V158, P153, DOI 10.1083/jcb.200201105; Keller KE, 2009, EXP EYE RES, V88, P676, DOI 10.1016/j.exer.2008.11.023; Linder S, 2005, J CELL SCI, V118, P2079, DOI 10.1242/jcs.02390; Linder S, 2009, J CELL SCI, V122, P3009, DOI 10.1242/jcs.032631; Lo WR, 2003, INVEST OPHTH VIS SCI, V44, P473, DOI 10.1167/iovs.02-0444; Mandal S, 2008, EXP CELL RES, V314, P3478, DOI 10.1016/j.yexcr.2008.09.013; Murphy DA, 2011, NAT REV MOL CELL BIO, V12, P413, DOI 10.1038/nrm3141; Oser M, 2011, EUR J CELL BIOL, V90, P181, DOI 10.1016/j.ejcb.2010.08.006; Osiak AE, 2005, EXP CELL RES, V307, P342, DOI 10.1016/j.yexcr.2005.03.035; Polansky JR, 1979, INVEST OPHTHALMOL VI, V18; Rao PV, 2001, INVEST OPHTH VIS SCI, V42, P1029; Rhee DJ, 2003, EXP EYE RES, V77, P749, DOI 10.1016/j.exer.2003.07.008; ROHEN JW, 1993, EXP EYE RES, V56, P683, DOI 10.1006/exer.1993.1085; Rottiers P, 2009, J CELL SCI, V122, P4311, DOI 10.1242/jcs.057448; Rozen S, 2000, Methods Mol Biol, V132, P365; Sakurai-Yageta M, 2008, J CELL BIOL, V181, P985, DOI 10.1083/jcb.200709076; Saltel F, 2011, EUR J CELL BIOL, V90, P100, DOI 10.1016/j.ejcb.2010.05.011; Stamer WD, 1998, INVEST OPHTH VIS SCI, V39, P1804; TARONE G, 1985, EXP CELL RES, V159, P141, DOI 10.1016/S0014-4827(85)80044-6; Tektas OY, 2009, EXP EYE RES, V88, P769, DOI 10.1016/j.exer.2008.11.025; TRIPATHI RC, 1994, EXP EYE RES, V59, P723, DOI 10.1006/exer.1994.1158; Varon C, 2006, MOL CELL BIOL, V26, P3582, DOI 10.1128/MCB.26.9.3582-3594.2006; Vishnubhotla R, 2007, LAB INVEST, V87, P1149, DOI 10.1038/labinvest.3700674; Williams RD, 2011, AM J OPHTHALMOL, V152, P834, DOI 10.1016/j.ajo.2011.04.012; Zhao XJ, 2004, INVEST OPHTH VIS SCI, V45, P4023, DOI 10.1167/iovs.04-0535	40	20	20	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2013	8	8							e70595	10.1371/journal.pone.0070595	http://dx.doi.org/10.1371/journal.pone.0070595			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	218XC	23940598	Green Published, gold, Green Submitted			2022-12-25	WOS:000324465000092
J	Kang, JJ; Allemann, N; Vajaranant, T; de la Cruz, J; Cortina, MS				Kang, Joann J.; Allemann, Norma; Vajaranant, Thasarat; de la Cruz, Jose; Cortina, Maria Soledad			Anterior Segment Optical Coherence Tomography for the Quantitative Evaluation of the Anterior Segment Following Boston Keratoprosthesis	PLOS ONE			English	Article							POST-PENETRATING-KERATOPLASTY; ULTRASOUND BIOMICROSCOPY; ANGLE-CLOSURE; GLAUCOMA; PREVENTION	Objective: To quantitatively evaluate the anterior segment using anterior segment optical coherence tomography (AS-OCT) following Boston keratoprosthesis type 1. Methods: A retrospective study consisted of AS-OCT imaging at a single time point postoperatively in 52 eyes. Main outcomes measures include anatomical and functional anterior chamber depth (ACD), angle (ACA) and peripheral and proximal synechiae. Results: The mean time point of imaging was 19.3 months postoperatively. Average anatomical and functional ACD was 2.0 and 0.21 mm respectively, and mean ACA ranged from 2.5 degrees to 6.14 degrees in representative meridians. An average of 8.7 clock hours of angle closure was observed in the 25 eyes in which all meridians were imaged. The majority of eyes showed peripheral (86.5%) and proximal (67.3%) synechiae. Conclusions: AS-OCT is a useful tool for quantitative evaluation of anterior segment and angle after keratoprosthesis, which is otherwise poorly visible. The majority of eyes showed shallow ACD, extensive angle closure and synechiae formation.	[Kang, Joann J.; Allemann, Norma; Vajaranant, Thasarat; de la Cruz, Jose; Cortina, Maria Soledad] Univ Illinois, Dept Ophthalmol & Visual Sci, Chicago, IL 60607 USA; [Allemann, Norma] Univ Fed Sao Paulo, Dept Ophthalmol, Sao Paulo, Brazil	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Universidade Federal de Sao Paulo (UNIFESP)	Cortina, MS (corresponding author), Univ Illinois, Dept Ophthalmol & Visual Sci, Chicago, IL 60607 USA.	mcortina@uic.edu	Allemann, Norma/K-5451-2013	Allemann, Norma/0000-0001-5432-4287; Cortina, Maria/0000-0001-7684-3424				Abbasian J, 2011, TECHNIQUES OPHTHALMO, V9, P71; Basu Sayan, 2011, International Ophthalmology, V31, P219, DOI 10.1007/s10792-011-9438-8; Bell NP, 2008, J CATARACT REFR SURG, V34, P121, DOI 10.1016/j.jcrs.2007.09.016; COHEN EJ, 1982, OPHTHALMIC SURG LAS, V13, P994; Dada T, 2008, CORNEA, V27, P402, DOI 10.1097/ICO.0b013e31816373c5; Dohlman CH, 2006, EXPERT REV OPHTHALMO, V1, P41, DOI 10.1586/17469899.1.1.41; Fernandez AGA, 2012, CLIN OPHTHALMOL, V6, P1355, DOI 10.2147/OPTH.S34787; Garcia JPS, 2008, CORNEA, V27, P180, DOI 10.1097/ICO.0b013e318159bc7d; Garcia JPS, 2007, OPHTHAL SURG LAS IM, V38, P314, DOI 10.3928/15428877-20070701-07; Garcia JPS, 2010, CORNEA, V29, P1031, DOI 10.1097/ICO.0b013e3181ca2ea5; GILVARRY A M E, 1989, Eye (London), V3, P713; Jancevski M, 2010, SEMIN OPHTHALMOL, V25, P317, DOI 10.3109/08820538.2010.518473; Khan Bilal F., 2007, International Ophthalmology Clinics, V47, P61, DOI 10.1097/IIO.0b013e318036bd8b; Kiang L, 2012, GRAEF ARCH CLIN EXP, V250, P1195, DOI 10.1007/s00417-012-1960-5; LASS JH, 1979, OPHTHALMOLOGY, V86, P51; Panarelli JF, 2012, J GLAUCOMA; PAVLIN CJ, 1991, OPHTHALMOLOGY, V98, P287; Radhakrishnan S, 2001, ARCH OPHTHALMOL-CHIC, V119, P1179, DOI 10.1001/archopht.119.8.1179	18	32	33	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2013	8	8							e70673	10.1371/journal.pone.0070673	http://dx.doi.org/10.1371/journal.pone.0070673			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	218XC	23940621	Green Published, Green Submitted, gold			2022-12-25	WOS:000324465000115
J	Koivisto, M; Kirjanen, S; Revonsuo, A; Kallio, S				Koivisto, Mika; Kirjanen, Svetlana; Revonsuo, Antti; Kallio, Sakari			A Preconscious Neural Mechanism of Hypnotically Altered Colors: A Double Case Study	PLOS ONE			English	Article							HYPNOSIS	Hypnotic suggestions may change the perceived color of objects. Given that chromatic stimulus information is processed rapidly and automatically by the visual system, how can hypnotic suggestions affect perceived colors in a seemingly immediate fashion? We studied the mechanisms of such color alterations by measuring electroencephalography in two highly suggestible participants as they perceived briefly presented visual shapes under posthypnotic color alternation suggestions such as "all the squares are blue''. One participant consistently reported seeing the suggested colors. Her reports correlated with enhanced evoked upper beta-band activity (22 Hz) 70-120 ms after stimulus in response to the shapes mentioned in the suggestion. This effect was not observed in a control condition where the participants merely tried to simulate the effects of the suggestion on behavior. The second participant neither reported color alterations nor showed the evoked beta activity, although her subjective experience and event-related potentials were changed by the suggestions. The results indicate a preconscious mechanism that first compares early visual input with a memory representation of the suggestion and consequently triggers the color alteration process in response to the objects specified by the suggestion. Conscious color experience is not purely the result of bottom-up processing but it can be modulated, at least in some individuals, by top-down factors such as hypnotic suggestions.	[Koivisto, Mika; Revonsuo, Antti] Univ Turku, Dept Psychol, Turku, Finland; [Koivisto, Mika; Revonsuo, Antti; Kallio, Sakari] Univ Turku, Ctr Cognit Neurosci, Turku, Finland; [Kirjanen, Svetlana] Univ Helsinki, Dept Behav Sci, Helsinki, Finland; [Revonsuo, Antti; Kallio, Sakari] Univ Skovde, Sch Humanities & Informat, Skovde, Sweden	University of Turku; University of Turku; University of Helsinki; University of Skovde	Kallio, S (corresponding author), Univ Turku, Ctr Cognit Neurosci, Turku, Finland.	sakari.kallio@his.se		Koivisto, Mika/0000-0002-5227-0091	Academy of Finland [125175, 266434, 218272]	Academy of Finland(Academy of Finland)	This study was funded by the Academy of Finland (http://www.aka.fi/eng)(grant numbers 125175, 266434 and 218272). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barber TX, 2000, AM J CLIN HYPN, V42, P208, DOI 10.1080/00029157.2000.10734361; Dehaene S, 2011, NEURON, V70, P200, DOI 10.1016/j.neuron.2011.03.018; Fingelkurts AA, 2007, CONT HYPNOSIS, V24, P3, DOI DOI 10.1002/CH.327; Fingelkurts AA, 2007, NEUROPSYCHOLOGIA, V45, P1452, DOI 10.1016/j.neuropsychologia.2006.11.018; Hansen T, 2006, NAT NEUROSCI, V11, P1637; Herrmann CS, 2010, NEUROSCI BIOBEHAV R, V34, P981, DOI 10.1016/j.neubiorev.2009.09.001; Hillyard SA, 1998, P NATL ACAD SCI USA, V95, P781, DOI 10.1073/pnas.95.3.781; Kadosh RC, 2009, PSYCHOL SCI, V20, P258, DOI 10.1111/j.1467-9280.2009.02286.x; Kallio S, 1999, NEUROREPORT, V10, P3579, DOI 10.1097/00001756-199911260-00021; Kallio S., 2003, CONT HYPNOSIS, V20, P111, DOI [10.1002/ch.273, DOI 10.1002/CH.273]; Kallio S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026374; Kihlstrom J.F., 2008, OXFORD HDB HYPNOSIS, P21, DOI [https://doi.org/10.1093/oxfordhb/9780198570097.013.0002, DOI 10.1093/OXFORDHB/9780198570097.013.0002]; King BJ, 1998, INT J CLIN EXP HYP, V46, P295, DOI 10.1080/00207149808410009; Kinnunen T, 2001, INT J CLIN EXP HYP, V49, P83, DOI 10.1080/00207140108410060; Kirsch I, 2001, CURR DIR PSYCHOL SCI, V10, P57, DOI 10.1111/1467-8721.00115; Kosslyn SM, 2000, AM J PSYCHIAT, V157, P1279, DOI 10.1176/appi.ajp.157.8.1279; Lamme VAF, 2004, NEURAL NETWORKS, V17, P861, DOI 10.1016/j.neunet.2004.02.005; Lynn S., 2012, OXFORD HDB HYPNOSIS, P111, DOI DOI 10.1093/OXFORDHB/9780198570097.013.0005; Mazzoni G, 2009, CONSCIOUS COGN, V18, P494, DOI 10.1016/j.concog.2009.02.002; MCCONKEY K M, 1989, Australian Journal of Clinical and Experimental Hypnosis, V17, P131; McGeown WJ, 2012, CONSCIOUS COGN, V21, P100, DOI 10.1016/j.concog.2011.10.015; Perugini EM, 1998, INT J CLIN EXP HYP, V46, P191, DOI 10.1080/00207149808409999; Raz A, 2005, P NATL ACAD SCI USA, V102, P9978, DOI 10.1073/pnas.0503064102; Shor R. E., 1962, HARVARD GROUP SCALE; Terhune DB, 2011, COGN NEUROPSYCHIATRY, V16, P113, DOI 10.1080/13546805.2010.503048; Wagstaff G, 1981, HYPNOSIS COMPLIANCE; Weitzenhoffer A. M., 1962, STANFORD HYPNOTIC SU; Weitzenhoffer AM, 1980, AM J CLIN HYPN, V44, P69	28	10	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2013	8	8							e70900	10.1371/journal.pone.0070900	http://dx.doi.org/10.1371/journal.pone.0070900			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	218XC	23940663	Green Published, gold, Green Submitted			2022-12-25	WOS:000324465000152
J	Tegtmeyer, N; Traverso, FR; Rohde, M; Oyarzabal, OA; Lehn, N; Schneider-Brachert, W; Ferrero, RL; Fox, JG; Berg, DE; Backert, S				Tegtmeyer, Nicole; Traverso, Francisco Rivas; Rohde, Manfred; Oyarzabal, Omar A.; Lehn, Norbert; Schneider-Brachert, Wulf; Ferrero, Richard L.; Fox, James G.; Berg, Douglas E.; Backert, Steffen			Electron Microscopic, Genetic and Protein Expression Analyses of Helicobacter acinonychis Strains from a Bengal Tiger	PLOS ONE			English	Article							ULCER PROMOTING GENE; VACUOLATING CYTOTOXIN; CAMPYLOBACTER-JEJUNI; PYLORI INFECTION; VIRULENCE FACTOR; INTEGRIN BETA1; CELL INVASION; MOUSE MODEL; E-CADHERIN; SP-NOV	Colonization by Helicobacter species is commonly noted in many mammals. These infections often remain unrecognized, but can cause severe health complications or more subtle host immune perturbations. The aim of this study was to isolate and characterize putative novel Helicobacter spp. from Bengal tigers in Thailand. Morphological investigation (Gram-staining and electron microscopy) and genetic studies (16SrRNA, 23SrRNA, flagellin, urease and prophage gene analyses, RAPD DNA fingerprinting and restriction fragment polymorphisms) as well as Western blotting were used to characterize the isolated Helicobacters. Electron microscopy revealed spiral-shaped bacteria, which varied in length (2.5-6 mu m) and contained up to four monopolar sheathed flagella. The 16SrRNA, 23SrRNA, sequencing and protein expression analyses identified novel H. acinonychis isolates closely related to H. pylori. These Asian isolates are genetically very similar to H. acinonychis strains of other big cats (cheetahs, lions, lion-tiger hybrid and other tigers) from North America and Europe, which is remarkable in the context of the great genetic diversity among worldwide H. pylori strains. We also found by immunoblotting that the Bengal tiger isolates express UreaseA/B, flagellin, BabA adhesin, neutrophil-activating protein NapA, HtrA protease, gamma-glutamyl-transpeptidase GGT, Slt lytic transglycosylase and two DNA transfer relaxase orthologs that were known from H. pylori, but not the cag pathogenicity island, nor CagA, VacA, SabA, DupA or OipA proteins. These results give fresh insights into H. acinonychis genetics and the expression of potential pathogenicity-associated factors and their possible pathophysiological relevance in related gastric infections.	[Tegtmeyer, Nicole; Traverso, Francisco Rivas; Backert, Steffen] Univ Magdeburg, Inst Med Microbiol, D-39106 Magdeburg, Germany; [Rohde, Manfred] Helmholtz Ctr Infect Res, Braunschweig, Germany; [Oyarzabal, Omar A.] Inst Environm Hlth Inc, Seattle, WA USA; [Lehn, Norbert; Schneider-Brachert, Wulf] Univ Regensburg, Inst Med Microbiol & Hyg, D-93053 Regensburg, Germany; [Ferrero, Richard L.] Monash Inst Med Res, Ctr Innate Immun & Infect Dis, Clayton, Vic, Australia; [Fox, James G.] MIT, Div Comparat Med, Cambridge, MA 02139 USA; [Berg, Douglas E.] Washington Univ, Sch Med, Dept Mol Microbiol, St Louis, MO 63110 USA	Otto von Guericke University; Helmholtz Association; Helmholtz-Center for Infection Research; University of Regensburg; Monash University; Massachusetts Institute of Technology (MIT); Washington University (WUSTL)	Backert, S (corresponding author), Univ Erlangen Nurnberg, Dept Biol, Chair Microbiol, D-91054 Erlangen, Germany.	Steffen.Backert@biologie.uni-erlangen.de	; Ferrero, Richard/U-1332-2017	Oyarzabal, Omar/0000-0002-7863-2767; Ferrero, Richard/0000-0001-6817-6211	DFG [CRC-796]; SENACYT (Secretaria Nacional de Ciencia y Tecnologia, Panama); Victorian Government; US National Institutes of Health [R21 AI078237, R21 AI088337]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI088337, R21AI078237] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES002109] Funding Source: NIH RePORTER	DFG(German Research Foundation (DFG)); SENACYT (Secretaria Nacional de Ciencia y Tecnologia, Panama); Victorian Government; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	The work of SB is supported through a DFG grant (project B10 of CRC-796). FRT was supported by a stipend of SENACYT (Secretaria Nacional de Ciencia y Tecnologia, Panama). RLF is a Senior Research Fellow of the NHMRC. Research at MIMR is supported by the Victorian Government's Operational Infrastructure Support Program. The research in DB's group has been supported by US National Institutes of Health Grants (R21 AI078237 and R21 AI088337). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKOPYANZ N, 1992, NUCLEIC ACIDS RES, V20, P5137, DOI 10.1093/nar/20.19.5137; Alm RA, 1999, J MOL MED, V77, P834, DOI 10.1007/s001099900067; Amieva MR, 2008, GASTROENTEROLOGY, V134, P306, DOI 10.1053/j.gastro.2007.11.009; Atherton JC, 2009, J CLIN INVEST, V119, P2475, DOI 10.1172/JCI38605; Backert S, 2005, MICROBIOL-SGM, V151, P3493, DOI 10.1099/mic.0.28250-0; Backert S, 1998, MOL MICROBIOL, V30, P673, DOI 10.1046/j.1365-2958.1998.01086.x; Backert S, 2010, TOXINS, V2, P69, DOI 10.3390/toxins2010069; Backert Steffen, 2002, Keio J Med, V51 Suppl 2, P6; Backert S, 2010, HELICOBACTER, V15, P163, DOI 10.1111/j.1523-5378.2010.00759.x; Boehm M, 2011, FRONT CELL INFECT MI, V1, DOI 10.3389/fcimb.2011.00017; Boehm M, 2012, GUT PATHOG, V4, DOI 10.1186/1757-4749-4-3; Bourzac KM, 2006, INFECT IMMUN, V74, P2537, DOI 10.1128/IAI.74.5.2537-2543.2006; Bridge DR, 2013, GUT MICROBES, V4, P101, DOI 10.4161/gmic.23797; Brisslert M, 2005, FEMS MICROBIOL LETT, V249, P95, DOI 10.1016/j.femsle.2005.06.008; Brussow H, 2004, MICROBIOL MOL BIOL R, V68, P560, DOI 10.1128/MMBR.68.3.560-602.2004; Cattoli G, 2000, VET REC, V147, P164, DOI 10.1136/vr.147.6.164; Dailidiene D, 2004, J BACTERIOL, V186, P356, DOI 10.1128/JB.186.2.356-365.2004; Dundon WG, 2002, INT J MED MICROBIOL, V291, P545; EATON KA, 1993, INT J SYST BACTERIOL, V43, P99, DOI 10.1099/00207713-43-1-99; EATON KA, 1991, SCAND J GASTROENTERO, V26, P38, DOI 10.3109/00365529109093206; EATON KA, 1993, ZBL BAKT-INT J MED M, V280, P28, DOI 10.1016/S0934-8840(11)80938-2; Eppinger M, 2006, PLOS GENET, V2, P1097, DOI 10.1371/journal.pgen.0020120; EVANS DJ, 1995, INFECT IMMUN, V63, P2213, DOI 10.1128/IAI.63.6.2213-2220.1995; Fox JG, 1998, GASTROENTEROLOGY, V114, P755, DOI 10.1016/S0016-5085(98)70589-X; Fox JG, 2002, GUT, V50, P273, DOI 10.1136/gut.50.2.273; FOX JG, 1995, INFECT IMMUN, V63, P2674, DOI 10.1128/IAI.63.7.2674-2681.1995; FOX JG, 1992, INFECT IMMUN, V60, P606, DOI 10.1128/IAI.60.2.606-611.1992; FOX JG, 1993, GASTROENTEROLOGY, V104, P86, DOI 10.1016/0016-5085(93)90839-5; FOX JG, 1994, J CLIN MICROBIOL, V32, P1238, DOI 10.1128/JCM.32.5.1238-1245.1994; Garcia A, 2006, J MED MICROBIOL, V55, P1591, DOI 10.1099/jmm.0.46707-0; Haesebrouck F, 2009, CLIN MICROBIOL REV, V22, P202, DOI 10.1128/CMR.00041-08; Hall T.A., 1999, NUCL ACIDS S SERIES, V41, P95, DOI [DOI 10.1021/BK-1999-0734.CH008, citeulike-article-id:691774, 10.12691/ajmr-6-4-3]; HANDT LK, 1994, INFECT IMMUN, V62, P2367, DOI 10.1128/IAI.62.6.2367-2374.1994; Herrera PM, 2008, J CLIN MICROBIOL, V46, P3912, DOI 10.1128/JCM.01453-08; Hirsch C, 2012, J GASTROENTEROL, V47, P936, DOI 10.1007/s00535-012-0618-8; Hoy B, 2012, J BIOL CHEM, V287, P10115, DOI 10.1074/jbc.C111.333419; Hoy B, 2010, EMBO REP, V11, P798, DOI 10.1038/embor.2010.114; Hussein NR, 2010, J INFECT DIS, V202, P261, DOI 10.1086/653587; Ilver D, 1998, SCIENCE, V279, P373, DOI 10.1126/science.279.5349.373; Josenhans C, 2002, INT J MED MICROBIOL, V291, P605, DOI 10.1078/1438-4221-00173; Kersulyte D, 2000, J BACTERIOL, V182, P3210, DOI 10.1128/JB.182.11.3210-3218.2000; Kersulyte D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015076; Kersulyte D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006859; KRAKOWKA S, 1991, REV INFECT DIS, V13, pS681; Krause-Gruszczynska M, 2007, CELL MICROBIOL, V9, P2431, DOI 10.1111/j.1462-5822.2007.00971.x; Krause-Gruszczynska M, 2011, CELL COMMUN SIGNAL, V9, DOI 10.1186/1478-811X-9-32; Kwok T, 2007, NATURE, V449, P862, DOI 10.1038/nature06187; Lee A, 1997, GASTROENTEROLOGY, V112, P1386, DOI 10.1016/S0016-5085(97)70155-0; Lee A, 1997, GUT, V41, P575, DOI 10.1136/gut.41.4.575; Lehours P, 2011, MBIO, V2, DOI 10.1128/mBio.00239-11; Linz B, 2007, NATURE, V445, P915, DOI 10.1038/nature05562; Lu H, 2005, GASTROENTEROLOGY, V128, P833, DOI 10.1053/j.gastro.2005.01.009; Luo CH, 2012, J VIROL, V86, P8781, DOI 10.1128/JVI.00446-12; Mahdavi J, 2002, SCIENCE, V297, P573, DOI 10.1126/science.1069076; MEGRAUD F, 1985, J CLIN MICROBIOL, V22, P1007, DOI 10.1128/JCM.22.6.1007-1010.1985; Moodley Y, 2009, SCIENCE, V323, P527, DOI 10.1126/science.1166083; Munson L, 1999, J ZOO WILDLIFE MED, V30, P342; Odenbreit S, 2005, INT J MED MICROBIOL, V295, P317, DOI 10.1016/j.ijmm.2005.06.003; Oertli M, 2013, P NATL ACAD SCI USA, V110, P3047, DOI 10.1073/pnas.1211248110; Parsonnet J, 1999, JAMA-J AM MED ASSOC, V282, P2240, DOI 10.1001/jama.282.23.2240; Pot RGJ, 2001, ANTIMICROB AGENTS CH, V45, P2975, DOI 10.1128/AAC.45.10.2975-2976.2001; Sachs G, 2006, J MEMBRANE BIOL, V212, P71, DOI 10.1007/s00232-006-0867-7; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Salama NR, 2001, INFECT IMMUN, V69, P730, DOI 10.1128/IAI.69.2.730-736.2001; Schmidt HMA, 2009, GUT PATHOG, V1, DOI 10.1186/1757-4749-1-5; Schoep TD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015042; Schroder HD, 1998, J COMP PATHOL, V119, P67, DOI 10.1016/S0021-9975(98)80072-8; Selbach M, 2002, J BIOL CHEM, V277, P6775, DOI 10.1074/jbc.C100754200; Simpson KW, 2001, HELICOBACTER, V6, P1, DOI 10.1046/j.1523-5378.2001.00010.x; Solnick JV, 2003, J CLIN MICROBIOL, V41, P5511, DOI 10.1128/JCM.41.12.5511-5516.2003; Solnick JV, 2001, CLIN MICROBIOL REV, V14, P59, DOI 10.1128/CMR.14.1.59-97.2001; Strauss-Ayali D, 2001, VET MICROBIOL, V79, P253, DOI 10.1016/S0378-1135(00)00360-6; Suerbaum S, 2007, NAT REV MICROBIOL, V5, P441, DOI 10.1038/nrmicro1658; Sutton P, 2010, ADV MOL CELLULAR BIO; Tamura K, 2004, P NATL ACAD SCI USA, V101, P11030, DOI 10.1073/pnas.0404206101; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Terio KA, 2005, J CLIN MICROBIOL, V43, P229, DOI 10.1128/JCM.43.1.229-234.2005; THOMAS JE, 1992, LANCET, V340, P1194, DOI 10.1016/0140-6736(92)92894-L; Traverso FR, 2010, HELICOBACTER, V15, P403, DOI 10.1111/j.1523-5378.2010.00770.x; Uberti AF, 2013, TOXICON, V69, P240, DOI 10.1016/j.toxicon.2013.02.009; Uchiyama J, 2013, APPL ENV MICROBIOL; Uchiyama J, 2012, J VIROL, V86, P11400, DOI 10.1128/JVI.01767-12; van Doorn LJ, 1998, J CLIN MICROBIOL, V36, P2597, DOI 10.1128/JCM.36.9.2597-2603.1998; Viala J, 2004, NAT IMMUNOL, V5, P1166, DOI 10.1038/ni1131; WARREN JR, 1983, LANCET, V1, P1273; Wroblewski LE, 2009, GASTROENTEROLOGY, V136, P236, DOI 10.1053/j.gastro.2008.10.011; Yamaoka Y, 2002, GASTROENTEROLOGY, V123, P414, DOI 10.1053/gast.2002.34781; Yamaoka Y, 2008, J INFECT DEV COUNTR, V2, P174, DOI 10.3855/jidc.259; Zhang L, 2006, DRUGS TODAY, V42, P605, DOI 10.1358/dot.2006.42.9.1025694	89	26	26	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2013	8	8							e71220	10.1371/journal.pone.0071220	http://dx.doi.org/10.1371/journal.pone.0071220			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	218XC	23940723	Green Published, Green Submitted, gold			2022-12-25	WOS:000324465000195
J	Viry, S; Sleimen-Malkoun, R; Temprado, JJ; Frances, JP; Berton, E; Laurent, M; Nicol, C				Viry, Sylvain; Sleimen-Malkoun, Rita; Temprado, Jean-Jacques; Frances, Jean-Philippe; Berton, Eric; Laurent, Michel; Nicol, Caroline			Patterns of Horse-Rider Coordination during Endurance Race: A Dynamical System Approach	PLOS ONE			English	Article							TROT-GALLOP TRANSITION; PHASE-TRANSITIONS; INTERLIMB COORDINATION; GAIT; LOCOMOTION; MOVEMENTS; WORK; CONSTRAINTS; VARIABILITY; ENERGETICS	In riding, most biomechanical studies have focused on the description of the horse locomotion in unridden condition. In this study, we draw the prospect of how the basic principles established in inter-personal coordination by the theory of Coordination Dynamics may provide a conceptual and methodological framework for understanding the horse-rider coupling. The recent development of mobile technologies allows combined horse and rider recordings during long lasting natural events such as endurance races. Six international horse-rider dyads were thus recorded during a 120 km race by using two tri-axial accelerometers placed on the horses and riders, respectively. The analysis concentrated on their combined vertical displacements. The obtained shapes and angles of Lissajous plots together with values of relative phase between horse and rider displacements at lower reversal point allowed us to characterize four coordination patterns, reflecting the use of two riding techniques per horse's gait (trot and canter). The present study shows that the concepts, methods and tools of self-organizing dynamic system approach offer new directions for understanding horse-rider coordination. The identification of the horse-rider coupling patterns constitutes a firm basis to further study the coalition of multiple constraints that determine their emergence and their dynamics in endurance race.	[Viry, Sylvain; Sleimen-Malkoun, Rita; Temprado, Jean-Jacques; Berton, Eric; Laurent, Michel; Nicol, Caroline] Aix Marseille Univ, CNRS, Inst Sci Mouvement, Marseille, France; [Viry, Sylvain] BRD Concept, Anglet, France; [Frances, Jean-Philippe] Ecuries JPF, Venelles, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite	Viry, S (corresponding author), Aix Marseille Univ, CNRS, Inst Sci Mouvement, Marseille, France.	s.viry@brdconcept.fr		Sleimen-Malkoun, Rita/0000-0002-3508-3403	ANRT [2009/0720]	ANRT(French National Research Agency (ANR))	This work has been funded by a doctoral fellowship from ANRT (no 2009/0720). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barrey E, 2001, Equine Vet J Suppl, P99; Barrey E, 1999, VET J, V157, P7, DOI 10.1053/tvjl.1998.0297; Barrey E., 1994, EQUINE VET J, V26, P7, DOI 10.1111/j.2042-3306.1994.tb04864.x; Barrey E, 1995, EQUINE VET J, V27, P156; BIEWENER AA, 1986, J EXP BIOL, V123, P383; FARLEY CT, 1991, SCIENCE, V253, P306, DOI 10.1126/science.1857965; GRILLNER S, 1985, ANNU REV NEUROSCI, V8, P233, DOI 10.1146/annurev.ne.08.030185.001313; HAKEN H, 1985, BIOL CYBERN, V51, P347, DOI 10.1007/BF00336922; Haken H., 1983, SYNERGETICS INTRO NO; Hamill J, 2000, J APPL BIOMECH, V16, P407, DOI 10.1123/jab.16.4.407; HOYT DF, 1981, NATURE, V292, P239, DOI 10.1038/292239a0; Janura M, 2009, HUM MOVEMENT SCI, V28, P387, DOI 10.1016/j.humov.2009.04.001; KAHN JF, 1989, ERGONOMICS, V32, P839, DOI 10.1080/00140138908966846; Kang OD, 2010, HUM MOVEMENT SCI, V29, P956, DOI 10.1016/j.humov.2010.05.010; Kelso J, 1984, AM J PHYSIOL-REG I, V15, pR1000, DOI DOI 10.1152/ajpregu.1984.246.6.R1000; Kelso J. A., 2009, ENCY COMPLEXITY SYST, P1537, DOI [10.1007/978-0-387-30440-3_101, DOI 10.1007/978-0-387-30440-3_101]; KELSO JAS, 1981, J MOTOR BEHAV, V13, P226; Kelso JAS, 1985, SYNERGETICS COMPLEX; Kelso S., 1995, DYNAMIC PATTERNS SEL; KITTLER J, 1986, PATTERN RECOGN, V19, P41, DOI 10.1016/0031-3203(86)90030-0; Lagarde J, 2005, J MOTOR BEHAV, V37, P418, DOI 10.3200/JMBR.37.6.418-424; LEE TD, 1995, J MOTOR BEHAV, V27, P263, DOI 10.1080/00222895.1995.9941716; Liesens L, 2010, ENDURANCE LIVRE CAVA; Minetti AE, 1999, J EXP BIOL, V202, P2329; Minetti AE, 1998, J BIOMECH, V31, P463, DOI 10.1016/S0021-9290(98)00038-4; Monno A, 2000, NEUROSCI LETT, V283, P93, DOI 10.1016/S0304-3940(00)00924-1; Nagy A, 2010, EQUINE VET J, V42, P637, DOI 10.1111/j.2042-3306.2010.00220.x; Neda Z, 2000, NATURE, V403, P849, DOI 10.1038/35002660; Neda Z, 2000, PHYS REV E, V61, P6987, DOI 10.1103/PhysRevE.61.6987; Oullier O, 2009, ENCY COMPLEXITY SYST; Peham C, 2004, HUM MOVEMENT SCI, V23, P663, DOI 10.1016/j.humov.2004.10.006; Peham C., 2001, SPORTS ENG, V4, P95, DOI [https://doi.org/10.1046/j.1460-2687.2001.00077.x, DOI 10.1046/J.1460-2687.2001.00077.X]; Pfau T, 2005, J EXP BIOL, V208, P2503, DOI 10.1242/jeb.01658; Pfau T, 2009, SCIENCE, V325, P289, DOI 10.1126/science.1174605; Rand R.H., 1988, NEURAL CONTROL RHYTH; Rosenblum MG, 2001, PHYS REV E, V63, DOI 10.1103/PhysRevE.63.058201; Salesse R, 2005, HUM MOVEMENT SCI, V24, P66, DOI 10.1016/j.humov.2004.12.002; SCHMIDT RC, 1990, J EXP PSYCHOL HUMAN, V16, P227, DOI 10.1037/0096-1523.16.2.227; Schollhorn W I, 2006, Equine Vet J Suppl, P400; SCHOLZ JP, 1990, J MOTOR BEHAV, V22, P98; SCHONER G, 1990, J THEOR BIOL, V142, P359, DOI 10.1016/S0022-5193(05)80558-2; Summers J, 2002, BRAIN COGNITION, V48, P166, DOI 10.1006/brcg.2001.1311; Swinnen SP, 1997, HUM MOVEMENT SCI, V16, P749, DOI 10.1016/S0167-9457(97)00020-1; Temprado JJ, 1999, J EXP PSYCHOL HUMAN, V25, P1579, DOI 10.1037/0096-1523.25.6.1579; Temprado JJ, 2004, ACTA PSYCHOL, V115, P1, DOI 10.1016/j.actpsy.2003.09.002; Temprado JJ, 2002, EUR J NEUROSCI, V16, P1390, DOI 10.1046/j.1460-9568.2002.02190.x; Terada Kayo, 2000, Journal of Equine Science, V11, P83, DOI 10.1294/jes.11.83; Thong YK, 2004, MEASUREMENT, V36, P73, DOI 10.1016/j.measurement.2004.04.005; TROWBRIDGE EA, 1995, EUR J APPL PHYSIOL O, V70, P66, DOI 10.1007/BF00601810; Wickler SJ, 2003, J EXP BIOL, V206, P1557, DOI 10.1242/jeb.00276; Witte K, 2009, HUM MOVEMENT SCI, V28, P394, DOI 10.1016/j.humov.2009.04.002; Wolframm IA, 2013, HUM MOV SCI; ZANONE PG, 1992, J EXP PSYCHOL HUMAN, V18, P403, DOI 10.1037/0096-1523.18.2.403; Zanone PG, 1997, J EXP PSYCHOL HUMAN, V23, P1454, DOI 10.1037/0096-1523.23.5.1454	54	17	18	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2013	8	8							e71804	10.1371/journal.pone.0071804	http://dx.doi.org/10.1371/journal.pone.0071804			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	218XC	23940788	Green Published, gold, Green Submitted			2022-12-25	WOS:000324465000227
J	Zhang, XM; Wang, ZG; Li, JX; Gu, DF; Li, ST; Shen, C; Song, ZY				Zhang, Ximei; Wang, Zhigang; Li, Jiaxin; Gu, Dongfang; Li, Songtao; Shen, Chen; Song, Zhenyuan			Increased 4-Hydroxynonenal Formation Contributes to Obesity-Related Lipolytic Activation in Adipocytes	PLOS ONE			English	Article							HORMONE-SENSITIVE LIPASE; ENDOPLASMIC-RETICULUM STRESS; PROTEIN-KINASE CASCADE; OXIDATIVE STRESS; POTENTIAL MECHANISM; METABOLIC SYNDROME; 3T3-L1 ADIPOCYTES; GENE-EXPRESSION; PATHWAY; INSULIN	Oxidative stress in adipose tissue plays an etiological role in a variety of obesity-related metabolic disorders. We previously reported that increased adipose tissue 4-hydroxynonenal (4-HNE) contents contributed to obesity-related plasma adiponectin decline in mice. In the present study, we investigated the effects of intracellular 4-HNE accumulation on lipolytic response in adipocytes/adipose tissues and underlying mechanisms. In both fully-differentiated 3T3-L1 and primary adipocytes, a 5-hour 4-HNE exposure elevated lipolytic reaction in a dose-dependent manner at both basal and isoproterenol-stimulated conditions, evidenced by significantly increased glycerol and fatty acids releases. This conclusion was corroborated by the comparable observations when the minced human visceral adipose tissues were used. Mechanistic investigations revealed that 4-HNE-stimulated lipolytic activation is multifactorial. 4-HNE exposure quickly increased intracellular cyclic AMP (cAMP) level, which was concomitant with increased phosphorylations of protein kinase A (PKA) and its direct downstream target, hormone sensitive lipase (HSL). Pre-incubation with H89, a potent PKA inhibitor, prevented 4-HNE stimulated glycerol release, suggesting that enhanced lipolytic action in response to 4-HNE increase is mediated mainly by cAMP/PKA signal pathway in adipocytes. In addition to activating cAMP/PKA/HSL pathway, 4-HNE exposure also suppresses AMP-activated protein kinase (AMPK), a suppressive pathway for lipolysis, measured by both Western blotting for phosphorylated form of AMPK and ELISA for enzyme activity. Furthermore, 5-Aminoimidazole-4-carboxamide 1-beta-D-ribofuranoside (AICAR), a pharmacological AMPK activator, alleviated 4-HNE-induced lipolysis, suggesting that AMPK suppression also contributes to 4-HNE elicited lipolytic response. In conclusion, our findings indicate that increased intracellular 4-HNE accumulation in adipocytes/adipose tissues contributes to obesity-related lipolytic activation.	[Zhang, Ximei; Wang, Zhigang; Li, Jiaxin; Gu, Dongfang; Li, Songtao; Shen, Chen; Song, Zhenyuan] Univ Illinois, Dept Kinesiol & Nutr, Chicago, IL 60607 USA; [Zhang, Ximei] Harbin Med Univ, Dept Histol & Embryol, Harbin, Heilongjiang, Peoples R China; [Song, Zhenyuan] Univ Illinois, Med Ctr, Dept Pathol, Chicago, IL USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Harbin Medical University; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Song, ZY (corresponding author), Univ Illinois, Dept Kinesiol & Nutr, Chicago, IL 60607 USA.	song2008@uic.edu			National Institutes of Health NIAAA [R01 AA017442]; 49th China Postdoctoral Science Foundation [20110491103]; National Natural Science Foundation of China [81000168]; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA017442] Funding Source: NIH RePORTER	National Institutes of Health NIAAA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); 49th China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	National Institutes of Health NIAAA grants R01 AA017442 (Z Song); The 49th China Postdoctoral Science Foundation: 20110491103 (X Zhang); The National Natural Science Foundation of China 81000168 (Z. Wang). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anthony NM, 2009, OBESITY, V17, P1312, DOI 10.1038/oby.2008.645; Aoi W, 2012, PHYSIOL RES, V61, P81, DOI 10.33549/physiolres.932239; Baynes JW, 1999, DIABETES, V48, P1, DOI 10.2337/diabetes.48.1.1; Bender AT, 2006, PHARMACOL REV, V58, P488, DOI 10.1124/pr.58.3.5; Cannon B, 2004, PHYSIOL REV, V84, P277, DOI 10.1152/physrev.00015.2003; Carling D, 2004, TRENDS BIOCHEM SCI, V29, P18, DOI 10.1016/j.tibs.2003.11.005; Chaves VE, 2011, BIOCHIMIE, V93, P1631, DOI 10.1016/j.biochi.2011.05.018; Cnop M, 2010, DIABETES OBES METAB, V12, P76, DOI 10.1111/j.1463-1326.2010.01279.x; Cong L, 2007, BIOCHEM J, V403, P519, DOI 10.1042/BJ20061478; Cunha DA, 2008, J CELL SCI, V121, P2308, DOI 10.1242/jcs.026062; Daval M, 2005, J BIOL CHEM, V280, P25250, DOI 10.1074/jbc.M414222200; Dianzani Mario Umberto, 2003, Molecular Aspects of Medicine, V24, P263; Doorn JA, 2002, CHEM RES TOXICOL, V15, P1445, DOI 10.1021/tx025590o; Dzamko N, 2010, J BIOL CHEM, V285, P115, DOI 10.1074/jbc.M109.056762; EGAN JJ, 1992, P NATL ACAD SCI USA, V89, P8537, DOI 10.1073/pnas.89.18.8537; Ellingson WJ, 2007, AM J PHYSIOL-ENDOC M, V292, pE400, DOI 10.1152/ajpendo.00322.2006; ESTERBAUER H, 1991, FREE RADICAL BIO MED, V11, P81, DOI 10.1016/0891-5849(91)90192-6; Furukawa S, 2004, J CLIN INVEST, V114, P1752, DOI [10.1172/JCI20042162S, 10.1172/JCI21625]; Gaidhu MP, 2010, AM J PHYSIOL-CELL PH, V298, pC961, DOI 10.1152/ajpcell.00547.2009; Gaidhu MP, 2009, J LIPID RES, V50, P704, DOI 10.1194/jlr.M800480-JLR200; Gauthier MS, 2008, J BIOL CHEM, V283, P16514, DOI 10.1074/jbc.M708177200; Greenberg AS, 2001, J BIOL CHEM, V276, P45456, DOI 10.1074/jbc.M104436200; Grimsrud PA, 2007, MOL CELL PROTEOMICS, V6, P624, DOI 10.1074/mcp.M600120-MCP200; Hardie DG, 2003, ENDOCRINOLOGY, V144, P5179, DOI 10.1210/en.2003-0982; Harndahl L, 2002, J BIOL CHEM, V277, P37446, DOI 10.1074/jbc.M205401200; Hawley Simon A, 2003, J Biol, V2, P28, DOI 10.1186/1475-4924-2-28; Heimann E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014191; Holm C, 2003, BIOCHEM SOC T, V31, P1120, DOI 10.1042/BST0311120; Jocken JWE, 2008, METABOLISM, V57, P326, DOI 10.1016/j.metabol.2007.10.006; Kharroubi I, 2004, ENDOCRINOLOGY, V145, P5087, DOI 10.1210/en.2004-0478; Kutuk O, 2007, REDOX REP, V12, P30, DOI 10.1179/135100007X162329; Londos C, 1999, ANN NY ACAD SCI, V892, P155, DOI 10.1111/j.1749-6632.1999.tb07794.x; Mattson MP, 2009, EXP GERONTOL, V44, P625, DOI 10.1016/j.exger.2009.07.003; Pennathur S, 2007, ANTIOXID REDOX SIGN, V9, P955, DOI 10.1089/ars.2007.1595; Qin SF, 2010, EXP EYE RES, V91, P818, DOI 10.1016/j.exer.2010.10.007; Resjo S, 1999, BIOCHEM J, V341, P839, DOI 10.1042/0264-6021:3410839; Soares AF, 2005, FREE RADICAL BIO MED, V38, P882, DOI 10.1016/j.freeradbiomed.2004.12.010; Stangherlin A, 2012, AM J PHYSIOL-HEART C, V302, pH379, DOI 10.1152/ajpheart.00766.2011; Stern Naftali, 2007, J Cardiometab Syndr, V2, P288, DOI 10.1111/j.1559-4564.2007.07297.x; Tang Y, 2001, EUR J ENDOCRINOL, V145, P93, DOI 10.1530/eje.0.1450093; Usatyuk PV, 2004, J BIOL CHEM, V279, P11789, DOI 10.1074/jbc.M311184200; Wang ZG, 2012, MOL CELL ENDOCRINOL, V349, P222, DOI 10.1016/j.mce.2011.10.027; Wang ZG, 2011, AM J PHYSIOL-ENDOC M, V301, pE703, DOI 10.1152/ajpendo.00050.2011; Wang ZG, 2010, EXP BIOL MED, V235, P1347, DOI 10.1258/ebm.2010.010160; Whaley-Connell A, 2011, REV CARDIOVASC MED, V12, P21, DOI 10.3909/ricm0555; Yin W, 2003, J BIOL CHEM, V278, P43074, DOI 10.1074/jbc.M308484200; Zarrouki B, 2007, FEBS LETT, V581, P2394, DOI 10.1016/j.febslet.2007.04.048	47	39	39	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2013	8	8							e70663	10.1371/journal.pone.0070663	http://dx.doi.org/10.1371/journal.pone.0070663			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	218XC	23940618	Green Submitted, Green Published, gold			2022-12-25	WOS:000324465000112
J	Zhou, YZ; Bu, LJ; Guo, M; Zhou, CR; Wang, YD; Chen, LY; Liu, J				Zhou, Yizhuang; Bu, Lijing; Guo, Min; Zhou, Chengran; Wang, Yongdong; Chen, Liyu; Liu, Jie			Comprehensive Genomic Characterization of Campylobacter Genus Reveals Some Underlying Mechanisms for its Genomic Diversification	PLOS ONE			English	Article							JEJUNI; IDENTIFICATION; SEQUENCES; ALIGNMENT; ABORTION; CLASSIFICATION; INFECTIONS; PREVALENCE; DIVERGENCE; DATABASE	Campylobacter species. are phenotypically diverse in many aspects including host habitats and pathogenicities, which demands comprehensive characterization of the entire Campylobacter genus to study their underlying genetic diversification. Up to now, 34 Campylobacter strains have been sequenced and published in public databases, providing good opportunity to systemically analyze their genomic diversities. In this study, we first conducted genomic characterization, which includes genome-wide alignments, pan-genome analysis, and phylogenetic identification, to depict the genetic diversity of Campylobacter genus. Afterward, we improved the tetranucleotide usage pattern-based naive Bayesian classifier to identify the abnormal composition fragments (ACFs, fragments with significantly different tetranucleotide frequency profiles from its genomic tetranucleotide frequency profiles) including horizontal gene transfers (HGTs) to explore the mechanisms for the genetic diversity of this organism. Finally, we analyzed the HGTs transferred via bacteriophage transductions. To our knowledge, this study is the first to use single nucleotide polymorphism information to construct liable microevolution phylogeny of 21 Campylobacter jejuni strains. Combined with the phylogeny of all the collected Campylobacter species based on genome-wide core gene information, comprehensive phylogenetic inference of all 34 Campylobacter organisms was determined. It was found that C. jejuni harbors a high fraction of ACFs possibly through intraspecies recombination, whereas other Campylobacter members possess numerous ACFs possibly via intragenus recombination. Furthermore, some Campylobacter strains have undergone significant ancient viral integration during their evolution process. The improved method is a powerful tool for bacterial genomic analysis. Moreover, the findings would provide useful information for future research on Campylobacter genus.	[Zhou, Yizhuang; Guo, Min] BGI Shenzhen, Shenzhen, Guangdong, Peoples R China; [Bu, Lijing] Univ New Mexico, Dept Biol, Albuquerque, NM 87131 USA; [Zhou, Chengran] Sichuan Univ, Dept Biol, Chengdu 610064, Sichuan Provinc, Peoples R China; [Wang, Yongdong] Univ South China, Key Discipline Lab Natl Def Biotechnol Uranium Mi, Hengyang, Hunan, Peoples R China; [Chen, Liyu] Cent South Univ, Xiangya Sch Med, Dept Microbiol, Changsha, Hunan, Peoples R China; [Liu, Jie] Tongji Univ, Translat Ctr Stem Cell Res, Tongji Hosp, Stem Cell Res Ctr,Sch Med, Shanghai 200092, Peoples R China	Beijing Genomics Institute (BGI); University of New Mexico; Sichuan University; University of South China; Central South University; Tongji University	Chen, LY (corresponding author), Cent South Univ, Xiangya Sch Med, Dept Microbiol, Changsha, Hunan, Peoples R China.	603966123@qq.com; liujie3131@hotmail.com		Bu, Lijing/0000-0001-8625-2732; Zhou, Yizhuang/0000-0003-2795-3111	Natural Science Foundation of Hunan Province, China [10JJ2012]	Natural Science Foundation of Hunan Province, China(Natural Science Foundation of Hunan Province)	This work was supported by The Natural Science Foundation of Hunan Province, China (10JJ2012). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbass Khurram, 2011, J Ark Med Soc, V108, P88; Acinas SG, 2004, J BACTERIOL, V186, P2629, DOI 10.1128/JB.186.9.2629-2635.2004; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Atanassova V, 1999, INT J FOOD MICROBIOL, V51, P187, DOI 10.1016/S0168-1605(99)00120-8; Bourke B, 1998, CLIN MICROBIOL REV, V11, P440, DOI 10.1128/CMR.11.3.440; BULGIN MS, 1984, AM J VET RES, V45, P555; Bullman S, 2012, EPIDEMIOL INFECT, V140, P684, DOI 10.1017/S0950268811000859; Caporaso JG, 2010, BIOINFORMATICS, V26, P266, DOI 10.1093/bioinformatics/btp636; Delcher AL, 2002, NUCLEIC ACIDS RES, V30, P2478, DOI 10.1093/nar/30.11.2478; Delcher AL, 2007, BIOINFORMATICS, V23, P673, DOI 10.1093/bioinformatics/btm009; Deschavanne PJ, 1999, MOL BIOL EVOL, V16, P1391, DOI 10.1093/oxfordjournals.molbev.a026048; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Etoh Y, 1998, MICROBIOL IMMUNOL, V42, P241, DOI 10.1111/j.1348-0421.1998.tb02278.x; Fouts DE, 2005, PLOS BIOL, V3, P72, DOI 10.1371/journal.pbio.0030015; Friis C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012253; Gibson Jr, 1998, METH MOLEC MED, V15, P407, DOI 10.1385/0-89603-498-4:407; Gilbreath JJ, 2011, MICROBIOL MOL BIOL R, V75, P84, DOI 10.1128/MMBR.00035-10; Gorkiewicz G, 2003, J CLIN MICROBIOL, V41, P2537, DOI 10.1128/JCM.41.6.2537-2546.2003; Heikema AP, 2012, CLIN MICROBIOL INFEC; Hepworth PJ, 2011, ENVIRON MICROBIOL, V13, P1549, DOI 10.1111/j.1462-2920.2011.02461.x; Islam Z, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043976; Karenlampi RI, 2004, J CLIN MICROBIOL, V42, P5731, DOI 10.1128/JCM.42.12.5731-5738.2004; Kent WJ, 2002, GENOME RES, V12, P656, DOI 10.1101/gr.229202; Ko KS, 2002, J CLIN MICROBIOL, V40, P2653, DOI 10.1128/JCM.40.7.2653-2658.2002; Koonin EV, 2000, CELL, V101, P573, DOI 10.1016/S0092-8674(00)80867-3; Korczak BM, 2006, INT J SYST EVOL MICR, V56, P937, DOI 10.1099/ijs.0.64109-0; Kramer JM, 2000, J FOOD PROTECT, V63, P1654, DOI 10.4315/0362-028X-63.12.1654; Kuwabara S, 2004, DRUGS, V64, P597, DOI 10.2165/00003495-200464060-00003; Lagesen K, 2007, NUCLEIC ACIDS RES, V35, P3100, DOI 10.1093/nar/gkm160; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lawrence JG, 1997, J MOL EVOL, V44, P383, DOI 10.1007/PL00006158; Lawrence JG, 1998, P NATL ACAD SCI USA, V95, P9413, DOI 10.1073/pnas.95.16.9413; Lefebure T, 2010, GENOME BIOL EVOL, V2, P646, DOI 10.1093/gbe/evq048; Miljkovic-Selimovic Biljana, 2010, J Med Case Rep, V4, P101, DOI 10.1186/1752-1947-4-101; Miller WG, 2006, MICROBIOL-SGM, V152, P245, DOI 10.1099/mic.0.28348-0; Moolhuijzen PM, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-86; Moore JE, 1998, J FOOD PROTECT, V61, P409, DOI 10.4315/0362-028X-61.4.409; Mshelia GD, 2012, TROP ANIM HEALTH PRO, V44, P1487, DOI 10.1007/s11250-012-0092-6; On S. L. W., 2001, Society for Applied Microbiology Symposium Series, p1S; Parkhill J, 2000, NATURE, V403, P665, DOI 10.1038/35001088; Pearson BM, 2007, J BACTERIOL, V189, P8402, DOI 10.1128/JB.01404-07; Pride DT, 2003, GENOME RES, V13, P145, DOI 10.1101/gr.335003; Quinones B, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002015; RUSSELL RG, 1989, INFECT IMMUN, V57, P1438, DOI 10.1128/IAI.57.5.1438-1444.1989; Sahin O, 2008, J CLIN MICROBIOL, V46, P1663, DOI 10.1128/JCM.00031-08; Sandberg R, 2001, GENOME RES, V11, P1404, DOI 10.1101/gr.186401; Schattner P, 2005, NUCLEIC ACIDS RES, V33, pW686, DOI 10.1093/nar/gki366; Schbath S, 1995, J Comput Biol, V2, P417, DOI 10.1089/cmb.1995.2.417; Scott AE, 2007, PLOS PATHOG, V3, P1142, DOI 10.1371/journal.ppat.0030119; SEBALD M, 1963, ANN I PASTEUR PARIS, V105, P897; Smith DR, 1997, J BACTERIOL, V179, P7135, DOI 10.1128/jb.179.22.7135-7155.1997; Swift J, 2009, LANGMUIR, V25, P5219, DOI 10.1021/la8040743; Tatusov RL, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-41; Teeling H, 2004, ENVIRON MICROBIOL, V6, P938, DOI 10.1111/j.1462-2920.2004.00624.x; Todorovic S, 2009, PHYS CHEM CHEM PHYS, V11, P1809, DOI 10.1039/b815489a; Tresierra-Ayala Alvaro, 1994, Revista do Instituto de Medicina Tropical de Sao Paulo, V36, P497; Uzoigwe C, 2005, CLIN MICROBIOL INFEC, V11, P253, DOI 10.1111/j.1469-0691.2004.01028.x; VASQUEZ LA, 1983, AM J VET RES, V44, P1553; WASSENAAR TM, 1995, MICROBIOL-UK, V141, P95, DOI 10.1099/00221287-141-1-95; WELSH RD, 1984, J AM VET MED ASSOC, V185, P549; Zhang MJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015060	61	6	8	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2013	8	8							e70241	10.1371/journal.pone.0070241	http://dx.doi.org/10.1371/journal.pone.0070241			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	218XC	23940551	Green Submitted, Green Published, gold			2022-12-25	WOS:000324465000045
J	Shang, BZ; Chang, R; Chu, JW				Shang, Barry Z.; Chang, Rakwoo; Chu, Jhih-Wei			Systems-level Modeling with Molecular Resolution Elucidates the Rate-limiting Mechanisms of Cellulose Decomposition by Cellobiohydrolases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cellulase; Computational Biology; Enzyme Inactivation; Enzyme Kinetics; Macromolecular Crowding; Molecular Modeling; Systems Biology; Interfacial Biocatalysis; Spatiotemporal Modeling	TRICHODERMA-REESEI CELLOBIOHYDROLASE; ENZYMATIC-HYDROLYSIS; BINDING DOMAIN; TRAFFIC JAMS; KINETICS; ADSORPTION; SURFACE; ENDOGLUCANASE; SIMULATIONS; DEGRADATION	Interprotein and enzyme-substrate couplings in interfacial biocatalysis induce spatial correlations beyond the capabilities of classical mass-action principles in modeling reaction kinetics. To understand the impact of spatial constraints on enzyme kinetics, we developed a computational scheme to simulate the reaction network of enzymes with the structures of individual proteins and substrate molecules explicitly resolved in the three-dimensional space. This methodology was applied to elucidate the rate-limiting mechanisms of crystalline cellulose decomposition by cellobiohydrolases. We illustrate that the primary bottlenecks are slow complexation of glucan chains into the enzyme active site and excessive enzyme jamming along the crowded substrate. Jamming could be alleviated by increasing the decomplexation rate constant but at the expense of reduced processivity. We demonstrate that enhancing the apparent reaction rate required a subtle balance between accelerating the complexation driving force and simultaneously avoiding enzyme jamming. Via a spatiotemporal systems analysis, we developed a unified mechanistic framework that delineates the experimental conditions under which different sets of rate-limiting behaviors emerge. We found that optimization of the complexation-exchange kinetics is critical for overcoming the barriers imposed by interfacial confinement and accelerating the apparent rate of enzymatic cellulose decomposition.	[Shang, Barry Z.; Chu, Jhih-Wei] Univ Calif Berkeley, Dept Chem & Biomol Engn, Berkeley, CA 94720 USA; [Chang, Rakwoo] Kwangwoon Univ, Dept Chem, Seoul 139701, South Korea; [Chu, Jhih-Wei] Natl Chiao Tung Univ, Dept Biol Sci & Technol, Hsinchu 300, Taiwan; [Chu, Jhih-Wei] Natl Chiao Tung Univ, Inst Bioinformat & Syst Biol, Hsinchu 300, Taiwan	University of California System; University of California Berkeley; Kwangwoon University; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University	Chu, JW (corresponding author), Natl Chiao Tung Univ, Dept Biol Sci & Technol, Hsinchu 300, Taiwan.	jwchu@nctu.edu.tw	Chang, Rakwoo/F-9909-2019; Chu, Jhih-Wei/M-2870-2013	Chu, Jhih-Wei/0000-0003-3842-2893	Office of Science of the United States Department of Energy [DE-AC02-05CH11231]	Office of Science of the United States Department of Energy(United States Department of Energy (DOE))	We acknowledge the computational resources provided by the National Energy Research Scientific Computing Center (NERSC), which is supported by the Office of Science of the United States Department of Energy under Contract DE-AC02-05CH11231.	Asztalos A, 2012, BIOTECHNOL BIOFUELS, V5, DOI 10.1186/1754-6834-5-55; Bansal P, 2009, BIOTECHNOL ADV, V27, P833, DOI 10.1016/j.biotechadv.2009.06.005; Berry H, 2002, BIOPHYS J, V83, P1891, DOI 10.1016/S0006-3495(02)73953-2; Cao Y, 2005, J CHEM PHYS, V122, DOI [10.1063/1.1824902, 10.1063/1.1924598]; Chang R, 2012, J PHYS CHEM B, V116, P8074, DOI 10.1021/jp302974x; Chatterjee A, 2007, J COMPUT-AIDED MATER, V14, P253, DOI 10.1007/s10820-006-9042-9; Chundawat SPS, 2011, ANNU REV CHEM BIOMOL, V2, P121, DOI 10.1146/annurev-chembioeng-061010-114205; Cruys-Bagger N, 2012, J BIOL CHEM, V287, P18451, DOI 10.1074/jbc.M111.334946; Ding SY, 2006, J AGR FOOD CHEM, V54, P597, DOI 10.1021/jf051851z; DIVNE C, 1994, SCIENCE, V265, P524, DOI 10.1126/science.8036495; Eriksson T, 2002, APPL BIOCHEM BIOTECH, V101, P41, DOI 10.1385/ABAB:101:1:41; Fox JM, 2012, BIOCHEMISTRY-US, V51, P442, DOI 10.1021/bi2011543; Gillespie DT, 2007, ANNU REV PHYS CHEM, V58, P35, DOI 10.1146/annurev.physchem.58.032806.104637; Gusakov AV, 2007, BIOTECHNOL BIOENG, V97, P1028, DOI 10.1002/bit.21329; Hendriks ATWM, 2009, BIORESOURCE TECHNOL, V100, P10, DOI 10.1016/j.biortech.2008.05.027; Himmel ME, 2007, SCIENCE, V315, P804, DOI 10.1126/science.1137016; Hong J, 2007, LANGMUIR, V23, P12535, DOI 10.1021/la7025686; Igarashi K, 2006, FEBS J, V273, P2869, DOI 10.1111/j.1742-4658.2006.05299.x; Igarashi K, 2011, SCIENCE, V333, P1279, DOI 10.1126/science.1208386; Imai T, 1998, FEBS LETT, V432, P113, DOI 10.1016/S0014-5793(98)00845-X; Jervis EJ, 1997, J BIOL CHEM, V272, P24016, DOI 10.1074/jbc.272.38.24016; Klein-Marcuschamer D, 2012, BIOTECHNOL BIOENG, V109, P1083, DOI 10.1002/bit.24370; Koivula A, 1998, FEBS LETT, V429, P341, DOI 10.1016/S0014-5793(98)00596-1; KRAULIS PJ, 1989, BIOCHEMISTRY-US, V28, P7241, DOI 10.1021/bi00444a016; Kurasin M, 2011, J BIOL CHEM, V286, P169, DOI 10.1074/jbc.M110.161059; Leduc C, 2012, P NATL ACAD SCI USA, V109, P6100, DOI 10.1073/pnas.1107281109; Lehtio J, 2003, P NATL ACAD SCI USA, V100, P484, DOI 10.1073/pnas.212651999; Levine SE, 2011, BIOTECHNOL BIOENG, V108, P2561, DOI 10.1002/bit.23249; LINDER M, 1995, PROTEIN SCI, V4, P1056, DOI 10.1002/pro.5560040604; Linder M, 1996, P NATL ACAD SCI USA, V93, P12251, DOI 10.1073/pnas.93.22.12251; Liu YS, 2011, J BIOL CHEM, V286, P11195, DOI 10.1074/jbc.M110.216556; Lynd LR, 2008, NAT BIOTECHNOL, V26, P169, DOI 10.1038/nbt0208-169; Maurer SA, 2012, IND ENG CHEM RES, V51, P11389, DOI 10.1021/ie3008538; Maurer SA, 2012, LANGMUIR, V28, P14598, DOI 10.1021/la3024524; Praestgaard E, 2011, FEBS J, V278, P1547, DOI 10.1111/j.1742-4658.2011.08078.x; Quirk A, 2010, LANGMUIR, V26, P5007, DOI 10.1021/la9037028; Smit B, 2008, CHEM REV, V108, P4125, DOI 10.1021/cr8002642; STAHLBERG J, 1991, BIO-TECHNOL, V9, P286, DOI 10.1038/nbt0391-286; Teeri TT, 1997, TRENDS BIOTECHNOL, V15, P160, DOI 10.1016/S0167-7799(97)01032-9; Valjamae P, 1998, EUR J BIOCHEM, V253, P469, DOI 10.1046/j.1432-1327.1998.2530469.x; von Ossowski I, 2003, J MOL BIOL, V333, P817, DOI 10.1016/S0022-2836(03)00881-7; Wang QQ, 2012, BIOTECHNOL BIOENG, V109, P1965, DOI 10.1002/bit.24483; Warden AC, 2011, BIOTECHNOL BIOFUELS, V4, DOI 10.1186/1754-6834-4-39; Yang B, 2011, BIOFUELS-UK, V2, P421, DOI 10.4155/BFS.11.116; Zhang YHP, 2004, BIOTECHNOL BIOENG, V88, P797, DOI 10.1002/bit.20282; Zhou HX, 2008, ANNU REV BIOPHYS, V37, P375, DOI 10.1146/annurev.biophys.37.032807.125817	46	31	31	0	46	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 4	2013	288	40					29081	29089		10.1074/jbc.M113.497412	http://dx.doi.org/10.1074/jbc.M113.497412			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	298BL	23950182	Green Published, hybrid			2022-12-25	WOS:000330298800061
J	Garcia-Alonso, V; Lopez-Vicario, C; Titos, E; Moran-Salvador, E; Gonzalez-Periz, A; Rius, B; Parrizas, M; Werz, O; Arroyo, V; Claria, J				Garcia-Alonso, Veronica; Lopez-Vicario, Cristina; Titos, Esther; Moran-Salvador, Eva; Gonzalez-Periz, Ana; Rius, Bibiana; Parrizas, Marcelina; Werz, Oliver; Arroyo, Vicente; Claria, Joan			Coordinate Functional Regulation between Microsomal Prostaglandin E Synthase-1 (mPGES-1) and Peroxisome Proliferator-activated Receptor gamma (PPAR gamma) in the Conversion of White-to-brown Adipocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ADIPOSE-TISSUE INFLAMMATION; HIGH-FAT DIET; INSULIN-RESISTANCE; STEM-CELLS; DIFFERENTIATION; CYCLOOXYGENASE-2; OBESITY; 5-LIPOXYGENASE; PROTEIN; MICE	Peroxisome proliferator-activated receptor gamma (PPAR gamma) is a ligand-activated nuclear receptor and a master regulator of adipogenesis. Microsomal prostaglandin E (PGE) synthase-1 (mPGES-1) is an inducible enzyme that couples with cyclooxygenase-2 for the biosynthesis of PGE(2). In this study we demonstrate the existence of a coordinate functional interaction between PPAR gamma and mPGES-1 in controlling the process of preadipocyte differentiation in white adipose tissue (WAT). Adipocyte-specific PPAR gamma knock-out mice carrying an aP2 promoter-driven Cre recombinase transgene showed a blunted response to the adipogenic effects of a high fat diet. Pre-adipocytes from these knock-out mice showed loss of PPAR gamma and were resistant to rosiglitazone-induced WAT differentiation. In parallel, WAT from these mice showed increased expression of uncoupling protein 1, a mitochondrial enzyme that dissipates chemical energy as heat. Adipose tissue from mice lacking PPAR gamma also showed mPGES-1 up-regulation and increased PGE(2) levels. In turn, PGE(2) suppressed PPAR gamma expression and blocked rosiglitazone-induced pre-adipocyte differentiation toward white adipocytes while directly elevating uncoupling protein 1 expression and pre-adipocyte differentiation into mature beige/brite adipocytes. Consistently, pharmacological mPGES-1 inhibition directed pre-adipocyte differentiation toward white adipocytes while suppressing differentiation into beige/brite adipocytes. This browning effect was reproduced in knockdown experiments using a siRNA directed against mPGES-1. The effects of PGE(2) on pre-adipocyte differentiation were not seen in mice lacking PPAR gamma in adipose tissue and were not mirrored by other eicosanoids (i.e. leukotriene B-4). Taken together, these findings identify PGE(2) as a key regulator of white-to-brown adipogenesis and suggest the existence of a coordinate regulation of adipogenesis between PPAR gamma and mPGES-1.	[Garcia-Alonso, Veronica; Lopez-Vicario, Cristina; Titos, Esther; Moran-Salvador, Eva; Gonzalez-Periz, Ana; Rius, Bibiana; Claria, Joan] Hosp Clin Barcelona, Dept Biochem & Mol Genet, IDIBAPS, Esther Koplowitz Ctr, E-08036 Barcelona, Spain; [Titos, Esther; Gonzalez-Periz, Ana; Arroyo, Vicente; Claria, Joan] CIBERehd, Barcelona 08036, Spain; [Parrizas, Marcelina] CIBERdem, IDIBAPS, Diabet & Obes Lab, Barcelona 08036, Spain; [Werz, Oliver] Univ Jena, D-07743 Jena, Germany; [Arroyo, Vicente] Hosp Clin Barcelona, Liver Unit, IDIBAPS, Esther Koplowitz Ctr, E-08036 Barcelona, Spain; [Claria, Joan] Univ Barcelona, Dept Physiol Sci 1, E-08036 Barcelona, Spain	University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; CIBER - Centro de Investigacion Biomedica en Red; CIBEREHD; CIBER - Centro de Investigacion Biomedica en Red; CIBERDEM; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; Friedrich Schiller University of Jena; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; University of Barcelona	Claria, J (corresponding author), Hosp Clin Barcelona, Dept Biochem & Mol Genet, Villarroel 170, E-08036 Barcelona, Spain.	jclaria@clinic.ub.es	Parrizas, Marcelina/AAS-3629-2021; Titos, Esther/AAA-5394-2019; Claria, Joan/M-7772-2019; Arroyo, Vicente/F-9189-2015	Titos, Esther/0000-0002-2543-2243; Arroyo, Vicente/0000-0002-2728-1848; Lopez-Vicario, Cristina/0000-0002-6609-8501; Claria, Joan/0000-0003-4333-7749; Parrizas, Marcelina/0000-0003-1296-8302	Instituto de Salud Carlos III; Generalitat de Catalunya [2009SGR1484]	Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission); Generalitat de Catalunya(Generalitat de Catalunya)	CIBERehd is funded by the Instituto de Salud Carlos III. Our laboratory is a Consolidated Research Group recognized by the Generalitat de Catalunya (Grant 2009SGR1484).	Ahfeldt T, 2012, NAT CELL BIOL, V14, P209, DOI 10.1038/ncb2411; Barak Y, 1999, MOL CELL, V4, P585, DOI 10.1016/S1097-2765(00)80209-9; Bell-Parikh LC, 2003, J CLIN INVEST, V112, P945, DOI 10.1172/JCI200318012; Cederberg A, 2001, CELL, V106, P563, DOI 10.1016/S0092-8674(01)00474-3; CHATZIPANTELI K, 1992, DIABETES, V41, P927, DOI 10.2337/diabetes.41.8.927; Chu XQ, 2009, BBA-MOL CELL BIOL L, V1791, P273, DOI 10.1016/j.bbalip.2009.01.022; Cristancho AG, 2011, NAT REV MOL CELL BIO, V12, P722, DOI 10.1038/nrm3198; Fisher FM, 2012, GENE DEV, V26, P271, DOI 10.1101/gad.177857.111; Galic S, 2010, MOL CELL ENDOCRINOL, V316, P129, DOI 10.1016/j.mce.2009.08.018; Ghoshal S, 2011, J BIOL CHEM, V286, P889, DOI 10.1074/jbc.M110.139139; He WM, 2003, P NATL ACAD SCI USA, V100, P15712, DOI 10.1073/pnas.2536828100; Horrillo R, 2010, J IMMUNOL, V184, P3978, DOI 10.4049/jimmunol.0901355; Huang ZF, 2000, BIOCHEM PHARMACOL, V59, P187, DOI 10.1016/S0006-2952(99)00312-3; Jakobsson PJ, 1999, P NATL ACAD SCI USA, V96, P7220, DOI 10.1073/pnas.96.13.7220; Jones JR, 2005, P NATL ACAD SCI USA, V102, P6207, DOI 10.1073/pnas.0306743102; Kajimura S, 2010, CELL METAB, V11, P257, DOI 10.1016/j.cmet.2010.03.005; Kapoor M, 2007, J BIOL CHEM, V282, P5356, DOI 10.1074/jbc.M610153200; Karg EM, 2009, J MED CHEM, V52, P3474, DOI 10.1021/jm900212y; Koeberle A, 2009, BIOORGAN MED CHEM, V17, P7924, DOI 10.1016/j.bmc.2009.10.025; Koppen A, 2010, FEBS LETT, V584, P3250, DOI 10.1016/j.febslet.2010.06.035; Leonardsson G, 2004, P NATL ACAD SCI USA, V101, P8437, DOI 10.1073/pnas.0401013101; Madsen L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011391; Moran-Salvador E, 2011, FASEB J, V25, P2538, DOI 10.1096/fj.10-173716; OBrien SN, 1996, ANAL QUANT CYTOL, V18, P137; Ohno H, 2012, CELL METAB, V15, P395, DOI 10.1016/j.cmet.2012.01.019; Ricote M, 1998, NATURE, V391, P79, DOI 10.1038/34178; Rodeheffer MS, 2008, CELL, V135, P240, DOI 10.1016/j.cell.2008.09.036; Romano M, 2003, FASEB J, V17, P1986, DOI 10.1096/fj.03-0053rev; Rosen ED, 2006, NATURE, V444, P847, DOI 10.1038/nature05483; Santos SHS, 2012, REGUL PEPTIDES, V178, P64, DOI 10.1016/j.regpep.2012.06.009; Scott MA, 2011, STEM CELLS DEV, V20, P1793, DOI 10.1089/scd.2011.0040; Seale P, 2011, J CLIN INVEST, V121, P96, DOI 10.1172/JCI44271; Shan TZ, 2013, FASEB J, V27, P277, DOI 10.1096/fj.12-211516; Smith WL, 2000, ANNU REV BIOCHEM, V69, P145, DOI 10.1146/annurev.biochem.69.1.145; Sun L, 2011, NAT CELL BIOL, V13, P958, DOI 10.1038/ncb2286; Titos E, 2011, J IMMUNOL, V187, P5408, DOI 10.4049/jimmunol.1100225; Trayhurn P, 2005, ACTA PHYSIOL SCAND, V184, P285, DOI 10.1111/j.1365-201X.2005.01468.x; Tsuboi H, 2004, BIOCHEM BIOPH RES CO, V322, P1066, DOI 10.1016/j.bbrc.2004.08.018; Vegiopoulos A, 2010, SCIENCE, V328, P1158, DOI 10.1126/science.1186034; Waclawik A, 2009, ENDOCRINOLOGY, V150, P3823, DOI 10.1210/en.2008-1499; WILLOUGHBY DA, 1993, J LIPID MEDIATOR, V6, P287; Wu J, 2012, CELL, V150, P366, DOI 10.1016/j.cell.2012.05.016	42	57	58	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 27	2013	288	39					28230	28242		10.1074/jbc.M113.468603	http://dx.doi.org/10.1074/jbc.M113.468603			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302OB	23943621	Green Published, hybrid			2022-12-25	WOS:000330612800045
J	Dick, G; Tan, CL; Alves, JN; Ehlert, EME; Miller, GM; Hsieh-Wilson, LC; Sugahara, K; Oosterhof, A; van Kuppevelt, TH; Verhaagen, J; Fawcett, JW; Kwok, JCF				Dick, Gunnar; Tan, Chin Lik; Alves, Joao Nuno; Ehlert, Erich M. E.; Miller, Gregory M.; Hsieh-Wilson, Linda C.; Sugahara, Kazuyuki; Oosterhof, Arie; van Kuppevelt, Toin H.; Verhaagen, Joost; Fawcett, James W.; Kwok, Jessica C. F.			Semaphorin 3A Binds to the Perineuronal Nets via Chondroitin Sulfate Type E Motifs in Rodent Brains	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ADULT NERVOUS-SYSTEM; EXTRACELLULAR-MATRIX; AXON GUIDANCE; HIPPOCAMPAL-NEURONS; CORTICAL-NEURONS; HEPARAN-SULFATE; SPINAL-CORD; RAT-BRAIN; PROTEOGLYCANS; RECEPTOR	Chondroitin sulfate (CS) and the CS-rich extracellular matrix structures called perineuronal nets (PNNs) restrict plasticity and regeneration in the CNS. Plasticity is enhanced by chondroitinase ABC treatment that removes CS from its core protein in the chondroitin sulfate proteoglycans or by preventing the formation of PNNs, suggesting that chondroitin sulfate proteoglycans in the PNNs control plasticity. Recently, we have shown that semaphorin3A (Sema3A), a repulsive axon guidance molecule, localizes to the PNNs and is removed by chondroitinase ABC treatment (Vo, T., Carulli, D., Ehlert, E. M., Kwok, J. C., Dick, G., Mecollari, V., Moloney, E. B., Neufeld, G., de Winter, F., Fawcett, J. W., and Verhaagen, J. (2013) Mol. Cell. Neurosci. 56C, 186-200). Sema3A is therefore a candidate for a PNN effector in controlling plasticity. Here, we characterize the interaction of Sema3A with CS of the PNNs. Recombinant Sema3A interacts with CS type E (CS-E), and this interaction is involved in the binding of Sema3A to rat brain-derived PNN glycosaminoglycans, as demonstrated by the use of CS-E blocking antibody GD3G7. In addition, we investigate the release of endogenous Sema3A from rat brain by biochemical and enzymatic extractions. Our results confirm the interaction of Sema3A with CS-E containing glycosaminoglycans in the dense extracellular matrix of rat brain. We also demonstrate that the combination of Sema3A and PNN GAGs is a potent inhibitor of axon growth, and this inhibition is reduced by the CS-E blocking antibody. In conclusion, Sema3A binding to CS-E in the PNNs may be a mechanism whereby PNNs restrict growth and plasticity and may represent a possible point of intervention to facilitate neuronal plasticity.	[Dick, Gunnar; Tan, Chin Lik; Alves, Joao Nuno; Fawcett, James W.; Kwok, Jessica C. F.] Univ Cambridge, John van Geest Ctr Brain Repair, Cambridge CB2 0PY, England; [Dick, Gunnar] Univ Oslo, Fac Math & Nat Sci, Dept Biosci, N-0316 Oslo, Norway; [Ehlert, Erich M. E.; Verhaagen, Joost] Inst Royal Netherlands Acad Arts & Sci, Netherlands Inst Neurosci, NL-1105 BA Amsterdam, Netherlands; [Miller, Gregory M.; Hsieh-Wilson, Linda C.] CALTECH, Pasadena, CA 91125 USA; [Miller, Gregory M.; Hsieh-Wilson, Linda C.] CALTECH, Howard Hughes Med Inst, Div Chem & Chem Engn, Pasadena, CA 91125 USA; [Sugahara, Kazuyuki] Hokkaido Univ, Lab Proteoglycan Signaling & Therapeut, Grad Sch Life Sci, Fac Adv Life Sci, Sapporo, Hokkaido 0010021, Japan; [Oosterhof, Arie; van Kuppevelt, Toin H.] Radboud Univ Nijmegen, Med Ctr, Dept Biochem, Nijmegen Ctr Mol Life Sci, NL-6500 HB Nijmegen, Netherlands; [Verhaagen, Joost] Vrije Univ Amsterdam, Ctr Neurogen & Cognit Res, NL-1081 HV Amsterdam, Netherlands	University of Cambridge; University of Oslo; Royal Netherlands Academy of Arts & Sciences; Netherlands Institute for Neuroscience (NIN-KNAW); California Institute of Technology; California Institute of Technology; Howard Hughes Medical Institute; Hokkaido University; Radboud University Nijmegen; Vrije Universiteit Amsterdam	Kwok, JCF (corresponding author), Univ Cambridge, John van Geest Ctr Brain Repair, Forvie Site,Robinson Way, Cambridge CB2 0PY, England.	jcfk2@cam.ac.uk	Kwok, Jessica/A-6740-2013; van Kuppevelt, A.H.M.S.M./L-4463-2015; Verhaagen, Joost/G-4773-2012	Kwok, Jessica/0000-0002-9798-9083; Dick, Gunnar/0000-0003-4529-5239; Fawcett, James/0000-0002-7990-4568; Tan, Chin Lik/0000-0002-3877-7347	National Institutes of Health [R01 GM093627]; Christopher and Dana Reeve Foundation; Wings for Life; European Union; Ministry of Education, Culture, Sports, Science, and Technology of Japan (MEXT) [24110501]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM093627] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Christopher and Dana Reeve Foundation; Wings for Life; European Union(European Commission); Ministry of Education, Culture, Sports, Science, and Technology of Japan (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 GM093627 (to L. H. W.). This work was also supported by The Christopher and Dana Reeve Foundation (to J. W. F. and L. H. W.), Wings for Life (to J. C. F. K.), European Union FP7 Programme AxRegen, and Grants-in-aid for Scientific Research on Innovative Areas 24110501 from the Ministry of Education, Culture, Sports, Science, and Technology of Japan (MEXT) (to K. S.).	Achur RN, 2004, BBA-PROTEINS PROTEOM, V1701, P109, DOI 10.1016/j.bbapap.2004.06.007; Bao XF, 2004, J BIOL CHEM, V279, P9765, DOI 10.1074/jbc.M310877200; Behar O, 1996, NATURE, V383, P525, DOI 10.1038/383525a0; Ben-Zvi A, 2006, J NEUROCHEM, V96, P585, DOI 10.1111/j.1471-4159.2005.03580.x; Blackhall FH, 2003, BIOCHEM J, V375, P131, DOI 10.1042/BJ20030730; Bouzioukh F, 2006, EUR J NEUROSCI, V23, P2247, DOI 10.1111/j.1460-9568.2006.04783.x; Bruckner G, 1996, J NEUROCYTOL, V25, P333, DOI 10.1007/BF02284806; Carulli D, 2007, J COMP NEUROL, V501, P83, DOI 10.1002/cne.21231; Carulli D, 2010, BRAIN, V133, P2331, DOI 10.1093/brain/awq145; CELIO MR, 1994, BRAIN RES REV, V19, P128, DOI 10.1016/0165-0173(94)90006-X; Chen G, 2008, NAT NEUROSCI, V11, P36, DOI 10.1038/nn2018; Coles CH, 2011, SCIENCE, V332, P484, DOI 10.1126/science.1200840; De Wit J, 2005, MOL CELL NEUROSCI, V29, P40, DOI 10.1016/j.mcn.2004.12.009; de Wit J, 2003, PROG NEUROBIOL, V71, P249, DOI 10.1016/j.pneurobio.2003.06.001; de Wit J, 2009, J NEUROSCI, V29, P23, DOI 10.1523/JNEUROSCI.3931-08.2009; Deepa SS, 2006, J BIOL CHEM, V281, P17789, DOI 10.1074/jbc.M600544200; Dickendesher TL, 2012, NAT NEUROSCI, V15, P703, DOI 10.1038/nn.3070; Feiner L, 1997, NEURON, V19, P539, DOI 10.1016/S0896-6273(00)80370-0; Fisher D, 2011, J NEUROSCI, V31, P14051, DOI 10.1523/JNEUROSCI.1737-11.2011; Frischknecht R, 2009, NAT NEUROSCI, V12, P897, DOI 10.1038/nn.2338; Galtrey CM, 2007, BRAIN, V130, P926, DOI 10.1093/brain/awl372; Galtrey CM, 2007, BRAIN RES REV, V54, P1, DOI 10.1016/j.brainresrev.2006.09.006; Gama CI, 2006, NAT CHEM BIOL, V2, P467, DOI 10.1038/nchembio810; Giger RJ, 1998, J NEUROSCI RES, V52, P27, DOI 10.1002/(SICI)1097-4547(19980401)52:1<27::AID-JNR4>3.0.CO;2-M; Harris NG, 2013, J NEUROTRAUM, V30, P1257, DOI 10.1089/neu.2012.2737; HARTIG W, 1994, BRAIN RES, V635, P307, DOI 10.1016/0006-8993(94)91452-4; He ZG, 1997, CELL, V90, P739, DOI 10.1016/S0092-8674(00)80534-6; Kantor DB, 2004, NEURON, V44, P961, DOI 10.1016/j.neuron.2004.12.002; Kolodkin AL, 1997, CELL, V90, P753, DOI 10.1016/S0092-8674(00)80535-8; Kreuger J, 2006, J CELL BIOL, V174, P323, DOI 10.1083/jcb.200604035; Kwok J. C. F., 2013, NEUROMETHODS EXTRACE; Li C., 2009, FRONT NEURAL CIRCUIT, DOI [10.3389/neuro.04.011.2009, DOI 10.3389/D0WNL0ADED]; Manns RPC, 2012, J NEUROSCI, V32, P8554, DOI 10.1523/JNEUROSCI.5964-11.2012; Maroto M, 2013, J NEUROCHEM, V125, P205, DOI 10.1111/jnc.12159; Matthews RT, 2002, J NEUROSCI, V22, P7536; Mikami T, 2009, J BIOL CHEM, V284, P4494, DOI 10.1074/jbc.M809227200; Pizzorusso T, 2002, SCIENCE, V298, P1248, DOI 10.1126/science.1072699; Purushothaman A, 2007, J BIOL CHEM, V282, P19442, DOI 10.1074/jbc.M700630200; Rogers CJ, 2011, P NATL ACAD SCI USA, V108, P9747, DOI 10.1073/pnas.1102962108; Romberg C, 2013, J NEUROSCI, V33, P7057, DOI 10.1523/JNEUROSCI.6267-11.2013; Sahay A, 2005, J NEUROSCI, V25, P3613, DOI 10.1523/JNEUROSCI.5255-04.2005; Schwarting GA, 2000, J NEUROSCI, V20, P7691; Shen YJ, 2009, SCIENCE, V326, P592, DOI 10.1126/science.1178310; Shipp EL, 2007, CHEM BIOL, V14, P195, DOI 10.1016/j.chembiol.2006.12.009; SUGAHARA K, 1991, EUR J BIOCHEM, V202, P805, DOI 10.1111/j.1432-1033.1991.tb16436.x; SUGAHARA K, 1994, CARBOHYD RES, V255, P145, DOI 10.1016/S0008-6215(00)90976-5; Sugahara K, 1996, EUR J BIOCHEM, V239, P865, DOI 10.1111/j.1432-1033.1996.0865u.x; Takahashi T, 1999, CELL, V99, P59, DOI 10.1016/S0092-8674(00)80062-8; Taniguchi M, 1997, NEURON, V19, P519, DOI 10.1016/S0896-6273(00)80368-2; Tran TS, 2009, NATURE, V462, P1065, DOI 10.1038/nature08628; Vitellaro-Zuccarello L, 2001, CELL TISSUE RES, V306, P15; Vo T, 2013, MOL CELL NEUROSCI, V56, P186, DOI 10.1016/j.mcn.2013.04.009; Wang DF, 2011, J NEUROSCI, V31, P9332, DOI 10.1523/JNEUROSCI.0983-11.2011; Winberg ML, 1998, CELL, V95, P903, DOI 10.1016/S0092-8674(00)81715-8; YAMAGATA T, 1968, J BIOL CHEM, V243, P1523; Yamaguchi Y, 2000, CELL MOL LIFE SCI, V57, P276, DOI 10.1007/PL00000690; Zimmer G, 2010, CEREB CORTEX, V20, P2411, DOI 10.1093/cercor/bhp309	57	99	101	0	26	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 20	2013	288	38					27384	27395		10.1074/jbc.M111.310029	http://dx.doi.org/10.1074/jbc.M111.310029			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302IG	23940048	hybrid, Green Published, Green Accepted			2022-12-25	WOS:000330597300034
J	Jensen, JL; Berry, DA; Kummer, TA				Jensen, Jamie L.; Berry, Dane A.; Kummer, Tyler A.			Investigating the Effects of Exam Length on Performance and Cognitive Fatigue	PLOS ONE			English	Article							RETRIEVAL; TESTS; ENHANCE; RETENTION	This study examined the effects of exam length on student performance and cognitive fatigue in an undergraduate biology classroom. Exams tested higher order thinking skills. To test our hypothesis, we administered standard- and extended-length high-level exams to two populations of non-majors biology students. We gathered exam performance data between conditions as well as performance on the first and second half of exams within conditions. We showed that lengthier exams led to better performance on assessment items shared between conditions, possibly lending support to the spreading activation theory. It also led to greater performance on the final exam, lending support to the testing effect in creative problem solving. Lengthier exams did not result in lower performance due to fatiguing conditions, although students perceived subjective fatigue. Implications of these findings are discussed with respect to assessment practices.	[Jensen, Jamie L.; Berry, Dane A.; Kummer, Tyler A.] Brigham Young Univ, Dept Biol, Provo, UT 84602 USA	Brigham Young University	Jensen, JL (corresponding author), Brigham Young Univ, Dept Biol, Provo, UT 84602 USA.	Jamie.Jensen@byu.edu						Ackerman PL, 2009, J EXP PSYCHOL-APPL, V15, P163, DOI 10.1037/a0015719; Ackerman PL, 2006, TEST LENGTH COGNITIV; ANBAR M, 1991, ACAD MED, V66, P420, DOI 10.1097/00001888-199107000-00012; Anderson J.R., 1976, LANGUAGE MEMORY THOU; Anderson L. W., 2001, TAXONOMY LEARNING TE; Arai T, 1912, CONTRIBUTIONS ED, V54, P1; Bloom BS, 1984, BLOOM TAXONOMY ED OB; Bybee R., 1993, BIOL SCI CURRICULUM; Carpenter SK, 2008, MEM COGNITION, V36, P438, DOI 10.3758/MC.36.2.438; Carpenter SK, 2009, APPL COGNITIVE PSYCH, V23, P760, DOI 10.1002/acp.1507; Carpenter SK, 2006, MEM COGNITION, V34, P268, DOI 10.3758/BF03193405; Carpenter SK, 2007, PSYCHON B REV, V14, P474, DOI 10.3758/BF03194092; CARRIER M, 1992, MEM COGNITION, V20, P633, DOI 10.3758/BF03202713; Chan JCK, 2007, J EXP PSYCHOL LEARN, V33, P431, DOI 10.1037/0278-7393.33.2.431; Chan JCK, 2006, J EXP PSYCHOL GEN, V135, P553, DOI 10.1037/0096-3445.135.4.553; Collins Allan M., 1972, EXPT SEMANTIC MEMORY; DAVIS DR, 1946, J NEUROL NEUROSUR PS, V9, P23, DOI 10.1136/jnnp.9.1.23; FairTest, 2021, MOR 1830 SCH DO NOT; FOXNews, 2006, FOXNEWS; Heiss E.D., 1950, MODERN SCI TEACHING; Heyborne W.H., 2011, J COLL SCI TEACH, V40, P28; Howard David R, 2005, Cell Biol Educ, V4, P249, DOI 10.1187/cbe.04-09-0052; Jensen JL, 2011, CBE-LIFE SCI EDUC, V10, P64, DOI 10.1187/cbe.10-07-0089; Johnson CI, 2009, J EDUC PSYCHOL, V101, P621, DOI 10.1037/a0015183; Karpicke JD, 2008, SCIENCE, V319, P966, DOI 10.1126/science.1152408; Laitusis CC, 2007, 20071 COLL BOARD; Lawson A. E., 1978, J RES SCI TEACH, V15, P11, DOI [10.1002/tea.3660150103, DOI 10.1002/TEA.3660150103]; Lawson AE, 2000, J RES SCI TEACH, V37, P996, DOI 10.1002/1098-2736(200011)37:9<996::AID-TEA8>3.0.CO;2-J; Lawson AE, 2002, SCI TEACHING DEV THI; Lewin K., 1935, DYNAMIC THEORY PERS; Liu J, 2004, 20045 COLL BOARD; Martyn GW, 1913, BRIT J PSYCHOL, V5, P427, DOI 10.1111/j.2044-8295.1913.tb00073.x; McDaniel MA, 2007, EUR J COGN PSYCHOL, V19, P494, DOI 10.1080/09541440701326154; National Research Council (NRC), 1996, NAT SCI ED STAND; Renner JW, 1973, SCH SCI MATH, V73, P291; Rissing SW, 2009, CBE-LIFE SCI EDUC, V8, P55, DOI 10.1187/cbe.08-05-0023; Rohrer D, 2010, J EXP PSYCHOL LEARN, V36, P233, DOI 10.1037/a0017678; Shi J, 2010, CBE-LIFE SCI EDUC, V9, P453, DOI 10.1187/cbe.10-04-0055; Spiro MD, 2008, CBE-LIFE SCI EDUC, V7, P82, DOI 10.1187/cbe.07-82-88; Thorndike R., 2005, MEASUREMENT EVALUATI; TRAUB R E, 1977, Applied Psychological Measurement, V1, P355, DOI 10.1177/014662167700100304; Wiggins G., 1998, UNDERSTANDING DESIGN	43	17	17	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2013	8	8							e70270	10.1371/journal.pone.0070270	http://dx.doi.org/10.1371/journal.pone.0070270			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	200UV	23950918	Green Published, gold, Green Submitted			2022-12-25	WOS:000323097300013
J	Pettersson, E; Ahmadian, A; Stahl, PL				Pettersson, Erik; Ahmadian, Afshin; Stahl, Patrik L.			A Novel Method for Rapid Hybridization of DNA to a Solid Support	PLOS ONE			English	Article							EQUINE ENCEPHALOSIS VIRUS; ISRAEL	Here we present a novel approach entitled Magnetic Forced Hybridization (MFH) that provides the means for efficient and direct hybridization of target nucleic acids to complementary probes immobilized on a glass surface in less than 15 seconds at ambient temperature. In addition, detection is carried out instantly since the beads become visible on the surface. The concept of MFH was tested for quality control of array manufacturing, and was combined with a multiplex competitive hybridization (MUCH) approach for typing of Human Papilloma Virus (HPV). Magnetic Forced Hybridization of bead-DNA constructs to a surface achieves a significant reduction in diagnostic testing time. In addition, readout of results by visual inspection of the unassisted eye eliminates the need for additional expensive instrumentation. The method uses the same set of beads throughout the whole process of manipulating and washing DNA constructs prior to detection, as in the actual detection step itself.	[Pettersson, Erik; Ahmadian, Afshin] Royal Inst Technol, Div Gene Technol, Sci Life Lab, Stockholm, Sweden; [Stahl, Patrik L.] Karolinska Inst, Stockholm, Sweden	Royal Institute of Technology; Karolinska Institutet	Stahl, PL (corresponding author), Karolinska Inst, Stockholm, Sweden.	patrik.stahl@ki.se						Aharonson-Raz K, 2011, EMERG INFECT DIS, V17, P1883, DOI 10.3201/eid1710.110350; Howell P. G., 2004, Infectious diseases of livestock. Volume Two, P1247; Karber G., 1931, ARCH EXP PATHOL PH, V162, P480, DOI DOI 10.1007/BF01863914; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Mildenberg Z, 2009, TRANSBOUND EMERG DIS, V56, P291, DOI 10.1111/j.1865-1682.2009.01087_1.x; Oura CAL, 2012, EPIDEMIOL INFECT, V140, P1982, DOI 10.1017/S0950268811002688; Rasmussen TB, 2008, J VIROL METHODS, V149, P330, DOI 10.1016/j.jviromet.2008.01.029; Rasmussen TB, 2010, VET MICROBIOL, V142, P13, DOI 10.1016/j.vetmic.2009.09.037; Senne D. A., 1985, Proceedings of the United States Animal Health Association, V89, P29; SMITH GH, 1988, J VIROL METHODS, V19, P319, DOI 10.1016/0166-0934(88)90026-2; VILJOEN GJ, 1989, J GEN VIROL, V70, P2007, DOI 10.1099/0022-1317-70-8-2007	11	3	3	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2013	8	8							e70504	10.1371/journal.pone.0070504	http://dx.doi.org/10.1371/journal.pone.0070504			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	200UV	23950946	Green Submitted, gold, Green Published			2022-12-25	WOS:000323097300023
J	Zhang, W; Zhao, P; Xu, XL; Cai, L; Song, ZS; Cao, DY; Tao, KS; Zhou, WP; Chen, ZN; Dou, KF				Zhang, Wei; Zhao, Pu; Xu, Xiu-Li; Cai, Lei; Song, Zhen-Shun; Cao, Da-Yong; Tao, Kai-Shan; Zhou, Wen-Ping; Chen, Zhi-Nan; Dou, Ke-Feng			Annexin A2 Promotes the Migration and Invasion of Human Hepatocellular Carcinoma Cells In Vitro by Regulating the Shedding of CD147-Harboring Microvesicles from Tumor Cells	PLOS ONE			English	Article							METALLOPROTEINASE INDUCER EMMPRIN; ENHANCED EXPRESSION; CANCER; SURFACE; METASTASIS; ANGIOGENESIS; VESICLES; RECEPTOR; GROWTH; LINES	It has been reported that Annexin A2 (ANXA2) is up-regulated in hepatocellular carcinoma (HCC), but the roles of ANXA2 in the migration and invasion of HCC cells have not been determined. In this study, we found that ANXA2-specific siRNA (si-ANXA2) significantly inhibited the migration and invasion of HCC cells co-cultured with fibroblasts in vitro. In addition, the production of MMP-2 by fibroblasts cultured in supernatant collected from si-ANXA2-transfected HCC cells was notably down-regulated. ANXA2 was also found to be co-localized and co-immunoprecipitated with CD147. Further investigation revealed that the expression of ANXA2 in HCC cells affected the shedding of CD147-harboring membrane microvesicles, acting as a vehicle for CD147 in tumor-stromal interactions and thereby regulating the production of MMP-2 by fibroblasts. Together, these results suggest that ANXA2 enhances the migration and invasion potential of HCC cells in vitro by regulating the trafficking of CD147-harboring membrane microvesicles.	[Zhang, Wei; Cai, Lei; Song, Zhen-Shun; Cao, Da-Yong; Tao, Kai-Shan; Dou, Ke-Feng] Fourth Mil Med Univ, Dept Hepatobiliary Surg, Xijing Hosp, Xian 710032, Shaanxi Provinc, Peoples R China; [Zhang, Wei; Zhou, Wen-Ping] Gen Hosp Shenyang Mil Area Command, Dept Hepatobiliary Surg, Shenyang, Liaoning Provin, Peoples R China; [Zhao, Pu] Northeastern Univ, Coll Life & Hlth Sci, Shenyang, Liaoning Provin, Peoples R China; [Zhao, Pu; Chen, Zhi-Nan] Fourth Mil Med Univ, Cell Engn Res Ctr, Xian 710032, Shaanxi Provinc, Peoples R China; [Zhao, Pu; Chen, Zhi-Nan] Fourth Mil Med Univ, State Key Discipline Cell Univ, State Key Lab Canc Biol, Dept Cell Biol, Xian 710032, Shaanxi Provinc, Peoples R China; [Xu, Xiu-Li] Fourth Mil Med Univ, Xijing Hosp, Ctr Clin Lab Med Peoples Liberat Army, Xian 710032, Shaanxi Provinc, Peoples R China	Air Force Military Medical University; Northeastern University - China; Air Force Military Medical University; Air Force Military Medical University; Air Force Military Medical University	Zhou, WP (corresponding author), Gen Hosp Shenyang Mil Area Command, Dept Hepatobiliary Surg, Shenyang, Liaoning Provin, Peoples R China.	zhouwpsyzy@163.com; zhinanchen@fmmu.edu.cn; gdwkgwx@fmmu.edu.cn		Chen, Zhi-Nan/0000-0001-5512-4623	Dr. Start-up Fund of Liaoning Province, China [20121086]	Dr. Start-up Fund of Liaoning Province, China	This work was supported by grant 20121086 from Dr. Start-up Fund of Liaoning Province, China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BISWAS C, 1982, BIOCHEM BIOPH RES CO, V109, P1026, DOI 10.1016/0006-291X(82)92042-3; BISWAS C, 1995, CANCER RES, V55, P434; Brichory FM, 2001, P NATL ACAD SCI USA, V98, P9824, DOI 10.1073/pnas.171320598; Brownstein C, 2004, BLOOD, V103, P317, DOI 10.1182/blood-2003-04-1304; Chen Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040965; Egawa N, 2006, J BIOL CHEM, V281, P37576, DOI 10.1074/jbc.M606993200; FROHLICH M, 1990, MOL CELL BIOL, V10, P3216, DOI 10.1128/MCB.10.6.3216; Gerke V, 2005, NAT REV MOL CELL BIO, V6, P449, DOI 10.1038/nrm1661; Gerke V, 2002, PHYSIOL REV, V82, P331, DOI 10.1152/physrev.00030.2001; Ginestra A, 1998, ANTICANCER RES, V18, P3433; Hajjar KA, 1996, J BIOL CHEM, V271, P21652, DOI 10.1074/jbc.271.35.21652; Hastie C, 2008, J BIOL CHEM, V283, P12595, DOI 10.1074/jbc.M800189200; Heijnen HFG, 1999, BLOOD, V94, P3791, DOI 10.1182/blood.V94.11.3791.423a22_3791_3799; Hwang J, 2006, ATHEROSCLEROSIS, V189, P76, DOI 10.1016/j.atherosclerosis.2005.11.026; KEUTZER JC, 1990, EXP CELL RES, V188, P153, DOI 10.1016/0014-4827(90)90291-H; Liu JW, 2003, ONCOGENE, V22, P1475, DOI 10.1038/sj.onc.1206196; Lorusso A, 2006, EMBO J, V25, P5443, DOI 10.1038/sj.emboj.7601419; MASAKI T, 1994, HEPATOLOGY, V20, P425, DOI 10.1002/hep.1840200224; Millimaggi D, 2007, NEOPLASIA, V9, P349, DOI 10.1593/neo.07133; Mohammad HS, 2008, INT J ONCOL, V33, P1157, DOI 10.3892/ijo_00000105; Mussunoor S, 2008, J PATHOL, V216, P131, DOI 10.1002/path.2400; Pena-Alonso E, 2008, CANCER LETT, V263, P89, DOI 10.1016/j.canlet.2007.12.029; Sharma MC, 2007, CURR PHARM DESIGN, V13, P3568, DOI 10.2174/138161207782794167; Sharma MR, 2006, EXP MOL PATHOL, V81, P136, DOI 10.1016/j.yexmp.2006.03.002; Sharma MR, 2006, EXP MOL PATHOL, V81, P146, DOI 10.1016/j.yexmp.2006.03.003; Sidhu SS, 2004, ONCOGENE, V23, P956, DOI 10.1038/sj.onc.1207070; Singh P, 2007, CANCER LETT, V252, P19, DOI 10.1016/j.canlet.2006.11.012; Sun JX, 2001, CANCER RES, V61, P2276; Tang J, 2008, CELL MOL LIFE SCI, V65, P2933, DOI 10.1007/s00018-008-8315-8; Tang Y, 2004, MOL CANCER RES, V2, P73; Taraboletti G, 2002, AM J PATHOL, V160, P673, DOI 10.1016/S0002-9440(10)64887-0; Wu WG, 2002, CLIN EXP METASTAS, V19, P319, DOI 10.1023/A:1015515119300; Xu J, 2007, MOL CANCER RES, V5, P605, DOI 10.1158/1541-7786.MCR-06-0286; Yan L, 2005, THROMB HAEMOSTASIS, V93, P199, DOI 10.1160/TH04-08-0536; Zhao P, 2011, HEPATOLOGY, V54, P2012, DOI 10.1002/hep.24592; Zhao P, 2010, CANCER SCI, V101, P387, DOI 10.1111/j.1349-7006.2009.01420.x; Zheng L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019390; Zimmermann U, 2004, VIRCHOWS ARCH, V445, P368, DOI 10.1007/s00428-004-1103-4	38	48	55	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2013	8	8							e67268	10.1371/journal.pone.0067268	http://dx.doi.org/10.1371/journal.pone.0067268			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	200UV	23950866	Green Published, Green Submitted, gold			2022-12-25	WOS:000323097300005
J	Morgan, DR; Arrow, J; Smith, MP				Morgan, David R.; Arrow, Jane; Smith, Mark P.			Combining Aspirin with Cholecalciferol (Vitamin D-3) - A Potential New Tool for Controlling Possum Populations	PLOS ONE			English	Article							ACETYLSALICYLIC-ACID; INTRODUCED MAMMALS; CALCIUM-CARBONATE; BRUSHTAIL POSSUM; SALICYLIC-ACID; RODENT CONTROL; TISSUE FACTOR; NEW-ZEALAND; TROPONIN-I; PHARMACOKINETICS	The introduced Australian brushtail possum is a major vertebrate pest in New Zealand, with impacts on conservation and agriculture being managed largely through poisoning operations. Cholecalciferol (vitamin D-3) is registered for use in controlling possums and despite its many advantages it is expensive and relatively inhumane. Combination of a high proportion of aspirin with a low proportion of cholecalciferol was effective in killing high proportions of groups of acclimatised, caged possums: this is attributed to both an unexpectedly high toxicity of the type of cholecalciferol used, and a proposed synergistic mechanism between the two compounds. Death was caused by localised damage to heart ventricles by aspirin, and inhibition of tissue repair by both aspirin and cholecalciferol. The observed toxicosis had lower impact on the welfare of possums than either compound administered alone, particularly aspirin alone. Residue analyses of bait remains in the GI tract suggested a low risk of secondary poisoning by either compound. The combination of cholecalciferol and aspirin has the potential to meet key requirements of cost-effectiveness and humaneness in controlling possum populations, but the effect of the combination in non-target species has yet to be tested.	[Morgan, David R.; Arrow, Jane] Landcare Res, Canterbury, New Zealand; [Smith, Mark P.] Canterbury Dist Hlth Board, Canterbury, New Zealand	Landcare Research - New Zealand	Morgan, DR (corresponding author), Landcare Res, Canterbury, New Zealand.	morgand@landcareresearch.co.nz			Animal Health Board [R-10657, R-10657-01, R-10657-02]; Ministry of Business, Innovation and Employment [C09X1007]	Animal Health Board; Ministry of Business, Innovation and Employment(New Zealand Ministry of Business, Innovation and Employment (MBIE))	The research was funded by the Animal Health Board (grant numbers R-10657, R-10657-01, and R-10657-02), and the Foundation for Research, Science and Technology (now Ministry of Business, Innovation and Employment) (grant number C09X1007). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams JE, 1996, AM HEART J, V131, P308, DOI 10.1016/S0002-8703(96)90359-2; Agmon-Levin N, 2011, ANN RHEUM DIS, V70, P145, DOI 10.1136/ard.2010.134817; Aihara K, 2004, J BIOL CHEM, V279, P35798, DOI 10.1074/jbc.M404865200; Aktas B, 2005, J BIOL CHEM, V280, P39716, DOI 10.1074/jbc.M507762200; Andre P, 2003, CIRCULATION, V108, P2697, DOI 10.1161/01.CIR.0000093279.36628.12; [Anonymous], 2012, ANN REPORT 2011 12; [Anonymous], 2000, BRUSHTAIL POSSUM BIO; Atkinson IAE, 2001, BIOL CONSERV, V99, P81, DOI 10.1016/S0006-3207(00)00189-0; Beausoleil NJ, 2010, VERTEBRATE TOXIC AGE, P11; BEDFORD C, 1965, BRIT J PHARM CHEMOTH, V24, P418, DOI 10.1111/j.1476-5381.1965.tb01729.x; Berger JS, 2006, JAMA-J AM MED ASSOC, V295, P306, DOI 10.1001/jama.295.3.306; Bers DM, 2000, CIRC RES, V87, P275, DOI 10.1161/01.RES.87.4.275; Bikle DD, 2011, EXP DERMATOL, V20, P7, DOI 10.1111/j.1600-0625.2010.01202.x; BOYD EM, 1959, TOXICOL APPL PHARM, V1, P229, DOI 10.1016/0041-008X(59)90107-3; Bushinsky DA, 2010, CLIN J AM SOC NEPHRO, V5, pS12, DOI 10.2215/CJN.05970809; Butenas S, 2002, BIOCHEMISTRY-MOSCOW+, V67, P3; Carmeliet G, 2003, BEST PRACT RES CL EN, V17, P529, DOI 10.1016/j.beem.2003.08.001; Diehl KH, 2001, J APPL TOXICOL, V21, P15, DOI 10.1002/jat.727; Eason CT, 2010, INTEGR ZOOL, V5, P31, DOI 10.1111/j.1749-4877.2010.00183.x; EASON CT, 1993, NEW ZEAL J ZOOL, V20, P329, DOI 10.1080/03014223.1993.10420354; EASON CT, 1996, P 17 VERT PEST CONTR, P54; Eason CT, 2011, EUR VERT PEST MAN C, P146; EASON CT, 2001, VERTEBRATE PESTICIDE; *ERMA, 2007, REASS 1080; ETIEVENT JP, 1995, ANN THORAC SURG, V59, P1192, DOI 10.1016/0003-4975(95)00129-9; Fisher NG, 2001, EUR J HEART FAIL, V3, P373, DOI 10.1016/S1388-9842(01)00125-8; Franeta JT, 2002, FARMACO, V57, P709, DOI 10.1016/S0014-827X(02)01265-X; Glisson JK, 2011, SOUTH MED J, V104, P225, DOI 10.1097/SMJ.0b013e318205e548; Green W, 2011, J R SOC NZ, V42, P1, DOI [10.1080/03036758.2011.556130, DOI 10.1080/03036758.2011.556130.4.ERMA]; Hall JE., 2011, TXB MED PHYSL; Hennekens CH, 1997, CIRCULATION, V96, P2751, DOI 10.1161/01.CIR.96.8.2751; Hickman PE, 2010, CLIN CHIM ACTA, V411, P318, DOI 10.1016/j.cca.2009.12.009; Hiroyuki K, 1985, BIOCHEM PHARMACOL, V34, P1901, DOI [10.1016/0006-2952(85)90306-5, DOI 10.1016/0006-2952(85)90306-5]; Hix S, 2012, NEW ZEAL J AGR RES, V55, P207, DOI 10.1080/00288233.2012.665806; JOLLY SE, 1995, WILDLIFE RES, V22, P579, DOI 10.1071/WR9950579; JOLLY SE, 1993, PESTIC BIOCHEM PHYS, V47, P159, DOI 10.1006/pest.1993.1074; KATO Y, 1982, TOXICOL APPL PHARM, V64, P64, DOI 10.1016/0041-008X(82)90322-2; Kerins, 2002, COMP CLIN PATHOL, V11, P59, DOI DOI 10.1007/S580-002-8083-9; Koyama T, 1998, BLOOD, V92, P160, DOI 10.1182/blood.V92.1.160.413k16_160_167; Lanfranchi PA, 2002, AM J PHYSIOL-REG I, V283, pR815, DOI 10.1152/ajpregu.00051.2002; Liamis G, 2010, DRUG SAFETY, V33, P371, DOI 10.2165/11533790-000000000-00000; Littin KE, 2009, WILDLIFE RES, V36, P709, DOI 10.1071/WR09009; Manning EP, 2011, BIOCHEMISTRY-US, V50, P7405, DOI 10.1021/bi200506k; Marshall EF., 1984, P 11 VERT PEST C, P95; Mason G, 2003, ANIM WELFARE, V12, P1; Mauldin RE, 1999, J AOAC INT, V82, P792; Meerburg BG, 2008, PEST MANAG SCI, V64, P1205, DOI 10.1002/ps.1623; MOORE E W, 1970, Journal of Clinical Investigation, V49, P318, DOI 10.1172/JCI106241; MORGAN DR, 1981, NEW ZEAL J FOR SCI, V11, P271; Morgan DR, 2000, POSSUMS NZ BIOL IMPA, P143; Nadir MA, 2010, CARDIOVASC THER, V28, pe5, DOI 10.1111/j.1755-5922.2010.00192.x; NEEDS CJ, 1985, CLIN PHARMACOKINET, V10, P164, DOI 10.2165/00003088-198510020-00004; Nulton-Persson AC, 2004, J CARDIOVASC PHARM, V44, P591, DOI 10.1097/00005344-200411000-00012; O'Connor CE, 2003, LC0203158; Ohsawa M, 2000, CIRCULATION, V102, P2867; Parkes J, 2003, NEW ZEAL J ZOOL, V30, P335, DOI 10.1080/03014223.2003.9518346; Plum LA, 2010, NAT REV DRUG DISCOV, V9, P941, DOI 10.1038/nrd3318; Scragg R, 2011, VITAMIN D AND CANCER, P115, DOI 10.1007/978-1-4419-7188-3_6; Shaffer JF, 2010, PHYSIOL GENOMICS, V42, P406, DOI 10.1152/physiolgenomics.00055.2010; SHORT CR, 1991, J VET PHARMACOL THER, V14, P70, DOI 10.1111/j.1365-2885.1991.tb00806.x; Spyracopoulos L, 1997, BIOCHEMISTRY-US, V36, P12138, DOI 10.1021/bi971223d; Stenflo J, 2000, BBA-PROTEIN STRUCT M, V1477, P51, DOI 10.1016/S0167-4838(99)00262-9; TOMODA T, 1994, LIVER, V14, P103	63	6	6	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 9	2013	8	8							e70683	10.1371/journal.pone.0070683	http://dx.doi.org/10.1371/journal.pone.0070683			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	245OM	23950982	Green Published, Green Submitted, gold			2022-12-25	WOS:000326473200016
J	Barros, SP; Suruki, R; Loewy, ZG; Beck, JD; Offenbacher, S				Barros, Silvana P.; Suruki, Robert; Loewy, Zvi G.; Beck, James D.; Offenbacher, Steven			A Cohort Study of the Impact of Tooth Loss and Periodontal Disease on Respiratory Events among COPD Subjects: Modulatory Role of Systemic Biomarkers of Inflammation	PLOS ONE			English	Article							OBSTRUCTIVE PULMONARY-DISEASE; C-REACTIVE PROTEIN; DENTURE STOMATITIS; UNITED-STATES; ASSOCIATION; HEALTH; COMMUNITIES; PREVALENCE; PREVENTION; MANAGEMENT	Background: In COPD patients, fatal and non-fatal respiratory-related events are influenced by age, severity of respiratory disease, and comorbidities. Objectives: Analyze the effects of edentulism, periodontal disease and systemic biomarkers of inflammation on the occurrence of serious fatal and non-fatal respiratory-related events among subjects with COPD. Methods: Cases were identified from Dental Atherosclerosis Risk in Communities study. Edentulism was defined as study participants without any natural teeth or implants. Participants with one or more natural teeth (comprising 11,378 subjects) were studied as dentate subjects. Periodontal disease status among dentate individuals was determined using the consensus definitions published by the joint Center for Disease Control/American Association of Periodontology working group). Adjusted Hazard Models are developed to evaluate the relationship between edentulism/periodontal disease and COPD Related Events. Models were then stratified by GOLD Stage I, II and III/IV. Serum biomarkers were also evaluated to explore the effect of systemic inflammation. Results: A statistically significant association was found between oral health status and COPD-related events, even adjusting for conditions such as hypertension, smoking and diabetes. Edentulous individuals who had been diagnosed with COPD had a higher incidence and were at greater risk of having a COPD related event (hospitalization and death) than individuals who had teeth and whose mouths had healthy periodontal status. However, being edentulous did not convey excess risk for COPD-related events for those study participants who were classified as GOLD III/IV at baseline. Finally, we showed that individuals who had levels of serum IL-6 in the highest two quartiles were at even higher risk for COPD-related events. Conclusions: These findings suggest that the risk for COPD-related events after adjusting for potential confounders may be attributable to both edentulism and elevated serum IL-6 levels.	[Barros, Silvana P.; Offenbacher, Steven] Univ N Carolina, Sch Dent, Dept Periodontol, Chapel Hill, NC 27515 USA; [Suruki, Robert] GlaxoSmithKline R&D, Worldwide Epidemiol, Res Triangle Pk, NC USA; [Loewy, Zvi G.] GlaxoSmithKline Consumer Healthcare, Parsippany, NJ USA; [Beck, James D.] Univ N Carolina, Sch Dent, Dept Dent Ecol, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill; GlaxoSmithKline; GlaxoSmithKline; University of North Carolina; University of North Carolina Chapel Hill	Offenbacher, S (corresponding author), Univ N Carolina, Sch Dent, Dept Periodontol, Chapel Hill, NC 27515 USA.	steve_offenbacher@dentistry.unc.edu			GlaxoSmithKline	GlaxoSmithKline(GlaxoSmithKline)	This work was supported by a grant from GlaxoSmithKline. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agusti AGN, 2005, RESP MED, V99, P670, DOI 10.1016/j.rmed.2004.11.006; Andriankaja OM, 2009, J PERIODONTOL, V80, P307, DOI [10.1902/jop.2009.080385, 10.1902/jop.2009.080385 ]; ARENDORF TM, 1987, J ORAL REHABIL, V14, P217, DOI 10.1111/j.1365-2842.1987.tb00713.x; Azarpazhooh A, 2006, J PERIODONTOL, V77, P1465, DOI 10.1902/jop.2006.060010; Barros SP, 2012, OJST; Brown DW, 2010, COPD, V7, P59, DOI 10.3109/15412550903499548; BUDTZJORGENSEN E, 1975, COMMUNITY DENT ORAL, V3, P115, DOI 10.1111/j.1600-0528.1975.tb00291.x; Buist AS, 2007, LANCET, V370, P741, DOI 10.1016/S0140-6736(07)61377-4; Campos MS, 2008, ORAL MICROBIOL IMMUN, V23, P419, DOI 10.1111/j.1399-302X.2008.00445.x; Corbridge S, 2012, AM J NURS, V112, P46, DOI 10.1097/01.NAJ.0000412639.08764.21; Elter JR, 2006, AM HEART J, V151, DOI 10.1016/j.ahj.2005.10.002; Figueiral MH, 2007, J ORAL REHABIL, V34, P448, DOI 10.1111/j.1365-2842.2007.01709.x; Gan WQ, 2004, THORAX, V59, P574, DOI 10.1136/thx.2003.019588; Glass RT, 2010, J PROSTHET DENT, V103, P384, DOI 10.1016/S0022-3913(10)60083-2; Karadag F, 2008, EUR J INTERN MED, V19, P104, DOI 10.1016/j.ejim.2007.04.026; Koromantzos PA, 2012, J PERIODONTOL, V83, P3, DOI 10.1902/jop.2011.110148; Mannino DM, 2006, RESP MED, V100, P115, DOI 10.1016/j.rmed.2005.03.035; Offenbacher S, 2009, J PERIODONTOL, V80, P190, DOI [10.1902/jop.2009.080007, 10.1902/jop.2009.080007 ]; Preshaw PM, 2011, J DENT, V39, P711, DOI 10.1016/j.jdent.2011.08.018; Quirynen M, 2011, J CLIN PERIODONTOL, V38, P581, DOI 10.1111/j.1600-051X.2011.01728.x; Rabe KF, 2007, AM J RESP CRIT CARE, V176, P532, DOI 10.1164/rccm.200703-456SO; Scannapieco Frank A, 2003, Ann Periodontol, V8, P54, DOI 10.1902/annals.2003.8.1.54; Shulman JD, 2004, J AM DENT ASSOC, V135, P1279, DOI 10.14219/jada.archive.2004.0403; Sin DD, 2008, CHEST, V133, P4, DOI 10.1378/chest.07-2085; Zandvoort A, 2006, EUR RESPIR J, V28, P113, DOI 10.1183/09031936.06.00116205	25	40	41	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2013	8	8							e68592	10.1371/journal.pone.0068592	http://dx.doi.org/10.1371/journal.pone.0068592			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	201ER	23950871	Green Published, gold, Green Submitted			2022-12-25	WOS:000323124000003
J	Leon-Mimila, P; Villamil-Ramirez, H; Villalobos-Comparan, M; Villarreal-Molina, T; Romero-Hidalgo, S; Lopez-Contreras, B; Gutierrez-Vidal, R; Vega-Badillo, J; Jacobo-Albavera, L; Posadas-Romeros, C; Canizalez-Roman, A; Del Rio-Navarro, B; Campos-Perez, F; Acuna-Alonzo, V; Aguilar-Salinas, C; Canizales-Quinteros, S				Leon-Mimila, Paola; Villamil-Ramirez, Hugo; Villalobos-Comparan, Marisela; Villarreal-Molina, Teresa; Romero-Hidalgo, Sandra; Lopez-Contreras, Blanca; Gutierrez-Vidal, Roxana; Vega-Badillo, Joel; Jacobo-Albavera, Leonor; Posadas-Romeros, Carlos; Canizalez-Roman, Adrian; Del Rio-Navarro, Blanca; Campos-Perez, Francisco; Acuna-Alonzo, Victor; Aguilar-Salinas, Carlos; Canizales-Quinteros, Samuel			Contribution of Common Genetic Variants to Obesity and Obesity-Related Traits in Mexican Children and Adults	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; BODY-MASS INDEX; FTO GENE; MC4R; CHILDHOOD; RISK; LOCI; REPLICATION; POPULATIONS; MESTIZO	Background: Several studies have identified multiple obesity-associated loci mainly in European populations. However, their contribution to obesity in other ethnicities such as Mexicans is largely unknown. The aim of this study was to examine 26 obesity-associated single-nucleotide polymorphisms (SNP) in a sample of Mexican mestizos. Methods: 9 SNPs in biological candidate genes showing replications (PPARG, ADRB3, ADRB2, LEPR, GNB3, UCP3, ADIPOQ, UCP2, and NR3C1), and 17 SNPs in or near genes associated with obesity in first, second and third wave GWAS (INSIG2, FTO, MC4R, TMEM18, FAIM2/BCDIN3, BDNF, SH2B1, GNPDA2, NEGR1, KCTD15, SEC16B/RASAL2, NPC1, SFRF10/ETV5, MAF, PRL, MTCH2, and PTER) were genotyped in 1,156 unrelated Mexican-Mestizos including 683 cases (441 obese class I/II and 242 obese class III) and 473 normal-weight controls. In a second stage we selected 12 of the SNPs showing nominal associations with obesity, to seek associations with quantitative obesity-related traits in 3 cohorts including 1,218 Mexican Mestizo children, 945 Mexican Mestizo adults, and 543 Indigenous Mexican adults. Results: After adjusting for age, sex and admixture, significant associations with obesity were found for 6 genes in the case-control study (ADIPOQ, FTO, TMEM18, INSIG2, FAIM2/BCDIN3 and BDNF). In addition, SH2B1 was associated only with class I/II obesity and MC4R only with class III obesity. SNPs located at or near FAIM2/BCDIN3, TMEM18, INSIG2, GNPDA2 and SEC16B/RASAL2 were significantly associated with BMI and/or WC in the combined analysis of Mexican-mestizo children and adults, and FTO locus was significantly associated with increased BMI in Indigenous Mexican populations. Conclusions: Our findings replicate the association of 8 obesity-related SNPs with obesity risk in Mexican adults, and confirm the role of some of these SNPs in BMI in Mexican adults and children.	[Villamil-Ramirez, Hugo; Lopez-Contreras, Blanca; Gutierrez-Vidal, Roxana; Vega-Badillo, Joel; Canizales-Quinteros, Samuel] Univ Nacl Autonoma Mexico, Inst Nacl Med Genom INMEGEN, Fac Quim, Unidad Genom Poblac Aplicada Salud, Mexico City 04510, DF, Mexico; [Leon-Mimila, Paola; Villamil-Ramirez, Hugo; Gutierrez-Vidal, Roxana; Vega-Badillo, Joel; Canizales-Quinteros, Samuel] Inst Nacl Ciencias Med & Nutr Salvador Zubiran IN, Unidad Biol Mol & Med Genom, Mexico City, DF, Mexico; [Villalobos-Comparan, Marisela; Romero-Hidalgo, Sandra] INMEGEN, Dept Genom Computac, Mexico City, DF, Mexico; [Villarreal-Molina, Teresa; Jacobo-Albavera, Leonor] INMEGEN, Lab Enfermedades Cardiovasc, Mexico City, DF, Mexico; [Posadas-Romeros, Carlos] Inst Nacl Cardiol Ignacio Chavez INCICh, Dept Endocrinol, Mexico City, DF, Mexico; [Canizalez-Roman, Adrian] Univ Autonoma Sinaloa, Fac Med, Culiacan, Mexico; [Del Rio-Navarro, Blanca] Hosp Infantil Mexico Dr Federico Gomez, Dept Alergia & Inmunol Clin, Mexico City, DF, Mexico; [Campos-Perez, Francisco] Hosp Ruben Lenero, Clin Obesidad, Mexico City, DF, Mexico; [Acuna-Alonzo, Victor] Escuela Nacl Antropol & Hist, Mexico City, DF, Mexico; [Aguilar-Salinas, Carlos] INCMNSZ, Dept Endocrinol & Metabol, Mexico City, DF, Mexico	Instituto Nacional de Medicina Genomica; Universidad Nacional Autonoma de Mexico; Instituto Nacional de Medicina Genomica; Instituto Nacional de Medicina Genomica; National Institute of Cardiology - Mexico; Universidad Autonoma de Sinaloa; Hospital Infantil de Mexico Federico Gomez	Canizales-Quinteros, S (corresponding author), Univ Nacl Autonoma Mexico, Inst Nacl Med Genom INMEGEN, Fac Quim, Unidad Genom Poblac Aplicada Salud, Mexico City 04510, DF, Mexico.	cani@unam.mx	Canizalez-Roman, Adrian/B-7621-2019; Salinas, Carlos A Aguilar/AAL-4491-2020; Leon-Mimila, Paola/U-2375-2019; Aradillas Garcia, Celia/B-5830-2014	Canizalez-Roman, Adrian/0000-0001-8605-0639; Leon, Paola/0000-0001-6334-1492; Vega-Badillo, Joel/0000-0002-7110-6377; Jacobo-Albavera, Leonor/0000-0001-5129-8108; VILLARREAL MOLINA, TERESA/0000-0003-4450-7690; Aradillas Garcia, Celia/0000-0003-3643-6992; Romero-Hidalgo, Sandra/0000-0003-3077-7825	Consejo Nacional de Ciencia y Tecnologia (CONACyT) [11386]	Consejo Nacional de Ciencia y Tecnologia (CONACyT)(Consejo Nacional de Ciencia y Tecnologia (CONACyT))	This research was supported by grant 11386 from the Consejo Nacional de Ciencia y Tecnologia (CONACyT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bastarrachea RA, 2007, HUM BIOL, V79, P121, DOI 10.1353/hub.2007.0021; Bressler J, 2009, BMC MED GENET, V10, DOI 10.1186/1471-2350-10-56; Cai ZJ, 1999, WHO TECH REP SER, V887, P1; Canizales-Quinteros S, 2007, HUM BIOL, V79, P111, DOI 10.1353/hub.2007.0022; Cotsapas C, 2009, HUM MOL GENET, V18, P3502, DOI 10.1093/hmg/ddp292; Day FR, 2011, J NUTRIGENET NUTRIGE, V4, P222, DOI 10.1159/000332158; Dina C, 2007, NAT GENET, V39, P724, DOI 10.1038/ng2048; Dina C, 2007, SCIENCE, V315, DOI [10.1126/science.1129402, 10.1126/science.1130571, 10.1126/science.1130012]; Dorajoo R, 2012, INT J OBESITY, V36, P159, DOI 10.1038/ijo.2011.86; Farooqi IS, 2000, J CLIN INVEST, V106, P271, DOI 10.1172/JCI9397; Fleury C, 1997, NAT GENET, V15, P269, DOI 10.1038/ng0397-269; Flores-Dorantes T, 2010, CLIN CHIM ACTA, V411, P1214, DOI 10.1016/j.cca.2010.04.025; Frayling TM, 2007, SCIENCE, V316, P889, DOI 10.1126/science.1141634; Gray J, 2006, DANCING TIMES, V96, P55; Hardy R, 2010, HUM MOL GENET, V19, P545, DOI 10.1093/hmg/ddp504; Helgason A, 2007, NAT GENET, V39, P218, DOI 10.1038/ng1960; Herbert A, 2006, SCIENCE, V312, P279, DOI 10.1126/science.1124779; Hoggart CJ, 2004, AM J HUM GENET, V74, P965, DOI 10.1086/420855; Hoggart CJ, 2003, AM J HUM GENET, V72, P1492, DOI 10.1086/375613; Hotta K, 2008, J HUM GENET, V53, P857, DOI 10.1007/s10038-008-0317-8; Hotta K, 2008, J HUM GENET, V53, P546, DOI 10.1007/s10038-008-0283-1; Hotta K, 2009, J HUM GENET, V54, P727, DOI 10.1038/jhg.2009.106; Kelly T, 2008, INT J OBESITY, V32, P1431, DOI 10.1038/ijo.2008.102; Kuczmarski Robert J, 2002, Vital Health Stat 11, P1; Levy JC, 1998, DIABETES CARE, V21, P2191, DOI 10.2337/diacare.21.12.2191; Li SX, 2010, AM J CLIN NUTR, V91, P184, DOI 10.3945/ajcn.2009.28403; Li XH, 2006, OBESITY, V14, P1192, DOI 10.1038/oby.2006.136; Lohman T. G., 1998, ANTROPOMETRIC STANDA; Loos RJF, 2008, NAT GENET, V40, P768, DOI 10.1038/ng.140; Lyon HN, 2007, PLOS GENET, V3, DOI 10.1371/journal.pgen.0030061; Maes HH, 2007, BEHAV GENET, V27, P325; Mei H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031470; Mejia-Benitez A, 2013, BMC MED GENET, V14, DOI 10.1186/1471-2350-14-21; Meyre D, 2009, NAT GENET, V41, P157, DOI 10.1038/ng.301; Ng MCY, 2010, J CLIN ENDOCR METAB, V95, P2418, DOI 10.1210/jc.2009-2077; Rankinen T, 2006, OBESITY, V14, P529, DOI 10.1038/oby.2006.71; Renstrom F, 2009, HUM MOL GENET, V18, P1489, DOI 10.1093/hmg/ddp041; Rong R, 2009, DIABETES, V58, P478, DOI 10.2337/db08-0877; Rouskas K, 2012, OBESITY, V20, P389, DOI 10.1038/oby.2011.177; Sandholt CH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023531; Secretaria de Salud-Instituto Nacional de Salud Publica, 2012, ENC NAC SAL NUTR; Silva-Zolezzi I, 2009, P NATL ACAD SCI USA, V106, P8611, DOI 10.1073/pnas.0903045106; Stoddard P, 2011, SOC SCI MED, V73, P1635, DOI 10.1016/j.socscimed.2011.09.006; Thorleifsson G, 2009, NAT GENET, V41, P18, DOI 10.1038/ng.274; Villalobos-Comparan M, 2008, OBESITY, V16, P2296, DOI 10.1038/oby.2008.367; Villalobos-Comparan M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039037; Villarreal-Molina MT, 2007, DIABETES, V56, P1881, DOI 10.2337/db06-0905; Willer CJ, 2009, NAT GENET, V41, P25, DOI 10.1038/ng.287; Yamauchi T, 2001, NAT MED, V7, P941, DOI 10.1038/90984; Zeggini E, 2009, PHARMACOGENOMICS, V10, P191, DOI 10.2217/14622416.10.2.191	50	78	80	0	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2013	8	8							e70640	10.1371/journal.pone.0070640	http://dx.doi.org/10.1371/journal.pone.0070640			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	201ER	23950976	Green Submitted, Green Published, gold			2022-12-25	WOS:000323124000024
J	Xu, JY; Shi, HB; Ruth, M; Yu, HS; Lazar, L; Zou, BB; Yang, C; Wu, AG; Zhao, JS				Xu, Jiaying; Shi, Hongbo; Ruth, Magaye; Yu, Hongsheng; Lazar, Lissy; Zou, Baobo; Yang, Cui; Wu, Aiguo; Zhao, Jinshun			Acute Toxicity of Intravenously Administered Titanium Dioxide Nanoparticles in Mice	PLOS ONE			English	Article							INTRATRACHEAL INSTILLATION; PARTICLE-SIZE; RATS; INFLAMMATION; INHALATION; RESPONSES; ULTRAFINE	Background: With a wide range of applications, titanium dioxide (TiO2) nanoparticles (NPs) are manufactured worldwide in large quantities. Recently, in the field of nanomedicine, intravenous injection of TiO2 nanoparticulate carriers directly into the bloodstream has raised public concerns on their toxicity to humans. Methods: In this study, mice were injected intravenously with a single dose of TiO2 NPs at varying dose levels (0, 140, 300, 645, or 1387 mg/kg). Animal mortality, blood biochemistry, hematology, genotoxicity and histopathology were investigated 14 days after treatment. Results: Death of mice in the highest dose (1387 mg/kg) group was observed at day two after TiO2 NPs injection. At day 7, acute toxicity symptoms, such as decreased physical activity and decreased intake of food and water, were observed in the highest dose group. Hematological analysis and the micronucleus test showed no significant acute hematological or genetic toxicity except an increase in the white blood cell (WBC) count among mice 645 mg/kg dose group. However, the spleen of the mice showed significantly higher tissue weight/body weight (BW) coefficients, and lower liver and kidney coefficients in the TiO2 NPs treated mice compared to control. The biochemical parameters and histological tissue sections indicated that TiO2 NPs treatment could induce different degrees of damage in the brain, lung, spleen, liver and kidneys. However, no pathological effects were observed in the heart in TiO2 NPs treated mice. Conclusions: Intravenous injection of TiO2 NPs at high doses in mice could cause acute toxicity effects in the brain, lung, spleen, liver, and kidney. No significant hematological or genetic toxicity was observed.	[Xu, Jiaying] Ningbo Univ, Coll Sci & Technol, Fac Life Sci, Ningbo 315211, Zhejiang, Peoples R China; [Shi, Hongbo; Ruth, Magaye; Lazar, Lissy; Zou, Baobo; Zhao, Jinshun] Ningbo Univ, Dept Publ Hlth, Ningbo 315211, Zhejiang, Peoples R China; [Yu, Hongsheng] Ningbo Univ, Sch Med, Affiliated Hosp, Ningbo 315211, Zhejiang, Peoples R China; [Yang, Cui; Wu, Aiguo] Chinese Acad Sci, Key Lab Magnet Mat & Devices, Div Funct Mat & Nanodevices, Ningbo Inst Mat Technol & Engn NIMTE, Ningbo, Zhejiang, Peoples R China	Ningbo University; Ningbo University; Ningbo University; Chinese Academy of Sciences; Ningbo Institute of Materials Technology and Engineering, CAS	Zhao, JS (corresponding author), Ningbo Univ, Dept Publ Hlth, Ningbo 315211, Zhejiang, Peoples R China.	jinshunzhao@nbu.edu.cn	xu, jia/GSD-6347-2022; Wu, Aiguo/C-1837-2015; Wu, Aiguo/A-5414-2008	Wu, Aiguo/0000-0001-7200-8923; 	National Nature Science Foundation of China [81273111]; Foundations of Innovative Research Team of Educational Commission of Zhejiang Province [T200907]; Nature Science Foundation of Ningbo city [2012A610185]; Ningbo Scientific Project [SZX11073]; Scientific Innovation Team Project of Ningbo [2011B82014]; Innovative Research Team of Ningbo [2009B21002]; Ningbo University	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); Foundations of Innovative Research Team of Educational Commission of Zhejiang Province; Nature Science Foundation of Ningbo city; Ningbo Scientific Project; Scientific Innovation Team Project of Ningbo; Innovative Research Team of Ningbo; Ningbo University	This work was partly supported by the National Nature Science Foundation of China (Grant No.81273111), the Foundations of Innovative Research Team of Educational Commission of Zhejiang Province (T200907), the Nature Science Foundation of Ningbo city (Grant No.2012A610185), the Ningbo Scientific Project (SZX11073), the Scientific Innovation Team Project of Ningbo (no. 2011B82014), and Innovative Research Team of Ningbo (2009B21002). This work was partly supported by K.C. Wong Magna Fund in Ningbo University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bermudez E, 2004, TOXICOL SCI, V77, P347, DOI 10.1093/toxsci/kfh019; Chen JY, 2009, J APPL TOXICOL, V29, P330, DOI 10.1002/jat.1414; Fabian E, 2008, ARCH TOXICOL, V82, P151, DOI 10.1007/s00204-007-0253-y; FERIN J, 1992, AM J RESP CELL MOL, V6, P535, DOI 10.1165/ajrcmb/6.5.535; Grassian VH, 2007, ENVIRON HEALTH PERSP, V115, P397, DOI 10.1289/ehp.9469; Iavicoli I, 2011, EUR REV MED PHARMACO, V15, P481; Kisin ER, 2007, J TOXICOL ENV HEAL A, V70, P2071, DOI 10.1080/15287390701601251; Kutzing MK, 2008, J PHARMACOL EXP THER, V324, P1, DOI 10.1124/jpet.107.129031; Madhavan M, 1997, ATHEROSCLEROSIS, V131, P107, DOI 10.1016/S0021-9150(97)06088-7; OBERDORSTER G, 1994, ENVIRON HEALTH PERSP, V102, P173, DOI 10.2307/3432080; Park EJ, 2009, TOXICOLOGY, V260, P37, DOI 10.1016/j.tox.2009.03.005; Robertson TA, 2010, J BIOMED NANOTECHNOL, V6, P452, DOI 10.1166/jbn.2010.1145; Roursgaard M, 2011, THESCIENTIFICWORLDJO, V11, P801, DOI 10.1100/tsw.2011.67; Wang JX, 2007, TOXICOL LETT, V168, P176, DOI 10.1016/j.toxlet.2006.12.001; Warheit DB, 2007, TOXICOLOGY, V230, P90, DOI 10.1016/j.tox.2006.11.002; Wu JH, 2009, TOXICOL LETT, V191, P1, DOI 10.1016/j.toxlet.2009.05.020; Zhao JS, 2011, J TOXICOL ENV HEAL B, V14, P593, DOI 10.1080/10937404.2011.615113; Zhao JS, 2009, J TOXICOL ENV HEAL A, V72, P1141, DOI 10.1080/15287390903091764	18	76	80	0	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2013	8	8							e70618	10.1371/journal.pone.0070618	http://dx.doi.org/10.1371/journal.pone.0070618			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	201ER	23950972	Green Published, gold, Green Submitted			2022-12-25	WOS:000323124000023
J	de Vries, SPW; Eleveld, MJ; Hermans, PWM; Bootsma, HJ				de Vries, Stefan P. W.; Eleveld, Marc J.; Hermans, Peter W. M.; Bootsma, Hester J.			Characterization of the Molecular Interplay between Moraxella catarrhalis and Human Respiratory Tract Epithelial Cells	PLOS ONE			English	Article							SURFACE-PROTEINS A1; DISTINCT SUBPOPULATION; PHASE VARIATION; USPA1 PROTEIN; OTITIS-MEDIA; MECHANISM; PATHOGEN; LIPOOLIGOSACCHARIDE; COLONIZATION; ACTIVATION	Moraxella catarrhalis is a mucosal pathogen that causes childhood otitis media and exacerbations of chronic obstructive pulmonary disease in adults. During the course of infection, M. catarrhalis needs to adhere to epithelial cells of different host niches such as the nasopharynx and lungs, and consequently, efficient adhesion to epithelial cells is considered an important virulence trait of M. catarrhalis. By using Tn-seq, a genome-wide negative selection screenings technology, we identified 15 genes potentially required for adherence of M. catarrhalis BBH18 to pharyngeal epithelial Detroit 562 and lung epithelial A549 cells. Validation with directed deletion mutants confirmed the importance of aroA (3-phosphoshikimate 1-carboxyvinyl-transferase), ecnAB (entericidin EcnAB), lgt1 (glucosyltransferase), and MCR_1483 (outer membrane lipoprotein) for cellular adherence, with.MCR_1483 being most severely attenuated in adherence to both cell lines. Expression profiling of M. catarrhalis BBH18 during adherence to Detroit 562 cells showed increased expression of 34 genes in cell-attached versus planktonic bacteria, among which ABC transporters for molybdate and sulfate, while reduced expression of 16 genes was observed. Notably, neither the newly identified genes affecting adhesion nor known adhesion genes were differentially expressed during adhesion, but appeared to be constitutively expressed at a high level. Profiling of the transcriptional response of Detroit 562 cells upon adherence of M. catarrhalis BBH18 showed induction of a panel of pro-inflammatory genes as well as genes involved in the prevention of damage of the epithelial barrier. In conclusion, this study provides new insight into the molecular interplay between M. catarrhalis and host epithelial cells during the process of adherence.	[de Vries, Stefan P. W.; Eleveld, Marc J.; Hermans, Peter W. M.; Bootsma, Hester J.] Radboud Univ Nijmegen, Med Ctr, Lab Pediat Infect Dis, NL-6525 ED Nijmegen, Netherlands	Radboud University Nijmegen	Bootsma, HJ (corresponding author), Radboud Univ Nijmegen, Med Ctr, Lab Pediat Infect Dis, NL-6525 ED Nijmegen, Netherlands.	H.Bootsma@cukz.umc.nl	Eleveld, Marc J/J-9146-2016; Hermans, Peter W.M./H-8042-2014		Vienna Spot of Excellence (VSOE) grant [ID337956]	Vienna Spot of Excellence (VSOE) grant	This study was financially supported by Vienna Spot of Excellence (VSOE) grant (ID337956). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed K, 2000, MICROB PATHOGENESIS, V28, P203, DOI 10.1006/mpat.1999.0342; Bishop RE, 1998, J MOL BIOL, V280, P583, DOI 10.1006/jmbi.1998.1894; Bittner F, 2010, PLANT CELL MONOGR, V17, P119, DOI [10.1016/j.bbamcr.2006.03.013, 10.1007/978-3-642-10613-2_6]; Bootsma HJ, 2000, J INFECT DIS, V181, P1376, DOI 10.1086/315374; Brooks MJ, 2008, INFECT IMMUN, V76, P5330, DOI 10.1128/IAI.00573-08; Bullard B, 2005, INFECT IMMUN, V73, P5127, DOI 10.1128/IAI.73.8.5127-5136.2005; Burghout P, 2013, J BACTERIOL, V195, P1573, DOI 10.1128/JB.01942-12; de Vries SPW, 2013, MOL MICROBIOL, V87, P14, DOI 10.1111/mmi.12081; de Vries SPW, 2010, J BACTERIOL, V192, P3574, DOI 10.1128/JB.00121-10; de Vries SPW, 2009, MICROBIOL MOL BIOL R, V73, P389, DOI 10.1128/MMBR.00007-09; Dekkers LC, 1998, P NATL ACAD SCI USA, V95, P7051, DOI 10.1073/pnas.95.12.7051; DIXIT VM, 1990, J BIOL CHEM, V265, P2973; Edwards KJ, 2005, J BACTERIOL, V187, P2939, DOI 10.1128/JB.187.9.2939-2947.2005; Forsgren A, 2003, INFECT IMMUN, V71, P3302, DOI 10.1128/IAI.71.6.3302-3309.2003; Hassan F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037610; Hieshima K, 1997, J BIOL CHEM, V272, P5846, DOI 10.1074/jbc.272.9.5846; Hill DJ, 2003, MOL MICROBIOL, V48, P117, DOI 10.1046/j.1365-2958.2003.03433.x; Holm MM, 2004, INFECT IMMUN, V72, P1906, DOI 10.1128/IAI.72.4.1906-1913.2004; JANN A, 1990, MOL MICROBIOL, V4, P677, DOI 10.1111/j.1365-2958.1990.tb00637.x; Jenner RG, 2005, NAT REV MICROBIOL, V3, P281, DOI 10.1038/nrmicro1126; Krishnamurthy A, 2009, MICROBES INFECT, V11, P545, DOI 10.1016/j.micinf.2009.03.001; Lafontaine ER, 2000, J BACTERIOL, V182, P1364, DOI 10.1128/JB.182.5.1364-1373.2000; Lafontaine ER, 2001, J BACTERIOL, V183, P1540, DOI 10.1128/JB.183.5.1540-1551.2001; Luke NR, 2007, INFECT IMMUN, V75, P5559, DOI 10.1128/IAI.00946-07; Manolov T, 2008, AM J RESP CELL MOL, V38, P609, DOI 10.1165/rcmb.2007-0289OC; Meier PS, 2005, VACCINE, V23, P2000, DOI 10.1016/j.vaccine.2004.09.036; Meier PS, 2002, VACCINE, V20, P1754, DOI 10.1016/S0264-410X(02)00030-0; Mollenkvist A, 2003, J BACTERIOL, V185, P2285, DOI 10.1128/JB.185.7.2285-2295.2003; Molzen TE, 2011, INFECT IMMUN, V79, P288, DOI 10.1128/IAI.00631-10; Peng DX, 2005, INFECT IMMUN, V73, P7569, DOI 10.1128/IAI.73.11.7569-7577.2005; Peng RH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039579; Racz R, 2013, VACCINE, V31, P797, DOI 10.1016/j.vaccine.2012.11.066; Sabbagh SC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036643; Schutyser E, 2000, J IMMUNOL, V165, P4470, DOI 10.4049/jimmunol.165.8.4470; Senaratne RH, 2006, MOL MICROBIOL, V59, P1744, DOI 10.1111/j.1365-2958.2006.05075.x; Sethi S, 2008, NEW ENGL J MED, V359, P2355, DOI 10.1056/NEJMra0800353; Short KR, 2013, INFECT IMMUN, V81, P645, DOI 10.1128/IAI.01278-12; Slevogt H, 2006, AM J PHYSIOL-LUNG C, V290, pL818, DOI 10.1152/ajplung.00428.2005; Slevogt H, 2008, NAT IMMUNOL, V9, P1270, DOI 10.1038/ni.1661; Slevogt H, 2007, CELL MICROBIOL, V9, P694, DOI 10.1111/j.1462-5822.2006.00821.x; Spaniol V, 2008, MICROBES INFECT, V10, P3, DOI 10.1016/j.micinf.2007.09.014; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Su YC, 2012, FUTURE MICROBIOL, V7, P1073, DOI [10.2217/fmb.12.80, 10.2217/FMB.12.80]; Swamy M, 2011, NAT IMMUNOL, V12, P1131, DOI 10.1038/ni.2164; Tan TT, 2006, J INFECT DIS, V194, P493, DOI 10.1086/505581; Tan TT, 2005, J INFECT DIS, V192, P1029, DOI 10.1086/432759; Timpe JM, 2003, INFECT IMMUN, V71, P4341, DOI 10.1128/IAI.71.8.4341-4350.2003; van Opijnen T, 2009, NAT METHODS, V6, P767, DOI [10.1038/NMETH.1377, 10.1038/nmeth.1377]; Wirth T, 2007, GENOME RES, V17, P1647, DOI 10.1101/gr.6122607; Xie H, 2008, CELL MICROBIOL, V10, P1453, DOI 10.1111/j.1462-5822.2008.01138.x; Zomer A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043012	51	30	30	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2013	8	8							e72193	10.1371/journal.pone.0072193	http://dx.doi.org/10.1371/journal.pone.0072193			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	217ZG	23936538	Green Published, Green Submitted, gold			2022-12-25	WOS:000324401500088
J	Gleave, JA; Lerch, JP; Henkelman, RM; Nieman, BJ				Gleave, Jacqueline A.; Lerch, Jason P.; Henkelman, R. Mark; Nieman, Brian J.			A Method for 3D Immunostaining and Optical Imaging of the Mouse Brain Demonstrated in Neural Progenitor Cells	PLOS ONE			English	Article							TOMOGRAPHY; MICROSCOPY; LIGHT	It is important to understand changes in cell distribution that occur as a part of disease progression. This is typically achieved using standard sectioning and immunostaining, however, many structures and cell distribution patterns are not readily appreciated in two-dimensions, including the distribution of neural stem and progenitor cells in the mouse forebrain. Three-dimensional immunostaining in the mouse brain has been hampered by poor penetration. For this reason, we have developed a method that allows for entire hemispheres of the mouse brain to be stained using commercially available antibodies. Brains stained for glial fibrillary acidic protein, doublecortin and nestin were imaged in three-dimensions using optical projection tomography and serial two-photon tomography. This staining method is simple, using a combination of heat, time and specimen preparation procedures readily available, so that it can be easily implemented without the need for specialized equipment, making it accessible to most laboratories.	[Gleave, Jacqueline A.; Lerch, Jason P.; Henkelman, R. Mark; Nieman, Brian J.] Hosp Sick Children, Mouse Imaging Ctr, Toronto, ON M5G 1X8, Canada; [Gleave, Jacqueline A.] Univ Toronto, Dept Biol Sci, Toronto, ON, Canada; [Lerch, Jason P.; Henkelman, R. Mark; Nieman, Brian J.] Univ Toronto, Dept Med Biophys, Toronto, ON, Canada	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University of Toronto	Nieman, BJ (corresponding author), Hosp Sick Children, Mouse Imaging Ctr, 555 Univ Ave, Toronto, ON M5G 1X8, Canada.	bjnieman@mouseimaging.ca	HENKELMAN, MARK/W-6847-2019	Nieman, Brian/0000-0001-8914-3814	Ontario Institute for Cancer Research through Government of Ontario	Ontario Institute for Cancer Research through Government of Ontario	This work was supported by the Ontario Institute for Cancer Research through funding provided by the Government of Ontario. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alanentalo T, 2007, NAT METHODS, V4, P31, DOI 10.1038/NMETH985; Alanentalo T, 2008, J BIOMED OPT, V13, DOI 10.1117/1.3000430; Anderson GA, 2013, DEV DYNAM, V242, P527, DOI 10.1002/dvdy.23947; Becker K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033916; Chung K, 2013, NAT METHODS, V10, P508, DOI [10.1038/NMETH.2481, 10.1038/nmeth.2481]; Dodt HU, 2007, NAT METHODS, V4, P331, DOI 10.1038/NMETH1036; Doetsch F, 1997, J NEUROSCI, V17, P5046; Doetsch F, 1996, P NATL ACAD SCI USA, V93, P14895, DOI 10.1073/pnas.93.25.14895; Ellegood Jacob, 2012, Front Psychiatry, V3, P37, DOI 10.3389/fpsyt.2012.00037; Erturk A, 2012, NAT MED, V18, P166, DOI 10.1038/nm.2600; Gazdzinski LM, 2012, INT J RADIAT ONCOL, V84, pE631, DOI 10.1016/j.ijrobp.2012.06.053; Gleave JA, 2012, PHYSIOL GENOMICS, V44, P778, DOI 10.1152/physiolgenomics.00055.2012; Hama H, 2011, NAT NEUROSCI, V14, P1481, DOI 10.1038/nn.2928; Jahrling N, 2009, ORGANOGENESIS, V5, P227, DOI 10.4161/org.5.4.10403; Kamphuis W, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042823; Kumar V, 2010, BLOOD, V115, P4725, DOI 10.1182/blood-2009-10-250118; Lagace DC, 2007, J NEUROSCI, V27, P12623, DOI 10.1523/JNEUROSCI.3812-07.2007; Li AA, 2010, SCIENCE, V330, P1404, DOI 10.1126/science.1191776; Ragan T, 2012, NAT METHODS, V9, P255, DOI [10.1038/nmeth.1854, 10.1038/NMETH.1854]; Sharpe J, 2002, SCIENCE, V296, P541, DOI 10.1126/science.1068206; Sillitoe RV, 2002, J HISTOCHEM CYTOCHEM, V50, P235, DOI 10.1177/002215540205000211; Sled JG, 1998, IEEE T MED IMAGING, V17, P87, DOI 10.1109/42.668698; Tomer R, 2011, CURR OPIN GENET DEV, V21, P558, DOI 10.1016/j.gde.2011.07.003; Verveer PJ, 2007, NAT METHODS, V4, P311, DOI 10.1038/NMETH1017; Walls JR, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002853; Weninger WJ, 2006, ANAT EMBRYOL, V211, P213, DOI 10.1007/s00429-005-0073-x	26	34	36	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2013	8	8							e72039	10.1371/journal.pone.0072039	http://dx.doi.org/10.1371/journal.pone.0072039			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	217ZG	23936537	Green Published, gold, Green Submitted			2022-12-25	WOS:000324401500087
J	Bateman, HR; Liang, QL; Fan, DP; Rodriguez, V; Lessner, SM				Bateman, Henry R.; Liang, Qiaoli; Fan, Daping; Rodriguez, Vanessa; Lessner, Susan M.			Sparstolonin B Inhibits Pro-Angiogenic Functions and Blocks Cell Cycle Progression in Endothelial Cells	PLOS ONE			English	Article							CANCER CELLS; TUMOR; CHECKPOINTS; MECHANISMS; REGULATORS; APOPTOSIS; DISEASE; TISSUES; MITOSIS; GROWTH	Sparstolonin B (SsnB) is a novel bioactive compound isolated from Sparganium stoloniferum, an herb historically used in Traditional Chinese Medicine as an anti-tumor agent. Angiogenesis, the process of new capillary formation from existing blood vessels, is dysregulated in many pathological disorders, including diabetic retinopathy, tumor growth, and atherosclerosis. In functional assays, SsnB inhibited endothelial cell tube formation (Matrigel method) and cell migration (Transwell method) in a dose-dependent manner. Microarray experiments with human umbilical vein endothelial cells (HUVECs) and human coronary artery endothelial cells (HCAECs) demonstrated differential expression of several hundred genes in response to SsnB exposure (916 and 356 genes, respectively, with fold change >= 2, p<0.05, unpaired t-test). Microarray data from both cell types showed significant overlap, including genes associated with cell proliferation and cell cycle. Flow cytometric cell cycle analysis of HUVECs treated with SsnB showed an increase of cells in the G1 phase and a decrease of cells in the S phase. Cyclin E2 (CCNE2) and Cell division cycle 6 (CDC6) are regulatory proteins that control cell cycle progression through the G1/S checkpoint. Both CCNE2 and CDC6 were downregulated in the microarray data. Real Time quantitative PCR confirmed that gene expression of CCNE2 and CDC6 in HUVECs was downregulated after SsnB exposure, to 64% and 35% of controls, respectively. The data suggest that SsnB may exert its anti-angiogenic properties in part by downregulating CCNE2 and CDC6, halting progression through the G1/S checkpoint. In the chick chorioallantoic membrane (CAM) assay, SsnB caused significant reduction in capillary length and branching number relative to the vehicle control group. Overall, SsnB caused a significant reduction in angiogenesis (ANOVA, p<0.05), demonstrating its ex vivo efficacy.	[Bateman, Henry R.; Liang, Qiaoli; Fan, Daping; Lessner, Susan M.] Univ S Carolina, Sch Med, Dept Cell Biol & Anat, Columbia, SC 29208 USA; [Liang, Qiaoli] Nanjing Univ Chinese Med, Sch Pharm, Nanjing, Jiangsu, Peoples R China; [Rodriguez, Vanessa] South Carolina Governors Sch Sci & Math, Hartsville, SC USA	University of South Carolina; University of South Carolina System; University of South Carolina Columbia; Nanjing University of Chinese Medicine	Lessner, SM (corresponding author), Univ S Carolina, Sch Med, Dept Cell Biol & Anat, Columbia, SC 29208 USA.	susan.lessner@uscmed.sc.edu		Lessner, Susan/0000-0002-8409-5216	South Carolina Center of Biomaterials for Tissue Regeneration - COBRE Program [NIH P20 RR021949, GM103444-04]; South Carolina EPSCoR INBRE [NIH 2P20RR016461-10]; National Natural Science Foundation of China [81173515]; NIH [R01HL116626]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR016461, P20RR021949] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL116626] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103444] Funding Source: NIH RePORTER	South Carolina Center of Biomaterials for Tissue Regeneration - COBRE Program; South Carolina EPSCoR INBRE; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The project was funded by the following grants: South Carolina Center of Biomaterials for Tissue Regeneration - COBRE Program - (NIH P20 RR021949 and GM103444-04), Bioinformatics Pilot Project grant from the South Carolina EPSCoR INBRE (NIH 2P20RR016461-10), National Natural Science Foundation of China (81173515), NIH R01HL116626. The funding agencies had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Borlado LR, 2008, CARCINOGENESIS, V29, P237, DOI 10.1093/carcin/bgm268; Bussolino F, 1997, TRENDS BIOCHEM SCI, V22, P251, DOI 10.1016/S0968-0004(97)01074-8; Carmeliet P, 2003, NAT MED, V9, P653, DOI 10.1038/nm0603-653; Cude K, 2007, J CELL BIOL, V177, P253, DOI 10.1083/jcb.200609166; FOLKMAN J, 1971, NEW ENGL J MED, V285, P1182; Hsu WH, 2010, J SCI FOOD AGR, V90, P2709, DOI 10.1002/jsfa.4144; Huang B, 2008, ONCOGENE, V27, P218, DOI 10.1038/sj.onc.1210904; Johnson C, 2004, CIRC RES, V94, P262, DOI 10.1161/01.RES.0000111527.42357.62; Kwak HJ, 2006, INT J CANCER, V118, P2711, DOI 10.1002/ijc.21641; Liang QL, 2011, J BIOL CHEM, V286, P26470, DOI 10.1074/jbc.M111.227934; Liekens S, 2001, BIOCHEM PHARMACOL, V61, P253, DOI 10.1016/S0006-2952(00)00529-3; Liu FN, 2009, INT J CANCER, V125, P2511, DOI 10.1002/ijc.24588; Maxwell PH, 1999, NATURE, V399, P271, DOI 10.1038/20459; Meng H, 2010, ACS NANO, V4, P2773, DOI 10.1021/nn100448z; Meteoglu I, 2008, J EXP CLIN CANC RES, V27, DOI 10.1186/1756-9966-27-53; Nigg EA, 2001, NAT REV MOL CELL BIO, V2, P21, DOI 10.1038/35048096; O'Farrell PH, 2001, TRENDS CELL BIOL, V11, P512, DOI 10.1016/S0962-8924(01)02142-0; Pandya NM, 2006, VASC PHARMACOL, V44, P265, DOI 10.1016/j.vph.2006.01.005; Qiu C., 2008, PHARM CLIN CHINESE M, V14, P7; Risau W, 1997, NATURE, V386, P671, DOI 10.1038/386671a0; Rohde Luis E P, 2003, Semin Vasc Med, V3, P347; Scoditti E, 2012, ARCH BIOCHEM BIOPHYS, V527, P81, DOI 10.1016/j.abb.2012.05.003; Staton CA, 2009, INT J EXP PATHOL, V90, P195, DOI 10.1111/j.1365-2613.2008.00633.x; Sullivan M, 2007, NAT REV MOL CELL BIO, V8, P894, DOI 10.1038/nrm2276; TASSAN JP, 1994, J CELL BIOL, V127, P467, DOI 10.1083/jcb.127.2.467; Wang QO, 2011, PHARMACOL BIOCHEM BE, V98, P140, DOI 10.1016/j.pbb.2010.12.006; Wang Xin-hua, 2004, Yaoxue Xuebao, V39, P254; Wu Z, 2009, NEOPLASIA, V11, P66, DOI 10.1593/neo.81048; Xiong Y, 2009, ARCH PHARM RES, V32, P717, DOI 10.1007/s12272-009-1510-9	29	21	22	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2013	8	8							e70500	10.1371/journal.pone.0070500	http://dx.doi.org/10.1371/journal.pone.0070500			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	218XC	23940584	Green Published, gold, Green Submitted			2022-12-25	WOS:000324465000078
J	Chakraborty, A; Perales, MM; Reddy, GV; Roy-Chowdhury, AK				Chakraborty, Anirban; Perales, Mariano M.; Reddy, G. Venugopala; Roy-Chowdhury, Amit K.			Adaptive Geometric Tessellation for 3D Reconstruction of Anisotropically Developing Cells in Multilayer Tissues from Sparse Volumetric Microscopy Images	PLOS ONE			English	Article							TRACKING; GROWTH	The need for quantification of cell growth patterns in a multilayer, multi-cellular tissue necessitates the development of a 3D reconstruction technique that can estimate 3D shapes and sizes of individual cells from Confocal Microscopy (CLSM) image slices. However, the current methods of 3D reconstruction using CLSM imaging require large number of image slices per cell. But, in case of Live Cell Imaging of an actively developing tissue, large depth resolution is not feasible in order to avoid damage to cells from prolonged exposure to laser radiation. In the present work, we have proposed an anisotropic Voronoi tessellation based 3D reconstruction framework for a tightly packed multilayer tissue with extreme z-sparsity (2-4 slices/cell) and wide range of cell shapes and sizes. The proposed method, named as the 'Adaptive Quadratic Voronoi Tessellation' (AQVT), is capable of handling both the sparsity problem and the non-uniformity in cell shapes by estimating the tessellation parameters for each cell from the sparse data-points on its boundaries. We have tested the proposed 3D reconstruction method on time-lapse CLSM image stacks of the Arabidopsis Shoot Apical Meristem (SAM) and have shown that the AQVT based reconstruction method can correctly estimate the 3D shapes of a large number of SAM cells.	[Chakraborty, Anirban; Perales, Mariano M.; Reddy, G. Venugopala; Roy-Chowdhury, Amit K.] Univ Calif Riverside, Riverside, CA 92521 USA	University of California System; University of California Riverside	Roy-Chowdhury, AK (corresponding author), Univ Calif Riverside, Riverside, CA 92521 USA.	amitrc@ee.ucr.edu	perales, mariano/L-5412-2014	perales, mariano/0000-0002-7351-8439	National Science Foundation [IIS-0712253, IOS-1147250]	National Science Foundation(National Science Foundation (NSF))	This work is funded by National Science Foundation grant IIS-0712253 to Amit Roy-Chowdhury and NSF IOS-1147250 to Venugopala Gonehal Reddy. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aurenhammer F., 1999, HDB COMPUTATIONAL GE, P201; Bacarian T., 2005, IEEE COMP SOC C COMP, P142; Boissonnat J-D., 2006, EFFECTIVE COMPUTATIO, P67, DOI [10.1007/978-3-540-33259-6_2, DOI 10.1007/978-3-540-33259-6-2]; Chakraborty A, 2011, IEEE INT C BIOINFORM, P378, DOI 10.1109/BIBM.2011.123; Chan TF, 2001, IEEE T IMAGE PROCESS, V10, P266, DOI 10.1109/83.902291; DUBUISSON MP, 1994, INT C PATT RECOG, P566, DOI 10.1109/ICPR.1994.576361; Errington RJ, 1997, AM J PHYSIOL-CELL PH, V272, pC1040, DOI 10.1152/ajpcell.1997.272.3.C1040; EVANS DG, 1987, MATH GEOL, V19, P523, DOI 10.1007/BF00896918; Farinas J, 1997, J GEN PHYSIOL, V110, P283, DOI 10.1085/jgp.110.3.283; Fernandez R, 2010, NAT METHODS, V7, P547, DOI [10.1038/nmeth.1472, 10.1038/NMETH.1472]; Ferrero MMA, 2011, CORRABS11054246; Gor V, 2005, BIOINF GENOME REGUL; KAWAHARA K, 1994, JPN J PHYSIOL, V44, P411, DOI 10.2170/jjphysiol.44.411; Khachiyan LG, 1996, MATH OPER RES, V21, P307, DOI 10.1287/moor.21.2.307; Kumar P, 2005, J OPTIMIZ THEORY APP, V126, P1, DOI 10.1007/s10957-005-2653-6; Kwiatkowska D, 2009, J EXP BOT, V60, P3407, DOI 10.1093/jxb/erp176; Liu M, 2011, MOL PLANT, V4, P922, DOI 10.1093/mp/ssr071; Liu M, 2010, PLANT J, V62, P135, DOI 10.1111/j.1365-313X.2009.04117.x; Mjolsness E, 2006, J PLANT GROWTH REGUL, V25, P270, DOI 10.1007/s00344-006-0069-7; Mkrtchyan K., 2011, 2011 18th IEEE International Conference on Image Processing (ICIP 2011), P2165, DOI 10.1109/ICIP.2011.6116040; NAKAHARI T, 1990, AM J PHYSIOL, V258, pG878, DOI 10.1152/ajpgi.1990.258.6.G878; Okabe A., 2000, SPATIAL TESSELLATION, P43, DOI 10.1002/9780470317013.ch2; Tataw OM, 2010, IEEE IMAGE PROC, P3617, DOI 10.1109/ICIP.2010.5652018; VINCENT L, 1991, IEEE T PATTERN ANAL, V13, P583, DOI 10.1109/34.87344; Viola P, 1997, INT J COMPUT VISION, V24, P137, DOI 10.1023/A:1007958904918; Wyrzykowska J, 2003, P NATL ACAD SCI USA, V100, P5561, DOI 10.1073/pnas.0930352100; Yin ZZ, 2010, I S BIOMED IMAGING, P125, DOI 10.1109/ISBI.2010.5490399; ZHU QZ, 1994, ANAL QUANT CYTOL, V16, P145	29	11	11	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2013	8	8							e67202	10.1371/journal.pone.0067202	http://dx.doi.org/10.1371/journal.pone.0067202			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	218XC	23940509	Green Submitted, Green Published, gold			2022-12-25	WOS:000324465000003
J	Rajshankar, D; Sima, C; Wang, Q; Goldberg, SR; Kazembe, M; Wang, YQ; Glogauer, M; Downey, GP; McCulloch, CA				Rajshankar, Dhaarmini; Sima, Corneliu; Wang, Qin; Goldberg, Stephanie R.; Kazembe, Mwayi; Wang, Yongqiang; Glogauer, Michael; Downey, Gregory P.; McCulloch, Christopher A.			Role of PTP alpha in the Destruction of Periodontal Connective Tissues	PLOS ONE			English	Article							PROTEIN-TYROSINE-PHOSPHATASE; SRC-FAMILY KINASES; CATALYTIC DOMAINS; FOCAL ADHESIONS; INFLAMMATORY MEDIATORS; ENDOPLASMIC-RETICULUM; GINGIVAL FIBROBLASTS; KINETIC-ANALYSIS; FIBRONECTIN; EXPRESSION	IL-1 beta contributes to connective tissue destruction in part by up-regulating stromelysin-1 (MMP-3), which in fibroblasts is a focal adhesion-dependent process. Protein tyrosine phosphatase-a (PTP alpha) is enriched in and regulates the formation of focal adhesions, but the role of PTP alpha in connective tissue destruction is not defined. We first examined destruction of periodontal connective tissues in adult PTP alpha(+/+) and PTP alpha(-/-) mice subjected to ligature-induced periodontitis, which increases the levels of multiple cytokines, including IL-1 beta. Three weeks after ligation, maxillae were processed for morphometry, micro-computed tomography and histomorphometry. Compared with unligated controls, there was similar to 1.5-3 times greater bone loss as well as 3-fold reduction of the thickness of the gingival lamina propria and 20-fold reduction of the amount of collagen fibers in WT than PTP alpha(-/-) mice. Immunohistochemical staining of periodontal tissue showed elevated expression of MMP-3 at ligated sites. Second, to examine mechanisms by which PTP alpha may regulate matrix degradation, human MMP arrays were used to screen conditioned media from human gingival fibroblasts treated with vehicle, IL-1 beta or TNF alpha. Although MMP-3 was upregulated by both cytokines, only IL-1 beta stimulated ERK activation in human gingival fibroblasts plated on fibronectin. TIRF microscopy and immunoblotting analyses of cells depleted of PTP alpha activity with the use of various mutated constructs or with siRNA or PTP alpha(KO) and matched wild type fibroblasts were plated on fibronectin to enable focal adhesion formation and stimulated with IL-1 beta. These data showed that the catalytic and adaptor functions of PTP alpha were required for IL-1 beta-induced focal adhesion formation, ERK activation and MMP-3 release. We conclude that inflammation-induced connective tissue degradation involving fibroblasts requires functionally active PTP alpha and in part is mediated by IL-1 beta signaling through focal adhesions.	[Rajshankar, Dhaarmini; Sima, Corneliu; Wang, Qin; Goldberg, Stephanie R.; Kazembe, Mwayi; Wang, Yongqiang; Glogauer, Michael; McCulloch, Christopher A.] Univ Toronto, Fac Dent, Matrix Dynam Grp, Toronto, ON, Canada; [Downey, Gregory P.] Univ Colorado, Dept Med, Div Pulm & Crit Care Med, Natl Jewish Hlth, Denver, CO USA; [Downey, Gregory P.] Univ Colorado, Integrated Dept Immunol, Denver, CO 80202 USA	University of Toronto; National Jewish Health; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; University of Colorado System; University of Colorado Denver	Rajshankar, D (corresponding author), Univ Toronto, Fac Dent, Matrix Dynam Grp, Toronto, ON, Canada.	dhaarmini.rajshankar@utoronto.ca	Glogauer, Michael/D-2504-2011	Downey, Gregory P/0000-0003-3253-5862; Glogauer, Michael/0000-0002-6248-5977; Sima, Corneliu/0000-0003-3526-4850	Canadian Institute of Health Research (CIHR) [MOP-384254]; CIHR Team; National Institutes of Health/NHLBI [HL090669]; CIHR [TGF-53887]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL090669] Funding Source: NIH RePORTER	Canadian Institute of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); CIHR Team(Canadian Institutes of Health Research (CIHR)); National Institutes of Health/NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); CIHR(Canadian Institutes of Health Research (CIHR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This project was supported by a Canadian Institute of Health Research (CIHR) operating grant to CAM (MOP-384254) and by a CIHR Team grant to CAM and MG, and by an operating grant from the National Institutes of Health/NHLBI HL090669 to GPD. CAM is supported by a Canada Research Chair (Tier 1). SRG is supported by a CIHR Strategic Training Interdisciplinary Health Training Program grant (Cell Signals; TGF-53887). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abreu MTH, 2008, AM J PHYSIOL-CELL PH, V294, pC931, DOI 10.1152/ajpcell.00359.2007; Astolfi CM, 2006, J CLIN PERIODONTOL, V33, P699, DOI 10.1111/j.1600-051X.2006.00979.x; BIRKEDALHANSEN H, 1993, J PERIODONTAL RES, V28, P500, DOI 10.1111/j.1600-0765.1993.tb02113.x; Chen M, 2006, J BIOL CHEM, V281, P11972, DOI 10.1074/jbc.M600561200; DENHERTOG J, 1994, EMBO J, V13, P3020, DOI 10.1002/j.1460-2075.1994.tb06601.x; DENHERTOG J, 1993, EMBO J, V12, P3789, DOI 10.1002/j.1460-2075.1993.tb06057.x; Desban N, 2006, J CELL SCI, V119, P3206, DOI 10.1242/jcs.03057; DUNCAN MR, 1989, J INVEST DERMATOL, V92, P699, DOI 10.1111/1523-1747.ep12696891; GOLDRING MB, 1987, J RHEUMATOL, V14, P64; Harder KW, 1998, J BIOL CHEM, V273, P31890, DOI 10.1074/jbc.273.48.31890; Hassell T M, 1993, Periodontol 2000, V3, P9, DOI 10.1111/j.1600-0757.1993.tb00230.x; HavemosePoulsen A, 1997, CRIT REV ORAL BIOL M, V8, P217, DOI 10.1177/10454411970080020801; Herrera Abreu MT CPP, 2008, AM J PHYSL CELL PHYS; ILLC D, 1995, NATURE, V377, P539; Khoontawad J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045460; KRUEGER NX, 1990, EMBO J, V9, P3241, DOI 10.1002/j.1460-2075.1990.tb07523.x; Kubota T, 2008, J PERIODONTOL, V79, P166, DOI [10.1902/jop.2008.070159, 10.1902/jop.2008.070159 ]; Li CH, 2007, J PERIODONTOL, V78, P1120, DOI 10.1902/jop.2007.060320; Lim KL, 1997, EUR J BIOCHEM, V245, P693, DOI 10.1111/j.1432-1033.1997.00693.x; Lo YYC, 1998, J BIOL CHEM, V273, P7059, DOI 10.1074/jbc.273.12.7059; Lohinai Z, 1998, BRIT J PHARMACOL, V123, P353, DOI 10.1038/sj.bjp.0701604; MAURO LJ, 1994, TRENDS BIOCHEM SCI, V19, P151, DOI 10.1016/0968-0004(94)90274-7; McCulloch CA, 2006, NAT REV DRUG DISCOV, V5, P864, DOI 10.1038/nrd2109; Mustelin T, 2005, NAT REV IMMUNOL, V5, P43, DOI 10.1038/nri1530; Ohnishi T, 2010, J DENT RES, V89, P192, DOI 10.1177/0022034509353405; Pacios S, 2012, FASEB J, V26, P1423, DOI 10.1096/fj.11-196279; PAGE RC, 1991, J PERIODONTAL RES, V26, P230, DOI 10.1111/j.1600-0765.1991.tb01649.x; PAWSON T, 1995, NATURE, V373, P573, DOI 10.1038/373573a0; QWARNSTROM EE, 1988, J BIOL CHEM, V263, P8261; Rajshankar D, 2012, FASEB J, V26, P4429, DOI 10.1096/fj.12-207381; Saadi-Thiers K, 2013, J PERIODONTOL, V84, P396, DOI 10.1902/jop.2012.110540; SCHROEDER HE, 1973, ARCH ORAL BIOL, V18, P899, DOI 10.1016/0003-9969(73)90060-5; SINGER II, 1984, J CELL BIOL, V98, P2091, DOI 10.1083/jcb.98.6.2091; SINGER II, 1982, J CELL SCI, V56, P1; STASHENKO P, 1991, J PERIODONTOL, V62, P504, DOI 10.1902/jop.1991.62.8.504; Su J, 1999, CURR BIOL, V9, P505, DOI 10.1016/S0960-9822(99)80234-6; Tanabe SI, 2008, J CELL PHYSIOL, V216, P727, DOI 10.1002/jcp.21447; Vardar-Sengul S, 2009, J PERIODONTOL, V80, P833, DOI 10.1902/jop.2009.080483; Volberg T, 2001, J CELL SCI, V114, P2279; von Wichert G, 2003, J CELL BIOL, V161, P143, DOI 10.1083/jcb.200211061; Wang Q, 2009, J BIOL CHEM, P20763; Wang Q, 2006, J BIOL CHEM, V281, P31093, DOI 10.1074/jbc.M606392200; Wang Q, 2013, BIOCHEM J, V449, P771, DOI 10.1042/BJ20121170; Wang Q, 2010, J BIOL CHEM, V285, P22308, DOI 10.1074/jbc.M110.102426; Wang Q, 2009, J BIOL CHEM, V284, P20763, DOI 10.1074/jbc.M808828200; WANG Y, 1991, EMBO J, V10, P3231, DOI 10.1002/j.1460-2075.1991.tb04886.x; Wu L, 1997, J BIOL CHEM, V272, P6994, DOI 10.1074/jbc.272.11.6994; Zeng L, 2003, J CELL BIOL, V160, P137, DOI 10.1083/jcb.200206049; Zheng XM, 2000, EMBO J, V19, P964, DOI 10.1093/emboj/19.5.964; ZHENG XM, 1992, NATURE, V359, P336, DOI 10.1038/359336a0	50	12	12	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2013	8	8							e70659	10.1371/journal.pone.0070659	http://dx.doi.org/10.1371/journal.pone.0070659			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	218XC	23940616	Green Submitted, gold, Green Published			2022-12-25	WOS:000324465000110
J	Rzucidlo, JK; Roseman, PL; Laurienti, PJ; Dagenbach, D				Rzucidlo, Justyna K.; Roseman, Paige L.; Laurienti, Paul J.; Dagenbach, Dale			Stability of Whole Brain and Regional Network Topology within and between Resting and Cognitive States	PLOS ONE			English	Article							DEFAULT-MODE NETWORK; FUNCTIONAL CONNECTIVITY; FMRI DATA; CORTEX	Background: Graph-theory based analyses of resting state functional Magnetic Resonance Imaging (fMRI) data have been used to map the network organization of the brain. While numerous analyses of resting state brain organization exist, many questions remain unexplored. The present study examines the stability of findings based on this approach over repeated resting state and working memory state sessions within the same individuals. This allows assessment of stability of network topology within the same state for both rest and working memory, and between rest and working memory as well. Methodology/Principal Findings: fMRI scans were performed on five participants while at rest and while performing the 2-back working memory task five times each, with task state alternating while they were in the scanner. Voxel-based whole brain network analyses were performed on the resulting data along with analyses of functional connectivity in regions associated with resting state and working memory. Network topology was fairly stable across repeated sessions of the same task, but varied significantly between rest and working memory. In the whole brain analysis, local efficiency, Eloc, differed significantly between rest and working memory. Analyses of network statistics for the precuneus and dorsolateral prefrontal cortex revealed significant differences in degree as a function of task state for both regions and in local efficiency for the precuneus. Conversely, no significant differences were observed across repeated sessions of the same state. Conclusions/Significance: These findings suggest that network topology is fairly stable within individuals across time for the same state, but also fluid between states. Whole brain voxel-based network analyses may prove to be a valuable tool for exploring how functional connectivity changes in response to task demands.	[Rzucidlo, Justyna K.; Roseman, Paige L.; Dagenbach, Dale] Wake Forest Univ, Dept Psychol, Winston Salem, NC 27109 USA; [Laurienti, Paul J.] Wake Forest Univ, Bowman Gray Sch Med, Dept Radiol, Winston Salem, NC 27109 USA	Wake Forest University; Wake Forest University; Wake Forest Baptist Medical Center	Dagenbach, D (corresponding author), Wake Forest Univ, Dept Psychol, Winston Salem, NC 27109 USA.	dagenbac@wfu.edu			Internal institutional grants	Internal institutional grants	Internal institutional grants to the first and third author supported this research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baddeley A, 2010, CURR BIOL, V20, pR136, DOI 10.1016/j.cub.2009.12.014; BISWAL B, 1995, MAGNET RESON MED, V34, P537, DOI 10.1002/mrm.1910340409; Buckner RL, 2009, J NEUROSCI, V29, P1860, DOI 10.1523/JNEUROSCI.5062-08.2009; Bullmore ET, 2009, NAT REV NEUROSCI, V10, P186, DOI 10.1038/nrn2575; Cavanna AE, 2006, BRAIN, V129, P564, DOI 10.1093/brain/awl004; Eguiluz VM, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.018102; Fox MD, 2005, P NATL ACAD SCI USA, V102, P9673, DOI 10.1073/pnas.0504136102; Fransson P, 2008, NEUROIMAGE, V42, P1178, DOI 10.1016/j.neuroimage.2008.05.059; Gusnard DA, 2001, NAT REV NEUROSCI, V2, P685, DOI 10.1038/35094500; Hayasaka S, 2010, NEUROIMAGE, V50, P499, DOI 10.1016/j.neuroimage.2009.12.051; Latora V, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.198701; Maldjian JA, 2003, NEUROIMAGE, V19, P1233, DOI 10.1016/S1053-8119(03)00169-1; McKeown MJ, 1998, HUM BRAIN MAPP, V6, P368, DOI 10.1002/(SICI)1097-0193(1998)6:5/6<368::AID-HBM7>3.0.CO;2-E; Meindl T, 2010, HUM BRAIN MAPP, V31, P237, DOI 10.1002/hbm.20860; Miller EK, 2001, ANNU REV NEUROSCI, V24, P167, DOI 10.1146/annurev.neuro.24.1.167; Moussa MN, 2011, FRONT HUM NEUROSCI, V5, DOI 10.3389/fnhum.2011.00083; Pyka M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007198; Rubinov M, 2010, NEUROIMAGE, V52, P1059, DOI 10.1016/j.neuroimage.2009.10.003; Rypma B, 1999, P NATL ACAD SCI USA, V96, P6558, DOI 10.1073/pnas.96.11.6558; Schroter MS, 2012, J NEUROSCI, V32, P12832, DOI 10.1523/JNEUROSCI.6046-11.2012; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Sporns O, 2005, PLOS COMPUT BIOL, V1, P245, DOI 10.1371/journal.pcbi.0010042; Stevens AA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030468; Telesford Qawi K, 2010, Front Neuroinform, V4, P117, DOI 10.3389/fninf.2010.00117; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; Wang JH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021976; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918	27	27	27	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2013	8	8							e70275	10.1371/journal.pone.0070275	http://dx.doi.org/10.1371/journal.pone.0070275			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	218XC	23940554	Green Submitted, Green Published, gold			2022-12-25	WOS:000324465000048
J	Sewelam, N; Kazan, K; Thomas-Hall, SR; Kidd, BN; Manners, JM; Schenk, PM				Sewelam, Nasser; Kazan, Kemal; Thomas-Hall, Skye R.; Kidd, Brendan N.; Manners, John M.; Schenk, Peer M.			Ethylene Response Factor 6 Is a Regulator of Reactive Oxygen Species Signaling in Arabidopsis	PLOS ONE			English	Article							FINGER PROTEIN ZAT12; GENOME-WIDE ANALYSIS; TRANSCRIPTION FACTOR; OXIDATIVE STRESS; ABSCISIC-ACID; DISEASE RESISTANCE; CELL-DEATH; STOMATAL RESPONSES; DEFENSE RESPONSES; GENE-EXPRESSION	Reactive oxygen species (ROS) are produced in plant cells in response to diverse biotic and abiotic stresses as well as during normal growth and development. Although a large number of transcription factor (TF) genes are up-or down-regulated by ROS, currently very little is known about the functions of these TFs during oxidative stress. In this work, we examined the role of ERF6 (ETHYLENE RESPONSE FACTOR6), an AP2/ERF domain-containing TF, during oxidative stress responses in Arabidopsis. Mutant analyses showed that NADPH oxidase (RbohD) and calcium signaling are required for ROS-responsive expression of ERF6. erf6 insertion mutant plants showed reduced growth and increased H2O2 and anthocyanin levels. Expression analyses of selected ROS-responsive genes during oxidative stress identified several differentially expressed genes in the erf6 mutant. In particular, a number of ROS responsive genes, such as ZAT12, HSFs, WRKYs, MAPKs, RBOHs, DHAR1, APX4, and CAT1 were more strongly induced by H2O2 in erf6 plants than in wild-type. In contrast, MDAR3, CAT3, VTC2 and EX1 showed reduced expression levels in the erf6 mutant. Taken together, our results indicate that ERF6 plays an important role as a positive antioxidant regulator during plant growth and in response to biotic and abiotic stresses.	[Sewelam, Nasser; Thomas-Hall, Skye R.; Kidd, Brendan N.; Schenk, Peer M.] Univ Queensland, Sch Agr & Food Sci, Plant Microbe Interact Lab, Brisbane, Qld, Australia; [Kazan, Kemal; Kidd, Brendan N.; Manners, John M.] Commonwealth Sci & Ind Res Org Plant Ind, Queensland Biosci Precinct, Brisbane, Qld, Australia	University of Queensland; Commonwealth Scientific & Industrial Research Organisation (CSIRO)	Schenk, PM (corresponding author), Univ Queensland, Sch Agr & Food Sci, Plant Microbe Interact Lab, Brisbane, Qld, Australia.	p.schenk@uq.edu.au	Schenk, Peer/B-7879-2016; Manners, John M/A-4922-2008; Kidd, Brendan N/J-9672-2014; Kidd, Brendan N/D-9801-2017; Kazan, Kemal/B-8032-2008	Schenk, Peer/0000-0003-4878-3799; Kidd, Brendan N/0000-0003-1770-1404; Kazan, Kemal/0000-0002-5169-8934; Thomas-Hall, Skye/0000-0002-4208-5992	University of Queensland; Australian Research Council [DP1094749]; Egyptian Government (Ministry of Higher Education)	University of Queensland(University of Queensland); Australian Research Council(Australian Research Council); Egyptian Government (Ministry of Higher Education)(Ministry of Higher Education & Scientific Research (MHESR))	This work was supported by the University of Queensland, the Australian Research Council (DP1094749) and the Egyptian Government (Ministry of Higher Education). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AbuQamar S, 2006, PLANT J, V48, P28, DOI 10.1111/j.1365-313X.2006.02849.x; Achard P, 2008, CURR BIOL, V18, P656, DOI 10.1016/j.cub.2008.04.034; Anderson JP, 2004, PLANT CELL, V16, P3460, DOI 10.1105/tpc.104.025833; Apel K, 2004, ANNU REV PLANT BIOL, V55, P373, DOI 10.1146/annurev.arplant.55.031903.141701; Berridge MJ, 2000, NAT REV MOL CELL BIO, V1, P11, DOI 10.1038/35036035; Bowler C, 2000, TRENDS PLANT SCI, V5, P241, DOI 10.1016/S1360-1385(00)01628-9; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Danon A, 2005, PLANT J, V41, P68, DOI 10.1111/j.1365-313X.2004.02276.x; Davletova S, 2005, PLANT PHYSIOL, V139, P847, DOI 10.1104/pp.105.068254; Desmond OJ, 2008, MOL PLANT PATHOL, V9, P435, DOI 10.1111/J.1364-3703.2008.00475.X; Dombrecht B, 2007, PLANT CELL, V19, P2225, DOI 10.1105/tpc.106.048017; FEINBAUM RL, 1988, MOL CELL BIOL, V8, P1985, DOI 10.1128/MCB.8.5.1985; Finkelstein RR, 2000, PLANT CELL, V12, P599, DOI 10.1105/tpc.12.4.599; Foyer CH, 2009, ANTIOXID REDOX SIGN, V11, P861, DOI 10.1089/ars.2008.2177; Gadjev I, 2006, PLANT PHYSIOL, V141, P436, DOI 10.1104/pp.106.078717; Grant M, 2000, PLANT J, V23, P441, DOI 10.1046/j.1365-313x.2000.00804.x; Gudesblat GE, 2007, NEW PHYTOL, V173, P713, DOI 10.1111/j.1469-8137.2006.01953.x; Hellens RP, 2000, PLANT MOL BIOL, V42, P819, DOI 10.1023/A:1006496308160; HOSSAIN MA, 1984, PLANT CELL PHYSIOL, V25, P385; Jiang YQ, 2009, PLANT MOL BIOL, V69, P91, DOI 10.1007/s11103-008-9408-3; Joo JH, 2005, PLANT CELL, V17, P957, DOI 10.1105/tpc.104.029603; Kazan K, 2006, TRENDS PLANT SCI, V11, P109, DOI 10.1016/j.tplants.2006.01.004; Khandelwal A, 2008, PLANT PHYSIOL, V148, P2050, DOI 10.1104/pp.108.128488; Kollist T, 2007, PHYSIOL PLANTARUM, V129, P796, DOI 10.1111/j.1399-3054.2006.00851.x; Kwak JM, 2003, EMBO J, V22, P2623, DOI 10.1093/emboj/cdg277; Lamattina L, 2003, ANNU REV PLANT BIOL, V54, P109, DOI 10.1146/annurev.arplant.54.031902.134752; Lee JS, 2007, J BIOL CHEM, V282, P25020, DOI 10.1074/jbc.M701888200; Lee YJ, 2008, CURR OPIN PLANT BIOL, V11, P662, DOI 10.1016/j.pbi.2008.10.002; Libault M, 2007, MOL PLANT MICROBE IN, V20, P900, DOI 10.1094/MPMI-20-8-0900; Linster CL, 2007, J BIOL CHEM, V282, P18879, DOI 10.1074/jbc.M702094200; Liu YD, 2004, PLANT CELL, V16, P3386, DOI 10.1105/tpc.104.026609; Logemann E, 2006, PLANT METHODS, V2, DOI 10.1186/1746-4811-2-16; LONG SP, 1994, ANNU REV PLANT PHYS, V45, P633, DOI 10.1146/annurev.pp.45.060194.003221; Lorenzo O, 2003, PLANT CELL, V15, P165, DOI 10.1105/tpc.007468; Ma SS, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-4-r49; McGrath KC, 2005, PLANT PHYSIOL, V139, P949, DOI 10.1104/pp.105.068544; McNeal Rehrig E, 2010, THESIS U MISSOURI CO; Meng XZ, 2013, PLANT CELL, V25, P1126, DOI 10.1105/tpc.112.109074; Miao Y, 2007, PLANT CELL, V19, P819, DOI 10.1105/tpc.106.042705; Miller G, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000448; Mittler R, 2002, TRENDS PLANT SCI, V7, P405, DOI 10.1016/S1360-1385(02)02312-9; Mittler R, 2011, TRENDS PLANT SCI, V16, P300, DOI 10.1016/j.tplants.2011.03.007; Moffat CS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035995; Moller IM, 2007, ANNU REV PLANT BIOL, V58, P459, DOI 10.1146/annurev.arplant.58.032806.103946; Nakano T, 2006, PLANT PHYSIOL, V140, P411, DOI 10.1104/pp.105.073783; Navarro L, 2004, PLANT PHYSIOL, V135, P1113, DOI 10.1104/pp.103.036749; Noctor G, 2002, ANN BOT-LONDON, V89, P841, DOI 10.1093/aob/mcf096; Park JM, 2001, PLANT CELL, V13, P1035, DOI 10.1105/tpc.13.5.1035; Pitzschke A, 2009, MOL PLANT, V2, P120, DOI 10.1093/mp/ssn079; Pnueli L, 2003, PLANT J, V34, P187, DOI 10.1046/j.1365-313X.2003.01715.x; RABINO I, 1986, PLANT PHYSIOL, V81, P922, DOI 10.1104/pp.81.3.922; Rentel MC, 2004, NATURE, V427, P858, DOI 10.1038/nature02353; Riechmann JL, 1998, BIOL CHEM, V379, P633; Riechmann JL, 2000, SCIENCE, V290, P2105, DOI 10.1126/science.290.5499.2105; Rizhsky L, 2004, J BIOL CHEM, V279, P11736, DOI 10.1074/jbc.M313350200; Rossel JB, 2007, PLANT CELL, V19, P4091, DOI 10.1105/tpc.106.045898; Sagi M, 2006, PLANT PHYSIOL, V141, P336, DOI 10.1104/pp.106.078089; Scheel D, 1998, CURR OPIN PLANT BIOL, V1, P305, DOI 10.1016/1369-5266(88)80051-7; Scott B, 2008, CURR OPIN MICROBIOL, V11, P488, DOI 10.1016/j.mib.2008.10.008; Seki M, 2003, CURR OPIN BIOTECH, V14, P194, DOI 10.1016/S0958-1669(03)00030-2; Shetty NP, 2008, EUR J PLANT PATHOL, V121, P267, DOI 10.1007/s10658-008-9302-5; Smirnoff N, 1998, CURR OPIN BIOTECH, V9, P214, DOI 10.1016/S0958-1669(98)80118-3; Son GH, 2012, MOL PLANT MICROBE IN, V25, P48, DOI 10.1094/MPMI-06-11-0165; Stockinger EJ, 1997, P NATL ACAD SCI USA, V94, P1035, DOI 10.1073/pnas.94.3.1035; Suzuki N, 2011, CURR OPIN PLANT BIOL, V14, P691, DOI 10.1016/j.pbi.2011.07.014; Torres MA, 2005, CURR OPIN PLANT BIOL, V8, P397, DOI 10.1016/j.pbi.2005.05.014; Torres MA, 2006, PLANT PHYSIOL, V141, P373, DOI 10.1104/pp.106.079467; Vanderauwera S, 2005, PLANT PHYSIOL, V139, P806, DOI 10.1104/pp.105.065896; Wang PC, 2006, J INTEGR PLANT BIOL, V48, P62, DOI 10.1111/j.1744-7909.2006.00213.x; Wang PC, 2013, PLANT PHYSIOL, V161, P1392, DOI 10.1104/pp.112.210724; Wu AH, 2012, PLANT CELL, V24, P482, DOI 10.1105/tpc.111.090894; Xu J, 2008, J BIOL CHEM, V283, P26996, DOI 10.1074/jbc.M801392200; Zhu JK, 2002, ANNU REV PLANT BIOL, V53, P247, DOI 10.1146/annurev.arplant.53.091401.143329; Zimmermann P, 2004, PLANT PHYSIOL, V136, P2621, DOI 10.1104/pp.104.046367	75	103	104	4	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2013	8	8							e70289	10.1371/journal.pone.0070289	http://dx.doi.org/10.1371/journal.pone.0070289			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	218XC	23940555	Green Published, gold, Green Submitted			2022-12-25	WOS:000324465000049
J	Yao, C; Zhang, X; Bai, X; Liu, WY; Ma, Y; Tu, ZW				Yao, Cong; Zhang, Xin; Bai, Xiang; Liu, Wenyu; Ma, Yi; Tu, Zhuowen			Rotation-Invariant Features for Multi-Oriented Text Detection in Natural Images	PLOS ONE			English	Article							VIDEO; RECOGNITION; SPARSE; LOCALIZATION; EXTRACTION; CAPTION	Texts in natural scenes carry rich semantic information, which can be used to assist a wide range of applications, such as object recognition, image/video retrieval, mapping/navigation, and human computer interaction. However, most existing systems are designed to detect and recognize horizontal (or near-horizontal) texts. Due to the increasing popularity of mobile-computing devices and applications, detecting texts of varying orientations from natural images under less controlled conditions has become an important but challenging task. In this paper, we propose a new algorithm to detect texts of varying orientations. Our algorithm is based on a two-level classification scheme and two sets of features specially designed for capturing the intrinsic characteristics of texts. To better evaluate the proposed method and compare it with the competing algorithms, we generate a comprehensive dataset with various types of texts in diverse real-world scenes. We also propose a new evaluation protocol, which is more suitable for benchmarking algorithms for detecting texts in varying orientations. Experiments on benchmark datasets demonstrate that our system compares favorably with the state-of-the-art algorithms when handling horizontal texts and achieves significantly enhanced performance on variant texts in complex natural scenes.	[Yao, Cong; Bai, Xiang; Liu, Wenyu] Huazhong Univ Sci & Technol, Dept Elect & Informat Engn, Wuhan 430074, Peoples R China; [Zhang, Xin] Tsinghua Univ, Dept Comp Sci & Technol, Beijing 100084, Peoples R China; [Ma, Yi; Tu, Zhuowen] Microsoft Res Asia, Beijing, Peoples R China; [Tu, Zhuowen] Univ Calif Los Angeles, Los Angeles, CA USA	Huazhong University of Science & Technology; Tsinghua University; Microsoft; Microsoft Research Asia; University of California System; University of California Los Angeles	Bai, X (corresponding author), Huazhong Univ Sci & Technol, Dept Elect & Informat Engn, Wuhan 430074, Peoples R China.	xbai@hust.edu.cn	Liu, Wenyu/AAG-1426-2019	Liu, Wenyu/0000-0002-4582-7488	National Natural Science Foundation of China [61173120, 60903096, 61222308]; Ministry of Education of China [NCET-12-0217]; NSF CAREER award [IIS-0844566, NSF IIS-0844566]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Education of China(Ministry of Education, China); NSF CAREER award(National Science Foundation (NSF)NSF - Office of the Director (OD))	This work was supported by National Natural Science Foundation of China (grant No. 61173120, 60903096 and 61222308), and Ministry of Education of China project NCET-12-0217. ZT is supported by NSF CAREER award IIS-0844566 and NSF IIS-0844566. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABBYY, 2012, ABBYY MOB PROD; Belongie S, 2002, IEEE T PATTERN ANAL, V24, P509, DOI 10.1109/34.993558; Bosch A, 2007, P CIVR; Bouman KL, 2011, IEEE T MULTIMEDIA, V13, P922, DOI 10.1109/TMM.2011.2154317; Bradski GR, 1998, P IEEE WORKSH APPL C; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; CANNY J, 1986, IEEE T PATTERN ANAL, V8, P679, DOI 10.1109/TPAMI.1986.4767851; Chen DT, 2004, PATTERN RECOGN, V37, P595, DOI 10.1016/j.patcog.2003.06.001; Chen H, 2011, P ICIP; Chen X., 2004, P CVPR; Coates A, 2011, P ICDAR; Cu C., 2009, P CVPR; Dalal N., 2005, IEEE COMPUTER SOC C, DOI [DOI 10.1109/CVPR.2005.177, 10.1109/CVPR.2005.177]; DeSouza GN, 2002, IEEE T PATTERN ANAL, V24, P237, DOI 10.1109/34.982903; Elad M, 2006, IEEE T IMAGE PROCESS, V15, P3736, DOI 10.1109/TIP.2006.881969; Epshtein B, 2010, P CVPR; Everingham M, 2010, INT J COMPUT VISION, V88, P303, DOI 10.1007/s11263-009-0275-4; FREEMAN H, 1975, COMMUN ACM, V18, P409, DOI 10.1145/360881.360919; Friedman J., 2001, ELEMENTS STAT LEARNI, DOI DOI 10.1007/978-0-387-84858-7; Gllavata J, 2004, P ICPR; GVision, 2012, 3GVISIONS BUS CARD R; Hasan YMY, 2000, IEEE T IMAGE PROCESS, V9, P1978, DOI 10.1109/83.877220; Hua XS, 2004, IEEE T CIRC SYST VID, V14, P498, DOI 10.1109/TCSVT.2004.825538; Ikica A, 2011, P EUROCON; Jain AK, 1998, PATTERN RECOGN, V31, P2055, DOI 10.1016/S0031-3203(98)00067-3; Jung K, 2004, PATTERN RECOGN, V37, P977, DOI 10.1016/j.patcog.2003.10.012; Kim KI, 2003, IEEE T PATTERN ANAL, V25, P1631, DOI 10.1109/TPAMI.2003.1251157; Kisacanin B, 2005, REAL-TIME VISION FOR HUMAN-COMPUTER INTERACTION, P15, DOI 10.1007/0-387-27890-7_2; Lazebnik S., 2006, P IEEE INT C COMP VI, V2, P2169, DOI DOI 10.1109/CVPR.2006.68; Li HP, 2000, IEEE T IMAGE PROCESS, V9, P147, DOI 10.1109/83.817607; Liang J., 2005, International Journal on Document Analysis and Recognition, V7, P84, DOI 10.1007/s10032-004-0138-z; Lienhart R, 2002, IEEE T CIRC SYST VID, V12, P256, DOI 10.1109/76.999203; Liu XQ, 2012, IEEE T MULTIMEDIA, V14, P482, DOI 10.1109/TMM.2011.2177646; Liu YX, 2006, IEICE T INF SYST, VE89D, P1221, DOI 10.1093/ietisy/e89-d.3.1221; Lucas SM, 2005, P ICDAR; Lucas SM, 2003, P ICDAR; Lyu MR, 2005, IEEE T CIRC SYST VID, V15, P243, DOI 10.1109/TCSVT.2004.841653; Matas J, 2004, IMAGE VISION COMPUT, V22, P761, DOI 10.1016/j.imavis.2004.02.006; Minetto R, 2013, PATTERN RECOGNITION; Minetto R, 2010, PROC OF ICIP; Nagy R, 2011, CBDAR WORKSH ICDAR; Neumann L, 2010, P ACCV; Neumann L, 2011, P ICDAR; Neumann L., 2012, P CVPR; Pan W, 2009, P ICIP; Pan YF, 2011, IEEE T IMAGE PROCESS, V20, P800, DOI 10.1109/TIP.2010.2070803; Peng YG, 2012, IEEE T PATTERN ANAL, V34, P2233, DOI 10.1109/TPAMI.2011.282; Rijsbergen C.J.V, 1979, INFORM RETRIEVAL; Ruiz A, 2002, 8 INT WORKSH FRONT H; Shahab A, 2011, P ICDAR; Shechtman E, 2007, P CVPR; Shivakumara P, 2011, IEEE T PATTERN ANAL, V33, P412, DOI 10.1109/TPAMI.2010.166; Tsai S, 2011, P ICIP; Wang K., 2010, P ECCV, p[2, 4, 6]; Wang K, 2011, P ICCV; Wang X, 2011, P CVPR; Weinman J, 2004, P WMLSP; Wintone, 2012, TH OCR; Wolf C, 2006, INT J DOC ANAL RECOG, V8, P280, DOI 10.1007/s10032-006-0014-0; Wright J, 2009, IEEE T PATTERN ANAL, V31, P210, DOI 10.1109/TPAMI.2008.79; Wu V, 1997, P 2 ACM INT C DIG LI; Yao C, 2012, P CVPR; Yi Chucai, 2011, IEEE Trans Image Process, V20, P2594, DOI 10.1109/TIP.2011.2126586; Yi CC, 2012, IEEE T IMAGE PROCESS, V21, P4256, DOI 10.1109/TIP.2012.2199327; Zhang ZD, 2012, INT J COMPUT VISION, V99, P1, DOI 10.1007/s11263-012-0515-x; Zhao M, 2010, IMAGE VISION COMPUT, V28, P1590, DOI 10.1016/j.imavis.2010.04.002; Zhao X, 2011, IEEE T IMAGE PROCESS, V20, P790, DOI 10.1109/TIP.2010.2068553; ZHONG Y, 1995, PATTERN RECOGN, V28, P1523, DOI 10.1016/0031-3203(95)00030-4; Zhong Y, 2000, IEEE T PATTERN ANAL, V22, P385, DOI 10.1109/34.845381	69	3	4	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2013	8	8							e70173	10.1371/journal.pone.0070173	http://dx.doi.org/10.1371/journal.pone.0070173			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	218XC	23940544	Green Published, Green Submitted, gold			2022-12-25	WOS:000324465000038
J	Bella, SD; Bialunska, A; Sowinski, J				Bella, Simone Dalla; Bialunska, Anita; Sowinski, Jakub			Why Movement Is Captured by Music, but Less by Speech: Role of Temporal Regularity	PLOS ONE			English	Article							SENSORIMOTOR SYNCHRONIZATION; COORDINATION DYNAMICS; AUDITORY SEQUENCES; LINGUISTIC RHYTHM; PHASE ATTRACTION; ENTRAINMENT; BEAT; TIME; PERCEPTION; ENGLISH	Music has a pervasive tendency to rhythmically engage our body. In contrast, synchronization with speech is rare. Music's superiority over speech in driving movement probably results from isochrony of musical beats, as opposed to irregular speech stresses. Moreover, the presence of regular patterns of embedded periodicities (i.e., meter) may be critical in making music particularly conducive to movement. We investigated these possibilities by asking participants to synchronize with isochronous auditory stimuli (target), while music and speech distractors were presented at one of various phase relationships with respect to the target. In Exp. 1, familiar musical excerpts and fragments of children poetry were used as distractors. The stimuli were manipulated in terms of beat/stress isochrony and average pitch to achieve maximum comparability. In Exp. 2, the distractors were well-known songs performed with lyrics, on a reiterated syllable, and spoken lyrics, all having the same meter. Music perturbed synchronization with the target stimuli more than speech fragments. However, music superiority over speech disappeared when distractors shared isochrony and the same meter. Music's peculiar and regular temporal structure is likely to be the main factor fostering tight coupling between sound and movement.	[Bella, Simone Dalla] Univ Montpellier I, Movement Hlth Lab EuroMov, Montpellier, France; [Bella, Simone Dalla] Inst Univ France, Paris, France; [Bella, Simone Dalla; Bialunska, Anita; Sowinski, Jakub] Univ Finance & Management, Dept Cognit Psychol, Warsaw, Poland	Universite de Montpellier; Institut Universitaire de France; University of Finance & Management Warsaw	Bella, SD (corresponding author), Univ Montpellier I, Movement Hlth Lab EuroMov, Montpellier, France.	simone.dalla-bella@univ-montp1.fr		Dalla Bella, Simone/0000-0001-9813-7408; Sowinski, Jakub/0000-0002-8075-7120	European Commission [14847]	European Commission(European CommissionEuropean Commission Joint Research Centre)	Funding provided by International Reintegration Grant (n. 14847) from the European Commission. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abercrombie D., 1967, ELEMENTS GEN PHONETI; Arvaniti A, 2009, PHONETICA, V66, P46, DOI 10.1159/000208930; Aschersleben G, 2003, INT J PSYCHOPHYSIOL, V50, P157, DOI 10.1016/S0167-8760(03)00131-4; Aschersleben G, 2002, ATTENTION PERFORM, V19, P227; Aschersleben G, 2002, BRAIN COGNITION, V48, P66, DOI 10.1006/brcg.2001.1304; Benzon W, 2001, BEETHOVENS ANVIL MUS; Bergeson TR, 2006, MUSIC PERCEPT, V23, P345, DOI 10.1525/mp.2006.23.4.345; BISKUPSKA M, 1998, LATWE PIOSENKI FORTE, P20239; Boersma P., 1993, P I PHONETIC SCI, V17, P97; Boersma P., 2008, PRAAT DOING PHONETIC; BOLTZ M, 1986, COGNITIVE PSYCHOL, V18, P389, DOI 10.1016/0010-0285(86)90005-8; Brown S, 2000, ORIGINS OF MUSIC, P3; BRZECHWA J, 1980, BRZECHWA DZIECIOM, P20239; BUCK J, 1988, Q REV BIOL, V63, P265, DOI 10.1086/415929; BUCK J, 1968, SCIENCE, V159, P1319, DOI 10.1126/science.159.3821.1319; Chen JL, 2008, J COGNITIVE NEUROSCI, V20, P226, DOI 10.1162/jocn.2008.20018; Chen JL, 2006, NEUROIMAGE, V32, P1771, DOI 10.1016/j.neuroimage.2006.04.207; Cooper G., 1960, RHYTHMIC STRUCTURE M; Corriveau K, 2007, J SPEECH LANG HEAR R, V50, P647, DOI 10.1044/1092-4388(2007/046); Cummins F, 2009, PHONETICA, V66, P15, DOI 10.1159/000208928; Dalla Bella S, 2003, ANN NY ACAD SCI, V999, P166, DOI 10.1196/annals.1284.021; DAUER RM, 1983, J PHONETICS, V11, P51, DOI 10.1016/S0095-4470(19)30776-4; Dissanayake E, 2000, ORIGINS OF MUSIC, P389; Drake C, 2001, ANN NY ACAD SCI, V930, P17, DOI 10.1111/j.1749-6632.2001.tb05722.x; Drake C, 2000, COGNITION, V77, P251, DOI 10.1016/S0010-0277(00)00106-2; Ellis RJ, 2009, J EXP PSYCHOL HUMAN, V35, P264, DOI 10.1037/a0013482; Hannon EE, 2005, PSYCHOL SCI, V16, P48, DOI 10.1111/j.0956-7976.2005.00779.x; Hayes B, 1985, ADV NONLINEAR PHONOL, P59; Hove MJ, 2013, PSYCHOL RES-PSYCH FO, V77, P388, DOI 10.1007/s00426-012-0441-0; Hove MJ, 2009, SOC COGNITION, V27, P949, DOI 10.1521/soco.2009.27.6.949; Huss M, 2011, CORTEX, V47, P674, DOI 10.1016/j.cortex.2010.07.010; Jones M., 2009, OXFORD HDB MUSIC PSY, P81, DOI DOI 10.1093/OXFORDHB/9780199298457.013.0008; Jones M. R., 1993, PSYCHOL MUSIC UNDERS, P67; Jones Mari Riess, 2010, ATTENTION TIME, P317; Jones MR, 1997, CAN J EXP PSYCHOL, V51, P271, DOI 10.1037/1196-1961.51.4.271; JONES MR, 1987, PERCEPT PSYCHOPHYS, V41, P621, DOI 10.3758/BF03210494; Kelso JAS, 2002, J EXP PSYCHOL HUMAN, V28, P776, DOI 10.1037//0096-1523.28.4.776; Kirschner S, 2009, J EXP CHILD PSYCHOL, V102, P299, DOI 10.1016/j.jecp.2008.07.005; Large EW, 2002, COGNITIVE SCI, V26, P1, DOI 10.1207/s15516709cog2601_1; Large EW, 1999, PSYCHOL REV, V106, P119, DOI 10.1037/0033-295X.106.1.119; Lehiste I., 1977, J PHONET, V5, P253, DOI [DOI 10.1016/S0095-4470, 10.1016/S0095-4470]; Lerdahl F, 2001, ANN NY ACAD SCI, V930, P337, DOI 10.1111/j.1749-6632.2001.tb05743.x; Lerdahl F., 1983, GENERATIVE THEORY TO; Lerdahl Fred, 2003, COGNITIVE NEUROSCIEN, P413; LIBERMAN M, 1977, LINGUIST INQ, V8, P249; Lidji P, 2011, PSYCHON B REV, V18, P1035, DOI 10.3758/s13423-011-0163-0; London J., 2004, HEARING TIME; Marie C, 2011, J COGNITIVE NEUROSCI, V23, P294, DOI 10.1162/jocn.2010.21413; McDermott J, 2005, MUSIC PERCEPT, V23, P29, DOI 10.1525/mp.2005.23.1.29; McNeill W. H., 1995, KEEPING TOGETHER TIM; Merker B, 2000, ORIGINS OF MUSIC, P315; Merker BH, 2009, CORTEX, V45, P4, DOI 10.1016/j.cortex.2008.06.011; Mithen S, 2006, SINGING NEANDERTHALS; Morein-Zamir S, 2003, COGNITIVE BRAIN RES, V17, P154, DOI 10.1016/S0926-6410(03)00089-2; Muller Frank E., 1999, LANGUAGE TIME THE RH; Nettl B, 2000, ORIGINS OF MUSIC, P463; Patel A. D., 2008, MUSIC LANGUAGE BRAIN; Patel AD, 2005, EXP BRAIN RES, V163, P226, DOI 10.1007/s00221-004-2159-8; Patel AD, 2003, COGNITION, V87, pB35, DOI 10.1016/S0010-0277(02)00187-7; Patel AD, 2006, J ACOUST SOC AM, V119, P3034, DOI 10.1121/1.2179657; Patel AD, 2006, MUSIC PERCEPT, V24, P99, DOI 10.1525/mp.2006.24.1.99; Patel AD, 2009, CURR BIOL, V19, P827, DOI 10.1016/j.cub.2009.03.038; Peelle JE, 2012, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2012.00320; Phillips-Silver J, 2005, SCIENCE, V308, P1430, DOI 10.1126/science.1110922; Phillips-Silver J, 2011, NEUROPSYCHOLOGIA, V49, P961, DOI 10.1016/j.neuropsychologia.2011.02.002; Phillips-Silver J, 2010, MUSIC PERCEPT, V28, P3, DOI 10.1525/MP.2010.28.1.3; Pike K., 1945, INTONATION AM ENGLIS, DOI DOI 10.HTTPS://D0I.0RG/10.1111/J.1360-6441; Port RF, 2003, J PHONETICS, V31, P599, DOI 10.1016/j.wocn.2003.08.001; Pressing J, 1999, PSYCHOL REV, V106, P714, DOI 10.1037/0033-295X.106.4.714; Provasi JL, 2003, INT J BEHAV DEV, V27, P220, DOI 10.1080/01650250244000290; Ramus F, 1999, COGNITION, V73, P265, DOI 10.1016/S0010-0277(99)00058-X; Repp B. H., 2006, MUSIC MOTOR CONTROL, P55, DOI DOI 10.1093/ACPROF:OSO/9780199298723.003.0004; Repp BH, 2005, PSYCHON B REV, V12, P969, DOI 10.3758/BF03206433; Repp BH, 2006, ACTA PSYCHOL, V121, P81, DOI 10.1016/j.actpsy.2005.06.006; Repp BH, 2004, HUM MOVEMENT SCI, V23, P389, DOI 10.1016/j.humov.2004.08.014; Repp BH, 2004, PSYCHOL RES-PSYCH FO, V68, P252, DOI 10.1007/s00426-003-0143-8; Repp BH, 2003, J EXP PSYCHOL HUMAN, V29, P290, DOI 10.1037/0096-1523.29.2.290; Repp BH, 2002, J EXP PSYCHOL HUMAN, V28, P1085, DOI 10.1037//0096-1523.28.5.1085; Repp BH, 1998, J ACOUST SOC AM, V104, P1085, DOI 10.1121/1.423325; Roach P. J., 1982, LINGUISTIC CONTROVER, P73; Schachner A, 2009, CURR BIOL, V19, P831, DOI 10.1016/j.cub.2009.03.061; Selkirk Elisabeth, 1984, PHONOLOGY SYNTAX REL; Snyder J, 2001, MUSIC PERCEPT, V18, P455, DOI 10.1525/mp.2001.18.4.455; Sowinski J, 2013, NEUROPSYCHOLOGIA, V51, P1952, DOI 10.1016/j.neuropsychologia.2013.06.027; Stevens C., 2009, OXFORD HDB MUSIC PSY, P14; Tillmann B, 2007, MEM COGNITION, V35, P628, DOI 10.3758/BF03193301; TUWIM J, 1980, WIERSZE DLA DZIECI, P20239; Villing RC, 2011, ATTEN PERCEPT PSYCHO, V73, P1614, DOI 10.3758/s13414-011-0110-1; Vorberg D, 2002, J MATH PSYCHOL, V46, P56, DOI 10.1006/jmps.2001.1375; Vorberg D., 1996, HDB PERCEPT ACTION, P181, DOI [10.1016/S1874-5822(06)80007-1, DOI 10.1016/S1874-5822(06)80007-1, 10.1016/S1874-5822(06)80007-1.]; Wing AM, 2002, BRAIN COGNITION, V48, P7, DOI 10.1006/brcg.2001.1301; Winkler I, 2009, P NATL ACAD SCI USA, V106, P2468, DOI 10.1073/pnas.0809035106; Zanone PG, 1997, J EXP PSYCHOL HUMAN, V23, P1454, DOI 10.1037/0096-1523.23.5.1454; Zatorre RJ, 2007, NAT REV NEUROSCI, V8, P547, DOI 10.1038/nrn2152	94	17	17	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 2	2013	8	8							e71945	10.1371/journal.pone.0071945	http://dx.doi.org/10.1371/journal.pone.0071945			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	219XU	23936534	Green Published, gold, Green Submitted			2022-12-25	WOS:000324545800073
J	Verbruggen, H; Tyberghein, L; Belton, GS; Mineur, F; Jueterbock, A; Hoarau, G; Gurgel, CFD; De Clerck, O				Verbruggen, Heroen; Tyberghein, Lennert; Belton, Gareth S.; Mineur, Frederic; Jueterbock, Alexander; Hoarau, Galice; Gurgel, C. Frederico D.; De Clerck, Olivier			Improving Transferability of Introduced Species' Distribution Models: New Tools to Forecast the Spread of a Highly Invasive Seaweed	PLOS ONE			English	Article							ALGA CAULERPA-RACEMOSA; VAR. CYLINDRACEA; NICHE SHIFTS; CHLOROPHYTA; PREDICTION; BIAS; ORIGIN; RANGE; BRYOPSIDALES; CHALLENGES	The utility of species distribution models for applications in invasion and global change biology is critically dependent on their transferability between regions or points in time, respectively. We introduce two methods that aim to improve the transferability of presence-only models: density-based occurrence thinning and performance-based predictor selection. We evaluate the effect of these methods along with the impact of the choice of model complexity and geographic background on the transferability of a species distribution model between geographic regions. Our multifactorial experiment focuses on the notorious invasive seaweed Caulerpa cylindracea (previously Caulerpa racemosa var. cylindracea) and uses Maxent, a commonly used presence-only modeling technique. We show that model transferability is markedly improved by appropriate predictor selection, with occurrence thinning, model complexity and background choice having relatively minor effects. The data shows that, if available, occurrence records from the native and invaded regions should be combined as this leads to models with high predictive power while reducing the sensitivity to choices made in the modeling process. The inferred distribution model of Caulerpa cylindracea shows the potential for this species to further spread along the coasts of Western Europe, western Africa and the south coast of Australia.	[Verbruggen, Heroen] Univ Melbourne, Sch Bot, Parkville, Vic 3052, Australia; [Tyberghein, Lennert; De Clerck, Olivier] Univ Ghent, Phycol Res Grp, B-9000 Ghent, Belgium; [Tyberghein, Lennert] Flanders Marine Inst VLIZ, Oostende, Belgium; [Belton, Gareth S.; Gurgel, C. Frederico D.] Univ Adelaide, Sch Earth & Environm Sci, Adelaide, SA, Australia; [Mineur, Frederic] Aix Marseille Univ, MIO, Marseille, France; [Jueterbock, Alexander; Hoarau, Galice] Univ Nordland, Marine Ecol Grp, Bodo, Norway; [Gurgel, C. Frederico D.] South Australia State Herbarium, Dept Environm Water & Nat Resources, Adelaide, SA, Australia; [Gurgel, C. Frederico D.] South Australia Res & Dev Inst Aquat Sci, Henley Beach, SA, Australia	University of Melbourne; Ghent University; University of Adelaide; UDICE-French Research Universities; Aix-Marseille Universite; Nord University	Verbruggen, H (corresponding author), Univ Melbourne, Sch Bot, Parkville, Vic 3052, Australia.	heroen.verbruggen@gmail.com	De Clerck, Olivier/AAU-4295-2020; De Clerck, Olivier/ABC-2683-2020; Jueterbock, Alexander/Q-8639-2018; Verbruggen, Heroen/C-6951-2009; Mineur, Frederic/K-2743-2012; De Clerck, Olivier/A-9083-2010; Gurgel, Carlos Frederico Deluqui/E-6897-2014; Jueterbock, Alexander/ABH-4869-2020	De Clerck, Olivier/0000-0002-3699-8402; Jueterbock, Alexander/0000-0002-0659-3172; Verbruggen, Heroen/0000-0002-6305-4749; De Clerck, Olivier/0000-0002-3699-8402; Gurgel, Carlos Frederico Deluqui/0000-0002-7321-6115; Jueterbock, Alexander/0000-0002-0659-3172; Mineur, Frederic/0000-0001-7779-5903	Australian Research Council [FT110100585, LP0882109, LP0991083]; Research Foundation-Flanders; AXA Research Fund; Adelaide & Mt Lofty Ranges Natural Resource Management Board; Australian Census of Coral Reef Life; Australia Biological Research Study [ABRS 209-62]	Australian Research Council(Australian Research Council); Research Foundation-Flanders(FWO); AXA Research Fund(AXA Research Fund); Adelaide & Mt Lofty Ranges Natural Resource Management Board; Australian Census of Coral Reef Life; Australia Biological Research Study	Funding was provided by the Australian Research Council (FT110100585 to HV, LP0882109 and LP0991083 to CFDG), Research Foundation-Flanders, the AXA Research Fund (to FM), the Adelaide & Mt Lofty Ranges Natural Resource Management Board, the Australian Census of Coral Reef Life and the Australia Biological Research Study (ABRS 209-62 to CFDG). LT is a doctoral fellow of the Agency for Innovation by Science and Technology (IWT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acevedo P, 2012, J BIOGEOGR, V39, P1383, DOI 10.1111/j.1365-2699.2012.02713.x; Alexander JM, 2010, OIKOS, V119, P1377, DOI 10.1111/j.1600-0706.2009.17977.x; Alongi G, 1993, B ACCADEMIA GIOENIA, V26, P9; Araujo MB, 2006, J BIOGEOGR, V33, P1677, DOI 10.1111/j.1365-2699.2006.01584.x; Baldacconi R, 2009, MAR ECOL-EVOL PERSP, V30, P337, DOI 10.1111/j.1439-0485.2009.00282.x; Barve N, 2011, ECOL MODEL, V222, P1810, DOI 10.1016/j.ecolmodel.2011.02.011; Bean WT, 2012, ECOGRAPHY, V35, P250, DOI 10.1111/j.1600-0587.2011.06545.x; Bedia J, 2011, APPL VEG SCI, V14, P415, DOI 10.1111/j.1654-109X.2011.01128.x; Belton GS, 2013, J PHYCOL IN PRESS; Broennimann O, 2007, ECOL LETT, V10, P701, DOI 10.1111/j.1461-0248.2007.01060.x; Broennimann O, 2008, BIOL LETTERS, V4, P585, DOI 10.1098/rsbl.2008.0254; Buia MC, 1998, BIOL MAR MEDIT, V5, P527; Burnham K.P., 2002, MODEL SELECTION MULT, DOI 10.1007/b97636; Ceccherelli G, 2002, BOT MAR, V45, P71, DOI 10.1515/BOT.2002.009; Collings G, 2004, RD040169 S AUSTR RES; Cossu A, 1997, SOS CAULERPA INTRO N, P87; Djellouli AS, 2000, ACT 1 S MED VEG MAR, P124; Dormann CF, 2007, ECOGRAPHY, V30, P609, DOI 10.1111/j.2007.0906-7590.05171.x; Durand C, 2002, J EVOLUTION BIOL, V15, P122, DOI 10.1046/j.1420-9101.2002.00370.x; Elith J, 2011, DIVERS DISTRIB, V17, P43, DOI 10.1111/j.1472-4642.2010.00725.x; Elith J, 2010, METHODS ECOL EVOL, V1, P330, DOI 10.1111/j.2041-210X.2010.00036.x; Elith J, 2009, ANNU REV ECOL EVOL S, V40, P677, DOI 10.1146/annurev.ecolsys.110308.120159; Fielding AH, 1997, ENVIRON CONSERV, V24, P38, DOI 10.1017/S0376892997000088; Fitzpatrick MC, 2007, GLOBAL ECOL BIOGEOGR, V16, P24, DOI 10.1111/j.1466-8238.2006.00258.x; Franklin J, 2009, MAPPING SPECIES DIST; Gambi MC, 1998, BIOL MAR MEDIT, V5, P553; Giaccone G, 1995, BIOL MARINA MEDITERR, V2, P607; HANISAK MD, 1979, MAR BIOL, V50, P333, DOI 10.1007/BF00387010; Hastie T., 2009, UNSUPERVISED LEARNIN; Hijmans RJ, 2012, ECOLOGY, V93, P679, DOI 10.1890/11-0826.1; Huisman JM, 2000, MARINE PLANTS AUSTR; Infantes E, 2011, ESTUAR COAST SHELF S, V91, P434, DOI 10.1016/j.ecss.2010.11.005; Jimenez-Valverde A, 2011, BIOL INVASIONS, V13, P2785, DOI 10.1007/s10530-011-9963-4; Jimenez-Valverde A, 2012, GLOBAL ECOL BIOGEOGR, V21, P498, DOI 10.1111/j.1466-8238.2011.00683.x; Jousson O, 1998, MAR ECOL PROG SER, V172, P275, DOI 10.3354/meps172275; Katsanevakis S, 2010, AQUAT BIOL, V10, P57, DOI 10.3354/ab00267; Katsanevakis S, 2010, MAR ENVIRON RES, V70, P210, DOI 10.1016/j.marenvres.2010.05.003; Klein J, 2007, THESIS U AIX MARSEIL; Klein J, 2008, MAR POLLUT BULL, V56, P205, DOI 10.1016/j.marpolbul.2007.09.043; Kruzic P, 2008, CORAL REEFS, V27, P441, DOI 10.1007/s00338-008-0358-7; Lapointe BE, 2010, HARMFUL ALGAE, V9, P1, DOI 10.1016/j.hal.2009.06.001; Leathwick JR, 2001, ECOLOGY, V82, P2560, DOI 10.1890/0012-9658(2001)082[2560:CIBTSI]2.0.CO;2; Liu CR, 2005, ECOGRAPHY, V28, P385, DOI 10.1111/j.0906-7590.2005.03957.x; Lobban C.S., 1994, SEAWEED ECOLOGY PHYS; Lobo JM, 2008, GLOBAL ECOL BIOGEOGR, V17, P145, DOI 10.1111/j.1466-8238.2007.00358.x; Luning K, 1990, SEAWEEDS THEIR ENV B, P527; Maloney B, 2011, PHYCOLOGIA, V50, P132, DOI 10.2216/09-83.1; Medley KA, 2010, GLOBAL ECOL BIOGEOGR, V19, P122, DOI 10.1111/j.1466-8238.2009.00497.x; Meynard CN, 2013, J BIOGEOGR, V40, P1, DOI 10.1111/jbi.12006; Meynard CN, 2012, ECOGRAPHY, V35, P499, DOI 10.1111/j.1600-0587.2011.07157.x; Mineur F, 2010, P ROY SOC B-BIOL SCI, V277, P2693, DOI 10.1098/rspb.2010.0494; Nizamuddin M, 1991, GREEN MARINE ALGAE L; Nuber N, 2007, EUR J PHYCOL, V42, P113, DOI 10.1080/09670260600933774; Pena Martin C., 2003, Anales del Jardin Botanico de Madrid, V60, P448; Peterson AT, 2008, GLOBAL ECOL BIOGEOGR, V17, P135, DOI 10.1111/j.1466-8238.2007.00347.x; Peterson AT, 2003, Q REV BIOL, V78, P419, DOI 10.1086/378926; Petitpierre B, 2012, SCIENCE, V335, P1344, DOI 10.1126/science.1215933; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Phillips SJ, 2008, ECOGRAPHY, V31, P161, DOI 10.1111/j.0906-7590.2008.5203.x; Phillips SJ, 2009, ECOL APPL, V19, P181, DOI 10.1890/07-2153.1; Piazzi L, 1997, CRYPTOGAMIE ALGOL, V18, P343; PIAZZI L, 1994, CRYPTOGAMIE ALGOL, V15, P183; Piazzi L, 2005, CRYPTOGAMIE ALGOL, V26, P189; Piazzi L, 2001, MAR ECOL PROG SER, V210, P149, DOI 10.3354/meps210149; Piazzi L, 2009, BIOL INVASIONS, V11, P193, DOI 10.1007/s10530-008-9224-3; Piazzi L, 2006, ESTUAR COAST SHELF S, V68, P455, DOI 10.1016/j.ecss.2006.02.011; Randin CF, 2006, J BIOGEOGR, V33, P1689, DOI 10.1111/j.1365-2699.2006.01466.x; Reineking B, 2006, ECOL MODEL, V193, P675, DOI 10.1016/j.ecolmodel.2005.10.003; Ripley B, 2011, KERNSMOOTH; Robinson LM, 2011, GLOBAL ECOL BIOGEOGR, V20, P789, DOI 10.1111/j.1466-8238.2010.00636.x; Rodda GH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014670; Rodder D, 2011, GLOBAL ECOL BIOGEOGR, V20, P915, DOI 10.1111/j.1466-8238.2011.00659.x; Rodder D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007843; Rodder D, 2010, NATURWISSENSCHAFTEN, V97, P781, DOI 10.1007/s00114-010-0694-7; Rodder D, 2009, GLOBAL ECOL BIOGEOGR, V18, P674, DOI 10.1111/j.1466-8238.2009.00477.x; Royle JA, 2012, METHODS ECO IN PRESS; Santika T, 2009, ECOL MODEL, V220, P2365, DOI 10.1016/j.ecolmodel.2009.06.004; Sauvage T, 2013, PHYCOLOGIA, V52, P6, DOI 10.2216/11-116.1; SCHOENER TW, 1968, ECOLOGY, V49, P704, DOI 10.2307/1935534; Serio D, 1999, B ACCAD GIOENIA SCI, V31, P201; Soberon J, 2011, REV MEX BIODIVERS, V82, P1348; Sonder G, 1845, PH DR BOT ZEITUNG, V3, P49; Theil M, 2007, AQUAT BOT, V87, P221, DOI 10.1016/j.aquabot.2007.06.001; Tyberghein L, 2012, GLOBAL ECOL BIOGEOGR, V21, P272, DOI 10.1111/j.1466-8238.2011.00656.x; Vaclavik T, 2012, DIVERS DISTRIB, V18, P73, DOI 10.1111/j.1472-4642.2011.00854.x; Verbruggen H, 2011, MAXENT MODEL SURVEYO; Verbruggen H, 2011, OCCURRENCETHINNER 1; Verlaque M, 2000, BOT MAR, V43, P49, DOI 10.1515/BOT.2000.005; Verlaque M, 2004, BIOL INVASIONS, V6, P269, DOI 10.1023/B:BINV.0000034589.18347.d3; Verlaque M, 2003, EUR J PHYCOL, V38, P325, DOI 10.1080/09670260310001612592; Wand M. P., 1994, KERNEL SMOOTHING; Warren DL, 2011, ECOL APPL, V21, P335, DOI 10.1890/10-1171.1; Wenger SJ, 2012, METHODS ECOL EVOL, V3, P260, DOI 10.1111/j.2041-210X.2011.00170.x; Whitney KD, 2008, DIVERS DISTRIB, V14, P569, DOI 10.1111/j.1472-4642.2008.00473.x; Wiens JA, 2009, P NATL ACAD SCI USA, V106, P19729, DOI 10.1073/pnas.0901639106; Wiltshire KH, 2010, AQUATIC SCI; Wolmarans R, 2010, J BIOGEOGR, V37, P1797, DOI 10.1111/j.1365-2699.2010.02325.x; Womersley H., 1984, MARINE BENTHIC FLORA, P329; Zuljevic A, 2003, J MAR BIOL ASSOC UK, V83, P711, DOI 10.1017/S0025315403007689h; Zurell D, 2012, DIVERS DISTRIB, V18, P628, DOI 10.1111/j.1472-4642.2012.00887.x	100	73	85	1	66	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2013	8	6							e68337	10.1371/journal.pone.0068337	http://dx.doi.org/10.1371/journal.pone.0068337			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	174IH	23950789	Green Published, Green Submitted, Green Accepted, gold			2022-12-25	WOS:000321148400190
J	Cai, K; Frederick, RO; Kim, JH; Reinen, NM; Tonelli, M; Markley, JL				Cai, Kai; Frederick, Ronnie O.; Kim, Jin Hae; Reinen, Nichole M.; Tonelli, Marco; Markley, John L.			Human Mitochondrial Chaperone (mtHSP70) and Cysteine Desulfurase (NFS1) Bind Preferentially to the Disordered Conformation, Whereas Co-chaperone (HSC20) Binds to the Structured Conformation of the Iron-Sulfur Cluster Scaffold Protein (ISCU)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						ATPases; Chaperone Chaperonin; Enzyme Catalysis; Mitochondria; NMR; Protein Conformation; Protein-Protein Interactions; Scaffold Proteins; Spectroscopy	CRYSTAL-STRUCTURE; ASSEMBLY PROTEIN; BIOGENESIS; FRATAXIN; BIOSYNTHESIS; SUBSTRATE; MORTALIN; 2FE-2S; ISD11; FORM	Human ISCU is the scaffold protein for mitochondrial iron-sulfur (Fe-S) cluster biogenesis and transfer. NMR spectra have revealed that ISCU populates two conformational states; that is, a more structured state (S) and a partially disordered state (D). We identified two single amino acid substitutions (D39V and N90A) that stabilize the S-state and two (D39A and H105A) that stabilize the D-state. We isolated the two constituent proteins of the human cysteine desulfurase complex (NFS1 and ISD11) separately and used NMR spectroscopy to investigate their interaction with ISCU. We found that ISD11 does not interact directly with ISCU. By contrast, NFS1 binds preferentially to the D-state of ISCU as does the NFS1-ISD11 complex. An in vitro Fe-S cluster assembly assay showed that [2Fe-2S] and [4Fe-4S] clusters are assembled on ISCU when catalyzed by NFS1 alone and at a higher rate when catalyzed by the NFS1-ISD11 complex. The DnaK-type chaperone (mtHSP70) and DnaJ-type co-chaperone (HSC20) are involved in the transfer of clusters bound to ISCU to acceptor proteins in an ATP-dependent reaction. We found that the ATPase activity of mtHSP70 is accelerated by HSC20 and further accelerated by HSC20 plus ISCU. NMR studies have shown that mtHSP70 binds preferentially to the D-state of ISCU and that HSC20 binds preferentially to the S-state of ISCU.	[Cai, Kai; Frederick, Ronnie O.; Kim, Jin Hae; Reinen, Nichole M.; Markley, John L.] Univ Wisconsin, Ctr Eukaryot Struct Genom, Madison, WI 53706 USA; [Tonelli, Marco; Markley, John L.] Univ Wisconsin, Natl Magnet Resonance Facil Madison, Dept Biochem, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Markley, JL (corresponding author), Univ Wisconsin, Ctr Eukaryot Struct Genom, Madison, WI 53706 USA.	jmarkley@wisc.edu	Cai, Kai/J-7137-2019	Cai, Kai/0000-0002-4771-7450; Kim, Jin Hae/0000-0002-6776-2451	NIGMS, National Institutes of Health [U01 GM94622, 8P41 GM103399, 3R01GM058667-11S1]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR002301] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM058667, P41GM103399, U01GM094622] Funding Source: NIH RePORTER	NIGMS, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by NIGMS, National Institutes of Health Grants U01 GM94622 (Protein Structure Initiative: Biology, Mitochondrial Protein Partnership), 8P41 GM103399 (to the National Magnetic Resonance Facility at Madison, WI), and 3R01GM058667-11S1.	Adam AC, 2006, EMBO J, V25, P174, DOI 10.1038/sj.emboj.7600905; Agar JN, 2000, BIOCHEMISTRY-US, V39, P7856, DOI 10.1021/bi000931n; Bandyopadhyay S, 2008, BIOCHEM SOC T, V36, P1112, DOI 10.1042/BST0361112; Bitto E, 2008, J BIOL CHEM, V283, P30184, DOI 10.1074/jbc.M804746200; Blommel PG, 2007, BIOTECHNOL PROGR, V23, P585, DOI 10.1021/bp070011x; Blommel PG, 2006, PROTEIN EXPRES PURIF, V47, P562, DOI 10.1016/j.pep.2005.11.007; Bridwell-Rabb J, 2012, BIOCHEMISTRY-US, V51, P2506, DOI 10.1021/bi201628j; Burbulla LF, 2010, HUM MOL GENET, V19, P4437, DOI 10.1093/hmg/ddq370; Chandramouli K, 2006, BIOCHEMISTRY-US, V45, P11087, DOI 10.1021/bi061237w; Chylla RA, 2011, ANAL CHEM, V83, P4871, DOI 10.1021/ac200536b; Colin F, 2013, J AM CHEM SOC, V135, P733, DOI 10.1021/ja308736e; Cupp-Vickery JR, 2004, J MOL BIOL, V342, P1265, DOI 10.1016/j.jmb.2004.07.025; Cupp-Vickery JR, 2004, J MOL BIOL, V338, P127, DOI 10.1016/j.jmb.2004.02.027; Cupp-Vickery JR, 2003, J MOL BIOL, V330, P1049, DOI 10.1016/S0022-2836(03)00690-9; Cupp-Vickery JR, 2000, J MOL BIOL, V304, P835, DOI 10.1006/jmbi.2000.4252; Dai ZQ, 2012, BIOCHEMISTRY-US, V51, P9595, DOI 10.1021/bi301413y; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Deocaris CC, 2009, PROTEIN PEPTIDE LETT, V16, P517, DOI 10.2174/092986609788167770; Fontecave M, 2006, NAT CHEM BIOL, V2, P171, DOI 10.1038/nchembio0406-171; Fontecave M, 2008, ARCH BIOCHEM BIOPHYS, V474, P226, DOI 10.1016/j.abb.2007.12.014; Foster MW, 2000, J AM CHEM SOC, V122, P6805, DOI 10.1021/ja000800+; Frazzon J, 2003, CURR OPIN CHEM BIOL, V7, P166, DOI 10.1016/S1367-5931(03)00021-8; Goddard T. D., 2008, SPARKY VERSION 3 3; Goswami AV, 2010, J BIOL CHEM, V285, P19472, DOI 10.1074/jbc.M110.105957; Hoff KG, 2003, J BIOL CHEM, V278, P37582, DOI 10.1074/jbc.M305292200; Hoff KG, 2000, P NATL ACAD SCI USA, V97, P7790, DOI 10.1073/pnas.130201997; Johnson DC, 2005, ANNU REV BIOCHEM, V74, P247, DOI 10.1146/annurev.biochem.74.082803.133518; Kaul SC, 2007, EXP GERONTOL, V42, P263, DOI 10.1016/j.exger.2006.10.020; Kim JH, 2012, J BIOL CHEM, V287, P31406, DOI 10.1074/jbc.M112.352617; Kim JH, 2012, BIOCHEMISTRY-US, V51, P5557, DOI 10.1021/bi300579p; Kim JH, 2012, P NATL ACAD SCI USA, V109, P454, DOI 10.1073/pnas.1114372109; Kim JH, 2009, BIOCHEMISTRY-US, V48, P6062, DOI 10.1021/bi9002277; Klock Heath E., 2009, V498, P91, DOI 10.1007/978-1-59745-196-3_6; KNELLER DG, 1993, J CELL BIOCHEM, P254; Lill R, 2008, ANNU REV BIOCHEM, V77, P669, DOI 10.1146/annurev.biochem.76.052705.162653; Lill R, 2012, BBA-MOL CELL RES, V1823, P1491, DOI 10.1016/j.bbamcr.2012.05.009; Lill R, 2009, NATURE, V460, P831, DOI 10.1038/nature08301; Liu JY, 2005, PROTEINS, V59, P875, DOI 10.1002/prot.20421; Liu QL, 2001, J BIOL CHEM, V276, P6112, DOI 10.1074/jbc.M009519200; Markley JL, 2013, FEBS LETT, V587, P1172, DOI 10.1016/j.febslet.2013.01.003; Mochel F, 2008, AM J HUM GENET, V82, P652, DOI 10.1016/j.ajhg.2007.12.012; Murzin AG, 2008, SCIENCE, V320, P1725, DOI 10.1126/science.1158868; Perez-Iratxeta C, 2008, BMC STRUCT BIOL, V8, DOI 10.1186/1472-6807-8-25; Py B, 2010, NAT REV MICROBIOL, V8, P436, DOI 10.1038/nrmicro2356; Roche B, 2013, BBA-BIOENERGETICS, V1827, P455, DOI 10.1016/j.bbabio.2012.12.010; Rouault TA, 2012, DIS MODEL MECH, V5, P155, DOI 10.1242/dmm.009019; Schilke B, 2006, CURR BIOL, V16, P1660, DOI 10.1016/j.cub.2006.06.069; Schwartz CJ, 2000, P NATL ACAD SCI USA, V97, P9009, DOI 10.1073/pnas.160261497; Shan YX, 2012, HUM MOL GENET, V21, P1457, DOI 10.1093/hmg/ddr582; Shi R, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000354; Shi YB, 2009, HUM MOL GENET, V18, P3014, DOI 10.1093/hmg/ddp239; Shimomura Y, 2008, J MOL BIOL, V383, P133, DOI 10.1016/j.jmb.2008.08.015; Sreenath HK, 2005, PROTEIN EXPRES PURIF, V40, P256, DOI 10.1016/j.pep.2004.12.022; Tapley TL, 2004, J BIOL CHEM, V279, P28435, DOI 10.1074/jbc.M400803200; Tong WH, 2000, EMBO J, V19, P5692, DOI 10.1093/emboj/19.21.5692; Tong WH, 2006, CELL METAB, V3, P199, DOI 10.1016/j.cmet.2006.02.003; Tsai CL, 2010, BIOCHEMISTRY-US, V49, P9132, DOI 10.1021/bi1013062; Unciuleac MC, 2007, BIOCHEMISTRY-US, V46, P6812, DOI 10.1021/bi6026665; Vickery LE, 2007, CRIT REV BIOCHEM MOL, V42, P95, DOI 10.1080/10409230701322298; Voisine C, 2001, P NATL ACAD SCI USA, V98, P1483, DOI 10.1073/pnas.98.4.1483; Wadhwa R, 2002, CELL STRESS CHAPERON, V7, P309, DOI 10.1379/1466-1268(2002)007<0309:AHFCMM>2.0.CO;2; Wiedemann N, 2006, EMBO J, V25, P184, DOI 10.1038/sj.emboj.7600906; Xu XM, 2011, ANTIOXID REDOX SIGN, V15, P271, DOI 10.1089/ars.2010.3259; Zhao Qin, 2004, Journal of Structural and Functional Genomics, V5, P87, DOI 10.1023/B:JSFG.0000029205.65813.42	64	42	44	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 4	2013	288	40					28755	28770		10.1074/jbc.M113.482042	http://dx.doi.org/10.1074/jbc.M113.482042			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	298BL	23940031	Green Published, hybrid			2022-12-25	WOS:000330298800029
J	Derler, I; Plenk, P; Fahrner, M; Muik, M; Jardin, I; Schindl, R; Gruber, HJ; Groschner, K; Romanin, C				Derler, Isabella; Plenk, Peter; Fahrner, Marc; Muik, Martin; Jardin, Isaac; Schindl, Rainer; Gruber, Hermann J.; Groschner, Klaus; Romanin, Christoph			Region Combines Binding Interface and Gate for Orai1 Activation by STIM1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Calcium Channels; Calcium Intracellular Release; Calcium Signaling; Electrophysiology; Ion Channels	PROTEIN-PROTEIN INTERACTIONS; CRAC CHANNEL ACTIVATION; OPERATED CA2+ ENTRY; CRYSTAL-STRUCTURE; PLASMA-MEMBRANE; MOLECULAR DETERMINANTS; STORE; DOMAIN; PORE; ORGANIZATION	STIM1 and Orai1 represent the two molecular key components of the Ca2+ release-activated Ca2+ channels. Their activation involves STIM1 C terminus coupling to both the N terminus and the C terminus of Orai. Here we focused on the extended transmembrane Orai1 N-terminal (ETON, aa73-90) region, conserved among the Orai family forming an elongated helix of TM1 as recently shown by x-ray crystallography. To identify hot spot residues in the ETON binding interface for STIM1 interaction, numerous Orai1 constructs with N-terminal truncations or point mutations within the ETON region were generated. N-terminal truncations of the first four residues of the ETON region or beyond completely abolished STIM1-dependent Orai1 function. Loss of Orai1 function resulted from neither an impairment of plasma membrane targeting nor pore damage, but from a disruption of STIM1 interaction. In a complementary approach, we monitored STIM1-Orai interaction via Orai1 V102A by determining restored Ca2+ selectivity as a consequence of STIM1 coupling. Orai1 N-terminal truncations that led to a loss of function consistently failed to restore Ca2+ selectivity of Orai1 V102A in the presence of STIM1, demonstrating impairment of STIM1 binding. Hence, the major portion of the ETON region (aa76-90) is essential for STIM1 binding and Orai1 activation. Mutagenesis within the ETON region revealed several hydrophobic and basic hot spot residues that appear to control STIM1 coupling to Orai1 in a concerted manner. Moreover, we identified two basic residues, which protrude into the elongated pore to redound to Orai1 gating. We suggest that several hot spot residues in the ETON region contribute in aggregate to the binding of STIM1, which in turn is coupled to a conformational reorientation of the gate.	[Derler, Isabella; Plenk, Peter; Fahrner, Marc; Muik, Martin; Jardin, Isaac; Schindl, Rainer; Gruber, Hermann J.; Romanin, Christoph] Johannes Kepler Univ Linz, Inst Biophys, A-4020 Linz, Austria; [Groschner, Klaus] Med Univ Graz, Inst Biophys, A-8010 Graz, Austria	Johannes Kepler University Linz; Medical University of Graz	Derler, I (corresponding author), Johannes Kepler Univ Linz, Inst Biophys, Gruberstr 40, A-4020 Linz, Austria.	isabella.derler@jku.at; christoph.romanin@jku.at	Derler, Isabella/B-7871-2019; Schindl, Rainer/V-4205-2019; Groschner, Klaus/A-2550-2010; Jardin, Isaac/E-8310-2016; Romanin, Christoph/D-5399-2009; Gruber, Hermann J./C-4234-2013; Fahrner, Marc/AAI-7927-2021; Schindl, Rainer/E-3959-2013	Derler, Isabella/0000-0002-4768-146X; Groschner, Klaus/0000-0002-8659-377X; Jardin, Isaac/0000-0003-4575-8264; Romanin, Christoph/0000-0003-3756-4136; Fahrner, Marc/0000-0002-2689-0158; Schindl, Rainer/0000-0003-0896-8887	Austrian Science Fund (FWF) [P25210, P22747, P21925, P25172]; Austrian Research Promotion Agency (FFG, Austrian Nanoscience Initiative) [VO104-08-BI, 819703]; Austrian Science Fund (FWF) [M 1506, P 22747, P 25172, P 21925] Funding Source: researchfish	Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); Austrian Research Promotion Agency (FFG, Austrian Nanoscience Initiative); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This work was supported by the Austrian Science Fund (FWF Project P25210 to I. D., FWF Project P22747 to R. S., FWF Project P21925 to K. G., and FWF Project P25172 to C. R.) and the Austrian Research Promotion Agency (FFG, Austrian Nanoscience Initiative VO104-08-BI Project 819703 NSI-NABIOS to H. J. G).	Bergsmann J, 2011, J BIOL CHEM, V286, P31565, DOI 10.1074/jbc.M111.227546; Derler I, 2009, J BIOL CHEM, V284, P15903, DOI 10.1074/jbc.M808312200; Fahmer M, 2009, IMMUNOL REV, V231, P99, DOI 10.1111/j.1600-065X.2009.00815.x; Feske S, 2006, NATURE, V441, P179, DOI 10.1038/nature04702; Frischauf I, 2008, CHANNELS, V2, P261, DOI 10.4161/chan.2.4.6705; Frischauf I, 2009, J BIOL CHEM, V284, P21696, DOI 10.1074/jbc.M109.018408; Hou XW, 2012, SCIENCE, V338, P1308, DOI 10.1126/science.1228757; Keskin O, 2005, J MOL BIOL, V345, P1281, DOI 10.1016/j.jmb.2004.10.077; Keskin O, 2005, PHYS BIOL, V2, pS24, DOI 10.1088/1478-3975/2/2/S03; Korzeniowski MK, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2001122; Li ZZ, 2007, J BIOL CHEM, V282, P29448, DOI 10.1074/jbc.M703573200; Liou J, 2005, CURR BIOL, V15, P1235, DOI 10.1016/j.cub.2005.05.055; Lis A, 2010, J GEN PHYSIOL, V136, P673, DOI 10.1085/jgp.201010484; Liu YS, 2012, J BIOL CHEM, V287, P43030, DOI 10.1074/jbc.M112.380964; Luik RM, 2008, NATURE, V454, P538, DOI 10.1038/nature07065; Luik RM, 2006, J CELL BIOL, V174, P815, DOI 10.1083/jcb.200604015; McNally BA, 2013, J PHYSIOL-LONDON, V591, P2833, DOI 10.1113/jphysiol.2012.250456; McNally BA, 2012, NATURE, V482, P241, DOI 10.1038/nature10752; Moreira IS, 2013, BBA-PROTEINS PROTEOM, V1834, P404, DOI 10.1016/j.bbapap.2012.07.005; Muik M, 2008, J BIOL CHEM, V283, P8014, DOI 10.1074/jbc.M708898200; Muik M, 2011, EMBO J, V30, P1678, DOI 10.1038/emboj.2011.79; Muik M, 2009, J BIOL CHEM, V284, P8421, DOI 10.1074/jbc.C800229200; Navarro-Borelly L, 2008, J PHYSIOL-LONDON, V586, P5383, DOI 10.1113/jphysiol.2008.162503; Ozbabacan SEA, 2011, PROTEIN ENG DES SEL, V24, P635, DOI 10.1093/protein/gzr025; Park CY, 2009, CELL, V136, P876, DOI 10.1016/j.cell.2009.02.014; Perkins JR, 2010, STRUCTURE, V18, P1233, DOI 10.1016/j.str.2010.08.007; Prakriya M, 2006, NATURE, V443, P230, DOI 10.1038/nature05122; Raj M, 2013, BIOORGAN MED CHEM, V21, P4051, DOI 10.1016/j.bmc.2012.11.023; Roos J, 2005, J CELL BIOL, V169, P435, DOI 10.1083/jcb.200502019; Rothberg BS, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2003971; Schindl R, 2012, J BIOL CHEM, V287, P35612, DOI 10.1074/jbc.M112.400952; Singh A, 2006, NAT NEUROSCI, V9, P1108, DOI 10.1038/nn1751; Soboloff J, 2006, J BIOL CHEM, V281, P20661, DOI 10.1074/jbc.C600126200; Vig M, 2006, SCIENCE, V312, P1220, DOI 10.1126/science.1127883; Vig M, 2006, CURR BIOL, V16, P2073, DOI 10.1016/j.cub.2006.08.085; Zhang SYL, 2011, P NATL ACAD SCI USA, V108, P17838, DOI 10.1073/pnas.1114821108; Zhang SYL, 2005, NATURE, V437, P902, DOI 10.1038/nature04147; Zheng HY, 2013, J BIOL CHEM, V288, P11263, DOI 10.1074/jbc.M113.450254	38	84	85	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 4	2013	288	40					29025	29034		10.1074/jbc.M113.501510	http://dx.doi.org/10.1074/jbc.M113.501510			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	298BL	23943619	Green Published, hybrid			2022-12-25	WOS:000330298800056
J	Hill, DR; Rho, HK; Kessler, SP; Amin, R; Homer, CR; McDonald, C; Cowman, MK; de la Motte, CA				Hill, David R.; Rho, Hyunjin K.; Kessler, Sean P.; Amin, Ripal; Homer, Craig R.; McDonald, Christine; Cowman, Mary K.; de la Motte, Carol A.			Human Milk Hyaluronan Enhances Innate Defense of the Intestinal Epithelium	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cd44; Defensins; Epithelium; Host Defense; Hyaluronate; Toll-like Receptors (TLR); Salmonella Infection; Human Milk	MOLECULAR-WEIGHT HYALURONAN; IMMUNE-SYSTEM; BREAST; OLIGOSACCHARIDES; EXPRESSION; BETA-DEFENSIN-2; FRAGMENTS; ACID; CD44; PROTECTION	Breast-feeding is associated with enhanced protection from gastrointestinal disease in infants, mediated in part by an array of bioactive glycan components in milk that act through molecular mechanisms to inhibit enteric pathogen infection. Human milk contains hyaluronan (HA), a glycosaminoglycan polymer found in virtually all mammalian tissues. We have shown that synthetic HA of a specific size range promotes expression of antimicrobial peptides in intestinal epithelium. We hypothesize that hyaluronan from human milk also enhances innate antimicrobial defense. Here we define the concentration of HA in human milk during the first 6 months postpartum. Importantly, HA isolated from milk has a biological function. Treatment of HT-29 colonic epithelial cells with human milk HA at physiologic concentrations results in time- and dose-dependent induction of the antimicrobial peptide human -defensin 2 and is abrogated by digestion of milk HA with a specific hyaluronidase. Milk HA induction of human -defensin 2 expression is also reduced in the presence of a CD44-blocking antibody and is associated with a specific increase in ERK1/2 phosphorylation, suggesting a role for the HA receptor CD44. Furthermore, oral administration of human milk-derived HA to adult, wild-type mice results in induction of the murine H D2 ortholog in intestinal mucosa and is dependent upon both TLR4 and CD44 in vivo. Finally, treatment of cultured colonic epithelial cells with human milk HA enhances resistance to infection by the enteric pathogen Salmonella typhimurium. Together, our observations suggest that maternally provided HA stimulates protective antimicrobial defense in the newborn.	[Hill, David R.; McDonald, Christine; de la Motte, Carol A.] Cleveland Clin, Dept Mol Med, Cleveland, OH 44195 USA; [Hill, David R.; Rho, Hyunjin K.; Kessler, Sean P.; Amin, Ripal; Homer, Craig R.; McDonald, Christine; de la Motte, Carol A.] Cleveland Clin, Dept Pathobiol, Lerner Res Inst, Cleveland, OH 44195 USA; [Cowman, Mary K.] NYU, Polytech Inst, Dept Chem & Biol Sci, Brooklyn, NY 11201 USA	Cleveland Clinic Foundation; Cleveland Clinic Foundation; New York University; New York University Tandon School of Engineering	de la Motte, CA (corresponding author), Cleveland Clin, Dept Pathobiol, Lerner Res Inst, NC2, Cleveland, OH 44195 USA.	delamoc@ccf.org	Hill, David/H-9285-2019	Hill, David/0000-0002-1626-6079; McDonald, Christine/0000-0002-6745-9487	National Institutes of Health [HD061918, HL17147, R01DK82437]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD061918] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000439] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK082437] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants HD061918 and HL17147 (to C. A. de la M.) and R01DK82437 (to C. M.).	Aksamitiene E, 2007, ELECTROPHORESIS, V28, P3163, DOI 10.1002/elps.200700002; Anderson JW, 1999, AM J CLIN NUTR, V70, P525; Angeloni S, 2005, GLYCOBIOLOGY, V15, P31, DOI 10.1093/glycob/cwh143; Arnett E, 2011, CELL MICROBIOL, V13, P635, DOI 10.1111/j.1462-5822.2010.01563.x; Asakuma S, 2011, J BIOL CHEM, V286, P34583, DOI 10.1074/jbc.M111.248138; Asari A, 2010, J BIOL CHEM, V285, P24751, DOI 10.1074/jbc.M110.104950; Balogh L, 2008, J AGR FOOD CHEM, V56, P10582, DOI 10.1021/jf8017029; Bals R, 1999, INFECT IMMUN, V67, P3542, DOI 10.1128/IAI.67.7.3542-3547.1999; Beck-Schimmer B, 1998, J AM SOC NEPHROL, V9, P2283; Bhilocha S, 2011, ANAL BIOCHEM, V417, P41, DOI 10.1016/j.ab.2011.05.026; Bode L, 2012, GLYCOBIOLOGY, V22, P1147, DOI 10.1093/glycob/cws074; Bokor S, 2007, ANN NUTR METAB, V51, P550, DOI 10.1159/000114209; Brandtzaeg P, 2003, VACCINE, V21, P3382, DOI 10.1016/S0264-410X(03)00338-4; Brandtzaeg P, 2010, J PEDIATR-US, V156, pS8, DOI 10.1016/j.jpeds.2009.11.014; Calabro A, 2000, GLYCOBIOLOGY, V10, P273, DOI 10.1093/glycob/10.3.273; Campo GM, 2010, BIOCHEM PHARMACOL, V80, P480, DOI 10.1016/j.bcp.2010.04.024; Cederlund A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053876; Chen GY, 2010, NAT REV IMMUNOL, V10, P826, DOI 10.1038/nri2873; Coppa GV, 2012, NEONATOLOGY, V101, P74, DOI 10.1159/000330848; Coppa GV, 2011, GLYCOBIOLOGY, V21, P295, DOI 10.1093/glycob/cwq164; Costello EK, 2012, SCIENCE, V336, P1255, DOI 10.1126/science.1224203; de la Motte CA, 2003, AM J PATHOL, V163, P121, DOI 10.1016/S0002-9440(10)63636-X; Dominguez-Bello MG, 2010, P NATL ACAD SCI USA, V107, P11971, DOI 10.1073/pnas.1002601107; Dusio GF, 2011, IMMUNOL CELL BIOL, V89, P630, DOI 10.1038/icb.2010.140; Froy O, 2005, CELL MICROBIOL, V7, P1387, DOI 10.1111/j.1462-5822.2005.00590.x; Gariboldi S, 2008, J IMMUNOL, V181, P2103, DOI 10.4049/jimmunol.181.3.2103; Garreis F, 2010, HISTOCHEM CELL BIOL, V134, P59, DOI 10.1007/s00418-010-0713-y; Gdalevich M, 2001, J AM ACAD DERMATOL, V45, P520, DOI 10.1067/mjd.2001.114741; Grulee CG, 1934, J AMER MED ASSOC, V103, P0735, DOI 10.1001/jama.1934.02750360011006; Hill DR, 2012, J BIOL CHEM, V287, P30610, DOI 10.1074/jbc.M112.356238; Hisada N, 2008, BIOSCI BIOTECH BIOCH, V72, P1111, DOI 10.1271/bbb.70748; Homer CR, 2010, GASTROENTEROLOGY, V139, P1630, DOI 10.1053/j.gastro.2010.07.006; HOWIE PW, 1990, BRIT MED J, V300, P11, DOI 10.1136/bmj.300.6716.11; Hunt KM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021313; Jiang DH, 2005, NAT MED, V11, P1173, DOI 10.1038/nm1315; Jiang DH, 2011, PHYSIOL REV, V91, P221, DOI 10.1152/physrev.00052.2009; Jones TF, 2006, PEDIATRICS, V118, P2380, DOI 10.1542/peds.2006-1218; Klement E, 2004, AM J CLIN NUTR, V80, P1342, DOI 10.1093/ajcn/80.5.1342; Kuntz S, 2008, BRIT J NUTR, V99, P462, DOI 10.1017/S0007114507824068; Kuntz S, 2009, BRIT J NUTR, V101, P1306, DOI 10.1017/S0007114508079622; LAURENT TC, 1995, ANN RHEUM DIS, V54, P429, DOI 10.1136/ard.54.5.429; Le Huerou-Luron I, 2010, NUTR RES REV, V23, P23, DOI 10.1017/S0954422410000065; Liu B, 2012, ANDROLOGIA, V44, P142, DOI 10.1111/j.1439-0272.2010.01122.x; M'Rabet L, 2008, J NUTR, V138, p1782S, DOI 10.1093/jn/138.9.1782S; Marcobal A, 2011, CELL HOST MICROBE, V10, P507, DOI 10.1016/j.chom.2011.10.007; Martin LJ, 2006, AM J CLIN NUTR, V83, P1106, DOI 10.1093/ajcn/83.5.1106; Meran S, 2011, J BIOL CHEM, V286, P17618, DOI 10.1074/jbc.M111.226563; Moon SK, 2002, BBA-MOL CELL RES, V1590, P41, DOI 10.1016/S0167-4889(02)00196-9; Morrow AL, 1999, LANCET, V353, P1226, DOI 10.1016/S0140-6736(98)08037-4; Morrow AL, 2004, J PEDIATR-US, V145, P297, DOI 10.1016/j.jpeds.2004.04.054; Newburg DS, 2009, J ANIM SCI, V87, P26, DOI 10.2527/jas.2008-1347; Newburg DS, 2007, PEDIATR RES, V61, P2, DOI 10.1203/01.pdr.0000250274.68571.18; NEWBURG DS, 1995, J NUTR, V125, P419; Noble PW, 1996, J EXP MED, V183, P2373, DOI 10.1084/jem.183.5.2373; O'Neil DA, 2003, MOL IMMUNOL, V40, P445, DOI 10.1016/S0161-5890(03)00161-5; O'Neill LAJ, 2002, CURR TOP MICROBIOL, V270, P47; Oddy Wendy H, 2012, Breastfeed Rev, V20, P7; Ogushi K, 2001, J BIOL CHEM, V276, P30521, DOI 10.1074/jbc.M011618200; OHYA T, 1970, BIOCHIM BIOPHYS ACTA, V198, P607, DOI 10.1016/0005-2744(70)90139-7; Owen CG, 2005, PEDIATRICS, V115, P1367, DOI 10.1542/peds.2004-1176; Palma GD, 2012, PLOS ONE, V7; Penders J, 2006, PEDIATRICS, V118, P511, DOI 10.1542/peds.2005-2824; Pure E, 2009, CELL SIGNAL, V21, P651, DOI 10.1016/j.cellsig.2009.01.024; Riehl TE, 2012, AM J PHYSIOL-GASTR L, V302, pG309, DOI 10.1152/ajpgi.00248.2011; Ruiz-Palacios GM, 2003, J BIOL CHEM, V278, P14112, DOI 10.1074/jbc.M207744200; Salzman NH, 2010, NAT IMMUNOL, V11, P76, DOI 10.1038/ni.1825; Scheibner KA, 2006, J IMMUNOL, V177, P1272, DOI 10.4049/jimmunol.177.2.1272; Sela DA, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.193359; Selsted ME, 2005, NAT IMMUNOL, V6, P551, DOI 10.1038/ni1206; SHIMADA E, 1980, J BIOCHEM-TOKYO, V88, P1015, DOI 10.1093/oxfordjournals.jbchem.a133052; Stern R, 2006, EUR J CELL BIOL, V85, P699, DOI 10.1016/j.ejcb.2006.05.009; Taylor KR, 2004, J BIOL CHEM, V279, P17079, DOI 10.1074/jbc.M310859200; Taylor KR, 2007, J BIOL CHEM, V282, P18265, DOI 10.1074/jbc.M606352200; van Odijk J, 2003, ALLERGY, V58, P833, DOI 10.1034/j.1398-9995.2003.00264.x; Vora P, 2004, J IMMUNOL, V173, P5398, DOI 10.4049/jimmunol.173.9.5398; Wada A, 1999, BIOCHEM BIOPH RES CO, V263, P770, DOI 10.1006/bbrc.1999.1452; Ward PP, 2002, BIOCHEM CELL BIOL, V80, P95, DOI 10.1139/o01-214; Yang CX, 2012, J BIOL CHEM, V287, P43094, DOI 10.1074/jbc.M112.349209; Yu ZT, 2013, GLYCOBIOLOGY, V23, P169, DOI 10.1093/glycob/cws138; Zasloff M, 2002, NATURE, V415, P389, DOI 10.1038/415389a; Zheng L, 2009, GASTROENTEROLOGY, V137, P2041, DOI 10.1053/j.gastro.2009.08.055	81	60	63	2	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 4	2013	288	40					29090	29104		10.1074/jbc.M113.468629	http://dx.doi.org/10.1074/jbc.M113.468629			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	298BL	23950179	Green Published, hybrid			2022-12-25	WOS:000330298800062
J	Tykwinska, K; Lauster, R; Knaus, P; Rosowski, M				Tykwinska, Karolina; Lauster, Roland; Knaus, Petra; Rosowski, Mark			Growth and Differentiation Factor 3 Induces Expression of Genes Related to Differentiation in a Model of Cancer Stem Cells and Protects Them from Retinoic Acid-Induced Apoptosis	PLOS ONE			English	Article							DEVELOPMENTAL REGULATION; GDF3; INHIBITOR; CARCINOMA; NANOG; TUBB3; IDENTIFICATION; PROLIFERATION; SUPPRESSION; PREVENTION	Misexpression of growth factors, particularly those related to stem cell-like phenotype, is often observed in several cancer types. It has been found to influence parameters of disease progression like cell proliferation, differentiation, maintenance of undifferentiated phenotype and modulation of the immune system. GDF3 is a TGFB family member associated with pluripotency and differentiation during embryonic development that has been previously reported to be re-expressed in a number of cancer types. However, its role in tumor development and progression has not been clarified yet. In this study we decipher the role of GDF3 in an in vitro model of cancer stem cells, NCCIT cells. By classical approach to study protein function combined with high-throughput technique for transcriptome analysis and differentiation assays we evaluated GDF3 as a potential therapeutic target. We observed that GDF3 robustly induces a panel of genes related to differentiation, including several potent tumor suppressors, without impacting the proliferative capacity. Moreover, we report for the first time the protective effect of GDF3 against retinoic acid-induced apoptosis in cells with stem cell-like properties. Our study implies that blocking of GDF3 combined with retinoic acid-treatment of solid cancers is a compelling direction for further investigations, which can lead to re-design of cancer differentiation therapies.	[Tykwinska, Karolina; Lauster, Roland; Rosowski, Mark] Tech Univ Berlin, Dept Biotechnol, Inst Med Biotechnol, Berlin, Germany; [Tykwinska, Karolina] Charite Campus Virchow Klinikum, Berlin Brandenburg Sch Regenerat Therapies, Berlin, Germany; [Knaus, Petra] Free Univ Berlin, Inst Chem & Biochem, Berlin, Germany	Technical University of Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin	Tykwinska, K (corresponding author), Tech Univ Berlin, Dept Biotechnol, Inst Med Biotechnol, Berlin, Germany.	tykwinska@mailbox.tu-berlin.de			Technische Universitat Berlin; DFG through the Berlin-Brandenburg School for Regenerative Therapies [GSC 203]	Technische Universitat Berlin; DFG through the Berlin-Brandenburg School for Regenerative Therapies	The authors would like to state that this work was funded by Technische Universitat Berlin and by DFG through the Berlin-Brandenburg School for Regenerative Therapies GSC 203. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abate-Shen C, 2002, NAT REV CANCER, V2, P777, DOI 10.1038/nrc907; Andersson O, 2008, P NATL ACAD SCI USA, V105, P7252, DOI 10.1073/pnas.0800272105; Andersson O, 2007, DEV BIOL, V311, P500, DOI 10.1016/j.ydbio.2007.08.060; Ben-Porath I, 2008, NAT GENET, V40, P499, DOI 10.1038/ng.127; Burlacu A, 2003, J CELL MOL MED, V7, P249, DOI 10.1111/j.1582-4934.2003.tb00225.x; Caricasole AAD, 1998, ONCOGENE, V16, P95, DOI 10.1038/sj.onc.1201515; Chen CH, 2006, DEVELOPMENT, V133, P319, DOI 10.1242/dev.02210; Cheng AMS, 2000, DEVELOPMENT, V127, P1049; Chu MC, 2004, CANCER BIOL THER, V3, P568, DOI 10.4161/cbt.3.6.848; Clarke Nicole, 2004, Expert Reviews in Molecular Medicine, V6, P1, DOI 10.1017/S1462399404008488; Dalhoff K, 2003, BRIT J CANCER, V89, P252, DOI 10.1038/sj.bjc.6601104; Darini CY, 2012, ONCOGENE, V31, P2438, DOI 10.1038/onc.2011.421; Ehira N, 2010, J EXP CLIN CANC RES, V29, DOI 10.1186/1756-9966-29-135; Eppert K, 2011, NAT MED, V17, P1086, DOI 10.1038/nm.2415; Esmailpour T, 2012, STEM CELLS, V30, P2152, DOI 10.1002/stem.1187; Ezeh UI, 2005, CANCER-AM CANCER SOC, V104, P2255, DOI 10.1002/cncr.21432; Gao S, 2012, TUMOR BIOL, V33, P1759, DOI 10.1007/s13277-012-0435-y; Ghoshal K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010338; Gilbert PM, 2010, J CLIN INVEST, V120, P1535, DOI 10.1172/JCI39534; Grier DG, 2005, J PATHOL, V205, P154, DOI 10.1002/path.1710; Guzman-Ayala M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004268; Hamada H, 2002, NAT REV GENET, V3, P103, DOI 10.1038/nrg732; Holmberg J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018454; HONG WK, 1990, NEW ENGL J MED, V323, P795, DOI 10.1056/NEJM199009203231205; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Jimenez-Lara AM, 2004, TRENDS MOL MED, V10, P508, DOI 10.1016/j.molmed.2004.08.006; Jung C, 2004, CANCER RES, V64, P9185, DOI 10.1158/0008-5472.CAN-04-1330; Kallioniemi A, 2012, CANCER GENET-NY, V205, P267, DOI 10.1016/j.cancergen.2012.05.009; Korchynskyi O, 2002, J BIOL CHEM, V277, P4883, DOI 10.1074/jbc.M111023200; Lee KL, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002130; Leong HS, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp310; Levine AJ, 2006, DEVELOPMENT, V133, P209, DOI 10.1242/dev.02192; Li Q, 2012, J CANCER RES CLIN, V138, P1073, DOI 10.1007/s00432-012-1213-3; Li Q, 2012, MOL CELL BIOCHEM, V359, P115, DOI 10.1007/s11010-011-1005-0; Luo WR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056324; Magee JA, 2012, CANCER CELL, V21, P283, DOI 10.1016/j.ccr.2012.03.003; Manor D, 2003, CANCER RES, V63, P4426; Mariani M, 2011, CURR MOL MED, V11, P726, DOI 10.2174/156652411798062368; Massague J, 2012, NAT REV MOL CELL BIO, V13, P616, DOI 10.1038/nrm3434; Medrano EE, 2003, ONCOGENE, V22, P3123, DOI 10.1038/sj.onc.1206452; Muthusamy V, 2006, CANCER RES, V66, P11187, DOI 10.1158/0008-5472.CAN-06-1274; Narvi E, 2013, BRIT J CANCER, V108, P82, DOI 10.1038/bjc.2012.553; Okazawa H, 1996, J CELL BIOL, V132, P955, DOI 10.1083/jcb.132.5.955; Okuda H, 2006, ONCOGENE, V25, P1733, DOI 10.1038/sj.onc.1209200; Park SW, 2012, FEBS LETT, V586, P3529, DOI 10.1016/j.febslet.2012.08.013; Quail DF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048237; Reynolds CP, 2003, CANCER LETT, V197, P185, DOI 10.1016/S0304-3835(03)00108-3; Rots NY, 1998, MOL CELL BIOL, V18, P1911, DOI 10.1128/MCB.18.4.1911; Samuel S, 2005, EUR J CANCER, V41, P2428, DOI 10.1016/j.ejca.2005.08.014; Sell S, 2004, CRIT REV ONCOL HEMAT, V51, P1, DOI 10.1016/j.critrevonc.2004.04.007; Sharif T, 2011, INVEST NEW DRUG, V29, P239, DOI 10.1007/s10637-009-9352-3; Shen MM, 2007, DEVELOPMENT, V134, P1023, DOI 10.1242/dev.000166; Tanaka C, 2007, GENE DEV, V21, P3272, DOI 10.1101/gad.1623907; Visvader JE, 2012, CELL STEM CELL, V10, P717, DOI 10.1016/j.stem.2012.05.007; von Bubnoff A, 2001, DEV BIOL, V239, P1, DOI 10.1006/dbio.2001.0388; Wu YJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035684; You JS, 2009, CANCER RES, V69, P5716, DOI 10.1158/0008-5472.CAN-08-4953	57	11	11	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2013	8	8							e70612	10.1371/journal.pone.0070612	http://dx.doi.org/10.1371/journal.pone.0070612			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	200UV	23950971	Green Published, Green Submitted, gold			2022-12-25	WOS:000323097300034
J	Zammit, CM; Quaranta, D; Gibson, S; Zaitouna, AJ; Ta, C; Brugger, J; Lai, RY; Grass, G; Reith, F				Zammit, Carla M.; Quaranta, Davide; Gibson, Shane; Zaitouna, Anita J.; Ta, Christine; Brugger, Joel; Lai, Rebecca Y.; Grass, Gregor; Reith, Frank			A Whole-Cell Biosensor for the Detection of Gold	PLOS ONE			English	Article							EXPLORATION; EXTRACTION; RESISTANCE; BIOMINERALIZATION; SPECIATION; BIOFILMS; FUTURE; SOIL	Geochemical exploration for gold (Au) is becoming increasingly important to the mining industry. Current processes for Au analyses require sampling materials to be taken from often remote localities. Samples are then transported to a laboratory equipped with suitable analytical facilities, such as Inductively Coupled Plasma-Mass Spectrometry (ICP-MS) or Instrumental Neutron Activation Analysis (INAA). Determining the concentration of Au in samples may take several weeks, leading to long delays in exploration campaigns. Hence, a method for the on-site analysis of Au, such as a biosensor, will greatly benefit the exploration industry. The golTSB genes from Salmonella enterica serovar typhimurium are selectively induced by Au(I/III)-complexes. In the present study, the golTSB operon with a reporter gene, lacZ, was introduced into Escherichia coli. The induction of golTSB::lacZ with Au(I/III)-complexes was tested using a colorimetric beta-galactosidase and an electrochemical assay. Measurements of the b-galactosidase activity for concentrations of both Au(I)-and Au(III)-complexes ranging from 0.1 to 5 mu M (equivalent to 20 to 1000 ng g(-1) or parts-per-billion (ppb)) were accurately quantified. When testing the ability of the biosensor to detect Au(I/III)-complexes((aq)) in the presence of other metal ions (Ag(I), Cu(II), Fe(III), Ni(II), Co(II), Zn, As(III), Pb(II), Sb(III) or Bi(III)), cross-reactivity was observed, i.e. the amount of Au measured was either under- or over-estimated. To assess if the biosensor would work with natural samples, soils with different physiochemical properties were spiked with Au-complexes. Subsequently, a selective extraction using 1 M thiosulfate was applied to extract the Au. The results showed that Au could be measured in these extracts with the same accuracy as ICP-MS (P<0.05). This demonstrates that by combining selective extraction with the biosensor system the concentration of Au can be accurately measured, down to a quantification limit of 20 ppb (0.1 mu M) and a detection limit of 2 ppb (0.01 mu M).	[Zammit, Carla M.; Brugger, Joel; Reith, Frank] Univ Adelaide, Sch Earth & Environm Sci, Ctr Tecton Resources & Explorat TRaX, Adelaide, SA, Australia; [Zammit, Carla M.; Reith, Frank] Commonwealth Sci & Ind Res Org CSIRO Land & Water, PMB2, Glen Osmond, SA, Australia; [Quaranta, Davide; Gibson, Shane; Grass, Gregor] Univ Nebraska, Sch Biol Sci, Lincoln, NE USA; [Zaitouna, Anita J.; Lai, Rebecca Y.] Univ Nebraska, Dept Chem, Lincoln, NE 68588 USA; [Ta, Christine] Flinders Univ S Australia, Sch Chem & Phys Sci, Adelaide, SA 5001, Australia; [Brugger, Joel] S Australian Museum, Adelaide, SA 5000, Australia; [Grass, Gregor] Bundeswehr Inst Microbiol, Munich, Germany	University of Adelaide; Commonwealth Scientific & Industrial Research Organisation (CSIRO); University of Nebraska System; University of Nebraska Lincoln; University of Nebraska System; University of Nebraska Lincoln; Flinders University South Australia; Bundeswehr Institute of Microbiology (IMB)	Zammit, CM (corresponding author), Univ Adelaide, Sch Earth & Environm Sci, Ctr Tecton Resources & Explorat TRaX, Adelaide, SA, Australia.	carla.zammit@adelaide.edu.au; Frank.Reith@csiro.au	Zaitouna, Anita/AAM-5632-2020; Brugger, Joël/C-7113-2008; Grass, Gregor/A-9981-2009; Zammit, Carla/D-9306-2014	Zaitouna, Anita/0000-0001-5513-6886; Brugger, Joël/0000-0003-1510-5764; Grass, Gregor/0000-0002-8002-7718; 	Australian Research Council (ARC); Commonwealth Scientific and Industrial Research Organisation; University of Adelaide; Newmont Exploration Proprietary Limited and Barrick Gold of Australia Limited; Institute for Mineral and Energy Resources; Centre for Tectonics, Resources and Exploration	Australian Research Council (ARC)(Australian Research Council); Commonwealth Scientific and Industrial Research Organisation(Commonwealth Scientific & Industrial Research Organisation (CSIRO)); University of Adelaide; Newmont Exploration Proprietary Limited and Barrick Gold of Australia Limited; Institute for Mineral and Energy Resources; Centre for Tectonics, Resources and Exploration	This study was funded via an Australian Research Council (ARC) Linkage Grant and the following partners Commonwealth Scientific and Industrial Research Organisation, The University of Adelaide, Newmont Exploration Proprietary Limited and Barrick Gold of Australia Limited, the Institute for Mineral and Energy Resources and the Centre for Tectonics, Resources and Exploration. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bethke C.M., 2008, GEOCHEMICAL BIOGEOCH; Bontidean I, 1998, ANAL CHEM, V70, P4162, DOI 10.1021/ac9803636; Boyle R.W., 1973, J GEOCHEM EXPLOR, V2, P251, DOI [10.1016/0375-6742(73)90003-4, DOI 10.1016/0375-6742(73)90003-4]; Boyle RW, 1966, NOVA SCOTIA CAN MINE, V8, P662; Butt CRM, 2000, ORE GEOL REV, V16, P167, DOI 10.1016/S0169-1368(99)00029-3; Checa SK, 2007, MOL MICROBIOL, V63, P1307, DOI 10.1111/j.1365-2958.2007.05590.x; Checa SK, 2011, BIOMETALS, V24, P419, DOI 10.1007/s10534-010-9393-2; Cohen DR, 2010, GEOCHEM-EXPLOR ENV A, V10, P3, DOI 10.1144/1467-7873/09-215; Coker WB, 2010, GEOCHEM-EXPLOR ENV A, V10, P75, DOI 10.1144/1467-7873/09-218; Dugdale AL, 2010, ORE GEOL REV, V37, P41, DOI 10.1016/j.oregeorev.2009.08.001; Fairbrother L, 2013, ENVIRON SCI TECHNOL, V47, P2628, DOI 10.1021/es302381d; Finney LA, 2003, SCIENCE, V300, P931, DOI 10.1126/science.1085049; Grass G, 2005, ARCH MICROBIOL, V183, P9, DOI 10.1007/s00203-004-0739-4; Gray DJ, 1999, J GEOCHEM EXPLOR, V67, P51, DOI 10.1016/S0375-6742(99)00049-7; Gray DJ, 1998, FURTHER ASPECTS CHEM; Grimm B, 1988, GOLD LATERITIC SOILS, P11; Haldimann A, 2001, J BACTERIOL, V183, P6384, DOI 10.1128/JB.183.21.6384-6393.2001; Hall GEM, 1998, J GEOCHEM EXPLOR, V61, P1, DOI 10.1016/S0375-6742(97)00046-0; HALL GEM, 1995, J GEOCHEM EXPLOR, V54, P27, DOI 10.1016/0375-6742(95)00010-M; Hall GEM, 1998, J GEOCHEM EXPLOR, V64, P153, DOI 10.1016/S0375-6742(98)00029-6; KUO MS, 1986, CARBOHYD RES, V156, P173, DOI 10.1016/S0008-6215(00)90109-5; Lintern MJ, 1989, STUDY DISTRIBUTION G; Luong JHT, 2008, BIOTECHNOL ADV, V26, P492, DOI 10.1016/j.biotechadv.2008.05.007; MERGEAY M, 1985, J BACTERIOL, V162, P328, DOI 10.1128/JB.162.1.328-334.1985; Mumm AS, 2007, J GEOCHEM EXPLOR, V92, P13, DOI 10.1016/j.gexplo.2006.06.003; Nies DH, 2003, FEMS MICROBIOL REV, V27, P313, DOI 10.1016/S0168-6445(03)00048-2; Reith F, 2008, GEOMICROBIOL J, V25, P203, DOI 10.1080/01490450802081846; Reith F, 2005, J GEOCHEM EXPLOR, V85, P81, DOI 10.1016/j.gexplo.2004.11.001; Reith F., 2012, ISME J, V2012, P1; Reith F, 2007, ISME J, V1, P567, DOI 10.1038/ismej.2007.75; Reith F, 2006, SCIENCE, V313, P233, DOI 10.1126/science.1125878; Reith F, 2010, GEOLOGY, V38, P843, DOI 10.1130/G31052.1; Reith F, 2009, P NATL ACAD SCI USA, V106, P17757, DOI 10.1073/pnas.0904583106; Shafiee S, 2010, RESOUR POLICY, V35, P178, DOI 10.1016/j.resourpol.2010.05.004; Stoyanov JV, 2003, J BIOL CHEM, V278, P1407, DOI 10.1074/jbc.C200580200; Usher A, 2009, GEOCHIM COSMOCHIM AC, V73, P3359, DOI 10.1016/j.gca.2009.01.036; VLASSOPOULOS D, 1990, GEOCHIM COSMOCHIM AC, V54, P3, DOI 10.1016/0016-7037(90)90189-R; Wang XQ, 1998, J GEOCHEM EXPLOR, V61, P39; Wiesemann N, 2013, J BACTERIOLOGY; Zammit CM, 2012, MINER ENG, V32, P45, DOI 10.1016/j.mineng.2012.03.016	40	10	11	0	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 9	2013	8	8							e69292	10.1371/journal.pone.0069292	http://dx.doi.org/10.1371/journal.pone.0069292			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	245OM	23950889	Green Published, gold			2022-12-25	WOS:000326473200004
J	Holmberg, RC; Gindlesperger, A; Stokes, T; Lopez, D; Hyman, L; Freed, M; Belgrader, P; Harvey, J; Li, Z				Holmberg, Rebecca C.; Gindlesperger, Alissa; Stokes, Tinsley; Lopez, David; Hyman, Lynn; Freed, Michelle; Belgrader, Phil; Harvey, Jeanne; Li, Zheng			Akonni TruTip (R) and Qiagen (R) Methods for Extraction of Fetal Circulating DNA - Evaluation by Real-Time and Digital PCR	PLOS ONE			English	Article							CELL-FREE DNA; MATERNAL PLASMA; IMPROVEMENT	Due to the low percentage of fetal DNA present in maternal plasma (< 10%) during early gestation, efficient extraction processes are required for successful downstream detection applications in non-invasive prenatal diagnostic testing. In this study, two extraction methods using similar chemistries but different workflows were compared for isolation efficiency and percent fetal DNA recovery. The Akonni Biosystems TruTip technology uses a binding matrix embedded in a pipette tip; the Circulating Nucleic Acids Kit from Qiagen employs a spin column approach. The TruTip method adds an extra step to decrease the recovery of DNA fragments larger than 600 bp from the sample to yield an overall higher percentage of smaller molecular weight DNA, effectively enriching for fetal DNA. In this evaluation, three separate extraction comparison studies were performed - a dilution series of fragmented DNA in plasma, a set of clinical maternal samples, and a blood collection tube time point study of maternal samples. Both extraction methods were found to efficiently extract small fragment DNA from large volumes of plasma. In the amended samples, the TruTip extraction method was similar to 15% less efficient with overall DNA recovery, but yielded an 87% increase in % fetal DNA relative to the Qiagen method. The average percent increase of fetal DNA of TruTip extracted samples compared to the Qiagen method was 55% for all sets of blinded clinical samples. A study comparing extraction efficiencies from whole blood samples incubated up to 48 hours prior to processing into plasma resulted in more consistent % fetal DNA recoveries using TruTip. The extracted products were tested on two detection platforms, quantitative real-time PCR and droplet digital PCR, and yielded similar results for both extraction methods.	[Holmberg, Rebecca C.; Gindlesperger, Alissa; Stokes, Tinsley; Belgrader, Phil] Akonni Biosyst Inc, Frederick, MD USA; [Lopez, David; Hyman, Lynn; Freed, Michelle; Harvey, Jeanne; Li, Zheng] Novartis Vaccines & Diagnost Inc, Emeryville, CA USA	Novartis	Holmberg, RC (corresponding author), Akonni Biosyst Inc, Frederick, MD USA.	rholmberg@akonni.com			Novartis	Novartis(Novartis)	The work described was supported by Novartis and performed in the Research and Development facilities of both Novartis and Akonni Biosystems. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BOOM R, 1990, J CLIN MICROBIOL, V28, P495, DOI 10.1128/JCM.28.3.495-503.1990; Chan KCA, 2004, CLIN CHEM, V50, P88, DOI 10.1373/clinchem.2003.024893; Chandler DP, 2012, J VIROL METHODS, V183, P8, DOI 10.1016/j.jviromet.2012.03.002; Clausen FB, 2007, PRENATAL DIAG, V27, P6, DOI 10.1002/pd.1605; Dhallan R, 2004, JAMA-J AM MED ASSOC, V291, P1114, DOI 10.1001/jama.291.9.1114; Fan HC, 2008, P NATL ACAD SCI USA, V105, P16266, DOI 10.1073/pnas.0808319105; Fernando MR, 2010, PRENATAL DIAG, V30, P418, DOI 10.1002/pd.2484; Gindlesperger A, 2012, ANN C ASS HUM GEN C, P6; Hahn SH, 2008, SEMIN FETAL NEONAT M, V13, P57, DOI 10.1016/j.siny.2007.11.001; Hidestrand M, 2012, FETAL DIAGN THER, V31, P122, DOI 10.1159/000335020; Holmberg RC, J VIS EXP IN PRESS; Huang DJ, 2005, CLIN CHEM, V51, P2419, DOI 10.1373/clinchem.2005.056010; Huang DJ, 2006, ANN NY ACAD SCI, V1075, P308, DOI 10.1196/annals.1368.041; Kitzman JO, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004323; Legler TJ, 2007, PRENATAL DIAG, V27, P824, DOI 10.1002/pd.1783; Legler TJ, 2009, TRANSFUS APHER SCI, V40, P153, DOI 10.1016/j.transci.2009.03.003; Li Y, 2004, CLIN CHEM, V50, P1002, DOI 10.1373/clinchem.2003.029835; Lo YMD, 2009, BJOG-INT J OBSTET GY, V116, P152, DOI 10.1111/j.1471-0528.2008.02010.x; Lo YMD, 2007, P NATL ACAD SCI USA, V104, P13116, DOI 10.1073/pnas.0705765104; Lo YMD, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001720; Lo YMD, 1998, AM J HUM GENET, V62, P768, DOI 10.1086/301800; Lo YMD, 1997, LANCET, V350, P485, DOI 10.1016/S0140-6736(97)02174-0; Lui YYN, 2003, CLIN CHEM, V49, P495, DOI 10.1373/49.3.495; Lun FMF, 2008, CLIN CHEM, V54, P1664, DOI 10.1373/clinchem.2008.111385; Schwarzenbach H, 2011, NAT REV CANCER, V11, P426, DOI 10.1038/nrc3066; Sehnert AJ, 2011, CLIN CHEM, V57, P1042, DOI 10.1373/clinchem.2011.165910; Shih DQ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016090; Snyder TM, 2011, P NATL ACAD SCI USA, V108, P6229, DOI 10.1073/pnas.1013924108; Tynan JA, 2011, J MOL DIAGN, V13, P382, DOI 10.1016/j.jmoldx.2011.02.001; Xue XY, 2009, CLIN CHIM ACTA, V404, P100, DOI 10.1016/j.cca.2009.02.018; Zimmermann B, 2005, CLIN CHEM, V51, P1598, DOI 10.1373/clinchem.2005.051235; Zimmermann Bernhard G., 2008, V444, P219, DOI 10.1007/978-1-59745-066-9_17	32	19	31	2	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2013	8	8							e73068	10.1371/journal.pone.0073068	http://dx.doi.org/10.1371/journal.pone.0073068			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	217ZG	23936545	Green Published, gold, Green Submitted			2022-12-25	WOS:000324401500096
J	Eligini, S; Porro, B; Lualdi, A; Squellerio, I; Veglia, F; Chiorino, E; Crisci, M; Garlasche, A; Giovannardi, M; Werba, JP; Tremoli, E; Cavalca, V				Eligini, Sonia; Porro, Benedetta; Lualdi, Alessandro; Squellerio, Isabella; Veglia, Fabrizio; Chiorino, Elisa; Crisci, Mauro; Garlasche, Anna; Giovannardi, Marta; Werba, Jose-Pablo; Tremoli, Elena; Cavalca, Viviana			Nitric Oxide Synthetic Pathway in Red Blood Cells Is Impaired in Coronary Artery Disease	PLOS ONE			English	Article							ARGININE METABOLISM; OXIDATIVE STRESS; ASYMMETRIC DIMETHYLARGININE; CARDIOVASCULAR EVENTS; HUMAN ERYTHROCYTES; ENDOTHELIAL-CELLS; RENAL-FUNCTION; ARGINASE; BIOAVAILABILITY; SYNTHASE	Background: All the enzymatic factors/cofactors involved in nitric oxide (NO) metabolism have been recently found in red blood cells. Increased oxidative stress impairs NO bioavailability and has been described in plasma of coronary artery disease (CAD) patients. The aim of the study was to highlight a potential dysfunction of the metabolic profile of NO in red blood cells and in plasma from CAD patients compared with healthy controls. Methods: We determined L-arginine/NO pathway by liquid-chromatography tandem mass spectrometry and high performance liquid chromatography methods. The ratio of oxidized and reduced forms of glutathione, as index of oxidative stress, was measured by liquid-chromatography tandem mass spectrometry method. NO synthase expression and activity were evaluated by immunofluorescence staining and ex-vivo experiments of L-[N-15(2)]arginine conversion to L-[N-15]citrulline respectively. Results: Increased amounts of asymmetric and symmetric dimethylarginines were found both in red blood cells and in plasma of CAD patients in respect to controls. Interestingly NO synthase expression and activity were reduced in CAD red blood cells. In contrast, oxidized/reduced glutathione ratio was increased in CAD and was associated to arginase activity. Conclusion: Our study analyzed for the first time the whole metabolic pathway of L-arginine/NO, both in red blood cells and in plasma, highlighting an impairment of NO pathway in erythrocytes from CAD patients, associated with decreased NO synthase expression/activity and increased oxidative stress.	[Eligini, Sonia; Porro, Benedetta; Lualdi, Alessandro; Squellerio, Isabella; Veglia, Fabrizio; Chiorino, Elisa; Crisci, Mauro; Garlasche, Anna; Giovannardi, Marta; Werba, Jose-Pablo; Tremoli, Elena; Cavalca, Viviana] IRCCS, Ctr Cardiol Monzino, Milan, Italy; [Lualdi, Alessandro; Cavalca, Viviana] Univ Milan, Dipartimento Sci Clin & Comunita, Milan, Italy; [Tremoli, Elena] Univ Milan, Dipartimento Sci Farmacol & Biomol, Milan, Italy	IRCCS Centro Cardiologico Monzino; University of Milan; University of Milan	Cavalca, V (corresponding author), IRCCS, Ctr Cardiol Monzino, Milan, Italy.	viviana.cavalca@unimi.it	Veglia, Fabrizio/K-1958-2016; Eligini, Sonia/K-3047-2016; Eligini, Sonia/F-3846-2018; Werba, José Pablo/AAC-8973-2019; Porro, Benedetta/K-1390-2016; TREMOLI, ELENA/I-8126-2018	Veglia, Fabrizio/0000-0002-9378-8874; Eligini, Sonia/0000-0002-5507-6737; Eligini, Sonia/0000-0002-5507-6737; Werba, José Pablo/0000-0001-7188-1157; Porro, Benedetta/0000-0002-4019-4618; Cavalca, Viviana/0000-0003-1349-8365; TREMOLI, ELENA/0000-0002-0929-6106	Italian Ministry of Health [BIO 05 2011]	Italian Ministry of Health(Ministry of Health, Italy)	This work was supported by the Italian Ministry of Health (Ricerca Corrente BIO 05 2011) to the Centro Cardiologico Monzino, IRCCS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asensi M, 1999, METHOD ENZYMOL, V299, P267; Billecke SS, 2006, AM J PHYSIOL-HEART C, V291, pH1788, DOI 10.1152/ajpheart.00066.2006; Bode-Boger SM, 2006, J AM SOC NEPHROL, V17, P1128, DOI 10.1681/ASN.2005101119; Bohmer A, 2012, BLOOD, V119, P1322, DOI 10.1182/blood-2011-11-393124; Bor-Kucukatay M, 2005, CLIN HEMORHEOL MICRO, V33, P363; Cavalca V, 2009, EUR J CLIN INVEST, V39, P267, DOI 10.1111/j.1365-2362.2009.02094.x; Cavalca V, 2001, CLIN CHEM, V47, P887; Cavalca V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048499; Chen LY, 1998, J CARDIOVASC PHARM, V32, P57, DOI 10.1097/00005344-199807000-00009; Chicoine LG, 2004, AM J PHYSIOL-LUNG C, V287, pL60, DOI 10.1152/ajplung.00194.2003; Cortese-Krott MM, 2012, BLOOD, V120, P4229, DOI 10.1182/blood-2012-07-442277; Davids M, 2012, AM J PHYSIOL-HEART C, V302, pH1762, DOI 10.1152/ajpheart.01205.2011; Dhawan SS, 2011, ATHEROSCLEROSIS, V219, P266, DOI 10.1016/j.atherosclerosis.2011.05.020; Durak I, 2001, CLIN CHIM ACTA, V314, P265, DOI 10.1016/S0009-8981(01)00659-3; Durante W, 2007, CLIN EXP PHARMACOL P, V34, P906, DOI 10.1111/j.1440-1681.2007.04638.x; Dzau VJ, 2006, CIRCULATION, V114, P2850, DOI 10.1161/CIRCULATIONAHA.106.655688; FUKUSHIMA T, 1980, ANAL BIOCHEM, V102, P176, DOI 10.1016/0003-2697(80)90336-X; Harris Craig, 2012, Methods Mol Biol, V889, P325, DOI 10.1007/978-1-61779-867-2_21; Heitzer T, 2001, CIRCULATION, V104, P2673, DOI 10.1161/hc4601.099485; Huang KT, 2001, P NATL ACAD SCI USA, V98, P11771, DOI 10.1073/pnas.201276698; Jensen FB, 2009, J EXP BIOL, V212, P3387, DOI 10.1242/jeb.023697; Jung C, 2010, CARDIOVASC RES, V85, P147, DOI 10.1093/cvr/cvp303; Kang ES, 2001, FREE RADICAL RES, V35, P693, DOI 10.1080/10715760100301211; Kang ES, 2000, J LAB CLIN MED, V135, P444, DOI 10.1067/mlc.2000.106805; Kielstein JT, 2006, NEPHROL DIAL TRANSPL, V21, P2446, DOI 10.1093/ndt/gfl292; Kleinbongard P, 2006, BLOOD, V107, P2943, DOI 10.1182/blood-2005-10-3992; Kosenko E, 2012, J CLIN PHARMACOL, V52, P102, DOI 10.1177/0091270010388647; Kulier A, 2007, CIRCULATION, V116, P471, DOI 10.1161/CIRCULATIONAHA.106.653501; Li H, 2001, AM J PHYSIOL-ENDOC M, V280, pE75, DOI 10.1152/ajpendo.2001.280.1.E75; Lu TM, 2011, INT J CARDIOL, V153, P135, DOI 10.1016/j.ijcard.2011.06.120; Ludolph B, 2007, VASC HEALTH RISK MAN, V3, P1069; Mehta JL, 2000, J LAB CLIN MED, V135, P430, DOI 10.1067/mlc.2000.106802; MONCADA S, 1991, PHARMACOL REV, V43, P109; Morris CR, 2005, JAMA-J AM MED ASSOC, V294, P81, DOI 10.1001/jama.294.1.81; Morris SM, 2005, VASC MED, V10, pS83, DOI 10.1191/1358863x05vm601oa; Ozuyaman B, 2008, TRENDS MOL MED, V14, P314, DOI 10.1016/j.molmed.2008.05.002; Omodeo-Sale F, 2010, AM J PHYSIOL-CELL PH, V299, pC148, DOI 10.1152/ajpcell.00405.2009; Profumo E, 2011, THROMB HAEMOSTASIS, V106, P1117, DOI 10.1160/TH11-02-0110; RADOMSKI MW, 1987, LANCET, V2, P1057, DOI 10.1016/S0140-6736(87)91481-4; Reiter CD, 2002, NAT MED, V8, P1383, DOI 10.1038/nm799; Romero MJ, 2008, CIRC RES, V102, P95, DOI 10.1161/CIRCRESAHA.107.155028; Sabatine MS, 2005, CIRCULATION, V111, P2042, DOI 10.1161/01.CIR.0000162477.70955.5F; Schulze F, 2006, AM HEART J, V152, DOI 10.1016/j.ahj.2006.06.005; Shemyakin A, 2012, CIRCULATION, V126, P2943, DOI 10.1161/CIRCULATIONAHA.112.140335; Sourij H, 2011, ATHEROSCLEROSIS, V218, P220, DOI 10.1016/j.atherosclerosis.2011.04.041; Squellerio I, 2012, J PHARMACEUT BIOMED, V71, P111, DOI 10.1016/j.jpba.2012.08.013; Squellerio I, 2011, ANAL BIOCHEM, V412, P108, DOI 10.1016/j.ab.2011.01.018; Tang WHW, 2009, J AM COLL CARDIOL, V53, P2061, DOI 10.1016/j.jacc.2009.02.036; Ulker P, 2012, CLIN HEMORHEOL MICRO; Wu GY, 1998, BIOCHEM J, V336, P1, DOI 10.1042/bj3360001; Yokoro M, 2012, BIOSCI BIOTECH BIOCH, V76, P1334, DOI 10.1271/bbb.120086	51	35	35	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2013	8	8							e66945	10.1371/journal.pone.0066945	http://dx.doi.org/10.1371/journal.pone.0066945			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	218XC	23940508	gold, Green Submitted, Green Published			2022-12-25	WOS:000324465000002
J	Fries, R; Scholten, A; Saftel, W; Koch, KW				Fries, Ramona; Scholten, Alexander; Saeftel, Werner; Koch, Karl-Wilhelm			Zebrafish Guanylate Cyclase Type 3 Signaling in Cone Photoreceptors	PLOS ONE			English	Article							KINASE GRK7; KNOCKDOWN; BEHAVIOR; CALCIUM; MODEL; LEADS; FORM; RED	The zebrafish guanylate cyclase type 3 (zGC3) is specifically expressed in cone cells. A specifc antibody directed against zGC3 revealed expression at the protein level at 3.5 dpf in outer and inner retinal layers, which increased in intensity between 3.5 and 7 dpf. This expression pattern differed from sections of the adult retina showing strong immunostaining in outer segments of double cones and short single cones, less intense immunoreactivity in long single cones, but no staining in the inner retina. Although transcription and protein expression levels of zGC3 are similar to that of the cyclase regulator guanylate cyclase-activating protein 3 (zGCAP3), we surprisingly found that zGCAP3 is present in a 28-fold molar excess over zGC3 in zebrafish retinae. Further, zGCAP3 was an efficient regulator of guanylate cyclases activity in native zebrafish retinal membrane preparations. Therefore, we investigated the physiological function of zGCAP3 by two different behavioral assays. Using the morpholino antisense technique, we knocked down expression of zGCAP3 and recorded the optokinetic and optomotor responses of morphants, control morphants, and wild type fish at 5-6 dpf. No significant differences in behavioral responses among wild type, morphants and control morphants were found, indicating that a loss of zGCAP3 has no consequences in primary visual processing in the larval retina despite its prominent expression pattern. Its physiological function is therefore compensated by other zGCAP isoforms.	[Fries, Ramona; Scholten, Alexander; Saeftel, Werner; Koch, Karl-Wilhelm] Carl von Ossietzky Univ Oldenburg, Dept Neurosci, Biochem Grp, D-26111 Oldenburg, Germany; [Koch, Karl-Wilhelm] Carl von Ossietzky Univ Oldenburg, Res Ctr Neurosensory Sci, D-26111 Oldenburg, Germany	Carl von Ossietzky Universitat Oldenburg; Carl von Ossietzky Universitat Oldenburg	Koch, KW (corresponding author), Carl von Ossietzky Univ Oldenburg, Dept Neurosci, Biochem Grp, D-26111 Oldenburg, Germany.	karl.w.koch@uni-oldenburg.de	Koch, Karl-Wilhelm/C-9551-2015	Koch, Karl-Wilhelm/0000-0003-1501-0044	Deutsche Forschungsgemeinschaft (DFG) [KO 948/7-2]	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	This work was funded by a grant from the Deutsche Forschungsgemeinschaft (DFG) to KWK (KO 948/7-2). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baier H, 2000, CURR OPIN NEUROBIOL, V10, P451, DOI 10.1016/S0959-4388(00)00116-1; Behnen P, 2009, J BIOL INORG CHEM, V14, P89, DOI 10.1007/s00775-008-0426-z; Bilotta J, 2001, INT J DEV NEUROSCI, V19, P621, DOI 10.1016/S0736-5748(01)00050-8; Brockerhoff SE, 1997, J NEUROSCI, V17, P4236; Brockerhoff SE, 2003, J NEUROSCI, V23, P470, DOI 10.1523/JNEUROSCI.23-02-00470.2003; Cilluffo MC, 2004, VISUAL NEUROSCI, V21, P599, DOI 10.1017/S0952523804214092; Dell'Orco D, 2010, CELL MOL LIFE SCI, V67, P973, DOI 10.1007/s00018-009-0243-8; Fries R, 2012, J NEUROCHEM, V121, P54, DOI 10.1111/j.1471-4159.2011.07643.x; GORIDIS C, 1973, FEBS LETT, V30, P163, DOI 10.1016/0014-5793(73)80642-8; Haug MF, 2010, FRONT ZOOL, V7, DOI 10.1186/1742-9994-7-8; Hwang JY, 2003, EUR J BIOCHEM, V270, P3814, DOI 10.1046/j.1432-1033.2003.03770.x; Imanishi Y, 2004, J MOL EVOL, V59, P204, DOI 10.1007/s00239-004-2614-y; Kitiratschky VBD, 2009, HUM MUTAT, V30, pE782, DOI 10.1002/humu.21055; Koch KW, 2010, MOL CELL BIOCHEM, V334, P105, DOI 10.1007/s11010-009-0330-z; Koch KW, 2013, ACS CHEM NEUROSCI, V4, P909, DOI 10.1021/cn400027z; Kretschmer F., 2011, 2011 4th International Congress on Image and Signal Processing (CISP 2011), P441, DOI 10.1109/CISP.2011.6099935; Leung YT, 2007, J PHYSIOL-LONDON, V579, P15, DOI 10.1113/jphysiol.2006.120162; Luo DG, 2008, P NATL ACAD SCI USA, V105, P9855, DOI 10.1073/pnas.0708405105; Mueller KP, 2010, J NEUROSCI METH, V186, P29, DOI 10.1016/j.jneumeth.2009.10.020; Muto A, 2005, PLOS GENET, V1, P575, DOI 10.1371/JOURNAL.PGEN.0010066; Orger MB, 2005, VISUAL NEUROSCI, V22, P275, DOI 10.1017/S0952523805223039; Palczewski K, 2000, BIOESSAYS, V22, P337, DOI 10.1002/(SICI)1521-1878(200004)22:4<337::AID-BIES4>3.0.CO;2-Z; Ratscho N, 2010, MOL CELL BIOCHEM, V334, P207, DOI 10.1007/s11010-009-0320-1; Ratscho N, 2009, BBA-MOL CELL RES, V1793, P1110, DOI 10.1016/j.bbamcr.2008.12.021; Reed R, 2007, PRACTICAL SKILLS BIO; Rinner O, 2005, NEURON, V47, P231, DOI 10.1016/j.neuron.2005.06.010; Scholten A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023117; Stearns G, 2007, J NEUROSCI, V27, P13866, DOI 10.1523/JNEUROSCI.3136-07.2007; Stiebel-Kalish H, 2012, EUR J HUM GENET, V20, P884, DOI 10.1038/ejhg.2012.10; Summerton JE, 2007, CURR TOP MED CHEM, V7, P651, DOI 10.2174/156802607780487740; Takemoto N, 2009, P NATL ACAD SCI USA, V106, P11788, DOI 10.1073/pnas.0812781106; THOMPSON D, 1992, BIOTECHNIQUES, V12, P656; Vogalis F, 2011, J PHYSIOL-LONDON, V589, P2321, DOI 10.1113/jphysiol.2010.204156; Yang RB, 1997, J BIOL CHEM, V272, P13738, DOI 10.1074/jbc.272.21.13738	34	10	10	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2013	8	8							e69656	10.1371/journal.pone.0069656	http://dx.doi.org/10.1371/journal.pone.0069656			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	218XC	23940527	gold, Green Published, Green Submitted			2022-12-25	WOS:000324465000021
J	Jiang, B; Zhang, P; Zhou, D; Zhang, J; Xu, X; Tang, LS				Jiang, Bing; Zhang, Pu; Zhou, Dan; Zhang, Jun; Xu, Xiang; Tang, Luosheng			Intravitreal Transplantation of Human Umbilical Cord Blood Stem Cells Protects Rats from Traumatic Optic Neuropathy	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM; STROMAL CELLS; INJURY; THERAPY; STRESS; DEATH; MODEL	Objectives: To treat traumatic optic neuropathy (TON) with transplantation of human umbilical cord blood stem cells (hUCBSC) and explore how transplanted stem cells participate in the neuron repairing process. Methods: A total of 195 Sprague-Dawley rats were randomly assigned to three groups: sham-surgery, optic nerve injury, and stem cell transplant group. Optic nerve injury was established in rats by directly clamping the optic nerve for 30 seconds. hUCBSC was microinjected into the vitreous cavity of injured rats. Optic nerve function was evaluated by flash visual evoked potentials (F-VEP). Apoptosis in retina tissues was detected by TUNEL staining. GRP78 and CHOP gene expression was measured by RT-PCR. Results: After injury, transplantation of hUCBSC significantly blunted a reduction in optic nerve function indicated by smaller decreases in amplitude and smaller increases in peak latency of F-VEP waveform compared to the injury alone group. Also, significant more in retinal ganglion cell (RGC) count and less in RGC apoptosis were detected after transplantation compared to injured rats. The protective effect correlated with upregulated GRP78 and downregulated CHOP mRNA expression. Conclusion: Intravitreal transplantation of hUCBSCs significantly blunted a reduction in optic nerve function through increasing RGC survival and decreasing retinal cell apoptosis. The protective role of transplantation was associated with upregulation of GRP78 expression and downregulation of CHOP expression in retinal cells.	[Jiang, Bing; Zhang, Pu; Zhou, Dan; Tang, Luosheng] Cent S Univ, Xiangya Hosp 2, Dept Ophthalmol, Changsha, Hunan, Peoples R China; [Zhang, Jun; Xu, Xiang] Shenzhen Beike Cell Engn Res Inst, Shenzhen, Peoples R China	Central South University	Tang, LS (corresponding author), Cent S Univ, Xiangya Hosp 2, Dept Ophthalmol, Changsha, Hunan, Peoples R China.	tangls57@gmail.com	Jiang, Bing/V-9606-2019		Department of Science and Technology, Hunan Province [2010FJ3066]; National Natural Science Foundation of China [NSFC 81271004]; Scientific Research Foundation for the Returned Overseas Chinese Scholars, State Education Ministry [2010-609]	Department of Science and Technology, Hunan Province(Department of Science & Technology (India)); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Scientific Research Foundation for the Returned Overseas Chinese Scholars, State Education Ministry(Scientific Research Foundation for the Returned Overseas Chinese Scholars)	This project was supported by grants from Department of Science and Technology, Hunan Province (2010FJ3066 to Bing Jiang), National Natural Science Foundation of China (NSFC 81271004 to Bing Jiang), and Scientific Research Foundation for the Returned Overseas Chinese Scholars, State Education Ministry (2010-609 to Bing Jiang). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Awai M, 2006, J NEUROCHEM, V96, P43, DOI 10.1111/j.1471-4159.2005.03502.x; Bien A, 1999, J NEUROTRAUM, V16, P153, DOI 10.1089/neu.1999.16.153; Borlongan CV, 2006, CAN MED ASSOC J, V174, P954, DOI 10.1503/cmaj.060199; Domanska-Janik K, 2008, INT J DEV BIOL, V52, P237, DOI 10.1387/ijdb.072315kd; Garbuzova-Davis S, 2003, J HEMATOTH STEM CELL, V12, P255, DOI 10.1089/152581603322022990; Koike-Kiriyama N, 2007, ACTA NEUROBIOL EXP, V67, P359; Kuznetsov G, 1997, J BIOL CHEM, V272, P3057, DOI 10.1074/jbc.272.5.3057; Lu P, 2005, EXP NEUROL, V191, P344, DOI 10.1016/j.expneurol.2004.09.018; MAHONEY WC, 1979, J BIOL CHEM, V254, P6572; MAN PYW, 2005, COCHRANE DB SYST REV, V19; Masson S, 2004, STEM CELLS, V22, P897, DOI 10.1634/stemcells.22-6-897; Nan ZH, 2005, ANN NY ACAD SCI, V1049, P84, DOI 10.1196/annals.1334.009; Newcomb JD, 2006, CELL TRANSPLANT, V15, P213, DOI 10.3727/000000006783982043; Newman MB, 2006, EXP NEUROL, V199, P201, DOI 10.1016/j.expneurol.2006.04.001; Nystedt J, 2006, ACTA NEUROBIOL EXP, V66, P293; Schuettauf F, 2000, INVEST OPHTH VIS SCI, V41, P4313; Shimazawa M, 2007, MOL VIS, V13, P578; STEINSAPIR KD, 1994, SURV OPHTHALMOL, V38, P487, DOI 10.1016/0039-6257(94)90145-7; Wu N, 2008, J INT MED RES, V36, P883, DOI 10.1177/147323000803600503; Zwart I, 2009, EXP NEUROL, V216, P439, DOI 10.1016/j.expneurol.2008.12.028	20	20	23	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2013	8	8							e69938	10.1371/journal.pone.0069938	http://dx.doi.org/10.1371/journal.pone.0069938			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	218XC	23940534	Green Published, gold, Green Submitted			2022-12-25	WOS:000324465000028
J	Kim, J; Yang, M; Kim, SH; Kim, JC; Wang, HB; Shin, T; Moon, C				Kim, Juhwan; Yang, Miyoung; Kim, Sung-Ho; Kim, Jong-Choon; Wang, Hongbing; Shin, Taekyun; Moon, Changjong			Possible Role of the Glycogen Synthase Kinase-3 Signaling Pathway in Trimethyltin-Induced Hippocampal Neurodegeneration in Mice	PLOS ONE			English	Article							TRAUMATIC BRAIN-INJURY; DENTATE GRANULE CELLS; NEUROTOXICITY IN-VIVO; PROTEIN-KINASE; NEURONAL DEGENERATION; RAT HIPPOCAMPUS; POTENTIAL ROLE; BETA-CATENIN; LITHIUM; ACTIVATION	Trimethyltin (TMT) is an organotin compound with potent neurotoxic effects characterized by neuronal destruction in selective regions, including the hippocampus. Glycogen synthase kinase-3 (GSK-3) regulates many cellular processes, and is implicated in several neurodegenerative disorders. In this study, we evaluated the therapeutic effect of lithium, a selective GSK-3 inhibitor, on the hippocampus of adult C57BL/6 mice with TMT treatment (2.6 mg/kg, intraperitoneal [i.p.]) and on cultured hippocampal neurons (12 days in vitro) with TMT treatment (5 mM). Lithium (50 mg/kg, i.p., 0 and 24 h after TMT injection) significantly attenuated TMT-induced hippocampal cell degeneration, seizure, and memory deficits in mice. In cultured hippocampal neurons, lithium treatment (0-10 mM; 1 h before TMT application) significantly reduced TMT-induced cytotoxicity in a dose-dependent manner. Additionally, the dynamic changes in GSK-3/beta-catenin signaling were observed in the mouse hippocampus and cultured hippocampal neurons after TMT treatment with or without lithium. Therefore, lithium inhibited the detrimental effects of TMT on the hippocampal neurons in vivo and in vitro, suggesting involvement of the GSK-3/beta-catenin signaling pathway in TMT-induced hippocampal cell degeneration and dysfunction.	[Kim, Juhwan; Yang, Miyoung; Kim, Sung-Ho; Kim, Jong-Choon; Moon, Changjong] Chonnam Natl Univ, Coll Vet Med, Dept Vet Anat, Kwangju, South Korea; [Kim, Juhwan; Yang, Miyoung; Kim, Sung-Ho; Kim, Jong-Choon; Moon, Changjong] Chonnam Natl Univ, Coll Vet Med, Dept Vet Toxicol, Kwangju, South Korea; [Kim, Juhwan; Yang, Miyoung; Kim, Sung-Ho; Kim, Jong-Choon; Moon, Changjong] Chonnam Natl Univ, Anim Med Inst, Kwangju, South Korea; [Yang, Miyoung; Wang, Hongbing] Michigan State Univ, Dept Physiol, E Lansing, MI 48824 USA; [Yang, Miyoung; Wang, Hongbing] Michigan State Univ, Neurosci Program, E Lansing, MI 48824 USA; [Shin, Taekyun] Jeju Natl Univ, Coll Vet Med, Dept Vet Anat, Cheju, South Korea	Chonnam National University; Chonnam National University; Chonnam National University; Michigan State University; Michigan State University; Jeju National University	Shin, T (corresponding author), Jeju Natl Univ, Coll Vet Med, Dept Vet Anat, Cheju, South Korea.	shint@jejunu.ac.kr; moonc@chonnam.ac.kr	Moon, Changjong/AAI-2005-2020	Moon, Changjong/0000-0003-2451-0374; SHIN, Taekyun/0000-0002-9851-4354	Basic Science Research Program through the National Research Foundation of Korea (NRF); Ministry of Education, Science and Technology [2012R1A1B4001262]	Basic Science Research Program through the National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea)	This research was supported by Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science and Technology (2012R1A1B4001262). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alessi DR, 1996, FEBS LETT, V399, P333, DOI 10.1016/S0014-5793(96)01370-1; Alvarez G, 1999, FEBS LETT, V453, P260, DOI 10.1016/S0014-5793(99)00685-7; Avila J, 2010, EXPERT REV NEUROTHER, V10, P703, DOI 10.1586/ERN.10.40; Bahremand A, 2011, EUR J PHARMACOL, V666, P93, DOI 10.1016/j.ejphar.2011.05.043; BESSER R, 1987, NEUROLOGY, V37, P945, DOI 10.1212/WNL.37.6.945; Bian QM, 2007, BRAIN RES, V1184, P270, DOI 10.1016/j.brainres.2007.09.054; Casalbore P, 2010, J CELL PHYSIOL, V224, P710, DOI 10.1002/jcp.22170; Chang L W, 1990, J Toxicol Sci, V15 Suppl 4, P125; Chen SQ, 2001, J CELL BIOL, V152, P87, DOI 10.1083/jcb.152.1.87; Chong ZZ, 2004, HISTOL HISTOPATHOL, V19, P495, DOI 10.14670/HH-19.495; Chuang DM, 2011, FRONT MOL NEUROSCI, V4, DOI 10.3389/fnmol.2011.00015; Crespo-Biel N, 2010, BIPOLAR DISORD, V12, P425, DOI 10.1111/j.1399-5618.2010.00825.x; CROSS DAE, 1995, NATURE, V378, P785, DOI 10.1038/378785a0; Dash PK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024648; De Sarno P, 2002, NEUROPHARMACOLOGY, V43, P1158, DOI 10.1016/S0028-3908(02)00215-0; Doble BW, 2003, J CELL SCI, V116, P1175, DOI 10.1242/jcs.00384; EARLEY B, 1992, NEUROCHEM INT, V21, P351, DOI 10.1016/0197-0186(92)90186-U; Eldar-Finkelman H, 2002, TRENDS MOL MED, V8, P126, DOI 10.1016/S1471-4914(01)02266-3; Emamian ES, 2004, NAT GENET, V36, P131, DOI 10.1038/ng1296; EMBI N, 1980, EUR J BIOCHEM, V107, P519, DOI 10.1111/j.1432-1033.1980.tb06059.x; Eom TY, 2009, BIOL PSYCHIAT, V66, P494, DOI 10.1016/j.biopsych.2009.04.015; Fabrizi C, 2012, J NEURAL TRANSM, V119, P1295, DOI 10.1007/s00702-012-0785-z; FELDMAN RG, 1993, ARCH NEUROL-CHICAGO, V50, P1320, DOI 10.1001/archneur.1993.00540120035010; Fiedorowicz A, 2001, BRAIN RES, V912, P116, DOI 10.1016/S0006-8993(01)02675-0; Fiorentini A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014382; Geloso MC, 2011, NEUROCHEM INT, V58, P729, DOI 10.1016/j.neuint.2011.03.009; Ghasemi M, 2010, EPILEPSY BEHAV, V18, P171, DOI 10.1016/j.yebeh.2010.04.002; Gold AB, 2011, CURR DRUG TARGETS, V12, P243; Goodenough S, 2004, BRAIN RES, V1026, P116, DOI 10.1016/j.brainres.2004.08.021; Harry GJ, 2008, BRAIN RES, V1194, P8, DOI 10.1016/j.brainres.2007.11.076; Harry GJ, 2002, TOXICOL APPL PHARM, V180, P205, DOI 10.1006/taap.2002.9390; Tran HYP, 2012, FREE RADICAL BIO MED, V52, P1159, DOI 10.1016/j.freeradbiomed.2011.12.008; Jope RS, 2006, CURR DRUG TARGETS, V7, P1421, DOI 10.2174/1389450110607011421; Jope RS, 2004, TRENDS BIOCHEM SCI, V29, P95, DOI 10.1016/j.tibs.2003.12.004; Jope RS, 2003, TRENDS PHARMACOL SCI, V24, P441, DOI 10.1016/S0165-6147(03)00206-2; Jope RS, 2002, MOL PSYCHIATR, V7, pS35, DOI 10.1038/sj.mp.4001017; Kaidanovich-Beilin O, 2011, FRONT MOL NEUROSCI, V4, DOI 10.3389/fnmol.2011.00040; Kikuchi A, 2006, EXP MOL MED, V38, P1, DOI 10.1038/emm.2006.1; Kim JS, 2008, J RADIAT RES, V49, P517, DOI 10.1269/jrr.08020; Kuramoto N, 2011, J NEUROSCI RES, V89, P552, DOI 10.1002/jnr.22588; Lai JS, 2006, EUR J PHARMACOL, V539, P18, DOI 10.1016/j.ejphar.2006.03.076; Leng Y, 2008, J NEUROSCI, V28, P2576, DOI 10.1523/JNEUROSCI.5467-07.2008; Little AR, 2012, NEUROTOXICOL TERATOL, V34, P72, DOI 10.1016/j.ntt.2011.09.012; Liu CM, 2002, CELL, V108, P837, DOI 10.1016/S0092-8674(02)00685-2; Logan CY, 2004, ANNU REV CELL DEV BI, V20, P781, DOI 10.1146/annurev.cellbio.20.010403.113126; Miller JR, 1999, ONCOGENE, V18, P7860, DOI 10.1038/sj.onc.1203245; Mora A, 2001, J NEUROCHEM, V78, P199, DOI 10.1046/j.1471-4159.2001.00410.x; MORRIS R, 1984, J NEUROSCI METH, V11, P47, DOI 10.1016/0165-0270(84)90007-4; Ogita K, 2004, NEUROPHARMACOLOGY, V47, P619, DOI 10.1016/j.neuropharm.2004.06.012; Perez-Costas E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008911; Ponce-Lopez T, 2011, BRAIN RES, V1426, P73, DOI 10.1016/j.brainres.2011.09.056; Schmued LC, 2000, BRAIN RES, V874, P123, DOI 10.1016/S0006-8993(00)02513-0; Sereno L, 2009, NEUROBIOL DIS, V35, P359, DOI 10.1016/j.nbd.2009.05.025; Shapira M, 2007, MOL CELL NEUROSCI, V34, P571, DOI 10.1016/j.mcn.2006.12.006; Shin EJ, 2005, NEUROSCIENCE, V133, P715, DOI 10.1016/j.neuroscience.2005.02.030; Shirakawa T, 2007, NEUROSCI RES, V59, P117, DOI 10.1016/j.neures.2007.06.1468; SIEGFRIED E, 1992, CELL, V71, P1167, DOI 10.1016/S0092-8674(05)80065-0; Stambolic V, 1996, CURR BIOL, V6, P1664, DOI 10.1016/S0960-9822(02)70790-2; SUTHERLAND C, 1993, BIOCHEM J, V296, P15, DOI 10.1042/bj2960015; Takashima A, 1996, NEUROSCI LETT, V203, P33, DOI 10.1016/0304-3940(95)12257-5; Ueki K, 1998, J BIOL CHEM, V273, P5315, DOI 10.1074/jbc.273.9.5315; van Noort M, 2002, J BIOL CHEM, V277, P17901, DOI 10.1074/jbc.M111635200; Wang Z, 2012, NEUROSCIENCE, V206, P190, DOI 10.1016/j.neuroscience.2011.12.043; Wine RN, 2009, NEUROTOX RES, V16, P280, DOI 10.1007/s12640-009-9060-y; WOODGETT JR, 1990, EMBO J, V9, P2431, DOI 10.1002/j.1460-2075.1990.tb07419.x; Yan XB, 2007, BEHAV BRAIN RES, V177, P282, DOI 10.1016/j.bbr.2006.11.021; Yang M, 2012, NEUROCHEM INT, V61, P955, DOI 10.1016/j.neuint.2012.09.015; Yang M, 2011, BIOCHEM PHARMACOL, V82, P72, DOI 10.1016/j.bcp.2011.03.020; Yang M, 2010, NEUROBIOL LEARN MEM, V93, P487, DOI 10.1016/j.nlm.2010.01.006; Yao HB, 2002, J CHEM NEUROANAT, V23, P291, DOI 10.1016/S0891-0618(02)00014-5; Yoneyama M, 2008, NEUROCHEM INT, V52, P761, DOI 10.1016/j.neuint.2007.09.003; Yu FS, 2012, J NEUROTRAUM, V29, P362, DOI 10.1089/neu.2011.1942; Zhang M, 2008, J NEUROSCI, V28, P4736, DOI 10.1523/JNEUROSCI.1177-08.2008	73	30	30	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2013	8	8							e70356	10.1371/journal.pone.0070356	http://dx.doi.org/10.1371/journal.pone.0070356			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	218XC	23940567	Green Submitted, gold, Green Published			2022-12-25	WOS:000324465000061
J	Lam, TK; Moore, SC; Brinton, LA; Smith, L; Hollenbeck, AR; Gierach, GL; Freedman, ND				Lam, Tram Kim; Moore, Steve C.; Brinton, Louise A.; Smith, Llewellyn; Hollenbeck, Albert R.; Gierach, Gretchen L.; Freedman, Neal D.			Anthropometric Measures and Physical Activity and the Risk of Lung Cancer in Never-Smokers: A Prospective Cohort Study	PLOS ONE			English	Article							BODY-MASS INDEX; WAIST CIRCUMFERENCE; WOMEN; ASSOCIATION; RELIABILITY; VALIDITY; DISEASE; FORMER	Worldwide, lung cancer in never-smokers is ranked the seventh most common cause of cancer death; however, the etiology of lung cancer in never-smokers is unclear. We investigated associations for body mass index (BMI) at various ages, waist circumference, hip circumference, and physical activity with lung cancer in 158,415 never-smokers of the NIH-AARP Diet and Health Study. Multivariable hazard ratios (HR) and 95% confidence intervals (CI) were estimated from Cox proportional hazards models. Over 11 years of follow-up, 532 lung cancer cases occurred. The risk estimate for obese (BMI >= 30 kg/m(2)) participants at baseline was 1.21 (95% CI = 0.95-1.53) relative to those with a normal BMI between 18.5 <= BMI<25.0. Overweight (25.0 <= BMI<30.0) at age 18 (HRoverweight-vs-normal = 1.51; 95% CI = 1.01-2.26) and time spent sitting (HR approximate to 3 hrs-vs<3 (hrs) = 1.32; 95% CI = 1.00-1.73) was each associated with lung cancer after adjustment for baseline BMI, as was waist (HRQ4vs-Q1 = 1.75; 95% CI = 1.09-2.79) and hip circumference (HRQ4-vs-Q1 = 0.62; 95% CI = 0.39-0.99), after mutual adjustment for each other and baseline BMI. No associations were observed for vigorous activity or television watching. In summary, using a large prospective cohort study, we found no evidence that BMI at baseline or middle age was associated with decreased lung cancer risk in never smokers. If anything, we observed some evidence for positive associations with a larger BMI or waist circumference.	[Lam, Tram Kim] NCI, Genet Epidemiol Branch, Div Canc Epidemiol & Genet, NIH, Rockville, MD USA; [Moore, Steve C.; Freedman, Neal D.] NCI, Nutr Epidemiol Branch, Div Canc Epidemiol & Genet, NIH, Rockville, MD USA; [Brinton, Louise A.; Gierach, Gretchen L.] NCI, Hormonal & Reprod Epidemiol Branch, Div Canc Epidemiol & Genet, NIH, Rockville, MD USA; [Smith, Llewellyn] Williams Coll, Williamstown, MA 01267 USA; [Hollenbeck, Albert R.] AARP, Org & Tracking Res Dept, Washington, DC USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Williams College; American Association of Retired Persons (AARP)	Lam, TK (corresponding author), NCI, Genet Epidemiol Branch, Div Canc Epidemiol & Genet, NIH, Rockville, MD USA.	lamt@mail.nih.gov	Gierach, Gretchen L/E-1817-2016; Freedman, Neal David/B-9741-2015; Moore, Steven/D-8760-2016; Brinton, Louise A/G-7486-2015; Hollenbeck, Albert/AAG-9461-2020	Gierach, Gretchen L/0000-0002-0165-5522; Freedman, Neal David/0000-0003-0074-1098; Moore, Steven/0000-0002-8169-1661; Brinton, Louise A/0000-0003-3853-8562; 				Andreotti G, CANC CAUSES CONTROL, V21, P1759; [Anonymous], 1995, WHO TECH REP SER, V854, P1; [Anonymous], 2012, SCIENCEDAILY; Cameron AJ, 2012, INT J EPIDEMIOL, V41, P484, DOI 10.1093/ije/dyr198; COX DR, 1972, J R STAT SOC B, V34, P187; Freedman ND, 2008, LANCET ONCOL, V9, P649, DOI 10.1016/S1470-2045(08)70154-2; Fritz A, 2000, INT CLASSIFICATION D; Gray L, ANN ONCOL; Heitmann BL, 2011, OBES REV, V12, P478, DOI 10.1111/j.1467-789X.2010.00794.x; Hsiung CA, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001051; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20115, 10.3322/caac.20107]; Kabat GC, 2008, AM J EPIDEMIOL, V168, P158, DOI 10.1093/aje/kwn109; Leitzmann MF, 2009, AM J EPIDEMIOL, V169, P542, DOI 10.1093/aje/kwn371; Lin CJ, 2012, PUBLIC HEALTH NUTR, V15, P989, DOI 10.1017/S1368980011003193; Marshall AL, 2005, BRIT J SPORT MED, V39, P294, DOI 10.1136/bjsm.2004.013771; Ness-Abramof R, 2008, NUTR CLIN PRACT, V23, P397, DOI 10.1177/0884533608321700; Olson JE, 2002, AM J EPIDEMIOL, V156, P606, DOI 10.1093/aje/kwf084; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Perrini S, 2008, DIABETOLOGIA, V51, P155, DOI 10.1007/s00125-007-0841-7; Reeves GK, 2007, BRIT MED J, V335, P1134, DOI 10.1136/bmj.39367.495995.AE; Renehan AG, 2008, LANCET, V371, P569, DOI 10.1016/S0140-6736(08)60269-X; Samet JM, 2009, CLIN CANCER RES, V15, P5626, DOI 10.1158/1078-0432.CCR-09-0376; Schatzkin A, 2001, AM J EPIDEMIOL, V154, P1119, DOI 10.1093/aje/154.12.1119; Seidell JC, 2001, AM J CLIN NUTR, V74, P315; Sinner P, 2006, CANCER EPIDEM BIOMAR, V15, P2359, DOI 10.1158/1055-9965.EPI-06-0251; Sisti J, 2012, INT J CANC; Smith L, 2012, JNCI-J NATL CANCER I, V104, P778, DOI 10.1093/jnci/djs179; Sun S, 2007, NAT REV CANCER, V7, P778, DOI 10.1038/nrc2190; Tardon A, 2005, CANCER CAUSE CONTROL, V16, P389, DOI 10.1007/s10552-004-5026-9; Tehard B, 2002, J AM DIET ASSOC, V102, P1779, DOI 10.1016/S0002-8223(02)90381-0; Thun MJ, 2008, PLOS MED, V5, P1357, DOI 10.1371/journal.pmed.0050185; VANDERKOOY K, 1993, AM J CLIN NUTR, V57, P327, DOI 10.1093/ajcn/57.3.327	32	30	32	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2013	8	8							e70672	10.1371/journal.pone.0070672	http://dx.doi.org/10.1371/journal.pone.0070672			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	218XC	23940620	Green Submitted, Green Published, gold			2022-12-25	WOS:000324465000114
J	Mitchell, J; Pabon, N; Collier, ZA; Egeghy, PP; Cohen-Hubal, E; Linkov, I; Vallero, DA				Mitchell, Jade; Pabon, Nicolas; Collier, Zachary A.; Egeghy, Peter P.; Cohen-Hubal, Elaine; Linkov, Igor; Vallero, Daniel A.			A Decision Analytic Approach to Exposure-Based Chemical Prioritization	PLOS ONE			English	Article								The manufacture of novel synthetic chemicals has increased in volume and variety, but often the environmental and health risks are not fully understood in terms of toxicity and, in particular, exposure. While efforts to assess risks have generally been effective when sufficient data are available, the hazard and exposure data necessary to assess risks adequately are unavailable for the vast majority of chemicals in commerce. The US Environmental Protection Agency has initiated the ExpoCast Program to develop tools for rapid chemical evaluation based on potential for exposure. In this context, a model is presented in which chemicals are evaluated based on inherent chemical properties and behaviorally-based usage characteristics over the chemical's life cycle. These criteria are assessed and integrated within a decision analytic framework, facilitating rapid assessment and prioritization for future targeted testing and systems modeling. A case study outlines the prioritization process using 51 chemicals. The results show a preliminary relative ranking of chemicals based on exposure potential. The strength of this approach is the ability to integrate relevant statistical and mechanistic data with expert judgment, allowing for an initial tier assessment that can further inform targeted testing and risk management strategies.	[Mitchell, Jade] Michigan State Univ, E Lansing, MI 48824 USA; [Pabon, Nicolas] Carnegie Mellon Univ, Dept Phys, Pittsburgh, PA 15213 USA; [Collier, Zachary A.; Linkov, Igor] USA, Environm Lab, Engn Res & Dev Ctr, Corps Engineers, Concord, MA USA; [Egeghy, Peter P.; Cohen-Hubal, Elaine; Vallero, Daniel A.] US EPA, Off Res & Dev, Res Triangle Pk, NC 27711 USA	Michigan State University; Carnegie Mellon University; United States Department of Defense; United States Army; U.S. Army Corps of Engineers; U.S. Army Engineer Research & Development Center (ERDC); ERDC - Risk Modeling; United States Environmental Protection Agency	Linkov, I (corresponding author), USA, Environm Lab, Engn Res & Dev Ctr, Corps Engineers, Concord, MA USA.	Igor.Linkov@usace.army.mil	Vallero, Daniel/ACA-4734-2022; Linkov, Igor/AAH-5981-2019	Vallero, Daniel/0000-0003-4680-4605; Linkov, Igor/0000-0002-0823-8107	United States Environmental Protection Agency through its Office of Research and Development; U.S. Army Corps of Engineers [DW-96-95807601-0]	United States Environmental Protection Agency through its Office of Research and Development(United States Environmental Protection Agency); U.S. Army Corps of Engineers(United States Department of DefenseUnited States Army)	The United States Environmental Protection Agency through its Office of Research and Development (funded and managed or partially funded and collaborated in) the research described here under an Interagency Agreement with the U.S. Army Corps of Engineers (DW-96-95807601-0). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], TITLE ERROR; Belton V., 2002, MULTIPLE CRITERIA DE, DOI DOI 10.1007/978-1-4615-1495-4; Canis L, 2010, ENVIRON SCI TECHNOL, V44, P8704, DOI 10.1021/es102117k; Cox LA, 2008, RISK ANAL, V28, P497, DOI 10.1111/j.1539-6924.2008.01030.x; Dellarco V, 2010, J TOXICOL ENV HEAL B, V13, P347, DOI 10.1080/10937404.2010.483950; *DOW CORNING CORP, 1999, 01112801 HERA DOW CO; Egeghy PP, 2012, SCI TOTAL ENVIRON, V414, P159, DOI 10.1016/j.scitotenv.2011.10.046; Egeghy PP, 2011, ENVIRON SCI POLICY, V14, P950, DOI 10.1016/j.envsci.2011.07.010; *ENV SCI CTR, 2007, PBT PROF; Gabbert S, 2010, NAT RESOUR FORUM, V34, P155, DOI 10.1111/j.1477-8947.2010.01300.x; Hubal EAC, 2010, J TOXICOL ENV HEAL B, V13, P299, DOI 10.1080/10937404.2010.483947; Judson R, 2009, ENVIRON HEALTH PERSP, V117, P685, DOI 10.1289/ehp.0800168; Linkov I, 2011, MULTICRITERIA DECISI; Linkov I, 2011, NAT NANOTECHNOL, V6, P784, DOI [10.1038/nnano.2011.163, 10.1038/NNANO.2011.163]; Mitchell J, 2013, SCI TOTAL ENVIRON, V458, P555, DOI [10.1016/j.scitotenv.2013.04.051, 10.1016/j.scitotenv.2013.04,051]; Muir DCG, 2006, ENVIRON SCI TECHNOL, V40, P7157, DOI 10.1021/es061677a; Muller M., 2007, LIT STUDY EFFECTS MO; OECD, 1992, TEST 301 READ BIOD O, DOI [10.1787/9789264070349-en, DOI 10.1787/9789264070349-EN]; Paralikas AN, 2005, PROCESS SAF ENVIRON, V83, P122, DOI 10.1205/psep.04236; ROSSI M, 2009, GREEN SCREEN SAFER C; Scheringer Martin, 2009, Integrated Environmental Assessment and Management, V5, P557, DOI 10.1897/IEAM_2009-007.1; SHATKIN J, 2005, COMP RISK ASSESSMENT, P213; STILLWELL WG, 1981, ORGAN BEHAV HUM PERF, V28, P62, DOI 10.1016/0030-5073(81)90015-5; USEPA, 2011, DES ENV PROGR ALT AS; *USEPA, 2009, CONC FRAM US EPAS NA; USEPA, 2011, EST PROGR INT SUIT M; USEPA T, 2012, TSCA WORK PLAN CHEM; Vermeire T, 2010, REGUL TOXICOL PHARM, V58, P408, DOI 10.1016/j.yrtph.2010.08.007; VONWINTERFELDD, 1986, DECISION ANAL BEHAV; Wilson MP, 2009, ENVIRON HEALTH PERSP, V117, P1202, DOI 10.1289/ehp.0800404; Yokota F, 2004, RISK ANAL, V24, P1625, DOI 10.1111/j.0272-4332.2004.00555.x; Zartarian V, 2005, J EXPO ANAL ENV EPID, V15, P1, DOI 10.1038/sj.jea.7500411	32	20	21	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2013	8	8							e70911	10.1371/journal.pone.0070911	http://dx.doi.org/10.1371/journal.pone.0070911			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	218XC	23940664	Green Published, gold, Green Submitted			2022-12-25	WOS:000324465000153
J	Neumann, C; Agil, M; Widdig, A; Engelhardt, A				Neumann, Christof; Agil, Muhammad; Widdig, Anja; Engelhardt, Antje			Personality of Wild Male Crested Macaques (Macaca nigra)	PLOS ONE			English	Article							TEMPORAL STABILITY; FITNESS CONSEQUENCES; ANIMAL PERSONALITY; NONHUMAN-PRIMATES; RHESUS MACAQUES; 5-FACTOR MODEL; SOCIAL-CONTEXT; ZEBRA FINCHES; GENUS MACACA; BEHAVIOR	Animal personalities, i.e. consistent differences in behavior across time and/or context, have received increased attention of behavioral biologists over the last years. Recent research shows that personalities represent traits on which natural and sexual selection work and which can have substantial fitness consequences. The aim of this study is to establish the personality structure of crested macaque (Macaca nigra) males as foundation for future studies on its adaptive value. We collected behavioral data through focal animal sampling and additionally conducted two sets of playback experiments. Results of a factor analysis on the behavioral data revealed a four factor structure with components we labeled Anxiety, Sociability, Connectedness and Aggressiveness. Results from the experiments revealed an additional and independent Boldness factor but the absence of Neophilia. Overall, this structure resembles other macaque and animal species with the exception of Connectedness, which might be a consequence of the species' tolerant social style. Our results thus not only form the basis for future studies on the adaptive value of personality in crested macaques but also contribute an important data point for investigating the evolution of personality structure from a comparative perspective by refining, for example, which personality factors characterized the last common ancestor of hominids and macaques.	[Neumann, Christof; Engelhardt, Antje] German Primate Ctr, Jr Res Grp Primate Sexual Select, Gottingen, Germany; [Neumann, Christof; Engelhardt, Antje] Univ Gottingen, Courant Res Ctr Evolut Social Behav, D-37073 Gottingen, Germany; [Neumann, Christof; Widdig, Anja] Max Planck Inst Evolutionary Anthropol, Jr Res Grp Primate Kin Select, Leipzig, Germany; [Neumann, Christof; Widdig, Anja] Univ Leipzig, Inst Biol, Fac Biosci Pharm & Psychol, D-04109 Leipzig, Germany; [Agil, Muhammad] Bogor Agr Univ, Fac Vet Med, Bogor, Indonesia	Deutsches Primatenzentrum (DPZ); University of Gottingen; Max Planck Society; Leipzig University; Bogor Agricultural University	Neumann, C (corresponding author), German Primate Ctr, Jr Res Grp Primate Sexual Select, Gottingen, Germany.	cneumann@dpz.eu	Agil, Muhammad/GPP-6160-2022; Engelhardt, Antje/A-2660-2013	Engelhardt, Antje/0000-0003-2704-7493; Neumann, Christof/0000-0002-0236-1219	German Research Foundation within the Emmy-Noether Program [EN 719/2]; Saxon State Ministry for Higher Education, Research and the Arts	German Research Foundation within the Emmy-Noether Program; Saxon State Ministry for Higher Education, Research and the Arts	This project was funded by the German Research Foundation (http://www.dfg.de), within the Emmy-Noether Program (grant No. EN 719/2 to AE). Additionally, CN received a stipend of the Saxon State Ministry for Higher Education, Research and the Arts (http://sachsen.de/en/1218.htm). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamowicz M, 2011, COMPAT POW ELECTR, P137, DOI 10.1109/CPE.2011.5942221; ALTMANN J, 1974, BEHAVIOUR, V49, P227, DOI 10.1163/156853974X00534; Anestis SF, 2011, DEV PRIMATOL-PROG PR, P169, DOI 10.1007/978-1-4614-0176-6_7; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bergman TJ, 2009, ANIM COGN, V12, P63, DOI 10.1007/s10071-008-0171-2; Berman CM, 2010, BEHAVIOUR, V147, P1863, DOI 10.1163/000579510X539691; BOLIG R, 1992, INT J PRIMATOL, V13, P287, DOI 10.1007/BF02547817; Budaev SV, 2010, ETHOLOGY, V116, P472, DOI 10.1111/j.1439-0310.2010.01758.x; CAINE NG, 1983, AM J PRIMATOL, V4, P253, DOI 10.1002/ajp.1350040304; Capitanio JP, 1999, AM J PRIMATOL, V47, P299, DOI 10.1002/(SICI)1098-2345(1999)47:4<299::AID-AJP3>3.0.CO;2-P; CAPITANIO JP, 2004, MACAQUE SOC MODEL ST, P13; Carter AJ, 2012, ANIM BEHAV, V84, P603, DOI 10.1016/j.anbehav.2012.06.015; CHENEY DL, 1992, BEHAV ECOL, V3, P334, DOI 10.1093/beheco/3.4.334; Dammhahn M, 2012, ANIM BEHAV, V84, P1131, DOI 10.1016/j.anbehav.2012.08.014; Dammhahn M, 2012, P ROY SOC B-BIOL SCI, V279, P2645, DOI 10.1098/rspb.2012.0212; David M, 2012, ETHOLOGY, V118, P932, DOI 10.1111/j.1439-0310.2012.02085.x; DEWAAL FBM, 1989, AM J PRIMATOL, V19, P83, DOI 10.1002/ajp.1350190203; DIGMAN JM, 1990, ANNU REV PSYCHOL, V41, P417, DOI 10.1146/annurev.psych.41.1.417; Dingemanse NJ, 2010, TRENDS ECOL EVOL, V25, P81, DOI 10.1016/j.tree.2009.07.013; Dingemanse NJ, 2004, P ROY SOC B-BIOL SCI, V271, P847, DOI 10.1098/rspb.2004.2680; Drea CM, 1998, AM J PRIMATOL, V44, P205, DOI 10.1002/(SICI)1098-2345(1998)44:3<205::AID-AJP3>3.0.CO;2-#; DREWS C, 1993, BEHAVIOUR, V125, P283, DOI 10.1163/156853993X00290; Duboscq J, 2013, AM J PRIMATOL, V75, P361, DOI 10.1002/ajp.22114; Evers E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026189; Field A., 2012, DISCOVERING STAT USI; Freeman HD, 2010, AM J PRIMATOL, V72, P653, DOI 10.1002/ajp.20833; Gosling SD, 1999, CURR DIR PSYCHOL SCI, V8, P69, DOI 10.1111/1467-8721.00017; Gosling SD, 2001, PSYCHOL BULL, V127, P45, DOI 10.1037//0033-2909.127.1.45; Higley JD, 2011, DEV PRIMATOL-PROG PR, P257, DOI 10.1007/978-1-4614-0176-6_10; John O.P., 1999, HDB PERSONALITY THEO, V1999, P102, DOI DOI 10.1037/A0019265; King JE, 1997, J RES PERS, V31, P257, DOI 10.1006/jrpe.1997.2179; Konecna M, 2008, J COMP PSYCHOL, V122, P379, DOI 10.1037/a0012625; Konecna M, 2012, J RES PERS, V46, P581, DOI 10.1016/j.jrp.2012.06.004; Koski SE, 2011, BEHAV ECOL SOCIOBIOL, V65, P2161, DOI 10.1007/s00265-011-1224-0; Koski SE, 2011, PRIMATOL MONOGR, P115, DOI 10.1007/978-4-431-53892-9_5; Kulik L, 2012, MOL ECOL, V21, P699, DOI 10.1111/j.1365-294X.2011.05250.x; LESSELLS CM, 1987, AUK, V104, P116, DOI 10.2307/4087240; Li J, 2009, GENE, V448, P242, DOI 10.1016/j.gene.2009.05.013; Maciej P, 2013, BEHAV ECOL SOCIOBIOL, V67, P61, DOI 10.1007/s00265-012-1425-1; MAESTRIPIERI D, 1992, ANIM BEHAV, V44, P967, DOI 10.1016/S0003-3472(05)80592-5; Majolo B, INT J PRIMA IN PRESS, DOI DOI 10.1007/S10764-013-9678-8.ACCESSED; Martin P., 1993, MEASURING BEHAV, V2nd, DOI [10.1017/CBO9781139168342, DOI 10.1017/CBO9781139168342]; McDonald DB, 2007, P NATL ACAD SCI USA, V104, P10910, DOI 10.1073/pnas.0701159104; MCGUIRE MT, 1994, AM J PRIMATOL, V33, P1, DOI 10.1002/ajp.1350330102; Micheletta J, 2012, P ROY SOC B-BIOL SCI, V279, P4042, DOI 10.1098/rspb.2012.1470; Micheletta J, 2012, ANIM BEHAV, V83, P459, DOI 10.1016/j.anbehav.2011.11.018; Mitani J., 2012, EVOLUTION PRIMATE SO; MONDRAGONCEBALL.R, 1994, CURRENT PRIMATOLOGY, V2, P241; Morales JC, 1998, J HUM EVOL, V34, P1, DOI 10.1006/jhev.1997.0171; Nakagawa S, 2010, BIOL REV, V85, P935, DOI 10.1111/j.1469-185X.2010.00141.x; Neumann C, 2011, ANIM BEHAV, V82, P911, DOI 10.1016/j.anbehav.2011.07.016; Neumann C, 2010, ANIM BEHAV, V79, P187, DOI 10.1016/j.anbehav.2009.10.026; Petit O, 1997, BEHAVIOUR, V134, P415, DOI 10.1163/156853997X00610; R Core Team, 2012, R LANG ENV STAT COMP; Reale D, 2007, BIOL REV, V82, P291, DOI 10.1111/j.1469-185X.2007.00010.x; Revelle W., 2012, PSYCH PROCEDURES PSY; Schielzeth H, 2011, RPTR REPEATABILITY G; Schuett W, 2010, BIOL REV, V85, P217, DOI 10.1111/j.1469-185X.2009.00101.x; Schuett W, 2009, ANIM BEHAV, V77, P1041, DOI 10.1016/j.anbehav.2008.12.024; Seyfarth RM, 2012, P NATL ACAD SCI USA, V109, P16980, DOI 10.1073/pnas.1210780109; Sih A, 2009, BEHAV ECOL SOCIOBIOL, V63, P975, DOI 10.1007/s00265-009-0725-6; Smith BR, 2008, BEHAV ECOL, V19, P448, DOI 10.1093/beheco/arm144; STEVENSON-HINDE J, 1978, Primates, V19, P473, DOI 10.1007/BF02373309; Sueur C, 2011, ANIM BEHAV, V82, P845, DOI 10.1016/j.anbehav.2011.07.020; Supriatna J, 2008, IUCN 2012 IUCN RED L; Sussman AF, 2013, AM J PRIMATOL, V75, P303, DOI 10.1002/ajp.22104; Theirry B, 2011, PRIMATES PERSPECTIVE, P229; THIERRY B, 1990, J THEOR BIOL, V145, P511, DOI 10.1016/S0022-5193(05)80485-0; Thierry B., 2000, Primate Research, V16, P203; Thierry B, 2000, ETHOLOGY, V106, P713, DOI 10.1046/j.1439-0310.2000.00583.x; Thierry B, 2007, EVOL ANTHROPOL, V16, P224, DOI 10.1002/evan.20147; Thierry Bernard, 2000, P106; Uher J, 2008, EUR J PERSONALITY, V22, P427, DOI 10.1002/per.680; Uher J, 2008, ANIM BEHAV, V75, P99, DOI 10.1016/j.anbehav.2007.04.018; Weiss A, 2006, J PERS SOC PSYCHOL, V90, P501, DOI 10.1037/0022-3514.90.3.501; Weiss A, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2012.2231; Weiss A, 2011, J COMP PSYCHOL, V125, P72, DOI 10.1037/a0021187; Wilson ADM, 2013, BEHAV ECOL SOCIOBIOL, V67, P163, DOI 10.1007/s00265-012-1428-y; Yokoyama C, 2011, PRIMATOL MONOGR, P389, DOI 10.1007/978-4-431-53892-9_19; Young LJ, 2004, NAT NEUROSCI, V7, P1048, DOI 10.1038/nn1327	80	32	33	3	80	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2013	8	8							e69383	10.1371/journal.pone.0069383	http://dx.doi.org/10.1371/journal.pone.0069383			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	218XC	23940517	Green Published, Green Submitted, Green Accepted, gold			2022-12-25	WOS:000324465000012
J	Nyati, P; Nouzova, M; Rivera-Perez, C; Clifton, ME; Mayoral, JG; Noriega, FG				Nyati, Pratik; Nouzova, Marcela; Rivera-Perez, Crisalejandra; Clifton, Mark E.; Mayoral, Jaime G.; Noriega, Fernando G.			Farnesyl Phosphatase, a Corpora allata Enzyme Involved in Juvenile Hormone Biosynthesis in Aedes aegypti	PLOS ONE			English	Article							NUTRITIONAL REGULATION; HAD SUPERFAMILY; SWISS-MODEL; DEHYDROGENASE; EXPRESSION; SPECIFICITY; PATHWAY; DOMAIN	Background: The juvenile hormones (JHs) are sesquiterpenoid compounds that play a central role in insect reproduction, development and behavior. The late steps of JH III biosynthesis in the mosquito Aedes aegypti involve the hydrolysis of farnesyl pyrophosphate (FPP) to farnesol (FOL), which is then successively oxidized to farnesal and farnesoic acid, methylated to form methyl farnesoate and finally transformed to JH III by a P450 epoxidase. The only recognized FPP phosphatase (FPPase) expressed in the corpora allata (CA) of an insect was recently described in Drosophila melanogaster (DmFPPase). In the present study we sought to molecularly and biochemically characterize the FPP phosphatase responsible for the transformation of FPP into FOL in the CA of A. aegypti. Methods: A search for orthologs of the DmFPPase in Aedes aegypti led to the identification of 3 putative FPPase paralogs expressed in the CA of the mosquito (AaFPPases-1, -2, and -3). The activities of recombinant AaFPPases were tested against general phosphatase substrates and isoprenoid pyrophosphates. Using a newly developed assay utilizing fluorescent tags, we analyzed AaFPPase activities in CA of sugar and blood-fed females. Double-stranded RNA (dsRNA) was used to evaluate the effect of reduction of AaFPPase mRNAs on JH biosynthesis. Conclusions: AaFPPase-1 and AaFPPase-2 are members of the NagD family of the Class IIA C2 cap-containing haloalkanoic acid dehalogenase (HAD) super family and efficiently hydrolyzed FPP into FOL. AaFPPase activities were different in CA of sugar and blood-fed females. Injection of dsRNAs resulted in a significant reduction of AaFPPase-1 and AaFPPase-2 mRNAs, but only reduction of AaFPPase-1 caused a significant decrease of JH biosynthesis. These results suggest that AaFPPase-1 is predominantly involved in the catalysis of FPP into FOL in the CA of A. aegypti.	[Nyati, Pratik; Nouzova, Marcela; Rivera-Perez, Crisalejandra; Clifton, Mark E.; Mayoral, Jaime G.; Noriega, Fernando G.] Florida Int Univ, Dept Biol Sci, Miami, FL 33199 USA	State University System of Florida; Florida International University	Noriega, FG (corresponding author), Florida Int Univ, Dept Biol Sci, Miami, FL 33199 USA.	noriegaf@fiu.edu	Nouzova, Marcela/AAK-8609-2021; Rivera-Perez, Crisalejandra/AAM-1269-2021; G. Mayoral, Jaime/J-5392-2018	Nouzova, Marcela/0000-0002-4562-1383; G. Mayoral, Jaime/0000-0002-8813-6804; Rivera Perez, Crisalejandra/0000-0002-9746-3225	National Institutes of Health [AI 45545]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI045545] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institutes of Health grant AI 45545 to FGN. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen KN, 2009, CURR OPIN STRUC BIOL, V19, P658, DOI 10.1016/j.sbi.2009.09.008; Allen KN, 2004, TRENDS BIOCHEM SCI, V29, P495, DOI 10.1016/j.tibs.2004.07.008; Aravind L, 1998, TRENDS BIOCHEM SCI, V23, P127, DOI 10.1016/S0968-0004(98)01189-X; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Burroughs AM, 2006, J MOL BIOL, V361, P1003, DOI 10.1016/j.jmb.2006.06.049; Cao L, 2009, BIOCHEM BIOPH RES CO, V380, P188, DOI 10.1016/j.bbrc.2009.01.079; Cronin A, 2003, P NATL ACAD SCI USA, V100, P1552, DOI 10.1073/pnas.0437829100; Goodman W.G., 2012, INSECT ENDOCRINOLOGY, P310, DOI DOI 10.1016/B978-0-12-384749-2.10008-1; JAKOBY WB, 1990, J BIOL CHEM, V265, P20715; Joo JH, 2010, CANCER LETT, V287, P123, DOI 10.1016/j.canlet.2009.05.015; Journe F, 2008, BREAST CANCER RES TR, V107, P49, DOI 10.1007/s10549-007-9535-6; Kinjoh T, 2007, INSECT BIOCHEM MOLEC, V37, P808, DOI 10.1016/j.ibmb.2007.03.008; Klowden MJ, 1997, ARCH INSECT BIOCHEM, V35, P491, DOI 10.1002/(SICI)1520-6327(1997)35:4<491::AID-ARCH10>3.3.CO;2-5; KOONIN EV, 1994, J MOL BIOL, V244, P125, DOI 10.1006/jmbi.1994.1711; Lahiri SD, 2004, BIOCHEMISTRY-US, V43, P2812, DOI 10.1021/bi0356810; Lawson D, 2009, NUCLEIC ACIDS RES, V37, pD583, DOI 10.1093/nar/gkn857; Li YP, 2003, INSECT BIOCHEM MOLEC, V33, P1307, DOI 10.1016/j.ibmb.2003.07.003; Mayoral JG, 2009, P NATL ACAD SCI USA, V106, P21091, DOI 10.1073/pnas.0909938106; Mayoral JG, 2009, INSECT BIOCHEM MOLEC, V39, P31, DOI 10.1016/j.ibmb.2008.09.010; Noriega FG, 2004, INSECT BIOCHEM MOLEC, V34, P687, DOI 10.1016/j.ibmb.2004.03.021; Nouzova M, 2011, INSECT BIOCHEM MOLEC, V41, P660, DOI 10.1016/j.ibmb.2011.04.008; Pechlivanis M, 2006, BBA-PROTEINS PROTEOM, V1764, P1914, DOI 10.1016/j.bbapap.2006.09.017; Perez-Hedo M, 2013, INSECT BIOCHEM MOLEC, V43, P495, DOI 10.1016/j.ibmb.2013.03.008; Rivera-Perez C, 2013, INSECT BIOCHEM MOLEC, V43, P675, DOI 10.1016/j.ibmb.2013.04.002; Rivera-Perez C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043784; RIZZO WB, 1991, J CLIN INVEST, V88, P1643, DOI 10.1172/JCI115478; Roullet JB, 1999, J BIOL CHEM, V274, P25439, DOI 10.1074/jbc.274.36.25439; Schwede T, 2003, NUCLEIC ACIDS RES, V31, P3381, DOI 10.1093/nar/gkg520; Seifried A, 2013, FEBS J, V280, P549, DOI 10.1111/j.1742-4658.2012.08633.x; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; TOBE SS, 1985, ADV INSECT PHYSIOL, V18, P305; Tschantz WR, 2001, J BIOL CHEM, V276, P2321, DOI 10.1074/jbc.C000616200; Ueda H, 2009, J INSECT PHYSIOL, V55, P798, DOI 10.1016/j.jinsphys.2009.04.013; VANVELDHOVEN PP, 1987, ANAL BIOCHEM, V161, P45, DOI 10.1016/0003-2697(87)90649-X	34	23	23	3	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2013	8	8							e71967	10.1371/journal.pone.0071967	http://dx.doi.org/10.1371/journal.pone.0071967			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	218XC	23940797	gold, Green Published, Green Submitted			2022-12-25	WOS:000324465000236
J	Wang, SC; Yu, CF; Hong, JH; Tsai, CS; Chiang, CS				Wang, Shu-Chi; Yu, Ching-Fang; Hong, Ji-Hong; Tsai, Chien-Sheng; Chiang, Chi-Shiun			Radiation Therapy-Induced Tumor Invasiveness Is Associated with SDF-1-Regulated Macrophage Mobilization and Vasculogenesis	PLOS ONE			English	Article							HUMAN GLIOBLASTOMA; FACTOR-I; MALIGNANT ASTROCYTOMAS; PROTEOMIC ANALYSIS; PROGENITOR CELLS; STEM-CELLS; IRRADIATION; ANGIOGENESIS; RADIOTHERAPY; HYPOXIA	Radiation therapy (RT) remains the front-line treatment for high-grade gliomas; however, tumor recurrence remains the main obstacle for the clinical success of RT. Using a murine astrocytoma tumor cell line, ALTS1C1, the present study demonstrates that whole brain irradiation prolonged the survival of tumor-bearing mice, although the mice eventually died associated with increased tumor infiltration. Immunohistochemical (IHC) analysis indicated that RT decreased the microvascular density (MVD) of the primary tumor core, but increased the MVD of the tumor invasion front. RT also increased the number of tumor-associated macrophages (TAMs) and the expression of stromal cell-derived factor-1 (SDF-1) and hypoxia-inducible factor-1 (HIF-1) at the tumor invasion front. SDF-1 expression suppressed by siRNA (SDFkd tumors) showed a decrease in RT-enhanced tumor invasiveness, leading to prolonged survival of mice bearing these tumors. The invasion front in SDFkd tumors showed a lower MVD and TAM density than that in the islands of the control or irradiated ALTS1C1 tumors. Our results indicate that tumor-secreted SDF-1 is one key factor in RT-induced tumor invasiveness, and that it exerts its effect likely through macrophage mobilization and tumor revascularization.	[Wang, Shu-Chi; Yu, Ching-Fang; Chiang, Chi-Shiun] Natl Tsing Hua Univ, Dept Biomed Engn & Environm Sci, Hsinchu, Taiwan; [Wang, Shu-Chi] Univ Texas SW Med Ctr Dallas, Dept Radiat Oncol, Dallas, TX 75390 USA; [Hong, Ji-Hong; Tsai, Chien-Sheng] Chang Gung Mem Hosp, Dept Radiat Oncol, Tao Yuan, Taiwan; [Hong, Ji-Hong] Chang Gung Univ, Dept Med Imaging & Radiol Sci, Tao Yuan, Taiwan	National Tsing Hua University; University of Texas System; University of Texas Southwestern Medical Center Dallas; Chang Gung Memorial Hospital; Chang Gung University	Chiang, CS (corresponding author), Natl Tsing Hua Univ, Dept Biomed Engn & Environm Sci, Hsinchu, Taiwan.	cschiang@mx.nthu.edu.tw	Chiang, Chi-Shiun/A-9562-2008	Chiang, Chi-Shiun/0000-0002-2581-4129	NSC [100-2314-B-182A-094]; National Tsing Hua University, Taiwan;  [NHRI-EX101-10132BI];  [NSC 101-2627-N-007-001];  [NTHU-101N2050E1];  [NHTU-101N2760E1]	NSC(Ministry of Science and Technology, Taiwan); National Tsing Hua University, Taiwan; ; ; ; 	This study is supported by NHRI-EX101-10132BI, NSC 101-2627-N-007-001, NTHU-101N2050E1, and NHTU-101N2760E1 grants to Chiang, C. S.; NSC 100-2314-B-182A-094 grant to Tsai, C. S.; Wang S. C. was supported by the post-doctor fellowship of National Tsing Hua University, Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aghi M, 2006, CANCER RES, V66, P9054, DOI 10.1158/0008-5472.CAN-05-3759; Aiuti A, 1997, J EXP MED, V185, P111, DOI 10.1084/jem.185.1.111; Badiga AV, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020614; Canazza A, 2011, CANCER BIOL THER, V12, P629, DOI 10.4161/cbt.12.7.16862; Chen FH, 2009, CLIN CANCER RES, V15, P1721, DOI 10.1158/1078-0432.CCR-08-1471; Chen J, 2012, CELL, V149, P36, DOI 10.1016/j.cell.2012.03.009; Chiang CS, 2012, FRONT ONCOL, V2, P1, DOI 10.3389/fonc.2012.00089; DeNardo DG, 2011, CANCER DISCOV, V1, P54, DOI 10.1158/2159-8274.CD-10-0028; FINE HA, 1993, CANCER, V71, P2585, DOI 10.1002/1097-0142(19930415)71:8<2585::AID-CNCR2820710825>3.0.CO;2-S; GARDEN AS, 1991, RADIOTHER ONCOL, V20, P99, DOI 10.1016/0167-8140(91)90143-5; Gazitt Y, 2004, STEM CELLS, V22, P65, DOI 10.1634/stemcells.22-1-65; Gimenez M, 2010, PROTEOMICS, V10, P2812, DOI 10.1002/pmic.200900722; Hoelzinger DB, 2007, J NATL CANCER I, V99, P1583, DOI 10.1093/jnci/djm187; Kioi M, 2010, J CLIN INVEST, V120, P694, DOI 10.1172/JCI40283; Komatani H, 2009, INT J ONCOL, V34, P665, DOI 10.3892/ijo_00000192; Kozin SV, 2010, CANCER RES, V70, P5679, DOI 10.1158/0008-5472.CAN-09-4446; Louis DN, 2006, ANNU REV PATHOL-MECH, V1, P97, DOI 10.1146/annurev.pathol.1.110304.100043; MASSEY V, 1990, INT J RADIAT ONCOL, V18, P395, DOI 10.1016/0360-3016(90)90106-T; Moeller BJ, 2004, CANCER CELL, V5, P429, DOI 10.1016/S1535-6108(04)00115-1; Odemis V, 2002, J BIOL CHEM, V277, P39801, DOI 10.1074/jbc.M200472200; Priceman SJ, 2010, BLOOD, V115, P1461, DOI 10.1182/blood-2009-08-237412; Pusic I, 2010, CURR OPIN HEMATOL, V17, P319, DOI 10.1097/MOH.0b013e328338b7d5; Rempel SA, 2000, CLIN CANCER RES, V6, P102; Rofstad EK, 2005, CANCER RES, V65, P2387, DOI 10.1158/0008-5472.CAN-04-3039; Salmaggi A, 2004, J NEURO-ONCOL, V67, P305, DOI 10.1023/B:NEON.0000024241.05346.24; Salvucci O, 2002, BLOOD, V99, P2703, DOI 10.1182/blood.V99.8.2703; Stupp R, 2005, NEW ENGL J MED, V352, P987, DOI 10.1056/NEJMoa043330; Thirant C, 2012, STEM CELLS, V30, P845, DOI 10.1002/stem.1062; Tsai JH, 2005, CANCER BIOL THER, V4, P1395, DOI 10.4161/cbt.4.12.2331; Tseng D, 2011, BRIT J CANCER, V104, P1805, DOI 10.1038/bjc.2011.169; Wang SC, 2012, LAB INVEST, V92, P151, DOI 10.1038/labinvest.2011.128; Wild-Bode C, 2001, CANCER RES, V61, P2744; Xu J, 2013, CANC RES; Zips D, 2001, INT J RADIAT BIOL, V77, P1185, DOI 10.1080/09553000110073402	34	52	55	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2013	8	8							e69182	10.1371/journal.pone.0069182	http://dx.doi.org/10.1371/journal.pone.0069182			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	218XC	23940516	Green Published, gold, Green Submitted			2022-12-25	WOS:000324465000011
J	Chatterjee, P; Seal, S; Mukherjee, S; Kundu, R; Mukherjee, S; Ray, S; Mukhopadhyay, S; Majumdar, SS; Bhattacharya, S				Chatterjee, Priyajit; Seal, Soma; Mukherjee, Sandip; Kundu, Rakesh; Mukherjee, Sutapa; Ray, Sukanta; Mukhopadhyay, Satinath; Majumdar, Subeer S.; Bhattacharya, Samir			Adipocyte Fetuin-A Contributes to Macrophage Migration into Adipose Tissue and Polarization of Macrophages	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MECHANISMS LINKING OBESITY; INDUCED INSULIN-RESISTANCE; CRUCIAL ROLE; KAPPA-B; INFLAMMATION; ACCUMULATION; DISEASE; PLAYS; TLR4; MICE	Macrophage infiltration into adipose tissue during obesity and their phenotypic conversion from anti-inflammatory M2 to proinflammatory M1 subtype significantly contributes to develop a link between inflammation and insulin resistance; signaling molecule(s) for these events, however, remains poorly understood. We demonstrate here that excess lipid in the adipose tissue environment may trigger one such signal. Adipose tissue from obese diabetic db/db mice, high fat diet-fed mice, and obese diabetic patients showed significantly elevated fetuin-A (FetA) levels in respect to their controls; partially hepatectomized high fat diet mice did not show noticeable alteration, indicating adipose tissue to be the source of this alteration. In adipocytes, fatty acid induces FetA gene and protein expressions, resulting in its copious release. We found that FetA could act as a chemoattractant for macrophages. To simulate lipid-induced inflammatory conditions when proinflammatory adipose tissue and macrophages create a niche of an altered microenvironment, we set up a transculture system of macro-phages and adipocytes; the addition of fatty acid to adipocytes released FetA into the medium, which polarized M2 macrophages to M1. This was further confirmed by direct FetA addition to macrophages. Taken together, lipid-induced FetA from adipocytes is an efficient chemokine for macrophage migration and polarization. These findings open a new dimension for understanding obesity-induced inflammation.	[Chatterjee, Priyajit; Seal, Soma; Mukherjee, Sandip; Kundu, Rakesh; Mukherjee, Sutapa; Bhattacharya, Samir] Visva Bharati Univ, Sch Life Sci, Dept Zool, Santini Ketan 731235, W Bengal, India; [Ray, Sukanta; Mukhopadhyay, Satinath] Postgrad Inst Med Educ & Res, Dept Endocrinol & Metab, Kolkata 700020, India; [Ray, Sukanta; Mukhopadhyay, Satinath] IPGMER SSKM Hosp, Seth Sukhlal Karnani Mem Hosp, Kolkata 700020, India; [Majumdar, Subeer S.] Natl Inst Immunol, Div Cellular Endocrinol, New Delhi 110067, India	Visva Bharati University; Institute of Post Graduate Medical Education & Research (IPGMER), Kolkata; Institute of Post Graduate Medical Education & Research (IPGMER), Kolkata; Department of Biotechnology (DBT) India; National Institute of Immunology (NII)	Bhattacharya, S (corresponding author), Visva Bharati Univ, Ctr Adv Studies Zool, Santini Ketan 731235, W Bengal, India.	bhattacharyasa@gmail.com	Kundu, Rakesh/AAG-2582-2021; Mukherjee, Sutapa/AAV-1322-2020; Kundu, Rakesh Kundu/AAC-3543-2019; Kundu, Rakesh/ABE-3083-2021	Kundu, Rakesh Kundu/0000-0001-8871-0565; Majumdar, Subeer/0000-0003-1724-7483; CHATTERJEE, PRIYAJIT/0000-0001-6728-0981; Mukhopadhyay, Satinath/0000-0001-8033-5748	National Academy of Sciences, India (NASI); Department of Science and Technology, Ministry of Science and Technology [VI-D&P/413/2012-13/TDT]; Council of Scientific and Industrial Research [CSC 207]	National Academy of Sciences, India (NASI)(Department of Science & Technology (India)); Department of Science and Technology, Ministry of Science and Technology(Department of Science & Technology (DOST), Philippines); Council of Scientific and Industrial Research(Council of Scientific & Industrial Research (CSIR) - India)	This work was supported by the Department of Science and Technology, Ministry of Science and Technology (Grant VI-D&P/413/2012-13/TDT) and Council of Scientific and Industrial Research (Grant CSC 207).; Supported by a fellowship from National Academy of Sciences, India (NASI). To whom correspondence should be addressed: Centre for Advanced Studies in Zoology, Visva-Bharati University, Santiniketan-731 235, West Bengal, India. Tel.: 91-3463-261268; Fax: 91-3463-261176; E-mail: bhattacharyasa@gmail.com.	Dasgupta S, 2010, BIOCHEM J, V429, P451, DOI 10.1042/BJ20100330; Despres JP, 2006, NATURE, V444, P881, DOI 10.1038/nature05488; Dey D, 2006, MOL CELL ENDOCRINOL, V246, P60, DOI 10.1016/j.mce.2005.12.014; Feve B, 2009, NAT REV ENDOCRINOL, V5, P305, DOI 10.1038/nrendo.2009.62; Glass CK, 2012, CELL METAB, V15, P635, DOI 10.1016/j.cmet.2012.04.001; Gregor MF, 2011, ANNU REV IMMUNOL, V29, P415, DOI 10.1146/annurev-immunol-031210-101322; Hostamisligil GS, 1999, EXP CLIN ENDOCR DIAB, V107, P119, DOI 10.1055/s-0029-1212086; Inouye KE, 2007, DIABETES, V56, P2242, DOI 10.2337/db07-0425; Ix JH, 2010, J AM SOC NEPHROL, V21, P406, DOI 10.1681/ASN.2009080820; Johnson AMF, 2013, CELL, V152, P673, DOI 10.1016/j.cell.2013.01.041; Kahn SE, 2006, NATURE, V444, P840, DOI 10.1038/nature05482; Lumeng CN, 2007, DIABETES, V56, P16, DOI 10.2337/db06-1076; Lumeng CN, 2007, J CLIN INVEST, V117, P175, DOI 10.1172/JCI29881; Lumeng CN, 2011, J CLIN INVEST, V121, P2111, DOI 10.1172/JCI57132; Mori K, 2006, DIABETES CARE, V29, P468, DOI 10.2337/diacare.29.02.06.dc05-1484; Nguyen MTA, 2007, J BIOL CHEM, V282, P35279, DOI 10.1074/jbc.M706762200; Oh DY, 2012, DIABETES, V61, P346, DOI 10.2337/db11-0860; Pal D, 2012, NAT MED, V18, P1279, DOI 10.1038/nm.2851; Schenk S, 2008, J CLIN INVEST, V118, P2992, DOI 10.1172/JCI34260; Shi H, 2006, J CLIN INVEST, V116, P3015, DOI 10.1172/JCI28898; Takashiba S, 1999, INFECT IMMUN, V67, P5573, DOI 10.1128/IAI.67.11.5573-5578.1999; Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI200319246; Xu HY, 2003, J CLIN INVEST, V112, P1821, DOI 10.1172/JCI200319451; Yu RN, 2006, OBESITY, V14, P1353, DOI 10.1038/oby.2006.153	24	88	90	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 27	2013	288	39					28324	28330		10.1074/jbc.C113.495473	http://dx.doi.org/10.1074/jbc.C113.495473			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302OB	23943623	hybrid, Green Published			2022-12-25	WOS:000330612800061
J	Santorelli, G; Petherick, ES; Wright, J; Wilson, B; Samiei, H; Cameron, N; Johnson, W				Santorelli, Gillian; Petherick, Emily S.; Wright, John; Wilson, Brad; Samiei, Haider; Cameron, Noel; Johnson, William			Developing Prediction Equations and a Mobile Phone Application to Identify Infants at Risk of Obesity	PLOS ONE			English	Article							BODY-MASS INDEX; CHILDHOOD OBESITY; WEIGHT-GAIN; MATERNAL SMOKING; CRITICAL PERIODS; SOCIAL NETWORK; OVERWEIGHT; GROWTH; TRACKING; BIRTH	Background: Advancements in knowledge of obesity aetiology and mobile phone technology have created the opportunity to develop an electronic tool to predict an infant's risk of childhood obesity. The study aims were to develop and validate equations for the prediction of childhood obesity and integrate them into a mobile phone application (App). Methods and Findings: Anthropometry and childhood obesity risk data were obtained for 1868 UK-born White or South Asian infants in the Born in Bradford cohort. Logistic regression was used to develop prediction equations (at 6 +/- 1.5, 9 +/- 1.5 and 12 +/- 1.5 months) for risk of childhood obesity (BMI at 2 years >91st centile and weight gain from 0-2 years >1 centile band) incorporating sex, birth weight, and weight gain as predictors. The discrimination accuracy of the equations was assessed by the area under the curve (AUC); internal validity by comparing area under the curve to those obtained in bootstrapped samples; and external validity by applying the equations to an external sample. An App was built to incorporate six final equations (two at each age, one of which included maternal BMI). The equations had good discrimination (AUCs 86-91%), with the addition of maternal BMI marginally improving prediction. The AUCs in the bootstrapped and external validation samples were similar to those obtained in the development sample. The App is user-friendly, requires a minimum amount of information, and provides a risk assessment of low, medium, or high accompanied by advice and website links to government recommendations. Conclusions: Prediction equations for risk of childhood obesity have been developed and incorporated into a novel App, thereby providing proof of concept that childhood obesity prediction research can be integrated with advancements in technology.	[Santorelli, Gillian; Petherick, Emily S.; Wright, John] Bradford Royal Infirm, Bradford Inst Hlth Res, Bradford BD9 6RJ, W Yorkshire, England; [Wilson, Brad; Samiei, Haider] iED, Bradford, W Yorkshire, England; [Cameron, Noel] Univ Loughborough, Sch Sport Exercise & Hlth Sci, Loughborough, Leics, England; [Johnson, William] MRC, Unit Lifelong Hlth & Ageing, London, England	Bradford Royal Infirmary; Loughborough University	Santorelli, G (corresponding author), Bradford Royal Infirm, Bradford Inst Hlth Res, Bradford BD9 6RJ, W Yorkshire, England.	Gillian.Santorelli@bthft.nhs.uk	Wright, John/H-1624-2012; Petherick, Emily s/J-9755-2012	Wright, John/0000-0001-9572-7293; Petherick, Emily s/0000-0001-6778-8128; Johnson, Will/0000-0002-0347-4354; Santorelli, Gillian/0000-0003-0427-1783	Child Growth Foundation; National Institute for Health Research (NIHR) [RP-PG-0407-10044]; Medical Research Council [G9815508] Funding Source: researchfish; National Institute for Health Research [RP-PG-0407-10044] Funding Source: researchfish	Child Growth Foundation; National Institute for Health Research (NIHR)(National Institute for Health Research (NIHR)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR))	This paper presents independent research funded by the Child Growth Foundation and by the National Institute for Health Research (NIHR) under the Collaborations for Leadership in Applied Health Research and Care (CLAHRC) programme for Leeds, York and Bradford and the Programme Grants for Applied Research funding scheme (RP-PG-0407-10044). The views expressed in this publication are those of the author(s) and not necessarily those of the Child Growth Foundation, NHS, the NIHR or the Department of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adair LS, 2007, AM J HUM BIOL, V19, P327, DOI 10.1002/ajhb.20587; Ali MM, 2011, SOUTH ECON J, V77, P827, DOI 10.4284/0038-4038-77.4.827; Ali MM, 2007, NEW ENGL J MED, V257, P370; [Anonymous], 1993, INTRO BOOTSTRAP; Baird J, 2005, BMJ-BRIT MED J, V331, P929, DOI 10.1136/bmj.38586.411273.E0; Baptiste-Roberts K, 2012, MATERN CHILD HLTH J, V16, P125, DOI 10.1007/s10995-011-0756-2; Betoko A, 2012, MATERNCHILD NUTR; Boyd A, 2012, INT J EPIDEMIOL; Bryant M, 2013, LONGITUD LIFE COURSE, V4, P119; Bundred P, 2001, BMJ-BRIT MED J, V322, P326, DOI 10.1136/bmj.322.7282.326; Cameron N, 2005, AM J HUM BIOL, V17, P412, DOI 10.1002/ajhb.20408; Cameron N, 2002, YEARB PHYS ANTHROPOL, V45, P159, DOI 10.1002/ajpa.10183; Christakis NA, 2007, NEW ENGL J MED, V357, P370, DOI 10.1056/NEJMsa066082; Christensen VT, 2012, HEALTH, V16, P382, DOI 10.1177/1363459311425512; Chrzanowska M, 2012, AM J HUM BIOL, V24, P62, DOI 10.1002/ajhb.22204; Crume TL, 2011, J PEDIATR-US, V158, P941, DOI 10.1016/j.jpeds.2010.12.007; Department of Health, 2008, HLTH WEIGHT HLTH LIV; Druet C, 2012, PAEDIATR PERINAT EP, V26, P19, DOI 10.1111/j.1365-3016.2011.01213.x; Freedman DS, 2001, PEDIATRICS, V108, P712, DOI 10.1542/peds.108.3.712; FREEMAN JV, 1995, ARCH DIS CHILD, V73, P17, DOI 10.1136/adc.73.1.17; Freitas D, 2012, ANN HUM BIOL, V39, P59, DOI 10.3109/03014460.2011.638322; Ge S, 2011, ASIA PAC J CLIN NUTR, V20, P432; Han JC, 2010, LANCET, V375, P1737, DOI 10.1016/S0140-6736(10)60171-7; Horowitz B, 2011, EWEEK; Howe LD, 2009, ARCH DIS CHILD, V94, P950, DOI 10.1136/adc.2009.162552; Johnson W, 2009, INT J NURS STUD, V46, P310, DOI 10.1016/j.ijnurstu.2008.10.003; Kimbro RT, 2007, AM J PUBLIC HEALTH, V97, P298, DOI 10.2105/AJPH.2005.080812; Koshy G, 2011, EUR J PUBLIC HEALTH, V21, P286, DOI 10.1093/eurpub/ckq173; Kuzawa CW, 2012, AM J HUM BIOL, V24, P5, DOI 10.1002/ajhb.21227; Lampl M, 2011, SLEEP, V34, P641, DOI 10.1093/sleep/34.5.641; Lawlor DA, 2006, INT J EPIDEMIOL, V35, P3, DOI 10.1093/ije/dyi309; Lawlor DA, 2011, CIRCULATION, V123, P258, DOI 10.1161/CIRCULATIONAHA.110.980169; Lobstein T., 2004, OBESITY REV OFFIC S1, V5, P4, DOI [10.1111/j.1467-789X.2004.00133.x, DOI 10.1111/J.1467-789X.2004.00133.X]; MCPHERSON K, 2007, MODELLING FUTURE TRE; Monasta L, 2010, OBES REV, V11, P695, DOI 10.1111/j.1467-789X.2010.00735.x; Morandi A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049919; Norris SA, 2012, DIABETES CARE, V35, P72, DOI 10.2337/dc11-0456; Oellingrath IM, 2011, NUTR J, V10, DOI 10.1186/1475-2891-10-106; Oken E, 2008, INT J OBESITY, V32, P201, DOI 10.1038/sj.ijo.0803760; Parsons TJ, 2001, BRIT MED J, V323, P1331, DOI 10.1136/bmj.323.7325.1331; Procter KL, 2007, NUTR RES REV, V20, P29, DOI 10.1017/S0954422407746991; Raynor P, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-327; Reilly JJ, 2005, BMJ-BRIT MED J, V330, P1357, DOI 10.1136/bmj.38470.670903.E0; Rudolf M, 2011, ARCH DIS CHILD, V96, P995, DOI 10.1136/adc.2010.197251; Singh AS, 2008, OBES REV, V9, P474, DOI 10.1111/j.1467-789X.2008.00475.x; Singhal A, 2003, LANCET, V361, P1089, DOI 10.1016/S0140-6736(03)12895-4; StataCorp, 2019, STATA STAT SOFTWARE; Suzuki K, 2012, J EPIDEMIOL, V22, P175, DOI 10.2188/jea.JE20110033; Taveras EM, 2010, PEDIATRICS, V125, P686, DOI 10.1542/peds.2009-2100; Toselli S, 2012, COLLEGIUM ANTROPOL, V36, P63; van der Gugten AC, 2012, EUR RESPIR J, V39, P403, DOI 10.1183/09031936.00188310; Wang Y, 2006, INT J PEDIATR OBES, V1, P11, DOI 10.1080/17477160600586747; Wright J, 2012, INT J EPIDE IN PRESS	53	22	22	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2013	8	8							e71183	10.1371/journal.pone.0071183	http://dx.doi.org/10.1371/journal.pone.0071183			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	200ZE	23940713	gold, Green Published			2022-12-25	WOS:000323109700086
J	Koizumi, M; Hiasa, Y; Kumagi, T; Yamanishi, H; Azemoto, N; Kobata, T; Matsuura, B; Abe, M; Onji, M				Koizumi, Mitsuhito; Hiasa, Yoichi; Kumagi, Teru; Yamanishi, Hirofumi; Azemoto, Nobuaki; Kobata, Tetsuji; Matsuura, Bunzo; Abe, Masanori; Onji, Morikazu			Increased B Cell-Activating Factor Promotes Tumor Invasion and Metastasis in Human Pancreatic Cancer	PLOS ONE			English	Article							NECROSIS-FACTOR FAMILY; EPITHELIAL-MESENCHYMAL TRANSITIONS; HUMAN BREAST-CANCER; NF-KAPPA-B; BAFF-R; TNF RECEPTOR; PHASE-III; MEMBER; APRIL; SNAIL	B cell-activating factor (BAFF) is a cytokine belonging to the tumor necrosis factor (TNF) superfamily. It has been reported that BAFF is elevated in patients with autoimmune pancreatitis and contributes to the malignant potential of blood cancers and solid tumors. In this study, clinical evidence of increased BAFF levels in patients with pancreatic ductal adenocarcinoma (PDAC) was obtained, and the roles and mechanisms of BAFF in PDAC were clarified in human tissues of PDAC and from in vitro data of PDAC cell lines. Serum levels of BAFF in patients with PDAC were significantly higher than in healthy subjects (p = 0.0121). Patients with UICC stage IV PDAC (T1-4, N0-1, M1) had significantly higher levels of serum BAFF compared to patients with PDAC (p = 0.0182). BAFF was remarkably expressed in infiltrating B lymphocytes surrounding pancreatic cancer in human pancreatic tissues, suggesting that BAFF may play a role in progression of pancreatic cancer. PDAC cell lines were cultured with human recombinant BAFF, and morphology and gene expression were analyzed; pancreatic cancer cells changed to a fibroblast-like morphology, and showed altered gene expression of E-cadherin, vimentin and Snail. These BAFF-induced changes reflect enhanced cell motility and invasion. BAFF-R-overexpressing cell clones confirmed the association between these BAFF-induced changes and epithelial-mesenchymal transition (EMT)-related genes. BAFF was elevated in patients with metastatic advanced PDAC and induced alterations in PDAC cells via regulation of EMT-related genes. Elucidation of the precise role and mechanism of control of BAFF may lead to new therapeutic approaches with the aim of improving pancreatic cancer survival.	[Koizumi, Mitsuhito; Hiasa, Yoichi; Kumagi, Teru; Yamanishi, Hirofumi; Azemoto, Nobuaki; Matsuura, Bunzo; Abe, Masanori; Onji, Morikazu] Ehime Univ, Grad Sch Med, Dept Gastroenterol & Metabol, Matsuyama, Ehime 790, Japan; [Kobata, Tetsuji] Dokkyo Med Univ, Sch Med, Dept Immunol, Mibu, Tochigi, Japan	Ehime University; Dokkyo Medical University	Hiasa, Y (corresponding author), Ehime Univ, Grad Sch Med, Dept Gastroenterol & Metabol, Matsuyama, Ehime 790, Japan.	hiasa@m.ehime-u.ac.jp	Hiasa, Yoichi/ABD-2759-2021; Kumagi, Teru/AAS-7427-2021	Hiasa, Yoichi/0000-0003-4117-339X; Kumagi, Teru/0000-0002-2292-7750	Japan Society for the Promotion of Science [KAKENHI 24590980]; Ministry of Education, Culture, Sports, Science and Technology, Japan; Japanese Ministry of Health, Labour and Welfare, Japan	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japanese Ministry of Health, Labour and Welfare, Japan(Ministry of Health, Labour and Welfare, Japan)	This work was supported in part by a Grant-in-Aid for Scientific Research (Japan Society for the Promotion of Science, KAKENHI 24590980 to Y.H.) and the Program for Enhancing Systematic Education in Graduate School (to M. K.) from the Ministry of Education, Culture, Sports, Science and Technology, Japan, and by a Grant-in-Aid for Scientific Research and Development (to Y.H.) from the Japanese Ministry of Health, Labour and Welfare, Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Badr G, 2008, BLOOD, V111, P2744, DOI 10.1182/blood-2007-03-081232; Cano A, 2000, NAT CELL BIOL, V2, P76, DOI 10.1038/35000025; Christiansen JJ, 2006, CANCER RES, V66, P8319, DOI 10.1158/0008-5472.CAN-06-0410; Chu VT, 2007, J IMMUNOL, V179, P5947, DOI 10.4049/jimmunol.179.9.5947; Claudio E, 2002, NAT IMMUNOL, V3, P958, DOI 10.1038/ni842; Cohen SB, 2006, ARTHRITIS RHEUM-US, V54, P2793, DOI 10.1002/art.22025; Coiffier B, 2002, NEW ENGL J MED, V346, P235, DOI 10.1056/NEJMoa011795; Conroy T, 2011, NEW ENGL J MED, V364, P1817, DOI 10.1056/NEJMoa1011923; Dennis GJ, 2012, CLIN PHARMACOL THER, V91, P143, DOI 10.1038/clpt.2011.290; Gross JA, 2000, NATURE, V404, P995, DOI 10.1038/35010115; Hahne M, 1998, J EXP MED, V188, P1185, DOI 10.1084/jem.188.6.1185; Hatzoglou A, 2000, J IMMUNOL, V165, P1322, DOI 10.4049/jimmunol.165.3.1322; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Kern C, 2004, BLOOD, V103, P679, DOI 10.1182/blood-2003-02-0540; LIEBER M, 1975, INT J CANCER, V15, P741, DOI 10.1002/ijc.2910150505; Mackay F, 2006, SEMIN IMMUNOL, V18, P284, DOI 10.1016/j.smim.2006.04.005; Mackay F, 2009, NAT REV IMMUNOL, V9, P491, DOI 10.1038/nri2572; Moisini I, 2009, CLIN EXP IMMUNOL, V158, P155, DOI 10.1111/j.1365-2249.2009.04007.x; Moore PA, 1999, SCIENCE, V285, P260, DOI 10.1126/science.285.5425.260; Moreaux J, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-83; Nakajima K, 2007, SCAND J RHEUMATOL, V36, P365, DOI 10.1080/03009740701286615; Nakamura N, 2005, VIRCHOWS ARCH, V447, P53, DOI 10.1007/s00428-005-1275-6; Olmeda D, 2007, ONCOGENE, V26, P1862, DOI 10.1038/sj.onc.1209997; Parameswaran R, 2010, CANCER RES, V70, P4346, DOI 10.1158/0008-5472.CAN-10-0300; Peinado H, 2007, NAT REV CANCER, V7, P415, DOI 10.1038/nrc2131; Petersen OW, 2003, AM J PATHOL, V162, P391, DOI 10.1016/S0002-9440(10)63834-5; Philip PA, 2010, J CLIN ONCOL, V28, P3605, DOI 10.1200/JCO.2009.25.7550; Schneider P, 1999, J EXP MED, V189, P1747, DOI 10.1084/jem.189.11.1747; Shu HB, 2000, P NATL ACAD SCI USA, V97, P9156, DOI 10.1073/pnas.160213497; Takahashi M, 2008, CLIN EXP METASTAS, V25, P517, DOI 10.1007/s10585-008-9163-5; Thiery JP, 2002, NAT REV CANCER, V2, P442, DOI 10.1038/nrc822; Thompson JS, 2001, SCIENCE, V293, P2108, DOI 10.1126/science.1061965; vonBulow GU, 1997, SCIENCE, V278, P138, DOI 10.1126/science.278.5335.138; Wray CJ, 2005, GASTROENTEROLOGY, V128, P1626, DOI 10.1053/j.gastro.2005.03.035; Wu Y, 2009, CANCER CELL, V15, P416, DOI 10.1016/j.ccr.2009.03.016; Yamanishi H, 2011, PANCREAS, V40, P840, DOI 10.1097/MPA.0b013e3182143b10; Yan MH, 2000, NAT IMMUNOL, V1, P37, DOI 10.1038/76889; Yilmaz M, 2009, CANCER METAST REV, V28, P15, DOI 10.1007/s10555-008-9169-0; Zhu J, 2012, J EXP CLIN CANC RES, V31, DOI 10.1186/1756-9966-31-31	39	24	26	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2013	8	8							e71367	10.1371/journal.pone.0071367	http://dx.doi.org/10.1371/journal.pone.0071367			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	217ZG	23940742	Green Published, Green Submitted, gold			2022-12-25	WOS:000324401500066
J	Solodushko, V; Khader, HA; Fouty, BW				Solodushko, Victor; Khader, Heba A.; Fouty, Brian W.			Serum Can Overcome Contact Inhibition in Confluent Human Pulmonary Artery Smooth Muscle Cells	PLOS ONE			English	Article							VASCULAR ENDOTHELIAL-CELLS; PROTEIN-KINASE ACTIVITY; TYROSINE-PHOSPHATASE; CHRONIC HYPOXIA; UP-REGULATION; HYPERTENSION; PROLIFERATION; GROWTH; P27(KIP1); RHO	Pulmonary artery endothelial cells (PAEC) in an intact vessel are continually exposed to serum, but unless injured, do not proliferate, constrained by confluence. In contrast, pulmonary artery smooth muscle cells (PASMC) attain, and maintain, confluence in the presence of minimal serum, protected from serum's stimulatory effects except when the endothelial barrier becomes more permeable. We hypothesized therefore, that confluent PASMC may be less constrained by contact inhibition in the presence of serum than PAEC and tested this idea by exposing confluent non-transformed human PAEC and PASMC to media containing increasing concentrations of fetal bovine serum (FBS) and determining cell growth over 7 days. PAEC that had attained confluence in low serum did not proliferate even when exposed to 5% serum, the highest concentration tested. In contrast, PASMC that attained confluence in low serum did proliferate once serum levels were increased, an effect that was dose dependent. Consistent with this observation, PASMC had more BrdU incorporation and a greater percentage of cells in S phase in 5% compared to 0.2% FBS, whereas no such difference was seen in PAEC. These results suggest that confluent human PAEC are resistant to the stimulatory effects of serum, whereas confluent PASMC can proliferate when serum levels are increased, an effect mediated in part by differences in phosphoinositide 3-kinase activation. This observation may be relevant to understanding the PASMC hyperplasia observed in humans and animals with pulmonary hypertension in which changes in endothelial permeability due to hypoxia or injury expose the underlying smooth muscle to serum.	[Solodushko, Victor; Fouty, Brian W.] Univ S Alabama, Sch Med, Ctr Lung Biol, Mobile, AL 36688 USA; [Solodushko, Victor; Khader, Heba A.; Fouty, Brian W.] Univ S Alabama, Sch Med, Dept Pharmacol, Mobile, AL 36688 USA; [Fouty, Brian W.] Univ S Alabama, Sch Med, Dept Med, Div Pulm & Crit Care Med, Mobile, AL 36688 USA	University of South Alabama; University of South Alabama; University of South Alabama	Fouty, BW (corresponding author), Univ S Alabama, Sch Med, Ctr Lung Biol, Mobile, AL 36688 USA.	bfouty@southalabama.edu	Khader, Heba/AAA-2908-2022	Khader, Heba/0000-0003-3309-8123; Solodushko, Victor/0000-0002-3137-8650	National Heart Lung Blood Institute/NIH [RO1 HL70273-01]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL070273] Funding Source: NIH RePORTER	National Heart Lung Blood Institute/NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This study financially supported by funds from National Heart Lung Blood Institute/NIH RO1 award, RO1 HL70273-01. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe K, 2010, CIRCULATION, V121, P2747, DOI 10.1161/CIRCULATIONAHA.109.927681; Aoshima D, 2009, J PHARMACOL SCI, V110, P182, DOI 10.1254/jphs.09059FP; Azar R, 2010, CELL CYCLE, V9, P1241, DOI 10.4161/cc.9.7.11047; Burkart A, 2003, J BIOL CHEM, V278, P18360, DOI 10.1074/jbc.M210701200; CHRISTMAN BW, 1992, NEW ENGL J MED, V327, P70, DOI 10.1056/NEJM199207093270202; Corvera S, 2000, J BIOL CHEM, V275, P31414, DOI 10.1074/jbc.M001708200; Fiaschi T, 2001, J BIOL CHEM, V276, P49156, DOI 10.1074/jbc.M107538200; Fouty BW, 2001, AM J RESP CELL MOL, V25, P652, DOI 10.1165/ajrcmb.25.5.4592; Frederick R, 2009, BIOORG MED CHEM LETT, V19, P5842, DOI 10.1016/j.bmcl.2009.08.087; FRY DL, 1968, CIRC RES, V22, P165, DOI 10.1161/01.RES.22.2.165; Hannan KM, 2000, ONCOGENE, V19, P3487, DOI 10.1038/sj.onc.1203690; Hirano M, 2001, EXP CELL RES, V271, P356, DOI 10.1006/excr.2001.5384; Ihle NT, 2010, CURR OPIN DRUG DISC, V13, P41; King J, 2004, MICROVASC RES, V67, P139, DOI 10.1016/j.mvr.2003.11.006; Lai KH, 1996, J CLIN INVEST, V98, P1560, DOI 10.1172/JCI118949; Lampugnani MG, 1997, J CELL SCI, V110, P2065; Lee SL, 1999, AM J PHYSIOL-LUNG C, V277, pL282, DOI 10.1152/ajplung.1999.277.2.L282; Medina JR, 2011, J MED CHEM, V54, P1871, DOI 10.1021/jm101527u; MEYRICK BO, 1982, AM J PATHOL, V106, P84; Pani G, 2000, J BIOL CHEM, V275, P38891, DOI 10.1074/jbc.M007319200; Pelisek J, 2001, CELL PROLIFERAT, V34, P305, DOI 10.1046/j.0960-7722.2001.00215.x; POWIS G, 1994, CANCER RES, V54, P2419; REINDEL JF, 1991, AM J PATHOL, V138, P707; Seasholtz TM, 1999, CIRC RES, V84, P1186, DOI 10.1161/01.RES.84.10.1186; Solodushko V, 2008, AM J RESP CELL MOL, V38, P491, DOI 10.1165/rcmb.2007-0127OC; Somanath PR, 2006, CELL CYCLE, V5, P512, DOI 10.4161/cc.5.5.2538; Sun X, 2012, J GERIATR CARDIOL, V9, P180, DOI 10.3724/SP.J.1263.2012.03301; Tanner FC, 2000, CIRCULATION, V101, P2022, DOI 10.1161/01.CIR.101.17.2022; Vinals F, 1999, MOL CELL BIOL, V19, P2763; VLAHOS CJ, 1994, J BIOL CHEM, V269, P5241; Walker EH, 2000, MOL CELL, V6, P909, DOI 10.1016/S1097-2765(05)00089-4; Wojciak-Stothard B, 2006, AM J PHYSIOL-LUNG C, V290, pL1173, DOI 10.1152/ajplung.00309.2005; Wojciak-Stothard B, 2005, AM J PHYSIOL-LUNG C, V288, pL749, DOI 10.1152/ajplung.00361.2004; Yu LY, 2011, AM J RESP CELL MOL, V44, P524, DOI 10.1165/rcmb.2010-0145OC	34	3	3	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2013	8	8							e71490	10.1371/journal.pone.0071490	http://dx.doi.org/10.1371/journal.pone.0071490			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	217ZG	23940764	Green Published, Green Submitted, gold			2022-12-25	WOS:000324401500074
J	Banerjee, D; Banerjee, A; Mookherjee, S; Vishal, M; Mukhopadhyay, A; Sen, A; Basu, A; Ray, K				Banerjee, Deblina; Banerjee, Antara; Mookherjee, Suddhasil; Vishal, Mansi; Mukhopadhyay, Arijit; Sen, Abhijit; Basu, Analabha; Ray, Kunal			Mitochondrial Genome Analysis of Primary Open Angle Glaucoma Patients	PLOS ONE			English	Article							HEREDITARY OPTIC NEUROPATHY; NADH-QUINONE OXIDOREDUCTASE; DIFFERENTIATED RGC-5 CELLS; TRANSFER-RNA MUTATIONS; 12S RIBOSOMAL-RNA; COMPLEX-I DEFECT; TRABECULAR MESHWORK; PARKINSONS-DISEASE; RESPIRATORY-CHAIN; OXIDATIVE STRESS	Primary open angle glaucoma (POAG) is a multi-factorial optic disc neuropathy characterized by accelerating damage of the retinal ganglion cells and atrophy of the optic nerve head. The vulnerability of the optic nerve damage leading to POAG has been postulated to result from oxidative stress and mitochondrial dysfunction. In this study, we investigated the possible involvement of the mitochondrial genomic variants in 101 patients and 71 controls by direct sequencing of the entire mitochondrial genome. The number of variable positions in the mtDNA with respect to the revised Cambridge Reference Sequence (rCRS), have been designated "Segregating Sites". The segregating sites present only in the patients or controls have been designated "Unique Segregating Sites (USS)". The population mutation rate (theta=4N(e)mu) as estimated by Watterson's theta (theta(w)), considering only the USS, was significantly higher among the patients (p = 9.8x10(-15)) compared to controls. The difference in theta(w) and the number of USS were more pronounced when restricted to the coding region (p<1.31x10(-21) and p = 0.006607, respectively). Further analysis of the region revealed non-synonymous variations were significantly higher in Complex I among the patients (p = 0.0053). Similar trends were retained when USS was considered only within complex I (frequency 0.49 vs 0.31 with p<0.0001 and mutation rate p-value <1.49x10(-43)) and ND5 within its gene cluster (frequency 0.47 vs 0.23 with p<0.0001 and mutation rate p-value <4.42x10(-47)). ND5 is involved in the proton pumping mechanism. Incidentally, glaucomatous trabecular meshwork cells have been reported to be more sensitive to inhibition of complex I activity. Thus mutations in ND5, expected to inhibit complex I activity, could lead to generation of oxidative stress and favor glaucomatous condition.	[Banerjee, Deblina; Banerjee, Antara; Mookherjee, Suddhasil; Vishal, Mansi; Ray, Kunal] CSIR Indian Inst Chem Biol, Mol & Human Genet Div, Kolkata, India; [Vishal, Mansi; Mukhopadhyay, Arijit] CSIR Inst Genom & Integrat Biol, Delhi, India; [Sen, Abhijit] Dristi Pradip, Kolkata, India; [Basu, Analabha] Natl Inst Biomed Genom, Kalyani, W Bengal, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Indian Institute of Chemical Biology (IICB); Council of Scientific & Industrial Research (CSIR) - India; CSIR - Institute of Genomics & Integrative Biology (IGIB); Department of Biotechnology (DBT) India; National Institute of Biomedical Genomics (NIBMG)	Basu, A (corresponding author), Natl Inst Biomed Genom, Kalyani, W Bengal, India.	ab1@nibmg.ac.in; kunalray@gmail.com	; Ray, Kunal/E-6515-2011	Mukhopadhyay, Arijit/0000-0002-1089-7179; Ray, Kunal/0000-0001-9989-1760	Council of Scientific and Industrial Research (CSIR), India [SIP-007, MLP-0016, NWP 004]	Council of Scientific and Industrial Research (CSIR), India(Council of Scientific & Industrial Research (CSIR) - India)	This study was supported by grants SIP-007, MLP-0016 and NWP 004 from the Council of Scientific and Industrial Research (CSIR), India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu-Amero KK, 2008, MOL VIS, V14, P518; Abu-Amero KK, 2006, INVEST OPHTH VIS SCI, V47, P2533, DOI 10.1167/iovs.05-1639; Abu-Amero KK, 2011, MOL VIS, V17, P1468; Acharya M, 2006, MOL VIS, V12, P399; Acharya M, 2007, BMC MOL BIOL, V8, DOI 10.1186/1471-2199-8-21; Andrews R, 2006, BRIT J OPHTHALMOL, V90, P488, DOI 10.1136/bjo.2005.084335; Arenas J, 1998, ANN NEUROL, V43, P397, DOI 10.1002/ana.410430321; BABIZHAYEV MA, 1993, MECH AGEING DEV, V72, P1, DOI 10.1016/0047-6374(93)90126-C; Banerjee D, 2012, MOL VIS, V18, P1548; Bhattacharjee A, 2008, MOL VIS, V14, P841; Bhattacharya SK, 2005, J BIOL CHEM, V280, P6080, DOI 10.1074/jbc.M411233200; Blok MJ, 2007, J MED GENET, V44, DOI 10.1136/jmg.2006.045716; Bossy-Wetzel E, 2003, CURR OPIN CELL BIOL, V15, P706, DOI 10.1016/j.ceb.2003.10.015; BOVERIS A, 1973, BIOCHEM J, V134, P707, DOI 10.1042/bj1340707; Boveris A, 2000, IUBMB LIFE, V50, P245, DOI 10.1080/15216540051080912; Boveris A, 2008, IUBMB LIFE, V60, P308, DOI 10.1002/iub.46; Brahmachari SK, 2008, J GENET, V87, P3; Brandt U, 2006, ANNU REV BIOCHEM, V75, P69, DOI 10.1146/annurev.biochem.75.103004.142539; BROWN MD, 1992, GENETICS, V130, P163; Calandrella N, 2007, MOL CELL BIOCHEM, V301, P155, DOI 10.1007/s11010-006-9407-0; Cardol P, 2002, J MOL BIOL, V319, P1211, DOI 10.1016/S0022-2836(02)00407-2; Carelli V, 1999, ANN NEUROL, V45, P320, DOI 10.1002/1531-8249(199903)45:3<320::AID-ANA7>3.0.CO;2-L; CHANCE B, 1979, PHYSIOL REV, V59, P527, DOI 10.1152/physrev.1979.59.3.527; Chrysostomou V, 2013, CURR OPIN PHARMACOL, V13, P12, DOI 10.1016/j.coph.2012.09.008; COOPER JM, 1992, J NEUROL SCI, V113, P91, DOI 10.1016/0022-510X(92)90270-U; Coskun P, 2012, BBA-GEN SUBJECTS, V1820, P553, DOI 10.1016/j.bbagen.2011.08.008; DAVIES J, 1968, J BIOL CHEM, V243, P3312; DiMauro S, 2005, NEUROMUSCULAR DISORD, V15, P276, DOI 10.1016/j.nmd.2004.12.008; Elson JL, 2009, HUM MUTAT, V30, pE984, DOI 10.1002/humu.21113; Exner N, 2012, EMBO J, V31, P3038, DOI 10.1038/emboj.2012.170; Florentz C, 2002, BIOSCIENCE REP, V22, P81, DOI 10.1023/A:1016065107165; Goto H, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-6-r59; Greenamyre JT, 2001, IUBMB LIFE, V52, P135, DOI 10.1080/15216540152845939; Guan MX, 2011, MITOCHONDRION, V11, P237, DOI 10.1016/j.mito.2010.10.006; Han CB, 2005, WORLD J GASTROENTERO, V11, P31, DOI 10.3748/wjg.v11.i1.31; He Y, 2008, INVEST OPHTH VIS SCI, V49, P1447, DOI 10.1167/iovs.07-1361; Herrnstadt C, 2004, MITOCHONDRION, V4, P791, DOI 10.1016/j.mito.2004.07.041; Ingman M, 2000, NATURE, V408, P708, DOI 10.1038/35047064; Izzotti A, 2010, ARCH OPHTHALMOL-CHIC, V128, P724, DOI 10.1001/archophthalmol.2010.87; Joseph JA, 2000, MECH AGEING DEV, V116, P141, DOI 10.1016/S0047-6374(00)00128-7; Ju WK, 2007, INVEST OPHTH VIS SCI, V48, P2145, DOI 10.1167/iovs.06-0573; Ju WK, 2009, MOL VIS, V15, P120; Kao MC, 2005, BIOCHEMISTRY-US, V44, P3562, DOI 10.1021/bi0476477; Katano H, 2001, NEUROSCI LETT, V306, P101, DOI 10.1016/S0304-3940(01)01832-8; Keeney PM, 2006, J NEUROSCI, V26, P5256, DOI 10.1523/JNEUROSCI.0984-06.2006; Knott AB, 2008, NAT REV NEUROSCI, V9, P505, DOI 10.1038/nrn2417; Kolmogorov AN., 1933, GIORN I ITAL DEGLI A, V4, P83; Kwong JQ, 2006, J NEUROCHEM, V97, P1659, DOI 10.1111/j.1471-4159.2006.03990.x; Lascaratos G, 2012, MITOCHONDRION, V12, P202, DOI 10.1016/j.mito.2011.11.004; Lee S, 2011, EXP EYE RES, V93, P204, DOI 10.1016/j.exer.2010.07.015; Leske MC, 2007, OPHTHAL EPIDEMIOL, V14, P166, DOI 10.1080/09286580701501931; Leung D, 2009, HONG KONG MED DIARY, P12; Loewen N, 2001, HUM GENE THER, V12, P2109, DOI 10.1089/10430340152677449; Lu JX, 2010, MITOCHONDRION, V10, P380, DOI 10.1016/j.mito.2010.01.007; Mabuchi F, 2007, AM J OPHTHALMOL, V143, P125, DOI 10.1016/j.ajo.2006.09.028; McFarland R, 2004, TRENDS GENET, V20, P591, DOI 10.1016/j.tig.2004.09.014; Monemi S, 2005, HUM MOL GENET, V14, P725, DOI 10.1093/hmg/ddi068; Mookherjee S, 2011, MOL VIS, V17, P2618; Mukhopadhyay A, 2005, MOL VIS, V11, P792; Munemasa Y, 2010, J NEUROCHEM, V115, P1508, DOI 10.1111/j.1471-4159.2010.07057.x; Naini AB, 2005, ARCH NEUROL-CHICAGO, V62, P473, DOI 10.1001/archneur.62.3.473; Nakamaru-Ogiso E, 2010, J BIOL CHEM, V285, P39070, DOI 10.1074/jbc.M110.157826; Navarro A, 2007, AM J PHYSIOL-CELL PH, V292, pC670, DOI 10.1152/ajpcell.00213.2006; Navarro A, 2010, FRONT AGING NEUROSCI, V2, DOI 10.3389/fnagi.2010.00034; NOLLER HF, 1991, ANNU REV BIOCHEM, V60, P191, DOI 10.1146/annurev.biochem.60.1.191; Ojaimi J, 1999, MECH AGEING DEV, V111, P39, DOI 10.1016/S0047-6374(99)00071-8; OLANOW CW, 1992, ANN NEUROL, V32, pS2, DOI 10.1002/ana.410320703; Pascolini D, 2012, BRIT J OPHTHALMOL, V96, P614, DOI 10.1136/bjophthalmol-2011-300539; Pasutto F, 2012, HUM MOL GENET, V21, P1336, DOI 10.1093/hmg/ddr572; Pasutto F, 2009, AM J HUM GENET, V85, P447, DOI 10.1016/j.ajhg.2009.08.016; Pereira L, 2009, AM J HUM GENET, V84, P628, DOI 10.1016/j.ajhg.2009.04.013; Racette L, 2003, SURV OPHTHALMOL, V48, P295, DOI 10.1016/S0039-6257(03)00028-6; Ray K, 2003, MOL CELL BIOCH; Ray K, 2009, J GENET, V88, P451, DOI 10.1007/s12041-009-0065-3; Reddy PH, 2011, CURR ALZHEIMER RES, V8, P393; Rezaie T, 2002, SCIENCE, V295, P1077, DOI 10.1126/science.1066901; Ruiz-Pesini E, 2007, NUCLEIC ACIDS RES, V35, pD823, DOI 10.1093/nar/gkl927; Sacca SC, 2007, EXP EYE RES, V84, P389, DOI 10.1016/j.exer.2006.10.008; Salinas T, 2008, TRENDS BIOCHEM SCI, V33, P320, DOI 10.1016/j.tibs.2008.04.010; Scaglia F, 2008, MUSCLE NERVE, V37, P150, DOI 10.1002/mus.20917; Schapira AHV, 2002, J INHERIT METAB DIS, V25, P207, DOI 10.1023/A:1015629912477; SEILER T, 1985, GRAEF ARCH CLIN EXP, V223, P88, DOI 10.1007/BF02150951; SMIRNOV N, 1948, ANN MATH STAT, V19, P279, DOI 10.1214/aoms/1177730256; Stone EM, 1997, SCIENCE, V275, P668, DOI 10.1126/science.275.5300.668; Swindell S R, 1997, Methods Mol Biol, V70, P75, DOI 10.1385/0-89603-358-9:75; Tarassov I, 2007, CELL CYCLE, V6, P2473, DOI 10.4161/cc.6.20.4783; Thyagarajan D, 2000, ANN NEUROL, V48, P730, DOI 10.1002/1531-8249(200011)48:5<730::AID-ANA6>3.0.CO;2-0; Trushina E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032737; Turrens JF, 2003, J PHYSIOL-LONDON, V552, P335, DOI 10.1113/jphysiol.2003.049478; Valente L, 2009, BBA-BIOENERGETICS, V1787, P491, DOI 10.1016/j.bbabio.2008.10.001; WALLACE DC, 1988, SCIENCE, V242, P1427, DOI 10.1126/science.3201231; WATTERSON GA, 1975, THEOR POPUL BIOL, V7, P256, DOI 10.1016/0040-5809(75)90020-9; WELCH BL, 1947, BIOMETRIKA, V34, P28, DOI 10.2307/2332510; Wolf C, 2009, BMC MED GENET, V10, DOI 10.1186/1471-2350-10-91; Zhao H, 2005, NUCLEIC ACIDS RES, V33, P1132, DOI 10.1093/nar/gki262; Zifa E, 2007, RNA BIOL, V4, P38, DOI 10.4161/rna.4.1.4548	96	21	22	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2013	8	8							e70760	10.1371/journal.pone.0070760	http://dx.doi.org/10.1371/journal.pone.0070760			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	218XC	23940637	Green Published, Green Submitted, gold			2022-12-25	WOS:000324465000129
J	Jarzab, A; Witkowska, D; Ziomek, E; Dabrowska, A; Szewczuk, Z; Gamian, A				Jarzab, Anna; Witkowska, Danuta; Ziomek, Edmund; Dabrowska, Anna; Szewczuk, Zbigniew; Gamian, Andrzej			Shigella flexneri 3a Outer Membrane Protein C Epitope Is Recognized by Human Umbilical Cord Sera and Associated with Protective Activity	PLOS ONE			English	Article							ESCHERICHIA-COLI; SWISS-MODEL; VACCINE DEVELOPMENT; DYSENTERIAE TYPE-1; IMMUNE-RESPONSE; B-CELL; 2A; PEPTIDE; MICE; IMMUNOGENICITY	Shigella flexneri 3a is one of the five major strains of the Shigella genus responsible for dysentery, especially among children, in regions of high poverty and poor sanitation. The outer membrane proteins (OMP) of this bacterium elicit immunological responses and are considered a prime target for vaccine development. When injected into mice they elicit a protective immunological response against a lethal dose of the pathogen. The OMPs from S. flexneri 3a were isolated and resolved by two-dimension-SDS-PAGE. Two 38-kDa spots were of particular interest since in our earlier studies OMPs of such molecular mass were found to interact with umbilical cord sera. These two spots were identified as OmpC by ESI-MS/MS spectrometry. By DNA sequencing, the ompC gene from S. flexneri 3a was identical to ompC from S. flexneri 2a [ Gene Bank: 24113600]. A 3D model of OmpC was built and used to predict B-cell type (discontinuous) antigenic epitopes. Six epitopes bearing the highest score were selected and the corresponding peptides were synthesized. Only the peptides representing loop V of OmpC reacted strongly with the umbilical cord serum immunoglobulins. To determine which amino acids are essential for the antigenic activity of the epitope, the loop V was scanned with a series of dodecapeptides. The peptide RYDERY was identified as a minimal sequence for the loop V epitope. Truncation at either the C- or N-terminus rendered this peptide inactive. Apart from C-terminal tyrosine, substitution of each of the remaining five amino acids with glycine, led to a precipitous loss of immunological activity. This peptide may serve as a ligand in affinity chromatography of OmpC-specific antibodies and as a component of a vaccine designed to boost human immune defenses against enterobacterial infections.	[Jarzab, Anna; Witkowska, Danuta; Gamian, Andrzej] Polish Acad Sci, Ludwik Hirszfeld Inst Immunol & Expt Therapy, Dept Immunol Infect Dis, Wroclaw, Poland; [Dabrowska, Anna] Wroclaw Univ Environm & Life Sci, Dept Anim Prod Technol & Qual Management, Wroclaw, Poland; [Szewczuk, Zbigniew] Univ Wroclaw, Dept Organ Chem, PL-50138 Wroclaw, Poland; [Ziomek, Edmund; Gamian, Andrzej] Wroclaw Res Ctr Ctr EIT, Wroclaw, Poland	Polish Academy of Sciences; Hirszfeld Institute of Immunology & Experimental Therapy of the Polish Academy of Sciences; Wroclaw University of Environmental & Life Sciences; University of Wroclaw	Witkowska, D (corresponding author), Polish Acad Sci, Ludwik Hirszfeld Inst Immunol & Expt Therapy, Dept Immunol Infect Dis, Wroclaw, Poland.	witkows@iitd.pan.wroc.pl; gamian@iitd.pan.wroc.pl	Jarzab, Anna/AAK-5814-2021; Jarzab, Anna/HHN-6781-2022; Witkowska, Danuta/O-3951-2019; Szewczuk, Zbigniew/A-2243-2013	Jarzab, Anna/0000-0002-1059-9147; Dabrowska, Anna/0000-0002-8524-5802; Gamian, Andrzej/0000-0002-2206-6591; Szewczuk, Zbigniew/0000-0001-5884-9363; Witkowska, Danuta/0000-0003-3494-8724	Wroclaw Research Center EIT+ [POIG 01.01.02-02-003/08-00]; European Regional Development Fund (Operational Programme Innovative Economy, 1.1.2)	Wroclaw Research Center EIT+; European Regional Development Fund (Operational Programme Innovative Economy, 1.1.2)	This research was supported by Wroclaw Research Center EIT+ under the project "Biotechnologies and advanced medical technologies - BioMed" (POIG 01.01.02-02-003/08-00) financed from the European Regional Development Fund (Operational Programme Innovative Economy, 1.1.2). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMUS G, 1980, INFECT IMMUN, V30, P321; ANDERS K, 1995, VACCINE, V13, P88; Arcidiacono S, 2002, PROTEIN EXPRES PURIF, V25, P134, DOI 10.1006/prep.2002.1619; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Baldridge JR, 1999, METHODS, V19, P103, DOI 10.1006/meth.1999.0834; Basle A, 2006, J MOL BIOL, V362, P933, DOI 10.1016/j.jmb.2006.08.002; Benz I, 2002, MOL MICROBIOL, V45, P267, DOI 10.1046/j.1365-2958.2002.03030.x; Biswas T, 2000, FEMS IMMUNOL MED MIC, V29, P129; Black RE, 2010, LANCET, V375, P1969, DOI 10.1016/S0140-6736(10)60549-1; Borrelli S, 2008, CLIN VACCINE IMMUNOL, V15, P1106, DOI 10.1128/CVI.00050-08; Carter J M, 1994, Methods Mol Biol, V36, P207; Coster TS, 1999, INFECT IMMUN, V67, P3437, DOI 10.1128/IAI.67.7.3437-3443.1999; Fujita Y, 2011, CHEM CENT J, V5, DOI 10.1186/1752-153X-5-48; Gharahdaghi F, 1999, ELECTROPHORESIS, V20, P601, DOI 10.1002/(SICI)1522-2683(19990301)20:3<601::AID-ELPS601>3.0.CO;2-6; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Jarzab A, 2011, SEPSIS, V4, P39; Jennison AV, 2004, FEMS MICROBIOL REV, V28, P43, DOI 10.1016/j.femsre.2003.07.002; Katz DE, 2004, INFECT IMMUN, V72, P923, DOI 10.1128/IAI.72.2.923-930.2004; Koebnik R, 2000, MOL MICROBIOL, V37, P239, DOI 10.1046/j.1365-2958.2000.01983.x; Kotloff KL, 2007, HUM VACCINES, V3, P268, DOI 10.4161/hv.4746; Kotloff KL, 1999, B WORLD HEALTH ORGAN, V77, P651; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lin J, 2002, MICROBES INFECT, V4, P325, DOI 10.1016/S1286-4579(02)01545-9; LOWRY OH, 1951, J BIOL CHEM, V193, P265; McCarty M, 1973, MICROBIOLOGY; Mukhopadhaya A, 2006, VACCINE, V24, P6028, DOI 10.1016/j.vaccine.2006.03.026; Mukhopadhaya A, 2003, VACCINE, V21, P3043, DOI 10.1016/S0264-410X(03)00111-7; MULCZYK M, 1981, ARCH IMMUNOL THER EX, V29, P85; Nardin E, 2010, HUM VACCINES, V6, P27, DOI 10.4161/hv.6.1.9601; Paterson DL, 2006, AM J MED, V119, pS20, DOI 10.1016/j.amjmed.2006.03.013; Peng XX, 2002, APPL ENVIRON MICROB, V68, P2580, DOI 10.1128/AEM.68.5.2580-2583.2002; Pore D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022663; Ranallo RT, 2005, INFECT IMMUN, V73, P258, DOI 10.1128/IAI.73.1.258-267.2005; ROY S, 1994, INFECT IMMUN, V62, P4333, DOI 10.1128/IAI.62.10.4333-4338.1994; Sansonetti PJ, 2001, AM J PHYSIOL-GASTR L, V280, pG319, DOI 10.1152/ajpgi.2001.280.3.G319; Schwede T, 2003, NUCLEIC ACIDS RES, V31, P3381, DOI 10.1093/nar/gkg520; SESARDIC D, 1993, J MED MICROBIOL, V39, P241, DOI 10.1099/00222615-39-4-241; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Simon JK, 2011, CLIN IMMUNOL, V139, P185, DOI 10.1016/j.clim.2011.02.003; Sweredoski MJ, 2008, BIOINFORMATICS, V24, P1459, DOI 10.1093/bioinformatics/btn199; Wieser A, 2010, INFECT IMMUN, V78, P3432, DOI 10.1128/IAI.00174-10; Williams KM, 2000, INFECT IMMUN, V68, P2535, DOI 10.1128/IAI.68.5.2535-2545.2000; WITKOWSKA D, 1986, ARCH IMMUNOL THER EX, V34, P499; WITKOWSKA D, 1985, ARCH IMMUNOL THER EX, V33, P629; Witkowska D, 2006, FEMS IMMUNOL MED MIC, V48, P205, DOI 10.1111/j.1574-695X.2006.00137.x; Witkowska Danuta, 1992, Archivum Immunologiae et Therapiae Experimentalis, V40, P301; Ying TY, 2005, PROTEOMICS, V5, P4777, DOI 10.1002/pmic.200401326	47	17	17	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2013	8	8							e70539	10.1371/journal.pone.0070539	http://dx.doi.org/10.1371/journal.pone.0070539			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	218XC	23940590	Green Published, gold, Green Submitted			2022-12-25	WOS:000324465000084
J	Kim, HW; Kim, JE; Hwang, MH; Jeon, YH; Lee, SW; Lee, J; Zeon, SK; Ahn, BC				Kim, Hae Won; Kim, Jung Eun; Hwang, Mi-Hye; Jeon, Yong Hyun; Lee, Sang-Woo; Lee, Jaetae; Zeon, Seok Kil; Ahn, Byeong-Cheol			Enhancement of Natural Killer Cell Cytotoxicity by Sodium/Iodide Symporter Gene-Mediated Radioiodine Pretreatment in Breast Cancer Cells	PLOS ONE			English	Article							SODIUM-IODIDE SYMPORTER; THERAPY; EXPRESSION; LIGAND; IMMUNOTHERAPY; APOPTOSIS; MELANOMA; SURVIVAL; TRAIL; LINES	A phase II study of NK cell therapy in treatment of patients with recurrent breast cancer has recently been reported. However, because of the complexities of tumor microenvironments, effective therapeutic effects have not been achieved in NK cell therapy. Radioiodine (I-131) therapy inhibits cancer growth by inducing the apoptosis and necrosis of cancer cells. Furthermore, it can modify cancer cell phenotypes and enhance the effect of immunotherapy against cancer cells. The present study showed that I-131 therapy can modulate microenvironment of breast cancer and improve the therapeutic effect by enhancing NK cell cytotoxicity to the tumor cells. The susceptibility of breast cancer cells to NK cell was increased by precedent I-131 treatment in vitro. Tumor burden in mice treated with I-131 plus NK cell was significantly lower than that in mice treated with NK cell or I-131 alone. The up-regulation of Fas, DR5 and MIC A/B on irradiated tumor cells could be the explanation for the enhancement of NK cell cytotoxicity to tumor cells. It can be applied to breast cancer patients with iodine avid metastatic lesions that are non-responsive to conventional treatments.	[Kim, Hae Won; Kim, Jung Eun; Hwang, Mi-Hye; Jeon, Yong Hyun; Lee, Sang-Woo; Lee, Jaetae; Ahn, Byeong-Cheol] Kyungpook Natl Univ, Sch Med, Dept Nucl Med, Taegu, South Korea; [Kim, Hae Won; Zeon, Seok Kil] Keimyung Univ, Sch Med, Dept Nucl Med, Taegu, South Korea	Kyungpook National University; Keimyung University	Ahn, BC (corresponding author), Kyungpook Natl Univ, Sch Med, Dept Nucl Med, Taegu, South Korea.	abc2000@knu.ac.kr	Lee, Jaetae/AAR-3317-2021; Lee, Jaetae/ABF-3980-2020; Jeon, Yong hyun/N-6910-2019	Jeon, Yong hyun/0000-0003-3161-7698	National Nuclear R&D Programs through the National Research Foundation of Korea (NRF); Ministry of Education, Science and Technology [2012M2A2A7014020, 2009-0078234]; Korea Health Technology R&D Project, Ministry of Health & Welfare, Republic of Korea [A111345, A091224]	National Nuclear R&D Programs through the National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea); Korea Health Technology R&D Project, Ministry of Health & Welfare, Republic of Korea	This research was supported by National Nuclear R&D Programs through the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science and Technology (No. 2012M2A2A7014020, 2009-0078234) and by a grant of the Korea Health Technology R&D Project, Ministry of Health & Welfare, Republic of Korea (A111345, A091224). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe O, 2005, LANCET, V365, P1687, DOI 10.1016/s0140-6736(05)66544-0; Ahn BC, 2012, THERANOSTICS, V2, P392, DOI 10.7150/thno.3722; Ames E, 2009, CLIN EXP IMMUNOL, V155, P504, DOI 10.1111/j.1365-2249.2008.03818.x; Boelaert K, 2003, LANCET, V361, P796, DOI 10.1016/S0140-6736(03)12720-1; Castriconi R, 2007, CANCER IMMUNOL IMMUN, V56, P1733, DOI 10.1007/s00262-007-0317-0; Chatterjee S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054055; Dent R, 2007, CLIN CANCER RES, V13, P4429, DOI 10.1158/1078-0432.CCR-06-3045; DeSantis C, 2011, CA-CANCER J CLIN, V61, P409, DOI 10.3322/caac.20134; Dewan MZ, 2007, BREAST CANCER RES TR, V104, P267, DOI 10.1007/s10549-006-9416-4; Dohan O, 2006, MOL ENDOCRINOL, V20, P1121, DOI 10.1210/me.2005-0376; Fogler WE, 1996, J IMMUNOL, V156, P4707; Fortunati N, 2010, BREAST CANCER RES TR, V124, P667, DOI 10.1007/s10549-010-0789-z; Geller MA, 2011, CYTOTHERAPY, V13, P98, DOI 10.3109/14653249.2010.515582; GONG JH, 1994, LEUKEMIA, V8, P652; Hori T, 2010, J ORTHOP RES, V28, P739, DOI 10.1002/jor.21056; Ishikawa E, 2004, INT J RADIAT ONCOL, V59, P1505, DOI 10.1016/j.ijrobp.2004.04.046; Jeon YH, 2010, MOL CANCER THER, V9, P126, DOI 10.1158/1535-7163.MCT-09-0540; Kogai T, 2000, P NATL ACAD SCI USA, V97, P8519, DOI 10.1073/pnas.140217197; Kruschinski A, 2008, P NATL ACAD SCI USA, V105, P17481, DOI 10.1073/pnas.0804788105; Lanier LL, 2008, NAT IMMUNOL, V9, P495, DOI 10.1038/ni1581; Moretta A, 2001, ANNU REV IMMUNOL, V19, P197, DOI 10.1146/annurev.immunol.19.1.197; Moretta L, 2004, CURR OPIN IMMUNOL, V16, P626, DOI 10.1016/j.coi.2004.07.010; Nagashima S, 1998, BLOOD, V91, P3850, DOI 10.1182/blood.V91.10.3850.3850_3850_3861; Nieto Y, 2003, HAEMATOLOGICA, V88, P201; Nowosielska EM, 2011, INT J RADIAT BIOL, V87, P202, DOI 10.3109/09553002.2010.519422; Rosenberg SA, 2003, HUM GENE THER, V14, P709, DOI 10.1089/104303403765255110; Ryan J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016023; Schmidt J, 2006, CANCER IMMUNOL IMMUN, V55, P1396, DOI 10.1007/s00262-006-0140-z; Smyth MJ, 2001, NAT IMMUNOL, V2, P293, DOI 10.1038/86297; Sutlu T, 2009, J INTERN MED, V266, P154, DOI 10.1111/j.1365-2796.2009.02121.x; Tam YK, 1999, HUM GENE THER, V10, P1359, DOI 10.1089/10430349950018030; Tonn T, 2001, J HEMATOTH STEM CELL, V10, P535, DOI 10.1089/15258160152509145; Ugnat AM, 2004, BRIT J CANCER, V90, P1138, DOI 10.1038/sj.bjc.6601662; Upadhyay G, 2003, BREAST CANCER RES TR, V77, P157, DOI 10.1023/A:1021321409159; Xu XL, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-194; Zamai L, 1998, J EXP MED, V188, P2375, DOI 10.1084/jem.188.12.2375; Zhou YX, 2010, PIGM CELL MELANOMA R, V23, P661, DOI 10.1111/j.1755-148X.2010.00729.x	37	14	14	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2013	8	8							e70194	10.1371/journal.pone.0070194	http://dx.doi.org/10.1371/journal.pone.0070194			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	218XC	23940545	Green Submitted, gold, Green Published			2022-12-25	WOS:000324465000039
J	Perek, B; Malinska, A; Stefaniak, S; Ostalska-Nowicka, D; Misterski, M; Zabel, M; Suri, A; Nowicki, M				Perek, Bartlomiej; Malinska, Agnieszka; Stefaniak, Sebastian; Ostalska-Nowicka, Danuta; Misterski, Marcin; Zabel, Maciej; Suri, Anuj; Nowicki, Michal			Predictive Factors of Late Venous Aortocoronary Graft Failure: Ultrastructural Studies	PLOS ONE			English	Article							CORONARY-ARTERY-BYPASS; INTERNAL MAMMARY ARTERY; SAPHENOUS-VEIN; DISEASE; ATHEROSCLEROSIS; SURVIVAL; SURGERY; PROLIFERATION; MECHANISMS; CONDUITS	Background: Venous aortocoronary graft arterialization may precede a preterm occlusion in some coronary artery bypass grafting (CABG) patients. The aim of the present study was to identify ultrastructural variations in the saphenous vein wall that may have an impact on the development of venous graft disease in CABG patients. Methods: The study involved 365 consecutive patients with a mean age of 62.9 +/- 9.4 years who underwent isolated CABG. The thickness and area of the whole venous wall, the tunica intima, the tunica media and the adventitia and the number and shape (length, thickness and length/thickness ratio) of the nuclei in the medial smooth muscle cells nuclei in the distal saphenous vein segments were evaluated by ultrastructural studies. Patients were followed up for 41 to 50 months (mean 45.1 +/- 5.1). Saphenous vein graft patency was assessed by follow-up coronary angiography. Logistic regression models were used to identify independent risk factors for late graft failure. Results: In 71 patients significant lesions in the saphenous vein grafts were observed. The whole venous wall thickness (437.5 mu m vs. 405.5 mu m), tunica media thickness (257.2 mu m vs. 211.5 mu m), whole venous wall area (2.23 mm(2) vs. 2.02 mm(2)) and tunica media area (1.09 mm(2) vs. 0.93 mm(2)) were significantly larger for this group of patients than for those without graft disease. In the latter group more elongated smooth muscle cell nuclei (higher length/thickness ratio) were found in the tunica media of the saphenous vein segments. Thickening of the saphenous vein tunica media and chunky smooth muscle cell nuclei were identified as independent risk factors for graft disease development. Conclusions: Saphenous vein tunica media hypertrophy (resulting in wall thickening) and chunky smooth muscle cell nuclei might predict the development of venous graft disease.	[Perek, Bartlomiej; Stefaniak, Sebastian; Misterski, Marcin; Suri, Anuj] Univ Med Sci, Dept Cardiac Surg & Transplantol, Poznan, Poland; [Malinska, Agnieszka; Zabel, Maciej; Nowicki, Michal] Univ Med Sci, Dept Histol & Embryol, Poznan, Poland; [Ostalska-Nowicka, Danuta] Univ Med Sci, Dept Pediat Cardiol & Nephrol, Poznan, Poland		Perek, B (corresponding author), Univ Med Sci, Dept Cardiac Surg & Transplantol, Poznan, Poland.	bperek@yahoo.com	Perek, Bartłomiej/AAS-6564-2021	Perek, Bartłomiej/0000-0003-2398-9571; Malinska, Agnieszka/0000-0001-8696-8845; Nowicki, Michal/0000-0002-7265-8181	State Committee for Scientific Research [5958/B/P01/2010/38]	State Committee for Scientific Research(Polish State Committee for Scientific Research)	This study was supported by State Committee for Scientific Research (grant no. 5958/B/P01/2010/38). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANGELINI GD, 1987, CARDIOVASC RES, V21, P902, DOI 10.1093/cvr/21.12.902; Bascands JL, 2001, HYPERTENSION, V38, P1294, DOI 10.1161/hy1201.096540; BOURASSA MG, 1986, CARDIOLOGY, V73, P259, DOI 10.1159/000174019; Campbell JH, 2012, ARTERIOSCL THROM VAS, V32, P1784, DOI 10.1161/ATVBAHA.111.243212; Chung M. K., 2007, ENCY MEASUREMENT STA, V1, P189; Cooper GJ, 1996, EUR J CARDIO-THORAC, V10, P129, DOI 10.1016/S1010-7940(96)80135-7; DAVIES AH, 1995, ANN ROY COLL SURG, V77, P63; DAVIS KB, 1995, J AM COLL CARDIOL, V25, P1000, DOI 10.1016/0735-1097(94)00518-U; Dimitrova KR, 2012, ANN THORAC SURG, V94, P475, DOI 10.1016/j.athoracsur.2012.04.035; Ditchburn CJ, 2001, POSTGRAD MED J, V77, P395, DOI 10.1136/pmj.77.908.395; Domanski MJ, 2000, J AM COLL CARDIOL, V36, P1877, DOI 10.1016/S0735-1097(00)00973-6; Epstein AJ, 2011, JAMA-J AM MED ASSOC, V305, P1769, DOI 10.1001/jama.2011.551; FitzGibbon GM, 1996, J AM COLL CARDIOL, V28, P616, DOI 10.1016/0735-1097(96)00206-9; Goldman S, 2004, J AM COLL CARDIOL, V44, P2149, DOI 10.1016/j.jacc.2004.08.064; Halabi AR, 2005, AM J CARDIOL, V96, P1254, DOI 10.1016/j.amjcard.2005.06.067; Hao HY, 2003, ARTERIOSCL THROM VAS, V23, P1510, DOI 10.1161/01.ATV.0000090130.85752.ED; Hassantash Seyed-Ahmad, 2008, Asian Cardiovasc Thorac Ann, V16, P331; Hubbell MC, 2012, AM J PHYSIOL-CELL PH, V303, pC1090, DOI 10.1152/ajpcell.00408.2011; Klinkert P, 2004, EUR J VASC ENDOVASC, V27, P357, DOI 10.1016/j.ejvs.2003.12.027; Li SH, 2001, CIRC RES, V89, P517, DOI 10.1161/hh1801.097165; LYTLE BW, 1985, J THORAC CARDIOV SUR, V89, P248; MARIN ML, 1993, J VASC SURG, V18, P407, DOI 10.1016/0741-5214(93)90258-N; Millette E, 2006, TRENDS CARDIOVAS MED, V16, P25, DOI 10.1016/j.tcm.2005.11.003; Mitra AK, 2006, IMMUNOL CELL BIOL, V84, P115, DOI 10.1111/j.1440-1711.2005.01407.x; Motwani JG, 1998, CIRCULATION, V97, P916, DOI 10.1161/01.CIR.97.9.916; Muto A, 2010, CIRC J, V74, P1501, DOI 10.1253/circj.CJ-10-0495; Rauch BH, 2005, J BIOL CHEM, V280, P17507, DOI 10.1074/jbc.M410848200; Sabik JF, 2006, CIRCULATION, V114, pI454, DOI 10.1161/CIRCULATIONAHA.105.001149; Thakar RG, 2009, BIOPHYS J, V96, P3423, DOI 10.1016/j.bpj.2008.11.074; Thygesen K, 2012, EUR HEART J, V33, P2551, DOI 10.1093/eurheartj/ehs184; TODA T, 1980, J ANAT, V131, P25; Wang ZB, 2005, AM J PHYSIOL-HEART C, V288, pH293, DOI 10.1152/ajpheart.00165.2004; Zacharias A, 2004, CIRCULATION, V109, P1489, DOI 10.1161/01.CIR.0000121743.10146.78	33	14	17	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2013	8	8							e70628	10.1371/journal.pone.0070628	http://dx.doi.org/10.1371/journal.pone.0070628			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	218XC	23940610	Green Submitted, gold, Green Published			2022-12-25	WOS:000324465000104
J	Pezier, A; Blagburn, JM				Pezier, Adeline; Blagburn, Jonathan M.			Auditory Responses of Engrailed and Invected-Expressing Johnston's Organ Neurons in Drosophila melanogaster	PLOS ONE			English	Article							TARGETED CELL-ABLATION; VIRAL PROTEIN M2(H37A); SENSORY NEURONS; OPTIC TECTUM; SYNAPTIC SPECIFICITY; DOPAMINERGIC-NEURONS; ADULT DROSOPHILA; NERVOUS-SYSTEM; GENES; HEARING	The roles of the transcription factor Engrailed (En), and its paralogue Invected (Inv), in adult Drosophila Johnston's Organ sensory neurons are unknown. We used en-GAL4 driven CD8-GFP and antibody staining to characterize these neurons in the pedicel (second antennal segment). The majority of En and Inv-expressing Johnston's Organ neurons (En-JONs) are located in the ventral part of the posterior group of JONs, with only a few in the medial group. Anatomical classification of En-JON axon projections shows they are mainly type A and E, with a few type B. Extracellular recording of sound-evoked potentials (SEPs) from the antennal nerve was used along with Kir2.1 silencing to assess the contribution that En-JONs make to the auditory response to pure-tone sound stimuli. Silencing En-JONs reduces the SEP amplitude at the onset of the stimulus by about half at 100, 200 and 400 Hz, and also reduces the steady-state response to 200 Hz. En-JONs respond to 82 dB and 92 dB sounds but not 98 dB. Despite their asymmetrical distribution in the Johnston's Organ they respond equally strongly to both directions of movement of the arista. This implies that individual neurons are excited in both directions, a conclusion supported by reanalysis of the morphology of the pedicel-funicular joint. Other methods of silencing the JONs were also used: RNAi against the voltage-gated Na+ channel encoded by the para gene, expression of attenuated diphtheria toxin, and expression of a modified influenza toxin M2(H37A). Only the latter was found to be more effective than Kir2.1. Three additional JON subsets were characterized using Flylight GAL4 lines. inv-GAL4 88B12 and Gyc beta 100B-GAL4 12G03 express in different subsets of A group neurons and CG12484-GAL4 91G04 is expressed in B neurons. All three contribute to the auditory response to 200 Hz tones.	[Pezier, Adeline; Blagburn, Jonathan M.] Univ Puerto Rico, Inst Neurobiol, San Juan, PR 00901 USA	University of Puerto Rico	Blagburn, JM (corresponding author), Univ Puerto Rico, Inst Neurobiol, San Juan, PR 00901 USA.	jonathan.blagburn@upr.edu		Blagburn, Jonathan/0000-0002-7681-2764	National Science Foundation [DBI-115825]; US ARO [W911NF-07-1-0555]; NIH [NIMHD G12MD007600, NINDS SC1NSS081726]; NIMHD [G12MD007600]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103642] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [SC1NS081726] Funding Source: NIH RePORTER; National Institute on Minority Health and Health Disparities [G12MD007600] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); US ARO; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIMHD; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	The confocal microscope used for this work was funded by National Science Foundation grant DBI-115825, US ARO Grant W911NF-07-1-0555 and NIH grant NIMHD G12MD007600. The Drosophila resource center at the Institute is supported by NIMHD G12MD007600. JMB is supported by a National Institutes of Health grant NINDS SC1NSS081726. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert JT, 2007, CURR BIOL, V17, P1000, DOI 10.1016/j.cub.2007.05.004; Baader SL, 1999, J NEUROSCI, V19, P5370; BAINBRIDGE SP, 1981, J EMBRYOL EXP MORPH, V66, P57; Baines RA, 2001, J NEUROSCI, V21, P1523, DOI 10.1523/JNEUROSCI.21-05-01523.2001; Blagburn JM, 2004, ANNU REV NEUROSCI, V27, P29, DOI 10.1146/annurev.neuro.27.070203.144143; Blagburn Jonathan M., 2008, Invertebrate Neuroscience, V8, P133, DOI 10.1007/s10158-008-0074-6; Booth D, 2009, J NEUROSCI, V29, P7181, DOI 10.1523/JNEUROSCI.1374-09.2009; Caldwell JC, 2002, J NEUROBIOL, V53, P172, DOI 10.1002/neu.10126; Chung YD, 2001, NEURON, V29, P415, DOI 10.1016/S0896-6273(01)00215-X; CONDRON BG, 1994, NEURON, V13, P541, DOI 10.1016/0896-6273(94)90024-8; Duffy JB, 2002, GENESIS, V34, P1, DOI 10.1002/gene.10150; Ebacher DJS, 2007, FLY, V1, P86, DOI 10.4161/fly.4242; Eberl D.F., 2011, COLD SPRING HARB PRO; Eberl DF, 2007, INT J DEV BIOL, V51, P679, DOI 10.1387/ijdb.072364de; Eberl DF, 2000, J NEUROSCI, V20, P5981, DOI 10.1523/JNEUROSCI.20-16-05981.2000; Fischler W, 2007, NATURE, V448, P1054, DOI 10.1038/nature06101; Friedman GC, 1996, J NEUROSCI, V16, P5498; Gibert JM, 2002, DEV GENES EVOL, V212, P307, DOI 10.1007/s00427-002-0243-2; Gopfert MC, 2002, J EXP BIOL, V205, P1199; Han DD, 2000, DEVELOPMENT, V127, P573; Itasaki N, 1996, NEURON, V16, P55, DOI 10.1016/S0896-6273(00)80023-9; Jafari S, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001280; Jenett A, 2012, CELL REP, V2, P991, DOI 10.1016/j.celrep.2012.09.011; Joly W, 2007, DEV BIOL, V301, P542, DOI 10.1016/j.ydbio.2006.10.019; Kamikouchi A, 2006, J COMP NEUROL, V499, P317, DOI 10.1002/cne.21075; Kamikouchi A, 2009, NATURE, V458, P165, DOI 10.1038/nature07810; KORNBERG T, 1981, P NATL ACAD SCI-BIOL, V78, P1095, DOI 10.1073/pnas.78.2.1095; Lam VK, 2010, FLY, V4, P338, DOI 10.4161/fly.4.4.13114; LAWRENCE PA, 1976, DEV BIOL, V50, P321, DOI 10.1016/0012-1606(76)90155-X; LAWRENCE PA, 1982, EMBO J, V1, P827, DOI 10.1002/j.1460-2075.1982.tb01255.x; Le Tissier PR, 2005, MOL ENDOCRINOL, V19, P1251, DOI 10.1210/me.2004-0223; Lehnert BP, 2013, NEURON, V77, P115, DOI 10.1016/j.neuron.2012.11.030; Logan C, 1996, CURR BIOL, V6, P1006, DOI 10.1016/S0960-9822(02)00645-0; Lundell MJ, 1996, MOL CELL NEUROSCI, V7, P46, DOI 10.1006/mcne.1996.0004; Makhijani K, 2011, DEVELOPMENT, V138, P5379, DOI 10.1242/dev.067322; Marie B, 2000, CURR BIOL, V10, P289, DOI 10.1016/S0960-9822(00)00361-4; Marie B, 2003, J NEUROSCI, V23, P7854; Marie B, 2002, J NEUROSCI, V22, P832, DOI 10.1523/JNEUROSCI.22-03-00832.2002; McGuire SE, 2003, SCIENCE, V302, P1765, DOI 10.1126/science.1089035; MORATA G, 1975, NATURE, V255, P614, DOI 10.1038/255614a0; Nadrowski B, 2008, CURR BIOL, V18, P1365, DOI 10.1016/j.cub.2008.07.095; Sgado P, 2006, P NATL ACAD SCI USA, V103, P15242, DOI 10.1073/pnas.0602116103; Sharma Y, 2002, GENESIS, V34, P115, DOI 10.1002/gene.10127; Shigetani Y, 1997, NEUROSCI RES, V27, P211, DOI 10.1016/S0168-0102(96)01151-0; Sillitoe RV, 2010, J NEUROSCI, V30, P10015, DOI 10.1523/JNEUROSCI.0653-10.2010; Simon HH, 2001, J NEUROSCI, V21, P3126, DOI 10.1523/JNEUROSCI.21-09-03126.2001; Smith SJ, 2007, DEV DYNAM, V236, P2159, DOI 10.1002/dvdy.21233; Song E, 2012, DEV CELL, V22, P363, DOI 10.1016/j.devcel.2011.12.015; Sweeney LB, 2007, NEURON, V53, P185, DOI 10.1016/j.neuron.2006.12.022; Thum AS, 2006, J COMP NEUROL, V498, P194, DOI 10.1002/cne.21022; Todi SV, 2004, MICROSC RES TECHNIQ, V63, P388, DOI 10.1002/jemt.20053; Tootoonian S, 2012, J NEUROSCI, V32, P787, DOI 10.1523/JNEUROSCI.5104-11.2012; WEBSTER PJ, 1992, MECH DEVELOP, V38, P25, DOI 10.1016/0925-4773(92)90035-I; Wenner P, 2000, J NEUROPHYSIOL, V84, P2651, DOI 10.1152/jn.2000.84.5.2651; Yorozu S, 2009, NATURE, V458, P201, DOI 10.1038/nature07843	55	11	11	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2013	8	8							e71419	10.1371/journal.pone.0071419	http://dx.doi.org/10.1371/journal.pone.0071419			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	218XC	23940751	Green Published, Green Submitted, gold			2022-12-25	WOS:000324465000210
J	Zhao, B; Zhu, YS; Wang, W; Cui, HM; Wang, YP; Lai, JH				Zhao, Bin; Zhu, Yongsheng; Wang, Wei; Cui, Hai-min; Wang, Yun-peng; Lai, Jiang-hua			Analysis of Variations in the Glutamate Receptor, N-Methyl D-Aspartate 2A (GRIN2A) Gene Reveals Their Relative Importance as Genetic Susceptibility Factors for Heroin Addiction	PLOS ONE			English	Article							LONG-TERM POTENTIATION; NMDA RECEPTORS; MICE LACKING; SUBUNIT EXPRESSION; MOLECULAR-GENETICS; EPSILON-1 SUBUNIT; NUCLEUS-ACCUMBENS; ASSOCIATION; PROMOTER; RATS	The glutamate receptor, N-methyl D-aspartate 2A (GRIN2A) gene that encodes the 2A subunit of the N-methyl D-aspartate (NMDA) receptor was recently shown to be involved in the development of opiate addiction. Genetic polymorphisms in GRIN2A have a plausible role in modulating the risk of heroin addiction. An association of GRIN2A single-nucleotide polymorphisms (SNPs) with heroin addiction was found earlier in African Americans. To identify markers that contribute to the genetic susceptibility to heroin addiction, we examined the potential association between heroin addiction and forty polymorphisms of the GRIN2A gene using the MassARRAY system and GeneScan in this study. The frequency of the (GT) 26 repeats (rs3219790) in the heroin addiction group was significantly higher than that in the control group (chi(2) = 5.360, P = 0.021). The allele frequencies of three polymorphisms (rs1102972, rs1650420, and rs3104703 in intron 3) were strongly associated with heroin addiction (P<0.001, 0.0002, and <0.001, after Bonferroni correction). Three additional SNPs from the same intron (rs1071502, rs6497730, and rs1070487) had nominally significant P values for association (P<0.05), but did not pass the threshold value. Haplotype analysis revealed that the G-C-T-C-C-T-A (block 6) and T-T (block 10) haplotypes of the GRIN2A gene displayed a protective effect (P = <0.001 and 0.003). These findings point to a role for GRIN2A polymorphisms in heroin addiction among the Han Chinese from Shaanxi province, and may be informative for future genetic or neurobiological studies on heroin addiction.	[Zhao, Bin; Zhu, Yongsheng; Wang, Wei; Cui, Hai-min; Wang, Yun-peng; Lai, Jiang-hua] Xi An Jiao Tong Univ, Coll Forens Sci, Key Lab, Minist Publ Hlth Forens Sci, Xian 710049, Shaanxi, Peoples R China; [Lai, Jiang-hua] Xi An Jiao Tong Univ, Key Lab Environm & Genes Related Dis, Minist Educ, Xian 710049, Shaanxi, Peoples R China; [Zhu, Yongsheng] Ningxia Med Univ, Dept Med Genet & Cell Biol, Key Lab Fertil Preservat & Maintenance, Minist Educ, Ningxia, Yinchuan, Peoples R China	Xi'an Jiaotong University; Xi'an Jiaotong University; Ningxia Medical University	Lai, JH (corresponding author), Xi An Jiao Tong Univ, Coll Forens Sci, Key Lab, Minist Publ Hlth Forens Sci, Xian 710049, Shaanxi, Peoples R China.	laijh1011@hotmail.com			National Science Foundation of China [NSFC81172910]	National Science Foundation of China(National Natural Science Foundation of China (NSFC))	This research was supported by the National Science Foundation of China (#NSFC81172910).(http://www.nsfc.gov.cn/Portal0/default152.htm). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akashi K, 2009, J NEUROSCI, V29, P10869, DOI 10.1523/JNEUROSCI.5531-08.2009; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Ben-Shahar O, 2009, SYNAPSE, V63, P598, DOI 10.1002/syn.20640; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; Boyce-Rustay JM, 2006, PSYCHOPHARMACOLOGY, V187, P455, DOI 10.1007/s00213-006-0448-6; CADORET RJ, 1995, ARCH GEN PSYCHIAT, V52, P42; Chatterton JE, 2002, NATURE, V415, P793, DOI 10.1038/nature715; Domart MC, 2012, ADDICT BIOL, V17, P783, DOI 10.1111/j.1369-1600.2011.00321.x; Gabriel SB, 2002, SCIENCE, V296, P2225, DOI 10.1126/science.1069424; Inoue M, 2003, J NEUROSCI, V23, P6529; Itokawa M, 2003, NEUROSCI LETT, V345, P53, DOI 10.1016/S0304-3940(03)00501-9; Iwayama-Shigeno Y, 2005, NEUROSCI LETT, V378, P102, DOI 10.1016/j.neulet.2004.12.013; Kindlundh-Hogberg AMS, 2008, BMC NEUROSCI, V9, DOI 10.1186/1471-2202-9-39; Kiyama Y, 1998, J NEUROSCI, V18, P6704; Levran O, 2009, GENES BRAIN BEHAV, V8, P531, DOI 10.1111/j.1601-183X.2009.00501.x; Martin G, 2004, J PHARMACOL EXP THER, V311, P265, DOI 10.1124/jpet.104.067504; MCBAIN CJ, 1994, PHYSIOL REV, V74, P723, DOI 10.1152/physrev.1994.74.3.723; Murray F, 2007, EUR J PHARMACOL, V562, P191, DOI 10.1016/j.ejphar.2007.01.027; Nagy Jozsef, 2005, Current Neuropharmacology, V3, P281, DOI 10.2174/157015905774322499; Paoletti P, 2007, CURR OPIN PHARMACOL, V7, P39, DOI 10.1016/j.coph.2006.08.011; Russo SJ, 2003, NEUROSCIENCE, V120, P523, DOI 10.1016/S0306-4522(03)00317-8; SAKIMURA K, 1995, NATURE, V373, P151, DOI 10.1038/373151a0; Schumann G, 2008, ARCH GEN PSYCHIAT, V65, P826, DOI 10.1001/archpsyc.65.7.826; Schumann J, 2009, NEUROSCI LETT, V461, P159, DOI 10.1016/j.neulet.2009.06.002; Simoes PE, 2008, ANN NY ACAD SCI, V1139, P232, DOI 10.1196/annals.1432.028; SQUIRE LR, 1992, PSYCHOL REV, V99, P195, DOI 10.1037/0033-295X.99.2.195; Tang JS, 2006, NEUROSCI LETT, V409, P80, DOI 10.1016/j.neulet.2006.09.022; Thomas DC, 2002, CANCER EPIDEM BIOMAR, V11, P505; Trujillo KA, 2000, PSYCHOPHARMACOLOGY, V151, P121, DOI 10.1007/s002130000416; Uhl GR, 2008, BIOCHEM PHARMACOL, V75, P98, DOI 10.1016/j.bcp.2007.06.042; Uhl GR, 2004, ANN NY ACAD SCI, V1025, P1, DOI 10.1196/annals.1316.001; Wang F, 2007, NEUROPSYCHOPHARMACOL, V32, P103, DOI 10.1038/sj.npp.1301033; Yang SN, 1999, J NEUROPHYSIOL, V81, P781, DOI 10.1152/jn.1999.81.2.781; Zhuo M, 2009, MOL BRAIN, V2, DOI 10.1186/1756-6606-2-4	34	16	17	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2013	8	8							e70817	10.1371/journal.pone.0070817	http://dx.doi.org/10.1371/journal.pone.0070817			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	218XC	23940648	Green Submitted, gold, Green Published			2022-12-25	WOS:000324465000139
J	Zheng, YB; Devitt, C; Liu, J; Iqbal, N; Skapek, SX				Zheng, Yanbin; Devitt, Caitlin; Liu, Jing; Iqbal, Nida; Skapek, Stephen X.			Arf Induction by Tgf beta Is Influenced by Sp1 and C/ebp beta in Opposing Directions	PLOS ONE			English	Article							TUMOR-SUPPRESSOR GENE; BINDING-PROTEIN-BETA; CELL-CYCLE ARREST; TRANSCRIPTION FACTOR; NONCODING RNA; ONCOGENIC RAS; CANCER CELLS; INK4A LOCUS; MOUSE EYE; GROWTH	Recent studies show that Arf, a bona fide tumor suppressor, also plays an essential role during mouse eye development. Tgf beta is required for Arf promoter activation in developing mouse eyes, and its capacity to induce Arf depends on Smads 2/3 as well as p38 Mapk. Substantial delay between activation of these pathways and increased Arf transcription imply that changes in the binding of additional transcription factors help orchestrate changes in Arf expression. Focusing on proteins with putative DNA binding elements near the mouse Arf transcription start, we now show that Tgf beta induction of this gene correlated with decreased expression and DNA binding of C/ebp beta to the proximal Arf promoter. Ectopic expression of C/ebp beta in mouse embryo fibroblasts (MEFs) blocked Arf induction by Tgf beta. Although basal levels of Arf mRNA were increased by C/ebp beta loss in MEFs and in the developing eye, Tgf beta was still able to increase Arf, indicating that derepression was not the sole factor. Chromatin immunoprecipitation (ChIP) assay showed increased Sp1 binding to the Arf promotor at 24 and 48 hours after Tgf beta treatment, at which time points Arf expression was significantly induced by Tgf beta. Chemical inhibition of Sp1 and its knockdown by RNA interference blocked Arf induction by Tgf beta in MEFs. In summary, our results indicate that C/ebp beta and Sp1 are negative and positive Arf regulators that are influenced by Tgf beta.	[Zheng, Yanbin; Devitt, Caitlin; Liu, Jing; Iqbal, Nida; Skapek, Stephen X.] Univ Texas SW Med Ctr Dallas, Dept Pediat, Div Hematol Oncol, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas	Zheng, YB (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Pediat, Div Hematol Oncol, Dallas, TX 75390 USA.	Yanbin.Zheng@UTSouthwestern.edu; Stephen.Skapek@UTSouthwestern.edu		Iqbal, Nida/0000-0003-3305-2352	National Eye Institute [EY 014368, EY 019942]; NATIONAL EYE INSTITUTE [R01EY014368, R01EY019942] Funding Source: NIH RePORTER	National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This research was funded by the National Eye Institute (EY 014368 and EY 019942), http://www.nei.nih.gov/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ameyar-Zazoua M, 2005, ONCOGENE, V24, P2298, DOI 10.1038/sj.onc.1208424; Aslanian A, 2004, GENE DEV, V18, P1413, DOI 10.1101/gad.1196704; Bates S, 1998, NATURE, V395, P124, DOI 10.1038/25867; BLUME SW, 1991, J CLIN INVEST, V88, P1613, DOI 10.1172/JCI115474; Bouchard C, 2007, GENE DEV, V21, P2775, DOI 10.1101/gad.453107; BRIGGS MR, 1986, SCIENCE, V234, P47, DOI 10.1126/science.3529394; DeGregori J, 1997, P NATL ACAD SCI USA, V94, P7245, DOI 10.1073/pnas.94.14.7245; del Arroyo AG, 2007, CELL CYCLE, V6, P2697; DESCOMBES P, 1991, CELL, V67, P569, DOI 10.1016/0092-8674(91)90531-3; DYNAN WS, 1983, CELL, V35, P79, DOI 10.1016/0092-8674(83)90210-6; Elliott MJ, 2001, CLIN CANCER RES, V7, P3590; Esteller M, 2001, CANCER RES, V61, P2816; Ewing SJ, 2008, CELL DEATH DIFFER, V15, P1734, DOI 10.1038/cdd.2008.105; Feng XH, 2000, EMBO J, V19, P5178, DOI 10.1093/emboj/19.19.5178; Freeman-Anderson NE, 2009, DEVELOPMENT, V136, P2081, DOI 10.1242/dev.033548; Inoue K, 1999, P NATL ACAD SCI USA, V96, P3993, DOI 10.1073/pnas.96.7.3993; Jacobs JJL, 1999, NATURE, V397, P164, DOI 10.1038/16476; Jungert K, 2007, CANCER RES, V67, P1563, DOI 10.1158/0008-5472.CAN-06-1670; Kamijo T, 1997, CELL, V91, P649, DOI 10.1016/S0092-8674(00)80452-3; Karlseder J, 1996, MOL CELL BIOL, V16, P1659; Komori H, 2005, EMBO J, V24, P3724, DOI 10.1038/sj.emboj.7600836; Koziczak M, 2000, MOL CELL BIOL, V20, P2014, DOI 10.1128/MCB.20.6.2014-2022.2000; LI JM, 1995, J BIOL CHEM, V270, P26750, DOI 10.1074/jbc.270.45.26750; LIN AE, 1990, OPHTHALMIC PAED GEN, V11, P121, DOI 10.3109/13816819009012956; Liu S, 1999, J CLIN INVEST, V103, P207, DOI 10.1172/JCI4243; Ma YH, 2008, CANCER RES, V68, P6292, DOI 10.1158/0008-5472.CAN-08-0121; Maeda T, 2005, NATURE, V433, P278, DOI 10.1038/nature03203; Marin M, 1997, CELL, V89, P619, DOI 10.1016/S0092-8674(00)80243-3; McKeller RN, 2002, P NATL ACAD SCI USA, V99, P3848, DOI 10.1073/pnas.052484199; Parisi T, 2002, BIOCHEM BIOPH RES CO, V291, P1138, DOI 10.1006/bbrc.2002.6591; Pasmant E, 2007, CANCER RES, V67, P3963, DOI 10.1158/0008-5472.CAN-06-2004; QUELLE DE, 1995, CELL, V83, P993; Ramji DP, 2002, BIOCHEM J, V365, P561, DOI 10.1042/BJ20020508; Robertson KD, 1998, MOL CELL BIOL, V18, P6457, DOI 10.1128/MCB.18.11.6457; Sanford LP, 1997, DEVELOPMENT, V124, P2659; SCREPANTI I, 1995, EMBO J, V14, P1932, DOI 10.1002/j.1460-2075.1995.tb07185.x; Sebastian T, 2005, EMBO J, V24, P3301, DOI 10.1038/sj.emboj.7600789; Sebastian T, 2009, CANCER RES, V69, P2588, DOI 10.1158/0008-5472.CAN-08-2312; Sherr CJ, 2012, WIRES DEV BIOL, V1, P731, DOI 10.1002/wdev.40; Sherr CJ, 2000, CELL, V102, P407, DOI 10.1016/S0092-8674(00)00046-5; Silva RLA, 2005, EMBO J, V24, P2803, DOI 10.1038/sj.emboj.7600751; Sreeramaneni R, 2005, MOL CELL BIOL, V25, P220, DOI 10.1128/MCB.25.1.220-232.2005; WANG MK, 1973, ACTA OPHTHALMOL, V51, P434; Widau RC, 2012, MOL CELL BIOL, V32, P4270, DOI 10.1128/MCB.06424-11; Xing EP, 1999, CLIN CANCER RES, V5, P2704; Yap KL, 2010, MOL CELL, V38, P662, DOI 10.1016/j.molcel.2010.03.021; Yu Y S, 1997, Korean J Ophthalmol, V11, P123; Zhang HJ, 2009, J CELL BIOCHEM, V106, P464, DOI 10.1002/jcb.22033; Zhang YP, 1998, CELL, V92, P725, DOI 10.1016/S0092-8674(00)81401-4; Zheng YB, 2010, J BIOL CHEM, V285, P35654, DOI 10.1074/jbc.M110.128959; Zhu SY, 2002, P NATL ACAD SCI USA, V99, P207, DOI 10.1073/pnas.012437299; Zindy F, 1997, ONCOGENE, V15, P203, DOI 10.1038/sj.onc.1201178	52	3	3	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2013	8	8							e70371	10.1371/journal.pone.0070371	http://dx.doi.org/10.1371/journal.pone.0070371			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	218XC	23940569	Green Published, Green Submitted, gold			2022-12-25	WOS:000324465000063
J	Huh, Y; Cho, J				Huh, Yeowool; Cho, Jeiwon			Discrete Pattern of Burst Stimulation in the Ventrobasal Thalamus for Anti-Nociception	PLOS ONE			English	Article							DEEP BRAIN-STIMULATION; NEUROPATHIC PAIN; FORMALIN TEST; ELECTRICAL-STIMULATION; RAT MODEL; NEURONS; SLEEP; OSCILLATIONS; INHIBITION; TREMOR	The thalamus has been proposed to play a role in sensory modulation via switching between tonic and burst dual firing of individual neurons. Of the two firing modes, altered burst firing has been repeatedly implicated with pathological pain conditions, which suggests that maintaining a certain form of thalamic burst could be crucial for controlling pain. However, specific elements of burst firing that may contribute to pain control have not yet been actively investigated. Utilizing the deep brain stimulation (DBS) technique, we explored the effects of bursting properties in pain control by electrically stimulating the ventrobasal (VB) thalamus in forms of burst patterned to test different aspects of bursts during the formalin induced nociception in mice. Our results demonstrated that electrical stimulations mimicking specific burst firing properties are important in producing an anti-nociceptive effect and found that the <= 3 ms interval between burst pluses (intra-burst-interval: IntraBI) and >= 3 pulses per burst were required to reliably reduce formalin induced nociceptive responses in mice. Periodicity of IntraBI was also suggested to contribute to anti-nociception to a limited extent.	[Huh, Yeowool; Cho, Jeiwon] Korea Inst Sci & Technol, Ctr Neural Sci, Seoul, South Korea; [Huh, Yeowool; Cho, Jeiwon] Univ Sci & Technol, Dept Neurosci, Taejon, South Korea	Korea Institute of Science & Technology (KIST)	Cho, J (corresponding author), Korea Inst Sci & Technol, Ctr Neural Sci, Seoul, South Korea.	jeiwon@kist.re.kr			National Research Foundation of Korea (NRF); Korean government (MEST) [2012R1A2A2A02011838]; Korea Institute of Science and Technology Intramural Funding	National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Korean government (MEST)(Ministry of Education, Science & Technology (MEST), Republic of KoreaKorean Government); Korea Institute of Science and Technology Intramural Funding	This study was supported by the National Research Foundation of Korea (NRF) grant funded by the Korean government (MEST) (No. 2012R1A2A2A02011838) and the Korea Institute of Science and Technology Intramural Funding. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABBOTT FV, 1995, PAIN, V60, P91, DOI 10.1016/0304-3959(94)00095-V; Davis KD, 1998, STEREOT FUNCT NEUROS, V71, P173, DOI 10.1159/000029661; De Ridder D, 2010, NEUROSURGERY, V66, P986, DOI 10.1227/01.NEU.0000368153.44883.B3; Destexhe A, 1996, J NEUROPHYSIOL, V76, P2049, DOI 10.1152/jn.1996.76.3.2049; DUBUISSON D, 1977, PAIN, V4, P161, DOI 10.1016/0304-3959(77)90130-0; Fuentealba P, 2005, PROG NEUROBIOL, V75, P125, DOI 10.1016/j.pneurobio.2005.01.002; Gubellini P, 2009, PROG NEUROBIOL, V89, P79, DOI 10.1016/j.pneurobio.2009.06.003; Gybels J, 2001, ACTA NEUROL BELG, V101, P65; Hains BC, 2006, J NEUROPHYSIOL, V95, P3343, DOI 10.1152/jn.01009.2005; Halassa MM, 2011, NAT NEUROSCI, V14, P1118, DOI 10.1038/nn.2880; Hamani C, 2006, PAIN, V125, P188, DOI 10.1016/j.pain.2006.05.019; HOSOBUCHI Y, 1973, ARCH NEUROL-CHICAGO, V29, P158, DOI 10.1001/archneur.1973.00490270040005; Huh Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030699; Iwata M, 2011, PAIN, V152, P2505, DOI 10.1016/j.pain.2011.07.011; Jones E.G., 2012, THALAMUS; Kim D, 2003, SCIENCE, V302, P117, DOI 10.1126/science.1088886; Koller W, 1997, ANN NEUROL, V42, P292, DOI 10.1002/ana.410420304; Kringelbach ML, 2007, NAT REV NEUROSCI, V8, P623, DOI 10.1038/nrn2196; KUPERS RC, 1993, NEUROSCI LETT, V150, P95, DOI 10.1016/0304-3940(93)90116-3; Le Bars D, 2001, PHARMACOL REV, V53, P597; Le Masson G, 2002, NATURE, V417, P854, DOI 10.1038/nature00825; LENZ FA, 1989, BRAIN RES, V496, P357, DOI 10.1016/0006-8993(89)91088-3; LENZ FA, 1987, PAIN, V31, P225, DOI 10.1016/0304-3959(87)90038-8; LEVY RM, 1987, NEUROSURGERY, V21, P885, DOI 10.1227/00006123-198712000-00017; LIVINGSTONE MS, 1981, NATURE, V291, P554, DOI 10.1038/291554a0; Llinas RR, 1999, P NATL ACAD SCI USA, V96, P15222, DOI 10.1073/pnas.96.26.15222; LU SM, 1992, J NEUROPHYSIOL, V68, P2185, DOI 10.1152/jn.1992.68.6.2185; MAFFEI L, 1965, SCIENCE, V149, P563, DOI 10.1126/science.149.3683.563; MCCORMICK DA, 1990, NEUROSCIENCE, V39, P103, DOI 10.1016/0306-4522(90)90225-S; Merrill DR, 2005, J NEUROSCI METH, V141, P171, DOI 10.1016/j.jneumeth.2004.10.020; MORGAN MJ, 1988, PAIN, V33, P109, DOI 10.1016/0304-3959(88)90210-2; Pahwa R, 1999, NEUROLOGY, V53, P1447, DOI 10.1212/WNL.53.7.1447; Paxinos G., 2001, MOUSE BRAIN STEREOTA; Sherman SM, 2001, TRENDS NEUROSCI, V24, P122, DOI 10.1016/S0166-2236(00)01714-8; STERIADE M, 1995, J NEUROSCI, V15, P623; STERIADE M, 1993, SCIENCE, V262, P679, DOI 10.1126/science.8235588; Swadlow HA, 2001, NAT NEUROSCI, V4, P402, DOI 10.1038/86054; Swadlow HA, 2002, PHILOS T R SOC B, V357, P1717, DOI 10.1098/rstb.2002.1156; TJOLSEN A, 1992, PAIN, V51, P5, DOI 10.1016/0304-3959(92)90003-T; TURNBULL IM, 1980, J NEUROSURG, V52, P486, DOI 10.3171/jns.1980.52.4.0486; Yousif N, 2007, BRAIN RES BULL, V74, P361, DOI 10.1016/j.brainresbull.2007.07.007; ZIMMERMANN M, 1983, PAIN, V16, P109, DOI 10.1016/0304-3959(83)90201-4	42	17	17	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2013	8	6							e67655	10.1371/journal.pone.0067655	http://dx.doi.org/10.1371/journal.pone.0067655			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182JP	23950787	gold, Green Submitted, Green Published			2022-12-25	WOS:000321738400164
J	Hagan, CC; Woods, W; Johnson, S; Green, GGR; Young, AW				Hagan, Cindy C.; Woods, Will; Johnson, Sam; Green, Gary G. R.; Young, Andrew W.			Involvement of Right STS in Audio-Visual Integration for Affective Speech Demonstrated Using MEG	PLOS ONE			English	Article							SUPERIOR TEMPORAL SULCUS; HUMAN BRAIN; IMPAIRED RECOGNITION; OBJECT RECOGNITION; CROSSMODAL BINDING; EMOTIONAL SIGNALS; AUDITORY-CORTEX; GAMMA-ACTIVITY; VISUAL SPEECH; PERCEPTION	Speech and emotion perception are dynamic processes in which it may be optimal to integrate synchronous signals emitted from different sources. Studies of audio-visual (AV) perception of neutrally expressed speech demonstrate supra-additive (i.e., where AV>[unimodal auditory+unimodal visual]) responses in left STS to crossmodal speech stimuli. However, emotions are often conveyed simultaneously with speech; through the voice in the form of speech prosody and through the face in the form of facial expression. Previous studies of AV nonverbal emotion integration showed a role for right (rather than left) STS. The current study therefore examined whether the integration of facial and prosodic signals of emotional speech is associated with supra-additive responses in left (cf. results for speech integration) or right (due to emotional content) STS. As emotional displays are sometimes difficult to interpret, we also examined whether supra-additive responses were affected by emotional incongruence (i.e., ambiguity). Using magnetoencephalography, we continuously recorded eighteen participants as they viewed and heard AV congruent emotional and AV incongruent emotional speech stimuli. Significant supra-additive responses were observed in right STS within the first 250 ms for emotionally incongruent and emotionally congruent AV speech stimuli, which further underscores the role of right STS in processing crossmodal emotive signals.	[Hagan, Cindy C.; Green, Gary G. R.; Young, Andrew W.] Univ York, Dept Psychol, York YO10 5DD, N Yorkshire, England; [Hagan, Cindy C.; Woods, Will; Johnson, Sam; Green, Gary G. R.; Young, Andrew W.] Univ York, York Neuroimaging Ctr, York YO10 5DD, N Yorkshire, England; [Hagan, Cindy C.] Univ Cambridge, Dept Psychiat, Brain Mapping Unit, Cambridge, England; [Woods, Will] Swinburne Univ Technol, Brain & Psychol Sci Res Ctr, Melbourne, Vic, Australia	University of York - UK; University of York - UK; University of Cambridge; Swinburne University of Technology	Hagan, CC (corresponding author), Univ York, Dept Psychol, York YO10 5DD, N Yorkshire, England.	cindy.hagan@gmail.com	Young, Andy/G-2189-2011; Green, Gary GR/D-3543-2009	Young, Andy/0000-0002-1202-6297; Green, Gary GR/0000-0003-1977-7509; Hagan, Cindy/0000-0002-4576-7120; Woods, William/0000-0001-6653-6105				ADOLPHS R, 1994, NATURE, V372, P669, DOI 10.1038/372669a0; Arnal LH, 2009, J NEUROSCI, V29, P13445, DOI 10.1523/JNEUROSCI.3194-09.2009; Barraclough NE, 2005, J COGNITIVE NEUROSCI, V17, P377, DOI 10.1162/0898929053279586; Beauchamp MS, 2005, CURR OPIN NEUROBIOL, V15, P145, DOI 10.1016/j.conb.2005.03.011; BLONDER LX, 1991, BRAIN, V114, P1115, DOI 10.1093/brain/114.3.1115; Bradley M. M., 1999, C1 U FLOR CTR RES PS, V30, P25; Calder AJ, 2000, NAT NEUROSCI, V3, P1077, DOI 10.1038/80586; Calder AJ, 2005, NAT REV NEUROSCI, V6, P641, DOI 10.1038/nrn1724; Calvert GA, 2000, CURR BIOL, V10, P649, DOI 10.1016/S0960-9822(00)00513-3; Calvert GA, 2001, CEREB CORTEX, V11, P1110, DOI 10.1093/cercor/11.12.1110; Chen YH, 2010, EUR J NEUROSCI, V31, P1818, DOI 10.1111/j.1460-9568.2010.07203.x; Classen J, 1998, J NEUROPHYSIOL, V79, P1567, DOI 10.1152/jn.1998.79.3.1567; de Gelder B, 2000, COGNITION EMOTION, V14, P289, DOI 10.1080/026999300378824; de Gelder B, 1999, NEUROSCI LETT, V260, P133, DOI 10.1016/S0304-3940(98)00963-X; De Gelder B, 1996, NATO ASI SERIES F, V150, P179; Ethofer T, 2006, NEUROIMAGE, V30, P580, DOI 10.1016/j.neuroimage.2005.09.059; Ethofer T, 2006, PROG BRAIN RES, V156, P345, DOI 10.1016/S0079-6123(06)56019-4; Fingelkurts Alexander A, 2007, Cogn Process, V8, P183, DOI 10.1007/s10339-007-0175-x; Frith CD, 2006, BRAIN RES, V1079, P36, DOI 10.1016/j.brainres.2005.12.126; Giard MH, 1999, J COGNITIVE NEUROSCI, V11, P473, DOI 10.1162/089892999563544; Hagan CC, 2009, P NATL ACAD SCI USA, V106, P20010, DOI 10.1073/pnas.0905792106; Haxby JV, 2000, TRENDS COGN SCI, V4, P223, DOI 10.1016/S1364-6613(00)01482-0; Haxby JV, 2002, BIOL PSYCHIAT, V51, P59, DOI 10.1016/S0006-3223(01)01330-0; Herdman AT, 2006, NEUROSCI LETT, V399, P61, DOI 10.1016/j.neulet.2006.01.069; Hillebrand A, 2005, HUM BRAIN MAPP, V25, P199, DOI 10.1002/hbm.20102; Hocking J, 2008, CEREB CORTEX, V18, P2439, DOI 10.1093/cercor/bhn007; Huang MX, 2004, BRAIN TOPOGR, V16, P139; Jokisch D, 2007, J NEUROSCI, V27, P3244, DOI 10.1523/JNEUROSCI.5399-06.2007; Jones JA, 2003, NEUROREPORT, V14, P1129, DOI 10.1097/00001756-200306110-00006; Klasen M, 2012, REV NEUROSCIENCE, V23, P381, DOI 10.1515/revneuro-2012-0040; Kozinska D, 2001, CLIN NEUROPHYSIOL, V112, P1553, DOI 10.1016/S1388-2457(01)00556-9; Kreifelts B, 2007, NEUROIMAGE, V37, P1445, DOI 10.1016/j.neuroimage.2007.06.020; Lakatos P, 2005, J NEUROPHYSIOL, V94, P1904, DOI 10.1152/jn.00263.2005; Luo H, 2007, NEURON, V54, P1001, DOI 10.1016/j.neuron.2007.06.004; MCGURK H, 1976, NATURE, V264, P746, DOI 10.1038/264746a0; MEREDITH MA, 1983, SCIENCE, V221, P389, DOI 10.1126/science.6867718; Miller LM, 2005, J NEUROSCI, V25, P5884, DOI 10.1523/JNEUROSCI.0896-05.2005; Pourtois G, 2000, NEUROREPORT, V11, P1329, DOI 10.1097/00001756-200004270-00036; Robins DL, 2009, BRAIN COGNITION, V69, P269, DOI 10.1016/j.bandc.2008.08.007; Schroeder CE, 2008, TRENDS COGN SCI, V12, P106, DOI 10.1016/j.tics.2008.01.002; Scott SK, 1997, NATURE, V385, P254, DOI 10.1038/385254a0; Senkowski D, 2008, TRENDS NEUROSCI, V31, P401, DOI 10.1016/j.tins.2008.05.002; SINGER W, 1995, ANNU REV NEUROSCI, V18, P555, DOI 10.1146/annurev.ne.18.030195.003011; Stein BE., 1993, MERGING SENSES; STEIN BE, 2004, HDB MULTISENSORY PRO, P243; Stevenson RA, 2009, NEUROIMAGE, V44, P1210, DOI 10.1016/j.neuroimage.2008.09.034; Tallon-Baudry C, 1999, TRENDS COGN SCI, V3, P151, DOI 10.1016/S1364-6613(99)01299-1; Talsma D, 2007, CEREB CORTEX, V17, P679, DOI 10.1093/cercor/bhk016; van Wassenhove V, 2005, P NATL ACAD SCI USA, V102, P1181, DOI 10.1073/pnas.0408949102; van Wassenhove V, 2007, NEUROPSYCHOLOGIA, V45, P598, DOI 10.1016/j.neuropsychologia.2006.01.001; VanVeen BD, 1997, IEEE T BIO-MED ENG, V44, P867, DOI 10.1109/10.623056; YOUNG AW, 1995, BRAIN, V118, P15, DOI 10.1093/brain/118.1.15	52	17	19	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2013	8	8							e70648	10.1371/journal.pone.0070648	http://dx.doi.org/10.1371/journal.pone.0070648			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	200UV	23950977	Green Submitted, Green Accepted, gold, Green Published			2022-12-25	WOS:000323097300037
J	Weitman, ES; Aschen, SZ; Farias-Eisner, G; Albano, N; Cuzzone, DA; Ghanta, S; Zampell, JC; Thorek, D; Mehrara, BJ				Weitman, Evan S.; Aschen, Seth Z.; Farias-Eisner, Gina; Albano, Nicholas; Cuzzone, Daniel A.; Ghanta, Swapna; Zampell, Jamie C.; Thorek, Daniel; Mehrara, Babak J.			Obesity Impairs Lymphatic Fluid Transport and Dendritic Cell Migration to Lymph Nodes	PLOS ONE			English	Article							ADIPOSE-TISSUE INFLAMMATION; HIGH-RESOLUTION; STEADY-STATE; MICE; ACCUMULATION; DYSFUNCTION; ACTIVATION; CONTRIBUTE; ATROPHY; FAT	Introduction: Obesity is a major cause of morbidity and mortality resulting in pathologic changes in virtually every organ system. Although the cardiovascular system has been a focus of intense study, the effects of obesity on the lymphatic system remain essentially unknown. The purpose of this study was to identify the pathologic consequences of diet induced obesity (DIO) on the lymphatic system. Methods: Adult male wild-type or RAG C57B6-6J mice were fed a high fat (60%) or normal chow diet for 8-10 weeks followed by analysis of lymphatic transport capacity. In addition, we assessed migration of dendritic cells (DCs) to local lymph nodes, lymph node architecture, and lymph node cellular make up. Results: High fat diet resulted in obesity in both wild-type and RAG mice and significantly impaired lymphatic fluid transport and lymph node uptake; interestingly, obese wild-type but not obese RAG mice had significantly impaired migration of DCs to the peripheral lymph nodes. Obesity also resulted in significant changes in the macro and microscopic anatomy of lymph nodes as reflected by a marked decrease in size of inguinal lymph nodes (3.4-fold), decreased number of lymph node lymphatics (1.6-fold), loss of follicular pattern of B cells, and dysregulation of CCL21 expression gradients. Finally, obesity resulted in a significant decrease in the number of lymph node T cells and increased number of B cells and macrophages. Conclusions: Obesity has significant negative effects on lymphatic transport, DC cell migration, and lymph node architecture. Loss of T and B cell inflammatory reactions does not protect from impaired lymphatic fluid transport but preserves DC migration capacity. Future studies are needed to determine how the interplay between diet, obesity, and the lymphatic system modulate systemic complications of obesity.	[Weitman, Evan S.; Aschen, Seth Z.; Farias-Eisner, Gina; Albano, Nicholas; Cuzzone, Daniel A.; Ghanta, Swapna; Zampell, Jamie C.; Thorek, Daniel; Mehrara, Babak J.] Mem Sloan Kettering Canc Ctr, Dept Surg, Div Plast & Reconstruct Surg, New York, NY 10021 USA	Memorial Sloan Kettering Cancer Center	Mehrara, BJ (corresponding author), Mem Sloan Kettering Canc Ctr, Dept Surg, Div Plast & Reconstruct Surg, 1275 York Ave, New York, NY 10021 USA.	mehrarab@mskcc.org		Cuzzone, Daniel/0000-0003-1131-7305	National Institute of Health [1R01HL111130-01A1]; Plastic Surgery Foundation; Society of Memorial Sloan Kettering; NATIONAL CANCER INSTITUTE [T32CA009501, P30CA008748] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL111130] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Plastic Surgery Foundation; Society of Memorial Sloan Kettering; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	National Institute of Health (nih.gov) #1R01HL111130-01A1 (Mechanisms of fibrosis and lymphatic dysfunction in post-surgical lymphedema). Plastic Surgery Foundation (http://www.thepsf.org). Society of Memorial Sloan Kettering (http://mskcc.convio.net/site/PageServer?pagename=soc_home). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arngrim N, 2012, INT J OBES LOND; Avraham T, 2012, FASEB J; Avraham T, 2013, FASEB J, V27, P1114, DOI 10.1096/fj.12-222695; Avraham T, 2010, AM J PATHOL, V177, P3202, DOI 10.2353/ajpath.2010.100594; Beattie BJ, 2007, MOL IMAGING, V6, P108, DOI 10.2310/7290.2007.00008; Greene AK, 2012, NEW ENGL J MED, V366, P2136, DOI 10.1056/NEJMc1201684; Howard JK, 1999, J CLIN INVEST, V104, P1051, DOI 10.1172/JCI6762; Kataru RP, 2011, IMMUNITY, V34, P96, DOI 10.1016/j.immuni.2010.12.016; Kennedy AJ, 2010, DIS MODEL MECH, V3, P156, DOI 10.1242/dmm.003467; Kim CS, 2008, OBESITY, V16, P1261, DOI 10.1038/oby.2008.55; Kintscher U, 2008, ARTERIOSCL THROM VAS, V28, P1304, DOI 10.1161/ATVBAHA.108.165100; Lim HY, 2009, AM J PATHOL, V175, P1328, DOI 10.2353/ajpath.2009.080963; Maruyama K, 2007, AM J PATHOL, V170, P1178, DOI 10.2353/ajpath.2007.060018; McLaughlin SA, 2008, J CLIN ONCOL, V26, P5213, DOI 10.1200/JCO.2008.16.3725; Nishimura S, 2009, NAT MED, V15, P914, DOI 10.1038/nm.1964; Nitschke M, 2012, BLOOD, V120, P2249, DOI 10.1182/blood-2012-03-417923; Ogden Cynthia L, 2012, NCHS Data Brief, P1; Qi JY, 1998, PHYS MED BIOL, V43, P1001, DOI 10.1088/0031-9155/43/4/027; Rocha VZ, 2011, INT J INFLAMM, V2011, DOI 10.4061/2011/529061; SURWIT RS, 1995, METABOLISM, V44, P645, DOI 10.1016/0026-0495(95)90123-X; Tabibiazar R, 2006, PLOS MED, V3, P1114, DOI 10.1371/journal.pmed.0030254; Thomas SN, 2012, J IMMUNOL, V189, P2181, DOI 10.4049/jimmunol.1103545; Thorek DLJ, 2012, J NUCL MED, V53, P1438, DOI 10.2967/jnumed.112.104349; Tomei AA, 2009, J IMMUNOL, V183, P4273, DOI 10.4049/jimmunol.0900835; Wendland M, 2011, IMMUNITY, V35, P945, DOI 10.1016/j.immuni.2011.10.017; Winer S, 2009, NAT MED, V15, P921, DOI 10.1038/nm.2001; Wu HZ, 2007, CIRCULATION, V115, P1029, DOI 10.1161/CIRCULATIONAHA.106.638379; Zampell JC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049940; Zampell JC, 2012, AM J PHYSIOL-CELL PH, V302, pC392, DOI 10.1152/ajpcell.00306.2011	29	111	119	2	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2013	8	8							e70703	10.1371/journal.pone.0070703	http://dx.doi.org/10.1371/journal.pone.0070703			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	200UV	23950984	Green Submitted, gold, Green Published			2022-12-25	WOS:000323097300041
J	dos Santos, RV; da Silva, LM				dos Santos, Renato Vieira; da Silva, Linaena Mericy			A Possible Explanation for the Variable Frequencies of Cancer Stem Cells in Tumors	PLOS ONE			English	Article							INITIATING CELLS; SOLID TUMORS; GROWTH; HETEROGENEITY; RARE; MODELS	A controversy surrounds the frequency of cancer stem cells (CSCs) in solid tumors. Initial studies indicated that these cells had a frequency ranging from 0.0001 to 0.1% of the total cells. Recent studies have shown that this does not always seem to be the case. Some of these studies have indicated a frequency of 40%. In this paper we propose a stochastic model that is able to capture this potential variability in the frequency of CSCs among the various type of tumors. Considerations regarding the heterogeneity of the tumor cells and its consequences are included. Possible effects on conventional treatments in clinical practice are also described. The model results suggest that traditional attempts to combat cancer cells with rapid cycling can be very stimulating for the cancer stem cell populations.	[dos Santos, Renato Vieira] Univ Fed Minas Gerais, Dept Fis, Inst Ciencias Exatas, BR-30161 Belo Horizonte, MG, Brazil; [da Silva, Linaena Mericy] Univ Fed Minas Gerais, Inst Ciencias Biol, Lab Patol Comparada, Belo Horizonte, MG, Brazil	Universidade Federal de Minas Gerais; Universidade Federal de Minas Gerais	dos Santos, RV (corresponding author), Univ Fed Minas Gerais, Dept Fis, Inst Ciencias Exatas, BR-30161 Belo Horizonte, MG, Brazil.	econofisico@gmail.com; linaena.mericy@gmail.com			Conselho Nacional de Desenvolvimento Cientifico e Tecnologico, Brazil	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico, Brazil(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work was supported by the Conselho Nacional de Desenvolvimento Cientifico e Tecnologico, Brazil. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arens NC, 2008, PALEOBIOLOGY, V34, P456, DOI 10.1666/07034.1; Atkinson RL, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001447; Baker M., 2008, NATURE REPORTS STEM; Baker M, 2008, NATURE, V454, P556, DOI [10.1038/454556a, 10.1038/456553a]; Berglund N, 2006, PROB APPL S; Boiko AD, 2010, NATURE, V466, P133, DOI 10.1038/nature09161; Bomken S, 2010, BRIT J CANCER, V103, P439, DOI 10.1038/sj.bjc.6605821; Braumann CA, 2007, J THEOR BIOL, V244, P424, DOI 10.1016/j.jtbi.2006.08.029; Burness ML, 2010, SEMIN CANCER BIOL, V20, P107, DOI 10.1016/j.semcancer.2010.05.006; Castorina P, 2006, PHYSICA A, V365, P473, DOI 10.1016/j.physa.2005.09.063; Chaffer CL, 2011, P NATL ACAD SCI USA, V108, P7950, DOI 10.1073/pnas.1102454108; Chen J, 2012, NATURE, V488, P522, DOI 10.1038/nature11287; Choe SC, 2011, SCI REP-UK, V1, DOI 10.1038/srep00031; Chow E, 2012, J LAB AUTOMATION; Clarke MF, 2006, CELL, V124, P1111, DOI 10.1016/j.cell.2006.03.011; Dalerba P, 2007, ANNU REV MED, V58, P267, DOI 10.1146/annurev.med.58.062105.204854; Denison TA, 2012, J CONTROLLED RELEASE; Driessens G, 2012, NATURE, V488, P527, DOI 10.1038/nature11344; Gammaitoni L, 1998, REV MOD PHYS, V70, P223, DOI 10.1103/RevModPhys.70.223; Gardiner C, 2009, SPRINGER SERIES SYNE; Gliozzi AS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005358; Grunewald TGP, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-79; Guiot C, 2003, J THEOR BIOL, V225, P147, DOI 10.1016/S0022-5193(03)00221-2; Guiot C, 2006, J THEOR BIOL, V240, P459, DOI 10.1016/j.jtbi.2005.10.006; Gupta PB, 2009, NAT MED, V15, P1010, DOI 10.1038/nm0909-1010; Herman AB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022973; Hill RP, 2006, CANCER RES, V66, P1891, DOI 10.1158/0008-5472.CAN-05-3450; Hirsch M.W., 2004, DIFF EQUAT+; Horsthemke W., 1984, SPRINGER SERIES SYNE; Ishizawa K, 2010, CELL STEM CELL, V7, P279, DOI 10.1016/j.stem.2010.08.009; Iwasaki H, 2009, CANCER SCI, V100, P1166, DOI 10.1111/j.1349-7006.2009.01177.x; Johnston MD, 2010, J THEOR BIOL, V266, P708, DOI 10.1016/j.jtbi.2010.07.031; Kalialis LV, 2009, MELANOMA RES, V19, P275, DOI 10.1097/CMR.0b013e32832eabd5; Karlin S., 2000, 2 COURSE STOCHASTIC; Kavinoky R., 2008, AMATYC REV, V29, P3; Kelly PN, 2007, SCIENCE, V317, P337, DOI 10.1126/science.1142596; Kloeden P.E., 1992, APPL MATH; LAIRD AK, 1964, BRIT J CANCER, V18, P490, DOI 10.1038/bjc.1964.55; Lander AD, 2012, BMC BIOL, V10, DOI 10.1186/1741-7007-10-19; Leder K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014366; Lewis MT, 2008, FUTURE ONCOL, V4, P585, DOI 10.2217/14796694.4.5.585; Maffini MV, 2004, J CELL SCI, V117, P1495, DOI 10.1242/jcs.01000; Marusyk A, 2012, NATURE REV CANC; Marusyk A, 2010, BBA-REV CANCER, V1805, P105, DOI 10.1016/j.bbcan.2009.11.002; Morrison SJ, 2006, NATURE, V441, P1068, DOI 10.1038/nature04956; Oksendal B., 2003, UNIVERSITEXT; Perko L., 2000, TEXTS APPL MATH, V7; Pietras A, 2011, ADV CANCER RES, V112, P255, DOI 10.1016/B978-0-12-387688-1.00009-0; Quintana E, 2008, NATURE, V456, P593, DOI 10.1038/nature07567; Rapp UR, 2008, CELL CYCLE, V7, P45, DOI 10.4161/cc.7.1.5203; Reya T, 2001, NATURE, V414, P105, DOI 10.1038/35102167; Ridolfi L., 2011, NOISE INDUCED PHENOM; Sarry JE, 2011, J CLIN INVEST, V121, P384, DOI 10.1172/JCI41495; Schatton T, 2008, NATURE, V451, P345, DOI 10.1038/nature06489; Shackleton M, 2009, CELL, V138, P822, DOI 10.1016/j.cell.2009.08.017; Stewart JM, 2011, P NATL ACAD SCI USA, V108, P6468, DOI 10.1073/pnas.1005529108; Strauss R, 2012, MOL THERAPY; Tian TH, 2011, INTEGR BIOL-UK, V3, P17, DOI 10.1039/c0ib00046a; Tomasetti C, 2010, P NATL ACAD SCI USA, V107, P16766, DOI 10.1073/pnas.1007726107; Turner C, 2009, CELL PROLIFERAT, V42, P529, DOI 10.1111/j.1365-2184.2009.00619.x; VAIDYA VG, 1982, INT J BIOMED COMPUT, V13, P19, DOI 10.1016/0020-7101(82)90048-4; VandenBroeck C, 1997, PHYS REV E, V55, P4084, DOI 10.1103/PhysRevE.55.4084; Vargaftig J, 2012, LEUKEMIA, V26, P858, DOI 10.1038/leu.2011.250; Vermeulen L, 2008, CELL DEATH DIFFERENT; VONBERTALANFFY L, 1957, Q REV BIOL, V32, P217, DOI 10.1086/401873; Weedon-Fekjaer H, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr2092; Welte Y, 2010, CELL COMMUN SIGNAL, V8, DOI 10.1186/1478-811X-8-6; Whiteside TL, 2008, ONCOGENE, V27, P5904, DOI 10.1038/onc.2008.271; Williams RT, 2007, GENE DEV, V21, P2283, DOI 10.1101/gad.1588607; WU DJ, 1994, PHYS REV E, V50, P2496, DOI 10.1103/PhysRevE.50.2496; Zapperi S, 2012, SCI REPORTS; Zhong Y, 2010, CANCER LETT, V292, P17, DOI 10.1016/j.canlet.2009.10.021	72	12	12	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2013	8	8							e69131	10.1371/journal.pone.0069131	http://dx.doi.org/10.1371/journal.pone.0069131			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	200ZE	23950884	Green Submitted, Green Published, gold			2022-12-25	WOS:000323109700014
J	Rooney, NJ; Morant, S; Guest, C				Rooney, Nicola J.; Morant, Steve; Guest, Claire			Investigation into the Value of Trained Glycaemia Alert Dogs to Clients with Type I Diabetes	PLOS ONE			English	Article							HYPOGLYCEMIA; BEHAVIOR	Previous studies have suggested that some pet dogs respond to their owners' hypoglycaemic state. Here, we show that trained glycaemia alert dogs placed with clients living with diabetes afford significant improvements to owner well-being. We investigated whether trained dogs reliably respond to their owners' hypoglycaemic state, and whether owners experience facilitated tightened glycaemic control, and wider psychosocial benefits. Since obtaining their dog, all seventeen clients studied reported positive effects including reduced paramedic call outs, decreased unconscious episodes and improved independence. Owner-recorded data showed that dogs alerted their owners, with significant, though variable, accuracy at times of low and high blood sugar. Eight out of the ten dogs (for which owners provided adequate records) responded consistently more often when their owner's blood sugars were reported to be outside, than within, target range. Comparison of nine clients' routine records showed significant overall change after obtaining their dogs, with seven clients recording a significantly higher proportion of routine tests within target range after obtaining a dog. HbA1C showed a small, non significant reduction after dog allocation. Based on owner-reported data we have shown, for the first time, that trained detection dogs perform above chance level. This study points to the potential value of alert dogs, for increasing glycaemic control, client independence and consequent quality of life and even reducing the costs of long-term health care.	[Rooney, Nicola J.] Univ Bristol, Anthrozool Inst, Bristol, Avon, England; [Morant, Steve] Univ Dundee, Med Monitoring Unit, Dundee, Scotland; [Guest, Claire] Med Detect Dogs, Milton Keynes, Bucks, England	University of Bristol; University of Dundee	Rooney, NJ (corresponding author), Univ Bristol, Anthrozool Inst, Bristol, Avon, England.	Nicola.Rooney@bristol.ac.uk	Rooney, Nicola/AAE-8131-2022	Morant, Steven/0000-0001-5674-3784; rooney, nicola/0000-0001-9629-1700; Guest BSc (Hons) MSc HonDSc. DHP BCAh FRSA, Claire/0000-0002-1169-9246	Company of Animals	Company of Animals	The study was funded by the Company of Animals. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amiel S, 2002, BRIT MED J, V325, P746, DOI 10.1136/bmj.325.7367.746; Bilous R., 2010, HDB OF DIABETES, P96; Blackwell EJ, 2008, J VET BEHAV, V3, P207, DOI 10.1016/j.jveb.2007.10.008; Boland EA, 1999, DIABETES CARE, V22, P1779, DOI 10.2337/diacare.22.11.1779; Bradley C, 1999, QUAL LIFE RES, V8, P79, DOI 10.1023/A:1026485130100; Bradley G, 2000, DIABETES CARE, V23, P875; Chen M, 2002, BMJ-BRIT MED J, V321, P1565; Fiallo-Scharer R, 2005, J CLIN ENDOCR METAB, V90, P3387, DOI 10.1210/jc.2004-2510; Gonder-Frederick LA, 2011, DIABETES CARE, V34, P801, DOI 10.2337/dc10-1343; Hiby EF, 2004, ANIM WELFARE, V13, P63; Kunjan Kislaya, 2008, J Diabetes Sci Technol, V2, P194; Lim K, 1992, DIABETIC MED S2, pS3; NICE, 2011, CONT SUBC INS INF TR; O'Connor MB, 2008, IRISH J MED SCI, V177, P155, DOI 10.1007/s11845-008-0128-0; PRAMMING S, 1991, DIABETIC MED, V8, P217, DOI 10.1111/j.1464-5491.1991.tb01575.x; Rooney NJ, 2011, APPL ANIM BEHAV SCI, V132, P169, DOI 10.1016/j.applanim.2011.03.007; Rooney NJ, 2004, APPL ANIM BEHAV SCI, V86, P123, DOI 10.1016/j.applanim.2003.12.007; Rooney NJ, 2013, INT WORK DOG ASS LAC; Stocks AE, 2002, DIABETOLOGIA, V45, pA79; Strong V, 2002, SEIZURE-EUR J EPILEP, V11, P402, DOI 10.1053/seiz.2001.0656; Tauveron I, 2006, DIABETIC MED, V23, P335, DOI 10.1111/j.1464-5491.2006.01820.x; Tenzer-Iglesias Penny, 2012, J Fam Pract, V61, pS1; Wells DL, 2009, J SOC ISSUES, V65, P523, DOI 10.1111/j.1540-4560.2009.01612.x; Wells DL, 2008, J ALTERN COMPLEM MED, V14, P1235, DOI 10.1089/acm.2008.0288	24	51	52	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2013	8	8							e69921	10.1371/journal.pone.0069921	http://dx.doi.org/10.1371/journal.pone.0069921			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	200ZE	23950905	Green Published, gold, Green Submitted			2022-12-25	WOS:000323109700021
J	Sewall, BJ; Freestone, AL; Hawes, JE; Andriamanarina, E				Sewall, Brent J.; Freestone, Amy L.; Hawes, Joseph E.; Andriamanarina, Ernest			Size-Energy Relationships in Ecological Communities	PLOS ONE			English	Article							GENERAL QUANTITATIVE THEORY; BODY-SIZE; POPULATION-DENSITY; FOOD WEBS; ABUNDANCE RELATIONSHIPS; FOREST STRUCTURE; METABOLIC THEORY; EQUIVALENCE; ENERGETICS; CONSERVATION	Hypotheses that relate body size to energy use are of particular interest in community ecology and macroecology because of their potential to facilitate quantitative predictions about species interactions and to clarify complex ecological patterns. One prominent size-energy hypothesis, the energetic equivalence hypothesis, proposes that energy use from shared, limiting resources by populations or size classes of foragers will be independent of body size. Alternative hypotheses propose that energy use will increase with body size, decrease with body size, or peak at an intermediate body size. Despite extensive study, however, size-energy hypotheses remain controversial, due to a lack of directly-measured data on energy use, a tendency to confound distinct scaling relationships, and insufficient attention to the ecological contexts in which predicted relationships are likely to occur. Our goal, therefore, was to directly evaluate size-energy hypotheses while clarifying how results would differ with alternate methods and assumptions. We comprehensively tested size-energy hypotheses in a vertebrate frugivore guild in a tropical forest in Madagascar. Our test of size-energy hypotheses, which is the first to examine energy intake directly, was consistent with the energetic equivalence hypothesis. This finding corresponds with predictions of metabolic theory and models of energy distribution in ecological communities, which imply that body size does not confer an advantage in competition for energy among populations or size classes of foragers. This result was robust to different assumptions about energy regulation. Our results from direct energy measurement, however, contrasted with those obtained with conventional methods of indirect inference from size-density relationships, suggesting that size-density relationships do not provide an appropriate proxy for size-energy relationships as has commonly been assumed. Our research also provides insights into mechanisms underlying local size-energy relationships and has important implications for predicting species interactions and for understanding the structure and dynamics of ecological communities.	[Sewall, Brent J.; Freestone, Amy L.] Temple Univ, Dept Biol, Philadelphia, PA 19122 USA; [Sewall, Brent J.] Univ Calif Davis, Dept Wildlife Fish & Conservat Biol, Davis, CA 95616 USA; [Hawes, Joseph E.] Univ E Anglia, Sch Environm Sci, Norwich NR4 7TJ, Norfolk, England; [Andriamanarina, Ernest] Univ Antsiranana, Dept Sci Nat & Environnement, Antsiranana, Madagascar	Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; University of California System; University of California Davis; University of East Anglia	Sewall, BJ (corresponding author), Temple Univ, Dept Biol, Philadelphia, PA 19122 USA.	bjsewall@temple.edu		Hawes, Joseph/0000-0003-0053-2018	Robert and Patricia Switzer Foundation; Selma Herr Endowment Fund for Ornithological Research; Achievement Rewards for College Scientists Foundation; Bat Conservation International; Davis Botanical Society; British Ecological Society; United States National Science Foundation [DEB-1257916]; Division Of Environmental Biology [1257916] Funding Source: National Science Foundation	Robert and Patricia Switzer Foundation; Selma Herr Endowment Fund for Ornithological Research; Achievement Rewards for College Scientists Foundation(General Electric); Bat Conservation International; Davis Botanical Society; British Ecological Society; United States National Science Foundation(National Science Foundation (NSF)); Division Of Environmental Biology(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	The authors are grateful to the Robert and Patricia Switzer Foundation (http://www.switzernetwork.org), the Selma Herr Endowment Fund for Ornithological Research, the Achievement Rewards for College Scientists Foundation (http://www.arcsfoundation.org), Bat Conservation International (http://www.batcon.org), the Davis Botanical Society (http://herbarium.ucdavis.edu/society.html), the British Ecological Society (http://www.britishecologicalsociety.org), and the United States National Science Foundation grant DEB-1257916 (http://www.nsf.gov) for financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackerman JL, 2004, OECOLOGIA, V139, P568, DOI 10.1007/s00442-004-1536-0; Allen AP, 2002, SCIENCE, V297, P1545, DOI 10.1126/science.1072380; Arim M, 2011, ADV ECOL RES, V45, P1, DOI 10.1016/B978-0-12-386475-8.00001-0; Arneberg P, 1998, AM NAT, V151, P497, DOI 10.1086/286136; BERG CC, 1989, EXPERIENTIA, V45, P605, DOI 10.1007/BF01975677; BLACKBURN TM, 1994, TRENDS ECOL EVOL, V9, P471, DOI 10.1016/0169-5347(94)90311-5; Blackburn TM, 1996, OIKOS, V75, P551, DOI 10.2307/3545899; Breed GA., 2012, PLOS ONE, V7; Brown JH, 2004, ECOLOGY, V85, P1771, DOI 10.1890/03-9000; Brown JH, 2003, P NATL ACAD SCI USA, V100, P1467, DOI 10.1073/pnas.0630310100; BROWN JH, 1989, SCIENCE, V243, P1145, DOI 10.1126/science.243.4895.1145; BROWN JH, 1986, NATURE, V324, P248, DOI 10.1038/324248a0; Buckland S.T., 2001, pi; Burnham K.P., 2002, MODEL SELECTION MULT, DOI 10.1007/b97636; Cardiff SG, 2009, AFR J ECOL, V47, P640, DOI 10.1111/j.1365-2028.2008.01015.x; Clauss M, 2007, COMP BIOCHEM PHYS A, V148, P249, DOI 10.1016/j.cbpa.2007.05.024; Cordeiro NJ, 2009, ECOLOGY, V90, P1030, DOI 10.1890/07-1208.1; COTGREAVE P, 1993, TRENDS ECOL EVOL, V8, P244, DOI 10.1016/0169-5347(93)90199-Y; DAMUTH J, 1993, NATURE, V365, P748, DOI 10.1038/365748a0; DAMUTH J, 1981, NATURE, V290, P699, DOI 10.1038/290699a0; DAMUTH J, 1987, BIOL J LINN SOC, V31, P193, DOI 10.1111/j.1095-8312.1987.tb01990.x; Damuth J, 2007, AM NAT, V169, P621, DOI 10.1086/513495; DeLong JP, 2012, ECOLOGY, V93, P470, DOI 10.1890/11-1138.1; Enquist BJ, 1998, NATURE, V395, P163, DOI 10.1038/25977; Enquist BJ, 2009, P NATL ACAD SCI USA, V106, P7046, DOI 10.1073/pnas.0812303106; Ernest SKM, 2008, AM NAT, V172, pE257, DOI 10.1086/592402; Ernest SKM, 2005, ECOLOGY, V86, P1407, DOI 10.1890/03-3179; Ernest SKM, 2003, ECOL LETT, V6, P990, DOI 10.1046/j.1461-0248.2003.00526.x; Fisher R. A, 1925, STAT METHODS RES WOR, V1, DOI DOI 10.1111/J.2397-2335.1926.TB01837.X; FOWLER SV, 1989, BIOL CONSERV, V47, P297, DOI 10.1016/0006-3207(89)90072-4; Garbutt N, 2007, MAMMALS MADAGASCAR C; GRIFFITHS D, 1992, J ANIM ECOL, V61, P307, DOI 10.2307/5323; HAWKINS AFA, 1990, BIOL CONSERV, V54, P83, DOI 10.1016/0006-3207(90)90136-D; Hayward A, 2010, ECOL COMPLEX, V7, P115, DOI 10.1016/j.ecocom.2009.08.005; Hayward A, 2009, GLOBAL ECOL BIOGEOGR, V18, P553, DOI 10.1111/j.1466-8238.2009.00459.x; Hechinger RF, 2011, SCIENCE, V333, P445, DOI 10.1126/science.1204337; Isaac NJB, 2013, GLOBAL ECOL BIOGEOGR, V22, P1, DOI 10.1111/j.1466-8238.2012.00782.x; Isaac Nick J.B., 2012, P77; Isaac NJB, 2010, ECOL LETT, V13, P728, DOI 10.1111/j.1461-0248.2010.01461.x; JANZEN DH, 1979, ANNU REV ECOL SYST, V10, P13, DOI 10.1146/annurev.es.10.110179.000305; Kelt DA, 1997, BIOL J LINN SOC, V62, P15; King JR, 2010, ECOL ENTOMOL, V35, P287, DOI 10.1111/j.1365-2311.2010.01177.x; Kleiber M., 1975, FIRE LIFE; Loeuille N, 2006, ECOL LETT, V9, P171, DOI 10.1111/j.1461-0248.2005.00861.x; Marquet PA, 2005, J EXP BIOL, V208, P1749, DOI 10.1242/jeb.01588; MARQUET PA, 1995, J ANIM ECOL, V64, P325, DOI 10.2307/5894; McNab BK, 2003, NATURE, V426, P620, DOI 10.1038/426620b; MCNAB BK, 1986, ECOL MONOGR, V56, P1, DOI 10.2307/2937268; MITTERMEIER RA, 2006, LEMURS MADAGASCAR; Nagy KA, 2005, J EXP BIOL, V208, P1621, DOI 10.1242/jeb.01553; Nagy KA, 1999, ANNU REV NUTR, V19, P247, DOI 10.1146/annurev.nutr.19.1.247; NEE S, 1991, NATURE, V351, P312, DOI 10.1038/351312a0; Nekaris KAI, 2008, BIODIVERS CONSERV, V17, P733, DOI 10.1007/s10531-007-9308-x; Nunez-Iturri G, 2007, BIOTROPICA, V39, P348, DOI 10.1111/j.1744-7429.2007.00276.x; R-Development-Core-Team, 2010, R VERS 2 11 1; Radhakrishna S, 2006, INT J PRIMATOL, V27, P971, DOI 10.1007/s10764-006-9057-9; Rasoloarison RM, 2000, INT J PRIMATOL, V21, P963, DOI 10.1023/A:1005511129475; Ravokatra M, 2003, NATURAL HIST MADAGAS, P1059; Reuman DC, 2008, ECOL LETT, V11, P1216, DOI 10.1111/j.1461-0248.2008.01236.x; Reuman DC, 2009, ADV ECOL RES, V41, P1, DOI 10.1016/S0065-2504(09)00401-2; Russo SE, 2003, AM NAT, V161, P267, DOI 10.1086/345938; Saracco JF, 2004, OECOLOGIA, V139, P235, DOI 10.1007/s00442-004-1493-7; SAS Institute, 2008, JMP VERS 8 0 STAT SO; Savage VM, 2004, AM NAT, V163, P429, DOI 10.1086/381872; Shanahan M, 2001, BIOL REV, V76, P529, DOI 10.1017/S1464793101005760; Terborgh J., 1986, CONSERVATION BIOL SC, P330; Thibault KM, 2011, GLOBAL ECOL BIOGEOGR, V20, P145, DOI 10.1111/j.1466-8238.2010.00576.x; Thomas L, 2010, DISTANCE 6 0 RELEASE; Thomas L, 2010, J APPL ECOL, V47, P5, DOI 10.1111/j.1365-2664.2009.01737.x; Tilman D, 2004, ECOLOGY, V85, P1797, DOI 10.1890/03-0725; Warton DI, 2006, BIOL REV, V81, P259, DOI 10.1017/S1464793106007007; West GB, 2009, P NATL ACAD SCI USA, V106, P7040, DOI 10.1073/pnas.0812294106; White EP, 2008, ECOLOGY, V89, P905, DOI 10.1890/07-1288.1; White EP, 2007, TRENDS ECOL EVOL, V22, P323, DOI 10.1016/j.tree.2007.03.007; Yvon-Durocher G, 2011, OIKOS, V120, P550, DOI 10.1111/j.1600-0706.2010.18863.x	75	9	9	0	64	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2013	8	8							e68657	10.1371/journal.pone.0068657	http://dx.doi.org/10.1371/journal.pone.0068657			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	200ZE	23950873	Green Submitted, Green Published, gold			2022-12-25	WOS:000323109700007
J	Kobayashi, S; Totoki, Y; Soma, M; Matsumoto, K; Fujihara, Y; Toyoda, A; Sakaki, Y; Okabe, M; Ishino, F				Kobayashi, Shin; Totoki, Yasushi; Soma, Miki; Matsumoto, Kazuya; Fujihara, Yoshitaka; Toyoda, Atsushi; Sakaki, Yoshiyuki; Okabe, Masaru; Ishino, Fumitoshi			Identification of an Imprinted Gene Cluster in the X-Inactivation Center	PLOS ONE			English	Article							EARLY MOUSE DEVELOPMENT; LONG NONCODING RNAS; CHROMOSOME INACTIVATION; XIST EXPRESSION; DEFICIENT MICE; EMBRYOS; OOCYTES; BIOGENESIS; MECHANISMS; ORIGIN	Mammalian development is strongly influenced by the epigenetic phenomenon called genomic imprinting, in which either the paternal or the maternal allele of imprinted genes is expressed. Paternally expressed Xist, an imprinted gene, has been considered as a single cis-acting factor to inactivate the paternally inherited X chromosome (Xp) in preimplantation mouse embryos. This means that X-chromosome inactivation also entails gene imprinting at a very early developmental stage. However, the precise mechanism of imprinted X-chromosome inactivation remains unknown and there is little information about imprinted genes on X chromosomes. In this study, we examined whether there are other imprinted genes than Xist expressed from the inactive paternal X chromosome and expressed in female embryos at the preimplantation stage. We focused on small RNAs and compared their expression patterns between sexes by tagging the female X chromosome with green fluorescent protein. As a result, we identified two micro (mi) RNAs-miR-374-5p and miR-421-3p-mapped adjacent to Xist that were predominantly expressed in female blastocysts. Allelic expression analysis revealed that these miRNAs were indeed imprinted and expressed from the Xp. Further analysis of the imprinting status of adjacent locus led to the discovery of a large cluster of imprinted genes expressed from the Xp: Jpx, Ftx and Zcchc13. To our knowledge, this is the first identified cluster of imprinted genes in the cis-acting regulatory region termed the X-inactivation center. This finding may help in understanding the molecular mechanisms regulating imprinted X-chromosome inactivation during early mammalian development.	[Kobayashi, Shin] Japan Sci & Technol Agcy, Precursory Res Embryon Sci & Technol, Kawaguchi, Saitama, Japan; [Kobayashi, Shin; Soma, Miki; Matsumoto, Kazuya; Ishino, Fumitoshi] Tokyo Med & Dent Univ, Med Res Inst, Dept Epigenet, Bunkyo Ku, Tokyo, Japan; [Totoki, Yasushi] Natl Canc Ctr, Res Inst, Div Canc Genom, Chuo Ku, Tokyo 104, Japan; [Fujihara, Yoshitaka; Okabe, Masaru] Osaka Univ, Microbial Dis Res Inst, Suita, Osaka 565, Japan; [Toyoda, Atsushi] Natl Inst Genet, Ctr Informat Biol, Comparat Genom Lab, Mishima, Shizuoka 411, Japan; [Sakaki, Yoshiyuki] Toyohashi Univ Technol, Toyohashi, Aichi, Japan	Japan Science & Technology Agency (JST); Tokyo Medical & Dental University (TMDU); National Cancer Center - Japan; Osaka University; Research Organization of Information & Systems (ROIS); National Institute of Genetics (NIG) - Japan; Toyohashi University of Technology	Kobayashi, S (corresponding author), Japan Sci & Technol Agcy, Precursory Res Embryon Sci & Technol, Kawaguchi, Saitama, Japan.	kobayashi.mtt@mri.tmd.ac.jp	Kobayashi, Shin/L-8087-2018; Kobayashi, Shin/X-5413-2019; Fujihara, Yoshitaka/G-2043-2011; Okabe, Masaru/B-6917-2015	Kobayashi, Shin/0000-0001-6639-3810; Kobayashi, Shin/0000-0001-6639-3810; Fujihara, Yoshitaka/0000-0001-8332-3507; Okabe, Masaru/0000-0002-0803-9044	Japan Science and Technology Agency, Precursory Research for Embryonic Science and Technology (PRESTO); Ministry of Education, Culture, Sports, Science and Technology; Sumitomo Foundation	Japan Science and Technology Agency, Precursory Research for Embryonic Science and Technology (PRESTO); Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Sumitomo Foundation	This work was supported by the Japan Science and Technology Agency, Precursory Research for Embryonic Science and Technology (PRESTO); a Grant-in-Aid for Scientific Research from The Ministry of Education, Culture, Sports, Science and Technology; and by the Sumitomo Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Calabrese JM, 2012, CELL, V151, P951, DOI 10.1016/j.cell.2012.10.037; Chiba H, 2008, GENESIS, V46, P768, DOI 10.1002/dvg.20438; Chureau C, 2011, HUM MOL GENET, V20, P705, DOI 10.1093/hmg/ddq516; Fedoriw A, 2012, COLD SPRING HARB PER, V4, P1; Girardot M, EPIGENETICS, V7, P1341; Huynh KD, 2003, NATURE, V426, P857, DOI 10.1038/nature02222; Isotani A, 2005, P NATL ACAD SCI USA, V102, P4039, DOI 10.1073/pnas.0406769102; Jamieson RV, 1998, DEV BIOL, V201, P13, DOI 10.1006/dbio.1998.8972; KAY GF, 1994, CELL, V77, P639, DOI 10.1016/0092-8674(94)90049-3; Kim VN, 2009, NAT REV MOL CELL BIO, V10, P126, DOI 10.1038/nrm2632; Kobayashi H, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002440; Kobayashi S, 2006, CURR BIOL, V16, P166, DOI 10.1016/j.cub.2005.11.071; Kobayashi S, 2010, NUCLEIC ACIDS RES, V38, P3672, DOI 10.1093/nar/gkq113; Krol J, 2010, NAT REV GENET, V11, P597, DOI 10.1038/nrg2843; Lee JT, 2000, CELL, V103, P17, DOI 10.1016/S0092-8674(00)00101-X; LYON MF, 1961, NATURE, V190, P372, DOI 10.1038/190372a0; Mak W, 2004, SCIENCE, V303, P666, DOI 10.1126/science.1092674; Marahrens Y, 1997, GENE DEV, V11, P156, DOI 10.1101/gad.11.2.156; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Nakanishi T, 2002, GENOMICS, V80, P564, DOI 10.1006/geno.2002.7008; Okamoto I, 2005, NATURE, V438, P369, DOI 10.1038/nature04155; Okamoto I, 2004, SCIENCE, V303, P644, DOI 10.1126/science.1092727; Patrat C, 2009, P NATL ACAD SCI USA, V106, P5198, DOI 10.1073/pnas.0810683106; Pitman JL, 1998, DEV BIOL, V202, P196, DOI 10.1006/dbio.1998.8978; Ponting CP, 2009, CELL, V136, P629, DOI 10.1016/j.cell.2009.02.006; RASTAN S, 1983, J EMBRYOL EXP MORPH, V78, P1; RASTAN S, 1985, J EMBRYOL EXP MORPH, V90, P379; Sado T, 2001, DEVELOPMENT, V128, P1275; Skuse DH, 1997, NATURE, V387, P705, DOI 10.1038/42706; Smallwood SA, 2011, NAT GENET, V43, P811, DOI 10.1038/ng.864; TAKAGI N, 1975, NATURE, V256, P640, DOI 10.1038/256640a0; THORNHILL AR, 1993, DEVELOPMENT, V118, P171; Tian D, 2010, CELL, V143, P390, DOI 10.1016/j.cell.2010.09.049; Wang KC, 2011, MOL CELL, V43, P904, DOI 10.1016/j.molcel.2011.08.018; Watanabe T, 2007, METHOD ENZYMOL, V427, P155, DOI 10.1016/S0076-6879(07)27009-0; Williamson C, 2012, MOUSE IMPRINTING DAT; Yamamoto M, 2004, NATURE, V428, P387, DOI 10.1038/nature02418	37	17	17	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2013	8	8							e71222	10.1371/journal.pone.0071222	http://dx.doi.org/10.1371/journal.pone.0071222			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	217ZG	23940725	Green Published, gold, Green Submitted			2022-12-25	WOS:000324401500062
J	Koriyama, Y; Takagi, Y; Chiba, K; Yamazaki, M; Sugitani, K; Arai, K; Suzuki, H; Kato, S				Koriyama, Yoshiki; Takagi, Yusuke; Chiba, Kenzo; Yamazaki, Matsumi; Sugitani, Kayo; Arai, Kunizo; Suzuki, Hirokazu; Kato, Satoru			Requirement of Retinoic Acid Receptor beta for Genipin Derivative-Induced Optic Nerve Regeneration in Adult Rat Retina	PLOS ONE			English	Article							NITRIC-OXIDE SYNTHASE; IN-VIVO; NEURITE OUTGROWTH; GANGLION-CELLS; GROWTH-FACTOR; AXON REGENERATION; DIFFERENTIATION; ACTIVATION; EXPRESSION; INHIBITOR	Like other CNS neurons, mature retinal ganglion cells (RGCs) are unable to regenerate their axons after nerve injury due to a diminished intrinsic regenerative capacity. One of the reasons why they lose the capacity for axon regeneration seems to be associated with a dramatic shift in RGCs' program of gene expression by epigenetic modulation. We recently reported that (1R)-isoPropyloxygenipin (IPRG001), a genipin derivative, has both neuroprotective and neurite outgrowth activities in murine RGC-5 retinal precursor cells. These effects were both mediated by nitric oxide (NO)/S-nitrosylation signaling. Neuritogenic activity was mediated by S-nitrosylation of histone deacetylase-2 (HDAC2), which subsequently induced retinoic acid receptor beta (RAR beta) expression via chromatin remodeling in vitro. RAR beta plays important roles of neural growth and differentiation in development. However, the role of RAR beta expression during adult rat optic nerve regeneration is not clear. In the present study, we extended this hypothesis to examine optic nerve regeneration by IPRG001 in adult rat RGCs in vivo. We found a correlation between RAR beta expression and neurite outgrowth with age in the developing rat retina. Moreover, we found that IPRG001 significantly induced RAR beta expression in adult rat RGCs through the S-nitrosylation of HDAC2 processing mechanism. Concomitant with RAR beta expression, adult rat RGCs displayed a regenerative capacity for optic axons in vivo by IPRG001 treatment. These neuritogenic effects of IPRG001 were specifically suppressed by siRNA for RAR beta. Thus, the dual neuroprotective and neuritogenic actions of genipin via S-nitrosylation might offer a powerful therapeutic tool for the treatment of RGC degenerative disorders.	[Koriyama, Yoshiki; Kato, Satoru] Kanazawa Univ, Grad Sch Med, Dept Mol Neurobiol, Kanazawa, Ishikawa, Japan; [Takagi, Yusuke; Arai, Kunizo] Kanazawa Univ, Fac Pharm, Dept Clin Drug Informat, Kanazawa, Ishikawa, Japan; [Chiba, Kenzo; Yamazaki, Matsumi] Hokuriku Univ, Fac Pharmaceut Sci, Dept Biochem, Kanazawa, Ishikawa 92011, Japan; [Sugitani, Kayo] Kanazawa Univ, Grad Sch Med, Div Hlth Sci, Kanazawa, Ishikawa, Japan; [Suzuki, Hirokazu] Hokuriku Univ, Fac Pharmaceut Sci, Dept Med Chem, Kanazawa, Ishikawa 92011, Japan	Kanazawa University; Kanazawa University; Hokuriku University; Kanazawa University; Hokuriku University	Koriyama, Y (corresponding author), Kanazawa Univ, Grad Sch Med, Dept Mol Neurobiol, Kanazawa, Ishikawa, Japan.	koriyama@med.kanazawa-u.ac.jp	ARAI, KUNIZO/D-8387-2015; Koriyama, Yoshiki/AAA-1830-2022	ARAI, KUNIZO/0000-0002-8373-1137; Koriyama, Yoshiki/0000-0001-8777-329X	Ministry of Education, Culture, Sports, Science and Technology of Japan [25462753, 23650163, 23618006]	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was partly supported by research grants from the Ministry of Education, Culture, Sports, Science and Technology of Japan (Nos 25462753 to YK, 23650163 to SK and 23618006 to KS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benowitz LI, 1997, TRENDS NEUROSCI, V20, P84, DOI 10.1016/S0166-2236(96)10072-2; Biermann J, 2010, INVEST OPHTH VIS SCI, V51, P526, DOI 10.1167/iovs.09-3903; BREGMAN BS, 1982, SCIENCE, V217, P553, DOI 10.1126/science.7089581; CARONI P, 1988, NEURON, V1, P85, DOI 10.1016/0896-6273(88)90212-7; Chambon P, 1996, FASEB J, V10, P940, DOI 10.1096/fasebj.10.9.8801176; CHEN DF, 1995, P NATL ACAD SCI USA, V92, P7287, DOI 10.1073/pnas.92.16.7287; COLELLO RJ, 1994, J NEUROSCI, V14, P2594; Corcoran J, 1999, NAT NEUROSCI, V2, P307, DOI 10.1038/7214; Corcoran J, 2002, J CELL SCI, V115, P3779, DOI 10.1242/jcs.00046; Corcoran J, 2000, J CELL SCI, V113, P2567; DAWSON TM, 1991, P NATL ACAD SCI USA, V88, P7797, DOI 10.1073/pnas.88.17.7797; Frassetto LJ, 2006, INVEST OPHTH VIS SCI, V47, P427, DOI 10.1167/iovs.05-0340; Gaub P, 2011, BRAIN, V134, P2134, DOI 10.1093/brain/awr142; Goldberg JL, 2002, SCIENCE, V296, P1860, DOI 10.1126/science.1068428; Grondona JM, 1996, DEVELOPMENT, V122, P2173; Hayashi K, 2001, DIFFERENTIATION, V68, P13, DOI 10.1046/j.1432-0436.2001.068001013.x; Hironaka K, 2011, EUR J PHARM BIOPHARM, V79, P119, DOI 10.1016/j.ejpb.2011.01.019; Inoue T, 2002, J NEUROSCI, V22, P4468, DOI 10.1523/JNEUROSCI.22-11-04468.2002; Isenmann S, 2003, PROG RETIN EYE RES, V22, P483, DOI 10.1016/S1350-9462(03)00027-2; Jaffrey S R, 2001, Sci STKE, V2001, ppl1, DOI 10.1126/stke.2001.86.pl1; Jarvis CI, 2010, EUR J NEUROSCI, V32, P1246, DOI 10.1111/j.1460-9568.2010.07426.x; Kawasaki H, 1998, NATURE, V393, P284, DOI 10.1038/30538; Koriyama Y, 2011, J NEUROCHEM, V119, P1232, DOI 10.1111/j.1471-4159.2011.07533.x; Koriyama Y, 2010, J NEUROCHEM, V115, P79, DOI 10.1111/j.1471-4159.2010.06903.x; Koriyama Y, 2009, BRAIN RES, V1296, P187, DOI 10.1016/j.brainres.2009.08.016; Koriyama Y, 2009, J NEUROCHEM, V110, P890, DOI 10.1111/j.1471-4159.2009.06182.x; Koriyama Y, 2008, BRAIN RES, V1240, P196, DOI 10.1016/j.brainres.2008.09.021; Lee EJ, 2003, BRAIN RES, V986, P174, DOI 10.1016/S0006-8993(03)03250-5; Lee S, 2009, NEURON, V62, P641, DOI 10.1016/j.neuron.2009.04.025; Leon S, 2000, J NEUROSCI, V20, P4615, DOI 10.1523/JNEUROSCI.20-12-04615.2000; Lieven CJ, 2007, EXP EYE RES, V85, P678, DOI 10.1016/j.exer.2007.08.001; Matsuda T, 2004, P NATL ACAD SCI USA, V101, P16, DOI 10.1073/pnas.2235688100; Matsuda T, 2007, P NATL ACAD SCI USA, V104, P1027, DOI 10.1073/pnas.0610155104; Minucci S, 1997, P NATL ACAD SCI USA, V94, P11295, DOI 10.1073/pnas.94.21.11295; Moore DL, 2009, SCIENCE, V326, P298, DOI 10.1126/science.1175737; Mori M, 2001, INVEST OPHTH VIS SCI, V42, P1312; Nott A, 2008, NATURE, V455, P411, DOI 10.1038/nature07238; Park HYL, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.26; Perez-Juste G, 1999, ONCOGENE, V18, P5393, DOI 10.1038/sj.onc.1202906; Puttagunta R, 2011, J CELL BIOL, V193, P1147, DOI 10.1083/jcb.201102066; Qian DZ, 2005, PROSTATE, V64, P20, DOI 10.1002/pros.20209; Santos MDL, 2007, MOL ENDOCRINOL, V21, P2416, DOI 10.1210/me.2007-0151; Schwechter BR, 2007, INVEST OPHTH VIS SCI, V48, P2845, DOI 10.1167/iovs.06-1364; SHEWAN D, 1995, J NEUROSCI, V15, P2057, DOI 10.1523/JNEUROSCI.15-03-02057.1995; Suzuki H, 2007, J HEALTH SCI, V53, P730, DOI 10.1248/jhs.53.730; Suzuki H, 2010, CHEM PHARM BULL, V58, P168, DOI 10.1248/cpb.58.168; Symonds ACE, 2000, EXP NEUROL, V170, P364, DOI 10.1006/exnr.2001.7722; Van Bergen NJ, 2009, INVEST OPHTH VIS SCI, V50, P4267, DOI 10.1167/iovs.09-3484; Wang JT, 2007, J NEUROSCI, V27, P8593, DOI 10.1523/JNEUROSCI.4488-06.2007; Watson P Marc D, 2009, Commun Integr Biol, V2, P11; Wolf HK, 1996, J HISTOCHEM CYTOCHEM, V44, P1167, DOI 10.1177/44.10.8813082; Yamazaki M, 2005, J HEALTH SCI, V51, P687, DOI 10.1248/jhs.51.687; Yamazaki M, 1996, BIOL PHARM BULL, V19, P791, DOI 10.1248/bpb.19.791; Yamazaki M, 2004, EUR J PHARMACOL, V488, P35, DOI 10.1016/j.ejphar.2004.02.009; Yamazaki M, 2001, J NEUROCHEM, V79, P45, DOI 10.1046/j.1471-4159.2001.00533.x; Yamazaki M, 2008, J HEALTH SCI, V54, P638, DOI 10.1248/jhs.54.638	56	16	16	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2013	8	8							e71252	10.1371/journal.pone.0071252	http://dx.doi.org/10.1371/journal.pone.0071252			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	217ZG	23940731	Green Published, gold			2022-12-25	WOS:000324401500064
J	Best, LG; Saxena, R; Anderson, CM; Barnes, MR; Hakonarson, H; Falcon, G; Martin, C; Castillo, BA; Karumanchi, A; Keplin, K; Pearson, N; Lamb, F; Bercier, S; Keating, BJ				Best, Lyle G.; Saxena, Richa; Anderson, Cindy M.; Barnes, Michael R.; Hakonarson, Hakon; Falcon, Gilbert; Martin, Candelaria; Castillo, Berta Almoguera; Karumanchi, Ananth; Keplin, Kylie; Pearson, Nichole; Lamb, Felicia; Bercier, Shellee; Keating, Brendan J.			Two Variants of the C-Reactive Protein Gene Are Associated with Risk of Pre-Eclampsia in an American Indian Population	PLOS ONE			English	Article							MATERNAL SUSCEPTIBILITY LOCUS; HYPERTENSIVE DISORDERS; PREGNANCY; CRP; MARKERS; FETAL; POLYMORPHISMS; EXPRESSION; ECLAMPSIA; INNATE	Background: The etiology of pre-eclampsia (PE) is unknown; but it is accepted that normal pregnancy represents a distinctive challenge to the maternal immune system. C-reactive protein is a prominent component of the innate immune system; and we previously reported an association between PE and the CRP polymorphism, rs1205. Our aim was to explore the effects of additional CRP variants. The IBC (Cardiochip) genotyping microarray focuses on candidate genes and pathways related to the pathophysiology of cardiovascular disease. Methods: This study recruited 140 cases of PE and 270 matched controls, of which 95 cases met criteria as severe PE, from an American Indian community. IBC array genotypes from 10 suitable CRP SNPs were analyzed. A replication sample of 178 cases and 427 controls of European ancestry was also genotyped. Results: A nominally significant difference (p value <0.05) was seen in the distribution of discordant matched pairs for rs3093068; and Bonferroni corrected differences (P<0.005) were seen for rs876538, rs2794521, and rs3091244. Univariate conditional logistic regression odds ratios (OR) were nominally significant for rs3093068 and rs876538 models only. Multivariate logistic models with adjustment for mother's age, nulliparity and BMI attenuated the effect (OR 1.58, P = 0.066, 95% CI 0.97-2.58) for rs876538 and (OR 2.59, P = 0.050, 95% CI 1.00-6.68) for rs3093068. An additive risk score of the above two risk genotypes shows a multivariate adjusted OR of 2.04 (P = 0.013, 95% CI 1.16-3.56). The replication sample also demonstrated significant association between PE and the rs876538 allele (OR = 1.55, P = 0.01, 95% CI 2.16-1.10). We also show putative functionality for the rs876538 and rs3093068 CRP variants. Conclusion: The CRP variants, rs876538 and rs3093068, previously associated with other cardiovascular disease phenotypes, show suggestive association with PE in this American Indian population, further supporting a possible role for CRP in PE.	[Best, Lyle G.; Falcon, Gilbert; Martin, Candelaria; Keplin, Kylie; Pearson, Nichole; Lamb, Felicia; Bercier, Shellee] Turtle Mt Community Coll, Dept Sci, Belcourt, ND USA; [Best, Lyle G.] Univ N Dakota, Sch Med & Hlth Sci, Grand Forks, ND 58201 USA; [Saxena, Richa] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Ctr Human Genet Res, Boston, MA USA; [Anderson, Cindy M.] Univ N Dakota, Coll Nursing, Grand Forks, ND 58201 USA; [Barnes, Michael R.] Barts & London Queen Marys Sch Med & Dent, William Harvey Res Inst, London, England; [Hakonarson, Hakon; Castillo, Berta Almoguera; Keating, Brendan J.] Childrens Hosp Philadelphia, Ctr Appl Genom, Philadelphia, PA 19104 USA; [Karumanchi, Ananth] Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Vasc Biol Res Ctr, Boston, MA 02215 USA	University of North Dakota Grand Forks; Harvard University; Harvard Medical School; Massachusetts General Hospital; University of North Dakota Grand Forks; University of London; Queen Mary University London; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School	Best, LG (corresponding author), Turtle Mt Community Coll, Dept Sci, Belcourt, ND USA.	lbest@restel.com	Saxena, Richa/AAG-7279-2020	Anderson, Cindy/0000-0002-8276-6557; Barnes, Michael/0000-0001-9097-7381	National Institute of General Medical Sciences of the National Institutes of Health [P20GM12345]; Department of Defense [W911NF-09-1-0016]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR016471] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103442] Funding Source: NIH RePORTER	National Institute of General Medical Sciences of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Department of Defense(United States Department of Defense); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Research reported in this publication was supported by an Institutional Development Award from the National Institute of General Medical Sciences of the National Institutes of Health under grant number P20GM12345, and grant number W911NF-09-1-0016 from the Department of Defense. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ACOG Committee on Obstetric Practice, 2002, Int J Gynaecol Obstet, V77, P67; Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Arngrimsson R, 1999, HUM MOL GENET, V8, P1799, DOI 10.1093/hmg/8.9.1799; ARNGRIMSSON R, 1990, BRIT J OBSTET GYNAEC, V97, P762, DOI 10.1111/j.1471-0528.1990.tb02569.x; Baumwell S, 2007, NEPHRON CLIN PRACT, V106, pC72, DOI 10.1159/000101801; Benjamin EJ, 2007, BMC MED GENET, V8, DOI 10.1186/1471-2350-8-S1-S11; Best LG, 2004, HUM HERED, V58, P112, DOI 10.1159/000083032; Best LG, 2012, AM J REPROD IMMUNOL, V67, P152, DOI 10.1111/j.1600-0897.2011.01076.x; Blake GJ, 2002, J INTERN MED, V252, P283, DOI 10.1046/j.1365-2796.2002.01019.x; Bodnar LM, 2007, AM J OBSTET GYNECOL, V196, DOI 10.1016/j.ajog.2006.11.028; Boyle AP, 2012, GENOME RES, V22, P1790, DOI 10.1101/gr.137323.112; Carlson CS, 2005, AM J HUM GENET, V77, P64, DOI 10.1086/431366; Cebesoy FB, 2009, HYPERTENS PREGNANCY, V28, P201, DOI 10.1080/10641950802601187; CHESLEY LC, 1968, OBSTET GYNECOL, V32, P303; Choi YS, 2007, NUCLEIC ACIDS RES, V35, P5511, DOI 10.1093/nar/gkm547; Cnattingius S, 2004, AM J MED GENET A, V130A, P365, DOI 10.1002/ajmg.a.30257; Dehghan A, 2011, CIRCULATION, V123, P731, DOI 10.1161/CIRCULATIONAHA.110.948570; Derzsy Z, 2010, MOL IMMUNOL, V47, P1500, DOI 10.1016/j.molimm.2010.01.021; Du Clos TW, 2004, IMMUNOL RES, V30, P261, DOI 10.1385/IR:30:3:261; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Feng XF, 2009, OPHTHALMOLOGY, V116, P1908, DOI 10.1016/j.ophtha.2009.03.011; Folgero T, 1996, AM J OBSTET GYNECOL, V174, P1626, DOI 10.1016/S0002-9378(96)70619-1; Founds SA, 2009, PLACENTA, V30, P15, DOI 10.1016/j.placenta.2008.09.015; Gammill HS, 2010, HYPERTENS PREGNANCY, V29, P399, DOI 10.3109/10641950903214633; Gandevani SB, 2012, J PERINAT MED, V1, P1, DOI [DOI 10.1515/JPM-2011-0190, 10.1515/jpm-2011-0190]; Gifford RW, 2000, AM J OBSTET GYNECOL, V183, pS1, DOI 10.1067/mob.2000.107928; Gulec UK, 2012, AM J REPROD IMMUNOL, V68, P331, DOI 10.1111/j.1600-0897.2012.01171.x; Guven MA, 2009, HYPERTENS PREGNANCY, V28, P190, DOI 10.1080/10641950802601179; Ilekis JV, 2007, REPROD SCI, V14, P508, DOI 10.1177/1933719107306232; Johnson MP, 2009, HUM GENET, V126, P655, DOI 10.1007/s00439-009-0714-x; Kaptoge S, 2012, NEW ENGL J MED, V367, P1310, DOI 10.1056/NEJMoa1107477; Kardys I, 2007, AM J CARDIOL, V100, P646, DOI 10.1016/j.amjcard.2007.03.079; Kathiresan S, 2006, CIRCULATION, V113, P1415, DOI 10.1161/CIRCULATIONAHA.105.591271; Keating BJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003583; Kestlerova A, 2012, J REPROD IMMUNOL, V96, P90, DOI 10.1016/j.jri.2012.10.002; Kim IK, 2008, MOL VIS, V14, P1487; Laivuori H, 2003, AM J HUM GENET, V72, P168, DOI 10.1086/345311; Lee CC, 2009, CLIN CHEM, V55, P351, DOI 10.1373/clinchem.2008.117176; LEVY MT, 1994, ARCH INTERN MED, V154, P2181, DOI 10.1001/archinte.154.19.2181; Lie RT, 1998, BRIT MED J, V316, P1343, DOI 10.1136/bmj.316.7141.1343; Lindheimer MD, 2010, J AM SOC HYPERTENS, V4, P68, DOI 10.1016/j.jash.2010.03.002; Lindheimer MD, 2009, J CLIN HYPERTENS, V11, P214, DOI 10.1111/j.1751-7176.2009.00085.x; Livingston JC, 2003, WIEN KLIN WOCHENSCHR, V115, P145, DOI 10.1007/BF03040298; Maynard S, 2008, ANNU REV MED, V59, P61, DOI 10.1146/annurev.med.59.110106.214058; Mignini LE, 2006, AM J OBSTET GYNECOL, V194, P317, DOI 10.1016/j.ajog.2005.08.065; Moses EK, 2000, AM J HUM GENET, V67, P1581, DOI 10.1086/316888; Nilsson E, 2004, BJOG-INT J OBSTET GY, V111, P200, DOI 10.1111/j.1471-0528.2004.00042x.x; Paternoster DM, 2006, CLIN APPL THROMB-HEM, V12, P330, DOI 10.1177/1076029606291382; Perry TE, 2009, BMC MED GENET, V10, DOI 10.1186/1471-2350-10-38; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Qiu CF, 2004, AM J HYPERTENS, V17, P154, DOI 10.1016/j.amjhyper.2003.09.011; Rebelo F, 2013, J HYPERTENS, V31, P16, DOI 10.1097/HJH.0b013e32835b0556; Roten LT, 2009, EUR J HUM GENET, V17, P250, DOI 10.1038/ejhg.2008.158; Salihu H M, 2012, Minerva Ginecol, V64, P259; Sesso HD, 2003, JAMA-J AM MED ASSOC, V290, P2945, DOI 10.1001/jama.290.22.2945; Sibai B, 2005, LANCET, V365, P785, DOI 10.1016/S0140-6736(05)71003-5; SUTHERLAND A, 1981, BRIT J OBSTET GYNAEC, V88, P785, DOI 10.1111/j.1471-0528.1981.tb01304.x; Tanaka M, 2007, AM J PUBLIC HEALTH, V97, P163, DOI 10.2105/AJPH.2005.068577; Thilaganathan B, 2010, OBSTET GYNECOL, V115, P1233, DOI 10.1097/AOG.0b013e3181dd5137; Visser N, 2007, OBSTET GYNECOL SURV, V62, P191, DOI 10.1097/01.ogx.0000256779.06275.c4; Ward LD, 2012, NUCLEIC ACIDS RES, V40, pD930, DOI 10.1093/nar/gkr917; Young BC, 2010, ANNU REV PATHOL-MECH, V5, P173, DOI 10.1146/annurev-pathol-121808-102149	62	15	15	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2013	8	8							e71231	10.1371/journal.pone.0071231	http://dx.doi.org/10.1371/journal.pone.0071231			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	218XC	23940726	Green Submitted, gold, Green Published			2022-12-25	WOS:000324465000197
J	Helle, F; Brochot, E; Fournier, C; Descamps, V; Izquierdo, L; Hoffmann, TW; Morel, V; Herpe, YE; Bengrine, A; Belouzard, S; Wychowski, C; Dubuisson, J; Francois, C; Regimbeau, JM; Castelain, S; Duverlie, G				Helle, Francois; Brochot, Etienne; Fournier, Carole; Descamps, Veronique; Izquierdo, Laure; Hoffmann, Thomas W.; Morel, Virginie; Herpe, Yves-Edouard; Bengrine, Abderrahmane; Belouzard, Sandrine; Wychowski, Czeslaw; Dubuisson, Jean; Francois, Catherine; Regimbeau, Jean-Marc; Castelain, Sandrine; Duverlie, Gilles			Permissivity of Primary Human Hepatocytes and Different Hepatoma Cell Lines to Cell Culture Adapted Hepatitis C Virus	PLOS ONE			English	Article							INFECTION IN-VITRO; ROBUST PRODUCTION; HCV INFECTION; HUH-7 CELLS; REPLICATION; MUTATIONS; LIVER; PROTEINS; SYSTEMS; LIPOPROTEINS	Significant progress has been made in Hepatitis C virus (HCV) culture since the JFH1 strain cloning. However, developing efficient and physiologically relevant culture systems for all viral genotypes remains an important goal. In this work, we aimed at producing a high titer JFH1 derived virus to test different hepatic cells' permissivity. To this end, we performed successive infections and obtained a JFH1 derived virus reaching high titers. Six potential adaptive mutations were identified (I599V in E2, R1373Q and M1611T in NS3, S2364P and C2441S in NS5A and R2523K in NS5B) and the effect of these mutations on HCV replication and infectious particle production was investigated. This cell culture adapted virus enabled us to efficiently infect primary human hepatocytes, as demonstrated using the RFP-NLS-IPS reporter protein and intracellular HCV RNA quantification. However, the induction of a strong type III interferon response in these cells was responsible for HCV inhibition. The disruption of this innate immune response led to a strong infection enhancement and permitted the detection of viral protein expression by western blotting as well as progeny virus production. This cell culture adapted virus also enabled us to easily compare the permissivity of seven hepatoma cell lines. In particular, we demonstrated that HuH-7, HepG2-CD81, PLC/PRF/5 and Hep3B cells were permissive to HCV entry, replication and secretion even if the efficiency was very low in PLC/PRF/5 and Hep3B cells. In contrast, we did not observe any infection of SNU-182, SNU-398 and SNU-449 hepatoma cells. Using iodixanol density gradients, we also demonstrated that the density profiles of HCV particles produced by PLC/PRF/5 and Hep3B cells were different from that of HuH-7 and HepG2-CD81 derived virions. These results will help the development of a physiologically relevant culture system for HCV patient isolates.	[Helle, Francois; Brochot, Etienne; Fournier, Carole; Descamps, Veronique; Izquierdo, Laure; Hoffmann, Thomas W.; Morel, Virginie; Francois, Catherine; Castelain, Sandrine; Duverlie, Gilles] Ctr Hosp Univ, Lab Virol, EA4294, Amiens, France; [Helle, Francois; Brochot, Etienne; Fournier, Carole; Descamps, Veronique; Izquierdo, Laure; Hoffmann, Thomas W.; Morel, Virginie; Herpe, Yves-Edouard; Bengrine, Abderrahmane; Francois, Catherine; Regimbeau, Jean-Marc; Castelain, Sandrine; Duverlie, Gilles] Univ Picardie Jules Verne, Amiens, France; [Herpe, Yves-Edouard; Bengrine, Abderrahmane; Duverlie, Gilles] Ctr Hosp Univ, Biobanque Picardie, Amiens, France; [Belouzard, Sandrine; Wychowski, Czeslaw; Dubuisson, Jean] Inst Pasteur, CIIL, F-59019 Lille, France; [Belouzard, Sandrine; Wychowski, Czeslaw; Dubuisson, Jean] INSERM, U1019, F-59019 Lille, France; [Belouzard, Sandrine; Wychowski, Czeslaw; Dubuisson, Jean] CNRS, UMR8204, F-59021 Lille, France; [Belouzard, Sandrine; Wychowski, Czeslaw; Dubuisson, Jean] Univ Lille Nord France, F-59000 Lille, France; [Regimbeau, Jean-Marc] Ctr Hosp Univ, Dept Chirurg Digest, Amiens, France	Picardie Universites; Universite de Picardie Jules Verne (UPJV); CHU Amiens; Picardie Universites; Universite de Picardie Jules Verne (UPJV); Picardie Universites; Universite de Picardie Jules Verne (UPJV); CHU Amiens; Le Reseau International des Instituts Pasteur (RIIP); Universite de Lille - ISITE; Institut Pasteur Lille; Universite de Lille; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Lille - ISITE; Universite de Lille; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Lille - ISITE; Universite de Lille; Universite de Lille - ISITE; Universite de Lille; Picardie Universites; Universite de Picardie Jules Verne (UPJV); CHU Amiens	Helle, F (corresponding author), Ctr Hosp Univ, Lab Virol, EA4294, Amiens, France.	francois.helle@u-picardie.fr	BROCHOT, ETIENNE/I-5318-2012; Belouzard, Sandrine/AAX-1584-2021; CASTELAIN, SANDRINE/AAJ-7506-2020; Belouzard, Sandrine/O-8527-2016; Herpe, Yves-Edouard/S-9241-2019; Castelain, Sandrine/AAA-6344-2019; FRANCOIS, Catherine/AAJ-8289-2020; HELLE, Francois/G-7427-2011; Dubuisson, Jean/E-6813-2016	BROCHOT, ETIENNE/0000-0002-8677-6349; Belouzard, Sandrine/0000-0002-9972-4054; CASTELAIN, SANDRINE/0000-0002-2670-3148; Belouzard, Sandrine/0000-0002-9972-4054; HELLE, Francois/0000-0001-6884-2456; FRANCOIS, Catherine/0000-0002-1797-4253; Dubuisson, Jean/0000-0003-1626-7693; Herpe, Yves-Edouard/0000-0002-0570-0917	Conseil Regional de Picardie (Hepanovir) [AAP08-12]	Conseil Regional de Picardie (Hepanovir)(Region Hauts-de-France)	This study was funded by the Conseil Regional de Picardie (Hepanovir, grant no AAP08-12). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADEN DP, 1979, NATURE, V282, P615, DOI 10.1038/282615a0; Banaudha K, 2010, HEPATOLOGY, V51, P1922, DOI 10.1002/hep.23616; Bartenschlager R, 2011, TRENDS MICROBIOL, V19, P95, DOI 10.1016/j.tim.2010.11.005; Biron-Andreani C, 2010, METHODS MOL BIOL, V640, P431, DOI 10.1007/978-1-60761-688-7_23; Buck M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002660; Castelain S, 2004, J CLIN VIROL, V31, P227, DOI 10.1016/j.jcv.2004.03.009; Coulouarn C, 2009, ONCOGENE, V28, P3526, DOI 10.1038/onc.2009.211; Delgrange D, 2007, J GEN VIROL, V88, P2495, DOI 10.1099/vir.0.82872-0; Descamps V, 2012, J CLIN MICROBIOL, V50, P465, DOI 10.1128/JCM.06503-11; DUBUISSON J, 1994, J VIROL, V68, P6147, DOI 10.1128/JVI.68.10.6147-6160.1994; Flint M, 1999, J VIROL, V73, P6235, DOI 10.1128/JVI.73.8.6235-6244.1999; FOGH J, 1977, JNCI-J NATL CANCER I, V59, P221, DOI 10.1093/jnci/59.1.221; FORTE TM, 1989, J LIPID RES, V30, P817; Fournier C, 2013, J GEN VIROL IN PRESS; GLUZMAN Y, 1981, CELL, V23, P175, DOI 10.1016/0092-8674(81)90282-8; Gottwein JM, 2007, GASTROENTEROLOGY, V133, P1614, DOI 10.1053/j.gastro.2007.08.005; Gottwein JM, 2009, HEPATOLOGY, V49, P364, DOI 10.1002/hep.22673; Goueslain L, 2010, J VIROL, V84, P773, DOI 10.1128/JVI.01190-09; Han QX, 2009, VIRUS RES, V145, P63, DOI 10.1016/j.virusres.2009.06.005; Helle F, 2010, J VIROL, V84, P11905, DOI 10.1128/JVI.01548-10; Icard V, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004233; Jammart B, 2013, J VIROL IN PRESS; Jones CT, 2010, NAT BIOTECHNOL, V28, P167, DOI 10.1038/nbt.1604; Kambara H, 2012, J VIROL, V86, P1382, DOI 10.1128/JVI.06242-11; Kang JI, 2009, VIRUS RES, V144, P107, DOI 10.1016/j.virusres.2009.04.002; Kato T, 2003, GASTROENTEROLOGY, V125, P1808, DOI 10.1053/j.gastro.2003.09.023; Kaul A, 2007, J VIROL, V81, P13168, DOI 10.1128/JVI.01362-07; LEMON SM, 2007, FIELDS VIROLOGY, P1253; Lindenbach BD, 2006, P NATL ACAD SCI USA, V103, P3805, DOI 10.1073/pnas.0511218103; Lindenbach BD, 2005, SCIENCE, V309, P623, DOI 10.1126/science.1114016; MACNAB GM, 1976, BRIT J CANCER, V34, P509, DOI 10.1038/bjc.1976.205; Marukian S, 2011, HEPATOLOGY, V54, P1913, DOI 10.1002/hep.24580; Mee CJ, 2008, J VIROL, V82, P461, DOI 10.1128/JVI.01894-07; Murray CL, 2011, ANNU REV MICROBIOL, V65, P307, DOI 10.1146/annurev-micro-090110-102954; NAKABAYASHI H, 1982, CANCER RES, V42, P3858; Narbus CM, 2011, J VIROL, V85, P12087, DOI 10.1128/JVI.05843-11; Pacini L, 2009, J VIROL, V83, P9079, DOI 10.1128/JVI.00308-09; Park H, 2012, HEPATOLOGY, V56, P2060, DOI 10.1002/hep.25897; PARK JG, 1995, INT J CANCER, V62, P276, DOI 10.1002/ijc.2910620308; Ploss A, 2010, P NATL ACAD SCI USA, V107, P3141, DOI 10.1073/pnas.0915130107; Podevin P, 2010, GASTROENTEROLOGY, V139, P1355, DOI 10.1053/j.gastro.2010.06.058; Pokrovskii MV, 2011, J VIROL, V85, P3978, DOI 10.1128/JVI.01760-10; Russell RS, 2008, P NATL ACAD SCI USA, V105, P4370, DOI 10.1073/pnas.0800422105; Sainz B, 2012, VIROL J, V9, DOI 10.1186/1743-422X-9-30; Sainz B, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006561; Scheel TKH, 2008, P NATL ACAD SCI USA, V105, P997, DOI 10.1073/pnas.0711044105; Scheel TKH, 2011, J VIROL, V85, P2891, DOI 10.1128/JVI.01605-10; Takeda M, 2012, J GEN VIROL, V93, P1422, DOI 10.1099/vir.0.040725-0; Thibault PA, 2013, VIROLOGY, V436, P179, DOI 10.1016/j.virol.2012.11.007; Thomas E, 2012, GASTROENTEROLOGY, V142, P978, DOI 10.1053/j.gastro.2011.12.055; Timpe JM, 2008, HEPATOLOGY, V47, P17, DOI 10.1002/hep.21959; Vausselin T, 2013, HEPATOLOGY IN PRESS; Wakita T, 2005, NAT MED, V11, P791, DOI 10.1038/nm1268; Witte K, 2010, CYTOKINE GROWTH F R, V21, P237, DOI 10.1016/j.cytogfr.2010.04.002; Zeisel MB, 2011, J HEPATOL, V54, P566, DOI 10.1016/j.jhep.2010.10.014; Zhong J, 2005, P NATL ACAD SCI USA, V102, P9294, DOI 10.1073/pnas.0503596102; Zhong J, 2006, J VIROL, V80, P11082, DOI 10.1128/JVI.01307-06	57	21	21	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2013	8	8							e70809	10.1371/journal.pone.0070809	http://dx.doi.org/10.1371/journal.pone.0070809			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	218XC	23940646	gold, Green Submitted, Green Published			2022-12-25	WOS:000324465000137
J	Huxlin, KR; Hindman, HB; Jeon, KI; Buhren, J; MacRae, S; DeMagistris, M; Ciufo, D; Sime, PJ; Phipps, RP				Huxlin, Krystel R.; Hindman, Holly B.; Jeon, Kye-Im; Buehren, Jens; MacRae, Scott; DeMagistris, Margaret; Ciufo, David; Sime, Patricia J.; Phipps, Richard P.			Topical Rosiglitazone Is an Effective Anti-Scarring Agent in the Cornea	PLOS ONE			English	Article							ACTIVATED-RECEPTOR-GAMMA; OPTICAL COHERENCE TOMOGRAPHY; IN-SITU KERATOMILEUSIS; WOUND-HEALING RESPONSE; SMOOTH-MUSCLE-CELLS; GROWTH-FACTOR-BETA; PHOTOREFRACTIVE KERATECTOMY; MYOFIBROBLAST DIFFERENTIATION; PPAR-GAMMA; MITOMYCIN-C	Corneal scarring remains a major cause of blindness world-wide, with limited treatment options, all of which have side-effects. Here, we tested the hypothesis that topical application of Rosiglitazone, a Thiazolidinedione and ligand of peroxisome proliferator activated receptor gamma (PPAR gamma), can effectively block scar formation in a cat model of corneal damage. Adult cats underwent bilateral epithelial debridement followed by excimer laser ablation of the central corneal stroma to a depth of similar to 160 mu m as a means of experimentally inducing a reproducible wound. Eyes were then left untreated, or received 50 mu l of either 10 mu M Rosiglitazone in DMSO/Celluvisc, DMSO/Celluvisc vehicle or Celluvisc vehicle twice daily for 2 weeks. Cellular aspects of corneal wound healing were evaluated with in vivo confocal imaging and post-mortem immunohistochemistry for alpha smooth muscle actin (alpha SMA). Impacts of the wound and treatments on optical quality were assessed using wavefront sensing and optical coherence tomography at 2, 4, 8 and 12 weeks post-operatively. In parallel, cat corneal fibroblasts were cultured to assess the effects of Rosiglitazone on TGF beta-induced alpha SMA expression. Topical application of Rosiglitazone to cat eyes after injury decreased alpha SMA expression and haze, as well as the induction of lower-order and residual, higher-order wavefront aberrations compared to vehicle-treated eyes. Rosiglitazone also inhibited TGF beta-induced alpha SMA expression in cultured corneal fibroblasts. In conclusion, Rosiglitazone effectively controlled corneal fibrosis in vivo and in vitro, while restoring corneal thickness and optics. Its topical application may represent an effective, new avenue for the prevention of corneal scarring with distinct advantages for pathologically thin corneas.	[Huxlin, Krystel R.; Hindman, Holly B.; Jeon, Kye-Im; MacRae, Scott; DeMagistris, Margaret; Ciufo, David; Phipps, Richard P.] Univ Rochester, Flaum Eye Inst, Rochester, NY 14627 USA; [Huxlin, Krystel R.; Hindman, Holly B.; MacRae, Scott] Univ Rochester, Ctr Visual Sci, Rochester, NY 14627 USA; [Buehren, Jens] Goethe Univ Frankfurt, Dept Ophthalmol, D-60054 Frankfurt, Germany; [Sime, Patricia J.; Phipps, Richard P.] Univ Rochester, Dept Environm Med, Rochester, NY USA; [Sime, Patricia J.; Phipps, Richard P.] Univ Rochester, Dept Med, Rochester, NY USA	University of Rochester; University of Rochester; Goethe University Frankfurt; University of Rochester; University of Rochester	Huxlin, KR (corresponding author), Univ Rochester, Flaum Eye Inst, Rochester, NY 14627 USA.	huxlin@cvs.rochester.edu	Jeon, Kye-Im/AAJ-8346-2021	Ciufo, David/0000-0003-4324-0525; Huxlin, Krystel/0000-0001-7138-6156	National Institutes of Health [EY015836, EY017123, HL75432, K23 EY019353, P30 EY001319]; Research to Prevent Blindness Foundation, Inc.; Deutsche Forschungsgemeinschaft (DFG) [Bu2163/1-1]; RPB Lew R. Wasserman Merit Award; NATIONAL EYE INSTITUTE [R01EY015836, R01EY017123, P30EY001319, K23EY019353] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL066988, R01HL075432] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Research to Prevent Blindness Foundation, Inc.(Research to Prevent Blindness (RPB)); Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); RPB Lew R. Wasserman Merit Award; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This project was supported by the National Institutes of Health (grants # EY015836, EY017123, HL75432, K23 EY019353, and core grant P30 EY001319 to the Center for Visual Science) and an unrestricted grant to the University of Rochester's Department of Ophthalmology from the Research to Prevent Blindness Foundation, Inc. JB was supported by a grant from the Deutsche Forschungsgemeinschaft (DFG, Bu2163/1-1) while working on this project, and KRH was the recipient of an RPB Lew R. Wasserman Merit Award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberts DS, 1001, ONCOL NURS FORUM, V18, P693; Arshinoff SA, 1996, J CATARACT REFR SURG, V22, P1037, DOI 10.1016/S0886-3350(96)80116-7; Baek SH, 1997, J REFRACT SURG, V13, P644; BAHN CF, 1982, OPHTHALMOLOGY, V89, P687; Beales MP, 1999, INVEST OPHTH VIS SCI, V40, P1658; Buhren J, 2009, INVEST OPHTH VIS SCI, V50, P634, DOI 10.1167/iovs.08-2277; Buhren J, 2007, INVEST OPHTH VIS SCI, V48, P5806, DOI 10.1167/iovs.07-0661; Burgess HA, 2005, AM J PHYSIOL-LUNG C, V288, pL1146, DOI 10.1152/ajplung.00383.2004; Chinetti G, 2000, INFLAMM RES, V49, P497, DOI 10.1007/s000110050622; CORBETT MC, 1995, J REFRACT SURG, V11, P380; Cuzzocrea S, 2003, ARTHRITIS RHEUM-US, V48, P3544, DOI 10.1002/art.11351; Cuzzocrea S, 2002, MOL PHARMACOL, V61, P997, DOI 10.1124/mol.61.5.997; Delerive P, 2001, J ENDOCRINOL, V169, P453, DOI 10.1677/joe.0.1690453; Dupps WJ, 2006, EXP EYE RES, V83, P709, DOI 10.1016/j.exer.2006.03.015; Esquenazi S, 2005, J CATARACT REFR SURG, V31, P1632, DOI 10.1016/j.jcrs.2005.01.011; Gambato C, 2005, OPHTHALMOLOGY, V112, P208, DOI 10.1016/j.ophtha.2004.07.035; Garrett Q, 2008, CURR EYE RES, V33, P567, DOI 10.1080/02713680802140213; Garrett Q, 2007, INVEST OPHTH VIS SCI, V48, P1559, DOI 10.1167/iovs.06-0848; GARTRY DS, 1993, EYE, V7, P584, DOI 10.1038/eye.1993.127; GRANT MB, 1992, INVEST OPHTH VIS SCI, V33, P3292; Hassell JR, 2010, EXP EYE RES, V91, P326, DOI 10.1016/j.exer.2010.06.021; Hughes A., 1977, HDB SENSORY PHYSL, V7/5; Huxlin KR, 2004, VISION RES, V44, P2159, DOI 10.1016/j.visres.2004.03.017; Iwamoto Y, 1996, DIABETES CARE, V19, P151, DOI 10.2337/diacare.19.2.151; JACOB SW, 1986, CRYOBIOLOGY, V23, P14, DOI 10.1016/0011-2240(86)90014-3; Janabi N, 2002, J IMMUNOL, V168, P4747, DOI 10.4049/jimmunol.168.9.4747; Jester JV, 2012, MOL VIS, V18, P1828; Jester JV, 2012, INVEST OPHTH VIS SCI, V53, P770, DOI 10.1167/iovs.11-9092; JESTER JV, 1992, INVEST OPHTH VIS SCI, V33, P3255; JESTER JV, 1987, AM J PATHOL, V127, P140; Jester JV, 1996, CORNEA, V15, P505; Jester JV, 1999, J CELL SCI, V112, P613; JESTER JV, 1994, INVEST OPHTH VIS SCI, V35, P730; Jester JV, 1999, INVEST OPHTH VIS SCI, V40, P1959; JESTER JV, 1995, INVEST OPHTH VIS SCI, V36, P809; Jester JV, 2002, EXP EYE RES, V75, P645, DOI 10.1006/exer.2002.2066; Jester JV, 1999, PROG RETIN EYE RES, V18, P311, DOI 10.1016/S1350-9462(98)00021-4; Ji YY, 2011, CYTOKINE, V55, P409, DOI 10.1016/j.cyto.2011.05.020; Kim TI, 2004, INVEST OPHTH VIS SCI, V45, P2978, DOI 10.1167/iovs.04-0070; KLIEWER SA, 1994, P NATL ACAD SCI USA, V91, P7355, DOI 10.1073/pnas.91.15.7355; KLIEWER SA, 1995, CELL, V83, P813, DOI 10.1016/0092-8674(95)90194-9; KOLB KH, 1967, ANN NY ACAD SCI, V141, P85, DOI 10.1111/j.1749-6632.1967.tb34869.x; Kulkarni A, 2012, PPAR RES, V2012, P13; Kuriyan AE, 2012, EXP EYE RES, V94, P136, DOI 10.1016/j.exer.2011.11.018; Lee YC, 2001, J REFRACT SURG, V17, P334; LEHMANN JM, 1995, J BIOL CHEM, V270, P12953, DOI 10.1074/jbc.270.22.12953; Long EM, 2011, P NATL ACAD SCI USA, V108, P16357, DOI 10.1073/pnas.1100702108; LUDWIG CU, 1987, EUR J CANCER CLIN ON, V23, P327, DOI 10.1016/0277-5379(87)90077-0; Mohan RR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018771; Mohan RR, 2003, EXP EYE RES, V76, P71, DOI 10.1016/S0014-4835(02)00251-8; Moller-Pedersen T, 1998, INVEST OPHTH VIS SCI, V39, P487; Moller-Pedersen T, 1998, CORNEA, V17, P627, DOI 10.1097/00003226-199811000-00011; Moller-Pedersen T, 1998, CURR EYE RES, V17, P736, DOI 10.1076/ceyr.17.7.736.5163; Moraes LA, 2006, PHARMACOL THERAPEUT, V110, P371, DOI 10.1016/j.pharmthera.2005.08.007; Nagy LJ, 2007, J CATARACT REFR SURG, V33, P1051, DOI 10.1016/j.jcrs.2007.02.021; Nakajima A, 2001, GASTROENTEROLOGY, V120, P460, DOI 10.1053/gast.2001.21191; Nakamura K, 2002, INVEST OPHTH VIS SCI, V43, P2603; Nakamura K, 2001, BRIT J OPHTHALMOL, V85, P209, DOI 10.1136/bjo.85.2.209; Natarajan C, 2002, GENES IMMUN, V3, P59, DOI 10.1038/sj.gene.6363832; Netto MV, 2006, J REFRACT SURG, V22, P562; Netto MV, 2006, EXP EYE RES, V82, P788, DOI 10.1016/j.exer.2005.09.021; Netto MV, 2005, CORNEA, V24, P509, DOI 10.1097/01.ico.0000151544.23360.17; O'Brien TP, 1998, ARCH OPHTHALMOL-CHIC, V116, P1470, DOI 10.1001/archopht.116.11.1470; OHJI M, 1993, CURR EYE RES, V12, P703, DOI 10.3109/02713689308995765; Pan HW, 2011, MOL BIOL REP, V38, P4501, DOI 10.1007/s11033-010-0581-5; Patel HJ, 2003, J IMMUNOL, V170, P2663, DOI 10.4049/jimmunol.170.5.2663; Pawliczak R, 2002, J BIOL CHEM, V277, P33153, DOI 10.1074/jbc.M200246200; Pei Y, 2004, EXP EYE RES, V79, P705, DOI 10.1016/j.exer.2004.08.002; Radhakrishnan S, 2001, ARCH OPHTHALMOL-CHIC, V119, P1179, DOI 10.1001/archopht.119.8.1179; Reddy RC, 2004, AM J PHYSIOL-LUNG C, V286, pL613, DOI 10.1152/ajplung.00206.2003; Saika S, 2004, INVEST OPHTH VIS SCI, V45, P100, DOI 10.1167/iovs.03-0700; Saika S, 2007, AM J PHYSIOL-CELL PH, V293, pC75, DOI 10.1152/ajpcell.00332.2006; Schipper I, 1997, EYE, V11, P649, DOI 10.1038/eye.1997.171; Spiegelman BM, 1996, CELL, V87, P377, DOI 10.1016/S0092-8674(00)81359-8; Su CG, 1999, J CLIN INVEST, V104, P383, DOI 10.1172/JCI7145; TALAMO JH, 1991, ARCH OPHTHALMOL-CHIC, V109, P1141, DOI 10.1001/archopht.1991.01080080101040; Terai K, 2011, INVEST OPHTH VIS SCI, V52, P8208, DOI 10.1167/iovs.11-8017; Thibos LN, 2002, J REFRACT SURG, V18, pS652; Tontonoz T, 1994, CELL, V79, P1147; Vesaluoma M, 1997, CURR EYE RES, V16, P19, DOI 10.1076/ceyr.16.1.19.5119; Vetrugno M, 2001, ACTA OPHTHALMOL SCAN, V79, P23, DOI 10.1034/j.1600-0420.2001.079001023.x; Wang JH, 2006, J REFRACT SURG, V22, P604, DOI 10.3928/1081-597X-20060601-14; Wang JH, 2004, INVEST OPHTH VIS SCI, V45, P3493, DOI 10.1167/iovs.04-0096; Wang JH, 2004, INVEST OPHTH VIS SCI, V45, P1812, DOI 10.1167/iovs.03-1088; Wang JH, 2003, INVEST OPHTH VIS SCI, V44, P1070, DOI 10.1167/iovs.02-0343; Wang JH, 2002, AM J OPHTHALMOL, V133, P315, DOI 10.1016/S0002-9394(01)01382-4; Wang JH, 2002, AM J OPHTHALMOL, V134, P93, DOI 10.1016/S0002-9394(02)01517-9; Whitcher JP, 2001, B WORLD HEALTH ORGAN, V79, P214; Willson TM, 2000, J MED CHEM, V43, P527, DOI 10.1021/jm990554g; Willson TM, 1996, J MED CHEM, V39, P665, DOI 10.1021/jm950395a; Wilson SE, 1999, PROG RETIN EYE RES, V18, P293, DOI 10.1016/S1350-9462(98)00017-2; Wilson SE, 1996, EXP EYE RES, V62, P325, DOI 10.1006/exer.1996.0038; Wilson SE, 2001, PROG RETIN EYE RES, V20, P625, DOI 10.1016/S1350-9462(01)00008-8; Wilson Steven E, 2002, Trans Am Ophthalmol Soc, V100, P411	94	29	30	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2013	8	8							e70785	10.1371/journal.pone.0070785	http://dx.doi.org/10.1371/journal.pone.0070785			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	218XC	23940641	Green Published, Green Submitted, gold			2022-12-25	WOS:000324465000133
J	Kwon, JA; Park, EC; Lee, M; Yoo, KB; Park, S				Kwon, Jeoung A.; Park, Eun-Cheol; Lee, Minjee; Yoo, Ki-Bong; Park, Sohee			Does Stress Increase the Risk of Atopic Dermatitis in Adolescents? Results of the Korea Youth Risk Behavior Web-Based Survey (KYRBWS-VI)	PLOS ONE			English	Article							ENVIRONMENTAL-FACTORS; SEX-DIFFERENCES; LIFE EVENTS; ASTHMA; PREVALENCE; FAMILY; RESPONSES; CHILDREN; ALLERGY; ANXIETY	This study investigated the relationship between level of stress in middle and high school students aged 12-18 and risk of atopic dermatitis. Data from the Sixth Korea Youth Risk Behavior Web-based Survey (KYRBWS-VI), a cross-sectional study among 74,980 students in 800 middle schools and high schools with a response rate of 97.7%, were analyzed. Ordinal logistic regression analyses were conducted to determine the relationship between stress and atopic dermatitis with severity. A total of 5,550 boys and 6,964 girls reported having been diagnosed with atopic dermatitis. Younger students were more likely to have atopic dermatitis. Interestingly, the educational level of parents was found to be associated with having atopic dermatitis and having more severe condition. In particular, girls with mothers with at least college education had a 41% higher risk of having atopic dermatitis and severe atopic condition (odds ratio (OR)) = 1.41, 95% CI, 1.22-1.63; P<0.0001) compared with those with mothers who had attended middle school at most. Similar trend was shown among both boys and girls for their father's education level. The stress level was found to be significantly associated with the risk of atopic dermatitis. Compared to boys with who reported "no stress", boys with "very high" stress had 46% higher the risk of having more severe atopic dermatitis (OR = 1.46, 95% CI, 1.20-1.78; P<0.0001), 44% higher (OR = 1.44, 95% CI, 1.19-1.73; P<0.0001) with "high" stress, and 21% higher (OR = 1.21, 95% CI, 1.00-1.45; P = 0.05) with "moderate" stress. In contrast, we found no statistically significant relationship between stress and atopic dermatitis in girls. This study suggests that stress and parents' education level were associated with atopic dermatitis. Specifically, degree of stress is positively correlated with likelihood of being diagnosed with this condition and increasing the severity.	[Kwon, Jeoung A.; Lee, Minjee; Yoo, Ki-Bong] Yonsei Univ, Grad Sch, Dept Publ Hlth, Seoul 120749, South Korea; [Kwon, Jeoung A.; Park, Eun-Cheol; Lee, Minjee; Yoo, Ki-Bong] Yonsei Univ, Coll Med, Inst Hlth Serv Res, Seoul, South Korea; [Park, Eun-Cheol] Yonsei Univ, Coll Med, Dept Prevent Med, Seoul, South Korea; [Park, Sohee] Yonsei Univ, Grad Sch Publ Hlth, Dept Biostat, Seoul 120749, South Korea	Yonsei University; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System	Park, S (corresponding author), Yonsei Univ, Grad Sch Publ Hlth, Dept Biostat, Seoul 120749, South Korea.	soheepark@yuhs.ac	Park, Eun-Cheol/O-5644-2019	Park, Eun-Cheol/0000-0002-2306-5398; Park, Sohee/0000-0001-8513-5163; Lee, Min Jee/0000-0002-8385-1796	Yonsei University Graduate School of Public Health [6-2012-0113]	Yonsei University Graduate School of Public Health	This study was supported by a new faculty research seed money grant of Yonsei University Graduate School of Public Health for 2012 (6-2012-0113). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bae Jisuk, 2010, J Prev Med Public Health, V43, P403, DOI 10.3961/jpmph.2010.43.5.403; Bae Jisuk, 2010, J Prev Med Public Health, V43, P396, DOI 10.3961/jpmph.2010.43.5.396; Barankin B, 2002, CAN FAM PHYSICIAN, V48, P712; Bieber T, 2010, ANN DERMATOL, V22, P125, DOI 10.5021/ad.2010.22.2.125; Buske-Kirschbaum A, 2002, J NEUROIMMUNOL, V129, P161, DOI 10.1016/S0165-5728(02)00168-6; Buske-Kirschbaum A, 2002, J CLIN ENDOCR METAB, V87, P4245, DOI 10.1210/jc.2001-010872; Buske-Kirschbaum A, 2001, PSYCHOTHER PSYCHOSOM, V70, P6, DOI 10.1159/000056219; Carroll CL, 2005, PEDIATR DERMATOL, V22, P192, DOI 10.1111/j.1525-1470.2005.22303.x; Centers for Disease Control and Prevention, 2011, YOUTH RISK BEH SURV; Chamlin SL, 2006, DERMATOL THER, V19, P104, DOI 10.1111/j.1529-8019.2006.00060.x; Chamlin SL, 2004, PEDIATRICS, V114, P607, DOI 10.1542/peds.2004-0374; Chang T, 2004, KOREAN E W EC STUDIE, V16, P19; Christie D, 2005, BRIT MED J, V330, P301, DOI 10.1136/bmj.330.7486.301; ELIASSON O, 1986, J ALLERGY CLIN IMMUN, V77, P87, DOI 10.1016/0091-6749(86)90328-3; GIL KM, 1987, J PSYCHOSOM RES, V31, P673, DOI 10.1016/0022-3999(87)90016-X; Hall JMF, 2012, DERMAT RES PRACT, V2012, DOI 10.1155/2012/403908; HANIFIN JM, 1980, ACTA DERM-VENEREOL, P44; Harangi Ferenc, 2007, Orvosi Hetilap, V148, P1643, DOI 10.1556/OH.2007.28005; Hashizume H, 2006, CURR OPIN ALLERGY CL, V6, P335, DOI 10.1097/01.all.0000244793.03239.40; Helmbold P, 2000, ACTA DERM-VENEREOL, V80, P348; Howlett S, 1999, BRIT J DERMATOL, V140, P381; Kilpelainen M, 2002, CLIN EXP ALLERGY, V32, P256, DOI 10.1046/j.1365-2222.2002.01282.x; Kimata H, 2003, EUR J CLIN INVEST, V33, P513, DOI 10.1046/j.1365-2362.2003.01177.x; Kimyai-Asadi A, 2001, J CUTAN MED SURG, V5, P140, DOI 10.1007/s102270000016; KING RM, 1991, J PSYCHOSOM RES, V35, P697, DOI 10.1016/0022-3999(91)90120-D; Kodama A, 1999, J ALLERGY CLIN IMMUN, V104, P173, DOI 10.1016/S0091-6749(99)70130-2; Korea Centers for Disease Control and Prevention, 2010, STAT 6 KOR YOUTH RIS; Kudielka BM, 2005, BIOL PSYCHOL, V69, P113, DOI 10.1016/j.biopsycho.2004.11.009; Kupfer J, 2001, INT ARCH ALLERGY IMM, V124, P353, DOI 10.1159/000053755; Lee JH, 2012, ASIA PAC ALLERGY, V2, P59, DOI 10.5415/apallergy.2012.2.1.59; Leung R, 1997, EUR RESPIR J, V10, P354, DOI 10.1183/09031936.97.10020354; Linnet J, 2001, INT J DERMATOL, V40, P632, DOI 10.1046/j.1365-4362.2001.01272.x; MORREN MA, 1994, J AM ACAD DERMATOL, V31, P467, DOI 10.1016/S0190-9622(94)70213-6; Osman M, 2003, ARCH DIS CHILD, V88, P587, DOI 10.1136/adc.88.7.587; Picardi A, 2001, PSYCHOTHER PSYCHOSOM, V70, P118, DOI 10.1159/000056237; RAJKA G, 1986, INT J DERMATOL, V25, P301, DOI 10.1111/j.1365-4362.1986.tb02249.x; Ramage-Morin Pamela L, 2010, Health Rep, V21, P45; Rehal B, 2011, PLOS ONE, V6, DOI DOI 10.1371/J0URNAL.-P0NE.0017520; Schmid-Grendelmeier Peter, 2010, Ther Umsch, V67, P175, DOI 10.1024/0040-5930/a000031; Schmid-Ott G, 2001, J ALLERGY CLIN IMMUN, V107, P171, DOI 10.1067/mai.2001.111850; Schut C, 2013, ACTA DERM-VENEREOL, V93, P57, DOI 10.2340/00015555-1415; Shaw TE, 2011, J INVEST DERMATOL, V131, P67, DOI 10.1038/jid.2010.251; Sisk CL, 2005, FRONT NEUROENDOCRIN, V26, P163, DOI 10.1016/j.yfrne.2005.10.003; Snijders BEP, 2008, PEDIATRICS, V122, pE115, DOI 10.1542/peds.2007-1651; Tan KS, 1997, AM J RESP CRIT CARE, V155, P1273, DOI 10.1164/ajrccm.155.4.9105066; Werner S, 2002, BRIT J DERMATOL, V147, P95, DOI 10.1046/j.1365-2133.2002.04782.x; World Health Organization, 2010, GLOB HLTH OBS DAT RE; Xu F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036174	48	9	12	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2013	8	8							e67890	10.1371/journal.pone.0067890	http://dx.doi.org/10.1371/journal.pone.0067890			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	218XC	23940513	Green Published, gold, Green Submitted			2022-12-25	WOS:000324465000007
J	Newbould, RD; Miller, SR; Upadhyay, N; Rao, AW; Swann, P; Gold, GE; Strachan, RK; Matthews, PM; Taylor, PC; Brown, AP				Newbould, Rexford D.; Miller, Sam R.; Upadhyay, Neil; Rao, Anil W.; Swann, Peter; Gold, Garry E.; Strachan, Robin K.; Matthews, Paul M.; Taylor, Peter C.; Brown, Andrew P.			T1-Weighted Sodium MRI of the Articulator Cartilage in Osteoarthritis: A Cross Sectional and Longitudinal Study	PLOS ONE			English	Article							INVERSION-RECOVERY MRI; FIXED CHARGE-DENSITY; JOINT IN-VIVO; NA-23 MRI; KNEE; QUANTITATION; SEQUENCE; T-1	Structural magnetic resonance imaging (MRI) has shown great utility in diagnosing soft tissue burden in osteoarthritis (OA), though MRI measures of cartilage integrity have proven more elusive. Sodium MRI can reflect the proteoglycan content of cartilage; however, it requires specialized hardware, acquisition sequences, and long imaging times. This study was designed to assess the potential of a clinically feasible sodium MRI acquisition to detect differences in the knee cartilage of subjects with OA versus healthy controls (HC), and to determine whether longitudinal changes in sodium content are observed at 3 and 6 months. 28 subjects with primary knee OA and 19 HC subjects age and gender matched were enrolled in this ethically-approved study. At baseline, 3 and 6 months subjects underwent structural MRI and a 0.4ms echo time 3D T1-weighted sodium scan as well as the knee injury and osteoarthritis outcome score (KOOS) and knee pain by visual analogue score (VAS). A standing radiograph of the knee was taken for Kellgren-Lawrence (K-L) scoring. A blinded reader outlined the cartilage on the structural images which was used to determine median T1-weighted sodium concentrations in each region of interest on the co-registered sodium scans. VAS, K-L, and KOOS all significantly separated the OA and HC groups. OA subjects had higher T1-weighted sodium concentrations, most strongly observed in the lateral tibial, lateral femoral and medial patella ROIs. There were no significant changes in cartilage volume or sodium concentration over 6 months. This study has shown that a clinically-feasible sodium MRI at a moderate 3T field strength and imaging time with fluid attenuation by T1 weighting significantly separated HCs from OA subjects.	[Newbould, Rexford D.; Brown, Andrew P.] Univ London Imperial Coll Sci Technol & Med, Hammersmith Hosp, Imanova Ctr Imaging Sci, London, England; [Miller, Sam R.; Rao, Anil W.] GlaxoSmithKline, Brentford, England; [Upadhyay, Neil] Univ London Imperial Coll Sci Technol & Med, Charing Cross Hosp, Dept Imaging, London, England; [Swann, Peter] Univ Oxford, Dept Med, Sch Med, Oxford, England; [Gold, Garry E.] Stanford Univ, Dept Radiol, Stanford, CA 94305 USA; [Strachan, Robin K.] Univ London Imperial Coll Sci Technol & Med, Charing Cross Hosp, Dept Orthopaed Surg, London, England; [Matthews, Paul M.] Univ London Imperial Coll Sci Technol & Med, Ctr Clin Neurosci, Dept Med, London, England; [Taylor, Peter C.] Univ Oxford, Kennedy Inst Rheumatol, Nuffield Dept Orthopaed Rheumatol & Musculoskelet, Oxford, England	Imperial College London; GlaxoSmithKline; Imperial College London; University of Oxford; Stanford University; Imperial College London; Imperial College London; University of Oxford	Newbould, RD (corresponding author), Univ London Imperial Coll Sci Technol & Med, Hammersmith Hosp, Imanova Ctr Imaging Sci, London, England.	rexford.newbould@imanova.co.uk		Gold, Garry/0000-0002-3207-822X; Brown, Andy/0000-0001-9692-2154; Matthews, Paul M/0000-0002-1619-8328	GlaxoSmithKline; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [K24AR062068] Funding Source: NIH RePORTER	GlaxoSmithKline(GlaxoSmithKline); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	The study was sponsored and funded by GlaxoSmithKline. GlaxoSmithKline contributed to the study design, collection, analysis and interpretation of data in the writing the manuscript.	Abadie E, 2004, OSTEOARTHR CARTILAGE, V12, P263, DOI 10.1016/j.joca.2004.01.006; ALTMAN R, 1986, ARTHRITIS RHEUM, V29, P1039, DOI 10.1002/art.1780290816; Bashir A, 1999, MAGNET RESON MED, V41, P857, DOI 10.1002/(SICI)1522-2594(199905)41:5<857::AID-MRM1>3.0.CO;2-E; Borthakur A, 2000, OSTEOARTHR CARTILAGE, V8, P288, DOI 10.1053/joca.1999.0303; Borthakur A, 2006, NMR BIOMED, V19, P781, DOI 10.1002/nbm.1102; Chang G, 2012, EUR RADIOL, V22, P1341, DOI 10.1007/s00330-012-2383-8; Cibere J, 2011, OSTEOARTHR CARTILAGE, V19, P683, DOI 10.1016/j.joca.2011.02.008; Craig CL, 2003, MED SCI SPORT EXER, V35, P1381, DOI 10.1249/01.MSS.0000078924.61453.FB; Duvvuri U, 1997, MAGN RESON MED, V38, P863, DOI 10.1002/mrm.1910380602; Eckstein F, 2006, NMR BIOMED, V19, P822, DOI 10.1002/nbm.1063; ERNST RR, 1966, REV SCI INSTRUM, V37, P93, DOI 10.1063/1.1719961; Gurney PT, 2006, MAGN RESON MED, V55, P575, DOI 10.1002/mrm.20796; Hardy PA, 1996, JMRI-J MAGN RESON IM, V6, P329, DOI 10.1002/jmri.1880060212; Insko EK, 1999, MAGNET RESON MED, V41, P30, DOI 10.1002/(SICI)1522-2594(199901)41:1<30::AID-MRM6>3.0.CO;2-U; KASSEY VB, 2010, P 18 INT SOC MAGN RE, V1, P3189; KELLGREN JH, 1957, ANN RHEUM DIS, V16, P494, DOI 10.1136/ard.16.4.494; LEHNER KB, 1989, RADIOLOGY, V170, P495, DOI 10.1148/radiology.170.2.2911674; LESPERANCE LM, 1992, J ORTHOPAED RES, V10, P1, DOI 10.1002/jor.1100100102; Madelin G, 2012, MAGN RESON MED, V68, P841, DOI 10.1002/mrm.23307; Madelin G, 2010, J MAGN RESON, V207, P42, DOI 10.1016/j.jmr.2010.08.003; Menezes NM, 2004, MAGN RESON MED, V51, P503, DOI 10.1002/mrm.10710; Newbould RD, 2012, OSTEOARTHR CARTILAGE, V20, P29, DOI 10.1016/j.joca.2011.10.007; PAUL PK, 1991, BRIT J RHEUMATOL, V30, P318; Pritzker KPH, 2006, OSTEOARTHR CARTILAGE, V14, P13, DOI 10.1016/j.joca.2005.07.014; Regatte RR, 1999, JMRI-J MAGN RESON IM, V10, P961, DOI 10.1002/(SICI)1522-2586(199912)10:6<961::AID-JMRI8>3.0.CO;2-A; Rong P, 2008, J MAGN RESON, V193, P207, DOI 10.1016/j.jmr.2008.04.036; Roos EM, 1998, J ORTHOP SPORT PHYS, V28, P88, DOI 10.2519/jospt.1998.28.2.88; Shapiro EM, 2000, J MAGN RESON, V142, P24, DOI 10.1006/jmre.1999.1932; Shapiro EM, 2002, MAGNET RESON MED, V47, P284, DOI 10.1002/mrm.10054; Staroswiecki E, 2010, J MAGN RESON IMAGING, V32, P446, DOI 10.1002/jmri.22191; Wang LG, 2009, J MAGN RESON IMAGING, V30, P606, DOI 10.1002/jmri.21881; Wheaton AJ, 2004, RADIOLOGY, V231, P900, DOI 10.1148/radiol.2313030521	32	23	24	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2013	8	8							e73067	10.1371/journal.pone.0073067	http://dx.doi.org/10.1371/journal.pone.0073067			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	218XC	23940822	Green Published, Green Submitted, gold			2022-12-25	WOS:000324465000251
J	Tao, RY; Xiong, XW; Harris, RA; White, MF; Dong, XCC				Tao, Rongya; Xiong, Xiwen; Harris, Robert A.; White, Morris F.; Dong, Xiaocheng C.			Genetic Inactivation of Pyruvate Dehydrogenase Kinases Improves Hepatic Insulin Resistance Induced Diabetes	PLOS ONE			English	Article							ACTIVATED RECEPTOR-ALPHA; 4 PDK4; TRANSCRIPTION FACTORS; NUTRIENT HOMEOSTASIS; THYROID-HORMONE; GROWTH-HORMONE; PROTEIN-KINASE; FATTY-ACIDS; EXPRESSION; STARVATION	Pyruvate dehydrogenase kinases (PDK1-4) play a critical role in the inhibition of the mitochondrial pyruvate dehydrogenase complex especially when blood glucose levels are low and pyruvate can be conserved for gluconeogenesis. Under diabetic conditions, the Pdk genes, particularly Pdk4, are often induced, and the elevation of the Pdk4 gene expression has been implicated in the increased gluconeogenesis in the liver and the decreased glucose utilization in the peripheral tissues. However, there is no direct evidence yet to show to what extent that the dysregulation of hepatic Pdk genes attributes to hyperglycemia and insulin resistance in vivo. To address this question, we crossed Pdk2 or Pdk4 null mice with a diabetic model that is deficient in hepatic insulin receptor substrates 1 and 2 (Irs1/2). Metabolic analyses reveal that deletion of the Pdk4 gene had better improvement in hyperglycemia and glucose tolerance than knockout of the Pdk2 gene whereas the Pdk2 gene deletion showed better insulin tolerance as compared to the Pdk4 gene inactivation on the Irs1/2 knockout genetic background. To examine the specific hepatic effects of Pdks on diabetes, we also knocked down the Pdk2 or Pdk4 gene using specific shRNAs. The data also indicate that the Pdk4 gene knockdown led to better glucose tolerance than the Pdk2 gene knockdown. In conclusion, our data suggest that hepatic Pdk4 may be critically involved in the pathogenesis of diabetes.	[Tao, Rongya; Xiong, Xiwen; Harris, Robert A.; Dong, Xiaocheng C.] Indiana Univ Sch Med, Dept Biochem & Mol Biol, Indianapolis, IN 46202 USA; [Harris, Robert A.] Richard L Roudebush Vet Affairs Med Ctr, Indianapolis, IN 46202 USA; [White, Morris F.] Harvard Univ, Sch Med, Div Endocrinol, Childrens Hosp Boston, Boston, MA USA	Indiana University System; Indiana University Bloomington; US Department of Veterans Affairs; Veterans Health Administration (VHA); Richard L. Roudebush VA Medical Center; Harvard University; Boston Children's Hospital; Harvard Medical School	Dong, XCC (corresponding author), Indiana Univ Sch Med, Dept Biochem & Mol Biol, Indianapolis, IN 46202 USA.	xcdong@iu.edu	tao, rongya/B-8042-2014; Xiong, Xiwen/GSN-0686-2022	tao, rongya/0000-0002-3316-5587; 	National Institute of Diabetes And Digestive And Kidney Diseases [R00DK077505]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK098655, R00DK077505, K99DK077505, R01DK038712] Funding Source: NIH RePORTER	National Institute of Diabetes And Digestive And Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by the grants R00DK077505 (to X. C. Dong) from the National Institute of Diabetes And Digestive And Kidney Diseases. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Attia RR, 2011, J BIOL CHEM, V286, P23799, DOI 10.1074/jbc.M111.246389; Attia RR, 2010, J BIOL CHEM, V285, P2375, DOI 10.1074/jbc.M109.039081; Bao HY, 2004, BIOCHEMISTRY-US, V43, P13432, DOI 10.1021/bi049488x; Bowker-Kinley MM, 1998, BIOCHEM J, V329, P191, DOI 10.1042/bj3290191; Cadoudal T, 2008, DIABETES, V57, P2272, DOI 10.2337/db08-0477; Connaughton S, 2010, MOL CELL ENDOCRINOL, V315, P159, DOI 10.1016/j.mce.2009.08.011; Dong XC, 2008, CELL METAB, V8, P65, DOI 10.1016/j.cmet.2008.06.006; GUDI R, 1995, J BIOL CHEM, V270, P28989, DOI 10.1074/jbc.270.48.28989; Guo S, 2009, MOL CELL BIOL, V29, P5070, DOI 10.1128/MCB.00138-09; Harris RA, 2002, ADV ENZYME REGUL, V42, P249, DOI 10.1016/S0065-2571(01)00061-9; Houten SM, 2009, CELL MOL LIFE SCI, V66, P1283, DOI 10.1007/s00018-009-9066-x; Huang BL, 2002, DIABETES, V51, P276, DOI 10.2337/diabetes.51.2.276; Hwang B, 2012, FEBS J, V279, P1883, DOI 10.1111/j.1742-4658.2012.08569.x; Hwang B, 2009, BIOCHEM J, V423, P243, DOI 10.1042/BJ20090390; Jeoung NH, 2008, AM J PHYSIOL-ENDOC M, V295, pE46, DOI 10.1152/ajpendo.00536.2007; Jeoung NH, 2006, BIOCHEM J, V397, P417, DOI 10.1042/BJ20060125; Jeoung NH, 2012, BIOCHEM J, V443, P829, DOI 10.1042/BJ20112197; Kim YD, 2012, DIABETES, V61, P2484, DOI 10.2337/db11-1665; Klyuyeva A, 2008, BIOCHEMISTRY-US, V47, P8358, DOI 10.1021/bi800631h; Kubota N, 2008, CELL METAB, V8, P49, DOI 10.1016/j.cmet.2008.05.007; Kwon HS, 2004, DIABETES, V53, P899, DOI 10.2337/diabetes.53.4.899; Kwon HS, 2006, BBA-GENE STRUCT EXPR, V1759, P141, DOI 10.1016/j.bbaexp.2006.04.005; Lee JH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046324; McAinch AJ, 2009, DIABETES OBES METAB, V11, P721, DOI 10.1111/j.1463-1326.2009.01042.x; Mori J, 2013, AM J PHYSIOL-HEART C, V304, pH1103, DOI 10.1152/ajpheart.00636.2012; Motojima K, 2003, BIOL PHARM BULL, V26, P954; Roche TE, 2007, CELL MOL LIFE SCI, V64, P830, DOI 10.1007/s00018-007-6380-z; Rowles J, 1996, J BIOL CHEM, V271, P22376, DOI 10.1074/jbc.271.37.22376; Shin DJ, 2012, NUCLEIC ACIDS RES, V40, P11499, DOI 10.1093/nar/gks932; STACE PB, 1992, BIOCHIM BIOPHYS ACTA, V1135, P201, DOI 10.1016/0167-4889(92)90137-Z; Sugden M. C., 2002, Current Drug Targets - Immune Endocrine and Metabolic Disorders, V2, P151, DOI 10.2174/1568008023340785; Sugden MC, 2003, AM J PHYSIOL-ENDOC M, V284, pE855, DOI 10.1152/ajpendo.00526.2002; Sugden MC, 2001, ARCH BIOCHEM BIOPHYS, V395, P246, DOI 10.1006/abbi.2001.2586; Thakran S, 2013, J BIOL CHEM, V288, P807, DOI 10.1074/jbc.M112.437970; Wei D, 2011, AM J PHYSIOL-ENDOC M, V300, pE312, DOI 10.1152/ajpendo.00524.2010; White MF, 2003, SCIENCE, V302, P1710, DOI 10.1126/science.1092952; White UA, 2007, DIABETES, V56, P1623, DOI 10.2337/db06-1286; Wu PF, 2000, ARCH BIOCHEM BIOPHYS, V381, P1, DOI 10.1006/abbi.2000.1946; Wu PF, 2001, BIOCHEM BIOPH RES CO, V287, P391, DOI 10.1006/bbrc.2001.5608; Wu PF, 1998, BIOCHEM J, V329, P197, DOI 10.1042/bj3290197; Xiong XW, 2012, J BIOL CHEM, V287, P39107, DOI 10.1074/jbc.M112.412569	41	42	43	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2013	8	8							e71997	10.1371/journal.pone.0071997	http://dx.doi.org/10.1371/journal.pone.0071997			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	218XC	23940800	gold, Green Submitted, Green Published			2022-12-25	WOS:000324465000239
J	Majewska, J; Ciesielski, SJ; Schilke, B; Kominek, J; Blenska, A; Delewski, W; Song, JY; Marszalek, J; Craig, EA; Dutkiewicz, R				Majewska, Julia; Ciesielski, Szymon J.; Schilke, Brenda; Kominek, Jacek; Blenska, Anna; Delewski, Wojciech; Song, Ji-Yoon; Marszalek, Jaroslaw; Craig, Elizabeth A.; Dutkiewicz, Rafal			Binding of the Chaperone Jac1 Protein and Cysteine Desulfurase Nfs1 to the Iron-Sulfur Cluster Scaffold Isu Protein Is Mutually Exclusive	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Iron-Sulfur Protein; Mitochondria; Molecular Chaperone; Scaffold Proteins; Yeast; ISC System; J-protein	MULTIPLE SEQUENCE ALIGNMENT; INTERACTING PROTEIN; FRIEDREICHS-ATAXIA; IN-VIVO; BIOGENESIS; FRATAXIN; ISCU; HSCB; MITOCHONDRIA; REFINEMENT	Biogenesis of mitochondrial iron-sulfur (Fe/S) cluster proteins requires the interaction of multiple proteins with the highly conserved 14-kDa scaffold protein Isu, on which clusters are built prior to their transfer to recipient proteins. For example, the assembly process requires the cysteine desulfurase Nfs1, which serves as the sulfur donor for cluster assembly. The transfer process requires Jac1, a J-protein Hsp70 cochaperone. We recently identified three residues on the surface of Jac1 that form a hydrophobic patch critical for interaction with Isu. The results of molecular modeling of the Isu1-Jac1 interaction, which was guided by these experimental data and structural/biophysical information available for bacterial homologs, predicted the importance of three hydrophobic residues forming a patch on the surface of Isu1 for interaction with Jac1. Using Isu variants having alterations in residues that form the hydrophobic patch on the surface of Isu, this prediction was experimentally validated by in vitro binding assays. In addition, Nfs1 was found to require the same hydrophobic residues of Isu for binding, as does Jac1, suggesting that Jac1 and Nfs1 binding is mutually exclusive. In support of this conclusion, Jac1 and Nfs1 compete for binding to Isu. Evolutionary analysis revealed that residues involved in these interactions are conserved and that they are critical residues for the biogenesis of Fe/S cluster protein in vivo. We propose that competition between Jac1 and Nfs1 for Isu binding plays an important role in transitioning the Fe/S cluster biogenesis machinery from the cluster assembly step to the Hsp70-mediated transfer of the Fe/S cluster to recipient proteins.	[Majewska, Julia; Kominek, Jacek; Blenska, Anna; Delewski, Wojciech; Marszalek, Jaroslaw; Dutkiewicz, Rafal] Univ Gdansk, Intercollegiate Fac Biotechnol, PL-80822 Gdansk, Poland; [Ciesielski, Szymon J.; Schilke, Brenda; Song, Ji-Yoon; Marszalek, Jaroslaw; Craig, Elizabeth A.] Univ Wisconsin, Dept Biochem, Madison, WI 53706 USA; [Ciesielski, Szymon J.; Schilke, Brenda; Song, Ji-Yoon; Marszalek, Jaroslaw; Craig, Elizabeth A.] Univ Wisconsin, Madison, WI 53706 USA	Fahrenheit Universities; University of Gdansk; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Craig, EA (corresponding author), Univ Wisconsin, Dept Biochem, 433 Babcock Dr, Madison, WI 53706 USA.	ecraig@wisc.edu; dutkiew@biotech.ug.gda.pl	Dutkiewicz, Rafal/F-5956-2011; Dutkiewicz, Rafal/ABE-6979-2020; Marszalek, Jaroslaw/F-5824-2011	Dutkiewicz, Rafal/0000-0003-4150-0450; Ciesielski, Szymon/0000-0002-9041-7162; Marszalek, Jaroslaw/0000-0002-6978-1189; Kominek, Jacek/0000-0002-1916-0122	National Institutes of Health [GM27870]; Polish Ministry of Science and Higher Education [N N301314137]; Foundation for Polish Science International PhD Projects [MPD/2010/5]; European Union; Operational Program Innovative Economy; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM027870] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Polish Ministry of Science and Higher Education(Ministry of Science and Higher Education, Poland); Foundation for Polish Science International PhD Projects; European Union(European Commission); Operational Program Innovative Economy; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM27870 (to E. A. C.). This work was also supported by Polish Ministry of Science and Higher Education Grant N N301314137 (to R. D.) and by Foundation for Polish Science International PhD Projects Grant MPD/2010/5) cofinanced by the European Union European Regional Development Fund, Operational Program Innovative Economy 2007-2013 (to J. M.).	Adam AC, 2006, EMBO J, V25, P174, DOI 10.1038/sj.emboj.7600905; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Amela I, 2013, PROTEIN J, V32, P183, DOI 10.1007/s10930-013-9475-4; Andrew AJ, 2006, J BIOL CHEM, V281, P14580, DOI 10.1074/jbc.M600842200; Bonomi F, 2011, BIOCHEMISTRY-US, V50, P9641, DOI 10.1021/bi201123z; Bonomi F, 2008, BIOCHEMISTRY-US, V47, P12795, DOI 10.1021/bi801565j; Campuzano V, 1996, SCIENCE, V271, P1423, DOI 10.1126/science.271.5254.1423; Chandramouli K, 2006, BIOCHEMISTRY-US, V45, P11087, DOI 10.1021/bi061237w; Ciesielski SJ, 2012, J MOL BIOL, V417, P1, DOI 10.1016/j.jmb.2012.01.022; Colin F, 2013, J AM CHEM SOC, V135, P733, DOI 10.1021/ja308736e; Cook JD, 2010, BIOCHEMISTRY-US, V49, P8756, DOI 10.1021/bi1008613; Dutkiewicz R, 2006, J BIOL CHEM, V281, P7801, DOI 10.1074/jbc.M513301200; Dutkiewicz R, 2004, J BIOL CHEM, V279, P29167, DOI 10.1074/jbc.M402947200; Dutkiewicz R, 2003, J BIOL CHEM, V278, P29719, DOI 10.1074/jbc.M303527200; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Fiser A, 2003, METHOD ENZYMOL, V374, P461, DOI 10.1016/S0076-6879(03)74020-8; Fuzery AK, 2011, BMC BIOCHEM, V12, DOI 10.1186/1471-2091-12-3; Fuzery AK, 2008, BIOCHEMISTRY-US, V47, P9394, DOI 10.1021/bi800502r; GAMBILL BD, 1993, J CELL BIOL, V123, P109, DOI 10.1083/jcb.123.1.109; Garland SA, 1999, J MOL BIOL, V294, P897, DOI 10.1006/jmbi.1999.3294; Gerber J, 2004, MOL CELL BIOL, V24, P4848, DOI 10.1128/MCB.24.11.4848-4857.2004; Gerber J, 2003, EMBO REP, V4, P906, DOI 10.1038/sj.embor.embor918; Gray MW, 1999, SCIENCE, V283, P1476, DOI 10.1126/science.283.5407.1476; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Hoff KG, 2000, P NATL ACAD SCI USA, V97, P7790, DOI 10.1073/pnas.130201997; Jaschkowitz K, 2000, BIOCHEMISTRY-US, V39, P3416, DOI 10.1021/bi992147c; Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010; Kim JH, 2009, BIOCHEMISTRY-US, V48, P6062, DOI 10.1021/bi9002277; Kota P, 2011, BIOINFORMATICS, V27, P2209, DOI 10.1093/bioinformatics/btr374; Kurowski MA, 2003, NUCLEIC ACIDS RES, V31, P3305, DOI 10.1093/nar/gkg557; Lill R, 2012, BBA-MOL CELL RES, V1823, P1491, DOI 10.1016/j.bbamcr.2012.05.009; Marinoni EN, 2012, ANGEW CHEM INT EDIT, V51, P5439, DOI 10.1002/anie.201201708; Mashiach E, 2008, NUCLEIC ACIDS RES, V36, pW229, DOI 10.1093/nar/gkn186; Muhlenhoff U, 2003, EMBO J, V22, P4815, DOI 10.1093/emboj/cdg446; Pandey A, 2012, BIOCHEM J, V448, P171, DOI 10.1042/BJ20120951; Pierce BG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024657; Prischi F, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1097; Ramachandran S, 2011, PROTEINS, V79, P261, DOI 10.1002/prot.22879; Schmucker S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016199; Schmucker S, 2010, HUM MOL GENET, V19, pR103, DOI 10.1093/hmg/ddq165; SHERMAN F, 1991, METHOD ENZYMOL, V194, P3; Shi R, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000354; Song JY, 2012, P NATL ACAD SCI USA, V109, P10370, DOI 10.1073/pnas.1206945109; Stehling Oliver, 2007, Methods Mol Biol, V372, P325, DOI 10.1007/978-1-59745-365-3_24; THORPE GHG, 1985, CLIN CHEM, V31, P1335; Tsai CL, 2010, BIOCHEMISTRY-US, V49, P9132, DOI 10.1021/bi1013062; Vickery LE, 2007, CRIT REV BIOCHEM MOL, V42, P95, DOI 10.1080/10409230701322298; Wiedemann N, 2006, EMBO J, V25, P184, DOI 10.1038/sj.emboj.7600906; YAFFE MP, 1984, P NATL ACAD SCI-BIOL, V81, P4819, DOI 10.1073/pnas.81.15.4819	49	40	42	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 4	2013	288	40					29134	29142		10.1074/jbc.M113.503524	http://dx.doi.org/10.1074/jbc.M113.503524			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	298BL	23946486	Green Published, hybrid			2022-12-25	WOS:000330298800066
J	Ricard, MJ; Gudas, LJ				Ricard, Megan J.; Gudas, Lorraine J.			Cytochrome P450 Cyp26a1 Alters Spinal Motor Neuron Subtype Identity in Differentiating Embryonic Stem Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cytochrome P450; Differentiation; Neurological Diseases; Retinoid; Stem Cells	AMYOTROPHIC-LATERAL-SCLEROSIS; RETINOIC ACID SYNTHESIS; COLUMNAR ORGANIZATION; TRANSCRIPTION FACTORS; POSITIONAL IDENTITY; REPRESSOR ACTIVITY; GENE-EXPRESSION; HOMEOBOX GENES; REQUIREMENT; GROWTH	The ability to differentiate embryonic stem cells (ESCs) into specific cell types is critical for improved regenerative medicine strategies, cancer chemotherapeutic approaches, and regimens to combat chronic diseases associated with aging. Subclasses of motor neurons (MNs) are generated at different positions along the rostrocaudal axis of the spinal cord, and the signals that specify MN subtype fates remain poorly defined. We show here that the cytochrome P450 enzyme Cyp26a1, which metabolizes all-trans-retinoic acid (RA) and thereby reduces RA levels, plays a crucial role in specifying MN columnar subtypes. Lack of Cyp26a1 in ESCs during differentiation to spinal MNs increases Aldh1a2 (RALDH2) and Hoxc6, markers of the Hox-dependent, lateral motor column (LMC) subtype identity. In contrast, Lhx3, a marker for median motor column identity, showed lower expression in Cyp26a1(-/-)-derived MNs compared with WT. Without Cyp26a1, an increase in intracellular RA concentration plus sonic hedgehog agonist treatment confer an LMC fate on differentiating MNs. Our data suggest a strategy for increasing LMC-type MNs from ESCs by blocking Cyp26a1 in cell replacement/ESC differentiation therapy to treat neurodegenerative diseases, such as amyotrophic lateral sclerosis.	[Ricard, Megan J.; Gudas, Lorraine J.] Weill Cornell Med Coll, Dept Pharmacol, New York, NY 10065 USA; [Gudas, Lorraine J.] Weill Cornell Med Coll, Dept Med, New York, NY 10065 USA; [Gudas, Lorraine J.] Weill Cornell Canc Ctr, New York, NY 10065 USA	Cornell University; Cornell University	Gudas, LJ (corresponding author), Weill Cornell Med Coll, Dept Pharmacol, 1300 York Ave, New York, NY 10065 USA.	ljgudas@med.cornell.edu			National Institutes of Health [R01CA43796, T32CA062948]; Weill Cornell funds; Department of Defense [W81XWH-09-1-0158]; NATIONAL CANCER INSTITUTE [R01CA043796] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Weill Cornell funds; Department of Defense(United States Department of Defense); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant R01CA43796 (to L. J. G.). This work was also supported by Weill Cornell funds.; Supported for a portion of this research by Department of Defense Grant W81XWH-09-1-0158 and by National Institutes of Health Grant T32CA062948.	Abu-Abed S, 2002, MECH DEVELOP, V110, P173, DOI 10.1016/S0925-4773(01)00572-X; Arber S, 1999, NEURON, V23, P659, DOI 10.1016/S0896-6273(01)80026-X; Bain G, 1996, BIOCHEM BIOPH RES CO, V223, P691, DOI 10.1006/bbrc.1996.0957; Bjorklund LM, 2002, PROG BRAIN RES, V138, P411, DOI 10.1016/S0079-6123(02)38090-7; Briscoe J, 2001, CURR OPIN NEUROBIOL, V11, P43, DOI 10.1016/S0959-4388(00)00172-0; Bruijn LI, 2004, ANNU REV NEUROSCI, V27, P723, DOI 10.1146/annurev.neuro.27.070203.144244; Chen AC, 1997, CANCER RES, V57, P4642; Chen AC, 1996, J BIOL CHEM, V271, P14971, DOI 10.1074/jbc.271.25.14971; Dasen JS, 2008, CELL, V134, P304, DOI 10.1016/j.cell.2008.06.019; Dasen JS, 2009, CURR TOP DEV BIOL, V88, P169, DOI 10.1016/S0070-2153(09)88006-X; Dasen JS, 2003, NATURE, V425, P926, DOI 10.1038/nature02051; de Castro BM, 2009, MOL CELL BIOL, V29, P5238, DOI 10.1128/MCB.00245-09; Deshpande DM, 2006, ANN NEUROL, V60, P32, DOI 10.1002/ana.20901; Diez del Corral R, 2004, BIOESSAYS, V26, P857, DOI 10.1002/bies.20080; Dimos JT, 2008, SCIENCE, V321, P1218, DOI 10.1126/science.1158799; Duester G, 2008, CELL, V134, P921, DOI 10.1016/j.cell.2008.09.002; Egawa N, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004052; Ericson J, 1997, CELL, V90, P169, DOI 10.1016/S0092-8674(00)80323-2; Frank-Kamenetsky Maria, 2002, J Biol, V1, P10, DOI 10.1186/1475-4924-1-10; Golden MG, 2012, GENE DEV, V26, P2236, DOI 10.1101/gad.199133.112; Gudas LJ, 2011, J CELL PHYSIOL, V226, P322, DOI 10.1002/jcp.22417; Guo XJ, 1998, CANCER RES, V58, P166; GUTMAN CR, 1993, BRAIN RES, V609, P129, DOI 10.1016/0006-8993(93)90865-K; Harper JM, 2004, P NATL ACAD SCI USA, V101, P7123, DOI 10.1073/pnas.0401103101; HOLLYDAY M, 1980, J COMP NEUROL, V194, P143, DOI 10.1002/cne.901940108; Hollyday M., 1980, Current Topics in Developmental Biology, V15, P181; Hu BY, 2009, NAT PROTOC, V4, P1295, DOI 10.1038/nprot.2009.127; Jessell TM, 2000, NAT REV GENET, V1, P20, DOI 10.1038/35049541; Jung H, 2010, NEURON, V67, P781, DOI 10.1016/j.neuron.2010.08.008; Kania A, 2000, CELL, V102, P161, DOI 10.1016/S0092-8674(00)00022-2; LANDMESSER L, 1978, J PHYSIOL-LONDON, V284, P391, DOI 10.1113/jphysiol.1978.sp012546; Langton S, 2008, DEV BIOL, V315, P331, DOI 10.1016/j.ydbio.2007.12.021; Laursen KB, 2012, NUCLEIC ACIDS RES, V40, P102, DOI 10.1093/nar/gkr637; Liang XQ, 2011, MOL CELL NEUROSCI, V47, P215, DOI 10.1016/j.mcn.2011.04.007; Liu JP, 2001, NEURON, V32, P997, DOI 10.1016/S0896-6273(01)00544-X; Livet J, 2002, NEURON, V35, P877, DOI 10.1016/S0896-6273(02)00863-2; Lopez-Gonzalez R, 2009, CELL TRANSPLANT, V18, P1171, DOI 10.3727/096368909X12483162197123; Lu QR, 2002, CELL, V109, P75, DOI 10.1016/S0092-8674(02)00678-5; Ludolph AC, 2012, CURR OPIN NEUROL, V25, P530, DOI 10.1097/WCO.0b013e328356d328; Mic FA, 2002, DEVELOPMENT, V129, P2271; Miles GB, 2004, J NEUROSCI, V24, P7848, DOI 10.1523/JNEUROSCI.1972-04.2004; Mizuguchi R, 2001, NEURON, V31, P757, DOI 10.1016/S0896-6273(01)00413-5; Niederreither K, 1999, NAT GENET, V21, P444, DOI 10.1038/7788; Niwa H, 2000, NAT GENET, V24, P372, DOI 10.1038/74199; Novitch BG, 2003, NEURON, V40, P81, DOI 10.1016/j.neuron.2003.08.006; Novitch BG, 2001, NEURON, V31, P773, DOI 10.1016/S0896-6273(01)00407-X; Pasinelli P, 2006, NAT REV NEUROSCI, V7, P710, DOI 10.1038/nrn1971; Peljto M, 2011, CURR OPIN NEUROBIOL, V21, P43, DOI 10.1016/j.conb.2010.09.012; Peljto M, 2010, CELL STEM CELL, V7, P355, DOI 10.1016/j.stem.2010.07.013; Pfaff SL, 1996, CELL, V84, P309, DOI 10.1016/S0092-8674(00)80985-X; Rousso DL, 2008, NEURON, V59, P226, DOI 10.1016/j.neuron.2008.06.025; Sander M, 2000, GENE DEV, V14, P2134, DOI 10.1101/gad.820400; Sockanathan S, 2003, NEURON, V40, P97, DOI 10.1016/S0896-6273(03)00532-4; Sockanathan S, 1998, CELL, V94, P503, DOI 10.1016/S0092-8674(00)81591-3; Soundararajan P, 2006, J NEUROSCI, V26, P3256, DOI 10.1523/JNEUROSCI.5537-05.2006; Soundararajan P, 2010, J NEUROSCI, V30, P6595, DOI 10.1523/JNEUROSCI.4932-09.2010; Takebayashi H, 2002, CURR BIOL, V12, P1157, DOI 10.1016/S0960-9822(02)00926-0; Tanabe Y, 1996, SCIENCE, V274, P1115, DOI 10.1126/science.274.5290.1115; Tang XH, 2011, ANNU REV PATHOL-MECH, V6, P345, DOI 10.1146/annurev-pathol-011110-130303; Thaler J, 1999, NEURON, V23, P675, DOI 10.1016/S0896-6273(01)80027-1; Touma SE, 2009, BIOCHEM PHARMACOL, V78, P1127, DOI 10.1016/j.bcp.2009.06.022; TSUCHIDA T, 1994, CELL, V79, P957, DOI 10.1016/0092-8674(94)90027-2; Vallstedt A, 2001, NEURON, V31, P743, DOI 10.1016/S0896-6273(01)00412-3; White JA, 2000, P NATL ACAD SCI USA, V97, P6403, DOI 10.1073/pnas.120161397; Wichterle H, 2002, CELL, V110, P385, DOI 10.1016/S0092-8674(02)00835-8; Wichterle H, 2008, CURR PROTOC STEM CEL; William CM, 2003, DEVELOPMENT, V130, P1523, DOI 10.1242/dev.00358; Zhao D, 1996, EUR J BIOCHEM, V240, P15, DOI 10.1111/j.1432-1033.1996.0015h.x; Zhou Q, 2002, CELL, V109, P61, DOI 10.1016/S0092-8674(02)00677-3	69	6	6	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 4	2013	288	40					28801	28813		10.1074/jbc.M113.474254	http://dx.doi.org/10.1074/jbc.M113.474254			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	298BL	23946489	Green Published, hybrid			2022-12-25	WOS:000330298800033
J	Tsukamoto, H; Farrens, DL				Tsukamoto, Hisao; Farrens, David L.			A Constitutively Activating Mutation Alters the Dynamics and Energetics of a Key Conformational Change in a Ligand-free G Protein-coupled Receptor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSMEMBRANE HELICES; CRYSTAL-STRUCTURE; BINDING-SITE; RHODOPSIN; OPSIN; LIGHT; FLUORESCENCE; SPECTROSCOPY; STABILITY; NANODISCS	G protein-coupled receptors (GPCRs) undergo dynamic transitions between active and inactive conformations. Usually, these conversions are triggered when the receptor detects an external signal, but some so-called constitutively activating mutations, or CAMs, induce a GPCR to bind and activate G proteins in the absence of external stimulation, in ways still not fully understood. Here, we investigated how a CAM alters the structure of a GPCR and the dynamics involved as the receptor transitions between different conformations. Our approach used site-directed fluorescence labeling (SDFL) spectroscopy to compare opsin, the ligand-free form of the GPCR rhodopsin, with opsin containing the CAM M257Y, focusing specifically on key movements that occur in the sixth transmembrane helix (TM6) during GPCR activation. The site-directed fluorescence labeling data indicate opsin is constrained to an inactive conformation both in detergent micelles and lipid membranes, but when it contains the M257Y CAM, opsin is more dynamic and can interact with a G protein mimetic. Further study of these receptors using tryptophan-induced quenching (TrIQ) methods indicates that in detergent, the CAM significantly increases the population of receptors in the active state, but not in lipids. Subsequent Arrhenius analysis of the TrIQ data suggests that, both in detergent and lipids, the CAM lowers the energy barrier for TM6 movement, a key transition required for conversion between the inactive and active conformations. Together, these data suggest that the lowered energy barrier is a primary effect of the CAM on the receptor dynamics and energetics.	[Tsukamoto, Hisao; Farrens, David L.] Oregon Hlth & Sci Univ, Dept Biochem & Mol Biol, Portland, OR 97239 USA	Oregon Health & Science University	Farrens, DL (corresponding author), 3181 SW Sam Jackson Pk Rd, Portland, OR 97239 USA.	farrensd@ohsu.edu			National Institutes of Health [EY015436]; Grants-in-Aid for Scientific Research [25840122] Funding Source: KAKEN; NATIONAL EYE INSTITUTE [R01EY015436] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported, in whole or in part, by National Institutes of Health Grant EY015436 (to D.L.F.).	Altenbach C, 1996, BIOCHEMISTRY-US, V35, P12470, DOI 10.1021/bi960849l; Angel TE, 2009, P NATL ACAD SCI USA, V106, P8555, DOI 10.1073/pnas.0903545106; Ballesteros J. A., 1995, RECEPTOR MOL BIOL, V25, P366, DOI [10.1016/S1043-9471(05)80049-7, DOI 10.1016/S1043-9471(05)80049-7]; Bayburt TH, 2010, FEBS LETT, V584, P1721, DOI 10.1016/j.febslet.2009.10.024; Choe HW, 2011, NATURE, V471, P651, DOI 10.1038/nature09789; COHEN GB, 1993, BIOCHEMISTRY-US, V32, P6111, DOI 10.1021/bi00074a024; Deupi X, 2012, P NATL ACAD SCI USA, V109, P119, DOI 10.1073/pnas.1114089108; Deupi X, 2010, PHYSIOLOGY, V25, P293, DOI 10.1152/physiol.00002.2010; Dunham TD, 1999, J BIOL CHEM, V274, P1683, DOI 10.1074/jbc.274.3.1683; Farrens DL, 2010, PHOTOCH PHOTOBIO SCI, V9, P1466, DOI 10.1039/c0pp00283f; Farrens DL, 1996, SCIENCE, V274, P768, DOI 10.1126/science.274.5288.768; Gether U, 1997, EMBO J, V16, P6737, DOI 10.1093/emboj/16.22.6737; Han M, 1998, BIOCHEMISTRY-US, V37, P8253, DOI 10.1021/bi980147r; Janz JM, 2004, J BIOL CHEM, V279, P29767, DOI 10.1074/jbc.M402567200; Knierim B, 2007, P NATL ACAD SCI USA, V104, P20290, DOI 10.1073/pnas.0710393104; Kobilka BK, 2007, BBA-BIOMEMBRANES, V1768, P794, DOI 10.1016/j.bbamem.2006.10.021; Kusnetzow AK, 2006, BIOCHEMISTRY-US, V45, P5538, DOI 10.1021/bi060101v; Li J, 2004, J MOL BIOL, V343, P1409, DOI 10.1016/j.jmb.2004.08.090; Mansoor SE, 2004, BIOCHEMISTRY-US, V43, P9426, DOI 10.1021/bi036259m; Mansoor SE, 2002, BIOCHEMISTRY-US, V41, P2475, DOI 10.1021/bi011198i; Mansoor SE, 2010, BIOCHEMISTRY-US, V49, P9722, DOI 10.1021/bi100907m; Martin EL, 1996, J BIOL CHEM, V271, P361, DOI 10.1074/jbc.271.1.361; Melia TJ, 1997, BIOPHYS J, V73, P3182, DOI 10.1016/S0006-3495(97)78344-9; Nygaard R, 2013, CELL, V152, P532, DOI 10.1016/j.cell.2013.01.008; Okada T, 2004, J MOL BIOL, V342, P571, DOI 10.1016/j.jmb.2004.07.044; Park JH, 2008, NATURE, V454, P183, DOI 10.1038/nature07063; Sheikh SP, 1996, NATURE, V383, P347, DOI 10.1038/383347a0; Shi XG, 2008, J PHYS CHEM B, V112, P12801, DOI 10.1021/jp8033598; Spencer R. D., 1970, THESIS U ILLINOIS UR; Standfuss J, 2011, NATURE, V471, P656, DOI 10.1038/nature09795; Thompson Miles D., 2008, V448, P109, DOI 10.1007/978-1-59745-205-2_7; Tsukamoto H, 2011, BIOCHEMISTRY-US, V50, P5086, DOI 10.1021/bi200391a; Tsukamoto H, 2010, J MOL BIOL, V399, P501, DOI 10.1016/j.jmb.2010.04.029; Tsukamoto H, 2009, J BIOL CHEM, V284, P20676, DOI 10.1074/jbc.M109.016212; Venkatakrishnan AJ, 2013, NATURE, V494, P185, DOI 10.1038/nature11896; Vogel R, 2001, J BIOL CHEM, V276, P38487, DOI 10.1074/jbc.M105423200; Xie GF, 2003, BIOCHEMISTRY-US, V42, P1995, DOI 10.1021/bi020611z; Yao XJ, 2009, P NATL ACAD SCI USA, V106, P9501, DOI 10.1073/pnas.0811437106; Yao XJ, 2006, NAT CHEM BIOL, V2, P417, DOI 10.1038/nchembio801; Ye SX, 2010, NATURE, V464, P1386, DOI 10.1038/nature08948	40	26	26	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 27	2013	288	39					28207	28216		10.1074/jbc.M113.472464	http://dx.doi.org/10.1074/jbc.M113.472464			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302OB	23940032	Green Published, hybrid			2022-12-25	WOS:000330612800043
J	Gopal, S; Krysiak, R; Liomba, NG; Horner, MJ; Shores, CG; Alide, N; Kamiza, S; Kampani, C; Chimzimu, F; Fedoriw, Y; Dittmer, DP; Hosseinipour, MC; Hoffman, IF				Gopal, Satish; Krysiak, Robert; Liomba, N. George; Horner, Marie-Josephe; Shores, Carol G.; Alide, Noor; Kamiza, Steve; Kampani, Coxcilly; Chimzimu, Fred; Fedoriw, Yuri; Dittmer, Dirk P.; Hosseinipour, Mina C.; Hoffman, Irving F.			Early Experience after Developing a Pathology Laboratory in Malawi, with Emphasis on Cancer Diagnoses	PLOS ONE			English	Article							SUB-SAHARAN AFRICA; REGISTRY; CHALLENGE; GAMBIA; UGANDA; HIV	Background: Despite increasing cancer burden in Malawi, pathology services are limited. We describe operations during the first 20 months of a new pathology laboratory in Lilongwe, with emphasis on cancer diagnoses. Methods and Findings: We performed a cross-sectional study of specimens from the Kamuzu Central Hospital pathology laboratory between July 1, 2011 and February 28, 2013. Patient and specimen characteristics, and final diagnoses are summarized. Diagnoses were categorized as malignant, premalignant, infectious, other pathology, normal or benign, or nondiagnostic. Patient characteristics associated with premalignancy and malignancy were assessed using logistic regression. Of 2772 specimens, 2758 (99%) with a recorded final diagnosis were included, drawn from 2639 unique patients. Mean age was 38 years and 63% were female. Of those with documented HIV status, 51% had unknown status, and 36% with known status were infected. Histologic specimens comprised 91% of cases, and cytologic specimens 9%. Malignant diagnoses were most common overall (n = 861, 31%). Among cancers, cervical cancer was most common (n = 117, 14%), followed by lymphoma (n = 91, 11%), esophageal cancer (n = 86, 10%), sarcoma excluding Kaposi sarcoma (n = 75, 9%), and breast cancer (n = 61, 7%). HIV status was known for 95 (11%) of malignancies, with HIV prevalence ranging from 9% for breast cancer to 81% for cervical cancer. Increasing age was consistently associated with malignancy [bivariable odds ratio 1.24 per decade increase (95% CI 1.19-1.29) among 2685 patients with known age; multivariable odds ratio 1.33 per decade increase (95% CI 1.14-1.56) among 317 patients with known age, gender, and HIV status], while HIV infection and gender were not. Conclusions: Despite selection and referral bias inherent in these data, a new pathology laboratory in Lilongwe has created a robust platform for cancer care and research. Strategies to effectively capture clinical information for pathologically confirmed cancers can allow these data to complement population-based registration.	[Gopal, Satish; Dittmer, Dirk P.; Hosseinipour, Mina C.; Hoffman, Irving F.] Univ N Carolina, Inst Global Hlth & Infect Dis, Chapel Hill, NC 27515 USA; [Gopal, Satish; Shores, Carol G.; Fedoriw, Yuri; Dittmer, Dirk P.] Univ N Carolina, Lineberger Comprehens Canc Ctr, Program Global Oncol, Chapel Hill, NC 27599 USA; [Gopal, Satish; Krysiak, Robert; Liomba, N. George; Kampani, Coxcilly; Chimzimu, Fred; Hosseinipour, Mina C.; Hoffman, Irving F.] UNC Project Malawi, Lilongwe, Malawi; [Horner, Marie-Josephe] Univ N Carolina, Dept Epidemiol, Chapel Hill, NC USA; [Shores, Carol G.] Malawi Surg Initiat, Lilongwe, Malawi; [Shores, Carol G.] Univ N Carolina, Dept Otolaryngol, Chapel Hill, NC USA; [Alide, Noor] Kamuzu Cent Hosp, Lilongwe, Malawi; [Gopal, Satish; Kamiza, Steve; Hosseinipour, Mina C.] Univ Malawi, Coll Med, Blantyre, Malawi; [Fedoriw, Yuri] Univ N Carolina, Dept Pathol & Lab Med, Chapel Hill, NC USA; [Dittmer, Dirk P.] Univ N Carolina, Dept Microbiol & Immunol, Chapel Hill, NC USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of Malawi; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Gopal, S (corresponding author), Univ N Carolina, Inst Global Hlth & Infect Dis, Chapel Hill, NC 27515 USA.	gopal@med.unc.edu	Dittmer, Dirk/AAH-3535-2021; Dittmer, Dirk/GPW-7423-2022	Dittmer, Dirk/0000-0003-4968-5656; 	United States National Institutes of Health (NIH) through the Medical Education Partnership Initiative (MEPI); AIDS Malignancy Consortium (AMC) [U01CA121947]; Division of AIDS (DAIDS, Malawi Clinical Trials Unit, Lilongwe Clinical Research Site) [5UM1AI06951807]; UNC Lineberger Compehensive Cancer Center; UNC Department of Pathology and Laboratory Medicine; NIH Fogarty International Center through the Fogarty Global Health Fellows Program [1R25TW009340-01]; International Research Scientist Development Award [5K01TW009488-02]; AMC Fellowship Award; FOGARTY INTERNATIONAL CENTER [K01TW009488, R25TW009340] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [P30CA016086, P01CA019014, P50CA058223, U01CA121947] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI050410] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE023946] Funding Source: NIH RePORTER	United States National Institutes of Health (NIH) through the Medical Education Partnership Initiative (MEPI); AIDS Malignancy Consortium (AMC); Division of AIDS (DAIDS, Malawi Clinical Trials Unit, Lilongwe Clinical Research Site); UNC Lineberger Compehensive Cancer Center; UNC Department of Pathology and Laboratory Medicine; NIH Fogarty International Center through the Fogarty Global Health Fellows Program; International Research Scientist Development Award; AMC Fellowship Award; FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	Support for these activities was provided by the United States National Institutes of Health (NIH) through the Medical Education Partnership Initiative (MEPI), the AIDS Malignancy Consortium (AMC, U01CA121947), and the Division of AIDS (DAIDS, Malawi Clinical Trials Unit, Lilongwe Clinical Research Site, 5UM1AI06951807). Additional support was provided by the UNC Lineberger Compehensive Cancer Center, and the UNC Department of Pathology and Laboratory Medicine. Dr. Gopal is supported by the NIH Fogarty International Center through the Fogarty Global Health Fellows Program (1R25TW009340-01) and an International Research Scientist Development Award (5K01TW009488-02), as well as an AMC Fellowship Award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adesina A, 2013, LANCET ONCOL, V14, pE152, DOI 10.1016/S1470-2045(12)70598-3; Akinkuotu A, 2011, INT J STD AIDS, V22, P465, DOI 10.1258/ijsa.2011.011021; American Medical Association, 2011, PHYS CHAR DISTR US; Bah E, 2011, IARC Sci Publ, P97; Bah E, 2001, BRIT J CANCER, V84, P1207, DOI 10.1054/bjoc.2001.1730; Benediktsson H, 2007, ARCH PATHOL LAB MED, V131, P1636; Chokunonga E, 2011, IARC Sci Publ, P249; Chokunonga E, 2013, INT J CANCER, DOI [10.1002/ijc.28063, DOI 10.1002/IJC.28063.EPUB]; Ferlay J, 2010, IARC CANCERBASE; International Agency for Research on Cancer International Association of Cancer Registries, 2007, CANC INCIDENCE 5 CON, VIX; Jedy-Agba E, 2012, CANCER EPIDEMIOL, V36, pE271, DOI 10.1016/j.canep.2012.04.007; LaCourse S, 2012, 19 INT AIDS C JUL 22; Mbulaiteye SM, 2006, INT J CANCER, V118, P985, DOI 10.1002/ijc.21443; Morhason-Bello IO, 2013, LANCET ONCOL, V14, pE142, DOI 10.1016/S1470-2045(12)70482-5; Parkin DM, 2006, NAT REV CANCER, V6, P603, DOI 10.1038/nrc1948; Parkin DM, 2010, INT J CANCER, V126, P1187, DOI 10.1002/ijc.24838; Republic of Mozambique National AIDS Control Council 2012, 2012, GLOB AIDS RESP PROGR; Sankaranarayanan R, 2010, LANCET ONCOL, V11, P165, DOI 10.1016/S1470-2045(09)70335-3; Sasco AJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008621; Shimakawa Y, 2013, INT J CANCER, V132, P658, DOI 10.1002/ijc.27646; Tanon A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048108; Wabinga H, 2011, IARC Sci Publ, P243	23	46	46	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2013	8	8							e70361	10.1371/journal.pone.0070361	http://dx.doi.org/10.1371/journal.pone.0070361			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	200ZE	23950924	Green Published, Green Submitted, gold			2022-12-25	WOS:000323109700029
J	Li, ZF; Liang, YM; Lau, PN; Shen, W; Wang, DK; Cheung, WT; Xue, CJ; Poon, LM; Lam, YW				Li, Zhou Fang; Liang, Yi Min; Lau, Pui Ngan; Shen, Wei; Wang, Dai Kui; Cheung, Wing Tai; Xue, Chun Jason; Poon, Lit Man; Lam, Yun Wah			Dynamic Localisation of Mature MicroRNAs in Human Nucleoli is Influenced by Exogenous Genetic Materials	PLOS ONE			English	Article							RIBOSOMAL-RNA; EXPRESSION; TRANSCRIPTION; INHIBITION; IMMUNOLOCALIZATION; SEQUESTRATION; TRANSLOCATION; MECHANISMS; COMPONENTS; PROTEINS	Although microRNAs are commonly known to function as a component of RNA-induced silencing complexes in the cytoplasm, they have been detected in other organelles, notably the nucleus and the nucleolus, of mammalian cells. We have conducted a systematic search for miRNAs in HeLa cell nucleoli, and identified 11 abundant miRNAs with a high level of nucleolar accumulation. Through in situ hybridisation, we have localised these miRNAs, including miR-191 and miR-484, in the nucleolus of a diversity of human and rodent cell lines. The nucleolar association of these miRNAs is resistant to various cellular stresses, but highly sensitive to the presence of exogenous nucleic acids. Introduction of both single-and double-stranded DNA as well as double stranded RNA rapidly induce the redistribution of nucleolar miRNAs to the cytoplasm. A similar change in subcellular distribution is also observed in cells infected with the influenza A virus. The partition of miRNAs between the nucleolus and the cytoplasm is affected by Leptomycin B, suggesting a role of Exportin-1 in the intracellular shuttling of miRNAs. This study reveals a previously unknown aspect of miRNA biology, and suggests a possible link between these small noncoding RNAs and the cellular management of foreign genetic materials.	[Li, Zhou Fang; Liang, Yi Min; Shen, Wei; Lam, Yun Wah] City Univ Hong Kong, Dept Biol, Hong Kong, Hong Kong, Peoples R China; [Li, Zhou Fang; Liang, Yi Min; Shen, Wei; Lam, Yun Wah] City Univ Hong Kong, Dept Chem, Hong Kong, Hong Kong, Peoples R China; [Lau, Pui Ngan; Poon, Lit Man] Univ Hong Kong, Influenza Res Ctr, Hong Kong, Hong Kong, Peoples R China; [Lau, Pui Ngan; Poon, Lit Man] Univ Hong Kong, Sch Publ Hlth, Hong Kong, Hong Kong, Peoples R China; [Wang, Dai Kui; Cheung, Wing Tai] Chinese Univ Hong Kong, Sch Biomed Sci, Hong Kong, Hong Kong, Peoples R China; [Xue, Chun Jason] City Univ Hong Kong, Dept Comp Sci, Hong Kong, Hong Kong, Peoples R China	City University of Hong Kong; City University of Hong Kong; University of Hong Kong; University of Hong Kong; Chinese University of Hong Kong; City University of Hong Kong	Lam, YW (corresponding author), City Univ Hong Kong, Dept Biol, Hong Kong, Hong Kong, Peoples R China.	yunwlam@cityu.edu.hk	Poon, Leo/AAP-6887-2020; ZHOUFANG, LI/GWN-1360-2022; Cheung, Wing-Tai/AAE-2658-2020	Cheung, Wing-Tai/0000-0001-6358-7855; Lam, Yun Wah/0000-0001-8929-5965; Xue, Chun Jason/0000-0002-6431-9868	Research Grant Council, Hong Kong [9041520]; National Institutes of Health (NIAID) [HHSN266200700005C]; Area of Excellence Scheme of the University Grants Committee Hong Kong [AoE/M-12/06]	Research Grant Council, Hong Kong(Hong Kong Research Grants Council); National Institutes of Health (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Area of Excellence Scheme of the University Grants Committee Hong Kong	This work was supported by a General Research Fund (project number 9041520) provided by the Research Grant Council, Hong Kong. Influenza work was partially supported by the National Institutes of Health (NIAID contract HHSN266200700005C) and the Area of Excellence Scheme of the University Grants Committee Hong Kong (AoE/M-12/06). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen JS, 2005, NATURE, V433, P77, DOI 10.1038/nature03207; Arora A, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-5-r82; Bernardi R, 2004, NAT CELL BIOL, V6, P665, DOI 10.1038/ncb1147; Bushati N, 2007, ANNU REV CELL DEV BI, V23, P175, DOI 10.1146/annurev.cellbio.23.090506.123406; Carthew RW, 2009, CELL, V136, P642, DOI 10.1016/j.cell.2009.01.035; Castanotto D, 2009, P NATL ACAD SCI USA, V106, P21655, DOI 10.1073/pnas.0912384106; Chen CF, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni178; de Planell-Saguer M, 2010, NAT PROTOC, V5, P1061, DOI 10.1038/nprot.2010.62; Deo M, 2006, DEV DYNAM, V235, P2538, DOI 10.1002/dvdy.20847; Fazi F, 2008, CARDIOVASC RES, V79, P553, DOI 10.1093/cvr/cvn151; Fimognari C, 1997, MUTAGENESIS, V12, P91, DOI 10.1093/mutage/12.2.91; Fox AH, 2005, MOL BIOL CELL, V16, P5304, DOI 10.1091/mbc.E05-06-0587; Goodman AG, 2010, J VIROL, V84, P2027, DOI 10.1128/JVI.01595-09; HADJIOLOVA K, 1986, EXP CELL RES, V165, P481, DOI 10.1016/0014-4827(86)90601-4; Hiscox JA, 2007, NAT REV MICROBIOL, V5, P119, DOI 10.1038/nrmicro1597; Hu Z, 2012, CARCINOGENESIS; Hunter MP, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003694; Hwang HW, 2007, SCIENCE, V315, P97, DOI 10.1126/science.1136235; Jeffries CD, 2011, RNA, V17, P675, DOI 10.1261/rna.2006511; Jia DL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013927; Lagos-Quintana M, 2002, CURR BIOL, V12, P735, DOI 10.1016/S0960-9822(02)00809-6; Lam YW, 2007, CURR BIOL, V17, P749, DOI 10.1016/j.cub.2007.03.064; Leung AKL, 2006, COLD SPRING HARB SYM, V71, P29, DOI 10.1101/sqb.2006.71.049; Leung AKL, 2010, MOL CELL, V40, P205, DOI 10.1016/j.molcel.2010.09.027; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Liao JY, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010563; Martindill DMJ, 2007, NAT CELL BIOL, V9, P1131, DOI 10.1038/ncb1633; Meister G, 2004, MOL CELL, V15, P185, DOI 10.1016/j.molcel.2004.07.007; Meister G, 2004, RNA, V10, P544, DOI 10.1261/rna.5235104; Mestdagh P, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-6-r64; Mitchell PS, 2008, P NATL ACAD SCI USA, V105, P10513, DOI 10.1073/pnas.0804549105; Obernosterer G, 2007, NAT PROTOC, V2, P1508, DOI 10.1038/nprot.2007.153; Olson Mark O J, 2004, Sci STKE, V2004, ppe10; Park CW, 2010, RNA BIOL, V7, P606, DOI 10.4161/rna.7.5.13215; Politz JCR, 2006, P NATL ACAD SCI USA, V103, P18957, DOI 10.1073/pnas.0609466103; Politz JCR, 2009, RNA, V15, P1705, DOI 10.1261/rna.1470409; Rubbi CP, 2003, EMBO J, V22, P6068, DOI 10.1093/emboj/cdg579; Sansam CL, 2003, P NATL ACAD SCI USA, V100, P14018, DOI 10.1073/pnas.2336131100; SCHEER U, 1984, J CELL BIOL, V99, P672, DOI 10.1083/jcb.99.2.672; Schopman NCT, 2010, RNA BIOL, V7, P573, DOI [10.4161/rna.7.5.13141, 10.4161/rna.7.4.13141]; Scott M, 2001, NUCLEIC ACIDS RES, V29, P2052, DOI 10.1093/nar/29.10.2052; Shav-Tal Y, 2005, MOL BIOL CELL, V16, P2395, DOI 10.1091/mbc.E04-11-0992; Shiao YH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007505; Slavotinek A, 1996, INT J RADIAT BIOL, V70, P393, DOI 10.1080/095530096144860; Sood P, 2006, P NATL ACAD SCI USA, V103, P2746, DOI 10.1073/pnas.0511045103; Stark LA, 2005, MOL CELL BIOL, V25, P5985, DOI 10.1128/MCB.25.14.5985-6004.2005; Taft RJ, 2010, NAT STRUCT MOL BIOL, V17, P1030, DOI 10.1038/nsmb.1841; Thiry M, 2005, TRENDS CELL BIOL, V15, P194, DOI 10.1016/j.tcb.2005.02.007; Wienholds E, 2005, SCIENCE, V309, P310, DOI 10.1126/science.1114519; Wolff B, 1997, CHEM BIOL, V4, P139, DOI 10.1016/S1074-5521(97)90257-X; Yi R, 2003, GENE DEV, V17, P3011, DOI 10.1101/gad.1158803	51	45	45	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2013	8	8							e70869	10.1371/journal.pone.0070869	http://dx.doi.org/10.1371/journal.pone.0070869			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	217ZG	23940654	Green Submitted, Green Published, gold			2022-12-25	WOS:000324401500052
J	Benest, AV; Kruse, K; Savant, S; Thomas, M; Laib, AM; Loos, EK; Fiedler, U; Augustin, HG				Benest, Andrew V.; Kruse, Karoline; Savant, Soniya; Thomas, Markus; Laib, Anna M.; Loos, Elias K.; Fiedler, Ulrike; Augustin, Hellmut G.			Angiopoietin-2 Is Critical for Cytokine-Induced Vascular Leakage	PLOS ONE			English	Article							TIE-2 LIGAND ANGIOPOIETIN-2; ENDOTHELIAL-CELLS; MICROVASCULAR PERMEABILITY; TYROSINE KINASE; PLASMA LEAKAGE; GROWTH-FACTORS; TNF-ALPHA; IN-VIVO; ANGIOGENESIS; RECEPTOR	Genetic experiments (loss-of-function and gain-of-function) have established the role of Angiopoietin/Tie ligand/receptor tyrosine kinase system as a regulator of vessel maturation and quiescence. Angiopoietin-2 (Ang-2) acts on Tie2-expressing resting endothelial cells as an antagonistic ligand to negatively interfere with the vessel stabilizing effects of constitutive Ang-1/Tie-2 signaling. Ang-2 thereby controls the vascular response to inflammation-inducing as well as angiogenesis-inducing cytokines. This study was aimed at assessing the role of Ang-2 as an autocrine (i.e. endothelial-derived) regulator of rapid vascular responses (within minutes) caused by permeability-inducing agents. Employing two independent in vivo assays to quantitatively assess vascular leakage (tracheal microsphere assay, 1-5 min and Miles assay, 20 min), the immediate vascular response to histamine, bradykinin and VEGF was analyzed in Ang-2-deficient (Ang-2(-/-)) mice. In comparison to the wild type control mice, the Ang2(-/-) mice demonstrated a significantly attenuated response. The Ang-2(-/-) phenotype was rescued by systemic administration (paracrine) of an adenovirus encoding Ang-2. Furthermore, cytokine-induced intracellular calcium influx was impaired in Ang-2(-/-) endothelioma cells, consistent with reduced phospholipase activation in vivo. Additionally, recombinant human Ang-2 (rhAng-2) alone was unable to induce vascular leakage. In summary, we report here in a definite genetic setting that Ang-2 is critical for multiple vascular permeability-inducing cytokines.	[Benest, Andrew V.; Kruse, Karoline; Savant, Soniya; Thomas, Markus; Laib, Anna M.; Loos, Elias K.; Augustin, Hellmut G.] German Canc Res Ctr DKFZ ZMBH Alliance, Div Vasc Oncol & Metastasis, Heidelberg, Germany; [Kruse, Karoline; Savant, Soniya; Thomas, Markus; Loos, Elias K.; Augustin, Hellmut G.] Heidelberg Univ, Med Fac Mannheim CBTM, Dept Vasc Biol & Angiogenesis Res, Heidelberg, Germany; [Fiedler, Ulrike] ProQinase GmbH, Freiburg, Germany; [Augustin, Hellmut G.] German Canc Consortium, Heidelberg, Germany	Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg; ProQinase; Helmholtz Association; German Cancer Research Center (DKFZ)	Augustin, HG (corresponding author), German Canc Res Ctr DKFZ ZMBH Alliance, Div Vasc Oncol & Metastasis, Heidelberg, Germany.	augustin@angiogenese.de	Mai, Elias Karl/AAY-7476-2020; Augustin, Hellmut/AAA-5246-2020	Mai, Elias Karl/0000-0002-6226-1252; Augustin, Hellmut/0000-0002-7173-4242; Savant, Soniya/0000-0003-2730-8526; Benest, Andrew/0000-0002-8225-5159	German Research Council (DFG) [SFB-TR23]	German Research Council (DFG)(German Research Foundation (DFG))	This study was supported by a grant from the German Research Council (DFG, SFB-TR23 [Vascular Differentiation and Remodeling], project A3). The funding agency had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Augustin HG, 2009, NAT REV MOL CELL BIO, V10, P165, DOI 10.1038/nrm2639; Baffert F, 2006, AM J PHYSIOL-HEART C, V290, pH107, DOI 10.1152/ajpheart.00542.2005; Bao Philip, 2009, J Surg Res, V153, P347, DOI 10.1016/j.jss.2008.04.023; Bates DO, 2010, CARDIOVASC RES, V87, P262, DOI 10.1093/cvr/cvq105; Bates DO, 1997, AM J PHYSIOL-HEART C, V273, pH687, DOI 10.1152/ajpheart.1997.273.2.H687; BYRON KL, 1992, J BIOL CHEM, V267, P108; Daly C, 2006, P NATL ACAD SCI USA, V103, P15491, DOI 10.1073/pnas.0607538103; Daly C, 2013, CANCER RES, V73, P108, DOI 10.1158/0008-5472.CAN-12-2064; Davis S, 1996, CELL, V87, P1161, DOI 10.1016/S0092-8674(00)81812-7; Dellinger M, 2008, DEV BIOL, V319, P309, DOI 10.1016/j.ydbio.2008.04.024; DUMONT DJ, 1994, GENE DEV, V8, P1897, DOI 10.1101/gad.8.16.1897; Felcht M, 2012, J CLIN INVEST, V122, P1991, DOI 10.1172/JCI58832; Fiedler U, 2004, BLOOD, V103, P4150, DOI 10.1182/blood-2003-10-3685; Fiedler U, 2003, J BIOL CHEM, V278, P1721, DOI 10.1074/jbc.M208550200; Fiedler U, 2006, NAT MED, V12, P235, DOI 10.1038/nm1351; Gale NW, 2002, DEV CELL, V3, P411, DOI 10.1016/S1534-5807(02)00217-4; Gamble JR, 2000, CIRC RES, V87, P603, DOI 10.1161/01.RES.87.7.603; Gavard J, 2008, DEV CELL, V14, P25, DOI 10.1016/j.devcel.2007.10.019; Hughes DP, 2003, CIRC RES, V92, P630, DOI 10.1161/01.RES.0000063422.38690.DC; Imhof BA, 2006, NAT MED, V12, P171, DOI 10.1038/nm0206-171; Korff T, 1999, J CELL SCI, V112, P3249; Maisonpierre PC, 1997, SCIENCE, V277, P55, DOI 10.1126/science.277.5322.55; Ngok SP, 2012, J CELL BIOL, V199, P1103, DOI 10.1083/jcb.201207009; Parikh SM, 2006, PLOS MED, V3, P356, DOI 10.1371/journal.pmed.0030046; Reiss Y, 2007, CIRC RES, V101, P88, DOI 10.1161/CIRCRESAHA.106.143594; RIDLEY AJ, 1992, CELL, V70, P389, DOI 10.1016/0092-8674(92)90163-7; Salmon AHJ, 2009, CARDIOVASC RES, V83, P24, DOI 10.1093/cvr/cvp093; SATO TN, 1995, NATURE, V376, P70, DOI 10.1038/376070a0; Scharpfenecker M, 2005, J CELL SCI, V118, P771, DOI 10.1242/jcs.01653; Thomas M, 2010, J BIOL CHEM, V285, P23842, DOI 10.1074/jbc.M109.097543; Thurston G, 2000, NAT MED, V6, P460, DOI 10.1038/74725; Thurston G, 1999, SCIENCE, V286, P2511, DOI 10.1126/science.286.5449.2511; WILLIAMS RL, 1989, CELL, V57, P1053, DOI 10.1016/0092-8674(89)90343-7; Wojciak-Stothard B, 1998, J CELL PHYSIOL, V176, P150, DOI 10.1002/(SICI)1097-4652(199807)176:1<150::AID-JCP17>3.0.CO;2-B; ZENTGRAF H, 1984, J CELL BIOL, V99, P272, DOI 10.1083/jcb.99.1.272	35	90	96	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2013	8	8							e70459	10.1371/journal.pone.0070459	http://dx.doi.org/10.1371/journal.pone.0070459			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	218XC	23940579	Green Submitted, Green Published, gold			2022-12-25	WOS:000324465000073
J	Chen, HC; Zou, W; Tien, YJ; Chen, JJ				Chen, Hung-Chia; Zou, Wen; Tien, Yin-Jing; Chen, James J.			Identification of Bicluster Regions in a Binary Matrix and Its Applications	PLOS ONE			English	Article							GENE-EXPRESSION DATA; MICROARRAY DATA; PATTERNS; ALGORITHMS	Biclustering has emerged as an important approach to the analysis of large-scale datasets. A biclustering technique identifies a subset of rows that exhibit similar patterns on a subset of columns in a data matrix. Many biclustering methods have been proposed, and most, if not all, algorithms are developed to detect regions of "coherence'' patterns. These methods perform unsatisfactorily if the purpose is to identify biclusters of a constant level. This paper presents a two-step biclustering method to identify constant level biclusters for binary or quantitative data. This algorithm identifies the maximal dimensional submatrix such that the proportion of non-signals is less than a pre-specified tolerance delta. The proposed method has much higher sensitivity and slightly lower specificity than several prominent biclustering methods from the analysis of two synthetic datasets. It was further compared with the Bimax method for two real datasets. The proposed method was shown to perform the most robust in terms of sensitivity, number of biclusters and number of serotype-specific biclusters identified. However, dichotomization using different signal level thresholds usually leads to different sets of biclusters; this also occurs in the present analysis.	[Chen, Hung-Chia; Zou, Wen; Chen, James J.] US FDA, Natl Ctr Toxicol Res, Div Bioinformat & Biostat, Jefferson, AR 72079 USA; [Chen, Hung-Chia; Chen, James J.] China Med Univ, Grad Inst Biostat, Taichung, Taiwan; [Chen, Hung-Chia; Chen, James J.] China Med Univ, Biostat Ctr, Taichung, Taiwan; [Tien, Yin-Jing] Acad Sinica, Inst Stat Sci, Taipei 11529, Taiwan	US Food & Drug Administration (FDA); China Medical University Taiwan; China Medical University Taiwan; Academia Sinica - Taiwan	Chen, JJ (corresponding author), US FDA, Natl Ctr Toxicol Res, Div Bioinformat & Biostat, Jefferson, AR 72079 USA.	jamesj.chen@fda.hhs.gov		Zou, Wen/0000-0002-3735-1133				Barkow S, 2006, BIOINFORMATICS, V22, P1282, DOI 10.1093/bioinformatics/btl099; Ben-Dor A, 2003, J COMPUT BIOL, V10, P373, DOI 10.1089/10665270360688075; Brunet JP, 2004, P NATL ACAD SCI USA, V101, P4164, DOI 10.1073/pnas.0308531101; Carmona-Saez P, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-78; Causton HC, 2001, MOL BIOL CELL, V12, P323, DOI 10.1091/mbc.12.2.323; Cheng KO, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-210; Cheng Y, 2000, Proc Int Conf Intell Syst Mol Biol, V8, P93; DuMouchel W, 1999, AM STAT, V53, P177, DOI 10.2307/2686093; Gan XC, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-209; Gasch AP, 2000, MOL BIOL CELL, V11, P4241, DOI 10.1091/mbc.11.12.4241; Getz G, 2000, P NATL ACAD SCI USA, V97, P12079, DOI 10.1073/pnas.210134797; Gu JJ, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-S1-S4; Harpaz R, 2011, CLIN PHARMACOL THER, V89, P243, DOI 10.1038/clpt.2010.285; HARTIGAN JA, 1972, J AM STAT ASSOC, V67, P123, DOI 10.2307/2284710; Healy MJR, 1986, MATRICES STATISTICIA, P64; Hochreiter S, 2010, BIOINFORMATICS, V26, P1520, DOI 10.1093/bioinformatics/btq227; Horvath S, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000117; Jiang DX, 2004, IEEE T KNOWL DATA EN, V16, P1370, DOI 10.1109/TKDE.2004.68; Kaiser S, 2008, 2008 P COMP STAT, P201; Kluger Y, 2003, GENOME RES, V13, P703, DOI 10.1101/gr.648603; Kotetishvili M, 2002, J CLIN MICROBIOL, V40, P1626, DOI 10.1128/JCM.40.5.1626-1635.2002; Koyuturk M, 2004, 2004 IEEE COMPUTATIONAL SYSTEMS BIOINFORMATICS CONFERENCE, PROCEEDINGS, P480; Kriegel HP, 2009, ACM T KNOWL DISCOV D, V3, DOI 10.1145/1497577.1497578; Langfelder P, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-559; Lazzeroni L, 2002, STAT SINICA, V12, P61; LI J, 1994, P NATL ACAD SCI USA, V91, P2552, DOI 10.1073/pnas.91.7.2552; Li Tao, 2005, P 11 ACM SIGKDD INT, P188; Liu L, 2003, P NATL ACAD SCI USA, V100, P13167, DOI 10.1073/pnas.1733249100; Madeira SC, 2004, IEEE ACM T COMPUT BI, V1, P24, DOI 10.1109/TCBB.2004.2; MIRKIN B, 1995, J CLASSIF, V12, P243, DOI 10.1007/BF03040857; Murali TM, 2003, PAC S BIOC PSB; Prelic A, 2006, BIOINFORMATICS, V22, P1122, DOI 10.1093/bioinformatics/btl060; Rodriguez-Baena DS, 2011, BIOINFORMATICS, V27, P2738, DOI 10.1093/bioinformatics/btr464; SHAFFER JP, 1995, ANNU REV PSYCHOL, V46, P561, DOI 10.1146/annurev.ps.46.020195.003021; Szarfman A, 2002, DRUG SAFETY, V25, P381, DOI 10.2165/00002018-200225060-00001; Szpankowski W, 2001, AVERAGE CASE ANAL AL; Tanay A, 2005, HDB COMPUTATIONAL MO, V9, P261; Tanay Amos, 2002, Bioinformatics, V18 Suppl 1, pS136; TENOVER FC, 1995, J CLIN MICROBIOL, V33, P2233, DOI 10.1128/JCM.33.9.2233-2239.1995; Wang H., 2002, P 2002 ACM SIGMOD IN, P394, DOI DOI 10.1145/564691.564737; Yang WH, 2007, LECT NOTES COMPUT SC, V4819, P194; Zhang ZY, 2010, DATA MIN KNOWL DISC, V20, P28, DOI 10.1007/s10618-009-0145-2; Zou W, 2012, J CLIN MICROBIOL, V48, P3122	43	8	9	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2013	8	8							e71680	10.1371/journal.pone.0071680	http://dx.doi.org/10.1371/journal.pone.0071680			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	218XC	23940779	Green Submitted, gold, Green Published			2022-12-25	WOS:000324465000222
J	Clemens, MJ; Elia, A; Morley, SJ				Clemens, Michael J.; Elia, Androulla; Morley, Simon J.			Requirement for the eIF4E Binding Proteins for the Synergistic Down-Regulation of Protein Synthesis by Hypertonic Conditions and mTOR Inhibition	PLOS ONE			English	Article							TRANSLATION INITIATION; MAMMALIAN TARGET; MESSENGER-RNA; BREAST-CANCER; C-MYC; RAPAMYCIN; CELLS; KINASE; GROWTH; 4E-BP1	The protein kinase mammalian target of rapamycin (mTOR) regulates the phosphorylation and activity of several proteins that have the potential to control translation, including p70S6 kinase and the eIF4E binding proteins 4E-BP1 and 4E-BP2. In spite of this, in exponentially growing cells overall protein synthesis is often resistant to mTOR inhibitors. We report here that sensitivity of wild-type mouse embryonic fibroblasts (MEFs) to mTOR inhibitors can be greatly increased when the cells are subjected to the physiological stress imposed by hypertonic conditions. In contrast, protein synthesis in MEFs with a double knockout of 4E-BP1 and 4E-BP2 remains resistant to mTOR inhibitors under these conditions. Phosphorylation of p70S6 kinase and protein kinase B (Akt) is blocked by the mTOR inhibitor Ku0063794 equally well in both wild-type and 4E-BP knockout cells, under both normal and hypertonic conditions. The response of protein synthesis to hypertonic stress itself does not require the 4E-BPs. These data suggest that under certain stress conditions: (i) translation has a greater requirement for mTOR activity and (ii) there is an absolute requirement for the 4E-BPs for regulation by mTOR. Importantly, dephosphorylation of p70S6 kinase and Akt is not sufficient to affect protein synthesis acutely.	[Clemens, Michael J.; Morley, Simon J.] Univ Sussex, Sch Life Sci, Dept Biochem & Mol Biol, Brighton, E Sussex, England; [Elia, Androulla] Univ London, Div Biomed Sci, London, England	University of Sussex; University of London	Elia, A (corresponding author), Univ London, Div Biomed Sci, Cranmer Terrace, London, England.	a.elia@sgul.ac.uk	Elia, Androulla/AAE-6854-2021		Biotechnology and Biological Sciences Research Council (BBSRC) U.K. [BB/H018956]; Ralph Bates Pancreatic Cancer Research Fund; Wellcome Trust	Biotechnology and Biological Sciences Research Council (BBSRC) U.K.(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Ralph Bates Pancreatic Cancer Research Fund; Wellcome Trust(Wellcome TrustEuropean Commission)	This work was supported by grants from the Biotechnology and Biological Sciences Research Council (BBSRC) U.K. (grant number BB/H018956) and the Ralph Bates Pancreatic Cancer Research Fund. The authors would also like to acknowledge the Wellcome Trust, which provided part of the funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armengol G, 2007, CANCER RES, V67, P7551, DOI 10.1158/0008-5472.CAN-07-0881; Azar R, 2010, CELL CYCLE, V9, P1241, DOI 10.4161/cc.9.7.11047; Barnhart BC, 2008, CANCER BIOL THER, V7, P1443; BATTISTINI A, 1988, EXP CELL RES, V176, P162, DOI 10.1016/0014-4827(88)90130-9; Ortells MC, 2012, NUCLEIC ACIDS RES, V40, P4368, DOI 10.1093/nar/gks038; Cencic R, 2011, P NATL ACAD SCI USA, V108, P1046, DOI 10.1073/pnas.1011477108; Choo AY, 2008, P NATL ACAD SCI USA, V105, P17414, DOI 10.1073/pnas.0809136105; Constantinou C, 2007, CELL DEATH DIFFER, V14, P576, DOI 10.1038/sj.cdd.4402045; De Benedetti A, 2004, ONCOGENE, V23, P3189, DOI 10.1038/sj.onc.1207545; Dowling RJO, 2010, SCIENCE, V328, P1172, DOI 10.1126/science.1187532; Dubois L, 2009, INT J RADIAT ONCOL, V73, P1219, DOI 10.1016/j.ijrobp.2008.12.003; DUNCAN RF, 1987, MOL CELL BIOL, V7, P1293, DOI 10.1128/MCB.7.3.1293; Elia A, 2008, ONCOGENE, V27, P811, DOI 10.1038/sj.onc.1210678; Fenton TR, 2011, INT J BIOCHEM CELL B, V43, P47, DOI 10.1016/j.biocel.2010.09.018; Garcia-Martinez JM, 2009, BIOCHEM J, V421, P29, DOI 10.1042/BJ20090489; Genolet R, 2011, NUCLEIC ACIDS RES, V39, P989, DOI 10.1093/nar/gkq805; Genolet R, 2008, BMC MED GENOMICS, V1, DOI 10.1186/1755-8794-1-33; Graff JR, 2007, J CLIN INVEST, V117, P2638, DOI 10.1172/JCI32044; Graff JR, 2009, CANCER RES, V69, P3866, DOI 10.1158/0008-5472.CAN-08-3472; Grolleau A, 2002, J BIOL CHEM, V277, P22175, DOI 10.1074/jbc.M202014200; Grosso S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029136; Hernandez-Jimenez M, 2012, BBA-MOL CELL RES, V1823, P430, DOI 10.1016/j.bbamcr.2011.11.008; Hers I, 2011, CELL SIGNAL, V23, P1515, DOI 10.1016/j.cellsig.2011.05.004; Hoang B, 2010, BLOOD, V116, P4560, DOI 10.1182/blood-2010-05-285726; Holz MK, 2005, J BIOL CHEM, V280, P26089, DOI 10.1074/jbc.M504045200; Hresko RC, 2005, J BIOL CHEM, V280, P40406, DOI 10.1074/jbc.M508361200; Hsieh AC, 2012, NATURE, V485, P55, DOI 10.1038/nature10912; Hsieh AC, 2010, CANCER CELL, V17, P249, DOI 10.1016/j.ccr.2010.01.021; Hsu PP, 2011, SCIENCE, V332, P1317, DOI 10.1126/science.1199498; Huo YL, 2012, BIOCHEM J, V444, P141, DOI 10.1042/BJ20112107; Huo YL, 2011, BIOCHEM SOC T, V39, P446, DOI 10.1042/BST0390446; Jeffrey IW, 2002, CANCER RES, V62, P2272; Jiang H, 2003, CANCER CELL INT, V3, DOI 10.1186/1475-2867-3-2; KRUPPA J, 1984, EMBO J, V3, P95, DOI 10.1002/j.1460-2075.1984.tb01767.x; Kwak D, 2012, J BIOL CHEM, V287, P18398, DOI 10.1074/jbc.M111.326538; Laplante M, 2012, CELL, V149, P274, DOI 10.1016/j.cell.2012.03.017; Lee T, 2012, FUTURE MED CHEM, V4, P19, DOI [10.4155/FMC.11.150, 10.4155/fmc.11.150]; Lehman JA, 2003, J BIOL CHEM, V278, P28130, DOI 10.1074/jbc.M300376200; Li S, 2003, J BIOL CHEM, V278, P3015, DOI 10.1074/jbc.M208821200; Li SN, 2004, J BIOL CHEM, V279, P21312, DOI 10.1074/jbc.M312467200; Lynch M, 2004, J BIOL CHEM, V279, P3327, DOI 10.1074/jbc.M310872200; Magnuson B, 2012, BIOCHEM J, V441, P1, DOI 10.1042/BJ20110892; Martelli AM, 2011, LEUKEMIA, V25, P1064, DOI 10.1038/leu.2011.46; MECHLER B, 1981, J CELL BIOL, V88, P42, DOI 10.1083/jcb.88.1.42; Morley SJ, 2002, J BIOL CHEM, V277, P32855, DOI 10.1074/jbc.C200376200; Naegele S, 2004, J BIOL CHEM, V279, P46023, DOI 10.1074/jbc.M404945200; Nathan CAO, 2004, CLIN CANCER RES, V10, P5820, DOI 10.1158/1078-0432.CCR-03-0483; Petroulakis E, 2009, CANCER CELL, V16, P439, DOI 10.1016/j.ccr.2009.09.025; Raynaud FI, 2007, CANCER RES, V67, P5840, DOI 10.1158/0008-5472.CAN-06-4615; Rousseau D, 1996, ONCOGENE, V13, P2415; Ruggero D, 2004, NAT MED, V10, P484, DOI 10.1038/nm1042; Scheuner D, 2001, MOL CELL, V7, P1165, DOI 10.1016/S1097-2765(01)00265-9; She QB, 2010, CANCER CELL, V18, P39, DOI 10.1016/j.ccr.2010.05.023; Sokolosky ML, 2011, ONCOTARGET, V2, P538, DOI 10.18632/oncotarget.302; Sonenberg N, 2009, CELL, V136, P731, DOI 10.1016/j.cell.2009.01.042; Sparks CA, 2010, ONCOGENE, V29, P3733, DOI 10.1038/onc.2010.139; Teleman AA, 2005, GENE DEV, V19, P1844, DOI 10.1101/gad.341505; Thoreen CC, 2012, NATURE, V485, P109, DOI 10.1038/nature11083; Thoreen CC, 2009, J BIOL CHEM, V284, P8023, DOI 10.1074/jbc.M900301200; Wells SE, 1998, MOL CELL, V2, P135, DOI 10.1016/S1097-2765(00)80122-7; Wendel HG, 2004, NATURE, V428, P332, DOI 10.1038/nature02369; Workman P, 2010, CANCER RES, V70, P2146, DOI 10.1158/0008-5472.CAN-09-4355; YATES JR, 1982, J BIOL CHEM, V257, P5030	63	7	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2013	8	8							e71138	10.1371/journal.pone.0071138	http://dx.doi.org/10.1371/journal.pone.0071138			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	218XC	23940704	Green Published, Green Accepted, gold, Green Submitted			2022-12-25	WOS:000324465000183
J	Clements, ME; Chaber, CJ; Ledbetter, SR; Zuk, A				Clements, Meghan E.; Chaber, Christopher J.; Ledbetter, Steven R.; Zuk, Anna			Increased Cellular Senescence and Vascular Rarefaction Exacerbate the Progression of Kidney Fibrosis in Aged Mice Following Transient Ischemic Injury	PLOS ONE			English	Article							ACUTE-RENAL-FAILURE; AGING KIDNEY; OXIDATIVE STRESS; EPITHELIAL-CELLS; PROXIMAL TUBULE; GROWTH-FACTOR; RAT-KIDNEY; DISEASE; REPAIR; MACROPHAGES	Recent findings indicate that elderly patients with acute kidney injury (AKI) have an increased incidence of progression to chronic kidney disease (CKD) due to incomplete recovery from an acute insult. In the current study, a co-morbid model of AKI was developed to better mimic the patient population and to investigate whether age exacerbates the fibrosis and inflammation that develop in the sequelae of progressive kidney disease following acute injury. Young (8-10 weeks) and aged (46-49 weeks) C57BL/6 mice were subjected to 30 min bilateral renal ischemia-reperfusion (I/R) to induce AKI. The aged animals have greater mortality and prolonged elevation of plasma creatinine correlating with less tubular epithelial cell proliferation compared to the young. Six weeks post-reperfusion, interstitial fibrosis is greater in aged kidneys based on picrosirius red staining and immunolocalization of cellular fibronectin, collagen III and collagen IV. Aged kidneys 6 weeks post-reperfusion also express higher levels of p53 and p21 compared to the young, correlating with greater increases in senescence associated (SA) beta-galactosidase, a known marker of cellular senescence. A higher influx of F4/80(+) macrophages and CD4(+) T lymphocytes is measured and is accompanied by increases in mRNA of monocyte chemoattractant protein-1 (MCP-1) and tumor necrosis factor-alpha (TNF-alpha). Importantly, microvascular density is significantly less, correlating with an increase in nitro-tyrosine, a marker of oxidative stress. Collectively, these data demonstrate that prolonged acute injury in the aged animals results in an accelerated progression of kidney disease in a chronic state.	[Clements, Meghan E.; Chaber, Christopher J.; Ledbetter, Steven R.; Zuk, Anna] Genzyme Corp, Genzyme R&D, Tissue Protect & Repair Unit, Framingham, MA 01701 USA	Sanofi-Aventis; Genzyme Corporation	Zuk, A (corresponding author), Genzyme Corp, Genzyme R&D, Tissue Protect & Repair Unit, Framingham, MA 01701 USA.	anna.zuk@genzyme.com			Genzyme, a Sanofi Company	Genzyme, a Sanofi Company(Sanofi-AventisGenzyme Corporation)	The work was supported by Genzyme, a Sanofi Company and its employees were involved in study design, data collection and analysis, decision to publish and preparation of the manuscript.	Abdel-Kader K, 2009, CLIN GERIATR MED, V25, P331, DOI 10.1016/j.cger.2009.04.001; Ascon M, 2009, KIDNEY INT, V75, P526, DOI 10.1038/ki.2008.602; Basile DP, 2001, AM J PHYSIOL-RENAL, V281, pF887, DOI 10.1152/ajprenal.0050.2001; Bonventre JV, 2003, J AM SOC NEPHROL, V14, pS55, DOI 10.1097/01.ASN.0000067652.51441.21; Braun H, 2012, J AM SOC NEPHROL, V23, P1467, DOI 10.1681/ASN.2011100967; Chen G, 2007, AM J PHYSIOL-RENAL, V293, pF1272, DOI 10.1152/ajprenal.00138.2007; Chertow GM, 2006, KIDNEY INT, V70, P1120, DOI 10.1038/sj.ki.5001579; Chertow GM, 2005, J AM SOC NEPHROL, V16, P3365, DOI 10.1681/ASN.2004090740; Clements M, 2011, J AM SOC NEPHROL, V22; de Keizer PLJ, 2010, AGING-US, V2, P377, DOI 10.18632/aging.100178; DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363; Eardley KS, 2006, KIDNEY INT, V69, P1189, DOI 10.1038/sj.ki.5000212; Eddy AA, 1996, J AM SOC NEPHROL, V7, P2495; Ferenbach DA, 2011, KIDNEY INT, V79, P966, DOI 10.1038/ki.2010.535; Freund A, 2010, TRENDS MOL MED, V16, P238, DOI 10.1016/j.molmed.2010.03.003; Furuichi K, 2009, CLIN EXP NEPHROL, V13, P9, DOI 10.1007/s10157-008-0119-5; GLAUMANN B, 1977, VIRCHOWS ARCH B, V25, P281; Goldberg R, 2008, ADV CHRONIC KIDNEY D, V15, P297, DOI 10.1053/j.ackd.2008.04.009; Heyman SN, 2010, KIDNEY INT, V77, P9, DOI 10.1038/ki.2009.347; Hoenig MR, 2008, CURR MOL MED, V8, P754, DOI 10.2174/156652408786733685; Horbelt M, 2007, AM J PHYSIOL-RENAL, V293, pF688, DOI 10.1152/ajprenal.00452.2006; Holbrook NJ, 2002, BIOCHEM PHARMACOL, V64, P999, DOI 10.1016/S0006-2952(02)01169-3; Humphreys BD, 2008, CELL STEM CELL, V2, P284, DOI 10.1016/j.stem.2008.01.014; Ishani A, 2009, J AM SOC NEPHROL, V20, P223, DOI 10.1681/ASN.2007080837; Kang DH, 2001, AM J KIDNEY DIS, V37, P601, DOI 10.1053/ajkd.2001.22087; Kheterpal S, 2009, ANESTHESIOLOGY, V110, P505, DOI 10.1097/ALN.0b013e3181979440; Kim J, 2009, AM J PHYSIOL-RENAL, V297, pF461, DOI 10.1152/ajprenal.90735.2008; Kliem V, 1996, KIDNEY INT, V49, P666, DOI 10.1038/ki.1996.95; Ko GJ, 2008, NEPHROL DIAL TRANSPL, V23, P842; Kobayashi N, 2005, ARTERIOSCL THROM VAS, V25, P2114, DOI 10.1161/01.ATV.0000178993.13222.f2; Kusaka J, 2012, J SURG RES, V172, P153, DOI 10.1016/j.jss.2010.08.034; Liano F, 2007, KIDNEY INT, V71, P679, DOI 10.1038/sj.ki.5002086; Lieberthal W, 2000, AM J PHYSIOL-RENAL, V278, pF1, DOI 10.1152/ajprenal.2000.278.1.F1; Naesens M, 2011, DISCOV MED, V11, P65; Ricardo SD, 2008, J CLIN INVEST, V118, P3522, DOI 10.1172/JCI36150; RODGERS H, 1990, AGE AGEING, V19, P36, DOI 10.1093/ageing/19.1.36; Rosner Mitchell H, 2009, Curr Aging Sci, V2, P158; Schaier M, 2009, AM J PHYSIOL-RENAL, V297, pF769, DOI 10.1152/ajprenal.90530.2008; Schmitt R, 2008, AM J KIDNEY DIS, V52, P262, DOI 10.1053/j.ajkd.2008.03.005; Schmitt R, 2008, AM J PHYSIOL-RENAL, V294, pF1265, DOI 10.1152/ajprenal.00543.2007; Schmitt R, 2008, J AM SOC NEPHROL, V19, P2375, DOI 10.1681/ASN.2008010035; Sharfuddin AA, 2011, NAT REV NEPHROL, V7, P189, DOI 10.1038/nrneph.2011.16; Shimizu H, 2010, AM J PHYSIOL-CELL PH, V299, pC1110, DOI 10.1152/ajpcell.00217.2010; Stallone G, 2012, J NEPHROL, P0; System URD, 2010, USRDS 2010 ANN DAT R; Tapmeier TT, 2010, KIDNEY INT, V78, P351, DOI 10.1038/ki.2010.177; VENKATACHALAM MA, 1978, KIDNEY INT, V14, P31, DOI 10.1038/ki.1978.87; Venkatachalam MA, 2010, AM J PHYSIOL-RENAL, V298, pF1078, DOI 10.1152/ajprenal.00017.2010; Yang HC, 2010, J AM SOC NEPHROL, V21, P1436, DOI 10.1681/ASN.2010020205; Yang L, 2010, NAT MED, V16, P535, DOI 10.1038/nm.2144; Zuk A, 1998, AM J PHYSIOL-CELL PH, V275, pC711, DOI 10.1152/ajpcell.1998.275.3.C711	51	93	97	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2013	8	8							e70464	10.1371/journal.pone.0070464	http://dx.doi.org/10.1371/journal.pone.0070464			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	218XC	23940580	Green Published, gold, Green Submitted			2022-12-25	WOS:000324465000074
J	Dessein, R; Corbiere, V; Nortier, J; Dratwa, M; Gastaldello, K; Pozdzik, A; Lecher, S; Grandbastien, B; Locht, C; Mascart, F				Dessein, Rodrigue; Corbiere, Veronique; Nortier, Joelle; Dratwa, Max; Gastaldello, Karine; Pozdzik, Agnieszka; Lecher, Sophie; Grandbastien, Bruno; Locht, Camille; Mascart, Francoise			Heparin-Binding Haemagglutinin, a New Tool for the Detection of Latent Mycobacterium tuberculosis Infection in Hemodialysis Patients	PLOS ONE			English	Article							GAMMA-RELEASE ASSAYS; STAGE RENAL-DISEASE; T-CELL; HIGH PREVALENCE; SKIN-TEST; DIAGNOSIS; ANTIGEN; RESPONSES; GOLD	Background: Patients with end-stage renal disease (ESRD) and latently infected with Mycobacterium tuberculosis (LTBI) are at higher risk to develop tuberculosis (TB) than healthy subjects. Interferon-gamma release assays (IGRAs) were reported to be more sensitive than tuberculin skin tests for the detection of infected individuals in dialysis patients. Methods: On 143 dialysis patients prospectively enrolled, we compared the results from the QuantiFERON (R)-TB Gold assay (QFT), to those of an IGRA in response to in vitro stimulation of circulating mononuclear cells with the mycobacterial latency antigen Heparin-Binding Haemagglutinin purified from Mycobacterium bovis BCG (native HBHA, nHBHA). Results: Seven patients had a past history of active TB and 1 had an undetermined result with both IGRAs. Among the other 135 patients, 94 had concordant results with the QFT and nHBHA-IGRA, 40.0% being negative and therefore not latently infected, and 29.6% being positive and thus LTBI. Discrepant results between these tests were found for 36 patients positive only with the nHBHA-IGRA and 5 only with the QFT. Conclusions: The nHBHA-IGRA is more sensitive than the QFT for the detection of LTBI dialysis patients, and follow-up of the patients will allow us to define the clinical significance of discrepant results between the nHBHA-IGRA and the QFT.	[Dessein, Rodrigue; Corbiere, Veronique; Mascart, Francoise] Univ Libre Bruxelles, Lab Vaccinol & Mucosal Immun, Brussels, Belgium; [Nortier, Joelle; Gastaldello, Karine; Pozdzik, Agnieszka] Univ Libre Bruxelles, Hop Erasme, Dept Nephrol, Brussels, Belgium; [Dratwa, Max] Univ Libre Bruxelles, Hop Brugmann, Dept Nephrol, Brussels, Belgium; [Lecher, Sophie; Locht, Camille] INSERM, F-59045 Lille, France; [Lecher, Sophie; Locht, Camille] Inst Pasteur, Ctr Infect & Immun Lille, F-59019 Lille, France; [Lecher, Sophie; Locht, Camille] Inst Pasteur, Ctr Immunol & Biol Parasitaire, CNRS, UMR8204, F-59019 Lille, France; [Lecher, Sophie; Grandbastien, Bruno; Locht, Camille] Univ Lille Nord France, Lille, France; [Grandbastien, Bruno] CHRU Lille, Serv Gest Risque Infect Vigilances & Infectiol, F-59037 Lille, France; [Mascart, Francoise] Univ Libre Bruxelles, Hop Erasme, Immunobiol Clin, Brussels, Belgium	Universite Libre de Bruxelles; Universite Libre de Bruxelles; Universite Libre de Bruxelles; Institut National de la Sante et de la Recherche Medicale (Inserm); Le Reseau International des Instituts Pasteur (RIIP); Universite de Lille - ISITE; Institut Pasteur Lille; Universite de Lille; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Le Reseau International des Instituts Pasteur (RIIP); Universite de Lille - ISITE; Institut Pasteur Lille; Universite de Lille; Universite de Lille - ISITE; Universite de Lille; Universite de Lille - ISITE; CHU Lille; Universite Libre de Bruxelles	Mascart, F (corresponding author), Univ Libre Bruxelles, Lab Vaccinol & Mucosal Immun, Brussels, Belgium.	fmascart@ulb.ac.be	Dessein, Rodrigue/R-6134-2018; Locht, Camille/L-3516-2018	Nortier, Joelle/0000-0003-3609-8217; Locht, Camille/0000-0001-7295-7336	"Brains back to Brussels," from the "Institut d'Encouragement de la Recherche Scientifique et de l'Innovation de Bruxelles - Region de Bruxelles-Capitale"; E.C. FP7 program NEWTB-VAC (Discovery and preclinical development of new generation tuberculosis vaccines) [HEALTH-2009-2.3.2-2]; Fonds National de la Recherche Scientifique (FNRS); "Charge de recherches" fellowship from the Fonds National de la Recherche Scientifique (FNRS)	"Brains back to Brussels," from the "Institut d'Encouragement de la Recherche Scientifique et de l'Innovation de Bruxelles - Region de Bruxelles-Capitale"; E.C. FP7 program NEWTB-VAC (Discovery and preclinical development of new generation tuberculosis vaccines); Fonds National de la Recherche Scientifique (FNRS)(Fonds de la Recherche Scientifique - FNRS); "Charge de recherches" fellowship from the Fonds National de la Recherche Scientifique (FNRS)(Fonds de la Recherche Scientifique - FNRS)	This study was supported by a grant, "Brains back to Brussels," from the "Institut d'Encouragement de la Recherche Scientifique et de l'Innovation de Bruxelles - Region de Bruxelles-Capitale", and by the E.C. FP7 program NEWTB-VAC (Discovery and preclinical development of new generation tuberculosis vaccines) (HEALTH-2009-2.3.2-2). FM was partially supported by a grant from the Fonds National de la Recherche Scientifique (FNRS). VC was supported by a "Charge de recherches" fellowship from the Fonds National de la Recherche Scientifique (FNRS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Broekmans JF, 2002, EUR RESPIR J, V19, P765, DOI 10.1183/09031936.02.00261402; Cengiz K, 1996, NEPHRON, V73, P421; Chou KJ, 2001, NEPHRON, V88, P138, DOI 10.1159/000045974; Chung WK, 2010, CLIN MICROBIOL INFEC, V16, P960, DOI 10.1111/j.1469-0691.2009.02949.x; COHEN J, 1960, EDUC PSYCHOL MEAS, V20, P37, DOI 10.1177/001316446002000104; Corbiere V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043285; Demissie A, 2006, CLIN VACCINE IMMUNOL, V13, P179, DOI 10.1128/CVI.13.2.179-186.2006; Diel R, 2011, EUR RESPIR J, V37, P88, DOI 10.1183/09031936.00115110; Doherty TM, 2002, J CLIN MICROBIOL, V40, P704, DOI 10.1128/JCM.40.2.704-706.2002; Feske M, 2008, CLIN VACCINE IMMUNOL, V15, P1616, DOI 10.1128/CVI.00185-08; Girndt M, 1999, NEPHROL DIAL TRANSPL, V14, P2807, DOI 10.1093/ndt/14.12.2807; Goletti D, 2010, EUR RESPIR J, V36, P135, DOI 10.1183/09031936.00140009; Hoffmann M, 2010, SWISS MED WKLY, V140, P286, DOI smw-12960; HOSMER DW, 1989, APPL LOGISTIC REGRES; Hougardy JM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000926; Hursitoglu M, 2009, TRANSPL INFECT DIS, V11, P28, DOI 10.1111/j.1399-3062.2008.00348.x; Jasmer RM, 2002, NEW ENGL J MED, V347, P1860, DOI 10.1056/NEJMcp021045; Jereb John A., 2011, Morbidity and Mortality Weekly Report, V60, P1650; Lee SSJ, 2009, INFECTION, V37, P96, DOI 10.1007/s15010-008-8082-3; Leyten EMS, 2007, CLIN VACCINE IMMUNOL, V14, P880, DOI 10.1128/CVI.00132-07; Locht C, 2006, TUBERCULOSIS, V86, P303, DOI 10.1016/j.tube.2006.01.016; MALHOTRA KK, 1981, POSTGRAD MED J, V57, P492, DOI 10.1136/pgmj.57.670.492; Masungi C, 2002, J INFECT DIS, V185, P513, DOI 10.1086/338833; Menozzi FD, 1996, J EXP MED, V184, P993, DOI 10.1084/jem.184.3.993; Moore DAJ, 2002, EMERG INFECT DIS, V8, P77, DOI 10.3201/eid0801.010017; Passalent L, 2007, CLIN J AM SOC NEPHRO, V2, P68, DOI 10.2215/CJN.01280406; Petrescu L, 2010, J RENAL NUTR, V20, pS109, DOI 10.1053/j.jrn.2010.06.011; Richardson RMA, 2012, SEMIN DIALYSIS, V25, P419, DOI 10.1111/j.1525-139X.2012.01093.x; Richeldi L, 2009, CHEST, V136, P198, DOI 10.1378/chest.08-2575; Rogerson TE, 2013, AM J KIDNEY DIS, V61, P33, DOI 10.1053/j.ajkd.2012.07.019; Rose DN, 2000, ARCH INTERN MED, V160, P1513, DOI 10.1001/archinte.160.10.1513; Segall L, 2010, CLIN J AM SOC NEPHRO, V5, P1114, DOI 10.2215/CJN.09231209; Sester M, 2004, KIDNEY INT, V65, P1826, DOI 10.1111/j.1523-1755.2004.00586.x; Seyhan EC, 2010, TRANSPL INFECT DIS, V12, P98, DOI 10.1111/j.1399-3062.2009.00469.x; Shu CC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042592; Simon TA, 1999, INFECT CONT HOSP EP, V20, P607, DOI 10.1086/501679; Smirnoff M, 1998, CHEST, V113, P25, DOI 10.1378/chest.113.1.25; Temmerman S, 2004, NAT MED, V10, P935, DOI 10.1038/nm1090; Triverio PA, 2009, NEPHROL DIAL TRANSPL, V24, P1952, DOI 10.1093/ndt/gfn748; Winthrop KL, 2008, CLIN J AM SOC NEPHRO, V3, P1357, DOI 10.2215/CJN.01010208; Young DB, 2009, TRENDS MICROBIOL, V17, P183, DOI 10.1016/j.tim.2009.02.005	41	9	10	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2013	8	8							e71088	10.1371/journal.pone.0071088	http://dx.doi.org/10.1371/journal.pone.0071088			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	218XC	23940693	Green Published, Green Submitted, gold			2022-12-25	WOS:000324465000176
J	Jho, Y; Brown, FLH; Kim, M; Pincus, PA				Jho, YongSeok; Brown, Frank L. H.; Kim, MahnWon; Pincus, Philip A.			Repulsion between Oppositely Charged Planar Macroions	PLOS ONE			English	Article							MONTE-CARLO; DNA; ELECTROLYTES; RENORMALIZATION; CONDENSATION; COUNTERIONS; INVERSION; SURFACES	The repulsive interaction between oppositely charged macroions is investigated using Grand Canonical Monte Carlo simulations of an unrestricted primitive model, including the effect of inhomogeneous surface charge and its density, the depth of surface charge, the cation size, and the dielectric permittivity of solvent and macroions, and their contrast. The origin of the repulsion is a combination of osmotic pressure and ionic screening resulting from excess salt between the macroions. The excess charge over-reduces the electrostatic attraction between macroions and raises the entropic repulsion. The magnitude of the repulsion increases when the dielectric constant of the solvent is lowered (below that of water) and/or the surface charge density is increased, in good agreement with experiment. Smaller size of surface charge and the cation, their discreteness and mobility are other factors that enhance the repulsion and charge inversion phenomenons.	[Jho, YongSeok] Asia Pacific Ctr Theoret Phys, Pohang, Gyeongbuk Do, South Korea; [Jho, YongSeok] Pohang Univ Sci & Technol, Dept Phys, Pohang, Gyeongbuk Do, South Korea; [Brown, Frank L. H.] Univ Calif Santa Barbara, Dept Phys, Santa Barbara, CA 93106 USA; [Brown, Frank L. H.] Univ Calif Santa Barbara, Dept Chem & Biochem, Santa Barbara, CA 93106 USA; [Kim, MahnWon; Pincus, Philip A.] Korea Adv Inst Sci & Technol, Dept Phys, Taejon 305701, South Korea; [Kim, MahnWon; Pincus, Philip A.] Univ Calif Santa Barbara, Mat Res Lab, Santa Barbara, CA 93106 USA	Asia Pacific Center for Theoretical Physics; Pohang University of Science & Technology (POSTECH); University of California System; University of California Santa Barbara; University of California System; University of California Santa Barbara; Korea Advanced Institute of Science & Technology (KAIST); University of California System; University of California Santa Barbara	Jho, Y (corresponding author), Asia Pacific Ctr Theoret Phys, Pohang, Gyeongbuk Do, South Korea.	ysjho@apctp.org	JHO, YONGSEOK/A-4856-2010; Kim, Mahn Won/C-1541-2011		Max Planck Society; Korea Ministry of Education, Science and Technology, Gyeongsangbuk-Do and Pohang City; National Research Foundation (NRF) of Korea; Korea government [NRFC2012R1A1A2009275]; WCU program through NRF [R33-2008-000-10163-0]; National Science Foundation [CHE-0848809, CHE-1153096]; PLSI supercomputing resources of Korea Institute of Science and Technology Information	Max Planck Society(Max Planck SocietyFoundation CELLEX); Korea Ministry of Education, Science and Technology, Gyeongsangbuk-Do and Pohang City; National Research Foundation (NRF) of Korea(National Research Foundation of Korea); Korea government(Korean Government); WCU program through NRF(National Research Foundation of Korea); National Science Foundation(National Science Foundation (NSF)); PLSI supercomputing resources of Korea Institute of Science and Technology Information	Y.S.J. acknowledges the Max Planck Society, the Korea Ministry of Education, Science and Technology, Gyeongsangbuk-Do and Pohang City for the support of the Independent Junior Research Group at the Asia Pacific Center for Theoretical Physics, and was supported by the National Research Foundation (NRF) of Korea grant funded by the Korea government (NRFC2012R1A1A2009275). P.A.P. and M.W.K. acknowledge the WCU program through NRF (Grant no. R33-2008-000-10163-0). F.L.H.B. was supported by the National Science Foundation (CHE-0848809 and CHE-1153096). This work was supported by PLSI supercomputing resources of Korea Institute of Science and Technology Information. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allahyarov E, 2005, J PHYS-CONDENS MAT, V17, pS1827, DOI 10.1088/0953-8984/17/20/012; ATTARD P, 1993, PHYS REV E, V48, P3604, DOI 10.1103/PhysRevE.48.3604; Besteman K, 2005, PHYS REV E, V72, DOI 10.1103/PhysRevE.72.061501; Besteman K, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.170802; BLOOMFIELD VA, 1991, BIOPOLYMERS, V31, P1471, DOI 10.1002/bip.360311305; Calero C, 2010, J CHEM PHYS, V132, DOI 10.1063/1.3289726; Dahirel V, 2009, J CHEM PHYS, V131, DOI 10.1063/1.3193556; De Jong H. B., 1949, COLLOID SCI, V2, P335, DOI DOI 10.2516/OGST/2009070; Debye P, 1923, PHYS Z, V24, P185; Fleck CC, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.128101; Gouy G, 1910, J PHYS, V9, P457, DOI DOI 10.1051/JPHYSTAP:019100090045700; Grosberg AY, 2002, REV MOD PHYS, V74, P329, DOI 10.1103/RevModPhys.74.329; Ha BY, 2001, PHYS REV E, V64, DOI 10.1103/PhysRevE.64.031507; Hatlo MM, 2008, J CHEM PHYS, V128, DOI 10.1063/1.2908738; Hatlo MM, 2008, SOFT MATTER, V4, P1582, DOI 10.1039/b803783c; Hatlo MM, 2009, SOFT MATTER, V5, P125, DOI 10.1039/b815578j; Heinz H, 2005, PHYS REV E, V72, DOI 10.1103/PhysRevE.72.066704; HONIG B, 1993, J PHYS CHEM-US, V97, P1101, DOI 10.1021/j100108a002; Jho YS, 2008, J CHEM PHYS, V129, DOI 10.1063/1.2970885; Jho YS, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.188101; Jho YS, 2006, PHYS REV E, V73, DOI 10.1103/PhysRevE.73.021502; KABANOV AV, 1995, BIOCONJUGATE CHEM, V6, P7, DOI 10.1021/bc00031a002; Kanduc M, 2008, PHYS REV E, V78, DOI 10.1103/PhysRevE.78.061105; Kjellander R, 2007, COLLOID J+, V69, P20, DOI 10.1134/S1061933X07010048; KJELLANDER R, 1994, J CHEM PHYS, V101, P603, DOI 10.1063/1.468116; Lau AWC, 2002, PHYS REV E, V65, DOI 10.1103/PhysRevE.65.051502; Lau AWC, 2002, PHYS REV E, V66, DOI 10.1103/PhysRevE.66.041501; Li ZD, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.048302; Linse P, 2008, J CHEM PHYS, V128, DOI 10.1063/1.2908077; Martin-Molina A, 2011, SOFT MATTER, V7, P1441, DOI 10.1039/c0sm00609b; Meyer S, 2001, LANGMUIR, V17, P7433, DOI 10.1021/la0108508; Nguyen TT, 2000, J CHEM PHYS, V113, P1110, DOI 10.1063/1.481890; Nguyen TT, 2001, J CHEM PHYS, V115, P7298, DOI 10.1063/1.1402988; Poon WCK, 2006, SCOT GRAD SER, P1; Ramirez R, 2003, J CHEM PHYS, V119, P11380, DOI 10.1063/1.1623179; Ravindran S, 2009, CONDENS MATTER PHYS, V8, P377; Safran S. A., 1994, STAT THERMODYNAMICS; Schonhoff M, 2003, CURR OPIN COLLOID IN, V8, P86, DOI 10.1016/S1359-0294(03)00003-7; SJOSTROM L, 1993, J CHEM PHYS, V99, P4739, DOI 10.1063/1.466045; Taboada-Serrano P, 2005, J CHEM PHYS, V123, DOI 10.1063/1.1992484; Taboada-Serrano P, 2006, J CHEM PHYS, V125, DOI 10.1063/1.2238869; Trulsson M, 2007, LANGMUIR, V23, P11562, DOI 10.1021/la701222b; Trulsson M, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.068302; Ulander J, 2001, J CHEM PHYS, V115, P7144, DOI 10.1063/1.1398587; Wu JZ, 2000, PHYS REV E, V62, P5273, DOI 10.1103/PhysRevE.62.5273	46	3	3	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2013	8	8							e69436	10.1371/journal.pone.0069436	http://dx.doi.org/10.1371/journal.pone.0069436			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	218XC	23940518	gold, Green Submitted, Green Published			2022-12-25	WOS:000324465000013
J	Liu, GZ; Cao, DD; Li, SS; Su, AG; Geng, JN; Grover, CE; Hu, SN; Hua, JP				Liu, Guozheng; Cao, Dandan; Li, Shuangshuang; Su, Aiguo; Geng, Jianing; Grover, Corrinne E.; Hu, Songnian; Hua, Jinping			The Complete Mitochondrial Genome of Gossypium hirsutum and Evolutionary Analysis of Higher Plant Mitochondrial Genomes	PLOS ONE			English	Article							COMPLETE NUCLEOTIDE-SEQUENCE; TRANSFER-RNA GENES; DNA-SEQUENCE; CHLOROPLAST; L.; CONTAINS; FAMILY; MAIZE	Background: Mitochondria are the main manufacturers of cellular ATP in eukaryotes. The plant mitochondrial genome contains large number of foreign DNA and repeated sequences undergone frequently intramolecular recombination. Upland Cotton (Gossypium hirsutum L.) is one of the main natural fiber crops and also an important oil-producing plant in the world. Sequencing of the cotton mitochondrial (mt) genome could be helpful for the evolution research of plant mt genomes. Methodology/Principal Findings: We utilized 454 technology for sequencing and combined with Fosmid library of the Gossypium hirsutum mt genome screening and positive clones sequencing and conducted a series of evolutionary analysis on Cycas taitungensis and 24 angiosperms mt genomes. After data assembling and contigs joining, the complete mitochondrial genome sequence of G. hirsutum was obtained. The completed G. hirsutum mt genome is 621,884 bp in length, and contained 68 genes, including 35 protein genes, four rRNA genes and 29 tRNA genes. Five gene clusters are found conserved in all plant mt genomes; one and four clusters are specifically conserved in monocots and dicots, respectively. Homologous sequences are distributed along the plant mt genomes and species closely related share the most homologous sequences. For species that have both mt and chloroplast genome sequences available, we checked the location of cp-like migration and found several fragments closely linked with mitochondrial genes. Conclusion: The G. hirsutum mt genome possesses most of the common characters of higher plant mt genomes. The existence of syntenic gene clusters, as well as the conservation of some intergenic sequences and genic content among the plant mt genomes suggest that evolution of mt genomes is consistent with plant taxonomy but independent among different species.	[Liu, Guozheng; Li, Shuangshuang; Su, Aiguo; Hua, Jinping] China Agr Univ, Beijing Key Lab Crop Genet Improvement, Dept Plant Genet & Breeding,Minist Educ, Coll Agron & Biotechnol,Key Lab Crop Heterosis &, Beijing 100094, Peoples R China; [Cao, Dandan; Geng, Jianing; Hu, Songnian] Chinese Acad Sci, Beijing Inst Genom, CAS Key Lab Genome Sci & Informat, Beijing, Peoples R China; [Grover, Corrinne E.] Iowa State Univ, Dept Ecol Evolut & Organismal Biol, Ames, IA USA	China Agricultural University; Chinese Academy of Sciences; Beijing Institute of Genomics, CAS; Iowa State University	Hu, SN (corresponding author), Chinese Acad Sci, Beijing Inst Genom, CAS Key Lab Genome Sci & Informat, Beijing, Peoples R China.	husn@big.ac.cn; jinping_hua@cau.edu.cn	Hua, Jinping/L-3221-2019; Grover, Corrinne E/K-3194-2019; Hu, Songnian/C-6509-2013	Grover, Corrinne E/0000-0003-3878-5459; Hu, Songnian/0000-0003-3966-3111	National Natural Science Foundation of China (NSFC) [31171591]; National High Technology Research and Development Program [2011AA10A102]; Key Project of MOE [107012]; Training Program Foundation for the New Century Excellent Talents in University [NCET-06-0106]; Innovation Fund for Graduate Student of China Agricultural University [KYCX2010024]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); National High Technology Research and Development Program(National High Technology Research and Development Program of China); Key Project of MOE; Training Program Foundation for the New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET)); Innovation Fund for Graduate Student of China Agricultural University	This work was supported by grants from the National Natural Science Foundation of China (NSFC grant number 31171591), the National High Technology Research and Development Program (grant number 2011AA10A102), Key Project of MOE (grant number 107012), and Training Program Foundation for the New Century Excellent Talents in University (NCET-06-0106) to J. Hua, and the support by the Innovation Fund for Graduate Student of China Agricultural University (KYCX2010024) to S. Li. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams KL, 2002, PLANT CELL, V14, P931, DOI 10.1105/tpc.010483; Allen JO, 2007, GENETICS, V177, P1173, DOI 10.1534/genetics.107.073312; Alverson AJ, 2011, PLANT CELL, V23, P2499, DOI 10.1105/tpc.111.087189; Alverson AJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016404; Alverson AJ, 2010, MOL BIOL EVOL, V27, P1436, DOI 10.1093/molbev/msq029; Boore JL, 1998, CURR OPIN GENET DEV, V8, P668, DOI 10.1016/S0959-437X(98)80035-X; Chaw SM, 2008, MOL BIOL EVOL, V25, P603, DOI 10.1093/molbev/msn009; Clifton SW, 2004, PLANT PHYSIOL, V136, P3486, DOI 10.1104/pp.104.044602; Dietrich A, 1996, BIOCHIMIE, V78, P518, DOI 10.1016/0300-9084(96)84758-4; Fang YJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037164; Fujii S, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-209; Goremykin VV, 2009, MOL BIOL EVOL, V26, P99, DOI 10.1093/molbev/msn226; Handa H, 2003, NUCLEIC ACIDS RES, V31, P5907, DOI 10.1093/nar/gkg795; Kitazaki K., 2010, Journal of Botany, V2010, P620137, DOI 10.1155/2010/620137; Kubo T, 2000, NUCLEIC ACIDS RES, V28, P2571, DOI 10.1093/nar/28.13.2571; Li SM, 2013, CZECH J ANIM SCI, V58, P1, DOI 10.17221/6519-CJAS; Liu Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035168; Liu Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025836; Lowe TM, 1997, NUCLEIC ACIDS RES, V25, P955, DOI 10.1093/nar/25.5.955; Ma PF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030297; MARECHALDROUARD L, 1990, NUCLEIC ACIDS RES, V18, P3689, DOI 10.1093/nar/18.13.3689; MARECHALDROUARD L, 1993, ANNU REV PLANT PHYS, V44, P13, DOI 10.1146/annurev.pp.44.060193.000305; NAKAZONO M, 1995, CURR GENET, V27, P184, DOI 10.1007/BF00313433; Nakazono M, 1996, MOL GEN GENET, V252, P371; Notsu Y, 2002, MOL GENET GENOMICS, V268, P434, DOI 10.1007/s00438-002-0767-1; ODA K, 1992, J MOL BIOL, V223, P1, DOI 10.1016/0022-2836(92)90708-R; Ogihara Y, 2005, NUCLEIC ACIDS RES, V33, P6235, DOI 10.1093/nar/gki925; Overbeek R, 1999, P NATL ACAD SCI USA, V96, P2896, DOI 10.1073/pnas.96.6.2896; PALMER JD, 1984, NATURE, V307, P437, DOI 10.1038/307437a0; PALMER JD, 1987, CURR GENET, V11, P565, DOI 10.1007/BF00384620; PALMER JD, 1988, J MOL EVOL, V28, P87, DOI 10.1007/BF02143500; Qiu YL, 2010, J SYST EVOL, V48, P391, DOI 10.1111/j.1759-6831.2010.00097.x; QUETIER F, 1977, NATURE, V268, P365, DOI 10.1038/268365a0; Rivarola M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021743; Salinas T, 2008, TRENDS BIOCHEM SCI, V33, P320, DOI 10.1016/j.tibs.2008.04.010; Sloan DB, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-274; STERN DB, 1982, NATURE, V299, P698, DOI 10.1038/299698a0; Sugiyama Y, 2005, MOL GENET GENOMICS, V272, P603, DOI 10.1007/s00438-004-1075-8; Tian XJ, 2006, PLANT PHYSIOL, V140, P401, DOI 10.1104/pp.105.070060; Unseld M, 1997, NAT GENET, V15, P57, DOI 10.1038/ng0197-57; VAUGHN JC, 1995, J MOL EVOL, V41, P563, DOI 10.1007/BF00175814; Wang D, 2012, MOL BIOL EVOL, V29, P1707, DOI 10.1093/molbev/mss016; WARD BL, 1981, CELL, V25, P793, DOI 10.1016/0092-8674(81)90187-2; WOLFE KH, 1987, P NATL ACAD SCI USA, V84, P9054, DOI 10.1073/pnas.84.24.9054; Zhang TW, 2011, PLANT METHODS, V7, DOI 10.1186/1746-4811-7-38	45	37	40	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2013	8	8							e69476	10.1371/journal.pone.0069476	http://dx.doi.org/10.1371/journal.pone.0069476			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	218XC	23940520	Green Submitted, Green Published, gold			2022-12-25	WOS:000324465000015
J	Rasooly, R; Hernlem, B; Friedman, M				Rasooly, Reuven; Hernlem, Bradley; Friedman, Mendel			Low Levels of Aflatoxin B1, Ricin, and Milk Enhance Recombinant Protein Production in Mammalian Cells	PLOS ONE			English	Article							STAPHYLOCOCCAL-ENTEROTOXIN; HSV-TK; COMBINATION; EXPRESSION; GENE; B-1	Gene expression in transduced mammalian cells correlates with virus titer, but high doses of vector for gene therapy leads to toxicity in humans and in animals. Changing the optimal tissue culture medium by adding low levels of environmental stressors, such as 1 mu M of the fungal toxin aflatoxin B1 (AFB1), 1 ng of the castor bean protein toxin ricin, or 1% reconstituted milk, enhances transcription and increases production of proteins in transduced mammalian cells as demonstrated by production of the following three recombinant proteins: firefly luciferase, beta-galactosidase, and green fluorescent protein (GFP). Higher concentrations of the stress-producing substances damage the cells beyond recovery, resulting in inhibited gene expression and cell death. We also evaluated the effect of the stressor substances on the enhanced infectivity of virus. The presented findings extend methods for large-scale transient recombinant protein production in mammalian cells and suggest that it may be possible to reduce the cytotoxicity of the adenovirus by reducing the virus titer without adversely affecting gene expression levels.	[Rasooly, Reuven; Hernlem, Bradley] ARS, USDA, Albany, CA USA; [Friedman, Mendel] ARS, Produce Safety Unit, USDA, Albany, CA USA; [Friedman, Mendel] ARS, Microbiol Res Unit, USDA, Albany, CA USA	United States Department of Agriculture (USDA); United States Department of Agriculture (USDA); United States Department of Agriculture (USDA)	Rasooly, R (corresponding author), ARS, USDA, Albany, CA USA.	reuven.rasooly@ars.usda.gov		Friedman, Mendel/0000-0003-2582-7517				Cohen CJ, 2001, P NATL ACAD SCI USA, V98, P15191, DOI 10.1073/pnas.261452898; Cousin M. A., 2005, Foodborne pathogens: microbiology and molecular biology, P163; El Golli-Bennour E, 2010, J BIOCHEM MOL TOXIC, V24, P42, DOI 10.1002/jbt.20310; Friedman M, 2011, J FOOD SCI, V76, pM558, DOI 10.1111/j.1750-3841.2011.02365.x; Goncalez E, 2003, ARQ I BIOL-SAO PAULO, V7, P139; Goodman JC, 1996, HUM GENE THER, V7, P1241, DOI 10.1089/hum.1996.7.10-1241; Guo YF, 2008, ACTA BIOCH BIOPH SIN, V40, P426, DOI 10.1111/j.1745-7270.2008.00418.x; Hammond B. G., 2008, FOOD SAFETY PROTEINS; Jubert C, 2009, CANCER PREV RES, V2, P1015, DOI 10.1158/1940-6207.CAPR-09-0099; Maheshwari S, 2011, GLOBAL PROTEIN THERA; Mendez-Albores A, 2005, FOOD CHEM TOXICOL, V43, P233, DOI 10.1016/j.fct.2004.09.009; Rasooly R, 2009, FEMS IMMUNOL MED MIC, V56, P172, DOI 10.1111/j.1574-695X.2009.00561.x; Rawal S, 2011, TOXICOL APPL PHARM, V254, P349, DOI 10.1016/j.taap.2011.05.010; Siissalo S, 2007, EUR J PHARM BIOPHARM, V67, P548, DOI 10.1016/j.ejpb.2007.03.017; Smith JG, 1997, HUM GENE THER, V8, P943, DOI 10.1089/hum.1997.8.8-943; Trask TW, 2000, MOL THER, V1, P195, DOI 10.1006/mthe.2000.0030	16	9	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2013	8	8							e71682	10.1371/journal.pone.0071682	http://dx.doi.org/10.1371/journal.pone.0071682			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	218XC	23940780	Green Published, Green Submitted, gold			2022-12-25	WOS:000324465000223
J	SanGiovanni, JP; Lee, PH				SanGiovanni, John Paul; Lee, Phil H.			AMD-Associated Genes Encoding Stress-Activated MAPK Pathway Constituents Are Identified by Interval-Based Enrichment Analysis	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; MACULAR DEGENERATION; PROTEIN-KINASES; THERAPEUTIC TARGETS; INDUCED RETINOPATHY; UNITED-STATES; JNK; POLYMORPHISMS; PATHOGENESIS; INHIBITION	Purpose: To determine whether common DNA sequence variants within groups of genes encoding elements of stress-activated mitogen-activated protein kinase (MAPK) signaling pathways are, in aggregate, associated with advanced AMD (AAMD). Methods: We used meta-regression and exact testing methods to identify AAMD-associated SNPs in 1177 people with AAMD and 1024 AMD-free elderly peers from 3 large-scale genotyping projects on the molecular genetics of AMD. SNPs spanning independent AAMD-associated genomic intervals were examined with a multi-locus-testing method (INRICH) for enrichment within five sets of genes encoding constituents of stress-activated MAPK signaling cascades. Results: Four-of-five pathway gene sets showed enrichment with AAMD-associated SNPs; findings persisted after adjustment for multiple testing in two. Strongest enrichment signals (P = 0.006) existed in a c-Jun N-terminal kinase (JNK)/MAPK cascade (Science Signaling, STKE CMP_10827). In this pathway, seven independent AAMD-associated regions were resident in 6 of 25 genes examined. These included sequence variants in: 1) three MAP kinase kinase kinases (MAP3K4, MAP3K5, MAP3K9) that phosphorylate and activate the MAP kinase kinases MAP2K4 and MAP2K7 (molecules that phosphorylate threonine and tyrosine residues within the activation loop of JNK); 2) a target of MAP2K7 (JNK3A1) that activates complexes involved in transcriptional regulation of stress related genes influencing cell proliferation, apoptosis, motility, metabolism and DNA repair; and 3) NR2C2, a transcription factor activated by JNK1A1 (a drugable molecule influencing retinal cell viability in model systems). We also observed AAMD-related sequence variants resident in genes encoding PPP3CA (a drugable molecule that inactivates MAP3K5), and two genes (TGFB2, TGFBR2) encoding factors involved in MAPK sensing of growth factors/cytokines. Conclusions: Linkage disequilibrium (LD)-independent genomic enrichment analysis yielded associations of AAMD with aggregates of functionally related genes encoding constituents of the JNK MAPK signaling pathway. FDA-approved drugs now exist to target constituents of stress-activated MAPK pathways and may offer reasonable approaches to preventing or treating AAMD.	[SanGiovanni, John Paul] NEI, Clin Trials Branch, NIH, Bethesda, MD 20892 USA; [Lee, Phil H.] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Analyt & Translat Genet Unit,Ctr Human Genet Res, Boston, MA USA	National Institutes of Health (NIH) - USA; NIH National Eye Institute (NEI); Harvard University; Harvard Medical School; Massachusetts General Hospital	SanGiovanni, JP (corresponding author), NEI, Clin Trials Branch, NIH, Bethesda, MD 20892 USA.	jpsangio@post.harvard.edu	SanGiovanni, John Paul/AAU-3895-2020		National Eye Institute	National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	Funding for NEI-AMD was provided by the National Eye Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Access Economics prepared for AMD Alliance International, 2010, GLOB EC COST VIS IMP; Aiello L P, 1997, Curr Opin Ophthalmol, V8, P19; Almeida LN, 2012, GRAEF ARCH CLIN EXP, V250, P185, DOI 10.1007/s00417-011-1807-5; Ambati J, 2003, SURV OPHTHALMOL, V48, P257, DOI 10.1016/S0039-6257(03)00030-4; Bird AC, 2010, J CLIN INVEST, V120, P3033, DOI 10.1172/JCI42437; Bogatcheva NV, 2003, J INVEST MED, V51, P341, DOI 10.1136/jim-51-06-30; Bromberg-White JL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006956; Cao GF, 2012, MOL MED REP, V5, P54, DOI 10.3892/mmr.2011.582; Chiu CJ, 2011, INVEST OPHTH VIS SCI, V52, P9099, DOI 10.1167/iovs.11-7782; Churchill AJ, 2006, HUM MOL GENET, V15, P2955, DOI 10.1093/hmg/ddl238; Congdon N, 2004, ARCH OPHTHALMOL-CHIC, V122, P477; Du HJ, 2013, P NATL ACAD SCI USA, V110, P2377, DOI 10.1073/pnas.1221729110; Duesbery NS, 1998, SCIENCE, V280, P734, DOI 10.1126/science.280.5364.734; Friedman DS, 2004, ARCH OPHTHALMOL-CHIC, V122, P532; Fritsche LG, 2013, NAT GENET, V45, P433, DOI 10.1038/ng.2578; Galan A, 2010, OPHTHALMOLOGY, V117, P1769, DOI 10.1016/j.ophtha.2010.01.030; Guma M, 2009, P NATL ACAD SCI USA, V106, P8760, DOI 10.1073/pnas.0902659106; Hageman G.S., 2008, WEBVISION ORG RETINA; Holmans P, 2010, ADV GENET, V72, P141, DOI [10.1016/S0065-2660(10)72007-1, 10.1016/B978-0-12-380862-2.00007-2]; Holmans P, 2009, AM J HUM GENET, V85, P13, DOI 10.1016/j.ajhg.2009.05.011; Johnson GL, 2002, SCIENCE, V298, P1911, DOI 10.1126/science.1072682; Kumar S, 2003, NAT REV DRUG DISCOV, V2, P717, DOI 10.1038/nrd1177; Lee PH, 2012, BIOINFORMATICS, V28, P1797, DOI 10.1093/bioinformatics/bts191; Lu Ming, 2002, Ophthalmol Clin North Am, V15, P69, DOI 10.1016/S0896-1549(01)00010-4; Pages G, 2000, J BIOL CHEM, V275, P26484, DOI 10.1074/jbc.M002104200; Pons M, 2011, AM J PATHOL, V178, P2665, DOI 10.1016/j.ajpath.2011.02.006; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Purcell SM, 2009, NATURE, V460, P748, DOI 10.1038/nature08185; SanGiovanni JP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053155; SanGiovanni JP, 2009, INVEST OPHTH VIS SCI, V50, P3096; SMITH LEH, 1994, INVEST OPHTH VIS SCI, V35, P101; Smith LEH, 2002, ACTA PAEDIATR, V91, P26, DOI 10.1080/08035250260095771; Smoller JW, 2013, LANCET, V381, P1371, DOI 10.1016/S0140-6736(12)62129-1; Ward LD, 2012, NAT BIOTECHNOL, V30, P1095, DOI 10.1038/nbt.2422; Weng CY, 2009, CURR EYE RES, V34, P867, DOI 10.3109/02713680903177890; Xu J, 2011, FASEB J, V25, P2221, DOI 10.1096/fj.10-178350; Yang JA, 2010, NAT GENET, V42, P565, DOI 10.1038/ng.608	37	15	15	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2013	8	8							e71239	10.1371/journal.pone.0071239	http://dx.doi.org/10.1371/journal.pone.0071239			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	218XC	23940728	gold, Green Published, Green Submitted			2022-12-25	WOS:000324465000199
J	Soufflet-Freslon, V; Jourdan, M; Clotault, J; Huet, S; Briard, M; Peltier, D; Geoffriau, E				Soufflet-Freslon, Vanessa; Jourdan, Matthieu; Clotault, Jeremy; Huet, Sebastien; Briard, Mathilde; Peltier, Didier; Geoffriau, Emmanuel			Functional Gene Polymorphism to Reveal Species History: The Case of the CRTISO Gene in Cultivated Carrots	PLOS ONE			English	Article							CAROTENOID BIOSYNTHESIS PATHWAY; LINKAGE DISEQUILIBRIUM; DAUCUS-CAROTA; NUCLEOTIDE POLYMORPHISM; MOLECULAR EVOLUTION; PATTERNS; DOMESTICATION; DIVERSITY; SOFTWARE; ASSOCIATION	Background: Carrot is a vegetable cultivated worldwide for the consumption of its root. Historical data indicate that root colour has been differentially selected over time and according to geographical areas. Root pigmentation depends on the relative proportion of different carotenoids for the white, yellow, orange and red types but only internally for the purple one. The genetic control for root carotenoid content might be partially associated with carotenoid biosynthetic genes. Carotenoid isomerase (CRTISO) has emerged as a regulatory step in the carotenoid biosynthesis pathway and could be a good candidate to show how a metabolic pathway gene reflects a species genetic history. Methodology/Principal Findings: In this study, the nucleotide polymorphism and the linkage disequilibrium among the complete CRTISO sequence, and the deviation from neutral expectation were analysed by considering population subdivision revealed with 17 microsatellite markers. A sample of 39 accessions, which represented different geographical origins and root colours, was used. Cultivated carrot was divided into two genetic groups: one from Middle East and Asia (Eastern group), and another one mainly from Europe (Western group). The Western and Eastern genetic groups were suggested to be differentially affected by selection: a signature of balancing selection was detected within the first group whereas the second one showed no selection. A focus on orange-rooted carrots revealed that cultivars cultivated in Asia were mainly assigned to the Western group but showed CRTISO haplotypes common to Eastern carrots. Conclusion: The carotenoid pathway CRTISO gene data proved to be complementary to neutral markers in order to bring critical insight in the cultivated carrot history. We confirmed the occurrence of two migration events since domestication. Our results showed a European background in material from Japan and Central Asia. While confirming the introduction of European carrots in Japanese resources, the history of Central Asia material remains unclear.	[Soufflet-Freslon, Vanessa; Jourdan, Matthieu; Clotault, Jeremy; Huet, Sebastien; Briard, Mathilde; Peltier, Didier; Geoffriau, Emmanuel] Agrocampus Ouest, Inst Rech Hort & Semences, QUASAV SFR4207, UMR1345, Angers, France; [Soufflet-Freslon, Vanessa; Jourdan, Matthieu; Clotault, Jeremy; Huet, Sebastien; Briard, Mathilde; Peltier, Didier; Geoffriau, Emmanuel] Univ Angers, Inst Rech Hort & Semences, QUASAV SFR4207, UMR1345, Angers, France; [Soufflet-Freslon, Vanessa; Jourdan, Matthieu; Clotault, Jeremy; Huet, Sebastien; Briard, Mathilde; Peltier, Didier; Geoffriau, Emmanuel] INRA, Inst Rech Hort & Semences, QUASAV SFR4207, UMR1345, Beaucouze, France	Institut Agro; Agrocampus Ouest; Universite d'Angers; Universite d'Angers; INRAE	Geoffriau, E (corresponding author), Agrocampus Ouest, Inst Rech Hort & Semences, QUASAV SFR4207, UMR1345, Angers, France.	emmanuel.geoffriau@agrocampus-ouest.fr	martel, celine/O-6651-2016	martel, celine/0000-0002-1800-4558; Clotault, Jeremy/0000-0002-7678-1929	French Ministry of Research; French Ministry of Agriculture (DGER); Ministry of Agriculture (DGER); Ministry of Research	French Ministry of Research(Ministry of Research, FranceEuropean Commission); French Ministry of Agriculture (DGER); Ministry of Agriculture (DGER); Ministry of Research(Ministry of Research and Technology of the Republic of Indonesia (RISTEK))	This study was supported by grants from the French Ministry of Research and the French Ministry of Agriculture (DGER). Vanessa Soufflet-Freslon was a post-doctoral researcher funded by the Ministry of Agriculture (DGER). Matthieu Jourdan is a PhD student funded by the Ministry of Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; BANGA O., 1963, Genetica Agraria, V17, P357; Baranski R, 2012, GENET RESOUR CROP EV, V59, P163, DOI 10.1007/s10722-011-9777-3; BARTLEY GE, 1995, PLANT CELL, V7, P1027, DOI 10.1105/tpc.7.7.1027; Belkhir K., 1996, 5171 CNRS UMR; Bradbury PJ, 2007, BIOINFORMATICS, V23, P2633, DOI 10.1093/bioinformatics/btm308; Briard M, 2000, PLANT MOL BIOL REP, V18, P235, DOI 10.1007/BF02823994; Caicedo AL, 2007, PLOS GENET, V3, P1745, DOI 10.1371/journal.pgen.0030163; Camus-Kulandaivelu L, 2008, GENETICS, V180, P1107, DOI 10.1534/genetics.108.088849; Cavagnaro PF, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-386; Chai CL, 2011, PLANT MOL BIOL, V75, P211, DOI 10.1007/s11103-010-9719-z; Charlesworth D, 2006, PLOS GENET, V2, P379, DOI 10.1371/journal.pgen.0020064; Clotault J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038724; Clotault J, 2012, MOL BIOL EVOL, V29, P1199, DOI 10.1093/molbev/msr287; Clotault J, 2010, THEOR APPL GENET, V121, P659, DOI 10.1007/s00122-010-1338-1; Cunningham FX, 1998, ANNU REV PLANT PHYS, V49, P557, DOI 10.1146/annurev.arplant.49.1.557; De Mita S, 2012, BMC GENET, V13, DOI 10.1186/1471-2156-13-27; Drummond AJ, 2011, GEN V5 1; Dutheil J, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-188; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Eyre-Walker A, 1998, P NATL ACAD SCI USA, V95, P4441, DOI 10.1073/pnas.95.8.4441; Falush D, 2003, GENETICS, V164, P1567; Fang J, 2008, PLANT J, V54, P177, DOI 10.1111/j.1365-313X.2008.03411.x; Flint-Garcia SA, 2003, ANNU REV PLANT BIOL, V54, P357, DOI 10.1146/annurev.arplant.54.031902.134907; Fu ZY, 2010, THEOR APPL GENET, V120, P709, DOI 10.1007/s00122-009-1188-x; Galpaz N, 2006, PLANT CELL, V18, P1947, DOI 10.1105/tpc.105.039966; Goudet J, 1995, J HERED, V86, P485, DOI 10.1093/oxfordjournals.jhered.a111627; Gupta PK, 2005, PLANT MOL BIOL, V57, P461, DOI 10.1007/s11103-005-0257-z; Hannoufa A, 2012, BIOCATAL AGR BIOTECH, V1, P198, DOI 10.1016/j.bcab.2012.03.004; Hirschberg J, 2001, CURR OPIN PLANT BIOL, V4, P210, DOI 10.1016/S1369-5266(00)00163-1; Hudson R.R., 1990, Oxford Surveys in Evolutionary Biology, V7, P1; Hudson RR, 2002, BIOINFORMATICS, V18, P337, DOI 10.1093/bioinformatics/18.2.337; Ingvarsson PK, 2008, GENETICS, V180, P329, DOI 10.1534/genetics.108.090431; Iorizzo M, 2013, AM J BOT, V100, P930, DOI 10.3732/ajb.1300055; Isaacson T, 2004, PLANT PHYSIOL, V136, P4246, DOI 10.1104/pp.104.052092; Isaacson T, 2002, PLANT CELL, V14, P333, DOI 10.1105/tpc.010303; Just BJ, 2007, THEOR APPL GENET, V114, P693, DOI 10.1007/s00122-006-0469-x; Just BJ, 2009, THEOR APPL GENET, V119, P1155, DOI 10.1007/s00122-009-1117-z; Laufer B, 1919, SINO IRANICA CHINESE, P451; Li QR, 2010, TRANSGENIC RES, V19, P1053, DOI 10.1007/s11248-010-9381-x; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Maass D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006373; MACKEVIC VI, 1929, B APPL BOT GENET PL, V20, P517; Nei M, 1987, MOL EVOLUTIONARY GEN; Park H, 2002, PLANT CELL, V14, P321, DOI 10.1105/tpc.010302; Remington DL, 2001, P NATL ACAD SCI USA, V98, P11479, DOI 10.1073/pnas.201394398; Shinohara S, 1984, VEGETABLE SEED PRODU, P273; Smith AV, 2005, GENOME RES, V15, P1519, DOI 10.1101/gr.4421405; STEIN M, 1995, PLANT BREEDING, V114, P1, DOI 10.1111/j.1439-0523.1995.tb00750.x; Stenzel A, 2004, HUM GENET, V114, P377, DOI 10.1007/s00439-003-1075-5; Surles RL, 2004, J AGR FOOD CHEM, V52, P3417, DOI 10.1021/jf035472m; TAJIMA F, 1989, GENETICS, V123, P585; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; WATTERSON GA, 1975, THEOR POPUL BIOL, V7, P256, DOI 10.1016/0040-5809(75)90020-9; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI [10.2307/2408641, 10.1111/j.1558-5646.1984.tb05657.x]; Wright SI, 2005, SCIENCE, V308, P1310, DOI 10.1126/science.1107891; Xing Y, 2007, BMC PLANT BIOL, V7, DOI 10.1186/1471-2229-7-43; Zhu QH, 2007, MOL BIOL EVOL, V24, P875, DOI 10.1093/molbev/msm005	58	13	13	0	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2013	8	8							e70801	10.1371/journal.pone.0070801	http://dx.doi.org/10.1371/journal.pone.0070801			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	218XC	23940644	gold, Green Published, Green Submitted			2022-12-25	WOS:000324465000136
J	Tulsyan, S; Agarwal, G; Lal, P; Agrawal, S; Mittal, RD; Mittal, B				Tulsyan, Sonam; Agarwal, Gaurav; Lal, Punita; Agrawal, Sushma; Mittal, Rama Devi; Mittal, Balraj			CD44 Gene Polymorphisms in Breast Cancer Risk and Prognosis: A Study in North Indian Population	PLOS ONE			English	Article							TUMOR PROGRESSION; STEM-CELLS; ACTIVATION; HYALURONAN; EXPRESSION; SNP; ASSOCIATION; LYMPHOCYTES; PREVALENCE; MUTATIONS	Background: Cell surface biomarker CD44 plays an important role in breast cancer cell growth, differentiation, invasion, angiogenesis and tumour metastasis. Therefore, we aimed to investigate the role of CD44 gene polymorphisms in breast cancer risk and prognosis in North Indian population. Materials & Methods: A total of 258 breast cancer patients and 241 healthy controls were included in the case-control study for risk prediction. According to RECIST, 114 patients who received neo-adjuvant chemotherapy were recruited for the evaluation of breast cancer prognosis. We examined the association of tagging SNP (rs353639) of Hapmap Gujrati Indians in Houston (GIH population) in CD44 gene along with a significant reported SNP (rs13347) in Chinese population by genotyping using Taqman allelic discrimination assays. Statistical analysis was done using SPSS software, version 17. In-silico analysis for prediction of functional effects was done using F-SNP and FAST-SNP. Results: No significant association of both the genetic variants of the CD44 gene polymorphisms was found with breast cancer risk. On performing univariate analysis with clinicopathological characteristics and treatment response, we found significant association of genotype (CT+TT) of rs13347 polymorphism with earlier age of onset (P = 0.029, OR = 0.037). However, significance was lost in multivariate analysis. For rs353639 polymorphism, significant association was seen with clinical tumour size, both at the genotypic (AC+CC) (P = 0.039, OR = 3.02) as well as the allelic (C) (P = 0.042, OR = 2.87) levels. On performing multivariate analysis, increased significance of variant genotype (P = 0.017, OR = 4.29) and allele (P = 0.025, OR = 3.34) of rs353639 was found with clinical tumour size. In-silico analysis using F-SNP, showed altered transcriptional regulation for rs353639 polymorphism. Conclusions: These findings suggest that CD44 rs353639 genetic variants may have significant effect in breast cancer prognosis. However, both the polymorphisms-rs13347 and rs353639 had no effect on breast cancer susceptibility.	[Tulsyan, Sonam; Mittal, Balraj] Sanjay Gandhi Postgrad Inst Med Sci, Dept Genet, Lucknow, Uttar Pradesh, India; [Agarwal, Gaurav] Sanjay Gandhi Postgrad Inst Med Sci, Dept Endocrine & Breast Surg, Lucknow, Uttar Pradesh, India; [Lal, Punita; Agrawal, Sushma] Sanjay Gandhi Postgrad Inst Med Sci, Dept Radiotherapy, Lucknow, Uttar Pradesh, India; [Mittal, Rama Devi] Sanjay Gandhi Postgrad Inst Med Sci, Dept Urol, Lucknow, Uttar Pradesh, India	Sanjay Gandhi Postgraduate Institute of Medical Sciences; Sanjay Gandhi Postgraduate Institute of Medical Sciences; Sanjay Gandhi Postgraduate Institute of Medical Sciences; Sanjay Gandhi Postgraduate Institute of Medical Sciences	Mittal, B (corresponding author), Sanjay Gandhi Postgrad Inst Med Sci, Dept Genet, Lucknow, Uttar Pradesh, India.	bml_pgi@yahoo.com	Agarwal, Gaurav/K-2998-2013; agrawal, sushma/AAG-3937-2020	Agarwal, Gaurav/0000-0003-4194-2670; agrawal, sushma/0000-0002-7260-6509	Indian Council of Medical Research [BMS/NTF/1/2010-2-11]; Department of Science and Technology [SSD/SS/005/2009]	Indian Council of Medical Research(Indian Council of Medical Research (ICMR)); Department of Science and Technology(Department of Science & Technology (India))	This study was supported by grants from Indian Council of Medical Research (BMS/NTF/1/2010-2-11) and Department of Science and Technology (SSD/SS/005/2009). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Bankfalvi A, 1998, HISTOPATHOLOGY, V33, P107, DOI 10.1046/j.1365-2559.1998.00472.x; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Bourguignon Lilly Y. W., 1998, Frontiers in Bioscience, V3, pD637; Bourguignon LYW, 2003, J BIOL CHEM, V278, P29420, DOI 10.1074/jbc.M301885200; Bourguignon LYW, 2001, J MAMMARY GLAND BIOL, V6, P287, DOI 10.1023/A:1011371523994; Chen DW, 2001, J IMMUNOL, V166, P5889, DOI 10.4049/jimmunol.166.10.5889; Edge SB, 2010, ANN SURG ONCOL, V17, P1471, DOI 10.1245/s10434-010-0985-4; Gauderman WJ, 2006, QUANTO 1 1 COMPUTER; GOODFELLOW PN, 1982, EUR J IMMUNOL, V12, P659, DOI 10.1002/eji.1830120807; Gotte M, 2006, CANCER RES, V66, P10233, DOI 10.1158/0008-5472.CAN-06-1464; He-rui Y, 2009, CHINESE ARCH GEN SUR; Hill A, 2006, CANCER LETT, V237, P1, DOI 10.1016/j.canlet.2005.05.006; Hortobagyi Gabriel N, 2005, Clin Breast Cancer, V6, P391, DOI 10.3816/CBC.2005.n.043; Jiang L, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3225; Lee PH, 2008, NUCLEIC ACIDS RES, V36, pD820, DOI 10.1093/nar/gkm904; Lobo NA, 2007, ANNU REV CELL DEV BI, V23, P675, DOI 10.1146/annurev.cellbio.22.010305.104154; Lopez JI, 2005, CANCER RES, V65, P6755, DOI 10.1158/0008-5472.CAN-05-0863; Marhaba R, 2004, J MOL HISTOL, V35, P211; McKallip RJ, 2005, INFECT IMMUN, V73, P50, DOI 10.1128/IAI.73.1.50-61.2005; McKallip RJ, 2003, J BIOL CHEM, V278, P43818, DOI 10.1074/jbc.M304467200; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; O'Donnell CJ, 2007, BMC MED GENET, V8, DOI 10.1186/1471-2350-8-S1-S4; Peto J, 1999, J NATL CANCER I, V91, P943, DOI 10.1093/jnci/91.11.943; Ponder BAJ, 2000, BRIT J CANCER, V83, P1301; Rafi A, 1997, BLOOD, V89, P2901, DOI 10.1182/blood.V89.8.2901; Sales KM, 2007, STEM CELL REV, V3, P249, DOI 10.1007/s12015-007-9002-0; SCREATON GR, 1992, P NATL ACAD SCI USA, V89, P12160, DOI 10.1073/pnas.89.24.12160; SETH A, 1991, P NATL ACAD SCI USA, V88, P7877, DOI 10.1073/pnas.88.17.7877; So JY, 2011, MOL PHARMACOL, V79, P360, DOI 10.1124/mol.110.068403; Telen MJ, 1996, J BIOL CHEM, V271, P7147, DOI 10.1074/jbc.271.12.7147; Therasse P, 2000, J NATL CANCER I, V92, P205, DOI 10.1093/jnci/92.3.205; Vazquez A, 2010, CANCER RES, V70, P172, DOI 10.1158/0008-5472.CAN-09-2218; Winder T, 2011, INT J CANCER, V129, P1096, DOI 10.1002/ijc.25787; Xin Z, 2012, J JILIN U MED EDITIO, V38, P110; Yuan HY, 2006, NUCLEIC ACIDS RES, V34, pW635, DOI 10.1093/nar/gkl236; Zhou JH, 2011, EUR J CANCER PREV, V20, P396, DOI 10.1097/CEJ.0b013e3283463943; Zhou JH, 2010, ANTICANCER RES, V30, P1263	38	23	24	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2013	8	8							e71073	10.1371/journal.pone.0071073	http://dx.doi.org/10.1371/journal.pone.0071073			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	218XC	23940692	Green Published, gold, Green Submitted			2022-12-25	WOS:000324465000175
J	Wang, YF; Wu, XY; Li, Q; Zhang, SR; Li, SJ				Wang, Yifan; Wu, Xingye; Li, Qiang; Zhang, Shangrong; Li, Shu Jie			Human Voltage-Gated Proton Channel Hv1: A New Potential Biomarker for Diagnosis and Prognosis of Colorectal Cancer	PLOS ONE			English	Article							ALVEOLAR EPITHELIAL-CELLS; CARBOXYL-TERMINAL DOMAIN; NADPH OXIDASE; HUMAN-NEUTROPHILS; INTRACELLULAR PH; PUMP INHIBITORS; BREAST-CANCER; TUMORS; GROWTH; METASTASIS	Solid tumors exist in a hypoxic microenvironment, and possess high-glycolytic metabolites. To avoid the acidosis, tumor cells must exhibit a dynamic cytosolic pH regulation mechanism(s). The voltage-gated proton channel Hv1 mediates NADPH oxidase function by compensating cellular loss of electrons with protons. Here, we showed for the first time, that Hv1 expression is increased in colorectal tumor tissues and cell lines, associated with poor prognosis. Immunohistochemistry showed that Hv1 is strongly expressed in adenocarcinomas but not or lowly expressed in normal colorectal or hyperplastic polyps. Hv1 expression in colorectal cancer is significantly associated with the tumor size, tumor classification, lymph node status, clinical stage and p53 status. High Hv1 expression is associated significantly with shorter overall and recurrence-free survival. Furthermore, real-time RT-PCR and immunocytochemistry showed that Hv1 is highly expressed in colorectal cancer cell lines, SW620, HT29, LS174T and Colo205, but not in SW480. Inhibitions of Hv1 expression and activity in the highly metastatic SW620 cells by small interfering RNA (siRNA) and Zn2+ respectively, markedly decrease the cell invasion and migration, restraint proton extrusion and the intracellular pH recovery. Our results suggest that Hv1 may be used as a potential biomarker for diagnosis and prognosis of colorectal carcinoma, and a potential target for anticancer drugs in colorectal cancer therapy.	[Wang, Yifan; Li, Qiang; Zhang, Shangrong; Li, Shu Jie] Nankai Univ, Dept Biophys, Tianjin 300071, Peoples R China; [Wang, Yifan; Wu, Xingye; Li, Qiang; Zhang, Shangrong; Li, Shu Jie] Tonghua Ctr Hosp, Dept Pathol, Tonghua, Peoples R China	Nankai University	Li, SJ (corresponding author), Nankai Univ, Dept Biophys, Tianjin 300071, Peoples R China.	shujieli@nankai.edu.cn			National Natural Science Foundation of China [31271464]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by National Natural Science Foundation of China (31271464). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cardone RA, 2005, NAT REV CANCER, V5, P786, DOI 10.1038/nrc1713; Cherny VV, 1999, J GEN PHYSIOL, V114, P819, DOI 10.1085/jgp.114.6.819; CHERNY VV, 1995, J GEN PHYSIOL, V105, P861, DOI 10.1085/jgp.105.6.861; Chiche J, 2009, CANCER RES, V69, P358, DOI 10.1158/0008-5472.CAN-08-2470; CLARK RA, 1987, J BIOL CHEM, V262, P4065; De Milito A, 2007, CANCER RES, V67, P5408, DOI 10.1158/0008-5472.CAN-06-4095; De Milito A, 2010, INT J CANCER, V127, P207, DOI 10.1002/ijc.25009; DECOURSEY TE, 1994, J MEMBRANE BIOL, V141, P203; DeCoursey TE, 2006, PHYSIOL REV, V83, P475; Fais S, 2010, J INTERN MED, V267, P515, DOI 10.1111/j.1365-2796.2010.02225.x; Fais S, 2007, CANCER RES, V67, P10627, DOI 10.1158/0008-5472.CAN-07-1805; Gatenby RA, 2003, CANCER RES, V63, P3847; GILLIES RJ, 1994, AM J PHYSIOL, V267, pC195, DOI 10.1152/ajpcell.1994.267.1.C195; GILLIES RJ, 1991, J BIOL CHEM, V266, P1551; GOTTLIEB RA, 1995, P NATL ACAD SCI USA, V92, P5965, DOI 10.1073/pnas.92.13.5965; GRIFFITHS JR, 1991, BRIT J CANCER, V64, P425, DOI 10.1038/bjc.1991.326; HENDERSON LM, 1987, BIOCHEM J, V246, P325, DOI 10.1042/bj2460325; Huber V, 2010, J TRANSL MED, V8, DOI 10.1186/1479-5876-8-57; Iovannisci D, 2010, J GEN PHYSIOL, V136, P35, DOI 10.1085/jgp.200910379; Koch HP, 2008, P NATL ACAD SCI USA, V105, P9111, DOI 10.1073/pnas.0801553105; Lee SY, 2008, P NATL ACAD SCI USA, V105, P7692, DOI 10.1073/pnas.0803277105; Li SJ, 2010, J BIOL CHEM, V285, P12047, DOI 10.1074/jbc.M109.040360; Li SJ, 2009, ACTA CRYSTALLOGR F, V65, P279, DOI 10.1107/S1744309109003777; Long SB, 2005, SCIENCE, V309, P897, DOI 10.1126/science.1116269; Lu YD, 2005, CANCER RES, V65, P6843, DOI 10.1158/0008-5472.CAN-04-3822; Luciani F, 2004, JNCI-J NATL CANCER I, V96, P1702, DOI 10.1093/jnci/djh305; Morgan D, 2005, J PHYSIOL-LONDON, V569, P419, DOI 10.1113/jphysiol.2005.094748; Neri D, 2011, NAT REV DRUG DISCOV, V10, P767, DOI 10.1038/nrd3554; Nilsson Cathrine, 2003, Methods Cell Sci, V25, P185; Parks SK, 2011, J CELL PHYSIOL, V226, P299, DOI 10.1002/jcp.22400; POUYSSEGUR J, 1984, P NATL ACAD SCI-BIOL, V81, P4833, DOI 10.1073/pnas.81.15.4833; RACKER E, 1972, AM SCI, V60, P56; Raghunand N, 1999, BIOCHEM PHARMACOL, V57, P1047, DOI 10.1016/S0006-2952(99)00021-0; Ramsey IS, 2006, NATURE, V440, P1213, DOI 10.1038/nature04700; Sasaki M, 2006, SCIENCE, V312, P589, DOI 10.1126/science.1122352; Tombola F, 2008, NEURON, V58, P546, DOI 10.1016/j.neuron.2008.03.026; Wang YF, 2012, J BIOL CHEM, V287, P13877, DOI 10.1074/jbc.M112.345280; Wang YF, 2011, BIOCHEM BIOPH RES CO, V412, P353, DOI 10.1016/j.bbrc.2011.07.102	38	15	15	2	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2013	8	8							e70550	10.1371/journal.pone.0070550	http://dx.doi.org/10.1371/journal.pone.0070550			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	218XC	23940591	Green Published, gold, Green Submitted			2022-12-25	WOS:000324465000085
J	Ruzanski, C; Smirnova, J; Rejzek, M; Cockburn, D; Pedersen, HL; Pike, M; Willats, WGT; Svensson, B; Steup, M; Ebenhoh, O; Smith, AM; Field, RA				Ruzanski, Christian; Smirnova, Julia; Rejzek, Martin; Cockburn, Darrell; Pedersen, Henriette L.; Pike, Marilyn; Willats, William G. T.; Svensson, Birte; Steup, Martin; Ebenhoeh, Oliver; Smith, Alison M.; Field, Robert A.			A Bacterial Glucanotransferase Can Replace the Complex Maltose Metabolism Required for Starch to Sucrose Conversion in Leaves at Night	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Carbohydrate Metabolism; Computer Modeling; Metabolic Regulation; Oligosaccharide; Plant Biochemistry; Glucanotransferase; Leaf Cell; Maltose Metabolism; Starch Degradation	CYTOSOLIC HETEROGLYCANS; DISPROPORTIONATING ENZYME; ESCHERICHIA-COLI; ARABIDOPSIS; PHOSPHORYLASE; AMYLOMALTASE; DEGRADATION; IDENTIFICATION; RELOCATION; EVOLUTION	Controlled conversion of leaf starch to sucrose at night is essential for the normal growth of Arabidopsis. The conversion involves the cytosolic metabolism of maltose to hexose phosphates via an unusual, multidomain protein with 4-glucanotransferase activity, DPE2, believed to transfer glucosyl moieties to a complex heteroglycan prior to their conversion to hexose phosphate via a cytosolic phosphorylase. The significance of this complex pathway is unclear; conversion of maltose to hexose phosphate in bacteria proceeds via a more typical 4-glucanotransferase that does not require a heteroglycan acceptor. It has recently been suggested that DPE2 generates a heterogeneous series of terminal glucan chains on the heteroglycan that acts as a glucosyl buffer to ensure a constant rate of sucrose synthesis in the leaf at night. Alternatively, DPE2 and/or the heteroglycan may have specific properties important for their function in the plant. To distinguish between these ideas, we compared the properties of DPE2 with those of the Escherichia coli glucanotransferase MalQ. We found that MalQ cannot use the plant heteroglycan as an acceptor for glucosyl transfer. However, experimental and modeling approaches suggested that it can potentially generate a glucosyl buffer between maltose and hexose phosphate because, unlike DPE2, it can generate polydisperse malto-oligosaccharides from maltose. Consistent with this suggestion, MalQ is capable of restoring an essentially wild-type phenotype when expressed in mutant Arabidopsis plants lacking DPE2. In light of these findings, we discuss the possible evolutionary origins of the complex DPE2-heteroglycan pathway.	[Ruzanski, Christian; Rejzek, Martin; Pike, Marilyn; Smith, Alison M.; Field, Robert A.] John Innes Ctr Plant Sci Res, Norwich NR4 7UH, Norfolk, England; [Smirnova, Julia; Steup, Martin] Univ Potsdam, Inst Biochem & Biol, D-14476 Potsdam, Germany; [Cockburn, Darrell; Svensson, Birte] Tech Univ Denmark, Dept Syst Biol, DK-2800 Lyngby, Denmark; [Pedersen, Henriette L.; Willats, William G. T.] Univ Copenhagen, Dept Plant Biol & Biotechnol, DK-1871 Frederiksberg C, Denmark; [Ebenhoeh, Oliver] Univ Aberdeen, Inst Complex Syst & Math Biol, Aberdeen AB24 3UE, Scotland	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); John Innes Center; University of Potsdam; Technical University of Denmark; University of Copenhagen; University of Aberdeen	Smith, AM (corresponding author), John Innes Ctr Plant Sci Res, Dept Metab Biol, Norwich Res Pk, Norwich NR4 7UH, Norfolk, England.	alison.smith@jic.ac.uk	Cockburn, Darrell/F-6172-2011; Ebenhoeh, Oliver/C-8974-2011	Cockburn, Darrell/0000-0001-6791-6599; Ebenhoeh, Oliver/0000-0002-7229-7398; Willats, William/0000-0003-2064-4025; Svensson, Birte/0000-0002-2993-8196; Field, Rob/0000-0001-8574-0275	Biotechnology and Biological Sciences Research Council (UK) [BB/J004561/1]; John Innes Foundation; Deutsche Forschungsgemeinschaft [SFB 429]; instrument grant (Biacore T100); Danish Council for Independent Research, Natural Sciences; Danish Technical University; Danish Council for Independent Research, Technology and Production Sciences; Biotechnology and Biological Sciences Research Council [BBS/E/J/000C0618, BBS/E/J/00000020, BB/C507361/1] Funding Source: researchfish; BBSRC [BBS/E/J/000C0618] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council (UK)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); John Innes Foundation; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); instrument grant (Biacore T100); Danish Council for Independent Research, Natural Sciences(Det Frie Forskningsrad (DFF)); Danish Technical University; Danish Council for Independent Research, Technology and Production Sciences(Det Frie Forskningsrad (DFF)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	Work at the John Innes Centre was supported by Biotechnology and Biological Sciences Research Council (UK) Grant BB/J004561/1 and by the John Innes Foundation.; Supported by the Deutsche Forschungsgemeinschaft (SFB 429 Molecular Physiology, Energetics and Regulation of Primary Plant Metabolism, TPB2).; Supported by an instrument grant (Biacore T100) and a research grant from the Danish Council for Independent Research, Natural Sciences.; Recipient of an H. C. Orsted postdoctoral fellowship from Danish Technical University.; Supported by a research grant from the Danish Council for Independent Research, Technology and Production Sciences.	Alderwick LJ, 2005, J BIOL CHEM, V280, P32362, DOI 10.1074/jbc.M506339200; Arias Maria Cecilia, 2012, Mob Genet Elements, V2, P81; Ball S, 2011, J EXP BOT, V62, P1775, DOI 10.1093/jxb/erq411; Boos W, 1998, MICROBIOL MOL BIOL R, V62, P204, DOI 10.1128/MMBR.62.1.204-229.1998; Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663; Cheng HY, 1999, MOL CELL BIOL, V19, P8335; Chia T, 2004, PLANT J, V37, P853, DOI 10.1111/j.1365-313X.2003.02012.x; Ciucanu I, 2006, ANAL CHIM ACTA, V576, P147, DOI 10.1016/j.aca.2006.06.009; Critchley JH, 2001, PLANT J, V26, P89, DOI 10.1046/j.1365-313x.2001.01012.x; Deschamps P, 2008, TRENDS PLANT SCI, V13, P574, DOI 10.1016/j.tplants.2008.08.009; Deschamps P, 2008, MOL BIOL EVOL, V25, P536, DOI 10.1093/molbev/msm280; Deschamps P, 2008, GENETICS, V178, P2373, DOI 10.1534/genetics.108.087205; Dippel R, 2005, J BACTERIOL, V187, P8322, DOI 10.1128/JB.187.24.8322-8331.2005; Fettke J, 2006, PLANT J, V46, P668, DOI 10.1111/j.1365-313X.2006.02732.x; Fettke J, 2005, PLANT CELL PHYSIOL, V46, P1987, DOI 10.1093/pcp/pci214; Fettke J, 2005, PLANT J, V43, P568, DOI 10.1111/j.1365-313X.2005.02475.x; Fettke J, 2004, PLANT J, V39, P933, DOI 10.1111/j.1365-313X.2004.02181.x; Fettke J, 2008, PLANT PHYSIOL, V148, P1614, DOI 10.1104/pp.108.127969; Fettke J, 2009, J EXP BOT, V60, P2907, DOI 10.1093/jxb/erp054; Fettke J, 2009, PHYTOCHEMISTRY, V70, P696, DOI 10.1016/j.phytochem.2009.03.016; GILLESPIE DT, 1977, J PHYS CHEM-US, V81, P2340, DOI 10.1021/j100540a008; Kartal O, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.76; Lengsfeld C, 2009, J BACTERIOL, V191, P701, DOI 10.1128/JB.00767-08; Lloyd JR, 2004, PLANT PHYSIOL, V134, P1347, DOI 10.1104/pp.103.038026; Lu Y, 2004, PLANTA, V218, P466, DOI 10.1007/s00425-003-1127-z; Lu Y, 2006, PLANT PHYSIOL, V142, P878, DOI 10.1104/pp.106.086850; Malinova I, 2011, PLANT SIGNAL BEHAV, V6, P1060, DOI 10.4161/psb.6.7.15629; Malinova I, 2011, J PLANT PHYSIOL, V168, P1406, DOI 10.1016/j.jplph.2010.12.008; Mason JM, 2004, CHEMBIOCHEM, V5, P170, DOI 10.1002/cbic.200300781; Moller I, 2007, PLANT J, V50, P1118, DOI 10.1111/j.1365-313X.2007.03114.x; Oxley D., 2006, COLD SPRING HARB PRO, DOI 10.1101/pdb.prot4249; PALMER TN, 1976, EUR J BIOCHEM, V69, P105, DOI 10.1111/j.1432-1033.1976.tb10863.x; Park JT, 2011, J BACTERIOL, V193, P2517, DOI 10.1128/JB.01238-10; Pedersen HL, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.396598; Pereira S, 2009, FEMS MICROBIOL REV, V33, P917, DOI 10.1111/j.1574-6976.2009.00183.x; Schupp N, 2004, PLANT CELL PHYSIOL, V45, P1471, DOI 10.1093/pcp/pch170; Smith AM, 2006, NAT PROTOC, V1, P1342, DOI 10.1038/nprot.2006.232; Smith AM, 2012, STARCH-STARKE, V64, P421, DOI 10.1002/star.201100163; Sorensen I, 2011, METHODS MOL BIOL, V715, P115, DOI 10.1007/978-1-61779-008-9_8; Sorensen I, 2009, CARBOHYD RES, V344, P1872, DOI 10.1016/j.carres.2008.12.008; Steichen JM, 2008, J BIOL CHEM, V283, P20797, DOI 10.1074/jbc.M803051200; Zeeman SC, 2010, ANNU REV PLANT BIOL, V61, P209, DOI 10.1146/annurev-arplant-042809-112301	42	26	26	1	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 4	2013	288	40					28581	28598		10.1074/jbc.M113.497867	http://dx.doi.org/10.1074/jbc.M113.497867			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	298BL	23950181	Green Published, hybrid			2022-12-25	WOS:000330298800015
J	Johnson, BJ; Yukl, ET; Klema, VJ; Klinman, JP; Wilmot, CM				Johnson, Bryan J.; Yukl, Erik T.; Klema, Valerie J.; Klinman, Judith P.; Wilmot, Carrie M.			Structural Snapshots from the Oxidative Half-reaction of a Copper Amine Oxidase IMPLICATIONS FOR O-2 ACTIVATION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INTRAMOLECULAR ELECTRON-TRANSFER; ACTIVE-SITE COPPER; TOPA QUINONE; HANSENULA-POLYMORPHA; MOLECULAR-OXYGEN; SUBSTRATE-SPECIFICITY; CATALYTIC MECHANISM; GALACTOSE-OXIDASE; CRYSTAL-STRUCTURE; DIOXYGEN	The mechanism of molecular oxygen activation is the subject of controversy in the copper amine oxidase family. At their active sites, copper amine oxidases contain both a mononuclear copper ion and a protein-derived quinone cofactor. Proposals have been made for the activation of molecular oxygen via both a Cu(II)-aminoquinol catalytic intermediate and a Cu(I)-semiquinone intermediate. Using protein crystallographic freeze-trapping methods under low oxygen conditions combined with single-crystal microspectrophotometry, we have determined structures corresponding to the iminoquinone and semiquinone forms of the enzyme. Methylamine reduction at acidic or neutral pH has revealed protonated and deprotonated forms of the iminoquinone that are accompanied by a bound oxygen species that is likely hydrogen peroxide. However, methylamine reduction at pH 8.5 has revealed a copper-ligated cofactor proposed to be the semiquinone form. A copper-ligated orientation, be it the sole identity of the semiquinone or not, blocks the oxygen-binding site, suggesting that accessibility of Cu(I) may be the basis of partitioning O-2 activation between the aminoquinol and Cu(I).	Univ Minnesota, Dept Biochem Mol Biol & Biophys, Minneapolis, MN 55455 USA; [Klinman, Judith P.] Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA; [Klinman, Judith P.] Univ Calif Berkeley, Dept Mol & Cellular Biol, Berkeley, CA 94720 USA	University of Minnesota System; University of Minnesota Twin Cities; University of California System; University of California Berkeley; University of California System; University of California Berkeley	Wilmot, CM (corresponding author), Dept Biochem Mol Biol & Biophys, 6-155 Jackson Hall,321 Church St SE, Minneapolis, MN 55455 USA.	wilmo004@umn.edu		Yukl, Erik/0000-0001-6519-6938; Wilmot, Carrie/0000-0002-8706-0000	National Institutes of Health [GM008700, GM66569, GM25765]; Minnesota Medical Foundation [3714-9221-06]; United States Department of Energy, Office of Biological and Environmental Research [DE-AC02-06CH11357]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM025765, T32GM008700, R01GM066569, R37GM025765, R01GM039296] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Minnesota Medical Foundation; United States Department of Energy, Office of Biological and Environmental Research(United States Department of Energy (DOE)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Training Grant GM008700 (to B. J. J.) and Grants GM66569 (to C. M. W.) and GM25765 (to J. P. K.). This work was also supported by Minnesota Medical Foundation Grant 3714-9221-06 (to C. M. W.). Final X-ray diffraction data were collected at the Structural Biology Center of the Advanced Photon Source at Argonne National Laboratory. Argonne National Laboratory is operated by UChicago Argonne, LLC, for the United States Department of Energy, Office of Biological and Environmental Research, under Contract DE-AC02-06CH11357. Computer resources were provided by the Basic Sciences Computing Laboratory of the Minnesota Supercomputing Institute.	Airenne TT, 2005, PROTEIN SCI, V14, P1964, DOI 10.1110/ps.051438105; Bellelli A, 2000, EUR J BIOCHEM, V267, P3264, DOI 10.1046/j.1432-1327.2000.01351.x; CAI DY, 1994, BIOCHEMISTRY-US, V33, P7647, DOI 10.1021/bi00190a019; Chang CM, 2010, BIOCHEMISTRY-US, V49, P2540, DOI 10.1021/bi901933d; Dooley DM, 1996, J BIOL INORG CHEM, V1, P205, DOI 10.1007/s007750050044; Dooley DM, 1998, J AM CHEM SOC, V120, P2599, DOI 10.1021/ja970312a; DOOLEY DM, 1991, NATURE, V349, P262, DOI 10.1038/349262a0; Dooley DM, 1999, J BIOL INORG CHEM, V4, P1, DOI 10.1007/s007750050283; Dove JE, 2001, ADV PROTEIN CHEM, V58, P141; DRUMMOND JT, 1994, BIOCHEMISTRY-US, V33, P3732, DOI 10.1021/bi00178a033; DuBois JL, 2004, METHOD ENZYMOL, V378, P17; Duff AP, 2003, BIOCHEMISTRY-US, V42, P15148, DOI 10.1021/bi035338v; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Goto Y, 2002, BIOCHEMISTRY-US, V41, P13637, DOI 10.1021/bi0204591; HADFIELD A, 1993, J APPL CRYSTALLOGR, V26, P839, DOI 10.1107/S0021889893005552; Hirota S, 2001, BIOCHEMISTRY-US, V40, P15789, DOI 10.1021/bi011631o; Humphreys KJ, 2009, J AM CHEM SOC, V131, P4657, DOI 10.1021/ja807963e; Jazdzewski BA, 2003, J BIOL INORG CHEM, V8, P381, DOI 10.1007/s00775-002-0420-9; Johnson BJ, 2007, J BIOL CHEM, V282, P17767, DOI 10.1074/jbc.M701308200; Kishishita S, 2003, J AM CHEM SOC, V125, P1041, DOI 10.1021/ja017899k; Klema VJ, 2013, BIOCHEMISTRY-US, V52, P2291, DOI 10.1021/bi3016845; Klinman JP, 1996, CHEM REV, V96, P2541, DOI 10.1021/cr950047g; Lewis EA, 2004, CHEM REV, V104, P1047, DOI 10.1021/cr020633r; Liu Y, 2013, J PHYS CHEM B, V117, P218, DOI 10.1021/jp3121484; Medda R, 1999, FEBS LETT, V453, P1, DOI 10.1016/S0014-5793(99)00675-4; Mills SA, 2000, J AM CHEM SOC, V122, P9897, DOI 10.1021/ja000325f; Mills SA, 2002, BIOCHEMISTRY-US, V41, P10577, DOI 10.1021/bi0200864; Mills SA, 2012, J BIOL INORG CHEM, V17, P507, DOI 10.1007/s00775-011-0872-x; Mukherjee A, 2008, J AM CHEM SOC, V130, P9459, DOI 10.1021/ja801378f; Mure M, 2002, BIOCHEMISTRY-US, V41, P9269, DOI 10.1021/bi020246b; MURE M, 1995, METHOD ENZYMOL, V258, P39; MURE M, 1993, J AM CHEM SOC, V115, P7117, DOI 10.1021/ja00069a008; MURE M, 1995, J AM CHEM SOC, V117, P8707, DOI 10.1021/ja00139a003; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Padiglia A, 2001, EUR J BIOCHEM, V268, P4686, DOI 10.1046/j.1432-1327.2001.02390.x; Padiglia A, 2001, EUR J INORG CHEM, P35; Pearson AR, 2003, BBA-PROTEINS PROTEOM, V1647, P381, DOI 10.1016/S1570-9639(03)00099-2; Pietrangeli P, 2003, BBA-PROTEINS PROTEOM, V1647, P152, DOI 10.1016/S1570-9639(03)00083-9; Plastino J, 1999, BIOCHEMISTRY-US, V38, P8204, DOI 10.1021/bi9826660; Schwartz B, 2001, BIOCHEMISTRY-US, V40, P2954, DOI 10.1021/bi0021378; Shepard EM, 2006, J BIOL INORG CHEM, V11, P1039, DOI 10.1007/s00775-006-0153-2; Shepard EM, 2008, BIOCHEMISTRY-US, V47, P13907, DOI 10.1021/bi8011516; Smith MA, 2010, BIOCHEMISTRY-US, V49, P1268, DOI 10.1021/bi901738k; Su QJ, 1998, BIOCHEMISTRY-US, V37, P12513, DOI 10.1021/bi981103l; Takahashi K, 2006, BIOCHEMISTRY-US, V45, P4683, DOI 10.1021/bi0521893; TUROWSKI PN, 1993, J BIOL CHEM, V268, P17680; Welford RWD, 2007, BIOCHEMISTRY-US, V46, P10817, DOI 10.1021/bi700943r; Whittaker JW, 2005, ARCH BIOCHEM BIOPHYS, V433, P227, DOI 10.1016/j.abb.2004.08.034; Wilmot CM, 1999, SCIENCE, V286, P1724, DOI 10.1126/science.286.5445.1724; Wilmot CM, 2002, METHOD ENZYMOL, V353, P301; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749	52	15	15	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 27	2013	288	39					28409	28417		10.1074/jbc.M113.501791	http://dx.doi.org/10.1074/jbc.M113.501791			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302OB	23940035	hybrid, Green Published			2022-12-25	WOS:000330612800068
J	Mikhaylova, L; Zhang, YM; Kobzik, L; Fedulov, AV				Mikhaylova, Lyudmila; Zhang, Yiming; Kobzik, Lester; Fedulov, Alexey V.			Link between Epigenomic Alterations and Genome-Wide Aberrant Transcriptional Response to Allergen in Dendritic Cells Conveying Maternal Asthma Risk	PLOS ONE			English	Article							CHILDHOOD ASTHMA; BRONCHIAL-ASTHMA; GENE-EXPRESSION; GROWTH-FACTOR; MURINE MODEL; INFLAMMATION; SUSCEPTIBILITY; IMMUNE; TRANSMISSION; DISEASES	We investigated the link between epigenome-wide methylation aberrations at birth and genomic transcriptional changes upon allergen sensitization that occur in the neonatal dendritic cells (DC) due to maternal asthma. We previously demonstrated that neonates of asthmatic mothers are born with a functional skew in splenic DCs that can be seen even in allergen-naive pups and can convey allergy responses to normal recipients. However, minimal-to-no transcriptional or phenotypic changes were found to explain this alteration. Here we provide in-depth analysis of genome-wide DNA methylation profiles and RNA transcriptional (microarray) profiles before and after allergen sensitization. We identified differentially methylated and differentially expressed loci and performed manually-curated matching of methylation status of the key regulatory sequences (promoters and CpG islands) to expression of their respective transcripts before and after sensitization. We found that while allergen-naive DCs from asthma-at-risk neonates have minimal transcriptional change compared to controls, the methylation changes are extensive. The substantial transcriptional change only becomes evident upon allergen sensitization, when it occurs in multiple genes with the pre-existing epigenetic alterations. We demonstrate that maternal asthma leads to both hyper- and hypomethylation in neonatal DCs, and that both types of events at various loci significantly overlap with transcriptional responses to allergen. Pathway analysis indicates that approximately 1/2 of differentially expressed and differentially methylated genes directly interact in known networks involved in allergy and asthma processes. We conclude that congenital epigenetic changes in DCs are strongly linked to altered transcriptional responses to allergen and to early-life asthma origin. The findings are consistent with the emerging paradigm that asthma is a disease with underlying epigenetic changes.	[Mikhaylova, Lyudmila; Zhang, Yiming; Fedulov, Alexey V.] Harvard Univ, Sch Med, Brigham & Womens Hosp, Div Pulmonary & Crit Care Med, Boston, MA 02115 USA; [Kobzik, Lester; Fedulov, Alexey V.] Harvard Univ, Sch Publ Hlth, Dept Environm Hlth, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Harvard T.H. Chan School of Public Health	Fedulov, AV (corresponding author), Harvard Univ, Sch Med, Brigham & Womens Hosp, Div Pulmonary & Crit Care Med, Boston, MA 02115 USA.	afedulov@rics.bwh.harvard.edu	Zhang, Yiming/HGB-7344-2022		National Institute of Environmental Health Sciences [ES015425]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [K99ES015425, R00ES015425] Funding Source: NIH RePORTER	National Institute of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	Support provided by the National Institute of Environmental Health Sciences ES015425. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Banchereau J, 2000, ANNU REV IMMUNOL, V18, P767, DOI 10.1146/annurev.immunol.18.1.767; Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; Negrete-Garcia MC, 2010, CHEST, V138, P100, DOI 10.1378/chest.09-2104; Doganci A, 2005, CLIN REV ALLERG IMMU, V28, P257, DOI 10.1385/CRIAI:28:3:257; Du CL, 2010, EXP LUNG RES, V36, P201, DOI 10.3109/01902140903290022; Fedulov A, 2005, J IMMUNOL, V175, P4292, DOI 10.4049/jimmunol.175.7.4292; Fedulov AV, 2008, AM J RESP CELL MOL, V38, P57, DOI 10.1165/rcmb.2007-0124OC; Fedulov AV, 2007, AM J REPROD IMMUNOL, V58, P120, DOI 10.1111/j.1600-0897.2007.00496.x; Fedulov AV, 2011, AM J RESP CELL MOL, V44, P285, DOI 10.1165/rcmb.2009-0400OC; Gao P., 2012, CLIN DEV IMMUNOL, V2012; Ghavami S, 2009, BIOCHIM BIOPHYS ACTA, V1803, P452; Gonzalo JA, 2000, J IMMUNOL, V165, P499, DOI 10.4049/jimmunol.165.1.499; Gupta P, 2012, J ASTHMA, V49, P129, DOI 10.3109/02770903.2011.649873; Hamada K, 2003, J IMMUNOL, V170, P1683, DOI 10.4049/jimmunol.170.4.1683; Hammad H, 2006, J ALLERGY CLIN IMMUN, V118, P331, DOI 10.1016/j.jaci.2006.03.041; Han Z, 2003, RESP MED, V97, P563, DOI 10.1053/rmed.2001.1162; Holladay SD, 2002, HUM EXP TOXICOL, V21, P525, DOI 10.1191/0960327102ht292oa; Holsapple MP, 2004, TOXICOL APPL PHARM, V199, P61, DOI 10.1016/j.taap.2004.03.003; Ilmarinen-Salo P, 2010, PULM PHARMACOL THER, V23, P365, DOI 10.1016/j.pupt.2010.04.001; Jin Y, 2010, J ALLERGY CLIN IMMUN, V126, P618, DOI 10.1016/j.jaci.2010.06.007; Baay-Guzman GJ, 2012, CHEST, V141, P886, DOI 10.1378/chest.11-0633; Kim SR, 2012, ALLERGY, V67, P869, DOI 10.1111/j.1398-9995.2012.02837.x; Kim YS, 2009, J IMMUNOL, V183, P5113, DOI 10.4049/jimmunol.0901566; Lambrecht BN, 2001, CLIN EXP ALLERGY, V31, P206, DOI 10.1046/j.1365-2222.2001.01061.x; Litonjua AA, 2006, CURR OPIN PULM MED, V12, P12, DOI 10.1097/01.mcp.0000198068.50457.95; Litonjua AA, 1998, AM J RESP CRIT CARE, V158, P176, DOI 10.1164/ajrccm.158.1.9710014; Luster Michael I., 2003, Environmental Health Perspectives, V111, P579; MARTINEZ FD, 1995, NEW ENGL J MED, V332, P133, DOI 10.1056/NEJM199501193320301; Mgbemena V, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-409; Miller RL, 2008, AM J RESP CRIT CARE, V177, P567, DOI 10.1164/rccm.200710-1511PP; Miller RL, 2012, EPIGENETIC EPIDEMIOL, P307; Morales E, 2012, AM J RESP CRIT CARE, V185, P937, DOI 10.1164/rccm.201105-0870OC; Niedzwiecki M, 2012, ALLERGY, V67, P904, DOI 10.1111/j.1398-9995.2012.02841.x; Ning YY, 2011, TOXICOLOGY, V283, P32, DOI 10.1016/j.tox.2011.01.026; Nordlund B, 2012, ALLERGY, V67, P661, DOI 10.1111/j.1398-9995.2012.02797.x; Oliveti JF, 1996, AM J EPIDEMIOL, V143, P570; Prescott SL, 2006, CURR ALLERGY ASTHM R, V6, P75, DOI 10.1007/s11882-006-0014-7; Renauld JC, 2001, J CLIN PATHOL, V54, P577, DOI 10.1136/jcp.54.8.577; Robinson DS, 2002, CURR BIOL, V12, pR322, DOI 10.1016/S0960-9822(02)00830-8; Rothman Paul B, 2010, Trans Am Clin Climatol Assoc, V121, P156; Sabo-Attwood T, 2011, AM J PATHOL, V178, P1975, DOI 10.1016/j.ajpath.2011.01.048; Seki Y, 2003, NAT MED, V9, P1047, DOI 10.1038/nm896; Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23; Upham JW, 2003, PHARMACOL THERAPEUT, V100, P75, DOI 10.1016/S0163-7258(03)00094-9; Upham JW, 2003, RESPIROLOGY, V8, P140, DOI 10.1046/j.1440-1843.2003.00465.x; Visekruna A, 2012, EUR J IMMUNOL, DOI [10.1002/ eji. 201242825, DOI 10.1002/EJI.201242825.PMID:23254356]; von Mutius E, 2006, ALLERGY, V61, P407, DOI 10.1111/j.1398-9995.2006.01009.x; von Mutius E, 2000, ARCH DIS CHILD, V82, pS2; Wang YX, 2011, ADV EXP MED BIOL, V704, P731, DOI 10.1007/978-94-007-0265-3_38; Wang ZL, 2009, J BIOL CHEM, V284, P28599, DOI 10.1074/jbc.M109.047282; Weiss ST, 2001, ANN ALLERG ASTHMA IM, V87, P5, DOI 10.1016/S1081-1206(10)62188-6; Wheway J, 2007, CURR TOP MED CHEM, V7, P1743, DOI 10.2174/156802607782341046; Wills-Karp M, 2000, IMMUNOPHARMACOLOGY, V48, P263, DOI 10.1016/S0162-3109(00)00223-X; Wong WSF, 2004, BBA-PROTEINS PROTEOM, V1697, P53, DOI 10.1016/j.bbapap.2003.11.013; Zhu JF, 2004, NAT IMMUNOL, V5, P1157, DOI 10.1038/ni1128	55	26	26	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2013	8	8							e70387	10.1371/journal.pone.0070387	http://dx.doi.org/10.1371/journal.pone.0070387			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	200UV	23950928	gold, Green Published, Green Submitted			2022-12-25	WOS:000323097300016
J	Cashman, DJ; Ortega, DR; Zhulin, IB; Baudry, J				Cashman, Derek J.; Ortega, Davi R.; Zhulin, Igor B.; Baudry, Jerome			Homology Modeling of the CheW Coupling Protein of the Chemotaxis Signaling Complex	PLOS ONE			English	Article							CHEMORECEPTOR ARRAYS; INTERACTION SURFACES; COMPUTER-SIMULATION; MOLECULAR-DYNAMICS; BINDING; SEQUENCE; FLUCTUATIONS; ARCHITECTURE; MECHANISM; KINASE	Homology models of the E. coli and T. maritima chemotaxis protein CheW were constructed to assess the quality of structural predictions and their applicability in chemotaxis research: i) a model of E. coli CheW was constructed using the T. maritima CheW NMR structure as a template, and ii) a model of T. maritima CheW was constructed using the E. coli CheW NMR structure as a template. The conformational space accessible to the homology models and to the NMR structures was investigated using molecular dynamics and Monte Carlo simulations. The results show that even though static homology models of CheW may be partially structurally different from their corresponding experimentally determined structures, the conformational space they can access through their dynamic variations can be similar, for specific regions of the protein, to that of the experimental NMR structures. When CheW homology models are allowed to explore their local accessible conformational space, modeling can provide a rational path to predicting CheW interactions with the MCP and CheA proteins of the chemotaxis complex. Homology models of CheW (and potentially, of other chemotaxis proteins) should be seen as snapshots of an otherwise larger ensemble of accessible conformational space.	[Cashman, Derek J.; Baudry, Jerome] Univ Tennessee, Dept Biochem & Cellular & Mol Biol, Knoxville, TN 37996 USA; [Cashman, Derek J.; Baudry, Jerome] Univ Tennessee, UT ORNL Ctr Mol Biophys, Knoxville, TN USA; [Ortega, Davi R.] Univ Tennessee, Dept Phys, Knoxville, TN 37996 USA; [Ortega, Davi R.; Zhulin, Igor B.] Oak Ridge Natl Lab, Joint Inst Computat Sci, Oak Ridge, TN USA; [Zhulin, Igor B.] Univ Tennessee, Dept Microbiol, Knoxville, TN 37996 USA	University of Tennessee System; University of Tennessee Knoxville; University of Tennessee System; University of Tennessee Knoxville; University of Tennessee System; University of Tennessee Knoxville; United States Department of Energy (DOE); Oak Ridge National Laboratory; University of Tennessee System; University of Tennessee Knoxville; University of Tennessee System; University of Tennessee Knoxville	Baudry, J (corresponding author), Univ Tennessee, Dept Biochem & Cellular & Mol Biol, Knoxville, TN 37996 USA.	jbaudry@utk.edu	Zhulin, Igor/T-3509-2019; Zhulin, Igor B/A-2308-2012	Zhulin, Igor/0000-0002-6708-5323; Zhulin, Igor B/0000-0002-6708-5323; Cashman, Derek/0000-0002-6041-8922	National Institutes of Health [GM072285]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM072285] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health grant GM072285. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexandre G, 2003, J BACTERIOL, V185, P544, DOI 10.1128/JB.185.2.544-552.2003; Vu A, 2012, J MOL BIOL, V415, P759, DOI 10.1016/j.jmb.2011.11.043; Apweiler R, 2012, NUCLEIC ACIDS RES, V40, pD71, DOI 10.1093/nar/gkr981; Baker D, 2001, SCIENCE, V294, P93, DOI 10.1126/science.1065659; BERNSTEIN FC, 1977, J MOL BIOL, V112, P535, DOI 10.1016/S0022-2836(77)80200-3; Boukhvalova M, 2002, J BIOL CHEM, V277, P23596, DOI 10.1074/jbc.M202288200; Boukhvalova MS, 2002, J BIOL CHEM, V277, P22251, DOI 10.1074/jbc.M110908200; Bray D, 1998, NATURE, V393, P85, DOI 10.1038/30018; Briegel A, 2012, P NATL ACAD SCI USA, V109, P3766, DOI 10.1073/pnas.1115719109; Briegel A, 2009, P NATL ACAD SCI USA, V106, P17181, DOI 10.1073/pnas.0905181106; CAPUTO A, 1994, NAT STRUCT BIOL, V1, P364, DOI 10.1038/nsb0694-364; CARSON M, 1994, ACTA CRYSTALLOGR D, V50, P889, DOI 10.1107/S0907444994004907; Doolittle R. F., 1986, URFS ORFS PRIMER ANA; DROUPADI PR, 1994, MOL IMMUNOL, V31, P537, DOI 10.1016/0161-5890(94)90041-8; Eddy SR, 1998, BIOINFORMATICS, V14, P755, DOI 10.1093/bioinformatics/14.9.755; Finn RD, 2008, NUCLEIC ACIDS RES, V36, pD281, DOI 10.1093/nar/gkm960; Goh CS, 2004, CURR OPIN STRUC BIOL, V14, P104, DOI 10.1016/j.sbi.2004.01.005; Gray JJ, 2006, CURR OPIN STRUC BIOL, V16, P183, DOI 10.1016/j.sbi.2006.03.003; Griswold IJ, 2002, NAT STRUCT BIOL, V9, P121, DOI 10.1038/nsb753; Hazelbauer GL, 2008, TRENDS BIOCHEM SCI, V33, P9, DOI 10.1016/j.tibs.2007.09.014; Hazelbauer GL, 2010, CURR OPIN MICROBIOL, V13, P124, DOI 10.1016/j.mib.2009.12.014; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Katoh K, 2008, BRIEF BIOINFORM, V9, P286, DOI 10.1093/bib/bbn013; Labute P, 2008, J COMPUT CHEM, V29, P1693, DOI 10.1002/jcc.20933; Li Y, 2007, BIOCHEM BIOPH RES CO, V360, P863, DOI 10.1016/j.bbrc.2007.06.146; Liu J, 2012, P NATL ACAD SCI USA, V109, pE1481, DOI 10.1073/pnas.1200781109; MADDOCK JR, 1993, SCIENCE, V259, P1717; Mamonov AB, 2009, J PHYS CHEM B, V113, P10891, DOI 10.1021/jp901322v; Novoa EM, 2010, J CHEM THEORY COMPUT, V6, P2547, DOI 10.1021/ct100246y; MATSUMOTO R, 1995, J BIOL CHEM, V270, P19524, DOI 10.1074/jbc.270.33.19524; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Porter SL, 2011, NAT REV MICROBIOL, V9, P153, DOI 10.1038/nrmicro2505; Raval A, 2012, PROTEINS, V80, P2071, DOI 10.1002/prot.24098; RING CS, 1993, P NATL ACAD SCI USA, V90, P3583, DOI 10.1073/pnas.90.8.3583; Roberts E, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-382; SALI A, 1993, J BIOL CHEM, V268, P9023; Sourjik V, 2004, TRENDS MICROBIOL, V12, P569, DOI 10.1016/j.tim.2004.10.003; Sourjik V, 2010, EMBO J, V29, P2724, DOI 10.1038/emboj.2010.178; SUTCLIFFE MJ, 1992, BIOCHEMISTRY-US, V31, P2962, DOI 10.1021/bi00126a017; Szurmant L, 2004, MICROBIOL MOL BIOL R, V68, P301, DOI 10.1128/MMBR.68.2.301-319.2004; TAKETOMI H, 1975, INT J PEPT PROT RES, V7, P445; UEDA Y, 1978, BIOPOLYMERS, V17, P1531, DOI 10.1002/bip.1978.360170612; Ulrich LE, 2010, NUCLEIC ACIDS RES, V38, pD401, DOI 10.1093/nar/gkp940; Underbakke ES, 2011, J MOL BIOL, V409, P483, DOI 10.1016/j.jmb.2011.03.040; Wadhams GH, 2004, NAT REV MOL CELL BIO, V5, P1024, DOI 10.1038/nrm1524; Wuichet K, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000724; Zhang K, 2012, MOL MICROBIOL, V85, P782, DOI 10.1111/j.1365-2958.2012.08139.x	48	5	5	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2013	8	8							e70705	10.1371/journal.pone.0070705	http://dx.doi.org/10.1371/journal.pone.0070705			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	200ZE	23950985	Green Submitted, Green Published, gold			2022-12-25	WOS:000323109700046
J	Yang, CH; Yue, JM; Sims, M; Pfeffer, LM				Yang, Chuan He; Yue, Junming; Sims, Michelle; Pfeffer, Lawrence M.			The Curcumin Analog EF24 Targets NF-kappa B and miRNA-21, and Has Potent Anticancer Activity In Vitro and In Vivo	PLOS ONE			English	Article							PROMOTES CELL-SURVIVAL; PHOSPHATIDYLINOSITOL 3-KINASE; CANCER STATISTICS; PROSTATE-CANCER; MICRORNA MIR-21; BREAST-CANCER; STAT3; METHYLATION; SUPPRESSION; EXPRESSION	EF24 is a curcumin analog that has improved anticancer activity over curcumin, but its therapeutic potential and mechanism of action is unknown, which is important to address as curcumin targets multiple signaling pathways. EF24 inhibits the NF-kappa B but not the JAK-STAT signaling pathway in DU145 human prostate cancer cells and B16 murine melanoma cells. EF24 induces apoptosis in these cells apparently by inhibiting miR-21 expression, and also enhances the expression of several miR-21 target genes, PTEN and PDCD4. EF24 treatment significantly suppressed the growth of DU145 prostate cancer xenografts in immunocompromised mice and resulted in tumor regression. EF24 enhanced the expression of the miR-21 target PTEN in DU145 tumor tissue, but suppressed the expression of markers of proliferating cells (cyclin D1 and Ki67). In syngeneic mice injected with B16 cells, EF24 treatment inhibited the formation of lung metastasis, prolonged animal survival, inhibited miR-21 expression and increased the expression of miR-21 target genes. Expression profiling of miRNAs regulated by EF24 in vitro and in vivo showed that the antitumor activity of EF24 reflected the enhanced expression of potential tumor suppressor miRNAs as well as the suppressed expression of oncogenic miRNAs, including miR-21. Taken together, our data suggest that EF24 is a potent anticancer agent and selectively targets NF-kappa B signaling and miRNA expression, indicating that EF24 has significant potential as a therapeutic agent in various cancers.	Univ Tennessee, Ctr Hlth Sci, Dept Lab Med & Pathol, Memphis, TN 38163 USA; Univ Tennessee, Ctr Hlth Sci, Ctr Canc Res, Memphis, TN 38163 USA	University of Tennessee System; University of Tennessee Health Science Center; University of Tennessee System; University of Tennessee Health Science Center	Pfeffer, LM (corresponding author), Univ Tennessee, Ctr Hlth Sci, Dept Lab Med & Pathol, Memphis, TN 38163 USA.	lpfeffer@uthsc.edu		Pfeffer, Lawrence/0000-0003-2809-1234	National Institute of Health [CA133322]; Department of Defense [W81XWH-11-1-0533]; Muirhead Chair Endowment at the University of Tennessee Health Science Center; NATIONAL CANCER INSTITUTE [R01CA133322] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense(United States Department of Defense); Muirhead Chair Endowment at the University of Tennessee Health Science Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by National Institute of Health Grants CA133322, Department of Defense Award W81XWH-11-1-0533 and by funds from the Muirhead Chair Endowment at the University of Tennessee Health Science Center. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdulghani J, 2008, AM J PATHOL, V172, P1717, DOI 10.2353/ajpath.2008.071054; Adams BK, 2005, ANTI-CANCER DRUG, V16, P263, DOI 10.1097/00001813-200503000-00005; Asangani IA, 2008, ONCOGENE, V27, P2128, DOI 10.1038/sj.onc.1210856; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bharti AC, 2004, BLOOD, V103, P3175, DOI 10.1182/blood-2003-06-2151; Bryant A, 2012, MOL CANCER, V11, DOI 10.1186/1476-4598-11-8; Calin GA, 2006, NAT REV CANCER, V6, P857, DOI 10.1038/nrc1997; Du ZY, 2009, J BIOL CHEM, V284, P27808, DOI 10.1074/jbc.M109.028324; Frankel LB, 2008, J BIOL CHEM, V283, P1026, DOI 10.1074/jbc.M707224200; Greenlee RT, 2000, CA-CANCER J CLIN, V50, P7, DOI 10.3322/canjclin.50.1.7; Grivennikov SI, 2010, CYTOKINE GROWTH F R, V21, P11, DOI 10.1016/j.cytogfr.2009.11.005; Han YC, 2010, J EXP MED, V207, P475, DOI 10.1084/jem.20090831; Hayes RB, 1999, CANCER EPIDEM BIOMAR, V8, P25; HUANG MT, 1991, CANCER RES, V51, P813; Kim H, 2010, P NATL ACAD SCI USA, V107, P2183, DOI 10.1073/pnas.0909896107; Kuo SM, 1997, CRIT REV ONCOGENESIS, V8, P47, DOI 10.1615/CritRevOncog.v8.i1.30; Liang YJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023908; Lu Y, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006159; Meng FY, 2007, GASTROENTEROLOGY, V133, P647, DOI 10.1053/j.gastro.2007.05.022; NICOLSON GL, 1978, CANCER RES, V38, P4105; NICOLSON GL, 1979, SCI AM, V240, P66, DOI 10.1038/scientificamerican0379-66; Nohata N, 2012, ONCOTARGET, V3, P9; Ohori H, 2006, MOL CANCER THER, V5, P2563, DOI 10.1158/1535-7163.MCT-06-0174; Pfeffer LM, 1997, SCIENCE, V276, P1418, DOI 10.1126/science.276.5317.1418; POSTE G, 1982, CANCER RES, V42, P2770; RUBY AJ, 1995, CANCER LETT, V94, P79, DOI 10.1016/0304-3835(95)03827-J; Shishodia S, 2012, BIOFACTORS; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Subramaniam D, 2008, CANCER RES, V68, P1962, DOI 10.1158/0008-5472.CAN-07-6011; Suh JH, 2002, PROSTATE, V52, P183, DOI 10.1002/pros.10082; Tang JT, 2011, CARCINOGENESIS, V32, P1207, DOI 10.1093/carcin/bgr114; Walter BA, 2011, J CANCER, V2, P67, DOI 10.7150/jca.2.67; Wang H, 2008, CANCER CELL, V14, P369, DOI 10.1016/j.ccr.2008.10.006; Wong KY, 2012, CARCINOGENESIS, V33, P1629, DOI 10.1093/carcin/bgs212; Yang CH, 1996, J BIOL CHEM, V271, P8057, DOI 10.1074/jbc.271.14.8057; Yang CH, 2000, P NATL ACAD SCI USA, V97, P13631, DOI 10.1073/pnas.250477397; Yang Chuan He, 2010, Int J Interferon Cytokine Mediat Res, V2010, P1; Yang CH, 2011, J BIOL CHEM, V286, P39172, DOI 10.1074/jbc.M111.285098; Yang CH, 2010, CANCER RES, V70, P8108, DOI 10.1158/0008-5472.CAN-10-2579; Yang CL, 2001, J BIOL CHEM, V276, P47277, DOI 10.1074/jbc.M105396200; Zheng B., 2011, ONCOGENE; Zhu SJ, 2012, INTEGR BIOL-UK, V4, P633, DOI 10.1039/c2ib20007d	42	97	99	3	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2013	8	8							e71130	10.1371/journal.pone.0071130	http://dx.doi.org/10.1371/journal.pone.0071130			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	200ZE	23940701	Green Submitted, Green Published, gold			2022-12-25	WOS:000323109700080
J	Chang, W; Jaaskelainen, M; Li, SP; Schulman, AH				Chang, Wei; Jaaskelainen, Marko; Li, Song-ping; Schulman, Alan H.			BARE Retrotransposons Are Translated and Replicated via Distinct RNA Pools	PLOS ONE			English	Article							MESSENGER-RNA; TY1 RETROTRANSPOSITION; INTRON RECOGNITION; BARLEY; GAG; EXPRESSION; GENOME; PROTEINS; TRANSCRIPTS; ARABIDOPSIS	The replication of Long Terminal Repeat (LTR) retrotransposons, which can constitute over 80% of higher plant genomes, resembles that of retroviruses. A major question for retrotransposons and retroviruses is how the two conflicting roles of their transcripts, in translation and reverse transcription, are balanced. Here, we show that the BARE retrotransposon, despite its organization into just one open reading frame, produces three distinct classes of transcripts. One is capped, polyadenylated, and translated, but cannot be copied into cDNA. The second is not capped or polyadenylated, but is destined for packaging and ultimate reverse transcription. The third class is capped, polyadenylated, and spliced to favor production of a subgenomic RNA encoding only Gag, the protein forming virus-like particles. Moreover, the BARE2 subfamily, which cannot synthesize Gag and is parasitic on BARE1, does not produce the spliced sub-genomic RNA for translation but does make the replication competent transcripts, which are packaged into BARE1 particles. To our knowledge, this is first demonstration of distinct RNA pools for translation and transcription for any retrotransposon.	[Chang, Wei; Jaaskelainen, Marko; Schulman, Alan H.] Univ Helsinki, Inst Biotechnol, Viikki Bioctr, Helsinki, Finland; [Li, Song-ping] Univ Helsinki, Biomedicum, Genome Scale Biol Program, Helsinki, Finland; [Schulman, Alan H.] MTT Agrifood Res Finland, Biotechnol & Food Res, Jokioinen, Finland	University of Helsinki; University of Helsinki; Natural Resources Institute Finland (Luke)	Schulman, AH (corresponding author), Univ Helsinki, Inst Biotechnol, Viikki Bioctr, Helsinki, Finland.	alan.schulman@helsinki.fi	Schulman, Alan/A-9322-2011	Schulman, Alan/0000-0002-4126-6177; Jaaskelainen, Marko/0000-0002-6387-5539	Academy of Finland [123074]; University of Helsinki	Academy of Finland(Academy of Finland); University of Helsinki	This work was supported by the Academy of Finland (http://www.aka.fi/fi/A/), Project 123074. Funding for open access charge: University of Helsinki. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baek JM, 2008, PLANT MOL BIOL, V67, P499, DOI 10.1007/s11103-008-9334-4; Barbazuk WB, 2008, GENOME RES, V18, P1381, DOI 10.1101/gr.053678.106; Boeras I, 2012, RETROVIROLOGY, V9, DOI 10.1186/1742-4690-9-8; Bolinger C, 2009, RETROVIROLOGY, V6, DOI 10.1186/1742-4690-6-8; Brendel V, 1998, NUCLEIC ACIDS RES, V26, P4748, DOI 10.1093/nar/26.20.4748; BRIERLEY C, 1990, NUCLEIC ACIDS RES, V18, P2947, DOI 10.1093/nar/18.10.2947; Champoux JJ, 2009, FEBS J, V276, P1506, DOI 10.1111/j.1742-4658.2009.06909.x; Chang W, 2008, PLANT J, V56, P40, DOI 10.1111/j.1365-313X.2008.03572.x; Checkley MA, 2010, MOL CELL BIOL, V30, P382, DOI 10.1128/MCB.00251-09; Cheng Z, 2004, SCIENCE, V303, P240, DOI 10.1126/science.1087023; Dorman N, 2000, J VIROL, V74, P11413, DOI 10.1128/JVI.74.23.11413-11417.2000; Dreher TW, 2006, VIROLOGY, V344, P185, DOI 10.1016/j.virol.2005.09.031; Farabaugh PJ, 1996, ANNU REV GENET, V30, P507, DOI 10.1146/annurev.genet.30.1.507; FARABAUGH PJ, 1993, CELL, V74, P93, DOI 10.1016/0092-8674(93)90297-4; FLAVELL AJ, 1981, NUCLEIC ACIDS RES, V9, P6279, DOI 10.1093/nar/9.23.6279; Frankel AD, 1998, ANNU REV BIOCHEM, V67, P1, DOI 10.1146/annurev.biochem.67.1.1; Gao X, 2003, RNA, V9, P1422, DOI 10.1261/rna.5105503; Grigsby IF, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-75; Harger JW, 2001, VIROLOGY, V286, P216, DOI 10.1006/viro.2001.0997; Houck-Loomis B, 2011, NATURE, V480, P561, DOI 10.1038/nature10657; Irwin PA, 2001, J VIROL, V75, P1790, DOI 10.1128/JVI.75.4.1790-1797.2001; Jaaskelainen M, 1999, PLANT J, V20, P413, DOI 10.1046/j.1365-313x.1999.00616.x; Jiao YL, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.76; Kalendar R, 2000, P NATL ACAD SCI USA, V97, P6603, DOI 10.1073/pnas.110587497; Kanazawa A, 2009, J MOL EVOL, V69, P164, DOI 10.1007/s00239-009-9262-1; KAWAKAMI K, 1993, GENETICS, V135, P309; Kimura Y, 2001, PLANT CELL PHYSIOL, V42, P1345, DOI 10.1093/pcp/pce171; Ko CH, 1998, PLANT MOL BIOL, V36, P573, DOI 10.1023/A:1005932620374; Latijnhouwers MJ, 1999, PLANT MOL BIOL, V41, P637, DOI 10.1023/A:1006329517740; Liu RY, 2007, P NATL ACAD SCI USA, V104, P11844, DOI 10.1073/pnas.0704258104; MANNINEN I, 1993, PLANT MOL BIOL, V22, P829, DOI 10.1007/BF00027369; Meignin C, 2003, MOL CELL BIOL, V23, P8246, DOI 10.1128/MCB.23.22.8246-8254.2003; MESSER LI, 1981, J VIROL, V40, P683, DOI 10.1128/JVI.40.3.683-690.1981; Muniz LM, 2001, GENOME, V44, P979, DOI 10.1139/gen-44-6-979; Mustroph A, 2009, P NATL ACAD SCI USA, V106, P18843, DOI 10.1073/pnas.0906131106; Parker R, 2007, MOL CELL, V25, P635, DOI 10.1016/j.molcel.2007.02.011; Kneller ELP, 2006, VIRUS RES, V119, P63, DOI 10.1016/j.virusres.2005.10.010; Roulin A, 2008, PLANT J, V53, P950, DOI 10.1111/j.1365-313X.2007.03388.x; Sablok G, 2011, BIOTECHNOL LETT, V33, P629, DOI 10.1007/s10529-010-0475-6; Sabot F, 2006, HEREDITY, V97, P381, DOI 10.1038/sj.hdy.6800903; Shehu-Xhilaga M, 2001, J VIROL, V75, P1834, DOI 10.1128/JVI.75.4.1834-1841.2001; Smykal P, 2009, HEREDITY, V103, P157, DOI 10.1038/hdy.2009.45; Steinbauerova V, 2008, MOL GENET GENOMICS, V280, P427, DOI 10.1007/s00438-008-0376-8; Suoniemi A, 1996, PLANT MOL BIOL, V31, P295, DOI 10.1007/BF00021791; Tanskanen JA, 2007, GENE, V390, P166, DOI 10.1016/j.gene.2006.09.009; Vallejos M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035031; Van Der Kelen K, 2009, CRIT REV BIOCHEM MOL, V44, P143, DOI 10.1080/10409230902882090; Vicient CM, 2001, PLANT PHYSIOL, V125, P1283, DOI 10.1104/pp.125.3.1283; Vicient CM, 2001, GENOME RES, V11, P2041, DOI 10.1101/gr.193301; Wicker T, 2007, NAT REV GENET, V8, P973, DOI 10.1038/nrg2165; Wicker T, 2009, PLANT J, V59, P712, DOI 10.1111/j.1365-313X.2009.03911.x; WILSON W, 1986, NUCLEIC ACIDS RES, V14, P7001, DOI 10.1093/nar/14.17.7001; Wu XF, 2008, YEAST, V25, P327, DOI 10.1002/yea.1591; Xu J, 2011, CURR OPIN PLANT BIOL, V14, P88, DOI 10.1016/j.pbi.2010.10.003	54	17	18	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2013	8	8							e72270	10.1371/journal.pone.0072270	http://dx.doi.org/10.1371/journal.pone.0072270			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	217ZG	23940808	Green Published, Green Submitted, gold			2022-12-25	WOS:000324401500090
J	Weir, TL; Manter, DK; Sheflin, AM; Barnett, BA; Heuberger, AL; Ryan, EP				Weir, Tiffany L.; Manter, Daniel K.; Sheflin, Amy M.; Barnett, Brittany A.; Heuberger, Adam L.; Ryan, Elizabeth P.			Stool Microbiome and Metabolome Differences between Colorectal Cancer Patients and Healthy Adults	PLOS ONE			English	Article							STREPTOCOCCUS-BOVIS; GUT MICROBIOME; COLON; BACTERIA; IDENTIFICATION; ACETYLATION; MECHANISMS; BUTYRATE; IMPACT; MUCIN	In this study we used stool profiling to identify intestinal bacteria and metabolites that are differentially represented in humans with colorectal cancer (CRC) compared to healthy controls to identify how microbial functions may influence CRC development. Stool samples were collected from healthy adults (n = 10) and colorectal cancer patients (n = 11) prior to colon resection surgery at the University of Colorado Health-Poudre Valley Hospital in Fort Collins, CO. The V4 region of the 16s rRNA gene was pyrosequenced and both short chain fatty acids and global stool metabolites were extracted and analyzed utilizing Gas Chromatography-Mass Spectrometry (GC-MS). There were no significant differences in the overall microbial community structure associated with the disease state, but several bacterial genera, particularly butyrate-producing species, were under-represented in the CRC samples, while a mucin-degrading species, Akkermansia muciniphila, was about 4-fold higher in CRC (p<0.01). Proportionately higher amounts of butyrate were seen in stool of healthy individuals while relative concentrations of acetate were higher in stools of CRC patients. GC-MS profiling revealed higher concentrations of amino acids in stool samples from CRC patients and higher poly and monounsaturated fatty acids and ursodeoxycholic acid, a conjugated bile acid in stool samples from healthy adults (p<0.01). Correlative analysis between the combined datasets revealed some potential relationships between stool metabolites and certain bacterial species. These associations could provide insight into microbial functions occurring in a cancer environment and will help direct future mechanistic studies. Using integrated "omics" approaches may prove a useful tool in identifying functional groups of gastrointestinal bacteria and their associated metabolites as novel therapeutic and chemopreventive targets.	[Weir, Tiffany L.; Sheflin, Amy M.; Ryan, Elizabeth P.] Colorado State Univ, Dept Food Sci & Human Nutr, Ft Collins, CO 80523 USA; [Manter, Daniel K.; Barnett, Brittany A.] ARS, USDA, Soil Plant Nutrient Res Div, Ft Collins, CO USA; [Heuberger, Adam L.] Colorado State Univ, Prote & Metabol Facil, Ft Collins, CO 80523 USA; [Ryan, Elizabeth P.] Colorado State Univ, Dept Environm & Radiol Hlth Sci, Ft Collins, CO 80523 USA	Colorado State University; United States Department of Agriculture (USDA); Colorado State University; Colorado State University	Weir, TL (corresponding author), Colorado State Univ, Dept Food Sci & Human Nutr, Ft Collins, CO 80523 USA.	Tiffany.Weir@colostate.edu		Manter, Daniel/0000-0001-7729-7197; Sheflin, Amy/0000-0003-0018-8675	NIH NCI [R03CA150070]; Colorado Agriculture Experiment Station (CAES); Shipley Foundation; NATIONAL CANCER INSTITUTE [R03CA150070] Funding Source: NIH RePORTER	NIH NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Colorado Agriculture Experiment Station (CAES); Shipley Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by NIH NCI R03CA150070, Colorado Agriculture Experiment Station (CAES), and Shipley Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akare S, 2006, INT J CANCER, V119, P2958, DOI 10.1002/ijc.22231; Andersson AF, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002836; Bartosch S, 2004, APPL ENVIRON MICROB, V70, P3575, DOI 10.1128/AEM.70.6.3575-3581.2004; Byrd JC, 2004, CANCER METAST REV, V23, P77, DOI 10.1023/A:1025815113599; Castellarin M, 2012, GENOME RES, V22, P299, DOI 10.1101/gr.126516.111; Chen WG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039743; De Filippo C, 2010, P NATL ACAD SCI USA, V107, P14691, DOI 10.1073/pnas.1005963107; Delomenie C, 2001, J BACTERIOL, V183, P3417, DOI 10.1128/JB.183.11.3417-3427.2001; Fierer N, 2008, P NATL ACAD SCI USA, V105, P17994, DOI 10.1073/pnas.0807920105; HILL MJ, 1971, LANCET, V1, P95; Hirayama A, 2009, CANCER RES, V69, P4918, DOI 10.1158/0008-5472.CAN-08-4806; Huse SM, 2010, ENVIRON MICROBIOL, V12, P1889, DOI 10.1111/j.1462-2920.2010.02193.x; Huycke MM, 2004, EXP BIOL MED, V229, P586, DOI 10.1177/153537020422900702; Jacobs DM, 2008, NMR BIOMED, V21, P615, DOI 10.1002/nbm.1233; JOOSSENS M, 2011, GUT; Kelly D, 2005, TRENDS IMMUNOL, V26, P326, DOI 10.1016/j.it.2005.04.008; Kinross JM, 2011, GENOME MED, V3, DOI 10.1186/gm228; KLEIN RS, 1979, ANN INTERN MED, V91, P560, DOI 10.7326/0003-4819-91-4-560; Kostic AD, 2012, GENOME RES, V22, P292, DOI 10.1101/gr.126573.111; Lepercq P, 2011, MICROBIAL ECOLOGY HL, V16, P1651; LEPORT C, 1987, LANCET, V1, P748; MACLENNAN R, 1977, LANCET, V2, P133; Marchesi JR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020447; Martin FPJ, 2010, J PROTEOME RES, V9, P5284, DOI 10.1021/pr100554m; Matthews GM, 2012, CHEMOTHERAPY, V58, P102, DOI 10.1159/000335672; Monleon D, 2009, NMR BIOMED, V22, P342, DOI 10.1002/nbm.1345; MOORE WEC, 1995, APPL ENVIRON MICROB, V61, P3202, DOI 10.1128/AEM.61.9.3202-3207.1995; Neish AS, 2009, GASTROENTEROLOGY, V136, P65, DOI 10.1053/j.gastro.2008.10.080; Nicholls AW, 2003, CHEM RES TOXICOL, V16, P1395, DOI 10.1021/tx0340293; Nicholson JK, 2008, NATURE, V455, P1054, DOI 10.1038/4551054a; Png CW, 2010, AM J GASTROENTEROL, V105, P2420, DOI 10.1038/ajg.2010.281; Sartor RB, 2008, P NATL ACAD SCI USA, V105, P16413, DOI 10.1073/pnas.0809363105; Sato K, 2007, CANCER RES, V67, P9677, DOI 10.1158/0008-5472.CAN-07-1462; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Selgrad M, 2008, J CELL PHYSIOL, V216, P378, DOI 10.1002/jcp.21427; Shen XJ, 2010, GUT MICROBES, V1, P138, DOI 10.4161/gmic.1.3.12360; Smith CA, 2006, ANAL CHEM, V78, P779, DOI 10.1021/ac051437y; Sobhani I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016393; Stein SE, 1999, J AM SOC MASS SPECTR, V10, P770, DOI 10.1016/S1044-0305(99)00047-1; Tjalsma H, 2012, NAT REV MICROBIOL, V10, P575, DOI 10.1038/nrmicro2819; Turnbaugh PJ, 2006, NATURE, V444, P1027, DOI 10.1038/nature05414; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; WEAVER GA, 1988, GUT, V29, P1539, DOI 10.1136/gut.29.11.1539; Williams EA, 2003, P NUTR SOC, V62, P107, DOI 10.1079/PNS2002230; Yue JC, 2005, COMMUN STAT-THEOR M, V34, P2123, DOI 10.1080/STA-200066418; Zella GC, 2011, INFLAMM BOWEL DIS, V17, P1092, DOI 10.1002/ibd.21460	46	408	450	12	215	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2013	8	8							e70803	10.1371/journal.pone.0070803	http://dx.doi.org/10.1371/journal.pone.0070803			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	217ZG	23940645	Green Published, Green Submitted, gold			2022-12-25	WOS:000324401500051
J	Faraday, N; Schunke, K; Saleem, S; Fu, J; Wang, B; Zhang, J; Morrell, C; Dore, S				Faraday, Nauder; Schunke, Kathryn; Saleem, Sofiyan; Fu, Juan; Wang, Bing; Zhang, Jian; Morrell, Craig; Dore, Sylvain			Cathepsin G-Dependent Modulation of Platelet Thrombus Formation In Vivo by Blood Neutrophils	PLOS ONE			English	Article							PLATELET/POLYMORPHONUCLEAR LEUKOCYTE INTERACTION; P-SELECTIN; POLYMORPHONUCLEAR LEUKOCYTES; FIBRIN DEPOSITION; ADHESION; ACTIVATION; MODEL; FLOW; COUNT; MICROPARTICLES	Neutrophils are consistently associated with arterial thrombotic morbidity in human clinical studies but the causal basis for this association is unclear. We tested the hypothesis that neutrophils modulate platelet activation and thrombus formation in vivo in a cathepsin G-dependent manner. Neutrophils enhanced aggregation of human platelets in vitro in dose-dependent fashion and this effect was diminished by pharmacologic inhibition of cathepsin G activity and knockdown of cathepsin G expression. Tail bleeding time in the mouse was prolonged by a cathepsin G inhibitor and in cathepsin G knockout mice, and formation of neutrophil-platelet conjugates in blood that was shed from transected tails was reduced in the absence of cathepsin G. Bleeding time was highly correlated with blood neutrophil count in wildtype but not cathepsin G deficient mice. In the presence of elevated blood neutrophil counts, the anti-thrombotic effect of cathepsin G inhibition was greater than that of aspirin and additive to it when administered in combination. Both pharmacologic inhibition of cathepsin G and its congenital absence prolonged the time for platelet thrombus to form in ferric chloride-injured mouse mesenteric arterioles. In a vaso-occlusive model of ischemic stroke, inhibition of cathepsin G and its congenital absence improved cerebral blood flow, reduced histologic brain injury, and improved neurobehavioral outcome. These experiments demonstrate that neutrophil cathepsin G is a physiologic modulator of platelet thrombus formation in vivo and has potential as a target for novel anti-thrombotic therapies.	[Faraday, Nauder; Schunke, Kathryn; Saleem, Sofiyan; Fu, Juan; Wang, Bing; Zhang, Jian] Johns Hopkins Univ, Sch Med, Dept Anesthesiol Crit Care Med, Baltimore, MD 21218 USA; [Morrell, Craig] Univ Rochester, Sch Med, Dept Med, Rochester, NY USA; [Dore, Sylvain] Univ Florida, Coll Med, Dept Anesthesiol, Gainesville, FL USA	Johns Hopkins University; University of Rochester; State University System of Florida; University of Florida	Faraday, N (corresponding author), Johns Hopkins Univ, Sch Med, Dept Anesthesiol Crit Care Med, Baltimore, MD 21218 USA.	nfaraday@jhmi.edu	Schunke, Kathryn Jaques/AAQ-1524-2020; Dore, Sylvain/AAG-1470-2020	Dore, Sylvain/0000-0003-3771-5109; Schunke, Kathryn/0000-0002-0815-8457	National Heart Lung and Blood Institute [RC1 HL099677-01]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [RC1HL099677, U01HL107446] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM075774] Funding Source: NIH RePORTER	National Heart Lung and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by a grant from the National Heart Lung and Blood Institute (RC1 HL099677-01). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barbui T, 2009, BLOOD, V114, P759, DOI 10.1182/blood-2009-02-206797; Bhatt DL, 2006, NEW ENGL J MED, V354, P1706, DOI 10.1056/NEJMoa060989; Bruhl H, 2007, ARTHRITIS RHEUM, V56, P2975, DOI 10.1002/art.22854; Buck BH, 2008, STROKE, V39, P355, DOI 10.1161/STROKEAHA.107.490128; CERLETTI C, 1995, THROMB HAEMOSTASIS, V74, P218; CHIGNARD M, 1994, BBA-MOL CELL RES, V1224, P433, DOI 10.1016/0167-4889(94)90279-8; COLLINS SJ, 1987, BLOOD, V70, P1233; Danesh J, 1998, JAMA-J AM MED ASSOC, V279, P1477, DOI 10.1001/jama.279.18.1477; Dore S, 2003, ANN NEUROL, V54, P155, DOI 10.1002/ana.10612; Dowling MR, 2010, BLOOD, V116, P1776, DOI 10.1182/blood-2009-12-259663; Evangelista V, 1999, BLOOD, V93, P876, DOI 10.1182/blood.V93.3.876.403k25_876_885; EVANGELISTA V, 1993, BLOOD, V81, P2947; Evangelista V, 1996, BLOOD, V88, P4183, DOI 10.1182/blood.V88.11.4183.bloodjournal88114183; Faraday N, 2004, PLATELETS, V15, P9, DOI 10.1080/09537100310001644006; Faraday N, 2001, ANESTHESIOLOGY, V94, P145, DOI 10.1097/00000542-200101000-00025; Goel MS, 2003, J BIOL CHEM, V278, P9458, DOI 10.1074/jbc.M211956200; Goel MS, 2001, ARTERIOSCL THROM VAS, V21, P2093, DOI 10.1161/hq1201.100255; Grau AJ, 2004, STROKE, V35, P1147, DOI 10.1161/01.STR.0000124122.71702.64; Greco MN, 2002, J AM CHEM SOC, V124, P3810, DOI 10.1021/ja017506h; HAMBURGER SA, 1990, BLOOD, V75, P550; Horne BD, 2005, J AM COLL CARDIOL, V45, P1638, DOI 10.1016/j.jacc.2005.02.054; Hrachovinova I, 2003, NAT MED, V9, P1020, DOI 10.1038/nm899; Leger AJ, 2006, CIRCULATION, V114, P1070, DOI 10.1161/CIRCULATIONAHA.105.574830; MacIvor DM, 1999, BLOOD, V94, P4282, DOI 10.1182/blood.V94.12.4282.424k45_4282_4293; Massberg S, 2010, NAT MED, V16, P887, DOI 10.1038/nm.2184; MAUGERI N, 1992, BLOOD, V80, P447; Michelson AD, 2001, CIRCULATION, V104, P1533, DOI 10.1161/hc3801.095588; Morrell CN, 2005, P NATL ACAD SCI USA, V102, P3782, DOI 10.1073/pnas.0408310102; Nieswandt B, 2011, J THROMB HAEMOST, V9, P92, DOI 10.1111/j.1538-7836.2011.04361.x; Owens AP, 2011, CIRC RES, V108, P1284, DOI 10.1161/CIRCRESAHA.110.233056; PALABRICA T, 1992, NATURE, V359, P848, DOI 10.1038/359848a0; PLESNER T, 1994, BLOOD, V83, P808; PRATICO D, 1993, AM J PHYSIOL, V264, pH1582, DOI 10.1152/ajpheart.1993.264.5.H1582; Rainger GE, 1998, BLOOD, V92, P4819, DOI 10.1182/blood.V92.12.4819.424k16_4819_4827; Rana JS, 2007, J INTERN MED, V262, P678, DOI 10.1111/j.1365-2796.2007.01864.x; ROSENKRANZ B, 1985, PROSTA LEUKOTR MED, V19, P289, DOI 10.1016/0262-1746(85)90142-8; Saleem S, 2007, J NEUROSCI RES, V85, P2433, DOI 10.1002/jnr.21399; SALVEMINI D, 1989, P NATL ACAD SCI USA, V86, P6328, DOI 10.1073/pnas.86.16.6328; Sambrano GR, 2000, J BIOL CHEM, V275, P6819, DOI 10.1074/jbc.275.10.6819; SELAK MA, 1988, BIOCHEM J, V251, P293, DOI 10.1042/bj2510293; Shao BJ, 2011, BLOOD, V118, P4015, DOI 10.1182/blood-2011-07-368514; Takahashi T, 2007, AM J CARDIOL, V100, P35, DOI 10.1016/j.amjcard.2007.02.049; TSUJI T, 1994, J LEUKOCYTE BIOL, V56, P583, DOI 10.1002/jlb.56.5.583; VALLES J, 1993, J CLIN INVEST, V92, P1357, DOI 10.1172/JCI116709; Wohner N, 2010, J THROMB HAEMOST, V8, P1624, DOI 10.1111/j.1538-7836.2010.03890.x	45	51	52	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2013	8	8							e71447	10.1371/journal.pone.0071447	http://dx.doi.org/10.1371/journal.pone.0071447			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	218XC	23940756	Green Published, gold, Green Submitted			2022-12-25	WOS:000324465000212
J	Flannigan, KL; Ferraz, JGP; Wang, R; Wallace, JL				Flannigan, Kyle L.; Ferraz, Jose G. P.; Wang, Rui; Wallace, John L.			Enhanced Synthesis and Diminished Degradation of Hydrogen Sulfide in Experimental Colitis: A Site-Specific, Pro-Resolution Mechanism	PLOS ONE			English	Article							SMOOTH-MUSCLE RELAXANT; GASTROINTESTINAL-TRACT; NITRIC-OXIDE; CANCER-CELLS; RAT; H2S; INFLAMMATION; METABOLISM; INHIBITION; INJURY	Hydrogen sulfide (H2S) is produced throughout the gastrointestinal tract, and it contributes to maintenance of mucosal integrity, resolution of inflammation, and repair of damaged tissue. H2S synthesis is elevated in inflamed and damaged colonic tissue, but the enzymatic sources of that synthesis are not completely understood. In the present study, the contributions of three enzymatic pathways to colonic H2S synthesis were determined, with tissues taken from healthy rats and rats with colitis. The ability of the colonic tissue to inactivate H2S was also determined. Colonic tissue from rats with hapten-induced colitis produced significantly more H2S than tissue from healthy controls. The largest source of the H2S synthesis was the pathway involving cysteine amino transferase and 3-mercaptopyruvate sulfurtransferase (an alpha-ketoglutarate-dependent pathway). Elevated H2S synthesis occurred specifically at sites of mucosal ulceration, and was not related to the extent of granulocyte infiltration into the tissue. Inactivation of H2S by colonic tissue occurred rapidly, and was significantly reduced at sites of mucosal ulceration. This correlated with a marked decrease in the expression of sulfide quinone reductase in these regions. Together, the increased production and decreased inactivation of H2S at sites of mucosal ulceration would result in higher H2S levels at these sites, which promotes of resolution of inflammation and repair of damaged tissue.	[Flannigan, Kyle L.; Wallace, John L.] McMaster Univ, Farncombe Family Digest Hlth Res Inst, Hamilton, ON, Canada; [Ferraz, Jose G. P.; Wallace, John L.] Univ Calgary, Inflammat Res Network, Calgary, AB, Canada; [Wang, Rui] Lakehead Univ, Dept Biol, Thunder Bay, ON P7B 5E1, Canada	McMaster University; University of Calgary; Lakehead University	Wallace, JL (corresponding author), McMaster Univ, Farncombe Family Digest Hlth Res Inst, Hamilton, ON, Canada.	altapharm@hotmail.com	Wallace, John/AAL-3763-2021; Wang, Rui/C-7824-2012	Wang, Rui/0000-0003-3825-3620	Crohn's and Colitis Foundation of Canada; Canadian Institutes of Health Research	Crohn's and Colitis Foundation of Canada; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	The work described in this paper was supported by the Crohn's and Colitis Foundation of Canada and the Canadian Institutes of Health Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe K, 1996, J NEUROSCI, V16, P1066; Asimakopoulou A, 2013, BR J PHARM; Blachier F, 2010, AMINO ACIDS, V39, P335, DOI 10.1007/s00726-009-0445-2; Blackler R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035196; BOUGHTONSMITH NK, 1988, AGENTS ACTIONS, V25, P115, DOI 10.1007/BF01969102; BRADLEY PP, 1982, J INVEST DERMATOL, V78, P206, DOI 10.1111/1523-1747.ep12506462; Caliendo G, 2010, J MED CHEM, V53, P6275, DOI 10.1021/jm901638j; Cao QH, 2010, ANTIOXID REDOX SIGN, V12, P1101, DOI 10.1089/ars.2009.2915; Chattopadhyay M, 2012, BIOCHEM PHARMACOL, V83, P715, DOI 10.1016/j.bcp.2011.12.018; Collin M, 2005, BRIT J PHARMACOL, V146, P498, DOI 10.1038/sj.bjp.0706367; CORNELL NW, 1984, BIOCHEM J, V220, P707, DOI 10.1042/bj2200707; Distrutti E, 2006, J PHARMACOL EXP THER, V316, P325, DOI 10.1124/jpet.105.091595; Dufton N, 2012, SCI REP-UK, V2, DOI 10.1038/srep00499; Ekundi-Valentim E, 2010, BRIT J PHARMACOL, V159, P1463, DOI 10.1111/j.1476-5381.2010.00640.x; Elrod JW, 2007, P NATL ACAD SCI USA, V104, P15560, DOI 10.1073/pnas.0705891104; Fiorucci S, 2007, BRIT J PHARMACOL, V150, P996, DOI 10.1038/sj.bjp.0707193; Fiorucci S, 2005, GASTROENTEROLOGY, V129, P1210, DOI 10.1053/j.gastro.2005.07.060; Fiorucci S, 2006, GASTROENTEROLOGY, V131, P259, DOI 10.1053/j.gastro.2006.02.033; Flannigan KL, 2011, AM J PHYSIOL-GASTR L, V301, pG188, DOI 10.1152/ajpgi.00105.2011; Fu M, 2012, P NATL ACAD SCI USA, V109, P2943, DOI 10.1073/pnas.1115634109; Goubern M, 2007, FASEB J, V21, P1699, DOI 10.1096/fj.06-7407com; Hirata I, 2011, DIGEST DIS SCI, V56, P1379, DOI 10.1007/s10620-010-1461-5; Hosoki R, 1997, BIOCHEM BIOPH RES CO, V237, P527, DOI 10.1006/bbrc.1997.6878; Ise F, 2011, ACTA PHYSIOL, V201, P117, DOI 10.1111/j.1748-1716.2010.02152.x; Kimura H, 2011, AMINO ACIDS, V41, P113, DOI 10.1007/s00726-010-0510-x; Kimura Y, 2010, ANTIOXID REDOX SIGN, V12, P1, DOI 10.1089/ars.2008.2282; Lagoutte E, 2010, BBA-BIOENERGETICS, V1797, P1500, DOI 10.1016/j.bbabio.2010.04.004; Li L, 2008, CIRCULATION, V117, P2351, DOI 10.1161/CIRCULATIONAHA.107.753467; Li L, 2009, FREE RADICAL BIO MED, V47, P103, DOI 10.1016/j.freeradbiomed.2009.04.014; Linden DR, 2012, BRIT J PHARMACOL, V165, P2178, DOI 10.1111/j.1476-5381.2011.01681.x; Linden DR, 2008, J NEUROCHEM, V106, P1577, DOI 10.1111/j.1471-4159.2008.05502.x; Lowie BJ, 2011, AM J PHYSIOL-GASTR L, V301, pG835, DOI 10.1152/ajpgi.00077.2011; Ma L, 2000, AM J PHYSIOL-GASTR L, V279, pG341, DOI 10.1152/ajpgi.2000.279.2.G341; Martin GR, 2010, DIGEST LIVER DIS, V42, P103, DOI 10.1016/j.dld.2009.05.016; Matsunami M, 2012, J PHYSIOL PHARMACOL, V63, P61; Mimoun S, 2012, ANTIOXID REDOX SIGN, V17, P1, DOI 10.1089/ars.2011.4186; Mizuno H, 1997, GASTROENTEROLOGY, V112, P387, DOI 10.1053/gast.1997.v112.pm9024292; MORRIS GP, 1989, GASTROENTEROLOGY, V96, P795, DOI 10.1016/0016-5085(89)90904-9; Papapetropoulos A, 2009, P NATL ACAD SCI USA, V106, P21972, DOI 10.1073/pnas.0908047106; Picton R, 2002, GUT, V50, P201, DOI 10.1136/gut.50.2.201; Pouokam E, 2011, BRIT J PHARMACOL, V162, P392, DOI 10.1111/j.1476-5381.2010.01026.x; Schicho R, 2006, GASTROENTEROLOGY, V131, P1542, DOI 10.1053/j.gastro.2006.08.035; Shen XG, 2013, FREE RADICAL BIO MED, V60, P195, DOI 10.1016/j.freeradbiomed.2013.02.024; Shibuya N, 2009, J BIOCHEM, V146, P623, DOI 10.1093/jb/mvp111; Shibuya N, 2009, ANTIOXID REDOX SIGN, V11, P703, DOI [10.1089/ars.2008.2253, 10.1089/ARS.2008.2253]; STIPANUK MH, 1982, BIOCHEM J, V206, P267, DOI 10.1042/bj2060267; Szabo C, 2007, NAT REV DRUG DISCOV, V6, P917, DOI 10.1038/nrd2425; Szabo S, 1998, DIGEST DIS SCI, V43, p40S; Teague B, 2002, BRIT J PHARMACOL, V137, P139, DOI 10.1038/sj.bjp.0704858; Theissen U, 2003, MOL BIOL EVOL, V20, P1564, DOI 10.1093/molbev/msg174; WALLACE JL, 1995, J PHARMACOL TOXICOL, V33, P237, DOI 10.1016/1056-8719(95)00001-X; Wallace JL, 2007, FASEB J, V21, P4070, DOI 10.1096/fj.07-8669com; Wallace JL, 2007, TRENDS PHARMACOL SCI, V28, P501, DOI 10.1016/j.tips.2007.09.003; Wallace JL, 2007, GASTROENTEROLOGY, V132, P261, DOI 10.1053/j.gastro.2006.11.042; Wallace JL, 2012, ANTIOXID REDOX SIGN, V17, P58, DOI 10.1089/ars.2011.4351; Wallace JL, 2010, ANTIOXID REDOX SIGN, V12, P1125, DOI 10.1089/ars.2009.2900; Wallace JL, 2010, BRIT J PHARMACOL, V159, P1236, DOI 10.1111/j.1476-5381.2009.00611.x; Wallace JL, 2009, GASTROENTEROLOGY, V137, P569, DOI 10.1053/j.gastro.2009.04.012; Wang R, 2012, PHYSIOL REV, V92, P791, DOI 10.1152/physrev.00017.2011; WATANABE M, 1995, P NATL ACAD SCI USA, V92, P1585, DOI 10.1073/pnas.92.5.1585; Whiteman Matthew, 2011, Expert Rev Clin Pharmacol, V4, P13, DOI 10.1586/ecp.10.134; Yang GD, 2008, SCIENCE, V322, P587, DOI 10.1126/science.1162667; Zanardo RCO, 2006, FASEB J, V20, P2118, DOI 10.1096/fj.06-6270fje; Zhao WM, 2001, EMBO J, V20, P6008, DOI 10.1093/emboj/20.21.6008	64	53	55	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2013	8	8							e71962	10.1371/journal.pone.0071962	http://dx.doi.org/10.1371/journal.pone.0071962			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	218XC	23940796	gold, Green Published, Green Submitted			2022-12-25	WOS:000324465000235
J	Grasso, L; Wyss, R; Piguet, J; Werner, M; Hassaine, G; Hovius, R; Vogel, H				Grasso, Luigino; Wyss, Romain; Piguet, Joachim; Werner, Michael; Hassaine, Gherici; Hovius, Ruud; Vogel, Horst			Downscaling the Analysis of Complex Transmembrane Signaling Cascades to Closed Attoliter Volumes	PLOS ONE			English	Article							PROTEIN-COUPLED RECEPTORS; PLASMA-MEMBRANES; ACTIVATION; ARRAYS	Cellular signaling is classically investigated by measuring optical or electrical properties of single or populations of living cells. Here we show that ligand binding to cell surface receptors and subsequent activation of signaling cascades can be monitored in single, (sub-)micrometer sized native vesicles with single-molecule sensitivity. The vesicles are derived from live mammalian cells using chemicals or optical tweezers. They comprise parts of a cell's plasma membrane and cytosol and represent the smallest autonomous containers performing cellular signaling reactions thus functioning like minimized cells. Using fluorescence microscopies, we measured in individual vesicles the different steps of G-protein-coupled receptor mediated signaling like ligand binding to receptors, subsequent G-protein activation and finally arrestin translocation indicating receptor deactivation. Observing cellular signaling reactions in individual vesicles opens the door for downscaling bioanalysis of cellular functions to the attoliter range, multiplexing single cell analysis, and investigating receptor mediated signaling in multiarray format.	[Grasso, Luigino; Wyss, Romain; Piguet, Joachim; Werner, Michael; Hassaine, Gherici; Hovius, Ruud; Vogel, Horst] Ecole Polytech Fed Lausanne, Lab Phys Chem Polymers & Membranes, Lausanne, Switzerland	Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne	Vogel, H (corresponding author), Ecole Polytech Fed Lausanne, Lab Phys Chem Polymers & Membranes, Lausanne, Switzerland.	Horst.Vogel@epfl.ch	Vogel, Horst/AAJ-5490-2021; Piguet, Joachim/E-2329-2011; Hovius, Ruud/B-5647-2009	Piguet, Joachim/0000-0002-4762-4887; Hovius, Ruud/0000-0001-9258-6587	Swiss National Science Foundation (System X - CINA); Swiss National Science Foundation (NCCR Chemical Biology)	Swiss National Science Foundation (System X - CINA)(Swiss National Science Foundation (SNSF)); Swiss National Science Foundation (NCCR Chemical Biology)(Swiss National Science Foundation (SNSF))	This work was supported by the Swiss National Science Foundation (System X - CINA and NCCR Chemical Biology). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschuler SJ, 2010, CELL, V141, P559, DOI 10.1016/j.cell.2010.04.033; Bally M, 2010, SMALL, V6, P2481, DOI 10.1002/smll.201000644; Barak LS, 1997, J BIOL CHEM, V272, P27497, DOI 10.1074/jbc.272.44.27497; Bauer B, 2009, ANGEW CHEM INT EDIT, V48, P1656, DOI 10.1002/anie.200803898; Baumgart T, 2007, P NATL ACAD SCI USA, V104, P3165, DOI 10.1073/pnas.0611357104; Bolinger PY, 2008, ANGEW CHEM INT EDIT, V47, P5544, DOI 10.1002/anie.200801606; Chan YHM, 2007, CURR OPIN CHEM BIOL, V11, P581, DOI 10.1016/j.cbpa.2007.09.020; Cherney DP, 2004, ANAL CHEM, V76, P4920, DOI 10.1021/ac0492620; Christensen SM, 2010, SENSORS-BASEL, V10, P11352, DOI 10.3390/s101211352; de Souza N, 2012, NAT METHODS, V9, P35, DOI 10.1038/nmeth.1819; Doherty GJ, 2008, ANNU REV BIOPHYS, V37, P65, DOI 10.1146/annurev.biophys.37.032807.125912; Dzieciol AJ, 2012, CHEM SOC REV, V41, P79, DOI 10.1039/c1cs15211d; Gorris HH, 2010, ANGEW CHEM INT EDIT, V49, P3880, DOI 10.1002/anie.200906417; Hall D, 2008, ANAL BIOCHEM, V377, P24, DOI 10.1016/j.ab.2008.02.019; Hein P, 2005, EMBO J, V24, P4106, DOI 10.1038/sj.emboj.7600870; Hell SW, 2010, SPRINGER SER CHEM PH, V96, P365, DOI 10.1007/978-3-642-02597-6_19; Jean-Alphonse F, 2011, MOL CELL ENDOCRINOL, V331, P205, DOI 10.1016/j.mce.2010.07.010; Johnsen S, 1999, J THEOR BIOL, V199, P181, DOI 10.1006/jtbi.1999.0948; Koopman WJH, 2008, AM J PHYSIOL-CELL PH, V294, pC1124, DOI 10.1152/ajpcell.00079.2008; Levental I, 2011, P NATL ACAD SCI USA, V108, P11411, DOI 10.1073/pnas.1105996108; Lingwood D, 2008, P NATL ACAD SCI USA, V105, P10005, DOI 10.1073/pnas.0804374105; Martins SAM, 2012, TRENDS BIOTECHNOL, V30, P566, DOI 10.1016/j.tibtech.2012.07.004; Merenda F, 2007, P SPIE, V6644; Moerner WE, 2010, SPRINGER SER CHEM PH, V96, P25, DOI 10.1007/978-3-642-02597-6_2; Neuzil P, 2012, NAT REV DRUG DISCOV, V11, P620, DOI 10.1038/nrd3799; Pascoal P, 2010, LAB CHIP, V10, P2235, DOI 10.1039/c004659k; Pick H, 2005, J AM CHEM SOC, V127, P2908, DOI 10.1021/ja044605x; Roizard S, 2011, J AM CHEM SOC, V133, P16868, DOI 10.1021/ja205302g; Rosenbaum DM, 2009, NATURE, V459, P356, DOI 10.1038/nature08144; Ruiz-Velasco V, 2001, J PHYSIOL-LONDON, V537, P679; Schmidlin F, 2002, P NATL ACAD SCI USA, V99, P3324, DOI 10.1073/pnas.052161299; SCOTT RE, 1976, SCIENCE, V194, P743, DOI 10.1126/science.982043; Sezgin E, 2012, NAT PROTOC, V7, P1042, DOI 10.1038/nprot.2012.059; Stadler B, 2009, NANOSCALE, V1, P68, DOI 10.1039/b9nr00143c; Stamou D, 2003, ANGEW CHEM INT EDIT, V42, P5580, DOI 10.1002/anie.200351866; Wistuba II, 2011, NAT REV CLIN ONCOL, V8, P135, DOI 10.1038/nrclinonc.2011.2; Yu NC, 2006, ANAL CHEM, V78, P35, DOI 10.1021/ac051695v	37	11	11	2	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2013	8	8							e70929	10.1371/journal.pone.0070929	http://dx.doi.org/10.1371/journal.pone.0070929			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	218XC	23940670	Green Published, gold, Green Accepted			2022-12-25	WOS:000324465000159
J	Kreis, P; Hendricusdottir, R; Kay, L; Papageorgiou, IE; van Diepen, M; Mack, T; Ryves, J; Harwood, A; Leslie, NR; Kann, O; Parsons, M; Eickholt, BJ				Kreis, Patricia; Hendricusdottir, Rita; Kay, Louise; Papageorgiou, Ismini E.; van Diepen, Michiel; Mack, Till; Ryves, Jonny; Harwood, Adrian; Leslie, Nicholas R.; Kann, Oliver; Parsons, Maddy; Eickholt, Britta J.			Phosphorylation of the Actin Binding Protein Drebrin at S647 Is Regulated by Neuronal Activity and PTEN	PLOS ONE			English	Article							DENDRITIC SPINE; TUMOR-SUPPRESSOR; TENSIN HOMOLOG; IN-VIVO; BRAIN; HIPPOCAMPAL; PHOSPHATASE; EXPRESSION; TRANSMISSION; INHIBITION	Defects in actin dynamics affect activity-dependent modulation of synaptic transmission and neuronal plasticity, and can cause cognitive impairment. A salient candidate actin-binding protein linking synaptic dysfunction to cognitive deficits is Drebrin (DBN). However, the specific mode of how DBN is regulated at the central synapse is largely unknown. In this study we identify and characterize the interaction of the PTEN tumor suppressor with DBN. Our results demonstrate that PTEN binds DBN and that this interaction results in the dephosphorylation of a site present in the DBN C-terminus - serine 647. PTEN and pS647-DBN segregate into distinct and complimentary compartments in neurons, supporting the idea that PTEN negatively regulates DBN phosphorylation at this site. We further demonstrate that neuronal activity increases phosphorylation of DBN at S647 in hippocampal neurons in vitro and in ex vivo hippocampus slices exhibiting seizure activity, potentially by inducing rapid dissociation of the PTEN: DBN complex. Our results identify a novel mechanism by which PTEN is required to maintain DBN phosphorylation at dynamic range and signifies an unusual regulation of an actin-binding protein linked to cognitive decline and degenerative conditions at the CNS synapse.	[Kreis, Patricia; Hendricusdottir, Rita; Kay, Louise; van Diepen, Michiel; Eickholt, Britta J.] Kings Coll London, MRC Ctr Dev Neurobiol, London, England; [Kay, Louise] Univ Oxford, Dept Pharmacol, Oxford OX1 3QT, England; [Papageorgiou, Ismini E.; Kann, Oliver] Heidelberg Univ, Inst Physiol & Pathophysiol, Heidelberg, Germany; [van Diepen, Michiel] Novartis Pharmaceut UK Ltd, Horsham, W Sussex, England; [Mack, Till; Eickholt, Britta J.] Charite, Cluster Excellence NeuroCure, D-13353 Berlin, Germany; [Mack, Till; Eickholt, Britta J.] Charite, Inst Biochem, D-13353 Berlin, Germany; [Ryves, Jonny; Harwood, Adrian] Cardiff Univ, Cardiff Sch Biosci, Cardiff, S Glam, Wales; [Leslie, Nicholas R.] Univ Dundee, Coll Life Sci, Dundee, Scotland; [Parsons, Maddy] Kings Coll London, Randall Div Cell & Mol Biophys, London, England	University of London; King's College London; University of Oxford; Ruprecht Karls University Heidelberg; Novartis; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Cardiff University; University of Dundee; University of London; King's College London	Eickholt, BJ (corresponding author), Kings Coll London, MRC Ctr Dev Neurobiol, London, England.	Britta.Eickholt@charite.de	Eickholt, Britta/C-5337-2009; Kreis, Patricia/GYJ-3521-2022; Papageorgiou, Ismini/AAI-7329-2020; Kann, Oliver/M-4302-2019; Parsons, Maddy/B-2203-2013	Papageorgiou, Ismini/0000-0001-5810-0483; Kann, Oliver/0000-0003-4365-8067; Parsons, Maddy/0000-0002-2021-8379; Eickholt, Britta/0000-0001-7873-8687; Harwood, Adrian/0000-0003-3124-5169; LESLIE, Nicholas/0000-0001-5131-0541; van Diepen, Michiel/0000-0001-8156-4294; Kreis, Patricia/0000-0002-1702-4805	Biotechnology and Biological Science Research Council [BB/I022392/1, BB/F015321/1]; Research into Aging [320]; Biotechnology and Biological Sciences Research Council [BB/F015321/1, BB/I022392/1] Funding Source: researchfish; Medical Research Council [G0901899, G0802289, G0801865] Funding Source: researchfish; BBSRC [BB/F015321/1, BB/I022392/1] Funding Source: UKRI; MRC [G0801865, G0901899, G0802289] Funding Source: UKRI	Biotechnology and Biological Science Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Research into Aging; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was funded by a grant of the Biotechnology and Biological Science Research Council to BJE and MP (BB/I022392/1, BB/F015321/1; http://www.bbsrc.ac.uk/home/home.aspx) and a grant from Research into Aging to BJE (Ref. 320). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Backman SA, 2001, NAT GENET, V29, P396, DOI 10.1038/ng782; Ballif BA, 2004, MOL CELL PROTEOMICS, V3, P1093, DOI 10.1074/mcp.M400085-MCP200; Butler MG, 2005, J MED GENET, V42, P318, DOI 10.1136/jmg.2004.024646; Chadborn NH, 2006, J CELL SCI, V119, P951, DOI 10.1242/jcs.02801; Chew CS, 2005, AM J PHYSIOL-GASTR L, V289, pG320, DOI 10.1152/ajpgi.00002.2005; Collins MO, 2005, J BIOL CHEM, V280, P5972, DOI 10.1074/jbc.M411220200; Cuesto G, 2011, J NEUROSCI, V31, P2721, DOI 10.1523/JNEUROSCI.4477-10.2011; Dephoure N, 2008, P NATL ACAD SCI USA, V105, P10762, DOI 10.1073/pnas.0805139105; Endersby R, 2008, ONCOGENE, V27, P5416, DOI 10.1038/onc.2008.239; Fraser MM, 2008, NEUROSCIENCE, V151, P476, DOI 10.1016/j.neuroscience.2007.10.048; Greer JM, 2006, NEURON, V50, P343, DOI 10.1016/j.neuron.2006.04.021; Harigaya Y, 1996, J NEUROSCI RES, V43, P87, DOI 10.1002/jnr.490430111; Hayashi K, 1999, J NEUROSCI, V19, P3918; Hayashi K, 1996, J NEUROSCI, V16, P7161; Ivanov A, 2009, J CELL SCI, V122, P524, DOI 10.1242/jcs.033464; Joliot A, 2004, NAT CELL BIOL, V6, P189, DOI 10.1038/ncb0304-189; Jurado S, 2010, EMBO J, V29, P2827, DOI 10.1038/emboj.2010.160; Kovacs R, 2009, J NEUROSCI, V29, P8565, DOI 10.1523/JNEUROSCI.5698-08.2009; Kumar V, 2005, J NEUROSCI, V25, P11288, DOI 10.1523/JNEUROSCI.2284-05.2005; Kwon CH, 2006, NEURON, V50, P377, DOI 10.1016/j.neuron.2006.03.023; Lee CC, 2011, NEUROPHARMACOLOGY, V61, P867, DOI 10.1016/j.neuropharm.2011.06.003; Lee JO, 1999, CELL, V99, P323, DOI 10.1016/S0092-8674(00)81663-3; Leslie NR, 2009, ADV ENZYME REGUL, V49, P190, DOI 10.1016/j.advenzreg.2008.12.002; Leslie NR, 2000, BIOCHEM J, V346, P827, DOI 10.1042/0264-6021:3460827; Lois C, 2002, SCIENCE, V295, P868, DOI 10.1126/science.1067081; Molina H, 2007, P NATL ACAD SCI USA, V104, P2199, DOI 10.1073/pnas.0611217104; Myers MP, 1997, P NATL ACAD SCI USA, V94, P9052, DOI 10.1073/pnas.94.17.9052; Olsen JV, 2006, CELL, V127, P635, DOI 10.1016/j.cell.2006.09.026; Parsons M, 2008, J CELL SCI, V121, P265, DOI 10.1242/jcs.018440; Planchon SM, 2008, J CELL SCI, V121, P249, DOI 10.1242/jcs.022459; Rush J, 2005, NAT BIOTECHNOL, V23, P94, DOI 10.1038/nbt1046; Sasaki Y, 1996, J NEUROCHEM, V66, P980; Shiraishi-Yamaguchi Y, 2009, BMC NEUROSCI, V10, DOI 10.1186/1471-2202-10-25; Song MS, 2012, NAT REV MOL CELL BIO, V13, P283, DOI 10.1038/nrm3330; Sperow M, 2012, J PHYSIOL-LONDON, V590, P777, DOI 10.1113/jphysiol.2011.220236; STOPPINI L, 1991, J NEUROSCI METH, V37, P173, DOI 10.1016/0165-0270(91)90128-M; Tada T, 2006, CURR OPIN NEUROBIOL, V16, P95, DOI 10.1016/j.conb.2005.12.001; Takahashi H, 2006, J NEUROCHEM, V97, P110, DOI 10.1111/j.1471-4159.2005.03536.x; Takahashi H, 2003, J NEUROSCI, V23, P6586; Takahashi H, 2009, J CELL SCI, V122, P1211, DOI 10.1242/jcs.043729; Tao WA, 2005, NAT METHODS, V2, P591, DOI 10.1038/NMETH776; Trotman LC, 2007, CELL, V128, P141, DOI 10.1016/j.cell.2006.11.040; van Diepen MT, 2009, NAT CELL BIOL, V11, P1191, DOI 10.1038/ncb1961; Vosseller K, 2005, PROTEOMICS, V5, P388, DOI 10.1002/pmic.200401066; Xue MS, 2009, NEURON, V64, P367, DOI 10.1016/j.neuron.2009.09.043; Zheng HY, 2005, MOL CELL PROTEOMICS, V4, P721, DOI 10.1074/mcp.M400077-MCP200; Zhou J, 2009, J NEUROSCI, V29, P1773, DOI 10.1523/JNEUROSCI.5685-08.2009	47	29	29	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2013	8	8							e71957	10.1371/journal.pone.0071957	http://dx.doi.org/10.1371/journal.pone.0071957			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	218XC	23940795	Green Published, gold			2022-12-25	WOS:000324465000234
J	Michalak, M; Barciszewska, MZ; Barciszewski, J; Plitta, BP; Chmielarz, P				Michalak, Marcin; Barciszewska, Miroslawa Z.; Barciszewski, Jan; Plitta, Beata P.; Chmielarz, Pawel			Global Changes in DNA Methylation in Seeds and Seedlings of Pyrus communis after Seed Desiccation and Storage	PLOS ONE			English	Article							CYTOSINE METHYLTRANSFERASE; REPRESS EXPRESSION; PICKLE ACTS; PLANT; GENOME; DEMETHYLATION; TOLERANCE; STRESS; MECHANISMS; PATTERNS	The effects of storage and deep desiccation on structural changes of DNA in orthodox seeds are poorly characterized. In this study we analyzed the 5-methylcytosine (m(5)C) global content of DNA isolated from seeds of common pear (Pyrus communis L.) that had been subjected to extreme desiccation, and the seedlings derived from these seeds. Germination and seedling emergence tests were applied to determine seed viability after their desiccation. In parallel, analysis of the global content of m(5)C in dried seeds and DNA of seedlings obtained from such seeds was performed with a 2D TLC method. Desiccation of fresh seeds to 5.3% moisture content (mc) resulted in a slight reduction of DNA methylation, whereas severe desiccation down to 2-3% mc increased DNA methylation. Strong desiccation of seeds resulted in the subsequent generation of seedlings of shorter height. A 1-year period of seed storage induced a significant increase in the level of DNA methylation in seeds. It is possible that alterations in the m(5)C content of DNA in strongly desiccated pear seeds reflect a reaction of desiccation-tolerant (orthodox) seeds to severe desiccation. Epigenetic changes were observed not only in severely desiccated seeds but also in 3-month old seedlings obtained from these seeds. With regard to seed storage practices, epigenetic assessment could be used by gene banks for early detection of structural changes in the DNA of stored seeds.	[Michalak, Marcin; Plitta, Beata P.; Chmielarz, Pawel] Polish Acad Sci, Inst Dendrol, PL-62035 Kornik, Poland; [Barciszewska, Miroslawa Z.; Barciszewski, Jan] Polish Acad Sci, Inst Bioorgan Chem, Poznan, Poland	Polish Academy of Sciences; Polish Academy of Sciences; Institute of Bioorganic Chemistry of the Polish Academy of Sciences	Chmielarz, P (corresponding author), Polish Acad Sci, Inst Dendrol, PL-62035 Kornik, Poland.	pach@man.poznan.pl	Chmielarz, Paweł/AAF-9689-2020; Barciszewski, Jan/N-9283-2019; Michalak, Marcin/AAB-8712-2019	Chmielarz, Paweł/0000-0003-3280-3353; Barciszewski, Jan/0000-0001-7766-5594; Michalak, Marcin/0000-0003-1907-9719	National Science Centre, Poland [N309 072036]; General Directorate of the State Forests in Warsaw [OR-2717-2/12]	National Science Centre, Poland(National Science Centre, Poland); General Directorate of the State Forests in Warsaw	This work was partly supported by a grant from the National Science Centre, Poland (no. N309 072036) and General Directorate of the State Forests in Warsaw (OR-2717-2/12). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barciszewska MZ, 2007, BIOGERONTOLOGY, V8, P673, DOI 10.1007/s10522-007-9109-3; Berjak P, 2006, SEED SCI RES, V16, P1, DOI 10.1079/SSR2005236; Berjak P, 2008, ANN BOT-LONDON, V101, P213, DOI 10.1093/aob/mcm168; Bird A, 2002, GENE DEV, V16, P6, DOI 10.1101/gad.947102; Boyko A, 2007, NUCLEIC ACIDS RES, V35, P1714, DOI 10.1093/nar/gkm029; Cao XF, 2002, CURR BIOL, V12, P1138, DOI 10.1016/S0960-9822(02)00925-9; Causevic A, 2005, PLANT PHYSIOL BIOCH, V43, P681, DOI 10.1016/j.plaphy.2005.05.011; Chan SWL, 2005, NAT REV GENET, V6, P351, DOI 10.1038/nrg1601; Chan SWL, 2004, SCIENCE, V303, P1336, DOI 10.1126/science.1095989; Chen TP, 2004, CURR TOP DEV BIOL, V60, P55; Chinnusamy V, 2008, J INTEGR PLANT BIOL, V50, P1187, DOI 10.1111/j.1744-7909.2008.00727.x; Chinnusamy V, 2009, CURR OPIN PLANT BIOL, V12, P133, DOI 10.1016/j.pbi.2008.12.006; Choi CS, 2007, MOL GENET GENOMICS, V277, P589, DOI 10.1007/s00438-007-0209-1; Costa S, 2007, TRENDS CELL BIOL, V17, P101, DOI 10.1016/j.tcb.2006.12.005; FINNEGAN EJ, 1993, NUCLEIC ACIDS RES, V21, P2383, DOI 10.1093/nar/21.10.2383; Fraga MF, 2002, PLANTA, V215, P672, DOI 10.1007/s00425-002-0795-4; Gehring M, 2009, SCIENCE, V324, P1447, DOI 10.1126/science.1171609; Gordon A.G., 1982, FORESTRY COMMISSION, V59; Guzy-Wrobelska J, 2013, ACTA PHYSIOL PLANT, V35, P817, DOI 10.1007/s11738-012-1126-4; Harding K, 2004, CRYOLETTERS, V25, P3; Henderson JT, 2004, PLANT PHYSIOL, V134, P995, DOI 10.1104/pp.103.030148; Holdsworth MJ, 2008, NEW PHYTOL, V179, P33, DOI 10.1111/j.1469-8137.2008.02437.x; Hsieh TF, 2009, SCIENCE, V324, P1451, DOI [10.1126/science.1172417, 10.1126/science.112417]; Jackson JP, 2002, NATURE, V416, P556, DOI 10.1038/nature731; Kalemba EM, 2008, ENVIRON EXP BOT, V63, P274, DOI 10.1016/j.envexpbot.2007.12.011; Kankel MW, 2003, GENETICS, V163, P1109; Kermode Allison R., 2002, P149, DOI 10.1079/9780851995342.0149; Kovarik A, 1997, THEOR APPL GENET, V95, P301, DOI 10.1007/s001220050563; Law JA, 2010, NAT REV GENET, V11, P204, DOI 10.1038/nrg2719; Law JA, 2009, SCIENCE, V323, P1568, DOI 10.1126/science.1172782; Li HC, 2005, PLANT J, V44, P1010, DOI 10.1111/j.1365-313X.2005.02602.x; Lister R, 2008, CELL, V133, P523, DOI 10.1016/j.cell.2008.03.029; McDonald MB, 1999, SEED SCI TECHNOL, V27, P177; Molinier J, 2006, NATURE, V442, P1046, DOI 10.1038/nature05022; Morgan HD, 2005, HUM MOL GENET, V14, pR47, DOI 10.1093/hmg/ddi114; Pammenter NW, 1999, SEED SCI RES, V9, P13, DOI 10.1017/S0960258599000033; Pukacka S, 2007, FUNCT PLANT BIOL, V34, P601, DOI 10.1071/FP07013; Pukacka S, 2011, J PLANT PHYSIOL, V168, P220, DOI 10.1016/j.jplph.2010.07.021; Saze H, 2003, NAT GENET, V34, P65, DOI 10.1038/ng1138; Steward N, 2002, J BIOL CHEM, V277, P37741, DOI 10.1074/jbc.M204050200; Suszka B., 1996, SEEDS FOREST BROADLE; Verhoeven KJF, 2010, NEW PHYTOL, V185, P1108, DOI 10.1111/j.1469-8137.2009.03121.x; Vertucci C. W., 1995, SEED DEV GERMINATION, P237, DOI 10.1201/9780203740071-10; Vicre M, 2004, PLANT CELL ENVIRON, V27, P1329, DOI 10.1111/j.1365-3040.2004.01212.x; Wang WS, 2011, J EXP BOT, V62, P1951, DOI 10.1093/jxb/erq391; Zemach A, 2010, SCIENCE, V328, P916, DOI 10.1126/science.1186366; Zhang MS, 2010, J GENET GENOMICS, V37, P1, DOI 10.1016/S1673-8527(09)60020-5; Zhang XY, 2008, SCIENCE, V320, P489, DOI 10.1126/science.1153996; Zhou JL, 2007, PLANT MOL BIOL, V63, P591, DOI 10.1007/s11103-006-9111-1	49	36	37	2	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2013	8	8							e70693	10.1371/journal.pone.0070693	http://dx.doi.org/10.1371/journal.pone.0070693			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	218XC	23940629	Green Published, Green Submitted, gold			2022-12-25	WOS:000324465000123
J	Miyazaki, T; Miyazaki, S; Ashida, M; Tanaka, T; Tashiro, F; Miyazaki, J				Miyazaki, Tatsushi; Miyazaki, Satsuki; Ashida, Masafumi; Tanaka, Tomofumi; Tashiro, Fumi; Miyazaki, Jun-ichi			Functional Analysis of Tcl1 Using Tcl1-Deficient Mouse Embryonic Stem Cells	PLOS ONE			English	Article							BETA-CATENIN; SELF-RENEWAL; ES CELLS; TRANSCRIPTIONAL ACTIVATION; T-CELL; EXPRESSION; PLURIPOTENCY; WNT; DIFFERENTIATION; GENE	Tcl1 is highly expressed in embryonic stem (ES) cells, but its expression rapidly decreases following differentiation. To assess Tcl1's roles in ES cells, we generated Tcl1-deficient and -overexpressing mouse ES cell lines. We found that Tcl1 was neither essential nor sufficient for maintaining the undifferentiated state. Tcl1 is reported to activate Akt and to enhance cell proliferation. We found that Tcl1 expression levels correlated positively with the proliferation rate and negatively with the apoptosis of ES cells, but did not affect Akt phosphorylation. On the other hand, the phosphorylation level of beta-catenin decreased in response to Tcl1 overexpression. We measured the beta-catenin activity using the TOPflash reporter assay, and found that wild-type ES cells had low activity, which Tcl1 overexpression enhanced 1.8-fold. When the canonical Wnt signaling is activated by beta-catenin stabilization, it reportedly helps maintain ES cells in the undifferentiated state. We then performed DNA microarray analyses between the Tcl1-deficient and -expressing ES cells. The results revealed that Tcl1 expression downregulated a distinct group of genes, including Ndp52, whose expression is very high in blastocysts but reduced in the primitive ectoderm. Based on these results, we discuss the possible roles of Tcl1 in ES cells.	[Miyazaki, Tatsushi; Miyazaki, Satsuki; Ashida, Masafumi; Tanaka, Tomofumi; Tashiro, Fumi; Miyazaki, Jun-ichi] Osaka Univ, Grad Sch Med, Div Stem Cell Regulat Res, Suita, Osaka, Japan	Osaka University	Miyazaki, J (corresponding author), Osaka Univ, Grad Sch Med, Div Stem Cell Regulat Res, Suita, Osaka, Japan.	jimiyaza@nutri.med.osaka-u.ac.jp	Miyazaki, Jun-ichi/N-1976-2015	Miyazaki, Jun-ichi/0000-0003-2475-589X; Miyazaki, Satsuki/0000-0003-1781-1590	Grants-in-Aid for Scientific Research [25860213, 25460364] Funding Source: KAKEN	Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))		Ambrosetti DC, 2000, J BIOL CHEM, V275, P23387, DOI 10.1074/jbc.M000932200; Cartwright P, 2005, DEVELOPMENT, V132, P885, DOI 10.1242/dev.01670; Cervantes RB, 2002, P NATL ACAD SCI USA, V99, P3586, DOI 10.1073/pnas.062527199; Chan TO, 1999, ANNU REV BIOCHEM, V68, P965, DOI 10.1146/annurev.biochem.68.1.965; Eckfeldt CE, 2005, NAT REV MOL CELL BIO, V6, P726, DOI 10.1038/nrm1713; Ema M, 2008, CELL STEM CELL, V3, P555, DOI 10.1016/j.stem.2008.09.003; Ficz G, 2011, NATURE, V473, P398, DOI 10.1038/nature10008; Fujikura J, 2002, GENE DEV, V16, P784, DOI 10.1101/gad.968802; Glover CH, 2006, PLOS COMPUT BIOL, V2, P1463, DOI 10.1371/journal.pcbi.0020158; Hallas C, 1999, P NATL ACAD SCI USA, V96, P14418, DOI 10.1073/pnas.96.25.14418; Hallmann D, 2003, J BIOL CHEM, V278, P5099, DOI 10.1074/jbc.M208451200; Haq S, 2003, P NATL ACAD SCI USA, V100, P4610, DOI 10.1073/pnas.0835895100; Hayashi K, 2008, CELL STEM CELL, V3, P391, DOI 10.1016/j.stem.2008.07.027; Hering M, 2003, BLOOD, V101, P5007, DOI 10.1182/blood-2002-10-3297; Huelsken J, 2000, J CELL BIOL, V148, P567, DOI 10.1083/jcb.148.3.567; Jang H, 2012, CELL STEM CELL, V11, P62, DOI 10.1016/j.stem.2012.03.001; Jirmanova L, 2002, ONCOGENE, V21, P5515, DOI 10.1038/sj.onc.1205728; Kang SM, 2005, BLOOD, V105, P1288, DOI 10.1182/blood-2004-04-1453; Kemler R, 2004, DEVELOPMENT, V131, P5817, DOI 10.1242/dev.01458; Korinek V, 1997, SCIENCE, V275, P1784, DOI 10.1126/science.275.5307.1784; Laine J, 2002, J BIOL CHEM, V277, P3743, DOI 10.1074/jbc.M107069200; Lickert H, 2005, DEVELOPMENT, V132, P2599, DOI 10.1242/dev.01842; Matoba R, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000026; Moritoh Y, 2003, DIABETES, V52, P1163, DOI 10.2337/diabetes.52.5.1163; Morkel M, 2003, DEVELOPMENT, V130, P6283, DOI 10.1242/dev.00859; Najm FJ, 2011, CELL STEM CELL, V8, P318, DOI 10.1016/j.stem.2011.01.016; Narducci MG, 2002, P NATL ACAD SCI USA, V99, P11712, DOI 10.1073/pnas.182412399; Narducci MG, 1997, ONCOGENE, V15, P919, DOI 10.1038/sj.onc.1201246; Niwa H, 2000, NAT GENET, V24, P372, DOI 10.1038/74199; Niwa H, 1998, GENE DEV, V12, P2048, DOI 10.1101/gad.12.13.2048; Niwa H, 2011, NAT CELL BIOL, V13, P1024, DOI 10.1038/ncb2333; Paling NRD, 2004, J BIOL CHEM, V279, P48063, DOI 10.1074/jbc.M406467200; Pekarsky Y, 2000, P NATL ACAD SCI USA, V97, P3028, DOI 10.1073/pnas.040557697; Sato N, 2004, NAT MED, V10, P55, DOI 10.1038/nm979; SAUER B, 1993, METHOD ENZYMOL, V225, P890; Sokol SY, 2011, DEVELOPMENT, V138, P4341, DOI 10.1242/dev.066209; Song G, 2005, J CELL MOL MED, V9, P59, DOI 10.1111/j.1582-4934.2005.tb00337.x; Stiles B, 2002, MOL CELL BIOL, V22, P3842, DOI 10.1128/MCB.22.11.3842-3851.2002; Teitell MA, 2005, NAT REV CANCER, V5, P640, DOI 10.1038/nrc1672; Tian Q, 2004, P NATL ACAD SCI USA, V101, P15370, DOI 10.1073/pnas.0406499101; Virgilio L, 1998, P NATL ACAD SCI USA, V95, P3885, DOI 10.1073/pnas.95.7.3885; Wang JB, 2004, CURR OPIN GENET DEV, V14, P533, DOI 10.1016/j.gde.2004.07.013; Wray J, 2012, TRENDS CELL BIOL, V22, P159, DOI 10.1016/j.tcb.2011.11.004; Yanagawa Y, 1999, TRANSGENIC RES, V8, P215, DOI 10.1023/A:1008914020843	44	9	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2013	8	8							e71645	10.1371/journal.pone.0071645	http://dx.doi.org/10.1371/journal.pone.0071645			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	218XC	23940776	Green Submitted, Green Published, gold			2022-12-25	WOS:000324465000219
J	Mohrke, J; Kropp, P; Zettl, UK				Moehrke, Jan; Kropp, Peter; Zettl, Uwe K.			Headaches in Multiple Sclerosis Patients Might Imply an Inflammatorial Process	PLOS ONE			English	Article							TENSION-TYPE HEADACHE; CLUSTER HEADACHE; MENINGEAL INFLAMMATION; CLINICAL-FEATURES; MIGRAINE; PREVALENCE; DISABILITY; THERAPY; PAIN; MS	Recent studies on Multiple Sclerosis (MS) pathology mention the involvement of "tertiary B cell follicles" in MS pathogenesis. This inflammatory process, which occurs with interindividually great variance, might be a link between MS pathology and headaches. The aim of this study was to detect the prevalence of headaches and of subtypes of headaches (migraine, cluster, tension-type headache [TTH]) in an unselected MS collective and to compile possibly influencing factors. Unselected MS patients (n = 180) with and without headache were examined by a semi-structured interview using a questionnaire about headache, depression and the health status. Additionally clinical MS data (expanded disability state score [EDSS], MS course, medication, disease duration) were gathered. N = 98 MS patients (55.4%) reported headaches in the previous 4 weeks. We subsequently grouped headache patients according to the IHS criteria and detected 16 (16.3%) MS patients suffering from migraine (migraine with aura: 2 [2%]; migraine without aura: 14 [14.3%]), 23 (23.5%) suffering from TTH and none with a cluster headache. Thus, headaches of 59 (60.2%) MS patients remained unclassified. When comparing MS patients with and without headaches significant differences in age, gender, MS course, physical functioning, pain and social functioning occurred. MS patients with headaches were significantly younger of age (p = 0.001), female (p = 0.001) and reported more often of a clinically isolated syndrome (CIS) and relapsing/remitting MS (RRMS) instead of secondary chronic progressive MS (SCP). EDSS was significantly lower in MS patients suffering from headaches compared to the MS patients without headaches (p = 0.001). In conclusion headache in MS patients is a relevant symptom, especially in early stages of the MS disease. Especially unclassified headache seems to represent an important symptom in MS course and requires increased attention.	[Moehrke, Jan; Kropp, Peter] Univ Rostock, Fac Med, Inst Med Psychol & Med Sociol, D-18055 Rostock, Germany; [Moehrke, Jan; Zettl, Uwe K.] Univ Rostock, Fac Med, Dept Neurol, D-18055 Rostock, Germany	University of Rostock; University of Rostock	Kropp, P (corresponding author), Univ Rostock, Fac Med, Inst Med Psychol & Med Sociol, D-18055 Rostock, Germany.	peter.kropp@med.uni-rostock.de	Kropp, Peter/B-8132-2012					Akerman S, 2011, NAT REV NEUROSCI, V12, P570, DOI 10.1038/nrn3057; Boneschi FM, 2008, MULT SCLER, V14, P514, DOI 10.1177/1352458507085551; Chen Y, 2009, CURR PAIN HEADACHE R, V13, P484, DOI 10.1007/s11916-009-0078-x; Comabella M, 2012, CLIN IMMUNOL, V142, P2, DOI 10.1016/j.clim.2011.03.004; D'Amico D, 2004, CEPHALALGIA, V24, P980, DOI 10.1111/j.1468-2982.2004.00790.x; DALAKAS MC, 1994, NEUROLOGY, V44, P223, DOI 10.1212/WNL.44.2.223; Farkkila M, 2012, LANCET NEUROL, V11, P405, DOI 10.1016/S1474-4422(12)70047-9; Frischer JM, 2009, BRAIN, V132, P1175, DOI 10.1093/brain/awp070; Gaul C, 2011, DTSCH ARZTEBL INT, V108, P543, DOI 10.3238/arztebl.2011.0543; Gee JR, 2005, HEADACHE, V45, P670, DOI 10.1111/j.1526-4610.2005.05136.x; Gold Ralf, 2010, Ther Adv Neurol Disord, V3, P351, DOI 10.1177/1756285610385608; Hautzinger M., 2009, BDI 2 BECK DEPRESSIO; Hautzinger M, 2006, BDI 2 BECK DEPRESSIO; IHS, 2004, CEPHALALGIA S1, V24, P9; Kister I, 2010, CURR PAIN HEADACHE R, V14, P441, DOI 10.1007/s11916-010-0143-5; Kister I, 2010, J HEADACHE PAIN, V11, P417, DOI 10.1007/s10194-010-0237-9; Lassmann H, 2011, J NEURAL TRANSM, V118, P747, DOI 10.1007/s00702-011-0607-8; Levy D, 2009, CURR PAIN HEADACHE R, V13, P237, DOI 10.1007/s11916-009-0040-y; Magliozzi R, 2007, BRAIN, V130, P1089, DOI 10.1093/brain/awm038; Magliozzi R, 2010, ANN NEUROL, V68, P477, DOI 10.1002/ana.22230; May A, 2005, LANCET, V366, P843, DOI 10.1016/S0140-6736(05)67217-0; May A, 1998, LANCET, V352, P275, DOI 10.1016/S0140-6736(98)02470-2; Mix E, 2010, PROG NEUROBIOL, V92, P386, DOI 10.1016/j.pneurobio.2010.06.005; Morfeld M, 2005, SOZ PRAVENTIV MED, V50, P292, DOI 10.1007/s00038-005-4090-6; Nicoletti A, 2008, CEPHALALGIA, V28, P1163, DOI 10.1111/j.1468-2982.2008.01662.x; Obermann Mark, 2008, Expert Rev Neurother, V8, P1313, DOI 10.1586/14737175.8.9.1313; Pearson K, 1900, PHILOS MAG, V50, P157, DOI 10.1080/14786440009463897; Pollmann W, 2002, NEUROLOGY, V59, P636, DOI 10.1212/WNL.59.4.636; Polman CH, 2005, ANN NEUROL, V58, P840, DOI 10.1002/ana.20703; Putzki N, 2009, EUR J NEUROL, V16, P262, DOI 10.1111/j.1468-1331.2008.02406.x; Schramm SH, 2013, J HEADACHE PAIN, V14, DOI 10.1186/1129-2377-14-40; Sormani MP, 2010, NEUROLOGY, V75, P302, DOI 10.1212/WNL.0b013e3181ea15aa; Stovner LJ, 2007, CEPHALALGIA, V27, P193, DOI 10.1111/j.1468-2982.2007.01288.x; Trojano M, 2003, NEUROL SCI, V24, pS268, DOI 10.1007/s10072-003-0171-6; Vacca G, 2007, NEUROL SCI, V28, P133, DOI 10.1007/s10072-007-0805-1; Villani V, 2008, NEUROL SCI, V29, pS146, DOI 10.1007/s10072-008-0908-3; WEINSHENKER BG, 1989, BRAIN, V112, P1419, DOI 10.1093/brain/112.6.1419; Wittstock M, 2003, EUR NEUROL, V50, P172, DOI 10.1159/000073059; Yetimalar Y, 2008, NEW ZEAL MED J, V121, P47; Zettl UK, 2012, AUTOIMMUN REV, V11, P167, DOI 10.1016/j.autrev.2011.05.008; [No title captured]	41	25	26	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2013	8	8							e69570	10.1371/journal.pone.0069570	http://dx.doi.org/10.1371/journal.pone.0069570			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	218XC	23940524	Green Submitted, Green Published, gold			2022-12-25	WOS:000324465000018
J	Coulter, JB; O'Driscoll, CM; Bressler, JP				Coulter, Jonathan B.; O'Driscoll, Cliona M.; Bressler, Joseph P.			Hydroquinone Increases 5-Hydroxymethylcytosine Formation through Ten Eleven Translocation 1 (TET1) 5-Methylcytosine Dioxygenase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Dioxygenase; DNA Methylation; Epigenetics; Quinones; Reactive Oxygen Species (ROS); Benzene; DNA Demethylation; Hydroquinone; Ten Eleven Translocation 1; TET1	DNA METHYLATION; PROMOTER METHYLATION; 14-3-3 SIGMA; BENZENE; DEMETHYLATION; INACTIVATION; CONVERSION; INHIBITOR; REPRESSOR; DAMAGE	DNA methylation regulates gene expression throughout development and in a wide range of pathologies such as cancer and neurological disorders. Pathways controlling the dynamic levels and targets of methylation are known to be disrupted by chemicals and are therefore of great interest in both prevention and clinical contexts. Benzene and its metabolite hydroquinone have been shown to lead to decreased levels of DNA methylation, although the mechanism is not known. This study employs a cell culture model to investigate the mechanism of hydroquinone-mediated changes in DNA methylation. Exposures that do not affect HEK293 cell viability led to genomic and methylated reporter DNA demethylation. Hydroquinone caused reactivation of a methylated reporter plasmid that was prevented by the addition of N-acetylcysteine. Hydroquinone also caused an increase in Ten Eleven Translocation 1 activity and global levels of 5-hydroxymethylcytosine. 5-Hydroxymethylcytosine was found enriched at LINE-1 prior to a decrease in both 5-hydroxymethylcytosine and 5-methylcytosine. Ten Eleven Translocation-1 knockdown decreased 5-hydroxymethylcytosine formation following hydroquinone exposure as well as the induction of glutamate-cysteine ligase catalytic subunit and 14-3-3 sigma. Finally, Ten Eleven Translocation 1 knockdown decreased the percentage of cells accumulating in G(2)+M following hydroquinone exposure, indicating that it may have a role in cell cycle changes in response to toxicants. This work demonstrates that hydroquinone exposure leads to active and functional DNA demethylation in HEK293 cells in a mechanism involving reactive oxygen species and Ten Eleven Translocation 1 5-methylcytosine dioxygenase.	[Coulter, Jonathan B.] Johns Hopkins Univ, Dept Environm Hlth Sci, Bloomberg Sch Publ Hlth, Baltimore, MD 21205 USA; Hugo Moser Res Inst Kennedy Krieger, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Coulter, JB (corresponding author), Johns Hopkins Univ, Dept Environm Hlth Sci, Bloomberg Sch Publ Hlth, Baltimore, MD 21205 USA.	jcoulter@jhsph.edu; bressler@kennedykrieger.org		Coulter, Jonathan/0000-0003-0380-9254	National Institutes of Health [1U18TR000547]; Hopkins University Center in Urban and Environmental Health [30 ES003819]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [U18TR000547] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [T32ES007141, P30ES003819] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Hopkins University Center in Urban and Environmental Health; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported, in whole or in part, by National Institutes of Health Grant 1U18TR000547. This work was also supported by Johns Hopkins University Center in Urban and Environmental Health Grant 30 ES003819.	[Anonymous], 1987, IARC Monogr Eval Carcinog Risks Hum Suppl, V7, P1; Bollati V, 2007, CANCER RES, V67, P876, DOI 10.1158/0008-5472.CAN-06-2995; Castro GD, 1996, CHEM-BIOL INTERACT, V99, P289, DOI 10.1016/0009-2797(95)03680-6; Cerda S, 1997, MUTAT RES-REV MUTAT, V386, P141, DOI 10.1016/S1383-5742(96)00050-6; Christman JK, 2002, ONCOGENE, V21, P5483, DOI 10.1038/sj.onc.1205699; Du W, 2012, BLOOD, V119, P4142, DOI 10.1182/blood-2011-09-381970; Ferguson AT, 2000, P NATL ACAD SCI USA, V97, P6049, DOI 10.1073/pnas.100566997; Guo JJU, 2011, NAT NEUROSCI, V14, P1345, DOI 10.1038/nn.2900; Guo JU, 2011, CELL, V145, P423, DOI 10.1016/j.cell.2011.03.022; Hermeking H, 1997, MOL CELL, V1, P3, DOI 10.1016/S1097-2765(00)80002-7; Ponferrada-Marin MI, 2010, J BIOL CHEM, V285, P23030, DOI 10.1074/jbc.M110.124578; Ishida K, 2012, J PERIODONTOL, V83, P917, DOI 10.1902/jop.2011.110356; Ito S, 2010, NATURE, V466, P1129, DOI 10.1038/nature09303; Jaenisch R, 2003, NAT GENET, V33, P245, DOI 10.1038/ng1089; Ji Z, 2010, LEUKEMIA, V24, P986, DOI 10.1038/leu.2010.43; KOLACHANA P, 1993, CANCER RES, V53, P1023; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Lee BH, 2005, J BIOL CHEM, V280, P40749, DOI 10.1074/jbc.M505593200; Lee WJ, 2006, CARCINOGENESIS, V27, P269, DOI 10.1093/carcin/bgi206; Lertratanangkoon K, 1997, CANCER LETT, V120, P149, DOI 10.1016/S0304-3835(97)00300-5; Liu C, 2013, PLOS ONE, V8; Lodygin D, 2005, CELL RES, V15, P237, DOI 10.1038/sj.cr.7290292; Millan MJ, 2013, NEUROPHARMACOLOGY, V68, P2, DOI 10.1016/j.neuropharm.2012.11.015; Muotri AR, 2010, NATURE, V468, P443, DOI 10.1038/nature09544; O'Driscoll CM, 2013, BBA-MOL CELL RES, V1833, P460, DOI 10.1016/j.bbamcr.2012.11.012; O'Hagan HM, 2011, CANCER CELL, V20, P606, DOI 10.1016/j.ccr.2011.09.012; ONG CN, 1994, INT J CANCER, V59, P177, DOI 10.1002/ijc.2910590206; Orr BA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041036; PARKE DV, 1953, BIOCHEM J, V54, P231, DOI 10.1042/bj0540231; PARMENTIER R, 1948, NATURE, V161, P527, DOI 10.1038/161527a0; Shen DX, 2003, CHEM-BIOL INTERACT, V145, P225, DOI 10.1016/S0009-2797(03)00003-6; Snyder R, 1996, ENVIRON HEALTH PERSP, V104, P1165, DOI 10.1289/ehp.961041165; Tahiliani M, 2009, SCIENCE, V324, P930, DOI 10.1126/science.1170116; Tsai HC, 2011, CELL RES, V21, P502, DOI 10.1038/cr.2011.24; Wagner JR, 2010, ACCOUNTS CHEM RES, V43, P564, DOI 10.1021/ar9002637; Westfall MD, 2003, MOL CELL BIOL, V23, P2264, DOI 10.1128/MCB.23.7.2264-2276.2003; Yi B, 2009, J CELL BIOCHEM, V106, P858, DOI 10.1002/jcb.22051	37	74	76	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 4	2013	288	40					28792	28800		10.1074/jbc.M113.491365	http://dx.doi.org/10.1074/jbc.M113.491365			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	298BL	23940045	Green Published, hybrid			2022-12-25	WOS:000330298800032
J	Shen, S; Horowitz, ED; Troupes, AN; Brown, SM; Pulicherla, N; Samulski, RJ; Agbandje-McKenna, M; Asokan, A				Shen, Shen; Horowitz, Eric D.; Troupes, Andrew N.; Brown, Sarah M.; Pulicherla, Nagesh; Samulski, Richard J.; Agbandje-McKenna, Mavis; Asokan, Aravind			Engraftment of a Galactose Receptor Footprint onto Adeno-associated Viral Capsids Improves Transduction Efficiency	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Carbohydrate; Cell Surface Receptor; Gene Therapy; Protein Engineering; Virus Entry; Adeno-associated Virus	HEPARAN-SULFATE PROTEOGLYCAN; HUMAN GENE-THERAPY; VIRUS SEROTYPE 6; MUSCULAR-DYSTROPHY; AAV VECTOR; BINDING; IDENTIFICATION; TYPE-2; MICE; TRANSMISSION	New viral strains can be evolved to recognize different host glycans through mutagenesis and experimental adaptation. However, such mutants generally harbor amino acid changes that affect viral binding to a single class of carbohydrate receptors. We describe the rational design and synthesis of novel, chimeric adeno-associated virus (AAV) strains that exploit an orthogonal glycan receptor for transduction. A dual glycan-binding AAV strain was first engineered as proof of concept by grafting a galactose (Gal)-binding footprint from AAV serotype 9 onto the heparan sulfate-binding AAV serotype 2. The resulting chimera, AAV2G9, continues to bind heparin affinity columns but interchangeably exploits Gal and heparan sulfate receptors for infection, as evidenced by competitive inhibition assays with lectins, glycans, and parental AAV strains. Although remaining hepatotropic like AAV2, the AAV2G9 chimera mediates rapid onset and higher transgene expression in mice. Similarly, engraftment of the Gal footprint onto the laboratory-derived strain AAV2i8 yielded an enhanced AAV2i8G9 chimera. This new strain remains liver-detargeted like AAV2i8 while selectively transducing muscle tissues at high efficiency, comparable with AAV9. The AAV2i8G9 chimera is a promising vector candidate for targeted gene therapy of cardiac and musculoskeletal diseases. In addition to demonstrating the modularity of glycan receptor footprints on viral capsids, our approach provides design strategies to expand the AAV vector toolkit.	[Shen, Shen; Horowitz, Eric D.; Troupes, Andrew N.; Brown, Sarah M.; Pulicherla, Nagesh; Samulski, Richard J.; Asokan, Aravind] Univ N Carolina, Gene Therapy Ctr, Chapel Hill, NC 27599 USA; [Shen, Shen; Asokan, Aravind] Univ N Carolina, Dept Genet, Chapel Hill, NC 27599 USA; [Asokan, Aravind] Univ N Carolina, Dept Biochem & Biophys, Chapel Hill, NC 27599 USA; [Agbandje-McKenna, Mavis] Univ Florida, Dept Biochem & Mol Biol, Gainesville, FL 32610 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; State University System of Florida; University of Florida	Asokan, A (corresponding author), Univ N Carolina, Gene Therapy Ctr, CB 7352,5123 Thurston Bldg, Chapel Hill, NC 27599 USA.	aravind@med.unc.edu			National Institutes of Health [R01HL089221, P01HL112761, R01AI072176, R01GM082946]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL112761, R01HL089221] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI072176] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM082946] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01HL089221 and P01HL112761 (to A. A. and R. J. S.), R01AI072176 (to R. J. S.), and R01GM082946 (to M. A. M.).	Adachi K., 2012, 15 ANN M AM SOC GEN, pS4; Agbandje-McKenna M, 2011, METHODS MOL BIOL, V807, P47, DOI 10.1007/978-1-61779-370-7_3; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Asokan A, 2012, MOL THER, V20, P699, DOI 10.1038/mt.2011.287; Asokan A, 2010, NAT BIOTECHNOL, V28, P79, DOI 10.1038/nbt.1599; Bell CL, 2012, J VIROL, V86, P7326, DOI 10.1128/JVI.00448-12; Bell CL, 2011, J CLIN INVEST, V121, P2427, DOI 10.1172/JCI57367; Bowles DE, 2012, MOL THER, V20, P443, DOI 10.1038/mt.2011.237; Carrillo-Tripp M, 2009, NUCLEIC ACIDS RES, V37, pD436, DOI 10.1093/nar/gkn840; DEUTSCHER SL, 1986, J BIOL CHEM, V261, P96; DiMattia MA, 2012, J VIROL, V86, P6947, DOI 10.1128/JVI.07232-11; Fan Z, 2012, MOL THER, V20, P456, DOI 10.1038/mt.2011.137; Gao GP, 2002, P NATL ACAD SCI USA, V99, P11854, DOI 10.1073/pnas.182412299; Grieger JC, 2006, NAT PROTOC, V1, P1412, DOI 10.1038/nprot.2006.207; Halbert CL, 2001, J VIROL, V75, P6615, DOI 10.1128/JVI.75.14.6615-6624.2001; Herfst S, 2012, SCIENCE, V336, P1534, DOI 10.1126/science.1213362; High KA, 2012, BLOOD, V120, P4482, DOI 10.1182/blood-2012-05-423210; Imai M, 2012, NATURE, V486, P420, DOI 10.1038/nature10831; Inagaki K, 2006, MOL THER, V14, P45, DOI 10.1016/j.ymthe.2006.03.014; Kern A, 2003, J VIROL, V77, P11072, DOI 10.1128/JVI.77.20.11072-11081.2003; Kornegay JN, 2010, MOL THER, V18, P1501, DOI 10.1038/mt.2010.94; Lerch TF, 2012, VIROLOGY, V423, P6, DOI 10.1016/j.virol.2011.10.007; Levy HC, 2009, J STRUCT BIOL, V165, P146, DOI 10.1016/j.jsb.2008.12.002; Maheshri N, 2006, NAT BIOTECHNOL, V24, P198, DOI 10.1038/nbt1182; McCarty DM, 2008, MOL THER, V16, P1648, DOI 10.1038/mt.2008.171; Mingozzi F, 2011, NAT REV GENET, V12, P341, DOI 10.1038/nrg2988; Neu U, 2011, CURR OPIN STRUC BIOL, V21, P610, DOI 10.1016/j.sbi.2011.08.009; Ng R, 2010, J VIROL, V84, P12945, DOI 10.1128/JVI.01235-10; O'Donnell J, 2009, VIROLOGY, V385, P434, DOI 10.1016/j.virol.2008.11.037; Olofsson S, 2005, ANN MED, V37, P154, DOI 10.1080/07853890510007340; Opie SR, 2003, J VIROL, V77, P6995, DOI 10.1128/JVI.77.12.6995-7006.2003; Shen S, 2012, J VIROL, V86, P10408, DOI 10.1128/JVI.01155-12; Shen S, 2011, J BIOL CHEM, V286, P13532, DOI 10.1074/jbc.M110.210922; Summerford C, 1998, J VIROL, V72, P1438, DOI 10.1128/JVI.72.2.1438-1445.1998; Wu Z, 2006, J VIROL, V80, P11393, DOI 10.1128/JVI.01288-06; Xie Q, 2002, P NATL ACAD SCI USA, V99, P10405, DOI 10.1073/pnas.162250899; Xie Q, 2011, VIROLOGY, V420, P10, DOI 10.1016/j.virol.2011.08.011; Zhong L, 2008, P NATL ACAD SCI USA, V105, P7827, DOI 10.1073/pnas.0802866105; Zincarelli C, 2008, MOL THER, V16, P1073, DOI 10.1038/mt.2008.76	39	58	67	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 4	2013	288	40					28814	28823		10.1074/jbc.M113.482380	http://dx.doi.org/10.1074/jbc.M113.482380			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	298BL	23940044	Green Published, hybrid			2022-12-25	WOS:000330298800034
J	Asano, A; Nelson-Harrington, JL; Travis, AJ				Asano, Atsushi; Nelson-Harrington, Jacquelyn L.; Travis, Alexander J.			Phospholipase B Is Activated in Response to Sterol Removal and Stimulates Acrosome Exocytosis in Murine Sperm	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ZONA-PELLUCIDA; LIPID RAFTS; CRYPTOCOCCUS-NEOFORMANS; DIFFERENTIAL RELEASE; CHOLESTEROL EFFLUX; MOUSE SPERMATOZOA; MEMBRANE RAFTS; IDENTIFICATION; EXPRESSION; PROTEIN	Despite a strict requirement for sterol removal for sperm to undergo acrosome exocytosis (AE), the mechanisms by which changes in membrane sterols are transduced into changes in sperm fertilization competence are poorly understood. We have previously shown in live murine sperm that the plasma membrane overlying the acrosome (APM) contains several types of microdomains known as membrane rafts. When characterizing the membrane raft-associated proteomes, we identified phospholipase B (PLB), a calcium-independent enzyme exhibiting multiple activities. Here, we show that sperm surface PLB is activated in response to sterol removal. Both biochemical activity assays and immunoblots of subcellular fractions of sperm incubated with the sterol acceptor 2-hydroxypropyl-beta-cyclodextrin (2-OHCD) confirmed the release of an active PLB fragment. Specific protease inhibitors prevented PLB activation, revealing a mechanistic requirement for proteolytic cleavage. Competitive inhibitors of PLB reduced the ability of sperm both to undergo AE and to fertilize oocytes in vitro, suggesting an important role in fertilization. This was reinforced by our finding that incubation either with protein concentrate released from 2-OHCD-treated sperm or with recombinant PLB peptide corresponding to the catalytic domain was able to induce AE in the absence of other stimuli. Together, these results lead us to propose a novel mechanism by which sterol removal promotes membrane fusogenicity and AE, helping confer fertilization competence. Importantly, this mechanism provides a basis for the newly emerging model of AE in which membrane fusions occur during capacitation/transit through the cumulus, prior to any physical contact between the sperm and the oocyte's zona pellucida.	[Asano, Atsushi; Nelson-Harrington, Jacquelyn L.; Travis, Alexander J.] Cornell Univ, Coll Vet Med, Baker Inst Anim Hlth, Ithaca, NY 14853 USA	Cornell University	Asano, A (corresponding author), Univ Tsukuba, Fac Life & Environm Sci, Tsukuba, Ibaraki 3058577, Japan.	asano.atsushi.ft@u.tsukuba.ac.jp			National Institutes of Health [R01-HD-045664, DP-OD-006431]; Baker Institute for Animal Health; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD045664] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP1OD006431] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Baker Institute for Animal Health; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported, in whole or in part, by National Institutes of Health Grants R01-HD-045664 and DP-OD-006431 (to A.J.T.). This work was also supported by the Baker Institute for Animal Health.	Asano A, 2010, PROTEOMICS, V10, P3494, DOI 10.1002/pmic.201000002; Asano A, 2009, J CELL PHYSIOL, V218, P537, DOI 10.1002/jcp.21623; AUSTIN CR, 1951, AUST J SCI RES SER B, V4, P581, DOI 10.1071/BI9510581; Basak A, 2005, FEBS LETT, V579, P4813, DOI 10.1016/j.febslet.2005.07.062; Basak A, 2008, PROTEIN EXPRES PURIF, V60, P117, DOI 10.1016/j.pep.2008.03.013; BELLVE AR, 1977, J CELL BIOL, V74, P68, DOI 10.1083/jcb.74.1.68; Bergeron F, 2000, J MOL ENDOCRINOL, V24, P1, DOI 10.1677/jme.0.0240001; BORDIER C, 1981, J BIOL CHEM, V256, P1604; Buffone MG, 2008, J BIOL CHEM, V283, P12438, DOI 10.1074/jbc.M706421200; Buffone MG, 2009, J CELL SCI, V122, P3153, DOI 10.1242/jcs.052977; CHANG MC, 1951, NATURE, V168, P697, DOI 10.1038/168697b0; Chen SCA, 2000, BIOCHEM J, V347, P431, DOI 10.1042/0264-6021:3470431; CROSS NL, 1986, CELL BIOL INT REP, V10, P545, DOI 10.1016/0309-1651(86)90029-9; Darrow AL, 2011, J LIPID RES, V52, P374, DOI 10.1194/jlr.D007971; Delagebeaudeuf C, 1998, J BIOL CHEM, V273, P13407, DOI 10.1074/jbc.273.22.13407; DENAULT JB, 1995, J CARDIOVASC PHARM, V26, pS47; Djordjevic JT, 2005, BIOCHEM J, V389, P803, DOI 10.1042/BJ20050063; ERBACH GT, 1994, BIOL REPROD, V50, P1027, DOI 10.1095/biolreprod50.5.1027; Escoffier J, 2011, J CELL PHYSIOL, V226, P2601, DOI 10.1002/jcp.22606; Escoffier J, 2010, J CLIN INVEST, V120, P1415, DOI 10.1172/JCI40494; GASSAMADIAGNE A, 1989, J BIOL CHEM, V264, P9470; Ghannoum MA, 2000, CLIN MICROBIOL REV, V13, P122, DOI 10.1128/CMR.13.1.122-143.2000; Gyamera-Acheampong C, 2006, BIOL REPROD, V74, P666, DOI 10.1095/biolreprod.105.046821; Gyamera-Acheampong C, 2010, FERTIL STERIL, V93, P1112, DOI 10.1016/j.fertnstert.2008.12.013; Gyamera-Acheampong C, 2009, HUM REPROD UPDATE, V15, P237, DOI 10.1093/humupd/dmn060; Harper CV, 2008, J CELL SCI, V121, P2130, DOI 10.1242/jcs.030379; Hendrickson HS, 1999, METH MOL B, V109, P1; Honda A, 2002, J BIOL CHEM, V277, P16976, DOI 10.1074/jbc.M112470200; Hruskova-Heidingsfeldova O, 2008, FRONT BIOSCI, V13, P7227, DOI 10.2741/3224; Jin M, 2011, P NATL ACAD SCI USA, V108, P4892, DOI 10.1073/pnas.1018202108; Kim KS, 2003, DEV BIOL, V264, P141, DOI 10.1016/j.ydbio.2003.08.006; Kim KS, 2001, BIOL REPROD, V64, P148, DOI 10.1095/biolreprod64.1.148; Kohler GA, 2006, BBA-MOL CELL BIOL L, V1761, P1391, DOI 10.1016/j.bbalip.2006.09.011; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Larson JL, 1999, MOL REPROD DEV, V52, P445, DOI 10.1002/(SICI)1098-2795(199904)52:4&lt;445::AID-MRD14&gt;3.0.CO;2-6; Lu T, 2001, BIOCHEMISTRY-US, V40, P7133, DOI 10.1021/bi010237n; Maury E, 2002, BIOCHEM BIOPH RES CO, V295, P362, DOI 10.1016/S0006-291X(02)00657-5; Mbikay M, 1997, P NATL ACAD SCI USA, V94, P6842, DOI 10.1073/pnas.94.13.6842; NAKAYAMA K, 1992, J BIOL CHEM, V267, P5897; Nauze M, 2002, J BIOL CHEM, V277, P44093, DOI 10.1074/jbc.M205761200; Pike LJ, 2006, J LIPID RES, V47, P1597, DOI 10.1194/jlr.E600002-JLR200; Roldan E. R. S., 1998, Frontiers in Bioscience, V3, pD1109; Roldan ERS, 2007, FRONT BIOSCI-LANDMRK, V12, P89, DOI 10.2741/2050; SAITO K, 1991, METHOD ENZYMOL, V197, P446; Santangelo RT, 1999, J MED MICROBIOL, V48, P731, DOI 10.1099/00222615-48-8-731; Selvaraj V, 2006, J CELL PHYSIOL, V206, P636, DOI 10.1002/jcp.20504; Selvaraj V, 2010, DEV BIOL, V348, P177, DOI 10.1016/j.ydbio.2010.09.019; Selvaraj V, 2009, J CELL PHYSIOL, V218, P522, DOI 10.1002/jcp.21624; Shannon M, 1999, FEBS LETT, V462, P329, DOI 10.1016/S0014-5793(99)01546-X; Siafakas AR, 2006, EUKARYOT CELL, V5, P488, DOI 10.1128/EC.5.3.488-498.2006; Simons K, 2010, NAT REV MOL CELL BIO, V11, P688, DOI 10.1038/nrm2977; SUGATANI J, 1980, BIOCHIM BIOPHYS ACTA, V620, P372; Takemori H, 1998, J BIOL CHEM, V273, P2222, DOI 10.1074/jbc.273.4.2222; Tchoua U, 2000, BBA-MOL CELL BIOL L, V1487, P255, DOI 10.1016/S1388-1981(00)00101-3; Tojo H, 1998, J BIOL CHEM, V273, P2214, DOI 10.1074/jbc.273.4.2214; Travis AJ, 1998, MOL BIOL CELL, V9, P263, DOI 10.1091/mbc.9.2.263; Travis AJ, 2002, J CLIN INVEST, V110, P731, DOI [10.1172/JCI200216392, 10.1172/JCI0216392]; Travis AJ, 2001, DEV BIOL, V240, P599, DOI 10.1006/dbio.2001.0475; Travis AJ, 2001, J BIOL CHEM, V276, P7630, DOI 10.1074/jbc.M006217200; VISCONTI PE, 1995, DEVELOPMENT, V121, P1129; Visconti PE, 1999, DEV BIOL, V214, P429, DOI 10.1006/dbio.1999.9428; Wang X, 2001, J BIOL CHEM, V276, P35953, DOI 10.1074/jbc.M103680200; Wright LC, 2007, EUKARYOT CELL, V6, P37, DOI 10.1128/EC.00262-06; Yoda Y., 1971, JAPANESE J ANIM REPR, V16, P147, DOI [DOI 10.1262/JRD1955.16.147, 10.1262/jrd1955.16.147]	64	33	33	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 27	2013	288	39					28104	28115		10.1074/jbc.M113.450981	http://dx.doi.org/10.1074/jbc.M113.450981			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302OB	23943622	Green Published, hybrid			2022-12-25	WOS:000330612800035
J	Dillon, MBC; Rust, HL; Thompson, PR; Mowen, KA				Dillon, Myles B. C.; Rust, Heather L.; Thompson, Paul R.; Mowen, Kerri A.			Automethylation of Protein Arginine Methyltransferase 8 (PRMT8) Regulates Activity by Impeding S-Adenosylmethionine Sensitivity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SUBSTRATE-SPECIFICITY; N-METHYLTRANSFERASE; KINETIC MECHANISM; IN-VITRO; METHYLATION; RNA; SEQUENCES; REVEALS; FAMILY; DOMAIN	Protein arginine methyltransferase (PRMT) 8 is unique among the PRMTs, as it has a highly restricted tissue expression pattern and an N terminus that contains two automethylation sites and a myristoylation site. PRMTs catalyze the transfer of a methyl group from S-adenosylmethionine (AdoMet) to a peptidylarginine on a protein substrate. Currently, the physiological roles, regulation, and cellular substrates of PRMT8 are poorly understood. However, a thorough understanding of PRMT8 kinetics should provide insights into each of these areas, thereby enhancing our understanding of this unique enzyme. In this study, we determined how automethylation regulates the enzymatic activity of PRMT8. We found that preventing automethylation with lysine mutations (preserving the positive charge of the residue) increased the turnover rate and decreased the Km of AdoMet but did not affect the Km of the protein substrate. In contrast, mimicking automethylation with phenylalanine (i.e. mimicking the increased hydrophobicity) decreased the turnover rate. The inhibitory effect of the PRMT8 N terminus could be transferred to PRMT1 by creating a chimeric protein containing the N terminus of PRMT8 fused to PRMT1. Thus, automethylation of the N terminus likely regulates PRMT8 activity by decreasing the affinity of the enzyme for AdoMet.	[Dillon, Myles B. C.; Mowen, Kerri A.] Scripps Res Inst, Dept Physiol Chem, La Jolla, CA 92037 USA; [Rust, Heather L.; Thompson, Paul R.] Scripps Res Inst Florida, Dept Chem, Jupiter, FL 33458 USA	Scripps Research Institute; Scripps Research Institute	Mowen, KA (corresponding author), Scripps Res Inst, Dept Physiol Chem, IMM 11,10550 N Torrey Pines Rd, La Jolla, CA 92037 USA.	kmowen@scripps.edu			National Institutes of Health from NIAID [5R01 AI067460-05]; National Institutes of Health from NIGMS [5R01 GM85117-04, T32 AI007606]; Scripps Research Institute/Scripps Florida; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI067460, T32AI007606] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM085117] Funding Source: NIH RePORTER	National Institutes of Health from NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institutes of Health from NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Scripps Research Institute/Scripps Florida; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant 5R01 AI067460-05 from NIAID and Grants 5R01 GM85117-04 and T32 AI007606 from NIGMS (to M. B. C. D. and K. A. M.). This work was also supported by The Scripps Research Institute/Scripps Florida (to H. L. R. and P. R. T.).	Aggarwal P, 2010, CANCER CELL, V18, P329, DOI 10.1016/j.ccr.2010.08.012; Bedford MT, 2009, MOL CELL, V33, P1, DOI 10.1016/j.molcel.2008.12.013; Bedford MT, 2005, MOL CELL, V18, P263, DOI 10.1016/j.molcel.2005.04.003; Bicker KL, 2011, MOL BIOSYST, V7, P48, DOI 10.1039/c0mb00015a; Blanchet F, 2005, J EXP MED, V202, P371, DOI 10.1084/jem.20050176; Bolte S, 2006, J MICROSC-OXFORD, V224, P213, DOI 10.1111/j.1365-2818.2006.01706.x; Cheng DH, 2004, J BIOL CHEM, V279, P23892, DOI 10.1074/jbc.M401853200; Cheng DH, 2007, MOL CELL, V25, P71, DOI 10.1016/j.molcel.2006.11.019; Cheng XD, 2005, ANNU REV BIOPH BIOM, V34, P267, DOI 10.1146/annurev.biophys.34.040204.144452; Chin HG, 2007, NUCLEIC ACIDS RES, V35, P7313, DOI 10.1093/nar/gkm726; DEICHAITE I, 1988, MOL CELL BIOL, V8, P4295, DOI 10.1128/MCB.8.10.4295; Frankel A, 2000, J BIOL CHEM, V275, P32974, DOI 10.1074/jbc.M006445200; Gary JD, 1998, PROG NUCLEIC ACID RE, V61, P65, DOI 10.1016/S0079-6603(08)60825-9; Gui SY, 2011, J BIOL CHEM, V286, P29118, DOI 10.1074/jbc.M111.224097; Higashimoto K, 2007, P NATL ACAD SCI USA, V104, P12318, DOI 10.1073/pnas.0610792104; Huq MDM, 2006, EMBO J, V25, P5094, DOI 10.1038/sj.emboj.7601389; Krause CD, 2007, PHARMACOL THERAPEUT, V113, P50, DOI 10.1016/j.pharmthera.2006.06.007; Kuhn P, 2011, NUCLEIC ACIDS RES, V39, P2717, DOI 10.1093/nar/gkq1246; Lakowski TM, 2008, J BIOL CHEM, V283, P10015, DOI 10.1074/jbc.M710176200; Lee DY, 2007, MOL ENDOCRINOL, V21, P1381, DOI 10.1210/me.2006-0389; Lee J, 2005, J BIOL CHEM, V280, P32890, DOI 10.1074/jbc.M506944200; Lee J, 2002, EMBO REP, V3, P268, DOI 10.1093/embo-reports/kvf052; Lim Y, 2005, BBA-GEN SUBJECTS, V1723, P240, DOI 10.1016/j.bbagen.2005.02.015; Lin WJ, 1996, J BIOL CHEM, V271, P15034, DOI 10.1074/jbc.271.25.15034; Liu F, 2011, CANCER CELL, V19, P283, DOI 10.1016/j.ccr.2010.12.020; Liu Y, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0080097, 10.1371/journal.pone.0061031, 10.1371/journal.pone.0072930, 10.1371/journal.pone.0055221, 10.1371/journal.pone.0079417, 10.1371/journal.pone.0075318, 10.1371/journal.pone.0082678]; Mowen KA, 2004, MOL CELL, V15, P559, DOI 10.1016/j.molcel.2004.06.042; NAJBAUER J, 1993, J BIOL CHEM, V268, P10501; Obianyo O, 2008, BIOCHEMISTRY-US, V47, P10420, DOI 10.1021/bi800904m; Obianyo O, 2012, J BIOL CHEM, V287, P6062, DOI 10.1074/jbc.M111.333609; Pahlich S, 2006, BBA-PROTEINS PROTEOM, V1764, P1890, DOI 10.1016/j.bbapap.2006.08.008; Pak ML, 2011, BIOCHEMISTRY-US, V50, P8226, DOI 10.1021/bi200644c; Rho J, 2001, J BIOL CHEM, V276, P11393, DOI 10.1074/jbc.M008660200; Robin-Lespinasse Y, 2007, J CELL SCI, V120, P638, DOI 10.1242/jcs.03357; Rust HL, 2011, ACS CHEM BIOL, V6, P881, DOI 10.1021/cb200171d; Rust HL, 2011, BIOCHEMISTRY-US, V50, P3332, DOI 10.1021/bi102022e; Sayegh J, 2007, J BIOL CHEM, V282, P36444, DOI 10.1074/jbc.M704650200; Siddique A, 2011, FEBS J, V278, P2055, DOI 10.1111/j.1742-4658.2011.08121.x; Singh V, 2004, ONCOGENE, V23, P7761, DOI 10.1038/sj.onc.1208057; Singhroy DN, 2013, RETROVIROLOGY, V10, DOI 10.1186/1742-4690-10-73; Taneda T, 2007, BRAIN RES, V1155, P1, DOI 10.1016/j.brainres.2007.03.086; Troffer-Charlier N, 2007, EMBO J, V26, P4391, DOI 10.1038/sj.emboj.7601855; Wei Y, 2003, BIOCHEMISTRY-US, V42, P7044, DOI 10.1021/bi0343976; Weiss VH, 2000, NAT STRUCT BIOL, V7, P1165; WILCOX C, 1987, SCIENCE, V238, P1275, DOI 10.1126/science.3685978; WILLIAMSASHMAN HG, 1982, BIOCHEM PHARMACOL, V31, P277, DOI 10.1016/0006-2952(82)90171-X; Wooderchak WL, 2008, BIOCHEMISTRY-US, V47, P9456, DOI 10.1021/bi800984s; Xu W, 2004, GENE DEV, V18, P144, DOI 10.1101/gad.1141704; Yu ZB, 2009, MOL CELL BIOL, V29, P2982, DOI 10.1128/MCB.00042-09; Yue WW, 2007, EMBO J, V26, P4402, DOI 10.1038/sj.emboj.7601856; Zhang X, 2003, STRUCTURE, V11, P509, DOI 10.1016/S0969-2126(03)00071-6; Zhang X, 2000, EMBO J, V19, P3509, DOI 10.1093/emboj/19.14.3509; Zurita-Lopez CI, 2012, J BIOL CHEM, V287, P7859, DOI 10.1074/jbc.M111.336271	53	44	44	3	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 27	2013	288	39					27872	27880		10.1074/jbc.M113.491092	http://dx.doi.org/10.1074/jbc.M113.491092			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302OB	23946480	hybrid, Green Published			2022-12-25	WOS:000330612800015
J	Ahijado-Guzman, R; Alfonso, C; Reija, B; Salvarelli, E; Mingorance, J; Zorrilla, S; Monterroso, B; Rivas, G				Ahijado-Guzman, Ruben; Alfonso, Carlos; Reija, Belen; Salvarelli, Estefania; Mingorance, Jesus; Zorrilla, Silvia; Monterroso, Begona; Rivas, German			Control by Potassium of the Size Distribution of Escherichia coli FtsZ Polymers Is Independent of GTPase Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DIVISION PROTEIN FTSZ; BACTERIAL-CELL DIVISION; LIGHT-SCATTERING; POLYMERIZATION; DYNAMICS; TUBULIN; ULTRACENTRIFUGATION; PROTOFILAMENTS; HYDROLYSIS; TURNOVER	The influence of potassium content (at neutral pH and millimolar Mg2+) on the size distribution of FtsZ polymers formed in the presence of constantly replenished GTP under steady-state conditions was studied by a combination of biophysical methods. The size of the GTP-FtsZ polymers decreased with lower potassium concentration, in contrast with the increase in the mass of the GDP-FtsZ oligomers, whereas no effect was observed on FtsZ GTPase activity and critical concentration of polymerization. Remarkably, the concerted formation of a narrow size distribution of GTP-FtsZ polymers previously observed at high salt concentration was maintained in all KCl concentrations tested. Polymers induced with guanosine 5 '-(alpha,beta-methylene)triphosphate, a slowly hydrolyzable analog of GTP, became larger and polydisperse as the potassium concentration was decreased. Our results suggest that the potassium dependence of the GTP-FtsZ polymer size may be related to changes in the subunit turnover rate that are independent of the GTP hydrolysis rate. The formation of a narrow size distribution of FtsZ polymers under very different solution conditions indicates that it is an inherent feature of FtsZ, not observed in other filament forming proteins, with potential implications in the structural organization of the functional Z-ring.	[Ahijado-Guzman, Ruben; Alfonso, Carlos; Monterroso, Begona; Rivas, German] CSIC, Ctr Invest Biol, Madrid 28040, Spain; [Reija, Belen; Zorrilla, Silvia] CSIC, Inst Quim Fis Rocasolano, E-28006 Madrid, Spain; [Salvarelli, Estefania; Mingorance, Jesus] Hosp Univ La Paz, IdiPAZ, Microbiol Serv, Madrid 28046, Spain; [Salvarelli, Estefania] Biomol Informat SL, Madrid 28049, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigaciones Biologicas (CIB); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Quimica Fisica Rocasolano (IQFR); Hospital Universitario La Paz	Monterroso, B (corresponding author), CSIC, Ctr Invest Biol, Ramiro de Maeztu 9, Madrid 28040, Spain.	monterroso@cib.csic.es; grivas@cib.csic.es	Monterroso, Begoña/J-9748-2014; Rivas, German/AFL-7528-2022; Rivas, German/AAG-7458-2022; Ahijado-Guzmán, Rubén/F-7934-2016; Mingorance, Jesus/B-7562-2009; Alfonso, Carlos/K-1316-2014; Zorrilla, Silvia/J-9771-2014	Monterroso, Begoña/0000-0003-2538-084X; Rivas, German/0000-0003-3450-7478; Rivas, German/0000-0003-3450-7478; Ahijado-Guzmán, Rubén/0000-0002-9863-0443; Mingorance, Jesus/0000-0001-6173-5711; Alfonso, Carlos/0000-0001-7165-4800; Zorrilla, Silvia/0000-0002-6309-9058	Human Frontier Science Program [RGP0050/2010]; European Commission [HEALTH-F3-2009-223431]; Spanish Government [BIO2008-04478-C03, CSIC PIE-201020I001, BFU2010-14910, BIO2011-28941-C03]	Human Frontier Science Program(Human Frontier Science Program); European Commission(European CommissionEuropean Commission Joint Research Centre); Spanish Government(Spanish GovernmentEuropean Commission)	This work was supported in part by Human Frontier Science Program Grant RGP0050/2010; European Commission Contract HEALTH-F3-2009-223431 (to G. R.); and Spanish Government Grants BIO2008-04478-C03 (to G. R.), CSIC PIE-201020I001 (to C. A.), BFU2010-14910 (to S. Z.), and BIO2011-28941-C03 (to G. R. and S. Z.).	Chen YD, 2009, BIOCHEMISTRY-US, V48, P6664, DOI 10.1021/bi8022653; Chen YD, 2005, J BIOL CHEM, V280, P22549, DOI 10.1074/jbc.M500895200; Erickson HP, 2010, MICROBIOL MOL BIOL R, V74, P504, DOI 10.1128/MMBR.00021-10; Fernandez C, 2008, ANAL BIOCHEM, V381, P254, DOI 10.1016/j.ab.2008.06.032; Gonzalez JM, 2003, J BIOL CHEM, V278, P37664, DOI 10.1074/jbc.M305230200; Gonzalez JM, 2005, P NATL ACAD SCI USA, V102, P1895, DOI 10.1073/pnas.0409517102; Hernandez-Rocamora VM, 2013, J BIOL CHEM, V288, P24625, DOI 10.1074/jbc.M113.483222; Hernandez-Rocamora VM, 2012, J BIOL CHEM, V287, P30097, DOI 10.1074/jbc.M112.388959; HOENIG M, 1989, J BIOCHEM BIOPH METH, V19, P249, DOI 10.1016/0165-022X(89)90031-6; Huecas S, 2008, BIOPHYS J, V94, P1796, DOI 10.1529/biophysj.107.115493; Laue TN, 1992, ANAL ULTRACENTRIFUGA, V224, P90; Mateos-Gil P, 2012, P NATL ACAD SCI USA, V109, P8133, DOI 10.1073/pnas.1204844109; Mendieta J, 2009, J MOL BIOL, V390, P17, DOI 10.1016/j.jmb.2009.05.018; Mingorance J, 2010, TRENDS MICROBIOL, V18, P348, DOI 10.1016/j.tim.2010.06.001; Monterroso B, 2013, METHODS, V59, P349, DOI 10.1016/j.ymeth.2012.12.014; Monterroso B, 2012, BIOCHEMISTRY-US, V51, P6108, DOI 10.1021/bi300891q; Monterroso B, 2012, BIOCHEMISTRY-US, V51, P4541, DOI 10.1021/bi300401b; Mukherjee A, 1999, J BACTERIOL, V181, P823, DOI 10.1128/JB.181.3.823-832.1999; Pacheco-Gomez R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019369; Popp D, 2009, BIOPOLYMERS, V91, P340, DOI 10.1002/bip.21136; Record MT, 1998, TRENDS BIOCHEM SCI, V23, P190, DOI 10.1016/S0968-0004(98)01207-9; Reija B, 2011, ANAL BIOCHEM, V418, P89, DOI 10.1016/j.ab.2011.07.001; Rivas G, 2000, J BIOL CHEM, V275, P11740, DOI 10.1074/jbc.275.16.11740; Romberg L, 2001, J BIOL CHEM, V276, P11743, DOI 10.1074/jbc.M009033200; Romberg L, 2004, BIOCHEMISTRY-US, V43, P282, DOI 10.1021/bi035465r; Salvarelli E, 2011, FEBS LETT, V585, P3880, DOI 10.1016/j.febslet.2011.10.046; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Small E, 2003, MICROBIOL-SGM, V149, P2235, DOI 10.1099/mic.0.26126-0; Strauss MP, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001389; Svedberg T, 1940, THE ULTRACENTRIFUGE; Tadros M, 2006, FEBS LETT, V580, P4941, DOI 10.1016/j.febslet.2006.07.083; Turner DJ, 2012, BIOPHYS J, V102, P731, DOI 10.1016/j.bpj.2012.01.015	32	11	11	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 20	2013	288	38					27358	27365		10.1074/jbc.M113.482943	http://dx.doi.org/10.1074/jbc.M113.482943			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302IG	23940054	hybrid, Green Published			2022-12-25	WOS:000330597300031
J	Kurusu, T; Saito, K; Horikoshi, S; Hanamata, S; Negi, J; Yagi, C; Kitahata, N; Iba, K; Kuchitsu, K				Kurusu, Takamitsu; Saito, Katsunori; Horikoshi, Sonoko; Hanamata, Shigeru; Negi, Juntaro; Yagi, Chikako; Kitahata, Nobutaka; Iba, Koh; Kuchitsu, Kazuyuki			An S-Type Anion Channel SLAC1 Is Involved in Cryptogein-Induced Ion Fluxes and Modulates Hypersensitive Responses in Tobacco BY-2 Cells	PLOS ONE			English	Article							N-ACETYLCHITOOLIGOSACCHARIDE ELICITOR; POSITIVE FEEDBACK-REGULATION; PROTEIN-KINASE; NADPH OXIDASE; MEMBRANE DEPOLARIZATION; PHYTOALEXIN PRODUCTION; SIGNAL-TRANSDUCTION; PLANT; ACTIVATION; ARABIDOPSIS	Pharmacological evidence suggests that anion channel-mediated plasma membrane anion effluxes are crucial in early defense signaling to induce immune responses and hypersensitive cell death in plants. However, their molecular bases and regulation remain largely unknown. We overexpressed Arabidopsis SLAC1, an S-type anion channel involved in stomatal closure, in cultured tobacco BY-2 cells and analyzed the effect on cryptogein-induced defense responses including fluxes of Cl- and other ions, production of reactive oxygen species (ROS), gene expression and hypersensitive responses. The SLAC1-GFP fusion protein was localized at the plasma membrane in BY-2 cells. Overexpression of SLAC1 enhanced cryptogein-induced Cl- efflux and extracellular alkalinization as well as rapid/transient and slow/prolonged phases of NADPH oxidase-mediated ROS production, which was suppressed by an anion channel inhibitor, DIDS. The overexpressor also showed enhanced sensitivity to cryptogein to induce downstream immune responses, including the induction of defense marker genes and the hypersensitive cell death. These results suggest that SLAC1 expressed in BY-2 cells mediates cryptogein-induced plasma membrane Cl- efflux to positively modulate the elicitor-triggered activation of other ion fluxes, ROS as well as a wide range of defense signaling pathways. These findings shed light on the possible involvement of the SLAC/SLAH family anion channels in cryptogein signaling to trigger the plasma membrane ion channel cascade in the plant defense signal transduction network.	[Kurusu, Takamitsu; Saito, Katsunori; Horikoshi, Sonoko; Hanamata, Shigeru; Yagi, Chikako; Kitahata, Nobutaka; Kuchitsu, Kazuyuki] Tokyo Univ Sci, Dept Appl Biol Sci, Noda, Chiba 278, Japan; [Kurusu, Takamitsu; Kuchitsu, Kazuyuki] Tokyo Univ Sci, Res Inst Sci & Technol, Noda, Chiba 278, Japan; [Kurusu, Takamitsu] Tokyo Univ Technol, Sch Biosci & Biotechnol, Hachioji, Tokyo, Japan; [Negi, Juntaro] Kyushu Univ, Fac Sci, Dept Biol, Fukuoka 812, Japan	Tokyo University of Science; Tokyo University of Science; Tokyo University of Technology; Kyushu University	Kuchitsu, K (corresponding author), Tokyo Univ Sci, Dept Appl Biol Sci, Noda, Chiba 278, Japan.	kuchitsu@rs.noda.tus.ac.jp	Kurusu, Takamitsu/GMW-8785-2022; Kuchitsu, Kazuyuki/G-3024-2013; Kurusu, Takamitsu/GMW-8766-2022	Kurusu, Takamitsu/0000-0001-7740-3199; Kuchitsu, Kazuyuki/0000-0001-8854-0375; Kurusu, Takamitsu/0000-0001-7740-3199	MEXT, Japan [21117516, 23117718, 19370023, 23380027]; Grants-in-Aid for Scientific Research [25114515] Funding Source: KAKEN	MEXT, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by Grants-in-Aid for Scientific Research on Priority Area Nos. 21117516 and 23117718, and Grants-in-Aid for Scientific Research B Nos. 19370023 and 23380027 from MEXT, Japan to KK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amelot N, 2012, CELL CALCIUM, V51, P117, DOI 10.1016/j.ceca.2011.11.010; Amelot N, 2011, PLANT CELL ENVIRON, V34, P149, DOI 10.1111/j.1365-3040.2010.02233.x; AN GH, 1985, PLANT PHYSIOL, V79, P568, DOI 10.1104/pp.79.2.568; Barbier-Brygoo H, 2011, ANNU REV PLANT BIOL, V62, P25, DOI 10.1146/annurev-arplant-042110-103741; Blume B, 2000, PLANT CELL, V12, P1425, DOI 10.1105/tpc.12.8.1425; Boudsocq M, 2010, NATURE, V464, P418, DOI 10.1038/nature08794; Bricchi I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046673; Chiu WL, 1996, CURR BIOL, V6, P325, DOI 10.1016/S0960-9822(02)00483-9; Colcombet J, 2009, FUNCT PLANT BIOL, V36, P832, DOI 10.1071/FP09096; Drerup MM, 2013, MOL PLANT, V6, P559, DOI 10.1093/mp/sst009; Garcia-Brugger A, 2006, MOL PLANT MICROBE IN, V19, P711, DOI 10.1094/MPMI-19-0711; Gauthier A, 2007, PLANT SIGNAL BEHAV, V2, P86, DOI 10.4161/psb.2.2.4015; Geiger D, 2010, P NATL ACAD SCI USA, V107, P8023, DOI 10.1073/pnas.0912030107; Geiger D, 2009, P NATL ACAD SCI USA, V106, P21425, DOI 10.1073/pnas.0912021106; Gomez-Gomez L, 2002, TRENDS PLANT SCI, V7, P251, DOI 10.1016/S1360-1385(02)02261-6; Gopalan S, 1996, PLANT J, V10, P591, DOI 10.1046/j.1365-313X.1996.10040591.x; Heath MC, 2000, PLANT MOL BIOL, V44, P321, DOI 10.1023/A:1026592509060; Higaki T, 2007, PLANT CELL PHYSIOL, V48, P1414, DOI 10.1093/pcp/pcm109; Higaki T, 2011, J PLANT RES, V124, P315, DOI 10.1007/s10265-011-0408-z; Jeworutzki E, 2010, PLANT J, V62, P367, DOI 10.1111/j.1365-313X.2010.04155.x; Kadota Y, 2005, PLANT CELL PHYSIOL, V46, P156, DOI 10.1093/pcp/pci008; Kadota Y, 2004, PLANT CELL PHYSIOL, V45, P160, DOI 10.1093/pcp/pch020; Kadota Y, 2006, PLANT CELL PHYSIOL, V47, P1337, DOI 10.1093/pcp/pcj098; KAMOUN S, 1993, MOL PLANT MICROBE IN, V6, P15, DOI 10.1094/MPMI-6-015; Kikuyama M, 1997, PLANT CELL PHYSIOL, V38, P902, DOI 10.1093/oxfordjournals.pcp.a029250; Kimura S, 2012, BBA-MOL CELL RES, V1823, P398, DOI 10.1016/j.bbamcr.2011.09.011; Kobayashi M, 2007, PLANT CELL, V19, P1065, DOI 10.1105/tpc.106.048884; Kollist H, 2011, FEBS J, V278, P4277, DOI 10.1111/j.1742-4658.2011.08370.x; KUCHITSU K, 1995, PROTOPLASMA, V188, P138, DOI 10.1007/BF01276805; KUCHITSU K, 1993, PROTOPLASMA, V174, P79, DOI 10.1007/BF01404046; Kurusu T, 2005, PLANT J, V42, P798, DOI 10.1111/j.1365-313X.2005.02415.x; Kurusu T, 2012, J PLANT RES, V125, P555, DOI 10.1007/s10265-011-0462-6; Kurusu T, 2011, J PLANT RES, V124, P415, DOI 10.1007/s10265-010-0388-4; Kurusu T, 2010, PLANT PHYSIOL, V153, P678, DOI 10.1104/pp.109.151852; Lam E, 2001, NATURE, V411, P848, DOI 10.1038/35081184; Lee SC, 2009, P NATL ACAD SCI USA, V106, P21419, DOI 10.1073/pnas.0910601106; Manzoor H, 2012, CELL CALCIUM, V51, P434, DOI 10.1016/j.ceca.2012.02.006; Miao YS, 2007, NAT PROTOC, V2, P2348, DOI 10.1038/nprot.2007.360; Montillet JL, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001513; NAGATA T, 1992, INT REV CYTOL, V132, P1, DOI 10.1016/S0074-7696(08)62452-3; Negi J, 2008, NATURE, V452, P483, DOI 10.1038/nature06720; ODONOHUE MJ, 1995, PLANT MOL BIOL, V27, P577, DOI 10.1007/BF00019323; ODonohue MJ, 1996, PROTEIN EXPRES PURIF, V8, P254, DOI 10.1006/prep.1996.0098; Ogasawara Y, 2008, J BIOL CHEM, V283, P8885, DOI 10.1074/jbc.M708106200; Okada Y, 2006, J MEMBRANE BIOL, V209, P21, DOI 10.1007/s00232-005-0836-6; Pontier D, 1998, MOL PLANT MICROBE IN, V11, P544, DOI 10.1094/MPMI.1998.11.6.544; Pugin A, 1997, PLANT CELL, V9, P2077, DOI 10.1105/tpc.9.11.2077; Roelfsema MRG, 2012, TRENDS PLANT SCI, V17, P221, DOI 10.1016/j.tplants.2012.01.009; Saji S, 2008, PLANT CELL PHYSIOL, V49, P2, DOI 10.1093/pcp/pcm174; Simon-Plas F, 2002, PLANT J, V31, P137, DOI 10.1046/j.1365-313X.2002.01342.x; Stanislas T, 2009, MOL CELL PROTEOMICS, V8, P2186, DOI 10.1074/mcp.M900090-MCP200; Takeda S, 2008, SCIENCE, V319, P1241, DOI 10.1126/science.1152505; Torres MA, 2002, P NATL ACAD SCI USA, V99, P517, DOI 10.1073/pnas.012452499; TURNER JG, 1974, PHYTOPATHOLOGY, V64, P885, DOI 10.1094/Phyto-64-885; Vahisalu T, 2008, NATURE, V452, P487, DOI 10.1038/nature06608; Vatsa P, 2011, BIOCHIMIE, V93, P2095, DOI 10.1016/j.biochi.2011.04.006; Wendehenne D, 2002, PLANT CELL, V14, P1937, DOI 10.1105/tpc.002295; Wong HL, 2007, PLANT CELL, V19, P4022, DOI 10.1105/tpc.107.055624; Xue SW, 2011, EMBO J, V30, P1645, DOI 10.1038/emboj.2011.68; Yoshie Y., 2005, PLANT BIOTECHNOL-NAR, V22, P127, DOI [10.5511/plantbiotechnology.22.127, DOI 10.5511/PLANTBIOTECHNOLOGY.22.127]; Yoshioka H, 2001, MOL PLANT MICROBE IN, V14, P725, DOI 10.1094/MPMI.2001.14.6.725; Yu SP, 2000, P NATL ACAD SCI USA, V97, P9360, DOI 10.1073/pnas.97.17.9360; Zipfel C, 2004, NATURE, V428, P764, DOI 10.1038/nature02485; Zipfel C, 2009, CURR OPIN PLANT BIOL, V12, P414, DOI 10.1016/j.pbi.2009.06.003	64	20	20	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2013	8	8							e70623	10.1371/journal.pone.0070623	http://dx.doi.org/10.1371/journal.pone.0070623			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	200UV	23950973	Green Published, gold, Green Submitted			2022-12-25	WOS:000323097300035
J	Man, YKS; DiCara, D; Chan, N; Vessillier, S; Mather, SJ; Rowe, ML; Howard, MJ; Marshall, JF; Nissim, A				Man, Y. K. Stella; DiCara, Danielle; Chan, Nicole; Vessillier, Sandrine; Mather, Stephen J.; Rowe, Michelle L.; Howard, Mark J.; Marshall, John F.; Nissim, Ahuva			Structural Guided Scaffold Phage Display Libraries as a Source of Bio-Therapeutics	PLOS ONE			English	Article							MOUTH-DISEASE-VIRUS; MONOCLONAL-ANTIBODY THERAPEUTICS; SQUAMOUS CARCINOMA-CELLS; ALPHA-V-BETA-6 INTEGRIN; IN-VIVO; CANCER; INTEGRIN-ALPHA(V)BETA(6); INVASION; GROWTH; EXPRESSION	We have developed a structurally-guided scaffold phage display strategy for identification of ligand mimetic bio-therapeutics. As a proof of concept we used the ligand of integrin alpha nu beta 6, a tumour cell surface receptor and a major new target for imaging and therapy of many types of solid cancer. NMR structure analysis showed that RGD-helix structures are optimal for alpha nu beta 6 ligand-interaction, so we designed novel algorithms to generate human single chain fragment variable (scFv) libraries with synthetic V-H-CDR3 encoding RGD-helix hairpins with helices of differing pitch, length and amino acid composition. Study of the lead scFv clones D25scFv and D34scFv and their corresponding V-H-CDR3 derived peptides, D25p and D34p, demonstrated: specific binding to recombinant and cellular alpha nu beta 6; inhibition of alpha nu beta 6-dependent cell and ligand adhesion, alpha nu beta 6-dependent cell internalisation; and selective retention by alpha nu beta 6-expressing, but not alpha nu beta 6-negative, human xenografts. NMR analysis established that both the D25p and D34p retained RGD-helix structures confirming the success of the algorithm. In conclusion, scFv libraries can be engineered based on ligand structural motifs to increase the likelihood of developing powerful bio-therapeutics.	[Man, Y. K. Stella; DiCara, Danielle; Chan, Nicole; Marshall, John F.] Queen Marys Univ London, Barts Canc Inst, Ctr Tumour Biol, London, England; [Vessillier, Sandrine; Nissim, Ahuva] Queen Marys Univ London, William Harvey Res Inst, London, England; [Mather, Stephen J.] Queen Marys Univ London, Ctr Mol Oncol & Imaging, London, England; [Rowe, Michelle L.; Howard, Mark J.] Univ Kent, Sch Biosci, Biol NMR Spect, Canterbury, Kent, England	University of London; Queen Mary University London; University of London; Queen Mary University London; University of London; Queen Mary University London; University of Kent	Marshall, JF (corresponding author), Queen Marys Univ London, Barts Canc Inst, Ctr Tumour Biol, London, England.	j.f.marshall@qmul.ac.uk; a.nissim@qmul.ac.uk	Vessillier, Sandrine/E-2502-2013	Vessillier, Sandrine/0000-0002-9697-1834; Marshall, John/0000-0002-0494-2295; Howard, Mark/0000-0002-0762-2887	Dystrophic Epidermolyis Bullosa MARSHAL Research Association; Wellcome Trust [091163/Z/10/Z]	Dystrophic Epidermolyis Bullosa MARSHAL Research Association; Wellcome Trust(Wellcome TrustEuropean Commission)	YKSM and NC were funded by the Dystrophic Epidermolyis Bullosa MARSHAL Research Association (http://www.debra.org.uk/). MJH is grateful for the award of Wellcome Trust (http://www.wellcome.ac.uk) Equipment Grant 091163/Z/10/Z for the NMR Spectrometer used in this project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARBAS CF, 1993, P NATL ACAD SCI USA, V90, P10003, DOI 10.1073/pnas.90.21.10003; Bates RC, 2005, J CLIN INVEST, V115, P339, DOI 10.1172/JCI200523183; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Cheung MS, 2010, J MAGN RESON, V202, P223, DOI 10.1016/j.jmr.2009.11.008; CLARKE ND, 1994, PROTEIN SCI, V3, P1779, DOI 10.1002/pro.5560031018; Creighton TE., 1992, PROTEINS STRUCTURE M, V2nd Edn; de Wildt RMT, 2000, NAT BIOTECHNOL, V18, P989, DOI 10.1038/79494; DiCara D, 2008, J VIROL, V82, P1537, DOI 10.1128/JVI.01480-07; DiCara D, 2007, J BIOL CHEM, V282, P9657, DOI 10.1074/jbc.M610461200; Egloff AM, 2008, SEMIN ONCOL, V35, P286, DOI 10.1053/j.seminoncol.2008.03.008; Elayadi AN, 2007, CANCER RES, V67, P5889, DOI 10.1158/0008-5472.CAN-07-0245; Gianni S, 2003, P NATL ACAD SCI USA, V100, P13286, DOI 10.1073/pnas.1835776100; Hanes J, 2000, NAT BIOTECHNOL, V18, P1287, DOI 10.1038/82407; Harrison JL, 1996, METHOD ENZYMOL, V267, P83; Hattori T, 2010, J BIOL CHEM, V285, P7784, DOI 10.1074/jbc.M109.020156; Hausner SH, 2007, CANCER RES, V67, P7833, DOI 10.1158/0008-5472.CAN-07-1026; Hazelbag S, 2007, J PATHOL, V212, P316, DOI 10.1002/path.2168; Jiang PP, 2010, P NATL ACAD SCI USA, V107, P6765, DOI 10.1073/pnas.1001814107; JONES PT, 1986, NATURE, V321, P522, DOI 10.1038/321522a0; Jung KH, 2012, ARCH PHARM RES, V35, P595, DOI 10.1007/s12272-012-0402-6; Kogelberg H, 2008, J MOL BIOL, V382, P385, DOI 10.1016/j.jmb.2008.07.013; Kraft S, 1999, J BIOL CHEM, V274, P1979, DOI 10.1074/jbc.274.4.1979; Nelson AL, 2010, NAT REV DRUG DISCOV, V9, P767, DOI 10.1038/nrd3229; Nissim A., 2008, V181, P3; NISSIM A, 1994, EMBO J, V13, P692, DOI 10.1002/j.1460-2075.1994.tb06308.x; Nystrom ML, 2006, CANCER RES, V66, P10833, DOI 10.1158/0008-5472.CAN-06-1640; Saha A, 2010, J PATHOL, V222, P52, DOI 10.1002/path.2745; Thomas GJ, 2006, J ORAL PATHOL MED, V35, P1, DOI 10.1111/j.1600-0714.2005.00374.x; Thomas GJ, 2001, INT J CANCER, V92, P641, DOI 10.1002/1097-0215(20010601)92:5<641::AID-IJC1243>3.0.CO;2-P; Thomas GJ, 2001, J INVEST DERMATOL, V117, P67, DOI 10.1046/j.0022-202x.2001.01379.x; Van Aarsen LAK, 2008, CANCER RES, V68, P561, DOI 10.1158/0008-5472.CAN-07-2307; Wang LH, 2012, ONCOL REP, V28, P2043, DOI 10.3892/or.2012.2028	32	7	9	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 9	2013	8	8							e70452	10.1371/journal.pone.0070452	http://dx.doi.org/10.1371/journal.pone.0070452			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	245OM	23950939	gold, Green Published, Green Submitted			2022-12-25	WOS:000326473200013
J	Hamilton, PT; Jansen, MS; Ganesan, S; Benson, RE; Hyde-DeRuyscher, R; Beyer, WF; Gile, JC; Nair, SA; Hodges, JA; Gron, H				Hamilton, Paul T.; Jansen, Michelle S.; Ganesan, Sathya; Benson, R. Edward; Hyde-DeRuyscher, Robin; Beyer, Wayne F.; Gile, Joseph C.; Nair, Shrikumar A.; Hodges, Jonathan A.; Gron, Hanne			Improved Bone Morphogenetic Protein-2 Retention in an Injectable Collagen Matrix Using Bifunctional Peptides	PLOS ONE			English	Article							OSTEOGENIC FACTORS; DELIVERY; REGENERATION; FRACTURES; LIBRARIES; REPAIR	To promote healing of many orthopedic injuries, tissue engineering approaches are being developed that combine growth factors such as Bone Morphogenetic Proteins (BMP) with biomaterial carriers. Although these technologies have shown great promise, they still face limitations. We describe a generalized approach to create target-specific modular peptides that bind growth factors to implantable biomaterials. These bifunctional peptide coatings provide a novel way to modulate biology on the surface of an implant. Using phage display techniques, we have identified peptides that bind with high affinity to BMP-2. The peptides that bind to BMP-2 fall into two different sequence clusters. The first cluster of peptide sequences contains the motif W-X-X-F-X-X-L (where X can be any amino acid) and the second cluster contains the motif F-P-L-K-G. We have synthesized bifunctional peptide linkers that contain BMP-2 and collagen-binding domains. Using a rat ectopic bone formation model, we have injected rhBMP-2 into a collagen matrix with or without a bifunctional BMP-2: collagen peptide (BC-1). The presence of BC-1 significantly increased osteogenic cellular activity, the area of bone formed, and bone maturity at the site of injection. Our results suggest that bifunctional peptides that can simultaneously bind to a growth factor and an implantable biomaterial can be used to control the delivery and release of growth factors at the site of implantation.	[Hamilton, Paul T.] N Carolina State Univ, Dept Microbiol, Raleigh, NC 27695 USA; [Jansen, Michelle S.; Ganesan, Sathya; Nair, Shrikumar A.; Hodges, Jonathan A.] Affinergy LLC, Res Triangle Pk, NC USA; [Benson, R. Edward] GlaxoSmithKline, Platform Technol & Sci, Res Triangle Pk, NC USA; [Hyde-DeRuyscher, Robin] Biogen Idec Inc, Mfg Sci, Res Triangle Pk, NC USA; [Beyer, Wayne F.] QNS Grp LLC, Durham, NC USA; [Gile, Joseph C.] Gile Surg Support, Bangor, ME USA; [Gron, Hanne] Novo Nordisk, Haemophilia Biochem, Malov, Denmark	University of North Carolina; North Carolina State University; GlaxoSmithKline; Biogen; Novo Nordisk	Hodges, JA (corresponding author), Affinergy LLC, Res Triangle Pk, NC USA.	jhodges@affinergy.com	Hamilton, Paul/H-6267-2019	Hamilton, Paul/0000-0003-4028-424X	National Institutes of Arthritis and Musculoskeletal and Skin Disease, General Medicine, and Dental and Craniofacial Research of the National Institutes of Health (NIH) [R43AR053387, R43AR051264, R44GM077753, R44DE018071]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R43AR051264, R43AR053387] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R44DE018071] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R44GM077753] Funding Source: NIH RePORTER	National Institutes of Arthritis and Musculoskeletal and Skin Disease, General Medicine, and Dental and Craniofacial Research of the National Institutes of Health (NIH); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The work was supported in part by the National Institutes of Arthritis and Musculoskeletal and Skin Disease, General Medicine, and Dental and Craniofacial Research of the National Institutes of Health (NIH) under award numbers R43AR053387, R43AR051264, R44GM077753 and R44DE018071. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH.	Andrade FK, 2010, J BIOMED MATER RES A, V92A, P9, DOI 10.1002/jbm.a.32284; [Anonymous], 2000, MUSC INJ REP INC RIS; Bragdon B, 2011, CELL SIGNAL, V23, P609, DOI 10.1016/j.cellsig.2010.10.003; Carragee EJ, 2011, SPINE J, V11, P471, DOI 10.1016/j.spinee.2011.04.023; Edwards RB, 2004, J BONE JOINT SURG AM, V86A, P1425, DOI 10.2106/00004623-200407000-00010; Epstein Nancy E, 2011, Surg Neurol Int, V2, P10, DOI 10.4103/2152-7806.76147; Friedlaender GE, 2001, J BONE JOINT SURG AM, V83A, pS151; Geiger M, 2003, ADV DRUG DELIVER REV, V55, P1613, DOI 10.1016/j.addr.2003.08.010; Govender S, 2002, J BONE JOINT SURG AM, V84A, P2123, DOI 10.2106/00004623-200212000-00001; Gron H, 2008, METHODS COMPOSITIONS; Hyde-DeRuyscher R, 2000, CHEM BIOL, V7, P17, DOI 10.1016/S1074-5521(00)00062-4; Kwon Brian, 2005, Spine J, V5, p224S, DOI 10.1016/j.spinee.2005.02.007; Lee J. S., 2009, ANGEW CHEM, V121, P6384; Lee JS, 2010, ACTA BIOMATER, V6, P21, DOI 10.1016/j.actbio.2009.08.003; Lee JS, 2010, ADV MATER, V22, P5494, DOI 10.1002/adma.201002970; Lissenberg-Thunnissen SN, 2011, INT ORTHOP, V35, P1271, DOI 10.1007/s00264-011-1301-z; Luginbuehl V, 2004, EUR J PHARM BIOPHARM, V58, P197, DOI 10.1016/j.ejpb.2004.03.004; Pertile R, 2012, BIOTECHNOL PROGR, V28, P526, DOI 10.1002/btpr.1501; Seeherman H, 2005, CYTOKINE GROWTH F R, V16, P329, DOI 10.1016/j.cytogfr.2005.05.001; Seeherman H, 2003, J BONE JOINT SURG AM, V85A, P96, DOI 10.2106/00004623-200300003-00016; Seeherman H, 2002, SPINE, V27, pS16, DOI 10.1097/00007632-200208151-00005; Seeherman H, 2001, J BONE JOINT SURG AM, V83A, pS79; SPARKS AB, 1995, METHOD ENZYMOL, V255, P498; Sparks Andrew B., 1996, P227, DOI 10.1016/B978-012402380-2/50015-0	24	22	25	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2013	8	8							e70715	10.1371/journal.pone.0070715	http://dx.doi.org/10.1371/journal.pone.0070715			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	201ER	23950987	Green Published, Green Submitted, gold			2022-12-25	WOS:000323124000025
J	Banon-Rodriguez, I; de Guinoa, JS; Bernardini, A; Ragazzini, C; Fernandez, E; Carrasco, YR; Jones, GE; Wandosell, F; Anton, IM				Banon-Rodriguez, Inmaculada; de Guinoa, Julia Saez; Bernardini, Alejandra; Ragazzini, Chiara; Fernandez, Estefania; Carrasco, Yolanda R.; Jones, Gareth E.; Wandosell, Francisco; Anton, Ines Maria			WIP Regulates Persistence of Cell Migration and Ruffle Formation in Both Mesenchymal and Amoeboid Modes of Motility	PLOS ONE			English	Article							WISKOTT-ALDRICH-SYNDROME; INTERACTING PROTEIN WIP; GROWTH-FACTOR; N-WASP; ARP2/3 COMPLEX; ACTIN DYNAMICS; T-CELL; DENDRITIC CELLS; CHEMOTAXIS; DEFICIENCY	The spatial distribution of signals downstream from receptor tyrosine kinases (RTKs) or G-protein coupled receptors (GPCR) regulates fundamental cellular processes that control cell migration and growth. Both pathways rely significantly on actin cytoskeleton reorganization mediated by nucleation-promoting factors such as the WASP-(Wiskott-Aldrich Syndrome Protein) family. WIP (WASP Interacting Protein) is essential for the formation of a class of polarised actin microdomain, namely dorsal ruffles, downstream of the RTK for PDGF (platelet-derived growth factor) but the underlying mechanism is poorly understood. Using lentivirally-reconstituted WIP-deficient murine fibroblasts we define the requirement for WIP interaction with N-WASP (neural WASP) and Nck for efficient dorsal ruffle formation and of WIP-Nck binding for fibroblast chemotaxis towards PDGF-AA. The formation of both circular dorsal ruffles in PDGF-AA-stimulated primary fibroblasts and lamellipodia in CXCL13-treated B lymphocytes are also compromised by WIP-deficiency. We provide data to show that a WIP-Nck signalling complex interacts with RTK to promote polarised actin remodelling in fibroblasts and provide the first evidence for WIP involvement in the control of migratory persistence in both mesenchymal (fibroblast) and amoeboid (B lymphocytes) motility.	[Banon-Rodriguez, Inmaculada; Bernardini, Alejandra; Ragazzini, Chiara; Fernandez, Estefania; Anton, Ines Maria] Ctr Nacl Biotecnol CNB CSIC, Dept Mol & Cell Biol, Madrid, Spain; [de Guinoa, Julia Saez; Carrasco, Yolanda R.] Ctr Nacl Biotecnol CNB CSIC, Dept Immunol & Oncol, Madrid, Spain; [Jones, Gareth E.] Kings Coll London, Randall Div Cell & Mol Biophys, London, England; [Wandosell, Francisco] Ctr Biol Mol Severo Ochoa CBM UAM, Dept Mol Neurobiol, Madrid, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Nacional de Biotecnologia (CNB); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Nacional de Biotecnologia (CNB); University of London; King's College London; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Biologia Molecular Severo Ochoa (CBM)	Anton, IM (corresponding author), Ctr Nacl Biotecnol CNB CSIC, Dept Mol & Cell Biol, Madrid, Spain.	ianton@cnb.csic.es	Bernardini, Alejandra L/S-4285-2018; Carrasco, Yolanda/X-2629-2019; Anton, Ines M/G-6090-2015; Jones, Gareth E/H-2282-2012; Wandosell, Francisco/AAV-6391-2020; Wandosell, Francisco/G-6105-2015	Bernardini, Alejandra L/0000-0001-5722-9904; Anton, Ines M/0000-0002-2935-5919; Jones, Gareth E/0000-0001-5879-3048; Wandosell, Francisco/0000-0001-6537-2321; Carrasco, Yolanda R./0000-0003-2148-1926	Spanish Ministry of Science and Innovation [BFU2010-21374/BMC]; CIBERNED (Instituto de Salud Carlos III); CAM (Comunidad Autonoma de Madrid); Consejo Superior de Investigaciones Cientificas; MRC [G1100041]; EU [237946]; CAM; Spanish Ministry of Science [BFU2011-30097]; EU (FP7-integrated project Masterswicht) [223404 FP7]; Medical Research Council [G1100041] Funding Source: researchfish	Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); CIBERNED (Instituto de Salud Carlos III); CAM (Comunidad Autonoma de Madrid)(Comunidad de Madrid); Consejo Superior de Investigaciones Cientificas; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); EU(European Commission); CAM; Spanish Ministry of Science(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); EU (FP7-integrated project Masterswicht); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by grants from Spanish Ministry of Science and Innovation (BFU2010-21374/BMC) and CIBERNED (Instituto de Salud Carlos III) to IMA. IB held a contract from the CAM (Comunidad Autonoma de Madrid), AB a "La Caixa'' fellowship and EF a JAE-pre fellowship (Consejo Superior de Investigaciones Cientificas). Work in the laboratory of GEJ is supported by the MRC (G1100041; co-applicant IMA) and an EU FP7 award (237946, T3Net). In the laboratory of YRC, JS held a contract from the CAM and the work is supported by grants from the Spanish Ministry of Science (BFU2011-30097) and from the EU (FP7-integrated project Masterswicht 223404 FP7). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrae J, 2008, GENE DEV, V22, P1276, DOI 10.1101/gad.1653708; Anton IM, 1998, J BIOL CHEM, V273, P20992, DOI 10.1074/jbc.273.33.20992; Anton IM, 2006, EUR J CELL BIOL, V85, P295, DOI 10.1016/j.ejcb.2005.08.004; Anton IM, 2003, J CELL SCI, V116, P2443, DOI 10.1242/jcs.00433; Anton IM, 2002, IMMUNITY, V16, P193, DOI 10.1016/S1074-7613(02)00268-6; Anton IM, 2007, TRENDS CELL BIOL, V17, P555, DOI 10.1016/j.tcb.2007.08.005; Bailly M, 2001, CURR BIOL, V11, P620, DOI 10.1016/S0960-9822(01)00152-X; Becker-Herman S, 2011, J EXP MED, V208, P2033, DOI 10.1084/jem.20110200; Bouma G, 2011, BLOOD, V118, P2492, DOI 10.1182/blood-2011-03-340265; Chou HC, 2006, CURR BIOL, V16, P2337, DOI 10.1016/j.cub.2006.10.037; Cortesio CL, 2010, MOL BIOL CELL, V21, P186, DOI 10.1091/mbc.E09-02-0106; Curcio C, 2007, J PATHOL, V211, P67, DOI 10.1002/path.2088; de la Fuente MA, 2007, P NATL ACAD SCI USA, V104, P926, DOI 10.1073/pnas.0610275104; Ditlev JA, 2012, J CELL BIOL, V197, P643, DOI 10.1083/jcb.201111113; ERIKSSON A, 1992, EMBO J, V11, P543, DOI 10.1002/j.1460-2075.1992.tb05085.x; Friedl P, 2010, J CELL BIOL, V188, P11, DOI 10.1083/jcb.200909003; Gallego MD, 2006, INT IMMUNOL, V18, P221, DOI 10.1093/intimm/dxh310; Garcia E, 2012, EUR J CELL BIOL, V91, P869, DOI 10.1016/j.ejcb.2012.06.002; Guiet R, 2012, J BIOL CHEM, V287, P13051, DOI 10.1074/jbc.M111.307124; Hoon JL, 2012, MOL CELL BIOL, V32, P4246, DOI 10.1128/MCB.00551-12; Ishihara D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030033; Itoh T, 2013, J BIOCHEM, V153, P21, DOI 10.1093/jb/mvs138; Kellie S, 2004, J CELL SCI, V117, P609, DOI 10.1242/jcs.00879; King SJ, 2011, EMBO J, V30, P1705, DOI 10.1038/emboj.2011.82; Konno A, 2007, INT IMMUNOL, V19, P185, DOI 10.1093/intimm/dxl135; Krueger EW, 2003, MOL BIOL CELL, V14, P1085, DOI 10.1091/mbc.E02-08-0466; Lammermann T, 2009, CURR OPIN CELL BIOL, V21, P636, DOI 10.1016/j.ceb.2009.05.003; Lanzi G, 2012, J EXP MED, V209, P29, DOI 10.1084/jem.20110896; Legg JA, 2007, MOL BIOL CELL, V18, P678, DOI 10.1091/mbc.E06-06-0569; Machesky LM, 1999, J CELL BIOL, V146, P267, DOI 10.1083/jcb.146.2.267; Machesky LM, 1999, CURR OPIN CELL BIOL, V11, P117, DOI 10.1016/S0955-0674(99)80014-3; Martinez-Quiles N, 2001, NAT CELL BIOL, V3, P484, DOI 10.1038/35074551; MELLSTROM K, 1988, EXP CELL RES, V177, P347, DOI 10.1016/0014-4827(88)90468-5; Meyer-Bahlburg A, 2008, BLOOD, V112, P4158, DOI 10.1182/blood-2008-02-140814; Monypenny J, 2011, EUR J CELL BIOL, V90, P198, DOI 10.1016/j.ejcb.2010.05.009; Monypenny J, 2009, MOL CELL BIOL, V29, P2730, DOI 10.1128/MCB.01285-08; Orth JD, 2006, CANCER RES, V66, P3603, DOI 10.1158/0008-5472.CAN-05-2916; Parri M, 2010, CELL COMMUN SIGNAL, V8, DOI 10.1186/1478-811X-8-23; Rivera GM, 2006, P NATL ACAD SCI USA, V103, P9536, DOI 10.1073/pnas.0603786103; Rottner K, 2011, CURR OPIN CELL BIOL, V23, P569, DOI 10.1016/j.ceb.2011.07.003; de Guinoa JS, 2011, BLOOD, V118, P1560, DOI 10.1182/blood-2011-01-332106; Sanz-Moreno V, 2010, CURR OPIN CELL BIOL, V22, P690, DOI 10.1016/j.ceb.2010.08.020; SEPPA H, 1982, J CELL BIOL, V92, P584, DOI 10.1083/jcb.92.2.584; Sixt M, 2012, J CELL BIOL, V197, P346, DOI 10.1083/jcb.201204039; Suetsugu S, 2003, DEV CELL, V5, P595, DOI 10.1016/S1534-5807(03)00297-1; Suraneni P, 2012, J CELL BIOL, V197, P239, DOI 10.1083/jcb.201112113; van der Valk J, 2010, TOXICOL IN VITRO, V24, P1053, DOI 10.1016/j.tiv.2010.03.016; Westerberg L, 2005, BLOOD, V105, P1144, DOI 10.1182/blood-2004-03-1003; Westerberg LS, 2012, BLOOD, V119, P3966, DOI 10.1182/blood-2010-09-308197; Wu CY, 2012, CELL, V148, P973, DOI 10.1016/j.cell.2011.12.034; Yu XZ, 2012, J CELL BIOL, V199, P527, DOI 10.1083/jcb.201203025; Zicha D, 1997, Methods Mol Biol, V75, P449; Zufferey R, 1997, NAT BIOTECHNOL, V15, P871, DOI 10.1038/nbt0997-871	53	18	18	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2013	8	8							e70364	10.1371/journal.pone.0070364	http://dx.doi.org/10.1371/journal.pone.0070364			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	200ZE	23950925	Green Submitted, Green Published, gold			2022-12-25	WOS:000323109700030
J	Liu, C; Zwiebel, LJ				Liu, Chao; Zwiebel, Laurence J.			Molecular Characterization of Larval Peripheral Thermosensory Responses of the Malaria Vector Mosquito Anopheles gambiae	PLOS ONE			English	Article							WESTERN KENYA HIGHLANDS; DROSOPHILA-MELANOGASTER; BEHAVIORAL PLASTICITY; AQUATIC STAGES; TEMPERATURE; THERMOTAXIS; ELEGANS; TRPA1; SURVIVAL; DIPTERA	Thermosensation provides vital inputs for the malaria vector mosquito, Anopheles gambiae which utilizes heat-sensitivity within a broad spectrum of behaviors, most notably, the localization of human hosts for blood feeding. In this study, we examine thermosensory behaviors in larval-stage An. gambiae, which as a result of their obligate aquatic habitats and importance for vectorial capacity, represents an opportunistic target for vector control as part of the global campaign to eliminate malaria. As is the case for adults, immature mosquitoes respond differentially to a diverse array of external heat stimuli. In addition, larvae exhibit a striking phenotypic plasticity in thermal-driven behaviors that are established by temperature at which embryonic development occurs. Within this spectrum, RNAi-directed gene-silencing studies provide evidence for the essential role of the Transient Receptor Potential sub-family A1 (TRPA1) channel in mediating larval thermal-induced locomotion and thermal preference within a discrete upper range of ambient temperatures.	[Liu, Chao; Zwiebel, Laurence J.] Vanderbilt Univ, Dept Biol Sci, Nashville, TN 37235 USA; [Zwiebel, Laurence J.] Vanderbilt Univ, Med Ctr, Dept Pharmacol, Vanderbilt Brain Inst,Program Dev Biol, Nashville, TN 37232 USA; [Zwiebel, Laurence J.] Vanderbilt Univ, Med Ctr, Inst Chem Biol, Nashville, TN USA; [Zwiebel, Laurence J.] Vanderbilt Univ, Med Ctr, Inst Global Hlth, Nashville, TN USA	Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University	Zwiebel, LJ (corresponding author), Vanderbilt Univ, Dept Biol Sci, 221 Kirkland Hall, Nashville, TN 37235 USA.	l.zwiebel@vanderbilt.edu		Zwiebel, Laurence/0000-0001-6686-7289	Innovation and Discovery in Engineering And Science (IDEAS) program of Vanderbilt University; National Institutes of Health (NIAID) [AI056402]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI056402] Funding Source: NIH RePORTER	Innovation and Discovery in Engineering And Science (IDEAS) program of Vanderbilt University; National Institutes of Health (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by funds provided by the Innovation and Discovery in Engineering And Science (IDEAS) program of Vanderbilt University and from the National Institutes of Health (NIAID, AI056402) to LJZ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afrane YA, 2006, AM J TROP MED HYG, V74, P772, DOI 10.4269/ajtmh.2006.74.772; Bayoh MN, 2004, MED VET ENTOMOL, V18, P174, DOI 10.1111/j.0269-283X.2004.00495.x; Bayoh MN, 2003, B ENTOMOL RES, V93, P375, DOI 10.1079/BER2003259; Chi CA, 2007, J EXP BIOL, V210, P4043, DOI 10.1242/jeb.006551; Clements AN., 1999, SENSORY RECEPTION BE; David JR, 1997, J THERM BIOL, V22, P441, DOI 10.1016/S0306-4565(97)00063-6; Fillinger U, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-353; Fox AN, 2001, P NATL ACAD SCI USA, V98, P14693, DOI 10.1073/pnas.261432998; Garrity PA, 2010, GENE DEV, V24, P2365, DOI 10.1101/gad.1953710; GUNN DL, 1975, ANIM BEHAV, V23, P409, DOI 10.1016/0003-3472(75)90088-3; Hamada FN, 2008, NATURE, V454, P217, DOI 10.1038/nature07001; Huang J, 2006, MALARIA J, V5, DOI 10.1186/1475-2875-5-87; Kang KJ, 2012, NATURE, V481, P76, DOI 10.1038/nature10715; Kaufman MG, 2006, J MED ENTOMOL, V43, P669, DOI 10.1603/0022-2585(2006)43[669:IOABTG]2.0.CO;2; Kendeigh S, 1961, ANIMAL ECOLOGY; Koenraadt CJM, 2006, TROP MED INT HEALTH, V11, P1195, DOI 10.1111/j.1365-3156.2006.01675.x; Kwon Y, 2010, CURR BIOL, V20, P1672, DOI 10.1016/j.cub.2010.08.016; Liu C, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000467; Lu T, 2007, CURR BIOL, V17, P1533, DOI 10.1016/j.cub.2007.07.062; Luo LJ, 2010, J NEUROSCI, V30, P4261, DOI 10.1523/JNEUROSCI.4090-09.2010; LYIMO EO, 1992, ENTOMOL EXP APPL, V63, P265, DOI 10.1007/BF00192775; Merrill AW, 2008, J NEUROPHYSIOL, V99, P415, DOI 10.1152/jn.00883.2007; Neely GG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024343; Parvez S D, 2003, East Mediterr Health J, V9, P627; Pitts RJ, 2004, P NATL ACAD SCI USA, V101, P5058, DOI 10.1073/pnas.0308146101; RANGE R, 1962, PHARMACOL REV, V14, P281; Rosenzweig M, 2005, GENE DEV, V19, P419, DOI 10.1101/gad.1278205; Rosenzweig M, 2008, P NATL ACAD SCI USA, V105, P14668, DOI 10.1073/pnas.0805041105; Sayeed O, 1996, P NATL ACAD SCI USA, V93, P6079, DOI 10.1073/pnas.93.12.6079; Shen WL, 2011, SCIENCE, V331, P1333, DOI 10.1126/science.1198904; SIDDIQUI WH, 1972, ANN ENTOMOL SOC AM, V65, P993, DOI 10.1093/aesa/65.5.993; Sugi T, 2011, NAT NEUROSCI, V14, P984, DOI 10.1038/nn.2854; Walker K, 2007, MED VET ENTOMOL, V21, P2, DOI 10.1111/j.1365-2915.2007.00674.x; Wang GR, 2009, EUR J NEUROSCI, V30, P967, DOI 10.1111/j.1460-9568.2009.06901.x; Xia YF, 2008, P NATL ACAD SCI USA, V105, P6433, DOI 10.1073/pnas.0801007105; Zwiebel LJ, 2004, INSECT BIOCHEM MOLEC, V34, P645, DOI 10.1016/j.ibmb.2004.03.017	36	11	13	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2013	8	8							e72595	10.1371/journal.pone.0072595	http://dx.doi.org/10.1371/journal.pone.0072595			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	200ZE	23940815	Green Published, Green Submitted, gold			2022-12-25	WOS:000323109700138
J	Morozov, VA; Thi, VLD; Denner, J				Morozov, Vladimir A.; Viet Loan Dao Thi; Denner, Joachim			The Transmembrane Protein of the Human Endogenous Retrovirus - K (HERV-K) Modulates Cytokine Release and Gene Expression	PLOS ONE			English	Article							LYMPHOCYTE MITOGEN RESPONSE; SYNTHETIC PEPTIDE; KINASE-C; SEQUENCE IDENTITY; ENVELOPE GENE; HIV-1 GP41; CELLS; SYNCYTIN; INTERLEUKIN-10; INHIBITION	Numerous copies of endogenous retroviruses are present in the genome of mammals including man. Although most of them are defective, some, e.g., the human endogenous retroviruses HERV-K, were found to be expressed under certain physiological conditions. For instance, HERV-K is expressed in germ cell tumours and melanomas as well as in the placenta. Most exogenous retroviruses including the human immunodeficiency virus HIV-1 induce severe immunodeficiencies and there is increasing evidence that the transmembrane envelope (TM) proteins of these retroviruses may be involved. We show here that HERV-K particles released from a human teratocarcinoma cell line, a recombinant TM protein and a peptide corresponding to a highly conserved so-called immunosuppressive domain in the TM protein of HERV-K inhibit the proliferation of human immune cells, induce modulation of the expression of numerous cytokines, and modulate the expression of cellular genes as detected by a microarray analysis. The changes in cytokine release and gene expression induced by the TM protein of HERV-K are similar to those found previously induced by the TM protein of HIV-1. These data suggest that the mechanism of immunosuppression may be similar for different retroviruses and that the expression of the TM protein in tumours and in the placenta may suppress immune responses and thus prevent rejection of the tumour and the embryo.	[Morozov, Vladimir A.; Viet Loan Dao Thi; Denner, Joachim] Robert Koch Inst, Berlin, Germany	Robert Koch Institute	Denner, J (corresponding author), Robert Koch Inst, Berlin, Germany.	DennerJ@rki.de		Morozov, Vladimir/0000-0001-7013-7115; Vladimir, Morozov/0000-0001-6587-572X; Dao Thi, Viet Loan/0000-0003-2293-3592	Berliner Sparkassenstiftung Medizin	Berliner Sparkassenstiftung Medizin	The authors thank the Berliner Sparkassenstiftung Medizin (http://www.berlinersparkassenstiftung-medizin.de/) for financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMADORI A, 1988, CLIN IMMUNOL IMMUNOP, V46, P37, DOI 10.1016/0090-1229(88)90004-9; Arnaud F, 2008, CELL MOL LIFE SCI, V65, P3422, DOI 10.1007/s00018-008-8500-9; Bifulco K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044806; Bleharski JR, 2003, J IMMUNOL, V170, P3812, DOI 10.4049/jimmunol.170.7.3812; Blond JL, 2000, J VIROL, V74, P3321, DOI 10.1128/JVI.74.7.3321-3329.2000; Blond JL, 1999, J VIROL, V73, P1175, DOI 10.1128/JVI.73.2.1175-1185.1999; BOLLER K, 1993, VIROLOGY, V196, P349, DOI 10.1006/viro.1993.1487; Botella-Estrada R, 2005, MELANOMA RES, V15, P99, DOI 10.1097/00008390-200504000-00003; Bouchon A, 2000, J IMMUNOL, V164, P4991, DOI 10.4049/jimmunol.164.10.4991; Brewer G, 2003, J INTERF CYTOK RES, V23, P553, DOI 10.1089/107999003322485053; Buscher K, 2006, MELANOMA RES, V16, P223; Buscher K, 2005, CANCER RES, V65, P4172, DOI 10.1158/0008-5472.CAN-04-2983; Carpentier I, 2004, CURR MED CHEM, V11, P2205, DOI 10.2174/0929867043364694; CHEN YH, 1992, AIDS, V6, P533, DOI 10.1097/00002030-199206000-00002; Conrad CT, 1999, J EXP CLIN CANC RES, V18, P225; Cornelis G, 2012, P NATL ACAD SCI USA, V109, pE432, DOI 10.1073/pnas.1115346109; de Parseval N, 2005, CYTOGENET GENOME RES, V110, P318, DOI 10.1159/000084964; Degelmann A, 2002, FEMS YEAST RES, V2, P349, DOI 10.1016/S1567-1356(02)00096-X; DENNER J, 1980, ACTA BIOL MED GER, V39, pK19; Denner J, 1998, ANN NY ACAD SCI, V862, P75, DOI 10.1111/j.1749-6632.1998.tb09119.x; DENNER J, 1994, AIDS, V8, P1063, DOI 10.1097/00002030-199408000-00005; DENNER J, 1985, ARCH VIROL, V86, P177, DOI 10.1007/BF01309823; Denner J., 2013, PLOS ONE, V8; Denner J, 1995, J CANCER RES CLIN, V121, P35; Denner J, 2010, RETROVIRUSES: MOLECULAR BIOLOGY, GENOMICS AND PATHOGENESIS, P35; DUMMER W, 1995, MELANOMA RES, V5, P67, DOI 10.1097/00008390-199502000-00008; Dupressoir A, 2005, P NATL ACAD SCI USA, V102, P725, DOI 10.1073/pnas.0406509102; Dupressoir A, 2011, P NATL ACAD SCI USA, V108, pE1164, DOI 10.1073/pnas.1112304108; EBENBICHLER CF, 1993, AIDS, V7, P489, DOI 10.1097/00002030-199304000-00006; Endo Y, 2007, IMMUNOBIOLOGY, V212, P371, DOI 10.1016/j.imbio.2006.11.014; Fiebig U, 2006, J VIROL, V80, P5651, DOI 10.1128/JVI.02597-05; Ford JW, 2009, CURR OPIN IMMUNOL, V21, P38, DOI 10.1016/j.coi.2009.01.009; Gerlini G, 2004, AM J PATHOL, V165, P1853, DOI 10.1016/S0002-9440(10)63238-5; GOTTLIEB RA, 1990, J IMMUNOL, V145, P2566; HARAGUCHI S, 1995, IMMUNOL TODAY, V16, P595, DOI 10.1016/0167-5699(95)80083-2; Heidmann O, 2009, RETROVIROLOGY, V6, DOI 10.1186/1742-4690-6-107; HENDERSON LA, 1993, J BIOL CHEM, V268, P15291; Holmes VA, 2003, CYTOKINE, V21, P265, DOI 10.1016/S1043-4666(03)00097-8; Hurwitz BE, 2007, ARCH INTERN MED, V167, P148, DOI 10.1001/archinte.167.2.148; JOKHI PP, 1994, CYTOKINE, V6, P433, DOI 10.1016/1043-4666(94)90068-X; KADOTA J, 1991, MICROBIOL IMMUNOL, V35, P443, DOI 10.1111/j.1348-0421.1991.tb01575.x; Kammerer U, 2011, J REPROD IMMUNOL, V91, P1, DOI 10.1016/j.jri.2011.06.102; Karlas A, 2010, ANN TRANSPL, V15, P45; Larsson Erik, 1994, Upsala Journal of Medical Sciences, V99, P113; Lee JH, 2005, CLIN CANCER RES, V11, P107; Lower J, 1981, Haematol Blood Transfus, V26, P541; Lower R, 1996, P NATL ACAD SCI USA, V93, P5177, DOI 10.1073/pnas.93.11.5177; LOWER R, 1993, P NATL ACAD SCI USA, V90, P4480, DOI 10.1073/pnas.90.10.4480; Malassine A, 2007, PLACENTA, V28, P185, DOI 10.1016/j.placenta.2006.03.001; Malassine A, 2008, RETROVIROLOGY, V5, DOI 10.1186/1742-4690-5-6; Mangeney M, 1998, P NATL ACAD SCI USA, V95, P14920, DOI 10.1073/pnas.95.25.14920; Mangeney M, 2007, P NATL ACAD SCI USA, V104, P20534, DOI 10.1073/pnas.0707873105; Mi S, 2000, NATURE, V403, P785, DOI 10.1038/35001608; Morozov VA, 2012, RETROVIROLOGY, V9, DOI 10.1186/1742-4690-9-67; Muster T, 2003, CANCER RES, V63, P8735; Nagase H, 2000, MATRIX METALLOPROTEI; OLSEN RG, 1977, CANCER RES, V37, P2082; OOSTENDORP RAJ, 1993, CRIT REV ONCOL HEMAT, V14, P189, DOI 10.1016/1040-8428(93)90009-S; RUEGG CL, 1989, J VIROL, V63, P3257, DOI 10.1128/JVI.63.8.3257-3260.1989; RUEGG CL, 1990, J IMMUNOL, V144, P3928; RUEGG CL, 1991, CELL IMMUNOL, V137, P1, DOI 10.1016/0008-8749(91)90051-C; Ruprecht K, 2008, CELL MOL LIFE SCI, V65, P3366, DOI 10.1007/s00018-008-8496-1; SAUTER M, 1995, J VIROL, V69, P414, DOI 10.1128/JVI.69.1.414-421.1995; SCHALLER JP, 1977, J NATL CANCER I, V59, P1441, DOI 10.1093/jnci/59.5.1441; Schmitt K, 2013, GENOME BIOL EVOL, V5, P307, DOI 10.1093/gbe/evt010; Tacke SJ, 2000, VIROLOGY, V268, P87, DOI 10.1006/viro.1999.0149; Turner G, 2001, CURR BIOL, V11, P1531, DOI 10.1016/S0960-9822(01)00455-9; Vernochet C, 2011, PLACENTA, V32, P885, DOI 10.1016/j.placenta.2011.08.006; Yu TW, 2000, IMMUNOL LETT, V73, P19, DOI 10.1016/S0165-2478(00)00196-6	69	53	60	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2013	8	8							e70399	10.1371/journal.pone.0070399	http://dx.doi.org/10.1371/journal.pone.0070399			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	200ZE	23950929	Green Published, Green Submitted, gold			2022-12-25	WOS:000323109700032
J	Su, CH; Chang, SC; Yan, JJ; Tseng, SH; Chien, LJ; Fang, CT				Su, Chiu-Hsia; Chang, Shan-Chwen; Yan, Jer-Jea; Tseng, Shu-Hui; Chien, Li-Jung; Fang, Chi-Tai			Excess Mortality and Long-Term Disability from Healthcare-Associated Staphylococcus aureus Infections: A Population-Based Matched Cohort Study	PLOS ONE			English	Article							SURGICAL-SITE INFECTION; METHICILLIN-RESISTANT; NOSOCOMIAL INFECTIONS; ANTIMICROBIAL-RESISTANT; BACTEREMIA; OUTCOMES; IMPACT; SEPSIS; COST	Background: Staphylococcus aureus is a leading cause of healthcare-associated infections (HAIs), but the impact of S. aureus HAIs on the long-term survival and functional status of hospitalized patients remain unknown. This study aimed to examine whether S. aureus HAIs increase the risks for long-term mortality and disability. Methods: We conducted a retrospective population-based matched cohort study of inpatients at 8 medical centers, 43 regional hospitals, and 63 local hospitals which participated in the Taiwan Nosocomial Infection Surveillance (TNIS). We individually matched 3070 patients with S. aureus HAIs to 6140 inpatients without HAIs at a 1:2 ratio by age, gender, hospital, specialty, underlying diseases, and the length of stay before onset of the S. aureus HAI. Main outcome measures are one-year excess risks for mortality, new-onset chronic ventilator dependence, and new-onset dialysis-dependent end-stage renal disease. Results: We found that patients with S. aureus HAIs had an excess one-year mortality of 20.2% compared with matched uninfected inpatients (P<0.001). The excess risk for new-onset chronic ventilator dependence and dialysis-dependent end-stage renal disease was 7.3% and 2.6%, respectively (Ps<0.001). S. aureus HAIs were also associated with an excess hospital stay of 12 days and an extra cost of $5978 (Ps<0.001). Conclusion: S. aureus HAIs have substantial negative effect on the long-term outcome of hospitalized patients in terms of both mortality and disability, which should be taken into consideration in future cost-effectiveness studies of the control and prevention interventions for S. aureus HAIs.	[Su, Chiu-Hsia; Fang, Chi-Tai] Natl Taiwan Univ, Coll Publ Hlth, Inst Epidemiol & Prevent Med, Taipei 10764, Taiwan; [Su, Chiu-Hsia; Yan, Jer-Jea; Tseng, Shu-Hui; Chien, Li-Jung] Ctr Dis Control, Div 5, Taipei, Taiwan; [Chang, Shan-Chwen; Fang, Chi-Tai] Natl Taiwan Univ Hosp, Dept Internal Med, Taipei 100, Taiwan	National Taiwan University; Centers For Disease Control - Taiwan; National Taiwan University; National Taiwan University Hospital	Chien, LJ (corresponding author), Ctr Dis Control, Div 5, Taipei, Taiwan.	jung@cdc.gov.tw; fangct@ntu.edu.tw	Fang, Chi-Tai/P-2908-2016	Fang, Chi-Tai/0000-0002-7380-1699; CHANG, SHAN-CHWEN/0000-0001-6505-4139	Centers for Disease Control, Department of Health, Taiwan [DOH99-DC-2006]	Centers for Disease Control, Department of Health, Taiwan	This study was supported by the Centers for Disease Control, Department of Health, Taiwan (grant number DOH99-DC-2006). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramson MA, 1999, INFECT CONT HOSP EP, V20, P408, DOI 10.1086/501641; Anderson DJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008305; Blot SI, 2002, ARCH INTERN MED, V162, P2229, DOI 10.1001/archinte.162.19.2229; Bode LGM, 2010, NEW ENGL J MED, V362, P9, DOI 10.1056/NEJMoa0808939; Boyce JM, 2005, LANCET INFECT DIS, V5, P653, DOI 10.1016/S1473-3099(05)70243-7; Bureau of National Health Insurance Department of Health Taiwan Republic of China, 2010, NAT HLTH INS TAIW 20; Bureau of national health insurance (Taiwan), 2011, CAT ILLN PAT; Burke JP, 2003, NEW ENGL J MED, V348, P651, DOI 10.1056/NEJMhpr020557; Burton DC, 2009, JAMA-J AM MED ASSOC, V301, P727, DOI 10.1001/jama.2009.153; Centers for Disease Control (Taiwan), 2009, STAT COMM DIS SURV R; Chaix C, 1999, JAMA-J AM MED ASSOC, V282, P1745, DOI 10.1001/jama.282.18.1745; Chen ML, 1999, J FORMOS MED ASSOC, V98, P426; Chen YT, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0017876, 10.1371/journal.pone.0021428, 10.1371/journal.pone.0017844, 10.1371/journal.pone.0024144, 10.1371/journal.pone.0027163, 10.1371/journal.pone.0027333]; CLUFF LE, 1968, ANN INTERN MED, V69, P859, DOI 10.7326/0003-4819-69-5-859; Cosgrove SE, 2003, CLIN INFECT DIS, V36, P53, DOI 10.1086/345476; Eber MR, 2010, ARCH INTERN MED, V170, P347, DOI 10.1001/archinternmed.2009.509; Engemann JJ, 2003, CLIN INFECT DIS, V36, P592, DOI 10.1086/367653; Fang CT, 2006, J ANTIMICROB CHEMOTH, V57, P511, DOI 10.1093/jac/dkl006; GARNER JS, 1988, AM J INFECT CONTROL, V16, P128, DOI 10.1016/0196-6553(88)90053-3; Harbarth S, 2003, J HOSP INFECT, V54, P258, DOI 10.1016/S0195-6701(03)00150-6; Hidron AI, 2008, INFECT CONT HOSP EP, V29, P996, DOI 10.1086/591861; Hsueh PR, 2004, ANTIMICROB AGENTS CH, V48, P1361, DOI 10.1128/AAC.48.4.1361-1364.2004; JULANDER I, 1985, SCAND J INFECT DIS, V17, P179, DOI 10.3109/inf.1985.17.issue-2.09; Klevens RM, 2008, CLIN INFECT DIS, V47, P927, DOI 10.1086/591698; LEIBOVICI L, 1995, JAMA-J AM MED ASSOC, V274, P807, DOI 10.1001/jama.274.10.807; Lodise TP, 2007, PHARMACOTHERAPY, V27, P1001, DOI 10.1592/phco.27.7.1001; Martin GS, 2003, NEW ENGL J MED, V348, P1546, DOI 10.1056/NEJMoa022139; McGarry SA, 2004, INFECT CONT HOSP EP, V25, P461, DOI 10.1086/502422; Nixon M, 2006, J BONE JOINT SURG BR, V88B, P812, DOI 10.1302/0301-620X.88B6; Resch A, 2009, EUR J HEALTH ECON, V10, P287, DOI 10.1007/s10198-008-0132-3; Sroka S, 2010, J HOSP INFECT, V74, P204, DOI 10.1016/j.jhin.2009.08.023; Tseng SH, 2011, J MICROBIOL IMMUNOL, V44, P157, DOI 10.1016/j.jmii.2011.03.001; Whitby M, 2001, MED J AUSTRALIA, V175, P264, DOI 10.5694/j.1326-5377.2001.tb143562.x	33	28	30	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2013	8	8							e71055	10.1371/journal.pone.0071055	http://dx.doi.org/10.1371/journal.pone.0071055			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	217ZG	23940689	Green Published, Green Submitted, gold			2022-12-25	WOS:000324401500058
J	de Bekker, C; Smith, PB; Patterson, AD; Hughes, DP				de Bekker, Charissa; Smith, Philip B.; Patterson, Andrew D.; Hughes, David P.			Metabolomics Reveals the Heterogeneous Secretome of Two Entomopathogenic Fungi to Ex Vivo Cultured Insect Tissues	PLOS ONE			English	Article							BEAUVERIA-BASSIANA; METARHIZIUM-ANISOPLIAE; LIQUID-CHROMATOGRAPHY; VIRULENCE FACTOR; DESTRUXINS; CYCLODEPSIPEPTIDES; BEAUVEROLIDES; BIOSYNTHESIS; PATHOGENICITY; DEPSIPEPTIDES	Fungal entomopathogens rely on cellular heterogeneity during the different stages of insect host infection. Their pathogenicity is exhibited through the secretion of secondary metabolites, which implies that the infection life history of this group of environmentally important fungi can be revealed using metabolomics. Here metabolomic analysis in combination with ex vivo insect tissue culturing shows that two generalist isolates of the genus Metarhizium and Beauveria, commonly used as biological pesticides, employ significantly different arrays of secondary metabolites during infectious and saprophytic growth. It also reveals that both fungi exhibit tissue specific strategies by a distinguishable metabolite secretion on the insect tissues tested in this study. In addition to showing the important heterogeneous nature of these two entomopathogens, this study also resulted in the discovery of several novel destruxins and beauverolides that have not been described before, most likely because previous surveys did not use insect tissues as a culturing system. While Beauveria secreted these cyclic depsipeptides when encountering live insect tissues, Metarhizium employed them primarily on dead tissue. This implies that, while these fungi employ comparable strategies when it comes to entomopathogenesis, there are most certainly significant differences at the molecular level that deserve to be studied.	[de Bekker, Charissa; Hughes, David P.] Penn State Univ, Ctr Infect Dis Dynam, Dept Entomol, State Coll, PA USA; [de Bekker, Charissa; Hughes, David P.] Penn State Univ, Ctr Infect Dis Dynam, Dept Biol, State Coll, PA USA; [Smith, Philip B.; Patterson, Andrew D.] Penn State Univ, Huck Inst Life Sci, Metabol Core Facil, State Coll, PA USA; [Patterson, Andrew D.] Penn State Univ, Dept Vet & Biomed Sci, Ctr Mol Toxicol & Carcinogenesis, State Coll, PA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University	de Bekker, C (corresponding author), Penn State Univ, Ctr Infect Dis Dynam, Dept Entomol, Univ Pk, State Coll, PA USA.	c.debekker@psu.edu	Patterson, Andrew/G-3852-2012; de Bekker, Charissa/N-2743-2015; Patterson, Andrew/ABF-1575-2020	Patterson, Andrew/0000-0003-2073-0070; Patterson, Andrew/0000-0003-2073-0070; de Bekker, Charissa/0000-0002-7325-172X	National Science Foundation [MRI 1126373]; Marie Curie Actions IOF Project [299501]; Core Metabolomic Facility at the Huck Institute of the Life Sciences; Pennsylvania State University	National Science Foundation(National Science Foundation (NSF)); Marie Curie Actions IOF Project; Core Metabolomic Facility at the Huck Institute of the Life Sciences; Pennsylvania State University	This work was supported by National Science Foundation MRI 1126373, Marie Curie Actions IOF Project 299501 and Funds to DPH and ADP from the Core Metabolomic Facility at the Huck Institute of the Life Sciences and from the Pennsylvania State University. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akbarian J, 2012, AFR J MICROBIOL RES, V6, P6407, DOI 10.5897/AJMR12.1112; Anke H., 2011, MYCOTA, P151; Anke H, 2009, MYCOTA, V15, P273; Bukhari T, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-23; BUTT TM, 1994, BIOCONTROL SCI TECHN, V4, P207, DOI 10.1080/09583159409355328; Donzelli BGG, 2012, CURR GENET, V58, P105, DOI 10.1007/s00294-012-0368-4; Donzelli BGG, 2010, CURR GENET, V56, P151, DOI 10.1007/s00294-010-0288-0; ELSWORTH JF, 1980, J CHEM SOC PERK T 1, P1795, DOI 10.1039/p19800001795; ELSWORTH JF, 1977, J CHEM SOC PERK T 1, P270, DOI 10.1039/p19770000270; ELSWORTH JF, 1974, S AFR J SCI, V70, P379; GROVE JF, 1980, J CHEM SOC PERK T 1, P2878, DOI 10.1039/p19800002878; HAJEK AE, 1994, ANNU REV ENTOMOL, V39, P293, DOI 10.1146/annurev.en.39.010194.001453; Hansen L.D., 2005, CARPENTER ANTS US CA, DOI [10.7591/9781501734922/HTML, DOI 10.7591/9781501734922/HTML]; Hughes GL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036277; Jegorov A, 2004, J MASS SPECTROM, V39, P949, DOI 10.1002/jms.674; Jegorov A, 1998, J MASS SPECTROM, V33, P274, DOI 10.1002/(SICI)1096-9888(199803)33:3<274::AID-JMS630>3.0.CO;2-R; Kuzma M, 2001, J MASS SPECTROM, V36, P1108, DOI 10.1002/jms.213; LANGE C, 1992, BIOL MASS SPECTROM, V21, P33, DOI 10.1002/bms.1200210108; Liu BL, 2012, BIOTECHNOL ADV, V30, P1242, DOI 10.1016/j.biotechadv.2011.10.006; Mnyone LL, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-204; Molnar I, 2010, NAT PROD REP, V27, P1241, DOI 10.1039/c001459c; Nobile CJ, 2007, CURR BIOL, V17, pR349, DOI 10.1016/j.cub.2007.02.035; Paul J., 1968, Laboratory Practice, V17, P570; Pedras MSC, 2002, PHYTOCHEMISTRY, V59, P579, DOI 10.1016/S0031-9422(02)00016-X; Sarabia F, 2004, CURR MED CHEM, V11, P1309, DOI 10.2174/0929867043365224; Sung GH, 2008, MOL PHYLOGENET EVOL, V49, P495, DOI 10.1016/j.ympev.2008.08.028; Sung GH, 2007, MOL PHYLOGENET EVOL, V44, P1204, DOI 10.1016/j.ympev.2007.03.011; Sung GH, 2007, STUD MYCOL, P5, DOI 10.3114/sim.2007.57.01; TRUMAN JW, 1970, SCIENCE, V167, P1624, DOI 10.1126/science.167.3925.1624; Veening JW, 2008, ANNU REV MICROBIOL, V62, P193, DOI 10.1146/annurev.micro.62.081307.163002; Veening JW, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.18; Wang B, 2012, P NATL ACAD SCI USA, V109, P1287, DOI 10.1073/pnas.1115983109; WOSTEN HAB, 1991, J GEN MICROBIOL, V137, P2017, DOI 10.1099/00221287-137-8-2017; Xiao GH, 2012, SCI REP-UK, V2, DOI 10.1038/srep00483; Xu YQ, 2008, CHEM BIOL, V15, P898, DOI 10.1016/j.chembiol.2008.07.011; Xu YQ, 2009, FUNGAL GENET BIOL, V46, P353, DOI 10.1016/j.fgb.2009.03.001; Zimmermann G, 2007, BIOCONTROL SCI TECHN, V17, P879, DOI 10.1080/09583150701593963; Zimmermann G, 2007, BIOCONTROL SCI TECHN, V17, P553, DOI 10.1080/09583150701309006	38	29	29	2	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2013	8	8							e70609	10.1371/journal.pone.0070609	http://dx.doi.org/10.1371/journal.pone.0070609			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	218XC	23940603	Green Submitted, Green Published, gold			2022-12-25	WOS:000324465000097
J	Gaitan-Espitia, JD; Arias, MB; Lardies, MA; Nespolo, RF				Diego Gaitan-Espitia, Juan; Belen Arias, Maria; Lardies, Marco A.; Nespolo, Roberto F.			Variation in Thermal Sensitivity and Thermal Tolerances in an Invasive Species across a Climatic Gradient: Lessons from the Land Snail Cornu aspersum	PLOS ONE			English	Article							HEAT-SHOCK PROTEINS; REACTION NORMS; PHENOTYPIC PLASTICITY; LOCOMOTOR PERFORMANCE; MOLECULAR CHAPERONES; GEOGRAPHIC-VARIATION; MOUNTAIN PASSES; GENE-EXPRESSION; RECOVERY-TIME; CHILL-COMA	The ability of organisms to perform at different temperatures could be described by a continuous nonlinear reaction norm (i.e., thermal performance curve, TPC), in which the phenotypic trait value varies as a function of temperature. Almost any shift in the parameters of this performance curve could highlight the direct effect of temperature on organism fitness, providing a powerful framework for testing thermal adaptation hypotheses. Inter-and intraspecific differences in this performance curve are also reflected in thermal tolerances limits (e. g., critical and lethal limits), influencing the biogeographic patterns of species' distribution. Within this context, here we investigated the intraspecific variation in thermal sensitivities and thermal tolerances in three populations of the invasive snail Cornu aspersum across a geographical gradient, characterized by different climatic conditions. Thus, we examined population differentiation in the TPCs, thermal-coma recovery times, expression of heat-shock proteins and standard metabolic rate (i.e., energetic costs of physiological differentiation). We tested two competing hypotheses regarding thermal adaptation (the "hotter is better" and the generalist-specialist trade-offs). Our results show that the differences in thermal sensitivity among populations of C. aspersum follow a latitudinal pattern, which is likely the result of a combination of thermodynamic constraints ("hotter is better") and thermal adaptations to their local environments (generalist-specialist trade-offs). This finding is also consistent with some thermal tolerance indices such as the Heat-Shock Protein Response and the recovery time from chill-coma. However, mixed responses in the evaluated traits suggest that thermal adaptation in this species is not complete, as we were not able to detect any differences in neither energetic costs of physiological differentiation among populations, nor in the heat-coma recovery.	[Diego Gaitan-Espitia, Juan; Nespolo, Roberto F.] Univ Austral Chile, Inst Ciencias Ambientales & Evolut, Valdivia, Chile; [Diego Gaitan-Espitia, Juan] Univ Austral Chile, Fac Ciencias, Programa Doctorado Ciencias Menc Ecol & Evoluc, Valdivia, Chile; [Belen Arias, Maria; Lardies, Marco A.] Univ Adolfo Ibanez, Fac Artes Liberales, Dept Ciencias, Santiago, Chile; [Lardies, Marco A.] Univ Adolfo Ibanez, Dept Ciencias, Fac Ingn & Ciencias, Santiago, Chile	Universidad Austral de Chile; Universidad Austral de Chile; Universidad Adolfo Ibanez; Universidad Adolfo Ibanez	Nespolo, RF (corresponding author), Univ Austral Chile, Inst Ciencias Ambientales & Evolut, Valdivia, Chile.	robertonespolorossi@gmail.com	Arias, Maria Belen/AAB-3144-2020; Nespolo, Roberto/D-5601-2015; Gaitan-Espitia, Juan Diego/A-9945-2012; Lardies, Marco A/R-6203-2017; Nespolo, Roberto/D-5601-2015	Arias, Maria Belen/0000-0002-5538-5177; Nespolo, Roberto/0000-0001-9337-0606; Gaitan-Espitia, Juan Diego/0000-0001-8781-5736; Lardies, Marco A/0000-0003-3525-1830; Nespolo, Roberto/0000-0003-0825-9618	Chilean Fund for Science and Technology [1090423]; Comision Nacional de Investigacion Cientifica y Tecnologica Chile; Direccion de Investigacion y Desarrollo-Austral University of Chile [D-2011-02]; MECESUP [AUS-0703]	Chilean Fund for Science and Technology; Comision Nacional de Investigacion Cientifica y Tecnologica Chile; Direccion de Investigacion y Desarrollo-Austral University of Chile; MECESUP	This study was financially supported by the research funding of the Chilean Fund for Science and Technology grant number 1090423 to RN. JDGE was supported by a doctoral fellowship from Comision Nacional de Investigacion Cientifica y Tecnologica Chile. JDGE thanks Direccion de Investigacion y Desarrollo-Austral University of Chile grant D-2011-02 and the MECESUP AUS-0703 project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amigo J, 1998, PLANT ECOL, V136, P9, DOI 10.1023/A:1009714201917; Angert AL, 2011, INTEGR COMP BIOL, V51, P733, DOI 10.1093/icb/icr048; Angilletta MJ, 2006, J THERM BIOL, V31, P541, DOI 10.1016/j.jtherbio.2006.06.002; Angilletta MJ, 2010, PHYSIOL BIOCHEM ZOOL, V83, P197, DOI 10.1086/648567; Angilletta MJ, 2009, BIO HABIT, P1, DOI 10.1093/acprof:oso/9780198570875.001.1; [Anonymous], 2001, BIOL TERRESTRIAL MOL; Ansart A, 2002, J COMP PHYSIOL B, V172, P619, DOI 10.1007/s00360-002-0290-z; Asbury DA, 2010, AM NAT, V176, pE40, DOI 10.1086/653659; Barker G.M., 2001, P1, DOI 10.1079/9780851993188.0001; BECKER J, 1994, EUR J BIOCHEM, V219, P11, DOI 10.1111/j.1432-1033.1994.tb19910.x; Arias MB, 2011, J THERM BIOL, V36, P355, DOI 10.1016/j.jtherbio.2011.06.011; BENNETT AF, 1990, AM J PHYSIOL, V259, pR253, DOI 10.1152/ajpregu.1990.259.2.R253; Berger D, 2011, P ROY SOC B-BIOL SCI, V278, P313, DOI 10.1098/rspb.2010.1398; Bishop T, 2000, J EXP BIOL, V203, P3603; Castaneda LE, 2005, J INSECT PHYSIOL, V51, P1346, DOI 10.1016/j.jinsphys.2005.08.005; Castaneda LE, 2004, EVOL ECOL RES, V6, P579; CHRISTIAN KA, 1988, BIOTROPICA, V20, P236, DOI 10.2307/2388239; David JR, 2003, FUNCT ECOL, V17, P425, DOI 10.1046/j.1365-2435.2003.00750.x; DENNY M, 1980, SCIENCE, V208, P1288, DOI 10.1126/science.208.4449.1288; Deutsch CA, 2008, P NATL ACAD SCI USA, V105, P6668, DOI 10.1073/pnas.0709472105; Gaitan-Espitia JD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067299; Gaitan-Espitia JD, 2013, EVOL ECOL RES, V15, P61; Gaitan-Espitia JD, 2013, COMP BIOCHEM PHYS A, V165, P169, DOI 10.1016/j.cbpa.2013.03.002; Gaitan-Espitia JD, 2012, INVERTEBR BIOL, V131, P11, DOI 10.1111/j.1744-7410.2011.00255.x; Feder ME, 1999, ANNU REV PHYSIOL, V61, P243, DOI 10.1146/annurev.physiol.61.1.243; Frazier MR, 2006, AM NAT, V168, P512, DOI 10.1086/506977; GATTEN RE, 1988, PHYSIOL ZOOL, V61, P322, DOI 10.1086/physzool.61.4.30161249; Ghalambor CK, 2006, INTEGR COMP BIOL, V46, P5, DOI 10.1093/icb/icj003; Gianoli E, 2012, BIOL J LINN SOC, V105, P1, DOI 10.1111/j.1095-8312.2011.01793.x; Gibert P, 2001, EVOLUTION, V55, P1063, DOI 10.1554/0014-3820(2001)055[1063:CCTAMC]2.0.CO;2; GILCHRIST GW, 1995, AM NAT, V146, P252, DOI 10.1086/285797; Gilchrist GW, 1996, EVOLUTION, V50, P1560, DOI [10.2307/2410892, 10.1111/j.1558-5646.1996.tb03928.x]; Guiller A, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-18; Gvozdik L, 2012, BIOL LETTERS, V8, P262, DOI 10.1098/rsbl.2011.0960; Hanfling Bernd, 2002, Trends in Ecology and Evolution, V17, P545, DOI 10.1016/S0169-5347(02)02644-7; Hartl FU, 2002, SCIENCE, V295, P1852, DOI 10.1126/science.1068408; HAZEL WN, 1990, HEREDITY, V65, P449, DOI 10.1038/hdy.1990.116; Hoffmann AA, 2002, ECOL LETT, V5, P614, DOI 10.1046/j.1461-0248.2002.00367.x; Hoffmann AA, 2013, FUNCT ECOL, V27, P934, DOI 10.1111/j.1365-2435.2012.02036.x; Hofmann GE, 2005, INTEGR COMP BIOL, V45, P247, DOI 10.1093/icb/45.2.247; HUEY RB, 1979, AM ZOOL, V19, P357; HUEY RB, 1976, Q REV BIOL, V51, P363, DOI 10.1086/409470; Huey RB, 2001, AM NAT, V158, P204, DOI 10.1086/321314; HUEY RB, 1989, TRENDS ECOL EVOL, V4, P131, DOI 10.1016/0169-5347(89)90211-5; JANZEN DH, 1967, AM NAT, V101, P233, DOI 10.1086/282487; Johnston IA, 1996, SOC EXPT BIOL SEMINA, V59; KAUFMANN JS, 1989, PHYSIOL ZOOL, V62, P1047, DOI 10.1086/physzool.62.5.30156195; Kingsolver JG, 2004, INTEGR COMP BIOL, V44, P450, DOI 10.1093/icb/44.6.450; Kingsolver JG, 2008, EVOL ECOL RES, V10, P251; Kingsolver JG, 2007, AM NAT, V169, P163, DOI 10.1086/510631; Kingsolver JG, 2009, AM NAT, V174, P755, DOI 10.1086/648310; Knies JL, 2009, AM NAT, V173, P419, DOI 10.1086/597224; Kohler HR, 2009, J EXP ZOOL PART B, V312B, P136, DOI 10.1002/jez.b.21253; Krenek S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030598; Lam KKY, 2002, J MOLLUS STUD, V68, P297, DOI 10.1093/mollus/68.4.297; Latimer CAL, 2011, J EVOLUTION BIOL, V24, P965, DOI 10.1111/j.1420-9101.2011.02227.x; Lauga E, 2006, PHYS FLUIDS, V18, DOI 10.1063/1.2382591; LEVINS RICHARD, 1968; Lighton JRB, 2019, MEASURING METABOLIC RATES: A MANUAL FOR SCIENTISTS, 2ND EDITION, DOI 10.1093/oso/9780198830399.001.0001; Lighton JRB, 2004, J EXP BIOL, V207, P1903, DOI 10.1242/jeb.00970; Lindgren B, 2009, BIOL J LINN SOC, V98, P217, DOI 10.1111/j.1095-8312.2009.01255.x; Lutterschmidt WI, 1997, CAN J ZOOL, V75, P1561, DOI 10.1139/z97-783; LYNCH M, 1987, AM NAT, V129, P283, DOI 10.1086/284635; MACHIN J, 1967, J ZOOL, V152, P55; Madec L, 2003, HEREDITY, V91, P224, DOI 10.1038/sj.hdy.6800301; Madec L, 2000, BIOL J LINN SOC, V69, P25, DOI 10.1111/j.1095-8312.2000.tb01667.x; Magiafoglou A, 2003, FUNCT ECOL, V17, P664, DOI 10.1046/j.1365-2435.2003.00774.x; McNab B.K, 2002, PHYSL ECOLOGY VERTEB, DOI DOI 10.1643/0045-8511(2002)002[1170:]2.0.CO;2; Naya DE, 2011, EVOL ECOL RES, V13, P647; Niehaus AC, 2012, J EXP BIOL, V215, P694, DOI 10.1242/jeb.058032; Pearman PB, 2008, TRENDS ECOL EVOL, V23, P149, DOI 10.1016/j.tree.2007.11.005; Piersma T, 2003, TRENDS ECOL EVOL, V18, P228, DOI 10.1016/S0169-5347(03)00036-3; Piersma T., 2011, FLEXIBLE PHENOTYPE B; Portner HO, 2004, PHYSIOL BIOCHEM ZOOL, V77, P959, DOI 10.1086/423742; Portner HO, 2001, NATURWISSENSCHAFTEN, V88, P137; Prentis PJ, 2008, TRENDS PLANT SCI, V13, P288, DOI 10.1016/j.tplants.2008.03.004; Savage VM, 2004, AM NAT, V163, P429, DOI 10.1086/381872; Schneider KR, 2008, BIOL BULL-US, V215, P253, DOI 10.2307/25470709; Schuler MS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020905; Schulte PM, 2011, INTEGR COMP BIOL, V51, P691, DOI 10.1093/icb/icr097; Somero GN, 2010, J EXP BIOL, V213, P912, DOI 10.1242/jeb.037473; Somero George N., 2005, Frontiers in Zoology, V2, P1, DOI 10.1186/1742-9994-2-1; Somero GN, 2004, COMP BIOCHEM PHYS B, V139, P321, DOI 10.1016/j.cbpc.2004.05.003; SOMERO GN, 1995, ANNU REV PHYSIOL, V57, P43, DOI 10.1146/annurev.ph.57.030195.000355; Sorensen JG, 2002, FUNCT ECOL, V16, P379, DOI 10.1046/j.1365-2435.2002.00639.x; Sorensen JG, 2003, ECOL LETT, V6, P1025, DOI 10.1046/j.1461-0248.2003.00528.x; Stachowicz JJ, 2002, P NATL ACAD SCI USA, V99, P15497, DOI 10.1073/pnas.242437499; Sunday JM, 2011, P ROY SOC B-BIOL SCI, V278, P1823, DOI 10.1098/rspb.2010.1295; Tomanek L, 2010, J EXP BIOL, V213, P971, DOI 10.1242/jeb.038034; VORHABEN JE, 1984, PHYSIOL ZOOL, V57, P357, DOI 10.1086/physzool.57.3.30163725; WELSFORD IG, 1990, J EXP ZOOL, V253, P229, DOI 10.1002/jez.1402530214; Wilson RS, 2001, J EXP BIOL, V204, P4227; Yang J, 2008, J COMP PHYSIOL B, V178, P343, DOI 10.1007/s00360-007-0227-7; Zerebecki RA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014806	94	50	51	2	88	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2013	8	8							e70662	10.1371/journal.pone.0070662	http://dx.doi.org/10.1371/journal.pone.0070662			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	218XC	23940617	Green Submitted, Green Published, gold			2022-12-25	WOS:000324465000111
J	Hakkinen, A; Tran, H; Yli-Harja, O; Ribeiro, AS				Hakkinen, Antti; Huy Tran; Yli-Harja, Olli; Ribeiro, Andre S.			Effects of Rate-Limiting Steps in Transcription Initiation on Genetic Filter Motifs	PLOS ONE			English	Article							ESCHERICHIA-COLI; PROMOTER; MECHANISM; NETWORKS	The behavior of genetic motifs is determined not only by the gene-gene interactions, but also by the expression patterns of the constituent genes. Live single-molecule measurements have provided evidence that transcription initiation is a sequential process, whose kinetics plays a key role in the dynamics of mRNA and protein numbers. The extent to which it affects the behavior of cellular motifs is unknown. Here, we examine how the kinetics of transcription initiation affects the behavior of motifs performing filtering in amplitude and frequency domain. We find that the performance of each filter is degraded as transcript levels are lowered. This effect can be reduced by having a transcription process with more steps. In addition, we show that the kinetics of the stepwise transcription initiation process affects features such as filter cutoffs. These results constitute an assessment of the range of behaviors of genetic motifs as a function of the kinetics of transcription initiation, and thus will aid in tuning of synthetic motifs to attain specific characteristics without affecting their protein products.	[Hakkinen, Antti; Huy Tran; Yli-Harja, Olli; Ribeiro, Andre S.] Tampere Univ Technol, Dept Signal Proc, FIN-33101 Tampere, Finland; [Yli-Harja, Olli] Inst Syst Biol, Seattle, WA USA	Tampere University; Institute for Systems Biology (ISB)	Ribeiro, AS (corresponding author), Tampere Univ Technol, Dept Signal Proc, FIN-33101 Tampere, Finland.	andre.ribeiro@tut.fi	Ribeiro, Andre S/G-4294-2014	Ribeiro, Andre S/0000-0002-7255-5211; Tran, Huy/0000-0002-9057-060X; Yli-Harja, Olli/0000-0001-8581-4414; Hakkinen, Antti/0000-0002-8081-1588	Academy of Finland; Finnish Funding Agency for Technology and Innovation	Academy of Finland(Academy of Finland); Finnish Funding Agency for Technology and Innovation(Finnish Funding Agency for Technology & Innovation (TEKES))	This work was supported by the Academy of Finland and the Finnish Funding Agency for Technology and Innovation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bernstein JA, 2002, P NATL ACAD SCI USA, V99, P9697, DOI 10.1073/pnas.112318199; DeHaseth PL, 1998, J BACTERIOL, V180, P3019, DOI 10.1128/JB.180.12.3019-3025.1998; Dyson S, 1998, CELL, V93, P557, DOI 10.1016/S0092-8674(00)81185-X; Kandhavelu M, 2012, PHYS BIOL, V9, DOI 10.1088/1478-3975/9/2/026004; Kandhavelu M, 2011, BMC SYST BIOL, V5, DOI 10.1186/1752-0509-5-149; Loinger A, 2007, PHYS REV E, V76, DOI 10.1103/PhysRevE.76.051917; Lutz R, 2001, NUCLEIC ACIDS RES, V29, P3873, DOI 10.1093/nar/29.18.3873; MCCLURE WR, 1985, ANNU REV BIOCHEM, V54, P171, DOI 10.1146/annurev.bi.54.070185.001131; Muthukrishnan AB, 2012, NUCLEIC ACIDS RES, V40, P8472, DOI 10.1093/nar/gks583; Pedraza JM, 2008, SCIENCE, V319, P339, DOI 10.1126/science.1144331; Ribeiro A, 2006, J COMPUT BIOL, V13, P1630, DOI 10.1089/cmb.2006.13.1630; Ribeiro AS, 2007, BIOINFORMATICS, V23, P777, DOI 10.1093/bioinformatics/btm004; Ribeiro AS, 2010, PHYS REV E, V81, DOI 10.1103/PhysRevE.81.011912; Roussel MR, 2006, PHYS BIOL, V3, P274, DOI 10.1088/1478-3975/3/4/005; Taniguchi Y, 2010, SCIENCE, V329, P533, DOI 10.1126/science.1188308; Wolf DM, 2003, CURR OPIN MICROBIOL, V6, P125, DOI 10.1016/S1369-5274(03)00033-X; Xia K, 2007, P NATL ACAD SCI USA, V104, P17329, DOI 10.1073/pnas.0705417104	17	9	9	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2013	8	8							e70439	10.1371/journal.pone.0070439	http://dx.doi.org/10.1371/journal.pone.0070439			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	218XC	23940576	Green Published, Green Submitted, gold			2022-12-25	WOS:000324465000070
J	Kenkel, WM; Paredes, J; Lewis, GF; Yee, JR; Pournajafi-Nazarloo, H; Grippo, AJ; Porges, SW; Carter, CS				Kenkel, William M.; Paredes, Jamespaul; Lewis, Gregory F.; Yee, Jason R.; Pournajafi-Nazarloo, Hossein; Grippo, Angela J.; Porges, Stephen W.; Carter, C. Sue			Autonomic Substrates of the Response to Pups in Male Prairie Voles	PLOS ONE			English	Article							PHYSIOLOGICAL REACTIVITY; ALLOPARENTAL CARE; OXYTOCIN; VAGAL; VASOPRESSIN; EVOLUTION; STRESS; HEART; RISK	Caregiving by nonparents (alloparenting) and fathers is a defining aspect of human social behavior, yet this phenomenon is rare among mammals. Male prairie voles (Microtus ochrogaster) spontaneously exhibit high levels of alloparental care, even in the absence of reproductive experience. In previous studies, exposure to a pup was selectively associated with increased activity in oxytocin and vasopressin neurons along with decreased plasma corticosterone. In the present study, physiological, pharmacological and neuroanatomical methods were used to explore the autonomic and behavioral consequences of exposing male prairie voles to a pup. Reproductively naive, adult male prairie voles were implanted with radiotransmitters used for recording ECG, temperature and activity. Males responded with a sustained increase in heart-rate during pup exposure. This prolonged increase in heart rate was not explained by novelty, locomotion or thermoregulation. Although heart rate was elevated during pup exposure, respiratory sinus arrhythmia (RSA) did not differ between these males and males exposed to control stimuli indicating that vagal inhibition of the heart was maintained. Blockade of beta-adrenergic receptors with atenolol abolished the pup-induced heart rate increase, implicating sympathetic activity in the pup-induced increase in heart rate. Blockade of vagal input to the heart delayed the males' approach to the pup. Increased activity in brainstem autonomic regulatory nuclei was also observed in males exposed to pups. Together, these findings suggest that exposure to a pup activates both vagal and sympathetic systems. This unique physiological state (i.e. increased sympathetic excitation of the heart, while maintaining some vagal cardiac tone) associated with male caregiving behavior may allow males to both nurture and protect infants.	[Kenkel, William M.; Lewis, Gregory F.; Yee, Jason R.; Pournajafi-Nazarloo, Hossein; Porges, Stephen W.; Carter, C. Sue] Univ Illinois, Dept Psychiat, Brain & Body Ctr, Chicago, IL 60612 USA; [Paredes, Jamespaul] Emory Univ, Yerkes Natl Primate Res Ctr, Div Psychobiol, Atlanta, GA 30322 USA; [Grippo, Angela J.] No Illinois Univ, Dept Psychol, De Kalb, IL 60115 USA; [Pournajafi-Nazarloo, Hossein; Porges, Stephen W.; Carter, C. Sue] Univ N Carolina, Dept Psychiat, Chapel Hill, NC USA; [Kenkel, William M.; Yee, Jason R.; Porges, Stephen W.; Carter, C. Sue] Norteastern Univ, Dept Psychol, Boston, MA USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Emory University; Northern Illinois University; University of North Carolina; University of North Carolina Chapel Hill	Kenkel, WM (corresponding author), Univ Illinois, Dept Psychiat, Brain & Body Ctr, Chicago, IL 60612 USA.	w.kenkel@neu.edu	Kenkel, William/T-5695-2019	Kenkel, William/0000-0002-0271-1071; Lewis, Gregory/0000-0002-2548-8423	National Institutes of Mental Health [MH73233, MH67446, MH72935]; National Institute of Child Health and Human Development [HD38490]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [P01HD038490] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R21MH067446, R01MH072935, F32MH073233] Funding Source: NIH RePORTER	National Institutes of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This research was supported by National Institutes of Mental Health grants MH73233 (AJG), MH67446 (SWP), and MH72935 (CSC), and National Institute of Child Health and Human Development grant HD38490 (CSC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altemus M, 2001, PSYCHOSOM MED, V63, P814, DOI 10.1097/00006842-200109000-00015; Bakermans-Kranenburg M. J., 2011, SOC COGN AFFECT NEUR; Bales KL, 2007, HORM BEHAV, V52, P274, DOI 10.1016/j.yhbeh.2007.05.004; Bales KL, 2006, PHYSIOL BEHAV, V87, P424, DOI 10.1016/j.physbeh.2005.11.002; Bales KL, 2004, HORM BEHAV, V45, P354, DOI 10.1016/j.yhbeh.2004.01.004; Blascovich J., 2010, HDB SOCIAL PSYCHOL, V5th ed., P194, DOI DOI 10.1002/9780470561119.SOCPSY001006; Broad KD, 2006, PHILOS T R SOC B, V361, P2199, DOI 10.1098/rstb.2006.1940; Carter CS, 2008, PROG BRAIN RES, V170, P331, DOI 10.1016/S0079-6123(08)00427-5; Carter C. Sue, 1997, P231; CARTER CS, 1995, NEUROSCI BIOBEHAV R, V19, P303; Cushing BS, 2001, HORM BEHAV, V39, P48, DOI 10.1006/hbeh.2000.1633; DALY M, 1988, SCIENCE, V242, P519, DOI 10.1126/science.3175672; DeSilva JM, 2011, P NATL ACAD SCI USA, V108, P1022, DOI 10.1073/pnas.1003865108; Frodi A. M., 1978, INFANT BEHAV DEV, V1, P187, DOI [10.1016/s0163-6383(78)80029-0, DOI 10.1016/S0163-6383(78)80029-0]; Gamer M, 2012, PSYCHONEUROENDOCRINO, V37, P87, DOI 10.1016/j.psyneuen.2011.05.007; Grippo AJ, 2007, PHYSIOL BEHAV, V90, P386, DOI 10.1016/j.physbeh.2006.09.037; Grippo AJ, 2009, PSYCHONEUROENDOCRINO, V34, P1542, DOI 10.1016/j.psyneuen.2009.05.017; Higa KT, 2002, AM J PHYSIOL-REG I, V282, pR537, DOI 10.1152/ajpregu.00806.2000; HOOVER DB, 1985, BRAIN RES BULL, V15, P5, DOI 10.1016/0361-9230(85)90054-1; Hrdy SarahBlaffer., 2009, MOTHERS OTHERS EVOLU; Kenkel WM, 2012, J NEUROENDO IN PRESS; Kennedy GE, 2005, J HUM EVOL, V48, P123, DOI 10.1016/j.jhevol.2004.09.005; KOLLAI M, 1979, J AUTONOM NERV SYST, V1, P33, DOI 10.1016/0165-1838(79)90004-3; Lewis GF, 2011, BIOL PSYCHOL; Lewis GF, 2012, BIOL PSYCHOL, V89, P349, DOI 10.1016/j.biopsycho.2011.11.009; Neff RA, 1998, BRAIN RES, V792, P277, DOI 10.1016/S0006-8993(98)00149-8; Norman GJ, 2011, BIOL PSYCHOL, V86, P174, DOI 10.1016/j.biopsycho.2010.11.006; Numan Michael, 2006, Behav Cogn Neurosci Rev, V5, P163, DOI 10.1177/1534582306288790; Out D, 2010, GENES BRAIN BEHAV, V9, P868, DOI 10.1111/j.1601-183X.2010.00624.x; Paton JFR, 2005, BRAIN RES REV, V49, P555, DOI 10.1016/j.brainresrev.2005.02.005; Paxinos G, 2004, MOUSE BRAIN STEREOTA; Porges S. W., 1990, PRINCIPLES PSYCHOPHY, P708; Porges S. W., 1985, METHOD APPARATUS EVA, V4, P944; Porges SW, 2007, BIOL PSYCHOL, V74, P116, DOI 10.1016/j.biopsycho.2006.06.009; PORGES SW, 1995, PSYCHOPHYSIOLOGY, V32, P301, DOI 10.1111/j.1469-8986.1995.tb01213.x; Quinlan RJ, 2008, HUM NATURE-INT BIOS, V19, P87, DOI 10.1007/s12110-007-9026-9; Riem MME, 2011, BIOL PSYCHIAT, V70, P291, DOI 10.1016/j.biopsych.2011.02.006; Riem MME, 2011, SOC COGN AFFECT NEUR, V6, P294, DOI 10.1093/scan/nsq035; Ritter S., 1992, NEUROANATOMY PHYSL A; Robin I, 1994, NUCL SOLITARY TRACT; Ruscio MG, 2008, BEHAV BRAIN RES, V187, P9, DOI 10.1016/j.bbr.2007.08.028; Schnitzer PG, 2005, PEDIATRICS, V116, pE687, DOI 10.1542/peds.2005-0296; Selye H, 1956, J BONE JOINT SURG; Stiffman MN, 2002, PEDIATRICS, V109, P615, DOI 10.1542/peds.109.4.615; TAYLOR EW, 1994, CARDIOSCIENCE, V5, P173; WANG ZX, 1994, ANIM BEHAV, V47, P281, DOI 10.1006/anbe.1994.1040; Williamson JB, 2010, AUTON NEUROSCI-BASIC, V156, P60, DOI 10.1016/j.autneu.2010.03.009; Yang Z, 2009, AUTON NEUROSCI-BASIC, V147, P80, DOI 10.1016/j.autneu.2009.01.013	48	23	23	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2013	8	8							e69965	10.1371/journal.pone.0069965	http://dx.doi.org/10.1371/journal.pone.0069965			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	218XC	23940535	Green Published, gold, Green Submitted			2022-12-25	WOS:000324465000029
J	Kim, SB; Lee, JW; Kim, SY; Lee, DW				Kim, Seoung Bum; Lee, Jung Woo; Kim, Sin Young; Lee, Deok Won			Dental Informatics to Characterize Patients with Dentofacial Deformities	PLOS ONE			English	Article							FALSE DISCOVERY RATE	Relevant statistical modeling and analysis of dental data can improve diagnostic and treatment procedures. The purpose of this study is to demonstrate the use of various data mining algorithms to characterize patients with dentofacial deformities. A total of 72 patients with skeletal malocclusions who had completed orthodontic and orthognathic surgical treatments were examined. Each patient was characterized by 22 measurements related to dentofacial deformities. Clustering analysis and visualization grouped the patients into three different patterns of dentofacial deformities. A feature selection approach based on a false discovery rate was used to identify a subset of 22 measurements important in categorizing these three clusters. Finally, classification was performed to evaluate the quality of the measurements selected by the feature selection approach. The results showed that feature selection improved classification accuracy while simultaneously determining which measurements were relevant.	[Kim, Seoung Bum; Kim, Sin Young] Korea Univ, Sch Ind Management Engn, Seoul, South Korea; [Lee, Jung Woo; Lee, Deok Won] Kyung Hee Univ, Dept Oral & Maxillofacial Surg, Seoul, South Korea	Korea University; Kyung Hee University	Lee, DW (corresponding author), Kyung Hee Univ, Dept Oral & Maxillofacial Surg, Seoul, South Korea.	verycutebear@khu.ac.kr			Brain Korea 21 (Network Enterprise)	Brain Korea 21 (Network Enterprise)	This work was supported by Brain Korea 21 (Network Enterprise). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Jasser Nasser M, 2005, J Contemp Dent Pract, V6, P52; Benjamini Y, 2001, ANN STAT, V29, P1165; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; BURSTONE CJ, 1978, J ORAL SURG, V36, P269; COTTON W N, 1951, Angle Orthod, V21, P213; de Veld DCG, 2003, LASER SURG MED, V32, P367, DOI 10.1002/lsm.10185; DOWNS WB, 1948, AM J ORTHOD DENTOFAC, V34, P812, DOI 10.1016/0002-9416(48)90015-3; Gerber Jay W, 2006, Funct Orthod, V23, P32; Gordon AD, 1999, CLASSIFICATION; Higurashi N, 2001, PSYCHIAT CLIN NEUROS, V55, P259, DOI 10.1046/j.1440-1819.2001.00850.x; HUBERT L, 1985, J CLASSIF, V2, P193, DOI 10.1007/BF01908075; Hwang HS, 2007, AM J ORTHOD DENTOFAC, V132, DOI 10.1016/j.ajodo.2007.01.017; JACOBSON A, 1975, AM J ORTHOD DENTOFAC, V67, P125, DOI 10.1016/0002-9416(75)90065-2; Jolliffe, 2002, PRINCIPAL COMPONENT; Kaufman L, 1990, FIND GROUPS DATA INT; Kim SB, 2008, STAT ANAL DATA MININ, V1, P58; Kim Seoung Bum, 2006, Int J Bioinform Res Appl, V2, P193; Lee SJ, 2007, AM J ORTHOD DENTOFAC, V132, P796, DOI 10.1016/j.ajodo.2005.12.037; McNamara C M, 1989, J Ir Dent Assoc, V35, P36; Mei YJ, 2009, EXPERT SYST APPL, V36, P4703, DOI 10.1016/j.eswa.2008.06.032; Mitchell T.M, 2003, MACH LEARN; Nanda S K, 1965, Angle Orthod, V35, P311; Nguyen HP, 2008, RAPID COMMUN MASS SP, V22, P2220, DOI 10.1002/rcm.3606; Park T, 2003, BIOINFORMATICS, V19, P694, DOI 10.1093/bioinformatics/btg068; RABERIN M, 1993, AM J ORTHOD DENTOFAC, V104, P67, DOI 10.1016/0889-5406(93)70029-N; RAND WM, 1971, J AM STAT ASSOC, V66, P846, DOI 10.2307/2284239; Reissmann E, 1989, Z Stomatol, V86, P305; RICHARD A. J., 2002, APPL MULTIVARIATE ST; SASSOUNI V, 1969, AMER J ORTHODONTICS, V55, P109, DOI 10.1016/0002-9416(69)90122-5; Schleyer T, 2001, J AM DENT ASSOC, V132, P605, DOI 10.14219/jada.archive.2001.0237; Tibshirani R, 2001, J ROY STAT SOC B, V63, P411, DOI 10.1111/1467-9868.00293; Wu J, 2007, ANGLE ORTHOD, V77, P12, DOI 10.2319/021606-62R.1; Xu R, 2005, IEEE T NEURAL NETWOR, V16, P645, DOI 10.1109/TNN.2005.845141	33	3	3	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2013	8	8							e67862	10.1371/journal.pone.0067862	http://dx.doi.org/10.1371/journal.pone.0067862			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	218XC	23940512	Green Published, gold, Green Submitted			2022-12-25	WOS:000324465000006
J	Lautner-Csorba, O; Gezsi, A; Erdelyi, DJ; Hullam, G; Antal, P; Semsei, AF; Kutszegi, N; Kovacs, G; Falus, A; Szalai, C				Lautner-Csorba, Orsolya; Gezsi, Andras; Erdelyi, Daniel J.; Hullam, Gabor; Antal, Peter; Semsei, Agnes F.; Kutszegi, Nora; Kovacs, Gabor; Falus, Andras; Szalai, Csaba			Roles of Genetic Polymorphisms in the Folate Pathway in Childhood Acute Lymphoblastic Leukemia Evaluated by Bayesian Relevance and Effect Size Analysis	PLOS ONE			English	Article							METHIONINE SYNTHASE REDUCTASE; MULTILEVEL ANALYSIS; CHINESE POPULATION; A66G POLYMORPHISM; RISK; ASSOCIATION; SUSCEPTIBILITY; MTHFR; DEFECTS; METAANALYSIS	In this study we investigated whether polymorphisms in the folate pathway influenced the risk of childhood acute lymphoblastic leukemia (ALL) or the survival rate of the patients. For this we selected and genotyped 67 SNPs in 15 genes in the folate pathway in 543 children with ALL and 529 controls. The results were evaluated by gender adjusted logistic regression and by the Bayesian network based Bayesian multilevel analysis of relevance (BN-BMLA) methods. Bayesian structure based odds ratios for the relevant variables and interactions were also calculated. Altogether 9 SNPs in 8 genes were associated with altered susceptibility to ALL. After correction for multiple testing, two associations remained significant. The genotype distribution of the MTHFD1 rs1076991 differed significantly between the ALL and control population. Analyzing the subtypes of the disease the GG genotype increased only the risk of B-cell ALL (p = 3.52 x 10(-4); OR = 2.00). The GG genotype of the rs3776455 SNP in the MTRR gene was associated with a significantly reduced risk to ALL (p = 1.21 x 10(-3); OR = 0.55), which resulted mainly from the reduced risk to B-cell and hyperdiploid-ALL. The TC genotype of the rs9909104 SNP in the SHMT1 gene was associated with a lower survival rate comparing it to the TT genotype (80.2% vs. 88.8%; p = 0.01). The BN-BMLA confirmed the main findings of the frequentist-based analysis and showed structural interactional maps and the probabilities of the different structural association types of the relevant SNPs especially in the hyperdiploid-ALL, involving additional SNPs in genes like TYMS, DHFR and GGH. We also investigated the statistical interactions and redundancies using structural model properties. These results gave further evidence that polymorphisms in the folate pathway could influence the ALL risk and the effectiveness of the therapy. It was also shown that in gene association studies the BN-BMLA could be a useful supplementary to the traditional frequentist-based statistical method.	[Lautner-Csorba, Orsolya; Gezsi, Andras; Semsei, Agnes F.; Kutszegi, Nora; Falus, Andras; Szalai, Csaba] Semmelweis Univ, Dept Genet Cell & Immunobiol, H-1085 Budapest, Hungary; [Erdelyi, Daniel J.; Kovacs, Gabor] Semmelweis Univ, Dept Pediat 2, H-1085 Budapest, Hungary; [Hullam, Gabor; Antal, Peter] Univ Technol & Econ, Dept Measurement & Informat Syst, Budapest, Hungary; [Szalai, Csaba] Heim Pal Children Hosp, Budapest, Hungary; [Szalai, Csaba] Csertex Res Lab, Budapest, Hungary	Semmelweis University; Semmelweis University; Budapest University of Technology & Economics	Szalai, C (corresponding author), Semmelweis Univ, Dept Genet Cell & Immunobiol, H-1085 Budapest, Hungary.	genomika.cs@gmail.com	Erdelyi, Daniel J/N-8957-2017; Kovács, Gábor/AAM-5883-2020; Kutszegi, Nóra/AAM-3399-2020; Antal, Peter/G-7894-2012	Erdelyi, Daniel J/0000-0001-5544-9209; Antal, Peter/0000-0002-4370-2198; Hullam, Gabor/0000-0002-4765-2351; Falus, Andras/0000-0002-6843-6789; Kutszegi, Nora/0000-0001-5957-3215; Semsei, Agnes F./0000-0002-8709-2459	OTKA (Hungarian Scientific Research Fund) [K81941, TS/2 044707]; Economic Competitiveness Operational Program, Hungary GVOP [3.1.1-2004-05-0022/3.0]; OTKAPD (Hungarian Scientific Research Fund) [76348]; Bolyai Grant (Hungarian Academy of Science); NKTH (National Research and Technology) [TECH_08-A1/2-2008-0120]; New Szechenyi Plan [TAMOP-4.2.1/B-09/1/KMR-2010-0002]	OTKA (Hungarian Scientific Research Fund)(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA)); Economic Competitiveness Operational Program, Hungary GVOP; OTKAPD (Hungarian Scientific Research Fund); Bolyai Grant (Hungarian Academy of Science); NKTH (National Research and Technology)(National Office for Research and Technology); New Szechenyi Plan	This study was supported by OTKA (Hungarian Scientific Research Fund): K81941 (C. Szalai); TS/2 044707 (A. Falus); and the Economic Competitiveness Operational Program, Hungary GVOP 3.1.1-2004-05-0022/3.0 (A Falus, DJ Erdelyi); OTKAPD (Hungarian Scientific Research Fund):76348 (P. Antal), Bolyai Grant (Hungarian Academy of Science): (P. Antal) and NKTH (National Research and Technology) TECH_08-A1/2-2008-0120: (A. Falus, C. Szalai, P. Antal). This work is connected to the scientific program of the "Development of quality-oriented and harmonized R+D+I strategy and functional model at BME'' project. This project is supported by the New Szechenyi Plan (Project ID: TAMOP-4.2.1/B-09/1/KMR-2010-0002). Web pages for the funding organizations: OTKA: http://www.otka.hu/NKTH: www.nih.gov.hu ETT: http://www.ett.hu/palyazat.htm Bolyai Grant: http://www.bolyaitestamentum.hu/?m = 24 The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ansari M, 2007, PHARMACOGENOMICS, V8, P817, DOI 10.2217/14622416.8.7.817; Antal P, 2010, IMMUNOMICS REV, V3, P157, DOI 10.1007/978-1-4419-0540-6_11; Antal P MA, 2008, JMLR WORKSHOP C P, V4, P74; Assaraf YG, 2007, CANCER METAST REV, V26, P153, DOI 10.1007/s10555-007-9049-z; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Carroll N, 2009, HUM GENET, V125, P247, DOI 10.1007/s00439-008-0616-3; Chan JYS, 2011, HEMATOL ONCOL, V29, P116, DOI 10.1002/hon.965; de Deus Dayse Maria Vasconcelos, 2012, Leuk Res Treatment, V2012, P692348, DOI 10.1155/2012/692348; de Jonge R, 2005, BLOOD, V106, P717, DOI 10.1182/blood-2004-12-4941; de Jonge R, 2009, BLOOD, V113, P2284, DOI 10.1182/blood-2008-07-165928; Erdilyi DJ, 2008, PHARMACOGENOMICS J, V8, P321, DOI 10.1038/sj.tpj.6500480; Franco RF, 2001, BRIT J HAEMATOL, V115, P616, DOI 10.1046/j.1365-2141.2001.03140.x; Gaughan DJ, 2001, ATHEROSCLEROSIS, V157, P451, DOI 10.1016/S0021-9150(00)00739-5; Geisel J, 2001, CLIN CHEM LAB MED, V39, P698, DOI 10.1515/CCLM.2001.115; Hahn LW, 2003, BIOINFORMATICS, V19, P376, DOI 10.1093/bioinformatics/btf869; Han D, 2012, MOL BIOL REP, V39, P805, DOI 10.1007/s11033-011-0802-6; Hullam G., 2012, P 6 EUR WORKSH PROB, P147; Hullam G, 2010, EVALUATION BAYESIAN, P30; Hullam G, 2012, ESTIMATION EFFECT SI, P147; Hullam G, 2010, JMLR WORKSH CONF PRO, V8, P30; Krajinovic M, 2004, PHARMACOGENOMICS J, V4, P66, DOI 10.1038/sj.tpj.6500224; Krajinovic M, 2004, BLOOD, V103, P252, DOI 10.1182/blood-2003-06-1794; Krajinovic M, 2001, Rev Environ Health, V16, P263; Krajinovici M, 2008, PHARMACOGENOMICS, V9, P829, DOI 10.2217/14622416.9.7.829; Kuppers R, 1999, NEW ENGL J MED, V341, P1520; Lautner-Csorba O, 2012, BMC MED GENOMICS, V5, DOI 10.1186/1755-8794-5-42; Lightfoot TJ, 2010, BLOOD, V115, P3923, DOI 10.1182/blood-2009-10-249722; Liu L, 2011, CARCINOGENESIS, V32, P336, DOI 10.1093/carcin/bgq264; Metayer C, 2011, CANCER CAUSE CONTROL, V22, P1243, DOI 10.1007/s10552-011-9795-7; O'Leary VB, 2002, AM J MED GENET, V107, P151, DOI 10.1002/ajmg.10121; Olteanu H, 2002, BIOCHEMISTRY-US, V41, P13378, DOI 10.1021/bi020536s; Ongaro A, 2009, HAEMATOL-HEMATOL J, V94, P1391, DOI 10.3324/haematol.2009.008326; Pereira TV, 2006, CANCER EPIDEM BIOMAR, V15, P1956, DOI 10.1158/1055-9965.EPI-06-0334; Pui Ching-Hon, 2000, Acta Paediatrica Taiwanica, V41, P303; Purcell S, 2003, BIOINFORMATICS, V19, P149, DOI 10.1093/bioinformatics/19.1.149; Schwahn B, 2001, Am J Pharmacogenomics, V1, P189, DOI 10.2165/00129785-200101030-00004; Semsei AF, 2008, LEUKEMIA RES, V32, P1214, DOI 10.1016/j.leukres.2007.12.009; Semsei AF, 2010, LEUKEMIA RES, V34, P269, DOI 10.1016/j.leukres.2009.07.036; SHANE B, 1989, VITAM HORM, V45, P263; Shaw GM, 2009, BMC MED GENET, V10, DOI 10.1186/1471-2350-10-49; Sherborne AL, 2011, HAEMATOL-HEMATOL J, V96, P1049, DOI 10.3324/haematol.2011.040121; Sherborne AL, 2010, NAT GENET, V42, P492, DOI 10.1038/ng.585; Storey JD, 2002, J ROY STAT SOC B, V64, P479, DOI 10.1111/1467-9868.00346; Ungvari I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033573; Vijayakrishnan J, 2010, HAEMATOL-HEMATOL J, V95, P1405, DOI 10.3324/haematol.2010.022095; Wiemels JL, 2001, P NATL ACAD SCI USA, V98, P4004, DOI 10.1073/pnas.061408298; Yang L, 2011, LEUKEMIA LYMPHOMA, V52, P1770, DOI 10.3109/10428194.2011.578186; Zhang GC, 2011, PEDIAT ALLERG IMM-UK, V22, P621, DOI 10.1111/j.1399-3038.2011.01186.x; Zhong R, 2013, CARCINOGENESIS, V34, P936, DOI 10.1093/carcin/bgs395; Zingg JM, 1997, CARCINOGENESIS, V18, P869, DOI 10.1093/carcin/18.5.869	50	26	28	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2013	8	8							e69843	10.1371/journal.pone.0069843	http://dx.doi.org/10.1371/journal.pone.0069843			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	218XC	23940529	Green Published, gold			2022-12-25	WOS:000324465000023
J	Lobo, ML; Esteves, F; de Sousa, B; Cardoso, F; Cushion, MT; Antunes, F; Matos, O				Lobo, Maria Luisa; Esteves, Francisco; de Sousa, Bruno; Cardoso, Fernando; Cushion, Melanie T.; Antunes, Francisco; Matos, Olga			Therapeutic Potential of Caspofungin Combined with Trimethoprim-Sulfamethoxazole for Pneumocystis Pneumonia: A Pilot Study in Mice	PLOS ONE			English	Article							INVASIVE FUNGAL-INFECTIONS; CELL-WALL; CARINII PNEUMONIA; EPIDEMIOLOGY; GLUCAN; POLYMORPHISMS; ECHINOCANDIN; INFLAMMATION; DIAGNOSIS; EFFICACY	Pneumocystis pneumonia (PcP) is a major cause of mortality and morbidity in immunocompromised patients. There are limited alternative therapeutic choices to trimethoprim-sulfamethoxazole (TMP-SMX) which is the standard first line therapy/prophylaxis for PcP. The efficacy of low doses of caspofungin and caspofungin in association with TMP-SMX standard-prophylactic dose was evaluated in an experimental model of Pneumocystis. Susceptibility of Pneumocystis spp. to low doses of caspofungin and caspofungin/TMP-SMX was evaluated in Balb/c immunosuppressed mice, infected intranasally with P. murina. Caspofungin was administered once daily at 0.1 mg/kg, 0.05 mg/kg, and 0.001 mg/kg and TMP-SMX was administered by oral gavage (12.25 mg/62.5 mg/day), for 21 days. Efficacy was calculated based on the reduction in organism burden determined through quantitative fluorescent-based real-time PCR (qPCR). Serum beta-1,3-D-glucan was measured as an additional marker of infection. The present data showed that caspofungin demonstrated anti-Pneumomocystis effect. However, the doses administrated were too low to achieve Pneumocystis eradication, which suggests that echinocandin treatment should not be administrated as mono-therapy. After 21 days of treatment, P. murina was not detected in the lungs of mice with either TMP-SMX or caspofungin/TMP-SMX. The results showed that, even at the lowest concentrations tested, the efficacy of caspofungin in association with TMP-SMX was higher than the efficacy of either drug used alone. The administration of caspofungin/TMP-SMX was at least 1.4 times more effective against P. murina infection than TMP-SMX used alone. The most promising result was achieved with the combination of caspofungin 0.05 mg/kg/day with TMP-SMX 12.5 mg-62.5 mg/day, which reduced the parasite burden to undetectable levels immediately at the 14th day of treatment, showing a highly marked anti-Pneumomocystis effect. These data suggest that the administration of low doses of caspofungin in combination with low doses of TMP-SMX may provide an improved treatment protocol for Pneumocystis infection clearance.	[Lobo, Maria Luisa; Esteves, Francisco; Cardoso, Fernando; Matos, Olga] Univ Nova Lisboa, Inst Higiene & Med Trop, Grp Protozoarios Oportunistas VIH & Outros Protoz, Unidade Parasitol Med,CMDT, P-1200 Lisbon, Portugal; [de Sousa, Bruno] Univ Coimbra, CMDT, Fac Psicol & Ciencias Educ, Coimbra, Portugal; [Cushion, Melanie T.] Univ Cincinnati, Coll Med, Cincinnati, OH USA; [Antunes, Francisco] Univ Lisbon, Fac Med, Hosp Santa Maria, P-1699 Lisbon, Portugal	Universidade Nova de Lisboa; Institute of Hygiene & Tropical Medicine - UNL; Universidade de Coimbra; University System of Ohio; University of Cincinnati; Universidade de Lisboa; Hospital Santa Maria	Matos, O (corresponding author), Univ Nova Lisboa, Inst Higiene & Med Trop, Grp Protozoarios Oportunistas VIH & Outros Protoz, Unidade Parasitol Med,CMDT, P-1200 Lisbon, Portugal.	omatos@ihmt.unl.pt	Lobo, Maria/I-3527-2012; de Sousa, Bruno/A-1654-2012; Matos, Olga/J-8859-2012; de Sousa, Bruno/S-2600-2019; Cardoso, Fernando/A-7753-2013	Lobo, Maria/0000-0001-5811-7568; de Sousa, Bruno/0000-0001-9918-8100; Matos, Olga/0000-0001-5793-7716; Antunes, Francisco/0000-0001-7932-1154; Cardoso, Fernando/0000-0003-1501-9479; Esteves, Francisco/0000-0002-3046-1313; Cushion, Melanie T./0000-0001-6621-2784	Merck Sharp Dohme Corp [38903]	Merck Sharp Dohme Corp(Merck & Company)	The present study was supported by the scientific project Ref. 38903 financed by Merck Sharp & Dohme Corp. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aliouat-Denis CM, 2008, INFECT GENET EVOL, V8, P708, DOI 10.1016/j.meegid.2008.05.001; Annaloro C, 2006, EUR J CLIN MICROBIOL, V25, P52, DOI 10.1007/s10096-005-0065-z; Barry S M, 2001, HIV Med, V2, P123, DOI 10.1046/j.1468-1293.2001.00062.x; Beltz K, 2006, KLIN PADIATR, V218, P177, DOI 10.1055/s-2006-933433; Calderon EJ, 2010, EXPERT REV ANTI-INFE, V8, P683, DOI [10.1586/eri.10.42, 10.1586/eri.10.11, 10.1586/ERI.10.42]; Costa MC, 2005, SCAND J INFECT DIS, V37, P766, DOI 10.1080/00365540510038505; Cushion MT, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008524; Enoch DA, 2006, J MED MICROBIOL, V55, P809, DOI 10.1099/jmm.0.46548-0; Esgalhado R, 2013, MED MYCOL, V51, P66, DOI 10.3109/13693786.2012.700123; Espinel-Ingroff A, 2009, REV IBEROAM MICOL, V26, P15, DOI 10.1016/S1130-1406(09)70004-X; Esteves F, 2012, CLIN MICROBIOL INFEC, V18, pE177, DOI 10.1111/j.1469-0691.2012.03828.x; Esteves F, 2010, CLIN MICROBIOL INFEC, V16, P878, DOI 10.1111/j.1469-0691.2009.03030.x; Finkelman MA, 2010, CRIT REV MICROBIOL, V36, P271, DOI 10.3109/1040841X.2010.484001; HOLTENANDERSEN W, 1989, APMIS, V97, P745, DOI 10.1111/j.1699-0463.1989.tb00472.x; Huang Laurence, 2011, Proc Am Thorac Soc, V8, P294, DOI 10.1513/pats.201009-062WR; Hufeldt MR, 2010, LAB ANIM-UK, V44, P283, DOI 10.1258/la.2010.010058; Letscher-Bru V, 2003, J ANTIMICROB CHEMOTH, V51, P513, DOI 10.1093/jac/dkg117; Limper AH, 2003, J EUKARYOT MICROBIOL, V50, P646, DOI 10.1111/j.1550-7408.2003.tb00667.x; Linke MJ, 2013, INFECT IMMUN, V81, P984, DOI 10.1128/IAI.01181-12; Matos O, 2010, PARASITE, V17, P219, DOI 10.1051/parasite/2010173219; MATSUMOTO Y, 1991, J PROTOZOOL, V38, pS6; Morris A, 2008, COPD, V5, P43, DOI 10.1080/15412550701817656; Persat F, 2008, J CLIN MICROBIOL, V46, P1009, DOI 10.1128/JCM.02091-07; Powles MA, 1998, ANTIMICROB AGENTS CH, V42, P1985, DOI 10.1128/AAC.42.8.1985; Redhead S, 2006, J EUKARYOT MICROBIOL, V53, P2, DOI 10.1111/j.1550-7408.2005.00072.x; Ruan SB, 2002, INFECT IMMUN, V70, P6107, DOI 10.1128/IAI.70.11.6107-6113.2002; SCHMATZ DM, 1990, P NATL ACAD SCI USA, V87, P5950, DOI 10.1073/pnas.87.15.5950; Stringer JR, 1996, CLIN MICROBIOL REV, V9, P489, DOI 10.1128/CMR.9.4.489; Thomas CF, 2007, NAT REV MICROBIOL, V5, P298, DOI 10.1038/nrmicro1621; Utili R, 2007, TRANSPLANTATION, V84, P685, DOI 10.1097/01.tp.0000280546.91617.6c; Vassallo R, 2000, J IMMUNOL, V164, P3755, DOI 10.4049/jimmunol.164.7.3755; Vazquez JA, 2006, CLIN INFECT DIS, V43, P215, DOI 10.1086/505204; WALZER PD, 1992, ANTIMICROB AGENTS CH, V36, P1935, DOI 10.1128/AAC.36.9.1935; Yoshida M, 1996, J LAB CLIN MED, V128, P103, DOI 10.1016/S0022-2143(96)90119-5	34	37	45	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2013	8	8							e70619	10.1371/journal.pone.0070619	http://dx.doi.org/10.1371/journal.pone.0070619			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	218XC	23940606	Green Published, gold, Green Submitted			2022-12-25	WOS:000324465000100
J	Morgan, MS; Arlian, LG; Markey, MP				Morgan, Marjorie S.; Arlian, Larry G.; Markey, Michael P.			Sarcoptes scabiei Mites Modulate Gene Expression in Human Skin Equivalents	PLOS ONE			English	Article							CYTOKINE EXPRESSION; VAR CANIS; ACARI; KERATINOCYTES; EXTRACTS; CELLS; NORMALIZATION; FIBROBLASTS; MOLECULES; SUMMARIES	The ectoparasitic mite, Sarcoptes scabiei that burrows in the epidermis of mammalian skin has a long co-evolution with its hosts. Phenotypic studies show that the mites have the ability to modulate cytokine secretion and expression of cell adhesion molecules in cells of the skin and other cells of the innate and adaptive immune systems that may assist the mites to survive in the skin. The purpose of this study was to identify genes in keratinocytes and fibroblasts in human skin equivalents (HSEs) that changed expression in response to the burrowing of live scabies mites. Overall, of the more than 25,800 genes measured, 189 genes were up-regulated >2-fold in response to scabies mite burrowing while 152 genes were down-regulated to the same degree. HSEs differentially expressed large numbers of genes that were related to host protective responses including those involved in immune response, defense response, cytokine activity, taxis, response to other organisms, and cell adhesion. Genes for the expression of interleukin-1 alpha (IL-1 alpha) precursor, IL-1 beta, granulocyte/macrophage-colony stimulating factor (GM-CSF) precursor, and G-CSF precursor were up-regulated 2.8- to 7.4-fold, paralleling cytokine secretion profiles. A large number of genes involved in epithelium development and keratinization were also differentially expressed in response to live scabies mites. Thus, these skin cells are directly responding as expected in an inflammatory response to products of the mites and the disruption of the skin's protective barrier caused by burrowing. This suggests that in vivo the interplay among these skin cells and other cell types, including Langerhans cells, dendritic cells, lymphocytes and endothelial cells, is responsible for depressing the host's protective response allowing these mites to survive in the skin.	[Morgan, Marjorie S.; Arlian, Larry G.] Wright State Univ, Dept Biol Sci, Dayton, OH 45435 USA; [Markey, Michael P.] Wright State Univ, Dept Biochem & Mol Biol, Dayton, OH 45435 USA	University System of Ohio; Wright State University Dayton; University System of Ohio; Wright State University Dayton	Arlian, LG (corresponding author), Wright State Univ, Dept Biol Sci, Dayton, OH 45435 USA.	larry.arlian@wright.edu		Markey, Michael/0000-0002-8593-2290	United States National Institutes of Health, National Institute of Allergy and Infectious Disease [AI-017252]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI017252, R21AI017252] Funding Source: NIH RePORTER	United States National Institutes of Health, National Institute of Allergy and Infectious Disease; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was funded by a grant from the United States National Institutes of Health, National Institute of Allergy and Infectious Disease (AI-017252). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arend WP, 1998, ANNU REV IMMUNOL, V16, P27, DOI 10.1146/annurev.immunol.16.1.27; Arlian LG, 2007, J MED ENTOMOL, V44, P1054, DOI 10.1603/0022-2585(2007)44[1054:IVETSS]2.0.CO;2; Arlian LG, 2004, J MED ENTOMOL, V41, P69, DOI 10.1603/0022-2585-41.1.69; Arlian LG, 2003, AM J TROP MED HYG, V69, P652, DOI 10.4269/ajtmh.2003.69.652; Arlian LG, 1997, VET PARASITOL, V68, P347, DOI 10.1016/S0304-4017(96)01093-X; ARLIAN LG, 1994, EXP PARASITOL, V78, P51, DOI 10.1006/expr.1994.1005; ARLIAN LG, 1988, J MED ENTOMOL, V25, P64, DOI 10.1093/jmedent/25.1.64; Arlian LG, 2006, J MED ENTOMOL, V43, P283, DOI 10.1603/0022-2585(2006)043[0283:ETSMAS]2.0.CO;2; ARLIAN LG, 1984, J AM ACAD DERMATOL, V11, P210, DOI 10.1016/S0190-9622(84)70151-4; Barksby HE, 2007, CLIN EXP IMMUNOL, V149, P217, DOI 10.1111/j.1365-2249.2007.03441.x; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Bromley SK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058196; Chustz RT, 2011, AM J RESP CELL MOL, V45, P145, DOI 10.1165/rcmb.2010-0075OC; Cruikshank WW, 2000, J LEUKOCYTE BIOL, V67, P757, DOI 10.1002/jlb.67.6.757; Di Meglio Paola, 2010, F1000 Biol Rep, V2, DOI 10.3410/B2-40; Dunn E, 2001, TRENDS IMMUNOL, V22, P533, DOI 10.1016/S1471-4906(01)02034-8; Elder BL, 2006, J MED ENTOMOL, V43, P910, DOI 10.1603/0022-2585(2006)43[910:SSASME]2.0.CO;2; Elder BL, 2009, CYTOKINE, V47, P103, DOI 10.1016/j.cyto.2009.05.008; Emig D, 2010, NUCLEIC ACIDS RES, V38, pW755, DOI 10.1093/nar/gkq405; ESTES SA, 1983, J AM ACAD DERMATOL, V9, P397, DOI 10.1016/S0190-9622(83)70148-9; FALK ES, 1982, AM J DERMATOPATH, V4, P9; FALK ES, 1981, INT J DERMATOL, V20, P600, DOI 10.1111/j.1365-4362.1981.tb00844.x; Flicek P, 2013, NUCLEIC ACIDS RES, V41, pD48, DOI 10.1093/nar/gks1236; Frezzolini A, 2004, CLIN EXP IMMUNOL, V137, P595, DOI 10.1111/j.1365-2249.2004.02570.x; Frezzolini A, 2002, ALLERGY, V57, P815, DOI 10.1034/j.1398-9995.2002.23687.x; Griffiths CEM, 2010, NEW ENGL J MED, V362, P118, DOI 10.1056/NEJMoa0810652; Hara T, 2012, J BIOCHEM, V151, P469, DOI 10.1093/jb/mvs030; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015; Iwakura Y, 2006, J CLIN INVEST, V116, P1218, DOI 10.1172/JCI28508; Kryczek I, 2007, AM J PHYSIOL-CELL PH, V292, pC987, DOI 10.1152/ajpcell.00406.2006; Lee E, 2004, J EXP MED, V199, P125, DOI 10.1084/jem.20030451; Malik M, 2008, J IMMUNOL, V181, P4632, DOI 10.4049/jimmunol.181.7.4632; Mika A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040489; Mika A, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001563; Morgan MS, 2010, J MED ENTOMOL, V47, P877, DOI 10.1603/ME10012; Mullins JS, 2009, J MED ENTOMOL, V46, P845, DOI 10.1603/033.046.0415; Otkjaer K, 2005, BRIT J DERMATOL, V153, P911, DOI 10.1111/j.1365-2133.2005.06800.x; Piskin G, 2006, J IMMUNOL, V176, P1908, DOI 10.4049/jimmunol.176.3.1908; Rapp CM, 2006, J MED ENTOMOL, V43, P539, DOI 10.1603/0022-2585(2006)43[539:POHIIT]2.0.CO;2; Rich BE, 2001, CURR BIOL, V11, pR531, DOI 10.1016/S0960-9822(01)00312-8; Rizzo HL, 2011, J IMMUNOL, V186, P1495, DOI 10.4049/jimmunol.1001001; Sabat R, 2007, EXP DERMATOL, V16, P779, DOI 10.1111/j.1600-0625.2007.00629.x; Stemmer BL, 1996, VET PARASITOL, V67, P247, DOI 10.1016/S0304-4017(96)01038-2; Van Neste DJ, 1987, MODELS DERMATOLOGY, V3, P170; Walton SF, 2010, PARASITE IMMUNOL, V32, P532, DOI 10.1111/j.1365-3024.2010.01218.x; Wolk K, 2009, EUR J IMMUNOL, V39, P3570, DOI 10.1002/eji.200939687; Zambon AC, 2012, BIOINFORMATICS, V28, P2209, DOI 10.1093/bioinformatics/bts366	49	8	9	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2013	8	8							e71143	10.1371/journal.pone.0071143	http://dx.doi.org/10.1371/journal.pone.0071143			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	218XC	23940705	Green Published, gold, Green Submitted			2022-12-25	WOS:000324465000184
J	Rusnakova, V; Honsa, P; Dzamba, D; Stahlberg, A; Kubista, M; Anderova, M				Rusnakova, Vendula; Honsa, Pavel; Dzamba, David; Stahlberg, Anders; Kubista, Mikael; Anderova, Miroslava			Heterogeneity of Astrocytes: From Development to Injury - Single Cell Gene Expression	PLOS ONE			English	Article							RAT CORTICAL ASTROCYTES; GLUTAMATE-RECEPTOR 5; ADULT-RAT; BRAIN-INJURY; GLIAL-CELLS; HIPPOCAMPAL EXPRESSION; REACTIVE ASTROCYTES; NG2 PROTEOGLYCAN; TRANSGENIC MICE; MESSENGER-RNA	Astrocytes perform control and regulatory functions in the central nervous system; heterogeneity among them is still a matter of debate due to limited knowledge of their gene expression profiles and functional diversity. To unravel astrocyte heterogeneity during postnatal development and after focal cerebral ischemia, we employed single-cell gene expression profiling in acutely isolated cortical GFAP/EGFP-positive cells. Using a microfluidic qPCR platform, we profiled 47 genes encoding glial markers and ion channels/transporters/receptors participating in maintaining K+ and glutamate homeostasis per cell. Self-organizing maps and principal component analyses revealed three subpopulations within 10-50 days of postnatal development (P10-P50). The first subpopulation, mainly immature glia from P10, was characterized by high transcriptional activity of all studied genes, including polydendrocytic markers. The second subpopulation (mostly from P20) was characterized by low gene transcript levels, while the third subpopulation encompassed mature astrocytes (mainly from P30, P50). Within 14 days after ischemia (D3, D7, D14), additional astrocytic subpopulations were identified: resting glia (mostly from P50 and D3), transcriptionally active early reactive glia (mainly from D7) and permanent reactive glia (solely from D14). Following focal cerebral ischemia, reactive astrocytes underwent pronounced changes in the expression of aquaporins, nonspecific cationic and potassium channels, glutamate receptors and reactive astrocyte markers.	[Rusnakova, Vendula; Kubista, Mikael] Acad Sci Czech Republic, Inst Biotechnol, Gene Express Lab, Prague, Czech Republic; [Honsa, Pavel; Dzamba, David; Anderova, Miroslava] Acad Sci Czech Republic, Inst Expt Med, Dept Cellular Neurophysiol, Prague, Czech Republic; [Stahlberg, Anders] Univ Gothenburg, Sahlgrenska Acad, Dept Pathol, Sahlgrenska Canc Ctr, Gothenburg, Sweden	Czech Academy of Sciences; Institute of Biotechnology of the Czech Academy of Sciences; Czech Academy of Sciences; Institute of Experimental Medicine of the Czech Academy of Sciences; University of Gothenburg	Anderova, M (corresponding author), Acad Sci Czech Republic, Inst Expt Med, Dept Cellular Neurophysiol, Prague, Czech Republic.	anderova@biomed.cas.cz	Anderova, Miroslava/H-2249-2014; Kubista, Mikael/A-5689-2008; Novosadova, Vendula/AAJ-1449-2021; Novosadova, Vendula/G-6388-2014	Anderova, Miroslava/0000-0002-9030-4571; Kubista, Mikael/0000-0002-2940-352X; Stahlberg, Anders/0000-0003-4243-0191	Academy of Sciences of the Czech Republic IBT AS CR [AVOZ50520701]; Academy of Sciences of the Czech Republic UEM AS CR [AV0Z50390703]; Grant Agency of the Czech Republic [P303/13/02154S]; EMBO Short Term Fellowship [ASTF 110-2011]; ESF Functional Genomics Short Visit Grant [2426]	Academy of Sciences of the Czech Republic IBT AS CR; Academy of Sciences of the Czech Republic UEM AS CR; Grant Agency of the Czech Republic(Grant Agency of the Czech Republic); EMBO Short Term Fellowship(European Molecular Biology Organization (EMBO)); ESF Functional Genomics Short Visit Grant	This work was supported by the Academy of Sciences of the Czech Republic IBT AS CR [AVOZ50520701] and UEM AS CR [AV0Z50390703]; by Grant Agency of the Czech Republic [P303/13/02154S]; by an EMBO Short Term Fellowship [ASTF 110-2011] and an ESF Functional Genomics Short Visit Grant [2426]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguado F, 2002, J NEUROSCI, V22, P9430; Alonso G, 2005, GLIA, V49, P318, DOI 10.1002/glia.20121; Anderova M, 2004, GLIA, V48, P311, DOI 10.1002/glia.20076; Anderova M, 2011, J CEREBR BLOOD F MET, V31, P894, DOI 10.1038/jcbfm.2010.168; Arimura K, 2012, CURR NEUROVASC RES, V9, P1; Badaut J, 2004, NEUROSCIENCE, V129, P971, DOI 10.1016/j.neuroscience.2004.06.035; Badaut J, 2004, NEUROSCIENCE, V128, P27, DOI 10.1016/j.neuroscience.2004.05.042; Benesova J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029725; Benesova J, 2009, J NEUROSCI RES, V87, P96, DOI 10.1002/jnr.21828; Benfenati V, 2007, NEUROSCIENCE, V148, P876, DOI 10.1016/j.neuroscience.2007.06.039; Bengtsson M, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-63; Bezzi P, 1998, NATURE, V391, P281, DOI 10.1038/34651; Bordey A, 2001, J NEUROPHYSIOL, V85, P1719, DOI 10.1152/jn.2001.85.4.1719; Butenko O, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039959; Butt AM, 2005, J ANAT, V207, P695, DOI 10.1111/j.1469-7580.2005.00458.x; Cahoy JD, 2008, J NEUROSCI, V28, P264, DOI 10.1523/JNEUROSCI.4178-07.2008; Connors NC, 2004, J BIOL CHEM, V279, P28387, DOI 10.1074/jbc.M402604200; DACUNHA A, 1991, DEV BRAIN RES, V64, P212; Durand D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022235; Ferraguti F, 2001, EXP BRAIN RES, V137, P1, DOI 10.1007/s002210000633; Freeman MR, 2010, SCIENCE, V330, P774, DOI 10.1126/science.1190928; Ge WP, 2012, NATURE, V484, P376, DOI 10.1038/nature10959; Gorski JA, 2002, J NEUROSCI, V22, P6309; Hara-Chikuma M, 2006, J AM SOC NEPHROL, V17, P39, DOI 10.1681/ASN.2005080846; Hepp R, 1999, GLIA, V27, P181, DOI 10.1002/(SICI)1098-1136(199908)27:2<181::AID-GLIA8>3.0.CO;2-9; Honsa P, 2013, NEUROSCIENCE; Honsa P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036816; Hoshi A, 2012, J NEUROPATH EXP NEUR, V71, P750, DOI 10.1097/NEN.0b013e3182632566; Hwang IK, 2007, J NEUROSCI RES, V85, P2470, DOI 10.1002/jnr.21381; Illarionova NB, 2010, NEUROSCIENCE, V168, P915, DOI 10.1016/j.neuroscience.2009.11.062; JACQUE CM, 1978, J NEUROL SCI, V35, P147, DOI 10.1016/0022-510X(78)90107-7; Kimelberg HK, 2004, NEUROCHEM INT, V45, P191, DOI 10.1016/j.neuint.2003.08.015; Klein CA, 2005, GENE EXPRESSION ANAL; Komitova M, 2002, J CEREBR BLOOD F MET, V22, P852, DOI 10.1097/00004647-200207000-00010; Komitova M, 2011, GLIA, V59, P800, DOI 10.1002/glia.21152; Liu H, 2012, ARQ NEURO-PSIQUIAT, V70, P214, DOI 10.1590/S0004-282X2012000300012; Lyon L, 2008, SYNAPSE, V62, P842, DOI 10.1002/syn.20553; Machon O, 2002, NEUROSCIENCE, V112, P951, DOI 10.1016/S0306-4522(02)00053-2; Marshall CAG, 2003, GLIA, V43, P52, DOI 10.1002/glia.10213; MASOOD K, 1993, J NEUROCHEM, V61, P160, DOI 10.1111/j.1471-4159.1993.tb03551.x; Matthias K, 2003, J NEUROSCI, V23, P1750; Matyash V, 2010, BRAIN RES REV, V63, P2, DOI 10.1016/j.brainresrev.2009.12.001; Mccoy E, 2007, GLIA, V55, P1034, DOI 10.1002/glia.20524; Mccoy E, 2010, GLIA, V58, P209, DOI 10.1002/glia.20916; McKeon RJ, 1999, J NEUROSCI, V19, P10778, DOI 10.1523/JNEUROSCI.19-24-10778.1999; MEAROW KM, 1989, MOL BRAIN RES, V6, P223, DOI 10.1016/0169-328X(89)90068-5; Nagelhus EA, 1999, GLIA, V26, P47, DOI 10.1002/(SICI)1098-1136(199903)26:1<47::AID-GLIA5>3.0.CO;2-5; Neitz A, 2011, EUR J NEUROSCI, V33, P1611, DOI 10.1111/j.1460-9568.2011.07654.x; Nolte C, 2001, GLIA, V33, P72; Oberheim NA, 2009, J NEUROSCI, V29, P3276, DOI 10.1523/JNEUROSCI.4707-08.2009; Palygin O, 2011, BRIT J PHARMACOL, V163, P1755, DOI 10.1111/j.1476-5381.2011.01374.x; Pamenter ME, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051469; Papadopoulos MC, 2008, PROG BRAIN RES, V170, P589, DOI 10.1016/S0079-6123(08)00446-9; Paquet M, 2013, MOL BRAIN, V6, DOI 10.1186/1756-6606-6-9; Patanow CM, 1997, NEUROSCIENCE, V76, P187; Pekny M, 2005, GLIA, V50, P427, DOI 10.1002/glia.20207; Prajerova I, 2010, CELL MOL NEUROBIOL, V30, P199, DOI 10.1007/s10571-009-9443-x; Raj A, 2006, PLOS BIOL, V4, P1707, DOI 10.1371/journal.pbio.0040309; Raj A, 2009, ANNU REV BIOPHYS, V38, P255, DOI 10.1146/annurev.biophys.37.032807.125928; Ransom CB, 2001, J NEUROSCI, V21, P7674, DOI 10.1523/JNEUROSCI.21-19-07674.2001; Regan MR, 2007, J NEUROSCI, V27, P6607, DOI 10.1523/JNEUROSCI.0790-07.2007; Reichenbach WH, 2005, NEUROGLIA, P19; Robel S, 2011, NAT REV NEUROSCI, V12, P88, DOI 10.1038/nrn2978; Rodriguez A, 2006, ACTA NEUROPATHOL, V112, P573, DOI 10.1007/s00401-006-0117-1; Seifert G, 2009, J NEUROSCI, V29, P7474, DOI 10.1523/JNEUROSCI.3790-08.2009; Sik A, 2000, NEUROSCIENCE, V101, P51, DOI 10.1016/S0306-4522(00)00360-2; Sindelka R, 2006, DEV DYNAM, V235, P754, DOI 10.1002/dvdy.20665; Sofroniew MV, 2010, ACTA NEUROPATHOL, V119, P7, DOI 10.1007/s00401-009-0619-8; Stahlberg A, 2013, BRIEF FUNCT GENOMICS; Stahlberg A, 2013, METHODS, V59, P80, DOI 10.1016/j.ymeth.2012.09.007; Stahlberg A, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkq1182; Stahlberg A, 2010, METHODS, V50, P282, DOI 10.1016/j.ymeth.2010.01.002; STALLCUP WB, 1987, J NEUROSCI, V7, P2737; Stanimirovic DB, 1999, INT J DEV NEUROSCI, V17, P173, DOI 10.1016/S0736-5748(99)00028-3; Sun W, 2013, SCIENCE, V339, P197, DOI 10.1126/science.1226740; Trotter J, 2010, BRAIN RES REV, V63, P72, DOI 10.1016/j.brainresrev.2009.12.006; Ulas J, 2000, GLIA, V30, P352, DOI 10.1002/(SICI)1098-1136(200006)30:4<352::AID-GLIA40>3.0.CO;2-6; Wahl-Schott C, 2009, CELL MOL LIFE SCI, V66, P470, DOI 10.1007/s00018-008-8525-0; Walz W, 1998, NEUROSCI LETT, V257, P127, DOI 10.1016/S0304-3940(98)00813-1; Walz W, 2000, GLIA, V31, P95, DOI 10.1002/1098-1136(200008)31:2<95::AID-GLIA10>3.0.CO;2-6; Zamanian JL, 2012, J NEUROSCI, V32, P6391, DOI 10.1523/JNEUROSCI.6221-11.2012; Zelenina M, 2010, NEUROCHEM INT, V57, P468, DOI 10.1016/j.neuint.2010.03.022; Zhang Y, 2010, CURR OPIN NEUROBIOL, V20, P588, DOI 10.1016/j.conb.2010.06.005; Zhao JW, 2009, EUR J NEUROSCI, V29, P1853, DOI 10.1111/j.1460-9568.2009.06736.x; Zhou M, 2006, J NEUROPHYSIOL, V95, P134, DOI 10.1152/jn.00570.2005; Zhu XQ, 2012, DEVELOPMENT, V139, P2299, DOI 10.1242/dev.078873; Ziak D, 1998, PHYSIOL RES, V47, P365	87	84	85	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2013	8	8							e69734	10.1371/journal.pone.0069734	http://dx.doi.org/10.1371/journal.pone.0069734			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	218XC	23940528	Green Published, Green Submitted, gold			2022-12-25	WOS:000324465000022
J	Bajaj, M; Srayko, M				Bajaj, Megha; Srayko, Martin			Laulimalide Induces Dose-Dependent Modulation of Microtubule Behaviour in the C. elegans Embryo	PLOS ONE			English	Article							CAENORHABDITIS-ELEGANS; CELL-DEATH; DYNAMIC INSTABILITY; MITOTIC BLOCK; BINDING-SITE; TAXOID SITE; HELA-CELLS; PACLITAXEL; TUBULIN; AGENTS	Laulimalide is a microtubule-binding drug that was originally isolated from marine sponges. High concentrations of laulimalide stabilize microtubules and inhibit cell division similarly to paclitaxel; however, there are important differences with respect to the nature of the specific cellular defects between these two drugs and their binding sites on the microtubule. In this study, we used Caenorhabditis elegans embryos to investigate the acute effects of laulimalide on microtubules in vivo, with a direct comparison to paclitaxel. We observed surprising dose-dependent effects for laulimalide, whereby microtubules were stabilized at concentrations above 100 nM, but destabilized at concentrations between 50 and 100 nM. Despite this behaviour at low concentrations, laulimalide acted synergistically with paclitaxel to stabilize microtubules when both drugs were used at sub-effective concentrations, consistent with observations of synergistic interactions between these two drugs in other systems. Our results indicate that laulimalide induces a concentration-dependent, biphasic change in microtubule polymer dynamics in the C. elegans embryo.	[Bajaj, Megha; Srayko, Martin] Univ Alberta, Dept Biol Sci, Edmonton, AB, Canada	University of Alberta	Srayko, M (corresponding author), Univ Alberta, Dept Biol Sci, Edmonton, AB, Canada.	srayko@ualberta.ca	Srayko, Martin/A-3755-2014	Srayko, Martin/0000-0003-0196-0364	Canadian Institutes of Health Research; Alberta Heritage Foundation for Medical Research	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Alberta Heritage Foundation for Medical Research(Alberta Heritage Foundation for Medical ResearchGeneral Electric)	This work was supported by an operating grant from the Canadian Institutes of Health Research as well as scholar awards from Alberta Heritage Foundation for Medical Research and the Canadian Institutes of Health Research to MS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AAMODT EJ, 1986, J CELL BIOL, V103, P23, DOI 10.1083/jcb.103.1.23; Amos LA, 1999, CHEM BIOL, V6, pR65, DOI 10.1016/S1074-5521(99)89002-4; Bennett MJ, 2012, CELL CYCLE, V11, P3045, DOI 10.4161/cc.21411; Bennett MJ, 2010, CHEM BIOL, V17, P725, DOI 10.1016/j.chembiol.2010.05.019; Carvalho A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024656; CASSIMERIS L, 1988, J CELL BIOL, V107, P2223, DOI 10.1083/jcb.107.6.2223; Clark EA, 2006, MOL PHARMACEUT, V3, P457, DOI 10.1021/mp060016h; Desai A, 1997, ANNU REV CELL DEV BI, V13, P83, DOI 10.1146/annurev.cellbio.13.1.83; Dumontet C, 1999, J CLIN ONCOL, V17, P1061, DOI 10.1200/JCO.1999.17.3.1061; Dumontet C, 2010, NAT REV DRUG DISCOV, V9, P790, DOI 10.1038/nrd3253; Gapud EJ, 2004, MOL PHARMACOL, V66, P113, DOI 10.1124/mol.66.1.113; Gardner MK, 2013, CURR OPIN CELL BIOL, V25, P14, DOI 10.1016/j.ceb.2012.09.006; Hamel E, 2006, MOL PHARMACOL, V70, P1555, DOI 10.1124/mol.106.027847; Hannak E, 2002, J CELL BIOL, V157, P591, DOI 10.1083/jcb.200202047; Hannak E, 2001, J CELL BIOL, V155, P1109, DOI 10.1083/jcb.200108051; HYMAN AA, 1987, J CELL BIOL, V105, P2123, DOI 10.1083/jcb.105.5.2123; Jordan MA, 1996, CANCER RES, V56, P816; JORDAN MA, 1993, P NATL ACAD SCI USA, V90, P9552, DOI 10.1073/pnas.90.20.9552; Kaestner P, 2010, J CELL BIOCHEM, V111, P258, DOI 10.1002/jcb.22721; Kamath RS, 2003, NATURE, V421, P231, DOI 10.1038/nature01278; Meunier S, 2012, J CELL SCI, V125, P2805, DOI 10.1242/jcs.092429; MITCHISON T, 1984, NATURE, V312, P237, DOI 10.1038/312237a0; Mooberry SL, 1999, CANCER RES, V59, P653; Muller-Reichert T, 2010, CELL MOL LIFE SCI, V67, P2195, DOI 10.1007/s00018-010-0324-8; Nguyen TL, 2010, J CHEM INF MODEL, V50, P2019, DOI 10.1021/ci1002894; Nguyen-Ngoc T, 2007, NAT CELL BIOL, V9, P1294, DOI 10.1038/ncb1649; Nogales E, 1999, CELL, V96, P79, DOI 10.1016/S0092-8674(00)80961-7; NOGALES E, 1995, NATURE, V375, P424, DOI 10.1038/375424a0; Paoletti A, 1997, J CELL SCI, V110, P2403; Pryor DE, 2002, BIOCHEMISTRY-US, V41, P9109, DOI 10.1021/bi020211b; Srayko M, 2005, DEV CELL, V9, P223, DOI 10.1016/j.devcel.2005.07.003; Stanton RA, 2011, MED RES REV, V31, P443, DOI 10.1002/med.20242; Torres K, 1998, CANCER RES, V58, P3620; Yvon AMC, 1999, MOL BIOL CELL, V10, P947, DOI 10.1091/mbc.10.4.947	34	8	8	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 2	2013	8	8							e71889	10.1371/journal.pone.0071889	http://dx.doi.org/10.1371/journal.pone.0071889			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219XU	23936530	Green Published, gold, Green Submitted			2022-12-25	WOS:000324545800069
J	Giancaspero, TA; Busco, G; Panebianco, C; Carmone, C; Miccolis, A; Liuzzi, GM; Colella, M; Barile, M				Giancaspero, Teresa Anna; Busco, Giovanni; Panebianco, Concetta; Carmone, Claudia; Miccolis, Angelica; Liuzzi, Grazia Maria; Colella, Matilde; Barile, Maria			FAD Synthesis and Degradation in the Nucleus Create a Local Flavin Cofactor Pool	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Confocal Microscopy; FAD; FMN; Nucleus; Rat; Riboflavin; FAD Synthase; FAD Hydrolysis; NUDIX Hydrolase	SACCHAROMYCES-CEREVISIAE MITOCHONDRIA; ADENINE-DINUCLEOTIDE SYNTHESIS; RAT-LIVER MITOCHONDRIA; FUNCTIONAL-CHARACTERIZATION; RIBOFLAVIN TRANSPORTER; ESCHERICHIA-COLI; OVER-EXPRESSION; SYNTHETASE; IDENTIFICATION; PURIFICATION	FAD is a redox cofactor ensuring the activity of many flavoenzymes mainly located in mitochondria but also relevant for nuclear redox activities. The last enzyme in the metabolic pathway producing FAD is FAD synthase (EC 2.7.7.2), a protein known to be localized both in cytosol and in mitochondria. FAD degradation to riboflavin occurs via still poorly characterized enzymes, possibly belonging to the NUDIX hydrolase family. By confocal microscopy and immunoblotting experiments, we demonstrate here the existence of FAD synthase in the nucleus of different experimental rat models. HPLC experiments demonstrated that isolated rat liver nuclei contain approximate to 300 pmol of FADmg(-1) protein, which was mainly protein-bound FAD. A mean FAD synthesis rate of 18.1 pmolmin(-1)mg(-1) protein was estimated by both HPLC and continuous coupled enzymatic spectrophotometric assays. Rat liver nuclei were also shown to be endowed with a FAD pyrophosphatase that hydrolyzes FAD with an optimum at alkaline pH and is significantly inhibited by adenylate-containing nucleotides. The coordinate activity of these FAD forming and degrading enzymes provides a potential mechanism by which a dynamic pool of flavin cofactor is created in the nucleus. These data, which significantly add to the biochemical comprehension of flavin metabolism and its subcellular compartmentation, may also provide the basis for a more detailed comprehension of the role of flavin homeostasis in biologically and clinically relevant epigenetic events.	[Giancaspero, Teresa Anna; Barile, Maria] CNR, Ist Biomembrane & Bioenerget, I-70126 Bari, Italy; [Busco, Giovanni; Panebianco, Concetta; Carmone, Claudia; Miccolis, Angelica; Liuzzi, Grazia Maria; Colella, Matilde; Barile, Maria] Univ Bari Aldo Moro, Dipartimento Biosci Biotecnol & Biofarmaceut, I-70126 Bari, Italy	Consiglio Nazionale delle Ricerche (CNR); Istituto di Biomembrane e Bioenergetica (IBBE-CNR); Universita degli Studi di Bari Aldo Moro	Colella, M (corresponding author), Univ Bari Aldo Moro, Dipartimento Biosci Biotecnol & Biofarmaceut, Via Orabona 4, I-70126 Bari, Italy.	matilde.colella@uniba.it; maria.barile@uniba.it	Liuzzi, Grazia Maria/GVR-7164-2022; Busco, Giovanni/F-2711-2018; Panebianco, Concetta/K-6380-2016; Colella, Matilde/G-9246-2011; Barile, Maria/R-6171-2016	Busco, Giovanni/0000-0001-6859-9468; Panebianco, Concetta/0000-0003-2819-3505; Colella, Matilde/0000-0002-9584-7030; Latronico, Tiziana/0000-0001-6971-5416; Giancaspero, Teresa Anna/0000-0002-3293-7426; Liuzzi, Grazia Maria/0000-0001-5692-9335; Barile, Maria/0000-0001-5025-551X	PON-Ricerca e Competitivita [01_00937]; Fondazione Cassa di Risparmio di Puglia	PON-Ricerca e Competitivita(Ministry of Education, Universities and Research (MIUR)); Fondazione Cassa di Risparmio di Puglia	This work was supported by PON-Ricerca e Competitivita 2007-2013 Project 01_00937 Modelli sperimentali Biotecnologici integrati per lo Sviluppo e la selezione di molecole di interesse per la salute dell'uomo (to M. B.).; Supported by a post-doctoral fellowship from Fondazione Cassa di Risparmio di Puglia on the project "Caratterizzazione dei meccanismi biochimici implicati nell'induzione dell'ipertrofia cardiaca da parte dei recettori accoppiati a proteine G".	Abdelraheim SR, 2003, BIOCHEM J, V374, P329, DOI 10.1042/BJ20030441; Bafunno V, 2004, J BIOL CHEM, V279, P95, DOI 10.1074/jbc.M308230200; Barile M, 1997, EUR J BIOCHEM, V249, P777, DOI 10.1111/j.1432-1033.1997.00777.x; BARILE M, 1993, ARCH BIOCHEM BIOPHYS, V305, P442, DOI 10.1006/abbi.1993.1444; Barile M, 1996, BIOCHEM MOL BIOL INT, V38, P297; Barile M, 2000, EUR J BIOCHEM, V267, P4888, DOI 10.1046/j.1432-1327.2000.01552.x; Barile M, 2013, CURR PHARM DESIGN, V19, P2649, DOI 10.2174/1381612811319140014; Bergmeyer H.U., 1963, METHOD ENZYMAT AN, P736; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brizio C, 2000, EUR J BIOCHEM, V267, P4346, DOI 10.1046/j.1432-1327.2000.01464.x; Brizio C, 2008, INT J BIOL MACROMOL, V42, P455, DOI 10.1016/j.ijbiomac.2008.03.001; Brizio C, 2006, BIOCHEM BIOPH RES CO, V344, P1008, DOI 10.1016/j.bbrc.2006.04.003; Cardone A, 2012, BBA-BIOMEMBRANES, V1818, P2808, DOI 10.1016/j.bbamem.2012.06.011; Cardone RA, 2007, MOL BIOL CELL, V18, P1768, DOI 10.1091/mbc.E06-07-0617; CHAUVEAU J, 1957, B SOC CHIM BIOL, V39, P1521; Chiarugi A, 2012, NAT REV CANCER, V12, P741, DOI 10.1038/nrc3340; Colella M, 2008, ANN NY ACAD SCI, V1123, P64, DOI 10.1196/annals.1420.008; De Colibus L, 2006, CURR OPIN STRUC BIOL, V16, P722, DOI 10.1016/j.sbi.2006.10.003; DELUCA C, 1958, BIOCHIM BIOPHYS ACTA, V30, P6, DOI 10.1016/0006-3002(58)90233-6; DOSTAL DE, 1992, AM J PHYSIOL, V263, pC851, DOI 10.1152/ajpcell.1992.263.4.C851; GALLUCCIO M, 2013, FLAVINS FLAVOPROTEIN, P509; Galluccio M, 2007, PROTEIN EXPRES PURIF, V52, P175, DOI 10.1016/j.pep.2006.09.002; Gerbino A, 2012, CELL CALCIUM, V51, P393, DOI 10.1016/j.ceca.2012.01.002; Ghosal A, 2012, AM J PHYSIOL-GASTR L, V303, pG1052, DOI 10.1152/ajpgi.00314.2012; Giancaspero TA, 2010, EUR J CLIN INVEST, V40, P65; Giancaspero TA, 2009, FEBS J, V276, P219, DOI 10.1111/j.1742-4658.2008.06775.x; Heikal AA, 2010, BIOMARK MED, V4, P241, DOI 10.2217/BMM.10.1; Hino S, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1755; Joosten V, 2007, CURR OPIN CHEM BIOL, V11, P195, DOI 10.1016/j.cbpa.2007.01.010; Kasprzak KS, 2001, EXP TOXICOL PATHOL, V53, P325, DOI 10.1078/0940-2993-00201; KING TE, 1962, J BIOL CHEM, V237, P2941; Koch-Nolte F, 2011, FEBS LETT, V585, P1651, DOI 10.1016/j.febslet.2011.03.045; KUNZ WS, 1988, BIOCHIM BIOPHYS ACTA, V932, P8, DOI 10.1016/0005-2728(88)90134-X; Latronico T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0049656; Lau BW, 2005, GASTROENTEROLOGY, V128, P695, DOI 10.1053/j.gastro.2004.12.046; Lin J, 2009, J NEUROL, V256, P774, DOI 10.1007/s00415-009-5015-8; Macheroux P, 2011, FEBS J, V278, P2625, DOI 10.1111/j.1742-4658.2011.08202.x; Mansoorabadi SO, 2007, J ORG CHEM, V72, P6329, DOI 10.1021/jo0703092; MASSEY V, 1995, FASEB J, V9, P473, DOI 10.1096/fasebj.9.7.7737454; Massey V, 2000, BIOCHEM SOC T, V28, P283, DOI 10.1042/0300-5127:0280283; MCCORMICK DB, 1989, PHYSIOL REV, V69, P1170, DOI 10.1152/physrev.1989.69.4.1170; McCormick DB, 1997, METHOD ENZYMOL, V280, P407; McLennan AG, 2006, CELL MOL LIFE SCI, V63, P123, DOI 10.1007/s00018-005-5386-7; Merglen A, 2004, ENDOCRINOLOGY, V145, P667, DOI 10.1210/en.2003-1099; OKA M, 1987, J BIOL CHEM, V262, P7418; Oka S, 2012, CIRC RES, V111, P611, DOI 10.1161/CIRCRESAHA.111.247932; Pallotta ML, 1998, FEBS LETT, V428, P245, DOI 10.1016/S0014-5793(98)00544-4; Ren J, 2008, PROTEIN ENG DES SEL, V21, P639, DOI 10.1093/protein/gzn039; Ren J, 2009, PROTEOMICS, V9, P3409, DOI 10.1002/pmic.200800646; Safrany ST, 1998, EMBO J, V17, P6599, DOI 10.1093/emboj/17.22.6599; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; SHIBKO S, 1963, BIOCHIM BIOPHYS ACTA, V73, P76; Sun L, 2012, MOL BIOL REP, V39, P4119, DOI 10.1007/s11033-011-1194-3; Torchetti EM, 2011, FEBS J, V278, P4435, DOI 10.1111/j.1742-4658.2011.08368.x; Torchetti EM, 2010, MITOCHONDRION, V10, P263, DOI 10.1016/j.mito.2009.12.149; WU M, 1995, MOL CELL BIOL, V15, P264, DOI 10.1128/MCB.15.1.264; YAMADA Y, 1990, ARCH BIOCHEM BIOPHYS, V278, P125, DOI 10.1016/0003-9861(90)90240-Y; Yamamoto S, 2009, J BIOCHEM, V145, P437, DOI 10.1093/jb/mvn181; Yang HY, 2007, CELL, V130, P1095, DOI 10.1016/j.cell.2007.07.035; Yao Y, 2010, J NUTR, V140, P1220, DOI 10.3945/jn.110.122911; Yonezawa A, 2008, AM J PHYSIOL-CELL PH, V295, pC632, DOI 10.1152/ajpcell.00019.2008; Yonezawa A, 2013, MOL ASPECTS MED, V34, P693, DOI 10.1016/j.mam.2012.07.014	62	51	54	1	25	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 4	2013	288	40					29069	29080		10.1074/jbc.M113.500066	http://dx.doi.org/10.1074/jbc.M113.500066			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	298BL	23946482	hybrid, Green Published			2022-12-25	WOS:000330298800060
J	Takahashi, M; Dillon, TJ; Liu, C; Kariya, Y; Wang, ZP; Stork, PJS				Takahashi, Maho; Dillon, Tara J.; Liu, Chang; Kariya, Yumi; Wang, Zhiping; Stork, Philip J. S.			Protein Kinase A-dependent Phosphorylation of Rap1 Regulates Its Membrane Localization and Cell Migration	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYCLIC-AMP; PLASMA-MEMBRANE; CARCINOMA-CELLS; ELECTROSTATIC SWITCH; EPAC PROTEINS; LEADING-EDGE; SMALL GTPASE; ADHESION; ACTIVATION; INTEGRIN	The small G protein Rap1 can mediate "inside-out signaling" by recruiting effectors to the plasma membrane that signal to pathways involved in cell adhesion and cell migration. This action relies on the membrane association of Rap1, which is dictated by post-translational prenylation as well as by a stretch of basic residues within its carboxyl terminus. One feature of this stretch of acidic residues is that it lies adjacent to a functional phosphorylation site for the cAMP-dependent protein kinase PKA. This phosphorylation has two effects on Rap1 action. One, it decreases the level of Rap1 activity as measured by GTP loading and the coupling of Rap1 to RapL, a Rap1 effector that couples Rap1 GTP loading to integrin activation. Two, it destabilizes the membrane localization of Rap1, promoting its translocation into the cytoplasm. These two actions, decreased GTP loading and decreased membrane localization, are related, as the translocation of Rap1-GTP into the cytoplasm is associated with its increased GTP hydrolysis and inactivation. The consequences of this phosphorylation in Rap1-dependent cell adhesion and cell migration were also examined. Active Rap1 mutants that lack this phosphorylation site had a minimal effect on cell adhesion but strongly reduced cell migration, when compared with an active Rap1 mutant that retained the phosphorylation site. This suggests that optimal cell migration is associated with cycles of Rap1 activation, membrane egress, and inactivation, and requires the regulated phosphorylation of Rap1 by PKA.	[Takahashi, Maho; Dillon, Tara J.; Liu, Chang; Kariya, Yumi; Wang, Zhiping; Stork, Philip J. S.] Oregon Hlth & Sci Univ, Vollum Inst, Portland, OR 97239 USA; [Wang, Zhiping] Oregon Hlth & Sci Univ, Dept Surg, Portland, OR 97239 USA; [Kariya, Yumi] Univ Tokyo, Grad Sch Med, Bunkyo Ku, Tokyo 1130033, Japan	Oregon Health & Science University; Oregon Health & Science University; University of Tokyo	Stork, PJS (corresponding author), L474,3181 SW Sam Jackson Pk Rd, Portland, OR 97239 USA.	stork@ohsu.edu			National Institutes of Health [DK090309]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK090309] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant DK090309.	Almahariq M, 2013, MOL PHARMACOL, V83, P122, DOI 10.1124/mol.112.080689; ALTSCHULER D, 1993, J BIOL CHEM, V268, P7527; Baillie GS, 2005, FEBS LETT, V579, P3264, DOI 10.1016/j.febslet.2005.03.089; Bivona TG, 2006, MOL CELL, V21, P481, DOI 10.1016/j.molcel.2006.01.012; Boettner B, 2009, CURR OPIN CELL BIOL, V21, P684, DOI 10.1016/j.ceb.2009.06.004; Bos JL, 2003, BIOCHEM SOC T, V31, P83, DOI 10.1042/bst0310083; Bos JL, 2001, NAT REV MOL CELL BIO, V2, P369, DOI 10.1038/35073073; Bos JL, 2005, CURR OPIN CELL BIOL, V17, P123, DOI 10.1016/j.ceb.2005.02.009; Bos JL, 2006, TRENDS BIOCHEM SCI, V31, P680, DOI 10.1016/j.tibs.2006.10.002; Breckler M, 2011, CELL SIGNAL, V23, P1257, DOI 10.1016/j.cellsig.2011.03.007; Broussard JA, 2008, CURR OPIN CELL BIOL, V20, P85, DOI 10.1016/j.ceb.2007.10.009; Carey KD, 2000, MOL CELL BIOL, V20, P8409, DOI 10.1128/MCB.20.22.8409-8419.2000; Dustin ML, 2004, NAT IMMUNOL, V5, P363, DOI 10.1038/ni1057; Edreira MM, 2009, J BIOL CHEM, V284, P27480, DOI 10.1074/jbc.M109.011312; Emery AC, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2003993; Enserink JM, 2004, J BIOL CHEM, V279, P44889, DOI 10.1074/jbc.M404599200; FISCHER TH, 1991, FEBS LETT, V283, P173, DOI 10.1016/0014-5793(91)80581-M; Forget MA, 2002, BIOCHEM J, V361, P243, DOI 10.1042/0264-6021:3610243; Franke B, 1997, EMBO J, V16, P252, DOI 10.1093/emboj/16.2.252; Freeman SA, 2010, CANCER RES, V70, P4590, DOI 10.1158/0008-5472.CAN-09-3414; Fujita H, 2005, J BIOL CHEM, V280, P5022, DOI 10.1074/jbc.M409701200; GHOMASHCHI F, 1995, BIOCHEMISTRY-US, V34, P11910, DOI 10.1021/bi00037a032; Grandoch M, 2009, BRIT J CANCER, V101, P2038, DOI 10.1038/sj.bjc.6605439; He Y, 2011, J CELL SCI, V124, P2153, DOI 10.1242/jcs.078535; Heo WD, 2006, SCIENCE, V314, P1458, DOI 10.1126/science.1134389; Hernandez-Varas P, 2011, J BIOL CHEM, V286, P18492, DOI 10.1074/jbc.M110.189811; Holz GG, 2008, CELL SIGNAL, V20, P10, DOI 10.1016/j.cellsig.2007.07.009; Houslay MD, 2010, TRENDS BIOCHEM SCI, V35, P91, DOI 10.1016/j.tibs.2009.09.007; Hu CD, 1999, J BIOL CHEM, V274, P48, DOI 10.1074/jbc.274.1.48; Kinashi T, 2004, IMMUNOL LETT, V93, P1, DOI 10.1016/j.imlet.2004.02.008; Lafuente EM, 2004, DEV CELL, V7, P585, DOI 10.1016/j.devcel.2004.07.021; Lim CJ, 2008, MOL BIOL CELL, V19, P4930, DOI 10.1091/mbc.E08-06-0564; Liu C, 2008, MOL CELL BIOL, V28, P7109, DOI 10.1128/MCB.01060-08; Liu C, 2010, MOL CELL BIOL, V30, P3956, DOI 10.1128/MCB.00242-10; McKenzie AJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026552; MCLAUGHLIN S, 1995, TRENDS BIOCHEM SCI, V20, P272, DOI 10.1016/S0968-0004(00)89042-8; Menon J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049893; Meyer CJ, 2000, NAT CELL BIOL, V2, P666, DOI 10.1038/35023621; Mochizuki N, 1999, NATURE, V400, P891, DOI 10.1038/23738; Mor A, 2007, IMMUNOL REV, V218, P114, DOI 10.1111/j.1600-065X.2007.00538.x; Murray D, 1997, STRUCTURE, V5, P985, DOI 10.1016/S0969-2126(97)00251-7; O'Connor KL, 2001, J BIOL CHEM, V276, P47895, DOI 10.1074/jbc.M107235200; O'Connor KL, 1998, J CELL BIOL, V143, P1749, DOI 10.1083/jcb.143.6.1749; Paulucci-Holthauzen AA, 2009, J BIOL CHEM, V284, P5956, DOI 10.1074/jbc.M805606200; POLAKIS PG, 1991, P NATL ACAD SCI USA, V88, P239, DOI 10.1073/pnas.88.1.239; Price LS, 2004, NAT IMMUNOL, V5, P1007, DOI 10.1038/ni1004-1007; Raab M, 2011, J BIOL CHEM, V286, P29663, DOI 10.1074/jbc.M111.222661; Raab M, 2010, IMMUNITY, V32, P541, DOI 10.1016/j.immuni.2010.03.007; Rangarajan S, 2003, J CELL BIOL, V160, P487, DOI 10.1083/jcb.200209105; Raymond DR, 2007, CELL SIGNAL, V19, P2507, DOI 10.1016/j.cellsig.2007.08.005; Reedquist KA, 2000, J CELL BIOL, V148, P1151, DOI 10.1083/jcb.148.6.1151; Ross SH, 2011, J CELL SCI, V124, P1808, DOI 10.1242/jcs.079830; Roy MO, 2000, BIOCHEMISTRY-US, V39, P8298, DOI 10.1021/bi000512q; Rundell CJ, 2004, BIOCHEM BIOPH RES CO, V315, P1077, DOI 10.1016/j.bbrc.2004.01.161; Schmitt JM, 2002, MOL CELL, V9, P85, DOI 10.1016/S1097-2765(01)00432-4; Serrels Bryan, 2011, Small GTPases, V2, P54; Silvius JR, 2006, MOL BIOL CELL, V17, P192, DOI 10.1091/mbc.e05-05-0408; Smolen GA, 2007, GENE DEV, V21, P2131, DOI 10.1101/gad.1561507; Tkachenko E, 2011, NAT CELL BIOL, V13, P660, DOI 10.1038/ncb2231; Vossler MR, 1997, CELL, V89, P73, DOI 10.1016/S0092-8674(00)80184-1; Wang ZP, 2006, MOL CELL BIOL, V26, P2130, DOI 10.1128/MCB.26.6.2130-2145.2006; Whittard JD, 2001, J CELL SCI, V114, P3265; Zhang ZC, 2005, J BIOL CHEM, V280, P33200, DOI 10.1074/jbc.M505057200	63	40	40	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 27	2013	288	39					27712	27723		10.1074/jbc.M113.466904	http://dx.doi.org/10.1074/jbc.M113.466904			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302OB	23946483	Green Published, hybrid			2022-12-25	WOS:000330612800002
J	Asami, K; Inagaki, A; Imura, T; Sekiguchi, S; Fujimori, K; Masutani, H; Yodoi, J; Satomi, S; Ohuchi, N; Goto, M				Asami, Kengo; Inagaki, Akiko; Imura, Takehiro; Sekiguchi, Satoshi; Fujimori, Keisei; Masutani, Hiroshi; Yodoi, Junji; Satomi, Susumu; Ohuchi, Noriaki; Goto, Masafumi			Thioredoxin-1 Attenuates Early Graft Loss after Intraportal Islet Transplantation in Mice	PLOS ONE			English	Article							NF-KAPPA-B; TISSUE FACTOR; ENDOTHELIAL-CELLS; PANCREATIC-ISLETS; NITRIC-OXIDE; PROTECTS ISLETS; EXPRESSION; OVEREXPRESSION; DYSFUNCTION; LANGERHANS	Aims: Recent studies suggest that decreasing oxidative stress is crucial to achieve successful islet transplantation. Thioredoxin-1 (TRX), which is a multifunctional redox-active protein, has been reported to suppress oxidative stress. Furthermore, it also has anti-inflammatory and anti-apoptotic effects. In this study, we investigated the effects of TRX on early graft loss after islet transplantation. Methods: Intraportal islet transplantation was performed for two groups of streptozotocin-induced diabetic mice: a control and a TRX group. In addition, TRX-transgenic (Tg) mice were alternately used as islet donors or recipients. Results: The changes in blood glucose levels were significantly lower in the TRX group compared with the TRX-Tg donor and control groups (p<0.01). Glucose tolerance and the residual graft mass were considerably better in the TRX group. TRX significantly suppressed the serum levels of interleukin-1 beta (p<0.05), although neither anti-apoptotic nor anti-chemotactic effects were observed. Notably, no increase in the 8-hydroxy-29-deoxyguanosine level was observed after islet infusion, irrespective of TRX administration. Conclusions: The present study demonstrates that overexpression of TRX on the islet grafts is not sufficient to improve engraftment. In contrast, TRX administration to the recipients exerts protective effects on transplanted islet grafts by suppressing the serum levels of interleukin-1b. However, TRX alone appears to be insufficient to completely prevent early graft loss after islet transplantation. We therefore propose that a combination of TRX and other anti-inflammatory treatments represents a promising regimen for improving the efficacy of islet transplantation.	[Asami, Kengo; Sekiguchi, Satoshi; Fujimori, Keisei; Satomi, Susumu; Goto, Masafumi] Tohoku Univ, Div Adv Surg Sci & Technol, Sendai, Miyagi 980, Japan; [Inagaki, Akiko; Imura, Takehiro; Goto, Masafumi] Tohoku Univ, New Ind Creat Hatchery Ctr, Sendai, Miyagi 980, Japan; [Masutani, Hiroshi; Yodoi, Junji] Kyoto Univ, Inst Virus Res, Biostress Lab, Kyoto 606, Japan; [Yodoi, Junji] Ewha Womans Univ, CCSR, Seoul, South Korea; [Yodoi, Junji] Ewha Womans Univ, Dept Bioinspired Sci, Seoul, South Korea; [Ohuchi, Noriaki] Tohoku Univ, Div Surg Oncol, Sendai, Miyagi 980, Japan	Tohoku University; Tohoku University; Kyoto University; Ewha Womans University; Ewha Womans University; Tohoku University	Goto, M (corresponding author), Tohoku Univ, Div Adv Surg Sci & Technol, Sendai, Miyagi 980, Japan.	gotokichi@aol.com	Masutani, Hiroshi/B-5114-2014; Goto, Masafumi/GPF-7677-2022	Masutani, Hiroshi/0000-0001-7633-2827	Innovation Plaza Miyagi of JST (Japan Science and Technology Agency); Mochida Memorial Foundation for Medical and Pharmaceutical Research; World Class University [R31-10010]; Takeda Science Foundation	Innovation Plaza Miyagi of JST (Japan Science and Technology Agency)(Japan Science & Technology Agency (JST)); Mochida Memorial Foundation for Medical and Pharmaceutical Research; World Class University; Takeda Science Foundation(Takeda Science Foundation (TSF))	This study has been supported by grants from Innovation Plaza Miyagi of JST (Japan Science and Technology Agency), the Japanese Grant-in-Aid for Scientific Research (B), the Mochida Memorial Foundation for Medical and Pharmaceutical Research, the World Class University Grant R31-10010, and the Takeda Science Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1996, PHYSIOLOGIST; Barshes NR, 2005, J LEUKOCYTE BIOL, V77, P587, DOI 10.1189/jlb.1104649; Bennet W, 1999, DIABETES, V48, P1907, DOI 10.2337/diabetes.48.10.1907; Berman DM, 2007, TRANSPLANTATION, V84, P308, DOI 10.1097/01.tp.0000275401.80187.1e; Bertini R, 1999, J EXP MED, V189, P1783, DOI 10.1084/jem.189.11.1783; Billiet L, 2005, J BIOL CHEM, V280, P40310, DOI 10.1074/jbc.M503644200; Bottino R, 2004, DIABETES, V53, P2559, DOI 10.2337/diabetes.53.10.2559; Chen BD, 2010, AM J PHYSIOL-CELL PH, V298, pC1170, DOI 10.1152/ajpcell.00223.2009; Chou FC, 2009, J BIOMED SCI, V16, DOI 10.1186/1423-0127-16-71; CORBETT JA, 1993, AUTOIMMUNITY, V15, P145, DOI 10.3109/08916939309043889; Dechend R, 1999, CIRCULATION, V100, P1369, DOI 10.1161/01.CIR.100.13.1369; Goto M, 2006, AM J TRANSPLANT, V6, P2483, DOI 10.1111/j.1600-6143.2006.01474.x; Goto M, 2005, TRANSPLANT P, V37, P1315, DOI 10.1016/j.transproceed.2004.11.042; Goto M, 2004, XENOTRANSPLANTATION, V11, P195, DOI 10.1046/j.1399-3089.2003.00107.x; Hamada Y, 2007, NEPHROL DIAL TRANSPL, V22, P1547, DOI 10.1093/ndt/gfm099; HOLMGREN A, 1985, ANNU REV BIOCHEM, V54, P237, DOI 10.1146/annurev.bi.54.070185.001321; Hoshino T, 2003, AM J RESP CRIT CARE, V168, P1075, DOI 10.1164/rccm.200209-982OC; Johansson H, 2005, DIABETES, V54, P1755, DOI 10.2337/diabetes.54.6.1755; KASAI H, 1986, CARCINOGENESIS, V7, P1849, DOI 10.1093/carcin/7.11.1849; Lenzen S, 1996, FREE RADICAL BIO MED, V20, P463, DOI 10.1016/0891-5849(96)02051-5; Matsuoka N, 2010, J CLIN INVEST, V120, P735, DOI 10.1172/JCI41360; Moberg L, 2002, LANCET, V360, P2039, DOI 10.1016/S0140-6736(02)12020-4; MOLL T, 1995, J BIOL CHEM, V270, P3849, DOI 10.1074/jbc.270.8.3849; Montolio M, 2007, J ENDOCRINOL, V192, P169, DOI 10.1677/joe.1.06968; Nakamura H, 2001, P NATL ACAD SCI USA, V98, P15143, DOI 10.1073/pnas.191498798; Nakamura H, 1997, ANNU REV IMMUNOL, V15, P351, DOI 10.1146/annurev.immunol.15.1.351; Ohashi S, 2006, ANTIOXID REDOX SIGN, V8, P1835, DOI 10.1089/ars.2006.8.1835; Piemonti L, 2002, DIABETES, V51, P55, DOI 10.2337/diabetes.51.1.55; Saito Y, 2010, CELL TRANSPLANT, V19, P775, DOI 10.3727/096368910X508889; Schmidt P, 2004, XENOTRANSPLANTATION, V11, P347, DOI 10.1111/j.1399-3089.2004.00145.x; Schwarznau A, 2009, J CELL PHYSIOL, V220, P341, DOI 10.1002/jcp.21770; Shapiro AMJ, 2000, NEW ENGL J MED, V343, P230, DOI 10.1056/NEJM200007273430401; Sklavos MM, 2010, DIABETES, V59, P1731, DOI 10.2337/db09-0588; Son A, 2009, ANTIOXID REDOX SIGN, V11, P2595, DOI [10.1089/ars.2009.2522, 10.1089/ARS.2009.2522]; TAGAYA Y, 1994, EMBO J, V13, P2244, DOI 10.1002/j.1460-2075.1994.tb06502.x; Takagi Y, 1999, P NATL ACAD SCI USA, V96, P4131, DOI 10.1073/pnas.96.7.4131; Tokodai K, 2010, TRANSPLANTATION, V90, P1358, DOI 10.1097/TP.0b013e3181ffb9f5; Ueda S, 2006, LIFE SCI, V79, P1170, DOI 10.1016/j.lfs.2006.03.026; XENOS ES, 1994, TRANSPLANTATION, V57, P1208, DOI 10.1097/00007890-199404270-00012; Yasunami Y, 2005, J EXP MED, V202, P913, DOI 10.1084/jem.20050448; Yoshioka J, 2006, ANTIOXID REDOX SIGN, V8, P2143, DOI 10.1089/ars.2006.8.2143	41	8	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 9	2013	8	8							e70259	10.1371/journal.pone.0070259	http://dx.doi.org/10.1371/journal.pone.0070259			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	245OM	23950917	gold, Green Published, Green Submitted			2022-12-25	WOS:000326473200011
J	Wang, D; Zhang, T; Wu, J; Jiang, YW; Ding, YF; Hua, J; Li, Y; Zhang, J; Chen, LL; Feng, ZJ; Iuliano, D; McFarland, J; Zhao, GM				Wang, Dan; Zhang, Tao; Wu, Jing; Jiang, Yanwei; Ding, Yunfang; Hua, Jun; Li, Ying; Zhang, Jun; Chen, Liling; Feng, Zijian; Iuliano, Danielle; McFarland, Jeffrey; Zhao, Genming			Socio-Economic Burden of Influenza among Children Younger than 5 Years in the Outpatient Setting in Suzhou, China	PLOS ONE			English	Article							HEALTHY-CHILDREN; PEDIATRIC INFLUENZA; CHILDHOOD INFLUENZA; SEASONAL INFLUENZA; COST-EFFECTIVENESS; MEDICAL COSTS; ILLNESS; IMPACT; INFECTION; FAMILIES	Background: The disease burden of children with laboratory-confirmed influenza in China has not been well described. The aim of this study was to understand the epidemiology and socio-economic burden of influenza in children younger than 5 years in outpatient and emergency department settings. Methods: A prospective study of laboratory-confirmed influenza among children presenting to the outpatient settings in Soochow University Affiliated Children's Hospital with symptoms of influenza-like illness (ILI) was performed from March 2011 to February 2012. Throat swabs were collected for detection of influenza virus by reverse transcription polymerase chain reaction assay. Data were collected using a researcher administered questionnaire, concerning demographics, clinical characteristics, direct and indirect costs, day care absence, parental work loss and similar respiratory illness development in the family. Results: Among a total of 6,901 children who sought care at internal outpatient settings, 1,726 (25%) fulfilled the criteria of ILI and 1,537 were enrolled. Influenza was documented in 365 (24%) of enrolled 1,537 ILI cases. Among positive patients, 52 (14%) were type A and 313 (86%) were type B. About 52% of influenza outpatients had over-the-counter medications before physician visit and 41% visited hospitals two or more times. Children who attended daycare missed an average of 1.9 days. For each child with influenza-confirmed disease, the parents missed a mean of 1.8 work days. Similar respiratory symptoms were reported in 43% of family contacts of influenza positive children after onset of the child's illness. The mean direct and indirect costs per episode of influenza were $123.4 for outpatient clinics and $134.6 for emergency departments, and $125.9 for influenza A and $127.5 for influenza B. Conclusions: Influenza is a common cause of influenza-like illness among children and has substantial socio-economic impact on children and their families regarding healthcare seeking and day care/work absence. The direct and indirect costs of childhood influenza impose a heavy financial burden on families. Prevention measures such as influenza vaccine could reduce the occurrence of influenza in children and the economic burden on families.	[Wang, Dan; Zhang, Tao; Wu, Jing; Jiang, Yanwei; Zhao, Genming] Fudan Univ, Sch Publ Hlth, Dept Epidemiol, Key Lab Publ Hlth Safety,Minist Educ, Shanghai 200433, Peoples R China; [Ding, Yunfang; Hua, Jun; Li, Ying] Soochow Univ, Affiliated Childrens Hosp, Suzhou, Peoples R China; [Zhang, Jun; Chen, Liling] Suzhou Ctr Dis Prevent & Control, Suzhou, Peoples R China; [Feng, Zijian] Chinese Ctr Dis Control & Prevent, Beijing, Peoples R China; [Iuliano, Danielle; McFarland, Jeffrey] Centers Dis Control & Prevent, Atlanta, GA USA	Fudan University; Soochow University - China; Chinese Center for Disease Control & Prevention; Centers for Disease Control & Prevention - USA	Zhao, GM (corresponding author), Fudan Univ, Sch Publ Hlth, Dept Epidemiol, Key Lab Publ Hlth Safety,Minist Educ, Shanghai 200433, Peoples R China.	gmzhao@shmu.edu.cn			SINO-US collaborative program on Emerging and Re-emerging Infectious Diseases [1.18]; Shanghai Leading Academic Discipline Project of Public Health [12GWZX1010]; National Natural Science Fund [81102166]	SINO-US collaborative program on Emerging and Re-emerging Infectious Diseases; Shanghai Leading Academic Discipline Project of Public Health(Shanghai Leading Academic Discipline Project); National Natural Science Fund(National Natural Science Foundation of China (NSFC))	This research was funded by SINO-US collaborative program on Emerging and Re-emerging Infectious Diseases (1.18), Shanghai Leading Academic Discipline Project of Public Health (12GWZX1010), and National Natural Science Fund (81102166). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Academy of Pediatrics Committee on Infectious Diseases, 2008, Pediatrics, V122, P1135, DOI 10.1542/peds.2008-2449; Chinese National Influenza Center, 2011, NAT INFL WEEKL REP; Chiu SS, 2012, VACCINE, V30, P1895, DOI 10.1016/j.vaccine.2011.12.027; Dawood FS, 2010, J PEDIATR-US, V157, P808, DOI 10.1016/j.jpeds.2010.05.012; Esposito S, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-271; Esposito S, 2011, J INFECTION, V62, P379, DOI 10.1016/j.jinf.2011.02.015; Fairbrother G, 2010, VACCINE, V28, P4913, DOI 10.1016/j.vaccine.2010.05.036; FOX JP, 1982, AM J EPIDEMIOL, V116, P228, DOI 10.1093/oxfordjournals.aje.a113408; Ge YL, 2012, PEDIATR INFECT DIS J, V31, pE111, DOI 10.1097/INF.0b013e318257172d; Guo RN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041403; Gutierrez-Pizarraya A, 2012, J INFECTION, V65, P423, DOI 10.1016/j.jinf.2012.07.004; Heikkinen T, 2004, J INFECT DIS, V190, P1369, DOI 10.1086/424527; Hibbert CL, 2007, VACCINE, V25, P8010, DOI 10.1016/j.vaccine.2007.09.018; HURWITZ ES, 1991, PEDIATRICS, V87, P62; Ji W, 2010, BMC HEALTH SERV RES, V10, DOI 10.1186/1472-6963-10-82; Jordan R, 2006, VACCINE, V24, P1047, DOI 10.1016/j.vaccine.2005.09.017; Li S, 2007, RESP MED, V101, P1244, DOI 10.1016/j.rmed.2006.10.022; Loeb M, 2010, JAMA-J AM MED ASSOC, V303, P943, DOI 10.1001/jama.2010.250; Molinari NAM, 2007, VACCINE, V25, P5086, DOI 10.1016/j.vaccine.2007.03.046; Neuzil KM, 2000, NEW ENGL J MED, V342, P225, DOI 10.1056/NEJM200001273420401; Neuzil KM, 2002, ARCH PEDIAT ADOL MED, V156, P986, DOI 10.1001/archpedi.156.10.986; Nichol KL, 2011, VACCINE, V29, P7554, DOI 10.1016/j.vaccine.2011.08.015; Ortega-Sanchez IR, 2012, VACCINE, V30, P4175, DOI 10.1016/j.vaccine.2012.04.057; Paget WJ, 2010, EUR J PEDIATR, V169, P997, DOI 10.1007/s00431-010-1164-0; Poehling KA, 2006, NEW ENGL J MED, V355, P31, DOI 10.1056/NEJMoa054869; Principi N, 2003, PEDIATR INFECT DIS J, V22, pS207, DOI 10.1097/01.inf.0000092188.48726.e4; Principi N, 2004, ARCH DIS CHILD, V89, P1002, DOI 10.1136/adc.2003.045401; Rennels MB, 2002, PEDIATRICS, V110, DOI 10.1542/peds.110.6.e80; Simmerman JM, 2006, VACCINE, V24, P4417, DOI 10.1016/j.vaccine.2005.12.060; Suzhou statistics bureau, 2011, SUZH STAT YB 2011; Szucs T, 1999, J ANTIMICROB CHEMOTH, V44, P11, DOI 10.1093/jac/44.suppl_2.11; Teo SSS, 2005, ARCH DIS CHILD, V90, P532, DOI 10.1136/adc.2004.051896; Thompson WW, 2004, JAMA-J AM MED ASSOC, V292, P1333, DOI 10.1001/jama.292.11.1333; Tsolia MN, 2006, VACCINE, V24, P5970, DOI 10.1016/j.vaccine.2006.05.006; Wu J, 2013, CHINESE PRIMARY HLTH, V27, P41	36	11	28	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2013	8	8							e69035	10.1371/journal.pone.0069035	http://dx.doi.org/10.1371/journal.pone.0069035			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	201ER	23950882	Green Published, gold, Green Submitted			2022-12-25	WOS:000323124000005
J	Li, J; Chen, Q; Zhang, S; Huang, H; Yang, J; Tian, XP; Long, LJ				Li, Jie; Chen, Qi; Zhang, Si; Huang, Hui; Yang, Jian; Tian, Xin-Peng; Long, Li-Juan			Highly Heterogeneous Bacterial Communities Associated with the South China Sea Reef Corals Porites lutea, Galaxea fascicularis and Acropora millepora	PLOS ONE			English	Article							GREAT-BARRIER-REEF; PHYLOGENETIC CHARACTERIZATION; MICROBIAL ASSOCIATIONS; METAGENOMIC ANALYSIS; DIVERSITY; MUCUS; DIGITIFERA; MANNAR; CORE; GULF	Coral harbor diverse and specific bacteria play significant roles in coral holobiont function. Bacteria associated with three of the common and phylogenetically divergent reef-building corals in the South China Sea, Porites lutea, Galaxea fascicularis and Acropora millepora, were investigated using 454 barcoded-pyrosequencing. Three colonies of each species were sampled, and 16S rRNA gene libraries were constructed individually. Analysis of pyrosequencing libraries showed that bacterial communities associated with the three coral species were more diverse than previous estimates based on corals from the Caribbean Sea, Indo-Pacific reefs and the Red Sea. Three candidate phyla, including BRC1, OD1 and SR1, were found for the first time in corals. Bacterial communities were separated into three groups: P. lutea and G. fascicular, A. millepora and seawater. P. lutea and G. fascicular displayed more similar bacterial communities, and bacterial communities associated with A. millepora differed from the other two coral species. The three coral species shared only 22 OTUs, which were distributed in Alphaproteobacteria, Deltaproteobacteria, Gammaproteobacteria, Chloroflexi, Actinobacteria, Acidobacteria and an unclassified bacterial group. The composition of bacterial communities within each colony of each coral species also showed variation. The relatively small common and large specific bacterial communities in these corals implies that bacterial associations may be structured by multiple factors at different scales and that corals may associate with microbes in terms of similar function, rather than identical species.	[Li, Jie; Chen, Qi; Zhang, Si; Huang, Hui; Yang, Jian; Tian, Xin-Peng; Long, Li-Juan] Chinese Acad Sci, South China Sea Inst Oceanol, RNAM Ctr Marine Microbiol, CAS Key Lab Trop Marine Bioresources & Ecol, Guangzhou, Guangdong, Peoples R China; [Chen, Qi] Chinese Acad Sci, Grad Univ, Beijing, Peoples R China	Chinese Academy of Sciences; South China Sea Institute of Oceanology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Long, LJ (corresponding author), Chinese Acad Sci, South China Sea Inst Oceanol, RNAM Ctr Marine Microbiol, CAS Key Lab Trop Marine Bioresources & Ecol, Guangzhou, Guangdong, Peoples R China.	longlj@scsio.ac.cn	Tian, Xin peng/W-1599-2019		National Basic Research Program of China [CB833801]; National Natural Science Foundation of China [41106139, 41230962]; Knowledge Innovation Program of the Chinese Academy of Sciences [KSCX2-EW-G-12]; Academic Frontier Project for young researchers [SQ201013]	National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Knowledge Innovation Program of the Chinese Academy of Sciences(Chinese Academy of SciencesKnowledge Innovation Program of the Chinese Academy of Sciences); Academic Frontier Project for young researchers	This research was supported by the National Basic Research Program of China (No. CB833801), the National Natural Science Foundation of China (No. 41106139, 41230962), the Knowledge Innovation Program of the Chinese Academy of Sciences (No. KSCX2-EW-G-12) and the Academic Frontier Project for young researchers (No. SQ201013). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apprill A, 2009, ISME J, V3, P685, DOI 10.1038/ismej.2009.3; Barott KL, 2011, ENVIRON MICROBIOL, V13, P1192, DOI 10.1111/j.1462-2920.2010.02419.x; Bourne D, 2008, ISME J, V2, P350, DOI 10.1038/ismej.2007.112; Bourne DG, 2005, ENVIRON MICROBIOL, V7, P1162, DOI 10.1111/j.1462-2920.2005.00793.x; Ceh J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036920; Chen CP, 2011, ISME J, V5, P728, DOI 10.1038/ismej.2010.151; CLARKE KR, 1993, AUST J ECOL, V18, P117, DOI 10.1111/j.1442-9993.1993.tb00438.x; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Feng P, 2002, BACTERIOLOGICAL ANAL; Hong MJ, 2009, APPL ENVIRON MICROB, V75, P7797, DOI 10.1128/AEM.01418-09; Hongoh Y, 2003, FEMS MICROBIOL ECOL, V44, P231, DOI 10.1016/S0168-6496(03)00026-6; Kunin V, 2010, ENVIRON MICROBIOL, V12, P118, DOI 10.1111/j.1462-2920.2009.02051.x; Kvennefors ECE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010401; Lee OO, 2012, APPL ENVIRON MICROB, V78, P7173, DOI 10.1128/AEM.01111-12; Littman R, 2011, ENV MICROBIOL REP, V3, P651, DOI 10.1111/j.1758-2229.2010.00234.x; Littman RA, 2009, FEMS MICROBIOL ECOL, V68, P152, DOI 10.1111/j.1574-6941.2009.00666.x; Liu Z. F., 2009, S CHINA SEA DEV PALE, P229; McKew BA, 2012, APPL ENVIRON MICROB, V78, P5229, DOI 10.1128/AEM.07764-11; McLellan SL, 2010, ENVIRON MICROBIOL, V12, P378, DOI 10.1111/j.1462-2920.2009.02075.x; Morrow KM, 2012, APPL ENVIRON MICROB, V78, P6438, DOI 10.1128/AEM.01162-12; Neulinger SC, 2008, APPL ENVIRON MICROB, V74, P7272, DOI 10.1128/AEM.01777-08; Newton RJ, 2011, APPL ENVIRON MICROB, V77, P6972, DOI 10.1128/AEM.05480-11; Nithyanand P, 2011, FEMS MICROBIOL LETT, V314, P112, DOI 10.1111/j.1574-6968.2010.02149.x; Nithyanand P, 2009, FEMS MICROBIOL ECOL, V69, P384, DOI 10.1111/j.1574-6941.2009.00723.x; Nossa CW, 2010, WORLD J GASTROENTERO, V16, P4135, DOI 10.3748/wjg.v16.i33.4135; Raina JB, 2010, TRENDS MICROBIOL, V18, P101, DOI 10.1016/j.tim.2009.12.002; Rohwer F, 2002, MAR ECOL PROG SER, V243, P1, DOI 10.3354/meps243001; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Schmitt S, 2012, ISME J, V6, P564, DOI 10.1038/ismej.2011.116; Sunagawa S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009554; Sweet MJ, 2011, CORAL REEFS, V30, P39, DOI 10.1007/s00338-010-0695-1; Thurber RV, 2009, ENVIRON MICROBIOL, V11, P2148, DOI 10.1111/j.1462-2920.2009.01935.x; Turnbaugh PJ, 2009, NATURE, V457, P480, DOI 10.1038/nature07540; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Wegley L, 2007, ENVIRON MICROBIOL, V9, P2707, DOI 10.1111/j.1462-2920.2007.01383.x	35	16	17	3	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2013	8	8							e71301	10.1371/journal.pone.0071301	http://dx.doi.org/10.1371/journal.pone.0071301			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	200ZE	23940737	Green Published, gold			2022-12-25	WOS:000323109700091
J	Ko, MJ; Wu, HY; Chen, HY; Chiu, YL; Hsu, SP; Pai, MF; Ju-YehYang; Lai, CF; Lu, HM; Huang, SC; Yang, SY; Wen, SY; Chiu, HC; Hu, FC; Peng, YS; Jee, SH				Ko, Mei-Ju; Wu, Hon-Yen; Chen, Hung-Yuan; Chiu, Yen-Ling; Hsu, Shih-Ping; Pai, Mei-Fen; Ju-YehYang; Lai, Chun-Fu; Lu, Hui-Min; Huang, Shu-Chen; Yang, Shao-Yu; Wen, Su-Yin; Chiu, Hsien-Ching; Hu, Fu-Chang; Peng, Yu-Sen; Jee, Shiou-Hwa			Uremic Pruritus, Dialysis Adequacy, and Metabolic Profiles in Hemodialysis Patients: A Prospective 5-Year Cohort Study	PLOS ONE			English	Article							DOUBLE-BLIND; MEMBRANE; FLUX; DISAPPEARANCE; NALTREXONE; SURVIVAL	Background: Uremic pruritus is a common and intractable symptom in patients on chronic hemodialysis, but factors associated with the severity of pruritus remain unclear. This study aimed to explore the associations of metabolic factors and dialysis adequacy with the aggravation of pruritus. Methods: We conducted a 5-year prospective cohort study on patients with maintenance hemodialysis. A visual analogue scale (VAS) was used to assess the intensity of pruritus. Patient demographic and clinical characteristics, laboratory parameters, dialysis adequacy (assessed by Kt/V), and pruritus intensity were recorded at baseline and follow-up. Change score analysis of the difference score of VAS between baseline and follow-up was performed using multiple linear regression models. The optimal threshold of Kt/V, which is associated with the aggravation of uremic pruritus, was determined by generalized additive models and receiver operating characteristic analysis. Results: A total of 111 patients completed the study. Linear regression analysis showed that lower Kt/V and use of low-flux dialyzer were significantly associated with the aggravation of pruritus after adjusting for the baseline pruritus intensity and a variety of confounding factors. The optimal threshold value of Kt/V for pruritus was 1.5 suggested by both generalized additive models and receiver operating characteristic analysis. Conclusions: Hemodialysis with the target of Kt/V >1.5 and use of high-flux dialyzer may reduce the intensity of pruritus in patients on chronic hemodialysis. Further clinical trials are required to determine the optimal dialysis dose and regimen for uremic pruritus.	[Ko, Mei-Ju; Wen, Su-Yin] Taipei City Hosp, Ren Ai Branch, Dept Dermatol, Taipei, Taiwan; [Wu, Hon-Yen; Chen, Hung-Yuan; Chiu, Yen-Ling; Hsu, Shih-Ping; Pai, Mei-Fen; Ju-YehYang; Lai, Chun-Fu; Yang, Shao-Yu; Peng, Yu-Sen] Far Eastern Mem Hosp, Dept Internal Med, New Taipei City, Taiwan; [Lu, Hui-Min; Huang, Shu-Chen] Far Eastern Mem Hosp, Dept Nursing, New Taipei City, Taiwan; [Ko, Mei-Ju; Chiu, Hsien-Ching; Jee, Shiou-Hwa] Natl Taiwan Univ Hosp, Dept Dermatol, Taipei, Taiwan; [Ko, Mei-Ju; Wu, Hon-Yen; Chen, Hung-Yuan; Chiu, Yen-Ling; Hsu, Shih-Ping; Pai, Mei-Fen; Ju-YehYang; Lai, Chun-Fu; Yang, Shao-Yu; Chiu, Hsien-Ching; Peng, Yu-Sen; Jee, Shiou-Hwa] Natl Taiwan Univ, Coll Med, Taipei 10764, Taiwan; [Wu, Hon-Yen; Chen, Hung-Yuan; Chiu, Yen-Ling; Hsu, Shih-Ping; Pai, Mei-Fen; Ju-YehYang; Lai, Chun-Fu; Yang, Shao-Yu; Peng, Yu-Sen] Natl Taiwan Univ Hosp, Dept Internal Med, Taipei 100, Taiwan; [Ko, Mei-Ju; Hu, Fu-Chang] Natl Taiwan Univ, Grad Inst Clin Med, Taipei 10764, Taiwan; [Wu, Hon-Yen] Natl Taiwan Univ, Grad Inst Epidemiol & Prevent Med, Taipei 10764, Taiwan; [Hu, Fu-Chang] Natl Taiwan Univ, Sch Nursing, Taipei 10764, Taiwan	Taipei City Hospital; Far Eastern Memorial Hospital; Far Eastern Memorial Hospital; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University; National Taiwan University	Peng, YS (corresponding author), Far Eastern Mem Hosp, Dept Internal Med, New Taipei City, Taiwan.	taan70@yahoo.com.tw; shiouhwa@ntu.edu.tw	peng, yu/GXW-2071-2022; Chiu, Yen-Ling/AAV-3431-2021; Yang, SY/AAN-1918-2021	Chiu, Yen-Ling/0000-0003-4504-5571; CHIU, HSIEN-CHING/0000-0002-1409-8470; YANG, SHAO-YU/0000-0001-9170-2566; JEE, SHIOU-HWA/0000-0001-6737-6297; LAI, CHUN-FU/0000-0003-2109-1522	Taipei City Hospital; Ta-Tung Kidney Foundation; Mrs. Hsiu-Chin Lee Kidney Research Foundation (Taipei, Taiwan)	Taipei City Hospital; Ta-Tung Kidney Foundation; Mrs. Hsiu-Chin Lee Kidney Research Foundation (Taipei, Taiwan)	This work was financially supported by grants from the Taipei City Hospital (to Dr. Mei-Ju Ko), the Ta-Tung Kidney Foundation, and the Mrs. Hsiu-Chin Lee Kidney Research Foundation (Taipei, Taiwan). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2006, AM J KIDNEY DIS, DOI [10.1053/j.ajkd.2006.03.051, DOI 10.1053/J.AJKD.2006.03.051.MEDLINE]; Benedetti A, 2009, INT J BIOSTAT, V5, DOI 10.2202/1557-4679.1172; Chen HY, 2010, QJM-INT J MED, V103, P837, DOI 10.1093/qjmed/hcq036; Chertow GM, 2010, NEW ENGL J MED, V363, P2287, DOI 10.1056/NEJMoa1001593; Chiu YL, 2008, NEPHROL DIAL TRANSPL, V23, P3685, DOI 10.1093/ndt/gfn303; Clarke PS, 2004, EPIDEMIOLOGY, V15, P414, DOI 10.1097/01.ede.0000120882.86399.e8; Daugirdas J T, 1995, Adv Ren Replace Ther, V2, P295; DESTRIHOU CV, 1991, KIDNEY INT, V39, P1012, DOI 10.1038/ki.1991.128; Duque MI, 2006, CLIN NEPHROL, V66, P184; Dyachenko P, 2006, INT J DERMATOL, V45, P664, DOI 10.1111/j.1365-4632.2005.02592.x; Eknoyan G, 2002, NEW ENGL J MED, V347, P2010, DOI 10.1056/NEJMoa021583; GRAF H, 1979, BRIT MED J, V2, P1478, DOI 10.1136/bmj.2.6203.1478-a; Hastie T, 1990, GAM PACKAGE; Hastie T.J., 1991, GEN ADDITIVE MODELS, DOI DOI 10.1111/APT.14066; HIROSHIGE K, 1995, AM J KIDNEY DIS, V25, P413, DOI 10.1016/0272-6386(95)90102-7; Kaysen GA, 2001, J AM SOC NEPHROL, V12, P1549, DOI 10.1681/ASN.V1271549; Ko MJ, 2011, BRIT J DERMATOL, V165, P633, DOI 10.1111/j.1365-2133.2011.10448.x; Koda Y, 1997, KIDNEY INT, V52, P1096, DOI 10.1038/ki.1997.434; MASI CM, 1992, NEPHRON, V62, P257, DOI 10.1159/000187055; MASSRY SG, 1968, NEW ENGL J MED, V279, P697, DOI 10.1056/NEJM196809262791308; Mathur VS, 2010, CLIN J AM SOC NEPHRO, V5, P1410, DOI 10.2215/CJN.00100110; Mistik S, 2006, J EUR ACAD DERMATOL, V20, P672, DOI 10.1111/j.1468-3083.2006.01570.x; Morton CA, 1996, NEPHROL DIAL TRANSPL, V11, P2031, DOI 10.1093/oxfordjournals.ndt.a027092; Narita I, 2006, KIDNEY INT, V69, P1626, DOI 10.1038/sj.ki.5000251; Narita I, 2008, J NEPHROL, V21, P161; Owen WF, 1998, JAMA-J AM MED ASSOC, V280, P1764, DOI 10.1001/jama.280.20.1764; Pauli-Magnus C, 2000, J AM SOC NEPHROL, V11, P514, DOI 10.1681/ASN.V113514; Peer G, 1996, LANCET, V348, P1552, DOI 10.1016/S0140-6736(96)04176-1; Pisoni RL, 2006, NEPHROL DIAL TRANSPL, V21, P3495, DOI 10.1093/ndt/gfl461; Port FK, 2002, J AM SOC NEPHROL, V13, DOI 10.1681/ASN.V1341061; SERES DS, 1993, J AM SOC NEPHROL, V3, P1409; WARE JH, 1985, AM STAT, V39, P95, DOI 10.2307/2682803; Wikstrom B, 2005, J AM SOC NEPHROL, V16, P3742, DOI 10.1681/ASN.2005020152; Wolfe RA, 2000, AM J KIDNEY DIS, V35, P80, DOI 10.1016/S0272-6386(00)70305-2; Yee TW, 1996, J ROY STAT SOC B MET, V58, P481; Yee TW, 2012, VGAM VECTOR GEN LINE; Yosipovitch G, 2001, ACTA DERM-VENEREOL, V81, P108; YOUDEN WJ, 1950, BIOMETRICS, V6, P172, DOI 10.1002/1097-0142(1950)3:1<32::AID-CNCR2820030106>3.0.CO;2-3; Zucker I, 2003, J AM ACAD DERMATOL, V49, P842, DOI 10.1016/S0190-9622(03)02478-2	39	50	53	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2013	8	8							e71404	10.1371/journal.pone.0071404	http://dx.doi.org/10.1371/journal.pone.0071404			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	217ZG	23940749	Green Submitted, gold, Green Published			2022-12-25	WOS:000324401500069
J	Olarte, A; Mantri, N; Nugent, G; Pang, ECK				Olarte, Alexandra; Mantri, Nitin; Nugent, Gregory; Pang, Edwin C. K.			Subtracted Diversity Array Identifies Novel Molecular Markers Including Retrotransposons for Fingerprinting Echinacea Species	PLOS ONE			English	Article							VIRUSES; ASTERACEAE; GENOME; HYBRIDIZATION; PHYLOGENY; PROBES; PLANTS; WILD	Echinacea, native to the Canadian prairies and the prairie states of the United States, has a long tradition as a folk medicine for the Native Americans. Currently, Echinacea are among the top 10 selling herbal medicines in the U. S. and Europe, due to increasing popularity for the treatment of common cold and ability to stimulate the immune system. However, the genetic relationship within the species of this genus is unclear, making the authentication of the species used for the medicinal industry more difficult. We report the construction of a novel Subtracted Diversity Array (SDA) for Echinacea species and demonstrate the potential of this array for isolating highly polymorphic sequences. In order to selectively isolate Echinacea-specific sequences, a Suppression Subtractive Hybridization (SSH) was performed between a pool of twenty-four Echinacea genotypes and a pool of other angiosperms and non-angiosperms. A total of 283 subtracted genomic DNA (gDNA) fragments were amplified and arrayed. Twenty-seven Echinacea genotypes including four that were not used in the array construction could be successfully discriminated. Interestingly, unknown samples of E. paradoxa and E. purpurea could be unambiguously identified from the cluster analysis. Furthermore, this Echinacea-specific SDA was also able to isolate highly polymorphic retrotransposon sequences. Five out of the eleven most discriminatory features matched to known retrotransposons. This is the first time retrotransposon sequences have been used to fingerprint Echinacea, highlighting the potential of retrotransposons as based molecular markers useful for fingerprinting and studying diversity patterns in Echinacea.	[Olarte, Alexandra; Mantri, Nitin; Nugent, Gregory; Pang, Edwin C. K.] RMIT Univ, Hlth Innovat Res Inst, Sch Appl Sci, Melbourne, Vic, Australia	Royal Melbourne Institute of Technology (RMIT)	Mantri, N (corresponding author), RMIT Univ, Hlth Innovat Res Inst, Sch Appl Sci, Melbourne, Vic, Australia.	nitin.mantri@rmit.edu.au		Mantri, Nitin/0000-0002-7621-035X	Rural Industries Research and Development Corporation (RIRDC) [PRJ-000763]	Rural Industries Research and Development Corporation (RIRDC)(Rural Industries R&D Corp)	This study was supported by Rural Industries Research and Development Corporation (RIRDC) www.rirdc.gov.au through Project Number PRJ-000763. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barrett B, 2003, PHYTOMEDICINE, V10, P66, DOI 10.1078/094471103321648692; Baum BR, 2001, PHYTOCHEMISTRY, V56, P543, DOI 10.1016/S0031-9422(00)00425-8; Bennetzen JL, 2005, ANN BOT-LONDON, V95, P127, DOI 10.1093/aob/mci008; Binns SE, 2002, J AGR FOOD CHEM, V50, P3673, DOI 10.1021/jf011439t; Binns SE, 2002, SYST BOT, V27, P610; Blumenthal M, 2006, HERBALGRAM, V72, p[30, 80]; Bousalem M, 2008, ARCH VIROL, V153, P1085, DOI 10.1007/s00705-008-0095-9; Byng JW, 2016, BOT J LINN SOC, V181, P1, DOI 10.1111/boj.12385; Cavaliere C., 2010, HERBALGRAM, V86, P62; Chen CL, 2009, J SCI FOOD AGR, V89, P2137, DOI 10.1002/jsfa.3704; Chuang SJ, 2010, SCI HORTIC-AMSTERDAM, V124, P400, DOI 10.1016/j.scienta.2010.01.026; Coram TE, 2005, PHYSIOL MOL PLANT P, V66, P192, DOI 10.1016/j.pmpp.2005.08.003; Diatchenko L, 1996, P NATL ACAD SCI USA, V93, P6025, DOI 10.1073/pnas.93.12.6025; Duncan BD, 1994, FERNS ALLIED PLANTS; Flagel LE, 2008, AM J BOT, V95, P756, DOI 10.3732/ajb.0800049; Geering ADW, 2010, ARCH VIROL, V155, P123, DOI 10.1007/s00705-009-0488-4; Harper G, 2003, J VIROL METHODS, V107, P177, DOI 10.1016/S0166-0934(02)00231-8; Jayasinghe R, 2007, PLANT BIOTECHNOL J, V5, P282, DOI 10.1111/j.1467-7652.2007.00240.x; Jing R, 2007, GENETICS, V177, P2263, DOI 10.1534/genetics.107.081323; Kang HW, 2008, MOL BREEDING, V21, P283, DOI 10.1007/s11032-007-9128-4; Kapteyn J, 2002, THEOR APPL GENET, V105, P369, DOI 10.1007/s00122-002-0960-y; Kim DH, 2004, GENOME, V47, P102, DOI 10.1139/G03-086; KINDSCHER K, 1989, ECON BOT, V43, P498, DOI 10.1007/BF02935924; Li TX, 2006, J INTEGR PLANT BIOL, V48, P460, DOI 10.1111/j.1744-7909.2006.00249.x; Li TX, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh041; Mantri N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034873; MCGREGOR R L, 1968, University of Kansas Science Bulletin, V48, P113; Mechanda SM, 2004, CAN J BOT, V82, P461, DOI [10.1139/b04-006, 10.1139/B04-006]; Mechanda SM, 2004, GENOME, V47, P15, DOI 10.1139/G03-094; Melcher U, 2008, J VIROL METHODS, V152, P49, DOI 10.1016/j.jviromet.2008.05.030; Niu LH, 2011, J SCI FOOD AGR, V91, P1310, DOI 10.1002/jsfa.4319; Niu LH, 2011, CHIN MED-UK, V6, DOI 10.1186/1749-8546-6-18; Noma K, 1997, GENES GENET SYST, V72, P131, DOI 10.1266/ggs.72.131; Olarte A, 2013, MOL BIOTECHNOL, V54, P770, DOI 10.1007/s12033-012-9625-5; Percival SS, 2000, BIOCHEM PHARMACOL, V60, P155, DOI 10.1016/S0006-2952(99)00413-X; Schulman AH, 2004, METH MOL B, V260, P145, DOI 10.1007/978-1-61779-603-6_7; Staton SE, 2012, PLANT J, V72, P142, DOI 10.1111/j.1365-313X.2012.05072.x; Ungerer MC, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-40; Urbatsch LE, 2000, SYST BOT, V25, P539, DOI 10.2307/2666695; Vukich M, 2009, THEOR APPL GENET, V119, P1027, DOI 10.1007/s00122-009-1106-2; Wu L, 2009, PLANTA MED, V75, P178, DOI 10.1055/s-0028-1112199; Yu HC, 2004, POPULARITY DIVERSITY	42	4	4	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2013	8	8							e70347	10.1371/journal.pone.0070347	http://dx.doi.org/10.1371/journal.pone.0070347			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	218XC	23940565	Green Submitted, Green Published, gold			2022-12-25	WOS:000324465000059
J	Yang, JM; Hong, Y; Yuan, CX; Fu, ZQ; Shi, YJ; Zhang, M; Shen, LH; Han, YH; Zhu, CG; Li, H; Lu, K; Liu, JM; Feng, XG; Lin, JJ				Yang, Jianmei; Hong, Yang; Yuan, Chunxiu; Fu, Zhiqiang; Shi, Yaojun; Zhang, Min; Shen, Liuhong; Han, Yanhui; Zhu, Chuangang; Li, Hao; Lu, Ke; Liu, Jinming; Feng, Xingang; Lin, Jiaojiao			Microarray Analysis of Gene Expression Profiles of Schistosoma japonicum Derived from Less-Susceptible Host Water Buffalo and Susceptible Host Goat	PLOS ONE			English	Article							CAENORHABDITIS-ELEGANS; PARASITE RELATIONSHIPS; RECEPTOR; PROTEIN; GROWTH; DROSOPHILA; MANSONI; KINASE; MICE; CELL	Background: Water buffalo and goats are natural hosts for S. japonicum in endemic areas of China. The susceptibility of these two hosts to schistosome infection is different, as water buffalo are less conducive to S. japonicum growth and development. To identify genes that may affect schistosome development and survival, we compared gene expression profiles of schistosomes derived from these two natural hosts using high-throughput microarray technology. Results: The worm recovery rate was lower and the length and width of worms from water buffalo were smaller compared to those from goats following S. japonicum infection for 7 weeks. Besides obvious morphological difference between the schistosomes derived from the two hosts, differences were also observed by scanning and transmission electron microscopy. Microarray analysis showed differentially expressed gene patterns for parasites from the two hosts, which revealed that genes related to lipid and nucleotide metabolism, as well as protein folding, sorting, and degradation were upregulated, while others associated with signal transduction, endocrine function, development, immune function, endocytosis, and amino acid/carbohydrate/glycan metabolism were downregulated in schistosomes from water buffalo. KEGG pathway analysis deduced that the differentially expressed genes mainly involved lipid metabolism, the MAPK and ErbB signaling pathways, progesterone-mediated oocyte maturation, dorso-ventral axis formation, reproduction, and endocytosis, etc. Conclusion: The microarray gene analysis in schistosomes derived from water buffalo and goats provide a useful platform to disclose differences determining S. japonicum host compatibility to better understand the interplay between natural hosts and parasites, and identify schistosome target genes associated with susceptibility to screen vaccine candidates.	[Yang, Jianmei; Hong, Yang; Yuan, Chunxiu; Fu, Zhiqiang; Shi, Yaojun; Zhang, Min; Han, Yanhui; Zhu, Chuangang; Li, Hao; Lu, Ke; Liu, Jinming; Feng, Xingang; Lin, Jiaojiao] Chinese Acad Agr Sci, Key Lab Anim Parasitol, Minist Agr, Shanghai Vet Res Inst, Shanghai, Peoples R China; [Shen, Liuhong] Sichuan Agr Univ, Coll Vet Med, Yaan, Peoples R China	Chinese Academy of Agricultural Sciences; Shanghai Veterinary Research Institute, CAAS; Ministry of Agriculture & Rural Affairs; Sichuan Agricultural University	Feng, XG (corresponding author), Chinese Acad Agr Sci, Key Lab Anim Parasitol, Minist Agr, Shanghai Vet Res Inst, Shanghai, Peoples R China.	fengxingang@shvri.ac.cn; jjlin@shvri.ac.cn			National Science & Technology Major Project [2012ZX10004220-008, 2008ZX10004-011]; National Basic Research Program [2007CB513108]; Basic Foundation for Scientific Research of State-level Public Welfare Institutes of China [2012JB17]; Special Fund for Agro-scientific Research in the Public Interest [200903036]	National Science & Technology Major Project; National Basic Research Program(National Basic Research Program of China); Basic Foundation for Scientific Research of State-level Public Welfare Institutes of China; Special Fund for Agro-scientific Research in the Public Interest	This work was supported by research grants from the National Science & Technology Major Project (No. 2012ZX10004220-008, No. 2008ZX10004-011), the National Basic Research Program (No. 2007CB513108), Basic Foundation for Scientific Research of State-level Public Welfare Institutes of China (No. 2012JB17), and Special Fund for Agro-scientific Research in the Public Interest (No. 200903036). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beere HM, 2000, NAT CELL BIOL, V2, P469, DOI 10.1038/35019501; Berman KS, 2001, GENE, V279, P137, DOI 10.1016/S0378-1119(01)00752-1; Cadena DL, 1997, BIOCHEMISTRY-US, V36, P6960, DOI 10.1021/bi970091l; Cha DS, 2012, BBA-MOL CELL RES, V1823, P1847, DOI 10.1016/j.bbamcr.2012.07.006; Chai M, 2006, CELL MOL LIFE SCI, V63, P919, DOI 10.1007/s00018-005-5578-1; Chen WS, 2001, GENE DEV, V15, P2203, DOI 10.1101/gad.913901; Cho H, 2001, J BIOL CHEM, V276, P38349, DOI 10.1074/jbc.C100462200; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Da'Dara AA, 2008, VACCINE, V26, P3617, DOI 10.1016/j.vaccine.2008.04.080; Dai Z. J., 1992, Acta Veterinaria et Zootechnica Sinica, V23, P87; Dillon GP, 2006, INT J PARASITOL, V36, P1, DOI 10.1016/j.ijpara.2005.10.008; Fitzpatrick JM, 2004, MOL BIOCHEM PARASIT, V136, P191, DOI 10.1016/j.molbiopara.2004.03.014; Freitas TC, 2007, PLOS PATHOG, V3, P489, DOI 10.1371/journal.ppat.0030052; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; He Y. X., 1960, CHIN MED J, V46, P470; He YX, 2001, TRENDS PARASITOL, V17, P320, DOI 10.1016/S1471-4922(01)01904-3; Hershko A, 2000, NAT MED, V6, P1073, DOI 10.1038/80384; Hong Y, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.006098; Jiang WB, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013494; Kaji H, 2007, MOL CELL PROTEOMICS, V6, P2100, DOI 10.1074/mcp.M600392-MCP200; Kandel ES, 1999, EXP CELL RES, V253, P210, DOI 10.1006/excr.1999.4690; Koga M, 2000, EMBO J, V19, P5148, DOI 10.1093/emboj/19.19.5148; Krejcova R, 1997, CHEM LISTY, V91, P466; Lee HK, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-269; Liu F, 2006, PLOS PATHOG, V2, P268, DOI 10.1371/journal.ppat.0020029; Liu SX, 1997, VET PARASITOL, V69, P39, DOI 10.1016/S0304-4017(96)01092-8; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; McGarvey ST, 1999, PARASITOL TODAY, V15, P214, DOI 10.1016/S0169-4758(99)01409-X; Moertel L, 2006, MOL CELL PROBE, V20, P280, DOI 10.1016/j.mcp.2006.02.002; Morano KA, 2007, ANN NY ACAD SCI, V1113, P1, DOI 10.1196/annals.1391.018; Morey JS, 2006, BIOL PROCED ONLINE, V8, P175, DOI 10.1251/bpo126; Mujtaba S, 2007, ONCOGENE, V26, P5521, DOI 10.1038/sj.onc.1210618; Muller P, 2005, NATURE, V436, P871, DOI 10.1038/nature03869; Oda K, 2005, MOL SYST BIOL, V1, DOI 10.1038/msb4100014; Osman A, 2006, PLOS PATHOG, V2, P536, DOI 10.1371/journal.ppat.0020054; Parton RG, 2007, NAT REV MOL CELL BIO, V8, P185, DOI 10.1038/nrm2122; Patterson TA, 2006, NAT BIOTECHNOL, V24, P1140, DOI 10.1038/nbt1242; Peng JB, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-155; Peng JB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021109; Penton A, 2002, GENETICS, V161, P747; Philipps DL, 2008, DEV BIOL, V317, P72, DOI 10.1016/j.ydbio.2008.02.018; Ramos VC, 2002, BBA-GENE STRUCT EXPR, V1577, P377, DOI 10.1016/S0167-4781(02)00421-9; Saldanha AJ, 2004, BIOINFORMATICS, V20, P3246, DOI 10.1093/bioinformatics/bth349; Scanga SE, 2000, ONCOGENE, V19, P3971, DOI 10.1038/sj.onc.1203739; Shen W., 1992, CHIN J SCHISTOSOMIAS, V4, P82; Stein RA, 2000, J MOL EVOL, V50, P397, DOI 10.1007/s002390010043; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Sun Q, 2009, MOL ENDOCRINOL, V23, P2038, DOI 10.1210/me.2009-0092; Tanaka K, 2009, P JPN ACAD B-PHYS, V85, P12, DOI [10.2183/pjab.85.12, 10.2183/pjab/85.12]; Tsuboi K, 2002, PROSTAG OTH LIPID M, V68-9, P535, DOI 10.1016/S0090-6980(02)00054-0; Verdu J, 1999, NAT CELL BIOL, V1, P500, DOI 10.1038/70293; Vermeire JJ, 2006, MOL BIOCHEM PARASIT, V147, P39, DOI 10.1016/j.molbiopara.2006.01.006; Vicogne J, 2004, J BIOL CHEM, V279, P37407, DOI 10.1074/jbc.M313738200; Wallingford JB, 2005, DEVELOPMENT, V132, P4421, DOI 10.1242/dev.02068; World Health Organization, 2002, TDR TDR STRAT DIR SC; Wu Z W, 1992, Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi, V10, P194; Yang JianMei, 2012, Chinese Journal of Zoonoses, V28, P1207; Yang JM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047660; Yang JM, 2012, BMC VET RES, V8, DOI 10.1186/1746-6148-8-25; Zheng Jiang, 2000, Chinese Journal of Zoonoses, V16, P87; Zheng Jiang, 1997, Southeast Asian Journal of Tropical Medicine and Public Health, V28, P291; Zhou W, 2009, MOL CARCINOGEN, V48, P886, DOI 10.1002/mc.20533	62	8	8	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2013	8	8							e70367	10.1371/journal.pone.0070367	http://dx.doi.org/10.1371/journal.pone.0070367			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	218XC	23940568	Green Published, Green Submitted, gold			2022-12-25	WOS:000324465000062
J	Yokota, S; Hori, H; Umezawa, M; Kubota, N; Niki, R; Yanagita, S; Takeda, K				Yokota, Satoshi; Hori, Hiroshi; Umezawa, Masakazu; Kubota, Natsuko; Niki, Rikio; Yanagita, Shinya; Takeda, Ken			Gene Expression Changes in the Olfactory Bulb of Mice Induced by Exposure to Diesel Exhaust Are Dependent on Animal Rearing Environment	PLOS ONE			English	Article							MEDIAL PREOPTIC AREA; C-FOS; STEREOTYPED BEHAVIOR; MENTAL-RETARDATION; SYSTEM DEVELOPMENT; AIR-POLLUTION; UP-REGULATION; PARTICLES; RAT; STRESS	There is an emerging concern that particulate air pollution increases the risk of cranial nerve disease onset. Small nanoparticles, mainly derived from diesel exhaust particles reach the olfactory bulb by their nasal depositions. It has been reported that diesel exhaust inhalation causes inflammation of the olfactory bulb and other brain regions. However, these toxicological studies have not evaluated animal rearing environment. We hypothesized that rearing environment can change mice phenotypes and thus might alter toxicological study results. In this study, we exposed mice to diesel exhaust inhalation at 90 mu g/m(3), 8 hours/day, for 28 consecutive days after rearing in a standard cage or environmental enrichment conditions. Microarray analysis found that expression levels of 112 genes were changed by diesel exhaust inhalation. Functional analysis using Gene Ontology revealed that the dysregulated genes were involved in inflammation and immune response. This result was supported by pathway analysis. Quantitative RT-PCR analysis confirmed 10 genes. Interestingly, background gene expression of the olfactory bulb of mice reared in a standard cage environment was changed by diesel exhaust inhalation, whereas there was no significant effect of diesel exhaust exposure on gene expression levels of mice reared with environmental enrichment. The results indicate for the first time that the effect of diesel exhaust exposure on gene expression of the olfactory bulb was influenced by rearing environment. Rearing environment, such as environmental enrichment, may be an important contributive factor to causation in evaluating still undefined toxic environmental substances such as diesel exhaust.	[Yokota, Satoshi; Hori, Hiroshi; Takeda, Ken] Tokyo Univ Sci, Fac Pharmaceut Sci, Dept Hyg Chem, Noda, Chiba 278, Japan; [Yokota, Satoshi; Umezawa, Masakazu; Kubota, Natsuko; Niki, Rikio; Yanagita, Shinya; Takeda, Ken] Tokyo Univ Sci, Res Inst Sci & Technol, Ctr Environm Hlth Sci Next Generat, Noda, Chiba 278, Japan; [Yanagita, Shinya] Tokyo Univ Sci, Fac Sci & Technol, Noda, Chiba 278, Japan	Tokyo University of Science; Tokyo University of Science; Tokyo University of Science	Yokota, S (corresponding author), Tokyo Univ Sci, Fac Pharmaceut Sci, Dept Hyg Chem, 2641 Yamazaki, Noda, Chiba 278, Japan.	satoshi_yokota1008@yahoo.co.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan [22. 5895]; Ministry of Health, Labour and Welfare; NEXT; Grants-in-Aid for Scientific Research [25750335] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Health, Labour and Welfare(Ministry of Health, Labour and Welfare, Japan); NEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Grant-in-Aid for JSPS Fellows (Satoshi Yokota, 22. 5895) and in part by a Grant-in-Aid for Science Research from the Ministry of Education, Culture, Sports, Science and Technology of Japan. This work was also supported by a Grant-in Aid for the Private University Science Research Upgrade Promotion Business "Academic Frontier Project, a Grant-in Aid for Health and Labour Sciences Research Grants, Research on Risk of Chemical Substances, from the Ministry of Health, Labour and Welfare" and a Grant-in Aid for NEXT-Supported Program for the Strategic Research Foundation at Private Universities, 2011-2015. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARRY CC, 1994, ENVIRONMENT, V36, P5; Benefiel Ann C, 1998, ILAR J, V39, P5; BERKSON G, 1983, AM J MENT DEF, V88, P239; Block ML, 2004, FASEB J, V18, P1618, DOI 10.1096/fj.04-1945fje; Brazma A, 2001, NAT GENET, V29, P365, DOI 10.1038/ng1201-365; Brown JR, 1996, CELL, V86, P297, DOI 10.1016/S0092-8674(00)80101-4; Callahan TA, 1997, J NEUROIMMUNOL, V73, P207, DOI 10.1016/S0165-5728(96)00193-2; Cancedda L, 2004, J NEUROSCI, V24, P4840, DOI 10.1523/JNEUROSCI.0845-04.2004; Chen Y, 1997, J Biomed Opt, V2, P364, DOI 10.1117/12.281504; de Hennezel L, 2001, EUR RESPIR J, V17, P94; de Souza MA, 2012, PHYSIOL BEHAV, V105, P850, DOI 10.1016/j.physbeh.2011.10.012; Dean SW, 1999, LAB ANIM-UK, V33, P309, DOI 10.1258/002367799780487823; Donaldson K, 2005, PART FIBRE TOXICOL, V2, DOI 10.1186/1743-8977-2-10; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Elder A, 2006, ENVIRON HEALTH PERSP, V114, P1172, DOI 10.1289/ehp.9030; Garner JP, 2005, ILAR J, V46, P106, DOI 10.1093/ilar.46.2.106; Gerlofs-Nijland ME, 2010, PART FIBRE TOXICOL, V7, DOI 10.1186/1743-8977-7-12; GORCZYNSKI RM, 1992, BRAIN BEHAV IMMUN, V6, P87, DOI 10.1016/0889-1591(92)90062-S; Hartz AMS, 2008, FASEB J, V22, P2723, DOI 10.1096/fj.08-106997; Jacob A, 2011, FLUIDS BARRIERS CNS, V8, DOI 10.1186/2045-8118-8-23; Kelly JP, 1997, PHARMACOL THERAPEUT, V74, P299, DOI 10.1016/S0163-7258(97)00004-1; Kilkenny C, 2010, BRIT J PHARMACOL, V160, P1577, DOI [10.1111/j.1476-5381.2010.00872.x, 10.1113/expphysiol.2010.053793, 10.1113/jphysiol.2010.192278]; Kuroda KO, 2008, BRAIN RES, V1211, P57, DOI 10.1016/j.brainres.2008.02.100; Landrigan PJ, 2005, ENVIRON HEALTH PERSP, V113, P1230, DOI 10.1289/ehp.7571; Levesque S, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-105; Levesque S, 2011, ENVIRON HEALTH PERSP, V119, P1149, DOI 10.1289/ehp.1002986; Levy F, 2004, HORM BEHAV, V46, P284, DOI 10.1016/j.yhbeh.2004.02.005; Lewis MH, 2007, BEHAV BRAIN RES, V176, P66, DOI 10.1016/j.bbr.2006.08.023; Lewis MH, 2004, MENT RETARD DEV D R, V10, P91, DOI 10.1002/mrdd.20017; Lewis MH, 1996, AM J MENT RETARD, V100, P654; Lewis MH, 1996, AM J MENT RETARD, V100, P413; MACCARI S, 1995, J NEUROSCI, V15, P110; Matsui Y, 2009, SPECTROCHIM ACTA B, V64, P796, DOI 10.1016/j.sab.2009.06.017; MCCLELLAN RO, 1987, ANNU REV PHARMACOL, V27, P279; MURANAKA M, 1986, J ALLERGY CLIN IMMUN, V77, P616, DOI 10.1016/0091-6749(86)90355-6; Newton MA, 2001, J COMPUT BIOL, V8, P37, DOI 10.1089/106652701300099074; Numan M, 1998, BRAIN RES, V792, P348, DOI 10.1016/S0006-8993(98)00257-1; Oberdorster G, 2005, ENVIRON HEALTH PERSP, V113, P823, DOI 10.1289/ehp.7339; Oberdorster G, 2004, INHAL TOXICOL, V16, P437, DOI 10.1080/08958370490439597; Oliva AM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011359; Pan W., 2002, GENOME BIOL, V3; Peters A, 2006, PART FIBRE TOXICOL, V8, P3; Powell SB, 1999, PHYSIOL BEHAV, V66, P355, DOI 10.1016/S0031-9384(98)00303-5; Quackenbush J, 2001, NAT REV GENET, V2, P418, DOI 10.1038/35076576; Sagai M, 1996, FREE RADICAL BIO MED, V21, P199, DOI 10.1016/0891-5849(96)00032-9; Saldanha AJ, 2004, BIOINFORMATICS, V20, P3246, DOI 10.1093/bioinformatics/bth349; Serino R, 1999, ENDOCRINOLOGY, V140, P2334, DOI 10.1210/en.140.5.2334; Silverman DT, 2012, JNCI-J NATL CANCER I, V104, P855, DOI 10.1093/jnci/djs034; Song C, 2005, NEUROSCI BIOBEHAV R, V29, P627, DOI 10.1016/j.neubiorev.2005.03.010; Stack EC, 2000, BEHAV NEUROSCI, V114, P609, DOI 10.1037/0735-7044.114.3.609; Tibshirani R, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-106; Turner CA, 2003, PHYSIOL BEHAV, V80, P259, DOI 10.1016/j.physbeh.2003.07.008; Wichmann HE, 2007, INHAL TOXICOL, V19, P241, DOI 10.1080/08958370701498075; Win-Shwe TT, 2012, TOXICOL APPL PHARM, V262, P355, DOI 10.1016/j.taap.2012.05.015; Win-Shwe TT, 2012, NANOTOXICOLOGY, V6, P543, DOI 10.3109/17435390.2011.590904; Yamagishi N, 2012, INHAL TOXICOL, V24, P459, DOI 10.3109/08958378.2012.688225; Yokota S, 2009, NEUROSCI LETT, V449, P38, DOI 10.1016/j.neulet.2008.09.085; Zahurak M, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-142	58	17	17	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2013	8	8							e70145	10.1371/journal.pone.0070145	http://dx.doi.org/10.1371/journal.pone.0070145			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	218XC	23940539	gold, Green Published, Green Submitted			2022-12-25	WOS:000324465000033
J	Wagner, GR; Payne, RM				Wagner, Gregory R.; Payne, R. Mark			Widespread and Enzyme-independent N-is an element of-Acetylation and N-is an element of-Succinylation of Proteins in the Chemical Conditions of the Mitochondrial Matrix	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Acetyl Coenzyme A; Metabolic Diseases; Metabolic Regulation; Mitochondrial Metabolism; pH Regulation; Sirtuins; Acetylation; Nonenzymatic; Succinyl Coenzyme A; Succinylation	HISTONE ACETYLTRANSFERASE GCN5; STEADY-STATE CONCENTRATIONS; KETONE-BODY PRODUCTION; FATTY-ACID OXIDATION; LYSINE ACETYLATION; CALORIE RESTRICTION; PK(A) VALUES; SIRT3; DEACETYLATION; METABOLISM	Alterations in mitochondrial protein acetylation are implicated in the pathophysiology of diabetes, the metabolic syndrome, mitochondrial disorders, and cancer. However, a viable mechanism responsible for the widespread acetylation in mitochondria remains unknown. Here, we demonstrate that the physiologic pH and acyl-CoA concentrations of the mitochondrial matrix are sufficient to cause dose- and time-dependent, but enzyme-independent acetylation and succinylation of mitochondrial and nonmitochondrial proteins in vitro. These data suggest that protein acylation in mitochondria may be a chemical event facilitated by the alkaline pH and high concentrations of reactive acyl-CoAs present in the mitochondrial matrix. Although these results do not exclude the possibility of enzyme-mediated protein acylation in mitochondria, they demonstrate that such a mechanism may not be required in its unique chemical environment. These findings may have implications for the evolutionary roles that the mitochondria-localized SIRT3 deacetylase and SIRT5 desuccinylase have in the maintenance of metabolic health.	[Wagner, Gregory R.; Payne, R. Mark] Indiana Univ Sch Med, Dept Med & Mol Genet, Indianapolis, IN 46202 USA; [Payne, R. Mark] Indiana Univ Sch Med, Dept Pediat, Riley Heart Res Ctr, Wells Ctr Pediat Res, Indianapolis, IN 46202 USA	Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington	Payne, RM (corresponding author), Wells Ctr Pediat Res, Riley Heart Res Ctr, 1044 West Walnut,R4302B, Indianapolis, IN 46202 USA.	rpayne@iupui.edu			National Institutes of Health [1P01HL085098]; American Heart Association [0855646G, 11PRE7290079]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL085098] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant 1P01HL085098 (to R. M. P.). This work was also supported by American Heart Association Grant in Aid 0855646G (to R. M. P.) and American Heart Association Fellowship 11PRE7290079 (to G. R. W.).	Albaugh BN, 2011, CHEMBIOCHEM, V12, P290, DOI 10.1002/cbic.201000438; BADDILEY J, 1952, NATURE, V170, P968, DOI 10.1038/170968a0; Cai L, 2011, MOL CELL, V42, P426, DOI 10.1016/j.molcel.2011.05.004; Casey JR, 2010, NAT REV MOL CELL BIO, V11, P50, DOI 10.1038/nrm2820; Choudhary C, 2009, SCIENCE, V325, P834, DOI 10.1126/science.1175371; Du JT, 2011, SCIENCE, V334, P806, DOI 10.1126/science.1207861; Finley LWS, 2011, CANCER CELL, V19, P416, DOI 10.1016/j.ccr.2011.02.014; Fritz KS, 2011, CHEM RES TOXICOL, V24, P651, DOI 10.1021/tx100355a; GARLAND PB, 1965, BIOCHEM J, V97, P587, DOI 10.1042/bj0970587; Hafner AV, 2010, AGING-US, V2, P914, DOI 10.18632/aging.100252; HANSFORD RG, 1975, J BIOL CHEM, V250, P8361; Harris TK, 2002, IUBMB LIFE, V53, P85, DOI 10.1080/15216540211468; Hebert AS, 2013, MOL CELL, V49, P186, DOI 10.1016/j.molcel.2012.10.024; Hirschey MD, 2011, MOL CELL, V44, P177, DOI 10.1016/j.molcel.2011.07.019; Hirschey MD, 2010, NATURE, V464, P121, DOI 10.1038/nature08778; JENKINS DW, 1971, J AMER MED ASSOC, V217, P177, DOI 10.1001/jama.217.2.177; Jing EX, 2011, P NATL ACAD SCI USA, V108, P14608, DOI 10.1073/pnas.1111308108; Katan-Khaykovich Y, 2002, GENE DEV, V16, P743, DOI 10.1101/gad.967302; Kim SC, 2006, MOL CELL, V23, P607, DOI 10.1016/j.molcel.2006.06.026; KIRSCHENBAUM DM, 1982, MED HYPOTHESES, V8, P491, DOI 10.1016/0306-9877(82)90010-X; Lombard DB, 2007, MOL CELL BIOL, V27, P8807, DOI 10.1128/MCB.01636-07; MacKenzie JA, 2004, J BIOL CHEM, V279, P9803, DOI 10.1074/jbc.M307167200; Maillard LC, 1912, CR HEBD ACAD SCI, V154, P66; Marmorstein R, 2001, CELL MOL LIFE SCI, V58, P693, DOI 10.1007/PL00000893; Martin J, 2013, HEPATOLOGY, V57, P2037, DOI 10.1002/hep.26060; McBrian MA, 2013, MOL CELL, V49, P310, DOI 10.1016/j.molcel.2012.10.025; MCGARRY JD, 1980, ANNU REV BIOCHEM, V49, P395, DOI 10.1146/annurev.bi.49.070180.002143; McMurry J., 2005, ORGANIC CHEM BIOL PA, P26; Moellering RE, 2013, SCIENCE, V341, P549, DOI 10.1126/science.1238327; Newman JC, 2012, J BIOL CHEM, V287, P42436, DOI 10.1074/jbc.R112.404863; Park J, 2013, MOL CELL, V50, P919, DOI 10.1016/j.molcel.2013.06.001; Schwer B, 2009, AGING CELL, V8, P604, DOI 10.1111/j.1474-9726.2009.00503.x; Scott I, 2012, BIOCHEM J, V443, P655, DOI 10.1042/BJ20120118; Shimazu T, 2010, CELL METAB, V12, P654, DOI 10.1016/j.cmet.2010.11.003; Smith BC, 2011, ACS CHEM BIOL, V6, P146, DOI 10.1021/cb100218d; Someya S, 2010, CELL, V143, P802, DOI 10.1016/j.cell.2010.10.002; Sondergaard CR, 2011, J CHEM THEORY COMPUT, V7, P2284, DOI 10.1021/ct200133y; Stanton CL, 2008, J CHEM THEORY COMPUT, V4, P951, DOI 10.1021/ct8000014; Starai VJ, 2002, SCIENCE, V298, P2390, DOI 10.1126/science.1077650; STARK GR, 1965, BIOCHEMISTRY-US, V4, P1030, DOI 10.1021/bi00882a008; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; Tanner KG, 2000, J BIOL CHEM, V275, P22048, DOI 10.1074/jbc.M002893200; Tanner KG, 1999, J BIOL CHEM, V274, P18157, DOI 10.1074/jbc.274.26.18157; Tawfik DS, 2010, NAT CHEM BIOL, V6, P692, DOI 10.1038/nchembio.441; Wagner GR, 2012, HUM MOL GENET, V21, P2688, DOI 10.1093/hmg/dds095; Wang QJ, 2010, SCIENCE, V327, P1004, DOI 10.1126/science.1179687; Weinert BT, 2013, MOL CELL, V51, P265, DOI 10.1016/j.molcel.2013.06.003; Yang HY, 2007, CELL, V130, P1095, DOI 10.1016/j.cell.2007.07.035; Yu W, 2012, J BIOL CHEM, V287, P14078, DOI 10.1074/jbc.M112.355206; Yu W, 2009, J BIOL CHEM, V284, P13669, DOI 10.1074/jbc.M901921200; Zhang ZH, 2011, NAT CHEM BIOL, V7, P58, DOI [10.1038/nchembio.495, 10.1038/NCHEMBIO.495]	51	338	341	6	54	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 4	2013	288	40					29036	29045		10.1074/jbc.M113.486753	http://dx.doi.org/10.1074/jbc.M113.486753			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	298BL	23946487	Green Published, hybrid			2022-12-25	WOS:000330298800057
J	Martin-Montalvo, A; Gonzalez-Mariscal, I; Pomares-Viciana, T; Padilla-Lopez, S; Ballesteros, M; Vazquez-Fonseca, L; Gandolfo, P; Brautigan, DL; Navas, P; Santos-Ocana, C				Martin-Montalvo, Alejandro; Gonzalez-Mariscal, Isabel; Pomares-Viciana, Teresa; Padilla-Lopez, Sergio; Ballesteros, Manuel; Vazquez-Fonseca, Luis; Gandolfo, Pablo; Brautigan, David L.; Navas, Placido; Santos-Ocana, Carlos			The Phosphatase Ptc7 Induces Coenzyme Q Biosynthesis by Activating the Hydroxylase Coq7 in Yeast	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SACCHAROMYCES-CEREVISIAE; PROTEIN PHOSPHATASE; GENE; KINASE; 2C; PHOSPHORYLATION; IDENTIFICATION; RESPIRATION; METABOLISM; EXPRESSION	The study of the components of mitochondrial metabolism has potential benefits for health span and lifespan because the maintenance of efficient mitochondrial function and antioxidant capacity is associated with improved health and survival. In yeast, mitochondrial function requires the tight control of several metabolic processes such as coenzyme Q biosynthesis, assuring an appropriate energy supply and antioxidant functions. Many mitochondrial processes are regulated by phosphorylation cycles mediated by protein kinases and phosphatases. In this study, we determined that the mitochondrial phosphatase Ptc7p, a Ser/Thr phosphatase, was required to regulate coenzyme Q(6) biosynthesis, which in turn activated aerobic metabolism and enhanced oxidative stress resistance. We showed that Ptc7p phosphatase specifically activated coenzyme Q(6) biosynthesis through the dephosphorylation of the demethoxy-Q(6) hydroxylase Coq7p. The current findings revealed that Ptc7p is a regulator of mitochondrial metabolism that is essential to maintain proper function of the mitochondria by regulating energy metabolism and oxidative stress resistance.	[Martin-Montalvo, Alejandro; Gonzalez-Mariscal, Isabel; Pomares-Viciana, Teresa; Ballesteros, Manuel; Vazquez-Fonseca, Luis; Gandolfo, Pablo; Navas, Placido; Santos-Ocana, Carlos] Univ Pablo de Olavide, Ctr Invest Biomed Red Enfermedades Raras CIBERER, Inst Salud Carlos III, Ctr Andaluz Biol Desarrollo,CSIC, Seville 41013, Spain; [Padilla-Lopez, Sergio] Sanford Res Univ South Dakota, Sanford Children Hlth Res Ctr, Sioux Falls, SD 57104 USA; [Brautigan, David L.] Univ Virginia, Sch Med, Ctr Cell Signaling, Charlottesville, VA 22908 USA	CIBER - Centro de Investigacion Biomedica en Red; CIBERER; Consejo Superior de Investigaciones Cientificas (CSIC); Universidad Pablo de Olavide; CSIC - Andalusian Center for Developmental Biology (CABD); Instituto de Salud Carlos III; Sanford Health; University of South Dakota; University of Virginia	Martin-Montalvo, A (corresponding author), Univ Pablo de Olavide, Ctr Invest Biomed Red Enfermedades Raras CIBERER, Inst Salud Carlos III, Ctr Andaluz Biol Desarrollo,CSIC, Seville 41013, Spain.	amarsan@upo.es; csanoca@upo.es	Vazquez-Fonseca, Luis/Z-6251-2019; NAVAS, PLACIDO/R-5943-2019; Martin-Montalvo, Alejandro/C-2031-2017; Ocaña, Carlos Santos/E-8115-2011	Vazquez-Fonseca, Luis/0000-0002-0870-6935; NAVAS, PLACIDO/0000-0002-4115-7966; Martin-Montalvo, Alejandro/0000-0002-3886-5355; Ocaña, Carlos Santos/0000-0002-2379-796X; Gonzalez Mariscal, Isabel/0000-0003-1186-1212	Spanish Ministerio de Ciencia y Tecnologia [PI11/00078]; Junta de Andalucia Grant [P08-CTS-03988]; International Q10 Association	Spanish Ministerio de Ciencia y Tecnologia(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Junta de Andalucia Grant(Junta de Andalucia); International Q10 Association	The work was supported in part by the Spanish Ministerio de Ciencia y Tecnologia Grant PI11/00078, Junta de Andalucia Grant P08-CTS-03988, and the International Q<INF>10</INF> Association "Phosphorylation based regulation of coenzyme Q biosynthesis in yeast."	Abdulrehman D, 2011, NUCLEIC ACIDS RES, V39, pD136, DOI 10.1093/nar/gkq964; Barford D, 1998, ANNU REV BIOPH BIOM, V27, P133, DOI 10.1146/annurev.biophys.27.1.133; Belli G, 1998, NUCLEIC ACIDS RES, V26, P942, DOI 10.1093/nar/26.4.942; Bentinger M, 2010, BIOCHEM BIOPH RES CO, V396, P74, DOI 10.1016/j.bbrc.2010.02.147; Brautigan DL, 2005, BIOCHEMISTRY-US, V44, P11067, DOI 10.1021/bi0508845; CHRISTIANSON TW, 1992, GENE, V110, P119, DOI 10.1016/0378-1119(92)90454-W; Claros MG, 1996, EUR J BIOCHEM, V241, P779, DOI 10.1111/j.1432-1033.1996.00779.x; Colquhoun A, 2001, BBA-MOL CELL BIOL L, V1533, P207, DOI 10.1016/S1388-1981(01)00136-6; Costa Vitor, 2001, Molecular Aspects of Medicine, V22, P217, DOI 10.1016/S0098-2997(01)00012-7; FORSBURG SL, 1989, GENE DEV, V3, P1166, DOI 10.1101/gad.3.8.1166; Gee KR, 1999, BIOORG MED CHEM LETT, V9, P1395, DOI 10.1016/S0960-894X(99)00199-7; Gey U, 2008, J BIOL CHEM, V283, P9759, DOI 10.1074/jbc.M708779200; Hans SK, 2010, BIOORGAN MED CHEM, V18, P1103, DOI 10.1016/j.bmc.2009.12.056; Henriksen P, 2012, MOL CELL PROTEOMICS, V11, P1510, DOI 10.1074/mcp.M112.017251; Jiang LH, 2002, FEBS LETT, V527, P323, DOI 10.1016/S0014-5793(02)03247-7; Jimenez-Hidalgo M, 2009, AGING CELL, V8, P140, DOI 10.1111/j.1474-9726.2009.00461.x; Joseph-Horne T, 2001, BBA-BIOENERGETICS, V1504, P179, DOI 10.1016/S0005-2728(00)00251-6; Juneau K, 2009, GENETICS, V183, P185, DOI 10.1534/genetics.109.105155; Krause-Buchholz U, 2006, FEBS LETT, V580, P2553, DOI 10.1016/j.febslet.2006.04.002; Lammers T, 2007, CRIT REV BIOCHEM MOL, V42, P437, DOI 10.1080/10409230701693342; Lee J, 2007, MOL CELL PROTEOMICS, V6, P669, DOI 10.1074/mcp.M600218-MCP200; Leonard CJ, 1998, GENOME RES, V8, P1038, DOI 10.1101/gr.8.10.1038; MAEDA T, 1993, MOL CELL BIOL, V13, P5408, DOI 10.1128/MCB.13.9.5408; Mao M, 2004, GENOMICS, V83, P989, DOI 10.1016/j.ygeno.2003.12.019; Marbois B, 2009, BBA-MOL CELL BIOL L, V1791, P69, DOI 10.1016/j.bbalip.2008.10.006; Martin-Montalvo A, 2011, BIOCHEM J, V440, P107, DOI 10.1042/BJ20101422; Padilla S, 2004, J BIOL CHEM, V279, P25995, DOI 10.1074/jbc.M400001200; Padilla S, 2009, CELL MOL LIFE SCI, V66, P173, DOI 10.1007/s00018-008-8547-7; Rahman A, 2011, NEUROCHEM RES, V36, P195, DOI 10.1007/s11064-010-0300-6; Ramos CW, 2000, IUBMB LIFE, V50, P371, DOI 10.1080/152165400300089411; Reinders J, 2007, MOL CELL PROTEOMICS, V6, P1896, DOI 10.1074/mcp.M700098-MCP200; Ruan HH, 2007, FEMS YEAST RES, V7, P209, DOI 10.1111/j.1567-1364.2006.00160.x; Runner VM, 2003, YEAST, V20, P913, DOI 10.1002/yea.1019; Sakumoto NM, 1999, YEAST, V15, P1669, DOI 10.1002/(SICI)1097-0061(199911)15:15<1669::AID-YEA480>3.0.CO;2-6; Shi YG, 2009, CELL, V139, P468, DOI 10.1016/j.cell.2009.10.006; SIPPEL CJ, 1983, J BIOL CHEM, V258, P1057; Stetak A, 2001, BIOCHEM BIOPH RES CO, V288, P564, DOI 10.1006/bbrc.2001.5811; Suzuki YJ, 2010, ANTIOXID REDOX SIGN, V12, P323, DOI 10.1089/ars.2009.2887; Tamura S, 2006, CANCER SCI, V97, P563, DOI 10.1111/j.1349-7006.2006.00219.x; Tauche A, 2008, FEMS YEAST RES, V8, P1263, DOI 10.1111/j.1567-1364.2008.00436.x; Xie LTX, 2012, J BIOL CHEM, V287, P23571, DOI 10.1074/jbc.M112.360354; Xie LTX, 2011, BBA-MOL CELL BIOL L, V1811, P348, DOI 10.1016/j.bbalip.2011.01.009	42	35	35	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 27	2013	288	39					28126	28137		10.1074/jbc.M113.474494	http://dx.doi.org/10.1074/jbc.M113.474494			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302OB	23940037	Green Published, hybrid			2022-12-25	WOS:000330612800037
J	Peddada, N; Sagar, A; Rathore, YS; Choudhary, V; Pattnaik, UBK; Khatri, N; Garg, R; Ashish				Peddada, Nagesh; Sagar, Amin; Rathore, Yogendra S.; Choudhary, Vikas; Pattnaik, U. Bharat K.; Khatri, Neeraj; Garg, Renu; Ashish			Global Shapes of F-actin Depolymerization-competent Minimal Gelsolins INSIGHT INTO THE ROLE OF g2-g3 LINKER IN pH/Ca2+ INSENSITIVITY OF THE FIRST HALF	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMINO-TERMINAL HALF; PLASMA GELSOLIN; BINDING DOMAINS; SCAVENGER SYSTEM; LOW PH; ACTIVATION; CALCIUM; IDENTIFICATION; EXPRESSION; FILAMENTS	Because of its ability to rapidly depolymerize F-actin, plasma gelsolin has emerged as a therapeutic molecule in different disease conditions. High amounts of exogenous gelsolin are, however, required to treat animal models of different diseases. Knowing that the F-actin depolymerizing property of gelsolin resides in its N terminus, we made several truncated versions of plasma gelsolin. The smaller versions, particularly the one composed of the first 28-161 residues, depolymerized the F-actin much faster than the native gelsolin and other truncates at the same molar ratios. Although G1-G3 loses its dependence on Ca2+ or low pH for the actin depolymerization function, interestingly, G1-G2 and its smaller versions were found to regain this requirement. Small angle x-ray scattering-based shape reconstructions revealed that G1-G3 adopts an open shape in both the presence and the absence of Ca2+ as well as low pH, whereas G1-G2 and residues 28-161 prefer collapsed states in Ca2+ -free conditions at pH 8. The mutations in the g2-g3 linker resulted in the calcium sensitivity of the mutant G1-G3 for F-actin depolymerization activity, although the F-actin-binding sites remained exposed in the mutant G1-G3 as well as in the smaller truncates even in the Ca2+ -free conditions at pH 8. Furthermore, unlike wild type G1-G3, calcium-sensitive mutants of G1-G3 acquired closed shapes in the absence of free calcium, implying a role of g2-g3 linker in determining the open F-actin depolymerizing-competent shape of G1-G3 in this condition. We demonstrate that the mobility of the G1 domain, essential for F-actin depolymerization, is indirectly regulated by the gelsolin-like sequence of g2-g3 linker.	[Peddada, Nagesh; Sagar, Amin; Rathore, Yogendra S.; Choudhary, Vikas; Pattnaik, U. Bharat K.; Khatri, Neeraj; Garg, Renu; Ashish] CSIR, Inst Microbial Technol, Chandigarh 160036, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Institute of Microbial Technology (IMTECH)	Ashish (corresponding author), CSIR, Inst Microbial Technol, Chandigarh 160036, India.	ashgang@imtech.res.in	Sagar, Amin/AAF-4044-2021; Peddada, Nagesh/L-6760-2019	Sagar, Amin/0000-0002-6207-9557; Peddada, Nagesh/0000-0003-4033-7305	Projects UNSEEN NWP [OLP-0056, Sip-10]; Department of Biotechnology and Council of Scientific and Industrial Research; Department of Science and Technology-Women Scientist Scheme A Grant [SR/WOS-A/LS-106/2009]	Projects UNSEEN NWP; Department of Biotechnology and Council of Scientific and Industrial Research; Department of Science and Technology-Women Scientist Scheme A Grant	This work was supported in part by Projects UNSEEN NWP, OLP-0056, and Sip-10. This is IMTech Communication Number 65/2012.; Recipients of research fellowships from Department of Biotechnology and Council of Scientific and Industrial Research.; Recipient of Department of Science and Technology-Women Scientist Scheme A Grant SR/WOS-A/LS-106/2009.	Ashish, 2007, J BIOL CHEM, V282, P25884, DOI 10.1074/jbc.M702446200; Bucki R, 2005, BIOCHEMISTRY-US, V44, P9590, DOI 10.1021/bi0503504; Burtnick LD, 2004, EMBO J, V23, P2713, DOI 10.1038/sj.emboj.7600280; Burtnick LD, 1997, CELL, V90, P661, DOI 10.1016/S0092-8674(00)80527-9; CHAPONNIER C, 1986, J CELL BIOL, V103, P1473, DOI 10.1083/jcb.103.4.1473; Cohen TS, 2011, CYTOKINE, V54, P235, DOI 10.1016/j.cyto.2011.02.006; EICHINGER L, 1992, BIOCHEMISTRY-US, V31, P4779, DOI 10.1021/bi00135a006; Garg R, 2011, J BIOL CHEM, V286, P20387, DOI 10.1074/jbc.M111.236943; HADDAD JG, 1990, P NATL ACAD SCI USA, V87, P1381, DOI 10.1073/pnas.87.4.1381; Irobi E, 2003, FEBS LETT, V552, P86, DOI 10.1016/S0014-5793(03)00934-7; Kiselar JG, 2003, P NATL ACAD SCI USA, V100, P3942, DOI 10.1073/pnas.0736004100; Klaavuniemi T, 2008, J BIOL CHEM, V283, P26071, DOI 10.1074/jbc.M803618200; Konarev PV, 2003, J APPL CRYSTALLOGR, V36, P1277, DOI 10.1107/S0021889803012779; KOUYAMA T, 1981, EUR J BIOCHEM, V114, P33; Kozin MB, 2001, J APPL CRYSTALLOGR, V34, P33, DOI 10.1107/S0021889800014126; KWIATKOWSKI DJ, 1985, J BIOL CHEM, V260, P5232; KWIATKOWSKI DJ, 1989, J CELL BIOL, V108, P1717, DOI 10.1083/jcb.108.5.1717; LAMB JA, 1993, J BIOL CHEM, V268, P8999; Lee PS, 2007, CRIT CARE MED, V35, P849, DOI 10.1097/01.CCM.0000253815.26311.24; Lee PS, 2006, ANN SURG, V243, P399, DOI 10.1097/01.sla.0000201798.77133.55; Lee TS, 2002, NAT MED, V8, P240, DOI 10.1038/nm0302-240; LEE WM, 1992, NEW ENGL J MED, V326, P1335; Lin KM, 2000, J BIOL CHEM, V275, P27746; Liu ZM, 2010, BIOCHEMISTRY-US, V49, P4349, DOI 10.1021/bi100215b; Mazumdar B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044461; MCLAUGHLIN PJ, 1993, NATURE, V364, P685, DOI 10.1038/364685a0; Meier U, 2006, CLIN CHEM, V52, P1247, DOI 10.1373/clinchem.2005.065680; Nag S, 2009, P NATL ACAD SCI USA, V106, P13713, DOI 10.1073/pnas.0812374106; PANDITA R, 1992, FEBS LETT, V312, P87, DOI 10.1016/0014-5793(92)81416-J; PARDEE JD, 1982, METHOD ENZYMOL, V85, P164; Peddada N, 2012, MED HYPOTHESES, V78, P203, DOI 10.1016/j.mehy.2011.10.024; POLLARD TD, 1983, ANAL BIOCHEM, V134, P406, DOI 10.1016/0003-2697(83)90316-0; Pope BJ, 1997, BIOCHEMISTRY-US, V36, P15848, DOI 10.1021/bi972192p; Rothenbach PA, 2004, J APPL PHYSIOL, V96, P25, DOI 10.1152/japplphysiol.01074.2002; Roustan C, 2007, FEBS LETT, V581, P681, DOI 10.1016/j.febslet.2007.01.031; Sagar A, 2013, BIOCHEM BIOPH RES CO, V435, P740, DOI 10.1016/j.bbrc.2013.05.055; Selden LA, 1998, BIOPHYS J, V75, P3092, DOI 10.1016/S0006-3495(98)77750-1; SELVE N, 1986, EUR J BIOCHEM, V155, P397, DOI 10.1111/j.1432-1033.1986.tb09504.x; SOUTHWICK FS, 1995, J BIOL CHEM, V270, P45, DOI 10.1074/jbc.270.1.45; Sun HQ, 1999, J BIOL CHEM, V274, P33179, DOI 10.1074/jbc.274.47.33179; SUN HQ, 1994, J BIOL CHEM, V269, P9473; SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663; Svergun DI, 2001, BIOPHYS J, V80, P2946, DOI 10.1016/S0006-3495(01)76260-1; Terada N, 2007, BIOPHYS J, V92, P2162, DOI 10.1529/biophysj.106.098871; WAY M, 1992, J CELL BIOL, V119, P835, DOI 10.1083/jcb.119.4.835; WAY M, 1989, J CELL BIOL, V109, P593, DOI 10.1083/jcb.109.2.593; WAY M, 1990, EMBO J, V9, P4103, DOI 10.1002/j.1460-2075.1990.tb07632.x; WEBER A, 1991, BIOCHEMISTRY-US, V30, P9327, DOI 10.1021/bi00102a027; WEEDS AG, 1991, BIOCHEM SOC T, V19, P1016, DOI 10.1042/bst0191016; Zhang Y, 2006, EMBO J, V25, P4458, DOI 10.1038/sj.emboj.7601323	50	18	20	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 27	2013	288	39					28266	28282		10.1074/jbc.M113.463224	http://dx.doi.org/10.1074/jbc.M113.463224			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302OB	23940055	Green Published, hybrid			2022-12-25	WOS:000330612800048
J	Derkow, K; Bauer, JMJ; Hecker, M; Paap, BK; Thamilarasan, M; Koczan, D; Schott, E; Deuschle, K; Bellmann-Strobl, J; Paul, F; Zettl, UK; Ruprecht, K; Lehnardt, S				Derkow, Katja; Bauer, Jakob M. J.; Hecker, Michael; Paap, Brigitte K.; Thamilarasan, Madhan; Koczan, Dirk; Schott, Eckart; Deuschle, Katrin; Bellmann-Strobl, Judith; Paul, Friedemann; Zettl, Uwe K.; Ruprecht, Klemens; Lehnardt, Seija			Multiple Sclerosis: Modulation of Toll-Like Receptor (TLR) Expression by Interferon-beta Includes Upregulation of TLR7 in Plasmacytoid Dendritic Cells	PLOS ONE			English	Article							PATTERN-RECOGNITION RECEPTORS; DIAGNOSTIC-CRITERIA; ANTIVIRAL PROTEIN; INNATE IMMUNITY; DOUBLE-BLIND; IFN; RNA; SENSITIVITY; LEUKOCYTES; CYTOKINES	Interferon-beta is an established treatment for patients with multiple sclerosis (MS) but its mechanisms of action are not well understood. Viral infections are a known trigger of MS relapses. Toll-like receptors (TLRs) are key components of the innate immune system, which sense conserved structures of viruses and other pathogens. Effects of interferon-beta on mRNA levels of all known human TLRs (TLR1-10) and the TLR adaptor molecule MyD88 were analyzed in peripheral blood mononuclear cells (PBMCs) of healthy donors by quantitative real-time PCR and by transcriptome analysis in PBMCs of 25 interferon-beta-treated patients with relapsing-remitting MS. Regulation of TLR protein expression by interferon-beta was investigated by flow cytometry of leukocyte subsets of healthy subjects and of untreated, interferon-beta-, or glatiramer acetate-treated patients with MS. Interferon-beta specifically upregulated mRNA expression of TLR3, TLR7, and MyD88 and downregulated TLR9 mRNA in PBMCs of healthy donors as well as in PBMCs of patients with MS. Plasmacytoid dendritic cells (pDCs) were identified as the major cell type responding to interferon-beta with increased expression of TLR7 and MyD88 protein. In line with this, expression of TLR7 protein was increased in pDCs of interferon-beta-treated, but not untreated or glatiramer acetate-treated patients with MS. Interferon-beta-induced upregulation of TLR7 in pDCs is of functional relevance since pre-treatment of PBMCs with interferon-beta resulted in a strongly increased production of interferon-alpha upon stimulation with the TLR7 agonist loxoribine. Flow cytometry confirmed pDCs as the cellular source of interferon-alpha production induced by activation of TLR7. Thus, upregulation of TLR7 in pDCs and a consequently increased activation of pDCs by TLR7 ligands represents a novel immunoregulatory mechanism of interferon-beta. We hypothesize that this mechanism could contribute to a reduction of virus-triggered relapses in patients with MS.	[Derkow, Katja; Bauer, Jakob M. J.; Deuschle, Katrin; Ruprecht, Klemens; Lehnardt, Seija] Charite, Dept Neurol, D-13353 Berlin, Germany; [Hecker, Michael; Paap, Brigitte K.; Thamilarasan, Madhan; Zettl, Uwe K.] Univ Rostock, Dept Neurol, D-18055 Rostock, Germany; [Hecker, Michael; Paap, Brigitte K.; Thamilarasan, Madhan; Koczan, Dirk] Univ Rostock, Inst Immunol, D-18055 Rostock, Germany; [Schott, Eckart] Charite, Dept Gastroenterol & Hepatol, D-13353 Berlin, Germany; [Deuschle, Katrin; Bellmann-Strobl, Judith; Paul, Friedemann; Ruprecht, Klemens] Charite, Clin & Expt Multiple Sclerosis Res Ctr, D-13353 Berlin, Germany; [Bellmann-Strobl, Judith; Paul, Friedemann; Lehnardt, Seija] Charite, Cluster Excellence NeuroCure, D-13353 Berlin, Germany; [Bellmann-Strobl, Judith] Charite, Expt & Clin Res Ctr, D-13353 Berlin, Germany; [Bellmann-Strobl, Judith] Max Delbruck Ctr Mol Med, Berlin, Germany; [Lehnardt, Seija] Charite, Ctr Anat, Inst Cell Biol & Neurobiol, D-13353 Berlin, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University of Rostock; University of Rostock; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Helmholtz Association; Max Delbruck Center for Molecular Medicine; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Ruprecht, K (corresponding author), Charite, Dept Neurol, D-13353 Berlin, Germany.	klemens.ruprecht@charite.de	Paul, Friedemann/ABF-9415-2020; Lehnardt, Seija/AAA-4113-2022	paul, friedemann/0000-0002-6378-0070; Hecker, Michael/0000-0001-7015-3094; Bellmann-Strobl, Judith/0000-0003-2615-1643	Deutsche Forschungsgemeinschaft [SFB-TRR43/A1]; NeuroCure [Exc 257]; NeuroCure FlexFunds; United Europeans for the development of PHArmacogenomics in Multiple Sclerosis consortium (UEPHA*MS); Bayer HealthCare	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); NeuroCure; NeuroCure FlexFunds; United Europeans for the development of PHArmacogenomics in Multiple Sclerosis consortium (UEPHA*MS); Bayer HealthCare(Bayer AGBayer Healthcare Pharmaceuticals)	This work was supported by Deutsche Forschungsgemeinschaft SFB-TRR43/A1 and NeuroCure Exc 257 (to SL and FP), NeuroCure FlexFunds (to SL and KR), and the United Europeans for the development of PHArmacogenomics in Multiple Sclerosis consortium (UEPHA*MS) (to UKZ). The Affymetrix microarray experiments were funded by Bayer HealthCare (to UKZ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balashov KE, 2010, ANN NEUROL, V68, P899, DOI 10.1002/ana.22136; Barchet W, 2005, SEMIN IMMUNOL, V17, P253, DOI 10.1016/j.smim.2005.05.008; Bekeredjian-Ding IB, 2005, J IMMUNOL, V174, P4043, DOI 10.4049/jimmunol.174.7.4043; Chin KC, 2001, P NATL ACAD SCI USA, V98, P15125, DOI 10.1073/pnas.011593298; DUQUETTE P, 1993, NEUROLOGY, V43, P655, DOI 10.1212/wnl.43.4.655; Ebers GC, 1998, LANCET, V352, P1498, DOI 10.1016/S0140-6736(98)03334-0; Ferrari F, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-446; Goertsches RH, 2010, PHARMACOGENOMICS, V11, P147, DOI [10.2217/pgs.09.152, 10.2217/PGS.09.152]; Haller O, 2002, TRAFFIC, V3, P710, DOI 10.1034/j.1600-0854.2002.31003.x; Haller O, 2006, VIROLOGY, V344, P119, DOI 10.1016/j.virol.2005.09.024; Hayashi T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045860; Hornung V, 2002, J IMMUNOL, V168, P4531, DOI 10.4049/jimmunol.168.9.4531; Hundeshagen A, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-140; ISAACS A, 1957, PROC R SOC SER B-BIO, V147, P258, DOI 10.1098/rspb.1957.0048; Itsui Y, 2009, HEPATOLOGY, V50, P1727, DOI 10.1002/hep.23195; Jacobs LD, 1996, ANN NEUROL, V39, P285, DOI 10.1002/ana.410390304; Jarrossay D, 2001, EUR J IMMUNOL, V31, P3388, DOI 10.1002/1521-4141(200111)31:11<3388::AID-IMMU3388>3.0.CO;2-Q; Jongbloed SL, 2010, J EXP MED, V207, P1247, DOI 10.1084/jem.20092140; Kawai T, 2010, NAT IMMUNOL, V11, P373, DOI 10.1038/ni.1863; Krug A, 2001, EUR J IMMUNOL, V31, P3026, DOI 10.1002/1521-4141(2001010)31:10<3026::AID-IMMU3026>3.0.CO;2-H; Lande R, 2008, J NEUROPATH EXP NEUR, V67, P388, DOI 10.1097/NEN.0b013e31816fc975; Lehmann SM, 2012, NAT NEUROSCI, V15, P827, DOI 10.1038/nn.3113; Liu YJ, 2005, ANNU REV IMMUNOL, V23, P275, DOI 10.1146/annurev.immunol.23.021704.115633; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Longhini ALF, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-2; Loo YM, 2011, IMMUNITY, V34, P680, DOI 10.1016/j.immuni.2011.05.003; Lund JM, 2004, P NATL ACAD SCI USA, V101, P5598, DOI 10.1073/pnas.0400937101; McDonald WI, 2001, ANN NEUROL, V50, P121, DOI 10.1002/ana.1032; Muzio M, 2000, J IMMUNOL, V164, P5998, DOI 10.4049/jimmunol.164.11.5998; O'Brien K, 2010, J NEUROIMMUNOL, V221, P107, DOI 10.1016/j.jneuroim.2010.01.006; Oikonen M, 2011, MULT SCLER J, V17, P672, DOI 10.1177/1352458510394397; Pichlmair A, 2011, NAT IMMUNOL, V12, P624, DOI 10.1038/ni.2048; Polman CH, 2005, ANN NEUROL, V58, P840, DOI 10.1002/ana.20703; Rudick RA, 2011, EXP CELL RES, V317, P1301, DOI 10.1016/j.yexcr.2011.03.002; Rutschmann OT, 2002, NEUROLOGY, V59, P1837, DOI 10.1212/WNL.59.12.1837; Sadler AJ, 2008, NAT REV IMMUNOL, V8, P559, DOI 10.1038/nri2314; Severa M, 2007, J IMMUNOL, V178, P6208, DOI 10.4049/jimmunol.178.10.6208; Sibley A, 1985, LANCET, V1, P1313; Takeuchi O, 2010, CELL, V140, P805, DOI 10.1016/j.cell.2010.01.022; Zarember KA, 2002, J IMMUNOL, V168, P554, DOI 10.4049/jimmunol.168.2.554; Zhang X, 2009, J IMMUNOL, V182, P3928, DOI 10.4049/jimmunol.0802226	41	35	35	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2013	8	8							e70626	10.1371/journal.pone.0070626	http://dx.doi.org/10.1371/journal.pone.0070626			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	200UV	23950974	gold, Green Submitted, Green Accepted, Green Published			2022-12-25	WOS:000323097300036
J	McClenahan, SD; Scherba, G; Borst, L; Fredrickson, RL; Krause, PR; Uhlenhaut, C				McClenahan, Shasta D.; Scherba, Gail; Borst, Luke; Fredrickson, Richard L.; Krause, Philip R.; Uhlenhaut, Christine			Discovery of a Bovine Enterovirus in Alpaca	PLOS ONE			English	Article							VIRAL-DIARRHEA-VIRUS; NEW-WORLD CAMELIDS; REVERSE TRANSCRIPTION-PCR; POLYMERASE-CHAIN-REACTION; MOUTH-DISEASE; UNITED-STATES; INFECTION; LIONS; CORONAVIRUS; SERENGETI	A cytopathic virus was isolated using Madin-Darby bovine kidney (MDBK) cells from lung tissue of alpaca that died of a severe respiratory infection. To identify the virus, the infected cell culture supernatant was enriched for virus particles and a generic, PCR-based method was used to amplify potential viral sequences. Genomic sequence data of the alpaca isolate was obtained and compared with sequences of known viruses. The new alpaca virus sequence was most similar to recently designated Enterovirus species F, previously bovine enterovirus (BEVs), viruses that are globally prevalent in cattle, although they appear not to cause significant disease. Because bovine enteroviruses have not been previously reported in U. S. alpaca, we suspect that this type of infection is fairly rare, and in this case appeared not to spread beyond the original outbreak. The capsid sequence of the detected virus had greatest homology to Enterovirus F type 1 (indicating that the virus should be considered a member of serotype 1), but the virus had greater homology in 2A protease sequence to type 3, suggesting that it may have been a recombinant. Identifying pathogens that infect a new host species for the first time can be challenging. As the disease in a new host species may be quite different from that in the original or natural host, the pathogen may not be suspected based on the clinical presentation, delaying diagnosis. Although this virus replicated in MDBK cells, existing standard culture and molecular methods could not identify it. In this case, a highly sensitive generic PCR-based pathogen-detection method was used to identify this pathogen.	[McClenahan, Shasta D.; Krause, Philip R.; Uhlenhaut, Christine] US FDA, Ctr Biol Evaluat & Res, Bethesda, MD USA; [Scherba, Gail] Univ Illinois, Dept Pathobiol, Urbana, IL 61801 USA; [Scherba, Gail; Borst, Luke; Fredrickson, Richard L.] Univ Illinois, Vet Diagnost Lab, Urbana, IL 61801 USA	US Food & Drug Administration (FDA); University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign	Uhlenhaut, C (corresponding author), Robert Koch Inst, Ctr Biol Threats & Special Pathogens, Berlin, Germany.	uhlenhautc@rki.de		Krause, Philip/0000-0002-1045-7536; Borst, Luke/0000-0002-2736-1960	NIAID; FDA	NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); FDA(United States Department of Health & Human Services)	This work was supported by NIAID and FDA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barnett J, 2008, VET REC, V162, P795, DOI 10.1136/vr.162.24.795-a; Barrington GM, 1997, J AM VET MED ASSOC, V211, P294; Beld M, 2004, J CLIN MICROBIOL, V42, P3059, DOI 10.1128/JCM.42.7.3059-3064.2004; Belknap EB, 2000, J VET DIAGN INVEST, V12, P568, DOI 10.1177/104063870001200614; Byers SR, 2009, J VET DIAGN INVEST, V21, P145, DOI 10.1177/104063870902100125; Felsenstein J, 1997, SYST BIOL, V46, P101, DOI 10.2307/2413638; Goens SD, 2004, J GEN VIROL, V85, P3195, DOI 10.1099/vir.0.80159-0; Goyal SM, 2002, J VET DIAGN INVEST, V14, P523, DOI 10.1177/104063870201400616; Guiserix M, 2007, J R SOC INTERFACE, V4, P1127, DOI 10.1098/rsif.2007.0235; Halpin K, 2000, J GEN VIROL, V81, P1927, DOI 10.1099/0022-1317-81-8-1927; HUCK RA, 1963, AM J VET RES, V24, P1207; Jimenez-Clavero MA, 2005, APPL ENVIRON MICROB, V71, P3536, DOI 10.1128/AEM.71.7.3536-3543.2005; Kameo Y, 2012, VET MICROBIOL, V154, P222, DOI 10.1016/j.vetmic.2011.07.006; Kapil S, 2009, VET CLIN N AM-FOOD A, V25, P323, DOI 10.1016/j.cvfa.2009.03.005; Kim SG, 2009, VET MICROBIOL, V136, P209, DOI 10.1016/j.vetmic.2008.10.029; Knowles NJ, 2013, PICORNAVIRUS; Knowles NJ, 2012, VIRUS TAXONOMY CLASS; Lednicky JA, 2004, VIROL J, V1, DOI 10.1186/1743-422X-1-2; MATTSON DE, 1994, VET CLIN N AM-FOOD A, V10, P345, DOI 10.1016/S0749-0720(15)30567-3; Mattson DE, 2006, JAVMA-J AM VET MED A, V228, P1762, DOI 10.2460/javma.228.11.1762; Middleton DJ, 2012, CURR TOP MICROBIOL, V359, P105, DOI 10.1007/82_2012_210; MOLL T, 1963, AM J VET RES, V24, P545; Moniwa M, 2007, J VET DIAGN INVEST, V19, P9, DOI 10.1177/104063870701900103; Munson L, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002545; Nanda S, 2008, J VIROL METHODS, V152, P18, DOI 10.1016/j.jviromet.2008.06.007; Oberste MS, 2013, J VIROL, V87, P558, DOI 10.1128/JVI.00837-12; Oberste MS, 2013, J VIROL, V87, P572, DOI 10.1128/JVI.00838-12; Page RDM, 1996, COMPUT APPL BIOSCI, V12, P357; Pallansch MA, 2007, FIELDS VIROLOGY, P723; Phillip J I, 1971, Adv Vet Sci Comp Med, V15, P159; RoelkeParker ME, 1996, NATURE, V379, P441, DOI 10.1038/379441a0; Shi ZL, 2008, VIRUS RES, V133, P74, DOI 10.1016/j.virusres.2007.03.012; Topliff CL, 2009, JAVMA-J AM VET MED A, V234, P519, DOI 10.2460/javma.234.4.519; Uhlenhaut C, 2012, TRANSPL INFECT DIS, V14, P79, DOI 10.1111/j.1399-3062.2011.00657.x; Uhlenhaut C, 2009, J CLIN VIROL, V44, P337, DOI 10.1016/j.jcv.2009.01.011; USDA, 2009, 2007 CENS AGR; Walker CG, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-100; Wentz PA, 2003, J AM VET MED ASSOC, V223, P223, DOI 10.2460/javma.2003.223.223; Wernery U, 2004, VET J, V168, P134, DOI 10.1016/j.tvjl.2003.10.005; Wernery U, 2001, J VET MED B, V48, P561, DOI 10.1046/j.1439-0450.2001.00478.x; WOOD SL, 1995, CAN VET J, V36, P34; Zell R, 2006, J GEN VIROL, V87, P375, DOI 10.1099/vir.0.81298-0; Zheng T, 2007, ARCH VIROL, V152, P191, DOI 10.1007/s00705-006-0838-4	43	17	23	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2013	8	8							e68777	10.1371/journal.pone.0068777	http://dx.doi.org/10.1371/journal.pone.0068777			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	200UV	23950875	Green Submitted, Green Published, gold			2022-12-25	WOS:000323097300006
J	Voon, DCC; Wang, HJ; Koo, JKW; Chai, JH; Hor, YT; Tan, TZ; Chu, YS; Mori, S; Ito, Y				Voon, Dominic Chih-Cheng; Wang, Huajing; Koo, Jason Kin Wai; Chai, Juin Hsien; Hor, Yit Teng; Tan, Tuan Zea; Chu, Yeh-Shiu; Mori, Seiichi; Ito, Yoshiaki			EMT-Induced Stemness and Tumorigenicity Are Fueled by the EGFR/Ras Pathway	PLOS ONE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; TRANSFORMING GROWTH-FACTORS; WIDE EXPRESSION PROFILES; CELL SELF-RENEWAL; CANCER-CELLS; TGF-BETA; DIFFERENTIATION; BREAST; ENRICHMENT; PLASTICITY	Recent studies have revealed that differentiated epithelial cells would acquire stem cell-like and tumorigenic properties following an Epithelial-Mesenchymal Transition (EMT). However, the signaling pathways that participate in this novel mechanism of tumorigenesis have not been fully characterized. In Runx3(-/-) p53(-/-) murine gastric epithelial (GIF-14) cells, EMT-induced plasticity is reflected in the expression of the embryonal proto-oncogene Hmga2 and Lgr5, an exclusive gastrointestinal stem cell marker. Here, we report the concurrent activation of an EGFR/Ras gene expression signature during TGF-beta 1-induced EMT in GIF-14 cells. Amongst the altered genes was the induction of Egfr, which corresponded with a delayed sensitization to EGF treatment in GIF-14. Co-treatment with TGF-beta 1 and EGF or the expression of exogenous KRas led to increased Hmga2 or Lgr5 expression, sphere initiation and colony formation in soft agar assay. Interestingly, the gain in cellular plasticity/tumorigenicity was not accompanied by increased EMT. This uncoupling of EMT and the induction of plasticity reveals an involvement of distinct signaling cues, whereby the EGFR/Ras pathway specifically promotes stemness and tumorigenicity in EMT-altered GIF-14 cells. These data show that the EGFR/Ras pathway requisite for the sustenance of gastric stem cells in vivo and in vitro is involved in the genesis and promotion of EMT-induced tumor-initiating cells.	[Voon, Dominic Chih-Cheng; Wang, Huajing; Koo, Jason Kin Wai; Chai, Juin Hsien; Hor, Yit Teng; Tan, Tuan Zea; Ito, Yoshiaki] Natl Univ Singapore, Canc Sci Inst Singapore, Singapore 117548, Singapore; [Chu, Yeh-Shiu] Natl Yang Ming Univ, Brain Res Ctr, Taipei 112, Taiwan; [Mori, Seiichi] Japanese Fdn Canc Res, Inst Canc, Div Canc Genom, Tokyo 170, Japan; [Ito, Yoshiaki] Agcy Sci Technol & Res, Inst Mol & Cell Biol, Singapore, Singapore	National University of Singapore; National Yang Ming Chiao Tung University; Japanese Foundation for Cancer Research; Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Molecular & Cell Biology (IMCB)	Ito, Y (corresponding author), Natl Univ Singapore, Canc Sci Inst Singapore, Singapore 117548, Singapore.	csiitoy@nus.edu.sg	Tan, Tuan Zea/I-9227-2019	Tan, Tuan Zea/0000-0001-6624-1593; Voon, Dominic Chih-Cheng/0000-0002-2963-9305	National Research Foundation (NRF); Translational and Clinical Research (TCR) Flagship Programme; Singapore Stem Cell Consortium (SSCC) [SSCC/10/023]	National Research Foundation (NRF); Translational and Clinical Research (TCR) Flagship Programme; Singapore Stem Cell Consortium (SSCC)	This work is supported in part by the National Research Foundation (NRF, http://www.nrf.gov.sg), Translational and Clinical Research (TCR) Flagship Programme (http://www.nmrc.gov.sg), and the Singapore Stem Cell Consortium (SSCC, http://www.sscc.a-star.edu.sg) grant number SSCC/10/023. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANZANO MA, 1982, CANCER RES, V42, P4776; ASSOIAN RK, 1984, CELL, V36, P35, DOI 10.1016/0092-8674(84)90071-0; Barker N, 2010, GASTROENTEROLOGY, V138, P1681, DOI 10.1053/j.gastro.2010.03.002; Barker N, 2010, CELL STEM CELL, V6, P25, DOI 10.1016/j.stem.2009.11.013; Barker N, 2009, NATURE, V457, P608, DOI 10.1038/nature07602; Bernhardt M, 2012, BIOTECHNOL J, V7, P810, DOI 10.1002/biot.201100347; Brabletz S, 2009, J PATHOL, V217, P307, DOI 10.1002/path.2475; Caja L, 2007, CELL SIGNAL, V19, P683, DOI 10.1016/j.cellsig.2006.09.002; Cerrito MG, 2004, J CELL PHYSIOL, V201, P244, DOI 10.1002/jcp.20077; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; Cleynen I, 2008, INT J ONCOL, V32, P289; de Lau W, 2011, NATURE, V476, P293, DOI 10.1038/nature10337; Edelman E, 2006, BIOINFORMATICS, V22, pE108, DOI 10.1093/bioinformatics/btl231; Fukamachi H, 2004, BIOCHEM BIOPH RES CO, V321, P58, DOI 10.1016/j.bbrc.2004.06.099; Geback T, 2009, BIOTECHNIQUES, V46, P265, DOI 10.2144/000113083; Gibbons DL, 2009, GENE DEV, V23, P2140, DOI 10.1101/gad.1820209; Gupta PB, 2009, NAT MED, V15, P1010, DOI 10.1038/nm0909-1010; Gur G, 2004, EMBO J, V23, P3270, DOI 10.1038/sj.emboj.7600342; Hammond SM, 2008, CELL, V135, P1013, DOI 10.1016/j.cell.2008.11.026; He XC, 2004, NAT GENET, V36, P1117, DOI 10.1038/ng1430; Ikushima H, 2010, NAT REV CANCER, V10, P415, DOI 10.1038/nrc2853; Ito K, 2011, GASTROENTEROLOGY, V140, P1536, DOI 10.1053/j.gastro.2011.01.043; Jiang HQ, 2011, CELL STEM CELL, V8, P84, DOI 10.1016/j.stem.2010.11.026; Kang M, 2012, BIOCHEM J, V443, P691, DOI 10.1042/BJ20111584; Kemper K, 2012, STEM CELLS, V30, P2378, DOI 10.1002/stem.1233; Knoepfler PS, 2009, STEM CELLS, V27, P1050, DOI 10.1002/stem.37; Lee E, 2010, CANCER LETT, V290, P43, DOI 10.1016/j.canlet.2009.08.022; Li QL, 2002, CELL, V109, P113, DOI 10.1016/S0092-8674(02)00690-6; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; Morel AP, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002888; Nishino J, 2008, CELL, V135, P227, DOI 10.1016/j.cell.2008.09.017; Oft M, 1996, GENE DEV, V10, P2462, DOI 10.1101/gad.10.19.2462; Powell AE, 2012, CELL, V149, P146, DOI 10.1016/j.cell.2012.02.042; Rhim AD, 2012, CELL, V148, P349, DOI 10.1016/j.cell.2011.11.025; ROBERTS AB, 1980, P NATL ACAD SCI-BIOL, V77, P3494, DOI 10.1073/pnas.77.6.3494; Scheel C, 2011, CELL, V145, P926, DOI 10.1016/j.cell.2011.04.029; Schepers AG, 2012, SCIENCE, V337, P730, DOI 10.1126/science.1224676; Snyder EL, 2013, MOL CELL, V50, P185, DOI 10.1016/j.molcel.2013.02.018; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; van Es JH, 2012, NAT CELL BIOL, V14, P1099, DOI 10.1038/ncb2581; VanDussen KL, 2012, DEVELOPMENT, V139, P488, DOI 10.1242/dev.070763; Voon DCC, 2012, STEM CELLS, V30, P2088, DOI 10.1002/stem.1183; Yu F, 2007, CELL, V131, P1109, DOI 10.1016/j.cell.2007.10.054	45	51	53	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2013	8	8							e70427	10.1371/journal.pone.0070427	http://dx.doi.org/10.1371/journal.pone.0070427			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	200UV	23950932	Green Published, Green Submitted, gold			2022-12-25	WOS:000323097300017
J	Wang, Q; Li, T; Wu, ZG; Wu, Q; Ke, X; Luo, DL; Wang, H				Wang, Qin; Li, Tao; Wu, Zhigang; Wu, Quan; Ke, Xiao; Luo, Delun; Wang, Hui			Novel VEGF Decoy Receptor Fusion Protein Conbercept Targeting Multiple VEGF Isoforms Provide Remarkable Anti-Angiogenesis Effect In Vivo	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; MONOCLONAL-ANTIBODY; BEVACIZUMAB; NEUTRALIZATION; PEGAPTANIB; THERAPY; CANCER; FAB	VEGF family factors are known to be the principal stimulators of abnormal angiogenesis, which play a fundamental role in tumor and various ocular diseases. Inhibition of VEGF is widely applied in antiangiogenic therapy. Conbercept is a novel decoy receptor protein constructed by fusing VEGF receptor 1 and VEGF receptor 2 extracellular domains with the Fc region of human immunoglobulin. In this study, we systematically evaluated the binding affinity of conbercept with VEGF isoforms and PlGF by using anti-VEGF antibody (Avastin) as reference. BIACORE and ELISA assay results indicated that conbercept could bind different VEGF-A isoforms with higher affinity than reference. Furthermore, conbercept could also bind VEGF-B and PlGF, whereas Avastin showed no binding. Oxygen-induced retinopathy model showed that conbercept could inhibit the formation of neovasularizations. In tumor-bearing nude mice, conbercept could also suppress tumor growth very effectively in vivo. Overall, our study have demonstrated that conbercept could bind with high affinity to multiple VEGF isoforms and consequently provide remarkable anti-angiogenic effect, suggesting the possibility to treat angiogenesis-related diseases such as cancer and wet AMD etc.	[Wang, Qin; Li, Tao; Wang, Hui] Beijing Inst Microbiol & Epidemiol, State Key Lab Pathogens & Biosecur, Beijing, Peoples R China; [Wu, Zhigang; Wu, Quan; Ke, Xiao; Luo, Delun] Chengdu Kanghong Biotechnol Co Ltd, Chengdu, Peoples R China	Beijing Institute of Microbiology & Epidemiology	Luo, DL (corresponding author), Chengdu Kanghong Biotechnol Co Ltd, Chengdu, Peoples R China.	geno0109@vip.sina.com; luodelun@cnkh.com	wu, zhi/GXH-3041-2022	, Qin/0000-0002-5891-9621	National Natural Science Foundation of China [81072677, 31201352]; National Basic Research Program of China (973 Program) [2011CB510200]; National Grand Program of China [2008 ZX10004-015]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China (973 Program)(National Basic Research Program of China); National Grand Program of China	The authors are thankful for support from the National Natural Science Foundation of China (grant Nos. 81072677 and 31201352), the National Basic Research Program of China (973 Program No. 2011CB510200), and the National Grand Program of China (2008 ZX10004-015). The funders had no role in the design of experiments, data collection and analysis, decision to publish, or preparation of the paper.	Augustin HG, 2009, NAT REV MOL CELL BIO, V10, P165, DOI 10.1038/nrm2639; Avery RL, 2006, OPHTHALMOLOGY, V113, P363, DOI 10.1016/j.ophtha.2005.11.019; Baluk P, 2005, CURR OPIN GENET DEV, V15, P102, DOI 10.1016/j.gde.2004.12.005; Braghiroli MI, 2012, EXPERT REV ANTICANC, V12, P567, DOI [10.1586/ERA.12.13, 10.1586/era.12.13]; Bressler SB, 2009, OPHTHALMOLOGY, V116, pS1, DOI 10.1016/j.ophtha.2009.06.045; Campochiaro PA, 2007, DRUG TODAY, V43, P529, DOI 10.1358/dot.2007.43.8.1120868; Carmeliet P, 2000, NATURE, V407, P249, DOI 10.1038/35025220; Chen Y, 1999, J MOL BIOL, V293, P865, DOI 10.1006/jmbi.1999.3192; Economides AN, 2003, NAT MED, V9, P47, DOI 10.1038/nm811; Ferrara N, 2004, NAT REV DRUG DISCOV, V3, P391, DOI 10.1038/nrd1381; Ferrara N, 2004, ENDOCR REV, V25, P581, DOI 10.1210/er.2003-0027; Ferrara N, 2003, NAT MED, V9, P669, DOI 10.1038/nm0603-669; Folkman J, 2007, NAT REV DRUG DISCOV, V6, P273, DOI 10.1038/nrd2115; Gragoudas ES, 2004, NEW ENGL J MED, V351, P2805, DOI 10.1056/NEJMoa042760; Grothey A, 2009, NAT REV CLIN ONCOL, V6, P507, DOI 10.1038/nrclinonc.2009.110; Jin KT, 2011, CLIN TRANSL ONCOL, V13, P878, DOI 10.1007/s12094-011-0749-z; Liang XL, 2012, INT J OPHTHALMOL-CHI, V5, P1, DOI 10.3980/j.issn.2222-3959.2012.01.01; Loges S, 2009, CLIN CANCER RES, V15, P3648, DOI 10.1158/1078-0432.CCR-08-2276; Ma J, 2008, MOL CANCER THER, V7, P3670, DOI 10.1158/1535-7163.MCT-08-0715; Miao HQ, 2006, BIOCHEM BIOPH RES CO, V345, P438, DOI 10.1016/j.bbrc.2006.04.119; Mordenti J, 1999, TOXICOL PATHOL, V27, P14, DOI 10.1177/019262339902700104; Ng EWM, 2006, NAT REV DRUG DISCOV, V5, P123, DOI 10.1038/nrd1955; Papadopoulos N, 2012, ANGIOGENESIS, V15, P171, DOI 10.1007/s10456-011-9249-6; Presta LG, 1997, CANCER RES, V57, P4593; Shibuya M, 2006, EXP CELL RES, V312, P549, DOI 10.1016/j.yexcr.2005.11.012; Takahashi H, 2005, CLIN SCI, V109, P227, DOI 10.1042/CS20040370; Wang H, 2008, CANC IMMUNO IMMUNOTH, V57, P2031; Wang H, 2010, CANCER IMMUNOL IMMUN, V59, P239, DOI 10.1007/s00262-009-0744-1; Wu ZG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057642; Zhang M, 2008, MOL VIS, V14, P37	30	68	88	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2013	8	8							e70544	10.1371/journal.pone.0070544	http://dx.doi.org/10.1371/journal.pone.0070544			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	200UV	23950958	Green Published, Green Submitted, gold			2022-12-25	WOS:000323097300026
J	Wescott, DG; Mildenberg, Z; Bellaiche, M; McGowan, SL; Grierson, SS; Choudhury, B; Steinbach, F				Wescott, David G.; Mildenberg, Zvia; Bellaiche, Michel; McGowan, Sarah L.; Grierson, Sylvia S.; Choudhury, Bhudipa; Steinbach, Falko			Evidence for the Circulation of Equine Encephalosis Virus in Israel since 2001	PLOS ONE			English	Article								Equine encephalosis virus (EEV) distribution was thought to be limited to southern Africa until 2008 when we reported EEV in Israel. It was then assumed that the clinical presentation resembled the initial incursion in Israel. To investigate further we conducted a retrospective analysis of equine sera, which had been collected for diagnosis of other suspected diseases, via serum neutralisation test. The data demonstrated that EEV was circulating as early as 2001 with incidence ranging from 20-100% for time period 2001-2008. As the symptoms of EEV can be similar to other equine notifiable diseases this is a significant finding which highlights the need for vigilance and education to accurately diagnose new and emerging diseases.	[Wescott, David G.; McGowan, Sarah L.; Grierson, Sylvia S.; Choudhury, Bhudipa; Steinbach, Falko] Anim Hlth & Vet Labs Agcy, Dept Virol, Weybridge, Surrey, England; [Mildenberg, Zvia; Bellaiche, Michel] Kimron Vet Inst, IL-50250 Bet Dagan, Israel	Veterinary Laboratories Agency; Kimron Veterinary Institute	Choudhury, B (corresponding author), Anim Hlth & Vet Labs Agcy, Dept Virol, Weybridge, Surrey, England.	bhudipa.choudhury@ahvla.gsi.gov.uk	Steinbach, Falko/V-1682-2019; McGowan, Sarah/J-5410-2014; Grierson, S/D-9587-2011; Choudhury, Bhudipa/D-3863-2011	Steinbach, Falko/0000-0003-1236-2837; Choudhury, Bhudipa/0000-0002-1392-6414	Department for Environment, Food and Rural Affairs	Department for Environment, Food and Rural Affairs(Department for Environment, Food & Rural Affairs (DEFRA))	Financial support was provided by Department for Environment, Food and Rural Affairs. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.		0	10	10	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2013	8	8							e70532					3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	200UV	23950952	Green Published, Green Submitted, gold			2022-12-25	WOS:000323097300212
J	Gorokhova, E; Lehtiniemi, M; Motwani, NH				Gorokhova, Elena; Lehtiniemi, Maiju; Motwani, Nisha H.			Trade-Offs between Predation Risk and Growth Benefits in the Copepod Eurytemora affinis with Contrasting Pigmentation	PLOS ONE			English	Article							ULTRAVIOLET-RADIATION; ADAPTIVE SIGNIFICANCE; CUTICULAR PIGMENTATION; INVERTEBRATE PREDATOR; OXIDATIVE STRESS; ARCTIC DAPHNIA; ZOOPLANKTON; TEMPERATURE; LIGHT; THREATS	Intraspecific variation in body pigmentation is an ecologically and evolutionary important trait; however, the pigmentation related trade-offs in marine zooplankton are poorly understood. We tested the effects of intrapopulation phenotypic variation in the pigmentation of the copepod Eurytemora affinis on predation risk, foraging, growth, metabolic activity and antioxidant capacity. Using pigmented and unpigmented specimens, we compared (1) predation and selectivity by the invertebrate predator Cercopagis pengoi, (2) feeding activity of the copepods measured as grazing rate in experiments and gut fluorescence in situ, (3) metabolic activity assayed as RNA: DNA ratio in both experimental and field-collected copepods, (4) reproductive output estimated as egg ratio in the population, and (5) total antioxidant capacity. Moreover, mitochondrial DNA (mtDNA) COI gene variation was analysed. The pigmented individuals were at higher predation risk as evidenced by significantly higher predation rate by C. pengoi on pigmented individuals and positive selection by the predator fed pigmented and unpigmented copepods in a mixture. However, the antioxidant capacity, RNA: DNA and egg ratio values were significantly higher in the pigmented copepods, whereas neither feeding rate nor gut fluorescence differed between the pigmented and unpigmented copepods. The phenotypic variation in pigmentation was not associated with any specific mtDNA genotype. Together, these results support the metabolic stimulation hypothesis to explain variation in E. affinis pigmentation, which translates into beneficial increase in growth via enhanced metabolism and antioxidant protective capacity, together with disadvantageous increase in predation risk. We also suggest an alternative mechanism for the metabolic stimulation via elevated antioxidant levels as a primary means of increasing metabolism without the increase in heat absorbance. The observed trade-offs are relevant to evolutionary mechanisms underlying plasticity and adaptation and have the capacity to modify strength of complex trophic interactions.	[Gorokhova, Elena] Stockholm Univ, Dept Appl Environm Sci, S-10691 Stockholm, Sweden; [Lehtiniemi, Maiju] Ctr Marine Res, Finnish Environm Inst, Helsinki, Finland; [Gorokhova, Elena; Motwani, Nisha H.] Stockholm Univ, Dept Ecol Environm & Plant Sci, S-10691 Stockholm, Sweden	Stockholm University; Finnish Environment Institute; Stockholm University	Gorokhova, E (corresponding author), Stockholm Univ, Dept Appl Environm Sci, S-10691 Stockholm, Sweden.	elena.gorokhova@itm.su.se	Gorokhova, Elena/E-7105-2018; Lehtiniemi, Maiju/AAN-6012-2020	Gorokhova, Elena/0000-0002-4192-6956; 	Swedish Research Council for Environment, Agricultural Sciences and Spatial Planning (FORMAS); Walter and Andree de Nottbeck Foundation; Stockholm University	Swedish Research Council for Environment, Agricultural Sciences and Spatial Planning (FORMAS)(Swedish Research Council Formas); Walter and Andree de Nottbeck Foundation; Stockholm University	The financial support was provided by The Swedish Research Council for Environment, Agricultural Sciences and Spatial Planning (FORMAS), Walter and Andree de Nottbeck Foundation, and Stockholm University's strategic marine environmental research program "Baltic Ecosystem Adaptive Management''. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript,	Alekseev V R, 2009, Dokl Biol Sci, V429, P544; Alekseev VR, 2011, ZOOTAXA, P41; Bamstedt U., 2000, P297; BAN SH, 1994, J PLANKTON RES, V16, P721, DOI 10.1093/plankt/16.6.721; Biard C, 2005, OECOLOGIA, V144, P32, DOI 10.1007/s00442-005-0048-x; Bize P, 2008, ECOLOGY, V89, P2584, DOI 10.1890/07-1135.1; Brisson JA, 2005, EVOLUTION, V59, P1046; Browman HI, 2000, MAR ECOL PROG SER, V199, P293, DOI 10.3354/meps199293; BYRON ER, 1982, ECOLOGY, V63, P1871, DOI 10.2307/1940127; BYRON ER, 1981, P NATL ACAD SCI-BIOL, V78, P1765, DOI 10.1073/pnas.78.3.1765; Creel S, 2008, TRENDS ECOL EVOL, V23, P194, DOI 10.1016/j.tree.2007.12.004; DEMEESTER L, 1993, LIMNOL OCEANOGR, V38, P1193; Garcia PE, 2008, J PLANKTON RES, V30, P817, DOI 10.1093/plankt/fbn041; Gerrish GA, 2003, FRESHWATER BIOL, V48, P1971, DOI 10.1046/j.1365-2427.2003.01136.x; Gorokhova E, 2005, LIMNOL OCEANOGR-METH, V3, P143, DOI 10.4319/lom.2005.3.143; Gorokhova E, 2002, J PLANKTON RES, V24, P511, DOI 10.1093/plankt/24.5.511; Gorokhova E, 2012, J MICROBIOL METH, V89, P216, DOI 10.1016/j.mimet.2012.03.005; HAIRSTON NG, 1979, LIMNOL OCEANOGR, V24, P15, DOI 10.4319/lo.1979.24.1.0015; HAIRSTON NG, 1979, COMP BIOCHEM PHYS A, V62, P445, DOI 10.1016/0300-9629(79)90083-5; HAIRSTON NG, 1981, HYDROBIOLOGIA, V81-2, P151, DOI 10.1007/BF00048712; Hall T, 1999, NUCL ACIDS S SER, V41, P95, DOI DOI 10.1021/BK-1999-0734.CH008; Hansson LA, 2000, P ROY SOC B-BIOL SCI, V267, P2327, DOI 10.1098/rspb.2000.1287; Hansson LA, 2004, ECOLOGY, V85, P1005, DOI 10.1890/02-0525; Hansson LA, 2007, ECOLOGY, V88, P1932, DOI 10.1890/06-2038.1; HEBERT PDN, 1990, FUNCT ECOL, V4, P703; HEBERT PDN, 1983, AM NAT, V122, P286, DOI 10.1086/284134; Hessen DO, 1996, POLAR BIOL, V16, P573; Hook TO, 2008, ESTUAR COAST SHELF S, V76, P29, DOI 10.1016/j.ecss.2007.06.012; Holmborn T, 2009, LIMNOL OCEANOGR-METH, V7, P785, DOI 10.4319/lom.2009.7.785; Hubbard JK, 2010, TRENDS GENET, V26, P231, DOI 10.1016/j.tig.2010.02.002; Hylander S, 2009, LIMNOL OCEANOGR, V54, P1883, DOI 10.4319/lo.2009.54.6.1883; Lee CE, 2002, HYDROBIOLOGIA, V480, P111, DOI 10.1023/A:1021293203512; Lehtiniemi M, 2008, MAR ECOL PROG SER, V362, P193, DOI 10.3354/meps07441; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; MANLY BFJ, 1974, BIOMETRICS, V30, P281, DOI 10.2307/2529649; Martin I, 2006, MECH AGEING DEV, V127, P411, DOI 10.1016/j.mad.2006.01.008; McGraw KJ, 2005, ANIM BEHAV, V69, P757, DOI 10.1016/j.anbehav.2004.06.022; Monaghan P, 2009, ECOL LETT, V12, P75, DOI 10.1111/j.1461-0248.2008.01258.x; Morgan SG, 1996, LIMNOL OCEANOGR, V41, P498, DOI 10.4319/lo.1996.41.3.0498; Pangle KL, 2007, ECOLOGY, V88, P402, DOI 10.1890/06-0768; Prior RL, 2003, J AGR FOOD CHEM, V51, P3273, DOI 10.1021/jf0262256; Protas ME, 2011, P NATL ACAD SCI USA, V108, P5702, DOI 10.1073/pnas.1013850108; RAMCHARAN CW, 1986, LIMNOL OCEANOGR, V31, P414, DOI 10.4319/lo.1986.31.2.0414; Rao K R, 1988, Peptides, V9 Suppl 1, P153, DOI 10.1016/0196-9781(88)90239-2; Rivier IK., 1998, GUIDES IDENTIFICATIO, P166; Rodriguez-Grana L, 2004, J FISH BIOL, V64, P1455, DOI 10.1111/j.0022-1112.2004.00413.x; Safran RJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009420; Schneider T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043063; Schubert H, 2001, HELGOLAND MAR RES, V55, P12, DOI 10.1007/s101520000064; Sies H., 2005, CAROTENOIDS RETINOID, P315; Slos S, 2008, FUNCT ECOL, V22, P637, DOI 10.1111/j.1365-2435.2008.01424.x; Speekmann CL, 2000, J PLANKTON RES, V22, P2325, DOI 10.1093/plankt/22.12.2325; STEVENSON J R, 1985, P1; Tarjuelo I, 2004, MOL ECOL, V13, P3125, DOI 10.1111/j.1365-294X.2004.02306.x; Teacher AGF, 2011, MOL ECOL RESOUR, V11, P151, DOI 10.1111/j.1755-0998.2010.02890.x; Tsoi KH, 2005, MAR BIOL, V147, P367, DOI 10.1007/s00227-005-1585-x; Van der Veen IT, 2005, J EVOLUTION BIOL, V18, P992, DOI 10.1111/j.1420-9101.2005.00903.x; VANRAAY TJ, 1995, MOL ECOL, V4, P149; Viherluoto M, 2001, J EXP MAR BIOL ECOL, V261, P237, DOI 10.1016/S0022-0981(01)00277-5; VUORINEN I, 1982, ANN ZOOL FENN, V19, P129; Westphal MF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024199; Williamson CE, 2011, LIMNOL OCEANOGR, V56, P1603, DOI 10.4319/lo.2011.56.5.1603; Winkler G, 2008, MOL ECOL, V17, P415, DOI 10.1111/j.1365-294X.2007.03480.x; Winkler G, 2011, MAR BIOL, V158, P1841, DOI 10.1007/s00227-011-1696-5; Yan ND, 2002, ECOL LETT, V5, P481, DOI 10.1046/j.1461-0248.2002.00348.x	65	19	20	0	66	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2013	8	8							e71385	10.1371/journal.pone.0071385	http://dx.doi.org/10.1371/journal.pone.0071385			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	200ZE	23940745	Green Submitted, Green Published, gold			2022-12-25	WOS:000323109700098
J	Hagen, F; Ceresini, PC; Polacheck, I; Ma, HS; van Nieuwerburgh, F; Gabaldon, T; Kagan, S; Pursall, ER; Hoogveld, HL; van Iersel, LJJ; Klau, GW; Kelk, SM; Stougie, L; Bartlett, KH; Voelz, K; Pryszcz, LP; Castaneda, E; Lazera, M; Meyer, W; Deforce, D; Meis, JF; May, RC; Klaassen, CHW; Boekhout, T				Hagen, Ferry; Ceresini, Paulo C.; Polacheck, Itzhack; Ma, Hansong; van Nieuwerburgh, Filip; Gabaldon, Toni; Kagan, Sarah; Pursall, E. Rhiannon; Hoogveld, Hans L.; van Iersel, Leo J. J.; Klau, Gunnar W.; Kelk, Steven M.; Stougie, Leen; Bartlett, Karen H.; Voelz, Kerstin; Pryszcz, Leszek P.; Castaneda, Elizabeth; Lazera, Marcia; Meyer, Wieland; Deforce, Dieter; Meis, Jacques F.; May, Robin C.; Klaassen, Corne H. W.; Boekhout, Teun			Ancient Dispersal of the Human Fungal Pathogen Cryptococcus gattii from the Amazon Rainforest	PLOS ONE			English	Article							NEOFORMANS VAR. GATTII; BRITISH-COLUMBIA; VANCOUVER-ISLAND; ENVIRONMENTAL SOURCES; PACIFIC-NORTHWEST; SPECIES COMPLEX; NATURAL HABITAT; UNITED-STATES; OUTBREAK; CANADA	Over the past two decades, several fungal outbreaks have occurred, including the high-profile 'Vancouver Island' and 'Pacific Northwest' outbreaks, caused by Cryptococcus gattii, which has affected hundreds of otherwise healthy humans and animals. Over the same time period, C. gattii was the cause of several additional case clusters at localities outside of the tropical and subtropical climate zones where the species normally occurs. In every case, the causative agent belongs to a previously rare genotype of C. gattii called AFLP6/VGII, but the origin of the outbreak clades remains enigmatic. Here we used phylogenetic and recombination analyses, based on AFLP and multiple MLST datasets, and coalescence gene genealogy to demonstrate that these outbreaks have arisen from a highly-recombining C. gattii population in the native rainforest of Northern Brazil. Thus the modern virulent C. gattii AFLP6/VGII outbreak lineages derived from mating events in South America and then dispersed to temperate regions where they cause serious infections in humans and animals.	[Hagen, Ferry; Boekhout, Teun] CBS KNAW Fungal Biodivers Ctr, Dept Yeast & Basidiomycete Res, Utrecht, Netherlands; [Hagen, Ferry; Meis, Jacques F.; Klaassen, Corne H. W.] Canisius Wilhelmina Hosp, Dept Med Microbiol & Infect Dis, Nijmegen, Netherlands; [Ceresini, Paulo C.] Univ Sao Paulo State, Dept Phytopathol, UNESP, Ilha Solteira, Brazil; [Polacheck, Itzhack; Kagan, Sarah] Hadassah Hebrew Univ Med Ctr, Dept Clin Microbiol & Infect Dis, Jerusalem, Israel; [Ma, Hansong; Pursall, E. Rhiannon; Voelz, Kerstin; May, Robin C.] Univ Birmingham, Sch Biosci, Birmingham, W Midlands, England; [van Nieuwerburgh, Filip; Deforce, Dieter] Univ Ghent, Fac Pharmaceut Sci, Lab Pharmaceut Biotechnol, B-9000 Ghent, Belgium; [Gabaldon, Toni; Pryszcz, Leszek P.] Ctr Genom Regulat, Barcelona, Spain; [Gabaldon, Toni; Pryszcz, Leszek P.] UPF Doctor Aiguader, Barcelona, Spain; [Hoogveld, Hans L.] Netherlands Inst Ecol NIOO KNAW, Ctr Limnol, Wageningen, Netherlands; [van Iersel, Leo J. J.; Klau, Gunnar W.; Kelk, Steven M.; Stougie, Leen] Ctr Wiskunde & Informat, Amsterdam, Netherlands; [Stougie, Leen] Vrije Univ Amsterdam, Dept Operat Res, Amsterdam, Netherlands; [Bartlett, Karen H.] Univ British Columbia, Sch Environm Hlth, Vancouver, BC V5Z 1M9, Canada; [Castaneda, Elizabeth] Inst Nacl Salud, Microbiol Grp, Bogota, Colombia; [Lazera, Marcia] Fiocruz MS, Fundacao Oswaldo Cruz, Lab Micol, Inst Pesquisa Clin Evandro Chagas, BR-21045900 Rio De Janeiro, Brazil; [Meyer, Wieland] Univ Sydney, Westmead Hosp, Ctr Infect Dis & Microbiol,Sydney Emerging Dis &, Mol Mycol Res Lab,Westmead Millennium Inst,Sydney, Westmead, NSW 2145, Australia; [Meis, Jacques F.] Radboud Univ Nijmegen, Med Ctr, Dept Med Microbiol, NL-6525 ED Nijmegen, Netherlands; [Boekhout, Teun] Second Mil Med Univ, Changzheng Hosp, Shanghai Key Lab Mol Med Mycol, Shanghai, Peoples R China; [Boekhout, Teun] Univ Med Ctr, Dept Internal Med & Infect Dis, Utrecht, Netherlands	Royal Netherlands Academy of Arts & Sciences; Westerdijk Fungal Biodiversity Institute (KNAW); Canisius-Wilhelmina Hospital; Hebrew University of Jerusalem; University of Birmingham; Ghent University; Barcelona Institute of Science & Technology; Pompeu Fabra University; Centre de Regulacio Genomica (CRG); Royal Netherlands Academy of Arts & Sciences; Netherlands Institute of Ecology (NIOO-KNAW); Vrije Universiteit Amsterdam; University of British Columbia; Instituto Nacional de Salud (Colombia); Fundacao Oswaldo Cruz; University of Sydney; Westmead Institute for Medical Research; Radboud University Nijmegen; Naval Medical University; Utrecht University; Utrecht University Medical Center	Boekhout, T (corresponding author), CBS KNAW Fungal Biodivers Ctr, Dept Yeast & Basidiomycete Res, Utrecht, Netherlands.	t.boekhout@cbs.knaw.nl	Meis, Jacques F/A-9241-2010; Klau, Gunnar W./A-6934-2011; Ma, Hansong/A-7794-2012; Deforce, Dieter LD/J-4725-2013; Ma, Hansong/O-7736-2019; Meyer, Wieland/G-1204-2015; Ceresini, Paulo Cezar/B-8476-2008; May, Robin Charles/ABA-9266-2021; Boekhout, Teunis/ABF-2538-2020; Pryszcz, Leszek/H-4764-2014; Gabaldón, Toni/A-7336-2008; Van Nieuwerburgh, Filip/H-9697-2015; Hagen, Ferry/B-9044-2009; Voelz, Kerstin/A-8888-2011; KNAW, NIOO-KNAW/A-4320-2012	Meis, Jacques F/0000-0003-3253-6080; Klau, Gunnar W./0000-0002-6340-0090; Ma, Hansong/0000-0002-2705-1970; Deforce, Dieter LD/0000-0002-0635-661X; Ma, Hansong/0000-0002-2705-1970; Meyer, Wieland/0000-0001-9933-8340; Ceresini, Paulo Cezar/0000-0003-2381-2792; May, Robin Charles/0000-0001-5364-1838; Boekhout, Teunis/0000-0002-0476-3609; Pryszcz, Leszek/0000-0003-0790-067X; Gabaldón, Toni/0000-0003-0019-1735; Van Nieuwerburgh, Filip/0000-0001-8815-5485; Hagen, Ferry/0000-0002-5622-1916; Voelz, Kerstin/0000-0003-0973-4353; KNAW, NIOO-KNAW/0000-0002-3835-159X; Castaneda, Elizabeth/0000-0001-5970-1598	NPRP grant from the Qatar National Research Fund (a member of Qatar foundation) [5-298-3-06]; NCF (Netherlands Computer Facility Foundation); NWO (Nederlandse Organisatie voor Wetenschappelijk Onderzoek); Odo van Vloten Foundation	NPRP grant from the Qatar National Research Fund (a member of Qatar foundation); NCF (Netherlands Computer Facility Foundation); NWO (Nederlandse Organisatie voor Wetenschappelijk Onderzoek)(Netherlands Organization for Scientific Research (NWO)); Odo van Vloten Foundation	This publication was made possible by NPRP grant 5-298-3-06 from the Qatar National Research Fund (a member of Qatar foundation) to TB, JFM, CHWK, and TG. Computational experiments were sponsored by the NCF (Netherlands Computer Facility Foundation) for the use of supercomputer facilities, with financial support from NWO (Nederlandse Organisatie voor Wetenschappelijk Onderzoek). Contributions of FH were supported by the Odo van Vloten Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baro T, 1998, J CLIN MICROBIOL, V36, P458; Blehert DS, 2009, SCIENCE, V323, P227, DOI 10.1126/science.1163874; Bovers M, 2008, FUNGAL GENET BIOL, V45, P400, DOI 10.1016/j.fgb.2007.12.004; Brown JKM, 2002, SCIENCE, V297, P537, DOI 10.1126/science.1072678; Byrnes EJ, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000850; Byrnes EJ, 2009, J INFECT DIS, V199, P1081, DOI 10.1086/597306; Carriconde F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016936; Chowdhary A, 2012, EMERG INFECT DIS, V18, P172, DOI 10.3201/eid1801.111190; Chowdhary A, 2012, CRIT REV MICROBIOL, V38, P1, DOI 10.3109/1040841X.2011.606426; Costa SDSE, 2009, MEM I OSWALDO CRUZ, V104, P662, DOI 10.1590/S0074-02762009000400023; Datta K, 2009, EMERG INFECT DIS, V15, P1185, DOI 10.3201/eid1508.081384; dos Santos WRA, 2008, MEM I OSWALDO CRUZ, V103, P813, DOI 10.1590/S0074-02762008000800012; Duncan C, 2006, J WILDLIFE DIS, V42, P175, DOI 10.7589/0090-3558-42.1.175; ELLIS DH, 1990, J CLIN MICROBIOL, V28, P1642, DOI 10.1128/JCM.28.7.1642-1644.1990; Fortes ST, 2001, MYCOSES, V44, P137, DOI 10.1046/j.1439-0507.2001.00651.x; Colom MF, 2012, MED MYCOL, V50, P67, DOI 10.3109/13693786.2011.574239; Fraser JA, 2005, NATURE, V437, P1360, DOI 10.1038/nature04220; Griffin DW, 2007, CLIN MICROBIOL REV, V20, P459, DOI 10.1128/CMR.00039-06; Griffiths A, 2006, THESIS U BRIT COLUMB; Hagen F, 2012, EMERG INFECT DIS, V18, P1618, DOI 10.3201/eid1810.120068; Hagen F, 2010, ANTIMICROB AGENTS CH, V54, P5139, DOI 10.1128/AAC.00746-10; Hagen F, 2010, MYCOPATHOLOGIA, V170, P209, DOI 10.1007/s11046-010-9313-6; Harvell CD, 2002, SCIENCE, V296, P2158, DOI 10.1126/science.1063699; James TY, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000458; Jones KE, 2008, NATURE, V451, P990, DOI 10.1038/nature06536; Kidd SE, 2007, APPL ENVIRON MICROB, V73, P1433, DOI 10.1128/AEM.01330-06; Kidd SE, 2007, EMERG INFECT DIS, V13, P51, DOI 10.3201/eid1301.060823; Kidd SE, 2004, P NATL ACAD SCI USA, V101, P17258, DOI 10.1073/pnas.0402981101; KWONCHUNG KJ, 1984, ZBL BAKT-INT J MED M, V257, P213, DOI 10.1016/S0174-3031(84)80074-8; Levitus S, 2001, SCIENCE, V292, P267, DOI 10.1126/science.1058154; Loarie SR, 2009, NATURE, V462, P1052, DOI 10.1038/nature08649; Ma HS, 2009, P NATL ACAD SCI USA, V106, P12980, DOI 10.1073/pnas.0902963106; McGill S, 2009, MED MYCOL, V47, P625, DOI 10.1080/13693780802512519; Meyer W, 2003, EMERG INFECT DIS, V9, P189; Ngamskulrungroj P, 2011, CLIN MICROBIOL INFEC, V17, P251, DOI 10.1111/j.1469-0691.2010.03222.x; Ngamskulrungroj P, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005862; Peel MC, 2007, HYDROL EARTH SYST SC, V11, P1633, DOI 10.5194/hess-11-1633-2007; Raso TF, 2004, MED MYCOL, V42, P355, DOI 10.1080/13693780410001712061; Springer DJ, 2010, EMERG INFECT DIS, V16, P14, DOI 10.3201/eid1601.090369; Trilles L, 2003, MED MYCOL, V41, P383, DOI 10.1080/1369378031000137206; Trilles L, 2008, MEM I OSWALDO CRUZ, V103, P455, DOI 10.1590/S0074-02762008000500008; Xu ML, 2001, GENOME, V44, P63, DOI 10.1139/gen-44-1-63; Xue CY, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002869	43	103	105	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2013	8	8							e71148	10.1371/journal.pone.0071148	http://dx.doi.org/10.1371/journal.pone.0071148			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	200ZE	23940707	Green Published, gold			2022-12-25	WOS:000323109700082
J	Oyane, NMF; Pallesen, S; Moen, BE; Akerstedt, T; Bjorvatn, B				Oyane, Nicolas M. F.; Pallesen, Stale; Moen, Bente Elisabeth; Akerstedt, Torbjorn; Bjorvatn, Bjorn			Associations Between Night Work and Anxiety, Depression, Insomnia, Sleepiness and Fatigue in a Sample of Norwegian Nurses	PLOS ONE			English	Article							SHIFT-WORK; DAYTIME SLEEPINESS; HOSPITAL ANXIETY; MENTAL-HEALTH; SCALE; POPULATION; PREVALENCE; IMPACT	Background: Night work has been reported to be associated with various mental disorders and complaints. We investigated relationships between night work and anxiety, depression, insomnia, sleepiness and fatigue among Norwegian nurses. Methods: The study design was cross-sectional, based on validated self-assessment questionnaires. A total of 5400 nurses were invited to participate in a health survey through the Norwegian Nurses' Organization, whereof 2059 agreed to participate (response rate 38.1%). Nurses completed a questionnaire containing items on demographic variables (gender, age, years of experience as a nurse, marital status and children living at home), work schedule, anxiety/depression (Hospital Anxiety and Depression Scale), insomnia (Bergen Insomnia Scale), sleepiness (Epworth Sleepiness Scale) and fatigue (Fatigue Questionnaire). They were also asked to report number of night shifts in the last 12 months (NNL). First, the parameters were compared between nurses i) never working nights, ii) currently working nights, and iii) previously working nights, using binary logistic regression analyses. Subsequently, a cumulative approach was used investigating associations between NNL with the continuous scores on the same dependent variables in hierarchical multiple regression analyses. Results: Nurses with current night work were more often categorized with insomnia (OR = 1.48, 95% CI = 1.10-1.99) and chronic fatigue (OR = 1.78, 95% CI = 1.02-3.11) than nurses with no night work experience. Previous night work experience was also associated with insomnia (OR = 1.45, 95% CI = 1.04-2.02). NNL was not associated with any parameters in the regression analyses. Conclusion: Nurses with current or previous night work reported more insomnia than nurses without any night work experience, and current night work was also associated with chronic fatigue. Anxiety, depression and sleepiness were not associated with night work, and no cumulative effect of night shifts during the last 12 months was found on any parameters.	[Oyane, Nicolas M. F.; Moen, Bente Elisabeth; Bjorvatn, Bjorn] Univ Bergen, Dept Publ Hlth & Primary Hlth Care, Bergen, Norway; [Oyane, Nicolas M. F.; Pallesen, Stale; Bjorvatn, Bjorn] Haukeland Hosp, Norwegian Competence Ctr Sleep Disorders, N-5021 Bergen, Norway; [Pallesen, Stale] Univ Bergen, Dept Psychosocial Sci, Bergen, Norway; [Akerstedt, Torbjorn] Karolinska Inst, Dept Clin Neurosci, Stockholm, Sweden	University of Bergen; University of Bergen; Haukeland University Hospital; University of Bergen; Karolinska Institutet	Oyane, NMF (corresponding author), Univ Bergen, Dept Publ Hlth & Primary Hlth Care, Bergen, Norway.	nicolas.oyane@gmail.com	Moen, BE/P-9329-2017		Helse Vest, Bergen	Helse Vest, Bergen	Helse Vest, Bergen provided financial support for this research, although the funding source had no involvement in study design, in the collection, analysis and interpretation of data, in the writing of the report, or in the decision to submit the paper for publication. (URL:www.helse-bergen.no).	AKERSTEDT T, 1988, SLEEP, V11, P17, DOI 10.1093/sleep/11.1.17; American Psychiatric Association, 2000, DIAGN STAT MAN MENT; Bara AC, 2009, SCAND J WORK ENV HEA, V35, P361, DOI 10.5271/sjweh.1344; Bildt C, 2002, INT ARCH OCC ENV HEA, V75, P252, DOI 10.1007/s00420-001-0299-8; Bjelland I, 2002, J PSYCHOSOM RES, V52, P69, DOI 10.1016/S0022-3999(01)00296-3; BOHLE P, 1989, ERGONOMICS, V32, P1089, DOI 10.1080/00140138908966876; Bonnet MH, 2010, SLEEP MED REV, V14, P9, DOI 10.1016/j.smrv.2009.05.002; CHALDER T, 1993, J PSYCHOSOM RES, V37, P147, DOI 10.1016/0022-3999(93)90081-P; Costa G, 2003, OCCUP MED-OXFORD, V53, P83, DOI 10.1093/occmed/kqg045; Davidson JR, 2008, SLEEP MED CLIN, V3, P109, DOI 10.1016/j.jsmc.2007.10.002; Dumont, 1997, Int J Occup Environ Health, V3, pS10; Flo E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033981; GREENLAND S, 1994, ENVIRON HEALTH PERSP, V102, P33, DOI 10.1289/ehp.94102s833; Hansen V, 2001, AM J EPIDEMIOL, V154, P891, DOI 10.1093/aje/154.10.891; Harma M, 2010, SCAND J WORK ENV HEA, V36, P81; Ingre M, 2004, J SLEEP RES, V13, P45, DOI 10.1111/j.1365-2869.2004.00390.x; Johns M, 1997, SLEEP, V20, P844, DOI 10.1093/sleep/20.10.844; JOHNS MW, 1991, SLEEP, V14, P540, DOI 10.1093/sleep/14.6.540; Knutsson A, 2004, CHRONOBIOL INT, V21, P1037, DOI 10.1081/CBI-200038525; Mitler MM, 1997, NEW ENGL J MED, V337, P755, DOI 10.1056/NEJM199709113371106; Muecke S, 2005, J ADV NURS, V50, P433, DOI 10.1111/j.1365-2648.2005.03409.x; Natvik S, 2011, APPL ERGON, V42, P719, DOI 10.1016/j.apergo.2010.11.006; Pallesen S, 2007, SLEEP, V30, P619, DOI 10.1093/sleep/30.5.619; Pallesen S, 2010, SCAND J WORK ENV HEA, V36, P109, DOI 10.5271/sjweh.2886; Pallesen S, 2008, PERCEPT MOTOR SKILL, V107, P691, DOI 10.2466/PMS.107.3.691-706; Parkes JD, 1998, J SLEEP RES, V7, P41, DOI 10.1046/j.1365-2869.1998.00093.x; Parkes K R, 1999, J Occup Health Psychol, V4, P256, DOI 10.1037/1076-8998.4.3.256; Pilcher JJ, 2000, SLEEP, V23, P155; Scott, 1997, Int J Occup Environ Health, V3, pS2; Shen JH, 2006, J SLEEP RES, V15, P1, DOI 10.1111/j.1365-2869.2006.00493.x; SKIPPER JK, 1990, J ADV NURS, V15, P835, DOI 10.1111/j.1365-2648.1990.tb01915.x; Tepas DI, 2004, REV SAUDE PUBL, V38, P26, DOI 10.1590/S0034-89102004000700005; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	33	104	107	0	68	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2013	8	8							e70228	10.1371/journal.pone.0070228	http://dx.doi.org/10.1371/journal.pone.0070228			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	200ZE	23950914	Green Published, gold, Green Submitted			2022-12-25	WOS:000323109700023
J	Perez-Jimenez, M; Besnard, G; Dorado, G; Hernandez, P				Perez-Jimenez, Marga; Besnard, Guillaume; Dorado, Gabriel; Hernandez, Pilar			Varietal Tracing of Virgin Olive Oils Based on Plastid DNA Variation Profiling	PLOS ONE			English	Article							OLEA-EUROPAEA; SCAR MARKERS; IDENTIFICATION; AUTHENTICATION; TRACEABILITY; EXTRACTION; GERMPLASM; TREE	Olive oil traceability remains a challenge nowadays. DNA analysis is the preferred approach to an effective varietal identification, without any environmental influence. Specifically, olive organelle genomics is the most promising approach for setting up a suitable set of markers as they would not interfere with the pollinator variety DNA traces. Unfortunately, plastid DNA (cpDNA) variation of the cultivated olive has been reported to be low. This feature could be a limitation for the use of cpDNA polymorphisms in forensic analyses or oil traceability, but rare cpDNA haplotypes may be useful as they can help to efficiently discriminate some varieties. Recently, the sequencing of olive plastid genomes has allowed the generation of novel markers. In this study, the performance of cpDNA markers on olive oil matrices, and their applicability on commercial Protected Designation of Origin (PDO) oils were assessed. By using a combination of nine plastid loci (including multi-state microsatellites and short indels), it is possible to fingerprint six haplotypes (in 17 Spanish olive varieties), which can discriminate high-value commercialized cultivars with PDO. In particular, a rare haplotype was detected in genotypes used to produce a regional high-value commercial oil. We conclude that plastid haplotypes can help oil traceability in commercial PDO oils and set up an experimental methodology suitable for organelle polymorphism detection in the complex olive oil matrices.	[Perez-Jimenez, Marga; Hernandez, Pilar] Inst Agri Sostenible IAS CSIC, Alameda Obispo S-N, Cordoba, Spain; [Besnard, Guillaume] CNRS UPS ENFA, Lab Evolut & Diversite Biol EDB, UMR 5174, Toulouse 9, France; [Dorado, Gabriel] Univ Cordoba, Dep Bioquim & Biol Mol, Cordoba, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Agricultura Sostenible (IAS); Universidad de Cordoba	Hernandez, P (corresponding author), Inst Agri Sostenible IAS CSIC, Alameda Obispo S-N, Cordoba, Spain.	phernandez@ias.csic.es	Besnard, Guillaume/B-9785-2008; Hernandez, Pilar/B-5996-2016	Besnard, Guillaume/0000-0003-2275-6012; Hernandez, Pilar/0000-0001-5166-4454	MINECO, Spain [AGL2010-17316]; LABEX entitled TULIP [ANR-10-LABX-41]; "Consejeria de Agricultura y Pesca" of "Junta de Andalucia" [041/C/2007, 75/C/2009, 56/C/2010];  [PIEF-GA-2008-220813]	MINECO, Spain; LABEX entitled TULIP; "Consejeria de Agricultura y Pesca" of "Junta de Andalucia"; 	Supported by the project AGL2010-17316 from the MINECO, Spain. GB was funded by the fellowship PIEF-GA-2008-220813 and the LABEX entitled TULIP (ANR-10-LABX-41). GD was funded by "Consejeria de Agricultura y Pesca" of "Junta de Andalucia" (041/C/2007, 75/C/2009 and 56/C/2010). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrimonti C, 2011, TRENDS FOOD SCI TECH, V22, P237, DOI 10.1016/j.tifs.2011.02.002; Alba V, 2009, EUR FOOD RES TECHNOL, V229, P375, DOI 10.1007/s00217-009-1062-8; Aparicio R, 1997, J AGR FOOD CHEM, V45, P1076, DOI 10.1021/jf960659h; Arvanitoyannis IS, 2007, CRIT REV FOOD SCI, V47, P441, DOI 10.1080/10408390600846325; Bautista R, 2003, EUPHYTICA, V130, P185, DOI 10.1023/A:1022804326468; Ben Ayed R, 2009, EUR FOOD RES TECHNOL, V229, P757, DOI 10.1007/s00217-009-1111-3; Ben-Ayed R, 2013, COMPR REV FOOD SCI F, V12, P218, DOI 10.1111/1541-4337.12003; Ben-Ayed R, 2012, EUR FOOD RES TECHNOL, V234, P263, DOI 10.1007/s00217-011-1631-5; Besnard G, 2000, THEOR APPL GENET, V100, P1018, DOI 10.1007/s001220051383; Besnard G, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2012.2833; Besnard G, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-80; Busconi M, 2003, FOOD CHEM, V83, P127, DOI 10.1016/S0308-8146(03)00218-8; Consolandi C, 2008, EUR FOOD RES TECHNOL, V227, P1429, DOI 10.1007/s00217-008-0863-5; Doveri S, 2006, J AGR FOOD CHEM, V54, P9221, DOI 10.1021/jf061564a; Estruch R, 2013, NEW ENGL J MED, V368, P1279, DOI 10.1056/NEJMoa1200303; Faria MA, 2010, OLIVES AND OLIVE OIL IN HEALTH AND DISEASE PREVENTION, P101, DOI 10.1016/B978-0-12-374420-3.00012-7; FIRESTONE D, 1988, J AM OIL CHEM SOC, V65, P788, DOI 10.1007/BF02542533; FIRESTONE D, 1985, J AM OIL CHEM SOC, V62, P1558, DOI 10.1007/BF02541684; Hernandez P, 2001, THEOR APPL GENET, V102, P1082, DOI 10.1007/s001220000515; Hernandez P, 2001, THEOR APPL GENET, V103, P788, DOI 10.1007/s001220100603; Kumar S, 2011, FOOD CHEM, V127, P1335, DOI 10.1016/j.foodchem.2011.01.094; Lopez-Miranda J, 2010, NUTR METAB CARDIOVAS, V20, P284, DOI 10.1016/j.numecd.2009.12.007; Martines Suarez J. M., 1975, Grasas y Aceites, V26, P379; Martins-Lopes P, 2008, J AGR FOOD CHEM, V56, P11786, DOI 10.1021/jf801146z; Montealegre C, 2010, J AGR FOOD CHEM, V58, P28, DOI 10.1021/jf902619z; Montemurro C, 2008, EUR FOOD RES TECHNOL, V226, P1439, DOI 10.1007/s00217-007-0675-z; MURRAY MG, 1980, NUCLEIC ACIDS RES, V8, P4321, DOI 10.1093/nar/8.19.4321; Muzzalupo I, 2007, EUR FOOD RES TECHNOL, V224, P469, DOI 10.1007/s00217-006-0340-y; Owen CA, 2005, THEOR APPL GENET, V110, P1169, DOI 10.1007/s00122-004-1861-z; Pafundo S, 2005, J AGR FOOD CHEM, V53, P6995, DOI 10.1021/jf050775x; Pafundo S, 2007, J AGR FOOD CHEM, V55, P6052, DOI 10.1021/jf0701638; Pafundo S, 2010, FOOD CHEM, V123, P787, DOI 10.1016/j.foodchem.2010.05.027; Pasqualone A, 2007, J AGR FOOD CHEM, V55, P3857, DOI 10.1021/jf063708r; Perri E, 2012, OLIVE GERMPLASM - THE OLIVE CULTIVATION, TABLE OLIVE AND OLIVE OIL INDUSTRY IN ITALY, P265, DOI 10.5772/51796; Rabiei Zohreh, 2010, Iranian Journal of Biotechnology, V8, P24; Rallo P, 2000, THEOR APPL GENET, V101, P984, DOI 10.1007/s001220051571; Roche HM, 2000, FOOD RES INT, V33, P227, DOI 10.1016/S0963-9969(00)00043-0; Sefc KM, 2000, MOL ECOL, V9, P1171, DOI 10.1046/j.1365-294x.2000.00954.x; Vietina M, 2011, J SCI FOOD AGR, V91, P1381, DOI 10.1002/jsfa.4317; Woolfe M, 2004, TRENDS BIOTECHNOL, V22, P222, DOI 10.1016/j.tibtech.2004.03.010	40	39	40	0	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2013	8	8							e70507	10.1371/journal.pone.0070507	http://dx.doi.org/10.1371/journal.pone.0070507			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	200ZE	23950947	Green Published, Green Submitted, gold			2022-12-25	WOS:000323109700038
J	Tang, K; Liu, KS; Jiao, NZ; Zhang, Y; Chen, CTA				Tang, Kai; Liu, Keshao; Jiao, Nianzhi; Zhang, Yao; Chen, Chen-Tung Arthur			Functional Metagenomic Investigations of Microbial Communities in a Shallow-Sea Hydrothermal System	PLOS ONE			English	Article							DEEP-SEA; ARCHAEAL POPULATIONS; GENOME SEQUENCE; BACTERIAL; VENTS; GLYCOSYLATION; DIVERSITY; HYDROGEN; ENZYMES; GENES	Little is known about the functional capability of microbial communities in shallow-sea hydrothermal systems (water depth of <200 m). This study analyzed two high-throughput pyrosequencing metagenomic datasets from the vent and the surface water in the shallow-sea hydrothermal system offshore NE Taiwan. This system exhibited distinct geochemical parameters. Metagenomic data revealed that the vent and the surface water were predominated by Epsilonproteobacteria (Nautiliales-like organisms) and Gammaproteobacteria (Thiomicrospira-like organisms), respectively. A significant difference in microbial carbon fixation and sulfur metabolism was found between the vent and the surface water. The chemoautotrophic microorganisms in the vent and in the surface water might possess the reverse tricarboxylic acid cycle and the Calvin-Bassham-Benson cycle for carbon fixation in response to carbon dioxide highly enriched in the environment, which is possibly fueled by geochemical energy with sulfur and hydrogen. Comparative analyses of metagenomes showed that the shallow-sea metagenomes contained some genes similar to those present in other extreme environments. This study may serve as a basis for deeply understanding the genetic network and functional capability of the microbial members of shallow-sea hydrothermal systems.	[Tang, Kai; Liu, Keshao; Jiao, Nianzhi; Zhang, Yao] Xiamen Univ, State Key Lab Marine Environm Sci, Xiamen, Fujian, Peoples R China; [Tang, Kai; Liu, Keshao; Jiao, Nianzhi; Zhang, Yao] Xiamen Univ, Inst Marine Microbes & Ecospheres, Xiamen, Fujian, Peoples R China; [Chen, Chen-Tung Arthur] Natl Sun Yat Sen Univ, Inst Marine Geol & Chem, Kaohsiung 80424, Taiwan	Xiamen University; Xiamen University; National Sun Yat Sen University	Tang, K (corresponding author), Xiamen Univ, State Key Lab Marine Environm Sci, Xiamen, Fujian, Peoples R China.	tangkai@xmu.edu.cn; jiao@xmu.edu.cn	CHEN, CHEN/HDM-6657-2022; chen, chen/GRY-7085-2022; Chen, Chen-Tung Arthur/C-8901-2011	Chen, Chen-Tung Arthur/0000-0002-5170-6471	National Basic Research Program of China [2011CB808800/2013CB955700]; NSFC [41276131/91028001]; Public Science and Technology Research Funds Projects of Ocean [201105021, MELRI1005 *LMSR 7.26.13]	National Basic Research Program of China(National Basic Research Program of China); NSFC(National Natural Science Foundation of China (NSFC)); Public Science and Technology Research Funds Projects of Ocean	This work was supported by National Basic Research Program of China (2011CB808800/2013CB955700), NSFC (41276131/91028001) Public Science and Technology Research Funds Projects of Ocean 201105021&MELRI1005 *LMSR 7.26.13. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez-Martinez CE, 2009, MICROBIOL MOL BIOL R, V73, P775, DOI 10.1128/MMBR.00023-09; Anantharaman K, 2013, P NATL ACAD SCI USA, V110, P330, DOI 10.1073/pnas.1215340110; Baker BJ, 2012, ISME J, V6, P2269, DOI 10.1038/ismej.2012.64; Bouxin G, 2005, J VEG SCI, V16, P355, DOI 10.1111/j.1654-1103.2005.tb02374.x; Brazelton WJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013530; Brazelton WJ, 2009, ISME J, V3, P1420, DOI 10.1038/ismej.2009.79; Burke C, 2011, P NATL ACAD SCI USA, V108, P14288, DOI 10.1073/pnas.1101591108; Campbell BJ, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000362; Canfield DE, 2010, SCIENCE, V330, P192, DOI 10.1126/science.1186120; CHAO YP, 1993, APPL ENVIRON MICROB, V59, P4261, DOI 10.1128/AEM.59.12.4261-4265.1993; Chen CTA, 2005, CHEM GEOL, V224, P69, DOI 10.1016/j.chemgeo.2005.07.022; Clarke K., 2001, PRIMER V5 USER MANUA; CLARKE KR, 1993, AUST J ECOL, V18, P117, DOI 10.1111/j.1442-9993.1993.tb00438.x; CORLISS JB, 1979, SCIENCE, V203, P1073, DOI 10.1126/science.203.4385.1073; Flores GE, 2011, ENVIRON MICROBIOL, V13, P2158, DOI 10.1111/j.1462-2920.2011.02463.x; Giovannelli D, 2011, STAND GENOMIC SCI, V5, P135, DOI 10.4056/sigs.2094859; Grzymski JJ, 2008, P NATL ACAD SCI USA, V105, P17516, DOI 10.1073/pnas.0802782105; Hugler M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016018; Hugler M, 2011, ANNU REV MAR SCI, V3, P261, DOI 10.1146/annurev-marine-120709-142712; Jeffries TC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025173; Jervis AJ, 2010, J BACTERIOL, V192, P5228, DOI 10.1128/JB.00211-10; Kelley DS, 2005, SCIENCE, V307, P1428, DOI 10.1126/science.1102556; Lertsethtakarn P, 2011, ANNU REV MICROBIOL, V65, P389, DOI 10.1146/annurev-micro-090110-102908; Lesniewski RA, 2012, ISME J, V6, P2257, DOI 10.1038/ismej.2012.63; Maugeri TL, 2010, CHEM ECOL, V26, P285, DOI 10.1080/02757541003693250; Maugeri TL, 2009, EXTREMOPHILES, V13, P199, DOI 10.1007/s00792-008-0210-6; Meyer F, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-386; Moran MA, 2004, NATURE, V432, P910, DOI 10.1038/nature03170; Mundry M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031410; Parks DH, 2010, BIOINFORMATICS, V26, P715, DOI 10.1093/bioinformatics/btq041; Petersen JM, 2011, NATURE, V476, P176, DOI 10.1038/nature10325; Pignatelli M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019984; Pitcher RS, 2002, BIOCHEM SOC T, V30, P653, DOI 10.1042/bst0300653; Reysenbach AL, 2002, SCIENCE, V296, P1077, DOI 10.1126/science.1072483; Robidart JC, 2008, ENVIRON MICROBIOL, V10, P727, DOI 10.1111/j.1462-2920.2007.01496.x; Roussel EG, 2011, FEMS MICROBIOL ECOL, V77, P647, DOI 10.1111/j.1574-6941.2011.01161.x; Scott KM, 2006, PLOS BIOL, V4, P2196, DOI 10.1371/journal.pbio.0040383; Smith RJ, 2012, ENVIRON MICROBIOL, V14, P240, DOI 10.1111/j.1462-2920.2011.02614.x; Stock AM, 2000, ANNU REV BIOCHEM, V69, P183, DOI 10.1146/annurev.biochem.69.1.183; Tarasov VG, 2005, CHEM GEOL, V224, P5, DOI 10.1016/j.chemgeo.2005.07.021; Taylor BL, 1999, MICROBIOL MOL BIOL R, V63, P479, DOI 10.1128/MMBR.63.2.479-506.1999; Toulza E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030931; Villarreal-Chiu JF, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00019; Walsh David A, 2009, J Vis Exp, DOI 10.3791/1161; Wang FP, 2009, P NATL ACAD SCI USA, V106, P4840, DOI 10.1073/pnas.0810418106; WRIGHT J, 2009, TLS TIMES LIT S 1113, P31; Xie W, 2011, ISME J, V5, P414, DOI 10.1038/ismej.2010.144; Yamamoto M, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00192; Yang LY, 2012, MAR CHEM, V128, P64, DOI 10.1016/j.marchem.2011.10.003; Yoshizawa Y, 2004, J BACTERIOL, V186, P5685, DOI 10.1128/JB.186.17.5685-5691.2004; ZHANG YQ, 2012, PLOS ONE; Zhou MX, 2010, J BIOL CHEM, V285, P12140, DOI 10.1074/jbc.M109.066928	52	43	45	1	75	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2013	8	8							e72958	10.1371/journal.pone.0072958	http://dx.doi.org/10.1371/journal.pone.0072958			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	217ZG	23940820	Green Submitted, Green Published, gold			2022-12-25	WOS:000324401500095
J	Tranberg, B; Hellgren, LI; Lykkesfeldt, J; Sejrsen, K; Jeamet, A; Rune, I; Ellekilde, M; Nielsen, DS; Hansen, AK				Tranberg, Britt; Hellgren, Lars I.; Lykkesfeldt, Jens; Sejrsen, Kristen; Jeamet, Aymeric; Rune, Ida; Ellekilde, Merete; Nielsen, Dennis S.; Hansen, Axel Kornerup			Whey Protein Reduces Early Life Weight Gain in Mice Fed a High-Fat Diet	PLOS ONE			English	Article							DAIRY CONSUMPTION; BODY-WEIGHT; METABOLIC SYNDROME; INDUCED OBESITY; GUT MICROBIOTA; YOUNG-WOMEN; PREVALENCE; CALCIUM; INSULIN; MILK	An increasing number of studies indicate that dairy products, including whey protein, alleviate several disorders of the metabolic syndrome. Here, we investigated the effects of whey protein isolate (whey) in mice fed a high-fat diet hypothesising that the metabolic effects of whey would be associated with changes in the gut microbiota composition. Five-week-old male C57BL/6 mice were fed a high-fat diet ad libitum for 14 weeks with the protein source being either whey or casein. Faeces were collected at week 0, 7, and 13 and the fecal microbiota was analysed by denaturing gradient gel electrophoresis analyses of PCR-derived 16S rRNA gene (V3-region) amplicons. At the end of the study, plasma samples were collected and assayed for glucose, insulin and lipids. Whey significantly reduced body weight gain during the first four weeks of the study compared with casein (P<0.001-0.05). Hereafter weight gain was similar resulting in a 15% lower final body weight in the whey group relative to casein (34.0 +/- 1.0 g vs. 40.2 +/- 1.3 g, P<0.001). Food intake was unaffected by protein source throughout the study period. Fasting insulin was lower in the whey group (P<0.01) and glucose clearance was improved after an oral glucose challenge (P<0.05). Plasma cholesterol was lowered by whey compared to casein (P<0.001). The composition of the fecal microbiota differed between high-and low-fat groups at 13 weeks (P<0.05) whereas no difference was seen between whey and casein. In conclusion, whey initially reduced weight gain in young C57BL/6 mice fed a high-fat diet compared to casein. Although the effect on weight gain ceased, whey alleviated glucose intolerance, improved insulin sensitivity and reduced plasma cholesterol. These findings could not be explained by changes in food intake or gut microbiota composition. Further studies are needed to clarify the mechanisms behind the metabolic effects of whey.	[Tranberg, Britt; Lykkesfeldt, Jens; Jeamet, Aymeric; Rune, Ida; Ellekilde, Merete; Hansen, Axel Kornerup] Univ Copenhagen, Dept Vet Dis Biol, Fac Hlth & Med Sci, Frederiksberg C, Denmark; [Hellgren, Lars I.] Tech Univ Denmark, Dept Syst Biol, Ctr Biol Sequence Anal, DK-2800 Lyngby, Denmark; [Sejrsen, Kristen] Aarhus Univ, Dept Anim Sci, DK-8000 Aarhus C, Denmark; [Nielsen, Dennis S.] Univ Copenhagen, Fac Sci, Dept Food Sci, Frederiksberg C, Denmark	University of Copenhagen; Technical University of Denmark; Aarhus University; University of Copenhagen	Tranberg, B (corresponding author), Univ Copenhagen, Dept Vet Dis Biol, Fac Hlth & Med Sci, Frederiksberg C, Denmark.	btc@sund.ku.dk	Nielsen, Dennis/A-9769-2015; Hellgren, Lars/B-5137-2010; Lykkesfeldt, Jens/A-1072-2011	Nielsen, Dennis/0000-0001-8121-1114; Hellgren, Lars/0000-0001-9215-4880; Lykkesfeldt, Jens/0000-0002-6514-8407	Danish Agency for Science, Technology and Innovation [2101-07-0094]	Danish Agency for Science, Technology and Innovation	This work was supported by the Danish Agency for Science, Technology and Innovation (grant No. 2101-07-0094), www.fi.dk. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberti KGMM, 2006, DIABETIC MED, V23, P469, DOI 10.1111/j.1464-5491.2006.01858.x; [Anonymous], 2013, OB OV; Azadbakht L, 2005, AM J CLIN NUTR, V82, P523, DOI 10.1093/ajcn/82.3.523; Baer DJ, 2011, J NUTR, V141, P1489, DOI 10.3945/jn.111.139840; Belobrajdic DP, 2004, J NUTR, V134, P1454, DOI 10.1093/jn/134.6.1454; Boirie Y, 1997, P NATL ACAD SCI USA, V94, P14930, DOI 10.1073/pnas.94.26.14930; Coles L, 2013, FOOD FUNCT, V4, P432, DOI 10.1039/c2fo30239j; Delzenne NM, 2011, MICROB CELL FACT, V10, DOI 10.1186/1475-2859-10-S1-S10; Eagan MS, 2006, OBESITY, V14, P2242, DOI 10.1038/oby.2006.263; Elwood PC, 2008, J AM COLL NUTR, V27, p723S, DOI 10.1080/07315724.2008.10719750; Gerrits WJJ, 1997, J NUTR, V127, P1229, DOI 10.1093/jn/127.6.1229; Grundy SM, 2002, CIRCULATION, V106, P3143, DOI 10.1161/circ.106.25.3143; Hildebrandt MA, 2009, GASTROENTEROLOGY, V137, P1716, DOI 10.1053/j.gastro.2009.08.042; HO A, 1988, PHYSIOL BEHAV, V43, P651, DOI 10.1016/0031-9384(88)90221-1; Hoffman JR, 2004, J SPORT SCI MED, V3, P118; Hufeldt MR, 2010, COMPARATIVE MED, V60, P336; Lacroix M, 2006, AM J CLIN NUTR, V84, P1070, DOI 10.1093/ajcn/84.5.1070; Larsen N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009085; Liu S, 2005, DIABETES CARE, V28, P2926, DOI 10.2337/diacare.28.12.2926; Marques-Vidal P, 2006, INT J OBESITY, V30, P88, DOI 10.1038/sj.ijo.0803045; Mirmiran P, 2005, INT J OBESITY, V29, P115, DOI 10.1038/sj.ijo.0802838; Mortensen LS, 2009, AM J CLIN NUTR, V90, P41, DOI 10.3945/ajcn.2008.27281; Murphy EF, 2010, GUT, V59, P1635, DOI 10.1136/gut.2010.215665; Pal S, 2010, BRIT J NUTR, V104, P716, DOI 10.1017/S0007114510000991; Pereira MA, 2002, JAMA-J AM MED ASSOC, V287, P2081, DOI 10.1001/jama.287.16.2081; Pilvi TK, 2007, BRIT J NUTR, V98, P900, DOI 10.1017/S0007114507764760; ROSENWASSER AM, 1981, PHYSIOL BEHAV, V27, P33, DOI 10.1016/0031-9384(81)90296-1; Royle PJ, 2008, BRIT J NUTR, V100, P88, DOI 10.1017/S0007114507883000; Shertzer HG, 2011, J NUTR, V141, P582, DOI 10.3945/jn.110.133736; Shi J, 2011, INT DAIRY J, V21, P513, DOI 10.1016/j.idairyj.2011.03.006; Sprong RC, 2010, J DAIRY SCI, V93, P1364, DOI 10.3168/jds.2009-2397; Turnbaugh PJ, 2008, CELL HOST MICROBE, V3, P213, DOI 10.1016/j.chom.2008.02.015; Turnbaugh PJ, 2006, NATURE, V444, P1027, DOI 10.1038/nature05414; Van Loan MD, 2011, J OBES, V2011, DOI 10.1155/2011/989657; Varenna M, 2007, AM J CLIN NUTR, V86, P639, DOI 10.1093/ajcn/86.3.639; Wennersberg MH, 2009, AM J CLIN NUTR, V90, P960, DOI 10.3945/ajcn.2009.27664; Zemel MB, 2009, NUTRIENTS, V1, P83, DOI 10.3390/nu1010083; Zhang YY, 2007, DIABETES, V56, P1647, DOI 10.2337/db07-0123	38	34	35	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2013	8	8							e71439	10.1371/journal.pone.0071439	http://dx.doi.org/10.1371/journal.pone.0071439			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	217ZG	23940754	Green Published, gold, Green Submitted			2022-12-25	WOS:000324401500072
J	Di Noto, G; Paolini, L; Zendrini, A; Radeghieri, A; Caimi, L; Ricotta, D				Di Noto, Giuseppe; Paolini, Lucia; Zendrini, Andrea; Radeghieri, Annalisa; Caimi, Luigi; Ricotta, Doris			C-src Enriched Serum Microvesicles Are Generated in Malignant Plasma Cell Dyscrasia	PLOS ONE			English	Article							LIGHT-CHAIN RATIO; ASYMPTOMATIC MULTIPLE-MYELOMA; INDEPENDENT RISK-FACTOR; MONOCLONAL GAMMOPATHY; UNDETERMINED SIGNIFICANCE; BIOLOGICAL SIGNIFICANCE; PROGNOSTIC VALUE; MESANGIAL CELLS; EXOSOMES; PROGRESSION	Plasma cell dyscrasias are immunosecretory disorders that can lead to hematological malignancies such as Multiple Myeloma (MM). MM accounts for 15% of all hematologic cancers, and those diagnosed with MM typically become severely ill and have a low life expectancy. Monoclonal immunoglobulin Free Light Chains (FLC) are present in the serum and urine of many patients with plasma cell diseases. The biological differences between monoclonal FLCs, produced under malignant or benign dyscrasias, has not yet been characterized. In the present study, we show that endothelial and heart muscle cell lines internalize kappa and lambda FLCs. After internalization, FLCs are rerouted in the extracellular space via microvesicles and exosomes that can be re-internalized in contiguous cells. Only FLCs secreted from malignant B Lymphocytes were carried in Hsp70, annexin V, and c-src positive vesicles. In both MM and AL Amyloidosis patients we observed an increase in microvesicle and exosome production. Isolated serum vesicles from MM, AL Amyloidosis and monoclonal gammopathy of undetermined significance (MGUS) patients contained FLCs. Furthermore MM and AL amyloidosis vesicles were strongly positive for Hsp70, annexin V, and c-src compared to MGUS and control patients. These are the first data implying that FLCs reroute via microvesicles in the blood stream, and also suggest a potential novel mechanism of c-src activation in plasma cell dyscrasia.	[Di Noto, Giuseppe; Paolini, Lucia; Zendrini, Andrea; Radeghieri, Annalisa; Caimi, Luigi; Ricotta, Doris] Univ Brescia, Fac Med, Dept Mol & Translat Med, Brescia, Italy	University of Brescia	Ricotta, D (corresponding author), Univ Brescia, Fac Med, Dept Mol & Translat Med, Brescia, Italy.	ricotta@med.unibs.it	Zendrini, Andrea/AAB-3902-2019; Radeghieri, Annalisa/E-4841-2016	Zendrini, Andrea/0000-0002-3626-0360; Radeghieri, Annalisa/0000-0003-2737-1090; Paolini, Lucia/0000-0002-4410-5272; Caimi, Luigi/0000-0002-7163-9405	University of Brescia Research found; "Prima spes onlus" foundation	University of Brescia Research found; "Prima spes onlus" foundation	This work was supported by University of Brescia Research found (ex 60%) and "Prima spes onlus" foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alais S, 2008, BIOL CELL, V100, P603, DOI 10.1042/BC20080025; Bradwell AR, 2009, SERUM FREE LIGHT CHA; Butch AW, 2001, EXP HEMATOL, V29, P85, DOI 10.1016/S0301-472X(00)00619-6; Chen GY, 2010, NAT REV IMMUNOL, V10, P826, DOI 10.1038/nri2873; Dispenzieri A, 2008, BLOOD, V111, P785, DOI 10.1182/blood-2007-08-108357; Falk RH, 1997, NEW ENGL J MED, V337, P898, DOI 10.1056/NEJM199709253371306; Fevrier B, 2004, P NATL ACAD SCI USA, V101, P9683, DOI 10.1073/pnas.0308413101; Herrera GA, 2009, ARCH PATHOL LAB MED, V133, P249, DOI 10.1043/1543-2165-133.2.249; Johnstone RM, 2006, BLOOD CELL MOL DIS, V36, P315, DOI 10.1016/j.bcmd.2005.12.001; Keeling J, 2004, LAB INVEST, V84, P1322, DOI 10.1038/labinvest.3700161; Kharaziha P, 2012, BBA-REV CANCER, V1826, P103, DOI 10.1016/j.bbcan.2012.03.006; Koga K, 2005, ANTICANCER RES, V25, P3703; Kyle RA, 2010, LEUKEMIA, V24, P1121, DOI 10.1038/leu.2010.60; Kyle RA, 2003, MAYO CLIN PROC, V78, P21, DOI 10.4065/78.1.21; Kyle RA, 2006, NEW ENGL J MED, V354, P1362, DOI 10.1056/NEJMoa054494; Kyle RA, 2007, NEW ENGL J MED, V356, P2582, DOI 10.1056/NEJMoa070389; Kyrtsonis MC, 2007, BRIT J HAEMATOL, V137, P240, DOI 10.1111/j.1365-2141.2007.06561.x; Lavatelli F, 2011, BBA-PROTEINS PROTEOM, V1814, P409, DOI 10.1016/j.bbapap.2010.12.012; Logozzi M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005219; Lori CK, 2009, NATURE REV CLIN ONCO, V6, P587; Masyuk AI, 2010, AM J PHYSIOL-GASTR L, V299, pG990, DOI 10.1152/ajpgi.00093.2010; Mathivanan S, 2010, J PROTEOMICS, V73, P1907, DOI 10.1016/j.jprot.2010.06.006; Matsumori A, 2010, CIRC RES, V106, P1533, DOI 10.1161/CIRCRESAHA.110.218438; Merlini G, 2003, NEW ENGL J MED, V349, P583, DOI 10.1056/NEJMra023144; Mineo M, 2012, ANGIOGENESIS, V15, P33, DOI 10.1007/s10456-011-9241-1; Monis GF, 2006, AM J PATHOL, V169, P1939, DOI 10.2353/ajpath.2006.060183; Obici L, 2005, BBA-PROTEINS PROTEOM, V1753, P11, DOI 10.1016/j.bbapap.2005.08.014; Pant S, 2012, BIOCHEM PHARMACOL, V83, P1484, DOI 10.1016/j.bcp.2011.12.037; Paolini L, 2011, TRAFFIC, V12, P1604, DOI 10.1111/j.1600-0854.2011.01262.x; Perez-Persona E, 2007, BLOOD, V110, P2586, DOI 10.1182/blood-2007-05-088443; Rajkumar SV, 2010, MAYO CLIN PROC, V85, P945, DOI 10.4065/mcp.2010.0520; Rajkumar SV, 2005, BLOOD, V106, P812, DOI 10.1182/blood-2005-03-1038; Ramirez-Alvarado M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038061; Schneider A, 2012, J NEUROCHEM, V120, P1, DOI 10.1111/j.1471-4159.2011.07548.x; Sengul S, 2002, KIDNEY INT, V62, P1977, DOI 10.1046/j.1523-1755.2002.00660.x; Snozek CLH, 2008, LEUKEMIA, V22, P1933, DOI 10.1038/leu.2008.171; Tauro BJ, 2012, METHODS, V56, P293, DOI 10.1016/j.ymeth.2012.01.002; Teng JM, 2004, LAB INVEST, V84, P440, DOI 10.1038/labinvest.3700069; Thomas LM, 2010, J IMMUNOL, V185, P3740, DOI 10.4049/jimmunol.1001231; Vingtdeux V, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00229; Weiss BM, 2009, BLOOD, V113, P5418, DOI 10.1182/blood-2008-12-195008; Ying WZ, 2011, BLOOD, V117, P1301, DOI 10.1182/blood-2010-08-302505; Zadeh MS, 2000, J LEUKOCYTE BIOL, V67, P327, DOI 10.1002/jlb.67.3.327	43	29	29	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2013	8	8							e70811	10.1371/journal.pone.0070811	http://dx.doi.org/10.1371/journal.pone.0070811			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	218XC	23940647	Green Published, Green Submitted, gold			2022-12-25	WOS:000324465000138
J	Di Pasquale, G; Salignon, M; Le Conte, Y; Belzunces, LP; Decourtye, A; Kretzschmar, A; Suchail, S; Brunet, JL; Alaux, C				Di Pasquale, Garance; Salignon, Marion; Le Conte, Yves; Belzunces, Luc P.; Decourtye, Axel; Kretzschmar, Andre; Suchail, Severine; Brunet, Jean-Luc; Alaux, Cedric			Influence of Pollen Nutrition on Honey Bee Health: Do Pollen Quality and Diversity Matter?	PLOS ONE			English	Article							NOSEMA-CERANAE; WORKER HONEYBEES; GENE-EXPRESSION; HYPOPHARYNGEAL GLANDS; OVARY ACTIVATION; PROTEIN-QUALITY; IMMUNE FUNCTION; APIS; HYMENOPTERA; INFECTION	Honey bee colonies are highly dependent upon the availability of floral resources from which they get the nutrients (notably pollen) necessary to their development and survival. However, foraging areas are currently affected by the intensification of agriculture and landscape alteration. Bees are therefore confronted to disparities in time and space of floral resource abundance, type and diversity, which might provide inadequate nutrition and endanger colonies. The beneficial influence of pollen availability on bee health is well-established but whether quality and diversity of pollen diets can modify bee health remains largely unknown. We therefore tested the influence of pollen diet quality (different monofloral pollens) and diversity (polyfloral pollen diet) on the physiology of young nurse bees, which have a distinct nutritional physiology (e. g. hypopharyngeal gland development and vitellogenin level), and on the tolerance to the microsporidian parasite Nosema ceranae by measuring bee survival and the activity of different enzymes potentially involved in bee health and defense response (glutathione-S-transferase (detoxification), phenoloxidase (immunity) and alkaline phosphatase (metabolism)). We found that both nurse bee physiology and the tolerance to the parasite were affected by pollen quality. Pollen diet diversity had no effect on the nurse bee physiology and the survival of healthy bees. However, when parasitized, bees fed with the polyfloral blend lived longer than bees fed with monofloral pollens, excepted for the protein-richest monofloral pollen. Furthermore, the survival was positively correlated to alkaline phosphatase activity in healthy bees and to phenoloxydase activities in infected bees. Our results support the idea that both the quality and diversity (in a specific context) of pollen can shape bee physiology and might help to better understand the influence of agriculture and land-use intensification on bee nutrition and health.	[Di Pasquale, Garance; Le Conte, Yves; Belzunces, Luc P.; Decourtye, Axel; Kretzschmar, Andre; Brunet, Jean-Luc; Alaux, Cedric] UMT, Avignon, France; [Di Pasquale, Garance; Decourtye, Axel] ACTA, Avignon, France; [Salignon, Marion; Le Conte, Yves; Belzunces, Luc P.; Brunet, Jean-Luc; Alaux, Cedric] INRA, UR Abeilles & Environm 406, Avignon, France; [Kretzschmar, Andre] INRA, UR Biostat & Proc Spatiaux 546, Avignon, France; [Suchail, Severine] Univ Avignon & Pays Vaucluse, UMR 7263, Inst Mediterraneen Biodiversite & Ecol, Avignon, France	INRAE; INRAE; Avignon Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; Aix-Marseille Universite; Institut de Recherche pour le Developpement (IRD)	Alaux, C (corresponding author), UMT, CS 40509, Avignon, France.	cedric.alaux@avignon.inra.fr	BRUNET, Jean-Luc/ABE-9178-2021; , Belzunces/P-7061-2019; Le Conte, Yves/M-4442-2018; Le Conte, Yves M/B-3246-2016; Le Conte, Yves/AAP-2379-2021; Alaux, Cedric/B-4667-2013	BRUNET, Jean-Luc/0000-0002-3827-1135; , Belzunces/0000-0003-1798-9962; Le Conte, Yves/0000-0002-8466-5370; Le Conte, Yves M/0000-0002-8466-5370; Le Conte, Yves/0000-0002-8466-5370; Alaux, Cedric/0000-0002-3045-2599	European Agricultural Guarantee Fund [797/2004]; Conventions Industrielles de Formation par la REcherche fellowship (ANRT)	European Agricultural Guarantee Fund; Conventions Industrielles de Formation par la REcherche fellowship (ANRT)(French National Research Agency (ANR))	This work was funded by a grant from the European Agricultural Guarantee Fund (797/2004). GDP was supported by a Conventions Industrielles de Formation par la REcherche fellowship (ANRT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alaux C, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-496; Alaux C, 2010, BIOL LETTERS, V6, P562, DOI 10.1098/rsbl.2009.0986; Alaux C, 2010, ENVIRON MICROBIOL, V12, P774, DOI 10.1111/j.1462-2920.2009.02123.x; Amdam GV, 2010, ANIM BEHAV, V79, P973, DOI 10.1016/j.anbehav.2010.02.007; Amdam GV, 2004, EXP GERONTOL, V39, P767, DOI 10.1016/j.exger.2004.02.010; Amdam GV, 2004, P NATL ACAD SCI USA, V101, P11350, DOI 10.1073/pnas.0403073101; Amdam GV, 2003, P NATL ACAD SCI USA, V100, P1799, DOI 10.1073/pnas.0333979100; Ament SA, 2011, J EXP BIOL, V214, P3808, DOI 10.1242/jeb.060244; Ament SA, 2010, WIRES SYST BIOL MED, V2, P566, DOI 10.1002/wsbm.73; [Anonymous], 2009, 15662 AFNOR; Baude M, 2011, J ECOL, V99, P828, DOI 10.1111/j.1365-2745.2011.01793.x; Bitondi MMG, 1996, J APICULT RES, V35, P27, DOI 10.1080/00218839.1996.11100910; Bounias M, 1996, ECOTOX ENVIRON SAFE, V35, P67, DOI 10.1006/eesa.1996.0082; BRAKEFIELD PM, 1987, TRENDS ECOL EVOL, V2, P117, DOI 10.1016/0169-5347(87)90051-6; Brodschneider R, 2010, APIDOLOGIE, V41, P278, DOI 10.1051/apido/2010012; Buchon N, 2009, CELL HOST MICROBE, V5, P200, DOI 10.1016/j.chom.2009.01.003; CAMPANA BJ, 1977, J ECON ENTOMOL, V70, P39, DOI 10.1093/jee/70.1.39; COX DR, 1972, J R STAT SOC B, V34, P187; CRAILSHEIM K, 1992, J COMP PHYSIOL B, V162, P681, DOI 10.1007/BF00301617; CRAILSHEIM K, 1989, J INSECT PHYSIOL, V35, P595, DOI 10.1016/0022-1910(89)90121-2; CRAILSHEIM K, 1992, J INSECT PHYSIOL, V38, P409, DOI 10.1016/0022-1910(92)90117-V; de GROOT A. P., 1953, PHYSIOL COMPARATA ET OECOL, V3, P197; Decourtye A, 2010, APIDOLOGIE, V41, P264, DOI 10.1051/apido/2010024; DeGrandi-Hoffman G, 2010, J INSECT PHYSIOL, V56, P1184, DOI 10.1016/j.jinsphys.2010.03.017; Dussaubat C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037017; EGUCHI M, 1995, COMP BIOCHEM PHYS B, V111, P151, DOI 10.1016/0305-0491(94)00248-S; European Union, 2009, OFF J EUR UNION, V54, P23; Fischer P, 2008, NATURWISSENSCHAFTEN, V95, P723, DOI 10.1007/s00114-008-0378-8; FOLCH J, 1957, J BIOL CHEM, V226, P497; Foley K, 2012, J INVERTEBR PATHOL, V111, P68, DOI 10.1016/j.jip.2012.06.006; Forsgren E, 2010, VET PARASITOL, V170, P212, DOI 10.1016/j.vetpar.2010.02.010; Fries I, 2010, J INVERTEBR PATHOL, V103, pS73, DOI 10.1016/j.jip.2009.06.017; Gallai N, 2009, ECOL ECON, V68, P810, DOI 10.1016/j.ecolecon.2008.06.014; Gonzalez-Santoyo I, 2012, ENTOMOL EXP APPL, V142, P1, DOI 10.1111/j.1570-7458.2011.01187.x; Hahn DA, 2011, ANNU REV ENTOMOL, V56, P103, DOI 10.1146/annurev-ento-112408-085436; HAYDAK MH, 1970, ANNU REV ENTOMOL, V15, P143, DOI 10.1146/annurev.en.15.010170.001043; HERBERT EW, 1978, APIDOLOGIE, V9, P33, DOI 10.1051/apido:19780103; HERBERT EW, 1980, J APICULT RES, V19, P115, DOI 10.1080/00218839.1980.11100008; Higes M, 2007, J INVERTEBR PATHOL, V94, P211, DOI 10.1016/j.jip.2006.11.001; Higes M, 2013, ENV MICROBIOL REP, V5, P17, DOI 10.1111/1758-2229.12024; Higes M, 2010, APIDOLOGIE, V41, P375, DOI 10.1051/apido/2010019; ISO, 1997, KJELDAHL METHOD ISO; Keller I, 2005, BEE WORLD, V86, P27, DOI 10.1080/0005772X.2005.11099650; Klein AM, 2007, P ROY SOC B-BIOL SCI, V274, P303, DOI 10.1098/rspb.2006.3721; Klemola N, 2007, ENTOMOL EXP APPL, V123, P167, DOI 10.1111/j.1570-7458.2007.00533.x; Koywiwattrakul P, 2005, J INSECT SCI, V5, DOI 10.1093/jis/5.1.36; Koywiwattrakul P, 2009, BIOCHEM GENET, V47, P19, DOI 10.1007/s10528-008-9202-6; Kucharski R, 2003, J INSECT SCI, V3, DOI 10.1093/jis/3.1.27; Lalles JP, 2010, NUTR REV, V68, P323, DOI 10.1111/j.1753-4887.2010.00292.x; Le Conte Y, 2008, REV SCI TECH OIE, V27, P499; Le Conte Y, 2011, RECENT INVESTIGATION, P215; Lee KP, 2008, FUNCT ECOL, V22, P1052, DOI 10.1111/j.1365-2435.2008.01459.x; Lee KP, 2006, P ROY SOC B-BIOL SCI, V273, P823, DOI 10.1098/rspb.2005.3385; Louveaux J, 1959, ANN ABEILLE, V2; Malone LA, 1998, J INVERTEBR PATHOL, V71, P169, DOI 10.1006/jipa.1997.4715; Maurizio A., 1950, BEE WORLD, V31, P9, DOI 10.1080/0005772X.1950.11094617; MORSE RA, 1991, TRENDS ECOL EVOL, V6, P337, DOI 10.1016/0169-5347(91)90043-W; Naug D, 2009, BIOL CONSERV, V142, P2369, DOI 10.1016/j.biocon.2009.04.007; Neumann P, 2010, J APICULT RES, V49, P1, DOI 10.3896/IBRA.1.49.1.01; Nino EL, 2013, INSECT MOL BIOL; Odoux JF, 2012, APIDOLOGIE, V43, P561, DOI 10.1007/s13592-012-0125-1; Ou BX, 2001, J AGR FOOD CHEM, V49, P4619, DOI 10.1021/jf010586o; Paxton RJ, 2010, J APICULT RES, V49, P80, DOI 10.3896/IBRA.1.49.1.11; Pernal SF, 2000, APIDOLOGIE, V31, P387, DOI 10.1051/apido:2000130; RINDERER TE, 1977, J ECON ENTOMOL, V70, P431, DOI 10.1093/jee/70.4.431; RINDERER TE, 1974, J INVERTEBR PATHOL, V23, P347, DOI 10.1016/0022-2011(74)90100-1; Roulston TH, 2000, EVOL ECOL RES, V2, P627; Roulston TH, 2000, PLANT SYST EVOL, V222, P187, DOI 10.1007/BF00984102; SCHMIDT JO, 1987, ANN ENTOMOL SOC AM, V80, P176, DOI 10.1093/aesa/80.2.176; SCHMIDT LS, 1995, J ECON ENTOMOL, V88, P1591, DOI 10.1093/jee/88.6.1591; Seehuus SC, 2006, P NATL ACAD SCI USA, V103, P962, DOI 10.1073/pnas.0502681103; Sies H, 1997, EXP PHYSIOL, V82, P291, DOI 10.1113/expphysiol.1997.sp004024; Singh RP, 1996, APIDOLOGIE, V27, P21, DOI 10.1051/apido:19960103; STANDIFER LN, 1967, INSECT SOC, V14, P415, DOI 10.1007/BF02223687; Stanley RG., 1974, POLLEN, DOI [10.1007/978-3-642-65905-8, DOI 10.1007/978-3-642-65905-8]; Tasei JN, 2008, APIDOLOGIE, V39, P397, DOI 10.1051/apido:2008017; Thompson GJ, 2007, J EXP ZOOL PART A, V307A, P600, DOI 10.1002/jez.415; Toth AL, 2005, J EXP BIOL, V208, P4641, DOI 10.1242/jeb.01956; vanEngelsdorp D, 2010, J INVERTEBR PATHOL, V103, pS80, DOI 10.1016/j.jip.2009.06.011; Vanengelsdorp D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004071; Vidau C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021550; WAHL O, 1983, OECOLOGIA, V59, P106, DOI 10.1007/BF00388082	82	435	445	10	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2013	8	8							e72016	10.1371/journal.pone.0072016	http://dx.doi.org/10.1371/journal.pone.0072016			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	218XC	23940803	Green Published, Green Submitted, gold			2022-12-25	WOS:000324465000241
J	Gagnon, A; Miller, MS; Hallman, SA; Bourbeau, R; Herring, DA; Earn, DJD; Madrenas, J				Gagnon, Alain; Miller, Matthew S.; Hallman, Stacey A.; Bourbeau, Robert; Herring, D. Ann; Earn, David J. D.; Madrenas, Joaquin			Age-Specific Mortality During the 1918 Influenza Pandemic: Unravelling the Mystery of High Young Adult Mortality	PLOS ONE			English	Article							INFECTIOUS-DISEASES; SEX DIFFERENTIALS; IMMUNE-RESPONSE; A VIRUS; EPITOPES; RISK; MICE; OLD	The worldwide spread of a novel influenza A (H1N1) virus in 2009 showed that influenza remains a significant health threat, even for individuals in the prime of life. This paper focuses on the unusually high young adult mortality observed during the Spanish flu pandemic of 1918. Using historical records from Canada and the U. S., we report a peak of mortality at the exact age of 28 during the pandemic and argue that this increased mortality resulted from an early life exposure to influenza during the previous Russian flu pandemic of 1889-90. We posit that in specific instances, development of immunological memory to an influenza virus strain in early life may lead to a dysregulated immune response to antigenically novel strains encountered in later life, thereby increasing the risk of death. Exposure during critical periods of development could also create holes in the T cell repertoire and impair fetal maturation in general, thereby increasing mortality from infectious diseases later in life. Knowledge of the age-pattern of susceptibility to mortality from influenza could improve crisis management during future influenza pandemics.	[Gagnon, Alain; Bourbeau, Robert] Univ Montreal, Dept Demog, Montreal, PQ, Canada; [Miller, Matthew S.] Icahn Sch Med Mt Sinai, Dept Microbiol, New York, NY USA; [Hallman, Stacey A.] Univ Western Ontario, Dept Sociol, London, ON, Canada; [Herring, D. Ann] McMaster Univ, Dept Anthropol, Hamilton, ON, Canada; [Earn, David J. D.] McMaster Univ, Dept Math & Stat, Hamilton, ON, Canada; [Earn, David J. D.] McMaster Univ, MG DeGroote Inst Infect Dis Res, Hamilton, ON, Canada; [Madrenas, Joaquin] McGill Univ, Dept Microbiol & Immunol, Montreal, PQ, Canada	Universite de Montreal; Icahn School of Medicine at Mount Sinai; Western University (University of Western Ontario); McMaster University; McMaster University; McMaster University; McGill University	Gagnon, A (corresponding author), Univ Montreal, Dept Demog, Montreal, PQ, Canada.	alain.gagnon.4@umontreal.ca	Madrenas, Quim/P-5008-2019	Earn, David/0000-0002-7562-1341; Miller, Matthew/0000-0003-3426-5069	Social Science and Humanity and Research council of Canada; Canadian Institutes of Health Research; Natural Sciences and Engineering Research Council of Canada	Social Science and Humanity and Research council of Canada; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	This work was supported by the Social Science and Humanity and Research council of Canada http://www.sshrc-crsh.gc.ca/home-accueil-eng.aspx (AG, SAH, DAH, and RB), the Canadian Institutes of Health Research http://www.cihr-irsc.gc.ca/e/193.html (AG, MSM, DJDE, and JM) and the Natural Sciences and Engineering Research Council of Canada http://www.nserc-crsng.gc.ca/index_eng.asp (DJDE). JM holds a Tier I Canada Research Chair in Human Immunology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adkins B, 2004, NAT REV IMMUNOL, V4, P553, DOI 10.1038/nri1394; Ahmed R, 2007, NAT IMMUNOL, V8, P1188, DOI 10.1038/ni1530; Almond D, 2006, J POLIT ECON, V114, P672, DOI 10.1086/507154; [Anonymous], 1940, T ACTUARIAL SOC AM; BARKER DJP, 1992, EUR J CLIN NUTR, V46, pS3; Bengtsson T, 2003, INT J EPIDEMIOL, V32, P286, DOI 10.1093/ije/dyg061; Bengtsson T, 2009, SOC SCI MED, V68, P1583, DOI 10.1016/j.socscimed.2009.02.020; BERTOLETTI A, 1994, NATURE, V369, P407, DOI 10.1038/369407a0; Boni MF, 2004, THEOR POPUL BIOL, V65, P179, DOI 10.1016/j.tpb.2003.10.002; Braciale TJ, 2012, NAT REV IMMUNOL, V12, P295, DOI 10.1038/nri3166; Chowell G, 2011, VACCINE, V29, pB21, DOI 10.1016/j.vaccine.2011.02.048; Clemow FG, 2011, GEOGRAPHY DIS; CLEVELAND WS, 1988, J AM STAT ASSOC, V83, P596, DOI 10.2307/2289282; Crosby A., 1989, AM FORGOTTEN PANDEMI; Curtin RG, 1891, T AM CLIM ASS M, V8, P109; Damjanovic D, 2012, CLIN IMMUNOL, V144, P57, DOI 10.1016/j.clim.2012.05.005; den Braber I, 2012, IMMUNITY, V36, P288, DOI 10.1016/j.immuni.2012.02.006; Dominion Bureau of Statistics, 1922, CAN YB 1921; Dowdle WR, 1999, B WORLD HEALTH ORGAN, V77, P820; Dubois F, 2007, GRIPPE ESPAGNOLE QUE; FRANCIS T, 1953, ANN INTERN MED, V39, P203, DOI 10.7326/0003-4819-39-2-203; Gagnon A, 2012, AM J HUM BIOL, V24, P654, DOI 10.1002/ajhb.22287; Gina K, 2001, FLU STORY GREAT INFL; Hallman S, MODERN ENV HUMAN HLT; Herring A, 2011, MIASMA MICROSCOPES R; Hill Kenneth, 2011, Genus, V67, P9; Hogquist KA, 2005, NAT REV IMMUNOL, V5, P772, DOI 10.1038/nri1707; Jobe AJ, 1999, PEDIATR RES, V46, P641, DOI 10.1203/00006450-199912000-00007; Kim JH, 2009, J IMMUNOL, V183, P3294, DOI 10.4049/jimmunol.0900398; Kobasa D, 2007, NATURE, V445, P319, DOI 10.1038/nature05495; Le Goff Jean-Marie, 2011, Genus, V67, P77; Lessler J, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002802; LIANG SH, 1994, J IMMUNOL, V152, P1653; Loo YM, 2007, NATURE, V445, P267, DOI 10.1038/445267a; Luk J, 2001, CLIN INFECT DIS, V33, P1375, DOI 10.1086/322662; Ma JL, 2011, J THEOR BIOL, V288, P29, DOI 10.1016/j.jtbi.2011.08.003; Mamelund SE, 2011, EPIDEMICS-NETH, V3, P46, DOI 10.1016/j.epidem.2011.02.001; Mitchell, 1920, SPECIAL TABLES MORTA; Morens DM, 2007, J INFECT DIS, V195, P1018, DOI 10.1086/511989; Myrskyla M, 2013, AM J PUBLIC HEALTH, V103, pE83, DOI 10.2105/AJPH.2012.301060; Nguyen AM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064198; Noymer A, 2000, POPUL DEV REV, V26, P565, DOI 10.1111/j.1728-4457.2000.00565.x; Oertel H, 1919, CAN MED ASSOC J, V9, P339; Palese P, 2004, NAT MED, V10, pS82, DOI 10.1038/nm1141; Palese P, 2011, MBIO, V2, DOI 10.1128/mBio.00150-11; Phillips Howard, 2003, SPANISH INFLUENZA PA; Reichert T, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-5; Rimmelzwaan GF, 2009, VACCINE, V27, P6363, DOI 10.1016/j.vaccine.2009.01.016; Sawchuk LA, 2009, AM J PHYS ANTHROPOL, V139, P584, DOI 10.1002/ajpa.21022; SHAHEEN SO, 1994, AM J RESP CRIT CARE, V149, P616, DOI 10.1164/ajrccm.149.3.8118627; Shanks GD, 2012, EMERG INFECT DIS, V18, P201, DOI 10.3201/eid1802.102042; SMITH FB, 1995, SOC HIST MED, V8, P55, DOI 10.1093/shm/8.1.55; Summers JA, 2010, EMERG INFECT DIS, V16, P1931, DOI 10.3201/eid1612.100429; Suzuki Y, 2011, GENES GENET SYST, V86, P287, DOI 10.1266/ggs.86.287; Swanson D., 2004, METHODS MAT DEMOGRAP; Taubenberger JK, 2006, EMERG INFECT DIS, V12, P15, DOI 10.3201/eid1209.05-0979; Valleron AJ, 2010, P NATL ACAD SCI USA, V107, P8778, DOI 10.1073/pnas.1000886107; Viboud C, 2013, J INFECT DIS, V207, P721, DOI 10.1093/infdis/jis745; Winter J., 1997, CAPITAL CITIES WAR; Wlodarczyk MF, 2013, J IMMUNOL, V190, P2736, DOI 10.4049/jimmunol.1201936	60	85	88	0	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2013	8	8							e69586	10.1371/journal.pone.0069586	http://dx.doi.org/10.1371/journal.pone.0069586			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	218XC	23940526	Green Submitted, Green Published, gold			2022-12-25	WOS:000324465000020
J	Hayasaka, D; Shirai, K; Aoki, K; Nagata, N; Simantini, DS; Kitaura, K; Takamatsu, Y; Gould, E; Suzuki, R; Morita, K				Hayasaka, Daisuke; Shirai, Kenji; Aoki, Kotaro; Nagata, Noriyo; Simantini, Dash Sima; Kitaura, Kazutaka; Takamatsu, Yuki; Gould, Ernest; Suzuki, Ryuji; Morita, Kouichi			TNF-alpha Acts as an Immunoregulator in the Mouse Brain by Reducing the Incidence of Severe Disease Following Japanese Encephalitis Virus Infection	PLOS ONE			English	Article							TUMOR-NECROSIS-FACTOR; CD8(+) T-CELLS; CENTRAL-NERVOUS-SYSTEM; NEURONAL DEATH; PERIPHERAL INFECTION; MURINE MODEL; WEST; MICE; PATHOGENESIS; MICROGLIA	Japanese encephalitis virus (JEV) causes acute central nervous system (CNS) disease in humans, in whom the clinical symptoms vary from febrile illness to meningitis and encephalitis. However, the mechanism of severe encephalitis has not been fully elucidated. In this study, using a mouse model, we investigated the pathogenetic mechanisms that correlate with fatal JEV infection. Following extraneural infection with the JaOArS982 strain of JEV, infected mice exhibited clinical signs ranging from mild to fatal outcome. Comparison of the pathogenetic response between severe and mild cases of JaOArS982-infected mice revealed increased levels of TNF-alpha in the brains of severe cases. However, unexpectedly, the mortality rate of TNF-alpha KO mice was significantly increased compared with that of WT mice, indicating that TNF-alpha plays a protective role against fatal infection. Interestingly, there were no significant differences of viral load in the CNS between WT and TNF-alpha KO mice. However, exaggerated inflammatory responses were observed in the CNS of TNF-alpha KO mice. Although these observations were also obtained in IL-10 KO mice, the mortality and enhanced inflammatory responses were more pronounced in TNF-alpha KO mice. Our findings therefore provide the first evidence that TNF-alpha has an immunoregulatory effect on pro-inflammatory cytokines in the CNS during JEV infection and consequently protects the animals from fatal disease. Thus, we propose that the increased level of TNF-alpha in severe cases was the result of severe disease, and secondly that immunopathological effects contribute to severe neuronal degeneration resulting in fatal disease. In future, further elucidation of the immunoregulatory mechanism of TNF-alpha will be an important priority to enable the development of effective treatment strategies for Japanese encephalitis.	[Hayasaka, Daisuke; Aoki, Kotaro; Simantini, Dash Sima; Takamatsu, Yuki; Morita, Kouichi] Nagasaki Univ, Dept Virol, Inst Trop Med, GCOE Program,Leading Grad Sch Program, Nagasaki 852, Japan; [Shirai, Kenji; Kitaura, Kazutaka; Suzuki, Ryuji] Natl Hosp Org Sagamihara Hosp, Clin Res Ctr, Sagamihara, Kanagawa, Japan; [Nagata, Noriyo] Natl Inst Infect Dis Musashimurayama, Dept Pathol, Tokyo, Japan; [Gould, Ernest] Aix Marseille Univ, UMR Emergence Pathol Viraies 190, Marseille, France; [Gould, Ernest] Inst Rech Dev, Marseille, France; [Gould, Ernest] NERC CEH, Wallingford, Oxon, England	Nagasaki University; UDICE-French Research Universities; Aix-Marseille Universite; Institut de Recherche pour le Developpement (IRD); UK Centre for Ecology & Hydrology (UKCEH)	Hayasaka, D (corresponding author), Nagasaki Univ, Dept Virol, Inst Trop Med, GCOE Program,Leading Grad Sch Program, Nagasaki 852, Japan.	hayasaka@nagasaki-u.ac.jp		AOKI, KOTARO/0000-0002-2615-9058	KAKENHI from Japan Society for the Promotion of Science [23658243]; Health and Labour Sciences Research Grant on Emerging and Re-emerging Infectious Diseases from the Japanese Ministry of Health, Labour and Welfare; Natural Environment Research Council [ceh010010] Funding Source: researchfish; Grants-in-Aid for Scientific Research [23590554] Funding Source: KAKEN	KAKENHI from Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Health and Labour Sciences Research Grant on Emerging and Re-emerging Infectious Diseases from the Japanese Ministry of Health, Labour and Welfare; Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	KAKENHI (Grant-in-Aid for Challenging Exploratory Research (23658243)) from Japan Society for the Promotion of Science. Health and Labour Sciences Research Grant on Emerging and Re-emerging Infectious Diseases from the Japanese Ministry of Health, Labour and Welfare. The Global COE Program for control of emerging and re-emerging infectious diseases (Nagasaki University). The Japan Initiative for Global Research Network on Infectious Diseases. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albrecht P, 1968, Curr Top Microbiol Immunol, V43, P44; Bai FW, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000610; Biswas SM, 2010, J MED VIROL, V82, P304, DOI 10.1002/jmv.21688; BURKE SD, 2001, FIELDS VIROLOGY, P991; Byrne SN, 2001, J INVEST DERMATOL, V117, P702, DOI 10.1046/j.0022-202x.2001.01454.x; Chen CJ, 2012, GLIA, V60, P487, DOI 10.1002/glia.22282; Chen CJ, 2011, NEUROCHEM INT, V58, P234, DOI 10.1016/j.neuint.2010.12.009; Dumpis U, 1999, CLIN INFECT DIS, V28, P882, DOI 10.1086/515195; DUNN AJ, 1989, PHYSIOL BEHAV, V45, P591, DOI 10.1016/0031-9384(89)90078-4; Erlanger TE, 2009, EMERG INFECT DIS, V15, P1, DOI 10.3201/eid1501.080311; Fujii Y, 2008, JPN J INFECT DIS, V61, P40; Fujii Y, 2011, VIRAL IMMUNOL, V24, P291, DOI 10.1089/vim.2011.0017; Garcia-Tapia D, 2007, J NEUROVIROL, V13, P130, DOI 10.1080/13550280601187185; German AC, 2006, T ROY SOC TROP MED H, V100, P1135, DOI 10.1016/j.trstmh.2006.02.008; Ghoshal A, 2007, GLIA, V55, P483, DOI 10.1002/glia.20474; GUBLER JD, 2007, FIELDS VIROLOGY, P1153; HASE T, 1990, INT J EXP PATHOL, V71, P857; Hayasaka D, 2001, J GEN VIROL, V82, P1319, DOI 10.1099/0022-1317-82-6-1319; Hayasaka D, 2007, VIROL J, V4, DOI 10.1186/1743-422X-4-22; Hayasaka D, 2009, VIROLOGY, V390, P139, DOI 10.1016/j.virol.2009.04.026; KAGI D, 1994, SCIENCE, V265, P528, DOI 10.1126/science.7518614; Kagi D, 1996, ANNU REV IMMUNOL, V14, P207, DOI 10.1146/annurev.immunol.14.1.207; Kimura T, 2010, VET PATHOL, V47, P806, DOI 10.1177/0300985810372507; King NJC, 2007, IMMUNOL CELL BIOL, V85, P33, DOI 10.1038/sj.icb.7100012; Klein RS, 2005, J VIROL, V79, P11457, DOI 10.1128/JVI.79.17.11457-11466.2005; KOJIMA H, 1994, IMMUNITY, V1, P357, DOI 10.1016/1074-7613(94)90066-3; Konishi E, 2010, VACCINE, V28, P2664, DOI 10.1016/j.vaccine.2010.01.008; KUHN R, 1993, CELL, V75, P263, DOI 10.1016/0092-8674(93)80068-P; Larena M, 2011, FLAVIVIRUS ENCEPHALI, P317; Larena M, 2011, J VIROL, V85, P5446, DOI 10.1128/JVI.02611-10; Lennette EH, 1944, J IMMUNOL, V49, P175; Luna RML, 2002, J VIROL, V76, P3202, DOI 10.1128/JVI.76.7.3202-3211.2002; Mandl CW, 2005, VIRUS RES, V111, P161, DOI 10.1016/j.virusres.2005.04.007; Misra UK, 2010, PROG NEUROBIOL, V91, P108, DOI 10.1016/j.pneurobio.2010.01.008; Monath TP, 2003, J INFECT DIS, V188, P1213, DOI 10.1086/378356; Montgomery SL, 2012, J NEUROIMMUNE PHARM, V7, P42, DOI 10.1007/s11481-011-9287-2; Moore KW, 2001, ANNU REV IMMUNOL, V19, P683, DOI 10.1146/annurev.immunol.19.1.683; Mullbacher A, 1999, P NATL ACAD SCI USA, V96, P13950, DOI 10.1073/pnas.96.24.13950; Nagata N, 2007, J VIROL, V81, P1848, DOI 10.1128/JVI.01967-06; Pasparakis M, 1997, P NATL ACAD SCI USA, V94, P6319, DOI 10.1073/pnas.94.12.6319; Pasparakis M, 1996, J EXP MED, V184, P1397, DOI 10.1084/jem.184.4.1397; Pestka S, 2004, ANNU REV IMMUNOL, V22, P929, DOI 10.1146/annurev.immunol.22.012703.104622; Pinto AK, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002407; Ravi V, 1997, J MED VIROL, V51, P132, DOI 10.1002/(SICI)1096-9071(199702)51:2&lt;132::AID-JMV8&gt;3.0.CO;2-8; Robertson SJ, 2009, IMMUNOL RES, V43, P172, DOI 10.1007/s12026-008-8065-6; Ruzek D, 2009, VIROLOGY, V384, P1, DOI 10.1016/j.virol.2008.11.023; Samuel MA, 2006, J VIROL, V80, P9349, DOI 10.1128/JVI.01122-06; Savino W, 2006, PLOS PATHOG, V2, P472, DOI 10.1371/journal.ppat.0020062; Saxena V, 2008, ARCH VIROL, V153, P283, DOI 10.1007/s00705-007-1098-7; Saxena V, 2008, MICROBES INFECT, V10, P1210, DOI 10.1016/j.micinf.2008.06.015; Shrestha B, 2004, J VIROL, V78, P8312, DOI [10.1128/JVI.78.15.8312-8321.2004, 10.1128/jvi.78.15.8312-8321.2004]; Shrestha B, 2008, J VIROL, V82, P8956, DOI 10.1128/JVI.01118-08; Shrestha B, 2012, J VIROL, V86, P8937, DOI 10.1128/JVI.00673-12; Sitati E, 2007, J VIROL, V81, P9801, DOI 10.1128/JVI.00941-07; Smith JA, 2012, BRAIN RES BULL, V87, P10, DOI 10.1016/j.brainresbull.2011.10.004; Swarup V, 2008, NEUROCHEM INT, V52, P1310, DOI 10.1016/j.neuint.2008.01.014; Swarup V, 2007, J NEUROCHEM, V103, P771, DOI 10.1111/j.1471-4159.2007.04790.x; Szretter KJ, 2009, J VIROL, V83, P9329, DOI 10.1128/JVI.00836-09; Taniguchi T, 1997, LAB INVEST, V77, P647; Thongtan T, 2012, CLIN DEV IMMUNOL, DOI 10.1155/2012/890586; Tsai Theodore F., 2000, Vaccine, V18, P1, DOI 10.1016/S0264-410X(00)00037-2; Turtle L, 2012, QJM-INT J MED, V105, P219, DOI 10.1093/qjmed/hcs013; Wang Y, 2003, J VIROL, V77, P13323, DOI [10.1128/JVI.77.24.13323-13334.2003, 10.1128/JVi.77.24.13323-13334.2003]; Winter PM, 2004, J INFECT DIS, V190, P1618, DOI 10.1086/423328; Zhang B, 2008, J IMMUNOL, V180, P2641, DOI 10.4049/jimmunol.180.4.2641; Zhang B, 2010, J NEUROIMMUNOL, V224, P28, DOI 10.1016/j.jneuroim.2010.05.003	66	28	28	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2013	8	8							e71643	10.1371/journal.pone.0071643	http://dx.doi.org/10.1371/journal.pone.0071643			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	218XC	23940775	Green Published, Green Accepted, Green Submitted, gold			2022-12-25	WOS:000324465000218
J	Silver, AC; Dunne, DW; Zeiss, CJ; Bockenstedt, LK; Radolf, JD; Salazar, JC; Fikrig, E				Silver, Adam C.; Dunne, Dana W.; Zeiss, Caroline J.; Bockenstedt, Linda K.; Radolf, Justin D.; Salazar, Juan C.; Fikrig, Erol			MyD88 Deficiency Markedly Worsens Tissue Inflammation and Bacterial Clearance in Mice Infected with Treponema pallidum, the Agent of Syphilis	PLOS ONE			English	Article							HUMORAL IMMUNE-RESPONSE; OUTER-MEMBRANE PROTEINS; TOLL-LIKE RECEPTOR-2; BORRELIA-BURGDORFERI; LIPID MODIFICATION; HOST-DEFENSE; LIPOPROTEINS; PHAGOCYTOSIS; POLYPEPTIDES; PATHOGENESIS	Research on syphilis, a sexually transmitted infection caused by the non-cultivatable spirochete Treponema pallidum, has been hampered by the lack of an inbred animal model. We hypothesized that Toll-like receptor (TLR)-dependent responses are essential for clearance of T. pallidum and, consequently, compared infection in wild-type (WT) mice and animals lacking MyD88, the adaptor molecule required for signaling by most TLRs. MyD88-deficient mice had significantly higher pathogen burdens and more extensive inflammation than control animals. Whereas tissue infiltrates in WT mice consisted of mixed mononuclear and plasma cells, infiltrates in MyD88-deficient animals were predominantly neutrophilic. Although both WT and MyD88-deficient mice produced antibodies that promoted uptake of treponemes by WT macrophages, MyD88-deficient macrophages were deficient in opsonophagocytosis of treponemes. Our results demonstrate that TLR-mediated responses are major contributors to the resistance of mice to syphilitic disease and that MyD88 signaling and FcR-mediated opsonophagocytosis are linked to the macrophage-mediated clearance of treponemes.	[Silver, Adam C.; Dunne, Dana W.; Fikrig, Erol] Yale Univ, Sch Med, Dept Internal Med, Infect Dis Sect, New Haven, CT 06510 USA; [Zeiss, Caroline J.] Yale Univ, Sch Med, Comparat Med Sect, New Haven, CT 06510 USA; [Bockenstedt, Linda K.] Yale Univ, Sch Med, Dept Internal Med, Rheumatol Sect, New Haven, CT 06510 USA; [Radolf, Justin D.] Univ Connecticut, Ctr Hlth, Dept Med, Farmington, CT USA; [Radolf, Justin D.; Salazar, Juan C.] Univ Connecticut, Ctr Hlth, Dept Pediat, Farmington, CT USA; [Radolf, Justin D.] Univ Connecticut, Ctr Hlth, Dept Genet & Dev Biol, Farmington, CT USA; [Radolf, Justin D.; Salazar, Juan C.] Univ Connecticut, Ctr Hlth, Dept Immunol, Farmington, CT USA; [Radolf, Justin D.; Salazar, Juan C.] Connecticut Childrens Med Ctr, Div Pediat Infect Dis, Hartford, CT USA; [Fikrig, Erol] Howard Hughes Med Inst, Chevy Chase, MD USA	Yale University; Yale University; Yale University; University of Connecticut; University of Connecticut; University of Connecticut; University of Connecticut; Connecticut Children's Medical Center; Howard Hughes Medical Institute	Fikrig, E (corresponding author), Yale Univ, Sch Med, Dept Internal Med, Infect Dis Sect, New Haven, CT 06510 USA.	erol.fikrig@yale.edu			National Institutes of Health (NIH) [AI49200]; NIH/National Institute of Allergy and Infectious Diseases [AI26756, AI090166AI]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R29AI026756, R01AI090166, R37AI026756, R01AI026756, R37AI049200, R01AI049200, R56AI090166] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH/National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	EF is an investigator of the Howard Hughes Medical Institute. This work was also supported in part by National Institutes of Health (NIH) grant AI49200 (EF), and NIH/National Institute of Allergy and Infectious Diseases AI26756 (JDR) and AI090166AI (JCS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKINS DR, 1993, INFECT IMMUN, V61, P1202, DOI 10.1128/IAI.61.4.1202-1210.1993; Baughn RE, 2005, CLIN MICROBIOL REV, V18, P205, DOI 10.1128/CMR.18.1.205-216.2005; Blander JM, 2004, SCIENCE, V304, P1014, DOI 10.1126/science.1096158; BOURELL KW, 1994, J BACTERIOL, V176, P1598, DOI 10.1128/jb.176.6.1598-1608.1994; Brightbill HD, 1999, SCIENCE, V285, P732, DOI 10.1126/science.285.5428.732; Cruz AR, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000690; Cruz AR, 2012, PLOS NEGL TROP DIS, V6, pe1717; Desrosiers DC, 2011, MOL MICROBIOL, V80, P1496, DOI 10.1111/j.1365-2958.2011.07662.x; FOLDS JD, 1983, SCAND J IMMUNOL, V18, P201, DOI 10.1111/j.1365-3083.1983.tb00858.x; GUEFT B, 1948, Am J Syph Gonorrhea Vener Dis, V32, P59; HANFF PA, 1982, J IMMUNOL, V129, P1287; HANFF PA, 1983, J IMMUNOL, V131, P1973; Hazlett KRO, 2001, J EXP MED, V193, P1015, DOI 10.1084/jem.193.9.1015; JONES JD, 1995, INFECT IMMUN, V63, P2424, DOI 10.1128/IAI.63.7.2424-2434.1995; JONES SA, 1984, J EXP MED, V160, P1404, DOI 10.1084/jem.160.5.1404; KLEIN JR, 1980, NATURE, V283, P572, DOI 10.1038/283572a0; LaFond RE, 2006, CLIN MICROBIOL REV, V19, P29, DOI 10.1128/CMR.19.1.29-49.2006; Lien E, 1999, J BIOL CHEM, V274, P33419, DOI 10.1074/jbc.274.47.33419; Liu NY, 2004, INFECT IMMUN, V72, P3195, DOI 10.1128/IAI.72.6.3195-3203.2004; LUKEHART SA, 1978, J IMMUNOL, V121, P2014; LUKEHART SA, 1982, J IMMUNOL, V129, P833; LUKEHART SA, 2004, HARRISONS PRINCIPLES, P977; Lukehart SA, 2007, CURR PROTOC MICROBIO, P11; Lukehart SA, 2008, SEX TRANSM DIS, V35, P2, DOI 10.1097/OLQ.0b013e318162c4f2; Magnuson Harold J., 1948, AMER JOUR SYPHILIS GONORRHEA AND VENEREAL DIS, V32, P1; Overbergh L, 1999, CYTOKINE, V11, P305, DOI 10.1006/cyto.1998.0426; Peeling RW, 2006, J PATHOL, V208, P224, DOI 10.1002/path.1903; PURCELL BK, 1990, MOL MICROBIOL, V4, P1371, DOI 10.1111/j.1365-2958.1990.tb00716.x; RADOLF JD, 1989, P NATL ACAD SCI USA, V86, P2051, DOI 10.1073/pnas.86.6.2051; RADOLF JD, 1995, MOL MICROBIOL, V16, P1067, DOI 10.1111/j.1365-2958.1995.tb02332.x; Radolf JD, 2006, PATHOGENIC TREPONEMA : MOLECULAR AND CELLULAR BIOLOGY, P285; Radolf JD, 2006, PATHOGENIC TREPONEMA : MOLECULAR AND CELLULAR BIOLOGY, P197; Radolf Justin D., 1994, Trends in Microbiology, V2, P307, DOI 10.1016/0966-842X(94)90446-4; ROSAHN PAUL D., 1948, AMER JOUR SYPHILIS GONORRHEA AND VENEREAL PIS, V32, P327; Salazar JC, 2007, INFECT IMMUN, V75, P2954, DOI 10.1128/IAI.00090-07; SAUNDERS JM, 1985, GENITOURIN MED, V61, P221; Schell RF., 1983, PATHOGENESIS IMMUNOL, P121; SELL S, 1983, INT REV EXP PATHOL, V24, P203; Sellati TJ, 1998, J IMMUNOL, V160, P5455; Shin OS, 2008, INFECT IMMUN, V76, P2341, DOI 10.1128/IAI.01600-07; Tramont EC, 2010, MANDELL DOUGLAS BENN, P3035; TURNER T B, 1957, Monogr Ser World Health Organ, P3; TURNER TB, 1969, BRIT J VENER DIS, V45, P183; Wang XH, 2005, INFECT IMMUN, V73, P657, DOI 10.1128/IAI.73.1.657-660.2005; WHO, 1970, WHO TECH REP SER, V455, P1; Wooten RM, 2002, J IMMUNOL, V168, P348, DOI 10.4049/jimmunol.168.1.348	46	9	12	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2013	8	8							e71388	10.1371/journal.pone.0071388	http://dx.doi.org/10.1371/journal.pone.0071388			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	218XC	23940747	Green Submitted, Green Published, gold			2022-12-25	WOS:000324465000208
J	Wang, WQ; Liu, L; Xu, HX; Luo, GP; Chen, T; Wu, CT; Xu, YF; Xu, J; Liu, C; Zhang, B; Long, J; Tang, ZY; Yu, XJ				Wang, Wen-Quan; Liu, Liang; Xu, Hua-Xiang; Luo, Guo-Pei; Chen, Tao; Wu, Chun-Tao; Xu, Yong-Feng; Xu, Jin; Liu, Chen; Zhang, Bo; Long, Jiang; Tang, Zhao-You; Yu, Xian-Jun			Intratumoral alpha-SMA Enhances the Prognostic Potency of CD34 Associated with Maintenance of Microvessel Integrity in Hepatocellular Carcinoma and Pancreatic Cancer	PLOS ONE			English	Article							COLONY-STIMULATING FACTOR; PERITUMORAL LIVER-TISSUE; HEPATIC STELLATE CELLS; INHIBITS METASTASIS; TUMOR ANGIOGENESIS; CURATIVE RESECTION; HIGH EXPRESSION; BREAST-CANCER; RECURRENCE; DENSITY	Microvessel density (MVD) as an angiogenesis predictor is inefficient per se in cancer prognosis. We evaluated prognostic values of combining intratumoral alpha-smooth muscle actin (alpha-SMA)-positive stromal cell density and MVD after curative resection in hypervascular hepatocellular carcinoma (HCC) and hypovascular pancreatic cancer (PC). Tissue microarrays were constructed from tumors of 305 HCC and 57 PC patients who underwent curative resection and analyzed for alpha-SMA and CD34 expression by immunostaining. Prognostic values of these two proteins and other clinicopathological features were examined. Both low alpha-SMA density and high MVD-CD34 were associated in HCC with the presence of intrahepatic metastasis and microvascular invasion, and they were related to lymph node involvement and microvascular invasion in PC (p<0.05). Although CD34 alone, but not alpha-SMA, was an independent prognostic factor for overall survival and recurrence-free survival, the combination of low alpha-SMA and high CD34 was a predictor of worst prognosis for both types of tumors and had a better power to predict patient death and early recurrence (p<0.01). Furthermore, the results show that distribution of most of the alpha-SMA-positive cells and vascular endothelial cells overlap, showing major colocalization on vascular walls. Poor microvessel integrity, as indicated by high MVD, together with low perivascular alpha-SMA-positive cell coverage is associated with early recurrence, unfavorable metastasis, and short survival after tumor resection. This finding highlights the significance of vascular quality in tumor progression, which provides an optimized complement to vascular quantity in prognosis of postoperative patients.	[Wang, Wen-Quan; Liu, Liang; Xu, Hua-Xiang; Luo, Guo-Pei; Chen, Tao; Wu, Chun-Tao; Xu, Yong-Feng; Xu, Jin; Liu, Chen; Zhang, Bo; Long, Jiang; Yu, Xian-Jun] Fudan Univ, Shanghai Canc Ctr, Dept Pancreat & Hepatobiliary Surg, Shanghai 200433, Peoples R China; [Wang, Wen-Quan; Liu, Liang; Xu, Hua-Xiang; Luo, Guo-Pei; Chen, Tao; Wu, Chun-Tao; Xu, Yong-Feng; Xu, Jin; Liu, Chen; Zhang, Bo; Long, Jiang; Yu, Xian-Jun] Fudan Univ, Shanghai Med Coll, Dept Oncol, Shanghai 200433, Peoples R China; [Wang, Wen-Quan; Liu, Liang; Xu, Hua-Xiang; Luo, Guo-Pei; Chen, Tao; Wu, Chun-Tao; Xu, Yong-Feng; Xu, Jin; Liu, Chen; Zhang, Bo; Long, Jiang; Yu, Xian-Jun] Fudan Univ, Pancreat Canc Inst, Shanghai 200433, Peoples R China; [Tang, Zhao-You] Fudan Univ, Key Lab Carcinogenesis & Canc Invas, Chinese Minist Educ, Liver Canc Inst,Zhongshan Hosp, Shanghai 200433, Peoples R China	Fudan University; Fudan University; Fudan University; Fudan University	Yu, XJ (corresponding author), Fudan Univ, Shanghai Canc Ctr, Dept Pancreat & Hepatobiliary Surg, Shanghai 200433, Peoples R China.	yuxianjun88@hotmail.com	Luo, Guopei/Y-4642-2018	Luo, Guopei/0000-0002-6582-9624; yu, xianjun/0000-0002-6697-7143	National Natural Science Foundation of China [81172005, 81172276]; National Natural Science Foundation of Shanghai [11ZR1407000]; Ph.D. Programs Foundation of Ministry of Education of China [20110071120096]; Chinesisch-Deutsches Forschungsprojekt [GZ 857]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Natural Science Foundation of Shanghai; Ph.D. Programs Foundation of Ministry of Education of China(Ministry of Education, China); Chinesisch-Deutsches Forschungsprojekt	Supported by the National Natural Science Foundation of China (81172005 and 81172276), the National Natural Science Foundation of Shanghai (11ZR1407000), Ph.D. Programs Foundation of Ministry of Education of China (20110071120096), and the Chinesisch-Deutsches Forschungsprojekt (GZ 857). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bao BN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050860; Batchelor TT, 2007, CANCER CELL, V11, P83, DOI 10.1016/j.ccr.2006.11.021; Carmeliet P, 2011, NATURE, V473, P298, DOI 10.1038/nature10144; Cascone T, 2012, J CLIN ONCOL, V30, P441, DOI 10.1200/JCO.2011.38.7621; CHARPIN C, 1995, AM J CLIN PATHOL, V103, P443; Cooke VG, 2012, CANCER CELL, V21, P66, DOI 10.1016/j.ccr.2011.11.024; de Oliveira RL, 2012, CANCER CELL, V22, P263, DOI 10.1016/j.ccr.2012.06.028; Ebos JML, 2009, CANCER CELL, V15, P232, DOI 10.1016/j.ccr.2009.01.021; Edge SB, 2010, AJCC CANC STAGING MA; Feig C, 2012, CLIN CANCER RES, V18, P4266, DOI 10.1158/1078-0432.CCR-11-3114; Friedman SL, 2008, PHYSIOL REV, V88, P125, DOI 10.1152/physrev.00013.2007; Goel S, 2011, PHYSIOL REV, V91, P1071, DOI 10.1152/physrev.00038.2010; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hezel AF, 2012, CANCER RES, V72, P4840, DOI 10.1158/0008-5472.CAN-12-0634; Hidalgo M, 2010, NEW ENGL J MED, V362, P1605, DOI 10.1056/NEJMra0901557; Jain RK, 2006, NAT CLIN PRACT ONCOL, V3, P24, DOI 10.1038/ncponc0403; Jain RK, 2001, NAT MED, V7, P987, DOI 10.1038/nm0901-987; Jia JB, 2011, INVEST NEW DRUG, V29, P861, DOI 10.1007/s10637-010-9435-1; Jia JB, 2010, ONCOLOGIST, V15, P732, DOI 10.1634/theoncologist.2009-0170; Johansson A, 2012, P NATL ACAD SCI USA, V109, P7841, DOI 10.1073/pnas.1118296109; Ju MJ, 2009, AM J CLIN PATHOL, V131, P498, DOI 10.1309/AJCP86PPBNGOHNNL; Kumar S, 1999, CANCER RES, V59, P856; Liu C, 2012, J SURG RES, V172, pE11, DOI 10.1016/j.jss.2011.09.002; Liu LA, 2010, CLIN CANCER RES, V16, P2740, DOI 10.1158/1078-0432.CCR-09-2610; MAEDA K, 1995, J CLIN ONCOL, V13, P477, DOI 10.1200/JCO.1995.13.2.477; Mazzone M, 2009, CELL, V136, P839, DOI 10.1016/j.cell.2009.01.020; Niedergethmann M, 2000, INT J PANCREATOL, V28, P31, DOI 10.1385/IJGC:28:1:31; Paez-Ribes M, 2009, CANCER CELL, V15, P220, DOI 10.1016/j.ccr.2009.01.027; Paradiso A, 2001, CLIN EXP MED, V1, P127, DOI 10.1007/s10238-001-8023-2; Poon RTP, 2002, J CLIN ONCOL, V20, P1775, DOI 10.1200/JCO.2002.07.089; Poon RTP, 2000, CANCER, V89, P500, DOI 10.1002/1097-0142(20000801)89:3<500::AID-CNCR4>3.3.CO;2-F; Raza A, 2010, AM J HEMATOL, V85, P593, DOI 10.1002/ajh.21745; Rolny C, 2011, CANCER CELL, V19, P31, DOI 10.1016/j.ccr.2010.11.009; Roskoski R, 2007, BIOCHEM BIOPH RES CO, V356, P323, DOI 10.1016/j.bbrc.2007.02.156; Sasajima J, 2010, CANCER RES, V70, P6283, DOI 10.1158/0008-5472.CAN-10-0412; Sugimoto H, 2006, CANCER BIOL THER, V5, P1640, DOI 10.4161/cbt.5.12.3354; Sun HC, 1999, J CANCER RES CLIN, V125, P419, DOI 10.1007/s004320050296; Sun HC, 2007, J HEPATOL, V47, P684, DOI 10.1016/j.jhep.2007.06.019; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Uzzan B, 2004, CANCER RES, V64, P2941, DOI 10.1158/0008-5472.CAN-03-1957; van der Zee JA, 2011, EUR J CANCER, V47, P2576, DOI 10.1016/j.ejca.2011.08.016; Wang WQ, 2012, J HEMATOL ONCOL, V5, DOI 10.1186/1756-8722-5-69; Zhang W, 2012, GASTROENTEROLOGY, V143, P1641, DOI 10.1053/j.gastro.2012.08.032; Zhu XD, 2008, J CLIN ONCOL, V26, P2707, DOI 10.1200/JCO.2007.15.6521	44	61	64	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2013	8	8							e71189	10.1371/journal.pone.0071189	http://dx.doi.org/10.1371/journal.pone.0071189			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	218XC	23940715	gold, Green Published, Green Submitted			2022-12-25	WOS:000324465000190
J	Xie, WW; Donohue, RC; Birchler, JA				Xie, Weiwu; Donohue, Ryan C.; Birchler, James A.			Quantitatively Increased Somatic Transposition of Transposable Elements in Drosophila Strains Compromised for RNAi	PLOS ONE			English	Article							L1 RETROTRANSPOSITION; DISTINCT ROLES; MELANOGASTER; PATHWAY; CELLS; HOBO	In Drosophila melanogaster, small RNAs homologous to transposable elements (TEs) are of two types: piRNA (piwi-interacting RNA) with size 23-29nt and siRNA (small interfering RNA) with size 19-22nt. The siRNA pathway is suggested to silence TE activities in somatic tissues based on TE expression profiles, but direct evidence of transposition is lacking. Here we developed an efficient FISH (fluorescence in Situ hybridization) based method for polytene chromosomes from larval salivary glands to reveal new TE insertions. Analysis of the LTR-retrotransposon 297 and the non-LTR retroposon DOC shows that in the argonaut 2 (Ago2) and Dicer 2 (Dcr2) mutant strains, new transposition events are much more frequent than in heterozygous strains or wild type strains. The data demonstrate that the siRNA pathway represses TE transposition in somatic cells. Nevertheless, we found that loss of one functional copy of Ago2 or Dcr2 increases somatic transpositions of the elements at a lower level depending on the genetic background, suggesting a quantitative role for RNAi core components on mutation frequency.	[Xie, Weiwu; Donohue, Ryan C.; Birchler, James A.] Univ Missouri, Div Biol Sci, Columbia, MO 65211 USA	University of Missouri System; University of Missouri Columbia	Birchler, JA (corresponding author), Univ Missouri, Div Biol Sci, Columbia, MO 65211 USA.	BirchlerJ@Missouri.edu		Donohue, Ryan/0000-0001-9941-5246	NSF [MCB 0923607]	NSF(National Science Foundation (NSF))	Research supported by NSF grant MCB 0923607. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baillie JK, 2011, NATURE, V479, P534, DOI 10.1038/nature10531; Biemont C, 2004, METH MOL B, V260, P21, DOI 10.1385/1-59259-755-6:021; Brennecke J, 2007, CELL, V128, P1089, DOI 10.1016/j.cell.2007.01.043; BRIZUELA BJ, 1994, GENETICS, V137, P803; CHABOISSIER MC, 1990, EMBO J, V9, P3557, DOI 10.1002/j.1460-2075.1990.tb07566.x; Chung WJ, 2008, CURR BIOL, V18, P795, DOI 10.1016/j.cub.2008.05.006; Conte D, 2000, MOL MICROBIOL, V35, P415, DOI 10.1046/j.1365-2958.2000.01710.x; Coufal NG, 2009, NATURE, V460, P1127, DOI 10.1038/nature08248; Czech B, 2008, NATURE, V453, P798, DOI 10.1038/nature07007; Del Re B, 2010, EXP CELL RES, V316, P3358, DOI 10.1016/j.yexcr.2010.06.024; Eickbush MT, 2011, MOBILE DNA-UK, V2, DOI 10.1186/1759-8753-2-11; Ghildiyal M, 2008, SCIENCE, V320, P1077, DOI 10.1126/science.1157396; Golden DE, 2008, MOL CELL, V31, P309, DOI 10.1016/j.molcel.2008.07.008; KAMINKER JS, 2002, GENOME BIOL, V0003; Kano H, 2009, GENE DEV, V23, P1303, DOI 10.1101/gad.1803909; Kato A, 2011, METHODS MOL BIOL, V701, P67, DOI 10.1007/978-1-61737-957-4_4; Kawamura Y, 2008, NATURE, V453, P793, DOI 10.1038/nature06938; Kazazian HH, 2011, BMC BIOL, V9, DOI 10.1186/1741-7007-9-62; Kovalenko LV, 2006, RUSS J GENET+, V42, P122, DOI 10.1134/S1022795406020049; LASKI FA, 1986, CELL, V44, P7, DOI 10.1016/0092-8674(86)90480-0; Lee YS, 2004, CELL, V117, P69, DOI 10.1016/S0092-8674(04)00261-2; Malone CD, 2009, CELL, V137, P522, DOI 10.1016/j.cell.2009.03.040; Malone CD, 2009, CELL, V136, P656, DOI 10.1016/j.cell.2009.01.045; Moschetti R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013142; Muotri AR, 2010, NATURE, V468, P443, DOI 10.1038/nature09544; Muotri AR, 2005, NATURE, V435, P903, DOI 10.1038/nature03663; Okamura K, 2004, GENE DEV, V18, P1655, DOI 10.1101/gad.1210204; Okamura K, 2008, NATURE, V453, P803, DOI 10.1038/nature07015; Scholes DT, 2001, GENETICS, V159, P1449; van den Hurk JAJM, 2007, HUM MOL GENET, V16, P1587, DOI 10.1093/hmg/ddm108; Vitte C, 2003, MOL BIOL EVOL, V20, P528, DOI 10.1093/molbev/msg055; Zakharenko LP, 2007, HEREDITY, V99, P525, DOI 10.1038/sj.hdy.6801029	32	12	13	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2013	8	8							e72163	10.1371/journal.pone.0072163	http://dx.doi.org/10.1371/journal.pone.0072163			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	218XC	23940807	Green Published, Green Submitted, gold			2022-12-25	WOS:000324465000245
J	Zhang, JF; Lu, YX; Yue, XP; Li, HM; Luo, X; Wang, Y; Wang, KP; Wan, J				Zhang, Jufeng; Lu, Yanxin; Yue, Xupeng; Li, Huiming; Luo, Xia; Wang, Ying; Wang, Kepeng; Wan, Jun			MiR-124 Suppresses Growth of Human Colorectal Cancer by Inhibiting STAT3	PLOS ONE			English	Article							DNA METHYLATION; MICRORNAS; GENES; INFLAMMATION; SURVIVAL; IL-6; PROLIFERATION; DYSREGULATION; ACTIVATION; DELETIONS	Emerging evidence indicate that microRNAs (miRNAs) may play important roles in cancer. Aberrant expression of miRNAs has been frequently identified in different human malignancies, including colorectal cancer (CRC). However, the mechanism by which deregulated miRNAs impact the development of CRC remains largely elusive. In this study, we show that miR-124 is significantly down-regulated in CRC compared to adjacent non-tumor colorectal tissues. MiR-124 suppresses the expression of STAT3 by directly binding to its 3'-untranslated region (3'-UTR). Overexpression of miR-124 led to increased apoptosis of CRC cells and reduced tumor growth in vitro and in vivo. Knocking down STAT3 expression by specific siRNA suppressed the growth of CRC cells in vitro and in vivo, resembling that of miR-124 overexpression. Moreover, overexpression of STAT3 in miR-124-transfected CRC cells effectively rescued the inhibition of cell proliferation caused by miR-124. These data suggest that miR-124 serves as a tumor suppressor by targeting STAT3, and call for the use of miR-124 as a potential therapeutic tool for CRC, where STAT3 is often hyper-activated.	[Zhang, Jufeng] Guangdong Pharmaceut Univ, Sch Life Sci, Guangzhou, Guangdong, Peoples R China; [Zhang, Jufeng; Lu, Yanxin; Yue, Xupeng; Wang, Ying; Wang, Kepeng; Wan, Jun] Shenzhen PKU HKUST Med Ctr, Biomed Res Inst, Shenzhen, Peoples R China; [Li, Huiming] Shanghai Jiao Tong Univ, Sch Med, Peoples Hosp 1, Expt Res Ctr, Shanghai 200030, Peoples R China; [Luo, Xia] South China Agr Univ, Coll Engn, Guangzhou, Guangdong, Peoples R China; [Wan, Jun] Hong Kong Univ Sci & Technol, Div Life Sci, Hong Kong, Hong Kong, Peoples R China	Guangdong Pharmaceutical University; Hong Kong University of Science & Technology; Peking University; Shenzhen PKU-HKUST Medical Center; Shanghai Jiao Tong University; South China Agricultural University; Hong Kong University of Science & Technology	Zhang, JF (corresponding author), Guangdong Pharmaceut Univ, Sch Life Sci, Guangzhou, Guangdong, Peoples R China.	jfzhang111@163.com; kepengwang@gmail.com; wanj@ust.hk	Wang, Kepeng/F-8363-2014	Wang, Kepeng/0000-0001-6428-4709; Wan, Jun/0000-0001-7308-0150; lu, yanxin/0000-0003-4598-3015	National Natural Scientific Foundation of China [81171447]; Natural Science Foundation of Guangdong Province, China [104518036002006310]; Shenzhen Science and Technology Project [GJHZ20120616153140827]	National Natural Scientific Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Guangdong Province, China(National Natural Science Foundation of Guangdong Province); Shenzhen Science and Technology Project	This work was supported by the National Natural Scientific Foundation of China (Grant No. 81171447), the Natural Science Foundation of Guangdong Province, China (Grant No. 104518036002006310), Shenzhen Science and Technology Project (GJHZ20120616153140827). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bollrath J, 2009, CANCER CELL, V15, P91, DOI 10.1016/j.ccr.2009.01.002; Bromberg JF, 1999, CELL, V98, P295, DOI 10.1016/S0092-8674(00)81959-5; Calin GA, 2002, P NATL ACAD SCI USA, V99, P15524, DOI 10.1073/pnas.242606799; Calin GA, 2004, P NATL ACAD SCI USA, V101, P2999, DOI 10.1073/pnas.0307323101; Chandrasekar V, 2009, MOL CELL NEUROSCI, V42, P350, DOI 10.1016/j.mcn.2009.08.009; Cimmino A, 2005, P NATL ACAD SCI USA, V102, P13944, DOI 10.1073/pnas.0506654102; Croce CM, 2009, NAT REV GENET, V10, P704, DOI 10.1038/nrg2634; Datta J, 2008, CANCER RES, V68, P5049, DOI 10.1158/0008-5472.CAN-07-6655; Dela Cruz F, 2011, DISCOV MED, V12, P307; Edwards BK, 2010, CANCER-AM CANCER SOC, V116, P544, DOI 10.1002/cncr.24760; Esquela-Kerscher A, 2006, NAT REV CANCER, V6, P259, DOI 10.1038/nrc1840; Esteller M, 2011, NAT REV GENET, V12, P861, DOI 10.1038/nrg3074; FEARON ER, 1990, CELL, V61, P759, DOI 10.1016/0092-8674(90)90186-I; Grivennikov S, 2008, CANCER CELL, V13, P7, DOI 10.1016/j.ccr.2007.12.020; Grivennikov S, 2009, CANCER CELL, V15, P103, DOI 10.1016/j.ccr.2009.01.001; Grivennikov SI, 2010, CYTOKINE GROWTH F R, V21, P11, DOI 10.1016/j.cytogfr.2009.11.005; Hammond SM, 2007, NAT GENET, V39, P582, DOI 10.1038/ng0507-582; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hatziapostolou M, 2011, CELL, V147, P1233, DOI 10.1016/j.cell.2011.10.043; He L, 2004, NAT REV GENET, V5, P522, DOI 10.1038/nrg1379; Johnson SM, 2005, CELL, V120, P635, DOI 10.1016/j.cell.2005.01.014; Kasinski AL, 2011, NAT REV CANCER, V11, P849, DOI 10.1038/nrc3166; Kusaba T, 2006, ONCOL REP, V15, P1445; Levy DE, 2002, NAT REV MOL CELL BIO, V3, P651, DOI 10.1038/nrm909; Li KKW, 2009, HUM PATHOL, V40, P1234, DOI 10.1016/j.humpath.2009.02.003; Lian JB, 2012, NAT REV ENDOCRINOL, V8, P212, DOI 10.1038/nrendo.2011.234; Lin L, 2011, CANCER RES, V71, P7226, DOI 10.1158/0008-5472.CAN-10-4660; Liu CG, 2004, P NATL ACAD SCI USA, V101, P9740, DOI 10.1073/pnas.0403293101; Lujambio A, 2008, P NATL ACAD SCI USA, V105, P13556, DOI 10.1073/pnas.0803055105; Mendell JT, 2005, CELL CYCLE, V4, P1179, DOI 10.4161/cc.4.9.2032; Morikawa T, 2011, CLIN CANCER RES, V17, P1452, DOI 10.1158/1078-0432.CCR-10-2694; Nicoloso MS, 2009, NAT REV CANCER, V9, P293, DOI 10.1038/nrc2619; Nugent M, 2011, EJSO-EUR J SURG ONC, V37, P649, DOI 10.1016/j.ejso.2011.05.005; Rebouissou S, 2009, NATURE, V457, P200, DOI 10.1038/nature07475; Sansone P, 2007, J CLIN INVEST, V117, P3988, DOI 10.1172/JCI32533; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Starczynowski DT, 2011, BLOOD, V117, P595, DOI 10.1182/blood-2010-03-277012; Sun W, 2010, CELL RES, V20, P1158, DOI 10.1038/cr.2010.134; Takamizawa J, 2004, CANCER RES, V64, P3753, DOI 10.1158/0008-5472.CAN-04-0637; Trinchieri G, 2012, ANNU REV IMMUNOL, V30, P677, DOI 10.1146/annurev-immunol-020711-075008; Ullman TA, 2011, GASTROENTEROLOGY, V140, P1807, DOI 10.1053/j.gastro.2011.01.057; Vogelstein B, 2004, NAT MED, V10, P789, DOI 10.1038/nm1087; Wilting SM, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-167; Wong KY, 2011, EPIGENOMICS-UK, V3, P83, DOI 10.2217/EPI.10.74; Xia HP, 2012, J BIOL CHEM, V287, P9962, DOI 10.1074/jbc.M111.332627; Yu H, 2004, NAT REV CANCER, V4, P97, DOI 10.1038/nrc1275; Yu H, 2009, NAT REV CANCER, V9, P798, DOI 10.1038/nrc2734; Zhai Haiyan, 2011, Frontiers in Genetics, V2, P78, DOI 10.3389/fgene.2011.00078; ZHONG Z, 1994, SCIENCE, V264, P95, DOI 10.1126/science.8140422	49	76	82	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2013	8	8							e70300	10.1371/journal.pone.0070300	http://dx.doi.org/10.1371/journal.pone.0070300			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	218XC	23940556	gold, Green Published, Green Submitted			2022-12-25	WOS:000324465000050
J	Foden, WB; Butchart, SHM; Stuart, SN; Vie, JC; Akcakaya, HR; Angulo, A; DeVantier, LM; Gutsche, A; Turak, E; Cao, L; Donner, SD; Katariya, V; Bernard, R; Holland, RA; Hughes, AF; O'Hanlon, SE; Garnett, ST; Sekercioglu, CH; Mace, GM				Foden, Wendy B.; Butchart, Stuart H. M.; Stuart, Simon N.; Vie, Jean-Christophe; Akcakaya, H. Resit; Angulo, Ariadne; DeVantier, Lyndon M.; Gutsche, Alexander; Turak, Emre; Cao, Long; Donner, Simon D.; Katariya, Vineet; Bernard, Rodolphe; Holland, Robert A.; Hughes, Adrian F.; O'Hanlon, Susannah E.; Garnett, Stephen T.; Sekercioglu, Cagan H.; Mace, Georgina M.			Identifying the World's Most Climate Change Vulnerable Species: A Systematic Trait-Based Assessment of all Birds, Amphibians and Corals	PLOS ONE			English	Article							GLOBAL BIODIVERSITY; POPULATION DECLINES; CONSERVATION; ENVELOPE; IMPACTS; RANGE; ADAPTATION; SCENARIOS; MODELS; RATES	Climate change will have far-reaching impacts on biodiversity, including increasing extinction rates. Current approaches to quantifying such impacts focus on measuring exposure to climatic change and largely ignore the biological differences between species that may significantly increase or reduce their vulnerability. To address this, we present a framework for assessing three dimensions of climate change vulnerability, namely sensitivity, exposure and adaptive capacity; this draws on species' biological traits and their modeled exposure to projected climatic changes. In the largest such assessment to date, we applied this approach to each of the world's birds, amphibians and corals (16,857 species). The resulting assessments identify the species with greatest relative vulnerability to climate change and the geographic areas in which they are concentrated, including the Amazon basin for amphibians and birds, and the central Indo-west Pacific (Coral Triangle) for corals. We found that high concentration areas for species with traits conferring highest sensitivity and lowest adaptive capacity differ from those of highly exposed species, and we identify areas where exposure-based assessments alone may over or under-estimate climate change impacts. We found that 608-851 bird (6-9%), 670-933 amphibian (11-15%), and 47-73 coral species (6-9%) are both highly climate change vulnerable and already threatened with extinction on the IUCN Red List. The remaining highly climate change vulnerable species represent new priorities for conservation. Fewer species are highly climate change vulnerable under lower IPCC SRES emissions scenarios, indicating that reducing greenhouse emissions will reduce climate change driven extinctions. Our study answers the growing call for a more biologically and ecologically inclusive approach to assessing climate change vulnerability. By facilitating independent assessment of the three dimensions of climate change vulnerability, our approach can be used to devise species and area-specific conservation interventions and indices. The priorities we identify will strengthen global strategies to mitigate climate change impacts.	[Foden, Wendy B.; Katariya, Vineet; Hughes, Adrian F.] Int Union Conservat Nat, Global Species Programme, Cambridge, England; [Foden, Wendy B.] Univ Witwatersrand, Johannesburg, South Africa; [Butchart, Stuart H. M.] BirdLife Int, Science, Cambridge, England; [Stuart, Simon N.] Int Union Conservat Nat, Species Survival Commiss, Gland, Switzerland; [Stuart, Simon N.] World Conservat Monitoring Ctr, United Nations Environm Programme, Cambridge, England; [Stuart, Simon N.] Ain Wildlife Pk & Resort, Al Ain, U Arab Emirates; [Stuart, Simon N.] Univ Bath, Dept Biol & Biochem, Bath BA2 7AY, Somerset, England; [Vie, Jean-Christophe; Angulo, Ariadne] Int Union Conservat Nat, Global Species Programme, Gland, Switzerland; [Akcakaya, H. Resit] SUNY Stony Brook, Dept Ecol & Evolut, Stony Brook, NY USA; Leibniz Inst Res Evolut & Biodivers, Museum Nat Kunde, Berlin, Germany; [Turak, Emre] James Cook Univ, Catchment Reef Res Grp, Ctr Trop Water & Aquat Ecosyst Res, Townsville, Qld, Australia; [Turak, Emre] Zhejiang Univ, Dept Earth Sci, Hangzhou 310027, Peoples R China; [Donner, Simon D.] Univ British Columbia, Dept Geog, Vancouver, BC, Canada; [Katariya, Vineet] Univ London Imperial Coll Sci Technol & Med, Ctr Populat Biol, Ascot SL5 7PY, Berks, England; [Holland, Robert A.] Univ Southampton, Ctr Biol Sci, Southampton, Hants, England; [O'Hanlon, Susannah E.] Anglia Ruskin Univ, Dept Life Sci, Cambridge, England; [Garnett, Stephen T.] Charles Darwin Univ, Res Inst Environm & Livelihoods, Darwin, NT 0909, Australia; [Sekercioglu, Cagan H.] Univ Utah, Dept Biol, Salt Lake City, UT 84112 USA; [Mace, Georgina M.] UCL, Dept Genet Evolut & Environm, Ctr Biodivers & Environm Res, London, England	University of Witwatersrand; BirdLife International; University of Bath; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; Leibniz Institut fur Evolutions und Biodiversitatsforschung; James Cook University; Zhejiang University; University of British Columbia; Imperial College London; University of Southampton; Anglia Ruskin University; Charles Darwin University; Utah System of Higher Education; University of Utah; University of London; University College London	Foden, WB (corresponding author), Int Union Conservat Nat, Global Species Programme, Cambridge, England.	fodenw@gmail.com	Akcakaya, H. Resit/A-7830-2008; Holland, Robert Alan/C-1928-2012; Butchart, Stuart/AAJ-1852-2021; Sekercioglu, Cagan H/A-2331-2013; Mace, Georgina M/I-3072-2016; Butchart, Stuart HM/Y-2711-2018; Garnett, Stephen/M-3877-2013	Akcakaya, H. Resit/0000-0002-8679-5929; Holland, Robert Alan/0000-0002-3038-9227; Butchart, Stuart/0000-0002-1140-4049; Sekercioglu, Cagan H/0000-0001-9639-294X; Mace, Georgina M/0000-0001-8965-5211; Garnett, Stephen/0000-0002-0724-7060; Holland, Robert/0000-0002-5927-9160; Hughes, Adrian/0000-0002-0807-6646; Sekercioglu, Cagan H./0000-0003-3193-0377	John D. and Catherine T. MacArthur Foundation [06-87945-000-GSS]	John D. and Catherine T. MacArthur Foundation	This study was funded by the John D. and Catherine T. MacArthur Foundation. Grant number: 06-87945-000-GSS (http://www.macfound.org/). In kind contributions were also made by Imperial College London and Conservation International. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2010, IUCN RED LIST ONL; [Anonymous], 2004, IUCN RED LIST THREAT, DOI [10.2305/IUCN.UK.2004.RLTS.T44557A10919695.en, DOI 10.2305/IUCN.UK.2004.RLTS.T44557A10919695.EN]; [Anonymous], 2007, CLIMATE CHANGE 2007; Barnosky AD, 2011, NATURE, V471, P51, DOI 10.1038/nature09678; Beale CM, 2008, P NATL ACAD SCI USA, V105, P14908, DOI 10.1073/pnas.0803506105; Beresford AE, 2011, ANIM CONSERV, V14, P99, DOI 10.1111/j.1469-1795.2010.00398.x; Both C, 2006, NATURE, V441, P81, DOI 10.1038/nature04539; Bradshaw WE, 2006, SCIENCE, V312, P1477, DOI 10.1126/science.1127000; Cao L, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2008GL035072; Chevin LM, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000357; Dawson TP, 2011, SCIENCE, V332, P53, DOI 10.1126/science.1200303; de Grammont PC, 2006, CONSERV BIOL, V20, P14, DOI 10.1111/j.1523-1739.2006.00352.x; Deutsch CA, 2008, P NATL ACAD SCI USA, V105, P6668, DOI 10.1073/pnas.0709472105; Doak DF, 2010, NATURE, V467, P959, DOI 10.1038/nature09439; Donner SD, 2005, GLOBAL CHANGE BIOL, V11, P2251, DOI 10.1111/j.1365-2486.2005.01073.x; Donner SD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005712; Foden W, 2007, DIVERS DISTRIB, V13, P645, DOI 10.1111/j.1472-4642.2007.00391.x; Geyer J, 2011, CONSERV BIOL, V25, P708, DOI 10.1111/j.1523-1739.2011.01676.x; Guinotte JM, 2003, CORAL REEFS, V22, P551, DOI 10.1007/s00338-003-0331-4; Guisan A, 2005, ECOL LETT, V8, P993, DOI 10.1111/j.1461-0248.2005.00792.x; Hannah L, 2007, FRONT ECOL ENVIRON, V5, P131, DOI 10.1890/1540-9295(2007)5[131:PANIAC]2.0.CO;2; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Hoffmann M, 2010, SCIENCE, V330, P1503, DOI 10.1126/science.1194442; Jiguet F, 2007, GLOBAL CHANGE BIOL, V13, P1672, DOI 10.1111/j.1365-2486.2007.01386.x; Keith DA, 2008, BIOL LETTERS, V4, P560, DOI 10.1098/rsbl.2008.0049; Lamoreux J, 2003, TRENDS ECOL EVOL, V18, P214, DOI 10.1016/S0169-5347(03)00090-9; McCain CM, 2009, ECOL LETT, V12, P550, DOI 10.1111/j.1461-0248.2009.01308.x; Moller AP, 2011, P ROY SOC B-BIOL SCI, V278, P733, DOI 10.1098/rspb.2010.1592; Nakicenovic N., 2000, SPECIAL REPORT EMISS; Parmesan C, 2011, NAT CLIM CHANGE, V1, P2, DOI 10.1038/nclimate1056; Pearson RG, 2003, GLOBAL ECOL BIOGEOGR, V12, P361, DOI 10.1046/j.1466-822X.2003.00042.x; Pereira HM, 2010, SCIENCE, V330, P1496, DOI 10.1126/science.1196624; Sala OE, 2000, SCIENCE, V287, P1770, DOI 10.1126/science.287.5459.1770; Tabor K, 2010, ECOL APPL, V20, P554, DOI 10.1890/09-0173.1; Thackeray SJ, 2010, GLOBAL CHANGE BIOL, V16, P3304, DOI 10.1111/j.1365-2486.2010.02165.x; Thomas CD, 2004, NATURE, V427, P145, DOI 10.1038/nature02121; Thomas CD, 2011, METHODS ECOL EVOL, V2, P125, DOI 10.1111/j.2041-210X.2010.00065.x; Veron JEN, 2009, MAR POLLUT BULL, V58, P1428, DOI 10.1016/j.marpolbul.2009.09.009; Visser ME, 2008, P ROY SOC B-BIOL SCI, V275, P649, DOI 10.1098/rspb.2007.0997; Weaver AJ, 2001, ATMOS OCEAN, V39, P361, DOI 10.1080/07055900.2001.9649686; Williams SE, 2008, PLOS BIOL, V6, P2621, DOI 10.1371/journal.pbio.0060325	41	529	543	15	162	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2013	8	6							e65427	10.1371/journal.pone.0065427	http://dx.doi.org/10.1371/journal.pone.0065427			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163FW	23950785	Green Published, Green Accepted, gold			2022-12-25	WOS:000320322400025
J	Bradford, HN; Orcutt, SJ; Krishnaswamy, S				Bradford, Harlan N.; Orcutt, Steven J.; Krishnaswamy, Sriram			Membrane Binding by Prothrombin Mediates Its Constrained Presentation to Prothrombinase for Cleavage	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GAMMA-CARBOXYGLUTAMIC ACID; FACTOR-XA; MACROMOLECULAR SUBSTRATE; FACTOR-VA; CATALYZED ACTIVATION; REACTION-MECHANISM; ENDOTHELIAL-CELLS; ENZYME COMPLEXES; MEIZOTHROMBIN; BLOOD	Long-standing dogma proposes a profound contribution of membrane binding by prothrombin in determining the rate at which it is converted to thrombin by prothrombinase. We have examined the action of prothrombinase on full-length prothrombin variants lacking gamma-carboxyglutamate modifications (desGla) with impaired membrane binding. We show an unexpectedly modest decrease in the rate of thrombin formation for desGla prothrombin but with a major effect on the pathway for substrate cleavage. Using desGla prothrombin variants in which the individual cleavage sites have been singly rendered uncleavable, we find that loss of membrane binding and other Gla-dependent functions in the substrate leads to a decrease in the rate of cleavage at Arg(320) and a surprising increase in the rate of cleavage at Arg(271). These compensating effects arise from a loss in the membrane component of exosite-dependent tethering of substrate to prothrombinase and a relaxation in the constrained presentation of the individual cleavage sites for active site docking and catalysis. Loss of constraint is evident as a switch in the pathway for prothrombin cleavage and the intermediate produced but without the expected profound decrease in rate. Extension of these findings to the action of prothrombinase assembled on platelets and endothelial cells on fully carboxylated prothrombin reveals new mechanistic insights into function on physiological membranes. Cell-dependent enzyme function is probably governed by a differential ability to support prothrombin binding and the variable accumulation of intermediates from the two possible pathways of prothrombin activation.	[Bradford, Harlan N.; Orcutt, Steven J.; Krishnaswamy, Sriram] Univ Penn, Childrens Hosp Philadelphia, Res Inst, Philadelphia, PA 19104 USA; [Krishnaswamy, Sriram] Univ Penn, Dept Pediat, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania	Krishnaswamy, S (corresponding author), Childrens Hosp Philadelphia, 310 Abramson,3615 Civ Ctr Blvd, Philadelphia, PA 19104 USA.	skrishna@mail.med.upenn.edu	Krishnaswamy, Sriram/Z-4380-2019	Bradford, Harlan/0000-0001-5582-278X	National Institutes of Health [HL-074124, HL-108933]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL108933, P01HL074124] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants HL-074124 and HL-108933 (to S. K.).	Baugh RJ, 1996, J BIOL CHEM, V271, P16126, DOI 10.1074/jbc.271.27.16126; Bevington P. R, 1992, DATA REDUCTION ERROR; Bianchini EP, 2005, P NATL ACAD SCI USA, V102, P10099, DOI 10.1073/pnas.0504704102; Blostein MD, 2000, J BIOL CHEM, V275, P38120, DOI 10.1074/jbc.M007174200; Bock PE, 2007, J THROMB HAEMOST, V5, P81, DOI 10.1111/j.1538-7836.2007.02496.x; BOCK PE, 1993, METHOD ENZYMOL, V222, P478; Boskovic DS, 2000, J BIOL CHEM, V275, P38561, DOI 10.1074/jbc.M006637200; BOSKOVIC DS, 1990, J BIOL CHEM, V265, P10497; BOVILL EG, 1995, ARTERIOSCL THROM VAS, V15, P754, DOI 10.1161/01.ATV.15.6.754; Bradford HN, 2012, J BIOL CHEM, V287, P30414, DOI 10.1074/jbc.M112.394809; Bradford HN, 2010, J BIOL CHEM, V285, P328, DOI 10.1074/jbc.M109.070334; Brufatto N, 2003, J BIOL CHEM, V278, P6755, DOI 10.1074/jbc.M206413200; Buddai SK, 2002, J BIOL CHEM, V277, P26689, DOI 10.1074/jbc.M202507200; DISCIPIO RG, 1977, BIOCHEMISTRY-US, V16, P5253, DOI 10.1021/bi00643a015; DOYLE MF, 1993, METHOD ENZYMOL, V222, P299; FRIEDMAN PA, 1977, BIOCHIM BIOPHYS ACTA, V494, P271, DOI 10.1016/0005-2795(77)90155-6; GITEL SN, 1973, P NATL ACAD SCI USA, V70, P1344, DOI 10.1073/pnas.70.5.1344; Gomori G, 1942, J LAB CLIN MED, V27, P955; Hacisalihoglu A, 2007, J BIOL CHEM, V282, P32974, DOI 10.1074/jbc.M706529200; Hackeng TM, 1996, BIOCHEM J, V319, P399, DOI 10.1042/bj3190399; Haynes LM, 2012, J BIOL CHEM, V287, P38647, DOI 10.1074/jbc.M112.407791; Kim PY, 2007, J BIOL CHEM, V282, P32568, DOI 10.1074/jbc.M701781200; Krishnaswamy S, 2005, J THROMB HAEMOST, V3, P54, DOI 10.1111/j.1538-7836.2004.01021.x; KRISHNASWAMY S, 1994, BIOCHEMISTRY-US, V33, P7897, DOI 10.1021/bi00191a017; Krishnaswamy S, 2013, J THROMB HAEMOST, V11, P265, DOI 10.1111/jth.12217; KRISHNASWAMY S, 1990, J BIOL CHEM, V265, P3708; Krishnaswamy S, 1997, BIOCHEMISTRY-US, V36, P12080, DOI 10.1021/bi970979+; KRISHNASWAMY S, 1988, J BIOL CHEM, V263, P3823; KRISHNASWAMY S, 1987, J BIOL CHEM, V262, P3291; Kuzmic P, 1996, ANAL BIOCHEM, V237, P260, DOI 10.1006/abio.1996.0238; Lee CJ, 2010, BIOPHYS CHEM, V149, P28, DOI 10.1016/j.bpc.2010.03.011; Lu WP, 2003, ANAL BIOCHEM, V316, P58, DOI 10.1016/S0003-2697(03)00034-4; Lundblad R L, 1976, Methods Enzymol, V45, P156; MALHOTRA OP, 1985, J BIOL CHEM, V260, P279; MANN KG, 1981, METHOD ENZYMOL, V80, P286; MANN KG, 1988, ANNU REV BIOCHEM, V57, P915, DOI 10.1146/annurev.bi.57.070188.004411; MANN KG, 1990, BLOOD, V76, P1; Mannucci P. M., 2013, HEMOSTASIS THROMBOSI, P685; Nelsestuen GL, 2000, VITAM HORM, V58, P355, DOI 10.1016/S0083-6729(00)58031-5; NESHEIM ME, 1984, J BIOL CHEM, V259, P1447; NESHEIM ME, 1992, METHOD ENZYMOL, V215, P316; NISHIDA S, 1995, BIOCHEMISTRY-US, V34, P1771, DOI 10.1021/bi00005a034; Orcutt SJ, 2002, J BIOL CHEM, V277, P46191, DOI 10.1074/jbc.M208677200; Pozzi N, 2013, J BIOL CHEM, V288, P22734, DOI 10.1074/jbc.M113.466946; PRICE PA, 1983, METHOD ENZYMOL, V91, P13; ROSING J, 1988, THROMB HAEMOSTASIS, V60, P355; Shan N., 2013, HEMOSTASIS THROMBOSI, P1267; TANS G, 1991, J BIOL CHEM, V266, P21864; TIJBURG PNM, 1991, J BIOL CHEM, V266, P4017; Toso R, 2004, J BIOL CHEM, V279, P21643, DOI 10.1074/jbc.M402107200; WALKER RK, 1994, J BIOL CHEM, V269, P27441; Wood JP, 2011, BLOOD, V117, P1710, DOI 10.1182/blood-2010-09-311035; Zwaal RFA, 1997, BLOOD, V89, P1121, DOI 10.1182/blood.V89.4.1121	53	21	21	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 27	2013	288	39					27789	27800		10.1074/jbc.M113.502005	http://dx.doi.org/10.1074/jbc.M113.502005			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302OB	23940050	Green Published, hybrid			2022-12-25	WOS:000330612800008
J	Dowdy, DW; Davis, JL; den Boon, S; Walter, ND; Katamba, A; Cattamanchi, A				Dowdy, David W.; Davis, J. Lucian; den Boon, Saskia; Walter, Nicholas D.; Katamba, Achilles; Cattamanchi, Adithya			Population-Level Impact of Same-Day Microscopy and Xpert MTB/RIF for Tuberculosis Diagnosis in Africa	PLOS ONE			English	Article							POSITIVE PULMONARY TUBERCULOSIS; INITIAL DEFAULT; MYCOBACTERIUM-TUBERCULOSIS; ACTIVE TUBERCULOSIS; MATHEMATICAL-MODEL; POTENTIAL IMPACT; SMEAR MICROSCOPY; SOUTH-AFRICA; HIV; REINFECTION	Objective: To compare the population-level impact of two World Health Organization-endorsed strategies for improving the diagnosis of tuberculosis (TB): same-day microscopy and Xpert MTB/RIF (Cepheid, USA). Methods: We created a compartmental transmission model of TB in a representative African community, fit to the regional incidence and mortality of TB and HIV. We compared the population-level reduction in TB burden over ten years achievable with implementation over two years of same-day microscopy, Xpert MTB/RIF testing, and the combination of both approaches. Findings: Same-day microscopy averted an estimated 11.0% of TB incidence over ten years (95% uncertainty range, UR: 3.3%-22.5%), and prevented 11.8% of all TB deaths (95% UR: 7.7%-27.1%). Scaling up Xpert MTB/RIF to all centralized laboratories to achieve 75% population coverage had similar impact on incidence (9.3% reduction, 95% UR: 1.9%-21.5%) and greater effect on mortality (23.8% reduction, 95% UR: 8.6%-33.4%). Combining the two strategies (i.e., same-day microscopy plus Xpert MTB/RIF) generated synergistic effects: an 18.7% reduction in incidence (95% UR: 5.6%-39.2%) and 33.1% reduction in TB mortality (95% UR: 18.1%-50.2%). By the end of year ten, combining same-day microscopy and Xpert MTB/RIF could reduce annual TB mortality by 44% relative to the current standard of care. Conclusion: Scaling up novel diagnostic tests for TB and optimizing existing ones are complementary strategies that, when combined, may have substantial impact on TB epidemics in Africa.	[Dowdy, David W.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD USA; [Davis, J. Lucian; Cattamanchi, Adithya] Univ Calif San Francisco, Div Pulm & Crit Care Med, San Francisco Gen Hosp, San Francisco, CA 94143 USA; [Davis, J. Lucian; Cattamanchi, Adithya] Univ Calif San Francisco, Curry Int TB Ctr, San Francisco Gen Hosp, San Francisco, CA 94143 USA; [den Boon, Saskia] Makerere Univ Univ Calif San Francisco Res Collab, Kampala, Uganda; [Walter, Nicholas D.] Univ Colorado Denver, Div Pulm & Crit Care Med, Aurora, CO USA; [Katamba, Achilles] Makerere Univ, Dept Med, Kampala, Uganda	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; San Francisco General Hospital Medical Center; University of California System; University of California San Francisco; San Francisco General Hospital Medical Center; University of California System; University of California San Francisco; Makerere University; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; Makerere University	Cattamanchi, A (corresponding author), Univ Calif San Francisco, Div Pulm & Crit Care Med, San Francisco Gen Hosp, San Francisco, CA 94143 USA.	acattamanchi@medsfgh.ucsf.edu	Davis, J. Lucian/AAC-8376-2019	Davis, J. Lucian/0000-0002-8629-9992	US National Institutes of Health [R21 AI101152, K23 HL094141, K23 AI080147]; National Center for Research Resources [NIH KL2RR024130]; NATIONAL CENTER FOR RESEARCH RESOURCES [KL2RR024130] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K23HL094141] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI101152, P30AI027763, K23AI080147] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported in part by the US National Institutes of Health, grants R21 AI101152 (DWD), K23 HL094141 (AC), and K23 AI080147 (JLD), as well as technical assistance from the UCSF Clinical and Translational Sciences Institute Career Development Program funded by the National Center for Research Resources (NIH KL2RR024130, AC and JLD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu-Raddad LJ, 2009, P NATL ACAD SCI USA, V106, P13980, DOI 10.1073/pnas.0901720106; Andrews JR, 2012, CLIN INFECT DIS, V54, P784, DOI 10.1093/cid/cir951; Babu BS, 2008, INT J TUBERC LUNG D, V12, P1055; Behr MA, 1999, LANCET, V353, P444, DOI 10.1016/S0140-6736(98)03406-0; Boehme CC, 2010, NEW ENGL J MED, V363, P1005, DOI 10.1056/NEJMoa0907847; Botha E, 2008, INT J TUBERC LUNG D, V12, P820; Brownell R, 2012, AM J RESP CRIT CARE, V185, pA4715; Buu TN, 2003, INT J TUBERC LUNG D, V7, P735; Corbett EL, 2003, ARCH INTERN MED, V163, P1009, DOI 10.1001/archinte.163.9.1009; Creek TL, 2000, INT J TUBERC LUNG D, V4, P956; DALEY CL, 1992, NEW ENGL J MED, V326, P231, DOI 10.1056/NEJM199201233260404; Davis JL, 2012, JAIDS-J ACQ IMM DEF, V61, pE6, DOI 10.1097/QAI.0b013e3182614bc5; DIPERRI G, 1989, LANCET, V2, P1502; Dowdy DW, 2008, P NATL ACAD SCI USA, V105, P11293, DOI 10.1073/pnas.0800965105; Dowdy DW, 2006, AIDS, V20, P751, DOI 10.1097/01.aids.0000216376.07185.cc; Dye C, 1998, LANCET, V352, P1886, DOI 10.1016/S0140-6736(98)03199-7; Edginton ME, 2005, INT J TUBERC LUNG D, V9, P398; Garnett GP, 2011, LANCET, V378, P515, DOI 10.1016/S0140-6736(10)61505-X; Getahun H, 2007, LANCET, V369, P2042, DOI 10.1016/S0140-6736(07)60284-0; Horsburgh CR, 2010, AM J RESP CRIT CARE, V182, P420, DOI 10.1164/rccm.200909-1355OC; Khan MS, 2009, TROP MED INT HEALTH, V14, P1437, DOI 10.1111/j.1365-3156.2009.02406.x; Lawn SD, 2012, INT J TUBERC LUNG D, V16, P701, DOI 10.5588/ijtld.12.0131; Menzies NA, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001347; Murray CJL, 1998, P NATL ACAD SCI USA, V95, P13881, DOI 10.1073/pnas.95.23.13881; Nyirenda T, 1998, INT J TUBERC LUNG D, V2, P944; Steingart K, 2006, LANCET INFECT DIS, V6, P570, DOI 10.1016/S1473-3099(06)70578-3; Rao Nisar Ahmed, 2009, JPMA Journal of the Pakistan Medical Association, V59, P223; Squire SB, 2005, INT J TUBERC LUNG D, V9, P25; Steingart KR, 2006, LANCET INFECT DIS, V6, P664, DOI 10.1016/S1473-3099(06)70602-8; TB Stop partnership, 2011, GLOB PLAN STOP TB 20; Theron G, 2012, EUR RESPIR J, V40, P161, DOI 10.1183/09031936.00145511; Tiemersma EW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017601; UNAIDS, 2010, UNAIDS REP GLOB AIDS; United Nations Department of Economic and Social Affairs, 2012, WORLD POP PROSP 2010; Vynnycky E, 1997, EPIDEMIOL INFECT, V119, P183, DOI 10.1017/S0950268897007917; WHO, 2012, GLOBAL TUBERCULOSIS REPORT 2012, P1; WHO, 2010, AUT REAL TIM NUCL AC; WHO, 2011, WHO GLOBAL TUBERCULO; World Health Organization, 2011, SAM DAY DIAGN TUB MI; World Health Organization, 2012, LIF TABL WHO MEMB ST; World Health Organization Regional Office for Africa, 2011, HLTH SIT AN AFR REG	41	22	22	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2013	8	8							e70485	10.1371/journal.pone.0070485	http://dx.doi.org/10.1371/journal.pone.0070485			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	200UV	23950942	Green Published, Green Submitted, gold			2022-12-25	WOS:000323097300021
J	Schmidt, C; Weiss, T; Lehmann, T; Witte, H; Leistritz, L				Schmidt, Christoph; Weiss, Thomas; Lehmann, Thomas; Witte, Herbert; Leistritz, Lutz			Extracting Labeled Topological Patterns from Samples of Networks	PLOS ONE			English	Article							SMALL-WORLD NETWORKS; FUNCTIONAL CONNECTIVITY; CORTICAL THICKNESS; COMPLEX NETWORKS; PAIN PERCEPTION; MOTIFS; EMOTION; DEPRESSION; GRAPHS; PERSPECTIVES	An advanced graph theoretical approach is introduced that enables a higher level of functional interpretation of samples of directed networks with identical fixed pairwise different vertex labels that are drawn from a particular population. Compared to the analysis of single networks, their investigation promises to yield more detailed information about the represented system. Often patterns of directed edges in sample element networks are too intractable for a direct evaluation and interpretation. The new approach addresses the problem of simplifying topological information and characterizes such a sample of networks by finding its locatable characteristic topological patterns. These patterns, essentially sample-specific network motifs with vertex labeling, might represent the essence of the intricate topological information contained in all sample element networks and provides as well a means of differentiating network samples. Central to the accurateness of this approach is the null model and its properties, which is needed to assign significance to topological patterns. As a proof of principle the proposed approach has been applied to the analysis of networks that represent brain connectivity before and during painful stimulation in patients with major depression and in healthy subjects. The accomplished reduction of topological information enables a cautious functional interpretation of the altered neuronal processing of pain in both groups.	[Schmidt, Christoph; Lehmann, Thomas; Witte, Herbert; Leistritz, Lutz] Univ Jena, Jena Univ Hosp, Inst Med Stat Comp Sci & Documentat, Bernstein Grp Computat Neurosci Jena, Jena, Germany; [Weiss, Thomas] Univ Jena, Dept Biol & Clin Psychol, Jena, Germany	Friedrich Schiller University of Jena; Friedrich Schiller University of Jena	Schmidt, C (corresponding author), Univ Jena, Jena Univ Hosp, Inst Med Stat Comp Sci & Documentat, Bernstein Grp Computat Neurosci Jena, Jena, Germany.	christoph.schmidt@med.uni-jena.de		Schmidt, Christoph/0000-0002-5442-551X	Federal Ministry of Education and Research, Germany [01GQ1202]; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA034977] Funding Source: NIH RePORTER	Federal Ministry of Education and Research, Germany(Federal Ministry of Education & Research (BMBF)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This study was supported by the grant 01GQ1202 of the Federal Ministry of Education and Research, Germany (http://www.bmbf.de/en/index.php). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert I, 2004, BIOINFORMATICS, V20, P3346, DOI 10.1093/bioinformatics/bth402; Aldous D, 1994, FDN COMP SCI 1994 P, P492; Alon U, 2007, NAT REV GENET, V8, P450, DOI 10.1038/nrg2102; Artzy-Randrup Yael, 2004, Science, V305, P1107; Baccala LA, 2007, PROCEEDINGS OF THE 2007 15TH INTERNATIONAL CONFERENCE ON DIGITAL SIGNAL PROCESSING, P163, DOI 10.1109/ICDSP.2007.4288544; Bar KJ, 2007, BIOL PSYCHIAT, V62, P1281, DOI 10.1016/j.biopsych.2007.02.011; Bar KR, 2006, EUR J PAIN, V10, P467, DOI 10.1016/j.ejpain.2005.07.001; Bar KJ, 2005, PAIN, V117, P97, DOI 10.1016/j.pain.2005.05.016; Bassett DS, 2006, NEUROSCIENTIST, V12, P512, DOI 10.1177/1073858406293182; Beber ME, 2012, J R SOC INTERFACE, V9, P3426, DOI 10.1098/rsif.2012.0490; Bernhardt BC, 2011, CEREB CORTEX, V21, P2147, DOI 10.1093/cercor/bhq291; Blitzstein J, 2011, INTERNET MATH, V6, P489, DOI 10.1080/15427951.2010.557277; Boccaletti S, 2006, PHYS REP, V424, P175, DOI 10.1016/j.physrep.2005.10.009; Catani M, 2008, CORTEX, V44, P911, DOI 10.1016/j.cortex.2008.05.001; Ciriello Giovanni, 2008, Briefings in Functional Genomics & Proteomics, V7, P147, DOI 10.1093/bfgp/eln015; Davidson RJ, 2000, PSYCHOL BULL, V126, P890, DOI 10.1037/0033-2909.126.6.890; Davidson RJ, 2002, ANNU REV PSYCHOL, V53, P545, DOI 10.1146/annurev.psych.53.100901.135148; Davidson RJ, 1999, TRENDS COGN SCI, V3, P11, DOI 10.1016/S1364-6613(98)01265-0; Delbeuck X, 2003, NEUROPSYCHOL REV, V13, P79, DOI 10.1023/A:1023832305702; Diener C, 2012, NEUROIMAGE, V61, P677, DOI 10.1016/j.neuroimage.2012.04.005; Friston KJ, 1999, ACTA PSYCHIAT SCAND, V99, P68, DOI 10.1111/j.1600-0447.1999.tb05985.x; He Y, 2007, CEREB CORTEX, V17, P2407, DOI 10.1093/cercor/bhl149; Hilgetag CC, 2000, PHILOS T ROY SOC B, V355, P91, DOI 10.1098/rstb.2000.0551; HOLM S, 1979, SCAND J STAT, V6, P65; Humphries MD, 2006, P ROY SOC B-BIOL SCI, V273, P503, DOI 10.1098/rspb.2005.3354; Iannetti GD, 2010, EXP BRAIN RES, V205, P1, DOI 10.1007/s00221-010-2340-1; Ingram PJ, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-108; Itzkovitz S, 2004, PHYS REV E, V70, DOI 10.1103/PhysRevE.70.058102; Itzkovitz S, 2005, PHYS REV E, V71, DOI 10.1103/PhysRevE.71.026117; Itzkovitz S, 2003, PHYS REV E, V68, DOI 10.1103/PhysRevE.68.026127; Johnstone T, 2007, J NEUROSCI, V27, P8877, DOI 10.1523/JNEUROSCI.2063-07.2007; Kannan R, 1999, RANDOM STRUCT ALGOR, V14, P293, DOI 10.1002/(SICI)1098-2418(199907)14:4<293::AID-RSA1>3.0.CO;2-G; Kashtan N, 2004, BIOINFORMATICS, V20, P1746, DOI 10.1093/bioinformatics/bth163; Kino OD, 2004, PHYS REV E, V70, DOI 10.1103/PhysRevE.70.058101; Knabe JF, 2008, BIOSYSTEMS, V94, P68, DOI 10.1016/j.biosystems.2008.05.012; Lautenbacher S, 1999, PSYCHOSOM MED, V61, P822, DOI 10.1097/00006842-199911000-00015; Lee TI, 2002, SCIENCE, V298, P799, DOI 10.1126/science.1075090; Leistritz L, 2010, METHOD INFORM MED, V49, P484, DOI 10.3414/ME09-02-0038; Leistritz L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060956; Liu Y, 2008, BRAIN, V131, P945, DOI 10.1093/brain/awn018; Maslov S, 2004, PHYSICA A, V333, P529, DOI 10.1016/j.physa.2003.06.002; Maslov S, 2002, SCIENCE, V296, P910, DOI 10.1126/science.1065103; Micheloyannis S, 2006, SCHIZOPHR RES, V87, P60, DOI 10.1016/j.schres.2006.06.028; Miller LR, 2009, J PAIN, V10, P619, DOI 10.1016/j.jpain.2008.12.007; Milo R, 2004, SCIENCE, V305; Milo R, 2004, SCIENCE, V303, P1538, DOI 10.1126/science.1089167; Milo R, 2002, SCIENCE, V298, P824, DOI 10.1126/science.298.5594.824; Milo R, 2003, ARXIVCONDMAT0312028; MOLLOY M, 1995, RANDOM STRUCT ALGOR, V6, P161, DOI 10.1002/rsa.3240060204; Mutschler I, 2012, NEUROSCI LETT, V520, P204, DOI 10.1016/j.neulet.2012.03.095; Newman M.E.J., 2010, NETWORKS INTRO; Newman MEJ, 2003, HANDBOOK OF GRAPHS AND NETWORKS: FROM THE GENOME TO THE INTERNET, P35; Newman MEJ, 2003, SIAM REV, V45, P167, DOI 10.1137/S003614450342480; Newman MEJ, 2001, PHYS REV E, V64, DOI [10.1103/PhysRevE.64.016131, 10.1103/PhysRevE.64.016132]; Onnela JP, 2005, PHYS REV E, V71, DOI 10.1103/PhysRevE.71.065103; Przulj N, 2006, J R SOC INTERFACE, V3, P711, DOI 10.1098/rsif.2006.0147; Rubinov M, 2010, NEUROIMAGE, V52, P1059, DOI 10.1016/j.neuroimage.2009.10.003; Schmidt C, 2012, COMPUT MATH METHOD M, V2012, DOI 10.1155/2012/910380; Shen-Orr SS, 2002, NAT GENET, V31, P64, DOI 10.1038/ng881; Shoval O, 2010, CELL, V143, P326, DOI 10.1016/j.cell.2010.09.050; Sporns O, 2000, CEREB CORTEX, V10, P127, DOI 10.1093/cercor/10.2.127; Sporns O, 2004, PLOS BIOL, V2, P1910, DOI 10.1371/journal.pbio.0020369; Sporns O, 2004, NEUROINFORMATICS, V2, P145, DOI 10.1385/NI:2:2:145; Stam CJ, 2007, CEREB CORTEX, V17, P92, DOI 10.1093/cercor/bhj127; Stam Cornelis J, 2007, Nonlinear Biomed Phys, V1, P3, DOI 10.1186/1753-4631-1-3; Strigo IA, 2008, ARCH GEN PSYCHIAT, V65, P1275, DOI 10.1001/archpsyc.65.11.1275; Terhaar J, 2011, PAIN, V152, P1796, DOI 10.1016/j.pain.2011.03.027; Wernicke S, 2006, IEEE ACM T COMPUT BI, V3, P347, DOI 10.1109/TCBB.2006.51; Yeger-Lotem E, 2004, P NATL ACAD SCI USA, V101, P5934, DOI 10.1073/pnas.0306752101; Ziv E, 2005, PHYS REV E, V71, DOI 10.1103/PhysRevE.71.016110	70	0	0	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2013	8	8							e70497	10.1371/journal.pone.0070497	http://dx.doi.org/10.1371/journal.pone.0070497			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	200UV	23950945	Green Published, Green Submitted, gold			2022-12-25	WOS:000323097300022
J	Jonchere, V; Bennett, D				Jonchere, Vincent; Bennett, Daimark			Validating RNAi Phenotypes in Drosophila Using a Synthetic RNAi-Resistant Transgene	PLOS ONE			English	Article							MRL PROTEINS; INTERFERENCE; MELANOGASTER	RNA interference (RNAi) is a powerful and widely used approach to investigate gene function, but a major limitation of the approach is the high incidence of non-specific phenotypes that arise due to off-target effects. We previously showed that RNAi-mediated knock-down of pico, which encodes the only member of the MRL family of adapter proteins in Drosophila, resulted in reduction in cell number and size leading to reduced tissue growth. In contrast, a recent study reported that pico knockdown leads to tissue dysmorphology, pointing to an indirect role for pico in the control of wing size. To understand the cause of this disparity we have utilised a synthetic RNAi-resistant transgene, which bears minimal sequence homology to the predicted dsRNA but encodes wild type Pico protein, to reanalyse the RNAi lines used in the two studies. We find that the RNAi lines from different sources exhibit different effects, with one set of lines uniquely resulting in a tissue dysmorphology phenotype when expressed in the developing wing. Importantly, the loss of tissue morphology fails to be complemented by co-overexpression of RNAi-resistant pico suggesting that this phenotype is the result of an off-target effect. This highlights the importance of careful validation of RNAi-induced phenotypes, and shows the potential of synthetic transgenes for their experimental validation.	[Jonchere, Vincent; Bennett, Daimark] Univ Liverpool, Inst Integrat Biol, Liverpool L69 3BX, Merseyside, England	University of Liverpool	Bennett, D (corresponding author), Univ Liverpool, Inst Integrat Biol, Liverpool L69 3BX, Merseyside, England.	daimark.bennett@liverpool.ac.uk	Jonchere, Vincent/AAF-8049-2020; Jonchere, Vincent/ABF-1285-2020; Bennett, Daimark/E-2701-2014	Jonchere, Vincent/0000-0002-1925-6650; Bennett, Daimark/0000-0002-0014-2290	CRUK [C20691/A11834]	CRUK(Cancer Research UK)	This work was funded by CRUK grant C20691/A11834. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2003, NAT CELL BIOL, V5, P489, DOI 10.1038/ncb0603-490; Barrientos A, 2000, MOL BIOL EVOL, V17, P1508, DOI 10.1093/oxfordjournals.molbev.a026250; Colo GP, 2012, EUR J CELL BIOL, V91, P861, DOI 10.1016/j.ejcb.2012.03.001; Dietzl G, 2007, NATURE, V448, P151, DOI 10.1038/nature05954; Kondo S, 2009, GENETICS, V183, P1165, DOI 10.1534/genetics.109.106567; Kulkarni MM, 2006, NAT METHODS, V3, P833, DOI 10.1038/nmeth935; Langer CCH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008928; Lassus Patrice, 2002, Sci STKE, V2002, ppl13; Legg JA, 2004, NAT CELL BIOL, V6, P1015, DOI 10.1038/ncb1104-1015; Lyulcheva E, 2008, DEV CELL, V15, P680, DOI 10.1016/j.devcel.2008.09.020; Ma Y, 2006, NATURE, V443, P359, DOI 10.1038/nature05179; Naito Y, 2005, NUCLEIC ACIDS RES, V33, pW589, DOI 10.1093/nar/gki419; Rodriguez AD, 2012, NAT METHODS, V9, P47, DOI [10.1038/NMETH.1800, 10.1038/nmeth.1800]; Rozen S, 2000, Methods Mol Biol, V132, P365; Stielow B, 2008, MOL CELL, V29, P742, DOI 10.1016/j.molcel.2007.12.032; Thompson BJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010077; Yokokura T, 2004, J BIOL CHEM, V279, P52603, DOI 10.1074/jbc.M409691200	17	12	12	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2013	8	8							e70489	10.1371/journal.pone.0070489	http://dx.doi.org/10.1371/journal.pone.0070489			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	201ER	23950943	Green Published, gold, Green Submitted			2022-12-25	WOS:000323124000016
J	Cox, R; Sanchez, J; Revie, CW				Cox, Ruth; Sanchez, Javier; Revie, Crawford W.			Multi-Criteria Decision Analysis Tools for Prioritising Emerging or Re-Emerging Infectious Diseases Associated with Climate Change in Canada	PLOS ONE			English	Article							PUBLIC-HEALTH; RISK-ASSESSMENT; CHAGAS-DISEASE; EMERGENCE; MODEL; METHODOLOGY; MANAGEMENT	Global climate change is known to result in the emergence or re-emergence of some infectious diseases. Reliable methods to identify the infectious diseases of humans and animals and that are most likely to be influenced by climate are therefore required. Since different priorities will affect the decision to address a particular pathogen threat, decision makers need a standardised method of prioritisation. Ranking methods and Multi-Criteria Decision approaches provide such a standardised method and were employed here to design two different pathogen prioritisation tools. The opinion of 64 experts was elicited to assess the importance of 40 criteria that could be used to prioritise emerging infectious diseases of humans and animals in Canada. A weight was calculated for each criterion according to the expert opinion. Attributes were defined for each criterion as a transparent and repeatable method of measurement. Two different Multi-Criteria Decision Analysis tools were tested, both of which used an additive aggregation approach. These were an Excel spreadsheet tool and a tool developed in software 'M-MACBETH'. The tools were trialed on nine 'test' pathogens. Two different methods of criteria weighting were compared, one using fixed weighting values, the other using probability distributions to account for uncertainty and variation in expert opinion. The ranking of the nine pathogens varied according to the weighting method that was used. In both tools, using both weighting methods, the diseases that tended to rank the highest were West Nile virus, Giardiasis and Chagas, while Coccidioidomycosis tended to rank the lowest. Both tools are a simple and user friendly approach to prioritising pathogens according to climate change by including explicit scoring of 40 criteria and incorporating weighting methods based on expert opinion. They provide a dynamic interactive method that can help to identify pathogens for which a full risk assessment should be pursued.	[Cox, Ruth; Sanchez, Javier; Revie, Crawford W.] Univ Prince Edward Isl, Atlantic Vet Coll, Charlottetown, PE C1A 4P3, Canada	University of Prince Edward Island	Cox, R (corresponding author), Univ Prince Edward Isl, Atlantic Vet Coll, Charlottetown, PE C1A 4P3, Canada.	rucox@upei.ca	Revie, Crawford/B-5002-2011; sanchez, javier/AAA-4179-2022	Revie, Crawford/0000-0002-5018-0340; 	Public Health Agency of Canada [4500217733]	Public Health Agency of Canada	Funding for this research was provided by the Public Health Agency of Canada (www.publichealth.gc.ca), grant number: 4500217733. The funders provided advice about potential study participants. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert I, 2012, BAYESIAN ANAL, V7, P503, DOI 10.1214/12-BA717; Anand P, 2002, SCIENCE, V295, P1839, DOI 10.1126/science.1061744; [Anonymous], 2002, EMERG INFECT DIS; Aspinall W, 2010, NATURE, V463, P294, DOI 10.1038/463294a; Bana E Costa CA, 2004, EUR J OPER RES, V153, P323, DOI 10.1016/S0377-2217(03)00155-3; Bana E Costa CA, 2005, INT SER OPER RES MAN, V78, P409, DOI 10.1007/0-387-23081-5_10; Belton V., 2002, MULTIPLE CRITERIA DE, DOI DOI 10.1007/978-1-4615-1495-4; Bots PWG, 2000, J MULTICRITERIA DECI, V9, P56, DOI DOI 10.1002/1099-1360(200001/05)9:1/3; Brosig J, 2012, ALTERNATIVE CLASSICA, P1; Canadian Food Inspection Agency, 2011, REP DIS IMM NOT ANN; Cooke R. M., 1991, EXPERTS UNCERTAINTY; Cox R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041590; Department for Environment Food and Rural Affairs, 2010, DOC D2R2 DAT DIS BRI; Doherty J A, 2000, Can J Infect Dis, V11, P21; Figueira J, 2005, INT SER OPER RES MAN, V78, P1, DOI 10.1007/b100605; Furgal C, 2006, ENVIRON HEALTH PERSP, V114, P1964, DOI 10.1289/ehp.8433; Gale P, 2010, EPIDEMIOL INFECT, V138, P214, DOI 10.1017/S0950268809990367; Gilsdorf A, 2011, EUROSURVEILLANCE, V16, P15; Greer A, 2008, CAN MED ASSOC J, V178, P715, DOI 10.1503/cmaj.081325; Guis H, 2012, J R SOC INTERFACE, V9, P339, DOI 10.1098/rsif.2011.0255; Hasan NA, 2012, P NATL ACAD SCI USA, V109, pE2010, DOI 10.1073/pnas.1207359109; Horby P, 2001, Commun Dis Public Health, V4, P8; Huang IB, 2011, SCI TOTAL ENVIRON, V409, P3578, DOI 10.1016/j.scitotenv.2011.06.022; Hubalek Z, 2004, J WILDLIFE DIS, V40, P639, DOI 10.7589/0090-3558-40.4.639; Intergovernmental Panel on Climate Change, 2007, CLIMATE CHANGE 2007; Keeney RL, 1993, DECISIONS MULTIPLE O, DOI DOI 10.1017/CBO9781139174084; Krause G, 2008, Euro Surveill, V13; Krause G, 2008, EMBO REP, V9, pS22, DOI 10.1038/embor.2008.76; Lambert RC, 2008, GEOSPATIAL HEALTH, V2, P227, DOI 10.4081/gh.2008.246; Lemmen D, 2007, CLIMATE CHANGE IMPAC; Linkov I, 2006, ENVIRON INT, V32, P1072, DOI 10.1016/j.envint.2006.06.013; McKendrick IJ, 2000, PREV VET MED, V47, P141, DOI 10.1016/S0167-5877(00)00172-0; McKenzie J, 2007, PREV VET MED, V81, P194, DOI 10.1016/j.prevetmed.2007.04.003; Morgan D, 2009, EPIDEMIOL INFECT, V137, P1521, DOI 10.1017/S0950268809990227; MORSE SS, 1995, EMERG INFECT DIS, V1, P7, DOI 10.3201/eid0101.950102; MURRAY CJL, 1994, B WORLD HEALTH ORGAN, V72, P429; National Assessment Synthesis Team, 2000, CLIM CHANG IMP US PO; O'Hagan A., 2006, UNCERTAIN JUDGEMENTS; Ogden NH, 2008, APPL ENVIRON MICROB, V74, P1780, DOI 10.1128/AEM.01982-07; Olson MJ, 1997, J BEHAV DECIS MAKING, V10, P117, DOI 10.1002/(SICI)1099-0771(199706)10:2<117::AID-BDM251>3.0.CO;2-7; Oreskes N, 2004, SCIENCE, V306, P1686, DOI 10.1126/science.1103618; Patz JA, 2008, MED CLIN N AM, V92, P1473, DOI 10.1016/j.mcna.2008.07.007; Peel MC, 2007, HYDROL EARTH SYST SC, V11, P1633, DOI 10.5194/hess-11-1633-2007; Pheloung PC, 1999, J ENVIRON MANAGE, V57, P239, DOI 10.1006/jema.1999.0297; Pirlot M., 2006, EVALUATION DECISION; Public Health Agency of Canada, 2010, NOT DIS LIN INC NOT; Roberts H, 2010, ZOON CLIM CHANG C U; Rose JB, 2001, ENVIRON HEALTH PERSP, V109, P211, DOI 10.2307/3435011; Soon JM, 2012, EXPERT SYST APPL, V39, P8325, DOI 10.1016/j.eswa.2012.01.189; Soverow JE, 2009, ENVIRON HEALTH PERSP, V117, P1049, DOI 10.1289/ehp.0800487; Statistics Canada, 2009, CAN YB 2009, P385; Steele K, 2009, RISK ANAL, V29, P26, DOI 10.1111/j.1539-6924.2008.01130.x; Tanowitz HB, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001136; Van der Fels-Klerx HJ, 2005, RISK ANAL, V25, P109, DOI 10.1111/j.0272-4332.2005.00571.x; Vilas VJD, 2013, PREV VET MED, V108, P94, DOI 10.1016/j.prevetmed.2012.08.007; WHO, 2006, SETT PRIOR COMM DIS	56	53	53	1	64	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2013	8	8							e68338	10.1371/journal.pone.0068338	http://dx.doi.org/10.1371/journal.pone.0068338			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	200ZE	23950868	Green Published, Green Submitted, gold, Green Accepted			2022-12-25	WOS:000323109700004
J	Bian, XX; Liu, DZ; Zeng, H; Zhang, GQ; Wei, RP; Hou, R				Bian, Xiaoxing; Liu, Dingzhen; Zeng, Hua; Zhang, Guiquan; Wei, Rongping; Hou, Rong			Exposure to Odors of Rivals Enhances Sexual Motivation in Male Giant Pandas	PLOS ONE			English	Article							SPERM COMPETITION; AILUROPODA-MELANOLEUCA; CHEMICAL COMMUNICATION; RISK; EJACULATE; RESPONSES; AGE	Males will alter their mating behavior to cope with the presence of their competitors. Even exposure to odors from potential competitors can greatly increase male ejaculate expenditure in a variety of animals including insects, fishes, birds and rodents. Major efforts have been made to examine males' plastic responses to sperm competition and its fitness benefits. However, the effects of competitor absence on male's sexual motivation and behaviors remain unclear, which has been proposed to be one of the causes for the poor sexual performance of some captive mammals. This study revealed that sexual motivation can be greatly enhanced in captive male giant pandas (Ailuropoda melanoleuca) by exposure to chemosensory cues from either one or three conspecifics males. It had been shown that potential rivals' odors increased males' chemosensory investigation behavior, as well as their observing, following and sniffing behaviors towards estrous females. Behaviors changed regardless of the number of rivals (one or three). Our results demonstrate the effects of potential competition on male giant pandas' sexual motivation and behavioral coping strategy. We anticipate that our research will provide a fresh insight into the mechanisms underlying poor sexual performance in male captive mammals, and valuable information for the practical management and ex situ conservation of endangered species.	[Bian, Xiaoxing; Liu, Dingzhen; Zeng, Hua] Beijing Normal Univ, Sch Life Sci, Minist Educ, Key Lab Biodivers Sci & Ecol Engn, Beijing 100875, Peoples R China; [Zhang, Guiquan; Wei, Rongping] China Conservat & Res Ctr Giant Panda, Key Lab Reprod & Conservat Genet Endangered Wildl, Wolong, Sichuan, Peoples R China; [Hou, Rong] Chengdu Res Base Giant Panda Breeding, Key Lab Conservat Biol Endangered Wildlife Sichua, Chengdu, Sichuan, Peoples R China	Beijing Normal University	Liu, DZ (corresponding author), Beijing Normal Univ, Sch Life Sci, Minist Educ, Key Lab Biodivers Sci & Ecol Engn, Beijing 100875, Peoples R China.	dzliu@bnu.edu.cn	Liu, Dingzhen/D-3400-2012	Liu, Dingzhen/0000-0002-1870-6197	National Natural Science Foundation of China NSFC [31172097]; National Key Technology R D Program [2012BAC01B06]; International Collaborative Project on the Conservation for the Giant Panda [SD0630]	National Natural Science Foundation of China NSFC(National Natural Science Foundation of China (NSFC)); National Key Technology R D Program(National Key Technology R&D Program); International Collaborative Project on the Conservation for the Giant Panda	This work was supported by the National Natural Science Foundation of China NSFC (grant #31172097), National Key Technology R & D Program (grant #2012BAC01B06) and grants from the International Collaborative Project on the Conservation for the Giant Panda (grant #SD0630). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson Malte, 1994; Bretman A, 2011, TRENDS ECOL EVOL, V26, P467, DOI 10.1016/j.tree.2011.05.002; Bretman A, 2011, CURR BIOL, V21, P617, DOI 10.1016/j.cub.2011.03.008; Bretman A, 2010, BEHAV ECOL, V21, P317, DOI 10.1093/beheco/arp189; Brown RE., 1985, SOCIAL ODOURS MAMMAL; Darwin C, 2010, DESCENT MAN; delBarco-Trillo J, 2004, NATURE, V431, P446, DOI 10.1038/nature02845; Ferkin MH, 2007, BEHAVIOUR, V144, P1297, DOI 10.1163/156853907781890913; GAGE MJG, 1991, ANIM BEHAV, V42, P1036, DOI 10.1016/S0003-3472(05)80162-9; Hasegawa M, 2012, J ETHOL, V30, P143, DOI 10.1007/s10164-011-0307-8; Hu J, 1990, RES PROGR BIOL GIANT, P309; Kleiman D.G., 1979, International Zoo Yearbook, V19, P217, DOI 10.1111/j.1748-1090.1979.tb00568.x; KLEIMAN DG, 1983, Z TIERPSYCHOL, V62, P1; LINDBURG DG, 1994, ZOO BIOL, V13, P433, DOI 10.1002/zoo.1430130506; Martin P., 2007, MEASURING BEHAV INTR, V3; Nie YG, 2012, BEHAV ECOL SOCIOBIOL, V66, P721, DOI 10.1007/s00265-012-1320-9; Parker GA, 1997, P ROY SOC B-BIOL SCI, V264, P1793, DOI 10.1098/rspb.1997.0249; Pilastro A, 2002, P NATL ACAD SCI USA, V99, P9913, DOI 10.1073/pnas.152133499; Pizzari T, 2003, NATURE, V426, P70, DOI 10.1038/nature02004; Schaller G.B., 1985, GIANT PANDAS WOLONG; Swaisgood RR, 2000, ANIM BEHAV, V60, P227, DOI 10.1006/anbe.2000.1464; Swaisgood RR, 1999, ANIM BEHAV, V57, P1045, DOI 10.1006/anbe.1998.1070; Vaughn AA, 2011, BEHAVIOUR, V148, P927, DOI 10.1163/000579511X584375; Waterman Jane, 2007, P27; Wedell N, 1999, P ROY SOC B-BIOL SCI, V266, P1033, DOI 10.1098/rspb.1999.0740; White AM, 2003, J ZOOL, V259, P171, DOI 10.1017/S0952836902003187; White AM, 2002, BEHAV ECOL SOCIOBIOL, V51, P519, DOI 10.1007/s00265-002-0473-3; Williams JM, 2004, ANIM BEHAV, V68, P523, DOI 10.1016/j.anbehav.2003.09.015; Xie Z, 2011, 2011 INT STUDBOOK GI; Yong Yange, 2004, Acta Theriologica Sinica, V24, P346; Yuan H, 2004, CAN J ZOOL, V82, P1596, DOI 10.1139/Z04-144; Zhang GQ, 2004, ZOO BIOL, V23, P15, DOI 10.1002/zoo.10118; Zhang JX, 2008, J CHEM ECOL, V34, P398, DOI 10.1007/s10886-008-9441-3	33	12	13	1	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2013	8	8							e69889	10.1371/journal.pone.0069889	http://dx.doi.org/10.1371/journal.pone.0069889			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	218XC	23940532	Green Submitted, Green Published, gold			2022-12-25	WOS:000324465000026
J	Bowden, NA; Ashton, KA; Vilain, RE; Avery-Kiejda, KA; Davey, RJ; Murray, HC; Budden, T; Braye, SG; Zhang, XD; Hersey, P; Scott, RJ				Bowden, Nikola A.; Ashton, Katie A.; Vilain, Ricardo E.; Avery-Kiejda, Kelly A.; Davey, Ryan J.; Murray, Heather C.; Budden, Timothy; Braye, Stephen G.; Zhang, Xu Dong; Hersey, Peter; Scott, Rodney J.			Regulators of Global Genome Repair Do Not Respond to DNA Damaging Therapy but Correlate with Survival in Melanoma	PLOS ONE			English	Article							XERODERMA-PIGMENTOSUM; XPC PROTEIN; GROUP-C; EXPRESSION; GENE; CANCER; APOPTOSIS; P53; CISPLATIN; CELLS	Nucleotide excision repair (NER) orchestrates the repair of helix distorting DNA damage, induced by both ultraviolet radiation (UVR) and cisplatin. There is evidence that the global genome repair (GGR) arm of NER is dysfunctional in melanoma and it is known to have limited induction in melanoma cell lines after cisplatin treatment. The aims of this study were to examine mRNA transcript levels of regulators of GGR and to investigate the downstream effect on global transcript expression in melanoma cell lines after cisplatin treatment and in melanoma tumours. The GGR regulators, BRCA1 and PCNA, were induced in melanocytes after cisplatin, but not in melanoma cell lines. Transcripts associated with BRCA1, BRCA2, ATM and CHEK2 showed altered expression in melanoma cell lines after cisplatin treatment. In melanoma tumour tissue BRCA1 transcript expression correlated with poor survival and XPB expression correlated with solar elastosis levels. Taken together, these findings provide evidence of the mechanisms underlying NER deficiency in melanoma.	[Bowden, Nikola A.; Ashton, Katie A.; Vilain, Ricardo E.; Avery-Kiejda, Kelly A.; Davey, Ryan J.; Murray, Heather C.; Budden, Timothy; Zhang, Xu Dong; Scott, Rodney J.] Univ Newcastle, Fac Hlth, Sch Biomed Sci & Pharm, Callaghan, NSW 2308, Australia; [Bowden, Nikola A.; Ashton, Katie A.; Vilain, Ricardo E.; Avery-Kiejda, Kelly A.; Davey, Ryan J.; Murray, Heather C.; Budden, Timothy; Zhang, Xu Dong; Scott, Rodney J.] Hunter Med Res Inst, Newcastle, NSW, Australia; [Vilain, Ricardo E.; Braye, Stephen G.; Scott, Rodney J.] John Hunter Hosp, Hunter Area Pathol Serv, Newcastle, NSW, Australia; [Hersey, Peter] Univ Sydney, Kolling Inst, Sydney, NSW 2006, Australia	University of Newcastle; Hunter Medical Research Institute; University of Newcastle; John Hunter Hospital; University of Sydney; Kolling Institute of Medical Research	Bowden, NA (corresponding author), Univ Newcastle, Fac Hlth, Sch Biomed Sci & Pharm, Callaghan, NSW 2308, Australia.	Nikola.Bowden@newcastle.edu.au	zhang, xu/GRX-9733-2022; Murray, Heather/GQY-8016-2022; Bowden, Nikola A/E-6527-2013; zhang, xu/GYE-3558-2022; zhang, xian/GYA-0290-2022; Zhang, xiaoyu/GXA-3206-2022; Scott, Rodney/B-2827-2013	Bowden, Nikola A/0000-0002-6047-1694; Murray, Heather/0000-0001-8953-3708; Zhang, Xu Dong/0000-0001-9457-8003; Budden, Timothy/0000-0003-2500-2814; Avery-Kiejda, Kelly/0000-0003-2285-9118; Scott, Rodney/0000-0001-7724-3404	Hunter Medical Research Institute; University of Newcastle Centre for Information Based Medicine; Cancer Council, New South Wales, Australia; Cancer Australia; Cure Cancer Australia Foundation; National Health & Medical Research Council; Mrs. Joyce and Dr. George Bogner Estate; Melanoma and Skin Cancer Research Institute	Hunter Medical Research Institute; University of Newcastle Centre for Information Based Medicine; Cancer Council, New South Wales, Australia(Cancer Council New South Wales); Cancer Australia; Cure Cancer Australia Foundation; National Health & Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Mrs. Joyce and Dr. George Bogner Estate; Melanoma and Skin Cancer Research Institute	This work was supported by the Hunter Medical Research Institute; the University of Newcastle Centre for Information Based Medicine; the Cancer Council, New South Wales, Australia; Cancer Australia; and the Cure Cancer Australia Foundation. NB and RV are supported by the National Health & Medical Research Council. KA is supported by the Mrs. Joyce and Dr. George Bogner Estate and the Hunter Medical Research Institute. KAK is the recipient of the Cameron Melanoma Research Fellowship from the Melanoma and Skin Cancer Research Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adimoolam S, 2002, P NATL ACAD SCI USA, V99, P12985, DOI 10.1073/pnas.202485699; Ashton KA, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-382; Avery-Kiejda KA, 2008, CLIN CANCER RES, V14, P1659, DOI 10.1158/1078-0432.CCR-07-1422; Balch CM, 2001, J CLIN ONCOL, V19, P3622, DOI 10.1200/JCO.2001.19.16.3622; Banks D, 2006, CELL CYCLE, V5, P1719, DOI 10.4161/cc.5.15.3150; Ben-Porath I, 2008, NAT GENET, V40, P499, DOI 10.1038/ng.127; Berger MF, 2012, NATURE, V485, P502, DOI 10.1038/nature11071; Bowden NA, 2006, SCHIZOPHR RES, V82, P175, DOI 10.1016/j.schres.2005.11.012; Bowden NA, 2010, CANCER RES, V70, P7905; Chen ZW, 2007, CANCER RES, V67, P4578, DOI 10.1158/0008-5472.CAN-06-0877; Cleaver JE, 2005, NAT REV CANCER, V5, P564, DOI 10.1038/nrc1652; da Costa RMA, 2005, ONCOGENE, V24, P1359, DOI 10.1038/sj.onc.1208288; Dazard JE, 2003, ONCOGENE, V22, P2993, DOI 10.1038/sj.onc.1206537; DeBiasi RL, 2003, J VIROL, V77, P8934, DOI 10.1128/JVI.77.16.8934-8947.2003; EASTMAN A, 1985, BIOCHEMISTRY-US, V24, P5027, DOI 10.1021/bi00340a011; Enk CD, 2006, ONCOGENE, V25, P2601, DOI 10.1038/sj.onc.1209292; Fitch ME, 2003, CARCINOGENESIS, V24, P843, DOI 10.1093/carcin/bgg031; Franco AV, 2001, J IMMUNOL, V166, P5337, DOI 10.4049/jimmunol.166.9.5337; Friedberg EC, 2001, NAT REV CANCER, V1, P22, DOI 10.1038/35094000; Gaddameedhi S, 2010, CANCER RES, V70, P4922, DOI 10.1158/0008-5472.CAN-10-0095; Gentile M, 2003, NUCLEIC ACIDS RES, V31, P4779, DOI 10.1093/nar/gkg675; GLOVER D, 1987, J CLIN ONCOL, V5, P574, DOI 10.1200/JCO.1987.5.4.574; Hartman AR, 2002, NAT GENET, V32, P180, DOI 10.1038/ng953; Higa LA, 2006, CELL CYCLE, V5, P1675, DOI 10.4161/cc.5.15.3149; Hollmann CA, 2006, CANCER RES, V66, P3550, DOI 10.1158/0008-5472.CAN-05-2498; Hwang BJ, 1999, P NATL ACAD SCI USA, V96, P424, DOI 10.1073/pnas.96.2.424; Jewell R, 2010, CLIN CANCER RES, V16, P5211, DOI 10.1158/1078-0432.CCR-10-1521; Kaufmann WK, 2008, J INVEST DERMATOL, V128, P175, DOI 10.1038/sj.jid.5700935; Marini F, 2006, P NATL ACAD SCI USA, V103, P17325, DOI 10.1073/pnas.0605446103; Matthews L, 2009, NUCLEIC ACIDS RES, V37, pD619, DOI 10.1093/nar/gkn863; Monjardet-Bas W, 2002, CHEM-EUR J, V8, P1144, DOI 10.1002/1521-3765(20020301)8:5<1144::AID-CHEM1144>3.0.CO;2-K; Navaraj A, 2005, CANCER BIOL THER, V4, P1409, DOI 10.4161/cbt.4.12.2378; Nouspikel T, 2009, CELL MOL LIFE SCI, V66, P994, DOI 10.1007/s00018-009-8737-y; Onken MD, 2006, CANCER RES, V66, P4602, DOI 10.1158/0008-5472.CAN-05-4196; Perez CA, 2007, ONCOGENE, V26, P7363, DOI 10.1038/sj.onc.1210561; Pleasance ED, 2010, NATURE, V463, P191, DOI 10.1038/nature08658; Pujana MA, 2007, NAT GENET, V39, P1338, DOI 10.1038/ng.2007.2; Siddik ZH, 2003, ONCOGENE, V22, P7265, DOI 10.1038/sj.onc.1206933; Stoyanova T, 2009, P NATL ACAD SCI USA, V106, P10690, DOI 10.1073/pnas.0812254106; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Sugasawa K, 2010, MUTAT RES-FUND MOL M, V685, P29, DOI 10.1016/j.mrfmmm.2009.08.004; Thomas WD, 1998, J IMMUNOL, V161, P2195; Wang G, 2004, CELL RES, V14, P303, DOI 10.1038/sj.cr.7290375; Wang G, 2004, NUCLEIC ACIDS RES, V32, P2231, DOI 10.1093/nar/gkh541; Wang HT, 2010, P NATL ACAD SCI USA, V107, P12180, DOI 10.1073/pnas.1005244107; Zhang XD, 1999, CANCER RES, V59, P2747	46	7	7	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2013	8	8							e70424	10.1371/journal.pone.0070424	http://dx.doi.org/10.1371/journal.pone.0070424			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	218XC	23940574	Green Submitted, Green Published, gold			2022-12-25	WOS:000324465000068
J	Bricher, PK; Lucieer, A; Shaw, J; Terauds, A; Bergstrom, DM				Bricher, Phillippa K.; Lucieer, Arko; Shaw, Justine; Terauds, Aleks; Bergstrom, Dana M.			Mapping Sub-Antarctic Cushion Plants Using Random Forests to Combine Very High Resolution Satellite Imagery and Terrain Modelling	PLOS ONE			English	Article							VEGETATION; CLASSIFICATION; COVER; VARIABLES; TEXTURE; SCALE	Monitoring changes in the distribution and density of plant species often requires accurate and high-resolution baseline maps of those species. Detecting such change at the landscape scale is often problematic, particularly in remote areas. We examine a new technique to improve accuracy and objectivity in mapping vegetation, combining species distribution modelling and satellite image classification on a remote sub-Antarctic island. In this study, we combine spectral data from very high resolution WorldView-2 satellite imagery and terrain variables from a high resolution digital elevation model to improve mapping accuracy, in both pixel- and object-based classifications. Random forest classification was used to explore the effectiveness of these approaches on mapping the distribution of the critically endangered cushion plant Azorella macquariensis Orchard (Apiaceae) on sub-Antarctic Macquarie Island. Both pixel- and object-based classifications of the distribution of Azorella achieved very high overall validation accuracies (91.6-96.3%, kappa = 0.849-0.924). Both two-class and three-class classifications were able to accurately and consistently identify the areas where Azorella was absent, indicating that these maps provide a suitable baseline for monitoring expected change in the distribution of the cushion plants. Detecting such change is critical given the threats this species is currently facing under altering environmental conditions. The method presented here has applications to monitoring a range of species, particularly in remote and isolated environments.	[Bricher, Phillippa K.; Lucieer, Arko] Univ Tasmania, Sch Geog & Environm Studies, Hobart, Tas, Australia; [Bricher, Phillippa K.] Univ Queensland, Ctr Mined Land Rehabil, Sustainable Minerals Inst, St Lucia, Qld, Australia; [Shaw, Justine; Terauds, Aleks; Bergstrom, Dana M.] Australian Antarctic Div, Dept Environm Water Heritage & Arts, Kingston, Tas, Australia; [Shaw, Justine; Terauds, Aleks] Univ Queensland, Sch Biol Sci, Environm Decis Grp, St Lucia, Qld, Australia	University of Tasmania; University of Queensland; Australian Antarctic Division; University of Queensland	Bricher, PK (corresponding author), Univ Queensland, Sustainable Minerals Inst, Ctr Mined Land Rehabil, Brisbane, Qld, Australia.	p.bricher@uq.edu.au	Bergstrom, Dana/AAC-2837-2022; Lucieer, Arko/F-1247-2013	Bergstrom, Dana/0000-0001-8484-8954; Lucieer, Arko/0000-0002-9468-4516; Terauds, Aleks/0000-0001-7804-6648; Shaw, Justine/0000-0002-9603-2271	Australian Antarctic Division [ASAC 3095]; Tasmanian Postgraduate Research Award	Australian Antarctic Division; Tasmanian Postgraduate Research Award	This work was supported by the Australian Antarctic Division (ASAC 3095), www.aad.gov.au, and a Tasmanian Postgraduate Research Award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamson DA, 2000, MAP STRUCTURAL VEGET; Addink EA, 2007, PHOTOGRAMM ENG REM S, V73, P905, DOI 10.14358/PERS.73.8.905; Atkinson DM, 2012, REMOTE SENS-BASEL, V4, P3948, DOI 10.3390/rs4123948; Beck PSA, 2013, GLOBAL PLANET CHANGE, V100, P109, DOI 10.1016/j.gloplacha.2012.10.005; Bergstrom DM, 2009, J APPL ECOL, V46, P73, DOI 10.1111/j.1365-2664.2008.01601.x; Blaschke T, 2010, ISPRS J PHOTOGRAMM, V65, P2, DOI 10.1016/j.isprsjprs.2009.06.004; Boyd DS, 2006, INT J REMOTE SENS, V27, P2631, DOI 10.1080/01431160600554348; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Brolsma H., 2008, MACQUARIE ISLAND AIR; Bureau of Meterorology B, 2011, CLIM STAT AUSTR LOC; Copson GR, 1984, ANARE RES NOTES, V18; Cutler DR, 2007, ECOLOGY, V88, P2783, DOI 10.1890/07-0539.1; Department of Primary Industries. P and W, 2009, TASM THREAT SPEC LIS; Dirnbock T, 2003, APPL VEG SCI, V6, P85, DOI 10.1658/1402-2001(2003)006[0085:MAVBOI]2.0.CO;2; Dobrowski SZ, 2008, APPL VEG SCI, V11, P499, DOI 10.3170/2008-7-18560; Dorigo W, 2012, INT J APPL EARTH OBS, V19, P185, DOI 10.1016/j.jag.2012.05.004; Evans JS, 2009, LANDSCAPE ECOL, V24, P673, DOI 10.1007/s10980-009-9341-0; Franklin J, 1995, PROG PHYS GEOG, V19, P474, DOI 10.1177/030913339501900403; Franklin SE, 2001, PHOTOGRAMM ENG REM S, V67, P849; Fretwell PT, 2011, POLAR BIOL, V34, P273, DOI 10.1007/s00300-010-0880-2; Gallant J.C., 2000, TERRAIN ANAL PRINCIP, P51, DOI [10.1016/S0925-8574(00)00178-6, DOI 10.1016/S0925-8574(00)00178-6]; Gislason PO, 2006, PATTERN RECOGN LETT, V27, P294, DOI 10.1016/j.patrec.2005.08.011; Grossmann E., 2010, GAP ANAL B, V17, P16; Guisan A, 2000, ECOL MODEL, V135, P147, DOI 10.1016/S0304-3800(00)00354-9; HARALICK RM, 1973, IEEE T SYST MAN CYB, VSMC3, P610, DOI 10.1109/TSMC.1973.4309314; Kohler KE, 2006, COMPUT GEOSCI-UK, V32, P1259, DOI 10.1016/j.cageo.2005.11.009; Lawrence RL, 2006, REMOTE SENS ENVIRON, V100, P356, DOI 10.1016/j.rse.2005.10.014; Liston GE, 1998, J GLACIOL, V44, P498, DOI 10.3189/S0022143000002021; Lu D, 2007, INT J REMOTE SENS, V28, P823, DOI 10.1080/01431160600746456; Lucieer A, 2008, AUSTR REM SENS PHOT; Luscier JD, 2006, FRONT ECOL ENVIRON, V4, P408, DOI 10.1890/1540-9295(2006)4[408:UDPAOI]2.0.CO;2; Mallinis G, 2008, ISPRS J PHOTOGRAMM, V63, P237, DOI 10.1016/j.isprsjprs.2007.08.007; Mannel S, 2011, INT J REMOTE SENS, V32, P5321, DOI 10.1080/01431161.2010.498841; McManus KM, 2012, GLOBAL CHANGE BIOL, V18, P2313, DOI 10.1111/j.1365-2486.2012.02708.x; Murray H, 2010, INT J APPL EARTH OBS, V12, P138, DOI 10.1016/j.jag.2010.01.006; Pal M, 2005, INT J REMOTE SENS, V26, P217, DOI 10.1080/01431160412331269698; Selkirk P, 1990, SUBANTARCTIC MACQUAR; SELLERS PJ, 1985, INT J REMOTE SENS, V6, P1335, DOI 10.1080/01431168508948283; Shaw J, 2013, MACQUARIE ISLAND AZO; Stohlgren TJ, 2010, RISK ANAL, V30, P224, DOI 10.1111/j.1539-6924.2009.01343.x; Stow DA, 2004, REMOTE SENS ENVIRON, V89, P281, DOI 10.1016/j.rse.2003.10.018; Tapley I, 2004, IEEE T GEOSCI REMOTE; Tweedie C. E., 2000, ANTARCTIC ECOSYSTEMS, P272; Van Niel KP, 2004, J VEG SCI, V15, P747, DOI 10.1111/j.1654-1103.2004.tb02317.x; Wallace L, 2006, GIS BASED SNOW ACCUM; Wallentin G, 2008, ECOL MODEL, V218, P235, DOI 10.1016/j.ecolmodel.2008.07.005; Wood J, 1996, GEOMORPHOLOGICAL CHA; Wood J., 1996, GEOMORPHOLOGICAL CHA; Xie YC, 2008, J PLANT ECOL, V1, P9, DOI 10.1093/jpe/rtm005; ZEVENBERGEN LW, 1987, EARTH SURF PROCESSES, V12, P47, DOI 10.1002/esp.3290120107	50	23	23	1	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2013	8	8							e72093	10.1371/journal.pone.0072093	http://dx.doi.org/10.1371/journal.pone.0072093			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	218XC	23940805	Green Submitted, gold, Green Published			2022-12-25	WOS:000324465000243
J	Elkalaf, M; Andel, M; Trnka, J				Elkalaf, Moustafa; Andel, Michal; Trnka, Jan			Low Glucose but Not Galactose Enhances Oxidative Mitochondrial Metabolism in C2C12 Myoblasts and Myotubes	PLOS ONE			English	Article							SKELETAL-MUSCLE; INSULIN-RESISTANCE; MESSENGER-RNA; CELLS; DIFFERENTIATION; FIBROBLASTS; NUCLEAR; CHAIN; ASSAY	Background: Substituting galactose for glucose in cell culture media has been suggested to enhance mitochondrial metabolism in a variety of cell lines. We studied the effects of carbohydrate availability on growth, differentiation and metabolism of C2C12 myoblasts and myotubes. Methodology/Principal Findings: We measured growth rates, ability to differentiate, citrate synthase and respiratory chain activities and several parameters of mitochondrial respiration in C2C12 cells grown in media with varying carbohydrate availability (5 g/l glucose, 1 g/l glucose, 1 g/l galactose, and no added carbohydrates). C2C12 myoblasts grow more slowly without glucose irrespective of the presence of galactose, which is not consumed by the cells, and they fail to differentiate without glucose in the medium. Cells grown in a no-glucose medium (with or without galactose) have lower maximal respiration and spare respiratory capacity than cells grown in the presence of glucose. However, increasing glucose concentration above physiological levels decreases the achievable maximal respiration. C2C12 myotubes differentiated at a high glucose concentration showed higher dependency on oxidative respiration under basal conditions but had lower maximal and spare respiratory capacity when compared to cells differentiated under low glucose condition. Citrate synthase activity or mitochondrial yield were not significantly affected by changes in the available substrate concentration but a trend towards a higher respiratory chain activity was observed at reduced glucose levels. Conclusions/Significance: Our results show that using galactose to increase oxidative metabolism may not be applicable to every cell line, and the changes in mitochondrial respiratory parameters associated with treating cells with galactose are mainly due to glucose deprivation. Moderate concentrations of glucose (1 g/l) in a growth medium are optimal for mitochondrial respiration in C2C12 cell line while supraphysiological concentrations of glucose cause mitochondrial dysfunction in C2C12 myoblasts and myotubes.	[Elkalaf, Moustafa; Trnka, Jan] Charles Univ Prague, Fac Med 3, Lab Metab & Bioenerget, Prague, Czech Republic; [Elkalaf, Moustafa; Andel, Michal; Trnka, Jan] Charles Univ Prague, Fac Med 3, Ctr Res Diabet Metab & Nutr, Prague, Czech Republic	Charles University Prague; Charles University Prague	Trnka, J (corresponding author), Charles Univ Prague, Fac Med 3, Lab Metab & Bioenerget, Prague, Czech Republic.	jan.trnka@lf3.cuni.cz	Elkalaf, Moustafa/AAL-4938-2020; Trnka, Jan/B-8951-2012; Anděl, Michal/E-4305-2012	Elkalaf, Moustafa/0000-0002-0418-2732; Trnka, Jan/0000-0002-1786-7562; 	Charles University in Prague, Czech Republic [262707/SVV/2011, 264701/SVV/2012, UNCE 204015, PRVOUK P31]	Charles University in Prague, Czech Republic(Czech Republic Government)	This work was supported by research projects 262707/SVV/2011, 264701/SVV/2012, UNCE 204015 and PRVOUK P31 from Charles University in Prague, Czech Republic. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguer C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028536; BLAU HM, 1983, CELL, V32, P1171, DOI 10.1016/0092-8674(83)90300-8; Brand MD, 2011, BIOCHEM J, V435, P297, DOI 10.1042/BJ20110162; Brown DM, 2012, J MUSCLE RES CELL M, V32, P383, DOI 10.1007/s10974-011-9267-4; Burattini S, 2004, EUR J HISTOCHEM, V48, P223; COOPERSTEIN SJ, 1951, J BIOL CHEM, V189, P665; Cumming G, 2012, NEW STAT EFFECT SIZE; Fulco M, 2008, DEV CELL, V14, P661, DOI 10.1016/j.devcel.2008.02.004; GARDNER MJ, 1986, BMJ-BRIT MED J, V292, P746, DOI 10.1136/bmj.292.6522.746; HEIDENREICH RA, 1993, PEDIATR RES, V34, P416, DOI 10.1203/00006450-199310000-00006; Holloszy OJ, 1970, BIOCH BIOPHYSICAL RE, V40, P1368; HOOD DA, 1989, EUR J BIOCHEM, V179, P275, DOI 10.1111/j.1432-1033.1989.tb14551.x; IBSEN KH, 1961, CANCER RES, V21, P829; Janssen AJM, 2007, CLIN CHEM, V53, P729, DOI 10.1373/clinchem.2006.078873; Leary SC, 1998, BBA-BIOENERGETICS, V1365, P522, DOI 10.1016/S0005-2728(98)00105-4; Luo C, 2008, CLIN CHIM ACTA, V395, P38, DOI 10.1016/j.cca.2008.04.025; Mailloux RJ, 2010, FASEB J, V24, P2495, DOI 10.1096/fj.09-151803; Marroquin LD, 2007, TOXICOL SCI, V97, P539, DOI 10.1093/toxsci/kfm052; Miyake T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028628; Nedachi T, 2008, AM J PHYSIOL-ENDOC M, V294, pE668, DOI 10.1152/ajpendo.00640.2007; Palmfeldt J, 2009, PROTEOME SCI, V7, DOI 10.1186/1477-5956-7-20; Petersen KF, 2007, P NATL ACAD SCI USA, V104, P12587, DOI 10.1073/pnas.0705408104; Phielix E, 2008, PHYSIOL BEHAV, V94, P252, DOI 10.1016/j.physbeh.2008.01.020; RESNICK O, 1957, J BIOL CHEM, V224, P941; Rossignol R, 2004, CANCER RES, V64, P985, DOI 10.1158/0008-5472.CAN-03-1101; SINACORE DR, 1993, PHYS THER, V73, P878, DOI 10.1093/ptj/73.12.878; SPARGO E, 1979, J ROY SOC MED, V72, P921; WILLIAMS RS, 1986, J BIOL CHEM, V261, P376; Wu M, 2007, AM J PHYSIOL-CELL PH, V292, pC125, DOI 10.1152/ajpcell.00247.2006; YAFFE D, 1977, NATURE, V270, P725, DOI 10.1038/270725a0	30	41	44	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2013	8	8							e70772	10.1371/journal.pone.0070772	http://dx.doi.org/10.1371/journal.pone.0070772			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	218XC	23940640	gold, Green Submitted, Green Published			2022-12-25	WOS:000324465000132
J	Goldenstein, PT; Elias, RM; do Carmo, LPD; Coelho, FO; Magalhaes, LP; Antunes, GL; Custodio, MR; Montenegro, FLD; Titan, SM; Jorgetti, V; Moyses, RMA				Goldenstein, Patricia Taschner; Elias, Rosilene Motta; de Freitas do Carmo, Lilian Pires; Coelho, Fernanda Oliveira; Magalhaes, Luciene Pereira; Antunes, Gisele Lins; Custodio, Melani Ribeiro; de Menezes Montenegro, Fabio Luiz; Titan, Silvia Maria; Jorgetti, Vanda; Affonso Moyses, Rosa Maria			Parathyroidectomy Improves Survival In Patients with Severe Hyperparathyroidism: A Comparative Study	PLOS ONE			English	Article							DOSE VITAMIN-D; DIALYSIS PATIENTS; SECONDARY HYPERPARATHYROIDISM; HEMODIALYSIS-PATIENTS; MORTALITY; CALCIFICATION; CINACALCET; CALCIUM; DISEASE; PTH	Background and objectives: Secondary hyperparathyroidism (SHPT) in CKD is associated with an increased risk for mortality, but definitive data showing that parathormone control decreases mortality is still lacking. This study aimed to compare the mortality of patients with severe SHPT submitted to parathyroidectomy(PTX) with those who did not have access to surgery. Methods: This is a retrospective study in a cohort of 251 CKD patients with severe SHPT who were referred to a CKD-MBD Center for PTX from 2005 until 2012. Results: Most of our patients had indication of PTX, but only 49% of them had access to this surgical procedure. After a mean follow-up of 23 months, 72 patients had died. Non-survivors were older; more often had diabetes, lower serum 25 vitamin D and mostly had not been submitted to surgery. The relative risk of death was lower in the PTX patients (0.428; 95% CI, 0.28 to 0.67; p<0.0001). After adjustments, mortality risk was dependent on age (1.04; 95% CI, 1.01 to 1.07; p = 0.002), 25 vitamin D (0.43; 95% CI, 0.24 to 0.81; p = 0.006) and no access to PTX (4.13; 95% CI, 2.16 to 7.88; p<0.0001). Results remained the same in a second model using the PTX date as the study start date for the PTX group. Conclusions: Our data confirms the benefit of PTX on mortality in patients with severe SHPT. The high mortality encountered in our population is significant and urges the need to better treat these patients.	[Goldenstein, Patricia Taschner; Elias, Rosilene Motta; de Freitas do Carmo, Lilian Pires; Coelho, Fernanda Oliveira; Magalhaes, Luciene Pereira; Antunes, Gisele Lins; Custodio, Melani Ribeiro; Titan, Silvia Maria; Jorgetti, Vanda; Affonso Moyses, Rosa Maria] Univ Sao Paulo, Fac Med, Hosp Clin, Div Nephrol, Sao Paulo, Brazil; [de Menezes Montenegro, Fabio Luiz] Univ Sao Paulo, Fac Med, Hosp Clin, Head & Neck Surg Div, Sao Paulo, Brazil	Universidade de Sao Paulo; Universidade de Sao Paulo	Moyses, RMA (corresponding author), Univ Sao Paulo, Fac Med, Hosp Clin, Div Nephrol, Sao Paulo, Brazil.	rosa.moyses@uol.com.br	JORGETTI, VANDA/C-9470-2012; Elias, Rosilene M/J-1099-2012; Moyses, Rosa M A/F-8268-2012; de Menezes Montenegro, Fabio Luiz/AAN-9601-2020; Custodio, Melani R/L-9509-2015; Montenegro, Fabio LM/F-9741-2011	JORGETTI, VANDA/0000-0002-4824-8879; Elias, Rosilene M/0000-0003-2212-041X; Moyses, Rosa M A/0000-0002-7902-2127; de Menezes Montenegro, Fabio Luiz/0000-0002-5749-2363; Montenegro, Fabio LM/0000-0002-5749-2363; Ribeiro Custodio, Melani/0000-0001-6358-8727	CNPQ, Conselho Nacional de Desenvolvimento Cientifico e Tecnologico [303325/2010-0]	CNPQ, Conselho Nacional de Desenvolvimento Cientifico e Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	Research in the laboratory of RMAM is supported by CNPQ, Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (grant 303325/2010-0). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bleyer AJ, 2005, AM J KIDNEY DIS, V46, P464, DOI 10.1053/j.ajkd.2005.04.035; Block GA, 2004, J AM SOC NEPHROL, V15, P2208, DOI 10.1097/01.ASN.0000133041.27682.A2; Chertow GM, 2012, NEW ENGL J MED, V367, P2482, DOI 10.1056/NEJMoa1205624; Chou FF, 2008, SURGERY, V143, P526, DOI 10.1016/j.surg.2007.11.019; Coen G, 2007, NEPHROL DIAL TRANSPL, V22, P3262, DOI 10.1093/ndt/gfm370; Costa-Hong V, 2007, SURGERY, V142, P699, DOI 10.1016/j.surg.2007.06.015; Covic A, 2009, NEPHROL DIAL TRANSPL, V24, P1506, DOI 10.1093/ndt/gfn613; Esposito MG, 2008, J NEPHROL, V21, pS92; Goldsmith DJA, 1996, AM J KIDNEY DIS, V27, P819, DOI 10.1016/S0272-6386(96)90519-3; Goodman WG, 2000, NEW ENGL J MED, V342, P1478, DOI 10.1056/NEJM200005183422003; Graciolli FG, 2009, NEPHROL DIAL TRANSPL, V24, P1416, DOI 10.1093/ndt/gfn686; Guerin AP, 2000, NEPHROL DIAL TRANSPL, V15, P1014, DOI 10.1093/ndt/15.7.1014; Iwamoto N, 2012, J NEPHROL, V25, P755, DOI 10.5301/jn.5000056; Jono S, 2000, CIRC RES, V87, pE10, DOI 10.1161/01.RES.87.7.e10; Kestenbaum B, 2004, KIDNEY INT, V66, P2010, DOI 10.1111/j.1523-1755.2004.00972.x; Ketteler M, 2012, NEPHROL DIAL TRANSPL, V27, P3270, DOI 10.1093/ndt/gfs018; LACOUR B, 1986, AM J KIDNEY DIS, V8, P422, DOI 10.1016/S0272-6386(86)80169-X; Moe SM, 2003, KIDNEY INT, V63, P1003, DOI 10.1046/j.1523-1755.2003.00820.x; Perkovic V, 2012, NEW ENGL J MED, V367, P2541, DOI 10.1056/NEJMe1212368; Raggi P, 2011, NEPHROL DIAL TRANSPL, V26, P1327, DOI 10.1093/ndt/gfq725; Schluter KD, 1998, CARDIOVASC RES, V37, P34, DOI 10.1016/S0008-6363(97)00194-6; Sharma J, 2012, J AM COLL SURGEONS, V214, P400, DOI 10.1016/j.jamcollsurg.2011.12.046; Sharma J, 2007, CLIN REV BONE MINER, V5, P103, DOI 10.1007/s12018-007-0006-8; Skaaby T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052423; Tentori F, 2008, AM J KIDNEY DIS, V52, P519, DOI 10.1053/j.ajkd.2008.03.020; Wolf M, 2007, KIDNEY INT, V72, P1004, DOI 10.1038/sj.ki.5002451; Yang H, 2004, KIDNEY INT, V66, P2293, DOI 10.1111/j.1523-1755.2004.66015.x; Yasunaga C, 1999, AM J SURG, V178, P332, DOI 10.1016/S0002-9610(99)00194-4	28	47	56	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2013	8	8							e68870	10.1371/journal.pone.0068870	http://dx.doi.org/10.1371/journal.pone.0068870			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	218XC	23940515	Green Published, gold, Green Submitted			2022-12-25	WOS:000324465000010
J	Jew, CP; Wu, CS; Sun, H; Zhu, J; Huang, JY; Yu, DH; Justice, NJ; Lu, HC				Jew, Chris P.; Wu, Chia-Shan; Sun, Hao; Zhu, Jie; Huang, Jui-Yen; Yu, Dinghui; Justice, Nicholas J.; Lu, Hui-Chen			mGluR5 Ablation in Cortical Glutamatergic Neurons Increases Novelty-Induced Locomotion	PLOS ONE			English	Article							BEHAVIORAL-TEST BATTERIES; LONG-TERM DEPRESSION; FRAGILE-X-SYNDROME; MOUSE MODEL; GROUP-I; ENDOCANNABINOID SYSTEM; PREPULSE INHIBITION; RECEPTOR SUBUNIT; PHENOTYPES; ANXIETY	The group I metabotropic glutamate receptor 5 (mGluR5) has been implicated in the pathology of various neurological disorders including schizophrenia, ADHD, and autism. mGluR5-dependent synaptic plasticity has been described at a variety of neural connections and its signaling has been implicated in several behaviors. These behaviors include locomotor reactivity to novel environment, sensorimotor gating, anxiety, and cognition. mGluR5 is expressed in glutamatergic neurons, inhibitory neurons, and glia in various brain regions. In this study, we show that deleting mGluR5 expression only in principal cortical neurons leads to defective cannabinoid receptor 1 (CB1R) dependent synaptic plasticity in the prefrontal cortex. These cortical glutamatergic mGluR5 knockout mice exhibit increased novelty-induced locomotion, and their locomotion can be further enhanced by treatment with the psychostimulant methylphenidate. Despite a modest reduction in repetitive behaviors, cortical glutamatergic mGluR5 knockout mice are normal in sensorimotor gating, anxiety, motor balance/learning and fear conditioning behaviors. These results show that mGluR5 signaling in cortical glutamatergic neurons is required for precisely modulating locomotor reactivity to a novel environment but not for sensorimotor gating, anxiety, motor coordination, several forms of learning or social interactions.	[Jew, Chris P.; Wu, Chia-Shan; Sun, Hao; Zhu, Jie; Huang, Jui-Yen; Lu, Hui-Chen] Baylor Coll Med, Cain Fdn Labs, Houston, TX 77030 USA; [Jew, Chris P.; Wu, Chia-Shan; Sun, Hao; Zhu, Jie; Huang, Jui-Yen; Yu, Dinghui; Lu, Hui-Chen] Texas Childrens Hosp, Baylor Coll Med, Jan & Dan Duncan Neurol Res Inst, Houston, TX 77030 USA; [Jew, Chris P.; Wu, Chia-Shan; Sun, Hao; Zhu, Jie; Huang, Jui-Yen; Yu, Dinghui; Lu, Hui-Chen] Baylor Coll Med, Dept Pediat, Houston, TX 77030 USA; [Justice, Nicholas J.; Lu, Hui-Chen] Baylor Coll Med, Huffington Ctr Aging, Houston, TX 77030 USA; [Lu, Hui-Chen] Baylor Coll Med, Program Dev Biol, Houston, TX 77030 USA; [Lu, Hui-Chen] Baylor Coll Med, Dept Neurosci, Houston, TX 77030 USA	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine	Lu, HC (corresponding author), Baylor Coll Med, Cain Fdn Labs, Houston, TX 77030 USA.	hclu@bcm.edu	Sun, Hao/F-7926-2013; Wu, Chia Shan/AAH-7825-2020; Huang, Jui-Yen/AAG-4505-2020	Wu, Chia Shan/0000-0002-6034-939X; Huang, Jui-Yen/0000-0003-4745-9970; Sun, Hao/0000-0002-3670-2886	National Institutes of Health [NS048884, DA029381, HD065561, AG036738]; Eunice Kennedy Shriver National Institute of Child Health & Human Development [BCM IDDRC 5P30HD024064]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD024064] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R21HD065561] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS048884] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [K01AG036738] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [K05DA021696, R21DA029381] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Eunice Kennedy Shriver National Institute of Child Health & Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work is supported by the National Institutes of Health: grant numbers NS048884 (HCL), DA029381 (HCL), HD065561 (HCL), and AG036738 (NJJ). Confocal Imaging and Mouse Neurobehavior cores are supported by BCM IDDRC 5P30HD024064 from the Eunice Kennedy Shriver National Institute of Child Health & Human Development. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler L, 2004, PSYCHIAT CLIN N AM, V27, P187, DOI 10.1016/j.psc.2003.12.003; Avale ME, 2004, MOL PSYCHIATR, V9, P718, DOI 10.1038/sj.mp.4001474; Ballard TM, 2005, PSYCHOPHARMACOLOGY, V179, P218, DOI 10.1007/s00213-005-2211-9; Ballester-Rosado CJ, 2010, J NEUROSCI, V30, P16896, DOI 10.1523/JNEUROSCI.2462-10.2010; Balschun D, 2006, NEUROSCIENCE, V142, P691, DOI 10.1016/j.neuroscience.2006.06.043; Barker GRI, 2006, LEARN MEMORY, V13, P178, DOI 10.1101/lm.77806; Bear MF, 2004, TRENDS NEUROSCI, V27, P370, DOI 10.1016/j.tins.2004.04.009; Bhakar AL, 2012, ANNU REV NEUROSCI, V35, P417, DOI 10.1146/annurev-neuro-060909-153138; Bird MK, 2010, INT J NEUROPSYCHOPH, V13, P133, DOI 10.1017/S1461145709990162; Bordi F, 1996, NEUROPHARMACOLOGY, V35, P1557, DOI 10.1016/S0028-3908(96)00101-3; Bouwknecht J. Adriaan, 2002, Behavioural Brain Research, V136, P489, DOI 10.1016/S0166-4328(02)00200-0; Bouwknecht JA, 2004, EUR J PHARMACOL, V494, P45, DOI 10.1016/j.ejphar.2004.04.037; Brody SA, 2004, MOL PSYCHIATR, V9, P35, DOI 10.1038/sj.mp.4001404; Campanac E, 2013, NEURON, V77, P712, DOI 10.1016/j.neuron.2012.12.020; Catania MV, 2007, MOL NEUROBIOL, V35, P298, DOI 10.1007/s12035-007-0022-1; Chao HT, 2010, NATURE, V468, P263, DOI 10.1038/nature09582; Chevaleyre V, 2003, NEURON, V38, P461, DOI 10.1016/S0896-6273(03)00235-6; Conn PJ, 2009, TRENDS PHARMACOL SCI, V30, P25, DOI 10.1016/j.tips.2008.10.006; Conn PJ, 1997, ANNU REV PHARMACOL, V37, P205, DOI 10.1146/annurev.pharmtox.37.1.205; Crawley JN, 1997, HORM BEHAV, V31, P197, DOI 10.1006/hbeh.1997.1382; Crawley JN, 2004, MENT RETARD DEV D R, V10, P248, DOI 10.1002/mrdd.20039; Dolen G, 2008, J PHYSIOL-LONDON, V586, P1503, DOI 10.1113/jphysiol.2008.150722; Dolen G, 2007, NEURON, V56, P955, DOI 10.1016/j.neuron.2007.12.001; Durston S, 2003, MENT RETARD DEV D R, V9, P184, DOI 10.1002/mrdd.10079; Eisener-Dorman AF, 2013, PSYCHOPHARMACOLOGY, V225, P407, DOI 10.1007/s00213-012-2827-5; Elia J, 2012, CURR PSYCHIAT REP, V14, P579, DOI 10.1007/s11920-012-0309-4; Gentile Julie P, 2006, Psychiatry (Edgmont), V3, P25; Giedd JN, 2001, ANN NY ACAD SCI, V931, P33; Goebbels S, 2006, GENESIS, V44, P611, DOI 10.1002/dvg.20256; Gray L, 2009, INT J NEUROPSYCHOPH, V12, P45, DOI 10.1017/S1461145708009085; Greenhill LL, 2001, STIMULANT DRUGS ADHD, P31; Iossifov I, 2012, NEURON, V74, P285, DOI 10.1016/j.neuron.2012.04.009; Jacquemont S, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001708; Kachroo A, 2005, J NEUROSCI, V25, P10414, DOI 10.1523/JNEUROSCI.3660-05.2005; Kano M, 2009, PHYSIOL REV, V89, P309, DOI 10.1152/physrev.00019.2008; Kelleher RJ, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0035003, 10.1371/journal.pone.0050716]; Kessler RC, 2005, ARCH GEN PSYCHIAT, V62, P593, DOI 10.1001/archpsyc.62.6.593; Kettunen P, 2005, NEURON, V45, P95, DOI 10.1016/j.neuron.2004.12.022; Kinney GG, 2003, J PHARMACOL EXP THER, V306, P116, DOI 10.1124/jpet.103.048702; Kirov G, 2012, MOL PSYCHIATR, V17, P142, DOI 10.1038/mp.2011.154; Kreitzer AC, 2005, J NEUROSCI, V25, P10537, DOI 10.1523/JNEUROSCI.2959-05.2005; Krueger DD, 2011, ANNU REV MED, V62, P411, DOI 10.1146/annurev-med-061109-134644; Lafourcade M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000709; Lopez-Bendito G, 2002, CEREB CORTEX, V12, P625, DOI 10.1093/cercor/12.6.625; Lu YM, 1997, J NEUROSCI, V17, P5196; Luscher C, 2010, NEURON, V65, P445, DOI 10.1016/j.neuron.2010.01.016; Matosin N, 2013, NEUROSCI BIOBEHAV R, V37, P256, DOI 10.1016/j.neubiorev.2012.12.005; McIlwain KL, 2001, PHYSIOL BEHAV, V73, P705, DOI 10.1016/S0031-9384(01)00528-5; Monory K, 2006, NEURON, V51, P455, DOI 10.1016/j.neuron.2006.07.006; Moretti P, 2005, HUM MOL GENET, V14, P205, DOI 10.1093/hmg/ddi016; Nair Jyotsna, 2006, Mo Med, V103, P617; Niswender CM, 2010, ANNU REV PHARMACOL, V50, P295, DOI 10.1146/annurev.pharmtox.011008.145533; Olsen CM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015085; Palucha A, 2007, PHARMACOL THERAPEUT, V115, P116, DOI 10.1016/j.pharmthera.2007.04.007; Panenka WJ, 2012, DRUG ALCOHOL DEPEND; Paylor R, 2006, PHYSIOL BEHAV, V87, P95, DOI 10.1016/j.physbeh.2005.09.002; Paylor R, 1997, PSYCHOPHARMACOLOGY, V132, P169, DOI 10.1007/s002130050333; Paylor R, 1998, LEARN MEMORY, V5, P302; Peier AM, 2000, HUM MOL GENET, V9, P1145, DOI 10.1093/hmg/9.8.1145; Pietraszek M, 2005, EUR J PHARMACOL, V514, P25, DOI 10.1016/j.ejphar.2005.03.028; Polter A, 2010, NEUROPSYCHOPHARMACOL, V35, P1761, DOI 10.1038/npp.2010.43; Regehr WG, 2009, NEURON, V63, P154, DOI 10.1016/j.neuron.2009.06.021; Rouach N, 2003, EUR J NEUROSCI, V18, P1017, DOI 10.1046/j.1460-9568.2003.02823.x; Safo PK, 2005, NEURON, V48, P647, DOI 10.1016/j.neuron.2005.09.020; Sanon NT, 2010, EPILEPSIA, V51, P1607, DOI 10.1111/j.1528-1167.2010.02689.x; Shaltiel G, 2008, MOL PSYCHIATR, V13, P858, DOI 10.1038/mp.2008.20; She WC, 2009, EUR J NEUROSCI, V29, P1379, DOI 10.1111/j.1460-9568.2009.06696.x; SHIGEMOTO R, 1993, NEUROSCI LETT, V163, P53, DOI 10.1016/0304-3940(93)90227-C; Shigemoto R, 2000, GLUTAMATE; Spencer CM, 2006, HUM MOL GENET, V15, P1984, DOI 10.1093/hmg/ddl121; Spencer CM, 2011, AUTISM RES, V4, P40, DOI 10.1002/aur.168; Sun QQ, 2009, J NEUROPHYSIOL, V101, P2679, DOI 10.1152/jn.90566.2008; Sun W, 2013, SCIENCE, V339, P197, DOI 10.1126/science.1226740; Thomas A, 2009, PSYCHOPHARMACOLOGY, V204, P361, DOI 10.1007/s00213-009-1466-y; Thomas AM, 2011, PSYCHOPHARMACOLOGY B; Tritto T, 2004, NICOTINE TOB RES, V6, P145, DOI 10.1080/14622200310001656966; van Hooft JA, 2000, J NEUROSCI, V20, P3544, DOI 10.1523/JNEUROSCI.20-10-03544.2000; Volkow N D, 2001, J Neurosci, V21, pRC121; Witkin Jeffrey M., 2007, CNS & Neurological Disorders-Drug Targets, V6, P87, DOI 10.2174/187152707780363302; Wu CS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060314; Xu J, 2009, J NEUROSCI, V29, P3676, DOI 10.1523/JNEUROSCI.5716-08.2009; Yan QJ, 2005, NEUROPHARMACOLOGY, V49, P1053, DOI 10.1016/j.neuropharm.2005.06.004; Zhu JM, 2012, J NEUROSCI, V32, P9410, DOI 10.1523/JNEUROSCI.1041-12.2012	83	23	23	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2013	8	8							e70415	10.1371/journal.pone.0070415	http://dx.doi.org/10.1371/journal.pone.0070415			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	218XC	23940572	gold, Green Published, Green Submitted			2022-12-25	WOS:000324465000066
J	Klinker, MW; Reed, TJ; Fox, DA; Lundy, SK				Klinker, Matthew W.; Reed, Tamra J.; Fox, David A.; Lundy, Steven K.			Interleukin-5 Supports the Expansion of Fas Ligand-Expressing Killer B Cells that Induce Antigen-Specific Apoptosis of CD4(+) T Cells and Secrete Interleukin-10	PLOS ONE			English	Article							SYSTEMIC AUTOIMMUNITY; NATURAL ANTIBODIES; MARGINAL ZONE; B10 CELLS; MICE; LYMPHOCYTES; ACTIVATION; TOLERANCE; DEATH; IL-5	Beyond their critical role in humoral immunity, B lymphocytes can employ a variety of immunomodulatory mechanisms including expression of the apoptosis-inducing molecule Fas ligand (FasL; CD178). Here, we extensively characterized the surface phenotype of FasL(+) killer B cells, showing they are enriched in the IgM(high)CD5(+)CD1d(high) B cell subset previously reported to contain a higher frequency of B cells producing interleukin-10 (IL-10). A rare population of B cells expressing IL-10 was present among FasL(+) B cells, but most FasL(+) B cells did not produce IL-10. We also identify interleukin-5 (IL-5) as a novel inducer of killer B cell function. Constitutively FasL(+) B cells expressed higher levels of the IL-5 receptor, and treating B cells with IL-5 and CD40L resulted in the expansion of a B cell population enriched for FasL(+) cells. B cells stimulated with IL-5 and CD40L were potent inducers of apoptosis in activated primary CD4(+) T cells, and this killing function was antigen-specific and dependent upon FasL. IL-5 also enhanced IL-10 secretion in B cells stimulated with CD40L. Taken together these findings elucidate the relationship of FasL(+) B cells and IL-10-producing B cells and demonstrate that IL-5 can induce or enhance both killer B cell activity and IL-10 secretion in B cells. Finally, we found that the killer B cell activity induced by IL-5 was completely blocked by IL-4, suggesting the existence of a previously unknown antagonistic relationship between these type-2 cytokines in modulating the activity of killer B cells. Targeting this IL-5/IL-4 signaling axis may therefore represent a novel area of drug discovery in inflammatory disorders.	[Klinker, Matthew W.; Fox, David A.; Lundy, Steven K.] Univ Michigan, Grad Program Immunol, Ann Arbor, MI 48109 USA; [Klinker, Matthew W.; Reed, Tamra J.; Fox, David A.; Lundy, Steven K.] Univ Michigan, Dept Internal Med, Div Rheumatol, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Lundy, SK (corresponding author), Univ Michigan, Grad Program Immunol, Ann Arbor, MI 48109 USA.	sklundy@med.umich.edu		Lundy, Steven/0000-0002-3655-2216	Edward T. and Ellen K. Dryer Foundation; Arthritis Foundation; National Institutes of Health [5-K01-AR-053846]; Herman and Dorothy Miller Award for Innovative Immunology Research; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [K01AR053846] Funding Source: NIH RePORTER	Edward T. and Ellen K. Dryer Foundation; Arthritis Foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Herman and Dorothy Miller Award for Innovative Immunology Research; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported by grants from the Edward T. and Ellen K. Dryer Foundation, the Arthritis Foundation, the National Institutes of Health (5-K01-AR-053846), and the Herman and Dorothy Miller Award for Innovative Immunology Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afford SC, 1999, J EXP MED, V189, P441, DOI 10.1084/jem.189.2.441; Allen CDC, 2008, SEMIN IMMUNOL, V20, P14, DOI 10.1016/j.smim.2007.12.001; Binder CJ, 2004, J CLIN INVEST, V114, P427, DOI 10.1172/jci200420479; Bonardelle D, 2005, J LEUKOCYTE BIOL, V78, P1052, DOI 10.1189/jlb.0904536; Bossi G, 1999, NAT MED, V5, P90, DOI 10.1038/4779; Chen YF, 2009, J IMMUNOL, V182, P6031, DOI 10.4049/jimmunol.0804191; Chou MY, 2009, J CLIN INVEST, V119, P1335, DOI 10.1172/JCI36800; Ding Q, 2011, J CLIN INVEST, V121, P3645, DOI 10.1172/JCI46274; Eliopoulos AG, 2000, MOL CELL BIOL, V20, P5503, DOI 10.1128/MCB.20.15.5503-5515.2000; Erickson LD, 2001, J IMMUNOL, V166, P1531, DOI 10.4049/jimmunol.166.3.1531; Evans JG, 2007, J IMMUNOL, V178, P7868, DOI 10.4049/jimmunol.178.12.7868; Fillatreau S, 2002, NAT IMMUNOL, V3, P944, DOI 10.1038/ni833; Frommer F, 2008, J IMMUNOL, V181, P5748, DOI 10.4049/jimmunol.181.8.5748; Green DR, 2003, IMMUNOL REV, V193, P70, DOI 10.1034/j.1600-065X.2003.00051.x; Haas KM, 2010, J IMMUNOL, V184, P4789, DOI 10.4049/jimmunol.0902391; Hahne M, 1996, EUR J IMMUNOL, V26, P721, DOI 10.1002/eji.1830260332; Hussain S, 2007, J IMMUNOL, V179, P7225, DOI 10.4049/jimmunol.179.11.7225; Ikutani M, 2012, J IMMUNOL, V188, P703, DOI 10.4049/jimmunol.1101270; Islam SA, 2011, NAT IMMUNOL, V12, P167, DOI 10.1038/ni.1984; Kearney JF, 2005, SPRINGER SEMIN IMMUN, V26, P377, DOI 10.1007/s00281-004-0184-0; Klinker MW, 2012, MOL MED, V18, P123, DOI 10.2119/molmed.2011.00333; Kotecha Nikesh, 2010, Curr Protoc Cytom, VChapter 10, DOI 10.1002/0471142956.cy1017s53; Kroenke MA, 2008, J EXP MED, V205, P1535, DOI 10.1084/jem.20080159; Lundy SK, 2005, INFLAMM RES, V54, P514, DOI 10.1007/s00011-005-1387-0; Lundy SK, 2002, INFECT IMMUN, V70, P812, DOI 10.1128/IAI.70.2.812-819.2002; Lundy SK, 2001, INFECT IMMUN, V69, P271, DOI 10.1128/IAI.69.1.271-280.2001; Lundy SK, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2795; Lundy SK, 2009, INFLAMM RES, V58, P345, DOI 10.1007/s00011-009-0014-x; Mabrouk I, 2008, IMMUNITY, V29, P922, DOI 10.1016/j.immuni.2008.10.007; Martin F, 2001, IMMUNITY, V14, P617, DOI 10.1016/S1074-7613(01)00129-7; Matsushita T, 2010, J IMMUNOL, V185, P2240, DOI 10.4049/jimmunol.1001307; Mauri C, 2003, J EXP MED, V197, P489, DOI 10.1084/jem.20021293; Mauri C, 2012, ANNU REV IMMUNOL, V30, P221, DOI 10.1146/annurev-immunol-020711-074934; Minagawa R, 2004, TRANSPLANTATION, V78, P799, DOI 10.1097/01.TP.0000129799.96439.6F; Mizoguchi A, 2002, IMMUNITY, V16, P219, DOI 10.1016/S1074-7613(02)00274-1; Montandon R, 2013, P NATL ACAD SCI US; Montecino-Rodriguez E, 2006, NAT IMMUNOL, V7, P293, DOI 10.1038/ni1301; Morita Y, 2005, J GENE MED, V7, P869, DOI 10.1002/jgm.730; Moro K, 2010, NATURE, V463, P540, DOI 10.1038/nature08636; Neill DR, 2010, NATURE, V464, P1367, DOI 10.1038/nature08900; Schutz C, 2010, IMMUNOTHERAPY-UK, V2, P539, DOI 10.2217/IMT.10.26; Shaw PX, 2000, J CLIN INVEST, V105, P1731, DOI 10.1172/JCI8472; Shibaki A, 2001, EUR J IMMUNOL, V31, P3006, DOI 10.1002/1521-4141(2001010)31:10<3006::AID-IMMU3006>3.0.CO;2-L; TAKAHASHI T, 1994, CELL, V76, P969, DOI 10.1016/0092-8674(94)90375-1; Taniguchi RT, 2012, P NATL ACAD SCI USA, V109, P7847, DOI 10.1073/pnas.1120607109; Teichmann LL, 2012, J IMMUNOL, V188, P678, DOI 10.4049/jimmunol.1102456; Tian J, 2001, J IMMUNOL, V167, P1081, DOI 10.4049/jimmunol.167.2.1081; TOMINAGA A, 1991, J EXP MED, V173, P429, DOI 10.1084/jem.173.2.429; Tran GT, 2012, BLOOD, V119, P4441, DOI 10.1182/blood-2011-12-396101; Watanabe R, 2010, J IMMUNOL, V184, P4801, DOI 10.4049/jimmunol.0902385; WATANABEFUKUNAGA R, 1992, NATURE, V356, P314, DOI 10.1038/356314a0; Weir C, 2003, INT IMMUNOL, V15, P1283, DOI 10.1093/intimm/dxg127; Wolf SD, 1996, J EXP MED, V184, P2271, DOI 10.1084/jem.184.6.2271; Xiang YF, 2012, J IMMUNOL, V188, P4747, DOI 10.4049/jimmunol.1103055; Yanaba K, 2008, IMMUNITY, V28, P639, DOI 10.1016/j.immuni.2008.03.017; Yoshimoto M, 2011, P NATL ACAD SCI USA, V108, P1468, DOI 10.1073/pnas.1015841108; Yoshizaki A, 2012, NATURE, V491, P264, DOI 10.1038/nature11501; Zhang HG, 1998, NAT BIOTECHNOL, V16, P1045, DOI 10.1038/3488; Zuccato E, 2007, J CELL SCI, V120, P191, DOI 10.1242/jcs.03315	59	35	35	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2013	8	8							e70131	10.1371/journal.pone.0070131	http://dx.doi.org/10.1371/journal.pone.0070131			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	218XC	23940537	gold, Green Submitted, Green Published			2022-12-25	WOS:000324465000031
J	Larson, JH; Richardson, WB; Knights, BC; Bartsch, LA; Bartsch, MR; Nelson, JC; Veldboom, JA; Vallazza, JM				Larson, James H.; Richardson, William B.; Knights, Brent C.; Bartsch, Lynn A.; Bartsch, Michelle R.; Nelson, John C.; Veldboom, Jason A.; Vallazza, Jon M.			Fatty Acid Composition at the Base of Aquatic Food Webs Is Influenced by Habitat Type and Watershed Land Use	PLOS ONE			English	Article							RIVER; QUALITY; LAKES; EUTROPHICATION; RESPONSES; GRADIENT; PLANKTON; DAPHNIA; FISH	Spatial variation in food resources strongly influences many aspects of aquatic consumer ecology. Although large-scale controls over spatial variation in many aspects of food resources are well known, others have received little study. Here we investigated variation in the fatty acid (FA) composition of seston and primary consumers within (i.e., among habitats) and among tributary systems of Lake Michigan, USA. FA composition of food is important because all metazoans require certain FAs for proper growth and development that cannot be produced de novo, including many polyunsaturated fatty acids (PUFAs). Here we sampled three habitat types (river, rivermouth and nearshore zone) in 11 tributaries of Lake Michigan to assess the amount of FA in seston and primary consumers of seston. We hypothesize that among-system and among-habitat variation in FAs at the base of food webs would be related to algal production, which in turn is influenced by three land cover characteristics: 1) combined agriculture and urban lands (an indication of anthropogenic nutrient inputs that fuel algal production), 2) the proportion of surface waters (an indication of water residence times that allow algal producers to accumulate) and 3) the extent of riparian forested buffers (an indication of stream shading that reduces algal production). Of these three land cover characteristics, only intense land use appeared to strongly related to seston and consumer FA and this effect was only strong in rivermouth and nearshore lake sites. River seston and consumer FA composition was highly variable, but that variation does not appear to be driven by the watershed land cover characteristics investigated here. Whether the spatial variation in FA content at the base of these food webs significantly influences the production of economically important species higher in the food web should be a focus of future research.	[Larson, James H.; Richardson, William B.; Knights, Brent C.; Bartsch, Lynn A.; Bartsch, Michelle R.; Nelson, John C.; Veldboom, Jason A.; Vallazza, Jon M.] US Geol Survey, Upper Midwest Environm Sci Ctr, La Crosse, WI USA	United States Department of the Interior; United States Geological Survey	Larson, JH (corresponding author), US Geol Survey, Upper Midwest Environm Sci Ctr, La Crosse, WI USA.	jhlarson@usgs.gov		Nelson, John/0000-0002-7105-0107; Bartsch, Michelle/0000-0002-9571-5564; Bartsch, Lynn/0000-0002-1483-4845	Great Lakes Restoration Initiative [82]	Great Lakes Restoration Initiative	This project was funded by a Great Lakes Restoration Initiative Grant (Project #82). Any use of trade, product or firm names does not imply endorsement by the U.S. government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahlgren G, 2009, LIPIDS IN AQUATIC ECOSYSTEMS, P147, DOI 10.1007/978-0-387-89366-2_7; Allan J.D., 2021, STREAM ECOLOGY STRUC, DOI DOI 10.1007/978-3-030-61286-3; American Public Health Association (APHA), 1998, AM PHYS ED REV, V20th; [Anonymous], 2010, R LANG ENV STAT COMP; Arts MT, 2009, LIPIDS IN AQUATIC ECOSYSTEMS, P237, DOI 10.1007/978-0-387-89366-2_10; Black J.T, 1992, MULTIVARIATE DATA AN; Boechat IG, 2011, FEMS MICROBIOL ECOL, V77, P568, DOI 10.1111/j.1574-6941.2011.01137.x; Brett MT, 2009, LIPIDS IN AQUATIC ECOSYSTEMS, P115, DOI 10.1007/978-0-387-89366-2_6; Brett MT, 1997, FRESHWATER BIOL, V38, P483, DOI 10.1046/j.1365-2427.1997.00220.x; Carlin BP, 2008, BAYESIAN METHODS DAT; DeMott WR, 1997, FRESHWATER BIOL, V38, P649, DOI 10.1046/j.1365-2427.1997.00222.x; Environmental Systems Research Institute (ESRI), 2011, ARCGIS DESKT; Evans MA, 2011, ENVIRON SCI TECHNOL, V45, P3297, DOI 10.1021/es103892w; Frost PC, 2009, ECOLOGY, V90, P1631, DOI 10.1890/08-1534.1; Frost PC, 2005, OIKOS, V109, P18, DOI 10.1111/j.0030-1299.2005.14049.x; Ghermandi A, 2009, ECOL ENG, V35, P92, DOI 10.1016/j.ecoleng.2008.09.014; Grigorovich IA, 2008, J GREAT LAKES RES, V34, P342, DOI 10.3394/0380-1330(2008)34[342:TQMITL]2.0.CO;2; Grimes CB, 1996, MAR FRESHWATER RES, V47, P191, DOI 10.1071/MF9960191; Guschina IA, 2009, LIPIDS IN AQUATIC ECOSYSTEMS, P1, DOI 10.1007/978-0-387-89366-2_1; Hansen LK, 2008, AQUAT TOXICOL, V86, P99, DOI 10.1016/j.aquatox.2007.10.005; Hebert CE, 2009, OECOLOGIA, V160, P15, DOI 10.1007/s00442-009-1285-1; Hill Walter, 1996, P121, DOI 10.1016/B978-012668450-6/50034-5; Hill WR, 2011, FRESHWATER BIOL, V56, P1825, DOI 10.1111/j.1365-2427.2011.02622.x; Hilton J, 2006, SCI TOTAL ENVIRON, V365, P66, DOI 10.1016/j.scitotenv.2006.02.055; Homer C, 2004, PHOTOGRAMM ENG REM S, V70, P829, DOI 10.14358/PERS.70.7.829; Iverson SJ, 2009, LIPIDS IN AQUATIC ECOSYSTEMS, P281, DOI 10.1007/978-0-387-89366-2_12; James LAH, 2007, J N AM BENTHOL SOC, V26, P523, DOI 10.1899/06-101.1; Johengen TH, 2008, J GREAT LAKES RES, V34, P213, DOI 10.3394/0380-1330(2008)34[213:SOLMPM]2.0.CO;2; Jones NE, 2010, CAN J FISH AQUAT SCI, V67, P1350, DOI 10.1139/F10-069; Kainz M, 2004, LIMNOL OCEANOGR, V49, P1784, DOI 10.4319/lo.2004.49.5.1784; Lane RL, 2006, N AM J AQUACULT, V68, P141, DOI 10.1577/A05-009.1; Larson JH, 2012, J GREAT LAKES RES, V38, P610, DOI 10.1016/j.jglr.2012.09.016; Martin-Creuzburg D, 2012, OECOLOGIA, V168, P901, DOI 10.1007/s00442-011-2155-1; Masuda R, 1999, ENVIRON BIOL FISH, V56, P243, DOI 10.1023/A:1007565508398; McCarthy MA, 2007, BAYESIAN METHODS FOR ECOLOGY, P1, DOI 10.1017/CBO9780511802454; Montero D, 2004, J FISH DIS, V27, P297, DOI 10.1111/j.1365-2761.2004.00543.x; Muller-Navarra DC, 2004, NATURE, V427, P69, DOI 10.1038/nature02210; Niyogi DK, 2007, ENVIRON MANAGE, V39, P213, DOI 10.1007/s00267-005-0310-3; Parrish CC, 2009, LIPIDS IN AQUATIC ECOSYSTEMS, P309, DOI 10.1007/978-0-387-89366-2_13; Peterson GS, 2007, J GREAT LAKES RES, V33, P27, DOI 10.3394/0380-1330(2007)33[27:SNIOPA]2.0.CO;2; Qiming C., 1996, J ENVIRON QUAL, V6, P364, DOI DOI 10.2134/JEQ2007.0401; Reichert JM, 2010, CAN J FISH AQUAT SCI, V67, P987, DOI 10.1139/F10-036; ROJO C, 1994, HYDROBIOLOGIA, V289, P43, DOI 10.1007/BF00007407; Schindler DW, 2012, P ROY SOC B-BIOL SCI, V279, P4322, DOI 10.1098/rspb.2012.1032; Small GE, 2009, J N AM BENTHOL SOC, V28, P747, DOI 10.1899/08-099.1; Sterner R.W, 2002, ECOLOGICAL STOICHIOM, DOI DOI 10.1086/382444; Tomer MD, 2008, J SOIL WATER CONSERV, V63, P360, DOI 10.2489/jswc.63.6.360; Trebitz AS, 2007, J GREAT LAKES RES, V33, P67, DOI 10.3394/0380-1330(2007)33[67:WQIGLC]2.0.CO;2; Vanderploeg HA, 2010, J GREAT LAKES RES, V36, P50, DOI 10.1016/j.jglr.2010.04.005; VANNOTE RL, 1980, CAN J FISH AQUAT SCI, V37, P130, DOI 10.1139/f80-017; Weller DE, 2011, ECOL APPL, V21, P1679, DOI 10.1890/10-0789.1; Wiggins G.B., 1984, P271; [No title captured]; [No title captured]	54	3	3	5	63	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2013	8	8							e70666	10.1371/journal.pone.0070666	http://dx.doi.org/10.1371/journal.pone.0070666			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	218XC	23940619	gold, Green Submitted, Green Published			2022-12-25	WOS:000324465000113
J	Li, Z; Wang, J; Chen, L; Zhang, M; Wan, Y				Li, Zheng; Wang, Jing; Chen, Lin; Zhang, Meng; Wan, You			Basolateral Amygdala Lesion Inhibits the Development of Pain Chronicity in Neuropathic Pain Rats	PLOS ONE			English	Article							TACTILE ALLODYNIA; ANIMAL-MODEL; FEAR; CORTEX; BEHAVIOR; EMOTION	Background: Chronicity of pain is one of the most interesting questions in chronic pain study. Clinical and experimental data suggest that supraspinal areas responsible for negative emotions such as depression and anxiety contribute to the chronicity of pain. The amygdala is suspected to be a potential structure for the pain chronicity due to its critical role in processing negative emotions and pain information. Objective: This study aimed to investigate whether amygdala or its subregions, the basolateral amygdala (BLA) and the central medial amygdala (CeA), contributes to the pain chronicity in the spared nerve injury (SNI)-induced neuropathic pain model of rats. Methodology/Principal Findings: (1) Before the establishment of the SNI-induced neuropathic pain model of rats, lesion of the amygdaloid complex with stereotaxic injection of ibotenic acid (IBO) alleviated mechanical allodynia significantly at days 7 and 14, even no mechanical allodynia at day 28 after SNI; Lesion of the BLA, but not the CeA had similar effects; (2) however, 7 days after SNI when the neuropathic pain model was established, lesion of the amygdala complex or the BLA or the CeA, mechanical allodynia was not affected. Conclusion: These results suggest that BLA activities in the early stage after nerve injury might be crucial to the development of pain chronicity, and amygdala-related negative emotions and pain-related memories could promote pain chronicity.	[Li, Zheng; Chen, Lin; Zhang, Meng; Wan, You] Peking Univ, Neurosci Res Inst, Beijing 100871, Peoples R China; [Wang, Jing] Beijing Normal Univ, Natl Key Lab Cognit Neurosci & Learning, Sch Brain & Cognit Sci, Beijing 100875, Peoples R China; [Li, Zheng; Chen, Lin; Zhang, Meng; Wan, You] Peking Univ, Key Lab Neurosci, Minist Educ, Natl Hlth & Family Planning Commiss, Beijing 100871, Peoples R China	Peking University; Beijing Normal University; Peking University	Wan, Y (corresponding author), Peking Univ, Neurosci Res Inst, Beijing 100871, Peoples R China.	ywan@hsc.pku.edu.cn	Wan, You/M-5279-2019	Wan, You/0000-0001-6110-7192; Wang, Jing/0000-0001-9742-4034	Ministry of Education of China [109003, B07001]; Specialized Research Fund for Doctoral Program of Higher Education [20110001110058]; National Natural Science Foundation of China [81230023, 81221002]	Ministry of Education of China(Ministry of Education, China); Specialized Research Fund for Doctoral Program of Higher Education(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by grants from the Key Project of Ministry of Education of China (109003), Specialized Research Fund for Doctoral Program of Higher Education (20110001110058), National Natural Science Foundation of China (81230023, 81221002) and the "111" Project of the Ministry of Education of China (B07001). The founders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apkarian AV, 2011, PAIN, V152, pS49, DOI 10.1016/j.pain.2010.11.010; Apkarian AV, 2009, PROG NEUROBIOL, V87, P81, DOI 10.1016/j.pneurobio.2008.09.018; BLACKWELL B, 1984, HOSP COMMUNITY PSYCH, V35, P999; Cardinal RN, 2002, NEUROSCI BIOBEHAV R, V26, P321, DOI 10.1016/S0149-7634(02)00007-6; CHAPLAN SR, 1994, J NEUROSCI METH, V53, P55, DOI 10.1016/0165-0270(94)90144-9; CHEUNG RTF, 1995, J COMP NEUROL, V362, P535, DOI 10.1002/cne.903620408; DAVIS M, 1992, ANNU REV NEUROSCI, V15, P353, DOI 10.1146/annurev.neuro.15.1.353; Decosterd I, 2000, PAIN, V87, P149, DOI 10.1016/S0304-3959(00)00276-1; Fendt M, 1999, NEUROSCI BIOBEHAV R, V23, P743, DOI 10.1016/S0149-7634(99)00016-0; GARDINER IM, 1987, BRAIN RES, V407, P263, DOI 10.1016/0006-8993(87)91104-8; Geha PY, 2007, PAIN, V128, P88, DOI 10.1016/j.pain.2006.09.014; Goncalves L, 2008, EXP NEUROL, V213, P48, DOI 10.1016/j.expneurol.2008.04.043; Goncalves L, 2012, EUR J NEUROSCI, V36, P3204, DOI 10.1111/j.1460-9568.2012.08235.x; Ikeda R, 2007, PAIN, V127, P161, DOI 10.1016/j.pain.2006.09.003; JEANMONOD D, 1993, NEUROREPORT, V4, P475, DOI 10.1097/00001756-199305000-00003; Ji GC, 2010, J NEUROSCI, V30, P5451, DOI 10.1523/JNEUROSCI.0225-10.2010; LaGraize SC, 2004, EXP NEUROL, V188, P139, DOI 10.1016/j.expneurol.2004.04.003; LeDoux JE, 2000, ANNU REV NEUROSCI, V23, P155, DOI 10.1146/annurev.neuro.23.1.155; Maren S, 2004, NAT REV NEUROSCI, V5, P844, DOI 10.1038/nrn1535; Maren S, 2001, ANNU REV NEUROSCI, V24, P897, DOI 10.1146/annurev.neuro.24.1.897; Merskey H., 1994, CLASSIFICATION CHRON, V2nd ed; Neugebauer V, 2004, NEUROSCIENTIST, V10, P221, DOI 10.1177/1073858403261077; Pitkanen A, 1997, TRENDS NEUROSCI, V20, P517, DOI 10.1016/S0166-2236(97)01125-9; Simons LE, 2012, HUMAN BRAIN MAPPING; Sun Q, 2005, EXP NEUROL, V191, P128, DOI 10.1016/j.expneurol.2004.09.008; Toyoda H, 2011, NEURAL PLAST, V2011, DOI 10.1155/2011/813749; Valdes-Gonzalez T, 2001, NEUROSCI RES, V39, P197, DOI 10.1016/S0168-0102(00)00215-7; Vazdarjanova A, 1998, P NATL ACAD SCI USA, V95, P15003, DOI 10.1073/pnas.95.25.15003; Wang CK, 2009, CURR PAIN HEADACHE R, V13, P7, DOI 10.1007/s11916-009-0003-3; Watson C, 2006, RAT BRAIN STEREOTAXI	30	42	46	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2013	8	8							e70921	10.1371/journal.pone.0070921	http://dx.doi.org/10.1371/journal.pone.0070921			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	218XC	23940666	Green Published, Green Submitted, gold			2022-12-25	WOS:000324465000155
J	Poormasjedi-Meibod, MS; Jalili, RB; Hosseini-Tabatabaei, A; Hartwell, R; Ghahary, A				Poormasjedi-Meibod, Malihe-Sadat; Jalili, Raza B.; Hosseini-Tabatabaei, Azadeh; Hartwell, Ryan; Ghahary, Aziz			Immuno-Regulatory Function of Indoleamine 2,3 Dioxygenase through Modulation of Innate Immune Responses	PLOS ONE			English	Article							PLASMACYTOID DENDRITIC CELLS; NITRIC-OXIDE PRODUCTION; T-CELLS; TRYPTOPHAN CATABOLISM; LOCAL EXPRESSION; XENOGRAFT REJECTION; ALLOGRAFT-REJECTION; 2,3-DIOXYGENASE IDO; MACROPHAGES; FIBROBLASTS	Successful long-term treatment of type-1 diabetes mainly relies on replacement of beta-cells via islet transplantation. Donor shortage is one of the main obstacles preventing transplantation from becoming the treatment of choice. Although animal organs could be an alternative source for transplantation, common immunosuppressive treatments demonstrate low efficacy in preventing xenorejection. Immunoprotective effects of indoleamine 2,3-dioxygenase (IDO) on T-cell mediated allorejection has been extensively studied. Our studies revealed that IDO expression by fibroblasts, induced apoptosis in T-cells while not affecting non-immune cell survival/function. Since macrophages play a pivotal role in xenograft rejection, herein we investigated the effect of IDO-induced tryptophan deficiency/kynurenine accumulation on macrophage function/survival. Moreover, we evaluated the local immunosuppressive effect of IDO on islet-xenograft protection. Our results indicated that IDO expression by bystander fibroblasts significantly reduced the viability of primary macrophages via apoptosis induction. Treatment of peritoneal macrophages by IDO-expressing fibroblast conditioned medium significantly reduced their proinflammatory activity through inhibition of iNOS expression. To determine whether IDO-induced tryptophan starvation or kynurenine accumulation is responsible for macrophage apoptosis and inhibition of their proinflammatory activity, Raw264.7 cell viability and proinflammatory responses were evaluated in tryptophan deficient medium or in the presence of kynurenine. Tryptophan deficiency, but not kynurenine accumulation, reduced Raw264.7 cell viability and suppressed their proinflammatory activity. Next a three-dimensional islet-xenograft was engineered by embedding rat islets within either control or IDO-expressing fibroblast-populated collagen matrix. Islets morphology and immune cell infiltration were then studied in the xenografts transplanted into the C57BL/6 mouse renal sub-capsular space. Local IDO significantly decreased the number of infiltrating macrophages (11 +/- 1.47 vs. 70.5 +/- 7.57 cells/HPF), T-cells (8.75 +/- 1.03 vs. 75.75 +/- 5.72 cells/HPF) and iNOS expression in IDO-expressing xenografts versus controls. Islet morphology remained intact in IDO-expressing grafts and islets were strongly stained for insulin/glucagon compared to control. These findings support the immunosuppressive role of IDO on macrophage-mediated xeno-rejection.	[Poormasjedi-Meibod, Malihe-Sadat; Jalili, Raza B.; Hosseini-Tabatabaei, Azadeh; Hartwell, Ryan; Ghahary, Aziz] Univ British Columbia, Dept Surg, Div Plast Surg, Vancouver, BC V6T 1W5, Canada	University of British Columbia	Ghahary, A (corresponding author), Univ British Columbia, Dept Surg, Div Plast Surg, Vancouver, BC V6T 1W5, Canada.	aghahary@ubc.ca			Canadian Institute of Health Research (CIHR); Vanier Canada Graduate Scholarship (Vanier CGS); CIHR/Skin Research Training Centre (CIHR/SRTC); CIHR Training program in Transplantation	Canadian Institute of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Vanier Canada Graduate Scholarship (Vanier CGS); CIHR/Skin Research Training Centre (CIHR/SRTC)(Canadian Institutes of Health Research (CIHR)); CIHR Training program in Transplantation	The Canadian Institute of Health Research (CIHR) supported this study through a grant held by A. Ghahary. M.S. Poormasjedi-Meibod holds the Vanier Canada Graduate Scholarship (Vanier CGS) and was also supported by scholarships from CIHR/Skin Research Training Centre (CIHR/SRTC) and CIHR Training program in Transplantation. The URLs for the CIHR and Vanier CGS websites are: http://www.cihr-irsc.gc.ca/ and http://www.vanier.gc.ca/ respectively. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bach FH, 1998, ANNU REV MED, V49, P301; Beutelspacher SC, 2006, EUR J IMMUNOL, V36, P690, DOI 10.1002/eji.200535238; Cadili A, 2008, TRANSPL P, V40, P3289, DOI 10.1016/j.transproceed.2008.08.125; Chen W, 2008, J IMMUNOL, V181, P5396, DOI 10.4049/jimmunol.181.8.5396; Dai HH, 2008, CURR OPIN ORGAN TRAN, V13, P31, DOI 10.1097/MOT.0b013e3282f3dee1; Forouzandeh F, 2008, WOUND REPAIR REGEN, V16, P379, DOI 10.1111/j.1524-475X.2008.00377.x; Forouzandeh F, 2008, MOL CELL BIOCHEM, V309, P1, DOI 10.1007/s11010-007-9635-y; Fox A, 1998, TRANSPLANTATION, V66, P1407, DOI 10.1097/00007890-199812150-00002; Fox A, 2001, J IMMUNOL, V166, P2133, DOI 10.4049/jimmunol.166.3.2133; Grohmann U, 2010, IMMUNOL REV, V236, P243, DOI 10.1111/j.1600-065X.2010.00915.x; Guillonneau C, 2007, J CLIN INVEST, V117, P1096, DOI 10.1172/JCI28801; Huang A, 2002, BRIT J CANCER, V86, P1691, DOI 10.1038/sj.bjc.6600336; Ito T, 2007, J EXP MED, V204, P105, DOI 10.1084/jem.20061660; Jalili RB, 2007, J CELL PHYSIOL, V213, P137, DOI 10.1002/jcp.21100; Jalili RB, 2010, DIABETES, V59, P2219, DOI 10.2337/db09-1560; Jalili RB, 2009, AM J PATHOL, V174, P196, DOI 10.2353/ajpath.2009.080539; LANGREHR JM, 1992, J CLIN INVEST, V90, P679, DOI 10.1172/JCI115911; Lee GK, 2002, IMMUNOLOGY, V107, P452, DOI 10.1046/j.1365-2567.2002.01526.x; Li JP, 2007, AM J PHYSIOL-HEART C, V293, pH3415, DOI 10.1152/ajpheart.00532.2007; Li M, 2009, MOL CELL BIOCHEM, V332, P1, DOI 10.1007/s11010-009-0167-5; Li YY, 2006, J INVEST DERMATOL, V126, P128, DOI 10.1038/sj.jid.5700022; Lin Y, 1997, J IMMUNOL, V158, P5658; Meisel R, 2004, BLOOD, V103, P4619, DOI 10.1182/blood-2003-11-3909; Mellor AL, 2004, NAT REV IMMUNOL, V4, P762, DOI 10.1038/nri1457; Miki T, 2001, TRANSPLANT P, V33, P129, DOI 10.1016/S0041-1345(00)02792-5; Mulley WR, 2008, XENOTRANSPLANTATION, V15, P174, DOI 10.1111/j.1399-3089.2008.00472.x; Munn DH, 2005, IMMUNITY, V22, P633, DOI 10.1016/j.immuni.2005.03.013; Munn DH, 1998, SCIENCE, V281, P1191, DOI 10.1126/science.281.5380.1191; Munn DH, 2004, J CLIN INVEST, V114, P280, DOI 10.1172/JCI200421583; Okamoto A, 2005, CLIN CANCER RES, V11, P6030, DOI 10.1158/1078-0432.CCR-04-2671; Platten M, 2005, SCIENCE, V310, P850, DOI 10.1126/science.1117634; Puccetti P, 2008, BLOOD CELL MOL DIS, V40, P101, DOI 10.1016/j.bcmd.2007.06.026; Rezakhanlou AM, 2010, BIOL PROCED ONLINE, V12, P107, DOI 10.1007/s12575-010-9028-6; Salh B, 1998, J IMMUNOL, V161, P6947; Schuurman HJ, 2003, XENOTRANSPLANTATION, V10, P293, DOI 10.1034/j.1399-3089.2003.02092.x; Sekkai D, 1997, ARCH BIOCHEM BIOPHYS, V340, P117, DOI 10.1006/abbi.1997.9913; Soliman H, CANC J, V16, P354; VANDERVLIET A, 1994, BIOCHEM J, V303, P295, DOI 10.1042/bj3030295; Vos IHC, 2000, EUR J PHARMACOL, V391, P31, DOI 10.1016/S0014-2999(00)00021-2; Wee JLK, 2008, IMMUNOL CELL BIOL, V86, P460, DOI 10.1038/icb.2008.8; Wennberg L, 1997, XENOTRANSPLANTATION, V4, P228, DOI 10.1111/j.1399-3089.1997.tb00187.x; Worrall NK, 1997, TRANSPLANTATION, V63, P1095, DOI 10.1097/00007890-199704270-00008; Yasuda H, 1998, J CLIN INVEST, V102, P1807, DOI 10.1172/JCI2675; Yi SN, 2003, J IMMUNOL, V170, P2750, DOI 10.4049/jimmunol.170.5.2750	44	25	26	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2013	8	8							e71044	10.1371/journal.pone.0071044	http://dx.doi.org/10.1371/journal.pone.0071044			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	218XC	23940687	Green Published, Green Submitted, gold			2022-12-25	WOS:000324465000171
J	Wang, L; Zhang, Q; Chen, W; Shan, BE; Ding, Y; Zhang, GC; Cao, NN; Liu, L; Zhang, YZ				Wang, Ling; Zhang, Qi; Chen, Wei; Shan, Baoen; Ding, Yang; Zhang, Guochuan; Cao, Nana; Liu, Lei; Zhang, Yingze			B7-H3 is Overexpressed in Patients Suffering Osteosarcoma and Associated with Tumor Aggressiveness and Metastasis	PLOS ONE			English	Article							B7 FAMILY; T-CELLS; COSTIMULATORY MOLECULE; PROSTATE-CANCER; EXPRESSION; LIGAND; MEMBER; IMMUNOTHERAPY; MODULATION; DISEASE	B7-H3 is a member of the B7-family of co-stimulatory molecules, which has been shown to be broadly expressed in various tumor tissues, and which plays an important role in adaptive immune responses. The role of B7-H3 in osteosarcoma, however, remains unknown. In this study we used immunohistochemistry to analyze B7-H3 expression in 61 primary osteosarcoma tissues with case-matched adjacent normal tissues, and 37 osteochondroma and 20 bone fibrous dysplasia tissues. B7-H3 expression was expressed in 91.8% (56/61) of the osteosarcoma lesions, and the intensity of B7-H3 expression in osteosarcoma was significantly increased compared with adjacent normal tissues, osteochondroma and bone fibrous dysplasia tissues (p<0.001). Patients with high tumor B7-H3 levels had a significantly shorter survival time and recurrence time than patients with low tumor B7-H3 levels (p<0.001). Moreover, tumor B7-H3 expression inversely correlated with the number of tumor-infiltrating CD8(+) T cells (p<0.05). In vitro, increasing expression of B7-H3 promotes osteosarcoma cell invasion, at least in part by upregulating matrix metalloproteinase-2 (MMP-2). In conclusion, our study provides the first evidence of B7-H3 expression in osteosarcoma cells as a potential mechanism controlling tumor immunity and invasive malignancy, and which is correlated with patients' survival and metastasis.	[Wang, Ling; Zhang, Qi; Chen, Wei; Zhang, Yingze] Hebei Med Univ, Hosp 3, Hebei Bone Res Inst, Shijiazhuang, Hebei, Peoples R China; [Wang, Ling; Shan, Baoen; Cao, Nana] Hebei Med Univ, Hosp 4, Hebei Canc Res Inst, Shijiazhuang, Hebei, Peoples R China; [Zhang, Qi; Chen, Wei; Liu, Lei; Zhang, Yingze] Hebei Med Univ, Hosp 3, Dept Orthopaed Surg, Shijiazhuang, Hebei, Peoples R China; [Ding, Yang] Hebei Med Univ, Hosp 3, Dept Pathol, Shijiazhuang, Hebei, Peoples R China; [Zhang, Guochuan] Hebei Med Univ, Hosp 3, Dept Orthoped Oncol, Shijiazhuang, Hebei, Peoples R China	Hebei Medical University; Hebei Medical University; Hebei Medical University; Hebei Medical University; Hebei Medical University	Zhang, YZ (corresponding author), Hebei Med Univ, Hosp 3, Hebei Bone Res Inst, Shijiazhuang, Hebei, Peoples R China.	dryzzhang@126.com			Medical Research Project of Hebei Provincial Health Department [20110481]	Medical Research Project of Hebei Provincial Health Department	This work was financially supported by Grants from Medical Research Project of Hebei Provincial Health Department (20110481). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed N, 2009, MOL THER, V17, P1779, DOI 10.1038/mt.2009.133; Arigami T, 2011, CANCER SCI, V102, P1019, DOI 10.1111/j.1349-7006.2011.01877.x; Arigami T, 2010, ANN SURG, V252, P1044, DOI 10.1097/SLA.0b013e3181f1939d; Bielack S, 2009, CANCER TREAT RES, V152, P289, DOI 10.1007/978-1-4419-0284-9_15; Biller BJ, 2010, J VET INTERN MED, V24, P1118, DOI 10.1111/j.1939-1676.2010.0557.x; Boland JM, 2012, CLIN LUNG CANC; Brandt CS, 2009, J EXP MED, V206, P1495, DOI 10.1084/jem.20090681; Brunner A, 2012, GYNECOL ONCOL, V124, P105, DOI 10.1016/j.ygyno.2011.09.012; Carrle D, 2009, CANCER TREAT RES, V152, P165, DOI 10.1007/978-1-4419-0284-9_8; Castriconi R, 2004, P NATL ACAD SCI USA, V101, P12640, DOI 10.1073/pnas.0405025101; Chapoval AI, 2001, NAT IMMUNOL, V2, P269, DOI 10.1038/85339; Chavin G, 2009, CLIN CANCER RES, V15, P2174, DOI 10.1158/1078-0432.CCR-08-2262; Dong HD, 1999, NAT MED, V5, P1365; Errani C, 2011, EXPERT REV ANTICANC, V11, P217, DOI [10.1586/era.10.172, 10.1586/ERA.10.172]; Fromigue O, 2008, J BIOL CHEM, V283, P30549, DOI 10.1074/jbc.M801436200; Fukushima A, 2007, IMMUNOL LETT, V113, P52, DOI 10.1016/j.imlet.2007.07.011; Gill J, 2013, PHARMACOL THERAPEUT, V137, P89, DOI 10.1016/j.pharmthera.2012.09.003; Harting Matthew T, 2006, Semin Pediatr Surg, V15, P25, DOI 10.1053/j.sempedsurg.2005.11.005; Himoudi N, 2012, CLIN TRANSL ONCOL, V14, P271, DOI 10.1007/s12094-012-0795-1; Kobori H, 2010, IMMUNOLOGY, V130, P363, DOI 10.1111/j.1365-2567.2009.03236.x; Korpi JT, 2011, SURG ONCOL, V20, pE18, DOI 10.1016/j.suronc.2010.08.004; Li ZX, 2013, MOL BIOL REP, V40, P427, DOI 10.1007/s11033-012-2077-y; Ling V, 2003, GENOMICS, V82, P365, DOI 10.1016/S0888-7543(03)00126-5; Loeb DM, 2009, CANC TREAT, V152, P447, DOI 10.1007/978-1-4419-0284-9_25; Nardin A, 2006, CURR CANCER DRUG TAR, V6, P123, DOI 10.2174/156800906776056473; Pautke C, 2004, ANTICANCER RES, V24, P3743; Ritter J, 2010, ANN ONCOL, V21, P320, DOI 10.1093/annonc/mdq276; Schneider T, 2011, J THORAC ONCOL, V6, P1162, DOI 10.1097/JTO.0b013e31821c421d; Sica GL, 2003, IMMUNITY, V18, P849, DOI 10.1016/S1074-7613(03)00152-3; Smith-Garvin JE, 2009, ANNU REV IMMUNOL, V27, P591, DOI 10.1146/annurev.immunol.021908.132706; Strauss SJ, 2010, ONCOLOGIST, V15, P627, DOI 10.1634/theoncologist.2010-0093; Suh WK, 2003, NAT IMMUNOL, V4, P899, DOI 10.1038/ni967; Sun J, 2010, CANCER IMMUNOL IMMUN, V59, P1163, DOI 10.1007/s00262-010-0841-1; Sun TW, 2012, CANCER IMMUNOL IMMUN, V61, P2171, DOI 10.1007/s00262-012-1278-5; Tekle C, 2012, INT J CANCER, V130, P2282, DOI 10.1002/ijc.26238; Tseng SY, 2001, J EXP MED, V193, P839, DOI 10.1084/jem.193.7.839; Wang L, 2013, COMMUN COMPUT PHYS, V13, P13, DOI 10.4208/cicp.300611.120911s; Wang SD, 2000, BLOOD, V96, P2808; Wu CP, 2006, WORLD J GASTROENTERO, V12, P457, DOI 10.3748/wjg.v12.i3.457; Yamato I, 2009, BRIT J CANCER, V101, P1709, DOI 10.1038/sj.bjc.6605375; Zang X, 2007, P NATL ACAD SCI USA, V104, P19458, DOI 10.1073/pnas.0709802104	41	97	107	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2013	8	8							e70689	10.1371/journal.pone.0070689	http://dx.doi.org/10.1371/journal.pone.0070689			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	218XC	23940627	Green Submitted, Green Published, gold			2022-12-25	WOS:000324465000121
J	Abdelhady, S; Kitambi, SS; Lundin, V; Aufschnaiter, R; Sekyrova, P; Sinha, I; Lundgren, KT; Castelo-Branco, G; Linnarsson, S; Wedlich-Soldner, R; Teixeira, A; Andang, M				Abdelhady, Shaimaa; Kitambi, Satish Srinivas; Lundin, Vanessa; Aufschnaiter, Roland; Sekyrova, Petra; Sinha, Indranil; Lundgren, Kalle T.; Castelo-Branco, Goncalo; Linnarsson, Sten; Wedlich-Soeldner, Roland; Teixeira, Ana; Andang, Michael			Erg Channel Is Critical in Controlling Cell Volume during Cell Cycle in Embryonic Stem Cells	PLOS ONE			English	Article							HERG K+ CHANNEL; RNA-SEQ; PROLIFERATION; DERIVATION; APOPTOSIS	The cell cycle progression in mouse embryonic stem cells (mESCs) is controlled by ion fluxes that alter cell volume [1]. This suggests that ion fluxes might control dynamic changes in morphology over the cell cycle, such as rounding up of the cell at mitosis. However, specific channels regulating such dynamic changes and the possible interactions with actomyosin complex have not been clearly identified. Following RNAseq transcriptome analysis of cell cycle sorted mESCs, we found that expression of the K+ ion channel Erg1 peaked in G1 cell cycle phase, which was confirmed by immunostaining. Inhibition of Erg channel activity caused loss of G1 phase cells via non-apoptotic cell death. Cells first lost the ability of membrane blebbing, a typical feature of cultured embryonic stem cells. Continued Erg inhibition further increased cell volume and the cell eventually ruptured. In addition, atomic force measurements on live cells revealed a decreased cortical stiffness after treatment, suggesting alterations in actomyosin organization. When the intracellular osmotic pressure was experimentally decreased by hypertonic solution or block of K+ ion import via the Na, K-ATPase, cell viability was restored and cells acquired normal volume and blebbing activity. Our results suggest that Erg channels have a critical function in K+ ion homeostasis of mESCs over the cell cycle, and that cell death following Erg inhibition is a consequence of the inability to regulate cell volume.	[Abdelhady, Shaimaa; Sekyrova, Petra; Castelo-Branco, Goncalo; Andang, Michael] Karolinska Inst, Dept Physiol & Pharmacol, Stockholm, Sweden; [Kitambi, Satish Srinivas; Sinha, Indranil; Lundgren, Kalle T.; Linnarsson, Sten] Karolinska Inst, Dept Med Biochem & Biophys, Stockholm, Sweden; [Lundin, Vanessa; Teixeira, Ana] Karolinska Inst, Dept Cell & Mol Biol, Stockholm, Sweden; [Aufschnaiter, Roland; Wedlich-Soeldner, Roland] Max Planck Inst Biochem, D-82152 Martinsried, Germany; [Lundgren, Kalle T.] Karolinska Univ Hosp, Dept Reconstruct Plast Surg, Stockholm, Sweden	Karolinska Institutet; Karolinska Institutet; Karolinska Institutet; Max Planck Society; Karolinska Institutet; Karolinska University Hospital	Andang, M (corresponding author), Karolinska Inst, Dept Physiol & Pharmacol, Stockholm, Sweden.	michael.andang@ki.se	Castelo-Branco, Goncalo/A-8357-2015; Andäng, Michael/GRE-9898-2022; Kitambi, Satish S/J-4521-2013; Linnarsson, Sten/HCH-3909-2022; Castelo-Branco, Gonçalo/O-9162-2019; Conneryd Lundgren, Kalle/E-9056-2015	Castelo-Branco, Gonçalo/0000-0003-2247-9393; Sinha, Indranil/0000-0002-2513-5927; Andang, Michael/0000-0002-2886-7891; Teixeira, Ana/0000-0001-8169-8815; Conneryd Lundgren, Kalle/0000-0001-6781-762X	Swedish Cancer Society; Swedish Childhood Cancer Foundation; Swedish Research Council; Linne Center DBRM; Karolinska Institutet; KI-PhD scholarship	Swedish Cancer Society(Swedish Cancer Society); Swedish Childhood Cancer Foundation(European Commission); Swedish Research Council(Swedish Research CouncilEuropean Commission); Linne Center DBRM; Karolinska Institutet(Karolinska Institutet); KI-PhD scholarship	This study was supported by grants from the Swedish Cancer Society, the Swedish Childhood Cancer Foundation, the Swedish Research Council, the Linne Center DBRM and Karolinska Institutet (to MA). SA was supported by a KI-PhD scholarship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andang M, 2008, NATURE, V451, P460, DOI 10.1038/nature06488; Blackiston DJ, 2009, CELL CYCLE, V8, P3527, DOI 10.4161/cc.8.21.9888; Brons IGM, 2007, NATURE, V448, P191, DOI 10.1038/nature05950; Callies C, 2011, J CELL SCI, V124, P1936, DOI 10.1242/jcs.084657; Caspi O, 2009, STEM CELLS DEV, V18, P161, DOI 10.1089/scd.2007.0280; Charras GT, 2008, J MICROSC-OXFORD, V231, P466, DOI 10.1111/j.1365-2818.2008.02059.x; Cherubini A, 2005, MOL BIOL CELL, V16, P2972, DOI 10.1091/mbc.E04-10-0940; Fiske JL, 2006, CANCER METAST REV, V25, P493, DOI 10.1007/s10555-006-9017-z; Heng YW, 2010, INT J BIOCHEM CELL B, V42, P1622, DOI 10.1016/j.biocel.2010.04.007; Islam S, 2011, GENOME RES, V21, P1160, DOI 10.1101/gr.110882.110; Jehle J, 2011, CELL DEATH DIS, V2, DOI 10.1038/cddis.2011.77; Koivusalo M, 2009, J BIOL CHEM, V284, P6595, DOI 10.1074/jbc.R800049200; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Li Gui-Rong, 2011, World J Stem Cells, V3, P19, DOI 10.4252/wjsc.v3.i3.19; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; NAGY A, 1993, P NATL ACAD SCI USA, V90, P8424, DOI 10.1073/pnas.90.18.8424; Oberleithner H, 2009, P NATL ACAD SCI USA, V106, P2829, DOI 10.1073/pnas.0813069106; Ohgushi M, 2010, CELL STEM CELL, V7, P225, DOI 10.1016/j.stem.2010.06.018; Pillozzi S, 2007, BLOOD, V110, P1238, DOI 10.1182/blood-2006-02-003772; Riedl J, 2008, NAT METHODS, V5, P605, DOI 10.1038/nmeth.1220; Roy J, 2008, ONCOL REP, V19, P1511; Stewart MP, 2011, NATURE, V469, P226, DOI 10.1038/nature09642; Watanabe K, 2007, NAT BIOTECHNOL, V25, P681, DOI 10.1038/nbt1310; Winston NJ, 2004, BIOL REPROD, V70, P1070, DOI 10.1095/biolreprod.103.020917	24	5	5	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 2	2013	8	8							e72409	10.1371/journal.pone.0072409	http://dx.doi.org/10.1371/journal.pone.0072409			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219XU	23936540	Green Submitted, Green Published, gold			2022-12-25	WOS:000324545800074
J	Abe, A; Takahashi-Niki, K; Takekoshi, Y; Shimizu, T; Kitaura, H; Maita, H; Iguchi-Ariga, SMM; Ariga, H				Abe, Akira; Takahashi-Niki, Kazuko; Takekoshi, Yuka; Shimizu, Takashi; Kitaura, Hirotake; Maita, Hiroshi; Iguchi-Ariga, Sanae M. M.; Ariga, Hiroyoshi			Prefoldin Plays a Role as a Clearance Factor in Preventing Proteasome Inhibitor-induced Protein Aggregation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MOLECULAR CHAPERONE PREFOLDIN; MYC-BINDING PROTEIN; C-MYC; UNFOLDED PROTEINS; TUMOR-SUPPRESSOR; COMPLEX; GENE; MM-1; SYSTEM; CELLS	Prefoldin is a molecular chaperone composed of six subunits, PFD1-6, and prevents misfolding of newly synthesized nascent polypeptides. Although it is predicted that prefoldin, like other chaperones, modulates protein aggregation, the precise function of prefoldin against protein aggregation under physiological conditions has never been elucidated. In this study, we first established an anti-prefoldin monoclonal antibody that recognizes the prefoldin complex but not its subunits. Using this antibody, it was found that prefoldin was localized in the cytoplasm with dots in co-localization with polyubiquitinated proteins and that the number and strength of dots were increased in cells that had been treated with lactacystin, a proteasome inhibitor, and thapsigargin, an inducer of endoplasmic reticulum stress. Knockdown of prefoldin increased the level of SDS-insoluble ubiquitinated protein and reduced cell viability in lactacystin and thapsigargin-treated cells. Opposite results were obtained in prefoldin-overexpressed cells. It has been reported that mice harboring a missense mutation L110R of MM-1 alpha/PFD5 exhibit neurodegeneration in the cerebellum. Although the prefoldin complex containing L110R MM-1 alpha was properly formed in vitro and in cells derived from L110R MM-1 alpha mice, the levels of ubiquitinated proteins and cytotoxicity were higher in L110R MM-1 alpha cells than in wild-type cells under normal conditions and were increased by lactacystin and thapsigargin treatment, and growth of L110R MM-1 alpha cells was attenuated. Furthermore, the polyubiquitinated protein aggregation level was increased in the brains of L110R MM-1 alpha mice. These results suggest that prefoldin plays a role in quality control against protein aggregation and that dysfunction of prefoldin is one of the causes of neurodegenerative diseases.	[Abe, Akira; Takahashi-Niki, Kazuko; Takekoshi, Yuka; Shimizu, Takashi; Kitaura, Hirotake; Maita, Hiroshi; Ariga, Hiroyoshi] Hokkaido Univ, Grad Sch Pharmaceut Sci, Kita Ku, Sapporo, Hokkaido 0600812, Japan; [Iguchi-Ariga, Sanae M. M.] Hokkaido Univ, Grad Sch Agr, Kita Ku, Sapporo, Hokkaido 0608589, Japan	Hokkaido University; Hokkaido University	Ariga, H (corresponding author), Hokkaido Univ, Grad Sch Pharmaceut Sci, Kita Ku, Sapporo, Hokkaido 0600812, Japan.	hiro@pharm.hokudai.ac.jp	Maita, Hiroshi/D-5495-2012		Ministry of Education, Culture, Sports, Science and Technology	Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by grants-in-aid from the Ministry of Education, Culture, Sports, Science and Technology.	ARIGA H, 1983, J VIROL, V48, P481, DOI 10.1128/JVI.48.2.481-491.1983; Cao S, 2008, J IMMUNOL, V181, P476, DOI 10.4049/jimmunol.181.1.476; Dix DJ, 1996, P NATL ACAD SCI USA, V93, P3264, DOI 10.1073/pnas.93.8.3264; Fujioka Y, 2001, J BIOL CHEM, V276, P45137, DOI 10.1074/jbc.M106127200; Geissler S, 1998, EMBO J, V17, P952, DOI 10.1093/emboj/17.4.952; Gstaiger M, 2003, SCIENCE, V302, P1208, DOI 10.1126/science.1088401; Hara T, 2006, NATURE, V441, P885, DOI 10.1038/nature04724; Hartl FU, 2002, SCIENCE, V295, P1852, DOI 10.1126/science.1068408; Komatsu M, 2006, NATURE, V441, P880, DOI 10.1038/nature04723; Lee Y, 2011, J BIOL CHEM, V286, P726, DOI 10.1074/jbc.M110.177352; Martin-Benito J, 2007, STRUCTURE, V15, P101, DOI 10.1016/j.str.2006.11.006; Miyazawa M, 2011, J BIOL CHEM, V286, P19191, DOI 10.1074/jbc.M110.216259; Mori K, 1998, J BIOL CHEM, V273, P29794, DOI 10.1074/jbc.273.45.29794; Mousnier A, 2007, P NATL ACAD SCI USA, V104, P13615, DOI 10.1073/pnas.0705162104; Sakono M, 2008, FEBS J, V275, P5982, DOI 10.1111/j.1742-4658.2008.06727.x; Satou A, 2004, FEBS LETT, V572, P211, DOI 10.1016/j.febslet.2004.07.034; Satou A, 2001, J BIOL CHEM, V276, P46562, DOI 10.1074/jbc.M104937200; Siegers K, 1999, EMBO J, V18, P75, DOI 10.1093/emboj/18.1.75; Siegert R, 2000, CELL, V103, P621, DOI 10.1016/S0092-8674(00)00165-3; Simons CT, 2004, J BIOL CHEM, V279, P4196, DOI 10.1074/jbc.M306053200; Soergjerd KM, 2013, BIOCHEMISTRY-US, V52, P3532, DOI 10.1021/bi301705c; Tashiro E, 2013, J BIOL CHEM, V288, P19958, DOI 10.1074/jbc.M113.477984; Terada K, 2005, EMBO J, V24, P611, DOI 10.1038/sj.emboj.7600549; Tsuchiya H, 1996, CANCER RES, V56, P2881; Vainberg IE, 1998, CELL, V93, P863, DOI 10.1016/S0092-8674(00)81446-4; Yoshida T, 2008, EXP CELL RES, V314, P1217, DOI 10.1016/j.yexcr.2008.01.002	26	23	23	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 27	2013	288	39					27764	27776		10.1074/jbc.M113.476358	http://dx.doi.org/10.1074/jbc.M113.476358			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302OB	23946485	hybrid, Green Published			2022-12-25	WOS:000330612800006
J	Guo, J; Hammar, M; Oberg, L; Padmanabhuni, SS; Bjareland, M; Dalevi, D				Guo, Jing; Hammar, Marten; Oberg, Lisa; Padmanabhuni, Shanmukha S.; Bjareland, Marcus; Dalevi, Daniel			Combining Evidence of Preferential Gene-Tissue Relationships from Multiple Sources	PLOS ONE			English	Article							MICROARRAY DATA; DATA INTEGRATION; ARRAY DATA; EXPRESSION; MICRORNA; CANCER; METAANALYSIS; CHALLENGES; DIAGNOSIS; DATABASE	An important challenge in drug discovery and disease prognosis is to predict genes that are preferentially expressed in one or a few tissues, i.e. showing a considerably higher expression in one tissue(s) compared to the others. Although several data sources and methods have been published explicitly for this purpose, they often disagree and it is not evident how to retrieve these genes and how to distinguish true biological findings from those that are due to choice-of-method and/or experimental settings. In this work we have developed a computational approach that combines results from multiple methods and datasets with the aim to eliminate method/study-specific biases and to improve the predictability of preferentially expressed human genes. A rule-based score is used to merge and assign support to the results. Five sets of genes with known tissue specificity were used for parameter pruning and cross-validation. In total we identify 3434 tissue-specific genes. We compare the genes of highest scores with the public databases: PaGenBase (microarray), TiGER (EST) and HPA (protein expression data). The results have 85% overlap to PaGenBase, 71% to TiGER and only 28% to HPA. 99% of our predictions have support from at least one of these databases. Our approach also performs better than any of the databases on identifying drug targets and biomarkers with known tissue-specificity.	[Guo, Jing] Karolinska Inst, Dept Med Biochem & Biophys, Stockholm, Sweden; [Hammar, Marten] AstraZeneca R&D, Cardiovasc & Gastrointestinal iMed, Molndal, Sweden; [Oberg, Lisa] AstraZeneca R&D, Resp Inflammat & Autoimmune iMed, Molndal, Sweden; [Padmanabhuni, Shanmukha S.] Digital Enterprise Res Inst, Galway, Ireland; [Bjareland, Marcus] AstraZeneca R&D, R&D Informat, Molndal, Sweden; [Dalevi, Daniel] AstraZeneca R&D, Biometr & Informat Sci, Molndal, Sweden	Karolinska Institutet; AstraZeneca; AstraZeneca; Ollscoil na Gaillimhe-University of Galway; AstraZeneca; AstraZeneca	Dalevi, D (corresponding author), AstraZeneca R&D, Biometr & Informat Sci, Molndal, Sweden.	Daniel.Dalevi@astrazeneca.com		Padmanabhuni, Shanmukha Sampath/0000-0002-3090-9181; Guo, Jing/0000-0002-6399-3877				Cahan P, 2007, GENE, V401, P12, DOI 10.1016/j.gene.2007.06.016; Chen X, 2008, CELL RES, V18, P997, DOI 10.1038/cr.2008.282; Dezso Z, 2008, BMC BIOL, V6, DOI 10.1186/1741-7007-6-49; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Ghosh Debashis, 2003, Functional & Integrative Genomics, V3, P180; Greller LD, 1999, GENOME RES, V9, P282; Gremse M, 2011, NUCLEIC ACIDS RES, V39, pD507, DOI 10.1093/nar/gkq968; Hamosh A, 2005, NUCLEIC ACIDS RES, V33, pD514; Haverty PM, 2002, NUCLEIC ACIDS RES, V30, P214, DOI 10.1093/nar/30.1.214; Kadota K, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-294; Knox C, 2011, NUCLEIC ACIDS RES, V39, pD1035, DOI 10.1093/nar/gkq1126; Kouadjo KE, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-127; Landgraf P, 2007, CELL, V129, P1401, DOI 10.1016/j.cell.2007.04.040; Liang S, 2006, PHYSIOL GENOMICS, V26, P158, DOI 10.1152/physiolgenomics.00313.2005; Liang Y, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-166; Mitchell PS, 2008, P NATL ACAD SCI USA, V105, P10513, DOI 10.1073/pnas.0804549105; Moreau Y, 2003, TRENDS GENET, V19, P570, DOI 10.1016/j.tig.2003.08.006; Padmanabhuni SS, 2012, THESIS CHALMERS U TE; PEPYS MB, 1983, ADV IMMUNOL, V34, P141, DOI 10.1016/S0065-2776(08)60379-X; Rudy J, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-467; Searls DB, 2005, NAT REV DRUG DISCOV, V4, P45, DOI 10.1038/nrd1608; TILLETT WILLIAM S., 1930, JOUR EXP MED, V52, P561, DOI 10.1084/jem.52.4.561; Ueda T, 2009, ELECTRON J APPL STAT, V2, P67, DOI 10.1285/i20705948v2n1p67; Van Deun K, 2009, BIOINFORMATICS, V25, P2588, DOI 10.1093/bioinformatics/btp439; van Ruissen Fred, 2008, V387, P169; Wang GK, 2010, EUR HEART J, V31, P659, DOI 10.1093/eurheartj/ehq013; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Warnat P, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-265; Wu C, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-11-r130; Xia XQ, 2009, BIOINFORMATICS, V25, P2425, DOI 10.1093/bioinformatics/btp430; Xiao SJ, 2010, BIOINFORMATICS, V26, P1273, DOI 10.1093/bioinformatics/btq109; Xiong HL, 2010, INT J DATA MIN BIOIN, V4, P142, DOI 10.1504/IJDMB.2010.032168	32	2	2	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2013	8	8							e70568	10.1371/journal.pone.0070568	http://dx.doi.org/10.1371/journal.pone.0070568			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	200UV	23950964	gold, Green Submitted, Green Published			2022-12-25	WOS:000323097300030
J	Kobayashi, K; Hayashi, I; Kouda, S; Kato, F; Fujiwara, T; Kayama, S; Hirakawa, H; Itaha, H; Ohge, H; Gotoh, N; Usui, T; Matsubara, A; Sugai, M				Kobayashi, Kanao; Hayashi, Ikue; Kouda, Syuntaro; Kato, Fuminori; Fujiwara, Tamaki; Kayama, Shizuo; Hirakawa, Hideki; Itaha, Hideyuki; Ohge, Hiroki; Gotoh, Naomasa; Usui, Tsuguru; Matsubara, Akio; Sugai, Motoyuki			Identification and Characterization of a Novel aac(6 ')-Iag Associated with the bla(IMP-1)-Integron in a Multidrug-Resistant Pseudomonas aeruginosa	PLOS ONE			English	Article							AMINOGLYCOSIDE RESISTANCE; MOLECULAR CHARACTERIZATION; GENE CASSETTE; ARBEKACIN; SEQUENCE; STRAIN; SPREAD	In a continuing study from Dec 2006 to Apr 2008, we characterized nine multi-drug resistant Pseudomonas aeruginosa strains isolated from four patients in a ward at the Hiroshima University Hospital, Japan. Pulsed-field gel electrophoresis of SpeI-digested genomic DNAs from the isolates suggested the clonal expansion of a single strain; however, only one strain, NK0009, was found to produce metallo-beta-lactamase. PCR and subsequent sequencing analysis indicated NK0009 possessed a novel class 1 integron, designated as In124, that carries an array of four gene cassettes: a novel aminoglycoside (AG) resistance gene, aac(6')-Iag, bla(IMP-1), a truncated form of bla(IMP-1), and a truncated form of aac(6')-Iag. The aac(6')-Iag encoded a 167-amino-acid protein that shows 40% identity with AAC(6')-Iz. Recombinant AAC(6')-Iag protein showed aminoglycoside 6'-N-acetyltransferase activity using thin-layer chromatography (TLC) and MS spectrometric analysis. Escherichia coli carrying aac(6')-Iag showed resistance to amikacin, arbekacin, dibekacin, isepamicin, kanamycin, sisomicin, and tobramycin; but not to gentamicin. A conjugation experiment and subsequent Southern hybridization with the gene probes for bla(IMP-1) and aac(6')-Ig strongly suggested In124 is on a conjugal plasmid. Transconjugants acquired resistance to gentamicin and were resistant to virtually all AGs, suggesting that the In124 conjugal plasmid also possesses a gene conferring resistance to gentamicin.	[Kobayashi, Kanao; Kouda, Syuntaro; Kato, Fuminori; Fujiwara, Tamaki; Kayama, Shizuo; Itaha, Hideyuki; Ohge, Hiroki; Sugai, Motoyuki] Hiroshima Univ, Project Res Ctr Nosocomial Infect Dis, Hiroshima, Japan; [Kobayashi, Kanao; Kouda, Syuntaro; Kato, Fuminori; Fujiwara, Tamaki; Kayama, Shizuo; Sugai, Motoyuki] Hiroshima Univ, Grad Sch Biomed & Hlth Sci, Dept Bacteriol, Hiroshima, Japan; [Kobayashi, Kanao; Kouda, Syuntaro; Usui, Tsuguru; Matsubara, Akio] Hiroshima Univ, Grad Sch Biomed & Hlth Sci, Dept Urol, Hiroshima, Japan; [Hayashi, Ikue] Hiroshima Univ, Fac Dent, Res Facil, Hiroshima, Japan; [Hirakawa, Hideki] Kazusa DNA Res Inst, Chiba, Japan; [Itaha, Hideyuki] Hiroshima Univ Hosp, Dept Clin Lab Med, Hiroshima, Japan; [Ohge, Hiroki] Hiroshima Univ Hosp, Div Infect Dis, Hiroshima, Japan; [Gotoh, Naomasa] Kyoto Pharmaceut Univ, Dept Microbiol & Infect Control Sci, Kyoto 607, Japan	Hiroshima University; Hiroshima University; Hiroshima University; Hiroshima University; Kazusa DNA Research Institute; Hiroshima University; Hiroshima University; Kyoto Pharmaceutical University	Sugai, M (corresponding author), Hiroshima Univ, Project Res Ctr Nosocomial Infect Dis, Hiroshima, Japan.	sugai@hiroshima-u.ac.jp	Kato, Fuminori/V-2948-2017	Kato, Fuminori/0000-0001-8177-1728	Ministry of Education, Culture, Sports, Science and Technology of Japan [17019048]; Grants-in-Aid for Scientific Research [25460533] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Grants-in-Aid for Scientific Research on Priority Areas 'Applied Genomics' (No. 17019048 to MS) from the Ministry of Education, Culture, Sports, Science and Technology of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Clinical and Laboratory Standards Institute, 2007, M07A7 CLIN LAB STAND; Doi Y, 2004, ANTIMICROB AGENTS CH, V48, P2075, DOI 10.1128/AAC.48.6.2075-2080.2004; GENTHNER FJ, 1988, APPL ENVIRON MICROB, V54, P115, DOI 10.1128/AEM.54.1.115-117.1988; HALL RM, 1995, MOL MICROBIOL, V15, P593, DOI 10.1111/j.1365-2958.1995.tb02368.x; HannecartPokorni E, 1997, ANTIMICROB AGENTS CH, V41, P314, DOI 10.1128/AAC.41.2.314; Higgins DG, 1996, METHOD ENZYMOL, V266, P383; Hotta K, 1998, J ANTIBIOT, V51, P735, DOI 10.7164/antibiotics.51.735; Hotta K, 1996, J ANTIBIOT, V49, P458, DOI 10.7164/antibiotics.49.458; Jana S, 2006, APPL MICROBIOL BIOT, V70, P140, DOI 10.1007/s00253-005-0279-0; Kitao T, 2009, ANTIMICROB AGENTS CH, V53, P2327, DOI 10.1128/AAC.01360-08; KONDO S, 1993, J ANTIBIOT, V46, P310, DOI 10.7164/antibiotics.46.310; Kouda S, 2009, J ANTIMICROB CHEMOTH, V64, P46, DOI 10.1093/jac/dkp142; LAMBERT T, 1993, ANTIMICROB AGENTS CH, V37, P2093, DOI 10.1128/AAC.37.10.2093; LAMBERT T, 1994, ANTIMICROB AGENTS CH, V38, P1883, DOI 10.1128/AAC.38.9.1883; Lambert T, 1999, ANTIMICROB AGENTS CH, V43, P2366, DOI 10.1128/AAC.43.10.2366; Magnet S, 1999, J BACTERIOL, V181, P6650, DOI 10.1128/JB.181.21.6650-6655.1999; Ohara M, 2007, MICROBIOL IMMUNOL, V51, P271, DOI 10.1111/j.1348-0421.2007.tb03908.x; Rudant E, 1999, SYST APPL MICROBIOL, V22, P59, DOI 10.1016/S0723-2020(99)80028-9; RUDANT E, 1994, FEMS MICROBIOL LETT, V124, P49, DOI 10.1111/j.1574-6968.1994.tb07260.x; Salipante SJ, 2003, MOL BIOL EVOL, V20, P653, DOI 10.1093/molbev/msg074; Sekiguchi JI, 2005, ANTIMICROB AGENTS CH, V49, P3734, DOI 10.1128/AAC.49.9.3734-3742.2005; SHAW KJ, 1992, ANTIMICROB AGENTS CH, V36, P1447, DOI 10.1128/AAC.36.7.1447; SHAW KJ, 1993, MICROBIOL REV, V57, P138, DOI 10.1128/MMBR.57.1.138-163.1993; Stokes HW, 1997, MOL MICROBIOL, V26, P731, DOI 10.1046/j.1365-2958.1997.6091980.x; Tada T, 2013, ANTIMICROB AGENTS CH, V57, P96, DOI 10.1128/AAC.01105-12; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; TERAN FJ, 1991, ANTIMICROB AGENTS CH, V35, P714, DOI 10.1128/AAC.35.4.714; Toleman MA, 2002, J ANTIMICROB CHEMOTH, V50, P673, DOI 10.1093/jac/dkf210; Vakulenko SB, 2003, CLIN MICROBIOL REV, V16, P430, DOI 10.1128/CMR.16.3.430-450.2003; Vetting MW, 2008, BIOCHEMISTRY-US, V47, P9825, DOI 10.1021/bi800664x; Walsh TR, 2008, CURR OPIN INFECT DIS, V21, P367, DOI 10.1097/QCO.0b013e328303670b; Zhu CB, 1999, J ANTIBIOT, V52, P889, DOI 10.7164/antibiotics.52.889	32	9	10	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2013	8	8							e70557	10.1371/journal.pone.0070557	http://dx.doi.org/10.1371/journal.pone.0070557			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	200UV	23950962	Green Submitted, Green Published, gold			2022-12-25	WOS:000323097300029
J	Berentzen, NE; Beulens, JW; Hoevenaar-Blom, MP; Kampman, E; Bueno-de-Mesquita, HB; Romaguera-Bosch, D; Peeters, PHM; May, AM				Berentzen, Nina E.; Beulens, Joline W.; Hoevenaar-Blom, Marieke P.; Kampman, Ellen; Bueno-de-Mesquita, H. Bas; Romaguera-Bosch, Dora; Peeters, Petra H. M.; May, Anne M.			Adherence to the WHO's Healthy Diet Indicator and Overall Cancer Risk in the EPIC-NL Cohort	PLOS ONE			English	Article							MAJOR CHRONIC DISEASE; GUIDELINES-FOR-AMERICANS; DAIRY-PRODUCTS; PHYSICAL-ACTIVITY; QUALITY; NETHERLANDS; PREVENTION; MORTALITY; PATTERN; QUESTIONNAIRE	Background: A healthy dietary pattern defined by international recommendations of the World Health Organisation (WHO) has been shown to reduce overall mortality risk. It is unknown whether this healthy dietary pattern is associated with overall cancer incidence. Design: In total 35,355 men and women within the Dutch European Prospective Investigation into Cancer and Nutrition-cohort were followed for cancer occurrence. Diet was assessed through a validated food-frequency questionnaire. We computed a dietary score for all participants based on the seven WHO dietary guidelines for the prevention of chronic diseases (Healthy Diet Indicator (HDI)). We used the existing HDI score based on the 1990 WHO guidelines, and adapted it to meet with the 2002 WHO guidelines. Multivariate-adjusted Cox proportional hazards analysis was used to examine the association between adherence to the HDI and subsequent overall cancer risk. Results: A number of 3,007 new cancers were identified during a mean follow-up of 12.7 years. Adherence to the HDI was not associated with a reduced overall cancer risk. The hazard ratio (HR) of overall cancer associated with a one-point increment of the HDI was 0.96 (95% CI 0.89-1.03) in men, and 1.00 (95% CI 0.96-1.04) in women. Adherence to the HDI was not associated with smoking-related cancer ((HR men: 0.94 (95% CI 0.84-1.04); HR women: 1.00 (95% CI 0.94-1.07)), or alcohol-related cancer ((HR men: 1.02 (95% CI 0.87-1.20); HR women: 1.03 (95% CI 0.98-1.08)). Conclusions: Greater adherence to the WHO's Healthy Diet Indicator, a dietary pattern for prevention of chronic diseases, was not associated with reduced overall, smoking-related or alcohol-related cancer risk in men or women.	[Berentzen, Nina E.; Beulens, Joline W.; Peeters, Petra H. M.; May, Anne M.] Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, Utrecht, Netherlands; [Berentzen, Nina E.; Hoevenaar-Blom, Marieke P.] Natl Inst Publ Hlth & Environm RIVM, Ctr Nutr Prevent & Hlth Serv, Bilthoven, Netherlands; [Hoevenaar-Blom, Marieke P.; Kampman, Ellen] Wageningen Univ, Div Human Nutr, NL-6700 AP Wageningen, Netherlands; [Bueno-de-Mesquita, H. Bas] Natl Inst Publ Hlth & Environm, NL-3720 BA Bilthoven, Netherlands; [Bueno-de-Mesquita, H. Bas] Univ Med Ctr Utrecht, Dept Gastroenterol & Hepatol, Utrecht, Netherlands; [Romaguera-Bosch, Dora] Univ London Imperial Coll Sci Technol & Med, Sch Publ Hlth, Dept Epidemiol & Biostat, London, England; [Peeters, Petra H. M.] Univ London Imperial Coll Sci Technol & Med, Dept Epidemiol & Publ Hlth, London, England	Utrecht University; Utrecht University Medical Center; Netherlands National Institute for Public Health & the Environment; Wageningen University & Research; Netherlands National Institute for Public Health & the Environment; Utrecht University; Utrecht University Medical Center; Imperial College London; Imperial College London	Berentzen, NE (corresponding author), Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, Utrecht, Netherlands.	n.berentzen@umcutrecht.nl	May, Anne M/G-9183-2011; Hoevenaar-Blom, Maria/AGI-1087-2022; Kampman, E./H-8057-2014	Beulens, Joline/0000-0002-4181-0937; Romaguera, Dora/0000-0002-5762-8558	"Europe against Cancer" Programme of the European Commission (SANCO); Dutch Ministry of Health, Welfare and Sports; Dutch Cancer Society; Netherlands Organisation for Health Research and Development (ZonMW); World Cancer Research Fund (WCRF); Dutch Research Council (NWO-ZonMw) [40-00812-98-10040]	"Europe against Cancer" Programme of the European Commission (SANCO)(European CommissionEuropean Commission Joint Research Centre); Dutch Ministry of Health, Welfare and Sports; Dutch Cancer Society(KWF Kankerbestrijding); Netherlands Organisation for Health Research and Development (ZonMW)(Netherlands Organization for Health Research and Development); World Cancer Research Fund (WCRF)(World Cancer Research Fund International (WCRF)); Dutch Research Council (NWO-ZonMw)	This work was supported by "Europe against Cancer" Programme of the European Commission (SANCO), the Dutch Ministry of Health, Welfare and Sports, the Dutch Cancer Society, the Netherlands Organisation for Health Research and Development (ZonMW), the World Cancer Research Fund (WCRF) and by a grant of the Dutch Research Council (NWO-ZonMw; grant no 40-00812-98-10040). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anand P, 2008, PHARM RES-DORDR, V25, P2097, DOI 10.1007/s11095-008-9661-9; [Anonymous], 1990, World Health Organ Tech Rep Ser, V797, P1; [Anonymous], 2011, STAT NETH; Aune D, 2012, ANN ONCOL, V23, P37, DOI 10.1093/annonc/mdr269; Beulens JWJ, 2010, INT J EPIDEMIOL, V39, P1170, DOI 10.1093/ije/dyp217; Bianchini F, 2002, LANCET ONCOL, V3, P565, DOI 10.1016/S1470-2045(02)00849-5; BLOKSTRA A, 1998, MONITORING PROJECT R; Boffetta P, 2010, JNCI-J NATL CANCER I, V102, P529, DOI 10.1093/jnci/djq072; Boker LK, 2001, EUR J EPIDEMIOL, V17, P1047, DOI 10.1023/A:1020009325797; Cade JE, 2011, EUR J CLIN NUTR, V65, P920, DOI 10.1038/ejcn.2011.69; Cerhan JR, 2004, CANCER EPIDEM BIOMAR, V13, P1114; Chan AT, 2010, GASTROENTEROLOGY, V138, P2029, DOI 10.1053/j.gastro.2010.01.057; Chan DSM, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0020456, 10.1371/journal.pone.0027218]; Couto E, 2011, BRIT J CANCER, V104, P1493, DOI 10.1038/bjc.2011.106; Donders ART, 2006, J CLIN EPIDEMIOL, V59, P1087, DOI 10.1016/j.jclinepi.2006.01.014; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Fitzgerald AL, 2002, NUTR CANCER, V43, P127, DOI 10.1207/S15327914NC432_2; Haftenberger M, 2002, PUBLIC HEALTH NUTR, V5, P1163, DOI 10.1079/PHN2002397; Harnack L, 2002, AM J CLIN NUTR, V76, P889, DOI 10.1093/ajcn/76.4.889; Huijbregts P, 1997, BRIT MED J, V315, P13, DOI 10.1136/bmj.315.7099.13; Huncharek M, 2009, NUTR CANCER, V61, P47, DOI 10.1080/01635580802395733; International Agency for Research on Cancer (IARC) Working Group on the Evaluation of Carcinogenic Risks to Humans, 2004, MONOGR EVAL CARCINOG, V83; Kant AK, 2004, J AM DIET ASSOC, V104, P615, DOI 10.1016/j.jada.2004.01.010; KLESGES RC, 1995, J CONSULT CLIN PSYCH, V63, P438; Knoops KTB, 2006, EUR J CLIN NUTR, V60, P746, DOI 10.1038/sj.ejcn.1602378; McCullough ML, 2000, AM J CLIN NUTR, V72, P1223; McCullough ML, 2000, AM J CLIN NUTR, V72, P1214; McCullough ML, 2004, ONCOGENE, V23, P6349, DOI 10.1038/sj.onc.1207716; McCullough ML, 2002, AM J CLIN NUTR, V76, P1261, DOI 10.1093/ajcn/76.6.1261; Ocke MC, 1997, INT J EPIDEMIOL, V26, pS37, DOI 10.1093/ije/26.suppl_1.S37; Ocke MC, 1997, INT J EPIDEMIOL, V26, pS49, DOI 10.1093/ije/26.suppl_1.S49; Peters T, 2012, EUR J EPIDEMIOL, V27, P15, DOI 10.1007/s10654-011-9625-y; Pufulete M, 2008, NUTR RES REV, V21, P56, DOI 10.1017/S0954422408035920; Riboli E, 1997, INT J EPIDEMIOL, V26, pS6, DOI 10.1093/ije/26.suppl_1.S6; Romaguera D, 2012, AM J CLIN NUTR, V96, P150, DOI 10.3945/ajcn.111.031674; Ross S. A., 2010, Experimental Oncology, V32, P137; Secretan B, 2009, LANCET ONCOL, V10, P1033, DOI 10.1016/S1470-2045(09)70326-2; Sluijs I, 2010, AM J CLIN NUTR, V92, P905, DOI 10.3945/ajcn.2010.29620; Van Loon AJM, 2003, ANN EPIDEMIOL, V13, P105, DOI 10.1016/S1047-2797(02)00257-0; Verberne L, 2010, NUTR CANCER, V62, P860, DOI 10.1080/01635581.2010.509834; Vergnaud AC, 2013, AM J CLIN NUTR; Waijers PMCM, 2007, BRIT J NUTR, V97, P219, DOI 10.1017/S0007114507250421; Wareham NJ, 2003, PUBLIC HEALTH NUTR, V6, P407, DOI 10.1079/PHN2002439; WHO, 2003, WHO TECH REP SER, V916, P1; World Cancer Research Fund American Institute for Cancer Research (WCRF/AICR), CANC PREV EST FOOD N	45	28	28	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2013	8	8							e70535	10.1371/journal.pone.0070535	http://dx.doi.org/10.1371/journal.pone.0070535			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	200ZE	23950954	gold, Green Published, Green Submitted			2022-12-25	WOS:000323109700040
J	Honeywell, DR; Cabrita, MA; Zhao, HJ; Dimitroulakos, J; Addison, CL				Honeywell, D. Rice; Cabrita, Miguel A.; Zhao, Huijun; Dimitroulakos, Jim; Addison, Christina L.			miR-105 Inhibits Prostate Tumour Growth by Suppressing CDK6 Levels	PLOS ONE			English	Article							CANCER-CELLS; MICRORNA BIOGENESIS; BREAST-CANCER; C-ELEGANS; TARGETS; EXPRESSION; PROLIFERATION; TISSUES; GENES; IDENTIFICATION	A significant role for micro (mi)RNA in the regulation of gene expression in tumours has been recently established. In order to further understand how miRNA expression may contribute to prostate tumour growth and progression, we evaluated expression of miRNA in two invasive prostate tumour lines, PC3 and DU145, and compared it to that in normal prostate epithelial cells. Although a number of miRNAs were differentially expressed, we focused our analysis on miR-105, a novel miRNA not previously linked to prostate cancer. miR-105 levels were significantly decreased in both tumour cell lines in comparison to normal prostate epithelial cells. To determine its potential role in prostate cancer pathogenesis, we overexpressed miR-105 in both PC3 and DU145 cells and determined its effect on various tumourigenic properties. miR-105 overexpression inhibited tumour cell proliferation, tumour growth in anchorage-independent three-dimensional conditions and tumour invasion in vitro, properties of highly aggressive tumour cells. Of potential clinical significance, miR-105 overexpression inhibited tumour growth in vivo in xenograft models using these cell lines. We further identified CDK6 as a putative target of miR-105 which is likely a main contributor to the inhibition of tumour cell growth observed in our assays. Our results suggest that miR-105 inhibits tumour cell proliferation and hence may represent a novel therapeutically relevant cellular target to inhibit tumour growth or a marker of aggressive tumours in prostate cancer patients.	[Honeywell, D. Rice; Cabrita, Miguel A.; Zhao, Huijun; Dimitroulakos, Jim; Addison, Christina L.] Ottawa Hosp, Res Inst, Canc Therapeut Program, Ottawa, ON, Canada; [Honeywell, D. Rice; Dimitroulakos, Jim; Addison, Christina L.] Univ Ottawa, Dept Biochem, Ottawa, ON K1N 6N5, Canada; [Honeywell, D. Rice; Dimitroulakos, Jim; Addison, Christina L.] Univ Ottawa, Dept Microbiol & Immunol, Ottawa, ON K1N 6N5, Canada; [Dimitroulakos, Jim; Addison, Christina L.] Univ Ottawa, Dept Med, Ottawa, ON K1N 6N5, Canada	University of Ottawa; Ottawa Hospital Research Institute; University of Ottawa; University of Ottawa; University of Ottawa	Addison, CL (corresponding author), Ottawa Hosp, Res Inst, Canc Therapeut Program, Ottawa, ON, Canada.	caddison@ohri.ca	Dimitroulakos, Jim/AAK-3398-2020		Canadian Institutes in Health Research [MOP-84369]; Prostate Fight Foundation; Ontario Ministry of Training, Colleges and Universities	Canadian Institutes in Health Research(Canadian Institutes of Health Research (CIHR)); Prostate Fight Foundation; Ontario Ministry of Training, Colleges and Universities	This work was supported by operating grants to CLA from the Canadian Institutes in Health Research (MOP-84369) and the Prostate Fight Foundation through funds raised by the Motorcycle Ride for Dad. DRH was also a recipient of an Ontario Graduate Scholarship from the Ontario Ministry of Training, Colleges and Universities. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aqeilan RI, 2010, CELL DEATH DIFFER, V17, P215, DOI 10.1038/cdd.2009.69; Bader Andreas G., 2012, Frontiers in Genetics, V3, P120, DOI 10.3389/fgene.2012.00120; Blazejczyk M., 2007, FLEXARRAY STAT DATA; Boll K, 2013, ONCOGENE, V32, P277, DOI 10.1038/onc.2012.55; Calin GA, 2006, CANCER RES, V66, P7390, DOI 10.1158/0008-5472.CAN-06-0800; Carlsson J, 2010, CANCER GENET CYTOGEN, V202, P71, DOI 10.1016/j.cancergencyto.2010.06.009; Corcoran C, 2011, CLIN CHEM, V57, P18, DOI 10.1373/clinchem.2010.150730; Dean JL, 2012, CELL CYCLE, V11, P2756, DOI 10.4161/cc.21195; Dong CG, 2012, INT J ONCOL; Fahraeus R, 1999, EMBO J, V18, P2106, DOI 10.1093/emboj/18.8.2106; Gandellini P, 2009, CANCER RES, V69, P2287, DOI 10.1158/0008-5472.CAN-08-2894; Gao W, 2012, BIOMED PHARMACOTHER, V66, P21, DOI 10.1016/j.biopha.2011.09.004; Gordanpour A, 2012, PROSTATE CANC PROSTA; Gregory Richard I., 2006, V342, P33, DOI 10.1385/1-59745-123-1:33; Hassan O, 2012, J HEMATOL ONCOL, V5, DOI 10.1186/1756-8722-5-9; He L, 2004, NAT REV GENET, V5, P522, DOI 10.1038/nrg1379; KAIGHN ME, 1979, INVEST UROL, V17, P16; Kole AJ, 2011, GENE DEV, V25, P125, DOI 10.1101/gad.1975411; Kolfschoten IGM, 2009, DIABETES OBES METAB, V11, P118, DOI 10.1111/j.1463-1326.2009.01118.x; Konecny GE, 2011, CLIN CANCER RES, V17, P1591, DOI 10.1158/1078-0432.CCR-10-2307; Kong DJ, 2009, STEM CELLS, V27, P1712, DOI 10.1002/stem.101; Lee EJ, 2008, RNA, V14, P35, DOI 10.1261/rna.804508; Lee I, 2009, GENOME RES, V19, P1175, DOI 10.1101/gr.089367.108; Lee KH, 2009, PANCREATOLOGY, V9, P293, DOI 10.1159/000186051; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; Lee Y, 2003, NATURE, V425, P415, DOI 10.1038/nature01957; Lee Y, 2004, EMBO J, V23, P4051, DOI 10.1038/sj.emboj.7600385; Lim JTE, 2005, P NATL ACAD SCI USA, V102, P5156, DOI 10.1073/pnas.0501203102; Lin SL, 2008, RNA, V14, P417, DOI 10.1261/rna.874808; Lucas JJ, 2004, MOL CANCER RES, V2, P105; Lund E, 2004, SCIENCE, V303, P95, DOI 10.1126/science.1090599; Mazar J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024922; Melo SA, 2010, CANCER CELL, V18, P303, DOI 10.1016/j.ccr.2010.09.007; Mickey D D, 1980, Prog Clin Biol Res, V37, P67; Ortega S, 2002, BBA-REV CANCER, V1602, P73, DOI 10.1016/S0304-419X(02)00037-9; Peltier HJ, 2008, RNA, V14, P844, DOI 10.1261/rna.939908; Ribas J, 2009, CANCER RES, V69, P7165, DOI 10.1158/0008-5472.CAN-09-1448; Schaefer A, 2010, INT J CANCER, V126, P1166, DOI 10.1002/ijc.24827; Sevli S, 2010, PROSTATE CANCER P D, V13, P208, DOI 10.1038/pcan.2010.21; Sikand K, 2011, INT J CANCER, V129, P810, DOI 10.1002/ijc.25753; Sirotkin AV, 2010, J CELL PHYSIOL, V223, P49, DOI 10.1002/jcp.21999; Tie J, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000879; Van Rooij E, 2007, J CLIN INVEST, V117, P2369, DOI 10.1172/JCI33099; Wach S, 2012, INT J CANCER, V130, P611, DOI 10.1002/ijc.26064; Wang WZ, 2011, INT J CANCER, V129, P1624, DOI 10.1002/ijc.25818; WIGHTMAN B, 1993, CELL, V75, P855, DOI 10.1016/0092-8674(93)90530-4; Winter J, 2009, NAT CELL BIOL, V11, P228, DOI 10.1038/ncb0309-228; Wu JJ, 2010, CELL CYCLE, V9, P1809, DOI 10.4161/cc.9.9.11535; Xu B, 2011, MOL CELL BIOCHEM, V350, P207, DOI 10.1007/s11010-010-0700-6; Yang XJ, 2009, GENE DEV, V23, P2388, DOI 10.1101/gad.1819009; Yi R, 2005, RNA, V11, P220, DOI 10.1261/rna.7233305	51	41	48	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2013	8	8							e70515	10.1371/journal.pone.0070515	http://dx.doi.org/10.1371/journal.pone.0070515			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	200ZE	23950948	Green Published, gold, Green Submitted			2022-12-25	WOS:000323109700039
J	Stefanska, B; Bouzelmat, A; Huang, J; Suderman, M; Hallett, M; Han, ZG; Al-Mahtab, M; Akbar, SMF; Khan, WA; Raqib, R; Szyf, M				Stefanska, Barbara; Bouzelmat, Aurelie; Huang, Jian; Suderman, Matthew; Hallett, Michael; Han, Ze-Guang; Al-Mahtab, Mamun; Akbar, Sheikh Mohammad Fazle; Khan, Wasif Ali; Raqib, Rubhana; Szyf, Moshe			Discovery and Validation of DNA Hypomethylation Biomarkers for Liver Cancer Using HRM-Specific Probes	PLOS ONE			English	Article							GENE-EXPRESSION; BREAST-CANCER; HEPATOCELLULAR-CARCINOMA; METHYLATION ANALYSIS; DEMETHYLATION; MELANOMA; MAGE-A12; CELLS	Poor prognosis of hepatocellular carcinoma (HCC) associated with late diagnosis necessitates the development of early diagnostic biomarkers. We have previously delineated the landscape of DNA methylation in HCC patients unraveling the importance of promoter hypomethylation in activation of cancer- and metastasis-driving genes. The purpose of the present study was to test the feasibility that genes that are hypomethylated in HCC could serve as candidate diagnostic markers. We use high resolution melting analysis (HRM) as a simple translatable PCR-based method to define methylation states in clinical samples. We tested seven regions selected from the shortlist of genes hypomethylated in HCC and showed that HRM analysis of several of them distinguishes methylation states in liver cancer specimens from normal adjacent liver and chronic hepatitis in the Shanghai area. Such regions were identified within promoters of neuronal membrane glycoprotein M6-B (GPM6B) and melanoma antigen family A12 (MAGEA12) genes. Differences in HRM in the immunoglobulin superfamily Fc receptor (FCRL1) separated invasive tumors from less invasive HCC. The identified biomarkers differentiated HCC from chronic hepatitis in another set of samples from Dhaka. Although the main thrust in DNA methylation diagnostics in cancer is on hypermethylated genes, our study for the first time illustrates the potential use of hypomethylated genes as markers for solid tumors. After further validation in a larger cohort, the identified DNA hypomethylated regions can become important candidate biomarkers for liver cancer diagnosis and prognosis, especially in populations with high risk for HCC development.	[Stefanska, Barbara; Bouzelmat, Aurelie; Suderman, Matthew; Szyf, Moshe] McGill Univ, Dept Pharmacol & Therapeut, Montreal, PQ, Canada; [Huang, Jian; Han, Ze-Guang] Chinese Natl Human Genome Ctr Shanghai, Shanghai MOST Key Lab Dis & Hlth Genom, Shanghai, Peoples R China; [Hallett, Michael] McGill Univ, McGill Ctr Bioinformat, Montreal, PQ, Canada; [Al-Mahtab, Mamun] Bangabandhu Sheikh Mujib Med Univ, Dept Hepatol, Dhaka, Dhaka District, Bangladesh; [Akbar, Sheikh Mohammad Fazle] Toshiba Gen Hosp, Dept Med Sci, Tokyo, Kanto, Japan; [Khan, Wasif Ali; Raqib, Rubhana] Int Ctr Diarrhoeal Dis Res, Dhaka 1000, Dhaka District, Bangladesh; [Szyf, Moshe] McGill Univ, Sackler Program Psychobiol & Epigenet, Montreal, PQ, Canada	McGill University; McGill University; Bangabandhu Sheikh Mujib Medical University (BSMMU); Toshiba Corporation; International Centre for Diarrhoeal Disease Research (ICDDR); McGill University	Szyf, M (corresponding author), McGill Univ, Dept Pharmacol & Therapeut, Montreal, PQ, Canada.	moshe.szyf@mcgill.ca		Hallett, Michael/0000-0001-6738-6786; Suderman, Matthew/0000-0002-2715-9930; Han, Ze-Guang/0000-0002-1018-1752; Raqib, Rubhana/0000-0002-8116-4511	Ministere du Developpement Economique, de l'Innovation et de l'Exportation (MDEIE) program of the government of Quebec [215004]; Canadian Institute of Health Research [MOP-42411]; International Centre for Diarrhoeal Diseases Research, Bangladesh (icddr,b)	Ministere du Developpement Economique, de l'Innovation et de l'Exportation (MDEIE) program of the government of Quebec; Canadian Institute of Health Research(Canadian Institutes of Health Research (CIHR)); International Centre for Diarrhoeal Diseases Research, Bangladesh (icddr,b)	This research was supported by grants from Ministere du Developpement Economique, de l'Innovation et de l'Exportation (MDEIE) program of the government of Quebec (No. 215004, to MS), the Canadian Institute of Health Research (No. MOP-42411, to MS) and International Centre for Diarrhoeal Diseases Research, Bangladesh (icddr,b). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baylin SB, 2001, HUM MOL GENET, V10, P687, DOI 10.1093/hmg/10.7.687; Brennan K, 2012, CANCER RES, V72, P2304, DOI 10.1158/0008-5472.CAN-11-3157; Campan M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028141; Castells X, 2010, OMICS, V14, P157, DOI 10.1089/omi.2009.0093; Castells X, 2009, DIAGN MOL PATHOL, V18, P206, DOI 10.1097/PDM.0b013e31818f071b; Charfi C, 2011, BLOOD, V117, P1899, DOI 10.1182/blood-2010-10-311001; Colella S, 2003, BIOTECHNIQUES, V35, P146, DOI 10.2144/03351md01; deVos T, 2009, CLIN CHEM, V55, P1337, DOI 10.1373/clinchem.2008.115808; Drabek K, 2011, J BONE MINER RES, V26, P2045, DOI 10.1002/jbmr.435; Du X, 2008, BLOOD, V111, P338, DOI 10.1182/blood-2007-07-102350; Gibbs P, 2000, MELANOMA RES, V10, P259, DOI 10.1097/00008390-200010030-00008; Heidecker L, 2000, J IMMUNOL, V164, P6041, DOI 10.4049/jimmunol.164.11.6041; Jones PA, 2007, CELL, V128, P683, DOI 10.1016/j.cell.2007.01.029; Koh SS, 2012, MODERN PATHOL, V25, P828, DOI 10.1038/modpathol.2012.32; Kristensen LS, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn113; Kuo TC, 2012, BIOCHEM PHARMACOL, V83, P758, DOI 10.1016/j.bcp.2011.12.034; Liao MM, 2012, PATHOL ONCOL RES, V18, P397, DOI 10.1007/s12253-011-9458-8; Martens JWM, 2009, FUTURE ONCOL, V5, P1245, DOI [10.2217/fon.09.89, 10.2217/FON.09.89]; Mayol G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048401; Miyashiro I, 2001, CLIN CHEM, V47, P505; Mollaoglu N, 2008, DIS MARKERS, V24, P27, DOI 10.1155/2008/359840; Otte M, 2001, CANCER RES, V61, P6682; Song MA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055761; Stefanska B, 2011, CANCER RES, V71, P5891, DOI 10.1158/0008-5472.CAN-10-3823; Szyf M, 2005, BIOCHEMISTRY-MOSCOW+, V70, P533, DOI 10.1007/s10541-005-0147-7; Takayama T, 2011, JPN J CLIN ONCOL, V41, P447, DOI 10.1093/jjco/hyr016; Tost J, 2007, NAT PROTOC, V2, P2265, DOI 10.1038/nprot.2007.314; Werner HB, 2013, GLIA, V61, P567, DOI 10.1002/glia.22456; Wischnewski F, 2007, MOL CANCER RES, V5, P749, DOI 10.1158/1541-7786.MCR-06-0364; Wischnewski F, 2006, MOL CANCER RES, V4, P339, DOI 10.1158/1541-7786.MCR-05-0229	30	11	12	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2013	8	8							e68439	10.1371/journal.pone.0068439	http://dx.doi.org/10.1371/journal.pone.0068439			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	200ZE	23950870	gold, Green Published, Green Submitted			2022-12-25	WOS:000323109700005
J	Wu, TT; Tai, YT; Cherng, YG; Chen, TG; Lin, CJ; Chen, TL; Chang, HC; Chen, RM				Wu, Tsu-Tuan; Tai, Yu-Ting; Cherng, Yih-Giun; Chen, Tyng-Guey; Lin, Chien-Ju; Chen, Ta-Liang; Chang, Huai-Chia; Chen, Ruei-Ming			GATA-2 Transduces LPS-Induced il-1 beta Gene Expression in Macrophages via a Toll-Like Receptor 4/MD88/MAPK-Dependent Mechanism	PLOS ONE			English	Article							NECROSIS-FACTOR-ALPHA; ACUTE LUNG INJURY; KINASE PHOSPHORYLATION; SIGNAL-TRANSDUCTION; IN-VIVO; LIPOPOLYSACCHARIDE; PATHWAY; DIFFERENTIATION; PHAGOCYTOSIS; ACTIVATION	Lipopolysaccharide (LPS) is a critical factor for inducing acute lung injury. GATA-2, a transcription factor, contributes to the control of cell activity and function. Exposure of RAW 264.7 cells to LPS induced interleukin (IL)-1 beta mRNA and protein expression and GATA-2 translocation from the cytoplasm to nuclei in concentration-and time-dependent manners. A bioinformatic search revealed that GATA-2-specific binding elements exist in the 5'-promoter region of the il-1 beta gene. LPS could enhance the transactivation activity of GATA-2 in macrophages. Knocking-down translation of GATA-2 mRNA using RNA interference significantly alleviated LPS-induced IL-1 beta mRNA and protein expression. As to the mechanism, transfection of toll-like receptor (TLR) 4 small interfering (si) RNA into macrophages concurrently decreased LPS-caused increases in nuclear GATA-2 levels. Sequentially, treatment with myeloid differentiation factor 88 (MyD88) siRNA decreased LPS-induced phosphorylation of mitogen-activated protein kinases (MAPKs) kinase 1/2 and subsequent translocation of GATA-2. Reducing MAPK activities using specific inhibitors simultaneously decreased GATA-2 activation. Furthermore, exposure of primary macrophages to LPS significantly increased the transactivation activities of GATA-2 and IL-1 beta mRNA and protein expression. Transfection of GATA-2 siRNA inhibited LPS-induced IL-1 beta mRNA expression. Results of this study show that LPS induction of il-1 beta gene expression in macrophages is mediated by GATA-2 via activation of TLR4, MyD88, and MAPKs.	[Wu, Tsu-Tuan; Lin, Chien-Ju; Chen, Ruei-Ming] Taipei Med Univ, Grad Inst Med Sci, Taipei, Taiwan; [Wu, Tsu-Tuan; Lin, Chien-Ju; Chen, Ruei-Ming] Taipei Med Univ, Ctr Excellent Canc Res, Taipei, Taiwan; [Wu, Tsu-Tuan] Taipei Cty Hosp, Dept Internal Med, Sect Resp & Crit Care Med, Taipei, Taiwan; [Tai, Yu-Ting; Chen, Tyng-Guey] Taipei Med Univ, Wan Fang Hosp, Dept Anesthesiol, Taipei, Taiwan; [Cherng, Yih-Giun] Taipei Med Univ, Shuang Ho Hosp, Dept Anesthesiol, Taipei, Taiwan; [Chen, Ta-Liang; Chang, Huai-Chia; Chen, Ruei-Ming] Taipei Med Univ Hosp, Anesthet & Toxicol Res Ctr, Dept Anesthesiol, Taipei, Taiwan; [Chen, Ruei-Ming] Taipei Med Univ, Wan Fang Hosp, Cell Physiol & Mol Image Res Ctr, Taipei, Taiwan	Taipei Medical University; Taipei Medical University; Taipei Medical University; Taipei Municipal WanFang Hospital; Taipei Medical University; Shuang Ho Hospital; Taipei Medical University; Taipei Medical University Hospital; Taipei Medical University; Taipei Municipal WanFang Hospital	Chen, RM (corresponding author), Taipei Med Univ, Grad Inst Med Sci, Taipei, Taiwan.	rmchen@tmu.edu.tw		Cherng, Yih-Giun/0000-0002-0201-4380	Taipei County Hospital [TPCH97-007, TPCH98-a01, TPCH99-b03]; Department of Health, Taipei, Taiwan [DOH101-TD-C-111-008]	Taipei County Hospital; Department of Health, Taipei, Taiwan	Taipei County Hospital (TPCH97-007, TPCH98-a01, TPCH99-b03) and Department of Health (DOH101-TD-C-111-008,)Taipei, Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; BERNARD GR, 1994, AM J RESP CRIT CARE, V149, P818, DOI 10.1164/ajrccm.149.3.7509706; Beutler B, 2003, NAT REV IMMUNOL, V3, P169, DOI 10.1038/nri1004; Buck I, 2008, BIOCHEM PHARMACOL, V76, P1229, DOI 10.1016/j.bcp.2008.08.025; Burch JBE, 2005, SEMIN CELL DEV BIOL, V16, P71, DOI 10.1016/j.semcdb.2004.10.002; BYSANI GK, 1990, CRIT CARE MED, V18, P67, DOI 10.1097/00003246-199001000-00015; Calandra T, 2003, NAT REV IMMUNOL, V3, P791, DOI 10.1038/nri1200; Chang HC, 2011, J CEREBR BLOOD F MET, V31, P842, DOI 10.1038/jcbfm.2010.180; Chen RM, 2010, J BONE MINER RES, V25, P2193, DOI 10.1002/jbmr.121; Chen TL, 2009, TOXICOL APPL PHARM, V240, P15, DOI 10.1016/j.taap.2009.06.013; Chiu WT, 2009, CHEM-BIOL INTERACT, V181, P430, DOI 10.1016/j.cbi.2009.06.011; Chuang CY, 2011, IMMUNOBIOLOGY, V216, P707, DOI 10.1016/j.imbio.2010.10.009; Davidson TA, 1999, JAMA-J AM MED ASSOC, V281, P354, DOI 10.1001/jama.281.4.354; Dillon S, 2004, J IMMUNOL, V172, P4733, DOI 10.4049/jimmunol.172.8.4733; Dye JR, 2007, J IMMUNOL, V179, P229, DOI 10.4049/jimmunol.179.1.229; Fan HK, 2004, SHOCK, V22, P57, DOI 10.1097/01.shk.0000129759.58490.d6; Heinemeyer T, 1998, NUCLEIC ACIDS RES, V26, P362, DOI 10.1093/nar/26.1.362; Henneke P, 2004, J EXP MED, V199, P1, DOI 10.1084/jem.20031256; Ho IC, 2009, NAT REV IMMUNOL, V9, P125, DOI 10.1038/nri2476; Jones BW, 2001, J LEUKOCYTE BIOL, V69, P1036; KANNAN Y, 1991, BLOOD, V77, P1320; Kitajima K, 2006, BLOOD, V107, P1857, DOI 10.1182/blood-2005-06-2527; Kolch W, 2005, NAT REV MOL CELL BIO, V6, P827, DOI 10.1038/nrm1743; Lee CJ, 2010, SHOCK, V33, P93, DOI 10.1097/SHK.0b013e3181a6eaf5; LEENEN PJM, 1994, J IMMUNOL METHODS, V174, P5, DOI 10.1016/0022-1759(94)90005-1; Liu W, 2007, THROMB HAEMOSTASIS, V97, P839, DOI 10.1160/TH06-09-0536; Matthay MA, 2003, AM J RESP CRIT CARE, V167, P1027, DOI 10.1164/rccm.200208-966WS; Medzhitov R, 2009, NAT REV IMMUNOL, V9, P692, DOI 10.1038/nri2634; NATHAN CF, 1987, J CLIN INVEST, V80, P1550, DOI 10.1172/JCI113241; O'Neill LAJ, 2003, J ENDOTOXIN RES, V9, P55, DOI 10.1179/096805103125001351; Puneet P, 2011, NAT IMMUNOL, V12, P344, DOI 10.1038/ni.2004; REPINE JE, 1994, ENVIRON HEALTH PERSP, V102, P75, DOI 10.2307/3432219; Schingnitz U, 2010, J IMMUNOL, V184, P5271, DOI 10.4049/jimmunol.0903035; Schippers EF, 2005, CYTOKINE, V29, P215, DOI 10.1016/j.cyto.2004.12.005; Shyamsundar M, 2009, AM J RESP CRIT CARE, V179, P1107, DOI 10.1164/rccm.200810-1584OC; Smith KA, 2011, NAT IMMUNOL, V12, P284, DOI 10.1038/ni0411-284; Suzuki E, 1996, GENOMICS, V38, P283, DOI 10.1006/geno.1996.0630; Sweet MJ, 1996, J LEUKOCYTE BIOL, V60, P8, DOI 10.1002/jlb.60.1.8; Ware LB, 2000, NEW ENGL J MED, V342, P1334, DOI 10.1056/NEJM200005043421806; Wu GJ, 2008, TOXICOL APPL PHARM, V228, P105, DOI 10.1016/j.taap.2007.11.027; Wu TT, 2009, TOXICOL LETT, V191, P195, DOI 10.1016/j.toxlet.2009.08.025; Yu YL, 2005, J BIOL CHEM, V280, P29533, DOI 10.1074/jbc.M506514200	42	24	26	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2013	8	8							e72404	10.1371/journal.pone.0072404	http://dx.doi.org/10.1371/journal.pone.0072404			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	217ZG	23940812	Green Published, Green Submitted, gold			2022-12-25	WOS:000324401500091
J	Ide, S; Nishizawa, D; Fukuda, K; Kasai, S; Hasegawa, J; Hayashida, M; Minami, M; Ikeda, K				Ide, Soichiro; Nishizawa, Daisuke; Fukuda, Ken-ichi; Kasai, Shinya; Hasegawa, Junko; Hayashida, Masakazu; Minami, Masabumi; Ikeda, Kazutaka			Association between Genetic Polymorphisms in Ca(v)2.3 (R-type) Ca2+ Channels and Fentanyl Sensitivity in Patients Undergoing Painful Cosmetic Surgery	PLOS ONE			English	Article							E CALCIUM-CHANNEL; MORPHINE ANALGESIA; ANTAGONISTS; DEPENDENCE; TOLERANCE; RESPONSES; SUBUNIT; POWER	Individual differences in the sensitivity to fentanyl, a widely used opioid analgesic, lead to different proper doses of fentanyl, which can hamper effective pain treatment. Voltage-activated Ca2+ channels (VACCs) play a crucial role in the nervous system by controlling membrane excitability and calcium signaling. Ca(v)2.3 (R-type) VACCs have been especially thought to play critical roles in pain pathways and the analgesic effects of opioids. However, unknown is whether single-nucleotide polymorphisms (SNPs) of the human CACNA1E (calcium channel, voltage-dependent, R type, alpha 1E subunit) gene that encodes Ca(v)2.3 VACCs influence the analgesic effects of opioids. Thus, the present study examined associations between fentanyl sensitivity and SNPs in the human CACNA1E gene in 355 Japanese patients who underwent painful orofacial cosmetic surgery, including bone dissection. We first conducted linkage disequilibrium (LD) analyses of 223 SNPs in a region that contains the CACNA1E gene using genomic samples from 100 patients, and a total of 13 LD blocks with 42 Tag SNPs were observed within and around the CACNA1E gene region. In the preliminary study using the same 100 genomic samples, only the rs3845446 A/G SNP was significantly associated with perioperative fentanyl use among these 42 Tag SNPs. In a confirmatory study using the other 255 genomic samples, this SNP was also significantly associated with perioperative fentanyl use. Thus, we further analyzed associations between genotypes of this SNP and all of the clinical data using a total of 355 samples. The rs3845446 A/G SNP was associated with intraoperative fentanyl use, 24 h postoperative fentanyl requirements, and perioperative fentanyl use. Subjects who carried the minor G allele required significantly less fentanyl for pain control compared with subjects who did not carry this allele. Although further validation is needed, the present findings show the possibility of the involvement of CACNA1E gene polymorphisms in fentanyl sensitivity.	[Ide, Soichiro; Nishizawa, Daisuke; Kasai, Shinya; Hasegawa, Junko; Ikeda, Kazutaka] Tokyo Metropolitan Inst Med Sci, Addict Subst Project, Tokyo 113, Japan; [Ide, Soichiro; Minami, Masabumi] Hokkaido Univ, Grad Sch Pharmaceut Sci, Dept Pharmacol, Sapporo, Hokkaido, Japan; [Fukuda, Ken-ichi] Suidoubashi Hosp, Tokyo Dent Coll, Orofacial Pain Ctr, Dept Oral Hlth & Clin Sci,Div Dent Anesthesiol, Tokyo, Japan; [Hayashida, Masakazu] Juntendo Univ, Sch Med, Dept Anesthesiol & Pain Med, Tokyo 113, Japan	Tokyo Metropolitan Institute of Medical Science; Hokkaido University; Tokyo Dental College; Juntendo University	Ikeda, K (corresponding author), Tokyo Metropolitan Inst Med Sci, Addict Subst Project, Tokyo 113, Japan.	ikeda-kz@igakuken.or.jp	Minami, Masabumi/A-3883-2012	Minami, Masabumi/0000-0002-0144-0679; Ide, Soichiro/0000-0002-9112-2841	Ministry of Education, Culture, Sports, Science and Technology [20390162, 22790518, 23390377, 25116532]; Japanese Ministry of Health, Labour and Welfare [H21-3jigan-ippan-011, H22-Iyaku-015]; Smoking Research Foundation; Astellas Foundation for Research on Metabolic Disorders	Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japanese Ministry of Health, Labour and Welfare(Ministry of Health, Labour and Welfare, Japan); Smoking Research Foundation; Astellas Foundation for Research on Metabolic Disorders	This research was supported by Grants-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology (20390162, 22790518, 23390377, 25116532), Japanese Ministry of Health, Labour and Welfare (H21-3jigan-ippan-011, H22-Iyaku-015), Smoking Research Foundation, and Astellas Foundation for Research on Metabolic Disorders. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angst MS, 2012, PAIN, V153, P1397, DOI 10.1016/j.pain.2012.02.022; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Bisgaard T, 2001, PAIN, V90, P261, DOI 10.1016/S0304-3959(00)00406-1; Carlson CS, 2003, NAT GENET, V33, P518, DOI 10.1038/ng1128; Carlson CS, 2004, AM J HUM GENET, V74, P106, DOI 10.1086/381000; Catterall WA, 2000, ANNU REV CELL DEV BI, V16, P521, DOI 10.1146/annurev.cellbio.16.1.521; CONTRERAS E, 1988, EUR J PHARMACOL, V148, P463, DOI 10.1016/0014-2999(88)90129-X; Coulbault L, 2006, CLIN PHARMACOL THER, V79, P316, DOI 10.1016/j.clpt.2006.01.007; de Bakker PIW, 2005, NAT GENET, V37, P1217, DOI 10.1038/ng1669; Dogrul A, 2002, LIFE SCI, V71, P725, DOI 10.1016/S0024-3205(02)01736-8; Ertel EA, 2000, NEURON, V25, P533, DOI 10.1016/S0896-6273(00)81057-0; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; Fukuda K, 2009, PAIN, V147, P194, DOI 10.1016/j.pain.2009.09.004; Gabriel SB, 2002, SCIENCE, V296, P2225, DOI 10.1126/science.1069424; Holmkvist J, 2007, DIABETOLOGIA, V50, P2467, DOI 10.1007/s00125-007-0846-2; Ikeda K, 2005, TRENDS PHARMACOL SCI, V26, P311, DOI 10.1016/j.tips.2005.04.001; Kasai S, 2011, PHARMACOGENOMICS, V12, P1305, DOI [10.2217/PGS.11.68, 10.2217/pgs.11.68]; Loh HH, 1998, MOL BRAIN RES, V54, P321, DOI 10.1016/S0169-328X(97)00353-7; Marubio LM, 1996, RECEPTOR CHANNEL, V4, P243; Michaluk J, 1998, EUR J PHARMACOL, V352, P189, DOI 10.1016/S0014-2999(98)00373-2; Muller YL, 2007, DIABETES, V56, P3089, DOI 10.2337/db07-0587; Murakami M, 2004, BRAIN RES, V1024, P122, DOI 10.1016/j.brainres.2004.07.066; Newcomb R, 1998, BIOCHEMISTRY-US, V37, P15353, DOI 10.1021/bi981255g; Park JF, 2010, CHANNELS, V4, P510, DOI 10.4161/chan.4.6.12869; Pereverzev A, 2002, MOL CELL NEUROSCI, V21, P352, DOI 10.1006/mcne.2002.1179; Saegusa H, 2000, P NATL ACAD SCI USA, V97, P6132, DOI 10.1073/pnas.100124197; Sora I, 1997, P NATL ACAD SCI USA, V94, P1544, DOI 10.1073/pnas.94.4.1544; Sora I, 2001, NEUROPSYCHOPHARMACOL, V25, P41, DOI 10.1016/S0893-133X(00)00252-9; Westenbroek RE, 1998, J NEUROSCI, V18, P6319; YOKOYAMA CT, 1995, J NEUROSCI, V15, P6419; Yokoyama K, 2004, EUR J NEUROSCI, V20, P3516, DOI 10.1111/j.1460-9568.2004.03810.x; ZHANG JF, 1993, NEUROPHARMACOLOGY, V32, P1075, DOI 10.1016/0028-3908(93)90003-L	33	19	20	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2013	8	8							e70694	10.1371/journal.pone.0070694	http://dx.doi.org/10.1371/journal.pone.0070694			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	218XC	23940630	gold, Green Published			2022-12-25	WOS:000324465000124
J	Nishigami, Y; Ichikawa, M; Kazama, T; Kobayashi, R; Shimmen, T; Yoshikawa, K; Sonobe, S				Nishigami, Yukinori; Ichikawa, Masatoshi; Kazama, Toshiya; Kobayashi, Ryo; Shimmen, Teruo; Yoshikawa, Kenichi; Sonobe, Seiji			Reconstruction of Active Regular Motion in Amoeba Extract: Dynamic Cooperation between Sol and Gel States	PLOS ONE			English	Article							CONTRACTION; LOCOMOTION; MOTILITY; CALCIUM; CELLS	Amoeboid locomotion is one of the typical modes of biological cell migration. Cytoplasmic sol-gel conversion of an actomyosin system is thought to play an important role in locomotion. However, the mechanisms underlying sol-gel conversion, including trigger, signal, and regulating factors, remain unclear. We developed a novel model system in which an actomyosin fraction moves like an amoeba in a cytoplasmic extract. Rheological study of this model system revealed that the actomyosin fraction exhibits shear banding: the sol-gel state of actomyosin can be regulated by shear rate or mechanical force. Furthermore, study of the living cell indicated that the shear-banding property also causes sol-gel conversion with the same order of magnitude as that of shear rate. Our results suggest that the inherent sol-gel transition property plays an essential role in the self-regulation of autonomous translational motion in amoeba.	[Nishigami, Yukinori; Shimmen, Teruo; Sonobe, Seiji] Univ Hyogo, Grad Sch Life Sci, Dept Life Sci, Harima, Hyogo, Japan; [Ichikawa, Masatoshi; Yoshikawa, Kenichi] Kyoto Univ, Dept Phys, Grad Sch Sci, Kyoto 606, Japan; [Kazama, Toshiya; Kobayashi, Ryo] Hiroshima Univ, Grad Sch Sci, Dept Math & Life Sci, Higashihiroshima 724, Japan; [Yoshikawa, Kenichi] Doshisha Univ, Fac Life & Med Sci, Kyoto 602, Japan	University of Hyogo; Kyoto University; Hiroshima University; Doshisha University	Ichikawa, M (corresponding author), Kyoto Univ, Dept Phys, Grad Sch Sci, Kyoto 606, Japan.	ichi@scphys.kyoto-u.ac.jp; sonobe@sci.u-hyogo.ac.jp	Yoshikawa, Kenichi/N-1867-2019; Kobayashi, Ryo/G-8714-2019; Ichikawa, Masatoshi/ADA-3491-2022	Yoshikawa, Kenichi/0000-0002-2751-7136; Kobayashi, Ryo/0000-0003-0750-5848; Ichikawa, Masatoshi/0000-0002-6345-2106; Nishigami, Yukinori/0000-0002-9996-8606	JSPS Research Fellowship for Young Scientists from the Japan Society for Promotion of Science; JSPS Core-to-Core Program	JSPS Research Fellowship for Young Scientists from the Japan Society for Promotion of Science; JSPS Core-to-Core Program(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by the JSPS Research Fellowship for Young Scientists from the Japan Society for Promotion of Science, the JSPS Core-to-Core Program "Non-equilibrium dynamics of soft matter and information" and the Scientific Research on Innovative Areas to SS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blaser H, 2006, DEV CELL, V11, P613, DOI 10.1016/j.devcel.2006.09.023; Charras GT, 2005, NATURE, V435, P365, DOI 10.1038/nature03550; Charras G, 2008, NAT REV MOL CELL BIO, V9, P730, DOI 10.1038/nrm2453; Charras GT, 2006, J CELL BIOL, V175, P477, DOI 10.1083/jcb.200602085; COBBOLD PH, 1980, NATURE, V285, P441, DOI 10.1038/285441a0; Fackler OT, 2008, J CELL BIOL, V181, P879, DOI 10.1083/jcb.200802081; Goldstein H., 2001, CLASSICAL MECH; GOLLNICK F, 1991, EUR J CELL BIOL, V55, P262; Heald R, 1996, NATURE, V382, P420, DOI 10.1038/382420a0; ISHIWATA S, 1993, PHASE TRANSIT, V45, P105, DOI 10.1080/01411599308223720; JANSON LW, 1993, J CELL BIOL, V123, P345, DOI 10.1083/jcb.123.2.345; Kunita I, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.248303; KURODA K, 1988, PROTOPLASMA, V144, P64, DOI 10.1007/BF01320282; Lee K, 2010, SCIENCE, V329, P1341, DOI 10.1126/science.1191710; Mahadevan L, 1999, PHYS FLUIDS, V11, P2449, DOI 10.1063/1.870107; Marion S, 2005, EUR BIOPHYS J BIOPHY, V34, P262, DOI 10.1007/s00249-004-0449-5; Mast SO, 1923, P NATL ACAD SCI USA, V9, P258, DOI 10.1073/pnas.9.7.258; MURRAY AW, 1989, NATURE, V339, P275, DOI 10.1038/339275a0; Nishihara E, 2008, BIOL CELL, V100, P179, DOI 10.1042/BC20070091; Olson MF, 2009, CLIN EXP METASTAS, V26, P273, DOI 10.1007/s10585-008-9174-2; Paluch E, 2005, BIOPHYS J, V89, P724, DOI 10.1529/biophysj.105.060590; Paluch E, 2006, TRENDS CELL BIOL, V16, P5, DOI 10.1016/j.tcb.2005.11.003; Pollard TD, 2003, CELL, V112, P453, DOI 10.1016/S0092-8674(03)00120-X; Rogers SS, 2008, BIOPHYS J, V94, P3313, DOI 10.1529/biophysj.107.123851; Sanchez T, 2011, SCIENCE, V333, P456, DOI 10.1126/science.1203963; SONOBE S, 1986, PROTOPLASMA, V130, P41, DOI 10.1007/BF01283329; TAKIGUCHI K, 1991, J BIOCHEM-TOKYO, V109, P520, DOI 10.1093/oxfordjournals.jbchem.a123414; TAYLOR DL, 1980, J CELL BIOL, V86, P599, DOI 10.1083/jcb.86.2.599; Tinevez JY, 2009, P NATL ACAD SCI USA, V106, P18581, DOI 10.1073/pnas.0903353106; Toyota T, 2011, SOFT MATTER, V7, P3234, DOI 10.1039/c0sm00925c; van der Gucht J, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a001909; Zhao M, 2009, SEMIN CELL DEV BIOL, V20, P674, DOI 10.1016/j.semcdb.2008.12.009	32	18	18	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2013	8	8							e70317	10.1371/journal.pone.0070317	http://dx.doi.org/10.1371/journal.pone.0070317			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	218XC	23940560	Green Published, gold, Green Submitted			2022-12-25	WOS:000324465000054
J	Perelygina, L; Zheng, Q; Metcalfe, M; Icenogle, J				Perelygina, Ludmila; Zheng, Qi; Metcalfe, Maureen; Icenogle, Joseph			Persistent Infection of Human Fetal Endothelial Cells with Rubella Virus	PLOS ONE			English	Article							HEMODYNAMIC SHEAR-STRESS; CONGENITAL-RUBELLA; LYTIC INFECTION; MEASLES-VIRUS; HOST-CELL; REPLICATION; GROWTH; MECHANISMS; PATHOLOGY; STRAINS	Cardiovascular abnormalities are the leading cause of neonatal death among patients with congenital rubella syndrome (CRS). Although persistence of rubella virus (RV) in fetal endothelium has been repeatedly suggested as a possible cause of cardiovascular birth defects, evidence of the permissiveness of fetal endothelial cells to RV is lacking. In this study we evaluated the ability of RV to infect and persist in primary fetal endothelial cells derived from human umbilical vein (HUVEC). We found that wild type (wt) low passage clinical RV productively infected HUVEC cultures without producing cytopathology or ultrastructural changes. RV did not inhibit host cell protein synthesis, cell proliferation, or interfere with the cell cycle. Persistently infected cultures were easily established at low and high multiplicities of infection (MOI) with both laboratory and wt clinical RV strains. However, synchronous infections of entire HUVEC monolayers were only observed with clinical RV strains. The release of infectious virions into media remained at consistently high levels for several subcultures of infected HUVEC. The results indicate that macrovascular fetal endothelial cells are highly permissive to RV and allow slow persistent RV replication. The findings provide more evidence for the suggestion that vascular pathologies in CRS are triggered by persistent rubella virus infection of the endothelium.	[Perelygina, Ludmila; Zheng, Qi; Metcalfe, Maureen; Icenogle, Joseph] Ctr Dis Control & Prevent, Atlanta, GA 30333 USA	Centers for Disease Control & Prevention - USA	Icenogle, J (corresponding author), Ctr Dis Control & Prevent, Atlanta, GA 30333 USA.	jci1@cdc.gov		Perelygina, Ludmila/0000-0003-0812-8124	Centers for Disease Control and Prevention	Centers for Disease Control and Prevention(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	This work was supported by core funding from the Centers for Disease Control and Prevention. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abernathy E, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-32; Abernathy ES, 2011, J INFECT DIS, V204, pS524, DOI 10.1093/infdis/jir099; ABERNATHY ES, 1990, J VIROL, V64, P5183, DOI 10.1128/JVI.64.10.5183-5187.1990; Adamo MP, 2008, VIROLOGY, V370, P1, DOI 10.1016/j.virol.2007.08.003; Adler B, 2009, THROMB HAEMOSTASIS, V102, P1057, DOI 10.1160/TH09-04-0213; ANDZHAPARIDZE OG, 1981, VOP VIRUSOL+, P586; Atreya CD, 2004, ARCH VIROL, V149, P779, DOI 10.1007/s00705-003-0267-6; BARDELETTI G, 1979, INTERVIROLOGY, V11, P97, DOI 10.1159/000149019; BOUE A, 1969, AM J DIS CHILD, V118, P45, DOI 10.1001/archpedi.1969.02100040047008; CAMPBELL PE, 1965, BRIT HEART J, V27, P134; Cheeran MCJ, 2009, CLIN MICROBIOL REV, V22, P99, DOI 10.1128/CMR.00023-08; Chen MH, 2007, J VIROL METHODS, V146, P414, DOI 10.1016/j.jviromet.2007.08.021; Conaldi PG, 1997, J INFECT DIS, V175, P693, DOI 10.1093/infdis/175.3.693; COOPER LZ, 1965, AM J DIS CHILD, V110, P416, DOI 10.1001/archpedi.1965.02090030436011; CUNNINGHAM AL, 1985, J INFECT DIS, V151, P638, DOI 10.1093/infdis/151.4.638; Datta YH, 2001, THROMB HAEMOSTASIS, V86, P1148; Davies PF, 2009, NAT CLIN PRACT CARD, V6, P16, DOI 10.1038/ncpcardio1397; DELAHUNT CS, 1967, AM J OBSTET GYNECOL, V99, P580; Dieterich DC, 2006, P NATL ACAD SCI USA, V103, P9482, DOI 10.1073/pnas.0601637103; Domegan LM, 2002, J GEN VIROL, V83, P2135, DOI 10.1099/0022-1317-83-9-2135; Drexler HG, 2002, IN VITRO CELL DEV-AN, V38, P185; DRISCOLL SG, 1969, AM J DIS CHILD, V118, P49, DOI 10.1001/archpedi.1969.02100040051009; Epstein SE, 2009, CIRCULATION, V119, P3133, DOI 10.1161/CIRCULATIONAHA.109.849455; ESTERLY JR, 1967, CIRCULATION, V36, P544, DOI 10.1161/01.CIR.36.4.544; ESTERLY JR, 1967, J PEDIATR-US, V71, P676, DOI 10.1016/S0022-3476(67)80203-8; FREY TK, 1994, ADV VIRUS RES, V44, P69, DOI 10.1016/S0065-3527(08)60328-0; FRIEDMAN HM, 1989, REV INFECT DIS, V11, pS700; Gabrielli L, 2009, J CLIN VIROL, V46, pS16, DOI 10.1016/j.jcv.2009.09.026; GARCIA AGP, 1985, PLACENTA, V6, P281, DOI 10.1016/S0143-4004(85)80038-2; Griffin DE, 2012, FEMS MICROBIOL REV, V36, P649, DOI 10.1111/j.1574-6976.2012.00330.x; HEGGIE AD, 1977, TERATOLOGY, V15, P47, DOI 10.1002/tera.1420150107; HEMPHILL ML, 1988, VIROLOGY, V162, P65, DOI 10.1016/0042-6822(88)90395-9; Hubschen JM, 2008, J VIROL METHODS, V149, P246, DOI 10.1016/j.jviromet.2008.01.032; Ilkow CS, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001291; Jarvis MA, 2002, CURR OPIN MICROBIOL, V5, P403, DOI 10.1016/S1369-5274(02)00334-X; Kahl M, 2000, J VIROL, V74, P7628, DOI 10.1128/JVI.74.16.7628-7635.2000; KONO R, 1969, LANCET, V1, P343; LEE JY, 1992, ARCH VIROL, V122, P95, DOI 10.1007/BF01321120; Lee JY, 1996, J SUBMICR CYTOL PATH, V28, P101; Liang YY, 2001, VIROLOGY, V282, P307, DOI 10.1006/viro.2001.0862; LIEBHABE.H, 1967, P SOC EXP BIOL MED, V125, P636, DOI 10.3181/00379727-125-32167; MAES R, 1966, NATURE, V210, P384, DOI 10.1038/210384a0; Malek AM, 1999, JAMA-J AM MED ASSOC, V282, P2035, DOI 10.1001/jama.282.21.2035; Marin V, 2001, J IMMUNOL METHODS, V254, P183, DOI 10.1016/S0022-1759(01)00408-2; MENSER MA, 1974, PATHOLOGY, V6, P215, DOI 10.3109/00313027409068988; MIFUNE K, 1970, Infection and Immunity, V2, P132; MIKI NPH, 1992, CLIN EXP RHEUMATOL, V10, P3; Mo XY, 2007, J MED VIROL, V79, P1783, DOI 10.1002/jmv.20942; MONIF GRG, 1965, AM J OBSTET GYNECOL, V91, P1143, DOI 10.1016/0002-9378(65)90714-3; NUMAZAKI K, 1989, AM J CLIN PATHOL, V91, P446, DOI 10.1093/ajcp/91.4.446; OKERBLOM C, 1983, J VIROL, V46, P964, DOI 10.1128/JVI.46.3.964-973.1983; Oster ME, 2010, BIRTH DEFECTS RES A, V88, P1, DOI 10.1002/bdra.20621; Plotkin S., 2011, INFECT DIS FETUS NEW, P861; PLOTKIN SA, 1965, AM J EPIDEMIOL, V81, P71, DOI 10.1093/oxfordjournals.aje.a120499; Popovic M, 2012, J THROMB THROMBOLYS, V33, P160, DOI 10.1007/s11239-011-0662-x; Pugachev KV, 1997, J VIROL, V71, P562, DOI 10.1128/JVI.71.1.562-568.1997; RAWLS WE, 1968, PROG MED VIROL, V10, P238; Reef SE, 2011, J INFECT DIS, V204, pS24, DOI 10.1093/infdis/jir155; Ricotta D, 2001, CARDIOVASC RES, V49, P440, DOI 10.1016/S0008-6363(00)00258-3; Rima BK, 2005, VIRUS RES, V111, P132, DOI 10.1016/j.virusres.2005.04.005; Rosenberg H S, 1981, Perspect Pediatr Pathol, V6, P183; Rowe R D, 1973, Cardiovasc Clin, V5, P61; SEDWICK WD, 1970, J VIROL, V5, P478, DOI 10.1128/JVI.5.4.478-489.1970; Seno Akemi, 1994, Journal of Dermatology (Tokyo), V21, P323, DOI 10.1111/j.1346-8138.1994.tb01747.x; SINGER DB, 1967, J PEDIATR-US, V71, P665, DOI 10.1016/S0022-3476(67)80202-6; Sinzger C, 1999, J GEN VIROL, V80, P2867, DOI 10.1099/0022-1317-80-11-2867; STANWICK TL, 1974, INFECT IMMUN, V10, P810, DOI 10.1128/IAI.10.4.810-815.1974; Streblow DN, 2008, CURR TOP MICROBIOL, V325, P397; Suarez AL, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000152; TONDURY G, 1966, J PEDIATR-US, V68, P867, DOI 10.1016/S0022-3476(66)80204-4; Urade M, 1981, J Osaka Univ Dent Sch, V21, P165; VAHERI A, 1965, VIROLOGY, V27, P239, DOI 10.1016/0042-6822(65)90170-4; VARGHESE PJ, 1969, BRIT HEART J, V31, P59; Webster WS, 1998, TERATOLOGY, V58, P13; YONEDA T, 1986, J CLIN INVEST, V77, P1613, DOI 10.1172/JCI112477	75	19	19	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2013	8	8							e73014	10.1371/journal.pone.0073014	http://dx.doi.org/10.1371/journal.pone.0073014			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	218XC	23940821	Green Published, gold			2022-12-25	WOS:000324465000250
J	Schwerk, J; Koster, M; Hauser, H; Rohde, M; Fulde, M; Hornef, MW; May, T				Schwerk, Johannes; Koester, Mario; Hauser, Hansjoerg; Rohde, Manfred; Fulde, Marcus; Hornef, Mathias W.; May, Tobias			Generation of Mouse Small Intestinal Epithelial Cell Lines That Allow the Analysis of Specific Innate Immune Functions	PLOS ONE			English	Article							INTERFERON-PRODUCTION; ROTAVIRUS INFECTION; IN-VITRO; EXPRESSION; RECEPTOR; CACO-2; MICE; RECOGNITION; ABSORPTION; DETERMINES	Cell lines derived from the small intestine that reflect authentic properties of the originating intestinal epithelium are of high value for studies on mucosal immunology and host microbial homeostasis. A novel immortalization procedure was applied to generate continuously proliferating cell lines from murine E19 embryonic small intestinal tissue. The obtained cell lines form a tight and polarized epithelial cell layer, display characteristic tight junction, microvilli and surface protein expression and generate increasing transepithelial electrical resistance during in vitro culture. Significant up-regulation of Cxcl2 and Cxcl5 chemokine expression upon exposure to defined microbial innate immune stimuli and endogenous cytokines is observed. Cell lines were also generated from a transgenic interferon reporter (Mx2-Luciferase) mouse, allowing reporter technology-based quantification of the cellular response to type I and III interferon. Thus, the newly created cell lines mimic properties of the natural epithelium and can be used for diverse studies including testing of the absorption of drug candidates. The reproducibility of the method to create such cell lines from wild type and transgenic mice provides a new tool to study molecular and cellular processes of the epithelial barrier.	[Schwerk, Johannes; Koester, Mario; Hauser, Hansjoerg] Helmholtz Ctr Infect Res, Dept Gene Regulat & Differentiat, Braunschweig, Germany; [Rohde, Manfred] Helmholtz Ctr Infect Res, Dept Med Microbiol, Braunschweig, Germany; [Fulde, Marcus; Hornef, Mathias W.] Hannover Med Sch, Inst Microbiol & Hosp Epidemiol, Hannover, Germany; [May, Tobias] InSCREENeX GmbH, Braunschweig, Germany	Helmholtz Association; Helmholtz-Center for Infection Research; Helmholtz Association; Helmholtz-Center for Infection Research; Hannover Medical School	May, T (corresponding author), InSCREENeX GmbH, Braunschweig, Germany.	tobias.may@inscreenex.com	Schwerk, Johannes/AAN-2937-2020	Schwerk, Johannes/0000-0002-5964-7162; Hornef, Mathias/0000-0001-6096-9110	Deutsche Forschungsgemeinschaft for the Cluster of Excellence REBIRTH (From Regenerative Biology to Reconstructive Therapy) [Ho 2236/8-1, SFB900]; German Ministry of Education and Research [01KI1003D]; Europaischer Fonds fur regionale Entwicklung grant from the "Niedersachsisches Ministerium fur Wissenschaft und Kultur" [80029155]; Hannover Biomedical Research School, the Center for Infection Biology; Helmholtz Centre for Infection Research GradSchool	Deutsche Forschungsgemeinschaft for the Cluster of Excellence REBIRTH (From Regenerative Biology to Reconstructive Therapy); German Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); Europaischer Fonds fur regionale Entwicklung grant from the "Niedersachsisches Ministerium fur Wissenschaft und Kultur"; Hannover Biomedical Research School, the Center for Infection Biology; Helmholtz Centre for Infection Research GradSchool	This study was supported by funding from the Deutsche Forschungsgemeinschaft for the Cluster of Excellence REBIRTH (From Regenerative Biology to Reconstructive Therapy), the research grant Ho 2236/8-1, the priority program SPP1656 and the Collaborative Research Center SFB900 (Chronic Infection), the German Ministry of Education and Research (01KI1003D) and an Europaischer Fonds fur regionale Entwicklung grant (80029155) from the "Niedersachsisches Ministerium fur Wissenschaft und Kultur". JS was supported by the Hannover Biomedical Research School, the Center for Infection Biology, as well as by the Helmholtz Centre for Infection Research GradSchool. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abreu MT, 2010, NAT REV IMMUNOL, V10, P131, DOI 10.1038/nri2707; Ahuja D, 2005, ONCOGENE, V24, P7729, DOI 10.1038/sj.onc.1209046; Auerbuch V, 2004, J EXP MED, V200, P527, DOI 10.1084/jem.20040976; Bens M, 1996, AM J PHYSIOL-CELL PH, V270, pC1666, DOI 10.1152/ajpcell.1996.270.6.C1666; Bierne H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039080; BJERKNES M, 1981, ANAT REC, V199, P565, DOI 10.1002/ar.1091990412; Buzza MS, 2010, P NATL ACAD SCI USA, V107, P4200, DOI 10.1073/pnas.0903923107; CANOGAUCI DF, 1993, EXP CELL RES, V208, P344, DOI 10.1006/excr.1993.1255; Cheng KC, 2008, EXPERT OPIN DRUG MET, V4, P581, DOI [10.1517/17425255.4.5.581, 10.1517/17425255.4.5.581 ]; COHN SM, 1992, J CELL BIOL, V119, P27, DOI 10.1083/jcb.119.1.27; Decker T, 2005, NAT REV IMMUNOL, V5, P675, DOI 10.1038/nri1684; Deferme S., 2008, DRUG ABSORPTION STUD, P182, DOI DOI 10.1007/978-0-387-74901-3; Eglen R, 2011, ASSAY DRUG DEV TECHN, V9, P108, DOI 10.1089/adt.2010.0305; El Marjou F, 2004, GENESIS, V39, P186, DOI 10.1002/gene.20042; Elankumaran S, 2006, J VIROL, V80, P7522, DOI 10.1128/JVI.00241-06; Feng N, 2008, J VIROL, V82, P7578, DOI 10.1128/JVI.00391-08; Fogh J, 1975, HUMAN TUMOR CELLS IN; Freudenberg MA, 2002, J IMMUNOL, V169, P1665, DOI 10.4049/jimmunol.169.4.1665; ITO Y, 1982, J GEN VIROL, V62, P349, DOI 10.1099/0022-1317-62-2-349; Kamiyama E, 2009, DRUG METAB DISPOS, V37, P1956, DOI 10.1124/dmd.109.027490; Katakura K, 2005, J CLIN INVEST, V115, P695, DOI 10.1172/JCI200522996; Katz J, 2000, INFECT IMMUN, V68, P1441, DOI 10.1128/IAI.68.3.1441-1449.2000; Kawai T, 2006, NAT IMMUNOL, V7, P131, DOI 10.1038/ni1303; Kernbauer E, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002763; Krishnamurthy S, 2006, J VIROL, V80, P5145, DOI 10.1128/JVI.02618-05; Kugel D, 2011, J INTERF CYTOK RES, V31, P345, DOI 10.1089/jir.2010.0079; Lotz M, 2006, J EXP MED, V203, P973, DOI 10.1084/jem.20050625; May T, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002372; Mineo H, 2002, J NUTR, V132, P3394, DOI 10.1093/jn/132.11.3394; O'Connell RM, 2004, J EXP MED, V200, P437, DOI 10.1084/jem.20040712; PINTO M, 1983, BIOL CELL, V47, P323; Pott J, 2012, EMBO REP, V13, P684, DOI 10.1038/embor.2012.96; Pott J, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002670; Pott J, 2011, P NATL ACAD SCI USA, V108, P7944, DOI 10.1073/pnas.1100552108; Pulverer JE, 2010, J VIROL, V84, P8626, DOI 10.1128/JVI.00303-10; Rangarajan A, 2004, CANCER CELL, V6, P171, DOI 10.1016/j.ccr.2004.07.009; Robinson N, 2012, NAT IMMUNOL, V13, P954, DOI 10.1038/ni.2397; Rothen-Rutishauser B, 2000, PHARMACEUT RES, V17, P460, DOI 10.1023/A:1007585105753; Samuelsson CV, 2005, BIOCHEM BIOPH RES CO, V335, P584, DOI 10.1016/j.bbrc.2005.07.124; Sato T, 2009, NATURE, V459, P262, DOI 10.1038/nature07935; Sen A, 2012, P NATL ACAD SCI USA, V109, P20667, DOI 10.1073/pnas.1212188109; SPURR AR, 1969, J ULTRA MOL STRUCT R, V26, P31, DOI 10.1016/S0022-5320(69)90033-1; Trinchieri G, 2010, J EXP MED, V207, P2053, DOI 10.1084/jem.20101664; Turner JR, 2009, NAT REV IMMUNOL, V9, P799, DOI 10.1038/nri2653; Wang N., 2009, J BIOANAL BIOMED, V1, P033, DOI DOI 10.4172/1948-593X.1000007; Wirtz S, 2005, J CLIN INVEST, V115, P586, DOI 10.1172/JCI200524518; Zufferey R, 1998, J VIROL, V72, P9873, DOI 10.1128/JVI.72.12.9873-9880.1998	47	18	18	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2013	8	8							e72700	10.1371/journal.pone.0072700	http://dx.doi.org/10.1371/journal.pone.0072700			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	218XC	23940817	Green Submitted, Green Published, gold			2022-12-25	WOS:000324465000247
J	Abbott, SM; Arnold, JM; Chang, Q; Miao, H; Ota, N; Cecala, C; Gold, PE; Sweedler, JV; Gillette, MU				Abbott, Sabra M.; Arnold, Jennifer M.; Chang, Qing; Miao, Hai; Ota, Nobutoshi; Cecala, Christine; Gold, Paul E.; Sweedler, Jonathan V.; Gillette, Martha U.			Signals from the Brainstem Sleep/Wake Centers Regulate Behavioral Timing via the Circadian Clock	PLOS ONE			English	Article							LATERODORSAL TEGMENTAL NUCLEUS; SUPRACHIASMATIC NUCLEUS; CAPILLARY-ELECTROPHORESIS; ACETYLCHOLINE-RELEASE; CHOLINERGIC NEURONS; LOCOMOTOR-ACTIVITY; SEROTONIN RELEASE; REM-SLEEP; DEPRIVATION; LIGHT	Sleep-wake cycling is controlled by the complex interplay between two brain systems, one which controls vigilance state, regulating the transition between sleep and wake, and the other circadian, which communicates time-of-day. Together, they align sleep appropriately with energetic need and the day-night cycle. Neural circuits connect brain stem sites that regulate vigilance state with the suprachiasmatic nucleus (SCN), the master circadian clock, but the function of these connections has been unknown. Coupling discrete stimulation of pontine nuclei controlling vigilance state with analytical chemical measurements of intra-SCN microdialysates in mouse, we found significant neurotransmitter release at the SCN and, concomitantly, resetting of behavioral circadian rhythms. Depending upon stimulus conditions and time-of-day, SCN acetylcholine and/or glutamate levels were augmented and generated shifts of behavioral rhythms. These results establish modes of neurochemical communication from brain regions controlling vigilance state to the central circadian clock, with behavioral consequences. They suggest a basis for dynamic integration across brain systems that regulate vigilance states, and a potential vulnerability to altered communication in sleep disorders.	[Abbott, Sabra M.; Arnold, Jennifer M.; Gold, Paul E.; Sweedler, Jonathan V.; Gillette, Martha U.] Univ Illinois, Dept Mol & Integrat Physiol, Urbana, IL USA; [Chang, Qing; Miao, Hai; Ota, Nobutoshi; Cecala, Christine; Gold, Paul E.; Sweedler, Jonathan V.; Gillette, Martha U.] Univ Illinois, Urbana, IL USA; [Abbott, Sabra M.; Arnold, Jennifer M.; Gold, Paul E.; Gillette, Martha U.] Univ Illinois, Coll Med, Urbana, IL USA	University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign	Gillette, MU (corresponding author), Univ Illinois, Dept Mol & Integrat Physiol, Urbana, IL USA.	mgillett@illinois.edu	Sweedler, Jonathan V/A-9405-2009	Sweedler, Jonathan V/0000-0003-3107-9922; Abbott, Sabra/0000-0002-8947-9649	United States National Institutes of Health [GM07143, NS47802, AG07648, DA024129, P30 DA018310, HL092571Z, HL086870, MH101655]; National Science Foundation [CHE-1111705, 08-43175, 10-52464]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL086870] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007143] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R21MH101655] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [F30NS047802] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG007648] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R21DA024129, P30DA018310] Funding Source: NIH RePORTER; Direct For Mathematical & Physical Scien [1111705] Funding Source: National Science Foundation	United States National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); Direct For Mathematical & Physical Scien(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	This work was supported by grants from the United States National Institutes of Health to SMA (GM07143 and NS47802); PEG (AG07648 and DA024129); JVS (P30 DA018310); and MUG (HL092571Z, HL086870, and MH101655); and the National Science Foundation to JVS (CHE-1111705) and PEG (08-43175 and 10-52464). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antle MC, 2000, J NEUROSCI, V20, P9326; Aston-Jones G, 2001, NAT NEUROSCI, V4, P732, DOI 10.1038/89522; BINA KG, 1993, J COMP NEUROL, V335, P295, DOI 10.1002/cne.903350212; Buchanan GF, 2005, EXP NEUROL, V193, P489, DOI 10.1016/j.expneurol.2005.01.008; CASSONE VM, 1988, AM J PHYSIOL, V255, pR332, DOI 10.1152/ajpregu.1988.255.2.R332; Castillo-Ruiz A, 2007, BRAIN RES, V1151, P91, DOI 10.1016/j.brainres.2007.03.010; Chang Q, 2003, J NEUROSCI, V23, P3001; Chen D, 1999, P NATL ACAD SCI USA, V96, P13468, DOI 10.1073/pnas.96.23.13468; Cheng MY, 2002, NATURE, V417, P405, DOI 10.1038/417405a; CLEMENTS JR, 1990, NEUROSCI LETT, V120, P70, DOI 10.1016/0304-3940(90)90170-E; CORNWALL J, 1990, BRAIN RES BULL, V25, P271, DOI 10.1016/0361-9230(90)90072-8; Curie T, 2013, SLEEP, V36, P311, DOI 10.5665/sleep.2440; Datta S, 2002, J NEUROSCI RES, V70, P611, DOI 10.1002/jnr.10405; Datta S, 2001, AM J PHYSIOL-REG I, V280, pR752, DOI 10.1152/ajpregu.2001.280.3.R752; Deboer T, 2003, NAT NEUROSCI, V6, P1086, DOI 10.1038/nn1122; Deboer T, 2007, SLEEP, V30, P257, DOI 10.1093/sleep/30.3.257; Deurveilher S, 2001, EUR J NEUROSCI, V13, P1963, DOI 10.1046/j.0953-816x.2001.01562.x; DING JM, 1994, SCIENCE, V266, P1713, DOI 10.1126/science.7527589; Erhardt C, 2004, EUR J NEUROSCI, V19, P1773, DOI 10.1111/j.1460-9568.2004.03281.x; Franklin K.B.J., 2008, MOUSE BRAIN STEREOTA; Fuller RR, 1998, NEURON, V20, P173, DOI 10.1016/S0896-6273(00)80446-8; Gall AJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045338; Gritton HJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056206; Gritton HJ, 2009, BEHAV NEUROSCI, V123, P937, DOI 10.1037/a0017128; Grossman GH, 2000, NEUROREPORT, V11, P1929, DOI 10.1097/00001756-200006260-00024; Homma Y, 2002, J NEUROPHYSIOL, V87, P3033, DOI 10.1152/jn.2002.87.6.3033; Hut RA, 2011, BEHAV BRAIN RES, V221, P466, DOI 10.1016/j.bbr.2010.11.039; Kramer A, 2001, SCIENCE, V294, P2511, DOI 10.1126/science.1067716; Krout KE, 2002, NEUROSCIENCE, V110, P73, DOI 10.1016/S0306-4522(01)00551-6; Lapainis T, 2007, ANAL BIOANAL CHEM, V387, P97, DOI 10.1007/s00216-006-0775-9; Lapainis T, 2008, J CHROMATOGR A, V1184, P144, DOI 10.1016/j.chroma.2007.10.098; LEGORATTISANCHEZ MO, 1989, BRAIN RES BULL, V23, P283, DOI 10.1016/0361-9230(89)90210-4; Lewy AJ, 2007, COLD SPRING HARB SYM, V72, P623, DOI 10.1101/sqb.2007.72.055; Liu C, 1996, J NEUROSCI, V16, P744; LOSIER BJ, 1993, BRAIN RES, V604, P41, DOI 10.1016/0006-8993(93)90350-V; Lu J, 2006, NATURE, V441, P589, DOI 10.1038/nature04767; Markwald RR, 2013, P NATL ACAD SCI USA, V110, P5695, DOI 10.1073/pnas.1216951110; Materi LM, 2001, EUR J NEUROSCI, V14, P38, DOI 10.1046/j.0953-816x.2001.01619.x; McArthur AJ, 1997, ENDOCRINOLOGY, V138, P627, DOI 10.1210/en.138.2.627; Miao H, 2003, ANAL BIOANAL CHEM, V377, P1007, DOI 10.1007/s00216-003-2191-8; Mintz EM, 1999, J NEUROSCI, V19, P5124; Mistlberger RE, 2005, BRAIN RES REV, V49, P429, DOI 10.1016/j.brainresrev.2005.01.005; MOORE RY, 1972, BRAIN RES, V42, P201, DOI 10.1016/0006-8993(72)90054-6; MURAKAMI N, 1984, BRAIN RES, V311, P358, DOI 10.1016/0006-8993(84)90100-8; PAULY JR, 1985, BRAIN RES, V348, P163, DOI 10.1016/0006-8993(85)90373-7; Paxinos G, 2009, RAT BRAIN STEREOTAXI; RUSAK B, 1979, FED PROC, V38, P2589; SEMBA K, 1992, J COMP NEUROL, V323, P387, DOI 10.1002/cne.903230307; Shiromani PJ, 1996, MOL BRAIN RES, V38, P77, DOI 10.1016/0169-328X(95)00325-M; SHOUSE MN, 1992, BRAIN RES, V571, P50, DOI 10.1016/0006-8993(92)90508-7; STEPHAN FK, 1972, P NATL ACAD SCI USA, V69, P1583, DOI 10.1073/pnas.69.6.1583; Thakkar M, 1996, BRAIN RES, V723, P223, DOI 10.1016/0006-8993(96)00256-9; Tischkau SA, 2000, J NEUROSCI, V20, P7830; TOBLER I, 1983, NEUROSCI LETT, V42, P49, DOI 10.1016/0304-3940(83)90420-2; VANDENPOL AN, 1985, NEUROSCIENCE, V15, P1049, DOI 10.1016/0306-4522(85)90254-4; ZATZ M, 1979, SCIENCE, V203, P358, DOI 10.1126/science.32619	56	13	14	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2013	8	8							e70481	10.1371/journal.pone.0070481	http://dx.doi.org/10.1371/journal.pone.0070481			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	200UV	23950941	Green Published, Green Submitted, gold			2022-12-25	WOS:000323097300020
J	Sen, S; Kawahara, B; Fukuto, J; Chaudhuri, G				Sen, Suvajit; Kawahara, Brian; Fukuto, Jon; Chaudhuri, Gautam			Induction of a Feed Forward Pro-Apoptotic Mechanistic Loop by Nitric Oxide in a Human Breast Cancer Model	PLOS ONE			English	Article							OXIDATIVE STRESS; CELL-SURVIVAL; SUPEROXIDE; 2A; DEPHOSPHORYLATION; PEROXYNITRITE; INJURY; AGENTS; FOXO1; PP2A	We have previously demonstrated that relatively high concentrations of NO [Nitric Oxide] as produced by activated macrophages induced apoptosis in the human breast cancer cell line, MDA-MB-468. More recently, we also demonstrated the importance of endogenous H2O2 in the regulation of growth in human breast cancer cells. In the present study we assessed the interplay between exogenously administered NO and the endogenously produced reactive oxygen species [ROS] in human breast cancer cells and evaluated the mechanism[s] in the induction of apoptosis. To this end we identified a novel mechanism by which NO down regulated endogenous hydrogen peroxide [H2O2] formation via the down-regulation of superoxide [O-2(center dot-)] and the activation of catalase. We further demonstrated the existence of a feed forward mechanistic loop involving protein phosphatase 2A [PP2A] and its downstream substrate FOXO1 in the induction of apoptosis and the synthesis of catalase. We utilized gene silencing of PP2A, FOXO1 and catalase to assess their relative importance and key roles in NO mediated apoptosis. This study provides the potential for a therapeutic approach in treating breast cancer by targeted delivery of NO where NO donors and activators of downstream players could initiate a self sustaining apoptotic cascade in breast cancer cells.	[Sen, Suvajit; Kawahara, Brian; Chaudhuri, Gautam] Univ Calif Los Angeles, David Geffen Sch Med, Dept Obstet & Gynecol, Los Angeles, CA 90095 USA; [Fukuto, Jon] Sonoma State Univ, Dept Chem, Rohnert Pk, CA 94928 USA; [Chaudhuri, Gautam] Univ Calif Los Angeles, David Geffen Sch Med, Dept Mol & Med Pharmacol, Los Angeles, CA 90095 USA; [Chaudhuri, Gautam] Johnson Comprehens Canc Ctr, Los Angeles, CA USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; California State University System; Sonoma State University; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; UCLA Jonsson Comprehensive Cancer Center	Sen, S (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Obstet & Gynecol, Los Angeles, CA 90095 USA.	ssen@mednet.ucla.edu; gchaudhuri@mednet.ucla.edu	kawahara, brian/GQP-4272-2022		Carl and Roberta Deutsch Foundation; Kelly Day	Carl and Roberta Deutsch Foundation; Kelly Day	The authors thank the Carl and Roberta Deutsch Foundation and Kelly Day for their financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alcendor RR, 2007, CIRC RES, V100, P1512, DOI 10.1161/01.RES.0000267723.65696.4a; Batinic-Haberle I, 2009, FREE RADICAL BIO MED, V46, P192, DOI 10.1016/j.freeradbiomed.2008.09.042; BEERS RF, 1952, J BIOL CHEM, V195, P133; Cifarelli V, 2012, MOL ENDOCRINOL, V26, P1213, DOI 10.1210/me.2011-1276; Day BJ, 1995, J PHARMACOL EXP THER, V275, P1227; Espey MG, 2000, J BIOL CHEM, V275, P11341, DOI 10.1074/jbc.275.15.11341; Fujii H, 1997, J BIOL CHEM, V272, P32773, DOI 10.1074/jbc.272.52.32773; Fukuto JM, 2012, CHEM RES TOXICOL, V25, P769, DOI 10.1021/tx2005234; Graham KA, 2010, CANCER BIOL THER, V10, DOI 10.4161/cbt.10.3.12207; JaramilloBabb VL, 1996, J BIOL CHEM, V271, P5988, DOI 10.1074/jbc.271.11.5988; LITTLE C, 1967, ARCH BIOCHEM BIOPHYS, V122, P406, DOI 10.1016/0003-9861(67)90212-3; Perrotti D, 2008, CANCER METAST REV, V27, P159, DOI 10.1007/s10555-008-9119-x; Pervin S, 2003, CANCER RES, V63, P8853; Sen S, 2012, FREE RADICAL BIO MED, V53, P1541, DOI 10.1016/j.freeradbiomed.2012.06.030; SQUADRITO GL, 1995, CHEM-BIOL INTERACT, V96, P203, DOI 10.1016/0009-2797(94)03591-U; Tezil T, 2012, CELL SIGNAL, V24, P1361, DOI 10.1016/j.cellsig.2012.01.012; Xin MG, 2006, J BIOL CHEM, V281, P18859, DOI 10.1074/jbc.M512543200; Yan L, 2008, J BIOL CHEM, V283, P7411, DOI 10.1074/jbc.M708083200; Zhong FF, 2011, J BIOL INORG CHEM, V16, P1227, DOI 10.1007/s00775-011-0811-x; Zielonka J, 2008, NAT PROTOC, V3, P8, DOI 10.1038/nprot.2007.473	20	2	2	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2013	8	8							e70593	10.1371/journal.pone.0070593	http://dx.doi.org/10.1371/journal.pone.0070593			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	200UV	23950968	Green Submitted, Green Published, gold			2022-12-25	WOS:000323097300033
J	Vanderperre, B; Lucier, JF; Bissonnette, C; Motard, J; Tremblay, G; Vanderperre, S; Wisztorski, M; Salzet, M; Boisvert, FM; Roucou, X				Vanderperre, Benoit; Lucier, Jean-Francois; Bissonnette, Cyntia; Motard, Julie; Tremblay, Guillaume; Vanderperre, Solene; Wisztorski, Maxence; Salzet, Michel; Boisvert, Francois-Michel; Roucou, Xavier			Direct Detection of Alternative Open Reading Frames Translation Products in Human Significantly Expands the Proteome	PLOS ONE			English	Article							GENE; IDENTIFICATION; PROTEINS; EPITOPES; CONSEQUENCES; LYMPHOCYTES; BIOMARKERS; DISCOVERY; REVEALS; SEARCH	A fully mature mRNA is usually associated to a reference open reading frame encoding a single protein. Yet, mature mRNAs contain unconventional alternative open reading frames (AltORFs) located in untranslated regions (UTRs) or overlapping the reference ORFs (RefORFs) in non-canonical +2 and +3 reading frames. Although recent ribosome profiling and footprinting approaches have suggested the significant use of unconventional translation initiation sites in mammals, direct evidence of large-scale alternative protein expression at the proteome level is still lacking. To determine the contribution of alternative proteins to the human proteome, we generated a database of predicted human AltORFs revealing a new proteome mainly composed of small proteins with a median length of 57 amino acids, compared to 344 amino acids for the reference proteome. We experimentally detected a total of 1,259 alternative proteins by mass spectrometry analyses of human cell lines, tissues and fluids. In plasma and serum, alternative proteins represent up to 55% of the proteome and may be a potential unsuspected new source for biomarkers. We observed constitutive co-expression of RefORFs and AltORFs from endogenous genes and from transfected cDNAs, including tumor suppressor p53, and provide evidence that out-of-frame clones representing AltORFs are mistakenly rejected as false positive in cDNAs screening assays. Functional importance of alternative proteins is strongly supported by significant evolutionary conservation in vertebrates, invertebrates, and yeast. Our results imply that coding of multiple proteins in a single gene by the use of AltORFs may be a common feature in eukaryotes, and confirm that translation of unconventional ORFs generates an as yet unexplored proteome.	[Vanderperre, Benoit; Bissonnette, Cyntia; Motard, Julie; Tremblay, Guillaume; Vanderperre, Solene; Roucou, Xavier] Univ Sherbrooke, Fac Med & Sci Sante, Dept Biochim, Quebec City, PQ, Canada; [Lucier, Jean-Francois] Univ Sherbrooke, Fac Med & Sci Sante, Dept Microbiol, Quebec City, PQ, Canada; [Wisztorski, Maxence; Salzet, Michel] Univ Lille 1, PRISM, Lab Prote, EA 4550,SN3, F-59655 Villeneuve Dascq, France; [Boisvert, Francois-Michel] Univ Sherbrooke, Fac Med & Sci Sante, Dept Anat & Biol Cellulaire, Quebec City, PQ, Canada	University of Sherbrooke; University of Sherbrooke; Universite de Lille - ISITE; Universite de Lille; University of Sherbrooke	Roucou, X (corresponding author), Univ Sherbrooke, Fac Med & Sci Sante, Dept Biochim, Quebec City, PQ, Canada.	xavier.roucou@usherbrooke.ca	Salzet, Michel/A-7675-2011; Wisztorski, Maxence/F-4380-2010	Salzet, Michel/0000-0003-4318-0817; Wisztorski, Maxence/0000-0003-1320-075X; Vanderperre, Benoit/0000-0002-2111-1071	Canadian Institutes for Health Research [MOP-89881, MOP-123469]; Fonds de Recherche Nature et Technologies du Quebec; National Sciences and Engineering Research Council of Canada; Ministere de L'Education Nationale de l'Enseignement Superieur et de la Recherche; Agence Nationale de la Recherche; PRISM Laboratory; Thermofisher	Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); Fonds de Recherche Nature et Technologies du Quebec; National Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); Ministere de L'Education Nationale de l'Enseignement Superieur et de la Recherche; Agence Nationale de la Recherche(French National Research Agency (ANR)); PRISM Laboratory; Thermofisher	Most of this work was supported by an operating grant from the Canadian Institutes for Health Research MOP-89881 to XR. BV was supported in part by a scholarship from the Fonds de Recherche Nature et Technologies du Quebec and CB by a scholarship from the National Sciences and Engineering Research Council of Canada. Work in Francois-Michel Boisvert was supported by an operating grant from the Canadian Institutes for Health Research (MOP-123469). Work in Michel Salzet's laboratory was supported by the Ministere de L'Education Nationale de l'Enseignement Superieur et de la Recherche (to MS), Agence Nationale de la Recherche, and a collaboration between PRISM Laboratory and Thermofisher. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aebersold R, 2013, J PROTEOME RES, V12, P23, DOI 10.1021/pr301151m; Akimoto C, 2012, BIOCH BIOPHYS ACTA; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Anikin M, 2010, NUCLEIC ACIDS MOL BI, V24, P409, DOI 10.1007/978-0-387-89382-2_19; Beaudoin S, 2009, BBA-MOL CELL RES, V1793, P335, DOI 10.1016/j.bbamcr.2008.10.009; Blennow K, 2010, NAT REV NEUROL, V6, P131, DOI 10.1038/nrneurol.2010.4; Boisvert FM, 2012, MOL CELL PROTEOMICS, V11, DOI DOI 10.1074/MCP.M111.011429; Bonnel D, 2011, ANAL BIOANAL CHEM, V401, P149, DOI 10.1007/s00216-011-5020-5; Cox J, 2009, NAT PROTOC, V4, P698, DOI 10.1038/nprot.2009.36; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; Davuluri RV, 2008, TRENDS GENET, V24, P167, DOI 10.1016/j.tig.2008.01.008; Desiere F, 2006, NUCLEIC ACIDS RES, V34, pD655, DOI [10.1093/nar/gkj040, 10.1007/978-1-60761-444-9_19]; Di Giammartino DC, 2011, MOL CELL, V43, P853, DOI 10.1016/j.molcel.2011.08.017; Farajollahi S, 2010, TRENDS GENET, V26, P221, DOI 10.1016/j.tig.2010.02.001; Franck J, 2009, ANAL CHEM, V81, P8193, DOI 10.1021/ac901328p; Freson K, 2003, HUM MOL GENET, V12, P1121, DOI 10.1093/hmg/ddg130; Frith MC, 2006, PLOS GENET, V2, P515, DOI 10.1371/journal.pgen.0020052; Gerszten RE, 2008, NATURE, V451, P949, DOI 10.1038/nature06802; Gomes I, 2009, FASEB J, V23, P3020, DOI 10.1096/fj.09-132142; Hanash SM, 2011, NAT REV CLIN ONCOL, V8, P142, DOI 10.1038/nrclinonc.2010.220; Hashimoto Y, 2001, P NATL ACAD SCI USA, V98, P6336, DOI 10.1073/pnas.101133498; Ho O, 2006, J IMMUNOL, V177, P8283, DOI 10.4049/jimmunol.177.12.8283; Ingolia NT, 2011, CELL, V147, P789, DOI 10.1016/j.cell.2011.10.002; Ivanov IP, 2011, NUCLEIC ACIDS RES, V39, P4220, DOI 10.1093/nar/gkr007; Klemke M, 2001, EMBO J, V20, P3849, DOI 10.1093/emboj/20.14.3849; Kochetov AV, 2008, BIOESSAYS, V30, P683, DOI 10.1002/bies.20771; Kochetov AV, 2013, J BIOMOL STRUCT DYN, V31, P103, DOI 10.1080/07391102.2012.691367; Kondo T, 2007, NAT CELL BIOL, V9, P660, DOI 10.1038/ncb1595; Lee S, 2012, P NATL ACAD SCI USA, V109, pE2424, DOI 10.1073/pnas.1207846109; Legrain P, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M111.009993; Lemaire R, 2007, J PROTEOME RES, V6, P1295, DOI 10.1021/pr060549i; Lemaire R, 2007, J PROTEOME RES, V6, P4127, DOI 10.1021/pr0702722; Li CW, 2009, P NATL ACAD SCI USA, V106, P10770, DOI 10.1073/pnas.0902269106; Licatalosi DD, 2010, NAT REV GENET, V11, P75, DOI 10.1038/nrg2673; Liu Y, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr600; Lubec G, 2007, CHEM REV, V107, P3568, DOI 10.1021/cr068213f; Menschaert G, 2013, MOL CELL PROTEOMICS, V12, P1780, DOI 10.1074/mcp.M113.027540; Michel AM, 2012, GENOME RES; Namy O, 2004, MOL CELL, V13, P157, DOI 10.1016/S1097-2765(04)00031-0; Nilsen TW, 2010, NATURE, V463, P457, DOI 10.1038/nature08909; NORMARK S, 1983, ANNU REV GENET, V17, P499, DOI 10.1146/annurev.ge.17.120183.002435; Oh S, 2004, CANCER RES, V64, P2610, DOI 10.1158/0008-5472.CAN-03-2183; Oyama M, 2004, GENOME RES, V14, P2048, DOI 10.1101/gr.2384604; PAROLA AL, 1994, J BIOL CHEM, V269, P4497; Pendleton LC, 2005, J BIOL CHEM, V280, P24252, DOI 10.1074/jbc.M500106200; Poulin F, 2003, J BIOL CHEM, V278, P52290, DOI 10.1074/jbc.M310761200; Ronsin C, 1999, J IMMUNOL, V163, P483; Rosenberg SA, 2002, J IMMUNOL, V168, P2402, DOI 10.4049/jimmunol.168.5.2402; Roucou X, 2005, CELL DEATH DIFFER, V12, P783, DOI 10.1038/sj.cdd.4401629; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Slavoff SA, 2013, NAT CHEM BIOL, V9, P59, DOI [10.1038/NCHEMBIO.1120, 10.1038/nchembio.1120]; Steen H, 2004, NAT REV MOL CELL BIO, V5, P699, DOI 10.1038/nrm1468; Van Damme P, 2011, FEBS J, V278, P3822, DOI 10.1111/j.1742-4658.2011.08230.x; Vanderperre B, 2012, DATABASE-OXFORD, DOI 10.1093/database/bas025; Vanderperre B, 2011, FASEB J, V25, P2373, DOI 10.1096/fj.10-173815; Vidal M, 1999, NUCLEIC ACIDS RES, V27, P919, DOI 10.1093/nar/27.4.919; Wang RF, 1996, J EXP MED, V183, P1131, DOI 10.1084/jem.183.3.1131; Wills NM, 2006, RNA, V12, P1149, DOI 10.1261/rna.84406	58	127	133	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2013	8	8							e70698	10.1371/journal.pone.0070698	http://dx.doi.org/10.1371/journal.pone.0070698			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	200UV	23950983	gold, Green Published, Green Submitted			2022-12-25	WOS:000323097300040
J	Zanto, TP; Sekuler, R; Dube, C; Gazzaley, A				Zanto, Theodore P.; Sekuler, Robert; Dube, Chad; Gazzaley, Adam			Age-Related Changes in Expectation-Based Modulation of Motion Detectability	PLOS ONE			English	Article							APPARENT MOTION; PERCEPTION; DIRECTION; UNCERTAINTY; CONNECTIONS; ATTENTION; STIMULUS; CORTEX; MEMORY; TASKS	Expecting motion in some particular direction biases sensitivity to that direction, which speeds detection of motion. However, the neural processes underlying this effect remain underexplored, especially in the context of normal aging. To address this, we examined younger and older adults' performance in a motion detection task. In separate conditions, the probability was either 50% or 100% that a field of dots would move coherently in the direction a participant expected (either vertically or horizontally). Expectation and aging effects were assessed via response times (RT) to detect motion and electroencephalography (EEG). In both age groups, RTs were fastest when motion was similar to the expected direction of motion. RT tuning curves exhibited a characteristic U-shape such that detection time increased with an increasing deviation from the participant's expected direction. Strikingly, EEG results showed an analogous, hyperbolic curve for N1 amplitude, reflecting neural biasing. Though the form of behavioral and EEG curves did not vary with age, older adults displayed a clear decline in the speed of detection and a corresponding reduction in EEG N1 amplitude when horizontal (but not vertical) motion was expected. Our results suggest that expectation-based detection ability varies with age and, for older adults, also with axis of motion.	[Zanto, Theodore P.; Gazzaley, Adam] Univ Calif San Francisco, Dept Neurol, San Francisco, CA USA; [Gazzaley, Adam] Univ Calif San Francisco, Dept Physiol, San Francisco, CA USA; [Gazzaley, Adam] Univ Calif San Francisco, Dept Psychiat, San Francisco, CA USA; [Sekuler, Robert; Dube, Chad] Brandeis Univ, Volen Ctr Complex Syst, Waltham, MA USA; [Sekuler, Robert; Dube, Chad] Brandeis Univ, Dept Psychol, Waltham, MA USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Brandeis University; Brandeis University	Zanto, TP (corresponding author), Univ Calif San Francisco, Dept Neurol, San Francisco, CA USA.	theodore.zanto@ucsf.edu			NIH [4F32AG030249-03, 5R01AG030395]; AFOSR [FA95550-10-0420]; NSF [SMA-0835976]; NATIONAL INSTITUTE ON AGING [R01AG030395, F32AG030249] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); AFOSR(United States Department of DefenseAir Force Office of Scientific Research (AFOSR)); NSF(National Science Foundation (NSF)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by NIH grants 4F32AG030249-03 & 5R01AG030395, AFOSR grant FA95550-10-0420, and NSF grant SMA-0835976. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander GE, 2006, NEUROREPORT, V17, P951, DOI 10.1097/01.wnr.0000220135.16844.b6; Astheimer LB, 2011, NEUROPSYCHOLOGIA, V49, P3512, DOI 10.1016/j.neuropsychologia.2011.08.014; BALL K, 1980, PSYCHOL REV, V87, P435, DOI 10.1037/0033-295X.87.5.435; Balota DA, 1999, J EXP PSYCHOL GEN, V128, P32, DOI 10.1037/0096-3445.128.1.32; Balota DA, 2011, CURR DIR PSYCHOL SCI, V20, P160, DOI 10.1177/0963721411408885; BARBAS H, 1991, J COMP NEUROL, V313, P65, DOI 10.1002/cne.903130106; Barnett-Cowan M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019289; Behrens TEJ, 2003, NAT NEUROSCI, V6, P750, DOI 10.1038/nn1075; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bennett PJ, 2007, VISION RES, V47, P799, DOI 10.1016/j.visres.2007.01.001; Billino J, 2008, VISION RES, V48, P1254, DOI 10.1016/j.visres.2008.02.014; Billino J, 2011, NEUROPSYCHOLOGIA, V49, P3151, DOI 10.1016/j.neuropsychologia.2011.07.009; Billino J, 2009, PERCEPTION, V38, P508, DOI 10.1068/p5886; Bollinger J, 2011, NEUROPSYCHOLOGIA, V49, P1466, DOI 10.1016/j.neuropsychologia.2010.12.021; Bollinger J, 2010, J NEUROSCI, V30, P14399, DOI 10.1523/JNEUROSCI.1547-10.2010; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; Brickman AM, 2007, NEUROBIOL AGING, V28, P284, DOI 10.1016/j.neurobiolaging.2005.12.016; Bubic A, 2010, BRAIN RES, V1317, P192, DOI 10.1016/j.brainres.2009.12.072; CHAUDHURI A, 1991, VISUAL NEUROSCI, V7, P397, DOI 10.1017/S0952523800009706; Coull JT, 2004, COGNITIVE BRAIN RES, V21, P216, DOI 10.1016/j.cogbrainres.2004.02.011; Crossman ER, 1956, EXPERIENTIA SUPPLEME, V4, P128; Delis DC, 2001, D KEFS EXAMINERS MAN, DOI DOI 10.1037/T15082-000; Delis DC, 2000, CALIFORNIA VERBAL LE, DOI DOI 10.1016/j.schres.2003.09.011; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Gazzaley A, 2008, P NATL ACAD SCI USA, V105, P13122, DOI 10.1073/pnas.0806074105; Genc E, 2011, CURR BIOL, V21, P1494, DOI 10.1016/j.cub.2011.08.003; GENGERELLI JA, 1948, J EXP PSYCHOL, V38, P592, DOI 10.1037/h0062438; GOLDMANRAKIC PS, 1985, J COMP NEUROL, V242, P535, DOI 10.1002/cne.902420406; Gomez CA, 2007, BRAIN RES BULL, V73, P40, DOI 10.1016/j.brainresbull.2007.01.015; Goodglass H., 1983, ASSESSMENT APHASIA R, V2; HAKAMIESBLOMQVIST LE, 1993, ACCIDENT ANAL PREV, V25, P19, DOI 10.1016/0001-4575(93)90093-C; Heaton R., 1992, COMPREHENSIVE NORMS; Hoffmann S, 2011, PLOS ONE, V6, P9; Jackson JD, 2012, NEUROPSYCHOLOGIA, V50, P357, DOI 10.1016/j.neuropsychologia.2011.11.024; Kertesz A., 2007, W APHASIA BATTERY RE; LEWIS R, 1992, CLIN NEUROPSYCHOL, V6, P374, DOI 10.1080/13854049208401865; Li SC, 2001, TRENDS COGN SCI, V5, P479, DOI 10.1016/S1364-6613(00)01769-1; Li SC, 2005, COGNITIVE NEUROSCIEN, P354; Matthews C, 1964, INSTRUCTION MANUAL A; McGwin G, 1999, ACCIDENT ANAL PREV, V31, P181; MITTELSTAEDT H, 1986, ACTA PSYCHOL, V63, P63, DOI 10.1016/0001-6918(86)90043-0; Naikar N, 1996, NEUROPSYCHOLOGIA, V34, P297, DOI 10.1016/0028-3932(95)00110-7; NELDER JA, 1965, COMPUT J, V7, P308, DOI 10.1093/comjnl/7.4.308; Pelli DG, 1997, SPATIAL VISION, V10, P437, DOI 10.1163/156856897X00366; Rabbitt P, 2007, NEUROPSYCHOLOGY, V21, P363, DOI 10.1037/0894-4105.21.3.363; Rahnev D, 2011, J NEUROSCI, V31, P10741, DOI 10.1523/JNEUROSCI.1478-11.2011; RAMACHANDRAN VS, 1986, NATURE, V320, P358, DOI 10.1038/320358a0; Reuter-Lorenz PA, 2005, CURR OPIN NEUROBIOL, V15, P245, DOI 10.1016/j.conb.2005.03.016; Robertson G, 2006, WIDE RANGE ACHIEVEME; Sabri M, 2006, J COGNITIVE NEUROSCI, V18, P689, DOI 10.1162/jocn.2006.18.5.689; Schoenfeld MA, 2007, CEREB CORTEX, V17, P2468, DOI 10.1093/cercor/bhl154; SEKULER R, 1977, SCIENCE, V198, P60, DOI 10.1126/science.897682; Shimono M, 2012, CEREB CORTEX, V22, P337, DOI 10.1093/cercor/bhr108; Spreen O., 1977, NEUROSENSORY CTR COM; Stroop JR, 1935, J EXP PSYCHOL, V18, P643, DOI 10.1037/h0054651; SWETS JA, 1961, J ACOUST SOC AM, V33, P1586, DOI 10.1121/1.1908507; Takahashi R, 2011, HUM BRAIN MAPP, V32, P1050, DOI 10.1002/hbm.21088; Turken AU, 2008, NEUROIMAGE, V42, P1032, DOI 10.1016/j.neuroimage.2008.03.057; van Beuzekom AD, 2000, J NEUROPHYSIOL, V84, P11, DOI 10.1152/jn.2000.84.1.11; WARREN WH, 1989, J GERONTOL, V44, pP147, DOI 10.1093/geronj/44.5.P147; Wechsler D, 1987, WMS R WECHSLER MEMOR; Wechsler D, 2009, WECHSLER MEMORY SCAL; WELFORD AT, 1981, HUM FACTORS, V23, P97, DOI 10.1177/001872088102300109; Weschsler D., 2008, WECHSLER ADULT INTEL; Woodrow H, 1914, PSYCHOL MONOGR, V17, P1; Yang JM, 2012, NEUROSCI LETT, V514, P198, DOI 10.1016/j.neulet.2012.02.094; YESAVAGE JA, 1983, J PSYCHIATR RES, V17, P37, DOI 10.1016/0022-3956(82)90033-4; Zanto TP, 2011, J NEUROSCI, V31, P12461, DOI 10.1523/JNEUROSCI.1149-11.2011; Zanto TP, 2010, NEUROIMAGE, V53, P736, DOI 10.1016/j.neuroimage.2010.06.012; Zanto TP, 2010, CORTEX, V46, P564, DOI 10.1016/j.cortex.2009.08.003; Zanto TP, 2010, NEUROPSYCHOLOGIA, V48, P13, DOI 10.1016/j.neuropsychologia.2009.08.003	71	6	6	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 9	2013	8	8							e69766	10.1371/journal.pone.0069766	http://dx.doi.org/10.1371/journal.pone.0069766			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	245OM	23950903	Green Published, gold, Green Submitted			2022-12-25	WOS:000326473200007
J	Bruells, CS; Maes, K; Rossaint, R; Thomas, D; Cielen, N; Bleilevens, C; Bergs, I; Loetscher, U; Dreier, A; Gayan-Ramirez, G; Behnke, BJ; Weis, J				Bruells, Christian S.; Maes, Karen; Rossaint, Rolf; Thomas, Debby; Cielen, Nele; Bleilevens, Christian; Bergs, Ingmar; Loetscher, Ursina; Dreier, Agnes; Gayan-Ramirez, Ghislaine; Behnke, Brad J.; Weis, Joachim			Prolonged Mechanical Ventilation Alters the Expression Pattern of Angio-neogenetic Factors in a Pre-Clinical Rat Model	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; HYPOXIA-INDUCIBLE FACTOR; SKELETAL-MUSCLE; KAPPA-B; ANGIOPOIETIN-2 EXPRESSION; GENE-EXPRESSION; DIAPHRAGM; ANGIOGENESIS; DYSFUNCTION; RECEPTORS	Objective: Mechanical ventilation (MV) is a life saving intervention for patients with respiratory failure. Even after 6 hours of MV, diaphragm atrophy and dysfunction (collectively referred to as ventilator-induced diaphragmatic dysfunction, VIDD) occurs in concert with a blunted blood flow and oxygen delivery. The regulation of hypoxia sensitive factors (i.e. hypoxia inducible factor 1 alpha, 2 zeta (HIF-1 alpha,-2 alpha), vascular endothelial growth factor (VEGF)) and angio-neogenetic factors (angiopoietin 1-3, Ang) might contribute to reactive and compensatory alterations in diaphragm muscle. Methods: Male Wistar rats (n = 8) were ventilated for 24 hours or directly sacrificed (n = 8), diaphragm and mixed gastrocnemius muscle tissue was removed. Quantitative real time PCR and western blot analyses were performed to detect changes in angio-neogenetic factors and inflammatory markers. Tissues were stained using Isolectin (IB 4) to determine capillarity and calculate the capillary/fiber ratio. Results: MV resulted in up-regulation of Ang 2 and HIF-1 alpha mRNA in both diaphragm and gastrocnemius, while VEGF mRNA was down-regulated in both tissues. HIF-2 alpha mRNA was reduced in both tissues, while GLUT 4 mRNA was increased in gastrocnemius and reduced in diaphragm samples. Protein levels of VEGF, HIF-1a, -2a and 4 did not change significantly. Additionally, inflammatory cytokine mRNA (Interleukin (IL)-6, IL-1 beta and TNF alpha) were elevated in diaphragm tissue. Conclusion: The results demonstrate that 24 hrs of MV and the associated limb disuse induce an up-regulation of angio-neogenetic factors that are connected to HIF-1 alpha. Changes in HIF-1 alpha expression may be due to several interactions occurring during MV.	[Bruells, Christian S.; Rossaint, Rolf; Bleilevens, Christian; Bergs, Ingmar; Loetscher, Ursina] Rhein Westfal TH Aachen, Dept Anesthesiol, Univ Hosp, D-52062 Aachen, Germany; [Bruells, Christian S.] Rhein Westfal TH Aachen, Dept Surg Intens & Intermediate Care, Univ Hosp, D-52062 Aachen, Germany; [Maes, Karen; Thomas, Debby; Cielen, Nele; Gayan-Ramirez, Ghislaine] Katholieke Univ Leuven, Lab Pneumol, Louvain, Belgium; [Dreier, Agnes; Weis, Joachim] Rhein Westfal TH Aachen, Inst Neuropathol, D-52062 Aachen, Germany; [Dreier, Agnes; Weis, Joachim] Rhein Westfal TH Aachen, Aachen Univ Hosp, JARA Translat Brain Med, D-52062 Aachen, Germany; [Behnke, Brad J.] Univ Florida, Inst Appl Physiol & Kinesiol, Coll Hlth & Human Performance, Gainesville, FL USA	RWTH Aachen University; RWTH Aachen University Hospital; RWTH Aachen University; RWTH Aachen University Hospital; KU Leuven; RWTH Aachen University; RWTH Aachen University; RWTH Aachen University Hospital; State University System of Florida; University of Florida	Bruells, CS (corresponding author), Rhein Westfal TH Aachen, Dept Anesthesiol, Univ Hosp, D-52062 Aachen, Germany.	cbruells@ukaachen.de	Thomas, Debby/D-9626-2018; Weis, Joachim/G-1984-2014; Bleilevens, Christian/AAG-8034-2020	Thomas, Debby/0000-0003-3075-9846; Weis, Joachim/0000-0003-3280-6773; Bleilevens, Christian/0000-0002-2104-1843; Gayan-Ramirez, Ghislaine/0000-0001-9652-7437	medical faculty of the RWTH Aachen	medical faculty of the RWTH Aachen	Dr. Bruells has been funded by the medical faculty of the RWTH Aachen. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdulmalek K, 2001, AM J PHYSIOL-LUNG C, V281, pL582, DOI 10.1152/ajplung.2001.281.3.L582; Bey L, 2003, PHYSIOL GENOMICS, V13, P157, DOI 10.1152/physiolgenomics.00001.2002; Brautigam K, 2009, TRANSL ONCOL, V2, P164, DOI 10.1593/tlo.09121; Brandao D, 2011, INT ANGIOL, V30, P25; Brown M. D., 2003, Angiogenesis, V6, P1, DOI 10.1023/A:1025809808697; Coer A, 2007, IFMBE PROC, V16, P465; Davis RT, 2012, CRIT CARE MED, V40, P2858, DOI 10.1097/CCM.0b013e31825b933a; Delp MD, 1996, J APPL PHYSIOL, V80, P261, DOI 10.1152/jappl.1996.80.1.261; Dermitzaki D, 2013, RESPIRATION, V85, P228, DOI 10.1159/000338841; DeRuisseau KC, 2005, AM J RESP CRIT CARE, V172, P1267, DOI 10.1164/rccm.200503-403OC; DeRuisseau KC, 2005, J APPL PHYSIOL, V98, P1314, DOI 10.1152/japplphysiol.00993.2004; Deveci D, 2001, AM J PHYSIOL-HEART C, V281, pH241, DOI 10.1152/ajpheart.2001.281.1.H241; Dodd SL, 2010, MUSCLE NERVE, V41, P110, DOI 10.1002/mus.21526; Eltzschig HK, 2011, NEW ENGL J MED, V364, P656, DOI 10.1056/NEJMra0910283; Gayan-Ramirez G, 2002, EUR RESPIR J, V20, P1579, DOI 10.1183/09031936.02.00063102; HENRIKSEN EJ, 1991, J APPL PHYSIOL, V70, P2322, DOI 10.1152/jappl.1991.70.5.2322; Holash J, 1999, SCIENCE, V284, P1994, DOI 10.1126/science.284.5422.1994; Hoppeler H, 2003, EXP PHYSIOL, V88, P109, DOI 10.1113/eph8802513; HUDLICKA O, 1991, J PHYSIOL-LONDON, V444, P1; HUDLICKA O, 1992, PHYSIOL REV, V72, P369, DOI 10.1152/physrev.1992.72.2.369; Jung YJ, 2003, FASEB J, V17, P2115, DOI 10.1096/fj.03-0329fje; Jung YJ, 2003, BIOCHEM J, V370, P1011, DOI 10.1042/BJ20021279; Kindig CA, 1998, MICROVASC RES, V55, P249, DOI 10.1006/mvre.1998.2075; Lobov IB, 2002, P NATL ACAD SCI USA, V99, P11205, DOI 10.1073/pnas.172161899; Maes K, 2007, AM J RESP CRIT CARE, V175, P1134, DOI 10.1164/rccm.200609-1342OC; Majmundar AJ, 2010, MOL CELL, V40, P294, DOI 10.1016/j.molcel.2010.09.022; McClung JM, 2007, AM J RESP CRIT CARE, V175, P150, DOI 10.1164/rccm.200601-142OC; Mounier R, 2010, EXP PHYSIOL, V95, P899, DOI 10.1113/expphysiol.2010.052928; Pichiule P, 2004, J BIOL CHEM, V279, P12171, DOI 10.1074/jbc.M305146200; Powers SK, 2002, J APPL PHYSIOL, V92, P1851, DOI 10.1152/japplphysiol.00881.2001; Racz GZ, 2003, AM J RESP CRIT CARE, V168, P297, DOI 10.1164/rccm.200206-541OC; Saltiel AR, 2001, NATURE, V414, P799, DOI 10.1038/414799a; Schellekens WJM, 2012, ANESTHESIOLOGY, V117, P329, DOI 10.1097/ALN.0b013e3182608cc0; Skuli N, 2012, J CLIN INVEST, V122, P1427, DOI 10.1172/JCI57322; Smuder AJ, 2012, CRIT CARE MED, V40, P927, DOI 10.1097/CCM.0b013e3182374a84; Tanaka T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029378; Wagatsuma A, 2008, PHYSIOL RES, V57, P613, DOI 10.33549/physiolres.931288; Wakamatsu T, 2009, EUR J PHARMACOL, V617, P17, DOI 10.1016/j.ejphar.2009.06.060; XIA Y, 1997, AM J PHYSIOL-REG I, V273, pR1734	39	19	20	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2013	8	8							e70524	10.1371/journal.pone.0070524	http://dx.doi.org/10.1371/journal.pone.0070524			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	201ER	23950950	Green Published, gold, Green Submitted			2022-12-25	WOS:000323124000018
J	Boakye, CHA; Doddapaneni, R; Shah, PP; Patel, AR; Godugu, C; Safe, S; Katiyar, SK; Singh, M				Boakye, Cedar H. A.; Doddapaneni, Ravi; Shah, Punit P.; Patel, Apurva R.; Godugu, Chandraiah; Safe, Stephen; Katiyar, Santosh K.; Singh, Mandip			Chemoprevention of Skin Cancer with 1,1-Bis (3 '-Indolyl)-1-(Aromatic) Methane Analog through Induction of the Orphan Nuclear Receptor, NR4A2 (Nurr1)	PLOS ONE			English	Article							INDUCED IMMUNE SUPPRESSION; GREEN TEA; PANCREATIC-CANCER; 3,3'-DIINDOLYLMETHANE DIM; EPIGALLOCATECHIN GALLATE; INDEPENDENT PATHWAYS; DEPENDENT ACTIVATION; HUMAN KERATINOCYTES; LUNG-CANCER; CELL-GROWTH	Background: The objective of this study was to demonstrate the anti-skin cancer and chemopreventive potential of 1,1-bis(3'-indolyl)-1-(p-chlorophenyl methane) (DIM-D) using an in vitro model. Methods: In vitro cell cytotoxicity and viability assays were carried out in A431 human epidermoid carcinoma cell line and normal human epidermal keratinocytes (NHEK) respectively by crystal violet staining. Apoptosis induction in A431 cells (DIM-D treated) and NHEK cells pretreated with DIM-D (2 hr) prior to UVB irradiation, were assessed. The accumulation of reactive oxygen species (ROS) in DIM-D pretreated NHEK cells (2 hr) prior to UVB exposure was also determined. Immunocytochemistry and western blot analysis was performed to determine cleaved caspase 3 and DNA damage markers in DIM-D treated A431 cells and in DIM-D pretreated NHEK cells prior to UVB irradiation. Results: The IC50 values of DIM-D were 68.7 +/- 7.3, 48.3 +/- 10.1 and 11.5 +/- 3.1 mu M whilst for Epigallocatechin gallate (EGCG) were 419.1 +/- 8.3, 186.1 +/- 5.2 and 56.7 +/- 3.1 mM for 24, 48 and 72 hr treatments respectively. DIM-D exhibited a significantly (p<0.05) greater induction of DNA fragmentation in A431 cells compared to EGCG with percent cell death of 38.9. In addition, DIM-D induced higher expression in A431 cells compared to EGCG of cleaved caspase 3 (3.0-fold vs. 2.4-fold changes), Nurr1 (2.7-fold vs. 1.7-fold changes) and NF kappa B (1.3-fold vs. 1.1-fold changes). DIM-D also exhibited chemopreventive activity in UVB-irradiated NHEK cells by significantly (p<0.05) reducing UVB-induced ROS formation and apoptosis compared to EGCG. Additionally, DIM-D induced expression of Nurr1 but reduced expression of 8-OHdG significantly in UVB-irradiated NHEK cells compared to EGCG and UV only. Conclusion: Our results suggest that DIM-D exhibits Nurr1-dependent transactivation in the induction of apoptosis in A431 cells and it protects NHEK cells against UVB-induced ROS formation and DNA damage.	[Boakye, Cedar H. A.; Doddapaneni, Ravi; Shah, Punit P.; Patel, Apurva R.; Godugu, Chandraiah; Singh, Mandip] Florida A&M Univ, Coll Pharm & Pharmaceut Sci, Tallahassee, FL 32307 USA; [Safe, Stephen] Texas A&M Univ, Dept Vet Physiol & Pharmacol, College Stn, TX 77843 USA; [Katiyar, Santosh K.] Univ Alabama Birmingham, Dept Dermatol, Birmingham, AL 35294 USA	State University System of Florida; Florida A&M University; Texas A&M University System; Texas A&M University College Station; University of Alabama System; University of Alabama Birmingham	Singh, M (corresponding author), Florida A&M Univ, Coll Pharm & Pharmaceut Sci, Tallahassee, FL 32307 USA.	mandip.sachdeva@gmail.com	Godugu, Chandraiah/F-4741-2018	Godugu, Chandraiah/0000-0001-5904-3134	National Center on Minority Health and Health Disparities grant from National Institutes of Health [P20 MD 006738-01]; SC-1 grant from National Institutes of Health [5SC1CA161676-03]; NATIONAL CANCER INSTITUTE [SC1CA161676] Funding Source: NIH RePORTER; National Institute on Minority Health and Health Disparities [P20MD006738] Funding Source: NIH RePORTER	National Center on Minority Health and Health Disparities grant from National Institutes of Health; SC-1 grant from National Institutes of Health; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	This work was supported by National Center on Minority Health and Health Disparities grant P20 MD 006738-01 and SC-1 grant 5SC1CA161676-03 from National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdelrahim M, 2006, CARCINOGENESIS, V27, P717, DOI 10.1093/carcin/bgi270; Agarwal R, 2006, ANTICANCER RES, V26, P4457; [Anonymous], 2011, NAT CANC I SKIN CANC; [Anonymous], 2012, CANC RFACTS FIG; [Anonymous], 2009, AM CANC ASS CANC FAC; [Anonymous], 2012, AM CANC ASS CANC FAC; Aziz MH, 2005, FASEB J, V19, P1193, DOI 10.1096/fj.04-3582fje; Banerjee S, 2009, CANCER RES, V69, P5592, DOI 10.1158/0008-5472.CAN-09-0838; Bensinger SJ, 2009, CELL, V137, P26, DOI 10.1016/j.cell.2009.03.024; Bonta PI, 2006, ARTERIOSCL THROM VAS, V26, P2288, DOI 10.1161/01.ATV.0000238346.84458.5d; Chintharlapalli S, 2006, MOL CANCER THER, V5, P1362, DOI 10.1158/1535-7163.MCT-06-0002; Chiu AE, 2005, DERMATOL SURG, V31, P855; Chow HHS, 2001, CANCER EPIDEM BIOMAR, V10, P53; Cimino F, 2007, BIOFACTORS, V30, P129, DOI 10.1002/biof.5520300206; Davies Mark R, 2005, J Inflamm (Lond), V2, P15, DOI 10.1186/1476-9255-2-15; Du GJ, 2012, NUTRIENTS, V4, P1679, DOI 10.3390/nu4111679; Elmets CA, 2001, J AM ACAD DERMATOL, V44, P425, DOI 10.1067/mjd.2001.112919; Glauert HP, 2010, MOL NUTR FOOD RES, V54, P875, DOI 10.1002/mnfr.200900482; Hong C, 2002, BIOCHEM PHARMACOL, V63, P1085, DOI 10.1016/S0006-2952(02)00856-0; Hou Z, 2004, MUTAT RES-FUND MOL M, V555, P3, DOI 10.1016/j.mrfmmm.2004.06.040; Huang W, 2010, ARTERIOSCL THROM VAS, V30, P1542, DOI 10.1161/ATVBAHA.109.191189; Ichite N, 2010, MOL CANCER THER, V9, P3003, DOI 10.1158/1535-7163.MCT-09-1104; Ichite N, 2009, CLIN CANCER RES, V15, P543, DOI 10.1158/1078-0432.CCR-08-1558; Inamoto T, 2008, MOL CANCER THER, V7, P3825, DOI 10.1158/1535-7163.MCT-08-0730; Ishida T, 2007, BIOL PHARM BULL, V30, P928, DOI 10.1248/bpb.30.928; Johnson TM, 1998, J AM ACAD DERMATOL, V38, P681, DOI 10.1016/S0190-9622(98)70196-3; Katiyar SK, 2007, CANCER LETT, V255, P1, DOI 10.1016/j.canlet.2007.02.010; Kuo PL, 2003, J BIOMED SCI, V10, P219, DOI 10.1159/000068711; Lei P, 2008, MOL CANCER THER, V7, P3363, DOI 10.1158/1535-7163.MCT-08-0439; Lei P, 2006, MOL CANCER THER, V5, P2324, DOI 10.1158/1535-7163.MCT-06-0184; Li XB, 2012, EXP THERM FLUID SCI, V39, P1, DOI 10.1016/j.expthermflusci.2011.12.014; Liu XL, 2011, NUTR CANCER, V63, P466, DOI 10.1080/01635581.2011.532901; MILLER DL, 1994, J AM ACAD DERMATOL, V30, P774, DOI 10.1016/S0190-9622(08)81509-5; Ouhtit Allal, 2001, J Biomed Biotechnol, V1, P5; Patel AR, 2012, EUR J PHARM SCI, V46, P8, DOI 10.1016/j.ejps.2012.01.012; Rahimi M, 2010, CANCER LETT, V295, P59, DOI 10.1016/j.canlet.2010.02.014; Rittie L, 2002, AGEING RES REV, V1, P705, DOI 10.1016/S1568-1637(02)00024-7; Robinson JK, 2005, JAMA-J AM MED ASSOC, V294, P1541, DOI 10.1001/jama.294.12.1541; Sander CS, 2002, J INVEST DERMATOL, V118, P618, DOI 10.1046/j.1523-1747.2002.01708.x; Scharffetter-Kochanek K, 1997, BIOL CHEM, V378, P1247; Shi YH, 2007, DRUG DISCOV TODAY, V12, P440, DOI 10.1016/j.drudis.2007.04.006; Stagos D, 2012, FOOD CHEM TOXICOL, V50, P2155, DOI 10.1016/j.fct.2012.04.002; Thiagarajan G, 2001, EXP EYE RES, V73, P393, DOI 10.1006/exer.2001.1049; Thiele JJ, 2001, CURR PROBL DERMATOL, V29, P26; URBACH F, 1991, DERMATOL CLIN, V9, P751; Vaid M, 2013, BIOCHEM PHARMACOL, V85, P1066, DOI 10.1016/j.bcp.2013.01.026; Valavanidis A, 2009, J ENVIRON SCI HEAL C, V27, P120, DOI 10.1080/10590500902885684; Vanderlaag K, 2006, CANCER LETT, V236, P198, DOI 10.1016/j.canlet.2005.05.036; Wright TI, 2006, J AM ACAD DERMATOL, V54, P933, DOI 10.1016/j.jaad.2005.08.062; Yang CS, 2002, ANNU REV PHARMACOL, V42, P25, DOI 10.1146/annurev.pharmtox.42.082101.154309	50	11	11	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2013	8	8							e69519	10.1371/journal.pone.0069519	http://dx.doi.org/10.1371/journal.pone.0069519			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	200ZE	23950896	Green Published, gold, Green Submitted			2022-12-25	WOS:000323109700019
J	Omouendze, PL; Henry, VJ; Porte, B; Dupre, N; Carmeliet, P; Gonzalez, BJ; Marret, S; Leroux, P				Omouendze, Priscilla L.; Henry, Vincent J.; Porte, Baptiste; Dupre, Nicolas; Carmeliet, Peter; Gonzalez, Bruno J.; Marret, Stephane; Leroux, Philippe			Hypoxia-Ischemia or Excitotoxin-Induced Tissue Plasminogen Activator-Dependent Gelatinase Activation in Mice Neonate Brain Microvessels	PLOS ONE			English	Article							FOCAL CEREBRAL-ISCHEMIA; MICROVASCULAR ENDOTHELIAL-CELLS; RECEPTOR-RELATED PROTEIN; WHITE-MATTER LESIONS; T-PA; MATRIX METALLOPROTEINASES; MOUSE MODEL; HEMORRHAGIC TRANSFORMATION; CHANGING PANORAMA; S-NITROSYLATION	Hypoxia-ischemia (HI) and excitotoxicity are validated causes of neonatal brain injuries and tissue plasminogen activator (t-PA) participates in the processes through proteolytic and receptor-mediated pathways. Brain microvascular endothelial cells from neonates in culture, contain and release more t-PA and gelatinases upon glutamate challenge than adult cells. We have studied t-PA to gelatinase (MMP-2 and MMP-9) activity links in HI and excitotoxicity lesion models in 5 day-old pups in wild type and in t-PA or its inhibitor (PAI-1) genes inactivated mice. Gelatinolytic activities were detected in SDS-PAGE zymograms and by in situ fluorescent DQ-gelatin microscopic zymographies. HI was achieved by unilateral carotid ligature followed by a 40 min hypoxia (8%O-2). Excitotoxic lesions were produced by intra parenchymal cortical (i.c.) injections of 10 mu g ibotenate (Ibo). Gel zymograms in WT cortex revealed progressive extinction of MMP-2 and MMP-9 activities near day 15 or day 8 respectively. MMP-2 expression was the same in all strains while MMP-9 activity was barely detectable in t-PA(-/-) and enhanced in PAI-1(-/-) mice. HI or Ibo produced activation of MMP-2 activities 6 hours post-insult, in cortices of WT mice but not in t-PA(-/-) mice. In PAI-1(-/-) mice, HI or vehicle i.c. injection increased MMP-2 and MMP-9 activities. In situ zymograms using DQ-gelatin revealed vessel associated gelatinolytic activity in lesioned areas in PAI-1(-/-) and in WT mice. In WT brain slices incubated ex vivo, glutamate (200 mu M) induced DQ-gelatin activation in vessels. The effect was not detected in t-PA(-/-) mice, but was restored by concomitant exposure to recombinant t-PA (20 mu g/mL). In summary, neonatal brain lesion paradigms and ex vivo excitotoxic glutamate evoked t-PA-dependent gelatinases activation in vessels. Both MMP-2 and MMP-9 activities appeared t-PA-dependent. The data suggest that vascular directed protease inhibition may have neuroprotection potential against neonatal brain injuries.	[Omouendze, Priscilla L.; Henry, Vincent J.; Porte, Baptiste; Dupre, Nicolas; Gonzalez, Bruno J.; Marret, Stephane; Leroux, Philippe] Univ Rouen, Haute Normandie INSERM ERI 28, Inst Res & Innovat Biomed, Rouen, France; [Carmeliet, Peter] VIB, Lab Angiogenesis & Neurovasc Link, Vesalius Res Ctr, Louvain, Belgium; [Marret, Stephane] Rouen Univ Hosp, Dept Neonatal Paediat & Intens Care, Rouen, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Rouen Normandie; Flanders Institute for Biotechnology (VIB); CHU de Rouen	Leroux, P (corresponding author), Univ Rouen, Haute Normandie INSERM ERI 28, Inst Res & Innovat Biomed, Rouen, France.	philippe.leroux@univ-rouen.fr	Gonzalez, Bruno/E-6103-2016; Carmeliet, Peter/AAQ-5140-2020; Leroux, Philippe/M-2002-2018; Porte, Baptiste/L-7381-2017	Gonzalez, Bruno/0000-0002-7176-1320; Carmeliet, Peter/0000-0001-7961-1821; Omouendze Mouaragadja, Priscilla/0000-0002-0340-2895; Marret, Stephane/0000-0002-2858-148X; Porte, Baptiste/0000-0003-3728-6308	INSERM; Region Haute-Normandie; FEDER (E.U.); European Leucodystrophy Association (ELA); University of Rouen; Gabon Republic doctoral grant; FEDER; efondation des Gueules Cassees; Flemish Government; long-term structural Methusalem	INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Region Haute-Normandie(Region Normandie); FEDER (E.U.)(European Commission); European Leucodystrophy Association (ELA); University of Rouen; Gabon Republic doctoral grant; FEDER(European Commission); efondation des Gueules Cassees; Flemish Government(European Commission); long-term structural Methusalem	This work was supported by grants from the INSERM, the Region Haute-Normandie, the FEDER (E.U.), the European Leucodystrophy Association (ELA) and the University of Rouen. PLO was funded by Gabon Republic doctoral grant. BP was funded by the FEDER, VH was funded by the FEDER and the "efondation des Gueules Cassees." The work of PC is supported by long-term structural Methusalem funding by the Flemish Government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adhami F, 2008, AM J PATHOL, V172, P1704, DOI 10.2353/ajpath.2008.070979; Agrawal SM, 2008, SEMIN CELL DEV BIOL, V19, P42, DOI 10.1016/j.semcdb.2007.06.003; Aoki T, 2002, STROKE, V33, P2711, DOI 10.1161/01.STR.0000033932.34467.97; Ayoub AE, 2005, J COMP NEUROL, V481, P403, DOI 10.1002/cne.20375; Bauer AT, 2010, J CEREBR BLOOD F MET, V30, P837, DOI 10.1038/jcbfm.2009.248; Bednarek N, 2012, PEDIATR RES, V71, P63, DOI 10.1038/pr.2011.3; Bednarek N, 2009, PEDIATR RES, V65, P296, DOI 10.1203/PDR.0b013e3181973aee; Buchan AM, 2000, NEUROLOGY, V54, P679, DOI 10.1212/WNL.54.3.679; Candelario-Jalil E, 2009, NEUROSCIENCE, V158, P983, DOI 10.1016/j.neuroscience.2008.06.025; CARMELIET P, 1994, NATURE, V368, P419, DOI 10.1038/368419a0; CARMELIET P, 1993, J CLIN INVEST, V92, P2746, DOI 10.1172/JCI116892; Chang DI, 2003, J CEREBR BLOOD F MET, V23, P1408, DOI 10.1097/01.WCB.0000091765.61714.30; Chen WQ, 2009, J NEUROCHEM, V111, P726, DOI 10.1111/j.1471-4159.2009.06362.x; Christoforidis GA, 2010, INTERV NEURORADIOL, V16, P297, DOI 10.1177/159101991001600312; Chung KKK, 2005, METHOD ENZYMOL, V396, P139, DOI 10.1016/S0076-6879(05)96014-X; Fukuda S, 2004, STROKE, V35, P998, DOI 10.1161/01.STR.0000119383.76447.05; Girolamo F, 2004, HISTOCHEM CELL BIOL, V122, P261, DOI 10.1007/s00418-004-0705-x; Gould DB, 2005, SCIENCE, V308, P1167, DOI 10.1126/science.1109418; Gu ZZ, 2002, SCIENCE, V297, P1186, DOI 10.1126/science.1073634; Hennebert O, 2005, NEUROSCIENCE, V130, P697, DOI 10.1016/j.neuroscience.2004.09.049; Hennebert O, 2004, J NEUROPATH EXP NEUR, V63, P53, DOI 10.1093/jnen/63.1.53; Henry VJ, 2013, NEUROBIOL DIS, V50, P201, DOI 10.1016/j.nbd.2012.10.020; Hill JW, 2012, NEUROSCIENCE, V220, P277, DOI 10.1016/j.neuroscience.2012.06.019; Himmelmann K, 2010, ACTA PAEDIATR, V99, P1337, DOI 10.1111/j.1651-2227.2010.01819.x; Himmelmann K, 2005, ACTA PAEDIATR, V94, P287, DOI 10.1111/j.1651-2227.2005.tb03071.x; Lee SR, 2004, J NEUROSCI, V24, P671, DOI 10.1523/JNEUROSCI.4243-03.2004; Legros H, 2009, J CEREBR BLOOD F MET, V29, P1146, DOI 10.1038/jcbfm.2009.39; Leroux P, 2007, NEUROSCIENCE, V146, P670, DOI 10.1016/j.neuroscience.2007.01.029; Leroux P, 2013, ARCH DIS CHILD-FETAL, V98, pF281, DOI 10.1136/archdischild-2012-303603; Liu J, 2012, J NEUROSCI, V32, P3044, DOI 10.1523/JNEUROSCI.6409-11.2012; Manabe S, 2005, INVEST OPHTH VIS SCI, V46, P4747, DOI 10.1167/iovs.05-0128; Mantuano E, 2008, J NEUROSCI, V28, P11571, DOI 10.1523/JNEUROSCI.3053-08.2008; MARRET S, 1995, J NEUROPATH EXP NEUR, V54, P358, DOI 10.1097/00005072-199505000-00009; Montaner J, 2003, CIRCULATION, V107, P598, DOI 10.1161/01.CIR.0000046451.38849.90; Morancho A, 2010, ANN NY ACAD SCI, V1207, P123, DOI 10.1111/j.1749-6632.2010.05734.x; Nicole O, 2001, NAT MED, V7, P59, DOI 10.1038/83358; Ning M, 2006, NEUROLOGY, V66, P1550, DOI 10.1212/01.wnl.0000216133.98416.b4; Paneth N, 2006, CLIN PERINATOL, V33, P251, DOI 10.1016/j.clp.2006.03.011; Parathath SR, 2006, J CELL SCI, V119, P339, DOI 10.1242/jcs.02734; Paxinos G, 2007, ATLAS DEV MOUSE BRAI, P374; Polavarapu R, 2007, BLOOD, V109, P3270, DOI 10.1182/blood-2006-08-043125; RICE JE, 1981, ANN NEUROL, V9, P131, DOI 10.1002/ana.410090206; Rosell A, 2008, STROKE, V39, P1121, DOI 10.1161/STROKEAHA.107.500868; Sashindranath M, 2012, BRAIN, V135, P3251, DOI 10.1093/brain/aws178; Sentilhes L, 2011, J PEDIATR-US, V158, P377, DOI 10.1016/j.jpeds.2010.08.033; Svedin P, 2007, J NEUROSCI, V27, P1511, DOI 10.1523/JNEUROSCI.4391-06.2007; Tang J, 2010, NEUROL RES, V32, P541, DOI 10.1179/174313209X414560; Tsuji K, 2005, STROKE, V36, P1954, DOI 10.1161/01.STR.0000177517.01203.eb; Yang Y, 2011, PROG MOL BIOL TRANSL, V99, P241, DOI 10.1016/S1877-1173(11)99006-1; Yang Y, 2010, J NEUROCHEM, V112, P134, DOI 10.1111/j.1471-4159.2009.06433.x; Zhang C, 2009, J CEREBR BLOOD F MET, V29, P1946, DOI 10.1038/jcbfm.2009.174; Zhao BQ, 2004, BLOOD, V103, P2610, DOI 10.1182/blood-2003-03-0835	52	14	14	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2013	8	8							e71263	10.1371/journal.pone.0071263	http://dx.doi.org/10.1371/journal.pone.0071263			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	217ZG	23940734	Green Published, gold, Green Submitted			2022-12-25	WOS:000324401500065
J	Hare, KM; Singleton, RJ; Grimwood, K; Valery, PC; Cheng, AC; Morris, PS; Leach, AJ; Smith-Vaughan, HC; Chatfield, M; Redding, G; Reasonover, AL; McCallum, GB; Chikoyak, L; McDonald, MI; Brown, N; Torzillo, PJ; Chang, AB				Hare, Kim M.; Singleton, Rosalyn J.; Grimwood, Keith; Valery, Patricia C.; Cheng, Allen C.; Morris, Peter S.; Leach, Amanda J.; Smith-Vaughan, Heidi C.; Chatfield, Mark; Redding, Greg; Reasonover, Alisa L.; McCallum, Gabrielle B.; Chikoyak, Lori; McDonald, Malcolm I.; Brown, Ngiare; Torzillo, Paul J.; Chang, Anne B.			Longitudinal Nasopharyngeal Carriage and Antibiotic Resistance of Respiratory Bacteria in Indigenous Australian and Alaska Native Children with Bronchiectasis	PLOS ONE			English	Article							CYSTIC FIBROSIS BRONCHIECTASIS; RANDOMIZED CONTROLLED-TRIAL; STREPTOCOCCUS-PNEUMONIAE; STAPHYLOCOCCUS-AUREUS; HAEMOPHILUS-INFLUENZAE; MORAXELLA-CATARRHALIS; HEALTHY-CHILDREN; KILIFI DISTRICT; CO-COLONIZATION; DOUBLE-BLIND	Background: Indigenous children in Australia and Alaska have very high rates of chronic suppurative lung disease (CSLD)/bronchiectasis. Antibiotics, including frequent or long-term azithromycin in Australia and short-term beta-lactam therapy in both countries, are often prescribed to treat these patients. In the Bronchiectasis Observational Study we examined over several years the nasopharyngeal carriage and antibiotic resistance of respiratory bacteria in these two PCV7-vaccinated populations. Methods: Indigenous children aged 0.5-8.9 years with CSLD/bronchiectasis from remote Australia (n = 79) and Alaska (n = 41) were enrolled in a prospective cohort study during 2004-8. At scheduled study visits until 2010 antibiotic use in the preceding 2-weeks was recorded and nasopharyngeal swabs collected for culture and antimicrobial susceptibility testing. Analysis of respiratory bacterial carriage and antibiotic resistance was by baseline and final swabs, and total swabs by year. Results: Streptococcus pneumoniae carriage changed little over time. In contrast, carriage of Haemophilus influenzae declined and Staphylococcus aureus increased (from 0% in 2005-6 to 23% in 2010 in Alaskan children); these changes were associated with increasing age. Moraxella catarrhalis carriage declined significantly in Australian, but not Alaskan, children (from 64% in 2004-6 to 11% in 2010). While beta-lactam antibiotic use was similar in the two cohorts, Australian children received more azithromycin. Macrolide resistance was significantly higher in Australian compared to Alaskan children, while H. influenzae beta-lactam resistance was higher in Alaskan children. Azithromycin use coincided significantly with reduced carriage of S. pneumoniae, H. influenzae and M. catarrhalis, but increased carriage of S. aureus and macrolide-resistant strains of S. pneumoniae and S. aureus (proportion of carriers and all swabs), in a 'cumulative dose-response' relationship. Conclusions: Over time, similar (possibly age-related) changes in nasopharyngeal bacterial carriage were observed in Australian and Alaskan children with CSLD/bronchiectasis. However, there were also significant frequency-dependent differences in carriage and antibiotic resistance that coincided with azithromycin use.	[Hare, Kim M.; Valery, Patricia C.; Morris, Peter S.; Leach, Amanda J.; Smith-Vaughan, Heidi C.; Chatfield, Mark; McCallum, Gabrielle B.; Chang, Anne B.] Charles Darwin Univ, Menzies Sch Hlth Res, Darwin, NT 0909, Australia; [Singleton, Rosalyn J.] Alaska Native Tribal Hlth Consortium, Anchorage, AK USA; [Singleton, Rosalyn J.; Reasonover, Alisa L.] Ctr Dis Control & Prevent, Arctic Invest Program, Natl Ctr Emerging & Zoonot Infect Dis, Anchorage, AK USA; [Grimwood, Keith] Univ Queensland, Queensland Childrens Med Res Inst, Brisbane, Qld, Australia; [Grimwood, Keith] Royal Childrens Hosp, Dept Infect Dis, Brisbane, Qld, Australia; [Cheng, Allen C.] Monash Univ, Dept Epidemiol & Prevent Med, Melbourne, Vic 3004, Australia; [Cheng, Allen C.] Alfred Hosp, Infect Dis Unit, Melbourne, Vic, Australia; [Morris, Peter S.] Royal Darwin Hosp, Darwin, NT, Australia; [Redding, Greg] Univ Washington, Sch Med, Seattle, WA USA; [Redding, Greg] Childrens Hosp & Reg Med Ctr, Div Pulm, Seattle, WA USA; [Chikoyak, Lori] Yukon Kuskokwim Hlth Corp, Bethel, AK USA; [McDonald, Malcolm I.] James Cook Univ, Sch Med & Dent, Cairns, Qld, Australia; [Brown, Ngiare] Univ Wollongong, Wollongong, NSW, Australia; [Brown, Ngiare] Australian Indigenous Doctors Assoc, Parkes, ACT, Australia; [Torzillo, Paul J.] Nganampa Hlth Council, Alice Springs, NT, Australia; [Torzillo, Paul J.] Royal Prince Alfred Hosp, Sydney, NSW, Australia; [Torzillo, Paul J.] Univ Sydney, Dept Med, Sydney, NSW 2006, Australia; [Chang, Anne B.] Royal Childrens Hosp, Queensland Childrens Med Res Inst, Dept Resp Med, Brisbane, Qld, Australia	Charles Darwin University; Menzies School of Health Research; Alaska Native Tribal Health Consortium; Centers for Disease Control & Prevention - USA; University of Queensland; Royal Children's Hospital Brisbane; Monash University; Florey Institute of Neuroscience & Mental Health; University of Washington; University of Washington Seattle; Seattle Children's Hospital; James Cook University; University of Wollongong; University of Sydney; University of Sydney; Royal Children's Hospital Brisbane	Hare, KM (corresponding author), Charles Darwin Univ, Menzies Sch Hlth Res, Darwin, NT 0909, Australia.	kim.hare@menzies.edu.au	Chang, Anne/F-2066-2013; Hare, Kim M/N-2300-2013; VALERY, Patricia/G-6230-2013; McCallum, Gabrielle/AAO-8158-2020; Valery, Patricia/AAV-5448-2020; Chatfield, Mark D/N-2278-2013	Chang, Anne/0000-0002-1331-3706; VALERY, Patricia/0000-0002-8823-3006; McCallum, Gabrielle/0000-0002-0210-1468; Valery, Patricia/0000-0002-8823-3006; Chatfield, Mark D/0000-0002-0004-6274; Grimwood, Keith/0000-0003-3174-9834; Cheng, Allen/0000-0003-3152-116X	National Health and Medical Research Council of Australia (National Health and Medical Research Council (NHMRC)) [389837]; National Health and Medical Research Council of Australia [545223]; National Health and Medical Research Council of Australia (Centre for Research Excellence in Lung Health of Aboriginal and Torres Strait Islanders) [1040830]; National Institutes of Health; National Heart Lung and Blood Institute [U26IHS3000001/01]; NHMRC [1038072, 1009945, 1024175, 545216, 1020561]; Australian Academy of Science's Douglas and Lola Douglas Scholarship; Australian Research Council [100100511]	National Health and Medical Research Council of Australia (National Health and Medical Research Council (NHMRC))(National Health and Medical Research Council (NHMRC) of Australia); National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); National Health and Medical Research Council of Australia (Centre for Research Excellence in Lung Health of Aboriginal and Torres Strait Islanders)(National Health and Medical Research Council (NHMRC) of Australia); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Heart Lung and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHMRC(National Health and Medical Research Council (NHMRC) of Australia); Australian Academy of Science's Douglas and Lola Douglas Scholarship; Australian Research Council(Australian Research Council)	This work was supported by the National Health and Medical Research Council of Australia (http://www.nhmrc.gov.au/, National Health and Medical Research Council (NHMRC) project grants 389837 (clinical component) and 545223 (microbiology component), and Centre for Research Excellence in Lung Health of Aboriginal and Torres Strait Islanders grant 1040830). The Alaskan study site received funding from the National Institutes of Health (http://www.nih.gov/) and the National Heart Lung and Blood Institute (http://www.nhlbi.nih.gov/, No. U26IHS3000001/01). KMH is supported by the NHMRC Gustav Nossal Postgraduate Scholarship 1038072 and the Australian Academy of Science's (http://science.org.au/) Douglas and Lola Douglas Scholarship; PCV is supported by an Australian Research Council (http://www.arc.gov.au/) Future Fellowship No. 100100511; ACC and HSV are funded by NHMRC Career Development Fellowships 1009945 and 1024175; AJL is supported by the NHMRC Elizabeth Blackburn Research Fellowship 1020561; and ABC is supported by a NHMRC Practitioner Fellowship 545216. The findings and conclusions in this article are those of the authors and do not necessarily represent the official position of the funding agencies. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdullahi O, 2008, PEDIATR INFECT DIS J, V27, P59, DOI 10.1097/INF.0b013e31814da70c; Abdullahi O, 2012, J INFECT DIS, V206, P1020, DOI 10.1093/infdis/jis447; Altenburg J, 2013, JAMA-J AM MED ASSOC, V309, P1251, DOI 10.1001/jama.2013.1937; Bell SM, 2012, ANTIBIOTIC SENSITIVI; Bogaert D, 2004, LANCET, V363, P1871, DOI 10.1016/S0140-6736(04)16357-5; Budhani RK, 1998, ANTIMICROB AGENTS CH, V42, P2521, DOI 10.1128/AAC.42.10.2521; CLSI, 2012, M100S22 CLSI; Hare KM, 2012, INT J ANTIMICROB AG, V40, P365, DOI 10.1016/j.ijantimicag.2012.05.018; Hare KM, 2011, J MICROBIOL METH, V86, P364, DOI 10.1016/j.mimet.2011.06.016; Hare KM, 2010, J PEDIATR-US, V157, P1001, DOI 10.1016/j.jpeds.2010.06.002; Harrison CJ, 2009, J ANTIMICROB CHEMOTH, V63, P511, DOI 10.1093/jac/dkn538; Jacobs MR, 2003, PEDIAT INFECT DIS S, V22, pS81; Kaieda S, 2005, INT J PEDIATR OTORHI, V69, P479, DOI 10.1016/j.ijporl.2004.11.013; Kapur N, 2012, CHEST, V141, P1018, DOI 10.1378/chest.11-0679; Kuehnert MJ, 2006, J INFECT DIS, V193, P172, DOI 10.1086/499632; Kwambana BA, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-175; Leach AJ, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-121; Mackenzie GA, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-304; Morris PS, 2010, MED J AUSTRALIA, V192, P24, DOI 10.5694/j.1326-5377.2010.tb03396.x; O'Brien KL, 2003, PEDIATR INFECT DIS J, V22, P133, DOI [10.1097/00006454-200302000-00009, 10.1097/00006454-200302000-00010]; Peric M, 2003, ANTIMICROB AGENTS CH, V47, P1017, DOI 10.1128/AAC.47.3.1017-1022.2003; Phaff SJ, 2006, J ANTIMICROB CHEMOTH, V57, P741, DOI 10.1093/jac/dkl014; Regev-Yochay G, 2004, JAMA-J AM MED ASSOC, V292, P716, DOI 10.1001/jama.292.6.716; Shakl JR, 2013, TRENDS MICROBIOL, V21, P129, DOI 10.1016/j.tim.2012.11.005; Singleton RJ, 2014, PEDIATR PULM, V49, P189, DOI 10.1002/ppul.22763; Stevens AM, 2010, EMERG INFECT DIS, V16, P797, DOI [10.3201/eid1605.090851, 10.3201/eid1605.091851]; Tramper-Stranders GA, 2007, J ANTIMICROB CHEMOTH, V60, P665, DOI 10.1093/jac/dkm235; Verhaegh SJC, 2011, MICROBIOL-SGM, V157, P169, DOI 10.1099/mic.0.042929-0; Wong C, 2012, LANCET, V380, P660, DOI 10.1016/S0140-6736(12)60953-2	29	27	32	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2013	8	8							e70478	10.1371/journal.pone.0070478	http://dx.doi.org/10.1371/journal.pone.0070478			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	218XC	23940582	gold, Green Submitted, Green Accepted, Green Published			2022-12-25	WOS:000324465000076
J	Hernandez-Baltazar, D; Mendoza-Garrido, ME; Martinez-Fong, D				Hernandez-Baltazar, Daniel; Mendoza-Garrido, Maria E.; Martinez-Fong, Daniel			Activation of GSK-3 beta and Caspase-3 Occurs in Nigral Dopamine Neurons during the Development of Apoptosis Activated by a Striatal Injection of 6-Hydroxydopamine	PLOS ONE			English	Article							GLYCOGEN-SYNTHASE KINASE-3-BETA; INDUCED DNA DENATURATION; SUBSTANTIA-NIGRA; PARKINSONS-DISEASE; TIME-COURSE; MICROGLIAL ACTIVATION; CELL-DEATH; PKC-DELTA; RAT MODEL; INTRASTRIATAL 6-HYDROXYDOPAMINE	The 6-Hydroxydopamine (6-OHDA) rat model of Parkinson's disease is essential for a better understanding of the pathological processes underlying the human disease and for the evaluation of promising therapeutic interventions. This work evaluated whether a single striatal injection of 6-OHDA causes progressive apoptosis of dopamine (DA) neurons and activation of glycogen synthase kinase 3 beta (GSK-3 beta) and caspase-3 in the substantia nigra compacta (SNc). The loss of DA neurons was shown by three neuron markers; tyrosine hydroxylase (TH), NeuN, and beta-III tubulin. Apoptosis activation was determined using Apostain and immunostaining against cleaved caspase-3 and GSK-3 beta pY216. We also explored the possibility that cleaved caspase-3 is produced by microglia and astrocytes. Our results showed that the 6-OHDA caused loss of nigral TH(+) cells, progressing mainly in rostrocaudal and lateromedial directions. In the neostriatum, a severe loss of TH(+) terminals occurred from day 3 after lesion. The disappearance of TH(+) cells was associated with a decrease in NeuN and beta-III tubulin immunoreactivity and an increase in Apostain, cleaved caspase-3, and GSK-3 beta pY216 in the SNc. Apostain immunoreactivity was observed from days 3 to 21 postlesion. Increased levels of caspase-3 immunoreactivity in TH(+) cells were detected from days 1 to 15, and the levels then decreased to day 30 postlesion. The cleaved caspase-3 also collocated with microglia and astrocytes indicating its participation in glial activation. Our results suggest that caspase-3 and GSK-3 beta pY216 activation might participate in the DA cell death and that the active caspase-3 might also participate in the neuroinflammation caused by the striatal 6-OHDA injection.	[Hernandez-Baltazar, Daniel; Mendoza-Garrido, Maria E.; Martinez-Fong, Daniel] Inst Politecn Nacl, Ctr Invest & Estudios Avanzados, Dept Fisiol Biofis & Neurociencias, Mexico City, DF, Mexico; [Martinez-Fong, Daniel] Inst Politecn Nacl, Ctr Invest & Estudios Avanzados, Programa Nanociencias & Nanotecnol, Mexico City, DF, Mexico	CINVESTAV - Centro de Investigacion y de Estudios Avanzados del Instituto Politecnico Nacional; Instituto Politecnico Nacional - Mexico; CINVESTAV - Centro de Investigacion y de Estudios Avanzados del Instituto Politecnico Nacional; Instituto Politecnico Nacional - Mexico	Martinez-Fong, D (corresponding author), Inst Politecn Nacl, Ctr Invest & Estudios Avanzados, Dept Fisiol Biofis & Neurociencias, Mexico City, DF, Mexico.	dmartine@fisio.cinvestav.mx	BALTAZAR, DANIEL HERNANDEZ/S-9655-2019	BALTAZAR, DANIEL HERNANDEZ/0000-0002-3658-4808	El Consejo Nacional de Ciencia y Tecnologia (CONACYT) [83229]; El Instituto Cientifico Pfizer	El Consejo Nacional de Ciencia y Tecnologia (CONACYT)(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); El Instituto Cientifico Pfizer	This work was supported by El Consejo Nacional de Ciencia y Tecnologia (CONACYT) grant # 83229 and El Instituto Cientifico Pfizer (DMF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguzzi A, 2013, SCIENCE, V339, P156, DOI 10.1126/science.1227901; Anaya-Martinez V, 2006, NEUROSCIENCE, V143, P477, DOI 10.1016/j.neuroscience.2006.08.033; Bernstein AI, 2011, MOL NEURODEGENER, V6, DOI 10.1186/1750-1326-6-2; Biswas SC, 2005, NEUROCHEM RES, V30, P839, DOI 10.1007/s11064-005-6877-5; Blandini F, 2007, EUR J NEUROSCI, V25, P397, DOI 10.1111/j.1460-9568.2006.05285.x; Blandini F, 2013, J NEUROIMMUNE PHARM, V8, P189, DOI 10.1007/s11481-013-9435-y; Blum D, 2001, PROG NEUROBIOL, V65, P135, DOI 10.1016/S0301-0082(01)00003-X; Bove J, 2012, NEUROSCIENCE, V211, P51, DOI 10.1016/j.neuroscience.2011.10.057; Brawek B, 2013, CELL CALCIUM, V53, P159, DOI 10.1016/j.ceca.2012.12.003; Burguillos MA, 2011, NATURE, V472, P319, DOI 10.1038/nature09788; CharriautMarlangue C, 1995, NEUROREPORT, V7, P61, DOI 10.1097/00001756-199512290-00014; Chaudhry ZL, 2013, NEUROL RES, V35, P435, DOI 10.1179/1743132812Y.0000000135; Chen G, 2004, FASEB J, V18, P1162, DOI 10.1096/fj.04-1551fje; Chu WK, 2008, J CELL BIOCHEM, V105, P447, DOI 10.1002/jcb.21839; Cross DAE, 2001, J NEUROCHEM, V77, P94, DOI 10.1046/j.1471-4159.2001.00251.x; Ezcurra ALD, 2010, NEUROBIOL DIS, V37, P630, DOI 10.1016/j.nbd.2009.11.018; Decressac M, 2012, EXP NEUROL, V235, P306, DOI 10.1016/j.expneurol.2012.02.012; Ebert AD, 2008, J NEUROSCI RES, V86, P317, DOI 10.1002/jnr.21480; Esposito E, 2010, CURR MED CHEM, V17, P2764, DOI 10.2174/092986710791859324; Frankfurt OS, 1996, EXP CELL RES, V226, P387, DOI 10.1006/excr.1996.0240; Frankfurt OS, 2001, J HISTOCHEM CYTOCHEM, V49, P369, DOI 10.1177/002215540104900311; Gomez-Sintes R, 2011, FRONT MOL NEUROSCI, V4, DOI 10.3389/fnmol.2011.00045; Gong L, 2012, J NEUROCHEM, V123, P876, DOI 10.1111/jnc.12038; Gonzalez-Barrios JA, 2006, MOL THER, V14, P857, DOI 10.1016/j.ymthe.2006.09.001; Gonzalez-Hernandez T, 2000, J COMP NEUROL, V421, P107, DOI 10.1002/(SICI)1096-9861(20000522)421:1<107::AID-CNE7>3.0.CO;2-F; Han BS, 2003, J NEUROSCI, V23, P5069; Hanrott K, 2006, J BIOL CHEM, V281, P5373, DOI 10.1074/jbc.M511560200; Hanrott K, 2008, EUR J NEUROSCI, V27, P1086, DOI 10.1111/j.1460-9568.2008.06097.x; He Y, 2000, BRAIN RES, V858, P163, DOI 10.1016/S0006-8993(99)02459-2; Hetman M, 2000, J NEUROSCI, V20, P2567; Ito Y, 2006, J HISTOCHEM CYTOCHEM, V54, P683, DOI 10.1369/jhc.5A6799.2006; Iwata SI, 2004, SYNAPSE, V51, P279, DOI 10.1002/syn.10307; Jeon BS, 1999, J NEUROCHEM, V73, P322, DOI 10.1046/j.1471-4159.1999.0730322.x; Jordan J, 2003, J PHYSIOL BIOCHEM, V59, P129, DOI 10.1007/BF03179878; Kanthasamy AG, 2006, FREE RADICAL BIO MED, V41, P1578, DOI 10.1016/j.freeradbiomed.2006.08.016; Katsetos CD, 2003, J CHILD NEUROL, V18, P851, DOI 10.1177/088307380301801205; Kaytor MD, 2002, CURR OPIN NEUROBIOL, V12, P275, DOI 10.1016/S0959-4388(02)00320-3; Kihlmark M, 2004, EXP CELL RES, V293, P346, DOI 10.1016/j.yexcr.2003.10.019; Kim TW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025346; Kirik D, 1998, EXP NEUROL, V152, P259, DOI 10.1006/exnr.1998.6848; Kostrzewa RM, 2000, NEUROTOX RES, V2, P239, DOI 10.1007/BF03033797; Kostrzewa RM, 2003, NEUROTOX RES, V5, P375, DOI 10.1007/BF03033166; Latchoumycandane C, 2011, TOXICOL APPL PHARM, V256, P314, DOI 10.1016/j.taap.2011.07.021; Lei Peng, 2011, Int J Alzheimers Dis, V2011, P189246, DOI 10.4061/2011/189246; Li Y, 2011, NEUROSCI LETT, V487, P41, DOI 10.1016/j.neulet.2010.09.070; Liang ZQ, 2007, BRAIN RES, V1145, P190, DOI 10.1016/j.brainres.2007.01.130; Liu XS, 1997, CELL, V89, P175, DOI 10.1016/S0092-8674(00)80197-X; Luk KC, 2013, J NEUROCHEM, V125, P932, DOI 10.1111/jnc.12160; Marinova-Mutafchieva L, 2009, J NEUROCHEM, V110, P966, DOI 10.1111/j.1471-4159.2009.06189.x; Marti MJ, 2002, BRAIN RES, V958, P185, DOI 10.1016/S0006-8993(02)03694-6; MARTINEZFONG D, 2012, NANOMEDICINE, DOI DOI 10.1016/J.NAN0.2012.02.009; Middeldorp J, 2011, PROG NEUROBIOL, V93, P421, DOI 10.1016/j.pneurobio.2011.01.005; Mladenovic A, 2004, BRAIN RES, V996, P237, DOI 10.1016/j.brainres.2003.10.035; MULLEN RJ, 1992, DEVELOPMENT, V116, P201; Nair VD, 2006, APOPTOSIS, V11, P955, DOI 10.1007/s10495-006-6316-3; Naoi M, 2010, CURR PHARM DESIGN, V16, P2799, DOI 10.2174/138161210793176527; Nemoto C, 1999, BRAIN RES, V846, P129, DOI 10.1016/S0006-8993(99)01950-2; Oo TF, 2002, EXP NEUROL, V175, P1, DOI 10.1006/exnr.2002.7881; Pap M, 1998, J BIOL CHEM, V273, P19929, DOI 10.1074/jbc.273.32.19929; Perez-Martinez FC, 2012, J ALZHEIMERS DIS, V31, P697, DOI 10.3233/JAD-2012-120661; Petit-Paitel A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005491; Phani Sudarshan, 2012, Parkinsonism Relat Disord, V18 Suppl 1, pS207, DOI 10.1016/S1353-8020(11)70064-5; Godoy MCP, 2010, J NEUROIMMUNOL, V222, P29, DOI 10.1016/j.jneuroim.2010.02.018; Rodrigues RWP, 2004, INT J NEUROSCI, V114, P197, DOI 10.1080/00207450490249338; Rodriguez M, 2001, EXP NEUROL, V169, P163, DOI 10.1006/exnr.2000.7624; Rodriguez-Pallares J, 2007, J NEUROCHEM, V103, P145, DOI 10.1111/j.1471-4159.2007.04699.x; Rybakowska Iwona, 2011, Przegl Lek, V68, P486; Sakahira H, 1998, NATURE, V391, P96, DOI 10.1038/34214; Sanchez-Iglesias S, 2007, NEUROCHEM RES, V32, P99, DOI 10.1007/s11064-006-9232-6; SAUER H, 1994, NEUROSCIENCE, V59, P401, DOI 10.1016/0306-4522(94)90605-X; Shrivastava P, 2013, J NUTR BIOCHEM, V24, P680, DOI 10.1016/j.jnutbio.2012.03.018; Tornero D, 2002, REV NEUROLOGIA, V35, P354, DOI 10.33588/rn.3504.2002389; Tsuboi K, 2000, BRAIN RES, V866, P55, DOI 10.1016/S0006-8993(00)02219-8; UNGERSTEDT U, 1968, EUR J PHARMACOL, V5, P107, DOI 10.1016/0014-2999(68)90164-7; Venero JL, 2013, DEV NEUROSCI-BASEL, V35, P88, DOI 10.1159/000346155; Walsh S, 2011, NEUROSCIENCE, V175, P251, DOI 10.1016/j.neuroscience.2010.12.005; Wildburger NC, 2012, FRONT MOL NEUROSCI, V5, DOI 10.3389/fnmol.2012.00080; Yakovlev AG, 2001, MOL NEUROBIOL, V24, P131; YAMADA T, 1990, BRAIN RES, V526, P303, DOI 10.1016/0006-8993(90)91236-A; Yong Y, 2011, NEUROCHEM RES, V36, P367, DOI 10.1007/s11064-010-0368-z; Zhang H, 2011, J MED CHEM, V54, P4324, DOI 10.1021/jm200347t; Zuch CL, 2000, J COMP NEUROL, V427, P440, DOI 10.1002/1096-9861(20001120)427:3<440::AID-CNE10>3.0.CO;2-7	82	67	68	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2013	8	8							e70951	10.1371/journal.pone.0070951	http://dx.doi.org/10.1371/journal.pone.0070951			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	218XC	23940672	Green Published, Green Submitted, gold			2022-12-25	WOS:000324465000161
J	Laurieri, N; Egleton, JE; Varney, A; Thinnes, CC; Quevedo, CE; Seden, PT; Thompson, S; Rodrigues-Lima, F; Dairou, J; Dupret, JM; Russell, AJ; Sim, E				Laurieri, Nicola; Egleton, James E.; Varney, Amy; Thinnes, Cyrille C.; Quevedo, Camilo E.; Seden, Peter T.; Thompson, Sam; Rodrigues-Lima, Fernando; Dairou, Julien; Dupret, Jean-Marie; Russell, Angela J.; Sim, Edith			A Novel Color Change Mechanism for Breast Cancer Biomarker Detection: Naphthoquinones as Specific Ligands of Human Arylamine N-Acetyltransferase 1	PLOS ONE			English	Article							ESTROGEN-RECEPTOR-ALPHA; N-ACETYLTRANSFERASE-1; IDENTIFICATION; EXPRESSION; DRUG; DISCOVERY; GENES; NAT1	Human arylamine N-acetyltransferase 1 (hNAT1) has become an attractive potential biomarker for estrogen-receptor-positive breast cancers. We describe here the mechanism of action of a selective non-covalent colorimetric biosensor for the recognition of hNAT1 and its murine homologue, mNat2, over their respective isoenzymes, leading to new opportunities in diagnosis. On interaction with the enzyme, the naphthoquinone probe undergoes an instantaneous and striking visible color change from red to blue. Spectroscopic, chemical, molecular modelling and biochemical studies reported here show that the color change is mediated by selective recognition between the conjugate base of the sulfonamide group within the probe and the conjugate acid of the arginine residue within the active site of both hNAT1 and mNat2. This represents a new mechanism for selective biomarker sensing and may be exploited as a general approach to the specific detection of biomarkers in disease.	[Laurieri, Nicola; Egleton, James E.; Varney, Amy; Thinnes, Cyrille C.; Russell, Angela J.; Sim, Edith] Univ Oxford, Dept Pharmacol, Oxford OX1 3QT, England; [Laurieri, Nicola; Egleton, James E.; Thinnes, Cyrille C.; Quevedo, Camilo E.; Seden, Peter T.; Thompson, Sam; Russell, Angela J.] Univ Oxford, Chem Res Lab, Dept Chem, Oxford OX1 3QT, England; [Rodrigues-Lima, Fernando; Dairou, Julien; Dupret, Jean-Marie] Univ Paris Diderot, Sorbonne Paris Cite, Unit Funct & Adapt Biol, CNRS,BFA,EAC 4413, F-75205 Paris, France; [Sim, Edith] Univ Kingston, Fac Sci Engn & Comp, Kingston Upon Thames, Surrey, England	University of Oxford; University of Oxford; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Cite; Kingston University	Russell, AJ (corresponding author), Univ Oxford, Dept Pharmacol, S Parks Rd, Oxford OX1 3QT, England.	angela.russell@chem.ox.ac.uk; E.Sim@kingston.ac.uk	Thompson, Sam/I-5599-2013	Thompson, Sam/0000-0001-6267-5693; Russell, Angela/0000-0003-3610-9369	Cancer Research United Kingdom through a Cancer Medicinal Chemistry Studentship; Oxford Cancer Research Centre Prize DPhil Studentship [C38302/A12450]; Small Molecule Cancer Drug Discovery Award [C17468/A9332]; Research Councils United Kingdom	Cancer Research United Kingdom through a Cancer Medicinal Chemistry Studentship; Oxford Cancer Research Centre Prize DPhil Studentship; Small Molecule Cancer Drug Discovery Award; Research Councils United Kingdom	This work was supported by: Cancer Research United Kingdom through a Cancer Medicinal Chemistry Studentship (NL), an Oxford Cancer Research Centre Prize DPhil Studentship (C38302/A12450, JEE) and a Small Molecule Cancer Drug Discovery Award (C17468/A9332; PTS, CEQ and ST). (http://www.cancerresearchuk.org/home/). The authors also thank Research Councils United Kingdom for a fellowship (AJR). (http://www.rcuk.ac.uk/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adam PJ, 2003, MOL CANCER RES, V1, P826; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Bieche I, 2004, BREAST CANCER RES, V6, pR252, DOI 10.1186/bcr784; Brooke EW, 2003, BIOORGAN MED CHEM, V11, P1227, DOI 10.1016/S0968-0896(02)00642-9; Dairou J, 2003, BIOCHEM BIOPH RES CO, V307, P1059, DOI 10.1016/S0006-291X(03)01311-1; Dalton WS, 2006, SCIENCE, V312, P1165, DOI 10.1126/science.1125948; Goodfellow GH, 2000, BIOCHEM J, V348, P159, DOI 10.1042/0264-6021:3480159; Johansson I, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3116; Kawamura A, 2008, BIOCHEM PHARMACOL, V75, P1550, DOI 10.1016/j.bcp.2007.12.012; Kelloff GJ, 2012, NAT REV DRUG DISCOV, V11, P201, DOI 10.1038/nrd3651; Kiefer Florian, 2009, Nucleic Acids Res, V37, pD387, DOI 10.1093/nar/gkn750; Laurieri N, 2010, J AM CHEM SOC, V132, P3238, DOI 10.1021/ja909165u; Li N, 2012, CURR OPIN CHEM BIOL, V16, P227, DOI 10.1016/j.cbpa.2012.01.008; Nomura DK, 2010, NAT REV CANCER, V10, P630, DOI 10.1038/nrc2901; PEITSCH MC, 1995, BIO-TECHNOL, V13, P658, DOI 10.1038/nbt0795-658; Ransohoff DF, 2003, SCIENCE, V299, P1679, DOI 10.1126/science.1083158; Russell AJ, 2009, BIOORGAN MED CHEM, V17, P905, DOI 10.1016/j.bmc.2008.11.032; Sambrook J., 2002, MOL CLONING LAB MANU; Sim E, 2012, ADV PHARMACOL, V63, P169, DOI 10.1016/B978-0-12-398339-8.00005-7; Soh N, 2008, SENSORS-BASEL, V8, P1004, DOI 10.3390/s8021004; Tozlu S, 2006, ENDOCR-RELAT CANCER, V13, P1109, DOI 10.1677/erc.1.01120; Verdonk ML, 2003, PROTEINS, V52, P609, DOI 10.1002/prot.10465; Wakefield L, 2008, GENE CHROMOSOME CANC, V47, P118, DOI 10.1002/gcc.20512; Wang BQ, 2011, MATER TECHNOL, V26, P236, DOI 10.1179/175355511X13110717549350; Wang HQ, 2004, PROTEIN J, V23, P153, DOI 10.1023/B:JOPC.0000020082.14480.e2; Wang HQ, 2004, BIOCHEMISTRY-US, V43, P8234, DOI 10.1021/bi0497244; Westwood IM, 2006, CURR TOP MED CHEM, V6, P1641, DOI 10.2174/156802606778108979; Westwood IM, 2011, COMB CHEM HIGH T SCR, V14, P117; Wu H, 2007, J BIOL CHEM, V282, P30189, DOI 10.1074/jbc.M704138200	29	14	14	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2013	8	8							e70600	10.1371/journal.pone.0070600	http://dx.doi.org/10.1371/journal.pone.0070600			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	218XC	23940600	Green Submitted, Green Published, gold, Green Accepted			2022-12-25	WOS:000324465000094
J	Taylor, RL; Tack, JD; Naugle, DE; Mills, LS				Taylor, Rebecca L.; Tack, Jason D.; Naugle, David E.; Mills, L. Scott			Combined Effects of Energy Development and Disease on Greater Sage-Grouse	PLOS ONE			English	Article							WEST-NILE-VIRUS; CONSERVATION; HABITAT; POPULATIONS; GUIDELINES; INFECTION	Species of conservation concern are increasingly threatened by multiple, anthropogenic stressors which are outside their evolutionary experience. Greater sage-grouse are highly susceptible to the impacts of two such stressors: oil and gas (energy) development and West Nile virus (WNv). However, the combined effects of these stressors and their potential interactions have not been quantified. We used lek (breeding ground) counts across a landscape encompassing extensive local and regional variation in the intensity of energy development to quantify the effects of energy development on lek counts, in years with widespread WNv outbreaks and in years without widespread outbreaks. We then predicted the effects of well density and WNv outbreak years on sage-grouse in northeast Wyoming. Absent an outbreak year, drilling an undeveloped landscape to a high permitting level (3.1 wells/km(2)) resulted in a 61% reduction in the total number of males counted in northeast Wyoming (total count). This was similar in magnitude to the 55% total count reduction that resulted from an outbreak year alone. However, energy-associated reductions in the total count resulted from a decrease in the mean count at active leks, whereas outbreak-associated reductions resulted from a near doubling of the lek inactivity rate (proportion of leks with a last count = 0). Lek inactivity quadrupled when 3.1 wells/km(2) was combined with an outbreak year, compared to no energy development and no outbreak. Conservation measures should maintain sagebrush landscapes large and intact enough so that leks are not chronically reduced in size due to energy development, and therefore vulnerable to becoming inactive due to additional stressors.	[Taylor, Rebecca L.; Tack, Jason D.; Naugle, David E.; Mills, L. Scott] Univ Montana, Wildlife Biol Program, Missoula, MT 59812 USA	University of Montana System; University of Montana	Taylor, RL (corresponding author), US Geol Survey, Alaska Sci Ctr, Anchorage, AK USA.	rebeccataylor@usgs.gov	Mills, L. Scott/K-2458-2012	Mills, L. Scott/0000-0001-8771-509X	Bureau of Land Management's Buffalo; Miles City Field Offices under BLM [09-3225-0012, G09AC00013]	Bureau of Land Management's Buffalo; Miles City Field Offices under BLM	The Bureau of Land Management's Buffalo and Miles City Field Offices funded this project under BLM Contract 09-3225-0012 Number G09AC00013. The funders had no role in study design, data analysis, decision to publish, or preparation of the manuscript. They did collect some, but not all of the data the authors used as part of their routine monitoring efforts.	Brook BW, 2008, TRENDS ECOL EVOL, V23, P453, DOI 10.1016/j.tree.2008.03.011; Burnham K. P., 1998, MODEL SELECTION INFE; Clark L, 2006, J WILDLIFE DIS, V42, P14, DOI 10.7589/0090-3558-42.1.14; Connelly JW, 2011, STUD AVIAN BIOL, P549; Connelly J.W., 2004, CONSERVATION ASSESSM; Connelly JW, 2000, WILDLIFE SOC B, V28, P967; Doherty K. E., 2010, MAPPING BREEDING DEN; Doherty KE, 2011, STUD AVIAN BIOL, P505; Doherty KE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010339; Doherty M.K., 2007, THESIS MONTANA STATE; Dunn KP, 1996, J COMPUTATIONAL GRAP, V5, P1, DOI DOI 10.2307/1390802; Fedy BC, 2011, J WILDLIFE MANAGE, V75, P1022, DOI 10.1002/jwmg.155; Fleishman E, 2011, BIOSCIENCE, V61, P290, DOI 10.1525/bio.2011.61.4.9; Garton EO, 2011, STUD AVIAN BIOL, P293; Hardin J. W., 2007, GEN LINEAR MODELS EX, DOI DOI 10.1016/j.marpol.2012.12.026; Harju SM, 2010, J WILDLIFE MANAGE, V74, P437, DOI 10.2193/2008-289; Hebblewhite Mark, 2011, P71; Hess JE, 2012, J WILDLIFE MANAGE, V76, P1625, DOI 10.1002/jwmg.417; Holloran M., 2005, THESIS U WYOMING LAR; Holloran MRJ, 2005, CONDOR, V107, P742, DOI 10.1650/7749.1; Johnson DH, 2011, STUD AVIAN BIOL, P407; Knick ST, 2013, ECOL EVOL, V3, P1539, DOI 10.1002/ece3.557; McDonald RI, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006802; Murphy T, 2013, RANGELANDS IN PRESS; Naugle DE, 2011, STUD AVIAN BIOL, P489; Naugle DE, 2005, WILDLIFE SOC B, V33, P616, DOI 10.2193/0091-7648(2005)33[616:WNVASW]2.0.CO;2; Naugle DE, 2004, ECOL LETT, V7, P704, DOI 10.1111/j.1461-0248.2004.00631.x; R Development Core Team, 2009, R FDN STAT COMP; Range-wide Interagency Sage-grouse Conservation Team, 2012, NEAR TERM GREAT SAG; Reinjen R, 1995, J APPL ECOL, V32, P481; Schroeder MA, 2004, CONDOR, V106, P363, DOI 10.1650/7425; Schultz C, 2010, BIOSCIENCE, V60, P545, DOI 10.1525/bio.2010.60.7.10; Soule ME, 1998, SCIENCE, V282, P1658, DOI 10.1126/science.282.5394.1658; Tack J. D., 2009, THESIS U MONTANA MIS; Taylor RL, 2012, J WILDLIFE MANAGE, V76, P336, DOI 10.1002/jwmg.267; U.S. Fish and Wildlife Service, 2013, GREAT SAG GROUS CENT; Walker BL, 2004, WILDLIFE SOC B, V32, P1000, DOI 10.2193/0091-7648(2004)032[1000:FTFOOW]2.0.CO;2; Walker BL, 2007, AVIAN DIS, V51, P691, DOI 10.1637/0005-2086(2007)51[691:WNVAGS]2.0.CO;2; Walker BL, 2007, J WILDLIFE MANAGE, V71, P2644, DOI 10.2193/2006-529; Walker BL, 2011, STUD AVIAN BIOL, P127; Wyoming Office of the Governor, 2011, EO20115 WYOM OFF GOV; Zou L, 2006, J MED ENTOMOL, V43, P1034, DOI 10.1603/0022-2585(2006)43[1034:MLHMUR]2.0.CO;2; [No title captured]	43	41	41	0	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2013	8	8							e71256	10.1371/journal.pone.0071256	http://dx.doi.org/10.1371/journal.pone.0071256			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	218XC	23940732	Green Published, gold			2022-12-25	WOS:000324465000201
J	Chen, PK; Chang, BI; Kuo, CH; Chen, PS; Cho, CF; Chang, CF; Shi, GY; Wu, HL				Chen, Po-Ku; Chang, Bi-Ing; Kuo, Cheng-Hsiang; Chen, Pin-Shern; Cho, Chia-Fong; Chang, Chuan-Fa; Shi, Guey-Yueh; Wu, Hua-Lin			Thrombomodulin functions as a plasminogen receptor to modulate angiogenesis	FASEB JOURNAL			English	Article						cell migration; pericellular proteolysis; lipid raft; endothelial cells	PROTEIN-C ACTIVATION; ENDOTHELIAL-CELL MIGRATION; HUMAN KERATINOCYTES; SIGNALING PATHWAYS; BINDING-SITE; LIPID RAFTS; EXPRESSION; MEMBRANE; POLARIZATION; MICRODOMAINS	Urokinase-type plasminogen activator (uPA) activates plasminogen (Plg) through a major pericellular proteolytic system involved in cell migration and angiogenesis; however, the Plg receptor that participates in uPA-mediated Plg activation has not yet been identified. In this study, we demonstrated that thrombomodulin (TM), a type I transmembrane glycoprotein, is a novel Plg receptor that plays a role in pericellular proteolysis and cell migration. Plg activation at the cell surface and the extent of its cell migration- and invasion-promoting effect are cellular TM expression dependent. Direct binding of Plg and the recombinant TM extracellular domain, with a K-D of 0.1-0.3 M, was determined through surface plasmon resonance analysis. Colocalization of TM, Plg, and the uPA receptor within plasma membrane lipid rafts, at the leading edge of migrating endothelial cells, was demonstrated and was also shown to overlap with areas of major pericellular proteolysis. Moreover, the roles of TM and Plg in neoangiogenesis were demonstrated in vivo through the skin wound-healing model. In conclusion, we propose that TM is a novel Plg receptor that regulates uPA/uPA receptor-mediated Plg activation and pericellular proteolysis within lipid rafts at the leading edge of migrating cells during angiogenesis.Chen, P.-K., Chang, B.-I., Kuo, C.-H., Chen, P.-S., Cho, C.-F., Chang, C.-F., Shi, G.-Y., Wu, H.-L. Thrombomodulin functions as a plasminogen receptor to modulate angiogenesis.	[Chen, Po-Ku; Chang, Bi-Ing; Kuo, Cheng-Hsiang; Chen, Pin-Shern; Cho, Chia-Fong; Shi, Guey-Yueh; Wu, Hua-Lin] Natl Cheng Kung Univ, Coll Med, Dept Biochem & Mol Biol, Tainan 701, Taiwan; [Chen, Po-Ku; Kuo, Cheng-Hsiang; Cho, Chia-Fong] Natl Cheng Kung Univ, Coll Med, Inst Basic Med Sci, Tainan 701, Taiwan; [Chen, Po-Ku; Chang, Chuan-Fa] Natl Cheng Kung Univ, Coll Med, Dept Med Lab Sci & Biotechnol, Tainan 701, Taiwan; [Chang, Bi-Ing; Kuo, Cheng-Hsiang; Chen, Pin-Shern; Shi, Guey-Yueh; Wu, Hua-Lin] Natl Cheng Kung Univ, Cardiovasc Res Ctr, Tainan 701, Taiwan; [Shi, Guey-Yueh; Wu, Hua-Lin] Natl Cheng Kung Univ, Ctr Biosci & Biotechnol, Tainan 701, Taiwan	National Cheng Kung University; National Cheng Kung University; National Cheng Kung University; National Cheng Kung University; National Cheng Kung University	Wu, HL (corresponding author), Natl Cheng Kung Univ, Coll Med, Dept Biochem & Mol Biol, 1 Univ Rd, Tainan 701, Taiwan.	gyshi@mail.ncku.edu.tw; halnwu@mail.ncku.edu.tw	Kuo, Cheng-Hsiang/GRJ-7463-2022; Chang, Chuan-Fa/F-8660-2011	Kuo, Cheng-Hsiang/0000-0002-4885-9020; Chang, Chuan-Fa/0000-0003-2404-1248	National Science Council, Executive Yuan, Taipei, Taiwan [NSC 99-2320-B-006-008-MY3, NSC 99-2628-B-006-003-MY3, NSC 100-2325-B-006-003-MY3]; National Cheng Kung University Aim for the Top University Plan grant from the Ministry of Education, Taiwan	National Science Council, Executive Yuan, Taipei, Taiwan(Ministry of Science and Technology, Taiwan); National Cheng Kung University Aim for the Top University Plan grant from the Ministry of Education, Taiwan	This work was supported by National Science Council, Executive Yuan, Taipei, Taiwan grants NSC 99-2320-B-006-008-MY3, NSC 99-2628-B-006-003-MY3, and NSC 100-2325-B-006-003-MY3 and by a National Cheng Kung University Aim for the Top University Plan grant from the Ministry of Education, Taiwan. P.-K.C. designed and performed the study and wrote the paper; G.-Y.S. and H.-L. W. designed the study, wrote the paper, and supervised the research; B.-I.C. performed the ELISA assay; C.-H. K. performed immunofluorescence microscopy; P.-S.C. and C.-F. Cho contributed vital reagents and analytical tools; C. F. Chang performed the SPR assay. The authors declare no conflicts of interest.	Andronicos NM, 2010, BLOOD, V115, P1319, DOI 10.1182/blood-2008-11-188938; Ass K, 2008, CANCER TREAT REV, V34, P122, DOI 10.1016/j.ctrv.2007.10.005; Bae JS, 2007, P NATL ACAD SCI USA, V104, P2867, DOI 10.1073/pnas.0611493104; BOFFA MC, 1984, REV FR TRANSFUS IMMU, V27, P807, DOI 10.1016/S0338-4535(84)80133-6; Brown DA, 2000, J BIOL CHEM, V275, P17221, DOI 10.1074/jbc.R000005200; Castellino FJ, 2005, THROMB HAEMOSTASIS, V93, P647, DOI 10.1160/TH04-12-0842; COLLEN D, 1991, BLOOD, V78, P3114; COLLEN D, 1975, THROMB DIATH HAEMOST, V34, P403, DOI 10.1055/s-0038-1651399; CONWAY EM, 1992, BLOOD, V80, P1254; Czekay RP, 2001, MOL BIOL CELL, V12, P1467, DOI 10.1091/mbc.12.5.1467; Das R, 2007, BLOOD, V110, P3763, DOI 10.1182/blood-2007-03-079392; DEUTSCH DG, 1970, SCIENCE, V170, P1095, DOI 10.1126/science.170.3962.1095; Drew AF, 2001, BLOOD, V97, P3691, DOI 10.1182/blood.V97.12.3691; Dudani AK, 1996, BRIT J HAEMATOL, V95, P168, DOI 10.1046/j.1365-2141.1996.7482367.x; ESTREICHER A, 1990, J CELL BIOL, V111, P783, DOI 10.1083/jcb.111.2.783; HAJJAR KA, 1994, J BIOL CHEM, V269, P21191; Han HS, 2000, FIBRINOLYSIS PROTEOL, V14, P221, DOI 10.1054/fipr.2000.0059; Hsu YY, 2012, FASEB J, V26, P3440, DOI 10.1096/fj.12-204917; Katoh SY, 2009, EXP CELL RES, V315, P2818, DOI 10.1016/j.yexcr.2009.07.008; Kindzelskii AL, 2004, HISTOCHEM CELL BIOL, V121, P299, DOI 10.1007/s00418-004-0639-3; Kindzelskii AL, 1996, J IMMUNOL, V156, P297; Kinney CM, 2008, AM J PHYSIOL-CELL PH, V294, pC241, DOI 10.1152/ajpcell.00187.2007; KUROSAWA S, 1988, J BIOL CHEM, V263, P5993; Lauffenburger DA, 1996, CELL, V84, P359, DOI 10.1016/S0092-8674(00)81280-5; Ledesma MD, 2003, BRAIN RES, V987, P107, DOI 10.1016/S0006-8993(03)03296-7; Li YH, 2006, THROMB HAEMOSTASIS, V95, P128, DOI 10.1160/TH05-06-0415; Lishko V. K., 2004, BLOOD, V104, P719; Lund LR, 2006, EMBO J, V25, P2686, DOI 10.1038/sj.emboj.7601173; Manes S, 1999, EMBO J, V18, P6211, DOI 10.1093/emboj/18.22.6211; MCCACHREN SS, 1991, BLOOD, V78, P3128; MILES LA, 1991, BIOCHEMISTRY-US, V30, P1682, DOI 10.1021/bi00220a034; Moon JJ, 2005, J CELL PHYSIOL, V203, P166, DOI 10.1002/jcp.20220; Nomura T, 2005, J MED INVESTIG, V52, P1, DOI 10.2152/jmi.52.1; Oh CW, 2003, J THROMB HAEMOST, V1, P1683, DOI 10.1046/j.1538-7836.2003.00182.x; Parat MO, 2003, MOL BIOL CELL, V14, P3156, DOI 10.1091/mbc.e02-11-0761; Peterson JJ, 1999, AM J PATHOL, V155, P1569, DOI 10.1016/S0002-9440(10)65473-9; RAIFE TJ, 1994, J CLIN INVEST, V93, P1846, DOI 10.1172/JCI117171; Ridley AJ, 2003, SCIENCE, V302, P1704, DOI 10.1126/science.1092053; Senet P, 1997, ARCH DERMATOL RES, V289, P151, DOI 10.1007/s004030050171; Shi CS, 2008, BLOOD, V112, P3661, DOI 10.1182/blood-2008-03-142760; Simons K, 2000, NAT REV MOL CELL BIO, V1, P31, DOI 10.1038/35036052; Small JV, 2002, TRENDS CELL BIOL, V12, P112, DOI 10.1016/S0962-8924(01)02237-1; SOFF GA, 1991, BLOOD, V77, P515; SUZUKI K, 1987, EMBO J, V6, P1891, DOI 10.1002/j.1460-2075.1987.tb02448.x; Tarui T, 2002, J BIOL CHEM, V277, P33564, DOI 10.1074/jbc.M205514200; Tsopanoglou NE, 1999, J BIOL CHEM, V274, P23969, DOI 10.1074/jbc.274.34.23969; vanLeeuwen RTJ, 1996, FIBRINOLYSIS, V10, P59, DOI 10.1016/S0268-9499(96)80081-6; Wang H, 2006, CANCER RES, V66, P7211, DOI 10.1158/0008-5472.CAN-05-4331; WU HL, 1992, BIOCHEM BIOPH RES CO, V188, P703, DOI 10.1016/0006-291X(92)91113-5	49	13	13	1	5	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2013	27	11					4520	4531		10.1096/fj.13-227561	http://dx.doi.org/10.1096/fj.13-227561			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	292YB	23943648				2022-12-25	WOS:000329937500019
J	Hannedouche, S; Beck, V; Leighton-Davies, J; Beibel, M; Roma, G; Oakeley, EJ; Lannoy, V; Bernard, J; Hamon, J; Barbieri, S; Preuss, I; Lasbennes, MC; Sailer, AW; Suply, T; Seuwen, K; Parker, CN; Bassilana, F				Hannedouche, Sebastien; Beck, Valerie; Leighton-Davies, Juliet; Beibel, Martin; Roma, Guglielmo; Oakeley, Edward J.; Lannoy, Vincent; Bernard, Jerome; Hamon, Jacques; Barbieri, Samuel; Preuss, Inga; Lasbennes, Marie-Christine; Sailer, Andreas W.; Suply, Thomas; Seuwen, Klaus; Parker, Christian N.; Bassilana, Frederic			Identification of the C3a Receptor (C3AR1) as the Target of the VGF-derived Peptide TLQP-21 in Rodent Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DIET-INDUCED OBESITY; RNA-SEQ; IN-VITRO; ANAPHYLATOXIN; COMPLEMENT; MICE; VIVO; RAT; TRANSCRIPTOMICS; RESISTANCE	TLQP-21, a peptide derived from VGF (non-acronymic) by proteolytic processing, has been shown to modulate energy metabolism, differentiation, and cellular response to stress. Although extensively investigated, the receptor for this endogenous peptide has not previously been described. This study describes the use of a series of studies that show G protein-coupled receptor-mediated biological activity of TLQP-21 signaling in CHO-K1 cells. Unbiased genome-wide sequencing of the transcriptome from responsive CHO-K1 cells identified a prioritized list of possible G protein-coupled receptors bringing about this activity. Further experiments using a series of defined receptor antagonists and siRNAs led to the identification of complement C3a receptor-1 (C3AR1) as a target for TLQP-21 in rodents. We have not been able to demonstrate so far that this finding is translatable to the human receptor. Our results are in line with a large number of physiological observations in rodent models of food intake and metabolic control, where TLQP-21 shows activity. In addition, the sensitivity of TLQP-21 signaling to pertussis toxin is consistent with the known signaling pathway of C3AR1. The binding of TLQP-21 to C3AR1 not only has effects on signaling but also modulates cellular functions, as TLQP-21 was shown to have a role in directing migration of mouse RAW264.7 cells.	[Beck, Valerie; Leighton-Davies, Juliet; Beibel, Martin; Roma, Guglielmo; Oakeley, Edward J.; Hamon, Jacques; Barbieri, Samuel; Preuss, Inga; Lasbennes, Marie-Christine; Sailer, Andreas W.; Suply, Thomas; Seuwen, Klaus; Parker, Christian N.; Bassilana, Frederic] Novartis AG, CH-4056 Basel, Switzerland; [Hannedouche, Sebastien; Lannoy, Vincent; Bernard, Jerome] Euroscreen SA, B-6041 Gosselies, Belgium	Novartis	Bassilana, F (corresponding author), Novartis AG, NIBR, Dev & Mol Pathways,Novartis Campus,Fabrikstr 22, CH-4056 Basel, Switzerland.	frederic.bassilana@novartis.com	; Sailer, Andreas/M-9913-2016	Bassilana, Frederic/0000-0003-2063-8450; Hannedouche, Sebastien/0000-0001-5909-242X; Sailer, Andreas/0000-0002-9015-7946				Aguilar E, 2013, NEUROENDOCRINOLOGY, V98, P38, DOI 10.1159/000350323; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Ames RS, 2001, J IMMUNOL, V166, P6341, DOI 10.4049/jimmunol.166.10.6341; Bartolomucci A, 2007, GROWTH HORM IGF RES, V17, P342, DOI 10.1016/j.ghir.2007.02.002; Bartolomucci A, 2006, P NATL ACAD SCI USA, V103, P14584, DOI 10.1073/pnas.0606102103; Bartolomucci A, 2009, GENES NUTR, V4, P49, DOI 10.1007/s12263-009-0110-0; Benard M, 2008, MOL IMMUNOL, V45, P3767, DOI 10.1016/j.molimm.2008.05.027; Brancia C, 2010, J ENDOCRINOL, V207, P329, DOI 10.1677/JOE-10-0189; Cassina V, 2013, BBA-BIOMEMBRANES, V1828, P455, DOI 10.1016/j.bbamem.2012.10.023; Ferri GL, 2011, J CHEM NEUROANAT, V42, P249, DOI 10.1016/j.jchemneu.2011.05.007; Francis K, 2003, FASEB J, V17, P2266, DOI 10.1096/fj.02-1103fje; Gao JM, 2003, J BIOL CHEM, V278, P37902, DOI 10.1074/jbc.M306061200; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Hahm S, 1999, NEURON, V23, P537, DOI 10.1016/S0896-6273(00)80806-5; Hahm S, 2002, J NEUROSCI, V22, P6929; Jethwa PH, 2007, ENDOCRINOLOGY, V148, P4044, DOI 10.1210/en.2007-0038; Jimenez-Guri E, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-123; Klos A, 2009, MOL IMMUNOL, V46, P2753, DOI 10.1016/j.molimm.2009.04.027; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; LEVI A, 1985, SCIENCE, V229, P393, DOI 10.1126/science.3839317; Lim J, 2013, FASEB J, V27, P822, DOI 10.1096/fj.12-220582; Mamane Y, 2009, DIABETES, V58, P2006, DOI 10.2337/db09-0323; Martin U, 1997, J EXP MED, V186, P199, DOI 10.1084/jem.186.2.199; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Overington JP, 2006, NAT REV DRUG DISCOV, V5, P993, DOI 10.1038/nrd2199; Passeri PP, 2013, NEUROENDOCRINOLOGY, V97, P212, DOI 10.1159/000339855; Petrella C, 2012, PEPTIDES, V36, P133, DOI 10.1016/j.peptides.2012.03.035; Pinilla L, 2011, AM J PHYSIOL-ENDOC M, V300, pE837, DOI 10.1152/ajpendo.00598.2010; Possenti R, 2012, BIOCHEM J, V441, P511, DOI 10.1042/BJ20111165; Rahpeymai Y, 2006, EMBO J, V25, P1364, DOI 10.1038/sj.emboj.7601004; Razzoli M, 2012, BEHAV BRAIN RES, V229, P333, DOI 10.1016/j.bbr.2012.01.038; Roberts A, 2011, BIOINFORMATICS, V27, P2325, DOI 10.1093/bioinformatics/btr355; Rosethorne EM, 2004, N-S ARCH PHARMACOL, V370, P64, DOI 10.1007/s00210-004-0932-7; Settmacher B, 2003, EUR J IMMUNOL, V33, P920, DOI 10.1002/eji.200323293; Severini C, 2009, BRIT J PHARMACOL, V157, P984, DOI 10.1111/j.1476-5381.2009.00192.x; Sibilia V, 2012, AMINO ACIDS, V42, P1261, DOI 10.1007/s00726-010-0818-6; Stephens SB, 2012, CELL METAB, V16, P33, DOI 10.1016/j.cmet.2012.05.011; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Winden AWJOV, 2012, BREAST CANCER RES TR, V134, P1, DOI 10.1007/s10549-011-1907-2; Xu X, 2011, NAT BIOTECHNOL, V29, P735, DOI 10.1038/nbt.1932	41	72	72	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 20	2013	288	38					27434	27443		10.1074/jbc.M113.497214	http://dx.doi.org/10.1074/jbc.M113.497214			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302IG	23940034	Green Published, hybrid			2022-12-25	WOS:000330597300039
J	Prive, F; Kaderbhai, NN; Girdwood, S; Worgan, HJ; Pinloche, E; Scollan, ND; Huws, SA; Newbold, CJ				Prive, Florence; Kaderbhai, Naheed N.; Girdwood, Susan; Worgan, Hilary J.; Pinloche, Eric; Scollan, Nigel D.; Huws, Sharon A.; Newbold, C. Jamie			Identification and Characterization of Three Novel Lipases Belonging to Families II and V from Anaerovibrio lipolyticus 5ST	PLOS ONE			English	Article							GENOME SEQUENCE; RUMEN; PROTEIN; BACTERIUM; PURIFICATION; ANNOTATIONS; SECRETION; SURFACE; SHIFTS; NOV.	Following the isolation, cultivation and characterization of the rumen bacterium Anaerovibrio lipolyticus in the 1960s, it has been recognized as one of the major species involved in lipid hydrolysis in ruminant animals. However, there has been limited characterization of the lipases from the bacterium, despite the importance of understanding lipolysis and its impact on subsequent biohydrogenation of polyunsaturated fatty acids by rumen microbes. This study describes the draft genome of Anaerovibrio lipolytica 5ST, and the characterization of three lipolytic genes and their translated protein. The uncompleted draft genome was 2.83 Mbp and comprised of 2,673 coding sequences with a G+C content of 43.3%. Three putative lipase genes, alipA, alipB and alipC, encoding 492-, 438- and 248-amino acid peptides respectively, were identified using RAST. Phylogenetic analysis indicated that alipA and alipB clustered with the GDSL/SGNH family II, and alipC clustered with lipolytic enzymes from family V. Subsequent expression and purification of the enzymes showed that they were thermally unstable and had higher activities at neutral to alkaline pH. Substrate specificity assays indicated that the enzymes had higher hydrolytic activity against caprylate (C8), laurate (C12) and myristate (C14).	[Prive, Florence; Kaderbhai, Naheed N.; Girdwood, Susan; Worgan, Hilary J.; Pinloche, Eric; Scollan, Nigel D.; Huws, Sharon A.; Newbold, C. Jamie] Aberystwyth Univ, Inst Biol Environm & Rural Sci, Aberystwyth, Ceredigion, Wales	Aberystwyth University; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Institute of Biological, Environmental, Rural & Sciences (IBERS)	Newbold, CJ (corresponding author), Aberystwyth Univ, Inst Biol Environm & Rural Sci, Aberystwyth, Ceredigion, Wales.	cjn@aber.ac.uk	Huws, Sharon/A-7768-2015	Huws, Sharon/0000-0002-0966-5354; Huws, Sharon/0000-0002-9284-2453	Biotechnology and Biological Sciences Research Council (UK), Department of Environment Food and Rural Affairs, English Beef and Lamb Executive, Hybu Cig Cymru, Quality Meat Scotland; Welsh Government [BEACON: 80561]; European Union Prosafebeef [FOOD-CT-2006-36241]; BBSRC [BBS/E/W/10964A01C, BBS/E/W/10964A01B, BBS/E/W/10964A01A] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BBS/E/W/10964A01A, BBS/E/W/10964A01B, BBS/E/W/10964A01C, BBS/B/11818] Funding Source: researchfish	Biotechnology and Biological Sciences Research Council (UK), Department of Environment Food and Rural Affairs, English Beef and Lamb Executive, Hybu Cig Cymru, Quality Meat Scotland(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Welsh Government; European Union Prosafebeef; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	The authors acknowledge funding from the Biotechnology and Biological Sciences Research Council (UK), Department of Environment Food and Rural Affairs, English Beef and Lamb Executive, Hybu Cig Cymru, Quality Meat Scotland, the Welsh Government (BEACON: 80561) and European Union Prosafebeef (FOOD-CT-2006-36241). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akoh CC, 2004, PROG LIPID RES, V43, P534, DOI 10.1016/j.plipres.2004.09.002; Al-Mahrous MM, 2011, FEMS IMMUNOL MED MIC, V62, P273, DOI 10.1111/j.1574-695X.2011.00811.x; Arpigny JL, 1999, BIOCHEM J, V343, P177, DOI 10.1042/0264-6021:3430177; Aziz RK, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-75; Bakke P, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006291; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Cai JG, 2011, APPL MICROBIOL BIOT, V89, P1463, DOI 10.1007/s00253-010-2971-y; Cirne DG, 2006, INT J SYST EVOL MICR, V56, P625, DOI 10.1099/ijs.0.63730-0; Dautin N, 2007, ANNU REV MICROBIOL, V61, P89, DOI 10.1146/annurev.micro.61.080706.093233; FAY JP, 1990, CAN J MICROBIOL, V36, P585, DOI 10.1139/m90-103; Ferrer M, 2005, ENVIRON MICROBIOL, V7, P1996, DOI 10.1111/j.1462-2920.2005.00920.x; Gao F, 2011, J BACTERIOL, V193, P2365, DOI 10.1128/JB.00226-11; Harfoot C, 1997, RUMEN MICROBIAL ECOS, P382; HARFOOT C G, 1978, Progress in Lipid Research, V17, P21, DOI 10.1016/0079-6832(78)90004-6; Hausmann S, 2010, HDB HYDROCARBON LIPI, P1099, DOI DOI 10.1007/978-3-540-77587-4_77; HAZLEWOOD GP, 1975, J GEN MICROBIOL, V89, P163, DOI 10.1099/00221287-89-1-163; Hazlewood GP, 1979, CHARACTERISTICS LIPO; HENDERSO.C, 1970, BIOCHEM J, V119, pP5; HENDERSO.C, 1973, J GEN MICROBIOL, V76, P389, DOI 10.1099/00221287-76-2-389; HENDERSON C, 1971, J GEN MICROBIOL, V65, P81, DOI 10.1099/00221287-65-1-81; Henderson C, 1969, P 4 S CONT CULT MICR, P89; Henderson IR, 1998, TRENDS MICROBIOL, V6, P370, DOI 10.1016/S0966-842X(98)01318-3; HOBSON PN, 1967, J GEN MICROBIOL, V47, P53, DOI 10.1099/00221287-47-1-53; HOBSON PN, 1966, NATURE, V209, P736, DOI 10.1038/209736a0; HOBSON PN, 1961, J GEN MICROBIOL, V25, P227, DOI 10.1099/00221287-25-2-227; Hotta Y, 2002, APPL ENVIRON MICROB, V68, P3925, DOI 10.1128/AEM.68.8.3925-3931.2002; HUNGATE RE, 1966, RUMEN ITS MICROBES; Huws SA, 2010, FEMS MICROBIOL ECOL, V73, P396, DOI 10.1111/j.1574-6941.2010.00892.x; Jarvis GN, 1998, SYST APPL MICROBIOL, V21, P135, DOI 10.1016/S0723-2020(98)80017-9; Kalendar R., 2009, GENES GENOMES GENOMI, V3, P1; Kashima Y, 1999, J BIOSCI BIOENG, V87, P19, DOI 10.1016/S1389-1723(99)80003-6; Kashima Y, 1998, J FERMENT BIOENG, V85, P584, DOI 10.1016/S0922-338X(98)80009-3; Koike S, 2007, ANIM SCI J, V78, P135, DOI 10.1111/j.1740-0929.2007.00417.x; Lagesen K, 2007, NUCLEIC ACIDS RES, V35, P3100, DOI 10.1093/nar/gkm160; LEE YP, 1993, BIOCHIM BIOPHYS ACTA, V1169, P156; Liu KL, 2009, BIOCHEM BIOPH RES CO, V385, P605, DOI 10.1016/j.bbrc.2009.05.110; Lowe TM, 1997, NUCLEIC ACIDS RES, V25, P955, DOI 10.1093/nar/25.5.955; Madupu R, 2010, DATABASE-OXFORD, DOI 10.1093/database/baq001; Marchler-Bauer A, 2011, NUCLEIC ACIDS RES, V39, pD225, DOI 10.1093/nar/gkq1189; Marx H, 2011, J BACTERIOL, V193, P5578, DOI 10.1128/JB.05861-11; Molgaard A, 2000, STRUCTURE, V8, P373, DOI 10.1016/S0969-2126(00)00118-0; Molgaard A, 2002, ADV PECTIN PECTINASE, P299; Nam SH, 2011, J BACTERIOL, V193, P1280, DOI 10.1128/JB.01505-10; Nam SH, 2010, J BACTERIOL, V192, P6094; Oomen CJ, 2004, EMBO J, V23, P1257, DOI 10.1038/sj.emboj.7600148; OTOOLE PW, 1994, MOL MICROBIOL, V11, P349, DOI 10.1111/j.1365-2958.1994.tb00315.x; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Pinsirodom P, 2001, CURR PROT FOOD ANAL, pC311; POHLNER J, 1987, NATURE, V325, P458, DOI 10.1038/325458a0; PRINS RA, 1975, A VAN LEEUW J MICROB, V41, P1, DOI 10.1007/BF02565031; REYNOLDS RD, 1982, ARCH BIOCHEM BIOPHYS, V219, P140, DOI 10.1016/0003-9861(82)90142-4; Ruiz C, 2007, APPL ENVIRON MICROB, V73, P2423, DOI 10.1128/AEM.02215-06; St Geme JW, 2000, J BACTERIOL, V182, P6005, DOI 10.1128/JB.182.21.6005-6013.2000; Steinhauer J, 1999, MOL MICROBIOL, V32, P367, DOI 10.1046/j.1365-2958.1999.01356.x; Stewart CS., 1997, RUMEN MICROBIAL ECOS, P10, DOI [10.1007/978-94-009-1453-7_2, DOI 10.1007/978-94-009-1453-7_2]; Stothard P, 2006, CURR OPIN MICROBIOL, V9, P505, DOI 10.1016/j.mib.2006.08.002; Strompl C, 1999, INT J SYST BACTERIOL, V49, P1861, DOI 10.1099/00207713-49-4-1861; Suen G, 2011, J BACTERIOL, V193, P5574, DOI 10.1128/JB.05621-11; Suen G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018814; Suhr M, 1996, MOL MICROBIOL, V22, P31, DOI 10.1111/j.1365-2958.1996.tb02653.x; Tajima K, 2001, APPL ENVIRON MICROB, V67, P2766, DOI 10.1128/AEM.67.6.2766-2774.2001; Tamm LK, 2001, J BIOL CHEM, V276, P32399, DOI 10.1074/jbc.R100021200; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; UPTON C, 1995, TRENDS BIOCHEM SCI, V20, P178, DOI 10.1016/S0968-0004(00)89002-7	65	28	30	2	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2013	8	8							e69076	10.1371/journal.pone.0069076	http://dx.doi.org/10.1371/journal.pone.0069076			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	200UV	23950883	Green Published, gold, Green Submitted			2022-12-25	WOS:000323097300008
J	Wang, Y; Yuan, JL; Zhang, YT; Ma, JJ; Xu, P; Shi, CH; Zhang, W; Li, YM; Fu, Q; Zhu, GF; Xue, W; Lei, YH; Gao, JY; Wang, JY; Shao, C; Yi, CG; Wang, H				Wang, Yong; Yuan, Jian Lin; Zhang, Yun Tao; Ma, Jian Jun; Xu, Peng; Shi, Chang Hong; Zhang, Wei; Li, Yu Mei; Fu, Qiang; Zhu, Guang Feng; Xue, Wei; Lei, Yong Hua; Gao, Jing Yu; Wang, Juan Ying; Shao, Chen; Yi, Cheng Gang; Wang, He			Inhibition of Both EGFR and IGF1R Sensitized Prostate Cancer Cells to Radiation by Synergistic Suppression of DNA Homologous Recombination Repair	PLOS ONE			English	Article							GROWTH-FACTOR RECEPTOR; FACTOR-I RECEPTOR; MECHANISMS; EXPRESSION; RESISTANCE; RADIOTHERAPY; ACTIVATION	Reduced sensitivity of prostate cancer (PC) cells to radiation therapy poses a significant challenge in the clinic. Activation of epidermal growth factor receptor (EGFR), type 1 insulin-like growth factor receptor (IGF1R), and crosstalk between these two signaling pathways have been implicated in the development of radiation resistance in PC. This study assessed the effects of targeting both receptors on the regulation of radio-sensitivity in PC cells. Specific inhibitors of EGFR and IGF1R, Erlotinib and AG1024, as well as siRNA targeting EGFR and IGF1R, were used to radio-sensitize PC cells. Our results showed that co-inhibiting both receptors significantly dampened cellular growth and DNA damage repair, and increased radiosensitivity in PC cells. These effects were carried out through synergistic inhibition of homologous recombination-directed DNA repair (HRR), but not via inhibition of non-homologous end joining (NHEJ). Furthermore, the compromised HRR capacity was caused by reduced phosphorylation of insulin receptor substrate 1 (IRS1) and its subsequent interaction with Rad51. The synergistic effect of the EGFR and IGF1R inhibitors was also confirmed in nude mouse xenograft assay. This is the first study testing co-inhibiting EGFR and IGF1R signaling in the context of radio-sensitivity in PC and it may provide a promising adjuvant therapeutic approach to improve the outcome of PC patients to radiation treatment.	[Wang, Yong; Ma, Jian Jun; Zhang, Wei; Li, Yu Mei; Fu, Qiang; Zhu, Guang Feng; Xue, Wei; Lei, Yong Hua; Gao, Jing Yu; Wang, Juan Ying; Wang, He] Fourth Mil Med Univ, Tangdu Hosp, Dept Urol, Xian 710032, Shaanxi Provinc, Peoples R China; [Yuan, Jian Lin; Zhang, Yun Tao; Shao, Chen] Fourth Mil Med Univ, Xijing Hosp, Dept Urol, Xian 710032, Shaanxi Provinc, Peoples R China; [Xu, Peng] Fourth Mil Med Univ, Tangdu Hosp, Dept Med & Training, Xian 710032, Shaanxi Provinc, Peoples R China; [Shi, Chang Hong] Fourth Mil Med Univ, Dept Expt Anim, Xian 710032, Shaanxi Provinc, Peoples R China; [Yi, Cheng Gang] Fourth Mil Med Univ, Xijing Hosp, Dept Plast Surg, Xian 710032, Shaanxi Provinc, Peoples R China	Air Force Military Medical University; Air Force Military Medical University; Air Force Military Medical University; Air Force Military Medical University; Air Force Military Medical University	Shao, C (corresponding author), Fourth Mil Med Univ, Xijing Hosp, Dept Urol, Xian 710032, Shaanxi Provinc, Peoples R China.	shaochen@fmmu.edu.cn; yichg@163.com; profwanghe@163.com			National Natural Science Foundation of China [30100185, 81250036, 30973000, 30872583, 81072116]; Natural Science Foundation of Shaan'xi Province [2009JQ4003]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Shaan'xi Province(Natural Science Foundation of Shaanxi Province)	Funded by grants from the National Natural Science Foundation of China (No. 30100185, No. 81250036, No. 30973000, No. 30872583, No. 81072116) and the Natural Science Foundation of Shaan'xi Province (2009JQ4003). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barber PR, 2007, P SOC PHOTO-OPT INS, V6441, P1; Buck E, 2008, CANCER RES, V68, P8322, DOI 10.1158/0008-5472.CAN-07-6720; Burma S, 2006, DNA REPAIR, V5, P1042, DOI 10.1016/j.dnarep.2006.05.026; Dent P, 2003, RADIAT RES, V159, P283, DOI 10.1667/0033-7587(2003)159[0283:SARIAO]2.0.CO;2; DEWINTER JAR, 1994, AM J PATHOL, V144, P735; Ganswindt U, 2008, EUR UROL, V54, P528, DOI 10.1016/j.eururo.2008.06.059; Graham TR, 2008, CANCER RES, V68, P2479, DOI 10.1158/0008-5472.CAN-07-2559; Hellawell GO, 2002, CANCER RES, V62, P2942; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Jin Q, 2008, J MAMMARY GLAND BIOL, V13, P485, DOI 10.1007/s10911-008-9107-3; Jones HE, 1997, INT J CANCER, V71, P1010, DOI 10.1002/(SICI)1097-0215(19970611)71:6<1010::AID-IJC17>3.0.CO;2-H; Jones HE, 2006, ENDOCR-RELAT CANCER, V13, pS45, DOI 10.1677/erc.1.01275; Kent Elizabeth C, 2003, Rev Urol, V5 Suppl 3, pS28; Kim TJ, 2006, BRIT J CANCER, V94, P1678, DOI 10.1038/sj.bjc.6603180; Liu F, 2010, UROL ONCOL-SEMIN ORI, V28, P59, DOI 10.1016/j.urolonc.2008.07.001; Liu YB, 2005, CANCER RES, V65, P3404, DOI 10.1158/0008-5472.CAN-04-4292; Nelson WG, 2003, NEW ENGL J MED, V349, P366, DOI 10.1056/NEJMra021562; Pienta KJ, 2006, CLIN CANCER RES, V12, P1665, DOI 10.1158/1078-0432.CCR-06-0067; Raderschall E, 1999, P NATL ACAD SCI USA, V96, P1921, DOI 10.1073/pnas.96.5.1921; Riedemann J, 2007, BIOCHEM BIOPH RES CO, V355, P700, DOI 10.1016/j.bbrc.2007.02.041; Ryan CJ, 2007, UROL ONCOL-SEMIN ORI, V25, P134, DOI 10.1016/j.urolonc.2006.07.019; Schlomm T, 2007, CLIN CANCER RES, V13, P6579, DOI 10.1158/1078-0432.CCR-07-1257; Sharma S, 2010, J NUCLEIC ACIDS, V2010, DOI 10.4061/2010/389129; Thoms J, 2010, SEMIN RADIAT ONCOL, V20, P217, DOI 10.1016/j.semradonc.2010.06.003; Tokunaga E, 2006, EUR J CANCER, V42, P629, DOI 10.1016/j.ejca.2005.11.025; Trojanek J, 2003, MOL CELL BIOL, V23, P7510, DOI 10.1128/MCB.23.21.7510-7524.2003; van der Veeken J, 2009, CURR CANCER DRUG TAR, V9, P748; Yang S, 2005, AM J PHYSIOL-RENAL, V289, pF1144, DOI 10.1152/ajprenal.00094.2005; Zhau HYE, 1996, P NATL ACAD SCI USA, V93, P15152, DOI 10.1073/pnas.93.26.15152	29	16	16	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2013	8	8							e68784	10.1371/journal.pone.0068784	http://dx.doi.org/10.1371/journal.pone.0068784			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	200UV	23950876	Green Published, gold, Green Submitted			2022-12-25	WOS:000323097300007
J	Hao, YP; Zhou, J; Zhou, M; Ma, XJ; Lu, ZG; Gao, MF; Pan, XP; Tang, JL; Bao, YQ; Jia, WP				Hao, Yaping; Zhou, Jian; Zhou, Mi; Ma, Xiaojing; Lu, Zhigang; Gao, Meifang; Pan, Xiaoping; Tang, Junling; Bao, Yuqian; Jia, Weiping			Serum Levels of Fibroblast Growth Factor 19 Are Inversely Associated with Coronary Artery Disease in Chinese Individuals	PLOS ONE			English	Article							HEART-DISEASE; INSULIN-RESISTANCE; METABOLIC SYNDROME; ACID SYNTHESIS; MICE; FIBROBLAST-GROWTH-FACTOR-19; ADIPONECTIN; HYPERINSULINEMIA; ADIPOSITY; OBESITY	Background: The fibroblast growth factor 19 (FGF19) has been implicated in recent studies as a potential regulator of glucose and lipid metabolism, which may lead to atherosclerosis. Here, we investigated the association of FGF19 with the presence and severity of coronary artery disease (CAD) in a Chinese population. Methods: A total of 315 patients with suspected or established CAD, including 205 males and 110 postmenopausal females, were enrolled and assessed by coronary angiography. CAD severity was determined by the Gensini score. Serum FGF19 was measured by quantitative sandwich ELISA. Results: FGF19 levels were not significantly different between male and female patients (median [interquartile range], 143.40 [87.96-250.80] vs. 141.60 [87.13-226.32] pg/mL, P = 0.773). CAD patients had lower levels of FGF19 than those without CAD (128.20 [80.62-226.58] vs. 188.00 [105.10-284.70] pg/mL, P = 0.007). FGF19 was negatively correlated with 2hPG (r = -0.150, P = 0.008), FINS (r = -0.169, P = 0.004), HOMA-IR (r = -0.171, P = 0.004), and the Gensini score (r = -0.141, P = 0.012), but positively correlated with HDL-c (r = 0.116, P = 0.041) and adiponectin (r = 0.128, P = 0.024). Moreover, FGF19 was found to be independently correlated with 2hPG (beta = -0.146, P = 0.022) and adiponectin (b = 0.154, P = 0.016). After adjusting for other CAD risk factors, FGF19 was demonstrated to be an independent factor for Gensini score (beta = -0.140, P = 0.019) and the presence of CAD (beta = -1.248, P = 0.036). Conclusions: Serum FGF19 is associated with the presence and severity of CAD in a Chinese population.	[Hao, Yaping; Zhou, Jian; Zhou, Mi; Ma, Xiaojing; Pan, Xiaoping; Tang, Junling; Bao, Yuqian; Jia, Weiping] Shanghai Jiao Tong Univ, Dept Endocrinol & Metab,Shanghai Key Clin Ctr Met, Shanghai Clin Ctr Diabet,Affiliated Peoples Hosp, Shanghai Diabet Inst,Shanghai Key Lab Diabet Mell, Shanghai 200030, Peoples R China; [Lu, Zhigang; Gao, Meifang] Shanghai Jiao Tong Univ, Dept Cardiol, Affiliated Peoples Hosp 6, Shanghai 200030, Peoples R China	Shanghai Jiao Tong University; Shanghai Jiao Tong University	Bao, YQ (corresponding author), Shanghai Jiao Tong Univ, Dept Endocrinol & Metab,Shanghai Key Clin Ctr Met, Shanghai Clin Ctr Diabet,Affiliated Peoples Hosp, Shanghai Diabet Inst,Shanghai Key Lab Diabet Mell, Shanghai 200030, Peoples R China.	byq522@163.com			973 Program of China [2013CB530606]; National Key Technology R&D Program of China [2012BAI02B03]; National Natural Science Foundation of China [81100590]; Shanghai Municipal Hospitals' Project of Appropriate Technology [SHDC12012201]; Key Discipline of Public Health of Shanghai (Epidemiology) [12GWZX0104]	973 Program of China(National Basic Research Program of China); National Key Technology R&D Program of China(National Key Technology R&D Program); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Municipal Hospitals' Project of Appropriate Technology; Key Discipline of Public Health of Shanghai (Epidemiology)	This work was funded by 973 Program of China (2013CB530606), National Key Technology R&D Program of China (2012BAI02B03), Project of National Natural Science Foundation of China (81100590), Shanghai Municipal Hospitals' Project of Appropriate Technology (SHDC12012201), and Key Discipline of Public Health of Shanghai (Epidemiology)(12GWZX0104). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu-Elheiga L, 2001, SCIENCE, V291, P2613, DOI 10.1126/science.1056843; Barutcuoglu B, 2011, ANN CLIN LAB SCI, V41, P390; Bhatnagar S, 2009, J BIOL CHEM, V284, P10023, DOI 10.1074/jbc.M808818200; Eren F, 2012, CLIN BIOCHEM, V45, P655, DOI 10.1016/j.clinbiochem.2012.03.019; Frystyk J, 2007, J CLIN ENDOCR METAB, V92, P571, DOI 10.1210/jc.2006-1067; Fu L, 2004, ENDOCRINOLOGY, V145, P2594, DOI 10.1210/en.2003-1671; GENSINI GG, 1983, AM J CARDIOL, V51, P606, DOI 10.1016/S0002-9149(83)80105-2; JUDKINS MP, 1968, RADIOL CLIN N AM, V6, P467; Lundasen T, 2006, J INTERN MED, V260, P530, DOI 10.1111/j.1365-2796.2006.01731.x; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Mraz M, 2011, PHYSIOL RES, V60, P627, DOI 10.33549/physiolres.932099; Nakamura T, 2007, ATHEROSCLEROSIS, V193, P449, DOI 10.1016/j.atherosclerosis.2006.08.028; Ntambi JM, 2002, P NATL ACAD SCI USA, V99, P11482, DOI 10.1073/pnas.132384699; Parul S S, 2011, Mymensingh Med J, V20, P78; Reiche M, 2010, HORM METAB RES, V42, P178, DOI 10.1055/s-0029-1243249; Song KH, 2009, HEPATOLOGY, V49, P297, DOI 10.1002/hep.22627; Soubassi LP, 2006, INT UROL NEPHROL, V38, P795, DOI 10.1007/s11255-066-0039-9; Stejskal D, 2008, SCAND J CLIN LAB INV, V68, P501, DOI 10.1080/00365510701854967; Strack AM, 2004, ENDOCRINOLOGY, V145, P2591, DOI 10.1210/en.2004-0367; Tomlinson E, 2002, ENDOCRINOLOGY, V143, P1741, DOI 10.1210/en.143.5.1741; Weyer C, 2001, J CLIN ENDOCR METAB, V86, P1930, DOI 10.1210/jc.86.5.1930; Wu XL, 2012, ADV EXP MED BIOL, V728, P195, DOI 10.1007/978-1-4614-0887-1_13; Wu XL, 2011, EXPERT OPIN THER TAR, V15, P1307, DOI 10.1517/14728222.2011.624514; Yamauchi T, 2003, J BIOL CHEM, V278, P2461, DOI 10.1074/jbc.M209033200	24	28	30	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2013	8	8							e72345	10.1371/journal.pone.0072345	http://dx.doi.org/10.1371/journal.pone.0072345			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	200ZE	23940810	gold, Green Published, Green Submitted			2022-12-25	WOS:000323109700134
J	Schofield, TP; Denson, TF				Schofield, Timothy P.; Denson, Thomas F.			Temporal Alcohol Availability Predicts First-Time Drunk Driving, but Not Repeat Offending	PLOS ONE			English	Article							EXTENDED DRINKING HOURS; OUTLET DENSITY; MULTILEVEL ANALYSIS; NEW-MEXICO; IMPACT; CRASHES; CITIES; VIOLENCE; ONTARIO; CITY	Alcohol availability has been linked to drunk driving, but research has not examined whether this relationship is the same for first-time and repeat offenses. We examined the relationship between the business hours of alcohol outlets licensed to serve alcohol for on-premises consumption and misdemeanor-level (first offense) and felony-level drunk driving (repeat offense) charges in New York State in 2009. Longer outlet business hours were associated with more misdemeanor drunk driving charges, but were not associated with felony drunk driving charges. The per capita density of on-premises alcohol outlets did not affect misdemeanor or felony drunk driving charges. The results suggest that temporal alcohol availability may be an impelling factor for first-time drunk driving, but other factors likely influence repeat drunk driving behaviors.	[Schofield, Timothy P.; Denson, Thomas F.] Univ New S Wales, Sch Psychol, Sydney, NSW, Australia	University of New South Wales Sydney	Schofield, TP (corresponding author), Univ New S Wales, Sch Psychol, Sydney, NSW, Australia.	t.schofield@unsw.edu.au	Schofield, Timothy/D-3801-2015; Denson, Thomas F./J-7840-2019	Schofield, Timothy/0000-0002-0357-9607; Denson, Thomas F./0000-0002-9620-4280	Australia's National Health and Medical Research Council [630671]	Australia's National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia)	This research was supported by Project Grant 630671 from Australia's National Health and Medical Research Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Caetano R, 2005, ACCIDENT ANAL PREV, V37, P217, DOI 10.1016/j.aap.2004.07.004; CDC, 2011, DRINK DRIV THREAT EV; Center for Disease Control, 2010, MMWR-MORBID MORTAL W, V60, P1351; DeCoster J, 1998, COMP CORRELATION COE; Division of Criminal Justice Services, AD ARR 2002 2011; Division of Criminal Justice Services, 2009 COUNT VIOL CRIM; Duailibi S, 2007, AM J PUBLIC HEALTH, V97, P2276, DOI 10.2105/AJPH.2006.092684; EHRLICH I, 1973, J POLIT ECON, V81, P521, DOI 10.1086/260058; Empire State Development, PER CAP PERS INC NEW; Escobedo LG, 2002, ACCIDENT ANAL PREV, V34, P689, DOI 10.1016/S0001-4575(01)00068-9; Ferguson SA, 2012, TRAFFIC INJ PREV, V13, P427, DOI 10.1080/15389588.2012.656858; Gruenewald PJ, 2002, J STUD ALCOHOL, V63, P460, DOI 10.15288/jsa.2002.63.460; Kypri K, 2011, ADDICTION, V106, P303, DOI 10.1111/j.1360-0443.2010.03125.x; McMillan GP, 2006, AM J PUBLIC HEALTH, V96, P1944, DOI 10.2105/AJPH.2005.069153; MCMILLEN DL, 1992, ADDICT BEHAV, V17, P407, DOI 10.1016/0306-4603(92)90001-C; Norstrom T, 2005, ADDICTION, V100, P767, DOI 10.1111/j.1360-0443.2005.01068.x; NY Department of Labor, LOC AR UN STAT LAUS; Ponce JD, 2011, ACCIDENT ANAL PREV, V43, P782, DOI 10.1016/j.aap.2010.10.025; RAGNARSDOTTIR T, 2002, PUBLICATION NORDIC C, V42, P145; Romano E, 2010, ALCOBOL HIGHWAY SAFE; Rossow I, 2012, ADDICTION, V107, P530, DOI 10.1111/j.1360-0443.2011.03643.x; Schofield TP, 2013, ALCOHOL ALCOHOLISM, V48, P363, DOI 10.1093/alcalc/agt003; SCRIBNER RA, 1994, J STUD ALCOHOL, V55, P447, DOI 10.15288/jsa.1994.55.447; Scribner RA, 2000, ALCOHOL CLIN EXP RES, V24, P188, DOI 10.1111/j.1530-0277.2000.tb04590.x; STEIGER JH, 1980, PSYCHOL BULL, V87, P245, DOI 10.1037/0033-2909.87.2.245; Stockwell T., 2003, ESSENTIAL HDB TREATM, P213; Stockwell T, 2009, CRIME PREV COMMUNITY, V11, P153, DOI 10.1057/cpcs.2009.11; Treno AJ, 2003, ALCOHOL CLIN EXP RES, V27, P835, DOI 10.1097/01.ALC.0000067979.85714.22; Treno AJ, 2007, ACCIDENT ANAL PREV, V39, P894, DOI 10.1016/j.aap.2006.12.011; US Census Bureau, 2010, AM FACTFINDER TABL Q; US Census Bureau, 2000, AM FACTFINDER TABL G; US Census Bureau, 2000, AM FACTFINDER TABL Q; US Census Bureau, 2009, AM FACTFINDER TABL S; US Census Bureau, 2011, AM FACTFINDER TABL B; Vingilis E, 2006, ACCIDENT ANAL PREV, V38, P63, DOI 10.1016/j.aap.2005.06.023; Vingilis E, 2007, J STUD ALCOHOL DRUGS, V68, P905, DOI 10.15288/jsad.2007.68.905	37	2	2	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2013	8	8							e71169	10.1371/journal.pone.0071169	http://dx.doi.org/10.1371/journal.pone.0071169			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	200ZE	23940711	gold, Green Published			2022-12-25	WOS:000323109700083
J	Lu, YP; Liu, Q; Xu, W; Li, ZJ; Jiang, M; Li, XF; Zhao, N; Liu, W; Sui, Y; Ma, C; Feng, WH; Han, WT; Li, JX				Lu, Yongping; Liu, Qiang; Xu, Wei; Li, Zengjian; Jiang, Miao; Li, Xuefu; Zhao, Ning; Liu, Wei; Sui, Yu; Ma, Chao; Feng, Wenhua; Han, Weitian; Li, Jianxin			TGFA and IRF6 Contribute to the Risk of Nonsyndromic Cleft Lip with or without Cleft Palate in Northeast China	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; FACTOR-ALPHA-GENE; SUSCEPTIBILITY LOCUS; OROFACIAL CLEFTS; CANDIDATE GENES; ORAL CLEFTS; POPULATION; VARIANTS; POLYMORPHISMS; ENVIRONMENT	Nonsyndromic cleft lip with or without cleft palate (NSCL/P) are common birth defects with a complex etiology. Multiple interacting loci and possible environmental factors influence the risk of NSCL/P. 12 single nucleotide polymorphisms (SNPs) in 7 candidate genes were tested using an allele-specific primer extension for case-control and case-parent analyses in northeast China in 236 unrelated patients, 185 mothers and 154 fathers, including 128 complete trios, and 400 control individuals. TGFA and IRF6 genes showed a significant association with NSCL/P. In IRF6, statistical evidence of an association between rs2235371 (p = 0.003), rs2013162 (p < 0.0001) and NSCL/P was observed in case-control analyses. Family based association tests (FBATs) showed over-transmission of the C allele at the rs2235371 polymorphism (p = 0.007). In TGFA, associations between rs3771494, rs3771523 (G3822A), rs11466285 (T3851C) and NSCL/P were observed in case-control and FBAT analyses. Associations between other genes (BCL3, TGFB3, MTHFR, PVRL1 and SUMO1) and NSCL/P were not detected.	[Lu, Yongping; Xu, Wei; Jiang, Miao; Li, Xuefu; Zhao, Ning; Liu, Wei; Sui, Yu; Ma, Chao; Feng, Wenhua; Han, Weitian; Li, Jianxin] Liaoning Prov Res Inst Family Planning, Key Lab Reprod Hlth, Shenyang, Peoples R China; [Liu, Qiang; Li, Zengjian] China Med Univ, Dept Oral Maxillofacial Surg & Plast Surg, Sch Stomatol, Shenyang, Peoples R China	China Medical University	Han, WT (corresponding author), Liaoning Prov Res Inst Family Planning, Key Lab Reprod Hlth, Shenyang, Peoples R China.	hwtzzf@sohu.com; jxinl@vip.sina.com			 [2009225007-7];  [2011010192-401]	; 	The funders of Scientific and Technological Project of Liaoning Province (Grant No. 2009225007-7) played an important role in study design, data analysis, preparation of the manuscript and decision to publish, the Natural Science Foundation of Liaoning Province (Grant No. 2011010192-401) played an important role in the sample collection and diagnosis of the NSCL/P.	Alkuraya FS, 2006, SCIENCE, V313, P1751, DOI 10.1126/science.1128406; ARDINGER HH, 1989, AM J HUM GENET, V45, P348; Avila JR, 2006, AM J MED GENET A, V140A, P2562, DOI 10.1002/ajmg.a.31367; Beaty TH, 2010, NAT GENET, V42, P525, DOI 10.1038/ng.580; Birnbaum S, 2009, EUR J ORAL SCI, V117, P766, DOI 10.1111/j.1600-0722.2009.00680.x; Birnbaum S, 2009, NAT GENET, V41, P473, DOI 10.1038/ng.333; Blanco R, 2004, CLEFT PALATE-CRAN J, V41, P163, DOI 10.1597/02-147; Blanton SH, 2005, AM J MED GENET A, V137A, P259, DOI 10.1002/ajmg.a.30887; Brito LA, 2012, AM J MED GENET A, V158A, P2170, DOI 10.1002/ajmg.a.35526; Butali A, 2013, AM J MED GENET A, V161A, P965, DOI 10.1002/ajmg.a.35749; Carinci F, 2007, INT J PEDIATR OTORHI, V71, P1509, DOI 10.1016/j.ijporl.2007.06.007; Carter TC, 2010, BIRTH DEFECTS RES A, V88, P84, DOI 10.1002/bdra.20639; Dixon MJ, 2011, NAT REV GENET, V12, P167, DOI 10.1038/nrg2933; Erdogan F, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.7.e36; Ghassibe M, 2005, EUR J HUM GENET, V13, P1239, DOI 10.1038/sj.ejhg.5201486; Grant SFA, 2009, J PEDIATR-US, V155, P909, DOI 10.1016/j.jpeds.2009.06.020; Huang Y, 2009, J DENT RES, V88, P715, DOI 10.1177/0022034509341040; Ichikawa E, 2006, J HUM GENET, V51, P38, DOI 10.1007/s10038-005-0319-8; Ingraham CR, 2006, NAT GENET, V38, P1335, DOI 10.1038/ng1903; Jagomagi T, 2010, EUR J ORAL SCI, V118, P213, DOI 10.1111/j.1600-0722.2010.00729.x; Jia ZL, 2010, DNA CELL BIOL, V29, P675, DOI 10.1089/dna.2010.1034; Jugessur A, 2003, AM J EPIDEMIOL, V157, P1083, DOI 10.1093/aje/kwg097; Jugessur A, 2008, GENET EPIDEMIOL, V32, P413, DOI 10.1002/gepi.20314; Leslie EJ, 2012, BIRTH DEFECTS RES A, V94, P934, DOI 10.1002/bdra.23076; Letra A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045441; Li Meng-jie, 2012, Zhonghua Yixue Yichuanxue Zazhi, V29, P149, DOI 10.3760/cma.j.issn.1003-9406.2012.02.007; Ludwig KU, 2012, NAT GENET, V44, P968, DOI 10.1038/ng.2360; Machida J, 1999, GENOMICS, V61, P237, DOI 10.1006/geno.1999.5962; Mangold E, 2010, NAT GENET, V42, P24, DOI 10.1038/ng.506; Moreno LM, 2009, HUM MOL GENET, V18, P4879, DOI 10.1093/hmg/ddp444; Mostowska A, 2010, BIRTH DEFECTS RES A, V88, P538, DOI 10.1002/bdra.20687; MURRAY JC, 1995, AM J HUM GENET, V57, P227, DOI 10.2134/agronj1965.00021962005700020028x; Nikopensius T, 2010, EUR J ORAL SCI, V118, P317, DOI 10.1111/j.1600-0722.2010.00741.x; Park JW, 2007, GENET MED, V9, P219, DOI 10.1097/GIM.0b013e3180423cca; Pauws E, 2007, TRENDS GENET, V23, P631, DOI 10.1016/j.tig.2007.09.002; Richardson RJ, 2006, NAT GENET, V38, P1329, DOI 10.1038/ng1894; Rojas-Martinez A, 2010, BIRTH DEFECTS RES A, V88, P535, DOI 10.1002/bdra.20689; Scapoli L, 2005, AM J HUM GENET, V76, P180, DOI 10.1086/427344; Schliekelman P, 2002, AM J HUM GENET, V71, P1369, DOI 10.1086/344779; SHIANG R, 1993, AM J HUM GENET, V53, P836; Song T, 2008, BIOCHEM BIOPH RES CO, V377, P1265, DOI 10.1016/j.bbrc.2008.10.138; Srichomthong C, 2005, J MED GENET, V42, DOI 10.1136/jmg.2005.032235; STEIN J, 1995, AM J HUM GENET, V57, P257; Sull JW, 2009, HUM GENET, V126, P385, DOI 10.1007/s00439-009-0680-3; Vieira AR, 2006, AM J EPIDEMIOL, V163, P790, DOI 10.1093/aje/kwj103; Vieira AR, 2003, J DENT RES, V82, P289, DOI 10.1177/154405910308200409; Wu T, 2010, HUM GENET, V128, P401, DOI 10.1007/s00439-010-0863-y; Yeetong P, 2009, AM J MED GENET A, V149A, P2489, DOI 10.1002/ajmg.a.33048; Zucchero TM, 2004, NEW ENGL J MED, V351, P769, DOI 10.1056/NEJMoa032909	49	11	16	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2013	8	8							e70754	10.1371/journal.pone.0070754	http://dx.doi.org/10.1371/journal.pone.0070754			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	217ZG	23940636	Green Published, gold, Green Submitted			2022-12-25	WOS:000324401500050
J	Talluri, S; Francis, SM; Dick, FA				Talluri, Srikanth; Francis, Sarah M.; Dick, Frederick A.			Mutation of the LXCXE Binding Cleft of pRb Facilitates Transformation by ras In Vitro but Does Not Promote Tumorigenesis In Vivo	PLOS ONE			English	Article							ONCOGENE-INDUCED SENESCENCE; DAMAGE SIGNALING PATHWAY; HUMAN LUNG-CANCER; CELLULAR SENESCENCE; RETINOBLASTOMA PROTEIN; K-RAS; SKIN CARCINOGENESIS; MOUSE MODELS; HA-RAS; RB	Background: The Retinoblastoma protein (pRB) is a key tumor suppressor that is functionally inactivated in most cancers. pRB regulates the cell division cycle and cell cycle exit through protein-protein interactions mediated by its multiple binding interfaces. The LXCXE binding cleft region of pRB mediates interactions with cellular proteins that have chromatin regulatory functions. Chromatin regulation mediated by pRB is required for a stress responsive cell cycle arrest, including oncogene induced senescence. The in vivo role of chromatin regulation by pRB during senescence, and its relevance to cancer is not clear. Methodology/Principal Findings: Using gene-targeted mice, uniquely defective for pRB mediated chromatin regulation, we investigated its role during transformation and tumor progression in response to activation of oncogenic ras. We report that the pRB(Delta L) mutation confers susceptibility to escape from HrasV12 induced senescence and allows transformation in vitro, although these cells possess high levels of DNA damage. Intriguingly, LSL-Kras, Rb1(Delta L/Delta L) mice show delayed lung tumor formation compared to controls. This is likely due to the increased apoptosis seen in the early hyperplastic lesions shortly following ras activation that inhibits tumor progression. Furthermore, DMBA treatment to induce sporadic ras mutations in other tissues also failed to reveal greater susceptibility to cancer in Rb1(Delta L/Delta L) mice. Conclusions/Significance: Our data suggests that chromatin regulation by pRB can function to limit proliferation, but its loss fails to contribute to cancer susceptibility in ras driven tumor models because of elevated levels of DNA damage and apoptosis.	[Talluri, Srikanth; Francis, Sarah M.; Dick, Frederick A.] Univ Western Ontario, London Reg Canc Program, London, ON, Canada; [Dick, Frederick A.] Univ Western Ontario, Childrens Hlth Res Inst, London, ON, Canada; [Talluri, Srikanth; Francis, Sarah M.; Dick, Frederick A.] Univ Western Ontario, Dept Biochem, London, ON, Canada	Western University (University of Western Ontario); Western University (University of Western Ontario); Western University (University of Western Ontario)	Dick, FA (corresponding author), Univ Western Ontario, London Reg Canc Program, London, ON, Canada.	fdick@uwo.ca			Canadian Cancer Society Research Institute [700720]	Canadian Cancer Society Research Institute(Canadian Cancer Society (CCS))	This work was supported by the Canadian Cancer Society Research Institute, grant number 700720. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartkova J, 2006, NATURE, V444, P633, DOI 10.1038/nature05268; Bernardi R, 2003, ONCOGENE, V22, P9048, DOI 10.1038/sj.onc.1207106; Braig M, 2005, NATURE, V436, P660, DOI 10.1038/nature03841; Campisi J, 2001, TRENDS CELL BIOL, V11, pS27, DOI 10.1016/S0962-8924(01)02151-1; Campisi J, 2005, CELL, V120, P513, DOI 10.1016/j.cell.2005.02.003; Campisi J, 2007, NAT REV MOL CELL BIO, V8, P729, DOI 10.1038/nrm2233; Chandra T, 2012, MOL CELL, V47, P203, DOI 10.1016/j.molcel.2012.06.010; Chen ZB, 2005, NATURE, V436, P725, DOI 10.1038/nature03918; Collado M, 2010, NAT REV CANCER, V10, P51, DOI 10.1038/nrc2772; Coschi CH, 2010, GENE DEV, V24, P1351, DOI 10.1101/gad.1917610; Dankort D, 2007, GENE DEV, V21, P379, DOI 10.1101/gad.1516407; de Stanchina E, 2004, MOL CELL, V13, P523, DOI 10.1016/S1097-2765(04)00062-0; Di Micco R, 2006, NATURE, V444, P638, DOI 10.1038/nature05327; Di Micco R, 2011, NAT CELL BIOL, V13, P292, DOI 10.1038/ncb2170; Dick FA, 2013, NAT REV MOL CELL BIO, V14, P297, DOI 10.1038/nrm3567; DuPage M, 2009, NAT PROTOC, V4, P1064, DOI 10.1038/nprot.2009.95; Ferbeyre G, 2000, GENE DEV, V14, P2015; Lara MF, 2007, MOL CARCINOGEN, V46, P618, DOI 10.1002/mc.20338; Fikaris AJ, 2006, J BIOL CHEM, V281, P34759, DOI 10.1074/jbc.M606737200; Francis SM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016434; Goel VK, 2009, ONCOGENE, V28, P2289, DOI 10.1038/onc.2009.95; Herbst RS, 2008, NEW ENGL J MED, V359, P1367, DOI 10.1056/NEJMra0802714; Ho VM, 2009, ONCOGENE, V28, P1393, DOI 10.1038/onc.2008.491; Hurford RK, 1997, GENE DEV, V11, P1447, DOI 10.1101/gad.11.11.1447; Isaac CE, 2006, MOL CELL BIOL, V26, P3659, DOI 10.1128/MCB.26.9.3659-3671.2006; Jackson EL, 2001, GENE DEV, V15, P3243, DOI 10.1101/gad.943001; Jemal A, 2008, CA-CANCER J CLIN, V58, P71, DOI 10.3322/CA.2007.0010; Mallette FA, 2007, CELL CYCLE, V6, P1831, DOI 10.4161/cc.6.15.4516; Mallette FA, 2007, GENE DEV, V21, P43, DOI 10.1101/gad.1487307; Meuwissen R, 2005, GENE DEV, V19, P643, DOI 10.1101/gad.1284505; Meuwissen R, 2001, ONCOGENE, V20, P6551, DOI 10.1038/sj.onc.1204837; Michaloglou C, 2005, NATURE, V436, P720, DOI 10.1038/nature03890; Narita M, 2003, CELL, V113, P703, DOI 10.1016/S0092-8674(03)00401-X; Narita M, 2007, BRIT J CANCER, V96, P686, DOI 10.1038/sj.bjc.6603636; Nikitin AY, 2004, CANCER RES, V64, P2307, DOI 10.1158/0008-5472.CAN-03-3376; Pazzaglia S, 2001, MOL CARCINOGEN, V30, P111, DOI 10.1002/1098-2744(200102)30:2<111::AID-MC1019>3.0.CO;2-L; QUINTANILLA M, 1986, NATURE, V322, P78, DOI 10.1038/322078a0; RODENHUIS S, 1990, AM REV RESPIR DIS, V142, pS27, DOI 10.1164/ajrccm/142.6_Pt_2.S27; Sarkisian CJ, 2007, NAT CELL BIOL, V9, P493, DOI 10.1038/ncb1567; Serrano M, 1997, CELL, V88, P593, DOI 10.1016/S0092-8674(00)81902-9; Sherr CJ, 2002, CANCER CELL, V2, P103, DOI 10.1016/S1535-6108(02)00102-2; Talluri S, 2010, MOL CELL BIOL, V30, P948, DOI 10.1128/MCB.01168-09; Wistuba II, 2001, SEMIN ONCOL, V28, P3, DOI 10.1053/sonc.2001.25738	43	7	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2013	8	8							e72236	10.1371/journal.pone.0072236	http://dx.doi.org/10.1371/journal.pone.0072236			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	217ZG	23936539	Green Published, gold, Green Submitted			2022-12-25	WOS:000324401500089
J	Wong, YF; Jakt, LM; Nishikawa, SI				Wong, Yan-Fung; Jakt, Lars Martin; Nishikawa, Shin-Ichi			Prolonged Treatment with DNMT Inhibitors Induces Distinct Effects in Promoters and Gene-Bodies	PLOS ONE			English	Article							ISLAND METHYLATOR PHENOTYPE; GENOME-WIDE ANALYSIS; DNA METHYLATION; MYELODYSPLASTIC SYNDROME; DECITABINE TREATMENT; TUMOR-SUPPRESSOR; CANCER; DEMETHYLATION; AZACITIDINE; EXPRESSION	Treatment with the demethylating drugs 5-azacytidine (AZA) and decitabine (DAC) is now recognised as an effective therapy for patients with Myelodysplastic Syndromes (MDS), a range of disorders arising in clones of hematopoietic progenitor cells. A variety of cell models have been used to study the effect of these drugs on the methylation of promoter regions of tumour suppressor genes, with recent efforts focusing on the ability of these drugs to inhibit DNA methylation at low doses. However, it is still not clear how nano-molar drug treatment exerts its effects on the methylome. In this study, we have characterised changes in DNA methylation caused by prolonged low-dose treatment in a leukemic cell model (SKM-1), and present a genome-wide analysis of the effects of AZA and DAC. At nano-molar dosages, a one-month continuous treatment halved the total number of hypermethylated probes in leukemic cells and our analysis identified 803 candidate regions with significant demethylation after treatment. Demethylated regions were enriched in promoter sequences whereas gene-body CGIs were more resistant to the demethylation process. CGI methylation in promoters was strongly correlated with gene expression but this correlation was lost after treatment. Our results indicate that CGI demethylation occurs preferentially at promoters, but that it is not generally sufficient to modify expression patterns, and emphasises the roles of other means of maintaining cell state.	[Wong, Yan-Fung; Jakt, Lars Martin; Nishikawa, Shin-Ichi] RIKEN Ctr Dev Biol, Lab Stem Cell Biol, Kobe, Hyogo, Japan	RIKEN	Wong, YF (corresponding author), RIKEN Ctr Dev Biol, Lab Stem Cell Biol, Kobe, Hyogo, Japan.	fung@cdb.riken.jp		Jakt, Lars Martin/0000-0002-3787-8138; Wong, Yan Fung/0000-0003-3072-4424	Ministry of Education, Culture, Sports, Science and Technology of Japan [20229005]	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	Grants-in-Aid for Scientific Research (S) (20229005) from the Ministry of Education, Culture, Sports, Science and Technology of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bashtrykov P, 2012, CHEM BIOL, V19, P572, DOI 10.1016/j.chembiol.2012.03.010; Baylin SB, 2000, TRENDS GENET, V16, P168, DOI 10.1016/S0168-9525(99)01971-X; Bejar R, 2011, J CLIN ONCOL, V29, P504, DOI 10.1200/JCO.2010.31.1175; Chen MY, 2011, CANCER-AM CANCER SOC, V117, P4424, DOI 10.1002/cncr.26073; Daskalakis M, 2002, BLOOD, V100, P2957, DOI 10.1182/blood.V100.8.2957; Egger G, 2004, NATURE, V429, P457, DOI 10.1038/nature02625; Esteller M, 2007, HUM MOL GENET, V16, pR50, DOI 10.1093/hmg/ddm018; Figueroa ME, 2009, BLOOD, V114, P3448, DOI 10.1182/blood-2009-01-200519; Flotho C, 2009, LEUKEMIA, V23, P1019, DOI 10.1038/leu.2008.397; Foran JM, 2012, AM J MED, V125, pS6, DOI 10.1016/j.amjmed.2012.04.015; Gautier L, 2004, BIOINFORMATICS, V20, P307, DOI 10.1093/bioinformatics/btg405; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Ghoshal K, 2005, MOL CELL BIOL, V25, P4727, DOI 10.1128/MCB.25.11.4727-4741.2005; Gingras MC, 2002, MOL IMMUNOL, V38, P817, DOI 10.1016/S0161-5890(02)00004-4; Heyn H, 2012, NAT REV GENET, V13, P679, DOI 10.1038/nrg3270; Hollenbach PW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009001; Huong TTT, 2011, J KOREAN MED SCI, V26, P207, DOI 10.3346/jkms.2011.26.2.207; Irizarry RA, 2008, GENOME RES, V18, P780, DOI 10.1101/gr.7301508; Itzykson R, 2011, B CANCER, V98, P927, DOI 10.1684/bdc.2011.1411; Jiang Y, 2009, BLOOD, V113, P1315, DOI 10.1182/blood-2008-06-163246; Jin BL, 2012, CELL REP, V2, P1411, DOI 10.1016/j.celrep.2012.10.017; Kantarjian H, 2006, CANCER-AM CANCER SOC, V106, P1794, DOI 10.1002/cncr.21792; Kinney SRM, 2013, ADV EXP MED BIOL, V754, P57, DOI 10.1007/978-1-4419-9967-2_3; Klco JM, 2013, BLOOD, V121, P1633, DOI 10.1182/blood-2012-09-459313; Klesney-Tait J, 2006, NAT IMMUNOL, V7, P1266, DOI 10.1038/ni1411; Kumaki Y, 2008, NUCLEIC ACIDS RES, V36, pW170, DOI 10.1093/nar/gkn294; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Li LC, 2002, BIOINFORMATICS, V18, P1427, DOI 10.1093/bioinformatics/18.11.1427; McDevitt MA, 2012, SEMIN ONCOL, V39, P109, DOI 10.1053/j.seminoncol.2011.11.003; Mossman D, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-366; NAKAGAWA T, 1993, BRIT J HAEMATOL, V85, P469; Negrotto S, 2012, LEUKEMIA, V26, P244, DOI 10.1038/leu.2011.207; Pandiyan K, 2013, NUCLEIC ACIDS RES, V41, P3973, DOI 10.1093/nar/gkt077; Patel K, 2010, NUCLEIC ACIDS RES, V38, P4313, DOI 10.1093/nar/gkq187; Sanada M, 2009, NATURE, V460, P904, DOI 10.1038/nature08240; Saxonov S, 2006, P NATL ACAD SCI USA, V103, P1412, DOI 10.1073/pnas.0510310103; Si J, 2010, CANCER RES, V70, P6968, DOI 10.1158/0008-5472.CAN-09-4474; Silverman LR, 2002, J CLIN ONCOL, V20, P2429, DOI 10.1200/JCO.2002.04.117; Stathis A, 2011, CLIN CANCER RES, V17, P1582, DOI 10.1158/1078-0432.CCR-10-1893; Stresemann C, 2008, MOL CANCER THER, V7, P2998, DOI 10.1158/1535-7163.MCT-08-0411; Toyota M, 1999, P NATL ACAD SCI USA, V96, P8681, DOI 10.1073/pnas.96.15.8681; Tsai HC, 2012, CANCER CELL, V21, P430, DOI 10.1016/j.ccr.2011.12.029; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Venables W.N., 2002, MODERN APPL STAT S, V4th ed, DOI DOI 10.1007/978-0-387-21706-2; Venter JC, 2001, SCIENCE, V291, P1304, DOI 10.1126/science.1058040; Weisenberger DJ, 2006, NAT GENET, V38, P787, DOI 10.1038/ng1834; Williams K, 2012, EMBO REP, V13, P28, DOI 10.1038/embor.2011.233; Williams K, 2011, NATURE, V473, P343, DOI 10.1038/nature10066; Wu H, 2011, GENE DEV, V25, P679, DOI 10.1101/gad.2036011; Yang YT, 2009, NEOPLASIA, V11, P552, DOI 10.1593/neo.09204	50	14	15	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2013	8	8							e71099	10.1371/journal.pone.0071099	http://dx.doi.org/10.1371/journal.pone.0071099			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	217ZG	23940695	Green Published, gold, Green Submitted			2022-12-25	WOS:000324401500059
J	Bliss-Moreau, E; Machado, CJ; Amaral, DG				Bliss-Moreau, Eliza; Machado, Christopher J.; Amaral, David G.			Macaque Cardiac Physiology Is Sensitive to the Valence of Passively Viewed Sensory Stimuli	PLOS ONE			English	Article							HEART-RATE-VARIABILITY; RESPIRATORY SINUS ARRHYTHMIA; RHESUS-MONKEYS; STRESS REACTIVITY; MACACA-MULATTA; MALE MIGRATION; VAGAL CONTROL; RESPONSES; EMOTION; ANXIETY	Autonomic nervous system activity is an important component of affective experience. We demonstrate in the rhesus monkey that both the sympathetic and parasympathetic branches of the autonomic nervous system respond differentially to the affective valence of passively viewed video stimuli. We recorded cardiac impedance and an electrocardiogram while adult macaques watched a series of 300 30-second videos that varied in their affective content. We found that sympathetic activity (as measured by cardiac pre-ejection period) increased and parasympathetic activity (as measured by respiratory sinus arrhythmia) decreased as video content changes from positive to negative. These findings parallel the relationship between autonomic nervous system responsivity and valence of stimuli in humans. Given the relationship between human cardiac physiology and affective processing, these findings suggest that macaque cardiac physiology may be an index of affect in nonverbal animals.	[Bliss-Moreau, Eliza; Machado, Christopher J.; Amaral, David G.] Univ Calif Davis, Dept Psychiat & Behav Sci, Sacramento, CA 95817 USA; [Bliss-Moreau, Eliza; Machado, Christopher J.; Amaral, David G.] Calif Natl Primate Res Ctr, Davis, CA USA; [Amaral, David G.] Univ Calif Davis, MIND Inst, Sacramento, CA 95817 USA; [Amaral, David G.] Univ Calif Davis, Ctr Neurosci, Davis, CA 95616 USA	University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis	Bliss-Moreau, E (corresponding author), Univ Calif Davis, Dept Psychiat & Behav Sci, Sacramento, CA 95817 USA.	eblissmoreau@ucdavis.edu			National Institutes of Health [F32MH087067, K99MH083883, R37MH57502]; California National Primate Research Center [RR00169]; NATIONAL CENTER FOR RESEARCH RESOURCES [P51RR000169] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [K99MH083883, F32MH087067, R37MH057502] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P51OD011107] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); California National Primate Research Center; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	Preparation of this manuscript was supported by National Institutes of Health funding to EBM (F32MH087067), CJM (K99MH083883), DGA (R37MH57502), and the California National Primate Research Center (RR00169). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLEN ML, 1981, AM J PRIMATOL, V1, P15, DOI 10.1002/ajp.1350010104; [Anonymous], 2000, HDB PSYCHOPHYSIOLOGY, DOI DOI 10.3109/07853890008995935; Aureli F, 1999, J COMP PSYCHOL, V113, P59, DOI 10.1037/0735-7036.113.1.59; Bauman M. D., 2008, HDB DEV COGNITIVE NE, P161; Berntson G. G., 2000, HDB PSYCHOPHYSIOLOGY, V2nd, P459; Berntson GG, 1996, BIOL PSYCHOL, V44, P1, DOI 10.1016/S0301-0511(96)05197-6; Berntson GG, 1997, PSYCHOPHYSIOLOGY, V34, P623, DOI 10.1111/j.1469-8986.1997.tb02140.x; BERNTSON GG, 1991, PSYCHOL REV, V98, P459, DOI 10.1037/0033-295X.98.4.459; Bliss-Moreau E, 2011, BEHAV NEUROSCI, V125, P848, DOI 10.1037/a0025757; Bowers CL, 1998, AM J PRIMATOL, V45, P245, DOI 10.1002/(SICI)1098-2345(1998)45:3<245::AID-AJP2>3.0.CO;2-W; Bradley MM, 2001, EMOTION, V1, P276, DOI 10.1037//1528-3542.1.3.276; Cacioppo J.T., 2000, HDB EMOTIONS, P173, DOI DOI 10.1017/CBO9780511546396.025; Cannon WB., BODILY CHANGES PAIN, DOI [10.1037/10013-000, DOI 10.1037/10013-000]; Capitanio JP, 2008, LANCET, V371, P1126, DOI 10.1016/S0140-6736(08)60489-4; Capitanio JP, 2002, PRIMATES, V43, P169, DOI 10.1007/BF02629645; De Waal FBM, 2003, ANN NY ACAD SCI, V1000, P7, DOI 10.1196/annals.1280.003; Doyle LA, 2008, AM J PRIMATOL, V70, P542, DOI 10.1002/ajp.20526; Duchowski A., 2007, EYE TRACKING METHODO; Flack JC, 2005, AM NAT, V165, pE126, DOI 10.1086/429277; GROSS JJ, 1995, COGNITION EMOTION, V9, P87, DOI 10.1080/02699939508408966; Hofmann SG, 2005, EMOTION, V5, P464, DOI 10.1037/1528-3542.5.4.464; Houtveen JH, 2002, PSYCHOPHYSIOLOGY, V39, P427, DOI 10.1017/S0048577202394022; James W., 1884, MIND, V9, P34, DOI [10.1093/mind/os-IX.34.188, DOI 10.1093/MIND/OS-IX.34.188]; Kreibig SD, 2010, BIOL PSYCHOL, V84, P394, DOI 10.1016/j.biopsycho.2010.03.010; Kuraoka K, 2011, PHYSIOL BEHAV, V102, P347, DOI 10.1016/j.physbeh.2010.11.029; Laine CM, 2009, J NEUROPHYSIOL, V101, P1749, DOI 10.1152/jn.91110.2008; LANG PJ, 1993, PSYCHOPHYSIOLOGY, V30, P261, DOI 10.1111/j.1469-8986.1993.tb03352.x; LIBBY WL, 1973, PSYCHOPHYSIOLOGY, V10, P270, DOI 10.1111/j.1469-8986.1973.tb00526.x; Licht CMM, 2009, PSYCHOSOM MED, V71, P508, DOI 10.1097/PSY.0b013e3181a292a6; Licht CMM, 2008, ARCH GEN PSYCHIAT, V65, P1358, DOI 10.1001/archpsyc.65.12.1358; Machado CJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026598; Machado CJ, 2011, AM J PRIMATOL, V73, P562, DOI 10.1002/ajp.20928; Mauss I, 2009, COGNITION EMOTION, V23, P209, DOI 10.1080/02699930802204677; MELNICK DJ, 1984, AM J PRIMATOL, V7, P229, DOI 10.1002/ajp.1350070303; Mendes W. B., 2011, STEREOTYPE THREAT TH, P51; Mendes W.B., 2009, METHODS SOCIAL NEURO, P118; Mosher CP, 2011, BEHAV NEUROSCI, V125, P639, DOI 10.1037/a0024264; Nakayama K, 2005, PHYSIOL BEHAV, V84, P783, DOI 10.1016/j.physbeh.2005.03.009; Novak MA, 2003, AM J PRIMATOL, V59, P3, DOI 10.1002/ajp.10063; Oveis C, 2009, EMOTION, V9, P265, DOI 10.1037/a0015383; Parr LA, 2002, BEHAV NEUROSCI, V116, P378, DOI 10.1037//0735-7044.116.3.378; Pattyn N, 2010, PHYSIOL BEHAV, V101, P218, DOI 10.1016/j.physbeh.2010.04.037; PHILIPPOT P, 1993, COGNITION EMOTION, V7, P171, DOI 10.1080/02699939308409183; Platt DM, 1997, APPL ANIM BEHAV SCI, V52, P139, DOI 10.1016/S0168-1591(96)01093-3; PLIMPTON EH, 1981, DEV PSYCHOBIOL, V14, P109, DOI 10.1002/dev.420140204; Porges SW, 2007, BIOL PSYCHOL, V74, P116, DOI 10.1016/j.biopsycho.2006.06.009; Quigley KS, 2006, PSYCHOPHYSIOLOGY, V43, P357, DOI 10.1111/j.1469-8986.2006.00405.x; Quigley KS, 2013, HDB RES MET IN PRESS; Raudenbush SW, 2004, SSI; SHERWOOD A, 1992, PSYCHOPHYSIOLOGY, V29, P734; Shively CA, 2007, PSYCHOPHARMACOLOGY, V192, P183, DOI 10.1007/s00213-007-0709-z; Stuiver A, 2012, INT J PSYCHOPHYSIOL, V85, P153, DOI 10.1016/j.ijpsycho.2012.06.003; Tomaka J, 1997, MOTIV EMOTION, V21, P275, DOI 10.1023/A:1024414005745; Tomasello M, 1997, PRIMATE COGNITION; VANNOORDWIJK MA, 1985, ANIM BEHAV, V33, P849, DOI 10.1016/S0003-3472(85)80019-1; Watkins LL, 1998, PSYCHOSOM MED, V60, P498, DOI 10.1097/00006842-199807000-00018; Wetzel JM, 2006, J PSYCHOPHYSIOL, V20, P276, DOI 10.1027/0269-8803.20.4.276; WOOD BS, 1979, J COMP PHYSIOL PSYCH, V93, P368, DOI 10.1037/h0077561	58	19	19	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2013	8	8							e71170	10.1371/journal.pone.0071170	http://dx.doi.org/10.1371/journal.pone.0071170			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	218XC	23940712	Green Published, Green Submitted, gold			2022-12-25	WOS:000324465000188
J	Crow, AR; Yu, HH; Han, DJ; Lazarus, AH				Crow, Andrew R.; Yu, Honghui; Han, Dongji; Lazarus, Alan H.			Amelioration of Murine Passive Immune Thrombocytopenia by IVIg and a Therapeutic Monoclonal CD44 Antibody Does Not Require the Myd88 Signaling Pathway	PLOS ONE			English	Article							TOLL-LIKE RECEPTOR; B-CELLS; IMMUNOGLOBULIN-G; MEDIATED AMELIORATION; DENDRITIC CELLS; MICE; COMPLEXES; IGG; ITP; LIPOPOLYSACCHARIDE	Immune thrombocytopenia (ITP) is an autoimmune bleeding disorder characterized by a low platelet count and the production of anti-platelet antibodies. The majority of ITP patients have antibodies to platelet integrin alpha(IIb)beta(3) (GPIIbIIIa) which can direct platelet phagocytosis by macrophages. One effective treatment for patients with ITP is intravenous immunoglobulin (IVIg) which rapidly reverses thrombocytopenia. The exact mechanism of IVIg action in human patients is unclear, although in mouse models of passive ITP, IVIg can rapidly increase platelet counts in the absence of adaptive immunity. Another antibody therapeutic that can similarly increase platelet counts independent of adaptive immunity are CD44 antibodies. Toll-like receptors (TLRs) are pattern recognition receptors which play a central role in helping direct the innate immune system. Dendritic cells, which are notable for their expression of TLRs, have been directly implicated in IVIg function as an initiator cell, while CD44 can associate with TLR2 and TLR4. We therefore questioned whether IVIg, or the therapeutic CD44 antibody KM114, mediate their ameliorative effects in a manner dependent upon normal TLR function. Here, we demonstrate that the TLR4 agonist LPS does not inhibit IVIg or KM114 amelioration of antibody-induced thrombocytopenia, and that these therapeutics do not ameliorate LPS-induced thrombocytopenia. IVIg was able to significantly ameliorate murine ITP in C3H/HeJ mice which have defective TLR4. All known murine TLRs except TLR3 utilize the Myd88 adapter protein to drive TLR signaling. Employing Myd88 deficient mice, we found that both IVIg and KM114 ameliorate murine ITP in Myd88 deficient mice to the same extent as normal mice. Thus both IVIg and anti-CD44 antibody can mediate their ameliorative effects in murine passive ITP independent of the Myd88 signaling pathway. These data help shed light on the mechanism of action of IVIg and KM114 in the amelioration of murine ITP.	[Crow, Andrew R.; Yu, Honghui; Lazarus, Alan H.] Canadian Blood Serv, Toronto, ON, Canada; [Crow, Andrew R.; Yu, Honghui; Han, Dongji; Lazarus, Alan H.] St Michaels Hosp, Li Ka Shing Knowledge Inst, Dept Lab Med, Toronto, ON M5B 1W8, Canada; [Crow, Andrew R.; Yu, Honghui; Han, Dongji; Lazarus, Alan H.] St Michaels Hosp, Li Ka Shing Knowledge Inst, Keenan Res Ctr, Toronto, ON M5B 1W8, Canada; [Yu, Honghui; Han, Dongji] Huazhong Univ Sci & Technol, Tongji Hosp, Dept Anesthesiol, Wuhan 430074, Peoples R China; [Lazarus, Alan H.] Univ Toronto, Dept Med, Toronto, ON, Canada; [Lazarus, Alan H.] Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON, Canada	Canadian Blood Services; University of Toronto; Li Ka Shing Knowledge Institute; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Toronto; Li Ka Shing Knowledge Institute; University Toronto Affiliates; Saint Michaels Hospital Toronto; Huazhong University of Science & Technology; University of Toronto; University of Toronto	Lazarus, AH (corresponding author), Canadian Blood Serv, Toronto, ON, Canada.	lazarusa@smh.ca		Lazarus, Alan/0000-0002-5051-6916; Crow, Andrew R/0000-0001-6978-4999	CBS/CIHR [FRN6897]	CBS/CIHR(Canadian Institutes of Health Research (CIHR))	This work was supported by a grant from the CBS/CIHR partnership fund to AHL, #FRN6897 (CBS: www.blood.ca; CIHR: http://www.cihr-irsc.gc.ca/e/193.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adachi O, 1998, IMMUNITY, V9, P143, DOI 10.1016/S1074-7613(00)80596-8; Ambarus CA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035994; Anthony RM, 2011, NATURE, V475, P110, DOI 10.1038/nature10134; Arnson Y, 2009, AUTOIMMUNITY, V42, P553, DOI 10.1080/08916930902785363; Ballow M, 2011, CLIN IMMUNOL, V139, P208, DOI 10.1016/j.clim.2011.02.006; Bayry J, 2003, BLOOD, V101, P758, DOI 10.1182/blood-2002-05-1447; Bazin R, 2006, BRIT J HAEMATOL, V135, P97, DOI 10.1111/j.1365-2141.2006.06245.x; Bourguignon LYW, 2011, CYTOSKELETON, V68, P671, DOI 10.1002/cm.20544; Crow AR, 2009, J THROMB HAEMOST, V7, P245, DOI 10.1111/j.1538-7836.2009.03420.x; Crow AR, 2007, BLOOD, V109, P155, DOI 10.1182/blood-2006-05-023796; Crow AR, 2011, BLOOD, V118, P6403, DOI 10.1182/blood-2011-08-374223; Crow AR, 2011, BLOOD, V117, P971, DOI 10.1182/blood-2010-05-280115; Crow AR, 2001, BRIT J HAEMATOL, V115, P679, DOI 10.1046/j.1365-2141.2001.03136.x; DiMartino SJ, 2008, CLIN IMMUNOL, V127, P56, DOI 10.1016/j.clim.2007.11.014; Go RS, 2007, HAEMATOLOGICA, V92, P283, DOI 10.3324/haematol.10667; Hoshino K, 1999, J IMMUNOL, V162, P3749; Huang HS, 2010, BLOOD, V116, P5002, DOI 10.1182/blood-2010-03-275123; Jain A, 2012, ARTHRITIS RES THER, V14, DOI 10.1186/ar4024; Kawai T, 1999, IMMUNITY, V11, P115, DOI 10.1016/S1074-7613(00)80086-2; Kawana H, 2008, J IMMUNOL, V180, P4235, DOI 10.4049/jimmunol.180.6.4235; Kessel A, 2011, J CLIN IMMUNOL, V31, P30, DOI 10.1007/s10875-010-9469-3; Kondo T, 2012, TRENDS IMMUNOL, V33, P449, DOI 10.1016/j.it.2012.05.002; Lazarus AH, 2010, J CLIN IMMUNOL, V30, pS20, DOI 10.1007/s10875-010-9410-9; Leadbetter EA, 2002, NATURE, V416, P603, DOI 10.1038/416603a; Lee CC, 2012, NAT REV IMMUNOL, V12, P168, DOI 10.1038/nri3151; Li Z, 2009, BLOOD, V113, P6051, DOI 10.1182/blood-2008-07-170571; Lin IC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038635; Maddur MS, 2013, J CLIN IMMUNOL, V33, pS62, DOI 10.1007/s10875-012-9752-6; Maddur MS, 2012, AM J PATHOL, V181, P8, DOI 10.1016/j.ajpath.2012.03.044; Maddur MS, 2011, AUTOIMMUN REV, V11, P154, DOI 10.1016/j.autrev.2011.08.004; Maddur MS, 2011, J ALLERGY CLIN IMMUN, V127, P823, DOI 10.1016/j.jaci.2010.12.1102; Mills KHG, 2011, NAT REV IMMUNOL, V11, P807, DOI 10.1038/nri3095; Murakami K, 2012, N-S ARCH PHARMACOL, V385, P891, DOI 10.1007/s00210-012-0765-8; Nakano S, 2008, RHEUMATOLOGY, V47, P145, DOI 10.1093/rheumatology/kem327; Nieswandt B, 2000, BLOOD, V96, P2520; Ohkuma K, 2007, CLIN EXP IMMUNOL, V150, P397, DOI 10.1111/j.1365-2249.2007.03496.x; Olsson B, 2003, NAT MED, V9, P1123, DOI 10.1038/nm921; Othy S, 2012, J AUTOIMMUN, V39, P168, DOI 10.1016/j.jaut.2012.05.013; Papadimitraki ED, 2007, J AUTOIMMUN, V29, P310, DOI 10.1016/j.jaut.2007.09.001; Papadimitraki ED, 2006, ARTHRITIS RHEUM-US, V54, P3601, DOI 10.1002/art.22197; Poltorak A, 1998, SCIENCE, V282, P2085, DOI 10.1126/science.282.5396.2085; Qureshi ST, 1999, J EXP MED, V189, P615, DOI 10.1084/jem.189.4.615; Richez C, 2011, JOINT BONE SPINE, V78, P124, DOI 10.1016/j.jbspin.2010.09.005; Rittirsch D, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000464; Schnare M, 2000, CURR BIOL, V10, P1139, DOI 10.1016/S0960-9822(00)00700-4; Semple JW, 2002, BLOOD REV, V16, P9, DOI 10.1054/blre.2001.0172; Shioji K, 2001, CIRC RES, V89, P540, DOI 10.1161/hh1801.096263; Siragam V, 2005, J CLIN INVEST, V115, P155, DOI 10.1172/JCI200522753; Siragam V, 2006, NAT MED, V12, P688, DOI 10.1038/nm1416; Sokolove J, 2011, ARTHRITIS RHEUM-US, V63, P53, DOI 10.1002/art.30081; Song S, 2003, BLOOD, V101, P3708, DOI 10.1182/blood-2002-10-3078; Taylor KR, 2007, J BIOL CHEM, V282, P18265, DOI 10.1074/jbc.M606352200; Tha-In T, 2008, TRENDS IMMUNOL, V29, P608, DOI 10.1016/j.it.2008.08.004; Trepanier P, 2012, BLOOD, V120, P2769, DOI 10.1182/blood-2012-07-445007; Webster ML, 2006, BLOOD, V108, P943, DOI 10.1182/blood-2005-06-009761; Yang Q, 2011, THROMB RES, V128, P237, DOI 10.1016/j.thromres.2011.02.024; Yu HM, 2011, EUR J HAEMATOL, V86, P67, DOI 10.1111/j.1600-0609.2010.01534.x; Zhang GY, 2009, J IMMUNOL, V182, P7997, DOI 10.4049/jimmunol.0802884; Zhang Y, 2009, J IMMUNOL, V182, P554, DOI 10.4049/jimmunol.182.1.554	59	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2013	8	8							e71882	10.1371/journal.pone.0071882	http://dx.doi.org/10.1371/journal.pone.0071882			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	218XC	23940791	gold, Green Published, Green Submitted			2022-12-25	WOS:000324465000230
J	Hudson, AG; Parrott, BB; Qian, Y; Schulz, C				Hudson, Alicia G.; Parrott, Benjamin B.; Qian, Yue; Schulz, Cordula			A Temporal Signature of Epidermal Growth Factor Signaling Regulates the Differentiation of Germline Cells in Testes of Drosophila melanogaster	PLOS ONE			English	Article							BAG-OF-MARBLES; MESENCHYMAL STEM-CELLS; SOMATIC SUPPORT CELLS; SELF-RENEWAL; GENE-EXPRESSION; ECTOPIC ACTIVATION; RECEPTOR PATHWAY; PROLIFERATION; EGF; NICHE	Tissue replenishment from stem cells follows a precise cascade of events, during which stem cell daughters first proliferate by mitotic transit amplifying divisions and then enter terminal differentiation. Here we address how stem cell daughters are guided through the early steps of development. In Drosophila testes, somatic cyst cells enclose the proliferating and differentiating germline cells and the units of germline and surrounding cyst cells are commonly referred to as cysts. By characterizing flies with reduced or increased Epidermal Growth Factor (EGF) signaling we show that EGF triggers different responses in the cysts dependent on its dose. In addition to the previously reported requirement for EGF signaling in cyst formation, a low dose of EGF signaling is required for the progression of the germline cells through transit amplifying divisions, and a high dose of EGF signaling promotes terminal differentiation. Terminal differentiation was promoted in testes expressing a constitutively active EGF Receptor (EGFR) and in testes expressing both a secreted EGF and the EGFR in the cyst cells, but not in testes expressing either only EGF or only EGFR. We propose that as the cysts develop, a temporal signature of EGF signaling is created by the coordinated increase of both the production of active ligands by the germline cells and the amount of available receptor molecules on the cyst cells.	[Hudson, Alicia G.; Parrott, Benjamin B.; Qian, Yue; Schulz, Cordula] Univ Georgia, Dept Cellular Biol, Athens, GA 30602 USA; [Parrott, Benjamin B.] Med Univ S Carolina, Dept Obstet & Gynecol, Charleston, SC 29425 USA	University System of Georgia; University of Georgia; Medical University of South Carolina	Schulz, C (corresponding author), Univ Georgia, Dept Cellular Biol, Athens, GA 30602 USA.	cschulz@uga.edu			American Foundation for Aging Research; University of Georgia, Athens; NSF [0841419]; Direct For Biological Sciences [0841419] Funding Source: National Science Foundation	American Foundation for Aging Research; University of Georgia, Athens; NSF(National Science Foundation (NSF)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	The work was supported by a grant from the American Foundation for Aging Research given to B. B. P. (no grant #), and start-up funds from University of Georgia, Athens, and NSF grant #0841419 given to C. S. The funders have no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amoyel M, 2013, DEVELOPMENT, V140, P56, DOI 10.1242/dev.086413; BIER E, 1990, GENE DEV, V4, P190, DOI 10.1101/gad.4.2.190; Blanpain C, 2006, ANNU REV CELL DEV BI, V22, P339, DOI 10.1146/annurev.cellbio.22.010305.104357; BRAND AH, 1993, DEVELOPMENT, V118, P401; Brawley C, 2004, SCIENCE, V304, P1331, DOI 10.1126/science.1097676; Bunt SM, 2004, GENESIS, V39, P84, DOI 10.1002/gene.20030; Chen X, 2005, SCIENCE, V310, P869, DOI 10.1126/science.1118101; Cheng J, 2011, DEVELOPMENT, V138, P831, DOI 10.1242/dev.057901; Cheung LS, 2011, CURR OPIN GENET DEV, V21, P719, DOI 10.1016/j.gde.2011.07.009; de Cuevas M, 1998, DEVELOPMENT, V125, P2781; Desai BS, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-19; Devine SM, 2000, CURR OPIN HEMATOL, V7, P358, DOI 10.1097/00062752-200011000-00007; Duffy JB, 2002, GENESIS, V34, P1, DOI 10.1002/gene.10150; Fabrizio JJ, 2003, DEV BIOL, V258, P117, DOI 10.1016/S0012-1606(03)00127-1; Festa E, 2011, CELL, V146, P761, DOI 10.1016/j.cell.2011.07.019; Fuller Margaret T., 1993, P71; Gabay L, 1997, SCIENCE, V277, P1103, DOI 10.1126/science.277.5329.1103; Gelbart W, 2003, NUCLEIC ACIDS RES, V31, P172, DOI 10.1093/nar/gkg094; GONCZY P, 1992, DEVELOPMENT, V114, P89; Gonczy P, 1996, DEVELOPMENT, V122, P2437; Gonczy P, 1997, DEVELOPMENT, V124, P4361; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; HARDY RW, 1979, J ULTRA MOL STRUCT R, V69, P180, DOI 10.1016/S0022-5320(79)90108-4; Hrdlicka L, 2002, GENESIS, V34, P51, DOI 10.1002/gene.10125; HUCKINS C, 1971, ANAT REC, V169, P533, DOI 10.1002/ar.1091690306; Insco ML, 2009, P NATL ACAD SCI USA, V106, P22311, DOI 10.1073/pnas.0912454106; Kawase E, 2004, DEVELOPMENT, V131, P1365, DOI 10.1242/dev.01025; Kiger AA, 2000, NATURE, V407, P750, DOI 10.1038/35037606; Kiger AA, 2001, SCIENCE, V294, P2542, DOI 10.1126/science.1066707; Leatherman JL, 2010, NAT CELL BIOL, V12, P806, DOI 10.1038/ncb2086; Lee T, 1999, NEURON, V22, P451, DOI 10.1016/S0896-6273(00)80701-1; Lesokhin AM, 1999, DEV BIOL, V205, P129, DOI 10.1006/dbio.1998.9121; Li CY, 2007, DEV BIOL, V309, P70, DOI 10.1016/j.ydbio.2007.06.019; Li MA, 2003, NAT CELL BIOL, V5, P994, DOI 10.1038/ncb1058; Li T, 2011, BONE MARROW RES, DOI 10.1155/2011/353878; Li-Kroeger D, 2008, DEV CELL, V15, P298, DOI 10.1016/j.devcel.2008.06.001; LIN HF, 1994, DEVELOPMENT, V120, P947; Liu YL, 2008, FLY, V2, P92, DOI 10.4161/fly.6311; Matunis E, 1997, DEVELOPMENT, V124, P4383; MCKEARIN D, 1995, DEVELOPMENT, V121, P2937; MCKEARIN DM, 1990, GENE DEV, V4, P2242, DOI 10.1101/gad.4.12b.2242; Metcalf D, 2007, STEM CELLS, V25, P2390, DOI 10.1634/stemcells.2007-0544; Michel M, 2012, DEVELOPMENT, V139, P2663, DOI 10.1242/dev.075242; Moghal N, 2003, EXP CELL RES, V284, P150, DOI 10.1016/S0014-4827(02)00097-6; Nilson LA, 1999, CURR TOP DEV BIOL, V44, P203; Nishimura EK, 2011, PIGM CELL MELANOMA R, V24, P401, DOI 10.1111/j.1755-148X.2011.00855.x; Normanno N, 2006, GENE, V366, P2, DOI 10.1016/j.gene.2005.10.018; Papagiannouli F, 2009, CELL RES, V19, P1139, DOI 10.1038/cr.2009.71; Parrott BB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036460; Parrott BB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025087; PEIFER M, 1993, DEVELOPMENT, V118, P1191; Pellettieri J, 2007, ANNU REV GENET, V41, P83, DOI 10.1146/annurev.genet.41.110306.130244; Phelps CB, 1998, METHODS, V14, P367, DOI 10.1006/meth.1998.0592; POTTEN CS, 1990, DEVELOPMENT, V110, P1001; Queenan AM, 1997, DEVELOPMENT, V124, P3871; Rabbani P, 2011, CELL, V145, P941, DOI 10.1016/j.cell.2011.05.004; Raz E, 2000, GENOME BIOL, V1, DOI [10.1186/gb-2000-1-3-reviews1017, DOI 10.1186/GB-2000-1-3-REVIEWS1017]; Reya T, 2001, NATURE, V414, P105, DOI 10.1038/35102167; Riparbelli MG, 2009, J CELL SCI, V122, P3613, DOI 10.1242/jcs.049957; Rotkopf S, 2011, DEVELOPMENT, V138, P2729, DOI 10.1242/dev.059865; Sarkar A, 2007, CURR BIOL, V17, P1253, DOI 10.1016/j.cub.2007.06.048; Schlesinger A, 2004, DEV CELL, V7, P535, DOI 10.1016/j.devcel.2004.09.001; Schlessinger J, 2004, SCIENCE, V306, P1506, DOI 10.1126/science.1105396; Schulz C, 2004, GENETICS, V167, P707, DOI 10.1534/genetics.103.023184; Schulz C, 2002, DEVELOPMENT, V129, P4523; SCHWEITZER R, 1995, NATURE, V376, P699, DOI 10.1038/376699a0; Sheng XR, 2009, CELL STEM CELL, V5, P191, DOI 10.1016/j.stem.2009.05.024; Shilo BZ, 2007, CURR BIOL, V17, pR1038, DOI 10.1016/j.cub.2007.10.062; Shilo BZ, 2003, EXP CELL RES, V284, P140, DOI 10.1016/S0014-4827(02)00094-0; Shivdasani AA, 2003, CURR BIOL, V13, P2065, DOI 10.1016/j.cub.2003.10.063; Tran J, 2000, NATURE, V407, P754, DOI 10.1038/35037613; Tulina N, 2001, SCIENCE, V294, P2546, DOI 10.1126/science.1066700; Urban S, 2002, EMBO J, V21, P4277, DOI 10.1093/emboj/cdf434; Urban S, 2006, GENE DEV, V20, P3054, DOI 10.1101/gad.1488606; Van Doren M, 1998, CURR BIOL, V8, P243; Weissman IL, 2000, SCIENCE, V287, P1442, DOI 10.1126/science.287.5457.1442; WILEY LM, 1995, BIOESSAYS, V17, P839, DOI 10.1002/bies.950171005; Wong C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033635; Yamashita YM, 2003, SCIENCE, V301, P1547, DOI 10.1126/science.1087795; Zettervall CJ, 2004, P NATL ACAD SCI USA, V101, P14192, DOI 10.1073/pnas.0403789101; Zoller Richard, 2012, Spermatogenesis, V2, P145	81	32	32	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2013	8	8							e70678	10.1371/journal.pone.0070678	http://dx.doi.org/10.1371/journal.pone.0070678			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	218XC	23940622	Green Submitted, Green Published, gold			2022-12-25	WOS:000324465000116
J	Escobar, MJ; Rivera-Rei, A; Decety, J; Huepe, D; Cardona, JF; Canales-Johnson, A; Sigman, M; Mikulan, E; Helgiu, E; Baez, S; Manes, F; Lopez, V; Ibanez, A				Josefina Escobar, Maria; Rivera-Rei, Alvaro; Decety, Jean; Huepe, David; Felipe Cardona, Juan; Canales-Johnson, Andres; Sigman, Mariano; Mikulan, Ezequiel; Helgiu, Elena; Baez, Sandra; Manes, Facundo; Lopez, Vladimir; Ibanez, Agustin			Attachment Patterns Trigger Differential Neural Signature of Emotional Processing in Adolescents	PLOS ONE			English	Article							ADULT ATTACHMENT; SOCIAL COGNITION; CHILDRENS ATTACHMENT; BRAIN POTENTIALS; FACE; ATTENTION; PERCEPTION; REPRESENTATIONS; RESPONSES; SECURITY	Background: Research suggests that individuals with different attachment patterns process social information differently, especially in terms of facial emotion recognition. However, few studies have explored social information processes in adolescents. This study examined the behavioral and ERP correlates of emotional processing in adolescents with different attachment orientations (insecure attachment group and secure attachment group; IAG and SAG, respectively). This study also explored the association of these correlates to individual neuropsychological profiles. Methodology/Principal Findings: We used a modified version of the dual valence task (DVT), in which participants classify stimuli (faces and words) according to emotional valence (positive or negative). Results showed that the IAG performed significantly worse than SAG on tests of executive function (EF attention, processing speed, visuospatial abilities and cognitive flexibility). In the behavioral DVT, the IAG presented lower performance and accuracy. The IAG also exhibited slower RTs for stimuli with negative valence. Compared to the SAG, the IAG showed a negative bias for faces; a larger P1 and attenuated N170 component over the right hemisphere was observed. A negative bias was also observed in the IAG for word stimuli, which was demonstrated by comparing the N170 amplitude of the IAG with the valence of the SAG. Finally, the amplitude of the N170 elicited by the facial stimuli correlated with EF in both groups (and negative valence with EF in the IAG). Conclusions/Significance: Our results suggest that individuals with different attachment patterns process key emotional information and corresponding EF differently. This is evidenced by an early modulation of ERP components' amplitudes, which are correlated with behavioral and neuropsychological effects. In brief, attachments patterns appear to impact multiple domains, such as emotional processing and EFs.	[Felipe Cardona, Juan; Mikulan, Ezequiel; Baez, Sandra; Manes, Facundo; Ibanez, Agustin] Favaloro Univ, INECO Inst Cognit Neurol, Lab Expt Psychol & Neurosci LPEN, Buenos Aires, CABA, Argentina; [Felipe Cardona, Juan; Mikulan, Ezequiel; Baez, Sandra; Manes, Facundo; Ibanez, Agustin] Favaloro Univ, Inst Neurosci, Buenos Aires, CABA, Argentina; [Felipe Cardona, Juan; Ibanez, Agustin] Natl Sci & Tech Res Council CONICET, Buenos Aires, CABA, Argentina; [Rivera-Rei, Alvaro; Huepe, David; Canales-Johnson, Andres; Ibanez, Agustin] Diego Port Univ, UDP INECO Fdn Core Neurosci UIFCoN, Lab Cognit & Social Neurosci LaNCyS, Santiago, RM, Chile; [Josefina Escobar, Maria; Lopez, Vladimir] Pontificia Univ Catolica Chile, Escuela Psicol, Santiago, RM, Chile; [Helgiu, Elena] Harvard Univ, Coll Psychol, Cambridge, MA 02138 USA; [Decety, Jean] Univ Chicago, Dept Psychol, Chicago, IL 60637 USA; [Decety, Jean] Univ Chicago, Dept Psychiat & Behav Neurosci, Chicago, IL 60637 USA; [Sigman, Mariano] Univ Buenos Aires, FCEN, Dept Fis, Buenos Aires, CABA, Argentina; [Sigman, Mariano] Consejo Nacl Invest Cient & Tecn, IFIBA, Buenos Aires, CABA, Argentina; [Sigman, Mariano] Univ Torcuato Di Tella, Buenos Aires, CABA, Argentina; [Canales-Johnson, Andres] MRC, Cognit & Brain Sci Unit, Cambridge, England	Centro Nacional Patagonico (CENPAT); Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Pontificia Universidad Catolica de Chile; Harvard University; University of Chicago; University of Chicago; University of Buenos Aires; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Universidad Torcuato Di Tella	Ibanez, A (corresponding author), Favaloro Univ, INECO Inst Cognit Neurol, Lab Expt Psychol & Neurosci LPEN, Buenos Aires, CABA, Argentina.	aibanez@ineco.org.ar	Cardona, Juan F./O-9436-2015; Lopez, Vladimir/N-7188-2017; Mikulan, Ezequiel P./AAC-5276-2022; Ibanez, Agustin/H-7976-2015; Cardona, Juan Felipe/M-7939-2019	Cardona, Juan F./0000-0001-6795-7753; Ibanez, Agustin/0000-0001-6758-5101; Cardona, Juan Felipe/0000-0001-6795-7753; Mikulan, Ezequiel/0000-0001-7259-6120; Rivera-Rei, Alvaro/0000-0002-3674-7291; Huepe, David/0000-0001-8351-5314; Escobar, Maria Josefina/0000-0001-6096-9479; Baez, Sandra/0000-0003-0875-1709	Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT/FONDECYT) [1090610, 1130920]; Fondo para la Investigacion Cientifica y Tecnologica (FONCyT- PICT) [2012-0412]; FONCyT- PICT [2012-1309]; James McDonnell Foundation; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); INECO Foundation	Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT/FONDECYT)(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); Fondo para la Investigacion Cientifica y Tecnologica (FONCyT- PICT); FONCyT- PICT(ANPCyTFONCyT); James McDonnell Foundation; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); INECO Foundation	This work was supported by grants from Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT/FONDECYT Regular 1090610 to VL and 1130920 to AI); Fondo para la Investigacion Cientifica y Tecnologica (FONCyT- PICT) 2012-0412 to FM), FONCyT- PICT 2012-1309 to AI; James McDonnell Foundation to MS; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET) and INECO Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AINSWORTH MDS, 1989, AM PSYCHOL, V44, P709, DOI 10.1037/0003-066X.44.4.709; Allen J. P., 2008, HDB ATTACHMENT THEOR, P419; Aviezer O, 2002, INT J BEHAV DEV, V26, P397, DOI 10.1080/01650250143000328; Beebe B, 2010, ATTACH HUM DEV, V12, P3, DOI 10.1080/14616730903338985; Bernier A, 2012, DEVELOPMENTAL SCI, V15, P12, DOI 10.1111/j.1467-7687.2011.01093.x; Blakemore SJ, 2008, Q J EXP PSYCHOL, V61, P40, DOI 10.1080/17470210701508715; Bowlby J, 1969, ATTACHMENT LOSS SEPA; Bowlby J., 1973, SEPARATION ANXIETY A, V2; Bretherton I., 2008, HDB ATTACHMENT THEOR, P102; CASSIDY J, 1994, CHILD DEV, V65, P971, DOI 10.2307/1131298; Chavis JM, 2012, J RES PERS, V46, P55, DOI 10.1016/j.jrp.2011.12.004; Dan O, 2012, BIOL PSYCHOL, V91, P212, DOI 10.1016/j.biopsycho.2012.06.003; Dewitte M, 2008, J RES PERS, V42, P498, DOI 10.1016/j.jrp.2007.07.010; Donges US, 2012, NEUROSCIENCE, V220, P149, DOI 10.1016/j.neuroscience.2012.06.036; Dykas MJ, 2011, PSYCHOL BULL, V137, P19, DOI 10.1037/a0021367; Feng WF, 2012, NEUROPSYCHOLOGIA, V50, P3461, DOI 10.1016/j.neuropsychologia.2012.09.031; Fraedrich EM, 2010, ATTACH HUM DEV, V12, P231, DOI 10.1080/14616731003759724; Fraley RC, 2006, J PERS, V74, P1163, DOI 10.1111/j.1467-6494.2006.00406.x; Gillath O, 2009, J EXP SOC PSYCHOL, V45, P647, DOI 10.1016/j.jesp.2009.02.011; Hesse E, 2006, DEV PSYCHOPATHOL, V18, P309, DOI 10.1017/S0954579406060172; Hillyard SA, 1998, P NATL ACAD SCI USA, V95, P781, DOI 10.1073/pnas.95.3.781; Ibanez A, 2011, PSYCHIAT RES; Ibanez A, 2014, SOC COGN AFFECT NEUR, V9, P939, DOI 10.1093/scan/nst067; Ibanez A, 2013, PERS INDIV DIFFER, V54, P616, DOI 10.1016/j.paid.2012.11.022; Ibanez A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046877; Ibanez A, 2012, SOC NEUROSCI-UK, V7, P632, DOI 10.1080/17470919.2012.691078; Ibanez A, 2012, NEUROLOGY, V78, P1354, DOI 10.1212/WNL.0b013e3182518375; Ibanez A, 2012, PSYCHIAT RES, V195, P18, DOI 10.1016/j.psychres.2011.07.027; Ibanez A, 2011, SOC NEUROSCI-UK, V6, P464, DOI 10.1080/17470919.2011.620769; Ibanez A, 2010, FRONT HUM NEUROSCI, V4, DOI 10.3389/fnhum.2010.00188; Ibanez A, 2011, BEHAV BRAIN FUNCT, V7, DOI 10.1186/1744-9081-7-8; JACOBSEN T, 1994, DEV PSYCHOL, V30, P112, DOI 10.1037/0012-1649.30.1.112; Jacobsen T, 1997, DEV PSYCHOL, V33, P703, DOI 10.1037/0012-1649.33.4.703; Kirsh SJ, 1997, CHILD DEV, V68, P1143, DOI 10.2307/1132297; LUCK SJ, 1990, ELECTROEN CLIN NEURO, V75, P528, DOI 10.1016/0013-4694(90)90139-B; Maier MA, 2005, ATTACH HUM DEV, V7, P67, DOI 10.1080/14616730500039606; Main M, 1990, ATTACHMENT PRESCHOOL, P121; Millan MJ, 2012, NAT REV DRUG DISCOV, V11, P141, DOI 10.1038/nrd3628; Mueller EM, 2009, PSYCHOL MED, V39, P1141, DOI 10.1017/S0033291708004820; Niedenthal PM, 2002, J PERS SOC PSYCHOL, V82, P419, DOI 10.1037//0022-3514.82.3.419; Partington J, 1949, PSYCHOL CTR B, V1; Pessoa L, 2008, NAT REV NEUROSCI, V9, P148, DOI 10.1038/nrn2317; Petroni A, 2011, NEUROSCI LETT, V505, P41, DOI 10.1016/j.neulet.2011.09.062; Proverbio AM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011242; Rodriguez V, 2012, J COGNITIVE NEUROSCI, V24, P396, DOI 10.1162/jocn_a_00137; Rognoni E, 2008, PERS INDIV DIFFER, V44, P909, DOI 10.1016/j.paid.2007.10.021; Rossion B, 2003, NEUROIMAGE, V20, P1609, DOI 10.1016/j.neuroimage.2003.07.010; Rossion B, 2008, NEUROIMAGE, V39, P1959, DOI 10.1016/j.neuroimage.2007.10.011; Schacht A, 2009, BRAIN COGNITION, V69, P538, DOI 10.1016/j.bandc.2008.11.005; Schendan HE, 1998, PSYCHOPHYSIOLOGY, V35, P240, DOI 10.1017/S004857729897010X; Sonnby-Borgstrom M, 2004, SCAND J PSYCHOL, V45, P103, DOI 10.1111/j.1467-9450.2004.00385.x; Steele H, 2005, ATTACHMENT IN MIDDLE CHILDHOOD, P137; Steele H., 2009, FRIENDS FAMILY UNPUB; Steele H, 2008, ATTACH HUM DEV, V10, P379, DOI 10.1080/14616730802461409; Stievenart M, 2012, EUROPEAN J DEV PSYCH, P1; Suslow T, 2010, AUST J PSYCHOL, V62, P181, DOI 10.1080/00049530903567203; Suslow T, 2009, HUM BRAIN MAPP, V30, P3553, DOI 10.1002/hbm.20778; Teo A, 1996, J SCHOOL PSYCHOL, V34, P285, DOI 10.1016/0022-4405(96)00016-7; VAN IJZENDOORN MH, 1995, SOC DEV, V4, P115; von der Lippe A, 2010, ATTACH HUM DEV, V12, P429, DOI 10.1080/14616734.2010.501967; Vrticka P, 2012, FRONT HUM NEUROSCI, V6, DOI [10.3389/fnhum.2012.00358, 10.3389/fnhum.2012.00212]; Vrticka P, 2012, SOC NEUROSCI-UK, V7, P473, DOI 10.1080/17470919.2011.647410; Vrticka P, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002868; Vuilleumier P, 2007, NEUROPSYCHOLOGIA, V45, P174, DOI 10.1016/j.neuropsychologia.2006.06.003; Waters E, 2000, CHILD DEV, V71, P684, DOI 10.1111/1467-8624.00176; Waters E, 2000, CHILD DEV, V71, P678, DOI 10.1111/1467-8624.00175; Waters E, 2000, CHILD DEV, V71, P703, DOI 10.1111/1467-8624.00179; Weschler D., 2003, WECHSLER INTELLIGENC, Vfourth; West KK, 2012, EARLY CHILDHOOD RES; White LO, 2012, EMOTION, V12, P690, DOI 10.1037/a0026750; White LO, 2013, DEV SCI; Zhang X, 2008, NEUROREPORT, V19, P437, DOI 10.1097/WNR.0b013e3282f55728; Zilber A, 2007, PERS INDIV DIFFER, V43, P1898, DOI 10.1016/j.paid.2007.06.015	73	31	32	2	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2013	8	8							e70247	10.1371/journal.pone.0070247	http://dx.doi.org/10.1371/journal.pone.0070247			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	218XC	23940552	Green Published, gold, Green Submitted			2022-12-25	WOS:000324465000046
J	Shao, JF; Lou, XY; Wang, J; Zhang, J; Chen, C; Hua, DS; Mo, F; Han, X; Zheng, S; Lin, BY				Shao, Jiaofang; Lou, Xiaoyan; Wang, Jun; Zhang, Jing; Chen, Chen; Hua, Dasong; Mo, Fan; Han, Xu; Zheng, Shu; Lin, Biaoyang			Targeted Re-Sequencing Identified rs3106189 at the 5 ' UTR of TAPBP and rs1052918 at the 3 ' UTR of TCF3 to Be Associated with the Overall Survival of Colorectal Cancer Patients	PLOS ONE			English	Article							SINGLE-NUCLEOTIDE POLYMORPHISMS; EXONIC SPLICING ENHANCERS; CELL LUNG-CANCER; FUNCTIONAL ANNOTATION; MUTATIONAL ANALYSIS; PROTEIN FUNCTION; DOWN-REGULATION; HUMAN BREAST; HUMAN GENES; DNA-REPAIR	Recent studies have demonstrated the power of deep re-sequencing of the whole genome or exome in understanding cancer genomes. However, targeted capture of selected genomic whole gene-body regions, rather than the whole exome, have several advantages: 1) the genes can be selected based on biology or a hypothesis; 2) mutations in promoter and intronic regions, which have important regulatory roles, can be investigated; and 3) less expensive than whole genome or whole exome sequencing. Therefore, we designed custom high-density oligonucleotide microarrays (NimbleGen Inc.) to capture approximately 1.7 Mb target regions comprising the genomic regions of 28 genes related to colorectal cancer including genes belonging to the WNT signaling pathway, as well as important transcription factors or colon-specific genes that are over expressed in colorectal cancer (CRC). The 1.7 Mb targeted regions were sequenced with a coverage ranged from 32x to 45x for the 28 genes. We identified a total of 2342 sequence variations in the CRC and corresponding adjacent normal tissues. Among them, 738 were novel sequence variations based on comparisons with the SNP database (dbSNP135). We validated 56 of 66 SNPs in a separate cohort of 30 CRC tissues using Sequenom MassARRAY iPLEX Platform, suggesting a validation rate of at least 85% (56/66). We found 15 missense mutations among the exonic variations, 21 synonymous SNPs that were predicted to change the exonic splicing motifs, 31 UTR SNPs that were predicted to occur at the transcription factor binding sites, 20 intronic SNPs located near the splicing sites, 43 SNPs in conserved transcription factor binding sites and 32 in CpG islands. Finally, we determined that rs3106189, localized to the 5' UTR of antigen presenting tapasin binding protein (TAPBP), and rs1052918, localized to the 3' UTR of transcription factor 3 (TCF3), were associated with overall survival of CRC patients.	[Shao, Jiaofang; Zheng, Shu; Lin, Biaoyang] Zhejiang Univ, Coll Med, Affiliated Hosp 2, China Natl Minist Educ,Canc Inst,Key Lab Canc Pre, Hangzhou 310003, Zhejiang, Peoples R China; [Shao, Jiaofang; Lin, Biaoyang] Zhejiang Univ, Coll Med, Affiliated Hosp 1, Collaborat Innovat Ctr Diag & Treatment Infect Di, Hangzhou 310003, Zhejiang, Peoples R China; [Shao, Jiaofang; Lin, Biaoyang] Zhejiang Univ, Coll Med, Affiliated Hosp 1, State Key Lab Diag & Treatment Infect Dis, Hangzhou 310003, Zhejiang, Peoples R China; [Shao, Jiaofang; Lou, Xiaoyan; Wang, Jun; Zhang, Jing; Chen, Chen; Hua, Dasong; Mo, Fan; Han, Xu; Lin, Biaoyang] Zhejiang Univ, Zhejiang Calif Int Nanosyst Inst ZCNI, Syst Biol Div, Hangzhou 310003, Zhejiang, Peoples R China; [Shao, Jiaofang; Lou, Xiaoyan; Wang, Jun; Zhang, Jing; Chen, Chen; Hua, Dasong; Mo, Fan; Han, Xu; Lin, Biaoyang] Zhejiang Univ, Zhejiang Calif Int Nanosyst Inst ZCNI, Propriumbio Res Ctr, Hangzhou 310003, Zhejiang, Peoples R China; [Lin, Biaoyang] Swedish Med Ctr, Seattle, WA USA; [Lin, Biaoyang] Univ Washington, Dept Urol, Seattle, WA 98195 USA	Zhejiang University; Collaborative Innovation Center for Diagnosis & Treatment of Infectious Diseases; Zhejiang University; Zhejiang University; Zhejiang University; Zhejiang University; Swedish Medical Center; University of Washington; University of Washington Seattle	Zheng, S (corresponding author), Zhejiang Univ, Coll Med, Affiliated Hosp 2, China Natl Minist Educ,Canc Inst,Key Lab Canc Pre, Hangzhou 310003, Zhejiang, Peoples R China.	zhengshu@zju.edu.cn; Biaoylin@gmail.com	Lin, Biaoyang/AAA-1258-2020	Lin, Biaoyang/0000-0002-2189-0407	Ministry of Science and Technology, China [2006DFA32950, 2006AA02A303, 2012AA02A204, 2011ZX09307-001-05]; National Science Foundation, China [81072060/H1618]	Ministry of Science and Technology, China(Ministry of Science and Technology, China); National Science Foundation, China(National Natural Science Foundation of China (NSFC))	This study was supported by grants from the Ministry of Science and Technology, China (2006DFA32950, 2006AA02A303, 2012AA02A204,2011ZX09307-001-05) and a grant from the National Science Foundation, China (81072060/H1618). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahlquist T, 2008, MOL CANCER, V7, DOI 10.1186/1476-4598-7-94; Atkins D, 2004, INT J CANCER, V109, P265, DOI 10.1002/ijc.11681; Bass AJ, 2011, NAT GENET, V43, P964, DOI 10.1038/ng.936; Biaoyang Lin, 2008, Recent Patents on Biomedical Engineering, V1, P60, DOI 10.2174/1874764710801010060; Bienz M, 2000, CELL, V103, P311, DOI 10.1016/S0092-8674(00)00122-7; Bond GL, 2004, CELL, V119, P591, DOI 10.1016/j.cell.2004.11.022; Boyle AP, 2012, GENOME RES, V22, P1790, DOI 10.1101/gr.137323.112; Cargill M, 1999, NAT GENET, V22, P231, DOI 10.1038/10290; Cartegni L, 2003, NUCLEIC ACIDS RES, V31, P3568, DOI 10.1093/nar/gkg616; Chaki M, 2012, CELL, V150, P533, DOI 10.1016/j.cell.2012.06.028; Chelala C, 2009, BIOINFORMATICS, V25, P655, DOI 10.1093/bioinformatics/btn653; Chiaro C, 2012, BIOCHEM BIOPH RES CO, V428, P121, DOI 10.1016/j.bbrc.2012.10.018; Chiu BCH, 2003, CANCER EPIDEM BIOMAR, V12, P201; Choi Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046688; Fairbrother WG, 2002, SCIENCE, V297, P1007, DOI 10.1126/science.1073774; Fodde R, 2002, EUR J CANCER, V38, P867, DOI 10.1016/S0959-8049(02)00040-0; Greenman C, 2007, NATURE, V446, P153, DOI 10.1038/nature05610; Hao B, 2006, ONCOGENE, V25, P3613, DOI 10.1038/sj.onc.1209355; Ikura T, 2000, CELL, V102, P463, DOI 10.1016/S0092-8674(00)00051-9; Jongeneel CV, 2005, GENOME RES, V15, P1007, DOI 10.1101/gr.4041005; KINZLER KW, 1991, SCIENCE, V253, P661, DOI 10.1126/science.1651562; Kumar P, 2009, NAT PROTOC, V4, P1073, DOI 10.1038/nprot.2009.86; Latorra D, 2003, HUM MUTAT, V22, P79, DOI 10.1002/humu.10228; Li H, 2008, GENOME RES, V18, P1851, DOI 10.1101/gr.078212.108; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Lind GE, 2006, CELL ONCOL, V28, P259; Lou Y, 2008, CLIN CANCER RES, V14, P1494, DOI 10.1158/1078-0432.CCR-07-1066; Mardis ER, 2008, ANNU REV GENOM HUM G, V9, P387, DOI 10.1146/annurev.genom.9.081307.164359; Muzny DM, 2012, NATURE, V487, P330, DOI 10.1038/nature11252; Nejentsev S, 2009, SCIENCE, V324, P387, DOI 10.1126/science.1167728; Ng PC, 2003, NUCLEIC ACIDS RES, V31, P3812, DOI 10.1093/nar/gkg509; Ng PC, 2001, GENOME RES, V11, P863, DOI 10.1101/gr.176601; Ng SB, 2009, NATURE, V461, P272, DOI 10.1038/nature08250; Ortmann B, 1997, SCIENCE, V277, P1306, DOI 10.1126/science.277.5330.1306; Passarelli MN, 2013, CANCER RES, V73, P767, DOI 10.1158/0008-5472.CAN-12-2484; Picelli S, 2010, EUR J CANCER, V46, P1041, DOI 10.1016/j.ejca.2010.01.013; Pritchard CC, 2012, J MOL DIAGN, V14, P357, DOI 10.1016/j.jmoldx.2012.03.002; Ramensky V, 2002, NUCLEIC ACIDS RES, V30, P3894, DOI 10.1093/nar/gkf493; Sakuraba K, 2009, ANTICANCER RES, V29, P3953; Schuster SC, 2008, NAT METHODS, V5, P16, DOI 10.1038/NMETH1156; Seliger B, 2001, TISSUE ANTIGENS, V57, P39, DOI 10.1034/j.1399-0039.2001.057001039.x; Sjoblom T, 2006, SCIENCE, V314, P268, DOI 10.1126/science.1133427; Slyper M, 2012, CANCER RES, V72, P5613, DOI 10.1158/0008-5472.CAN-12-0119; Sparks AB, 1998, CANCER RES, V58, P1130; Topol EJ, 2007, NAT GENET, V39, P439, DOI 10.1038/ng0407-439; Wagle N, 2012, CANCER DISCOV, V2, P82, DOI 10.1158/2159-8290.CD-11-0184; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603; Wang ZF, 2004, CELL, V119, P831, DOI 10.1016/j.cell.2004.11.010; Wangkumhang P, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-275; Wood LD, 2007, SCIENCE, V318, P1108, DOI 10.1126/science.1145720; Ye S, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.17.e88; You FM, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-59; Yuan HY, 2006, NUCLEIC ACIDS RES, V34, pW635, DOI 10.1093/nar/gkl236; Zhang MF, 2010, CLIN CANCER RES, V16, P1236, DOI 10.1158/1078-0432.CCR-09-2719; Zhang YW, 2005, JNCI-J NATL CANCER I, V97, P1616, DOI 10.1093/jnci/dji344; Zhou DE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053310	57	6	7	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2013	8	8							e70307	10.1371/journal.pone.0070307	http://dx.doi.org/10.1371/journal.pone.0070307			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	218XC	23940558	gold, Green Submitted, Green Published			2022-12-25	WOS:000324465000052
J	Suissa, Y; Magenheim, J; Stolovich-Rain, M; Hija, A; Collombat, P; Mansouri, A; Sussel, L; Sosa-Pineda, B; McCracken, K; Wells, JM; Heller, RS; Dor, Y; Glaser, B				Suissa, Yaron; Magenheim, Judith; Stolovich-Rain, Miri; Hija, Ayat; Collombat, Patrick; Mansouri, Ahmed; Sussel, Lori; Sosa-Pineda, Beatriz; McCracken, Kyle; Wells, James M.; Heller, R. Scott; Dor, Yuval; Glaser, Benjamin			Gastrin: A Distinct Fate of Neurogenin3 Positive Progenitor Cells in the Embryonic Pancreas	PLOS ONE			English	Article							GROWTH-FACTOR; ENDOCRINE; DIFFERENTIATION; MICE; SPECIFICATION; EXPRESSION; LINEAGES; TYPE-1; NKX2.2; PAX4	Neurogenin(3+) (Ngn(3+)) progenitor cells in the developing pancreas give rise to five endocrine cell types secreting insulin, glucagon, somatostatin, pancreatic polypeptide and ghrelin. Gastrin is a hormone produced primarily by G-cells in the stomach, where it functions to stimulate acid secretion by gastric parietal cells. Gastrin is expressed in the embryonic pancreas and is common in islet cell tumors, but the lineage and regulators of pancreatic gastrin(+) cells are not known. We report that gastrin is abundantly expressed in the embryonic pancreas and disappears soon after birth. Some gastrin(+) cells in the developing pancreas co-express glucagon, ghrelin or pancreatic polypeptide, but many gastrin(+) cells do not express any other islet hormone. Pancreatic gastrin(+) cells express the transcription factors Nkx6.1, Nkx2.2 and low levels of Pdx1, and derive from Ngn(3+) endocrine progenitor cells as shown by genetic lineage tracing. Using mice deficient for key transcription factors we show that gastrin expression depends on Ngn3, Nkx2.2, NeuroD1 and Arx, but not Pax4 or Pax6. Finally, gastrin expression is induced upon differentiation of human embryonic stem cells to pancreatic endocrine cells expressing insulin. Thus, gastrin(+) cells are a distinct endocrine cell type in the pancreas and an alternative fate of Ngn(3+) cells.	[Suissa, Yaron; Glaser, Benjamin] Hadassah Hebrew Univ, Med Ctr, Dept Internal Med, Endocrinol & Metab Serv, Jerusalem, Israel; [Suissa, Yaron; Magenheim, Judith; Stolovich-Rain, Miri; Hija, Ayat; Dor, Yuval] Hebrew Univ Jerusalem, Hadassah Med Sch, Inst Med Res Israel Canada, Dept Dev Biol & Canc Res, IL-91010 Jerusalem, Israel; [Collombat, Patrick] Fac Med Nice, INSERM, Dept Diabet Genet, F-06034 Nice, France; [Collombat, Patrick] Univ Nice Sophia Antipolis, UFR Sci, F-06189 Nice, France; [Mansouri, Ahmed] Max Planck Inst Biophys Chem, Dept Mol Cell Biol, Gottingen, Germany; [Sussel, Lori] Columbia Univ, Dept Genet & Dev, New York, NY USA; [Sosa-Pineda, Beatriz] St Jude Childrens Res Hosp, Dept Genet, Memphis, TN 38105 USA; [McCracken, Kyle; Wells, James M.] Cincinnati Childrens Hosp Med Ctr, Div Dev Biol, Cincinnati, OH 45229 USA; [Heller, R. Scott] Novo Nordisk, Histol & Delivery Dept, Malov, Denmark	Hebrew University of Jerusalem; Hadassah University Medical Center; Hebrew University of Jerusalem; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Cote d'Azur; UDICE-French Research Universities; Universite Cote d'Azur; Max Planck Society; Columbia University; St Jude Children's Research Hospital; Cincinnati Children's Hospital Medical Center; Novo Nordisk	Dor, Y (corresponding author), Hebrew Univ Jerusalem, Hadassah Med Sch, Inst Med Res Israel Canada, Dept Dev Biol & Canc Res, IL-91010 Jerusalem, Israel.	yuvald@ekmd.huji.ac.il; beng@cc.huji.ac.il	Glaser, Benjamin/F-8411-2017; collombat, patrick/F-4495-2015; collombat, patrick/P-3741-2019	Glaser, Benjamin/0000-0003-4711-5000; collombat, patrick/0000-0001-8232-1438; collombat, patrick/0000-0001-8232-1438; McCracken, Kyle/0000-0001-7650-5513	Juvenile Diabetes Research Foundation; Beta Cell Biology Consortium (National Institutes of Health (NIH)); Helmsley Trust; Dutch Friends of Hebrew University; European Union [241883]; DON foundation; I-CORE Program of the Planning and Budgeting Committee; Israel Science Foundation [41.11]; Beta Cell Biology Consortium, NIH [U01 DK072504]; JDRF; European Union (ERC); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U01DK072504, R01DK082590, P30DK026687] Funding Source: NIH RePORTER	Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); Beta Cell Biology Consortium (National Institutes of Health (NIH))(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Helmsley Trust; Dutch Friends of Hebrew University; European Union(European Commission); DON foundation; I-CORE Program of the Planning and Budgeting Committee; Israel Science Foundation(Israel Science Foundation); Beta Cell Biology Consortium, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); JDRF(Juvenile Diabetes Research Foundation); European Union (ERC)(European Research Council (ERC)European Commission); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Funding provided by the Juvenile Diabetes Research Foundation, Beta Cell Biology Consortium (National Institutes of Health (NIH)), The Helmsley Trust, The Dutch Friends of Hebrew University, The European Union Seventh Framework Program (grant no241883 and ERC), The DON foundation, The I-CORE Program of the Planning and Budgeting Committee, The Israel Science Foundation #41.11 (all to YD), Beta Cell Biology Consortium, NIH, U01 DK072504 (to LS) and YS was supported by a post-doctoral fellowship from JDRF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahnfelt-Ronne J, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-63; BALDWIN GS, 1995, J GASTROEN HEPATOL, V10, P215, DOI 10.1111/j.1440-1746.1995.tb01083.x; BARDRAM L, 1990, P NATL ACAD SCI USA, V87, P298, DOI 10.1073/pnas.87.1.298; Bertolino P, 2003, MOL ENDOCRINOL, V17, P1880, DOI 10.1210/me.2003-0154; Bouwens L, 2005, PHYSIOL REV, V85, P1255, DOI 10.1152/physrev.00025.2004; Carty SE, 1998, SURGERY, V124, P1106, DOI 10.1067/msy.1998.93107; Choi MY, 2008, MOL CELL BIOL, V28, P3208, DOI 10.1128/MCB.01737-07; Collombat P, 2003, GENE DEV, V17, P2591, DOI 10.1101/gad.269003; D'Amour KA, 2006, NAT BIOTECHNOL, V24, P1392, DOI 10.1038/nbt1259; Desai S, 2008, DEV BIOL, V313, P58, DOI 10.1016/j.ydbio.2007.09.047; Dockray GJ, 2001, ANNU REV PHYSIOL, V63, P119, DOI 10.1146/annurev.physiol.63.1.119; Du AP, 2012, DEV BIOL, V365, P175, DOI 10.1016/j.ydbio.2012.02.024; GITTES GK, 1993, AM J SURG, V165, P23, DOI 10.1016/S0002-9610(05)80399-X; Gradwohl G, 2000, P NATL ACAD SCI USA, V97, P1607, DOI 10.1073/pnas.97.4.1607; GREGORY RA, 1960, LANCET, V1, P1045; Gu GQ, 2002, DEVELOPMENT, V129, P2447; Hao W, 2004, J CLIN ENDOCR METAB, V89, P3776, DOI 10.1210/jc.2003-031511; Heller RS, 2005, DEV BIOL, V286, P217, DOI 10.1016/j.ydbio.2005.06.041; Jenny M, 2002, EMBO J, V21, P6338, DOI 10.1093/emboj/cdf649; Kokubu H, 2008, GENES CELLS, V13, P41, DOI 10.1111/j.1365-2443.2007.01146.x; Larsson LI, 1998, MECH DEVELOP, V79, P153, DOI 10.1016/S0925-4773(98)00182-8; Larsson LI, 1996, MECH DEVELOP, V60, P175, DOI 10.1016/S0925-4773(96)00609-0; Lee CS, 2002, GENE DEV, V16, P1488, DOI 10.1101/gad.985002; LOGAN CJH, 1966, LANCET, V1, P996; Magenheim J, 2011, DEVELOPMENT, V138, P4743, DOI 10.1242/dev.066548; Mfopou JK, 2010, DIABETES, V59, P2094, DOI 10.2337/db10-0439; Miyata T, 1999, GENE DEV, V13, P1647, DOI 10.1101/gad.13.13.1647; Rooman I, 2002, DIABETES, V51, P686, DOI 10.2337/diabetes.51.3.686; SAMAAN NA, 1989, CANCER, V64, P741, DOI 10.1002/1097-0142(19890801)64:3<741::AID-CNCR2820640329>3.0.CO;2-F; Samuelson LC, 2003, ANNU REV PHYSIOL, V65, P383, DOI 10.1146/annurev.physiol.65.092101.142213; Sawada M, 1997, ANNU REV PHYSIOL, V59, P273, DOI 10.1146/annurev.physiol.59.1.273; Schonhoff SE, 2004, DEV BIOL, V270, P443, DOI 10.1016/j.ydbio.2004.03.013; SOLL AH, 1984, AM J PHYSIOL, V247, pG558, DOI 10.1152/ajpgi.1984.247.5.G558; SosaPineda B, 1997, NATURE, V386, P399, DOI 10.1038/386399a0; Srinivas S, 2001, BMC Dev Biol, V1, P4, DOI 10.1186/1471-213X-1-4; StOnge L, 1997, NATURE, V387, P406, DOI 10.1038/387406a0; Suarez-Pinzon WL, 2005, DIABETES, V54, P2596, DOI 10.2337/diabetes.54.9.2596; Sussel L, 1998, DEVELOPMENT, V125, P2213; Takaishi S, 2011, AM J PHYSIOL-GASTR L, V300, pG334, DOI 10.1152/ajpgi.00134.2010; Tellez N, 2011, ENDOCRINOLOGY, V152, P2580, DOI 10.1210/en.2011-0066; Wang M, 2012, SCI TRANSL MED, V4; Wang S, 2010, DEV BIOL, V339, P26, DOI 10.1016/j.ydbio.2009.12.009; Wang TC, 1999, AM J PHYSIOL-GASTR L, V277, pG6, DOI 10.1152/ajpgi.1999.277.1.G6; WANG TC, 1993, J CLIN INVEST, V92, P1349, DOI 10.1172/JCI116708	44	32	33	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2013	8	8							e70397	10.1371/journal.pone.0070397	http://dx.doi.org/10.1371/journal.pone.0070397			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	218XC	23940571	Green Published, gold, Green Submitted			2022-12-25	WOS:000324465000065
J	Feng, YB; Yu, WY; Li, XX; Lin, SY; Zhou, Y; Hu, JJ; Liu, XQ				Feng, Yanbin; Yu, Wenying; Li, Xinxin; Lin, Shaoyu; Zhou, Ying; Hu, Junjie; Liu, Xinqi			Structural Insight into Golgi Membrane Stacking by GRASP65 and GRASP55 Proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							UNCONVENTIONAL SECRETION; CISTERNAL STACKING; CELL-DIVISION; PDZ LIGAND; ULTRACENTRIFUGATION; PHOSPHORYLATION; SUGGESTS; PATHWAY; GM130; ACB1	The stacking of Golgi cisternae involves GRASP65 and GRASP55. The oligomerization of the N-terminal GRASP domain of these proteins, which consists of two tandem PDZ domains, is required to tether the Golgi membranes. However, the molecular basis for GRASP assembly is unclear. Here, we determined the crystal structures of the GRASP domain of GRASP65 and GRASP55. The structures reveal similar homotypic interactions: the GRASP domain forms a dimer in which the peptide-binding pockets of the two neighboring PDZ2 domains face each other, and the dimers are further connected by the C-terminal tail of one GRASP domain inserting into the binding pocket of the PDZ1 domain in another dimer. Biochemical analysis suggests that both types of contacts are relatively weak but are needed in combination for GRASP-mediated Golgi stacking. Our results unveil a novel mode of membrane tethering by GRASP proteins and provide insight into the mechanism of Golgi stacking.	[Feng, Yanbin; Li, Xinxin; Liu, Xinqi] Nankai Univ, Coll Life Sci, Dept Biochem & Mol Biol, Tianjin 300071, Peoples R China; [Feng, Yanbin; Li, Xinxin; Liu, Xinqi] Nankai Univ, State Key Lab Med Chem Biol, Tianjin 300071, Peoples R China; [Yu, Wenying; Lin, Shaoyu; Zhou, Ying; Hu, Junjie] Nankai Univ, Coll Life Sci, Dept Genet & Cell Biol, Tianjin 300071, Peoples R China; [Yu, Wenying; Lin, Shaoyu; Zhou, Ying; Hu, Junjie] Nankai Univ, Tianjin Key Lab Prot Sci, Tianjin 300071, Peoples R China	Nankai University; Nankai University; Nankai University; Nankai University	Hu, JJ (corresponding author), Nankai Univ, Coll Life Sci, Dept Genet & Cell Biol, Tianjin 300071, Peoples R China.	huj@nankai.edu.cn; liu2008@nankai.edu.cn			National Basic Research Program of China 973 Program [2010CB911800, 2010CB833702]; National S&T Major Project on Major Infectious Diseases Grants from the Ministry of Science and Technology of China [2012ZX10001006-002, 2012ZX10001-008]; National Science Foundation of China [31225006]; International Early Career Scientist grant from the Howard Hughes Medical Institute	National Basic Research Program of China 973 Program(National Basic Research Program of China); National S&T Major Project on Major Infectious Diseases Grants from the Ministry of Science and Technology of China; National Science Foundation of China(National Natural Science Foundation of China (NSFC)); International Early Career Scientist grant from the Howard Hughes Medical Institute(Howard Hughes Medical Institute)	This work was supported by National Basic Research Program of China 973 Program Grant 2010CB911800 and National S&T Major Project on Major Infectious Diseases Grants 2012ZX10001006-002 and 2012ZX10001-008 from the Ministry of Science and Technology of China (to X. L.) and by National Basic Research Program of China 973 Program Grant 2010CB833702, National Science Foundation of China Grant 31225006, and an International Early Career Scientist grant from the Howard Hughes Medical Institute (to J. H.).	Bachert C, 2010, J BIOL CHEM, V285, P16294, DOI 10.1074/jbc.M110.116129; Barr FA, 1998, EMBO J, V17, P3258, DOI 10.1093/emboj/17.12.3258; Barr FA, 1997, CELL, V91, P253, DOI 10.1016/S0092-8674(00)80407-9; Bernstein A, 2008, TRENDS MICROBIOL, V16, P553, DOI 10.1016/j.tim.2008.08.009; CLUETT EB, 1992, J CELL SCI, V103, P773; Craig RB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046778; Doyle DA, 1996, CELL, V85, P1067, DOI 10.1016/S0092-8674(00)81307-0; Dupont N, 2011, EMBO J, V30, P4701, DOI 10.1038/emboj.2011.398; Duran JM, 2010, J CELL BIOL, V188, P527, DOI 10.1083/jcb.200911154; FARQUHAR MG, 1985, ANNU REV CELL BIOL, V1, P447, DOI 10.1146/annurev.cb.01.110185.002311; Feinstein TN, 2008, MOL BIOL CELL, V19, P2696, DOI 10.1091/mbc.E07-11-1200; Jesch SA, 2001, MOL BIOL CELL, V12, P1811, DOI 10.1091/mbc.12.6.1811; KLAUSNER RD, 1992, J CELL BIOL, V116, P1071, DOI 10.1083/jcb.116.5.1071; Lin CY, 2000, P NATL ACAD SCI USA, V97, P12589, DOI 10.1073/pnas.220423497; LIPPINCOTTSCHWARTZ J, 1990, CELL, V60, P821, DOI 10.1016/0092-8674(90)90096-W; Manjithaya R, 2010, J CELL BIOL, V188, P537, DOI 10.1083/jcb.200911149; Pfeffer SR, 2001, J CELL BIOL, V155, P873, DOI 10.1083/jcb.200109095; Preisinger C, 2005, EMBO J, V24, P753, DOI 10.1038/sj.emboj.7600569; Puthenveedu MA, 2006, NAT CELL BIOL, V8, P238, DOI 10.1038/ncb1366; RAMBOURG A, 1990, EUR J CELL BIOL, V51, P189; Schuck P, 2003, ANAL BIOCHEM, V320, P104, DOI 10.1016/S0003-2697(03)00289-6; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Sengupta D, 2010, J BIOL CHEM, V285, P39994, DOI 10.1074/jbc.M110.189449; Sengupta D, 2009, J CELL BIOL, V186, P41, DOI 10.1083/jcb.200902110; Short B, 2001, J CELL BIOL, V155, P877, DOI 10.1083/jcb.200108079; Shorter J, 1999, EMBO J, V18, P4949, DOI 10.1093/emboj/18.18.4949; Sutterlin C, 2005, MOL BIOL CELL, V16, P3211, DOI 10.1091/mbc.E04-12-1065; Tang DM, 2010, TRAFFIC, V11, P827, DOI 10.1111/j.1600-0854.2010.01055.x; Truschel ST, 2011, J BIOL CHEM, V286, P20125, DOI 10.1074/jbc.C111.245324; Wang YZ, 2005, J BIOL CHEM, V280, P4921, DOI 10.1074/jbc.M412407200; Wang YZ, 2003, EMBO J, V22, P3279, DOI 10.1093/emboj/cdg317; WARREN G, 1993, ANNU REV BIOCHEM, V62, P323, DOI 10.1146/annurev.bi.62.070193.001543; Wu YH, 2011, NATURE, V475, P510, DOI 10.1038/nature10183; Xiang Y, 2010, J CELL BIOL, V188, P237, DOI 10.1083/jcb.200907132; Zhang MY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044241	35	36	38	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 27	2013	288	39					28418	28427		10.1074/jbc.M113.478024	http://dx.doi.org/10.1074/jbc.M113.478024			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302OB	23940043	Green Published, hybrid			2022-12-25	WOS:000330612800069
J	Tan, EP; Caro, S; Potnis, A; Lanza, C; Slawson, C				Tan, Ee Phie; Caro, Sarah; Potnis, Anish; Lanza, Christopher; Slawson, Chad			O-Linked N-Acetylglucosamine Cycling Regulates Mitotic Spindle Organization	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AURORA-B KINASE; CELL-CYCLE; CHROMOSOME CONDENSATION; HISTONE H3; CENP-A; PHOSPHORYLATION; GLCNAC; ACTIVATION; COMPLEX; MECHANISM	Any defects in the correct formation of the mitotic spindle will lead to chromosomal segregation errors, mitotic arrest, or aneuploidy. We demonstrate that O-linked N-acetylglucosamine (O-GlcNAc), a post-translational modification of serine and threonine residues in nuclear and cytoplasmic proteins, regulates spindle function. In O-GlcNAc transferase or O-GlcNAcase gain of function cells, the mitotic spindle is incorrectly assembled. Chromosome condensation and centrosome assembly is impaired in these cells. The disruption in spindle architecture is due to a reduction in histone H3 phosphorylation by Aurora kinase B. However, gain of function cells treated with the O-GlcNAcase inhibitor Thiamet-G restored the assembly of the spindle and partially rescued histone phosphorylation. Together, these data suggest that the coordinated addition and removal of O-GlcNAc, termed O-GlcNAc cycling, regulates mitotic spindle organization and provides a potential new perspective on how O-GlcNAc regulates cellular events.	[Tan, Ee Phie; Caro, Sarah; Potnis, Anish; Lanza, Christopher; Slawson, Chad] Univ Kansas, Med Ctr, Dept Biochem & Mol Biol, Kansas City, MO 64108 USA; [Slawson, Chad] Univ Kansas, Med Ctr, KUMC Canc Ctr, Kansas City, MO 64108 USA; [Slawson, Chad] Univ Kansas, Med Ctr, Inst Reprod Hlth & Regenerat Med, Kansas City, MO 64108 USA	University of Kansas; University of Kansas; University of Kansas	Slawson, C (corresponding author), Univ Kansas, Med Ctr, Dept Biochem & Mol Biol, Kansas City, MO 64108 USA.	cslawson@kumc.edu	Tan, Ee Phie/AAC-8378-2021		Institutional Development Award (IDeA) from the NIGMS of the National Institutes of Health [P20GM12345]	Institutional Development Award (IDeA) from the NIGMS of the National Institutes of Health	This work was supported, in whole or in part, by an Institutional Development Award (IDeA) from the NIGMS of the National Institutes of Health under Grant Number P20GM12345.	Bolton MA, 2002, MOL BIOL CELL, V13, P3064, DOI 10.1091/mbc.E02-02-0092; Carmena M, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001250; Cheung WD, 2008, J BIOL CHEM, V283, P33935, DOI 10.1074/jbc.M806199200; Clark RJ, 2003, J BIOL CHEM, V278, P44230, DOI 10.1074/jbc.M303810200; CLARKE PR, 1993, MOL BIOL CELL, V4, P397, DOI 10.1091/mbc.4.4.397; Daub H, 2008, MOL CELL, V31, P438, DOI 10.1016/j.molcel.2008.07.007; DeLuca JG, 2006, CELL, V127, P969, DOI 10.1016/j.cell.2006.09.047; Dephoure N, 2008, P NATL ACAD SCI USA, V105, P10762, DOI 10.1073/pnas.0805139105; Dias WB, 2009, J BIOL CHEM, V284, P21327, DOI 10.1074/jbc.M109.007310; Eyers PA, 2003, CURR BIOL, V13, P691, DOI 10.1016/S0960-9822(03)00166-0; Fisher D, 2012, J CELL SCI, V125, P4703, DOI 10.1242/jcs.106351; Fong JJ, 2012, J BIOL CHEM, V287, P12195, DOI 10.1074/jbc.M111.315804; Fujiki R, 2011, NATURE, V480, P557, DOI 10.1038/nature10656; Giet R, 2001, J CELL BIOL, V152, P669, DOI 10.1083/jcb.152.4.669; Grosstessner-Hain K, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M111.008540; Hayama S, 2007, CANCER RES, V67, P4113, DOI 10.1158/0008-5472.CAN-06-4705; Heng YW, 2012, J CELL SCI, V125, P1579, DOI 10.1242/jcs.096818; Hirota T, 2003, CELL, V114, P585, DOI 10.1016/S0092-8674(03)00642-1; Hutterer A, 2006, DEV CELL, V11, P147, DOI 10.1016/j.devcel.2006.06.002; Jang YJ, 2002, J BIOL CHEM, V277, P44115, DOI 10.1074/jbc.M202172200; Kimura K, 2001, J BIOL CHEM, V276, P5417, DOI 10.1074/jbc.C000873200; Kunitoku N, 2003, DEV CELL, V5, P853, DOI 10.1016/S1534-5807(03)00364-2; Loncarek J, 2007, NATURE, V450, P745, DOI 10.1038/nature06344; Macauley MS, 2010, CHEM BIOL, V17, P937, DOI 10.1016/j.chembiol.2010.07.006; Macauley MS, 2008, J BIOL CHEM, V283, P34687, DOI 10.1074/jbc.M804525200; Meunier S, 2012, J CELL SCI, V125, P2805, DOI 10.1242/jcs.092429; MUELLER PR, 1995, MOL BIOL CELL, V6, P119, DOI 10.1091/mbc.6.1.119; Nigg EA, 2001, NAT REV MOL CELL BIO, V2, P21, DOI 10.1038/35048096; Ozlu N, 2010, MOL CELL PROTEOMICS, V9, P336, DOI 10.1074/mcp.M900308-MCP200; Petsalaki E, 2011, J CELL BIOL, V195, P449, DOI 10.1083/jcb.201104023; Pfau SJ, 2012, EMBO REP, V13, P515, DOI 10.1038/embor.2012.65; Qi GY, 2010, ORAL ONCOL, V46, P263, DOI 10.1016/j.oraloncology.2010.01.004; Rahal R, 2008, GENE DEV, V22, P1534, DOI 10.1101/gad.1638308; Sakabe K, 2010, P NATL ACAD SCI USA, V107, P19915, DOI 10.1073/pnas.1009023107; Sakabe K, 2010, J BIOL CHEM, V285, P34460, DOI 10.1074/jbc.M110.158170; Seshan A, 2004, CURR OPIN CELL BIOL, V16, P41, DOI 10.1016/j.ceb.2003.11.003; Slawson C, 2005, J BIOL CHEM, V280, P32944, DOI 10.1074/jbc.M503396200; Slawson C, 2008, MOL BIOL CELL, V19, P4130, DOI 10.1091/mbc.E07-11-1146; Slawson C, 2011, NAT REV CANCER, V11, P678, DOI 10.1038/nrc3114; Tong Y, 2008, ONCOGENE, V27, P6385, DOI 10.1038/onc.2008.234; Tseng BS, 2010, DEV CELL, V18, P903, DOI 10.1016/j.devcel.2010.05.018; Verdaasdonk JS, 2011, NAT REV MOL CELL BIO, V12, P320, DOI 10.1038/nrm3107; Walter AO, 2000, ONCOGENE, V19, P4906, DOI 10.1038/sj.onc.1203847; Wang ZH, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000526; Wei Y, 1999, CELL, V97, P99, DOI 10.1016/S0092-8674(00)80718-7; Welburn JPI, 2010, MOL CELL, V38, P383, DOI 10.1016/j.molcel.2010.02.034; Yang J, 2009, BIOCHEM J, V417, P355, DOI 10.1042/BJ20081365; Yi W, 2012, SCIENCE, V337, P975, DOI 10.1126/science.1222278; Yuzwa SA, 2008, NAT CHEM BIOL, V4, P483, DOI 10.1038/nchembio.96; Zeitlin SG, 2001, J CELL BIOL, V155, P1147, DOI 10.1083/jcb.200108125; Zhang SS, 2011, J BIOL CHEM, V286, P37483, DOI 10.1074/jbc.M111.284885	51	27	29	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 20	2013	288	38					27085	27099		10.1074/jbc.M113.470187	http://dx.doi.org/10.1074/jbc.M113.470187			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302IG	23946484	Green Published, hybrid			2022-12-25	WOS:000330597300009
J	Simon, S; Dimitrova, V; Gibert, B; Virot, S; Mounier, N; Nivon, M; Kretz-Remy, C; Corset, V; Mehlen, P; Arrigo, AP				Simon, Stephanie; Dimitrova, Valeriya; Gibert, Benjamin; Virot, Sophie; Mounier, Nicole; Nivon, Mathieu; Kretz-Remy, Carole; Corset, Veronique; Mehlen, Patrick; Arrigo, Andre-Patrick			Analysis of the Dominant Effects Mediated by Wild Type or R120G Mutant of alpha B-crystallin (HspB5) towards Hsp27 (HspB1)	PLOS ONE			English	Article							HEAT-SHOCK-PROTEIN; SMALL STRESS-PROTEINS; OXIDATIVE STRESS; A-CRYSTALLIN; CHAPERONE FUNCTION; TNF-ALPHA; HETEROOLIGOMERIC COMPLEXES; PROTECTIVE FUNCTION; ACTIN CYTOSKELETON; REDOX HOMEOSTASIS	Several human small heat shock proteins (sHsps) are phosphorylated oligomeric chaperones that enhance stress resistance. They are characterized by their ability to interact and form polydispersed hetero-oligomeric complexes. We have analyzed the cellular consequences of the stable expression of either wild type HspB5 or its cataracts and myopathies inducing R120G mutant in growing and oxidative stress treated HeLa cells that originally express only HspB1. Here, we describe that wild type and mutant HspB5 induce drastic and opposite effects on cell morphology and oxidative stress resistance. The cellular distribution and phosphorylation of these polypeptides as well as the oligomerization profile of the resulting hetero-oligomeric complexes formed by HspB1 with the two types of exogenous polypeptides revealed the dominant effects induced by HspB5 polypeptides towards HspB1. The R120G mutation enhanced the native size and salt resistance of HspB1-HspB5 complex. However, in oxidative conditions the interaction between HspB1 and mutant HspB5 was drastically modified resulting in the aggregation of both partners. The mutation also induced the redistribution of HspB1 phosphorylated at serine 15, originally observed at the level of the small oligomers that do not interact with wild type HspB5, to the large oligomeric complex formed with mutant HspB5. This phosphorylation stabilized the interaction of HspB1 with mutant HspB5. A dominant negative effect towards HspB1 appears therefore as an important event in the cellular sensitivity to oxidative stress mediated by mutated HspB5 expression. These observations provide novel data that describe how a mutated sHsp can alter the protective activity of another member of this family of chaperones.	[Simon, Stephanie] Hop Henri Mondor Univ, Creteil, France; [Dimitrova, Valeriya] Univ Bern, Inst Pathol, Dept Clin Res, Div Pediat Hematol Oncol,Insel Spital, Bern, Switzerland; [Simon, Stephanie; Dimitrova, Valeriya; Gibert, Benjamin; Virot, Sophie; Mounier, Nicole; Nivon, Mathieu; Kretz-Remy, Carole; Arrigo, Andre-Patrick] Univ Lyon 1, CNRS, CGphiMC, UMR 5534, F-69622 Villeurbanne, France; [Gibert, Benjamin; Corset, Veronique; Mehlen, Patrick; Arrigo, Andre-Patrick] Univ Lyon 1, Ctr Leon Berard, Lyon Canc Res Ctr, Apoptosis Canc & Dev Lab,INSERM,CNRS,U1052,UMR286, F-69365 Lyon, France	Assistance Publique Hopitaux Paris (APHP); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Henri-Mondor - APHP; University of Bern; University Hospital of Bern; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; UNICANCER; Centre Leon Berard	Arrigo, AP (corresponding author), Univ Lyon 1, CNRS, CGphiMC, UMR 5534, F-69622 Villeurbanne, France.	parrigo@me.com	Stephanie, Simon/A-3845-2013; Kretz-Remy, Carole/J-7850-2019	Kretz-Remy, Carole/0000-0002-9553-5598; GIBERT, Benjamin/0000-0002-5295-3124	Retina France; Association Francaise contre les Myopathies (AFM); CNRS	Retina France; Association Francaise contre les Myopathies (AFM)(Association Francaise contre les Myopathies); CNRS(Centre National de la Recherche Scientifique (CNRS))	This work was supported by Retina France http://www.retina.fr (A-PA), the Association Francaise contre les Myopathies (AFM) (A-PA and SS) and CNRS (PM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aquilina JA, 2004, J BIOL CHEM, V279, P28675, DOI 10.1074/jbc.M403348200; Arrigo AP, 2012, SCIENTIFICA, V2012, DOI 10.6064/2012/185641; Arrigo AP, 2010, CURR MOL MED, V10, P776, DOI 10.2174/156652410793937804; Arrigo AP, 2012, CURR MOL MED, V12, P1151, DOI 10.2174/156652412803306693; Arrigo AP, 2007, ADV EXP MED BIOL, V594, P14; Arrigo AP, 2013, FEBS LETT, V587, P1959, DOI 10.1016/j.febslet.2013.05.011; Arrigo AP, 2011, METHODS MOL BIOL, V787, P105, DOI 10.1007/978-1-61779-295-3_9; Arrigo Andre-Patrick, 2007, V2, P73; Arrigo Andre-Patrick, 2002, Prog Mol Subcell Biol, V28, P171; Arrigo AP, 2005, ANTIOXID REDOX SIGN, V7, P414, DOI 10.1089/ars.2005.7.414; ARRIGO AP, 1987, J BIOL CHEM, V262, P15359; ARRIGO AP, 1988, MOL CELL BIOL, V8, P5059, DOI 10.1128/MCB.8.12.5059; Arrigo AP, 1994, BIOL HEAT SHOCK PROT, P335; Bagchi M, 2002, J CELL BIOCHEM, V84, P278, DOI 10.1002/jcb.10023; BELLOMO G, 1990, J CELL PHYSIOL, V143, P118, DOI 10.1002/jcp.1041430116; BENNARDINI F, 1992, CIRC RES, V71, P288, DOI 10.1161/01.RES.71.2.288; BHAT SP, 1989, BIOCHEM BIOPH RES CO, V158, P319, DOI 10.1016/S0006-291X(89)80215-3; Bolte S, 2006, J MICROSC-OXFORD, V224, P213, DOI 10.1111/j.1365-2818.2006.01706.x; Bova MP, 1999, P NATL ACAD SCI USA, V96, P6137, DOI 10.1073/pnas.96.11.6137; Braun N, 2011, P NATL ACAD SCI USA, V108, P20491, DOI 10.1073/pnas.1111014108; Bruey JM, 2000, ONCOGENE, V19, P4855, DOI 10.1038/sj.onc.1203850; Bukach OV, 2009, BBA-PROTEINS PROTEOM, V1794, P486, DOI 10.1016/j.bbapap.2008.11.010; Ciocca DR, 2013, ARCH TOXICOL, V87, P19, DOI 10.1007/s00204-012-0918-z; Criddle DN, 2006, J BIOL CHEM, V281, P40485, DOI 10.1074/jbc.M607704200; den Engelsman J, 2003, J BIOL CHEM, V278, P4699, DOI 10.1074/jbc.M211403200; den Englesman J, 2005, J BIOL CHEM, V280, P37139, DOI 10.1074/jbc.M504106200; Djabali K, 1999, EXP CELL RES, V253, P649, DOI 10.1006/excr.1999.4679; Ehrnsperger M, 1997, EMBO J, V16, P221, DOI 10.1093/emboj/16.2.221; Fu L, 2003, BIOCHEM BIOPH RES CO, V302, P710, DOI 10.1016/S0006-291X(03)00257-2; Gibert B, 2011, ONCOGENE, V30, P3672, DOI 10.1038/onc.2011.73; Gibert B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029719; Guay J, 1997, J CELL SCI, V110, P357; Guo ZY, 2000, BIOCHEM BIOPH RES CO, V270, P183, DOI 10.1006/bbrc.2000.2401; HORWITZ J, 1992, P NATL ACAD SCI USA, V89, P10449, DOI 10.1073/pnas.89.21.10449; Ito H, 2003, CELL MOL LIFE SCI, V60, P1217, DOI 10.1007/s00018-003-3024-9; Ito K, 2001, J BIOL CHEM, V276, P5346, DOI 10.1074/jbc.M009004200; JAKOB U, 1993, J BIOL CHEM, V268, P1517; Kappe G, 2003, CELL STRESS CHAPERON, V8, P53, DOI 10.1379/1466-1268(2003)8<53:THGECS>2.0.CO;2; KATO K, 1994, J BIOL CHEM, V269, P11274; Khansari N, 2009, RECENT PATENTS INFLA, V3, P73, DOI 10.2174/187221309787158371; Kostenko S, 2009, CELL MOL LIFE SCI, V66, P3289, DOI 10.1007/s00018-009-0086-3; Koteiche HA, 2003, J BIOL CHEM, V278, P10361, DOI 10.1074/jbc.M211851200; Kundu M, 2007, BIOPOLYMERS, V86, P177, DOI 10.1002/bip.20716; Lambert H, 1999, J BIOL CHEM, V274, P9378, DOI 10.1074/jbc.274.14.9378; LANDRY J, 1989, J CELL BIOL, V109, P7, DOI 10.1083/jcb.109.1.7; Lee GJ, 1997, EMBO J, V16, P659, DOI 10.1093/emboj/16.3.659; Liang JJN, 2000, MOL VIS, V6, P10; Liu CH, 1999, BIOCHEM BIOPH RES CO, V255, P256, DOI 10.1006/bbrc.1999.0174; Liu JP, 2004, EXP EYE RES, V79, P393, DOI 10.1016/j.exer.2004.06.015; MEHLEN P, 1995, J IMMUNOL, V154, P363; Mehlen P, 1997, BIOCHEM BIOPH RES CO, V241, P187, DOI 10.1006/bbrc.1997.7635; Mehlen P, 1996, EMBO J, V15, P2695, DOI 10.1002/j.1460-2075.1996.tb00630.x; MEHLEN P, 1994, EUR J BIOCHEM, V221, P327, DOI 10.1111/j.1432-1033.1994.tb18744.x; Michiel M, 2009, BIOCHEMISTRY-US, V48, P442, DOI 10.1021/bi8014967; MIRON T, 1991, J CELL BIOL, V114, P255, DOI 10.1083/jcb.114.2.255; Mounier N, 2002, CELL STRESS CHAPERON, V7, P167, DOI 10.1379/1466-1268(2002)007<0167:ACASHS>2.0.CO;2; Mymrikov EV, 2012, CELL STRESS CHAPERON, V17, P157, DOI 10.1007/s12192-011-0296-0; NICHOLL ID, 1994, EMBO J, V13, P945, DOI 10.1002/j.1460-2075.1994.tb06339.x; Paul C, 2010, EXP CELL RES, V316, P1535, DOI 10.1016/j.yexcr.2010.03.006; Preville X, 1999, EXP CELL RES, V247, P61, DOI 10.1006/excr.1998.4347; Preville X, 1998, CELL STRESS CHAPERON, V3, P177, DOI 10.1379/1466-1268(1998)003<0177:PINEFP>2.3.CO;2; Preville X, 1998, J CELL BIOCHEM, V69, P436, DOI 10.1002/(SICI)1097-4644(19980615)69:4<436::AID-JCB5>3.0.CO;2-O; Quinlan Roy, 2002, Prog Mol Subcell Biol, V28, P219; Raju I, 2013, BIOCHEM BIOPH RES CO, V430, P107, DOI 10.1016/j.bbrc.2012.11.051; Renzing J, 1996, J CELL SCI, V109, P1105; Richards EH, 1996, CANCER RES, V56, P2446; Rogalla T, 1999, J BIOL CHEM, V274, P18947, DOI 10.1074/jbc.274.27.18947; ROUSE J, 1994, CELL, V78, P1027, DOI 10.1016/0092-8674(94)90277-1; Saha S, 2004, PROTEINS, V57, P610, DOI 10.1002/prot.20230; Simon S, 2007, J BIOL CHEM, V282, P34276, DOI 10.1074/jbc.M703267200; Simon S, 2007, BIOCHEMISTRY-US, V46, P9605, DOI 10.1021/bi7003125; Simon S, 2010, PROTEIN SCI ENG, P457; Skouri-Panet F, 2012, BIOCHIMIE, V94, P975, DOI 10.1016/j.biochi.2011.12.018; Sreelakshmi Y, 2005, BIOCHEMISTRY-US, V44, P12245, DOI 10.1021/bi051005h; Sreelakshmi Y, 2006, MOL VIS, V12, P581; SRINIVASAN AN, 1992, J BIOL CHEM, V267, P23337; Sun TX, 1997, J BIOL CHEM, V272, P6220, DOI 10.1074/jbc.272.10.6220; Sun TX, 1998, J BIOL CHEM, V273, P286, DOI 10.1074/jbc.273.1.286; Theriault JR, 2004, J BIOL CHEM, V279, P23463, DOI 10.1074/jbc.M402325200; Treweek TM, 2005, FEBS J, V272, P711, DOI 10.1111/j.1742-4658.2004.04507.x; van den Ijssel PRLA, 1998, BIOCHEM BIOPH RES CO, V247, P518, DOI 10.1006/bbrc.1998.8699; Vicart P, 1998, NAT GENET, V20, P92, DOI 10.1038/1765; VOORTER CEM, 1989, FEBS LETT, V259, P50; Wang XJ, 2001, CIRC RES, V89, P84, DOI 10.1161/hh1301.092688; Yan LJ, 2002, EMBO J, V21, P5164, DOI 10.1093/emboj/cdf528; ZANTEMA A, 1992, J BIOL CHEM, V267, P12936; Zhang HL, 2010, J MOL CELL CARDIOL, V49, P918, DOI 10.1016/j.yjmcc.2010.09.004; Zhang X, 2010, HYPERTENSION, V55, P1412, DOI 10.1161/HYPERTENSIONAHA.109.147066; Zobel ATC, 2003, HUM MOL GENET, V12, P1609, DOI 10.1093/hmg/ddg173	89	20	20	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2013	8	8							e70545	10.1371/journal.pone.0070545	http://dx.doi.org/10.1371/journal.pone.0070545			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	200UV	23950959	Green Published, gold, Green Submitted			2022-12-25	WOS:000323097300027
J	Teuchies, J; Vandenbruwaene, W; Carpentier, R; Bervoets, L; Temmerman, S; Wang, C; Maris, T; Cox, TJS; Van Braeckel, A; Meire, P				Teuchies, Johannes; Vandenbruwaene, Wouter; Carpentier, Roos; Bervoets, Lieven; Temmerman, Stijn; Wang, Chen; Maris, Tom; Cox, Tom J. S.; Van Braeckel, Alexander; Meire, Patrick			Estuaries as Filters: The Role of Tidal Marshes in Trace Metal Removal	PLOS ONE			English	Article							SUSPENDED SEDIMENT CONCENTRATIONS; SCHELDT ESTUARY; HUMBER ESTUARY; MANAGED REALIGNMENT; GIRONDE ESTUARY; SW NETHERLANDS; WATER-QUALITY; HEAVY-METALS; MASS-BALANCE; SEA-LEVEL	Flux calculations demonstrate that many estuaries are natural filters for trace metals. Yet, the underlying processes are poorly investigated. In the present study, it was hypothesized that intertidal marshes contribute significantly to the contaminant filter function of estuaries. Trace metal concentrations and sediment characteristics were measured along a transect from the subtidal, over an intertidal flat and marsh to a restored marsh with controlled reduced tide. Metal concentrations in the intertidal and restored marsh were found to be a factor two to five higher than values in the subtidal and intertidal flat sediments. High metal concentrations and high accretion rates indicate a high metal accumulation capacity of the intertidal marshes. Overbank sedimentation in the tidal marshes of the entire estuary was calculated to remove 25% to 50% of the riverine metal influx, even though marshes comprise less than 8% of the total surface of the estuary. In addition, the large-scale implementation of planned tidal marsh restoration projects was estimated to almost double the trace metal storage capacity of the present natural tidal marshes in the estuary.	[Teuchies, Johannes; Carpentier, Roos; Temmerman, Stijn; Wang, Chen; Maris, Tom; Cox, Tom J. S.; Meire, Patrick] Univ Antwerp, Ecosyst Management Res Grp, Dept Biol, Antwerp, Belgium; [Vandenbruwaene, Wouter] Flemish Govt, Flanders Hydraul Res, Antwerp, Belgium; [Bervoets, Lieven] Univ Antwerp, Syst Physiol & Ecotoxicol Res Grp, Dept Biol, B-2020 Antwerp, Belgium; [Van Braeckel, Alexander] Res Inst Nat & Forest, Dept Biodivers & Nat Environm, Brussels, Belgium	University of Antwerp; Flanders Hydraulics Research (FHR); University of Antwerp; Research Institute for Nature & Forest	Teuchies, J (corresponding author), Univ Antwerp, Ecosyst Management Res Grp, Dept Biol, Antwerp, Belgium.	johannes.teuchies@ua.ac.be	Temmerman, Stijn/C-5521-2009; Wang, Chen/AAX-7615-2021; Bervoets, Lieven/E-5012-2015	Wang, Chen/0000-0003-3914-0767; Temmerman, Stijn/0000-0003-3346-9115; Van Braeckel, Alexander/0000-0002-6197-3012; Vandenbruwaene, Wouter/0000-0003-3779-6076	Water- wegen en Zeekanaal NV; afdeling Zeeschelde; Agentschap voor Natuur en Bos; The Research Foundation - Flanders	Water- wegen en Zeekanaal NV; afdeling Zeeschelde; Agentschap voor Natuur en Bos; The Research Foundation - Flanders(FWO)	The authors gratefully acknowledge financial support from Water- wegen en Zeekanaal NV, afdeling Zeeschelde and Agentschap voor Natuur en Bos. Johannes Teuchies acknowledges The Research Foundation - Flanders for personal funding (PhD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrews JE, 2008, SCI TOTAL ENVIRON, V405, P1, DOI 10.1016/j.scitotenv.2008.07.044; Andrews JE, 2006, SCI TOTAL ENVIRON, V371, P19, DOI 10.1016/j.scitotenv.2006.08.021; Audry S, 2007, MAR CHEM, V107, P433, DOI 10.1016/j.marchem.2007.09.008; Baeyens W, 2007, SCI TOTAL ENVIRON, V384, P409, DOI 10.1016/j.scitotenv.2007.05.044; Baeyens W, 2005, HYDROBIOLOGIA, V540, P141, DOI 10.1007/s10750-004-7129-4; Baeyens W, 1998, HYDROBIOLOGIA, V366, P91; Baeyens W, 1998, HYDROBIOLOGIA, V366, P109; Baeyens Willy, 1997, Hydrobiologia, V366, P1, DOI 10.1023/A:1003164009031; Beauchard O, 2011, ECOL ENG, V37, P1849, DOI 10.1016/j.ecoleng.2011.06.010; BEEFTINK WG, 1982, SCI TOTAL ENVIRON, V25, P199, DOI 10.1016/0048-9697(82)90015-8; Birch GF, 2011, J SOIL SEDIMENT, V11, P194, DOI 10.1007/s11368-010-0304-5; Bouezmarni M, 2005, HYDROBIOLOGIA, V540, P155, DOI 10.1007/s10750-004-7131-x; Buggy CJ, 2008, ENVIRON POLLUT, V155, P308, DOI 10.1016/j.envpol.2007.11.032; Cave RR, 2005, ESTUAR COAST SHELF S, V62, P547, DOI 10.1016/j.ecss.2004.09.017; Chaudry MA, 2008, ESTUAR COAST, V31, P430, DOI 10.1007/s12237-007-9030-7; Claus J, 2009, 77042 WL BELG WAT LA; Cox TJS, 2006, ECOL ENG, V28, P55, DOI 10.1016/j.ecoleng.2006.04.001; De Gieter M, 2005, MAR CHEM, V95, P15, DOI 10.1016/j.marchem.2004.06.012; De Smedt F, 1998, HYDROBIOLOGIA, V366, P143; Du Laing G, 2009, SCI TOTAL ENVIRON, V407, P3972, DOI 10.1016/j.scitotenv.2008.07.025; Du Laing G, 2007, J ENVIRON MONITOR, V9, P449, DOI 10.1039/b618772b; Fettweis M, 1998, ESTUAR COAST SHELF S, V47, P21, DOI 10.1006/ecss.1998.0338; Flemish Government, 2007, WEST ZEESCH DREDG 20; Gerringa LJA, 2001, J SEA RES, V46, P201, DOI 10.1016/S1385-1101(01)00081-8; Luoma SN, 2008, METAL CONTAMINATION IN AQUATIC ENVIRONMENTS: SCIENCE AND LATERAL MANAGEMENT, P1; Maris T, 2007, HYDROBIOLOGIA, V588, P31, DOI 10.1007/s10750-007-0650-5; Masson M, 2009, APPL GEOCHEM, V24, P1747, DOI 10.1016/j.apgeochem.2009.05.004; Meire P, 2005, HYDROBIOLOGIA, V540, P1, DOI 10.1007/s10750-005-0896-8; Millward GE, 1997, ESTUAR COAST SHELF S, V44, P97, DOI 10.1016/S0272-7714(97)80011-X; Monbet P, 2006, MAR CHEM, V98, P59, DOI 10.1016/j.marchem.2005.08.003; OSPAR, 2009, TRENDS WAT INP ASS R; Ouboter MRL, 1998, HYDROBIOLOGIA, V366, P129; Overesch M, 2007, ENVIRON POLLUT, V145, P800, DOI 10.1016/j.envpol.2006.05.016; Pan K, 2012, SCI TOTAL ENVIRON, V421, P3, DOI 10.1016/j.scitotenv.2011.03.013; Paucot H, 1997, MAR CHEM, V58, P229, DOI 10.1016/S0304-4203(97)00037-6; Pope ND, 2011, HYDROBIOLOGIA, V672, P49, DOI 10.1007/s10750-011-0758-5; REGNIER P, 1993, MAR CHEM, V43, P3, DOI 10.1016/0304-4203(93)90212-7; Rozan TF, 1999, MAR ENVIRON RES, V48, P335, DOI 10.1016/S0141-1136(99)00063-X; Rozan TF, 2001, LIMNOL OCEANOGR, V46, P2032, DOI 10.4319/lo.2001.46.8.2032; Sas M, 1993, BEHAV PARTICULATE MA; Spencer KL, 2003, ESTUAR COAST SHELF S, V57, P43, DOI 10.1016/S0272-7714(02)00324-4; Struyf E, 2007, BIOGEOCHEMISTRY, V82, P41, DOI 10.1007/s10533-006-9051-5; Temmerman S, 2004, MAR GEOL, V212, P1, DOI 10.1016/j.margeo.2004.10.021; Temmerman S, 2004, GEOMORPHOLOGY, V63, P39, DOI 10.1016/j.geomorph.2004.03.004; Temmerman S, 2003, MAR GEOL, V193, P151, DOI 10.1016/S0025-3227(02)00642-4; Temmerman S, 2003, EARTH SURF PROC LAND, V28, P739, DOI 10.1002/esp.495; Temmerman S, 2012, GEOPHYS RES LETT, V39, DOI 10.1029/2011GL050502; Teuchies J, 2012, SCI TOTAL ENVIRON, V419, P187, DOI 10.1016/j.scitotenv.2012.01.016; Thevenot DR, 2007, SCI TOTAL ENVIRON, V375, P180, DOI 10.1016/j.scitotenv.2006.12.008; Van Damme S, 2005, HYDROBIOLOGIA, V540, P29, DOI [10.1007/s10750-004-7102-2, 10.1007/s1050-004-7102-2]; Van Damme S, 2009, ESTUAR COAST SHELF S, V85, P197, DOI 10.1016/j.ecss.2009.08.005; Van der Kooij LA, 1982, WATERQUALITY WESTERS; VANALSENOY V, 1993, SCI TOTAL ENVIRON, V133, P153, DOI 10.1016/0048-9697(93)90119-Q; Vandecasteele B, 2003, ENVIRON POLLUT, V122, P7, DOI 10.1016/S0269-7491(02)00282-8; Vandenbruwaene W, 2011, GEOMORPHOLOGY, V130, P115, DOI 10.1016/j.geomorph.2011.03.004; Verlaan PAJ, 1998, ESTUAR COAST SHELF S, V46, P873, DOI 10.1006/ecss.1997.0323; Verlaan PAJ, 2000, ESTUAR COAST SHELF S, V50, P627, DOI 10.1006/ecss.1999.0599; Walling DE, 2003, HYDROBIOLOGIA, V494, P83, DOI 10.1023/A:1025489526364; Wartel S., 1977, GEOL MIJNBOUW, V56, P219; Weis JS, 2004, ENVIRON INT, V30, P685, DOI 10.1016/j.envint.2003.11.002; Weis JS, 2011, BIOSCIENCE, V61, P375, DOI 10.1525/bio.2011.61.5.6; Zwolsman J, 1999, THESIS UTRECHT; ZWOLSMAN JJG, 1993, MAR CHEM, V44, P73, DOI 10.1016/0304-4203(93)90007-B; [No title captured]	64	20	21	0	56	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2013	8	8							e70381	10.1371/journal.pone.0070381	http://dx.doi.org/10.1371/journal.pone.0070381			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	200ZE	23950927	gold, Green Published, Green Submitted			2022-12-25	WOS:000323109700031
J	Villanti, AC; Jiang, Y; Abrams, DB; Pyenson, BS				Villanti, Andrea C.; Jiang, Yiding; Abrams, David B.; Pyenson, Bruce S.			A Cost-Utility Analysis of Lung Cancer Screening and the Additional Benefits of Incorporating Smoking Cessation Interventions	PLOS ONE			English	Article							COMPUTED-TOMOGRAPHY; CLINICAL-PRACTICE; HEALTH; MORTALITY; DECISION; POPULATION; SMOKERS; IMPACT; VALUES; STAGE	Background: A 2011 report from the National Lung Screening Trial indicates that three annual low-dose computed tomography (LDCT) screenings for lung cancer reduced lung cancer mortality by 20% compared to chest X-ray among older individuals at high risk for lung cancer. Discussion has shifted from clinical proof to financial feasibility. The goal of this study was to determine whether LDCT screening for lung cancer in a commercially-insured population (aged 50-64) at high risk for lung cancer is cost-effective and to quantify the additional benefits of incorporating smoking cessation interventions in a lung cancer screening program. Methods and Findings: The current study builds upon a previous simulation model to estimate the cost-utility of annual, repeated LDCT screenings over 15 years in a high risk hypothetical cohort of 18 million adults between age 50 and 64 with 30+ pack-years of smoking history. In the base case, the lung cancer screening intervention cost $27.8 billion over 15 years and yielded 985,284 quality-adjusted life years (QALYs) gained for a cost-utility ratio of $28,240 per QALY gained. Adding smoking cessation to these annual screenings resulted in increases in both the costs and QALYs saved, reflected in cost-utility ratios ranging from $16,198 per QALY gained to $23,185 per QALY gained. Annual LDCT lung cancer screening in this high risk population remained cost-effective across all sensitivity analyses. Conclusions: The findings of this study indicate that repeat annual lung cancer screening in a high risk cohort of adults aged 50-64 is highly cost-effective. Offering smoking cessation interventions with the annual screening program improved the cost-effectiveness of lung cancer screening between 20% and 45%. The cost-utility ratios estimated in this study were in line with other accepted cancer screening interventions and support inclusion of annual LDCT screening for lung cancer in a high risk population in clinical recommendations.	[Villanti, Andrea C.; Abrams, David B.] Schroeder Inst Tobacco Res & Policy Studies, Washington, DC USA; [Villanti, Andrea C.; Abrams, David B.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Hlth Behav & Soc, Baltimore, MD USA; [Jiang, Yiding; Pyenson, Bruce S.] Milliman Inc, New York, NY USA; [Abrams, David B.] Georgetown Univ, Med Ctr, Dept Oncol, Washington, DC 20007 USA; [Abrams, David B.] Lombardi Comprehens Canc Ctr, Washington, DC USA	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Georgetown University	Pyenson, BS (corresponding author), Milliman Inc, New York, NY USA.	bruce.pyenson@milliman.com	Villanti, Andrea/ABE-6283-2020; Villanti, Andrea/AAM-9433-2021; Abrams, David B/AAY-7699-2020	Villanti, Andrea/0000-0003-3104-966X; Villanti, Andrea/0000-0003-3104-966X; Abrams, David B/0000-0002-0868-4350	American Legacy Foundation; Lung Cancer Alliance	American Legacy Foundation; Lung Cancer Alliance	This study was funded by the American Legacy Foundation and the Lung Cancer Alliance. The funders had no role in study design, data collection and analysis, decision to publish the manuscript or preparation of the manuscript.	Aberle DR, 2011, NEW ENGL J MED, V365, P395, DOI 10.1056/NEJMoa1102873; Abrams DB, 2010, AM J PREV MED, V38, pS351, DOI 10.1016/j.amepre.2009.12.011; Adhikari B., 2008, Morbidity and Mortality Weekly Report, V57, P1226; American Cancer Society, 2012, CANC FACTS FIG 2012; Bach PB, 2012, JAMA-J AM MED ASSOC, P1; Berman M, 2013, TOB CONTROL; Braithwaite RS, 2008, MED CARE, V46, P349, DOI 10.1097/MLR.0b013e31815c31a7; Brenner DJ, 2007, NEW ENGL J MED, V357, P2277, DOI 10.1056/NEJMra072149; Bureau of Labor Statistics, 2013, LAB FORC STAT CURR P; Burns D, 2000, SMOKING TOBACCO CONT, V12; Centers for Disease Control and Prevention (CDC), 1999, MMWR Morb Mortal Wkly Rep, V48, P986; Cox LS, 2003, CANCER, V98, P2495, DOI 10.1002/cncr.11813; Cromwell J, 1997, JAMA-J AM MED ASSOC, V278, P1759, DOI 10.1001/jama.278.21.1759; Doll R, 2004, BMJ-BRIT MED J, V328, P1519, DOI 10.1136/bmj.38142.554479.AE; Engelgau MM, 1998, JAMA-J AM MED ASSOC, V280, P1757; Farrelly MC, 2008, AM J PUBLIC HEALTH, V98, P304, DOI 10.2105/AJPH.2006.106377; Fiscella K, 1996, JAMA-J AM MED ASSOC, V275, P1247, DOI 10.1001/jama.275.16.1247; Gatsonis CA, 2011, RADIOLOGY, V258, P243, DOI 10.1148/radiol.10091808; Goldberg SW, 2010, POPUL HEALTH MANAG, V13, P33, DOI 10.1089/pop.2009.0010; Hanmer J, 2006, MED DECIS MAKING, V26, P391, DOI 10.1177/0272989X06290497; Heitman SJ, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000370; Henschke CI, 1999, LANCET, V354, P99, DOI 10.1016/S0140-6736(99)06093-6; Henschke CI, 2013, ANN INTERN MED, V158, P246, DOI 10.7326/0003-4819-158-4-201302190-00004; Javitz HS, 2004, AM J MANAG CARE, V10, P217; Maarcher Ann, 2011, Morbidity and Mortality Weekly Report, V60, P1513; Mahadevia PJ, 2003, JAMA-J AM MED ASSOC, V289, P313, DOI 10.1001/jama.289.3.313; Mandelblatt JS, 2002, JAMA-J AM MED ASSOC, V287, P2372, DOI 10.1001/jama.287.18.2372; Manser R, 2005, LUNG CANCER, V48, P171, DOI 10.1016/j.lungcan.2004.11.001; Marshall D, 2001, LUNG CANCER, V32, P227, DOI 10.1016/S0169-5002(00)00239-7; Marshall D, 2001, EUR J CANCER, V37, P1759, DOI 10.1016/S0959-8049(01)00205-2; McMahon PM, 2011, J THORAC ONCOL, V6, P1841, DOI 10.1097/JTO.0b013e31822e59b3; Musich S, 2003, AM J HEALTH PROMOT, V18, P133, DOI 10.4278/0890-1171-18.2.133; National Cancer Institute, 2012, SEER CANC STAT REV 1; National Comprehensive Cancer Network, 2011, NCCN CLIN PRACT GUID; New York Early Cancer Action Inv, 2007, RADIOLOGY, V243, P239, DOI 10.1148/radiol.2431060467; Ostroff JS, 2001, PREV MED, V33, P613, DOI 10.1006/pmed.2001.0935; Paltiel AD, 2005, NEW ENGL J MED, V352, P586, DOI 10.1056/NEJMsa042088; Park ER, 2009, ANN BEHAV MED, V37, P268, DOI 10.1007/s12160-009-9112-9; Polonsky TS, 2010, JAMA-J AM MED ASSOC, V303, P1610, DOI 10.1001/jama.2010.461; Prosser LA, 2000, ANN INTERN MED, V132, P769, DOI 10.7326/0003-4819-132-10-200005160-00002; Pyenson BS, 2012, HEALTH AFFAIR, V31, P770, DOI 10.1377/hlthaff.2011.0814; Rock V. J., 2007, Morbidity and Mortality Weekly Report, V56, P1157; Schiller J. S., 2012, VITAL HLTH STAT, V10, P10; Schoenbaum M, 1997, AM J PUBLIC HEALTH, V87, P755, DOI 10.2105/AJPH.87.5.755; Smith-Bindman R, 2012, JAMA-J AM MED ASSOC, V307, P2400, DOI 10.1001/jama.2012.5960; Social Security Administration, 2012, ACT LIF TABL PER LIF; Solberg LI, 2006, AM J PREV MED, V31, P62, DOI 10.1016/j.amepre.2006.03.013; Stout NK, 2006, JNCI-J NATL CANCER I, V98, P774, DOI 10.1093/jnci/djj210; Sturza J, 2010, MED DECIS MAKING, V30, P685, DOI 10.1177/0272989X10369004; Taylor KL, 2007, LUNG CANCER, V56, P125, DOI 10.1016/j.lungcan.2006.11.015; Tobacco Use and Dependence Guideline Panel, 2008, TREATING TOBACCO USE; Townsend CO, 2005, CANCER-AM CANCER SOC, V103, P2154, DOI 10.1002/cncr.21045; Tynan M., 2010, Morbidity and Mortality Weekly Report, V59, P487; Weinstein MC, 2008, MED CARE, V46, P343, DOI 10.1097/MLR.0b013e31816a7144; Winkelmayer WC, 2002, MED DECIS MAKING, V22, P417, DOI 10.1177/027298902236927; Yankelevitz DF, 2013, NEW ENGL J MED, V368, P1460, DOI 10.1056/NEJMc1213744; Yip R, 2013, EUR J CANC PREV	57	174	177	2	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2013	8	8							e71379	10.1371/journal.pone.0071379	http://dx.doi.org/10.1371/journal.pone.0071379			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	200ZE	23940744	gold, Green Published, Green Submitted			2022-12-25	WOS:000323109700097
J	Pritchard, SM; Cunha, CW; Nicola, AV				Pritchard, Suzanne M.; Cunha, Cristina W.; Nicola, Anthony V.			Analysis of Herpes Simplex Virion Tegument ICP4 Derived from Infected Cells and ICP4-Expressing Cells	PLOS ONE			English	Article							TRANSCRIPTIONAL REGULATORY PROTEIN; VIRUS TYPE-1 VIRIONS; BINDING PROTEIN; LOW PH; ENTRY; MUTANT; LOCALIZATION; POLYPEPTIDE; DELETION; ASSOCIATION	ICP4 is the major transcriptional regulatory protein of herpes simplex virus (HSV). It is expressed in infected cells with immediate early kinetics and is essential for viral growth. ICP4 is also a structural component of the virion tegument layer. Herpesviral tegument proteins exert regulatory functions important for takeover of the host cell. Tegument ICP4 has not been well characterized. We examined the ICP4 present in HSV-1 virions that were either derived from wild type infected cells or from ICP4-expressing (E5) cells infected with ICP4 deletion virus d120. Limited proteolysis demonstrated that virion-associated ICP4 from particles derived from E5 cells was indeed an internal component of the virion. A similar subset of virion structural proteins was detected in viral particles regardless of the cellular origin of ICP4. Genotypically ICP4-negative virions complemented with tegument ICP4 entered cells via a proteasome-dependent, pH-dependent pathway similar to wild type virions. In infected cells, ICP4 was distributed predominantly in intranuclear replication compartments regardless of whether it was expressed from a transgene or from the HSV genome.	[Pritchard, Suzanne M.; Cunha, Cristina W.; Nicola, Anthony V.] Washington State Univ, Dept Vet Microbiol & Pathol, Pullman, WA 99164 USA; [Cunha, Cristina W.] ARS, Anim Dis Res Unit, USDA, Pullman, WA USA; [Nicola, Anthony V.] Washington State Univ, Paul G Allen Sch Global Anim Hlth, Pullman, WA 99164 USA	Washington State University; United States Department of Agriculture (USDA); Washington State University	Nicola, AV (corresponding author), Washington State Univ, Dept Vet Microbiol & Pathol, Pullman, WA 99164 USA.	nicola@vetmed.wsu.edu	Cunha, Cristina/V-7622-2019; Cunha, Cristina/AAC-6120-2021	Cunha, Cristina/0000-0002-8168-5448	Public Health Service from the National Institute of Allergy and Infectious Diseases [AI096103, AI007025]; Marvel Shields Autzen Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007025, R21AI096103] Funding Source: NIH RePORTER	Public Health Service from the National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Marvel Shields Autzen Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This investigation was supported by Public Health Service grants AI096103 and AI007025 from the National Institute of Allergy and Infectious Diseases and a grant from the Marvel Shields Autzen Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BROWN SM, 1973, J GEN VIROL, V18, P329, DOI 10.1099/0022-1317-18-3-329; CAI WZ, 1992, J VIROL, V66, P2904, DOI 10.1128/JVI.66.5.2904-2915.1992; Connolly SA, 2011, NAT REV MICROBIOL, V9, P369, DOI 10.1038/nrmicro2548; COURTNEY RJ, 1974, VIROLOGY, V62, P539, DOI 10.1016/0042-6822(74)90414-0; Delboy MG, 2008, J VIROL, V82, P3381, DOI 10.1128/JVI.02296-07; Delboy MG, 2010, J VIROL, V84, P1637, DOI 10.1128/JVI.02041-09; Delboy MG, 2011, J VIROLOGY; DELUCA NA, 1985, J VIROL, V56, P558, DOI 10.1128/JVI.56.2.558-570.1985; DELUCA NA, 1987, NUCLEIC ACIDS RES, V15, P4491, DOI 10.1093/nar/15.11.4491; DeLuca NA, 2011, ALPHAHERPESVIRUSES: MOLECULAR VIROLOGY, P17; Dollery SJ, 2010, J VIROL, V84, P3759, DOI 10.1128/JVI.02573-09; Eisenberg RJ, 2012, VIRUSES-BASEL, V4, P800, DOI 10.3390/v4050800; FENG Y, 1992, J VIROL, V66, P2709, DOI 10.1128/JVI.66.5.2709-2716.1992; Geraghty RJ, 1998, SCIENCE, V280, P1618, DOI 10.1126/science.280.5369.1618; GU BH, 1993, P NATL ACAD SCI USA, V90, P9528, DOI 10.1073/pnas.90.20.9528; Kelly BJ, 2009, VIRUS RES, V145, P173, DOI 10.1016/j.virusres.2009.07.007; KNIPE DM, 1986, MOL CELL BIOL, V6, P2371, DOI 10.1128/MCB.6.7.2371; KNIPE DM, 1987, J VIROL, V61, P276, DOI 10.1128/JVI.61.2.276-284.1987; Leopardi R, 1997, J VIROL, V71, P1133, DOI 10.1128/JVI.71.2.1133-1139.1997; Loret S, 2008, J VIROL, V82, P8605, DOI 10.1128/JVI.00904-08; Loret S, 2012, J GEN VIROL, V93, P624, DOI 10.1099/vir.0.039776-0; Maringer K, 2010, J VIROL, V84, P4682, DOI 10.1128/JVI.00126-10; Nicola AV, 2003, J VIROL, V77, P5324, DOI 10.1128/JVI.77.9.5324-5332.2003; QUINLAN MP, 1985, MOL CELL BIOL, V5, P957, DOI 10.1128/MCB.5.5.957; Radtke K, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000991; Roizman B, 2007, FIELDS VIROLOGY, V2, P2501, DOI DOI 10.1148/RADIOL.14144045; Sedlackova L, 2008, J VIROL, V82, P268, DOI 10.1128/JVI.01588-07; SMITH CA, 1993, J VIROL, V67, P4676, DOI 10.1128/JVI.67.8.4676-4687.1993; STOW ND, 1986, J GEN VIROL, V67, P2571, DOI 10.1099/0022-1317-67-12-2571; Su YH, 2006, J VIROL, V80, P11589, DOI 10.1128/JVI.01869-06; YAO F, 1989, J VIROL, V63, P3338, DOI 10.1128/JVI.63.8.3338-3344.1989; ZHU ZM, 1994, J VIROL, V68, P3027, DOI 10.1128/JVI.68.5.3027-3040.1994; Zhu ZM, 1996, J VIROL, V70, P5346, DOI 10.1128/JVI.70.8.5346-5356.1996	33	6	7	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2013	8	8							e70889	10.1371/journal.pone.0070889	http://dx.doi.org/10.1371/journal.pone.0070889			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	217ZG	23940659	Green Submitted, Green Published, gold			2022-12-25	WOS:000324401500053
J	Ahn, SJ; Park, MS; Kim, KA; Park, JY; Kim, I; Kang, WJ; Lee, SK; Kim, MJ				Ahn, Sung Jun; Park, Mi-Suk; Kim, Kyung Ah; Park, Jun Yong; Kim, InSeong; Kang, Won Joon; Lee, Seung-Koo; Kim, Myeong-Jin			F-18-FDG PET Metabolic Parameters and MRI Perfusion and Diffusion Parameters in Hepatocellular Carcinoma: A Preliminary Study	PLOS ONE			English	Article							SORAFENIB; CHEMOTHERAPY; SURVIVAL; GRADE; LIVER	Objectives: Glucose metabolism, perfusion, and water diffusion may have a relationship or affect each other in the same tumor. The understanding of their relationship could expand the knowledge of tumor characteristics and contribute to the field of oncologic imaging. The purpose of this study was to evaluate the relationships between metabolism, vasculature and cellularity of advanced hepatocellular carcinoma (HCC), using multimodality imaging such as F-18-FDG positron emission tomography (PET), dynamic contrast enhanced (DCE)-MRI, and diffusion weighted imaging(DWI). Materials and Methods: Twenty-one patients with advanced HCC underwent F-18-FDG PET, DCE-MRI, and DWI before treatment. Maximum standard uptake values (SUVmax) from F-18-FDG-PET, variables of the volume transfer constant (K-trans) from DCE-MRI and apparent diffusion coefficient (ADC) from DWI were obtained for the tumor and their relationships were examined by Spearman's correlation analysis. The influence of portal vein thrombosis on SUVmax and variables of K-trans and ADC was evaluated by Mann-Whitney test. Results: SUVmax showed significant negative correlation with K-max(trans) (p = -20.622, p = 0.002). However, variables of ADC showed no relationship with variables of K-trans or SUVmax (p>0.05). Whether portal vein thrombosis was present or not did not influence the SUVmax and variables of ADC and K-trans (p>0.05). Conclusion: In this study, SUV was shown to be correlated with K-trans in advanced HCCs; the higher the glucose metabolism a tumor had, the lower the perfusion it had, which might help in guiding target therapy.	[Ahn, Sung Jun; Park, Mi-Suk; Kim, Kyung Ah; Kang, Won Joon; Lee, Seung-Koo; Kim, Myeong-Jin] Yonsei Univ, Coll Med, Dept Radiol, Yonsei Liver Canc Special Clin, Seoul, South Korea; [Park, Mi-Suk; Kang, Won Joon; Lee, Seung-Koo; Kim, Myeong-Jin] Yonsei Univ, Coll Med, Res Inst Radiol Sci, Yonsei Liver Canc Special Clin, Seoul, South Korea; [Park, Jun Yong] Yonsei Univ, Coll Med, Div Gastroenterol, Yonsei Liver Canc Special Clin, Seoul, South Korea; [Park, Jun Yong] Yonsei Univ, Coll Med, Dept Nucl Med, Yonsei Liver Canc Special Clin, Seoul, South Korea; [Kim, InSeong] Siemens Med Syst Inc, Forchheim, Germany	Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Siemens AG; Siemens Germany	Park, MS (corresponding author), Yonsei Univ, Coll Med, Dept Radiol, Yonsei Liver Canc Special Clin, Seoul, South Korea.	radpms@yuhs.ac	Park, Jun Yong/H-7127-2019; Kim, Myeong-Jin/E-1623-2011	Kim, Myeong-Jin/0000-0001-7949-5402; Park, Mi-Suk/0000-0001-5817-2444; Park, Jun Yong/0000-0001-6324-2224; Lee, Seung-Koo/0000-0001-5646-4072; Ahn, Sung Jun/0000-0003-0075-2432; Kang, Won Jun/0000-0002-2107-8160	National Research Foundation of Korea [7-2010-0288]	National Research Foundation of Korea(National Research Foundation of Korea)	This study was supported by a grant from the National Research Foundation of Korea (7-2010-0288). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asayama Y, 2008, AM J ROENTGENOL, V190, pW28, DOI 10.2214/AJR.07.2117; Cheng AL, 2009, LANCET ONCOL, V10, P25, DOI 10.1016/S1470-2045(08)70285-7; Crowley LV, 2011, ESSENTIALS HUMAN DIS, Vxxi; Crum WR, 2004, BRIT J RADIOL, V77, pS140, DOI 10.1259/bjr/25329214; Delille JP, 2003, RADIOLOGY, V228, P63, DOI 10.1148/radiol.2281011303; Emblem KE, 2008, RADIOLOGY, V247, P808, DOI 10.1148/radiol.2473070571; Hsu CY, 2011, J HEPATOL, V55, P858, DOI 10.1016/j.jhep.2011.01.032; Jarnagin WR, 2009, ANN ONCOL, V20, P1589, DOI 10.1093/annonc/mdp029; Law M, 2003, AM J NEURORADIOL, V24, P1989; Lee JH, 2011, LIVER INT, V31, P1144, DOI 10.1111/j.1478-3231.2011.02541.x; Llovet JM, 1999, SEMIN LIVER DIS, V19, P329, DOI 10.1055/s-2007-1007122; Llovet JM, 2008, NEW ENGL J MED, V359, P378, DOI 10.1056/NEJMoa0708857; MINEURA K, 1986, Neurological Research, V8, P164; Park MS, 2009, RADIOLOGY, V250, P110, DOI 10.1148/radiol.2493080226; Patankar TF, 2005, AM J NEURORADIOL, V26, P2455; Sahani DV, 2007, RADIOLOGY, V243, P736, DOI 10.1148/radiol.2433052020; Schraml C, 2009, AM J ROENTGENOL, V193, pW301, DOI 10.2214/AJR.08.2289; Strosberg JR, 2010, PANCREAS, V39, P799, DOI 10.1097/MPA.0b013e3181ebb56f; Toh CH, 2008, AM J NEURORADIOL, V29, P471, DOI 10.3174/ajnr.A0872; Zasadny KR, 2003, EUR J NUCL MED MOL I, V30, P274, DOI 10.1007/s00259-002-1022-z; Zhu AX, 2009, J CLIN ONCOL, V27, P3027, DOI 10.1200/JCO.2008.20.9908; Zigeuner R, 2010, EUR UROL, V57, P575, DOI 10.1016/j.eururo.2009.11.035	22	18	21	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2013	8	8							e71571	10.1371/journal.pone.0071571	http://dx.doi.org/10.1371/journal.pone.0071571			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	218XC	23940769	gold, Green Published, Green Submitted			2022-12-25	WOS:000324465000216
J	Alves, LGA; Ribeiro, HV; Lenzi, EK; Mendes, RS				Alves, Luiz G. A.; Ribeiro, Haroldo V.; Lenzi, Ervin K.; Mendes, Renio S.			Distance to the Scaling Law: A Useful Approach for Unveiling Relationships between Crime and Urban Metrics	PLOS ONE			English	Article							COMPLEX NETWORKS; INEQUALITY; PUNISHMENT; UNIVERSALITY; UNEMPLOYMENT; STRATEGIES; BEHAVIOR; GROWTH; CITIES; LIFE	We report on a quantitative analysis of relationships between the number of homicides, population size and ten other urban metrics. By using data from Brazilian cities, we show that well-defined average scaling laws with the population size emerge when investigating the relations between population and number of homicides as well as population and urban metrics. We also show that the fluctuations around the scaling laws are log-normally distributed, which enabled us to model these scaling laws by a stochastic-like equation driven by a multiplicative and log-normally distributed noise. Because of the scaling laws, we argue that it is better to employ logarithms in order to describe the number of homicides in function of the urban metrics via regression analysis. In addition to the regression analysis, we propose an approach to correlate crime and urban metrics via the evaluation of the distance between the actual value of the number of homicides ( as well as the value of the urban metrics) and the value that is expected by the scaling law with the population size. This approach has proved to be robust and useful for unveiling relationships/behaviors that were not properly carried out by the regression analysis, such as i) the non-explanatory potential of the elderly population when the number of homicides is much above or much below the scaling law, ii) the fact that unemployment has explanatory potential only when the number of homicides is considerably larger than the expected by the power law, and iii) a gender difference in number of homicides, where cities with female population below the scaling law are characterized by a number of homicides above the power law.	[Ribeiro, Haroldo V.] Univ Estadual Maringa, Dept Fis, Maringa, Parana, Brazil; Univ Estadual Maringa, Natl Inst Sci & Technol Complex Syst, Maringa, Parana, Brazil	Universidade Estadual de Maringa; Universidade Estadual de Maringa	Ribeiro, HV (corresponding author), Univ Estadual Maringa, Dept Fis, Maringa, Parana, Brazil.	hvr@dfi.uem.br	Lenzi, Ervin Kaminski/N-1767-2019; Ribeiro, Haroldo Valentin/C-8614-2012; Mendes, Renio/F-9261-2017; Alves, Luiz G A/H-3389-2013	Lenzi, Ervin Kaminski/0000-0003-3853-1790; Ribeiro, Haroldo Valentin/0000-0002-9532-5195; Alves, Luiz G A/0000-0001-6204-5552	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior; Fundacao Araucaria [113/2013]	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Fundacao Araucaria(Fundacao Araucaria de Apoio ao Desenvolvimento Cientifico e Tecnologico do Estado do Parana FAFundacao de Amparo a Pesquisa e Inovacoo Estado de Santa Catarina (FAPESC))	This work has been supported by the agencies Conselho Nacional de Desenvolvimento Cientifico e Tecnologico, Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior, and Fundacao Araucaria. HVR is especially grateful to Fundacao Araucaria for financial support under grant number 113/2013. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alves LGA, 2013, PHYSICA A, V392, P2672, DOI 10.1016/j.physa.2013.02.002; Amancio DR, 2012, EPL-EUROPHYS LETT, V98, DOI 10.1209/0295-5075/98/18002; Amaral LAN, 2004, EUR PHYS J B, V38, P147, DOI 10.1140/epjb/e2004-00110-5; Angel S., 2005, DYNAMICS GLOBAL URBA; [Anonymous], 1999, INTRO ECONOPHYSICS C; BAILEY WC, 1984, CRIMINOLOGY, V22, P531, DOI 10.1111/j.1745-9125.1984.tb00314.x; BECKER GS, 1968, J POLIT ECON, V76, P169, DOI 10.1086/259394; Bettencourt LMA, 2008, EUR PHYS J B, V63, P285, DOI 10.1140/epjb/e2008-00250-6; Bettencourt L, 2010, NATURE, V467, P912, DOI 10.1038/467912a; Bettencourt LMA, 2007, P NATL ACAD SCI USA, V104, P7301, DOI 10.1073/pnas.0610172104; Bettencourt LMA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013541; BLAU JR, 1982, AM SOCIOL REV, V47, P114, DOI 10.2307/2095046; Castellano C, 2009, REV MOD PHYS, V81, P591, DOI 10.1103/RevModPhys.81.591; Chatterjee A, 2013, SCI REP-UK, V3, DOI 10.1038/srep01049; Conte R, 2012, EUR PHYS J-SPEC TOP, V214, P325, DOI 10.1140/epjst/e2012-01697-8; Corder G. W., 2009, NONPARAMETRIC STAT N, DOI DOI 10.1002/; Poveda AC, 2012, J INT DEV, V24, P809, DOI 10.1002/jid.2819; Crane P, 2005, SCIENCE, V308, P1225, DOI 10.1126/science.1114165; Peron TKD, 2012, CHAOS, V22, DOI 10.1063/1.3683467; Davidson R, 1993, ESTIMATION INFERENCE; Efron B., 1994, INTRO BOOTSTRAP; EHRLICH I, 1975, AM ECON REV, V65, P397; Ehrlich I, 1996, J ECON PERSPECT, V10, P43, DOI 10.1257/jep.10.1.43; Glaeser EL, 1996, Q J ECON, V111, P507, DOI 10.2307/2946686; Glaeser EL, 1999, J POLIT ECON, V107, pS225, DOI 10.1086/250109; Gomez-Lievano A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040393; Gordon MB, 2010, EUR J APPL MATH, V21, P283, DOI 10.1017/S0956792510000069; Gordon MB, 2009, EUR PHYS J B, V68, P133, DOI 10.1140/epjb/e2009-00066-x; Hojman D., 2002, B LAT AM RES, V21, P121; Hojman DE, 2004, CRIME LAW SOCIAL CH, V41, P33, DOI 10.1023/B:CRIS.0000015327.30140.8d; Iglesias JR, 2012, PHYSICA A, V391, P3942, DOI 10.1016/j.physa.2012.03.001; Kates RW, 2003, P NATL ACAD SCI USA, V100, P8062, DOI 10.1073/pnas.1231331100; Kelly M, 2000, REV ECON STAT, V82, P530, DOI 10.1162/003465300559028; Kennedy BP, 1998, SOC SCI MED, V47, P7, DOI 10.1016/S0277-9536(98)00097-5; Levitt SD, 1997, AM ECON REV, V87, P270; Levitt SD, 2001, J QUANT CRIMINOL, V17, P377, DOI 10.1023/A:1012541821386; Mantovani MC, 2011, EPL-EUROPHYS LETT, V96, DOI 10.1209/0295-5075/96/48001; Petersen AM, 2012, SCI REP-UK, V2, DOI 10.1038/srep00313; Podobnik B, 2012, SCI REP-UK, V2, DOI 10.1038/srep00678; Preacher KJ, 2008, BEHAV RES METHODS, V40, P879, DOI 10.3758/BRM.40.3.879; Rozenfeld HD, 2008, P NATL ACAD SCI USA, V105, P18702, DOI 10.1073/pnas.0807435105; Rybski D, 2009, P NATL ACAD SCI USA, V106, P12640, DOI 10.1073/pnas.0902667106; Sachsida A, 2010, EMPIR ECON, V39, P93, DOI 10.1007/s00181-009-0296-4; Stanley MHR, 1996, NATURE, V379, P804, DOI 10.1038/379804a0; Wichmann S, 2008, LANG LINGUIST COMPAS, V2, DOI 10.1111/j.1749-818x.2008.00062.x	45	56	58	3	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2013	8	8							e69580	10.1371/journal.pone.0069580	http://dx.doi.org/10.1371/journal.pone.0069580			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	218XC	23940525	Green Published, gold, Green Submitted			2022-12-25	WOS:000324465000019
J	Khan, MS; Baig, MH; Ahmad, S; Siddiqui, SA; Srivastava, AK; Srinivasan, KV; Ansari, IA				Khan, Mohd Sajid; Baig, Mohd Hassan; Ahmad, Saheem; Siddiqui, Shapi Ahmad; Srivastava, Ashwini Kumar; Srinivasan, Kumar Venkatraman; Ansari, Irfan A.			Design, Synthesis, Evaluation and Thermodynamics of 1-Substituted Pyridylimidazo[1,5-a]Pyridine Derivatives as Cysteine Protease Inhibitors	PLOS ONE			English	Article							BINDING; PROTEINS	Targeting papain family cysteine proteases is one of the novel strategies in the development of chemotherapy for a number of diseases. Novel cysteine protease inhibitors derived from 1-pyridylimidazo[1,5-a]pyridine representing pharmacologically important class of compounds are being reported here for the first time. The derivatives were initially designed and screened in silico by molecular docking studies against papain to explore the possible mode of action. The molecular interaction between the compounds and cysteine protease (papain) was found to be very similar to the interactions observed with the respective epoxide inhibitor (E-64c) of papain. Subsequently, compounds were synthesized to validate their efficacy in wet lab experiments. When characterized kinetically, these compounds show their K-i and IC50 values in the range of 13.75 to 99.30 mu M and 13.40 to 96.50 mu M, respectively. The thermodynamics studies suggest their binding with papain hydrophobically and entropically driven. These inhibitors also inhibit the growth of clinically important different types of Gram positive and Gram negative bacteria having MIC50 values in the range of 0.6-1.4 mu g/ml. Based on Lipinski's rule of Five, we also propose these compounds as potent antibacterial prodrugs. The most active antibacterial compound was found to be 1-(2-pyridyl)-3-(2-hydroxyphenyl)imidazo[1,5-a]pyridine (3a).	[Khan, Mohd Sajid] Natl Chem Lab, Div Biochem Sci, Pune, Maharashtra, India; [Khan, Mohd Sajid; Baig, Mohd Hassan; Ahmad, Saheem; Srivastava, Ashwini Kumar; Ansari, Irfan A.] Integral Univ, Dept Biotechnol, Lucknow, Uttar Pradesh, India; [Siddiqui, Shapi Ahmad; Srinivasan, Kumar Venkatraman] Natl Chem Lab, Organ Chem Technol Div, Pune, Maharashtra, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - National Chemical Laboratory (NCL); Integral University; Council of Scientific & Industrial Research (CSIR) - India; CSIR - National Chemical Laboratory (NCL)	Khan, MS (corresponding author), Natl Chem Lab, Div Biochem Sci, Pune, Maharashtra, India.	sajid_987@rediffmail.com	Ahmad, Saheem/T-2609-2019; Ansari, Irfan/AFM-0976-2022; Ansari, Irfan/AAH-3733-2022; Ahmad, Saheem/R-7016-2017	Ahmad, Saheem/0000-0003-1215-0279; Ahmad, Saheem/0000-0003-1215-0279; Khan, Mohd Sajid/0000-0002-0883-5200; Ansari, Irfan/0000-0002-9966-1225; Baig, Mohd Hassan/0000-0001-8227-4838	Department of Biotechnology (DBT), government of India; CSIR	Department of Biotechnology (DBT), government of India(Department of Biotechnology (DBT) India); CSIR(Council of Scientific & Industrial Research (CSIR) - India)	MSK thanks the Department of Biotechnology (DBT), government of India, for financial assistance and SAS acknowledges CSIR for fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amsterdam D, 1991, SUSCEPTIBILITY TESTI, P72; AOKI H, 1995, ANTIMICROB AGENTS CH, V39, P846, DOI 10.1128/AAC.39.4.846; ARBILLA S, 1986, EUR J PHARMACOL, V130, P257, DOI 10.1016/0014-2999(86)90276-1; BAUER AW, 1966, AM J CLIN PATHOL, V45, P493; BOLGER L, 1972, NATURE, V238, P354, DOI 10.1038/238354a0; BROOKS BR, 1983, J COMPUT CHEM, V4, P187, DOI 10.1002/jcc.540040211; Collins AR, 1998, ORAL MICROBIOL IMMUN, V13, P59, DOI 10.1111/j.1399-302X.1998.tb00753.x; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; DIXON M, 1953, BIOCHEM J, V55, P170, DOI 10.1042/bj0550170; EAKIN AE, 1993, J BIOL CHEM, V268, P6115; FLETCHER HM, 1995, INFECT IMMUN, V63, P1521, DOI 10.1128/IAI.63.4.1521-1528.1995; Gaikwad SM, 2006, PHOTOCHEM PHOTOBIOL, V82, P1315, DOI 10.1562/2006-05-04-RN-892; GRUBB A, 1990, BIOL CHEM H-S, V371, P137; Ismail MA, 2004, J MED CHEM, V47, P3658, DOI 10.1021/jm0400092; KNOLKER HJ, 1990, CHEM BER, V123, P327, DOI 10.1002/cber.19901230218; Lipinski CA, 2001, ADV DRUG DELIVER REV, V46, P3, DOI 10.1016/S0169-409X(00)00129-0; Liu TY, 1971, ENZYMES, P609; MAEDA H, 1989, CLIN CHIM ACTA, V185, P357, DOI 10.1016/0009-8981(89)90226-X; McKerrow JH, 1999, BIOORGAN MED CHEM, V7, P639, DOI 10.1016/S0968-0896(99)00008-5; MCKERROW JH, 1993, ANNU REV MICROBIOL, V47, P821, DOI 10.1146/annurev.mi.47.100193.004133; MOLLA A, 1986, INFECT IMMUN, V53, P522, DOI 10.1128/IAI.53.3.522-529.1986; Morris GM, 1998, J COMPUT CHEM, V19, P1639, DOI 10.1002/(SICI)1096-987X(19981115)19:14<1639::AID-JCC10>3.0.CO;2-B; Muegge I, 2003, MED RES REV, V23, P302, DOI 10.1002/med.10041; National Committee for Clinical Laboratory Standards, 2006, METH DIL ANT SUSC TE; National committee for clinical laboratory standards, 1999, M26A NCCLS; POLGAR L, 1982, BIOCHEM J, V207, P1; RAWLINGS ND, 1990, J MOL EVOL, V30, P60, DOI 10.1007/BF02102453; SHAW E, 1990, ADV ENZYMOL RAMB, V63, P271; Siddiqui SA, 2006, SYNTHESIS-STUTTGART, P2849, DOI 10.1055/s-2006-942522; Turk D, 1998, BIOL CHEM, V379, P137, DOI 10.1515/bchm.1998.379.2.137; YAMAMOTO D, 1991, J BIOL CHEM, V266, P14771; Yao Q, 2009, P NATL ACAD SCI USA, V106, P3716, DOI 10.1073/pnas.0900212106; Zhu MF, 2004, P NATL ACAD SCI USA, V101, P302, DOI 10.1073/pnas.2036536100	33	8	11	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2013	8	8							e69982	10.1371/journal.pone.0069982	http://dx.doi.org/10.1371/journal.pone.0069982			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	218XC	23940536	gold, Green Published, Green Submitted			2022-12-25	WOS:000324465000030
J	Li, ZH; Li, XL				Li, Zhaohui; Li, Xiaoli			Estimating Temporal Causal Interaction between Spike Trains with Permutation and Transfer Entropy	PLOS ONE			English	Article							INFORMATION-TRANSFER; SYNCHRONY; NETWORKS; SYSTEMS; NEURONS; BRAIN; MODEL	Estimating the causal interaction between neurons is very important for better understanding the functional connectivity in neuronal networks. We propose a method called normalized permutation transfer entropy (NPTE) to evaluate the temporal causal interaction between spike trains, which quantifies the fraction of ordinal information in a neuron that has presented in another one. The performance of this method is evaluated with the spike trains generated by an Izhikevich's neuronal model. Results show that the NPTE method can effectively estimate the causal interaction between two neurons without influence of data length. Considering both the precision of time delay estimated and the robustness of information flow estimated against neuronal firing rate, the NPTE method is superior to other information theoretic method including normalized transfer entropy, symbolic transfer entropy and permutation conditional mutual information. To test the performance of NPTE on analyzing simulated biophysically realistic synapses, an Izhikevich's cortical network that based on the neuronal model is employed. It is found that the NPTE method is able to characterize mutual interactions and identify spurious causality in a network of three neurons exactly. We conclude that the proposed method can obtain more reliable comparison of interactions between different pairs of neurons and is a promising tool to uncover more details on the neural coding.	[Li, Zhaohui] Yanshan Univ, Inst Informat Sci & Engn, Qinhuangdao, Peoples R China; [Li, Xiaoli] Beijing Normal Univ, Natl Key Lab Cognit Neurosci & Learning, Beijing 100875, Peoples R China	Yanshan University; Beijing Normal University	Li, XL (corresponding author), Beijing Normal Univ, Natl Key Lab Cognit Neurosci & Learning, Beijing 100875, Peoples R China.	xiaoli@bnu.edu.cn	Li, Xiaoli/GYQ-7384-2022; Li, Xiaoli/B-6565-2016	Li, Xiaoli/0000-0003-1359-5130	National Natural Science Foundation of China [61025019, 61273063]; Specialized Research Fund for the Doctoral Program of Higher Education in China [20101333110006]; Research and Development Program of Science and Technology in Qinhuangdao, China [2012021A047]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Specialized Research Fund for the Doctoral Program of Higher Education in China(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); Research and Development Program of Science and Technology in Qinhuangdao, China	This research was partly supported by National Natural Science Foundation of China (61025019 and 61273063), Specialized Research Fund for the Doctoral Program of Higher Education in China (20101333110006), Research and Development Program of Science and Technology in Qinhuangdao, China (2012021A047). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bahraminasab A, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.084101; Bandt C, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.174102; Cadotte AJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003355; Dhamala M, 2008, NEUROIMAGE, V41, P354, DOI 10.1016/j.neuroimage.2008.02.020; Gourevitch B, 2007, J NEUROPHYSIOL, V97, P2533, DOI 10.1152/jn.01106.2006; Ito SY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027431; Izhikevich EM, 2003, IEEE T NEURAL NETWOR, V14, P1569, DOI 10.1109/TNN.2003.820440; Izhikevich EM, 2008, P NATL ACAD SCI USA, V105, P3593, DOI 10.1073/pnas.0712231105; Izhikevich EM, 2007, CEREB CORTEX, V17, P2443, DOI 10.1093/cercor/bhl152; Izhikevich EM, 2006, NEURAL COMPUT, V18, P245, DOI 10.1162/089976606775093882; Kaiser A, 2002, PHYSICA D, V166, P43, DOI 10.1016/S0167-2789(02)00432-3; Kim S, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1001110; Kreuz T, 2007, J NEUROSCI METH, V165, P151, DOI 10.1016/j.jneumeth.2007.05.031; Li XL, 2010, NEUROIMAGE, V52, P497, DOI 10.1016/j.neuroimage.2010.05.003; Li ZH, 2011, PHYS REV E, V84, DOI 10.1103/PhysRevE.84.021929; Lubenov EV, 2008, NEURON, V58, P118, DOI 10.1016/j.neuron.2008.01.036; Martini M, 2011, PHYS REV E, V83, DOI 10.1103/PhysRevE.83.011919; Olofsen E, 2008, BRIT J ANAESTH, V101, P810, DOI 10.1093/bja/aen290; Quiroga RQ, 2002, PHYS REV E, V66, DOI 10.1103/PhysRevE.66.041904; Rolls ET, 2011, PROG NEUROBIOL, V95, P448, DOI 10.1016/j.pneurobio.2011.08.002; Schreiber S, 2003, NEUROCOMPUTING, V52-4, P925, DOI 10.1016/S0925-2312(02)00838-X; Schreiber T, 2000, PHYS REV LETT, V85, P461, DOI 10.1103/PhysRevLett.85.461; Staniek M, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.158101; Strong SP, 1998, PHYS REV LETT, V80, P197, DOI 10.1103/PhysRevLett.80.197; Szczepanski J, 2011, BIOL CYBERN, V104, P161, DOI 10.1007/s00422-011-0425-y; van Rossum MCW, 2001, NEURAL COMPUT, V13, P751, DOI 10.1162/089976601300014321; Vejmelka M, 2008, PHYS REV E, V77, DOI 10.1103/PhysRevE.77.026214; Victor JD, 1996, J NEUROPHYSIOL, V76, P1310, DOI 10.1152/jn.1996.76.2.1310; Waddell J, 2007, J NEUROSCI METH, V162, P320, DOI 10.1016/j.jneumeth.2006.12.008	29	11	11	1	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2013	8	8							e70894	10.1371/journal.pone.0070894	http://dx.doi.org/10.1371/journal.pone.0070894			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	218XC	23940662	Green Published, Green Submitted, gold			2022-12-25	WOS:000324465000151
J	Li, ZM; Qiu, YS; Personett, D; Huang, P; Edenfield, B; Katz, J; Babusis, D; Tang, Y; Shirely, MA; Moghaddam, MF; Copland, JA; Tun, HW				Li, Zhimin; Qiu, Yushi; Personett, David; Huang, Peng; Edenfield, Brandy; Katz, Jason; Babusis, Darius; Tang, Yang; Shirely, Michael A.; Moghaddam, Mehran F.; Copland, John A.; Tun, Han W.			Pomalidomide Shows Significant Therapeutic Activity against CNS Lymphoma with a Major Impact on the Tumor Microenvironment in Murine Models	PLOS ONE			English	Article							CENTRAL-NERVOUS-SYSTEM; B-CELL LYMPHOMA; LENALIDOMIDE; CC-4047	Primary CNS lymphoma carries a poor prognosis. Novel therapeutic agents are urgently needed. Pomalidomide (POM) is a novel immunomodulatory drug with anti-lymphoma activity. CNS pharmacokinetic analysis was performed in rats to assess the CNS penetration of POM. Preclinical evaluation of POM was performed in two murine models to assess its therapeutic activity against CNS lymphoma. The impact of POM on the CNS lymphoma immune microenvironment was evaluated by immunohistochemistry and immunofluorescence. In vitro cell culture experiments were carried out to further investigate the impact of POM on the biology of macrophages. POM crosses the blood brain barrier with CNS penetration of similar to 39%. Preclinical evaluations showed that it had significant therapeutic activity against CNS lymphoma with significant reduction in tumor growth rate and prolongation of survival, that it had a major impact on the tumor microenvironment with an increase in macrophages and natural killer cells, and that it decreased M2-polarized tumor-associated macrophages and increased M1-polarized macrophages when macrophages were evaluated based on polarization status. In vitro studies using various macrophage models showed that POM converted the polarization status of IL4-stimulated macrophages from M2 to M1, that M2 to M1 conversion by POM in the polarization status of lymphoma-associated macrophages is dependent on the presence of NK cells, that POM induced M2 to M1 conversion in the polarization of macrophages by inactivating STAT6 signaling and activating STAT1 signaling, and that POM functionally increased the phagocytic activity of macrophages. Based on our findings, POM is a promising therapeutic agent for CNS lymphoma with excellent CNS penetration, significant preclinical therapeutic activity, and a major impact on the tumor microenvironment. It can induce significant biological changes in tumor-associated macrophages, which likely play a major role in its therapeutic activity against CNS lymphoma. POM should be further evaluated in clinical trials.	[Li, Zhimin; Qiu, Yushi; Personett, David; Huang, Peng; Edenfield, Brandy; Copland, John A.] Mayo Clin, Dept Canc Biol, Jacksonville, FL 32224 USA; [Katz, Jason; Babusis, Darius; Tang, Yang; Shirely, Michael A.; Moghaddam, Mehran F.] Celgene Corp, Dept Drug Metab & Pharmacokinet, San Diego, CA USA; [Tun, Han W.] Mayo Clin, Dept Hematol Oncol, Jacksonville, FL 32224 USA	Mayo Clinic; Bristol-Myers Squibb; Celgene Corporation; Mayo Clinic	Tun, HW (corresponding author), Mayo Clin, Dept Hematol Oncol, Jacksonville, FL 32224 USA.	tun.han@mayo.edu			Celgene	Celgene(Bristol-Myers SquibbCelgene Corporation)	Han W. Tun received a research grant from Celgene to support this research. CNS pharmacokinetic analysis was performed by Celgene scientists. Otherwise, Celgene had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Camilleri-Broet S, 2006, BLOOD, V107, P190, DOI 10.1182/blood-2005-03-1024; Cox MC, 2011, AM J HEMATOL, V86, P957, DOI 10.1002/ajh.22148; Davies John Q, 2005, Methods Mol Biol, V290, P91; Dimopoulos MA, 2006, HIGH S HELD 10 C EUR; Ferreri AJM, 2011, BLOOD, V118, P510, DOI 10.1182/blood-2011-03-321349; Hernandez-Ilizaliturri FJ, 2005, CLIN CANCER RES, V11, P5984, DOI 10.1158/1078-0432.CCR-05-0577; Hernandez-Ilizaliturri FJ, 2011, CANCER-AM CANCER SOC, V117, P5058, DOI 10.1002/cncr.26135; Jiang LY, 2010, INT J CLIN EXP PATHO, V3, P763; Kadoch C, 2009, CLIN CANCER RES, V15, P1989, DOI 10.1158/1078-0432.CCR-08-2054; Mantovani A, 2002, TRENDS IMMUNOL, V23, P549, DOI 10.1016/S1471-4906(02)02302-5; Moussaud S, 2010, J NEUROSCI METH, V187, P243, DOI 10.1016/j.jneumeth.2010.01.017; Paxinos G, 2001, HE MOUSE BRAIN STERE; Reichlin A, 2001, CURR PROTOC IMMUNOL; Rubenstein JL, 2011, J CLIN ONCOL, V29, pE595, DOI 10.1200/JCO.2011.34.7252; Rubenstein JL, 2006, BLOOD, V107, P3716, DOI 10.1182/blood-2005-03-0897; Tun HW, 2008, BLOOD, V111, P3200, DOI 10.1182/blood-2007-10-119099; WAN CP, 1993, J IMMUNOL METHODS, V162, P1, DOI 10.1016/0022-1759(93)90400-2; Zhu D, 2008, CANCER IMMUNOL IMMUN, V57, P1849, DOI 10.1007/s00262-008-0512-7	18	60	64	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2013	8	8							e71754	10.1371/journal.pone.0071754	http://dx.doi.org/10.1371/journal.pone.0071754			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	218XC	23940785	Green Published, gold, Green Submitted			2022-12-25	WOS:000324465000225
J	Antoon, JW; Martin, EC; Lai, RY; Salvo, VA; Tang, Y; Nitzchke, AM; Elliott, S; Nam, SY; Xiong, W; Rhodes, LV; Collins-Burow, B; David, O; Wang, GD; Shan, B; Beckman, BS; Nephew, KP; Burow, ME				Antoon, James W.; Martin, Elizabeth C.; Lai, Rongye; Salvo, Virgilo A.; Tang, Yan; Nitzchke, Ashley M.; Elliott, Steven; Nam, Seung Yoon; Xiong, Wei; Rhodes, Lyndsay V.; Collins-Burow, Bridgette; David, Odile; Wang, Guandi; Shan, Bin; Beckman, Barbara S.; Nephew, Kenneth P.; Burow, Matthew E.			MEK5/ERK5 Signaling Suppresses Estrogen Receptor Expression and Promotes Hormone-Independent Tumorigenesis	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; BREAST-CANCER CELLS; NF-KAPPA-B; EPITHELIAL-MESENCHYMAL TRANSITION; PROSTATE-CANCER; GENE-EXPRESSION; ANTIESTROGEN RESISTANCE; CARCINOMA CELLS; ER-ALPHA; PATHWAY	Endocrine resistance and metastatic progression are primary causes of treatment failure in breast cancer. While mitogen activated protein kinases (MAPKs) are known to promote ligand-independent cell growth, the role of the MEK5-ERK5 pathway in the progression of clinical breast carcinoma remains poorly understood. Here, we demonstrated increased ERK5 activation in 30 of 39 (76.9%) clinical tumor samples, as well as across breast cancer cell systems. Overexpression of MEK5 in MCF-7 cells promoted both hormone-dependent and hormone-independent tumorigenesis in vitro and in vivo and conferred endocrine therapy resistance to previously sensitive breast cancer cells. Expression of MEK5 suppressed estrogen receptor (ER)alpha, but not ER-beta protein levels, and abrogated downstream estrogen response element (ERE) transcriptional activity and ER-mediated gene transcription. Global gene expression changes associated with upregulation of MEK5 included increased activation of ER-alpha independent growth signaling pathways and promotion of epithelial-to-mesenchymal transition (EMT) markers. Taken together, our findings show that the MEK5-ERK5 pathway mediates progression to an ER(2), mesenchymal and endocrine therapy resistant phenotype. Given the need for new clinical therapeutic targets, our results demonstrate the therapeutic potential of targeting the MEK5-ERK5 pathway in breast cancer.	[Antoon, James W.; Tang, Yan; Xiong, Wei; Beckman, Barbara S.; Burow, Matthew E.] Tulane Univ, Sch Med, Dept Pharmacol, New Orleans, LA 70112 USA; [Martin, Elizabeth C.; Salvo, Virgilo A.; Nitzchke, Ashley M.; Elliott, Steven; Rhodes, Lyndsay V.; Collins-Burow, Bridgette] Tulane Univ, Sch Med, Dept Med, Sect Hematol & Med Oncol, New Orleans, LA 70112 USA; [David, Odile] Tulane Univ, Sch Med, Dept Pathol, New Orleans, LA 70112 USA; [Shan, Bin] Tulane Univ, Sch Med, Dept Pulm Dis Crit Care & Environm Med, New Orleans, LA 70112 USA; [Nam, Seung Yoon; Wang, Guandi] Xavier Univ, Dept Chem, New Orleans, LA 70125 USA; [Lai, Rongye; Nephew, Kenneth P.] Indiana Univ Sch Med, Dept Cellular & Integrat Physiol, Bloomington, IN USA	Tulane University; Tulane University; Tulane University; Tulane University; Xavier University of Louisiana; Indiana University System; Indiana University Bloomington	Burow, ME (corresponding author), Tulane Univ, Sch Med, Dept Pharmacol, New Orleans, LA 70112 USA.	mburow@tulane.edu	Rhodes, Lyndsay/AAC-4989-2020	Rhodes, Lyndsay/0000-0001-7672-2059; Shan, Bin/0000-0002-6869-2678; Antoon, James/0000-0001-6188-2658	National Institutes of Health [CA125806]; National Cancer Institute [U54 CA113001]; NATIONAL CANCER INSTITUTE [R01CA125806, U54CA113001] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the National Institutes of Health Grants CA125806 (MB) and National Cancer Institute U54 CA113001 (KN). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antoon JW, 2010, ENDOCRINOLOGY, V151, P5124, DOI 10.1210/en.2010-0420; Antoon JW, 2009, J MED CHEM, V52, P5748, DOI 10.1021/jm9009668; Bayliss J, 2007, CLIN CANCER RES, V13, P7029, DOI 10.1158/1078-0432.CCR-07-0587; Brinkman JA, 2009, J MAMMARY GLAND BIOL, V14, P67, DOI 10.1007/s10911-009-9113-0; Burow ME, 1998, CANCER RES, V58, P4940; Buschbeck M, 2005, J BIOL CHEM, V280, P2659, DOI 10.1074/jbc.M412599200; Buschbeck M, 2002, J BIOL CHEM, V277, P29503, DOI 10.1074/jbc.M202149200; Cameron SJ, 2004, J BIOL CHEM, V279, P1506, DOI 10.1074/jbc.M308755200; Montero JC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005565; Cavanaugh JE, 2006, J NEUROSCI RES, V84, P1367, DOI 10.1002/jnr.21024; Cavanaugh JE, 2004, EUR J BIOCHEM, V271, P2056, DOI 10.1111/j.1432-1033.2004.04131.x; Cavanaugh JE, 2001, J NEUROSCI, V21, P434, DOI 10.1523/JNEUROSCI.21-02-00434.2001; Chua HL, 2007, ONCOGENE, V26, P711, DOI 10.1038/sj.onc.1209808; Clarke R, 2003, ONCOGENE, V22, P7316, DOI 10.1038/sj.onc.1206937; Creighton CJ, 2006, CANCER RES, V66, P3903, DOI 10.1158/0008-5472.CAN-05-4363; Dimple C, 2008, CANCER RES, V68, P4902, DOI 10.1158/0008-5472.CAN-07-5698; Drew BA, 2012, BBA-REV CANCER, V1825, P37, DOI 10.1016/j.bbcan.2011.10.002; Duong BN, 2006, CANCER RES, V66, P8373, DOI 10.1158/0008-5472.CAN-05-3845; Fan MY, 2006, CANCER RES, V66, P11954, DOI 10.1158/0008-5472.CAN-06-1666; Gee JMW, 2009, J PATHOL, V217, P32, DOI 10.1002/path.2430; Hsieh FC, 2005, BIOCHEM BIOPH RES CO, V335, P292, DOI 10.1016/j.bbrc.2005.07.075; Huang AH, 1996, J PATHOL, V180, P223, DOI 10.1002/(SICI)1096-9896(199610)180:2<223::AID-PATH635>3.0.CO;2-H; Kamakura S, 1999, J BIOL CHEM, V274, P26563, DOI 10.1074/jbc.274.37.26563; Kato Y, 1998, NATURE, V395, P713, DOI 10.1038/27234; McPherson LA, 1997, P NATL ACAD SCI USA, V94, P4342, DOI 10.1073/pnas.94.9.4342; Mehta PB, 2003, ONCOGENE, V22, P1381, DOI 10.1038/sj.onc.1206154; Musgrove EA, 2009, NAT REV CANCER, V9, P631, DOI 10.1038/nrc2713; Neve RM, 2006, CANCER CELL, V10, P515, DOI 10.1016/j.ccr.2006.10.008; Oh AS, 2001, MOL ENDOCRINOL, V15, P1344, DOI 10.1210/me.15.8.1344; Park KJ, 2005, MOL CELL, V18, P71, DOI 10.1016/j.molcel.2005.03.006; Payton-Stewart F, 2009, MOL CARCINOGEN, V48, P862, DOI 10.1002/mc.20532; Pearson G, 2001, J BIOL CHEM, V276, P7927, DOI 10.1074/jbc.M009764200; Rhodes LV, 2011, CANCER RES, V71, P603, DOI 10.1158/0008-5472.CAN-10-3185; Rhodes LV, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-295; Rubio MF, 2006, ONCOGENE, V25, P1367, DOI 10.1038/sj.onc.1209176; Sivaraman VS, 1997, J CLIN INVEST, V99, P1478, DOI 10.1172/JCI119309; Sosic D, 2003, CELL, V112, P169, DOI 10.1016/S0092-8674(03)00002-3; Thiery JP, 2004, NAT MED, V10, P777, DOI 10.1038/nm0804-777; Thompson EW, 2005, CANCER RES, V65, P5991, DOI 10.1158/0008-5472.CAN-05-0616; van Agthoven T, 2009, J CLIN ONCOL, V27, P542, DOI 10.1200/JCO.2008.17.1462; Vereide AB, 2006, GYNECOL ONCOL, V101, P214, DOI 10.1016/j.ygyno.2005.10.030; Wang X, 2006, CELL SIGNAL, V18, P753, DOI 10.1016/j.cellsig.2005.11.003; Weldon CB, 2005, INT J ONCOL, V26, P763; Weldon CB, 2002, SURGERY, V132, P293, DOI 10.1067/msy.2002.125389; Whyte J, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2361; Woodfield GW, 2007, CANCER RES, V67, P8439, DOI 10.1158/0008-5472.CAN-07-2293; Xin FX, 2009, BIOINFORMATICS, V25, P430, DOI 10.1093/bioinformatics/btn646; Yan C, 2001, J BIOL CHEM, V276, P10870, DOI 10.1074/jbc.M009286200; Yang QK, 2010, CANCER CELL, V18, P258, DOI 10.1016/j.ccr.2010.08.008; Zhang X, 2007, ONCOGENE, V26, P7346, DOI 10.1038/sj.onc.1210537; Zhao C, 2003, CANCER, V98, P18, DOI 10.1002/cncr.11482; Zhou CH, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr2210	52	33	33	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 9	2013	8	8							e69291	10.1371/journal.pone.0069291	http://dx.doi.org/10.1371/journal.pone.0069291			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	245OM	23950888	Green Published, gold, Green Submitted			2022-12-25	WOS:000326473200003
J	Maltseva, I; Chan, M; Kalus, I; Dierks, T; Rosen, SD				Maltseva, Inna; Chan, Matilda; Kalus, Ina; Dierks, Thomas; Rosen, Steven D.			The SULFs, Extracellular Sulfatases for Heparan Sulfate, Promote the Migration of Corneal Epithelial Cells during Wound Repair	PLOS ONE			English	Article							6-O-ENDOSULFATASES SULF1; GROWTH; EXPRESSION; WNT; PROLIFERATION; BINDING; QSULF1; DOMAIN; PROTEOGLYCANS; PATHWAY	Corneal epithelial wound repair involves the migration of epithelial cells to cover the defect followed by the proliferation of the cells to restore thickness. Heparan sulfate proteoglycans (HSPGs) are ubiquitous extracellular molecules that bind to a plethora of growth factors, cytokines, and morphogens and thereby regulate their signaling functions. Ligand binding by HS chains depends on the pattern of four sulfation modifications, one of which is 6-O-sulfation of glucosamine (6OS). SULF1 and SULF2 are highly homologous, extracellular endosulfatases, which post-synthetically edit the sulfation status of HS by removing 6OS from intact chains. The SULFs thereby modulate multiple signaling pathways including the augmentation of Wnt/beta-catenin signaling. We found that wounding of mouse corneal epithelium stimulated SULF1 expression in superficial epithelial cells proximal to the wound edge. Sulf1(-/-), but not Sulf2(-/-), mice, exhibited a marked delay in healing. Furthermore, corneal epithelial cells derived from Sulf1(-/-) mice exhibited a reduced rate of migration in repair of a scratched monolayer compared to wild-type cells. In contrast, human primary corneal epithelial cells expressed SULF2, as did a human corneal epithelial cell line (THCE). Knockdown of SULF2 in THCE cells also slowed migration, which was restored by overexpression of either mouse SULF2 or human SULF1. The interchangeability of the two SULFs establishes their capacity for functional redundancy. Knockdown of SULF2 decreased Wnt/beta-catenin signaling in THCE cells. Extracellular antagonists of Wnt signaling reduced migration of THCE cells. However in SULF2-knockdown cells, these antagonists exerted no further effects on migration, consistent with the SULF functioning as an upstream regulator of Wnt signaling. Further understanding of the mechanistic action of the SULFs in promoting corneal repair may lead to new therapeutic approaches for the treatment of corneal injuries.	[Maltseva, Inna; Chan, Matilda; Rosen, Steven D.] Univ Calif San Francisco, Dept Anat, San Francisco, CA 94143 USA; [Kalus, Ina; Dierks, Thomas] Univ Bielefeld, Dept Chem, D-33615 Bielefeld, Germany	University of California System; University of California San Francisco; University of Bielefeld	Rosen, SD (corresponding author), Univ Calif San Francisco, Dept Anat, San Francisco, CA 94143 USA.	steven.rosen@ucsf.edu	Dierks, Thomas/A-3596-2012	Dierks, Thomas/0000-0001-6426-1339; Rosen, Steven/0000-0002-6245-701X	Deutsche Forschungsgemeinschaft [DI 575/6];  [NIH P01 AI053194]; NATIONAL EYE INSTITUTE [K08EY018858] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI053194] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK063720] Funding Source: NIH RePORTER	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); ; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The research was supported by grants to Dr. Steven Rosen (NIH P01 AI053194), Dr. Zena Werb (NIH P01 AI053194, Core C), and Dr. Thomas Dierks (DI 575/6, from the Deutsche Forschungsgemeinschaft). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ai XB, 2006, J BIOL CHEM, V281, P4969, DOI 10.1074/jbc.M511902200; Ai XB, 2003, J CELL BIOL, V162, P341, DOI 10.1083/jcb.200212083; Ai XB, 2007, DEVELOPMENT, V134, P3327, DOI 10.1242/dev.007674; ARAKISASAKI K, 1995, INVEST OPHTH VIS SCI, V36, P614; AWATA T, 1988, J OCUL PHARMACOL, V4, P195, DOI 10.1089/jop.1988.4.195; Block ER, 2004, J BIOL CHEM, V279, P24307, DOI 10.1074/jbc.M401058200; Bulow HE, 2006, ANNU REV CELL DEV BI, V22, P375, DOI 10.1146/annurev.cellbio.22.010605.093433; Chandler HL, 2007, EXP EYE RES, V84, P400, DOI 10.1016/j.exer.2006.10.010; Chen KY, 2010, HEPATOLOGY, V52, P1957, DOI 10.1002/hep.23916; Chen LA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016132; Chung EH, 1999, INVEST OPHTH VIS SCI, V40, P1952; Clevers H, 2012, CELL, V149, P1192, DOI 10.1016/j.cell.2012.05.012; Crewe JM, 2001, INVEST OPHTH VIS SCI, V42, P1757; Dennissen MABA, 2002, J BIOL CHEM, V277, P10982, DOI 10.1074/jbc.M104852200; Dhoot GK, 2001, SCIENCE, V293, P1663, DOI 10.1126/science.293.5535.1663; Dreyfuss JL, 2009, AN ACAD BRAS CIENC, V81, P409, DOI 10.1590/S0001-37652009000300007; Esko JD, 2002, ANNU REV BIOCHEM, V71, P435, DOI 10.1146/annurev.biochem.71.110601.135458; Freeman SD, 2008, DEV BIOL, V320, P436, DOI 10.1016/j.ydbio.2008.05.554; Guiral EC, 2010, DEV BIOL, V341, P375, DOI 10.1016/j.ydbio.2010.02.034; Hacker U, 2005, NAT REV MOL CELL BIO, V6, P530, DOI 10.1038/nrm1681; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; HANNA C, 1966, AM J OPHTHALMOL, V61, P55, DOI 10.1016/0002-9394(66)90747-1; Hayano S, 2012, J BIOL CHEM, V287, P12217, DOI 10.1074/jbc.M111.332924; Heuberger J, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a002915; Holst CR, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000575; Hossain MM, 2010, GLYCOBIOLOGY, V20, P175, DOI 10.1093/glycob/cwp159; JUMBLATT MM, 1983, INVEST OPHTH VIS SCI, V24, P1139; Kakinuma Y, 2004, J NEUROSCI RES, V77, P653, DOI 10.1002/jnr.20197; Kalus I, 2009, J CELL MOL MED, V13, P4505, DOI 10.1111/j.1582-4934.2008.00558.x; Kao WWY, 2010, JPN J OPHTHALMOL, V54, P206, DOI 10.1007/s10384-010-0800-6; Kawakita T, 2004, INVEST OPHTH VIS SCI, V45, P3507, DOI 10.1167/iovs.04-0266; Lai JP, 2008, HEPATOLOGY, V47, P1211, DOI 10.1002/hep.22202; Lamanna WC, 2007, J BIOTECHNOL, V129, P290, DOI 10.1016/j.jbiotec.2007.01.022; Lamanna WC, 2006, BIOCHEM J, V400, P63, DOI 10.1042/BJ20060848; Langsdorf A, 2007, DEV BIOL, V311, P464, DOI 10.1016/j.ydbio.2007.08.053; Langsdorf A, 2011, GLYCOBIOLOGY, V21, P152, DOI 10.1093/glycob/cwq133; Lemjabbar-Alaoui H, 2010, ONCOGENE, V29, P635, DOI 10.1038/onc.2009.365; Levin MH, 2006, INVEST OPHTH VIS SCI, V47, P4365, DOI 10.1167/iovs.06-0335; Lindahl U, 2009, INT REV CEL MOL BIO, V276, P105, DOI 10.1016/S1937-6448(09)76003-4; Liu CY, 2012, METHODS MOL BIOL, V836, P285, DOI 10.1007/978-1-61779-498-8_18; Lochter A, 1997, J BIOL CHEM, V272, P5007, DOI 10.1074/jbc.272.8.5007; Lum DH, 2007, MOL CELL BIOL, V27, P678, DOI 10.1128/MCB.01279-06; Lyu J, 2005, J BIOL CHEM, V280, P21653, DOI 10.1074/jbc.m500374200; Lyu J, 2006, CORNEA, V25, pS24, DOI 10.1097/01.ico.0000247209.01262.4e; Maupin KA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013002; Morimoto-Tomita M, 2005, NEOPLASIA, V7, P1001, DOI 10.1593/neo.05496; Morimoto-Tomita M, 2002, J BIOL CHEM, V277, P49175, DOI 10.1074/jbc.M205131200; Nawroth R, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000392; Noe V, 2001, J CELL SCI, V114, P111; Phillips JJ, 2012, J CLIN INVEST, V122, P911, DOI 10.1172/JCI58215; Polyak K, 2009, NAT REV CANCER, V9, P265, DOI 10.1038/nrc2620; Prince RN, 2010, J CELL SCI, V123, P2308, DOI 10.1242/jcs.058321; Ratzka A, 2008, DEV DYNAM, V237, P339, DOI 10.1002/dvdy.21423; Rosen SD, 2010, EXPERT OPIN THER TAR, V14, P935, DOI 10.1517/14728222.2010.504718; Roy S, 2007, P NATL ACAD SCI USA, V104, P14472, DOI 10.1073/pnas.0706793104; Saika Shizuya, 2002, Cornea, V21, pS23, DOI 10.1097/00003226-200203001-00006; Sarrazin S, 2011, COLD SPRING HARB PER, P3; Savagner P, 2001, BIOESSAYS, V23, P912, DOI 10.1002/bies.1132; Schlange T, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1769; Schumacher VA, 2011, J AM SOC NEPHROL, V22, P1286, DOI 10.1681/ASN.2010080860; Stepp MA, 2002, J CELL SCI, V115, P4517, DOI 10.1242/jcs.00128; Stepp MA, 2007, J CELL SCI, V120, P2851, DOI 10.1242/jcs.03480; Tan XP, 2005, GASTROENTEROLOGY, V129, P285, DOI 10.1053/j.gastro.2005.04.013; Thakker MM, 2006, CAN J OPHTHALMOL, V41, P86, DOI 10.1016/S0008-4182(06)80074-8; Tran TH, 2012, J BIOL CHEM, V287, P32651, DOI 10.1074/jbc.M112.353243; Turnbull J, 2001, TRENDS CELL BIOL, V11, P75, DOI 10.1016/S0962-8924(00)01897-3; Viviano BL, 2004, J BIOL CHEM, V279, P5604, DOI 10.1074/jbc.M310691200; Wang SW, 2004, P NATL ACAD SCI USA, V101, P4833, DOI 10.1073/pnas.0401028101; Wilson SE, 2003, METH MOLEC MED, V78, P67; Xu K, 2011, INVEST OPHTHALMOL VI; Xu KP, 2004, INVEST OPHTH VIS SCI, V45, P813, DOI 10.1167/iovs.03-0851; Yu FSX, 2010, BRAIN RES BULL, V81, P229, DOI 10.1016/j.brainresbull.2009.08.024; Yue XP, 2013, GLYCOBIOLOGY, V23, P709, DOI 10.1093/glycob/cwt010; Zieske JD, 2001, CURR OPIN OPHTHALMOL, V12, P237, DOI 10.1097/00055735-200108000-00001; Zieske JD, 2000, PROG RETIN EYE RES, V19, P257, DOI 10.1016/S1350-9462(99)00018-X	75	28	28	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2013	8	8							e69642	10.1371/journal.pone.0069642	http://dx.doi.org/10.1371/journal.pone.0069642			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	201ER	23950901	gold, Green Published, Green Submitted			2022-12-25	WOS:000323124000010
J	Huang, XD; Lu, ZH; Lv, ZW; Yu, TT; Yang, PR; Shen, YN; Ding, Y; Fu, D; Zhang, XP; Fu, QH; Yu, YG				Huang, Xiaodong; Lu, Zhaohui; Lv, Zhongwei; Yu, Tingting; Yang, Peirong; Shen, Yongnian; Ding, Yu; Fu, Da; Zhang, Xiaoping; Fu, Qihua; Yu, Yongguo			The Fas/Fas Ligand Death Receptor Pathway Contributes to Phenylalanine-Induced Apoptosis in Cortical Neurons	PLOS ONE			English	Article							ER STRESS; PHENYLKETONURIA; MITOCHONDRIA; ACTIVATION; CASPASES; DISEASES; CELLS	Phenylketonuria (PKU), an autosomal recessive disorder of amino acid metabolism caused by mutations in the phenylalanine hydroxylase (PAH) gene, leads to childhood mental retardation by exposing neurons to cytotoxic levels of phenylalanine (Phe). A recent study showed that the mitochondria-mediated (intrinsic) apoptotic pathway is involved in Phe-induced apoptosis in cultured cortical neurons, but it is not known if the death receptor (extrinsic) apoptotic pathway and endoplasmic reticulum (ER) stress-associated apoptosis also contribute to neurodegeneration in PKU. To answer this question, we used specific inhibitors to block each apoptotic pathway in cortical neurons under neurotoxic levels of Phe. The caspase-8 inhibitor Z-IETD-FMK strongly attenuated apoptosis in Phe-treated neurons (0.9 mM, 18 h), suggesting involvement of the Fas receptor (FasR)-mediated cell death receptor pathway in Phe toxicity. In addition, Phe significantly increased cell surface Fas expression and formation of the Fas/FasL complex. Blocking Fas/FasL signaling using an anti-Fas antibody markedly inhibited apoptosis caused by Phe. In contrast, blocking the ER stress-induced cell death pathway with salubrinal had no effect on apoptosis in Phe-treated cortical neurons. These experiments demonstrate that the Fas death receptor pathway contributes to Phe-induced apoptosis and suggest that inhibition of the death receptor pathway may be a novel target for neuroprotection in PKU patients.	[Huang, Xiaodong; Yang, Peirong; Shen, Yongnian; Ding, Yu] Shanghai Jiao Tong Univ, Sch Med, Shanghai Childrens Med Ctr, Dept Internal Med, Shanghai 200030, Peoples R China; [Lu, Zhaohui] Shanghai Jiao Tong Univ, Sch Med, Shanghai Children Med Ctr, Dept Pediat Cardiothorac Surg, Shanghai 200030, Peoples R China; [Lv, Zhongwei; Fu, Da; Zhang, Xiaoping] Tongji Univ, Sch Med, Shanghai Peoples Hosp 10, Dept Nucl Med, Shanghai 200092, Peoples R China; [Yu, Tingting; Fu, Qihua] Shanghai Jiao Tong Univ, Sch Med, Shanghai Children Med Ctr, Dept Lab Med, Shanghai 200030, Peoples R China; [Yu, Yongguo] Shanghai Jiao Tong Univ, Sch Med, Shanghai Children Med Ctr, Inst Pediat Translat Med, Shanghai 200030, Peoples R China	Shanghai Jiao Tong University; Shanghai Jiao Tong University; Tongji University; Shanghai Jiao Tong University; Shanghai Jiao Tong University	Zhang, XP (corresponding author), Tongji Univ, Sch Med, Shanghai Peoples Hosp 10, Dept Nucl Med, Shanghai 200092, Peoples R China.	zxpkxy@126.com; Yuyongguo@shsmu.edu.cn.com	Fu, Qihua/AAW-9989-2020	Lu, Zhaohui/0000-0001-9644-341X; yu, yongguo/0000-0002-4472-0910	Major Program of Shanghai Committee of Science and Technology [11dz195030]; Chinese National Natural Science Foundation [81000346]	Major Program of Shanghai Committee of Science and Technology(Shanghai Science & Technology Committee); Chinese National Natural Science Foundation(National Natural Science Foundation of China (NSFC))	This work was supported by the Major Program of Shanghai Committee of Science and Technology (No. 11dz195030, Y.G.Y.) (URL: http://www.stcsm.gov.cn), and a foundation grant from the Chinese National Natural Science Foundation (No. 81000346, Y.G.Y.) (URL: http://www.nsfc.gov.cn). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acehan D, 2002, MOL CELL, V9, P423, DOI 10.1016/S1097-2765(02)00442-2; Ashkenazi A, 2002, NAT REV CANCER, V2, P420, DOI 10.1038/nrc821; Boyce M, 2005, SCIENCE, V307, P935, DOI 10.1126/science.1101902; Cohen FE, 2003, NATURE, V426, P905, DOI 10.1038/nature02265; Costabeber E, 2003, INT J DEV NEUROSCI, V21, P111, DOI 10.1016/S0736-5748(02)00108-9; Elmore S, 2007, TOXICOL PATHOL, V35, P495, DOI 10.1080/01926230701320337; Finucane DM, 1999, J BIOL CHEM, V274, P2225, DOI 10.1074/jbc.274.4.2225; Friedlander R.M., 2003, NEW ENGL J MED, V348, P1365; Huttenlocher PR, 2000, EUR J PEDIATR, V159, pS102, DOI 10.1007/PL00014371; Ilangovan R, 2003, J BIOL CHEM, V278, P30993, DOI 10.1074/jbc.M303763200; Joseph B, 2003, J NEUROCHEM, V86, P615, DOI 10.1046/j.1471-4159.2003.01887.x; Kadowaki H, 2004, J CHEM NEUROANAT, V28, P93, DOI 10.1016/j.jchemneu.2004.05.004; Li D, 2010, MOL CELL BIOCHEM, V339, P1, DOI 10.1007/s11010-009-0364-2; Naismith JH, 1998, TRENDS BIOCHEM SCI, V23, P74, DOI 10.1016/S0968-0004(97)01164-X; Nakagawa T, 2000, NATURE, V403, P98, DOI 10.1038/47513; Pey AL, 2008, J CLIN INVEST, V118, P2858, DOI 10.1172/JCI34355; Rathinam ML, 2012, ENVIRON TOXICOL PHAR, V33, P353, DOI 10.1016/j.etap.2011.12.027; Rudel T, 1999, HERZ, V24, P236, DOI 10.1007/BF03044967; Thornberry NA, 1998, SCIENCE, V281, P1312, DOI 10.1126/science.281.5381.1312; Yakovlev AG, 2001, MOL NEUROBIOL, V24, P131; Zhang HW, 2005, METAB BRAIN DIS, V20, P61, DOI 10.1007/s11011-005-2477-y; Zhang YJ, 2007, EUR J NEUROSCI, V25, P1341, DOI 10.1111/j.1460-9568.2007.05404.x; Zhang YJ, 2010, NEUROCHEM RES, V35, P480, DOI 10.1007/s11064-009-0084-8	23	23	24	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2013	8	8							e71553	10.1371/journal.pone.0071553	http://dx.doi.org/10.1371/journal.pone.0071553			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	200ZE	23940767	gold, Green Published, Green Submitted			2022-12-25	WOS:000323109700107
J	Nogueras, MM; Pons, I; Ortuno, A; Miret, J; Pla, J; Castella, J; Segura, F				Mercedes Nogueras, Maria; Pons, Immaculada; Ortuno, Ana; Miret, Jaime; Pla, Julia; Castella, Joaquim; Segura, Ferran			Molecular Detection of Rickettsia typhi in Cats and Fleas	PLOS ONE			English	Article							LOS-ANGELES-COUNTY; MURINE TYPHUS; INTERMEDIATE DURATION; DOMESTIC CATS; SPOTTED-FEVER; FELIS; POPULATION; SIPHONAPTERA; ASSOCIATION; PREVALENCE	Background: Rickettsia typhi is the etiological agent of murine typhus (MT), a disease transmitted by two cycles: rat-flea-rat, and peridomestic cycle. Murine typhus is often misdiagnosed and underreported. A correct diagnosis is important because MT can cause severe illness and death. Our previous seroprevalence results pointed to presence of human R. typhi infection in our region; however, no clinical case has been reported. Although cats have been related to MT, no naturally infected cat has been described. The aim of the study is to confirm the existence of R. typhi in our location analyzing its presence in cats and fleas. Methodology/Principal Findings: 221 cats and 80 fleas were collected from Veterinary clinics, shelters, and the street (2001-2009). Variables surveyed were: date of collection, age, sex, municipality, living place, outdoor activities, demographic area, healthy status, contact with animals, and ectoparasite infestation. IgG against R. typhi were evaluated by indirect immunofluorescence assay. Molecular detection in cats and fleas was performed by real-time PCR. Cultures were performed in those cats with positive molecular detection. Statistical analysis was carried out using SPSS. A p < 0.05 was considered significant. Thirty-five (15.8%) cats were seropositive. There were no significant associations among seropositivity and any variables. R. typhi was detected in 5 blood and 2 cultures. High titres and molecular detection were observed in stray cats and pets, as well as in spring and winter. All fleas were Ctenocephalides felis. R. typhi was detected in 44 fleas (55%), from shelters and pets. Co-infection with R. felis was observed. Conclusions: Although no clinical case has been described in this area, the presence of R. typhi in cats and fleas is demonstrated. Moreover, a considerable percentage of those animals lived in households. To our knowledge, this is the first time R. typhi is detected in naturally infected cats.	[Mercedes Nogueras, Maria; Pons, Immaculada; Segura, Ferran] Autonomous Univ Barcelona, Dept Infect Dis, Corporacio Sanitaria & Univ Parc Tauli, Inst Univ Parc Tauli, Barcelona, Spain; [Ortuno, Ana; Castella, Joaquim] Autonomous Univ Barcelona, Dept Anim Hlth, Barcelona, Spain; [Miret, Jaime] Anim Shelter Co Valles Oriental, Barcelona, Spain; [Pla, Julia] Clin Vet, Barcelona, Spain; [Segura, Ferran] Univ Autonoma Barcelona, Dept Med, E-08193 Barcelona, Spain	Autonomous University of Barcelona; Parc Tauli Hospital Universitari; Autonomous University of Barcelona; Autonomous University of Barcelona	Nogueras, MM (corresponding author), Autonomous Univ Barcelona, Dept Infect Dis, Corporacio Sanitaria & Univ Parc Tauli, Inst Univ Parc Tauli, Barcelona, Spain.	mnogueras@tauli.cat	Ortuño, Anna/AAJ-8933-2021	Castella, Joaquim/0000-0002-4757-0372; Nogueras, Maria-Mercedes/0000-0001-5925-1929	Ministerio de Sanidad y Consumo [FIS06/0433]; Instituto de Salud Carlos III - FEDER; Spanish Network for the Research in Infectious Diseases -REIPI [RD06/0008]; Catalan Society of Infectious Diseases and Microbiology	Ministerio de Sanidad y Consumo(Instituto de Salud Carlos III); Instituto de Salud Carlos III - FEDER(Instituto de Salud Carlos IIIEuropean Commission); Spanish Network for the Research in Infectious Diseases -REIPI; Catalan Society of Infectious Diseases and Microbiology	This study was supported by Ministerio de Sanidad y Consumo (Grant number FIS06/0433). Supported partially by Ministerio de Sanidad y Consumo, Instituto de Salud Carlos III - FEDER, Spanish Network for the Research in Infectious Diseases -REIPI (Grant number RD06/0008); and Catalan Society of Infectious Diseases and Microbiology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adjemian J, 2010, EMERG INFECT DIS, V16, P412, DOI 10.3201/eid1603.091028; Angelakis E, 2010, J TRAVEL MED, V17, P310, DOI 10.1111/j.1708-8305.2010.00435.x; Basrai D, 2007, INTERNIST, V48, P413, DOI 10.1007/s00108-007-1808-y; Beltran LM, 2011, ENFERM INFEC MICR CL, V29, P235, DOI 10.1016/j.eimc.2010.05.009; Bernabeu-Wittel M, 2006, EUR J CLIN MICROBIOL, V25, P375, DOI 10.1007/s10096-006-0147-6; Bernabeu-Wittel M, 1999, ARCH INTERN MED, V159, P872, DOI 10.1001/archinte.159.8.872; Bolanos-Rivero M, 2011, INT J INFECT DIS, V15, pE481, DOI 10.1016/j.ijid.2011.03.019; Boostrom A, 2002, EMERG INFECT DIS, V8, P549, DOI 10.3201/eid0806.010350; Campbell J., 2009, Morbidity and Mortality Weekly Report, V58, P1267; Case JB, 2006, J FELINE MED SURG, V8, P111, DOI 10.1016/j.jfms.2005.10.004; Eremeeva ME, 2008, EMERG INFECT DIS, V14, P1613, DOI 10.3201/eid1410.080571; Espinosa N, 2010, ENFERM INFEC MICR CL, V28, P317; Gillespie JJ, 2009, VET RES, V40, DOI 10.1051/vetres:2008050; Henry KM, 2007, MOL CELL PROBE, V21, P17, DOI 10.1016/j.mcp.2006.06.002; Hernandez-Cabrera M, 2004, EMERG INFECT DIS, V10, P740, DOI 10.3201/eid1004.030532; Kaabia N, 2009, ANN NY ACAD SCI, V1166, P167, DOI 10.1111/j.1749-6632.2009.04521.x; Lledo L, 2001, EUR J EPIDEMIOL, V17, P927, DOI 10.1023/A:1016248630809; Luria BJ, 2004, J FELINE MED SURG, V6, P287, DOI 10.1016/j.jfms.2003.11.005; Matthewman L, 1997, EUR J EPIDEMIOL, V13, P109, DOI 10.1023/A:1007375718204; Miguelez M, 2003, MED CLIN-BARCELONA, V121, P613, DOI 10.1157/13054190; Sanchez FJN, 2008, AN MED INTERN, V25, P46; Noden BH, 1998, J MED ENTOMOL, V35, P410, DOI 10.1093/jmedent/35.4.410; Nogueras MM, 2011, VECTOR-BORNE ZOONOT, V11, P479, DOI 10.1089/vbz.2010.0008; Nogueras MM, 2006, AM J TROP MED HYG, V74, P123, DOI 10.4269/ajtmh.2006.74.123; Restrepo MI, 2010, DIAGN MICR INFEC DIS, V66, P322, DOI 10.1016/j.diagmicrobio.2009.10.019; SCHRIEFER ME, 1994, J MED ENTOMOL, V31, P681, DOI 10.1093/jmedent/31.5.681; SORVILLO FJ, 1993, AM J TROP MED HYG, V48, P269, DOI 10.4269/ajtmh.1993.48.269; Stenos J, 2005, AM J TROP MED HYG, V73, P1083, DOI 10.4269/ajtmh.2005.73.1083; Stevenson HL, 2005, J MED ENTOMOL, V42, P163, DOI 10.1603/0022-2585(2005)042[0163:DORFIA]2.0.CO;2; WILLIAMS SG, 1992, J CLIN MICROBIOL, V30, P1758, DOI 10.1128/JCM.30.7.1758-1762.1992	30	29	30	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2013	8	8							e71386	10.1371/journal.pone.0071386	http://dx.doi.org/10.1371/journal.pone.0071386			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	217ZG	23940746	Green Published, gold, Green Submitted			2022-12-25	WOS:000324401500068
J	Chong, YH; Dennis, NA; Connolly, MJ; Teh, R; Jones, GT; van Rij, AM; Farrand, S; Campbell, AJ; MLennan, IS				Chong, Yih Harng; Dennis, Nicola A.; Connolly, Martin J.; Teh, Ruth; Jones, Gregory T.; van Rij, Andre M.; Farrand, Stephanie; Campbell, A. John; MLennan, Ian S.			Elderly Men Have Low Levels of Anti-Mullerian Hormone and Inhibin B, but with High Interpersonal Variation: A Cross-Sectional Study of the Sertoli Cell Hormones in 615 Community-Dwelling Men	PLOS ONE			English	Article							LUTEINIZING-HORMONE; ADVANCED AGE; LILACS NZ; MALE BIAS; SUBSTANCE; TESTOSTERONE; POPULATION; MECHANISMS; ACTIVIN; DECLINE	The Sertoli cells of the testes secrete anti-Mullerian hormone (Mullerian inhibiting Substance, AMH) and inhibin B (InhB). AMH triggers the degeneration of the uterine precursor in male embryos, whereas InhB is part of the gonadal-pituitary axis for the regulation of sperm production in adults. However, both hormones are also putative regulators of homeostasis, and age-related changes in these hormones may therefore be important to the health status of elderly men. The levels of AMH in elderly men are unknown, with limited information being available about age-related changes in InhB. We have therefore used ELISAs to measure Sertoli cell hormone levels in 3 cohorts of community-dwelling men in New Zealand. In total, 615 men were examined, 493 of which were aged 65 or older. Serum AMH and InhB levels inversely correlated with age in men older than 50 years (p < 0.001) but not in the younger men. A minority of elderly men had undetectable levels of AMH and InhB. The variation in hormone levels between similarly aged men increased with the age of men. AMH and InhB partially correlated with each other as expected (r = 0.48, p < 0.001). However, the ratio of the two Sertoli hormones varied significantly between men, with this variation increasing with age. Elderly men selected for the absence of cardiovascular disease had AMH levels similar to those of young men whereas their InhB levels did not differ from aged-matched controls. These data suggests that Sertoli cell number and function changes with age, but with the extent and nature of the changes varying between men.	[Chong, Yih Harng; Dennis, Nicola A.] Univ Otago, Dept Anat, Otago Sch Med Sci, Dunedin, New Zealand; [Chong, Yih Harng; Farrand, Stephanie; Campbell, A. John] Univ Otago, Dept Med, Dunedin Sch Med, Dunedin, New Zealand; [Jones, Gregory T.; van Rij, Andre M.] Dunedin Sch Med, Dept Surg Sci, Dunedin, New Zealand; [Jones, Gregory T.; van Rij, Andre M.] Univ Otago, Dunedin, New Zealand; [MLennan, Ian S.] Univ Otago, Brain Hlth Res Ctr, Dunedin, New Zealand; [Connolly, Martin J.] Univ Auckland, Freemasons Dept Geriatr Med, Auckland 1, New Zealand; [Teh, Ruth] Univ Auckland, Dept Gen Practice & Primary Hlth Care, Auckland 1, New Zealand	University of Otago; University of Otago; University of Otago; University of Otago; University of Otago; University of Auckland; University of Auckland	MLennan, IS (corresponding author), Univ Otago, Brain Hlth Res Ctr, Dunedin, New Zealand.	ian.mclennan@otago.ac.nz		Teh, Ruth/0000-0001-7135-1850; Jones, Gregory T/0000-0002-6950-4210; Dennis, Nicola/0000-0002-0658-6140	Ministry of Business, Innovation and Employment, New Zealand; Health Research Council of New Zealand; Nga Pae o te Maramatanga, New Zealand; Oakley Mental Health Foundation, New Zealand; National Heart Foundation, New Zealand; Faculty of Medical and Health Sciences, University of Auckland, New Zealand	Ministry of Business, Innovation and Employment, New Zealand(New Zealand Ministry of Business, Innovation and Employment (MBIE)); Health Research Council of New Zealand(Health Research Council of New Zealand); Nga Pae o te Maramatanga, New Zealand; Oakley Mental Health Foundation, New Zealand; National Heart Foundation, New Zealand; Faculty of Medical and Health Sciences, University of Auckland, New Zealand	This study was funded by the following sources: Ministry of Business, Innovation and Employment, New Zealand; Health Research Council of New Zealand; Nga Pae o te Maramatanga, New Zealand; Oakley Mental Health Foundation, New Zealand; National Heart Foundation, New Zealand; and the Faculty of Medical and Health Sciences, University of Auckland, New Zealand. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aksglaede L, 2010, J CLIN ENDOCR METAB, V95, P5357, DOI 10.1210/jc.2010-1207; Andersson AM, 2001, MOL CELL ENDOCRINOL, V180, P103, DOI 10.1016/S0303-7207(01)00520-2; Andersson AM, 2007, J CLIN ENDOCR METAB, V92, P4696, DOI 10.1210/jc.2006-2633; Appt SE, 2012, MENOPAUSE, V19, P1353, DOI 10.1097/gme.0b013e31825b4fe2; Bergendahl M, 1996, HUM REPROD UPDATE, V2, P507, DOI 10.1093/humupd/2.6.507; Broer SL, 2011, J CLIN ENDOCR METAB, V96, P2532, DOI 10.1210/jc.2010-2776; Burger HG, 1999, J CLIN ENDOCR METAB, V84, P4025, DOI 10.1210/jc.84.11.4025; CATLIN EA, 1990, AM REV RESPIR DIS, V141, P466, DOI 10.1164/ajrccm/141.2.466; Chong YH, 2012, INT J GYNEC IN PRESS; Dennis NA, 2012, IS ANTIMULLERIAN HOR; Dyall L, 2013, AUST NZ J PUBL HEAL, V37, P124, DOI 10.1111/1753-6405.12029; Eldar-Geva T, 2010, EUR J ENDOCRINOL, V162, P177, DOI 10.1530/EJE-09-0366; Feldman HA, 2002, J CLIN ENDOCR METAB, V87, P589, DOI 10.1210/jc.87.2.589; Halm S, 2007, GENE, V388, P148, DOI 10.1016/j.gene.2006.10.018; Hayman KJ, 2012, BMC GERIATR, V12, DOI 10.1186/1471-2318-12-33; Hedger MP, 2012, MOL CELL ENDOCRINOL, V359, P30, DOI 10.1016/j.mce.2011.09.031; JOHNSON L, 1986, J ANDROL, V7, P316; JOHNSON L, 1984, BIOL REPROD, V31, P785, DOI 10.1095/biolreprod31.4.785; Lee MM, 1996, J CLIN ENDOCR METAB, V81, P571, DOI 10.1210/jc.81.2.571; MacLaughlin DT, 2004, NEW ENGL J MED, V350, P367, DOI 10.1056/NEJMra022784; Mahmoud AM, 2000, CLIN ENDOCRINOL, V53, P141; Morgan K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020533; Morgan K, 2011, BEHAV BRAIN RES, V221, P304, DOI 10.1016/j.bbr.2011.02.048; Nicks KM, 2009, MOL CELL ENDOCRINOL, V310, P11, DOI 10.1016/j.mce.2009.07.001; O'Connor AE, 2004, SEMIN REPROD MED, V 22, P177, DOI 10.1055/s-2004-831893; Pankhurst MW, 2012, TRANSL PSYCHIAT, V2, DOI 10.1038/tp.2012.72; Pincus SM, 1996, P NATL ACAD SCI USA, V93, P14100, DOI 10.1073/pnas.93.24.14100; Ricci M, 2010, J CARD FAIL, V16, P628, DOI 10.1016/j.cardfail.2010.03.007; Robeva R, 2012, ANDROLOGIA, V44, P329, DOI 10.1111/j.1439-0272.2011.01185.x; Shi YG, 2003, CELL, V113, P685, DOI 10.1016/S0092-8674(03)00432-X; Streuli I, 2009, FERTIL STERIL, V91, P226, DOI 10.1016/j.fertnstert.2007.10.067; VIGIER B, 1983, J REPROD FERTIL, V69, P207; Wang PY, 2009, P NATL ACAD SCI USA, V106, P7203, DOI 10.1073/pnas.0902253106; Wang PY, 2005, P NATL ACAD SCI USA, V102, P16421, DOI 10.1073/pnas.0508304102; Wittmann W, 2011, J NEUROENDOCRINOL, V23, P831, DOI 10.1111/j.1365-2826.2011.02187.x; Yan W, 2003, APMIS, V111, P174, DOI 10.1034/j.1600-0463.2003.1110121.x	36	26	26	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2013	8	8							e70967	10.1371/journal.pone.0070967	http://dx.doi.org/10.1371/journal.pone.0070967			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	218XC	23940675	Green Published, Green Submitted, gold			2022-12-25	WOS:000324465000164
J	Tang, LL; Zhang, HB; Lei, L; Gong, SQ; Zhou, ZG; Baseman, J; Zhong, GM				Tang, Lingli; Zhang, Hongbo; Lei, Lei; Gong, Siqi; Zhou, Zhiguang; Baseman, Joel; Zhong, Guangming			Oviduct Infection and Hydrosalpinx in DBA1/j Mice Is Induced by Intracervical but Not Intravaginal Inoculation with Chlamydia muridarum	PLOS ONE			English	Article							GENITAL-TRACT INFECTION; OUTER-MEMBRANE PROTEIN; TRANSCRIPTIONAL REGULATOR; MONOCLONAL-ANTIBODIES; TRACHOMATIS PLASMID; PATHOLOGY; IMMUNITY; INFERTILITY; PROTECTION; DEFICIENT	Intravaginal infection with C. muridarum in mice often results in hydrosalpinx similar to that found in women urogenitally infected with C. trachomatis, making the C. muridarum lower genital tract infection murine model suitable for studying C. trachomatis pathogenesis. To our surprise, DBA1/j mice were highly resistant to hydrosalpinx following an intravaginal infection with C. muridarum although these mice were as susceptible to lower genital tract infection as other mouse strains. A significantly lower level of C. muridarum organisms was recovered from the oviduct of DBA1/j mice, correlating the resistance to hydrosalpinx with reduced ascension of C. muridarum to the oviduct. The DBA1/j resistance to hydrosalpinx was effectively overcome by intracervical inoculation with C. muridarum. The intracervically inoculated DBA1/j mice developed severe hydrosalpinx with the highest levels of live C. muridarum organisms recovered from uterine tissue on day 3 and oviduct tissue on day 7 post inoculation while in intravaginally inoculated DBA1/j mice, the peak of live organism recovery from uterine tissue was delayed to day 7 with no rise in the amount of live organisms recovered from the oviduct. These observations have not only validated the correlation between hydrosalpinx and live organism invasion in the oviduct but also demonstrated that the intracervical inoculation, by promoting rapid chlamydial replication in the uterine epithelial cells and ascension to the oviduct of DBA1/j mice, may be used for further understanding chlamydial pathogenic mechanisms. The above findings also suggest that strategies aimed at reducing tubal infection may be most effective in blocking tubal pathology.	[Tang, Lingli; Zhang, Hongbo; Lei, Lei; Gong, Siqi; Baseman, Joel; Zhong, Guangming] Univ Texas Hlth Sci Ctr San Antonio, Dept Microbiol & Immunol, San Antonio, TX 78229 USA; [Tang, Lingli; Zhang, Hongbo; Zhou, Zhiguang] Cent S Univ, Dept Clin Lab, Xiangya Hosp 2, Changsha, Hunan, Peoples R China; [Tang, Lingli; Zhang, Hongbo; Zhou, Zhiguang] Cent S Univ, Dept Pathol, Xiangya Hosp 2, Changsha, Hunan, Peoples R China; [Tang, Lingli; Zhang, Hongbo; Zhou, Zhiguang] Cent S Univ, Dept Endocrinol, Xiangya Hosp 2, Changsha, Hunan, Peoples R China	University of Texas System; University of Texas Health San Antonio; Central South University; Central South University; Central South University	Zhong, GM (corresponding author), Univ Texas Hlth Sci Ctr San Antonio, Dept Microbiol & Immunol, San Antonio, TX 78229 USA.	Zhongg@UTHSCSA.EDU	Gong, Siqi/AAM-1568-2021; Gong, Siqi/ABD-9207-2020; Lei, Lei/I-3002-2013	Gong, Siqi/0000-0002-1111-6039; Zhou, Zhiguang/0000-0002-0374-1838	US NIH [R01AI064537, R01AI047997]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI047997, R01AI064537] Funding Source: NIH RePORTER	US NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The study was supported by US NIH grants R01AI064537 & R01AI047997. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Carlson JH, 2008, INFECT IMMUN, V76, P2273, DOI 10.1128/IAI.00102-08; Chen CQ, 2006, INFECT IMMUN, V74, P4826, DOI 10.1128/IAI.00081-06; Chen DJ, 2010, WIRELESSHART: REAL-TIME MESH NETWORK FOR INDUSTRIAL AUTOMATION, P3, DOI 10.1007/978-1-4419-6047-4_1; Chen LL, 2010, J IMMUNOL, V184, P2602, DOI 10.4049/jimmunol.0901593; Cheng W, 2008, INFECT IMMUN, V76, P515, DOI 10.1128/IAI.01064-07; COTTER TW, 1995, INFECT IMMUN, V63, P4704, DOI 10.1128/IAI.63.12.4704-4714.1995; Darville T, 2003, J IMMUNOL, V171, P6187, DOI 10.4049/jimmunol.171.11.6187; DELAMAZA LM, 1994, INFECT IMMUN, V62, P2094, DOI 10.1128/IAI.62.5.2094-2097.1994; Galaleldeen A, 2013, J BIOL CHEM; Gondek DC, 2012, J IMMUNOL, V189, P2441, DOI 10.4049/jimmunol.1103032; Li Z, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-90; Li ZY, 2008, INFECT IMMUN, V76, P3415, DOI 10.1128/IAI.01377-07; Morrison RP, 2002, INFECT IMMUN, V70, P2741, DOI 10.1128/IAI.70.6.2741-2751.2002; Morrison SG, 2005, J IMMUNOL, V175, P7536, DOI 10.4049/jimmunol.175.11.7536; O'Connell CM, 2007, J IMMUNOL, V179, P4027, DOI 10.4049/jimmunol.179.6.4027; O'Connell CM, 2011, INFECT IMMUN, V79, P1044, DOI 10.1128/IAI.01118-10; Pal S, 2005, INFECT IMMUN, V73, P8153, DOI 10.1128/IAI.73.12.8153-8160.2005; Ramsey KH, 2001, INFECT IMMUN, V69, P7374, DOI 10.1128/IAI.69.12.7374-7379.2001; Shah AA, 2005, SEX TRANSM DIS, V32, P49, DOI 10.1097/01.olq.0000148299.14513.11; SHERMAN KJ, 1990, SEX TRANSM DIS, V17, P115, DOI 10.1097/00007435-199007000-00001; Song LH, 2013, INFECT IMMUN, V81, P636, DOI 10.1128/IAI.01305-12; Stephens RS, 2003, TRENDS MICROBIOL, V11, P44, DOI 10.1016/S0966-842X(02)00011-2; SWENSON CE, 1984, SEX TRANSM DIS, V11, P64, DOI 10.1097/00007435-198404000-00002; Warner N, 2013, J IMMUNOL, V190, P3, DOI 10.4049/jimmunol.1203103; Zhong GM, 1997, P NATL ACAD SCI USA, V94, P13856, DOI 10.1073/pnas.94.25.13856; Zhong GM, 2001, J EXP MED, V193, P935, DOI 10.1084/jem.193.8.935	26	17	17	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2013	8	8							e71649	10.1371/journal.pone.0071649	http://dx.doi.org/10.1371/journal.pone.0071649			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	218XC	23940777	Green Submitted, Green Published, gold			2022-12-25	WOS:000324465000220
J	Yamashita, F; Azuma, K; Yoshida, T; Yamada, K; Kawahara, A; Hattori, S; Takeoka, H; Zaizen, Y; Kawayama, T; Kage, M; Hoshino, T				Yamashita, Fumie; Azuma, Koichi; Yoshida, Tsukasa; Yamada, Kazuhiko; Kawahara, Akihiko; Hattori, Satoshi; Takeoka, Hiroaki; Zaizen, Yoshiaki; Kawayama, Tomotaka; Kage, Masayoshi; Hoshino, Tomoaki			Prognostic Value of EGFR Mutation and ERCC1 in Patients with Non-Small Cell Lung Cancer Undergoing Platinum-Based Chemotherapy	PLOS ONE			English	Article							GROWTH-FACTOR-RECEPTOR; FRONT-LINE CHEMOTHERAPY; ACTIVATING MUTATIONS; GEFITINIB; EXPRESSION; GENE; ASSOCIATION; SURVIVAL; EXON-19	Background: In order to improve the outcome of patients with non-small cell lung cancer (NSCLC), a biomarker that can predict the efficacy of chemotherapy is needed. The aim of this study was to assess the role of EGFR mutations and ERCC1 in predicting the efficacy of platinum-based chemotherapy and the outcome of patients with NSCLC. Methods: We conducted a retrospective study to analyze the relationships between EGFR mutations or ERCC1 expression and progression-free survival (PFS) in patients with NSCLC who received platinum-based chemotherapy. EGFR mutation status was determined using the peptide nucleic acid-locked nucleic acid polymerase chain reaction clamp method, and immunohistochemistry was used to examine the expression of ERCC1 in tumor samples obtained from the patients. Results: Among the NSCLC patients who received platinum-based chemotherapy, the median PFS was significantly better in those who had never smoked and those with exon 19 deletion, and the median overall survival (OS) was significantly better in those who had never smoked, those with exon 19 deletion, and women. Cox regression analysis revealed that exon 19 deletion and having never smoked were significantly associated with both PFS and OS. Subset analysis revealed a significant correlation between ERCC1 expression and EGFR mutation, and ERCC1-negative patients with exon 19 deletion had a longer PFS than the other patients; ERCC1-positive patients without exon 19 deletion had a shorter PFS than the other patients. Conclusions: Our results indicate that among NSCLC patients receiving platinum-based chemotherapy, those with exon 19 deletion have a longer PFS and OS. Our findings suggest that platinum-based chemotherapy is more effective against ERCC1-negative and exon 19-positive NSCLC.	[Yamashita, Fumie; Azuma, Koichi; Yoshida, Tsukasa; Yamada, Kazuhiko; Takeoka, Hiroaki; Zaizen, Yoshiaki; Kawayama, Tomotaka; Hoshino, Tomoaki] Kurume Univ, Sch Med, Div Respirol Neurol & Rheumatol, Dept Internal Med, Kurume, Fukuoka 830, Japan; [Kawahara, Akihiko; Kage, Masayoshi] Kurume Univ Hosp, Dept Diagnost Pathol, Kurume, Fukuoka, Japan; [Hattori, Satoshi] Kurume Univ, Ctr Biostat, Kurume, Fukuoka 830, Japan	Kurume University; Kurume University; Kurume University	Azuma, K (corresponding author), Kurume Univ, Sch Med, Div Respirol Neurol & Rheumatol, Dept Internal Med, Kurume, Fukuoka 830, Japan.	azuma@med.kurume-u.ac.jp	Zaizen, Yoshiaki/AEY-7320-2022; Yamada, Kazuhiko/GPG-2804-2022		Fukuoka Foundation for Sound Health, Japan; Grants-in-Aid for Scientific Research [23790425] Funding Source: KAKEN	Fukuoka Foundation for Sound Health, Japan; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported by Fukuoka Foundation for Sound Health, Japan (http://www.sukoken.or.jp/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Azuma K, 2009, LUNG CANCER, V64, P326, DOI 10.1016/j.lungcan.2008.09.002; Besse B, 2013, J CLIN ONCOL, V31, P1050, DOI 10.1200/JCO.2012.43.0900; Gandara DR, 2010, J THORAC ONCOL, V5, P1933, DOI 10.1097/JTO.0b013e3181fd418d; Hotta K, 2007, J THORAC ONCOL, V2, P632, DOI 10.1097/JTO.0b013e318074bc0d; Hubner RA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025164; Jackman DM, 2006, CLIN CANCER RES, V12, P3908, DOI 10.1158/1078-0432.CCR-06-0462; Kalikaki A, 2010, LUNG CANCER, V69, P110, DOI 10.1016/j.lungcan.2009.09.010; Kawahara A, 2010, HUM PATHOL, V41, P951, DOI 10.1016/j.humpath.2009.12.007; Kosaka T, 2004, CANCER RES, V64, P8919, DOI 10.1158/0008-5472.CAN-04-2818; Lee KH, 2008, LUNG CANCER, V60, P401, DOI 10.1016/j.lungcan.2007.10.014; Lin CC, 2010, J THORAC ONCOL, V5, P1424, DOI 10.1097/JTO.0b013e3181e9db73; Lynch TJ, 2004, NEW ENGL J MED, V350, P2129, DOI 10.1056/NEJMoa040938; Maemondo M, 2010, NEW ENGL J MED, V362, P2380, DOI 10.1056/NEJMoa0909530; Mitsudomi T, 2010, LANCET ONCOL, V11, P121, DOI 10.1016/S1470-2045(09)70364-X; Mok TS, 2009, NEW ENGL J MED, V361, P947, DOI 10.1056/NEJMoa0810699; Nagai Y, 2005, CANCER RES, V65, P7276, DOI 10.1158/0008-5472.CAN-05-0331; Paez JG, 2004, SCIENCE, V304, P1497, DOI 10.1126/science.1099314; Park JH, 2012, LUNG CANCER, V77, P433, DOI 10.1016/j.lungcan.2012.03.020; Parkin DM, 2001, EUR J CANCER, V37, pS4, DOI 10.1016/S0959-8049(01)00267-2; Rafael R, 2012, LANCET ONCOL, V13, P239, DOI DOI 10.1016/S1470-2045(11)70393-X; Ren SX, 2012, CANCER-AM CANCER SOC, V118, P5588, DOI 10.1002/cncr.27603; Riely GJ, 2006, CLIN CANCER RES, V12, P839, DOI 10.1158/1078-0432.CCR-05-1846; Simon GR, 2005, CHEST, V127, P978, DOI 10.1378/chest.127.3.978; Wu MN, 2010, LUNG CANCER, V67, P343, DOI 10.1016/j.lungcan.2009.04.011; Zhou CC, 2011, LANCET ONCOL, V12, P735, DOI 10.1016/S1470-2045(11)70184-X	25	20	23	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2013	8	8							e71356	10.1371/journal.pone.0071356	http://dx.doi.org/10.1371/journal.pone.0071356			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	218XC	23940741	Green Published, gold, Green Submitted			2022-12-25	WOS:000324465000207
J	Genovart, M; Thibault, JC; Igual, JM; Bauza-Ribot, MD; Rabouam, C; Bretagnolle, V				Genovart, Meritxell; Thibault, Jean-Claude; Manuel Igual, Jose; del Mar Bauza-Ribot, Maria; Rabouam, Corinne; Bretagnolle, Vincent			Population Structure and Dispersal Patterns within and between Atlantic and Mediterranean Populations of a Large-Range Pelagic Seabird	PLOS ONE			English	Article							SHEARWATER CALONECTRIS-DIOMEDEA; ENDANGERED BALEARIC SHEARWATER; MAXIMUM-LIKELIHOOD-ESTIMATION; CORYS SHEARWATER; GENE FLOW; AVIAN PHYLOGEOGRAPHY; WANDERING ALBATROSS; COALESCENT APPROACH; MITOCHONDRIAL-DNA; MIGRATION RATES	Dispersal is critically linked to the demographic and evolutionary trajectories of populations, but in most seabird species it may be difficult to estimate. Using molecular tools, we explored population structure and the spatial dispersal pattern of a highly pelagic but philopatric seabird, the Cory's shearwater Calonectris diomedea. Microsatellite fragments were analysed from samples collected across almost the entire breeding range of the species. To help disentangle the taxonomic status of the two subspecies described, the Atlantic form C. d. borealis and the Mediterranean form C. d. diomedea, we analysed genetic divergence between subspecies and quantified both historical and recent migration rates between the Mediterranean and Atlantic basins. We also searched for evidence of isolation by distance (IBD) and addressed spatial patterns of gene flow. We found a low genetic structure in the Mediterranean basin. Conversely, strong genetic differentiation appeared in the Atlantic basin. Even if the species was mostly philopatric (97%), results suggest recent dispersal between basins, especially from the Atlantic to the Mediterranean (aprox. 10% of migrants/generation across the last two generations). Long-term gene flow analyses also suggested an historical exchange between basins (about 70 breeders/generation). Spatial analysis of genetic variation indicates that distance is not the main factor in shaping genetic structure in this species. Given our results we recommend gathering more data before concluded whether these taxa should be treated as two species or subspecies.	[Genovart, Meritxell; Manuel Igual, Jose; del Mar Bauza-Ribot, Maria] Inst Mediterrani Estudis Avancats IMEDEA CSIC UIB, Populat Ecol Grp, Esporles, Mallorca, Spain; [Thibault, Jean-Claude] Museum Natl Hist Nat, Dept Systemat & Evolut, UMR Origine Struct & Evolut Biodiversite 7205, F-75231 Paris, France; [Rabouam, Corinne; Bretagnolle, Vincent] CNRS, Ctr Etud Biol Chize, UPR 1934, Villiers En Bois, France	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto Mediterraneo de Estudios Avanzados (IMEDEA); Museum National d'Histoire Naturelle (MNHN); UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS)	Genovart, M (corresponding author), Inst Mediterrani Estudis Avancats IMEDEA CSIC UIB, Populat Ecol Grp, Esporles, Mallorca, Spain.	m.genovart@uib.es	Igual, Jose/N-3975-2014; Genovart, Meritxell/L-4873-2014	Igual, Jose/0000-0002-8369-3150; Genovart, Meritxell/0000-0003-2919-1288	Spanish Ministry of Education and Science; Spanish Ministry of Science and Innovation [CGL2009-08298]; Consell Insular de Menorca [645/541A]	Spanish Ministry of Education and Science(Spanish Government); Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Consell Insular de Menorca	MG was partially funded by an I3P postdoctoral fellowship from the Spanish Ministry of Education and Science. This work received partial financial support from the project CGL2009-08298 from the Spanish Ministry of Science and Innovation and 645/541A from the Consell Insular de Menorca. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balloux F, 2002, MOL ECOL, V11, P771, DOI 10.1046/j.1365-294X.2002.01474.x; Beerli P, 1999, GENETICS, V152, P763; Beerli P, 2001, P NATL ACAD SCI USA, V98, P4563, DOI 10.1073/pnas.081068098; Beerli Peter, 2009, V17, P42; Belkhir K, 2001, GENETIX 4 05 LOGICIE; Benjamini Y, 2001, ANN STAT, V29, P1165; Bicknell AWJ, 2012, MOL ECOL, V21, P2863, DOI 10.1111/j.1365-294X.2012.05558.x; Bohonak AJ, 1999, Q REV BIOL, V74, P21, DOI 10.1086/392950; BRETAGNOLLE V, 1990, ETHOLOGY, V85, P313; Brito PH, 2007, MOL ECOL, V16, P3423, DOI 10.1111/j.1365-294X.2007.03401.x; Brooke M, 2004, ALBATROSSES PETRELS; Cachia-Zammit R, 1986, IL MERILL, V24, P1; Cagnon C, 2004, MAR BIOL, V145, P1257, DOI 10.1007/s00227-004-1407-6; Chapuis MP, 2007, MOL BIOL EVOL, V24, P621, DOI 10.1093/molbev/msl191; Congdon BC, 2000, EVOLUTION, V54, P974; Cure C, 2010, BEHAV ECOL SOCIOBIOL, V64, P1823, DOI 10.1007/s00265-010-0994-0; Cure C, 2009, BIOL J LINN SOC, V96, P115, DOI 10.1111/j.1095-8312.2008.01104.x; da Silva MC, 1999, CONDOR, V101, P174, DOI 10.2307/1370461; de Juana A. Eduardo, 1994, Ardeola, V41, P91; Dearborn DC, 2003, MOL ECOL, V12, P2835, DOI 10.1046/j.1365-294X.2003.01931.x; Deregnaucourt S, 2003, ETHOLOGY, V109, P107, DOI 10.1046/j.1439-0310.2003.00854.x; Edwards S, 2009, MOL ECOL, V18, P2930, DOI 10.1111/j.1365-294X.2009.04270.x; Epperson B. K., 2003, GEOGRAPHICAL GENETIC; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; EXCOFFIER L, 1992, GENETICS, V131, P479; Falush D, 2003, SCIENCE, V299, P1582, DOI 10.1126/science.1080857; Felicisimo AM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002928; Friesen VL, 2007, MOL ECOL, V16, P1765, DOI 10.1111/j.1365-294X.2006.03197.x; Gaggiotti OE, 1999, MOL ECOL, V8, P1513, DOI 10.1046/j.1365-294x.1999.00730.x; Gauthier G, 2010, J ANIM ECOL, V79, P879, DOI 10.1111/j.1365-2656.2010.01683.x; Gee JM, 2009, BRAIN BEHAV EVOLUT, V74, P258, DOI 10.1159/000264661; Genovart M, 2013, J ANIM ECOL, V82, P121, DOI 10.1111/j.1365-2656.2012.02015.x; Genovart M, 2012, J HERED, V103, P330, DOI 10.1093/jhered/ess010; Gomez-Diaz E, 2006, MOL PHYLOGENET EVOL, V41, P322, DOI 10.1016/j.ympev.2006.05.006; Gomez-Diaz E, 2009, MAR ECOL PROG SER, V382, P197, DOI 10.3354/meps07974; Gonzalez EG, 2009, MOL ECOL RESOUR, V9, P1044, DOI 10.1111/j.1755-0998.2009.02563.x; Gonzalez-Solis J, 2009, MAR ECOL PROG SER, V391, P221, DOI 10.3354/meps08128; Goudet J., 2001, FSTAT PROGRAM ESTIMA; Granadeiro JP, 1991, SEABIRD, V13, P30; Guinand B, 1996, BIOL J LINN SOC, V58, P173, DOI 10.1111/j.1095-8312.1996.tb01430.x; Hazevoet CJ, 1995, BIRDS CAPE VERDE ISL, V13; Hubisz MJ, 2009, MOL ECOL RESOUR, V9, P1322, DOI 10.1111/j.1755-0998.2009.02591.x; Inchausti P, 2002, J ANIM ECOL, V71, P765, DOI 10.1046/j.1365-2656.2002.00638.x; Jenkins DG, 2010, ECOGRAPHY, V33, P315, DOI 10.1111/j.1600-0587.2010.06285.x; Jenouvrier S, 2008, OIKOS, V117, P620, DOI 10.1111/j.0030-1299.2008.16394.x; Juliano MF, 2007, J PHYS OCEANOGR, V37, P2573, DOI 10.1175/2007JPO3150.1; lo Valvo M., 1988, Bocagiana (Funchal), P1; Manel S, 2003, TRENDS ECOL EVOL, V15, P290; Martinez-Abrain A, 2002, WATERBIRDS, V25, P221, DOI 10.1675/1524-4695(2002)025[0221:ACSBIA]2.0.CO;2; Massa B., 1986, NATO ASI Series Series G Ecological Sciences, V12, P293; Mays Gilles, 2006, Ornithos, V13, P316; Milot E, 2008, MOL ECOL, V17, P1658, DOI 10.1111/j.1365-294X.2008.03700.x; Molina B, 2005, ARDEOLA, V52, P423; Mougin J.L., 1987, Gerfaut, V77, P353; Munilla I, 2008, PLAN INTEGRAL RECUPE; NEI M, 1978, GENETICS, V89, P583; Nichols J., 2001, DISPERSAL; ODEN NL, 1986, SYST ZOOL, V35, P608, DOI 10.2307/2413120; Patarnello T, 2007, MOL ECOL, V16, P4426, DOI 10.1111/j.1365-294X.2007.03477.x; Pons JM, 2004, J ZOOL SYST EVOL RES, V42, P245, DOI 10.1111/j.1439-0469.2004.00255.x; Pritchard JK, 2000, GENETICS, V155, P945; Rabouam C, 1998, AUK, V115, P483; Rabouam C, 2000, AUK, V117, P651, DOI 10.1642/0004-8038(2000)117[0651:GROCSS]2.0.CO;2; Rabouam C, 1997, THESIS U F RABELAIS; RANDI E, 1989, AUK, V106, P411; RAYMOND M, 1995, J HERED, V86, P248, DOI 10.1093/oxfordjournals.jhered.a111573; Reyes-Gonzalez JM, 2012, ENCICLOPEDIA VIRTUAL; RISTOW D, 1990, Vogelwelt, V111, P172; Rosenberg NA, 2004, MOL ECOL NOTES, V4, P137, DOI 10.1046/j.1471-8286.2003.00566.x; Rousset F, 2008, MOL ECOL RESOUR, V8, P103, DOI 10.1111/j.1471-8286.2007.01931.x; Sambrook J., 1989, MOL CLONING LAB MANU, V2; Sangster G, 2012, IBIS, V154, P874, DOI 10.1111/j.1474-919X.2012.01273.x; Sanz-Aguilar A, 2011, ECOL APPL, V21, P555, DOI 10.1890/09-2339.1; Schneider S, 2000, ARLEQUIN V 2 0 SOFRW; SLATKIN M, 1987, SCIENCE, V236, P787, DOI 10.1126/science.3576198; SMOUSE PE, 1986, SYST ZOOL, V35, P627, DOI 10.2307/2413122; SOKAL RR, 1979, SYST ZOOL, V28, P227, DOI 10.2307/2412528; STAMPS JA, 1987, AM NAT, V129, P629, DOI 10.1086/284663; Thibault J-C, 1997, BIRDS W PALEARCTIC U, V1, P75; Thibault JC, 1998, IBIS, V140, P523, DOI 10.1111/j.1474-919X.1998.tb04615.x; Waser PM, 1998, TRENDS ECOL EVOL, V13, P43, DOI 10.1016/S0169-5347(97)01255-X; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI [10.2307/2408641, 10.1111/j.1558-5646.1984.tb05657.x]; Welch AJ, 2012, HEREDITY, V109, P19, DOI 10.1038/hdy.2012.7; Whitlock MC, 1999, HEREDITY, V82, P117, DOI 10.1038/sj.hdy.6884960; Whitlock MC, 2011, MOL ECOL, V20, P1083, DOI 10.1111/j.1365-294X.2010.04996.x; Wilson GA, 2003, GENETICS, V163, P1177; Zink RM, 2008, MOL ECOL, V17, P2107, DOI 10.1111/j.1365-294X.2008.03737.x; Zotier R, 1999, J BIOGEOGR, V26, P297, DOI 10.1046/j.1365-2699.1999.00260.x	88	26	27	2	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2013	8	8							e70711	10.1371/journal.pone.0070711	http://dx.doi.org/10.1371/journal.pone.0070711			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	200UV	23950986	Green Published, gold, Green Submitted			2022-12-25	WOS:000323097300042
J	Rusine, J; Asiimwe-Kateera, B; van de Wijgert, J; Boer, KR; Mukantwali, E; Karita, E; Gasengayire, A; Jurriaans, S; de Jong, M; Ondoa, P				Rusine, John; Asiimwe-Kateera, Brenda; van de Wijgert, Janneke; Boer, Kimberly Rachel; Mukantwali, Enatha; Karita, Etienne; Gasengayire, Agnes; Jurriaans, Suzanne; de Jong, Menno; Ondoa, Pascale			Low Primary and Secondary HIV Drug-Resistance after 12 Months of Antiretroviral Therapy in Human Immune-Deficiency Virus Type 1 (HIV-1)-Infected Individuals from Kigali, Rwanda	PLOS ONE			English	Article							LOGISTIC-REGRESSION ANALYSIS; SUB-SAHARAN AFRICA; REVERSE-TRANSCRIPTASE; SOUTH-AFRICA; MUTATIONS; SURVEILLANCE; ZIDOVUDINE; FAILURE; PATTERNS; STRATEGY	Treatment outcomes of HIV patients receiving antiretroviral therapy (ART) in Rwanda are scarcely documented. HIV viral load (VL) and HIV drug-resistance (HIVDR) outcomes at month 12 were determined in a prospective cohort study of antiretroviral-naive HIV patients initiating first-line therapy in Kigali. Treatment response was monitored clinically and by regular CD4 counts and targeted HIV viral load (VL) to confirm drug failure. VL measurements and HIVDR genotyping were performed retrospectively on baseline and month 12 samples. One hundred and fifty-eight participants who completed their month 12 follow-up visit had VL data available at month 12. Most of them (88%) were virologically suppressed (VL <= 1000 copies/mL) but 18 had virological failure (11%), which is in the range of WHO-suggested targets for HIVDR prevention. If only CD4 criteria had been used to classify treatment response, 26% of the participants would have been misclassified as treatment failure. Pre-therapy HIVDR was documented in 4 of 109 participants (3.6%) with an HIVDR genotyping results at baseline. Eight of 12 participants (66.7%) with virological failure and HIVDR genotyping results at month 12 were found to harbor mutation(s), mostly NNRTI resistance mutations, whereas 4 patients had no HIVDR mutations. Almost half (44%) of the participants initiated ART at CD4 count <= 200cell/mu l and severe CD4 depletion at baseline (<50 cells/mu l) was associated with virological treatment failure (p = 0.008). Although the findings may not be generalizable to all HIV patients in Rwanda, our data suggest that first-line ART regimen changes are currently not warranted. However, the accumulation of acquired HIVDR mutations in some participants underscores the need to reinforce HIVDR prevention strategies, such as increasing the availability and appropriate use of VL testing to monitor ART response, ensuring high quality adherence counseling, and promoting earlier identification of HIV patients and enrollment into HIV care and treatment programs.	[Rusine, John; Asiimwe-Kateera, Brenda; van de Wijgert, Janneke; Boer, Kimberly Rachel; Ondoa, Pascale] Univ Amsterdam, Acad Med Ctr, Dept Global Hlth, Amsterdam Inst Global Hlth & Dev, NL-1105 AZ Amsterdam, Netherlands; [Rusine, John; Mukantwali, Enatha; Gasengayire, Agnes] Natl Reference Lab, Kigali, Rwanda; [Karita, Etienne] Project San Francisco, Kigali, Rwanda; [Jurriaans, Suzanne; de Jong, Menno] Univ Amsterdam, Acad Med Ctr, Dept Med Microbiol, NL-1105 AZ Amsterdam, Netherlands; [van de Wijgert, Janneke] Univ Liverpool, Inst Infect & Global Hlth, Liverpool L69 3BX, Merseyside, England; [Boer, Kimberly Rachel] Royal Trop Inst, NL-1105 AZ Amsterdam, Netherlands; [Rusine, John; Asiimwe-Kateera, Brenda; Boer, Kimberly Rachel] Infect Dis Network Treatment & Res Africa INTERAC, Kigali, Rwanda	University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; University of Liverpool	Ondoa, P (corresponding author), Univ Amsterdam, Acad Med Ctr, Dept Global Hlth, Amsterdam Inst Global Hlth & Dev, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands.	p.ondoa@aighd.org	Asiimwe-Kateera, Brenda/H-3378-2019	Asiimwe Kateera, Brenda/0000-0001-6134-1042; van de Wijgert, Janneke H.H.M./0000-0003-2728-4560	Netherlands-African Partnership for Capacity Development and Clinical Interventions against Poverty-Related Diseases of the Netherlands Organisation for Scientific Research (NACCAP-NWO/WOTRO); European and Developing Countries Clinical Trials Partnership (EDCTP) [CT_ct_05_33070_001]	Netherlands-African Partnership for Capacity Development and Clinical Interventions against Poverty-Related Diseases of the Netherlands Organisation for Scientific Research (NACCAP-NWO/WOTRO); European and Developing Countries Clinical Trials Partnership (EDCTP)	This work was part of the INTERACT Programme funded by the Netherlands-African Partnership for Capacity Development and Clinical Interventions against Poverty-Related Diseases of the Netherlands Organisation for Scientific Research - The Netherlands Foundation for the Advancement of Tropical Research (NACCAP-NWO/WOTRO, www.nwo.nl). Funding was also received from the European and Developing Countries Clinical Trials Partnership (EDCTP, www.edctp.org) as part of a project entitled: 'Preparing for Phase III vaginal microbicide trials in Rwanda and Kenya: Preparedness studies, capacity building, and strengthening of medical referral systems' (CT_ct_05_33070_001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ait-Khaled M, 2002, AIDS, V16, P1686, DOI 10.1097/00002030-200208160-00017; Barth RE, 2010, LANCET INFECT DIS, V10, P155, DOI 10.1016/S1473-3099(09)70328-7; Bennett DE, 2008, ANTIVIR THER, V13, P1; Bennett DE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004724; Blower S, 2005, AIDS, V19, P1, DOI 10.1097/00002030-200501030-00001; Brinkhof MWG, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000066; Center for Research and Treatment on AIDS Malaria Tuberculosis and Other Epidemics Rwanda, 2010, HIV AIDS RWAND 2010; de Oliveira T, 2005, BIOINFORMATICS, V21, P3797, DOI 10.1093/bioinformatics/bti607; Delaugerre C, 2009, ANTIMICROB AGENTS CH, V53, P2934, DOI 10.1128/AAC.01643-08; El-Khatib Z, 2009, SAMJ S AFR MED J, V99, P412; Gilks CF, 2006, LANCET, V368, P505, DOI 10.1016/S0140-6736(06)69158-7; Gupta A, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0022730, 10.1371/journal.pone.0028691]; Gupta RK, 2012, LANCET, V380, P1250, DOI 10.1016/S0140-6736(12)61038-1; Gupta RK, 2009, LANCET INFECT DIS, V9, P409, DOI 10.1016/S1473-3099(09)70136-7; Hamers RL, 2012, CLIN INFECT DIS, V54, P1660, DOI 10.1093/cid/cis254; Hamers RL, 2011, LANCET INFECT DIS, V11, P750, DOI 10.1016/S1473-3099(11)70149-9; Hunt GM, 2012, CLIN INFECT DIS, V54, pS334, DOI 10.1093/cid/cir1017; Johnson Victoria A, 2010, Top HIV Med, V18, P156; Kayigamba FR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036792; Levison JH, 2013, CLIN INFECT DIS, V56, P587, DOI 10.1093/cid/cis887; Liegeois F, 2012, J INT AIDS SOC, V15, DOI 10.7448/IAS.15.2.17985; Lyagoba F, 2010, JAIDS-J ACQ IMM DEF, V55, P277, DOI 10.1097/QAI.0b013e3181ea0df8; Mugglin C, 2012, TROP MED INT HEALTH, DOI [10.1111/j.1365-3156.2012.03089.x, DOI 10.1111/J.1365-3156.2012.03089.X.[]; Nash D, 2011, AIDS, V25, P1523, DOI 10.1097/QAD.0b013e32834811b2; Nijhuis M, 1997, J INFECT DIS, V176, P398, DOI 10.1086/514056; Pillay V, 2008, ANTIVIR THER, V13, P101; Price MA, 2011, AIDS RES HUM RETROV, V27, P5, DOI 10.1089/aid.2010.0030; Rawizza HE, 2011, CLIN INFECT DIS, V53, P1283, DOI 10.1093/cid/cir729; Rusine J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042557; Rwanda Ministry of Health, 2009, GUID PROV COMPR CAR; Shafer RW, 2007, AIDS, V21, P215, DOI 10.1097/QAD.0b013e328011e691; Sigaloff KCE, 2011, JAIDS-J ACQ IMM DEF, V58, P23, DOI 10.1097/QAI.0b013e318227fc34; Stadeli KM, 2013, ANTIVIR THER, V18, P115, DOI 10.3851/IMP2437; Steyerberg EW, 2001, MED DECIS MAKING, V21, P45, DOI 10.1177/0272989X0102100106; Steyerberg EW, 2000, STAT MED, V19, P1059, DOI 10.1002/(SICI)1097-0258(20000430)19:8<1059::AID-SIM412>3.0.CO;2-0; Turner D, 2004, MICROBIOLOGICA, V27, P31; Vyankandondera J, 2013, AIDS CARE, V25, P1504, DOI 10.1080/09540121.2013.779626; Wainberg MA, 1998, JAMA-J AM MED ASSOC, V279, P1977, DOI 10.1001/jama.279.24.1977; WHO, 2010, ANT THER HIV INF AD; WHO, 2012, WHO HIV DRUG RES REP; Wittkop L, 2011, LANCET INFECT DIS, V377, P1580; World Health Organization, 2011, GLOB AIDS RESP EP UP	42	22	22	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2013	8	8							e64345	10.1371/journal.pone.0064345	http://dx.doi.org/10.1371/journal.pone.0064345			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	200UV	23950859	Green Published, gold, Green Submitted			2022-12-25	WOS:000323097300001
J	Carvalho, JS; Marques, TA; Vicente, L				Carvalho, Joana S.; Marques, Tiago A.; Vicente, Luis			Population Status of Pan troglodytes verus in Lagoas de Cufada Natural Park, Guinea-Bissau	PLOS ONE			English	Article							LINE-TRANSECT SURVEYS; NATIONAL-PARK; GORILLA-GORILLA; HABITAT USE; CHIMPANZEES; FOREST; CENSUS; ABUNDANCE; PRIMATES; DENSITY	The western chimpanzee, Pan troglodytes verus, has been classified as Endangered on the IUCN Red List since 1988. Intensive agriculture, commercial plantations, logging, and mining have eliminated or degraded the habitats suitable for P. t. verus over a large part of its range. In this study we assessed the effect of land-use change on the population size and density of chimpanzees at Lagoas de Cufada Natural Park (LCNP), Guinea-Bissau. We further explored chimpanzee distribution in relation to landscape-level proxies of human disturbance. Nest count and distance-sampling methods were employed along 11 systematically placed linear transects in 2010 and 2011. Estimated nest decay rate was 293.9 days (%CV = 58.8). Based on this estimate of decay time and using the Standing-Crop Nest Count Method, we obtained a habitat-weighted average chimpanzee density estimate for 2011 of 0.22 nest building chimpanzees/km(2) (95% CI 0.08-0.62), corresponding to 137 (95% CI 51.0-390.0) chimpanzees for LCNP. Human disturbance had a negative influence on chimpanzee distribution as nests were built farther away from human settlements, roads, and rivers than if they were randomly distributed, coinciding with the distribution of the remaining patches of dense canopy forest. We conclude that the continuous disappearance of suitable habitat (e. g. the replacement of LCNP's dense forests by monocultures of cashew plantations) may be compromising the future of one of the most threatened Guinean coastal chimpanzee populations. We discuss strategies to ensure long-term conservation in this important refuge for this chimpanzee subspecies at its westernmost margin of geographic distribution.	[Carvalho, Joana S.; Vicente, Luis] Univ Lisbon, Dept Biol, Ctr Environm & Marine Studies, P-1699 Lisbon, Portugal; [Marques, Tiago A.] Univ St Andrews, Ctr Res Ecol & Environm Modelling, St Andrews, Fife, Scotland; [Marques, Tiago A.] Univ Lisbon, Ctr Estatist & Aplicacoes, P-1699 Lisbon, Portugal	Universidade de Lisboa; University of St Andrews; Universidade de Lisboa	Carvalho, JS (corresponding author), Univ Lisbon, Dept Biol, Ctr Environm & Marine Studies, Campo Grande C2, P-1699 Lisbon, Portugal.	jicarvalho@fc.ul.pt	Marques, Tiago A/A-5530-2010; Marques, Tiago A./M-3253-2019; Vicente, Luis/A-7443-2013	Marques, Tiago A/0000-0002-2581-1972; Marques, Tiago A./0000-0002-2581-1972; Vicente, Luis/0000-0002-3383-5480; Carvalho, Joana Silva/0000-0002-4235-1242	Fundacao para a Ciencia e Tecnologia, Portugal [SFRH/BD/60702/2009]; Conservation International (CI); Fundacao Nacional para a Ciencia e Tecnologia, Portugal [PEst-OE/MAT/UI0006/2011]	Fundacao para a Ciencia e Tecnologia, Portugal(Portuguese Foundation for Science and Technology); Conservation International (CI); Fundacao Nacional para a Ciencia e Tecnologia, Portugal	This work was supported by a doctoral research grant (SFRH/BD/60702/2009) to JSC from the Fundacao para a Ciencia e Tecnologia, Portugal. JSC would further like to acknowledge financial support from Conservation International (CI). TAM research is partially supported by Fundacao Nacional para a Ciencia e Tecnologia, Portugal, under the project PEst-OE/MAT/UI0006/2011. Publication costs for this work were covered by the University of St Andrews. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amaro AP, 2011, CONSTITUICAO BASELIN, P102; Balde S, 2008, BUBA QUEBO CORREDOR, P122; Blom A, 2001, AFR J ECOL, V39, P98, DOI 10.1046/j.0141-6707.2000.00280.x; Boesch-Achermann H, 2000, CHIMPANZEES TAI FORE; Boyer KM, 2011, CHIMPANZEE CONSERVAT, P68; Boyko RH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010754; Brugiere D, 2009, FOLIA PRIMATOL, V80, P353, DOI 10.1159/000259335; Buckland S., 1993, DISTANCE SAMPLING ES, DOI [10.1007/978-94-011-1574-2, DOI 10.1007/978-94-011-1574-2]; Buckland S.T., 2001, pi; Buckland ST, 2010, INT J PRIMATOL, V31, P833, DOI 10.1007/s10764-010-9431-5; Buckland ST, 2010, INT J PRIMATOL, V31, P485, DOI 10.1007/s10764-010-9408-4; Buij R, 2002, BIOL CONSERV, V107, P83, DOI 10.1016/S0006-3207(02)00048-4; Buij R, 2003, BIOL CONSERV, V114, P103, DOI 10.1016/S0006-3207(03)00015-6; Butsic V, 2012, CONSERV BIOL, V26, P883, DOI 10.1111/j.1523-1739.2012.01887.x; Campbell G, 2008, CURR BIOL, V18, pR903, DOI 10.1016/j.cub.2008.08.015; Casanova C, 2005, 14 U TECN LISB I SUP, P14; Casanova C, 2007, PLANO ACCAO NACL CON, P101; Catarino L., 2006, Garcia de Orta. Serie de Botanica, V17, P97; Catarino L, 2002, AFR J ECOL, V40, P252, DOI 10.1046/j.1365-2028.2002.00367.x; Catarino L, 2006, GARCIA ORTA B, V17, P69; Chapman CA., 1988, BRENESIA, V30, P67; Devos C, 2008, AM J PRIMATOL, V70, P439, DOI 10.1002/ajp.20514; Fa JE, 2002, CONSERV BIOL, V16, P232, DOI 10.1046/j.1523-1739.2002.00275.x; FAO, 2012, STAT WORLDS FOR; Fleury-Brugiere MC, 2010, INT J PRIMATOL, V31, P383, DOI 10.1007/s10764-010-9391-9; Furuichi T, 2001, INT J PRIMATOL, V22, P913, DOI 10.1023/A:1012057403512; Ghiglieri MP, 1984, CHIMPANZEES KIBALE F, P226; Gippoliti Spartaco, 1996, Oryx, V30, P74, DOI 10.1017/S0030605300021414; Gippoliti Spartaco, 2003, Primate Conservation, V19, P73; Gippoliti Spartaco, 1995, African Primates, V1, P3; Hall JS, 1998, INT J PRIMATOL, V19, P207, DOI 10.1023/A:1020375430965; Harcourt AH, 2012, INT J PRIMATOL, V33, P168, DOI 10.1007/s10764-011-9558-z; HASHIMOTO C, 1995, PRIMATES, V36, P477, DOI 10.1007/BF02382870; Hernnandez-Aguilar RA, 2006, THESIS U SO CALIFORN, P218; Hockings KJ, 2011, IUCN SSC PRIMATE SPE, V26, P1; Hockings KJ, 2007, HUMAN CHIMPANZEE COE, P272; Inogwabini BI, 2012, AFR J ECOL, V50, P285, DOI 10.1111/j.1365-2028.2012.01323.x; IUCN, 2013, IUCN RED LIST THREAT; Jones JPG, 2011, J APPL ECOL, V48, P9, DOI 10.1111/j.1365-2664.2010.01917.x; Junker J, 2012, DIVERS DISTRIB, V18, P1077, DOI 10.1111/ddi.12005; Kamilar JM, 2009, AM J PHYS ANTHROPOL, V139, P382, DOI 10.1002/ajpa.20993; Kormos R, 2003, W AFRICAN CHIMPANZEE, P219; Kouakou CY, 2009, AM J PRIMATOL, V71, P447, DOI 10.1002/ajp.20673; Kuehl HS, 2009, BIOL CONSERV, V142, P1500, DOI 10.1016/j.biocon.2009.02.032; Kuhl HS, 2008, BEST PRACTICE GUIDEL, P36; Lahm SA, 1998, J TROP ECOL, V14, P629, DOI 10.1017/S0266467498000443; Laing SE, 2003, J APPL ECOL, V40, P1102, DOI 10.1111/j.1365-2664.2003.00861.x; Lehman SM, 2006, DEV PRIMATOL, P1; Linder JM, 2011, BIOL CONSERV, V144, P738, DOI 10.1016/j.biocon.2010.10.023; Manly BFJ, 1997, RANDOMIZATION BOOTST, P455; MARCHESI P, 1995, PRIMATES, V36, P591, DOI 10.1007/BF02382880; Marques TA, 2013, BIOL REV, V88, P287, DOI 10.1111/brv.12001; Marshall AR, 2008, AM J PRIMATOL, V70, P452, DOI 10.1002/ajp.20516; Morgan D, 2006, INT J PRIMATOL, V27, P147, DOI 10.1007/s10764-005-9013-0; Moutinho Sa Rui Miguel, 2012, Traffic Bulletin, V24, P31; Nkurunungi JB, 2006, DEV PRIMATOL, P193; Oates JF, 1996, AUST J ECOL, V21, P1, DOI 10.1111/j.1442-9993.1996.tb00580.x; Ogutu JO, 2006, J ZOOL, V269, P149, DOI 10.1111/j.1469-7998.2006.00055.x; Oom D., 2009, 33 INT S REM SENS EN; Paudel PK, 2012, ANIM CONSERV, V15, P283, DOI 10.1111/j.1469-1795.2011.00514.x; Plumptre AJ, 1996, INT J PRIMATOL, V17, P85, DOI 10.1007/BF02696160; Plumptre AJ, 1997, INT J PRIMATOL, V18, P475, DOI 10.1023/A:1026302920674; Powell LA, 2007, CONDOR, V109, P949, DOI 10.1650/0010-5422(2007)109[949:AVODPU]2.0.CO;2; Pruetz JD, 2002, AM J PRIMATOL, V58, P35, DOI 10.1002/ajp.10035; Pusey AE, 2008, AM J PRIMATOL, V70, P738, DOI 10.1002/ajp.20567; *R DEV COR TEAM, 2013, R LANG ENV STAT COMP; Sousa Claudia, 2005, P362; Sousa FM, 2009, DENSIDADE PAN TROGLO, P81; Sousa J, 2008, DENSIDADE PAN TROGLO, P55; Sousa J, 2011, AM J PRIMATOL, V73, P485, DOI 10.1002/ajp.20926; Stokes EJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010294; Thomas L, 2010, J APPL ECOL, V47, P5, DOI 10.1111/j.1365-2664.2009.01737.x; Torres J, 2010, BIOL CONSERV, V143, P416, DOI 10.1016/j.biocon.2009.11.007; TUTIN CEG, 1984, AM J PRIMATOL, V6, P313, DOI 10.1002/ajp.1350060403; UNEP, 2008, NAT BIOT BIOS FRAM G, P123; vanSchaik CP, 1995, NEGLECTED APE, P129; Vanthomme H, 2013, CONSERV BIOL, V27, P281, DOI 10.1111/cobi.12017; Walsh PD, 2003, NATURE, V422, P611, DOI 10.1038/nature01566; WHITESIDES GH, 1988, J ANIM ECOL, V57, P345, DOI 10.2307/4910; Yackulic CB, 2011, ECOL APPL, V21, P1296, DOI 10.1890/09-1099.1	80	9	9	1	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2013	8	8							e71527	10.1371/journal.pone.0071527	http://dx.doi.org/10.1371/journal.pone.0071527			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	200ZE	23940766	Green Published, Green Submitted, gold			2022-12-25	WOS:000323109700106
J	Fan, JH; Xie, YP; Xue, JL; Zhang, YL; Yang, Q				Fan, Jinhua; Xie, Yingping; Xue, Jiaoliang; Zhang, Yingling; Yang, Qian			Cellular Apoptosis of Hemocytes from Dendrolimus tabulaeformis Tsai et Liu Larvae Induced with the Secondary Metabolites of Beauveria brongniartii (Sacc.) Petch	PLOS ONE			English	Article							ENTOMOPATHOGENIC FUNGUS; EURYGASTER-INTEGRICEPS; SUNN PEST; IMMUNITY; LEPIDOPTERA; ARTHROPODS; DESTRUXIN; TOXICITY; BASSIANA	To investigate the effect of the secondary metabolites of entomopathogenic fungus on the hemocyte immunity of host insect, the secondary metabolite complex (SMC) of Beauveria brongniartii was used in three concentrations (5.5, 55, and 550 mu g/mL), and the 4th instar larvae of the pine caterpillar Dendrolimus tabulaeformis were employed as host insects. The larvae were inoculated with the SMC solutions by injection in bioassays. Apoptosis of the larval hemocytes was observed using fluorescence microscopy (FM), transmission electron microscopy (TEM), and flow cytometry (FCM). The FM results showed that in the treated groups, larval hemocytes exhibited symptoms of early apoptosis at 6 h post-treatment by radiating a non-uniform kelly fluorescence and exhibited symptoms of late apoptosis at 12 h post-treatment by radiating a non-uniform orange fluorescence. Under TEM, the following ultrastructural changes associated with apoptosis of the larval hemocytes were observed in the treated groups: the nuclei were hypertrophied, slight folds were on the nuclear envelope, the chromatin became concentrated, the mitochondrial cristae disappeared or were disorderly, most cells developed blebs, and fibrillar aggregation appeared and accumulated in the cytoplasm. Apoptosis of the larval hemocytes was detected by FCM at 6 h post-treatment; the percentage of early apoptotic cells in the SMC 5.5, 55, and 550 mu g/mL treatment groups were 11.93%, 13.10%, and 18.42%, respectively. Late apoptosis first occurred at 12 h post-treatment; the highest rate of apoptosis was 36.54 +/- 4.37% at 24 h post-treatment in the SMC 55 mu g/mL treatment group. In general, the cellular apoptosis rate was positively correlated with the SMC concentration and the time post-treatment. These results indicate that secondary metabolites of B. brongniartii are able to attack the hemocytes of D. tabulaeformis larvae and induce cellular apoptosis, thereby providing new evidence that secondary metabolites of mycopathogens can act on host immune systems.	[Fan, Jinhua; Xie, Yingping; Xue, Jiaoliang; Zhang, Yingling; Yang, Qian] Shanxi Univ, Sch Life Sci, Taiyuan, Peoples R China	Shanxi University	Xie, YP (corresponding author), Shanxi Univ, Sch Life Sci, Taiyuan, Peoples R China.	xieyingping410@163.com			Shanxi Provincial Key Technologies Research and Development Program [021041, 2007032009]; Shanxi Province Forestry Key Program	Shanxi Provincial Key Technologies Research and Development Program; Shanxi Province Forestry Key Program	This work was supported by the Shanxi Provincial Key Technologies Research and Development Program (021041 and 2007032009) and the Shanxi Province Forestry Key Program (2010-2012). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bandani AR, 2005, BIOCONTROL SCI TECHN, V15, P67, DOI 10.1080/09583150400015961; Carton Y, 1997, PARASITOL TODAY, V13, P218, DOI 10.1016/S0169-4758(97)01058-2; Da Silveira EB, 2007, VIRUS RES, V130, P182, DOI 10.1016/j.virusres.2007.06.010; Fan JH, 2007, J SHANXI U NAT SCI, V30; Fan JH, 2013, J INSECT SCI, V13, DOI 10.1673/031.013.4401; Fan Jinhua, 2008, Weishengwu Xuebao, V48, P596; Goettel MS, 1997, CAN ENTOMOL, V129, P1059, DOI 10.4039/Ent1291059-6; Hagler JR, 2004, J INSECT SCI, V4, DOI 10.1093/jis/4.1.1; HAJEK AE, 1994, ANNU REV ENTOMOL, V39, P293, DOI 10.1146/annurev.en.39.010194.001453; Hoffmann JA, 1999, SCIENCE, V284, P1313, DOI 10.1126/science.284.5418.1313; [胡丰林 Hu Fenglin], 2006, [菌物学报, Mygosystema], V25, P273; Hu QB, 2006, TOXICON, V48, P491, DOI 10.1016/j.toxicon.2006.06.018; Jiravanichpaisal P, 2006, IMMUNOBIOLOGY, V211, P213, DOI 10.1016/j.imbio.2005.10.015; Klowden M.J., 2007, PHYSL SYSTEMS INSECT; Luo KJ, 2006, J INSECT PHYSIOL, V52, P795, DOI 10.1016/j.jinsphys.2006.04.007; Masahiro S, 2009, APPL ENTOMOL ZOOL, V44, P115, DOI [10.1303/aez.2009.115, DOI 10.1303/AEZ.2009.115]; MEAD GP, 1986, J INSECT PHYSIOL, V32, P167, DOI 10.1016/0022-1910(86)90137-X; Meng X, 2011, TOXICON, V58, P327, DOI 10.1016/j.toxicon.2011.06.002; Oliver JD, 2011, J INVERTEBR PATHOL, V108, P126, DOI 10.1016/j.jip.2011.07.004; Ortiz-Urquiza A, 2010, J APPL ENTOMOL, V134, P581, DOI 10.1111/j.1439-0418.2010.01533.x; Roberts DW, 2004, ADV APPL MICROBIOL, V54, P1, DOI 10.1016/S0065-2164(04)54001-7; Schmidt O, 2001, BIOESSAYS, V23, P344, DOI 10.1002/bies.1049; Strand MR, 2008, INSECT IMMUNOLOGY, P25, DOI 10.1016/S0965-1748(02)00092-9; Tajudin TJSA, 2012, EVID-BASED COMPL ALT, V2012, DOI 10.1155/2012/127373; Thomas MB, 2007, NAT REV MICROBIOL, V5, P377, DOI 10.1038/nrmicro1638; Wahab SIA, 2009, J BIOMED BIOTECHNOL, DOI 10.1155/2009/769568; Xia Q, 2005, CHINESE SCI BULL, V50, P2856, DOI 10.1007/BF02899656; Yedjou CG, 2010, INT J ENV RES PUB HE, V7, P2008, DOI 10.3390/ijerph7052008; Zibaee A, 2011, J INSECT SCI, V11, DOI 10.1673/031.011.13801; Zibaee A, 2009, BIOCONTROL SCI TECHN, V19, P485, DOI 10.1080/09583150902847127	30	5	5	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2013	8	8							e71600	10.1371/journal.pone.0071600	http://dx.doi.org/10.1371/journal.pone.0071600			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	200ZE	23940771	gold, Green Published, Green Submitted			2022-12-25	WOS:000323109700108
J	Srinivasan, VJ; Mandeville, ET; Can, A; Blasi, F; Climov, M; Daneshmand, A; Lee, JH; Yu, E; Radhakrishnan, H; Lo, EH; Sakadzic, S; Eikermann-Haerter, K; Ayata, C				Srinivasan, Vivek J.; Mandeville, Emiri T.; Can, Anil; Blasi, Francesco; Climov, Mihail; Daneshmand, Ali; Lee, Jeong Hyun; Yu, Esther; Radhakrishnan, Harsha; Lo, Eng H.; Sakadzic, Sava; Eikermann-Haerter, Katharina; Ayata, Cenk			Multiparametric, Longitudinal Optical Coherence Tomography Imaging Reveals Acute Injury and Chronic Recovery in Experimental Ischemic Stroke	PLOS ONE			English	Article							CEREBRAL-BLOOD-FLOW; PENETRATING ARTERIOLES; SPREADING DEPRESSION; ARTERY OCCLUSION; MICROSCOPY; NEOCORTEX; TISSUE; RAT; PERFUSION; BRAIN	Progress in experimental stroke and translational medicine could be accelerated by high-resolution in vivo imaging of disease progression in the mouse cortex. Here, we introduce optical microscopic methods that monitor brain injury progression using intrinsic optical scattering properties of cortical tissue. A multi-parametric Optical Coherence Tomography (OCT) platform for longitudinal imaging of ischemic stroke in mice, through thinned-skull, reinforced cranial window surgical preparations, is described. In the acute stages, the spatiotemporal interplay between hemodynamics and cell viability, a key determinant of pathogenesis, was imaged. In acute stroke, microscopic biomarkers for eventual infarction, including capillary non-perfusion, cerebral blood flow deficiency, altered cellular scattering, and impaired autoregulation of cerebral blood flow, were quantified and correlated with histology. Additionally, longitudinal microscopy revealed remodeling and flow recovery after one week of chronic stroke. Intrinsic scattering properties serve as reporters of acute cellular and vascular injury and recovery in experimental stroke. Multi-parametric OCT represents a robust in vivo imaging platform to comprehensively investigate these properties.	[Srinivasan, Vivek J.; Radhakrishnan, Harsha] Univ Calif Davis, Dept Biomed Engn, Davis, CA 95616 USA; [Mandeville, Emiri T.; Lo, Eng H.] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Dept Radiol,Neuroprotect Res Lab, Charlestown, MA USA; [Mandeville, Emiri T.; Lo, Eng H.] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Dept Neurol,Neuroprotect Res Lab, Charlestown, MA USA; [Can, Anil; Blasi, Francesco; Climov, Mihail; Daneshmand, Ali; Lee, Jeong Hyun; Yu, Esther; Eikermann-Haerter, Katharina; Ayata, Cenk] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Neurovasc Res Lab,Dept Radiol, Charlestown, MA USA; [Lee, Jeong Hyun] Korea Res Inst Chem Technol, Div Drug Discovery Res, Taejon 305606, South Korea; [Radhakrishnan, Harsha; Lo, Eng H.; Sakadzic, Sava] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Dept Radiol,Martinos Ctr Biomed Imaging, Boston, MA USA; [Ayata, Cenk] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Dept Neurol,Stroke Serv, Boston, MA USA; [Ayata, Cenk] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Dept Neurol,Neurosci Intens Care Unit, Boston, MA USA	University of California System; University of California Davis; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Korea Research Institute of Chemical Technology (KRICT); Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School; Massachusetts General Hospital	Srinivasan, VJ (corresponding author), Univ Calif Davis, Dept Biomed Engn, Davis, CA 95616 USA.	vjsriniv@ucdavis.edu	Climov, Mihail/T-5853-2017; Blasi, Francesco/G-1055-2015; Lee, Jeong Hyun/G-1676-2013	Climov, Mihail/0000-0001-9150-8608; Blasi, Francesco/0000-0002-6616-8418; Lee, Jeong Hyun/0000-0003-0504-0119	National Institutes of Health [R00NS067050, NS055104, EB001954 R01]; American Heart Association [IRG5440002, SDG7600037, SDG2610275]; Glaucoma Research Foundation Catalyst for a Cure 2; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB001954] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R00NS067050, P01NS055104] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); Glaucoma Research Foundation Catalyst for a Cure 2; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	The authors acknowledge support from the National Institutes of Health (R00NS067050, NS055104, EB001954 R01), the American Heart Association (IRG5440002, SDG7600037, SDG2610275), and the Glaucoma Research Foundation Catalyst for a Cure 2. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baird AE, 1998, J CEREBR BLOOD F MET, V18, P583, DOI 10.1097/00004647-199806000-00001; Blinder P, 2010, P NATL ACAD SCI USA, V107, P12670, DOI 10.1073/pnas.1007239107; Chuquet J, 2007, J NEUROSCI, V27, P4036, DOI 10.1523/JNEUROSCI.0721-07.2007; Cimalla P, 2011, J BIOMED OPT, V16, DOI 10.1117/1.3653235; DENK W, 1990, SCIENCE, V248, P73, DOI 10.1126/science.2321027; Dijkhuizen RM, 2001, P NATL ACAD SCI USA, V98, P12766, DOI 10.1073/pnas.231235598; Ding GL, 2008, J CEREBR BLOOD F MET, V28, P1440, DOI 10.1038/jcbfm.2008.33; Drew PJ, 2010, NAT METHODS, V7, P981, DOI 10.1038/NMETH.1530; Dunn AK, 2001, J CEREBR BLOOD F MET, V21, P195, DOI 10.1097/00004647-200103000-00002; Faber DJ, 2009, OPT LETT, V34, P1435, DOI 10.1364/OL.34.001435; Faber DJ, 2004, OPT EXPRESS, V12, P4353, DOI 10.1364/OPEX.12.004353; FROSTIG RD, 1990, P NATL ACAD SCI USA, V87, P6082, DOI 10.1073/pnas.87.16.6082; Heiss WD, 1997, J CEREBR BLOOD F MET, V17, P388, DOI 10.1097/00004647-199704000-00004; HEISS WD, 1992, J CEREBR BLOOD F MET, V12, P193, DOI 10.1038/jcbfm.1992.29; HOSSMANN KA, 1994, ANN NEUROL, V36, P557, DOI 10.1002/ana.410360404; Jacobs MA, 2001, STROKE, V32, P943, DOI 10.1161/01.STR.32.4.943; Jia YL, 2011, MICROVASC RES, V81, P73, DOI 10.1016/j.mvr.2010.11.003; Nguyen J, 2011, J CEREBR BLOOD F MET, V31, P2243, DOI 10.1038/jcbfm.2011.95; Johnston DG, 2013, CEREB CORTEX, V23, P751, DOI 10.1093/cercor/bhs092; Jones PB, 2008, J BIOMED OPT, V13, DOI 10.1117/1.2950312; Kawauchi S, 2011, J BIOMED OPT, V16, DOI 10.1117/1.3542046; Kleinfeld D, 1998, P NATL ACAD SCI USA, V95, P15741, DOI 10.1073/pnas.95.26.15741; Kretschmann H J, 1986, Bibl Anat, P1; Li P, 2008, J NEUROSCI, V28, P11970, DOI 10.1523/JNEUROSCI.3724-08.2008; Liu RR, 2009, J BIOL CHEM, V284, P36109, DOI 10.1074/jbc.M109.055301; Mace E, 2011, NAT METHODS, V8, P662, DOI [10.1038/NMETH.1641, 10.1038/nmeth.1641]; Murphy TH, 2008, J NEUROSCI, V28, P1756, DOI 10.1523/JNEUROSCI.5128-07.2008; Nishimura N, 2006, NAT METHODS, V3, P99, DOI 10.1038/NMETH844; Nishimura N, 2007, P NATL ACAD SCI USA, V104, P365, DOI 10.1073/pnas.0609551104; Parthasarathy AB, 2008, OPT EXPRESS, V16, P1975, DOI 10.1364/OE.16.001975; Paxinos G., 2001, MOUSE BRAIN STEREOTA; Popp A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004764; SAKURADA O, 1978, AM J PHYSIOL, V234, pH59, DOI 10.1152/ajpheart.1978.234.1.H59; Schaffer CB, 2006, PLOS BIOL, V4, P258, DOI 10.1371/journal.pbio.0040022; Schlaug G, 1999, NEUROLOGY, V53, P1528, DOI 10.1212/WNL.53.7.1528; Shen Q, 2011, J CEREBR BLOOD F MET, V31, P2076, DOI 10.1038/jcbfm.2011.64; Shih AY, 2009, J CEREBR BLOOD F MET, V29, P738, DOI 10.1038/jcbfm.2008.166; Shin HK, 2006, J CEREBR BLOOD F MET, V26, P1018, DOI 10.1038/sj.jcbfm.9600252; Srinivasan VJ, 2012, BIOMED OPT EXPRESS, V3, P612, DOI 10.1364/BOE.3.000612; Srinivasan VJ, 2012, OPT EXPRESS, V20, P2220, DOI 10.1364/OE.20.002220; Srinivasan VJ, 2011, J CEREBR BLOOD F MET, V31, P1339, DOI 10.1038/jcbfm.2011.19; Srinivasan VJ, 2010, OPT EXPRESS, V18, P2477, DOI 10.1364/OE.18.002477; Srinivasan VJ, 2010, OPT LETT, V35, P43, DOI 10.1364/OL.35.000043; Takano T, 2007, NAT NEUROSCI, V10, P754, DOI 10.1038/nn1902; Vakoc BJ, 2009, NAT MED, V15, P1219, DOI 10.1038/nm.1971; Wei L, 2001, STROKE, V32, P2179, DOI 10.1161/hs0901.094282; Wilt BA, 2009, ANNU REV NEUROSCI, V32, P435, DOI 10.1146/annurev.neuro.051508.135540; Zhang SX, 2005, J NEUROSCI, V25, P5333, DOI 10.1523/JNEUROSCI.1085-05.2005; Zhang ZG, 2009, LANCET NEUROL, V8, P491, DOI 10.1016/S1474-4422(09)70061-4; Zhao YH, 2000, OPT LETT, V25, P114, DOI 10.1364/OL.25.000114	50	65	66	2	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2013	8	8							e71478	10.1371/journal.pone.0071478	http://dx.doi.org/10.1371/journal.pone.0071478			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	200ZE	23940761	Green Published, Green Submitted, gold			2022-12-25	WOS:000323109700104
J	Yang, S; Wang, F; Guo, F; Meng, JJ; Li, XG; Dong, ST; Wan, SB				Yang, Sha; Wang, Fang; Guo, Feng; Meng, Jing-Jing; Li, Xin-Guo; Dong, Shu-Ting; Wan, Shu-Bo			Exogenous Calcium Alleviates Photoinhibition of PSII by Improving the Xanthophyll Cycle in Peanut (Arachis Hypogaea) Leaves during Heat Stress under High Irradiance	PLOS ONE			English	Article							D1 PROTEIN; HIGH LIGHT; ENERGY-DISSIPATION; CHILLING STRESS; PHOTOSYSTEM-II; CHLOROPHYLL FLUORESCENCE; SIGNALING PATHWAYS; PHOTOSYNTHESIS; PHOTOPROTECTION; DEFICIENCY	Peanut is one of the calciphilous plants. Calcium (Ca) serves as a ubiquitous central hub in a large number of signaling pathways. The effect of exogenous calcium nitrate [Ca(NO3)(2)] (6 mM) on the dissipation of excess excitation energy in the photosystem II (PSII) antenna, especially on the level of D1 protein and the xanthophyll cycle in peanut plants under heat (40 degrees C) and high irradiance (HI) (1 200 mu mol m(-2) s(-1)) stress were investigated. Compared with the control plants [cultivated in 0 mM Ca(NO3)(2) medium], the maximal photochemical efficiency of PSII (Fv/Fm) in Ca2+-treated plants showed a slighter decrease after 5 h of stress, accompanied by higher non-photochemical quenching (NPQ), higher expression of antioxidative genes and less reactive oxygen species (ROS) accumulation. Meanwhile, higher content of D1 protein and higher ratio of (A+Z)/(V+A+Z) were also detected in Ca2+-treated plants under such stress. These results showed that Ca2+ could help protect the peanut photosynthetic system from severe photoinhibition under heat and HI stress by accelerating the repair of D1 protein and improving the de-epoxidation ratio of the xanthophyll cycle. Furthermore, EGTA (a chelant of Ca ion), LaCl3 (a blocker of Ca2+ channel in cytoplasmic membrane), and CPZ [a calmodulin (CaM) antagonist] were used to analyze the effects of Ca2+/CaM on the variation of (A+Z)/(V+A+Z) (%) and the expression of violaxanthin de-epoxidase (VDE). The results indicated that CaM, an important component of the Ca2+ signal transduction pathway, mediated the expression of the VDE gene in the presence of Ca to improve the xanthophyll cycle.	[Yang, Sha; Wang, Fang; Guo, Feng; Meng, Jing-Jing; Li, Xin-Guo] Shandong Acad Agr Sci, High Tech Res Ctr, Jinan, Peoples R China; [Yang, Sha; Guo, Feng; Meng, Jing-Jing; Li, Xin-Guo; Wan, Shu-Bo] Shandong Prov Key Lab Crop Genet Improvement Ecol, Jinan, Peoples R China; [Wang, Fang; Dong, Shu-Ting] Shandong Agr Univ, Coll Life Sci, State Key Lab Crop Biol, Tai An, Shandong, Peoples R China	Shandong Academy of Agricultural Sciences; Shandong Agricultural University	Li, XG (corresponding author), Shandong Acad Agr Sci, High Tech Res Ctr, Jinan, Peoples R China.	lixinguo@tom.com; wansb@saas.ac.cn			Natural Science Foundation of Shandong Province [ZR2009DZ007, ZR2011CQ042]; Supporting Plan of National Science and Technology of China [2006BAD21B04]; earmarked fund for Modern Agro-industry Technology Research System [CARS-14]; Shandong Major Projects of Independent Innovation Achievement Transformation [2012ZHZXIA0418]	Natural Science Foundation of Shandong Province(Natural Science Foundation of Shandong Province); Supporting Plan of National Science and Technology of China; earmarked fund for Modern Agro-industry Technology Research System; Shandong Major Projects of Independent Innovation Achievement Transformation	This work was supported by the Natural Science Foundation of Shandong Province (ZR2009DZ007, ZR2011CQ042), the Supporting Plan of National Science and Technology of China (2006BAD21B04) and the earmarked fund for Modern Agro-industry Technology Research System (CARS-14) and Shandong Major Projects of Independent Innovation Achievement Transformation (2012ZHZXIA0418). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADIR N, 1990, J BIOL CHEM, V265, P12563; Ai XiZhen, 2006, Scientia Agricultura Sinica, V39, P1865; Allakhverdiev SI, 2004, BBA-BIOENERGETICS, V1657, P23, DOI 10.1016/j.bbabio.2004.03.003; ARO EM, 1993, BIOCHIM BIOPHYS ACTA, V1143, P113, DOI 10.1016/0005-2728(93)90134-2; ARORA R, 1988, PLANT PHYSIOL, V87, P622, DOI 10.1104/pp.87.3.622; Asada K, 2006, PLANT PHYSIOL, V141, P391, DOI 10.1104/pp.106.082040; Baroli I, 2003, PLANT CELL, V15, P992, DOI 10.1105/tpc.010405; Bhattacharjee S, 2008, BIOL PLANTARUM, V52, P137, DOI 10.1007/s10535-008-0028-1; Bjorkman O., 1989, PHOTOSYNTHESIS, P45; Bowler C, 2000, TRENDS PLANT SCI, V5, P241, DOI 10.1016/S1360-1385(00)01628-9; Brookes PS, 2004, AM J PHYSIOL-CELL PH, V287, pC817, DOI 10.1152/ajpcell.00139.2004; BUSH DS, 1995, ANNU REV PLANT PHYS, V46, P95, DOI 10.1146/annurev.pp.46.060195.000523; Chen YZ, 2003, PHYSIOL PLANTARUM, V117, P343, DOI 10.1034/j.1399-3054.2003.00048.x; Chinnusamy V, 2005, CROP SCI, V45, P437, DOI 10.2135/cropsci2005.0437; COOKE A, 1986, NEW PHYTOL, V102, P491, DOI 10.1111/j.1469-8137.1986.tb00825.x; DemmigAdams B, 1996, PLANTA, V198, P460, DOI 10.1007/BF00620064; DEMMIGADAMS B, 1990, BIOCHIM BIOPHYS ACTA, V1020, P1, DOI 10.1016/0005-2728(90)90088-L; DEMMIGADAMS B, 1992, ANNU REV PLANT PHYS, V43, P599, DOI 10.1146/annurev.pp.43.060192.003123; Farooq M, 2008, J AGRON CROP SCI, V194, P350, DOI 10.1111/j.1439-037X.2008.00322.x; Gilmore AM, 2002, FUNCT PLANT BIOL, V29, P1125, DOI 10.1071/FP02127; Horton P, 1996, ANNU REV PLANT PHYS, V47, P655, DOI 10.1146/annurev.arplant.47.1.655; HORTON P, 1994, PLANT PHYSIOL, V106, P415, DOI 10.1104/pp.106.2.415; Jiang YW, 2001, J EXP BOT, V52, P341, DOI 10.1093/jexbot/52.355.341; KHAMIS S, 1990, PLANT PHYSIOL, V94, P1436, DOI 10.1104/pp.94.3.1436; KREIMER G, 1988, PLANT PHYSIOL, V86, P423, DOI 10.1104/pp.86.2.423; Li XG, 2005, PHOTOSYNTHETICA, V43, P261, DOI 10.1007/s11099-005-0042-x; Li XG, 2004, PLANT CELL PHYSIOL, V45, P103, DOI 10.1093/pcp/pch011; Li XG, 2003, PHOTOSYNTHETICA, V41, P259, DOI 10.1023/B:PHOT.0000011959.30746.c0; Liang WJ, 2009, SCI HORTIC-AMSTERDAM, V123, P34, DOI 10.1016/j.scienta.2009.07.015; Liu C, 2008, BIOL TRACE ELEM RES, V121, P266, DOI 10.1007/s12011-007-8054-y; Liu P, 2001, PHOTOSYNTHETICA, V39, P467, DOI 10.1023/A:1015155032135; Ma LG, 1999, PLANT CELL, V11, P1351, DOI 10.1105/tpc.11.7.1351; Melgar A, 2007, ENERG CONVERS MANAGE, V48, P59, DOI 10.1016/j.enconman.2006.05.004; Muller P, 2001, PLANT PHYSIOL, V125, P1558, DOI 10.1104/pp.125.4.1558; Muller-Moule P, 2003, PLANT PHYSIOL, V133, P748, DOI 10.1104/pp.103.026252; Murata N, 2007, BBA-BIOENERGETICS, V1767, P414, DOI 10.1016/j.bbabio.2006.11.019; Nishiyama Y, 2004, BIOCHEMISTRY-US, V43, P11321, DOI 10.1021/bi036178q; Niyogi KK, 1998, PLANT CELL, V10, P1121, DOI 10.1105/tpc.10.7.1121; Niyogi KK, 1999, ANNU REV PLANT PHYS, V50, P333, DOI 10.1146/annurev.arplant.50.1.333; Niyogi KK, 2001, PHOTOSYNTH RES, V67, P139, DOI 10.1023/A:1010661102365; Noctor G, 1998, ANNU REV PLANT PHYS, V49, P249, DOI 10.1146/annurev.arplant.49.1.249; Ottow EA, 2005, PLANT PHYSIOL, V139, P1762, DOI 10.1104/pp.105.069971; PORRA RJ, 1989, BIOCHIM BIOPHYS ACTA, V975, P384, DOI 10.1016/S0005-2728(89)80347-0; Pospisil P, 2009, BBA-BIOENERGETICS, V1787, P1151, DOI 10.1016/j.bbabio.2009.05.005; QUICK WP, 1989, BIOCHIM BIOPHYS ACTA, V977, P287, DOI 10.1016/S0005-2728(89)80082-9; Rudd JJ, 2001, NEW PHYTOL, V151, P7, DOI 10.1046/j.1469-8137.2001.00173.x; Schreiber U., 1995, ECOL STUD, P49, DOI DOI 10.1007/978-3-642-79354-7_3; Sui N, 2007, PHOTOSYNTHETICA, V45, P447, DOI 10.1007/s11099-007-0074-5; Szymanski DB, 1996, PLANT CELL, V8, P1069, DOI 10.1105/tpc.8.6.1069; Takahashi S, 2006, BBA-BIOENERGETICS, V1757, P198, DOI 10.1016/j.bbabio.2006.02.002; Tan W, 2011, J PLANT PHYSIOL, V168, P2063, DOI 10.1016/j.jplph.2011.06.009; van der Luit AH, 1999, PLANT PHYSIOL, V121, P705, DOI 10.1104/pp.121.3.705; VANKOOTEN O, 1990, PHOTOSYNTH RES, V25, P147, DOI 10.1007/BF00033156; Verhoeven AS, 1997, PLANT PHYSIOL, V113, P817, DOI 10.1104/pp.113.3.817; Wang A. G., 1990, PLANT PHYSL COMMUN, V6, P55, DOI DOI 10.1021/ja00874a010; Wang LJ, 2004, PLANT SCI, V167, P71, DOI 10.1016/j.plantsci.2004.02.028; Wang N, 2008, PHYSIOL PLANTARUM, V132, P384, DOI 10.1111/j.1399-3054.2007.01016.x; Wang ZH, 1997, CHIN B BOT, V14, P1; YAMAMOTO HY, 1979, PURE APPL CHEM, V51, P639, DOI 10.1351/pac197951030639; Yang T, 2002, P NATL ACAD SCI USA, V99, P4097, DOI 10.1073/pnas.052564899; Yang TB, 2000, J BIOL CHEM, V275, P3137, DOI 10.1074/jbc.275.5.3137; Zhang LX, 1999, J BIOL CHEM, V274, P16062, DOI 10.1074/jbc.274.23.16062; Zhao HJ, 2005, PHOTOSYNTHETICA, V43, P473, DOI 10.1007/s11099-005-0076-0; Zhao S. J., 1995, PLANT PHYSL COMMUN, V31, P438	64	23	29	0	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2013	8	8							e71214	10.1371/journal.pone.0071214	http://dx.doi.org/10.1371/journal.pone.0071214			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	200ZE	23940721	Green Published, gold, Green Submitted			2022-12-25	WOS:000323109700088
J	Kiwelu, IE; Novitsky, V; Margolin, L; Baca, J; Manongi, R; Sam, N; Shao, J; McLane, MF; Kapiga, SH; Essex, M				Kiwelu, Ireen E.; Novitsky, Vladimir; Margolin, Lauren; Baca, Jeannie; Manongi, Rachel; Sam, Noel; Shao, John; McLane, Mary F.; Kapiga, Saidi H.; Essex, M.			Frequent Intra-Subtype Recombination among HIV-1 Circulating in Tanzania	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; MOSAIC STRUCTURE; IN-VIVO; SUPERINFECTION; INFECTION; SEQUENCES; RESISTANCE; EVOLUTION; TRANSMISSION; MULTIPLE	The study estimated the prevalence of HIV-1 intra-subtype recombinant variants among female bar and hotel workers in Tanzania. While intra-subtype recombination occurs in HIV-1, it is generally underestimated. HIV-1 env gp120 V1-C5 quasispecies from 45 subjects were generated by single-genome amplification and sequencing (median (IQR) of 38 (28-50) sequences per subject). Recombination analysis was performed using seven methods implemented within the recombination detection program version 3, RDP3. HIV-1 sequences were considered recombinant if recombination signals were detected by at least three methods with p-values of <= 0.05 after Bonferroni correction for multiple comparisons. HIV-1 in 38 (84%) subjects showed evidence for intra-subtype recombination including 22 with HIV-1 subtype A1, 13 with HIV-1 subtype C, and 3 with HIV-1 subtype D. The distribution of intra-patient recombination breakpoints suggested ongoing recombination and showed selective enrichment of recombinant variants in 23 (60%) subjects. The number of subjects with evidence of intra-subtype recombination increased from 29 (69%) to 36 (82%) over one year of follow-up, although the increase did not reach statistical significance. Adjustment for intra-subtype recombination is important for the analysis of multiplicity of HIV infection. This is the first report of high prevalence of intra-subtype recombination in the HIV/AIDS epidemic in Tanzania, a region where multiple HIV-1 subtypes co-circulate. HIV-1 intra-subtype recombination increases viral diversity and presents additional challenges for HIV-1 vaccine design.	[Kiwelu, Ireen E.; Manongi, Rachel; Sam, Noel; Shao, John] Tumaini Univ, Kilimanjaro Christian Med Ctr & Coll, Moshi, Tanzania; [Kiwelu, Ireen E.; Novitsky, Vladimir; Margolin, Lauren; Baca, Jeannie; McLane, Mary F.; Essex, M.] Harvard Univ, Sch Publ Hlth, Dept Immunol & Infect Dis, Boston, MA 02115 USA; [Kapiga, Saidi H.] London Sch Hyg & Trop Med, London WC1, England; [Manongi, Rachel; Sam, Noel; Kapiga, Saidi H.] Kilimanjaro Reprod Hlth Program, Moshi, Tanzania	Harvard University; Harvard T.H. Chan School of Public Health; University of London; London School of Hygiene & Tropical Medicine	Essex, M (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Immunol & Infect Dis, 665 Huntington Ave, Boston, MA 02115 USA.	messex@hsph.harvard.edu	shao, jianfu/N-2447-2018	shao, jianfu/0000-0002-6632-8207; Kapiga, Saidi/0000-0003-1753-4060	International Partnership for Microbicides (IPM), National Institutes of Health [D43 TW000004]; Fogarty International Center Scholars and Fellows Program; FOGARTY INTERNATIONAL CENTER [D43TW000004] Funding Source: NIH RePORTER; Medical Research Council [G0901756] Funding Source: researchfish; MRC [G0901756] Funding Source: UKRI	International Partnership for Microbicides (IPM), National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Fogarty International Center Scholars and Fellows Program; FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This study was supported by a grant from the International Partnership for Microbicides (IPM), National Institutes of Health grant D43 TW000004 (IEK), and by the Fogarty International Center Scholars and Fellows Program (IEK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altfeld M, 2002, NATURE, V420, P434, DOI 10.1038/nature01200; Ao TTH, 2011, AIDS BEHAV, V15, P330, DOI 10.1007/s10461-010-9849-y; Ao TTH, 2006, SEX TRANSM DIS, V33, P163, DOI 10.1097/01.olq.0000187204.57006.b3; Blackard JT, 2002, CLIN INFECT DIS, V34, P1108, DOI 10.1086/339547; Boni MF, 2007, GENETICS, V176, P1035, DOI 10.1534/genetics.106.068874; Brown RJP, 2011, J VIROL, V85, P6024, DOI 10.1128/JVI.00131-11; COFFIN JM, 1979, J GEN VIROL, V42, P1, DOI 10.1099/0022-1317-42-1-1; DIAZ RS, 1995, J VIROL, V69, P3273, DOI 10.1128/JVI.69.6.3273-3281.1995; Gibbs MJ, 2000, BIOINFORMATICS, V16, P573, DOI 10.1093/bioinformatics/16.7.573; Gottlieb GS, 2004, LANCET, V363, P619, DOI 10.1016/S0140-6736(04)15596-7; Grobler J, 2004, J INFECT DIS, V190, P1355, DOI 10.1086/423940; Gu ZX, 1995, J BIOL CHEM, V270, P31046, DOI 10.1074/jbc.270.52.31046; Jung A, 2002, NATURE, V418, P144, DOI 10.1038/418144a; Kiwanuka N, 2010, JAIDS-J ACQ IMM DEF, V54, P180, DOI 10.1097/QAI.0b013e3181c98fc0; Kiwelu IE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047605; Koelsch KK, 2003, AIDS, V17, pF11, DOI 10.1097/00002030-200305020-00001; Kozaczynska K, 2007, RETROVIROLOGY, V4, DOI 10.1186/1742-4690-4-59; Lamers SL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005065; Liu SL, 1996, SCIENCE, V273, P415, DOI 10.1126/science.273.5274.415; Liu Y, 2004, VIROLOGY, V329, P101, DOI 10.1016/j.virol.2004.08.014; Lole KS, 1999, J VIROL, V73, P152, DOI 10.1128/JVI.73.1.152-160.1999; Martin DP, 2010, BIOINFORMATICS, V26, P2462, DOI 10.1093/bioinformatics/btq467; Martin DP, 2005, AIDS RES HUM RETROV, V21, P98, DOI 10.1089/aid.2005.21.98; Martinez-Picado J, 2000, P NATL ACAD SCI USA, V97, P10948, DOI 10.1073/pnas.97.20.10948; McVean G, 2002, GENETICS, V160, P1231; Molla A, 1996, NAT MED, V2, P760, DOI 10.1038/nm0796-760; Moutouh L, 1996, P NATL ACAD SCI USA, V93, P6106, DOI 10.1073/pnas.93.12.6106; Novitsky V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016714; Padidam M, 1999, VIROLOGY, V265, P218, DOI 10.1006/viro.1999.0056; Palmer S, 2005, J CLIN MICROBIOL, V43, P406, DOI 10.1128/JCM.43.1.406-413.2005; Pernas M, 2006, JAIDS-J ACQ IMM DEF, V42, P12, DOI 10.1097/01.qai.0000214810.65292.73; Philpott S, 2005, J VIROL, V79, P353, DOI 10.1128/JVI.79.1.353-363.2005; Posada D, 2001, P NATL ACAD SCI USA, V98, P13757, DOI 10.1073/pnas.241370698; Posada D, 2002, J MOL EVOL, V54, P396, DOI 10.1007/s00239-001-0034-9; Robertson DL, 2000, SCIENCE, V288, P55, DOI 10.1126/science.288.5463.55d; ROBERTSON DL, 1995, NATURE, V374, P124, DOI 10.1038/374124b0; Rose PP, 2000, BIOINFORMATICS, V16, P400, DOI 10.1093/bioinformatics/16.4.400; Rousseau CM, 2007, J VIROL, V81, P4492, DOI 10.1128/JVI.02050-06; Salazar-Gonzalez JF, 2008, J VIROL, V82, P3952, DOI 10.1128/JVI.02660-07; SALMINEN MO, 1995, AIDS RES HUM RETROV, V11, P1423, DOI 10.1089/aid.1995.11.1423; Salminen MO, 1997, J VIROL, V71, P2647, DOI 10.1128/JVI.71.4.2647-2655.1997; Schierup MH, 2000, GENETICS, V156, P879; Sentandreu V, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003239; SHARP PM, 1995, PHILOS T R SOC B, V349, P41, DOI 10.1098/rstb.1995.0089; Shriner D, 2004, GENETICS, V167, P1573, DOI 10.1534/genetics.103.023382; Smith DM, 2005, AIDS, V19, P1251, DOI 10.1097/01.aids.0000180095.12276.ac; SMITH JM, 1992, J MOL EVOL, V34, P126; Takehisa J, 1999, J VIROL, V73, P6810, DOI 10.1128/JVI.73.8.6810-6820.1999; Taylor Jesse E., 2005, Infection Genetics and Evolution, V5, P85, DOI 10.1016/j.meegid.2004.07.001; Templeton AR, 2009, RETROVIROLOGY, V6, DOI 10.1186/1742-4690-6-54; Thomson MM, 2011, VIROLOGY, V415, P30, DOI 10.1016/j.virol.2011.03.021; van Rij RP, 2003, VIROLOGY, V314, P451, DOI 10.1016/S0042-6822(03)00454-9; ZHU TF, 1995, J VIROL, V69, P1324, DOI 10.1128/JVI.69.2.1324-1327.1995	53	11	12	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2013	8	8							e71131	10.1371/journal.pone.0071131	http://dx.doi.org/10.1371/journal.pone.0071131			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	218XC	23940702	Green Accepted, Green Published, Green Submitted, gold			2022-12-25	WOS:000324465000181
J	Li, Q; Hori, K; Minagi, Y; Ono, T; Chen, YJ; Kondo, J; Fujiwara, S; Tamine, K; Hayashi, H; Inoue, M; Maeda, Y				Li, Qiang; Hori, Kazuhiro; Minagi, Yoshitomo; Ono, Takahiro; Chen, Yong-jin; Kondo, Jyugo; Fujiwara, Shigehiro; Tamine, Kenichi; Hayashi, Hirokazu; Inoue, Makoto; Maeda, Yoshinobu			Development of a System to Monitor Laryngeal Movement during Swallowing Using a Bend Sensor	PLOS ONE			English	Article							UPPER ESOPHAGEAL SPHINCTER; ACUTE STROKE; DYSPHAGIA; GENDER; PHARYNGEAL; ASPIRATION; TONGUE; OROPHARYNGEAL; DEGLUTITION; IMPAIRMENTS	Background: Swallowing dysfunction (also known as dysphagia), which results in a deterioration of nutritional intake, slows rehabilitation and causes aspiration pneumonia, is very common following neurological impairments. Although videofluorographic (VF) examination is widely used for detecting aspiration, an objective and non-invasive method for assessing swallowing function has yet to be established because of a lack of adequate devices and protocols. In this paper, a bend sensor whose resistance is altered by bending was introduced to monitor swallowing-related laryngeal movement. Methods: Six healthy male volunteers were recruited in the present study. Specific time points on the signal waveform produced by the bend sensor were defined to describe laryngeal movement by differential analysis. Additionally, the physiological significance of the obtained waveform was confirmed by analyzing the sequential correlations between the signal waveform from the bend sensor and hyoid bone kinetics simultaneously recorded by VF. Results: Seven time points were successfully defined on the signal waveform to reference laryngeal movement. Each time point was well correlated with certain VF events, with evidence of no significant time lags, and there were positive correlations between waveform time points and matched VF events. Furthermore, obvious similarities were noticed between the duration of each phase on the signal waveform and the duration of the matched hyoid bone activity. Conclusions: The present monitoring system using a bend sensor might be useful for observing the temporal aspects of laryngeal movement during swallowing, and it was well coordinated with hyoid bone movement.	[Li, Qiang; Chen, Yong-jin] Fourth Mil Med Univ, Sch Stomatol, Dept Gen Dent & Emergency, Xian 710032, Peoples R China; [Li, Qiang; Minagi, Yoshitomo; Ono, Takahiro; Kondo, Jyugo; Fujiwara, Shigehiro; Tamine, Kenichi; Maeda, Yoshinobu] Osaka Univ, Grad Sch Dent, Dept Prosthodont Gerodontol & Oral Rehabil, Osaka, Japan; [Hori, Kazuhiro; Hayashi, Hirokazu; Inoue, Makoto] Niigata Univ, Grad Sch Med & Dent Sci, Div Dysphagia Rehabil, Niigata, Japan	Air Force Military Medical University; Osaka University; Niigata University	Hori, K (corresponding author), Niigata Univ, Grad Sch Med & Dent Sci, Div Dysphagia Rehabil, Niigata, Japan.	hori@dent.niigata-u.ac.jp; cyj1229@fmmu.edu.cn		Inoue, Makoto/0000-0002-6503-2973	Ministry of Education, Culture, Sports, Science and Technology of Japan [24659859]	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This research was supported by the Grants-in-Aid from the Ministry of Education, Culture, Sports, Science and Technology of Japan (No. 24659859). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe Shinichi, 2002, Bull Tokyo Dent Coll, V43, P199, DOI 10.2209/tdcpublication.43.199; Ashida I., 2009, Journal of Medical Engineering & Technology, V33, P496, DOI 10.1080/03091900902952691; Burnett TA, 2003, J APPL PHYSIOL, V94, P128, DOI 10.1152/japplphysiol.00406.2002; Butler SG, 2009, J SPEECH LANG HEAR R, V52, P240, DOI 10.1044/1092-4388(2008/07-0092); COOK IJ, 1989, AM J PHYSIOL, V257, pG748, DOI 10.1152/ajpgi.1989.257.5.G748; Dantas Roberto Oliveira, 2011, Arq. Gastroenterol., V48, P195, DOI 10.1590/S0004-28032011000300008; Dantas RO, 2009, DYSPHAGIA, V24, P280, DOI 10.1007/s00455-008-9202-z; ERTEKIN C, 1995, MUSCLE NERVE, V18, P1177, DOI 10.1002/mus.880181014; Ertekin C, 2001, J NEUROL NEUROSUR PS, V70, P363, DOI 10.1136/jnnp.70.3.363; Furuta M, 2013, COMMUNITY DENT ORAL, V41, P173, DOI 10.1111/cdoe.12000; Gentner R, 2009, J NEUROSCI METH, V178, P138, DOI 10.1016/j.jneumeth.2008.11.005; Halper AS, 1999, J HEAD TRAUMA REHAB, V14, P486, DOI 10.1097/00001199-199910000-00009; Hiiemae KM, 2002, ARCH ORAL BIOL, V47, P11, DOI 10.1016/S0003-9969(01)00092-9; Honda Y, 2007, J MAGN RESON IMAGING, V26, P172, DOI 10.1002/jmri.20992; Hongama S, 2012, J PROSTHODONT RES, V56, P53, DOI 10.1016/j.jpor.2011.04.003; Inamoto Y, 2011, DYSPHAGIA, V26, P209, DOI 10.1007/s00455-010-9276-2; Kuhlemeier KV, 1998, DYSPHAGIA, V13, P142, DOI 10.1007/PL00009564; Kurosu A, 2010, DYSPHAGIA, V25, P284, DOI 10.1007/s00455-009-9257-5; Matsuo K, 2010, ARCH ORAL BIOL, V55, P325, DOI 10.1016/j.archoralbio.2010.02.008; Matsuo K, 2008, PHYS MED REH CLIN N, V19, P691, DOI 10.1016/j.pmr.2008.06.001; Mepani R, 2009, DYSPHAGIA, V24, P26, DOI 10.1007/s00455-008-9167-y; Morton R, 2002, DYSPHAGIA, V17, P192, DOI 10.1007/s00455-002-0051-x; Okamoto N, 2012, J AM GERIATR SOC, V60, P849, DOI 10.1111/j.1532-5415.2012.03935.x; PALMER J B, 1992, Dysphagia, V7, P187, DOI 10.1007/BF02493469; Palmer JB, 2000, ARCH PHYS MED REHAB, V81, P1520, DOI 10.1053/apmr.2000.17829; Perlman AL, 1999, J APPL PHYSIOL, V86, P1663, DOI 10.1152/jappl.1999.86.5.1663; Perry L, 2001, DYSPHAGIA, V16, P7, DOI 10.1007/PL00021290; Raber-Durlacher JE, 2012, SUPPORT CARE CANCER, V20, P433, DOI 10.1007/s00520-011-1342-2; Simone Lisa K, 2005, J Neuroeng Rehabil, V2, P5, DOI 10.1186/1743-0003-2-5; Sonoda Naohiro, 2008, Okajimas Folia Anatomica Japonica, V85, P79; Starck JR, 1999, MED ENG PHYS, V21, P725, DOI 10.1016/S1350-4533(99)00097-1; Sundar U, 2008, NEUROL INDIA, V56, P463, DOI 10.4103/0028-3886.44828; Takagi M, 2001, J JPN SOC STOMATOGNA, V8, P25; Alves Leda Maria Tavares, 2007, Arq. Gastroenterol., V44, P227, DOI 10.1590/S0004-28032007000300009; Toyosato A., 2007, PROSTHODONTIC RES PR, V6, P272, DOI DOI 10.2186/PRP.6.272; Tsuga K, 2003, J ORAL REHABIL, V30, P985, DOI 10.1046/j.1365-2842.2003.01077.x; Tutor JD, 2012, PEDIATR PULM, V47, P321, DOI 10.1002/ppul.21576; VANDAELE DJ, 1995, J ANAT, V186, P1; Yabunaka K, 2011, RADIOL PHYS TECHNOL, V4, P73, DOI 10.1007/s12194-010-0107-9; Yokoyama M, 2000, LARYNGOSCOPE, V110, P434, DOI 10.1097/00005537-200003000-00021; Yoshida T., 1979, OTOLOGIA FUKUOKA, V25, P824	41	28	31	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2013	8	8							e70850	10.1371/journal.pone.0070850	http://dx.doi.org/10.1371/journal.pone.0070850			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	218XC	23940652	gold, Green Published, Green Submitted			2022-12-25	WOS:000324465000143
J	Madsen, DH; Jurgensen, HJ; Ingvarsen, S; Melander, MC; Albrechtsen, R; Hald, A; Holmbeck, K; Bugge, TH; Behrendt, N; Engelholm, LH				Madsen, Daniel H.; Jurgensen, Henrik J.; Ingvarsen, Signe; Melander, Maria C.; Albrechtsen, Reidar; Hald, Andreas; Holmbeck, Kenn; Bugge, Thomas H.; Behrendt, Niels; Engelholm, Lars H.			Differential Actions of the Endocytic Collagen Receptor uPARAP/Endo180 and the Collagenase MMP-2 in Bone Homeostasis	PLOS ONE			English	Article							PLASMINOGEN-ACTIVATOR RECEPTOR; MANNOSE RECEPTOR; MATRIX METALLOPROTEINASES; MULTICENTRIC OSTEOLYSIS; DENATURED COLLAGEN; IV COLLAGENASE; HUMAN BREAST; DEGRADATION; ENDO180; CELL	A well-coordinated remodeling of uncalcified collagen matrices is a pre-requisite for bone development and homeostasis. Collagen turnover proceeds through different pathways, either involving extracellular reactions exclusively, or being dependent on endocytic processes. Extracellular collagen degradation requires the action of secreted or membrane attached collagenolytic proteases, whereas the alternative collagen degradation pathway proceeds intracellularly after receptor-mediated uptake and delivery to the lysosomes. In this study we have examined the functional interplay between the extracellular collagenase, MMP-2, and the endocytic collagen receptor, uPARAP, by generating mice with combined deficiency of both components. In both uPARAP-deficient and MMP-2-deficient adult mice the length of the tibia and femur was decreased, along with a reduced bone mineral density and trabecular bone quality. An additional decrease in bone length was observed when combining the two deficiencies, pointing to both components being important for the remodeling processes in long bone growth. In agreement with results found by others, a different effect of MMP-2 deficiency was observed in the distinct bone structures of the calvaria. These membranous bones were found to be thickened in MMP-2-deficient mice, an effect likely to be related to an accompanying defect in the canalicular system. Surprisingly, both of the latter defects in MMP-2-deficient mice were counteracted by concurrent uPARAP deficiency, demonstrating that the collagen receptor does not support the same matrix remodeling processes as the MMP in the growth of the skull. We conclude that both uPARAP and MMP-2 take part in matrix turnover processes important for bone growth. However, in some physiological situations, these two components do not support the same step in the growth process.	[Madsen, Daniel H.; Jurgensen, Henrik J.; Ingvarsen, Signe; Melander, Maria C.; Hald, Andreas; Behrendt, Niels; Engelholm, Lars H.] Univ Copenhagen, Rigshosp, Finsen Lab, Biotech Res & Innovat Ctr, DK-2100 Copenhagen, Denmark; [Albrechtsen, Reidar] Univ Copenhagen, Dept Biomed Sci, Copenhagen, Denmark; [Albrechtsen, Reidar] Univ Copenhagen, Biotech Res & Innovat Ctr, Copenhagen, Denmark; [Holmbeck, Kenn] Natl Inst Dent & Craniofacial Res, Matrix Metalloproteinase Unit, Craniofacial & Skeletal Dis Branch, NIH, Bethesda, MD USA; [Madsen, Daniel H.; Bugge, Thomas H.] Natl Inst Dent & Craniofacial Res, Proteases & Tissue Remodeling Sect, NIH, Bethesda, MD USA	Rigshospitalet; University of Copenhagen; University of Copenhagen; University of Copenhagen; National Institutes of Health (NIH) - USA; NIH National Institute of Dental & Craniofacial Research (NIDCR); National Institutes of Health (NIH) - USA; NIH National Institute of Dental & Craniofacial Research (NIDCR)	Madsen, DH (corresponding author), Univ Copenhagen, Rigshosp, Finsen Lab, Biotech Res & Innovat Ctr, DK-2100 Copenhagen, Denmark.	daniel.madsen@nih.gov	Ingvarsen, Signe Ziir/AAT-3296-2020	Madsen, Daniel Hargboel/0000-0002-3183-6201; Ingvarsen, Signe Ziir/0000-0001-7800-6443; Albrechtsen, Reidar/0000-0003-4180-1827; Behrendt, Niels/0000-0003-1833-3922; Engelholm, Lars/0000-0002-6616-1232	Danish Cancer Society; Danish Medical Research Council; Danish Cancer Research Foundation; Novo Nordisk Foundation; Danish National Research Foundation (Danish-Chinese Center for Proteases and Cancer); European Community [201279]; Lundbeck Foundation; "Grosserer Alfred Nielsen og Hustrus" foundation; NIDCR; Copenhagen University Hospital; University of Copenhagen, Faculty of Science; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [ZIADE000676, ZIADE000699] Funding Source: NIH RePORTER; Lundbeck Foundation [R67-2010-6200, R118-2012-11578] Funding Source: researchfish; Novo Nordisk Fonden [NNF12OC0002353] Funding Source: researchfish	Danish Cancer Society(Danish Cancer Society); Danish Medical Research Council(Danish Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Danish Cancer Research Foundation; Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Danish National Research Foundation (Danish-Chinese Center for Proteases and Cancer)(Danmarks Grundforskningsfond); European Community(European Commission); Lundbeck Foundation(Lundbeckfonden); "Grosserer Alfred Nielsen og Hustrus" foundation; NIDCR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); Copenhagen University Hospital; University of Copenhagen, Faculty of Science; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); Lundbeck Foundation(Lundbeckfonden); Novo Nordisk Fonden(Novo Nordisk Foundation)	This work was supported by the Danish Cancer Society, the Danish Medical Research Council, the Danish Cancer Research Foundation, the Novo Nordisk Foundation, the Danish National Research Foundation (Danish-Chinese Center for Proteases and Cancer) and the European Community's Seventh Framework Programme FP7/2007-2011 under grant agreement no201279 (NB), by the Lundbeck Foundation (NB and LHE), the "Grosserer Alfred Nielsen og Hustrus" foundation (LHE) and by the NIDCR Intramural Research Program (THB and KH). The work was supported by personal grants from Copenhagen University Hospital (DHM and HJJ), the Lundbeck Foundation (DHM) and from the University of Copenhagen, Faculty of Science (SI). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Aqeel AL, 2005, SAUDI MED J, V26, P24; Andersen TL, 2004, BONE, V35, P1107, DOI 10.1016/j.bone.2004.06.019; Bundesmann MM, 2012, AM J RESP CELL MOL, V46, P233, DOI 10.1165/rcmb.2010-0485OC; Caley MP, 2012, J PATHOL, V226, P775, DOI 10.1002/path.3958; CULLEN J C, 1972, Journal of Bone and Joint Surgery British Volume, V54, P351; Curino AC, 2005, J CELL BIOL, V169, P977, DOI 10.1083/jcb.200411153; East L, 2003, EMBO REP, V4, P710, DOI 10.1038/sj.embor.embor882; Egeblad M, 2007, DEV DYNAM, V236, P1683, DOI 10.1002/dvdy.21159; Engelholm LH, 2003, J CELL BIOL, V160, P1009, DOI 10.1083/jcb.200211091; Engelholm LH, 2001, LAB INVEST, V81, P1403, DOI 10.1038/labinvest.3780354; Everts V, 2002, J BONE MINER RES, V17, P77, DOI 10.1359/jbmr.2002.17.1.77; Fasquelle C, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000666; Friedman SL, 2008, TOXICOLOGY, V254, P120, DOI 10.1016/j.tox.2008.06.013; GARANT PR, 1976, J PERIODONTOL, V47, P380, DOI 10.1902/jop.1976.47.7.380; HIPPS DS, 1991, BIOL CHEM H-S, V372, P287, DOI 10.1515/bchm3.1991.372.1.287; Holmbeck K, 2003, J CELL BIOL, V163, P661, DOI 10.1083/jcb.200307061; Holmbeck K, 1999, CELL, V99, P81, DOI 10.1016/S0092-8674(00)80064-1; Holmbeck Kenn, 2006, Birth Defects Research, V78, P11, DOI 10.1002/bdrc.20064; Howard MJ, 2004, OSTEOARTHR CARTILAGE, V12, P74, DOI 10.1016/j.joca.2003.07.001; Huijbers IJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009808; Inoue K, 2006, J BIOL CHEM, V281, P33814, DOI 10.1074/jbc.M607290200; ISACKE CM, 1990, MOL CELL BIOL, V10, P2606, DOI 10.1128/MCB.10.6.2606; Itoh T, 1997, J BIOL CHEM, V272, P22389, DOI 10.1074/jbc.272.36.22389; Karaplis AC, 2008, PRINCIPLES OF BONE BIOLOGY, VOL 1, 3RD EDITION, P53, DOI 10.1016/B978-0-12-373884-4.00025-2; Kinoh H, 1996, J CELL SCI, V109, P953; Kjoller L, 2004, EXP CELL RES, V293, P106, DOI 10.1016/j.yexcr.2003.10.008; Kogianni G, 2009, EUR J CANCER, V45, P685, DOI 10.1016/j.ejca.2008.11.023; Lauer-Fields JL, 2002, BIOPOLYMERS, V66, P19, DOI 10.1002/bip.10201; Lee M, 2008, PRINCIPLES OF BONE BIOLOGY, VOL 1, 3RD EDITION, P367, DOI 10.1016/B978-0-12-373884-4.00038-0; Lopez-Guisa JM, 2012, J AM SOC NEPHROL, V23, P236, DOI 10.1681/ASN.2011030310; Madsen DH, 2007, J BIOL CHEM, V282, P27037, DOI 10.1074/jbc.M701088200; Madsen DH, 2012, J PATHOL, V227, P94, DOI 10.1002/path.3981; Madsen DH, 2011, J BIOL CHEM, V286, P26996, DOI 10.1074/jbc.M110.208033; Malovic I, 2007, HEPATOLOGY, V45, P1454, DOI 10.1002/hep.21639; Martignetti JA, 2001, NAT GENET, V28, P261, DOI 10.1038/90100; Messaritou G, 2009, J CELL SCI, V122, P4042, DOI 10.1242/jcs.044305; Milner Jennifer M., 2005, Current Drug Targets - Inflammation and Allergy, V4, P363, DOI 10.2174/1568010054022141; Mosig RA, 2007, HUM MOL GENET, V16, P1113, DOI 10.1093/hmg/ddm060; Mousavi SA, 2005, BIOCHEM J, V387, P39, DOI 10.1042/BJ20040966; Nielsen BS, 2002, INT J CANCER, V98, P656, DOI 10.1002/ijc.10227; Ohuchi E, 1997, J BIOL CHEM, V272, P2446, DOI 10.1074/jbc.272.4.2446; Rowe RG, 2009, ANNU REV CELL DEV BI, V25, P567, DOI 10.1146/annurev.cellbio.24.110707.175315; SATO H, 1994, NATURE, V370, P61, DOI 10.1038/370061a0; Smith L, 2008, GENE EXPR PATTERNS, V8, P486, DOI 10.1016/j.gep.2008.06.006; STRONGIN AY, 1995, J BIOL CHEM, V270, P5331, DOI 10.1074/jbc.270.10.5331; Sulek J, 2007, J HISTOCHEM CYTOCHEM, V55, P347, DOI 10.1369/jhc.6A7133.2006; Wagenaar-Miller RA, 2007, MOL CELL BIOL, V27, P6309, DOI 10.1128/MCB.00291-07; Wewer UM, 1997, AM J PATHOL, V151, P1191; Wienke D, 2007, CANCER RES, V67, P10230, DOI 10.1158/0008-5472.CAN-06-3496; Wu K, 1996, J BIOL CHEM, V271, P21323, DOI 10.1074/jbc.271.35.21323; Zhao WG, 2000, J CLIN INVEST, V106, P941, DOI 10.1172/JCI10158	51	23	23	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2013	8	8							e71261	10.1371/journal.pone.0071261	http://dx.doi.org/10.1371/journal.pone.0071261			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	218XC	23940733	gold, Green Submitted, Green Published			2022-12-25	WOS:000324465000202
J	Nin, DS; Bin Ali, A; Okumura, K; Asou, N; Chen, CS; Chng, WJ; Khan, M				Nin, Dawn Sijin; Bin Ali, Azhar; Okumura, Koichi; Asou, Norio; Chen, Chien-Shing; Chng, Wee Joo; Khan, Matiullah			Akt-Induced Phosphorylation of N-CoR at Serine 1450 Contributes to Its Misfolded Conformational Dependent Loss (MCDL) in Acute Myeloid Leukemia of the M5 Subtype	PLOS ONE			English	Article							NUCLEAR RECEPTOR COREPRESSOR; PROTEIN-KINASE B/AKT; PML-RAR-ALPHA; GLUCOSE-6-PHOSPHATASE GENE-TRANSCRIPTION; MONOCYTIC LEUKEMIA; UNFOLDED PROTEIN; STEM-CELLS; REPRESSION; ACTIVATION; INSULIN	The nuclear receptor co-repressor (N-CoR) is a key component of the generic co-repressor complex that plays an important role in the control of cellular growth and differentiation. As shown by us recently, the growth suppressive function of N-CoR largely relies on its capacity to repress Flt3, a key regulator of cellular gorwth during normal and malignant hematopoesis. We further demonstrated how de-repression of Flt3 due to the misfolded conformation dependent loss (MCDL) of N-CoR contributed to malignant growth in acute myeloid leukemia (AML). However, the molecular mechanism underlying the MCDL of N-CoR and its implication in AML pathogenesis is not fully understood. Here, we report that Akt-induced phosphorylation of N-CoR at the consensus Akt motif is crucial for its misfolding and subsequent loss in AML (AML-M5). NCoR displayed significantly higher level of serine specific phosphorylation in almost all AML-M5 derived cells and was subjected to processing by AML-M5 specific aberrant protease activity. To identify the kinase linked to N-CoR phosphorylation, a library of activated kinases was screened with the extracts of AML cells; leading to the identification of Akt as the putative kinase linked to N-CoR phosphorylation. Consistent with this finding, a constitutively active Akt consistently phosphorylated N-CoR leading to its misfolding; while the therapeutic and genetic ablation of Akt largely abrogated the MCDL of N-CoR in AML-M5 cells. Site directed mutagenic analysis of N-CoR identified serine 1450 as the crucial residue whose phosphorylation by Akt was essential for the misfolding and loss of N-CoR protein. Moreover, Akt-induced phosphorylation of N-CoR contributed to the de-repression of Flt3, suggesting a cross talk between Akt signaling and N-CoR misfolding pathway in the pathogenesis of AML-M5. The N-CoR misfolding pathway could be the common downstream thread of pleiotropic Akt signaling activated by various oncogenic insults in some subtypes of leukemia and solid tumors.	[Nin, Dawn Sijin; Bin Ali, Azhar; Okumura, Koichi; Chng, Wee Joo; Khan, Matiullah] Natl Univ Singapore, Yong Loo Lin Sch Med, Canc Sci Inst Singapore, Singapore 117595, Singapore; [Nin, Dawn Sijin; Chng, Wee Joo; Khan, Matiullah] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Med, Singapore 117595, Singapore; [Nin, Dawn Sijin] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Biochem, Singapore 117595, Singapore; [Asou, Norio] Kumamoto Univ, Dept Haematol, Kumamoto, Japan; [Chen, Chien-Shing] Loma Linda Univ, Sch Med, Div Hematologyand Oncol, Loma Linda, CA USA; [Chng, Wee Joo] Natl Univ Hlth Syst, Natl Canc Inst Singapore, Dept Haematol Oncol, Singapore, Singapore; [Khan, Matiullah] AIMST, Sch Med, Bedong, Malaysia	National University of Singapore; National University of Singapore; National University of Singapore; Kumamoto University; Loma Linda University; National University of Singapore	Khan, M (corresponding author), Natl Univ Singapore, Yong Loo Lin Sch Med, Canc Sci Inst Singapore, Singapore 117595, Singapore.	khanmmd@gmail.com	Ali, Azhar/J-3507-2019	Ali, Azhar/0000-0002-5895-9076	Singapore Stem Cell Consortium [SSCC-04-06]; National Medical Research Council of Singapore [NMRC/1213/2009]	Singapore Stem Cell Consortium; National Medical Research Council of Singapore(National Medical Research Council, Singapore)	This work was supported by generous funding from Singapore Stem Cell Consortium grant SSCC-04-06 (M Khan) and National Medical Research Council of Singapore grant NMRC/1213/2009 (M Khan). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALI A, 2011, PLOS ONE, V0006; AMANCHY R, 2007, J BIOL CHEM, V279, P49420; Anderson MJ, 1998, GENOMICS, V47, P187, DOI 10.1006/geno.1997.5122; Andjelkovic M, 1997, J BIOL CHEM, V272, P31515, DOI 10.1074/jbc.272.50.31515; Bellacosa A, 1998, ONCOGENE, V17, P313, DOI 10.1038/sj.onc.1201947; Biggs WH, 1999, P NATL ACAD SCI USA, V96, P7421, DOI 10.1073/pnas.96.13.7421; Borkhardt A, 1997, ONCOGENE, V14, P195, DOI 10.1038/sj.onc.1200814; Brunet A, 1999, CELL, V96, P857, DOI 10.1016/S0092-8674(00)80595-4; Bullock AN, 2001, NAT REV CANCER, V1, P68, DOI 10.1038/35094077; Cichy SB, 1998, J BIOL CHEM, V273, P6482, DOI 10.1074/jbc.273.11.6482; Clifford SC, 2001, HUM MOL GENET, V10, P1029, DOI 10.1093/hmg/10.10.1029; DAVIS RJ, 1995, HUM MOL GENET, V4, P2355, DOI 10.1093/hmg/4.12.2355; Dickens M, 1998, J BIOL CHEM, V273, P20144, DOI 10.1074/jbc.273.32.20144; Dome JS, 2002, CURR OPIN PEDIATR, V14, P5, DOI 10.1097/00008480-200202000-00002; DUAN DR, 1995, SCIENCE, V269, P1402, DOI 10.1126/science.7660122; FRANKE TF, 1995, CELL, V81, P727, DOI 10.1016/0092-8674(95)90534-0; Frias MA, 2006, CURR BIOL, V16, P1865, DOI 10.1016/j.cub.2006.08.001; Furuya F, 2007, MOL CELL BIOL, V27, P6116, DOI 10.1128/MCB.00900-07; HABER DA, 1992, P NATL ACAD SCI USA, V89, P6010, DOI 10.1073/pnas.89.13.6010; Haferlach T, 2002, BRIT J HAEMATOL, V118, P426, DOI 10.1046/j.1365-2141.2002.03599.x; Heinzel T, 1997, NATURE, V387, P43, DOI 10.1038/387043a0; Hermanson O, 2002, NATURE, V419, P934, DOI 10.1038/nature01156; HORLEIN AJ, 1995, NATURE, V377, P397, DOI 10.1038/377397a0; Ishimaru D, 2003, J MOL BIOL, V333, P443, DOI 10.1016/j.jmb.2003.08.026; Khan MM, 2004, J BIOL CHEM, V279, P11814, DOI 10.1074/jbc.M312121200; Khan MM, 2001, J BIOL CHEM, V276, P43491, DOI 10.1074/jbc.C100532200; Khan MM, 2001, MOL CELL, V7, P1233, DOI 10.1016/S1097-2765(01)00257-X; Kharas MG, 2010, BLOOD, V115, P1406, DOI 10.1182/blood-2009-06-229443; Laherty CD, 1997, CELL, V89, P349, DOI 10.1016/S0092-8674(00)80215-9; Laherty CD, 1998, MOL CELL, V2, P33, DOI 10.1016/S1097-2765(00)80111-2; Liao JF, 1998, J BIOL CHEM, V273, P27320, DOI 10.1074/jbc.273.42.27320; Lin K, 1997, SCIENCE, V278, P1319, DOI 10.1126/science.278.5341.1319; LUBBERT M, 1991, BLOOD, V77, P909; Meier R, 1997, J BIOL CHEM, V272, P30491, DOI 10.1074/jbc.272.48.30491; Menghini R, 2005, CIRCULATION, V111, P1946, DOI 10.1161/01.CIR.0000161814.02942.B2; Morrow KA, 2011, J BIOL CHEM, V286, P40376, DOI 10.1074/jbc.M111.250035; Nakatani K, 1999, J BIOL CHEM, V274, P21528, DOI 10.1074/jbc.274.31.21528; Ng APP, 2007, MOL CANCER THER, V6, P2240, DOI 10.1158/1535-7163.MCT-06-0705; Ng APP, 2006, CANCER RES, V66, P9903, DOI 10.1158/0008-5472.CAN-06-0002; Ng APP, 2011, MOL CANCER RES, V9, P878, DOI 10.1158/1541-7786.MCR-10-0545; Nin DS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034501; Nomura T, 1999, GENE DEV, V13, P412, DOI 10.1101/gad.13.4.412; Ogg S, 1997, NATURE, V389, P994, DOI 10.1038/40194; Paradis S, 1998, GENE DEV, V12, P2488, DOI 10.1101/gad.12.16.2488; Roca H, 2008, J BIOL CHEM, V283, P25057, DOI 10.1074/jbc.M801073200; Rosenbauer F, 2007, NAT REV IMMUNOL, V7, P105, DOI 10.1038/nri2024; Rudiger S, 2002, P NATL ACAD SCI USA, V99, P11085, DOI 10.1073/pnas.132393699; Sarbassov DD, 2004, CURR BIOL, V14, P1296, DOI 10.1016/j.cub.2004.06.054; Scharnhorst V, 2001, GENE, V273, P141, DOI 10.1016/S0378-1119(01)00593-5; Streeper RS, 1997, J BIOL CHEM, V272, P11698, DOI 10.1074/jbc.272.18.11698; Testa JR, 2001, P NATL ACAD SCI USA, V98, P10983, DOI 10.1073/pnas.211430998; Thimmaiah KN, 2005, J BIOL CHEM, V280, P31924, DOI 10.1074/jbc.M507057200; Vanden Berghe W, 2006, CANCER RES, V66, P4852, DOI 10.1158/0008-5472.CAN-05-2957; Villeneuve P, 2008, LEUKEMIA RES, V32, P269, DOI 10.1016/j.leukres.2007.06.019; Wolff L, 1997, BBA-REV CANCER, V1332, pF67, DOI 10.1016/S0304-419X(97)00006-1; Yu H, 2010, LEUKEMIA, V24, P1077, DOI 10.1038/leu.2010.34	56	3	3	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2013	8	8							e70891	10.1371/journal.pone.0070891	http://dx.doi.org/10.1371/journal.pone.0070891			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	218XC	23940660	Green Published, Green Submitted, gold			2022-12-25	WOS:000324465000149
J	Yu, HH; Chen, PC; Wang, LC; Lee, JH; Lin, YT; Yang, YH; Lin, CP; Chiang, BL				Yu, Hsin-Hui; Chen, Pau-Chung; Wang, Li-Chieh; Lee, Jyh-Hong; Lin, Yu-Tsan; Yang, Yao-Hsu; Lin, Chang-Ping; Chiang, Bor-Luen			Juvenile Idiopathic Arthritis-Associated Uveitis: A Nationwide Population-Based Study in Taiwan	PLOS ONE			English	Article							TERM-FOLLOW-UP; RHEUMATOID-ARTHRITIS; CHINESE POPULATION; RISK-FACTORS; PREVALENCE; CHILDREN; EPIDEMIOLOGY; COHORT; CLASSIFICATION; CRITERIA	Objective: The incidence and prevalence of juvenile idiopathic arthritis (JIA) vary widely across the world but data in East Asia is lacking. Uveitis is a serious cause of morbidity in JIA. This study aimed to analyze the incidence and prevalence of JIA, and the characteristics of JIA-associated uveitis in Taiwan. Methods: A population-based cohort study was conducted using the Taiwan National Health Insurance Research Database. Each patient was individually tracked from 1999 to 2009 to identify the diagnosis of JIA and uveitis using the International Classification of Diseases diagnostic codes. Multivariate logistic regression was used to determine the risk factors and complications of uveitis in patients with JIA. Results: The study cohort had 2636 cases of JIA and included juvenile rheumatoid arthritis (57.7%), enthesitis-related arthritis (ERA) (39.2%), and psoriatic arthritis (3.1%). The average annual incidence of JIA and JIA-associated uveitis were 4.93 (range, 3.93-6.23) and 0.25 (range, 0.12-0.37) cases per 100,000 population, respectively. The average period prevalence of JIA was 33.8 cases per 100,000 population. Uveitis occurred in 4.7% of patients with JIA, while JIA-associated uveitis was complicated by cataract (11.2%) and glaucoma (24.8%). Enthesitis-related arthritis was significantly associated with uveitis (OR: 3.47; 95% CI: 2.24-5.37) (p<0.0001). Uveitis diagnosed before JIA was the most significant risk factor for complications of glaucoma or cataract (OR: 3.54; 95% CI: 1.44-8.72) (p = 0.006). Conclusions: The incidence of JIA is low but that of JIA-associated uveitis is increasing. Higher percentage of males in patients with ERA and the strong association between ERA and uveitis are unique for children with JIA in Taiwan. Uveitis diagnosed before arthritis is an important risk factor for complications. Continuous ophthalmologic follow-up is needed for children with JIA or uveitis of unknown etiology.	[Yu, Hsin-Hui; Wang, Li-Chieh; Lee, Jyh-Hong; Lin, Yu-Tsan; Yang, Yao-Hsu] Natl Taiwan Univ Hosp, Dept Pediat, Taipei 10016, Taiwan; [Chen, Pau-Chung] Natl Taiwan Univ, Inst Occupat Med & Ind Hyg, Coll Publ Hlth, Taipei 10764, Taiwan; [Lin, Chang-Ping] Natl Taiwan Univ Hosp, Dept Ophthalmol, Taipei, Taiwan; [Chiang, Bor-Luen] Natl Taiwan Univ Hosp, Dept Med Res, Taipei, Taiwan	National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University Hospital	Chiang, BL (corresponding author), Natl Taiwan Univ Hosp, Dept Med Res, Taipei, Taiwan.	gicmbor@ntu.edu.tw	Chen, Pau-Chung/H-5686-2011; Yu, Hsin-Hui/AAV-2068-2020; Yang, Yao-Hsu/A-3450-2019	Chen, Pau-Chung/0000-0002-6242-5974; Yu, Hsin-Hui/0000-0003-2611-5175; CHIANG, BOR-LUEN/0000-0002-6705-0286; Yang, Yao-Hsu/0000-0002-6266-9864; Yang, Yao-Hsu/0000-0002-8080-0504; LIN, CHANG-PING/0000-0003-0302-7711; WANG, LI-CHIEH/0000-0002-5773-1627; LEE, JYH-HONG/0000-0003-4285-4912; LIN, YU-TSAN/0000-0002-4192-3165	National Taiwan University Hospital [100-S1547, 100-M1717]	National Taiwan University Hospital(National Taiwan University)	This study was supported by the study grant (100-S1547, 100-M1717) from the National Taiwan University Hospital. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1977, EUR LEAG RHEUM EULAR; Bemtson L, 2013, J RHEUMATOL, V40, P725, DOI 10.3899/jrheum.121257; Berkun Y, 2010, AUTOIMMUN REV, V9, pA319, DOI 10.1016/j.autrev.2009.11.018; Berntson L, 2003, J RHEUMATOL, V30, P2275; Brewer E J Jr, 1977, Arthritis Rheum, V20, P195; Carvounis PE, 2006, GRAEF ARCH CLIN EXP, V244, P281, DOI 10.1007/s00417-005-0087-3; Cassidy J, 2006, PEDIATRICS, V117, P1843, DOI 10.1542/peds.2006-0421; Chung YM, 2009, SCAND J RHEUMATOL, V38, P84, DOI 10.1080/03009740802385423; Colbert RA, 2010, NAT REV RHEUMATOL, V6, P477, DOI 10.1038/nrrheum.2010.103; Feltkamp TEW, 2001, CURR OPIN RHEUMATOL, V13, P285, DOI 10.1097/00002281-200107000-00007; Fernandez-Melon J, 2004, J RHEUMATOL, V31, P524; Foster H, 2010, RHEUMATOLOGY, V49, P401, DOI 10.1093/rheumatology/kep347; Fujikawa S, 1997, ACTA PAEDIATR JAPON, V39, P242; Grassi A, 2007, J RHEUMATOL, V34, P1139; Gregory AC, 2013, OPHTHALMOLOGY, V120, P186, DOI 10.1016/j.ophtha.2012.07.052; Hanova P, 2006, CLIN EXP RHEUMATOL, V24, P499; Heiligenhaus A, 2007, RHEUMATOLOGY, V46, P1015, DOI 10.1093/rheumatology/kem053; Hofer ME, 2001, J RHEUMATOL, V28, P1083; Hsu CT, 2004, SCAND J RHEUMATOL, V33, P312, DOI 10.1080/03009740410005854; Huang JL, 2004, CLIN EXP RHEUMATOL, V22, P776; Hwang DK, 2012, OPHTHALMOLOGY, V119, P2371, DOI 10.1016/j.ophtha.2012.05.026; Kesen Muge R, 2008, Int Ophthalmol Clin, V48, P21, DOI 10.1097/IIO.0b013e31817d998f; Kotaniemi K, 2003, SURV OPHTHALMOL, V48, P489, DOI 10.1016/S0039-6257(03)00084-5; Krumpey-Langkammerer M, 2001, J RHEUMATOL, V28, P2544; Kump LI, 2005, OPHTHALMOLOGY, V112, P1287, DOI 10.1016/j.ophtha.2005.01.044; Kunjir V, 2010, J RHEUMATOL, V37, P1756, DOI 10.3899/jrheum.090937; Macaubas C, 2009, NAT REV RHEUMATOL, V5, P616, DOI 10.1038/nrrheum.2009.209; Manners PJ, 2002, J RHEUMATOL, V29, P1520; Modesto C, 2010, SCAND J RHEUMATOL, V39, P472, DOI 10.3109/03009741003742722; Nordal E, 2011, ARTHRITIS RHEUM-US, V63, P2809, DOI 10.1002/art.30426; Petty RE, 2004, J RHEUMATOL, V31, P390; Petty RE, 2003, AM J OPHTHALMOL, V135, P879, DOI 10.1016/S0002-9394(03)00104-1; Pruunsild C, 2007, CLIN EXP RHEUMATOL, V25, P649; Pruunsild C, 2007, SCAND J RHEUMATOL, V36, P7, DOI 10.1080/03009740601089259; Riise OR, 2008, PEDIATRICS, V121, pE299, DOI 10.1542/peds.2007-0291; Saurenmann RK, 2007, ARTHRITIS RHEUM, V56, P1974, DOI 10.1002/art.22709; Saurenmann RK, 2007, ARTHRITIS RHEUM, V56, P647, DOI 10.1002/art.22381; Shen CC, 2012, J MICROBIOL IMMUNOL; Skarin A, 2009, OCUL IMMUNOL INFLAMM, V17, P104, DOI 10.1080/09273940802650398; Solau-Gervais E, 2010, JOINT BONE SPINE, V77, P47, DOI 10.1016/j.jbspin.2009.11.002; Tsan YT, 2012, J CLIN ONCOL, V30, P623, DOI 10.1200/JCO.2011.36.0917	41	11	14	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2013	8	8							e70625	10.1371/journal.pone.0070625	http://dx.doi.org/10.1371/journal.pone.0070625			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	218XC	23940609	Green Published, Green Submitted, gold			2022-12-25	WOS:000324465000103
J	Voak, AA; Gobalakrishnapillai, V; Seifert, K; Balczo, E; Hu, LQ; Hall, BS; Wilkinson, SR				Voak, Andrew A.; Gobalakrishnapillai, Vithurshaa; Seifert, Karin; Balczo, Edina; Hu, Longqin; Hall, Belinda S.; Wilkinson, Shane R.			An Essential Type I Nitroreductase from Leishmania major Can Be Used to Activate Leishmanicidal Prodrugs	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Drug Discovery; Drug Screening; Oxidation-Reduction; Parasite; Trypanosoma brucei; Trypanosome	ESCHERICHIA-COLI; DRUG CANDIDATE; RESPIRATORY-CHAIN; PURIFICATION; NIFURTIMOX; RAT; CARCINOGENESIS; FEXINIDAZOLE; NITAZOXANIDE; BENZNIDAZOLE	Nitroaromatic prodrugs are used to treat a range of microbial infections with selectivity achieved by specific activation reactions. For trypanosomatid parasites, this is mediated by type I nitroreductases. Here, we demonstrate that the causative agent of leishmaniasis, Leishmania major, expresses an FMN-containing nitroreductase (LmNTR) that metabolizes a wide range of substrates, and based on electron donor and acceptor preferences, it may function as an NADH:quinone oxidoreductase. Using gene deletion approaches, we demonstrate that this activity is essential to L. major promastigotes, the parasite forms found in the insect vector. Intriguingly, LmNTR(+/-) heterozygote promastigote parasites could readily differentiate into infectious metacyclic cells but these were unable to establish infections in cultured mammalian cells and caused delayed pathology in mice. Furthermore, we exploit the LmNTR activity evaluating a library of nitrobenzylphosphoramide mustards using biochemical and phenotypic screens. We identify a subset of compounds that display significant growth inhibitory properties against the intracellular parasite form found in the mammalian hosts. The leishmanicidal activity was shown to be LmNTR-specific as the LmNTR(+/-) heterozygote promastigotes displayed resistance to the most potent mustards. We conclude that LmNTR can be targeted for drug development by exploiting its prodrug activating property or by designing specific inhibitors to block its endogenous function.	[Voak, Andrew A.; Gobalakrishnapillai, Vithurshaa; Balczo, Edina; Hall, Belinda S.; Wilkinson, Shane R.] Queen Mary Univ London, Sch Biol & Chem Sci, Queen Mary Preclin Drug Discovery Grp, London E1 4NS, England; [Seifert, Karin] Univ London London Sch Hyg & Trop Med, Immunol & Infect Dept, London WC1E 7HT, England; [Hu, Longqin] Rutgers State Univ, Dept Med Chem, Ernest Mario Sch Pharm, Piscataway, NJ 08854 USA	University of London; Queen Mary University London; University of London; London School of Hygiene & Tropical Medicine; Rutgers State University New Brunswick	Wilkinson, SR (corresponding author), Queen Mary Univ London, Sch Biol & Chem Sci, Queen Mary Preclin Drug Discovery Grp, Mile End Rd, London E1 4NS, England.	s.r.wilkinson@qmul.ac.uk	Hu, Longqin/AAR-7076-2021; Hall, Belinda/AGU-6214-2022	Hu, Longqin/0000-0002-1799-5652; Voak, Andrew/0000-0002-1010-4781; Hall, Belinda/0000-0002-3753-1978	Queen Mary University of London Graduate Training Studentship	Queen Mary University of London Graduate Training Studentship	Recipient of a Queen Mary University of London Graduate Training Studentship. Present address: Immunology and Infection Dept., London School of Hygiene and Tropical Medicine, London WC1E 7HT, United Kingdom.	Adagu IS, 2002, J ANTIMICROB CHEMOTH, V49, P103, DOI 10.1093/jac/49.1.103; Arya SC, 2009, BJU INT, V103, P994, DOI [10.1111/j.1464-410X.2009.08510_1.x, 10.1111/j.1464-410X.2009.08510_2.x]; Balasegaram M, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000234; BRYANT C, 1991, J BIOL CHEM, V266, P4119; Charest H, 1996, J BIOL CHEM, V271, P17081, DOI 10.1074/jbc.271.29.17081; Chen S, 1997, J BIOL CHEM, V272, P1437, DOI 10.1074/jbc.272.3.1437; Chen Y, 2009, MED RES REV, V29, P29, DOI 10.1002/med.20137; Croft SL, 2011, CLIN MICROBIOL INFEC, V17, P1478, DOI 10.1111/j.1469-0691.2011.03630.x; Croft SL, 2006, CLIN MICROBIOL REV, V19, P111, DOI 10.1128/CMR.19.1.111-126.2006; Cruz I, 2002, LANCET, V359, P1124, DOI 10.1016/S0140-6736(02)08160-6; DASILVA R, 1987, INFECT IMMUN, V55, P2802, DOI 10.1128/IAI.55.11.2802-2806.1987; de Oliveira IM, 2007, BIOCHEM BIOPH RES CO, V355, P919, DOI 10.1016/j.bbrc.2007.02.049; Denny WA, 2003, J BIOMED BIOTECHNOL, P48; FAEDER EJ, 1973, ANAL BIOCHEM, V53, P332, DOI 10.1016/0003-2697(73)90442-9; Gonzalez C, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000585; GRUNBERG E, 1973, ANNU REV MICROBIOL, V27, P317, DOI 10.1146/annurev.mi.27.100173.001533; Hall BS, 2012, ANTIMICROB AGENTS CH, V56, P5821, DOI 10.1128/AAC.01227-12; Hall BS, 2012, ANTIMICROB AGENTS CH, V56, P115, DOI 10.1128/AAC.05135-11; Hall BS, 2011, J BIOL CHEM, V286, P13088, DOI 10.1074/jbc.M111.230847; Hall BS, 2010, ANTIMICROB AGENTS CH, V54, P1193, DOI 10.1128/AAC.01213-09; HART DT, 1981, MOL BIOCHEM PARASIT, V4, P39, DOI 10.1016/0166-6851(81)90027-X; Hiraku Y, 2004, CANCER LETT, V215, P141, DOI 10.1016/j.canlet.2004.05.016; Hu LQ, 2011, BIOORG MED CHEM LETT, V21, P3986, DOI 10.1016/j.bmcl.2011.05.009; Hu LQ, 2003, J MED CHEM, V46, P4818, DOI 10.1021/jm034133h; Jiang YY, 2008, BIOORG MED CHEM LETT, V18, P4059, DOI 10.1016/j.bmcl.2008.05.099; Jiang YY, 2006, J MED CHEM, V49, P4333, DOI 10.1021/jm051246n; Kaiser M, 2011, ANTIMICROB AGENTS CH, V55, P5602, DOI 10.1128/AAC.00246-11; Korba BE, 2008, ANTIVIR RES, V77, P56, DOI 10.1016/j.antiviral.2007.08.005; Matsumoto M, 2006, PLOS MED, V3, P2131, DOI 10.1371/journal.pmed.0030466; MCCALLA DR, 1983, ENVIRON MUTAGEN, V5, P745, DOI 10.1002/em.2860050512; MORENO SNJ, 1984, J BIOL CHEM, V259, P6298; Opperdoes FR, 2008, TRENDS PARASITOL, V24, P310, DOI 10.1016/j.pt.2008.03.013; Pal D, 2009, ANTIMICROB AGENTS CH, V53, P458, DOI 10.1128/AAC.00909-08; Pavli A, 2010, INT J INFECT DIS, V14, pE1032, DOI 10.1016/j.ijid.2010.06.019; PETERSON FJ, 1979, J BIOL CHEM, V254, P4009; Race PR, 2007, J MOL BIOL, V368, P481, DOI 10.1016/j.jmb.2007.02.012; ROVERA G, 1979, SCIENCE, V204, P868, DOI 10.1126/science.286421; Santhamma KR, 1995, MOL BIOCHEM PARASIT, V75, P43, DOI 10.1016/0166-6851(95)02510-3; Sholler GLS, 2006, J PEDIAT HEMATOL ONC, V28, P693, DOI 10.1097/01.mph.0000212994.56812.f2; Stover CK, 2000, NATURE, V405, P962, DOI 10.1038/35016103; Stuart K, 2008, J CLIN INVEST, V118, P1301, DOI 10.1172/JCI33945; Takahashi M, 2000, CANCER LETT, V156, P177, DOI 10.1016/S0304-3835(00)00459-6; Trunz BB, 2011, EUR J MED CHEM, V46, P1524, DOI 10.1016/j.ejmech.2011.01.071; Tweats D, 2012, MUTAGENESIS, V27, P523, DOI 10.1093/mutage/ges015; VanHellemond JJ, 1997, MOL BIOCHEM PARASIT, V85, P135, DOI 10.1016/S0166-6851(97)02828-4; Watanabe M, 1998, J BIOL CHEM, V273, P23922, DOI 10.1074/jbc.273.37.23922; Wilkinson SR, 2008, P NATL ACAD SCI USA, V105, P5022, DOI 10.1073/pnas.0711014105; Wyllie S, 2013, ANTIMICROB AGENTS CH, V57, P901, DOI 10.1128/AAC.01788-12; Wyllie S, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003326; Zenno S, 1996, J BIOCHEM-TOKYO, V120, P736	50	22	23	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 4	2013	288	40					28466	28476		10.1074/jbc.M113.494781	http://dx.doi.org/10.1074/jbc.M113.494781			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	298BL	23946481	Green Published, Green Submitted, hybrid			2022-12-25	WOS:000330298800005
J	Wang, ZL; Weitzmann, MN; Sangadala, S; Hutton, WC; Yoon, ST				Wang, Zili; Weitzmann, M. Neale; Sangadala, Sreedhara; Hutton, William C.; Yoon, S. Tim			Link Protein N-terminal Peptide Binds to Bone Morphogenetic Protein (BMP) Type II Receptor and Drives Matrix Protein Expression in Rabbit Intervertebral Disc Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CARTILAGE PROTEOGLYCANS; EXTRACELLULAR-MATRIX; NUCLEUS PULPOSUS; GROWTH; SOX9; BIOSYNTHESIS; DEGENERATION; INHIBITOR; AGGRECAN; REPAIR	Intervertebral disc (IVD) degeneration and associated spinal disorders are leading sources of morbidity, and they can be responsible for chronic low back pain. Treatments for degenerative disc diseases continue to be a challenge. Intensive research is now focusing on promoting regeneration of degenerated discs by stimulating production of the disc matrix. Link protein N-terminal peptide (LPP) is a proteolytic fragment of link protein, an important cross-linker and stabilizer of the major structural components of cartilage, aggrecan and hyaluronan. In this study we investigated LPP action in rabbit primary intervertebral disc cells cultured ex vivo in a three-dimensional alginate matrix. Our data reveal that LPP promotes disc matrix production, which was evidenced by increased expression of the chondrocyte-specific transcription factor SOX9 and the extracellular matrix macromolecules aggrecan and collagen II. Using colocalization and pulldown studies we further document a noggin-insensitive direct peptide-protein association between LPP and BMP-RII. This association mediated Smad signaling that converges on BMP genes leading to expression of BMP-4 and BMP-7. Furthermore, through a cell-autonomous loop BMP-4 and BMP-7 intensified Smad 1/5 signaling though a feedforward circuit involving BMP-RI, ultimately promoting expression of SOX9 and downstream aggrecan and collagen II genes. Our data define a complex regulatory signaling cascade initiated by LPP and suggest that LPP may be a useful therapeutic substitute for direct BMP administration to treat IVD degeneration and to ameliorate IVD-associated chronic low back pain.	[Wang, Zili; Weitzmann, M. Neale; Sangadala, Sreedhara; Hutton, William C.; Yoon, S. Tim] Vet Affairs Med Ctr, Atlanta Dept, Decatur, GA 30033 USA; [Wang, Zili; Sangadala, Sreedhara; Hutton, William C.; Yoon, S. Tim] Emory Univ, Sch Med, Emory Spine Ctr, Atlanta, GA 30322 USA; [Weitzmann, M. Neale] Emory Univ, Sch Med, Dept Med, Div Endocrinol & Metab & Lipids, Atlanta, GA 30322 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); Emory University; Emory University	Wang, ZL (corresponding author), Atlanta VA Med Ctr, Res Bldg,Rm 4A-189,1670 Clairmont Rd, Decatur, GA 30033 USA.	zwang084@gmail.com			Atlanta Research and Education Foundation, Atlanta Veterans Affairs Medical Center; Biomedical Laboratory Research and Development Service of the Veterans Affairs Office of Research and Development [5I01BX000105]; National Institutes of Health through the NIAMS [R01AR059364]; National Institutes of Health through the NIA [R01AG040013]	Atlanta Research and Education Foundation, Atlanta Veterans Affairs Medical Center; Biomedical Laboratory Research and Development Service of the Veterans Affairs Office of Research and Development; National Institutes of Health through the NIAMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); National Institutes of Health through the NIA	This work was supported by Atlanta Research and Education Foundation, Atlanta Veterans Affairs Medical Center (to S.T.Y.).; Supported by Grant 5I01BX000105 from the Biomedical Laboratory Research and Development Service of the Veterans Affairs Office of Research and Development and National Institutes of Health Awards R01AR059364 through the NIAMS and R01AG040013 through the NIA.	Akiyama H, 2002, GENE DEV, V16, P2813, DOI 10.1101/gad.1017802; An HS, 2005, SPINE, V30, P25, DOI 10.1097/01.brs.0000148002.68656.4d; Andersson GBJ, 1999, LANCET, V354, P581, DOI 10.1016/S0140-6736(99)01312-4; Antoniou J, 1996, J CLIN INVEST, V98, P996, DOI 10.1172/JCI118884; Bi WM, 1999, NAT GENET, V22, P85, DOI 10.1038/8792; Bogduk N, 1991, Neurosurg Clin N Am, V2, P791; Boswell Mark V, 2007, Pain Physician, V10, P7; Carragee EJ, 2011, SPINE J, V11, P471, DOI 10.1016/j.spinee.2011.04.023; Cohen EEW, 2009, CANCER RES, V69, P65, DOI 10.1158/0008-5472.CAN-08-0377; Colombini A, 2008, INT J BIOCHEM CELL B, V40, P837, DOI 10.1016/j.biocel.2007.12.011; Derynck R, 1997, BBA-REV CANCER, V1333, pF105, DOI 10.1016/S0304-419X(97)00017-6; FALTZ LL, 1979, J BIOL CHEM, V254, P1381; Fassett DR, 2009, J SPINAL DISORD TECH, V22, P297, DOI 10.1097/BSD.0b013e31816d5f64; Freemont AJ, 2009, RHEUMATOLOGY, V48, P5, DOI 10.1093/rheumatology/ken396; Hao JJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002904; HARDINGHAM TE, 1979, BIOCHEM J, V177, P237, DOI 10.1042/bj1770237; Hoy D, 2012, ARTHRITIS RHEUM-US, V64, P2028, DOI 10.1002/art.34347; Hsiao CJ, 2010, CTR DIS CONTROL PREV, V27, P1; Inman GJ, 2002, MOL PHARMACOL, V62, P65, DOI 10.1124/mol.62.1.65; Karppinen J, 2011, ORTHOP CLIN N AM, V42, P513, DOI 10.1016/j.ocl.2011.07.009; Kawakami Y, 2005, P NATL ACAD SCI USA, V102, P2414, DOI 10.1073/pnas.0407510102; Kepler CK, 2011, J AM ACAD ORTHOP SUR, V19, P543, DOI 10.5435/00124635-201109000-00005; KIMURA JH, 1980, J BIOL CHEM, V255, P7134; Kishi S, 2011, J BIOL CHEM, V286, P32162, DOI 10.1074/jbc.M111.244541; Le Maitre CL, 2007, BIOCHEM SOC T, V35, P652, DOI 10.1042/BST0350652; Li Jun, 2003, J Orthop Sci, V8, P829, DOI 10.1007/s00776-003-0719-6; Liu H., 1997, BIOCHEM SOC T, V25, p427S; Liu HX, 1999, BBA-GEN SUBJECTS, V1428, P191, DOI 10.1016/S0304-4165(99)00074-4; Masuda K, 2003, J ORTHOP RES, V21, P922, DOI 10.1016/S0736-0266(03)00037-8; Masuda K, 2008, EUR SPINE J, V17, pS441, DOI 10.1007/s00586-008-0749-z; McKenna LA, 1998, ARTHRITIS RHEUM, V41, P157, DOI 10.1002/1529-0131(199801)41:1<157::AID-ART19>3.0.CO;2-J; McMahon JA, 1998, GENE DEV, V12, P1438, DOI 10.1101/gad.12.10.1438; MORGELIN M, 1988, BIOCHEM J, V253, P175; Mwale F, 2003, J CELL BIOCHEM, V88, P1202, DOI 10.1002/jcb.10479; Petit A, 2011, TISSUE ENG PT A, V17, P899, DOI [10.1089/ten.tea.2010.0494, 10.1089/ten.TEA.2010.0494]; Roughley P, 2006, EUR CELLS MATER, V11, P1; Roughley PJ, 2002, BIOCHEM SOC T, V30, P869, DOI 10.1042/BST0300869; Seyfried NT, 2005, J BIOL CHEM, V280, P5435, DOI 10.1074/jbc.M411297200; Wan DC, 2007, J BIOL CHEM, V282, P26450, DOI 10.1074/jbc.M703282200; Yoon ST, 2006, EUR SPINE J, V15, pS379, DOI 10.1007/s00586-006-0155-3; Yui PB, 2008, NAT CHEM BIOL, V4, P33, DOI 10.1038/nchembio.2007.54; Zhao Q, 1997, DEV DYNAM, V209, P377, DOI 10.1002/(SICI)1097-0177(199708)209:4<377::AID-AJA5>3.0.CO;2-F	42	29	31	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 27	2013	288	39					28243	28253		10.1074/jbc.M113.451948	http://dx.doi.org/10.1074/jbc.M113.451948			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302OB	23940040	Green Published, hybrid			2022-12-25	WOS:000330612800046
J	Ahmed, AH; Ptak, CP; Fenwick, MK; Hsieh, CL; Weiland, GA; Oswald, RE				Ahmed, Ahmed H.; Ptak, Christopher P.; Fenwick, Michael K.; Hsieh, Ching-Lin; Weiland, Gregory A.; Oswald, Robert E.			Dynamics of Cleft Closure of the GluA2 Ligand-binding Domain in the Presence of Full and Partial Agonists Revealed by Hydrogen-Deuterium Exchange	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLUTAMATE-RECEPTOR; AMPA RECEPTOR; KAINATE RECEPTORS; NMR-SPECTROSCOPY; ACTIVATION; DESENSITIZATION; MECHANISMS; WILLARDIINE; DERIVATIVES; COMPLEXES	The majority of excitatory neurotransmission in the CNS is mediated by tetrameric AMPA receptors. Channel activation begins with a series of interactions with an agonist that binds to the cleft between the two lobes of the ligand-binding domain of each subunit. Binding leads to a series of conformational transitions, including the closure of the two lobes of the binding domain around the ligand, culminating in ion channel opening. Although a great deal has been learned from crystal structures, determining the molecular details of channel activation, deactivation, and desensitization requires measures of dynamics and stabilities of hydrogen bonds that stabilize cleft closure. The use of hydrogen-deuterium exchange at low pH provides a measure of the variation of stability of specific hydrogen bonds among agonists of different efficacy. Here, we used NMR measurements of hydrogen-deuterium exchange to determine the stability of hydrogen bonds in the GluA2 (AMPA receptor) ligand-binding domain in the presence of several full and partial agonists. The results suggest that the stabilization of hydrogen bonds between the two lobes of the binding domain is weaker for partial than for full agonists, and efficacy is correlated with the stability of these hydrogen bonds. The closure of the lobes around the agonists leads to a destabilization of the hydrogen bonding in another portion of the lobe interface, and removing an electrostatic interaction in Lobe 2 can relieve the strain. These results provide new details of transitions in the binding domain that are associated with channel activation and desensitization.	[Ahmed, Ahmed H.; Ptak, Christopher P.; Weiland, Gregory A.; Oswald, Robert E.] Cornell Univ, Dept Mol Med, Ithaca, NY 14853 USA; [Fenwick, Michael K.] Cornell Univ, Dept Chem & Chem Biol, Ithaca, NY 14853 USA; [Hsieh, Ching-Lin] Cornell Univ, Dept Populat Med & Diagnost Sci, Ithaca, NY 14853 USA	Cornell University; Cornell University; Cornell University	Oswald, RE (corresponding author), Cornell Univ, Dept Mol Med, Ithaca, NY 14853 USA.	reo1@cornell.edu	Ptak, Christopher/I-3126-2012; Ptak, Christopher/AAP-7763-2021; Hsieh, Ching-Lin/ABA-6461-2021; Hsieh, Ching-Lin/K-4139-2018; HSIEH, CHING-LIN/G-6057-2011	Ptak, Christopher/0000-0003-2752-0367; Ptak, Christopher/0000-0003-2752-0367; Hsieh, Ching-Lin/0000-0002-3665-5717; HSIEH, CHING-LIN/0000-0001-9468-9969	National Institutes of Health [R01 GM068935]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM068935] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 GM068935 (to R. E. O.).	Abele R, 2000, J BIOL CHEM, V275, P21355, DOI 10.1074/jbc.M909883199; Ahmed AH, 2011, J BIOL CHEM, V286, P35257, DOI 10.1074/jbc.M111.269001; Ahmed AH, 2010, BIOCHEMISTRY-US, V49, P2843, DOI 10.1021/bi1000678; Ahmed AH, 2009, PROTEINS, V75, P628, DOI 10.1002/prot.22274; Ahmed AH, 2007, J BIOL CHEM, V282, P12773, DOI 10.1074/jbc.M610077200; Armstrong N, 2000, NEURON, V28, P165, DOI 10.1016/S0896-6273(00)00094-5; BERGER ARIEH, 1957, ARCH BIOCHEM AND BIOPHYS, V69, P106, DOI 10.1016/0003-9861(57)90478-2; Carbone AL, 2012, NEURON, V74, P845, DOI 10.1016/j.neuron.2012.04.020; Chen GQ, 1997, P NATL ACAD SCI USA, V94, P13431, DOI 10.1073/pnas.94.25.13431; Englander SW, 1996, CURR OPIN STRUC BIOL, V6, P18, DOI 10.1016/S0959-440X(96)80090-X; Fenwick MK, 2007, BIOMOL NMR ASSIGN, V1, P241, DOI 10.1007/s12104-007-9067-3; Fenwick MK, 2008, J MOL BIOL, V378, P673, DOI 10.1016/j.jmb.2008.03.012; Fenwick MK, 2010, J BIOL CHEM, V285, P12334, DOI 10.1074/jbc.M109.086371; Goddard T.D., SPARKY 3; HOLLMANN M, 1994, ANNU REV NEUROSCI, V17, P31, DOI 10.1146/annurev.ne.17.030194.000335; HVIDT AASE, 1966, ADVANCE PROTEIN CHEM, V21, P287, DOI 10.1016/S0065-3233(08)60129-1; Jin RS, 2003, NAT NEUROSCI, V6, P803, DOI 10.1038/nn1091; Kumar J, 2013, ANNU REV PHYSIOL, V75, P313, DOI 10.1146/annurev-physiol-030212-183711; Lidak M. Y., 1972, CHEM HETEROCYCL COMP, V8, P644; Madden DR, 2000, EUR J BIOCHEM, V267, P4281; Maltsev AS, 2008, BIOCHEMISTRY-US, V47, P10600, DOI 10.1021/bi800843c; Maltsev AS, 2010, J BIOL CHEM, V285, P10154, DOI 10.1074/jbc.M109.088641; PARTIN KM, 1993, NEURON, V11, P1069, DOI 10.1016/0896-6273(93)90220-L; PATNEAU DK, 1992, J NEUROSCI, V12, P595; PATNEAU DK, 1991, NEURON, V6, P785, DOI 10.1016/0896-6273(91)90175-Y; Poon K, 2011, MOL PHARMACOL, V80, P49, DOI 10.1124/mol.111.071688; Sekiguchi M, 1997, J NEUROSCI, V17, P5760; Sobolevsky AI, 2009, NATURE, V462, P745, DOI 10.1038/nature08624; SOMMER B, 1990, SCIENCE, V249, P1580, DOI 10.1126/science.1699275; Sun Y, 2002, NATURE, V417, P245, DOI 10.1038/417245a; Traynelis SF, 2010, PHARMACOL REV, V62, P405, DOI 10.1124/pr.109.002451; WEMPEN I, 1964, J AM CHEM SOC, V86, P2474, DOI 10.1021/ja01066a034	32	22	23	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 20	2013	288	38					27658	27666		10.1074/jbc.M113.495564	http://dx.doi.org/10.1074/jbc.M113.495564			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302IG	23940029	Green Published, hybrid			2022-12-25	WOS:000330597300059
J	Shi, H; Cui, WS; He, XX; Guo, QP; Wang, KM; Ye, XS; Tang, JL				Shi, Hui; Cui, Wensi; He, Xiaoxiao; Guo, Qiuping; Wang, Kemin; Ye, Xiaosheng; Tang, Jinlu			Whole Cell-SELEX Aptamers for Highly Specific Fluorescence Molecular Imaging of Carcinomas In Vivo	PLOS ONE			English	Article							CANCER-CELLS; LUNG-CANCER; PROBES; RECOGNITION; LIGANDS; TUMORS; NANOPARTICLES; SELECTION	Background: Carcinomas make up the majority of cancers. Their accurate and specific diagnoses are of great significance for the improvement of patients' curability. Methodology/Principal Findings: In this paper, we report an effectual example of the in vivo fluorescence molecular imaging of carcinomas with extremely high specificity based on whole cell-SELEX aptamers. Firstly, S6, an aptamer against A549 lung carcinoma cells, was adopted and labeled with Cy5 to serve as a molecular imaging probe. Flow cytometry assays revealed that Cy5-S6 could not only specifically label in vitro cultured A549 cells in buffer, but also successfully achieve the detection of ex vivo cultured target cells in serum. When applied to in vivo imaging, Cy5-S6 was demonstrated to possess high specificity in identifying A549 carcinoma through a systematic comparison investigation. Particularly, after Cy5-S6 was intravenously injected into nude mice which were simultaneously grafted with A549 lung carcinoma and Tca8113 tongue carcinoma, a much longer retention time of Cy5-S6 in A549 tumor was observed and a clear targeted cancer imaging result was presented. On this basis, to further promote the application to imaging other carcinomas, LS2 and ZY8, which are two aptamers selected by our group against Bel-7404 and SMMC-7721 liver carcinoma cells respectively, were tested in a similar way, both in vitro and in vivo. Results showed that these aptamers were even effective in differentiating liver carcinomas of different subtypes in the same body. Conclusions/Significance: This work might greatly advance the application of whole cell-SELEX aptamers to carcinomas-related in vivo researches.	[Shi, Hui; He, Xiaoxiao; Guo, Qiuping; Wang, Kemin] Hunan Univ, State Key Lab Chemo Biosensing & Chemometr, Changsha 410082, Hunan, Peoples R China; [Shi, Hui; Wang, Kemin; Ye, Xiaosheng] Hunan Univ, Coll Chem & Chem Engn, Changsha 410082, Hunan, Peoples R China; [Cui, Wensi; He, Xiaoxiao; Guo, Qiuping; Wang, Kemin; Tang, Jinlu] Hunan Univ, Inst Biol, Changsha 410082, Hunan, Peoples R China; [Shi, Hui; Cui, Wensi; He, Xiaoxiao; Guo, Qiuping; Wang, Kemin; Ye, Xiaosheng; Tang, Jinlu] Key Lab Bionanotechnol & Mol Engn Hunan Prov, Changsha, Hunan, Peoples R China	Hunan University; Hunan University; Hunan University	He, XX (corresponding author), Hunan Univ, State Key Lab Chemo Biosensing & Chemometr, Changsha 410082, Hunan, Peoples R China.	xiaoxiaohe@hnu.edu.cn; kmwang@hnu.edu.cn		tang, jinlu/0000-0001-9666-8758	Key Project of Natural Science Foundation of China [21175039, 21190041, 21190044]; International Science & Technology Cooperation Program of China [2010DFB30300]; Key Technologies Research and Development Program of China [2011AA02a114]; Research Fund for the Doctoral Program of Higher Education of China [20110161110016]; Hunan Provincial Natural Science Foundation; Hunan Provincial Science and Technology Plan of China [10JJ7002, 2012TT1003]	Key Project of Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); International Science & Technology Cooperation Program of China; Key Technologies Research and Development Program of China(National Key Technology R&D Program); Research Fund for the Doctoral Program of Higher Education of China(Research Fund for the Doctoral Program of Higher Education of China (RFDP)Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); Hunan Provincial Natural Science Foundation(Natural Science Foundation of Hunan Province); Hunan Provincial Science and Technology Plan of China	This work was supported in part by the Key Project of Natural Science Foundation of China (grants 21175039, 21190041 and 21190044), International Science & Technology Cooperation Program of China (grant 2010DFB30300), Key Technologies Research and Development Program of China (grant 2011AA02a114), Research Fund for the Doctoral Program of Higher Education of China (grant 20110161110016) and the project supported by Hunan Provincial Natural Science Foundation and Hunan Provincial Science and Technology Plan of China (grants 10JJ7002, and 2012TT1003). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Backer MV, 2007, NAT MED, V13, P504, DOI 10.1038/nm1522; Bamrungsap S, 2012, ACS NANO, V6, P3974, DOI 10.1021/nn3002328; Becker A, 2001, NAT BIOTECHNOL, V19, P327, DOI 10.1038/86707; Berman JJ, 2004, BMC CANCER, V4, DOI 10.1186/1471-2407-4-88; Blum G, 2007, NAT CHEM BIOL, V3, P668, DOI 10.1038/nchembio.2007.26; Chen HW, 2008, CHEMMEDCHEM, V3, P991, DOI 10.1002/cmdc.200800030; Coudert B, 2001, EUR J CANCER, V37, P2194, DOI 10.1016/S0959-8049(01)00286-6; Ding CF, 2012, CHEM-EUR J, V18, P7263, DOI 10.1002/chem.201104019; ELLINGTON AD, 1990, NATURE, V346, P818, DOI 10.1038/346818a0; Fang XH, 2010, ACCOUNTS CHEM RES, V43, P48, DOI 10.1021/ar900101s; Ferreira CSM, 2009, NUCLEIC ACIDS RES, V37, P866, DOI 10.1093/nar/gkn967; Forner A, 2012, LANCET, V379, P1245, DOI 10.1016/S0140-6736(11)61347-0; Guo Q, 2013, CHINESE SCI IN PRESS; Hong H, 2011, CURR MED CHEM, V18, P4195, DOI 10.2174/092986711797189691; Jemal A, 2007, CA-CANCER J CLIN, V57, P43, DOI 10.3322/canjclin.57.1.43; LEDERLE FA, 1994, ARCH INTERN MED, V154, P2397, DOI 10.1001/archinte.154.21.2397; Massoud TF, 2003, GENE DEV, V17, P545, DOI 10.1101/gad.1047403; Sefah K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014269; Shangguan DH, 2007, CLIN CHEM, V53, P1153, DOI 10.1373/clinchem.2006.083246; Shangguan D, 2006, P NATL ACAD SCI USA, V103, P11838, DOI 10.1073/pnas.0602615103; Shi H, 2011, P NATL ACAD SCI USA, V108, P3900, DOI 10.1073/pnas.1016197108; Shi H, 2010, CHEM-ASIAN J, V5, P2209, DOI 10.1002/asia.201000242; Simaeys DV, 2010, PLOS ONE, V5, P13770; Tang ZW, 2007, ANAL CHEM, V79, P4900, DOI 10.1021/ac070189y; Tavitian B, 1998, NAT MED, V4, P467, DOI 10.1038/nm0498-467; TUERK C, 1990, SCIENCE, V249, P505, DOI 10.1126/science.2200121; Urano Y, 2009, NAT MED, V15, P104, DOI 10.1038/nm.1854; Weissleder R, 1999, NAT BIOTECHNOL, V17, P375, DOI 10.1038/7933; Wu YR, 2010, P NATL ACAD SCI USA, V107, P5, DOI 10.1073/pnas.0909611107; Zhao ZL, 2009, ANALYST, V134, P1808, DOI 10.1039/b904476k	30	46	47	4	106	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2013	8	8							e70476	10.1371/journal.pone.0070476	http://dx.doi.org/10.1371/journal.pone.0070476			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	200UV	23950940	gold, Green Published, Green Submitted			2022-12-25	WOS:000323097300019
J	De Francesco, EM; Angelone, T; Pasqua, T; Pupo, M; Cerra, MC; Maggiolini, M				De Francesco, Ernestina Marianna; Angelone, Tommaso; Pasqua, Teresa; Pupo, Marco; Cerra, Maria Carmela; Maggiolini, Marcello			GPER Mediates Cardiotropic Effects in Spontaneously Hypertensive Rat Hearts	PLOS ONE			English	Article							GENE-EXPRESSION CHANGES; COUPLED RECEPTOR GPR30; NITRIC-OXIDE SYNTHASE; BREAST-CANCER CELLS; ESTROGEN-RECEPTOR; G-PROTEIN; SIGNALING PATHWAYS; REPERFUSION INJURY; S-NITROSYLATION; UP-REGULATION	Estrogens promote beneficial effects in the cardiovascular system mainly through the estrogen receptor (ER)alpha and ER beta, which act as ligand-gated transcription factors. Recently, the G protein-coupled estrogen receptor (GPER) has been implicated in the estrogenic signaling in diverse tissues, including the cardiovascular system. In this study, we demonstrate that left ventricles of male Spontaneously Hypertensive Rats (SHR) express higher levels of GPER compared to normotensive Wistar Kyoto (WKY) rats. In addition, we show that the selective GPER agonist G-1 induces negative inotropic and lusitropic effects to a higher extent in isolated and Langendorff perfused hearts of male SHR compared to WKY rats. These cardiotropic effects elicited by G-1 involved the GPER/eNOS transduction signaling, as determined by using the GPER antagonist G15 and the eNOS inhibitor L-NIO. Similarly, the G-1 induced activation of ERK1/2, AKT, GSK3 beta, c-Jun and eNOS was abrogated by G15, while L-NIO prevented only the eNOS phosphorylation. In hypoxic Langendorff perfused WKY rat heart preparations, we also found an increased expression of GPER along with that of the hypoxic mediator HIF-1 alpha and the fibrotic marker CTGF. Interestingly, G15 and L-NIO prevented the ability of G-1 to down-regulate the expression of both HIF-1 alpha and CTGF, which were found expressed to a higher extent in SHR compared to WKY rat hearts. Collectively, the present study provides novel data into the potential role played by GPER in hypertensive disease on the basis of its involvement in myocardial inotropism and lusitropism as well as the expression of the apoptotic HIF-1 alpha and fibrotic CTGF factors. Hence, GPER may be considered as a useful target in the treatment of some cardiac dysfunctions associated with stressful conditions like the essential hypertension.	[De Francesco, Ernestina Marianna; Pupo, Marco; Maggiolini, Marcello] Univ Calabria, Dept Pharm Hlth & Nutr Sci, I-87036 Cosenza, Italy; [Angelone, Tommaso; Pasqua, Teresa; Cerra, Maria Carmela] Univ Calabria, Dept Biol Ecol & Earth Sci, I-87036 Cosenza, Italy	University of Calabria; University of Calabria	Cerra, MC (corresponding author), Univ Calabria, Dept Biol Ecol & Earth Sci, I-87036 Cosenza, Italy.	cerramc@unical.it; marcellomaggiolini@yahoo.it	Angelone, Tommaso/AAM-1230-2020; Pasqua, Teresa/AAA-9067-2022; Maggiolini, Marcello/Z-4729-2019	Angelone, Tommaso/0000-0001-7797-7862; Cerra, Maria Carmela/0000-0002-2091-928X; Maggiolini, Marcello/0000-0002-7485-854X	Associazione Italiana per la Ricerca sul Cancro (biennial fellowship "Isabella Adonio Curcio"); Animal Biology of the PhD School "Life Sciences" at the University of Calabria; Associazione Italiana per la Ricerca sul Cancro (AIRC) [12849/2012]; Fondazione Cassa di Risparmio di Calabria e Lucania; AIRC project Calabria	Associazione Italiana per la Ricerca sul Cancro (biennial fellowship "Isabella Adonio Curcio")(Fondazione AIRC per la ricerca sul cancro); Animal Biology of the PhD School "Life Sciences" at the University of Calabria; Associazione Italiana per la Ricerca sul Cancro (AIRC)(Fondazione AIRC per la ricerca sul cancro); Fondazione Cassa di Risparmio di Calabria e Lucania; AIRC project Calabria(Fondazione AIRC per la ricerca sul cancro)	EMDF was supported by Associazione Italiana per la Ricerca sul Cancro (biennial fellowship "Isabella Adonio Curcio"); EMDF, TA and MCC were supported by PhD course in Animal Biology of the PhD School "Life Sciences" at the University of Calabria; MM was supported by Associazione Italiana per la Ricerca sul Cancro (AIRC, project n. 12849/2012), AIRC project Calabria 2011 (http://www.airc.it/) and Fondazione Cassa di Risparmio di Calabria e Lucania. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adhikary G, 2000, ADV EXP MED BIOL, V475, P285; Albanito L, 2007, CANCER RES, V67, P1859, DOI 10.1158/0008-5472.CAN-06-2909; Angelone T, 2012, NUTR METAB CARDIOVAS, V22, P486, DOI 10.1016/j.numecd.2010.07.014; Angelone T, 2012, AM J PHYSIOL-HEART C, V302, pH431, DOI 10.1152/ajpheart.00491.2011; Ao Qilin, 2004, J Huazhong Univ Sci Technolog Med Sci, V24, P5; Barton M, 2012, STEROIDS, V77, P935, DOI 10.1016/j.steroids.2012.04.001; Bertrand J, 2012, ONCOGENE, V31, P694, DOI 10.1038/onc.2011.258; Chimento A, 2010, MOL CELL ENDOCRINOL, V320, P136, DOI 10.1016/j.mce.2010.01.035; Czibik G, 2010, J MOL MED, V88, P1101, DOI 10.1007/s00109-010-0646-x; Delbeck M, 2011, MOL MED REP, V4, P37, DOI 10.3892/mmr.2010.402; Denger S, 2001, MOL ENDOCRINOL, V15, P2064, DOI 10.1210/me.15.12.2064; Dennis MK, 2009, NAT CHEM BIOL, V5, P421, DOI 10.1038/nchembio.168; Deschamps AM, 2009, AM J PHYSIOL-HEART C, V297, pH1806, DOI 10.1152/ajpheart.00283.2009; Doggrell SA, 1998, CARDIOVASC RES, V39, P89, DOI 10.1016/S0008-6363(98)00076-5; Filardo EJ, 2000, MOL ENDOCRINOL, V14, P1649, DOI 10.1210/me.14.10.1649; Filice E, 2009, J PHYSIOL PHARMACOL, V60, P3; Filice E, 2011, CELL PHYSIOL BIOCHEM, V28, P41, DOI 10.1159/000331712; Greijer AE, 2004, J CLIN PATHOL, V57, P1009, DOI 10.1136/jcp.2003.015032; Haas E, 2009, CIRC RES, V104, P288, DOI 10.1161/CIRCRESAHA.108.190892; Hausenloy DJ, 2007, HEART FAIL REV, V12, P217, DOI 10.1007/s10741-007-9026-1; Huang LE, 1999, J BIOL CHEM, V274, P9038, DOI 10.1074/jbc.274.13.9038; Jessup JA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015433; Kang LG, 2010, MOL ENDOCRINOL, V24, P709, DOI 10.1210/me.2009-0317; Katoh M, 2006, CANCER BIOL THER, V5, P1059, DOI 10.4161/cbt.5.9.3151; Krick S, 2005, AM J RESP CELL MOL, V32, P395, DOI 10.1165/rcmb.2004-0314OC; Kuiper GGJM, 1996, P NATL ACAD SCI USA, V93, P5925, DOI 10.1073/pnas.93.12.5925; Kuwahara F, 2002, HYPERTENSION, V39, P46, DOI 10.1161/hy1201.097200; Lappano R, 2012, CURR CANCER DRUG TAR, V12, P531, DOI 10.2174/156800912800673284; Lappano R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016631; Lappano R, 2010, MOL CELL ENDOCRINOL, V320, P162, DOI 10.1016/j.mce.2010.02.006; Lei L, 2008, MOL CELL BIOL, V28, P3790, DOI 10.1128/MCB.01580-07; Lindsey SH, 2009, ENDOCRINOLOGY, V150, P3753, DOI 10.1210/en.2008-1664; Madeo A, 2010, CANCER RES, V70, P6036, DOI 10.1158/0008-5472.CAN-10-0408; Maggiolini M, 1999, BIOL CHEM, V380, P695, DOI 10.1515/BC.1999.086; Maggiolini M, 2004, J BIOL CHEM, V279, P27008, DOI 10.1074/jbc.M403588200; Maggiolini M, 2010, J ENDOCRINOL, V204, P105, DOI 10.1677/JOE-09-0242; Mendelsohn ME, 1999, NEW ENGL J MED, V340, P1801, DOI 10.1056/NEJM199906103402306; Mendelsohn ME, 2002, AM J CARDIOL, V89, p12E; Meyer MR, 2011, VASC PHARMACOL, V55, P17, DOI 10.1016/j.vph.2011.06.003; Meyer MR, 2009, MOL CELL ENDOCRINOL, V308, P9, DOI 10.1016/j.mce.2009.03.009; Mitchell GF, 1997, AM J HYPERTENS, V10, pS120; MORLEY P, 1992, ENDOCRINOLOGY, V131, P1305, DOI 10.1210/en.131.3.1305; Murphy E, 2011, CIRC RES, V109, P687, DOI 10.1161/CIRCRESAHA.110.236687; Pandey DP, 2009, EMBO J, V28, P523, DOI 10.1038/emboj.2008.304; Panno ML, 1996, J CANCER RES CLIN, V122, P745, DOI 10.1007/BF01209122; Park JH, 2012, BIOCHEM BIOPH RES CO, V417, P340, DOI 10.1016/j.bbrc.2011.11.112; Patel VH, 2010, INT J MOL MED, V26, P193, DOI 10.3892/ijmm_00000452; Pedram A, 2006, MOL ENDOCRINOL, V20, P1996, DOI 10.1210/me.2005-0525; Penna C, 2008, J CELL MOL MED, V12, P435, DOI 10.1111/j.1582-4934.2007.00210.x; Prossnitz ER, 2011, NAT REV ENDOCRINOL, V7, P715, DOI 10.1038/nrendo.2011.122; Prossnitz ER, 2009, MOL CELL ENDOCRINOL, V308, P32, DOI 10.1016/j.mce.2009.03.026; Pupo M, 2012, ENVIRON HEALTH PERSP, V120, P1177, DOI 10.1289/ehp.1104526; Recchia AG, 2011, J BIOL CHEM, V286, P10773, DOI 10.1074/jbc.M110.172247; Revankar CM, 2005, SCIENCE, V307, P1625, DOI 10.1126/science.1106943; Schulman D, 2002, AM J PHYSIOL-HEART C, V283, pH1481, DOI 10.1152/ajpheart.01089.2001; Semenza GL, 2001, CURR OPIN CELL BIOL, V13, P167, DOI 10.1016/S0955-0674(00)00194-0; Semenza GL, 2007, ANTIOXID REDOX SIGN, V9, P1391, DOI 10.1089/ars.2007.1691; Semenza Gregg L, 2006, Novartis Found Symp, V272, P2; Sogawa K, 1998, P NATL ACAD SCI USA, V95, P7368, DOI 10.1073/pnas.95.13.7368; Thomas P, 2005, ENDOCRINOLOGY, V146, P624, DOI 10.1210/en.2004-1064; Vitale C, 2010, FUND CLIN PHARMACOL, V24, P675, DOI 10.1111/j.1472-8206.2010.00817.x; Vivacqua A, 2006, MOL ENDOCRINOL, V20, P631, DOI 10.1210/me.2005-0280; Vivacqua A, 2006, MOL PHARMACOL, V70, P1414, DOI 10.1124/mol.106.026344; Vivacqua A, 2012, BREAST CANCER RES TR, V133, P1025, DOI 10.1007/s10549-011-1901-8; Wang H, 2012, CARDIOVASC RES, V94, P96, DOI 10.1093/cvr/cvs090; Wang ZY, 2005, BIOCHEM BIOPH RES CO, V336, P1023, DOI 10.1016/j.bbrc.2005.08.226; Weil BR, 2010, SURGERY, V148, P436, DOI 10.1016/j.surg.2010.03.011; Wyckoff MH, 2001, J BIOL CHEM, V276, P27071, DOI 10.1074/jbc.M100312200	68	40	40	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 9	2013	8	8							e69322	10.1371/journal.pone.0069322	http://dx.doi.org/10.1371/journal.pone.0069322			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	245OM	23950890	Green Published, gold, Green Submitted			2022-12-25	WOS:000326473200005
J	Lee, K; Huang, XQ; Yang, CC; Lee, D; Ho, V; Nobuta, K; Fan, JB; Wang, K				Lee, Keunsub; Huang, Xiaoqiu; Yang, Chichun; Lee, Danny; Ho, Vincent; Nobuta, Kan; Fan, Jian-Bing; Wang, Kan			A Genome-Wide Survey of Highly Expressed Non-Coding RNAs and Biological Validation of Selected Candidates in Agrobacterium tumefaciens	PLOS ONE			English	Article							COLE1 PLASMID REPLICATION; ANTISENSE RNA; MESSENGER-RNA; PLANT PATHOGEN; RIBOSOMAL-RNA; SOLUBLE-RNAS; DIFFERENTIAL EXPRESSION; REGULATES EXPRESSION; GENE-EXPRESSION; DUAL-FUNCTION	Agrobacterium tumefaciens is a plant pathogen that has the natural ability of delivering and integrating a piece of its own DNA into plant genome. Although bacterial non-coding RNAs (ncRNAs) have been shown to regulate various biological processes including virulence, we have limited knowledge of how Agrobacterium ncRNAs regulate this unique inter-Kingdom gene transfer. Using whole transcriptome sequencing and an ncRNA search algorithm developed for this work, we identified 475 highly expressed candidate ncRNAs from A. tumefaciens C58, including 101 trans-encoded small RNAs (sRNAs), 354 antisense RNAs (asRNAs), 20 5' untranslated region (UTR) leaders including a RNA thermosensor and 6 riboswitches. Moreover, transcription start site (TSS) mapping analysis revealed that about 51% of the mapped mRNAs have 5' UTRs longer than 60 nt, suggesting that numerous cis-acting regulatory elements might be encoded in the A. tumefaciens genome. Eighteen asRNAs were found on the complementary strands of virA, virB, virC, virD, and virE operons. Fifteen ncRNAs were induced and 7 were suppressed by the Agrobacterium virulence (vir) gene inducer acetosyringone (AS), a phenolic compound secreted by the plants. Interestingly, fourteen of the AS-induced ncRNAs have putative vir box sequences in the upstream regions. We experimentally validated expression of 36 ncRNAs using Northern blot and Rapid Amplification of cDNA Ends analyses. We show functional relevance of two 5' UTR elements: a RNA thermonsensor (C1_109596F) that may regulate translation of the major cold shock protein cspA, and a thi-box riboswitch (C1_2541934R) that may transcriptionally regulate a thiamine biosynthesis operon, thiCOGG. Further studies on ncRNAs functions in this bacterium may provide insights and strategies that can be used to better manage pathogenic bacteria for plants and to improve Agrobacterum-mediated plant transformation.	[Lee, Keunsub; Yang, Chichun; Wang, Kan] Iowa State Univ, Inst Plant Sci, Ctr Plant Transformat, Ames, IA 50011 USA; [Lee, Keunsub; Yang, Chichun; Wang, Kan] Iowa State Univ, Dept Agron, Ames, IA USA; [Huang, Xiaoqiu] Iowa State Univ, Dept Comp Sci, Ames, IA USA; [Lee, Danny; Ho, Vincent; Nobuta, Kan; Fan, Jian-Bing] Illumina Inc, Sci Res, San Diego, CA USA	Iowa State University; Iowa State University; Iowa State University; Illumina	Wang, K (corresponding author), Iowa State Univ, Inst Plant Sci, Ctr Plant Transformat, Ames, IA 50011 USA.	kanwang@iastate.edu	Wang, Kan/X-2324-2019; Lee, Keunsub/AAI-3673-2020	Lee, Keunsub/0000-0002-3174-2475	Iowa State University Plant Sciences Institute	Iowa State University Plant Sciences Institute	This work was supported by Iowa State University Plant Sciences Institute. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alkan C, 2006, J COMPUT BIOL, V13, P267, DOI 10.1089/cmb.2006.13.267; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; BANTA LM, 1994, J BACTERIOL, V176, P3242, DOI 10.1128/jb.176.11.3242-3249.1994; BELASCO JG, 1988, GENE, V72, P15, DOI 10.1016/0378-1119(88)90123-0; Bullard JH, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-94; Cascales E, 2004, P NATL ACAD SCI USA, V101, P17228, DOI 10.1073/pnas.0405843101; Chai YR, 2005, MOL MICROBIOL, V56, P1574, DOI 10.1111/j.1365-2958.2005.04636.x; Clark MB, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000625; Clemente T, 2006, METH MOL B, V343, P143; Croucher NJ, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp811; Dorazi R, 2003, J THEOR BIOL, V225, P383, DOI 10.1016/S0022-5193(03)00268-6; Dornenburg JE, 2010, MBIO, V1, DOI 10.1128/mBio.00024-10; Duhring U, 2006, P NATL ACAD SCI USA, V103, P7054, DOI 10.1073/pnas.0600927103; Evguenieva-Hackenberg E, 2005, MOL MICROBIOL, V57, P318, DOI 10.1111/j.1365-2958.2005.04662.x; Farran I, 2008, PLANT BIOTECHNOL J, V6, P516, DOI 10.1111/j.1467-7652.2008.00334.x; FIGURSKI DH, 1979, P NATL ACAD SCI USA, V76, P1648, DOI 10.1073/pnas.76.4.1648; Fozo EM, 2008, MOL MICROBIOL, V70, P1076, DOI 10.1111/j.1365-2958.2008.06394.x; Frame BR, 2006, METH MOL B, V343, P185; Gelvin SB, 2006, METH MOL B, V343, P77; Gelvin SB, 2006, METH MOL B, V343, P105; Georg J, 2011, MICROBIOL MOL BIOL R, V75, P286, DOI 10.1128/MMBR.00032-10; Gerhart E, 2005, APPROACHES IDENTIFY; Gimpel M, 2010, MOL MICROBIOL, V76, P990, DOI 10.1111/j.1365-2958.2010.07158.x; Giuliodori AM, 2010, MOL CELL, V37, P21, DOI 10.1016/j.molcel.2009.11.033; Goodner B, 2001, SCIENCE, V294, P2323, DOI 10.1126/science.1066803; GOTTESMAN S, 2010, COLD SPRING HARB PER; Green NJ, 2010, FEBS LETT, V584, P318, DOI 10.1016/j.febslet.2009.11.056; Greenbaum D, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-117; Gripenland J, 2010, NAT REV MICROBIOL, V8, P857, DOI 10.1038/nrmicro2457; Guell M, 2011, NAT REV MICROBIOL, V9, P658, DOI 10.1038/nrmicro2620; Guillier M, 2008, NUCLEIC ACIDS RES, V36, P6781, DOI 10.1093/nar/gkn742; Gullerova M, 2010, COLD SH Q B, V75, P299, DOI 10.1101/sqb.2010.75.048; Gustafson AM, 2002, CAN J MICROBIOL, V48, P821, DOI [10.1139/w02-078, 10.1139/W02-078]; Gygi SP, 1999, MOL CELL BIOL, V19, P1720, DOI 10.1128/mcb.19.3.1720; He FL, 2009, J BACTERIOL, V191, P5802, DOI 10.1128/JB.00451-09; He SM, 2010, NAT METHODS, V7, P807, DOI [10.1038/nmeth.1507, 10.1038/NMETH.1507]; Henkin TM, 2008, GENE DEV, V22, P3383, DOI 10.1101/gad.1747308; Hollands K, 2012, P NATL ACAD SCI USA, V109, P5376, DOI 10.1073/pnas.1112211109; Hu XZ, 2013, P NATL ACAD SCI USA, V110, P678, DOI 10.1073/pnas.1215033110; Ji YD, 1999, J BACTERIOL, V181, P6585, DOI 10.1128/JB.181.21.6585-6590.1999; JIN SG, 1990, J BACTERIOL, V172, P525, DOI 10.1128/jb.172.2.525-530.1990; Johansson J, 2002, CELL, V110, P551, DOI 10.1016/S0092-8674(02)00905-4; Kawano M, 2007, MOL MICROBIOL, V64, P738, DOI 10.1111/j.1365-2958.2007.05688.x; Klusener S, 2010, MOL GENET GENOMICS, V283, P575, DOI 10.1007/s00438-010-0542-7; Krulwich TA, 2011, NAT REV MICROBIOL, V9, P330, DOI 10.1038/nrmicro2549; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/nmeth.1923, 10.1038/NMETH.1923]; Lasa I, 2011, P NATL ACAD SCI USA, V108, P20172, DOI 10.1073/pnas.1113521108; Levine E, 2007, PLOS BIOL, V5, P1998, DOI 10.1371/journal.pbio.0050229; Li H, 2010, BRIEF BIOINFORM, V11, P473, DOI 10.1093/bib/bbq015; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Liu Y, 2010, FEBS LETT, V584, P4325, DOI 10.1016/j.febslet.2010.09.024; Livny J, 2006, NUCLEIC ACIDS RES, V34, P3484, DOI 10.1093/nar/gkl453; Loh E, 2009, CELL, V139, P770, DOI 10.1016/j.cell.2009.08.046; Malmgren C, 1997, J BIOL CHEM, V272, P12508, DOI 10.1074/jbc.272.19.12508; Masse E, 2007, CURR OPIN MICROBIOL, V10, P140, DOI 10.1016/j.mib.2007.03.013; Matthysse AG, 2000, BBA-GENE STRUCT EXPR, V1490, P208, DOI 10.1016/S0167-4781(99)00250-X; Miranda-Rios J, 2001, P NATL ACAD SCI USA, V98, P9736, DOI 10.1073/pnas.161168098; Mitschke J, 2011, P NATL ACAD SCI USA, V108, P2124, DOI 10.1073/pnas.1015154108; Narberhaus F, 2006, FEMS MICROBIOL REV, V30, P3, DOI 10.1111/j.1574-6976.2005.004.x; Naville M, 2010, BRIEF FUNCT GENOMICS, V9, P178, DOI 10.1093/bfgp/elq008; Nelson BK, 2007, PLANT J, V51, P1126, DOI 10.1111/j.1365-313X.2007.03212.x; Paz MM, 2004, EUPHYTICA, V136, P167, DOI 10.1023/B:EUPH.0000030670.36730.a4; PAZOUR GJ, 1990, NUCLEIC ACIDS RES, V18, P6909, DOI 10.1093/nar/18.23.6909; PAZOUR GJ, 1991, NUCLEIC ACIDS RES, V19, P1358, DOI 10.1093/nar/19.6.1358-a; Pitzschke A, 2010, EMBO J, V29, P1021, DOI 10.1038/emboj.2010.8; Saad NY, 2012, J BIOL CHEM; SCHAFER A, 1994, GENE, V145, P69, DOI 10.1016/0378-1119(94)90324-7; Schluter JP, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-245; Sharma CM, 2010, NATURE, V464, P250, DOI 10.1038/nature08756; Sharma CM, 2009, CURR OPIN MICROBIOL, V12, P536, DOI 10.1016/j.mib.2009.07.006; Shearwin KE, 2005, TRENDS GENET, V21, P339, DOI 10.1016/j.tig.2005.04.009; Slater SC, 2009, J BACTERIOL, V191, P2501, DOI 10.1128/JB.01779-08; STACHEL SE, 1985, NATURE, V318, P624, DOI 10.1038/318624a0; Toledo-Arana A, 2009, NATURE, V459, P950, DOI 10.1038/nature08080; TOMIZAWA J, 1984, CELL, V38, P861, DOI 10.1016/0092-8674(84)90281-2; TOMIZAWA J, 1984, CELL, V38, P871, DOI 10.1016/0092-8674(84)90282-4; Tzfira T, 2008, AGROBACTERIUM BIOL B, P735; Valverde C, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-416; Vecerek B, 2003, MOL MICROBIOL, V50, P897, DOI 10.1046/j.1365-2958.2003.03727.x; Venkova-Canova T, 2003, J BACTERIOL, V185, P2402, DOI 10.1128/JB.185.8.2402-2409.2003; Vesper O, 2011, CELL, V147, P147, DOI 10.1016/j.cell.2011.07.047; Vijayan V, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-5-r47; Wadler CS, 2007, P NATL ACAD SCI USA, V104, P20454, DOI 10.1073/pnas.0708102104; Weinberg Z, 2007, NUCLEIC ACIDS RES, V35, P4809, DOI 10.1093/nar/gkm487; Wilms I, 2012, J BACTERIOL, V194, P5209, DOI 10.1128/JB.00510-12; Wilms I, 2012, RNA BIOL, V9, P446, DOI 10.4161/rna.17212; Wilms I, 2011, MOL MICROBIOL, V80, P492, DOI 10.1111/j.1365-2958.2011.07589.x; WINANS SC, 1988, J BACTERIOL, V170, P4047, DOI 10.1128/jb.170.9.4047-4054.1988; Yuan ZC, 2008, CELL MICROBIOL, V10, P2339, DOI 10.1111/j.1462-5822.2008.01215.x; Yuan ZC, 2008, J BACTERIOL, V190, P494, DOI 10.1128/JB.01387-07; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	91	25	25	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2013	8	8							e70720	10.1371/journal.pone.0070720	http://dx.doi.org/10.1371/journal.pone.0070720			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	201ER	23950988	gold, Green Submitted, Green Published			2022-12-25	WOS:000323124000026
J	Ceballos, I; Ruiz, M; Fernandez, C; Pena, R; Rodriguez, A; Sanders, IR				Ceballos, Isabel; Ruiz, Michael; Fernandez, Cristhian; Pena, Ricardo; Rodriguez, Alia; Sanders, Ian R.			The In Vitro Mass-Produced Model Mycorrhizal Fungus, Rhizophagus irregularis, Significantly Increases Yields of the Globally Important Food Security Crop Cassava	PLOS ONE			English	Article							GLOMUS-INTRARADICES; ARBUSCULAR MYCORRHIZA; GENETIC DIVERSITY; CHALLENGE; EXCHANGE; GROWTH	The arbuscular mycorrhizal symbiosis is formed between arbuscular mycorrhizal fungi (AMF) and plant roots. The fungi provide the plant with inorganic phosphate (P). The symbiosis can result in increased plant growth. Although most global food crops naturally form this symbiosis, very few studies have shown that their practical application can lead to large-scale increases in food production. Application of AMF to crops in the tropics is potentially effective for improving yields. However, a main problem of using AMF on a large-scale is producing cheap inoculum in a clean sterile carrier and sufficiently concentrated to cheaply transport. Recently, mass-produced in vitro inoculum of the model mycorrhizal fungus Rhizophagus irregularis became available, potentially making its use viable in tropical agriculture. One of the most globally important food plants in the tropics is cassava. We evaluated the effect of in vitro mass-produced R. irregularis inoculum on the yield of cassava crops at two locations in Colombia. A significant effect of R. irregularis inoculation on yield occurred at both sites. At one site, yield increases were observed irrespective of P fertilization. At the other site, inoculation with AMF and 50% of the normally applied P gave the highest yield. Despite that AMF inoculation resulted in greater food production, economic analyses revealed that AMF inoculation did not give greater return on investment than with conventional cultivation. However, the amount of AMF inoculum used was double the recommended dose and was calculated with European, not Colombian, inoculum prices. R. irregularis can also be manipulated genetically in vitro, leading to improved plant growth. We conclude that application of in vitro R. irregularis is currently a way of increasing cassava yields, that there is a strong potential for it to be economically profitable and that there is enormous potential to improve this efficiency further in the future.	[Ceballos, Isabel; Ruiz, Michael; Rodriguez, Alia] Univ Nacl Colombia, Bogota, Colombia; [Fernandez, Cristhian; Pena, Ricardo] La Salle Univ, Yopal, Colombia; [Sanders, Ian R.] Univ Lausanne, Dept Ecol & Evolut, Lausanne, Switzerland	Universidad Nacional de Colombia; Universidad de La Salle; University of Lausanne	Sanders, IR (corresponding author), Univ Lausanne, Dept Ecol & Evolut, Lausanne, Switzerland.	ian.sanders@unil.ch	Sanders, Ian R/T-9988-2017	Sanders, Ian R/0000-0002-9591-8214; Ceballos R, Isabel C/0000-0002-0368-6349; Fernandez Lizarazo, John Cristhian/0000-0001-9015-7404; Pena Venegas, Ricardo Alexander/0000-0002-4204-9043	Swiss National Science Foundation [IZ70Z0-131311/1]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	The authors thank the Swiss National Science Foundation (http://www.snf.ch) for funding this study with a Joint Research Project awarded to AR and IRS (project number: IZ70Z0-131311/1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angelard C, 2010, CURR BIOL, V20, P1216, DOI 10.1016/j.cub.2010.05.031; Bever JD, 2001, BIOSCIENCE, V51, P923, DOI 10.1641/0006-3568(2001)051[0923:AMFMDT]2.0.CO;2; Borstler B, 2008, NEW PHYTOL, V180, P452, DOI 10.1111/j.1469-8137.2008.02574.x; Colard A, 2011, APPL ENVIRON MICROB, V77, P6510, DOI 10.1128/AEM.05696-11; Croll D, 2009, NEW PHYTOL, V181, P924, DOI 10.1111/j.1469-8137.2008.02726.x; Croll D, 2008, NEW PHYTOL, V178, P672, DOI 10.1111/j.1469-8137.2008.02381.x; Ehinger MO, 2012, NEW PHYTOL, V196, P853, DOI 10.1111/j.1469-8137.2012.04278.x; F.A.O, 2005, P VAL FOR GLOB CASS; FAO, 2013, FAOSTAT; Foresight, 2011, MIGR GLOB ENV CHANG; Friesen DK, 1997, PLANT SOIL, V196, P289, DOI 10.1023/A:1004226708485; Gilbert N, 2009, NATURE, V461, P716, DOI 10.1038/461716a; GIOVANNETTI M, 1980, NEW PHYTOL, V84, P489, DOI 10.1111/j.1469-8137.1980.tb04556.x; Godfray HCJ, 2010, SCIENCE, V327, P812, DOI 10.1126/science.1185383; Gross M, 2010, CURR BIOL, V20, pR386, DOI 10.1016/j.cub.2010.04.031; HOWELER RH, 1983, PLANT SOIL, V75, P245, DOI 10.1007/BF02375570; Kruger M, 2012, NEW PHYTOL, V193, P970, DOI 10.1111/j.1469-8137.2011.03962.x; Martin F, 2008, NEW PHYTOL, V180, P747, DOI 10.1111/j.1469-8137.2008.02671.x; Sanders IR, 2010, ANNU REV GENET, V44, P271, DOI 10.1146/annurev-genet-102108-134239; Schwartz MW, 2006, ECOL LETT, V9, P501, DOI 10.1111/j.1461-0248.2006.00910.x; SIEVERDING E, 1985, PLANT SOIL, V88, P213, DOI 10.1007/BF02182447; Sieverding E., 1991, SCHRIFTENREIHE GTZ G; Smith S.E., 2008, MYCORRHIZAL SYMBIOSI, V3rd ed; Stockinger H, 2009, NEW PHYTOL, V183, P1176, DOI 10.1111/j.1469-8137.2009.02874.x; Tisserant E, 2012, NEW PHYTOL, V193, P755, DOI 10.1111/j.1469-8137.2011.03948.x; van der Heijden MGA, 1998, NATURE, V396, P69, DOI 10.1038/23932; van der Heijden MGA, 1998, ECOLOGY, V79, P2082, DOI 10.1890/0012-9658(1998)079[2082:DAMFSA]2.0.CO;2; Vierheilig H, 1998, APPL ENVIRON MICROB, V64, P5004; Vogelsang KM, 2006, NEW PHYTOL, V172, P554, DOI 10.1111/j.1469-8137.2006.01854.x	29	90	95	1	107	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2013	8	8							e70633	10.1371/journal.pone.0070633	http://dx.doi.org/10.1371/journal.pone.0070633			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	200ZE	23950975	gold, Green Published, Green Submitted			2022-12-25	WOS:000323109700045
J	Montagna, PA; Baguley, JG; Cooksey, C; Hartwell, I; Hyde, LJ; Hyland, JL; Kalke, RD; Kracker, LM; Reuscher, M; Rhodes, ACE				Montagna, Paul A.; Baguley, Jeffrey G.; Cooksey, Cynthia; Hartwell, Ian; Hyde, Larry J.; Hyland, Jeffrey L.; Kalke, Richard D.; Kracker, Laura M.; Reuscher, Michael; Rhodes, Adelaide C. E.			Deep-Sea Benthic Footprint of the Deepwater Horizon Blowout	PLOS ONE			English	Article							NEMATODE-COPEPOD RATIO; SPECIES RICHNESS; OIL; DIVERSITY; MEIOFAUNA; POLLUTION; COMMUNITY; SEDIMENTS; BIOMASS; FLOW	The Deepwater Horizon (DWH) accident in the northern Gulf of Mexico occurred on April 20, 2010 at a water depth of 1525 meters, and a deep-sea plume was detected within one month. Oil contacted and persisted in parts of the bottom of the deep-sea in the Gulf of Mexico. As part of the response to the accident, monitoring cruises were deployed in fall 2010 to measure potential impacts on the two main soft-bottom benthic invertebrate groups: macrofauna and meiofauna. Sediment was collected using a multicorer so that samples for chemical, physical and biological analyses could be taken simultaneously and analyzed using multivariate methods. The footprint of the oil spill was identified by creating a new variable with principal components analysis where the first factor was indicative of the oil spill impacts and this new variable mapped in a geographic information system to identify the area of the oil spill footprint. The most severe relative reduction of faunal abundance and diversity extended to 3 km from the wellhead in all directions covering an area about 24 km(2). Moderate impacts were observed up to 17 km towards the southwest and 8.5 km towards the northeast of the wellhead, covering an area 148 km(2). Benthic effects were correlated to total petroleum hydrocarbon, polycyclic aromatic hydrocarbons and barium concentrations, and distance to the wellhead; but not distance to hydrocarbon seeps. Thus, benthic effects are more likely due to the oil spill, and not natural hydrocarbon seepage. Recovery rates in the deep sea are likely to be slow, on the order of decades or longer.	[Montagna, Paul A.; Hyde, Larry J.; Kalke, Richard D.; Reuscher, Michael; Rhodes, Adelaide C. E.] Texas A&M Univ, Harte Res Inst Gulf Mexico Studies, Corpus Christi, TX 78412 USA; [Baguley, Jeffrey G.] Univ Nevada, Dept Biol, Reno, NV 89557 USA; [Cooksey, Cynthia; Hyland, Jeffrey L.; Kracker, Laura M.] Natl Ocean & Atmospher Adm, Natl Ctr Coastal Ocean Sci, Charleston, SC USA; [Hartwell, Ian] Natl Ocean & Atmospher Adm, Natl Ctr Coastal Ocean Sci, Silver Spring, MD USA	Texas A&M University System; Nevada System of Higher Education (NSHE); University of Nevada Reno; National Oceanic Atmospheric Admin (NOAA) - USA; National Ocean Service, NOAA; National Centers for Coastal Ocean Science (NOOCS); National Oceanic Atmospheric Admin (NOAA) - USA; National Ocean Service, NOAA; National Centers for Coastal Ocean Science (NOOCS)	Montagna, PA (corresponding author), Texas A&M Univ, Harte Res Inst Gulf Mexico Studies, Corpus Christi, TX 78412 USA.	paul.montagna@tamucc.edu	Montagna, Paul A./J-8208-2017; Reuscher, Michael/O-5498-2015	Montagna, Paul A./0000-0003-4199-3312; Reuscher, Michael/0000-0001-5150-9876; Rhodes, Adelaide/0000-0002-1714-1972	BP; NOAA as part of the DWH Response; National Oceanic and Atmospheric Administration (NOAA) [DG133C06NC1729]; Industrial Economics as part of the Deepwater Horizon Oil Spill Natural Resource Damage Assessment (NRDA) [1050-TAMUCC]	BP; NOAA as part of the DWH Response; National Oceanic and Atmospheric Administration (NOAA)(National Oceanic Atmospheric Admin (NOAA) - USA); Industrial Economics as part of the Deepwater Horizon Oil Spill Natural Resource Damage Assessment (NRDA)	Sample collection during cruises on board R/V Gyre and R/V Ocean Veritas during the Response phase was funded by BP and NOAA as part of the DWH Response effort through funds from BP under the direction of the DWH Unified Area Command (UAC). Sample analysis and production of this paper was funded in part by contract DG133C06NC1729 from the National Oceanic and Atmospheric Administration (NOAA) via subcontract 1050-TAMUCC from Industrial Economics as part of the Deepwater Horizon Oil Spill Natural Resource Damage Assessment (NRDA). Christopher Lewis (Industrial Economics, Inc.) and Rob Ricker (NOAA) reviewed and commented on earlier versions of the manuscript. The views expressed herein are those of the authors and do not necessarily reflect the views of NOAA or any of its personnel. The study design and scope of work for the present deep-water/soft-bottom benthic study was approved jointly by representatives of the DWH NRDA Trustees and BP; neither party had a role in the corresponding sample processing, data analysis, decision to publish, or preparation of the manuscript. Pre-approval to submit the manuscript for publication was provided by representatives of the NRDA Trustees.	Baguley JG, 2006, DEEP-SEA RES PT I, V53, P1344, DOI 10.1016/j.dsr.2006.05.012; Baguley JG, 2008, DEEP-SEA RES PT II, V55, P2607, DOI 10.1016/j.dsr2.2008.07.010; Beazley MJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041305; Beolchini F, 2010, J HAZARD MATER, V182, P403, DOI 10.1016/j.jhazmat.2010.06.047; Bik HM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038550; BOUCHER G, 1985, MAR POLLUT BULL, V16, P328, DOI 10.1016/0025-326X(85)90449-7; Camilli R, 2010, SCIENCE, V330, P201, DOI 10.1126/science.1195223; COULL BC, 1981, MAR POLLUT BULL, V12, P378, DOI 10.1016/0025-326X(81)90408-2; Danovaro R, 2008, CURR BIOL, V18, P1, DOI 10.1016/j.cub.2007.11.056; Das Nilanjana, 2011, Biotechnol Res Int, V2011, P941810, DOI 10.4061/2011/941810; Dauvin JC, 1998, MAR POLLUT BULL, V36, P669, DOI 10.1016/S0025-326X(98)00058-7; Etter RJ, 1999, DEEP-SEA RES PT I, V46, P1095, DOI 10.1016/S0967-0637(98)00100-9; GEE JM, 1985, J EXP MAR BIOL ECOL, V91, P247, DOI 10.1016/0022-0981(85)90179-0; GRASSLE JF, 1992, AM NAT, V139, P313, DOI 10.1086/285329; GRASSLE JF, 1977, NATURE, V265, P618, DOI 10.1038/265618a0; Griffiths SK, 2012, ENVIRON SCI TECHNOL, V46, P5616, DOI 10.1021/es204569t; Haedrich RL, 2008, DEEP-SEA RES PT II, V55, P2650, DOI 10.1016/j.dsr2.2008.09.003; Hazen TC, 2010, SCIENCE, V330, P204, DOI 10.1126/science.1195979; HESSLER RR, 1967, DEEP-SEA RES, V14, P65; HILL MO, 1973, ECOLOGY, V54, P427, DOI 10.2307/1934352; Jenks G.F., 1967, INT YB CARTOGR, V7, P186; Kennicutt MC, 1996, CAN J FISH AQUAT SCI, V53, P2554, DOI 10.1139/f96-214; Kennicutt MC, 1996, CAN J FISH AQUAT SCI, V53, P2540, DOI 10.1139/cjfas-53-11-2540; Kessler JD, 2011, SCIENCE, V331, P312, DOI 10.1126/science.1199697; Lu ZM, 2012, ISME J, V6, P451, DOI 10.1038/ismej.2011.91; Ludwig J. A., 1988, STAT ECOLOGY; MARCOTTE BM, 1974, VIE MILIEU B OCEANOG, V24, P281; Montagna PA, 1996, CAN J FISH AQUAT SCI, V53, P2567, DOI 10.1139/cjfas-53-11-2567; Neff J.M., 1987, LONG TERM ENV EFFECT, P149; NOAA USGS, 2010, BP DEEPW HOR OIL BUD; Peterson CH, 2012, BIOSCIENCE, V62, P461, DOI 10.1525/bio.2012.62.5.7; RAFFAELLI DG, 1981, MAR POLLUT BULL, V12, P158, DOI 10.1016/0025-326X(81)90227-7; REX MA, 1981, ANNU REV ECOL SYST, V12, P331, DOI 10.1146/annurev.es.12.110181.001555; Rowe GT, 2008, DEEP-SEA RES PT II, V55, P2699, DOI 10.1016/j.dsr2.2008.07.020; Ryerson TB, 2012, P NATL ACAD SCI USA, V109, P20246, DOI 10.1073/pnas.1110564109; SHIELLS GM, 1985, MAR POLLUT BULL, V16, P62, DOI 10.1016/0025-326X(85)90125-0; Tyler P.A., 2003, ECOSYSTEMS DEEP; UAC (Unified Area Command), 2010, DEEPW HOR MC 252 RES; Valentine DL, 2012, P NATL ACAD SCI USA, V109, P20286, DOI 10.1073/pnas.1108820109; WARWICK RM, 1981, MAR POLLUT BULL, V12, P329, DOI 10.1016/0025-326X(81)90105-3; Wei CL, 2010, MAR ECOL PROG SER, V399, P1, DOI 10.3354/meps08388; Weisberg RH, 2011, GEOPHYS MONOGR SER, V195, P205, DOI 10.1029/2011GM001131	42	166	168	5	190	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2013	8	8							e70540	10.1371/journal.pone.0070540	http://dx.doi.org/10.1371/journal.pone.0070540			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	200ZE	23950956	gold, Green Submitted, Green Published			2022-12-25	WOS:000323109700041
J	Sonntag, R; Reinders, J; Rieger, JS; Heitzmann, DWW; Kretzer, JP				Sonntag, Robert; Reinders, Joern; Rieger, Johannes S.; Heitzmann, Daniel W. W.; Kretzer, J. Philippe			Hard-on-Hard Lubrication in the Artificial Hip under Dynamic Loading Conditions	PLOS ONE			English	Article							JOINT REPLACEMENTS; ELASTOHYDRODYNAMIC LUBRICATION; FRICTION MOMENTS; WEAR MECHANISMS; ELASTIC-MODULUS; METAL BEARINGS; FILM THICKNESS; PROSTHESES; GAIT; ARTHROPLASTY	The tribological performance of an artificial hip joint has a particularly strong influence on its success. The principle causes for failure are adverse short-and long-term reactions to wear debris and high frictional torque in the case of poor lubrication that may cause loosening of the implant. Therefore, using experimental and theoretical approaches models have been developed to evaluate lubrication under standardized conditions. A steady-state numerical model has been extended with dynamic experimental data for hard-on-hard bearings used in total hip replacements to verify the tribological relevance of the ISO 14242-1 gait cycle in comparison to experimental data from the Orthoload database and instrumented gait analysis for three additional loading conditions: normal walking, climbing stairs and descending stairs. Ceramic-on-ceramic bearing partners show superior lubrication potential compared to hard-on-hard bearings that work with at least one articulating metal component. Lubrication regimes during the investigated activities are shown to strongly depend on the kinematics and loading conditions. The outcome from the ISO gait is not fully confirmed by the normal walking data and more challenging conditions show evidence of inferior lubrication. These findings may help to explain the differences between the in vitro predictions using the ISO gait cycle and the clinical outcome of some hard-on-hard bearings, e. g., using metal-on-metal.	[Sonntag, Robert; Reinders, Joern; Rieger, Johannes S.; Kretzer, J. Philippe] Univ Heidelberg Hosp, Clin Orthoped & Trauma Surg, Lab Biomech & Implant Res, Heidelberg, Germany; [Heitzmann, Daniel W. W.] Univ Heidelberg Hosp, Clin Orthoped & Trauma Surg, Heidelberg Mot Lab, Heidelberg, Germany	Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg	Sonntag, R (corresponding author), Univ Heidelberg Hosp, Clin Orthoped & Trauma Surg, Lab Biomech & Implant Res, Heidelberg, Germany.	robert.sonntag@med.uni-heidelberg.de	Heitzmann, Daniel Walter Werner/H-5546-2012	Heitzmann, Daniel Walter Werner/0000-0001-8121-1923; Reinders, Jorn/0000-0002-8258-7735	Ministry of Art and Science of Baden-Wurttemberg, Germany	Ministry of Art and Science of Baden-Wurttemberg, Germany	The work was funded through the Ministry of Art and Science of Baden-Wurttemberg, Germany. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aqil A, 2013, INT ORTHOP, V37, P795, DOI 10.1007/s00264-013-1819-3; Bergmann G, 2001, J BIOMECH, V34, P859, DOI 10.1016/S0021-9290(01)00040-9; Bishop NE, 2008, MED ENG PHYS, V30, P1057, DOI 10.1016/j.medengphy.2008.01.001; Bishop NE, 2013, J ORTHOP RES, V31, P807, DOI 10.1002/jor.22255; Brockett C, 2007, J BIOMED MATER RES B, V81B, P508, DOI 10.1002/jbm.b.30691; Buscher R, 2005, J BIOMED MATER RES B, V72B, P206, DOI 10.1002/jbm.b.30132; Chan FW, 1999, CLIN ORTHOP RELAT R, P10; Davies AP, 2005, J BONE JOINT SURG AM, V87A, P18, DOI 10.2106/JBJS.C.00949; Fam H, 2007, BIORHEOLOGY, V44, P59; Fisher J, 2006, CLIN ORTHOP RELAT R, P25, DOI 10.1097/01.blo.0000238871.07604.49; Flanagan S, 2010, P I MECH ENG H, V224, P853, DOI 10.1243/09544119JEIM733; HAMROCK BJ, 1978, J LUBRIC TECH-T ASME, V100, P236, DOI 10.1115/1.3453152; HODGE WA, 1986, P NATL ACAD SCI USA, V83, P2879, DOI 10.1073/pnas.83.9.2879; Jagatia M, 2001, P I MECH ENG H, V215, P531, DOI 10.1243/0954411011536136; Jalali-Vahid D, 2001, J BIOMECH, V34, P261, DOI 10.1016/S0021-9290(00)00181-0; Jin ZM, 2006, CURR ORTHOPAED, V20, P32, DOI 10.1016/j.cuor.2005.09.005; Jin ZM, 1999, P I MECH ENG C-J MEC, V213, P355, DOI 10.1243/0954406991522310; Jin ZM, 1997, P I MECH ENG H, V211, P247, DOI 10.1243/0954411971534359; Langton DJ, 2011, J BONE JOINT SURG BR, V93B, P164, DOI 10.1302/0301-620X.93B2.25099; Lavigne M, 2010, CLIN ORTHOP RELAT R, V468, P326, DOI 10.1007/s11999-009-0938-z; Liu F, 2008, J BIOMECH, V41, P686, DOI 10.1016/j.jbiomech.2007.09.020; Malviya A, 2010, J BONE JOINT SURG AM, V92A, P1675, DOI 10.2106/JBJS.I.01426; Mattei L, 2011, TRIBOL INT, V44, P532, DOI 10.1016/j.triboint.2010.06.010; Mazzucco D, 2002, J ORTHOP RES, V20, P1157, DOI 10.1016/S0736-0266(02)00050-5; McClure G, 1996, Proc Inst Mech Eng H, V210, P89, DOI 10.1243/PIME_PROC_1996_210_397_02; Neville A, 2007, P I MECH ENG C-J MEC, V221, P1223, DOI 10.1243/09544062JMES724; Protopapadaki A, 2007, CLIN BIOMECH, V22, P203, DOI 10.1016/j.clinbiomech.2006.09.010; Smith SL, 2001, P I MECH ENG C-J MEC, V215, P265, DOI 10.1243/0954406011520706; Sonntag R, 2012, ACTA BIOMATER, V8, P2434, DOI 10.1016/j.actbio.2012.03.029; Udofia IJ, 2001, TRIBOLOGY BIOMECHANI, P102; Vassiliou K, 2007, P I MECH ENG H, V221, P11, DOI 10.1243/09544119JEIM124; WILLERT HG, 1990, CLIN ORTHOP RELAT R, P95; Willert HG, 2005, J BONE JOINT SURG AM, V87A, P28, DOI 10.2106/JBJS.A.02039pp; Williams S, 2006, J BIOMECH, V39, P2274, DOI 10.1016/j.jbiomech.2005.07.011; Wimmer MA, 2001, WEAR, V250, P129, DOI 10.1016/S0043-1648(01)00654-8; Wimmer MA, 2010, J ORTHOP RES, V28, P436, DOI 10.1002/jor.21020	37	19	19	1	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2013	8	8							e71622	10.1371/journal.pone.0071622	http://dx.doi.org/10.1371/journal.pone.0071622			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	200ZE	23940772	Green Published, gold, Green Submitted			2022-12-25	WOS:000323109700109
J	Benscoter, AM; Reece, JS; Noss, RF; Brandt, LA; Mazzotti, FJ; Romanach, SS; Watling, JI				Benscoter, Allison M.; Reece, Joshua S.; Noss, Reed F.; Brandt, Laura A.; Mazzotti, Frank J.; Romanach, Stephanie S.; Watling, James I.			Threatened and Endangered Subspecies with Vulnerable Ecological Traits Also Have High Susceptibility to Sea Level Rise and Habitat Fragmentation	PLOS ONE			English	Article							EXTINCTION RISK; CONSERVATION; FLORIDA; CLIMATE; BONFERRONI; DISPERSAL; IMPACTS; MODELS; CHALLENGES	The presence of multiple interacting threats to biodiversity and the increasing rate of species extinction make it critical to prioritize management efforts on species and communities that maximize conservation success. We implemented a multi-step approach that coupled vulnerability assessments evaluating threats to Florida taxa such as climate change, sea-level rise, and habitat fragmentation with in-depth literature surveys of taxon-specific ecological traits. The vulnerability, adaptive capacity, and ecological traits of 12 threatened and endangered subspecies were compared to non-listed subspecies of the same parent species. Overall, the threatened and endangered subspecies showed high vulnerability and low adaptive capacity, in particular to sea level rise and habitat fragmentation. They also exhibited larger home ranges and greater dispersal limitation compared to non-endangered subspecies, which may inhibit their ability to track changing climate in fragmented landscapes. There was evidence for lower reproductive capacity in some of the threatened or endangered taxa, but not for most. Taxa located in the Florida Keys or in other low coastal areas were most vulnerable to sea level rise, and also showed low levels of adaptive capacity, indicating they may have a lower probability of conservation success. Our analysis of at-risk subspecies and closely related non-endangered subspecies demonstrates that ecological traits help to explain observed differences in vulnerability and adaptive capacity. This study points to the importance of assessing the relative contributions of multiple threats and evaluating conservation value at the species (or subspecies) level when resources are limited and several factors affect conservation success.	[Benscoter, Allison M.; Mazzotti, Frank J.; Watling, James I.] Univ Florida, Ft Lauderdale Res & Educ Ctr, Davie, FL USA; [Reece, Joshua S.] Valdosta State Univ, Dept Biol, Valdosta, GA USA; [Noss, Reed F.] Univ Cent Florida, Dept Biol, Orlando, FL 32816 USA; [Brandt, Laura A.] US Fish & Wildlife Serv, Davie, FL USA; [Romanach, Stephanie S.] US Geol Survey, Southeast Ecol Sci Ctr, Davie, FL USA	State University System of Florida; University of Florida; University System of Georgia; Valdosta State University; State University System of Florida; University of Central Florida; United States Department of the Interior; US Fish & Wildlife Service; United States Department of the Interior; United States Geological Survey	Benscoter, AM (corresponding author), Univ Florida, Ft Lauderdale Res & Educ Ctr, Davie, FL USA.	ambenscoter@gmail.com		Romanach, Stephanie S./0000-0003-0271-7825; Brandt, Laura A./0000-0001-9655-0290	United States Fish and Wildlife Service; National Park Service (Everglades and Dry Tortugas National Park through the South Florida and Caribbean Cooperative Ecosystem Studies Unit); United States Geological Survey (Greater Everglades Priority Ecosystems Science); Kresge Foundation; Florida Fish and Wildlife Conservation Commission	United States Fish and Wildlife Service(US Fish & Wildlife Service); National Park Service (Everglades and Dry Tortugas National Park through the South Florida and Caribbean Cooperative Ecosystem Studies Unit); United States Geological Survey (Greater Everglades Priority Ecosystems Science); Kresge Foundation; Florida Fish and Wildlife Conservation Commission	Funding was provided by United States Fish and Wildlife Service, National Park Service (Everglades and Dry Tortugas National Park through the South Florida and Caribbean Cooperative Ecosystem Studies Unit), United States Geological Survey (Greater Everglades Priority Ecosystems Science), Kresge Foundation, and Florida Fish and Wildlife Conservation Commission. The views expressed here do not necessarily represent the views of the United States Fish and Wildlife Service, nor the United States Department of the Interior. Use of trade, product, or firm names does not imply endorsement by the United States Government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2010, EX SUMM 2010 S FLOR; Benjamini Y, 2001, ANN STAT, V29, P1165; Bolker BM, 2009, TRENDS ECOL EVOL, V24, P127, DOI 10.1016/j.tree.2008.10.008; Brooks TM, 2002, CONSERV BIOL, V16, P909, DOI 10.1046/j.1523-1739.2002.00530.x; Brussaard L, 2010, CURR OPIN ENV SUST, V2, P34, DOI 10.1016/j.cosust.2010.03.007; Cardillo M, 2003, ANIM CONSERV, V6, P63, DOI 10.1017/S1367943003003093; Cardillo M, 2008, P ROY SOC B-BIOL SCI, V275, P1441, DOI 10.1098/rspb.2008.0179; Christensen JH, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P847; Clevenger AP, 2002, CONSERV BIOL, V16, P503, DOI 10.1046/j.1523-1739.2002.00328.x; Culver M, 2000, J HERED, V91, P186, DOI 10.1093/jhered/91.3.186; Finkl CW, 2003, J COASTAL RES, V19, P934; Fisher DO, 2004, TRENDS ECOL EVOL, V19, P391, DOI 10.1016/j.tree.2004.05.004; Fritz SA, 2009, ECOL LETT, V12, P538, DOI 10.1111/j.1461-0248.2009.01307.x; Garcia LV, 2004, OIKOS, V105, P657, DOI 10.1111/j.0030-1299.2004.13046.x; Hothorn T, 2008, BIOMETRICAL J, V50, P346, DOI 10.1002/bimj.200810425; Indorf JL, 2010, THESIS U MIAMI CORAL; Kautz R, 2006, BIOL CONSERV, V130, P118, DOI 10.1016/j.biocon.2005.12.007; Knight G.R., 2011, ATLAS FLORIDAS NATUR; Loehle C, 2012, DIVERS DISTRIB, V18, P84, DOI 10.1111/j.1472-4642.2011.00856.x; Mackun P, 2011, C2010BR01 US DEP COM; Martin TG, 2012, CONSERV BIOL, V26, P29, DOI 10.1111/j.1523-1739.2011.01806.x; Maschinski J, 2011, CLIMATIC CHANGE, V107, P147, DOI 10.1007/s10584-011-0083-z; Massot M, 2008, GLOBAL CHANGE BIOL, V14, P461, DOI 10.1111/j.1365-2486.2007.01514.x; McGeoch MA, 2010, DIVERS DISTRIB, V16, P95, DOI 10.1111/j.1472-4642.2009.00633.x; Misra V, 2011, CTR OCEAN ATMOSPHERI, V14, P1; Moran MD, 2003, OIKOS, V100, P403, DOI 10.1034/j.1600-0706.2003.12010.x; Naeem S, 2012, SCIENCE, V336, P1401, DOI 10.1126/science.1215855; Nakagawa S, 2004, BEHAV ECOL, V15, P1044, DOI 10.1093/beheco/arh107; Noss RF, 2011, CLIMATIC CHANGE, V107, P1, DOI 10.1007/s10584-011-0109-6; NOSS RF, 1995, CONSERV BIOL, V9, P229, DOI 10.1046/j.1523-1739.1995.9020229.x; Pachauri Rajendra, 2007, AR4 CLIMATE CHANGE 2; Parmesan C, 2003, NATURE, V421, P37, DOI 10.1038/nature01286; Parmesan C, 2000, B AM METEOROL SOC, V81, P443, DOI 10.1175/1520-0477(2000)081<0443:IOEWAC>2.3.CO;2; Parmesan C, 2006, ANNU REV ECOL EVOL S, V37, P637, DOI 10.1146/annurev.ecolsys.37.091305.110100; Pearson RG, 2005, BIOL CONSERV, V123, P389, DOI 10.1016/j.biocon.2004.12.006; Pfeffer WT, 2008, SCIENCE, V321, P1340, DOI 10.1126/science.1159099; Phillips BL, 2008, AM NAT, V172, pS34, DOI 10.1086/588255; Pimentel D, 2005, ECOL ECON, V52, P273, DOI 10.1016/j.ecolecon.2004.10.002; Purvis A, 2000, P ROY SOC B-BIOL SCI, V267, P1947, DOI 10.1098/rspb.2000.1234; R Core Team, 2018, R LANG ENV STAT COMP; Reece JS, 2014, NAT AREAS J IN PRESS; Rockstrom J, 2009, NATURE, V461, P472, DOI 10.1038/461472a; Root TL, 2003, NATURE, V421, P57, DOI 10.1038/nature01333; Ross MS, 2009, FRONT ECOL ENVIRON, V7, P471, DOI 10.1890/070221; Saha AK, 2011, CLIMATIC CHANGE, V107, P81, DOI 10.1007/s10584-011-0082-0; Schmidt JA, 2012, GLOBAL CHANGE BIOL, V18, P3536, DOI 10.1111/gcb.12024; Smith KF, 2009, ANIM CONSERV, V12, P1, DOI 10.1111/j.1469-1795.2008.00228.x; Stein B., 2000, PRECIOUS HERITAGE ST; Strauss BH, 2012, ENVIRON RES LETT, V7, DOI 10.1088/1748-9326/7/1/014033; Thatcher CA, 2006, J WILDLIFE MANAGE, V70, P752, DOI 10.2193/0022-541X(2006)70[752:ISSFFP]2.0.CO;2; Thatcher CA, 2009, J MAMMAL, V90, P918, DOI 10.1644/08-MAMM-A-219.1; Tscharntke T, 2012, BIOL CONSERV, V151, P53, DOI 10.1016/j.biocon.2012.01.068; Van Teeffelen AJA, 2012, BIOL CONSERV, V153, P239, DOI 10.1016/j.biocon.2012.05.001; Vermeer M, 2009, P NATL ACAD SCI USA, V106, P21527, DOI 10.1073/pnas.0907765106; Von Holle B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011500; Walker R. T., 1997, Urban Ecosystems, V1, P37, DOI 10.1023/A:1014311116523; Warton DI, 2011, ECOLOGY, V92, P3, DOI 10.1890/10-0340.1; WEIHER E, 1995, OIKOS, V74, P159, DOI 10.2307/3545686; Woodroffe R, 1998, SCIENCE, V280, P2126, DOI 10.1126/science.280.5372.2126; Zhang KQ, 2011, CLIMATIC CHANGE, V107, P129, DOI 10.1007/s10584-011-0080-2; Zwick P.D., 2006, FLORIDA 2060 POPULAT	61	16	17	2	82	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2013	8	8							e70647	10.1371/journal.pone.0070647	http://dx.doi.org/10.1371/journal.pone.0070647			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	218XC	23940614	Green Published, Green Submitted, gold			2022-12-25	WOS:000324465000108
J	Gesteira, TF; Pol-Fachin, L; Coulson-Thomas, VJ; Lima, MA; Verli, H; Nader, HB				Gesteira, Tarsis F.; Pol-Fachin, Laercio; Coulson-Thomas, Vivien Jane; Lima, Marcelo A.; Verli, Hugo; Nader, Helena B.			Insights into the N-Sulfation Mechanism: Molecular Dynamics Simulations of the N-Sulfotransferase Domain of Ndst1 and Mutants	PLOS ONE			English	Article							HUMAN ESTROGEN SULFOTRANSFERASE; SULFURYL TRANSFER-REACTION; HEPARAN-SULFATE; DEACETYLASE/N-SULFOTRANSFERASE; CRYSTAL-STRUCTURE; AQUEOUS-SOLUTIONS; PROTEINS; BIOSYNTHESIS; CONFORMATION; RECOGNITION	Sulfation patterns along glycosaminoglycan (GAG) chains dictate their functional role. The N-deacetylase N-sulfotransferase family (NDST) catalyzes the initial downstream modification of heparan sulfate and heparin chains by removing acetyl groups from subsets of N-acetylglucosamine units and, subsequently, sulfating the residual free amino groups. These enzymes transfer the sulfuryl group from 3'-phosphoadenosine-5'-phosphosulfate (PAPS), yielding sulfated sugar chains and 3'-phosphoadenosine-5'-phosphate (PAP). For the N-sulfotransferase domain of NDST1, Lys833 has been implicated to play a role in holding the substrate glycan moiety close to the PAPS cofactor. Additionally, Lys833 together with His716 interact with the sulfonate group, stabilizing the transition state. Such a role seems to be shared by Lys614 through donation of a proton to the bridging oxygen of the cofactor, thereby acting as a catalytic acid. However, the relevance of these boundary residues at the hydrophobic cleft is still unclear. Moreover, whether Lys833, His716 and Lys614 play a role in both glycan recognition and glycan sulfation remains elusive. In this study we evaluate the contribution of NDST mutants (Lys833, His716 and Lys614) to dynamical effects during sulfate transfer using comprehensive combined docking and essential dynamics. In addition, the binding location of the glycan moiety, PAPS and PAP within the active site of NDST1 throughout the sulfate transfer were determined by intermediate state analysis. Furthermore, NDST1 mutants unveiled Lys833 as vital for both the glycan binding and subsequent N-sulfotransferase activity of NDST1.	[Gesteira, Tarsis F.; Coulson-Thomas, Vivien Jane; Lima, Marcelo A.; Nader, Helena B.] Univ Fed Sao Paulo, Dept Bioquim, Sao Paulo, Brazil; [Pol-Fachin, Laercio; Verli, Hugo] Univ Fed Rio Grande do Sul, Ctr Biotecnol, Porto Alegre, RS, Brazil	Universidade Federal de Sao Paulo (UNIFESP); Universidade Federal do Rio Grande do Sul	Gesteira, TF (corresponding author), Univ Fed Sao Paulo, Dept Bioquim, Sao Paulo, Brazil.	tarsis.ferreira@cchmc.org	Lima, Marcelo/E-6841-2012; Verli, Hugo/G-8703-2012; Verli, Hugo/AAZ-2148-2021; Nader, Helena Bonciani/D-9253-2012	Verli, Hugo/0000-0002-4796-8620; NADER, HELENA/0000-0002-7569-2166	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo [2010/52426-3]; Conselho Nacional do Desenvolvimento Cientifico e Tecnologico; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Conselho Nacional do Desenvolvimento Cientifico e Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This work was supported by Fundacao de Amparo a Pesquisa do Estado de Sao Paulo - Process 2010/52426-3 (http://www.fapesp.br/en/), Conselho Nacional do Desenvolvimento Cientifico e Tecnologico (www.cnpq.br/) and Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (www.capes.gov.br/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Becker CF, 2007, J MOL GRAPH MODEL, V26, P391, DOI 10.1016/j.jmgm.2007.01.008; Becker CF, 2005, CARBOHYD RES, V340, P1499, DOI 10.1016/j.carres.2005.03.018; BERENDSEN HJC, 1987, COMPUT PHYS COMMUN, V44, P233, DOI 10.1016/0010-4655(87)90078-6; BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; Bishop JR, 2007, NATURE, V446, P1030, DOI 10.1038/nature05817; Chapman E, 2004, ANGEW CHEM INT EDIT, V43, P3526, DOI 10.1002/anie.200300631; Cornell WD, 1996, J AM CHEM SOC, V118, P2309, DOI 10.1021/ja955032e; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; de Groot BL, 2001, SCIENCE, V294, P2353, DOI 10.1126/science.1062459; Dreyfuss JL, 2009, AN ACAD BRAS CIENC, V81, P409, DOI 10.1590/S0001-37652009000300007; Gamage N, 2006, TOXICOL SCI, V90, P5, DOI 10.1093/toxsci/kfj061; Gesteira TF, 2011, J BIOL CHEM, V286, P5338, DOI 10.1074/jbc.M110.100719; Gorokhov A, 2000, BIOPHYS J, V79, P2909, DOI 10.1016/S0006-3495(00)76528-3; Hess B, 1997, J COMPUT CHEM, V18, P1463, DOI 10.1002/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H; Honke K, 2002, MED RES REV, V22, P637, DOI 10.1002/med.10020; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; Kakuta Y, 1999, J BIOL CHEM, V274, P10673, DOI 10.1074/jbc.274.16.10673; Kakuta Y, 2003, BIOCHEM SOC T, V31, P331, DOI 10.1042/BST0310331; Kreuger J, 2006, J CELL BIOL, V174, P323, DOI 10.1083/jcb.200604035; Kuhn JFau, 2001, 1 ISOLATION HUMAN UD; Lin P, 2006, INT J QUANTUM CHEM, V106, P2981, DOI 10.1002/qua.21123; Lowdin P, 1950, J CHEM PHYS, V18, P11; Morris GM, 1998, J COMPUT CHEM, V19, P1639, DOI 10.1002/(SICI)1096-987X(19981115)19:14<1639::AID-JCC10>3.0.CO;2-B; Negishi M, 2001, ARCH BIOCHEM BIOPHYS, V390, P149, DOI 10.1006/abbi.2001.2368; Pedersen LC, 2002, J BIOL CHEM, V277, P17928, DOI 10.1074/jbc.M111651200; Peters GH, 1999, PROTEIN ENG, V12, P747, DOI 10.1093/protein/12.9.747; Peters GH, 1999, BIOPHYS J, V77, P505, DOI 10.1016/S0006-3495(99)76907-9; Petrotchenko EV, 1999, J BIOL CHEM, V274, P30019, DOI 10.1074/jbc.274.42.30019; Pol-Fachin L, 2008, CARBOHYD RES, V343, P1435, DOI 10.1016/j.carres.2008.04.016; Pol-Fachin L, 2009, CARBOHYD RES, V344, P491, DOI 10.1016/j.carres.2008.12.025; RENSDOMIANO SS, 1987, J NEUROCHEM, V48, P1411, DOI 10.1111/j.1471-4159.1987.tb05679.x; Samsonov SA, 2011, J COMPUT AID MOL DES, V25, P477, DOI 10.1007/s10822-011-9433-1; Schaftenaar G, 2000, J COMPUT AID MOL DES, V14, P123, DOI 10.1023/A:1008193805436; SCHMIDT MW, 1993, J COMPUT CHEM, V14, P1347, DOI 10.1002/jcc.540141112; Schrodinger L., 2020, PYMOL; Schuttelkopf AW, 2004, ACTA CRYSTALLOGR D, V60, P1355, DOI 10.1107/S0907444904011679; Stoolmiller Ac Fau-Horwitz AL, 1972, PURIFICATION PROPERT; Sueyoshi T, 1998, FEBS LETT, V433, P211, DOI 10.1016/S0014-5793(98)00913-2; Van der Spoel D, 2005, J COMPUT CHEM, V26, P1701, DOI 10.1002/jcc.20291; van Gunsteren W, 1996, BIOMOLECULAR SIMULAT; Verli H, 2004, CARBOHYD RES, V339, P281, DOI 10.1016/j.carres.2003.09.026; WALLACE AC, 1995, PROTEIN ENG, V8, P127, DOI 10.1093/protein/8.2.127; Xu D, 2008, NAT CHEM BIOL, V4, P200, DOI 10.1038/nchembio.66; Xu D, 2007, J BIOL CHEM, V282, P8356, DOI 10.1074/jbc.M608062200; Yoshinari K, 2001, J BIOCHEM MOL TOXIC, V15, P67, DOI 10.1002/jbt.1; Zhang HP, 1998, J BIOL CHEM, V273, P10888, DOI 10.1074/jbc.273.18.10888; Zhang LJ, 2010, PROG MOL BIOL TRANSL, V93, P1, DOI 10.1016/S1877-1173(10)93001-9	48	13	13	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2013	8	8							e70880	10.1371/journal.pone.0070880	http://dx.doi.org/10.1371/journal.pone.0070880			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	218XC	23940657	gold, Green Published, Green Submitted			2022-12-25	WOS:000324465000147
J	Keaton, MA; Rosato, RR; Plata, KB; Singh, CR; Rosato, AE				Keaton, Mignon A.; Rosato, Roberto R.; Plata, Konrad B.; Singh, Christopher R.; Rosato, Adriana E.			Exposure of Clinical MRSA Heterogeneous Strains to beta-Lactams Redirects Metabolism to Optimize Energy Production through the TCA Cycle	PLOS ONE			English	Article							RESISTANT STAPHYLOCOCCUS-AUREUS; METHICILLIN RESISTANCE; BACILLUS-SUBTILIS; BINDING PROTEINS; EXPRESSION; IDENTIFICATION; ACETATE; ACID; DEHYDROGENASE; LOCALIZATION	Methicillin-resistant Staphylococcus aureus (MRSA) has emerged as one of the most important pathogens both in health care and community-onset infections. The prerequisite for methicillin resistance is mecA, which encodes a beta-lactam-insensitive penicillin binding protein PBP2a. A characteristic of MRSA strains from hospital and community associated infections is their heterogeneous expression of resistance to beta-lactam (HeR) in which only a small portion (<= 0.1%) of the population expresses resistance to oxacillin (OXA) >= 10 mu g/ml, while in other isolates, most of the population expresses resistance to a high level (homotypic resistance, HoR). The mechanism associated with heterogeneous expression requires both increase expression of mecA and a mutational event that involved the triggering of a beta-lactam-mediated SOS response and related lexA and recA genes. In the present study we investigated the cellular physiology of HeR-MRSA strains during the process of beta-lactam-mediated HeR/HoR selection at sub-inhibitory concentrations by using a combinatorial approach of microarray analyses and global biochemical profiling employing gas chromatography/mass spectrometry (GC/MS) and liquid chromatography/mass spectrometry (LC/MS) to investigate changes in metabolic pathways and the metabolome associated with beta-lactam-mediated HeR/HoR selection in clinically relevant heterogeneous MRSA. We found unique features present in the oxacillin-selected SA13011-HoR derivative when compared to the corresponding SA13011-HeR parental strain that included significant increases in tricarboxyl citric acid (TCA) cycle intermediates and a concomitant decrease in fermentative pathways. Inactivation of the TCA cycle enzyme cis-aconitase gene in the SA13011-HeR strain abolished beta-lactam-mediated HeR/HoR selection demonstrating the significance of altered TCA cycle activity during the HeR/HoR selection. These results provide evidence of both the metabolic cost and the adaptation that HeR-MRSA clinical strains undergo when exposed to beta-lactam pressure, indicating that the energy production is redirected to supply the cell wall synthesis/metabolism, which in turn contributes to the survival response in the presence of beta-lactam antibiotics.	[Rosato, Roberto R.; Plata, Konrad B.; Singh, Christopher R.; Rosato, Adriana E.] Methodist Hosp, Dept Pathol & Genom Med, Ctr Mol & Translat Human Infect Dis Res, Res Inst, Houston, TX 77030 USA; [Keaton, Mignon A.] Metabolon Inc, Durham, NC USA	The Methodist Hospital System; The Methodist Hospital - Houston; Metabolon	Rosato, AE (corresponding author), Methodist Hosp, Dept Pathol & Genom Med, Ctr Mol & Translat Human Infect Dis Res, Res Inst, 6535 Fannin, Houston, TX 77030 USA.	aerosato@tmhs.org		Rosato, Adriana E./0000-0001-6115-6955	National Institutes of Health [5R01AI080688-03]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI080688] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was funded by National Institutes of Health grant 5R01AI080688-03 (AER, PI). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berger-Bachi B, 2002, ARCH MICROBIOL, V178, P165, DOI 10.1007/s00203-002-0436-0; Birkenstock T, 2012, J BIOL CHEM, V287, P2887, DOI 10.1074/jbc.M111.288894; Bizzini A, 2007, J ANTIMICROB CHEMOTH, V59, P607, DOI 10.1093/jac/dkm021; Boudonck KJ, 2009, TOXICOL PATHOL, V37, P280, DOI 10.1177/0192623309332992; COLLINS FM, 1962, J GEN MICROBIOL, V29, P531, DOI 10.1099/00221287-29-3-531; Cuirolo A, 2009, J ANTIMICROB CHEMOTH, V64, P37, DOI 10.1093/jac/dkp164; Dehaven CD, 2010, J CHEMINFORMATICS, V2, P1758; Deutscher J, 2006, MICROBIOL MOL BIOL R, V70, P939, DOI 10.1128/MMBR.00024-06; Evans AM, 2009, ANAL CHEM, V81, P6656, DOI 10.1021/ac901536h; Finan JE, 2002, ANTIMICROB AGENTS CH, V46, P24, DOI 10.1128/AAC.46.1.24-30.2002; Forbes BA, 2008, DIAGN MICR INFEC DIS, V61, P387, DOI 10.1016/j.diagmicrobio.2008.04.003; Formstone A, 2008, J BACTERIOL, V190, P1812, DOI 10.1128/JB.01394-07; Friedman DB, 2006, PLOS PATHOG, V2, P777, DOI 10.1371/journal.ppat.0020087; GARDNER JF, 1962, J GEN MICROBIOL, V29, P157, DOI 10.1099/00221287-29-1-157; GEORGOPAPADAKOU NH, 1993, ANTIMICROB AGENTS CH, V37, P2045, DOI 10.1128/AAC.37.10.2045; GOLDSCHMIDT MC, 1953, ARCH BIOCHEM BIOPHYS, V46, P154, DOI 10.1016/0003-9861(53)90178-7; Goldstein F, 2007, ANTIMICROB AGENTS CH, V51, P2514, DOI 10.1128/AAC.00040-07; Herold BC, 1998, JAMA-J AM MED ASSOC, V279, P593, DOI 10.1001/jama.279.8.593; Kim MS, 2003, J BIOL CHEM, V278, P28173, DOI 10.1074/jbc.M304523200; Krebs HA, 1937, BIOCHEM J, V31, P661, DOI 10.1042/bj0310661; Kriegeskorte A, 2011, PROTEOMICS, V11, P2476, DOI 10.1002/pmic.201000796; Lawton KA, 2008, PHARMACOGENOMICS, V9, P383, DOI 10.2217/14622416.9.4.383; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Massilamany C, 2011, MOL CELL BIOCHEM, V355, P75, DOI 10.1007/s11010-011-0840-3; McKinney TK, 2001, J BACTERIOL, V183, P6862, DOI 10.1128/JB.183.23.6862-6868.2001; Nelson JL, 2007, ANTIMICROB AGENTS CH, V51, P616, DOI 10.1128/AAC.01057-06; NOVICK R, 1967, VIROLOGY, V33, P155, DOI 10.1016/0042-6822(67)90105-5; Pinho MG, 2005, MOL MICROBIOL, V55, P799, DOI 10.1111/j.1365-2958.2004.04420.x; Plata KB, 2011, ANTIMICROB AGENTS CH, V55, P3176, DOI 10.1128/AAC.01119-09; Sadykov MR, 2010, J BACTERIOL, V192, P1459, DOI 10.1128/JB.01377-09; Scheffers DJ, 2005, MICROBIOL MOL BIOL R, V69, P585, DOI 10.1128/MMBR.69.4.585-607.2005; Seidl K, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-95; Somerville GA, 2002, INFECT IMMUN, V70, P6373, DOI 10.1128/IAI.70.11.6373-6382.2002; Sreekumar A, 2009, NATURE, V457, P910, DOI 10.1038/nature07762; Starai VJ, 2004, CELL MOL LIFE SCI, V61, P2020, DOI 10.1007/s00018-004-3448-x; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Swenson JM, 2007, DIAGN MICR INFEC DIS, V58, P33, DOI 10.1016/j.diagmicrobio.2006.10.022; TOMASZ A, 1991, ANTIMICROB AGENTS CH, V35, P124, DOI 10.1128/AAC.35.1.124; WEISSENBORN DL, 1992, J BIOL CHEM, V267, P6122; YASBIN RE, 1977, MOL GEN GENET, V153, P219, DOI 10.1007/BF00264739	40	15	15	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2013	8	8							e71025	10.1371/journal.pone.0071025	http://dx.doi.org/10.1371/journal.pone.0071025			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	218XC	23940684	Green Submitted, Green Published, gold			2022-12-25	WOS:000324465000169
J	Schaible, EV; Steinstrasser, A; Jahn-Eimermacher, A; Luh, C; Sebastiani, A; Kornes, F; Pieter, D; Schafer, MK; Engelhard, K; Thal, SC				Schaible, Eva-Verena; Steinstraesser, Arne; Jahn-Eimermacher, Antje; Luh, Clara; Sebastiani, Anne; Kornes, Frida; Pieter, Dana; Schaefer, Michael K.; Engelhard, Kristin; Thal, Serge C.			Single Administration of Tripeptide alpha-MSH(11-13) Attenuates Brain Damage by Reduced Inflammation and Apoptosis after Experimental Traumatic Brain Injury in Mice	PLOS ONE			English	Article							MELANOCYTE-STIMULATING HORMONE; NITRIC-OXIDE SYNTHASE; NECROSIS-FACTOR-ALPHA; MELANOCORTIN RECEPTORS; MICROGLIAL ACTIVATION; CEREBRAL-ISCHEMIA; TIME-COURSE; EXPRESSION; PEPTIDES; NEUROPROTECTION	Following traumatic brain injury (TBI) neuroinflammatory processes promote neuronal cell loss. Alpha-melanocyte-stimulating hormone (alpha-MSH) is a neuropeptide with immunomodulatory properties, which may offer neuroprotection. Due to short half-life and pigmentary side-effects of alpha-MSH, the C-terminal tripeptide alpha-MSH(11-13) may be an anti-inflammatory alternative. The present study investigated the mRNA concentrations of the precursor hormone proopiomelanocortin (POMC) and of melanocortin receptors 1 and 4 (MC1R/MC4R) in naive mice and 15 min, 6, 12, 24, and 48 h after controlled cortical impact (CCI). Regulation of POMC and MC4R expression did not change after trauma, while MC1R levels increased over time with a 3-fold maximum at 12 h compared to naive brain tissue. The effect of alpha-MSH(11-13) on secondary lesion volume determined in cresyl violet stained sections (intraperitoneal injection 30 min after insult of 1 mg/kg alpha-MSH(11-13) or 0.9% NaCl) showed a considerable smaller trauma in alpha-MSH(11-13) injected mice. The expression of the inflammatory markers TNF-alpha and IL-1 beta as well as the total amount of Iba-1 positive cells were not reduced. However, cell branch counting of Iba-1 positive cells revealed a reduced activation of microglia. Furthermore, tripeptide injection reduced neuronal apoptosis analyzed by cleaved caspase-3 and NeuN staining. Based on the results single alpha-MSH(11-13) administration offers a promising neuroprotective property by modulation of inflammation and prevention of apoptosis after traumatic brain injury.	[Schaible, Eva-Verena; Steinstraesser, Arne; Luh, Clara; Sebastiani, Anne; Kornes, Frida; Pieter, Dana; Schaefer, Michael K.; Engelhard, Kristin; Thal, Serge C.] Johannes Gutenberg Univ Mainz, Dept Anesthesiol, Med Ctr, D-55122 Mainz, Germany; [Schaefer, Michael K.; Engelhard, Kristin; Thal, Serge C.] Johannes Gutenberg Univ Mainz, Med Ctr, Focus Program Translat Neurosci, D-55122 Mainz, Germany; [Jahn-Eimermacher, Antje] Johannes Gutenberg Univ Mainz, Inst Med Biostat Epidemiol & Informat, D-55122 Mainz, Germany	Johannes Gutenberg University of Mainz; Johannes Gutenberg University of Mainz; Johannes Gutenberg University of Mainz	Thal, SC (corresponding author), Johannes Gutenberg Univ Mainz, Dept Anesthesiol, Med Ctr, D-55122 Mainz, Germany.	thal@uni-mainz.de	Thal, Serge/D-6593-2011	Thal, Serge/0000-0002-1222-8729				Aronsson AF, 2006, NEUROPEPTIDES, V40, P65, DOI 10.1016/j.npep.2005.10.006; Bhardwaj RS, 1996, J IMMUNOL, V156, P2517; Bitto A, 2012, CRIT CARE MED, V40, P945, DOI 10.1097/CCM.0b013e318236efde; Caruso C, 2004, NEUROENDOCRINOLOGY, V79, P278, DOI 10.1159/000079321; Caruso C, 2007, ENDOCRINOLOGY, V148, P4918, DOI 10.1210/en.2007-0366; Catania A, 2004, PHARMACOL REV, V56, P1, DOI 10.1124/pr.56.1.1; Catania A, 2010, THESCIENTIFICWORLDJO, V10, P1840, DOI 10.1100/tsw.2010.173; Cernak I, 2006, EXPERT OPIN INV DRUG, V15, P1371, DOI 10.1517/13543784.15.11.1371; Chai BX, 2006, PEPTIDES, V27, P2846, DOI 10.1016/j.peptides.2006.05.005; Charnley M, 2008, PEPTIDES, V29, P1004, DOI 10.1016/j.peptides.2008.02.004; Chen G, 2008, NEUROPEPTIDES, V42, P331, DOI 10.1016/j.npep.2008.01.004; Chen S, 2003, EXP NEUROL, V182, P87, DOI 10.1016/S0014-4886(03)00002-5; CLARK RSB, 1994, J NEUROTRAUM, V11, P499, DOI 10.1089/neu.1994.11.499; Cone RD, 2005, NAT NEUROSCI, V8, P571, DOI 10.1038/nn1455; Csuka E, 2000, NEUROREPORT, V11, P2587, DOI 10.1097/00001756-200008030-00047; Dalmasso G, 2008, GASTROENTEROLOGY, V134, P166, DOI 10.1053/j.gastro.2007.10.026; Davalos D, 2005, NAT NEUROSCI, V8, P752, DOI 10.1038/nn1472; DAVIS EJ, 1994, BRAIN RES BULL, V34, P73, DOI 10.1016/0361-9230(94)90189-9; DEANGELIS E, 1995, MICROVASC RES, V50, P25, DOI 10.1006/mvre.1995.1035; Delgado R, 1998, J LEUKOCYTE BIOL, V63, P740, DOI 10.1002/jlb.63.6.740; Dessinioti C, 2011, PHOTOCHEM PHOTOBIOL, V87, P978, DOI 10.1111/j.1751-1097.2011.00970.x; Elliott RJ, 2004, J INVEST DERMATOL, V122, P1010, DOI 10.1111/j.0022-202X.2004.22404.x; Faden AI, 2011, ANN NEUROL, V70, P345, DOI 10.1002/ana.22555; GANTZ I, 1993, J BIOL CHEM, V268, P15174; Getting SJ, 2002, TRENDS PHARMACOL SCI, V23, P447, DOI 10.1016/S0165-6147(02)02103-X; Getting SJ, 2003, J PHARMACOL EXP THER, V306, P631, DOI 10.1124/jpet.103.051623; Giuliani D, 2006, ENDOCRINOLOGY, V147, P1126, DOI 10.1210/en.2005-0692; Giuliani D, 2011, ACTA NEUROPATHOL, V122, P443, DOI 10.1007/s00401-011-0873-4; Haddad JJE, 2001, BIOCHEM J, V355, P29, DOI 10.1042/bj3550029; HRUBY VJ, 1987, J MED CHEM, V30, P2126, DOI 10.1021/jm00394a033; Huang QH, 1998, AM J PHYSIOL-REG I, V275, pR524, DOI 10.1152/ajpregu.1998.275.2.R524; Ichiyama T, 1999, BRAIN RES, V836, P31, DOI 10.1016/S0006-8993(99)01584-X; Kishi T, 2003, J COMP NEUROL, V457, P213, DOI 10.1002/cne.10454; Land Stephen C, 2012, Int J Physiol Pathophysiol Pharmacol, V4, P59; Lenzlinger PM, 2001, MOL NEUROBIOL, V24, P169; Loane DJ, 2010, TRENDS PHARMACOL SCI, V31, P596, DOI 10.1016/j.tips.2010.09.005; Loane DJ, 2010, NEUROTHERAPEUTICS, V7, P366, DOI 10.1016/j.nurt.2010.07.002; Luh C, 2010, J NEUROCHEM, V112, P1015, DOI 10.1111/j.1471-4159.2009.06514.x; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Magnoni S, 2003, J NEUROTRAUM, V20, P251, DOI 10.1089/089771503321532833; Manna SX, 2006, EUR J IMMUNOL, V36, P754, DOI 10.1002/eji.200535209; Mountjoy KG, 2010, ADV EXP MED BIOL, V681, P29, DOI 10.1007/978-1-4419-6354-3_3; MOUNTJOY KG, 1994, MOL ENDOCRINOL, V8, P1298, DOI 10.1210/me.8.10.1298; Nahon JL, 2006, CR BIOL, V329, P623, DOI 10.1016/j.crvi.2006.03.021; Rajora N, 1997, J NEUROSCI, V17, P2181; Ramlackhansingh AF, 2011, ANN NEUROL, V70, P374, DOI 10.1002/ana.22455; Rupalla K, 1998, ACTA NEUROPATHOL, V96, P172, DOI 10.1007/s004010050878; Savos AV, 2011, J CEREBR BLOOD F MET, V31, P606, DOI 10.1038/jcbfm.2010.130; Spaccapelo L, 2011, EUR J PHARMACOL, V670, P479, DOI 10.1016/j.ejphar.2011.09.015; Springer JE, 2002, J BIOCHEM MOL BIOL, V35, P94; Stoica BA, 2010, NEUROTHERAPEUTICS, V7, P3, DOI 10.1016/j.nurt.2009.10.023; Tatro JB, 1996, NEUROIMMUNOMODULAT, V3, P259, DOI 10.1159/000097281; Taylor Andrew W., 1994, Neuroimmunomodulation, V1, P188, DOI 10.1159/000097167; TAYLOR AW, 1992, CURR EYE RES, V11, P1199, DOI 10.3109/02713689208999545; Thal SC, 2008, J NEUROTRAUM, V25, P785, DOI 10.1089/neu.2007.0497; Thal SC, 2011, J NEUROTRAUM, V28, P983, DOI 10.1089/neu.2010.1685; Timaru-Kast R, 2012, CRIT CARE MED, V40, P935, DOI 10.1097/CCM.0b013e31822f08b9; Todd SR, 2009, J TRAUMA, V66, P465, DOI 10.1097/TA.0b013e31818b1e04; Tsenter J, 2008, J NEUROTRAUM, V25, P324, DOI 10.1089/neu.2007.0452; vandeMeent HV, 1997, NEUROSURGERY, V40, P122, DOI 10.1097/00006123-199701000-00028; Wada K, 1998, NEUROSURGERY, V43, P1427, DOI 10.1097/00006123-199812000-00096; WILSON JF, 1980, J ENDOCRINOL, V86, P61, DOI 10.1677/joe.0.0860061; Wong KY, 1997, NEUROIMMUNOMODULAT, V4, P37; XIA Y, 1995, NEUROREPORT, V6, P2193, DOI 10.1097/00001756-199511000-00022; Zhang Z, 2006, NEUROSCIENCE, V141, P637, DOI 10.1016/j.neuroscience.2006.04.027; Zierath D, 2011, STROKE, V42, P3415, DOI 10.1161/STROKEAHA.111.627331	66	43	46	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2013	8	8							e71056	10.1371/journal.pone.0071056	http://dx.doi.org/10.1371/journal.pone.0071056			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	218XC	23940690	Green Published, gold, Green Submitted			2022-12-25	WOS:000324465000173
J	Tai, HY; Zhou, JK; Chou, H; Tam, MF; Chen, YS; Sheu, SY; Shen, HD				Tai, Hsiao-Yun; Zhou, Jia-Kai; Chou, Hong; Tam, Ming F.; Chen, Yu-Sen; Sheu, Sheh-Yi; Shen, Horng-Der			Epitope Mapping and In Silico Characterization of Interactions between Der p 7 Allergen and MoAb WH9	PLOS ONE			English	Article							DUST-MITE ALLERGEN; MONOCLONAL-ANTIBODY BINDING; CRYSTAL-STRUCTURE; MOLECULAR-CLONING; COMPLEX-FORMATION; FAB FRAGMENT; ANTIGEN; IGE	Der p 7 is an important house dust mite allergen. However, antigenic determinants of Der p 7 are largely unknown. The purpose of this study is to analyze the determinants of Der p 7 and determine the structural basis of interactions between Der p 7 and WH9, an IgE-binding inhibition mouse monoclonal antibody (MoAb). IgE and WH9-reactive determinant(s) was identified by immunoblot using allergen mutants. A 3-D binary complex structure of Der p 7 and WH9 was simulated with homology modeling and docking methods. Our results obtained showed that among the five Der p 7 mutants (S156A, I157A, L158A, D159A, P160A), serum no. 1045 with IgE-binding against Der p 7 exhibited a reduced IgE immunoblot reactivity against Der p 7 L158A and D159A mutants. WH9 showed reduced immunoblot reactivity against S156A, L158A, D159A and P160A and the observation was confirmed by immunoblot inhibition. The WH9-binding determinant on Der p 7 containing S156, L158, D159 and P160 assumes a loop-like structure. The structural model of the Der p 7-WH9 complex suggests residues S156, I157, L158, D159 and P160 of Der p 7 contribute to WH9 binding via potential hydrogen bonds, electrostatic and hydrophobic interactions. In conclusion, MoAb WH9 interacts with critical residues L158 and D159 of Der p 7 and inhibits IgE-binding to Der p 7. Results obtained advance our understanding on molecular and structural bases of the antigenicity of Der p 7, its interactions with MoAb WH9 and facilitate the design of safer immunotherapy of human atopic disorders.	[Tai, Hsiao-Yun; Chou, Hong; Chen, Yu-Sen; Shen, Horng-Der] Natl Yang Ming Univ, Dept Med Res & Educ, Taipei Vet Gen Hosp, Taipei 112, Taiwan; [Zhou, Jia-Kai; Sheu, Sheh-Yi] Natl Yang Ming Univ, Dept Life Sci, Taipei 112, Taiwan; [Zhou, Jia-Kai; Sheu, Sheh-Yi] Natl Yang Ming Univ, Inst Genome Sci, Taipei 112, Taiwan; [Tam, Ming F.] Carnegie Mellon Univ, Dept Biol Sci, Pittsburgh, PA 15213 USA	National Yang Ming Chiao Tung University; Taipei Veterans General Hospital; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; Carnegie Mellon University	Shen, HD (corresponding author), Natl Yang Ming Univ, Dept Med Res & Educ, Taipei Vet Gen Hosp, Taipei 112, Taiwan.	hdshen@vghtpe.gov.tw			National Science Council [NSC98-2320-B-075-003-MY3]; Taipei Veterans General Hospital, Taipei, Taiwan [V101C-004]	National Science Council(Ministry of Science and Technology, Taiwan); Taipei Veterans General Hospital, Taipei, Taiwan(Taipei Veterans General Hospital)	This work was supported by grants from the National Science Council (Grant NSC98-2320-B-075-003-MY3) and the Taipei Veterans General Hospital (Grant V101C-004), Taipei, Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BROOKS BR, 1983, J COMPUT CHEM, V4, P187, DOI 10.1002/jcc.540040211; Chan SL, 2006, J IMMUNOL, V176, P4852, DOI 10.4049/jimmunol.176.8.4852; Chavali GB, 2003, STRUCTURE, V11, P875, DOI 10.1016/S0969-2126(03)00131-X; CHITARRA V, 1993, P NATL ACAD SCI USA, V90, P7711, DOI 10.1073/pnas.90.16.7711; Chou H, 2011, MOL IMMUNOL, V48, P2130, DOI 10.1016/j.molimm.2011.07.004; Chruszcz M, 2012, J BIOL CHEM, V287, P7388, DOI 10.1074/jbc.M111.311159; Correa A, 2013, ACTA CRYSTALLOGR D, V69, P388, DOI 10.1107/S0907444912048664; Dai YC, 2011, J MOL MED, V89, P701, DOI 10.1007/s00109-011-0744-4; DAVIES DR, 1990, ANNU REV BIOCHEM, V59, P439, DOI 10.1146/annurev.bi.59.070190.002255; Flicker S, 2003, INT ARCH ALLERGY IMM, V132, P13, DOI 10.1159/000073260; Gieras A, 2011, J IMMUNOL, V186, P5333, DOI 10.4049/jimmunol.1000804; Glesner J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022223; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Johnson G, 2000, NUCLEIC ACIDS RES, V28, P214, DOI 10.1093/nar/28.1.214; Li M, 2008, J BIOL CHEM, V283, P22806, DOI 10.1074/jbc.M800937200; Lin WL, 2000, CLIN EXP ALLERGY, V30, P1653, DOI 10.1046/j.1365-2222.2000.00922.x; Mirza O, 2000, J IMMUNOL, V165, P331, DOI 10.4049/jimmunol.165.1.331; Monaco-Malbet S, 2000, STRUCTURE, V8, P1069, DOI 10.1016/S0969-2126(00)00507-4; Mueller GA, 2010, J ALLERGY CLIN IMMUN, V125, P909, DOI 10.1016/j.jaci.2009.12.016; Naik MT, 2008, STRUCTURE, V16, P125, DOI 10.1016/j.str.2007.10.022; Niemi M, 2007, STRUCTURE, V15, P1413, DOI 10.1016/j.str.2007.09.012; Padavattan S, 2007, J MOL BIOL, V368, P742, DOI 10.1016/j.jmb.2007.02.036; Pierce BG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024657; Pomes A, 2010, INT ARCH ALLERGY IMM, V152, P1, DOI 10.1159/000260078; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; SHEN HD, 1993, CLIN EXP ALLERGY, V23, P934, DOI 10.1111/j.1365-2222.1993.tb00278.x; SHEN HD, 1995, CLIN EXP ALLERGY, V25, P1000, DOI 10.1111/j.1365-2222.1995.tb00403.x; Shen HD, 1996, CLIN EXP ALLERGY, V26, P308, DOI 10.1111/j.1365-2222.1996.tb00096.x; Shen HD, 1997, CLIN EXP ALLERGY, V27, P824, DOI 10.1046/j.1365-2222.1997.650890.x; SHEN HD, 1995, CLIN EXP ALLERGY, V25, P416, DOI 10.1111/j.1365-2222.1995.tb01072.x; Shen HD, 2011, IMMUNOL CELL BIOL, V89, P225, DOI 10.1038/icb.2010.77; Simonelli L, 2010, J MOL BIOL, V396, P1491, DOI 10.1016/j.jmb.2009.12.053; Sundberg EJ, 2003, ADV PROTEIN CHEM, V61, P119; Tan KW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044850; Xu JL, 2000, IMMUNITY, V13, P37, DOI 10.1016/S1074-7613(00)00006-6	35	3	3	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2013	8	8							e71269	10.1371/journal.pone.0071269	http://dx.doi.org/10.1371/journal.pone.0071269			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	218XC	23940735	Green Published, gold, Green Submitted			2022-12-25	WOS:000324465000203
J	Varin, A; Pontikoglou, C; Labat, E; Deschaseaux, F; Sensebe, L				Varin, Audrey; Pontikoglou, Charalampos; Labat, Elodie; Deschaseaux, Frederic; Sensebe, Luc			CD200R/CD200 Inhibits Osteoclastogenesis: New Mechanism of Osteoclast Control by Mesenchymal Stem Cells in Human	PLOS ONE			English	Article							CD200 RECEPTOR; DEFECTIVE INTERLEUKIN-1; MONOCLONAL-ANTIBODIES; DIFFERENTIATION; PROTEIN; MACROPHAGES; ACTIVATION; INDUCTION; FAMILY; MICE	Bone homeostasis is maintained by the balance between bone-forming osteoblasts and bone-degrading osteoclasts. Osteoblasts have a mesenchymal origin whereas osteoclasts belong to the myeloid lineage. Osteoclast and osteoblast communication occurs through soluble factors secretion, cell-bone interaction and cell-cell contact, which modulate their activities. CD200 is an immunoglobulin superfamilly member expressed on various types of cells including mesenchymal stem cells (MSCs). CD200 receptor (CD200R) is expressed on myeloid cells such as monocytes/macrophages. We assume that CD200 could be a new molecule involved in the control of osteoclastogenesis and could play a role in MSC-osteoclast communication in humans. In this study, we demonstrated that soluble CD200 inhibited the differentiation of osteoclast precursors as well as their maturation in bone-resorbing cells in vitro. Soluble CD200 did not modify the monocyte phenotype but inhibited the receptor activator of nuclear factor kappa-B ligand (RANKL) signaling pathway as well as the gene expression of osteoclast markers such as osteoclast-associated receptor (OSCAR) and nuclear factor of activated T cells cytoplasmic 1 (NFATc1). Moreover, MSCs inhibited osteoclast formation, which depended on cell-cell contact and was associated with CD200 expression on the MSC surface. Our results clearly demonstrate that MSCs, through the expression of CD200, play a major role in the regulation of bone resorption and bone physiology and that the CD200-CD200R couple could be a new target to control bone diseases.	[Varin, Audrey; Labat, Elodie; Deschaseaux, Frederic; Sensebe, Luc] Univ Toulouse 3, INSERM, U1031, CNRS 5273,UMR,STROMALab, F-31062 Toulouse, France; [Varin, Audrey; Labat, Elodie; Deschaseaux, Frederic; Sensebe, Luc] Etab Francais Sang Pyrenees Mediterranee, Toulouse, France; [Pontikoglou, Charalampos] Univ Crete, Dept Hematol, Sch Med, Iraklion, Crete, Greece	Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); University of Crete	Varin, A (corresponding author), Univ Toulouse 3, INSERM, U1031, CNRS 5273,UMR,STROMALab, F-31062 Toulouse, France.	audrey.varin@efs.sante.fr		Varin, Audrey/0000-0002-9182-9193	FEDER funds MoDiCSoME; European Commission Seventh Framework Programme through the REBORNE project [241879]	FEDER funds MoDiCSoME; European Commission Seventh Framework Programme through the REBORNE project	This work was support by FEDER funds MoDiCSoME (CP) and the European Commission Seventh Framework Programme (FP7/2007-2013) (grant no. 241879), through the REBORNE project. The funders had no role in study design, data collection and analysis, decison to publish, or preparation of the manuscript.	Arron JR, 2001, J BIOL CHEM, V276, P30011, DOI 10.1074/jbc.M100414200; Carter DA, 2004, CURR EYE RES, V28, P427, DOI 10.1080/02713680490503778; Cherwinski HM, 2005, J IMMUNOL, V174, P1348, DOI 10.4049/jimmunol.174.3.1348; Cui WG, 2007, P NATL ACAD SCI USA, V104, P14436, DOI 10.1073/pnas.0702811104; Delorme B, 2008, BLOOD, V111, P2631, DOI 10.1182/blood-2007-07-099622; Du Rocher B, 2012, CYTOTHERAPY, V14, P12, DOI 10.3109/14653249.2011.594792; Gao Y, 2000, Climacteric, V3, P278, DOI 10.1080/13697130008500123; Giunti D, 2012, STEM CELLS, V30, P2044, DOI 10.1002/stem.1174; Gorczynski R, 2008, J IMMUNOL, V180, P5946, DOI 10.4049/jimmunol.180.9.5946; Gorczynski RM, 2005, TRANSPLANTATION, V79, P488, DOI 10.1097/01.TP.0000152118.51622.F9; Gorczynski RM, 2004, TRANSPLANTATION, V77, P1138, DOI 10.1097/01.TP.0000121773.18476.1C; Harada H, 1998, ENDOCRINOLOGY, V139, P3967, DOI 10.1210/en.139.9.3967; Hatherley D, 2005, J IMMUNOL, V175, P2469, DOI 10.4049/jimmunol.175.4.2469; Hoek RM, 2000, SCIENCE, V290, P1768, DOI 10.1126/science.290.5497.1768; Jenmalm MC, 2006, J IMMUNOL, V176, P191, DOI 10.4049/jimmunol.176.1.191; Kim J, 2009, EXP HEMATOL, V37, P1445, DOI 10.1016/j.exphem.2009.09.004; Kim Y, 2005, J BIOL CHEM, V280, P32905, DOI 10.1074/jbc.M505820200; Kronsteiner B, 2011, CELL IMMUNOL, V267, P30, DOI 10.1016/j.cellimm.2010.11.001; Lee L, 2006, IMMUNOL LETT, V105, P150, DOI 10.1016/j.imlet.2006.02.002; Lomaga MA, 1999, GENE DEV, V13, P1015, DOI 10.1101/gad.13.8.1015; Maggini J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009252; Matsumoto M, 2004, J BIOL CHEM, V279, P45969, DOI 10.1074/jbc.M408795200; Mihrshahi R, 2009, J IMMUNOL, V183, P4879, DOI 10.4049/jimmunol.0901531; Minas K, 2006, CRIT REV IMMUNOL, V26, P213, DOI 10.1615/CritRevImmunol.v26.i3.20; Naito A, 1999, GENES CELLS, V4, P353, DOI 10.1046/j.1365-2443.1999.00265.x; Nemeth K, 2009, NAT MED, V15, P42, DOI 10.1038/nm.1905; Oshita K, 2011, ARTHRITIS RHEUM-US, V63, P1658, DOI 10.1002/art.30309; Pietila M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031671; Simelyte E, 2008, ARTHRITIS RHEUM, V58, P1038, DOI 10.1002/art.23378; Simonet WS, 1997, CELL, V89, P309, DOI 10.1016/S0092-8674(00)80209-3; Spaggiari GM, 2009, BLOOD, V113, P6576, DOI 10.1182/blood-2009-02-203943; Suda T, 1999, ENDOCR REV, V20, P345, DOI 10.1210/er.20.3.345; Takayanagi H, 2002, DEV CELL, V3, P889, DOI 10.1016/S1534-5807(02)00369-6; Takayanagi H, 2007, ANN NY ACAD SCI, V1116, P227, DOI 10.1196/annals.1402.071; Wong BR, 1998, J BIOL CHEM, V273, P28355, DOI 10.1074/jbc.273.43.28355; Wright GJ, 2000, IMMUNITY, V13, P233, DOI 10.1016/S1074-7613(00)00023-6; Wright GJ, 2003, J IMMUNOL, V171, P3034, DOI 10.4049/jimmunol.171.6.3034; Zhao C, 2006, CELL METAB, V4, P111, DOI 10.1016/j.cmet.2006.05.012; Zhu H, 2009, STEM CELLS DEV, V18, P1473, DOI 10.1089/scd.2009.0021	39	31	34	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2013	8	8							e72831	10.1371/journal.pone.0072831	http://dx.doi.org/10.1371/journal.pone.0072831			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	218XC	23940819	gold, Green Published, Green Submitted			2022-12-25	WOS:000324465000249
J	Xue, YT; Cai, XJ; Wang, LL; Liao, BJ; Zhang, H; Shan, YL; Chen, QY; Zhou, TC; Li, XR; Hou, JD; Chen, SB; Luo, RP; Qin, DJ; Pei, DQ; Pan, GJ				Xue, Yanting; Cai, Xiujuan; Wang, Linli; Liao, Baojian; Zhang, Hui; Shan, Yongli; Chen, Qianyu; Zhou, Tiancheng; Li, Xirui; Hou, Jundi; Chen, Shubin; Luo, Rongping; Qin, Dajiang; Pei, Duanqing; Pan, Guangjin			Generating a Non-Integrating Human Induced Pluripotent Stem Cell Bank from Urine-Derived Cells	PLOS ONE			English	Article							HUMAN FIBROBLASTS; DERIVATION; INDUCTION; PLASMID; MIR-302	Induced pluripotent stem cell (iPS cell) holds great potential for applications in regenerative medicine, drug discovery, and disease modeling. We describe here a practical method to generate human iPS cells from urine-derived cells (UCs) under feeder-free, virus-free, serum-free condition and without oncogene c-MYC. We showed that this approach could be applied in a large population with different genetic backgrounds. UCs are easily accessible and exhibit high reprogramming efficiency, offering advantages over other cell types used for the purpose of iPS generation. Using the approach described in this study, we have generated 93 iPS cell lines from 20 donors with diverse genetic backgrounds. The non-viral iPS cell bank with these cell lines provides a valuable resource for iPS cells research, facilitating future applications of human iPS cells.	[Xue, Yanting; Cai, Xiujuan; Wang, Linli; Liao, Baojian; Zhang, Hui; Shan, Yongli; Chen, Qianyu; Zhou, Tiancheng; Li, Xirui; Hou, Jundi; Chen, Shubin; Luo, Rongping; Qin, Dajiang; Pei, Duanqing; Pan, Guangjin] Chinese Acad Sci, Guangzhou Inst Biomed & Hlth, South China Inst Stem Cell Biol & Regenerat Med, CAS Key Lab Regenerat Biol, Guangzhou 510530, Guangdong, Peoples R China; [Xue, Yanting; Hou, Jundi; Pei, Duanqing; Pan, Guangjin] Univ Sci & Technol China, Sch Life Sci, Hefei 230026, Anhui, Peoples R China; [Xue, Yanting; Cai, Xiujuan; Wang, Linli; Liao, Baojian; Zhang, Hui; Shan, Yongli; Chen, Qianyu; Zhou, Tiancheng; Li, Xirui; Hou, Jundi; Chen, Shubin; Luo, Rongping; Qin, Dajiang; Pei, Duanqing; Pan, Guangjin] Chinese Acad Sci, Guangzhou Inst Biomed & Hlth, South China Inst Stem Cell Biol & Regenerat Med, Guangdong Prov Key Lab Stem Cell & Regenerat Med, Guangzhou 510530, Guangdong, Peoples R China	Chinese Academy of Sciences; Guangzhou Institute of Biomedicine & Health, CAS; Chinese Academy of Sciences; University of Science & Technology of China, CAS; Chinese Academy of Sciences; Guangzhou Institute of Biomedicine & Health, CAS	Pan, GJ (corresponding author), Chinese Acad Sci, Guangzhou Inst Biomed & Hlth, South China Inst Stem Cell Biol & Regenerat Med, CAS Key Lab Regenerat Biol, Guangzhou 510530, Guangdong, Peoples R China.	pan_guangjin@gibh.ac.cn	Wang, Linli/R-5688-2018; Liao, Baojian/AAI-6286-2021	Wang, Linli/0000-0002-8380-6135; 	Chinese Academy of Sciences [XDA01020202, XDA01020401]; 973 Program of China [2012CB966503 and 2012CB966802]; National Basic Research Program of China; National S&T Major Special Project on Major New Drug Innovation [2011ZX09102-010]; National Natural Science Foundation of China [31200970]; Chinese Academy of Sciences, China	Chinese Academy of Sciences(Chinese Academy of Sciences); 973 Program of China(National Basic Research Program of China); National Basic Research Program of China(National Basic Research Program of China); National S&T Major Special Project on Major New Drug Innovation; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese Academy of Sciences, China(Chinese Academy of Sciences)	This work is supported by "Strategic Priority Research Program" of the Chinese Academy of Sciences Grant No. XDA01020202 and XDA01020401 and National Basic Research Program of China, 973 Program of China, 2012CB966503 and 2012CB966802 and National S&T Major Special Project on Major New Drug Innovation, Grant No. 2011ZX09102-010, National Natural Science Foundation of China (31200970), D. Pei and G. Pan are supported by the "100 Talents Project" of Chinese Academy of Sciences, China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cai JL, 2010, J BIOL CHEM, V285, P11227, DOI 10.1074/jbc.M109.086389; Chen GK, 2011, NAT METHODS, V8, P424, DOI [10.1038/nmeth.1593, 10.1038/NMETH.1593]; Chen Y, 2013, RHEUMATOLOGY INT; Cheng LZ, 2012, CELL STEM CELL, V10, P337, DOI 10.1016/j.stem.2012.01.005; Chou BK, 2011, CELL RES, V21, P518, DOI 10.1038/cr.2011.12; Denham M, 2012, STEM CELLS, V30, P2400, DOI 10.1002/stem.1204; Geti I, 2012, STEM CELL TRANSL MED, V1, P855, DOI 10.5966/sctm.2012-0093; Gore A, 2011, NATURE, V471, P63, DOI 10.1038/nature09805; Hanna J, 2009, CELL STEM CELL, V4, P513, DOI 10.1016/j.stem.2009.04.015; Hu SJ, 2013, STEM CELLS, V31, P259, DOI 10.1002/stem.1278; Hussein SM, 2011, NATURE, V471, P58, DOI 10.1038/nature09871; Kim D, 2009, CELL STEM CELL, V4, P472, DOI 10.1016/j.stem.2009.05.005; Lefort N, 2008, NAT BIOTECHNOL, V26, P1364, DOI 10.1038/nbt.1509; Li RH, 2010, CELL STEM CELL, V7, P51, DOI 10.1016/j.stem.2010.04.014; Li WL, 2011, P NATL ACAD SCI USA, V108, P8299, DOI 10.1073/pnas.1014041108; Liao BJ, 2011, J BIOL CHEM, V286, P17359, DOI 10.1074/jbc.C111.235960; Lin SL, 2010, CANCER RES, V70, P9473, DOI 10.1158/0008-5472.CAN-10-2746; Loh YH, 2009, BLOOD, V113, P5476, DOI 10.1182/blood-2009-02-204800; Ludwig TE, 2006, NAT BIOTECHNOL, V24, P185, DOI 10.1038/nbt1177; Mack AA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027956; Martins-Taylor K, 2011, NAT BIOTECHNOL, V29, P488, DOI 10.1038/nbt.1890; Okita K, 2008, SCIENCE, V322, P949, DOI 10.1126/science.1164270; Okita K, 2007, NATURE, V448, P313, DOI 10.1038/nature05934; Plews JR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014397; Stadtfeld M, 2008, SCIENCE, V322, P945, DOI 10.1126/science.1162494; Subramanyam D, 2011, NAT BIOTECHNOL, V29, P443, DOI 10.1038/nbt.1862; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Utikal J, 2009, NATURE, V460, P1145, DOI 10.1038/nature08285; Wang LH, 2013, NAT METHODS, V10, P84, DOI [10.1038/NMETH.2283, 10.1038/nmeth.2283]; Warren L, 2012, SCI REP-UK, V2, DOI 10.1038/srep00657; Warren L, 2010, CELL STEM CELL, V7, P618, DOI 10.1016/j.stem.2010.08.012; Yamanaka S, 2009, CELL, V137, P13, DOI 10.1016/j.cell.2009.03.034; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Yu JY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017557; Yu JY, 2009, SCIENCE, V324, P797, DOI 10.1126/science.1172482; Zhou HY, 2009, CELL STEM CELL, V4, P381, DOI 10.1016/j.stem.2009.04.005; Zhou JM, 2013, STEM CELLS DEV, V22, DOI 10.1089/scd.2012.0260; Zhou T, 2012, NAT PROTOC, V7, P2080, DOI 10.1038/nprot.2012.115; Zhou T, 2011, J AM SOC NEPHROL, V22, P1221, DOI 10.1681/ASN.2011010106	39	131	139	0	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2013	8	8							e70573	10.1371/journal.pone.0070573	http://dx.doi.org/10.1371/journal.pone.0070573			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	218XC	23940595	gold, Green Submitted, Green Published			2022-12-25	WOS:000324465000089
J	Zhang, Z; Xu, K; Bi, YH; Yu, GB; Wang, SW; Qi, X; Zhong, HS				Zhang, Zhen; Xu, Ke; Bi, Yonghua; Yu, Guibo; Wang, Siwei; Qi, Xun; Zhong, Hongshan			Low Intensity Ultrasound Promotes the Sensitivity of Rat Brain Glioma to Doxorubicin by Down-Regulating the Expressions of P-Glucoprotein and Multidrug Resistance Protein 1 In Vitro and In Vivo	PLOS ONE			English	Article							NF-KAPPA-B; MOLECULAR-MECHANISM; GENE-EXPRESSION; CELLS; CANCER; TRANSPORTERS; INHIBITION; PATHWAY; MICROBUBBLES; APOPTOSIS	The overall prognosis for malignant glioma is extremely poor, and treatment options are limited in part because of multidrug resistant proteins. Our previous findings suggest low intensity ultrasound (LIUS) can induce apoptosis of glioma cells. Given this finding, we were interested in determining if LIUS could help treat glioma by inhibiting multidrug resistant proteins, and if so, which pathways are involved. In this study, the toxicity sensitivity and multidrug resistance proteins of glioma induced by LIUS were investigated using CCK-8, immunohistochemistry, immunofluorency, and RT-PCR in tissue samples and cultured cells. LIUS inhibited increase of C6 cells in an intensity-and time-dependent manner. The toxicity sensitivity of C6 cells increased significantly after LIUS sonication (intensity of 142.0 mW/cm(2)) or Doxorubicin (DOX) at different concentration, particularly by the combination of LIUS sonication and DOX. The expressions of P-gp and MRP1 decreased significantly post-sonication at intensity of 142.0 mW/cm(2) both in vitro and in vivo. The expressions of p110 delta (PI3K), NF-kappa B-p65, Akt/PKB, and p-Akt/PKB were downregulated by LIUS sonication and DOX treatment separately or in combination at the same parameters in rat glioma. These results indicate that LIUS could increase the toxicity sensitivity of glioma by down-regulating the expressions of P-gp and MRP1, which might be mediated by the PI3K/Akt/NF-kappa B pathway.	[Zhang, Zhen; Wang, Siwei] China Med Univ, Affiliated Hosp 1, Dept Ultrasound, Shenyang, Liaoning, Peoples R China; [Zhang, Zhen; Xu, Ke; Bi, Yonghua; Yu, Guibo; Qi, Xun; Zhong, Hongshan] China Med Univ, Affiliated Hosp 1, Key Lab Diag & Intervent Therapy Liaoning Prov, Liaoning, Peoples R China; [Xu, Ke; Bi, Yonghua; Zhong, Hongshan] China Med Univ, Affiliated Hosp 1, Dept Radiol, Shenyang, Liaoning, Peoples R China	China Medical University; China Medical University	Zhang, Z (corresponding author), China Med Univ, Affiliated Hosp 1, Dept Ultrasound, Shenyang, Liaoning, Peoples R China.	zhenshcc@163.com			National Natural Science Foundation of China [81000620]; Chinese national post-doctoral foundation	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese national post-doctoral foundation	This work was supported by grant 81000620 from the National Natural Science Foundation of China, and Chinese national post-doctoral foundation from 2010. All the materials, animals and antibodies were provided by these two funders. The funders played important roles in study design, data collection and analysis, decision to publish, and preparation of the manuscript.	Choi BH, 2008, CANCER LETT, V259, P111, DOI 10.1016/j.canlet.2007.10.003; Feng Y, 2010, J ULTRAS MED, V29, P963, DOI 10.7863/jum.2010.29.6.963; Fletcher JI, 2010, NAT REV CANCER, V10, P147, DOI 10.1038/nrc2789; Garcia MG, 2009, LEUKEMIA RES, V33, P288, DOI 10.1016/j.leukres.2008.06.010; Ghislin S, 2012, CELL CYCLE, V11, P1634, DOI 10.4161/cc.20095; Ghoshal G, 2012, ULTRASONIC IMAGING, V34, P15, DOI 10.1177/016173461203400102; Gottesman MM, 2002, NAT REV CANCER, V2, P48, DOI 10.1038/nrc706; Guo ZH, 2011, MOL BIOTECHNOL, V48, P138, DOI 10.1007/s12033-010-9354-6; Hien TT, 2010, MOL NUTR FOOD RES, V54, P918, DOI 10.1002/mnfr.200900146; Ibsen S, 2011, J ACOUST SOC AM, V130, P2503; Jeong SJ, 2005, ONCOGENE, V24, P6719, DOI 10.1038/sj.onc.1208825; Khokhlova TD, 2011, J GASTROINTEST ONCOL, V2, P175, DOI 10.3978/j.issn.2078-6891.2011.033; KONDO T, 1993, FREE RADICAL RES COM, V19, pS193, DOI 10.3109/10715769309056s193; Kuo MT, 2002, ONCOGENE, V21, P1945, DOI 10.1038/sj.onc.1205117; Li JH, 2008, NEUROL SCI, V29, P229, DOI 10.1007/s10072-008-0972-8; Li YC, 2012, LIFE SCI, V90, P962, DOI 10.1016/j.lfs.2012.04.044; Loscher W, 2005, NAT REV NEUROSCI, V6, P591, DOI 10.1038/nrn1728; Nakamura C, 2008, RHEUMATOLOGY, V47, P418, DOI 10.1093/rheumatology/ken003; Palumbo P, 2011, INT J IMMUNOPATH PH, V24, P411, DOI 10.1177/039463201102400214; Pellicer B, 2011, ULTRASOUND OBST GYN, V37, P643, DOI 10.1002/uog.8842; Sabbatini P, 1999, J BIOL CHEM, V274, P24263, DOI 10.1074/jbc.274.34.24263; Schuster A, 2013, ANN ANAT, V195, P57, DOI 10.1016/j.aanat.2012.03.008; Shao ZY, 2008, ULTRASONICS, V48, P297, DOI 10.1016/j.ultras.2007.11.004; TERHAAR G, 1989, PHYS MED BIOL, V34, P1743, DOI 10.1088/0031-9155/34/11/021; Wu F, 2011, ULTRASOUND MED BIOL, V37, P151, DOI 10.1016/j.ultrasmedbio.2010.10.009; Zeng DX, 2012, RHEUMATOL INT, V32, P3771, DOI 10.1007/s00296-011-2196-0; Zhang S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038343; Zhang Y, 2009, J PATHOL, V218, P248, DOI 10.1002/path.2533; Zhang Z, BRAIN RES, V1473, P25; Zhang Z, 2009, J NEUROSCI RES, V87, P2282, DOI 10.1002/jnr.22061	30	3	4	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2013	8	8							e70685	10.1371/journal.pone.0070685	http://dx.doi.org/10.1371/journal.pone.0070685			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	218XC	23940624	Green Submitted, gold, Green Published			2022-12-25	WOS:000324465000118
J	Jung, M				Jung, Minsoo			Sexual Behavior and Condom Use among Gay Men, Female Sex Workers, and Their Customers: Evidence from South Korea	PLOS ONE			English	Article							RISK BEHAVIOR; DETERMINANTS; VIETNAM; WOMEN	Background: Despite the significance for sexually transmitted diseases (STD) control in East Asia, few studies have examined the relationship between high-risk sexual behavior and condom use. We investigated how three sexually vulnerable groups for STDs show differences in condom use behaviors (CUBs) depending on their STD infection. Methods: The source of data came from the National Survey for STD Prevalence Rate and Sexual Behavior of the High-Risk Sexual Community. The effects of behavioral determinants on CUBs were estimated by using path analysis models. An 11-item questionnaire assessing subjects' health risk behaviors, sexual beliefs, sexual risk behaviors, and condom use. Results: Condom use was higher for men who have sex with men (MSM; n = 108) when they were bisexuals and had high self-efficacy, for Johns (Johns; n = 118) when they had experience of STD infection, and for female sex workers (FSWs; n = 1,083) when they had high self-efficacy, did not engage in drunken sex, and were anxious about infection. Regardless of whether they were infected with STDs, FSWs always used condom when they had high sexual beliefs. On the contrary, Johns exhibited a negative relationship between sexual risk behavior and condom use when they had experience of STD infection. The variable commonly significant to all three groups was the number of sex partners; but it exhibited a positive relationship with MSMs and Johns, and a negative one with FSWs. Conclusions: CUBs were related to sexual beliefs as well as sexual risk behavior. At the same time, the experience of STD infection mediated the relationship between the two. Therefore, we need to draw social attention to promote safer sex among STD-vulnerable groups.	[Jung, Minsoo] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; [Jung, Minsoo] Dongduk Womens Univ, Dept Hlth Sci, Seoul, South Korea	Harvard University; Dana-Farber Cancer Institute; Dongduk Women's University	Jung, M (corresponding author), Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA.	minsoo_jung@dfci.harvard.edu		Jung, Minsoo/0000-0003-3317-6507	National Research Foundation of Korea; Korean Government [NRF-2007-E00049-00]	National Research Foundation of Korea(National Research Foundation of Korea); Korean Government(Korean Government)	This work was supported by the National Research Foundation of Korea Grant funded by the Korean Government (NRF-2007-E00049-00). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AJZEN I, 1991, ORGAN BEHAV HUM DEC, V50, P179, DOI 10.1016/0749-5978(91)90020-T; Albarracin D, 2001, PSYCHOL BULL, V127, P142, DOI 10.1037//0033-2909.127.1.142; [Anonymous], 2011, PREVALENCE INCIDENCE; Bandura A, 1997, SELF EFFICACY EXERCI; Basen-Engquist K, 1999, HEALTH EDUC RES, V14, P25, DOI 10.1093/her/14.1.25; Becker MH, 1974, HLTH BELIEF MODEL PE; Behavioral Surveillance Surveys, 2000, GUID REP BEH SURV PO; Cho BH, 2008, SEXUALITY RISK HIV A; DEBRO SC, 1994, PSYCHOL WOMEN QUART, V18, P165, DOI 10.1111/j.1471-6402.1994.tb00449.x; Ellingson S., 2004, SEXUAL ORG CITY, P3, DOI [DOI 10.7208/CHICAGO/9780226470337.003.0001, 10.7208/chicago/9780226470337.003.0001]; Feinleib JA, 1994, SOCIAL ORG SEXUALITY, P376; Fishbein M., 1975, BELIEF ATTITUDE INTE; FISHER JD, 1992, PSYCHOL BULL, V111, P455, DOI 10.1037/0033-2909.111.3.455; Jeong HJ, 2014, ASIA-PAC J PUBLIC HE, V26, P147, DOI 10.1177/1010539512436873; Johnston LG, 2006, J URBAN HEALTH, V83, pI16, DOI 10.1007/s11524-006-9099-5; Jung M, 2012, J PREV MED PUBLIC HL, V45, P156; Jung M, 2012, SEX DISABIL, V30, P421, DOI 10.1007/s11195-012-9261-9; Jung M, 2012, SEX DISABIL, V30, P199, DOI 10.1007/s11195-011-9245-1; Jung M, 2009, SEX DISABIL, V27, P127, DOI 10.1007/s11195-009-9122-3; Kee Mee Kyung, 2004, J Prev Med Public Health, V37, P220; Lau JTF, 2007, ARCH SEX BEHAV, V36, P849, DOI 10.1007/s10508-007-9203-2; Leigh BC, 2008, AIDS BEHAV, V12, P104, DOI 10.1007/s10461-007-9216-9; Metcalf John, 2007, DANCING NIGHTLY TAVE, pix; Morisky DE, 2010, ASIA-PAC J PUBLIC HE, V22, p151S, DOI 10.1177/1010539510373018; Muhib FB, 2001, PUBLIC HEALTH REP, V116, P216, DOI 10.1093/phr/116.S1.216; Noar SM, 2002, PSYCHOL HEALTH, V17, P711, DOI 10.1080/0887044021000030580; PETERSON JL, 1992, AM J PUBLIC HEALTH, V82, P1490, DOI 10.2105/AJPH.82.11.1490; Salabarria-Pena Y, 2003, AIDS BEHAV, V7, P163, DOI 10.1023/A:1023998308892; Scorgie F, 2012, AIDS BEHAV, V16, P920, DOI 10.1007/s10461-011-9985-z; Semaan Salaam, 2002, AIDS Reviews, V4, P213; Swenson R, 2007, THESIS STATE U NEW Y; Thato S, 2002, THESIS U PITTSBURGH; Tran TTM, 2008, ASIA-PAC J PUBLIC HE, V20, P370, DOI 10.1177/1010539508322485; Tran TN, 2006, AIDS BEHAV, V10, P159, DOI 10.1007/s10461-005-9061-7; Tucker JD, 2011, J INFECT DIS, V204, pS1206, DOI 10.1093/infdis/jir534; Tucker JD, 2011, J INFECT DIS, V204, pS1203, DOI 10.1093/infdis/jir533; Tucker JD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024816; van Kesteren NMC, 2007, ARCH SEX BEHAV, V36, P437, DOI 10.1007/s10508-006-9125-4; World Health Organization, 2001, GLOB PREV INC SEL CU	39	12	12	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2013	8	6							e66867	10.1371/journal.pone.0066867	http://dx.doi.org/10.1371/journal.pone.0066867			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	182JP	23950786	gold, Green Published, Green Submitted			2022-12-25	WOS:000321738400072
J	Johnson, A; Wu, RH; Peetz, M; Gygi, SP; Moazed, D				Johnson, Aaron; Wu, Ronghu; Peetz, Matthew; Gygi, Steven P.; Moazed, Danesh			Heterochromatic Gene Silencing by Activator Interference and a Transcription Elongation Barrier	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Chromatin; Chromatin Modification; Gene Silencing; Heterochromatin; Transcription; Sir Proteins	RNA-POLYMERASE; SIR COMPLEX; CHROMATIN; YEAST; NUCLEOSOMES; BINDING; RECONSTITUTION; MECHANISM; DOMAIN; BLOCK	Heterochromatin silences transcription, contributing to development, differentiation, and genome stability in eukaryotic organisms. Budding yeast heterochromatic silencing is strictly dependent on the silent information regulator (SIR) complex composed of the Sir2 histone deacetylase and the chromatin-interacting proteins Sir3 and Sir4. We use reconstituted SIR heterochromatin to characterize the steps in transcription that are disrupted to achieve silencing. Transcriptional activator binding is permitted before and after heterochromatin assembly. A comprehensive proteomic approach identified heterochromatin-mediated disruption of activator interactions with coactivator complexes. We also find that if RNA polymerase II (Pol II) is allowed to initiate transcription, the SIR complex blocks elongation on chromatin while maintaining Pol II in a halted conformation. This Pol II elongation barrier functions for even one nucleosome, is more effective when assembled with multiple nucleosomes, and is sensitive to a histone mutation that is known to disrupt silencing. This dual mechanism of silencing suggests a conserved principle of heterochromatin in assembling a specific structure that targets multiple steps to achieve repression.	[Johnson, Aaron; Wu, Ronghu; Gygi, Steven P.; Moazed, Danesh] Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA; [Moazed, Danesh] Harvard Univ, Sch Med, Howard Hughes Med Inst, Boston, MA 02115 USA; [Johnson, Aaron; Peetz, Matthew] Univ Colorado, Dept Biochem & Mol Genet, Sch Med, Aurora, CO 80045 USA	Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Howard Hughes Medical Institute; University of Colorado System; University of Colorado Anschutz Medical Campus	Johnson, A (corresponding author), Univ Colorado, Dept Biochem & Mol Genet, Sch Med, 12801 E 17th Ave, Aurora, CO 80045 USA.	aaron.m.johnson@ucdenver.edu			National Institutes of Health [K99/R00 GM094291, HG3456, GM67945, RO1 GM061641]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG003456] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM067945, R01GM061641, K99GM094291, R00GM094291] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Pathway to Independence Award K99/R00 GM094291 (to A. J.), National Institutes of Health Grants HG3456 and GM67945 (to S. P. G.), and National Institutes of Health Grant RO1 GM061641 (to D. M.).	Armache KJ, 2011, SCIENCE, V334, P977, DOI 10.1126/science.1210915; Bhaumik SR, 2011, BBA-GENE REGUL MECH, V1809, P97, DOI 10.1016/j.bbagrm.2010.08.009; Bondarenko VA, 2006, MOL CELL, V24, P469, DOI 10.1016/j.molcel.2006.09.009; Buhler M, 2007, NAT STRUCT MOL BIOL, V14, P1041, DOI 10.1038/nsmb1315; Buhler M, 2009, CHROMOSOMA, V118, P141, DOI 10.1007/s00412-008-0195-z; Carey M, 2006, MOL CELL, V24, P481, DOI 10.1016/j.molcel.2006.09.012; Chen LY, 2004, BIOCHEM CELL BIOL, V82, P413, DOI 10.1139/O04-035; Chen LY, 2005, CELL, V120, P37, DOI 10.1016/j.cell.2004.11.030; Dellino GI, 2004, MOL CELL, V13, P887, DOI 10.1016/S1097-2765(04)00128-5; Elias JE, 2007, NAT METHODS, V4, P207, DOI 10.1038/nmeth1019; Fitzgerald DP, 2001, MOL CELL BIOL, V21, P6585, DOI 10.1128/MCB.21.19.6585-6597.2001; Francis NJ, 2004, SCIENCE, V306, P1574, DOI 10.1126/science.1100576; Gao L, 2008, MOL CELL BIOL, V28, P3979, DOI 10.1128/MCB.00019-08; Grewal SIS, 2003, SCIENCE, V301, P798, DOI 10.1126/science.1086887; HECHT A, 1995, CELL, V80, P583, DOI 10.1016/0092-8674(95)90512-X; Hoppe GJ, 2002, MOL CELL BIOL, V22, P4167, DOI 10.1128/MCB.22.12.4167-4180.2002; Huttlin EL, 2010, CELL, V143, P1174, DOI 10.1016/j.cell.2010.12.001; Johnson A, 2009, MOL CELL, V35, P769, DOI 10.1016/j.molcel.2009.07.030; Keogh MC, 2002, MOL CELL BIOL, V22, P1288, DOI 10.1128/MCB.22.5.1288-1297.2002; King IFG, 2002, MOL CELL BIOL, V22, P7919, DOI 10.1128/MCB.22.22.7919-7928.2002; Kitada T, 2012, GENE DEV, V26, P2443, DOI 10.1101/gad.201095.112; Kong SE, 2005, P NATL ACAD SCI USA, V102, P10094, DOI 10.1073/pnas.0503017102; Ku M, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000242; Lehmann L, 2012, J BIOL CHEM, V287, P35784, DOI 10.1074/jbc.M112.397430; Li G, 2004, NAT STRUCT MOL BIOL, V11, P763, DOI 10.1038/nsmb801; Liou GG, 2005, CELL, V121, P515, DOI 10.1016/j.cell.2005.03.035; LOO S, 1994, SCIENCE, V264, P1768, DOI 10.1126/science.8209257; Margueron R, 2008, MOL CELL, V32, P503, DOI 10.1016/j.molcel.2008.11.004; Martino F, 2009, MOL CELL, V33, P323, DOI 10.1016/j.molcel.2009.01.009; Reifsnyder C, 1996, NAT GENET, V14, P42, DOI 10.1038/ng0996-42; Rudner AD, 2005, MOL CELL BIOL, V25, P4514, DOI 10.1128/MCB.25.11.4514-4528.2005; Rusche LN, 2003, ANNU REV BIOCHEM, V72, P481, DOI 10.1146/annurev.biochem.72.121801.161547; Rusche LN, 2002, MOL BIOL CELL, V13, P2207, DOI 10.1091/mbc.E02-03-0175; SAWADOGO M, 1985, P NATL ACAD SCI USA, V82, P4394, DOI 10.1073/pnas.82.13.4394; Sekinger EA, 2001, CELL, V105, P403, DOI 10.1016/S0092-8674(01)00329-4; Sikorski TW, 2012, J BIOL CHEM, V287, P35397, DOI 10.1074/jbc.M112.391581; Sinha M, 2009, CELL, V138, P1109, DOI 10.1016/j.cell.2009.07.013; Trojer P, 2007, MOL CELL, V28, P1, DOI 10.1016/j.molcel.2007.09.011; van Leeuwen F, 2002, CELL, V109, P745, DOI 10.1016/S0092-8674(02)00759-6; Wang F, 2013, P NATL ACAD SCI USA, V110, P8495, DOI 10.1073/pnas.1300126110; Wong KH, 2011, GENE DEV, V25, P2525, DOI 10.1101/gad.179275.111; WOONTNER M, 1991, MOL CELL BIOL, V11, P4555, DOI 10.1128/MCB.11.9.4555; YATES JR, 1995, ANAL CHEM, V67, P1426, DOI 10.1021/ac00104a020	43	19	19	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 4	2013	288	40					28771	28782		10.1074/jbc.M113.460071	http://dx.doi.org/10.1074/jbc.M113.460071			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	298BL	23940036	Green Published, hybrid			2022-12-25	WOS:000330298800030
J	Fountzilas, E; Kotoula, V; Angouridakis, N; Karasmanis, I; Wirtz, RM; Eleftheraki, AG; Veltrup, E; Markou, K; Nikolaou, A; Pectasides, D; Fountzilas, G				Fountzilas, Elena; Kotoula, Vassiliki; Angouridakis, Nikolaos; Karasmanis, Ilias; Wirtz, Ralph M.; Eleftheraki, Anastasia G.; Veltrup, Elke; Markou, Konstantinos; Nikolaou, Angelos; Pectasides, Dimitrios; Fountzilas, George			Identification and Validation of a Multigene Predictor of Recurrence in Primary Laryngeal Cancer	PLOS ONE			English	Article							SQUAMOUS-CELL CARCINOMA; GENE-EXPRESSION SIGNATURE; PROTEIN-KINASE D1; NEGATIVE BREAST-CANCER; MOLECULAR CLASSIFICATION; PROGNOSTIC-SIGNIFICANCE; POOR-PROGNOSIS; PRIMARY HEAD; LUNG-CANCER; NECK-CANCER	Purpose: Local recurrence is the major manifestation of treatment failure in patients with operable laryngeal carcinoma. Established clinicopathological factors cannot sufficiently predict patients that are likely to recur after treatment. Additional tools are therefore required to accurately identify patients at high risk for recurrence. This study attempts to identify and independently validate gene expression models, prognostic of disease-free survival (DFS) in operable laryngeal cancer. Materials and Methods: Using Affymetrix U133A Genechips, we profiled fresh-frozen tumor tissues from 66 patients with laryngeal cancer treated locally with surgery. We applied Cox regression proportional hazards modeling to identify multigene predictors of recurrence. Gene models were then validated in two independent cohorts of 54 and 187 patients (fresh-frozen and formalin-fixed tissue validation sets, respectively). Results: We focused on genes univariately associated with DFS (p<0.01) in the training set. Among several models comprising different numbers of genes, a 30-probe set model demonstrated optimal performance in both the training (log-rank, p<0.001) and 1st validation (p = 0.010) sets. Specifically, in the 1st validation set, median DFS as predicted by the 30-probe set model, was 34 and 80 months for high-and low-risk patients, respectively. Hazard ratio (HR) for recurrence in the high-risk group was 3.87 (95% CI 1.28-11.73, Wald's p = 0.017). Testing the expression of selected genes from the above model in the 2nd validation set, with qPCR, revealed significant associations of single markers, such as ACE2, FLOT1 and PRKD1, with patient DFS. High PRKD1 remained an unfavorable prognostic marker upon multivariate analysis (HR = 2.00, 95% CI 1.28-3.14, p = 0.002) along with positive nodal status. Conclusions: We have established and validated gene models that can successfully stratify patients with laryngeal cancer, based on their risk for recurrence. It seems worthy to prospectively validate PRKD1 expression as a laryngeal cancer prognostic marker, for routine clinical applications.	[Fountzilas, Elena; Fountzilas, George] Aristotle Univ Thessaloniki, Sch Med, Papageorgiou Hosp, Dept Med Oncol, GR-54006 Thessaloniki, Greece; [Kotoula, Vassiliki] Aristotle Univ Thessaloniki, Sch Med, Dept Pathol, GR-54006 Thessaloniki, Greece; [Angouridakis, Nikolaos; Karasmanis, Ilias; Markou, Konstantinos; Nikolaou, Angelos] Aristotle Univ Thessaloniki, Sch Med, ENT Dept, AHEPA Hosp, GR-54006 Thessaloniki, Greece; [Wirtz, Ralph M.; Veltrup, Elke] Siemens Healthcare Diagnost, Cologne, Germany; [Eleftheraki, Anastasia G.] Hellen Cooperat Oncol Grp, Data Off, Sect Biostat, Athens, Greece; [Pectasides, Dimitrios] Univ Athens, Sch Med, Dept Internal Med 2, Oncol Sect,Hippokrat Hosp, GR-11527 Athens, Greece	Aristotle University of Thessaloniki; Papageorgiou Hospital; Aristotle University of Thessaloniki; Aristotle University of Thessaloniki; Ahepa University Hospital; Siemens AG; Siemens Germany; Hellenic Cooperative Oncology Group; Athens Medical School; Hippokration General Hospital; National & Kapodistrian University of Athens	Fountzilas, E (corresponding author), Aristotle Univ Thessaloniki, Sch Med, Papageorgiou Hosp, Dept Med Oncol, GR-54006 Thessaloniki, Greece.	elenafou@gmail.com	Fountzilas, George/ABF-2139-2020	ELEFTHERAKI, ANASTASIA/0000-0003-1826-4699; Markou, Konstantinos/0000-0001-9891-5185; Fountzilas, George/0000-0001-8045-2186	Hellenic Cooperative Oncology Group (HeCOG) [HE R_5G]	Hellenic Cooperative Oncology Group (HeCOG)	This work was supported by an internal Hellenic Cooperative Oncology Group (HeCOG) research grant (HE R_5G). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdueva D, 2010, J MOL DIAGN, V12, P409, DOI 10.2353/jmoldx.2010.090155; Argiris A, 2008, LANCET, V371, P1695, DOI 10.1016/S0140-6736(08)60728-X; Baek SK, 2009, LARYNGOSCOPE, V119, P1325, DOI 10.1002/lary.20483; Bair E, 2004, PLOS BIOL, V2, P511, DOI 10.1371/journal.pbio.0020108; Barnes CJ, 2007, CLIN CANCER RES, V13, P4291, DOI 10.1158/1078-0432.CCR-06-2040; Bild AH, 2006, NATURE, V439, P353, DOI 10.1038/nature04296; Carinci F, 2007, TRANSL RES, V150, P233, DOI 10.1016/j.trsl.2007.03.011; Chen HY, 2007, NEW ENGL J MED, V356, P11, DOI 10.1056/NEJMoa060096; Chung CH, 2004, CANCER CELL, V5, P489, DOI 10.1016/S1535-6108(04)00112-6; Chung CH, 2006, CANCER RES, V66, P8210, DOI 10.1158/0008-5472.CAN-06-1213; Colman H, 2010, NEURO-ONCOLOGY, V12, P49, DOI 10.1093/neuonc/nop007; Cromer A, 2004, ONCOGENE, V23, P2484, DOI 10.1038/sj.onc.1207345; Dionysopoulos D, 2013, STRAHLENTHER ONKOL; Eiseler T, 2012, J BIOL CHEM, V287, P32367, DOI 10.1074/jbc.M112.370999; Feng Y, 2011, ONCOL REP, V26, P1157, DOI 10.3892/or.2011.1394; Feng Y, 2010, ONCOL REP, V23, P941, DOI 10.3892/or_00000718; Ferlay J, 2001, GLOBOCAN 2002 CANC I; Fountzilas E, 2012, ANN ONCOL, V23, P2146, DOI 10.1093/annonc/mdr576; Fukai Y, 2003, INT J CANCER, V104, P161, DOI 10.1002/ijc.10929; Ginos MA, 2004, CANCER RES, V64, P55, DOI 10.1158/0008-5472.CAN-03-2144; Goeman JJ, 2004, BIOINFORMATICS, V20, P93, DOI 10.1093/bioinformatics/btg382; Gregoire V, 2010, ANN ONCOL, V21, pv184, DOI 10.1093/annonc/mdq185; Hennig G, 2010, CLIN CHEM, V56, P1845, DOI 10.1373/clinchem.2010.151233; Hensen EF, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-168; Hirashima K, 2010, ANN SURG ONCOL, V17, P2486, DOI 10.1245/s10434-010-1040-1; Hoa M, 2002, CANCER RES, V62, P7154; Hoshida Y, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001195; Ihnen M, 2010, BRIT J CANCER, V103, P1048, DOI 10.1038/sj.bjc.6605840; Jemal A, 2005, CA-CANCER J CLIN, V55, P10, DOI 10.3322/canjclin.55.1.10; Johnson WE, 2007, BIOSTATISTICS, V8, P118, DOI 10.1093/biostatistics/kxj037; Karam M, 2012, EXP CELL RES, V318, P558, DOI 10.1016/j.yexcr.2012.01.001; Koletsa T, 2008, NEOPLASIA, V10, P687, DOI 10.1593/neo.08314; Li AFY, 2009, ANN SURG ONCOL, V16, P2486, DOI 10.1245/s10434-009-0593-3; Li S, 2011, HEAD NECK-J SCI SPEC, V33, P368, DOI 10.1002/hed.21457; Lin CY, 2011, CLIN CANCER RES, V17, P3089, DOI 10.1158/1078-0432.CCR-10-3068; Mincione G, 2008, INT J ONCOL, V32, P323; Mirisola V, 2011, CANCER LETT, V307, P37, DOI 10.1016/j.canlet.2011.03.013; Mori Y, 2006, ONCOLOGY-BASEL, V70, P378, DOI 10.1159/000098111; Mountzios G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054048; Nathan CAO, 2007, CANCER RES, V67, P2160, DOI 10.1158/0008-5472.CAN-06-2449; Network NCC, 2013, NCCN GUID VERS 1 201; O'Connell MJ, 2010, J CLIN ONCOL, V28, P3937, DOI 10.1200/JCO.2010.28.9538; O'Donnell RK, 2005, ONCOGENE, V24, P1244, DOI 10.1038/sj.onc.1208285; Onesto C, 2006, BRIT J CANCER, V94, P1516, DOI 10.1038/sj.bjc.6603108; Paik S, 2004, NEW ENGL J MED, V351, P2817, DOI 10.1056/NEJMoa041588; Pentheroudakis G, 2012, ORAL ONCOL, V48, P709, DOI 10.1016/j.oraloncology.2012.02.002; Pust S., 2012, ONCOGENE; Roepman P, 2005, NAT GENET, V37, P182, DOI 10.1038/ng1502; Sanchez-Navarro I, 2010, BIOTECHNIQUES, V48, P389, DOI 10.2144/000113388; Schneider S, 2011, HEAD NECK-J SCI SPEC, V33, P244, DOI 10.1002/hed.21437; Shigyo H, 2007, ACTA OTO-LARYNGOL, V127, P970, DOI 10.1080/00016480601089382; Sundram V, 2011, MOL CANCER RES, V9, P985, DOI 10.1158/1541-7786.MCR-10-0365; Thurlow JK, 2010, J CLIN ONCOL, V28, P2881, DOI 10.1200/JCO.2009.24.8724; van de Vijver MJ, 2002, NEW ENGL J MED, V347, P1999, DOI 10.1056/NEJMoa021967	54	36	36	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 9	2013	8	8							e70429	10.1371/journal.pone.0070429	http://dx.doi.org/10.1371/journal.pone.0070429			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	245OM	23950933	Green Published, Green Submitted, gold			2022-12-25	WOS:000326473200012
J	Driedger, SM; Cooper, E; Jardine, C; Furgal, C; Bartlett, J				Driedger, S. Michelle; Cooper, Elizabeth; Jardine, Cindy; Furgal, Chris; Bartlett, Judith			Communicating Risk to Aboriginal Peoples: First Nations and Metis Responses to H1N1 Risk Messages	PLOS ONE			English	Article							INFLUENZA; CARE; COMMUNITIES; PERCEPTION; KNOWLEDGE	Developing appropriate risk messages during challenging situations like public health outbreaks is complicated. The focus of this paper is on how First Nations and Metis people in Manitoba, Canada, responded to the public health management of pandemic H1N1, using a focus group methodology (n = 23 focus groups). Focus group conversations explored participant reactions to messaging regarding the identification of H1N1 virus risk groups, the H1N1 vaccine and how priority groups to receive the vaccine were established. To better contextualize the intentions of public health professionals, key informant interviews (n = 20) were conducted with different health decision makers (e. g., public health officials, people responsible for communications, representatives from some First Nations and Metis self-governing organizations). While risk communication practice has improved, 'one size' messaging campaigns do not work effectively, particularly when communicating about who is most 'at-risk'. Public health agencies need to pay more attention to the specific socioeconomic, historical and cultural contexts of First Nations and Metis citizens when planning for, communicating and managing responses associated with pandemic outbreaks to better tailor both the messages and delivery. More attention is needed to directly engage First Nations and Metis communities in the development and dissemination of risk messaging.	[Driedger, S. Michelle; Cooper, Elizabeth; Bartlett, Judith] Univ Manitoba, Dept Community Hlth Sci, Fac Med, Winnipeg, MB R3T 2N2, Canada; [Jardine, Cindy] Univ Alberta, Sch Publ Hlth, Edmonton, AB, Canada; [Furgal, Chris] Trent Univ, Indigenous Environm Studies Program, Peterborough, ON K9J 7B8, Canada	University of Manitoba; University of Alberta; Trent University	Driedger, SM (corresponding author), Univ Manitoba, Dept Community Hlth Sci, Fac Med, Winnipeg, MB R3T 2N2, Canada.	michelle.driedger@med.umanitoba.ca		Driedger, S. Michelle/0000-0003-3769-5785	Canadian Institutes of Health Research; Institute of Aboriginal Peoples' Health; Manitoba Health Research Council Regional Partnerships program [MOP 200167]; Canadian Federation for Innovation; Manitoba Research and Innovation Fund [202990];  [MOP 209456]	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Institute of Aboriginal Peoples' Health; Manitoba Health Research Council Regional Partnerships program; Canadian Federation for Innovation; Manitoba Research and Innovation Fund; 	This research has been supported by a Canadian Institutes of Health Research (http://www.cihr-irsc.gc.ca/), Institute of Aboriginal Peoples' Health, grant held by the Principle Investigators SMD, CJ, CF. Risk Communication and Trust in Decision-Maker Action: Lessons from a First Nations/Inuit/Metis Case Studies in Canada. CIHR Operating Grant, 2010-2013 (MOP 209456) and CIHR and Manitoba Health Research Council (http://mhrc.mb.ca/) Regional Partnerships program, 2009-2010 (MOP 200167). This research was also supported by an equipment and infrastructure grant by the Canadian Federation for Innovation and the Manitoba Research and Innovation Fund: 202990. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baxter J, 1997, T I BRIT GEOGR, V22, P91; Charania NA, 2011, INT J CIRCUMPOL HEAL, V70, P564, DOI 10.3402/ijch.v70i5.17849; Clatworthy S., 2009, CANADIAN ISSUESTH ME, P19; Crabtree BF., 1999, DOING QUALITATIVE RE, V2nd ed; Crawford T, 2009, NATL POST; Curry B, 2013, NUMBER RECOGNIZED AB; Dickason Olive, 1992, CANADAS 1 NATIONS HI; Driedger SM, 2012, METHODOLOGICAL DETAI; Driedger SM, 2010, RISK TRUST GOVT ACTI; Driedger SM, 2009, RISK TRUST GOVT ACTI; Elledge BL, 2008, HEALTH PROMOT PRACT, V9, p54S, DOI 10.1177/1524839908319089; Engelhart K, 2009, UNSEEN COSTS SWINE F; [Federal Court of Canada Federal Court of Canada], 2013, H DAN G DAN L GARDN, P173; FISCHHOFF B, 1995, RISK ANAL, V15, P137, DOI 10.1111/j.1539-6924.1995.tb00308.x; Fischhoff B., 2005, MCGRAW HILL HDB TERR; Furgal CM, 2010, INT J CIRCUMPOL HEAL, V69, P322, DOI 10.3402/ijch.v69i4.17672; Furgal CM, 2005, ARCTIC, V58, P103, DOI 10.14430/arctic404; Gilchrist V.J., 1992, DOING QUALITATIVE RE; Glik DC, 2007, ANNU REV PUBL HEALTH, V28, P33, DOI 10.1146/annurev.publhealth.28.021406.144123; Government of Manitoba,, 2010, H1N1 FLU MAN MAN RES H1N1 FLU MAN MAN RES; Gray L, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-205; Grygier PS, 1997, LONG WAY HOME TUBERC; Hackett P, 2005, CAN J PUBLIC HEALTH, V96, pS17, DOI 10.1007/BF03405311; Haworth-Brockman M. J., 2009, J ABORIGINAL HLTH, V4, P17; Health Canada, 2006, STRAT RISK COMM FRAM STRAT RISK COMM FRAM; Helferty M, 2010, CAN MED ASSOC J, V182, P1981, DOI 10.1503/cmaj.100746; Jack SM, 2010, INT J ENV RES PUB HE, V7, P651, DOI 10.3390/ijerph7020651; Janssen AP, 2006, J PUBLIC HEALTH MAN, V12, P388; Jehn M, 2011, J PUBLIC HEALTH MAN, V17, P431, DOI 10.1097/PHH.0b013e3182113921; Krimsky Sheldon., 1988, ENV HAZARDS COMMUNIC; Krueger RA, 1988, ANAL REPORTING FOCUS; Kumar A, 2009, JAMA-J AM MED ASSOC, V302, P1872, DOI 10.1001/jama.2009.1496; LaRocque Emma., 2010, OTHER IS ME NATIVE R; Liamputtong Pranee, 2011, FOCUS GROUP METHODOL; Lindell M. K., 2004, COMMUNICATING ENV RI; Lux MK, 2010, CAN HIST REV, V91, P407, DOI 10.3138/chr.91.3.407; Manitoba Health, 2010, SUMM LAB CONF PAND H; Manitoba Health, 2009, H1N1 FLU INF INF PAR; Manitoba Metis Federation, MET; Massey PD, 2009, RURAL REMOTE HEALTH, V9, P7; Massey PD, 2011, HEALTH POLICY, V103, P184, DOI 10.1016/j.healthpol.2011.07.004; McMillan AlanD., 1995, NATIVE PEOPLES CULTU; Morgan DL, 1993, SUCCESSFUL FOCUS GRO, P3, DOI [DOI 10.4135/9781483349008.N1, 10.4135/9781483349008]; National Research Council, 1989, IMPR RISK COMM; Paek HJ, 2008, HEALTH PROMOT PRACT, V9, p60S, DOI 10.1177/1524839908322114; Patton M.Q., 1980, QUALITATIVE RES EVAL; *PUBL HLTH AG CAN, 2009, GUID H1N1 VACC SEQ; Public Health Agency of Canada, 2012, DO YOU FIGHT FLU; Public Health Agency of Canada, 2012, GET FACTS NOT FLU IN; [Public Health Agency of Canada Public Health Agency of Canada e], 2009, CAN PAND PLAN HLTH S; Pursaga J, 2009, WINNIPEG WINNIPEG SU; Rabson M, 2009, BODY BAGS SENT RESER; Rimal RN, 2009, B WORLD HEALTH ORGAN, V87, P247, DOI 10.2471/BLT.08.056713; Rubinstein E, 2011, CAN MED ASSOC J, V183, pE1033, DOI 10.1503/cmaj.110196; Rudge Sian, 2010, N S W Public Health Bull, V21, P26, DOI 10.1071/NB09040; Sawchuck J, 2001, AM INDIAN Q, V25, P73, DOI DOI 10.1353/AIQ.2001.0012; Slovic P, 2000, PERCEPTION RISK; Statistics Canada, 2006, 2006 CENS POP; Strauss AL, 1998, BASICS QUALITATIVE R, V2nd; Teasdale E, 2011, PATIENT EDUC COUNS, V85, P413, DOI 10.1016/j.pec.2010.12.026; Waldram J, 2006, ABORIGINAL HLTH CANA	61	20	20	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2013	8	8							e71106	10.1371/journal.pone.0071106	http://dx.doi.org/10.1371/journal.pone.0071106			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	200ZE	23940697	Green Published, gold, Green Submitted			2022-12-25	WOS:000323109700077
J	Navarro, MGJ; Basset, C; Arcondeguy, T; Touriol, C; Perez, G; Prats, H; Lacazette, E				Navarro, Marina Garcia-Jove; Basset, Celine; Arcondeguy, Tania; Touriol, Christian; Perez, Guillaume; Prats, Herve; Lacazette, Eric			Api5 Contributes to E2F1 Control of the G1/S Cell Cycle Phase Transition	PLOS ONE			English	Article							BIPARTITE REPRESSOR ELEMENT; E GENE-EXPRESSION; TRANSCRIPTION FACTOR; TARGET GENES; S-PHASE; FAMILY-MEMBERS; DNA-DAMAGE; APOPTOSIS; PROTEIN; AAC-11	Background: The E2f transcription factor family has a pivotal role in controlling the cell fate in general, and in particular cancer development, by regulating the expression of several genes required for S phase entry and progression through the cell cycle. It has become clear that the transcriptional activation of at least one member of the family, E2F1, can also induce apoptosis. An appropriate balance of positive and negative regulators appears to be necessary to modulate E2F1 transcriptional activity, and thus cell fate. Methodology/Principal Findings: In this report, we show that Api5, already known as a regulator of E2F1 induced-apoptosis, is required for the E2F1 transcriptional activation of G1/S transition genes, and consequently, for cell cycle progression and cell proliferation. Api5 appears to be a cell cycle regulated protein. Removal of Api5 reduces cyclin E, cyclin A, cyclin D1 and Cdk2 levels, causing G1 cell cycle arrest and cell cycle delay. Luciferase assays established that Api5 directly regulates the expression of several G1/S genes under E2F1 control. Using protein/protein and protein/DNA immunoprecipitation studies, we demonstrate that Api5, even if not physically interacting with E2F1, contributes positively to E2F1 transcriptional activity by increasing E2F1 binding to its target promoters, through an indirect mechanism. Conclusion/Significance: The results described here support the pivotal role of cell cycle related proteins, that like E2F1, may act as tumor suppressors or as proto-oncogenes during cancer development, depending on the behavior of their positive and negative regulators. According to our findings, Api5 contributes to E2F1 transcriptional activation of cell cycle-associated genes by facilitating E2F1 recruitment onto its target promoters and thus E2F1 target gene transcription.	[Navarro, Marina Garcia-Jove; Basset, Celine; Arcondeguy, Tania; Touriol, Christian; Perez, Guillaume; Prats, Herve; Lacazette, Eric] CRCT, Canc Dept, INSERM UMR 1037, Toulouse, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Toulouse; Universite Toulouse III - Paul Sabatier	Lacazette, E (corresponding author), CRCT, Canc Dept, INSERM UMR 1037, Toulouse, France.	eric.lacazette@inserm.fr	Lacazette, eric/M-7168-2014; Prats, Hervé/M-4495-2014; BASSET, CELINE/D-1903-2019; TOURIOL, Christian/O-8949-2014	Prats, Hervé/0000-0002-4861-2167; BASSET, CELINE/0000-0002-1822-4454; TOURIOL, Christian/0000-0003-1219-4693; Perez, Guillaume/0000-0002-1183-5420; lacazette, eric/0000-0003-1234-5260	Institut National du Cancer; Association de la Recherche sur le Cancer (ARC); La Ligue contre le Cancer	Institut National du Cancer(Institut National du Cancer (INCA) France); Association de la Recherche sur le Cancer (ARC)(Fondation ARC pour la Recherche sur le Cancer); La Ligue contre le Cancer(Ligue nationale contre le cancer)	This work was supported by grants from the Institut National du Cancer to HP; Association de la Recherche sur le Cancer (ARC) to MGJ, and La Ligue contre le Cancer to MGJ and EL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahel D, 2009, SCIENCE, V325, P1240, DOI 10.1126/science.1177321; Asano M, 1996, GENE DEV, V10, P1422, DOI 10.1101/gad.10.11.1422; BANDARA LR, 1991, NATURE, V351, P494, DOI 10.1038/351494a0; Bracken AP, 2004, TRENDS BIOCHEM SCI, V29, P409, DOI 10.1016/j.tibs.2004.06.006; CHELLAPPAN SP, 1991, CELL, V65, P1053, DOI 10.1016/0092-8674(91)90557-F; Clegg N, 2003, PROSTATE, V55, P55, DOI 10.1002/pros.10217; Darzynkiewicz Z, 2001, Curr Protoc Cytom, VChapter 7, DOI 10.1002/0471142956.cy0705s00; Denchi EL, 2005, EMBO REP, V6, P661, DOI 10.1038/sj.embor.7400452; Dyson N, 1998, GENE DEV, V12, P2245, DOI 10.1101/gad.12.15.2245; Fang ZH, 2006, HISTOL HISTOPATHOL, V21, P403, DOI 10.14670/HH-21.403; Field SJ, 1996, CELL, V85, P549, DOI 10.1016/S0092-8674(00)81255-6; Frolov MV, 2004, J CELL SCI, V117, P2173, DOI 10.1242/jcs.01227; Giangrande PH, 2004, EMBO J, V23, P1336, DOI 10.1038/sj.emboj.7600134; Hallstrom TC, 2008, CANCER CELL, V13, P11, DOI 10.1016/j.ccr.2007.11.031; Helin K, 1998, CURR OPIN GENET DEV, V8, P28, DOI 10.1016/S0959-437X(98)80058-0; Ishida S, 2001, MOL CELL BIOL, V21, P4684, DOI 10.1128/MCB.21.14.4684-4699.2001; Jackman J, 2001, Curr Protoc Cell Biol, VChapter 8, DOI 10.1002/0471143030.cb0803s00; Johnson DG, 2006, CURR MOL MED, V6, P731; Kel AE, 2001, J MOL BIOL, V309, P99, DOI 10.1006/jmbi.2001.4650; Kim JW, 2000, LAB INVEST, V80, P587, DOI 10.1038/labinvest.3780063; KOWALIK TF, 1995, J VIROL, V69, P2491, DOI 10.1128/JVI.69.4.2491-2500.1995; Krejci P, 2007, J LEUKOCYTE BIOL, V82, P1363, DOI 10.1189/jlb.0607425; Le Cam L, 1999, EMBO J, V18, P1878, DOI 10.1093/emboj/18.7.1878; Ma NF, 2008, HEPATOLOGY, V47, P503, DOI 10.1002/hep.22072; Martinez-Balbas MA, 2000, EMBO J, V19, P662, DOI 10.1093/emboj/19.4.662; Morris EJ, 2006, PLOS GENET, V2, P1834, DOI 10.1371/journal.pgen.0020196; Muller H, 2001, GENE DEV, V15, P267, DOI 10.1101/gad.864201; NEVINS JR, 1991, COLD SPRING HARB SYM, V56, P157; Ohtani K, 1995, P NATL ACAD SCI USA, V92, P12146, DOI 10.1073/pnas.92.26.12146; Pediconi N, 2003, NAT CELL BIOL, V5, P552, DOI 10.1038/ncb998; Pekow JR, 2011, INFLAMM BOWEL DIS; Polanowska J, 2001, ONCOGENE, V20, P4115, DOI 10.1038/sj.onc.1204514; QIN XQ, 1994, P NATL ACAD SCI USA, V91, P10918, DOI 10.1073/pnas.91.23.10918; Rigou P, 2009, EMBO J, V28, P1576, DOI 10.1038/emboj.2009.106; Salon C, 2007, ONCOGENE, V26, P6927, DOI 10.1038/sj.onc.1210499; Sasaki H, 2001, LUNG CANCER-J IASLC, V34, P53, DOI 10.1016/S0169-5002(01)00213-6; SHAN B, 1994, MOL CELL BIOL, V14, P8166, DOI 10.1128/MCB.14.12.8166; Tewari M, 1997, CANCER RES, V57, P4063; Van den Berghe L, 2000, MOL ENDOCRINOL, V14, P1709, DOI 10.1210/me.14.11.1709; Wang CG, 2006, NAT CELL BIOL, V8, P1025, DOI 10.1038/ncb1468; Wang ZM, 2010, MED SCI MONITOR, V16, pCR357; Wells J, 2000, MOL CELL BIOL, V20, P5797, DOI 10.1128/MCB.20.16.5797-5807.2000; Wells J, 2002, P NATL ACAD SCI USA, V99, P3890, DOI 10.1073/pnas.062047499; Zhang L, 2006, ONCOGENE, V25, P2615, DOI 10.1038/sj.onc.1209286	44	20	21	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2013	8	8							e71443	10.1371/journal.pone.0071443	http://dx.doi.org/10.1371/journal.pone.0071443			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	200ZE	23940755	Green Submitted, gold, Green Published			2022-12-25	WOS:000323109700100
J	Settergren, J; Eiermann, B; Mannheimer, B				Settergren, Jennifer; Eiermann, Birgit; Mannheimer, Buster			Adherence to Drug Label Recommendations for Avoiding Drug Interactions Causing Statin-Induced Myopathy-A Nationwide Register Study	PLOS ONE			English	Article							SIGNIFICANT PHARMACOKINETIC INTERACTION; PLASMA-CONCENTRATIONS; CLINICAL PHARMACOKINETICS; GEMFIBROZIL INCREASES; ADMINISTRATIVE CLAIMS; HEALTHY-VOLUNTEERS; CYP3A4 INHIBITORS; SIMVASTATIN ACID; RANDOMIZED-TRIAL; RISK-FACTORS	Purpose: To investigate the extent to which clinicians avoid well-established drug-drug interactions that cause statin-induced myopathy. We hypothesised that clinicians would avoid combining erythromycin or verapamil/diltiazem respectively with atorvastatin or simvastatin. In patients with statin-fibrate combination therapy, we hypothesised that gemfibrozil was avoided to the preference of bezafibrate or fenofibrate. When combined with verapamil/diltiazem or fibrates, we hypothesized that the dispensed doses of atorvastatin/simvastatin would be decreased. Methods: Cross-sectional analysis of nationwide dispensing data. Odds ratios of interacting erythromycin, verapamil/diltiazem versus respective prevalence of comparator drugs doxycycline, amlodipine/felodipine in patients co-dispensed interacting statins simvastatin/atorvastatin versus patients unexposed (pravastatin/fluvastatin/rosuvastatin) was calculated. For fibrates, OR of gemfibrozil versus fenofibrate/bezafibrate in patients co-dispensed any statin was assessed. Results: OR of interacting erythromycin versus comparator doxycycline did not differ between patients on interacting and comparator statins either in patients dispensed high or low statin doses (adjusted OR 0.87; 95% CI 0.60-1.25 and 0.92; 95% CI 0.69-1.23). Interacting statins were less common among patients dispensed verapamil/diltiazem as compared to patients on amlodipine/felodipine (OR high dose 0.62; CI 0.56-0.68 and low dose 0.63; CI 0.58-0.68). Patients on any statin were to a lesser extent dispensed gemfibrozil compared to patients not dispensed a statin (OR high dose 0.65; CI 0.55-0.76 and low dose 0.70; CI 0.63-0.78). Mean DDD (SD) for any statin was substantially higher in patients co-dispensed gemfibrozil 178 (149) compared to patients on statin monotherapy 127 (93), (p < 0.001). Conclusions: Prescribers may to some extent avoid co-prescription of statins with calcium blockers and fibrates with an increased risk of myopathy. We found no evidence for avoiding co-prescriptions of statins and antibiotics with an increased risk of statin-induced adverse drug reactions. Co-prescription of statins and gemfibrozil is paradoxically associated with a marked increased statin dose, further aggravating the risk for severe myopathy.	[Settergren, Jennifer; Mannheimer, Buster] Karolinska Inst, Dept Clin Sci & Educ Sodersjukhuset, Stockholm, Sweden; [Eiermann, Birgit] Karolinska Univ Hosp, Karolinska Inst, Dept Lab Med, Div Clin Pharmacol, Huddinge, Sweden	Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital	Mannheimer, B (corresponding author), Karolinska Inst, Dept Clin Sci & Educ Sodersjukhuset, Stockholm, Sweden.	buster.mannheimer@sodersjukhuset.se			Swedish Society for Medical Research	Swedish Society for Medical Research	This study was has been enabled by grants received by Buster Mannheimer from the Swedish Society for Medical Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manusript.	Ahearn MD, 2003, MED J AUSTRALIA, V179, P34, DOI 10.5694/j.1326-5377.2003.tb05415.x; Amsden GW, 2002, J CLIN PHARMACOL, V42, P444, DOI 10.1177/0091270002424011; Armitage J, 2010, LANCET, V376, P1658, DOI 10.1016/S0140-6736(10)60310-8; Azie NE, 1998, CLIN PHARMACOL THER, V64, P369, DOI 10.1016/S0009-9236(98)90067-4; Backman JT, 2005, CLIN PHARMACOL THER, V78, P154, DOI 10.1016/j.clpt.2005.04.007; Backman JT, 2000, CLIN PHARMACOL THER, V68, P122, DOI 10.1067/mcp.2000.108507; Bakhai A, 2012, PHARMACOEPIDEM DR S, V21, P485, DOI 10.1002/pds.2308; Bergman AJ, 2004, J CLIN PHARMACOL, V44, P1054, DOI 10.1177/0091270004268044; Bjerrum L, 1997, EUR J CLIN PHARMACOL, V53, P7, DOI 10.1007/s002280050329; Bottiger Y, 2009, EUR J CLIN PHARMACOL, V65, P627, DOI 10.1007/s00228-008-0612-5; Bottorff MB, 2006, AM J CARDIOL, V97, p27C, DOI 10.1016/j.amjcard.2005.12.007; Bravo AER, 2005, DRUG SAFETY, V28, P263; Cooper KJ, 2003, EUR J CLIN PHARMACOL, V59, P51, DOI 10.1007/s00228-003-0573-7; Cziraky MJ, 2006, AM J CARDIOL, V97, p61C, DOI 10.1016/j.amjcard.2005.12.011; Devold HM, 2009, BRIT J CLIN PHARMACO, V67, P234, DOI 10.1111/j.1365-2125.2008.03345.x; Egger SS, 2007, DRUG AGING, V24, P429, DOI 10.2165/00002512-200724050-00006; Eliasson M, 2006, EUR J CLIN PHARMACOL, V62, P251, DOI 10.1007/s00228-006-0114-2; Glassman PA, 2006, MED CARE, V44, P250, DOI 10.1097/01.mlr.0000199849.08389.91; Glassman PA, 2002, MED CARE, V40, P1161, DOI 10.1097/00005650-200212000-00004; Gustavson LE, 2005, J CLIN PHARMACOL, V45, P947, DOI 10.1177/0091270005278085; Heerey A, 2000, IRISH J MED SCI, V169, P176, DOI 10.1007/BF03167690; Jacobson TA, 2004, AM J CARDIOL, V94, P1140, DOI 10.1016/j.amjcard.2004.07.080; Jones PH, 2005, AM J CARDIOL, V95, P120, DOI 10.1016/j.amjcard.2004.08.076; Kantola T, 1998, CLIN PHARMACOL THER, V64, P177, DOI 10.1016/S0009-9236(98)90151-5; Kantola T, 1998, CLIN PHARMACOL THER, V64, P58, DOI 10.1016/S0009-9236(98)90023-6; Katoh M, 2000, EUR J CLIN PHARMACOL, V55, P843, DOI 10.1007/s002280050706; Kivisto KT, 1998, BRIT J CLIN PHARMACO, V46, P49, DOI 10.1046/j.1365-2125.1998.00034.x; Kyrklund C, 2003, CLIN PHARMACOL THER, V73, P538, DOI 10.1016/S0009-9236(03)00052-3; Kyrklund C, 2001, CLIN PHARMACOL THER, V69, P340, DOI 10.1067/mcp.2001.115542; Lau HS, 1997, J CLIN EPIDEMIOL, V50, P619, DOI 10.1016/S0895-4356(97)00040-1; Law M, 2006, AM J CARDIOL, V97, p52C, DOI 10.1016/j.amjcard.2005.12.010; Lennernas H, 2003, CLIN PHARMACOKINET, V42, P1141, DOI 10.2165/00003088-200342130-00005; Mannheimer B, 2010, BRIT J CLIN PHARMACO, V69, P411, DOI 10.1111/j.1365-2125.2009.03598.x; Mannheimer B, 2008, EUR J CLIN PHARMACOL, V64, P1209, DOI 10.1007/s00228-008-0547-x; Martin PD, 2003, CLIN THER, V25, P459, DOI 10.1016/S0149-2918(03)80089-9; Ming EE, 2008, J CLIN LIPIDOL, V2, P453, DOI 10.1016/j.jacl.2008.10.007; Mousa O, 2000, CLIN PHARMACOL THER, V67, P267, DOI 10.1067/mcp.2000.104609; Neuvonen PJ, 2006, CLIN PHARMACOL THER, V80, P565, DOI 10.1016/j.clpt.2006.09.003; Neuvonen PJ, 1998, CLIN PHARMACOL THER, V63, P332, DOI 10.1016/S0009-9236(98)90165-5; Nishio S, 2005, HYPERTENS RES, V28, P223, DOI 10.1291/hypres.28.223; Pan WJ, 2000, J CLIN PHARMACOL, V40, P316, DOI 10.1177/00912700022008874; PEDERSEN TR, 1994, LANCET, V344, P1383; PIPPc Marie Eliasson, 2011, COMMUNICATION; Ronaldson KJ, 2006, DRUG SAFETY, V29, P1061, DOI 10.2165/00002018-200629110-00005; SAIVIN S, 1988, CLIN PHARMACOKINET, V15, P355, DOI 10.2165/00003088-198815060-00001; Schech S, 2007, PHARMACOEPIDEM DR S, V16, P352, DOI 10.1002/pds.1287; Schneck DW, 2004, CLIN PHARMACOL THER, V75, P455, DOI 10.1016/j.clpt.2003.12.014; Siedlik PH, 1999, J CLIN PHARMACOL, V39, P501; SPENCE JD, 1995, AM J CARDIOL, V76, pA80; Wettermark B, 2007, PHARMACOEPIDEM DR S, V16, P726, DOI 10.1002/pds.1294	50	16	17	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2013	8	8							e69545	10.1371/journal.pone.0069545	http://dx.doi.org/10.1371/journal.pone.0069545			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	217ZG	23940522	Green Published, Green Submitted, gold			2022-12-25	WOS:000324401500012
J	Zhang, Y; Babaian, A; Gagnier, L; Mager, DL				Zhang, Ying; Babaian, Artem; Gagnier, Liane; Mager, Dixie L.			Visualized Computational Predictions of Transcriptional Effects by Intronic Endogenous Retroviruses	PLOS ONE			English	Article							SOMATIC RETROTRANSPOSITION; TRANSPOSABLE ELEMENTS; INTERSPERSED REPEATS; HUMAN GENOMES; HUMAN BRAIN; MOUSE; GENES; MUTAGENESIS; LANDSCAPE; PATTERNS	When endogenous retroviruses (ERVs) or other transposable elements (TEs) insert into an intron, the consequence on gene transcription can range from negligible to a complete ablation of normal transcripts. With the advance of sequencing technology, more and more insertionally polymorphic or private TE insertions are being identified in humans and mice, of which some could have a significant impact on host gene expression. Nevertheless, an efficient and low cost approach to prioritize their potential effect on gene transcription has been lacking. By building a computational model based on artificial neural networks (ANN), we demonstrate the feasibility of using machine-learning approaches to predict the likelihood that intronic ERV insertions will have major effects on gene transcription, focusing on the two ERV families, namely Intracisternal A-type Particle (IAP) and Early Transposon (ETn)/MusD elements, which are responsible for the majority of ERV-induced mutations in mice. We trained the ANN model using properties associated with these ERVs known to cause germ-line mutations (positive cases) and properties associated with likely neutral ERVs of the same families (negative cases), and derived a set of prediction plots that can visualize the likelihood of affecting gene transcription by ERV insertions. Our results show a highly reliable prediction power of our model, and offer a potential approach to computationally screen for other types of TE insertions that may affect gene transcription or even cause disease.	[Zhang, Ying; Babaian, Artem; Gagnier, Liane; Mager, Dixie L.] British Columbia Canc Agcy, Terry Fox Lab, Vancouver, BC V5Z 1L3, Canada; [Zhang, Ying; Babaian, Artem; Gagnier, Liane; Mager, Dixie L.] Univ British Columbia, Dept Med Genet, Vancouver, BC, Canada	British Columbia Cancer Agency; University of British Columbia	Mager, DL (corresponding author), British Columbia Canc Agcy, Terry Fox Lab, 601 W 10th Ave, Vancouver, BC V5Z 1L3, Canada.	dmager@bccrc.ca		Mager, Dixie/0000-0002-5955-2550; Babaian, Artem/0000-0002-4315-6262	Canadian Institutes of Health Research [MOP-10825]	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported by grant MOP-10825 from the Canadian Institutes of Health Research (http://www.cihr-irsc.gc.ca). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baillie JK, 2011, NATURE, V479, P534, DOI 10.1038/nature10531; Beck CR, 2010, CELL, V141, P1159, DOI 10.1016/j.cell.2010.05.021; Bishop C. M., 1995, NEURAL NETWORKS PATT; Cutter AD, 2005, J MOL EVOL, V61, P733, DOI 10.1007/s00239-004-0243-0; Druker R, 2004, NUCLEIC ACIDS RES, V32, P5800, DOI 10.1093/nar/gkh914; Evrony GD, 2012, CELL, V151, P483, DOI 10.1016/j.cell.2012.09.035; Ewing AD, 2010, GENOME RES, V20, P1262, DOI 10.1101/gr.106419.110; Grover D, 2003, MOL BIOL EVOL, V20, P1420, DOI 10.1093/molbev/msg153; Gunther F, 2010, R J; Ho M, 2004, HUM MOL GENET, V13, P1999, DOI 10.1093/hmg/ddh212; Huang CRL, 2010, CELL, V141, P1171, DOI 10.1016/j.cell.2010.05.026; Iskow RC, 2010, CELL, V141, P1253, DOI 10.1016/j.cell.2010.05.020; Kaer K, 2013, GENE, V518, P231, DOI 10.1016/j.gene.2013.01.008; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Lee E, 2012, SCIENCE, V337, P967, DOI 10.1126/science.1222077; Li JF, 2012, GENOME RES, V22, P870, DOI 10.1101/gr.130740.111; Maksakova IA, 2006, PLOS GENET, V2, P1, DOI 10.1371/journal.pgen.0020002; Medstrand P, 2002, GENOME RES, V12, P1483, DOI 10.1101/gr.388902; Mortada H, 2010, J MOL EVOL, V71, P180, DOI 10.1007/s00239-010-9376-5; Nellaker C, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-6-r45; Rebollo R, 2012, ANNU REV GENET, V46, P21, DOI 10.1146/annurev-genet-110711-155621; Sironi M, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-12-r120; Smit AFA, 1999, CURR OPIN GENET DEV, V9, P657, DOI 10.1016/S0959-437X(99)00031-3; Stocking C, 2008, CELL MOL LIFE SCI, V65, P3383, DOI 10.1007/s00018-008-8497-0; Tu JV, 1996, J CLIN EPIDEMIOL, V49, P1225, DOI 10.1016/S0895-4356(96)00002-9; van de Lagemaat LN, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-9-r86; Waterston RH, 2002, NATURE, V420, P520, DOI 10.1038/nature01262; Yeo G, 2004, J COMPUT BIOL, V11, P377, DOI 10.1089/1066527041410418; Zhang Y, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000007; Zhang Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030158; Zhang Y, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002046	31	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2013	8	8							e71971	10.1371/journal.pone.0071971	http://dx.doi.org/10.1371/journal.pone.0071971			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	217ZG	23936536	Green Submitted, gold, Green Published			2022-12-25	WOS:000324401500086
J	Beus, JM; Hashmi, SS; Selvaraj, SA; Duan, DX; Stempora, LL; Monday, SA; Cheeseman, JA; Hamby, KM; Speck, SH; Larsen, CP; Kirk, AD; Kean, LS				Beus, Jonathan M.; Hashmi, Salila S.; Selvaraj, Saranya A.; Duan, Danxia; Stempora, Linda L.; Monday, Stephanie A.; Cheeseman, Jennifer A.; Hamby, Kelly M.; Speck, Samuel H.; Larsen, Christian P.; Kirk, Allan D.; Kean, Leslie S.			Heterologous Immunity Triggered by a Single, Latent Virus in Mus musculus: Combined Costimulation- and Adhesion- Blockade Decrease Rejection	PLOS ONE			English	Article							CD8(+) T-CELLS; MURINE GAMMAHERPESVIRUS 68; ALLOGRAFT SURVIVAL; INFECTIOUS-MONONUCLEOSIS; TRANSPLANT REJECTION; CROSS-REACTIVITY; CHEMOKINES CXCL9; PHASE-III; B-CELLS; MEMORY	The mechanisms underlying latent-virus-mediated heterologous immunity, and subsequent transplant rejection, especially in the setting of T cell costimulation blockade, remain undetermined. To address this, we have utilized MHV68 to develop a rodent model of latent virus-induced heterologous alloimmunity. MHV68 infection was correlated with multimodal immune deviation, which included increased secretion of CXCL9 and CXCL10, and with the expansion of a CD8(dim) T cell population. CD8(dim) T cells exhibited decreased expression of multiple costimulation molecules and increased expression of two adhesion molecules, LFA-1 and VLA-4. In the setting of MHV68 latency, recipients demonstrated accelerated costimulation blockade-resistant rejection of skin allografts compared to non-infected animals (MST 13.5 d in infected animals vs 22 d in non-infected animals, p<.0001). In contrast, the duration of graft acceptance was equivalent between non-infected and infected animals when treated with combined anti-LFA-1/anti-VLA-4 adhesion blockade (MST 24 d for non-infected and 27 d for infected, p = n.s.). The combination of CTLA-4-Ig/anti-CD154-based costimulation blockade+anti-LFA-1/anti-VLA-4-based adhesion blockade led to prolonged graft acceptance in both non-infected and infected cohorts (MST>100 d for both, p<0001 versus costimulation blockade for either). While in the non-infected cohort, either CTLA-4-Ig or anti-CD154 alone could effectively pair with adhesion blockade to prolong allograft acceptance, in infected animals, the prolonged acceptance of skin grafts could only be recapitulated when anti-LFA-1 and anti-VLA-4 antibodies were combined with anti-CD154 (without CTLA-4-Ig, MST>100 d). Graft acceptance was significantly impaired when CTLA-4-Ig alone (no anti-CD154) was combined with adhesion blockade (MST 41 d). These results suggest that in the setting of MHV68 infection, synergy occurs predominantly between adhesion pathways and CD154-based costimulation, and that combined targeting of both pathways may be required to overcome the increased risk of rejection that occurs in the setting of latent-virus-mediated immune deviation.	[Beus, Jonathan M.; Hashmi, Salila S.; Selvaraj, Saranya A.; Duan, Danxia; Stempora, Linda L.; Monday, Stephanie A.; Cheeseman, Jennifer A.; Hamby, Kelly M.; Larsen, Christian P.; Kirk, Allan D.; Kean, Leslie S.] Emory Univ, Sch Med, Emory Transplant Ctr, Atlanta, GA 30322 USA; [Speck, Samuel H.] Emory Univ, Sch Med, Emory Vaccine Ctr, Atlanta, GA USA; [Speck, Samuel H.] Emory Univ, Sch Med, Dept Microbiol & Immunol, Atlanta, GA 30322 USA; [Kean, Leslie S.] Emory Univ, Sch Med, Dept Pediat, Atlanta, GA USA; [Kean, Leslie S.] Emory Univ, Sch Med, Childrens Healthcare Atlanta, Atlanta, GA USA	Emory University; Emory University; Emory University; Emory University; Children's Healthcare of Atlanta (CHOA); Emory University	Kean, LS (corresponding author), Emory Univ, Sch Med, Emory Transplant Ctr, Atlanta, GA 30322 USA.	leslie.kean@emory.edu	Speck, Samuel/L-5893-2019; Beus, Jonathan/ABI-7771-2020	Beus, Jonathan/0000-0003-0911-0823; Kirk, Allan/0000-0003-2004-5962	National Institutes of Health (NIH) NIAID [5P01AI044644]; Burroughs Wellcome Career Award in the Biological Sciences; NIH [K08AI065822]; Howard Hughes Medical Institute; St. Baldrick's Summer Fellows Program; Georgia Research Alliance; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K08AI065822, P01AI044644, R01AI097423] Funding Source: NIH RePORTER	National Institutes of Health (NIH) NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Burroughs Wellcome Career Award in the Biological Sciences; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); St. Baldrick's Summer Fellows Program; Georgia Research Alliance; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institutes of Health (NIH) NIAID 5P01AI044644 to LSK, ADK, and CPL (http://www.niaid.nih.gov/). LSK was also supported by a Burroughs Wellcome Career Award in the Biological Sciences (http://www.bwfund.org/) and NIH K08AI065822 (http://www.niaid.nih.gov/). JMB was supported by the Howard Hughes Medical Institute Medical Research Fellows Program (http://www.hhmi.org/) and the St. Baldrick's Summer Fellows Program (http://www.stbaldricks.org/). ADK was supported by the Georgia Research Alliance (http://gra.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams AB, 2003, J CLIN INVEST, V111, P1887, DOI 10.1172/JCI200317477; ANDERSSON EC, 1994, J IMMUNOL, V152, P1237; Badell IR, 2010, J CLIN INVEST, V120, P4520, DOI 10.1172/JCI43895; Berger JR, 2010, DRUG SAFETY, V33, P969, DOI 10.2165/11537510-000000000-00000; Coley SM, 2009, J IMMUNOL, V182, P225, DOI 10.4049/jimmunol.182.1.225; Coppola MA, 1999, J IMMUNOL, V163, P1481; Dufour JH, 2002, J IMMUNOL, V168, P3195, DOI 10.4049/jimmunol.168.7.3195; Durrbach A, 2010, AM J TRANSPLANT, V10, P547, DOI 10.1111/j.1600-6143.2010.03016.x; Evans AG, 2008, J EXP MED, V205, P669, DOI 10.1084/jem.20071135; Flano E, 2000, J IMMUNOL, V165, P1074, DOI 10.4049/jimmunol.165.2.1074; Flano E, 2004, J IMMUNOL, V172, P3078, DOI 10.4049/jimmunol.172.5.3078; Flano E, 2002, IMMUNOL RES, V25, P201, DOI 10.1385/IR:25:3:201; Forster R, 2008, NAT REV IMMUNOL, V8, P362, DOI 10.1038/nri2297; Freeman ML, 2010, J VIROL, V84, P2881, DOI 10.1128/JVI.02229-09; Gomez FJ, 1998, J CLIN INVEST, V102, P984, DOI 10.1172/JCI2963; Gredmark-Russ S, 2008, J VIROL, V82, P12205, DOI 10.1128/JVI.01463-08; Han KH, 1999, J BIOL CHEM, V274, P32055, DOI 10.1074/jbc.274.45.32055; Jackson JA, 2011, AM J TRANSPLANT, V11, P2228, DOI 10.1111/j.1600-6143.2011.03680.x; Joshi NS, 2007, IMMUNITY, V27, P281, DOI 10.1016/j.immuni.2007.07.010; Kaech SM, 2003, NAT IMMUNOL, V4, P1191, DOI 10.1038/ni1009; Kitchens WH, 2012, AM J TRANSPLANT, V12, P69, DOI 10.1111/j.1600-6143.2011.03762.x; Kitchens WH, 2012, TRANSPLANTATION, V93, P997, DOI 10.1097/TP.0b013e31824e75d7; Ko J, 2004, FASEB J, V18, P890, DOI 10.1096/fj.03-0867fje; Koga S, 1999, J IMMUNOL, V163, P4878; Lee BJ, 2005, J VIROL, V79, P9351, DOI 10.1128/JVI.79.14.9351-9355.2005; Lima M, 2003, BLOOD CELL MOL DIS, V30, P1, DOI 10.1016/S1079-9796(03)00014-7; Lo DJ, 2011, AM J TRANSPLANT, V11, P22, DOI 10.1111/j.1600-6143.2010.03317.x; Moorman NJ, 2003, J VIROL, V77, P10295, DOI 10.1128/JVI.77.19.10295-10303.2003; Neujahr DC, 2012, AM J TRANSPLANT, V12, P438, DOI 10.1111/j.1600-6143.2011.03857.x; Nicolls MR, 2006, AM J TRANSPLANT, V6, P27, DOI 10.1111/j.1600-6143.2005.01158.x; Obar JJ, 2004, J IMMUNOL, V173, P2705, DOI 10.4049/jimmunol.173.4.2705; PINGEL JT, 1989, CELL, V58, P1055, DOI 10.1016/0092-8674(89)90504-7; Ramana CV, 2002, TRENDS IMMUNOL, V23, P96, DOI 10.1016/S1471-4906(01)02118-4; Reisman NM, 2011, BLOOD, V118, P5851, DOI 10.1182/blood-2011-04-347252; Rushworth SA, 2008, BLOOD, V111, P3793, DOI 10.1182/blood-2007-07-104042; Sandoval-Montes C, 2005, J LEUKOCYTE BIOL, V77, P513, DOI 10.1189/jlb.0404262; Schmitz JE, 1998, BLOOD, V92, P198, DOI 10.1182/blood.V92.1.198.413k13_198_206; Selin LK, 2007, J AM SOC NEPHROL, V18, P2268, DOI 10.1681/ASN.2007030295; Selin LK, 2006, IMMUNOL REV, V211, P164, DOI 10.1111/j.0105-2896.2006.00394.x; SLOBOD KS, 1993, VIROLOGY, V196, P179, DOI 10.1006/viro.1993.1466; SMYTH MJ, 1995, IMMUNOL TODAY, V16, P202, DOI 10.1016/0167-5699(95)80122-7; Stapler D, 2008, J IMMUNOL, V180, P3190, DOI 10.4049/jimmunol.180.5.3190; Stevenson PG, 1999, EUR J IMMUNOL, V29, P1059, DOI 10.1002/(SICI)1521-4141(199904)29:04<1059::AID-IMMU1059>3.0.CO;2-L; SUNILCHANDRA NP, 1994, AM J PATHOL, V145, P818; Szabo SJ, 2000, CELL, V100, P655, DOI 10.1016/S0092-8674(00)80702-3; Trautmann A, 2003, IMMUNOLOGY, V108, P305, DOI 10.1046/j.1365-2567.2003.01590.x; Tripp RA, 1997, J EXP MED, V185, P1641, DOI 10.1084/jem.185.9.1641; Uppaluri R, 2008, TRANSPLANTATION, V86, P137, DOI 10.1097/TP.0b013e31817b8e4b; Valujskikh A, 2002, AM J TRANSPLANT, V2, P501, DOI 10.1034/j.1600-6143.2002.20603.x; Valujskikh A, 2007, J AM SOC NEPHROL, V18, P2252, DOI 10.1681/ASN.2007020151; Vincenti F, 2007, AM J TRANSPLANT, V7, P1770, DOI 10.1111/j.1600-6143.2007.01845.x; Vincenti F, 2010, AM J TRANSPLANT, V10, P535, DOI 10.1111/j.1600-6143.2009.03005.x; Virgin HW, 1997, J VIROL, V71, P5894, DOI 10.1128/JVI.71.8.5894-5904.1997; Weaver TA, 2009, NAT MED, V15, P746, DOI 10.1038/nm.1993; Weck KE, 1996, J VIROL, V70, P6775, DOI 10.1128/JVI.70.10.6775-6780.1996; Welsh RM, 2002, NAT REV IMMUNOL, V2, P417, DOI 10.1038/nri820; Welsh RM, 2000, J VIROL, V74, P2210, DOI 10.1128/JVI.74.5.2210-2218.2000; Zhai Y, 2002, J IMMUNOL, V169, P4667, DOI 10.4049/jimmunol.169.8.4667	58	12	12	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2013	8	8							e71221	10.1371/journal.pone.0071221	http://dx.doi.org/10.1371/journal.pone.0071221			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	218XC	23940724	Green Published, Green Submitted, gold			2022-12-25	WOS:000324465000196
J	Gomez-Sintes, R; Lucas, JJ				Gomez-Sintes, Raquel; Lucas, Jose J.			Neuronal Apoptosis and Motor Deficits in Mice with Genetic Inhibition of GSK-3 Are Fas-Dependent	PLOS ONE			English	Article							GLYCOGEN-SYNTHASE KINASE-3; ALZHEIMERS-DISEASE; HUNTINGTONS-DISEASE; BIPOLAR DISORDER; SIGNALING PATHWAYS; CELL-SURVIVAL; LITHIUM; ACTIVATION; DEATH; RECEPTOR	Glycogen synthase kinase-3 (GSK-3) inhibitors have been postulated as useful therapeutic tools for the treatment of chronic neurodegenerative and neuropsychiatric diseases. Nevertheless the clinical use of these inhibitors has been limited by their common side effects. Lithium, a non-selective GSK-3 inhibitor has been classically administered to treat bipolar patients but its prescription is decreasing due to its frequent side effects such as hand tremor. This toxicity seems to be higher in the elderly and a clinical trial with lithium for Alzheimer's disease was stopped due to high rate of discontinuation. We have previously described a mechanism for the adverse effects of chronic lithium that involves neuronal apoptosis via Fas signaling. As lithium inhibits many other enzymatic activities such as inositol monophosphatase and histone deacetylase, here we aim to genetically test whether GSK-3 inhibition induces those adverse effects through Fas receptor. For this purpose we took advantage of a transgenic mouse line with decreased GSK-3 activity (Tet/DN-GSK-3 mice) that shows increased rate of neuronal apoptosis as well as motor deficits and brought it to a Fas deficient background (lpr mice). We found that apoptosis induced by GSK-3 inhibition was absent in Fas deficient background. Interestingly, motor deficits were also absent in Fas deficient Tet/DN-GSK-3 mice. These results demonstrate that Fas signaling contributes to the neurological toxicity of GSK-3 inhibition and suggest that a combination of GSK-3 inhibitors with blockers of Fas signaling could help to improve the application of GSK-3 inhibitors to clinics.	[Gomez-Sintes, Raquel; Lucas, Jose J.] CSIC UAM, Ctr Biol Mol Severo Ochoa CBM SO, Madrid, Spain; [Gomez-Sintes, Raquel; Lucas, Jose J.] Inst Salud Carlos III, Ctr Invest Biomed Red Enfermedades Neurodegenerat, Madrid, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Biologia Molecular Severo Ochoa (CBM); CIBERNED; Instituto de Salud Carlos III	Lucas, JJ (corresponding author), CSIC UAM, Ctr Biol Mol Severo Ochoa CBM SO, Madrid, Spain.	jjlucas@cbm.uam.es	Gomez-Sintes, Raquel/S-6618-2019; Lucas, Jose J./U-6543-2019	Gomez-Sintes, Raquel/0000-0003-2854-6964; Lucas, Jose J./0000-0003-1597-3916	Centro de Investigacion Biomedica en Red de Enfermedades Neurodegenerativas (CiberNed-Instituto de salud Carlos III); Ministerio de Ciencia (MEC); Ministerio de Ciencia (MICINN); Ministerio de Ciencia (MINECO); Comunidad Autonoma de Madrid; Fundacion Ramon Areces	Centro de Investigacion Biomedica en Red de Enfermedades Neurodegenerativas (CiberNed-Instituto de salud Carlos III); Ministerio de Ciencia (MEC); Ministerio de Ciencia (MICINN); Ministerio de Ciencia (MINECO); Comunidad Autonoma de Madrid(Comunidad de Madrid); Fundacion Ramon Areces	This work was supported by Centro de Investigacion Biomedica en Red de Enfermedades Neurodegenerativas (CiberNed-Instituto de salud Carlos III) and by grants from Ministerio de Ciencia (MEC, MICINN, MINECO), Comunidad Autonoma de Madrid, and Fundacion Ramon Areces. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baldessarini RJ, 2002, CNS DRUGS, V16, P721, DOI 10.2165/00023210-200216110-00001; Bertram L, 2000, SCIENCE, V290, P2302, DOI 10.1126/science.290.5500.2302; Beurel E, 2006, PROG NEUROBIOL, V79, P173, DOI 10.1016/j.pneurobio.2006.07.006; BEYAERT R, 1989, P NATL ACAD SCI USA, V86, P9494, DOI 10.1073/pnas.86.23.9494; BLOKSMA N, 1994, INT J IMMUNOPHARMACO, V16, P261, DOI 10.1016/0192-0561(94)90021-3; Carmichael J, 2002, J BIOL CHEM, V277, P33791, DOI 10.1074/jbc.m204861200; Chiu CT, 2011, NEUROPSYCHOPHARMACOL, V36, P2406, DOI 10.1038/npp.2011.128; Cohen P, 2004, NAT REV DRUG DISCOV, V3, P479, DOI 10.1038/nrd1415; COHEN PL, 1991, ANNU REV IMMUNOL, V9, P243, DOI 10.1146/annurev.iy.09.040191.001331; Diaz-Hernandez M, 2005, J NEUROSCI, V25, P9773, DOI 10.1523/JNEUROSCI.3183-05.2005; Doble BW, 2003, J CELL SCI, V116, P1175, DOI 10.1242/jcs.00384; Emamian ES, 2004, NAT GENET, V36, P131, DOI 10.1038/ng1296; Erten-Lyons D, 2010, ALZHEIMERS DEMENT, V6, P118, DOI 10.1016/j.jalz.2009.05.663; Ethell DW, 2002, CURR BIOL, V12, P1595, DOI 10.1016/S0960-9822(02)01140-5; Feuk L, 2000, HUM GENET, V107, P391, DOI 10.1007/s004390000383; Forlenza OV, 2011, BRIT J PSYCHIAT, V198, P351, DOI 10.1192/bjp.bp.110.080044; Frame S, 2001, BIOCHEM J, V359, P1, DOI 10.1042/0264-6021:3590001; Gomez-Sintes R, 2007, EMBO J, V26, P2743, DOI 10.1038/sj.emboj.7601725; Gomez-Sintes R, 2010, J CLIN INVEST, V120, P2432, DOI 10.1172/JCI37873; Gould TD, 2004, INT J NEUROPSYCHOPH, V7, P387, DOI 10.1017/S1461145704004535; Gould TD, 2006, CURR DRUG TARGETS, V7, P1399, DOI 10.2174/1389450110607011399; Grimes CA, 2001, PROG NEUROBIOL, V65, P391, DOI 10.1016/S0301-0082(01)00011-9; Hampton TG, 2004, PHYSIOL BEHAV, V82, P381, DOI 10.1016/j.physbeh.2004.04.006; Henriksen EJ, 2006, CURR DRUG TARGETS, V7, P1435, DOI 10.2174/1389450110607011435; Hoeflich KP, 2000, NATURE, V406, P86, DOI 10.1038/35017574; Hooper C, 2008, J NEUROCHEM, V104, P1433, DOI 10.1111/j.1471-4159.2007.05194.x; Hooper C, 2007, EUR J NEUROSCI, V25, P81, DOI 10.1111/j.1460-9568.2006.05245.x; Hu SX, 2009, NEUROBIOL DIS, V33, P193, DOI 10.1016/j.nbd.2008.10.007; Hur EM, 2010, NAT REV NEUROSCI, V11, P539, DOI 10.1038/nrn2870; Jope RS, 2006, CURR DRUG TARGETS, V7, P1421, DOI 10.2174/1389450110607011421; Jope RS, 2004, TRENDS BIOCHEM SCI, V29, P95, DOI 10.1016/j.tibs.2003.12.004; Kato T, 2008, TRENDS NEUROSCI, V31, P495, DOI 10.1016/j.tins.2008.07.007; Klein PS, 1996, P NATL ACAD SCI USA, V93, P8455, DOI 10.1073/pnas.93.16.8455; Knight JC, 2010, J NEUROSCI RES, V88, P746, DOI 10.1002/jnr.22253; Kremer A, 2011, FRONT MOL NEUROSCI, V4, DOI 10.3389/fnmol.2011.00017; Macdonald A, 2008, INT J GERIATR PSYCH, V23, P704, DOI 10.1002/gps.1964; MACRITCHIE KAN, 2004, ADVERSE SYNDROMES PS, P89; Maelfait J, 2008, BIOCHEM PHARMACOL, V76, P1365, DOI 10.1016/j.bcp.2008.07.034; Manoukian AS, 2002, ADV CANCER RES, V84, P203, DOI 10.1016/S0065-230X(02)84007-6; Martinez M, 2000, BRAIN RES, V869, P216, DOI 10.1016/S0006-8993(00)02363-5; Matsuura K, 1997, J NEUROSCI METH, V73, P45, DOI 10.1016/S0165-0270(96)02211-X; Medina M, 2008, CURR OPIN DRUG DISC, V11, P533; Meijer L, 2004, TRENDS PHARMACOL SCI, V25, P471, DOI 10.1016/j.tips.2004.07.006; Myers A, 2000, SCIENCE, V290, P2304, DOI 10.1126/science.290.5500.2304; Paxinos G., 2001, MOUSE BRAIN STEREOTA; Peineau S, 2007, NEURON, V53, P703, DOI 10.1016/j.neuron.2007.01.029; Phiel CJ, 2001, ANNU REV PHARMACOL, V41, P789, DOI 10.1146/annurev.pharmtox.41.1.789; Reich A, 2008, TRENDS NEUROSCI, V31, P478, DOI 10.1016/j.tins.2008.06.007; Saavedra A, 2010, CELL DEATH DIFFER, V17, P324, DOI 10.1038/cdd.2009.127; Song L, 2004, BMC NEUROSCI, V5, DOI 10.1186/1471-2202-5-20; Stambolic V, 1996, CURR BIOL, V6, P1664, DOI 10.1016/S0960-9822(02)70790-2; Su JH, 2003, NEUROBIOL DIS, V12, P182, DOI 10.1016/S0969-9961(02)00019-0; Sun M, 2008, CELL DEATH DIFFER, V15, P1887, DOI 10.1038/cdd.2008.124; Tourneur L, 2010, TRENDS IMMUNOL, V31, P260, DOI 10.1016/j.it.2010.05.005; Young AH, 2006, J PSYCHOPHARMACOL, V20, P17, DOI 10.1177/1359786806063072	55	6	8	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2013	8	8							e70952	10.1371/journal.pone.0070952	http://dx.doi.org/10.1371/journal.pone.0070952			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	218XC	23940673	Green Published, gold, Green Submitted			2022-12-25	WOS:000324465000162
J	Irsik, DL; Carmines, PK; Lane, PH				Irsik, Debra L.; Carmines, Pamela K.; Lane, Pascale H.			Classical Estrogen Receptors and ER alpha Splice Variants in the Mouse	PLOS ONE			English	Article							OXIDATIVE STRESS; CARDIOVASCULAR-DISEASE; TISSUE DISTRIBUTION; SEX-DIFFERENCES; ADIPOSE-TISSUE; RENAL-DISEASE; EXPRESSION; BETA; ESTRADIOL; CELLS	Estrogens exert a variety of effects in both reproductive and non-reproductive tissues. With the discovery of ER alpha splice variants, prior assumptions concerning tissue-specific estrogen signaling need to be re-evaluated. Accordingly, we sought to determine the expression of the classical estrogen receptors and ER alpha splice variants across reproductive and nonreproductive tissues of male and female mice. Western blotting revealed that the full-length ER alpha 66 was mainly present in female reproductive tissues but was also found in non-reproductive tissues at lower levels. ER alpha 46 was most highly expressed in the heart of both sexes. ER alpha 36 was highly expressed in the kidneys and liver of female mice but not in the kidneys of males. ER beta was most abundant in non-reproductive tissues and in the ovaries. Because the kidney has been reported to be the most estrogenic non-reproductive organ, we sought to elucidate ER renal expression and localization. Immunofluorescence studies revealed ER alpha 66 in the vasculature and the glomerulus. It was also found in the brush border of the proximal tubule and in the cortical collecting duct of female mice. ER alpha 36 was evident in mesangial cells and tubular epithelial cells of both sexes, as well as podocytes of females but not males. ER beta was found primarily in the podocytes in female mice but was also present in the mesangial cells in both sexes. Within the renal cortex, ER alpha 46 and ER alpha 36 were mainly located in the membrane fraction although they were also present in the cytosolic fraction. Given the variability of expression patterns demonstrated herein, identification of the specific estrogen receptors expressed in a tissue is necessary for interpreting estrogenic effects. As this study revealed expression of the ER alpha splice variants at multiple sites within the kidney, further studies are warranted in order to elucidate the contribution of these receptors to renal estrogen responsiveness.	[Irsik, Debra L.; Carmines, Pamela K.; Lane, Pascale H.] Univ Nebraska Med Ctr, Dept Cellular & Integrat Physiol, Omaha, NE USA; [Lane, Pascale H.] Univ Oklahoma, Hlth Sci Ctr, Dept Pediat, Oklahoma City, OK 73190 USA	University of Nebraska System; University of Nebraska Medical Center; University of Oklahoma System; University of Oklahoma Health Sciences Center	Lane, PH (corresponding author), Univ Nebraska Med Ctr, Dept Cellular & Integrat Physiol, Omaha, NE USA.	pascale-lane@ouhsc.edu		Irsik, Debra/0000-0001-6209-3351	University of Nebraska Medical Center Department of Pediatrics; University of Nebraska Medical Center Department of Cellular and Integrative Physiology	University of Nebraska Medical Center Department of Pediatrics; University of Nebraska Medical Center Department of Cellular and Integrative Physiology	This work was funded by the University of Nebraska Medical Center Departments of Pediatrics and of Cellular and Integrative Physiology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLEN E, 1983, JAMA-J AM MED ASSOC, V250, P2681, DOI 10.1001/jama.250.19.2681; Amengual-Cladera E, 2012, METABOLISM, V61, P1108, DOI 10.1016/j.metabol.2011.12.016; Arias-Loza PA, 2013, PFLUG ARCH EUR J PHY, V465, P739, DOI 10.1007/s00424-013-1247-7; Baines H, 2008, REPROD BIOL ENDOCRIN, V6, DOI 10.1186/1477-7827-6-4; Catanuto P, 2009, KIDNEY INT, V75, P1194, DOI 10.1038/ki.2009.69; Chakraborty P, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0058291, 10.1371/journal.pone.0068543]; Couse JF, 1997, ENDOCRINOLOGY, V138, P4613, DOI 10.1210/en.138.11.4613; Esqueda MED, 2007, HYPERTENSION, V50, P768, DOI 10.1161/HYPERTENSIONAHA.107.095265; Dixon A, 2007, AM J PHYSIOL-RENAL, V293, pF1678, DOI 10.1152/ajprenal.00079.2007; Dubey RK, 2001, AM J PHYSIOL-RENAL, V280, pF365, DOI 10.1152/ajprenal.2001.280.3.F365; Fisher JS, 1997, J ENDOCRINOL, V153, P485, DOI 10.1677/joe.0.1530485; Flouriot G, 2000, EMBO J, V19, P4688, DOI 10.1093/emboj/19.17.4688; Gormsen LC, 2012, EUR J ENDOCRINOL, V167, P543, DOI 10.1530/EJE-12-0422; GREEN S, 1986, NATURE, V320, P134, DOI 10.1038/320134a0; Guccione M, 2002, AM J PHYSIOL-RENAL, V282, pF164, DOI 10.1152/ajprenal.0318.2000; Helmersson J, 2002, CLIN SCI, V102, P39, DOI 10.1042/CS20010179; Ide T, 2002, ARTERIOSCL THROM VAS, V22, P438, DOI 10.1161/hq0302.104515; Jelinsky SA, 2003, ENDOCRINOLOGY, V144, P701, DOI 10.1210/en.2002-220728; Ji H, 2007, GENDER MED, V4, P56, DOI 10.1016/S1550-8579(07)80009-X; Joseph A, 2010, BIOL REPROD, V82, P948, DOI 10.1095/biolreprod.109.079889; Krege JH, 1998, P NATL ACAD SCI USA, V95, P15677, DOI 10.1073/pnas.95.26.15677; Kuiper GGJM, 1996, P NATL ACAD SCI USA, V93, P5925, DOI 10.1073/pnas.93.12.5925; Kuiper GGJM, 1997, ENDOCRINOLOGY, V138, P863, DOI 10.1210/en.138.3.863; Li L, 2003, P NATL ACAD SCI USA, V100, P4807, DOI 10.1073/PNAS.0831079100; Li WY, 2001, BRAIN RES BULL, V54, P83, DOI 10.1016/S0361-9230(00)00428-7; Lindberg MK, 2003, MOL ENDOCRINOL, V17, P203, DOI 10.1210/me.2002-0206; Lovegrove AS, 2004, AM J PHYSIOL-RENAL, V287, pF586, DOI 10.1152/ajprenal.00414.2003; LUBAHN DB, 1993, P NATL ACAD SCI USA, V90, P11162, DOI 10.1073/pnas.90.23.11162; Marrian GF, 1931, SCIENCE, V74, P547, DOI 10.1126/science.74.1926.547; Mosselman S, 1996, FEBS LETT, V392, P49, DOI 10.1016/0014-5793(96)00782-X; Murphy AJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005539; Neugarten J, 2000, J AM SOC NEPHROL, V11, P319, DOI 10.1681/ASN.V112319; Pedram A, 2009, J BIOL CHEM, V284, P3488, DOI 10.1074/jbc.M806249200; Penot G, 2005, ENDOCRINOLOGY, V146, P5474, DOI 10.1210/en.2005-0866; Potier M, 2001, J AM SOC NEPHROL, V12, P241, DOI 10.1681/ASN.V122241; Reckelhoff JF, 2006, HYPERTENSION, V48, P372, DOI 10.1161/01.HYP.0000235866.97871.9d; Reckelhoff JF, 2005, HYPERTENSION, V45, P170, DOI 10.1161/01.HYP.0000151825.36598.36; Reslan OM, 2013, J CARDIOVASC PHARM, V62, P26, DOI 10.1097/FJC.0b013e31828bc88a; Ruz R, 2006, MOL REPROD DEV, V73, P226, DOI 10.1002/mrd.20390; Saunders PTK, 1998, J ENDOCRINOL, V156, pR13, DOI 10.1677/joe.0.156R013; Schreihofer DA, 2013, BRAIN RES, V1514, P107, DOI 10.1016/j.brainres.2013.02.051; Sullivan JC, 2009, GENDER MED, V6, P498, DOI 10.1016/j.genm.2009.09.003; Sun JH, 2006, AM J PHYSIOL-RENAL, V290, pF319, DOI 10.1152/ajprenal.00271.2005; Taylor SE, 2010, CANCER LETT, V288, P133, DOI 10.1016/j.canlet.2009.06.017; Wang ZY, 2006, P NATL ACAD SCI USA, V103, P9063, DOI 10.1073/pnas.0603339103; Wang ZY, 2005, BIOCHEM BIOPH RES CO, V336, P1023, DOI 10.1016/j.bbrc.2005.08.226; Wittnich C, 2013, PFLUG ARCH EUR J PHY, V465, P719, DOI 10.1007/s00424-013-1232-1; Zou Y, 2009, FEBS LETT, V583, P1368, DOI 10.1016/j.febslet.2009.03.047	48	47	47	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2013	8	8							e70926	10.1371/journal.pone.0070926	http://dx.doi.org/10.1371/journal.pone.0070926			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	218XC	23940668	Green Published, gold, Green Submitted			2022-12-25	WOS:000324465000157
J	Jacob, ST; Pavlinac, PB; Nakiyingi, L; Banura, P; Baeten, JM; Morgan, K; Magaret, A; Manabe, Y; Reynolds, SJ; Liles, WC; Wald, A; Joloba, ML; Mayanja-Kizza, H; Scheld, WM				Jacob, Shevin T.; Pavlinac, Patricia B.; Nakiyingi, Lydia; Banura, Patrick; Baeten, Jared M.; Morgan, Karen; Magaret, Amalia; Manabe, Yuka; Reynolds, Steven J.; Liles, W. Conrad; Wald, Anna; Joloba, Moses L.; Mayanja-Kizza, Harriet; Scheld, W. Michael			Mycobacterium tuberculosis Bacteremia in a Cohort of HIV-Infected Patients Hospitalized with Severe Sepsis in Uganda-High Frequency, Low Clinical Sand Derivation of a Clinical Prediction Score	PLOS ONE			English	Article							SUB-SAHARAN AFRICA; DIAGNOSTIC-ACCURACY; SEPTIC SHOCK; ADULTS; IMMUNODEFICIENCY; CONFIRMATION; PREVALENCE; MANAGEMENT; TANZANIA; AREAS	Background: When manifested as Mycobacterium tuberculosis (MTB) bacteremia, disseminated MTB infection clinically mimics other serious blood stream infections often hindering early diagnosis and initiation of potentially life-saving anti-tuberculosis therapy. In a cohort of hospitalized HIV-infected Ugandan patients with severe sepsis, we report the frequency, management and outcomes of patients with MTB bacteremia and propose a risk score based on clinical predictors of MTB bacteremia. Methods: We prospectively enrolled adult patients with severe sepsis at two Ugandan hospitals and obtained blood cultures for MTB identification. Multivariable logistic regression modeling was used to determine predictors of MTB bacteremia and to inform the stratification of patients into MTB bacteremia risk categories based on relevant patient characteristics. Results: Among 368 HIV-infected patients with a syndrome of severe sepsis, eighty-six (23%) had MTB bacteremia. Patients with MTB bacteremia had a significantly lower median CD4 count (17 vs 64 lymphocytes/mm(3), p<0.001) and a higher 30-day mortality (53% vs 32%, p = 0.001) than patients without MTB bacteremia. A minority of patients with MTB bacteremia underwent standard MTB diagnostic testing (24%) or received empiric anti-tuberculosis therapy (15%). Independent factors associated with MTB bacteremia included male sex, increased heart rate, low CD4 count, absence of highly active anti-retroviral therapy, chief complaint of fever, low serum sodium and low hemoglobin. A risk score derived from a model containing these independent predictors had good predictive accuracy [area under the curve = 0.85, 95% CI 0.80-0.89]. Conclusions: Nearly 1 in 4 adult HIV-infected patients hospitalized with severe sepsis in 2 Ugandan hospitals had MTB bacteremia. Among patients in whom MTB was suspected, standard tests for diagnosing pulmonary MTB were inaccurate for correctly classifying patients with or without bloodstream MTB infection. A MTB bacteremia risk score can improve early diagnosis of MTB bacteremia particularly in settings with increased HIV and MTB co-infection.	[Jacob, Shevin T.; Baeten, Jared M.; Liles, W. Conrad; Wald, Anna] Univ Washington, Dept Med, Seattle, WA 98195 USA; [Jacob, Shevin T.] Univ Washington, Int Resp & Severe Illness Ctr INTERSECT, Seattle, WA 98195 USA; [Pavlinac, Patricia B.; Baeten, Jared M.; Wald, Anna] Univ Washington, Dept Epidemiol, Seattle, WA 98195 USA; [Nakiyingi, Lydia; Mayanja-Kizza, Harriet] Makerere Univ, Coll Hlth Sci, Sch Med, Kampala, Uganda; [Nakiyingi, Lydia] Makerere Univ, Infect Dis Inst, Kampala, Uganda; [Banura, Patrick] Masaka Reg Referral Hosp, Masaka, Uganda; [Baeten, Jared M.] Univ Washington, Dept Global Hlth, Seattle, WA 98195 USA; [Morgan, Karen] Joint Clin Res Ctr, JCRC TB Lab, Mengo, Uganda; [Magaret, Amalia; Wald, Anna] Univ Washington, Dept Lab Med, Seattle, WA 98195 USA; [Magaret, Amalia] Fred Hutchinson Canc Res Ctr, Vaccine & Infect Dis Div, Seattle, WA 98104 USA; [Manabe, Yuka; Reynolds, Steven J.] Johns Hopkins Univ, Sch Med, Baltimore, MD USA; [Reynolds, Steven J.; Wald, Anna] Rakai Hlth Sci Program, Kalisizo, Uganda; [Reynolds, Steven J.] NIH, Dept Intramural Res, Bethesda, MD 20892 USA; [Joloba, Moses L.] Makerere Univ, Dept Med Microbiol, Kampala, Uganda; [Scheld, W. Michael] Univ Virginia, Dept Med, Charlottesville, VA USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Makerere University; Makerere University; University of Washington; University of Washington Seattle; Joint Clinic Research Center - United Arab Emirates; University of Washington; University of Washington Seattle; Fred Hutchinson Cancer Center; Johns Hopkins University; Rakai Health Sciences Program; National Institutes of Health (NIH) - USA; Makerere University; University of Virginia	Jacob, ST (corresponding author), Univ Washington, Dept Med, Seattle, WA 98195 USA.	sjacob2@uw.edu	Nakiyingi, Lydia/ABG-7669-2020; Mayanja-Kizza, Harriet/AAM-5372-2020; Jacob, Shevin/CAF-0449-2022	Nakiyingi, Lydia/0000-0001-7263-3198; Mayanja-Kizza, Harriet/0000-0002-9297-6208; Jacob, Shevin/0000-0003-2425-9394; Reynolds, Steven/0000-0002-5403-2759; Joloba, Moses/0000-0002-0334-9983	Pfizer, Inc.; Rakai Health Sciences Program through the Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health; National Institutes of Health [K24 (AI 071113)]; University of Washington STD/AIDS Research Training Program from the National Institutes of Health [T32 (AI007140)]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K24AI071113, T32AI007140] Funding Source: NIH RePORTER	Pfizer, Inc.(Pfizer); Rakai Health Sciences Program through the Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Washington STD/AIDS Research Training Program from the National Institutes of Health; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Primary funding for the study was from an Investigator-Initiated Award provided by Pfizer, Inc. Pfizer, Inc. had no role in the design and conduct of the study; the collection, management, analysis, and interpretation of the data; or the preparation, review or approval of the manuscript. Additional non-grant support was provided by the Rakai Health Sciences Program through the Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health. In addition, AW is supported by a National Institutes of Health K24 (AI 071113) and PP is supported by the University of Washington STD/AIDS Research Training Program, T32 (AI007140) from the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AHUJA SS, 1992, CRIT CARE MED, V20, P901, DOI 10.1097/00003246-199206000-00031; Archibald LK, 1998, CLIN INFECT DIS, V26, P290, DOI 10.1086/516297; Boehme CC, 2010, NEW ENGL J MED, V363, P1005, DOI 10.1056/NEJMoa0907847; Cain KP, 2010, NEW ENGL J MED, V362, P707, DOI 10.1056/NEJMoa0907488; Corbett EL, 2006, LANCET, V367, P926, DOI 10.1016/S0140-6736(06)68383-9; Cox JA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033685; Crump JA, 2012, CLIN INFECT DIS, V55, P242, DOI 10.1093/cid/cis409; Crump JA, 2011, J CLIN MICROBIOL, V49, P3054, DOI 10.1128/JCM.01035-11; DELONG ER, 1988, BIOMETRICS, V44, P837, DOI 10.2307/2531595; Ferrand RA, 2006, INT J STD AIDS, V17, P562, DOI 10.1258/095646206778145578; Fredricks DN, 1998, J CLIN MICROBIOL, V36, P2810, DOI 10.1128/JCM.36.10.2810-2816.1998; GILKS CF, 1990, LANCET, V336, P545, DOI 10.1016/0140-6736(90)92096-Z; Harries AD, 2000, INT J TUBERC LUNG D, V4, P998; Hillemann D, 2005, INT J TUBERC LUNG D, V9, P1409; Jacob ST, 2012, CRIT CARE MED, V40, P2050, DOI 10.1097/CCM.0b013e31824e65d7; Jacob ST, 2009, PLOS ONE, V4, pA115, DOI 10.1371/journal.pone.0007782; Lawn SD, 2011, INT J TUBERC LUNG D, V15, P287; Lawn SD, 2012, LANCET INFECT DIS, V12, P201, DOI 10.1016/S1473-3099(11)70251-1; LEE BL, 1993, CLIN PHARMACOL THER, V53, P529, DOI 10.1038/clpt.1993.66; Lewis DK, 2002, INT J TUBERC LUNG D, V6, P1067; Manabe YC, 2012, INT J TUBERC LUNG D, V16, P280, DOI 10.5588/ijtld.11.0242; Martinson NA, 2007, AIDS, V21, P2043, DOI 10.1097/QAD.0b013e3282eea47f; McDonald LC, 1999, LANCET, V354, P1159, DOI 10.1016/S0140-6736(98)12325-5; Munseri PJ, 2011, SCAND J INFECT DIS, V43, P696, DOI 10.3109/00365548.2011.577802; National Institute of Allergy and Infectious Diseases, DMID CLIN RES POL ST; PICARD RR, 1984, J AM STAT ASSOC, V79, P575, DOI 10.2307/2288403; Shah M, 2009, JAIDS-J ACQ IMM DEF, V52, P145, DOI 10.1097/QAI.0b013e3181b98430; Sullivan LM, 2004, STAT MED, V23, P1631, DOI 10.1002/sim.1742; WHO, 2012, GLOBAL TUBERCULOSIS REPORT 2012, P1	29	57	59	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2013	8	8							e70305	10.1371/journal.pone.0070305	http://dx.doi.org/10.1371/journal.pone.0070305			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	218XC	23940557	Green Published, Green Submitted, gold			2022-12-25	WOS:000324465000051
J	Li, QX; Gu, CY; Zhu, Y; Wang, MY; Yang, YJ; Wang, JC; Jin, L; Zhu, ML; Shi, TY; He, J; Zhou, XY; Ye, DW; Wei, QY				Li, Qiaoxin; Gu, Chengyuan; Zhu, Yao; Wang, Mengyun; Yang, Yajun; Wang, Jiucun; Jin, Li; Zhu, Mei-Ling; Shi, Ting-Yan; He, Jing; Zhou, Xiaoyan; Ye, Ding-wei; Wei, Qingyi			Polymorphisms in the mTOR Gene and Risk of Sporadic Prostate Cancer in an Eastern Chinese Population	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; PATHWAY; TARGET; GROWTH; LOCI	Background: The mTOR gene regulates cell growth by controlling mRNA translation, ribosome biogenesis, autophagy, and metabolism. Abnormally increased expression of mTOR was associated with carcinogenesis, and its functional single nucleotide polymorphisms (SNPs) may regulate the expression of mTOR and thus contribute to cancer risk. Methodology/Principal Findings: In a hospital-based case-control study of 1004 prostate cancer (PCa) cases and 1051 cancer-free controls, we genotyped six potentially functional SNPs of mTOR (rs2536 T>C, rs1883965 G>A, rs1034528 G>C, rs17036508 T>C, rs3806317 A>G, and rs2295080 T>G) and assessed their associations with risk of PCa by using logistic regression analysis. Conclusions/Significances: In the single-locus analysis, we found a significantly increased risk of PCa associated with mTOR rs2536 CT/CC and rs1034528 CG/CC genotypes [adjusted OR = 1.42 (1.13-1.78), P = 0.003 and 1.29 (1.07-1.55), P = 0.007), respectively], compared with their common homozygous genotypes, whereas mTOR rs2295080 GT/GG genotypes were associated with a decreased risk of PCa [adjusted OR = 0.76 (0.64-0.92), P = 0.003], compared with wild-type TT genotypes. In the combined analysis of the six SNPs, we found that individuals carrying two or more adverse genotypes had an increased risk of PCa [adjusted OR = 1.24 (1.04-1.47), P = 0.016], compared with individuals carrying less than two adverse genotypes. In the multiple dimension reduction analysis, body mass index (BMI) was the best one-factor model with the highest CVC (100%) and the lowest prediction error (42.7%) among all seven factors. The model including an interaction among BMI, rs17036508, and rs2536 was the best three-factor model with the highest CVC (100%) and the lowest prediction error of 41.9%. These findings suggested that mTOR SNPs may contribute to the risk of PCa in Eastern Chinese men, but the effect was weak and needs further validation by larger population-based studies.	[Li, Qiaoxin; Wang, Mengyun; Zhu, Mei-Ling; Shi, Ting-Yan; He, Jing; Wei, Qingyi] Fudan Univ, Inst Canc, Shanghai Canc Inst, Shanghai 200433, Peoples R China; [Li, Qiaoxin; Gu, Chengyuan; Zhu, Yao; Wang, Mengyun; Zhu, Mei-Ling; Shi, Ting-Yan; He, Jing; Zhou, Xiaoyan; Ye, Ding-wei] Fudan Univ, Shanghai Med Coll, Dept Oncol, Shanghai 200433, Peoples R China; [Gu, Chengyuan; Zhu, Yao; Ye, Ding-wei] Fudan Univ, Dept Urol, Shanghai Canc Inst, Shanghai 200433, Peoples R China; [Yang, Yajun; Wang, Jiucun; Jin, Li] Fudan Univ, Sch Life Sci, State Key Lab Genet Engn, Minist Educ,Key Lab Contemporary Anthropol, Shanghai 200433, Peoples R China; [Yang, Yajun; Wang, Jiucun; Jin, Li] Fudan Taizhou Inst Hlth Sci, Taizhou, Jiangsu, Peoples R China; [Zhou, Xiaoyan] Fudan Univ, Shanghai Med Coll, Dept Pathol, Shanghai 200433, Peoples R China; [Wei, Qingyi] Univ Texas MD Anderson Canc Ctr, Dept Epidemiol, Houston, TX 77030 USA	Fudan University; Shanghai Jiao Tong University; Fudan University; Fudan University; Shanghai Jiao Tong University; Fudan University; Fudan University; University of Texas System; UTMD Anderson Cancer Center	Ye, DW (corresponding author), Fudan Univ, Shanghai Med Coll, Dept Oncol, Shanghai 200433, Peoples R China.	dwye.shca@gmail.com; weiqingyi@yahoo.com	Jin, Li/M-5063-2019; He, Jing/M-5774-2015; Jin, Li/C-1468-2009	He, Jing/0000-0002-1954-2892; Jin, Li/0000-0002-4546-2415	"China's Thousand Talents Program'' Recruitment at Fudan University; Science and Technology Committee of Shanghai Municipality [12DZ2260100]; Ministry of Science and Technology [2011BAI09B00]; Ministry of Health [201002007]	"China's Thousand Talents Program'' Recruitment at Fudan University; Science and Technology Committee of Shanghai Municipality(Shanghai Science & Technology Committee); Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); Ministry of Health	This study was supported by the funds from "China's Thousand Talents Program'' Recruitment at Fudan University, the Science and Technology Committee of Shanghai Municipality (Grant No. 12DZ2260100), the Ministry of Science and Technology (Grant No. 2011BAI09B00), and Ministry of Health (Grant No. 201002007). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Buratti E, 2004, AM J HUM GENET, V74, P1322, DOI 10.1086/420978; Cao Q, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050302; Chen JW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040817; Edinger AL, 2002, MOL BIOL CELL, V13, P2276, DOI 10.1091/mbc.01-12-0584; Eeles RA, 2009, NAT GENET, V41, P1116, DOI 10.1038/ng.450; Fingar DC, 2004, MOL CELL BIOL, V24, P200, DOI 10.1128/MCB.24.1.200-216.2004; Freeman MR, 2004, J CELL BIOCHEM, V91, P54, DOI 10.1002/jcb.10724; Gudmundsson J, 2007, NAT GENET, V39, P631, DOI 10.1038/ng1999; Guertin DA, 2005, TRENDS MOL MED, V11, P353, DOI 10.1016/j.molmed.2005.06.007; Hahn LW, 2003, BIOINFORMATICS, V19, P376, DOI 10.1093/bioinformatics/btf869; He J, 2013, MOL CARCINOG; He J, 2012, HUM GENET, V131, P1235, DOI 10.1007/s00439-012-1152-8; Hidalgo M, 2000, ONCOGENE, V19, P6680, DOI 10.1038/sj.onc.1204091; Hildebrandt MAT, 2009, J CLIN ONCOL, V27, P857, DOI 10.1200/JCO.2008.17.6297; Huang LZ, 2012, LEUKEMIA LYMPHOMA, V53, P947, DOI 10.3109/10428194.2011.628062; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20115, 10.3322/caac.20107]; Liu L, 2011, CARCINOGENESIS, V32, P336, DOI 10.1093/carcin/bgq264; Matsuda T, 2009, JPN J CLIN ONCOL, V39, P435, DOI [10.1093/jjco/hyp047, 10.1093/jjco/hyp077]; Moore T, 2008, CANCER PREV RES, V1, P65, DOI 10.1158/1940-6207.CAPR-08-0022; Naukkarinen J, 2005, HUM MOL GENET, V14, P2595, DOI 10.1093/hmg/ddi294; OHORI M, 1994, CANCER-AM CANCER SOC, V74, P104, DOI 10.1002/1097-0142(19940701)74:1<104::AID-CNCR2820740119>3.0.CO;2-5; Patel PH, 2006, CLIN CANCER RES, V12, P7215, DOI 10.1158/1078-0432.CCR-06-2254; Ritchie MD, 2001, AM J HUM GENET, V69, P138, DOI 10.1086/321276; Sarbassov DD, 2005, CURR OPIN CELL BIOL, V17, P596, DOI 10.1016/j.ceb.2005.09.009; Sato T, 2010, ONCOGENE, V29, P2746, DOI 10.1038/onc.2010.28; Stadler ZK, 2010, HEMATOL ONCOL CLIN N, V24, P973, DOI 10.1016/j.hoc.2010.06.009; Thomas G, 2008, NAT GENET, V40, P310, DOI 10.1038/ng.91; Tokuhiro S, 2003, NAT GENET, V35, P341, DOI 10.1038/ng1267; Vivanco I, 2002, NAT REV CANCER, V2, P489, DOI 10.1038/nrc839; Wacholder S, 2004, J NATL CANCER I, V96, P434, DOI 10.1093/jnci/djh075; Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016; Xu M, 2013, PLOS ONE, V8; Yang Q, 2007, CELL RES, V17, P666, DOI 10.1038/cr.2007.64; Zhang XM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021894; Zhang XM, 2011, MOL CARCINOGEN, V50, P876, DOI 10.1002/mc.20784; Zhong R, 2013, CARCINOGENESIS, V34, P936, DOI 10.1093/carcin/bgs395; Zhou HY, 2010, CURR PROTEIN PEPT SC, V11, P409, DOI 10.2174/138920310791824093; Zhu ML, 2013, J THORAC ONCOL, V8, P788, DOI 10.1097/JTO.0b013e31828916c6	38	19	25	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2013	8	8							e71968	10.1371/journal.pone.0071968	http://dx.doi.org/10.1371/journal.pone.0071968			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	218XC	23940798	Green Published, Green Submitted, gold			2022-12-25	WOS:000324465000237
J	Shih, DF; Hsiao, CD; Min, MY; Lai, WS; Yang, CW; Lee, WT; Lee, SJ				Shih, De-Fen; Hsiao, Chung-Der; Min, Ming-Yuan; Lai, Wen-Sung; Yang, Chianne-Wen; Lee, Wang-Tso; Lee, Shyh-Jye			Aromatic L-Amino Acid Decarboxylase (AADC) Is Crucial for Brain Development and Motor Functions	PLOS ONE			English	Article							ZEBRAFISH DANIO-RERIO; DOPAMINE-RECEPTOR GENES; IN-SITU HYBRIDIZATION; LOCOMOTOR NETWORK; TYROSINE-HYDROXYLASE; CEREBRAL-CORTEX; PARKINSONS-DISEASE; CLINICAL-FEATURES; LARVAL ZEBRAFISH; MESSENGER-RNA	Aromatic L-amino acid decarboxylase (AADC) deficiency is a rare pediatric neuro-metabolic disease in children. Due to the lack of an animal model, its pathogenetic mechanism is poorly understood. To study the role of AADC in brain development, a zebrafish model of AADC deficiency was generated. We identified an aadc gene homolog, dopa decarboxylase (ddc), in the zebrafish genome. Whole-mount in situ hybridization analysis showed that the ddc gene is expressed in the epiphysis, locus caeruleus, diencephalic catecholaminergic clusters, and raphe nuclei of 36-h post-fertilization (hpf) zebrafish embryos. Inhibition of Ddc by AADC inhibitor NSD-1015 or anti-sense morpholino oligonucleotides (MO) reduced brain volume and body length. We observed increased brain cell apoptosis and loss of dipencephalic catecholaminergic cluster neurons in ddc morphants (ddc MO-injected embryos). Seizure-like activity was also detected in ddc morphants in a dose-dependent manner. ddc morphants had less sensitive touch response and impaired swimming activity that could be rescued by injection of ddc plasmids. In addition, eye movement was also significantly impaired in ddc morphants. Collectively, loss of Ddc appears to result in similar phenotypes as that of ADCC deficiency, thus zebrafish could be a good model for investigating pathogenetic mechanisms of AADC deficiency in children.	[Shih, De-Fen; Lee, Shyh-Jye] Natl Taiwan Univ, Inst Zool, Taipei 10764, Taiwan; [Hsiao, Chung-Der] Chung Yuan Christian Univ, Dept Biosci Technol, Chungli, Taiwan; [Min, Ming-Yuan; Lee, Shyh-Jye] Natl Taiwan Univ, Dept Life Sci, Taipei 10764, Taiwan; [Lai, Wen-Sung] Natl Taiwan Univ, Dept Psychol, Taipei 10764, Taiwan; [Yang, Chianne-Wen; Lee, Wang-Tso] Natl Taiwan Univ Hosp, Dept Pediat, Taipei 10016, Taiwan; [Lee, Wang-Tso] Natl Taiwan Univ Hosp, Clin Ctr Neurosci & Behav Med, Taipei, Taiwan; [Lee, Wang-Tso] Natl Taiwan Univ, Grad Inst Brain & Mind Sci, Taipei 10764, Taiwan; [Lee, Shyh-Jye] Natl Taiwan Univ, Ctr Biotechnol, Taipei 10764, Taiwan; [Lee, Shyh-Jye] Natl Taiwan Univ, Res Ctr Dev Biol & Regenerat Med, Taipei 10764, Taiwan	Academia Sinica - Taiwan; National Taiwan University; Chung Yuan Christian University; National Taiwan University; National Taiwan University; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University; National Taiwan University	Lee, WT (corresponding author), Natl Taiwan Univ Hosp, Dept Pediat, 1 Chang Te St, Taipei 10016, Taiwan.	leeped@hotmail.com; jefflee@ntu.edu.tw	Hsiao, Chung-Der/W-4535-2019; Lee, Shyh-Jye/C-6092-2008	Hsiao, Chung-Der/0000-0002-6398-8672; Lee, Shyh-Jye/0000-0001-8452-9152; Lee, Wang-Tso/0000-0003-3231-9764; Lai, Wen-Sung/0000-0001-6918-5531; MIN, MING-YUAN/0000-0003-4211-6725	National Science Council [NSC-98-2311-B-002-006-MY3, NSC-99-2314-B-002-011-MY3]; National Taiwan University [NTU CESRP-10R70602A5, NTU ERP-10R80600]	National Science Council(Ministry of Science and Technology, Taiwan); National Taiwan University(National Taiwan University)	The work was supported by the National Science Council (NSC-98-2311-B-002-006-MY3) and National Taiwan University (NTU CESRP-10R70602A5 and NTU ERP-10R80600) to SJL and NSC-99-2314-B-002-011-MY3 to WJL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Airhart MJ, 2012, NEUROTOXICOL TERATOL, V34, P152, DOI 10.1016/j.ntt.2011.08.008; Alenina N, 2009, P NATL ACAD SCI USA, V106, P10332, DOI 10.1073/pnas.0810793106; Araki KY, 2007, BRAIN RES, V1156, P31, DOI 10.1016/j.brainres.2007.04.043; BARINAGA M, 1990, SCIENCE, V250, P34, DOI 10.1126/science.2218513; Betten A, 2001, J LEUKOCYTE BIOL, V70, P65; Blechingberg J, 2010, BRAIN RES, V1308, P1, DOI 10.1016/j.brainres.2009.10.051; Boehmler W, 2007, GENES BRAIN BEHAV, V6, P155, DOI 10.1111/j.1601-183X.2006.00243.x; Boehmler W, 2004, DEV DYNAM, V230, P481, DOI 10.1002/dvdy.20075; Brun L, 2010, NEUROLOGY, V75, P64, DOI 10.1212/WNL.0b013e3181e620ae; Brustein E, 2005, J NEUROSCI, V25, P10607, DOI 10.1523/JNEUROSCI.2017-05.2005; Brustein E, 2003, J PHYSIOL-PARIS, V97, P77, DOI 10.1016/j.jphysparis.2003.10.009; Brustein E, 2003, J NEUROBIOL, V57, P303, DOI 10.1002/neu.10292; Bundschuh ST, 2012, J NEUROSCI, V32, P6830, DOI 10.1523/JNEUROSCI.6026-11.2012; Buss RR, 2001, J NEUROPHYSIOL, V86, P197, DOI 10.1152/jn.2001.86.1.197; Canestro C, 2007, NAT REV GENET, V8, P932, DOI 10.1038/nrg2226; Chatelin S, 2001, MOL BRAIN RES, V97, P149, DOI 10.1016/S0169-328X(01)00318-7; Chen Q, 2009, BIRTH DEFECTS RES B, V86, P85, DOI 10.1002/bdrb.20187; COSTA M, 1976, HISTOCHEMISTRY, V48, P129, DOI 10.1007/BF00494551; Crandall JE, 2007, J NEUROSCI, V27, P3813, DOI 10.1523/JNEUROSCI.5124-06.2007; Crisp KM, 2004, J EXP BIOL, V207, P4535, DOI 10.1242/jeb.01315; DeJesus OT, 2005, SYNAPSE, V56, P54, DOI 10.1002/syn.20119; Drapeau P, 2002, PROG NEUROBIOL, V68, P85, DOI 10.1016/S0301-0082(02)00075-8; Easter SS, 1996, DEV BIOL, V180, P646; Easter SS, 1997, DEV PSYCHOBIOL, V31, P267, DOI 10.1002/(SICI)1098-2302(199712)31:4<267::AID-DEV4>3.0.CO;2-P; EATON MJ, 1993, J COMP NEUROL, V337, P640, DOI 10.1002/cne.903370409; EBERLE ED, 1968, J NEUROCHEM, V15, P1071, DOI 10.1111/j.1471-4159.1968.tb06825.x; Eberling JL, 2002, NEUROBIOL AGING, V23, P479, DOI 10.1016/S0197-4580(01)00323-2; Flinn L, 2009, BRAIN, V132, P1613, DOI 10.1093/brain/awp108; Gaspar P, 2003, NAT REV NEUROSCI, V4, P1002, DOI 10.1038/nrn1256; Gilbert JA, 2000, CLIN CANCER RES, V6, P4365; HAYASHI H, 1993, BIOCHEMISTRY-US, V32, P812, DOI 10.1021/bi00054a011; Hosseini-Sharifabad M, 2007, J NEUROSCI METH, V162, P206, DOI 10.1016/j.jneumeth.2007.01.009; HYLAND K, 1990, J INHERIT METAB DIS, V13, P301, DOI 10.1007/BF01799380; Ide S, 2010, BRAIN DEV-JPN, V32, P506, DOI 10.1016/j.braindev.2009.05.004; Ito S, 2008, DEV MED CHILD NEUROL, V50, P876, DOI 10.1111/j.1469-8749.2008.03094.x; Kiehn O, 1996, J NEUROPHYSIOL, V75, P1472, DOI 10.1152/jn.1996.75.4.1472; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; King JM, 2011, LIFE SCI, V89, P638, DOI 10.1016/j.lfs.2011.08.008; Kitahama K, 2009, J CHEM NEUROANAT, V38, P130, DOI 10.1016/j.jchemneu.2009.06.010; Korenke G C, 1997, Eur J Paediatr Neurol, V1, P67; Kwak SS, 2011, AUTOPHAGY, V7, P1323, DOI 10.4161/auto.7.11.16627; Lee HF, 2009, EUR J PAEDIATR NEURO, V13, P135, DOI 10.1016/j.ejpn.2008.03.008; Lee WT, 2009, J INHERIT METAB DIS, V32, P361, DOI 10.1007/s10545-009-1106-z; Lin YL, 2010, BIOCHEMISTRY-US, V49, P84, DOI 10.1021/bi901790e; Manegold C, 2009, J INHERIT METAB DIS, V32, P371, DOI 10.1007/s10545-009-1076-1; MARDER E, 1984, J NEUROPHYSIOL, V51, P1362, DOI 10.1152/jn.1984.51.6.1362; McLean DL, 2004, J COMP NEUROL, V480, P57, DOI 10.1002/cne.20281; MINANO FJ, 1990, PHARMACOL BIOCHEM BE, V35, P465, DOI 10.1016/0091-3057(90)90186-L; Missale C, 1998, PHYSIOL REV, V78, P189, DOI 10.1152/physrev.1998.78.1.189; Moreira-Rodrigues M, 2009, LIFE SCI, V84, P409, DOI 10.1016/j.lfs.2008.12.018; Muller UK, 2004, J EXP BIOL, V207, P853, DOI 10.1242/jeb.00821; Neff NH, 1995, PROG BRAIN RES, V106, P91; Pons R, 2004, NEUROLOGY, V62, P1058, DOI 10.1212/WNL.62.7.1058; Previc FH, 1999, BRAIN COGNITION, V41, P299, DOI 10.1006/brcg.1999.1129; Rink E, 2001, BRAIN RES, V889, P316, DOI 10.1016/S0006-8993(00)03174-7; Rinkwitz S, 2011, PROG NEUROBIOL, V93, P231, DOI 10.1016/j.pneurobio.2010.11.003; Russek-Blum N, 2008, DEVELOPMENT, V135, P3401, DOI 10.1242/dev.024232; Saint-Amant L, 1998, J NEUROBIOL, V37, P622, DOI 10.1002/(SICI)1097-4695(199812)37:4<622::AID-NEU10>3.0.CO;2-S; SCHOTLAND J, 1995, NATURE, V374, P266, DOI 10.1038/374266a0; Schweitzer J, 2012, DEV NEUROBIOL, V72, P256, DOI 10.1002/dneu.20911; Schweitzer J, 2009, ADV EXP MED BIOL, V651, P1; Sumi-Ichinose C, 2005, J NEUROCHEM, V95, P703, DOI 10.1111/j.1471-4159.2005.03402.x; Swanson JM, 2007, NEUROPSYCHOL REV, V17, P39, DOI 10.1007/s11065-007-9019-9; Swoboda KJ, 1999, NEUROLOGY, V53, P1205, DOI 10.1212/WNL.53.6.1205; Swoboda KJ, 2003, ANN NEUROL, V54, pS49, DOI 10.1002/ana.10631; Takezako T, 2001, J AM SOC NEPHROL, V12, P29, DOI 10.1681/ASN.V12129; Thirumalai V, 2008, J NEUROPHYSIOL, V100, P1635, DOI 10.1152/jn.90568.2008; Thisse C, 2008, NAT PROTOC, V3, P59, DOI 10.1038/nprot.2007.514; Verbeek MM, 2007, MOL GENET METAB, V90, P363, DOI 10.1016/j.ymgme.2006.12.001; Verney C, 2002, ANAT REC, V267, P87, DOI 10.1002/ar.10089; WAYMIRE JC, 1978, J NEUROCHEM, V31, P693, DOI 10.1111/j.1471-4159.1978.tb07842.x; Whitlock KE, 2000, DEVELOPMENT, V127, P3645; Whitlock KE, 2004, MICROSC RES TECHNIQ, V65, P2, DOI 10.1002/jemt.20094; Xi YW, 2010, EUR J NEUROSCI, V31, P623, DOI 10.1111/j.1460-9568.2010.07091.x; Yamamoto K, 2011, J COMP NEUROL, V519, P576, DOI 10.1002/cne.22535; Yamamoto K, 2010, MOL CELL NEUROSCI, V43, P394, DOI 10.1016/j.mcn.2010.01.006; Yang S, 2006, AM J HUM GENET, V78, P575, DOI 10.1086/501372; Yang SL, 2012, AM J PHYSIOL-RENAL, V302, pF742, DOI 10.1152/ajprenal.00583.2011; Zhang M, 2012, NEUROPHARMACOLOGY, V62, P2219, DOI 10.1016/j.neuropharm.2012.01.012	79	24	24	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2013	8	8							e71741	10.1371/journal.pone.0071741	http://dx.doi.org/10.1371/journal.pone.0071741			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	218XC	23940784	Green Submitted, Green Published, gold			2022-12-25	WOS:000324465000224
J	Welter, M; Rieger, H				Welter, Michael; Rieger, Heiko			Interstitial Fluid Flow and Drug Delivery in Vascularized Tumors: A Computational Model	PLOS ONE			English	Article							VESSEL COOPTION; BLOOD-VESSELS; NETWORK; GROWTH; ANGIOGENESIS; VASCULATURE; DOXORUBICIN; CONVECTION; PRESSURE; NORMALIZATION	Interstitial fluid is a solution that bathes and surrounds the human cells and provides them with nutrients and a way of waste removal. It is generally believed that elevated tumor interstitial fluid pressure (IFP) is partly responsible for the poor penetration and distribution of therapeutic agents in solid tumors, but the complex interplay of extravasation, permeabilities, vascular heterogeneities and diffusive and convective drug transport remains poorly understood. Here we consider-with the help of a theoretical model-the tumor IFP, interstitial fluid flow (IFF) and its impact upon drug delivery within tumor depending on biophysical determinants such as vessel network morphology, permeabilities and diffusive vs. convective transport. We developed a vascular tumor growth model, including vessel co-option, regression, and angiogenesis, that we extend here by the interstitium (represented by a porous medium obeying Darcy's law) and sources (vessels) and sinks (lymphatics) for IFF. With it we compute the spatial variation of the IFP and IFF and determine its correlation with the vascular network morphology and physiological parameters like vessel wall permeability, tissue conductivity, distribution of lymphatics etc. We find that an increased vascular wall conductivity together with a reduction of lymph function leads to increased tumor IFP, but also that the latter does not necessarily imply a decreased extravasation rate: Generally the IF flow rate is positively correlated with the various conductivities in the system. The IFF field is then used to determine the drug distribution after an injection via a convection diffusion reaction equation for intra-and extracellular concentrations with parameters guided by experimental data for the drug Doxorubicin. We observe that the interplay of convective and diffusive drug transport can lead to quite unexpected effects in the presence of a heterogeneous, compartmentalized vasculature. Finally we discuss various strategies to increase drug exposure time of tumor cells.	[Welter, Michael; Rieger, Heiko] Univ Saarland, D-66123 Saarbrucken, Germany	Saarland University	Rieger, H (corresponding author), Univ Saarland, D-66123 Saarbrucken, Germany.	h.rieger@mx.uni-saarland.de	Rieger, Heiko/C-3298-2012	Rieger, Heiko/0000-0003-0205-3678	University, Deutsche Forschungsgemeinschaft	University, Deutsche Forschungsgemeinschaft	Funding: University, Deutsche Forschungsgemeinschaft. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baish JW, 1997, MICROVASC RES, V53, P128, DOI 10.1006/mvre.1996.2005; Bartha K, 2006, J THEOR BIOL, V241, P903, DOI 10.1016/j.jtbi.2006.01.022; Basan M, 2009, HFSP J, V3, P265, DOI 10.2976/1.3086732; Carmeliet P, 2000, NATURE, V407, P249, DOI 10.1038/35025220; Chaplain MAJ, 2006, MATH MED BIOL, V23, P197, DOI 10.1093/imammb/dql009; CHARY SR, 1989, P NATL ACAD SCI USA, V86, P5385, DOI 10.1073/pnas.86.14.5385; Dafni H, 2002, CANCER RES, V62, P6731; Dimmeler S, 2000, CIRC RES, V87, P434; Dome B, 2002, J PATHOL, V197, P355, DOI 10.1002/path.1124; El-Kareh AW, 2005, NEOPLASIA, V7, P705, DOI 10.1593/neo.05118; Fukumura D, 2007, J CELL BIOCHEM, V101, P937, DOI 10.1002/jcb.21187; Gevertz JL, 2006, J THEOR BIOL, V243, P517, DOI 10.1016/j.jtbi.2006.07.002; Godde R, 2001, DEV DYNAM, V220, P387, DOI 10.1002/dvdy.1118; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hassid Y, 2006, CANCER RES, V66, P4159, DOI 10.1158/0008-5472.CAN-05-3289; Heldin CH, 2004, NAT REV CANCER, V4, P806, DOI 10.1038/nrc1456; Heroux MA, 2005, ACM T MATH SOFTWARE, V31, P397, DOI 10.1145/1089014.1089021; Holash J, 1999, SCIENCE, V284, P1994, DOI 10.1126/science.284.5422.1994; Jain R, 1999, IEEE MULTIMEDIA, V6, P1, DOI 10.1109/MMUL.1999.809225; Jain RK, 2007, CANCER RES, V67, P2729, DOI 10.1158/0008-5472.CAN-06-4102; JAIN RK, 1988, CANCER RES, V48, P7022; Jain RK, 2005, SCIENCE, V307, P58, DOI 10.1126/science.1104819; Jiang GS, 2000, SIAM J SCI COMPUT, V21, P2126, DOI 10.1137/S106482759732455X; Kurganov A, 2000, J COMPUT PHYS, V160, P241, DOI 10.1006/jcph.2000.6459; Lankelma J, 1999, CLIN CANCER RES, V5, P1703; Lee DS, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.058104; LEU AJ, 1994, AM J PHYSIOL-HEART C, V267, pH1507, DOI 10.1152/ajpheart.1994.267.4.H1507; LeVeque R.J., 2007, SIAM; LEVICK JR, 1987, Q J EXP PHYSIOL CMS, V72, P409, DOI 10.1113/expphysiol.1987.sp003085; Minchinton AI, 2006, NAT REV CANCER, V6, P583, DOI 10.1038/nrc1893; Murray CD, 1926, P NATL ACAD SCI USA, V12, P207, DOI 10.1073/pnas.12.3.207; Nehls V, 1998, HISTOCHEM CELL BIOL, V109, P319, DOI 10.1007/s004180050232; Preziosi L, 2009, J MATH BIOL, V58, P625, DOI 10.1007/s00285-008-0218-7; Pries A, 1995, CIRCULATION RES, V77; Pries AR, 2005, HYPERTENSION, V46, P725, DOI 10.1161/01.HYP.0000184428.16429.be; PRIES AR, 1994, CIRC RES, V75, P904, DOI 10.1161/01.RES.75.5.904; Primeau AJ, 2005, CLIN CANCER RES, V11, P8782, DOI 10.1158/1078-0432.CCR-05-1664; Rajagopal K.R., 1995, MECH MIXTURES; SCHREINER W, 1993, IEEE T BIO-MED ENG, V40, P482, DOI 10.1109/10.243413; Sethian J., 1996, LEVEL SET METHODS; Shieh AC, 2011, PHYS BIOL, V8, DOI 10.1088/1478-3975/8/1/015012; Siemann DW, 2009, CELL TISSUE RES, V335, P241, DOI 10.1007/s00441-008-0646-0; Sinek JP, 2009, J MATH BIOL, V58, P485, DOI 10.1007/s00285-008-0214-y; Swartz MA, 2012, NAT REV CANCER, V12, P210, DOI 10.1038/nrc3186; Walocha JA, 2003, HUM REPROD, V18, P1088, DOI 10.1093/humrep/deg213; Welter M, 2008, J THEOR BIOL, V250, P257, DOI 10.1016/j.jtbi.2007.09.031; Welter M, 2010, EUR PHYS J E, V33, P149, DOI 10.1140/epje/i2010-10611-6; Welter M, 2009, J THEOR BIOL, V259, P405, DOI 10.1016/j.jtbi.2009.04.005; West J.B., 2012, RESP PHYSL ESSENTIAL; Wu J, 2008, J BIOMECH, V41, P996, DOI 10.1016/j.jbiomech.2007.12.008; Wu M, 2013, J THEOR BIOL, V320, P131, DOI 10.1016/j.jtbi.2012.11.031; Zhao JB, 2007, MICROVASC RES, V73, P224, DOI 10.1016/j.mvr.2006.12.003; Zheng JH, 2001, AAPS PHARMSCI, V3	53	106	109	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2013	8	8							e70395	10.1371/journal.pone.0070395	http://dx.doi.org/10.1371/journal.pone.0070395			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	218XC	23940570	Green Submitted, gold, Green Published			2022-12-25	WOS:000324465000064
J	Zheng, DH; Limmon, GV; Yin, L; Leung, NHN; Yu, H; Chow, VTK; Chen, JZ				Zheng, Dahai; Limmon, Gino V.; Yin, Lu; Leung, Nicola H. N.; Yu, Hanry; Chow, Vincent T. K.; Chen, Jianzhu			A Cellular Pathway Involved in Clara Cell to Alveolar Type II Cell Differentiation after Severe Lung Injury	PLOS ONE			English	Article							EPITHELIAL PROGENITOR CELLS; STEM-CELLS; MOUSE LUNG; AIRWAY; BLEOMYCIN; REPAIR; MICE; REGENERATION; MAINTENANCE; POPULATION	Regeneration of alveolar epithelia following severe pulmonary damage is critical for lung function. We and others have previously shown that Scgb1a1-expressing cells, most likely Clara cells, can give rise to newly generated alveolar type 2 cells (AT2s) in response to severe lung damage induced by either influenza virus infection or bleomycin treatment. In this study, we have investigated cellular pathway underlying the Clara cell to AT2 differentiation. We show that the initial intermediates are bronchiolar epithelial cells that exhibit Clara cell morphology and express Clara cell marker, Scgb1a1, as well as the AT2 cell marker, pro-surfactant protein C (pro-SPC). These cells, referred to as pro-SPC+ bronchiolar epithelial cells (or SBECs), gradually lose Scgb1a1 expression and give rise to pro-SPC+ cells in the ring structures in the damaged parenchyma, which appear to differentiate into AT2s via a process sharing some features with that observed during alveolar epithelial development in the embryonic lung. These findings suggest that SBECs are intermediates of Clara cell to AT2 differentiation during the repair of alveolar epithelia following severe pulmonary injury.	[Zheng, Dahai; Limmon, Gino V.; Yin, Lu; Leung, Nicola H. N.; Chen, Jianzhu] Singapore Massachusetts Inst Technol, Interdisciplinary Res Grp Infect Dis, Alliance Res & Technol, Singapore, Singapore; [Yu, Hanry] Agcy Sci Technol & Res, Inst Bioengn & Nanotechnol, Singapore, Singapore; [Yu, Hanry] Natl Univ Singapore, Dept Physiol & Mechanobiol, Singapore 117548, Singapore; [Chow, Vincent T. K.] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Microbiol, Human Genome Lab,Natl Univ Hlth Syst, Singapore 117595, Singapore; [Chen, Jianzhu] MIT, Koch Inst Integrat Canc Res, Cambridge, MA 02139 USA; [Chen, Jianzhu] MIT, Dept Biol, Cambridge, MA USA	Massachusetts Institute of Technology (MIT); Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; National University of Singapore; Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Bioengineering & Bioimaging (IBB); A*STAR - Institute of Bioengineering & Nanotechnology (IBN); National University of Singapore; National University of Singapore; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT)	Chow, VTK (corresponding author), Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Microbiol, Human Genome Lab,Natl Univ Hlth Syst, Singapore 117595, Singapore.	vincent_chow@nuhs.edu.sg; jchen@mit.edu	Limmon, Gino/X-5913-2019; Yu, Hanry/L-6050-2019; Yu, Hanry/C-1031-2013; Yu, Hanry/C-7375-2011	Limmon, Gino/0000-0003-3030-7022; Yu, Hanry/0000-0002-0339-3685; Yu, Hanry/0000-0002-0339-3685; Yin, Lu/0000-0002-3651-8608; Chow, Vincent/0000-0003-2634-6213	National Research Foundation Singapore through the Singapore-MIT Alliance for Research and Technology's Infectious Disease IRG research programme	National Research Foundation Singapore through the Singapore-MIT Alliance for Research and Technology's Infectious Disease IRG research programme	This research was supported by the National Research Foundation Singapore through the Singapore-MIT Alliance for Research and Technology's Infectious Disease IRG research programme. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMSON IYR, 1976, ENVIRON HEALTH PERSP, V16, P119, DOI 10.2307/3428592; ASO Y, 1976, LAB INVEST, V35, P558; Chapman HA, 2011, J CLIN INVEST, V121, P2855, DOI 10.1172/JCI57673; Daly HE, 1997, TOXICOL APPL PHARM, V142, P303, DOI 10.1006/taap.1996.8056; EVANS MJ, 1975, EXP MOL PATHOL, V22, P142, DOI 10.1016/0014-4800(75)90059-3; EVANS MJ, 1973, AM J PATHOL, V70, P175; FRENCH LE, 1993, J CELL BIOL, V122, P1119, DOI 10.1083/jcb.122.5.1119; Giangreco A, 2002, AM J PATHOL, V161, P173, DOI 10.1016/S0002-9440(10)64169-7; Hong KU, 2001, AM J RESP CELL MOL, V24, P671, DOI 10.1165/ajrcmb.24.6.4498; Kim CFB, 2005, CELL, V121, P823, DOI 10.1016/j.cell.2005.03.032; Kumar PA, 2011, CELL, V147, P525, DOI 10.1016/j.cell.2011.10.001; Liu XM, 2006, METHOD ENZYMOL, V419, P285, DOI 10.1016/S0076-6879(06)19012-6; McQualter JL, 2009, STEM CELLS, V27, P623, DOI 10.1634/stemcells.2008-0866; Min BH, 1998, J ENDOCRINOL, V158, P43, DOI 10.1677/joe.0.1580043; Muzumdar MD, 2007, GENESIS, V45, P593, DOI 10.1002/dvg.20335; Perl AKT, 2002, P NATL ACAD SCI USA, V99, P10482, DOI 10.1073/pnas.152238499; Rawlins EL, 2006, DEVELOPMENT, V133, P2455, DOI 10.1242/dev.02407; Rawlins EL, 2009, DEVELOPMENT, V136, P3741, DOI 10.1242/dev.037317; Rawlins EL, 2009, CELL STEM CELL, V4, P525, DOI 10.1016/j.stem.2009.04.002; Reynolds SD, 2000, AM J PATHOL, V156, P269, DOI 10.1016/S0002-9440(10)64727-X; Rock JR, 2011, P NATL ACAD SCI USA, V108, pE1475, DOI 10.1073/pnas.1117988108; Rock JR, 2011, ANNU REV CELL DEV BI, V27, P493, DOI 10.1146/annurev-cellbio-100109-104040; Teisanu RM, 2009, STEM CELLS, V27, P612, DOI 10.1634/stemcells.2008-0838; TENHAVEOPBROEK AAW, 1979, DEV BIOL, V69, P408, DOI 10.1016/0012-1606(79)90301-4; vanWinkle LS, 1995, AM J PHYSIOL-LUNG C, V269, pL800, DOI 10.1152/ajplung.1995.269.6.L800; Wuenschell CW, 1996, J HISTOCHEM CYTOCHEM, V44, P113, DOI 10.1177/44.2.8609367; Zheng DH, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0048451, 10.1371/journal.pone.0049495]	27	43	46	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2013	8	8							e71028	10.1371/journal.pone.0071028	http://dx.doi.org/10.1371/journal.pone.0071028			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	218XC	23940685	Green Published, gold, Green Submitted			2022-12-25	WOS:000324465000170
J	Hoggatt, AM; Kim, JR; Ustiyan, V; Ren, XM; Kalin, TV; Kalinichenko, VV; Herring, BP				Hoggatt, April M.; Kim, Ju-Ryoung; Ustiyan, Vladimir; Ren, Xiaomeng; Kalin, Tanya V.; Kalinichenko, Vladimir V.; Herring, B. Paul			The Transcription Factor Foxf1 Binds to Serum Response Factor and Myocardin to Regulate Gene Transcription in Visceral Smooth Muscle Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Gene Knockout; Gene Regulation; Gene Transcription; Smooth Muscle; Transcription; Developmental Factors; Forkhead Factors; telokin	MOUSE FORKHEAD-BOX-F1 GENE; MASTER REGULATOR; EXPRESSION; TARGET; LUNG; SRF; HAPLOINSUFFICIENCY; PROLIFERATION; OBSTRUCTION; ACTIVATION	Smooth muscle cells (SMCs) modulate their phenotype from a quiescent contractile state to a dedifferentiated, proliferative and migratory state during the pathogenesis of many diseases, including intestinal pseudoobstruction. Understanding how smooth muscle gene expression is regulated in these different phenotypic states is critical for unraveling the pathogenesis of these diseases. In the current study we examined the specific roles of Foxf1 in visceral SMC differentiation. Data show that Foxf1 is specifically required for expression of several contractile and regulatory proteins such as telokin, smooth muscle -actin, and Cav1.2b in visceral SMCs. Mechanistically, Foxf1 directly binds to and activates the telokin promoter. Foxf1 also directly binds to serum response factor (SRF) and myocardin-related transcription factors (MRTFs). Unlike Foxo4 and Foxq1, which bind to MRTFs and block their interaction with SRF, Foxf1 acts synergistically with these proteins to regulate telokin expression. Knock-out of Foxf1 specifically in SMCs results in neonatal lethality, with mice exhibiting GI tract abnormalities. Mice heterozygous for Foxf1 in SMC exhibited impaired colonic contractility and decreased expression of contractile proteins. These studies together with previous studies, suggest that different forkhead proteins can regulate gene expression in SMCs through modulating the activity of the SRF-myocardin axis to either promote or inhibit differentiation and proliferation thereby altering gastrointestinal contractility and development.	[Hoggatt, April M.; Kim, Ju-Ryoung; Herring, B. Paul] Indiana Univ Sch Med, Dept Cellular & Integrat Physiol, Indianapolis, IN 46202 USA; [Ustiyan, Vladimir; Ren, Xiaomeng; Kalin, Tanya V.; Kalinichenko, Vladimir V.] Cincinnati Childrens Res Fdn, Div Pulm Biol, Perinatal Inst, Cincinnati, OH 45229 USA	Indiana University System; Indiana University Bloomington; Cincinnati Children's Hospital Medical Center; Cincinnati Children's Hospital Research Foundation	Herring, BP (corresponding author), Indiana Univ Sch Med, Dept Cellular & Integrat Physiol, 635 Barnhill Dr, Indianapolis, IN 46202 USA.	pherring@iupui.edu	Ren, Xiaomeng/U-1751-2019		National Institutes of Health [DK61130, HL 84151]; NATIONAL CANCER INSTITUTE [R01CA142724] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL084151] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK061130] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants DK61130 (to B. P. H.) and HL 84151 (to V. V. K.).	Abid MR, 2005, J BIOL CHEM, V280, P29864, DOI 10.1074/jbc.M502149200; Adachi M, 2007, GASTROENTEROLOGY, V132, P1434, DOI 10.1053/j.gastro.2007.01.033; Allard D, 2008, J BIOL CHEM, V283, P19739, DOI 10.1074/jbc.M710098200; Angstenberger M, 2007, GASTROENTEROLOGY, V133, P1948, DOI 10.1053/j.gastro.2007.08.078; Chen J, 2008, NEUROGASTROENT MOTIL, V20, P829, DOI 10.1111/j.1365-2982.2008.01149.x; Clemens RA, 2007, J IMMUNOL, V178, P4606, DOI 10.4049/jimmunol.178.7.4606; Creemers EE, 2006, DEVELOPMENT, V133, P4245, DOI 10.1242/dev.02610; Freddie CT, 2007, NUCLEIC ACIDS RES, V35, P5203, DOI 10.1093/nar/gkm528; Fukuyama K, 2006, ARTERIOSCL THROM VAS, V26, P2049, DOI 10.1161/01.ATV.0000233358.87583.01; Herring BP, 2001, J BIOL CHEM, V276, P14482, DOI 10.1074/jbc.M011585200; Hoggatt AM, 2000, J BIOL CHEM, V275, P31162, DOI 10.1074/jbc.M005595200; Kalinichenko VV, 2002, J BIOL CHEM, V277, P12369, DOI 10.1074/jbc.M112162200; Kalinichenko VV, 2002, AM J PHYSIOL-LUNG C, V282, pL1253, DOI 10.1152/ajplung.00463.2001; Krupczak-Hollis K, 2004, DEV BIOL, V276, P74, DOI 10.1016/j.ydbio.2004.08.022; Kumar MS, 2003, ARTERIOSCL THROM VAS, V23, P737, DOI 10.1161/01.ATV.0000065197.07635.BA; Kumar MS, 2003, CIRC RES, V92, P840, DOI 10.1161/01.RES.0000069031.55281.7C; Li H, 2007, MOL CELL BIOL, V27, P2676, DOI 10.1128/MCB.01748-06; Lim L, 2002, AM J PHYSIOL-LUNG C, V282, pL1012, DOI 10.1152/ajplung.00371.2001; Littlewood TD, 2007, CIRC RES, V100, P302, DOI 10.1161/01.RES.0000259101.39931.d3; Liu ZP, 2005, DEV CELL, V9, P261, DOI 10.1016/j.devcel.2005.05.017; Mahlapuu M, 2001, DEVELOPMENT, V128, P2397; Mericskay M, 2007, GASTROENTEROLOGY, V133, P1960, DOI 10.1053/j.gastro.2007.09.010; Miano JM, 2007, AM J PHYSIOL-CELL PH, V292, pC70, DOI 10.1152/ajpcell.00386.2006; Ormestad M, 2006, DEVELOPMENT, V133, P833, DOI 10.1242/dev.02252; Owens Gary K, 2007, Novartis Found Symp, V283, P174; Owens GK, 2004, PHYSIOL REV, V84, P767, DOI 10.1152/physrev.00041.2003; Peterson RS, 1997, MECH DEVELOP, V69, P53, DOI 10.1016/S0925-4773(97)00153-6; Pipes GCT, 2006, GENE DEV, V20, P1545, DOI 10.1101/gad.1428006; Stankiewicz P, 2009, AM J HUM GENET, V84, P780, DOI 10.1016/j.ajhg.2009.05.005; Touw K, 2012, AM J PHYSIOL-GASTR L, V302, pG66, DOI 10.1152/ajpgi.00183.2011; Ustiyan V, 2009, DEV BIOL, V336, P266, DOI 10.1016/j.ydbio.2009.10.007; Varenne O, 1999, HUM GENE THER, V10, P1105, DOI 10.1089/10430349950018102; Wang DZ, 2001, CELL, V105, P851, DOI 10.1016/S0092-8674(01)00404-4; Wang ZG, 2003, P NATL ACAD SCI USA, V100, P7129, DOI 10.1073/pnas.1232341100; Wang ZG, 2004, NATURE, V428, P185, DOI 10.1038/nature02382; Xin HB, 2002, PHYSIOL GENOMICS, V10, P211, DOI 10.1152/physiolgenomics.00054.2002; Zhang M, 2007, J BIOL CHEM, V282, P25708, DOI 10.1074/jbc.M701925200; Zhang M, 2011, MOL CELL BIOL, V31, P2618, DOI 10.1128/MCB.01338-10; Zhou JL, 2009, ARTERIOSCL THROM VAS, V29, P921, DOI 10.1161/ATVBAHA.109.187229; Zhou JL, 2005, MOL CELL BIOL, V25, P9874, DOI 10.1128/MCB.25.22.9874-9885.2005; Zhou JL, 2005, J BIOL CHEM, V280, P10861, DOI 10.1074/jbc.M411586200; Zhou JL, 2004, J BIOL CHEM, V279, P15929, DOI 10.1074/jbc.M313822200	42	38	40	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 4	2013	288	40					28477	28487		10.1074/jbc.M113.478974	http://dx.doi.org/10.1074/jbc.M113.478974			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	298BL	23946491	Green Published, hybrid			2022-12-25	WOS:000330298800006
J	Lee, JJ; Kim, DG; Kim, DH; Simborio, HL; Min, W; Lee, HJ; Her, M; Jung, SC; Watarai, M; Kim, S				Lee, Jin Ju; Kim, Dae Geun; Kim, Dong Hyeok; Simborio, Hannah Leah; Min, Wongi; Lee, Hu Jang; Her, Moon; Jung, Suk Chan; Watarai, Masahisa; Kim, Suk			Interplay between Clathrin and Rab5 Controls the Early Phagocytic Trafficking and Intracellular Survival of Brucella abortus within HeLa cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIPID RAFTS; DEPENDENT ENDOCYTOSIS; CONTAINING PHAGOSOMES; DYNAMIN; ACTIN; INTERNALIZATION; MATURATION; MEMBRANE; RECEPTOR; CHOLESTEROL	Lipid raft-associated clathrin is essential for host-pathogen interactions during infection. Brucella abortus is an intracellular pathogen that circumvents host defenses, but little is known about the precise infection mechanisms that involve interaction with lipid raft-associated mediators. The aim of this study was to elucidate the clathrin-mediated phagocytic mechanisms of B. abortus. The clathrin dependence of B. abortus infection in HeLa cells was investigated using an infection assay and immunofluorescence microscopy. The redistribution of clathrin in the membrane and in phagosomes was investigated using sucrose gradient fractionation of lipid rafts and the isolation of B. abortus-containing vacuoles, respectively. Clathrin and dynamin were concentrated into lipid rafts during B. abortus infection, and the entry and intracellular survival of B. abortus within HeLa cells were abrogated by clathrin inhibition. Clathrin disruption decreased actin polymerization and the colocalization of B. abortus-containing vacuoles with clathrin and Rab5 but not lysosome-associated membrane protein 1 (LAMP-1). Thus, our data demonstrate that clathrin plays a fundamental role in the entry and intracellular survival of B. abortus via interaction with lipid rafts and actin rearrangement. This process facilitates the early intracellular trafficking of B. abortus to safe replicative vacuoles.	[Lee, Jin Ju; Kim, Dae Geun; Kim, Dong Hyeok; Simborio, Hannah Leah; Min, Wongi; Lee, Hu Jang; Kim, Suk] Gyeongsang Natl Univ, Coll Vet Med, Jinju 660701, South Korea; [Her, Moon; Jung, Suk Chan] Anim Plant & Fisheries Quarantine & Inspect Agcy, Anyang 430824, Gyeonggi Do, South Korea; [Watarai, Masahisa] Yamaguchi Univ, Fac Agr, Dept Vet Publ Hlth, Yamaguchi 7538515, Japan; [Kim, Suk] Gyeongsang Natl Univ, Inst Agr & Life Sci, Jinju 660701, South Korea	Gyeongsang National University; Animal & Plant Quarantine Agency; Yamaguchi University; Gyeongsang National University	Kim, S (corresponding author), Gyeongsang Natl Univ, Coll Vet Med, Jinju 660701, South Korea.	kimsuk@gnu.ac.kr			National Research Foundation of Korea (NRF) [20121032, 2010-0009080]; Ministry of Education, Science and Technology; National Veterinary Research and Quarantine Service [0468-2010002]	National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea); National Veterinary Research and Quarantine Service	This work was supported by Basic Science Research Program Grants 20121032 and 2010-0009080 through the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science and Technology and by National Veterinary Research and Quarantine Service Grant 0468-2010002.	Abrami L, 2003, J CELL BIOL, V160, P321, DOI 10.1083/jcb.200211018; AlvarezDominguez C, 1996, J BIOL CHEM, V271, P13834, DOI 10.1074/jbc.271.23.13834; Anitei M, 2012, NAT CELL BIOL, V14, P11, DOI 10.1038/ncb2409; Baldeon ME, 2001, CELL MICROBIOL, V3, P473, DOI 10.1046/j.1462-5822.2001.00130.x; Baldwin C L, 1994, Immunol Ser, V60, P363; Brown DA, 1998, ANNU REV CELL DEV BI, V14, P111, DOI 10.1146/annurev.cellbio.14.1.111; Brurnell JH, 2007, MICROBIOL MOL BIOL R, V71, P636, DOI 10.1128/MMBR.00023-07; Celli J, 2003, J EXP MED, V198, P545, DOI 10.1084/jem.20030088; Chaves-Olarte E, 2002, CELL MICROBIOL, V4, P663, DOI 10.1046/j.1462-5822.2002.00221.x; Clemente R, 2009, J VIROL, V83, P10406, DOI 10.1128/JVI.00990-09; Comerci DJ, 2001, CELL MICROBIOL, V3, P159, DOI 10.1046/j.1462-5822.2001.00102.x; DETILLEUX PG, 1990, INFECT IMMUN, V58, P2320, DOI 10.1128/IAI.58.7.2320-2328.1990; Ehrlich M, 2004, CELL, V118, P591, DOI 10.1016/j.cell.2004.08.017; Garnham P. C. C., 1958, Journal of Tropical Medicine and Hygiene, V61, P92; Gatfield J, 2000, SCIENCE, V288, P1647, DOI 10.1126/science.288.5471.1647; Gopaldass N, 2012, TRAFFIC, V13, P120, DOI 10.1111/j.1600-0854.2011.01296.x; Gorvel JP, 2002, VET MICROBIOL, V90, P281, DOI 10.1016/S0378-1135(02)00214-6; Henley JR, 1998, J CELL BIOL, V141, P85, DOI 10.1083/jcb.141.1.85; Hernaez B, 2010, J VIROL, V84, P2100, DOI 10.1128/JVI.01557-09; Hinrichsen L, 2003, J BIOL CHEM, V278, P45160, DOI 10.1074/jbc.M307290200; Holtta-Vuori M, 2012, CIRC RES, V110, P450, DOI 10.1161/CIRCRESAHA.111.256842; Kim S, 2004, MICROB PATHOGENESIS, V37, P11, DOI 10.1016/j.micpath.2004.04.002; Kim S, 2002, MICROB PATHOGENESIS, V33, P225, DOI 10.1006/mpat.2002.0531; Lafont F, 2004, CURR OPIN MICROBIOL, V7, P4, DOI 10.1016/j.mib.2003.12.007; Loerke D, 2009, PLOS BIOL, V7, P628, DOI 10.1371/journal.pbio.1000057; Luhrmann A, 2000, Methods Cell Sci, V22, P329, DOI 10.1023/A:1017963401560; Macdonald JL, 2005, J LIPID RES, V46, P1061, DOI 10.1194/jlr.D400041-JLR200; Manes S, 2003, NAT REV IMMUNOL, V3, P557, DOI 10.1038/nri1129; McLauchlan H, 1998, CURR BIOL, V8, P34, DOI 10.1016/S0960-9822(98)70018-1; Merrifield CJ, 2002, NAT CELL BIOL, V4, P691, DOI 10.1038/ncb837; Mettlen M, 2009, BIOCHEM SOC T, V37, P1022, DOI 10.1042/BST0371022; Naroeni A, 2002, INFECT IMMUN, V70, P1640, DOI 10.1128/IAI.70.3.1640-1644.2002; Nicoziani P, 2000, MOL BIOL CELL, V11, P481, DOI 10.1091/mbc.11.2.481; Perskvist N, 2002, J CELL SCI, V115, P1321; Praefcke GJK, 2004, NAT REV MOL CELL BIO, V5, P133, DOI 10.1038/nrm1313; Rzomp KA, 2003, INFECT IMMUN, V71, P5855, DOI 10.1128/IAI.71.10.5855-5870.2003; Sachse M, 2002, MOL BIOL CELL, V13, P1313, DOI 10.1091/mbc.01-10-0525; Sever S, 2000, TRAFFIC, V1, P385, DOI 10.1034/j.1600-0854.2000.010503.x; Shen-Tu G, 2010, LAB INVEST, V90, P266, DOI 10.1038/labinvest.2009.131; Starr T, 2008, TRAFFIC, V9, P678, DOI 10.1111/j.1600-0854.2008.00718.x; SturgillKoszycki S, 1996, EMBO J, V15, P6960, DOI 10.1002/j.1460-2075.1996.tb01088.x; Triantafilou M, 2002, J CELL SCI, V115, P2603; Veiga E, 2005, NAT CELL BIOL, V7, P894, DOI 10.1038/ncb1292; Veiga E, 2007, CELL HOST MICROBE, V2, P340, DOI 10.1016/j.chom.2007.10.001; Veiga E, 2006, TRENDS CELL BIOL, V16, P499, DOI 10.1016/j.tcb.2006.08.005; WANG LH, 1993, J CELL BIOL, V123, P1107, DOI 10.1083/jcb.123.5.1107; Wang M, 2008, CELL MICROBIOL, V10, P2029, DOI 10.1111/j.1462-5822.2008.01185.x; Watarai M, 2002, CELL MICROBIOL, V4, P341, DOI 10.1046/j.1462-5822.2002.00195.x; Weaver AM, 2003, CURR OPIN CELL BIOL, V15, P23, DOI 10.1016/S0955-0674(02)00015-7; Yarar D, 2005, MOL BIOL CELL, V16, P964, DOI 10.1091/mbc.e04-09-0774	50	21	22	1	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 27	2013	288	39					28049	28057		10.1074/jbc.M113.491555	http://dx.doi.org/10.1074/jbc.M113.491555			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302OB	23940042	Green Published, hybrid			2022-12-25	WOS:000330612800030
J	Lee, S; Gaspar, ML; Aregullin, MA; Jesch, SA; Henry, SA				Lee, Sojin; Gaspar, Maria L.; Aregullin, Manuel A.; Jesch, Stephen A.; Henry, Susan A.			Activation of Protein Kinase C-Mitogen-activated Protein Kinase Signaling in Response to Inositol Starvation Triggers Sir2p-dependent Telomeric Silencing in Yeast	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHRONOLOGICAL LIFE-SPAN; CALORIE RESTRICTION EXTENDS; SACCHAROMYCES-CEREVISIAE; PHOSPHOLIPID-METABOLISM; GENE-EXPRESSION; SPHINGOLIPID METABOLISM; SIR2 FAMILY; PATHWAY; BIOSYNTHESIS; NICOTINAMIDE	Depriving wild type yeast of inositol, a soluble precursor for phospholipid, phosphoinositide, and complex sphingolipid synthesis, activates the protein kinase C (PKC)-MAPK signaling pathway, which plays a key role in the activation of NAD(+)-dependent telomeric silencing. We now report that triggering PKC-MAPK signaling by inositol deprivation or by blocking inositol-containing sphingolipid synthesis with aureobasidin A results in increased telomeric silencing regulated by the MAPK, Slt2p, and the NAD(+)-dependent deacetylase, Sir2p. Consistent with the dependence on NAD(+) in Sir2p-regulated silencing, we found that inositol depletion induces the expression of BNA2, which is required for the de novo synthesis of NAD(+). Moreover, telomeric silencing is greatly reduced in bna2 Delta and npt1 Delta mutants, which are defective in de novo and salvage pathways for NAD(+) synthesis, respectively. Surprisingly, however, omitting nicotinic acid from the growth medium, which reduces cellular NAD(+) levels, leads to increased telomeric silencing in the absence of inositol and/or at high temperature. This increase in telomeric silencing in response to inositol starvation is correlated to chronological life span extension but is Sir2p-independent. We conclude that activation of the PKC-MAPK signaling by interruption of inositol sphingolipid synthesis leads to increased Sir2p-dependent silencing and is dependent upon the de novo and salvage pathways for NAD(+) synthesis but is not correlated with cellular NAD(+) levels.	[Lee, Sojin; Gaspar, Maria L.; Aregullin, Manuel A.; Jesch, Stephen A.; Henry, Susan A.] Cornell Univ, Dept Mol Biol & Genet, Ithaca, NY 14853 USA	Cornell University	Henry, SA (corresponding author), Cornell Univ, Dept Mol Biol & Genet, 245 Biotechnol Bldg, Ithaca, NY 14853 USA.	sah42@cornell.edu	Henry, Susan/K-5464-2014		National Institutes of Health [GM-19629]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM019629, R37GM019629, R01GM019629] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM-19629 (to S. A. H.). This study is taken in part from the Ph.D. thesis of Sojin Lee, Cornell University, 2009.	Aerts AM, 2006, FEBS LETT, V580, P1903, DOI 10.1016/j.febslet.2006.02.061; Ai WD, 2002, MOL CELL, V10, P1295, DOI 10.1016/S1097-2765(02)00695-0; Alvarez-Vasquez F, 2005, NATURE, V433, P425, DOI 10.1038/nature03232; Anderson RM, 2003, NATURE, V423, P181, DOI 10.1038/nature01578; Anderson RM, 2002, J BIOL CHEM, V277, P18881, DOI 10.1074/jbc.M111773200; Ashrafi K, 2000, GENE DEV, V14, P1872; Balla T, 2013, PHYSIOL REV, V93, P1019, DOI 10.1152/physrev.00028.2012; BECKER GW, 1977, J BIOL CHEM, V252, P8684; Bedalov A, 2003, MOL CELL BIOL, V23, P7044, DOI 10.1128/MCB.23.19.7044-7054.2003; Belenky P, 2007, CELL, V129, P473, DOI 10.1016/j.cell.2007.03.024; Bi X, 2004, J MOL BIOL, V344, P893, DOI 10.1016/j.jmb.2004.10.002; Blander G, 2004, ANNU REV BIOCHEM, V73, P417, DOI 10.1146/annurev.biochem.73.011303.073651; Carman GM, 2009, J LIPID RES, V50, pS69, DOI 10.1194/jlr.R800043-JLR200; Carman GM, 1999, PROG LIPID RES, V38, P361, DOI 10.1016/S0163-7827(99)00010-7; CARMAN GM, 1989, ANNU REV BIOCHEM, V58, P635, DOI 10.1146/annurev.biochem.58.1.635; Chang HJ, 2002, GENETICS, V162, P29; CORNELL NW, 1983, ANAL BIOCHEM, V132, P418, DOI 10.1016/0003-2697(83)90029-5; Cox JS, 1997, MOL BIOL CELL, V8, P1805, DOI 10.1091/mbc.8.9.1805; Craven RJ, 2000, MOL CELL BIOL, V20, P2378, DOI 10.1128/MCB.20.7.2378-2384.2000; Dickson RC, 2008, J LIPID RES, V49, P909, DOI 10.1194/jlr.R800003-JLR200; Endo M, 1997, ANTIMICROB AGENTS CH, V41, P672, DOI 10.1128/AAC.41.3.672; Evans Charles, 2010, BMC Chemical Biology, V10, P2, DOI 10.1186/1472-6769-10-2; Fabrizio P, 2005, CELL, V123, P655, DOI 10.1016/j.cell.2005.08.042; Fabrizio P, 2003, AGING CELL, V2, P73, DOI 10.1046/j.1474-9728.2003.00033.x; Frye RA, 2000, BIOCHEM BIOPH RES CO, V273, P793, DOI 10.1006/bbrc.2000.3000; Gasch AP, 2000, MOL BIOL CELL, V11, P4241, DOI 10.1091/mbc.11.12.4241; Gaspar ML, 2006, J BIOL CHEM, V281, P22773, DOI 10.1074/jbc.M603548200; Gaspar ML, 2011, J BIOL CHEM, V286, P1696, DOI 10.1074/jbc.M110.172296; GOTTSCHLING DE, 1990, CELL, V63, P751, DOI 10.1016/0092-8674(90)90141-Z; Hanscho M, 2012, FEMS YEAST RES, V12, P796, DOI 10.1111/j.1567-1364.2012.00830.x; HANSON BA, 1980, J LIPID RES, V21, P309; Hecht A, 1996, NATURE, V383, P92, DOI 10.1038/383092a0; Henry SA, 1998, PROG NUCLEIC ACID RE, V61, P133, DOI 10.1016/S0079-6603(08)60826-0; Henry SA, 2012, GENETICS, V190, P317, DOI 10.1534/genetics.111.130286; HIRSCH JP, 1986, MOL CELL BIOL, V6, P3320, DOI 10.1128/MCB.6.10.3320; Huang XH, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002493; Imai S, 2000, NATURE, V403, P795, DOI 10.1038/35001622; Jesch SA, 2005, J BIOL CHEM, V280, P9106, DOI 10.1074/jbc.M411770200; Jesch SA, 2006, J BIOL CHEM, V281, P24070, DOI 10.1074/jbc.M604541200; Jesch SA, 2010, J BIOL CHEM, V285, P41947, DOI 10.1074/jbc.M110.188607; KAMADA Y, 1995, GENE DEV, V9, P1559, DOI 10.1101/gad.9.13.1559; Levin DE, 2011, GENETICS, V189, P1145, DOI 10.1534/genetics.111.128264; Li MG, 2010, MOL CELL BIOL, V30, P3329, DOI 10.1128/MCB.01590-09; Lin SJ, 2004, GENE DEV, V18, P12, DOI 10.1101/gad.1164804; Lin SJ, 2003, CURR OPIN CELL BIOL, V15, P241, DOI 10.1016/S0955-0674(03)00006-1; Loewen CJR, 2004, SCIENCE, V304, P1644, DOI 10.1126/science.1096083; Moazed D, 1996, CELL, V86, P667, DOI 10.1016/S0092-8674(00)80139-7; MORTIMER RK, 1959, NATURE, V183, P1751, DOI 10.1038/1831751a0; Nagiec MM, 1997, J BIOL CHEM, V272, P9809, DOI 10.1074/jbc.272.15.9809; Nunez LR, 2008, J BIOL CHEM, V283, P34204, DOI 10.1074/jbc.M806391200; Panozzo C, 2002, FEBS LETT, V517, P97, DOI 10.1016/S0014-5793(02)02585-1; Ray A, 2003, NAT GENET, V33, P522, DOI 10.1038/ng1132; RINE J, 1987, GENETICS, V116, P9; Rusche LN, 2003, ANNU REV BIOCHEM, V72, P481, DOI 10.1146/annurev.biochem.72.121801.161547; Sandmeier JJ, 2002, GENETICS, V160, P877; Santiago TC, 2003, J BIOL CHEM, V278, P38723, DOI 10.1074/jbc.M303008200; Shears Stephen B, 2012, Subcell Biochem, V59, P389, DOI 10.1007/978-94-007-3015-1_13; Sherman F, 2002, METHOD ENZYMOL, V350, P3, DOI 10.1016/S0076-6879(02)50954-X; Smith DL, 2007, AGING CELL, V6, P649, DOI 10.1111/j.1474-9726.2007.00326.x; Smith JS, 2000, P NATL ACAD SCI USA, V97, P6658, DOI 10.1073/pnas.97.12.6658; Smith JS, 1997, GENE DEV, V11, P241, DOI 10.1101/gad.11.2.241; Smith JS, 2002, METHOD ENZYMOL, V353, P282; Sporty JL, 2008, J SEP SCI, V31, P3202, DOI 10.1002/jssc.200800238; Stone EM, 1996, J CELL BIOL, V135, P571, DOI 10.1083/jcb.135.3.571; Strahl T, 2007, BBA-MOL CELL BIOL L, V1771, P353, DOI 10.1016/j.bbalip.2007.01.015; StrahlBolsinger S, 1997, GENE DEV, V11, P83, DOI 10.1101/gad.11.1.83; Villa-Garcia MJ, 2011, MOL GENET GENOMICS, V285, P125, DOI 10.1007/s00438-010-0592-x; Ye CQ, 2013, J BIOL CHEM, V288, P24898, DOI 10.1074/jbc.M113.493353	68	11	11	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 27	2013	288	39					27861	27871		10.1074/jbc.M113.493072	http://dx.doi.org/10.1074/jbc.M113.493072			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302OB	23943620	Green Published, hybrid			2022-12-25	WOS:000330612800014
J	Brouwers, B; Pruniau, VPEG; Cauwelier, EJG; Schuit, F; Lerut, E; Ectors, N; Declercq, J; Creemers, JWM				Brouwers, Bas; Pruniau, Vincent P. E. G.; Cauwelier, Elisa J. G.; Schuit, Frans; Lerut, Evelyne; Ectors, Nadine; Declercq, Jeroen; Creemers, John W. M.			Phlorizin Pretreatment Reduces Acute Renal Toxicity in a Mouse Model for Diabetic Nephropathy	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACUTE KIDNEY INJURY; DES-ACYL GHRELIN; DIALYSIS PATIENTS; GASTRIC-MOTILITY; DESACYL GHRELIN; HEPATIC-CHANGES; MOTOR-ACTIVITY; IN-VIVO; STREPTOZOTOCIN; FAILURE	Streptozotocin (STZ) is widely used as diabetogenic agent in animal models for diabetic nephropathy (DN). However, it is also directly cytotoxic to kidneys, making it difficult to distinguish between DN-related and STZ-induced nephropathy. Therefore, an improved protocol to generate mice for DN studies, with a quick and robust achievement of the diabetic state, without direct kidney toxicity is required. To investigate the mechanism leading to STZ-induced nephropathy, kidney damage was induced with a high dose of STZ. This resulted in delayed gastric emptying, at least partially caused by impaired desacyl ghrelin clearance. STZ uptake in the kidneys is to a large extent mediated by the sodium/glucose cotransporters (Sglts) because the Sglt inhibitor phlorizin could reduce STZ uptake in the kidneys. Consequently, the direct toxic effects in the kidney and the gastric dilatation were resolved without interfering with the beta-cell toxicity. Furthermore, pancreatic STZ uptake was increased, hereby decreasing the threshold for beta-cell toxicity, allowing for single low non-nephrotoxic STZ doses (70 mg/kg). In conclusion, this study provides novel insights into the mechanism of STZ toxicity in kidneys and suggests a more efficient regime to induce DN with little or no toxic side effects.	[Brouwers, Bas; Pruniau, Vincent P. E. G.; Cauwelier, Elisa J. G.; Declercq, Jeroen; Creemers, John W. M.] Katholieke Univ Leuven, Dept Human Genet, Biochem Neuroendocrinol Lab, B-3000 Louvain, Belgium; [Schuit, Frans] Katholieke Univ Leuven, Dept Mol Cell Biol, Gene Express Unit, B-3000 Louvain, Belgium; [Lerut, Evelyne; Ectors, Nadine] Univ Hosp Gasthuisberg, Dept Pathol, B-3000 Louvain, Belgium	KU Leuven; KU Leuven; KU Leuven; University Hospital Leuven	Declercq, J (corresponding author), Katholieke Univ Leuven VIB, Dept Human Genet, Lab Biochem Neuroendocrinol, O&N1,Herestr 49 Bus 602, B-3000 Louvain, Belgium.	jeroen.declercq@med.kuleuven.be	Brouwers, Bas/C-3996-2015	Brouwers, Bas/0000-0001-6541-4835	Fonds Wetenschappelijk Onderzoek (FWO); "Geconcerteerde Onderzoeksacties" (GOA) [GOA/12/016]	Fonds Wetenschappelijk Onderzoek (FWO)(FWO); "Geconcerteerde Onderzoeksacties" (GOA)	This work was supported in part by grants from the Fonds Wetenschappelijk Onderzoek (FWO) and "Geconcerteerde Onderzoeksacties" (GOA) (GOA/12/016).	Asakawa A, 2005, GUT, V54, P18, DOI 10.1136/gut.2004.038737; Aygen B, 2009, J INT MED RES, V37, P757, DOI 10.1177/147323000903700319; Barcelona S, 2012, AM J PHYSIOL-CELL PH, V302, pC1073, DOI 10.1152/ajpcell.00436.2011; Belangero Vera Maria Santoro, 1998, Arquivos de Gastroenterologia, V35, P278; Bolzan AD, 2002, MUTAT RES-REV MUTAT, V512, P121, DOI 10.1016/S1383-5742(02)00044-3; Breyer MD, 2005, J AM SOC NEPHROL, V16, P27, DOI [10.1681/ASN.2009070721, 10.1681/ASN.2004080648]; Brosius FC, 2009, J AM SOC NEPHROL, V20, P2503, DOI 10.1681/ASN.2009070721; Campanile N, 2007, XENOTRANSPLANTATION, V14, P265, DOI 10.1111/j.1399-3089.2007.00406.x; De Schoenmakere G, 2001, NEPHROL DIAL TRANSPL, V16, P1850, DOI 10.1093/ndt/16.9.1850; Ehrenkranz JRL, 2005, DIABETES-METAB RES, V21, P31, DOI 10.1002/dmrr.532; Fu YC, 2004, BLOOD CELL MOL DIS, V32, P182, DOI 10.1016/j.bcmd.2003.09.002; Fujimiya M, 2012, DIGESTION, V85, P90, DOI 10.1159/000334654; Fujimiya M, 2011, PEPTIDES, V32, P2348, DOI 10.1016/j.peptides.2011.07.020; Fujino K, 2003, J PHYSIOL-LONDON, V550, P227, DOI 10.1113/jphysiol.2003.040600; Garcia A., 2001, COMPARATIVE MED, V51, P262; Havasi A, 2011, KIDNEY INT, V80, P29, DOI 10.1038/ki.2011.120; Hirako M, 2005, J GASTROENTEROL, V40, P1116, DOI 10.1007/s00535-005-1709-6; Janssen P, 2011, ALIMENT PHARM THER, V33, P880, DOI 10.1111/j.1365-2036.2011.04609.x; Jarkovska Z, 2005, GROWTH HORM IGF RES, V15, P369, DOI 10.1016/j.ghir.2005.07.004; Johnston APW, 2007, AM J PHYSIOL-CELL PH, V292, pC1033, DOI 10.1152/ajpcell.00338.2006; KARUNANAYAKE EH, 1976, DIABETOLOGIA, V12, P483, DOI 10.1007/BF01219512; Kim EM, 1999, AM J PHYSIOL-REG I, V276, pR1320, DOI 10.1152/ajpregu.1999.276.5.R1320; Kinne RKH, 2011, HANDB EXP PHARMACOL, V203, P105, DOI 10.1007/978-3-642-17214-4_5; Ko GJ, 2010, AM J PHYSIOL-RENAL, V298, pF1472, DOI 10.1152/ajprenal.00619.2009; Kojima M, 1999, NATURE, V402, P656, DOI 10.1038/45230; Kraynak AR, 1995, TOXICOL APPL PHARM, V135, P279, DOI 10.1006/taap.1995.1234; Kume E, 2004, EXP TOXICOL PATHOL, V55, P467, DOI 10.1078/0940-2993-00351; KUME E, 1994, EXP TOXICOL PATHOL, V46, P368, DOI 10.1016/S0940-2993(11)80119-3; Lenzen S, 2008, DIABETOLOGIA, V51, P216, DOI 10.1007/s00125-007-0886-7; Marks J, 2003, J PHYSIOL-LONDON, V553, P137, DOI 10.1113/jphysiol.2003.046268; Martindale W., 1989, MARTINDALE EXTRA PHA, P649; Mather A, 2010, NAT REV NEPHROL, V6, P307, DOI 10.1038/nrneph.2010.38; Mizuno TM, 1999, ENDOCRINOLOGY, V140, P4551, DOI 10.1210/en.140.10.4551; Muller YD, 2011, DIABETES, V60, P2331, DOI 10.2337/db11-0159; Palm F, 2004, DIABETES-METAB RES, V20, P452, DOI 10.1002/dmrr.472; Ravelli AM, 1995, PEDIATR NEPHROL, V9, P756, DOI 10.1007/BF00868736; RERUP C C, 1970, Pharmacological Reviews, V22, P485; Ross EA, 1998, AM J KIDNEY DIS, V31, P62, DOI 10.1053/ajkd.1998.v31.pm9428453; Santer R, 2010, CLIN J AM SOC NEPHRO, V5, P133, DOI 10.2215/CJN.04010609; SCHNEDL WJ, 1994, DIABETES, V43, P1326, DOI 10.2337/diabetes.43.11.1326; Silang R, 2001, AM J KIDNEY DIS, V37, P287, DOI 10.1053/ajkd.2001.21291; Stanley WC, 1997, CARDIOVASC RES, V33, P243, DOI 10.1016/S0008-6363(96)00245-3; Strid H, 2004, SCAND J GASTROENTERO, V39, P516, DOI 10.1080/00365520410004505; Tal MG, 2004, RADIOLOGY, V230, P163, DOI 10.1148/radiol.2301021413; Tay YC, 2005, KIDNEY INT, V68, P391, DOI 10.1111/j.1523-1755.2005.00405.x; Tesch GH, 2007, NEPHROLOGY, V12, P261, DOI 10.1111/j.1440-1797.2007.00796.x; Urbschat A, 2011, BIOMARKERS, V16, pS22, DOI 10.3109/1354750X.2011.587129; Waring WS, 2011, CLIN TOXICOL, V49, P720, DOI 10.3109/15563650.2011.615319; WEISS RB, 1982, CANCER TREAT REP, V66, P427; Wold LE, 2004, BIOCHEM BIOPH RES CO, V318, P1066, DOI 10.1016/j.bbrc.2004.04.138; Wright EM, 2001, AM J PHYSIOL-RENAL, V280, pF10, DOI 10.1152/ajprenal.2001.280.1.F10; Yoshikawa T, 2011, HISTOCHEM CELL BIOL, V135, P183, DOI 10.1007/s00418-011-0779-1; Yoshimoto A, 2002, J AM SOC NEPHROL, V13, P2748, DOI 10.1097/01.ASN.0000032420.12455.74; Zhang RX, 2011, NEUROGASTROENT MOTIL, V23, pE356, DOI 10.1111/j.1365-2982.2011.01753.x	54	30	31	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 20	2013	288	38					27200	27207		10.1074/jbc.M113.469486	http://dx.doi.org/10.1074/jbc.M113.469486			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302IG	23940028	Green Published, hybrid			2022-12-25	WOS:000330597300018
J	Sontag, JM; Nunbhakdi-Craig, V; Sontag, E				Sontag, Jean-Marie; Nunbhakdi-Craig, Viyada; Sontag, Estelle			Leucine Carboxyl Methyltransferase 1 (LCMT1)-dependent Methylation Regulates the Association of Protein Phosphatase 2A and Tau Protein with Plasma Membrane Microdomains in Neuroblastoma Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIPID RAFTS; ALZHEIMERS-DISEASE; DOWN-REGULATION; MOUSE-BRAIN; IN-VITRO; PHOSPHORYLATION; CAVEOLAE; DOMAINS; DEPHOSPHORYLATION; MICROTUBULES	Down-regulation of protein phosphatase 2A (PP2A) methylation occurs in Alzheimer disease (AD). However, the regulation of PP2A methylation remains poorly understood. We have reported that altered leucine carboxyl methyltransferase (LCMT1)-dependent PP2A methylation is associated with down-regulation of PP2A holoenzymes containing the B alpha subunit (PP2A/B alpha) and subsequent accumulation of phosphorylated Tau in N2a cells, in vivo and in AD. Here, we show that pools of LCMT1, methylated PP2A, and PP2A/B alpha are co-enriched in cholesterol-rich plasma membrane microdomains/rafts purified from N2a cells. In contrast, demethylated PP2A is preferentially distributed in non-rafts wherein small amounts of the PP2A methylesterase PME-1 are exclusively present. A methylation-incompetent PP2A mutant is excluded from rafts. Enhanced methylation of PP2A promotes the association of PP2A and Tau with the plasma membrane. Altered PP2A methylation following expression of a catalytically inactive LCMT1 mutant, knockdown of LCMT1, or alterations in one-carbon metabolism all result in a loss of plasma membrane-associated PP2A and Tau in N2a cells. This correlates with accumulation of soluble phosphorylated Tau, a hallmark of AD and other tauopathies. Thus, our findings reveal a distinct compartmentalization of PP2A and PP2A regulatory enzymes in plasma membrane microdomains and identify a novel methylation-dependent mechanism involved in modulating the targeting of PP2A, and its substrate Tau, to the plasma membrane. We propose that alterations in the membrane localization of PP2A and Tau following down-regulation of LCMT1 may lead to PP2A and Tau dysfunction in AD.	[Sontag, Jean-Marie; Sontag, Estelle] Univ Newcastle, Sch Biomed Sci & Pharm, Fac Hlth & Med, Callaghan, NSW 2308, Australia; [Nunbhakdi-Craig, Viyada] Univ Texas SW Med Ctr Dallas, Dept Pathol, Dallas, TX 75390 USA	University of Newcastle; University of Texas System; University of Texas Southwestern Medical Center Dallas	Sontag, E (corresponding author), Univ Newcastle, Sch Biomed Sci & Pharm, Fac Hlth & Med, Callaghan, NSW 2308, Australia.	Estelle.Sontag@newcastle.edu.au	SONTAG, ESTELLE/AAE-9805-2020		National Health and Medical Research Council (NHMRC) Australia	National Health and Medical Research Council (NHMRC) Australia(National Health and Medical Research Council (NHMRC) of Australia)	This research was supported in part by a National Health and Medical Research Council (NHMRC) Australia grant (to E. S. and J. M. S.).	Allen JA, 2007, NAT REV NEUROSCI, V8, P128, DOI 10.1038/nrn2059; Arrasate M, 2000, NEUROCHEM RES, V25, P43, DOI 10.1023/A:1007583214722; Berrou E, 2009, EXP CELL RES, V315, P836, DOI 10.1016/j.yexcr.2008.12.002; Bottiglieri T, 2012, J NEUROSCI, V32, P9173, DOI 10.1523/JNEUROSCI.0125-12.2012; BRANDT R, 1995, J CELL BIOL, V131, P1327, DOI 10.1083/jcb.131.5.1327; Chadwick W., 2010, INT J ALZHEIMERS DIS, V2010, DOI [10.4061/2010/604792, DOI 10.4061/2010/604792]; Chen DH, 2004, J BIOCHEM, V136, P371, DOI 10.1093/jb/mvh131; Eidenmuller J, 2001, BIOCHEM J, V357, P759, DOI 10.1042/0264-6021:3570759; Favre B, 1997, J BIOL CHEM, V272, P13856, DOI 10.1074/jbc.272.21.13856; Fowler Brian, 2005, Semin Vasc Med, V5, P77; Furuchi T, 1998, J BIOL CHEM, V273, P21099, DOI 10.1074/jbc.273.33.21099; Gentry MS, 2005, EUKARYOT CELL, V4, P1029, DOI 10.1128/EC.4.6.1029-1040.2005; GOEDERT M, 1992, FEBS LETT, V312, P95, DOI 10.1016/0014-5793(92)81418-L; Hernandez P, 2009, J ALZHEIMERS DIS, V16, P149, DOI 10.3233/JAD-2009-0933; Hiraga A, 2000, BIOCHEM J, V346, P433, DOI 10.1042/0264-6021:3460433; Hombauer H, 2007, PLOS BIOL, V5, P1355, DOI 10.1371/journal.pbio.0050155; Ittner LM, 2010, CELL, V142, P387, DOI 10.1016/j.cell.2010.06.036; Janssens V, 2008, TRENDS BIOCHEM SCI, V33, P113, DOI 10.1016/j.tibs.2007.12.004; Kawarabayashi T, 2004, J NEUROSCI, V24, P3801, DOI 10.1523/JNEUROSCI.5543-03.2004; Lee G, 1998, J CELL SCI, V111, P3167; Levental I, 2010, P NATL ACAD SCI USA, V107, P22050, DOI 10.1073/pnas.1016184107; Lingwood D, 2010, SCIENCE, V327, P46, DOI 10.1126/science.1174621; Longin S, 2008, EXP CELL RES, V314, P68, DOI 10.1016/j.yexcr.2007.07.030; Maas T, 2000, J BIOL CHEM, V275, P15733, DOI 10.1074/jbc.M000389200; Macdonald JL, 2005, J LIPID RES, V46, P1061, DOI 10.1194/jlr.D400041-JLR200; Martin BR, 2012, NAT METHODS, V9, P84, DOI [10.1038/NMETH.1769, 10.1038/nmeth.1769]; Nunbhakdi-Craig V, 2007, J NEUROCHEM, V101, P959, DOI 10.1111/j.1471-4159.2007.04503.x; Ogris E, 1999, J BIOL CHEM, V274, P14382, DOI 10.1074/jbc.274.20.14382; Oh P, 2001, MOL BIOL CELL, V12, P685, DOI 10.1091/mbc.12.3.685; Pike LJ, 2006, J LIPID RES, V47, P1597, DOI 10.1194/jlr.E600002-JLR200; Pooler AM, 2012, NEUROBIOL AGING, V33, DOI 10.1016/j.neurobiolaging.2011.01.005; Pooler AM, 2010, BIOCHEM SOC T, V38, P1012, DOI 10.1042/BST0381012; PORTER CW, 1984, BIOCHEM BIOPH RES CO, V122, P350, DOI 10.1016/0006-291X(84)90482-0; Reynolds CH, 2008, J BIOL CHEM, V283, P18177, DOI 10.1074/jbc.M709715200; Schild A, 2006, BIOCHEM BIOPH RES CO, V343, P1171, DOI 10.1016/j.bbrc.2006.03.066; Sents W, 2013, FEBS J, V280, P644, DOI 10.1111/j.1742-4658.2012.08579.x; SMART EJ, 1995, P NATL ACAD SCI USA, V92, P10104, DOI 10.1073/pnas.92.22.10104; Sontag E, 1999, J BIOL CHEM, V274, P25490, DOI 10.1074/jbc.274.36.25490; Sontag E, 1996, NEURON, V17, P1201, DOI 10.1016/S0896-6273(00)80250-0; Sontag E, 2004, J NEUROPATH EXP NEUR, V63, P1080, DOI 10.1093/jnen/63.10.1080; Sontag E, 2001, CELL SIGNAL, V13, P7, DOI 10.1016/S0898-6568(00)00123-6; Sontag E, 2007, J NEUROSCI, V27, P2751, DOI 10.1523/JNEUROSCI.3316-06.2007; Sontag JM, 2008, J NEUROSCI, V28, P11477, DOI 10.1523/JNEUROSCI.2816-08.2008; Sontag JM, 2012, J BIOL CHEM, V287, P14984, DOI 10.1074/jbc.M111.338681; Sontag JM, 2010, J NEUROCHEM, V115, P1455, DOI 10.1111/j.1471-4159.2010.07049.x; Stanevich V, 2011, MOL CELL, V41, P331, DOI 10.1016/j.molcel.2010.12.030; Staubach S, 2011, EXPERT REV PROTEOMIC, V8, P263, DOI [10.1586/EPR.11.2, 10.1586/epr.11.2]; Swingle Mark, 2007, V365, P23; Tolstykh T, 2000, EMBO J, V19, P5682, DOI 10.1093/emboj/19.21.5682; Usardi A, 2011, FEBS J, V278, P2927, DOI 10.1111/j.1742-4658.2011.08218.x; Vey M, 1996, P NATL ACAD SCI USA, V93, P14945, DOI 10.1073/pnas.93.25.14945; Virshup DM, 2009, MOL CELL, V33, P537, DOI 10.1016/j.molcel.2009.02.015; Wang PY, 2003, EMBO J, V22, P2658, DOI 10.1093/emboj/cdg255; Williamson R, 2011, CURR ALZHEIMER RES, V8, P213, DOI 10.2174/156720511795256008; Xu YH, 2008, MOL CELL, V31, P873, DOI 10.1016/j.molcel.2008.08.006; Zidovetzki R, 2007, BBA-BIOMEMBRANES, V1768, P1311, DOI 10.1016/j.bbamem.2007.03.026	56	35	38	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 20	2013	288	38					27396	27405		10.1074/jbc.M113.490102	http://dx.doi.org/10.1074/jbc.M113.490102			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302IG	23943618	Green Published, hybrid			2022-12-25	WOS:000330597300035
J	Demeler, J; Kruger, N; Krucken, J; von der Heyden, VC; Ramunke, S; Kuttler, U; Miltsch, S; Cepeda, ML; Knox, M; Vercruysse, J; Geldhof, P; Harder, A; von Samson-Himmelstjerna, G				Demeler, Janina; Krueger, Nina; Kruecken, Juergen; von der Heyden, Vera C.; Ramuenke, Sabrina; Kuettler, Ursula; Miltsch, Sandra; Lopez Cepeda, Michael; Knox, Malcolm; Vercruysse, Jozef; Geldhof, Peter; Harder, Achim; von Samson-Himmelstjerna, Georg			Phylogenetic Characterization of beta-Tubulins and Development of Pyrosequencing Assays for Benzimidazole Resistance in Cattle Nematodes	PLOS ONE			English	Article							REAL-TIME PCR; MACROCYCLIC LACTONE ANTHELMINTICS; SINGLE NUCLEOTIDE POLYMORPHISMS; HAEMONCHUS-CONTORTUS; DRUG-RESISTANCE; COOPERIA-ONCOPHORA; GENE; MUTATIONS; ISOTYPE-1; CODON-200	Control of helminth infections is a major task in livestock production to prevent health constraints and economic losses. However, resistance to established anthelmintic substances already impedes effective anthelmintic treatment in many regions worldwide. Thus, there is an obvious need for sensitive and reliable methods to assess the resistance status of at least the most important nematode populations. Several single nucleotide polymorphisms (SNPs) in the beta-tubulin isotype 1 gene of various nematodes correlate with resistance to benzimidazoles (BZ), a major anthelmintic class. Here we describe the full-length beta-tubulin isotype 1 and 2 and alpha-tubulin coding sequences of the cattle nematode Ostertagia ostertagi. Additionally, the Cooperia oncophora alpha-tubulin coding sequence was identified. Phylogenetic maximum-likelihood analysis revealed that both isotype 1 and 2 are orthologs to the Caenorhabditis elegans ben-1 gene which is also associated with BZ resistance upon mutation. In contrast, a Trichuris trichiura cDNA, postulated to be beta-tubulin isotype 1 involved in BZ resistance in this human parasite, turned out to be closely related to C. elegans beta-tubulins tbb-4 and mec-7 and would therefore represent the first non-ben-1-like beta-tubulin to be under selection through treatment with BZs. A pyrosequencing assay was established to detect BZ resistance associated SNPs in beta-tubulin isotype 1 codons 167, 198 and 200 of C. oncophora and O. ostertagi. PCR-fragments representing either of the two alleles were combined in defined ratios to evaluate the pyrosequencing assay. The correlation between the given and the measured allele frequencies of the respective SNPs was very high. Subsequently laboratory isolates and field populations with known resistance status were analyzed. With the exception of codon 167 in Cooperia, increases of resistance associated alleles were detected for all codons in at least one of the phenotypically resistant population. Pyrosequencing provides a fast, inexpensive and sensitive alternative to conventional resistance detection methods.	[Demeler, Janina; Krueger, Nina; Kruecken, Juergen; Ramuenke, Sabrina; Miltsch, Sandra; von Samson-Himmelstjerna, Georg] Free Univ Berlin, Inst Parasitol & Trop Vet Med, Berlin, Germany; [von der Heyden, Vera C.] Niedersachs Tierseuchenkasse, Hannover, Germany; [Kuettler, Ursula] Hannover Univ Vet Med, Inst Parasitol, Hannover, Germany; [Lopez Cepeda, Michael] UPTC, Direcc Invest DE, Tunja, Boyaca, Colombia; [Knox, Malcolm] CSIRO Anim Food & Hlth Sci, FD McMaster Lab, Armidale, NSW, Australia; [Vercruysse, Jozef; Geldhof, Peter] Univ Ghent, Dept Virol Parasitol & Immunol, Fac Vet Med, Merelbeke, Belgium; [Harder, Achim] Univ Dusseldorf, Inst Biol, Dusseldorf, Germany	Free University of Berlin; University of Veterinary Medicine Hannover, Foundation; Universidad Pedagogica y Tecnologica de Colombia (UPTC); Commonwealth Scientific & Industrial Research Organisation (CSIRO); Ghent University; Heinrich Heine University Dusseldorf	von Samson-Himmelstjerna, G (corresponding author), Free Univ Berlin, Inst Parasitol & Trop Vet Med, Berlin, Germany.	Gvsamson@fu-berlin.de	Krücken, Jürgen/CAF-6903-2022; Krücken, Jürgen/B-6794-2009; Demeler, Janina/A-1727-2014; Krücken, Jürgen/AAE-3133-2021; von Samson, Georg/R-1123-2016; McKay-Demeler, Janina/AAO-4336-2020	Krücken, Jürgen/0000-0002-2842-8100; Krücken, Jürgen/0000-0002-2842-8100; Krücken, Jürgen/0000-0002-2842-8100; Ramunke, Sabrina/0000-0003-0195-4175	EU [GLOWORM, FP7-KBBE-2011-5 Area 2.1.3, KBBE 2011.1.3-04, 288975]; Bayer Animal Health, Leverkusen, Germany	EU(European Commission); Bayer Animal Health, Leverkusen, Germany(Bayer AG)	The work presented herein was financed by the authors' resources and in part supported by an EU FP7-grant (GLOWORM, FP7-KBBE-2011-5 Area 2.1.3, KBBE 2011.1.3-04, Project-No. 288975) and Bayer Animal Health, Leverkusen, Germany. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez-Sanchez MA, 2005, VET PARASITOL, V129, P291, DOI 10.1016/j.vetpar.2005.02.004; Anziani OS, 2004, VET PARASITOL, V122, P303, DOI 10.1016/j.vetpar.2004.05.018; Anziani OS, 2001, VET REC, V149, P58, DOI 10.1136/vr.149.2.58; Barrere V, 2012, VET PARASITOL, V186, P344, DOI 10.1016/j.vetpar.2011.11.068; Beech RN, 2010, TRENDS PARASITOL, V26, P334, DOI 10.1016/j.pt.2010.04.003; Blackhall WJ, 2011, PARASITOL RES, V109, P1199, DOI 10.1007/s00436-011-2426-0; CABARET J, 2008, INFRA WEBSITE; Coles GC, 2006, VET PARASITOL, V136, P167, DOI 10.1016/j.vetpar.2005.11.019; Coles GC, 2002, VET RES, V33, P481, DOI 10.1051/vetres:2002034; Condi GK, 2009, VET PARASITOL, V161, P213, DOI 10.1016/j.vetpar.2009.01.031; CONWAY DP, 1964, AM J VET RES, V25, P844; Demeler J, 2010, VET PARASITOL, V170, P61, DOI 10.1016/j.vetpar.2010.01.032; Demeler J, 2009, VET PARASITOL, V160, P109, DOI 10.1016/j.vetpar.2008.10.030; Diawara A, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000397; DRISCOLL M, 1989, J CELL BIOL, V109, P2993, DOI 10.1083/jcb.109.6.2993; Drogemuller M, 2004, J PARASITOL, V90, P868, DOI 10.1645/GE3305RN; Gasbarre LC, 2009, VET PARASITOL, V166, P281, DOI 10.1016/j.vetpar.2009.08.018; Ghisi M, 2007, VET PARASITOL, V144, P313, DOI 10.1016/j.vetpar.2006.10.003; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Hodgkinson JE, 2008, INT J PARASITOL, V38, P1149, DOI 10.1016/j.ijpara.2008.02.001; Hoffmann C, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm435; Hoglund J, 2009, VET PARASITOL, V161, P60, DOI 10.1016/j.vetpar.2008.12.001; JUNG MK, 1990, CELL MOTIL CYTOSKEL, V17, P87, DOI 10.1002/cm.970170204; Kaplan RM, 2004, TRENDS PARASITOL, V20, P477, DOI 10.1016/j.pt.2004.08.001; KWA MSG, 1994, MOL BIOCHEM PARASIT, V63, P299, DOI 10.1016/0166-6851(94)90066-3; KWA MSG, 1993, BIOCHEM BIOPH RES CO, V191, P413, DOI 10.1006/bbrc.1993.1233; LACEY E, 1988, INT J PARASITOL, V18, P885, DOI 10.1016/0020-7519(88)90175-0; Loveridge B, 2003, NEW ZEAL VET J, V51, P139, DOI 10.1080/00480169.2003.36353; MARTIN PJ, 1989, AUST VET J, V66, P236, DOI 10.1111/j.1751-0813.1989.tb13578.x; Mejia ME, 2003, VET RES, V34, P461, DOI 10.1051/vetres:2003018; Melville LA, 2006, EXP PARASITOL, V112, P144, DOI 10.1016/j.exppara.2005.10.003; Mottier MD, 2008, PHARMACOGENET GENOM, V18, P129, DOI 10.1097/FPC.0b013e3282f4711d; Njue AI, 2003, PARASITOLOGY, V127, P579, DOI 10.1017/S0031182003004086; Pape M, 1999, INT J PARASITOL, V29, P1941, DOI 10.1016/S0020-7519(99)00156-3; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; PRICHARD RK, 1990, INT J PARASITOL, V20, P515, DOI 10.1016/0020-7519(90)90199-W; Rendell DK, 2010, AUST VET J, V88, P504, DOI 10.1111/j.1751-0813.2010.00648.x; Saunders GI, 2013, INT J PARASITOL, V43, P465, DOI 10.1016/j.ijpara.2012.12.011; Schwab AE, 2005, AM J TROP MED HYG, V73, P234, DOI 10.4269/ajtmh.2005.73.234; Silvestre A, 2000, EXP PARASITOL, V95, P271, DOI 10.1006/expr.2000.4542; Silvestre A, 2002, MOL BIOCHEM PARASIT, V120, P297, DOI 10.1016/S0166-6851(01)00455-8; Soutello RGV, 2007, VET PARASITOL, V148, P360, DOI 10.1016/j.vetpar.2007.06.023; Sutherland IA, 2011, TRENDS PARASITOL, V27, P176, DOI 10.1016/j.pt.2010.11.008; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Von Samson-Himmelstjerna G, 2003, PARASITOLOGY, V127, P489, DOI 10.1017/S0031182003003974; von Samson-Himmelstjerna G, 2002, J PARASITOL, V88, P254, DOI 10.1645/0022-3395(2002)088[0254:ASPFTB]2.0.CO;2; von Samson-Himmelstjerna G, 2009, PARASITOLOGY, V136, P349, DOI 10.1017/S003118200800543X; von Samson-Himmelstjerna G, 2001, PARASITOL RES, V87, P122, DOI 10.1007/s004360000326; von Samson-Himmelstjerna G, 2009, PARASITOL RES, V105, P825, DOI 10.1007/s00436-009-1466-1; Waghorn TS, 2006, NEW ZEAL VET J, V54, P278, DOI 10.1080/00480169.2006.36711; Walsh TK, 2007, VET PARASITOL, V144, P304, DOI 10.1016/j.vetpar.2006.10.014; Winterrowd CA, 2003, VET PARASITOL, V117, P161, DOI 10.1016/j.vetpar.2003.09.001; Wolstenholme AJ, 2004, TRENDS PARASITOL, V20, P469, DOI 10.1016/j.pt.2004.07.010; Zhou ZY, 2006, J CLIN MICROBIOL, V44, P3900, DOI 10.1128/JCM.01209-06; Zhu W, 2007, EUR J CLIN MICROBIOL, V26, P161, DOI 10.1007/s10096-007-0261-0	55	40	44	2	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2013	8	8							e70212	10.1371/journal.pone.0070212	http://dx.doi.org/10.1371/journal.pone.0070212			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	200UV	23950913	Green Published, Green Submitted, gold			2022-12-25	WOS:000323097300012
J	Harris, WT; Kelly, DR; Zhou, Y; Wang, DZ; Macewen, M; Hagood, JS; Clancy, JP; Ambalavanan, N; Sorscher, EJ				Harris, William T.; Kelly, David R.; Zhou, Yong; Wang, Dezhi; Macewen, Mark; Hagood, James S.; Clancy, J. P.; Ambalavanan, Namasivayam; Sorscher, Eric J.			Myofibroblast Differentiation and Enhanced Tgf-B Signaling in Cystic Fibrosis Lung Disease	PLOS ONE			English	Article							GROWTH-FACTOR-BETA; IDIOPATHIC PULMONARY-FIBROSIS; INHIBITION; PATHOGENESIS; MECHANISMS; CHILDREN; INTEGRIN-ALPHA-V-BETA-6; PIRFENIDONE; MODULATION; ACTIVATION	Rationale: TGF-beta, a mediator of pulmonary fibrosis, is a genetic modifier of CF respiratory deterioration. The mechanistic relationship between TGF-beta signaling and CF lung disease has not been determined. Objective: To investigate myofibroblast differentiation in CF lung tissue as a novel pathway by which TGF-beta signaling may contribute to pulmonary decline, airway remodeling and tissue fibrosis. Methods: Lung samples from CF and non-CF subjects were analyzed morphometrically for total TGF-beta(1), TGF-beta signaling (Smad2 phosphorylation), myofibroblast differentiation (alpha-smooth muscle actin), and collagen deposition (Masson trichrome stain). Results: TGF-beta signaling and fibrosis are markedly increased in CF (p<0.01), and the presence of myofibroblasts is four-fold higher in CF vs. normal lung tissue (p<0.005). In lung tissue with prominent TGF-beta signaling, both myofibroblast differentiation and tissue fibrosis are significantly augmented (p<0.005). Conclusions: These studies establish for the first time that a pathogenic mechanism described previously in pulmonary fibrosis is also prominent in cystic fibrosis lung disease. The presence of TGF-beta dependent signaling in areas of prominent myofibroblast proliferation and fibrosis in CF suggests that strategies under development for other pro-fibrotic lung conditions may also be evaluated for use in CF.	[Harris, William T.; Macewen, Mark; Ambalavanan, Namasivayam] Univ Alabama Birmingham, Dept Pediat, Birmingham, AL 35294 USA; [Kelly, David R.] Univ Alabama Birmingham, Dept Pathol, Birmingham, AL 35294 USA; [Zhou, Yong; Sorscher, Eric J.] Univ Alabama Birmingham, Dept Med, Birmingham, AL 35294 USA; [Wang, Dezhi] Univ Alabama Birmingham, Ctr Metab Bone Dis Histomorphometry, Birmingham, AL USA; [Wang, Dezhi] Univ Alabama Birmingham, Mol Analyses Core Lab, Birmingham, AL USA; [Hagood, James S.] Univ Calif San Diego, Dept Pediat, San Diego, CA 92103 USA; [Hagood, James S.] Rady Childrens Hosp San Diego, San Diego, CA USA; [Clancy, J. P.] Cincinnati Childrens Hosp Med Ctr, Dept Pediat, Cincinnati, OH 45229 USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of California System; University of California San Diego; Rady Childrens Hospital San Diego; Cincinnati Children's Hospital Medical Center	Harris, WT (corresponding author), Univ Alabama Birmingham, Dept Pediat, Birmingham, AL 35294 USA.	tharris@peds.uab.edu	Ambalavanan, Namasivayam/AAL-3832-2020; Ambalavanan, Namasivayam/AAI-4088-2020	Ambalavanan, Namasivayam/0000-0003-0731-9092; Sorscher, Eric J./0000-0001-9341-3354; Kelly, David/0000-0001-7604-5270	NIH; Cystic Fibrosis Foundation; Vertex Pharmaceuticals; Pulmonary Fibrosis Foundation; Children's Interstitial Lung Disease foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R21HL097215, R01HL092906] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cystic Fibrosis Foundation(Italian Cystic Fibrosis Research Foundation); Vertex Pharmaceuticals(Vertex Pharmaceuticals); Pulmonary Fibrosis Foundation; Children's Interstitial Lung Disease foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	MM, DW, and DRK do not report any conflicts of interest. NA receives grant NIH grant support. WTH and EJS receive NIH and Cystic Fibrosis Foundation grant support. WTH is currently a site PI for CF clinical studies sponsored by Vertex Pharmaceuticals. JSH receives NIH grant support and support from both the Pulmonary Fibrosis Foundation and Children's Interstitial Lung Disease foundation. JPC is a member of the Vertex Pharmaceutical Global Advisory Board and the Gilead CF Scholars Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambalavanan N, 2008, AM J PHYSIOL-LUNG C, V295, pL86, DOI 10.1152/ajplung.00534.2007; Andersen DH, 1938, AM J DIS CHILD, V56, P344, DOI 10.1001/archpedi.1938.01980140114013; Bai ST, 2011, ARCH PATHOL LAB MED, V135, P753, DOI 10.1043/2009-0230-OA.1; Bartram U, 2004, CHEST, V125, P754, DOI 10.1378/chest.125.2.754; Blobe GC, 2000, NEW ENGL J MED, V342, P1350, DOI 10.1056/NEJM200005043421807; Bremer LA, 2008, HUM MOL GENET, V17, P2228, DOI 10.1093/hmg/ddn123; *CFF, 2008, CFF REG DAT; Collaco JM, 2008, JAMA-J AM MED ASSOC, V299, P417, DOI 10.1001/jama.299.4.417; de Jong PA, 2004, EUR RESPIR J, V23, P93, DOI 10.1183/09031936.03.00006603; Dorfman R, 2008, J CLIN INVEST, V118, P1040, DOI [10.1172/JCI337S4, 10.1172/JCI33754]; Drumm ML, 2005, NEW ENGL J MED, V353, P1443, DOI 10.1056/NEJMoa051469; FALLOWFIELD JA, 2011, AM J PHYSL GASTROINT; Gaggar A, 2011, EUR RESPIR J, V38, P721, DOI 10.1183/09031936.00173210; Gibson RL, 2003, AM J RESP CRIT CARE, V168, P918, DOI 10.1164/rccm.200304-505SO; Goodwin A, 2009, BIOCHEM SOC T, V37, P849, DOI 10.1042/BST0370849; Hardie WD, 2009, AM J PATHOL, V175, P3, DOI 10.2353/ajpath.2009.081170; Harris WT, 2011, PEDIATR PULM, V46, P688, DOI 10.1002/ppul.21430; Harris WT, 2009, PEDIATR PULM, V44, P1057, DOI 10.1002/ppul.21079; Hilliard TN, 2007, THORAX, V62, P1074, DOI 10.1136/thx.2006.074641; Hinz B, 2007, AM J PATHOL, V170, P1807, DOI 10.2353/ajpath.2007.070112; Hinz Boris, 2010, F1000 Biol Rep, V2, P78, DOI 10.3410/B2-78; Horan GS, 2008, AM J RESP CRIT CARE, V177, P56, DOI 10.1164/rccm.200706-805OC; Katsumoto TR, 2011, INT J RHEUMATOL, V2011, DOI 10.1155/2011/208219; Knowles MR, 2006, CURR OPIN PULM MED, V12, P416, DOI 10.1097/01.mcp.0000245707.59138.40; Liu G, 2010, J EXP MED, V207, P1589, DOI 10.1084/jem.20100035; Makinde T, 2007, IMMUNOL CELL BIOL, V85, P348, DOI 10.1038/sj.icb.7100044; Meyerholz DK, 2010, AM J RESP CRIT CARE, V182, P1251, DOI 10.1164/rccm.201004-0643OC; Nicola T, 2011, AM J PHYSIOL-LUNG C, V301, pL125, DOI 10.1152/ajplung.00074.2011; Noble PW, 2011, LANCET, V377, P1760, DOI 10.1016/S0140-6736(11)60405-4; Puthawala K, 2008, AM J RESP CRIT CARE, V177, P82, DOI 10.1164/rccm.200706-806OC; Ratjen F, 2002, THORAX, V57, P930, DOI 10.1136/thorax.57.11.930; Richeldi L, 2011, NEW ENGL J MED, V365, P1079, DOI 10.1056/NEJMoa1103690; Robinson TE, 2005, CHEST, V128, P2327, DOI 10.1378/chest.128.4.2327; Rogan MP, 2010, P NATL ACAD SCI USA, V107, P20571, DOI 10.1073/pnas.1015281107; Rosenbloom J, 2010, ANN INTERN MED, V152, P159, DOI 10.7326/0003-4819-152-3-201002020-00007; Schaefer CJ, 2011, EUR RESPIR REV, V20, P85, DOI 10.1183/09059180.00001111; Selman M, 2001, ANN INTERN MED, V134, P136, DOI 10.7326/0003-4819-134-2-200101160-00015; Stoltz DA, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000928; Ulrich M, 2010, J CYST FIBROS, V9, P217, DOI 10.1016/j.jcf.2010.03.001; Wipff PJ, 2007, J CELL BIOL, V179, P1311, DOI 10.1083/jcb.200704042; Wynn TA, 2011, J EXP MED, V208, P1339, DOI 10.1084/jem.20110551; Ziobro R, 2013, BIOCHEM BIOPH RES CO, V434, P705, DOI 10.1016/j.bbrc.2013.03.032	42	57	62	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2013	8	8							e70196	10.1371/journal.pone.0070196	http://dx.doi.org/10.1371/journal.pone.0070196			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	200UV	23950911	Green Submitted, Green Published, gold			2022-12-25	WOS:000323097300011
J	Imoto, Y; Tokunaga, T; Matsumoto, Y; Hamada, Y; Ono, M; Yamada, T; Ito, Y; Arinami, T; Okano, M; Noguchi, E; Fujieda, S				Imoto, Yoshimasa; Tokunaga, Takahiro; Matsumoto, Yuri; Hamada, Yuko; Ono, Mizuho; Yamada, Takechiyo; Ito, Yumi; Arinami, Tadao; Okano, Mitsuhiro; Noguchi, Emiko; Fujieda, Shigeharu			Cystatin SN Upregulation in Patients with Seasonal Allergic Rhinitis	PLOS ONE			English	Article							JAPANESE CEDAR POLLEN; CRY-J-I; MAJOR ALLERGEN; EXPRESSION PROFILES; AIRWAY INFLAMMATION; ASTHMA; POLLINOSIS; ALPHA(1)-ANTITRYPSIN; IDENTIFICATION; PREVALENCE	Seasonal allergic rhinitis (SAR) to the Japanese cedar, Cryptomeria japonica (JC) pollen is an IgE-mediated type I allergy affecting nasal mucosa. However, the molecular events underlying its development remain unclear. We sought to identify SAR-associated altered gene expression in nasal epithelial cells during natural exposure to JC pollen. We recruited study participants in 2009 and 2010 and collected nasal epithelial cells between February and April, which is the period of natural pollen dispersion. Fifteen patients with SAR-JC and 13 control subjects were enrolled in 2009, and 17 SAR-JC patients, 13 sensitized asymptomatic subjects (Sensitized), and 15 control subjects were enrolled in 2010. Total RNA was extracted from nasal epithelial cells and 8 SAR-JC patients and 6 control subjects in 2009 were subjected to microarray analysis with the Illumina HumanRef-8 Expression BeadChip platform. Allergen-stimulated histamine release was examined in the peripheral blood basophils isolated from patients with SAR. We identified 32 genes with significantly altered expression during allergen exposure. One of these, CST1 encodes the cysteine protease inhibitor, cystatin SN. CST1 expression in nasal epithelial cells was significantly upregulated in both the 2009 and 2010 SAR-JC groups compared with the control groups. Immunohistochemical staining confirmed the increased expression of CST1 in the nasal epithelial cells of SAR patients. Addition of exogenous CST1 to basophils inhibited JC allergen-stimulated histamine release in vitro. We propose that CST1 may contribute to inactivation of protease allergens and help re-establish homeostasis of the nasal membranes.	[Imoto, Yoshimasa; Tokunaga, Takahiro; Yamada, Takechiyo; Ito, Yumi; Fujieda, Shigeharu] Univ Fukui, Fac Med Sci, Dept Otorhinolaryngol, Fukui 910, Japan; [Imoto, Yoshimasa; Tokunaga, Takahiro; Yamada, Takechiyo; Ito, Yumi; Fujieda, Shigeharu] Univ Fukui, Fac Med Sci, Dept Head Surg, Fukui 910, Japan; [Imoto, Yoshimasa; Tokunaga, Takahiro; Yamada, Takechiyo; Ito, Yumi; Fujieda, Shigeharu] Univ Fukui, Fac Med Sci, Dept Neck Surg, Fukui 910, Japan; [Imoto, Yoshimasa; Tokunaga, Takahiro; Matsumoto, Yuri; Hamada, Yuko; Ono, Mizuho; Arinami, Tadao; Noguchi, Emiko] Univ Tsukuba, Fac Med, Dept Med Genet, Tsukuba, Ibaraki, Japan; [Okano, Mitsuhiro] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Otorhinolaryngol, Okayama, Japan; [Noguchi, Emiko] Japan Sci & Technol Agcy, Core Res Evolut Sci & Technol, Tokyo, Japan	University of Fukui; University of Fukui; University of Fukui; University of Tsukuba; Okayama University; Japan Science & Technology Agency (JST)	Noguchi, E (corresponding author), Univ Tsukuba, Fac Med, Dept Med Genet, Tsukuba, Ibaraki, Japan.	enoguchi@md.tsukuba.ac.jp			Japan Science and Technology Agency, Japan [20590327]; Ministry of health and Welfare [H23-Immunoloy-006]; Grants-in-Aid for Scientific Research [23592511] Funding Source: KAKEN	Japan Science and Technology Agency, Japan(Japan Science & Technology Agency (JST)); Ministry of health and Welfare(Ministry of Health, Labour and Welfare, Japan); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported by research grants from Grant-in-Aid for Scientific Research (C) grant number 20590327, from Japan Science and Technology Agency, Japan, and from a Grant-in-Aid for Science Research from the Ministry of health and Welfare (H23-Immunoloy-006). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARRETT AJ, 1986, BIOMED BIOCHIM ACTA, V45, P1363; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bousquet J, 2008, ALLERGY, V63, P8, DOI 10.1111/j.1398-9995.2007.01620.x; Brown A, 2003, AM J RESP CELL MOL, V29, P381, DOI 10.1165/rcmb.2003-0060OC; Chen JC, 2011, J BIOL CHEM, V286, P26667, DOI 10.1074/jbc.M110.193987; Deb R, 2007, J BIOL CHEM, V282, P36808, DOI 10.1074/jbc.M702336200; DICKINSON DP, 1994, GENOMICS, V24, P172, DOI 10.1006/geno.1994.1595; Giovannini-Chami L, 2012, EUR RESPIR J, V39, P1197, DOI 10.1183/09031936.00070511; Guajardo JR, 2005, J ALLERGY CLIN IMMUN, V115, P243, DOI 10.1016/j.jaci.2004.10.032; HASHIMOTO M, 1995, CLIN EXP ALLERGY, V25, P848, DOI 10.1111/j.1365-2222.1995.tb00027.x; Henskens YMC, 1996, BIOL CHEM H-S, V377, P71; Kalsheker NA, 1996, BIOCHEM BIOPH RES CO, V221, P59, DOI 10.1006/bbrc.1996.0544; Koblinski JE, 2000, CLIN CHIM ACTA, V291, P113, DOI 10.1016/S0009-8981(99)00224-7; Matsumoto Yuri, 2011, Allergology International, V60, P87, DOI 10.2332/allergolint.10-OA-0230; McAleer MA, 2013, J ALLERGY CLIN IMMUN, V131, P280, DOI 10.1016/j.jaci.2012.12.668; Nakajima T, 2004, J ALLERGY CLIN IMMUN, V113, P528, DOI 10.1016/j.jaci.2003.12.036; Nishima Sankei, 2009, Allergology International, V58, P37, DOI 10.2332/allergolint.O-08-550; Okuda M, 2003, ANN ALLERG ASTHMA IM, V91, P288, DOI 10.1016/S1081-1206(10)63532-6; Palmer CNA, 2006, NAT GENET, V38, P441, DOI 10.1038/ng1767; Sakaguchi M, 1997, IMMUNOLOGY, V91, P161, DOI 10.1046/j.1365-2567.1997.00255.x; Sakashita M, 2010, INT ARCH ALLERGY IMM, V151, P255, DOI 10.1159/000242363; Shi W, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq871; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Takai T, 2005, INT ARCH ALLERGY IMM, V137, P194, DOI 10.1159/000086331; Takai T, 2009, J IMMUNOL, V183, P7958, DOI 10.4049/jimmunol.0713276; TANIGUCHI Y, 1995, ALLERGY, V50, P90, DOI 10.1111/j.1398-9995.1995.tb02489.x; Tseng CC, 2000, ARCH BIOCHEM BIOPHYS, V380, P133, DOI 10.1006/abbi.2000.1909; YASUEDA H, 1983, J ALLERGY CLIN IMMUN, V71, P77, DOI 10.1016/0091-6749(83)90550-X; Yoneda K, 2009, INT J ONCOL, V35, P33, DOI 10.3892/ijo_00000310	29	35	35	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2013	8	8							e67057	10.1371/journal.pone.0067057	http://dx.doi.org/10.1371/journal.pone.0067057			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	200UV	23950865	Green Published, gold, Green Submitted			2022-12-25	WOS:000323097300004
J	Mourino-Perez, RR; Linacre-Rojas, LP; Roman-Gavilanes, AI; Lew, TK; Callejas-Negrete, OA; Roberson, RW; Freitag, M				Mourino-Perez, Rosa R.; Linacre-Rojas, Lorena P.; Roman-Gavilanes, Ariana I.; Lew, Thomas K.; Callejas-Negrete, Olga A.; Roberson, Robert W.; Freitag, Michael			MTB-3, a Microtubule Plus-End Tracking Protein ( plus TIP) of Neurospora crassa	PLOS ONE			English	Article							BINDING-PROTEIN; EB1; DYNAMICS; ORGANIZATION; GROWTH; LOCALIZATION; CYTOSKELETON; P150(GLUED); NUCLEATION; DYNACTIN	The microtubule (MT) "plus end" constitutes the platform for the accumulation of a structurally and functionally diverse group of proteins, collectively called "MT plus-end tracking proteins" (+TIPs). +TIPs control MT dynamics and link MTs to diverse sub-cellular structures. Neurospora crassa MicroTubule Binding protein-3 (MTB-3) is the homolog of yeast EB1, a highly conserved +TIP. To address the function of MTB-3, we examined strains with mtb-3 deletions, and we tagged MTB-3 with GFP to assess its dynamic behavior. MTB-3-GFP was present as comet-like structures distributed more or less homogeneously within the hyphal cytoplasm, and moving mainly towards the apex at speeds up to 4x faster than the normal hyphal elongation rates. MTB-3-GFP comets were present in all developmental stages, but were most abundant in mature hyphae. MTB-3-GFP comets were observed moving in anterograde and retrograde direction along the hypha. Retrograde movement was also observed as originating from the apical dome. The integrity of the microtubular cytoskeleton affects the presence and dynamics of MTB-3-GFP comets, while actin does not seem to play a role. The size of MTB-3-GFP comets is affected by the absence of dynactin and conventional kinesin. We detected no obvious morphological phenotypes in Delta mtb-3 mutants but there were fewer MTs in Delta mtb-3, MTs were less bundled and less organized. Compared to WT, both MT polymerization and depolymerization rates were significantly decreased in Delta mtb-3. In summary, the lack of MTB-3 affects overall growth and morphological phenotypes of N. crassa only slightly, but deletion of mtb-3 has strong effect on MT dynamics.	[Mourino-Perez, Rosa R.; Linacre-Rojas, Lorena P.; Roman-Gavilanes, Ariana I.; Callejas-Negrete, Olga A.] Ctr Invest Cient & Educ Super Ensenada, Dept Microbiol, Ensenada, Baja California, Mexico; [Lew, Thomas K.; Freitag, Michael] Oregon State Univ, Dept Biochem & Biophys, Corvallis, OR 97331 USA; [Roberson, Robert W.] Arizona State Univ, Sch Life Sci, Tempe, AZ USA	CICESE - Centro de Investigacion Cientifica y de Educacion Superior de Ensenada; Oregon State University; Arizona State University; Arizona State University-Tempe	Mourino-Perez, RR (corresponding author), Ctr Invest Cient & Educ Super Ensenada, Dept Microbiol, Ensenada, Baja California, Mexico.	rmourino@cicese.mx	Mouriño-Pérez, Rosa Reyna Reyna/F-9192-2014; Linacre, Lorena/B-7815-2016	Mouriño-Pérez, Rosa Reyna Reyna/0000-0002-7958-2212; Linacre, Lorena/0000-0003-2650-6643; Callejas-Negrete, Olga Alicia/0000-0002-9285-7014	Consejo Nacional de Ciencia y Tecnologia Ciencia Basica [133518]; American Cancer Society [RSG-08-030-01-CCG]	Consejo Nacional de Ciencia y Tecnologia Ciencia Basica; American Cancer Society(American Cancer Society)	This work was supported by grants from Consejo Nacional de Ciencia y Tecnologia Ciencia Basica (133518) to RRMP and the American Cancer Society (RSG-08-030-01-CCG) to MF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akhmanova A, 2005, CURR OPIN CELL BIOL, V17, P47, DOI 10.1016/j.ceb.2004.11.001; Akhmanova A, 2008, NAT REV MOL CELL BIO, V9, P309, DOI 10.1038/nrm2369; Akhmanova A, 2011, CURR BIOL, V21, pR283, DOI 10.1016/j.cub.2011.03.023; Akhmanova A, 2010, J CELL SCI, V123, P3415, DOI 10.1242/jcs.062414; Alberts B, 2009, ESSENTIAL CELL BIOL; Beinhauer JD, 1997, J CELL BIOL, V139, P717, DOI 10.1083/jcb.139.3.717; Bieling P, 2007, NATURE, V450, P1100, DOI 10.1038/nature06386; Bieling P, 2008, J CELL BIOL, V183, P1223, DOI 10.1083/jcb.200809190; Chan J, 2005, PLANT CELL, V17, P1737, DOI 10.1105/tpc.105.032615; Colot HV, 2006, P NATL ACAD SCI USA, V103, P10352, DOI 10.1073/pnas.0601456103; Courtright JB, 1975, NEUROSPORA NEWSL, V22, P5; Davis R.H., 2000, NEUROSPORA CONTRIBUT; Delgado-Alvarez DL, 2010, FUNGAL GENET BIOL, V47, P573, DOI 10.1016/j.fgb.2010.03.004; Desai A, 1997, ANNU REV CELL DEV BI, V13, P83, DOI 10.1146/annurev.cellbio.13.1.83; Dixit R, 2009, P NATL ACAD SCI USA, V106, P492, DOI 10.1073/pnas.0807614106; Fink G, 2006, MOL BIOL CELL, V17, P3242, DOI 10.1091/mbc.E05-12-1118; Fischer R, 2008, MOL MICROBIOL, V68, P813, DOI 10.1111/j.1365-2958.2008.06193.x; Fischer-Parton S, 2000, J MICROSC-OXFORD, V198, P246, DOI 10.1046/j.1365-2818.2000.00708.x; Freitag M, 2004, FUNGAL GENET BIOL, V41, P897, DOI 10.1016/j.fgb.2004.06.008; Galjart N, 2003, CURR OPIN CELL BIOL, V15, P48, DOI 10.1016/S0955-0674(02)00007-8; Gardner MK, 2008, J CELL BIOL, V180, P91, DOI 10.1083/jcb.200710164; Hayashi I, 2005, MOL CELL, V19, P449, DOI 10.1016/j.molcel.2005.06.034; Hayashi I, 2003, J BIOL CHEM, V278, P36430, DOI 10.1074/jbc.M305773200; Hickey PC, 2002, FUNGAL GENET BIOL, V37, P109, DOI 10.1016/S1087-1845(02)00035-X; Honnappa S, 2009, CELL, V138, P366, DOI 10.1016/j.cell.2009.04.065; Komarova Y, 2005, MOL BIOL CELL, V16, P5334, DOI 10.1091/mbc.E05-07-0614; Komarova Y, 2009, J CELL BIOL, V184, P691, DOI 10.1083/jcb.200807179; Lansbergen G, 2006, TRAFFIC, V7, P499, DOI 10.1111/j.1600-0854.2006.00400.x; Ligon LA, 2003, MOL BIOL CELL, V14, P1405, DOI 10.1091/mbc.E02-03-0155; Margolin BS, 1997, FUNGAL GENET NEWSLET, V44, P34, DOI [10.4148/1941-4765.1281, DOI 10.1128/EC.00244-07]; Morrison EE, 1998, ONCOGENE, V17, P3471, DOI 10.1038/sj.onc.1202247; Mourino-Perez RR, 2006, FUNGAL GENET BIOL, V43, P389, DOI 10.1016/j.fgb.2005.10.007; Nakamura M, 2001, CURR BIOL, V11, P1062, DOI 10.1016/S0960-9822(01)00297-4; Ramos-Garcia SL, 2009, EUKARYOT CELL, V8, P1880, DOI 10.1128/EC.00062-09; Rogers SL, 2002, J CELL BIOL, V158, P873, DOI 10.1083/jcb.200202032; Seiler S, 1997, EMBO J, V16, P3025, DOI 10.1093/emboj/16.11.3025; Staudt MW, 2010, FUNGAL GENET BIOL, V47, P310, DOI 10.1016/j.fgb.2009.12.010; Stepanova T, 2003, J NEUROSCI, V23, P2655; Straube A, 2003, MOL BIOL CELL, V14, P642, DOI 10.1091/mbc.E02-08-0513; SU LK, 1995, CANCER RES, V55, P2972; Tinsley JH, 1996, MOL BIOL CELL, V7, P731, DOI 10.1091/mbc.7.5.731; Tirnauer JS, 2000, J CELL BIOL, V149, P761, DOI 10.1083/jcb.149.4.761; Tirnauer JS, 1999, J CELL BIOL, V145, P993, DOI 10.1083/jcb.145.5.993; Uchida M, 2008, FUNGAL GENET BIOL, V45, P683, DOI 10.1016/j.fgb.2007.10.013; Uchida Maho, 2010, Fungal Biology Reviews, V24, P132, DOI 10.1016/j.fbr.2010.12.003; Vaughan KT, 2005, J CELL BIOL, V171, P197, DOI 10.1083/jcb.200509150; Verdin J, 2008, 9 EUR C FUNG GEN ECF	47	7	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2013	8	8							e70655	10.1371/journal.pone.0070655	http://dx.doi.org/10.1371/journal.pone.0070655			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	200UV	23950979	Green Published, gold, Green Submitted			2022-12-25	WOS:000323097300039
J	Bassaneze, V; Sacramento, CB; Freire, R; De Alencar, PF; Ortega, NRS; Krieger, JE				Bassaneze, Vinicius; Sacramento, Chester Bittencourt; Freire, Rodolfo; De Alencar, Patricia Fernandes; Siqueira Ortega, Neli Regina; Krieger, Jose Eduardo			Development of a New Approach to Aid in Visual Identification of Murine iPS Colonies Using a Fuzzy Logic Decision Support System	PLOS ONE			English	Article							PLURIPOTENT STEM-CELLS; FIBROBLASTS; GENERATION; MOUSE; EXPRESSION; SELECTION; CULTURES; SETS	The a priori identification of induced pluripotent stem cells remains a challenge. Being able to quickly identify the most embryonic stem cell-similar induced pluripotent stem cells when validating results could help to reduce costs and save time. In this context, tools based on non-classic logic can be useful in creating aid-systems based on visual criteria. True colonies when viewed at 100x magnification have been found to have the following 3 characteristics: a high degree of border delineation, a more uniform texture, and the absence of a cracked texture. These visual criteria were used for fuzzy logic modeling. We investigated the possibility of predicting the presence of alkaline phosphatase activity, typical of true induced pluripotent stem cell colonies, after 25 individuals, with varying degrees of experience in working with murine iPS cells, categorized the images of 136 colonies based on visual criteria. Intriguingly, the performance evaluation by area under the ROC curve (16 individuals with satisfactory performance), Spearman correlation (all statistically significant), and Cohen's Kappa agreement analysis (all statistically significant) demonstrates that the discriminatory capacity of different evaluators are similar, even those who have never cultivated cells. Thus, we report on a new system to facilitate visual identification of murine-induced pluripotent stem cell colonies that can be useful for staff training and opens the possibility of exploring visual characteristics of induced pluripotent stem cell colonies with their functional peculiarities. The fuzzy model has been integrated as a web-based tool named "2see-iPS" which is freely accessed at http://genetica.incor.usp.br/2seeips/.	[Bassaneze, Vinicius; Sacramento, Chester Bittencourt; De Alencar, Patricia Fernandes; Krieger, Jose Eduardo] Univ Sao Paulo, Sch Med, Lab Genet & Mol Cardiol LIM 13, Heart Inst InCor, Sao Paulo, Brazil; [Freire, Rodolfo; Siqueira Ortega, Neli Regina] Univ Sao Paulo, Fac Med, Ctr Fuzzy Syst Hlth, Dept Pathol, Sao Paulo, Brazil	Universidade de Sao Paulo; Universidade de Sao Paulo	Krieger, JE (corresponding author), Univ Sao Paulo, Sch Med, Lab Genet & Mol Cardiol LIM 13, Heart Inst InCor, Sao Paulo, Brazil.	krieger@incor.usp.br	Bassaneze, Vinícius/E-5577-2012	Bassaneze, Vinícius/0000-0002-3481-2408; Krieger, Jose E/0000-0001-5464-1792	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo - FAPESP [2008/52334-1, 2008/52335-8]; FAPESP [2008/52436-9]; CNPq [573887/2008-0]	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo - FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	VB and CBS were recipients of training fellowships from Fundacao de Amparo a Pesquisa do Estado de Sao Paulo - FAPESP (2008/52334-1, 2008/52335-8, respectively). VB was enrolled in the PhD program at FMUSP. This work was funded by grants from FAPESP (2008/52436-9), CNPq (573887/2008-0) and an unrestricted gift from Roche Pharmaceutical. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Blelloch R, 2007, CELL STEM CELL, V1, P245, DOI 10.1016/j.stem.2007.08.008; Boheler KR, 2003, METHOD ENZYMOL, V365, P228; Gonzalez F, 2011, NAT REV GENET, V12, P231, DOI 10.1038/nrg2937; Gonzalez F, 2009, P NATL ACAD SCI USA, V106, P8918, DOI 10.1073/pnas.0901471106; Lin SF, 2011, J INF SCI ENG, V27, P749; Maherali N, 2007, CELL STEM CELL, V1, P55, DOI 10.1016/j.stem.2007.05.014; Massad E, 2009, FUZZY LOGIC ACTION A; Meissner A, 2007, NAT BIOTECHNOL, V25, P1177, DOI 10.1038/nbt1335; Nakagawa M, 2008, NAT BIOTECHNOL, V26, P101, DOI 10.1038/nbt1374; Ohi Y, 2011, NAT CELL BIOL, V13, P541, DOI 10.1038/ncb2239; Pereira JCR, 2004, BRAZ J MED BIOL RES, V37, P701, DOI 10.1590/S0100-879X2004000500012; Pfannkuche K, 2010, PLOS ONE, V5, pA140, DOI 10.1371/journal.pone.0009580; Singh U, 2012, STEM CELL REV REP, V8, P1021, DOI 10.1007/s12015-012-9359-6; Takahashi K, 2007, NAT PROTOC, V2, P3081, DOI 10.1038/nprot.2007.418; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Tan SM, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm704; Tang CM, 2005, LECT NOTES COMPUT SC, V3645, P851, DOI 10.1007/11538356_88; Vintersten K, 2004, GENESIS, V40, P241, DOI 10.1002/gene.20095; Wakao S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048677; Wernig M, 2007, NATURE, V448, P318, DOI 10.1038/nature05944; ZADEH LA, 1965, INFORM CONTROL, V8, P338, DOI 10.1016/S0019-9958(65)90241-X	22	1	1	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2013	8	8							e70605	10.1371/journal.pone.0070605	http://dx.doi.org/10.1371/journal.pone.0070605			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	201ER	23950970	gold, Green Published, Green Submitted			2022-12-25	WOS:000323124000022
J	Alvarez, S; Munoz-Fernandez, MA				Alvarez, Susana; Angeles Munoz-Fernandez, Ma			TNF-A May Mediate Inflammasome Activation in the Absence of Bacterial Infection in More than One Way	PLOS ONE			English	Article							SMOOTH-MUSCLE-CELLS; SPINAL-CORD-INJURY; INTERLEUKIN-1-BETA RELEASE; P2X(7) RECEPTOR; MOLECULAR PLATFORM; MICROGLIAL CELLS; NITRIC-OXIDE; EXPRESSION; CASPASE-1; ATP	Members of the mammalian nucleotide binding domain, leucine-rich repeat (LRR)-containing receptor family of proteins are key modulators of innate immunity regulating inflammation. To date, microbial pathogen-associated molecules and toxins have been identified as key triggers of activation of inflammasomes. However, recently, environmental, and neurodegenerative stimuli have been identified that lead to IL-1 beta release by means of inflammasomes. IL-1 beta plays a crucial role during brain inflammation, and caspase-1 appears to be a key modulator of IL-1 beta bioactivity and the consequent transcriptional regulation of gene expression within the brain during inflammation. We show here that exposure of a human neuroblastoma cell line (SK-N-MC cells) to TNF-alpha promotes ROS-mediated caspase-1 activation and IL-1 beta secretion. The involvement of NF-kappa B in the regulation of IL-1 beta synthesis is investigated through specific inhibition of this transcription factor. The effect of TNF-alpha was abolished in the presence of ROS inhibitors as NAC, or DPI. Remarkably, SK-N-MC cells do not respond to ATP stimulation in spite of P2X(7)R expression. These results provide a mechanism by which danger signals and particulate matter mediate inflammation via the inflammasome in the absence of microbial infection.	[Alvarez, Susana; Angeles Munoz-Fernandez, Ma] Hosp Gen Univ Gregorio Maranon, Lab InmunoBiol Mol, Madrid, Spain; [Alvarez, Susana; Angeles Munoz-Fernandez, Ma] Inst Invest Sanitaria Gregorio Maranon, Madrid, Spain; [Angeles Munoz-Fernandez, Ma] Networking Res Ctr Bioengn Biomat & Nanomed, Madrid, Spain	General University Gregorio Maranon Hospital; CIBER - Centro de Investigacion Biomedica en Red; CIBERBBN	Munoz-Fernandez, MA (corresponding author), Hosp Gen Univ Gregorio Maranon, Lab InmunoBiol Mol, Madrid, Spain.	mmunoz.hgugm@salud.madrid.org		Munoz-Fernandez/0000-0002-0813-4500; , Susana/0000-0001-8573-9370	Red Tematica de Investigacion Cooperativa Sanitaria ISCIII (RED RIS) [RD06/0006/0035, RD06/0006/0021]; FIPSE [240800/09]; Fondo de Investigacion Sanitaria (INTRASALUD) [RD09/0076/00103, FIS07/0110]; Redes Moleculares y Celulares en Enfermedades Inflamatorias Comunidad de Madrid	Red Tematica de Investigacion Cooperativa Sanitaria ISCIII (RED RIS); FIPSE; Fondo de Investigacion Sanitaria (INTRASALUD)(Instituto de Salud Carlos III); Redes Moleculares y Celulares en Enfermedades Inflamatorias Comunidad de Madrid	This work was supported in part by grants from Red Tematica de Investigacion Cooperativa Sanitaria ISCIII (RED RIS) [RD06/0006/0035 and RD06/0006/0021], FIPSE [240800/09], Fondo de Investigacion Sanitaria (INTRASALUD 2009) [RD09/0076/00103 and FIS07/0110], Redes Moleculares y Celulares en Enfermedades Inflamatorias Comunidad de Madrid. Consejeria de Educacion. Convocatoria Cofinanciada con Fondos Estructurales de la Union Europea (INDISNET S-2011-BMD2332), and DENPEPTHIV, EuroNanoMed (PS09/02669). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agostini L, 2004, IMMUNITY, V20, P319, DOI 10.1016/S1074-7613(04)00046-9; Alvarez S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016100; Bauernfeind FG, 2009, J IMMUNOL, V183, P787, DOI 10.4049/jimmunol.0901363; Brough D, 2003, J IMMUNOL, V170, P3029, DOI 10.4049/jimmunol.170.6.3029; Chakfe Y, 2002, J NEUROSCI, V22, P3061, DOI 10.1523/JNEUROSCI.22-08-03061.2002; Costas M, 1996, J CLIN INVEST, V98, P1409, DOI 10.1172/JCI118928; Dinarello CA, 1998, ANN NY ACAD SCI, V856, P1, DOI 10.1111/j.1749-6632.1998.tb08307.x; Dinarello CA, 2009, ANNU REV IMMUNOL, V27, P519, DOI 10.1146/annurev.immunol.021908.132612; Dostert C, 2008, SCIENCE, V320, P674, DOI 10.1126/science.1156995; Duncan JA, 2007, P NATL ACAD SCI USA, V104, P8041, DOI 10.1073/pnas.0611496104; Faustin B, 2007, MOL CELL, V25, P713, DOI 10.1016/j.molcel.2007.01.032; FENTON MJ, 1992, INT J IMMUNOPHARMACO, V14, P401, DOI 10.1016/0192-0561(92)90170-P; Fernandes-Alnemri T, 2009, NATURE, V458, P509, DOI 10.1038/nature07710; Ferrari D, 1997, J EXP MED, V185, P579, DOI 10.1084/jem.185.3.579; Ferrari D, 1997, J IMMUNOL, V159, P1451; Franchi L, 2012, NAT IMMUNOL, V13, P325, DOI 10.1038/ni.2231; Gardella S, 2001, BLOOD, V98, P2152, DOI 10.1182/blood.V98.7.2152; Ghayur T, 1997, NATURE, V386, P619, DOI 10.1038/386619a0; Herman WH, 1999, TRANSPLANT P, V31, P1412, DOI 10.1016/S0041-1345(98)02109-5; Hornung V, 2009, NATURE, V458, P514, DOI 10.1038/nature07725; Humphreys BD, 1998, J LEUKOCYTE BIOL, V64, P265, DOI 10.1002/jlb.64.2.265; KANNO K, 1993, HYPERTENSION, V22, P34, DOI 10.1161/01.HYP.22.1.34; Keller M, 2008, CELL, V132, P818, DOI 10.1016/j.cell.2007.12.040; Kummer JA, 2007, J HISTOCHEM CYTOCHEM, V55, P443, DOI 10.1369/jhc.6A7101.2006; Labbe K, 2008, CELL DEATH DIFFER, V15, P1339, DOI 10.1038/cdd.2008.91; Lamkanfi M, 2011, NAT REV IMMUNOL, V11, P213, DOI 10.1038/nri2936; Mariathasan S, 2004, NATURE, V430, P213, DOI 10.1038/nature02664; Mariathasan S, 2006, NATURE, V440, P228, DOI 10.1038/nature04515; Martinez FO, 2009, ANNU REV IMMUNOL, V27, P451, DOI 10.1146/annurev.immunol.021908.132532; Martinon F, 2002, MOL CELL, V10, P417, DOI 10.1016/S1097-2765(02)00599-3; Mautes AEM, 2000, PHYS THER, V80, P673, DOI 10.1093/ptj/80.7.673; Miao EA, 2006, NAT IMMUNOL, V7, P569, DOI 10.1038/ni1344; Mrak RE, 2001, NEUROBIOL AGING, V22, P903, DOI 10.1016/S0197-4580(01)00287-1; Narcisse L, 2005, GLIA, V49, P245, DOI 10.1002/glia.20110; Ogier-Denis E, 2008, SEMIN IMMUNOPATHOL, V30, P291, DOI 10.1007/s00281-008-0120-9; Pelegrin P, 2006, EMBO J, V25, P5071, DOI 10.1038/sj.emboj.7601378; Pierce JW, 1997, J BIOL CHEM, V272, P21096, DOI 10.1074/jbc.272.34.21096; Pop C, 2006, MOL CELL, V22, P269, DOI 10.1016/j.molcel.2006.03.009; Ralevic V, 1998, PHARMACOL REV, V50, P413; Rossi F, 1996, BIOCHEM BIOPH RES CO, V225, P474, DOI 10.1006/bbrc.1996.1197; RUBARTELLI A, 1990, EMBO J, V9, P1503, DOI 10.1002/j.1460-2075.1990.tb08268.x; Silverman WR, 2009, J BIOL CHEM, V284, P18143, DOI 10.1074/jbc.M109.004804; Skaper Stephen D, 2009, Cardiovasc Psychiatry Neurol, V2009, P861324, DOI 10.1155/2009/861324; TALLEY AK, 1995, MOL CELL BIOL, V15, P2359; THORNBERRY NA, 1992, NATURE, V356, P768, DOI 10.1038/356768a0; Ting JPY, 2008, IMMUNITY, V28, P285, DOI 10.1016/j.immuni.2008.02.005; Vaccari JPDR, 2008, J NEUROSCI, V28, P3404, DOI 10.1523/JNEUROSCI.0157-08.2008; Walev I, 2000, J IMMUNOL, V164, P5120, DOI 10.4049/jimmunol.164.10.5120; WANG XK, 1995, ATHEROSCLEROSIS, V115, P89, DOI 10.1016/0021-9150(94)05503-B; Weber A, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.3105cm1; Witting A, 2006, P NATL ACAD SCI USA, V103, P6362, DOI 10.1073/pnas.0510418103; WOODROOFE MN, 1991, J NEUROIMMUNOL, V33, P227, DOI 10.1016/0165-5728(91)90110-S; YAO JB, 1992, BRAIN RES, V591, P88, DOI 10.1016/0006-8993(92)90981-E; Zitvogel L, 2012, NAT IMMUNOL, V13, P343, DOI 10.1038/ni.2224	54	37	39	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2013	8	8							e71477	10.1371/journal.pone.0071477	http://dx.doi.org/10.1371/journal.pone.0071477			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	200ZE	23940760	Green Published, gold, Green Submitted			2022-12-25	WOS:000323109700103
J	Iwasaki, J; Smith, WA; Stone, SR; Thomas, WR; Hales, BJ				Iwasaki, Jua; Smith, Wendy-Anne; Stone, Shane R.; Thomas, Wayne R.; Hales, Belinda J.			Species-Specific and Cross-Reactive IgG1 Antibody Binding to Viral Capsid Protein 1 (VP1) Antigens of Human Rhinovirus Species A, B and C	PLOS ONE			English	Article							CIRCULAR-DICHROISM SPECTROSCOPY; IDENTIFIED HUMAN RHINOVIRUS; IGE BINDING; RESPONSES; ALLERGEN; VIRUS; IMMUNIZATION; REPLICATION; DIVERSITY; INFECTION	Background: Human rhinoviruses (HRV) are associated with upper and lower respiratory illnesses, including severe infections causing hospitalization in both children and adults. Although the clinical significance of HRV infections is now well established, no detailed investigation of the immune response against HRV has been performed. The purpose of this study was to assess the IgG1 antibody response to the three known HRV species, HRV-A, -B and -C in healthy subjects. Methods: Recombinant polypeptides of viral capsid protein 1 (VP1) from two genotypes of HRV-A, -B and -C were expressed as glutathione S-transferase (GST) fusion proteins and purified by affinity and then size exclusion chromatography. The presence of secondary structures similar to the natural antigens was verified by circular dichroism analysis. Total and species-specific IgG1 measurements were quantitated by immunoassays and immunoabsorption using sera from 63 healthy adults. Results: Most adult sera reacted with the HRV VP1 antigens, at high titres. As expected, strong cross-reactivity between HRV genotypes of the same species was found. A high degree of cross-reactivity between different HRV species was also evident, particularly between HRV-A and HRV-C. Immunoabsorption studies revealed HRV-C specific titres were markedly and significantly lower than the HRV-A and HRV-B specific titres (P<0.0001). A truncated construct of HRV-C VP1 showed greater specificity in detecting anti-HRV-C antibodies. Conclusions: High titres of IgG1 antibody were bound by the VP1 capsid proteins of HRV-A, -B and -C, but for the majority of people, a large proportion of the antibody to HRV-C was cross-reactive, especially to HRV-A. The improved specificity found for the truncated HRV-C VP1 indicates species-specific and cross-reactive regions could be defined.	[Iwasaki, Jua; Smith, Wendy-Anne; Stone, Shane R.; Thomas, Wayne R.; Hales, Belinda J.] Univ Western Australia, Ctr Child Hlth Res, Telethon Inst Child Hlth Res, Perth, WA 6009, Australia; [Iwasaki, Jua; Hales, Belinda J.] Univ Western Australia, Sch Paediat & Child Hlth, Perth, WA 6009, Australia	Telethon Kids Institute; University of Western Australia; University of Western Australia	Hales, BJ (corresponding author), Univ Western Australia, Ctr Child Hlth Res, Telethon Inst Child Hlth Res, Perth, WA 6009, Australia.	belinda@ichr.uwa.edu.au		Iwasaki, Jua/0000-0002-5833-7146	National Health and Medical Research Council of Australia grant [458513]; Australian Postgraduate Award; University of Western Australia Scholarship; Stan and Jean Perron Scholarship; Asthma Foundation of Western Australia Scholarship	National Health and Medical Research Council of Australia grant(National Health and Medical Research Council (NHMRC) of Australia); Australian Postgraduate Award(Australian Government); University of Western Australia Scholarship; Stan and Jean Perron Scholarship; Asthma Foundation of Western Australia Scholarship	This work was supported by a National Health and Medical Research Council of Australia grant (458513). J. Iwasaki was supported by an Australian Postgraduate Award, a University of Western Australia Scholarship, a Stan and Jean Perron Scholarship and an Asthma Foundation of Western Australia Scholarship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aarntzen EHJG, 2012, CANCER IMMUNOL IMMUN, V61, P2003, DOI 10.1007/s00262-012-1263-z; Ashraf S, 2013, VIROLOGY, V436, P143, DOI 10.1016/j.virol.2012.11.002; BARCLAY WS, 1989, EPIDEMIOL INFECT, V103, P659, DOI 10.1017/S095026880003106X; Bizzintino J, 2011, EUR RESPIR J, V37, P1037, DOI 10.1183/09031936.00092410; Bochkov YA, 2011, NAT MED, V17, P627, DOI 10.1038/nm.2358; Brockwell D, 2001, PROTEIN SCI, V10, P572, DOI 10.1110/ps.46001; BUTLER WT, 1970, J IMMUNOL, V105, P584; Ferguson PE, 2013, J CLIN VIROL, V56, P255, DOI 10.1016/j.jcv.2012.11.010; Fry AM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017780; Gern JE, 2006, J ALLERGY CLIN IMMUN, V117, P72, DOI 10.1016/j.jaci.2005.10.002; GIRANDA VL, 1992, P NATL ACAD SCI USA, V89, P10213, DOI 10.1073/pnas.89.21.10213; Granados A, 2012, DIAGN MICR INFEC DIS, V74, P384, DOI 10.1016/j.diagmicrobio.2012.08.023; Hales BJ, 2008, THORAX, V63, P221, DOI 10.1136/thx.2006.069492; Hales BJ, 2013, INT ARCH ALLERGY IMM, V160, P233, DOI 10.1159/000339760; Hales BJ, 2012, THORAX, V67, P321, DOI 10.1136/thoraxjnl-2011-200650; Hales BJ, 2004, INT ARCH ALLERGY IMM, V135, P101, DOI 10.1159/000080652; Hao WD, 2012, J VIROL, V86, P13524, DOI 10.1128/JVI.02094-12; Ichikawa K, 2001, CLIN EXP ALLERGY, V31, P1279, DOI 10.1046/j.1365-2222.2001.01169.x; Kennedy JL, 2012, CURR OPIN VIROL, V2, P287, DOI 10.1016/j.coviro.2012.03.008; Kim JH, 2009, J IMMUNOL, V183, P3294, DOI 10.4049/jimmunol.0900398; KIM S, 1989, J MOL BIOL, V210, P91, DOI 10.1016/0022-2836(89)90293-3; Kistler AL, 2007, VIROL J, V4, DOI 10.1186/1743-422X-4-40; Lau SKP, 2007, J CLIN MICROBIOL, V45, P3655, DOI 10.1128/JCM.01254-07; Lau SKP, 2009, J INFECT DIS, V200, P1096, DOI 10.1086/605697; Laza-Stanca V, 2006, J VIROL, V80, P8248, DOI 10.1128/JVI.00162-06; Ledford RM, 2004, J VIROL, V78, P3663, DOI 10.1128/JVI.78.7.3663-3674.2004; Lees JG, 2006, BIOINFORMATICS, V22, P1955, DOI 10.1093/bioinformatics/btl327; Makela MJ, 1998, J CLIN MICROBIOL, V36, P539; McErlean P, 2007, J CLIN VIROL, V39, P67, DOI 10.1016/j.jcv.2007.03.012; McErlean P, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001847; McIntyre CL, 2010, J VIROL, V84, P10297, DOI 10.1128/JVI.00962-10; Nabors GS, 2000, VACCINE, V18, P1743, DOI 10.1016/S0264-410X(99)00530-7; Niespodziana K, 2012, FASEB J, V26, P1001, DOI 10.1096/fj.11-193557; Rohm C, 1996, VIROLOGY, V217, P508, DOI 10.1006/viro.1996.0145; ROSSMANN MG, 1985, NATURE, V317, P145, DOI 10.1038/317145a0; Semenova VA, 2004, CLIN DIAGN LAB IMMUN, V11, P919, DOI 10.1128/CDLI.11.5.919-923.2004; Stanekova Z, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-351; van Kempen M., 1999, Rhinology (Utrecht), V37, P97; Vance E, 1998, BONE MARROW TRANSPL, V22, P735, DOI 10.1038/sj.bmt.1701424; Weghofer M, 2008, ALLERGY, V63, P758, DOI 10.1111/j.1398-9995.2008.01647.x; Weinfurter JT, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002381; Whitmore L, 2008, BIOPOLYMERS, V89, P392, DOI 10.1002/bip.20853; Wrammert J, 2011, J EXP MED, V208, P181, DOI 10.1084/jem.20101352; Zhang Y, 2004, J VIROL, V78, P11061, DOI 10.1128/JVI.78.20.11061-11069.2004	44	15	17	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2013	8	8							e70552	10.1371/journal.pone.0070552	http://dx.doi.org/10.1371/journal.pone.0070552			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	200ZE	23950960	Green Published, Green Submitted, gold			2022-12-25	WOS:000323109700042
J	Buxdorf, K; Yaffe, H; Barda, O; Levy, M				Buxdorf, Kobi; Yaffe, Hila; Barda, Omer; Levy, Maggie			The Effects of Glucosinolates and Their Breakdown Products on Necrotrophic Fungi	PLOS ONE			English	Article							MYROSINASE-CATALYZED HYDROLYSIS; ARABIDOPSIS-THALIANA LEAVES; NONHOST RESISTANCE; SECONDARY METABOLITES; DISEASE RESISTANCE; INDOLIC METABOLITES; INSECT RESISTANCE; BIOSYNTHESIS; CAMALEXIN; ISOTHIOCYANATES	Glucosinolates are a diverse class of S-and N-containing secondary metabolites that play a variety of roles in plant defense. In this study, we used Arabidopsis thaliana mutants that contain different amounts of glucosinolates and glucosinolate-breakdown products to study the effects of these phytochemicals on phytopathogenic fungi. We compared the fungus Botrytis cinerea, which infects a variety of hosts, with the Brassicaceae-specific fungus Alternaria brassicicola. B. cinerea isolates showed variable composition-dependent sensitivity to glucosinolates and their hydrolysis products, while A. brassicicola was more strongly affected by aliphatic glucosinolates and isothiocyanates as decomposition products. We also found that B. cinerea stimulates the accumulation of glucosinolates to a greater extent than A. brassicicola. In our work with A. brassicicola, we found that the type of glucosinolate-breakdown product is more important than the type of glucosinolate from which that product was derived, as demonstrated by the sensitivity of the Ler background and the sensitivity gained in Col-0 plants expressing epithiospecifier protein both of which accumulate simple nitrile and epithionitriles, but not isothiocyanates. Furthermore, in vivo, hydrolysis products of indole glucosinolates were found to be involved in defense against B. cinerea, but not in the host response to A. brassicicola. We suggest that the Brassicaceae-specialist A. brassicicola has adapted to the presence of indolic glucosinolates and can cope with their hydrolysis products. In contrast, some isolates of the generalist B. cinerea are more sensitive to these phytochemicals.	[Buxdorf, Kobi; Yaffe, Hila; Barda, Omer; Levy, Maggie] Hebrew Univ Jerusalem, Robert H Smith Fac Agr Food & Environm, Dept Plant Pathol & Microbiol, IL-76100 Rehovot, Israel	Hebrew University of Jerusalem	Levy, M (corresponding author), Hebrew Univ Jerusalem, Robert H Smith Fac Agr Food & Environm, Dept Plant Pathol & Microbiol, IL-76100 Rehovot, Israel.	Maggie.Levy@mail.huji.ac.il	Barda, Omer/HGA-5137-2022	Barda, Omer/0000-0002-6576-3784	Binational Agricultural Research and Development Fund [IS-4210-09]; Niedersachsen-Israel Fund [VWZN2556]	Binational Agricultural Research and Development Fund; Niedersachsen-Israel Fund	This work was supported by research grant number IS-4210-09 from the Binational Agricultural Research and Development Fund and by research grant no. VWZN2556 from the Niedersachsen-Israel Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adie BAT, 2007, PLANT CELL, V19, P1665, DOI 10.1105/tpc.106.048041; Agerbirk N, 1998, J AGR FOOD CHEM, V46, P1563, DOI 10.1021/jf9708498; Barth C, 2006, PLANT J, V46, P549, DOI 10.1111/j.1365-313X.2006.02716.x; Bednarek P, 2005, PLANT PHYSIOL, V138, P1058, DOI 10.1104/pp.104.057794; Bednarek P, 2009, SCIENCE, V323, P101, DOI 10.1126/science.1163732; Beekwilder J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002068; Bottcher C, 2009, PLANT CELL, V21, P1830, DOI 10.1105/tpc.109.066670; Brader G, 2001, PLANT PHYSIOL, V126, P849, DOI 10.1104/pp.126.2.849; Brader G, 2006, PLANT J, V46, P758, DOI 10.1111/j.1365-313X.2006.02743.x; Burow M, 2009, PLANT PHYSIOL, V149, P561, DOI 10.1104/pp.108.130732; Burow M, 2006, FEBS J, V273, P2432, DOI 10.1111/j.1742-4658.2006.05252.x; Burow M, 2006, J CHEM ECOL, V32, P2333, DOI 10.1007/s10886-006-9149-1; BUTTNER P, 1994, CURR GENET, V25, P445, DOI 10.1007/BF00351784; Canistro D, 2004, MUTAT RES-FUND MOL M, V545, P23, DOI 10.1016/j.mrfmmm.2003.08.001; Celenza JL, 2005, PLANT PHYSIOL, V137, P253, DOI 10.1104/pp.104.054395; Chen S, 2001, PLANT PHYSIOL BIOCH, V39, P743, DOI 10.1016/S0981-9428(01)01301-8; Chew FS, 1988, ACM S SERIES AM CHEM, P154; Clay NK, 2009, SCIENCE, V323, P95, DOI 10.1126/science.1164627; Conaway CC, 2002, CURR DRUG METAB, V3, P233, DOI 10.2174/1389200023337496; de Vos M, 2008, PLANT PHYSIOL, V146, P916, DOI 10.1104/pp.107.112185; DONKIN SG, 1995, J NEMATOL, V27, P258; Fahey JW, 2001, PHYTOCHEMISTRY, V56, P5, DOI 10.1016/S0031-9422(00)00316-2; Fan J, 2011, SCIENCE, V331, P1185, DOI 10.1126/science.1199707; GIAMOUSTARIS A, 1995, ANN APPL BIOL, V126, P347, DOI 10.1111/j.1744-7348.1995.tb05371.x; Giamoustaris A, 1997, PLANT PATHOL, V46, P271, DOI 10.1046/j.1365-3059.1997.d01-222.x; Gigolashvili T, 2008, NEW PHYTOL, V177, P627, DOI 10.1111/j.1469-8137.2007.02295.x; GLAZEBROOK J, 1994, P NATL ACAD SCI USA, V91, P8955, DOI 10.1073/pnas.91.19.8955; Grubb CD, 2006, TRENDS PLANT SCI, V11, P89, DOI 10.1016/j.tplants.2005.12.006; Hagemeier J, 2001, P NATL ACAD SCI USA, V98, P753, DOI 10.1073/pnas.021551098; Halkier BA, 2006, ANNU REV PLANT BIOL, V57, P303, DOI 10.1146/annurev.arplant.57.032905.105228; HAUGHN GW, 1991, PLANT PHYSIOL, V97, P217, DOI 10.1104/pp.97.1.217; Hirai MY, 2007, P NATL ACAD SCI USA, V104, P6478, DOI 10.1073/pnas.0611629104; Hirai MY, 2004, P NATL ACAD SCI USA, V101, P10205, DOI 10.1073/pnas.0403218101; Hiruma K, 2010, PLANT CELL, V22, P2429, DOI 10.1105/tpc.110.074344; Kelly PJ, 1998, PLANTA, V206, P370, DOI 10.1007/s004250050412; Kissen R, 2009, J BIOL CHEM, V284, P12057, DOI 10.1074/jbc.M807500200; Kliebenstein D, 2002, GENETICS, V161, P325; Kliebenstein DJ, 2005, PLANT J, V44, P25, DOI 10.1111/j.1365-313X.2005.02508.x; Kliebenstein DJ, 2002, GENETICS, V161, P1685; Kliebenstein DJ, 2001, PLANT PHYSIOL, V126, P811, DOI 10.1104/pp.126.2.811; Koroleva OA, 2000, PLANT PHYSIOL, V124, P599, DOI 10.1104/pp.124.2.599; Koroleva OA, 2010, PLANT J, V64, P456, DOI 10.1111/j.1365-313X.2010.04339.x; Lambrix V, 2001, PLANT CELL, V13, P2793, DOI 10.1105/tpc.13.12.2793; Lazzeri L, 2004, J AGR FOOD CHEM, V52, P6703, DOI 10.1021/jf030776u; Levy M, 2005, PLANT J, V43, P79, DOI 10.1111/j.1365-313X.2005.02435.x; Li Q, 2000, J CHEM ECOL, V26, P2401, DOI 10.1023/A:1005535129399; Lipka V, 2005, SCIENCE, V310, P1180, DOI 10.1126/science.1119409; Ludwig-Muller J, 1999, NEW PHYTOL, V141, P443, DOI 10.1046/j.1469-8137.1999.00368.x; Malitsky S, 2008, PLANT PHYSIOL, V148, P2021, DOI 10.1104/pp.108.124784; Manici LM, 1997, J AGR FOOD CHEM, V45, P2768, DOI 10.1021/jf9608635; Maruyama-Nakashita A, 2006, PLANT CELL, V18, P3235, DOI 10.1105/tpc.106.046458; Mewis I, 2005, PLANT PHYSIOL, V138, P1149, DOI 10.1104/pp.104.053389; Miao Y, 2007, PLANT CELL, V19, P819, DOI 10.1105/tpc.106.042705; Pedras MSC, 2009, FEBS J, V276, P7412, DOI 10.1111/j.1742-4658.2009.07457.x; Petersen BL, 2002, PLANTA, V214, P562, DOI 10.1007/s004250100659; Rask L, 2000, PLANT MOL BIOL, V42, P93, DOI 10.1023/A:1006380021658; Ratzka A, 2002, P NATL ACAD SCI USA, V99, P11223, DOI 10.1073/pnas.172112899; Robert-Seilaniantz A, 2011, PLANT J, V67, P218, DOI 10.1111/j.1365-313X.2011.04591.x; Rostas M, 2002, J CHEM ECOL, V28, P2449, DOI 10.1023/A:1021427917603; Sanchez-Vallet A, 2010, PLANT J, V63, P115, DOI 10.1111/j.1365-313X.2010.04224.x; Schlaeppi K, 2010, PLANT J, V62, P840, DOI 10.1111/j.1365-313X.2010.04197.x; Sellam A, 2007, PLANT PATHOL, V56, P296, DOI 10.1111/j.1365-3059.2006.01497.x; Sellam A, 2007, MOL PLANT PATHOL, V8, P195, DOI 10.1111/J.1364-3703.2007.00387.X; Shroff R, 2008, P NATL ACAD SCI USA, V105, P6196, DOI 10.1073/pnas.0711730105; Sonderby IE, 2010, TRENDS PLANT SCI, V15, P283, DOI 10.1016/j.tplants.2010.02.005; Sonderby IE, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001322; Sonderby IE, 2010, PLANT PHYSIOL, V153, P348, DOI 10.1104/pp.109.149286; Stotz HU, 2011, PLANT J, V67, P81, DOI 10.1111/j.1365-313X.2011.04578.x; Tan JW, 2004, PHYTOCHEMISTRY, V65, P691, DOI 10.1016/j.phytochem.2003.12.009; Tierens KFMJ, 2001, PLANT PHYSIOL, V125, P1688, DOI 10.1104/pp.125.4.1688; Wittstock U, 2004, P NATL ACAD SCI USA, V101, P4859, DOI 10.1073/pnas.0308007101; Wittstock U, 2002, TRENDS PLANT SCI, V7, P263, DOI 10.1016/S1360-1385(02)02273-2; Zhang ZY, 2006, PLANT CELL, V18, P1524, DOI 10.1105/tpc.105.039602; Zhao YD, 2002, GENE DEV, V16, P3100, DOI 10.1101/gad.1035402; Zhou N, 1999, PLANT CELL, V11, P2419, DOI 10.1105/tpc.11.12.2419	75	73	78	4	70	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2013	8	8							e70771	10.1371/journal.pone.0070771	http://dx.doi.org/10.1371/journal.pone.0070771			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	218XC	23940639	gold, Green Published, Green Submitted			2022-12-25	WOS:000324465000131
J	Defendi, F; Charignon, D; Ghannam, A; Baroso, R; Csopaki, F; Allegret-Cadet, M; Ponard, D; Favier, B; Cichon, S; Nicolie, B; Fain, O; Martin, L; Drouet, C				Defendi, Federica; Charignon, Delphine; Ghannam, Arije; Baroso, Remi; Csopaki, Francoise; Allegret-Cadet, Marion; Ponard, Denise; Favier, Bertrand; Cichon, Sven; Nicolie, Brigitte; Fain, Olivier; Martin, Ludovic; Drouet, Christian		Natl Reference Ctr Angioedema CREA	Enzymatic Assays for the Diagnosis of Bradykinin-Dependent Angioedema	PLOS ONE			English	Article							MOLECULAR-WEIGHT KININOGEN; HEREDITARY ANGIOEDEMA; FACTOR-XII; VASCULAR-PERMEABILITY; HUMAN-PLASMA; ACTIVATION; PREKALLIKREIN; KALLIKREIN; MAST; INDUCTION	Background: The kinins (primarily bradykinin, BK) represent the mediators responsible for local increase of vascular permeability in hereditary angioedema (HAE), HAE I-II associated with alterations of the SERPING1 gene and HAE with normal C1-Inhibitor function (HAE-nC1INH). Besides C1-Inhibitor function and concentration, no biological assay of kinin metabolism is actually available to help physicians for the diagnosis of angioedema (AE). We describe enzymatic tests on the plasma for diagnosis of BK-dependent AE. Methods: The plasma amidase assays are performed using the Pro-Phe-Arg-p-nitroanilide peptide substrate to evaluate the spontaneous amidase activity and the proenzyme activation. We analyzed data of 872 patients presenting with BK-dependent AE or BK-unrelated diseases, compared to 303 controls. Anti-high MW kininogen (HK) immunoblot was achieved to confirm HK cleavage in exemplary samples. Reproducibility, repeatability, limit of blank, limit of detection, precision, linearity and receiver operating characteristics (ROC) were used to calculate the diagnostic performance of the assays. Results: Spontaneous amidase activity was significantly increased in all BK-dependent AE, associated with the acute phase of disease in HAE-nC1INH, but preserved in BK-unrelated disorders. The increase of the amidase activity was associated to HK proteolysis, indicating its relevance to identify kininogenase activity. The oestrogens, known for precipitating AE episodes, were found as triggers of enzymatic activity. Calculations from ROC curves gave the optimum diagnostic cut-off for women (9.3 nmol.min(-1).mL(-1), area under curve [AUC] 92.1%, sensitivity 80.0%, and specificity 90.1%) and for men (6.6 nmol.min(-1).mL(-1), AUC 91.0%, sensitivity 87.0% and specificity 81.2%). Conclusion: The amidase assay represents a diagnostic tool to help physicians in the decision to distinguish between BK-related and -unrelated AE.	[Defendi, Federica; Charignon, Delphine; Csopaki, Francoise; Allegret-Cadet, Marion; Ponard, Denise; Nicolie, Brigitte; Fain, Olivier; Martin, Ludovic; Drouet, Christian] CREAK, Grenoble, France; [Defendi, Federica; Charignon, Delphine; Ghannam, Arije; Baroso, Remi; Favier, Bertrand; Drouet, Christian] Univ Grenoble 1, GREPI AGIM CNRS FRE 3405, Grenoble, France; [Cichon, Sven] Univ Bonn, Inst Humangenet, Bonn, Germany; [Cichon, Sven] Univ Basel, Dept Biomed, Div Med Genet, Basel, Switzerland; [Nicolie, Brigitte] CHU Angers, Dept Allergol, Angers, France; [Fain, Olivier] Univ Paris 13, Hop Jean Verdier, AP HP, Bondy, France; [Martin, Ludovic] Univ UNAM, Hop Angers, Dept Dermatol, Angers, France	UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); University of Bonn; University of Basel; Universite d'Angers; Centre Hospitalier Universitaire d'Angers; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Jean-Verdier - APHP; Universite Paris 13; Universite d'Angers; Centre Hospitalier Universitaire d'Angers	Defendi, F (corresponding author), CREAK, Grenoble, France.	FDefendi@chu-grenoble.fr	DROUET, Christian/J-8775-2019; Martin, Ludovic/K-2674-2015; Launay, David/H-1674-2016; Caballero, Teresa/H-6454-2014; DROUET, Christian/AAE-5682-2020; Cichon, Sven/B-9618-2014; Launay, David/A-5270-2018; Cichon, Sven/H-8803-2013; Favier, Bertrand/B-7258-2013	DROUET, Christian/0000-0003-1318-4278; Launay, David/0000-0003-1840-1817; Caballero, Teresa/0000-0003-3005-9858; DROUET, Christian/0000-0003-1318-4278; Cichon, Sven/0000-0002-9475-086X; Launay, David/0000-0003-1840-1817; Cichon, Sven/0000-0002-9475-086X; Grob, Jean-Jacques/0000-0002-0667-153X	ERA-Net E-RARE-1 research program within the framework of the project "Genetics, Pathophysiology, and Therapy of Hereditary Angioedema Type III" (HAEIII)	ERA-Net E-RARE-1 research program within the framework of the project "Genetics, Pathophysiology, and Therapy of Hereditary Angioedema Type III" (HAEIII)	This work was supported by an ERA-Net E-RARE-1 research program within the framework of the project "Genetics, Pathophysiology, and Therapy of Hereditary Angioedema Type III" (acronym HAEIII; S. Cichon, coordinator). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armbruster David A, 2008, Clin Biochem Rev, V29 Suppl 1, pS49; Bas M, 2007, ALLERGY, V62, P842, DOI 10.1111/j.1398-9995.2007.01427.x; BERRETTINI M, 1986, BLOOD, V68, P455; Binkley KE, 2000, J ALLERGY CLIN IMMUN, V106, P546; Bjorkqvist J, 2013, THROMB HAEMOSTASIS, V109, P368, DOI 10.1160/TH12-08-0549; Bork K, 2003, AM J MED, V114, P294, DOI 10.1016/S0002-9343(02)01526-7; Bork K, 2000, LANCET, V356, P213, DOI 10.1016/S0140-6736(00)02483-1; Bork K, 2009, J ALLERGY CLIN IMMUN, V124, P129, DOI 10.1016/j.jaci.2009.03.038; Caballero T, 2011, J INVEST ALLERG CLIN, V21, P333; Castelli R, 2007, HAEMATOL-HEMATOL J, V92, P716, DOI 10.3324/haematol.10769; Cichon S, 2006, AM J HUM GENET, V79, P1098, DOI 10.1086/509899; Citarella F, 1996, STEROIDS, V61, P270, DOI 10.1016/0039-128X(96)00037-2; Cugno M, 1996, IMMUNOPHARMACOLOGY, V33, P361, DOI 10.1016/0162-3109(96)00086-0; Cugno M, 2009, TRENDS MOL MED, V15, P69, DOI 10.1016/j.molmed.2008.12.001; Dlamini Z, 2005, J CLIN PATHOL, V58, P915, DOI 10.1136/jcp.2004.021444; FRANK MM, 1976, ANN INTERN MED, V84, P580, DOI 10.7326/0003-4819-84-5-580; Giard C, 2012, DERMATOLOGY, V225, P62, DOI 10.1159/000340029; Imamura T, 1996, LAB INVEST, V74, P861; ISHIZAKA T, 1985, J IMMUNOL, V134, P1880; JACKSON J, 1986, NATURE, V323, P722, DOI 10.1038/323722a0; Joseph K, 2008, ANN ALLERG ASTHMA IM, V101, P279, DOI 10.1016/S1081-1206(10)60493-0; KLUFT C, 1978, J LAB CLIN MED, V91, P83; Martin L, 2001, J ALLERGY CLIN IMMUN, V107, P747, DOI 10.1067/mai.2001.114242; Martin L, 2007, J ALLERGY CLIN IMMUN, V120, P975, DOI 10.1016/j.jaci.2007.07.002; McGlinchey PG, 2000, AM J MED SCI, V320, P212, DOI 10.1097/00000441-200009000-00014; Moreau ME, 2005, J PHARMACOL SCI, V99, P6, DOI 10.1254/jphs.SRJ05001X; Oschatz C, 2011, IMMUNITY, V34, P258, DOI 10.1016/j.immuni.2011.02.008; Renne T, 2012, THROMB HAEMOSTASIS, V107, P1012, DOI 10.1160/TH12-04-0264; SCHAPIRA M, 1983, NEW ENGL J MED, V308, P1050, DOI 10.1056/NEJM198305053081802; Vitrat-Hincky V, 2010, ALLERGY, V65, P1331, DOI 10.1111/j.1398-9995.2010.02368.x; Zuraw BL, 2012, ALLERGY ASTHMA PROC, DOI [10.2500/aap2012.33.3627, DOI 10.2500/AAP2012.33.3627]	31	47	51	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2013	8	8							e70140	10.1371/journal.pone.0070140	http://dx.doi.org/10.1371/journal.pone.0070140			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	218XC	23940538	gold, Green Published			2022-12-25	WOS:000324465000032
J	Dickey, JS; Gonzalez, Y; Aryal, B; Mog, S; Nakamura, AJ; Redon, CE; Baxa, U; Rosen, E; Cheng, G; Zielonka, J; Parekh, P; Mason, KP; Joseph, J; Kalyanaraman, B; Bonner, W; Herman, E; Shacter, E; Rao, VA				Dickey, Jennifer S.; Gonzalez, Yanira; Aryal, Baikuntha; Mog, Steven; Nakamura, Asako J.; Redon, Christophe E.; Baxa, Ulrich; Rosen, Elliot; Cheng, Gang; Zielonka, Jacek; Parekh, Palak; Mason, Karen P.; Joseph, Joy; Kalyanaraman, Balaraman; Bonner, William; Herman, Eugene; Shacter, Emily; Rao, V. Ashutosh			Mito-Tempol and Dexrazoxane Exhibit Cardioprotective and Chemotherapeutic Effects through Specific Protein Oxidation and Autophagy in a Syngeneic Breast Tumor Preclinical Model	PLOS ONE			English	Article							RAT MAMMARY-CARCINOMA; ANTHRACYCLINE-INDUCED CARDIOTOXICITY; CARDIAC TROPONIN-T; CELL CLONES; INTERCELLULAR COMMUNICATION; ANTIOXIDANT PROPERTIES; METASTATIC CAPACITY; GROWTH-INHIBITION; SERUM-ALBUMIN; DNA-DAMAGE	Several front-line chemotherapeutics cause mitochondria-derived, oxidative stress-mediated cardiotoxicity. Iron chelators and other antioxidants have not completely succeeded in mitigating this effect. One hindrance to the development of cardioprotectants is the lack of physiologically-relevant animal models to simultaneously study antitumor activity and cardioprotection. Therefore, we optimized a syngeneic rat model and examined the mechanisms by which oxidative stress affects outcome. Immune-competent spontaneously hypertensive rats (SHRs) were implanted with passaged, SHR-derived, breast tumor cell line, SST-2. Tumor growth and cytokine responses (IL-1A, MCP-1, TNF-alpha) were observed for two weeks post-implantation. To demonstrate the utility of the SHR/SST-2 model for monitoring both anticancer efficacy and cardiotoxicity, we tested cardiotoxic doxorubicin alone and in combination with an established cardioprotectant, dexrazoxane, or a nitroxide conjugated to a triphenylphosphonium cation, Mito-Tempol (4) [Mito-T (4)]. As predicted, tumor reduction and cardiomyopathy were demonstrated by doxorubicin. We confirmed mitochondrial accumulation of Mito-T (4) in tumor and cardiac tissue. Dexrazoxane and Mito-T (4) ameliorated doxorubicin-induced cardiomyopathy without altering the antitumor activity. Both agents increased the pro-survival autophagy marker LC3-II and decreased the apoptosis marker caspase-3 in the heart, independently and in combination with doxorubicin. Histopathology and transmission electron microscopy demonstrated apoptosis, autophagy, and necrosis corresponding to cytotoxicity in the tumor and cardioprotection in the heart. Changes in serum levels of 8-oxo-dG-modified DNA and total protein carbonylation corresponded to cardioprotective activity. Finally, 2D-electrophoresis/mass spectrometry identified specific serum proteins oxidized under cardiotoxic conditions. Our results demonstrate the utility of the SHR/SST-2 model and the potential of mitochondrially-directed agents to mitigate oxidative stress-induced cardiotoxicity. Our findings also emphasize the novel role of specific protein oxidation markers and autophagic mechanisms for cardioprotection.	[Dickey, Jennifer S.; Gonzalez, Yanira; Aryal, Baikuntha; Rosen, Elliot; Mason, Karen P.; Shacter, Emily; Rao, V. Ashutosh] US FDA, Div Therapeut Prot, Ctr Drug Evaluat & Res, Bethesda, MD 20014 USA; [Mog, Steven] US FDA, Ctr Food Safety & Appl Nutr, College Pk, MD USA; [Nakamura, Asako J.; Redon, Christophe E.; Parekh, Palak; Bonner, William] NCI, Mol Pharmacol Lab, Bethesda, MD 20892 USA; [Baxa, Ulrich] Frederick Natl Lab Canc Res, Electron Microscopy Lab, Adv Technol Program, Frederick, MD USA; [Cheng, Gang; Zielonka, Jacek; Joseph, Joy; Kalyanaraman, Balaraman] Med Coll Wisconsin, Dept Biophys, Milwaukee, WI 53226 USA; [Cheng, Gang; Zielonka, Jacek; Joseph, Joy; Kalyanaraman, Balaraman] Med Coll Wisconsin, Free Rad Res Ctr, Milwaukee, WI 53226 USA; [Herman, Eugene] US FDA, Div Drug Safety Res, Ctr Drug Evaluat & Res, Silver Spring, MD USA	US Food & Drug Administration (FDA); US Food & Drug Administration (FDA); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Medical College of Wisconsin; Medical College of Wisconsin; US Food & Drug Administration (FDA)	Rao, VA (corresponding author), US FDA, Div Therapeut Prot, Ctr Drug Evaluat & Res, Bethesda, MD 20014 USA.	ashutosh.rao@fda.hhs.gov	Rao, V Ashutosh/A-3569-2013; Zielonka, Jacek/N-9546-2014; Parekh, Palak/B-7042-2015	Rao, V Ashutosh/0000-0001-6817-8049; Zielonka, Jacek/0000-0002-2524-0145; Parekh, Palak/0000-0001-9201-5194; Baxa, Ulrich/0000-0002-7263-5078	Food and Drug Administration (FDA) Critical Path Initiative; National Cancer Institute-FDA Interagency Oncology Task Force Fellowship Program; National Cancer Institute [HHSN261200800001E, R01 CA152810]; NATIONAL CANCER INSTITUTE [ZIABC006140, R01CA152810] Funding Source: NIH RePORTER; Grants-in-Aid for Scientific Research [24700955] Funding Source: KAKEN	Food and Drug Administration (FDA) Critical Path Initiative(United States Department of Health & Human Services); National Cancer Institute-FDA Interagency Oncology Task Force Fellowship Program; National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	The authors would like to acknowledge support from the Food and Drug Administration (FDA) Critical Path Initiative and the National Cancer Institute-FDA Interagency Oncology Task Force Fellowship Program. The electron microscopy work was funded in part from the National Cancer Institute, Contract # HHSN261200800001E. The Mito-Tempol (4) synthesis was supported by a grant from the National Cancer Institute, R01 CA152810. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albini A, 2010, JNCI-J NATL CANCER I, V102, P14, DOI 10.1093/jnci/djp440; Aluise CD, 2011, FREE RADICAL BIO MED, V50, P1630, DOI 10.1016/j.freeradbiomed.2011.03.009; Arola OJ, 2000, CANCER RES, V60, P1789; BILLINGHAM ME, 1978, CANCER TREAT REP, V62, P865; Bonner WM, 2008, NAT REV CANCER, V8, P957, DOI 10.1038/nrc2523; Bryant HE, 2005, NATURE, V434, P913, DOI 10.1038/nature03443; Cardinale D, 2010, J CLIN ONCOL, V28, P3910, DOI 10.1200/JCO.2009.27.3615; Cunniff B, 2013, J CELL PHYSIOL, V228, P835, DOI 10.1002/jcp.24232; Doggrell SA, 1998, CARDIOVASC RES, V39, P89, DOI 10.1016/S0008-6363(98)00076-5; Doroshow JH, 2001, BLOOD, V97, P2839, DOI 10.1182/blood.V97.9.2839; Ferrans V J, 1997, Tsitologiia, V39, P928; Ferte C, 2010, AM J CLIN ONCOL-CANC, V35, P183; FOLKOW B, 1993, J CARDIOVASC PHARM, V22, pS1, DOI 10.1097/00005344-199306221-00002; Gurusamy N, 2009, ANTIOXID REDOX SIGN, V11, P1975, DOI [10.1089/ars.2009.2524, 10.1089/ARS.2009.2524]; HAHN SM, 1992, CANCER RES, V52, P1750; HAHN SM, 1994, CANCER RES, V54, pS2006; HAMADA J, 1988, CANCER RES, V48, P5129; HAMADA J, 1995, CANCER LETT, V89, P161, DOI 10.1016/0304-3835(95)03686-Q; HAMADA J, 1987, JPN J CANCER RES, V78, P1175; Hasinoff BB, 1999, ANTI-CANCER DRUG, V10, P47, DOI 10.1097/00001813-199901000-00007; Herman EH, 1999, J CLIN ONCOL, V17, P2237, DOI 10.1200/JCO.1999.17.7.2237; Herman EH, 2001, CANCER CHEMOTH PHARM, V48, P297, DOI 10.1007/s002800100348; Herman EH, 1998, SEMIN ONCOL, V25, P15; HERMAN EH, 1988, TOXICOL APPL PHARM, V92, P42, DOI 10.1016/0041-008X(88)90226-8; Herman EH, 2000, CANCER CHEMOTH PHARM, V45, P329, DOI 10.1007/s002800050048; Kimmelman AC, 2011, GENE DEV, V25, P1999, DOI 10.1101/gad.17558811; KOYANAGI N, 1994, CANCER RES, V54, P1702; KRUIT WH, 1994, CANCER, V74, P2850, DOI 10.1002/1097-0142(19941115)74:10<2850::AID-CNCR2820741018>3.0.CO;2-T; KULLER LH, 1991, AM J EPIDEMIOL, V134, P1266, DOI 10.1093/oxfordjournals.aje.a116030; Levine RL, 2001, EXP GERONTOL, V36, P1495, DOI 10.1016/S0531-5565(01)00135-8; Levine RL, 2000, METH MOL B, V99, P15; LINDPAINTNER K, 1992, HYPERTENSION, V19, P428, DOI 10.1161/01.HYP.19.5.428; Lipshultz SE, 2010, LANCET ONCOL, V11, P950, DOI 10.1016/S1470-2045(10)70204-7; Lu LH, 2009, INT J CARDIOL, V134, P82, DOI 10.1016/j.ijcard.2008.01.043; McDonnell AM, 2011, SEMIN IMMUNOPATHOL, V33, P353, DOI 10.1007/s00281-011-0246-z; Mellor HR, 2011, TOXICOL SCI, V120, P14, DOI 10.1093/toxsci/kfq378; Mitchell JB, 2012, CANCER RES, V72, P4846, DOI 10.1158/0008-5472.CAN-12-1879; MITCHELL JB, 1991, ARCH BIOCHEM BIOPHYS, V289, P62, DOI 10.1016/0003-9861(91)90442-L; Moghrabi A, 2007, BLOOD, V109, P896, DOI 10.1182/blood-2006-06-027714; Monti E, 1996, FREE RADICAL BIO MED, V21, P463, DOI 10.1016/0891-5849(96)00124-4; Nagayasu H, 1998, BRIT J CANCER, V77, P1371, DOI 10.1038/bjc.1998.229; Nishio Naomi, 2003, Environ Health Prev Med, V8, P1, DOI 10.1007/BF02897936; OLSON RD, 1981, LIFE SCI, V29, P1393, DOI 10.1016/0024-3205(81)90001-1; Rao VA, 2011, CANCER CHEMOTH PHARM, V68, P1125, DOI 10.1007/s00280-011-1587-y; Rao VA, 2010, J BIOL CHEM, V285, P34447, DOI 10.1074/jbc.M110.133579; Redon CE, 2011, METHODS MOL BIOL, V682, P249, DOI 10.1007/978-1-60327-409-8_18; Redon CE, 2010, P NATL ACAD SCI USA, V107, P17992, DOI 10.1073/pnas.1008260107; Roche M, 2008, FEBS LETT, V582, P1783, DOI 10.1016/j.febslet.2008.04.057; Samuni Y, 2010, FREE RADICAL BIO MED, V49, P667, DOI 10.1016/j.freeradbiomed.2010.05.028; SHACTER E, 1994, FREE RADICAL BIO MED, V17, P429, DOI 10.1016/0891-5849(94)90169-4; Shacter E, 2002, ONCOLOGY-NY, V16, P217; Simunek T, 2009, PHARMACOL REP, V61, P154; Sishi BJN, 2013, BIOCHEM PHARMACOL, V85, P124, DOI 10.1016/j.bcp.2012.10.005; Stevenson RT, 1998, KIDNEY INT, V53, P67, DOI 10.1046/j.1523-1755.1998.00734.x; Tanaka T, 2006, CELL CYCLE, V5, P1940, DOI 10.4161/cc.5.17.3191; Trnka J, 2009, FREE RADICAL RES, V43, P4, DOI 10.1080/10715760802582183; YUHKI N, 1986, JPN J CANCER RES, V77, P9	57	52	53	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2013	8	8							e70575	10.1371/journal.pone.0070575	http://dx.doi.org/10.1371/journal.pone.0070575			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	218XC	23940596	Green Submitted, gold, Green Published			2022-12-25	WOS:000324465000090
J	Jacob, DE; Grohe, B; Gessner, M; Beck, BB; Hoppe, B				Jacob, Dorrit E.; Grohe, Bernd; Gessner, Michaela; Beck, Bodo B.; Hoppe, Bernd			Kidney Stones in Primary Hyperoxaluria: New Lessons Learnt	PLOS ONE			English	Article							CALCIUM-OXALATE CRYSTALS; DIHYDRATE CRYSTALS; TYPE-1; CRYSTALLIZATION; DIAGNOSIS; CITRATE; URINE; UROLITHIASIS; PYRIDOXINE; INHIBITORS	To investigate potential differences in stone composition with regard to the type of Primary Hyperoxaluria (PH), and in relation to the patient's medical therapy (treatment naive patients versus those on preventive medication) we examined twelve kidney stones from ten PH I and six stones from four PH III patients. Unfortunately, no PH II stones were available for analysis. The study on this set of stones indicates a more diverse composition of PH stones than previously reported and a potential dynamic response of morphology and composition of calculi to treatment with crystallization inhibitors (citrate, magnesium) in PH I. Stones formed by PH I patients under treatment are more compact and consist predominantly of calcium-oxalate monohydrate (COM, whewellite), while calcium-oxalate dihydrate (COD, weddellite) is only rarely present. In contrast, the single stone available from a treatment naive PH I patient as well as stones from PH III patients prior to and under treatment with alkali citrate contained a wide size range of aggregated COD crystals. No significant effects of the treatment were noted in PH III stones. In disagreement with findings from previous studies, stones from patients with primary hyperoxaluria did not exclusively consist of COM. Progressive replacement of COD by small COM crystals could be caused by prolonged stone growth and residence times in the urinary tract, eventually resulting in complete replacement of calcium-oxalate dihydrate by the monohydrate form. The noted difference to the naive PH I stone may reflect a reduced growth rate in response to treatment. This pilot study highlights the importance of detailed stone diagnostics and could be of therapeutic relevance in calcium-oxalates urolithiasis, provided that the effects of treatment can be reproduced in subsequent larger studies.	[Jacob, Dorrit E.] Johannes Gutenberg Univ Mainz, Dept Geosci, D-55122 Mainz, Germany; [Grohe, Bernd] Univ Western Ontario, Sch Dent, Schulich Sch Med & Dent, London, ON, Canada; [Gessner, Michaela] Univ Hosp Cologne, Dept Pediat & Adolescent Med, Div Pediat Nephrol, Cologne, Germany; [Beck, Bodo B.] Univ Cologne, Inst Human Genet, D-50931 Cologne, Germany; [Hoppe, Bernd] Univ Hosp Bonn, Div Pediat Nephrol, Bonn, Germany; [Hoppe, Bernd] Univ Hosp Bonn, German Hyperoxaluria Ctr, Dept Pediat, Bonn, Germany	Johannes Gutenberg University of Mainz; Western University (University of Western Ontario); University of Cologne; University of Cologne; University of Bonn; University of Bonn	Jacob, DE (corresponding author), Macquarie Univ, Dept Earth & Planetary Sci, Macquarie Pk, N Ryde, NSW 2109, Australia.	dorrit.jacob@mq.edu.au	Jacob, Dorrit E/F-8617-2010	Jacob, Dorrit E/0000-0003-4744-6627	Canadian Institutes of Health Research; Faculty of Medicine, University of Cologne [25/2008]; German Society of Pediatric Nephrology (GPN); Earth Science Research Centre, Johannes Gutenberg University of Mainz	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Faculty of Medicine, University of Cologne; German Society of Pediatric Nephrology (GPN); Earth Science Research Centre, Johannes Gutenberg University of Mainz	The SEM analyses were supported by the Canadian Institutes of Health Research. BB acknowledges funding from a Koeln Fortune Program grant (25/2008)/Faculty of Medicine, University of Cologne and a research grant from the German Society of Pediatric Nephrology (GPN). This study was supported by the Earth Science Research Centre, Johannes Gutenberg University of Mainz. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beck BB, 2013, EUR J HUM GENET, V21, P162, DOI 10.1038/ejhg.2012.139; Belostotsky R, 2010, AM J HUM GENET, V87, P392, DOI 10.1016/j.ajhg.2010.07.023; Brecevic LJ, 1986, J CRYST GROWTH, V74, P309; Chan BPH, 2012, COLLOID SURFACE B, V96, P22, DOI 10.1016/j.colsurfb.2012.03.015; Cochat P, 2006, PEDIATR NEPHROL, V21, P1075, DOI 10.1007/s00467-006-0124-4; Cochat P, 2012, NEPHROL DIAL TRANSPL, V27, P1729, DOI 10.1093/ndt/gfs078; Coe FL, 2010, UROL RES, V38, P147, DOI 10.1007/s00240-010-0271-8; DAUDON M, 1983, KIDNEY INT, V23, P842, DOI 10.1038/ki.1983.104; Daudon M, 1998, J NEPHROL, V11, P51; Daudon M, 2008, NEW ENGL J MED, V359, P100, DOI 10.1056/NEJMc0800990; DYER R, 1967, NATURE, V215, P751, DOI 10.1038/215751a0; ELLIOT JS, 1980, J UROLOGY, V123, P324, DOI 10.1016/S0022-5347(17)55918-2; Fargue S, 2013, ACTA BIOENERG, DOI [10.1016/j.bbadis.2013.04.010, DOI 10.1016/J.BBADIS.2013.04.010]; FLEISCH H, 1978, KIDNEY INT, V13, P361, DOI 10.1038/ki.1978.54; Gargah T, 2012, SAUDI J KIDNEY DIS T, V23, P385; Grohe B, 2006, J CRYST GROWTH, V295, P148, DOI 10.1016/j.jcrysgro.2006.07.029; Grohe B, 2011, CELLS TISSUES ORGANS, V194, P176, DOI 10.1159/000324338; Grohe B, 2011, UROL RES, V39, P327, DOI 10.1007/s00240-010-0360-8; HALLSON PC, 1982, CLIN SCI, V62, P17, DOI 10.1042/cs0620017; Harambat J, 2010, KIDNEY INT, V77, P443, DOI 10.1038/ki.2009.435; Hoppe B, 2005, AM J NEPHROL, V25, P276, DOI 10.1159/000086358; Hoppe B, 2003, PEDIATR NEPHROL, V18, P986, DOI 10.1007/s00467-003-1234-x; Hoppe B, 2012, NEPHROL DIAL TRANSPL, V27, P3024, DOI 10.1093/ndt/gfs308; Hoppe B, 2012, NAT REV NEPHROL, V8, P467, DOI 10.1038/nrneph.2012.113; Hoppe B, 2009, KIDNEY INT, V75, P1264, DOI 10.1038/ki.2009.32; Kamoun A, 1997, NEPHROLOGIE, V18, P59; KOK DJ, 1986, LANCET, V1, P1056; Kopp N, 1995, NEPHROL DIAL TRANSPL, V10, P2224, DOI 10.1093/ndt/10.12.2224; LEPAGE L, 1982, J PHARM SCI, V71, P1059, DOI 10.1002/jps.2600710927; Leumann E, 2001, J AM SOC NEPHROL, V12, P1986, DOI 10.1681/ASN.V1291986; Lieske JC, 2005, AM J NEPHROL, V25, P290, DOI 10.1159/000086360; MILLINER DS, 1994, NEW ENGL J MED, V331, P1553, DOI 10.1056/NEJM199412083312304; Monico CG, 2011, CLIN J AM SOC NEPHRO, V6, P2289, DOI 10.2215/CJN.02760311; Monico CG, 2005, KIDNEY INT, V67, P1704, DOI 10.1111/j.1523-1755.2005.00267.x; Pedraza CE, 2008, J CELL BIOCHEM, V103, P1379, DOI 10.1002/jcb.21515; Putnis A, 2002, MINERAL MAG, V66, P689, DOI 10.1180/0026461026650056; Ryall RL, 2005, BJU INT, V96, P654, DOI 10.1111/j.1464-410X.2005.05701.x; RYALL RL, 1981, CLIN CHIM ACTA, V112, P349, DOI 10.1016/0009-8981(81)90458-7; Takayama T, 2005, AM J NEPHROL, V25, P297, DOI 10.1159/000086361; TISELIUS HG, 1993, SCANNING MICROSCOPY, V7, P381; TOMAZIC BB, 1992, WORLD J UROL, V10, P216; TOMAZIC BB, 1980, INVEST UROL, V18, P97; van der Hoeven SM, 2012, NEPHROL DIAL TRANSPL, V27, P3855, DOI 10.1093/ndt/gfs320; van Woerden C, 2010, PEDIATR NEPHROL, V25, P1921; van Woerden CS, 2003, NEPHROL DIAL TRANSPL, V18, P273, DOI 10.1093/ndt/18.2.273	45	26	29	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2013	8	8							e70617	10.1371/journal.pone.0070617	http://dx.doi.org/10.1371/journal.pone.0070617			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	218XC	23940605	gold, Green Published, Green Submitted			2022-12-25	WOS:000324465000099
J	Liu, YC; Peng, Y; Lwin, NC; Venkatraman, SS; Wong, TT; Mehta, JS				Liu, Yu-Chi; Peng, Yan; Lwin, Nyein Chan; Venkatraman, Subbu S.; Wong, Tina T.; Mehta, Jodhbir S.			A Biodegradable, Sustained-Released, Prednisolone Acetate Microfilm Drug Delivery System Effectively Prolongs Corneal Allograft Survival in the Rat Keratoplasty Model	PLOS ONE			English	Article							PENETRATING KERATOPLASTY; ENDOTHELIAL KERATOPLASTY; COST-EFFECTIVENESS; REJECTION; TRANSPLANTATION; CORTICOSTEROIDS; CYCLOSPORINE; POLY(L-LACTIDE-CO-EPSILON-CAPROLACTONE); OPHTHALMOLOGY; MICROSPHERES	Frequent and long-term use of topical corticosteroids after corneal transplantation is necessary to prevent graft rejection. However, it relies heavily on patient compliance, and sustained therapeutic drug levels are often not achieved with administration of topical eye drops. A biodegradable drug delivery system with a controlled and sustained drug release may circumvent these limitations. In this study, we investigated the efficacy of a prednisolone acetate (PA)-loaded poly (d,llactide-co-epsilon-caprolactone) (PLC) microfilm drug delivery system on promoting the survival of allogeneic grafts after penetrating keratoplasty (PK) using a rat model. The drug release profiles of the microfilms were characterized (group 1). Subsequently, forty-eight PK were performed in four experimental groups: syngeneic control grafts (group 2), allogeneic control grafts (group 3), allogeneic grafts with subconjunctivally-implanted PA microfilm (group 4), and allogeneic grafts with PA eye drops (group 5; n = 12 in each). PA-loaded microfilm achieved a sustained and steady release at a rate of 0.006-0.009 mg/day, with a consistent aqueous drug concentration of 207-209 ng/ml. The mean survival days was >28 days in group 2, 9.9 +/- 0.8 days in group 3, 26.8 +/- 2.7 days in group 4, and 26.4 +/- 3.4 days in group 5 (P = 0.023 and P = 0.027 compared with group 3). Statistically significant decrease in CD4+, CD163+, CD 25+, and CD54+ cell infiltration was observed in group 4 and group 5 compared with group 3 (P<0.001). There was no significant difference in the mean survival and immunohistochemical analysis between group 4 and group 5. These results showed that sustained PA-loaded microfilm effectively prolongs corneal allograft survival. It is as effective as conventional PA eye drops, providing a promising clinically applicable alternative for patients undergoing corneal transplantation.	[Liu, Yu-Chi; Lwin, Nyein Chan; Mehta, Jodhbir S.] Singapore Eye Res Inst, Tissue Engn & Stem Cell Grp, Singapore, Singapore; [Liu, Yu-Chi; Wong, Tina T.; Mehta, Jodhbir S.] Singapore Natl Eye Ctr, Singapore, Singapore; [Peng, Yan; Venkatraman, Subbu S.; Wong, Tina T.] Nanyang Technol Univ, Sch Mat Sci & Engn, Singapore 639798, Singapore; [Wong, Tina T.] Singapore Eye Res Inst, Ocular Therapeut & Drug Delivery Res Grp, Singapore, Singapore; [Mehta, Jodhbir S.] Duke NUS Grad Med Sch, Dept Clin Sci, Singapore, Singapore	National University of Singapore; Singapore National Eye Center; Singapore National Eye Center; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; National University of Singapore; Singapore National Eye Center; National University of Singapore	Wong, TT (corresponding author), Singapore Natl Eye Ctr, Singapore, Singapore.	tina.wong.t.l@snec.com.sg; jodmehta@gmail.com	Mehta, Jodhbir/O-6192-2015; Liu, Yu Chi/AAM-7010-2020; Venkatraman, Subramanian/A-2228-2011	Liu, Yu Chi/0000-0001-5408-0382; Venkatraman, Subramanian/0000-0002-8693-1070	Singapore National Research Foundation [NMRC/TCR/002-SERI/2008]	Singapore National Research Foundation(National Research Foundation, Singapore)	This research was supported by the Singapore National Research Foundation under its Translational and Clinical Research (TCR) Programme (NMRC/TCR/002-SERI/2008) and administrated by the Singapore Ministry of Health's National Medical Research Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ang M, 2011, CURR EYE RES, V36, P1123, DOI 10.3109/02713683.2011.627489; Awan MA, 2009, BRIT J OPHTHALMOL, V93, P708, DOI 10.1136/bjo.2008.154906; Barcia E, 2009, EXP EYE RES, V89, P238, DOI 10.1016/j.exer.2009.03.012; Bersudsky V, 2001, OPHTHALMOLOGY, V108, P461, DOI 10.1016/S0161-6420(00)00544-3; Bertelmann E, 2002, OPHTHALMOLOGICA, V216, P2, DOI 10.1159/000048289; Bose S, 2013, OPHTHALMOLOGY, V120, P464, DOI 10.1016/j.ophtha.2012.08.024; BUXTON JN, 1969, AM J OPHTHALMOL, V67, P46, DOI 10.1016/0002-9394(69)90006-3; Carrasquillo KG, 2003, INVEST OPHTH VIS SCI, V44, P290, DOI 10.1167/iovs.01-1156; Cho HH, 2008, BIOMATERIALS, V29, P884, DOI 10.1016/j.biomaterials.2007.10.052; Cho YK, 2012, INVEST OPHTH VIS SCI, V53, P2328, DOI 10.1167/iovs.11-8393; Cohn D, 2005, BIOMATERIALS, V26, P2297, DOI 10.1016/j.biomaterials.2004.07.052; Coster DJ, 2010, ESSENT OPHTHALMOL, P13, DOI 10.1007/978-3-540-85544-6_2; Gaudana R, 2009, PHARM RES-DORDR, V26, P1197, DOI 10.1007/s11095-008-9694-0; Haller JA, 2009, RETINA-J RET VIT DIS, V29, P46, DOI 10.1097/IAE.0b013e318188c814; HILL JC, 1994, OPHTHALMOLOGY, V101, P128; Honda M, 2003, BIOMATERIALS, V24, P3511, DOI 10.1016/S0142-9612(03)00210-2; Kagaya F, 2002, CORNEA, V21, P200, DOI 10.1097/00003226-200203000-00015; KATAMI M, 1995, EYE, V9, P197, DOI 10.1038/eye.1995.40; Koay PYP, 2005, CORNEA, V24, P292, DOI 10.1097/01.ico.0000138841.44926.f8; Lao LL, 2008, EUR J PHARM BIOPHARM, V70, P796, DOI 10.1016/j.ejpb.2008.05.024; Lawrence Matthew S., 2004, International Ophthalmology Clinics, V44, P53, DOI 10.1097/00004397-200404430-00008; Lee SS, 2010, PHARM RES-DORDR, V27, P2043, DOI 10.1007/s11095-010-0159-x; Liu YC, 2013, INVEST OPHTH VIS SCI, V54, P2607, DOI 10.1167/iovs.12-11466; Liu YC, 2013, CURR OPIN OPHTHALMOL, V24, P53, DOI 10.1097/ICU.0b013e32835a93fc; Loo SCJ, 2008, INT J PHARMACEUT, V360, P228, DOI 10.1016/j.ijpharm.2008.04.017; Lu XL, 2008, J APPL POLYM SCI, V108, P1109, DOI 10.1002/app.27703; Mayer K, 2004, BRIT J OPHTHALMOL, V88, P915, DOI 10.1136/bjo.2003.034017; MCGHEE CNJ, 1990, EYE, V4, P526, DOI 10.1038/eye.1990.70; Mohamed-Noriega K, 2011, TRANSPLANTATION, V92, pE31, DOI 10.1097/TP.0b013e31822d882d; Munger RJ, 2002, VET OPHTHALMOL, V5, P167, DOI 10.1046/j.1463-5224.2002.00243.x; Natarajan JV, 2012, INT J NANOMED, V7, DOI 10.2147/IJN.S25468; Nguyen P, 2010, J CLIN EXP OPHTHALMO, V1; Nicholson BP, 2012, AM J OPHTHALMOL, V154, P969, DOI 10.1016/j.ajo.2012.06.004; Olthoff CMG, 2005, OPHTHALMOLOGY, V112, P953, DOI 10.1016/j.ophtha.2004.12.035; Pan ZQ, 2003, INVEST OPHTH VIS SCI, V44, P3346, DOI 10.1167/iovs.02-0845; Panda A, 2007, SURV OPHTHALMOL, V52, P375, DOI 10.1016/j.survophthal.2007.04.008; Peng Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022507; Prabhu SS, 2013, AM J OPHTHALMOL, V155, P45, DOI 10.1016/j.ajo.2012.06.014; Rodriguez FJ, 1999, BIOMATERIALS, V20, P1489, DOI 10.1016/S0142-9612(99)00055-1; Sangwan VS, 2005, CLIN EXP OPHTHALMOL, V33, P623, DOI 10.1111/j.1442-9071.2005.01107.x; Santos LN, 2011, CORNEA, V30, P167, DOI 10.1097/ICO.0b013e3181e843e5; Shi WY, 2006, INVEST OPHTH VIS SCI, V47, P3339, DOI 10.1167/iovs.05-1425; Shi WY, 2005, CURR EYE RES, V30, P969, DOI 10.1080/02713680500320752; Shimazaki J, 2012, OPHTHALMOLOGY, V119, P668, DOI 10.1016/j.ophtha.2011.10.016; Silva MVD, 1999, GRAEF ARCH CLIN EXP, V237, P840, DOI 10.1007/s004170050321; Steele TWJ, 2011, ACTA BIOMATER, V7, P1973, DOI 10.1016/j.actbio.2011.02.002; Tan DTH, 2008, OPHTHALMOLOGY, V115, P975, DOI 10.1016/j.ophtha.2007.08.049; Tan DTH, 2012, LANCET, V379, P1749, DOI 10.1016/S0140-6736(12)60437-1; Tan DTH, 2001, OPHTHALMOLOGY, V108, P2172, DOI 10.1016/S0161-6420(01)00839-9; Xie LX, 2001, CORNEA, V20, P748, DOI 10.1097/00003226-200110000-00015; Yamagami S, 1996, GRAEF ARCH CLIN EXP, V234, P382, DOI 10.1007/BF00190715; Zhang EP, 1996, GRAEF ARCH CLIN EXP, V234, P714, DOI 10.1007/BF00292359; Zhang WS, 2004, J CONTROL RELEASE, V99, P241, DOI 10.1016/j.jconrel.2004.07.001; Zhu YB, 2006, BIOMATERIALS, V27, P68, DOI 10.1016/j.biomaterials.2005.05.069	54	16	17	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2013	8	8							e70419	10.1371/journal.pone.0070419	http://dx.doi.org/10.1371/journal.pone.0070419			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	218XC	23940573	Green Published, gold			2022-12-25	WOS:000324465000067
J	Moustakas, A; Evans, MR				Moustakas, Aristides; Evans, Matthew R.			Integrating Evolution into Ecological Modelling: Accommodating Phenotypic Changes in Agent Based Models	PLOS ONE			English	Article							PREDICTIVE ECOLOGY; FORMAL DARWINISM; RAPID EVOLUTION; CLIMATE-CHANGE; DYNAMICS; BIRDS; DISPERSAL; RESPONSES; SELECTION; FITNESS	Evolutionary change is a characteristic of living organisms and forms one of the ways in which species adapt to changed conditions. However, most ecological models do not incorporate this ubiquitous phenomenon. We have developed a model that takes a 'phenotypic gambit' approach and focuses on changes in the frequency of phenotypes (which differ in timing of breeding and fecundity) within a population, using, as an example, seasonal breeding. Fitness per phenotype calculated as the individual's contribution to population growth on an annual basis coincide with the population dynamics per phenotype. Simplified model variants were explored to examine whether the complexity included in the model is justified. Outputs from the spatially implicit model underestimated the number of individuals across all phenotypes. When no phenotype transitions are included (i.e. offspring always inherit their parent's phenotype) numbers of all individuals are always underestimated. We conclude that by using a phenotypic gambit approach evolutionary dynamics can be incorporated into individual based models, and that all that is required is an understanding of the probability of offspring inheriting the parental phenotype.	[Moustakas, Aristides; Evans, Matthew R.] Univ London, Sch Biol & Chem Sci, London, England	University of London	Moustakas, A (corresponding author), Univ London, Sch Biol & Chem Sci, London, England.	arismoustakas@gmail.com	Moustakas, Aristides/ABE-2662-2020	Evans, Matthew/0000-0002-5630-7621; Moustakas, Aristides (Aris)/0000-0002-6334-747X				Abrams PA, 2001, ECOL LETT, V4, P166, DOI 10.1046/j.1461-0248.2001.00199.x; Begon M., 2009, ECOLOGY INDIVIDUALS, V4th; Benton TG, 2012, PHILOS T R SOC B, V367, P200, DOI 10.1098/rstb.2011.0168; Both C, 2009, J ANIM ECOL, V78, P73, DOI 10.1111/j.1365-2656.2008.01458.x; Bridle JR, 2010, ECOL LETT, V13, P485, DOI 10.1111/j.1461-0248.2010.01442.x; Brommer JE, 2000, BIOL REV, V75, P377, DOI 10.1017/S000632310000551X; Clark JS, 2001, SCIENCE, V293, P657, DOI 10.1126/science.293.5530.657; Coulson T, 2006, EVOL ECOL RES, V8, P1155; Coulson T, 2006, P ROY SOC B-BIOL SCI, V273, P547, DOI 10.1098/rspb.2005.3357; CRICK HQP, 1993, J ANIM ECOL, V62, P263, DOI 10.2307/5357; Crick HQP, 1997, NATURE, V388, P526, DOI 10.1038/41453; Day T, 2007, ECOL LETT, V10, P876, DOI 10.1111/j.1461-0248.2007.01091.x; Descamps S, 2011, FUNCT ECOL, V25, P671, DOI 10.1111/j.1365-2435.2010.01824.x; Eisinger D, 2008, J APPL ECOL, V45, P415, DOI 10.1111/j.1365-2664.2007.01439.x; Ellner SP, 2011, ECOL LETT, V14, P603, DOI 10.1111/j.1461-0248.2011.01616.x; Evans MR, 2012, PHILOS T R SOC B, V367, P163, DOI 10.1098/rstb.2011.0191; Evans MR, 2000, ANIM BEHAV, V60, P101, DOI 10.1006/anbe.2000.1434; Ezard THG, 2009, PHILOS T R SOC B, V364, P1491, DOI 10.1098/rstb.2009.0006; Ghiselin M.T., 1974, EC NATURE EVOLUTION; GIVNISH TJ, 1994, NATURE, V371, P113, DOI 10.1038/371113b0; Grafen A, 2007, J EVOLUTION BIOL, V20, P1243, DOI 10.1111/j.1420-9101.2007.01321.x; Grafen A, 1999, P ROY SOC B-BIOL SCI, V266, P799, DOI 10.1098/rspb.1999.0708; Grafen A., 1984, BEHAV ECOLOGY EVOLUT, V2, P62; Grimm V, 2006, ECOL MODEL, V198, P115, DOI 10.1016/j.ecolmodel.2006.04.023; Hairston NG, 2005, ECOL LETT, V8, P1114, DOI 10.1111/j.1461-0248.2005.00812.x; Hoffmann AA, 2011, NATURE, V470, P479, DOI 10.1038/nature09670; LANDE R, 1976, EVOLUTION, V30, P314, DOI 10.1111/j.1558-5646.1976.tb00911.x; LAWLOR LR, 1976, AM NAT, V110, P79, DOI 10.1086/283049; Lyon BE, 2008, SCIENCE, V321, P1051, DOI 10.1126/science.1159822; Matsinos YG, 2012, ETHOL ECOL EVOL, V24, P209, DOI 10.1080/03949370.2011.601762; Matthews B, 2011, ECOL LETT, V14, P690, DOI 10.1111/j.1461-0248.2011.01627.x; McCleery RH, 1998, NATURE, V391, P30, DOI 10.1038/34073; MEDAWAR PB, 1984, LIMITS SCI; Millennium Ecosystem Assessment, 2005, WELL EC HUM BEING SY; Moorcroft PR, 2001, ECOL MONOGR, V71, P557, DOI 10.1890/0012-9615(2001)071[0557:AMFSVD]2.0.CO;2; Mustard MJ, 2003, EVOL ECOL RES, V5, P1067; Pacala SW, 1996, ECOL MONOGR, V66, P1, DOI 10.2307/2963479; Parmesan C, 2006, ANNU REV ECOL EVOL S, V37, P637, DOI 10.1146/annurev.ecolsys.37.091305.110100; PERRINS CM, 1970, IBIS, V112, P242, DOI 10.1111/j.1474-919X.1970.tb00096.x; R Development Core Team, 2008, R LANG ENV STAT COMP; Schiffers K, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0083; Stillman RA, 2010, BIOL REV, V85, P413, DOI 10.1111/j.1469-185X.2009.00106.x; Sutherland WJ, 2006, J APPL ECOL, V43, P599, DOI 10.1111/j.1365-2664.2006.01182.x; Sutherland WJ, 2012, PHILOS T R SOC B, V367, P322, DOI 10.1098/rstb.2011.0181; Travis JMJ, 1998, P ROY SOC B-BIOL SCI, V265, P17, DOI 10.1098/rspb.1998.0258; VANNOORDWIJK AJ, 1995, J ANIM ECOL, V64, P451, DOI 10.2307/5648; Verhulst S, 2008, PHILOS T R SOC B, V363, P399, DOI 10.1098/rstb.2007.2146; Visser ME, 2003, P ROY SOC B-BIOL SCI, V270, P367, DOI 10.1098/rspb.2002.2244; Walther GR, 2002, NATURE, V416, P389, DOI 10.1038/416389a; Watson R, 2011, UK NATL ECOSYSTEM AS; Zheng CZ, 2009, PHILOS T R SOC B, V364, P1519, DOI 10.1098/rstb.2009.0005	51	11	11	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2013	8	8							e71125	10.1371/journal.pone.0071125	http://dx.doi.org/10.1371/journal.pone.0071125			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	218XC	23940700	Green Published, Green Submitted, gold			2022-12-25	WOS:000324465000180
J	Wei, WH; Gyenesei, A; Semple, CAM; Haley, CS				Wei, Wenhua; Gyenesei, Attila; Semple, Colin A. M.; Haley, Chris S.			Properties of Local Interactions and Their Potential Value in Complementing Genome-Wide Association Studies	PLOS ONE			English	Article							GENE-GENE INTERACTIONS; EPISTASIS; TRAITS; HERITABILITY; ARCHITECTURE; VARIANTS	Local interactions between neighbouring SNPs are hypothesized to be able to capture variants missing from genome-wide association studies (GWAS) via haplotype effects but have not been thoroughly explored. We have used a new high-throughput analysis tool to probe this underexplored area through full pair-wise genome scans and conventional GWAS in diastolic and systolic blood pressure and six metabolic traits in the Northern Finland Birth Cohort 1966 (NFBC1966) and the Atherosclerosis Risk in Communities study cohort (ARIC). Genome-wide significant interactions were detected in ARIC for systolic blood pressure between PLEKHA7 (a known GWAS locus for blood pressure) and GPR180 (which plays a role in vascular remodelling), and also for triglycerides as local interactions within the 11q23.3 region (replicated significantly in NFBC1966), which notably harbours several loci (BUD13, ZNF259 and APOA5) contributing to triglyceride levels. Tests of the local interactions within the 11q23.3 region conditional on the top GWAS signal suggested the presence of two independent functional variants, each with supportive evidence for their roles in gene regulation. Local interactions captured 9 additional GWAS loci identified in this study (3 significantly replicated) and 73 from previous GWAS (24 in the eight traits and 49 in related traits). We conclude that the detection of local interactions requires adequate SNP coverage of the genome and that such interactions are only likely to be detectable between SNPs in low linkage disequilibrium. Analysing local interactions is a potentially valuable complement to GWAS and can provide new insights into the biology underlying variation in complex traits.	[Wei, Wenhua; Semple, Colin A. M.; Haley, Chris S.] Univ Edinburgh, MRC Inst Genet & Mol Med, MRC Human Genet Unit, Edinburgh, Midlothian, Scotland; [Gyenesei, Attila] Univ Turku, Turku Ctr Biotechnol, Finnish Microarray & Sequencing Ctr, Turku, Finland; [Gyenesei, Attila] Abo Akad Univ, Turku, Finland	University of Edinburgh; University of Turku; Abo Akademi University	Wei, WH (corresponding author), Univ Edinburgh, MRC Inst Genet & Mol Med, MRC Human Genet Unit, Edinburgh, Midlothian, Scotland.	wenhua.wei@igmm.ed.ac.uk	Haley, Chris S/F-3110-2013; Semple, Colin A M/A-5613-2009	Semple, Colin A M/0000-0003-1765-4118; Wei, Wenhua/0000-0001-5774-5941; Haley, Chris/0000-0002-9811-0210	UK Medical Research Council; Biotechnology and Biological Sciences Research Council [BB/H024484/2, BB/K004964/1]; National Heart, Lung, and Blood Institute (NHLBI) [phs000276.v1.p1, phs000090.v1.p1]; NHLBI [N01-HC-55015, N01-HC-55016, N01-HC-55018, N01-HC-55019, N01-HC-55020, N01-HC-55021, N01-HC-55022, R01HL087641, R01HL59367, R01HL086694]; National Human Genome Research Institute [U01HG004402]; National Institutes of Health [HHSN268200625226C, UL1RR025005]; NIH Roadmap for Medical Research; NHLBI; Broad Institute, UCLA, University of Oulu; National Institute for Health and Welfare in Finland; Biotechnology and Biological Sciences Research Council [BBS/E/D/20211554, BBS/E/D/20211553] Funding Source: researchfish; Medical Research Council [MC_PC_U127592696, MC_U127592696] Funding Source: researchfish; DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS [N01HC055015, N01HC055016, N01HC055019, N01HC055021, N01HC055020, N01HC055018, N01HC055022] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025005] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL087641, R01HL086694, R01HL059367] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U01HG004402] Funding Source: NIH RePORTER; BBSRC [BBS/E/D/20211553, BBS/E/D/20211554, BB/H024484/2] Funding Source: UKRI; MRC [MC_PC_U127592696, MC_U127592696] Funding Source: UKRI	UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); National Heart, Lung, and Blood Institute (NHLBI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH Roadmap for Medical Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Broad Institute, UCLA, University of Oulu; National Institute for Health and Welfare in Finland; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by the UK Medical Research Council Core Fund to the Human Genetic Unit and the Biotechnology and Biological Sciences Research Council (BB/H024484/2 to WHW, CAS and CSH, BB/K004964/1 to WHW). Funding for open access charge: the UK Medical Research Council Core Fund. Data access to the Northern Finland Birth Cohort 1966 (NFBC1966) study (phs000276.v1.p1) and the Atherosclerosis Risk in Communities (ARIC) study (phs000090.v1.p1) granted by the National Heart, Lung, and Blood Institute (NHLBI) Data Access Committee via Database of Genotypes and Phenotypes (http:// www.ncbi.nlm.nih.gov/gap). ARIC is carried out as a collaborative study supported by NHLBI contracts N01-HC-55015, N01-HC-55016, N01-HC-55018, N01-HC-55019, N01-HC-55020, N01-HC-55021, N01-HC-55022, R01HL087641, R01HL59367 and R01HL086694; National Human Genome Research Institute contract U01HG004402; and National Institutes of Health contract HHSN268200625226C. Infrastructure was partly supported by Grant Number UL1RR025005, a component of the National Institutes of Health and NIH Roadmap for Medical Research. The NFBC1966 Study is conducted and supported by NHLBI in collaboration with the Broad Institute, UCLA, University of Oulu, and the National Institute for Health and Welfare in Finland. This manuscript was not prepared in collaboration with investigators of the NFBC1966 Study and does not necessarily reflect the opinions or views of the NFBC1966 Study Investigators, Broad Institute, UCLA, University of Oulu, National Institute for Health and Welfare in Finland and the NHLBI. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aulchenko YS, 2007, GENETICS, V177, P577, DOI 10.1534/genetics.107.075614; Aulchenko YS, 2007, BIOINFORMATICS, V23, P1294, DOI 10.1093/bioinformatics/btm108; Becker J, 2012, EUR J HUM GENET, V20, P97, DOI 10.1038/ejhg.2011.156; Becker T, 2011, ANN HUM GENET, V75, P29, DOI 10.1111/j.1469-1809.2010.00610.x; Boyle AP, 2012, GENOME RES, V22, P1790, DOI 10.1101/gr.137323.112; Breen MS, 2012, NATURE, V490, P535, DOI 10.1038/nature11510; Chambers JC, 2011, NAT GENET, V43, P1131, DOI 10.1038/ng.970; Cordell HJ, 2009, NAT REV GENET, V10, P392, DOI 10.1038/nrg2579; Dehghan A, 2011, CIRCULATION, V123, P731, DOI 10.1161/CIRCULATIONAHA.110.948570; Dumitrescu L, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002138; Emily M, 2009, EUR J HUM GENET, V17, P1231, DOI 10.1038/ejhg.2009.15; Gauderman WJ, 2002, AM J EPIDEMIOL, V155, P478, DOI 10.1093/aje/155.5.478; Gerstein MB, 2012, NATURE, V489, P91, DOI 10.1038/nature11245; Gyenesei A, 2012, BIOINFORMATICS, V28, P1957, DOI 10.1093/bioinformatics/bts304; Gyenesei A, 2012, NUCLEIC ACIDS RES, V40, pW628, DOI 10.1093/nar/gks550; Haig D, 2011, EUR J HUM GENET, V19, P123, DOI 10.1038/ejhg.2010.161; Haroon N, 2010, J RHEUMATOL, V37, P1907, DOI 10.3899/jrheum.100019; Hemani G, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003295; Hindorff LA, 2009, P NATL ACAD SCI USA, V106, P9362, DOI 10.1073/pnas.0903103106; Huang W, 2012, P NATL ACAD SCI USA, V109, P15553, DOI 10.1073/pnas.1213423109; Iida A, 2003, J HUM GENET, V48, P170, DOI 10.1007/s10038-003-0002-x; Kamatani Y, 2010, NAT GENET, V42, P210, DOI 10.1038/ng.531; Kettunen J, 2012, NAT GENET, V44, P269, DOI 10.1038/ng.1073; Kraja AT, 2011, DIABETES, V60, P1329, DOI 10.2337/db10-1011; Lappalainen T, 2011, AM J HUM GENET, V89, P459, DOI 10.1016/j.ajhg.2011.08.004; Levy D, 2009, NAT GENET, V41, P677, DOI 10.1038/ng.384; Liu Y, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001338; Ma L, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002714; McCarthy MI, 2008, NAT REV GENET, V9, P356, DOI 10.1038/nrg2344; Middelberg RPS, 2011, BMC MED GENET, V12, DOI 10.1186/1471-2350-12-123; Pearson DL, 2001, NEW ENGL J MED, V344, P1832, DOI 10.1056/NEJM200106143442404; Pulimeno P, 2011, J BIOL CHEM, V286, P16743, DOI 10.1074/jbc.M111.230862; Sabatti C, 2009, NAT GENET, V41, P35, DOI 10.1038/ng.271; Schaub MA, 2012, GENOME RES, V22, P1748, DOI 10.1101/gr.136127.111; Schroeder EB, 2005, DIABETES CARE, V28, P668, DOI 10.2337/diacare.28.3.668; Schupbach T, 2010, BIOINFORMATICS, V26, P1468, DOI 10.1093/bioinformatics/btq147; Snitkin ES, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001294; Soranzo N, 2010, DIABETES, V59, P3229, DOI 10.2337/db10-0502; Summar ML, 2004, HYPERTENSION, V43, P186, DOI 10.1161/01.HYP.0000112424.06921.52; Tsui FWL, 2010, ANN RHEUM DIS, V69, P733, DOI 10.1136/ard.2008.103804; Turnbull C, 2012, HUM MOL GENET, V21, P958, DOI 10.1093/hmg/ddr525; Turner SD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019586; Ueki M, 2012, PLOS GENET, V8, P141, DOI 10.1371/journal.pgen.1002625; Wang CM, 2012, ARTHRITIS RES THER, V14, DOI 10.1186/ar3855; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603; Wei WH, 2012, EUR J HUM GENET, V20, P857, DOI 10.1038/ejhg.2012.17; Wei WH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023836; Yung LS, 2011, BIOINFORMATICS, V27, P1309, DOI 10.1093/bioinformatics/btr114; Zuk O, 2012, P NATL ACAD SCI USA, V109, P1193, DOI 10.1073/pnas.1119675109	49	8	8	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2013	8	8							e71203	10.1371/journal.pone.0071203	http://dx.doi.org/10.1371/journal.pone.0071203			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	218XC	23940718	Green Published, Green Submitted, gold			2022-12-25	WOS:000324465000192
J	Okemoto, K; Wagner, B; Meisen, H; Haseley, A; Kaur, B; Chiocca, EA				Okemoto, Kazuo; Wagner, Benjamin; Meisen, Hans; Haseley, Amy; Kaur, Balveen; Chiocca, Ennio Antonio			STAT3 Activation Promotes Oncolytic HSV1 Replication in Glioma Cells	PLOS ONE			English	Article							GLIOBLASTOMA-MULTIFORME; GENE-EXPRESSION; SMALL-MOLECULE; BRAIN-TUMORS; VIRUS; INHIBITION	Recent studies report that STAT3 signaling is a master regulator of mesenchymal transformation of gliomas and that STAT3 modulated genes are highly expressed in the mesenchymal transcriptome of gliomas. A currently studied experimental treatment for gliomas consists of intratumoral injection of oncolytic viruses (OV), such as oncolytic herpes simplex virus type 1 (oHSV). We have described one particular oHSV (rQNestin34.5) that exhibits potent anti-glioma activity in animal models. Here, we hypothesized that alterations in STAT3 signaling in glioma cells may affect the replicative ability of rQNestin34.5. In fact, human U251 glioma cells engineered to either over-express STAT3 or with genetic down-regulation of STAT3 supported oHSV replication to a significantly higher or lesser degree, respectively, when compared to controls. Administration of pharmacologic agents that increase STAT3 phosphorylation/activation (Valproic Acid) or increase STAT3 levels (Interleukin 6) also significantly enhanced oHSV replication. Instead, administration of inhibitors of STAT3 phosphorylation/activation (LLL12) significantly reduced oHSV replication. STAT3 led to a reduction in interferon signaling in oHSV infected cells and inhibition of interferon signaling abolished the effect of STAT3 on oHSV replication. These data thus indicate that STAT3 signaling in malignant gliomas enhances oHSV replication, likely by inhibiting the interferon response in infected glioma cells, thus suggesting avenues for possible potentiation of oncolytic virotherapy.	[Okemoto, Kazuo; Wagner, Benjamin; Meisen, Hans; Haseley, Amy; Kaur, Balveen; Chiocca, Ennio Antonio] Ohio State Univ, James Canc Hosp, Ctr Comprehens Canc,Dept Neurol Surg, Dardinger Ctr Neurooncol & Neurosci,Solove Res In, Columbus, OH 43210 USA; [Okemoto, Kazuo; Wagner, Benjamin; Meisen, Hans; Haseley, Amy; Kaur, Balveen; Chiocca, Ennio Antonio] Ohio State Univ, Wexner Med Ctr, Columbus, OH 43210 USA; [Chiocca, Ennio Antonio] Brigham & Womens Faulkner Hosp, Inst Neurosci Brigham, Dept Neurosurg, Harvey Cushing Neurooncol Labs, Boston, MA USA; [Chiocca, Ennio Antonio] Dana Farber Canc Inst, Ctr Neurooncol, Boston, MA 02115 USA	James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; Harvard University; Dana-Farber Cancer Institute	Chiocca, EA (corresponding author), Ohio State Univ, James Canc Hosp, Ctr Comprehens Canc,Dept Neurol Surg, Dardinger Ctr Neurooncol & Neurosci,Solove Res In, Columbus, OH 43210 USA.	Eachiocca@partners.org	kaur, Balveen/E-3355-2011		NIH [1P01CA163205-01A1]; NATIONAL CANCER INSTITUTE [R01CA150153, P01CA163205] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS064607] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by NIH grant 1P01CA163205-01A1 to EAC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwalla PK, 2012, METHODS MOL BIOL, V797, P1, DOI 10.1007/978-1-61779-340-0_1; Ahmed AU, 2012, METHODS MOL BIOL, V797, P97, DOI 10.1007/978-1-61779-340-0_8; Alvarez-Breckenridge CA, 2012, J VIROL, V86, P4566, DOI 10.1128/JVI.05545-11; Ball S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018820; Carro MS, 2010, NATURE, V463, P318, DOI 10.1038/nature08712; Cooper LAD, 2012, AM J PATHOL, V180, P2108, DOI 10.1016/j.ajpath.2012.01.040; Dempsey MF, 2006, NUCL MED COMMUN, V27, P611, DOI 10.1097/00006231-200608000-00003; Freeman AI, 2006, MOL THER, V13, P221, DOI 10.1016/j.ymthe.2005.08.016; Hernandez-Alcoceba R, 2011, CLIN TRANSL ONCOL, V13, P229, DOI 10.1007/s12094-011-0647-4; Hussain SF, 2007, CANCER RES, V67, P9630, DOI 10.1158/0008-5472.CAN-07-1243; Kambara H, 2005, CANCER RES, V65, P2832, DOI 10.1158/0008-5472.CAN-04-3227; Kohsaka S, 2012, MOL CANCER THER, V11, P1289, DOI 10.1158/1535-7163.MCT-11-0801; Lin L, 2010, NEOPLASIA, V12, P39, DOI 10.1593/neo.91196; Liu Y, 2010, ANTI-CANCER AGENT ME, V10, P512, DOI 10.2174/187152010793498636; Otsuki A, 2008, MOL THER, V16, P1546, DOI 10.1038/mt.2008.155; Pesonen S, 2011, MOL PHARMACEUT, V8, P12, DOI 10.1021/mp100219n; Wang WB, 2011, J IMMUNOL, V187, P2578, DOI 10.4049/jimmunol.1004128; Wei J, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0016195, 10.1371/journal.pone.0017868]; Wollmann G, 2012, CANCER J, V18, P69, DOI 10.1097/PPO.0b013e31824671c9	19	19	20	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 2	2013	8	8							e71932	10.1371/journal.pone.0071932	http://dx.doi.org/10.1371/journal.pone.0071932			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219XU	23936533	Green Submitted, gold, Green Published			2022-12-25	WOS:000324545800072
J	Madison, DL; Wirz, JA; Siess, D; Lundblad, JR				Madison, Dana L.; Wirz, Jacqueline A.; Siess, Don; Lundblad, James R.			Nicotinamide Adenine Dinucleotide-induced Multimerization of the Co-repressor CtBP1 Relies on a Switching Tryptophan	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TERMINAL-BINDING-PROTEIN; ADENOVIRUS E1A; TRANSCRIPTIONAL COREPRESSOR; GENE-EXPRESSION; CLEFT REGION; DEHYDROGENASE; COMPLEX; SITE; NADH; DIMERIZATION	The transcriptional co-repressor C-terminal binding protein (CtBP) interacts with a number of repressor proteins and chromatin modifying enzymes. How the biochemical properties including binding of dinucleotide, oligomerization, and dehydrogenase domains of CtBP1 direct the assembly of a functional co-repressor to influence gene expression is not well understood. In the current study we demonstrate that CtBP1 assembles into a tetramer in a NAD(H)-dependent manner, proceeding through a dimeric intermediate. We find that NAD-dependent oligomerization correlates with NAD(+) binding affinity and that the carboxyl terminus is required for assembly of a dimer of dimers. Mutant CtBP1 proteins that abrogate dinucleotide-binding retain wild type affinity for the PXDLS motif, but do not self-associate either in vitro or in vivo. CtBP1 proteins with mutations in the dehydrogenase domain still retain the ability to self-associate and bind target proteins. Both co-immunoprecipitation and mammalian two-hybrid experiments demonstrate that CtBP1 self-association occurs within the nucleus, and depends on dinucleotide binding. Repression of transcription does not depend on dinucleotide binding or an intact dehydrogenase domain, but rather depends on the amino-terminal domain that recruits PXDLS containing targets. We show that tryptophan 318 (Trp(318)) is a critical residue for tetramer assembly and likely functions as a switch for effective dimerization following NAD(+) binding. These results suggest that dinucleotide binding permits CtBP1 to form an intranuclear homodimer through a Trp(318) switch, creating a nucleation site for multimerization through the C-terminal domain for tetramerization to form an effective repression complex.	[Madison, Dana L.; Siess, Don; Lundblad, James R.] Oregon Hlth & Sci Univ, Div Endocrinol, Portland, OR 97201 USA; [Wirz, Jacqueline A.] Oregon Hlth & Sci Univ, Dept Biochem, Portland, OR 97201 USA; [Madison, Dana L.] Oregon Hlth & Sci Univ, Dept Otolaryngol, Portland, OR 97201 USA	Oregon Health & Science University; Oregon Health & Science University; Oregon Health & Science University	Madison, DL (corresponding author), Oregon Hlth & Sci Univ, Div Endocrinol, L-607,3181 SW Sam Jackson Pk Rd, Portland, OR 97201 USA.	madisond@ohsu.edu			National Institutes of Health from the NIDDK [K08CA109158, R01DK060133]; NATIONAL CANCER INSTITUTE [K08CA109158] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000128] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK060133] Funding Source: NIH RePORTER	National Institutes of Health from the NIDDK; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants K08CA109158 (to D. L. M.) and R01DK060133 from the NIDDK (to J. R. L.).	Balasubramanian P, 2003, FEBS LETT, V537, P157, DOI 10.1016/S0014-5793(03)00119-4; Bhambhani C, 2011, EMBO J, V30, P2031, DOI 10.1038/emboj.2011.100; BIRKTOFT JJ, 1983, J BIOL CHEM, V258, P472; Chinnadurai G, 2007, INT J BIOCHEM CELL B, V39, P1593, DOI 10.1016/j.biocel.2007.01.025; Chinnadurai G, 2002, MOL CELL, V9, P213, DOI 10.1016/S1097-2765(02)00443-4; Di LJ, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2438; Fjeld CC, 2003, P NATL ACAD SCI USA, V100, P9202, DOI 10.1073/pnas.1633591100; FRISCH SM, 1990, ONCOGENE, V5, P75; Grant GA, 2000, ARCH BIOCHEM BIOPHYS, V375, P171, DOI 10.1006/abbi.1999.1652; Grant GA, 2002, J BIOL CHEM, V277, P39548, DOI 10.1074/jbc.M208019200; Grooteclaes M, 2003, P NATL ACAD SCI USA, V100, P4568, DOI 10.1073/pnas.0830998100; Hildebrand JD, 2002, MOL CELL BIOL, V22, P5296, DOI 10.1128/MCB.22.15.5296-5307.2002; Kumar V, 2002, MOL CELL, V10, P857, DOI 10.1016/S1097-2765(02)00650-0; Kuppuswamy M, 2008, MOL CELL BIOL, V28, P269, DOI 10.1128/MCB.01077-07; Lin X, 2003, MOL CELL, V11, P1389, DOI 10.1016/S1097-2765(03)00175-8; LUNDBLAD JR, 2006, CTBP FAMILY PROTEINS, P83; Madison DL, 2010, ONCOGENE, V29, P6027, DOI 10.1038/onc.2010.338; Madison DL, 2002, J BIOL CHEM, V277, P38755, DOI 10.1074/jbc.M207512200; Mani-Telang P, 2007, FEBS LETT, V581, P5241, DOI 10.1016/j.febslet.2007.10.011; Molloy DP, 1998, J BIOL CHEM, V273, P20867, DOI 10.1074/jbc.273.33.20867; Nadauld LD, 2006, J BIOL CHEM, V281, P37828, DOI 10.1074/jbc.M602119200; Nardini M, 2003, EMBO J, V22, P3122, DOI 10.1093/emboj/cdg283; Nardini M, 2009, BIOCHEM BIOPH RES CO, V381, P70, DOI 10.1016/j.bbrc.2009.02.010; Nibu Y, 1998, SCIENCE, V280, P101, DOI 10.1126/science.280.5360.101; Phippen TM, 2000, J BIOL CHEM, V275, P37628, DOI 10.1074/jbc.M004234200; Postigo AA, 2003, EMBO J, V22, P2453, DOI 10.1093/emboj/cdg226; Quinlan KGR, 2006, MOL CELL BIOL, V26, P8202, DOI 10.1128/MCB.00445-06; SCHAEPER U, 1995, P NATL ACAD SCI USA, V92, P10467, DOI 10.1073/pnas.92.23.10467; Shi YJ, 2003, NATURE, V422, P735, DOI 10.1038/nature01550; Straza MW, 2010, CELL CYCLE, V9, P3740, DOI 10.4161/cc.9.18.12936; SUN PQ, 1994, GENE DEV, V8, P2527, DOI 10.1101/gad.8.21.2527; Thillainadesan G, 2008, MOL CELL BIOL, V28, P6066, DOI 10.1128/MCB.00246-08; Thio SSC, 2004, NUCLEIC ACIDS RES, V32, P1836, DOI 10.1093/nar/gkh344; Ueda J, 2006, J BIOL CHEM, V281, P20120, DOI 10.1074/jbc.M603087200; Yamada K, 2006, ANAL BIOCHEM, V352, P282, DOI 10.1016/j.ab.2006.02.017; Zhang QH, 2002, SCIENCE, V295, P1895; Zhang YW, 2011, MOL CELL BIOL, V31, P375, DOI 10.1128/MCB.00772-10; Zhao LJ, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-89	38	21	22	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 27	2013	288	39					27836	27848		10.1074/jbc.M113.493569	http://dx.doi.org/10.1074/jbc.M113.493569			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302OB	23940047	Green Published, hybrid			2022-12-25	WOS:000330612800012
J	Faisal, SM; Yan, FL; Chen, TT; Useh, NM; Guo, SG; Yan, WW; Wang, SJ; Glaser, AL; McDonough, SP; Singh, B; Chang, YF				Faisal, Syed M.; Yan, Falong; Chen, Tsai-Tzu; Useh, Nicodemus M.; Guo, Shanguang; Yan, Weiwei; Wang, Shih-Jon; Glaser, Amy L.; McDonough, Sean P.; Singh, Bhupinder; Chang, Yung-Fu			Evaluation of a Salmonella Vectored Vaccine Expressing Mycobacterium avium Subsp paratuberculosis Antigens Against Challenge in a Goat Model	PLOS ONE			English	Article							ENTERICA SEROVAR TYPHIMURIUM; LIVE RECOMBINANT SALMONELLA; BLOOD MONONUCLEAR-CELLS; PROTECTIVE EFFICACY; IMMUNE-RESPONSES; CROHNS-DISEASE; DAIRY HERDS; LONG-TERM; DELIVERY-SYSTEM; ANGORA-GOATS	Johnes disease (JD), caused by Mycobacterium avium subsp paratuberculosis (MAP), occurs worldwide as chronic granulomatous enteritis of domestic and wild ruminants. To develop a cost effective vaccine, in a previous study we constructed an attenuated Salmonella strain that expressed a fusion product made up of partial fragments of MAP antigens (Ag85A, Ag85B and SOD) that imparted protection against challenge in a mouse model. In the current study we evaluated the differential immune response and protective efficacy of the Sal-Ag vaccine against challenge in a goat model as compared to the live attenuated vaccine MAP316F. PBMCs from goats vaccinated with Sal-Ag and challenged with MAP generated significantly lower levels of IFN-gamma, following in vitro stimulation with either Antigen-mix or PPD jhonin, than PBMC from MAP316F vaccinated animals. Flow cytometric analysis showed the increase in IFN-gamma correlated with a significantly higher level of proliferation of CD4, CD8 and gamma delta T cells and an increased expression of CD25 and CD45R0 in MAP316F vaccinated animals as compared to control animals. Evaluation of a range of cytokines involved in Th1, Th2, Treg, and Th17 immune responses by quantitative PCR showed low levels of expression of Th1 (IFN-gamma, IL-2, IL-12) and proinflammatory cytokines (IL-6, IL-8, IL-18, TNF-alpha) in the Sal-Ag immunized group. Significant levels of Th2 and anti-inflammatory cytokines transcripts (IL-4, IL-10, IL-13, TGF-beta) were expressed but their level was low and with a pattern similar to the control group. Over all, Sal-Ag vaccine imparted partial protection that limited colonization in tissues of some animals upon challenge with wild type MAP but not to the level achieved with MAP316F. In conclusion, the data indicates that Sal-Ag vaccine induced only a low level of protective immunity that failed to limit the colonization of MAP in infected animals. Hence the Sal-Ag vaccine needs further refinement to increase its efficacy.	[Faisal, Syed M.; Yan, Falong; Chen, Tsai-Tzu; Useh, Nicodemus M.; Guo, Shanguang; Yan, Weiwei; Wang, Shih-Jon; Glaser, Amy L.; Chang, Yung-Fu] Cornell Univ, Coll Vet Med, Dept Populat Med & Diagnost Sci, Ithaca, NY 14853 USA; [McDonough, Sean P.] Cornell Univ, Coll Vet Med, Dept Biomed Sci, Ithaca, NY 14853 USA; [Singh, Bhupinder] Cornell Univ, Coll Vet Med, Ctr Anim Resources & Educ, Ithaca, NY 14853 USA; [Chen, Tsai-Tzu] Natl Chiayi Univ, Grad Inst Agr, Chiayi, Taiwan; [Wang, Shih-Jon] Chang Jung Christian Univ, Dept Biosci Technol, Tainan, Taiwan	Cornell University; Cornell University; Cornell University; National Chiayi University; Chang Jung Christian University	Chang, YF (corresponding author), Cornell Univ, Coll Vet Med, Dept Populat Med & Diagnost Sci, Ithaca, NY 14853 USA.	yc42@cornell.edu			Biotechnology Research and Development Corporation (BRDC); Agriculture and Food Research Initiative from the USDA National Institute of Food and Agriculture [2008-35204-04626, 2009-65119-05993, 2008-55620-18710, 4535-CU-USDA-8710, 3954-CU-USDA-8710]; Animal Formula Fund [NY-478455, NY-478437]	Biotechnology Research and Development Corporation (BRDC); Agriculture and Food Research Initiative from the USDA National Institute of Food and Agriculture; Animal Formula Fund	This work was supported by the Biotechnology Research and Development Corporation (BRDC), the Agriculture and Food Research Initiative competitive grant no. 2008-35204-04626, 2009-65119-05993 & 2008-55620-18710 (4535-CU-USDA-8710 & 3954-CU-USDA-8710) from the USDA National Institute of Food and Agriculture, and the Animal Formula Fund (NY-478455 and NY-478437). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bastida Felix, 2011, J Immune Based Ther Vaccines, V9, P8, DOI 10.1186/1476-8518-9-8; Begg DJ, 2005, VACCINE, V23, P4999, DOI 10.1016/j.vaccine.2005.05.031; Bumann D, 2001, INFECT IMMUN, V69, P4618, DOI 10.1128/IAI.69.7.4618-4626.2001; Caldwell RB, 2004, APPL ENVIRON MICROB, V70, P610, DOI 10.1128/AEM.70.1.610-612.2004; Chandra S, 2012, VACCINE, V31, P242, DOI 10.1016/j.vaccine.2012.09.024; Chen LH, 2008, VACCINE, V26, P1253, DOI 10.1016/j.vaccine.2007.12.014; CHIODINI RJ, 1992, MICROB PATHOGENESIS, V13, P447, DOI 10.1016/0882-4010(92)90012-D; Clarke CJ, 1997, J COMP PATHOL, V116, P217, DOI 10.1016/S0021-9975(97)80001-1; Coussens PM, 2004, INFECT IMMUN, V72, P1409, DOI 10.1128/IAI.72.3.1409-1422.2004; Davis WC, 2012, VET IMMUNOL IMMUNOP, V145, P1, DOI 10.1016/j.vetimm.2011.12.005; Emery DL, 2004, VET MICROBIOL, V104, P143, DOI 10.1016/j.vetmic.2004.08.014; Evans DT, 2003, J VIROL, V77, P2400, DOI 10.1128/JVI.77.4.2400-2409.2003; Faisal SM, 2013, CLIN VACCINE IMMUNOL, V20, P572, DOI 10.1128/CVI.00653-12; Fouts TR, 1995, VACCINE, V13, P1697, DOI 10.1016/0264-410X(95)00106-B; GRIFFIN JFT, 1994, NEW ZEAL VET J, V42, P173, DOI 10.1080/00480169.1994.35815; Gwozdz JM, 2000, AUST VET J, V78, P560, DOI 10.1111/j.1751-0813.2000.tb11902.x; Hess J, 2000, FEMS IMMUNOL MED MIC, V27, P283, DOI 10.1016/S0928-8244(99)00205-9; Johnson-Ifearulundu Y, 1999, J AM VET MED ASSOC, V214, P822; JUSTE RA, 1994, J COMP PATHOL, V110, P185, DOI 10.1016/S0021-9975(08)80189-2; Kathaperumal K, 2009, VACCINE, V27, P123, DOI 10.1016/j.vaccine.2008.10.019; Kathaperumal K, 2008, VACCINE, V26, P1652, DOI 10.1016/j.vaccine.2008.01.015; Kirkwood CD, 2009, INFLAMM BOWEL DIS, V15, P1643, DOI 10.1002/ibd.20967; Klawonn W, 2002, DEUT TIERARZTL WOCH, V109, P510; Konjufca V, 2008, INFECT IMMUN, V76, P5745, DOI 10.1128/IAI.00897-08; Laurence A, 2007, IMMUNITY, V26, P371, DOI 10.1016/j.immuni.2007.02.009; Muskens J, 2002, VET MICROBIOL, V86, P269, DOI 10.1016/S0378-1135(02)00006-8; Naser SA, 2004, LANCET, V364, P1039, DOI 10.1016/S0140-6736(04)17058-X; Parida SK, 2005, ANN NY ACAD SCI, V1056, P366, DOI 10.1196/annals.1352.030; Park KT, 2011, VACCINE, V29, P4709, DOI 10.1016/j.vaccine.2011.04.090; Park SU, 2008, VACCINE, V26, P4329, DOI 10.1016/j.vaccine.2008.06.016; Perez V, 1997, AM J VET RES, V58, P799; Reddacliff L, 2006, VET MICROBIOL, V115, P77, DOI 10.1016/j.vetmic.2005.12.021; Russmann H, 1998, SCIENCE, V281, P565, DOI 10.1126/science.281.5376.565; Scriba TJ, 2008, J IMMUNOL, V180, P1962, DOI 10.4049/jimmunol.180.3.1962; Shams H, 2001, VACCINE, V20, P577, DOI 10.1016/S0264-410X(01)00363-2; Shin SJ, 2004, J VET DIAGN INVEST, V16, P116; Stabel J. R., 2006, Animal Health Research Reviews, V7, P61, DOI 10.1017/S1466252307001168; Stabel JR, 2000, AM J VET RES, V61, P754, DOI 10.2460/ajvr.2000.61.754; Stewart DJ, 2007, VET MICROBIOL, V122, P83, DOI 10.1016/j.vetmic.2006.12.030; Stewart DJ, 2006, VET MICROBIOL, V113, P13, DOI 10.1016/j.vetmic.2005.09.015; VanCott JL, 1996, J IMMUNOL, V156, P1504; Wang QL, 2009, VACCINE, V27, P6712, DOI 10.1016/j.vaccine.2009.08.096; Windsor PA, 2005, AUST VET J, V83, P216, DOI 10.1111/j.1751-0813.2005.tb11654.x; Zekarias B, 2008, CLIN VACCINE IMMUNOL, V15, P805, DOI 10.1128/CVI.00457-07	44	15	16	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 9	2013	8	8							e70171	10.1371/journal.pone.0070171	http://dx.doi.org/10.1371/journal.pone.0070171			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	245OM	23950909	Green Submitted, Green Published, gold			2022-12-25	WOS:000326473200009
J	Hedrick, BP; Dodson, P				Hedrick, Brandon P.; Dodson, Peter			Lujiatun Psittacosaurids: Understanding Individual and Taphonomic Variation Using 3D Geometric Morphometrics	PLOS ONE			English	Article							DINOSAUR PSITTACOSAURUS; SEXUAL-DIMORPHISM; NEOCERATOPSIAN DINOSAUR; RELATIVE GROWTH; EARLY EVOLUTION; MORPHOLOGY; PROVINCE; FOSSILS; GENUS; SHAPE	Psittacosaurus is one of the most abundant and speciose genera in the Dinosauria, with fifteen named species. The genus is geographically and temporally widespread with large sample sizes of several of the nominal species allowing detailed analysis of intra- and interspecific variation. We present a reanalysis of three separate, coeval species within the Psittacosauridae; P. lujiatunensis, P. major, and Hongshanosaurus houi from the Lujiatun beds of the Yixian Formation, northeastern China, using three-dimensional geometric morphometrics on a sample set of thirty skulls in combination with a reevaluation of the proposed character states for each species. Using these complementary methods, we show that individual and taphonomic variation are the joint causes of a large range of variation among the skulls when they are plotted in a morphospace. Our results demonstrate that there is only one species of Psittacosaurus within the Lujiatun beds and that the three nominal species represent different taphomorphotypes of P. lujiatunensis. The wide range of geometric morphometric variation in a single species of Psittacosaurus implies that the range of variation found in other dinosaurian groups may also be related to taphonomic distortion rather than interspecific variation. As the morphospace is driven primarily by variation resulting from taphonomic distortion, this study demonstrates that the geometric morphometric approach can only be used with great caution to delineate interspecific variation in Psittacosaurus and likely other dinosaur groups without a complementary evaluation of character states. This study presents the first application of 3D geometric morphometrics to the dinosaurian morphospace and the first attempt to quantify taphonomic variation in dinosaur skulls.	[Hedrick, Brandon P.; Dodson, Peter] Univ Penn, Sch Arts & Sci, Dept Earth & Environm Sci, Philadelphia, PA 19104 USA; [Dodson, Peter] Univ Penn, Dept Anim Biol, Sch Vet Med, Philadelphia, PA 19104 USA	University of Pennsylvania; University of Pennsylvania	Hedrick, BP (corresponding author), Univ Penn, Sch Arts & Sci, Dept Earth & Environm Sci, Philadelphia, PA 19104 USA.	bhedrick@sas.upenn.edu			NSF [EAR 1024671]; University of Pennsylvania Research Foundation; EES Paleobiology Summer Research Stipend; Directorate For Geosciences [1024671] Funding Source: National Science Foundation	NSF(National Science Foundation (NSF)); University of Pennsylvania Research Foundation; EES Paleobiology Summer Research Stipend; Directorate For Geosciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	This project was funded by grant support from NSF EAR 1024671, University of Pennsylvania Research Foundation, and the EES Paleobiology Summer Research Stipend. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angielczyk KD, 2007, PALEOBIOLOGY, V33, P125, DOI 10.1666/06007.1; Arbour VM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039323; Averianov AO, 2006, J SYST PALAEONTOL, V4, P359, DOI 10.1017/S1477201906001933; Bonnan MF, 2004, PALEOBIOLOGY, V30, P444, DOI 10.1666/0094-8373(2004)030<0444:MAOHAF>2.0.CO;2; Bookstein F. L., 1997, MORPHOMETRIC TOOLS L; Bookstein FL, 1985, SPECIAL PUBLICATION; Brusatte SL, 2012, J EVOLUTION BIOL, V25, P365, DOI 10.1111/j.1420-9101.2011.02427.x; BUFFETAUT E, 1992, PALAEONTOLOGY, V35, P801; Campione NE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025186; Canudo JI, 2004, MORPHOMETRICS: APPLICATIONS IN BIOLOGY AND PALEONTOLOGY, P143; CARR SM, 1986, P NATL ACAD SCI USA, V83, P9576, DOI 10.1073/pnas.83.24.9576; CHAPMAN RE, 1981, J PALEONTOL, V55, P608; Chinnery B, 2004, J VERTEBR PALEONTOL, V24, P591, DOI 10.1671/0272-4634(2004)024[0591:MAOETI]2.0.CO;2; COOMBS WP, 1978, Q REV BIOL, V53, P393, DOI 10.1086/410790; DODSON P, 1993, AM J SCI, V293A, P200, DOI 10.2475/ajs.293.A.200; DODSON P, 1975, SYST ZOOL, V24, P37, DOI 10.2307/2412696; DODSON P, 1976, J PALEONTOL, V50, P929; Dong Zhiming, 1997, P68; Dunlavey T., 2004, GEOLOGICAL SOC AM AB, V36, P422; Egi Naoko, 2002, Senckenbergiana Lethaea, V82, P43; Erickson GM, 2009, ANAT REC, V292, P1514, DOI 10.1002/ar.20992; Evans D, 2006, J VERTEBR PALEONTOL, V26, p59A; Godfrey WE, 1986, BIRDS CANADA, P660; He HY, 2006, GEOCHEM GEOPHY GEOSY, V7, DOI 10.1029/2005GC001083; Kaliontzopoulou A, 2007, J MORPHOL, V268, P152, DOI 10.1002/jmor.10494; Leal M, 2002, P ROY SOC B-BIOL SCI, V269, P351, DOI 10.1098/rspb.2001.1904; Lockwood CA, 2002, J ANAT, V201, P447, DOI 10.1046/j.1469-7580.2002.00122.x; Lucas SG, 2006, CRETACEOUS RES, V27, P189, DOI 10.1016/j.cretres.2005.11.011; Marugan-Lobon J, 2004, MORPHOMETRICS: APPLICATIONS IN BIOLOGY AND PALEONTOLOGY, P157; Meiri S, 2005, ECOLOGY, V86, P1432, DOI 10.1890/04-1503; OHiggins P., 2006, TOOLS STAT SHAPE ANA; Osborn H. F., 1923, American Museum Novitates, V95, P1; Osborn HF, 1924, AM MUS NOVIT, V127, P1; Qi Z, 2007, PALAEONTOLOGY, V50, P1023, DOI 10.1111/j.1475-4983.2007.00709.x; Rodrigues LA, 2004, MORPHOMETRICS: APPLICATIONS IN BIOLOGY AND PALEONTOLOGY, P129; Rohlf F. James, 2002, Systematics Association Special Volume Series, V64, P175; ROHLF FJ, 1990, SYST ZOOL, V39, P40, DOI 10.2307/2992207; ROHLF FJ, 1993, TRENDS ECOL EVOL, V8, P129, DOI 10.1016/0169-5347(93)90024-J; Rohlf FJ, 1998, SYST BIOL, V47, P147, DOI 10.1080/106351598261094; Rohlf FJ, 1999, J CLASSIF, V16, P197, DOI 10.1007/s003579900054; Rohlf FJ, 1990, P MICH MORPH WORKSH, P217; Rohlf FJ, 1990, SPECIAL PUBLICATION, P380; ROSS CA, 1978, J PALEONTOL, V52, P943; Russell DA, 1996, CAN J EARTH SCI, V33, P637, DOI 10.1139/e96-047; Sereno P.C., 1988, Journal of Vertebrate Paleontology, V8, P353; Sereno P.C., 1988, Journal of Vertebrate Paleontology, V8, P366; Sereno PC, 2007, ACTA PALAEONTOL POL, V52, P275; Sereno Paul C., 2010, P21; Sereno PC, 2010, P ROY SOC B-BIOL SCI, V277, P199, DOI 10.1098/rspb.2009.0691; Sereno PC, 1987, THESIS COLUMBIA U; Sheets HD, 2004, MORPHOMETRICS: APPLICATIONS IN BIOLOGY AND PALEONTOLOGY, P67; Smith DK, 1997, SW PAL S P, P41; Snively E, 2004, ZOOL J LINN SOC-LOND, V142, P525, DOI 10.1111/j.1096-3642.2004.00137.x; Tschopp E, 2013, PALAEONTOL ELECTRON, V16; Viscosi V, 2009, PLANT BIOSYST, V143, P564, DOI 10.1080/11263500902723129; Wang SS, 2001, CHINESE SCI BULL, V46, P779, DOI 10.1007/BF03187222; Xing X, 2006, GEOL J, V41, P419, DOI 10.1002/gj.1044; Xu X, 2006, P ROY SOC B-BIOL SCI, V273, P2135, DOI 10.1098/rspb.2006.3566; Xu Xing, 1997, P48; You HL, 2008, ACTA PALAEONTOL POL, V53, P183, DOI 10.4202/app.2008.0202; You HL, 2005, ACTA GEOL SIN-ENGL, V79, P593; You HL, 2005, ACTA GEOL SIN-ENGL, V79, P168; You HL, 2003, ACTA PALAEONTOL POL, V48, P261; You HL, 2003, ACTA GEOL SIN-ENGL, V77, P15; Young CC., 1958, PALAEONTOLOGICA SI C, V16, P53; Zelditch M. L., 2004, GEOMETRIC MORPHOMETR, P443; Zhou Chang-Fu, 2006, Palaeoworld, V15, P100, DOI 10.1016/j.palwor.2005.11.001	67	41	41	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 9	2013	8	8							e69265	10.1371/journal.pone.0069265	http://dx.doi.org/10.1371/journal.pone.0069265			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	245OM	23950887	Green Published, gold, Green Submitted			2022-12-25	WOS:000326473200002
J	Melen, K; Partinen, M; Tynell, J; Sillanpaa, M; Himanen, SL; Saarenpaa-Heikkila, O; Hublin, C; Olsen, P; Ilonen, J; Nohynek, H; Syrjanen, R; Kilpi, T; Vuorela, A; Kirjavainen, T; Vaarala, O; Julkunen, I				Melen, Krister; Partinen, Markku; Tynell, Janne; Sillanpaa, Maarit; Himanen, Sari-Leena; Saarenpaa-Heikkila, Outi; Hublin, Christer; Olsen, Paivi; Ilonen, Jorma; Nohynek, Hanna; Syrjanen, Ritva; Kilpi, Terhi; Vuorela, Arja; Kirjavainen, Turkka; Vaarala, Outi; Julkunen, Ilkka			No Serological Evidence of Influenza A H1N1pdm09 Virus Infection as a Contributing Factor in Childhood Narcolepsy after Pandemrix Vaccination Campaign in Finland	PLOS ONE			English	Article							HLA-DR; ONSET; EPIDEMIOLOGY; ANTIBODIES; GENETICS; CHILDREN; NUCLEAR; PROTEIN; RISK	Background: Narcolepsy cataplexy syndrome, characterised by excessive daytime sleepiness and cataplexy, is strongly associated with a genetic marker, human leukocyte antigen (HLA) DQB1*06:02. A sudden increase in the incidence of childhood narcolepsy was observed after vaccination with AS03-adjuvanted Pandemrix influenza vaccine in Finland at the beginning of 2010. Here, we analysed whether the coinciding influenza A H1N1pdm pandemic contributed, together with the Pandemrix vaccination, to the increased incidence of childhood narcolepsy in 2010. The analysis was based on the presence or absence of antibody response against non-structural protein 1 (NS1) from H1N1pdm09 virus, which was not a component of Pandemrix vaccine. Methods: Non-structural (NS) 1 proteins from recombinant influenza A/Udorn/72 (H3N2) and influenza A/Finland/554/09 (H1N1pdm09) viruses were purified and used in Western blot analysis to determine specific antibody responses in human sera. The sera were obtained from 45 patients who fell ill with narcolepsy after vaccination with AS03-adjuvanted Pandemrix at the end of 2009, and from controls. Findings: Based on quantitative Western blot analysis, only two of the 45 (4.4%) Pandemrix-vaccinated narcoleptic patients showed specific antibody response against the NS1 protein from the H1N1pdm09 virus, indicating past infection with the H1N1pdm09 virus. Instead, paired serum samples from patients, who suffered from a laboratory confirmed H1N1pdm09 infection, showed high levels or diagnostic rises (96%) in H1N1pdm virus NS1-specific antibodies and very high cross-reactivity to H3N2 subtype influenza A virus NS1 protein. Conclusion: Based on our findings, it is unlikely that H1N1pdm09 virus infection contributed to a sudden increase in the incidence of childhood narcolepsy observed in Finland in 2010 after AS03-adjuvanted Pandemrix vaccination.	[Melen, Krister; Tynell, Janne; Sillanpaa, Maarit; Julkunen, Ilkka] Natl Inst Hlth & Welf, Dept Infect Dis Surveillance & Control, Helsinki, Finland; [Partinen, Markku] Univ Helsinki, Helsinki & Haartman Inst, Vitalmed Res Ctr, Helsinki Sleep Clin, Helsinki, Finland; [Himanen, Sari-Leena] Univ Tampere, FIN-33101 Tampere, Finland; [Himanen, Sari-Leena] Tampere Univ Hosp, Dept Clin Neurophysiol, Tampere, Finland; [Saarenpaa-Heikkila, Outi] Tampere Univ Hosp, Dept Pediat, Tampere, Finland; [Hublin, Christer] Finnish Inst Occupat Hlth, Helsinki, Finland; [Olsen, Paivi] Oulu Univ Hosp, Dept Child Neurol, Oulu, Finland; [Ilonen, Jorma] Univ Eastern Finland, Dept Clin Microbiol, Kuopio, Finland; [Ilonen, Jorma] Univ Turku, Immunogenet Lab, Turku, Finland; [Nohynek, Hanna; Syrjanen, Ritva; Kilpi, Terhi; Vuorela, Arja; Vaarala, Outi] Natl Inst Hlth & Welf, Dept Vaccines & Immune Protect, Helsinki, Finland; [Kirjavainen, Turkka] Helsinki Univ Hosp, Childrens Hosp, Dept Pediat, Helsinki, Finland; [Julkunen, Ilkka] Univ Turku, Dept Virol, Turku, Finland	Finland National Institute for Health & Welfare; University of Helsinki; Tampere University; Tampere University Hospital; Tampere University; Tampere University Hospital; Finnish Institute of Occupational Health; University of Oulu; University of Eastern Finland; University of Turku; Finland National Institute for Health & Welfare; University of Helsinki; Helsinki University Central Hospital; University of Turku	Melen, K (corresponding author), Natl Inst Hlth & Welf, Dept Infect Dis Surveillance & Control, Helsinki, Finland.	krister.melen@thl.fi	Hublin, Christer/AAM-7105-2021	Ilonen, Jorma/0000-0002-9973-2062; Partinen, Markku/0000-0002-8182-9368; Vuorela, Arja/0000-0001-9987-1903; Tynell, Janne/0000-0001-6930-5230; Himanen, Sari-Leena/0000-0003-0175-590X; Kirjavainen, Turkka/0000-0002-0043-5093; Julkunen, Ilkka/0000-0003-0165-2564	Medical Research Council of the Academy of Finland [252252, 260603, 261014]; Sigrid Juselius Foundation; Ministry of Social Affairs and Health	Medical Research Council of the Academy of Finland(Academy of Finland); Sigrid Juselius Foundation(Sigrid Juselius Foundation); Ministry of Social Affairs and Health	This study was supported by the Medical Research Council of the Academy of Finland (grants 252252, 260603 and 261014), the Sigrid Juselius Foundation and Ministry of Social Affairs and Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agence francaise de securite sanitaire des produits de sante, 2011, VACC PAND GRIPP AH1N; Aran A, 2009, SLEEP, V32, P979, DOI 10.1093/sleep/32.8.979; Battegay M, 2020, SWISS MED WKLY, V150, DOI [10.4414/smw.w20203, 10.4414/smw.2020.20203]; Chemelli RM, 1999, CELL, V98, P437, DOI 10.1016/S0092-8674(00)81973-X; Dauvilliers Y, 2001, NEUROLOGY, V57, P2029, DOI 10.1212/WNL.57.11.2029; Eurosurveillance Editorial Team, 2011, EURO SURVEILL, V16; Han F, 2012, ANN NEUROL, DOI [10.1002/ana.23799, DOI 10.1002/ANA.23799.[]; Han F, 2011, ANN NEUROL, V70, P410, DOI 10.1002/ana.22587; Harlow E., 1988, ANTIBODIES LAB MANUA; Hermann R, 2003, TISSUE ANTIGENS, V62, P162, DOI 10.1034/j.1399-0039.2003.00071.x; HILLIS DM, 1993, SYST BIOL, V42, P182, DOI 10.2307/2992540; Hong SC, 2006, SLEEP, V29, P1429, DOI 10.1093/sleep/29.11.1429; Ikonen N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013329; International Classification of Sleep Disorders, 2005, DIAGN COD MAN, V2nd; Kendal AP, 1982, CONCEPTS PROCEDURES; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lin L, 1999, CELL, V98, P365, DOI 10.1016/S0092-8674(00)81965-0; Longstreth WT, 2007, SLEEP, V30, P13, DOI 10.1093/sleep/30.1.13; Longstreth WT, 2009, SLEEP, V32, P1548, DOI 10.1093/sleep/32.12.1548; Melen K, 2007, J VIROL, V81, P5995, DOI 10.1128/JVI.01714-06; Mignot E, 2001, AM J HUM GENET, V68, P686, DOI 10.1086/318799; Miller E, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f794; Nishino S, 2000, LANCET, V355, P39, DOI 10.1016/S0140-6736(99)05582-8; Nohynek H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033536; Partinen M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033723; Ronkko E, 2011, J CLIN MICROBIOL, V49, P2009, DOI 10.1128/JCM.00259-11; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Silber MH, 2002, SLEEP, V25, P197, DOI 10.1093/sleep/25.2.197; Sillanpaa M, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-84; Szakacs A, 2013, NEUROLOGY, V80, P1315, DOI 10.1212/WNL.0b013e31828ab26f; Tamura K, 2004, P NATL ACAD SCI USA, V101, P11030, DOI 10.1073/pnas.0404206101; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Thannickal TC, 2000, NEURON, V27, P469, DOI 10.1016/S0896-6273(00)00058-1; Tumpey TM, 2005, SCIENCE, V310, P77, DOI 10.1126/science.1119392; Vainio A, 2006, VACCINE, V24, P1792, DOI 10.1016/j.vaccine.2005.10.034; World Health Organization Gisn, 2011, MAN LAB DIAGN VIR SU, P140	36	37	37	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2013	8	8							e68402	10.1371/journal.pone.0068402	http://dx.doi.org/10.1371/journal.pone.0068402			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	201ER	23950869	Green Published, gold, Green Submitted			2022-12-25	WOS:000323124000002
J	Zhang, LL; Dalal, K; Wang, SM				Zhang, Ling-Ling; Dalal, Koustuv; Wang, Shu-Mei			Injury Related Risk Behaviour: A Health Belief Model-Based Study of Primary School Students in a Safe Community in Shanghai	PLOS ONE			English	Article							UNINTENTIONAL INJURIES; YOUTH; EPIDEMIOLOGY; PREVALENCE; SUICIDE	Aim: To explore the relationship between Health belief model (HBM) and children and adolescents' unintentional injury risk behavior, to add some useful information for injury prevention. Methodology: We investigated injury related health risk behavior and health belief status of students at primary schools grade 3 to 4, in a Safe Community, in Shanghai. Self-administered injury questionnaires were used to investigate risk behavior of students and HBM factors. Principal Findings: The prevalence of risk behavior among students reported in this community was high. HBM scores showed differences between two groups of students classified by whether they had risk behavior or not. Self-efficacy was highly related with the status of socio-psychological behavior. Significance: HBM has been widely used in explaining the disease-related behavior; however, it has been seldom used in injury-related behavior. The study demonstrated important relation of HBM to students' injury issues, and HBM could explain injury related behavior as well, especially for traffic injury-related behavior. When developing injury prevention strategies, we can take it into account.	[Zhang, Ling-Ling; Wang, Shu-Mei] Fudan Univ, Sch Publ Hlth, Minist Educ, Key Lab Publ Hlth Safety, Shanghai 200433, Peoples R China; [Dalal, Koustuv] Univ Orebro, Sch Hlth & Med Sci, Ctr Injury Prevent & Safety Promot CIPSP, Orebro, Sweden	Fudan University; Orebro University	Wang, SM (corresponding author), Fudan Univ, Sch Publ Hlth, Minist Educ, Key Lab Publ Hlth Safety, Shanghai 200433, Peoples R China.	smwang@fudan.edu.cn	zhang, lingling/HDM-2189-2022; Dalal, Koustuv/O-6737-2017	Dalal, Koustuv/0000-0001-7393-796X				Blum RW, 2004, J ADOLESCENT HEALTH, V35, P402, DOI [10.1016/j.jadohealth.2003.10.007, 10.1016/S1054-139X(03)00537-8]; Bridge JA, 2006, J CHILD PSYCHOL PSYC, V47, P372, DOI 10.1111/j.1469-7610.2006.01615.x; Caine D, 2008, CLIN SPORT MED, V27, P19, DOI 10.1016/j.csm.2007.10.008; Carpenter CJ, 2010, HEALTH COMMUN, V25, P661, DOI 10.1080/10410236.2010.521906; Castelloe J, 2004, SAS STAT 9 1 USERS G; Chen G, 2005, J ADOLESCENT HEALTH, V37, P460, DOI 10.1016/j.jadohealth.2004.09.005; Fung SY, 1998, PATIENT EDUC COUNS, V33, P233, DOI 10.1016/S0738-3991(98)00023-8; Gortmaker SL, 1999, ARCH PEDIAT ADOL MED, V153, P409, DOI 10.1001/archpedi.153.4.409; Gould MS, 2003, J AM ACAD CHILD PSY, V42, P386, DOI 10.1097/01.CHI.0000046821.95464.CF; Green L.W., 2005, HLTH PROGRAM PLANNIN, V4th; JANZ NK, 1984, HEALTH EDUC QUART, V11, P1, DOI 10.1177/109019818401100101; Ji C., 2005, CHIN J PUBLIC HLTH, V21, P1150; Ji C. X., 2007, CHIN J SCH HLTH, V28, P289; Ji CYA., 2007, COMPREHENSIVE SURVEY; Jing J, 2006, CHIN J SCH HLTH, V2, P182; Li CF, 2008, MATERN CHILD HLTH J, V23, P3260; Li Hua, 2009, Chinese Journal of Prevention and Control of Chronic Diseases, V17, P544; Mock C, 2004, LANCET, V363, P2172, DOI 10.1016/S0140-6736(04)16510-0; Nansel TR, 2003, ARCH PEDIAT ADOL MED, V157, P348, DOI 10.1001/archpedi.157.4.348; Nansel TR, 2001, JAMA-J AM MED ASSOC, V285, P2094, DOI 10.1001/jama.285.16.2094; ROSENSTOCK IM, 1988, HEALTH EDUC QUART, V15, P175, DOI 10.1177/109019818801500203; Sheng QJ, 2007, J CLIN PSYCHOSOM DIS, V13, P369; Sleet DA, 2010, ANNU REV PUBL HEALTH, V31, P195, DOI 10.1146/annurev.publhealth.012809.103616; Tavafian Sedigheh Sadat, 2009, BMC Womens Health, V9, P37, DOI 10.1186/1472-6874-9-37; Trifiletti LB, 2005, HEALTH EDUC RES, V20, P298, DOI 10.1093/her/cyg126; Wang S, 2011, HEALTHMED, V5, P479; Wang S.Y., 2003, INJURY EPIDEMIOLOGY; Wang SM, 2013, J COMMUN HEALTH, V38, P205, DOI 10.1007/s10900-012-9594-4; Wang SM, 2010, COMMUNITY INJURY PRE; Wang SY, 2000, CHIN J PREV MED, V4, P6; Wolke D, 2001, BRIT J PSYCHOL, V92, P673, DOI 10.1348/000712601162419; Yin M.M., 2011, CHIN J SCH HLTH, V32, P601; ZHANG JX, 1995, PSYCHOLOGIA, V38, P174; Zhou Y, 2003, INJ PREV, V9, P124, DOI 10.1136/ip.9.2.124	34	12	13	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2013	8	8							e70563	10.1371/journal.pone.0070563	http://dx.doi.org/10.1371/journal.pone.0070563			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	201ER	23950963	gold, Green Published			2022-12-25	WOS:000323124000021
J	Tian, MX; Qu, J; Han, XG; Zhang, M; Ding, C; Ding, JB; Chen, GH; Yu, SQ				Tian, Mingxing; Qu, Jing; Han, Xiangan; Zhang, Min; Ding, Chan; Ding, Jiabo; Chen, Guanghua; Yu, Shengqing			Microarray-Based Identification of Differentially Expressed Genes in Intracellular Brucella abortus within RAW264.7 Cells	PLOS ONE			English	Article							COENZYME-A LIGASE; BENZOATE-COENZYME; MURINE MACROPHAGES; ESCHERICHIA-COLI; VACCINE STRAIN; HOMOPROTOCATECHUATE 2,3-DIOXYGENASE; RHODOPSEUDOMONAS-PALUSTRIS; ANAEROBIC DEGRADATION; THAUERA-AROMATICA; VIRULENCE GENES	Brucella spp. is a species of facultative intracellular Gram-negative bacteria that induces abortion and causes sterility in domesticated mammals and chronic undulant fever in humans. Important determinants of Brucella's virulence and potential for chronic infection include the ability to circumvent the host cell's internal surveillance system and the capability to proliferate within dedicated and non-dedicated phagocytes. Hence, identifying genes necessary for intracellular survival may hold the key to understanding Brucella infection. In the present study, microarray analysis reveals that 7.82% (244/3334) of all Brucella abortus genes were up-regulated and 5.4% (180/3334) were down-regulated in RAW264.7 cells, compared to free-living cells in TSB. qRT-PCR verification further confirmed a >5-fold up-regulation for fourteen genes. Functional analysis classified araC, ddp, and eryD as to partake in information storage and processing, alp, flgF and virB9 to be involved in cellular processes, hpcd and aldh to play a role in metabolism, mfs and nikC to be involved in both cellular processes and metabolism, and four hypothetical genes (bruAb1_1814, bruAb1_0475, bruAb1_1926, and bruAb1_0292) had unknown functions. Furthermore, we constructed a B. abortus 2308 mutant Delta ddp where the ddp gene is deleted in order to evaluate the role of ddp in intracellular survival. Infection assay indicated significantly higher adherence and invasion abilities of the Delta ddp mutant, however it does not survive well in RAW264.7 cells. Brucella may survive in hostile intracellular environment by modulating gene expression.	[Tian, Mingxing; Qu, Jing; Han, Xiangan; Zhang, Min; Ding, Chan; Yu, Shengqing] Chinese Acad Agr Sci, Shanghai Vet Res Inst, Shanghai, Peoples R China; [Qu, Jing; Zhang, Min] Yangzhou Univ, Coll Vet Med, Yangzhou, Peoples R China; [Ding, Jiabo; Chen, Guanghua] China Inst Vet Drug Control, Beijing, Peoples R China	Chinese Academy of Agricultural Sciences; Shanghai Veterinary Research Institute, CAAS; Yangzhou University; China Institute of Veterinary Drug Control	Chen, GH (corresponding author), China Inst Vet Drug Control, Beijing, Peoples R China.	chenguanghua@ivdc.gov.cn; yus@shvri.ac.cn		Han, Xiangan/0000-0001-5625-637X	Chinese National Programs for Fundamental Research and Development [2010CB530202]; 948 project of Chinese Agricultural Ministry [2012-Z9]; National Basic Fund for Research Institutes in Chinese Academy of Agricultural Sciences [2013JB04]	Chinese National Programs for Fundamental Research and Development; 948 project of Chinese Agricultural Ministry; National Basic Fund for Research Institutes in Chinese Academy of Agricultural Sciences	This work was supported by Chinese National Programs for Fundamental Research and Development (2010CB530202), 948 project of Chinese Agricultural Ministry (2012-Z9) and National Basic Fund for Research Institutes in Chinese Academy of Agricultural Sciences (2013JB04). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTENSCHMIDT U, 1991, J BACTERIOL, V173, P5494, DOI 10.1128/jb.173.17.5494-5501.1991; AMMERMAN JW, 1985, SCIENCE, V227, P1338, DOI 10.1126/science.227.4692.1338; Anderson ES, 2008, J BACTERIOL, V190, P1838, DOI 10.1128/JB.01551-07; ANDERSON JD, 1965, J GEN MICROBIOL, V38, P109, DOI 10.1099/00221287-38-1-109; Boschiroli ML, 2001, CURR OPIN MICROBIOL, V4, P58, DOI 10.1016/S1369-5274(00)00165-X; Chou HT, 2011, L LYSINE DECARBOXYLA; Corbel MJ, 1997, EMERG INFECT DIS, V3, P213, DOI 10.3201/eid0302.970219; Crasta OR, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002193; Crosby D, 1972, DEGRADATION SYNTHETI, P260; de Jong MF, 2012, FUTURE MICROBIOL, V7, P47, DOI [10.2217/fmb.11.136, 10.2217/FMB.11.136]; EGLAND PG, 1995, J BACTERIOL, V177, P6545, DOI 10.1128/jb.177.22.6545-6551.1995; Eskra L, 2003, INFECT IMMUN, V71, P1125, DOI 10.1128/IAI.71.3.1125-1133.2003; Ficht TA, 2003, VET MICROBIOL, V92, P213, DOI 10.1016/S0378-1135(02)00367-X; Fretin D, 2005, CELL MICROBIOL, V7, P687, DOI 10.1111/j.1462-5822.2005.00502.x; Frota CC, 2004, INFECT IMMUN, V72, P5483, DOI 10.1128/IAI.72.9.5483-5486.2004; Galdiero E, 2000, MICROBIOLOGICA, V23, P271; GEISSLER JF, 1988, J BACTERIOL, V170, P1709, DOI 10.1128/jb.170.4.1709-1714.1988; Groce SL, 2003, J AM CHEM SOC, V125, P11780, DOI 10.1021/ja0368103; Hermuth K, 2002, ARCH MICROBIOL, V177, P132, DOI 10.1007/s00203-001-0375-1; HORIUCHI T, 1959, NATURE, V183, P1529, DOI 10.1038/1831529b0; Jubier-Maurin V, 2001, J BACTERIOL, V183, P426, DOI 10.1128/JB.183.2.426-434.2001; Kim S, 2004, MICROB PATHOGENESIS, V37, P11, DOI 10.1016/j.micpath.2004.04.002; Kohler S, 2002, P NATL ACAD SCI USA, V99, P15711, DOI 10.1073/pnas.232454299; Lestrate P, 2000, MOL MICROBIOL, V38, P543, DOI 10.1046/j.1365-2958.2000.02150.x; LOCHMEYER C, 1992, J BACTERIOL, V174, P3621, DOI 10.1128/JB.174.11.3621-3628.1992; Marchitti SA, 2008, EXPERT OPIN DRUG MET, V4, P697, DOI [10.1517/17425255.4.6.697, 10.1517/17425255.4.6.697 ]; Miller MA, 1996, J BIOL CHEM, V271, P5524, DOI 10.1074/jbc.271.10.5524; Moreno E, 2002, P NATL ACAD SCI USA, V99, P1, DOI 10.1073/pnas.022622699; Naroeni A, 2002, INFECT IMMUN, V70, P1640, DOI 10.1128/IAI.70.3.1640-1644.2002; Pao SS, 1998, MICROBIOL MOL BIOL R, V62, P1; Pei JW, 2008, MICROBES INFECT, V10, P582, DOI 10.1016/j.micinf.2008.01.005; Pei JW, 2004, INFECT IMMUN, V72, P440, DOI 10.1128/IAI.72.1.440-450.2004; Pizarro-Cerda J, 1998, INFECT IMMUN, V66, P2387; Porte F, 1999, INFECT IMMUN, V67, P4041, DOI 10.1128/IAI.67.8.4041-4047.1999; SANGARI FJ, 1994, FEMS MICROBIOL LETT, V121, P337, DOI 10.1111/j.1574-6968.1994.tb07123.x; Sangari FJ, 1998, VACCINE, V16, P1640, DOI 10.1016/S0264-410X(98)00063-2; Sangari FJ, 2000, MICROBIOL-UK, V146, P487, DOI 10.1099/00221287-146-2-487; Schuhle K, 2003, J BACTERIOL, V185, P4920, DOI 10.1128/JB.185.16.4920-4929.2003; Seleem MN, 2008, VET MICROBIOL, V129, P1, DOI 10.1016/j.vetmic.2007.11.023; Song XM, 2008, CAN J MICROBIOL, V54, P189, DOI [10.1139/W07-133, 10.1139/w07-133]; Viadas C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010216; Walmsley AR, 1998, TRENDS BIOCHEM SCI, V23, P476, DOI 10.1016/S0968-0004(98)01326-7; WANNER BL, 1980, GENETICS, V96, P353; WU LF, 1989, MOL MICROBIOL, V3, P1709, DOI 10.1111/j.1365-2958.1989.tb00156.x; Zhang M, 2013, VET MICROBIOL	45	22	22	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2013	8	8							e67014	10.1371/journal.pone.0067014	http://dx.doi.org/10.1371/journal.pone.0067014			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	200ZE	23950864	Green Submitted, Green Published, gold			2022-12-25	WOS:000323109700003
J	Kaufhold, F; Zimmermann, H; Schneider, E; Ruprecht, K; Paul, F; Oberwahrenbrock, T; Brandt, AU				Kaufhold, Falko; Zimmermann, Hanna; Schneider, Elisa; Ruprecht, Klemens; Paul, Friedemann; Oberwahrenbrock, Timm; Brandt, Alexander U.			Optic Neuritis Is Associated with Inner Nuclear Layer Thickening and Microcystic Macular Edema Independently of Multiple Sclerosis	PLOS ONE			English	Article							PRIMARY RETINAL PATHOLOGY; COHERENCE TOMOGRAPHY; NEUROMYELITIS-OPTICA; DIAGNOSTIC-CRITERIA; DEGENERATION; DISABILITY; THICKNESS; VOLUME	Background: Microcystic macular edema (MME) and inner nuclear layer thickening (INL) were described in multiple sclerosis (MS) and neuromyelitis optica (NMO) patients using optical coherence tomography (OCT). The cause of these findings is currently unknown and a relation to inflammatory or degenerative processes in the optic nerve is discussed. Objective: The aim of our study was to investigate whether INL thickening and MME are related to optic neuritis (ON) in various neuro-inflammatory disorders causingON: MS, NMO and chronic inflammatory optic neuropathy. Methods: We retrospectively analyzed data from 216 MS patients, 39 patients with a clinically isolated syndrome, 20 NMO spectrum disorder patients, 9 patients with chronic inflammatory optic neuropathy and 121 healthy subjects. Intra-retinal layer segmentation was performed for the eyes of patients with unilateral ON. Scanning laser ophthalmoscopy (SLO) images were reviewed for characteristic ocular fundus changes. Results: Intra-retinal layer segmentation showed that eyes with a history of ON displayed MME independent INL thickening compared to contralateral eyes without previous ON. MME was detected in 22 eyes from 15 patients (5.3% of all screened patients), including 7 patients with bilateral edema. Of these, 21 had a prior history of ON (95%). The SLO images of all 22 MME-affected eyes showed crescent-shaped texture changes which were visible in the perifoveal region. A second grader who was blinded to the results of the OCT classified all SLO images for the presence of these characteristic fundus changes. All MME eyes were correctly classified (sensitivity = 100%) with high specificity (95.2%). Conclusion: This study shows that both MME and INL thickening occur in various neuro-inflammatory disorders associated with ON. We also demonstrate that detection and analysis of MME by OCT is not limited to B-scans, but also possible using SLO images.	[Kaufhold, Falko; Zimmermann, Hanna; Schneider, Elisa; Paul, Friedemann; Oberwahrenbrock, Timm; Brandt, Alexander U.] Charite, NeuroCure Clin Res Ctr, D-13353 Berlin, Germany; [Kaufhold, Falko; Zimmermann, Hanna; Schneider, Elisa; Paul, Friedemann; Oberwahrenbrock, Timm; Brandt, Alexander U.] Charite, Expt & Clin Res Ctr, D-13353 Berlin, Germany; [Kaufhold, Falko; Zimmermann, Hanna; Schneider, Elisa; Paul, Friedemann; Oberwahrenbrock, Timm; Brandt, Alexander U.] Max Delbruck Ctr Mol Med, Berlin, Germany; [Ruprecht, Klemens; Paul, Friedemann] Charite, Clin & Expt Multiple Sclerosis Res Ctr, Dept Neurol, D-13353 Berlin, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Helmholtz Association; Max Delbruck Center for Molecular Medicine; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Paul, F (corresponding author), Charite, NeuroCure Clin Res Ctr, D-13353 Berlin, Germany.	friedemann.paul@charite.de	Paul, Friedemann/ABF-9415-2020	Zimmermann, Hanna/0000-0002-0276-8051; paul, friedemann/0000-0002-6378-0070	Deutsche Forschungsgemeinschaft [DFG Exc. 257]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This study was supported in part by Deutsche Forschungsgemeinschaft (DFG Exc. 257). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Abegg M, 2012, BRAIN, V135, DOI 10.1093/brain/aws215; Albrecht P, 2012, MULT SCLER J, V18, P1422, DOI 10.1177/1352458512439237; Asgari N, 2011, NEUROLOGY, V76, P1589, DOI 10.1212/WNL.0b013e3182190f74; Balcer LJ, 2006, NEW ENGL J MED, V354, P1273, DOI 10.1056/NEJMcp053247; Balk LJ, 2012, BRAIN, V135, DOI 10.1093/brain/aws216; Barboni P, 2013, BRAIN, V136, DOI 10.1093/brain/awt014; Bock M, 2012, BRIT J OPHTHALMOL, V96, P62, DOI 10.1136/bjo.2010.193581; Bock M, 2010, CLIN NEUROL NEUROSUR, V112, P647, DOI 10.1016/j.clineuro.2010.04.014; Bock M, 2010, MULT SCLER J, V16, P893, DOI 10.1177/1352458510365156; Brandt AU, 2011, BRAIN, V134, DOI 10.1093/brain/awr095; Bringmann A, 2012, OPHTHALMOLOGICA, V227, P1, DOI 10.1159/000328979; Burkholder BM, 2009, ARCH NEUROL-CHICAGO, V66, P1366, DOI 10.1001/archneurol.2009.230; Compston A, 2008, LANCET, V372, P1502, DOI 10.1016/S0140-6736(08)61620-7; Costello F, 2006, ANN NEUROL, V59, P963, DOI 10.1002/ana.20851; Costello F, 2011, MULT SCLER INT, V2011, DOI 10.1155/2011/148394; de Seze J, 2008, ARCH NEUROL-CHICAGO, V65, P920, DOI 10.1001/archneur.65.7.920; Dinkin M, 2013, NEUROLOGY, V80, P128, DOI 10.1212/WNL.0b013e31827ccf4a; Fairless R, 2012, J NEUROSCI, V32, P5585, DOI 10.1523/JNEUROSCI.5705-11.2012; Gelfand JM, 2013, BRAIN, V136, pe240, DOI 10.1093/brain/awt018; Gelfand JM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036847; Gelfand JM, 2012, BRAIN, V135, P1786, DOI 10.1093/brain/aws098; Gelfand JMCB, 2013, JAMA NEUROL, P1, DOI 10.1001/jamaneurol.2013.1832; Green AJ, 2010, BRAIN, V133, P1591, DOI 10.1093/brain/awq080; Jarius S, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-14; Kidd D, 2003, BRAIN, V126, P276, DOI 10.1093/brain/awg045; KURTZKE JF, 1983, NEUROLOGY, V33, P1444, DOI 10.1212/WNL.33.11.1444; Lublin FD, 1996, NEUROLOGY, V46, P907, DOI 10.1212/WNL.46.4.907; Naismith RT, 2009, NEUROLOGY, V72, P1077, DOI 10.1212/01.wnl.0000345042.53843.d5; Nolan R, 2013, NEUROLOGY, V80, P139, DOI 10.1212/WNL.0b013e31827b9132; Oberwahrenbrock T, 2013, MULT SCLER J, V19, P1887, DOI 10.1177/1352458513489757; Oberwahrenbrock T, 2012, MULT SCLER INT, V2012, DOI 10.1155/2012/530305; Petzold A, 2010, LANCET NEUROL, V9, P921, DOI 10.1016/S1474-4422(10)70168-X; Polman CH, 2005, ANN NEUROL, V58, P840, DOI 10.1002/ana.20703; Polman CH, 2011, ANN NEUROL, V69, P292, DOI 10.1002/ana.22366; Ratchford JN, 2009, NEUROLOGY, V73, P302, DOI 10.1212/WNL.0b013e3181af78b8; Roxburgh RHSR, 2005, NEUROLOGY, V64, P1144, DOI 10.1212/01.WNL.0000156155.19270.F8; Saidha S, 2012, LANCET NEUROL, V11, P963, DOI 10.1016/S1474-4422(12)70213-2; Saidha S, 2011, BRAIN, V134, P518, DOI 10.1093/brain/awq346; Schneider E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066151; Seigo MA, 2012, J NEUROL, V259, P2119, DOI 10.1007/s00415-012-6466-x; Sotirchos ES, 2013, NEUROLOGY, V80, P1406, DOI 10.1212/WNL.0b013e31828c2f7a; Syc SB, 2012, BRAIN, V135, P521, DOI 10.1093/brain/awr264; Talman LS, 2010, ANN NEUROL, V67, P749, DOI 10.1002/ana.22005; Tewarie P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034823; Trip SA, 2005, ANN NEUROL, V58, P383, DOI 10.1002/ana.20575; Warner CV, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022947; Wingerchuk DM, 2006, NEUROLOGY, V66, P1485, DOI 10.1212/01.wnl.0000216139.44259.74; Wingerchuk DM, 2007, LANCET NEUROL, V6, P805, DOI 10.1016/S1474-4422(07)70216-8; Wingerchuk DM, 2003, NEUROLOGY, V60, P848, DOI 10.1212/01.WNL.0000049912.02954.2C; Zimmermann H, 2013, MULT SCLER J, V19, P443, DOI 10.1177/1352458512457844	50	88	88	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2013	8	8							e71145	10.1371/journal.pone.0071145	http://dx.doi.org/10.1371/journal.pone.0071145			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	217ZG	23940706	Green Accepted, Green Published, gold, Green Submitted			2022-12-25	WOS:000324401500060
J	Avanzi, S; Leoni, V; Rotola, A; Alviano, F; Solimando, L; Lanzoni, G; Bonsi, L; Di Luca, D; Marchionni, C; Alvisi, G; Ripalti, A				Avanzi, Simone; Leoni, Valerio; Rotola, Antonella; Alviano, Francesco; Solimando, Liliana; Lanzoni, Giacomo; Bonsi, Laura; Di Luca, Dario; Marchionni, Cosetta; Alvisi, Gualtiero; Ripalti, Alessandro			Susceptibility of Human Placenta Derived Mesenchymal Stromal/Stem Cells to Human Herpesviruses Infection	PLOS ONE			English	Article							EPSTEIN-BARR-VIRUS; PROCESSIVITY FACTOR PPUL44; HUMAN TERM PLACENTA; STEM-CELLS; BONE-MARROW; HUMAN CYTOMEGALOVIRUS; AMNIOTIC MEMBRANE; MULTIPLEX PCR; GENE-THERAPY; IN-VITRO	Fetal membranes (FM) derived mesenchymal stromal/stem cells (MSCs) are higher in number, expansion and differentiation abilities compared with those obtained from adult tissues, including bone marrow. Upon systemic administration, ex vivo expanded FM-MSCs preferentially home to damaged tissues promoting regenerative processes through their unique biological properties. These characteristics together with their immune-privileged nature and immune suppressive activity, a low infection rate and young age of placenta compared to other sources of SCs make FM-MSCs an attractive target for cell-based therapy and a valuable tool in regenerative medicine, currently being evaluated in clinical trials. In the present study we investigated the permissivity of FM-MSCs to all members of the human Herpesviridae family, an issue which is relevant to their purification, propagation, conservation and therapeutic use, as well as to their potential role in the vertical transmission of viral agents to the fetus and to their potential viral vector-mediated genetic modification. We present here evidence that FM-MSCs are fully permissive to infection with Herpes simplex virus 1 and 2 (HSV-1 and HSV-2), Varicella zoster virus (VZV), and Human Cytomegalovirus (HCMV), but not with Epstein-Barr virus (EBV), Human Herpesvirus-6, 7 and 8 (HHV-6, 7, 8) although these viruses are capable of entering FM-MSCs and transient, limited viral gene expression occurs. Our findings therefore strongly suggest that FM-MSCs should be screened for the presence of herpesviruses before xenotransplantation. In addition, they suggest that herpesviruses may be indicated as viral vectors for gene expression in MSCs both in gene therapy applications and in the selective induction of differentiation.	[Avanzi, Simone; Ripalti, Alessandro] AOU Bologna Policlin S Orsola Malpighi, Dept Oncol Haematol & Lab Med, Operat Unit Microbiol, Bologna, Italy; [Leoni, Valerio; Solimando, Liliana; Alvisi, Gualtiero] Univ Bologna, Dept Haematol & Oncol Sci LA Seragnoli, Microbiol Sect, Bologna, Italy; [Rotola, Antonella; Di Luca, Dario] Univ Ferrara, Dept Expt & Diagnost Med, Microbiol Sect, I-44100 Ferrara, Italy; [Alviano, Francesco; Lanzoni, Giacomo; Bonsi, Laura; Marchionni, Cosetta] Univ Bologna, Dept Histol Embryol & Appl Biol, Bologna, Italy; [Alvisi, Gualtiero] Univ Padua, Dept Mol Med, Microbiol Sect, Padua, Italy	IRCCS Azienda Ospedaliero-Universitaria di Bologna; University of Bologna; University of Ferrara; University of Bologna; University of Padua	Ripalti, A (corresponding author), AOU Bologna Policlin S Orsola Malpighi, Dept Oncol Haematol & Lab Med, Operat Unit Microbiol, Bologna, Italy.	alessandro.ripalti@unibo.it	Lanzoni, Giacomo/H-1695-2015; Lanzoni, Giacomo/K-7396-2019; Di Luca, Dario/M-9781-2014	Lanzoni, Giacomo/0000-0003-3996-4803; Di Luca, Dario/0000-0001-9643-9170; Alvisi, Gualtiero/0000-0002-8177-3616; LEONI, VALERIO/0000-0002-6805-2144	Universita di Bologna, Assegni di Ricerca; Fondi Ateneo per la Ricerca, Universita di Ferrara; Associazione Italiana per la Ricerca sui Virus, Bologna; Fondi attivita di ricerca istituzionali, Universita di Padova	Universita di Bologna, Assegni di Ricerca; Fondi Ateneo per la Ricerca, Universita di Ferrara; Associazione Italiana per la Ricerca sui Virus, Bologna; Fondi attivita di ricerca istituzionali, Universita di Padova	This work was supported by Universita di Bologna, Assegni di Ricerca, www.unibo.it; Fondi Ateneo per la Ricerca, Universita di Ferrara, www.unife.it; Associazione Italiana per la Ricerca sui Virus, Bologna, www.airv.it; and Fondi attivita di ricerca istituzionali, Universita di Padova, www.unipd.it. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alviano F, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-11; Alvisi G, 2005, TRAFFIC, V6, P1002, DOI 10.1111/j.1600-0854.2005.00331.x; Alvisi G, 2011, VIROLOGY, V417, P259, DOI 10.1016/j.virol.2011.06.015; Alvisi G, 2009, J VIROL, V83, P9567, DOI 10.1128/JVI.00669-09; Alvisi G, 2008, BIOCHEMISTRY-US, V47, P13764, DOI 10.1021/bi800869y; Ashshi AM, 2003, J INFECTION, V47, P59, DOI 10.1016/S0163-4453(03)00057-4; Bailo M, 2004, TRANSPLANTATION, V78, P1439, DOI 10.1097/01.TP.0000144606.84234.49; Barinaga M, 2002, SCIENCE, V296, P2169, DOI 10.1126/science.296.5576.2169; Bossolasco P, 2006, CELL RES, V16, P329, DOI 10.1038/sj.cr.7310043; Brooke G, 2007, SEMIN CELL DEV BIOL, V18, P846, DOI 10.1016/j.semcdb.2007.09.012; Brooke G, 2009, BRIT J HAEMATOL, V144, P571, DOI 10.1111/j.1365-2141.2008.07492.x; Burton EA, 2001, STEM CELLS, V19, P358, DOI 10.1634/stemcells.19-5-358; Campagnoli C, 2001, BLOOD, V98, P2396, DOI 10.1182/blood.V98.8.2396; Cargnoni A, 2009, CELL TRANSPLANT, V18, P405, DOI 10.3727/096368909788809857; Caruso A, 2009, P NATL ACAD SCI USA, V106, P20446, DOI 10.1073/pnas.0905535106; Caselli E, 2005, BLOOD, V106, P2790, DOI 10.1182/blood-2005-04-1390; Caselli E, 2007, BLOOD, V109, P2718, DOI 10.1182/blood-2006-03-012500; Chan J, 2005, STEM CELLS, V23, P93, DOI 10.1634/stemcells.2004-0138; Chan J, 2007, STEM CELLS, V25, P875, DOI 10.1634/stemcells.2006-0694; CHEN F, 1995, J VIROL, V69, P3752, DOI 10.1128/JVI.69.6.3752-3758.1995; Cho YH, 2012, BIOMATERIALS, V33, P1376, DOI 10.1016/j.biomaterials.2011.10.078; Choudhary S, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/264350; Chow SSW, 2006, J MED VIROL, V78, P747, DOI 10.1002/jmv.20618; Dai LJ, 2011, CANCER LETT, V305, P8, DOI 10.1016/j.canlet.2011.02.012; Degli Esposti Merli M, 2010, THESIS U BOLOGNA, P40; Enright Andrea M, 2002, Semin Neonatol, V7, P283, DOI 10.1016/S1084-2756(02)90115-6; FAULK WP, 1980, LANCET, V1, P1156; Fierro FA, 2011, STEM CELLS, V29, P1727, DOI 10.1002/stem.720; Fortunato EA, 2003, REV MED VIROL, V13, P21, DOI 10.1002/rmv.368; French C, 1999, VIROLOGY, V262, P139, DOI 10.1006/viro.1999.9875; Fuchs JR, 2004, J PEDIATR SURG, V39, P834, DOI 10.1016/j.jpedsurg.2004.02.014; Fujimuro M, 2006, EXP MOL PATHOL, V80, P124, DOI 10.1016/j.yexmp.2005.09.010; Fukuchi Y, 2004, STEM CELLS, V22, P649, DOI 10.1634/stemcells.22-5-649; GOMPELS UA, 1995, VIROLOGY, V209, P29, DOI 10.1006/viro.1995.1228; Gonelli A, 2001, J MED VIROL, V63, P277, DOI 10.1002/1096-9071(200104)63:4&lt;277::AID-JMV1002&gt;3.0.CO;2-K; Hai C, 2012, CHIN J CANCER, V31, P233, DOI 10.5732/cjc.011.10367; He QL, 2007, STEM CELLS, V25, P69, DOI 10.1634/stemcells.2006-0335; Hematti Peiman, 2008, Transplant Rev (Orlando), V22, P262, DOI 10.1016/j.trre.2008.05.002; Hwang DH, 2011, EXPERT OPIN BIOL TH, V11, P1599, DOI 10.1517/14712598.2011.631908; in't Anker PS, 2004, STEM CELLS, V22, P1338, DOI 10.1634/stemcells.2004-0058; Klein JD, 2011, STEM CELLS DEV, V20, P969, DOI 10.1089/scd.2010.0379; Kolf CM, 2007, ARTHRITIS RES THER, V9, DOI 10.1186/ar2116; Kunisaki SM, 2006, J PEDIATR SURG, V41, P34, DOI 10.1016/j.jpedsurg.2005.10.011; Kuppers R, 2003, NAT REV IMMUNOL, V3, P801, DOI 10.1038/nri1201; Lauterbach H, 2004, J VIROL, V78, P4020, DOI 10.1128/JVI.78.8.4020-4028.2004; Li HC, 2005, INVEST OPHTH VIS SCI, V46, P900, DOI 10.1167/iovs.04-0495; Liechty KW, 2000, NAT MED, V6, P1282, DOI 10.1038/81395; Ljungman P, 2007, BEST PRACT RES CL HA, V20, P209, DOI 10.1016/j.beha.2006.09.003; Maidji E, 2007, J VIROL, V81, P4701, DOI 10.1128/JVI.02748-06; Markoulatos P, 2001, J CLIN MICROBIOL, V39, P4426, DOI 10.1128/JCM.39.12.4426-4432.2001; Meisel R, 2011, LEUKEMIA, V25, P648, DOI 10.1038/leu.2010.310; Mellor AL, 2000, ANNU REV IMMUNOL, V18, P367, DOI 10.1146/annurev.immunol.18.1.367; Menegazzi P, 1999, J GEN VIROL, V80, P2705, DOI 10.1099/0022-1317-80-10-2705; Minguell JJ, 2001, EXP BIOL MED, V226, P507, DOI 10.1177/153537020122600603; Mirandola P, 1998, J VIROL, V72, P3837, DOI 10.1128/JVI.72.5.3837-3844.1998; Ruiz MM, 2012, ADV EXP MED BIOL, V741, P254, DOI 10.1007/978-1-4614-2098-9_17; Neumann AJ, 2013, MOL BIOTECHNOL, V53, P207, DOI 10.1007/s12033-012-9522-y; Nicholas J, 1996, J VIROL, V70, P5975, DOI 10.1128/JVI.70.9.5975-5989.1996; Ohshima M, 2012, J MOL CELL CARDIOL, V53, P420, DOI 10.1016/j.yjmcc.2012.06.020; Parolini O, 2008, STEM CELLS, V26, P300, DOI 10.1634/stemcells.2007-0594; Parsons CH, 2004, BLOOD, V104, P2736, DOI 10.1182/blood-2004-02-0693; Phinney DG, 2007, STEM CELLS, V25, P2896, DOI 10.1634/stemcells.2007-0637; Pincha M, 2011, GENE THER, V18, P750, DOI 10.1038/gt.2011.15; Portmann-Lanz CB, 2006, AM J OBSTET GYNECOL, V194, P664, DOI 10.1016/j.ajog.2006.01.101; PORTOLANI M, 1995, J MED VIROL, V45, P282, DOI 10.1002/jmv.1890450307; Prather WR, 2009, CYTOTHERAPY, V11, P427, DOI 10.1080/14653240902849762; Rath P, 2009, CURR STEM CELL RES T, V4, P44, DOI 10.2174/157488809787169138; Rawlinson WD, 2008, PATHOLOGY, V40, P149, DOI 10.1080/00313020701813792; Ringden O, 2013, STEM CELLS, V31, P592, DOI 10.1002/stem.1314; RIPALTI A, 1995, J VIROL, V69, P2047, DOI 10.1128/JVI.69.4.2047-2057.1995; Rollin R, 2007, OSTEOARTHR CARTILAGE, V15, P475, DOI 10.1016/j.joca.2006.11.007; Rotola A, 1998, P NATL ACAD SCI USA, V95, P13911, DOI 10.1073/pnas.95.23.13911; Schleiss Mark R, 2003, Herpes, V10, P4; Sia KC, 2010, J GENE MED, V12, P848, DOI 10.1002/jgm.1506; Sinigalia E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049630; Smirnov SV, 2007, VIROLOGY, V360, P6, DOI 10.1016/j.virol.2006.09.017; Steigman SA, 2007, CURR PROTOC STEM CEL; Strioga M, 2012, STEM CELLS DEV, V21, P2724, DOI 10.1089/scd.2011.0722; SUBRAHMANYAM M, 1995, BRIT J PLAST SURG, V48, P477, DOI 10.1016/0007-1226(95)90123-X; Sundin M, 2006, BONE MARROW TRANSPL, V37, P1051, DOI 10.1038/sj.bmt.1705368; Sundin M, 2008, BIOL BLOOD MARROW TR, V14, P1172, DOI 10.1016/j.bbmt.2008.08.003; Surbek DV, 2001, HUM REPROD UPDATE, V7, P85, DOI 10.1093/humupd/7.1.085; TEDDER RS, 1987, LANCET, V2, P390; Tran TC, 2011, J CELL PHYSIOL, V226, P224, DOI 10.1002/jcp.22329; van den Berk LCJ, 2008, ARCH IMMUNOL THER EX, V56, P325, DOI 10.1007/s00005-008-0036-z; Ventura C, 2007, J BIOL CHEM, V282, P14243, DOI 10.1074/jbc.M609350200; WARD DJ, 1984, BRIT J PLAST SURG, V37, P191, DOI 10.1016/0007-1226(84)90009-2; Wen WR, 2007, J VIROL, V81, P1037, DOI 10.1128/JVI.01416-06; Whitley R.J., 1996, MED MICROBIOLOGY, V4th ed.; Wolbank S, 2007, TISSUE ENG, V13, P1173, DOI 10.1089/ten.2006.0313; Wu W, 2006, BLOOD, V108, P141, DOI 10.1182/blood-2005-04-1697; Yen BL, 2005, STEM CELLS, V23, P3, DOI 10.1634/stemcells.2004-0098; Yu YQ, 2009, APPL BIOCHEM BIOTECH, V159, P110, DOI 10.1007/s12010-009-8556-5; Zheng L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039119	94	25	26	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2013	8	8							e71412	10.1371/journal.pone.0071412	http://dx.doi.org/10.1371/journal.pone.0071412			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	218XC	23940750	Green Published, gold, Green Submitted			2022-12-25	WOS:000324465000209
J	Chou, RH; Hsieh, SC; Yu, YL; Huang, MH; Huang, YC; Hsieh, YH				Chou, Ruey-Hwang; Hsieh, Shu-Ching; Yu, Yung-Luen; Huang, Min-Hsien; Huang, Yi-Chang; Hsieh, Yi-Hsien			Fisetin Inhibits Migration and Invasion of Human Cervical Cancer Cells by Down-Regulating Urokinase Plasminogen Activator Expression through Suppressing the p38 MAPK-Dependent NF-kappa B Signaling Pathway	PLOS ONE			English	Article							SENTINEL LYMPH-NODE; BONE METASTASIS; MATRIX METALLOPROTEINASE-2; MOLECULAR DIAGNOSIS; BREAST; FLAVONOIDS; CARCINOMA; APOPTOSIS; PROTEIN; LUNG	Fisetin (3,3',4',7-tetrahydroxyflavone), a naturally occurring flavonoid, has been reported to inhibit proliferation and induce apoptosis in several cancer types. However, its effect on the anti-metastatic potential of cervical cancer cells remains unclear. In the present study, we found that fisetin inhibits the invasion and migration of cervical cancer cells. The expression and activity of urokinase plasminogen activator (uPA) was significantly suppressed by fisetin in a dose-dependent manner. We also demonstrated that fisetin reduces the phosphorylation of p38 MAPK, but not that of ERK1/2, JNK1/2, or AKT. Addition of a p38 MAPK inhibitor, SB203580, further enhanced the inhibitory effect of fisetin on the expression and activity of uPA and the invasion and motility in cervical cancer cells. Fisetin suppressed the TPA (tetradecanoylphorbol-13-acetate)-induced activation of p38 MAPK and uPA, and inhibited the TPA-enhanced migratory and invasive abilities. Furthermore, the promoter activity of the uPA gene was dramatically repressed by fisetin, which disrupted the nuclear translocation of NF-kappa B and its binding amount on the promoter of the uPA gene, and these suppressive effects could be further enhanced by SB203580. This study provides strong evidence for the molecular mechanism of fisetin in inhibiting the aggressive phenotypes by repression of uPA via interruption of p38 MAPK-dependent NF-kappa B signaling pathway in cervical cancer cells and thus contributes insight to the potential of using fisetin as a therapeutic strategy against cervical cancer by inhibiting migration and invasion.	[Chou, Ruey-Hwang; Yu, Yung-Luen] China Med Univ, Grad Inst Canc Biol, Taichung, Taiwan; [Chou, Ruey-Hwang; Yu, Yung-Luen] China Med Univ, Ctr Mol Med, Taichung, Taiwan; [Chou, Ruey-Hwang] Asia Univ, Dept Biotechnol, Taichung, Taiwan; [Hsieh, Shu-Ching] Chung Shan Med Univ, Inst Med, Taichung, Taiwan; [Huang, Min-Hsien] Jen Teh Jr Coll Med Nursing & Management, Dept Rehabil Sci, Dept Acupressure Technol, Miaoli, Taiwan; [Huang, Yi-Chang; Hsieh, Yi-Hsien] Chung Shan Med Univ, Inst Biochem & Biotechnol, Coll Med, Taichung, Taiwan; [Hsieh, Yi-Hsien] Chung Shan Med Univ, Sch Med, Dept Biochem, Taichung, Taiwan; [Hsieh, Yi-Hsien] Chung Shan Med Univ Hosp, Dept Clin Lab, Taichung, Taiwan	China Medical University Taiwan; China Medical University Taiwan; Asia University Taiwan; Chung Shan Medical University; Chung Shan Medical University; Chung Shan Medical University; Chung Shan Medical University; Chung Shan Medical University Hospital	Hsieh, YH (corresponding author), Chung Shan Med Univ, Inst Biochem & Biotechnol, Coll Med, Taichung, Taiwan.	hyhsien@csmu.edu.tw	Chou, Ruey-Hwang/K-8541-2013	Chou, Ruey-Hwang/0000-0002-2297-2180	National Science Council, Taiwan [NSC 100-2313-B-040-001, NSC 101-2313-B-040-001]; National Science Council; Ministry of Education; Chung Shan Medical University	National Science Council, Taiwan(Ministry of Science and Technology, Taiwan); National Science Council(Ministry of Science and Technology, Taiwan); Ministry of Education; Chung Shan Medical University	This work was supported by grants from National Science Council, Taiwan (NSC 100-2313-B-040-001 and NSC 101-2313-B-040-001). Confocal microscope and luminescence microplate reader were performed in the Instrument Center of Chung Shan Medical University, which is supported by National Science Council, Ministry of Education and Chung Shan Medical University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal A, 2008, MOL MED REP, V1, P511; Amrouche-Mekkioui I, 2012, EUR J PHARMACOL, V691, P209, DOI 10.1016/j.ejphar.2012.06.014; Andreasen PA, 2000, CELL MOL LIFE SCI, V57, P25, DOI 10.1007/s000180050497; Ass K, 2008, CANCER TREAT REV, V34, P122, DOI 10.1016/j.ctrv.2007.10.005; Baldwin AS, 2001, J CLIN INVEST, V107, P241, DOI 10.1172/JCI11991; Barrantes ID, 2012, BIOCHEM SOC T, V40, P79, DOI 10.1042/BST20110676; Bode AM, 2007, MOL CARCINOGEN, V46, P591, DOI 10.1002/mc.20348; Chaffer CL, 2011, SCIENCE, V331, P1559, DOI 10.1126/science.1203543; Chen F, 2001, AM J PATHOL, V159, P387, DOI 10.1016/S0002-9440(10)61708-7; Chen PN, 2005, CHEM-BIOL INTERACT, V156, P141, DOI 10.1016/j.cbi.2005.08.005; Chen YC, 2002, ARCH TOXICOL, V76, P351, DOI 10.1007/s00204-002-0346-6; Chien CS, 2010, MOL CELL BIOCHEM, V333, P169, DOI 10.1007/s11010-009-0217-z; Clark JCM, 2008, EXPERT OPIN EMERG DR, V13, P609, DOI 10.1517/14728210802584217 ; Daneri-Navarro A, 1998, EUR J CANCER, V34, P566, DOI 10.1016/S0959-8049(97)10038-7; Deryugina EI, 2006, CANCER METAST REV, V25, P9, DOI 10.1007/s10555-006-7886-9; Duffy MJ, 1999, J SURG ONCOL, V71, P130, DOI 10.1002/(SICI)1096-9098(199906)71:2<130::AID-JSO14>3.0.CO;2-9; Eandi JA, 2001, BIOCHEM BIOPH RES CO, V288, P521, DOI 10.1006/bbrc.2001.5803; Faust D, 2012, CELL COMMUN SIGNAL, V10, DOI 10.1186/1478-811X-10-6; Forouzanfar MH, 2011, LANCET, V378, P1461, DOI 10.1016/S0140-6736(11)61351-2; Ghiso JAA, 1999, EUR J BIOCHEM, V263, P295, DOI 10.1046/j.1432-1327.1999.00507.x; Gochman E, 2011, ANTICANCER RES, V31, P1607; Haddad AQ, 2010, NUTR CANCER, V62, P668, DOI 10.1080/01635581003605524; Helbig G, 2003, J BIOL CHEM, V278, P21631, DOI 10.1074/jbc.M300609200; Ho YC, 2007, J ORAL PATHOL MED, V36, P588, DOI 10.1111/j.1600-0714.2007.00588.x; Huang S, 2000, J BIOL CHEM, V275, P12266, DOI 10.1074/jbc.275.16.12266; Kanthan R, 2011, WORLD J SURG ONCOL, V9, DOI 10.1186/1477-7819-9-113; Kao SJ, 2012, TOXICOL APPL PHARM, V261, P105, DOI 10.1016/j.taap.2012.03.020; Katika MR, 2011, TOXICOL APPL PHARM, V254, P311, DOI 10.1016/j.taap.2011.04.021; Lamy S, 2007, J CELL BIOCHEM, V100, P100, DOI 10.1002/jcb.21023; Lee WR, 2002, BIOCHEM PHARMACOL, V63, P225, DOI 10.1016/S0006-2952(01)00876-0; Li JK, 2009, INT J GYNECOL CANCER, V19, P1421, DOI 10.1111/IGC.0b013e3181b70445; Liao YC, 2009, J AGR FOOD CHEM, V57, P8933, DOI 10.1021/jf902630w; MACKAY AR, 1990, CANCER RES, V50, P5997; Beato VM, 2011, PLANT FOOD HUM NUTR, V66, P218, DOI 10.1007/s11130-011-0236-2; MAO L, 2012, BREAST CANCER RES, V12, pR107; Markovic ZS, 2009, J PHYS CHEM A, V113, P14170, DOI 10.1021/jp907071v; Meiyanto E, 2012, ASIAN PAC J CANCER P, V13, P427, DOI 10.7314/APJCP.2012.13.2.427; Moon YJ, 2006, TOXICOL IN VITRO, V20, P187, DOI 10.1016/j.tiv.2005.06.048; Moustapha B, 2011, MOLECULES, V16, P9397, DOI 10.3390/molecules16119397; No JH, 2009, ANN NY ACAD SCI, V1171, P100, DOI 10.1111/j.1749-6632.2009.04898.x; Pan MH, 2011, EVID-BASED COMPL ALT, V2011, P1, DOI 10.1093/ecam/nep093; Park BK, 2007, NAT MED, V13, P62, DOI 10.1038/nm1519; Park JY, 2008, INT J GYNECOL CANCER, V18, P176, DOI 10.1111/j.1525-1438.2007.00972.x; RATANATHARATHORN V, 1994, CANCER, V73, P2372, DOI 10.1002/1097-0142(19940501)73:9<2372::AID-CNCR2820730921>3.0.CO;2-E; Ren WY, 2003, MED RES REV, V23, P519, DOI 10.1002/med.10033; Rhode Jennifer, 2007, BMC Complement Altern Med, V7, P44, DOI 10.1186/1472-6882-7-44; Senthilkumar K, 2011, CELL BIOCHEM FUNCT, V29, P87, DOI 10.1002/cbf.1725; Sharma GD, 2003, J BIOL CHEM, V278, P21989, DOI 10.1074/jbc.M302650200; Sliva D, 2002, J BIOL CHEM, V277, P3150, DOI 10.1074/jbc.M109579200; Suh Y, 2010, CARCINOGENESIS, V31, P1424, DOI 10.1093/carcin/bgq115; Suh Y, 2009, CARCINOGENESIS, V30, P300, DOI 10.1093/carcin/bgn269; Takeuchi H, 2008, CANCER SCI, V99, P441, DOI 10.1111/j.1349-7006.2007.00672.x; TANG L, 2012, BIOMED PHARMACOTHER; Tangjitgamol S, 2004, INT J GYNECOL CANCER, V14, P399, DOI 10.1111/j.1048-891x.2004.14326.x; Thanapprapasr D, 2010, INT J GYNECOL CANCER, V20, P373, DOI 10.1111/IGC.0b013e3181d4a0a1; Tsai SJ, 2012, BIOCHEM BIOPH RES CO, V425, P462, DOI 10.1016/j.bbrc.2012.07.125; Wagner EF, 2009, NAT REV CANCER, V9, P537, DOI 10.1038/nrc2694; Wang CM, 2012, J ETHNOPHARMACOL, V144, P33, DOI 10.1016/j.jep.2012.08.020; Wu KC, 2012, ANTICANCER RES, V32, P4833; Yamamoto K, 2004, ANN THORAC SURG, V77, P1179, DOI 10.1016/j.athoracsur.2003.06.023; Yang AK, 2010, CURR MED CHEM, V17, P1635, DOI 10.2174/092986710791111279; Ying TH, 2012, ARCH TOXICOL, V86, P263, DOI 10.1007/s00204-011-0754-6; Yu YL, 2013, EMBO MOL MED, V5, P531, DOI 10.1002/emmm.201201783; Yu YL, 2012, J BIOL CHEM, V287, P31015, DOI 10.1074/jbc.M112.358077; Yuan SH, 2008, CLIN CANCER RES, V14, P5571, DOI 10.1158/1078-0432.CCR-08-0346; Zhang YY, 2012, MOL MED REP, V6, P1121, DOI 10.3892/mmr.2012.1047; Zong H, 2012, MOL BIOL REP, V39, P4803, DOI 10.1007/s11033-011-1273-5	67	82	87	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2013	8	8							e71983	10.1371/journal.pone.0071983	http://dx.doi.org/10.1371/journal.pone.0071983			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	218XC	23940799	Green Published, gold, Green Submitted			2022-12-25	WOS:000324465000238
J	Hellerbach, A; Schuster, V; Jansen, A; Sommer, J				Hellerbach, Alexandra; Schuster, Verena; Jansen, Andreas; Sommer, Jens			MRI Phantoms - Are There Alternatives to Agar?	PLOS ONE			English	Article							QUALITY-ASSURANCE PROTOCOL; TISSUE; GEL; RELAXOMETRY; RELAXATION	The suitability of different gelling agents as MRI phantoms was evaluated in terms of homogeneity, gel stability and reproducibility. Time and effort for preparation were also taken into account. The relaxation times of various gel compositions were estimated. Carbomer-980 and Carbopol-974P were determined to be promising novel phantom materials. These gelling agents are readily available, inexpensive and easy to handle given that thermal treatment is not required. Furthermore, the viscoelasticity of their polymer network is pH-dependent. With such characteristics, it was even possible to embed sensitive objects and retrieve them after testing. This was demonstrated with a fiber phantom for Diffusion Weighted MRI applications. Since Carbomer-980 and Carbopol-974P are non-hazardous, they are also suitable for multimodal setups (e.g., MRI as well as ultrasonic imaging).	[Hellerbach, Alexandra; Schuster, Verena; Jansen, Andreas; Sommer, Jens] Univ Marburg, Dept Psychiat & Psychotherapy, Marburg, Germany	Philipps University Marburg	Hellerbach, A (corresponding author), Univ Marburg, Dept Psychiat & Psychotherapy, Marburg, Germany.	hellerba@med.uni-marburg.de	Jansen, Andreas/AAL-5264-2020	Jansen, Andreas/0000-0002-3140-8207	Von-Behring-Rontgen-Stiftung, Marburg, Germany	Von-Behring-Rontgen-Stiftung, Marburg, Germany	This study was supported by the Von-Behring-Rontgen-Stiftung, Marburg, Germany. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bille J, 2002, MED PHYS; BLECHINGER JC, 1988, MED PHYS, V15, P629, DOI 10.1118/1.596219; Carneiro AAO, 2006, BRAZ J PHYS, V36, P9, DOI 10.1590/S0103-97332006000100005; Chen CC, 2004, J DIGIT IMAGING, V17, P279, DOI 10.1007/s10278-004-1023-5; CHRISTOFFERSSON JO, 1991, ACTA RADIOL, V32, P426, DOI 10.1177/028418519103200519; Chu KC, 1997, MAGNET RESON MED, V37, P314, DOI 10.1002/mrm.1910370230; DERBYSHIRE W, 1975, FARADAY DISCUSS, V57, P243; Friedman L, 2006, J MAGN RESON IMAGING, V23, P827, DOI 10.1002/jmri.20583; GROCH MW, 1991, MAGN RESON IMAGING, V9, P417, DOI 10.1016/0730-725X(91)90430-T; HOWE FA, 1988, MAGN RESON IMAGING, V6, P263, DOI 10.1016/0730-725X(88)90400-6; Ihalainen TM, 2011, ACTA ONCOL, V50, P966, DOI 10.3109/0284186X.2011.582515; KRAFT KA, 1987, MAGNET RESON MED, V5, P555, DOI 10.1002/mrm.1910050606; Laun FB, 2009, MAGN RESON IMAGING, V27, P541, DOI 10.1016/j.mri.2008.08.011; MADSEN E L, 1982, Magnetic Resonance Imaging, V1, P135, DOI 10.1016/0730-725X(82)90204-1; MANO I, 1986, MAGNET RESON MED, V3, P921, DOI 10.1002/mrm.1910030612; Mazzara GP, 1996, MAGN RESON IMAGING, V14, P639, DOI 10.1016/0730-725X(96)00054-9; MITCHELL M D, 1986, Magnetic Resonance Imaging, V4, P263, DOI 10.1016/0730-725X(86)91068-4; Nyul LG, 1999, MAGNET RESON MED, V42, P1072, DOI 10.1002/(SICI)1522-2594(199912)42:6<1072::AID-MRM11>3.0.CO;2-M; Ohno Seiichiro, 2008, Magn Reson Med Sci, V7, P131; Schnack HG, 2004, HUM BRAIN MAPP, V22, P312, DOI 10.1002/hbm.20040; Stanisz GJ, 2005, MAGNET RESON MED, V54, P507, DOI 10.1002/mrm.20605; Wang ZYJ, 2011, MED PHYS, V38, P4415, DOI 10.1118/1.3595111; Yoshimura K, 2003, MAGNET RESON MED, V50, P1011, DOI 10.1002/mrm.10619	23	62	66	2	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2013	8	8							e70343	10.1371/journal.pone.0070343	http://dx.doi.org/10.1371/journal.pone.0070343			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	218XC	23940563	Green Submitted, Green Published, gold			2022-12-25	WOS:000324465000057
J	Kiper, C; Grimes, B; Van Zant, G; Satin, J				Kiper, Carmen; Grimes, Barry; Van Zant, Gary; Satin, Jonathan			Mouse Strain Determines Cardiac Growth Potential	PLOS ONE			English	Article							SIDE POPULATION CELLS; STEM-CELLS; HUMAN HEART; PROGENITOR CELLS; MYOCARDIAL REGENERATION; INFARCTED MYOCARDIUM; GENE-EXPRESSION; FAILING HEART; C-KIT; HYPERTROPHY	Rationale: The extent of heart disease varies from person to person, suggesting that genetic background is important in pathology. Genetic background is also important when selecting appropriate mouse models to study heart disease. This study examines heart growth as a function of strain, specifically C57BL/6 and DBA/2 mouse strains. Objective: In this study, we test the hypothesis that two strains of mice, C57BL/6 and DBA/2, will produce varying degrees of heart growth in both physiological and pathological settings. Methods and Results: Differences in heart dimensions are detectable by echocardiography at 8 weeks of age. Percentages of cardiac progenitor cells (c-kit+ cells) and mononucleated cells were found to be in a higher percentage in DBA/2 mice, and more tri- and quad-nucleated cells were in C57BL/6 mice. Cardiomyocyte turnover shows no significant changes in mitotic activity, however, there is more apoptotic activity in DBA/2 mice. Cardiomyocyte cell size increased with age, but increased more in DBA/2 mice, although percentages of nucleated cells remained the same in both strains. Two-week isoproterenol stimulation showed an increase in heart growth in DBA/2 mice, both at cardiomyocyte and whole heart level. In isoproterenol-treated DBA/2 mice, there was also a greater expression level of the hypertrophy marker, ANF, compared to C57BL/6 mice. Conclusion: We conclude that the DBA/2 mouse strain has a more immature cardiac phenotype, which correlates to a cardiac protective response to hypertrophy in both physiological and pathological stimulations.	[Kiper, Carmen; Grimes, Barry; Van Zant, Gary; Satin, Jonathan] Univ Kentucky, Coll Med, Dept Physiol, Lexington, KY 40506 USA	University of Kentucky	Satin, J (corresponding author), Univ Kentucky, Coll Med, Dept Physiol, Lexington, KY 40506 USA.	Jsatin1@uky.edu			National Institutes of Health (NIH) [HL074091, T-32 HL086341, HD060915]; NIH-HNLBI [RO1 HL074091]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD060915] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R56HL074091, R01HL074091, T32HL086341] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH-HNLBI; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was funded by National Institutes of Health (NIH) grants HL074091 (JS), the NIH training grant T-32 HL086341 (CEK), HD060915(GV), and NIH-HNLBI RO1 HL074091. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anversa P, 2006, CIRCULATION, V113, P1451, DOI 10.1161/CIRCULATIONAHA.105.595181; Anversa P, 1998, LAB INVEST, V78, P767; Anversa P, 2007, STEM CELLS, V25, P589, DOI 10.1634/stemcells.2006-0623; Barrick CJ, 2007, AM J PHYSIOL-HEART C, V292, pH2119, DOI 10.1152/ajpheart.00816.2006; Bearzi C, 2007, P NATL ACAD SCI USA, V104, P14068, DOI 10.1073/pnas.0706760104; Beltrami AP, 2001, NEW ENGL J MED, V344, P1750, DOI 10.1056/NEJM200106073442303; Beltrami AP, 2003, CELL, V114, P763, DOI 10.1016/S0092-8674(03)00687-1; BENJAMIN IJ, 1989, CIRC RES, V65, P657, DOI 10.1161/01.RES.65.3.657; Bergmann O, 2009, SCIENCE, V324, P98, DOI 10.1126/science.1164680; Blizard DA, 2009, PHYSIOL GENOMICS, V36, P158, DOI 10.1152/physiolgenomics.00035.2008; Cameron VA, 1996, ENDOCRINOLOGY, V137, P817, DOI 10.1210/en.137.3.817; Chen XW, 2007, CIRC RES, V100, P536, DOI 10.1161/01.RES.0000259560.39234.99; Chimenti C, 2003, CIRC RES, V93, P604, DOI 10.1161/01.RES.0000093985.76901.AF; deHaan G, 1997, BLOOD, V89, P1543, DOI 10.1182/blood.V89.5.1543.1543_1543_1550; deHaan G, 1997, J EXP MED, V186, P529, DOI 10.1084/jem.186.4.529; Faulx MD, 2005, AM J PHYSIOL-HEART C, V289, pH30, DOI 10.1152/ajpheart.00636.2004; Faulx MD, 2007, CLIN EXP PHARMACOL P, V34, P77, DOI 10.1111/j.1440-1681.2007.04531.x; Ferreira-Martins J, 2009, CIRC RES, V105, P764, DOI 10.1161/CIRCRESAHA.109.206698; Fransioli J, 2008, STEM CELLS; GERSTENBLITH G, 1977, CIRCULATION, V56, P273, DOI 10.1161/01.CIR.56.2.273; Goldspink DF, 2003, EXP PHYSIOL, V88, P447, DOI 10.1113/eph8802549; Hsieh PCH, 2007, NAT MED, V13, P970, DOI 10.1038/nm1618; Kajstura J, 1998, P NATL ACAD SCI USA, V95, P8801, DOI 10.1073/pnas.95.15.8801; Kajstura J, 2010, CIRC RES, V107, P1374, DOI 10.1161/CIRCRESAHA.110.231498; Kajstura J, 2010, CIRC RES, V107, P305, DOI 10.1161/CIRCRESAHA.110.223024; Krenek P, 2009, EUR J HEART FAIL, V11, P140, DOI 10.1093/eurjhf/hfn026; Kubo H, 2008, CIRCULATION, V118, P649, DOI 10.1161/CIRCULATIONAHA.107.761031; Li M, 2008, CIRC RES, V102, P677, DOI 10.1161/CIRCRESAHA.107.161737; Limana F, 2007, CIRC RES, V101, P1255, DOI 10.1161/CIRCRESAHA.107.150755; Lyngbaek S, 2007, BASIC RES CARDIOL, V102, P101, DOI 10.1007/s00395-007-0638-3; Miyamoto S, 2010, STEM CELLS DEV, V19, P105, DOI 10.1089/scd.2009.0041; Oh H, 2003, P NATL ACAD SCI USA, V100, P12313, DOI 10.1073/pnas.2132126100; Olivetti G, 1996, J MOL CELL CARDIOL, V28, P1463, DOI 10.1006/jmcc.1996.0137; OLIVETTI G, 1987, J CLIN INVEST, V80, P1818, DOI 10.1172/JCI113278; Pfister O, 2005, CIRC RES, V97, P52, DOI 10.1161/01.RES.0000173297.53793.fa; Pfister O, 2008, CIRC RES, V103, P825, DOI 10.1161/CIRCRESAHA.108.174615; Porrello ER, 2010, CIRC RES, V107, P1292, DOI 10.1161/CIRCRESAHA.110.235168; Razeghi P, 2001, CIRCULATION, V104, P2923, DOI 10.1161/hc4901.100526; Rota M, 2008, CIRC RES, V103, P107, DOI 10.1161/CIRCRESAHA.108.178525; Rota M, 2007, CIRC RES, V101, P387, DOI 10.1161/CIRCRESAHA.107.151449; Shah AP, 2010, CARDIOVASC RES, V87, P683, DOI 10.1093/cvr/cvq111; SZABO J, 1975, ACTA PHYSIOL HUNG, V46, P281; Tallini YN, 2009, P NATL ACAD SCI USA, V106, P1808, DOI 10.1073/pnas.0808920106; Torella D, 2004, CIRC RES, V94, P514, DOI 10.1161/01.RES.0000117306.10142.50; Urbanek K, 2005, CIRC RES, V97, P663, DOI 10.1161/01.RES.0000183733.53101.11; Urbanek K, 2003, P NATL ACAD SCI USA, V100, P10440, DOI 10.1073/pnas.1832855100; van den Borne SWM, 2009, CARDIOVASC RES, V84, P273, DOI 10.1093/cvr/cvp207; Zaruba MM, 2010, CIRCULATION, V121, P1992, DOI 10.1161/CIRCULATIONAHA.109.909093	48	14	14	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2013	8	8							e70512	10.1371/journal.pone.0070512	http://dx.doi.org/10.1371/journal.pone.0070512			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	218XC	23940585	Green Published, Green Submitted, gold			2022-12-25	WOS:000324465000079
J	Dudakovic, A; Evans, JM; Li, Y; Middha, S; McGee-Lawrence, ME; van Wijnen, AJ; Westendorf, JJ				Dudakovic, Amel; Evans, Jared M.; Li, Ying; Middha, Sumit; McGee-Lawrence, Meghan E.; van Wijnen, Andre J.; Westendorf, Jennifer J.			Histone Deacetylase Inhibition Promotes Osteoblast Maturation by Altering the Histone H4 Epigenome and Reduces Akt Phosphorylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Akt; Bone; Corepressor Transcription; Epigenetics; Osteoblasts; Nherf1; Slc9a3r1; HDAC; Histone H4; Vorinostat	SUBEROYLANILIDE HYDROXAMIC ACID; ELEMENT ANNOTATION SYSTEM; MESENCHYMAL STEM-CELLS; LARGE GENE LISTS; OSTEOGENIC DIFFERENTIATION; SODIUM-BUTYRATE; TRICHOSTATIN-A; IN-VITRO; EXPRESSION; RUNX2	Bone has remarkable regenerative capacity, but this ability diminishes during aging. Histone deacetylase inhibitors (HDIs) promote terminal osteoblast differentiation and extracellular matrix production in culture. The epigenetic events altered by HDIs in osteoblasts may hold clues for the development of new anabolic treatments for osteoporosis and other conditions of low bone mass. To assess how HDIs affect the epigenome of committed osteoblasts, MC3T3 cells were treated with suberoylanilide hydroxamic acid (SAHA) and subjected to microarray gene expression profiling and high-throughput ChIP-Seq analysis. As expected, SAHA induced differentiation and matrix calcification of osteoblasts in vitro. ChIP-Seq analysis revealed that SAHA increased histone H4 acetylation genome-wide and in differentially regulated genes, except for the 500 bp upstream of transcriptional start sites. Pathway analysis indicated that SAHA increased the expression of insulin signaling modulators, including Slc9a3r1. SAHA decreased phosphorylation of insulin receptor , Akt, and the Akt substrate FoxO1, resulting in FoxO1 stabilization. Thus, SAHA induces genome-wide H4 acetylation and modulates the insulin/Akt/FoxO1 signaling axis, whereas it promotes terminal osteoblast differentiation in vitro.	[Dudakovic, Amel; McGee-Lawrence, Meghan E.; Westendorf, Jennifer J.] Mayo Clin, Dept Orthoped Surg, Rochester, MN 55905 USA; [Evans, Jared M.; Li, Ying; Middha, Sumit] Mayo Clin, Div Biomed Stat & Informat, Rochester, MN 55905 USA; [van Wijnen, Andre J.; Westendorf, Jennifer J.] Mayo Clin, Ctr Regenerat Med, Rochester, MN 55905 USA	Mayo Clinic; Mayo Clinic; Mayo Clinic	Westendorf, JJ (corresponding author), Mayo Clin, Dept Orthoped Surg, 200 First St SW, Rochester, MN 55905 USA.	westendorf.jennifer@mayo.edu	van Wijnen, Andre J./AAG-3578-2019	van Wijnen, Andre J./0000-0002-4458-0946; Middha, Sumit/0000-0003-4135-6268; McGee-Lawrence, Meghan/0000-0002-2728-5849; Dudakovic, Amel/0000-0002-8850-3977	National Institutes of Health [R01 AR048147, R01 DE020194, AR049069, AR60140]; Mayo Clinic Center for Individualized Medicine; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR049069, F32AR060140, R01AR048147] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE020194] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Mayo Clinic Center for Individualized Medicine; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 AR048147 and R01 DE020194 (to J. J. W.), Grant AR049069 (to A. J. v. W.), and Grant AR60140 (to M. E. M.-L.). This work was also supported by the Mayo Clinic Center for Individualized Medicine.	Alberts AS, 1998, CELL, V92, P475, DOI 10.1016/S0092-8674(00)80941-1; Ballman KV, 2004, BIOINFORMATICS, V20, P2778, DOI 10.1093/bioinformatics/bth327; Bradley EW, 2013, J BIOL CHEM, V288, P9572, DOI 10.1074/jbc.M112.423723; Di Bernardo G, 2009, STEM CELLS DEV, V18, P573, DOI 10.1089/scd.2008.0172; Gibney ER, 2010, HEREDITY, V105, P4, DOI 10.1038/hdy.2010.54; Grunstein M, 1997, NATURE, V389, P349, DOI 10.1038/38664; Gryder BE, 2012, FUTURE MED CHEM, V4, P505, DOI [10.4155/FMC.12.3, 10.4155/fmc.12.3]; Haberland M, 2010, J BIOL CHEM, V285, P14663, DOI 10.1074/jbc.M109.081679; Hu XQ, 2013, STEM CELLS DEV, V22, P248, DOI 10.1089/scd.2012.0105; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Hutt DM, 2010, NAT CHEM BIOL, V6, P25, DOI [10.1038/NCHEMBIO.275, 10.1038/nchembio.275]; IWAMI K, 1993, INT J BIOCHEM, V25, P1631, DOI 10.1016/0020-711X(93)90522-G; Jensen ED, 2008, J BONE MINER RES, V23, P361, DOI 10.1359/JBMR.071104; Ji XW, 2006, NUCLEIC ACIDS RES, V34, pW551, DOI 10.1093/nar/gkl322; Kaplan N, 2009, NATURE, V458, P362, DOI 10.1038/nature07667; Kim HN, 2011, J BONE MINER RES, V26, P2161, DOI 10.1002/jbmr.426; Kim HJ, 2011, AM J TRANSL RES, V3, P166; LaBonte MJ, 2009, BMC MED GENOMICS, V2, DOI 10.1186/1755-8794-2-67; Lee HW, 2006, MOL ENDOCRINOL, V20, P2432, DOI 10.1210/me.2006-0061; Lee S, 2009, CELL PROLIFERAT, V42, P711, DOI 10.1111/j.1365-2184.2009.00633.x; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Liu L, 2012, J BIOL CHEM, V287, P43312, DOI 10.1074/jbc.M112.422766; Maroni P, 2012, BIOCHEM BIOPH RES CO, V428, P271, DOI 10.1016/j.bbrc.2012.10.044; Marrocco DL, 2007, MOL CANCER THER, V6, P51, DOI 10.1158/1535-7163.MCT-06-0144; McGee-Lawrence ME, 2013, J BIOL CHEM, V288, P5291, DOI 10.1074/jbc.M112.414995; McGee-Lawrence ME, 2011, GENE, V474, P1, DOI 10.1016/j.gene.2010.12.003; Molina JR, 2012, ONCOGENE, V31, P1264, DOI 10.1038/onc.2011.324; Peterson CL, 2004, CURR BIOL, V14, pR546, DOI 10.1016/j.cub.2004.07.007; Rada-Iglesias A, 2007, GENOME RES, V17, P708, DOI 10.1101/gr.5540007; Rahman MM, 2003, BLOOD, V101, P3451, DOI 10.1182/blood-2002-08-2622; Sadeh R, 2011, CELL, V147, P263, DOI 10.1016/j.cell.2011.09.042; Schroeder TM, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-362; Schroeder TM, 2005, J BONE MINER RES, V20, P2254, DOI 10.1359/JBMR.050813; Schroeder TM, 2004, J BIOL CHEM, V279, P41998, DOI 10.1074/jbc.M403702200; Shin HJ, 2009, BIOINFORMATICS, V25, P2605, DOI 10.1093/bioinformatics/btp479; Wang B, 2007, J BIOL CHEM, V282, P36214, DOI 10.1074/jbc.M707263200; Wang B, 2009, MOL PHARMACOL, V75, P1189, DOI 10.1124/mol.108.054486; Wang D, 1999, J BONE MINER RES, V14, P893, DOI 10.1359/jbmr.1999.14.6.893; Westendorf JJ, 2004, GENE, V341, P19, DOI 10.1016/j.gene.2004.06.044; Westendorf JJ, 2002, MOL CELL BIOL, V22, P7982, DOI 10.1128/MCB.22.22.7982-7992.2002; Wightman F, 2012, IMMUNOL CELL BIOL, V90, P47, DOI 10.1038/icb.2011.95; Yi T, 2007, EXP MOL MED, V39, P213, DOI 10.1038/emm.2007.24; Yin D, 2007, CLIN CANCER RES, V13, P1045, DOI 10.1158/1078-0432.CCR-06-1261; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137	45	62	63	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 4	2013	288	40					28783	28791		10.1074/jbc.M113.489732	http://dx.doi.org/10.1074/jbc.M113.489732			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	298BL	23940046	Green Published, hybrid			2022-12-25	WOS:000330298800031
J	Weber, BW; Kimani, SW; Varsani, A; Cowan, DA; Hunter, R; Venter, GA; Gumbart, JC; Sewell, BT				Weber, Brandon W.; Kimani, Serah W.; Varsani, Arvind; Cowan, Donald A.; Hunter, Roger; Venter, Gerhard A.; Gumbart, James C.; Sewell, B. Trevor			The Mechanism of the Amidases MUTATING THE GLUTAMATE ADJACENT TO THE CATALYTIC TRIAD INACTIVATES THE ENZYME DUE TO SUBSTRATE MISPOSITIONING	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Chemical Biology; Enzyme Mechanisms; Enzyme Structure; Quantum Chemistry; X-ray Crystallography; Amidase	GEOBACILLUS-PALLIDUS RAPC8; AMINO ACID AMIDOHYDROLASE; AMBER FORCE-FIELD; NITRILASE SUPERFAMILY; ALIPHATIC AMIDASE; CRYSTAL-STRUCTURE; DENSITY; ENERGIES; ONIOM; SIMULATIONS	All known nitrilase superfamily amidase and carbamoylase structures have an additional glutamate that is hydrogen bonded to the catalytic lysine in addition to the Glu, Lys, Cys catalytic triad. In the amidase from Geobacillus pallidus, mutating this glutamate (Glu-142) to a leucine or aspartate renders the enzyme inactive. X-ray crystal structure determination shows that the structural integrity of the enzyme is maintained despite the mutation with the catalytic cysteine (Cys-166), lysine (Lys-134), and glutamate (Glu-59) in positions similar to those of the wild-type enzyme. In the case of the E142L mutant, a chloride ion is located in the position occupied by Glu-142 O-E1 in the wild-type enzyme and interacts with the active site lysine. In the case of the E142D mutant, this site is occupied by Asp-142 O-1. In neither case is an atom located at the position of Glu-142 O-E2 in the wild-type enzyme. The active site cysteine of the E142L mutant was found to form a Michael adduct with acrylamide, which is a substrate of the wild-type enzyme, due to an interaction that places the double bond of the acrylamide rather than the amide carbonyl carbon adjacent to the active site cysteine. Our results demonstrate that in the wild-type active site a crucial role is played by the hydrogen bond between Glu-142 O-E2 and the substrate amino group in positioning the substrate with the correct stereoelectronic alignment to enable the nucleophilic attack on the carbonyl carbon by the catalytic cysteine.	[Weber, Brandon W.; Kimani, Serah W.; Varsani, Arvind; Sewell, B. Trevor] Univ Cape Town, Struct Biol Res Unit, Div Med Biochem, Dept Clin Lab Sci, ZA-7925 Observatory, Western Cape, South Africa; [Sewell, B. Trevor] Univ Cape Town, Inst Infect Dis & Mol Med, ZA-7925 Observatory, Western Cape, South Africa; [Kimani, Serah W.] Univ Cape Town, Dept Mol & Cell Biol, ZA-7700 Rondebosch, Western Cape, South Africa; [Varsani, Arvind] Univ Canterbury, Sch Biol Sci, Christchurch 8140, New Zealand; [Varsani, Arvind] Univ Canterbury, Biomol Interact Ctr, Christchurch 8140, New Zealand; [Cowan, Donald A.] Univ Western Cape, Inst Microbial Biotechnol & Metagen, Dept Biotechnol, ZA-7535 Cape Town, South Africa; [Cowan, Donald A.] Univ Pretoria, Dept Genet, ZA-0002 Pretoria, South Africa; [Hunter, Roger; Venter, Gerhard A.] Univ Cape Town, Dept Chem, Sci Comp Res Unit, ZA-7700 Rondebosch, South Africa; [Gumbart, James C.] Georgia Inst Technol, Sch Phys, Atlanta, GA 30332 USA	University of Cape Town; University of Cape Town; University of Cape Town; University of Canterbury; University of Canterbury; University of the Western Cape; University of Pretoria; University of Cape Town; University System of Georgia; Georgia Institute of Technology	Sewell, BT (corresponding author), Univ Cape Town, Struct Biol Res Unit, Dept Clin Lab Sci, Inst Infect Dis & Mol Med, ZA-7925 Observatory, Western Cape, South Africa.	Trevor.Sewell@uct.ac.za	Cowan, Donald A/E-3991-2012; Venter, Gerhard/GQI-1207-2022	Cowan, Donald A/0000-0001-8059-861X; Venter, Gerhard/0000-0003-3993-1198; Varsani, Arvind/0000-0003-4111-2415; Sewell, Bryan Trevor/0000-0002-6701-2394; Hunter, Roger/0000-0001-8775-083X	National Research Foundation; Carnegie Corporation of New York; National Institutes of Health [K22-AI100927]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K22AI100927] Funding Source: NIH RePORTER	National Research Foundation; Carnegie Corporation of New York; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by grants from the National Research Foundation and the Carnegie Corporation of New York.; Supported by Grant K22-AI100927 from the National Institutes of Health.	Agarkar VB, 2006, ACTA CRYSTALLOGR F, V62, P1174, DOI 10.1107/S1744309106043855; Andrade J, 2007, J BIOL CHEM, V282, P19598, DOI 10.1074/jbc.M701039200; BAYLY CI, 1993, J PHYS CHEM-US, V97, P10269, DOI 10.1021/j100142a004; BECKE AD, 1993, J CHEM PHYS, V98, P5648, DOI 10.1063/1.464913; BORK P, 1994, PROTEIN SCI, V3, P1344, DOI 10.1002/pro.5560030821; Cameron RA, 2005, BBA-GEN SUBJECTS, V1725, P35, DOI 10.1016/j.bbagen.2005.03.019; Chen CY, 2003, J BIOL CHEM, V278, P26194, DOI 10.1074/jbc.M302384200; Chien CH, 2012, J BIOL CHEM, V287, P25715, DOI 10.1074/jbc.M111.259119; CORNELL WD, 1993, J AM CHEM SOC, V115, P9620, DOI 10.1021/ja00074a030; Dapprich S, 1999, J MOL STRUC-THEOCHEM, V461, P1, DOI 10.1016/S0166-1280(98)00475-8; Diederichs K, 1997, NAT STRUCT BIOL, V4, P269, DOI 10.1038/nsb0497-269; Duan Y, 2003, J COMPUT CHEM, V24, P1999, DOI 10.1002/jcc.10349; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Fernandes BCM, 2006, ADV SYNTH CATAL, V348, P2597, DOI 10.1002/adsc.200600269; Frisch M. J., 2009, GAUSSIAN 09 REVISION; HORN DB, 1966, CLIN CHIM ACTA, V14, P185, DOI 10.1016/0009-8981(66)90085-4; Hung CL, 2007, J BIOL CHEM, V282, P12220, DOI 10.1074/jbc.M609134200; Jandhyala DM, 2005, APPL MICROBIOL BIOT, V68, P327, DOI 10.1007/s00253-005-1903-8; Kimani SW, 2007, ACTA CRYSTALLOGR D, V63, P1048, DOI 10.1107/S090744490703836X; Krasnikov BF, 2009, BIOCHIMIE, V91, P1072, DOI 10.1016/j.biochi.2009.07.003; LEE CT, 1988, PHYS REV B, V37, P785, DOI 10.1103/PhysRevB.37.785; Lee MC, 2004, PROTEINS, V55, P620, DOI 10.1002/prot.10470; MAESTRACCI M, 1986, AGR BIOL CHEM TOKYO, V50, P2237, DOI 10.1080/00021369.1986.10867736; Makhongela HS, 2007, APPL MICROBIOL BIOT, V75, P801, DOI 10.1007/s00253-007-0883-2; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nakai T, 2000, STRUCTURE, V8, P729, DOI 10.1016/S0969-2126(00)00160-X; Nel AJM, 2011, APPL ENVIRON MICROB, V77, P3696, DOI 10.1128/AEM.02726-10; Pace HC, 2001, GENOME BIOL, V2; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pflugrath JW, 1999, ACTA CRYSTALLOGR D, V55, P1718, DOI 10.1107/S090744499900935X; Piotrowski M, 2008, PHYTOCHEMISTRY, V69, P2655, DOI 10.1016/j.phytochem.2008.08.020; Raczynska JE, 2011, J STRUCT BIOL, V173, P294, DOI 10.1016/j.jsb.2010.11.017; Soriano-Maldonado P, 2011, APPL ENVIRON MICROB, V77, P5761, DOI 10.1128/AEM.00312-11; STEPHENS PJ, 1994, J PHYS CHEM-US, V98, P11623, DOI 10.1021/j100096a001; STEVENSON DE, 1990, FEBS LETT, V277, P112, DOI 10.1016/0014-5793(90)80821-Y; Tao P, 2010, J COMPUT CHEM, V31, P2363, DOI 10.1002/jcc.21524; Thuku RN, 2009, J APPL MICROBIOL, V106, P703, DOI 10.1111/j.1365-2672.2008.03941.x; VOSKO SH, 1980, CAN J PHYS, V58, P1200, DOI 10.1139/p80-159; Vreven T, 2006, J CHEM THEORY COMPUT, V2, P815, DOI 10.1021/ct050289g; Wang JM, 2004, J COMPUT CHEM, V25, P1157, DOI 10.1002/jcc.20035	40	23	23	1	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 4	2013	288	40					28514	28523		10.1074/jbc.M113.503284	http://dx.doi.org/10.1074/jbc.M113.503284			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	298BL	23946488	Green Published, hybrid			2022-12-25	WOS:000330298800009
J	Qian, C; Qian, L; Yu, YZ; An, HZ; Guo, ZH; Han, YM; Chen, YJ; Bai, Y; Wang, QQ; Cao, XT				Qian, Cheng; Qian, Li; Yu, Yizhi; An, Huazhang; Guo, Zhenhong; Han, Yanmei; Chen, Yongjian; Bai, Yi; Wang, Qingqing; Cao, Xuetao			Fas Signal Promotes the Immunosuppressive Function of Regulatory Dendritic Cells via the ERK/beta-Catenin Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLYCOGEN-SYNTHASE KINASE-3; BETA-CATENIN; T-CELLS; TOLEROGENIC RESPONSES; IMMUNE-RESPONSES; EXPRESSION; TOLERANCE; ACTIVATION; DIFFERENTIATION; INNATE	Dendritic cells (DCs) play important roles in the initiation of immune response and also in the maintenance of immune tolerance. Now, many kinds of regulatory DCs with different phenotypes have been identified to suppress immune response and contribute to the control of autoimmune diseases. However, the mechanisms by which regulatory DCs can be regulated to exert the immunosuppressive function in the immune microenvironment remain to be fully investigated. In addition, how T cells, once activated, can feedback affect the function of regulatory DCs during immune response needs to be further identified. We previously identified a unique subset of CD11b(hi)Ia(low) regulatory DCs, differentiated from mature DCs or hematopoietic stem cells under a stromal microenvironment in spleen and liver, which can negatively regulate immune response in a feedback way. Here, we show that CD11b(hi)Ia(low) regulatory DCs expressed high level of Fas, and endothelial stromal cell-derived TGF-beta could induce high expression of Fas on regulatory DCs via ERK activation. Fas ligation could promote regulatory DCs to inhibit CD4(+) T cell proliferation more significantly. Furthermore, Fas ligation preferentially induced regulatory DCs to produce IL-10 and IP-10 via ERK-mediated inactivation of GSK-3 and subsequent up-regulation of beta-catenin. Interestingly, activated T cells could promote regulatory DCs to secrete more IL-10 and IP-10 partially through FasL. Therefore, our results demonstrate that Fas signal, at least from the activated T cells, can promote the immunosuppressive function of Fas-expressing regulatory DCs, providing a new manner for the regulatory DCs to regulate adaptive immunity.	[Qian, Cheng; Qian, Li; Yu, Yizhi; An, Huazhang; Guo, Zhenhong; Han, Yanmei; Chen, Yongjian; Bai, Yi; Cao, Xuetao] Second Mil Med Univ, Natl Key Lab Med Immunol, Shanghai 200433, Peoples R China; [Qian, Cheng; Qian, Li; Yu, Yizhi; An, Huazhang; Guo, Zhenhong; Han, Yanmei; Chen, Yongjian; Bai, Yi; Cao, Xuetao] Second Mil Med Univ, Inst Immunol, Shanghai 200433, Peoples R China; [Wang, Qingqing; Cao, Xuetao] Zhejiang Univ, Sch Med, Inst Immunol, Hangzhou 310058, Zhejiang, Peoples R China; [Cao, Xuetao] Chinese Acad Med Sci, Natl Key Lab Med Mol Biol, Beijing 100730, Peoples R China	Naval Medical University; Naval Medical University; Zhejiang University; Chinese Academy of Medical Sciences - Peking Union Medical College	Cao, XT (corresponding author), Second Mil Med Univ, Natl Key Lab Med Immunol, Shanghai 200433, Peoples R China.	caoxt@immunol.org	Guo, Zhenhong/HGB-4912-2022; Han, Yanmei/D-8995-2016; yu, yizhi/ADP-7854-2022		Shanghai Rising-Star Program (A type) Grant [12QA1404100]; National Natural Science Foundation of China [30972704, 81230074, 81123006]; National Key Basic Research Program of China [2013CB530500]; Foundation for the Authors of National Excellent Doctoral Dissertations of China [201180]; Training Program Foundation for Excellent Young Teachers of Colleges and Universities of Shanghai	Shanghai Rising-Star Program (A type) Grant; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Basic Research Program of China(National Basic Research Program of China); Foundation for the Authors of National Excellent Doctoral Dissertations of China(Foundation for the Author of National Excellent Doctoral Dissertation of China); Training Program Foundation for Excellent Young Teachers of Colleges and Universities of Shanghai	This work was supported by Shanghai Rising-Star Program (A type) Grant 12QA1404100; National Natural Science Foundation of China Grants 30972704, 81230074, and 81123006; National Key Basic Research Program of China Grant 2013CB530500; Foundation for the Authors of National Excellent Doctoral Dissertations of China Grant 201180; and the Training Program Foundation for Excellent Young Teachers of Colleges and Universities of Shanghai.	Angers S, 2009, NAT REV MOL CELL BIO, V10, P468, DOI 10.1038/nrm2717; Askenasy N, 2005, BLOOD, V105, P1396, DOI 10.1182/blood-2004-06-2364; Bai Y, 2012, J IMMUNOL, V188, P5293, DOI 10.4049/jimmunol.1102371; Belz GT, 2012, NAT REV IMMUNOL, V12, P101, DOI 10.1038/nri3149; Beurel E, 2010, TRENDS IMMUNOL, V31, P24, DOI 10.1016/j.it.2009.09.007; Bouillet P, 2009, NAT REV IMMUNOL, V9, P514, DOI 10.1038/nri2570; Collin M, 2011, NAT REV IMMUNOL, V11, P575, DOI 10.1038/nri3046; Ding QQ, 2005, MOL CELL, V19, P159, DOI 10.1016/j.molcel.2005.06.009; Feigelson SW, 2011, BLOOD, V117, P7042, DOI 10.1182/blood-2010-12-322859; Guo ZH, 2005, BLOOD, V106, P2033, DOI 10.1182/blood-2004-12-4831; Guo ZH, 2003, BLOOD, V102, P4441, DOI 10.1182/blood-2002-11-3420; Hammer GE, 2011, NAT IMMUNOL, V12, P1184, DOI 10.1038/ni.2135; Hartmann K, 1997, J IMMUNOL, V159, P4006; HUGHES K, 1993, EMBO J, V12, P803, DOI 10.1002/j.1460-2075.1993.tb05715.x; Ilarregui JM, 2009, NAT IMMUNOL, V10, P981, DOI 10.1038/ni.1772; Kalas W, 2002, LEUKEMIA LYMPHOMA, V43, P1469, DOI 10.1080/1042819022386815; Keir ME, 2008, ANNU REV IMMUNOL, V26, P677, DOI 10.1146/annurev.immunol.26.021607.090331; Letellier E, 2010, IMMUNITY, V32, P240, DOI 10.1016/j.immuni.2010.01.011; Li XR, 1999, J BIOL CHEM, V274, P35203, DOI 10.1074/jbc.274.49.35203; Liu XG, 2011, NAT IMMUNOL, V12, P416, DOI 10.1038/ni.2015; Lucas JA, 2008, J IMMUNOL, V181, P2513, DOI 10.4049/jimmunol.181.4.2513; Ma DY, 2009, SEMIN IMMUNOL, V21, P265, DOI 10.1016/j.smim.2009.05.010; Ma F, 2011, NAT IMMUNOL, V12, P861, DOI 10.1038/ni.2073; MacDonald BT, 2009, DEV CELL, V17, P9, DOI 10.1016/j.devcel.2009.06.016; Manicassamy S, 2011, IMMUNOL REV, V241, P206, DOI 10.1111/j.1600-065X.2011.01015.x; Martin M, 2005, NAT IMMUNOL, V6, P777, DOI 10.1038/ni1221; Mohammadzadeh A, 2012, RHEUMATOL INT, V32, P2833, DOI 10.1007/s00296-011-2065-x; Morelli AE, 2007, NAT REV IMMUNOL, V7, P610, DOI 10.1038/nri2132; Mosimann C, 2009, NAT REV MOL CELL BIO, V10, P276, DOI 10.1038/nrm2654; Pulendran B, 2010, NAT IMMUNOL, V11, P647, DOI 10.1038/ni.1894; Qian C, 2007, BLOOD, V109, P3308, DOI 10.1182/blood-2006-08-040337; Qian C, 2006, BLOOD, V108, P2307, DOI 10.1182/blood-2006-03-005595; Qian C, 2012, EUR J IMMUNOL, V42, P1388, DOI 10.1002/eji.201242632; Qian L, 2012, BLOOD, V120, P581, DOI 10.1182/blood-2011-08-377242; Quezada SA, 2004, ANNU REV IMMUNOL, V22, P307, DOI 10.1146/annurev.immunol.22.012703.104533; Rodionova E, 2007, BLOOD, V109, P1584, DOI 10.1182/blood-2006-06-028951; Roozendaal R, 2011, ANNU REV IMMUNOL, V29, P23, DOI 10.1146/annurev-immunol-031210-101357; Schutze S, 2008, NAT REV MOL CELL BIO, V9, P655, DOI 10.1038/nrm2430; Shortman K, 2007, NAT REV IMMUNOL, V7, P19, DOI 10.1038/nri1996; Strasser A, 2009, IMMUNITY, V30, P180, DOI 10.1016/j.immuni.2009.01.001; Strobl H, 1996, J IMMUNOL, V157, P1499; Takahashi-Yanaga F, 2004, BIOCHEM BIOPH RES CO, V316, P411, DOI 10.1016/j.bbrc.2004.02.061; Tang H, 2006, BLOOD, V108, P1189, DOI 10.1182/blood-2006-01-007187; Wang HZ, 2011, CYTOKINE, V53, P130, DOI 10.1016/j.cyto.2010.10.009; Wilson NS, 2009, NAT IMMUNOL, V10, P348, DOI 10.1038/ni.1714; Wood KJ, 2012, NAT REV IMMUNOL, V12, P417, DOI 10.1038/nri3227; Wray J, 2011, NAT CELL BIOL, V13, P838, DOI 10.1038/ncb2267; Xia S, 2008, BLOOD, V112, P3175, DOI 10.1182/blood-2008-05-159921; Xu S, 2012, NAT IMMUNOL, V13, P551, DOI 10.1038/ni.2283; Xu XF, 2011, BLOOD, V117, P1218, DOI 10.1182/blood-2010-05-285494; Yang PY, 2010, NAT IMMUNOL, V11, P487, DOI 10.1038/ni.1876; Zhang MH, 2004, NAT IMMUNOL, V5, P1124, DOI 10.1038/ni1130	53	33	33	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 27	2013	288	39					27825	27835		10.1074/jbc.M112.425751	http://dx.doi.org/10.1074/jbc.M112.425751			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302OB	23943615	Green Published, hybrid			2022-12-25	WOS:000330612800011
J	Orabi, AI; Muili, KA; Javed, TA; Jin, SQ; Jayaraman, T; Lund, FE; Husain, SZ				Orabi, Abrahim I.; Muili, Kamaldeen A.; Javed, Tanveer A.; Jin, Shunqian; Jayaraman, Thottala; Lund, Frances E.; Husain, Sohail Z.			Cluster of Differentiation 38 (CD38) Mediates Bile Acid-induced Acinar Cell Injury and Pancreatitis through Cyclic ADP-ribose and Intracellular Calcium Release	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INOSITOL TRISPHOSPHATE RECEPTORS; ADENINE-DINUCLEOTIDE PHOSPHATE; CERULEIN-INDUCED PANCREATITIS; CA2+-INDUCED CA2+ RELEASE; RYANODINE-RECEPTORS; INSULIN-SECRETION; ENDOPLASMIC-RETICULUM; PROTEASE ACTIVATION; SURFACE-MOLECULE; IP3 RECEPTORS	Aberrant Ca2+ signals within pancreatic acinar cells are an early and critical feature in acute pancreatitis, yet it is unclear how these signals are generated. An important mediator of the aberrant Ca2+ signals due to bile acid exposure is the intracellular Ca2+ channel ryanodine receptor. One putative activator of the ryanodine receptor is the nucleotide second messenger cyclic ADP-ribose (cADPR), which is generated by an ectoenzyme ADP-ribosyl cyclase, CD38. In this study, we examined the role of CD38 and cADPR in acinar cell Ca2+ signals and acinar injury due to bile acids using pharmacologic inhibitors of CD38 and cADPR as well as mice deficient in Cd38 (Cd38(-/-)). Cytosolic Ca2+ signals were imaged using live time-lapse confocal microscopy in freshly isolated mouse acinar cells during perifusion with the bile acid taurolithocholic acid 3-sulfate (TLCS; 500 mu M). To focus on intracellular Ca2+ release and to specifically exclude Ca2+ influx, cells were perifused in Ca2+-free medium. Cell injury was assessed by lactate dehydrogenase leakage and propidium iodide uptake. Pretreatment with either nicotinamide (20 mM) or the cADPR antagonist 8-Br-cADPR (30 mu M) abrogated TLCS-induced Ca2+ signals and cell injury. TLCS-induced Ca2+ release and cell injury were reduced by 30 and 95%, respectively, in Cd38-deficient acinar cells compared with wild-type cells (p < 0.05). Cd38-deficient mice were protected against a model of bile acid infusion pancreatitis. In summary, these data indicate that CD38-cADPR mediates bile acid-induced pancreatitis and acinar cell injury through aberrant intracellular Ca2+ signaling.	[Orabi, Abrahim I.; Muili, Kamaldeen A.; Javed, Tanveer A.; Jin, Shunqian; Husain, Sohail Z.] Univ Pittsburgh, Sch Med, UPMC, Childrens Hosp Pittsburgh,Dept Pediat, Pittsburgh, PA 15224 USA; [Jayaraman, Thottala] Univ Pittsburgh, Sch Med, UPMC, Childrens Hosp Pittsburgh,Dept Internal Med, Pittsburgh, PA 15224 USA; [Lund, Frances E.] Univ Alabama Birmingham, Dept Microbiol, Birmingham, AL 35213 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Alabama System; University of Alabama Birmingham	Husain, SZ (corresponding author), UPMC, Childrens Hosp Pittsburgh, Rangos Res Ctr, 4401 Penn Ave, Pittsburgh, PA 15224 USA.	sohail.husain@chp.edu		Husain, Sohail Z/0000-0003-3012-1308	National Institutes of Health [DK083327, DK093491]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK083327, R01DK093491, T32DK007017] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants DK083327 and DK093491 (to S. Z. H.).	Bai HX, 2011, J PEDIATR GASTR NUTR, V52, P262, DOI 10.1097/MPG.0b013e3182061d75; Bottino R., 2012, J TRANSPLANT, V2012; Bruzzone S, 2007, P NATL ACAD SCI USA, V104, P5759, DOI 10.1073/pnas.0609379104; Burdakov D, 2001, CELL CALCIUM, V29, P211, DOI 10.1054/ceca.2000.0188; Cancela JM, 1998, PFLUG ARCH EUR J PHY, V435, P746, DOI 10.1007/s004240050578; Chaudhuri A, 2007, AM J PHYSIOL-GASTR L, V292, pG1403, DOI 10.1152/ajpgi.00478.2005; Cockayne DA, 1998, BLOOD, V92, P1324, DOI 10.1182/blood.V92.4.1324.416k26_1324_1333; Cosker F, 2010, J BIOL CHEM, V285, P38251, DOI 10.1074/jbc.M110.125864; Criddle DN, 2004, P NATL ACAD SCI USA, V101, P10738, DOI 10.1073/pnas.0403431101; Criddle DN, 2006, GASTROENTEROLOGY, V130, P781, DOI 10.1053/j.gastro.2005.12.031; De Flora A, 1997, INT J BIOCHEM CELL B, V29, P1149, DOI 10.1016/S1357-2725(97)00062-9; Fukushi Y, 2001, J BIOL CHEM, V276, P649, DOI 10.1074/jbc.M004469200; Gale E A, 1996, Horm Res, V45 Suppl 1, P39; GALIONE A, 1993, NATURE, V365, P456, DOI 10.1038/365456a0; GALIONE A, 1991, SCIENCE, V253, P1143, DOI 10.1126/science.1909457; Gerasimenko JV, 2011, P NATL ACAD SCI USA, V108, P5873, DOI 10.1073/pnas.1016534108; Gerasimenko JV, 2009, P NATL ACAD SCI USA, V106, P10758, DOI 10.1073/pnas.0904818106; Gerasimenko JV, 2006, J BIOL CHEM, V281, P40154, DOI 10.1074/jbc.M606402200; Gerasimenko JV, 2006, J CELL SCI, V119, P226, DOI 10.1242/jcs.02721; Gobel A, 2001, CELL CALCIUM, V29, P29, DOI 10.1054/ceca.2000.0154; Higashida H, 2007, NEUROCHEM INT, V51, P192, DOI 10.1016/j.neuint.2007.06.023; HOFMANN AF, 1984, J LIPID RES, V25, P1477; Husain SZ, 2012, AM J PHYSIOL-GASTR L, V302, pG1423, DOI 10.1152/ajpgi.00546.2011; Husain SZ, 2005, P NATL ACAD SCI USA, V102, P14386, DOI 10.1073/pnas.0503215102; ITOH M, 1994, BIOCHEM BIOPH RES CO, V203, P1309, DOI 10.1006/bbrc.1994.2325; KAISHO T, 1994, P NATL ACAD SCI USA, V91, P5325, DOI 10.1073/pnas.91.12.5325; Kajimoto Y, 1996, BIOCHEM BIOPH RES CO, V219, P941, DOI 10.1006/bbrc.1996.0327; Kato I, 1999, J BIOL CHEM, V274, P1869, DOI 10.1074/jbc.274.4.1869; Kim JY, 2002, GASTROENTEROLOGY, V122, P1941, DOI 10.1053/gast.2002.33617; Kim MS, 2011, GASTROENTEROLOGY, V140, P2107, DOI 10.1053/j.gastro.2011.02.052; Kim MS, 2009, GASTROENTEROLOGY, V137, P1509, DOI 10.1053/j.gastro.2009.07.042; Krause E, 2002, J BIOL CHEM, V277, P11696, DOI 10.1074/jbc.M107794200; Kruger B, 2000, AM J PATHOL, V157, P43, DOI 10.1016/S0002-9440(10)64515-4; LEE HC, 1995, J BIOL CHEM, V270, P2152, DOI 10.1074/jbc.270.5.2152; LEE HC, 1995, J BIOL CHEM, V270, P9060, DOI 10.1074/jbc.270.16.9060; LEE HC, 1994, NATURE, V370, P307, DOI 10.1038/370307a0; LEE HC, 1993, J BIOL CHEM, V268, P293; Lee HC, 2012, J BIOL CHEM, V287, P31633, DOI 10.1074/jbc.R112.349464; Leite MF, 1999, BIOCHEM J, V337, P305, DOI 10.1042/0264-6021:3370305; Leite MF, 2002, GASTROENTEROLOGY, V122, P415, DOI 10.1053/gast.2002.30982; Liu D, 2009, NEUROMOL MED, V11, P28, DOI 10.1007/s12017-009-8058-1; Mareninova OA, 2009, J CLIN INVEST, V119, P3340, DOI 10.1172/JCI38674; Mooren FC, 2003, J BIOL CHEM, V278, P9361, DOI 10.1074/jbc.M207454200; Muili KA, 2013, J BIOL CHEM, V288, P21065, DOI 10.1074/jbc.M113.471425; Muili KA, 2013, J BIOL CHEM, V288, P570, DOI 10.1074/jbc.M112.428896; Orabi AI, 2011, J BIOL CHEM, V286, P14090, DOI 10.1074/jbc.M110.196832; Orabi AI, 2010, AM J PHYSIOL-GASTR L, V299, pG196, DOI 10.1152/ajpgi.00498.2009; Pandol SJ, 1999, GASTROENTEROLOGY, V117, P706, DOI 10.1016/S0016-5085(99)70465-8; Parekh AB, 2000, P NATL ACAD SCI USA, V97, P12933, DOI 10.1073/pnas.97.24.12933; Perides G, 2010, NAT PROTOC, V5, P335, DOI 10.1038/nprot.2009.243; Perides G, 2010, GASTROENTEROLOGY, V138, P715, DOI 10.1053/j.gastro.2009.10.052; Petersen OH, 2005, CELL CALCIUM, V38, P171, DOI 10.1016/j.ceca.2005.06.024; Raraty M, 2000, P NATL ACAD SCI USA, V97, P13126, DOI 10.1073/pnas.97.24.13126; Ricordi C., 1995, METHODS CELL TRANSPL; Sherwood MW, 2007, P NATL ACAD SCI USA, V104, P5674, DOI 10.1073/pnas.0700951104; Siegel C, 2011, ACTA PHYSIOL, V203, P225, DOI 10.1111/j.1748-1716.2010.02229.x; Straub SV, 2000, J GEN PHYSIOL, V116, P547, DOI 10.1085/jgp.116.4.547; TAKASAWA S, 1993, SCIENCE, V259, P370, DOI 10.1126/science.8420005; TANAKA Y, 1995, P NATL ACAD SCI USA, V92, P3244, DOI 10.1073/pnas.92.8.3244; THORN P, 1994, EMBO J, V13, P2038, DOI 10.1002/j.1460-2075.1994.tb06478.x; Togashi K, 2006, EMBO J, V25, P1804, DOI 10.1038/sj.emboj.7601083; Voronina S, 2002, J PHYSIOL-LONDON, V540, P49, DOI 10.1113/jphysiol.2002.017525; Voronina SG, 2004, J BIOL CHEM, V279, P27327, DOI 10.1074/jbc.M311698200; Voronina SG, 2010, GASTROENTEROLOGY, V138, P1976, DOI 10.1053/j.gastro.2010.01.037; Wildi S, 2007, GUT, V56, P685, DOI 10.1136/gut.2006.105833; Williams JA, 2001, ANNU REV PHYSIOL, V63, P77, DOI 10.1146/annurev.physiol.63.1.77; Yamasaki M, 2005, CURR BIOL, V15, P874, DOI 10.1016/j.cub.2005.04.033; Yamasaki M, 2004, J BIOL CHEM, V279, P7234, DOI 10.1074/jbc.M311088200	68	12	12	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 20	2013	288	38					27128	27137		10.1074/jbc.M113.494534	http://dx.doi.org/10.1074/jbc.M113.494534			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302IG	23940051	hybrid, Green Published			2022-12-25	WOS:000330597300012
J	Falkeborn, T; Brave, A; Larsson, M; Akerlind, B; Schroder, U; Hinkula, J				Falkeborn, Tina; Brave, Andreas; Larsson, Marie; Akerlind, Britt; Schroder, Ulf; Hinkula, Jorma			Endocine (TM), N3OA and N3OASq; Three Mucosal Adjuvants That Enhance the Immune Response to Nasal Influenza Vaccination	PLOS ONE			English	Article							A VIRUS; INTRANASAL IMMUNIZATION; PROTECTIVE EFFICACY; IGA ANTIBODIES; MICE; DNA; HEMAGGLUTININ; IMMUNOGENICITY; INDUCTION; VACCINES	Annual outbreaks of seasonal influenza are controlled or prevented through vaccination in many countries. The seasonal vaccines used are either inactivated, currently administered parenterally, or live-attenuated given intranasally. In this study three mucosal adjuvants were examined for the influence on the humoral (mucosal and systemic) and cellular influenza A-specific immune responses induced by a nasally administered vaccine. We investigated in detail how the anionic Endocine (TM) and the cationic adjuvants N3OA and N3OASq mixed with a split inactivated influenza vaccine induced influenza A-specific immune responses as compared to the vaccine alone after intranasal immunization. The study showed that nasal administration of a split virus vaccine together with Endocine (TM) or N3OA induced significantly higher humoral and cell-mediated immune responses than the non-adjuvanted vaccine. N3OASq only significantly increased the cell-mediated immune response. Furthermore, nasal administration of the influenza vaccine in combination with any of the adjuvants; Endocine (TM), N3OA or N3OASq, significantly enhanced the mucosal immunity against influenza HA protein. Thus the addition of these mucosal adjuvants leads to enhanced immunity in the most relevant tissues, the upper respiratory tract and the systemic circulation. Nasal influenza vaccination with an inactivated split vaccine can therefore provide an important mucosal immune response, which is often low or absent after traditional parenteral vaccination.	[Falkeborn, Tina; Larsson, Marie; Akerlind, Britt; Hinkula, Jorma] Linkoping Univ, Div Mol Virol, Dept Clin & Expt Med, Linkoping, Sweden; [Brave, Andreas] Swedish Inst Communicable Dis Control SMI, Stockholm, Sweden; [Schroder, Ulf; Hinkula, Jorma] Eurocine Vaccines AB, Solna, Sweden	Linkoping University; Swedish Institute for Infectious Disease Control	Hinkula, J (corresponding author), Linkoping Univ, Div Mol Virol, Dept Clin & Expt Med, Linkoping, Sweden.	jorma.hinkula@liu.se	Hinkula, Jorma/P-6849-2018	Hinkula, Jorma/0000-0003-1908-5609; Larsson, Marie/0000-0002-4524-0177	Eurocine Vaccines; Vinnova Research funds; Halsofonden	Eurocine Vaccines; Vinnova Research funds; Halsofonden	This work was supported by Eurocine Vaccines, Vinnova Research funds and Halsofonden. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbas AK, 2003, CELLULAR MOL IMMUNOL; Abbas AK, 2011, CELLULAR MOL IMMUNOL, P225; Ambrose CS, 2012, VACCINE, V30, P6794, DOI 10.1016/j.vaccine.2012.09.018; [Anonymous], 2011, INFLUENZA SEQUENCE E; Applequist SE, 2005, J IMMUNOL, V175, P3882, DOI 10.4049/jimmunol.175.6.3882; Asakura Y, 1997, SCAND J IMMUNOL, V46, P326, DOI 10.1046/j.1365-3083.1997.d01-146.x; ATASSI MZ, 1983, P NATL ACAD SCI-BIOL, V80, P840, DOI 10.1073/pnas.80.3.840; Babon JAB, 2012, J VIROL, V86, P9233, DOI 10.1128/JVI.06325-11; Bianchi E, 2005, J VIROL, V79, P7380, DOI 10.1128/JVI.79.12.7380-7388.2005; BLAST, BAS LOC ALIGNM SEARC; Boyce TG, 2000, VACCINE, V19, P217, DOI 10.1016/S0264-410X(00)00171-7; Brave A, 2010, VACCINE, V28, P2080, DOI 10.1016/j.vaccine.2009.12.040; Calabro S, 2011, VACCINE, V29, P1812, DOI 10.1016/j.vaccine.2010.12.090; Charo J, 2004, J VIROL, V78, P11321, DOI 10.1128/JVI.78.20.11321-11326.2004; Christensen D, 2011, EXPERT REV VACCINES, V10, P513, DOI [10.1586/erv.11.17, 10.1586/ERV.11.17]; Davis SS, 2001, ADV DRUG DELIVER REV, V51, P21, DOI 10.1016/S0169-409X(01)00162-4; Devito C, 2004, J IMMUNOL, V173, P7078, DOI 10.4049/jimmunol.173.11.7078; Dreyfus C, 2012, SCIENCE, V337, P1343, DOI 10.1126/science.1222908; Dupuis M, 2001, EUR J IMMUNOL, V31, P2910, DOI 10.1002/1521-4141(2001010)31:10<2910::AID-IMMU2910>3.0.CO;2-3; Durrer P, 2003, VACCINE, V21, P4328, DOI 10.1016/S0264-410X(03)00457-2; Even-Or O, 2011, VACCINE, V29, P2474, DOI 10.1016/j.vaccine.2011.01.009; Even-Or O, 2010, VACCINE, V28, P6527, DOI 10.1016/j.vaccine.2010.04.011; Farnsworth A, 2011, VACCINE, V29, P1529, DOI 10.1016/j.vaccine.2010.12.120; Greenbaum E, 2002, VACCINE, V20, P1232, DOI 10.1016/S0264-410X(01)00396-6; Henriksen-Lacey M, 2011, J CONTROL RELEASE, V154, P131, DOI 10.1016/j.jconrel.2011.05.019; Henriksen-Lacey M, 2010, J CONTROL RELEASE, V145, P102, DOI 10.1016/j.jconrel.2010.03.027; Hinkula J, 2006, VACCINE, V24, P4494, DOI 10.1016/j.vaccine.2005.08.015; Joseph A, 2006, VACCINE, V24, P3990, DOI 10.1016/j.vaccine.2005.12.017; Khurana S, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002336; Korhonen MH, 1999, CLIN DIAGN LAB IMMUN, V6, P725, DOI 10.1128/CDLI.6.5.725-728.1999; KUNOSAKAI H, 1994, VACCINE, V12, P1303, DOI 10.1016/S0264-410X(94)80056-6; LAWSON CM, 1994, J VIROL, V68, P3505, DOI 10.1128/JVI.68.6.3505-3511.1994; Marrack P, 2009, NAT REV IMMUNOL, V9, P287, DOI 10.1038/nri2510; Mittelholzer CM, 2006, SCAND J IMMUNOL, V63, P257, DOI 10.1111/j.1365-3083.2006.01740.x; Mizuno D, 2011, VACCINE, V29, P5368, DOI 10.1016/j.vaccine.2011.05.090; O'Hagan DT, 2012, VACCINE, V30, P4341, DOI 10.1016/j.vaccine.2011.09.061; OHLIN M, 1992, CLIN EXP IMMUNOL, V89, P290; Perrone LA, 2009, J VIROL, V83, P5726, DOI 10.1128/JVI.00207-09; Petersson P, 2010, VACCINE, V28, P6491, DOI 10.1016/j.vaccine.2010.07.001; Plotkin AS, 2008, VACCINES; Price GE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013162; Quan FS, 2008, VACCINE, V26, P3352, DOI 10.1016/j.vaccine.2008.03.055; Quan FS, 2008, J VIROL, V82, P1350, DOI 10.1128/JVI.01615-07; Rappuoli R, 2011, NAT REV IMMUNOL, V11, P865, DOI 10.1038/nri3085; Renegar KB, 2004, J IMMUNOL, V173, P1978, DOI 10.4049/jimmunol.173.3.1978; Rowcliffe E, 2004, SCAND J INFECT DIS, V36, P360, DOI 10.1080/00365540410020208; Schroder U, 1999, VACCINE, V17, P2096, DOI 10.1016/S0264-410X(98)00408-3; Sealy R, 2013, INT IMMUNOL, V25, P183, DOI 10.1093/intimm/dxs107; Shen XZ, 2000, INFECT IMMUN, V68, P5749, DOI 10.1128/IAI.68.10.5749-5755.2000; Shen XZ, 2001, VACCINE, V19, P3360, DOI 10.1016/S0264-410X(00)00532-6; Simonsen L, 1998, J INFECT DIS, V178, P53, DOI 10.1086/515616; Skowronski DM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038929; Song JH, 2008, P NATL ACAD SCI USA, V105, P1644, DOI 10.1073/pnas.0708684105; TAMURA S, 1990, VACCINE, V8, P479, DOI 10.1016/0264-410X(90)90250-P; TAMURA S, 1991, EUR J IMMUNOL, V21, P1337, DOI 10.1002/eji.1830210602; Tamura S, 2010, VACCINE, V28, P6393, DOI 10.1016/j.vaccine.2010.05.019; Tyring SK, 2006, MUCOSAL IMMUNOLOGY V; van den Brand JMA, 2011, J VIROL, V85, P2851, DOI 10.1128/JVI.01939-10; WHO, 2012, INFL; World Health Organization, 2011, MAN LAB DIAGN VIR SU, pxii; Zuercher AW, 2002, J IMMUNOL, V168, P1796, DOI 10.4049/jimmunol.168.4.1796	61	11	13	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2013	8	8							e70527	10.1371/journal.pone.0070527	http://dx.doi.org/10.1371/journal.pone.0070527			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	201ER	23950951	gold, Green Published, Green Submitted			2022-12-25	WOS:000323124000019
J	Govern, CC; Chakraborty, AK				Govern, Christopher C.; Chakraborty, Arup K.			Stochastic Responses May Allow Genetically Diverse Cell Populations to Optimize Performance with Simpler Signaling Networks	PLOS ONE			English	Article							FLUCTUATING ENVIRONMENTS; GENE-EXPRESSION; ACTIVATION; HETEROGENEITY; VARIABILITY; INFORMATION; ROBUSTNESS	Two theories have emerged for the role that stochasticity plays in biological responses: first, that it degrades biological responses, so the performance of biological signaling machinery could be improved by increasing molecular copy numbers of key proteins; second, that it enhances biological performance, by enabling diversification of population-level responses. Using T cell biology as an example, we demonstrate that these roles for stochastic responses are not sufficient to understand experimental observations of stochastic response in complex biological systems that utilize environmental and genetic diversity to make cooperative responses. We propose a new role for stochastic responses in biology: they enable populations to make complex responses with simpler biochemical signaling machinery than would be required in the absence of stochasticity. Thus, the evolution of stochastic responses may be linked to the evolvability of different signaling machineries.	[Govern, Christopher C.; Chakraborty, Arup K.] MIT, Dept Chem Engn, Cambridge, MA 02139 USA; [Chakraborty, Arup K.] MIT, Dept Chem, Cambridge, MA 02139 USA; [Chakraborty, Arup K.] MIT, Dept Biol Engn, Cambridge, MA 02139 USA; [Chakraborty, Arup K.] Ragon Inst MGH MIT & Harvard, Charlestown, MA USA	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Harvard University; Massachusetts Institute of Technology (MIT); Ragon Institute	Chakraborty, AK (corresponding author), MIT, Dept Chem Engn, Cambridge, MA 02139 USA.	arupc@mit.edu			NIH	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This research was supported by an NIH Director's Pioneer award to AKC. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acar M, 2008, NAT GENET, V40, P471, DOI 10.1038/ng.110; Altan-Bonnet G, 2005, PLOS BIOL, V3, P1925, DOI 10.1371/journal.pbio.0030356; Avlund M, 2009, J VIROL, V83, P11416, DOI 10.1128/JVI.01057-09; Balaban NQ, 2004, SCIENCE, V305, P1622, DOI 10.1126/science.1099390; Beaumont HJE, 2009, NATURE, V462, P90, DOI 10.1038/nature08504; Bertsekas D. P., 2005, DYNAMIC PROGRAMMING; Busse D, 2010, P NATL ACAD SCI USA, V107, P3058, DOI 10.1073/pnas.0812851107; Das J, 2009, CELL, V136, P337, DOI 10.1016/j.cell.2008.11.051; DVORETZKY A, 1950, P NATL ACAD SCI USA, V36, P256, DOI 10.1073/pnas.36.4.256; Feinberg EA, 2005, THEORY PROBABILITY I, V50, P463; Feinerman O, 2008, SCIENCE, V321, P1081, DOI 10.1126/science.1158013; Gibbons R., 1992, GAME THEORY APPL EC; Kussell E, 2005, SCIENCE, V309, P2075, DOI 10.1126/science.1114383; Lehmann, 1959, TESTING STAT HYPOTHE; Lestas I, 2010, NATURE, V467, P174, DOI 10.1038/nature09333; Lipniacki T, 2008, J THEOR BIOL, V254, P110, DOI 10.1016/j.jtbi.2008.05.001; McDonnell MD, 2009, PLOS COMPUTATIONAL B, V5, P9; Murphy K., 2007, JANEWAYS IMMUNOBIOLO; Noest AJ, 2000, J THEOR BIOL, V207, P195, DOI 10.1006/jtbi.2000.2164; Palmer E, 2003, NAT REV IMMUNOL, V3, P383, DOI 10.1038/nri1085; Paszek P, 2010, P NATL ACAD SCI USA, V107, P11644, DOI 10.1073/pnas.0913798107; Paulsson J, 2000, P NATL ACAD SCI USA, V97, P7148, DOI 10.1073/pnas.110057697; Perkins TJ, 2009, MOL SYSTEMS BIOL, V5, P15; Raj A, 2008, CELL, V135, P216, DOI 10.1016/j.cell.2008.09.050; Resnik MD., 1987, CHOICES INTRO DECISI; Spencer SL, 2009, NATURE, V459, P428, DOI 10.1038/nature08012; Tay S, 2010, NATURE, V466, P267, DOI 10.1038/nature09145; Thattai M, 2004, GENETICS, V167, P523, DOI 10.1534/genetics.167.1.523; van den Berg HA, 2007, IMMUNOL REV, V216, P81; Wolf DM, 2005, J THEOR BIOL, V234, P227, DOI 10.1016/j.jtbi.2004.11.020	30	0	0	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2013	8	8							e65086	10.1371/journal.pone.0065086	http://dx.doi.org/10.1371/journal.pone.0065086			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	200ZE	23950860	Green Published, gold, Green Submitted			2022-12-25	WOS:000323109700001
J	Viegas, SO; Machado, A; Groenheit, R; Ghebremichael, S; Pennhag, A; Gudo, PS; Cuna, Z; Langa, E; Miotto, P; Cirillo, DM; Rastogi, N; Warren, RM; van Helden, PD; Koivula, T; Kallenius, G				Viegas, Sofia O.; Machado, Adelina; Groenheit, Ramona; Ghebremichael, Solomon; Pennhag, Alexandra; Gudo, Paula S.; Cuna, Zaina; Langa, Egidio; Miotto, Paolo; Cirillo, Daniela M.; Rastogi, Nalin; Warren, Rob M.; van Helden, Paul D.; Koivula, Tuija; Kallenius, Gunilla			Mycobacterium tuberculosis Beijing Genotype Is Associated with HIV Infection in Mozambique	PLOS ONE			English	Article							MOLECULAR EPIDEMIOLOGY; GLOBAL DISSEMINATION; COMPLEX STRAINS; POLYMORPHISM; FAMILY; DIVERSITY; DELETIONS; CLASSIFY	The Beijing genotype is a lineage of Mycobacterium tuberculosis that is distributed worldwide and responsible for large epidemics, associated with multidrug-resistance. However, its distribution in Africa is less understood due to the lack of data. Our aim was to investigate the prevalence and possible transmission of Beijing strains in Mozambique by a multivariate analysis of genotypic, geographic and demographic data. A total of 543 M. tuberculosis isolates from Mozambique were spoligotyped. Of these, 33 were of the Beijing lineage. The genetic relationship between the Beijing isolates were studied by identification of genomic deletions within some Regions of Difference (RD), Restriction Fragment Length Polymorphism (RFLP) and Mycobacterial Interspersed Repetivie Unit - variable number tandem repeat (MIRU-VNTR). Beijing strains from South Africa, representing different sublineages were included as reference strains. The association between Beijing genotype, Human Immunodeficiency Virus (HIV) serology and baseline demographic data was investigated. HIV positive serostatus was significantly (p = 0.023) more common in patients with Beijing strains than in patients with non-Beijing strains in a multivariable analysis adjusted for age, sex and province (14 (10.9%) of the 129 HIV positive patients had Beijing strains while 6/141 (4.3%) of HIV negative patients had Beijing strains). The majority of Beijing strains were found in the Southern region of Mozambique, particularly in Maputo City (17%). Only one Beijing strain was drug resistant (multi-drug resistant). By combined use of RD and spoligotyping, three genetic sublineages could be tentatively identified where a distinct group of four isolates had deletion of RD150, a signature of the "sublineage 7" recently emerging in South Africa. The same group was very similar to South African "sublineage 7" by RFLP and MIRU-VNTR, suggesting that this sublineage could have been recently introduced in Mozambique from South Africa, in association with HIV infection.	[Viegas, Sofia O.] Minist Hlth, Natl Inst Hlth, Maputo, Mozambique; [Viegas, Sofia O.; Machado, Adelina] Eduardo Mondlane Univ, Fac Vet, Maputo, Mozambique; [Viegas, Sofia O.; Koivula, Tuija; Kallenius, Gunilla] Soder Sjukhuset, Karolinska Inst, Dept Clin Sci & Educ, S-10064 Stockholm, Sweden; [Groenheit, Ramona; Ghebremichael, Solomon; Pennhag, Alexandra; Koivula, Tuija] Swedish Inst Communicable Dis Control, Dept Preparedness, Solna, Sweden; [Gudo, Paula S.; Langa, Egidio] Minist Hlth, TB Natl Control Program, Maputo, Mozambique; [Cuna, Zaina] Jhpiego Mozambique, Maputo, Mozambique; [Miotto, Paolo; Cirillo, Daniela M.] Ist Sci San Raffaele, Emerging Bacterial Pathogens Unit, I-20132 Milan, Italy; [Rastogi, Nalin] Inst Pasteur Guadeloupe, TB & Mycobacteria Unit, WHO Supranatl TB Reference Lab, Abymes, Guadeloupe, France; [Warren, Rob M.; van Helden, Paul D.] Univ Stellenbosch, Fac Hlth Sci, Div Mol Biol & Human Genet, DST NRF Ctr Excellence Biomed TB Res,MRC Ctr Mol, ZA-7505 Tygerberg, Western Cape, South Africa	Eduardo Mondlane University; Karolinska Institutet; Sodersjukhuset Hospital; Swedish Institute for Infectious Disease Control; Jhpiego; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; National Research Foundation - South Africa; Stellenbosch University	Viegas, SO (corresponding author), Minist Hlth, Natl Inst Hlth, Maputo, Mozambique.	viegas_sofia@hotmail.com	Cirillo, Daniela Maria/AAB-3646-2019; Miotto, Paolo/E-3940-2017; RASTOGI, NALIN/AAP-1958-2020; Källenius, Gunilla/AGZ-3956-2022	Cirillo, Daniela Maria/0000-0001-6415-1535; Miotto, Paolo/0000-0003-4610-2427; RASTOGI, NALIN/0000-0002-7199-7747; Warren, Robin/0000-0001-5741-7358; Kallenius, Gunilla/0000-0002-8921-0551; Groenheit, Ramona/0000-0003-2696-437X	Sida/SAREC through the Eduardo Mondlane University; Karolinska Institutet Research and Training (KIRT) collaboration	Sida/SAREC through the Eduardo Mondlane University; Karolinska Institutet Research and Training (KIRT) collaboration	This study was funded by Sida/SAREC through the Eduardo Mondlane University and Karolinska Institutet Research and Training (KIRT) collaboration. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bifani PJ, 2002, TRENDS MICROBIOL, V10, P45, DOI 10.1016/S0966-842X(01)02277-6; Brudey K, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-23; Cadmus S, 2011, J CLIN MICROBIOL, V49, P220, DOI 10.1128/JCM.01241-10; Cowley D, 2008, CLIN INFECT DIS, V47, P1252, DOI 10.1086/592575; Drobniewski F, 2005, JAMA-J AM MED ASSOC, V293, P2726, DOI 10.1001/jama.293.22.2726; Filliol I, 2003, J CLIN MICROBIOL, V41, P1963, DOI 10.1128/JCM.41.5.1963-1970.2003; Flores L, 2007, J CLIN MICROBIOL, V45, P3393, DOI 10.1128/JCM.00828-07; Glynn JR, 2002, EMERG INFECT DIS, V8, P843; Glynn JR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012259; Hanekom M, 2008, J CLIN MICROBIOL, V46, P3338, DOI 10.1128/JCM.00770-08; Hanekom M, 2007, J CLIN MICROBIOL, V45, P1483, DOI 10.1128/JCM.02191-06; Kamerbeek J, 1997, J CLIN MICROBIOL, V35, P907, DOI 10.1128/JCM.35.4.907-914.1997; Kong Y, 2006, J CLIN MICROBIOL, V44, P3940, DOI 10.1128/JCM.01146-06; Kremer K, 2005, J CLIN MICROBIOL, V43, P314, DOI 10.1128/JCM.43.1.314-320.2005; Mathema B, 2006, CLIN MICROBIOL REV, V19, P658, DOI 10.1128/CMR.00061-05; Middelkoop K, 2009, J INFECT DIS, V200, P1207, DOI 10.1086/605930; Gudo PS, 2011, EUR RESPIR J, V38, P222, DOI 10.1183/09031936.00182010; Sreevatsan S, 1997, P NATL ACAD SCI USA, V94, P9869, DOI 10.1073/pnas.94.18.9869; Supply P, 2001, J CLIN MICROBIOL, V39, P3563, DOI 10.1128/JCM.39.10.3563-3571.2001; Tansuphasiri Unchalee, 2001, Journal of the Medical Association of Thailand, V84, P1467; Tsolaki AG, 2005, J CLIN MICROBIOL, V43, P3185, DOI 10.1128/JCM.43.7.3185-3191.2005; van Crevel R, 2001, EMERG INFECT DIS, V7, P880; VANEMBDEN JDA, 1993, J CLIN MICROBIOL, V31, P406, DOI 10.1128/JCM.31.2.406-409.1993; VANSOOLINGEN D, 1995, J CLIN MICROBIOL, V33, P3234, DOI 10.1128/JCM.33.12.3234-3238.1995; VANSOOLINGEN D, 1991, J CLIN MICROBIOL, V29, P2578, DOI 10.1128/JCM.29.11.2578-2586.1991; Viegas SO, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-195	26	19	19	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2013	8	8							e71999	10.1371/journal.pone.0071999	http://dx.doi.org/10.1371/journal.pone.0071999			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	200ZE	23940801	Green Submitted, Green Published, gold			2022-12-25	WOS:000323109700128
J	Zou, HF; Jiang, Z; Li, RS; Jia, YM; Yang, XJ; Ni, YD; Zhao, RQ				Zou, Huafeng; Jiang, Zheng; Li, Runsheng; Jia, Yimin; Yang, Xiaojing; Ni, Yingdong; Zhao, Ruqian			p53 Cooperates with Sp1 to Regulate Breed-Dependent Expression of Glucocorticoid Receptor in the Liver of Preweaning Piglets	PLOS ONE			English	Article							ELEMENT-BINDING PROTEIN; TUMOR-SUPPRESSOR P53; MESSENGER-RNA; GENE-EXPRESSION; TRANSCRIPTION FACTORS; PROMOTER; DOXORUBICIN; STRESS; BRAIN; ONTOGENY	Previous studies indicate that Chinese indigenous pig breeds demonstrate distinct pattern of glucocorticoid receptor (GR) expression, which is associated with their unique growth and metabolic phenotypes. Here we sought to unravel the transcriptional mechanisms underlying the breed-specific hepatic GR expression in preweaning Chinese Erhualian (EHL) and Western Large White (LW) piglets. Total GR mRNA and the predominant GR mRNA variant 1-9/10 were expressed significantly higher in EHL compared with LW piglets (P<0.01), which was associated with more enriched histone H3 acetylation on 1-9/10 promoter (P<0.05). Nuclear content of transcription factor specificity protein 1 (Sp1) was significantly lower in EHL piglets, yet its binding to GR 1-9/10 promoter was significantly higher in EHL piglets, as revealed by chromatin immunoprecipitation assays. Although p53 binding to GR promoter 1-9/10 did not differ between breeds, expression of p53 mRNA and protein, as well as its binding to Sp1, were significantly higher in EHL piglets. Moreover, p53 activator doxorubicin significantly enhanced GR 1-9/10 promoter activity in HepG2 cells at 100 nM, which was associated with significantly higher protein content of p53 and GR. Sp1 inhibitor, mithramycin A, significantly inhibited (P<0.05) the basal activity of GR promoter 1-9/10 and completely blocked doxorubicin - induced activation of GR promoter 1-9/10. These data indicate that higher hepatic GR expression in EHL piglets attributes mainly to the enhanced transcription of GR promoter 1-9/10, which is achieved from breed-specific interaction of p53 and Sp1 on porcine GR 1-9/10 promoter.	[Zou, Huafeng; Jiang, Zheng; Li, Runsheng; Jia, Yimin; Yang, Xiaojing; Ni, Yingdong; Zhao, Ruqian] Nanjing Agr Univ, Minist Agr, Key Lab Anim Physiol & Biochem, Nanjing, Jiangsu, Peoples R China	Ministry of Agriculture & Rural Affairs; Nanjing Agricultural University	Zhao, RQ (corresponding author), Nanjing Agr Univ, Minist Agr, Key Lab Anim Physiol & Biochem, Nanjing, Jiangsu, Peoples R China.	zhao.ruqian@gmail.com	LI, Runsheng/AFR-9519-2022	LI, Runsheng/0000-0003-1563-1844; Zou, Huafeng/0000-0002-6994-9586	National Basic Research Program of China [2012CB124703]; Major National Science and Technology Program [2009ZX08009-138B]; Special Fund for Agro-scientific Research in the Public Interest [201003011]; National "948" Project [2011-S11]; Fundamental Research Funds for the Central Universities [KYZ200913]; Priority Academic Program Development of Jiangsu Higher Education Institutions	National Basic Research Program of China(National Basic Research Program of China); Major National Science and Technology Program; Special Fund for Agro-scientific Research in the Public Interest; National "948" Project; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Priority Academic Program Development of Jiangsu Higher Education Institutions	This work was supported by the National Basic Research Program of China (2012CB124703), the Major National Science and Technology Program (2009ZX08009-138B), the Special Fund for Agro-scientific Research in the Public Interest (201003011), the National "948" Project (2011-S11), the Fundamental Research Funds for the Central Universities (KYZ200913) and the Priority Academic Program Development of Jiangsu Higher Education Institutions. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alastalo TP, 2003, J CELL SCI, V116, P3557, DOI 10.1242/jcs.00671; Bamberger CM, 1996, ENDOCR REV, V17, P245, DOI 10.1210/er.17.3.245; Berger SL, 2002, CURR OPIN GENET DEV, V12, P142, DOI 10.1016/S0959-437X(02)00279-4; Breslin MB, 1998, J STEROID BIOCHEM, V67, P369, DOI 10.1016/S0960-0760(98)00138-1; Cao-Lei L, 2011, HUM GENET, V129, P533, DOI 10.1007/s00439-011-0949-1; Cha JY, 2007, J BIOL CHEM, V282, P743, DOI 10.1074/jbc.M605023200; Chua HH, 2012, J MED VIROL, V84, P1279, DOI 10.1002/jmv.23316; D'Alessio JA, 2011, P NATL ACAD SCI USA, V108, P3906, DOI 10.1073/pnas.1100640108; Dhar SK, 2006, J BIOL CHEM, V281, P21698, DOI 10.1074/jbc.M601083200; FELDMAN D, 1974, ENDOCRINOLOGY, V95, P1219, DOI 10.1210/endo-95-5-1219; Govindan MV, 2010, J BIOL CHEM, V285, P4489, DOI 10.1074/jbc.M109.072728; Iwano S, 2006, FEBS LETT, V580, P890, DOI 10.1016/j.febslet.2006.01.009; Jenson M, 1996, OBES RES, V4, P133, DOI 10.1002/j.1550-8528.1996.tb00525.x; Ju J, 2007, CLIN CANCER RES, V13, P4245, DOI 10.1158/1078-0432.CCR-06-2890; Kaczynski J, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-2-206; KALINYAK JE, 1989, J CLIN INVEST, V84, P1843, DOI 10.1172/JCI114370; Kanitz E, 2011, J NEUROSCI RES, V89, P1134, DOI 10.1002/jnr.22621; Kataoka H, 2003, CANCER RES, V63, P5785; KITRAKI E, 1984, J STEROID BIOCHEM, V20, P263, DOI 10.1016/0022-4731(84)90215-2; Koblish HK, 2006, MOL CANCER THER, V5, P160, DOI 10.1158/1535-7163.MCT-05-0199; Koutsodontis G, 2005, BIOCHEM J, V389, P443, DOI 10.1042/BJ20041980; Lee JS, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-33; Li LA, 2008, LIVEST SCI, V113, P169, DOI 10.1016/j.livsci.2007.03.008; Li X, 2009, MEAT SCI, V81, P218, DOI 10.1016/j.meatsci.2008.07.022; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lu NZ, 2004, ANN NY ACAD SCI, V1024, P102, DOI 10.1196/annals.1321.008; Marelli SP, 2010, ANIM BIOTECHNOL, V21, P140, DOI 10.1080/10495391003608621; McCormick JA, 2000, MOL ENDOCRINOL, V14, P506, DOI 10.1210/me.14.4.506; McNeil CJ, 2007, REPRODUCTION, V133, P653, DOI 10.1530/rep.1.01198; Ming LH, 2008, CARCINOGENESIS, V29, P1878, DOI 10.1093/carcin/bgn150; Murphy SH, 2011, P NATL ACAD SCI USA, V108, P17117, DOI 10.1073/pnas.1114420108; Nishimura K, 2004, J NEUROENDOCRINOL, V16, P84, DOI 10.1111/j.1365-2826.2004.01131.x; NOBUKUNI Y, 1995, BIOCHEMISTRY-US, V34, P8207, DOI 10.1021/bi00025a028; Poletto R, 2006, BRAIN RES, V1067, P36, DOI 10.1016/j.brainres.2005.10.001; Reyer H, 2013, GEN COMP ENDOCR, V189, P127, DOI 10.1016/j.ygcen.2013.04.038; Rudiger JJ, 2002, FASEB J, V16, P177, DOI 10.1096/fj.01-0226com; Russcher H, 2007, J MOL ENDOCRINOL, V38, P91, DOI 10.1677/jme.1.02117; Sadji-Ouatas Z, 2002, BIOCHEM J, V364, P881, DOI 10.1042/BJ20020349; SAFFER JD, 1991, MOL CELL BIOL, V11, P2189, DOI 10.1128/MCB.11.4.2189; Sengupta S, 2004, ANN NY ACAD SCI, V1024, P54, DOI 10.1196/annals.1321.005; Shahbazian MD, 2007, ANNU REV BIOCHEM, V76, P75, DOI 10.1146/annurev.biochem.76.052705.162114; Singh DP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037012; STRAHLE U, 1992, P NATL ACAD SCI USA, V89, P6731, DOI 10.1073/pnas.89.15.6731; Suehiro T, 2004, MOL CELL ENDOCRINOL, V222, P33, DOI 10.1016/j.mce.2004.05.005; Thornborrow EC, 2001, J BIOL CHEM, V276, P15598, DOI 10.1074/jbc.M011643200; Turner JD, 2010, BIOCHEM PHARMACOL, V80, P1860, DOI 10.1016/j.bcp.2010.06.037; Velculescu VE, 1996, CLIN CHEM, V42, P858; Wang SB, 2012, J BIOL CHEM, V287, P8001, DOI 10.1074/jbc.M111.315812; Weaver ICG, 2004, NAT NEUROSCI, V7, P847, DOI 10.1038/nn1276; Wei S, 2010, LIVEST SCI, V131, P240, DOI 10.1016/j.livsci.2010.04.007; Yamabe Y, 1998, MOL CELL BIOL, V18, P6191, DOI 10.1128/MCB.18.11.6191; Yang XJ, 2012, ARCH TIERZUCHT, V55, P152, DOI 10.5194/aab-55-152-2012; Zhan QM, 1998, MOL CELL BIOL, V18, P2768, DOI 10.1128/MCB.18.5.2768; ZONG J, 1990, MOL CELL BIOL, V10, P5580, DOI 10.1128/MCB.10.10.5580; Zou HF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040432	55	7	7	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2013	8	8							e70494	10.1371/journal.pone.0070494	http://dx.doi.org/10.1371/journal.pone.0070494			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	200ZE	23950944	Green Submitted, Green Published, gold			2022-12-25	WOS:000323109700037
J	Lacy, RC; Alaks, G; Walsh, A				Lacy, Robert C.; Alaks, Glen; Walsh, Allison			Evolution of Peromyscus leucopus Mice in Response to a Captive Environment	PLOS ONE			English	Article							GENETIC ADAPTATION; REPRODUCTIVE-PERFORMANCE; INBREEDING DEPRESSION; MORPHOLOGICAL CHANGE; CONSERVATION; BEHAVIOR; POPULATIONS; MANAGEMENT; ZOOS; SELECTION	Many wildlife species are propagated in captivity as models for behavioral, physiological, and genetic research or to provide assurance populations to protect threatened species. However, very little is known about how animals evolve in the novel environment of captivity. The histories of most laboratory strains are poorly documented, and protected populations of wildlife species are usually too small and too short-term to allow robust statistical analysis. To document the evolutionary change in captive breeding programs, we monitored reproduction and behavior across 18 generations in six experimental populations of Peromyscus leucopus mice started from a common set of 20 wild-caught founders. The mice were propagated under three breeding protocols: a strategy to retain maximal genetic diversity, artificial selection against stereotypic behaviors that were hypothesized to reflect poor adaptation to captivity, and random bred controls. Two replicates were maintained with each protocol, and inter-replicate crosses at generations 19 and 20 were used to reverse accumulated inbreeding. We found that one of the stereotypic behaviors (repetitive flipping) was positively associated with reproductive fitness, while the other (gnawing) was relatively invariant. Selection to reduce these stereotypic behaviors caused marked reduction in reproduction, and populations not under artificial selection to reduce these behaviors responded with large increases in flipping. In non-selected populations, there was rapid evolution toward much higher proportion of pairs breeding and more rapid conception. Litter size, pup survival, and weaning mass all declined slowly, to the extent that would be predicted based on inbreeding depression. Inter-crossing between replicate populations reversed these declines in fitness components but did not reverse the changes in behavior or the accelerated breeding. These findings indicate that adaptation to captivity can be rapid, affecting reproductive patterns and behaviors, even under breeding protocols designed to minimize the rate of genetic change due to random drift and inadvertent selection.	[Lacy, Robert C.; Alaks, Glen; Walsh, Allison] Chicago Zool Soc, Brookfield, IL USA		Lacy, RC (corresponding author), Chicago Zool Soc, Brookfield, IL USA.	rlacy@ix.netcom.com			Chicago Zoological Society; Association of Zoos and Aquariums; Institute of Museum and Library Services [IC-03-02-0186-02]	Chicago Zoological Society; Association of Zoos and Aquariums; Institute of Museum and Library Services	Funding was provided by the Chicago Zoological Society, the Conservation Endowment Fund of the Association of Zoos and Aquariums, and the Institute of Museum and Library Services (Grant IC-03-02-0186-02). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Araki H, 2007, SCIENCE, V318, P100, DOI 10.1126/science.1145621; Ballou Jonathan D., 2010, P219; Ballou Jonathan D., 1995, P76; BELYAEV DK, 1979, J HERED, V70, P301, DOI 10.1093/oxfordjournals.jhered.a109263; BREWER BA, 1990, J HERED, V81, P257, DOI 10.1093/oxfordjournals.jhered.a110988; Carlstead K, 1999, ZOO BIOL, V18, P35, DOI 10.1002/(SICI)1098-2361(1999)18:1&lt;35::AID-ZOO5&gt;3.0.CO;2-L; Champagnon J, 2012, J NAT CONSERV, V20, P231, DOI 10.1016/j.jnc.2012.02.002; Christie MR, 2012, P NATL ACAD SCI USA, V109, P238, DOI 10.1073/pnas.1111073109; Conde DA, 2011, SCIENCE, V331, P1390, DOI 10.1126/science.1200674; Darwin C., 1868, VARIATION ANIMALS PL, V1; Fernandez J, 2004, CONSERV BIOL, V18, P1358, DOI 10.1111/j.1523-1739.2004.00341.x; Fernandez J, 1999, J ANIM BREED GENET, V116, P447, DOI 10.1046/j.1439-0388.1999.00196.x; Fischer J, 2000, BIOL CONSERV, V96, P1, DOI 10.1016/S0006-3207(00)00048-3; FORRESTER DJ, 1975, LAB ANIM SCI, V25, P446; Frankham R, 2000, ANIM CONSERV, V3, P357, DOI 10.1111/j.1469-1795.2000.tb00120.x; Frankham R, 2008, MOL ECOL, V17, P325, DOI 10.1111/j.1365-294X.2007.03399.x; Hendry AP, 1999, EVOLUTION, V53, P1637, DOI 10.1111/j.1558-5646.1999.tb04550.x; HOSMER DW, 1989, APPL LOGISTIC REGRES; Ivy JA, 2012, J HERED, V103, P186, DOI 10.1093/jhered/esr129; KING HELEN DEAN, 1939, AMER ANAT MEMOIR, V17, P1; Lacy RC, 2000, ZOO BIOL, V19, P279, DOI 10.1002/1098-2361(2000)19:4<279::AID-ZOO5>3.0.CO;2-V; Lacy RC, 1996, EVOLUTION, V50, P2187, DOI 10.1111/j.1558-5646.1996.tb03609.x; Lacy RC, 1995, ZOO BIOL, V14, P565, DOI 10.1002/zoo.1430140609; Lacy Robert C., 2009, P58; Lacy Robert C., 1994, P63, DOI 10.1017/CBO9780511623325.005; Leus K., 2011, International Zoo Yearbook, V45, P213, DOI 10.1111/j.1748-1090.2011.00138.x; Lewis RS, 2004, ANIM WELFARE, V13, P19; Malo AF, 2010, BIOL REPROD, V83, P540, DOI 10.1095/biolreprod.110.085316; Margan SH, 1998, ZOO BIOL, V17, P467; Mason GJ, 2004, ANIM WELFARE, V13, pS57; McDougall PT, 2006, ANIM CONSERV, V9, P39, DOI 10.1111/j.1469-1795.2005.00004.x; McPhee M.E., 2003, INT J COMP PSYCHOL, V16, P85; McPhee M. Elsbeth, 2010, P303; McPhee ME, 2004, J MAMMAL, V85, P1130, DOI 10.1644/BPR-017.1; McPhee ME, 2004, BIOL CONSERV, V115, P71, DOI 10.1016/S0006-3207(03)00095-8; Meagher RK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049180; MILLAR JS, 1987, CAN J ZOOL, V65, P1713, DOI 10.1139/z87-264; Montgomery ME, 1997, ZOO BIOL, V16, P377, DOI 10.1002/(SICI)1098-2361(1997)16:5<377::AID-ZOO1>3.0.CO;2-7; O'Regan HJ, 2005, MAMMAL REV, V35, P215, DOI 10.1111/j.1365-2907.2005.00070.x; Pergams ORW, 2008, MOL ECOL, V17, P450, DOI 10.1111/j.1365-294X.2007.03517.x; Pergams ORW, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006452; Powell SB, 2000, DEV PSYCHOBIOL, V37, P100, DOI 10.1002/1098-2302(200009)37:2<100::AID-DEV5>3.3.CO;2-Y; PRICE E, 1967, EVOLUTION, V21, P762, DOI 10.1111/j.1558-5646.1967.tb03432.x; PRICE EO, 1984, Q REV BIOL, V59, P1, DOI 10.1086/413673; Ryan KK, 2003, ANIM BEHAV, V65, P379, DOI 10.1006/anbe.2003.2040; Sonesson AK, 2001, GENET RES, V77, P285, DOI 10.1017/S0016672301005079; Soorae PS, 2010, GLOBAL REINTRODUCTIO, P352; Soorae PS, 2008, GLOBAL REINTRODUCTIO, P284; Soorae PS, 2011, GLOBAL REINTRODUCTIO, P250; Swaisgood R, 2006, STEREOTYPIC ANIMAL BEHAVIOUR: FUNDAMENTALS AND APPLICATIONS TO WELFARE, 2ND EDIITON, P256, DOI 10.1079/9780851990040.0256; Swaisgood RR, 2005, ZOO BIOL, V24, P499, DOI 10.1002/zoo.20066; WILLIAMS RG, 1965, AM MIDL NAT, V73, P101, DOI 10.2307/2423325; Williams SE, 2009, BIOL CONSERV, V142, P2388, DOI 10.1016/j.biocon.2009.05.034; Woodworth LM, 2002, CONSERV GENET, V3, P277, DOI 10.1023/A:1019954801089; Wurbel H, 2006, STEREOTYPIC ANIMAL BEHAVIOUR: FUNDAMENTALS AND APPLICATIONS TO WELFARE, 2ND EDIITON, P86, DOI 10.1079/9780851990040.0086	55	30	30	0	62	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2013	8	8							e72452	10.1371/journal.pone.0072452	http://dx.doi.org/10.1371/journal.pone.0072452			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	217ZG	23940813	Green Submitted, Green Published, gold			2022-12-25	WOS:000324401500092
J	Gong, ZJ; Wu, YQ; Miao, J; Duan, Y; Jiang, YL; Li, T				Gong, Zhong-Jun; Wu, Yu-Qing; Miao, Jin; Duan, Yun; Jiang, Yue-Li; Li, Tong			Global Transcriptome Analysis of Orange Wheat Blossom Midge, Sitodiplosis mosellana (Gehin) (Diptera: Cecidomyiidae) to Identify Candidate Transcripts Regulating Diapause	PLOS ONE			English	Article							MAMMALIAN SORBITOL DEHYDROGENASE; HEAT-SHOCK PROTEINS; GENE-EXPRESSION; FLESH FLY; PUPAL DIAPAUSE; UP-REGULATION; JUVENILE-HORMONE; LARVAL DIAPAUSE; DROSOPHILA; CONSEQUENCES	Background: Many insects enter a developmental arrest (diapause) that allows them to survive harsh seasonal conditions. Despite the well-established ecological significance of diapause, the molecular basis of this crucial adaptation remains largely unresolved. Sitodiplosis mosellana (Gehin), the orange wheat blossom midge (OWBM), causes serious damage to wheat throughout the northern hemisphere, and sporadic outbreaks occur in the world. Traits related to diapause appear to be important factors contributing to their rapid spread and outbreak. To better understand the diapause mechanisms of OWBM, we sequenced the transcriptome and determined the gene expression profile of this species. Methodology/Principal Findings: In this study, we performed de novo transcriptome analysis using short-read sequencing technology (Illumina) and gene expression analysis with a tag-based digital gene expression (DGE) system. The sequencing results generated 89,117 contigs, and 45,713 unigenes. These unigenes were annotated by Blastx alignment against the NCBI non-redundant (nr), Clusters of orthologous groups (COG), gene orthology (GO), and the Kyoto Encyclopedia of Genes and Genomes (KEGG) databases. 20,802 unigenes (45.5% of the total) matched with protein in the NCBI nr database. Two digital gene expression (DGE) libraries were constructed to determine differences in gene expression profiles during diapause and non-diapause developmental stages. Genes related to diapause were analyzed in detail and in addition, nine diapause-related genes were analyzed by real time PCR. Conclusions/Significance: The OWBM transcriptome greatly improves our genetic understanding and provides a platform for functional genomics research of this species. The DGE profiling data provides comprehensive information at the transcriptional level that facilitates our understanding of the molecular mechanisms of various physiological aspects including development and diapause stages in OWBM. From this study it is evident that various genes coding metabolic enzymes are crucial for diapause and metamorphosis.	[Gong, Zhong-Jun; Wu, Yu-Qing; Miao, Jin; Duan, Yun; Jiang, Yue-Li; Li, Tong] Henan Acad Agr Sci, Key Lab Crop Pest Control Henan Prov, Key Lab Crop Integrated Pest Management Southern, Inst Plant Protect,Minist Agr Peoples Republ Chin, Zhengzhou, Peoples R China	Henan Academy of Agricultural Sciences	Wu, YQ (corresponding author), Henan Acad Agr Sci, Key Lab Crop Pest Control Henan Prov, Key Lab Crop Integrated Pest Management Southern, Inst Plant Protect,Minist Agr Peoples Republ Chin, Zhengzhou, Peoples R China.	yuqingwu36@hotmail.com	Gong, Zhongjun/AAZ-4442-2020	Li, Tong/0000-0001-6269-5117	China Agricultural Research System [CARS-03]	China Agricultural Research System	This work was supported by the China Agricultural Research System (CARS-03). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Attardo GM, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-160; Audic S, 1997, GENOME RES, V7, P986, DOI 10.1101/gr.7.10.986; Bao B, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-224; BERGER EM, 1983, EXP CELL RES, V147, P437, DOI 10.1016/0014-4827(83)90225-2; Cheng WN, 2009, EUR J ENTOMOL, V106, P29, DOI 10.14411/eje.2009.004; Cheng Wei-Ning, 2009, Acta Entomologica Sinica, V52, P133; Cheng WN, 2008, THESIS NW A F U; Denlinger DL, 2002, ANNU REV ENTOMOL, V47, P93, DOI 10.1146/annurev.ento.47.091201.145137; Denlinger DL, 1985, HORMONAL CONTROL DIA; Ding H, 1992, AGR WORLD, V5, P31; Elliott RH, 2009, CROP PROT, V28, P588, DOI 10.1016/j.cropro.2009.03.005; Emerson KJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009574; FEDER JH, 1992, GENE DEV, V6, P1402, DOI 10.1101/gad.6.8.1402; Garber M, 2011, NAT METHODS, V8, P469, DOI [10.1038/NMETH.1613, 10.1038/nmeth.1613]; Gkouvitsas T, 2008, J INSECT PHYSIOL, V54, P1503, DOI 10.1016/j.jinsphys.2008.08.009; Goto M, 2001, J INSECT PHYSIOL, V47, P157, DOI 10.1016/S0022-1910(00)00099-8; Hahn DA, 2011, ANNU REV ENTOMOL, V56, P103, DOI 10.1146/annurev-ento-112408-085436; Hayward SAL, 2005, J INSECT PHYSIOL, V51, P631, DOI 10.1016/j.jinsphys.2004.11.009; HINKS CF, 1988, J ECON ENTOMOL, V81, P1816, DOI 10.1093/jee/81.6.1816; Hu Mu-Lin, 1995, Entomological Knowledge, V32, P13; Huang LH, 2009, J INSECT PHYSIOL, V55, P279, DOI 10.1016/j.jinsphys.2008.12.004; Iseli C, 1999, Proc Int Conf Intell Syst Mol Biol, P138; Kostal V, 2006, J INSECT PHYSIOL, V52, P113, DOI 10.1016/j.jinsphys.2005.09.008; Kostal V, 2001, COMP BIOCHEM PHYS B, V130, P365, DOI 10.1016/S1096-4959(01)00441-9; Kostal V, 2008, J INSECT PHYSIOL, V54, P77, DOI 10.1016/j.jinsphys.2007.08.004; Kostal V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025025; Krebs RA, 1997, CELL STRESS CHAPERON, V2, P60, DOI 10.1379/1466-1268(1997)002<0060:DCOHOI>2.3.CO;2; Li RQ, 2009, BIOINFORMATICS, V25, P1966, DOI 10.1093/bioinformatics/btp336; [李英梅 LI Yingmei], 2006, [西北农业学报, Acat Agriculturae Boreali-Occidentalis Sinica], V15, P73; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Luque T, 1998, J BIOL CHEM, V273, P34293, DOI 10.1074/jbc.273.51.34293; MEOLA RW, 1977, J INSECT PHYSIOL, V23, P683, DOI 10.1016/0022-1910(77)90084-1; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Ni Chen, 1998, ENTOMOL KNOWL, V35, P240; NIIMI T, 1993, COMP BIOCHEM PHYS B, V106, P437, DOI 10.1016/0305-0491(93)90326-Z; NIIMI T, 1993, EUR J BIOCHEM, V213, P1125, DOI 10.1111/j.1432-1033.1993.tb17862.x; Oakley JN, 1998, CROP PROT, V17, P145, DOI 10.1016/S0261-2194(97)00097-5; Qin W, 2005, INSECT MOL BIOL, V14, P607, DOI 10.1111/j.1365-2583.2005.00589.x; Ragland GJ, 2010, P NATL ACAD SCI USA, V107, P14909, DOI 10.1073/pnas.1007075107; RICHARD DS, 1987, J INSECT PHYSIOL, V33, P385, DOI 10.1016/0022-1910(87)90016-3; Rinehart JP, 2007, P NATL ACAD SCI USA, V104, P11130, DOI 10.1073/pnas.0703538104; Rinehart JP, 2000, INSECT BIOCHEM MOLEC, V30, P515, DOI 10.1016/S0965-1748(00)00021-7; Rinehart JP, 2000, INSECT MOL BIOL, V9, P641, DOI 10.1046/j.1365-2583.2000.00230.x; Sasibhushan S, 2012, COMP BIOCHEM PHYS B, V161, P371, DOI 10.1016/j.cbpb.2012.01.002; Schafellner C, 2008, J INSECT PHYSIOL, V54, P916, DOI 10.1016/j.jinsphys.2008.04.015; Shen GM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029127; SIEBER R, 1977, EXPERIENTIA, V33, P1598, DOI 10.1007/BF01934019; Wang HL, 2007, THESIS NW A F U; [王洪亮 WANG Hongliang], 2006, [西北农林科技大学学报. 自然科学版, Journal of northwest sci-tech university of agriculture and forestry], V34, P139; Wiegmann BM, 2011, P NATL ACAD SCI USA, V108, P5690, DOI 10.1073/pnas.1012675108; Wise IL, 2004, CAN ENTOMOL, V136, P77; Wu Jun-xiang, 2004, Entomologia Sinica, V11, P27, DOI 10.1111/j.1744-7917.2004.tb00177.x; Wu Jun-xiang, 2004, Acta Entomologica Sinica, V47, P178; Wu YQ, 2011, RES CONTROL ORANGE W; Wu Yuqing, 2009, Acta Phytophylacica Sinica, V36, P381; Xu WH, 2012, P NATL ACAD SCI USA, V109, P14687, DOI 10.1073/pnas.1212879109; Yocum GD, 1998, INSECT BIOCHEM MOLEC, V28, P677, DOI 10.1016/S0965-1748(98)00046-0	57	19	24	1	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2013	8	8							e71564	10.1371/journal.pone.0071564	http://dx.doi.org/10.1371/journal.pone.0071564			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	218XC	23940768	Green Published, gold, Green Submitted			2022-12-25	WOS:000324465000215
J	Hlebowicz, J; Drake, I; Gullberg, B; Sonestedt, E; Wallstrom, P; Persson, M; Nilsson, J; Hedblad, B; Wirfalt, E				Hlebowicz, Joanna; Drake, Isabel; Gullberg, Bo; Sonestedt, Emily; Wallstrom, Peter; Persson, Margaretha; Nilsson, Jan; Hedblad, Bo; Wirfalt, Elisabet			A High Diet Quality Is Associated with Lower Incidence of Cardiovascular Events in the Malmo Diet and Cancer Cohort	PLOS ONE			English	Article							MAJOR CHRONIC DISEASE; GUIDELINES-FOR-AMERICANS; CORONARY-HEART-DISEASE; BLOOD-PRESSURE; LIFE-STYLE; MYOCARDIAL-INFARCTION; MEDITERRANEAN DIET; RISK-FACTORS; FOOD; MORTALITY	Aims: To investigate if diet quality is related to incidence of cardiovascular (CV) events. Subjects and Methods: A diet quality index based on the 2005 Swedish Nutrition Recommendations and the Swedish Dietary Guidelines was created and included six dietary components: saturated fatty acids, polyunsaturated fatty acids, fish and shellfish, dietary fiber, fruit and vegetables, and sucrose. The index ranked 17126 participants (59% women) of the population-based Malmo Diet and Cancer cohort (Sweden) on their dietary intakes. Total index score was categorized as low, medium or high. Cox proportional hazard regression was used to model associations between index score categories and index components with risk of incident CV events, with adjustment for potential confounders. The incidence of first CV events (non-fatal or fatal myocardial infarction or ischemic stroke or death from ischemic heart disease) was monitored from baseline (1991-1996) until December 31, 2008; 703 CV events occurred in women and 1093 in men. Results: A high diet quality was associated with decreased risk of CV events when compared to a low diet quality. In multivariate analysis, the risk reduction was 32% (hazard ratio = 0.68, 95% confidence interval: 0.49-0.73) in men and 27% (hazard ratio = 0.73, 95% confidence interval: 0.59-0.91) in women. When examined separately and mutually adjusted for each other, the individual components were either not associated with CV risk or marginally decreased risks were seen. Conclusion: High quality diets in line with current recommendations may reduce the risk of CV events. This study illustrates the importance of considering a combination of dietary factors when evaluating diet-disease associations.	[Hlebowicz, Joanna; Persson, Margaretha; Nilsson, Jan; Hedblad, Bo] Skane Univ Hosp, Ctr Emergency, Malmo, Sweden; [Hlebowicz, Joanna; Drake, Isabel; Gullberg, Bo; Sonestedt, Emily; Wallstrom, Peter; Persson, Margaretha; Nilsson, Jan; Hedblad, Bo; Wirfalt, Elisabet] Lund Univ, Dept Clin Sci Malmo, S-22100 Lund, Sweden; [Hlebowicz, Joanna] Skane Univ Hosp, Dept Cardiol, Malmo, Sweden	Lund University; Skane University Hospital; Lund University; Lund University; Skane University Hospital	Drake, I (corresponding author), Lund Univ, Dept Clin Sci Malmo, S-22100 Lund, Sweden.	Isabel.Drake@med.lu.se	Sonestedt, Emily/I-3814-2016	Sonestedt, Emily/0000-0002-0747-4562; Persson, Margaretha/0000-0001-8188-5792; Drake, Isabel/0000-0002-6500-6310	Swedish Heart-Lung Foundation; Swedish Research Council; Swedish Government funds for clinical research (ALF); Foundations for Research at Skane University Hospital Malmo; Ernhold Lundstrom's Foundation; Funds by Region Skane	Swedish Heart-Lung Foundation(Swedish Heart-Lung Foundation); Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Government funds for clinical research (ALF); Foundations for Research at Skane University Hospital Malmo; Ernhold Lundstrom's Foundation; Funds by Region Skane	This work was supported by the Swedish Heart-Lung Foundation, the Swedish Research Council, Swedish Government funds for clinical research (ALF), the Foundations for Research at Skane University Hospital Malmo, Ernhold Lundstrom's Foundation and Funds by Region Skane. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamsson V, 2011, J INTERN MED, V269, P150, DOI 10.1111/j.1365-2796.2010.02290.x; Appel LJ, 1997, NEW ENGL J MED, V336, P1117, DOI 10.1056/NEJM199704173361601; Becker W, 1999, BRIT J NUTR, V81, pS113, DOI 10.1017/S0007114599000951; Belin RJ, 2011, AM J CLIN NUTR, V94, P49, DOI 10.3945/ajcn.110.011221; BERGLUND G, 1993, J INTERN MED, V233, P45, DOI 10.1111/j.1365-2796.1993.tb00647.x; Blumenthal JA, 2010, ARCH INTERN MED, V170, P126, DOI 10.1001/archinternmed.2009.470; Chiuve SE, 2012, J NUTR, V142, P1009, DOI 10.3945/jn.111.157222; de Lorgeril M, 1999, CIRCULATION, V99, P779, DOI 10.1161/01.CIR.99.6.779; Donnan GA, 2008, LANCET, V371, P1612, DOI 10.1016/S0140-6736(08)60694-7; Drake I, 2013, PUBLIC HEALTH NUTR, V16, P468, DOI 10.1017/S1368980012002789; Drake I, 2011, PUBLIC HEALTH NUTR, V14, P835, DOI 10.1017/S1368980010003848; Elmer PJ, 2006, ANN INTERN MED, V144, P485, DOI 10.7326/0003-4819-144-7-200604040-00007; Elmstahl S, 1996, EUR J CLIN NUTR, V50, P134; Fung TT, 2009, CIRCULATION, V119, P1093, DOI 10.1161/CIRCULATIONAHA.108.816736; Hammar N, 2001, INT J EPIDEMIOL, V30, pS30, DOI 10.1093/ije/30.suppl_1.S30; Howard BV, 2006, JAMA-J AM MED ASSOC, V295, P655, DOI 10.1001/jama.295.6.655; Jacobs DR, 2007, NUTR REV, V65, P439, DOI [10.1111/j.1753-4887.2007.tb00269.x, 10.1301/nr.2007.oct.439-450]; Jakobsen MU, 2009, AM J CLIN NUTR, V89, P1425, DOI 10.3945/ajcn.2008.27124; Kant AK, 2000, JAMA-J AM MED ASSOC, V283, P2109, DOI 10.1001/jama.283.16.2109; Lien LF, 2007, HYPERTENSION, V50, P609, DOI 10.1161/HYPERTENSIONAHA.107.089458; Manjer J, 2001, EUR J CANCER PREV, V10, P489, DOI 10.1097/00008469-200112000-00003; Manjer J, 2002, SCAND J PUBLIC HEALT, V30, P103, DOI 10.1080/14034940210133771; Mattisson I, 2005, BRIT J NUTR, V94, P832, DOI 10.1079/BJN20051573; McCullough ML, 2000, AM J CLIN NUTR, V72, P1223; McCullough ML, 2000, AM J CLIN NUTR, V72, P1214; McCullough ML, 2006, PUBLIC HEALTH NUTR, V9, P152, DOI 10.1079/PHN2005938; McCullough ML, 2002, AM J CLIN NUTR, V76, P1261, DOI 10.1093/ajcn/76.6.1261; Mente A, 2009, ARCH INTERN MED, V169, P659, DOI 10.1001/archinternmed.2009.38; Riboli E, 1997, INT J EPIDEMIOL, V26, pS161, DOI 10.1093/ije/26.suppl_1.S161; RICHARDSON MT, 1994, J CLIN EPIDEMIOL, V47, P271, DOI 10.1016/0895-4356(94)90008-6; Sofi F, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a1344; Sonestedt E, 2005, PUBLIC HEALTH NUTR, V8, P876, DOI 10.1079/PHN2005736; TAYLOR HL, 1978, J CHRON DIS, V31, P741, DOI 10.1016/0021-9681(78)90058-9; The National board of Health and Welfare, 2000, VARD DIAGN AK HJART; Thiebaut ACM, 2008, CANCER INVEST, V26, P68, DOI 10.1080/07357900701527918; Waijers PMCM, 2007, BRIT J NUTR, V97, P219, DOI 10.1017/S0007114507250421; Wallstrom P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031637; Yngve A, 2006, PUBLIC HEALTH NUTR, V9, P269, DOI 10.1079/PHN2006952; Zia E, 2007, STROKE, V38, P2681, DOI 10.1161/STROKEAHA.106.479725	39	34	34	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2013	8	8							e71095	10.1371/journal.pone.0071095	http://dx.doi.org/10.1371/journal.pone.0071095			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	218XC	23940694	gold, Green Published, Green Submitted			2022-12-25	WOS:000324465000177
J	Licata, A; Corrao, S; Petta, S; Genco, C; Cardillo, M; Calvaruso, V; Cabibbo, G; Massenti, F; Camma, C; Licata, G; Craxi, A				Licata, Anna; Corrao, Salvatore; Petta, Salvatore; Genco, Chiara; Cardillo, Mauro; Calvaruso, Vincenza; Cabibbo, Giuseppe; Massenti, Fatima; Camma, Calogero; Licata, Giuseppe; Craxi, Antonio			NT Pro BNP Plasma Level and Atrial Volume Are Linked to the Severity of Liver Cirrhosis	PLOS ONE			English	Article							BRAIN NATRIURETIC PEPTIDE; CARDIOMYOPATHY; DYSFUNCTION; RATS	Background and Aims: Plasma levels of NT-pro-BNP, a natriuretic peptide precursor, are raised in the presence of fluid retention of cardiac origin and can be used as markers of cardiac dysfunction. Recent studies showed high levels of NT pro BNP in patients with cirrhosis. We assessed NT pro-BNP and other parameters of cardiac dysfunction in patients with cirrhosis, with or without ascites, in order to determine whether the behaviour of NT pro BNP is linked to the stage of liver disease or to secondary cardiac dysfunction. Methods: Fifty eight consecutive hospitalized patients mostly with viral or NAFLD-related cirrhosis were studied. All underwent abdominal ultrasound and upper GI endoscopy. Cardiac morpho-functional changes were evaluated by echocardiography and NT-pro-BNP plasma levels determined upon admission. Twenty-eight hypertensive patients, without evidence of liver disease served as controls. Results: Fifty eight cirrhotic patients (72% men) with a median age of 62 years (11% with mild arterial hypertension and 31% with type 2 diabetes) had a normal renal function (mean creatinine 0.9 mg/dl, range 0.7-1.06). As compared to controls, cirrhotic patients had higher NT pro-BNP plasma levels (365.2 +/- 365.2 vs 70.8 +/- 70.6 pg/ml; p<0.001). Left atrial volume (LAV) (61.8 +/- 26.3 vs 43.5 +/- 14.1 ml; p = 0.001), and left ventricular ejection fraction (62.7 +/- 6.9 vs. 65.5 +/- 4%,; p = 0.05) were also altered in cirrhotic patients that in controls. Patients with F2-F3 oesophageal varices as compared to F0/F1, showed higher e' velocity (0.91 +/- 0.23 vs 0.66 +/- 0.19 m/s, p<0.001), and accordingly a higher E/A ratio (1.21 +/- 0.46 vs 0.89 +/- 0.33 m/s., p = 0.006). Conclusion: NT-pro-BNP plasma levels are increased proportionally to the stage of chronic liver disease. Advanced cirrhosis and high NT-pro-BNP levels are significantly associated to increased LAV and to signs of cardiac diastolic dysfunction. NT pro-BNP levels could hence be an useful prognostic indicators of early decompensation of cirrhosis.	[Licata, Anna; Petta, Salvatore; Genco, Chiara; Calvaruso, Vincenza; Cabibbo, Giuseppe; Camma, Calogero; Craxi, Antonio] Univ Palermo, Dipartimento Biomed Med Interna & Specialist, Palermo, Italy; [Corrao, Salvatore; Cardillo, Mauro; Licata, Giuseppe] Univ Palermo, Sez Med Interna & Cardioangiol, Dipartimento Biomed Med Interna & Specialist, Palermo, Italy; [Massenti, Fatima] Univ Palermo, Dipartimento Sci Promoz Salute, Sez Igiene, Palermo, Italy	University of Palermo; University of Palermo; University of Palermo	Licata, A (corresponding author), Univ Palermo, Dipartimento Biomed Med Interna & Specialist, Palermo, Italy.	annalisalicata@yahoo.com	Corrao, Salvatore/AAQ-5768-2020; Corrao, Salvatore SC/K-3504-2018; Cabibbo, Giuseppe/AAY-8284-2020; Cabibbo, Giuseppe/K-2966-2018; Craxi, Antonio/K-9529-2016; Calvaruso, Vincenza/K-8973-2016	Corrao, Salvatore/0000-0001-5621-1374; Corrao, Salvatore SC/0000-0001-5621-1374; Cabibbo, Giuseppe/0000-0002-0946-3859; CAMMA', CALOGERO/0000-0002-9224-1914; Craxi, Antonio/0000-0002-4480-9544; Cabibbo, Giuseppe/0000-0002-2463-1849; Calvaruso, Vincenza/0000-0002-0287-1059; Licata, Anna/0000-0003-0383-6121; Petta, Salvatore/0000-0002-0822-9673				Bortoluzzi A, 2013, HEPATOLOGY, V57, P266, DOI 10.1002/hep.26021; CORRAO S, 1995, CARDIOLOGY, V86, P503, DOI 10.1159/000176930; Coutu P, 2004, CIRC RES, V94, P1235, DOI 10.1161/01.RES.0000126923.46786.FD; de Lemos JA, 2003, LANCET, V362, P316, DOI 10.1016/S0140-6736(03)13976-1; Gavin JR, 2000, DIABETES CARE, V23, pS4; Giannini E, 2003, GUT, V52, P1200, DOI 10.1136/gut.52.8.1200; Goetze JP, 2002, CLIN CHEM, V48, P1035; Gottdiener JS, 2004, J AM SOC ECHOCARDIOG, V17, P1086, DOI 10.1016/j.echo.2004.07.013; Henriksen JH, 2003, GUT, V52, P1511, DOI 10.1136/gut.52.10.1511; Iwakiri Y, 2006, HEPATOLOGY, V43, pS121, DOI 10.1002/hep.20993; KOMEICHI H, 1995, J HEPATOL, V22, P319, DOI 10.1016/0168-8278(95)80285-1; Lee SS, 2007, GUT, V56, P746, DOI 10.1136/gut.2006.112169; Liu HQ, 2006, WORLD J GASTROENTERO, V12, P837, DOI 10.3748/wjg.v12.i6.837; Ma ZH, 1997, J HEPATOL, V26, P904, DOI 10.1016/S0168-8278(97)80259-0; Mani AR, 2012, BIOCHEM PHARMACOL, V84, P1062, DOI 10.1016/j.bcp.2012.07.028; Moller S, 2008, GUT, V57, P268, DOI 10.1136/gut.2006.112177; Moller S, 2002, HEART, V87, P9, DOI 10.1136/heart.87.1.9; Moller S, 2005, ASCITES AND RENAL DYSFUNCTION IN LIVER DISEASE: PATHOGENESIS, DIAGNOSIS, AND TREATMENT, 2ND EDITION, P139; Moller S, 2010, J HEPATOL, V53, P179, DOI 10.1016/j.jhep.2010.02.023; Nagueh SF, 2009, J AM SOC ECHOCARDIOG, V22, P107, DOI 10.1016/j.echo.2008.11.023; Padillo J, 2010, EUR J GASTROEN HEPAT, V22, P1331, DOI 10.1097/MEG.0b013e32833e6b2a; Pimenta J, 2010, LIVER INT, V30, P1059, DOI 10.1111/j.1478-3231.2010.02266.x; Pozzi M, 1997, HEPATOLOGY, V26, P1131; Scaglione R, 2010, INT J HYPERTENS, V2010, DOI 10.4061/2010/647147; Weber M, 2006, HEART, V92, P843, DOI 10.1136/hrt.2005.071233; Wong F, 2001, CLIN SCI, V101, P621, DOI 10.1042/CS20010183; Yildiz R, 2005, J GASTROEN HEPATOL, V20, P1115, DOI 10.1111/j.1440-1746.2005.03906.x; Zardi EM, 2010, J AM COLL CARDIOL, V56, P539, DOI 10.1016/j.jacc.2009.12.075	28	20	21	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2013	8	8							e68364	10.1371/journal.pone.0068364	http://dx.doi.org/10.1371/journal.pone.0068364			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	218XC	23940514	Green Published, gold, Green Submitted			2022-12-25	WOS:000324465000008
J	Siltanen, S; Fischer, D; Rantapero, T; Laitinen, V; Mpindi, JP; Kallioniemi, O; Wahlfors, T; Schleutker, J				Siltanen, Sanna; Fischer, Daniel; Rantapero, Tommi; Laitinen, Virpi; Mpindi, John Patrick; Kallioniemi, Olli; Wahlfors, Tiina; Schleutker, Johanna			ARLTS1 and Prostate Cancer Risk - Analysis of Expression and Regulation	PLOS ONE			English	Article							CHRONIC LYMPHOCYTIC-LEUKEMIA; COMPARATIVE GENOMIC HYBRIDIZATION; COLORECTAL-CANCER; CHROMOSOME 13Q14; GENETIC CHANGES; LINKAGE SCAN; INFLAMMATION; VARIANTS; SUSCEPTIBILITY; POLYMORPHISMS	Prostate cancer (PCa) is a heterogeneous trait for which several susceptibility loci have been implicated by genome-wide linkage and association studies. The genomic region 13q14 is frequently deleted in tumour tissues of both sporadic and familial PCa patients and is consequently recognised as a possible locus of tumour suppressor gene(s). Deletions of this region have been found in many other cancers. Recently, we showed that homozygous carriers for the T442C variant of the ARLTS1 gene (ADP-ribosylation factor-like tumour suppressor protein 1 or ARL11, located at 13q14) are associated with an increased risk for both unselected and familial PCa. Furthermore, the variant T442C was observed in greater frequency among malignant tissue samples, PCa cell lines and xenografts, supporting its role in PCa tumourigenesis. In this study, 84 PCa cases and 15 controls were analysed for ARLTS1 expression status in blood-derived RNA. A statistically significant (p = 0.0037) decrease of ARLTS1 expression in PCa cases was detected. Regulation of ARLTS1 expression was analysed with eQTL (expression quantitative trait loci) methods. Altogether fourteen significant cis-eQTLs affecting the ARLTS1 expression level were found. In addition, epistatic interactions of ARLTS1 genomic variants with genes involved in immune system processes were predicted with the MDR program. In conclusion, this study further supports the role of ARLTS1 as a tumour suppressor gene and reveals that the expression is regulated through variants localised in regulatory regions.	[Siltanen, Sanna; Rantapero, Tommi; Laitinen, Virpi; Wahlfors, Tiina; Schleutker, Johanna] Univ Tampere, Inst Biomed Technol, BioMediTech, FIN-33101 Tampere, Finland; [Siltanen, Sanna; Rantapero, Tommi; Laitinen, Virpi; Wahlfors, Tiina; Schleutker, Johanna] Fimlab Labs, Tampere, Finland; [Fischer, Daniel] Univ Tampere, Sch Hlth Sci, FIN-33101 Tampere, Finland; [Mpindi, John Patrick; Kallioniemi, Olli] Univ Helsinki, Inst Mol Med FIMM, Helsinki, Finland; [Schleutker, Johanna] Univ Turku, Inst Biomed, Dept Med Biochem & Genet, Turku, Finland	Tampere University; Tampere University; University of Helsinki; University of Turku	Schleutker, J (corresponding author), Univ Tampere, Inst Biomed Technol, BioMediTech, FIN-33101 Tampere, Finland.	Johanna.Schleutker@utu.fi	Fischer, Daniel/D-7324-2011; Kallioniemi, Olli P/H-5111-2011; Fischer, Daniel/C-8791-2017; Wahlfors, Tiina/U-7635-2018	Kallioniemi, Olli P/0000-0002-3231-0332; Fischer, Daniel/0000-0002-7513-683X; Wahlfors, Tiina/0000-0002-3910-796X; Schleutker, Johanna/0000-0002-1863-0305	Tampere Graduate Program in Biomedicine and Biotechnology; Orion-Farmos Research Foundation; Sigrid Juselius Foundation; Academy of Finland [251074]; Finnish Cancer Organisations; Competitive Research Funding of the Pirkanmaa Hospital District [9N069]	Tampere Graduate Program in Biomedicine and Biotechnology; Orion-Farmos Research Foundation; Sigrid Juselius Foundation(Sigrid Juselius Foundation); Academy of Finland(Academy of Finland); Finnish Cancer Organisations; Competitive Research Funding of the Pirkanmaa Hospital District	This work was supported by the Tampere Graduate Program in Biomedicine and Biotechnology salary and Orion-Farmos Research Foundation grant to S. S. and by the Sigrid Juselius Foundation, the Academy of Finland (251074), the Finnish Cancer Organisations, and the Competitive Research Funding of the Pirkanmaa Hospital District (9N069) grants to J.S. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Barretina J, 2012, NATURE, V483, P603, DOI 10.1038/nature11003; Bullaughey K, 2009, HUM MOL GENET, V18, P4296, DOI 10.1093/hmg/ddp382; Calin GA, 2005, NEW ENGL J MED, V352, P1667, DOI 10.1056/NEJMoa042280; Clarke E, 2008, J ALLERGY CLIN IMMUN, V121, P1148, DOI 10.1016/j.jaci.2008.02.028; Cropp CD, 2011, INT J CANCER, V129, P2400, DOI 10.1002/ijc.25906; De Marzo AM, 2007, NAT REV CANCER, V7, P256, DOI 10.1038/nrc2090; Ding J, 2010, AM J HUM GENET, V87, P779, DOI 10.1016/j.ajhg.2010.10.024; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Feighner SD, 1999, SCIENCE, V284, P2184, DOI 10.1126/science.284.5423.2184; Frank B, 2006, INT J CANCER, V118, P2505, DOI 10.1002/ijc.21687; Frank B, 2006, CANCER LETT, V244, P172, DOI 10.1016/j.canlet.2005.12.006; Frank B, 2006, INT J CANCER, V119, P1736, DOI 10.1002/ijc.22008; George RE, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000255; Hahn LW, 2003, BIOINFORMATICS, V19, P376, DOI 10.1093/bioinformatics/btf869; Hu R, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-20; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Kwon EM, 2011, CANCER EPIDEM BIOMAR, V20, P923, DOI 10.1158/1055-9965.EPI-10-0994; Lee S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052290; Loo LWM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030477; Loza MJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001035; Mabuchi H, 2001, CANCER RES, V61, P2870; Min JL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022070; Myers RM, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001046; Nica AC, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002003; Nicholson SE, 1998, J LEUKOCYTE BIOL, V63, P665, DOI 10.1002/jlb.63.6.665; Petrocca F, 2006, CANCER RES, V66, P10287, DOI 10.1158/0008-5472.CAN-06-2289; Rokman A, 2001, PROSTATE, V46, P233; Schleutker J, 2000, CLIN CANCER RES, V6, P4810; Sellick GS, 2006, LEUKEMIA RES, V30, P1573, DOI 10.1016/j.leukres.2006.02.021; Sfanos KS, 2012, HISTOPATHOLOGY, V60, P199, DOI 10.1111/j.1365-2559.2011.04033.x; Siltanen S, 2008, EUR J HUM GENET, V16, P983, DOI 10.1038/ejhg.2008.43; Siltanen S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026595; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; van Everdink WJ, 2003, CANCER GENET CYTOGEN, V146, P48, DOI 10.1016/S0165-4608(03)00126-2; Veyrieras JB, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000214; VISAKORPI T, 1995, CANCER RES, V55, P342; Ward LD, 2012, NUCLEIC ACIDS RES, V40, pD930, DOI 10.1093/nar/gkr917; Woo JS, 2006, MOL CELL, V24, P967, DOI 10.1016/j.molcel.2006.11.009; Xu JF, 2005, AM J HUM GENET, V77, P219, DOI 10.1086/432377; Yendamuri S, 2007, CANCER RES, V67, P7738, DOI 10.1158/0008-5472.CAN-07-1481; Zhang YM, 2003, NAT GENET, V34, P181, DOI 10.1038/ng1166	43	10	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2013	8	8							e72040	10.1371/journal.pone.0072040	http://dx.doi.org/10.1371/journal.pone.0072040			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	218XC	23940804	Green Published, Green Submitted, gold			2022-12-25	WOS:000324465000242
J	Webster, CM; Hokari, M; McManus, A; Tang, XN; Ma, HL; Kacimi, R; Yenari, MA				Webster, Corey M.; Hokari, Masaaki; McManus, April; Tang, Xian Nan; Ma, Hualong; Kacimi, Rachid; Yenari, Midori A.			Microglial P2Y(12) Deficiency/Inhibition Protects against Brain Ischemia	PLOS ONE			English	Article							PREVENTS ATP EXCITOTOXICITY; MILD HYPOTHERMIA; RECEPTOR; ACTIVATION; INJURY; NEUROPROTECTION; IDENTIFICATION; NEURONS; OLIGODENDROCYTES; INFLAMMATION	Objective: Microglia are among the first immune cells to respond to ischemic insults. Triggering of this inflammatory response may involve the microglial purinergic GPCR, P2Y(12), activation via extracellular release of nucleotides from injured cells. It is also the inhibitory target of the widely used antiplatelet drug, clopidogrel. Thus, inhibiting this GPCR in microglia should inhibit microglial mediated neurotoxicity following ischemic brain injury. Methods: Experimental cerebral ischemia was induced, in vitro with oxygen-glucose deprivation (OGD), or in vivo via bilateral common carotid artery occlusion (BCCAO). Genetic knock-down in vitro via siRNA, or in vivo P2Y(12) transgenic mice (P2Y(12)-/- or P2Y(12)+/-), or in vivo treatment with clopidogrel, were used to manipulate the receptor. Neuron death, microglial activation, and microglial migration were assessed. Results: The addition of microglia to neuron-astrocyte cultures increases neurotoxicity following OGD, which is mitigated by microglial P2Y(12) deficiency (P < 0.05). Wildtype microglia form clusters around these neurons following injury, which is also prevented in P2Y(12) deficient microglia (P < 0.01). P2Y(12) knock-out microglia migrated less than WT controls in response to OGD-conditioned neuronal supernatant. P2Y(12) (+/-) or clopidogrel treated mice subjected to global cerebral ischemia suffered less neuronal injury (P < 0.01, P < 0.001) compared to wild-type littermates or placebo treated controls. There were also fewer microglia surrounding areas of injury, and less activation of the pro-inflammatory transcription factor, nuclear factor Kappa B (NFkB). Interpretation: P2Y(12) participates in ischemia related inflammation by mediating microglial migration and potentiation of neurotoxicity. These data also suggest an additional anti-inflammatory, neuroprotective benefit of clopidogrel.	[Yenari, Midori A.] Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94143 USA; San Francisco VA Med Ctr, San Francisco, CA USA	University of California System; University of California San Francisco; US Department of Veterans Affairs; Veterans Health Administration (VHA); San Francisco VA Medical Center	Yenari, MA (corresponding author), Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94143 USA.	yenari@alum.mit.edu			National Institutes of Health [NS40516]; Veteran's Merit Award; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS040516] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Veteran's Merit Award; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by grants from the National Institutes of Health (NS40516) and the Veteran's Merit Award to MAY. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amadio S, 2006, NEUROSCIENCE, V141, P1171, DOI 10.1016/j.neuroscience.2006.05.058; Arbeloa J, 2012, NEUROBIOL DIS, V45, P954, DOI 10.1016/j.nbd.2011.12.014; Burguillos MA, 2011, NATURE, V472, P319, DOI 10.1038/nature09788; Burnstock G, 2011, CURR TOP MED CHEM, V11, P973, DOI 10.2174/156802611795347627; Cho Kyung-Ok, 2006, Korean Journal of Physiology & Pharmacology, V10, P167; Chu KT, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-69; Dienert HC, 2008, LANCET NEUROL, V7, P875, DOI 10.1016/S1474-4422(08)70198-4; Eleuteri S, 2008, NEUROSCI LETT, V448, P74, DOI 10.1016/j.neulet.2008.09.033; Faustino JV, 2011, J NEUROSCI, V31, P12992, DOI 10.1523/JNEUROSCI.2102-11.2011; Foster CJ, 2001, J CLIN INVEST, V107, P1591, DOI 10.1172/JCI12242; Gachet C, 2012, PURINERG SIGNAL, V8, P609, DOI 10.1007/s11302-012-9303-x; Gent M, 1996, LANCET, V348, P1329, DOI 10.1016/s0140-6736(96)09457-3; Han HS, 2003, J CEREBR BLOOD F MET, V23, P589, DOI 10.1097/01.WCB.0000059566.39780.8D; Han HS, 2002, J NEUROSCI, V22, P3921, DOI 10.1523/JNEUROSCI.22-10-03921.2002; Haynes SE, 2006, NAT NEUROSCI, V9, P1512, DOI 10.1038/nn1805; Hollopeter G, 2001, NATURE, V409, P202, DOI 10.1038/35051599; Honda S, 2001, J NEUROSCI, V21, P1975, DOI 10.1523/JNEUROSCI.21-06-01975.2001; Huang WC, 2010, ANAT CELL BIOL, V43, P325, DOI 10.5115/acb.2010.43.4.325; Inoue K, 2008, CELL MOL LIFE SCI, V65, P3074, DOI 10.1007/s00018-008-8210-3; Inoue K, 2002, GLIA, V40, P156, DOI 10.1002/glia.10150; Irino Y, 2008, J NEUROSCI RES, V86, P1511, DOI 10.1002/jnr.21610; Koizumi S, 2007, NATURE, V446, P1091, DOI 10.1038/nature05704; Kreutzberg GW, 1996, TRENDS NEUROSCI, V19, P312, DOI 10.1016/0166-2236(96)10049-7; Kriz Jasna, 2006, Critical Reviews in Neurobiology, V18, P145; Lee JE, 2001, EXP NEUROL, V170, P129, DOI 10.1006/exnr.2000.7614; Liu L, 2008, J NEUROCHEM, V106, P541, DOI 10.1111/j.1471-4159.2008.05411.x; Maeda M, 2010, GLIA, V58, P1838, DOI 10.1002/glia.21053; Marcellino D, 2010, J NEURAL TRANSM, V117, P681, DOI 10.1007/s00702-010-0400-0; Matute C, 2007, J NEUROSCI, V27, P9525, DOI 10.1523/JNEUROSCI.0579-07.2007; Melani A, 2006, J CEREBR BLOOD F MET, V26, P974, DOI 10.1038/sj.jcbfm.9600250; Nisar S, 2011, BLOOD, V118, P5641, DOI 10.1182/blood-2011-02-336826; Orr AG, 2009, NAT NEUROSCI, V12, P872, DOI 10.1038/nn.2341; Parkinson FE, 2002, NEUROPHARMACOLOGY, V43, P836, DOI 10.1016/S0028-3908(02)00083-7; Sanz JM, 2009, J IMMUNOL, V182, P4378, DOI 10.4049/jimmunol.0803612; Sasaki Y, 2003, GLIA, V44, P242, DOI 10.1002/glia.10293; Savi P, 2000, THROMB HAEMOSTASIS, V84, P891, DOI 10.1055/s-0037-1614133; Sharp AJ, 2008, J NEUROINFLAMM, V5, DOI 10.1186/1742-2094-5-33; Skaper SD, 2011, CNS NEUROL DISORD-DR, V10, P44; Tozaki-Saitoh H, 2008, J NEUROSCI, V28, P4949, DOI 10.1523/JNEUROSCI.0323-08.2008; Wang Q, 2007, J NEUROIMMUNOL, V184, P53, DOI 10.1016/j.jneuroim.2006.11.014; Watanabe H, 2000, NEUROSCI LETT, V289, P53, DOI 10.1016/S0304-3940(00)01252-0; Webster CM, 2009, NEUROBIOL DIS, V33, P301, DOI 10.1016/j.nbd.2008.11.001; Yanagisawa D, 2008, BIOL PHARM BULL, V31, P1121, DOI 10.1248/bpb.31.1121; Yenari MA, 2001, NEUROSCI LETT, V298, P5, DOI 10.1016/S0304-3940(00)01724-9; Yenari MA, 2010, NEUROTHERAPEUTICS, V7, P378, DOI 10.1016/j.nurt.2010.07.005; Zheng Z, 2008, J CEREBR BLOOD F MET, V28, P53, DOI 10.1038/sj.jcbfm.9600502	46	83	84	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2013	8	8							e70927	10.1371/journal.pone.0070927	http://dx.doi.org/10.1371/journal.pone.0070927			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	218XC	23940669	gold, Green Published, Green Submitted			2022-12-25	WOS:000324465000158
J	Suram, S; Silveira, LJ; Mahaffey, S; Brown, GD; Bonventre, JV; Williams, DL; Gow, NAR; Bratton, DL; Murphy, RC; Leslie, CC				Suram, Saritha; Silveira, Lori J.; Mahaffey, Spencer; Brown, Gordon D.; Bonventre, Joseph V.; Williams, David L.; Gow, Neil A. R.; Bratton, Donna L.; Murphy, Robert C.; Leslie, Christina C.			Cytosolic Phospholipase A(2)alpha and Eicosanoids Regulate Expression of Genes in Macrophages Involved in Host Defense and Inflammation	PLOS ONE			English	Article							ARACHIDONIC-ACID RELEASE; NUCLEAR RECEPTOR NR4A2; CANDIDA-ALBICANS; IMMUNE-RESPONSES; CYCLIC-AMP; TRANSCRIPTIONAL REPRESSOR; PROSTAGLANDIN E-2; RESOLUTION-PHASE; A(2) ACTIVATION; BINDING-PROTEIN	The role of Group IVA cytosolic phospholipase A(2) (cPLA(2)alpha) activation in regulating macrophage transcriptional responses to Candida albicans infection was investigated. cPLA(2)alpha releases arachidonic acid for the production of eicosanoids. In mouse resident peritoneal macrophages, prostacyclin, prostaglandin E-2 and leukotriene C-4 were produced within minutes of C. albicans addition before cyclooxygenase 2 expression. The production of TNF alpha was lower in C. albicans-stimulated cPLA(2)alpha(+/+) than cPLA(2)alpha(-/-)macrophages due to an autocrine effect of prostaglandins that increased cAMP to a greater extent in cPLA(2)alpha(+/+) than cPLA(2)alpha(-/-) macrophages. For global insight, differential gene expression in C. albicans-stimulated cPLA(2)alpha(+/+) and cPLA(2)alpha(-/-) macrophages (3 h) was compared by microarray. cPLA(2)alpha(+/+) macrophages expressed 86 genes at lower levels and 181 genes at higher levels than cPLA(2)alpha(-/-) macrophages (>= 2-fold, p<0.05). Several pro-inflammatory genes were expressed at lower levels (Tnf alpha, Cx3cl1, Cd40, Ccl5, Csf1, Edn1, CxCr7, Irf1, Irf4, Akna, Ifn gamma, several IFN gamma-inducible GTPases). Genes that dampen inflammation (Socs3, Il10, Crem, Stat3, Thbd, Thbs1, Abca1) and genes involved in host defense (Gja1, Csf3, Trem1, Hdc) were expressed at higher levels in cPLA(2)alpha(+/+) macrophages. Representative genes expressed lower in cPLA(2)alpha(+/+) macrophages (Tnfa, Csf1) were increased by treatment with a prostacyclin receptor antagonist and protein kinase A inhibitor, whereas genes expressed at higher levels (Crem, Nr4a2, Il10, Csf3) were suppressed. The results suggest that C. albicans stimulates an autocrine loop in macrophages involving cPLA(2)alpha, cyclooxygenase 1-derived prostaglandins and increased cAMP that globally effects expression of genes involved in host defense and inflammation.	[Suram, Saritha; Mahaffey, Spencer; Bratton, Donna L.; Leslie, Christina C.] Natl Jewish Hlth, Dept Pediat, Denver, CO USA; [Silveira, Lori J.] Natl Jewish Hlth, Div Biostat & Bioinformat, Denver, CO USA; [Brown, Gordon D.; Gow, Neil A. R.] Univ Aberdeen, Inst Med Sci, Aberdeen, Scotland; [Bonventre, Joseph V.] Brigham & Womens Hosp, Div Renal, Boston, MA 02115 USA; [Williams, David L.] E Tennessee State Univ, James H Quillen Coll Med, Dept Surg, Johnson City, TN 37614 USA; [Murphy, Robert C.; Leslie, Christina C.] Univ Colorado Denver, Dept Pharmacol, Aurora, CO USA; [Leslie, Christina C.] Univ Colorado Denver, Dept Pathol, Aurora, CO USA	National Jewish Health; National Jewish Health; University of Aberdeen; Harvard University; Brigham & Women's Hospital; East Tennessee State University; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus	Leslie, CC (corresponding author), Natl Jewish Hlth, Dept Pediat, Denver, CO USA.	lesliec@njhealth.org	GOW, Neil/AAS-5323-2021; Mahaffey, Spencer/AAC-8712-2021	GOW, Neil/0000-0002-2776-5850; 	National Institutes of Health [HL34303, DK54741, GM5322]; Wellcome Trust; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001082] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL034303] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK054741, R37DK039773, R56DK054741] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM053522] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Wellcome Trust(Wellcome TrustEuropean Commission); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by grants from the National Institutes of Health HL34303 (to C.C.L., R.C.M. and D.L.B), DK54741 (to J.V.B.), GM5322 (to D.L.W.) and the Wellcome Trust (to N.A.R.G. and G.D.B.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez Y, 2010, MEDIAT INFLAMM, V2010, DOI 10.1155/2010/201929; Alvarez Y, 2009, J IMMUNOL, V183, P1471, DOI 10.4049/jimmunol.0900312; Anand RJ, 2008, J IMMUNOL, V181, P8534, DOI 10.4049/jimmunol.181.12.8534; Aoki T, 2012, TRENDS PHARMACOL SCI, V33, P304, DOI 10.1016/j.tips.2012.02.004; Barclay JL, 2007, MOL ENDOCRINOL, V21, P2516, DOI 10.1210/me.2007-0030; Basu S, 2008, GROWTH FACTORS, V26, P23, DOI 10.1080/08977190801987513; Bates S, 2005, J BIOL CHEM, V280, P23408, DOI 10.1074/jbc.M502162200; Bonventre JV, 1997, NATURE, V390, P622, DOI 10.1038/37635; BRIKEN V, 1995, MOL CELL BIOL, V15, P975; Bystrom J, 2008, BLOOD, V112, P4117, DOI 10.1182/blood-2007-12-129767; Carballo E, 1998, SCIENCE, V281, P1001, DOI 10.1126/science.281.5379.1001; Cheng SC, 2012, INFECT IMMUN, V80, P1304, DOI 10.1128/IAI.06146-11; Chulada PC, 1997, J PHARMACOL EXP THER, V280, P606; Chung EY, 2007, IMMUNITY, V27, P952, DOI 10.1016/j.immuni.2007.11.014; Clarke DL, 2005, AM J PHYSIOL-LUNG C, V288, pL238, DOI 10.1152/ajplung.00313.2004; Conti HR, 2009, J EXP MED, V206, P299, DOI 10.1084/jem.20081463; D'Haese JG, 2012, EXPERT OPIN THER TAR, V16, P613, DOI 10.1517/14728222.2012.682574; de Kretser DM, 2012, MOL CELL ENDOCRINOL, V359, P101, DOI 10.1016/j.mce.2011.10.009; de Pedro MA, 2003, J BACTERIOL, V185, P1147, DOI 10.1128/JB.185.4.1147-11521.2003; Deacon K, 2010, J BIOL CHEM, V285, P25913, DOI 10.1074/jbc.M110.139485; Degrandi D, 2007, J IMMUNOL, V179, P7729, DOI 10.4049/jimmunol.179.11.7729; Dower K, 2008, J IMMUNOL, V180, P3520, DOI 10.4049/jimmunol.180.5.3520; Doyen V, 2003, J EXP MED, V198, P1277, DOI 10.1084/jem.20030705; Du XJ, 2011, J CELL BIOCHEM, V112, P1268, DOI 10.1002/jcb.23018; El Kasmi KC, 2007, J IMMUNOL, V179, P7215, DOI 10.4049/jimmunol.179.11.7215; Evans JF, 2003, PROSTAG LEUKOTR ESS, V69, P117, DOI 10.1016/S0952-3278(03)00072-3; Feng CL, 2006, BLOOD, V107, P3243, DOI 10.1182/blood-2005-07-2772; Ferwerda B, 2009, NEW ENGL J MED, V361, P1760, DOI 10.1056/NEJMoa0901053; Frasch SC, 2012, PROG LIPID RES, V51, P199, DOI 10.1016/j.plipres.2012.03.001; Frasch SC, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.181800; Frasch SC, 2008, J BIOL CHEM, V283, P33736, DOI 10.1074/jbc.M807047200; Funk CD, 2001, SCIENCE, V294, P1871, DOI 10.1126/science.294.5548.1871; Gagliardi MC, 2010, J LEUKOCYTE BIOL, V88, P947, DOI 10.1189/jlb.0310139; Ghosh M, 2006, PROG LIPID RES, V45, P487, DOI 10.1016/j.plipres.2006.05.003; Gijon MA, 2000, J BIOL CHEM, V275, P20146, DOI 10.1074/jbc.M908941199; Gijon MA, 2007, J LIPID RES, V48, P716, DOI 10.1194/jlr.M600508-JLR200; Goldszmid RS, 2012, NAT IMMUNOL, V13, P932, DOI 10.1038/ni.2422; Gorgani NN, 2011, AM J PATHOL, V179, P1310, DOI 10.1016/j.ajpath.2011.05.021; Gupta GP, 2007, NATURE, V446, P765, DOI 10.1038/nature05760; Hall LM, 1998, J AM SOC MASS SPECTR, V9, P527, DOI 10.1016/S1044-0305(98)00013-0; Hamilton JA, 2008, NAT REV IMMUNOL, V8, P533, DOI 10.1038/nri2356; Harzenetter MD, 2007, J IMMUNOL, V179, P607, DOI 10.4049/jimmunol.179.1.607; Holla VR, 2006, J BIOL CHEM, V281, P2676, DOI 10.1074/jbc.M507752200; Hu XY, 2009, IMMUNITY, V31, P539, DOI 10.1016/j.immuni.2009.09.002; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang ZL, 2003, J NEUROSCI, V23, P5975, DOI 10.1523/JNEUROSCI.23-14-05975.2003; Hunn JP, 2011, MAMM GENOME, V22, P43, DOI 10.1007/s00335-010-9293-3; Hutchins AP, 2012, BLOOD, V119, pE110, DOI 10.1182/blood-2011-09-381483; Iguchi G, 2009, CANCER LETT, V282, P152, DOI 10.1016/j.canlet.2009.03.006; Ivashkiv LB, 2011, EUR J IMMUNOL, V41, P2477, DOI 10.1002/eji.201141783; Jenner RG, 2005, NAT REV MICROBIOL, V3, P281, DOI 10.1038/nrmicro1126; KAINOH M, 1991, BIOCHEM PHARMACOL, V41, P1135, DOI 10.1016/0006-2952(91)90651-K; Kalinski P, 2012, J IMMUNOL, V188, P21, DOI 10.4049/jimmunol.1101029; Kanaoka Y, 2004, J IMMUNOL, V173, P1503, DOI 10.4049/jimmunol.173.3.1503; Kelly EK, 2010, J IMMUNOL, V184, P5545, DOI 10.4049/jimmunol.0901293; Kim BH, 2011, SCIENCE, V332, P717, DOI 10.1126/science.1201711; Le Goff W, 2006, ARTERIOSCL THROM VAS, V26, P527, DOI 10.1161/01.ATV.0000201042.00725.84; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Ma WY, 2010, IMMUNOLOGY, V130, P399, DOI 10.1111/j.1365-2567.2009.03239.x; Medeiros AI, 2009, J EXP MED, V206, P61, DOI 10.1084/jem.20082058; Menter David G, 2012, Int J Cell Biol, V2012, P723419, DOI 10.1155/2012/723419; Mix KS, 2012, ARTHRITIS RHEUM-US, V64, P2126, DOI 10.1002/art.34399; MIYAZAKI T, 1992, BIOCHIM BIOPHYS ACTA, V1133, P179, DOI 10.1016/0167-4889(92)90067-L; Moliterno AR, 2011, CELL RES, V21, P1528, DOI 10.1038/cr.2011.96; Morato-Marques M, 2011, J BIOL CHEM, V286, P28902, DOI 10.1074/jbc.M111.235309; Mosser DM, 2008, NAT REV IMMUNOL, V8, P958, DOI 10.1038/nri2448; Murakami Y, 2007, J IMMUNOL, V178, P1144, DOI 10.4049/jimmunol.178.2.1144; Netea MG, 2008, NAT REV MICROBIOL, V6, P67, DOI 10.1038/nrmicro1815; Netea MG, 2006, J CLIN INVEST, V116, P1642, DOI 10.1172/JCI27114; Noor S, 2008, J BIOL CHEM, V283, P4744, DOI 10.1074/jbc.M709956200; Norris PC, 2011, J LEUKOCYTE BIOL, V90, P563, DOI 10.1189/jlb.0311153; Okamoto T, 2012, CRIT CARE RES PRACT, V2012, DOI 10.1155/2012/614545; Oshima H, 2011, CANCER SCI, V102, P713, DOI 10.1111/j.1349-7006.2011.01847.x; Ouyang WJ, 2008, IMMUNITY, V28, P454, DOI 10.1016/j.immuni.2008.03.004; Peters-Golden M, 2005, J IMMUNOL, V174, P589, DOI 10.4049/jimmunol.174.2.589; Pfaller MA, 2007, CLIN MICROBIOL REV, V20, P133, DOI 10.1128/CMR.00029-06; Puel A, 2011, SCIENCE, V332, P65, DOI 10.1126/science.1200439; Qian XS, 2011, J BIOL CHEM, V286, P2111, DOI 10.1074/jbc.M110.154971; Qiu ZH, 1998, J BIOL CHEM, V273, P8203, DOI 10.1074/jbc.273.14.8203; QIU ZH, 1993, J BIOL CHEM, V268, P24506; QIU ZH, 1994, J BIOL CHEM, V269, P19480; Raica M, 2008, ANTICANCER RES, V28, P2997; Ricciotti E, 2011, ARTERIOSCL THROM VAS, V31, P986, DOI 10.1161/ATVBAHA.110.207449; Rouzer CA, 2004, J BIOL CHEM, V279, P34256, DOI 10.1074/jbc.M402594200; Saijo K, 2009, CELL, V137, P47, DOI 10.1016/j.cell.2009.01.038; Saraiva M, 2010, NAT REV IMMUNOL, V10, P170, DOI 10.1038/nri2711; Savitsky D, 2010, CANCER IMMUNOL IMMUN, V59, P489, DOI 10.1007/s00262-009-0804-6; Schneider E, 2002, TRENDS IMMUNOL, V23, P255, DOI 10.1016/S1471-4906(02)02215-9; Selvamurugan N, 2009, FEBS LETT, V583, P1141, DOI 10.1016/j.febslet.2009.02.040; Serhan CN, 2007, ANNU REV IMMUNOL, V25, P101, DOI 10.1146/annurev.immunol.25.022106.141647; Shinomiya S, 2001, BIOCHEM PHARMACOL, V61, P1153, DOI 10.1016/S0006-2952(01)00586-X; Siddiqa A, 2001, NATURE, V410, P383, DOI 10.1038/35066602; Silva MT, 2010, J LEUKOCYTE BIOL, V87, P805, DOI 10.1189/jlb.1109767; Smeekens SP, 2010, INT IMMUNOL, V22, P889, DOI 10.1093/intimm/dxq442; SPENGLER RN, 1989, INFECT IMMUN, V57, P2837, DOI 10.1128/IAI.57.9.2837-2841.1989; Stafford JB, 2008, BIOCHEM BIOPH RES CO, V366, P104, DOI 10.1016/j.bbrc.2007.11.091; Sun XQ, 2010, CANCER METAST REV, V29, P709, DOI 10.1007/s10555-010-9256-x; Suram S, 2006, J BIOL CHEM, V281, P5506, DOI 10.1074/jbc.M509824200; Suram S, 2010, J BIOL CHEM, V285, P30676, DOI 10.1074/jbc.M110.143800; Suttles J, 2009, SEMIN IMMUNOL, V21, P257, DOI 10.1016/j.smim.2009.05.011; Takeuchi O, 1999, IMMUNITY, V11, P443, DOI 10.1016/S1074-7613(00)80119-3; Taylor PR, 2007, NAT IMMUNOL, V8, P31, DOI 10.1038/ni1408; Teder P, 2000, AM J RESP CELL MOL, V23, P7, DOI 10.1165/ajrcmb.23.1.f192; Tilley SL, 2001, J CLIN INVEST, V108, P15, DOI 10.1172/JCI200113416; Toda A, 2002, PROSTAG OTH LIPID M, V68-9, P575, DOI 10.1016/S0090-6980(02)00056-4; Vestal DJ, 2011, J INTERF CYTOK RES, V31, P89, DOI 10.1089/jir.2010.0102; Vonk AG, 2006, EXPERT OPIN BIOL TH, V6, P891, DOI 10.1517/14712598.6.9.891; Wang DZ, 2010, NAT REV CANCER, V10, P181, DOI 10.1038/nrc2809; Wong MM, 2003, SEMIN IMMUNOL, V15, P5, DOI 10.1016/S1044-5323(02)00123-9; Woodward DF, 2011, PHARMACOL REV, V63, P471, DOI 10.1124/pr.110.003517; Xia XC, 2010, MOL CELL BIOL, V30, P206, DOI 10.1128/MCB.01844-08; Yao CC, 2009, NAT MED, V15, P633, DOI 10.1038/nm.1968; Yoshimura A, 2007, NAT REV IMMUNOL, V7, P454, DOI 10.1038/nri2093	113	29	29	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2013	8	7							e69002	10.1371/journal.pone.0069002	http://dx.doi.org/10.1371/journal.pone.0069002			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	191SQ	23950842	gold, Green Published, Green Submitted			2022-12-25	WOS:000322433300019
J	Lu, J; Xin, SC; Meng, H; Veldman, M; Schoenfeld, D; Che, C; Yan, RB; Zhong, HB; Li, S; Lin, S				Lu, Jing; Xin, Shengchang; Meng, Huan; Veldman, Matt; Schoenfeld, David; Che, Chao; Yan, Ruibin; Zhong, Hanbing; Li, Song; Lin, Shuo			A Novel Anti-Tumor Inhibitor Identified by Virtual Screen with PLK1 Structure and Zebrafish Assay	PLOS ONE			English	Article							POLO-LIKE-KINASE; CANCER-CELLS; PROGNOSTIC-SIGNIFICANCE; CENTRIOLE DUPLICATION; EMBRYONIC-DEVELOPMENT; DOWN-REGULATION; DNA-DAMAGE; PROTEIN; EXPRESSION; DROSOPHILA	Polo-like kinase 1 (PLK1), one of the key regulators of mitosis, is a target for cancer therapy due to its abnormally high activity in several tumors. Plk1 is highly conserved and shares a nearly identical 3-D structure between zebrafish and humans. The initial 10 mitoses of zebrafish embryonic cleavages occur every similar to 30 minutes, and therefore provide a rapid assay to evaluate mitosis inhibitors including those targeting Plk1. To increase efficiency and specificity, we first performed a computational virtual screen of similar to 60000 compounds against the human Plk1 3-D structure docked to both its kinase and Polo box domain. 370 candidates with the top free-energy scores were subjected to zebrafish assay and 3 were shown to inhibit cell division. Compared to general screen for compounds inhibiting zebrafish embryonic cleavage, computation increased the efficiency by 11 folds. One of the 3 compounds, named I2, was further demonstrated to effectively inhibit multiple tumor cell proliferation in vitro and PC3 prostate cancer growth in Xenograft mouse model in vivo. Furthermore, I2 inhibited Plk1 enzyme activity in a dose dependent manner. The IC50 values of I2 in these assays are compatible to those of ON-01910, a Plk1 inhibitor currently in Phase III clinic trials. Our studies demonstrate that zebrafish assays coupled with computational screening significantly improves the efficiency of identifying specific regulators of biological targets. The PLK1 inhibitor I2, and its analogs, may have potential in cancer therapeutics.	[Lu, Jing; Xin, Shengchang; Che, Chao; Yan, Ruibin; Zhong, Hanbing; Li, Song; Lin, Shuo] Peking Univ, Shenzhen Grad Sch, Shenzhen, Peoples R China; [Lu, Jing; Meng, Huan; Veldman, Matt; Schoenfeld, David; Lin, Shuo] Univ Calif Los Angeles, Dept Mol Cell & Dev Biol, Los Angeles, CA USA	Peking University; University Town of Shenzhen; University of California System; University of California Los Angeles	Lin, S (corresponding author), Peking Univ, Shenzhen Grad Sch, Shenzhen, Peoples R China.	shuolin@ucla.edu	WANG, Jiangxin/AFE-8446-2022; Meng, Huan/AAM-1072-2020; Meng, Huan/T-7954-2017; lu, shuhuan/AAV-6927-2020	WANG, Jiangxin/0000-0002-9917-067X; Meng, Huan/0000-0001-8844-3938; Meng, Huan/0000-0001-8844-3938; Che, Chao/0000-0001-7773-0907	National Institutes of Health [DK54508, HL097561, 973-2009CB941203, 973-ZYC201006170364A, JC201005270280A]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL097561] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was in part supported by research grants from the National Institutes of Health to SL (DK54508 and HL097561) and to ZH/SL (973-2009CB941203, 973-ZYC201006170364A, and JC201005270280A). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Ando K, 2004, J BIOL CHEM, V279, P25549, DOI 10.1074/jbc.M314182200; Andrysik Z, 2010, NUCLEIC ACIDS RES, V38, P2931, DOI 10.1093/nar/gkq011; Bahassi EM, 2002, ONCOGENE, V21, P6633, DOI 10.1038/sj.onc.1205850; Barr FA, 2004, NAT REV MOL CELL BIO, V5, P429, DOI 10.1038/nrm1401; Bettencourt-Dias M, 2005, CURR BIOL, V15, P2199, DOI 10.1016/j.cub.2005.11.042; Burkard ME, 2007, P NATL ACAD SCI USA, V104, P4383, DOI 10.1073/pnas.0701140104; Cogswell JP, 2000, CELL GROWTH DIFFER, V11, P615; Eckerdt F, 2006, CANCER RES, V66, P6895, DOI 10.1158/0008-5472.CAN-06-0358; Elia AEH, 2003, SCIENCE, V299, P1228, DOI 10.1126/science.1079079; Habedanck R, 2005, NAT CELL BIOL, V7, P1140, DOI 10.1038/ncb1320; Hauf S, 2005, PLOS BIOL, V3, P419, DOI 10.1371/journal.pbio.0030069; HOLTRICH U, 1994, P NATL ACAD SCI USA, V91, P1736, DOI 10.1073/pnas.91.5.1736; Hudson JW, 2001, CURR BIOL, V11, P441, DOI 10.1016/S0960-9822(01)00117-8; Jeong K, 2010, DEV BIOL, V345, P34, DOI 10.1016/j.ydbio.2010.06.004; Knecht R, 1999, CANCER RES, V59, P2794; Ko MA, 2005, NAT GENET, V37, P883, DOI 10.1038/ng1605; Lane HA, 1996, J CELL BIOL, V135, P1701, DOI 10.1083/jcb.135.6.1701; Liu XQ, 2006, MOL CELL BIOL, V26, P2093, DOI 10.1128/MCB.26.6.2093-2108.2006; Liu XQ, 2002, P NATL ACAD SCI USA, V99, P8672, DOI 10.1073/pnas.132269599; LLAMAZARES S, 1991, GENE DEV, V5, P2153, DOI 10.1101/gad.5.12a.2153; Lu LY, 2008, MOL CELL BIOL, V28, P6870, DOI 10.1128/MCB.00392-08; Ma S, 2003, MOL CELL BIOL, V23, P6936, DOI 10.1128/MCB.23.19.6936-6943.2003; McInnes C, 2005, CURR TOP MED CHEM, V5, P181, DOI 10.2174/1568026053507660; Pauls S, 2001, DEV GENES EVOL, V211, P603, DOI 10.1007/s00427-001-0196-x; Schoffski P, 2009, ONCOLOGIST, V14, P559, DOI 10.1634/theoncologist.2009-0010; Spankuch-Schmitt B, 2002, JNCI-J NATL CANCER I, V94, P1863, DOI 10.1093/jnci/94.24.1863; Spankuch-Schmitt B, 2002, ONCOGENE, V21, P3162, DOI 10.1038/sj.onc.1205412; Strebhardt K, 2006, NAT REV CANCER, V6, P321, DOI 10.1038/nrc1841; SUNKEL CE, 1988, J CELL SCI, V89, P25; Tan JL, 2011, METHOD CELL BIOL, V105, P493, DOI 10.1016/B978-0-12-381320-6.00021-7; van de Weerdt BCM, 2008, BBA-MOL CELL RES, V1783, P1015, DOI 10.1016/j.bbamcr.2008.02.019; van de Weerdt BCM, 2006, CELL CYCLE, V5, P853, DOI 10.4161/cc.5.8.2692; van Vugt MATM, 2005, ONCOGENE, V24, P2844, DOI 10.1038/sj.onc.1208617; Wolf G, 1997, ONCOGENE, V14, P543, DOI 10.1038/sj.onc.1200862; Xie SQ, 2001, J BIOL CHEM, V276, P43305, DOI 10.1074/jbc.M106050200; Yang YL, 2008, CANCER RES, V68, P4077, DOI 10.1158/0008-5472.CAN-07-6182; Zhong H, MOL BIOSYST, V6, P1463; Zhong HB, 2010, MOL BIOSYST, V6, P1463, DOI 10.1039/b919743e; Zimmerman WC, 2007, P NATL ACAD SCI USA, V104, P1847, DOI 10.1073/pnas.0610856104	39	31	32	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2013	8	4							e53317	10.1371/journal.pone.0053317	http://dx.doi.org/10.1371/journal.pone.0053317			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	136EF	23658603	Green Published, Green Submitted, gold			2022-12-25	WOS:000318343700001
J	Xuan, P; Han, K; Guo, MZ; Guo, YH; Li, JB; Ding, J; Liu, Y; Dai, QG; Li, J; Teng, ZX; Huang, YF				Xuan, Ping; Han, Ke; Guo, Maozu; Guo, Yahong; Li, Jinbao; Ding, Jian; Liu, Yong; Dai, Qiguo; Li, Jin; Teng, Zhixia; Huang, Yufei			Prediction of microRNAs Associated with Human Diseases Based on Weighted k Most Similar Neighbors	PLOS ONE			English	Article							GENE-EXPRESSION; CANCER; DEREGULATION; PROFILES; DATABASE; TARGETS; MIRNAS	Background: The identification of human disease-related microRNAs (disease miRNAs) is important for further investigating their involvement in the pathogenesis of diseases. More experimentally validated miRNA-disease associations have been accumulated recently. On the basis of these associations, it is essential to predict disease miRNAs for various human diseases. It is useful in providing reliable disease miRNA candidates for subsequent experimental studies. Methodology/Principal Findings: It is known that miRNAs with similar functions are often associated with similar diseases and vice versa. Therefore, the functional similarity of two miRNAs has been successfully estimated by measuring the semantic similarity of their associated diseases. To effectively predict disease miRNAs, we calculated the functional similarity by incorporating the information content of disease terms and phenotype similarity between diseases. Furthermore, the members of miRNA family or cluster are assigned higher weight since they are more probably associated with similar diseases. A new prediction method, HDMP, based on weighted k most similar neighbors is presented for predicting disease miRNAs. Experiments validated that HDMP achieved significantly higher prediction performance than existing methods. In addition, the case studies examining prostatic neoplasms, breast neoplasms, and lung neoplasms, showed that HDMP can uncover potential disease miRNA candidates. Conclusions: The superior performance of HDMP can be attributed to the accurate measurement of miRNA functional similarity, the weight assignment based on miRNA family or cluster, and the effective prediction based on weighted k most similar neighbors. The online prediction and analysis tool is freely available at http://nclab.hit.edu.cn/hdmpred.	[Xuan, Ping; Li, Jinbao; Ding, Jian; Liu, Yong] Heilongjiang Univ, Sch Comp Sci & Technol, Key Lab Database & Parallel Comp Heilongjiang Pro, Harbin, Peoples R China; [Han, Ke] Harbin Univ Commerce, Sch Comp & Informat Engn, Harbin, Peoples R China; [Guo, Maozu; Dai, Qiguo; Li, Jin; Teng, Zhixia] Harbin Inst Technol, Dept Comp Sci & Engn, Harbin 150006, Peoples R China; [Guo, Yahong] Heilongjiang Univ, Sch Informat Sci & Technol, Harbin, Peoples R China; [Huang, Yufei] Univ Texas San Antonio, Dept Elect & Comp Engn, San Antonio, TX USA	Heilongjiang University; Harbin University of Commerce; Harbin Institute of Technology; Heilongjiang University; University of Texas System; University of Texas at San Antonio (UTSA)	Guo, MZ (corresponding author), Harbin Inst Technol, Dept Comp Sci & Engn, Harbin 150006, Peoples R China.	maozuguo@hit.edu.cn; guoyahong7225@163.com; yufei.huang@utsa.edu	Huang, Yufei/AAU-2891-2021	Xuan, Ping/0000-0001-5328-691X	Natural Science Foundation of China [60932008, 61172098]; Natural Science Foundation of Heilongjiang Province [F201119]; National Institute of Health [R01 CA096512]; Qatar National Research Fund [09-874-3-235]; NATIONAL CANCER INSTITUTE [R01CA096512] Funding Source: NIH RePORTER	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Heilongjiang Province(Natural Science Foundation of Heilongjiang Province); National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Qatar National Research Fund(Qatar National Research Fund (QNRF)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work is supported by Natural Science Foundation of China (60932008 and 61172098, http://www.nsfc.gov.cn/Portal0/default152.htm), and Natural Science Foundation of Heilongjiang Province (F201119, http://nsf.hljkj.cn/zrjj/). Yufei Huang is supported by National Institute of Health (R01 CA096512, http://www.nih.gov/), and Qatar National Research Fund (09-874-3-235, http://www.qnrf.org/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Bandyopadhyay Sanghamitra, 2010, Silence, V1, P6, DOI 10.1186/1758-907X-1-6; Barad O, 2004, GENOME RES, V14, P2486, DOI 10.1101/gr.2845604; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Baskerville S, 2005, RNA, V11, P241, DOI 10.1261/rna.7240905; Chatterjee S, 2009, NATURE, V461, P546, DOI 10.1038/nature08349; Chen J, 2012, TRANSLATIONAL ANDROL, ps162; Chen X, 2012, MOL BIOSYST, V8, P2792, DOI 10.1039/c2mb25180a; Chen YX, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-407; Davis AP, 2013, NUCLEIC ACIDS RES, V41, pD1104, DOI 10.1093/nar/gks994; Esquela-Kerscher A, 2006, NAT REV CANCER, V6, P259, DOI 10.1038/nrc1840; Gardner PP, 2009, NUCLEIC ACIDS RES, V37, pD136, DOI 10.1093/nar/gkn766; Gaur A, 2007, CANCER RES, V67, P2456, DOI 10.1158/0008-5472.CAN-06-2698; Goh KI, 2007, P NATL ACAD SCI USA, V104, P8685, DOI 10.1073/pnas.0701361104; Griffiths-Jones S, 2008, NUCLEIC ACIDS RES, V36, pD154, DOI 10.1093/nar/gkm952; Gutierrez NC, 2010, LEUKEMIA, V24, P629, DOI 10.1038/leu.2009.274; Hamosh A, 2005, NUCLEIC ACIDS RES, V33, pD514; Iorio MV, 2005, CANCER RES, V65, P7065, DOI 10.1158/0008-5472.CAN-05-1783; Jiang QH, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-S1-S2; Jiang QH, 2009, NUCLEIC ACIDS RES, V37, pD98, DOI 10.1093/nar/gkn714; John B, 2005, PLOS BIOL, V3, P1328, DOI 10.1371/journal.pbio.0030264; Keller A, 2011, RNA BIOL, V8, P506, DOI 10.4161/rna.8.3.14994; Kertesz M, 2007, NAT GENET, V39, P1278, DOI 10.1038/ng2135; Krek A, 2005, NAT GENET, V37, P495, DOI 10.1038/ng1536; Landi MT, 2010, CLIN CANCER RES, V16, P430, DOI 10.1158/1078-0432.CCR-09-1736; Latronico MVG, 2007, CIRC RES, V101, P1225, DOI 10.1161/CIRCRESAHA.107.163147; Lee Y, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000730; Leidinger Petra, 2012, Frontiers in Genetics, V2, P104, DOI 10.3389/fgene.2011.00104; Lewis BP, 2003, CELL, V115, P787, DOI 10.1016/S0092-8674(03)01018-3; Li X, 2011, NUCLEIC ACIDS RES, V39, P1; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Lu M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003420; Lu Y, 2012, P NDSS, V0, P1; Lynam-Lennon N, 2009, BIOL REV, V84, P55, DOI 10.1111/j.1469-185X.2008.00061.x; Miyamoto K, 2009, CANC RES S2, P4051; Mosca E, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-76; Qinghua Jiang, 2010, Proceedings of the 2010 Fifth International Conference on Frontier of Computer Science and Technology (FCST 2010), P431, DOI 10.1109/FCST.2010.18; Ramalinga M, 2012, CANCER RES, V72, DOI 10.1158/1538-7445.AM2012-5028; Saba Reuben, 2006, BMC Biotechnol, V6, P47, DOI 10.1186/1472-6750-6-47; van Driel MA, 2006, EUR J HUM GENET, V14, P535, DOI 10.1038/sj.ejhg.5201585; Waltering KK, 2011, PROSTATE, V71, P604, DOI 10.1002/pros.21276; Wang D, 2010, BIOINFORMATICS, V26, P1644, DOI 10.1093/bioinformatics/btq241; Wang L, 2009, CANCER RES, V69, P9490, DOI 10.1158/0008-5472.CAN-09-2183; Watahiki A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024950; Xiong S, 2013, PATHOL ONCOL RES; Xu J, 2011, MOL CANCER THER, V10, P1857, DOI 10.1158/1535-7163.MCT-11-0055; Yakhini Z, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-120; Yamamoto Y, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-135; Yanaihara N, 2006, CANCER CELL, V9, P189, DOI 10.1016/j.ccr.2006.01.025; Yang XJ, 2009, GENE DEV, V23, P2388, DOI 10.1101/gad.1819009; Yang Z, 2008, BMC GENOMICS S4, pS5	52	267	272	5	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2013	8	8							e70204	10.1371/journal.pone.0070204	http://dx.doi.org/10.1371/journal.pone.0070204			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	201ER	23950912	Green Published, gold			2022-12-25	WOS:000323124000012
J	Regier, JC; Mitter, C; Zwick, A; Bazinet, AL; Cummings, MP; Kawahara, AY; Sohn, JC; Zwickl, DJ; Cho, S; Davis, DR; Baixeras, J; Brown, J; Parr, C; Weller, S; Lees, DC; Mitter, KT				Regier, Jerome C.; Mitter, Charles; Zwick, Andreas; Bazinet, Adam L.; Cummings, Michael P.; Kawahara, Akito Y.; Sohn, Jae-Cheon; Zwickl, Derrick J.; Cho, Soowon; Davis, Donald R.; Baixeras, Joaquin; Brown, John; Parr, Cynthia; Weller, Susan; Lees, David C.; Mitter, Kim T.			A Large-Scale, Higher-Level, Molecular Phylogenetic Study of the Insect Order Lepidoptera (Moths and Butterflies)	PLOS ONE			English	Article							EVOLUTION; GENE; BOOTSTRAP; TREE; CLASSIFICATION; HOMOLOGIES; SUPPORT	Background: Higher-level relationships within the Lepidoptera, and particularly within the species-rich subclade Ditrysia, are generally not well understood, although recent studies have yielded progress. We present the most comprehensive molecular analysis of lepidopteran phylogeny to date, focusing on relationships among superfamilies. Methodology / Principal Findings: 483 taxa spanning 115 of 124 families were sampled for 19 protein-coding nuclear genes, from which maximum likelihood tree estimates and bootstrap percentages were obtained using GARLI. Assessment of heuristic search effectiveness showed that better trees and higher bootstrap percentages probably remain to be discovered even after 1000 or more search replicates, but further search proved impractical even with grid computing. Other analyses explored the effects of sampling nonsynonymous change only versus partitioned and unpartitioned total nucleotide change; deletion of rogue taxa; and compositional heterogeneity. Relationships among the non-ditrysian lineages previously inferred from morphology were largely confirmed, plus some new ones, with strong support. Robust support was also found for divergences among non-apoditrysian lineages of Ditrysia, but only rarely so within Apoditrysia. Paraphyly for Tineoidea is strongly supported by analysis of nonsynonymous-only signal; conflicting, strong support for tineoid monophyly when synonymous signal was added back is shown to result from compositional heterogeneity. Conclusions / Significance: Support for among-superfamily relationships outside the Apoditrysia is now generally strong. Comparable support is mostly lacking within Apoditrysia, but dramatically increased bootstrap percentages for some nodes after rogue taxon removal, and concordance with other evidence, strongly suggest that our picture of apoditrysian phylogeny is approximately correct. This study highlights the challenge of finding optimal topologies when analyzing hundreds of taxa. It also shows that some nodes get strong support only when analysis is restricted to nonsynonymous change, while total change is necessary for strong support of others. Thus, multiple types of analyses will be necessary to fully resolve lepidopteran phylogeny.	[Regier, Jerome C.] Univ Maryland, Inst Biosci & Biotechnol Res, College Pk, MD 20742 USA; [Regier, Jerome C.; Mitter, Charles; Sohn, Jae-Cheon; Mitter, Kim T.] Univ Maryland, Dept Entomol, College Pk, MD 20742 USA; [Zwick, Andreas] State Museum Nat Hist, Stuttgart, Germany; [Bazinet, Adam L.; Cummings, Michael P.] Univ Maryland, Lab Mol Evolut, Ctr Bioinformat & Computat Biol, College Pk, MD 20742 USA; [Kawahara, Akito Y.] Univ Florida, Florida Museum Nat Hist, Gainesville, FL 32611 USA; [Zwickl, Derrick J.] Univ Arizona, Dept Ecol & Evolutionary Biol, Tucson, AZ USA; [Cho, Soowon] Chungbuk Natl Univ, Dept Plant Med, Chonju, South Korea; [Davis, Donald R.] Smithsonian Inst, Dept Entomol, Washington, DC 20560 USA; [Baixeras, Joaquin] Univ Valencia, Cavanilles Inst Biodivers & Evolutionary Biol, Valencia, Spain; [Brown, John] ARS, Systemat Entomol Lab, USDA, Beltsville, MD USA; [Parr, Cynthia] Smithsonian Inst, Encyclopedia Life, Washington, DC 20560 USA; [Weller, Susan] Univ Minnesota, Dept Entomol, St Paul, MN USA; [Lees, David C.] Nat Hist Museum, Dept Life Sci, London SW7 5BD, England	University System of Maryland; University of Maryland College Park; University System of Maryland; University of Maryland College Park; University System of Maryland; University of Maryland College Park; State University System of Florida; University of Florida; University of Arizona; Chungbuk National University; Smithsonian Institution; Smithsonian National Museum of Natural History; University of Valencia; Smithsonian Institution; United States Department of Agriculture (USDA); Smithsonian Institution; University of Minnesota System; University of Minnesota Twin Cities; Natural History Museum London	Regier, JC (corresponding author), Univ Maryland, Inst Biosci & Biotechnol Res, College Pk, MD 20742 USA.	regier@umd.edu; cmitter@umd.edu	Pedraza-Diaz, Susana/HGB-3199-2022; Zwick, Andreas/A-5735-2015; Cho, Soowon/AAF-7890-2019; Bazinet, Adam/H-3182-2019; Lees, David/AAD-7382-2021; Yakovlev, Roman/J-7243-2013; Almela, Joaquin Baixeras/L-1734-2014; Ortega-Mora, Luis-Miguel/F-1470-2016; Pedraza-Diaz, Susana/F-3988-2018	Zwick, Andreas/0000-0002-7532-1752; Almela, Joaquin Baixeras/0000-0002-6092-0496; Regidor Cerrillo, Javier/0000-0001-5831-6970; Katzer, Frank/0000-0001-5902-4136; GARCIA-CULEBRAS, ALICIA/0000-0003-2362-0117; Mezo, Mercedes/0000-0001-8819-453X; Ortega-Mora, Luis-Miguel/0000-0002-4986-6783; Diez-Fuertes, Francisco/0000-0003-2413-9229; Pedraza-Diaz, Susana/0000-0001-9401-6473; Schares, Gereon R. M./0000-0002-3217-289X; Gonzalez-Warleta, Marta/0000-0003-3315-5757; Moore, Dadin/0000-0001-6735-3810	U. S. National Science Foundation's Assembling the Tree of Life program [1042845, 0531626, 0531769]; Division Of Environmental Biology [1042845] Funding Source: National Science Foundation	U. S. National Science Foundation's Assembling the Tree of Life program; Division Of Environmental Biology(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	Financial support was provided by the U. S. National Science Foundation's Assembling the Tree of Life program, award numbers 1042845, 0531626, and 0531769. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aberer AJ, 2013, SYST BIOL, V62, P162, DOI 10.1093/sysbio/sys078; Aberer AJ, 2011, IEEE INT C BIOINFORM, P118, DOI 10.1109/BIBM.2011.70; Bazinet A, 2008, DISTRIBUTED GRID COM, P2; Bazinet A. L., 2011, 2011 IEEE International Symposium on Parallel & Distributed Processing, Workshops and Phd Forum, P1896, DOI 10.1109/IPDPS.2011.344; Bazinet AL, 2009, THESIS U MARYLAND US; Cho S, 2011, SYST BIOL, V60, P782, DOI 10.1093/sysbio/syr079; Cummings MP, 2003, SYST BIOL, V52, P477, DOI 10.1080/10635150390218213; Davi D. R., 1998, SMITHSONIAN CONTRIBU, V597, P1; de Jong Rienk, 2007, Tijdschrift voor Entomologie, V150, P319; DeBry RW, 2000, SYST BIOL, V49, P171; Drummond A. J., 2011, GENEIOUS VERSION 5 4; Epstein Marc E., 2003, Zootaxa, V247, P1; HEDGES SB, 1992, MOL BIOL EVOL, V9, P366; Heikkila M, 2012, P ROY SOC B-BIOL SCI, V279, P1093, DOI 10.1098/rspb.2011.1430; Hennig W., 1953, Beitraege zur Entomologie Berlin, V3, P1; Hittinger CT, 2010, P NATL ACAD SCI USA, V107, P1476, DOI 10.1073/pnas.0910449107; Kaila L, 2011, MOL PHYLOGENET EVOL, V61, P801, DOI 10.1016/j.ympev.2011.08.016; Kawahara AY, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005719; Kawahara AY, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-182; KRISTENSEN N P, 1984, Steenstrupia, V10, P141; Kristensen N.P., 1998, HDB ZOOLOGY, V4, P7, DOI 10.1515/9783110804744.7; Kristensen NP, 2012, SYST ENTOMOL, V37, P237, DOI 10.1111/j.1365-3113.2012.00619.x; KRISTENSEN NP, 2003, HDB ZOOLOGY 36, V4; LABANDEIRA CC, 1993, SCIENCE, V261, P310, DOI 10.1126/science.11536548; MILLER JS, 1991, B AM MUS NAT HIST, V204, P1; MINET J, 1991, ENTOMOL SCAND, V22, P69; MINET J, 1994, ENTOMOL SCAND, V25, P63, DOI 10.1163/187631294X00045; MINET J, 1986, Alexanor, V14, P291; MINET J, 1983, ANN SOC ENTOMOL FR, V19, P175; Mitchell A, 2006, SYST ENTOMOL, V31, P21, DOI 10.1111/j.1365-3113.2005.00306.x; Mort ME, 2000, SYST BIOL, V49, P160, DOI 10.1080/10635150050207456; Mutanen M, 2010, P ROY SOC B-BIOL SCI, V277, P2839, DOI 10.1098/rspb.2010.0392; Myers DS, 2008, GRID COMPUTING FOR BIOINFORMATICS AND COMPUTATIONAL BIOLOGY, P71; Powell Jerry A., 1999, Handbuch der Zoologie (Berlin), V4, P403; Rammert U, 1993, THESIS U BIELEFELD G; Ratnasingham S, 2007, MOL ECOL NOTES, V7, P355, DOI 10.1111/j.1471-8286.2007.01678.x; Regier JC, 2005, BIOTECHNIQUES, V38, P34, DOI 10.2144/05381BM02; Regier JC, 2008, SYST ENTOMOL, V33, P219, DOI 10.1111/j.1365-3113.2007.00416.x; Regier JC, 2008, SYST ENTOMOL, V33, P175, DOI 10.1111/j.1365-3113.2007.00409.x; Regier JC, 2012, SYST ENTOMOL, V37, P635, DOI 10.1111/j.1365-3113.2012.00641.x; Regier JC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035574; Regier JC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023408; Regier JC, 2010, NATURE, V463, P1079, DOI 10.1038/nature08742; Regier JC, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-280; Regier JC, 2008, SYST BIOL, V57, P920, DOI 10.1080/10635150802570791; Ripplinger J, 2010, MOL PHYLOGENET EVOL, V56, P642, DOI 10.1016/j.ympev.2010.04.035; Robinson GS, 1993, MONOGRAPHS AUSTR S2; Roe AD, 2009, GENETICS MOL BIOL LE, P1, DOI [10.1201/9781420060201-c1, DOI 10.1201/9781420060201-C1]; Rota J, 2011, SYST ENTOMOL, V36, P317, DOI 10.1111/j.1365-3113.2010.00563.x; Sanderson MJ, 2002, ANNU REV ECOL SYST, V33, P49, DOI 10.1146/annurev.ecolsys.33.010802.150509; Scoble MJ, 1992, LEPIDOPTERA FORM FUN; Sihvonen P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020356; Sohn J-C, 2013, PLOS ONE IN PRESS; Sohn JC, 2012, ZOOTAXA, P1; SWOFFORD DL, 2001, PHYLOGENETIC ANAL US; Wagner David L., 2001, P249; Wiegmann BM, 2011, P NATL ACAD SCI USA, V108, P5690, DOI 10.1073/pnas.1012675108; WILKINSON M, 1994, SYST BIOL, V43, P343, DOI 10.2307/2413673; Yamamoto S, 2007, MOL PHYLOGENET EVOL, V44, P711, DOI 10.1016/j.ympev.2006.12.027; Young CJ, 2006, ZOOTAXA, P1; Zahiri R, 2012, SYST ENTOMOL, V37, P102, DOI 10.1111/j.1365-3113.2011.00607.x; Zahiri R, 2011, ZOOL SCR, V40, P158, DOI 10.1111/j.1463-6409.2010.00459.x; Zhang ZQ, 2011, ZOOTAXA, P7, DOI 10.11646/zootaxa.3148.1.3; Zwick A., 2006, THESIS AUSTR NATL U; Zwick A, 2008, SYST ENTOMOL, V33, P190, DOI 10.1111/j.1365-3113.2007.00410.x; Zwick A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047450; Zwickl D., 2006, GARLI GENETIC ALGORI	67	222	233	3	148	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2013	8	3							e58568	10.1371/journal.pone.0058568	http://dx.doi.org/10.1371/journal.pone.0058568			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	107WV	23940816	Green Published, gold, Green Submitted			2022-12-25	WOS:000316252500031
J	He, ZY; Xiong, LP; Han, S; Chen, AX; Qiu, JW; Fu, XS				He Zhongyi; Xiong Liping; Han Sheng; Chen Aixi; Qiu Jianwei; Fu Xisheng			Tribological and Antioxidation Synergistic Effect Study of Sulfonate-Modified Nano Calcium Carbonate	PLOS ONE			English	Article							CACO3 NANOPARTICLES	A middle base number sulphonate-modified nano calcium carbonate (SMC) with an average size of 35 nm was synthesized, and its tribological and antioxidation synergistic behaviors with ashless antioxidant N-phenyl-alpha-naphthylamine (T531) in hydrogenated oil (5Cst) were evaluated. The results demonstrate that adding this synethesized additive even at a low amount (<2.0 wt.%) can evidently improve its load-carrying capacity by 1.5 times and enhance its antiwear performance; in addition, the friction-reducing effect of additive in the high load was better than that in low load. The SMC have a good synergistic antioxidation effect with T531, which verifies the nano calcium carbonate compound was a kind of multifunctional and high-performance additive. The chemical composition of the rubbing surface which formed on the boundary film was analyzed by using scanning electron microscopy (SEM) and X-ray photoelectron spectroscopy (XPS). The results indicating that the excellent antiwear and load-carrying performance could be attributed to the forming of boundary lubrication film which composed of calcium carbonate, oxides, ferrites, sulphide and FeSO4, and so on. Its ability to increase oxidation free energy of base oil is the main reason for increasing its antioxidant collaboration property with ashless antioxidant T531.	[He Zhongyi; Xiong Liping; Chen Aixi] East China Jiaotong Univ, Sch Basic Sci, Nanchang, Peoples R China; [He Zhongyi; Han Sheng] Shanghai Inst Technol, Shanghai, Peoples R China; [Qiu Jianwei; Fu Xisheng] PetroChina Lanzhou Lubricating Oil R&D Inst, Lanzhou, Peoples R China	East China Jiaotong University; Shanghai Institute of Technology; China National Petroleum Corporation	He, ZY (corresponding author), East China Jiaotong Univ, Sch Basic Sci, Nanchang, Peoples R China.	zhongyihe@yahoo.com.cn		Thomas, Stacey/0000-0002-5666-4311	Chinese Natural Science Foundation [21163006]; Jiangxi Provincial Natural Science Foundation [20122BAB203011]	Chinese Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Jiangxi Provincial Natural Science Foundation	The work reported here was sponsored by Chinese Natural Science Foundation (No: 21163006); Jiangxi Provincial Natural Science Foundation (No: 20122BAB203011). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bakunin VN, 2004, J NANOPART RES, V6, P273, DOI 10.1023/B:NANO.0000034720.79452.e3; Battez AH, 2008, WEAR, V265, P422, DOI 10.1016/j.wear.2007.11.013; Chen H, 2008, WEAR, V265, P1504, DOI 10.1016/j.wear.2008.02.034; FIERRO G, 1989, CORROSION, V45, P814, DOI 10.5006/1.3584988; Fu X, 1996, LUBR SCI, V8, P269; GIASSON S, 1994, THIN SOLID FILMS, V252, P111, DOI 10.1016/0040-6090(94)90782-X; He ZY, 2011, MATER SCI FORUM, V694, P98, DOI 10.4028/www.scientific.net/MSF.694.98; Hu HQ, 2008, TRIBOL INT, V41, P549, DOI 10.1016/j.triboint.2007.11.020; Ji XB, 2011, TRIBOL LETT, V41, P113, DOI 10.1007/s11249-010-9688-z; Jin DL, 2008, MATER LETT, V62, P1565, DOI 10.1016/j.matlet.2007.09.023; [李久盛 LI Jiusheng], 2008, [分析科学学报, Journal of Analytical Science], V24, P189; Li T, 2010, LUBES FUELS, V20, P30; Michael TC, 2006, TRIBOL T, V592, P49; Wager C. D., 1979, HDB XRAY PHOTOELECTR; Wang LB, 2007, TRIBOL INT, V40, P1179, DOI 10.1016/j.triboint.2006.12.003; Xiangdong S, 2004, LUBR ENG, V164, P92; Xiong LP, 2011, LUBR SCI, V23, P33, DOI 10.1002/ls.139; Yao JB, 1996, TRIBOL T, V39, P498, DOI 10.1080/10402009608983559; Yao W, 2007, LUBRICATING OIL, V22, P1; Yu HL, 2008, SURF COAT TECH, V203, P28, DOI 10.1016/j.surfcoat.2008.07.032; Zhang M, 2009, TRIBOL INT, V42, P1029, DOI 10.1016/j.triboint.2009.02.012	21	16	18	3	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 3	2013	8	5							e62050	10.1371/journal.pone.0062050	http://dx.doi.org/10.1371/journal.pone.0062050			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175AS	23658705	Green Published, Green Submitted, gold			2022-12-25	WOS:000321202100005
J	Lu, SH; Wang, JX; Ma, Q; Yang, J; Li, X; Yuan, YJ				Lu, Shuhuan; Wang, Jiangxin; Ma, Qian; Yang, Jie; Li, Xia; Yuan, Ying-Jin			Phospholipid Metabolism in an Industry Microalga Chlorella sorokiniana: The Impact of Inoculum Sizes	PLOS ONE			English	Article							LIPID CLASS COMPOSITION; BIODIESEL PRODUCTION; FATTY-ACID; CHAIN UNSATURATION; ENDOTHELIAL-CELLS; PHOTOSYSTEM-II; PHOSPHATIDYLGLYCEROL; CHLAMYDOMONAS; ACCUMULATION; PATHWAYS	Chlorella sorokiniana is an important industry microalga potential for biofuel production. Inoculum size is one of the important factors in algal large-scale culture, and has great effects on the growth, lipid accumulation and metabolism of microalgae. As the first barrier of cell contents, membrane plays a vital role in algal inoculum-related metabolism. The knowledge of phospholipids, the main membrane component and high accumulation of phospholipids as the major content of total lipids mass in some microalgae, is necessary to understand the role of membrane in cell growth and metabolism under different inoculum density. Profiling of C. sorokiniana phospholipids with LC-MS led to the identification of 119 phospholipid species. To discover the phospholipid molecules most related to change of inoculum sizes, Partial Least Squares Discriminant Analysis (PLS-DA) was employed and the results revealed that inoculum sizes significantly affected phospholipid profiling. Phosphatidylglycerol (PG), phosphatidyl-ethanolamine (PE) and several phosphatidylcholine (PC) species might play an important role under our experimental conditions. Further analysis of these biomarkers indicated that cell membrane status of C. sorokiniana might play an important role in the adaption to the inoculum sizes. And the culture with inoculum size of 1x10(6) cells mL(-1) presented the best membrane status with the highest content of PC and PG, and the lowest content of PE. We discovered that the inoculum size of 1x10(6) cells mL(-1) might provide the best growth condition for C. sorokiniana. Also we proposed that PG, PE and several PC may play an important role in inoculum-related metabolism in C. sorokiniana, which may work through thylakoid membrane and photosynthetic pathway. Thus this study would provide more potential targets for metabolic engineering to improve biofuel production and productivity in microalgae.	[Lu, Shuhuan; Wang, Jiangxin; Ma, Qian; Yang, Jie; Li, Xia; Yuan, Ying-Jin] Tianjin Univ, Key Lab Syst Bioengn, Minist Educ, Tianjin 300072, Peoples R China; [Lu, Shuhuan; Wang, Jiangxin; Ma, Qian; Yang, Jie; Li, Xia; Yuan, Ying-Jin] Tianjin Univ, Sch Chem Engn & Technol, Dept Pharmaceut Engn, Tianjin 300072, Peoples R China; [Lu, Shuhuan] CABIO Bioengn Wuhan Co Ltd, Wuhan, Hubei, Peoples R China	Tianjin University; Tianjin University	Yuan, YJ (corresponding author), Tianjin Univ, Key Lab Syst Bioengn, Minist Educ, Tianjin 300072, Peoples R China.	yjyuan@tju.edu.cn	WANG, Jiangxin/AFE-8446-2022; Meng, Huan/AAM-1072-2020; Meng, Huan/T-7954-2017; lu, shuhuan/AAV-6927-2020	WANG, Jiangxin/0000-0002-9917-067X; Meng, Huan/0000-0001-8844-3938; Meng, Huan/0000-0001-8844-3938; Che, Chao/0000-0001-7773-0907	National Basic Research Program of China ("973" Program) [2013CB733601]; National High Technology Research and Development Program of China ("863" Program) [2012AA02A701]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL097561] Funding Source: NIH RePORTER	National Basic Research Program of China ("973" Program)(National Basic Research Program of China); National High Technology Research and Development Program of China ("863" Program)(National High Technology Research and Development Program of China); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	The authors are grateful for the financial support from the National Basic Research Program of China ("973" Program: 2013CB733601), and the National High Technology Research and Development Program of China ("863" Program: 2012AA02A701). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arisz SA, 2011, J LIPID RES, V52, P2012, DOI 10.1194/jlr.M016873; Ballottari M, 2011, BIOCHIM BIOPHYS ACTA, V1817, P143; Beal CM, 2013, RENEW ENERG, V50, P86, DOI 10.1016/j.renene.2012.06.027; Birner R, 2001, MOL BIOL CELL, V12, P997, DOI 10.1091/mbc.12.4.997; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Brennan L, 2010, RENEW SUST ENERG REV, V14, P557, DOI 10.1016/j.rser.2009.10.009; Bumbak F, 2011, APPL MICROBIOL BIOT, V91, P31, DOI 10.1007/s00253-011-3311-6; Carswell H, 2012, BRIT J PHARMACOL, V90, P175; Cengiz EI, 2012, TURK J FISH AQUAT SC, V12, P31, DOI 10.4194/1303-2712-v12_1_05; Chen GQ, 2008, FOOD CHEM, V109, P88, DOI 10.1016/j.foodchem.2007.12.022; Chen GQ, 2007, FOOD CHEM, V104, P1580, DOI 10.1016/j.foodchem.2007.03.008; Chen L, 2012, BIORESOURCE TECHNOL, V111, P208, DOI 10.1016/j.biortech.2012.02.033; Chiou SY, 2001, J BIOTECHNOL, V85, P247, DOI 10.1016/S0168-1656(00)00346-1; Cuaresma M, 2009, BIOTECHNOL BIOENG, V104, P352, DOI 10.1002/bit.22394; de Kroon AIPM, 2007, BBA-MOL CELL BIOL L, V1771, P343, DOI 10.1016/j.bbalip.2006.07.010; Deng XD, 2009, AFR J MICROBIOL RES, V3, P1008; Gale SE, 2009, J BIOL CHEM, V284, P1755, DOI 10.1074/jbc.M807210200; Goncharova SN, 2004, RUSS J PLANT PHYSL+, V51, P169, DOI 10.1023/B:RUPP.0000019209.10747.9d; Guschina IA, 2009, LIPIDS IN AQUATIC ECOSYSTEMS, P1, DOI 10.1007/978-0-387-89366-2_1; Guskov A, 2009, NAT STRUCT MOL BIOL, V16, P334, DOI 10.1038/nsmb.1559; He H, 2011, ENERG FUEL, V25, P4770, DOI 10.1021/ef201061J; Ivanov AG, 2012, BBA-BIOENERGETICS, V1817, P1374, DOI 10.1016/j.bbabio.2012.03.010; Johnson MB, 2010, APPL MICROBIOL BIOT, V85, P525, DOI 10.1007/s00253-009-2133-2; Johnson MB, 2009, ENERG FUEL, V23, P5179, DOI 10.1021/ef900704h; Joyard J, 2010, PROG LIPID RES, V49, P128, DOI 10.1016/j.plipres.2009.10.003; Kacka A, 2008, BIORESOURCE TECHNOL, V99, P8348, DOI 10.1016/j.biortech.2008.02.042; Khandelia H, 2009, BIOPHYS J, V96, P2734, DOI 10.1016/j.bpj.2009.01.007; Kubota H, 2010, BBA-BIOENERGETICS, V1797, P98, DOI 10.1016/j.bbabio.2009.09.001; Lei AP, 2012, BIOTECHNOL BIOFUELS, V5, DOI 10.1186/1754-6834-5-18; Li XF, 2007, BIOTECHNOL BIOENG, V98, P764, DOI 10.1002/bit.21489; Li Y, 2011, ALGAE BIOFUELS; Li YQ, 2008, APPL MICROBIOL BIOT, V81, P629, DOI 10.1007/s00253-008-1681-1; Li YC, 2012, BIOTECHNOL BIOENG, V109, P2222, DOI 10.1002/bit.24491; Lin S, 2011, GENE, V473, P139, DOI 10.1016/j.gene.2010.11.011; Lin WC, 2007, BIOPHYS J, V92, P2831, DOI 10.1529/biophysj.106.095422; Liu J, 2012, BIOTECHNOL BIOFUELS, V5, DOI 10.1186/1754-6834-5-68; Lu N, 2012, EUR J LIPID SCI TECH, V114, P253, DOI 10.1002/ejlt.201100248; Lu SH, 2012, BIOTECHNOL BIOENG, V109, P1651, DOI 10.1002/bit.24447; Ma Q, 2013, BIOTECHNOL BIOENG, V110, P773, DOI 10.1002/bit.24762; Mock T, 2002, PHYTOCHEMISTRY, V61, P53, DOI 10.1016/S0031-9422(02)00215-7; Morita M, 2002, BIOTECHNOL BIOENG, V77, P155, DOI 10.1002/bit.10119; Muradyan EA, 2004, RUSS J PLANT PHYSL+, V51, P53, DOI 10.1023/B:RUPP.0000011303.11957.48; Niemela PS, 2006, BIOPHYS J, V90, P851, DOI 10.1529/biophysj.105.067371; Niu SL, 2002, BIOPHYS J, V83, P3408, DOI 10.1016/S0006-3495(02)75340-X; Pienkos PT, 2009, BIOFUEL BIOPROD BIOR, V3, P431, DOI 10.1002/bbb.159; Pineau B, 2004, EUR J BIOCHEM, V271, P329, DOI 10.1046/j.1432-1033.2003.03931.x; Prinetti A, 2009, BBA-BIOMEMBRANES, V1788, P184, DOI 10.1016/j.bbamem.2008.09.001; Quintana N, 2011, APPL MICROBIOL BIOT, V91, P471, DOI 10.1007/s00253-011-3394-0; Rodolfi L, 2009, BIOTECHNOL BIOENG, V102, P100, DOI 10.1002/bit.22033; Sakamoto A, 2004, PLANT CELL ENVIRON, V27, P99, DOI 10.1046/j.0016-8025.2003.01131.x; Salvador GA, 2002, J NEUROSCI RES, V70, P283, DOI 10.1002/jnr.10385; Scott SA, 2010, CURR OPIN BIOTECH, V21, P277, DOI 10.1016/j.copbio.2010.03.005; Singh NK, 2011, AGRON SUSTAIN DEV, V31, P605, DOI 10.1007/s13593-011-0018-0; Soh L, 2011, GREEN CHEM, V13, P1422, DOI 10.1039/c1gc15068e; Stephenson AL, 2010, BIOFUELS-UK, V1, P47, DOI 10.4155/BFS.09.1; Sun XL, 2011, PLANT CELL REP, V30, P1939, DOI 10.1007/s00299-011-1102-2; Tian HC, 2010, APPL MICROBIOL BIOT, V87, P1507, DOI 10.1007/s00253-010-2615-2; Van Gerpen J, 2005, FUEL PROCESS TECHNOL, V86, P1097, DOI 10.1016/j.fuproc.2004.11.005; Wada H, 2010, LIPIDS PHOTOSYNTHESI, P243; Wang JX, 2009, PLANTA, V230, P191, DOI 10.1007/s00425-009-0932-4; Wang L, 2010, BIORESOURCE TECHNOL, V101, P2623, DOI 10.1016/j.biortech.2009.10.062; Wu ZC, 2012, BIORESOURCE TECHNOL, V110, P496, DOI 10.1016/j.biortech.2012.01.101; Wyatt NB, 2012, BIOTECHNOL BIOENG, V109, P493, DOI 10.1002/bit.23319; Yang FX, 2012, BIOTECHNOL BIOFUELS, V5, DOI 10.1186/1754-6834-5-13; Yang J, 2012, OMICS, V16, P374, DOI 10.1089/omi.2011.0127; Yang J, 2012, MOL BIOSYST, V8, P1789, DOI 10.1039/c2mb05510d; Yang J, 2011, MOL BIOSYST, V7, P2428, DOI 10.1039/c1mb00002k; Yang S, 2008, BBA-MOL CELL BIOL L, V1781, P123, DOI 10.1016/j.bbalip.2007.11.005; Yang S, 2007, BBA-MOL CELL BIOL L, V1771, P600, DOI 10.1016/j.bbalip.2007.02.011; Yang S, 2009, CHEM PHYS LIPIDS, V159, P13, DOI 10.1016/j.chemphyslip.2009.02.004; Yoshioka M, 2012, AQUACULTURE, V338, P111, DOI 10.1016/j.aquaculture.2012.01.005; Yu B, 2003, PLANT J, V36, P762, DOI 10.1046/j.1365-313X.2003.01918.x; Zhang CF, 2010, FOOD CHEM, V120, P864, DOI 10.1016/j.foodchem.2009.11.029; Zhao LY, 2004, J COLLOID INTERF SCI, V274, P55, DOI 10.1016/j.jcis.2003.12.009; Zhu L, 2012, BIOCHEM CELL BIOL, V90, P188, DOI [10.1139/O11-081, 10.1139/o11-081]	75	31	32	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2013	8	8							e70827	10.1371/journal.pone.0070827	http://dx.doi.org/10.1371/journal.pone.0070827			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	218XC	23658603	Green Submitted, Green Published, gold			2022-12-25	WOS:000324465000140
J	Yan, LM; Kang, M; Qin, ZQ; Zhang, WY; Li, YM; Ou, HS				Yan, Limei; Kang, Min; Qin, Zhengqi; Zhang, Wenyu; Li, Yumei; Ou, Hesheng			An Intronic miRNA Regulates Expression of the Human Endothelial Nitric Oxide Synthase Gene and Proliferation of Endothelial Cells by a Mechanism Related to the Transcription Factor SP-1	PLOS ONE			English	Article							MICRORNAS; POLYMORPHISM; MIR-17-92; REPAIR	Objective: This study was to investigate the molecular mechanisms underlying the 27nt-miRNA-mediated regulation of expression of the endothelial nitric oxide synthase (eNOS) gene. Methods: Cell lines overexpressing 27nt-miRNA or its mutant were established by transfecting the miRNA expression vector into the endothelial cells. eNOS mRNA and protein expression were examined by RT-PCR and Western Blotting, respectively. Luciferase activity reporter system was used to study the target of 27nt-miRNA. Results: The results showed that overexpression of 27nt-miRNA significantly inhibited eNOS mRNA level and protein expression, and reduced the eNOS transcriptional efficiency. Such inhibitory effects of 27nt-miRNA were attenuated by the sequence mutations in 27nt-miRNA. Interestingly, the transcription factor SP-1 expression was reduced by 27nt-miRNA. Meanwhile, overxpression of SP-1 protein partially restored eNOS expression, and rescued the 27nt-miRNA-mediated reduction of endothelial cell proliferation. Moreover, certain sites in the SP-1 mRNA were found to be the direct target of 27nt-miRNA by a luciferase reporter system. Conclusions: These results demonstrate that the 27nt-miRNA suppresses eNOS gene expression and SP-1 expression in vascular endothelial cells. The 27nt-miRNA directly target to SP-1 mRNA, thereby contributing to proliferation of endothelial cells.	[Yan, Limei; Qin, Zhengqi] Univ South China, Biochem Res Ctr, Hengyang, Hunan, Peoples R China; [Kang, Min] Guangxi Med Univ, Affiliated Hosp 1, Nanning, Guangxi, Peoples R China; [Zhang, Wenyu; Li, Yumei; Ou, Hesheng] Guangxi Med Univ, Coll Pharm, Nanning, Guangxi, Peoples R China	University of South China; Guangxi Medical University; Guangxi Medical University	Ou, HS (corresponding author), Guangxi Med Univ, Coll Pharm, Nanning, Guangxi, Peoples R China.	hsou01@126.com			National Natural Science Foundation of China [30670834, 30871186]; Research Foundation of the Education Department of Hunan Province, China [06A060]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Research Foundation of the Education Department of Hunan Province, China	This work was supported by National Natural Science Foundation of China (Projects No. 30670834, and No. 30871186), and Research Foundation of the Education Department of Hunan Province, China (project No. 06A060). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguda BD, 2008, P NATL ACAD SCI USA, V105, P19678, DOI 10.1073/pnas.0811166106; Ambros V, 2003, CURR BIOL, V13, P807, DOI 10.1016/S0960-9822(03)00287-2; Atochin DN, 2010, PFLUG ARCH EUR J PHY, V460, P965, DOI 10.1007/s00424-010-0867-4; Bai X, 2010, VASC PHARMACOL, V52, P224, DOI 10.1016/j.vph.2010.02.001; Barik S, 2008, NUCLEIC ACIDS RES, V36, P5232, DOI 10.1093/nar/gkn513; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; BREUSS JM, 2012, CELL ADHES MIGR, V17, P6; Chang HM, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1909; Chen K, 2012, BIOCHEM BIOPH RES CO, V427, P138, DOI 10.1016/j.bbrc.2012.09.026; Clement JQ, 1999, RNA, V5, P206, DOI 10.1017/S1355838299981190; Ding ZF, 2012, EXP BIOL MED, V237, P1093, DOI 10.1258/ebm.2012.012082; Hobert O, 2008, SCIENCE, V319, P1785, DOI 10.1126/science.1151651; Huang Y, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gkr908; Hwang HW, 2007, SCIENCE, V315, P97, DOI 10.1126/science.1136235; Inoue T, 2011, JACC-CARDIOVASC INTE, V4, P1057, DOI 10.1016/j.jcin.2011.05.025; KAPPELMANN M, 2012, ONCOGENE; Karantzoulis-Fegaras F, 1999, J BIOL CHEM, V274, P3076, DOI 10.1074/jbc.274.5.3076; Kim IJ, 2007, THROMB RES, V119, P579, DOI 10.1016/j.thromres.2006.06.005; Lee YB, 2009, NUCLEIC ACIDS RES, V37, P123, DOI 10.1093/nar/gkn920; LI Y, 2012, CURR MOL MED; Makeyev EV, 2008, SCIENCE, V319, P1789, DOI 10.1126/science.1152326; MARSDEN PA, 1993, J BIOL CHEM, V268, P17478; Nakayama M, 1999, CIRCULATION, V99, P2864, DOI 10.1161/01.CIR.99.22.2864; Ohicita M, 2012, J PHARMACOL SCI, V119, P302, DOI 10.1254/jphs.12R01CR; Ou HS, 2005, ARTERIOSCL THROM VAS, V25, P2509, DOI 10.1161/01.ATV.0000189306.99112.4c; Rittig K, 2008, HORM METAB RES, V40, P13, DOI 10.1055/s-2007-1004527; Romania P, 2008, BRIT J HAEMATOL, V143, P570, DOI 10.1111/j.1365-2141.2008.07382.x; Ruvkun G, 2008, NAT MED, V14, P1041, DOI 10.1038/nm1008-1041; Sinici I, 2010, J INVEST MED, V58, P23, DOI 10.2310/JIM.0b013e3181c6197f; Spoto B, 2007, AM J HYPERTENS, V20, P758, DOI 10.1016/j.amjhyper.2007.02.009; Staszel T, 2011, POL ARCH MED WEWN, V121, P361, DOI 10.20452/pamw.1093; Taguchi A, 2008, CANCER RES, V68, P5540, DOI 10.1158/0008-5472.CAN-07-6460; Wang XL, 1996, NAT MED, V2, P41, DOI 10.1038/nm0196-41; Wattanapitayakul SK, 2001, TRENDS PHARMACOL SCI, V22, P361, DOI 10.1016/S0165-6147(00)01692-8; Wu ZQ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045825; Yan LM, 2011, MOL CELL BIOCHEM, V357, P9, DOI 10.1007/s11010-011-0870-x; Ying SY, 2004, GENE, V342, P25, DOI 10.1016/j.gene.2004.07.025; Zhang MX, 2005, P NATL ACAD SCI USA, V102, P16967, DOI 10.1073/pnas.0503853102; ZHANG R, 1995, J BIOL CHEM, V270, P15320, DOI 10.1074/jbc.270.25.15320; Zhang XL, 2012, MOL CANCER, V11, DOI 10.1186/1476-4598-11-56; Zhou YM, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-396	41	69	81	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2013	8	8							e70658	10.1371/journal.pone.0070658	http://dx.doi.org/10.1371/journal.pone.0070658			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	218XC	23940615	Green Submitted, Green Published, gold			2022-12-25	WOS:000324465000109
J	Hagen, CM; Aidt, FH; Hedley, PL; Jensen, MK; Havndrup, O; Kanters, JK; Moolman-Smook, JC; Larsen, SO; Bundgaard, H; Christiansen, M				Hagen, Christian M.; Aidt, Frederik H.; Hedley, Paula L.; Jensen, Morten K.; Havndrup, Ole; Kanters, Jorgen K.; Moolman-Smook, Johanna C.; Larsen, Severin O.; Bundgaard, Henning; Christiansen, Michael			Mitochondrial Haplogroups Modify the Risk of Developing Hypertrophic Cardiomyopathy in a Danish Population	PLOS ONE			English	Article							OXIDATIVE STRESS; DNA HAPLOGROUPS; HEART-FAILURE; MUTATIONS; DISEASE; SUPEROXIDE; LONGEVITY; ORGANIZATION; RADICALS; GENES	Hypertrophic cardiomyopathy (HCM) is a genetic disorder caused by mutations in genes coding for proteins involved in sarcomere function. The disease is associated with mitochondrial dysfunction. Evolutionarily developed variation in mitochondrial DNA (mtDNA), defining mtDNA haplogroups and haplogroup clusters, is associated with functional differences in mitochondrial function and susceptibility to various diseases, including ischemic cardiomyopathy. We hypothesized that mtDNA haplogroups, in particular H, J and K, might modify disease susceptibility to HCM. Mitochondrial DNA, isolated from blood, was sequenced and haplogroups identified in 91 probands with HCM. The association with HCM was ascertained using two Danish control populations. Haplogroup H was more prevalent in HCM patients, 60% versus 46% (p = 0.006) and 41% (p = 0.003), in the two control populations. Haplogroup J was less prevalent, 3% vs. 12.4% (p = 0.017) and 9.1%, (p = 0.06). Likewise, the UK haplogroup cluster was less prevalent in HCM, 11% vs. 22.1% (p = 0.02) and 22.8% (p = 0.04). These results indicate that haplogroup H constitutes a susceptibility factor and that haplogroup J and haplogroup cluster UK are protective factors in the development of HCM. Thus, constitutive differences in mitochondrial function may influence the occurrence and clinical presentation of HCM. This could explain some of the phenotypic variability in HCM. The fact that haplogroup H and J are also modifying factors in ischemic cardiomyopathy suggests that mtDNA haplotypes may be of significance in determining whether a physiological hypertrophy develops into myopathy. mtDNA haplotypes may have the potential of becoming significant biomarkers in cardiomyopathy.	[Hagen, Christian M.; Aidt, Frederik H.; Hedley, Paula L.; Larsen, Severin O.; Christiansen, Michael] Statens Serum Inst, Dept Clin Biochem & Immunol, DK-2300 Copenhagen, Denmark; [Hagen, Christian M.; Kanters, Jorgen K.] Univ Copenhagen, Dept Biomed Sci, Copenhagen, Denmark; [Hedley, Paula L.; Moolman-Smook, Johanna C.] Univ Stellenbosch, Dept Biomed Sci, Cape Town, South Africa; [Jensen, Morten K.; Bundgaard, Henning] Rigshosp, Dept Med B, Ctr Heart, DK-2100 Copenhagen, Denmark; [Havndrup, Ole] Roskilde Hosp, Dept Cardiol, Roskilde, Denmark; [Kanters, Jorgen K.] Gentofte Univ Hosp, Dept Cardiol, Copenhagen, Denmark	Statens Serum Institut; University of Copenhagen; Stellenbosch University; Rigshospitalet; University of Copenhagen; University of Copenhagen; Herlev & Gentofte Hospital	Christiansen, M (corresponding author), Statens Serum Inst, Dept Clin Biochem & Immunol, DK-2300 Copenhagen, Denmark.	mic@ssi.dk	Hedley, Paula L/E-6156-2011; Christiansen, Michael/B-4588-2009; Bundgaard, Henning/AAA-4381-2020	Hedley, Paula L/0000-0001-5801-960X; Christiansen, Michael/0000-0003-4713-755X; Bundgaard, Henning/0000-0002-0563-7049; Hagen, Christian/0000-0002-0513-7722; Norremolle, Anne/0000-0003-2561-7683; Jensen, Morten Kvistholm/0000-0003-1144-4603; Kanters, Jorgen/0000-0002-3267-4910	Statens Serum Institut; LUNDBECKFONDEN [R67-A6552]; Danish Strategic Research Council	Statens Serum Institut; LUNDBECKFONDEN(Lundbeckfonden); Danish Strategic Research Council(Danske Strategiske Forskningsrad (DSF))	The work was supported by Statens Serum Institut (www.ssi.dk), LUNDBECKFONDEN (www.lundbeckfonden.com), (Grant: R67-A6552) and The Danish Strategic Research Council (www.fivu.dk),(Grant: HEARTSAFE). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abel ED, 2011, CARDIOVASC RES, V90, P234, DOI 10.1093/cvr/cvr015; Andersen PS, 2009, HUM MUTAT, V30, P363, DOI 10.1002/humu.20862; Andrews RM, 1999, NAT GENET, V23, P147, DOI 10.1038/13779; Beckstead WA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005836; Benn M, 2008, CIRCULATION, V117, P2492, DOI 10.1161/CIRCULATIONAHA.107.756809; Brand MD, 2010, EXP GERONTOL, V45, P466, DOI 10.1016/j.exger.2010.01.003; Castro MG, 2006, INT J CARDIOL, V112, P202, DOI 10.1016/j.ijcard.2005.09.008; Chinnery PF, 2010, LANCET NEUROL, V9, P498, DOI 10.1016/S1474-4422(10)70083-1; Dato S, 2004, EUR J HUM GENET, V12, P1080, DOI 10.1038/sj.ejhg.5201278; Droge W, 2002, PHYSIOL REV, V82, P47, DOI 10.1152/physrev.00018.2001; Elliott HR, 2008, AM J HUM GENET, V83, P254, DOI 10.1016/j.ajhg.2008.07.004; Fernandez-Caggiano M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044128; Finkel T, 2003, CURR OPIN CELL BIOL, V15, P247, DOI 10.1016/S0955-0674(03)00002-4; Garnier A, 2003, J PHYSIOL-LONDON, V551, P491, DOI 10.1113/jphysiol.2003.045104; Gomez-Duran A, 2010, HUM MOL GENET, V19, P3343, DOI 10.1093/hmg/ddq246; Grieve DJ, 2003, EUR HEART J, V24, P2161, DOI 10.1016/j.ehj.2003.10.015; Havndrup O, 2010, EUR J HEART FAIL, V12, P535, DOI 10.1093/eurjhf/hfq073; Hedley PL, 2011, J NEGAT RESULTS BIOM, V10, DOI 10.1186/1477-5751-10-12; Ide T, 2000, CIRC RES, V86, P152, DOI 10.1161/01.RES.86.2.152; Ji YL, 2008, AM J HUM GENET, V83, P760, DOI 10.1016/j.ajhg.2008.11.002; Kalman B, 1999, ACTA NEUROL SCAND, V99, P16; Korshunov SS, 1997, FEBS LETT, V416, P15, DOI 10.1016/S0014-5793(97)01159-9; Mallat Z, 1998, CIRCULATION, V97, P1536, DOI 10.1161/01.CIR.97.16.1536; Marcuello A, 2009, MITOCHONDRION, V9, P326, DOI 10.1016/j.mito.2009.04.007; MARON BJ, 1987, NEW ENGL J MED, V316, P780, DOI 10.1056/NEJM198703263161305; Martinez-Redondo D, 2010, MITOCHONDRION, V10, P102, DOI 10.1016/j.mito.2009.11.005; Mikkelsen M, 2010, FORENSIC SCI INT-GEN, V4, pE87, DOI 10.1016/j.fsigen.2009.07.007; Murphy MP, 2009, BIOCHEM J, V417, P1, DOI 10.1042/BJ20081386; Ott M, 2007, APOPTOSIS, V12, P913, DOI 10.1007/s10495-007-0756-2; PINOS T, 2011, AGE DORDR; Richardson P, 1996, CIRCULATION, V93, P841, DOI 10.1161/01.CIR.93.5.841; Rosca MG, 2010, CARDIOVASC RES, V88, P40, DOI 10.1093/cvr/cvq240; Rosca MG, 2009, J BIOENERG BIOMEMBR, V41, P107, DOI 10.1007/s10863-009-9215-9; Rousset F, 2008, MOL ECOL RESOUR, V8, P103, DOI 10.1111/j.1471-8286.2007.01931.x; Seelert H, 2009, BBA-BIOENERGETICS, V1787, P657, DOI 10.1016/j.bbabio.2009.02.028; TENCATE FJ, 1979, AM J CARDIOL, V43, P731, DOI 10.1016/0002-9149(79)90071-7; Towbin JA, 2009, PACE, V32, pS23, DOI 10.1111/j.1540-8159.2009.02381.x; Tsutsui H, 2009, CARDIOVASC RES, V81, P449, DOI 10.1093/cvr/cvn280; Valenti L, 2004, J MED GENET, V41, P946, DOI 10.1136/jmg.2004.019588; van der Walt JM, 2004, NEUROSCI LETT, V365, P28, DOI 10.1016/j.neulet.2004.04.051; van der Walt JM, 2003, AM J HUM GENET, V72, P804, DOI 10.1086/373937; van Oven M, 2009, HUM MUTAT, V30, pE386, DOI 10.1002/humu.20921; Vonck J, 2009, BBA-MOL CELL RES, V1793, P117, DOI 10.1016/j.bbamcr.2008.05.019; Xu Q, 2010, J MOL CELL CARDIOL, V48, P899, DOI 10.1016/j.yjmcc.2010.03.005; Zielonka J, 2008, FREE RADICAL BIO MED, V45, P1217, DOI 10.1016/j.freeradbiomed.2008.07.025	45	47	49	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2013	8	8							e71904	10.1371/journal.pone.0071904	http://dx.doi.org/10.1371/journal.pone.0071904			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	218XC	23568011	gold, Green Published, Green Submitted			2022-12-25	WOS:000324465000231
J	Yan, L; Zhang, JD; Wang, B; Lv, YJ; Jiang, H; Liu, GL; Qiao, Y; Ren, M; Guo, XF				Yan, Lei; Zhang, Ji Dong; Wang, Bo; Lv, Yi Jing; Jiang, Hong; Liu, Gui Lin; Qiao, Yun; Ren, Ming; Guo, Xue Feng			Quercetin Inhibits Left Ventricular Hypertrophy in Spontaneously Hypertensive Rats and Inhibits Angiotensin II-Induced H9C2 Cells Hypertrophy by Enhancing PPAR-gamma Expression and Suppressing AP-1 Activity	PLOS ONE			English	Article							ACTIVATED RECEPTOR-GAMMA; INDUCED CARDIAC-HYPERTROPHY; NF-KAPPA-B; IN-VIVO; GENE-EXPRESSION; MUSCLE; GROWTH; CARDIOMYOBLASTS; MACROPHAGES; DYSFUNCTION	Background: Quercetin is the most abundant flavonoid in fruit and vegetables and is believed to attenuate cardiovascular disease. We hypothesized that quercetin inhibits cardiac hypertrophy by blocking AP-1 (c-fos, c-jun) and activating PPAR-gamma signaling pathways. Methodology/Principal Findings: The aim of this study was to identify the mechanism underlying quercetin-mediated attenuation of cardiac hypertrophy. Quercetin therapy reduced blood pressure and markedly reduced the ratio of left ventricular to body weight (LVW/BW) (P<0.05, vs. spontaneously hypertensive rats (SHRs)). In vitro, quercetin also significantly attenuated Ang II-induced H9C2 cells hypertrophy, as indicated by its concentration dependent inhibitory effects on [H-3] leucine incorporation into H9C2 cells (64% reduction) and by the reduced hypertrophic surface area in H9C2 cells compared with the Ang II group (P<0.01, vs. Ang II group). Concurrently, we found that PPAR-gamma activity was significantly increased in the quercetin-treated group both in vivo and in vitro when analyzed using immunofluorescent or immunohistochemical assays (P<0.05, vs. SHRs or P<0.01, vs. the Ang II group). Conversely, in vivo, AP-1 (c-fos, s-jun) activation was suppressed in the quercetin-treated group, as was the downstream hypertrophy gene, including mRNA levels of ANP and BNP (P<0.05, vs. SHRs). Additionally, both western blotting and real time-PCR demonstrated that PPAR-gamma protein and mRNA were increased in the myocardium and AP-1 protein and mRNA were significantly decreased in the quercetin-treated group (P<0.05, vs. SHRs). Furthermore, western blotting and real time-PCR analyses also showed that transfection with PPAR-gamma siRNA significantly increased AP-1 signaling and reversed the effects of quercetin inhibition on mRNA expression levels of genes such as ANP and BNP in hypertrophic H9C2 cells. Conclusions: Our data indicate that quercetin may inhibit cardiac hypertrophy by enhancing PPAR-gamma expression and by suppressing the AP-1 signaling pathway.	[Yan, Lei; Zhang, Ji Dong; Wang, Bo; Lv, Yi Jing; Qiao, Yun; Ren, Ming] Shandong Univ, Qilu Hosp, Dept Tradit Chinese Med, Jinan 250100, Shandong, Peoples R China; [Jiang, Hong] Shandong Univ, Qilu Hosp, Lab Cardiovasc Remodeling & Funct Res, Chinese Minist Educ, Jinan 250100, Shandong, Peoples R China; [Jiang, Hong] Chinese Minist Hlth, Jinan, Shandong, Peoples R China; [Liu, Gui Lin] Shandong Univ Tradit Chinese Med, Jinan, Shandong, Peoples R China; [Guo, Xue Feng] Shandong Univ Tradit Chinese Med, Hosp 2, Jinan, Shandong, Peoples R China	Shandong University; Shandong University; Shandong University of Traditional Chinese Medicine; Shandong University of Traditional Chinese Medicine	Zhang, JD (corresponding author), Shandong Univ, Qilu Hosp, Dept Tradit Chinese Med, Jinan 250100, Shandong, Peoples R China.	drzhangjidong@hotmail.com			National Natural Science Foundation of China [30873324, 81100103]; Natural Science Foundation of Shandong Province [ZR2011HQ020]; Postdoctoral special foundation for innovative projects of Shandong Province [201103049]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Shandong Province(Natural Science Foundation of Shandong Province); Postdoctoral special foundation for innovative projects of Shandong Province	This study was supported by the National Natural Science Foundation of China (30873324, 81100103); the Natural Science Foundation of Shandong Province (ZR2011HQ020); the Postdoctoral special foundation for innovative projects of Shandong Province (201103049). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angeloni C, 2012, OXID MED CELL LONGEV, V2012, DOI 10.1155/2012/837104; Asakawa M, 2002, CIRCULATION, V105, P1240, DOI 10.1161/hc1002.105225; Benson S, 2000, AM J HYPERTENS, V13, P74, DOI 10.1016/S0895-7061(99)00148-X; Calderone A, 2001, J APPL PHYSIOL, V91, P771, DOI 10.1152/jappl.2001.91.2.771; Chen X, 2010, PHARMACOGN MAG, V6, P135, DOI 10.4103/0973-1296.62900; Delerive P, 1999, J BIOL CHEM, V274, P32048, DOI 10.1074/jbc.274.45.32048; Duarte J, 2001, BRIT J PHARMACOL, V133, P117, DOI 10.1038/sj.bjp.0704064; Formica JV, 1995, FOOD CHEM TOXICOL, V33, P1061, DOI 10.1016/0278-6915(95)00077-1; Ha H, 2005, EXP MOL MED, V37, P169, DOI 10.1038/emm.2005.23; Han JJ, 2009, J VET MED SCI, V71, P737, DOI 10.1292/jvms.71.737; Izumi Y, 2000, HYPERTENSION, V36, P511, DOI 10.1161/01.HYP.36.4.511; Jeong K, 2009, EXP MOL MED, V41, P226, DOI 10.3858/emm.2009.41.4.025; Kleemann R, 2011, ATHEROSCLEROSIS, V218, P44, DOI 10.1016/j.atherosclerosis.2011.04.023; Kwon H, 2009, J CELL MOL MED, V13, P1549, DOI 10.1111/j.1582-4934.2009.00391.x; Liang YC, 2001, FEBS LETT, V496, P12, DOI 10.1016/S0014-5793(01)02393-6; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Majalahti T, 2007, MOL CELL ENDOCRINOL, V273, P59, DOI 10.1016/j.mce.2007.05.003; Matsumura T, 2011, ARTERIOSCL THROM VAS, V31, P1268, DOI 10.1161/ATVBAHA.110.222067; Mehrabi MR, 2002, BIOMED PHARMACOTHER, V56, P407, DOI 10.1016/S0753-3322(02)00251-2; Nelson MT, 2002, NATURE, V416, P273, DOI 10.1038/416273a; Omura T, 2002, HYPERTENSION, V39, P81, DOI 10.1161/hy0102.100783; Onai Y, 2007, AM J PHYSIOL-HEART C, V292, pH530, DOI 10.1152/ajpheart.00549.2006; Panicker SR, 2010, PHARMACOL RES, V62, P328, DOI 10.1016/j.phrs.2010.06.003; Schoonjans K, 1997, CURR OPIN LIPIDOL, V8, P159, DOI 10.1097/00041433-199706000-00006; Sun M, 2004, CIRCULATION, V110, P3221, DOI 10.1161/01.CIR.0000147233.10318.23; Takano H, 2000, CIRC RES, V87, P596, DOI 10.1161/01.RES.87.7.596; TAMARGO J, 1995, J CARDIOVASC PHARM, V26, P295, DOI 10.1097/00005344-199508000-00016; THAIK CM, 1995, J CLIN INVEST, V96, P1093, DOI 10.1172/JCI118095; Tokola H, 2001, CAN J PHYSIOL PHARM, V79, P646, DOI 10.1139/cjpp-79-8-646; Wang NP, 2002, J BIOL CHEM, V277, P34176, DOI 10.1074/jbc.M203436200; Wang P, 2012, DIABETES, V61, P1051, DOI 10.2337/db11-1180; Wang P, 2009, CARDIOVASC RES, V81, P370, DOI 10.1093/cvr/cvn288; Yamamoto K, 2009, HYPERTENSION, V54, P1353, DOI 10.1161/HYPERTENSIONAHA.109.138750; Yano P, 1998, CIRC RES, V83, P752, DOI 10.1161/01.RES.83.7.752; Yoshizumi M, 2002, BIOCHEM BIOPH RES CO, V293, P1458, DOI 10.1016/S0006-291X(02)00407-2; Zhang M, 2011, ADV EXP MED BIOL, V701, P283, DOI 10.1007/978-1-4419-7756-4_38; Zhou SS, 2012, EXP CELL RES, V318, P1480, DOI 10.1016/j.yexcr.2012.03.030	37	69	81	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 10	2013	8	9							e72548	10.1371/journal.pone.0072548	http://dx.doi.org/10.1371/journal.pone.0072548			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259PK	23940615	Green Published, gold, Green Submitted			2022-12-25	WOS:000327538600009
J	Zhu, X; Silva, LCR; Doane, TA; Horwath, WR				Zhu, Xia; Silva, Lucas C. R.; Doane, Timothy A.; Horwath, William R.			Iron: The Forgotten Driver of Nitrous Oxide Production in Agricultural Soil	PLOS ONE			English	Article							SPECTROPHOTOMETRIC DETERMINATION; WETLAND SOILS; NO EMISSIONS; FERROUS IRON; OXIDATION; REDUCTION; N2O; NITRATE; MICROORGANISMS; HYDROXYLAMINE	In response to rising interest over the years, many experiments and several models have been devised to understand emission of nitrous oxide (N2O) from agricultural soils. Notably absent from almost all of this discussion is iron, even though its role in both chemical and biochemical reactions that generate N2O was recognized well before research on N2O emission began to accelerate. We revisited iron by exploring its importance alongside other soil properties commonly believed to control N2O production in agricultural systems. A set of soils from California's main agricultural regions was used to observe N2O emission under conditions representative of typical field scenarios. Results of multivariate analysis showed that in five of the twelve different conditions studied, iron ranked higher than any other intrinsic soil property in explaining observed emissions across soils. Upcoming studies stand to gain valuable information by considering iron among the drivers of N2O emission, expanding the current framework to include coupling between biotic and abiotic reactions.	[Zhu, Xia] Chinese Acad Sci, Chengdu Inst Biol, Chengdu, Peoples R China; [Zhu, Xia] Univ Chinese Acad Sci, Beijing, Peoples R China; [Zhu, Xia; Silva, Lucas C. R.; Doane, Timothy A.; Horwath, William R.] Univ Calif Davis, Dept Land Air & Water Resources, Davis, CA 95616 USA	Chinese Academy of Sciences; Chengdu Institute of Biology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; University of California System; University of California Davis	Doane, TA (corresponding author), Univ Calif Davis, Dept Land Air & Water Resources, Davis, CA 95616 USA.	tadoane@ucdavis.edu	Zhu-Barker, Xia/F-1520-2015; Silva, Lucas C R/E-1202-2016; Silva, Lucas/GQH-8201-2022; Silva, Lucas/AAA-2476-2022; Feng, Yingang/B-6304-2008	Zhu-Barker, Xia/0000-0001-9050-3696; Silva, Lucas C R/0000-0002-4838-327X; Silva, Lucas/0000-0002-4838-327X; zhu, xinshu/0000-0002-2238-539X; He, Zhili/0000-0001-8225-7333; Feng, Yingang/0000-0002-0879-1316	California Department of Resources Recycling and Recovery [IWM09027]; J. G. Boswell Endowed Chair in Soil Science; University of California Agricultural Experiment Station	California Department of Resources Recycling and Recovery; J. G. Boswell Endowed Chair in Soil Science; University of California Agricultural Experiment Station(University of California System)	Support was provided by the California Department of Resources Recycling and Recovery (www.calrecycle.ca.gov), Agreement IWM09027; the J. G. Boswell Endowed Chair in Soil Science; and the University of California Agricultural Experiment Station (http://caes.ucdavis.edu/research/agexpstn). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bengtsson G, 2002, J CHEM SOC DALTON, P2548, DOI 10.1039/b201602h; BOUWMAN AF, 1993, GLOBAL BIOGEOCHEM CY, V7, P557, DOI 10.1029/93GB01186; Bouwman AF, 2002, GLOBAL BIOGEOCHEM CY, V16, DOI [10.1029/2001GB001811, 10.1029/2001GB001812]; BREMNER JM, 1946, NATURE, V158, P790, DOI 10.1038/158790b0; Bremner JM, 1997, NUTR CYCL AGROECOSYS, V49, P7, DOI 10.1023/A:1009798022569; BREMNER JM, 1980, SOIL BIOL BIOCHEM, V12, P263, DOI 10.1016/0038-0717(80)90072-3; BURESH RJ, 1976, J ENVIRON QUAL, V5, P320, DOI 10.2134/jeq1976.00472425000500030021x; Burger M, 2011, ACS SYM SER, V1072, P179; Burt R, 1992, 42 USDA; CASSEL DK, 1986, AGRONOMY, V9, P901; Chalamet A, 1976, SOIL BIOL BIOCHEM, V9, P281; CHAO TT, 1966, SOIL SCI SOC AM PRO, V30, P193, DOI 10.2136/sssaj1966.03615995003000020016x; Clement JC, 2005, SOIL BIOL BIOCHEM, V37, P2323, DOI 10.1016/j.soilbio.2005.03.027; Davidson EA, 2000, BIOSCIENCE, V50, P667, DOI 10.1641/0006-3568(2000)050[0667:TACMOS]2.0.CO;2; Doane TA, 2003, ANAL LETT, V36, P2713, DOI 10.1081/AL-120024647; Dobbie KE, 1999, J GEOPHYS RES-ATMOS, V104, P26891, DOI 10.1029/1999JD900378; Dominik P, 2000, TALANTA, V51, P701, DOI 10.1016/S0039-9140(99)00324-0; EICHNER MJ, 1990, J ENVIRON QUAL, V19, P272, DOI 10.2134/jeq1990.00472425001900020013x; Finzi AC, 2011, FRONT ECOL ENVIRON, V9, P74, DOI 10.1890/100137; Freibauer A, 2003, BIOGEOCHEMISTRY, V63, P93, DOI 10.1023/A:1023398108860; Freney JR, 1997, NUTR CYCL AGROECOSYS, V49, P1, DOI 10.1023/A:1009702832489; Glass JB, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00061; Goetz O., 2010, HDB PARTIAL LEAST SQ, P411, DOI [10.1007/978-3-540-32827-8_33, DOI 10.1007/978-3-540-32827-8]; HANSEN HCB, 1994, GEOCHIM COSMOCHIM AC, V58, P2599, DOI 10.1016/0016-7037(94)90131-7; HENDRICKSON AH, 1945, PLANT PHYSIOL, V20, P517, DOI 10.1104/pp.20.4.517; Li CS, 2000, J GEOPHYS RES-ATMOS, V105, P4369, DOI 10.1029/1999JD900949; LOVELAND PJ, 1984, J SOIL SCI, V35, P243, DOI 10.1111/j.1365-2389.1984.tb00280.x; LOVLEY DR, 1987, APPL ENVIRON MICROB, V53, P1536, DOI 10.1128/AEM.53.7.1536-1540.1987; Marcoulides GA, 2009, MIS QUART, V33, P171; MEIKLEJOHN J, 1953, J GEN MICROBIOL, V8, P58, DOI 10.1099/00221287-8-1-58; Reay DS, 2012, NAT CLIM CHANGE, V2, P410, DOI 10.1038/NCLIMATE1458; ROBERTSON K, 1994, J ENVIRON QUAL, V23, P805, DOI 10.2134/jeq1994.00472425002300040027x; Sahrawat K. L., 1986, Advances in Soil Science, USA, V4, P103; SCHUPPLI PA, 1983, SOIL SCI SOC AM J, V47, P1026, DOI 10.2136/sssaj1983.03615995004700050037x; Shrestha J, 2009, SOIL SCI, V174, P156, DOI 10.1097/SS.0b013e3181988fbf; Silver WL, 2011, IRON REDOX ENGINE DR; Singh BK, 2010, NAT REV MICROBIOL, V8, P779, DOI 10.1038/nrmicro2439; Skiba U., 2000, CHEMOSPHERE GLOBAL C, V2, P379, DOI DOI 10.1016/S1465-9972(00)00016-7; Stehfest E, 2006, NUTR CYCL AGROECOSYS, V74, P207, DOI 10.1007/s10705-006-9000-7; Straub KL, 1996, APPL ENVIRON MICROB, V62, P1458, DOI 10.1128/AEM.62.4.1458-1460.1996; Tenenhaus M, 2005, COMPUT STAT DATA AN, V48, P159, DOI 10.1016/j.csda.2004.03.005; Thomson AJ, 2012, PHILOS T R SOC B, V367, P1157, DOI 10.1098/rstb.2011.0415; Veihmeyer FJ, 1931, SOIL SCI, V32, P181, DOI 10.1097/00010694-193109000-00003; VERDOUW H, 1978, WATER RES, V12, P399, DOI 10.1016/0043-1354(78)90107-0; Weber KA, 2006, NAT REV MICROBIOL, V4, P752, DOI 10.1038/nrmicro1490; Williams EJ, 1992, GLOBAL BIOGEOCHEM CY, V6, P351, DOI 10.1029/92GB02124	46	194	208	28	177	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2013	8	3							e60146	10.1371/journal.pone.0060146	http://dx.doi.org/10.1371/journal.pone.0060146			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	121SG	23555906	Green Published, gold, Green Submitted			2022-12-25	WOS:000317263900060
J	Zhu, XY; Li, P; Yang, YB; Liu, ML				Zhu, Xin-Yuan; Li, Pei; Yang, Ya-Bing; Liu, Mei-Lin			Xuezhikang, Extract of Red Yeast Rice, Improved Abnormal Hemorheology, Suppressed Caveolin-1 and Increased eNOS Expression in Atherosclerotic Rats	PLOS ONE			English	Article							NITRIC-OXIDE SYNTHASE; BLOOD-CELLS; HEART-DISEASE; ERYTHROCYTES; VISCOSITY; AORTA; DEFORMABILITY; PATHOGENESIS; ACTIVATION; PATHWAY	Background: Xuezhikang is the extract of red yeast rice, which has been widely used for the management of atherosclerotic disease, but the molecular basis of its antiatherosclerotic effects has not yet been fully identified. Here we investigated the changes of eNOS in vascular endothelia and RBCs, eNOS regulatory factor Caveolin-1 in endothelia, and hemorheological parameters in atherosclerotic rats to explore the protective effects of Xuezhikang. Methodology/Principal Findings: Wistar rats were divided into 4 groups (n = 12/group) group C, controls; group M, high-cholesterol diet (HCD) induced atherosclerotic models; group X, HCD+Xuezhikang; and group L, HCD+Lovastatin. In group X, Xuezhikang inhibited oxidative stress, down-regulated caveolin-1 in aorta wall (P<0.05), up-regulated eNOS expression in vascular endothelia and erythrocytes (P<0.05), increased NOx (nitrite and nitrate) in plasma and cGMP in erythrocyte plasma and aorta wall (P<0.05), increased erythrocyte deformation index (EDI), and decreased whole blood viscosity and plasma viscosity (P<0.05), with the improvement of arterial pathology. Conclusions/Significance: Xuezhikang up-regulated eNOS expression in vascular endothelia and RBCs, increased plasma NOx and improved abnormal hemorheology in high cholesterol diet induced atherosclerotic rats. The elevated eNOS/NO and improved hemorheology may be beneficial to atherosclerotic disease.	[Zhu, Xin-Yuan; Li, Pei; Yang, Ya-Bing; Liu, Mei-Lin] Peking Univ, Dept Geriatr, Hosp 1, Beijing 100871, Peoples R China	Peking University	Liu, ML (corresponding author), Peking Univ, Dept Geriatr, Hosp 1, Beijing 100871, Peoples R China.	meilinliu@yahoo.com	Zhu-Barker, Xia/F-1520-2015; Silva, Lucas C R/E-1202-2016; Silva, Lucas/GQH-8201-2022; Silva, Lucas/AAA-2476-2022; Feng, Yingang/B-6304-2008	Zhu-Barker, Xia/0000-0001-9050-3696; Silva, Lucas C R/0000-0002-4838-327X; Silva, Lucas/0000-0002-4838-327X; zhu, xinshu/0000-0002-2238-539X; He, Zhili/0000-0001-8225-7333; Feng, Yingang/0000-0002-0879-1316	China Health & Medical Development Foundation	China Health & Medical Development Foundation	This work was supported by China Health & Medical Development Foundation (http://www.chmdf.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almofti MR, 2006, CLIN EXP PHARMACOL P, V33, P305, DOI 10.1111/j.1440-1681.2006.04366.x; Bor-Kucukatay M, 2003, AM J PHYSIOL-HEART C, V284, pH1577, DOI 10.1152/ajpheart.00665.2002; Chen LY, 1998, J CARDIOVASC PHARM, V32, P57, DOI 10.1097/00005344-199807000-00009; Cokic VP, 2008, BLOOD, V111, P1117, DOI 10.1182/blood-2007-05-088732; Cortese-Krott MM, 2012, BLOOD, V120, P4229, DOI 10.1182/blood-2012-07-442277; Crawford JH, 2006, BLOOD, V107, P566, DOI 10.1182/blood-2005-07-2668; Drab M, 2001, SCIENCE, V293, P2449, DOI 10.1126/science.1062688; Engel D, 2011, FASEB J, V25, P3838, DOI 10.1096/fj.11-183350; Feron O, 1998, J BIOL CHEM, V273, P3125, DOI 10.1074/jbc.273.6.3125; Gladwin MT, 2003, NAT MED, V9, P496, DOI 10.1038/nm0503-496; Gori T, 2011, CLIN HEMORHEOL MICRO, V49, P37, DOI 10.3233/CH-2011-1455; HAHN R, 1989, ANGIOLOGY, V40, P914, DOI 10.1177/000331978904001010; Herold S, 2004, INORG CHEM, V43, P3783, DOI 10.1021/ic035340a; Heyman SN, 1999, MICROCIRCULATION, V6, P199; Horn P, 2011, FREE RADICAL RES, V45, P653, DOI 10.3109/10715762.2011.574288; Huang ZY, 2004, LIFE SCI, V75, P3103, DOI 10.1016/j.lfs.2004.04.054; JORIS I, 1983, AM J PATHOL, V113, P341; Jubelin BC, 1996, AM J HYPERTENS, V9, P1214, DOI 10.1016/S0895-7061(96)00257-9; Kleinbongard P, 2006, BLOOD, V107, P2943, DOI 10.1182/blood-2005-10-3992; Koenig W, 1998, ARTERIOSCL THROM VAS, V18, P768, DOI 10.1161/01.ATV.18.5.768; Korbut RA, 2002, J PHYSIOL PHARMACOL, V53, P655; Kuhlencordt PJ, 2001, CIRCULATION, V104, P448, DOI 10.1161/hc2901.091399; Kuwai T, 2006, J ATHEROSCLER THROMB, V13, P286, DOI 10.5551/jat.13.286; Lam TY, 2006, EUR J PHARMACOL, V546, P134, DOI 10.1016/j.ejphar.2006.07.003; Laufs U, 1998, CIRCULATION, V97, P1129, DOI 10.1161/01.CIR.97.12.1129; Lee AJ, 1998, CIRCULATION, V97, P1467; Lee BK, 2008, CLIN HEMORHEOL MICRO, V39, P43, DOI 10.3233/CH-2008-1066; Li HG, 2000, J PATHOL, V190, P244, DOI 10.1002/(SICI)1096-9896(200002)190:3<244::AID-PATH575>3.0.CO;2-8; Li JJ, 2005, CLIN CHIM ACTA, V352, P217, DOI 10.1016/j.cccn.2004.09.026; Lu ZL, 2008, AM J CARDIOL, V101, P1689, DOI 10.1016/j.amjcard.2008.02.056; Ma JY, 2000, J AGR FOOD CHEM, V48, P5220, DOI 10.1021/jf000338c; MONCADA S, 1991, PHARMACOL REV, V43, P109; Ozuyaman B, 2008, TRENDS MOL MED, V14, P314, DOI 10.1016/j.molmed.2008.05.002; Pawloski JR, 2001, NATURE, V409, P622, DOI 10.1038/35054560; Rassaf T, 2003, NAT MED, V9, P481, DOI 10.1038/nm0503-481; Recchia FA, 2000, AM J PHYSIOL-HEART C, V279, pH852, DOI 10.1152/ajpheart.2000.279.2.H852; Toda N, 2011, INT J ANGIOL, V20, P121, DOI 10.1055/s-0031-1283220; Tsuda K, 2000, BIOCHEM BIOPH RES CO, V275, P946, DOI 10.1006/bbrc.2000.3408; Xue ZH, 2007, CLIN EXP PHARMACOL P, V34, P27, DOI 10.1111/j.1440-1681.2007.04547.x; Zorio E, 2008, CLIN HEMORHEOL MICRO, V39, P33, DOI 10.3233/CH-2008-1065	40	194	208	28	177	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 10	2013	8	5							e62731	10.1371/journal.pone.0062731	http://dx.doi.org/10.1371/journal.pone.0062731			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	143FO	23555906	Green Submitted, gold, Green Published			2022-12-25	WOS:000318852400008
